Inclusion NCT03931772 0 9 O
Criteria NCT03931772 10 18 O
: NCT03931772 19 20 O

- NCT03931772 24 25 O
18 NCT03931772 28 30 B-Eq-Value
years NCT03931772 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03931772 37 39 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03931772 40 45 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03931772 48 49 O
Able NCT03931772 51 55 O
to NCT03931772 56 58 O
read NCT03931772 59 63 O
and NCT03931772 64 67 O
understand NCT03931772 68 78 O
English NCT03931772 79 86 B-Language

- NCT03931772 89 90 O
Desire NCT03931772 92 98 O
to NCT03931772 99 101 O
quit NCT03931772 102 106 B-Condition-Name
smoking NCT03931772 107 114 I-Condition-Name
( NCT03931772 115 116 O
specifically NCT03931772 117 129 O
, NCT03931772 130 131 O
report NCT03931772 132 138 O
a NCT03931772 139 140 O
motivation NCT03931772 141 151 O
of NCT03931772 152 154 O
≥ NCT03931772 155 156 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03931772 158 159 B-Eq-Value
out NCT03931772 160 163 B-Eq-Operator___Eq-Operator-Value:BETWEEN
of NCT03931772 164 166 I-Eq-Operator___Eq-Operator-Value:BETWEEN
10 NCT03931772 168 170 B-Eq-Value
to NCT03931772 171 173 O
quit NCT03931772 174 178 B-Condition-Name
smoking NCT03931772 179 186 I-Condition-Name
on NCT03931772 187 189 O
a NCT03931772 190 191 O
10 NCT03931772 193 195 O
- NCT03931772 196 197 O
point NCT03931772 198 203 O
Likert NCT03931772 204 210 O
- NCT03931772 211 212 O
type NCT03931772 213 217 O
scale NCT03931772 218 223 O
) NCT03931772 224 225 O

- NCT03931772 229 230 O
Having NCT03931772 232 238 O
access NCT03931772 239 245 O
to NCT03931772 246 248 O
wireless NCT03931772 249 257 O
internet NCT03931772 258 266 O
connection NCT03931772 267 277 O
or NCT03931772 278 280 O
mobile NCT03931772 281 287 O
data NCT03931772 288 292 O

- NCT03931772 295 296 O
Reporting NCT03931772 298 307 O
being NCT03931772 308 313 O
a NCT03931772 314 315 O
daily NCT03931772 316 321 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
smoker NCT03931772 322 328 B-Condition-Name
for NCT03931772 329 332 O
at NCT03931772 333 335 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03931772 336 341 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03931772 342 345 B-Eq-Value
year NCT03931772 346 350 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03931772 351 352 O
smoking NCT03931772 353 360 B-Condition-Name
an NCT03931772 361 363 O
average NCT03931772 364 371 O
≥ NCT03931772 372 373 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03931772 375 376 B-Eq-Value
cigarettes NCT03931772 377 387 B-Eq-Unit
per NCT03931772 388 391 O
day NCT03931772 392 395 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

Exclusion NCT03931772 396 405 O
Criteria NCT03931772 406 414 O
: NCT03931772 415 416 O

- NCT03931772 420 421 O
Meeting NCT03931772 423 430 O
criteria NCT03931772 431 439 O
for NCT03931772 440 443 O
drug NCT03931772 444 448 B-Condition-Name
abuse NCT03931772 449 454 I-Condition-Name
of NCT03931772 455 457 O
depressants NCT03931772 458 469 B-Drug-Name
, NCT03931772 470 471 O
dissociative NCT03931772 472 484 B-Drug-Name
anesthetics NCT03931772 485 496 I-Drug-Name
, NCT03931772 497 498 O
hallucinogens NCT03931772 499 512 B-Drug-Name
, NCT03931772 513 514 O
opioids NCT03931772 515 522 B-Drug-Name
, NCT03931772 523 524 O
cocaine NCT03931772 525 532 B-Drug-Name
, NCT03931772 533 534 O
or NCT03931772 535 537 O
amphetamine NCT03931772 538 549 B-Drug-Name
within NCT03931772 550 556 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03931772 557 560 I-Eq-Operator___Eq-Operator-Value:LTEQ
last NCT03931772 561 565 I-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03931772 567 568 B-Eq-Value
months NCT03931772 569 575 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03931772 576 577 O

- NCT03931772 581 582 O
Severe NCT03931772 584 590 B-Severity___Severity-Value:severe
psychiatric NCT03931772 591 602 O
or NCT03931772 603 605 O
structural NCT03931772 606 616 O
brain NCT03931772 617 622 B-Condition-Name
disease NCT03931772 623 630 I-Condition-Name
( NCT03931772 631 632 O
i NCT03931772 633 634 O
. NCT03931772 635 636 O
e NCT03931772 637 638 O
. NCT03931772 639 640 O
psychosis NCT03931772 642 651 B-Condition-Name
, NCT03931772 652 653 O
stroke NCT03931772 654 660 B-Condition-Name
with NCT03931772 661 665 O
functional NCT03931772 666 676 B-Condition-Name
impairment NCT03931772 677 687 I-Condition-Name
, NCT03931772 688 689 O
dementia NCT03931772 690 698 B-Condition-Name
) NCT03931772 699 700 O
or NCT03931772 701 703 O
[ NCT03931772 704 705 O
current NCT03931772 706 713 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
/ NCT03931772 714 715 O
recent NCT03931772 716 722 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
risk NCT03931772 723 727 B-Condition-Name
to NCT03931772 728 730 I-Condition-Name
self NCT03931772 731 735 I-Condition-Name
. NCT03931772 736 737 O
Indicated NCT03931772 739 748 O
by NCT03931772 749 751 O
denial NCT03931772 752 758 O
of NCT03931772 759 761 O
question NCT03931772 762 770 O
pertaining NCT03931772 771 781 O
to NCT03931772 782 784 O
inpatient NCT03931772 785 794 B-Encounter-Type___Encounter-Type-Value:inpatient
hospitalization NCT03931772 795 810 I-Encounter-Type___Encounter-Type-Value:inpatient

- NCT03931772 813 814 O
Hearing NCT03931772 816 823 B-Condition-Name
impairment NCT03931772 824 834 I-Condition-Name
that NCT03931772 835 839 O
would NCT03931772 840 845 O
impede NCT03931772 846 852 B-Stability___Stability-Value:change
ability NCT03931772 853 860 O
to NCT03931772 861 863 O
listen NCT03931772 864 870 O
the NCT03931772 871 874 O
auditory NCT03931772 875 883 O
intervention NCT03931772 884 896 O

- NCT03931772 899 900 O
Major NCT03931772 902 907 B-Severity___Severity-Value:severe
illnesses NCT03931772 908 917 O
impacting NCT03931772 918 927 B-Stability___Stability-Value:change
the NCT03931772 928 931 O
study NCT03931772 932 937 O
results NCT03931772 938 945 O

- NCT03931772 948 949 O
Currently NCT03931772 951 960 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03931772 961 967 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Wellbutrin NCT03931772 968 978 B-Drug-Name
, NCT03931772 979 980 O
Chantix NCT03931772 981 988 B-Drug-Name
, NCT03931772 989 990 O
or NCT03931772 991 993 O
other NCT03931772 994 999 O
pharmacological NCT03931772 1000 1015 O
smoking NCT03931772 1016 1023 B-Drug-Name
cessation NCT03931772 1024 1033 I-Drug-Name
aids NCT03931772 1034 1038 I-Drug-Name
that NCT03931772 1039 1043 O
could NCT03931772 1044 1049 O
confound NCT03931772 1050 1058 B-Stability___Stability-Value:change
results NCT03931772 1059 1066 O
of NCT03931772 1067 1069 O
the NCT03931772 1070 1073 O
study NCT03931772 1074 1079 O

Inclusion NCT03931941 0 9 O
Criteria NCT03931941 10 18 O
: NCT03931941 19 20 O

1 NCT03931941 25 26 O
. NCT03931941 26 27 O
≥ NCT03931941 29 30 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03931941 32 34 B-Eq-Value
years NCT03931941 35 40 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03931941 41 44 O
. NCT03931941 45 46 O

2 NCT03931941 51 52 O
. NCT03931941 52 53 O
Medical NCT03931941 55 62 O
record NCT03931941 63 69 O
documentation NCT03931941 70 83 O
of NCT03931941 84 86 O
either NCT03931941 87 93 O
: NCT03931941 94 95 O
a NCT03931941 96 97 O
) NCT03931941 98 99 O
recurrent NCT03931941 100 109 O
CDI NCT03931941 110 113 B-Condition-Name
per NCT03931941 114 117 O
the NCT03931941 118 121 O
study NCT03931941 122 127 O
definition NCT03931941 128 138 O
, NCT03931941 139 140 O
that NCT03931941 141 145 O
includes NCT03931941 146 154 O
at NCT03931941 155 157 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03931941 158 163 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03931941 164 167 B-Eq-Value
recurrence NCT03931941 168 178 O
after NCT03931941 179 184 O
a NCT03931941 185 186 O
primary NCT03931941 187 194 O
episode NCT03931941 195 202 O
and NCT03931941 203 206 O
has NCT03931941 207 210 O
completed NCT03931941 211 220 O
at NCT03931941 221 223 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03931941 224 229 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03931941 230 233 B-Eq-Value
round NCT03931941 234 239 O
of NCT03931941 240 242 O
standard NCT03931941 243 251 O
- NCT03931941 252 253 O
of NCT03931941 254 256 O
- NCT03931941 257 258 O
care NCT03931941 259 263 O
oral NCT03931941 264 268 B-Procedure-Name
antibiotic NCT03931941 269 279 I-Procedure-Name
therapy NCT03931941 280 287 I-Procedure-Name
, NCT03931941 288 289 O
b NCT03931941 290 291 O
) NCT03931941 292 293 O
or NCT03931941 294 296 O
has NCT03931941 297 300 O
had NCT03931941 301 304 O
at NCT03931941 305 307 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03931941 308 313 I-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03931941 314 317 B-Eq-Value
episodes NCT03931941 318 326 O
of NCT03931941 327 329 O
severe NCT03931941 330 336 B-Severity___Severity-Value:severe
CDI NCT03931941 337 340 B-Condition-Name
resulting NCT03931941 341 350 O
in NCT03931941 351 353 O
hospitalization NCT03931941 354 369 B-Encounter-Type___Encounter-Type-Value:inpatient
. NCT03931941 370 371 O

3 NCT03931941 376 377 O
. NCT03931941 377 378 O
A NCT03931941 380 381 O
positive NCT03931941 382 390 B-Polarity___Polarity-Value:positive
stool NCT03931941 391 396 B-Observation-Specimen
test NCT03931941 397 401 B-Observation-Name___Observation-Type-Value:lab
for NCT03931941 402 405 O
the NCT03931941 406 409 O
presence NCT03931941 410 418 O
of NCT03931941 419 421 O
toxigenic NCT03931941 422 431 B-Organism-Name
C NCT03931941 432 433 I-Organism-Name
. NCT03931941 434 435 I-Organism-Name
difficile NCT03931941 437 446 I-Organism-Name
or NCT03931941 447 449 O
C NCT03931941 450 451 B-Organism-Name
. NCT03931941 452 453 I-Organism-Name
difficile NCT03931941 455 464 I-Organism-Name
toxin NCT03931941 465 470 I-Organism-Name
within NCT03931941 471 477 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
30 NCT03931941 479 481 B-Eq-Value
days NCT03931941 482 486 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03931941 487 492 O
to NCT03931941 493 495 O
or NCT03931941 496 498 O
on NCT03931941 499 501 O
the NCT03931941 502 505 O
date NCT03931941 506 510 O
of NCT03931941 511 513 O
enrollment NCT03931941 514 524 O
. NCT03931941 525 526 O

4 NCT03931941 531 532 O
. NCT03931941 532 533 O
Is NCT03931941 535 537 O
currently NCT03931941 538 547 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03931941 548 554 O
or NCT03931941 555 557 O
was NCT03931941 558 561 O
just NCT03931941 562 566 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
prescribed NCT03931941 567 577 O
antibiotics NCT03931941 578 589 B-Drug-Name
to NCT03931941 590 592 O
control NCT03931941 593 600 O
CDI NCT03931941 601 604 B-Condition-Name
related NCT03931941 605 612 O
diarrhea NCT03931941 613 621 B-Condition-Name
at NCT03931941 622 624 O
the NCT03931941 625 628 O
time NCT03931941 629 633 O
of NCT03931941 634 636 O
enrollment NCT03931941 637 647 O
. NCT03931941 648 649 O

[ NCT03931941 652 653 O
Note NCT03931941 654 658 O
: NCT03931941 659 660 O
Subject NCT03931941 661 668 O
's NCT03931941 668 670 O
CDI NCT03931941 671 674 B-Condition-Name
diarrhea NCT03931941 675 683 B-Condition-Name
must NCT03931941 684 688 O
be NCT03931941 689 691 O
controlled NCT03931941 692 702 O
( NCT03931941 703 704 O
< NCT03931941 706 707 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03931941 709 710 B-Eq-Value
unformed NCT03931941 711 719 O
/ NCT03931941 720 721 O
loose NCT03931941 722 727 O
stools NCT03931941 728 734 B-Eq-Unit
/ NCT03931941 735 736 O
day NCT03931941 737 740 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03931941 741 742 O
while NCT03931941 743 748 O

taking NCT03931941 749 755 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antibiotics NCT03931941 756 767 B-Drug-Name
during NCT03931941 768 774 O
screening NCT03931941 775 784 O
. NCT03931941 785 786 O
] NCT03931941 787 788 O

Exclusion NCT03931941 790 799 O
Criteria NCT03931941 800 808 O
: NCT03931941 809 810 O

1 NCT03931941 815 816 O
. NCT03931941 816 817 O
Has NCT03931941 819 822 O
continued NCT03931941 823 832 B-Stability___Stability-Value:stable
CDI NCT03931941 833 836 B-Condition-Name
diarrhea NCT03931941 837 845 B-Condition-Name
despite NCT03931941 846 853 O
being NCT03931941 854 859 O
on NCT03931941 860 862 O
a NCT03931941 863 864 O
course NCT03931941 865 871 O
of NCT03931941 872 874 O
antibiotics NCT03931941 875 886 B-Drug-Name
prescribed NCT03931941 887 897 O
for NCT03931941 898 901 O
CDI NCT03931941 902 905 B-Condition-Name
treatment NCT03931941 906 915 O
. NCT03931941 916 917 O

2 NCT03931941 922 923 O
. NCT03931941 923 924 O
Requires NCT03931941 926 934 O
systemic NCT03931941 935 943 O
antibiotic NCT03931941 944 954 B-Procedure-Name
therapy NCT03931941 955 962 I-Procedure-Name
for NCT03931941 963 966 O
a NCT03931941 967 968 O
condition NCT03931941 969 978 O
other NCT03931941 979 984 O
than NCT03931941 985 989 O
CDI NCT03931941 990 993 B-Condition-Name
. NCT03931941 994 995 O

3 NCT03931941 1000 1001 O
. NCT03931941 1001 1002 O
Fecal NCT03931941 1004 1009 B-Procedure-Name
microbiota NCT03931941 1010 1020 I-Procedure-Name
transplant NCT03931941 1021 1031 I-Procedure-Name
( NCT03931941 1032 1033 O
FMT NCT03931941 1034 1037 B-Procedure-Name
) NCT03931941 1038 1039 O
within NCT03931941 1040 1046 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
the NCT03931941 1047 1050 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
past NCT03931941 1051 1055 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03931941 1057 1058 B-Eq-Value
months NCT03931941 1059 1065 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03931941 1066 1067 O

4 NCT03931941 1072 1073 O
. NCT03931941 1073 1074 O
FMT NCT03931941 1076 1079 B-Procedure-Name
with NCT03931941 1080 1084 O
an NCT03931941 1085 1087 O
associated NCT03931941 1088 1098 O
serious NCT03931941 1099 1106 B-Severity___Severity-Value:severe
adverse NCT03931941 1107 1114 B-Observation-Name
event NCT03931941 1115 1120 I-Observation-Name
related NCT03931941 1121 1128 O
to NCT03931941 1129 1131 O
the NCT03931941 1132 1135 O
FMT NCT03931941 1136 1139 B-Procedure-Name
product NCT03931941 1140 1147 O
or NCT03931941 1148 1150 O
procedure NCT03931941 1151 1160 O
. NCT03931941 1161 1162 O

5 NCT03931941 1167 1168 O
. NCT03931941 1168 1169 O
Bezlotoxumab NCT03931941 1171 1183 B-Drug-Name
( NCT03931941 1184 1185 O
CDI NCT03931941 1186 1189 B-Condition-Name
monoclonal NCT03931941 1190 1200 B-Drug-Name
antibodies NCT03931941 1201 1211 I-Drug-Name
) NCT03931941 1212 1213 O
if NCT03931941 1214 1216 O
received NCT03931941 1217 1225 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
within NCT03931941 1226 1232 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
the NCT03931941 1233 1236 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
last NCT03931941 1237 1241 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03931941 1242 1246 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03931941 1247 1248 O

6 NCT03931941 1253 1254 O
. NCT03931941 1254 1255 O
CD NCT03931941 1257 1259 B-Observation-Name___Observation-Type-Value:lab
4 NCT03931941 1260 1261 I-Observation-Name___Observation-Type-Value:lab
count NCT03931941 1262 1267 I-Observation-Name___Observation-Type-Value:lab
< NCT03931941 1268 1269 B-Eq-Operator___Eq-Operator-Value:LT
200 NCT03931941 1271 1274 B-Eq-Value
/ NCT03931941 1275 1276 O
mm NCT03931941 1277 1279 B-Eq-Unit
3 NCT03931941 1280 1281 I-Eq-Unit
during NCT03931941 1282 1288 O
Screening NCT03931941 1289 1298 O
. NCT03931941 1299 1300 O

7 NCT03931941 1305 1306 O
. NCT03931941 1306 1307 O
An NCT03931941 1309 1311 O
absolute NCT03931941 1312 1320 B-Observation-Name___Observation-Type-Value:lab
neutrophil NCT03931941 1321 1331 I-Observation-Name___Observation-Type-Value:lab
count NCT03931941 1332 1337 I-Observation-Name___Observation-Type-Value:lab
of NCT03931941 1338 1340 O
< NCT03931941 1341 1342 B-Eq-Operator___Eq-Operator-Value:LT
1000 NCT03931941 1344 1348 B-Eq-Value
cells NCT03931941 1349 1354 B-Eq-Unit
/ NCT03931941 1355 1356 O
µL NCT03931941 1357 1359 B-Eq-Temporal-Unit
during NCT03931941 1360 1366 O
Screening NCT03931941 1367 1376 O
. NCT03931941 1377 1378 O

8 NCT03931941 1383 1384 O
. NCT03931941 1384 1385 O
Pregnant NCT03931941 1387 1395 B-Condition-Name
, NCT03931941 1396 1397 O
breastfeeding NCT03931941 1398 1411 B-Condition-Name
, NCT03931941 1412 1413 O
or NCT03931941 1414 1416 O
intends NCT03931941 1417 1424 O
to NCT03931941 1425 1427 O
become NCT03931941 1428 1434 O
pregnant NCT03931941 1435 1443 B-Condition-Name
during NCT03931941 1444 1450 O
study NCT03931941 1451 1456 O
participation NCT03931941 1457 1470 O
. NCT03931941 1471 1472 O

Inclusion NCT03930108 0 9 O
Criteria NCT03930108 10 18 O
: NCT03930108 19 20 O

- NCT03930108 24 25 O
adult NCT03930108 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03930108 33 41 O
( NCT03930108 42 43 O
age NCT03930108 44 47 O
18 NCT03930108 49 51 B-Eq-Value
and NCT03930108 52 55 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03930108 56 61 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03930108 62 63 O
who NCT03930108 64 67 O
admitted NCT03930108 68 76 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03930108 77 79 O
burn NCT03930108 80 84 B-Location___Location-Value:unit
unit NCT03930108 85 89 I-Location___Location-Value:unit
during NCT03930108 90 96 O
sampling NCT03930108 97 105 O
period NCT03930108 106 112 O

Exclusion NCT03930108 113 122 O
Criteria NCT03930108 123 131 O
: NCT03930108 132 133 O

- NCT03930108 137 138 O
patients NCT03930108 140 148 O
discharged NCT03930108 149 159 B-Encounter-Type___Encounter-Type-Value:discharge
or NCT03930108 160 162 O
deceased NCT03930108 163 171 O
less NCT03930108 172 176 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03930108 177 181 I-Eq-Operator___Eq-Operator-Value:LT
24 NCT03930108 183 185 B-Eq-Value
hours NCT03930108 186 191 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03930108 192 194 O
admission NCT03930108 195 204 B-Encounter-Type___Encounter-Type-Value:inpatient

- NCT03930108 207 208 O
patients NCT03930108 210 218 O
referred NCT03930108 219 227 B-Encounter-Type___Encounter-Type-Value:referral
to NCT03930108 228 230 O
other NCT03930108 231 236 O
hospital NCT03930108 237 245 B-Location___Location-Value:hospital
within NCT03930108 246 252 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03930108 254 256 B-Eq-Value
days NCT03930108 257 261 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
admission NCT03930108 262 271 B-Encounter-Type___Encounter-Type-Value:inpatient

Inclusion NCT03930134 0 9 O
Criteria NCT03930134 10 18 O
: NCT03930134 19 20 O

- NCT03930134 24 25 O
singleton NCT03930134 27 36 O
pregnancy NCT03930134 37 46 B-Condition-Name

- NCT03930134 49 50 O
Cicatricial NCT03930134 52 63 B-Condition-Name
uterus NCT03930134 64 70 I-Condition-Name
with NCT03930134 71 75 O
contraindication NCT03930134 76 92 O
to NCT03930134 93 95 O
vaginal NCT03930134 96 103 B-Procedure-Name
delivery NCT03930134 104 112 I-Procedure-Name
( NCT03930134 113 114 O
uterus NCT03930134 115 121 B-Condition-Name
bi NCT03930134 122 124 O
or NCT03930134 125 127 O
multi NCT03930134 128 133 O
- NCT03930134 134 135 O
cicatricial NCT03930134 136 147 O
, NCT03930134 148 149 O
corporal NCT03930134 150 158 B-Condition-Name
uterine NCT03930134 159 166 I-Condition-Name
scar NCT03930134 167 171 I-Condition-Name
, NCT03930134 172 173 O
intra NCT03930134 174 179 B-Procedure-Name
- NCT03930134 180 181 I-Procedure-Name
mural NCT03930134 182 187 I-Procedure-Name
myomectomy NCT03930134 188 198 I-Procedure-Name
, NCT03930134 199 200 O
dystocic NCT03930134 201 209 B-Condition-Name
presentation NCT03930134 210 222 I-Condition-Name
) NCT03930134 223 224 O

- NCT03930134 228 229 O
Fetal NCT03930134 231 236 B-Condition-Name
macrosomia NCT03930134 237 247 I-Condition-Name
with NCT03930134 248 252 O
a NCT03930134 253 254 O
weight NCT03930134 255 261 B-Observation-Name___Observation-Type-Value:vital
greater NCT03930134 262 269 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03930134 270 274 I-Eq-Operator___Eq-Operator-Value:GT
4 NCT03930134 276 277 B-Eq-Value
Kg NCT03930134 278 280 B-Eq-Unit

- NCT03930134 283 284 O
Placenta NCT03930134 286 294 B-Condition-Name
previa NCT03930134 295 301 I-Condition-Name

Exclusion NCT03930134 302 311 O
Criteria NCT03930134 312 320 O
: NCT03930134 321 322 O

- NCT03930134 326 327 O
Patients NCT03930134 329 337 O
who NCT03930134 338 341 O
refuse NCT03930134 342 348 O
to NCT03930134 349 351 O
participate NCT03930134 352 363 O
in NCT03930134 364 366 O
the NCT03930134 367 370 O
study NCT03930134 371 376 O

- NCT03930134 379 380 O
prenatally NCT03930134 382 392 O
diagnosed NCT03930134 393 402 O
fetal NCT03930134 403 408 B-Condition-Name
pathology NCT03930134 409 418 I-Condition-Name
( NCT03930134 419 420 O
intrauterine NCT03930134 421 433 B-Condition-Name
growth NCT03930134 434 440 I-Condition-Name
restriction NCT03930134 441 452 I-Condition-Name
, NCT03930134 453 454 O
malformation NCT03930134 455 467 B-Condition-Name
, NCT03930134 468 469 O
genetics NCT03930134 470 478 B-Condition-Name
disorders NCT03930134 479 488 I-Condition-Name
) NCT03930134 489 490 O

- NCT03930134 494 495 O
adherent NCT03930134 497 505 B-Condition-Name
placenta NCT03930134 506 514 I-Condition-Name
, NCT03930134 515 516 O
an NCT03930134 517 519 O
adnexal NCT03930134 520 527 B-Condition-Name
mass NCT03930134 528 532 I-Condition-Name
or NCT03930134 533 535 O
a NCT03930134 536 537 O
myoma NCT03930134 538 543 B-Condition-Name
at NCT03930134 544 546 I-Condition-Name
the NCT03930134 547 550 I-Condition-Name
lower NCT03930134 551 556 I-Condition-Name
uterine NCT03930134 557 564 I-Condition-Name
segment NCT03930134 565 572 I-Condition-Name

- NCT03930134 575 576 O
Cesarean NCT03930134 578 586 B-Procedure-Name
section NCT03930134 587 594 I-Procedure-Name
in NCT03930134 595 597 O
a NCT03930134 598 599 O
context NCT03930134 600 607 O
of NCT03930134 608 610 O
medical NCT03930134 611 618 O
or NCT03930134 619 621 O
obstetrical NCT03930134 622 633 O
emergency NCT03930134 634 643 B-Observation-Name

- NCT03930134 646 647 O
Caesarean NCT03930134 649 658 B-Procedure-Name
section NCT03930134 659 666 I-Procedure-Name
with NCT03930134 667 671 O
a NCT03930134 672 673 O
high NCT03930134 674 678 B-Polarity___Polarity-Value:high
risk NCT03930134 679 683 O
of NCT03930134 684 686 O
bleeding NCT03930134 687 695 B-Condition-Name

Inclusion NCT03932045 0 9 O
Criteria NCT03932045 10 18 O
: NCT03932045 19 20 O

1 NCT03932045 25 26 O
. NCT03932045 26 27 O
Individuals NCT03932045 29 40 O
who NCT03932045 41 44 O
desire NCT03932045 45 51 O
an NCT03932045 52 54 O
improvement NCT03932045 55 66 O
in NCT03932045 67 69 O
the NCT03932045 70 73 O
appearance NCT03932045 74 84 B-Observation-Name
of NCT03932045 85 87 I-Observation-Name
the NCT03932045 88 91 I-Observation-Name
nasolabial NCT03932045 92 102 I-Observation-Name
fold NCT03932045 103 107 I-Observation-Name
on NCT03932045 108 110 O
both NCT03932045 111 115 O
sides NCT03932045 116 121 O
of NCT03932045 122 124 O
the NCT03932045 125 128 O
face NCT03932045 129 133 O
and NCT03932045 134 137 O
who NCT03932045 138 141 O
have NCT03932045 142 146 O
a NCT03932045 147 148 O
score NCT03932045 149 154 B-Eq-Unit
of NCT03932045 155 157 O
3 NCT03932045 159 160 B-Eq-Value
or NCT03932045 161 163 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03932045 165 166 B-Eq-Value
on NCT03932045 167 169 O
the NCT03932045 170 173 O
Wrinkle NCT03932045 174 181 B-Observation-Name___Observation-Type-Value:clinical-score
Severity NCT03932045 182 190 I-Observation-Name___Observation-Type-Value:clinical-score
Rating NCT03932045 191 197 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03932045 198 203 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03932045 204 205 O
WSRS NCT03932045 206 210 B-Observation-Name
) NCT03932045 211 212 O

2 NCT03932045 217 218 O
. NCT03932045 218 219 O
Individuals NCT03932045 221 232 O
who NCT03932045 233 236 O
have NCT03932045 237 241 O
consented NCT03932045 242 251 O
to NCT03932045 252 254 O
abstain NCT03932045 255 262 O
from NCT03932045 263 267 O
any NCT03932045 268 271 O
other NCT03932045 272 277 O
dermatological NCT03932045 278 292 B-Procedure-Name
procedures NCT03932045 293 303 I-Procedure-Name
or NCT03932045 304 306 O
treatments NCT03932045 307 317 O
, NCT03932045 318 319 O
including NCT03932045 320 329 O
treatments NCT03932045 330 340 O
for NCT03932045 341 344 O
wrinkle NCT03932045 345 352 B-Procedure-Name
reduction NCT03932045 353 362 I-Procedure-Name
in NCT03932045 363 365 O
the NCT03932045 366 369 O
facial NCT03932045 370 376 O
area NCT03932045 377 381 O
, NCT03932045 382 383 O
during NCT03932045 384 390 O
the NCT03932045 391 394 O
duration NCT03932045 395 403 O
of NCT03932045 404 406 O
this NCT03932045 407 411 O
study NCT03932045 412 417 O
. NCT03932045 418 419 O

Exclusion NCT03932045 421 430 O
Criteria NCT03932045 431 439 O
: NCT03932045 440 441 O

1 NCT03932045 446 447 O
. NCT03932045 447 448 O
Administered NCT03932045 450 462 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
an NCT03932045 463 465 O
anticoagulant NCT03932045 466 479 B-Drug-Name
( NCT03932045 480 481 O
with NCT03932045 482 486 O
the NCT03932045 487 490 O
exception NCT03932045 491 500 O
of NCT03932045 501 503 O
low NCT03932045 504 507 B-Eq-Value
dosage NCT03932045 508 514 O
aspirin NCT03932045 515 522 B-Drug-Name
( NCT03932045 523 524 O
100 NCT03932045 526 529 B-Eq-Value
mg NCT03932045 530 532 B-Eq-Unit
, NCT03932045 533 534 O
up NCT03932045 535 537 B-Eq-Operator___Eq-Operator-Value:BETWEEN
to NCT03932045 538 540 I-Eq-Operator___Eq-Operator-Value:BETWEEN
300 NCT03932045 542 545 B-Eq-Value
mg NCT03932045 546 548 B-Eq-Unit
/ NCT03932045 549 550 O
day NCT03932045 551 554 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03932045 555 556 O
) NCT03932045 558 559 O
within NCT03932045 560 566 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03932045 568 569 B-Eq-Value
weeks NCT03932045 570 575 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03932045 576 578 O
the NCT03932045 579 582 O
date NCT03932045 583 587 O
of NCT03932045 588 590 O
the NCT03932045 591 594 O
screening NCT03932045 595 604 O

2 NCT03932045 608 609 O
. NCT03932045 609 610 O
Administered NCT03932045 612 624 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Vitamin NCT03932045 625 632 B-Drug-Name
E NCT03932045 633 634 I-Drug-Name
or NCT03932045 635 637 O
non NCT03932045 638 641 B-Drug-Name
- NCT03932045 642 643 I-Drug-Name
steroidal NCT03932045 644 653 I-Drug-Name
anti NCT03932045 654 658 I-Drug-Name
- NCT03932045 659 660 I-Drug-Name
inflammatory NCT03932045 661 673 I-Drug-Name
drugs NCT03932045 674 679 I-Drug-Name
or NCT03932045 680 682 O
Collagen NCT03932045 683 691 B-Drug-Name
within NCT03932045 692 698 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03932045 700 701 B-Eq-Value
week NCT03932045 702 706 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03932045 707 709 O
the NCT03932045 710 713 O
date NCT03932045 714 718 O
of NCT03932045 719 721 O
the NCT03932045 722 725 O
screening NCT03932045 726 735 O
, NCT03932045 736 737 O
or NCT03932045 738 740 O
who NCT03932045 741 744 O
require NCT03932045 745 752 O
these NCT03932045 753 758 O
during NCT03932045 759 765 O
the NCT03932045 766 769 O
period NCT03932045 770 776 O
of NCT03932045 777 779 O
the NCT03932045 780 783 O
study NCT03932045 784 789 O

3 NCT03932045 793 794 O
. NCT03932045 794 795 O
History NCT03932045 797 804 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03932045 805 807 O
bleeding NCT03932045 808 816 B-Condition-Name
disorder NCT03932045 817 825 I-Condition-Name
in NCT03932045 826 828 O
past NCT03932045 829 833 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03932045 834 836 O
present NCT03932045 837 844 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present

4 NCT03932045 848 849 O
. NCT03932045 849 850 O
Received NCT03932045 852 860 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
deep NCT03932045 861 865 B-Procedure-Name
- NCT03932045 866 867 I-Procedure-Name
peeling NCT03932045 868 875 I-Procedure-Name
, NCT03932045 876 877 O
skin NCT03932045 878 882 B-Procedure-Name
regeneration NCT03932045 883 895 I-Procedure-Name
, NCT03932045 896 897 O
plastic NCT03932045 898 905 B-Procedure-Name
surgery NCT03932045 906 913 I-Procedure-Name
( NCT03932045 914 915 O
including NCT03932045 916 925 O
botulinum NCT03932045 926 935 B-Procedure-Name
toxin NCT03932045 936 941 I-Procedure-Name
injection NCT03932045 942 951 I-Procedure-Name
) NCT03932045 952 953 O
, NCT03932045 955 956 O
wrinkle NCT03932045 957 964 B-Procedure-Name
improvement NCT03932045 965 976 I-Procedure-Name
or NCT03932045 977 979 O
acne NCT03932045 980 984 B-Procedure-Name
scar NCT03932045 985 989 I-Procedure-Name
treatment NCT03932045 990 999 I-Procedure-Name
in NCT03932045 1000 1002 O
the NCT03932045 1003 1006 O
facial NCT03932045 1007 1013 O
area NCT03932045 1014 1018 O
within NCT03932045 1019 1025 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03932045 1027 1029 B-Eq-Value
weeks NCT03932045 1030 1035 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03932045 1036 1038 O
the NCT03932045 1039 1042 O
date NCT03932045 1043 1047 O
of NCT03932045 1048 1050 O
the NCT03932045 1051 1054 O
screening NCT03932045 1055 1064 O

5 NCT03932045 1068 1069 O
. NCT03932045 1069 1070 O
Administered NCT03932045 1072 1084 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
an NCT03932045 1085 1087 O
hyaluronic NCT03932045 1088 1098 B-Drug-Name
acid NCT03932045 1099 1103 I-Drug-Name
filler NCT03932045 1104 1110 I-Drug-Name
within NCT03932045 1111 1117 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03932045 1119 1121 B-Eq-Value
weeks NCT03932045 1122 1127 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03932045 1128 1130 O
the NCT03932045 1131 1134 O
date NCT03932045 1135 1139 O
of NCT03932045 1140 1142 O
the NCT03932045 1143 1146 O
screening NCT03932045 1147 1156 O


Inclusion NCT03934346 0 9 O
Criteria NCT03934346 10 18 O
: NCT03934346 19 20 O

- NCT03934346 24 25 O
Apparently NCT03934346 27 37 O
healthy NCT03934346 38 45 B-Condition-Name
men NCT03934346 46 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03934346 52 53 O
Body NCT03934346 55 59 B-Observation-Name___Observation-Type-Value:vital
mass NCT03934346 60 64 I-Observation-Name___Observation-Type-Value:vital
index NCT03934346 65 70 I-Observation-Name___Observation-Type-Value:vital
between NCT03934346 71 78 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03934346 80 82 B-Eq-Value
and NCT03934346 83 86 O
30 NCT03934346 88 90 B-Eq-Value
kg NCT03934346 91 93 B-Eq-Unit
/ NCT03934346 94 95 O
m NCT03934346 96 97 B-Eq-Unit
2 NCT03934346 98 99 I-Eq-Unit

- NCT03934346 102 103 O
Willing NCT03934346 105 112 O
to NCT03934346 113 115 O
eat NCT03934346 116 119 B-Observation-Name
only NCT03934346 120 124 O
the NCT03934346 125 128 O
foods NCT03934346 129 134 O
provided NCT03934346 135 143 O
by NCT03934346 144 146 O
the NCT03934346 147 150 O
study NCT03934346 151 156 O
for NCT03934346 157 160 O
a NCT03934346 161 162 O
2 NCT03934346 164 165 B-Eq-Value
week NCT03934346 166 170 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
period NCT03934346 171 177 O

Exclusion NCT03934346 178 187 O
Criteria NCT03934346 188 196 O
: NCT03934346 197 198 O

- NCT03934346 202 203 O
Those NCT03934346 205 210 O
reporting NCT03934346 211 220 O
any NCT03934346 221 224 O
chronic NCT03934346 225 232 O
or NCT03934346 233 235 O
acute NCT03934346 236 241 B-Severity___Severity-Value:severe
diseases NCT03934346 242 250 B-Condition-Name
, NCT03934346 251 252 O
food NCT03934346 253 257 B-Allergy-Name
allergies NCT03934346 258 267 O
, NCT03934346 268 269 O
smoking NCT03934346 270 277 O
or NCT03934346 278 280 O
alcohol NCT03934346 281 288 O
abuse NCT03934346 289 294 B-Condition-Name

- NCT03934346 297 298 O
Use NCT03934346 300 303 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03934346 304 306 O
illicit NCT03934346 307 314 B-Drug-Name
drugs NCT03934346 315 320 I-Drug-Name
; NCT03934346 320 321 O
regular NCT03934346 322 329 O
consumption NCT03934346 330 341 O
of NCT03934346 342 344 O
medications NCT03934346 345 356 O
, NCT03934346 357 358 O
micronutrient NCT03934346 359 372 B-Drug-Name
supplements NCT03934346 373 384 I-Drug-Name
, NCT03934346 385 386 O
or NCT03934346 387 389 O
both NCT03934346 390 394 O

- NCT03934346 397 398 O
Vegetarians NCT03934346 400 411 B-Condition-Name
, NCT03934346 412 413 O
or NCT03934346 414 416 O
those NCT03934346 417 422 O
unable NCT03934346 423 429 B-Condition-Name
to NCT03934346 430 432 I-Condition-Name
eat NCT03934346 433 436 I-Condition-Name
meat NCT03934346 437 441 I-Condition-Name
, NCT03934346 442 443 O
are NCT03934346 444 447 O
also NCT03934346 448 452 O
excluded NCT03934346 453 461 O
since NCT03934346 462 467 O
the NCT03934346 468 471 O
foods NCT03934346 472 477 O
for NCT03934346 478 481 O
the NCT03934346 482 485 O
study NCT03934346 486 491 O
contain NCT03934346 492 499 O
meat NCT03934346 500 504 O

- NCT03934346 507 508 O
Unable NCT03934346 510 516 O
to NCT03934346 517 519 O
refrain NCT03934346 520 527 O
from NCT03934346 528 532 O
taking NCT03934346 533 539 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medications NCT03934346 540 551 O
during NCT03934346 552 558 O
the NCT03934346 559 562 O
study NCT03934346 563 568 O
period NCT03934346 569 575 O

Inclusion NCT03930849 0 9 O
Criteria NCT03930849 10 18 O
: NCT03930849 19 20 O

VA NCT03930849 22 24 B-Location___Location-Value:hospital
Patient NCT03930849 25 32 O

- NCT03930849 35 36 O
Diagnosed NCT03930849 38 47 O
with NCT03930849 48 52 O
depression NCT03930849 53 63 B-Condition-Name

- NCT03930849 66 67 O
Initiating NCT03930849 69 79 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
or NCT03930849 80 82 O
changing NCT03930849 83 91 B-Stability___Stability-Value:change
to NCT03930849 92 94 O
a NCT03930849 95 96 O
new NCT03930849 97 100 O
antidepressant NCT03930849 101 115 B-Drug-Name
medication NCT03930849 116 126 I-Drug-Name

- NCT03930849 129 130 O
Cell NCT03930849 132 136 O
phone NCT03930849 137 142 O
with NCT03930849 143 147 O
text NCT03930849 148 152 O
messaging NCT03930849 153 162 O
capabilities NCT03930849 163 175 O

- NCT03930849 178 179 O
Registered NCT03930849 181 191 O
with NCT03930849 192 196 O
My NCT03930849 197 199 O
HealtheVet NCT03930849 200 210 O

- NCT03930849 213 214 O
Follow NCT03930849 216 222 B-Encounter-Type___Encounter-Type-Value:outpatient
- NCT03930849 223 224 I-Encounter-Type___Encounter-Type-Value:outpatient
up NCT03930849 225 227 I-Encounter-Type___Encounter-Type-Value:outpatient
appointment NCT03930849 228 239 I-Encounter-Type___Encounter-Type-Value:outpatient
with NCT03930849 240 244 O
their NCT03930849 245 250 O
provider NCT03930849 251 259 O
in NCT03930849 260 262 O
the NCT03930849 263 266 O
next NCT03930849 267 271 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
12 NCT03930849 273 275 B-Eq-Value
weeks NCT03930849 276 281 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03930849 284 285 O
Internet NCT03930849 287 295 O
access NCT03930849 296 302 O

- NCT03930849 305 306 O
English NCT03930849 308 315 B-Language
speaking NCT03930849 316 324 O
VA NCT03930849 325 327 B-Location___Location-Value:hospital
Providers NCT03930849 328 337 O
: NCT03930849 338 339 O
provide NCT03930849 340 347 O
care NCT03930849 348 352 O
to NCT03930849 353 355 O
a NCT03930849 356 357 O
study NCT03930849 358 363 O
participant NCT03930849 364 375 O

Exclusion NCT03930849 376 385 O
Criteria NCT03930849 386 394 O
: NCT03930849 395 396 O

- NCT03930849 400 401 O
Lack NCT03930849 403 407 O
of NCT03930849 408 410 O
cell NCT03930849 411 415 O
phone NCT03930849 416 421 O
access NCT03930849 422 428 O
/ NCT03930849 429 430 O
willingness NCT03930849 431 442 O
to NCT03930849 443 445 O
receive NCT03930849 446 453 O
text NCT03930849 454 458 O
messages NCT03930849 459 467 O

- NCT03930849 470 471 O
Diagnosis NCT03930849 473 482 O
of NCT03930849 483 485 O
cognitive NCT03930849 486 495 B-Condition-Name
disorders NCT03930849 496 505 I-Condition-Name
, NCT03930849 506 507 O
psychotic NCT03930849 508 517 B-Condition-Name
disorders NCT03930849 518 527 I-Condition-Name
, NCT03930849 528 529 O
bipolar NCT03930849 530 537 B-Condition-Name
disorder NCT03930849 538 546 I-Condition-Name
, NCT03930849 547 548 O
or NCT03930849 549 551 O
active NCT03930849 552 558 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03930849 559 568 B-Condition-Name
abuse NCT03930849 569 574 I-Condition-Name
. NCT03930849 575 576 O

Inclusion NCT03934385 0 9 O
Criteria NCT03934385 10 18 O
: NCT03934385 19 20 O

- NCT03934385 24 25 O
English NCT03934385 27 34 B-Language
- NCT03934385 35 36 O
speaking NCT03934385 37 45 O

- NCT03934385 48 49 O
Elevated NCT03934385 51 59 B-Polarity___Polarity-Value:high
score NCT03934385 60 65 O
on NCT03934385 66 68 O
Spider NCT03934385 69 75 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Phobia NCT03934385 76 82 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03934385 83 96 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03934385 97 98 O
SPQ NCT03934385 99 102 B-Observation-Name
) NCT03934385 103 104 O

Exclusion NCT03934385 106 115 O
Criteria NCT03934385 116 124 O
: NCT03934385 125 126 O

- NCT03934385 130 131 O
Severe NCT03934385 133 139 B-Severity___Severity-Value:severe
allergies NCT03934385 140 149 O
to NCT03934385 150 152 O
bees NCT03934385 153 157 B-Allergy-Name
/ NCT03934385 158 159 O
spiders NCT03934385 160 167 B-Allergy-Name
/ NCT03934385 168 169 O
insects NCT03934385 170 177 B-Allergy-Name

Inclusion NCT03934554 0 9 O
Criteria NCT03934554 10 18 O
: NCT03934554 19 20 O

- NCT03934554 24 25 O
Dialysis NCT03934554 27 35 B-Procedure-Name
or NCT03934554 36 38 O
non NCT03934554 39 42 O
- NCT03934554 43 44 O
dialysis NCT03934554 45 53 B-Procedure-Name
patients NCT03934554 54 62 O
with NCT03934554 63 67 O
chronic NCT03934554 68 75 B-Condition-Name
renal NCT03934554 76 81 I-Condition-Name
insufficiency NCT03934554 82 95 I-Condition-Name
with NCT03934554 96 100 O
a NCT03934554 101 102 O
GFR NCT03934554 103 106 B-Observation-Name___Observation-Type-Value:lab
< NCT03934554 107 108 B-Eq-Operator___Eq-Operator-Value:LT
20 NCT03934554 110 112 B-Eq-Value
ml NCT03934554 113 115 B-Eq-Unit
/ NCT03934554 116 117 O
min NCT03934554 118 121 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
eligible NCT03934554 122 130 O
for NCT03934554 131 134 O
transplant NCT03934554 135 145 B-Procedure-Name

- NCT03934554 148 149 O
Patient NCT03934554 151 158 O
wishing NCT03934554 159 166 O
to NCT03934554 167 169 O
start NCT03934554 170 175 O
the NCT03934554 176 179 O
registration NCT03934554 180 192 O
process NCT03934554 193 200 O
at NCT03934554 201 203 O
the NCT03934554 204 207 O
transplant NCT03934554 208 218 B-Procedure-Name

- NCT03934554 221 222 O
Patient NCT03934554 224 231 O
giving NCT03934554 232 238 O
consent NCT03934554 239 246 O
for NCT03934554 247 250 O
the NCT03934554 251 254 O
transmission NCT03934554 255 267 O
of NCT03934554 268 270 O
his NCT03934554 271 274 O
data NCT03934554 275 279 O
via NCT03934554 280 283 O
an NCT03934554 284 286 O
electronic NCT03934554 287 297 O
platform NCT03934554 298 306 O

Exclusion NCT03934554 307 316 O
Criteria NCT03934554 317 325 O
: NCT03934554 326 327 O

- NCT03934554 331 332 O
Patient NCT03934554 334 341 O
already NCT03934554 342 349 O
enrolled NCT03934554 350 358 O

- NCT03934554 361 362 O
Patient NCT03934554 364 371 O
having NCT03934554 372 378 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03934554 379 380 O
pathology NCT03934554 381 390 B-Condition-Name
with NCT03934554 391 395 O
a NCT03934554 396 397 O
life NCT03934554 398 402 B-Observation-Name
expectancy NCT03934554 403 413 I-Observation-Name
of NCT03934554 414 416 O
less NCT03934554 417 421 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03934554 422 426 I-Eq-Operator___Eq-Operator-Value:LT
two NCT03934554 427 430 B-Eq-Unit
years NCT03934554 431 436 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03934554 439 440 O
Patient NCT03934554 442 449 O
with NCT03934554 450 454 O
serious NCT03934554 455 462 B-Severity___Severity-Value:severe
psychiatric NCT03934554 463 474 B-Condition-Name
disorders NCT03934554 475 484 I-Condition-Name
, NCT03934554 485 486 O
or NCT03934554 487 489 O
dementia NCT03934554 490 498 B-Condition-Name
. NCT03934554 499 500 O

Inclusion NCT03930901 0 9 O
Criteria NCT03930901 10 18 O
: NCT03930901 19 20 O

- NCT03930901 24 25 O
Grade NCT03930901 27 32 O
2 NCT03930901 34 35 O
- NCT03930901 36 37 O
6 NCT03930901 39 40 O

- NCT03930901 44 45 O
Orang NCT03930901 47 52 B-Ethnicity
Asli NCT03930901 53 57 I-Ethnicity
ethnicity NCT03930901 58 67 O

- NCT03930901 70 71 O
Schools NCT03930901 73 80 O
exclusively NCT03930901 81 92 O
for NCT03930901 93 96 O
Orang NCT03930901 97 102 B-Ethnicity
Asli NCT03930901 103 107 I-Ethnicity

Exclusion NCT03930901 108 117 O
Criteria NCT03930901 118 126 O
: NCT03930901 127 128 O

- NCT03930901 132 133 O
Grade NCT03930901 135 140 O
1 NCT03930901 142 143 O

- NCT03930901 147 148 O
Chronic NCT03930901 150 157 O
sever NCT03930901 158 163 B-Condition-Name
diseases NCT03930901 164 172 I-Condition-Name

- NCT03930901 175 176 O
no NCT03930901 178 180 O
consent NCT03930901 181 188 O

- NCT03930901 191 192 O
schools NCT03930901 194 201 O
for NCT03930901 202 205 O
mixed NCT03930901 206 211 O
population NCT03930901 212 222 O
groups NCT03930901 223 229 O

Inclusion NCT03930524 0 9 O
Criteria NCT03930524 10 18 O
: NCT03930524 19 20 O

- NCT03930524 24 25 O
Incoming NCT03930524 27 35 O
college NCT03930524 36 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
students NCT03930524 44 52 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
aged NCT03930524 53 57 O
18 NCT03930524 59 61 B-Eq-Value
- NCT03930524 62 63 B-Eq-Operator___Eq-Operator-Value:BETWEEN
21 NCT03930524 65 67 B-Eq-Value
at NCT03930524 68 70 O
the NCT03930524 71 74 O
University NCT03930524 75 85 B-Location___Location-Value:residence
of NCT03930524 86 88 I-Location___Location-Value:residence
Minnesota NCT03930524 89 98 I-Location___Location-Value:residence
will NCT03930524 99 103 O
be NCT03930524 104 106 O
eligible NCT03930524 107 115 O
and NCT03930524 116 119 O
randomly NCT03930524 120 128 O
selected NCT03930524 129 137 O
for NCT03930524 138 141 O
participation NCT03930524 142 155 O
. NCT03930524 156 157 O

Exclusion NCT03930524 159 168 O
Criteria NCT03930524 169 177 O
: NCT03930524 178 179 O

- NCT03930524 183 184 O
None NCT03930524 186 190 O

Inclusion NCT03931148 0 9 O
Criteria NCT03931148 10 18 O
: NCT03931148 19 20 O

- NCT03931148 24 25 O
French NCT03931148 27 33 B-Language
speaker NCT03931148 34 41 O

- NCT03931148 44 45 O
Recent NCT03931148 47 53 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
diagnosis NCT03931148 54 63 O
of NCT03931148 64 66 O
neurocognitive NCT03931148 67 81 B-Condition-Name
disorder NCT03931148 82 90 I-Condition-Name

- NCT03931148 93 94 O
Agreed NCT03931148 96 102 O
with NCT03931148 103 107 O
the NCT03931148 108 111 O
study NCT03931148 112 117 O

Exclusion NCT03931148 118 127 O
Criteria NCT03931148 128 136 O
: NCT03931148 137 138 O

- NCT03931148 142 143 O
Delirium NCT03931148 145 153 B-Condition-Name

- NCT03931148 156 157 O
Major NCT03931148 159 164 B-Severity___Severity-Value:severe
depressive NCT03931148 165 175 B-Condition-Name
symptoms NCT03931148 176 184 O

- NCT03931148 187 188 O
MRI NCT03931148 190 193 B-Procedure-Name
contraindication NCT03931148 194 210 O

Inclusion NCT03930121 0 9 O
Criteria NCT03930121 10 18 O
: NCT03930121 19 20 O

- NCT03930121 24 25 O
left NCT03930121 27 31 O
- NCT03930121 32 33 O
hemisphere NCT03930121 34 44 O
cortical NCT03930121 45 53 O
or NCT03930121 54 56 O
subcortical NCT03930121 57 68 O
stroke NCT03930121 69 75 B-Condition-Name
with NCT03930121 76 80 O
first NCT03930121 81 86 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
- NCT03930121 87 88 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
ever NCT03930121 89 93 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
aphasic NCT03930121 94 101 B-Condition-Name
symptoms NCT03930121 102 110 O

- NCT03930121 113 114 O
at NCT03930121 116 118 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03930121 119 124 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03930121 126 127 B-Eq-Value
months NCT03930121 128 134 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
post NCT03930121 135 139 O
- NCT03930121 140 141 O
onset NCT03930121 142 147 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03930121 148 150 O
stroke NCT03930121 151 157 B-Condition-Name
; NCT03930121 157 158 O

- NCT03930121 161 162 O
aphasia NCT03930121 164 171 B-Condition-Name
, NCT03930121 172 173 O
as NCT03930121 174 176 O
determined NCT03930121 177 187 O
by NCT03930121 188 190 O
the NCT03930121 191 194 O
Aachen NCT03930121 195 201 B-Observation-Name
Aphasia NCT03930121 202 209 I-Observation-Name
Test NCT03930121 210 214 I-Observation-Name
( NCT03930121 215 216 O
AAT NCT03930121 217 220 B-Observation-Name
) NCT03930121 221 222 O
; NCT03930121 223 224 O

- NCT03930121 227 228 O
13 NCT03930121 231 233 B-Eq-Value
moderate NCT03930121 234 242 B-Severity___Severity-Value:moderate
- NCT03930121 243 244 O
to NCT03930121 245 247 O
- NCT03930121 248 249 O
severe NCT03930121 250 256 B-Severity___Severity-Value:severe
word NCT03930121 257 261 B-Condition-Name
finding NCT03930121 262 269 I-Condition-Name
difficulties NCT03930121 270 282 I-Condition-Name
( NCT03930121 283 284 O
maximum NCT03930121 285 292 B-Eq-Operator___Eq-Operator-Value:LTEQ
of NCT03930121 293 295 O
60 NCT03930121 297 299 B-Eq-Value
% NCT03930121 300 301 B-Eq-Unit
correct NCT03930121 302 309 O
items NCT03930121 310 315 O
on NCT03930121 316 318 O
a NCT03930121 319 320 O
computerized NCT03930121 321 333 B-Observation-Name
naming NCT03930121 334 340 I-Observation-Name
task NCT03930121 341 345 I-Observation-Name
at NCT03930121 346 348 O
baseline NCT03930121 349 357 O
) NCT03930121 358 359 O
; NCT03930121 360 361 O

- NCT03930121 364 365 O
at NCT03930121 367 369 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03930121 370 375 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03930121 377 378 B-Eq-Value
correct NCT03930121 379 386 B-Eq-Unit
reaction NCT03930121 387 395 I-Eq-Unit
on NCT03930121 396 398 O
the NCT03930121 399 402 O
first NCT03930121 403 408 O
part NCT03930121 409 413 O
of NCT03930121 414 416 O
the NCT03930121 417 420 O
AAT NCT03930121 421 424 B-Observation-Name___Observation-Type-Value:measurement
subscale NCT03930121 425 433 I-Observation-Name___Observation-Type-Value:measurement
Token NCT03930121 434 439 I-Observation-Name___Observation-Type-Value:measurement
Test NCT03930121 440 444 I-Observation-Name___Observation-Type-Value:measurement
( NCT03930121 445 446 O
ensuring NCT03930121 447 455 O
basic NCT03930121 456 461 O
comprehension NCT03930121 462 475 O
skills NCT03930121 476 482 O
) NCT03930121 483 484 O
; NCT03930121 485 486 O

- NCT03930121 489 490 O
at NCT03930121 492 494 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03930121 495 500 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03930121 502 503 B-Eq-Value
point NCT03930121 504 509 B-Eq-Unit
on NCT03930121 510 512 O
the NCT03930121 513 516 O
communicative NCT03930121 517 530 O
task NCT03930121 531 535 O
of NCT03930121 536 538 O
the NCT03930121 539 542 O
AAT NCT03930121 543 546 B-Observation-Name___Observation-Type-Value:measurement
subscale NCT03930121 547 555 I-Observation-Name___Observation-Type-Value:measurement
Spontaneous NCT03930121 556 567 I-Observation-Name___Observation-Type-Value:measurement
Speech NCT03930121 568 574 I-Observation-Name___Observation-Type-Value:measurement
( NCT03930121 575 576 O
ensuring NCT03930121 577 585 O
basic NCT03930121 586 591 O
communication NCT03930121 592 605 O
abilities NCT03930121 606 615 O
) NCT03930121 616 617 O
; NCT03930121 618 619 O

- NCT03930121 622 623 O
German NCT03930121 625 631 B-Language
as NCT03930121 632 634 O
first NCT03930121 635 640 O
language NCT03930121 641 649 O
; NCT03930121 649 650 O

- NCT03930121 653 654 O
intact NCT03930121 656 662 O
left NCT03930121 663 667 B-Condition-Name
- NCT03930121 668 669 I-Condition-Name
hemisphere NCT03930121 670 680 I-Condition-Name
" NCT03930121 681 682 I-Condition-Name
hand NCT03930121 682 686 I-Condition-Name
knob NCT03930121 687 691 I-Condition-Name
" NCT03930121 691 692 I-Condition-Name
without NCT03930121 693 700 O
right NCT03930121 701 706 O
prefrontal NCT03930121 707 717 B-Condition-Name
lesions NCT03930121 718 725 I-Condition-Name
for NCT03930121 726 729 O
placement NCT03930121 730 739 B-Procedure-Name
of NCT03930121 740 742 I-Procedure-Name
tDCS NCT03930121 743 747 I-Procedure-Name
electrodes NCT03930121 748 758 I-Procedure-Name
, NCT03930121 759 760 O
as NCT03930121 761 763 O
confirmed NCT03930121 764 773 O
by NCT03930121 774 776 O
magnetic NCT03930121 777 785 B-Procedure-Name
resonance NCT03930121 786 795 I-Procedure-Name
imaging NCT03930121 796 803 I-Procedure-Name
or NCT03930121 804 806 O
computer NCT03930121 807 815 B-Procedure-Name
tomography NCT03930121 816 826 I-Procedure-Name
scans NCT03930121 827 832 I-Procedure-Name
. NCT03930121 833 834 O

Exclusion NCT03930121 836 845 O
Criteria NCT03930121 846 854 O
: NCT03930121 855 856 O

- NCT03930121 860 861 O
contraindications NCT03930121 863 880 O
for NCT03930121 881 884 O
tDCS NCT03930121 885 889 B-Procedure-Name
( NCT03930121 890 891 O
e NCT03930121 892 893 O
. NCT03930121 894 895 O
g NCT03930121 896 897 O
. NCT03930121 898 899 O
, NCT03930121 900 901 O
cardiac NCT03930121 902 909 B-Condition-Name
pacemaker NCT03930121 910 919 I-Condition-Name
, NCT03930121 920 921 O
history NCT03930121 922 929 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03930121 930 932 O
seizures NCT03930121 933 941 B-Condition-Name
, NCT03930121 942 943 O
implanted NCT03930121 944 953 B-Condition-Name
metal NCT03930121 954 959 I-Condition-Name
inside NCT03930121 960 966 I-Condition-Name
the NCT03930121 967 970 I-Condition-Name
head NCT03930121 971 975 I-Condition-Name
) NCT03930121 976 977 O
; NCT03930121 978 979 O

- NCT03930121 982 983 O
more NCT03930121 985 989 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03930121 990 994 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03930121 995 998 B-Eq-Value
clinically NCT03930121 999 1009 O
apparent NCT03930121 1010 1018 O
stroke NCT03930121 1019 1025 B-Condition-Name
with NCT03930121 1026 1030 O
aphasic NCT03930121 1031 1038 B-Condition-Name
symptoms NCT03930121 1039 1047 O
; NCT03930121 1047 1048 O

- NCT03930121 1051 1052 O
other NCT03930121 1054 1059 O
severe NCT03930121 1060 1066 B-Severity___Severity-Value:severe
neurological NCT03930121 1067 1079 B-Condition-Name
diseases NCT03930121 1080 1088 I-Condition-Name
( NCT03930121 1089 1090 O
e NCT03930121 1091 1092 O
. NCT03930121 1093 1094 O
g NCT03930121 1095 1096 O
. NCT03930121 1097 1098 O
, NCT03930121 1099 1100 O
epilepsy NCT03930121 1101 1109 B-Condition-Name
, NCT03930121 1110 1111 O
brain NCT03930121 1112 1117 B-Condition-Name
tumor NCT03930121 1118 1123 I-Condition-Name
, NCT03930121 1124 1125 O
and NCT03930121 1126 1129 O
subdural NCT03930121 1130 1138 B-Condition-Name
hematoma NCT03930121 1139 1147 I-Condition-Name
) NCT03930121 1148 1149 O
; NCT03930121 1150 1151 O

- NCT03930121 1154 1155 O
history NCT03930121 1157 1164 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03930121 1165 1167 O
severe NCT03930121 1168 1174 B-Severity___Severity-Value:severe
alcohol NCT03930121 1175 1182 O
or NCT03930121 1183 1185 O
drug NCT03930121 1186 1190 O
abuse NCT03930121 1191 1196 B-Condition-Name
; NCT03930121 1196 1197 O

- NCT03930121 1200 1201 O
current NCT03930121 1203 1210 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
severe NCT03930121 1211 1217 B-Severity___Severity-Value:severe
depression NCT03930121 1218 1228 B-Condition-Name
; NCT03930121 1228 1229 O

- NCT03930121 1232 1233 O
current NCT03930121 1235 1242 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
psychosis NCT03930121 1243 1252 B-Condition-Name
or NCT03930121 1253 1255 O
other NCT03930121 1256 1261 O
relevant NCT03930121 1262 1270 O
psychiatric NCT03930121 1271 1282 B-Condition-Name
condition NCT03930121 1283 1292 I-Condition-Name
; NCT03930121 1292 1293 O

- NCT03930121 1296 1297 O
very NCT03930121 1299 1303 O
severe NCT03930121 1304 1310 B-Severity___Severity-Value:severe
apraxia NCT03930121 1311 1318 B-Condition-Name
of NCT03930121 1319 1321 I-Condition-Name
speech NCT03930121 1322 1328 I-Condition-Name
, NCT03930121 1329 1330 O
as NCT03930121 1331 1333 O
revealed NCT03930121 1334 1342 O
by NCT03930121 1343 1345 O
Hierarchical NCT03930121 1346 1358 B-Observation-Name
Word NCT03930121 1359 1363 I-Observation-Name
Lists NCT03930121 1364 1369 I-Observation-Name
; NCT03930121 1369 1370 O

- NCT03930121 1373 1374 O
severe NCT03930121 1376 1382 B-Severity___Severity-Value:severe
non NCT03930121 1383 1386 B-Condition-Name
- NCT03930121 1387 1388 I-Condition-Name
verbal NCT03930121 1389 1395 I-Condition-Name
cognitive NCT03930121 1396 1405 I-Condition-Name
deficits NCT03930121 1406 1414 I-Condition-Name
, NCT03930121 1415 1416 O
as NCT03930121 1417 1419 O
indicated NCT03930121 1420 1429 O
by NCT03930121 1430 1432 O
the NCT03930121 1433 1436 O
Corsi NCT03930121 1437 1442 B-Observation-Name
Block NCT03930121 1443 1448 I-Observation-Name
- NCT03930121 1449 1450 I-Observation-Name
Tapping NCT03930121 1451 1458 I-Observation-Name
Task NCT03930121 1459 1463 I-Observation-Name
; NCT03930121 1463 1464 O

- NCT03930121 1467 1468 O
severe NCT03930121 1470 1476 B-Severity___Severity-Value:severe
uncontrolled NCT03930121 1477 1489 O
medical NCT03930121 1490 1497 O
problems NCT03930121 1498 1506 O
; NCT03930121 1506 1507 O

- NCT03930121 1510 1511 O
severely NCT03930121 1513 1521 B-Severity___Severity-Value:severe
impaired NCT03930121 1522 1530 B-Condition-Name
vision NCT03930121 1531 1537 O
or NCT03930121 1538 1540 O
hearing NCT03930121 1541 1548 O
that NCT03930121 1549 1553 O
prevents NCT03930121 1554 1562 O
patients NCT03930121 1563 1571 O
from NCT03930121 1572 1576 O
engaging NCT03930121 1577 1585 O
in NCT03930121 1586 1588 O
intensive NCT03930121 1589 1598 O
SLT NCT03930121 1599 1602 O
; NCT03930121 1602 1603 O

- NCT03930121 1606 1607 O
changes NCT03930121 1609 1616 B-Stability___Stability-Value:change
in NCT03930121 1617 1619 O
centrally NCT03930121 1620 1629 B-Drug-Name
active NCT03930121 1630 1636 I-Drug-Name
drugs NCT03930121 1637 1642 I-Drug-Name
within NCT03930121 1643 1649 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03930121 1651 1652 B-Eq-Value
weeks NCT03930121 1653 1658 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03930121 1659 1664 O
to NCT03930121 1665 1667 O
study NCT03930121 1668 1673 O
inclusion NCT03930121 1674 1683 O
. NCT03930121 1684 1685 O

Inclusion NCT03934151 0 9 O
Criteria NCT03934151 10 18 O
: NCT03934151 19 20 O

- NCT03934151 24 25 O
Patients NCT03934151 27 35 O
and NCT03934151 36 39 O
/ NCT03934151 40 41 O
or NCT03934151 42 44 O
legal NCT03934151 45 50 O
guardians NCT03934151 51 60 O
exhaustively NCT03934151 61 73 O
informed NCT03934151 74 82 O
by NCT03934151 83 85 O
the NCT03934151 86 89 O
investigator NCT03934151 90 102 O
, NCT03934151 103 104 O
and NCT03934151 105 108 O
who NCT03934151 109 112 O
have NCT03934151 113 117 O
voluntarily NCT03934151 118 129 O
provided NCT03934151 130 138 O
written NCT03934151 139 146 O
informed NCT03934151 147 155 O
consent NCT03934151 156 163 O
or NCT03934151 164 166 O
, NCT03934151 167 168 O
when NCT03934151 169 173 O
unable NCT03934151 174 180 O
to NCT03934151 181 183 O
read NCT03934151 184 188 O
and NCT03934151 189 192 O
/ NCT03934151 193 194 O
or NCT03934151 195 197 O
write NCT03934151 198 203 O
, NCT03934151 204 205 O
verbal NCT03934151 206 212 O
consent NCT03934151 213 220 O
put NCT03934151 221 224 O
into NCT03934151 225 229 O
writing NCT03934151 230 237 O
by NCT03934151 238 240 O
a NCT03934151 241 242 O
third NCT03934151 243 248 O
person NCT03934151 249 255 O

- NCT03934151 258 259 O
Patients NCT03934151 261 269 O
who NCT03934151 270 273 O
underwent NCT03934151 274 283 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
elective NCT03934151 284 292 O
laparoscopic NCT03934151 293 305 O
or NCT03934151 306 308 O
video NCT03934151 309 314 O
assisted NCT03934151 315 323 O
right NCT03934151 324 329 B-Procedure-Name
hemicolectomy NCT03934151 330 343 I-Procedure-Name
at NCT03934151 344 346 O
U NCT03934151 347 348 B-Location___Location-Value:hospital
. NCT03934151 349 350 I-Location___Location-Value:hospital
O NCT03934151 351 352 I-Location___Location-Value:hospital
. NCT03934151 353 354 I-Location___Location-Value:hospital
General NCT03934151 356 363 O
and NCT03934151 364 367 O
Thoracic NCT03934151 368 376 O
Surgery NCT03934151 377 384 B-Procedure-Name
for NCT03934151 385 388 O
malignant NCT03934151 389 398 O
or NCT03934151 399 401 O
bening NCT03934151 402 408 O
pathology NCT03934151 409 418 B-Condition-Name
. NCT03934151 419 420 O

- NCT03934151 424 425 O
Patients NCT03934151 427 435 O
who NCT03934151 436 439 O
had NCT03934151 440 443 O
prior NCT03934151 444 449 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
chemotherapy NCT03934151 450 462 B-Procedure-Name
and NCT03934151 463 466 O
radiotherapy NCT03934151 467 479 B-Procedure-Name

Exclusion NCT03934151 480 489 O
Criteria NCT03934151 490 498 O
: NCT03934151 499 500 O

- NCT03934151 504 505 O
Patients NCT03934151 507 515 O
operated NCT03934151 516 524 O
in NCT03934151 525 527 O
emergency NCT03934151 528 537 B-Encounter-Type___Encounter-Type-Value:emergency

- NCT03934151 540 541 O
Pregnant NCT03934151 543 551 B-Condition-Name
women NCT03934151 552 557 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03934151 560 561 O
Right NCT03934151 563 568 B-Procedure-Name
laparotomic NCT03934151 569 580 I-Procedure-Name
hemicolectomy NCT03934151 581 594 I-Procedure-Name

- NCT03934151 597 598 O
BMI NCT03934151 600 603 B-Observation-Name___Observation-Type-Value:vital
> NCT03934151 604 605 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03934151 607 609 B-Eq-Value

Inclusion NCT03932929 0 9 O
Criteria NCT03932929 10 18 O
: NCT03932929 19 20 O

- NCT03932929 24 25 O
over NCT03932929 27 31 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03932929 33 35 B-Eq-Value
years NCT03932929 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03932929 42 45 O

- NCT03932929 48 49 O
good NCT03932929 51 55 B-Condition-Name
oral NCT03932929 56 60 I-Condition-Name
hygiene NCT03932929 61 68 I-Condition-Name

- NCT03932929 71 72 O
available NCT03932929 74 83 O
for NCT03932929 84 87 O
recall NCT03932929 88 94 O

- NCT03932929 97 98 O
at NCT03932929 100 102 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03932929 103 108 I-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03932929 110 112 B-Eq-Value
teeth NCT03932929 113 118 B-Condition-Name
under NCT03932929 119 124 I-Condition-Name
occlusion NCT03932929 125 134 I-Condition-Name

- NCT03932929 137 138 O
the NCT03932929 140 143 O
presence NCT03932929 144 152 O
of NCT03932929 153 155 O
at NCT03932929 156 158 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03932929 159 164 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03932929 165 170 B-Eq-Value
non NCT03932929 171 174 O
- NCT03932929 175 176 O
carious NCT03932929 177 184 O
cervical NCT03932929 185 193 B-Condition-Name
lesions NCT03932929 194 201 I-Condition-Name

Exclusion NCT03932929 202 211 O
Criteria NCT03932929 212 220 O
: NCT03932929 221 222 O

- NCT03932929 226 227 O
poor NCT03932929 229 233 B-Condition-Name
oral NCT03932929 234 238 I-Condition-Name
hygiene NCT03932929 239 246 I-Condition-Name

- NCT03932929 249 250 O
bruxism NCT03932929 252 259 B-Condition-Name
habits NCT03932929 260 266 I-Condition-Name

- NCT03932929 269 270 O
severe NCT03932929 272 278 B-Severity___Severity-Value:severe
or NCT03932929 279 281 O
chronic NCT03932929 282 289 O
periodontitis NCT03932929 290 303 B-Condition-Name

- NCT03932929 306 307 O
If NCT03932929 309 311 O
the NCT03932929 312 315 O
teeth NCT03932929 316 321 O
selected NCT03932929 322 330 O
for NCT03932929 331 334 O
study NCT03932929 335 340 O
, NCT03932929 341 342 O
were NCT03932929 343 347 O
nonvital NCT03932929 348 356 O
, NCT03932929 357 358 O
or NCT03932929 359 361 O
had NCT03932929 362 365 O
any NCT03932929 366 369 O
restorations NCT03932929 370 382 O
on NCT03932929 383 385 O
other NCT03932929 386 391 O
surfaces NCT03932929 392 400 O
were NCT03932929 401 405 O
not NCT03932929 406 409 O
included NCT03932929 410 418 O
. NCT03932929 419 420 O

Inclusion NCT03931616 0 9 O
Criteria NCT03931616 10 18 O
: NCT03931616 19 20 O

1 NCT03931616 25 26 O
. NCT03931616 26 27 O
Suspected NCT03931616 29 38 O
acute NCT03931616 39 44 B-Severity___Severity-Value:severe
stroke NCT03931616 45 51 B-Condition-Name
according NCT03931616 52 61 O
to NCT03931616 62 64 O
the NCT03931616 65 68 O
dispatcher NCT03931616 69 79 O
stroke NCT03931616 80 86 O
identification NCT03931616 87 101 O
algorithm NCT03931616 102 111 O
during NCT03931616 112 118 O
STEMO NCT03931616 119 124 O
hours NCT03931616 125 130 O
( NCT03931616 131 132 O
7 NCT03931616 134 135 O
am NCT03931616 136 138 O
- NCT03931616 139 140 O
11 NCT03931616 142 144 O
pm NCT03931616 145 147 O
, NCT03931616 148 149 O
Monday NCT03931616 150 156 O
- NCT03931616 157 158 O
Sunday NCT03931616 159 165 O
) NCT03931616 166 167 O
and NCT03931616 168 171 O
within NCT03931616 172 178 O
the NCT03931616 179 182 O
STEMO NCT03931616 183 188 O
catchment NCT03931616 189 198 O
area NCT03931616 199 203 O
Inclusion NCT03931616 204 213 O
criteria NCT03931616 214 222 O
for NCT03931616 223 226 O
primary NCT03931616 227 234 O
study NCT03931616 235 240 O
population NCT03931616 241 251 O
: NCT03931616 252 253 O

2 NCT03931616 258 259 O
. NCT03931616 259 260 O
Final NCT03931616 262 267 B-Condition-Type___Condition-Type-Value:discharge
diagnosis NCT03931616 268 277 O
of NCT03931616 278 280 O
ischemic NCT03931616 281 289 B-Condition-Name
stroke NCT03931616 290 296 I-Condition-Name
( NCT03931616 297 298 O
ICD NCT03931616 299 302 B-Condition-Code
10 NCT03931616 304 306 I-Condition-Code
: NCT03931616 307 308 I-Condition-Code
I NCT03931616 309 310 I-Condition-Code
63 NCT03931616 311 313 I-Condition-Code
) NCT03931616 314 315 O
or NCT03931616 316 318 O
TIA NCT03931616 319 322 B-Condition-Name
( NCT03931616 323 324 O
Transient NCT03931616 325 334 B-Condition-Name
Ischemic NCT03931616 335 343 I-Condition-Name
Attack NCT03931616 344 350 I-Condition-Name
, NCT03931616 351 352 O
ICD NCT03931616 353 356 B-Condition-Code
10 NCT03931616 358 360 I-Condition-Code
: NCT03931616 361 362 I-Condition-Code
G NCT03931616 363 364 I-Condition-Code
45 NCT03931616 365 367 I-Condition-Code
except NCT03931616 368 374 O
G NCT03931616 375 376 B-Condition-Code
45.4 NCT03931616 377 381 I-Condition-Code
) NCT03931616 382 383 O

3 NCT03931616 388 389 O
. NCT03931616 389 390 O
Confirmed NCT03931616 392 401 O
onset NCT03931616 402 407 B-Observation-Name
- NCT03931616 408 409 I-Observation-Name
to NCT03931616 410 412 I-Observation-Name
- NCT03931616 413 414 I-Observation-Name
alarm NCT03931616 415 420 I-Observation-Name
time NCT03931616 421 425 I-Observation-Name
≤ NCT03931616 426 427 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03931616 429 430 B-Eq-Value
hours NCT03931616 431 436 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
at NCT03931616 437 439 O
dispatch NCT03931616 440 448 O

4 NCT03931616 452 453 O
. NCT03931616 453 454 O
Pre NCT03931616 456 459 O
- NCT03931616 460 461 O
stroke NCT03931616 462 468 B-Condition-Name
modified NCT03931616 469 477 B-Observation-Name___Observation-Type-Value:clinical-score
Rankin NCT03931616 478 484 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03931616 485 490 I-Observation-Name___Observation-Type-Value:clinical-score
≤ NCT03931616 491 492 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03931616 494 495 B-Eq-Value
( NCT03931616 496 497 O
being NCT03931616 498 503 O
able NCT03931616 504 508 B-Condition-Name
to NCT03931616 509 511 I-Condition-Name
ambulate NCT03931616 512 520 I-Condition-Name
, NCT03931616 521 522 O
in NCT03931616 523 525 O
routine NCT03931616 526 533 O
clinical NCT03931616 534 542 O
care NCT03931616 543 547 O
, NCT03931616 548 549 O
patients NCT03931616 550 558 O
with NCT03931616 559 563 O
mRS NCT03931616 564 567 B-Observation-Name
up NCT03931616 568 570 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03931616 571 573 I-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03931616 575 576 B-Eq-Value
are NCT03931616 577 580 O
usually NCT03931616 581 588 O
deemed NCT03931616 589 595 O
suitable NCT03931616 596 604 O
for NCT03931616 605 608 O
tissue NCT03931616 609 615 O
plasminogen NCT03931616 616 627 O
activator NCT03931616 628 637 O
treatment NCT03931616 638 647 O
) NCT03931616 648 649 O

Exclusion NCT03931616 651 660 O
Criteria NCT03931616 661 669 O
: NCT03931616 670 671 O

1 NCT03931616 676 677 O
. NCT03931616 677 678 O
Remission NCT03931616 680 689 B-Stability___Stability-Value:change
of NCT03931616 690 692 O
disabling NCT03931616 693 702 B-Condition-Name
symptoms NCT03931616 703 711 O
until NCT03931616 712 717 O
arrival NCT03931616 718 725 O
of NCT03931616 726 728 O
emergency NCT03931616 729 738 O
medical NCT03931616 739 746 O
service NCT03931616 747 754 O

2 NCT03931616 758 759 O
. NCT03931616 759 760 O
Malignant NCT03931616 762 771 O
or NCT03931616 772 774 O
other NCT03931616 775 780 O
severe NCT03931616 781 787 B-Severity___Severity-Value:severe
primary NCT03931616 788 795 B-Condition-Name
disease NCT03931616 796 803 I-Condition-Name
with NCT03931616 804 808 O
life NCT03931616 809 813 B-Observation-Name
expectancy NCT03931616 814 824 I-Observation-Name
< NCT03931616 825 826 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03931616 828 829 B-Eq-Value
year NCT03931616 830 834 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
Additional NCT03931616 835 845 O
exclusion NCT03931616 846 855 O
criteria NCT03931616 856 864 O
for NCT03931616 865 868 O
primary NCT03931616 869 876 O
study NCT03931616 877 882 O
population NCT03931616 883 893 O
: NCT03931616 894 895 O

3 NCT03931616 900 901 O
. NCT03931616 901 902 O
Major NCT03931616 904 909 O
surgery NCT03931616 910 917 B-Procedure-Name
within NCT03931616 918 924 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03931616 926 927 B-Eq-Value
weeks NCT03931616 928 933 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03931616 934 940 O
study NCT03931616 941 946 O
inclusion NCT03931616 947 956 O

4 NCT03931616 960 961 O
. NCT03931616 961 962 O
Confirmed NCT03931616 964 973 O
stroke NCT03931616 974 980 B-Condition-Name
within NCT03931616 981 987 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03931616 989 990 B-Eq-Value
months NCT03931616 991 997 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03931616 998 1004 O
study NCT03931616 1005 1010 O
inclusion NCT03931616 1011 1020 O

5 NCT03931616 1024 1025 O
. NCT03931616 1025 1026 O
Absolute NCT03931616 1028 1036 O
contraindications NCT03931616 1037 1054 O
for NCT03931616 1055 1058 O
thrombolysis NCT03931616 1059 1071 B-Procedure-Name
AND NCT03931616 1072 1075 O
thrombectomy NCT03931616 1076 1088 B-Procedure-Name

Inclusion NCT03934008 0 9 O
Criteria NCT03934008 10 18 O
( NCT03934008 19 20 O
primary NCT03934008 21 28 O
outcome NCT03934008 29 36 O
) NCT03934008 37 38 O
: NCT03934008 40 41 O

- NCT03934008 45 46 O
Patients NCT03934008 48 56 O
0 NCT03934008 58 59 B-Eq-Value
- NCT03934008 60 61 B-Eq-Operator___Eq-Operator-Value:BETWEEN
6 NCT03934008 63 64 B-Eq-Value
years NCT03934008 65 70 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03934008 71 73 O
age NCT03934008 74 77 O

- NCT03934008 80 81 O
Seen NCT03934008 83 87 B-Encounter-Type___Encounter-Type-Value:outpatient
in NCT03934008 88 90 O
the NCT03934008 91 94 O
Rocking NCT03934008 95 102 B-Location___Location-Value:clinic
Horse NCT03934008 103 108 I-Location___Location-Value:clinic
Community NCT03934008 109 118 I-Location___Location-Value:clinic
Center NCT03934008 119 125 I-Location___Location-Value:clinic
by NCT03934008 126 128 O
a NCT03934008 129 130 O
pediatric NCT03934008 131 140 B-Provider-Type
provider NCT03934008 141 149 O
during NCT03934008 150 156 O
the NCT03934008 157 160 O
baseline NCT03934008 161 169 O
or NCT03934008 170 172 O
study NCT03934008 173 178 O
period NCT03934008 179 185 O

Inclusion NCT03934008 186 195 O
Criteria NCT03934008 196 204 O
( NCT03934008 205 206 O
secondary NCT03934008 207 216 O
parental NCT03934008 217 225 O
health NCT03934008 226 232 O
belief NCT03934008 233 239 O
outcomes NCT03934008 240 248 O
) NCT03934008 249 250 O
: NCT03934008 252 253 O

- NCT03934008 257 258 O
Parents NCT03934008 260 267 O
/ NCT03934008 268 269 O
caregivers NCT03934008 270 280 O
( NCT03934008 281 282 O
1 NCT03934008 284 285 O
) NCT03934008 286 287 O
≥ NCT03934008 288 289 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03934008 291 293 B-Eq-Value
years NCT03934008 294 299 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03934008 300 303 O

- NCT03934008 306 307 O
Read NCT03934008 309 313 O
English NCT03934008 314 321 B-Language

- NCT03934008 324 325 O
Have NCT03934008 327 331 O
at NCT03934008 332 334 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03934008 335 340 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03934008 341 344 B-Eq-Value
child NCT03934008 345 350 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
≤ NCT03934008 351 352 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03934008 354 355 B-Eq-Value
years NCT03934008 356 361 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03934008 362 364 O
age NCT03934008 365 368 O

Inclusion NCT03934008 369 378 O
Criteria NCT03934008 379 387 O
( NCT03934008 388 389 O
secondary NCT03934008 390 399 O
provider NCT03934008 400 408 O
outcomes NCT03934008 409 417 O
) NCT03934008 418 419 O
: NCT03934008 421 422 O
All NCT03934008 423 426 O
providers NCT03934008 427 436 O
who NCT03934008 437 440 O
interact NCT03934008 441 449 O
with NCT03934008 450 454 O
pediatric NCT03934008 455 464 O

patients NCT03934008 465 473 O
in NCT03934008 474 476 O
the NCT03934008 477 480 O
Rocking NCT03934008 481 488 B-Location___Location-Value:clinic
Horse NCT03934008 489 494 I-Location___Location-Value:clinic
Community NCT03934008 495 504 I-Location___Location-Value:clinic
Center NCT03934008 505 511 I-Location___Location-Value:clinic
who NCT03934008 512 515 O

- NCT03934008 518 519 O
Complete NCT03934008 521 529 O
the NCT03934008 530 533 O
training NCT03934008 534 542 O
and NCT03934008 543 546 O

- NCT03934008 549 550 O
Implement NCT03934008 552 561 O
the NCT03934008 562 565 O
MOTIVE NCT03934008 566 572 O
tool NCT03934008 573 577 O
in NCT03934008 578 580 O
practice NCT03934008 581 589 O

Inclusion NCT03934034 0 9 O
Criteria NCT03934034 10 18 O
: NCT03934034 19 20 O

1 NCT03934034 25 26 O
. NCT03934034 26 27 O
Clinical NCT03934034 29 37 O
diagnosis NCT03934034 38 47 O
of NCT03934034 48 50 O
NTM NCT03934034 51 54 B-Condition-Name
pulmonary NCT03934034 55 64 I-Condition-Name
disease NCT03934034 65 72 I-Condition-Name
. NCT03934034 73 74 O

2 NCT03934034 79 80 O
. NCT03934034 80 81 O
The NCT03934034 83 86 O
causative NCT03934034 87 96 O
agent NCT03934034 97 102 O
of NCT03934034 103 105 O
NTM NCT03934034 106 109 B-Condition-Name
pulmonary NCT03934034 110 119 I-Condition-Name
disease NCT03934034 120 127 I-Condition-Name
includes NCT03934034 128 136 O
: NCT03934034 137 138 O
M NCT03934034 139 140 B-Organism-Name
. NCT03934034 141 142 I-Organism-Name
avium NCT03934034 144 149 I-Organism-Name
complex NCT03934034 150 157 I-Organism-Name
, NCT03934034 158 159 O
or NCT03934034 160 162 O
M NCT03934034 163 164 B-Organism-Name
. NCT03934034 165 166 I-Organism-Name
abscessus NCT03934034 168 177 I-Organism-Name
subspecies NCT03934034 178 188 I-Organism-Name
abscessus NCT03934034 189 198 I-Organism-Name
, NCT03934034 199 200 O
or NCT03934034 201 203 O
M NCT03934034 204 205 B-Organism-Name
. NCT03934034 206 207 I-Organism-Name
abscessus NCT03934034 209 218 I-Organism-Name
subspecies NCT03934034 219 229 I-Organism-Name
massiliense NCT03934034 230 241 I-Organism-Name
, NCT03934034 242 243 O
or NCT03934034 244 246 O
M NCT03934034 247 248 B-Organism-Name
. NCT03934034 249 250 I-Organism-Name
kansasii NCT03934034 252 260 I-Organism-Name
. NCT03934034 261 262 O

3 NCT03934034 267 268 O
. NCT03934034 268 269 O
Patients NCT03934034 271 279 O
who NCT03934034 280 283 O
starts NCT03934034 284 290 O
new NCT03934034 291 294 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
treatment NCT03934034 295 304 O
( NCT03934034 305 306 O
those NCT03934034 307 312 O
who NCT03934034 313 316 O
have NCT03934034 317 321 O
previous NCT03934034 322 330 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03934034 331 338 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03934034 339 341 O
treatment NCT03934034 342 351 O
are NCT03934034 352 355 O
eligible NCT03934034 356 364 O
) NCT03934034 365 366 O

Exclusion NCT03934034 368 377 O
Criteria NCT03934034 378 386 O

1 NCT03934034 390 391 O
. NCT03934034 391 392 O
Patients NCT03934034 394 402 O
who NCT03934034 403 406 O
have NCT03934034 407 411 O
been NCT03934034 412 416 O
treated NCT03934034 417 424 O
for NCT03934034 425 428 O
more NCT03934034 429 433 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03934034 434 438 I-Eq-Operator___Eq-Operator-Value:GT
4 NCT03934034 440 441 B-Eq-Value
weeks NCT03934034 442 447 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03934034 448 449 O

2 NCT03934034 454 455 O
. NCT03934034 455 456 O
The NCT03934034 458 461 O
causative NCT03934034 462 471 O
agent NCT03934034 472 477 O
of NCT03934034 478 480 O
NTM NCT03934034 481 484 B-Condition-Name
pulmonary NCT03934034 485 494 I-Condition-Name
disease NCT03934034 495 502 I-Condition-Name
is NCT03934034 503 505 O
none NCT03934034 506 510 O
of NCT03934034 511 513 O
M NCT03934034 514 515 B-Organism-Name
. NCT03934034 516 517 I-Organism-Name
avium NCT03934034 519 524 I-Organism-Name
complex NCT03934034 525 532 I-Organism-Name
, NCT03934034 533 534 O
M NCT03934034 535 536 B-Organism-Name
. NCT03934034 537 538 I-Organism-Name
abscessus NCT03934034 540 549 I-Organism-Name
subspecies NCT03934034 550 560 I-Organism-Name
abscessus NCT03934034 561 570 I-Organism-Name
, NCT03934034 571 572 O
M NCT03934034 573 574 B-Organism-Name
. NCT03934034 575 576 I-Organism-Name
abscessus NCT03934034 578 587 I-Organism-Name
subspecies NCT03934034 588 598 I-Organism-Name
massiliense NCT03934034 599 610 I-Organism-Name
, NCT03934034 611 612 O
or NCT03934034 613 615 O
M NCT03934034 616 617 B-Organism-Name
. NCT03934034 618 619 I-Organism-Name
kansasii NCT03934034 621 629 I-Organism-Name
. NCT03934034 630 631 O

Inclusion NCT03934593 0 9 O
Criteria NCT03934593 10 18 O
: NCT03934593 19 20 O

- NCT03934593 24 25 O
Church NCT03934593 27 33 O
eligibility NCT03934593 34 45 O
: NCT03934593 46 47 O
[ NCT03934593 48 49 O
Churches NCT03934593 50 58 O
must NCT03934593 59 63 O
be NCT03934593 64 66 O
predominantly NCT03934593 67 80 O
Hispanics NCT03934593 81 90 B-Ethnicity
( NCT03934593 91 92 O
60 NCT03934593 94 96 O
% NCT03934593 97 98 O
) NCT03934593 100 101 O
with NCT03934593 102 106 O
at NCT03934593 107 109 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03934593 110 115 I-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03934593 117 119 B-Eq-Value
adult NCT03934593 120 125 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
congregants NCT03934593 126 137 O
with NCT03934593 138 142 O
T NCT03934593 143 144 B-Condition-Name
2D NCT03934593 145 147 I-Condition-Name
willing NCT03934593 148 155 O
to NCT03934593 156 158 O
participate NCT03934593 159 170 O
in NCT03934593 171 173 O
the NCT03934593 174 177 O
study NCT03934593 178 183 O
. NCT03934593 184 185 O
The NCT03934593 187 190 O
rationale NCT03934593 191 200 O
for NCT03934593 201 204 O
20 NCT03934593 206 208 O
diabetic NCT03934593 209 217 O
voluntary NCT03934593 218 227 O
participants NCT03934593 228 240 O
per NCT03934593 241 244 O
church NCT03934593 245 251 O
is NCT03934593 252 254 O
based NCT03934593 255 260 O
on NCT03934593 261 263 O
the NCT03934593 264 267 O
Stanford NCT03934593 268 276 O
requirement NCT03934593 277 288 O
of NCT03934593 289 291 O

12 NCT03934593 298 300 O
- NCT03934593 301 302 O
16 NCT03934593 304 306 O
participants NCT03934593 307 319 O
allowed NCT03934593 320 327 O
per NCT03934593 328 331 O
support NCT03934593 332 339 O
group NCT03934593 340 345 O
and NCT03934593 346 349 O
with NCT03934593 350 354 O
an NCT03934593 355 357 O
anticipated NCT03934593 358 369 O
25 NCT03934593 371 373 O
% NCT03934593 374 375 O
attrition NCT03934593 376 385 O
. NCT03934593 386 387 O
] NCT03934593 388 389 O

- NCT03934593 393 394 O
Participants NCT03934593 396 408 O
' NCT03934593 408 409 O
eligibility NCT03934593 410 421 O
: NCT03934593 422 423 O
Participants NCT03934593 424 436 O
will NCT03934593 437 441 O
be NCT03934593 442 444 O
adults NCT03934593 445 451 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
age NCT03934593 452 455 O
21 NCT03934593 457 459 B-Eq-Value
and NCT03934593 460 463 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03934593 464 469 I-Eq-Operator___Eq-Operator-Value:GTEQ
that NCT03934593 470 474 O
have NCT03934593 475 479 O
been NCT03934593 480 484 O
diagnosed NCT03934593 485 494 O
with NCT03934593 495 499 O
T NCT03934593 500 501 B-Condition-Name
2D NCT03934593 502 504 I-Condition-Name
. NCT03934593 505 506 O

Exclusion NCT03934593 508 517 O
Criteria NCT03934593 518 526 O
: NCT03934593 527 528 O

- NCT03934593 532 533 O
Children NCT03934593 535 543 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
, NCT03934593 544 545 O
adults NCT03934593 546 552 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
under NCT03934593 553 558 B-Eq-Operator___Eq-Operator-Value:LT
21 NCT03934593 560 562 B-Eq-Value
years NCT03934593 563 568 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03934593 569 571 O
age NCT03934593 572 575 O
, NCT03934593 576 577 O
and NCT03934593 578 581 O
pregnant NCT03934593 582 590 B-Condition-Name
women NCT03934593 591 596 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

Inclusion NCT03934424 0 9 O
Criteria NCT03934424 10 18 O
: NCT03934424 19 20 O

- NCT03934424 24 25 O
Generally NCT03934424 27 36 O
healthy NCT03934424 37 44 B-Condition-Name
individuals NCT03934424 45 56 O
aged NCT03934424 57 61 O
from NCT03934424 62 66 O
18 NCT03934424 68 70 B-Eq-Value
to NCT03934424 71 73 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03934424 75 77 B-Eq-Value
years NCT03934424 78 83 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03934424 86 87 O
BMI NCT03934424 89 92 B-Observation-Name___Observation-Type-Value:vital
25 NCT03934424 94 96 B-Eq-Value
- NCT03934424 97 98 B-Eq-Operator___Eq-Operator-Value:BETWEEN
35 NCT03934424 100 102 B-Eq-Value
kg NCT03934424 103 105 B-Eq-Unit
/ NCT03934424 106 107 O
m NCT03934424 108 109 B-Eq-Unit
2 NCT03934424 110 111 I-Eq-Unit
will NCT03934424 112 116 O
be NCT03934424 117 119 O
recruited NCT03934424 120 129 O

Exclusion NCT03934424 130 139 O
Criteria NCT03934424 140 148 O
: NCT03934424 149 150 O

- NCT03934424 154 155 O
Being NCT03934424 157 162 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
on NCT03934424 163 165 O
a NCT03934424 166 167 O
weight NCT03934424 168 174 O
- NCT03934424 175 176 O
loss NCT03934424 177 181 O
or NCT03934424 182 184 O
special NCT03934424 185 192 O
diet NCT03934424 193 197 B-Procedure-Name

- NCT03934424 200 201 O
Taking NCT03934424 203 209 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03934424 210 213 O
medications NCT03934424 214 225 O
or NCT03934424 226 228 O
drugs NCT03934424 229 234 O
known NCT03934424 235 240 O
to NCT03934424 241 243 O
affect NCT03934424 244 250 B-Stability___Stability-Value:change
appetite NCT03934424 251 259 B-Condition-Name

- NCT03934424 262 263 O
Have NCT03934424 265 269 O
serious NCT03934424 270 277 B-Severity___Severity-Value:severe
claustrophobia NCT03934424 278 292 B-Condition-Name
. NCT03934424 293 294 O

- NCT03934424 298 299 O
Individuals NCT03934424 301 312 O
with NCT03934424 313 317 O
mental NCT03934424 318 324 B-Condition-Name
disorders NCT03934424 325 334 I-Condition-Name
( NCT03934424 335 336 O
self NCT03934424 337 341 O
- NCT03934424 342 343 O
report NCT03934424 344 350 O
) NCT03934424 351 352 O
will NCT03934424 353 357 O
be NCT03934424 358 360 O
excluded NCT03934424 361 369 O
. NCT03934424 370 371 O

- NCT03934424 375 376 O
Due NCT03934424 378 381 O
to NCT03934424 382 384 O
MRI NCT03934424 385 388 B-Procedure-Name
, NCT03934424 389 390 O
any NCT03934424 391 394 O
individuals NCT03934424 395 406 O
with NCT03934424 407 411 O
metallic NCT03934424 412 420 B-Condition-Name
objects NCT03934424 421 428 I-Condition-Name
in NCT03934424 429 431 I-Condition-Name
their NCT03934424 432 437 I-Condition-Name
body NCT03934424 438 442 I-Condition-Name
, NCT03934424 443 444 O
including NCT03934424 445 454 O
surgical NCT03934424 455 463 B-Condition-Name
staples NCT03934424 464 471 I-Condition-Name
left NCT03934424 472 476 I-Condition-Name
in NCT03934424 477 479 I-Condition-Name
the NCT03934424 480 483 I-Condition-Name
body NCT03934424 484 488 I-Condition-Name
following NCT03934424 489 498 O
surgery NCT03934424 499 506 B-Procedure-Name
, NCT03934424 507 508 O
middle NCT03934424 509 515 B-Condition-Name
ear NCT03934424 516 519 I-Condition-Name
prosthesis NCT03934424 520 530 I-Condition-Name
, NCT03934424 531 532 O
permanent NCT03934424 533 542 B-Condition-Name
eye NCT03934424 543 546 I-Condition-Name
liner NCT03934424 547 552 I-Condition-Name
, NCT03934424 553 554 O
metal NCT03934424 555 560 B-Condition-Name
foreign NCT03934424 561 568 I-Condition-Name
objects NCT03934424 569 576 I-Condition-Name
lodged NCT03934424 577 583 I-Condition-Name
inside NCT03934424 584 590 I-Condition-Name
the NCT03934424 591 594 I-Condition-Name
eye NCT03934424 595 598 I-Condition-Name
, NCT03934424 599 600 O
heart NCT03934424 601 606 B-Condition-Name
pacemakers NCT03934424 607 617 I-Condition-Name
, NCT03934424 618 619 O
and NCT03934424 620 623 O
/ NCT03934424 624 625 O
or NCT03934424 626 628 O
pins NCT03934424 629 633 B-Condition-Name
inside NCT03934424 634 640 I-Condition-Name
the NCT03934424 641 644 O
knee NCT03934424 645 649 O
or NCT03934424 650 652 O
other NCT03934424 653 658 O
joints NCT03934424 659 665 O
or NCT03934424 666 668 O
who NCT03934424 669 672 O
are NCT03934424 673 676 O
pregnant NCT03934424 677 685 B-Condition-Name
or NCT03934424 686 688 O
could NCT03934424 689 694 O
be NCT03934424 695 697 O
pregnant NCT03934424 698 706 B-Condition-Name
( NCT03934424 707 708 O
assessed NCT03934424 709 717 O
through NCT03934424 718 725 O
a NCT03934424 726 727 O
urine NCT03934424 728 733 B-Observation-Name
pregnancy NCT03934424 734 743 I-Observation-Name
test NCT03934424 744 748 I-Observation-Name
for NCT03934424 749 752 O
women NCT03934424 753 758 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
) NCT03934424 759 760 O
will NCT03934424 761 765 O
be NCT03934424 766 768 O
excluded NCT03934424 769 777 O
from NCT03934424 778 782 O
this NCT03934424 783 787 O
study NCT03934424 788 793 O
because NCT03934424 794 801 O
of NCT03934424 802 804 O
the NCT03934424 805 808 O
risk NCT03934424 809 813 O
associated NCT03934424 814 824 O
with NCT03934424 825 829 O
the NCT03934424 830 833 O
MRI NCT03934424 834 837 B-Procedure-Name
scanner NCT03934424 838 845 O
. NCT03934424 846 847 O

Inclusion NCT03862404 0 9 O
Criteria NCT03862404 10 18 O
: NCT03862404 19 20 O

- NCT03862404 24 25 O
Male NCT03862404 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03862404 32 35 O
Female NCT03862404 36 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03862404 43 44 O
between NCT03862404 45 52 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03862404 54 56 B-Eq-Value
and NCT03862404 57 60 O
80 NCT03862404 62 64 B-Eq-Value
years NCT03862404 65 70 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03862404 71 72 O
ASA NCT03862404 73 76 B-Condition-Name
1 NCT03862404 78 79 B-Eq-Value
- NCT03862404 80 81 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03862404 83 84 B-Eq-Value
, NCT03862404 85 86 O
Scheduled NCT03862404 87 96 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03862404 97 100 O
open NCT03862404 101 105 O
thoracotomy NCT03862404 106 117 B-Procedure-Name

Exclusion NCT03862404 118 127 O
Criteria NCT03862404 128 136 O
: NCT03862404 137 138 O

- NCT03862404 142 143 O
ASA NCT03862404 145 148 B-Condition-Name
> NCT03862404 149 150 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03862404 152 153 B-Eq-Value
, NCT03862404 154 155 O
morbid NCT03862404 156 162 B-Condition-Name
obesity NCT03862404 163 170 I-Condition-Name
BMI NCT03862404 171 174 B-Observation-Name___Observation-Type-Value:vital
> NCT03862404 175 176 B-Eq-Operator___Eq-Operator-Value:GT
40 NCT03862404 178 180 B-Eq-Value
, NCT03862404 181 182 O
Previous NCT03862404 183 191 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cardiac NCT03862404 192 199 O
or NCT03862404 200 202 O
ipsilateral NCT03862404 203 214 O
thoracic NCT03862404 215 223 B-Procedure-Name
surgery NCT03862404 224 231 I-Procedure-Name
, NCT03862404 232 233 O
Renal NCT03862404 234 239 O
or NCT03862404 240 242 O
hepatic NCT03862404 243 250 O
failure NCT03862404 251 258 B-Condition-Name
, NCT03862404 259 260 O
anemia NCT03862404 261 267 B-Condition-Name
, NCT03862404 268 269 O
allergy NCT03862404 270 277 O
to NCT03862404 278 280 O
local NCT03862404 281 286 B-Procedure-Name
anesthetics NCT03862404 287 298 I-Procedure-Name
, NCT03862404 299 300 O
contraindications NCT03862404 301 318 O
to NCT03862404 319 321 O
receive NCT03862404 322 329 O
regional NCT03862404 330 338 B-Procedure-Name
anesthesia NCT03862404 339 349 I-Procedure-Name
, NCT03862404 350 351 O
patient NCT03862404 352 359 O
refusal NCT03862404 360 367 O
, NCT03862404 368 369 O
reiteration NCT03862404 370 381 B-Observation-Name
due NCT03862404 382 385 O
to NCT03862404 386 388 O
complication NCT03862404 389 401 B-Condition-Name

Inclusion NCT03861858 0 9 O
Criteria NCT03861858 10 18 O
: NCT03861858 19 20 O

- NCT03861858 24 25 O
Age NCT03861858 27 30 O
13 NCT03861858 32 34 B-Eq-Value
- NCT03861858 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
17 NCT03861858 38 40 B-Eq-Value
years NCT03861858 41 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03861858 47 49 O
18 NCT03861858 51 53 B-Eq-Value
- NCT03861858 54 55 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03861858 57 59 B-Eq-Value
if NCT03861858 60 62 O
still NCT03861858 63 68 O
living NCT03861858 69 75 O
at NCT03861858 76 78 O
home NCT03861858 79 83 O
with NCT03861858 84 88 O
parent NCT03861858 89 95 O
. NCT03861858 96 97 O

- NCT03861858 101 102 O
Agreement NCT03861858 104 113 O
of NCT03861858 114 116 O
at NCT03861858 117 119 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861858 120 125 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03861858 126 129 B-Eq-Value
responsible NCT03861858 130 141 O
adult NCT03861858 142 147 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
parent NCT03861858 148 154 O
/ NCT03861858 155 156 O
caregiver NCT03861858 157 166 O
to NCT03861858 167 169 O
participate NCT03861858 170 181 O
in NCT03861858 182 184 O
treatment NCT03861858 185 194 B-Procedure-Name
. NCT03861858 195 196 O

- NCT03861858 200 201 O
Agreement NCT03861858 203 212 O
to NCT03861858 213 215 O
take NCT03861858 216 220 O
part NCT03861858 221 225 O
in NCT03861858 226 228 O
assessments NCT03861858 229 240 O
, NCT03861858 241 242 O
videotaping NCT03861858 243 254 O
/ NCT03861858 255 256 O
audiotaping NCT03861858 257 268 O
and NCT03861858 269 272 O
coding NCT03861858 273 279 O
of NCT03861858 280 282 O
their NCT03861858 283 288 O
sessions NCT03861858 289 297 O
by NCT03861858 298 300 O
research NCT03861858 301 309 O
personnel NCT03861858 310 319 O
. NCT03861858 320 321 O

- NCT03861858 325 326 O
Agreement NCT03861858 328 337 O
to NCT03861858 338 340 O
pay NCT03861858 341 344 O
for NCT03861858 345 348 O
mental NCT03861858 349 355 O
health NCT03861858 356 362 O
services NCT03861858 363 371 O
at NCT03861858 372 374 O
the NCT03861858 375 378 O
DBT NCT03861858 379 382 O
- NCT03861858 383 384 O
RU NCT03861858 385 387 O
on NCT03861858 388 390 O
a NCT03861858 391 392 O
sliding NCT03861858 393 400 O
scale NCT03861858 401 406 O
, NCT03861858 407 408 O
and NCT03861858 409 412 O
to NCT03861858 413 415 O
participate NCT03861858 416 427 O
in NCT03861858 428 430 O
research NCT03861858 431 439 O
assessments NCT03861858 440 451 O
as NCT03861858 452 454 O
volunteers NCT03861858 455 465 O
. NCT03861858 466 467 O

- NCT03861858 471 472 O
Residence NCT03861858 474 483 B-Location___Location-Value:residence
within NCT03861858 484 490 O
commuting NCT03861858 491 500 B-Observation-Name
distance NCT03861858 501 509 I-Observation-Name
of NCT03861858 510 512 O
clinic NCT03861858 513 519 B-Location___Location-Value:clinic
( NCT03861858 520 521 O
< NCT03861858 523 524 B-Eq-Operator___Eq-Operator-Value:LT
45 NCT03861858 526 528 B-Eq-Value
minutes NCT03861858 529 536 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
) NCT03861858 537 538 O
. NCT03861858 540 541 O

- NCT03861858 545 546 O
Agreement NCT03861858 548 557 O
to NCT03861858 558 560 O
discontinue NCT03861858 561 572 O
other NCT03861858 573 578 O
forms NCT03861858 579 584 O
of NCT03861858 585 587 O
talk NCT03861858 588 592 B-Procedure-Name
therapy NCT03861858 593 600 I-Procedure-Name
for NCT03861858 601 604 O
duration NCT03861858 605 613 O
of NCT03861858 614 616 O
DBT NCT03861858 617 620 B-Procedure-Name
program NCT03861858 621 628 I-Procedure-Name
( NCT03861858 629 630 O
does NCT03861858 631 635 O
not NCT03861858 636 639 O
refer NCT03861858 640 645 O
to NCT03861858 646 648 O
AA NCT03861858 649 651 O
/ NCT03861858 652 653 O
NA NCT03861858 654 656 O
programs NCT03861858 657 665 B-Procedure-Name
or NCT03861858 666 668 O
psychotropic NCT03861858 669 681 B-Drug-Name
medication NCT03861858 682 692 I-Drug-Name
management NCT03861858 693 703 B-Procedure-Name
) NCT03861858 704 705 O
. NCT03861858 707 708 O

- NCT03861858 712 713 O
Exhibits NCT03861858 715 723 O
dysregulation NCT03861858 724 737 B-Condition-Name
within NCT03861858 738 744 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861858 745 748 O
past NCT03861858 749 753 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03861858 754 757 B-Eq-Value
months NCT03861858 758 764 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
as NCT03861858 765 767 O
evidenced NCT03861858 768 777 O
by NCT03861858 778 780 O
1 NCT03861858 782 783 O
) NCT03861858 784 785 O
intentional NCT03861858 786 797 O
self NCT03861858 798 802 B-Condition-Name
- NCT03861858 803 804 I-Condition-Name
injury NCT03861858 805 811 I-Condition-Name
and NCT03861858 812 815 O
/ NCT03861858 816 817 O
or NCT03861858 818 820 O
suicide NCT03861858 821 828 B-Condition-Name
attempt NCT03861858 829 836 I-Condition-Name
and NCT03861858 837 840 O
/ NCT03861858 841 842 O
or NCT03861858 843 845 O
2 NCT03861858 847 848 O
) NCT03861858 849 850 O
substance NCT03861858 851 860 B-Condition-Name
use NCT03861858 861 864 I-Condition-Name
disorder NCT03861858 865 873 I-Condition-Name
. NCT03861858 874 875 O

- NCT03861858 879 880 O
Meets NCT03861858 882 887 O
two NCT03861858 888 891 B-Eq-Value
additional NCT03861858 892 902 O
criteria NCT03861858 903 911 O
for NCT03861858 912 915 O
borderline NCT03861858 916 926 B-Condition-Name
personality NCT03861858 927 938 I-Condition-Name
disorder NCT03861858 939 947 I-Condition-Name
( NCT03861858 948 949 O
BPD NCT03861858 950 953 B-Condition-Name
) NCT03861858 954 955 O
. NCT03861858 957 958 O

Exclusion NCT03861858 960 969 O
Criteria NCT03861858 970 978 O
: NCT03861858 979 980 O

- NCT03861858 984 985 O
Clients NCT03861858 987 994 O
who NCT03861858 995 998 O
need NCT03861858 999 1003 O
mental NCT03861858 1004 1010 B-Procedure-Name
health NCT03861858 1011 1017 I-Procedure-Name
services NCT03861858 1018 1026 I-Procedure-Name
not NCT03861858 1027 1030 O
available NCT03861858 1031 1040 O
at NCT03861858 1041 1043 O
the NCT03861858 1044 1047 O
DBT NCT03861858 1048 1051 B-Location
- NCT03861858 1052 1053 I-Location
RU NCT03861858 1054 1056 I-Location
, NCT03861858 1057 1058 O
such NCT03861858 1059 1063 O
as NCT03861858 1064 1066 O
treatment NCT03861858 1067 1076 O
for NCT03861858 1077 1080 O
schizophrenia NCT03861858 1081 1094 B-Condition-Name
or NCT03861858 1095 1097 O
life NCT03861858 1098 1102 O
- NCT03861858 1103 1104 O
threatening NCT03861858 1105 1116 O
anorexia NCT03861858 1117 1125 B-Condition-Name
, NCT03861858 1126 1127 O
or NCT03861858 1128 1130 O
who NCT03861858 1131 1134 O
are NCT03861858 1135 1138 O
currently NCT03861858 1139 1148 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
obtaining NCT03861858 1149 1158 O
optimum NCT03861858 1159 1166 O
professional NCT03861858 1167 1179 O
treatment NCT03861858 1180 1189 O
that NCT03861858 1190 1194 O
should NCT03861858 1195 1201 O
not NCT03861858 1202 1205 O
be NCT03861858 1206 1208 O
ended NCT03861858 1209 1214 O
. NCT03861858 1215 1216 O

- NCT03861858 1220 1221 O
Non NCT03861858 1223 1226 O
- NCT03861858 1227 1228 O
English NCT03861858 1229 1236 B-Language
speaking NCT03861858 1237 1245 O
. NCT03861858 1246 1247 O

- NCT03861858 1251 1252 O
IQ NCT03861858 1254 1256 B-Observation-Name___Observation-Type-Value:clinical-score
< NCT03861858 1257 1258 B-Eq-Operator___Eq-Operator-Value:LT
70 NCT03861858 1260 1262 B-Eq-Value
. NCT03861858 1262 1263 O

- NCT03861858 1267 1268 O
Unable NCT03861858 1270 1276 O
to NCT03861858 1277 1279 O
understand NCT03861858 1280 1290 O
research NCT03861858 1291 1299 O
consent NCT03861858 1300 1307 O
forms NCT03861858 1308 1313 O
. NCT03861858 1314 1315 O

- NCT03861858 1319 1320 O
Court NCT03861858 1322 1327 B-Observation-Name
- NCT03861858 1328 1329 I-Observation-Name
ordered NCT03861858 1330 1337 I-Observation-Name
to NCT03861858 1338 1340 O
participate NCT03861858 1341 1352 O
in NCT03861858 1353 1355 O
treatment NCT03861858 1356 1365 O
. NCT03861858 1366 1367 O

Inclusion NCT03869021 0 9 O
Criteria NCT03869021 10 18 O
: NCT03869021 19 20 O

1 NCT03869021 25 26 O
. NCT03869021 26 27 O
Patients NCT03869021 29 37 O
free NCT03869021 38 42 O
from NCT03869021 43 47 O
any NCT03869021 48 51 O
disease NCT03869021 52 59 O
affecting NCT03869021 60 69 O
bone NCT03869021 70 74 O
formation NCT03869021 75 84 O
of NCT03869021 85 87 O
both NCT03869021 88 92 O
sexes NCT03869021 93 98 O
was NCT03869021 99 102 O
included NCT03869021 103 111 O
in NCT03869021 112 114 O
the NCT03869021 115 118 O
study NCT03869021 119 124 O
. NCT03869021 125 126 O

2 NCT03869021 131 132 O
. NCT03869021 132 133 O
Patients NCT03869021 135 143 O
younger NCT03869021 144 151 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03869021 152 156 I-Eq-Operator___Eq-Operator-Value:LT
25 NCT03869021 158 160 B-Eq-Value
years NCT03869021 161 166 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869021 167 170 O
. NCT03869021 171 172 O

3 NCT03869021 177 178 O
. NCT03869021 178 179 O
Patients NCT03869021 181 189 O
included NCT03869021 190 198 O
in NCT03869021 199 201 O
the NCT03869021 202 205 O
study NCT03869021 206 211 O
were NCT03869021 212 216 O
hemifacial NCT03869021 217 227 B-Condition-Name
microsomia NCT03869021 228 238 I-Condition-Name

4 NCT03869021 242 243 O
. NCT03869021 243 244 O
Distraction NCT03869021 246 257 B-Observation-Name___Observation-Type-Value:measurement
range NCT03869021 258 263 I-Observation-Name___Observation-Type-Value:measurement
was NCT03869021 264 267 O
between NCT03869021 268 275 O
15 NCT03869021 277 279 B-Eq-Value
- NCT03869021 280 281 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03869021 283 285 B-Eq-Value
mm NCT03869021 286 288 B-Eq-Unit
. NCT03869021 289 290 O

Exclusion NCT03869021 292 301 O
Criteria NCT03869021 302 310 O
: NCT03869021 311 312 O

1 NCT03869021 317 318 O
. NCT03869021 318 319 O
The NCT03869021 321 324 O
presence NCT03869021 325 333 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03869021 334 336 O
uncontrolled NCT03869021 337 349 O
systemic NCT03869021 350 358 O
disease NCT03869021 359 366 B-Condition-Name
. NCT03869021 367 368 O

2 NCT03869021 373 374 O
. NCT03869021 374 375 O
Previous NCT03869021 377 385 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiotherapy NCT03869021 386 398 B-Procedure-Name
on NCT03869021 399 401 O
head NCT03869021 402 406 O
and NCT03869021 407 410 O
neck NCT03869021 411 415 O
region NCT03869021 416 422 O
. NCT03869021 423 424 O

3 NCT03869021 429 430 O
. NCT03869021 430 431 O
Chemotherapy NCT03869021 433 445 B-Procedure-Name
within NCT03869021 446 452 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03869021 453 456 O
past NCT03869021 457 461 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
12 NCT03869021 463 465 B-Eq-Value
- NCT03869021 466 467 O
month NCT03869021 468 473 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
period NCT03869021 474 480 O
. NCT03869021 481 482 O

4 NCT03869021 487 488 O
. NCT03869021 488 489 O
An NCT03869021 491 493 O
active NCT03869021 494 500 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03869021 501 510 B-Condition-Name
at NCT03869021 511 513 O
the NCT03869021 514 517 O
distraction NCT03869021 518 529 O
site NCT03869021 530 534 O
. NCT03869021 535 536 O

Inclusion NCT03864263 0 9 O
Criteria NCT03864263 10 18 O
: NCT03864263 19 20 O

- NCT03864263 24 25 O
The NCT03864263 27 30 O
father NCT03864263 31 37 O
or NCT03864263 38 40 O
( NCT03864263 41 42 O
and NCT03864263 43 46 O
) NCT03864263 47 48 O
mother NCT03864263 49 55 O
is NCT03864263 56 58 O
HBV NCT03864263 59 62 B-Condition-Name
- NCT03864263 63 64 I-Condition-Name
infected NCT03864263 65 73 I-Condition-Name
( NCT03864263 74 75 O
pre NCT03864263 76 79 O
- NCT03864263 80 81 O
pregnancy NCT03864263 82 91 B-Condition-Name
or NCT03864263 92 94 O
present NCT03864263 95 102 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
) NCT03864263 103 104 O
； NCT03864263 105 106 O

- NCT03864263 109 110 O
Children NCT03864263 112 120 O
is NCT03864263 121 123 O
vaccinated NCT03864263 124 134 O
with NCT03864263 135 139 O
hepatitis NCT03864263 140 149 B-Immunization-Name
B NCT03864263 150 151 I-Immunization-Name
vaccine NCT03864263 152 159 I-Immunization-Name
after NCT03864263 160 165 O
birth NCT03864263 166 171 O
; NCT03864263 171 172 O

Exclusion NCT03864263 173 182 O
Criteria NCT03864263 183 191 O
: NCT03864263 192 193 O

- NCT03864263 197 198 O
Children NCT03864263 200 208 O
with NCT03864263 209 213 O
HBV NCT03864263 214 217 B-Condition-Name
infection NCT03864263 218 227 I-Condition-Name
; NCT03864263 227 228 O

- NCT03864263 231 232 O
Participants NCT03864263 234 246 O
agreed NCT03864263 247 253 O
to NCT03864263 254 256 O
undergo NCT03864263 257 264 O
clinical NCT03864263 265 273 O
follow NCT03864263 274 280 O
- NCT03864263 281 282 O
up NCT03864263 283 285 O
studies NCT03864263 286 293 O
. NCT03864263 294 295 O

Inclusion NCT03862612 0 9 O
Criteria NCT03862612 10 18 O
: NCT03862612 19 20 O

- NCT03862612 24 25 O
Male NCT03862612 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03862612 32 35 O
Female NCT03862612 36 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
participants NCT03862612 43 55 O
providing NCT03862612 56 65 O
written NCT03862612 66 73 O
informed NCT03862612 74 82 O
consent NCT03862612 83 90 O
, NCT03862612 91 92 O

- NCT03862612 96 97 O
ASA NCT03862612 99 102 B-Condition-Name
grade NCT03862612 103 108 B-Eq-Unit
1 NCT03862612 110 111 B-Eq-Value
- NCT03862612 112 113 O
4 NCT03862612 115 116 B-Eq-Value
, NCT03862612 117 118 O

- NCT03862612 123 124 O
aged NCT03862612 126 130 O
over NCT03862612 131 135 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03862612 137 139 B-Eq-Value

- NCT03862612 143 144 O
undergoing NCT03862612 146 156 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03862612 157 158 O
VATS NCT03862612 159 163 B-Procedure-Name
procedure NCT03862612 164 173 I-Procedure-Name
under NCT03862612 174 179 O
General NCT03862612 180 187 B-Procedure-Name
Anaesthesia NCT03862612 188 199 I-Procedure-Name

Exclusion NCT03862612 200 209 O
Criteria NCT03862612 210 218 O
: NCT03862612 219 220 O

- NCT03862612 224 225 O
Absence NCT03862612 227 234 O
of NCT03862612 235 237 O
informed NCT03862612 238 246 O
written NCT03862612 247 254 O
consent NCT03862612 255 262 O
, NCT03862612 263 264 O

- NCT03862612 268 269 O
pre NCT03862612 271 274 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03862612 275 283 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
infection NCT03862612 284 293 B-Condition-Name
at NCT03862612 294 296 O
block NCT03862612 297 302 O
site NCT03862612 303 307 O
, NCT03862612 308 309 O
- NCT03862612 311 312 O

- NCT03862612 316 317 O
severe NCT03862612 319 325 B-Severity___Severity-Value:severe
coagulopathy NCT03862612 326 338 B-Condition-Name
, NCT03862612 339 340 O

- NCT03862612 344 345 O
allergy NCT03862612 347 354 O
to NCT03862612 355 357 O
local NCT03862612 358 363 B-Procedure-Name
anaesthesia NCT03862612 364 375 I-Procedure-Name
, NCT03862612 376 377 O

- NCT03862612 381 382 O
pre NCT03862612 384 387 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03862612 388 396 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
neurological NCT03862612 397 409 B-Condition-Name
deficit NCT03862612 410 417 I-Condition-Name
, NCT03862612 418 419 O

- NCT03862612 423 424 O
previous NCT03862612 426 434 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03862612 435 442 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862612 443 445 O
opiate NCT03862612 446 452 B-Condition-Name
abuse NCT03862612 453 458 I-Condition-Name
, NCT03862612 459 460 O

- NCT03862612 464 465 O
pre NCT03862612 467 470 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03862612 471 479 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
chronic NCT03862612 480 487 O
pain NCT03862612 488 492 B-Condition-Name
condition NCT03862612 493 502 I-Condition-Name
, NCT03862612 503 504 O

- NCT03862612 508 509 O
pre NCT03862612 511 514 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03862612 515 516 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03862612 517 525 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
dementia NCT03862612 526 534 B-Condition-Name
[ NCT03862612 535 536 O
because NCT03862612 537 544 O
of NCT03862612 545 547 O
need NCT03862612 548 552 O
to NCT03862612 553 555 O
co NCT03862612 556 558 O
- NCT03862612 559 560 O
operate NCT03862612 561 568 O
in NCT03862612 569 571 O
completing NCT03862612 572 582 O
QoR NCT03862612 583 586 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03862612 587 588 I-Observation-Name___Observation-Type-Value:clinical-score
15 NCT03862612 590 592 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03862612 593 598 I-Observation-Name___Observation-Type-Value:clinical-score
day NCT03862612 599 602 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
after NCT03862612 603 608 O
surgery NCT03862612 609 616 B-Procedure-Name
] NCT03862612 617 618 O
. NCT03862612 620 621 O

Inclusion NCT03866460 0 9 O
Criteria NCT03866460 10 18 O
: NCT03866460 19 20 O

- NCT03866460 24 25 O
Signed NCT03866460 27 33 O
informed NCT03866460 34 42 O
consent NCT03866460 43 50 O
indicating NCT03866460 51 61 O
awareness NCT03866460 62 71 O
of NCT03866460 72 74 O
the NCT03866460 75 78 O
investigational NCT03866460 79 94 O
nature NCT03866460 95 101 O
of NCT03866460 102 104 O
the NCT03866460 105 108 O
protocol NCT03866460 109 117 O
. NCT03866460 118 119 O

- NCT03866460 123 124 O
Children NCT03866460 126 134 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03866460 135 139 O
RB NCT03866460 140 142 B-Condition-Name
aged NCT03866460 143 147 O
3 NCT03866460 149 150 B-Eq-Value
months NCT03866460 151 157 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03866460 158 161 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03866460 162 167 I-Eq-Operator___Eq-Operator-Value:GTEQ
who NCT03866460 168 171 O
are NCT03866460 172 175 O
scheduled NCT03866460 176 185 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03866460 186 188 O
receive NCT03866460 189 196 O
their NCT03866460 197 202 O
first NCT03866460 203 208 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
dose NCT03866460 209 213 O
of NCT03866460 214 216 O
IA NCT03866460 217 219 B-Drug-Name
carboplatin NCT03866460 220 231 I-Drug-Name
chemotherapy NCT03866460 232 244 B-Procedure-Name
. NCT03866460 245 246 O

- NCT03866460 255 256 O
Retinoblastoma NCT03866460 258 272 B-Condition-Name
is NCT03866460 273 275 O
rarely NCT03866460 276 282 O
seen NCT03866460 283 287 O
in NCT03866460 288 290 O
children NCT03866460 291 299 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
over NCT03866460 300 304 B-Eq-Operator___Eq-Operator-Value:GT
8 NCT03866460 306 307 B-Eq-Value
years NCT03866460 308 313 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866460 314 317 O
, NCT03866460 318 319 O
however NCT03866460 320 327 O
we NCT03866460 328 330 O
will NCT03866460 331 335 O
not NCT03866460 336 339 O
include NCT03866460 340 347 O
an NCT03866460 348 350 O
upper NCT03866460 351 356 O
age NCT03866460 357 360 O
range NCT03866460 361 366 O
so NCT03866460 367 369 O
as NCT03866460 370 372 O
not NCT03866460 373 376 O
to NCT03866460 377 379 O
exclude NCT03866460 380 387 O
any NCT03866460 388 391 O
possible NCT03866460 392 400 O
participants NCT03866460 401 413 O

Exclusion NCT03866460 414 423 O
Criteria NCT03866460 424 432 O
: NCT03866460 433 434 O

- NCT03866460 438 439 O
Children NCT03866460 441 449 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03866460 450 454 O
known NCT03866460 455 460 O
and NCT03866460 461 464 O
documented NCT03866460 465 475 O
preexisting NCT03866460 476 487 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
hearing NCT03866460 488 495 B-Condition-Name
loss NCT03866460 496 500 I-Condition-Name
. NCT03866460 501 502 O

Inclusion NCT03863444 0 9 O
Criteria NCT03863444 10 18 O
: NCT03863444 19 20 O

- NCT03863444 24 25 O
( NCT03863444 27 28 O
1 NCT03863444 30 31 O
) NCT03863444 32 33 O
gestational NCT03863444 34 45 B-Observation-Name___Observation-Type-Value:measurement
age NCT03863444 46 49 I-Observation-Name___Observation-Type-Value:measurement
35 NCT03863444 51 53 B-Eq-Value
to NCT03863444 54 56 B-Eq-Operator___Eq-Operator-Value:BETWEEN
39 NCT03863444 58 60 B-Eq-Value
weeks NCT03863444 61 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03863444 69 70 O
( NCT03863444 72 73 O
2 NCT03863444 75 76 O
) NCT03863444 77 78 O
adults NCT03863444 79 85 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult

- NCT03863444 88 89 O
( NCT03863444 91 92 O
3 NCT03863444 94 95 O
) NCT03863444 96 97 O
primipara NCT03863444 98 107 B-Condition-Name
and NCT03863444 108 111 O
their NCT03863444 112 117 O
spouses NCT03863444 118 125 O

- NCT03863444 128 129 O
( NCT03863444 131 132 O
4 NCT03863444 134 135 O
) NCT03863444 136 137 O
having NCT03863444 138 144 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
routine NCT03863444 145 152 O
prenatal NCT03863444 153 161 O
visits NCT03863444 162 168 B-Encounter-Type___Encounter-Type-Value:observation
and NCT03863444 169 172 O
plan NCT03863444 173 177 O
to NCT03863444 178 180 O
have NCT03863444 181 185 O
the NCT03863444 186 189 O
birth NCT03863444 190 195 O
in NCT03863444 196 198 O
the NCT03863444 199 202 O
medical NCT03863444 203 210 B-Location___Location-Value:hospital
center NCT03863444 211 217 I-Location___Location-Value:hospital

- NCT03863444 220 221 O
( NCT03863444 223 224 O
5 NCT03863444 226 227 O
) NCT03863444 228 229 O
able NCT03863444 230 234 O
to NCT03863444 235 237 O
communicate NCT03863444 238 249 O
with NCT03863444 250 254 O
Mandarin NCT03863444 255 263 B-Language
or NCT03863444 264 266 O
Taiwanese NCT03863444 267 276 B-Language

- NCT03863444 279 280 O
( NCT03863444 282 283 O
6 NCT03863444 285 286 O
) NCT03863444 287 288 O
willing NCT03863444 289 296 O
to NCT03863444 297 299 O
participate NCT03863444 300 311 O
in NCT03863444 312 314 O
this NCT03863444 315 319 O
study NCT03863444 320 325 O
and NCT03863444 326 329 O
give NCT03863444 330 334 O
written NCT03863444 335 342 O
inform NCT03863444 343 349 O
- NCT03863444 350 351 O
consent NCT03863444 352 359 O
forms NCT03863444 360 365 O

Exclusion NCT03863444 366 375 O
Criteria NCT03863444 376 384 O
: NCT03863444 385 386 O

- NCT03863444 390 391 O
( NCT03863444 393 394 O
1 NCT03863444 396 397 O
) NCT03863444 398 399 O
having NCT03863444 400 406 O
fetus NCT03863444 407 412 B-Condition-Name
with NCT03863444 413 417 O
abnormality NCT03863444 418 429 B-Polarity___Polarity-Value:abnormal

- NCT03863444 432 433 O
( NCT03863444 435 436 O
2 NCT03863444 438 439 O
) NCT03863444 440 441 O
high NCT03863444 442 446 B-Polarity___Polarity-Value:high
- NCT03863444 447 448 O
risk NCT03863444 449 453 O
pregnancy NCT03863444 454 463 B-Condition-Name

- NCT03863444 466 467 O
( NCT03863444 469 470 O
3 NCT03863444 472 473 O
) NCT03863444 474 475 O
can NCT03863444 476 479 O
not NCT03863444 479 482 O
room NCT03863444 483 487 B-Observation-Name
- NCT03863444 488 489 I-Observation-Name
in NCT03863444 490 492 I-Observation-Name
due NCT03863444 493 496 O
to NCT03863444 497 499 O
newborn NCT03863444 500 507 O
's NCT03863444 507 509 O
medical NCT03863444 510 517 O
conditions NCT03863444 518 528 O

Inclusion NCT03864471 0 9 O
Criteria NCT03864471 10 18 O
: NCT03864471 19 20 O

- NCT03864471 24 25 O
lived NCT03864471 27 32 O
in NCT03864471 33 35 O
the NCT03864471 36 39 O
community NCT03864471 40 49 O
at NCT03864471 50 52 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864471 53 58 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03864471 59 64 B-Eq-Value
months NCT03864471 65 71 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03864471 74 75 O
over NCT03864471 77 81 B-Eq-Operator___Eq-Operator-Value:GT
65 NCT03864471 83 85 B-Eq-Value
years NCT03864471 86 91 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03864471 92 95 O

- NCT03864471 98 99 O
fluently NCT03864471 101 109 O
communicated NCT03864471 110 122 O
in NCT03864471 123 125 O
Mandarin NCT03864471 126 134 B-Language
or NCT03864471 135 137 O
Taiwanese NCT03864471 138 147 B-Language

- NCT03864471 150 151 O
screened NCT03864471 153 161 O
by NCT03864471 162 164 O
the NCT03864471 165 168 O
High NCT03864471 169 173 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03864471 174 175 I-Observation-Name___Observation-Type-Value:clinical-score
need NCT03864471 176 180 I-Observation-Name___Observation-Type-Value:clinical-score
Community NCT03864471 181 190 I-Observation-Name___Observation-Type-Value:clinical-score
Older NCT03864471 191 196 I-Observation-Name___Observation-Type-Value:clinical-score
Adults NCT03864471 197 203 I-Observation-Name___Observation-Type-Value:clinical-score
Screening NCT03864471 204 213 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03864471 214 219 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03864471 220 221 O
HCOASS NCT03864471 222 228 B-Observation-Name___Observation-Type-Value:clinical-score
) NCT03864471 229 230 O
as NCT03864471 231 233 O
high NCT03864471 234 238 B-Condition-Name
- NCT03864471 239 240 I-Condition-Name
need NCT03864471 241 245 I-Condition-Name
older NCT03864471 246 251 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:elderly
adults NCT03864471 252 258 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:elderly

Exclusion NCT03864471 259 268 O
Criteria NCT03864471 269 277 O
: NCT03864471 278 279 O

- NCT03864471 283 284 O
diagnosed NCT03864471 286 295 O
as NCT03864471 296 298 O
dementia NCT03864471 299 307 B-Condition-Name

Inclusion NCT03862014 0 9 O
Criteria NCT03862014 10 18 O
: NCT03862014 19 20 O

- NCT03862014 24 25 O
Patients NCT03862014 27 35 O
and NCT03862014 36 39 O
parents NCT03862014 40 47 O
of NCT03862014 48 50 O
the NCT03862014 51 54 O
patients NCT03862014 55 63 O
who NCT03862014 64 67 O
accept NCT03862014 68 74 O
to NCT03862014 75 77 O
participate NCT03862014 78 89 O
and NCT03862014 90 93 O
sign NCT03862014 94 98 O
the NCT03862014 99 102 O
informed NCT03862014 103 111 O
consent NCT03862014 112 119 O

- NCT03862014 122 123 O
Patients NCT03862014 125 133 O
whose NCT03862014 134 139 O
molar NCT03862014 140 145 O
teeth NCT03862014 146 151 O
are NCT03862014 152 155 O
diagnosed NCT03862014 156 165 O
as NCT03862014 166 168 O
molar NCT03862014 169 174 B-Condition-Name
incisor NCT03862014 175 182 I-Condition-Name
hypomineralization NCT03862014 183 201 I-Condition-Name
by NCT03862014 202 204 O
EAPD NCT03862014 205 209 O

- NCT03862014 212 213 O
Teeth NCT03862014 215 220 O
that NCT03862014 221 225 O
are NCT03862014 226 229 O
fully NCT03862014 230 235 B-Condition-Name
erupted NCT03862014 236 243 I-Condition-Name

- NCT03862014 246 247 O
Patients NCT03862014 249 257 O
who NCT03862014 258 261 O
have NCT03862014 262 266 O
at NCT03862014 267 269 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862014 270 275 I-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03862014 276 279 B-Eq-Value
permanent NCT03862014 280 289 O
first NCT03862014 290 295 O
molars NCT03862014 296 302 B-Condition-Name
that NCT03862014 303 307 O
need NCT03862014 308 312 O
fissure NCT03862014 313 320 B-Procedure-Name
sealant NCT03862014 321 328 I-Procedure-Name

- NCT03862014 331 332 O
Teeth NCT03862014 334 339 O
that NCT03862014 340 344 O
have NCT03862014 345 349 O
white NCT03862014 350 355 O
- NCT03862014 356 357 O
yellow NCT03862014 358 364 O
- NCT03862014 365 366 O
brown NCT03862014 367 372 O
discoloration NCT03862014 373 386 B-Condition-Name
that NCT03862014 387 391 O
indicate NCT03862014 392 400 O
high NCT03862014 401 405 B-Polarity___Polarity-Value:high
- NCT03862014 406 407 O
caries NCT03862014 408 414 B-Condition-Name
risk NCT03862014 415 419 O

Exclusion NCT03862014 420 429 O
Criteria NCT03862014 430 438 O
: NCT03862014 439 440 O

- NCT03862014 444 445 O
Teeth NCT03862014 447 452 B-Condition-Name
that NCT03862014 453 457 O
are NCT03862014 458 461 O
previously NCT03862014 462 472 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
restored NCT03862014 473 481 B-Procedure-Name
or NCT03862014 482 484 O
have NCT03862014 485 489 O
caries NCT03862014 490 496 B-Condition-Name

- NCT03862014 499 500 O
Patients NCT03862014 502 510 O
who NCT03862014 511 514 O
have NCT03862014 515 519 O
orthodontic NCT03862014 520 531 B-Procedure-Name
treatment NCT03862014 532 541 I-Procedure-Name

- NCT03862014 544 545 O
Patients NCT03862014 547 555 O
who NCT03862014 556 559 O
are NCT03862014 560 563 O
not NCT03862014 564 567 O
cooperative NCT03862014 568 579 O
for NCT03862014 580 583 O
the NCT03862014 584 587 O
dental NCT03862014 588 594 B-Procedure-Name
procedure NCT03862014 595 604 I-Procedure-Name

- NCT03862014 607 608 O
Teeth NCT03862014 610 615 O
that NCT03862014 616 620 O
have NCT03862014 621 625 O
dental NCT03862014 626 632 B-Condition-Name
flourosis NCT03862014 633 642 I-Condition-Name
or NCT03862014 643 645 O
enamel NCT03862014 646 652 B-Condition-Name
malformation NCT03862014 653 665 I-Condition-Name
according NCT03862014 666 675 O
to NCT03862014 676 678 O
the NCT03862014 679 682 O
specific NCT03862014 683 691 O
syndromes NCT03862014 692 701 O

Inclusion NCT03869814 0 9 O
Criteria NCT03869814 10 18 O
: NCT03869814 19 20 O

1 NCT03869814 25 26 O
. NCT03869814 26 27 O
Age NCT03869814 29 32 O
greater NCT03869814 33 40 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03869814 41 45 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03869814 46 48 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03869814 49 54 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03869814 55 57 I-Eq-Operator___Eq-Operator-Value:GTEQ
21 NCT03869814 59 61 B-Eq-Value
years NCT03869814 62 67 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869814 68 71 O

2 NCT03869814 75 76 O
. NCT03869814 76 77 O
Clinical NCT03869814 79 87 O
suspicion NCT03869814 88 97 O
of NCT03869814 98 100 O
malignancy NCT03869814 101 111 B-Condition-Name
based NCT03869814 112 117 O
on NCT03869814 118 120 O
signs NCT03869814 121 126 O
, NCT03869814 127 128 O
symptoms NCT03869814 129 137 O
, NCT03869814 138 139 O
imaging NCT03869814 140 147 B-Procedure-Name
studies NCT03869814 148 155 I-Procedure-Name
, NCT03869814 156 157 O
and NCT03869814 158 161 O
/ NCT03869814 162 163 O
or NCT03869814 164 166 O
non NCT03869814 167 170 O
- NCT03869814 171 172 O
surgical NCT03869814 173 181 O
biopsies NCT03869814 182 190 B-Procedure-Name
of NCT03869814 191 193 O
any NCT03869814 194 197 O
of NCT03869814 198 200 O
the NCT03869814 201 204 O
following NCT03869814 205 214 O
cancer NCT03869814 215 221 B-Condition-Name
types NCT03869814 222 227 O
: NCT03869814 228 229 O
bladder NCT03869814 230 237 O
, NCT03869814 238 239 O
breast NCT03869814 240 246 O
, NCT03869814 247 248 O
colorectal NCT03869814 249 259 O
, NCT03869814 260 261 O
kidney NCT03869814 262 268 O
, NCT03869814 269 270 O
liver NCT03869814 271 276 O
, NCT03869814 277 278 O
lung NCT03869814 279 283 O
, NCT03869814 284 285 O
pancreas NCT03869814 286 294 O
or NCT03869814 295 297 O
prostate NCT03869814 298 306 O
. NCT03869814 307 308 O

3 NCT03869814 313 314 O
. NCT03869814 314 315 O
Candidate NCT03869814 317 326 O
for NCT03869814 327 330 O
subsequent NCT03869814 331 341 O
medical NCT03869814 342 349 O
and NCT03869814 350 353 O
/ NCT03869814 354 355 O
or NCT03869814 356 358 O
surgical NCT03869814 359 367 O
work NCT03869814 368 372 B-Procedure-Name
- NCT03869814 373 374 I-Procedure-Name
up NCT03869814 375 377 I-Procedure-Name
to NCT03869814 378 380 O
complete NCT03869814 381 389 O
organ NCT03869814 390 395 O
- NCT03869814 396 397 O
specific NCT03869814 398 406 O
cancer NCT03869814 407 413 B-Condition-Name
diagnosis NCT03869814 414 423 O
inclusive NCT03869814 424 433 O
of NCT03869814 434 436 O
pathologic NCT03869814 437 447 B-Procedure-Name
staging NCT03869814 448 455 I-Procedure-Name
as NCT03869814 456 458 O
specified NCT03869814 459 468 O
by NCT03869814 469 471 O
the NCT03869814 472 475 O
College NCT03869814 476 483 O
of NCT03869814 484 486 O
American NCT03869814 487 495 O
Pathology NCT03869814 496 505 O
( NCT03869814 506 507 O
CAP NCT03869814 508 511 O
) NCT03869814 512 513 O
. NCT03869814 515 516 O

4 NCT03869814 521 522 O
. NCT03869814 522 523 O
Provision NCT03869814 525 534 O
of NCT03869814 535 537 O
informed NCT03869814 538 546 O
consent NCT03869814 547 554 O
. NCT03869814 555 556 O

Exclusion NCT03869814 558 567 O
Criteria NCT03869814 568 576 O
: NCT03869814 577 578 O

1 NCT03869814 583 584 O
. NCT03869814 584 585 O
Age NCT03869814 587 590 O
less NCT03869814 591 595 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03869814 596 600 I-Eq-Operator___Eq-Operator-Value:LT
21 NCT03869814 602 604 B-Eq-Value
years NCT03869814 605 610 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869814 611 614 O

2 NCT03869814 618 619 O
. NCT03869814 619 620 O
Any NCT03869814 622 625 O
prior NCT03869814 626 631 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cancer NCT03869814 632 638 B-Condition-Name
diagnosis NCT03869814 639 648 O
, NCT03869814 649 650 O
without NCT03869814 651 658 O
or NCT03869814 659 661 O
with NCT03869814 662 666 O
any NCT03869814 667 670 O
treatment NCT03869814 671 680 O
( NCT03869814 681 682 O
e NCT03869814 683 684 O
. NCT03869814 685 686 O
g NCT03869814 687 688 O
. NCT03869814 689 690 O
, NCT03869814 691 692 O
medical NCT03869814 693 700 O
, NCT03869814 701 702 O
surgical NCT03869814 703 711 O
, NCT03869814 712 713 O
or NCT03869814 714 716 O
radiation NCT03869814 717 726 O
oncology NCT03869814 727 735 O
) NCT03869814 736 737 O
within NCT03869814 738 744 B-Eq-Operator___Eq-Operator-Value:LTEQ
prior NCT03869814 745 750 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03869814 751 754 B-Eq-Value
months NCT03869814 755 761 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03869814 762 763 O

3 NCT03869814 768 769 O
. NCT03869814 769 770 O
Any NCT03869814 772 775 O
surgery NCT03869814 776 783 B-Procedure-Name
, NCT03869814 784 785 O
i NCT03869814 786 787 O
. NCT03869814 788 789 O
e NCT03869814 790 791 O
. NCT03869814 792 793 O
, NCT03869814 794 795 O
invasive NCT03869814 796 804 B-Procedure-Name
procedure NCT03869814 805 814 I-Procedure-Name
performed NCT03869814 815 824 O
in NCT03869814 825 827 O
the NCT03869814 828 831 O
operating NCT03869814 832 841 O
room NCT03869814 842 846 O
with NCT03869814 847 851 O
any NCT03869814 852 855 O
level NCT03869814 856 861 O
of NCT03869814 862 864 O
anesthesia NCT03869814 865 875 B-Procedure-Name
, NCT03869814 876 877 O
within NCT03869814 878 884 B-Eq-Operator___Eq-Operator-Value:LTEQ
prior NCT03869814 885 890 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03869814 891 896 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03869814 897 898 O

4 NCT03869814 903 904 O
. NCT03869814 904 905 O
Any NCT03869814 907 910 O
non NCT03869814 911 914 O
- NCT03869814 915 916 O
cancer NCT03869814 917 923 B-Condition-Name
systemic NCT03869814 924 932 B-Procedure-Name
therapy NCT03869814 933 940 I-Procedure-Name
associated NCT03869814 941 951 O
with NCT03869814 952 956 O
molecularly NCT03869814 957 968 O
targeted NCT03869814 969 977 O
immune NCT03869814 978 984 B-Procedure-Name
modulation NCT03869814 985 995 I-Procedure-Name
, NCT03869814 996 997 O
e NCT03869814 998 999 O
. NCT03869814 1000 1001 O
g NCT03869814 1002 1003 O
. NCT03869814 1004 1005 O
, NCT03869814 1006 1007 O
monoclonal NCT03869814 1008 1018 B-Procedure-Name
antibodies NCT03869814 1019 1029 I-Procedure-Name
. NCT03869814 1030 1031 O

5 NCT03869814 1036 1037 O
. NCT03869814 1037 1038 O
Any NCT03869814 1040 1043 O
concurrent NCT03869814 1044 1054 O
or NCT03869814 1055 1057 O
prior NCT03869814 1058 1063 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pregnancy NCT03869814 1064 1073 B-Condition-Name
within NCT03869814 1074 1080 B-Eq-Operator___Eq-Operator-Value:LTEQ
previous NCT03869814 1081 1089 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
twelve NCT03869814 1090 1096 B-Eq-Value
months NCT03869814 1097 1103 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03869814 1104 1105 O

6 NCT03869814 1110 1111 O
. NCT03869814 1111 1112 O
Any NCT03869814 1114 1117 O
history NCT03869814 1118 1125 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869814 1126 1128 O
organ NCT03869814 1129 1134 B-Procedure-Name
tissue NCT03869814 1135 1141 I-Procedure-Name
transplantation NCT03869814 1142 1157 I-Procedure-Name

7 NCT03869814 1161 1162 O
. NCT03869814 1162 1163 O
Any NCT03869814 1165 1168 O
history NCT03869814 1169 1176 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869814 1177 1179 O
blood NCT03869814 1180 1185 B-Procedure-Name
product NCT03869814 1186 1193 I-Procedure-Name
transfusion NCT03869814 1194 1205 I-Procedure-Name
within NCT03869814 1206 1212 B-Eq-Operator___Eq-Operator-Value:LTEQ
prior NCT03869814 1213 1218 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03869814 1219 1224 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03869814 1225 1226 O

8 NCT03869814 1231 1232 O
. NCT03869814 1232 1233 O
Any NCT03869814 1235 1238 O
major NCT03869814 1239 1244 B-Severity___Severity-Value:severe
trauma NCT03869814 1245 1251 B-Condition-Name
within NCT03869814 1252 1258 B-Eq-Operator___Eq-Operator-Value:LTEQ
prior NCT03869814 1259 1264 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03869814 1265 1268 B-Eq-Value
months NCT03869814 1269 1275 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03869814 1276 1277 O
e NCT03869814 1278 1279 O
. NCT03869814 1280 1281 O
g NCT03869814 1282 1283 O
. NCT03869814 1284 1285 O
, NCT03869814 1286 1287 O
burn NCT03869814 1288 1292 B-Condition-Name
injury NCT03869814 1293 1299 I-Condition-Name
, NCT03869814 1300 1301 O
extremity NCT03869814 1302 1311 B-Condition-Name
crush NCT03869814 1312 1317 I-Condition-Name
injury NCT03869814 1318 1324 I-Condition-Name
, NCT03869814 1325 1326 O
motor NCT03869814 1327 1332 B-Condition-Name
vehicle NCT03869814 1333 1340 I-Condition-Name
accident NCT03869814 1341 1349 I-Condition-Name
, NCT03869814 1350 1351 O
etc NCT03869814 1352 1355 O
. NCT03869814 1356 1357 O

9 NCT03869814 1362 1363 O
. NCT03869814 1363 1364 O
Unable NCT03869814 1366 1372 O
to NCT03869814 1373 1375 O
provide NCT03869814 1376 1383 O
informed NCT03869814 1384 1392 O
consent NCT03869814 1393 1400 O
. NCT03869814 1401 1402 O

Inclusion NCT03865784 0 9 O
Criteria NCT03865784 10 18 O
: NCT03865784 19 20 O

- NCT03865784 24 25 O
Federated NCT03865784 27 36 B-Observation-Name___Observation-Type-Value:social-habit
boxers NCT03865784 37 43 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03865784 46 47 O
Over NCT03865784 49 53 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03865784 55 57 B-Eq-Value
years NCT03865784 58 63 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03865784 66 67 O
Male NCT03865784 69 73 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03865784 76 77 O
With NCT03865784 79 83 O
non NCT03865784 84 87 O
- NCT03865784 88 89 O
specific NCT03865784 90 98 O
back NCT03865784 99 103 B-Condition-Name
pain NCT03865784 104 108 I-Condition-Name
that NCT03865784 109 113 O
does NCT03865784 114 118 O
not NCT03865784 119 122 O
incapacitate NCT03865784 123 135 O
them NCT03865784 136 140 O
for NCT03865784 141 144 O
the NCT03865784 145 148 O
realization NCT03865784 149 160 O
of NCT03865784 161 163 O
their NCT03865784 164 169 O
sport NCT03865784 170 175 O
or NCT03865784 176 178 O
work NCT03865784 179 183 O
activity NCT03865784 184 192 O
. NCT03865784 193 194 O

Exclusion NCT03865784 196 205 O
Criteria NCT03865784 206 214 O
: NCT03865784 215 216 O

- NCT03865784 220 221 O
Federated NCT03865784 223 232 B-Observation-Name___Observation-Type-Value:social-habit
boxers NCT03865784 233 239 I-Observation-Name___Observation-Type-Value:social-habit
with NCT03865784 240 244 O
lumbar NCT03865784 245 251 O
injury NCT03865784 252 258 B-Condition-Name
with NCT03865784 259 263 O
medical NCT03865784 264 271 O
diagnosis NCT03865784 272 281 O

- NCT03865784 284 285 O
Who NCT03865784 287 290 O
are NCT03865784 291 294 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03865784 295 297 O
have NCT03865784 298 302 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
been NCT03865784 303 307 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treated NCT03865784 308 315 O
by NCT03865784 316 318 O
pharmacological NCT03865784 319 334 B-Procedure-Name
or NCT03865784 335 337 O
physiotherapy NCT03865784 338 351 B-Procedure-Name
in NCT03865784 352 354 O
the NCT03865784 355 358 O
last NCT03865784 359 363 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03865784 365 366 B-Eq-Value
months NCT03865784 367 373 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03865784 376 377 O
Presenting NCT03865784 379 389 O
allergies NCT03865784 390 399 O
or NCT03865784 400 402 O
alterations NCT03865784 403 414 B-Condition-Name
of NCT03865784 415 417 O
the NCT03865784 418 421 O
skin NCT03865784 422 426 O

- NCT03865784 429 430 O
Not NCT03865784 432 435 O
sign NCT03865784 436 440 O
the NCT03865784 441 444 O
informed NCT03865784 445 453 O
consent NCT03865784 454 461 O
document NCT03865784 462 470 O
. NCT03865784 471 472 O

Inclusion NCT03863652 0 9 O
Criteria NCT03863652 10 18 O
: NCT03863652 19 20 O

- NCT03863652 24 25 O
Patients NCT03863652 27 35 O
≥ NCT03863652 36 37 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863652 39 41 B-Eq-Value
years NCT03863652 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863652 48 51 O
requiring NCT03863652 52 61 O
PCI NCT03863652 62 65 B-Procedure-Name

- NCT03863652 68 69 O
Patients NCT03863652 71 79 O
who NCT03863652 80 83 O
are NCT03863652 84 87 O
palpable NCT03863652 88 96 B-Condition-Name
distal NCT03863652 97 103 I-Condition-Name
radial NCT03863652 104 110 I-Condition-Name
arter NCT03863652 111 116 I-Condition-Name

- NCT03863652 119 120 O
The NCT03863652 122 125 O
decision NCT03863652 126 134 O
to NCT03863652 135 137 O
participate NCT03863652 138 149 O
voluntarily NCT03863652 150 161 O
in NCT03863652 162 164 O
this NCT03863652 165 169 O
study NCT03863652 170 175 O
and NCT03863652 176 179 O
the NCT03863652 180 183 O
written NCT03863652 184 191 O
consent NCT03863652 192 199 O
of NCT03863652 200 202 O
the NCT03863652 203 206 O
patient NCT03863652 207 214 O

Exclusion NCT03863652 215 224 O
Criteria NCT03863652 225 233 O
: NCT03863652 234 235 O

- NCT03863652 239 240 O
Patients NCT03863652 242 250 O
who NCT03863652 251 254 O
are NCT03863652 255 258 O
not NCT03863652 259 262 O
palpable NCT03863652 263 271 B-Condition-Name
distal NCT03863652 272 278 I-Condition-Name
radial NCT03863652 279 285 I-Condition-Name
artery NCT03863652 286 292 I-Condition-Name

- NCT03863652 295 296 O
Female NCT03863652 298 304 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03863652 305 307 O
childbearing NCT03863652 308 320 B-Condition-Name
potential NCT03863652 321 330 I-Condition-Name
, NCT03863652 331 332 O
who NCT03863652 333 336 O
possibly NCT03863652 337 345 O
plans NCT03863652 346 351 O
to NCT03863652 352 354 O
become NCT03863652 355 361 O
pregnant NCT03863652 362 370 B-Condition-Name
any NCT03863652 371 374 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
time NCT03863652 375 379 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
after NCT03863652 380 385 O
enrollment NCT03863652 386 396 O
into NCT03863652 397 401 O
this NCT03863652 402 406 O
study NCT03863652 407 412 O
. NCT03863652 413 414 O

- NCT03863652 418 419 O
Patients NCT03863652 421 429 O
who NCT03863652 430 433 O
are NCT03863652 434 437 O
not NCT03863652 438 441 O
appropriate NCT03863652 442 453 O
for NCT03863652 454 457 O
this NCT03863652 458 462 O
study NCT03863652 463 468 O

Inclusion NCT03860415 0 9 O
Criteria NCT03860415 10 18 O
: NCT03860415 19 20 O

- NCT03860415 24 25 O
Chronic NCT03860415 27 34 O
( NCT03860415 35 36 O
more NCT03860415 37 41 B-Eq-Operator
than NCT03860415 42 46 I-Eq-Operator
three NCT03860415 47 52 B-Eq-Value
months NCT03860415 53 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03860415 60 61 O
ESBL NCT03860415 62 66 B-Condition-Name
colonization NCT03860415 67 79 I-Condition-Name
of NCT03860415 80 82 O
the NCT03860415 83 86 O
same NCT03860415 87 91 O
strain NCT03860415 92 98 O
as NCT03860415 99 101 O
determined NCT03860415 102 112 O
by NCT03860415 113 115 O

- NCT03860415 118 119 O
species NCT03860415 121 128 B-Observation-Name___Observation-Type-Value:lab
, NCT03860415 129 130 O
phenotype NCT03860415 131 140 O
and NCT03860415 141 144 O
antibiogram NCT03860415 145 156 B-Procedure-Name
. NCT03860415 157 158 O

- NCT03860415 162 163 O
Patients NCT03860415 165 173 O
must NCT03860415 174 178 O
be NCT03860415 179 181 O
able NCT03860415 182 186 O
to NCT03860415 187 189 O
swallow NCT03860415 190 197 O
sachets NCT03860415 198 205 O
. NCT03860415 206 207 O

- NCT03860415 211 212 O
Must NCT03860415 214 218 O
be NCT03860415 219 221 O
able NCT03860415 222 226 O
to NCT03860415 227 229 O
speak NCT03860415 230 235 O
and NCT03860415 236 239 O
understand NCT03860415 240 250 O
Swedish NCT03860415 251 258 B-Language
. NCT03860415 259 260 O

- NCT03860415 264 265 O
Must NCT03860415 267 271 O
have NCT03860415 272 276 O
a NCT03860415 277 278 O
permanent NCT03860415 279 288 O
residence NCT03860415 289 298 O
in NCT03860415 299 301 O
Sweden NCT03860415 302 308 B-Location___Location-Value:residence
. NCT03860415 309 310 O

- NCT03860415 314 315 O
Must NCT03860415 317 321 O
be NCT03860415 322 324 O
able NCT03860415 325 329 O
to NCT03860415 330 332 O
sign NCT03860415 333 337 O
informed NCT03860415 338 346 O
consent NCT03860415 347 354 O
in NCT03860415 355 357 O
Swedish NCT03860415 358 365 B-Language
. NCT03860415 366 367 O

Exclusion NCT03860415 369 378 O
Criteria NCT03860415 379 387 O
: NCT03860415 388 389 O

- NCT03860415 393 394 O
Immunosuppression NCT03860415 396 413 B-Procedure-Name
( NCT03860415 414 415 O
i NCT03860415 416 417 O
. NCT03860415 418 419 O
e NCT03860415 420 421 O
. NCT03860415 422 423 O
chemotheraphy NCT03860415 425 438 B-Procedure-Name
, NCT03860415 439 440 O
treatment NCT03860415 441 450 B-Procedure-Name
with NCT03860415 451 455 I-Procedure-Name
TNF NCT03860415 456 459 I-Procedure-Name
- NCT03860415 460 461 I-Procedure-Name
alpha NCT03860415 462 467 I-Procedure-Name
- NCT03860415 468 469 I-Procedure-Name
inhibitors NCT03860415 470 480 I-Procedure-Name
) NCT03860415 481 482 O
. NCT03860415 484 485 O

- NCT03860415 489 490 O
In NCT03860415 492 494 O
patient NCT03860415 495 502 O
care NCT03860415 503 507 O
. NCT03860415 508 509 O

- NCT03860415 513 514 O
immunodeficiency NCT03860415 516 532 B-Condition-Name

- NCT03860415 535 536 O
psychiatric NCT03860415 538 549 B-Condition-Name
disorder NCT03860415 550 558 I-Condition-Name

- NCT03860415 561 562 O
alcohol NCT03860415 564 571 O
or NCT03860415 572 574 O
substance NCT03860415 575 584 O
abuse NCT03860415 585 590 B-Condition-Name

- NCT03860415 593 594 O
dementia NCT03860415 596 604 B-Condition-Name

- NCT03860415 607 608 O
Invasive NCT03860415 610 618 B-Procedure-Name
catheters NCT03860415 619 628 I-Procedure-Name
. NCT03860415 629 630 O

Inclusion NCT03866070 0 9 O
Criteria NCT03866070 10 18 O
: NCT03866070 19 20 O

- NCT03866070 24 25 O
Female NCT03866070 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03866070 36 37 O
Handball NCT03866070 39 47 B-Observation-Name___Observation-Type-Value:social-habit
players NCT03866070 48 55 I-Observation-Name___Observation-Type-Value:social-habit
federated NCT03866070 56 65 O
in NCT03866070 66 68 O
the NCT03866070 69 72 O
Madrid NCT03866070 73 79 O
Handball NCT03866070 80 88 O
Federation NCT03866070 89 99 O

- NCT03866070 102 103 O
With NCT03866070 105 109 O
an NCT03866070 110 112 O
age NCT03866070 113 116 O
range NCT03866070 117 122 O
between NCT03866070 123 130 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03866070 132 134 B-Eq-Value
and NCT03866070 135 138 O
37 NCT03866070 140 142 B-Eq-Value
years NCT03866070 143 148 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866070 151 152 O
More NCT03866070 154 158 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866070 159 163 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03866070 165 166 B-Eq-Value
years NCT03866070 167 172 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866070 173 175 O
handball NCT03866070 176 184 B-Observation-Name___Observation-Type-Value:social-habit
sports NCT03866070 185 191 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03866070 194 195 O
Currently NCT03866070 197 206 O
participate NCT03866070 207 218 O
in NCT03866070 219 221 O
amateur NCT03866070 222 229 O
competitions NCT03866070 230 242 O
of NCT03866070 243 245 O
First NCT03866070 246 251 O
National NCT03866070 252 260 O
Women NCT03866070 261 266 O
's NCT03866070 266 268 O
category NCT03866070 269 277 O
. NCT03866070 278 279 O

Exclusion NCT03866070 281 290 O
Criteria NCT03866070 291 299 O
: NCT03866070 300 301 O

- NCT03866070 305 306 O
Have NCT03866070 308 312 O
suffered NCT03866070 313 321 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03866070 322 323 O
shoulder NCT03866070 324 332 O
injury NCT03866070 333 339 B-Condition-Name
in NCT03866070 340 342 O
the NCT03866070 343 346 O
last NCT03866070 347 351 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03866070 352 355 B-Eq-Value
months NCT03866070 356 362 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03866070 365 366 O
Who NCT03866070 368 371 O
are NCT03866070 372 375 O
currently NCT03866070 376 385 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
doing NCT03866070 386 391 O
some NCT03866070 392 396 O
physiotherapy NCT03866070 397 410 B-Procedure-Name
treatment NCT03866070 411 420 I-Procedure-Name

- NCT03866070 423 424 O
Who NCT03866070 426 429 O
fail NCT03866070 430 434 O
to NCT03866070 435 437 O
participate NCT03866070 438 449 O
in NCT03866070 450 452 O
the NCT03866070 453 456 O
established NCT03866070 457 468 O
intervention NCT03866070 469 481 B-Procedure-Name
and NCT03866070 482 485 O
evaluation NCT03866070 486 496 B-Procedure-Name
sessions NCT03866070 497 505 O

- NCT03866070 508 509 O
Refusing NCT03866070 511 519 O
to NCT03866070 520 522 O
sign NCT03866070 523 527 O
the NCT03866070 528 531 O
informed NCT03866070 532 540 O
consent NCT03866070 541 548 O
document NCT03866070 549 557 O
. NCT03866070 558 559 O

Inclusion NCT03863691 0 9 O
Criteria NCT03863691 10 18 O
: NCT03863691 19 20 O

- NCT03863691 24 25 O
Common NCT03863691 27 33 O
European NCT03863691 34 42 O
Framework NCT03863691 43 52 O
of NCT03863691 53 55 O
Reference NCT03863691 56 65 O
for NCT03863691 66 69 O
Languages NCT03863691 70 79 O
level NCT03863691 80 85 O
B NCT03863691 86 87 O
2 NCT03863691 88 89 O
in NCT03863691 90 92 O
German NCT03863691 93 99 B-Language
language NCT03863691 100 108 O
. NCT03863691 109 110 O

- NCT03863691 114 115 O
Consent NCT03863691 117 124 O
ability NCT03863691 125 132 O
for NCT03863691 133 136 O
all NCT03863691 137 140 O
relevant NCT03863691 141 149 O
aspects NCT03863691 150 157 O
of NCT03863691 158 160 O
the NCT03863691 161 164 O
experiment NCT03863691 165 175 O
. NCT03863691 176 177 O

Exclusion NCT03863691 179 188 O
Criteria NCT03863691 189 197 O
: NCT03863691 198 199 O

- NCT03863691 203 204 O
Amisulpride NCT03863691 206 217 B-Drug-Name
allergy NCT03863691 218 225 O
. NCT03863691 226 227 O

- NCT03863691 231 232 O
Allergy NCT03863691 234 241 O
to NCT03863691 242 244 O
other NCT03863691 245 250 O
components NCT03863691 251 261 B-Drug-Name
of NCT03863691 262 264 I-Drug-Name
amisulpride NCT03863691 265 276 I-Drug-Name
/ NCT03863691 277 278 O
placebo NCT03863691 279 286 B-Drug-Name
capsules NCT03863691 287 295 I-Drug-Name
like NCT03863691 296 300 O
lactose NCT03863691 301 308 B-Drug-Name
. NCT03863691 309 310 O

- NCT03863691 314 315 O
Daily NCT03863691 317 322 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
intake NCT03863691 323 329 O
of NCT03863691 330 332 O
other NCT03863691 333 338 O
medication NCT03863691 339 349 O
including NCT03863691 350 359 O
contraceptives NCT03863691 360 374 B-Drug-Name
. NCT03863691 375 376 O

- NCT03863691 380 381 O
Tendency NCT03863691 383 391 O
to NCT03863691 392 394 O
seizures NCT03863691 395 403 B-Condition-Name
. NCT03863691 404 405 O

- NCT03863691 409 410 O
Diagnosis NCT03863691 412 421 O
of NCT03863691 422 424 O
cancer NCT03863691 425 431 B-Condition-Name
especially NCT03863691 432 442 O
pheochromocytoma NCT03863691 443 459 B-Condition-Name
, NCT03863691 460 461 O
prolactinoma NCT03863691 462 474 B-Condition-Name
, NCT03863691 475 476 O
or NCT03863691 477 479 O
breast NCT03863691 480 486 O
cancer NCT03863691 487 493 B-Condition-Name
. NCT03863691 494 495 O

- NCT03863691 499 500 O
Kidney NCT03863691 502 508 B-Condition-Name
dysfunction NCT03863691 509 520 I-Condition-Name
: NCT03863691 521 522 O
creatinine NCT03863691 523 533 B-Observation-Name___Observation-Type-Value:lab
clearance NCT03863691 534 543 I-Observation-Name___Observation-Type-Value:lab
below NCT03863691 544 549 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03863691 551 553 B-Eq-Value
ml NCT03863691 554 556 B-Eq-Unit
per NCT03863691 557 560 O
minute NCT03863691 561 567 B-Eq-Unit
. NCT03863691 568 569 O

- NCT03863691 573 574 O
High NCT03863691 576 580 B-Polarity___Polarity-Value:high
risk NCT03863691 581 585 O
for NCT03863691 586 589 O
stroke NCT03863691 590 596 B-Condition-Name
or NCT03863691 597 599 O
thrombosis NCT03863691 600 610 B-Condition-Name
. NCT03863691 611 612 O

- NCT03863691 616 617 O
Known NCT03863691 619 624 O
prolongation NCT03863691 625 637 B-Condition-Name
of NCT03863691 638 640 I-Condition-Name
the NCT03863691 641 644 I-Condition-Name
QT NCT03863691 645 647 I-Condition-Name
interval NCT03863691 648 656 I-Condition-Name
, NCT03863691 657 658 O

- NCT03863691 662 663 O
Any NCT03863691 665 668 O
substantial NCT03863691 669 680 B-Severity___Severity-Value:severe
medical NCT03863691 681 688 O
condition NCT03863691 689 698 O
that NCT03863691 699 703 O
is NCT03863691 704 706 O
capable NCT03863691 707 714 O
of NCT03863691 715 717 O
reducing NCT03863691 718 726 B-Stability___Stability-Value:change
the NCT03863691 727 730 O
volunteers NCT03863691 731 741 O
ability NCT03863691 742 749 O
to NCT03863691 750 752 O
participate NCT03863691 753 764 O
at NCT03863691 765 767 O
the NCT03863691 768 771 O
study NCT03863691 772 777 O
. NCT03863691 778 779 O

- NCT03863691 783 784 O
Suicidal NCT03863691 786 794 B-Condition-Name
thoughts NCT03863691 795 803 I-Condition-Name
or NCT03863691 804 806 O
suicide NCT03863691 807 814 B-Condition-Name
attempts NCT03863691 815 823 I-Condition-Name
in NCT03863691 824 826 O
the NCT03863691 827 830 O
past NCT03863691 831 835 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03863691 836 838 O
at NCT03863691 839 841 O
present NCT03863691 842 849 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
. NCT03863691 850 851 O

- NCT03863691 855 856 O
Substantial NCT03863691 858 869 B-Severity___Severity-Value:severe
mental NCT03863691 870 876 B-Condition-Name
disorders NCT03863691 877 886 I-Condition-Name
especially NCT03863691 887 897 O
schizophrenia NCT03863691 898 911 B-Condition-Name
, NCT03863691 912 913 O
bipolar NCT03863691 914 921 B-Condition-Name
disorder NCT03863691 922 930 I-Condition-Name
, NCT03863691 931 932 O
drug NCT03863691 933 937 B-Condition-Name
abuse NCT03863691 938 943 I-Condition-Name
, NCT03863691 944 945 O
or NCT03863691 946 948 O
personality NCT03863691 949 960 B-Condition-Name
disorders NCT03863691 961 970 I-Condition-Name
. NCT03863691 971 972 O

- NCT03863691 976 977 O
Pregnancy NCT03863691 979 988 B-Condition-Name
or NCT03863691 989 991 O
breastfeeding NCT03863691 992 1005 B-Condition-Name
. NCT03863691 1006 1007 O

Inclusion NCT03861910 0 9 O
Criteria NCT03861910 10 18 O
: NCT03861910 19 20 O

- NCT03861910 24 25 O
age NCT03861910 27 30 O
1 NCT03861910 32 33 B-Eq-Value
- NCT03861910 34 35 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03861910 37 39 B-Eq-Value
months NCT03861910 40 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03861910 49 50 O
IgE NCT03861910 52 55 O
- NCT03861910 56 57 O
mediated NCT03861910 58 66 O
CMA NCT03861910 67 70 B-Condition-Name

Exclusion NCT03861910 71 80 O
Criteria NCT03861910 81 89 O
: NCT03861910 90 91 O

- NCT03861910 95 96 O
cow NCT03861910 98 101 B-Drug-Name
's NCT03861910 101 103 I-Drug-Name
milk NCT03861910 104 108 I-Drug-Name
protein NCT03861910 109 116 I-Drug-Name
- NCT03861910 117 118 O
induced NCT03861910 119 126 O
anaphylaxis NCT03861910 127 138 B-Condition-Name
, NCT03861910 139 140 O

- NCT03861910 144 145 O
food NCT03861910 147 151 B-Drug-Name
protein NCT03861910 152 159 I-Drug-Name
induced NCT03861910 160 167 O
enterocolitis NCT03861910 168 181 B-Condition-Name
syndrome NCT03861910 182 190 I-Condition-Name
, NCT03861910 191 192 O

- NCT03861910 196 197 O
other NCT03861910 199 204 O
food NCT03861910 205 209 B-Allergy-Name
allergies NCT03861910 210 219 O
, NCT03861910 220 221 O

- NCT03861910 225 226 O
other NCT03861910 228 233 O
allergic NCT03861910 234 242 B-Condition-Name
diseases NCT03861910 243 251 I-Condition-Name
, NCT03861910 252 253 O

- NCT03861910 257 258 O
non NCT03861910 260 263 O
- NCT03861910 264 265 O
CMA NCT03861910 266 269 O
- NCT03861910 270 271 O
related NCT03861910 272 279 O
atopic NCT03861910 280 286 B-Condition-Name
eczema NCT03861910 287 293 I-Condition-Name
, NCT03861910 294 295 O

- NCT03861910 299 300 O
eosinophilic NCT03861910 302 314 B-Condition-Name
disorders NCT03861910 315 324 I-Condition-Name
of NCT03861910 325 327 O
the NCT03861910 328 331 O
gastrointestinal NCT03861910 332 348 O
tract NCT03861910 349 354 O
, NCT03861910 355 356 O

- NCT03861910 360 361 O
chronic NCT03861910 363 370 O
systemic NCT03861910 371 379 O
diseases NCT03861910 380 388 B-Condition-Name
, NCT03861910 389 390 O

- NCT03861910 394 395 O
congenital NCT03861910 397 407 O
cardiac NCT03861910 408 415 B-Condition-Name
defects NCT03861910 416 423 I-Condition-Name
, NCT03861910 424 425 O

- NCT03861910 429 430 O
active NCT03861910 432 438 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
tuberculosis NCT03861910 439 451 B-Condition-Name
, NCT03861910 452 453 O

- NCT03861910 457 458 O
autoimmune NCT03861910 460 470 B-Condition-Name
diseases NCT03861910 471 479 I-Condition-Name
, NCT03861910 480 481 O

- NCT03861910 485 486 O
immunodeficiency NCT03861910 488 504 B-Condition-Name
, NCT03861910 505 506 O

- NCT03861910 510 511 O
chronic NCT03861910 513 520 O
inflammatory NCT03861910 521 533 B-Condition-Name
bowel NCT03861910 534 539 I-Condition-Name
diseases NCT03861910 540 548 I-Condition-Name
, NCT03861910 549 550 O

- NCT03861910 554 555 O
celiac NCT03861910 557 563 B-Condition-Name
disease NCT03861910 564 571 I-Condition-Name
, NCT03861910 572 573 O

- NCT03861910 577 578 O
cystic NCT03861910 580 586 B-Condition-Name
fibrosis NCT03861910 587 595 I-Condition-Name
, NCT03861910 596 597 O

- NCT03861910 601 602 O
metabolic NCT03861910 604 613 B-Condition-Name
diseases NCT03861910 614 622 I-Condition-Name
, NCT03861910 623 624 O

- NCT03861910 628 629 O
malignancy NCT03861910 631 641 B-Condition-Name
, NCT03861910 642 643 O

- NCT03861910 647 648 O
chronic NCT03861910 650 657 O
pulmonary NCT03861910 658 667 B-Condition-Name
diseases NCT03861910 668 676 I-Condition-Name
, NCT03861910 677 678 O

- NCT03861910 682 683 O
malformations NCT03861910 685 698 B-Condition-Name
of NCT03861910 699 701 O
the NCT03861910 702 705 O
gastrointestinal NCT03861910 706 722 O
and NCT03861910 723 726 O
/ NCT03861910 727 728 O
or NCT03861910 729 731 O
respiratory NCT03861910 732 743 O
tract NCT03861910 744 749 O
, NCT03861910 750 751 O

- NCT03861910 755 756 O
administration NCT03861910 758 772 O
of NCT03861910 773 775 O
prebiotics NCT03861910 776 786 B-Drug-Name
or NCT03861910 787 789 O
probiotics NCT03861910 790 800 B-Drug-Name
during NCT03861910 801 807 O
the NCT03861910 808 811 O
4 NCT03861910 813 814 B-Eq-Value
weeks NCT03861910 815 820 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03861910 821 827 O
enrolment NCT03861910 828 837 O
. NCT03861910 838 839 O

Inclusion NCT03863860 0 9 O
Criteria NCT03863860 10 18 O
: NCT03863860 19 20 O

1 NCT03863860 25 26 O
. NCT03863860 26 27 O
Histologically NCT03863860 29 43 B-Procedure-Name
diagnosed NCT03863860 44 53 O
high NCT03863860 54 58 B-Severity___Severity-Value:severe
- NCT03863860 59 60 I-Severity___Severity-Value:severe
grade NCT03863860 61 66 I-Severity___Severity-Value:severe
serous NCT03863860 67 73 O
or NCT03863860 74 76 O
endometrioid NCT03863860 77 89 O
ovarian NCT03863860 90 97 O
cancer NCT03863860 98 104 B-Condition-Name
( NCT03863860 105 106 O
including NCT03863860 107 116 O
primary NCT03863860 117 124 O
peritoneal NCT03863860 125 135 O
and NCT03863860 136 139 O
fallopian NCT03863860 140 149 O
tube NCT03863860 150 154 O
cancer NCT03863860 155 161 B-Condition-Name
) NCT03863860 162 163 O

2 NCT03863860 168 169 O
. NCT03863860 169 170 O
Completion NCT03863860 172 182 O
of NCT03863860 183 185 O
≥ NCT03863860 186 187 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03863860 189 190 B-Eq-Value
previous NCT03863860 191 199 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
platinum NCT03863860 200 208 B-Procedure-Name
- NCT03863860 209 210 I-Procedure-Name
containing NCT03863860 211 221 I-Procedure-Name
regimens NCT03863860 222 230 I-Procedure-Name

3 NCT03863860 234 235 O
. NCT03863860 235 236 O
Complete NCT03863860 238 246 B-Condition-Name
response NCT03863860 247 255 I-Condition-Name
( NCT03863860 256 257 O
CR NCT03863860 258 260 B-Condition-Name
) NCT03863860 261 262 O
or NCT03863860 263 265 O
partial NCT03863860 266 273 B-Condition-Name
response NCT03863860 274 282 I-Condition-Name
( NCT03863860 283 284 O
PR NCT03863860 285 287 B-Condition-Name
) NCT03863860 288 289 O
achieved NCT03863860 290 298 O
with NCT03863860 299 303 O
last NCT03863860 304 308 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
platinum NCT03863860 309 317 O
- NCT03863860 318 319 O
based NCT03863860 320 325 O
chemotherapy NCT03863860 326 338 B-Procedure-Name
regimen NCT03863860 339 346 I-Procedure-Name
as NCT03863860 347 349 O
determined NCT03863860 350 360 O
by NCT03863860 361 363 O
investigator NCT03863860 364 376 O

4 NCT03863860 380 381 O
. NCT03863860 381 382 O
Ability NCT03863860 384 391 O
to NCT03863860 392 394 O
be NCT03863860 395 397 O
randomized NCT03863860 398 408 O
≤ NCT03863860 409 410 B-Eq-Operator___Eq-Operator-Value:LTEQ
8 NCT03863860 412 413 B-Eq-Value
weeks NCT03863860 414 419 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03863860 420 425 O
last NCT03863860 426 430 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
dose NCT03863860 431 435 O
of NCT03863860 436 438 O
platinum NCT03863860 439 447 B-Procedure-Name

Exclusion NCT03863860 448 457 O
Criteria NCT03863860 458 466 O
: NCT03863860 467 468 O

1 NCT03863860 473 474 O
. NCT03863860 474 475 O
Prior NCT03863860 477 482 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03863860 483 492 O
with NCT03863860 493 497 O
a NCT03863860 498 499 O
poly NCT03863860 500 504 B-Drug-Name
( NCT03863860 505 506 I-Drug-Name
ADP NCT03863860 507 510 I-Drug-Name
- NCT03863860 511 512 I-Drug-Name
ribose NCT03863860 513 519 I-Drug-Name
) NCT03863860 520 521 I-Drug-Name
polymerase NCT03863860 522 532 I-Drug-Name
( NCT03863860 533 534 O
PARP NCT03863860 535 539 B-Drug-Name
) NCT03863860 540 541 O
inhibitor NCT03863860 542 551 O

2 NCT03863860 555 556 O
. NCT03863860 556 557 O
Patients NCT03863860 559 567 O
who NCT03863860 568 571 O
have NCT03863860 572 576 O
received NCT03863860 577 585 O
other NCT03863860 586 591 O
study NCT03863860 592 597 O
drug NCT03863860 598 602 O
treatment NCT03863860 603 612 O
within NCT03863860 613 619 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03863860 621 622 B-Eq-Value
weeks NCT03863860 623 628 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03863860 629 634 O
to NCT03863860 635 637 O
the NCT03863860 638 641 O
first NCT03863860 642 647 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
administration NCT03863860 648 662 O
( NCT03863860 663 664 O
< NCT03863860 666 667 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03863860 669 670 B-Eq-Value
elimination NCT03863860 671 682 O
half NCT03863860 683 687 B-Eq-Unit
- NCT03863860 688 689 I-Eq-Unit
lives NCT03863860 690 695 I-Eq-Unit
of NCT03863860 696 698 O
the NCT03863860 699 702 O
study NCT03863860 703 708 O
drug NCT03863860 709 713 O
molecular NCT03863860 714 723 O
targeted NCT03863860 724 732 O
anti NCT03863860 733 737 O
- NCT03863860 738 739 O
cancer NCT03863860 740 746 B-Condition-Name
drugs NCT03863860 747 752 O
) NCT03863860 753 754 O
. NCT03863860 756 757 O

3 NCT03863860 762 763 O
. NCT03863860 763 764 O
Patients NCT03863860 766 774 O
with NCT03863860 775 779 O
clinical NCT03863860 780 788 O
symptoms NCT03863860 789 797 O
of NCT03863860 798 800 O
cancer NCT03863860 801 807 B-Condition-Name
ascites NCT03863860 808 815 I-Condition-Name
, NCT03863860 816 817 O
pleural NCT03863860 818 825 B-Condition-Name
effusion NCT03863860 826 834 I-Condition-Name
, NCT03863860 835 836 O
who NCT03863860 837 840 O
need NCT03863860 841 845 O
to NCT03863860 846 848 O
drainage NCT03863860 849 857 O
, NCT03863860 858 859 O
or NCT03863860 860 862 O
who NCT03863860 863 866 O
have NCT03863860 867 871 O
undergone NCT03863860 872 881 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ascites NCT03863860 882 889 B-Procedure-Name
drainage NCT03863860 890 898 I-Procedure-Name
within NCT03863860 899 905 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03863860 907 908 B-Eq-Value
months NCT03863860 909 915 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03863860 916 921 O
to NCT03863860 922 924 O
the NCT03863860 925 928 O
first NCT03863860 929 934 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
administration NCT03863860 935 949 O
. NCT03863860 950 951 O

Inclusion NCT03867409 0 9 O
Criteria NCT03867409 10 18 O
: NCT03867409 19 20 O

- NCT03867409 24 25 O
reside NCT03867409 27 33 O
within NCT03867409 34 40 O
the NCT03867409 41 44 O
United NCT03867409 45 51 B-Location___Location-Value:residence
States NCT03867409 52 58 I-Location___Location-Value:residence
but NCT03867409 59 62 O
outside NCT03867409 63 70 O
of NCT03867409 71 73 O
Florida NCT03867409 74 81 B-Location___Location-Value:residence

- NCT03867409 84 85 O
speak NCT03867409 87 92 O
English NCT03867409 93 100 B-Language

- NCT03867409 103 104 O
are NCT03867409 106 109 O
of NCT03867409 110 112 O
either NCT03867409 113 119 O
black NCT03867409 120 125 B-Ethnicity
or NCT03867409 126 128 O
white NCT03867409 129 134 B-Ethnicity
racial NCT03867409 135 141 O
background NCT03867409 142 152 O
. NCT03867409 153 154 O

- NCT03867409 158 159 O
are NCT03867409 161 164 O
out NCT03867409 165 168 O
- NCT03867409 169 170 O
of NCT03867409 171 173 O
- NCT03867409 174 175 O
guidelines NCT03867409 176 186 O
for NCT03867409 187 190 O
colorectal NCT03867409 191 201 B-Procedure-Name
cancer NCT03867409 202 208 I-Procedure-Name
screening NCT03867409 209 218 I-Procedure-Name
( NCT03867409 219 220 O
> NCT03867409 222 223 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03867409 225 227 B-Eq-Value
years NCT03867409 228 233 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
for NCT03867409 234 237 O
colonoscopy NCT03867409 238 249 B-Procedure-Name
, NCT03867409 250 251 O
> NCT03867409 252 253 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03867409 255 256 B-Eq-Value
years NCT03867409 257 262 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
for NCT03867409 263 266 O
Cologuard NCT03867409 267 276 B-Procedure-Name
, NCT03867409 277 278 O
> NCT03867409 279 280 B-Eq-Operator___Eq-Operator-Value:GT
1 NCT03867409 282 283 B-Eq-Value
year NCT03867409 284 288 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
for NCT03867409 289 292 O
fecal NCT03867409 293 298 B-Procedure-Name
immunochemical NCT03867409 299 313 I-Procedure-Name
test NCT03867409 314 318 I-Procedure-Name
) NCT03867409 319 320 O

Exclusion NCT03867409 322 331 O
Criteria NCT03867409 332 340 O
: NCT03867409 341 342 O

- NCT03867409 346 347 O
does NCT03867409 349 353 O
not NCT03867409 354 357 O
meet NCT03867409 358 362 O
the NCT03867409 363 366 O
above NCT03867409 367 372 O
criteria NCT03867409 373 381 O

Inclusion NCT03869424 0 9 O
Criteria NCT03869424 10 18 O
: NCT03869424 19 20 O

- NCT03869424 24 25 O
healthy NCT03869424 27 34 B-Condition-Name
volunteers NCT03869424 35 45 O

- NCT03869424 48 49 O
fluent NCT03869424 51 57 O
in NCT03869424 58 60 O
German NCT03869424 61 67 B-Language
language NCT03869424 68 76 O

Exclusion NCT03869424 77 86 O
Criteria NCT03869424 87 95 O
: NCT03869424 96 97 O

- NCT03869424 101 102 O
mental NCT03869424 104 110 B-Condition-Name
disorders NCT03869424 111 120 I-Condition-Name

- NCT03869424 123 124 O
allergic NCT03869424 126 134 O
to NCT03869424 135 137 O
capsaicin NCT03869424 138 147 B-Drug-Name

- NCT03869424 150 151 O
allergic NCT03869424 153 161 O
to NCT03869424 162 164 O
sesame NCT03869424 165 171 B-Drug-Name
oil NCT03869424 172 175 I-Drug-Name

- NCT03869424 178 179 O
intake NCT03869424 181 187 O
of NCT03869424 188 190 O
psychopharmacological NCT03869424 191 212 B-Drug-Name
drugs NCT03869424 213 218 I-Drug-Name
in NCT03869424 219 221 O
the NCT03869424 222 225 O
last NCT03869424 226 230 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
four NCT03869424 231 235 B-Eq-Value
weeks NCT03869424 236 241 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03869424 244 245 O
intake NCT03869424 247 253 O
of NCT03869424 254 256 O
illegal NCT03869424 257 264 O
drugs NCT03869424 265 270 O
in NCT03869424 271 273 O
the NCT03869424 274 277 O
last NCT03869424 278 282 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
two NCT03869424 283 286 B-Eq-Value
weeks NCT03869424 287 292 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03869424 295 296 O
consumption NCT03869424 298 309 O
of NCT03869424 310 312 O
alcohol NCT03869424 313 320 B-Drug-Name
in NCT03869424 321 323 O
the NCT03869424 324 327 O
last NCT03869424 328 332 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
twelve NCT03869424 333 339 B-Eq-Value
hours NCT03869424 340 345 B-Eq-Temporal-Unit

- NCT03869424 348 349 O
students NCT03869424 351 359 O
in NCT03869424 360 362 O
medicine NCT03869424 363 371 O
, NCT03869424 372 373 O
pharmacy NCT03869424 374 382 O
, NCT03869424 383 384 O
or NCT03869424 385 387 O
psychology NCT03869424 388 398 O

- NCT03869424 401 402 O
completed NCT03869424 404 413 O
studies NCT03869424 414 421 O
in NCT03869424 422 424 O
medicine NCT03869424 425 433 O
, NCT03869424 434 435 O
pharmacy NCT03869424 436 444 O
or NCT03869424 445 447 O
psychology NCT03869424 448 458 O

- NCT03869424 461 462 O
current NCT03869424 464 471 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnancy NCT03869424 472 481 B-Condition-Name
or NCT03869424 482 484 O
lactation NCT03869424 485 494 B-Condition-Name

- NCT03869424 497 498 O
cardio NCT03869424 500 506 B-Condition-Name
vascular NCT03869424 507 515 I-Condition-Name
disease NCT03869424 516 523 I-Condition-Name

- NCT03869424 526 527 O
kidney NCT03869424 529 535 B-Condition-Name
disease NCT03869424 536 543 I-Condition-Name

- NCT03869424 546 547 O
liver NCT03869424 549 554 B-Condition-Name
disease NCT03869424 555 562 I-Condition-Name

Inclusion NCT03861078 0 9 O
Criteria NCT03861078 10 18 O
- NCT03861078 19 20 O
- NCT03861078 22 23 O
Participants NCT03861078 24 36 O
must NCT03861078 37 41 O
be NCT03861078 42 44 O
: NCT03861078 45 46 O

- NCT03861078 50 51 O
Healthy NCT03861078 53 60 B-Condition-Name
( NCT03861078 61 62 O
determined NCT03861078 63 73 O
by NCT03861078 74 76 O
self NCT03861078 77 81 O
- NCT03861078 82 83 O
report NCT03861078 84 90 O
) NCT03861078 91 92 O

- NCT03861078 96 97 O
Between NCT03861078 99 106 O
the NCT03861078 107 110 O
ages NCT03861078 111 115 O
of NCT03861078 116 118 O
18 NCT03861078 120 122 B-Eq-Value
- NCT03861078 123 124 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03861078 126 128 B-Eq-Value
years NCT03861078 129 134 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861078 135 138 O

- NCT03861078 141 142 O
Current NCT03861078 144 151 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cigarette NCT03861078 152 161 B-Condition-Name
smokers NCT03861078 162 169 I-Condition-Name

- NCT03861078 172 173 O
Wiling NCT03861078 175 181 O
to NCT03861078 182 184 O
provide NCT03861078 185 192 O
informed NCT03861078 193 201 O
consent NCT03861078 202 209 O

- NCT03861078 212 213 O
Able NCT03861078 215 219 O
to NCT03861078 220 222 O
attend NCT03861078 223 229 O
the NCT03861078 230 233 O
lab NCT03861078 234 237 O
session NCT03861078 238 245 O
and NCT03861078 246 249 O
abstain NCT03861078 250 257 O
from NCT03861078 258 262 O
tobacco NCT03861078 263 270 O
/ NCT03861078 271 272 O
nicotine NCT03861078 273 281 O
products NCT03861078 282 290 O
as NCT03861078 291 293 O
required NCT03861078 294 302 O

- NCT03861078 305 306 O
Agree NCT03861078 308 313 O
to NCT03861078 314 316 O
use NCT03861078 317 320 O
designated NCT03861078 321 331 O
products NCT03861078 332 340 O
according NCT03861078 341 350 O
to NCT03861078 351 353 O
the NCT03861078 354 357 O
study NCT03861078 358 363 O
protocol NCT03861078 364 372 O

Exclusion NCT03861078 373 382 O
Criteria NCT03861078 383 391 O
: NCT03861078 392 393 O

- NCT03861078 397 398 O
Women NCT03861078 400 405 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
if NCT03861078 406 408 O
they NCT03861078 409 413 O
are NCT03861078 414 417 O
breast NCT03861078 418 424 B-Condition-Name
- NCT03861078 425 426 I-Condition-Name
feeding NCT03861078 427 434 I-Condition-Name
or NCT03861078 435 437 O
test NCT03861078 438 442 B-Observation-Name___Observation-Type-Value:lab
positive NCT03861078 443 451 B-Polarity___Polarity-Value:positive
for NCT03861078 452 455 O
pregnancy NCT03861078 456 465 B-Condition-Name
( NCT03861078 466 467 O
by NCT03861078 468 470 O
urinalysis NCT03861078 471 481 B-Observation-Name___Observation-Type-Value:lab
) NCT03861078 482 483 O
at NCT03861078 484 486 O
screening NCT03861078 487 496 O
. NCT03861078 497 498 O

- NCT03861078 502 503 O
Individuals NCT03861078 505 516 O
who NCT03861078 517 520 O
weigh NCT03861078 521 526 B-Observation-Name___Observation-Type-Value:vital
less NCT03861078 527 531 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03861078 532 536 I-Eq-Operator___Eq-Operator-Value:LT
110 NCT03861078 538 541 B-Eq-Value
pounds NCT03861078 542 548 B-Eq-Unit
. NCT03861078 549 550 O

Some NCT03861078 552 556 O
study NCT03861078 557 562 O
details NCT03861078 563 570 O
about NCT03861078 571 576 O
the NCT03861078 577 580 O
eligibility NCT03861078 581 592 O
criteria NCT03861078 593 601 O
are NCT03861078 602 605 O
purposely NCT03861078 606 615 O
omitted NCT03861078 616 623 O
at NCT03861078 624 626 O
this NCT03861078 627 631 O
time NCT03861078 632 636 O
to NCT03861078 637 639 O
preserve NCT03861078 640 648 O
scientific NCT03861078 649 659 O
integrity NCT03861078 660 669 O
. NCT03861078 670 671 O
Full NCT03861078 673 677 O
details NCT03861078 678 685 O
will NCT03861078 686 690 O
be NCT03861078 691 693 O
posted NCT03861078 694 700 O
at NCT03861078 701 703 O
the NCT03861078 704 707 O
conclusion NCT03861078 708 718 O
of NCT03861078 719 721 O
the NCT03861078 722 725 O
study NCT03861078 726 731 O
. NCT03861078 732 733 O


Inclusion NCT03860428 0 9 O
Criteria NCT03860428 10 18 O
: NCT03860428 19 20 O

- NCT03860428 24 25 O
Gestational NCT03860428 27 38 B-Observation-Name___Observation-Type-Value:measurement
age NCT03860428 39 42 I-Observation-Name___Observation-Type-Value:measurement
< NCT03860428 43 44 B-Eq-Operator___Eq-Operator-Value:LT
32 NCT03860428 46 48 B-Eq-Value
weeks NCT03860428 49 54 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03860428 57 58 O
Birthweight NCT03860428 60 71 B-Observation-Name___Observation-Type-Value:vital
< NCT03860428 72 73 B-Eq-Operator___Eq-Operator-Value:LT
1500 NCT03860428 75 79 B-Eq-Value
g NCT03860428 80 81 B-Eq-Unit

- NCT03860428 84 85 O
Age NCT03860428 87 90 O
less NCT03860428 91 95 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03860428 96 100 I-Eq-Operator___Eq-Operator-Value:LT
72 NCT03860428 102 104 B-Eq-Value
hours NCT03860428 105 110 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

- NCT03860428 113 114 O
PDA NCT03860428 116 119 B-Condition-Name
diameter NCT03860428 120 128 B-Observation-Name___Observation-Type-Value:measurement
> NCT03860428 129 130 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03860428 132 135 B-Eq-Value
mm NCT03860428 136 138 B-Eq-Unit

- NCT03860428 141 142 O
Signed NCT03860428 144 150 O
informed NCT03860428 151 159 O
consent NCT03860428 160 167 O
obtained NCT03860428 168 176 O
from NCT03860428 177 181 O
both NCT03860428 182 186 O
parents NCT03860428 187 194 O

Exclusion NCT03860428 195 204 O
Criteria NCT03860428 205 213 O
: NCT03860428 214 215 O

- NCT03860428 219 220 O
Birthweight NCT03860428 222 233 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03860428 234 235 B-Eq-Operator___Eq-Operator-Value:GTEQ
1500 NCT03860428 237 241 B-Eq-Value
g NCT03860428 242 243 B-Eq-Unit
and NCT03860428 244 247 O
/ NCT03860428 248 249 O
or NCT03860428 250 252 O
gestation NCT03860428 253 262 B-Observation-Name___Observation-Type-Value:measurement
age NCT03860428 263 266 I-Observation-Name___Observation-Type-Value:measurement
≥ NCT03860428 267 268 B-Eq-Operator___Eq-Operator-Value:GTEQ
32 NCT03860428 270 272 B-Eq-Value
weeks NCT03860428 273 278 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03860428 281 282 O
Lack NCT03860428 284 288 O
of NCT03860428 289 291 O
informed NCT03860428 292 300 O
consent NCT03860428 301 308 O
of NCT03860428 309 311 O
the NCT03860428 312 315 O
parents NCT03860428 316 323 O

- NCT03860428 326 327 O
Congenital NCT03860428 329 339 B-Condition-Name
heart NCT03860428 340 345 I-Condition-Name
defect NCT03860428 346 352 I-Condition-Name
, NCT03860428 353 354 O
other NCT03860428 355 360 O
than NCT03860428 361 365 O
PDA NCT03860428 366 369 B-Condition-Name
and NCT03860428 370 373 O
/ NCT03860428 374 375 O
or NCT03860428 376 378 O
patent NCT03860428 379 385 B-Condition-Name
foramen NCT03860428 386 393 I-Condition-Name
ovale NCT03860428 394 399 I-Condition-Name
( NCT03860428 400 401 O
PFO NCT03860428 402 405 B-Condition-Name
) NCT03860428 406 407 O

- NCT03860428 411 412 O
The NCT03860428 414 417 O
presence NCT03860428 418 426 O
of NCT03860428 427 429 O
a NCT03860428 430 431 O
clinically NCT03860428 432 442 O
apparent NCT03860428 443 451 O
hemorrhagic NCT03860428 452 463 B-Condition-Name
syndrome NCT03860428 464 472 I-Condition-Name

- NCT03860428 475 476 O
Any NCT03860428 478 481 O
intraventricular NCT03860428 482 498 B-Condition-Name
hemorrhage NCT03860428 499 509 I-Condition-Name
( NCT03860428 510 511 O
IVH NCT03860428 512 515 B-Condition-Name
) NCT03860428 516 517 O
in NCT03860428 518 520 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860428 521 524 I-Eq-Operator___Eq-Operator-Value:LTEQ
first NCT03860428 525 530 I-Eq-Operator___Eq-Operator-Value:LTEQ
48 NCT03860428 532 534 B-Eq-Value
hours NCT03860428 535 540 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03860428 541 543 O
IVH NCT03860428 544 547 B-Condition-Name
grade NCT03860428 548 553 B-Eq-Unit
3 NCT03860428 555 556 B-Eq-Value
- NCT03860428 557 558 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03860428 560 561 B-Eq-Value

- NCT03860428 565 566 O
A NCT03860428 568 569 O
platelet NCT03860428 570 578 B-Observation-Name___Observation-Type-Value:lab
count NCT03860428 579 584 I-Observation-Name___Observation-Type-Value:lab
of NCT03860428 585 587 O
< NCT03860428 588 589 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03860428 591 593 B-Eq-Value
, NCT03860428 594 595 I-Eq-Value
000 NCT03860428 596 599 I-Eq-Value
/ NCT03860428 600 601 O
mm NCT03860428 602 604 B-Eq-Unit
3 NCT03860428 605 606 I-Eq-Unit

- NCT03860428 609 610 O
A NCT03860428 612 613 O
serum NCT03860428 614 619 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03860428 620 630 I-Observation-Name___Observation-Type-Value:lab
concentration NCT03860428 631 644 I-Observation-Name___Observation-Type-Value:lab
of NCT03860428 645 647 O
> NCT03860428 648 649 B-Eq-Operator___Eq-Operator-Value:GT
110 NCT03860428 651 654 B-Eq-Value
μmol NCT03860428 655 659 B-Eq-Unit
/ NCT03860428 660 661 O
L NCT03860428 662 663 B-Eq-Unit

- NCT03860428 666 667 O
Oliguria NCT03860428 669 677 B-Condition-Name
< NCT03860428 678 679 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03860428 681 682 B-Eq-Value
ml NCT03860428 683 685 B-Eq-Unit
/ NCT03860428 686 687 O
kg NCT03860428 688 690 B-Eq-Unit
/ NCT03860428 691 692 O
h NCT03860428 693 694 B-Eq-Unit

- NCT03860428 697 698 O
Suspected NCT03860428 700 709 O
/ NCT03860428 710 711 O
apparent NCT03860428 712 720 O
NEC NCT03860428 721 724 B-Condition-Name

- NCT03860428 727 728 O
Suspected NCT03860428 730 739 O
/ NCT03860428 740 741 O
apparent NCT03860428 742 750 O
lung NCT03860428 751 755 B-Condition-Name
hypoplasia NCT03860428 756 766 I-Condition-Name

Inclusion NCT03865550 0 9 O
Criteria NCT03865550 10 18 O
: NCT03865550 19 20 O

- NCT03865550 24 25 O
18 NCT03865550 28 30 B-Eq-Value
- NCT03865550 31 32 B-Eq-Operator___Eq-Operator-Value:BETWEEN
85 NCT03865550 34 36 B-Eq-Value
years NCT03865550 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865550 43 45 O
age NCT03865550 46 49 O

- NCT03865550 52 53 O
ASA NCT03865550 55 58 B-Condition-Name
I NCT03865550 59 60 B-Eq-Value
- NCT03865550 61 62 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IV NCT03865550 63 65 B-Eq-Value

- NCT03865550 68 69 O
Undergoing NCT03865550 71 81 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
primary NCT03865550 82 89 O
unilateral NCT03865550 90 100 O
elective NCT03865550 101 109 O
total NCT03865550 110 115 B-Procedure-Name
knee NCT03865550 116 120 I-Procedure-Name
arthroplasty NCT03865550 121 133 I-Procedure-Name
with NCT03865550 134 138 O
spinal NCT03865550 139 145 B-Procedure-Name
anesthesia NCT03865550 146 156 I-Procedure-Name

Exclusion NCT03865550 157 166 O
Criteria NCT03865550 167 175 O
: NCT03865550 176 177 O

- NCT03865550 181 182 O
BMI NCT03865550 184 187 B-Observation-Name___Observation-Type-Value:vital
over NCT03865550 188 192 B-Eq-Operator___Eq-Operator-Value:GT
40 NCT03865550 194 196 B-Eq-Value
* NCT03865550 197 198 O

- NCT03865550 201 202 O
Contraindication NCT03865550 204 220 O
or NCT03865550 221 223 O
allergy NCT03865550 224 231 O
to NCT03865550 232 234 O
opioid NCT03865550 235 241 B-Drug-Name
pain NCT03865550 242 246 I-Drug-Name
medication NCT03865550 247 257 I-Drug-Name
or NCT03865550 258 260 O
ketamine NCT03865550 261 269 B-Drug-Name
* NCT03865550 269 270 O

- NCT03865550 273 274 O
Daily NCT03865550 276 281 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
opioid NCT03865550 282 288 B-Drug-Name
use NCT03865550 289 292 O
for NCT03865550 293 296 O
pain NCT03865550 297 301 B-Condition-Name
control NCT03865550 302 309 O
before NCT03865550 310 316 O
surgery NCT03865550 317 324 B-Procedure-Name
in NCT03865550 325 327 B-Eq-Operator___Eq-Operator-Value:GT
excess NCT03865550 328 334 I-Eq-Operator___Eq-Operator-Value:GT
of NCT03865550 335 337 I-Eq-Operator___Eq-Operator-Value:GT
systemic NCT03865550 338 346 O
morphine NCT03865550 347 355 O
equivalent NCT03865550 356 366 O
to NCT03865550 367 369 O
10 NCT03865550 371 373 B-Eq-Value
mg NCT03865550 374 376 B-Eq-Unit
* NCT03865550 376 377 O

- NCT03865550 380 381 O
Ejection NCT03865550 383 391 B-Observation-Name___Observation-Type-Value:measurement
fraction NCT03865550 392 400 I-Observation-Name___Observation-Type-Value:measurement
( NCT03865550 401 402 O
EF NCT03865550 403 405 B-Observation-Name___Observation-Type-Value:measurement
) NCT03865550 406 407 O
less NCT03865550 408 412 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03865550 413 417 I-Eq-Operator___Eq-Operator-Value:LT
30 NCT03865550 419 421 B-Eq-Value
% NCT03865550 422 423 B-Eq-Unit

- NCT03865550 427 428 O
Creatinine NCT03865550 430 440 B-Observation-Name___Observation-Type-Value:lab
clearance NCT03865550 441 450 I-Observation-Name___Observation-Type-Value:lab
less NCT03865550 451 455 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03865550 456 460 I-Eq-Operator___Eq-Operator-Value:LT
30 NCT03865550 462 464 B-Eq-Value
mL NCT03865550 465 467 B-Eq-Unit
/ NCT03865550 468 469 O
min NCT03865550 470 473 B-Eq-Unit
* NCT03865550 473 474 O

- NCT03865550 477 478 O
History NCT03865550 480 487 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865550 488 490 O
chronic NCT03865550 491 498 O
liver NCT03865550 499 504 B-Condition-Name
failure NCT03865550 505 512 I-Condition-Name

- NCT03865550 515 516 O
Desire NCT03865550 518 524 O
for NCT03865550 525 528 O
nerve NCT03865550 529 534 B-Procedure-Name
block NCT03865550 535 540 I-Procedure-Name
or NCT03865550 541 543 O
general NCT03865550 544 551 B-Procedure-Name
anesthesia NCT03865550 552 562 I-Procedure-Name

- NCT03865550 565 566 O
Any NCT03865550 568 571 O
neurologic NCT03865550 572 582 O
or NCT03865550 583 585 O
psychiatric NCT03865550 586 597 O
disorder NCT03865550 598 606 B-Condition-Name
( NCT03865550 607 608 O
including NCT03865550 609 618 O
bipolar NCT03865550 619 626 B-Condition-Name
disorder NCT03865550 627 635 I-Condition-Name
, NCT03865550 636 637 O
post NCT03865550 638 642 B-Condition-Name
traumatic NCT03865550 643 652 I-Condition-Name
stress NCT03865550 653 659 I-Condition-Name
disorder NCT03865550 660 668 I-Condition-Name
, NCT03865550 669 670 O
schizophrenia NCT03865550 671 684 B-Condition-Name
) NCT03865550 685 686 O

- NCT03865550 690 691 O
Prior NCT03865550 693 698 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgery NCT03865550 699 706 B-Procedure-Name
on NCT03865550 707 709 O
ipsilateral NCT03865550 710 721 O
knee NCT03865550 722 726 O
within NCT03865550 727 733 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865550 734 737 O
last NCT03865550 738 742 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03865550 744 745 B-Eq-Value
months NCT03865550 746 752 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03865550 755 756 O
Alcohol NCT03865550 758 765 B-Condition-Name
abuse NCT03865550 766 771 I-Condition-Name

Inclusion NCT03869801 0 9 O
Criteria NCT03869801 10 18 O
: NCT03869801 19 20 O

- NCT03869801 24 25 O
Elective NCT03869801 27 35 O
laparoscopic NCT03869801 36 48 B-Procedure-Name
Cholecystectomy NCT03869801 49 64 I-Procedure-Name
, NCT03869801 65 66 O
ASA NCT03869801 67 70 B-Condition-Name
status NCT03869801 71 77 O
1 NCT03869801 79 80 B-Eq-Value
- NCT03869801 81 82 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03869801 84 85 B-Eq-Value

Exclusion NCT03869801 87 96 O
Criteria NCT03869801 97 105 O
: NCT03869801 106 107 O

- NCT03869801 111 112 O
Patient NCT03869801 114 121 O
refusal NCT03869801 122 129 O
Contraindications NCT03869801 130 147 O
to NCT03869801 148 150 O
regional NCT03869801 151 159 B-Procedure-Name
anesthesia NCT03869801 160 170 I-Procedure-Name
Known NCT03869801 171 176 O
allergy NCT03869801 177 184 O
to NCT03869801 185 187 O
local NCT03869801 188 193 B-Drug-Name
anesthetics NCT03869801 194 205 I-Drug-Name
Bleeding NCT03869801 206 214 B-Condition-Name
diathesis NCT03869801 215 224 B-Condition-Name
Use NCT03869801 225 228 O
of NCT03869801 229 231 O
any NCT03869801 232 235 O
anti NCT03869801 236 240 B-Drug-Name
- NCT03869801 241 242 I-Drug-Name
coagulants NCT03869801 243 253 I-Drug-Name
Inability NCT03869801 254 263 O
to NCT03869801 264 266 O
provide NCT03869801 267 274 O
informed NCT03869801 275 283 O
consent NCT03869801 284 291 O
Severe NCT03869801 292 298 B-Severity___Severity-Value:severe
kidney NCT03869801 299 305 O
or NCT03869801 306 308 O
liver NCT03869801 309 314 O
disease NCT03869801 315 322 B-Condition-Name
Inability NCT03869801 323 332 O
to NCT03869801 333 335 O
operate NCT03869801 336 343 B-Procedure-Name
PCA NCT03869801 344 347 I-Procedure-Name
system NCT03869801 348 354 O
Patient NCT03869801 355 362 O
with NCT03869801 363 367 O
psychiatric NCT03869801 368 379 B-Condition-Name
disorders NCT03869801 380 389 I-Condition-Name

Inclusion NCT03867838 0 9 O
Criteria NCT03867838 10 18 O
: NCT03867838 19 20 O

- NCT03867838 24 25 O
greater NCT03867838 27 34 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867838 35 39 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03867838 41 42 B-Eq-Value
months NCT03867838 43 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
post NCT03867838 50 54 O
- NCT03867838 55 56 O
stroke NCT03867838 57 63 B-Condition-Name

- NCT03867838 66 67 O
passive NCT03867838 69 76 B-Condition-Name
abduction NCT03867838 77 86 I-Condition-Name
to NCT03867838 87 89 O
90 NCT03867838 91 93 B-Eq-Value
degrees NCT03867838 94 101 B-Eq-Unit
at NCT03867838 102 104 O
shoulder NCT03867838 105 113 O

- NCT03867838 116 117 O
reduced NCT03867838 119 126 B-Polarity___Polarity-Value:low
active NCT03867838 127 133 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
( NCT03867838 134 135 O
retro NCT03867838 136 141 O
) NCT03867838 142 143 O
flexion NCT03867838 144 151 B-Condition-Name
/ NCT03867838 152 153 O
extension NCT03867838 154 163 B-Condition-Name
at NCT03867838 164 166 O
shoulder NCT03867838 167 175 O
when NCT03867838 176 180 O
abducted NCT03867838 181 189 B-Observation-Name
to NCT03867838 190 192 O
90 NCT03867838 194 196 B-Eq-Value
degrees NCT03867838 197 204 B-Eq-Unit

- NCT03867838 207 208 O
reduced NCT03867838 210 217 B-Polarity___Polarity-Value:low
active NCT03867838 218 224 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
flexion NCT03867838 225 232 B-Condition-Name
/ NCT03867838 233 234 O
extension NCT03867838 235 244 B-Condition-Name
at NCT03867838 245 247 O
elbow NCT03867838 248 253 O

Exclusion NCT03867838 254 263 O
Criteria NCT03867838 264 272 O
: NCT03867838 273 274 O

- NCT03867838 278 279 O
unable NCT03867838 281 287 O
to NCT03867838 288 290 O
give NCT03867838 291 295 O
informed NCT03867838 296 304 O
consent NCT03867838 305 312 O

- NCT03867838 315 316 O
unable NCT03867838 318 324 O
to NCT03867838 325 327 O
comprehend NCT03867838 328 338 O
and NCT03867838 339 342 O
follow NCT03867838 343 349 O
instructions NCT03867838 350 362 O

- NCT03867838 365 366 O
have NCT03867838 368 372 O
a NCT03867838 373 374 O
condition NCT03867838 375 384 O
( NCT03867838 385 386 O
other NCT03867838 387 392 O
than NCT03867838 393 397 O
stroke NCT03867838 398 404 B-Condition-Name
) NCT03867838 405 406 O
affecting NCT03867838 407 416 B-Stability___Stability-Value:change
sensorimotor NCT03867838 417 429 B-Condition-Name
function NCT03867838 430 438 I-Condition-Name

- NCT03867838 441 442 O
show NCT03867838 444 448 O
evidence NCT03867838 449 457 O
of NCT03867838 458 460 O
unilateral NCT03867838 461 471 O
spatial NCT03867838 472 479 B-Condition-Name
neglect NCT03867838 480 487 I-Condition-Name

- NCT03867838 490 491 O
unable NCT03867838 493 499 O
to NCT03867838 500 502 O
sit NCT03867838 503 506 B-Condition-Name
in NCT03867838 507 509 O
a NCT03867838 510 511 O
chair NCT03867838 512 517 O
without NCT03867838 518 525 O
armrests NCT03867838 526 534 O
for NCT03867838 535 538 O
2 NCT03867838 540 541 B-Eq-Value
hours NCT03867838 542 547 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

Inclusion NCT03864302 0 9 O
Criteria NCT03864302 10 18 O
: NCT03864302 19 20 O

- NCT03864302 24 25 O
Doctors NCT03864302 27 34 B-Provider-Role

- NCT03864302 37 38 O
Informed NCT03864302 40 48 O
written NCT03864302 49 56 O
consent NCT03864302 57 64 O
. NCT03864302 65 66 O

- NCT03864302 70 71 O
Four NCT03864302 73 77 B-Eq-Value
video NCT03864302 78 83 O
- NCT03864302 84 85 O
recordings NCT03864302 86 96 O
of NCT03864302 97 99 O
TURBs NCT03864302 100 105 B-Procedure-Name
. NCT03864302 106 107 O

Exclusion NCT03864302 109 118 O
Criteria NCT03864302 119 127 O
: NCT03864302 128 129 O

- NCT03864302 133 134 O
Not NCT03864302 136 139 O
providing NCT03864302 140 149 O
four NCT03864302 150 154 B-Eq-Value
video NCT03864302 155 160 O
recordings NCT03864302 161 171 O
of NCT03864302 172 174 O
TURB NCT03864302 175 179 B-Procedure-Name
procedures NCT03864302 180 190 I-Procedure-Name

- NCT03864302 193 194 O
Simulation NCT03864302 196 206 B-Procedure-Name
- NCT03864302 207 208 I-Procedure-Name
based NCT03864302 209 214 I-Procedure-Name
training NCT03864302 215 223 I-Procedure-Name
course NCT03864302 224 230 O
in NCT03864302 231 233 O
TURB NCT03864302 234 238 B-Procedure-Name
within NCT03864302 239 245 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03864302 247 248 B-Eq-Value
months NCT03864302 249 255 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03864302 258 259 O
No NCT03864302 261 263 O
consent NCT03864302 264 271 O

Inclusion NCT03862001 0 9 O
Criteria NCT03862001 10 18 O
: NCT03862001 19 20 O

- NCT03862001 24 25 O
age NCT03862001 27 30 O
55 NCT03862001 32 34 B-Eq-Value
- NCT03862001 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03862001 38 40 B-Eq-Value

- NCT03862001 44 45 O
smoked NCT03862001 47 53 B-Condition-Name
at NCT03862001 54 56 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862001 57 62 I-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03862001 64 66 B-Eq-Value
pack NCT03862001 67 71 O
- NCT03862001 72 73 O
years NCT03862001 74 79 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
in NCT03862001 80 82 O
lifetime NCT03862001 83 91 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime

- NCT03862001 94 95 O
if NCT03862001 97 99 O
former NCT03862001 100 106 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
smoker NCT03862001 107 113 B-Condition-Name
, NCT03862001 114 115 O
quit NCT03862001 116 120 O
smoking NCT03862001 121 128 B-Condition-Name
within NCT03862001 129 135 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03862001 136 139 O
last NCT03862001 140 144 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
15 NCT03862001 146 148 B-Eq-Value
years NCT03862001 149 154 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862001 157 158 O
English NCT03862001 160 167 B-Language
speaker NCT03862001 168 175 O

- NCT03862001 178 179 O
no NCT03862001 181 183 O
prior NCT03862001 184 189 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03862001 190 197 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862001 198 200 O
lung NCT03862001 201 205 O
cancer NCT03862001 206 212 B-Condition-Name

- NCT03862001 215 216 O
did NCT03862001 218 221 O
not NCT03862001 222 225 O
have NCT03862001 226 230 O
a NCT03862001 231 232 O
lung NCT03862001 233 237 O
cancer NCT03862001 238 244 B-Condition-Name
screening NCT03862001 245 254 B-Procedure-Name
test NCT03862001 255 259 I-Procedure-Name
within NCT03862001 260 266 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03862001 267 270 O
last NCT03862001 271 275 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03862001 276 280 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862001 283 284 O
PCP NCT03862001 286 289 O
does NCT03862001 290 294 O
not NCT03862001 295 298 O
object NCT03862001 299 305 O
to NCT03862001 306 308 O
patient NCT03862001 309 316 O
's NCT03862001 316 318 O
participation NCT03862001 319 332 O

- NCT03862001 335 336 O
have NCT03862001 338 342 O
a NCT03862001 343 344 O
scheduled NCT03862001 345 354 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
visit NCT03862001 355 360 O
at NCT03862001 361 363 O
University NCT03862001 364 374 B-Location___Location-Value:hospital
of NCT03862001 375 377 I-Location___Location-Value:hospital
California NCT03862001 378 388 I-Location___Location-Value:hospital
, NCT03862001 389 390 I-Location___Location-Value:hospital
San NCT03862001 391 394 I-Location___Location-Value:hospital
Francisco NCT03862001 395 404 I-Location___Location-Value:hospital
( NCT03862001 405 406 O
UCSF NCT03862001 407 411 B-Location___Location-Value:hospital
) NCT03862001 412 413 O
internal NCT03862001 414 422 B-Location___Location-Value:clinic
medicine NCT03862001 423 431 I-Location___Location-Value:clinic
clinics NCT03862001 432 439 I-Location___Location-Value:clinic
. NCT03862001 440 441 O

Exclusion NCT03862001 443 452 O
Criteria NCT03862001 453 461 O
: NCT03862001 462 463 O

- NCT03862001 467 468 O
speaking NCT03862001 470 478 O
a NCT03862001 479 480 O
language NCT03862001 481 489 O
other NCT03862001 490 495 O
than NCT03862001 496 500 O
English NCT03862001 501 508 B-Language

- NCT03862001 511 512 O
has NCT03862001 514 517 O
a NCT03862001 518 519 O
history NCT03862001 520 527 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862001 528 530 O
lung NCT03862001 531 535 O
cancer NCT03862001 536 542 B-Condition-Name

- NCT03862001 545 546 O
had NCT03862001 548 551 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03862001 552 553 O
lung NCT03862001 554 558 O
cancer NCT03862001 559 565 B-Condition-Name
screening NCT03862001 566 575 B-Procedure-Name
test NCT03862001 576 580 I-Procedure-Name
within NCT03862001 581 587 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03862001 588 591 O
last NCT03862001 592 596 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03862001 597 601 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862001 604 605 O
PCP NCT03862001 607 610 O
objects NCT03862001 611 618 O
to NCT03862001 619 621 O
patient NCT03862001 622 629 O
's NCT03862001 629 631 O
participation NCT03862001 632 645 O
. NCT03862001 646 647 O

Inclusion NCT03861520 0 9 O
Criteria NCT03861520 10 18 O
: NCT03861520 19 20 O

1 NCT03861520 25 26 O
. NCT03861520 26 27 O
pregnant NCT03861520 29 37 B-Condition-Name
woman NCT03861520 38 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
between NCT03861520 44 51 O
( NCT03861520 52 53 O
16 NCT03861520 55 57 B-Eq-Value
- NCT03861520 58 59 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03861520 61 63 B-Eq-Value
) NCT03861520 64 65 O
weeks NCT03861520 66 71 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03861520 72 74 O
gestation NCT03861520 75 84 B-Observation-Name___Observation-Type-Value:measurement
. NCT03861520 85 86 O

2 NCT03861520 91 92 O
. NCT03861520 92 93 O
singelton NCT03861520 95 104 O
pregnancy NCT03861520 105 114 B-Condition-Name
. NCT03861520 115 116 O

Exclusion NCT03861520 118 127 O
Criteria NCT03861520 128 136 O
: NCT03861520 137 138 O

1 NCT03861520 143 144 O
. NCT03861520 144 145 O
Multiple NCT03861520 147 155 B-Eq-Operator___Eq-Operator-Value:GT
pregnancies NCT03861520 156 167 B-Condition-Name
. NCT03861520 168 169 O

2 NCT03861520 174 175 O
. NCT03861520 175 176 O
Mental NCT03861520 178 184 B-Condition-Name
condition NCT03861520 185 194 I-Condition-Name
rendering NCT03861520 195 204 O
the NCT03861520 205 208 O
patients NCT03861520 209 217 O
unable NCT03861520 218 224 B-Condition-Name
to NCT03861520 225 227 I-Condition-Name
understand NCT03861520 228 238 I-Condition-Name
the NCT03861520 239 242 O
nature NCT03861520 243 249 O
and NCT03861520 250 253 O
scope NCT03861520 254 259 O
of NCT03861520 260 262 O
the NCT03861520 263 266 O
study NCT03861520 267 272 O
. NCT03861520 273 274 O

Inclusion NCT03864289 0 9 O
Criteria NCT03864289 10 18 O
: NCT03864289 19 20 O

- NCT03864289 24 25 O
Children NCT03864289 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03864289 36 40 O
ASD NCT03864289 41 44 B-Condition-Name
or NCT03864289 45 47 O
high NCT03864289 48 52 B-Polarity___Polarity-Value:high
risk NCT03864289 53 57 O
for NCT03864289 58 61 O
autism NCT03864289 62 68 B-Condition-Name
; NCT03864289 68 69 O

- NCT03864289 72 73 O
Han NCT03864289 75 78 B-Ethnicity
ethic NCT03864289 79 84 O
; NCT03864289 84 85 O

- NCT03864289 88 89 O
Parents NCT03864289 91 98 O
were NCT03864289 99 103 O
at NCT03864289 104 106 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864289 107 112 I-Eq-Operator___Eq-Operator-Value:GTEQ
middle NCT03864289 113 119 B-Observation-Name
school NCT03864289 120 126 I-Observation-Name
educated NCT03864289 127 135 I-Observation-Name
, NCT03864289 136 137 O
and NCT03864289 138 141 O
agreed NCT03864289 142 148 O
to NCT03864289 149 151 O
do NCT03864289 152 154 O
at NCT03864289 155 157 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864289 158 163 I-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03864289 165 167 B-Eq-Value
hours NCT03864289 168 173 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
per NCT03864289 174 177 O
week NCT03864289 178 182 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03864289 183 185 O
planned NCT03864289 186 193 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
practice NCT03864289 194 202 B-Observation-Name
activities NCT03864289 203 213 I-Observation-Name
with NCT03864289 214 218 O
the NCT03864289 219 222 O
child NCT03864289 223 228 O
in NCT03864289 229 231 O
daily NCT03864289 232 237 O
life NCT03864289 238 242 O
. NCT03864289 243 244 O

Exclusion NCT03864289 246 255 O
Criteria NCT03864289 256 264 O
: NCT03864289 265 266 O

- NCT03864289 270 271 O
Children NCT03864289 273 281 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03864289 282 286 O
Syndromic NCT03864289 287 296 O
ASD NCT03864289 297 300 B-Condition-Name
caused NCT03864289 301 307 O
by NCT03864289 308 310 O
known NCT03864289 311 316 O
genetic NCT03864289 317 324 B-Condition-Name
defects NCT03864289 325 332 I-Condition-Name
or NCT03864289 333 335 O
inherited NCT03864289 336 345 O
metabolic NCT03864289 346 355 B-Condition-Name
diseases NCT03864289 356 364 I-Condition-Name
, NCT03864289 365 366 O
such NCT03864289 367 371 O
as NCT03864289 372 374 O
Rett NCT03864289 375 379 B-Condition-Name
Syndrome NCT03864289 380 388 I-Condition-Name
, NCT03864289 389 390 O
Fragile NCT03864289 391 398 B-Condition-Name
X NCT03864289 399 400 I-Condition-Name
Syndrome NCT03864289 401 409 I-Condition-Name
, NCT03864289 410 411 O
Angelman NCT03864289 412 420 B-Condition-Name
Syndrome NCT03864289 421 429 I-Condition-Name
, NCT03864289 430 431 O
Prader NCT03864289 432 438 B-Condition-Name
- NCT03864289 439 440 I-Condition-Name
Willi NCT03864289 441 446 I-Condition-Name
Syndrome NCT03864289 447 455 I-Condition-Name
, NCT03864289 456 457 O
tuberous NCT03864289 458 466 B-Condition-Name
sclerosis NCT03864289 467 476 I-Condition-Name
; NCT03864289 476 477 O

- NCT03864289 480 481 O
Visual NCT03864289 483 489 O
, NCT03864289 490 491 O
auditory NCT03864289 492 500 O
and NCT03864289 501 504 O
physical NCT03864289 505 513 O
disabilities NCT03864289 514 526 B-Condition-Name
; NCT03864289 526 527 O

- NCT03864289 530 531 O
Complication NCT03864289 533 545 O
with NCT03864289 546 550 O
other NCT03864289 551 556 O
serious NCT03864289 557 564 B-Severity___Severity-Value:severe
chronic NCT03864289 565 572 B-Condition-Name
diseases NCT03864289 573 581 I-Condition-Name
, NCT03864289 582 583 O
such NCT03864289 584 588 O
as NCT03864289 589 591 O
liver NCT03864289 592 597 O
and NCT03864289 598 601 O
kidney NCT03864289 602 608 O
failure NCT03864289 609 616 B-Condition-Name
, NCT03864289 617 618 O
connective NCT03864289 619 629 B-Condition-Name
tissue NCT03864289 630 636 I-Condition-Name
diseases NCT03864289 637 645 I-Condition-Name
, NCT03864289 646 647 O
tumors NCT03864289 648 654 B-Condition-Name
. NCT03864289 655 656 O

Inclusion NCT03862820 0 9 O
Criteria NCT03862820 10 18 O
: NCT03862820 19 20 O

Pregnant NCT03862820 22 30 B-Condition-Name
women NCT03862820 31 36 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
in NCT03862820 37 39 O
third NCT03862820 40 45 B-Condition-Name
trimester NCT03862820 46 55 I-Condition-Name
planned NCT03862820 56 63 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03862820 64 66 O
undergo NCT03862820 67 74 O
elective NCT03862820 75 83 B-Procedure-Name
cesarean NCT03862820 84 92 I-Procedure-Name
section NCT03862820 93 100 I-Procedure-Name

Exclusion NCT03862820 101 110 O
Criteria NCT03862820 111 119 O
: NCT03862820 120 121 O

Primary NCT03862820 123 130 O
elective NCT03862820 131 139 O
cesarean NCT03862820 140 148 B-Procedure-Name
section NCT03862820 149 156 I-Procedure-Name
. NCT03862820 157 158 O

Inclusion NCT03864276 0 9 O
Criteria NCT03864276 10 18 O
: NCT03864276 19 20 O

- NCT03864276 24 25 O
patients NCT03864276 27 35 O
with NCT03864276 36 40 O
liver NCT03864276 41 46 B-Condition-Name
cirrhosis NCT03864276 47 56 I-Condition-Name
who NCT03864276 57 60 O
will NCT03864276 61 65 O
undergo NCT03864276 66 73 O
planned NCT03864276 74 81 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
liver NCT03864276 82 87 B-Procedure-Name
transplantation NCT03864276 88 103 I-Procedure-Name

Exclusion NCT03864276 104 113 O
Criteria NCT03864276 114 122 O
: NCT03864276 123 124 O

- NCT03864276 128 129 O
1 NCT03864276 132 133 O
. NCT03864276 133 134 O
emergent NCT03864276 136 144 O
liver NCT03864276 145 150 B-Procedure-Name
transplantation NCT03864276 151 166 I-Procedure-Name

- NCT03864276 169 170 O
2 NCT03864276 173 174 O
. NCT03864276 174 175 O
unstable NCT03864276 177 185 B-Stability___Stability-Value:change
angina NCT03864276 186 192 B-Condition-Name

- NCT03864276 195 196 O
3 NCT03864276 199 200 O
. NCT03864276 200 201 O
recent NCT03864276 203 209 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
MI NCT03864276 210 212 B-Condition-Name
( NCT03864276 213 214 O
Myocardial NCT03864276 215 225 B-Condition-Name
Infarction NCT03864276 226 236 I-Condition-Name
) NCT03864276 237 238 O

- NCT03864276 242 243 O
4 NCT03864276 246 247 O
. NCT03864276 247 248 O
uncontrolled NCT03864276 250 262 O
hypertension NCT03864276 263 275 B-Condition-Name
( NCT03864276 276 277 O
diastolic NCT03864276 278 287 B-Observation-Name___Observation-Type-Value:vital
BP NCT03864276 288 290 I-Observation-Name___Observation-Type-Value:vital
> NCT03864276 291 292 B-Eq-Operator___Eq-Operator-Value:GT
110 NCT03864276 294 297 B-Eq-Value
mmHg NCT03864276 298 302 B-Eq-Unit
) NCT03864276 303 304 O

- NCT03864276 308 309 O
5 NCT03864276 312 313 O
. NCT03864276 313 314 O
implantable NCT03864276 316 327 B-Procedure-Name
cardiac NCT03864276 328 335 I-Procedure-Name
defibrillator NCT03864276 336 349 I-Procedure-Name

- NCT03864276 352 353 O
6 NCT03864276 356 357 O
. NCT03864276 357 358 O
severe NCT03864276 360 366 B-Severity___Severity-Value:severe
obesity NCT03864276 367 374 B-Condition-Name
( NCT03864276 375 376 O
BMI NCT03864276 377 380 B-Observation-Name___Observation-Type-Value:vital
> NCT03864276 381 382 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03864276 384 386 B-Eq-Value
kg NCT03864276 387 389 B-Eq-Unit
/ NCT03864276 390 391 O
m NCT03864276 392 393 B-Eq-Unit
2 NCT03864276 394 395 I-Eq-Unit
) NCT03864276 396 397 O

- NCT03864276 401 402 O
7 NCT03864276 405 406 O
. NCT03864276 406 407 O
allergy NCT03864276 409 416 O
to NCT03864276 417 419 O
propofol NCT03864276 420 428 B-Drug-Name

Inclusion NCT03864510 0 9 O
Criteria NCT03864510 10 18 O
: NCT03864510 19 20 O

- NCT03864510 24 25 O
Diabetes NCT03864510 27 35 B-Condition-Name
type NCT03864510 36 40 O
2 NCT03864510 42 43 O

- NCT03864510 47 48 O
Age NCT03864510 50 53 O
35 NCT03864510 55 57 B-Eq-Value
- NCT03864510 58 59 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03864510 61 63 B-Eq-Value
year NCT03864510 64 68 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03864510 69 78 O
Criteria NCT03864510 79 87 O
: NCT03864510 88 89 O

- NCT03864510 93 94 O
Contraindication NCT03864510 96 112 O
to NCT03864510 113 115 O
MR NCT03864510 116 118 B-Procedure-Name

- NCT03864510 121 122 O
Alcohol NCT03864510 124 131 B-Condition-Name
dependance NCT03864510 132 142 I-Condition-Name

- NCT03864510 145 146 O
Previously NCT03864510 148 158 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosed NCT03864510 159 168 O
liver NCT03864510 169 174 B-Condition-Name
cirrhosis NCT03864510 175 184 I-Condition-Name

- NCT03864510 187 188 O
Previously NCT03864510 190 200 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
known NCT03864510 201 206 O
liver NCT03864510 207 212 B-Condition-Name
disease NCT03864510 213 220 I-Condition-Name
( NCT03864510 221 222 O
other NCT03864510 223 228 O
than NCT03864510 229 233 O
fatty NCT03864510 234 239 B-Condition-Name
liver NCT03864510 240 245 I-Condition-Name
) NCT03864510 246 247 O

Inclusion NCT03861468 0 9 O
Criteria NCT03861468 10 18 O
: NCT03861468 19 20 O

- NCT03861468 24 25 O
Patients NCT03861468 27 35 O
aged NCT03861468 36 40 O
from NCT03861468 41 45 O
18 NCT03861468 47 49 B-Eq-Value
to NCT03861468 50 52 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03861468 54 56 B-Eq-Value
years NCT03861468 57 62 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861468 65 66 O
Obese NCT03861468 68 73 B-Condition-Name
( NCT03861468 74 75 O
BMI NCT03861468 76 79 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03861468 80 81 B-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03861468 83 85 B-Eq-Value
kg NCT03861468 86 88 B-Eq-Unit
/ NCT03861468 89 90 O
m² NCT03861468 91 93 B-Eq-Unit
) NCT03861468 94 95 O

- NCT03861468 99 100 O
Referred NCT03861468 102 110 B-Encounter-Type___Encounter-Type-Value:referral
by NCT03861468 111 113 O
GPs NCT03861468 114 117 B-Provider-Type
to NCT03861468 118 120 O
the NCT03861468 121 124 O
medical NCT03861468 125 132 O
analysis NCT03861468 133 141 O
laboratory NCT03861468 142 152 O
for NCT03861468 153 156 O
usual NCT03861468 157 162 O
biological NCT03861468 163 173 B-Observation-Name___Observation-Type-Value:lab
assessment NCT03861468 174 184 I-Observation-Name___Observation-Type-Value:lab

- NCT03861468 187 188 O
Patients NCT03861468 190 198 O
with NCT03861468 199 203 O
no NCT03861468 204 206 O
respiratory NCT03861468 207 218 B-Condition-Name
follow NCT03861468 219 225 O
- NCT03861468 226 227 O
up NCT03861468 228 230 O
already NCT03861468 231 238 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03861468 239 241 O
place NCT03861468 242 247 O

- NCT03861468 250 251 O
Bicarbonate NCT03861468 253 264 B-Observation-Name___Observation-Type-Value:lab
- NCT03861468 265 266 I-Observation-Name___Observation-Type-Value:lab
Concentration NCT03861468 267 280 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03861468 281 282 B-Eq-Operator___Eq-Operator-Value:GTEQ
27 NCT03861468 284 286 B-Eq-Value
mmol NCT03861468 287 291 B-Eq-Unit
/ NCT03861468 292 293 O
L NCT03861468 294 295 B-Eq-Unit

- NCT03861468 298 299 O
STOP NCT03861468 301 305 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03861468 306 307 I-Observation-Name___Observation-Type-Value:clinical-score
BANG NCT03861468 308 312 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03861468 313 318 O
≥ NCT03861468 319 320 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03861468 322 323 B-Eq-Value

Exclusion NCT03861468 325 334 O
Criteria NCT03861468 335 343 O
: NCT03861468 344 345 O

- NCT03861468 349 350 O
Acute NCT03861468 352 357 B-Severity___Severity-Value:severe
disease NCT03861468 358 365 B-Condition-Name
or NCT03861468 366 368 O
recently NCT03861468 369 377 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosed NCT03861468 378 387 O
chronic NCT03861468 388 395 O
disease NCT03861468 396 403 B-Condition-Name
( NCT03861468 404 405 O
< NCT03861468 407 408 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03861468 410 411 B-Eq-Value
months NCT03861468 412 418 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03861468 419 420 O

- NCT03861468 424 425 O
Hospitalization NCT03861468 427 442 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03861468 443 446 O
respiratory NCT03861468 447 458 O
, NCT03861468 459 460 O
metabolic NCT03861468 461 470 O
or NCT03861468 471 473 O
cardiovascular NCT03861468 474 488 O
event NCT03861468 489 494 B-Condition-Name
( NCT03861468 495 496 O
< NCT03861468 498 499 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03861468 501 502 B-Eq-Value
months NCT03861468 503 509 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03861468 510 511 O

- NCT03861468 515 516 O
Renal NCT03861468 518 523 B-Condition-Name
insufficiency NCT03861468 524 537 I-Condition-Name
stage NCT03861468 538 543 B-Eq-Unit
4 NCT03861468 545 546 B-Eq-Value
or NCT03861468 547 549 O
5 NCT03861468 551 552 B-Eq-Value
, NCT03861468 553 554 O
or NCT03861468 555 557 O
autoimmune NCT03861468 558 568 B-Condition-Name
disease NCT03861468 569 576 I-Condition-Name
, NCT03861468 577 578 O
or NCT03861468 579 581 O
viral NCT03861468 582 587 B-Condition-Name
hepatitis NCT03861468 588 597 I-Condition-Name
, NCT03861468 598 599 O
or NCT03861468 600 602 O
cirrhosis NCT03861468 603 612 B-Condition-Name

- NCT03861468 615 616 O
Pregnant NCT03861468 618 626 B-Condition-Name
women NCT03861468 627 632 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03861468 635 636 O
Patients NCT03861468 638 646 O
already NCT03861468 647 654 O
included NCT03861468 655 663 O
in NCT03861468 664 666 O
an NCT03861468 667 669 O
interventional NCT03861468 670 684 O
study NCT03861468 685 690 O
( NCT03861468 691 692 O
end NCT03861468 693 696 O
of NCT03861468 697 699 O
the NCT03861468 700 703 O
study NCT03861468 704 709 O
< NCT03861468 710 711 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03861468 713 714 B-Eq-Value
month NCT03861468 715 720 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03861468 721 722 O

Inclusion NCT03867019 0 9 O
Criteria NCT03867019 10 18 O
: NCT03867019 19 20 O

Subjects NCT03867019 22 30 O
with NCT03867019 31 35 O
BPPV NCT03867019 36 40 B-Condition-Name
- NCT03867019 41 42 O
Patients NCT03867019 43 51 O
diagnosed NCT03867019 52 61 O
with NCT03867019 62 66 O
BPPV NCT03867019 67 71 B-Condition-Name
, NCT03867019 72 73 O
who NCT03867019 74 77 O
meet NCT03867019 78 82 O
the NCT03867019 83 86 O
following NCT03867019 87 96 O
criteria NCT03867019 97 105 O
: NCT03867019 106 107 O

1 NCT03867019 112 113 O
. NCT03867019 113 114 O
Main NCT03867019 116 120 O
complain NCT03867019 121 129 O
of NCT03867019 130 132 O
spinning NCT03867019 133 141 B-Condition-Name
sensation NCT03867019 142 151 I-Condition-Name
( NCT03867019 152 153 O
Vertigo NCT03867019 154 161 B-Condition-Name
) NCT03867019 162 163 O
when NCT03867019 164 168 O
changes NCT03867019 169 176 O
are NCT03867019 177 180 O
made NCT03867019 181 185 O
in NCT03867019 186 188 O
head NCT03867019 189 193 O
position NCT03867019 194 202 O
relative NCT03867019 203 211 O
to NCT03867019 212 214 O
gravity NCT03867019 215 222 O
( NCT03867019 223 224 O
such NCT03867019 225 229 O
as NCT03867019 230 232 O
when NCT03867019 233 237 O
moving NCT03867019 238 244 O
from NCT03867019 245 249 O
sitting NCT03867019 250 257 O
to NCT03867019 258 260 O
lying NCT03867019 261 266 O
down NCT03867019 267 271 O
or NCT03867019 272 274 O
rolling NCT03867019 275 282 O
in NCT03867019 283 285 O
bed NCT03867019 286 289 O
, NCT03867019 290 291 O
bending NCT03867019 292 299 O
over NCT03867019 300 304 O
etc NCT03867019 305 308 O
. NCT03867019 309 310 O
) NCT03867019 311 312 O

2 NCT03867019 317 318 O
. NCT03867019 318 319 O
Positive NCT03867019 321 329 B-Polarity___Polarity-Value:positive
Dix NCT03867019 330 333 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03867019 334 335 I-Observation-Name___Observation-Type-Value:clinical-score
Hallpike NCT03867019 336 344 I-Observation-Name___Observation-Type-Value:clinical-score
/ NCT03867019 345 346 I-Observation-Name___Observation-Type-Value:clinical-score
Supine NCT03867019 347 353 I-Observation-Name___Observation-Type-Value:clinical-score
Roll NCT03867019 354 358 I-Observation-Name___Observation-Type-Value:clinical-score
Test NCT03867019 359 363 I-Observation-Name___Observation-Type-Value:clinical-score
, NCT03867019 364 365 O
confirmed NCT03867019 366 375 O
by NCT03867019 376 378 O
presence NCT03867019 379 387 O
of NCT03867019 388 390 O
nystagmus NCT03867019 391 400 B-Condition-Name
. NCT03867019 401 402 O

Subjects NCT03867019 404 412 O
without NCT03867019 413 420 O
BPPV NCT03867019 421 425 B-Condition-Name
( NCT03867019 426 427 O
Control NCT03867019 428 435 O
group NCT03867019 436 441 O
) NCT03867019 442 443 O
: NCT03867019 445 446 O

Subjects NCT03867019 448 456 O
who NCT03867019 457 460 O
do NCT03867019 461 463 O
not NCT03867019 464 467 O
suffer NCT03867019 468 474 O
from NCT03867019 475 479 O
dizziness NCT03867019 480 489 B-Condition-Name
/ NCT03867019 490 491 O
spinning NCT03867019 492 500 B-Condition-Name
sensation NCT03867019 501 510 I-Condition-Name
( NCT03867019 511 512 O
Vertigo NCT03867019 513 520 B-Condition-Name
) NCT03867019 521 522 O
. NCT03867019 524 525 O

Exclusion NCT03867019 527 536 O
Criteria NCT03867019 537 545 O
: NCT03867019 546 547 O

- NCT03867019 551 552 O
Suffering NCT03867019 554 563 O
from NCT03867019 564 568 O
pain NCT03867019 569 573 B-Condition-Name
in NCT03867019 574 576 O
the NCT03867019 577 580 O
day NCT03867019 581 584 O
of NCT03867019 585 587 O
assessment NCT03867019 588 598 O
. NCT03867019 599 600 O

- NCT03867019 604 605 O
Postural NCT03867019 607 615 O
Hypotension NCT03867019 616 627 B-Condition-Name
. NCT03867019 628 629 O

- NCT03867019 633 634 O
Familial NCT03867019 636 644 B-Condition-Name
Dysautonomia NCT03867019 645 657 I-Condition-Name
. NCT03867019 658 659 O

- NCT03867019 663 664 O
Diabetic NCT03867019 666 674 B-Condition-Name
Neuropathy NCT03867019 675 685 I-Condition-Name
. NCT03867019 686 687 O

- NCT03867019 691 692 O
History NCT03867019 694 701 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867019 702 704 O
Whiplash NCT03867019 705 713 B-Condition-Name
or NCT03867019 714 716 O
Traumatic NCT03867019 717 726 B-Condition-Name
Brain NCT03867019 727 732 I-Condition-Name
Injury NCT03867019 733 739 I-Condition-Name
( NCT03867019 740 741 O
TBI NCT03867019 742 745 B-Condition-Name
) NCT03867019 746 747 O
in NCT03867019 748 750 O
the NCT03867019 751 754 O
last NCT03867019 755 759 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03867019 760 764 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03867019 765 766 O

- NCT03867019 770 771 O
History NCT03867019 773 780 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867019 781 783 O
Stroke NCT03867019 784 790 B-Condition-Name
( NCT03867019 791 792 O
CVA NCT03867019 793 796 B-Condition-Name
) NCT03867019 797 798 O
, NCT03867019 800 801 O
Multiple NCT03867019 802 810 B-Condition-Name
Sclerosis NCT03867019 811 820 I-Condition-Name
( NCT03867019 821 822 O
MS NCT03867019 823 825 B-Condition-Name
) NCT03867019 826 827 O
or NCT03867019 828 830 O
Central NCT03867019 831 838 B-Condition-Name
Positional NCT03867019 839 849 I-Condition-Name
Vertigo NCT03867019 850 857 I-Condition-Name
. NCT03867019 858 859 O

- NCT03867019 863 864 O
Coronary NCT03867019 866 874 B-Condition-Name
Heart NCT03867019 875 880 I-Condition-Name
Disease NCT03867019 881 888 I-Condition-Name
( NCT03867019 889 890 O
CHD NCT03867019 891 894 B-Condition-Name
) NCT03867019 895 896 O
, NCT03867019 898 899 O
Cardiac NCT03867019 900 907 B-Condition-Name
Heart NCT03867019 908 913 I-Condition-Name
Failure NCT03867019 914 921 I-Condition-Name
( NCT03867019 922 923 O
CHF NCT03867019 924 927 B-Condition-Name
) NCT03867019 928 929 O
, NCT03867019 931 932 O
Cardiac NCT03867019 933 940 B-Condition-Name
arrhythmias NCT03867019 941 952 I-Condition-Name
, NCT03867019 953 954 O
Vertebrobasilar NCT03867019 955 970 B-Condition-Name
Insufficiency NCT03867019 971 984 I-Condition-Name
( NCT03867019 985 986 O
VBI NCT03867019 987 990 B-Condition-Name
) NCT03867019 991 992 O
. NCT03867019 994 995 O

- NCT03867019 999 1000 O
Under NCT03867019 1002 1007 O
treatment NCT03867019 1008 1017 O
of NCT03867019 1018 1020 O
Beta NCT03867019 1021 1025 B-Drug-Name
- NCT03867019 1026 1027 I-Drug-Name
Blockers NCT03867019 1028 1036 I-Drug-Name
. NCT03867019 1037 1038 O

- NCT03867019 1042 1043 O
Anxiety NCT03867019 1045 1052 B-Condition-Name
Disorders NCT03867019 1053 1062 I-Condition-Name
. NCT03867019 1063 1064 O

- NCT03867019 1068 1069 O
Vestibular NCT03867019 1071 1081 B-Condition-Name
Migraine NCT03867019 1082 1090 I-Condition-Name
, NCT03867019 1091 1092 O
Vestibular NCT03867019 1093 1103 B-Condition-Name
Neuritis NCT03867019 1104 1112 I-Condition-Name
, NCT03867019 1113 1114 O
Menier NCT03867019 1115 1121 B-Condition-Name
's NCT03867019 1121 1123 I-Condition-Name
Disease NCT03867019 1124 1131 I-Condition-Name
, NCT03867019 1132 1133 O
Perilymphatic NCT03867019 1134 1147 B-Condition-Name
Fistula NCT03867019 1148 1155 I-Condition-Name
, NCT03867019 1156 1157 O
Superior NCT03867019 1158 1166 B-Condition-Name
Canal NCT03867019 1167 1172 I-Condition-Name
Dehiscence NCT03867019 1173 1183 I-Condition-Name
Syndrome NCT03867019 1184 1192 I-Condition-Name
. NCT03867019 1193 1194 O

- NCT03867019 1198 1199 O
Medical NCT03867019 1201 1208 O
conditions NCT03867019 1209 1219 O
with NCT03867019 1220 1224 O
high NCT03867019 1225 1229 B-Polarity___Polarity-Value:high
risk NCT03867019 1230 1234 O
of NCT03867019 1235 1237 O
subluxation NCT03867019 1238 1249 B-Condition-Name
/ NCT03867019 1250 1251 O
dislocation NCT03867019 1252 1263 B-Condition-Name
of NCT03867019 1264 1266 O
the NCT03867019 1267 1270 O
Atlanto NCT03867019 1271 1278 O
- NCT03867019 1279 1280 O
axial NCT03867019 1281 1286 O
joint NCT03867019 1287 1292 O
. NCT03867019 1293 1294 O

- NCT03867019 1298 1299 O
Health NCT03867019 1301 1307 O
professionals NCT03867019 1308 1321 O
who NCT03867019 1322 1325 O
are NCT03867019 1326 1329 O
specialized NCT03867019 1330 1341 O
to NCT03867019 1342 1344 O
treat NCT03867019 1345 1350 O
Vestibular NCT03867019 1351 1361 B-Condition-Name
disorders NCT03867019 1362 1371 I-Condition-Name
( NCT03867019 1372 1373 O
such NCT03867019 1374 1378 O
as NCT03867019 1379 1381 O
Vestibular NCT03867019 1382 1392 B-Provider-Type
physiotherapists NCT03867019 1393 1409 I-Provider-Type
) NCT03867019 1410 1411 O

Inclusion NCT03869008 0 9 O
Criteria NCT03869008 10 18 O
: NCT03869008 19 20 O

• NCT03869008 22 23 O
Clinical NCT03869008 24 32 O
Diagnosis NCT03869008 33 42 O
of NCT03869008 43 45 O
Primary NCT03869008 46 53 B-Condition-Name
Raynaud NCT03869008 54 61 I-Condition-Name
's NCT03869008 61 63 I-Condition-Name
Phenomenon NCT03869008 64 74 I-Condition-Name

Exclusion NCT03869008 75 84 O
Criteria NCT03869008 85 93 O
: NCT03869008 94 95 O

- NCT03869008 99 100 O
Less NCT03869008 102 106 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03869008 107 111 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03869008 113 115 B-Eq-Value
years NCT03869008 116 121 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869008 122 124 O
age NCT03869008 125 128 O

- NCT03869008 131 132 O
Pregnant NCT03869008 134 142 B-Condition-Name
women NCT03869008 143 148 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03869008 151 152 O
Current NCT03869008 154 161 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
smokers NCT03869008 162 169 B-Condition-Name

- NCT03869008 172 173 O
Have NCT03869008 175 179 O
Digital NCT03869008 180 187 O
ulcers NCT03869008 188 194 B-Condition-Name

- NCT03869008 197 198 O
Diagnosed NCT03869008 200 209 O
Pulmonary NCT03869008 210 219 B-Condition-Name
hypertension NCT03869008 220 232 I-Condition-Name

- NCT03869008 235 236 O
Currently NCT03869008 238 247 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
on NCT03869008 248 250 O
vasodilators NCT03869008 251 263 B-Drug-Name
( NCT03869008 264 265 O
i NCT03869008 266 267 O
. NCT03869008 268 269 O
e NCT03869008 270 271 O
. NCT03869008 272 273 O
Phosphodiesterase NCT03869008 275 292 B-Drug-Name
type NCT03869008 293 297 I-Drug-Name
5 NCT03869008 299 300 I-Drug-Name
inhibitors NCT03869008 301 311 I-Drug-Name
, NCT03869008 312 313 O
prostacyclin NCT03869008 314 326 B-Drug-Name
, NCT03869008 327 328 O
nitroglycerine NCT03869008 329 343 B-Drug-Name
, NCT03869008 344 345 O
or NCT03869008 346 348 O
other NCT03869008 349 354 O
nitric NCT03869008 355 361 B-Drug-Name
oxide NCT03869008 362 367 I-Drug-Name
derivatives NCT03869008 368 379 I-Drug-Name
) NCT03869008 380 381 O

- NCT03869008 385 386 O
Currently NCT03869008 388 397 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
on NCT03869008 398 400 O
Calcium NCT03869008 401 408 B-Drug-Name
Channel NCT03869008 409 416 I-Drug-Name
Blockers NCT03869008 417 425 I-Drug-Name

Inclusion NCT03860038 0 9 O
criteria NCT03860038 10 18 O
: NCT03860038 19 20 O

1 NCT03860038 25 26 O
. NCT03860038 26 27 O
Age NCT03860038 29 32 O
≥ NCT03860038 33 34 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03860038 36 38 B-Eq-Value
, NCT03860038 39 40 O
male NCT03860038 41 45 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03860038 46 48 O
female NCT03860038 49 55 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
; NCT03860038 55 56 O

2 NCT03860038 60 61 O
. NCT03860038 61 62 O
Subject NCT03860038 64 71 O
must NCT03860038 72 76 O
have NCT03860038 77 81 O
had NCT03860038 82 85 O
documented NCT03860038 86 96 O
MM NCT03860038 97 99 B-Condition-Name
; NCT03860038 99 100 O

3 NCT03860038 104 105 O
. NCT03860038 105 106 O
At NCT03860038 108 110 O
screening NCT03860038 111 120 O
phase NCT03860038 121 126 O
, NCT03860038 127 128 O
subject NCT03860038 129 136 O
must NCT03860038 137 141 O
have NCT03860038 142 146 O
measurable NCT03860038 147 157 O
disease NCT03860038 158 165 B-Condition-Name
; NCT03860038 165 166 O

4 NCT03860038 170 171 O
. NCT03860038 171 172 O
Subject NCT03860038 174 181 O
is NCT03860038 182 184 O
in NCT03860038 185 187 O
a NCT03860038 188 189 O
state NCT03860038 190 195 O
of NCT03860038 196 198 O
progressive NCT03860038 199 210 B-Condition-Name
disease NCT03860038 211 218 I-Condition-Name
( NCT03860038 219 220 O
PD NCT03860038 221 223 B-Condition-Name
) NCT03860038 224 225 O
; NCT03860038 226 227 O

5 NCT03860038 231 232 O
. NCT03860038 232 233 O
Subject NCT03860038 235 242 O
must NCT03860038 243 247 O
have NCT03860038 248 252 O
life NCT03860038 253 257 B-Observation-Name___Observation-Type-Value:vital
expectancy NCT03860038 258 268 I-Observation-Name___Observation-Type-Value:vital
of NCT03860038 269 271 O
no NCT03860038 272 274 B-Eq-Operator___Eq-Operator-Value:GTEQ
less NCT03860038 275 279 I-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03860038 280 284 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03860038 286 287 B-Eq-Value
months NCT03860038 288 294 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03860038 294 295 O

6 NCT03860038 299 300 O
. NCT03860038 300 301 O
Subject NCT03860038 303 310 O
must NCT03860038 311 315 O
have NCT03860038 316 320 O
an NCT03860038 321 323 O
ECOG NCT03860038 324 328 B-Observation-Name___Observation-Type-Value:clinical-score
( NCT03860038 329 330 O
Eastern NCT03860038 331 338 B-Observation-Name
Cooperative NCT03860038 339 350 I-Observation-Name
Oncology NCT03860038 351 359 I-Observation-Name
Group NCT03860038 360 365 I-Observation-Name
) NCT03860038 366 367 O
performance NCT03860038 368 379 O
status NCT03860038 380 386 O
score NCT03860038 387 392 O
of NCT03860038 393 395 O
0 NCT03860038 397 398 B-Eq-Value
~ NCT03860038 399 400 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03860038 402 403 B-Eq-Value
; NCT03860038 404 405 O

Exclusion NCT03860038 406 415 O
criteria NCT03860038 416 424 O
: NCT03860038 425 426 O

1 NCT03860038 431 432 O
. NCT03860038 432 433 O
Subject NCT03860038 435 442 O
has NCT03860038 443 446 O
received NCT03860038 447 455 O
anti NCT03860038 456 460 B-Drug-Name
- NCT03860038 461 462 I-Drug-Name
CD NCT03860038 463 465 I-Drug-Name
38 NCT03860038 466 468 I-Drug-Name
monoclonal NCT03860038 469 479 I-Drug-Name
antibody NCT03860038 480 488 I-Drug-Name
treatment NCT03860038 489 498 I-Drug-Name
previously NCT03860038 499 509 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
; NCT03860038 509 510 O

2 NCT03860038 514 515 O
. NCT03860038 515 516 O
Subject NCT03860038 518 525 O
has NCT03860038 526 529 O
received NCT03860038 530 538 O
CAR NCT03860038 539 542 B-Procedure-Name
- NCT03860038 543 544 I-Procedure-Name
T NCT03860038 545 546 I-Procedure-Name
cell NCT03860038 547 551 I-Procedure-Name
therapy NCT03860038 552 559 I-Procedure-Name
previously NCT03860038 560 570 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
; NCT03860038 570 571 O

3 NCT03860038 575 576 O
. NCT03860038 576 577 O
Subject NCT03860038 579 586 O
has NCT03860038 587 590 O
previously NCT03860038 591 601 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
received NCT03860038 602 610 O
allogenic NCT03860038 611 620 O
stem NCT03860038 621 625 B-Procedure-Name
cell NCT03860038 626 630 I-Procedure-Name
transplant NCT03860038 631 641 I-Procedure-Name
, NCT03860038 642 643 O
or NCT03860038 644 646 O
subject NCT03860038 647 654 O
has NCT03860038 655 658 O
received NCT03860038 659 667 O
autologous NCT03860038 668 678 O
stem NCT03860038 679 683 B-Procedure-Name
cell NCT03860038 684 688 I-Procedure-Name
transplant NCT03860038 689 699 I-Procedure-Name
within NCT03860038 700 706 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03860038 708 709 B-Eq-Value
months NCT03860038 710 716 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03860038 717 723 O
administration NCT03860038 724 738 O
of NCT03860038 739 741 O
the NCT03860038 742 745 O
study NCT03860038 746 751 O
agent NCT03860038 752 757 O
; NCT03860038 757 758 O

4 NCT03860038 762 763 O
. NCT03860038 763 764 O
Primary NCT03860038 766 773 O
refractory NCT03860038 774 784 O
multiple NCT03860038 785 793 O
myeloma NCT03860038 794 801 B-Condition-Name
( NCT03860038 802 803 O
subject NCT03860038 804 811 O
failed NCT03860038 812 818 O
to NCT03860038 819 821 O
generate NCT03860038 822 830 O
any NCT03860038 831 834 O
minimal NCT03860038 835 842 O
response NCT03860038 843 851 O
or NCT03860038 852 854 O
any NCT03860038 855 858 O
degree NCT03860038 859 865 O
of NCT03860038 866 868 O
response NCT03860038 869 877 O
to NCT03860038 878 880 O
any NCT03860038 881 884 O
therapy NCT03860038 885 892 B-Procedure-Name
) NCT03860038 893 894 O
; NCT03860038 895 896 O

5 NCT03860038 900 901 O
. NCT03860038 901 902 O
Subject NCT03860038 904 911 O
has NCT03860038 912 915 O
received NCT03860038 916 924 O
anti NCT03860038 925 929 B-Procedure-Name
- NCT03860038 930 931 I-Procedure-Name
myeloma NCT03860038 932 939 I-Procedure-Name
treatment NCT03860038 940 949 I-Procedure-Name
( NCT03860038 950 951 O
radiotherapy NCT03860038 952 964 B-Procedure-Name
is NCT03860038 965 967 O
excluded NCT03860038 968 976 O
) NCT03860038 977 978 O
within NCT03860038 979 985 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03860038 987 988 B-Eq-Value
weeks NCT03860038 989 994 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
or NCT03860038 995 997 O
5 NCT03860038 999 1000 B-Eq-Value
PK NCT03860038 1001 1003 B-Eq-Unit
half NCT03860038 1004 1008 I-Eq-Unit
- NCT03860038 1009 1010 I-Eq-Unit
lives NCT03860038 1011 1016 I-Eq-Unit
of NCT03860038 1017 1019 O
the NCT03860038 1020 1023 O
treatment NCT03860038 1024 1033 O
, NCT03860038 1034 1035 O
whichever NCT03860038 1036 1045 O
longer NCT03860038 1046 1052 O
, NCT03860038 1053 1054 O
before NCT03860038 1055 1061 O
the NCT03860038 1062 1065 O
first NCT03860038 1066 1071 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
study NCT03860038 1072 1077 O
agent NCT03860038 1078 1083 O
administration NCT03860038 1084 1098 O
. NCT03860038 1099 1100 O

Inclusion NCT03869593 0 9 O
Criteria NCT03869593 10 18 O
: NCT03869593 19 20 O

- NCT03869593 24 25 O
Patient NCT03869593 27 34 O
with NCT03869593 35 39 O
S NCT03869593 40 41 B-Organism-Name
. NCT03869593 42 43 I-Organism-Name
aureus NCT03869593 45 51 I-Organism-Name
or NCT03869593 52 54 O
E NCT03869593 55 56 B-Organism-Name
. NCT03869593 57 58 I-Organism-Name
coli NCT03869593 60 64 I-Organism-Name
bacteriostatic NCT03869593 65 79 B-Condition-Name
bacteremia NCT03869593 80 90 I-Condition-Name
defined NCT03869593 91 98 O
by NCT03869593 99 101 O
at NCT03869593 102 104 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869593 105 110 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03869593 111 114 B-Eq-Value
positive NCT03869593 115 123 B-Polarity___Polarity-Value:positive
blood NCT03869593 124 129 B-Observation-Specimen
culture NCT03869593 130 137 B-Observation-Name___Observation-Type-Value:lab
bottle NCT03869593 138 144 O

- NCT03869593 147 148 O
Patient NCT03869593 150 157 O
requiring NCT03869593 158 167 O
a NCT03869593 168 169 O
blood NCT03869593 170 175 B-Observation-Name___Observation-Type-Value:lab
test NCT03869593 176 180 I-Observation-Name___Observation-Type-Value:lab
as NCT03869593 181 183 O
part NCT03869593 184 188 O
of NCT03869593 189 191 O
his NCT03869593 192 195 O
bacteremia NCT03869593 196 206 B-Condition-Name

- NCT03869593 209 210 O
not NCT03869593 212 215 O
subject NCT03869593 216 223 O
to NCT03869593 224 226 O
a NCT03869593 227 228 O
judicial NCT03869593 229 237 B-Observation-Name
protection NCT03869593 238 248 I-Observation-Name
measure NCT03869593 249 256 O

- NCT03869593 259 260 O
Signature NCT03869593 262 271 O
of NCT03869593 272 274 O
the NCT03869593 275 278 O
non NCT03869593 279 282 O
- NCT03869593 283 284 O
opposition NCT03869593 285 295 O
of NCT03869593 296 298 O
consent NCT03869593 299 306 O
( NCT03869593 307 308 O
for NCT03869593 309 312 O
minor NCT03869593 313 318 O
patients NCT03869593 319 327 O
signed NCT03869593 328 334 O
by NCT03869593 335 337 O
one NCT03869593 338 341 O
of NCT03869593 342 344 O
the NCT03869593 345 348 O
parents NCT03869593 349 356 O
or NCT03869593 357 359 O
the NCT03869593 360 363 O
representative NCT03869593 364 378 O
of NCT03869593 379 381 O
the NCT03869593 382 385 O
parental NCT03869593 386 394 O
authority NCT03869593 395 404 O
) NCT03869593 405 406 O

- NCT03869593 410 411 O
Affiliation NCT03869593 413 424 O
to NCT03869593 425 427 O
social NCT03869593 428 434 O
security NCT03869593 435 443 O

Exclusion NCT03869593 444 453 O
Criteria NCT03869593 454 462 O
: NCT03869593 463 464 O

- NCT03869593 468 469 O
Immunocompromised NCT03869593 471 488 B-Condition-Name
patient NCT03869593 489 496 O
defined NCT03869593 497 504 O
by NCT03869593 505 507 O
: NCT03869593 508 509 O

- NCT03869593 518 519 O
current NCT03869593 521 528 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
immunosuppressive NCT03869593 529 546 B-Procedure-Name
therapies NCT03869593 547 556 I-Procedure-Name
: NCT03869593 557 558 O
corticosteroids NCT03869593 559 574 B-Drug-Name
, NCT03869593 575 576 O
chemotherapy NCT03869593 577 589 B-Procedure-Name
, NCT03869593 590 591 O
biotherapy NCT03869593 592 602 B-Procedure-Name

- NCT03869593 610 611 O
solid NCT03869593 613 618 B-Procedure-Name
organ NCT03869593 619 624 I-Procedure-Name
transplant NCT03869593 625 635 I-Procedure-Name
patient NCT03869593 636 643 O
or NCT03869593 644 646 O
hematopoietic NCT03869593 647 660 O
stem NCT03869593 661 665 B-Procedure-Name
cell NCT03869593 666 670 I-Procedure-Name
transplant NCT03869593 671 681 I-Procedure-Name

- NCT03869593 689 690 O
chemotherapy NCT03869593 692 704 B-Procedure-Name
- NCT03869593 705 706 O
induced NCT03869593 707 714 O
neutropenia NCT03869593 715 726 B-Condition-Name

- NCT03869593 734 735 O
Congenital NCT03869593 737 747 O
immune NCT03869593 748 754 B-Condition-Name
deficiency NCT03869593 755 765 I-Condition-Name

- NCT03869593 768 769 O
bacteremia NCT03869593 771 781 B-Condition-Name
related NCT03869593 782 789 O
to NCT03869593 790 792 O
a NCT03869593 793 794 O
peripheral NCT03869593 795 805 O
or NCT03869593 806 808 O
central NCT03869593 809 816 O
catheter NCT03869593 817 825 B-Procedure-Name

- NCT03869593 828 829 O
Urinary NCT03869593 831 838 B-Condition-Name
obstruction NCT03869593 839 850 I-Condition-Name
not NCT03869593 851 854 O
lifted NCT03869593 855 861 B-Procedure-Name
within NCT03869593 862 868 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03869593 869 872 O
first NCT03869593 873 878 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
24 NCT03869593 880 882 B-Eq-Value
hours NCT03869593 883 888 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03869593 889 891 O
management NCT03869593 892 902 O

- NCT03869593 905 906 O
Intra NCT03869593 908 913 O
- NCT03869593 914 915 O
abdominal NCT03869593 916 925 O
infection NCT03869593 926 935 B-Condition-Name
collected NCT03869593 936 945 O
undrained NCT03869593 946 955 B-Procedure-Name
in NCT03869593 956 958 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03869593 959 962 O
first NCT03869593 963 968 O
24 NCT03869593 970 972 B-Eq-Value
hours NCT03869593 973 978 B-Eq-Temporal-Unit
of NCT03869593 979 981 O
management NCT03869593 982 992 O

- NCT03869593 995 996 O
primary NCT03869593 998 1005 O
infectious NCT03869593 1006 1016 B-Condition-Name
focus NCT03869593 1017 1022 O
represented NCT03869593 1023 1034 O
by NCT03869593 1035 1037 O
mechanically NCT03869593 1038 1050 B-Procedure-Name
ventilated NCT03869593 1051 1061 I-Procedure-Name
pneumonia NCT03869593 1062 1071 B-Condition-Name

- NCT03869593 1074 1075 O
Pregnant NCT03869593 1077 1085 B-Condition-Name
or NCT03869593 1086 1088 O
lactating NCT03869593 1089 1098 B-Condition-Name
woman NCT03869593 1099 1104 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

Inclusion NCT03866850 0 9 O
Criteria NCT03866850 10 18 O
: NCT03866850 19 20 O

- NCT03866850 24 25 O
Cochlear NCT03866850 27 35 O
Nucleus NCT03866850 36 43 O
cochlear NCT03866850 44 52 B-Procedure-Name
implant NCT03866850 53 60 I-Procedure-Name
users NCT03866850 61 66 O
or NCT03866850 67 69 O
Advanced NCT03866850 70 78 O
Bionics NCT03866850 79 86 O
cochlear NCT03866850 87 95 B-Procedure-Name
implant NCT03866850 96 103 I-Procedure-Name
users NCT03866850 104 109 O

- NCT03866850 112 113 O
Native NCT03866850 115 121 O
speakers NCT03866850 122 130 O
of NCT03866850 131 133 O
English NCT03866850 134 141 B-Language

- NCT03866850 144 145 O
Early NCT03866850 147 152 O
onset NCT03866850 153 158 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03866850 159 161 O
deafness NCT03866850 162 170 B-Condition-Name
( NCT03866850 171 172 O
< NCT03866850 174 175 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03866850 177 178 B-Eq-Value
years NCT03866850 179 184 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866850 185 187 O
age NCT03866850 188 191 O
) NCT03866850 192 193 O
; NCT03866850 194 195 O
no NCT03866850 196 198 O
requirement NCT03866850 199 210 O
for NCT03866850 211 214 O
age NCT03866850 215 218 O
at NCT03866850 219 221 O
implantation NCT03866850 222 234 B-Procedure-Name

- NCT03866850 237 238 O
Late NCT03866850 240 244 O
onset NCT03866850 245 250 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03866850 251 253 O
deafness NCT03866850 254 262 B-Condition-Name
( NCT03866850 263 264 O
> NCT03866850 266 267 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03866850 269 270 B-Eq-Value
years NCT03866850 271 276 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866850 277 279 O
age NCT03866850 280 283 O
) NCT03866850 284 285 O
; NCT03866850 286 287 O
matched NCT03866850 288 295 O
in NCT03866850 296 298 O
duration NCT03866850 299 307 O
of NCT03866850 308 310 O
deafness NCT03866850 311 319 O
to NCT03866850 320 322 O
the NCT03866850 323 326 O
early NCT03866850 327 332 O
onset NCT03866850 333 338 O
group NCT03866850 339 344 O

- NCT03866850 347 348 O
Has NCT03866850 350 353 O
had NCT03866850 354 357 O
device NCT03866850 358 364 O
experience NCT03866850 365 375 O
for NCT03866850 376 379 O
at NCT03866850 380 382 O
least NCT03866850 383 388 O
one NCT03866850 389 392 O
year NCT03866850 393 397 O

- NCT03866850 400 401 O
Can NCT03866850 403 406 O
be NCT03866850 407 409 O
child NCT03866850 410 415 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
or NCT03866850 416 418 O
adult NCT03866850 419 424 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
at NCT03866850 425 427 O
the NCT03866850 428 431 O
time NCT03866850 432 436 O
of NCT03866850 437 439 O
enrollment NCT03866850 440 450 O

Exclusion NCT03866850 451 460 O
Criteria NCT03866850 461 469 O
: NCT03866850 470 471 O

- NCT03866850 475 476 O
None NCT03866850 478 482 O

Inclusion NCT03865381 0 9 O
Criteria NCT03865381 10 18 O
: NCT03865381 19 20 O

- NCT03865381 24 25 O
Male NCT03865381 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03865381 32 35 O
Female NCT03865381 36 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
; NCT03865381 42 43 O
18 NCT03865381 45 47 B-Eq-Value
years NCT03865381 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865381 54 56 O
age NCT03865381 57 60 O
or NCT03865381 61 63 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865381 64 69 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03865381 72 73 O
Confirmed NCT03865381 75 84 O
diagnosis NCT03865381 85 94 O
of NCT03865381 95 97 O
Type NCT03865381 98 102 O
2 NCT03865381 104 105 O
diabetes NCT03865381 106 114 B-Condition-Name
mellitus NCT03865381 115 123 I-Condition-Name

- NCT03865381 126 127 O
Willing NCT03865381 129 136 O
to NCT03865381 137 139 O
use NCT03865381 140 143 O
CGM NCT03865381 144 147 B-Procedure-Name
and NCT03865381 148 151 O
BGM NCT03865381 152 155 B-Procedure-Name

- NCT03865381 158 159 O
A NCT03865381 161 162 B-Observation-Name___Observation-Type-Value:lab
1c NCT03865381 163 165 I-Observation-Name___Observation-Type-Value:lab
result NCT03865381 166 172 O
≥ NCT03865381 173 174 B-Eq-Operator___Eq-Operator-Value:GTEQ
8.0 NCT03865381 176 179 B-Eq-Value
% NCT03865381 180 181 B-Eq-Unit
and NCT03865381 182 185 O
≤ NCT03865381 186 187 B-Eq-Operator___Eq-Operator-Value:LTEQ
12.0 NCT03865381 189 193 B-Eq-Value
% NCT03865381 194 195 B-Eq-Unit

- NCT03865381 199 200 O
Receive NCT03865381 202 209 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
their NCT03865381 210 215 O
diabetes NCT03865381 216 224 B-Condition-Name
care NCT03865381 225 229 O
from NCT03865381 230 234 O
Premier NCT03865381 235 242 B-Location___Location-Value:clinic
Medical NCT03865381 243 250 I-Location___Location-Value:clinic
Associates NCT03865381 251 261 I-Location___Location-Value:clinic
or NCT03865381 262 264 O
the NCT03865381 265 268 O
Palo NCT03865381 269 273 B-Location___Location-Value:clinic
Alto NCT03865381 274 278 I-Location___Location-Value:clinic
Medical NCT03865381 279 286 I-Location___Location-Value:clinic
Foundation NCT03865381 287 297 I-Location___Location-Value:clinic

- NCT03865381 300 301 O
Own NCT03865381 303 306 O
a NCT03865381 307 308 O
Smartphone NCT03865381 309 319 O
with NCT03865381 320 324 O
a NCT03865381 325 326 O
data NCT03865381 327 331 O
plan NCT03865381 332 336 O
and NCT03865381 337 340 O
be NCT03865381 341 343 O
the NCT03865381 344 347 O
primary NCT03865381 348 355 O
user NCT03865381 356 360 O
of NCT03865381 361 363 O
that NCT03865381 364 368 O
smartphone NCT03865381 369 379 O

- NCT03865381 382 383 O
Smartphone NCT03865381 385 395 O
must NCT03865381 396 400 O
use NCT03865381 401 404 O
a NCT03865381 405 406 O
supported NCT03865381 407 416 O
Android NCT03865381 417 424 O
OS NCT03865381 425 427 O
or NCT03865381 428 430 O
iOS NCT03865381 431 434 O

Exclusion NCT03865381 435 444 O
Criteria NCT03865381 445 453 O
: NCT03865381 454 455 O

- NCT03865381 459 460 O
Pregnant NCT03865381 462 470 B-Condition-Name
or NCT03865381 471 473 O
breastfeeding NCT03865381 474 487 B-Condition-Name

- NCT03865381 490 491 O
Use NCT03865381 493 496 O
of NCT03865381 497 499 O
an NCT03865381 500 502 O
insulin NCT03865381 503 510 B-Procedure-Name
pump NCT03865381 511 515 I-Procedure-Name

- NCT03865381 518 519 O
Any NCT03865381 521 524 O
condition NCT03865381 525 534 O
or NCT03865381 535 537 O
situation NCT03865381 538 547 O
that NCT03865381 548 552 O
the NCT03865381 553 556 O
Sponsor NCT03865381 557 564 O
or NCT03865381 565 567 O
Investigator NCT03865381 568 580 O
determines NCT03865381 581 591 O
as NCT03865381 592 594 O
inappropriate NCT03865381 595 608 O
for NCT03865381 609 612 O
study NCT03865381 613 618 O
inclusion NCT03865381 619 628 O

Inclusion NCT03867227 0 9 O
Criteria NCT03867227 10 18 O
: NCT03867227 19 20 O

- NCT03867227 24 25 O
Patient NCT03867227 27 34 O
with NCT03867227 35 39 O
paroxysmal NCT03867227 40 50 O
/ NCT03867227 51 52 O
persistent NCT03867227 53 63 O
/ NCT03867227 64 65 O
permanent NCT03867227 66 75 O
atrial NCT03867227 76 82 B-Condition-Name
fibrillation NCT03867227 83 95 I-Condition-Name

- NCT03867227 98 99 O
CHA NCT03867227 101 104 B-Observation-Name___Observation-Type-Value:clinical-score
2DS NCT03867227 105 108 I-Observation-Name___Observation-Type-Value:clinical-score
2VASc NCT03867227 109 114 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03867227 115 120 O
≥ NCT03867227 121 122 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03867227 124 125 B-Eq-Value
for NCT03867227 126 129 O
male NCT03867227 130 134 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03867227 135 138 O
≥ NCT03867227 139 140 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03867227 142 143 B-Eq-Value
for NCT03867227 144 147 O
female NCT03867227 148 154 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03867227 157 158 O
Without NCT03867227 160 167 O
contraindications NCT03867227 168 185 O
to NCT03867227 186 188 O
anticoagulation NCT03867227 189 204 B-Procedure-Name
therapy NCT03867227 205 212 I-Procedure-Name

Exclusion NCT03867227 213 222 O
Criteria NCT03867227 223 231 O
: NCT03867227 232 233 O

- NCT03867227 237 238 O
LAA NCT03867227 240 243 O
thrombosis NCT03867227 244 254 B-Condition-Name

- NCT03867227 257 258 O
mechanical NCT03867227 260 270 B-Procedure-Name
prosthetic NCT03867227 271 281 I-Procedure-Name
heart NCT03867227 282 287 I-Procedure-Name
valve NCT03867227 288 293 I-Procedure-Name

- NCT03867227 296 297 O
moderate NCT03867227 299 307 B-Severity___Severity-Value:moderate
or NCT03867227 308 310 O
severe NCT03867227 311 317 B-Severity___Severity-Value:severe
mitral NCT03867227 318 324 B-Condition-Name
valve NCT03867227 325 330 I-Condition-Name
stenosis NCT03867227 331 339 I-Condition-Name

Inclusion NCT03861130 0 9 O
Criteria NCT03861130 10 18 O
: NCT03861130 19 20 O

- NCT03861130 24 25 O
Affected NCT03861130 27 35 O
children NCT03861130 36 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
will NCT03861130 45 49 O
be NCT03861130 50 52 O
recruited NCT03861130 53 62 O
if NCT03861130 63 65 O
the NCT03861130 66 69 O
treating NCT03861130 70 78 O
clinician NCT03861130 79 88 O
has NCT03861130 89 92 O
made NCT03861130 93 97 O
a NCT03861130 98 99 O
diagnosis NCT03861130 100 109 O
of NCT03861130 110 112 O
possible NCT03861130 113 121 O
Kawasaki NCT03861130 122 130 B-Condition-Name
disease NCT03861130 131 138 I-Condition-Name
( NCT03861130 139 140 O
even NCT03861130 141 145 O
if NCT03861130 146 148 O
they NCT03861130 149 153 O
do NCT03861130 154 156 O
not NCT03861130 157 160 O
fulfil NCT03861130 161 167 O
the NCT03861130 168 171 O
criteria NCT03861130 172 180 O
below NCT03861130 181 186 O
for NCT03861130 187 190 O
Kawasaki NCT03861130 191 199 B-Condition-Name
disease NCT03861130 200 207 I-Condition-Name
) NCT03861130 208 209 O
. NCT03861130 211 212 O

The NCT03861130 214 217 O
current NCT03861130 218 225 O
standard NCT03861130 226 234 O
diagnostic NCT03861130 235 245 O
criteria NCT03861130 246 254 O
for NCT03861130 255 258 O
KD NCT03861130 259 261 B-Condition-Name
( NCT03861130 262 263 O
Circulation NCT03861130 264 275 O
2001 NCT03861130 277 281 O
103 NCT03861130 283 286 O
335 NCT03861130 288 291 O
- NCT03861130 292 293 O
336 NCT03861130 295 298 O
doi NCT03861130 299 302 O
: NCT03861130 303 304 O
10.1161 NCT03861130 306 313 O
/ NCT03861130 314 315 O
01 NCT03861130 317 319 O
. NCT03861130 319 320 O
CIR NCT03861130 321 324 O
103.2.335 NCT03861130 326 335 O
) NCT03861130 336 337 O
are NCT03861130 338 341 O
: NCT03861130 342 343 O

The NCT03861130 345 348 O
presence NCT03861130 349 357 O
of NCT03861130 358 360 O
fever NCT03861130 361 366 B-Condition-Name
for NCT03861130 367 370 O
at NCT03861130 371 373 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861130 374 379 I-Eq-Operator___Eq-Operator-Value:GTEQ
five NCT03861130 380 384 B-Eq-Value
days NCT03861130 385 389 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
plus NCT03861130 390 394 O
four NCT03861130 395 399 B-Eq-Value
of NCT03861130 400 402 O
the NCT03861130 403 406 O
following NCT03861130 407 416 O
criteria NCT03861130 417 425 O
: NCT03861130 426 427 O

1 NCT03861130 432 433 O
. NCT03861130 433 434 O
Changes NCT03861130 436 443 B-Stability___Stability-Value:change
in NCT03861130 444 446 O
the NCT03861130 447 450 O
peripheral NCT03861130 451 461 B-Condition-Name
extremities NCT03861130 462 473 I-Condition-Name
Acute NCT03861130 474 479 B-Severity___Severity-Value:severe
: NCT03861130 480 481 O
erythema NCT03861130 482 490 B-Condition-Name
and NCT03861130 491 494 O
oedema NCT03861130 495 501 B-Condition-Name
of NCT03861130 502 504 O
hands NCT03861130 505 510 O
and NCT03861130 511 514 O
feet NCT03861130 515 519 O
Convalescent NCT03861130 520 532 O
: NCT03861130 533 534 O
membranous NCT03861130 535 545 B-Condition-Name
desquamation NCT03861130 546 558 I-Condition-Name
of NCT03861130 559 561 O
fingertips NCT03861130 562 572 O

2 NCT03861130 576 577 O
. NCT03861130 577 578 O
Polymorphous NCT03861130 580 592 B-Condition-Name
exanthema NCT03861130 593 602 I-Condition-Name

3 NCT03861130 606 607 O
. NCT03861130 607 608 O
Bilateral NCT03861130 610 619 O
painless NCT03861130 620 628 O
bulbar NCT03861130 629 635 B-Condition-Name
conjunctival NCT03861130 636 648 I-Condition-Name
injection NCT03861130 649 658 I-Condition-Name
without NCT03861130 659 666 O
exudate NCT03861130 667 674 O

4 NCT03861130 678 679 O
. NCT03861130 679 680 O
Changes NCT03861130 682 689 B-Stability___Stability-Value:change
in NCT03861130 690 692 O
lips NCT03861130 693 697 O
and NCT03861130 698 701 O
oral NCT03861130 702 706 O
cavity NCT03861130 707 713 B-Condition-Name
: NCT03861130 714 715 O
erythema NCT03861130 716 724 B-Condition-Name
and NCT03861130 725 728 O
cracking NCT03861130 729 737 B-Condition-Name
of NCT03861130 738 740 I-Condition-Name
lips NCT03861130 741 745 I-Condition-Name
, NCT03861130 746 747 O
strawberry NCT03861130 748 758 B-Condition-Name
tongue NCT03861130 759 765 I-Condition-Name
, NCT03861130 766 767 O
diffuse NCT03861130 768 775 B-Condition-Name
injection NCT03861130 776 785 I-Condition-Name
of NCT03861130 786 788 O
oral NCT03861130 789 793 O
and NCT03861130 794 797 O
pharyngeal NCT03861130 798 808 O
mucosae NCT03861130 809 816 O

5 NCT03861130 820 821 O
. NCT03861130 821 822 O
Cervical NCT03861130 824 832 B-Condition-Name
lymphadenopathy NCT03861130 833 848 I-Condition-Name
( NCT03861130 849 850 O
> NCT03861130 852 853 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03861130 855 858 B-Eq-Value
cm NCT03861130 859 861 B-Eq-Unit
diameter NCT03861130 862 870 B-Observation-Name___Observation-Type-Value:measurement
) NCT03861130 871 872 O
, NCT03861130 874 875 O
usually NCT03861130 876 883 O
unilateral NCT03861130 884 894 O
Patients NCT03861130 895 903 O
meeting NCT03861130 904 911 O
not NCT03861130 912 915 O
all NCT03861130 916 919 O
of NCT03861130 920 922 O
these NCT03861130 923 928 O
criteria NCT03861130 929 937 O
may NCT03861130 938 941 O
meet NCT03861130 942 946 O
the NCT03861130 947 950 O
criteria NCT03861130 951 959 O
for NCT03861130 960 963 O
atypical NCT03861130 964 972 O
Kawasaki NCT03861130 973 981 B-Condition-Name
disease NCT03861130 982 989 I-Condition-Name
, NCT03861130 990 991 O
ie NCT03861130 992 994 O
. NCT03861130 995 996 O
if NCT03861130 998 1000 O
they NCT03861130 1001 1005 O
have NCT03861130 1006 1010 O
fever NCT03861130 1011 1016 B-Condition-Name
and NCT03861130 1017 1020 O
two NCT03861130 1021 1024 O
or NCT03861130 1025 1027 O
three NCT03861130 1028 1033 O
of NCT03861130 1034 1036 O
the NCT03861130 1037 1040 O
above NCT03861130 1041 1046 O
criteria NCT03861130 1047 1055 O
and NCT03861130 1056 1059 O
elevation NCT03861130 1060 1069 B-Polarity___Polarity-Value:high
of NCT03861130 1070 1072 O
CRP NCT03861130 1073 1076 B-Condition-Name
or NCT03861130 1077 1079 O
echocardiographic NCT03861130 1080 1097 B-Observation-Name___Observation-Type-Value:lab
evidence NCT03861130 1098 1106 I-Observation-Name___Observation-Type-Value:lab
of NCT03861130 1107 1109 O
coronary NCT03861130 1110 1118 B-Condition-Name
artery NCT03861130 1119 1125 I-Condition-Name
dilatation NCT03861130 1126 1136 I-Condition-Name
. NCT03861130 1137 1138 O

Parents NCT03861130 1140 1147 O
of NCT03861130 1148 1150 O
affected NCT03861130 1151 1159 O
child NCT03861130 1160 1165 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
must NCT03861130 1166 1170 O
be NCT03861130 1171 1173 O
biological NCT03861130 1174 1184 O
parents NCT03861130 1185 1192 O
. NCT03861130 1193 1194 O

Exclusion NCT03861130 1196 1205 O
Criteria NCT03861130 1206 1214 O
: NCT03861130 1215 1216 O

- NCT03861130 1220 1221 O
children NCT03861130 1223 1231 O
who NCT03861130 1232 1235 O
do NCT03861130 1236 1238 O
not NCT03861130 1239 1242 O
have NCT03861130 1243 1247 O
a NCT03861130 1248 1249 O
diagnosis NCT03861130 1250 1259 O
of NCT03861130 1260 1262 O
possible NCT03861130 1263 1271 O
Kawasaki NCT03861130 1272 1280 B-Condition-Name
disease NCT03861130 1281 1288 I-Condition-Name


Inclusion NCT03865342 0 9 O
criteria NCT03865342 10 18 O
: NCT03865342 19 20 O

- NCT03865342 24 25 O
English NCT03865342 27 34 B-Language
- NCT03865342 35 36 O
speaking NCT03865342 37 45 O

- NCT03865342 48 49 O
18 NCT03865342 52 54 B-Eq-Value
years NCT03865342 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865342 61 63 O
age NCT03865342 64 67 O
and NCT03865342 68 71 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865342 72 77 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03865342 80 81 O
Referral NCT03865342 83 91 B-Encounter-Type___Encounter-Type-Value:referral
from NCT03865342 92 96 O
the NCT03865342 97 100 O
patient NCT03865342 101 108 O
's NCT03865342 108 110 O
physician NCT03865342 111 120 B-Provider-Role

- NCT03865342 123 124 O
Hemoglobin NCT03865342 126 136 B-Observation-Name___Observation-Type-Value:lab
A NCT03865342 137 138 I-Observation-Name___Observation-Type-Value:lab
1C NCT03865342 139 141 I-Observation-Name___Observation-Type-Value:lab
: NCT03865342 142 143 O
5.7 NCT03865342 145 148 B-Eq-Value
- NCT03865342 149 150 B-Eq-Operator___Eq-Operator-Value:BETWEEN
6.4 NCT03865342 152 155 B-Eq-Value
within NCT03865342 156 162 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865342 163 166 O
3 NCT03865342 168 169 B-Eq-Value
months NCT03865342 170 176 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03865342 177 182 O
to NCT03865342 183 185 O
enrollment NCT03865342 186 196 O

- NCT03865342 199 200 O
Own NCT03865342 202 205 O
a NCT03865342 206 207 O
smartphone NCT03865342 208 218 O
( NCT03865342 219 220 O
Apple NCT03865342 221 226 O
or NCT03865342 227 229 O
Android NCT03865342 230 237 O
) NCT03865342 238 239 O

Exclusion NCT03865342 241 250 O
criteria NCT03865342 251 259 O
: NCT03865342 260 261 O

- NCT03865342 265 266 O
Recent NCT03865342 268 274 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
weight NCT03865342 275 281 B-Condition-Name
loss NCT03865342 282 286 I-Condition-Name
( NCT03865342 287 288 O
by NCT03865342 289 291 O
patient NCT03865342 292 299 O
report NCT03865342 300 306 O
, NCT03865342 307 308 O
> NCT03865342 309 310 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03865342 312 313 B-Eq-Value
lbs NCT03865342 314 317 B-Eq-Unit
in NCT03865342 318 320 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865342 321 324 I-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03865342 326 327 B-Eq-Value
months NCT03865342 328 334 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
preceding NCT03865342 335 344 O
enrollment NCT03865342 345 355 O
visit NCT03865342 356 361 O
) NCT03865342 362 363 O

- NCT03865342 367 368 O
previous NCT03865342 370 378 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03865342 379 388 O
of NCT03865342 389 391 O
type NCT03865342 392 396 O
1 NCT03865342 398 399 O
or NCT03865342 400 402 O
type NCT03865342 403 407 O
2 NCT03865342 409 410 O
diabetes NCT03865342 411 419 B-Condition-Name

- NCT03865342 422 423 O
serious NCT03865342 425 432 B-Severity___Severity-Value:severe
or NCT03865342 433 435 O
persistent NCT03865342 436 446 O
mental NCT03865342 447 453 B-Condition-Name
illnesses NCT03865342 454 463 I-Condition-Name

- NCT03865342 466 467 O
more NCT03865342 469 473 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03865342 474 478 I-Eq-Operator___Eq-Operator-Value:GT
72 NCT03865342 480 482 B-Eq-Value
hours NCT03865342 483 488 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03865342 489 491 O
hospitalization NCT03865342 492 507 B-Encounter-Type___Encounter-Type-Value:inpatient
in NCT03865342 508 510 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865342 511 514 I-Eq-Operator___Eq-Operator-Value:LTEQ
last NCT03865342 515 519 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
30 NCT03865342 521 523 B-Eq-Value
days NCT03865342 524 528 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03865342 531 532 O
Enrollment NCT03865342 534 544 O
in NCT03865342 545 547 O
a NCT03865342 548 549 O
structured NCT03865342 550 560 O
weight NCT03865342 561 567 B-Procedure-Name
- NCT03865342 568 569 I-Procedure-Name
loss NCT03865342 570 574 I-Procedure-Name
program NCT03865342 575 582 I-Procedure-Name
currently NCT03865342 583 592 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03865342 593 595 O
within NCT03865342 596 602 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865342 603 606 O
1 NCT03865342 608 609 B-Eq-Value
month NCT03865342 610 615 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
preceding NCT03865342 616 625 O
study NCT03865342 626 631 O
enrollment NCT03865342 632 642 O

- NCT03865342 645 646 O
Pregnant NCT03865342 648 656 B-Condition-Name

- NCT03865342 659 660 O
Currently NCT03865342 662 671 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
nursing NCT03865342 672 679 B-Condition-Name

- NCT03865342 682 683 O
Have NCT03865342 685 689 O
given NCT03865342 690 695 B-Condition-Name
birth NCT03865342 696 701 I-Condition-Name
within NCT03865342 702 708 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865342 709 712 O
past NCT03865342 713 717 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03865342 719 720 B-Eq-Value
months NCT03865342 721 727 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03865342 730 731 O
Has NCT03865342 733 736 O
been NCT03865342 737 741 O
discouraged NCT03865342 742 753 O
by NCT03865342 754 756 O
a NCT03865342 757 758 O
physician NCT03865342 759 768 B-Provider-Type
to NCT03865342 769 771 O
enroll NCT03865342 772 778 O
in NCT03865342 779 781 O
a NCT03865342 782 783 O
DPP NCT03865342 784 787 B-Procedure-Name
program NCT03865342 788 795 I-Procedure-Name

Inclusion NCT03863678 0 9 O
Criteria NCT03863678 10 18 O
: NCT03863678 19 20 O

- NCT03863678 24 25 O
First NCT03863678 27 32 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
time NCT03863678 33 37 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
stroke NCT03863678 38 44 B-Condition-Name
, NCT03863678 45 46 O

- NCT03863678 50 51 O
Patients NCT03863678 53 61 O
who NCT03863678 62 65 O
has NCT03863678 66 69 O
spasticity NCT03863678 70 80 B-Condition-Name
due NCT03863678 81 84 O
to NCT03863678 85 87 O
stroke NCT03863678 88 94 B-Condition-Name
, NCT03863678 95 96 O

- NCT03863678 100 101 O
At NCT03863678 103 105 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863678 106 111 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03863678 113 114 B-Eq-Value
months NCT03863678 115 121 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03863678 122 127 O
stroke NCT03863678 128 134 B-Condition-Name
, NCT03863678 135 136 O

- NCT03863678 140 141 O
Individuals NCT03863678 143 154 O
between NCT03863678 155 162 B-Eq-Operator
the NCT03863678 163 166 O
ages NCT03863678 167 171 O
of NCT03863678 172 174 O
18 NCT03863678 176 178 B-Eq-Value
- NCT03863678 179 180 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03863678 182 184 B-Eq-Value
will NCT03863678 185 189 O
be NCT03863678 190 192 O
included NCT03863678 193 201 O
in NCT03863678 202 204 O
the NCT03863678 205 208 O
study NCT03863678 209 214 O
. NCT03863678 215 216 O

Exclusion NCT03863678 218 227 O
Criteria NCT03863678 228 236 O
: NCT03863678 237 238 O

- NCT03863678 242 243 O
Any NCT03863678 245 248 O
contraindication NCT03863678 249 265 O
for NCT03863678 266 269 O
dry NCT03863678 270 273 B-Procedure-Name
needling NCT03863678 274 282 I-Procedure-Name
( NCT03863678 283 284 O
eg NCT03863678 285 287 O
, NCT03863678 288 289 O
anticoagulants NCT03863678 290 304 B-Drug-Name
, NCT03863678 305 306 O
infections NCT03863678 307 317 B-Condition-Name
, NCT03863678 318 319 O
bleeding NCT03863678 320 328 B-Condition-Name
, NCT03863678 329 330 O
etc NCT03863678 331 334 O
. NCT03863678 335 336 O
) NCT03863678 337 338 O
, NCT03863678 340 341 O

- NCT03863678 345 346 O
Having NCT03863678 348 354 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diabetes NCT03863678 355 363 B-Condition-Name
, NCT03863678 364 365 O

- NCT03863678 369 370 O
Having NCT03863678 372 378 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cardiovascular NCT03863678 379 393 B-Condition-Name
diseases NCT03863678 394 402 I-Condition-Name
, NCT03863678 403 404 O

- NCT03863678 408 409 O
Having NCT03863678 411 417 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03863678 418 421 O
other NCT03863678 422 427 O
neurological NCT03863678 428 440 B-Condition-Name
problems NCT03863678 441 449 I-Condition-Name
, NCT03863678 450 451 O

- NCT03863678 455 456 O
Application NCT03863678 458 469 O
of NCT03863678 470 472 O
Botox NCT03863678 473 478 B-Procedure-Name
within NCT03863678 479 485 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03863678 487 488 B-Eq-Value
months NCT03863678 489 495 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03863678 496 501 O
to NCT03863678 502 504 O
the NCT03863678 505 508 O
study NCT03863678 509 514 O
, NCT03863678 515 516 O

- NCT03863678 520 521 O
Individuals NCT03863678 523 534 O
included NCT03863678 535 543 O
in NCT03863678 544 546 O
another NCT03863678 547 554 O
treatment NCT03863678 555 564 B-Procedure-Name
program NCT03863678 565 572 I-Procedure-Name
will NCT03863678 573 577 O
not NCT03863678 578 581 O
be NCT03863678 582 584 O
included NCT03863678 585 593 O
in NCT03863678 594 596 O
the NCT03863678 597 600 O
study NCT03863678 601 606 O
. NCT03863678 607 608 O

Inclusion NCT03867344 0 9 O
Criteria NCT03867344 10 18 O
: NCT03867344 19 20 O

- NCT03867344 24 25 O
Healthy NCT03867344 27 34 B-Condition-Name
volunteers NCT03867344 35 45 O

- NCT03867344 48 49 O
Males NCT03867344 51 56 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03867344 57 60 O
Females NCT03867344 61 68 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
age NCT03867344 69 72 O
18 NCT03867344 74 76 B-Eq-Value
to NCT03867344 77 79 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03867344 81 83 B-Eq-Value
years NCT03867344 84 89 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867344 92 93 O
BMI NCT03867344 95 98 B-Observation-Name___Observation-Type-Value:vital
18 NCT03867344 100 102 B-Eq-Value
- NCT03867344 103 104 B-Eq-Operator___Eq-Operator-Value:BETWEEN
30 NCT03867344 106 108 B-Eq-Value
kg NCT03867344 109 111 B-Eq-Unit
/ NCT03867344 112 113 O
m NCT03867344 114 115 B-Eq-Unit
2 NCT03867344 116 117 I-Eq-Unit

Exclusion NCT03867344 118 127 O
Criteria NCT03867344 128 136 O
: NCT03867344 137 138 O

- NCT03867344 142 143 O
Pregnancy NCT03867344 145 154 B-Condition-Name

- NCT03867344 157 158 O
Lactation NCT03867344 160 169 B-Condition-Name

- NCT03867344 172 173 O
Menopause NCT03867344 175 184 B-Condition-Name

- NCT03867344 187 188 O
Any NCT03867344 190 193 O
medical NCT03867344 194 201 O
condition NCT03867344 202 211 O

- NCT03867344 214 215 O
Current NCT03867344 217 224 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03867344 225 227 O
prior NCT03867344 228 233 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
alcohol NCT03867344 234 241 O
or NCT03867344 242 244 O
drug NCT03867344 245 249 O
abuse NCT03867344 250 255 B-Condition-Name

- NCT03867344 258 259 O
Active NCT03867344 261 267 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
tobacco NCT03867344 268 275 B-Condition-Name
use NCT03867344 276 279 I-Condition-Name

- NCT03867344 282 283 O
Abnormal NCT03867344 285 293 B-Polarity___Polarity-Value:abnormal
ECG NCT03867344 294 297 B-Procedure-Name

- NCT03867344 300 301 O
In NCT03867344 303 305 O
all NCT03867344 306 309 O
subjects NCT03867344 310 318 O
, NCT03867344 319 320 O
any NCT03867344 321 324 O
individuals NCT03867344 325 336 O
on NCT03867344 337 339 O
oral NCT03867344 340 344 O
, NCT03867344 345 346 O
injected NCT03867344 347 355 O
, NCT03867344 356 357 O
inhaled NCT03867344 358 365 O
or NCT03867344 366 368 O
topical NCT03867344 369 376 O
corticosteroids NCT03867344 377 392 B-Drug-Name
within NCT03867344 393 399 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867344 400 403 O
last NCT03867344 404 408 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03867344 409 413 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03867344 414 416 O
oral NCT03867344 417 421 O
contraceptives NCT03867344 422 436 B-Drug-Name
within NCT03867344 437 443 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867344 444 447 O
past NCT03867344 448 452 B-Eq-Temporal-Period
3 NCT03867344 454 455 B-Eq-Value
months NCT03867344 456 462 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
will NCT03867344 463 467 O
be NCT03867344 468 470 O
excluded NCT03867344 471 479 O
. NCT03867344 480 481 O

- NCT03867344 485 486 O
Use NCT03867344 488 491 O
of NCT03867344 492 494 O
medications NCT03867344 495 506 B-Drug-Name

- NCT03867344 509 510 O
Serum NCT03867344 512 517 B-Observation-Name___Observation-Type-Value:lab
potassium NCT03867344 518 527 I-Observation-Name___Observation-Type-Value:lab
> NCT03867344 528 529 B-Eq-Operator___Eq-Operator-Value:GT
5.0 NCT03867344 531 534 B-Eq-Value
mmol NCT03867344 535 539 B-Eq-Unit
/ NCT03867344 540 541 O
L NCT03867344 542 543 B-Eq-Unit

- NCT03867344 546 547 O
Estimated NCT03867344 549 558 B-Observation-Name___Observation-Type-Value:lab
GFR NCT03867344 559 562 I-Observation-Name___Observation-Type-Value:lab
< NCT03867344 563 564 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03867344 566 568 B-Eq-Value
mL NCT03867344 569 571 B-Eq-Unit
/ NCT03867344 572 573 O
min NCT03867344 574 577 B-Eq-Unit
/ NCT03867344 578 579 O
1.73 NCT03867344 581 585 B-Eq-Unit
m NCT03867344 586 587 I-Eq-Unit
2 NCT03867344 588 589 I-Eq-Unit

- NCT03867344 592 593 O
Hemoglobin NCT03867344 595 605 B-Observation-Name___Observation-Type-Value:lab
A NCT03867344 606 607 I-Observation-Name___Observation-Type-Value:lab
1c NCT03867344 608 610 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03867344 611 612 B-Eq-Operator___Eq-Operator-Value:GTEQ
6.5 NCT03867344 614 617 B-Eq-Value
% NCT03867344 618 619 B-Eq-Unit

- NCT03867344 623 624 O
LDL NCT03867344 626 629 B-Observation-Name___Observation-Type-Value:lab
> NCT03867344 630 631 B-Eq-Operator___Eq-Operator-Value:GT
130 NCT03867344 633 636 B-Eq-Value
mg NCT03867344 637 639 B-Eq-Unit
/ NCT03867344 640 641 O
dL NCT03867344 642 644 B-Eq-Unit
; NCT03867344 644 645 O
Triglycerides NCT03867344 646 659 B-Observation-Name___Observation-Type-Value:measurement
> NCT03867344 660 661 B-Eq-Operator___Eq-Operator-Value:GT
150 NCT03867344 663 666 B-Eq-Value
mg NCT03867344 667 669 B-Eq-Unit
/ NCT03867344 670 671 O
dL NCT03867344 672 674 B-Eq-Unit

- NCT03867344 677 678 O
Patient NCT03867344 680 687 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Health NCT03867344 688 694 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03867344 695 708 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03867344 709 710 O
PHQ NCT03867344 711 714 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
9 NCT03867344 715 716 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03867344 717 718 O
for NCT03867344 719 722 O
depression NCT03867344 723 733 O
score NCT03867344 734 739 O
≥ NCT03867344 740 741 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03867344 743 745 B-Eq-Value

- NCT03867344 749 750 O
GAD NCT03867344 752 755 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03867344 756 757 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
73 NCT03867344 759 761 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03867344 762 775 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
for NCT03867344 776 779 O
anxiety NCT03867344 780 787 O
score NCT03867344 788 793 O
≥ NCT03867344 794 795 B-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03867344 797 799 B-Eq-Value

- NCT03867344 803 804 O
Primary NCT03867344 806 813 O
Care NCT03867344 814 818 O
PTSD NCT03867344 819 823 B-Condition-Name
Screen NCT03867344 824 830 B-Procedure-Name
for NCT03867344 831 834 O
DSM NCT03867344 835 838 O
- NCT03867344 839 840 O
5 NCT03867344 842 843 O
for NCT03867344 844 847 O
post NCT03867344 848 852 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03867344 853 854 I-Observation-Name___Observation-Type-Value:clinical-score
traumatic NCT03867344 855 864 I-Observation-Name___Observation-Type-Value:clinical-score
stress NCT03867344 865 871 I-Observation-Name___Observation-Type-Value:clinical-score
disorder NCT03867344 872 880 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03867344 881 886 I-Observation-Name___Observation-Type-Value:clinical-score
≥ NCT03867344 887 888 B-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03867344 890 892 B-Eq-Value

- NCT03867344 896 897 O
Blood NCT03867344 899 904 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03867344 905 913 I-Observation-Name___Observation-Type-Value:vital
systolic NCT03867344 914 922 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03867344 923 924 B-Eq-Operator___Eq-Operator-Value:GTEQ
140 NCT03867344 926 929 B-Eq-Value
or NCT03867344 930 932 O
< NCT03867344 933 934 B-Eq-Operator___Eq-Operator-Value:LT
100 NCT03867344 936 939 B-Eq-Value
mmHg NCT03867344 940 944 B-Eq-Unit
; NCT03867344 944 945 O
Blood NCT03867344 946 951 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03867344 952 960 I-Observation-Name___Observation-Type-Value:vital
diastolic NCT03867344 961 970 I-Observation-Name___Observation-Type-Value:vital
> NCT03867344 971 972 B-Eq-Operator___Eq-Operator-Value:GT
90 NCT03867344 974 976 B-Eq-Value
mmHg NCT03867344 977 981 B-Eq-Unit

- NCT03867344 984 985 O
Metal NCT03867344 987 992 B-Condition-Name
in NCT03867344 993 995 I-Condition-Name
the NCT03867344 996 999 I-Condition-Name
body NCT03867344 1000 1004 I-Condition-Name
including NCT03867344 1005 1014 O
: NCT03867344 1015 1016 O
cardiac NCT03867344 1017 1024 B-Procedure-Name
pacemakers NCT03867344 1025 1035 I-Procedure-Name
, NCT03867344 1036 1037 O
stents NCT03867344 1038 1044 B-Procedure-Name
, NCT03867344 1045 1046 O
artificial NCT03867344 1047 1057 B-Procedure-Name
heart NCT03867344 1058 1063 I-Procedure-Name
valves NCT03867344 1064 1070 I-Procedure-Name
, NCT03867344 1071 1072 O
artificial NCT03867344 1073 1083 B-Procedure-Name
limbs NCT03867344 1084 1089 O
or NCT03867344 1090 1092 O
hands NCT03867344 1093 1098 O
, NCT03867344 1099 1100 O
brain NCT03867344 1101 1106 B-Procedure-Name
stimulator NCT03867344 1107 1117 I-Procedure-Name
devices NCT03867344 1118 1125 I-Procedure-Name
, NCT03867344 1126 1127 O
implanted NCT03867344 1128 1137 B-Procedure-Name
drug NCT03867344 1138 1142 I-Procedure-Name
pumps NCT03867344 1143 1148 I-Procedure-Name
, NCT03867344 1149 1150 O
ear NCT03867344 1151 1154 B-Procedure-Name
implants NCT03867344 1155 1163 I-Procedure-Name
, NCT03867344 1164 1165 O
eye NCT03867344 1166 1169 B-Procedure-Name
implants NCT03867344 1170 1178 I-Procedure-Name
or NCT03867344 1179 1181 O
known NCT03867344 1182 1187 O
metal NCT03867344 1188 1193 B-Condition-Name
fragments NCT03867344 1194 1203 I-Condition-Name
in NCT03867344 1204 1206 O
eyes NCT03867344 1207 1211 O
, NCT03867344 1212 1213 O
exposure NCT03867344 1214 1222 B-Condition-Name
to NCT03867344 1223 1225 O
shrapnel NCT03867344 1226 1234 O
or NCT03867344 1235 1237 O
metal NCT03867344 1238 1243 O
filings NCT03867344 1244 1251 O
( NCT03867344 1252 1253 O
wounded NCT03867344 1254 1261 B-Condition-Name
in NCT03867344 1262 1264 I-Condition-Name
military NCT03867344 1265 1273 I-Condition-Name
combat NCT03867344 1274 1280 I-Condition-Name
, NCT03867344 1281 1282 O
sheet NCT03867344 1283 1288 B-Observation-Name
metal NCT03867344 1289 1294 I-Observation-Name
workers NCT03867344 1295 1302 I-Observation-Name
, NCT03867344 1303 1304 O
welders NCT03867344 1305 1312 B-Observation-Name
, NCT03867344 1313 1314 O
and NCT03867344 1315 1318 O
others NCT03867344 1319 1325 O
) NCT03867344 1326 1327 O
, NCT03867344 1329 1330 O
other NCT03867344 1331 1336 O
metallic NCT03867344 1337 1345 B-Procedure-Name
surgical NCT03867344 1346 1354 I-Procedure-Name
hardware NCT03867344 1355 1363 I-Procedure-Name
in NCT03867344 1364 1366 O
vital NCT03867344 1367 1372 O
areas NCT03867344 1373 1378 O
, NCT03867344 1379 1380 O
certain NCT03867344 1381 1388 O
tattoos NCT03867344 1389 1396 B-Condition-Name
with NCT03867344 1397 1401 O
metallic NCT03867344 1402 1410 O
ink NCT03867344 1411 1414 O
, NCT03867344 1415 1416 O
certain NCT03867344 1417 1424 O
transdermal NCT03867344 1425 1436 B-Procedure-Name
medication NCT03867344 1437 1447 I-Procedure-Name
patches NCT03867344 1448 1455 I-Procedure-Name
, NCT03867344 1456 1457 O
and NCT03867344 1458 1461 O
metal NCT03867344 1462 1467 B-Procedure-Name
- NCT03867344 1468 1469 I-Procedure-Name
containing NCT03867344 1470 1480 I-Procedure-Name
IUDs NCT03867344 1481 1485 I-Procedure-Name

Inclusion NCT03867422 0 9 O
Criteria NCT03867422 10 18 O
: NCT03867422 19 20 O

- NCT03867422 24 25 O
more NCT03867422 27 31 B-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03867422 32 34 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03867422 35 40 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03867422 42 44 B-Eq-Value
years NCT03867422 45 50 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
- NCT03867422 51 52 O
old NCT03867422 53 56 O
and NCT03867422 57 60 O
less NCT03867422 61 65 B-Eq-Operator___Eq-Operator-Value:LTEQ
or NCT03867422 66 68 I-Eq-Operator___Eq-Operator-Value:LTEQ
equal NCT03867422 69 74 I-Eq-Operator___Eq-Operator-Value:LTEQ
45 NCT03867422 76 78 B-Eq-Value
years NCT03867422 79 84 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
- NCT03867422 85 86 O
old NCT03867422 87 90 O

- NCT03867422 93 94 O
no NCT03867422 96 98 O
known NCT03867422 99 104 O
hearing NCT03867422 105 112 B-Condition-Name
problem NCT03867422 113 120 I-Condition-Name

Exclusion NCT03867422 121 130 O
Criteria NCT03867422 131 139 O
: NCT03867422 140 141 O

- NCT03867422 145 146 O
professional NCT03867422 148 160 B-Observation-Name
musician NCT03867422 161 169 I-Observation-Name

- NCT03867422 172 173 O
history NCT03867422 175 182 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867422 183 185 O
neurologic NCT03867422 186 196 O
, NCT03867422 197 198 O
psychiatric NCT03867422 199 210 O
or NCT03867422 211 213 O
cadiologic NCT03867422 214 224 O
disease NCT03867422 225 232 B-Condition-Name

- NCT03867422 235 236 O
treatment NCT03867422 238 247 O
which NCT03867422 248 253 O
could NCT03867422 254 259 O
impact NCT03867422 260 266 B-Stability___Stability-Value:change
parameters NCT03867422 267 277 B-Observation-Name___Observation-Type-Value:measurement
of NCT03867422 278 280 O
brain NCT03867422 281 286 O
tissue NCT03867422 287 293 O
pulsatility NCT03867422 294 305 O
and NCT03867422 306 309 O
peripheral NCT03867422 310 320 O
nervous NCT03867422 321 328 O
system NCT03867422 329 335 O

- NCT03867422 338 339 O
opposition NCT03867422 341 351 O
to NCT03867422 352 354 O
use NCT03867422 355 358 O
the NCT03867422 359 362 O
data NCT03867422 363 367 O

Inclusion NCT03861286 0 9 O
Criteria NCT03861286 10 18 O
: NCT03861286 19 20 O

1 NCT03861286 25 26 O
. NCT03861286 26 27 O
Patients NCT03861286 29 37 O
undergoing NCT03861286 38 48 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
first NCT03861286 49 54 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
time NCT03861286 55 59 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
cardiopulmonary NCT03861286 60 75 B-Procedure-Name
bypass NCT03861286 76 82 I-Procedure-Name
surgery NCT03861286 83 90 I-Procedure-Name
for NCT03861286 91 94 O
correction NCT03861286 95 105 O
of NCT03861286 106 108 O
atrial NCT03861286 109 115 B-Condition-Name
septal NCT03861286 116 122 I-Condition-Name
defects NCT03861286 123 130 I-Condition-Name
or NCT03861286 131 133 O
tissue NCT03861286 134 140 B-Procedure-Name
mitral NCT03861286 141 147 I-Procedure-Name
valve NCT03861286 148 153 I-Procedure-Name
repair NCT03861286 154 160 I-Procedure-Name

2 NCT03861286 164 165 O
. NCT03861286 165 166 O
Receiving NCT03861286 168 177 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
intravenous NCT03861286 178 189 O
Heparin NCT03861286 190 197 B-Drug-Name
for NCT03861286 198 201 O
cardiopulmonary NCT03861286 202 217 B-Procedure-Name
bypass NCT03861286 218 224 I-Procedure-Name

Exclusion NCT03861286 225 234 O
Criteria NCT03861286 235 243 O
: NCT03861286 244 245 O

- NCT03861286 249 250 O
Concomitant NCT03861286 252 263 O
Aortic NCT03861286 264 270 B-Condition-Name
Stenosis NCT03861286 271 279 I-Condition-Name
which NCT03861286 280 285 O
is NCT03861286 286 288 O
associated NCT03861286 289 299 O
with NCT03861286 300 304 O
an NCT03861286 305 307 O
acquired NCT03861286 308 316 B-Condition-Name
von NCT03861286 317 320 I-Condition-Name
Willebrand NCT03861286 321 331 I-Condition-Name
Syndrome NCT03861286 332 340 I-Condition-Name
( NCT03861286 341 342 O
aVWS NCT03861286 343 347 B-Condition-Name
) NCT03861286 348 349 O

- NCT03861286 353 354 O
Patients NCT03861286 356 364 O
with NCT03861286 365 369 O
a NCT03861286 370 371 O
baseline NCT03861286 372 380 O
platelet NCT03861286 381 389 B-Observation-Name___Observation-Type-Value:lab
count NCT03861286 390 395 I-Observation-Name___Observation-Type-Value:lab
of NCT03861286 396 398 O
< NCT03861286 399 400 B-Eq-Operator___Eq-Operator-Value:LT
100 NCT03861286 402 405 B-Eq-Value
x NCT03861286 406 407 O
109 NCT03861286 409 412 B-Eq-Value
/ NCT03861286 413 414 O
L NCT03861286 415 416 B-Eq-Unit

- NCT03861286 419 420 O
Patients NCT03861286 422 430 O
with NCT03861286 431 435 O
a NCT03861286 436 437 O
known NCT03861286 438 443 O
coagulation NCT03861286 444 455 B-Condition-Name
factor NCT03861286 456 462 I-Condition-Name
deficiency NCT03861286 463 473 I-Condition-Name
or NCT03861286 474 476 O
platelet NCT03861286 477 485 B-Condition-Name
function NCT03861286 486 494 I-Condition-Name
disorder NCT03861286 495 503 I-Condition-Name

- NCT03861286 506 507 O
Patients NCT03861286 509 517 O
receiving NCT03861286 518 527 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
heparin NCT03861286 528 535 B-Procedure-Name
therapy NCT03861286 536 543 I-Procedure-Name
prior NCT03861286 544 549 O
to NCT03861286 550 552 O
CPB NCT03861286 553 556 B-Procedure-Name
within NCT03861286 557 563 B-Eq-Operator___Eq-Operator-Value:LTEQ
last NCT03861286 564 568 O
7 NCT03861286 570 571 B-Eq-Value
days NCT03861286 572 576 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

Inclusion NCT03864315 0 9 O
Criteria NCT03864315 10 18 O
: NCT03864315 19 20 O

1 NCT03864315 25 26 O
. NCT03864315 26 27 O
20 NCT03864315 30 32 B-Eq-Value
- NCT03864315 33 34 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03864315 36 38 B-Eq-Value
years NCT03864315 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03864315 45 48 O

2 NCT03864315 52 53 O
. NCT03864315 53 54 O
With NCT03864315 56 60 O
skin NCT03864315 61 65 B-Condition-Name
type NCT03864315 66 70 I-Condition-Name
Ⅲ NCT03864315 71 72 B-Eq-Value
or NCT03864315 73 75 O
Ⅳ NCT03864315 76 77 B-Eq-Value

3 NCT03864315 81 82 O
. NCT03864315 82 83 O
With NCT03864315 85 89 O
Vitiligo NCT03864315 90 98 B-Condition-Name

4 NCT03864315 102 103 O
. NCT03864315 103 104 O
Can NCT03864315 106 109 O
read NCT03864315 110 114 O
the NCT03864315 115 118 O
informed NCT03864315 119 127 O
consent NCT03864315 128 135 O
form NCT03864315 136 140 O

5 NCT03864315 144 145 O
. NCT03864315 145 146 O
Can NCT03864315 148 151 O
continue NCT03864315 152 160 O
the NCT03864315 161 164 O
original NCT03864315 165 173 O
treatments NCT03864315 174 184 O

Exclusion NCT03864315 185 194 O
Criteria NCT03864315 195 203 O
: NCT03864315 204 205 O

1 NCT03864315 210 211 O
. NCT03864315 211 212 O
With NCT03864315 214 218 O
segmental NCT03864315 219 228 O
vitiligo NCT03864315 229 237 B-Condition-Name
. NCT03864315 238 239 O

2 NCT03864315 244 245 O
. NCT03864315 245 246 O
Have NCT03864315 248 252 O
joined NCT03864315 253 259 O
other NCT03864315 260 265 O
clinical NCT03864315 266 274 O
trials NCT03864315 275 281 O

Inclusion NCT03865745 0 9 O
Criteria NCT03865745 10 18 O
: NCT03865745 19 20 O

1 NCT03865745 25 26 O
. NCT03865745 26 27 O
Age NCT03865745 29 32 O
of NCT03865745 33 35 O
40 NCT03865745 37 39 B-Eq-Value
~ NCT03865745 40 41 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03865745 43 45 B-Eq-Value
men NCT03865745 46 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03865745 50 53 O
women NCT03865745 54 59 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

2 NCT03865745 63 64 O
. NCT03865745 64 65 O
Those NCT03865745 67 72 O
who NCT03865745 73 76 O
visited NCT03865745 77 84 B-Encounter-Type___Encounter-Type-Value:outpatient
the NCT03865745 85 88 O
menopausal NCT03865745 89 99 B-Location___Location-Value:clinic
clinic NCT03865745 100 106 I-Location___Location-Value:clinic
with NCT03865745 107 111 O
complaints NCT03865745 112 122 O
of NCT03865745 123 125 O
climacteric NCT03865745 126 137 B-Condition-Name
symptoms NCT03865745 138 146 O
due NCT03865745 147 150 O
to NCT03865745 151 153 O
functional NCT03865745 154 164 O
deterioration NCT03865745 165 178 B-Condition-Name
of NCT03865745 179 181 I-Condition-Name
various NCT03865745 182 189 I-Condition-Name
organs NCT03865745 190 196 I-Condition-Name
such NCT03865745 197 201 O
as NCT03865745 202 204 O
fatigue NCT03865745 205 212 B-Condition-Name
, NCT03865745 213 214 O
helplessness NCT03865745 215 227 B-Condition-Name

3 NCT03865745 231 232 O
. NCT03865745 232 233 O
Those NCT03865745 235 240 O
who NCT03865745 241 244 O
have NCT03865745 245 249 O
agreed NCT03865745 250 256 O
to NCT03865745 257 259 O
voluntarily NCT03865745 260 271 O
decide NCT03865745 272 278 O
to NCT03865745 279 281 O
participate NCT03865745 282 293 O
and NCT03865745 294 297 O
observe NCT03865745 298 305 O
the NCT03865745 306 309 O
instructions NCT03865745 310 322 O
after NCT03865745 323 328 O
hearing NCT03865745 329 336 O
the NCT03865745 337 340 O
detailed NCT03865745 341 349 O
explanation NCT03865745 350 361 O
of NCT03865745 362 364 O
this NCT03865745 365 369 O
human NCT03865745 370 375 O
body NCT03865745 376 380 O
application NCT03865745 381 392 O
test NCT03865745 393 397 O

Exclusion NCT03865745 398 407 O
Criteria NCT03865745 408 416 O
: NCT03865745 417 418 O

1 NCT03865745 423 424 O
. NCT03865745 424 425 O
Those NCT03865745 427 432 O
who NCT03865745 433 436 O
have NCT03865745 437 441 O
suspected NCT03865745 442 451 O
symptoms NCT03865745 452 460 O
of NCT03865745 461 463 O
acute NCT03865745 464 469 B-Severity___Severity-Value:severe
disease NCT03865745 470 477 B-Condition-Name
( NCT03865745 478 479 O
severe NCT03865745 480 486 B-Severity___Severity-Value:severe
infectious NCT03865745 487 497 B-Condition-Name
disease NCT03865745 498 505 I-Condition-Name
, NCT03865745 506 507 O
severe NCT03865745 508 514 B-Severity___Severity-Value:severe
trauma NCT03865745 515 521 B-Condition-Name
, NCT03865745 522 523 O
severe NCT03865745 524 530 B-Severity___Severity-Value:severe
diarrhea NCT03865745 531 539 B-Condition-Name
, NCT03865745 540 541 O
vomiting NCT03865745 542 550 B-Condition-Name
, NCT03865745 551 552 O
etc NCT03865745 553 556 O
. NCT03865745 557 558 O
) NCT03865745 559 560 O

2 NCT03865745 565 566 O
. NCT03865745 566 567 O
Patients NCT03865745 569 577 O
with NCT03865745 578 582 O
a NCT03865745 583 584 O
history NCT03865745 585 592 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865745 593 595 O
antibiotic NCT03865745 596 606 B-Drug-Name
treatment NCT03865745 607 616 O
for NCT03865745 617 620 O
more NCT03865745 621 625 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03865745 626 630 I-Eq-Operator___Eq-Operator-Value:GT
1 NCT03865745 632 633 B-Eq-Value
month NCT03865745 634 639 B-Eq-Temporal-Unit
within NCT03865745 640 646 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865745 647 650 O
last NCT03865745 651 655 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03865745 657 658 B-Eq-Value
months NCT03865745 659 665 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

3 NCT03865745 674 675 O
. NCT03865745 675 676 O
Those NCT03865745 678 683 O
who NCT03865745 684 687 O
have NCT03865745 688 692 O
gastrointestinal NCT03865745 693 709 B-Condition-Name
diseases NCT03865745 710 718 I-Condition-Name
( NCT03865745 719 720 O
inflammatory NCT03865745 721 733 B-Condition-Name
growth NCT03865745 734 740 I-Condition-Name
disease NCT03865745 741 748 I-Condition-Name
, NCT03865745 749 750 O
active NCT03865745 751 757 B-Condition-Name
peptic NCT03865745 758 764 I-Condition-Name
ulcer NCT03865745 765 770 I-Condition-Name
, NCT03865745 771 772 O
etc NCT03865745 773 776 O
. NCT03865745 777 778 O
) NCT03865745 779 780 O
or NCT03865745 781 783 O
gastrointestinal NCT03865745 784 800 B-Procedure-Name
surgery NCT03865745 801 808 I-Procedure-Name
( NCT03865745 809 810 O
except NCT03865745 811 817 O
for NCT03865745 818 821 O
simple NCT03865745 822 828 O
appendectomy NCT03865745 829 841 B-Procedure-Name
or NCT03865745 842 844 O
hernia NCT03865745 845 851 B-Procedure-Name
surgery NCT03865745 852 859 I-Procedure-Name
) NCT03865745 860 861 O

4 NCT03865745 866 867 O
. NCT03865745 867 868 O
Those NCT03865745 870 875 O
taking NCT03865745 876 882 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
health NCT03865745 883 889 B-Drug-Name
functional NCT03865745 890 900 I-Drug-Name
foods NCT03865745 901 906 I-Drug-Name
, NCT03865745 907 908 O
lactic NCT03865745 909 915 B-Drug-Name
acid NCT03865745 916 920 I-Drug-Name
bacteria NCT03865745 921 929 I-Drug-Name
, NCT03865745 930 931 O
and NCT03865745 932 935 O
red NCT03865745 936 939 B-Drug-Name
ginseng NCT03865745 940 947 I-Drug-Name
extracts NCT03865745 948 956 I-Drug-Name
for NCT03865745 957 960 O
the NCT03865745 961 964 O
past NCT03865745 965 969 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03865745 970 974 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

5 NCT03865745 978 979 O
. NCT03865745 979 980 O
Those NCT03865745 982 987 O
who NCT03865745 988 991 O
are NCT03865745 992 995 O
currently NCT03865745 996 1005 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
participating NCT03865745 1006 1019 O
in NCT03865745 1020 1022 O
other NCT03865745 1023 1028 O
clinical NCT03865745 1029 1037 O
studies NCT03865745 1038 1045 O
or NCT03865745 1046 1048 O
human NCT03865745 1049 1054 O
trials NCT03865745 1055 1061 O
, NCT03865745 1062 1063 O
or NCT03865745 1064 1066 O
participating NCT03865745 1067 1080 O
in NCT03865745 1081 1083 O
clinical NCT03865745 1084 1092 O
trials NCT03865745 1093 1099 O
or NCT03865745 1100 1102 O
human NCT03865745 1103 1108 O
application NCT03865745 1109 1120 O
tests NCT03865745 1121 1126 O
within NCT03865745 1127 1133 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865745 1134 1137 O
past NCT03865745 1138 1142 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03865745 1143 1148 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month


Inclusion NCT03863730 0 9 O
Criteria NCT03863730 10 18 O
: NCT03863730 19 20 O

- NCT03863730 24 25 O
Prior NCT03863730 27 32 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03863730 33 35 O
ongoing NCT03863730 36 43 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
harmful NCT03863730 44 51 O
alcohol NCT03863730 52 59 B-Drug-Name
intake NCT03863730 60 66 O
defined NCT03863730 67 74 O
as NCT03863730 75 77 O
an NCT03863730 78 80 O
average NCT03863730 81 88 O
of NCT03863730 89 91 O
≥ NCT03863730 92 93 B-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03863730 95 97 B-Eq-Value
g NCT03863730 98 99 B-Eq-Unit
alcohol NCT03863730 100 107 B-Eq-Unit
/ NCT03863730 108 109 O
day NCT03863730 110 113 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
for NCT03863730 114 117 O
women NCT03863730 118 123 B-Life-Stage-And-Gender
and NCT03863730 124 127 O
≥ NCT03863730 128 129 B-Eq-Operator___Eq-Operator-Value:GTEQ
36 NCT03863730 131 133 B-Eq-Value
g NCT03863730 134 135 B-Eq-Unit
/ NCT03863730 136 137 O
d NCT03863730 138 139 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
for NCT03863730 140 143 O
men NCT03863730 144 147 B-Life-Stage-And-Gender
for NCT03863730 148 151 O
≥ NCT03863730 152 153 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03863730 155 156 B-Eq-Value
year NCT03863730 157 161 B-Eq-Temporal-Unit
. NCT03863730 162 163 O

- NCT03863730 172 173 O
Outpatients NCT03863730 175 186 B-Encounter-Type___Encounter-Type-Value:outpatient
with NCT03863730 187 191 O
compensated NCT03863730 192 203 O
advanced NCT03863730 204 212 O
chronic NCT03863730 213 220 O
alcohol NCT03863730 221 228 B-Drug-Name
- NCT03863730 229 230 O
related NCT03863730 231 238 O
liver NCT03863730 239 244 B-Condition-Name
disease NCT03863730 245 252 I-Condition-Name
, NCT03863730 253 254 O
defined NCT03863730 255 262 O
as NCT03863730 263 265 O
stable NCT03863730 266 272 O
patients NCT03863730 273 281 O
with NCT03863730 282 286 O
: NCT03863730 287 288 O

1 NCT03863730 303 304 O
. NCT03863730 304 305 O
liver NCT03863730 307 312 B-Condition-Name
stiffness NCT03863730 313 322 I-Condition-Name
≥ NCT03863730 323 324 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03863730 326 328 B-Eq-Value
kPa NCT03863730 329 332 B-Observation-Name___Observation-Type-Value:lab
and NCT03863730 333 336 O
asymptomatic NCT03863730 337 349 B-Condition-Name
and NCT03863730 350 353 O
/ NCT03863730 354 355 O
or NCT03863730 356 358 O

2 NCT03863730 372 373 O
. NCT03863730 373 374 O
New NCT03863730 376 379 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
liver NCT03863730 380 385 B-Procedure-Name
biopsy NCT03863730 386 392 I-Procedure-Name
( NCT03863730 393 394 O
< NCT03863730 396 397 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03863730 399 400 B-Eq-Value
months NCT03863730 401 407 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03863730 408 409 O
with NCT03863730 410 414 O
at NCT03863730 415 417 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863730 418 423 I-Eq-Operator___Eq-Operator-Value:GTEQ
F NCT03863730 424 425 B-Eq-Value
3 NCT03863730 426 427 I-Eq-Value
fibrosis NCT03863730 428 436 B-Condition-Name
( NCT03863730 437 438 O
kleiner NCT03863730 439 446 O
) NCT03863730 447 448 O
and NCT03863730 449 452 O
/ NCT03863730 453 454 O
or NCT03863730 455 457 O

3 NCT03863730 471 472 O
. NCT03863730 472 473 O
Liver NCT03863730 475 480 B-Procedure-Name
biopsy NCT03863730 481 487 I-Procedure-Name
older NCT03863730 488 493 B-Eq-Operator___Eq-Operator-Value:GT
that NCT03863730 494 498 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03863730 500 501 B-Eq-Value
months NCT03863730 502 508 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
with NCT03863730 509 513 O
liver NCT03863730 514 519 B-Condition-Name
stiffness NCT03863730 520 529 I-Condition-Name
≥ NCT03863730 530 531 B-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03863730 533 535 B-Eq-Value
kPa NCT03863730 536 539 B-Observation-Name___Observation-Type-Value:lab

- NCT03863730 547 548 O
Understand NCT03863730 550 560 O
and NCT03863730 561 564 O
speak NCT03863730 565 570 O
Danish NCT03863730 571 577 B-Language
written NCT03863730 578 585 O
and NCT03863730 586 589 O
orally NCT03863730 590 596 O

- NCT03863730 604 605 O
Informed NCT03863730 607 615 O
consent NCT03863730 616 623 O

Exclusion NCT03863730 624 633 O
Criteria NCT03863730 634 642 O
: NCT03863730 643 644 O

- NCT03863730 648 649 O
Hospitalised NCT03863730 651 663 B-Encounter-Type___Encounter-Type-Value:inpatient

- NCT03863730 666 667 O
Moderete NCT03863730 669 677 B-Severity___Severity-Value:moderate
or NCT03863730 678 680 O
severe NCT03863730 681 687 B-Severity___Severity-Value:severe
Ascites NCT03863730 688 695 B-Condition-Name
, NCT03863730 696 697 O
determined NCT03863730 698 708 O
from NCT03863730 709 713 O
imaging NCT03863730 714 721 B-Procedure-Name
diagnostics NCT03863730 722 733 I-Procedure-Name

- NCT03863730 736 737 O
High NCT03863730 739 743 B-Polarity___Polarity-Value:high
- NCT03863730 744 745 O
risk NCT03863730 746 750 O
varices NCT03863730 751 758 B-Condition-Name
needing NCT03863730 759 766 O
interventional NCT03863730 767 781 B-Procedure-Name
treatment NCT03863730 782 791 I-Procedure-Name
( NCT03863730 792 793 O
endoscopy NCT03863730 794 803 B-Procedure-Name
, NCT03863730 804 805 O
TIPS NCT03863730 806 810 B-Procedure-Name
) NCT03863730 811 812 O

- NCT03863730 816 817 O
Child NCT03863730 819 824 O
- NCT03863730 825 826 O
Pugh NCT03863730 827 831 O
C NCT03863730 832 833 O
score NCT03863730 834 839 O

- NCT03863730 842 843 O
MELD NCT03863730 845 849 B-Observation-Name
- NCT03863730 850 851 I-Observation-Name
Na NCT03863730 852 854 I-Observation-Name
≥ NCT03863730 855 856 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03863730 858 860 B-Eq-Value

- NCT03863730 864 865 O
Lactose NCT03863730 867 874 B-Condition-Name
intolerance NCT03863730 875 886 I-Condition-Name

- NCT03863730 889 890 O
Coeliac NCT03863730 892 899 B-Condition-Name
disease NCT03863730 900 907 I-Condition-Name

- NCT03863730 910 911 O
Irritable NCT03863730 913 922 B-Condition-Name
bowel NCT03863730 923 928 I-Condition-Name
syndrome NCT03863730 929 937 I-Condition-Name
defined NCT03863730 938 945 O
by NCT03863730 946 948 O
ROME NCT03863730 949 953 O
III NCT03863730 954 957 O
criteria NCT03863730 958 966 O

- NCT03863730 969 970 O
Antibiotic NCT03863730 972 982 B-Drug-Name
treatment NCT03863730 983 992 O
the NCT03863730 993 996 O
prior NCT03863730 997 1002 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863730 1004 1005 B-Eq-Value
months NCT03863730 1006 1012 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863730 1015 1016 O
Treatment NCT03863730 1018 1027 O
with NCT03863730 1028 1032 O
nutritional NCT03863730 1033 1044 B-Drug-Name
drinks NCT03863730 1045 1051 I-Drug-Name
, NCT03863730 1052 1053 O
probiotics NCT03863730 1054 1064 B-Drug-Name
or NCT03863730 1065 1067 O
prebiotics NCT03863730 1068 1078 B-Drug-Name
within NCT03863730 1079 1085 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863730 1086 1089 O
last NCT03863730 1090 1094 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863730 1096 1097 B-Eq-Value
months NCT03863730 1098 1104 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863730 1107 1108 O
The NCT03863730 1110 1113 O
investigator NCT03863730 1114 1126 O
judge NCT03863730 1127 1132 O
that NCT03863730 1133 1137 O
the NCT03863730 1138 1141 O
patient NCT03863730 1142 1149 O
would NCT03863730 1150 1155 O
not NCT03863730 1156 1159 O
be NCT03863730 1160 1162 O
compliant NCT03863730 1163 1172 O
with NCT03863730 1173 1177 O
trial NCT03863730 1178 1183 O
medicine NCT03863730 1184 1192 O

- NCT03863730 1195 1196 O
Pregnancy NCT03863730 1198 1207 B-Condition-Name

- NCT03863730 1210 1211 O
Known NCT03863730 1213 1218 O
liver NCT03863730 1219 1224 B-Condition-Name
disease NCT03863730 1225 1232 I-Condition-Name
other NCT03863730 1233 1238 O
than NCT03863730 1239 1243 O
alcoholic NCT03863730 1244 1253 B-Condition-Name
, NCT03863730 1254 1255 O
of NCT03863730 1256 1258 O
any NCT03863730 1259 1262 O
aetiology NCT03863730 1263 1272 O

- NCT03863730 1275 1276 O
Severe NCT03863730 1278 1284 B-Severity___Severity-Value:severe
malnutrition NCT03863730 1285 1297 B-Condition-Name

- NCT03863730 1300 1301 O
Malignancy NCT03863730 1303 1313 B-Condition-Name
- NCT03863730 1314 1315 O
except NCT03863730 1316 1322 O
spino NCT03863730 1323 1328 B-Condition-Name
- NCT03863730 1329 1330 I-Condition-Name
or NCT03863730 1331 1333 I-Condition-Name
basocellular NCT03863730 1334 1346 I-Condition-Name
skin NCT03863730 1347 1351 I-Condition-Name
cancer NCT03863730 1352 1358 I-Condition-Name
. NCT03863730 1359 1360 O
Patients NCT03863730 1362 1370 O
with NCT03863730 1371 1375 O
prior NCT03863730 1376 1381 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
malignant NCT03863730 1382 1391 B-Condition-Name
disease NCT03863730 1392 1399 I-Condition-Name
are NCT03863730 1400 1403 O
allowed NCT03863730 1404 1411 O
if NCT03863730 1412 1414 O
cancer NCT03863730 1415 1421 B-Condition-Name
- NCT03863730 1422 1423 O
free NCT03863730 1424 1428 O
for NCT03863730 1429 1432 O
at NCT03863730 1433 1435 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863730 1436 1441 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03863730 1442 1445 B-Eq-Value
year NCT03863730 1446 1450 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863730 1453 1454 O
Recent NCT03863730 1456 1462 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
infectious NCT03863730 1463 1473 O
gastroenteritis NCT03863730 1474 1489 B-Condition-Name
( NCT03863730 1490 1491 O
for NCT03863730 1492 1495 O
the NCT03863730 1496 1499 O
last NCT03863730 1500 1504 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03863730 1506 1507 B-Eq-Value
weeks NCT03863730 1508 1513 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03863730 1514 1515 O

Inclusion NCT03865355 0 9 O
Criteria NCT03865355 10 18 O
: NCT03865355 19 20 O

1 NCT03865355 25 26 O
. NCT03865355 26 27 O
All NCT03865355 29 32 O
patients NCT03865355 33 41 O
with NCT03865355 42 46 O
suspected NCT03865355 47 56 O
newly NCT03865355 57 62 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnosed NCT03865355 63 72 O
glioma NCT03865355 73 79 B-Condition-Name
( NCT03865355 80 81 O
grade NCT03865355 82 87 B-Eq-Unit
I NCT03865355 88 89 B-Eq-Value
, NCT03865355 90 91 O
II NCT03865355 92 94 B-Eq-Value
, NCT03865355 95 96 O
III NCT03865355 97 100 B-Eq-Value
or NCT03865355 101 103 O
glioblastoma NCT03865355 104 116 B-Condition-Name
) NCT03865355 117 118 O
with NCT03865355 119 123 O
planned NCT03865355 124 131 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
surgical NCT03865355 132 140 B-Procedure-Name
intervention NCT03865355 141 153 I-Procedure-Name
( NCT03865355 154 155 O
resection NCT03865355 156 165 B-Procedure-Name
or NCT03865355 166 168 O
biopsy NCT03865355 169 175 B-Procedure-Name
) NCT03865355 176 177 O
. NCT03865355 179 180 O

2 NCT03865355 185 186 O
. NCT03865355 186 187 O
Patient NCT03865355 189 196 O
aged NCT03865355 197 201 O
18 NCT03865355 203 205 B-Eq-Value
years NCT03865355 206 211 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03865355 212 214 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865355 215 220 I-Eq-Operator___Eq-Operator-Value:GTEQ

3 NCT03865355 224 225 O
. NCT03865355 225 226 O
Patients NCT03865355 228 236 O
have NCT03865355 237 241 O
to NCT03865355 242 244 O
be NCT03865355 245 247 O
able NCT03865355 248 252 O
to NCT03865355 253 255 O
give NCT03865355 256 260 O
informed NCT03865355 261 269 O
consent NCT03865355 270 277 O

Exclusion NCT03865355 278 287 O
Criteria NCT03865355 288 296 O
: NCT03865355 297 298 O

1 NCT03865355 303 304 O
. NCT03865355 304 305 O
Prior NCT03865355 307 312 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Radiotherapy NCT03865355 313 325 B-Procedure-Name
to NCT03865355 326 328 O
the NCT03865355 329 332 O
central NCT03865355 333 340 O
nervous NCT03865355 341 348 O
system NCT03865355 349 355 O

2 NCT03865355 359 360 O
. NCT03865355 360 361 O
Prior NCT03865355 363 368 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Chemotherapy NCT03865355 369 381 B-Procedure-Name
within NCT03865355 382 388 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865355 389 392 O
last NCT03865355 393 397 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03865355 399 400 B-Eq-Value
years NCT03865355 401 406 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

3 NCT03865355 410 411 O
. NCT03865355 411 412 O
Any NCT03865355 414 417 O
prior NCT03865355 418 423 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
central NCT03865355 424 431 O
nervous NCT03865355 432 439 O
system NCT03865355 440 446 O
malignancy NCT03865355 447 457 B-Condition-Name

4 NCT03865355 461 462 O
. NCT03865355 462 463 O
Any NCT03865355 465 468 O
surgery NCT03865355 469 476 B-Procedure-Name
during NCT03865355 477 483 O
last NCT03865355 484 488 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03865355 490 491 B-Eq-Value
month NCT03865355 492 497 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03865433 0 9 O
Criteria NCT03865433 10 18 O
: NCT03865433 19 20 O

1 NCT03865433 25 26 O
. NCT03865433 26 27 O
are NCT03865433 29 32 O
aged NCT03865433 33 37 O
13 NCT03865433 39 41 B-Eq-Value
- NCT03865433 42 43 B-Eq-Operator___Eq-Operator-Value:BETWEEN
17 NCT03865433 45 47 B-Eq-Value
, NCT03865433 48 49 O
years NCT03865433 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03865433 56 59 O
a NCT03865433 60 61 O
high NCT03865433 62 66 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
school NCT03865433 67 73 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
student NCT03865433 74 81 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
- NCT03865433 82 83 O
athlete NCT03865433 84 91 O
who NCT03865433 92 95 O
attends NCT03865433 96 103 O
school NCT03865433 104 110 O
where NCT03865433 111 116 O
an NCT03865433 117 119 O
athletic NCT03865433 120 128 O
trainer NCT03865433 129 136 O
can NCT03865433 137 140 O
supervise NCT03865433 141 150 O
the NCT03865433 151 154 O
exercise NCT03865433 155 163 O
protocol NCT03865433 164 172 O
; NCT03865433 172 173 O

2 NCT03865433 177 178 O
. NCT03865433 178 179 O
have NCT03865433 181 185 O
sustained NCT03865433 186 195 O
a NCT03865433 196 197 O
concussion NCT03865433 198 208 B-Condition-Name
within NCT03865433 209 215 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03865433 217 218 B-Eq-Value
- NCT03865433 219 220 B-Eq-Operator___Eq-Operator-Value:BETWEEN
7 NCT03865433 222 223 B-Eq-Value
days NCT03865433 224 228 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03865433 229 231 O
clinic NCT03865433 232 238 O
presentation NCT03865433 239 251 O
and NCT03865433 252 255 O
diagnosed NCT03865433 256 265 O
by NCT03865433 266 268 O
a NCT03865433 269 270 O
study NCT03865433 271 276 O
physician NCT03865433 277 286 B-Provider-Role
; NCT03865433 286 287 O

3 NCT03865433 291 292 O
. NCT03865433 292 293 O
demonstrate NCT03865433 295 306 O
symptom NCT03865433 307 314 O
exacerbation NCT03865433 315 327 O
during NCT03865433 328 334 O
a NCT03865433 335 336 O
graded NCT03865433 337 343 O
treadmill NCT03865433 344 353 O
exercise NCT03865433 354 362 O
test NCT03865433 363 367 O
and NCT03865433 368 371 O
can NCT03865433 372 375 O
not NCT03865433 375 378 O
complete NCT03865433 379 387 O
the NCT03865433 388 391 O
test NCT03865433 392 396 O
; NCT03865433 396 397 O

4 NCT03865433 401 402 O
. NCT03865433 402 403 O
are NCT03865433 405 408 O
currently NCT03865433 409 418 O
participating NCT03865433 419 432 O
in NCT03865433 433 435 O
a NCT03865433 436 437 O
school NCT03865433 438 444 O
or NCT03865433 445 447 O
club NCT03865433 448 452 O
sport NCT03865433 453 458 O
; NCT03865433 458 459 O

5 NCT03865433 463 464 O
. NCT03865433 464 465 O
are NCT03865433 467 470 O
English NCT03865433 471 478 B-Language
speaking NCT03865433 479 487 O
and NCT03865433 488 491 O
capable NCT03865433 492 499 O
of NCT03865433 500 502 O
giving NCT03865433 503 509 O
assent NCT03865433 510 516 O

Exclusion NCT03865433 517 526 O
Criteria NCT03865433 527 535 O
: NCT03865433 536 537 O

1 NCT03865433 542 543 O
. NCT03865433 543 544 O
have NCT03865433 546 550 O
a NCT03865433 551 552 O
reported NCT03865433 553 561 O
history NCT03865433 562 569 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865433 570 572 O
neurological NCT03865433 573 585 B-Condition-Name
condition NCT03865433 586 595 I-Condition-Name
or NCT03865433 596 598 O
disorder NCT03865433 599 607 B-Condition-Name
including NCT03865433 608 617 O
but NCT03865433 618 621 O
not NCT03865433 622 625 O
limited NCT03865433 626 633 O
to NCT03865433 634 636 O
brain NCT03865433 637 642 B-Procedure-Name
surgery NCT03865433 643 650 I-Procedure-Name
, NCT03865433 651 652 O
special NCT03865433 653 660 B-Procedure-Name
education NCT03865433 661 670 I-Procedure-Name
, NCT03865433 671 672 O
seizure NCT03865433 673 680 B-Condition-Name
disorder NCT03865433 681 689 I-Condition-Name
, NCT03865433 690 691 O
speech NCT03865433 692 698 B-Condition-Name
pathology NCT03865433 699 708 I-Condition-Name
, NCT03865433 709 710 O
previous NCT03865433 711 719 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03865433 720 729 O
of NCT03865433 730 732 O
Post NCT03865433 733 737 B-Condition-Name
- NCT03865433 738 739 I-Condition-Name
Concussion NCT03865433 740 750 I-Condition-Name
Syndrome NCT03865433 751 759 I-Condition-Name
( NCT03865433 760 761 O
PCS NCT03865433 762 765 B-Condition-Name
) NCT03865433 766 767 O
, NCT03865433 769 770 O

2 NCT03865433 775 776 O
. NCT03865433 776 777 O
are NCT03865433 779 782 O
unwilling NCT03865433 783 792 O
to NCT03865433 793 795 O
exercise NCT03865433 796 804 B-Observation-Name___Observation-Type-Value:social-habit
, NCT03865433 805 806 O

3 NCT03865433 811 812 O
. NCT03865433 812 813 O
have NCT03865433 815 819 O
focal NCT03865433 820 825 B-Condition-Name
neurologic NCT03865433 826 836 I-Condition-Name
deficit NCT03865433 837 844 I-Condition-Name
that NCT03865433 845 849 O
would NCT03865433 850 855 O
represent NCT03865433 856 865 O
risk NCT03865433 866 870 O
for NCT03865433 871 874 O
walking NCT03865433 875 882 B-Observation-Name
/ NCT03865433 883 884 O
running NCT03865433 885 892 B-Observation-Name
on NCT03865433 893 895 O
treadmill NCT03865433 896 905 O
, NCT03865433 906 907 O

4 NCT03865433 912 913 O
. NCT03865433 913 914 O
exhibit NCT03865433 916 923 O
an NCT03865433 924 926 O
inability NCT03865433 927 936 O
to NCT03865433 937 939 O
exercise NCT03865433 940 948 B-Observation-Name___Observation-Type-Value:social-habit
due NCT03865433 949 952 O
to NCT03865433 953 955 O
injury NCT03865433 956 962 B-Condition-Name
, NCT03865433 963 964 O
known NCT03865433 965 970 O
heart NCT03865433 971 976 B-Condition-Name
disease NCT03865433 977 984 I-Condition-Name
, NCT03865433 985 986 O
or NCT03865433 987 989 O
increased NCT03865433 990 999 B-Polarity___Polarity-Value:high
cardiac NCT03865433 1000 1007 B-Condition-Name
risk NCT03865433 1008 1012 O
, NCT03865433 1013 1014 O

5 NCT03865433 1019 1020 O
. NCT03865433 1020 1021 O
have NCT03865433 1023 1027 O
experienced NCT03865433 1028 1039 O
more NCT03865433 1040 1044 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03865433 1045 1049 I-Eq-Operator___Eq-Operator-Value:GT
3 NCT03865433 1051 1052 B-Eq-Value
previous NCT03865433 1053 1061 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
concussions NCT03865433 1062 1073 B-Condition-Name
, NCT03865433 1074 1075 O

6 NCT03865433 1080 1081 O
. NCT03865433 1081 1082 O
have NCT03865433 1084 1088 O
suffered NCT03865433 1089 1097 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03865433 1098 1099 O
substantial NCT03865433 1100 1111 B-Severity___Severity-Value:severe
comorbidity NCT03865433 1112 1123 B-Condition-Name
( NCT03865433 1124 1125 O
eg NCT03865433 1126 1128 O
, NCT03865433 1129 1130 O
cervical NCT03865433 1131 1139 B-Condition-Name
injury NCT03865433 1140 1146 I-Condition-Name
) NCT03865433 1147 1148 O
, NCT03865433 1150 1151 O

7 NCT03865433 1156 1157 O
. NCT03865433 1157 1158 O
currently NCT03865433 1160 1169 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03865433 1170 1176 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
β NCT03865433 1177 1178 B-Drug-Name
- NCT03865433 1179 1180 I-Drug-Name
blockers NCT03865433 1181 1189 I-Drug-Name
, NCT03865433 1190 1191 O
calcium NCT03865433 1192 1199 B-Drug-Name
channel NCT03865433 1200 1207 I-Drug-Name
blockers NCT03865433 1208 1216 I-Drug-Name
, NCT03865433 1217 1218 O
or NCT03865433 1219 1221 O
prophylactic NCT03865433 1222 1234 B-Drug-Name
headache NCT03865433 1235 1243 I-Drug-Name
medications NCT03865433 1244 1255 I-Drug-Name
( NCT03865433 1256 1257 O
e NCT03865433 1258 1259 O
. NCT03865433 1260 1261 O
g NCT03865433 1262 1263 O
. NCT03865433 1264 1265 O
, NCT03865433 1266 1267 O
amitriptyline NCT03865433 1268 1281 B-Drug-Name
, NCT03865433 1282 1283 O
topiramate NCT03865433 1284 1294 B-Drug-Name
) NCT03865433 1295 1296 O
, NCT03865433 1298 1299 O
or NCT03865433 1300 1302 O

8 NCT03865433 1306 1307 O
. NCT03865433 1307 1308 O
have NCT03865433 1310 1314 O
a NCT03865433 1315 1316 O
resting NCT03865433 1317 1324 O
blood NCT03865433 1325 1330 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03865433 1331 1339 I-Observation-Name___Observation-Type-Value:vital
of NCT03865433 1340 1342 O
> NCT03865433 1343 1344 B-Eq-Operator___Eq-Operator-Value:GT
140 NCT03865433 1346 1349 B-Eq-Value
/ NCT03865433 1350 1351 O
90 NCT03865433 1353 1355 B-Eq-Value
. NCT03865433 1355 1356 O

9 NCT03865433 1361 1362 O
. NCT03865433 1362 1363 O
If NCT03865433 1365 1367 O
the NCT03865433 1368 1371 O
potential NCT03865433 1372 1381 O
participant NCT03865433 1382 1393 O
or NCT03865433 1394 1396 O
parent NCT03865433 1397 1403 O
/ NCT03865433 1404 1405 O
guardian NCT03865433 1406 1414 O
is NCT03865433 1415 1417 O
unable NCT03865433 1418 1424 O
to NCT03865433 1425 1427 O
fully NCT03865433 1428 1433 O
understand NCT03865433 1434 1444 O
the NCT03865433 1445 1448 O
study NCT03865433 1449 1454 O
protocol NCT03865433 1455 1463 O
or NCT03865433 1464 1466 O
study NCT03865433 1467 1472 O
risks NCT03865433 1473 1478 O
due NCT03865433 1479 1482 O
to NCT03865433 1483 1485 O
injury NCT03865433 1486 1492 B-Condition-Name
or NCT03865433 1493 1495 O
developmental NCT03865433 1496 1509 B-Condition-Name
delay NCT03865433 1510 1515 I-Condition-Name
, NCT03865433 1516 1517 O
the NCT03865433 1518 1521 O
potential NCT03865433 1522 1531 O
participant NCT03865433 1532 1543 O
will NCT03865433 1544 1548 O
be NCT03865433 1549 1551 O
excluded NCT03865433 1552 1560 O
from NCT03865433 1561 1565 O
the NCT03865433 1566 1569 O
study NCT03865433 1570 1575 O
. NCT03865433 1576 1577 O

Inclusion NCT03868670 0 9 O
Criteria NCT03868670 10 18 O
: NCT03868670 19 20 O

- NCT03868670 24 25 O
BMI NCT03868670 27 30 B-Observation-Name___Observation-Type-Value:vital
45 NCT03868670 32 34 B-Eq-Value
- NCT03868670 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03868670 38 40 B-Eq-Value
kg NCT03868670 41 43 B-Eq-Unit
/ NCT03868670 44 45 O
m NCT03868670 46 47 B-Eq-Unit
2 NCT03868670 48 49 I-Eq-Unit

- NCT03868670 52 53 O
Failure NCT03868670 55 62 O
of NCT03868670 63 65 O
at NCT03868670 66 68 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868670 69 74 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03868670 75 78 B-Eq-Value
weight NCT03868670 79 85 B-Drug-Name
loss NCT03868670 86 90 I-Drug-Name
medication NCT03868670 91 101 I-Drug-Name

- NCT03868670 104 105 O
Previous NCT03868670 107 115 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Gastric NCT03868670 116 123 B-Procedure-Name
Bypass NCT03868670 124 130 I-Procedure-Name
Surgery NCT03868670 131 138 I-Procedure-Name
lead NCT03868670 139 143 O
to NCT03868670 144 146 O
less NCT03868670 147 151 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868670 152 156 I-Eq-Operator___Eq-Operator-Value:LT
50 NCT03868670 158 160 B-Eq-Value
% NCT03868670 161 162 B-Eq-Unit
of NCT03868670 163 165 O
excess NCT03868670 166 172 B-Observation-Name___Observation-Type-Value:measurement
weight NCT03868670 173 179 I-Observation-Name___Observation-Type-Value:measurement
lost NCT03868670 180 184 B-Stability___Stability-Value:change
by NCT03868670 185 187 O
2 NCT03868670 189 190 B-Eq-Value
years NCT03868670 191 196 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
after NCT03868670 197 202 O
surgery NCT03868670 203 210 O

- NCT03868670 213 214 O
Significant NCT03868670 216 227 B-Severity___Severity-Value:severe
Loss NCT03868670 228 232 B-Condition-Name
of NCT03868670 233 235 I-Condition-Name
Control NCT03868670 236 243 I-Condition-Name
over NCT03868670 244 248 O
eating NCT03868670 249 255 O

- NCT03868670 258 259 O
Subject NCT03868670 261 268 O
is NCT03868670 269 271 O
able NCT03868670 272 276 O
to NCT03868670 277 279 O
attend NCT03868670 280 286 O
all NCT03868670 287 290 O
scheduled NCT03868670 291 300 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
clinic NCT03868670 301 307 B-Encounter-Type___Encounter-Type-Value:outpatient
appointments NCT03868670 308 320 I-Encounter-Type___Encounter-Type-Value:outpatient
on NCT03868670 321 323 O
their NCT03868670 324 329 O
own NCT03868670 330 333 O
or NCT03868670 334 336 O
with NCT03868670 337 341 O
a NCT03868670 342 343 O
caregiver NCT03868670 344 353 O
. NCT03868670 354 355 O

- NCT03868670 359 360 O
Premenopausal NCT03868670 362 375 B-Condition-Name
women NCT03868670 376 381 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
must NCT03868670 382 386 O
agree NCT03868670 387 392 O
to NCT03868670 393 395 O
use NCT03868670 396 399 O
acceptable NCT03868670 400 410 O
methods NCT03868670 411 418 O
of NCT03868670 419 421 O
birth NCT03868670 422 427 B-Procedure-Name
control NCT03868670 428 435 I-Procedure-Name
. NCT03868670 436 437 O

- NCT03868670 441 442 O
Participants NCT03868670 444 456 O
provide NCT03868670 457 464 O
voluntary NCT03868670 465 474 O
, NCT03868670 475 476 O
decisionally NCT03868670 477 489 O
capable NCT03868670 490 497 O
, NCT03868670 498 499 O
and NCT03868670 500 503 O
appropriately NCT03868670 504 517 O
informed NCT03868670 518 526 O
consent NCT03868670 527 534 O
. NCT03868670 535 536 O

- NCT03868670 540 541 O
Subject NCT03868670 543 550 O
is NCT03868670 551 553 O
able NCT03868670 554 558 O
to NCT03868670 559 561 O
comply NCT03868670 562 568 O
w NCT03868670 569 570 O
/ NCT03868670 571 572 O
all NCT03868670 573 576 O
testing NCT03868670 577 584 O
and NCT03868670 585 588 O
follow NCT03868670 589 595 O
- NCT03868670 596 597 O
up NCT03868670 598 600 O
requirements NCT03868670 601 613 O
defined NCT03868670 614 621 O
by NCT03868670 622 624 O
the NCT03868670 625 628 O
study NCT03868670 629 634 O
protocol NCT03868670 635 643 O
. NCT03868670 644 645 O

- NCT03868670 649 650 O
Participant NCT03868670 652 663 O
has NCT03868670 664 667 O
no NCT03868670 668 670 O
immediate NCT03868670 671 680 O
plan NCT03868670 681 685 O
for NCT03868670 686 689 O
relocation NCT03868670 690 700 B-Observation-Name
beyond NCT03868670 701 707 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03868670 709 710 B-Eq-Value
hours NCT03868670 711 716 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03868670 717 719 O
the NCT03868670 720 723 O
study NCT03868670 724 729 O
site NCT03868670 730 734 O
. NCT03868670 735 736 O

- NCT03868670 740 741 O
Proficiency NCT03868670 743 754 O
with NCT03868670 755 759 O
the NCT03868670 760 763 O
English NCT03868670 764 771 B-Language
language NCT03868670 772 780 O
. NCT03868670 781 782 O

Exclusion NCT03868670 784 793 O
Criteria NCT03868670 794 802 O
: NCT03868670 803 804 O

- NCT03868670 808 809 O
Subject NCT03868670 811 818 O
has NCT03868670 819 822 O
an NCT03868670 823 825 O
implanted NCT03868670 826 835 B-Procedure-Name
medical NCT03868670 836 843 I-Procedure-Name
device NCT03868670 844 850 I-Procedure-Name
that NCT03868670 851 855 O
delivers NCT03868670 856 864 O
electrical NCT03868670 865 875 B-Procedure-Name
energy NCT03868670 876 882 I-Procedure-Name
to NCT03868670 883 885 O
the NCT03868670 886 889 O
brain NCT03868670 890 895 O
. NCT03868670 896 897 O

- NCT03868670 901 902 O
Subject NCT03868670 904 911 O
has NCT03868670 912 915 O
an NCT03868670 916 918 O
implantable NCT03868670 919 930 B-Procedure-Name
cardiac NCT03868670 931 938 I-Procedure-Name
pacemaker NCT03868670 939 948 I-Procedure-Name
, NCT03868670 949 950 O
defibrillator NCT03868670 951 964 B-Procedure-Name
, NCT03868670 965 966 O
or NCT03868670 967 969 O
neurostimulator NCT03868670 970 985 B-Procedure-Name
. NCT03868670 986 987 O

- NCT03868670 991 992 O
Subject NCT03868670 994 1001 O
is NCT03868670 1002 1004 O
likely NCT03868670 1005 1011 O
to NCT03868670 1012 1014 O
require NCT03868670 1015 1022 O
repeat NCT03868670 1023 1029 O
MR NCT03868670 1030 1032 B-Procedure-Name
imaging NCT03868670 1033 1040 I-Procedure-Name
after NCT03868670 1041 1046 O
implant NCT03868670 1047 1054 B-Procedure-Name
of NCT03868670 1055 1057 I-Procedure-Name
the NCT03868670 1058 1061 I-Procedure-Name
RNS NCT03868670 1062 1065 I-Procedure-Name
Neurostimulator NCT03868670 1066 1081 O
and NCT03868670 1082 1085 O
Leads NCT03868670 1086 1091 O
. NCT03868670 1092 1093 O

- NCT03868670 1097 1098 O
Subject NCT03868670 1100 1107 O
is NCT03868670 1108 1110 O
unable NCT03868670 1111 1117 O
to NCT03868670 1118 1120 O
fit NCT03868670 1121 1124 O
into NCT03868670 1125 1129 O
CT NCT03868670 1130 1132 B-Procedure-Name
scanner NCT03868670 1133 1140 I-Procedure-Name
( NCT03868670 1141 1142 O
500 NCT03868670 1144 1147 B-Eq-Value
lb NCT03868670 1148 1150 B-Eq-Unit
upper NCT03868670 1151 1156 B-Eq-Unit___Eq-Unit-Value:ref-range-high
weight NCT03868670 1157 1163 B-Observation-Name___Observation-Type-Value:vital
limit NCT03868670 1164 1169 B-Eq-Operator___Eq-Operator-Value:LTEQ
for NCT03868670 1170 1173 O
CT NCT03868670 1174 1176 B-Procedure-Name
scanner NCT03868670 1177 1184 I-Procedure-Name
) NCT03868670 1185 1186 O
. NCT03868670 1188 1189 O

- NCT03868670 1193 1194 O
Inability NCT03868670 1196 1205 O
to NCT03868670 1206 1208 O
provide NCT03868670 1209 1216 O
informed NCT03868670 1217 1225 O
consent NCT03868670 1226 1233 O
to NCT03868670 1234 1236 O
treatment NCT03868670 1237 1246 O
. NCT03868670 1247 1248 O

Inclusion NCT03865368 0 9 O
Criteria NCT03865368 10 18 O
: NCT03865368 19 20 O

- NCT03865368 24 25 O
Individuals NCT03865368 27 38 O
between NCT03865368 39 46 B-Eq-Operator___Eq-Operator-Value:BETWEEN
age NCT03865368 47 50 O
18 NCT03865368 52 54 B-Eq-Value
- NCT03865368 55 56 O
65 NCT03865368 58 60 B-Eq-Value
with NCT03865368 61 65 O
Body NCT03865368 66 70 B-Observation-Name___Observation-Type-Value:vital
Mass NCT03865368 71 75 I-Observation-Name___Observation-Type-Value:vital
Index NCT03865368 76 81 I-Observation-Name___Observation-Type-Value:vital
( NCT03865368 82 83 O
BMI NCT03865368 84 87 B-Observation-Name___Observation-Type-Value:vital
) NCT03865368 88 89 O
of NCT03865368 90 92 O
> NCT03865368 93 94 B-Eq-Operator___Eq-Operator-Value:GT
29.9 NCT03865368 96 100 B-Eq-Value
kg NCT03865368 101 103 B-Eq-Unit
/ NCT03865368 104 105 O
m NCT03865368 106 107 B-Eq-Unit
2 NCT03865368 108 109 I-Eq-Unit

Exclusion NCT03865368 110 119 O
Criteria NCT03865368 120 128 O
: NCT03865368 129 130 O

- NCT03865368 134 135 O
Unstable NCT03865368 137 145 B-Stability___Stability-Value:change
hypertensive NCT03865368 146 158 B-Condition-Name
patients NCT03865368 159 167 O

- NCT03865368 170 171 O
History NCT03865368 173 180 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865368 181 183 O
cardiovascular NCT03865368 184 198 O
, NCT03865368 199 200 O
neurologic NCT03865368 201 211 O
, NCT03865368 212 213 O
or NCT03865368 214 216 O
orthopedic NCT03865368 217 227 O
diseases NCT03865368 228 236 B-Condition-Name
, NCT03865368 237 238 O

- NCT03865368 242 243 O
Presence NCT03865368 245 253 O
of NCT03865368 254 256 O
knee NCT03865368 257 261 B-Procedure-Name
prosthesis NCT03865368 262 272 I-Procedure-Name
, NCT03865368 273 274 O
hip NCT03865368 275 278 B-Procedure-Name
replacement NCT03865368 279 290 I-Procedure-Name

- NCT03865368 293 294 O
Chronic NCT03865368 296 303 O
inflammatory NCT03865368 304 316 B-Condition-Name
disease NCT03865368 317 324 I-Condition-Name
, NCT03865368 325 326 O

- NCT03865368 330 331 O
Anti NCT03865368 333 337 B-Procedure-Name
- NCT03865368 338 339 I-Procedure-Name
inflammatory NCT03865368 340 352 I-Procedure-Name
treatment NCT03865368 353 362 I-Procedure-Name

- NCT03865368 365 366 O
Cognitive NCT03865368 368 377 B-Condition-Name
impairments NCT03865368 378 389 I-Condition-Name

- NCT03865368 392 393 O
Pregnancy NCT03865368 395 404 B-Condition-Name
. NCT03865368 405 406 O

Inclusion NCT03863080 0 9 O
Criteria NCT03863080 10 18 O
: NCT03863080 19 20 O

1 NCT03863080 25 26 O
. NCT03863080 26 27 O
Male NCT03863080 29 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03863080 34 36 O
female NCT03863080 37 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
≥ NCT03863080 44 45 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863080 47 49 B-Eq-Value
years NCT03863080 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03863080 56 58 O
age NCT03863080 59 62 O
. NCT03863080 63 64 O

2 NCT03863080 69 70 O
. NCT03863080 70 71 O
Myasthenia NCT03863080 73 83 B-Condition-Name
Gravis NCT03863080 84 90 I-Condition-Name
Foundation NCT03863080 91 101 I-Condition-Name
of NCT03863080 102 104 I-Condition-Name
America NCT03863080 105 112 I-Condition-Name
( NCT03863080 113 114 O
MGFA NCT03863080 115 119 B-Condition-Name
) NCT03863080 120 121 O
Class NCT03863080 122 127 B-Eq-Unit
II NCT03863080 128 130 B-Eq-Value
- NCT03863080 131 132 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IVa NCT03863080 133 136 B-Eq-Value
and NCT03863080 137 140 O
likely NCT03863080 141 147 O
not NCT03863080 148 151 O
in NCT03863080 152 154 O
need NCT03863080 155 159 O
of NCT03863080 160 162 O
a NCT03863080 163 164 O
respirator NCT03863080 165 175 B-Procedure-Name
for NCT03863080 176 179 O
the NCT03863080 180 183 O
duration NCT03863080 184 192 O
of NCT03863080 193 195 O
the NCT03863080 196 199 O
study NCT03863080 200 205 O
as NCT03863080 206 208 O
judged NCT03863080 209 215 O
by NCT03863080 216 218 O
the NCT03863080 219 222 O
Investigator NCT03863080 223 235 O
. NCT03863080 236 237 O

3 NCT03863080 242 243 O
. NCT03863080 243 244 O
QMG NCT03863080 246 249 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03863080 250 255 O
≥ NCT03863080 256 257 B-Eq-Operator___Eq-Operator-Value:GTEQ
12 NCT03863080 259 261 B-Eq-Value
at NCT03863080 262 264 O
Screening NCT03863080 265 274 O
and NCT03863080 275 278 O
Baseline NCT03863080 279 287 O
. NCT03863080 288 289 O

Other NCT03863080 291 296 O
, NCT03863080 297 298 O
more NCT03863080 299 303 O
specific NCT03863080 304 312 O
inclusion NCT03863080 313 322 O
criteria NCT03863080 323 331 O
are NCT03863080 332 335 O
defined NCT03863080 336 343 O
in NCT03863080 344 346 O
the NCT03863080 347 350 O
protocol NCT03863080 351 359 O
. NCT03863080 360 361 O

Exclusion NCT03863080 363 372 O
Criteria NCT03863080 373 381 O
: NCT03863080 382 383 O

1 NCT03863080 388 389 O
. NCT03863080 389 390 O
Use NCT03863080 392 395 O
of NCT03863080 396 398 O
rituximab NCT03863080 399 408 B-Drug-Name
, NCT03863080 409 410 O
belimumab NCT03863080 411 420 B-Drug-Name
, NCT03863080 421 422 O
eculizumab NCT03863080 423 433 B-Drug-Name
or NCT03863080 434 436 O
any NCT03863080 437 440 O
monoclonal NCT03863080 441 451 B-Drug-Name
antibody NCT03863080 452 460 I-Drug-Name
for NCT03863080 461 464 O
immunomodulation NCT03863080 465 481 B-Procedure-Name
within NCT03863080 482 488 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03863080 490 491 B-Eq-Value
months NCT03863080 492 498 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03863080 499 504 O
to NCT03863080 505 507 O
first NCT03863080 508 513 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
dosing NCT03863080 514 520 B-Procedure-Name
. NCT03863080 521 522 O

2 NCT03863080 527 528 O
. NCT03863080 528 529 O
Immunoglobulins NCT03863080 531 546 B-Drug-Name
given NCT03863080 547 552 O
by NCT03863080 553 555 O
SC NCT03863080 556 558 O
, NCT03863080 559 560 O
IV NCT03863080 561 563 O
( NCT03863080 564 565 O
IVIG NCT03863080 566 570 O
) NCT03863080 571 572 O
, NCT03863080 574 575 O
or NCT03863080 576 578 O
intramuscular NCT03863080 579 592 O
route NCT03863080 593 598 O
, NCT03863080 599 600 O
or NCT03863080 601 603 O
plasmapheresis NCT03863080 604 618 B-Procedure-Name
/ NCT03863080 619 620 O
plasma NCT03863080 621 627 B-Procedure-Name
exchange NCT03863080 628 636 I-Procedure-Name
( NCT03863080 637 638 O
PE NCT03863080 639 641 B-Procedure-Name
) NCT03863080 642 643 O
within NCT03863080 644 650 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03863080 652 653 B-Eq-Value
weeks NCT03863080 654 659 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03863080 660 666 O
Screening NCT03863080 667 676 O
. NCT03863080 677 678 O

3 NCT03863080 683 684 O
. NCT03863080 684 685 O
Thymectomy NCT03863080 687 697 B-Procedure-Name
performed NCT03863080 698 707 O
< NCT03863080 708 709 B-Eq-Operator___Eq-Operator-Value:LT
12 NCT03863080 711 713 B-Eq-Value
months NCT03863080 714 720 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03863080 721 726 O
to NCT03863080 727 729 O
screening NCT03863080 730 739 O
. NCT03863080 740 741 O

4 NCT03863080 746 747 O
. NCT03863080 747 748 O
Total NCT03863080 750 755 B-Observation-Name___Observation-Type-Value:clinical-score
IgG NCT03863080 756 759 I-Observation-Name___Observation-Type-Value:clinical-score
level NCT03863080 760 765 O
< NCT03863080 766 767 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03863080 769 770 B-Eq-Value
g NCT03863080 771 772 B-Eq-Unit
/ NCT03863080 773 774 O
L NCT03863080 775 776 B-Eq-Unit
( NCT03863080 777 778 O
at NCT03863080 779 781 O
screening NCT03863080 782 791 O
) NCT03863080 792 793 O
. NCT03863080 795 796 O

5 NCT03863080 801 802 O
. NCT03863080 802 803 O
Absolute NCT03863080 805 813 B-Observation-Name
neutrophil NCT03863080 814 824 I-Observation-Name
count NCT03863080 825 830 I-Observation-Name
< NCT03863080 831 832 B-Eq-Operator___Eq-Operator-Value:LT
1500 NCT03863080 834 838 B-Eq-Value
cells NCT03863080 839 844 B-Eq-Unit
/ NCT03863080 845 846 O
mm NCT03863080 847 849 B-Eq-Unit
3 NCT03863080 850 851 I-Eq-Unit
( NCT03863080 852 853 O
at NCT03863080 854 856 O
screening NCT03863080 857 866 O
) NCT03863080 867 868 O
. NCT03863080 870 871 O

Other NCT03863080 873 878 O
, NCT03863080 879 880 O
more NCT03863080 881 885 O
specific NCT03863080 886 894 O
exclusion NCT03863080 895 904 O
criteria NCT03863080 905 913 O
are NCT03863080 914 917 O
defined NCT03863080 918 925 O
in NCT03863080 926 928 O
the NCT03863080 929 932 O
protocol NCT03863080 933 941 O

Inclusion NCT03861442 0 9 O
Criteria NCT03861442 10 18 O
: NCT03861442 19 20 O

- NCT03861442 24 25 O
A NCT03861442 27 28 O
minimum NCT03861442 29 36 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03861442 37 39 O
18 NCT03861442 41 43 B-Eq-Value
years NCT03861442 44 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861442 50 53 O

- NCT03861442 56 57 O
Experienced NCT03861442 59 70 O
user NCT03861442 71 75 O
( NCT03861442 76 77 O
≥ NCT03861442 79 80 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03861442 82 83 B-Eq-Value
months NCT03861442 84 90 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03861442 91 92 O
of NCT03861442 93 95 O
a NCT03861442 96 97 O
MED NCT03861442 98 101 B-Procedure-Name
- NCT03861442 102 103 I-Procedure-Name
EL NCT03861442 104 106 I-Procedure-Name
cochlear NCT03861442 107 115 I-Procedure-Name
implant NCT03861442 116 123 I-Procedure-Name
( NCT03861442 124 125 O
CI NCT03861442 126 128 O
; NCT03861442 128 129 O
C NCT03861442 130 131 O
40 NCT03861442 132 134 O
+ NCT03861442 135 136 O
and NCT03861442 137 140 O
later NCT03861442 141 146 O
model NCT03861442 147 152 O
) NCT03861442 153 154 O

- NCT03861442 158 159 O
Experienced NCT03861442 161 172 O
user NCT03861442 173 177 O
of NCT03861442 178 180 O
a NCT03861442 181 182 O
MED NCT03861442 183 186 B-Procedure-Name
- NCT03861442 187 188 I-Procedure-Name
EL NCT03861442 189 191 I-Procedure-Name
SONNET NCT03861442 192 198 I-Procedure-Name
audio NCT03861442 199 204 I-Procedure-Name
processor NCT03861442 205 214 I-Procedure-Name
( NCT03861442 215 216 O
≥ NCT03861442 218 219 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03861442 221 222 B-Eq-Value
months NCT03861442 223 229 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03861442 230 231 O

- NCT03861442 235 236 O
Post NCT03861442 238 242 O
- NCT03861442 243 244 O
lingual NCT03861442 245 252 O
onset NCT03861442 253 258 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03861442 259 261 O
bilateral NCT03861442 262 271 O
severe NCT03861442 272 278 B-Severity___Severity-Value:severe
to NCT03861442 279 281 B-Eq-Operator___Eq-Operator-Value:BETWEEN
profound NCT03861442 282 290 B-Severity___Severity-Value:severe
sensory NCT03861442 291 298 B-Condition-Name
- NCT03861442 299 300 I-Condition-Name
neural NCT03861442 301 307 I-Condition-Name
hearing NCT03861442 308 315 I-Condition-Name
loss NCT03861442 316 320 I-Condition-Name

- NCT03861442 323 324 O
Unilateral NCT03861442 326 336 B-Procedure-Name
CI NCT03861442 337 339 I-Procedure-Name
user NCT03861442 340 344 O

- NCT03861442 347 348 O
A NCT03861442 350 351 O
minimum NCT03861442 352 359 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03861442 360 362 O
10 NCT03861442 364 366 B-Eq-Value
active NCT03861442 367 373 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
electrodes NCT03861442 374 384 B-Procedure-Name

- NCT03861442 387 388 O
A NCT03861442 390 391 O
minimum NCT03861442 392 399 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03861442 400 402 O
40 NCT03861442 404 406 B-Eq-Value
% NCT03861442 407 408 B-Eq-Unit
speech NCT03861442 409 415 O
recognition NCT03861442 416 427 O
in NCT03861442 428 430 O
the NCT03861442 431 434 O
Freiburg NCT03861442 435 443 B-Observation-Name___Observation-Type-Value:clinical-score
Monosyllables NCT03861442 444 457 I-Observation-Name___Observation-Type-Value:clinical-score
test NCT03861442 458 462 I-Observation-Name___Observation-Type-Value:clinical-score
in NCT03861442 463 465 O
quiet NCT03861442 466 471 O
at NCT03861442 472 474 O
65 NCT03861442 476 478 O
dB NCT03861442 479 481 O
sound NCT03861442 482 487 O
pressure NCT03861442 488 496 O
level NCT03861442 497 502 O
( NCT03861442 503 504 O
SPL NCT03861442 505 508 O
; NCT03861442 508 509 O
at NCT03861442 510 512 O
the NCT03861442 513 516 O
last NCT03861442 517 521 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
time NCT03861442 522 526 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
tested NCT03861442 527 533 O
) NCT03861442 534 535 O

- NCT03861442 539 540 O
Fluent NCT03861442 542 548 O
in NCT03861442 549 551 O
German NCT03861442 552 558 B-Language
( NCT03861442 559 560 O
the NCT03861442 561 564 O
language NCT03861442 565 573 O
of NCT03861442 574 576 O
the NCT03861442 577 580 O
test NCT03861442 581 585 O
centre NCT03861442 586 592 O
) NCT03861442 593 594 O

- NCT03861442 598 599 O
Signed NCT03861442 601 607 O
and NCT03861442 608 611 O
dated NCT03861442 612 617 O
Informed NCT03861442 618 626 O
Consent NCT03861442 627 634 O
Form NCT03861442 635 639 O
before NCT03861442 640 646 O
the NCT03861442 647 650 O
start NCT03861442 651 656 O
of NCT03861442 657 659 O
any NCT03861442 660 663 O
study NCT03861442 664 669 O
- NCT03861442 670 671 O
specific NCT03861442 672 680 O
procedure NCT03861442 681 690 O
. NCT03861442 691 692 O

Exclusion NCT03861442 694 703 O
Criteria NCT03861442 704 712 O
: NCT03861442 713 714 O

- NCT03861442 718 719 O
Lack NCT03861442 721 725 O
of NCT03861442 726 728 O
compliance NCT03861442 729 739 O
with NCT03861442 740 744 O
any NCT03861442 745 748 O
inclusion NCT03861442 749 758 O
criteria NCT03861442 759 767 O

- NCT03861442 770 771 O
CI NCT03861442 773 775 B-Procedure-Name
user NCT03861442 776 780 O
with NCT03861442 781 785 O
contralateral NCT03861442 786 799 B-Condition-Name
hearing NCT03861442 800 807 I-Condition-Name
equal NCT03861442 808 813 B-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03861442 814 816 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03861442 817 819 I-Eq-Operator___Eq-Operator-Value:GTEQ
better NCT03861442 820 826 I-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03861442 827 831 I-Eq-Operator___Eq-Operator-Value:GTEQ
60 NCT03861442 833 835 B-Eq-Value
dB NCT03861442 836 838 B-Eq-Unit
( NCT03861442 839 840 O
PTA NCT03861442 841 844 B-Observation-Name
measured NCT03861442 845 853 O
at NCT03861442 854 856 O
500 NCT03861442 858 861 B-Eq-Value
, NCT03861442 862 863 O
1000 NCT03861442 865 869 B-Eq-Value
, NCT03861442 870 871 O
and NCT03861442 872 875 O
2000 NCT03861442 877 881 B-Eq-Value
Hz NCT03861442 882 884 B-Eq-Unit
) NCT03861442 885 886 O

- NCT03861442 893 894 O
User NCT03861442 896 900 O
with NCT03861442 901 905 O
electric NCT03861442 906 914 B-Procedure-Name
- NCT03861442 915 916 I-Procedure-Name
acoustic NCT03861442 917 925 I-Procedure-Name
stimulation NCT03861442 926 937 I-Procedure-Name
( NCT03861442 938 939 O
EAS NCT03861442 940 943 B-Procedure-Name
; NCT03861442 943 944 O
user NCT03861442 945 949 O
of NCT03861442 950 952 O
an NCT03861442 953 955 O
EAS NCT03861442 956 959 B-Procedure-Name
audio NCT03861442 960 965 I-Procedure-Name
processor NCT03861442 966 975 I-Procedure-Name
) NCT03861442 976 977 O

- NCT03861442 981 982 O
Implanted NCT03861442 984 993 B-Procedure-Name
with NCT03861442 994 998 O
C NCT03861442 999 1000 O
40 NCT03861442 1001 1003 O
X NCT03861442 1004 1005 O
and NCT03861442 1006 1009 O
C NCT03861442 1010 1011 O
40 NCT03861442 1012 1014 O
C NCT03861442 1015 1016 O

- NCT03861442 1019 1020 O
Implanted NCT03861442 1022 1031 B-Procedure-Name
with NCT03861442 1032 1036 O
an NCT03861442 1037 1039 O
Auditory NCT03861442 1040 1048 O
Brainstem NCT03861442 1049 1058 O
Implant NCT03861442 1059 1066 O
or NCT03861442 1067 1069 O
Split NCT03861442 1070 1075 O
electrode NCT03861442 1076 1085 O
array NCT03861442 1086 1091 O

- NCT03861442 1094 1095 O
Known NCT03861442 1097 1102 O
allergic NCT03861442 1103 1111 O
reactions NCT03861442 1112 1121 O
to NCT03861442 1122 1124 O
components NCT03861442 1125 1135 O
of NCT03861442 1136 1138 O
the NCT03861442 1139 1142 O
investigational NCT03861442 1143 1158 O
medical NCT03861442 1159 1166 B-Procedure-Name
device NCT03861442 1167 1173 I-Procedure-Name

- NCT03861442 1176 1177 O
Unstable NCT03861442 1179 1187 B-Stability___Stability-Value:change
psychological NCT03861442 1188 1201 B-Condition-Name
status NCT03861442 1202 1208 I-Condition-Name

- NCT03861442 1211 1212 O
Anything NCT03861442 1214 1222 O
that NCT03861442 1223 1227 O
, NCT03861442 1228 1229 O
in NCT03861442 1230 1232 O
the NCT03861442 1233 1236 O
opinion NCT03861442 1237 1244 O
of NCT03861442 1245 1247 O
the NCT03861442 1248 1251 O
Investigator NCT03861442 1252 1264 O
, NCT03861442 1265 1266 O
would NCT03861442 1267 1272 O
place NCT03861442 1273 1278 O
the NCT03861442 1279 1282 O
subject NCT03861442 1283 1290 O
at NCT03861442 1291 1293 O
increased NCT03861442 1294 1303 B-Polarity___Polarity-Value:high
risk NCT03861442 1304 1308 O
or NCT03861442 1309 1311 O
preclude NCT03861442 1312 1320 O
the NCT03861442 1321 1324 O
subject NCT03861442 1325 1332 O
's NCT03861442 1332 1334 O
full NCT03861442 1335 1339 O
compliance NCT03861442 1340 1350 O
with NCT03861442 1351 1355 O
or NCT03861442 1356 1358 O
completion NCT03861442 1359 1369 O
of NCT03861442 1370 1372 O
the NCT03861442 1373 1376 O
study NCT03861442 1377 1382 O


Inclusion NCT03860012 0 9 O
Criteria NCT03860012 10 18 O
: NCT03860012 19 20 O

1 NCT03860012 25 26 O
. NCT03860012 26 27 O
inflammatory NCT03860012 29 41 B-Condition-Name
bowel NCT03860012 42 47 I-Condition-Name
disease NCT03860012 48 55 I-Condition-Name

2 NCT03860012 59 60 O
. NCT03860012 60 61 O
on NCT03860012 63 65 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
methotrexate NCT03860012 66 78 B-Drug-Name
at NCT03860012 79 81 O
appropriate NCT03860012 82 93 O
dosing NCT03860012 94 100 O

3 NCT03860012 104 105 O
. NCT03860012 105 106 O
normal NCT03860012 108 114 B-Polarity___Polarity-Value:normal
folate NCT03860012 115 121 B-Observation-Name___Observation-Type-Value:lab
levels NCT03860012 122 128 I-Observation-Name___Observation-Type-Value:lab
at NCT03860012 129 131 O
onset NCT03860012 132 137 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03860012 138 140 O
study NCT03860012 141 146 O

4 NCT03860012 150 151 O
. NCT03860012 151 152 O
treatment NCT03860012 154 163 O
with NCT03860012 164 168 O
folic NCT03860012 169 174 B-Drug-Name
acid NCT03860012 175 179 I-Drug-Name

5 NCT03860012 183 184 O
. NCT03860012 184 185 O
ages NCT03860012 187 191 O
2 NCT03860012 193 194 B-Eq-Value
- NCT03860012 195 196 B-Eq-Operator___Eq-Operator-Value:BETWEEN
21 NCT03860012 198 200 B-Eq-Value
years NCT03860012 201 206 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03860012 207 216 O
Criteria NCT03860012 217 225 O
: NCT03860012 226 227 O

1 NCT03860012 232 233 O
. NCT03860012 233 234 O
abnormal NCT03860012 236 244 B-Polarity___Polarity-Value:abnormal
folate NCT03860012 245 251 B-Observation-Name___Observation-Type-Value:lab
levels NCT03860012 252 258 I-Observation-Name___Observation-Type-Value:lab

2 NCT03860012 262 263 O
. NCT03860012 263 264 O
age NCT03860012 266 269 O
> NCT03860012 270 271 B-Eq-Operator___Eq-Operator-Value:GT
21 NCT03860012 273 275 B-Eq-Value
or NCT03860012 276 278 O
less NCT03860012 279 283 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03860012 284 288 I-Eq-Operator___Eq-Operator-Value:LT
2 NCT03860012 290 291 B-Eq-Value

Inclusion NCT03866265 0 9 O
Criteria NCT03866265 10 18 O
: NCT03866265 19 20 O

- NCT03866265 24 25 O
The NCT03866265 27 30 O
selection NCT03866265 31 40 O
criteria NCT03866265 41 49 O
of NCT03866265 50 52 O
the NCT03866265 53 56 O
subjects NCT03866265 57 65 O
will NCT03866265 66 70 O
be NCT03866265 71 73 O
as NCT03866265 74 76 O
follows NCT03866265 77 84 O
: NCT03866265 85 86 O

1 NCT03866265 96 97 O
. NCT03866265 97 98 O
they NCT03866265 100 104 O
need NCT03866265 105 109 O
to NCT03866265 110 112 O
be NCT03866265 113 115 O
off NCT03866265 116 119 O
medication NCT03866265 120 130 O
and NCT03866265 131 134 O
off NCT03866265 135 138 O
intake NCT03866265 139 145 O
of NCT03866265 146 148 O
dietary NCT03866265 149 156 B-Drug-Name
supplements NCT03866265 157 168 I-Drug-Name

2 NCT03866265 177 178 O
. NCT03866265 178 179 O
they NCT03866265 181 185 O
need NCT03866265 186 190 O
to NCT03866265 191 193 O
have NCT03866265 194 198 O
no NCT03866265 199 201 O
blood NCT03866265 202 207 B-Condition-Name
clotting NCT03866265 208 216 I-Condition-Name
disorders NCT03866265 217 226 I-Condition-Name
or NCT03866265 227 229 O
dyslipidaemia NCT03866265 230 243 B-Condition-Name
and NCT03866265 244 247 O

Exclusion NCT03866265 248 257 O
Criteria NCT03866265 258 266 O
: NCT03866265 267 268 O

Subjects NCT03866265 270 278 O
with NCT03866265 279 283 O
clotting NCT03866265 284 292 B-Condition-Name
disorders NCT03866265 293 302 I-Condition-Name
, NCT03866265 303 304 O
dyslipidemia NCT03866265 305 317 B-Condition-Name
or NCT03866265 318 320 O
being NCT03866265 321 326 O
on NCT03866265 327 329 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03866265 330 340 O
( NCT03866265 341 342 O
i NCT03866265 343 344 O
. NCT03866265 345 346 O
e NCT03866265 347 348 O
. NCT03866265 349 350 O
statins NCT03866265 352 359 B-Drug-Name
) NCT03866265 360 361 O
or NCT03866265 362 364 O
other NCT03866265 365 370 O
supplements NCT03866265 371 382 B-Drug-Name
during NCT03866265 383 389 O
the NCT03866265 390 393 O
study NCT03866265 394 399 O
will NCT03866265 400 404 O
be NCT03866265 405 407 O
excluded NCT03866265 408 416 O
. NCT03866265 417 418 O


Inclusion NCT03862573 0 9 O
Criteria NCT03862573 10 18 O
: NCT03862573 19 20 O

1 NCT03862573 25 26 O
. NCT03862573 26 27 O
Children NCT03862573 29 37 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
age NCT03862573 38 41 O
4 NCT03862573 43 44 B-Eq-Value
to NCT03862573 45 47 B-Eq-Operator___Eq-Operator-Value:BETWEEN
< NCT03862573 48 49 B-Eq-Operator___Eq-Operator-Value:LT
17 NCT03862573 51 53 B-Eq-Value
years NCT03862573 54 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

2 NCT03862573 63 64 O
. NCT03862573 64 65 O
Arriving NCT03862573 67 75 O
to NCT03862573 76 78 O
the NCT03862573 79 82 O
UBC NCT03862573 83 86 B-Location___Location-Value:clinic
dentistry NCT03862573 87 96 I-Location___Location-Value:clinic
clinic NCT03862573 97 103 I-Location___Location-Value:clinic
and NCT03862573 104 107 O
need NCT03862573 108 112 O
dental NCT03862573 113 119 B-Procedure-Name
assessment NCT03862573 120 130 O
/ NCT03862573 131 132 O
procedures NCT03862573 133 143 O

3 NCT03862573 147 148 O
. NCT03862573 148 149 O
Parents NCT03862573 151 158 O
will NCT03862573 159 163 O
sign NCT03862573 164 168 O
a NCT03862573 169 170 O
consent NCT03862573 171 178 O
form NCT03862573 179 183 O
and NCT03862573 184 187 O
children NCT03862573 188 196 O
will NCT03862573 197 201 O
sign NCT03862573 202 206 O
an NCT03862573 207 209 O
assent NCT03862573 210 216 O
form NCT03862573 217 221 O

Exclusion NCT03862573 222 231 O
Criteria NCT03862573 232 240 O
: NCT03862573 241 242 O

1 NCT03862573 247 248 O
. NCT03862573 248 249 O
Children NCT03862573 251 259 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03862573 260 264 O
conditions NCT03862573 265 275 O
that NCT03862573 276 280 O
may NCT03862573 281 284 O
prohibit NCT03862573 285 293 O
participation NCT03862573 294 307 O
or NCT03862573 308 310 O
evaluation NCT03862573 311 321 O
of NCT03862573 322 324 O
the NCT03862573 325 328 O
procedure NCT03862573 329 338 B-Procedure-Name
( NCT03862573 339 340 O
such NCT03862573 341 345 O
as NCT03862573 346 348 O
developmental NCT03862573 349 362 B-Condition-Name
delay NCT03862573 363 368 I-Condition-Name
, NCT03862573 369 370 O
autism NCT03862573 371 377 B-Condition-Name
, NCT03862573 378 379 O
challenging NCT03862573 380 391 B-Condition-Name
communication NCT03862573 392 405 I-Condition-Name
) NCT03862573 406 407 O

2 NCT03862573 412 413 O
. NCT03862573 413 414 O
Facial NCT03862573 416 422 B-Condition-Name
features NCT03862573 423 431 I-Condition-Name
prohibiting NCT03862573 432 443 O
wearing NCT03862573 444 451 B-Observation-Name
the NCT03862573 452 455 O
VR NCT03862573 456 458 O
goggles NCT03862573 459 466 O

3 NCT03862573 470 471 O
. NCT03862573 471 472 O
Children NCT03862573 474 482 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
needing NCT03862573 483 490 O
sedation NCT03862573 491 499 B-Procedure-Name
that NCT03862573 500 504 O
includes NCT03862573 505 513 O
inhalation NCT03862573 514 524 B-Procedure-Name
via NCT03862573 525 528 I-Procedure-Name
a NCT03862573 529 530 I-Procedure-Name
mask NCT03862573 531 535 I-Procedure-Name
( NCT03862573 536 537 O
N NCT03862573 538 539 B-Procedure-Name
2O NCT03862573 540 542 I-Procedure-Name
) NCT03862573 543 544 O
or NCT03862573 545 547 O
IV NCT03862573 548 550 O
/ NCT03862573 551 552 O
IM NCT03862573 553 555 O
sedation NCT03862573 556 564 B-Procedure-Name

Inclusion NCT03860402 0 9 O
Criteria NCT03860402 10 18 O
: NCT03860402 19 20 O

- NCT03860402 24 25 O
Among NCT03860402 27 32 O
the NCT03860402 33 36 O
pregnant NCT03860402 37 45 B-Condition-Name
women NCT03860402 46 51 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03860402 52 55 O
were NCT03860402 56 60 O
administered NCT03860402 61 73 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cesarean NCT03860402 74 82 B-Procedure-Name
section NCT03860402 83 90 I-Procedure-Name
in NCT03860402 91 93 O
this NCT03860402 94 98 O
study NCT03860402 99 104 O
, NCT03860402 105 106 O
those NCT03860402 107 112 O
who NCT03860402 113 116 O
agreed NCT03860402 117 123 O
to NCT03860402 124 126 O
participate NCT03860402 127 138 O
in NCT03860402 139 141 O
this NCT03860402 142 146 O
study NCT03860402 147 152 O
. NCT03860402 153 154 O

Exclusion NCT03860402 156 165 O
Criteria NCT03860402 166 174 O
: NCT03860402 175 176 O

- NCT03860402 180 181 O
Fetal NCT03860402 183 188 B-Condition-Name
distress NCT03860402 189 197 I-Condition-Name
requiring NCT03860402 198 207 O
fast NCT03860402 208 212 O
delivery NCT03860402 213 221 B-Procedure-Name
. NCT03860402 222 223 O

- NCT03860402 227 228 O
Patients NCT03860402 230 238 O
with NCT03860402 239 243 O
hypersensitivity NCT03860402 244 260 B-Condition-Name
, NCT03860402 261 262 O
allergic NCT03860402 263 271 O
response NCT03860402 272 280 B-Condition-Name
, NCT03860402 281 282 O
resistance NCT03860402 283 293 B-Condition-Name
to NCT03860402 294 296 O
the NCT03860402 297 300 O
drugs NCT03860402 301 306 O
used NCT03860402 307 311 O
in NCT03860402 312 314 O
this NCT03860402 315 319 O
study NCT03860402 320 325 O
( NCT03860402 326 327 O
fentanyl NCT03860402 328 336 B-Drug-Name
, NCT03860402 337 338 O
ropivacaine NCT03860402 339 350 B-Drug-Name
, NCT03860402 351 352 O
lidocaine NCT03860402 353 362 B-Drug-Name
) NCT03860402 363 364 O
. NCT03860402 366 367 O

- NCT03860402 371 372 O
Patients NCT03860402 374 382 O
who NCT03860402 383 386 O
is NCT03860402 387 389 O
not NCT03860402 390 393 O
possible NCT03860402 394 402 O
for NCT03860402 403 406 O
regional NCT03860402 407 415 B-Procedure-Name
anesthesia NCT03860402 416 426 I-Procedure-Name

- NCT03860402 429 430 O
Patients NCT03860402 432 440 O
who NCT03860402 441 444 O
refused NCT03860402 445 452 O
to NCT03860402 453 455 O
participate NCT03860402 456 467 O
in NCT03860402 468 470 O
this NCT03860402 471 475 O
study NCT03860402 476 481 O
. NCT03860402 482 483 O

- NCT03860402 487 488 O
Patients NCT03860402 490 498 O
who NCT03860402 499 502 O
can NCT03860402 503 506 O
not NCT03860402 506 509 O
read NCT03860402 510 514 O
or NCT03860402 515 517 O
understand NCT03860402 518 528 O
the NCT03860402 529 532 O
agreement NCT03860402 533 542 O
. NCT03860402 543 544 O

- NCT03860402 548 549 O
Patients NCT03860402 551 559 O
whose NCT03860402 560 565 O
weight NCT03860402 566 572 B-Observation-Name___Observation-Type-Value:vital
is NCT03860402 573 575 O
less NCT03860402 576 580 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03860402 581 585 I-Eq-Operator___Eq-Operator-Value:LT
50 NCT03860402 587 589 B-Eq-Value
kg NCT03860402 590 592 B-Eq-Unit
or NCT03860402 593 595 O
exceeds NCT03860402 596 603 B-Eq-Operator___Eq-Operator-Value:GT
100 NCT03860402 605 608 B-Eq-Value
kg NCT03860402 609 611 B-Eq-Unit
. NCT03860402 612 613 O

Inclusion NCT03861494 0 9 O
Criteria NCT03861494 10 18 O
: NCT03861494 19 20 O

- NCT03861494 24 25 O
patients NCT03861494 27 35 O
hospitalized NCT03861494 36 48 B-Encounter-Type___Encounter-Type-Value:inpatient
with NCT03861494 49 53 O
primary NCT03861494 54 61 O
diagnosis NCT03861494 62 71 O
of NCT03861494 72 74 O
acute NCT03861494 75 80 B-Severity___Severity-Value:severe
or NCT03861494 81 83 O
subacute NCT03861494 84 92 B-Severity___Severity-Value:moderate
ischemic NCT03861494 93 101 B-Condition-Name
cerebral NCT03861494 102 110 I-Condition-Name
infarction NCT03861494 111 121 I-Condition-Name

- NCT03861494 124 125 O
18 NCT03861494 128 130 B-Eq-Value
years NCT03861494 131 136 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03861494 137 139 O
age NCT03861494 140 143 O
or NCT03861494 144 146 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03861494 147 152 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03861494 155 156 O
English NCT03861494 158 165 B-Language
speaking NCT03861494 166 174 O

- NCT03861494 177 178 O
admitted NCT03861494 180 188 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03861494 189 191 O
hospital NCT03861494 192 200 B-Location___Location-Value:hospital
Sunday NCT03861494 201 207 B-Eq-Value
through NCT03861494 208 215 B-Eq-Operator___Eq-Operator-Value:BETWEEN
Thursday NCT03861494 216 224 B-Eq-Value

- NCT03861494 227 228 O
patient NCT03861494 230 237 O
or NCT03861494 238 240 O
responsible NCT03861494 241 252 O
primary NCT03861494 253 260 O
caregiver NCT03861494 261 270 O
able NCT03861494 271 275 O
to NCT03861494 276 278 O
understand NCT03861494 279 289 O
and NCT03861494 290 293 O
provide NCT03861494 294 301 O
informed NCT03861494 302 310 O
consent NCT03861494 311 318 O

- NCT03861494 321 322 O
prognosis NCT03861494 324 333 B-Condition-Name
for NCT03861494 334 337 I-Condition-Name
survival NCT03861494 338 346 I-Condition-Name
greater NCT03861494 347 354 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03861494 355 359 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03861494 361 362 B-Eq-Value
months NCT03861494 363 369 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03861494 372 373 O
one NCT03861494 375 378 B-Eq-Value
or NCT03861494 379 381 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03861494 382 386 I-Eq-Operator___Eq-Operator-Value:GTEQ
vascular NCT03861494 387 395 B-Condition-Name
risk NCT03861494 396 400 O
factors NCT03861494 401 408 O
( NCT03861494 409 410 O
HTN NCT03861494 411 414 B-Condition-Name
, NCT03861494 415 416 O
DLP NCT03861494 417 420 B-Condition-Name
, NCT03861494 421 422 O
current NCT03861494 423 430 B-Condition-Name
smoker NCT03861494 431 437 I-Condition-Name
, NCT03861494 438 439 O
DM NCT03861494 440 442 B-Condition-Name
, NCT03861494 443 444 O
obesity NCT03861494 445 452 B-Condition-Name
) NCT03861494 453 454 O

- NCT03861494 458 459 O
live NCT03861494 461 465 O
in NCT03861494 466 468 O
NWA NCT03861494 469 472 B-Location___Location-Value:residence
area NCT03861494 473 477 I-Location___Location-Value:residence
( NCT03861494 478 479 O
Benton NCT03861494 480 486 B-Location___Location-Value:residence
, NCT03861494 487 488 O
Boone NCT03861494 489 494 B-Location___Location-Value:residence
, NCT03861494 495 496 O
Carroll NCT03861494 497 504 B-Location___Location-Value:residence
, NCT03861494 505 506 O
Madison NCT03861494 507 514 B-Location___Location-Value:residence
, NCT03861494 515 516 O
and NCT03861494 517 520 O
Washington NCT03861494 521 531 B-Location___Location-Value:residence
counties NCT03861494 532 540 I-Location___Location-Value:residence
) NCT03861494 541 542 O
, NCT03861494 544 545 O

- NCT03861494 549 550 O
have NCT03861494 552 556 O
a NCT03861494 557 558 O
working NCT03861494 559 566 O
phone NCT03861494 567 572 O
. NCT03861494 573 574 O

Exclusion NCT03861494 576 585 O
Criteria NCT03861494 586 594 O
: NCT03861494 595 596 O

- NCT03861494 600 601 O
admitted NCT03861494 603 611 B-Encounter-Type___Encounter-Type-Value:inpatient
with NCT03861494 612 616 O
transient NCT03861494 617 626 B-Condition-Name
ischemic NCT03861494 627 635 I-Condition-Name
attack NCT03861494 636 642 I-Condition-Name

- NCT03861494 645 646 O
admitted NCT03861494 648 656 B-Encounter-Type___Encounter-Type-Value:inpatient
with NCT03861494 657 661 O
an NCT03861494 662 664 O
intracerebral NCT03861494 665 678 B-Condition-Name
hemorrhage NCT03861494 679 689 I-Condition-Name

- NCT03861494 692 693 O
experience NCT03861494 695 705 O
an NCT03861494 706 708 O
in NCT03861494 709 711 B-Location___Location-Value:hospital
- NCT03861494 712 713 I-Location___Location-Value:hospital
hospital NCT03861494 714 722 I-Location___Location-Value:hospital
ischemic NCT03861494 723 731 B-Condition-Name
cerebral NCT03861494 732 740 I-Condition-Name
infarction NCT03861494 741 751 I-Condition-Name

- NCT03861494 754 755 O
hospital NCT03861494 757 765 B-Location___Location-Value:hospital
to NCT03861494 766 768 O
hospital NCT03861494 769 777 B-Location___Location-Value:hospital
transfer NCT03861494 778 786 B-Encounter-Type___Encounter-Type-Value:transfer
patients NCT03861494 787 795 O

- NCT03861494 798 799 O
nursing NCT03861494 801 808 B-Location___Location-Value:residence
home NCT03861494 809 813 I-Location___Location-Value:residence
as NCT03861494 814 816 O
primary NCT03861494 817 824 B-Location___Location-Value:residence
residence NCT03861494 825 834 I-Location___Location-Value:residence
before NCT03861494 835 841 O
or NCT03861494 842 844 O
after NCT03861494 845 850 O
discharge NCT03861494 851 860 B-Encounter-Type___Encounter-Type-Value:discharge

- NCT03861494 863 864 O
hospice NCT03861494 866 873 B-Condition-Name

- NCT03861494 876 877 O
inability NCT03861494 879 888 B-Condition-Name
to NCT03861494 889 891 I-Condition-Name
comply NCT03861494 892 898 I-Condition-Name
with NCT03861494 899 903 O
post NCT03861494 904 908 O
discharge NCT03861494 909 918 B-Encounter-Type___Encounter-Type-Value:discharge
follow NCT03861494 919 925 O
up NCT03861494 926 928 O

Inclusion NCT03861325 0 9 O
Criteria NCT03861325 10 18 O
: NCT03861325 19 20 O

- NCT03861325 24 25 O
The NCT03861325 27 30 O
patient NCT03861325 31 38 O
or NCT03861325 39 41 O
his NCT03861325 42 45 O
/ NCT03861325 46 47 O
her NCT03861325 48 51 O
representative NCT03861325 52 66 O
has NCT03861325 67 70 O
been NCT03861325 71 75 O
informed NCT03861325 76 84 O
about NCT03861325 85 90 O
the NCT03861325 91 94 O
implementation NCT03861325 95 109 O
of NCT03861325 110 112 O
the NCT03861325 113 116 O
study NCT03861325 117 122 O
, NCT03861325 123 124 O
its NCT03861325 125 128 O
objectives NCT03861325 129 139 O
, NCT03861325 140 141 O
its NCT03861325 142 145 O
constraints NCT03861325 146 157 O
, NCT03861325 158 159 O
the NCT03861325 160 163 O
rights NCT03861325 164 170 O
of NCT03861325 171 173 O
the NCT03861325 174 177 O
patient NCT03861325 178 185 O
and NCT03861325 186 189 O
must NCT03861325 190 194 O
have NCT03861325 195 199 O
received NCT03861325 200 208 O
the NCT03861325 209 212 O
newsletter NCT03861325 213 223 O
and NCT03861325 224 227 O
no NCT03861325 228 230 O
opposition NCT03861325 231 241 O
of NCT03861325 242 244 O
the NCT03861325 245 248 O
study NCT03861325 249 254 O
. NCT03861325 255 256 O

- NCT03861325 260 261 O
The NCT03861325 263 266 O
patient NCT03861325 267 274 O
must NCT03861325 275 279 O
be NCT03861325 280 282 O
an NCT03861325 283 285 O
affiliate NCT03861325 286 295 O
or NCT03861325 296 298 O
beneficiary NCT03861325 299 310 O
of NCT03861325 311 313 O
a NCT03861325 314 315 O
health NCT03861325 316 322 B-Insurance
insurance NCT03861325 323 332 I-Insurance
plan NCT03861325 333 337 I-Insurance
. NCT03861325 338 339 O

- NCT03861325 343 344 O
The NCT03861325 346 349 O
patient NCT03861325 350 357 O
is NCT03861325 358 360 O
at NCT03861325 361 363 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861325 364 369 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03861325 371 373 B-Eq-Value
years NCT03861325 374 379 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861325 380 383 O
. NCT03861325 384 385 O

- NCT03861325 389 390 O
The NCT03861325 392 395 O
patient NCT03861325 396 403 O
has NCT03861325 404 407 O
septic NCT03861325 408 414 B-Condition-Name
shock NCT03861325 415 420 I-Condition-Name
as NCT03861325 421 423 O
defined NCT03861325 424 431 O
by NCT03861325 432 434 O
the NCT03861325 435 438 O
3 NCT03861325 440 441 O
rd NCT03861325 442 444 O
International NCT03861325 445 458 O
Conference NCT03861325 459 469 O
for NCT03861325 470 473 O
the NCT03861325 474 477 O
definition NCT03861325 478 488 O
of NCT03861325 489 491 O
sepsis NCT03861325 492 498 O
and NCT03861325 499 502 O
septic NCT03861325 503 509 O
shock NCT03861325 510 515 O

Exclusion NCT03861325 516 525 O
Criteria NCT03861325 526 534 O
: NCT03861325 535 536 O

- NCT03861325 540 541 O
The NCT03861325 543 546 O
patient NCT03861325 547 554 O
is NCT03861325 555 557 O
in NCT03861325 558 560 O
an NCT03861325 561 563 O
exclusion NCT03861325 564 573 O
period NCT03861325 574 580 O
determined NCT03861325 581 591 O
by NCT03861325 592 594 O
a NCT03861325 595 596 O
previous NCT03861325 597 605 O
study NCT03861325 606 611 O

- NCT03861325 614 615 O
The NCT03861325 617 620 O
patient NCT03861325 621 628 O
is NCT03861325 629 631 O
under NCT03861325 632 637 O
guardianship NCT03861325 638 650 O
, NCT03861325 651 652 O
under NCT03861325 653 658 O
guardianship NCT03861325 659 671 O
, NCT03861325 672 673 O
or NCT03861325 674 676 O
under NCT03861325 677 682 O
the NCT03861325 683 686 O
protection NCT03861325 687 697 O
of NCT03861325 698 700 O
justice NCT03861325 701 708 O

- NCT03861325 711 712 O
The NCT03861325 714 717 O
patient NCT03861325 718 725 O
has NCT03861325 726 729 O
already NCT03861325 730 737 O
participated NCT03861325 738 750 O
in NCT03861325 751 753 O
this NCT03861325 754 758 O
study NCT03861325 759 764 O

- NCT03861325 767 768 O
The NCT03861325 770 773 O
patient NCT03861325 774 781 O
or NCT03861325 782 784 O
his NCT03861325 785 788 O
/ NCT03861325 789 790 O
her NCT03861325 791 794 O
representative NCT03861325 795 809 O
refuses NCT03861325 810 817 O
to NCT03861325 818 820 O
participate NCT03861325 821 832 O
in NCT03861325 833 835 O
the NCT03861325 836 839 O
study NCT03861325 840 845 O

- NCT03861325 848 849 O
The NCT03861325 851 854 O
patient NCT03861325 855 862 O
is NCT03861325 863 865 O
pregnant NCT03861325 866 874 B-Condition-Name
, NCT03861325 875 876 O
parturient NCT03861325 877 887 B-Condition-Name
or NCT03861325 888 890 O
is NCT03861325 891 893 O
breastfeeding NCT03861325 894 907 B-Condition-Name

- NCT03861325 910 911 O
The NCT03861325 913 916 O
patient NCT03861325 917 924 O
is NCT03861325 925 927 O
a NCT03861325 928 929 O
minor NCT03861325 930 935 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child

- NCT03861325 938 939 O
The NCT03861325 941 944 O
patient NCT03861325 945 952 O
is NCT03861325 953 955 O
in NCT03861325 956 958 O
therapeutic NCT03861325 959 970 B-Condition-Name
limitation NCT03861325 971 981 I-Condition-Name
or NCT03861325 982 984 O
moribund NCT03861325 985 993 B-Condition-Name

- NCT03861325 996 997 O
The NCT03861325 999 1002 O
patient NCT03861325 1003 1010 O
has NCT03861325 1011 1014 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
undergone NCT03861325 1015 1024 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03861325 1025 1027 O
is NCT03861325 1028 1030 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
going NCT03861325 1031 1036 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03861325 1037 1039 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
have NCT03861325 1040 1044 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
scheduled NCT03861325 1045 1054 O
or NCT03861325 1055 1057 O
emergency NCT03861325 1058 1067 B-Encounter-Type___Encounter-Type-Value:emergency
digestive NCT03861325 1068 1077 B-Procedure-Name
surgery NCT03861325 1078 1085 I-Procedure-Name

- NCT03861325 1088 1089 O
The NCT03861325 1091 1094 O
patient NCT03861325 1095 1102 O
is NCT03861325 1103 1105 O
HIV NCT03861325 1106 1109 B-Condition-Name
- NCT03861325 1110 1111 O
positive NCT03861325 1112 1120 B-Polarity___Polarity-Value:positive

- NCT03861325 1123 1124 O
The NCT03861325 1126 1129 O
patient NCT03861325 1130 1137 O
has NCT03861325 1138 1141 O
Child NCT03861325 1142 1147 O
C NCT03861325 1148 1149 O
cirrhosis NCT03861325 1150 1159 B-Condition-Name

- NCT03861325 1162 1163 O
The NCT03861325 1165 1168 O
patient NCT03861325 1169 1176 O
has NCT03861325 1177 1180 O
progressive NCT03861325 1181 1192 O
digestive NCT03861325 1193 1202 B-Condition-Name
neoplasia NCT03861325 1203 1212 I-Condition-Name
, NCT03861325 1213 1214 O
digestive NCT03861325 1215 1224 B-Condition-Name
lymphoma NCT03861325 1225 1233 I-Condition-Name
, NCT03861325 1234 1235 O
chronic NCT03861325 1236 1243 O
inflammatory NCT03861325 1244 1256 B-Condition-Name
bowel NCT03861325 1257 1262 I-Condition-Name
disease NCT03861325 1263 1270 I-Condition-Name
( NCT03861325 1271 1272 O
Crohn NCT03861325 1273 1278 B-Condition-Name
's NCT03861325 1278 1280 I-Condition-Name
disease NCT03861325 1281 1288 I-Condition-Name
. NCT03861325 1290 1291 O
. NCT03861325 1292 1293 O
. NCT03861325 1294 1295 O
) NCT03861325 1296 1297 O
. NCT03861325 1299 1300 O

Inclusion NCT03867032 0 9 O
Criteria NCT03867032 10 18 O
: NCT03867032 19 20 O

- NCT03867032 24 25 O
Native NCT03867032 27 33 O
speakers NCT03867032 34 42 O
of NCT03867032 43 45 O
English NCT03867032 46 53 B-Language

- NCT03867032 56 57 O
Cochlear NCT03867032 59 67 B-Procedure-Name
Nucleus NCT03867032 68 75 I-Procedure-Name
cochlear NCT03867032 76 84 I-Procedure-Name
implant NCT03867032 85 92 I-Procedure-Name
users NCT03867032 93 98 O
or NCT03867032 99 101 O
Advanced NCT03867032 102 110 B-Procedure-Name
Bionics NCT03867032 111 118 I-Procedure-Name
users NCT03867032 119 124 O

- NCT03867032 127 128 O
Postlingually NCT03867032 130 143 O
deafened NCT03867032 144 152 B-Condition-Name

- NCT03867032 155 156 O
Has NCT03867032 158 161 O
had NCT03867032 162 165 O
device NCT03867032 166 172 B-Procedure-Name
experience NCT03867032 173 183 O
for NCT03867032 184 187 O
at NCT03867032 188 190 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867032 191 196 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03867032 197 200 B-Eq-Value
year NCT03867032 201 205 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867032 208 209 O
Can NCT03867032 211 214 O
be NCT03867032 215 217 O
child NCT03867032 218 223 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
or NCT03867032 224 226 O
adult NCT03867032 227 232 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
at NCT03867032 233 235 O
the NCT03867032 236 239 O
time NCT03867032 240 244 O
of NCT03867032 245 247 O
enrollment NCT03867032 248 258 O

Exclusion NCT03867032 259 268 O
Criteria NCT03867032 269 277 O
: NCT03867032 278 279 O

- NCT03867032 283 284 O
None NCT03867032 286 290 O

Inclusion NCT03862638 0 9 O
Criteria NCT03862638 10 18 O
: NCT03862638 19 20 O

- NCT03862638 24 25 O
Meeting NCT03862638 27 34 O
the NCT03862638 35 38 O
diagnostic NCT03862638 39 49 O
criteria NCT03862638 50 58 O
of NCT03862638 59 61 O
CTTH NCT03862638 62 66 B-Condition-Name
in NCT03862638 67 69 O
the NCT03862638 70 73 O
international NCT03862638 74 87 O
classification NCT03862638 88 102 O
of NCT03862638 103 105 O
headache NCT03862638 106 114 O
disorders NCT03862638 115 124 O
, NCT03862638 125 126 O
3 NCT03862638 128 129 O
rd NCT03862638 130 132 O
edition NCT03862638 133 140 O
( NCT03862638 141 142 O
beta NCT03862638 143 147 O
version NCT03862638 148 155 O
) NCT03862638 156 157 O
( NCT03862638 158 159 O
ICHD NCT03862638 160 164 O
- NCT03862638 165 166 O
III NCT03862638 167 170 O
beta NCT03862638 171 175 O
) NCT03862638 176 177 O
; NCT03862638 178 179 O

- NCT03862638 182 183 O
Aged NCT03862638 185 189 O
18 NCT03862638 191 193 B-Eq-Value
- NCT03862638 194 195 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03862638 197 199 B-Eq-Value
years NCT03862638 200 205 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03862638 205 206 O

- NCT03862638 209 210 O
Having NCT03862638 212 218 O
the NCT03862638 219 222 O
ability NCT03862638 223 230 O
of NCT03862638 231 233 O
understanding NCT03862638 234 247 O
and NCT03862638 248 251 O
completing NCT03862638 252 262 O
the NCT03862638 263 266 O
headache NCT03862638 267 275 B-Observation-Name
dairy NCT03862638 276 281 I-Observation-Name
; NCT03862638 281 282 O

- NCT03862638 285 286 O
Provide NCT03862638 288 295 O
written NCT03862638 296 303 O
informed NCT03862638 304 312 O
consent NCT03862638 313 320 O
. NCT03862638 321 322 O

Exclusion NCT03862638 324 333 O
Criteria NCT03862638 334 342 O
: NCT03862638 343 344 O

- NCT03862638 348 349 O
No NCT03862638 351 353 O
headache NCT03862638 354 362 B-Condition-Name
during NCT03862638 363 369 O
the NCT03862638 370 373 O
pervious NCT03862638 374 382 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03862638 384 385 B-Eq-Value
months NCT03862638 386 392 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03862638 392 393 O

- NCT03862638 396 397 O
Taking NCT03862638 399 405 O
any NCT03862638 406 409 O
prophylactic NCT03862638 410 422 B-Drug-Name
medication NCT03862638 423 433 I-Drug-Name
during NCT03862638 434 440 O
the NCT03862638 441 444 O
previous NCT03862638 445 453 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
one NCT03862638 454 457 B-Eq-Value
month NCT03862638 458 463 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03862638 463 464 O

- NCT03862638 467 468 O
Secondary NCT03862638 470 479 O
headache NCT03862638 480 488 B-Condition-Name
or NCT03862638 489 491 O
any NCT03862638 492 495 O
systematic NCT03862638 496 506 O
cause NCT03862638 507 512 O

- NCT03862638 515 516 O
Having NCT03862638 518 524 O
serious NCT03862638 525 532 B-Severity___Severity-Value:severe
conditions NCT03862638 533 543 B-Condition-Name
of NCT03862638 544 546 O
the NCT03862638 547 550 O
heart NCT03862638 551 556 O
, NCT03862638 557 558 O
liver NCT03862638 559 564 O
, NCT03862638 565 566 O
kidney NCT03862638 567 573 O
or NCT03862638 574 576 O
other NCT03862638 577 582 O
organs NCT03862638 583 589 O
; NCT03862638 589 590 O

- NCT03862638 593 594 O
In NCT03862638 596 598 O
pregnancy NCT03862638 599 608 B-Condition-Name
or NCT03862638 609 611 O
lactation NCT03862638 612 621 B-Condition-Name
, NCT03862638 622 623 O
or NCT03862638 624 626 O
planning NCT03862638 627 635 O
to NCT03862638 636 638 O
be NCT03862638 639 641 O
pregnant NCT03862638 642 650 B-Condition-Name
in NCT03862638 651 653 O
6 NCT03862638 655 656 B-Eq-Value
months NCT03862638 657 663 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03862638 663 664 O

- NCT03862638 667 668 O
Drug NCT03862638 670 674 O
and NCT03862638 675 678 O
Substance NCT03862638 679 688 O
abuse NCT03862638 689 694 B-Condition-Name

- NCT03862638 697 698 O
Diagnosed NCT03862638 700 709 O
psychiatric NCT03862638 710 721 B-Condition-Name
condition NCT03862638 722 731 I-Condition-Name

- NCT03862638 734 735 O
Taking NCT03862638 737 743 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03862638 744 747 O
other NCT03862638 748 753 O
complementary NCT03862638 754 767 O
and NCT03862638 768 771 O
alternative NCT03862638 772 783 O
medicines NCT03862638 784 793 O

- NCT03862638 796 797 O
Practicing NCT03862638 799 809 O
yoga NCT03862638 810 814 B-Observation-Name___Observation-Type-Value:social-habit
of NCT03862638 815 817 O
any NCT03862638 818 821 O
kind NCT03862638 822 826 O
in NCT03862638 827 829 O
last NCT03862638 830 834 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03862638 835 840 B-Eq-Value
months NCT03862638 841 847 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03864705 0 9 O
Criteria NCT03864705 10 18 O
: NCT03864705 19 20 O

- NCT03864705 24 25 O
Type NCT03864705 27 31 O
2 NCT03864705 33 34 O
diabetes NCT03864705 35 43 B-Condition-Name
mellitus NCT03864705 44 52 I-Condition-Name
on NCT03864705 53 55 O
metformin NCT03864705 56 65 B-Drug-Name
therapy NCT03864705 66 73 B-Procedure-Name
for NCT03864705 74 77 O
at NCT03864705 78 80 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864705 81 86 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03864705 88 89 B-Eq-Value
months NCT03864705 90 96 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Exclusion NCT03864705 97 106 O
Criteria NCT03864705 107 115 O
: NCT03864705 116 117 O

- NCT03864705 120 121 O

Inclusion NCT03868891 0 9 O
Criteria NCT03868891 10 18 O
: NCT03868891 19 20 O

- NCT03868891 24 25 O
6 NCT03868891 28 29 B-Eq-Value
- NCT03868891 30 31 B-Eq-Operator___Eq-Operator-Value:BETWEEN
17 NCT03868891 33 35 B-Eq-Value
years NCT03868891 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03868891 42 45 O

- NCT03868891 48 49 O
Otherwise NCT03868891 51 60 O
healthy NCT03868891 61 68 B-Condition-Name

- NCT03868891 71 72 O
Currently NCT03868891 74 83 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
have NCT03868891 84 88 O
unilateral NCT03868891 89 99 O
or NCT03868891 100 102 O
bilateral NCT03868891 103 112 O
ventilation NCT03868891 113 124 B-Procedure-Name
tube NCT03868891 125 129 I-Procedure-Name
( NCT03868891 130 131 O
s NCT03868891 132 133 O
) NCT03868891 134 135 O
( NCT03868891 136 137 O
VTs NCT03868891 138 141 B-Procedure-Name
) NCT03868891 142 143 O
inserted NCT03868891 144 152 O
for NCT03868891 153 156 O
otitis NCT03868891 157 163 B-Condition-Name
media NCT03868891 164 169 I-Condition-Name
with NCT03868891 170 174 I-Condition-Name
effusion NCT03868891 175 183 I-Condition-Name
( NCT03868891 184 185 O
OME NCT03868891 186 189 B-Condition-Name
) NCT03868891 190 191 O
or NCT03868891 192 194 O
tympanic NCT03868891 195 203 B-Procedure-Name
membrane NCT03868891 204 212 I-Procedure-Name
retraction NCT03868891 213 223 I-Procedure-Name
/ NCT03868891 224 225 O
retraction NCT03868891 226 236 B-Procedure-Name
pocket NCT03868891 237 243 I-Procedure-Name
( NCT03868891 244 245 O
TM NCT03868891 246 248 B-Procedure-Name
- NCT03868891 249 250 I-Procedure-Name
R NCT03868891 251 252 I-Procedure-Name
/ NCT03868891 253 254 I-Procedure-Name
RP NCT03868891 255 257 I-Procedure-Name
) NCT03868891 258 259 O
or NCT03868891 260 262 O
a NCT03868891 263 264 O
TM NCT03868891 265 267 B-Condition-Name
perforation NCT03868891 268 279 I-Condition-Name
after NCT03868891 280 285 O
extrusion NCT03868891 286 295 B-Procedure-Name
of NCT03868891 296 298 I-Procedure-Name
a NCT03868891 299 300 I-Procedure-Name
VT NCT03868891 301 303 I-Procedure-Name

- NCT03868891 306 307 O
History NCT03868891 309 316 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868891 317 319 O
at NCT03868891 320 322 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868891 323 328 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03868891 330 331 B-Eq-Value
sets NCT03868891 332 336 B-Eq-Unit
of NCT03868891 337 339 O
VT NCT03868891 340 342 B-Procedure-Name
insertions NCT03868891 343 353 I-Procedure-Name
in NCT03868891 354 356 O
the NCT03868891 357 360 O
past NCT03868891 361 365 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

- NCT03868891 368 369 O
Eustachian NCT03868891 371 381 B-Observation-Name___Observation-Type-Value:measurement
tube NCT03868891 382 386 I-Observation-Name___Observation-Type-Value:measurement
( NCT03868891 387 388 O
ET NCT03868891 389 391 B-Observation-Name
) NCT03868891 392 393 O
function NCT03868891 394 402 O
( NCT03868891 403 404 O
ETF NCT03868891 405 408 B-Observation-Name
) NCT03868891 409 410 O
tests NCT03868891 411 416 O
showing NCT03868891 417 424 O
an NCT03868891 425 427 O
active NCT03868891 428 434 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
muscular NCT03868891 435 443 O
pattern NCT03868891 444 451 O
of NCT03868891 452 454 O
Eustachian NCT03868891 455 465 B-Condition-Name
tube NCT03868891 466 470 I-Condition-Name
dysfunction NCT03868891 471 482 I-Condition-Name

- NCT03868891 485 486 O
Tubomanometry NCT03868891 488 501 B-Observation-Name___Observation-Type-Value:measurement
test NCT03868891 502 506 I-Observation-Name___Observation-Type-Value:measurement
results NCT03868891 507 514 O
showing NCT03868891 515 522 O
evidence NCT03868891 523 531 O
of NCT03868891 532 534 O
velopharyngeal NCT03868891 535 549 B-Condition-Name
dysfunction NCT03868891 550 561 I-Condition-Name
during NCT03868891 562 568 O
swallowing NCT03868891 569 579 B-Observation-Name

- NCT03868891 582 583 O
Cleft NCT03868891 585 590 B-Condition-Name
palate NCT03868891 591 597 I-Condition-Name
( NCT03868891 598 599 O
CP NCT03868891 600 602 B-Condition-Name
) NCT03868891 603 604 O
cohort NCT03868891 605 611 O
: NCT03868891 612 613 O
non NCT03868891 614 617 O
- NCT03868891 618 619 O
syndromic NCT03868891 620 629 B-Condition-Name
; NCT03868891 629 630 O
prior NCT03868891 631 636 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Furlow NCT03868891 637 643 B-Procedure-Name
palatoplasty NCT03868891 644 656 I-Procedure-Name
without NCT03868891 657 664 O
complications NCT03868891 665 678 B-Condition-Name
or NCT03868891 679 681 O
need NCT03868891 682 686 O
for NCT03868891 687 690 O
revision NCT03868891 691 699 B-Procedure-Name

- NCT03868891 702 703 O
Non NCT03868891 705 708 O
- NCT03868891 709 710 O
CP NCT03868891 711 713 B-Condition-Name
cohort NCT03868891 714 720 O
: NCT03868891 721 722 O
have NCT03868891 723 727 O
had NCT03868891 728 731 O
prior NCT03868891 732 737 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
adenoidectomy NCT03868891 738 751 B-Procedure-Name

Exclusion NCT03868891 752 761 O
Criteria NCT03868891 762 770 O
: NCT03868891 771 772 O

- NCT03868891 776 777 O
Concurrent NCT03868891 779 789 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03868891 790 792 O
past NCT03868891 793 797 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03868891 798 807 O
of NCT03868891 808 810 O
cancer NCT03868891 811 817 B-Condition-Name
or NCT03868891 818 820 O
history NCT03868891 821 828 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868891 829 831 O
radiation NCT03868891 832 841 B-Procedure-Name

- NCT03868891 844 845 O
Have NCT03868891 847 851 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03868891 852 854 O
had NCT03868891 855 858 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
vestibular NCT03868891 859 869 B-Condition-Name
pathology NCT03868891 870 879 I-Condition-Name
, NCT03868891 880 881 O
cranial NCT03868891 882 889 O
base NCT03868891 890 894 O
surgery NCT03868891 895 902 B-Procedure-Name
or NCT03868891 903 905 O
ossicular NCT03868891 906 915 O
chain NCT03868891 916 921 B-Procedure-Name
reconstruction NCT03868891 922 936 I-Procedure-Name

- NCT03868891 939 940 O
Craniofacial NCT03868891 942 954 B-Condition-Name
dysmorphology NCT03868891 955 968 I-Condition-Name
( NCT03868891 969 970 O
other NCT03868891 971 976 O
than NCT03868891 977 981 O
non NCT03868891 982 985 O
- NCT03868891 986 987 O
syndromic NCT03868891 988 997 O
CP NCT03868891 998 1000 B-Condition-Name
with NCT03868891 1001 1005 O
or NCT03868891 1006 1008 O
without NCT03868891 1009 1016 O
cleft NCT03868891 1017 1022 B-Condition-Name
lip NCT03868891 1023 1026 I-Condition-Name
in NCT03868891 1027 1029 O
the NCT03868891 1030 1033 O
CP NCT03868891 1034 1036 B-Condition-Name
cohort NCT03868891 1037 1043 O
) NCT03868891 1044 1045 O
or NCT03868891 1046 1048 O
other NCT03868891 1049 1054 O
syndrome NCT03868891 1055 1063 B-Condition-Name

- NCT03868891 1066 1067 O
A NCT03868891 1069 1070 O
non NCT03868891 1071 1074 O
- NCT03868891 1075 1076 O
patent NCT03868891 1077 1083 O
nasal NCT03868891 1084 1089 B-Condition-Name
cavity NCT03868891 1090 1096 I-Condition-Name

- NCT03868891 1099 1100 O
Patulous NCT03868891 1102 1110 B-Condition-Name
ET NCT03868891 1111 1113 I-Condition-Name
or NCT03868891 1114 1116 O
pathologically NCT03868891 1117 1131 B-Condition-Name
low NCT03868891 1132 1135 I-Condition-Name
ET NCT03868891 1136 1138 I-Condition-Name
opening NCT03868891 1139 1146 O
or NCT03868891 1147 1149 O
closing NCT03868891 1150 1157 O
pressures NCT03868891 1158 1167 O

- NCT03868891 1170 1171 O
Pregnancy NCT03868891 1173 1182 B-Condition-Name

- NCT03868891 1185 1186 O
Unable NCT03868891 1188 1194 O
or NCT03868891 1195 1197 O
unwilling NCT03868891 1198 1207 O
to NCT03868891 1208 1210 O
perform NCT03868891 1211 1218 O
the NCT03868891 1219 1222 O
tests NCT03868891 1223 1228 B-Observation-Name
and NCT03868891 1229 1232 O
exercises NCT03868891 1233 1242 B-Observation-Name___Observation-Type-Value:social-habit
outlined NCT03868891 1243 1251 O
in NCT03868891 1252 1254 O
the NCT03868891 1255 1258 O
study NCT03868891 1259 1264 O

Inclusion NCT03867552 0 9 O
Criteria NCT03867552 10 18 O
: NCT03867552 19 20 O

- NCT03867552 24 25 O
Woman NCT03867552 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
≥ NCT03867552 33 34 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03867552 36 38 B-Eq-Value
years NCT03867552 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867552 45 48 O

- NCT03867552 51 52 O
undergoing NCT03867552 54 64 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
laparoscopic NCT03867552 65 77 B-Procedure-Name
surgery NCT03867552 78 85 I-Procedure-Name
for NCT03867552 86 89 O
endometriosis NCT03867552 90 103 B-Condition-Name
, NCT03867552 104 105 O
uterine NCT03867552 106 113 B-Condition-Name
myoma NCT03867552 114 119 I-Condition-Name
's NCT03867552 119 121 I-Condition-Name
, NCT03867552 122 123 O
hysterectomy NCT03867552 124 136 B-Procedure-Name
or NCT03867552 137 139 O
colpopexy NCT03867552 140 149 B-Procedure-Name
. NCT03867552 150 151 O

Exclusion NCT03867552 153 162 O
Criteria NCT03867552 163 171 O
: NCT03867552 172 173 O

- NCT03867552 177 178 O
Women NCT03867552 180 185 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
< NCT03867552 186 187 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03867552 189 191 B-Eq-Value
years NCT03867552 192 197 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867552 198 201 O

- NCT03867552 204 205 O
Males NCT03867552 207 212 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03867552 215 216 O
Pregnancy NCT03867552 218 227 B-Condition-Name

- NCT03867552 230 231 O
Conditions NCT03867552 233 243 O
associated NCT03867552 244 254 O
with NCT03867552 255 259 O
chronic NCT03867552 260 267 O
pain NCT03867552 268 272 B-Condition-Name
, NCT03867552 273 274 O
such NCT03867552 275 279 O
as NCT03867552 280 282 O
peripheral NCT03867552 283 293 B-Condition-Name
neuropathy NCT03867552 294 304 I-Condition-Name
, NCT03867552 305 306 O
pathology NCT03867552 307 316 B-Condition-Name
of NCT03867552 317 319 O
the NCT03867552 320 323 O
vertebral NCT03867552 324 333 O
column NCT03867552 334 340 O
and NCT03867552 341 344 O
osteo NCT03867552 345 350 B-Condition-Name
- NCT03867552 351 352 I-Condition-Name
articular NCT03867552 353 362 I-Condition-Name
disease NCT03867552 363 370 I-Condition-Name
. NCT03867552 371 372 O

- NCT03867552 376 377 O
Conditions NCT03867552 379 389 O
causing NCT03867552 390 397 O
acute NCT03867552 398 403 B-Severity___Severity-Value:severe
pain NCT03867552 404 408 B-Condition-Name
e NCT03867552 409 410 O
. NCT03867552 411 412 O
g NCT03867552 413 414 O
. NCT03867552 415 416 O
abdominal NCT03867552 418 427 O
trauma NCT03867552 428 434 B-Condition-Name

Inclusion NCT03868852 0 9 O
Criteria NCT03868852 10 18 O
: NCT03868852 19 20 O

- NCT03868852 24 25 O
Patients NCT03868852 27 35 O
must NCT03868852 36 40 O
be NCT03868852 41 43 O
≥ NCT03868852 44 45 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03868852 47 48 B-Eq-Value
and NCT03868852 49 52 O
≤ NCT03868852 53 54 B-Eq-Operator___Eq-Operator-Value:LTEQ
18 NCT03868852 56 58 B-Eq-Value
years NCT03868852 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03868852 65 67 O
age NCT03868852 68 71 O
. NCT03868852 72 73 O

- NCT03868852 77 78 O
The NCT03868852 80 83 O
predicted NCT03868852 84 93 B-Observation-Name
survival NCT03868852 94 102 I-Observation-Name
period NCT03868852 103 109 O
is NCT03868852 110 112 O
more NCT03868852 113 117 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868852 118 122 I-Eq-Operator___Eq-Operator-Value:GT
3 NCT03868852 124 125 B-Eq-Value
months NCT03868852 126 132 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03868852 133 134 O

- NCT03868852 138 139 O
According NCT03868852 141 150 O
to NCT03868852 151 153 O
RECIST NCT03868852 154 160 O
version NCT03868852 161 168 O
1.1 NCT03868852 170 173 O
, NCT03868852 174 175 O
there NCT03868852 176 181 O
is NCT03868852 182 184 O
at NCT03868852 185 187 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868852 188 193 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03868852 194 197 B-Eq-Value
measurable NCT03868852 198 208 O
lesion NCT03868852 209 215 B-Condition-Name
. NCT03868852 216 217 O

- NCT03868852 221 222 O
Post NCT03868852 224 228 O
operative NCT03868852 229 238 B-Procedure-Name
pathological NCT03868852 239 251 B-Condition-Name
stage NCT03868852 252 257 I-Condition-Name
was NCT03868852 258 261 O
group NCT03868852 262 267 B-Eq-Unit
II NCT03868852 268 270 B-Eq-Value
- NCT03868852 271 272 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IV NCT03868852 273 275 B-Eq-Value
. NCT03868852 276 277 O

- NCT03868852 281 282 O
Patients NCT03868852 284 292 O
have NCT03868852 293 297 O
not NCT03868852 298 301 O
received NCT03868852 302 310 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiotherapy NCT03868852 311 323 B-Procedure-Name
before NCT03868852 324 330 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
, NCT03868852 331 332 O
and NCT03868852 333 336 O
can NCT03868852 337 340 O
accept NCT03868852 341 347 O
chemotherapy NCT03868852 348 360 B-Procedure-Name
and NCT03868852 361 364 O
surgical NCT03868852 365 373 B-Procedure-Name
treatment NCT03868852 374 383 I-Procedure-Name
. NCT03868852 384 385 O

- NCT03868852 389 390 O
No NCT03868852 392 394 O
other NCT03868852 395 400 O
anticancer NCT03868852 401 411 B-Procedure-Name
therapy NCT03868852 412 419 I-Procedure-Name
should NCT03868852 420 426 O
be NCT03868852 427 429 O
used NCT03868852 430 434 O
during NCT03868852 435 441 O
radiotherapy NCT03868852 442 454 B-Procedure-Name
. NCT03868852 455 456 O

- NCT03868852 460 461 O
The NCT03868852 463 466 O
main NCT03868852 467 471 B-Condition-Name
organs NCT03868852 472 478 I-Condition-Name
are NCT03868852 479 482 O
functioning NCT03868852 483 494 O
normally NCT03868852 495 503 B-Polarity___Polarity-Value:normal
, NCT03868852 504 505 O
which NCT03868852 506 511 O
meets NCT03868852 512 517 O
the NCT03868852 518 521 O
following NCT03868852 522 531 O
criteria NCT03868852 532 540 O
: NCT03868852 541 542 O

1 NCT03868852 552 553 O
. NCT03868852 553 554 O
Blood NCT03868852 556 561 B-Procedure-Name
routine NCT03868852 562 569 I-Procedure-Name
examination NCT03868852 570 581 I-Procedure-Name
standards NCT03868852 582 591 O
should NCT03868852 592 598 O
be NCT03868852 599 601 O
met NCT03868852 602 605 O
: NCT03868852 606 607 O
( NCT03868852 608 609 O
no NCT03868852 610 612 O
blood NCT03868852 613 618 B-Procedure-Name
transfusion NCT03868852 619 630 I-Procedure-Name
within NCT03868852 631 637 B-Eq-Operator___Eq-Operator-Value:LTEQ
14 NCT03868852 639 641 B-Eq-Value
days NCT03868852 642 646 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03868852 647 648 O
A NCT03868852 649 650 O
. NCT03868852 651 652 O
HB NCT03868852 654 656 B-Observation-Name___Observation-Type-Value:lab
> NCT03868852 657 658 B-Eq-Operator___Eq-Operator-Value:GT
90 NCT03868852 660 662 B-Eq-Value
g NCT03868852 663 664 B-Eq-Unit
/ NCT03868852 665 666 O
L NCT03868852 667 668 B-Eq-Unit
; NCT03868852 668 669 O
B NCT03868852 670 671 O
. NCT03868852 672 673 O
ANC NCT03868852 675 678 B-Observation-Name___Observation-Type-Value:lab
> NCT03868852 679 680 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03868852 682 685 B-Eq-Value
* NCT03868852 686 687 O
109 NCT03868852 689 692 B-Eq-Value
/ NCT03868852 693 694 O
L NCT03868852 695 696 B-Eq-Unit
; NCT03868852 696 697 O
C NCT03868852 698 699 O
. NCT03868852 700 701 O
PLT NCT03868852 703 706 B-Observation-Name___Observation-Type-Value:lab
> NCT03868852 707 708 B-Eq-Operator___Eq-Operator-Value:GT
80 NCT03868852 710 712 B-Eq-Value
* NCT03868852 713 714 O
109 NCT03868852 716 719 B-Eq-Value
/ NCT03868852 720 721 O
L NCT03868852 722 723 B-Eq-Unit

2 NCT03868852 732 733 O
. NCT03868852 733 734 O
Biochemical NCT03868852 736 747 B-Observation-Name___Observation-Type-Value:lab
tests NCT03868852 748 753 I-Observation-Name___Observation-Type-Value:lab
should NCT03868852 754 760 O
meet NCT03868852 761 765 O
the NCT03868852 766 769 O
following NCT03868852 770 779 O
criteria NCT03868852 780 788 O
: NCT03868852 789 790 O

A NCT03868852 792 793 O
. NCT03868852 794 795 O
BIL NCT03868852 797 800 B-Observation-Name___Observation-Type-Value:lab
< NCT03868852 801 802 B-Eq-Operator___Eq-Operator-Value:LT
1.25 NCT03868852 804 808 B-Eq-Value
times NCT03868852 809 814 O
normal NCT03868852 815 821 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
upper NCT03868852 822 827 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03868852 828 833 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
( NCT03868852 834 835 O
ULN NCT03868852 836 839 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
) NCT03868852 840 841 O
; NCT03868852 842 843 O
B NCT03868852 844 845 O
. NCT03868852 846 847 O
ALT NCT03868852 849 852 B-Observation-Name___Observation-Type-Value:lab
and NCT03868852 853 856 O
AST NCT03868852 857 860 B-Observation-Name___Observation-Type-Value:lab
< NCT03868852 861 862 B-Eq-Operator___Eq-Operator-Value:LT
2.5 NCT03868852 864 867 B-Eq-Value
ULN NCT03868852 868 871 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
; NCT03868852 871 872 O
C NCT03868852 873 874 O
. NCT03868852 875 876 O
Serum NCT03868852 878 883 B-Observation-Name___Observation-Type-Value:lab
Cr NCT03868852 884 886 I-Observation-Name___Observation-Type-Value:lab
< NCT03868852 887 888 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03868852 890 891 B-Eq-Value
ULN NCT03868852 892 895 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
, NCT03868852 896 897 O
endogenous NCT03868852 898 908 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03868852 909 919 I-Observation-Name___Observation-Type-Value:lab
clearance NCT03868852 920 929 I-Observation-Name___Observation-Type-Value:lab
> NCT03868852 930 931 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03868852 933 935 B-Eq-Value
ml NCT03868852 936 938 B-Eq-Unit
/ NCT03868852 939 940 O
min NCT03868852 941 944 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

- NCT03868852 947 948 O
Subjects NCT03868852 950 958 O
volunteered NCT03868852 959 970 O
to NCT03868852 971 973 O
participate NCT03868852 974 985 O
in NCT03868852 986 988 O
this NCT03868852 989 993 O
study NCT03868852 994 999 O
, NCT03868852 1000 1001 O
patients NCT03868852 1002 1010 O
or NCT03868852 1011 1013 O
legal NCT03868852 1014 1019 O
guardians NCT03868852 1020 1029 O
signed NCT03868852 1030 1036 O
informed NCT03868852 1037 1045 O
consent NCT03868852 1046 1053 O
through NCT03868852 1054 1061 O
patient NCT03868852 1062 1069 O
consent NCT03868852 1070 1077 O
, NCT03868852 1078 1079 O
good NCT03868852 1080 1084 O
compliance NCT03868852 1085 1095 O
, NCT03868852 1096 1097 O
with NCT03868852 1098 1102 O
follow NCT03868852 1103 1109 O
- NCT03868852 1110 1111 O
up NCT03868852 1112 1114 O
. NCT03868852 1115 1116 O

- NCT03868852 1120 1121 O
Doctors NCT03868852 1123 1130 O
believe NCT03868852 1131 1138 O
that NCT03868852 1139 1143 O
treatment NCT03868852 1144 1153 O
can NCT03868852 1154 1157 O
benefit NCT03868852 1158 1165 O
patients NCT03868852 1166 1174 O
. NCT03868852 1175 1176 O


Inclusion NCT03869580 0 9 O
Criteria NCT03869580 10 18 O
: NCT03869580 19 20 O

- NCT03869580 24 25 O
Patients NCT03869580 27 35 O
with NCT03869580 36 40 O
a NCT03869580 41 42 O
double NCT03869580 43 49 B-Procedure-Name
- NCT03869580 50 51 I-Procedure-Name
J NCT03869580 52 53 I-Procedure-Name
stent NCT03869580 54 59 I-Procedure-Name
placement NCT03869580 60 69 O
or NCT03869580 70 72 O
change NCT03869580 73 79 O
in NCT03869580 80 82 O
the NCT03869580 83 86 O
hospital NCT03869580 87 95 B-Location___Location-Value:hospital

Exclusion NCT03869580 96 105 O
Criteria NCT03869580 106 114 O
: NCT03869580 115 116 O

- NCT03869580 120 121 O
renal NCT03869580 123 128 O
transplants NCT03869580 129 140 B-Procedure-Name
less NCT03869580 141 145 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03869580 146 150 I-Eq-Operator___Eq-Operator-Value:LT
one NCT03869580 151 154 B-Eq-Value
year NCT03869580 155 159 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869580 160 163 O

Inclusion NCT03867591 0 9 O
Criteria NCT03867591 10 18 O
: NCT03867591 19 20 O

- NCT03867591 24 25 O
Able NCT03867591 27 31 O
to NCT03867591 32 34 O
provide NCT03867591 35 42 O
written NCT03867591 43 50 O
informed NCT03867591 51 59 O
consent NCT03867591 60 67 O
in NCT03867591 68 70 O
English NCT03867591 71 78 B-Language
. NCT03867591 79 80 O

- NCT03867591 84 85 O
Willing NCT03867591 87 94 O
to NCT03867591 95 97 O
have NCT03867591 98 102 O
height NCT03867591 103 109 B-Observation-Name___Observation-Type-Value:vital
and NCT03867591 110 113 O
weight NCT03867591 114 120 B-Observation-Name___Observation-Type-Value:vital
measured NCT03867591 121 129 O
and NCT03867591 130 133 O
provide NCT03867591 134 141 O
demographic NCT03867591 142 153 O
information NCT03867591 154 165 O
( NCT03867591 166 167 O
e NCT03867591 168 169 O
. NCT03867591 170 171 O
g NCT03867591 172 173 O
. NCT03867591 174 175 O
age NCT03867591 177 180 O
, NCT03867591 181 182 O
race NCT03867591 183 187 O
, NCT03867591 188 189 O
sex NCT03867591 190 193 O
) NCT03867591 194 195 O

- NCT03867591 199 200 O
Experience NCT03867591 202 212 O
heartburn NCT03867591 213 222 B-Condition-Name
symptoms NCT03867591 223 231 O
at NCT03867591 232 234 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867591 235 240 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03867591 242 243 B-Eq-Value
days NCT03867591 244 248 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
a NCT03867591 249 250 O
week NCT03867591 251 255 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
during NCT03867591 256 262 O
the NCT03867591 263 266 O
past NCT03867591 267 271 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03867591 273 274 B-Eq-Value
months NCT03867591 275 281 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03867591 282 283 O

- NCT03867591 287 288 O
Use NCT03867591 290 293 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
OTC NCT03867591 294 297 B-Drug-Name
product NCT03867591 298 305 I-Drug-Name
( NCT03867591 306 307 O
s NCT03867591 308 309 O
) NCT03867591 310 311 O
, NCT03867591 313 314 O
supplements NCT03867591 315 326 B-Drug-Name
, NCT03867591 327 328 O
or NCT03867591 329 331 O
dietary NCT03867591 332 339 B-Drug-Name
manipulation NCT03867591 340 352 I-Drug-Name
to NCT03867591 353 355 O
relieve NCT03867591 356 363 O
heartburn NCT03867591 364 373 B-Condition-Name
symptoms NCT03867591 374 382 O
in NCT03867591 383 385 O
the NCT03867591 386 389 O
last NCT03867591 390 394 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03867591 396 397 B-Eq-Value
months NCT03867591 398 404 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03867591 405 406 O

- NCT03867591 410 411 O
Willing NCT03867591 413 420 O
to NCT03867591 421 423 O
take NCT03867591 424 428 O
the NCT03867591 429 432 O
study NCT03867591 433 438 O
soy NCT03867591 439 442 B-Drug-Name
supplement NCT03867591 443 453 I-Drug-Name
before NCT03867591 454 460 O
resorting NCT03867591 461 470 O
to NCT03867591 471 473 O
OTC NCT03867591 474 477 B-Drug-Name
product NCT03867591 478 485 I-Drug-Name
( NCT03867591 486 487 O
s NCT03867591 488 489 O
) NCT03867591 490 491 O
to NCT03867591 492 494 O
control NCT03867591 495 502 O
heartburn NCT03867591 503 512 B-Condition-Name
symptoms NCT03867591 513 521 O
. NCT03867591 522 523 O

- NCT03867591 527 528 O
Willing NCT03867591 530 537 O
to NCT03867591 538 540 O
complete NCT03867591 541 549 O
questionnaires NCT03867591 550 564 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
, NCT03867591 565 566 O
records NCT03867591 567 574 B-Observation-Name
, NCT03867591 575 576 O
and NCT03867591 577 580 O
diaries NCT03867591 581 588 B-Observation-Name
associated NCT03867591 589 599 O
with NCT03867591 600 604 O
the NCT03867591 605 608 O
study NCT03867591 609 614 O
and NCT03867591 615 618 O
to NCT03867591 619 621 O
complete NCT03867591 622 630 O
all NCT03867591 631 634 O
clinical NCT03867591 635 643 O
visits NCT03867591 644 650 O
. NCT03867591 651 652 O

- NCT03867591 656 657 O
Willing NCT03867591 659 666 O
to NCT03867591 667 669 O
provide NCT03867591 670 677 O
information NCT03867591 678 689 O
about NCT03867591 690 695 O
dietary NCT03867591 696 703 B-Observation-Name___Observation-Type-Value:social-habit
intake NCT03867591 704 710 I-Observation-Name___Observation-Type-Value:social-habit
; NCT03867591 710 711 O
3 NCT03867591 713 714 B-Eq-Value
- NCT03867591 715 716 O
day NCT03867591 717 720 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
online NCT03867591 721 727 O
24 NCT03867591 729 731 B-Eq-Value
- NCT03867591 732 733 O
hr NCT03867591 734 736 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
recalls NCT03867591 737 744 B-Observation-Name
during NCT03867591 745 751 O
baseline NCT03867591 752 760 O
, NCT03867591 761 762 O
intervention NCT03867591 763 775 B-Procedure-Name
, NCT03867591 776 777 O
and NCT03867591 778 781 O
washout NCT03867591 782 789 B-Procedure-Name
. NCT03867591 790 791 O

- NCT03867591 795 796 O
Willing NCT03867591 798 805 O
and NCT03867591 806 809 O
able NCT03867591 810 814 O
to NCT03867591 815 817 O
provide NCT03867591 818 825 O
a NCT03867591 826 827 O
valid NCT03867591 828 833 O
social NCT03867591 834 840 O
security NCT03867591 841 849 O
for NCT03867591 850 853 O
study NCT03867591 854 859 O
payment NCT03867591 860 867 O
purposes NCT03867591 868 876 O
. NCT03867591 877 878 O

Exclusion NCT03867591 880 889 O
Criteria NCT03867591 890 898 O
: NCT03867591 899 900 O

- NCT03867591 904 905 O
Do NCT03867591 907 909 O
not NCT03867591 910 913 O
meet NCT03867591 914 918 O
the NCT03867591 919 922 O
above NCT03867591 923 928 O
criteria NCT03867591 929 937 O
. NCT03867591 938 939 O

- NCT03867591 943 944 O
Soy NCT03867591 946 949 B-Allergy-Name
allergy NCT03867591 950 957 O

- NCT03867591 960 961 O
Severe NCT03867591 963 969 B-Severity___Severity-Value:severe
heartburn NCT03867591 970 979 B-Condition-Name
problem NCT03867591 980 987 I-Condition-Name
( NCT03867591 988 989 O
can NCT03867591 990 993 O
not NCT03867591 993 996 O
be NCT03867591 997 999 O
ignored NCT03867591 1000 1007 O
and NCT03867591 1008 1011 O
often NCT03867591 1012 1017 O
limits NCT03867591 1018 1024 B-Stability___Stability-Value:change
your NCT03867591 1025 1029 O
concentration NCT03867591 1030 1043 B-Condition-Name
on NCT03867591 1044 1046 O
daily NCT03867591 1047 1052 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
activities NCT03867591 1053 1063 O
) NCT03867591 1064 1065 O
during NCT03867591 1066 1072 O
the NCT03867591 1073 1076 O
last NCT03867591 1077 1081 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
week NCT03867591 1082 1086 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03867591 1089 1090 O
Diagnosed NCT03867591 1092 1101 O
or NCT03867591 1102 1104 O
currently NCT03867591 1105 1114 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
being NCT03867591 1115 1120 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treated NCT03867591 1121 1128 O
for NCT03867591 1129 1132 O
any NCT03867591 1133 1136 O
gastrointestinal NCT03867591 1137 1153 B-Condition-Name
diseases NCT03867591 1154 1162 I-Condition-Name
including NCT03867591 1163 1172 O
GERD NCT03867591 1173 1177 B-Condition-Name
, NCT03867591 1178 1179 O
gastric NCT03867591 1180 1187 B-Condition-Name
ulcers NCT03867591 1188 1194 I-Condition-Name
, NCT03867591 1195 1196 O
Crohn NCT03867591 1197 1202 B-Condition-Name
's NCT03867591 1202 1204 I-Condition-Name
, NCT03867591 1205 1206 O
celiac NCT03867591 1207 1213 B-Condition-Name
, NCT03867591 1214 1215 O
ulcerative NCT03867591 1216 1226 B-Condition-Name
colitis NCT03867591 1227 1234 I-Condition-Name
, NCT03867591 1235 1236 O
etc NCT03867591 1237 1240 O
. NCT03867591 1241 1242 O

- NCT03867591 1246 1247 O
Self NCT03867591 1249 1253 O
- NCT03867591 1254 1255 O
disclosed NCT03867591 1256 1265 O
as NCT03867591 1266 1268 O
pregnant NCT03867591 1269 1277 B-Condition-Name
or NCT03867591 1278 1280 O
breast NCT03867591 1281 1287 B-Condition-Name
- NCT03867591 1288 1289 I-Condition-Name
feeding NCT03867591 1290 1297 I-Condition-Name
or NCT03867591 1298 1300 O
planning NCT03867591 1301 1309 O
on NCT03867591 1310 1312 O
becoming NCT03867591 1313 1321 O
pregnant NCT03867591 1322 1330 B-Condition-Name
during NCT03867591 1331 1337 O
the NCT03867591 1338 1341 O
study NCT03867591 1342 1347 O
duration NCT03867591 1348 1356 O
. NCT03867591 1357 1358 O

- NCT03867591 1362 1363 O
Currently NCT03867591 1365 1374 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
participating NCT03867591 1375 1388 O
in NCT03867591 1389 1391 O
another NCT03867591 1392 1399 O
clinical NCT03867591 1400 1408 O
study NCT03867591 1409 1414 O
. NCT03867591 1415 1416 O

Inclusion NCT03863522 0 9 O
Criteria NCT03863522 10 18 O
: NCT03863522 19 20 O

- NCT03863522 24 25 O
Patient NCT03863522 27 34 O
must NCT03863522 35 39 O
be NCT03863522 40 42 O
female NCT03863522 43 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03863522 52 53 O
Patient NCT03863522 55 62 O
must NCT03863522 63 67 O
be NCT03863522 68 70 O
18 NCT03863522 72 74 B-Eq-Value
years NCT03863522 75 80 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03863522 81 83 O
age NCT03863522 84 87 O
or NCT03863522 88 90 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03863522 91 96 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03863522 99 100 O
Patient NCT03863522 102 109 O
has NCT03863522 110 113 O
been NCT03863522 114 118 O
recommended NCT03863522 119 130 O
for NCT03863522 131 134 O
ultrasound NCT03863522 135 145 B-Procedure-Name
core NCT03863522 146 150 I-Procedure-Name
needle NCT03863522 151 157 I-Procedure-Name
biopsy NCT03863522 158 164 I-Procedure-Name
of NCT03863522 165 167 O
a NCT03863522 168 169 O
suspicious NCT03863522 170 180 O
breast NCT03863522 181 187 B-Condition-Name
lesion NCT03863522 188 194 I-Condition-Name

Exclusion NCT03863522 195 204 O
Criteria NCT03863522 205 213 O
: NCT03863522 214 215 O

- NCT03863522 219 220 O
Patients NCT03863522 222 230 O
may NCT03863522 231 234 O
be NCT03863522 235 237 O
excluded NCT03863522 238 246 O
for NCT03863522 247 250 O
any NCT03863522 251 254 O
condition NCT03863522 255 264 O
that NCT03863522 265 269 O
in NCT03863522 270 272 O
the NCT03863522 273 276 O
opinion NCT03863522 277 284 O
of NCT03863522 285 287 O
the NCT03863522 288 291 O
investigator NCT03863522 292 304 O
may NCT03863522 305 308 O
not NCT03863522 309 312 O
make NCT03863522 313 317 O
it NCT03863522 318 320 O
safe NCT03863522 321 325 O
to NCT03863522 326 328 O
take NCT03863522 329 333 O
part NCT03863522 334 338 O
( NCT03863522 339 340 O
e NCT03863522 341 342 O
. NCT03863522 343 344 O
g NCT03863522 345 346 O
. NCT03863522 347 348 O
certain NCT03863522 350 357 O
medicines NCT03863522 358 367 O
) NCT03863522 368 369 O
. NCT03863522 371 372 O

Inclusion NCT03868488 0 9 O
Criteria NCT03868488 10 18 O
: NCT03868488 19 20 O

- NCT03868488 24 25 O
The NCT03868488 27 30 O
scores NCT03868488 31 37 O
of NCT03868488 38 40 O
the NCT03868488 41 44 O
9 NCT03868488 46 47 O
items NCT03868488 48 53 O
of NCT03868488 54 56 O
The NCT03868488 57 60 O
Diagnostic NCT03868488 61 71 O
and NCT03868488 72 75 O
Statistical NCT03868488 76 87 O
Manual NCT03868488 88 94 O
of NCT03868488 95 97 O
Mental NCT03868488 98 104 O
Disorders NCT03868488 105 114 O
, NCT03868488 115 116 O
Fifth NCT03868488 117 122 O
Edition NCT03868488 123 130 O
( NCT03868488 131 132 O
DSM NCT03868488 133 136 O
- NCT03868488 137 138 O
5 NCT03868488 140 141 O
) NCT03868488 142 143 O
recommended NCT03868488 144 155 O
diagnosis NCT03868488 156 165 O
for NCT03868488 166 169 O
Internet NCT03868488 170 178 B-Condition-Name
gaming NCT03868488 179 185 I-Condition-Name
disorder NCT03868488 186 194 I-Condition-Name
≥ NCT03868488 195 196 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03868488 198 199 B-Eq-Value
. NCT03868488 199 200 O

- NCT03868488 204 205 O
Engagement NCT03868488 207 217 B-Observation-Name___Observation-Type-Value:social-habit
in NCT03868488 218 220 I-Observation-Name___Observation-Type-Value:social-habit
popular NCT03868488 221 228 I-Observation-Name___Observation-Type-Value:social-habit
Internet NCT03868488 229 237 I-Observation-Name___Observation-Type-Value:social-habit
games NCT03868488 238 243 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03868488 244 245 O
e NCT03868488 246 247 O
. NCT03868488 248 249 O
g NCT03868488 250 251 O
. NCT03868488 252 253 O
Arena NCT03868488 255 260 O
of NCT03868488 261 263 O
Valor NCT03868488 264 269 O
, NCT03868488 270 271 O
League NCT03868488 272 278 O
of NCT03868488 279 281 O
Legends NCT03868488 282 289 O
and NCT03868488 290 293 O
Player NCT03868488 294 300 O
Unknown NCT03868488 301 308 O
's NCT03868488 308 310 O
Battle NCT03868488 311 317 O
Grounds NCT03868488 318 325 O
) NCT03868488 326 327 O
for NCT03868488 328 331 O
over NCT03868488 332 336 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03868488 338 340 B-Eq-Value
hours NCT03868488 341 346 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
per NCT03868488 347 350 O
week NCT03868488 351 355 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
for NCT03868488 356 359 O
a NCT03868488 360 361 O
minimum NCT03868488 362 369 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03868488 370 372 O
12 NCT03868488 374 376 B-Eq-Value
months NCT03868488 377 383 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03868488 384 385 O

- NCT03868488 389 390 O
The NCT03868488 392 395 O
scores NCT03868488 396 402 O
of NCT03868488 403 405 O
the NCT03868488 406 409 O
Young NCT03868488 410 415 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03868488 416 417 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Internet NCT03868488 418 426 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Addiction NCT03868488 427 436 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Test NCT03868488 437 441 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03868488 442 443 O
Y NCT03868488 444 445 B-Observation-Name
- NCT03868488 446 447 I-Observation-Name
IAT NCT03868488 448 451 I-Observation-Name
) NCT03868488 452 453 O
≥ NCT03868488 454 455 B-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03868488 457 459 B-Eq-Value

Exclusion NCT03868488 461 470 O
Criteria NCT03868488 471 479 O
: NCT03868488 480 481 O

- NCT03868488 485 486 O
Current NCT03868488 488 495 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03868488 496 498 O
history NCT03868488 499 506 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868488 507 509 O
use NCT03868488 510 513 O
of NCT03868488 514 516 O
illegal NCT03868488 517 524 B-Drug-Name
substances NCT03868488 525 535 I-Drug-Name
and NCT03868488 536 539 O
gambling NCT03868488 540 548 B-Observation-Name___Observation-Type-Value:social-habit
; NCT03868488 548 549 O

- NCT03868488 552 553 O
Current NCT03868488 555 562 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03868488 563 565 O
history NCT03868488 566 573 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868488 574 576 O
psychiatric NCT03868488 577 588 O
or NCT03868488 589 591 O
neurological NCT03868488 592 604 O
illness NCT03868488 605 612 B-Condition-Name
; NCT03868488 612 613 O

- NCT03868488 616 617 O
Current NCT03868488 619 626 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03868488 627 630 O
of NCT03868488 631 633 O
psychotropic NCT03868488 634 646 B-Drug-Name
medications NCT03868488 647 658 I-Drug-Name
. NCT03868488 659 660 O


Inclusion NCT03866499 0 9 O
Criteria NCT03866499 10 18 O
: NCT03866499 19 20 O

- NCT03866499 24 25 O
Histologically NCT03866499 27 41 B-Procedure-Name
or NCT03866499 42 44 O
cytologically NCT03866499 45 58 B-Procedure-Name
confirmed NCT03866499 59 68 O
non NCT03866499 69 72 O
- NCT03866499 73 74 O
small NCT03866499 75 80 O
cell NCT03866499 81 85 O
lung NCT03866499 86 90 O
cancer NCT03866499 91 97 B-Condition-Name
. NCT03866499 98 99 O

- NCT03866499 103 104 O
The NCT03866499 106 109 O
ECOG NCT03866499 110 114 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03866499 115 120 O
of NCT03866499 121 123 O
performance NCT03866499 124 135 O
status NCT03866499 136 142 O
is NCT03866499 143 145 O
0 NCT03866499 147 148 B-Eq-Value
- NCT03866499 149 150 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1 NCT03866499 152 153 B-Eq-Value
. NCT03866499 153 154 O

- NCT03866499 158 159 O
Locally NCT03866499 161 168 O
advanced NCT03866499 169 177 O
or NCT03866499 178 180 O
recurrent NCT03866499 181 190 O
metastatic NCT03866499 191 201 O
NSCLC NCT03866499 202 207 B-Condition-Name
that NCT03866499 208 212 O
has NCT03866499 213 216 O
never NCT03866499 217 222 O
received NCT03866499 223 231 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
systemic NCT03866499 232 240 O
treatment NCT03866499 241 250 O
. NCT03866499 251 252 O

- NCT03866499 256 257 O
According NCT03866499 259 268 O
to NCT03866499 269 271 O
RECIST NCT03866499 272 278 O
1.1 NCT03866499 279 282 O
criteria NCT03866499 283 291 O
, NCT03866499 292 293 O
there NCT03866499 294 299 O
is NCT03866499 300 302 O
at NCT03866499 303 305 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866499 306 311 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03866499 313 314 B-Eq-Value
measurable NCT03866499 315 325 O
lesion NCT03866499 326 332 B-Condition-Name
that NCT03866499 333 337 O
has NCT03866499 338 341 O
not NCT03866499 342 345 O
been NCT03866499 346 350 O
previously NCT03866499 351 361 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
irradiated NCT03866499 362 372 B-Procedure-Name
. NCT03866499 373 374 O

- NCT03866499 378 379 O
Prior NCT03866499 381 386 O
to NCT03866499 387 389 O
enrollment NCT03866499 390 400 O
, NCT03866499 401 402 O
a NCT03866499 403 404 O
central NCT03866499 405 412 O
laboratory NCT03866499 413 423 B-Observation-Name___Observation-Type-Value:lab
testing NCT03866499 424 431 I-Observation-Name___Observation-Type-Value:lab
report NCT03866499 432 438 O
has NCT03866499 439 442 O
confirmed NCT03866499 443 452 O
that NCT03866499 453 457 O
the NCT03866499 458 461 O
tumor NCT03866499 462 467 B-Condition-Name
has NCT03866499 468 471 O
one NCT03866499 472 475 B-Eq-Value
of NCT03866499 476 478 O
two NCT03866499 479 482 B-Eq-Value
common NCT03866499 483 489 B-Condition-Name
EGFR NCT03866499 490 494 I-Condition-Name
mutations NCT03866499 495 504 I-Condition-Name
positive NCT03866499 505 513 B-Polarity___Polarity-Value:positive
that NCT03866499 514 518 O
are NCT03866499 519 522 O
sensitive NCT03866499 523 532 O
to NCT03866499 533 535 O
EGFR NCT03866499 536 540 B-Procedure-Name
- NCT03866499 541 542 I-Procedure-Name
TKI NCT03866499 543 546 I-Procedure-Name
therapy NCT03866499 547 554 I-Procedure-Name
, NCT03866499 555 556 O
accompanied NCT03866499 557 568 O
with NCT03866499 569 573 O
or NCT03866499 574 576 O
not NCT03866499 577 580 O
accompanied NCT03866499 581 592 O
with NCT03866499 593 597 O
other NCT03866499 598 603 O
EGFR NCT03866499 604 608 B-Condition-Name
mutation NCT03866499 609 617 I-Condition-Name
, NCT03866499 618 619 O
with NCT03866499 620 624 O
the NCT03866499 625 628 O
exception NCT03866499 629 638 O
of NCT03866499 639 641 O
exon NCT03866499 642 646 B-Condition-Name
20 NCT03866499 648 650 I-Condition-Name
insertion NCT03866499 651 660 I-Condition-Name
. NCT03866499 661 662 O

Exclusion NCT03866499 664 673 O
Criteria NCT03866499 674 682 O
: NCT03866499 683 684 O

- NCT03866499 688 689 O
Previously NCT03866499 691 701 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
received NCT03866499 702 710 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
systemic NCT03866499 711 719 O
treatment NCT03866499 720 729 O
for NCT03866499 730 733 O
locally NCT03866499 734 741 O
advanced NCT03866499 742 750 O
or NCT03866499 751 753 O
recurrent NCT03866499 754 763 O
metastatic NCT03866499 764 774 O
cancer NCT03866499 775 781 B-Condition-Name
. NCT03866499 782 783 O

- NCT03866499 787 788 O
Primary NCT03866499 790 797 O
T NCT03866499 798 799 B-Condition-Name
790 NCT03866499 800 803 I-Condition-Name
M NCT03866499 804 805 I-Condition-Name
mutation NCT03866499 806 814 I-Condition-Name
- NCT03866499 815 816 O
positive NCT03866499 817 825 B-Polarity___Polarity-Value:positive
patient NCT03866499 826 833 O
. NCT03866499 834 835 O

- NCT03866499 839 840 O
Previous NCT03866499 842 850 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
interstitial NCT03866499 851 863 B-Condition-Name
lung NCT03866499 864 868 I-Condition-Name
disease NCT03866499 869 876 I-Condition-Name
, NCT03866499 877 878 O
drug NCT03866499 879 883 O
- NCT03866499 884 885 O
induced NCT03866499 886 893 O
interstitial NCT03866499 894 906 B-Condition-Name
lung NCT03866499 907 911 I-Condition-Name
disease NCT03866499 912 919 I-Condition-Name
, NCT03866499 920 921 O
radiation NCT03866499 922 931 B-Condition-Name
pneumonia NCT03866499 932 941 I-Condition-Name
requiring NCT03866499 942 951 O
hormonal NCT03866499 952 960 B-Procedure-Name
therapy NCT03866499 961 968 I-Procedure-Name
, NCT03866499 969 970 O
or NCT03866499 971 973 O
any NCT03866499 974 977 O
clinically NCT03866499 978 988 O
proven NCT03866499 989 995 O
active NCT03866499 996 1002 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
interstitial NCT03866499 1003 1015 B-Condition-Name
lung NCT03866499 1016 1020 I-Condition-Name
disease NCT03866499 1021 1028 I-Condition-Name
. NCT03866499 1029 1030 O

- NCT03866499 1034 1035 O
Known NCT03866499 1037 1042 O
active NCT03866499 1043 1049 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infections NCT03866499 1050 1060 B-Condition-Name
such NCT03866499 1061 1065 O
as NCT03866499 1066 1068 O
hepatitis NCT03866499 1069 1078 B-Condition-Name
B NCT03866499 1079 1080 I-Condition-Name
, NCT03866499 1081 1082 O
hepatitis NCT03866499 1083 1092 B-Condition-Name
C NCT03866499 1093 1094 I-Condition-Name
, NCT03866499 1095 1096 O
and NCT03866499 1097 1100 O
human NCT03866499 1101 1106 B-Condition-Name
immunodeficiency NCT03866499 1107 1123 I-Condition-Name
virus NCT03866499 1124 1129 I-Condition-Name
. NCT03866499 1130 1131 O

- NCT03866499 1135 1136 O
Local NCT03866499 1138 1143 O
radiation NCT03866499 1144 1153 B-Procedure-Name
therapy NCT03866499 1154 1161 I-Procedure-Name
is NCT03866499 1162 1164 O
carried NCT03866499 1165 1172 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
out NCT03866499 1173 1176 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
within NCT03866499 1177 1183 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03866499 1185 1186 B-Eq-Value
week NCT03866499 1187 1191 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03866499 1191 1192 O
more NCT03866499 1193 1197 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866499 1198 1202 I-Eq-Operator___Eq-Operator-Value:GT
30 NCT03866499 1204 1206 B-Eq-Value
% NCT03866499 1207 1208 B-Eq-Unit
bone NCT03866499 1209 1213 B-Procedure-Name
marrow NCT03866499 1214 1220 I-Procedure-Name
radiation NCT03866499 1221 1230 I-Procedure-Name
therapy NCT03866499 1231 1238 I-Procedure-Name
or NCT03866499 1239 1241 O
extensive NCT03866499 1242 1251 B-Severity___Severity-Value:severe
radiation NCT03866499 1252 1261 B-Procedure-Name
therapy NCT03866499 1262 1269 I-Procedure-Name
is NCT03866499 1270 1272 O
performed NCT03866499 1273 1282 O
within NCT03866499 1283 1289 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03866499 1291 1292 B-Eq-Value
weeks NCT03866499 1293 1298 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03866499 1299 1300 O

- NCT03866499 1304 1305 O
≤ NCT03866499 1307 1308 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03866499 1310 1311 B-Eq-Value
weeks NCT03866499 1312 1317 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
from NCT03866499 1318 1322 O
major NCT03866499 1323 1328 B-Severity___Severity-Value:severe
surgery NCT03866499 1329 1336 B-Procedure-Name
or NCT03866499 1337 1339 O
≤ NCT03866499 1340 1341 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03866499 1343 1344 B-Eq-Value
weeks NCT03866499 1345 1350 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
from NCT03866499 1351 1355 O
minor NCT03866499 1356 1361 B-Severity___Severity-Value:mild
surgery NCT03866499 1362 1369 B-Procedure-Name
. NCT03866499 1370 1371 O

Inclusion NCT03866512 0 9 O
Criteria NCT03866512 10 18 O
: NCT03866512 19 20 O

- NCT03866512 24 25 O
Males NCT03866512 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03866512 33 36 O
females NCT03866512 37 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
18 NCT03866512 46 48 B-Eq-Value
- NCT03866512 49 50 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03866512 52 54 B-Eq-Value
years NCT03866512 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866512 61 63 O
age NCT03866512 64 67 O

- NCT03866512 70 71 O
Body NCT03866512 73 77 B-Observation-Name___Observation-Type-Value:vital
mass NCT03866512 78 82 I-Observation-Name___Observation-Type-Value:vital
index NCT03866512 83 88 I-Observation-Name___Observation-Type-Value:vital
between NCT03866512 89 96 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03866512 98 100 B-Eq-Value
and NCT03866512 101 104 O
27 NCT03866512 106 108 B-Eq-Value

Exclusion NCT03866512 110 119 O
Criteria NCT03866512 120 128 O
: NCT03866512 129 130 O

- NCT03866512 134 135 O
Any NCT03866512 137 140 O
diagnosed NCT03866512 141 150 O
metabolic NCT03866512 151 160 B-Condition-Name
impairment NCT03866512 161 171 I-Condition-Name
( NCT03866512 172 173 O
e NCT03866512 174 175 O
. NCT03866512 176 177 O
g NCT03866512 178 179 O
. NCT03866512 180 181 O
type NCT03866512 183 187 O
1 NCT03866512 189 190 O
or NCT03866512 191 193 O
2 NCT03866512 195 196 O
diabetes NCT03866512 197 205 B-Condition-Name
) NCT03866512 206 207 O

- NCT03866512 211 212 O
Any NCT03866512 214 217 O
diagnosed NCT03866512 218 227 O
cardiovascular NCT03866512 228 242 B-Condition-Name
disease NCT03866512 243 250 I-Condition-Name

- NCT03866512 253 254 O
Hypertension NCT03866512 256 268 B-Condition-Name
( NCT03866512 269 270 O
≥ NCT03866512 272 273 B-Eq-Operator___Eq-Operator-Value:GTEQ
140 NCT03866512 275 278 B-Eq-Value
mmHg NCT03866512 279 283 B-Eq-Unit
systolic NCT03866512 284 292 B-Observation-Name___Observation-Type-Value:vital
and NCT03866512 293 296 O
/ NCT03866512 297 298 O
or NCT03866512 299 301 O
≥ NCT03866512 302 303 B-Eq-Operator___Eq-Operator-Value:GTEQ
90 NCT03866512 305 307 B-Eq-Value
mmHg NCT03866512 308 312 B-Eq-Unit
diastolic NCT03866512 313 322 B-Observation-Name___Observation-Type-Value:vital
) NCT03866512 323 324 O

- NCT03866512 328 329 O
Chronic NCT03866512 331 338 O
use NCT03866512 339 342 O
of NCT03866512 343 345 O
any NCT03866512 346 349 O
prescribed NCT03866512 350 360 O
or NCT03866512 361 363 O
over NCT03866512 364 368 O
the NCT03866512 369 372 O
counter NCT03866512 373 380 O
pharmaceuticals NCT03866512 381 396 O
( NCT03866512 397 398 O
excluding NCT03866512 399 408 O
oral NCT03866512 409 413 B-Drug-Name
contraceptives NCT03866512 414 428 I-Drug-Name
and NCT03866512 429 432 O
contraceptive NCT03866512 433 446 B-Procedure-Name
devices NCT03866512 447 454 I-Procedure-Name
) NCT03866512 455 456 O

- NCT03866512 460 461 O
Regular NCT03866512 463 470 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03866512 471 474 O
of NCT03866512 475 477 O
nutritional NCT03866512 478 489 B-Drug-Name
supplements NCT03866512 490 501 I-Drug-Name

- NCT03866512 504 505 O
Metallic NCT03866512 507 515 B-Procedure-Name
implants NCT03866512 516 524 I-Procedure-Name

- NCT03866512 527 528 O
A NCT03866512 530 531 O
personal NCT03866512 532 540 O
or NCT03866512 541 543 O
family NCT03866512 544 550 O
history NCT03866512 551 558 O
of NCT03866512 559 561 O
thrombosis NCT03866512 562 572 B-Condition-Name
, NCT03866512 573 574 O
epilepsy NCT03866512 575 583 B-Condition-Name
, NCT03866512 584 585 O
seizures NCT03866512 586 594 B-Condition-Name
or NCT03866512 595 597 O
schizophrenia NCT03866512 598 611 B-Condition-Name

- NCT03866512 614 615 O
Any NCT03866512 617 620 O
previous NCT03866512 621 629 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
motor NCT03866512 630 635 B-Condition-Name
disorders NCT03866512 636 645 I-Condition-Name

- NCT03866512 648 649 O
Any NCT03866512 651 654 O
known NCT03866512 655 660 O
disorders NCT03866512 661 670 B-Condition-Name
in NCT03866512 671 673 I-Condition-Name
lipid NCT03866512 674 679 I-Condition-Name
metabolism NCT03866512 680 690 I-Condition-Name

- NCT03866512 693 694 O
Any NCT03866512 696 699 O
known NCT03866512 700 705 O
disorders NCT03866512 706 715 B-Condition-Name
in NCT03866512 716 718 I-Condition-Name
muscle NCT03866512 719 725 I-Condition-Name
metabolism NCT03866512 726 736 I-Condition-Name

- NCT03866512 739 740 O
Known NCT03866512 742 747 O
allergy NCT03866512 748 755 O
for NCT03866512 756 759 O
Acipimox NCT03866512 760 768 B-Drug-Name
, NCT03866512 769 770 O
beta NCT03866512 771 775 B-Drug-Name
agonist NCT03866512 776 783 I-Drug-Name
, NCT03866512 784 785 O
or NCT03866512 786 788 O
other NCT03866512 789 794 O
substances NCT03866512 795 805 O
in NCT03866512 806 808 O
the NCT03866512 809 812 O
tablets NCT03866512 813 820 O

- NCT03866512 823 824 O
Known NCT03866512 826 831 O
sensitivity NCT03866512 832 843 B-Condition-Name
for NCT03866512 844 847 O
sympathomimetic NCT03866512 848 863 B-Drug-Name
drugs NCT03866512 864 869 I-Drug-Name

- NCT03866512 872 873 O
Known NCT03866512 875 880 O
hypokalaemia NCT03866512 881 893 B-Condition-Name

- NCT03866512 896 897 O
Presence NCT03866512 899 907 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03866512 908 910 O
an NCT03866512 911 913 O
ulcer NCT03866512 914 919 B-Condition-Name
in NCT03866512 920 922 O
the NCT03866512 923 926 O
stomach NCT03866512 927 934 O
or NCT03866512 935 937 O
gut NCT03866512 938 941 O
and NCT03866512 942 945 O
/ NCT03866512 946 947 O
or NCT03866512 948 950 O
strong NCT03866512 951 957 B-Severity___Severity-Value:severe
history NCT03866512 958 965 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866512 966 968 O
indigestion NCT03866512 969 980 B-Condition-Name

- NCT03866512 983 984 O
Known NCT03866512 986 991 O
severe NCT03866512 992 998 B-Severity___Severity-Value:severe
kidney NCT03866512 999 1005 B-Condition-Name
problems NCT03866512 1006 1014 I-Condition-Name

- NCT03866512 1017 1018 O
Pregnancy NCT03866512 1020 1029 B-Condition-Name

- NCT03866512 1032 1033 O
Unable NCT03866512 1035 1041 O
to NCT03866512 1042 1044 O
give NCT03866512 1045 1049 O
consent NCT03866512 1050 1057 O

Inclusion NCT03867630 0 9 O
Criteria NCT03867630 10 18 O
: NCT03867630 19 20 O

- NCT03867630 24 25 O
20 NCT03867630 28 30 B-Eq-Value
to NCT03867630 31 33 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03867630 35 37 B-Eq-Value
years NCT03867630 38 43 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867630 44 47 O

- NCT03867630 50 51 O
Patients NCT03867630 53 61 O
with NCT03867630 62 66 O
a NCT03867630 67 68 O
herniated NCT03867630 69 78 B-Condition-Name
disc NCT03867630 79 83 I-Condition-Name
, NCT03867630 84 85 O
spinal NCT03867630 86 92 B-Condition-Name
stenosis NCT03867630 93 101 I-Condition-Name

- NCT03867630 104 105 O
Patients NCT03867630 107 115 O
with NCT03867630 116 120 O
chronic NCT03867630 121 128 O
low NCT03867630 129 132 O
back NCT03867630 133 137 O
pain NCT03867630 138 142 B-Condition-Name
and NCT03867630 143 146 O
lower NCT03867630 147 152 O
extremity NCT03867630 153 162 O
pain NCT03867630 163 167 B-Condition-Name
who NCT03867630 168 171 O
did NCT03867630 172 175 O
not NCT03867630 176 179 O
respond NCT03867630 180 187 O
to NCT03867630 188 190 O
lumbar NCT03867630 191 197 O
epidural NCT03867630 198 206 B-Procedure-Name
steroid NCT03867630 207 214 I-Procedure-Name
injections NCT03867630 215 225 I-Procedure-Name

- NCT03867630 228 229 O
Patients NCT03867630 231 239 O
who NCT03867630 240 243 O
are NCT03867630 244 247 O
performed NCT03867630 248 257 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
percutaneous NCT03867630 258 270 B-Procedure-Name
epidural NCT03867630 271 279 I-Procedure-Name
neuroplasty NCT03867630 280 291 I-Procedure-Name
with NCT03867630 292 296 O
wire NCT03867630 297 301 B-Procedure-Name
type NCT03867630 302 306 I-Procedure-Name
catheter NCT03867630 307 315 I-Procedure-Name
. NCT03867630 316 317 O

Exclusion NCT03867630 319 328 O
Criteria NCT03867630 329 337 O
: NCT03867630 338 339 O

- NCT03867630 343 344 O
Incomplete NCT03867630 346 356 O
medical NCT03867630 357 364 O
record NCT03867630 365 371 O

- NCT03867630 374 375 O
Contraindication NCT03867630 377 393 O
to NCT03867630 394 396 O
percutaneous NCT03867630 397 409 B-Procedure-Name
epidural NCT03867630 410 418 I-Procedure-Name
neuroplasty NCT03867630 419 430 I-Procedure-Name

Inclusion NCT03861533 0 9 O
Criteria NCT03861533 10 18 O
: NCT03861533 19 20 O

1 NCT03861533 25 26 O
. NCT03861533 26 27 O
Adults NCT03861533 29 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
≥ NCT03861533 36 37 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03861533 39 41 B-Eq-Value
years NCT03861533 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861533 48 51 O

2 NCT03861533 55 56 O
. NCT03861533 56 57 O
High NCT03861533 59 63 B-Polarity___Polarity-Value:high
risk NCT03861533 64 68 O
for NCT03861533 69 72 O
cardiovascular NCT03861533 73 87 B-Condition-Name
morbidity NCT03861533 88 97 I-Condition-Name
and NCT03861533 98 101 O
mortality NCT03861533 102 111 O
such NCT03861533 112 116 O
as NCT03861533 117 119 O
prior NCT03861533 120 125 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03861533 126 133 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861533 134 136 O
clinical NCT03861533 137 145 O
cardiovascular NCT03861533 146 160 B-Condition-Name
disease NCT03861533 161 168 I-Condition-Name
and NCT03861533 169 172 O
/ NCT03861533 173 174 O
or NCT03861533 175 177 O
history NCT03861533 178 185 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861533 186 188 O
familial NCT03861533 189 197 O
hypercholesterolemia NCT03861533 198 218 B-Condition-Name

3 NCT03861533 222 223 O
. NCT03861533 223 224 O
LDL NCT03861533 226 229 B-Observation-Name___Observation-Type-Value:lab
- NCT03861533 230 231 I-Observation-Name___Observation-Type-Value:lab
C NCT03861533 232 233 I-Observation-Name___Observation-Type-Value:lab
within NCT03861533 234 240 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861533 241 244 O
past NCT03861533 245 249 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03861533 251 252 B-Eq-Value
months NCT03861533 253 259 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
above NCT03861533 260 265 B-Eq-Operator___Eq-Operator-Value:GT
recommended NCT03861533 266 277 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
level NCT03861533 278 283 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
despite NCT03861533 284 291 O
maximal NCT03861533 292 299 O
tolerated NCT03861533 300 309 O
statin NCT03861533 310 316 B-Procedure-Name
therapy NCT03861533 317 324 I-Procedure-Name
± NCT03861533 325 326 O
ezetimibe NCT03861533 327 336 B-Drug-Name
for NCT03861533 337 340 O
the NCT03861533 341 344 B-Eq-Operator___Eq-Operator-Value:GTEQ
past NCT03861533 345 349 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03861533 351 352 B-Eq-Value
months NCT03861533 353 359 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03861533 360 361 O

Exclusion NCT03861533 363 372 O
Criteria NCT03861533 373 381 O
: NCT03861533 382 383 O

1 NCT03861533 388 389 O
. NCT03861533 389 390 O
Current NCT03861533 392 399 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03861533 400 409 O
with NCT03861533 410 414 O
PCSK NCT03861533 415 419 B-Drug-Name
9 NCT03861533 420 421 I-Drug-Name
inhibitor NCT03861533 422 431 I-Drug-Name

2 NCT03861533 435 436 O
. NCT03861533 436 437 O
Current NCT03861533 439 446 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
participation NCT03861533 447 460 O
in NCT03861533 461 463 O
investigational NCT03861533 464 479 O
study NCT03861533 480 485 O

3 NCT03861533 489 490 O
. NCT03861533 490 491 O
Prior NCT03861533 493 498 O
participation NCT03861533 499 512 O
in NCT03861533 513 515 O
the NCT03861533 516 519 O
GOAL NCT03861533 520 524 O
program NCT03861533 525 532 O

Inclusion NCT03865966 0 9 O
Criteria NCT03865966 10 18 O
: NCT03865966 19 20 O

- NCT03865966 24 25 O
Patients NCT03865966 27 35 O
with NCT03865966 36 40 O
end NCT03865966 41 44 O
- NCT03865966 45 46 O
stage NCT03865966 47 52 O
liver NCT03865966 53 58 B-Condition-Name
disease NCT03865966 59 66 I-Condition-Name
who NCT03865966 67 70 O
require NCT03865966 71 78 O
liver NCT03865966 79 84 B-Procedure-Name
transplantation NCT03865966 85 100 I-Procedure-Name

Exclusion NCT03865966 101 110 O
Criteria NCT03865966 111 119 O
: NCT03865966 120 121 O

- NCT03865966 125 126 O
Children NCT03865966 128 136 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
without NCT03865966 137 144 O
liver NCT03865966 145 150 B-Procedure-Name
transplantation NCT03865966 151 166 I-Procedure-Name
refer NCT03865966 167 172 O
to NCT03865966 173 175 O
children NCT03865966 176 184 O
; NCT03865966 184 185 O

- NCT03865966 188 189 O
Children NCT03865966 191 199 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
who NCT03865966 200 203 O
are NCT03865966 204 207 O
unwilling NCT03865966 208 217 O
to NCT03865966 218 220 O
participate NCT03865966 221 232 O
; NCT03865966 232 233 O

Inclusion NCT03864107 0 9 O
Criteria NCT03864107 10 18 O
: NCT03864107 19 20 O

- NCT03864107 24 25 O
Men NCT03864107 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03864107 31 34 O
women NCT03864107 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
aged NCT03864107 41 45 O
18 NCT03864107 47 49 B-Eq-Value
- NCT03864107 50 51 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03864107 53 55 B-Eq-Value
years NCT03864107 56 61 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864107 64 65 O
BMI NCT03864107 67 70 B-Observation-Name___Observation-Type-Value:vital
18.5 NCT03864107 72 76 B-Eq-Value
- NCT03864107 77 78 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03864107 80 82 B-Eq-Value
kg NCT03864107 83 85 B-Eq-Unit
/ NCT03864107 86 87 O
m NCT03864107 88 89 B-Eq-Unit
2 NCT03864107 90 91 I-Eq-Unit

- NCT03864107 94 95 O
Not NCT03864107 97 100 O
taking NCT03864107 101 107 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antibiotics NCT03864107 108 119 B-Drug-Name
and NCT03864107 120 123 O
antimicrobial NCT03864107 124 137 B-Drug-Name
drugs NCT03864107 138 143 I-Drug-Name
for NCT03864107 144 147 O
at NCT03864107 148 150 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864107 151 156 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03864107 157 162 B-Eq-Value
months NCT03864107 163 169 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03864107 172 173 O
Both NCT03864107 175 179 O
physically NCT03864107 180 190 B-Observation-Name___Observation-Type-Value:social-habit
active NCT03864107 191 197 I-Observation-Name___Observation-Type-Value:social-habit
and NCT03864107 198 201 O
sedentary NCT03864107 202 211 B-Observation-Name___Observation-Type-Value:social-habit
individuals NCT03864107 212 223 O
will NCT03864107 224 228 O
be NCT03864107 229 231 O
eligible NCT03864107 232 240 O
to NCT03864107 241 243 O
take NCT03864107 244 248 O
part NCT03864107 249 253 O
in NCT03864107 254 256 O
the NCT03864107 257 260 O
study NCT03864107 261 266 O

- NCT03864107 269 270 O
Weight NCT03864107 272 278 B-Observation-Name___Observation-Type-Value:measurement
stable NCT03864107 279 285 B-Stability___Stability-Value:stable
( NCT03864107 286 287 O
± NCT03864107 289 290 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
5 NCT03864107 292 293 B-Eq-Value
kg NCT03864107 294 296 B-Eq-Unit
) NCT03864107 297 298 O
for NCT03864107 299 302 O
at NCT03864107 303 305 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864107 306 311 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03864107 313 314 B-Eq-Value
months NCT03864107 315 321 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Excusion NCT03864107 322 330 O
Criteria NCT03864107 331 339 O
: NCT03864107 340 341 O

- NCT03864107 345 346 O
No NCT03864107 348 350 O
cardiometabolic NCT03864107 351 366 B-Condition-Name
( NCT03864107 367 368 O
e NCT03864107 369 370 O
. NCT03864107 371 372 O
g NCT03864107 373 374 O
. NCT03864107 375 376 O
heart NCT03864107 378 383 B-Condition-Name
disease NCT03864107 384 391 I-Condition-Name
, NCT03864107 392 393 O
high NCT03864107 394 398 B-Polarity___Polarity-Value:high
blood NCT03864107 399 404 B-Condition-Name
pressure NCT03864107 405 413 I-Condition-Name
) NCT03864107 414 415 O
or NCT03864107 416 418 O
inflammatory NCT03864107 419 431 O
illness NCT03864107 432 439 B-Condition-Name

- NCT03864107 442 443 O
Smokers NCT03864107 445 452 B-Condition-Name
( NCT03864107 453 454 O
including NCT03864107 455 464 O
the NCT03864107 465 468 O
use NCT03864107 469 472 O
of NCT03864107 473 475 O
vaporisers NCT03864107 476 486 B-Drug-Name
and NCT03864107 487 490 O
e NCT03864107 491 492 B-Drug-Name
- NCT03864107 493 494 I-Drug-Name
cigarettes NCT03864107 495 505 I-Drug-Name
) NCT03864107 506 507 O

- NCT03864107 511 512 O
Taking NCT03864107 514 520 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
anti NCT03864107 521 525 B-Drug-Name
- NCT03864107 526 527 I-Drug-Name
inflammatory NCT03864107 528 540 I-Drug-Name
drugs NCT03864107 541 546 I-Drug-Name
( NCT03864107 547 548 O
excluding NCT03864107 549 558 O
aspirin NCT03864107 559 566 B-Drug-Name
) NCT03864107 567 568 O

Inclusion NCT03865225 0 9 O
Criteria NCT03865225 10 18 O
: NCT03865225 19 20 O

- NCT03865225 24 25 O
male NCT03865225 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03865225 32 35 O
female NCT03865225 36 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subjects NCT03865225 43 51 O
aged NCT03865225 52 56 O
between NCT03865225 57 64 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03865225 66 68 B-Eq-Value
and NCT03865225 69 72 O
90 NCT03865225 74 76 B-Eq-Value

- NCT03865225 80 81 O
written NCT03865225 83 90 O
and NCT03865225 91 94 O
oral NCT03865225 95 99 O
informed NCT03865225 100 108 O
consent NCT03865225 109 116 O

- NCT03865225 119 120 O
evidence NCT03865225 122 130 O
of NCT03865225 131 133 O
an NCT03865225 134 136 O
ischaemic NCT03865225 137 146 B-Condition-Name
lesion NCT03865225 147 153 I-Condition-Name
on NCT03865225 154 156 O
cranial NCT03865225 157 164 B-Procedure-Name
computed NCT03865225 165 173 I-Procedure-Name
tomography NCT03865225 174 184 I-Procedure-Name
scan NCT03865225 185 189 I-Procedure-Name
or NCT03865225 190 192 O
magnetic NCT03865225 193 201 B-Procedure-Name
resonance NCT03865225 202 211 I-Procedure-Name
imaging NCT03865225 212 219 I-Procedure-Name

Exclusion NCT03865225 220 229 O
Criteria NCT03865225 230 238 O
: NCT03865225 239 240 O

- NCT03865225 244 245 O
intake NCT03865225 247 253 O
of NCT03865225 254 256 O
any NCT03865225 257 260 O
tricyclic NCT03865225 261 270 B-Drug-Name
antidepressant NCT03865225 271 285 I-Drug-Name
within NCT03865225 286 292 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865225 293 296 O
last NCT03865225 297 301 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
14 NCT03865225 303 305 B-Eq-Value
days NCT03865225 306 310 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03865225 313 314 O
atrial NCT03865225 316 322 B-Condition-Name
fibrillation NCT03865225 323 335 I-Condition-Name

- NCT03865225 338 339 O
prior NCT03865225 341 346 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosed NCT03865225 347 356 O
autonomic NCT03865225 357 366 B-Condition-Name
neuropathy NCT03865225 367 377 I-Condition-Name

- NCT03865225 380 381 O
malignant NCT03865225 383 392 B-Condition-Name
cerebral NCT03865225 393 401 I-Condition-Name
infarct NCT03865225 402 409 I-Condition-Name
or NCT03865225 410 412 O
indication NCT03865225 413 423 O
for NCT03865225 424 427 O
treatment NCT03865225 428 437 O
at NCT03865225 438 440 O
intensive NCT03865225 441 450 B-Location___Location-Value:unit
care NCT03865225 451 455 I-Location___Location-Value:unit
unit NCT03865225 456 460 I-Location___Location-Value:unit

- NCT03865225 463 464 O
aphasia NCT03865225 466 473 B-Condition-Name
or NCT03865225 474 476 O
cognitive NCT03865225 477 486 B-Condition-Name
deficit NCT03865225 487 494 I-Condition-Name
with NCT03865225 495 499 O
resulted NCT03865225 500 508 O
inability NCT03865225 509 518 O
to NCT03865225 519 521 O
participate NCT03865225 522 533 O
in NCT03865225 534 536 O
Heart NCT03865225 537 542 O
rate NCT03865225 543 547 O
variability NCT03865225 548 559 O
- NCT03865225 560 561 O
biofeedback NCT03865225 562 573 B-Procedure-Name
training NCT03865225 574 582 I-Procedure-Name

- NCT03865225 585 586 O
respiratory NCT03865225 588 599 B-Condition-Name
insufficiency NCT03865225 600 613 I-Condition-Name

- NCT03865225 616 617 O
blindness NCT03865225 619 628 B-Condition-Name
, NCT03865225 629 630 O
deafness NCT03865225 631 639 B-Condition-Name
or NCT03865225 640 642 O
other NCT03865225 643 648 O
physical NCT03865225 649 657 B-Condition-Name
limitations NCT03865225 658 669 I-Condition-Name
with NCT03865225 670 674 O
resulted NCT03865225 675 683 O
inability NCT03865225 684 693 O
to NCT03865225 694 696 O
participate NCT03865225 697 708 O
in NCT03865225 709 711 O
heart NCT03865225 712 717 O
rate NCT03865225 718 722 O
variability NCT03865225 723 734 O
- NCT03865225 735 736 O
biofeedback NCT03865225 737 748 B-Procedure-Name
training NCT03865225 749 757 I-Procedure-Name

Inclusion NCT03863873 0 9 O
Criteria NCT03863873 10 18 O
: NCT03863873 19 20 O

- NCT03863873 24 25 O
Patients NCT03863873 27 35 O
with NCT03863873 36 40 O
mild NCT03863873 41 45 B-Severity___Severity-Value:mild
- NCT03863873 46 47 O
to NCT03863873 48 50 B-Eq-Operator___Eq-Operator-Value:BETWEEN
- NCT03863873 51 52 O
moderate NCT03863873 53 61 B-Severity___Severity-Value:moderate
idiopathic NCT03863873 62 72 O
CTS NCT03863873 73 76 B-Condition-Name
with NCT03863873 77 81 O
clinical NCT03863873 82 90 O
manifestations NCT03863873 91 105 O
failed NCT03863873 106 112 O
to NCT03863873 113 115 O
respond NCT03863873 116 123 O
to NCT03863873 124 126 O
conservative NCT03863873 127 139 B-Procedure-Name
treatment NCT03863873 140 149 I-Procedure-Name
( NCT03863873 150 151 O
such NCT03863873 152 156 O
as NCT03863873 157 159 O
splint NCT03863873 160 166 B-Procedure-Name
, NCT03863873 167 168 O
medications NCT03863873 169 180 O
, NCT03863873 181 182 O
Physical NCT03863873 183 191 B-Procedure-Name
therapy NCT03863873 192 199 I-Procedure-Name
) NCT03863873 200 201 O
for NCT03863873 202 205 O
at NCT03863873 206 208 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863873 209 214 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03863873 216 217 B-Eq-Value
months NCT03863873 218 224 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03863873 225 228 O
they NCT03863873 229 233 O
were NCT03863873 234 238 O
diagnosed NCT03863873 239 248 O
by NCT03863873 249 251 O
electrophysiological NCT03863873 252 272 B-Procedure-Name
study NCT03863873 273 278 I-Procedure-Name
and NCT03863873 279 282 O
musculoskeletal NCT03863873 283 298 O
ultrasound NCT03863873 299 309 B-Procedure-Name
. NCT03863873 310 311 O

Exclusion NCT03863873 313 322 O
Criteria NCT03863873 323 331 O
: NCT03863873 332 333 O

- NCT03863873 337 338 O
Diabetes NCT03863873 340 348 B-Condition-Name

- NCT03863873 351 352 O
Hypothyroidism NCT03863873 354 368 B-Condition-Name

- NCT03863873 371 372 O
Rheumatoid NCT03863873 374 384 B-Condition-Name
arthritis NCT03863873 385 394 I-Condition-Name

- NCT03863873 397 398 O
Previous NCT03863873 400 408 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
carpal NCT03863873 409 415 B-Procedure-Name
tunnel NCT03863873 416 422 I-Procedure-Name
decompressive NCT03863873 423 436 I-Procedure-Name
surgery NCT03863873 437 444 I-Procedure-Name

- NCT03863873 447 448 O
Cervical NCT03863873 450 458 B-Condition-Name
radiculopathy NCT03863873 459 472 I-Condition-Name
, NCT03863873 473 474 O
polyneuropathy NCT03863873 475 489 B-Condition-Name
, NCT03863873 490 491 O
brachial NCT03863873 492 500 B-Condition-Name
plexopathy NCT03863873 501 511 I-Condition-Name
, NCT03863873 512 513 O
traumatic NCT03863873 514 523 B-Condition-Name
nerve NCT03863873 524 529 I-Condition-Name
injury NCT03863873 530 536 I-Condition-Name
, NCT03863873 537 538 O
thoracic NCT03863873 539 547 B-Condition-Name
outlet NCT03863873 548 554 I-Condition-Name
syndrome NCT03863873 555 563 I-Condition-Name

- NCT03863873 566 567 O
Previous NCT03863873 569 577 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
corticosteroid NCT03863873 578 592 B-Procedure-Name
injection NCT03863873 593 602 I-Procedure-Name
into NCT03863873 603 607 O
the NCT03863873 608 611 O
carpal NCT03863873 612 618 O
tunnel NCT03863873 619 625 O
in NCT03863873 626 628 O
the NCT03863873 629 632 O
preceding NCT03863873 633 642 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
4 NCT03863873 644 645 B-Eq-Value
weeks NCT03863873 646 651 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03863873 654 655 O
Anemia NCT03863873 657 663 B-Condition-Name
( NCT03863873 664 665 O
hemoglobin NCT03863873 666 676 B-Observation-Name___Observation-Type-Value:lab
< NCT03863873 677 678 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03863873 680 682 B-Eq-Value
gm NCT03863873 683 685 B-Eq-Unit
% NCT03863873 686 687 I-Eq-Unit
) NCT03863873 689 690 O

- NCT03863873 694 695 O
Coagulopathy NCT03863873 697 709 B-Condition-Name

- NCT03863873 712 713 O
Pregnancy NCT03863873 715 724 B-Condition-Name

Inclusion NCT03867396 0 9 O
Criteria NCT03867396 10 18 O
* NCT03867396 18 19 O
: NCT03867396 20 21 O

- NCT03867396 25 26 O
An NCT03867396 28 30 O
Advanced NCT03867396 31 39 B-Procedure-Name
Bionics NCT03867396 40 47 I-Procedure-Name
cochlear NCT03867396 48 56 I-Procedure-Name
implant NCT03867396 57 64 I-Procedure-Name
recipient NCT03867396 65 74 O
with NCT03867396 75 79 O
at NCT03867396 80 82 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867396 83 88 I-Eq-Operator___Eq-Operator-Value:GTEQ
12 NCT03867396 90 92 B-Eq-Value
months NCT03867396 93 99 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03867396 100 102 O
listening NCT03867396 103 112 O
experience NCT03867396 113 123 O

- NCT03867396 126 127 O
Low NCT03867396 129 132 B-Observation-Name___Observation-Type-Value:measurement
frequency NCT03867396 133 142 I-Observation-Name___Observation-Type-Value:measurement
Pure NCT03867396 143 147 I-Observation-Name___Observation-Type-Value:measurement
Tone NCT03867396 148 152 I-Observation-Name___Observation-Type-Value:measurement
Audiometry NCT03867396 153 163 I-Observation-Name___Observation-Type-Value:measurement
( NCT03867396 164 165 O
PTA NCT03867396 166 169 B-Observation-Name
) NCT03867396 170 171 O

Exclusion NCT03867396 173 182 O
Criteria NCT03867396 183 191 O
* NCT03867396 191 192 O
: NCT03867396 193 194 O

- NCT03867396 198 199 O
Non NCT03867396 201 204 O
- NCT03867396 205 206 O
English NCT03867396 207 214 B-Language
speakers NCT03867396 215 223 O

- NCT03867396 231 232 O
Additional NCT03867396 234 244 O
Inclusion NCT03867396 245 254 O
and NCT03867396 255 258 O
Exclusion NCT03867396 259 268 O
criteria NCT03867396 269 277 O
apply NCT03867396 278 283 O

Inclusion NCT03865797 0 9 O
Criteria NCT03865797 10 18 O
: NCT03865797 19 20 O

- NCT03865797 24 25 O
Rugby NCT03865797 27 32 B-Observation-Name___Observation-Type-Value:social-habit
players NCT03865797 33 40 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03865797 43 44 O
Both NCT03865797 46 50 O
gender NCT03865797 51 57 O

- NCT03865797 60 61 O
From NCT03865797 63 67 O
18 NCT03865797 69 71 B-Eq-Value
to NCT03865797 72 74 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03865797 76 78 B-Eq-Value
years NCT03865797 79 84 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03865797 85 88 O

- NCT03865797 91 92 O
Federated NCT03865797 94 103 O
. NCT03865797 104 105 O

Exclusion NCT03865797 107 116 O
Criteria NCT03865797 117 125 O
: NCT03865797 126 127 O

- NCT03865797 131 132 O
At NCT03865797 134 136 O
the NCT03865797 137 140 O
time NCT03865797 141 145 O
of NCT03865797 146 148 O
the NCT03865797 149 152 O
study NCT03865797 153 158 O
, NCT03865797 159 160 O
they NCT03865797 161 165 O
present NCT03865797 166 173 O
an NCT03865797 174 176 O
injury NCT03865797 177 183 B-Condition-Name
that NCT03865797 184 188 O
prevents NCT03865797 189 197 O
them NCT03865797 198 202 O
from NCT03865797 203 207 O
carrying NCT03865797 208 216 O
out NCT03865797 217 220 O
the NCT03865797 221 224 O
proposed NCT03865797 225 233 O
intervention NCT03865797 234 246 B-Procedure-Name

- NCT03865797 249 250 O
Included NCT03865797 252 260 O
in NCT03865797 261 263 O
a NCT03865797 264 265 O
personal NCT03865797 266 274 B-Observation-Name___Observation-Type-Value:social-habit
training NCT03865797 275 283 I-Observation-Name___Observation-Type-Value:social-habit
regime NCT03865797 284 290 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03865797 293 294 O
With NCT03865797 296 300 O
musculoskeletal NCT03865797 301 316 O
injuries NCT03865797 317 325 B-Condition-Name
in NCT03865797 326 328 O
the NCT03865797 329 332 O
ankle NCT03865797 333 338 O
in NCT03865797 339 341 O
the NCT03865797 342 345 O
last NCT03865797 346 350 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03865797 352 353 B-Eq-Value
months NCT03865797 354 360 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03865797 363 364 O
Not NCT03865797 366 369 O
sign NCT03865797 370 374 O
the NCT03865797 375 378 O
informed NCT03865797 379 387 O
consent NCT03865797 388 395 O
document NCT03865797 396 404 O
. NCT03865797 405 406 O

Inclusion NCT03863457 0 9 O
Criteria NCT03863457 10 18 O
: NCT03863457 19 20 O

- NCT03863457 24 25 O
Participants NCT03863457 27 39 O
will NCT03863457 40 44 O
be NCT03863457 45 47 O
≥ NCT03863457 48 49 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863457 51 53 B-Eq-Value
years NCT03863457 54 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03863457 60 62 O
age NCT03863457 63 66 O

- NCT03863457 69 70 O
Known NCT03863457 72 77 O
or NCT03863457 78 80 O
suspected NCT03863457 81 90 O
primary NCT03863457 91 98 O
or NCT03863457 99 101 O
metastatic NCT03863457 102 112 O
breast NCT03863457 113 119 O
cancer NCT03863457 120 126 B-Condition-Name
. NCT03863457 127 128 O

- NCT03863457 132 133 O
At NCT03863457 135 137 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863457 138 143 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03863457 144 147 B-Eq-Value
lesion NCT03863457 148 154 B-Condition-Name
≥ NCT03863457 155 156 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.5 NCT03863457 158 161 B-Eq-Value
cm NCT03863457 162 164 B-Eq-Unit
that NCT03863457 165 169 O
is NCT03863457 170 172 O
seen NCT03863457 173 177 O
on NCT03863457 178 180 O
standard NCT03863457 181 189 B-Procedure-Name
imaging NCT03863457 190 197 I-Procedure-Name
( NCT03863457 198 199 O
e NCT03863457 200 201 O
. NCT03863457 202 203 O
g NCT03863457 204 205 O
. NCT03863457 206 207 O
CT NCT03863457 209 211 B-Procedure-Name
, NCT03863457 212 213 O
MRI NCT03863457 214 217 B-Procedure-Name
, NCT03863457 218 219 O
mammogram NCT03863457 220 229 B-Procedure-Name
, NCT03863457 230 231 O
ultrasound NCT03863457 232 242 B-Procedure-Name
, NCT03863457 243 244 O
FDG NCT03863457 245 248 B-Procedure-Name
- NCT03863457 249 250 I-Procedure-Name
PET NCT03863457 251 254 I-Procedure-Name
/ NCT03863457 255 256 O
CT NCT03863457 257 259 B-Procedure-Name
) NCT03863457 260 261 O
. NCT03863457 263 264 O
Only NCT03863457 266 270 B-Eq-Operator___Eq-Operator-Value:EQ
one NCT03863457 271 274 B-Eq-Value
type NCT03863457 275 279 O
of NCT03863457 280 282 O
imaging NCT03863457 283 290 B-Procedure-Name
is NCT03863457 291 293 O
required NCT03863457 294 302 O
to NCT03863457 303 305 O
show NCT03863457 306 310 O
a NCT03863457 311 312 O
lesion NCT03863457 313 319 B-Condition-Name
. NCT03863457 320 321 O

- NCT03863457 325 326 O
Participants NCT03863457 328 340 O
must NCT03863457 341 345 O
be NCT03863457 346 348 O
informed NCT03863457 349 357 O
of NCT03863457 358 360 O
the NCT03863457 361 364 O
investigational NCT03863457 365 380 O
nature NCT03863457 381 387 O
of NCT03863457 388 390 O
this NCT03863457 391 395 O
study NCT03863457 396 401 O
and NCT03863457 402 405 O
be NCT03863457 406 408 O
willing NCT03863457 409 416 O
to NCT03863457 417 419 O
provide NCT03863457 420 427 O
written NCT03863457 428 435 O
informed NCT03863457 436 444 O
consent NCT03863457 445 452 O
and NCT03863457 453 456 O
participate NCT03863457 457 468 O
in NCT03863457 469 471 O
this NCT03863457 472 476 O
study NCT03863457 477 482 O
in NCT03863457 483 485 O
accordance NCT03863457 486 496 O
with NCT03863457 497 501 O
institutional NCT03863457 502 515 O
and NCT03863457 516 519 O
federal NCT03863457 520 527 O
guidelines NCT03863457 528 538 O
prior NCT03863457 539 544 O
to NCT03863457 545 547 O
study NCT03863457 548 553 O
- NCT03863457 554 555 O
specific NCT03863457 556 564 O
procedures NCT03863457 565 575 O
. NCT03863457 576 577 O

Exclusion NCT03863457 579 588 O
Criteria NCT03863457 589 597 O
: NCT03863457 598 599 O

- NCT03863457 603 604 O
Females NCT03863457 606 613 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03863457 614 617 O
are NCT03863457 618 621 O
pregnant NCT03863457 622 630 B-Condition-Name
or NCT03863457 631 633 O
breast NCT03863457 634 640 B-Condition-Name
feeding NCT03863457 641 648 I-Condition-Name
at NCT03863457 649 651 O
the NCT03863457 652 655 O
time NCT03863457 656 660 O
of NCT03863457 661 663 O
screening NCT03863457 664 673 O
; NCT03863457 673 674 O
a NCT03863457 675 676 O
urine NCT03863457 677 682 B-Observation-Name___Observation-Type-Value:lab
pregnancy NCT03863457 683 692 I-Observation-Name___Observation-Type-Value:lab
test NCT03863457 693 697 I-Observation-Name___Observation-Type-Value:lab
will NCT03863457 698 702 O
be NCT03863457 703 705 O
performed NCT03863457 706 715 O
in NCT03863457 716 718 O
women NCT03863457 719 724 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03863457 725 727 O
child NCT03863457 728 733 B-Condition-Name
- NCT03863457 734 735 I-Condition-Name
bearing NCT03863457 736 743 I-Condition-Name
potential NCT03863457 744 753 I-Condition-Name
at NCT03863457 754 756 O
screening NCT03863457 757 766 O
. NCT03863457 767 768 O

- NCT03863457 772 773 O
Inability NCT03863457 775 784 O
to NCT03863457 785 787 O
tolerate NCT03863457 788 796 O
imaging NCT03863457 797 804 B-Procedure-Name
procedures NCT03863457 805 815 I-Procedure-Name
in NCT03863457 816 818 O
the NCT03863457 819 822 O
opinion NCT03863457 823 830 O
of NCT03863457 831 833 O
an NCT03863457 834 836 O
investigator NCT03863457 837 849 O
or NCT03863457 850 852 O
treating NCT03863457 853 861 O
physician NCT03863457 862 871 O
. NCT03863457 872 873 O

- NCT03863457 877 878 O
Any NCT03863457 880 883 O
current NCT03863457 884 891 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medical NCT03863457 892 899 O
condition NCT03863457 900 909 O
, NCT03863457 910 911 O
illness NCT03863457 912 919 B-Condition-Name
, NCT03863457 920 921 O
or NCT03863457 922 924 O
disorder NCT03863457 925 933 B-Condition-Name
, NCT03863457 934 935 O
as NCT03863457 936 938 O
assessed NCT03863457 939 947 O
by NCT03863457 948 950 O
medical NCT03863457 951 958 O
record NCT03863457 959 965 O
review NCT03863457 966 972 O
and NCT03863457 973 976 O
/ NCT03863457 977 978 O
or NCT03863457 979 981 O
self NCT03863457 982 986 O
- NCT03863457 987 988 O
reported NCT03863457 989 997 O
, NCT03863457 998 999 O
that NCT03863457 1000 1004 O
is NCT03863457 1005 1007 O
considered NCT03863457 1008 1018 O
by NCT03863457 1019 1021 O
a NCT03863457 1022 1023 O
physician NCT03863457 1024 1033 O
investigator NCT03863457 1034 1046 O
to NCT03863457 1047 1049 O
be NCT03863457 1050 1052 O
a NCT03863457 1053 1054 O
condition NCT03863457 1055 1064 O
that NCT03863457 1065 1069 O
could NCT03863457 1070 1075 O
compromise NCT03863457 1076 1086 B-Stability___Stability-Value:change
participant NCT03863457 1087 1098 O
safety NCT03863457 1099 1105 O
or NCT03863457 1106 1108 O
successful NCT03863457 1109 1119 O
participation NCT03863457 1120 1133 O
in NCT03863457 1134 1136 O
the NCT03863457 1137 1140 O
study NCT03863457 1141 1146 O
. NCT03863457 1147 1148 O

Inclusion NCT03860610 0 9 O
Criteria NCT03860610 10 18 O
: NCT03860610 19 20 O

- NCT03860610 24 25 O
Patients NCT03860610 27 35 O
with NCT03860610 36 40 O
an NCT03860610 41 43 O
unilateral NCT03860610 44 54 O
THA NCT03860610 55 58 B-Procedure-Name
or NCT03860610 59 61 O
TKA NCT03860610 62 65 B-Procedure-Name
, NCT03860610 66 67 O
which NCT03860610 68 73 O
they NCT03860610 74 78 O
received NCT03860610 79 87 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
for NCT03860610 88 91 O
the NCT03860610 92 95 O
treatment NCT03860610 96 105 O
of NCT03860610 106 108 O
osteoarthritis NCT03860610 109 123 B-Condition-Name
( NCT03860610 124 125 O
Patient NCT03860610 126 133 O
groups NCT03860610 134 140 O
1 NCT03860610 142 143 O
+ NCT03860610 144 145 O
2 NCT03860610 147 148 O
) NCT03860610 149 150 O

- NCT03860610 154 155 O
Patients NCT03860610 157 165 O
diagnosed NCT03860610 166 175 O
with NCT03860610 176 180 O
unilateral NCT03860610 181 191 O
OA NCT03860610 192 194 B-Condition-Name
of NCT03860610 195 197 O
the NCT03860610 198 201 O
knee NCT03860610 202 206 O
or NCT03860610 207 209 O
hip NCT03860610 210 213 O
planned NCT03860610 214 221 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03860610 222 225 O
a NCT03860610 226 227 O
treatment NCT03860610 228 237 O
with NCT03860610 238 242 O
THA NCT03860610 243 246 B-Procedure-Name
or NCT03860610 247 249 O
TKA NCT03860610 250 253 B-Procedure-Name
( NCT03860610 254 255 O
Patient NCT03860610 256 263 O
groups NCT03860610 264 270 O
3 NCT03860610 272 273 O
+ NCT03860610 274 275 O
4 NCT03860610 277 278 O
) NCT03860610 279 280 O

- NCT03860610 284 285 O
Age NCT03860610 287 290 O
≥ NCT03860610 291 292 B-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03860610 294 296 B-Eq-Value
years NCT03860610 297 302 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03860610 303 304 O
Healthy NCT03860610 305 312 B-Condition-Name
control NCT03860610 313 320 O
group NCT03860610 321 326 O
) NCT03860610 327 328 O

Exclusion NCT03860610 330 339 O
Criteria NCT03860610 340 348 O
: NCT03860610 349 350 O

- NCT03860610 354 355 O
Body NCT03860610 357 361 B-Observation-Name___Observation-Type-Value:measurement
mass NCT03860610 362 366 I-Observation-Name___Observation-Type-Value:measurement
index NCT03860610 367 372 I-Observation-Name___Observation-Type-Value:measurement
> NCT03860610 373 374 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03860610 376 378 B-Eq-Value
kg NCT03860610 379 381 B-Eq-Unit
/ NCT03860610 382 383 O
m NCT03860610 384 385 B-Eq-Unit
2 NCT03860610 386 387 I-Eq-Unit

- NCT03860610 390 391 O
Use NCT03860610 393 396 O
of NCT03860610 397 399 O
walking NCT03860610 400 407 B-Procedure-Name
aids NCT03860610 408 412 I-Procedure-Name

- NCT03860610 415 416 O
Neuromuscular NCT03860610 418 431 B-Condition-Name
disorders NCT03860610 432 441 I-Condition-Name
affecting NCT03860610 442 451 B-Stability___Stability-Value:change
gait NCT03860610 452 456 B-Condition-Name

- NCT03860610 459 460 O
Inability NCT03860610 462 471 O
to NCT03860610 472 474 O
follow NCT03860610 475 481 O
procedures NCT03860610 482 492 O
due NCT03860610 493 496 O
to NCT03860610 497 499 O
psychological NCT03860610 500 513 B-Condition-Name
disorders NCT03860610 514 523 I-Condition-Name
or NCT03860610 524 526 O
dementia NCT03860610 527 535 B-Condition-Name

- NCT03860610 538 539 O
Diagnosed NCT03860610 541 550 O
hip NCT03860610 551 554 O
or NCT03860610 555 557 O
knee NCT03860610 558 562 O
OA NCT03860610 563 565 B-Condition-Name
( NCT03860610 566 567 O
Healthy NCT03860610 568 575 B-Condition-Name
control NCT03860610 576 583 O
group NCT03860610 584 589 O
) NCT03860610 590 591 O

- NCT03860610 595 596 O
Current NCT03860610 598 605 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pain NCT03860610 606 610 B-Condition-Name
in NCT03860610 611 613 O
the NCT03860610 614 617 O
lower NCT03860610 618 623 O
extremities NCT03860610 624 635 O
or NCT03860610 636 638 O
lower NCT03860610 639 644 O
back NCT03860610 645 649 O
( NCT03860610 650 651 O
Healthy NCT03860610 652 659 B-Condition-Name
control NCT03860610 660 667 O
group NCT03860610 668 673 O
) NCT03860610 674 675 O

- NCT03860610 679 680 O
Rheumatoid NCT03860610 682 692 B-Condition-Name
Arthritis NCT03860610 693 702 I-Condition-Name
( NCT03860610 703 704 O
Healthy NCT03860610 705 712 B-Condition-Name
control NCT03860610 713 720 O
group NCT03860610 721 726 O
) NCT03860610 727 728 O

- NCT03860610 732 733 O
Previous NCT03860610 735 743 B-Eq-Temporal-Period
corrective NCT03860610 744 754 B-Procedure-Name
osteotomy NCT03860610 755 764 I-Procedure-Name
( NCT03860610 765 766 O
Healthy NCT03860610 767 774 B-Condition-Name
control NCT03860610 775 782 O
group NCT03860610 783 788 O
) NCT03860610 789 790 O

- NCT03860610 794 795 O
Regular NCT03860610 797 804 O
intake NCT03860610 805 811 O
of NCT03860610 812 814 O
pain NCT03860610 815 819 B-Drug-Name
medication NCT03860610 820 830 I-Drug-Name
( NCT03860610 831 832 O
more NCT03860610 833 837 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03860610 838 842 I-Eq-Operator___Eq-Operator-Value:GT
4 NCT03860610 844 845 B-Eq-Value
times NCT03860610 846 851 B-Eq-Unit
per NCT03860610 852 855 O
week NCT03860610 856 860 B-Eq-Temporal-Unit
) NCT03860610 861 862 O
( NCT03860610 863 864 O
Healthy NCT03860610 865 872 B-Condition-Name
control NCT03860610 873 880 O
group NCT03860610 881 886 O
) NCT03860610 887 888 O

Inclusion NCT03863912 0 9 O
Criteria NCT03863912 10 18 O
: NCT03863912 19 20 O

- NCT03863912 24 25 O
planned NCT03863912 27 34 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
6 NCT03863912 36 37 B-Eq-Value
cycles NCT03863912 38 44 B-Eq-Unit
of NCT03863912 45 47 O
chemotherapy NCT03863912 48 60 B-Procedure-Name
with NCT03863912 61 65 O
carboplatin NCT03863912 66 77 B-Drug-Name
/ NCT03863912 78 79 O
paclitaxel NCT03863912 80 90 B-Drug-Name
or NCT03863912 91 93 O
carboplatin NCT03863912 94 105 B-Drug-Name
/ NCT03863912 106 107 O
pegylated NCT03863912 108 117 B-Drug-Name
liposomal NCT03863912 118 127 I-Drug-Name
doxorubicin NCT03863912 128 139 I-Drug-Name

- NCT03863912 142 143 O
Age NCT03863912 145 148 O
> NCT03863912 149 150 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03863912 152 154 B-Eq-Value
years NCT03863912 155 160 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03863912 161 170 O
Criteria NCT03863912 171 179 O
: NCT03863912 180 181 O

- NCT03863912 185 186 O
inadequate NCT03863912 188 198 O
knowledge NCT03863912 199 208 O
of NCT03863912 209 211 O
the NCT03863912 212 215 O
German NCT03863912 216 222 B-Language
language NCT03863912 223 231 O

Inclusion NCT03861650 0 9 O
Criteria NCT03861650 10 18 O
: NCT03861650 19 20 O

1 NCT03861650 25 26 O
. NCT03861650 26 27 O
Patients NCT03861650 29 37 O
free NCT03861650 38 42 O
from NCT03861650 43 47 O
any NCT03861650 48 51 O
disease NCT03861650 52 59 B-Condition-Name
affecting NCT03861650 60 69 B-Stability___Stability-Value:change
bone NCT03861650 70 74 B-Condition-Name
formation NCT03861650 75 84 I-Condition-Name
of NCT03861650 85 87 O
both NCT03861650 88 92 O
sexes NCT03861650 93 98 O
was NCT03861650 99 102 O
included NCT03861650 103 111 O
in NCT03861650 112 114 O
the NCT03861650 115 118 O
study NCT03861650 119 124 O
. NCT03861650 125 126 O

2 NCT03861650 131 132 O
. NCT03861650 132 133 O
Patients NCT03861650 135 143 O
younger NCT03861650 144 151 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03861650 152 156 I-Eq-Operator___Eq-Operator-Value:LT
25 NCT03861650 158 160 B-Eq-Value
years NCT03861650 161 166 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861650 167 170 O
. NCT03861650 171 172 O

3 NCT03861650 177 178 O
. NCT03861650 178 179 O
Patients NCT03861650 181 189 O
included NCT03861650 190 198 O
in NCT03861650 199 201 O
the NCT03861650 202 205 O
study NCT03861650 206 211 O
were NCT03861650 212 216 O
post NCT03861650 217 221 B-Condition-Name
traumatic NCT03861650 222 231 I-Condition-Name
patients NCT03861650 232 240 O
, NCT03861650 241 242 O
hemifacial NCT03861650 243 253 B-Condition-Name
microsomia NCT03861650 254 264 I-Condition-Name
, NCT03861650 265 266 O
Treacher NCT03861650 267 275 B-Condition-Name
Collins NCT03861650 276 283 I-Condition-Name
and NCT03861650 284 287 O
post NCT03861650 288 292 B-Condition-Name
ankylotic NCT03861650 293 302 I-Condition-Name
mandibular NCT03861650 303 313 I-Condition-Name
deformity NCT03861650 314 323 I-Condition-Name
. NCT03861650 324 325 O

4 NCT03861650 330 331 O
. NCT03861650 331 332 O
Distraction NCT03861650 334 345 B-Observation-Name___Observation-Type-Value:measurement
range NCT03861650 346 351 I-Observation-Name___Observation-Type-Value:measurement
was NCT03861650 352 355 O
between NCT03861650 356 363 B-Eq-Operator___Eq-Operator-Value:BETWEEN
15 NCT03861650 365 367 B-Eq-Value
- NCT03861650 368 369 O
20 NCT03861650 371 373 B-Eq-Value
mm NCT03861650 374 376 B-Eq-Unit
. NCT03861650 377 378 O

Exclusion NCT03861650 380 389 O
Criteria NCT03861650 390 398 O
: NCT03861650 399 400 O

1 NCT03861650 405 406 O
. NCT03861650 406 407 O
The NCT03861650 409 412 O
presence NCT03861650 413 421 O
of NCT03861650 422 424 O
uncontrolled NCT03861650 425 437 O
systemic NCT03861650 438 446 O
disease NCT03861650 447 454 B-Condition-Name
. NCT03861650 455 456 O

2 NCT03861650 461 462 O
. NCT03861650 462 463 O
Previous NCT03861650 465 473 B-Eq-Temporal-Period
radiotherapy NCT03861650 474 486 B-Procedure-Name
on NCT03861650 487 489 O
head NCT03861650 490 494 O
and NCT03861650 495 498 O
neck NCT03861650 499 503 O
region NCT03861650 504 510 O
. NCT03861650 511 512 O

3 NCT03861650 517 518 O
. NCT03861650 518 519 O
Chemotherapy NCT03861650 521 533 B-Procedure-Name
within NCT03861650 534 540 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861650 541 544 O
past NCT03861650 545 549 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
12 NCT03861650 551 553 B-Eq-Value
- NCT03861650 554 555 O
month NCT03861650 556 561 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
period NCT03861650 562 568 O
. NCT03861650 569 570 O

4 NCT03861650 575 576 O
. NCT03861650 576 577 O
An NCT03861650 579 581 O
active NCT03861650 582 588 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03861650 589 598 B-Condition-Name
at NCT03861650 599 601 O
the NCT03861650 602 605 O
distraction NCT03861650 606 617 O
site NCT03861650 618 622 O
. NCT03861650 623 624 O

Inclusion NCT03862417 0 9 O
Criteria NCT03862417 10 18 O
: NCT03862417 19 20 O

- NCT03862417 24 25 O
Adults NCT03862417 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
over NCT03862417 34 38 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03862417 40 42 B-Eq-Value
years NCT03862417 43 48 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862417 49 52 O
with NCT03862417 53 57 O
degenerative NCT03862417 58 70 B-Condition-Name
scoliosis NCT03862417 71 80 I-Condition-Name
( NCT03862417 81 82 O
n NCT03862417 83 84 O
= NCT03862417 85 86 O
20 NCT03862417 88 90 O
) NCT03862417 91 92 O
with NCT03862417 93 97 O
pain NCT03862417 98 102 B-Condition-Name
( NCT03862417 103 104 O
> NCT03862417 106 107 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03862417 109 110 B-Eq-Value
/ NCT03862417 111 112 O
10 NCT03862417 114 116 B-Eq-Value
) NCT03862417 117 118 O
. NCT03862417 120 121 O
Other NCT03862417 123 128 O
inclusion NCT03862417 129 138 O
criteria NCT03862417 139 147 O
are NCT03862417 148 151 O
: NCT03862417 152 153 O
( NCT03862417 154 155 O
1 NCT03862417 157 158 O
) NCT03862417 159 160 O
curves NCT03862417 161 167 B-Observation-Name
15 NCT03862417 169 171 B-Eq-Value
° NCT03862417 172 173 B-Eq-Unit
- NCT03862417 174 175 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03862417 177 179 B-Eq-Value
° NCT03862417 180 181 B-Eq-Unit
. NCT03862417 182 183 O

Exclusion NCT03862417 185 194 O
Criteria NCT03862417 195 203 O
: NCT03862417 204 205 O

- NCT03862417 209 210 O
Curves NCT03862417 212 218 B-Observation-Name
over NCT03862417 219 223 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03862417 225 227 B-Eq-Value
° NCT03862417 228 229 B-Eq-Unit
are NCT03862417 230 233 O
surgical NCT03862417 234 242 B-Procedure-Name
candidates NCT03862417 243 253 O
, NCT03862417 254 255 O
and NCT03862417 256 259 O
will NCT03862417 260 264 O
be NCT03862417 265 267 O
excluded NCT03862417 268 276 O
. NCT03862417 277 278 O
Patients NCT03862417 280 288 O
who NCT03862417 289 292 O
have NCT03862417 293 297 O
had NCT03862417 298 301 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cortisone NCT03862417 302 311 B-Drug-Name
or NCT03862417 312 314 O
anesthetic NCT03862417 315 325 B-Drug-Name
injections NCT03862417 326 336 B-Procedure-Name
within NCT03862417 337 343 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03862417 344 347 O
last NCT03862417 348 352 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03862417 354 355 B-Eq-Value
months NCT03862417 356 362 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03862417 363 364 O
surgery NCT03862417 365 372 B-Procedure-Name
or NCT03862417 373 375 O
presenting NCT03862417 376 386 O
contra NCT03862417 387 393 O
- NCT03862417 394 395 O
indications NCT03862417 396 407 O
to NCT03862417 408 410 O
exercises NCT03862417 411 420 B-Observation-Name___Observation-Type-Value:social-habit
( NCT03862417 421 422 O
fractures NCT03862417 423 432 B-Condition-Name
, NCT03862417 433 434 O
cancer NCT03862417 435 441 B-Condition-Name
, NCT03862417 442 443 O
severe NCT03862417 444 450 B-Severity___Severity-Value:severe
cardio NCT03862417 451 457 B-Condition-Name
- NCT03862417 458 459 I-Condition-Name
vascular NCT03862417 460 468 I-Condition-Name
co NCT03862417 469 471 I-Condition-Name
- NCT03862417 472 473 I-Condition-Name
morbidities NCT03862417 474 485 I-Condition-Name
, NCT03862417 486 487 O
or NCT03862417 488 490 O
osteopenia NCT03862417 491 501 B-Condition-Name
) NCT03862417 502 503 O
will NCT03862417 504 508 O
be NCT03862417 509 511 O
excluded NCT03862417 512 520 O
. NCT03862417 521 522 O

Inclusion NCT03868930 0 9 O
Criteria NCT03868930 10 18 O
: NCT03868930 19 20 O

- NCT03868930 24 25 O
Post NCT03868930 27 31 O
- NCT03868930 32 33 O
9 NCT03868930 35 36 O
/ NCT03868930 37 38 O
11 NCT03868930 40 42 O
Veterans NCT03868930 43 51 B-Observation-Name
who NCT03868930 52 55 O
report NCT03868930 56 62 O
some NCT03868930 63 67 O
reintegration NCT03868930 68 81 O
, NCT03868930 82 83 O
readjustment NCT03868930 84 96 O
, NCT03868930 97 98 O
or NCT03868930 99 101 O
anger NCT03868930 102 107 O
difficulty NCT03868930 108 118 B-Condition-Name

- NCT03868930 126 127 O
i NCT03868930 129 130 O
. NCT03868930 131 132 O
e NCT03868930 133 134 O
. NCT03868930 135 136 O
, NCT03868930 137 138 O
Veterans NCT03868930 139 147 B-Observation-Name
who NCT03868930 148 151 O
report NCT03868930 152 158 O
" NCT03868930 159 160 O
some NCT03868930 160 164 O
difficulty NCT03868930 165 175 O
" NCT03868930 175 176 O
( NCT03868930 177 178 O
Likert NCT03868930 179 185 O
rating NCT03868930 186 192 O
) NCT03868930 193 194 O
on NCT03868930 195 197 O
at NCT03868930 198 200 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868930 201 206 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03868930 207 210 B-Eq-Value
of NCT03868930 211 213 O
the NCT03868930 214 217 O
primary NCT03868930 218 225 B-Observation-Name
measures NCT03868930 226 234 I-Observation-Name
: NCT03868930 235 236 O
M NCT03868930 237 238 B-Observation-Name
2CQ NCT03868930 239 242 I-Observation-Name
; NCT03868930 242 243 O
PDRI NCT03868930 244 248 B-Observation-Name
; NCT03868930 248 249 O
STAXI NCT03868930 250 255 B-Observation-Name
- NCT03868930 256 257 I-Observation-Name
2 NCT03868930 259 260 I-Observation-Name

- NCT03868930 264 265 O
18 NCT03868930 268 270 B-Eq-Value
- NCT03868930 271 272 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03868930 274 276 B-Eq-Value
years NCT03868930 277 282 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03868930 283 286 O
( NCT03868930 287 288 O
to NCT03868930 289 291 O
avoid NCT03868930 292 297 O
outcomes NCT03868930 298 306 O
being NCT03868930 307 312 O
affected NCT03868930 313 321 O
by NCT03868930 322 324 O
aging NCT03868930 325 330 O
) NCT03868930 331 332 O

- NCT03868930 336 337 O
English NCT03868930 339 346 B-Language
- NCT03868930 347 348 O
speaking NCT03868930 349 357 O
( NCT03868930 358 359 O
sessions NCT03868930 360 368 O
will NCT03868930 369 373 O
be NCT03868930 374 376 O
conducted NCT03868930 377 386 O
in NCT03868930 387 389 O
English NCT03868930 390 397 B-Language
) NCT03868930 398 399 O

- NCT03868930 403 404 O
Agreeing NCT03868930 406 414 O
to NCT03868930 415 417 O
participate NCT03868930 418 429 O

- NCT03868930 437 438 O
i NCT03868930 440 441 O
. NCT03868930 442 443 O
e NCT03868930 444 445 O
. NCT03868930 446 447 O
, NCT03868930 448 449 O
completion NCT03868930 450 460 O
of NCT03868930 461 463 O
ICF NCT03868930 464 467 B-Observation-Name
/ NCT03868930 468 469 O
HIPAA NCT03868930 470 475 B-Observation-Name

Exclusion NCT03868930 476 485 O
Criteria NCT03868930 486 494 O
: NCT03868930 495 496 O

- NCT03868930 500 501 O
schizophreniform NCT03868930 503 519 B-Condition-Name
disorder NCT03868930 520 528 I-Condition-Name
/ NCT03868930 529 530 O
active NCT03868930 531 537 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
psychosis NCT03868930 538 547 B-Condition-Name

- NCT03868930 550 551 O
bipolar NCT03868930 553 560 B-Condition-Name
disorder NCT03868930 561 569 I-Condition-Name

- NCT03868930 572 573 O
active NCT03868930 575 581 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
suicidality NCT03868930 582 593 B-Condition-Name
/ NCT03868930 594 595 O
homicidality NCT03868930 596 608 B-Condition-Name
requiring NCT03868930 609 618 O
crisis NCT03868930 619 625 B-Procedure-Name
intervention NCT03868930 626 638 I-Procedure-Name

- NCT03868930 641 642 O
other NCT03868930 644 649 O
severe NCT03868930 650 656 B-Severity___Severity-Value:severe
psychiatric NCT03868930 657 668 B-Condition-Name
disorders NCT03868930 669 678 I-Condition-Name
prohibiting NCT03868930 679 690 O
appropriate NCT03868930 691 702 O
group NCT03868930 703 708 B-Procedure-Name
participation NCT03868930 709 722 I-Procedure-Name

- NCT03868930 725 726 O
neurological NCT03868930 728 740 B-Condition-Name
diagnosis NCT03868930 741 750 O
prohibiting NCT03868930 751 762 O
appropriate NCT03868930 763 774 O
group NCT03868930 775 780 B-Procedure-Name
participation NCT03868930 781 794 I-Procedure-Name
( NCT03868930 795 796 O
excluding NCT03868930 797 806 O
TBI NCT03868930 807 810 B-Condition-Name
) NCT03868930 811 812 O

- NCT03868930 816 817 O
current NCT03868930 819 826 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03868930 827 836 B-Condition-Name
dependence NCT03868930 837 847 I-Condition-Name

- NCT03868930 850 851 O
current NCT03868930 853 860 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
participation NCT03868930 861 874 O
in NCT03868930 875 877 O
any NCT03868930 878 881 O
other NCT03868930 882 887 O
form NCT03868930 888 892 O
of NCT03868930 893 895 O
active NCT03868930 896 902 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
behavioral NCT03868930 903 913 B-Procedure-Name
therapy NCT03868930 914 921 I-Procedure-Name
at NCT03868930 922 924 O
the NCT03868930 925 928 O
time NCT03868930 929 933 O
of NCT03868930 934 936 O
enrollment NCT03868930 937 947 O

- NCT03868930 955 956 O
e NCT03868930 958 959 O
. NCT03868930 960 961 O
g NCT03868930 962 963 O
. NCT03868930 964 965 O
, NCT03868930 966 967 O
Cognitive NCT03868930 968 977 B-Procedure-Name
Processing NCT03868930 978 988 I-Procedure-Name
Therapy NCT03868930 989 996 I-Procedure-Name
, NCT03868930 997 998 O
cognitive NCT03868930 999 1008 B-Procedure-Name
rehabilitation NCT03868930 1009 1023 I-Procedure-Name
for NCT03868930 1024 1027 O
mTBI NCT03868930 1028 1032 B-Condition-Name
, NCT03868930 1033 1034 O
or NCT03868930 1035 1037 O
other NCT03868930 1038 1043 O
psychotherapy NCT03868930 1044 1057 B-Procedure-Name

Inclusion NCT03864887 0 9 O
Criteria NCT03864887 10 18 O
: NCT03864887 19 20 O

- NCT03864887 24 25 O
Patients NCT03864887 27 35 O
who NCT03864887 36 39 O
have NCT03864887 40 44 O
had NCT03864887 45 48 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
brain NCT03864887 49 54 B-Condition-Name
death NCT03864887 55 60 I-Condition-Name
or NCT03864887 61 63 O
serious NCT03864887 64 71 B-Severity___Severity-Value:severe
brain NCT03864887 72 77 O
trauma NCT03864887 78 84 B-Condition-Name
. NCT03864887 85 86 O

- NCT03864887 90 91 O
Healthy NCT03864887 93 100 B-Condition-Name
people NCT03864887 101 107 O
who NCT03864887 108 111 O
are NCT03864887 112 115 O
interested NCT03864887 116 126 O
in NCT03864887 127 129 O
optical NCT03864887 130 137 B-Procedure-Name
assessment NCT03864887 138 148 I-Procedure-Name
of NCT03864887 149 151 O
hemodynamic NCT03864887 152 163 B-Observation-Name
parameters NCT03864887 164 174 I-Observation-Name

Exclusion NCT03864887 175 184 O
Criteria NCT03864887 185 193 O
: NCT03864887 194 195 O

- NCT03864887 199 200 O
Patients NCT03864887 202 210 O
who NCT03864887 211 214 O
are NCT03864887 215 218 O
in NCT03864887 219 221 O
pregnancy NCT03864887 222 231 B-Condition-Name
or NCT03864887 232 234 O
have NCT03864887 235 239 O
plan NCT03864887 240 244 O
to NCT03864887 245 247 O
conception NCT03864887 248 258 B-Condition-Name
. NCT03864887 259 260 O

- NCT03864887 264 265 O
Patients NCT03864887 267 275 O
who NCT03864887 276 279 O
have NCT03864887 280 284 O
vertebra NCT03864887 285 293 B-Procedure-Name
surgery NCT03864887 294 301 I-Procedure-Name
or NCT03864887 302 304 O
have NCT03864887 305 309 O
plan NCT03864887 310 314 O
of NCT03864887 315 317 O
surgery NCT03864887 318 325 B-Procedure-Name
. NCT03864887 326 327 O

- NCT03864887 331 332 O
Patients NCT03864887 334 342 O
who NCT03864887 343 346 O
are NCT03864887 347 350 O
inappropriate NCT03864887 351 364 O
to NCT03864887 365 367 O
join NCT03864887 368 372 O
this NCT03864887 373 377 O
trial NCT03864887 378 383 O
judged NCT03864887 384 390 O
by NCT03864887 391 393 O
the NCT03864887 394 397 O
radiologists NCT03864887 398 410 O
or NCT03864887 411 413 O
specialists NCT03864887 414 425 O
. NCT03864887 426 427 O

- NCT03864887 436 437 O
AIDS NCT03864887 439 443 B-Condition-Name
, NCT03864887 444 445 O
Active NCT03864887 446 452 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Hepatitis NCT03864887 453 462 B-Condition-Name
, NCT03864887 463 464 O
Tuberculosis NCT03864887 465 477 B-Condition-Name
, NCT03864887 478 479 O
Syphilis NCT03864887 480 488 B-Condition-Name

- NCT03864887 496 497 O
Patients NCT03864887 499 507 O
who NCT03864887 508 511 O
regularly NCT03864887 512 521 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
take NCT03864887 522 526 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
anticoagulants NCT03864887 527 541 B-Drug-Name
, NCT03864887 542 543 O
antiplatelet NCT03864887 544 556 B-Drug-Name
drugs NCT03864887 557 562 I-Drug-Name

Inclusion NCT03860363 0 9 O
Criteria NCT03860363 10 18 O
: NCT03860363 19 20 O

- NCT03860363 24 25 O
Adult NCT03860363 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03860363 33 34 O
age NCT03860363 35 38 O
≥ NCT03860363 39 40 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03860363 42 44 B-Eq-Value
) NCT03860363 45 46 O

- NCT03860363 50 51 O
Patient NCT03860363 53 60 O
undergoing NCT03860363 61 71 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
non NCT03860363 72 75 O
- NCT03860363 76 77 O
emergent NCT03860363 78 86 O
cardiac NCT03860363 87 94 B-Procedure-Name
surgery NCT03860363 95 102 I-Procedure-Name

- NCT03860363 105 106 O
Anticipated NCT03860363 108 119 O
requirement NCT03860363 120 131 O
for NCT03860363 132 135 O
mediastinal NCT03860363 136 147 B-Procedure-Name
chest NCT03860363 148 153 I-Procedure-Name
tube NCT03860363 154 158 I-Procedure-Name
drainage NCT03860363 159 167 I-Procedure-Name

Exclusion NCT03860363 168 177 O
Criteria NCT03860363 178 186 O
: NCT03860363 187 188 O

- NCT03860363 192 193 O
Emergency NCT03860363 195 204 O
surgery NCT03860363 205 212 B-Procedure-Name

- NCT03860363 215 216 O
Re NCT03860363 218 220 O
- NCT03860363 221 222 O
do NCT03860363 223 225 O
surgery NCT03860363 226 233 B-Procedure-Name

- NCT03860363 236 237 O
Prior NCT03860363 239 244 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cardiac NCT03860363 245 252 B-Procedure-Name
surgery NCT03860363 253 260 I-Procedure-Name

- NCT03860363 263 264 O
Congenital NCT03860363 266 276 O
cardiac NCT03860363 277 284 B-Condition-Name
disease NCT03860363 285 292 I-Condition-Name
or NCT03860363 293 295 O
deformation NCT03860363 296 307 B-Condition-Name

- NCT03860363 310 311 O
Transplant NCT03860363 313 323 B-Procedure-Name
surgery NCT03860363 324 331 I-Procedure-Name

- NCT03860363 334 335 O
Ventricular NCT03860363 337 348 B-Procedure-Name
Assist NCT03860363 349 355 I-Procedure-Name
Device NCT03860363 356 362 I-Procedure-Name
Surgery NCT03860363 363 370 I-Procedure-Name

- NCT03860363 373 374 O
Suspected NCT03860363 376 385 O
pulmonary NCT03860363 386 395 B-Condition-Name
air NCT03860363 396 399 I-Condition-Name
leak NCT03860363 400 404 I-Condition-Name

- NCT03860363 407 408 O
Atrial NCT03860363 410 416 B-Condition-Name
fibrillation NCT03860363 417 429 I-Condition-Name

- NCT03860363 432 433 O
In NCT03860363 435 437 O
the NCT03860363 438 441 O
opinion NCT03860363 442 449 O
of NCT03860363 450 452 O
the NCT03860363 453 456 O
investigator NCT03860363 457 469 O
the NCT03860363 470 473 O
patient NCT03860363 474 481 O
is NCT03860363 482 484 O
unsuitable NCT03860363 485 495 O
for NCT03860363 496 499 O
the NCT03860363 500 503 O
study NCT03860363 504 509 O
for NCT03860363 510 513 O
any NCT03860363 514 517 O
other NCT03860363 518 523 O
legitimate NCT03860363 524 534 O
reason NCT03860363 535 541 O
including NCT03860363 542 551 O
incarceration NCT03860363 552 565 O
, NCT03860363 566 567 O
pre NCT03860363 568 571 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03860363 572 573 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03860363 574 582 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
medical NCT03860363 583 590 O
or NCT03860363 591 593 O
psychiatric NCT03860363 594 605 O
condition NCT03860363 606 615 O
, NCT03860363 616 617 O
or NCT03860363 618 620 O
interfering NCT03860363 621 632 B-Stability___Stability-Value:change
medications NCT03860363 633 644 O

- NCT03860363 647 648 O
Known NCT03860363 650 655 O
previous NCT03860363 656 664 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03860363 665 667 O
concurrent NCT03860363 668 678 O
enrollment NCT03860363 679 689 O
in NCT03860363 690 692 O
a NCT03860363 693 694 O
clinical NCT03860363 695 703 O
trial NCT03860363 704 709 O
that NCT03860363 710 714 O
, NCT03860363 715 716 O
in NCT03860363 717 719 O
the NCT03860363 720 723 O
opinion NCT03860363 724 731 O
of NCT03860363 732 734 O
the NCT03860363 735 738 O
investigator NCT03860363 739 751 O
, NCT03860363 752 753 O
might NCT03860363 754 759 O
interfere NCT03860363 760 769 B-Stability___Stability-Value:change
with NCT03860363 770 774 O
the NCT03860363 775 778 O
objectives NCT03860363 779 789 O
of NCT03860363 790 792 O
this NCT03860363 793 797 O
clinical NCT03860363 798 806 O
trial NCT03860363 807 812 O

- NCT03860363 815 816 O
Pregnancy NCT03860363 818 827 B-Condition-Name

Inclusion NCT03862560 0 9 O
Criteria NCT03862560 10 18 O
: NCT03862560 19 20 O

- NCT03862560 24 25 O
Caucasian NCT03862560 27 36 B-Ethnicity
, NCT03862560 37 38 O
Healthy NCT03862560 39 46 B-Condition-Name
participant NCT03862560 47 58 O
, NCT03862560 59 60 O
from NCT03862560 61 65 O
12 NCT03862560 67 69 B-Eq-Value
to NCT03862560 70 72 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03862560 74 76 B-Eq-Value
years NCT03862560 77 82 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862560 83 86 O
, NCT03862560 87 88 O
with NCT03862560 89 93 O
a NCT03862560 94 95 O
history NCT03862560 96 103 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862560 104 106 O
training NCT03862560 107 115 B-Observation-Name___Observation-Type-Value:social-habit
at NCT03862560 116 118 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862560 119 124 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03862560 126 127 B-Eq-Value
years NCT03862560 128 133 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03862560 134 135 O

Exclusion NCT03862560 137 146 O
Criteria NCT03862560 147 155 O
: NCT03862560 156 157 O

- NCT03862560 161 162 O
Non NCT03862560 164 167 O
- NCT03862560 168 169 O
caucasian NCT03862560 170 179 B-Ethnicity
, NCT03862560 180 181 O
injury NCT03862560 182 188 B-Condition-Name
. NCT03862560 189 190 O

Inclusion NCT03868267 0 9 O
Criteria NCT03868267 10 18 O
: NCT03868267 19 20 O

- NCT03868267 24 25 O
adult NCT03868267 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03868267 33 41 O
( NCT03868267 42 43 O
≥ NCT03868267 45 46 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868267 48 50 B-Eq-Value
years NCT03868267 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03868267 57 59 O
age NCT03868267 60 63 O
) NCT03868267 64 65 O
who NCT03868267 66 69 O
are NCT03868267 70 73 O
undergoing NCT03868267 74 84 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
esophago NCT03868267 85 93 B-Procedure-Name
- NCT03868267 94 95 I-Procedure-Name
gastro NCT03868267 96 102 I-Procedure-Name
duodenoscopy NCT03868267 103 115 I-Procedure-Name
( NCT03868267 116 117 O
EGD NCT03868267 118 121 B-Procedure-Name
) NCT03868267 122 123 O
for NCT03868267 124 127 O
any NCT03868267 128 131 O
reason NCT03868267 132 138 O
and NCT03868267 139 142 O
are NCT03868267 143 146 O
consenting NCT03868267 147 157 O
to NCT03868267 158 160 O
be NCT03868267 161 163 O
enrolled NCT03868267 164 172 O
in NCT03868267 173 175 O
the NCT03868267 176 179 O
study NCT03868267 180 185 O
during NCT03868267 186 192 O
the NCT03868267 193 196 O
study NCT03868267 197 202 O
period NCT03868267 203 209 O
. NCT03868267 210 211 O

Exclusion NCT03868267 213 222 O
Criteria NCT03868267 223 231 O
: NCT03868267 232 233 O

- NCT03868267 237 238 O
the NCT03868267 240 243 O
patients NCT03868267 244 252 O
who NCT03868267 253 256 O
can NCT03868267 257 260 O
not NCT03868267 260 263 O
speak NCT03868267 264 269 O
English NCT03868267 270 277 B-Language
in NCT03868267 278 280 O
Canada NCT03868267 281 287 B-Location___Location-Value:residence
, NCT03868267 288 289 O
who NCT03868267 290 293 O
can NCT03868267 294 297 O
not NCT03868267 297 300 O
speak NCT03868267 301 306 O
Japanese NCT03868267 307 315 B-Language
in NCT03868267 316 318 O
Japan NCT03868267 319 324 B-Location___Location-Value:residence
, NCT03868267 325 326 O
and NCT03868267 327 330 O
can NCT03868267 331 334 O
not NCT03868267 334 337 O
speak NCT03868267 338 343 O
Persian NCT03868267 344 351 B-Language
in NCT03868267 352 354 O
Iran NCT03868267 355 359 B-Location___Location-Value:residence
. NCT03868267 360 361 O

Inclusion NCT03866538 0 9 O
Criteria NCT03866538 10 18 O

- NCT03866538 21 22 O
Patients NCT03866538 24 32 O
will NCT03866538 33 37 O
be NCT03866538 38 40 O
recruited NCT03866538 41 50 O
from NCT03866538 51 55 O
the NCT03866538 56 59 O
Division NCT03866538 60 68 B-Location___Location-Value:clinic
of NCT03866538 69 71 I-Location___Location-Value:clinic
Gastroenterology NCT03866538 72 88 I-Location___Location-Value:clinic
and NCT03866538 89 92 I-Location___Location-Value:clinic
Hepatology NCT03866538 93 103 I-Location___Location-Value:clinic
and NCT03866538 104 107 O
the NCT03866538 108 111 O
Mayo NCT03866538 112 116 B-Location___Location-Value:hospital
Clinic NCT03866538 117 123 I-Location___Location-Value:hospital
in NCT03866538 124 126 I-Location___Location-Value:hospital
Rochester NCT03866538 127 136 I-Location___Location-Value:hospital
, NCT03866538 137 138 I-Location___Location-Value:hospital
MN NCT03866538 139 141 I-Location___Location-Value:hospital
. NCT03866538 142 143 O

- NCT03866538 147 148 O
Adult NCT03866538 150 155 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03866538 156 164 O
with NCT03866538 165 169 O
immune NCT03866538 170 176 B-Condition-Name
mediated NCT03866538 177 185 I-Condition-Name
enteropathies NCT03866538 186 199 I-Condition-Name
who NCT03866538 200 203 O
have NCT03866538 204 208 O
had NCT03866538 209 212 O
improvement NCT03866538 213 224 O
in NCT03866538 225 227 O
symptoms NCT03866538 228 236 O
and NCT03866538 237 240 O
histology NCT03866538 241 250 B-Procedure-Name
on NCT03866538 251 253 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
oral NCT03866538 254 258 B-Procedure-Name
budesonide NCT03866538 259 269 I-Procedure-Name
therapy NCT03866538 270 277 I-Procedure-Name
. NCT03866538 278 279 O

Exclusion NCT03866538 281 290 O
Criteria NCT03866538 291 299 O

- NCT03866538 302 303 O
Age NCT03866538 305 308 O
< NCT03866538 309 310 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03866538 312 314 B-Eq-Value
years NCT03866538 315 320 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866538 323 324 O
Positive NCT03866538 326 334 B-Polarity___Polarity-Value:positive
stool NCT03866538 335 340 B-Observation-Name___Observation-Type-Value:lab
gluten NCT03866538 341 347 I-Observation-Name___Observation-Type-Value:lab
testing NCT03866538 348 355 I-Observation-Name___Observation-Type-Value:lab
in NCT03866538 356 358 O
patients NCT03866538 359 367 O
with NCT03866538 368 372 O
refractory NCT03866538 373 383 B-Condition-Name
celiac NCT03866538 384 390 I-Condition-Name
disease NCT03866538 391 398 I-Condition-Name

- NCT03866538 401 402 O
Small NCT03866538 404 409 B-Condition-Name
bowel NCT03866538 410 415 I-Condition-Name
malignancy NCT03866538 416 426 I-Condition-Name
or NCT03866538 427 429 O
history NCT03866538 430 437 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866538 438 440 O
small NCT03866538 441 446 B-Condition-Name
bowel NCT03866538 447 452 I-Condition-Name
malignancy NCT03866538 453 463 I-Condition-Name

- NCT03866538 466 467 O
Refractory NCT03866538 469 479 B-Condition-Name
celiac NCT03866538 480 486 I-Condition-Name
disease NCT03866538 487 494 I-Condition-Name
type NCT03866538 495 499 O
2 NCT03866538 501 502 O

- NCT03866538 506 507 O
Post NCT03866538 509 513 O
- NCT03866538 514 515 O
transplant NCT03866538 516 526 B-Procedure-Name
lymphoproliferative NCT03866538 527 546 B-Condition-Name
disorder NCT03866538 547 555 I-Condition-Name
associated NCT03866538 556 566 O
enteropathy NCT03866538 567 578 B-Condition-Name

- NCT03866538 581 582 O
No NCT03866538 584 586 O
prior NCT03866538 587 592 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
improvement NCT03866538 593 604 O
in NCT03866538 605 607 O
symptoms NCT03866538 608 616 O
and NCT03866538 617 620 O
histology NCT03866538 621 630 B-Procedure-Name
with NCT03866538 631 635 O
budesonide NCT03866538 636 646 B-Procedure-Name
therapy NCT03866538 647 654 I-Procedure-Name

- NCT03866538 657 658 O
Discontinuation NCT03866538 660 675 O
of NCT03866538 676 678 O
budesonide NCT03866538 679 689 B-Procedure-Name
therapy NCT03866538 690 697 I-Procedure-Name
prior NCT03866538 698 703 O
to NCT03866538 704 706 O
the NCT03866538 707 710 O
trial NCT03866538 711 716 O

- NCT03866538 719 720 O
Other NCT03866538 722 727 O
concurrent NCT03866538 728 738 O
systemic NCT03866538 739 747 O
corticosteroids NCT03866538 748 763 B-Drug-Name

- NCT03866538 766 767 O
Other NCT03866538 769 774 O
immune NCT03866538 775 781 B-Drug-Name
mediating NCT03866538 782 791 I-Drug-Name
medications NCT03866538 792 803 I-Drug-Name
, NCT03866538 804 805 O
for NCT03866538 806 809 O
example NCT03866538 810 817 O
but NCT03866538 818 821 O
not NCT03866538 822 825 O
limited NCT03866538 826 833 O
to NCT03866538 834 836 O
azathioprine NCT03866538 837 849 B-Drug-Name
, NCT03866538 850 851 O
6 NCT03866538 853 854 B-Drug-Name
- NCT03866538 855 856 I-Drug-Name
mercaptopurine NCT03866538 857 871 I-Drug-Name
, NCT03866538 872 873 O
cyclosporine NCT03866538 874 886 B-Drug-Name
, NCT03866538 887 888 O
methotrexate NCT03866538 889 901 B-Drug-Name
, NCT03866538 902 903 O
anti NCT03866538 904 908 B-Drug-Name
- NCT03866538 909 910 I-Drug-Name
TNF NCT03866538 911 914 I-Drug-Name
monoclonal NCT03866538 915 925 I-Drug-Name
antibodies NCT03866538 926 936 I-Drug-Name
, NCT03866538 937 938 O
alpha NCT03866538 939 944 B-Drug-Name
- NCT03866538 945 946 I-Drug-Name
4 NCT03866538 948 949 I-Drug-Name
beta NCT03866538 950 954 I-Drug-Name
- NCT03866538 955 956 I-Drug-Name
7 NCT03866538 958 959 I-Drug-Name
integrin NCT03866538 960 968 I-Drug-Name
inhibiting NCT03866538 969 979 I-Drug-Name
monoclonal NCT03866538 980 990 I-Drug-Name
antibody NCT03866538 991 999 I-Drug-Name
, NCT03866538 1000 1001 O
interleukin NCT03866538 1002 1013 B-Drug-Name
12 NCT03866538 1015 1017 I-Drug-Name
/ NCT03866538 1018 1019 I-Drug-Name
23 NCT03866538 1021 1023 I-Drug-Name
inhibiting NCT03866538 1024 1034 I-Drug-Name
monoclonal NCT03866538 1035 1045 I-Drug-Name
antibody NCT03866538 1046 1054 I-Drug-Name
, NCT03866538 1055 1056 O
JAK NCT03866538 1057 1060 B-Drug-Name
inhibitors NCT03866538 1061 1071 I-Drug-Name
. NCT03866538 1072 1073 O


Inclusion NCT03869151 0 9 O
Criteria NCT03869151 10 18 O
: NCT03869151 19 20 O

Patients NCT03869151 22 30 O
with NCT03869151 31 35 O
child NCT03869151 36 41 O
A NCT03869151 42 43 O
Hepatocellular NCT03869151 44 58 O
carcinoma NCT03869151 59 68 B-Condition-Name
. NCT03869151 69 70 O

Exclusion NCT03869151 72 81 O
Criteria NCT03869151 82 90 O
: NCT03869151 91 92 O

- NCT03869151 96 97 O
Patients NCT03869151 99 107 O
with NCT03869151 108 112 O
child NCT03869151 113 118 O
C NCT03869151 119 120 O
Hepatocellular NCT03869151 121 135 O
carcinoma NCT03869151 136 145 B-Condition-Name
. NCT03869151 146 147 O

- NCT03869151 151 152 O
Patients NCT03869151 154 162 O
with NCT03869151 163 167 O
heart NCT03869151 168 173 B-Condition-Name
failure NCT03869151 174 181 I-Condition-Name

Inclusion NCT03869970 0 9 O
Criteria NCT03869970 10 18 O
: NCT03869970 19 20 O

- NCT03869970 24 25 O
Diagnosis NCT03869970 27 36 O
of NCT03869970 37 39 O
mTBI NCT03869970 40 44 B-Condition-Name
in NCT03869970 45 47 O
the NCT03869970 48 51 O
past NCT03869970 52 56 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
48 NCT03869970 58 60 B-Eq-Value
hours NCT03869970 61 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

Exclusion NCT03869970 67 76 O
Criteria NCT03869970 77 85 O
: NCT03869970 86 87 O

- NCT03869970 91 92 O
Patients NCT03869970 94 102 O
having NCT03869970 103 109 O
conditions NCT03869970 110 120 O
otherwise NCT03869970 121 130 O
which NCT03869970 131 136 O
limit NCT03869970 137 142 B-Stability___Stability-Value:change
physical NCT03869970 143 151 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03869970 152 160 I-Observation-Name___Observation-Type-Value:social-habit
or NCT03869970 161 163 O
neurocognitive NCT03869970 164 178 O
assessment NCT03869970 179 189 B-Procedure-Name

- NCT03869970 192 193 O
Do NCT03869970 195 197 O
not NCT03869970 198 201 O
have NCT03869970 202 206 O
a NCT03869970 207 208 O
smart NCT03869970 209 214 O
phone NCT03869970 215 220 O

- NCT03869970 223 224 O
History NCT03869970 226 233 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869970 234 236 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
past NCT03869970 237 241 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
moderate NCT03869970 242 250 B-Severity___Severity-Value:moderate
/ NCT03869970 251 252 O
severe NCT03869970 253 259 B-Severity___Severity-Value:severe
TBI NCT03869970 260 263 B-Condition-Name
, NCT03869970 264 265 O

- NCT03869970 269 270 O
Substance NCT03869970 272 281 B-Condition-Name
abuse NCT03869970 282 287 I-Condition-Name
, NCT03869970 288 289 O

- NCT03869970 293 294 O
Major NCT03869970 296 301 B-Severity___Severity-Value:severe
psychiatric NCT03869970 302 313 B-Condition-Name
condition NCT03869970 314 323 I-Condition-Name
, NCT03869970 324 325 O

- NCT03869970 329 330 O
Vestibular NCT03869970 332 342 B-Condition-Name
disorder NCT03869970 343 351 I-Condition-Name
, NCT03869970 352 353 O

- NCT03869970 357 358 O
Cardiac NCT03869970 360 367 B-Condition-Name
condition NCT03869970 368 377 I-Condition-Name
, NCT03869970 378 379 O

- NCT03869970 383 384 O
Unable NCT03869970 386 392 O
to NCT03869970 393 395 O
provide NCT03869970 396 403 O
consent NCT03869970 404 411 O
/ NCT03869970 412 413 O
assent NCT03869970 414 420 O

Inclusion NCT03865186 0 9 O
Criteria NCT03865186 10 18 O
: NCT03865186 19 20 O

- NCT03865186 24 25 O
Clinical NCT03865186 27 35 O
diagnosis NCT03865186 36 45 O
of NCT03865186 46 48 O
schizophrenia NCT03865186 49 62 B-Condition-Name
according NCT03865186 63 72 O
to NCT03865186 73 75 O
DSM NCT03865186 76 79 O
- NCT03865186 80 81 O
IV NCT03865186 82 84 O

- NCT03865186 87 88 O
over NCT03865186 90 94 B-Eq-Operator___Eq-Operator-Value:GT
the NCT03865186 95 98 O
age NCT03865186 99 102 O
of NCT03865186 103 105 O
18 NCT03865186 107 109 B-Eq-Value

Exclusion NCT03865186 111 120 O
Criteria NCT03865186 121 129 O
: NCT03865186 130 131 O

- NCT03865186 135 136 O
having NCT03865186 138 144 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cominication NCT03865186 145 157 B-Condition-Name
problems NCT03865186 158 166 I-Condition-Name

- NCT03865186 169 170 O
having NCT03865186 172 178 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
another NCT03865186 179 186 O
psychiatric NCT03865186 187 198 B-Condition-Name
disease NCT03865186 199 206 I-Condition-Name

Inclusion NCT03865810 0 9 O
Criteria NCT03865810 10 18 O
: NCT03865810 19 20 O

- NCT03865810 24 25 O
All NCT03865810 27 30 O
patients NCT03865810 31 39 O
over NCT03865810 40 44 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03865810 46 48 B-Eq-Value
years NCT03865810 49 54 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865810 55 57 O
age NCT03865810 58 61 O
undergoing NCT03865810 62 72 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
gastric NCT03865810 73 80 B-Procedure-Name
resection NCT03865810 81 90 I-Procedure-Name
surgery NCT03865810 91 98 I-Procedure-Name
due NCT03865810 99 102 O
to NCT03865810 103 105 O
cancer NCT03865810 106 112 B-Condition-Name
within NCT03865810 113 119 O
or NCT03865810 120 122 O
not NCT03865810 123 126 O
of NCT03865810 127 129 O
an NCT03865810 130 132 O
intensified NCT03865810 133 144 O
recovery NCT03865810 145 153 B-Procedure-Name
program NCT03865810 154 161 I-Procedure-Name
( NCT03865810 162 163 O
ERAS NCT03865810 164 168 B-Procedure-Name
) NCT03865810 169 170 O
with NCT03865810 171 175 O
any NCT03865810 176 179 O
level NCT03865810 180 185 O
of NCT03865810 186 188 O
compliance NCT03865810 189 199 O
with NCT03865810 200 204 O
the NCT03865810 205 208 O
protocol NCT03865810 209 217 O
( NCT03865810 218 219 O
from NCT03865810 220 224 O
0 NCT03865810 226 227 B-Eq-Value
- NCT03865810 228 229 B-Eq-Operator___Eq-Operator-Value:BETWEEN
100 NCT03865810 231 234 B-Eq-Value
% NCT03865810 235 236 B-Eq-Unit
) NCT03865810 238 239 O
. NCT03865810 241 242 O

Exclusion NCT03865810 244 253 O
Criteria NCT03865810 254 262 O
: NCT03865810 263 264 O

- NCT03865810 268 269 O
Patients NCT03865810 271 279 O
undergoing NCT03865810 280 290 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
emergency NCT03865810 291 300 O
surgery NCT03865810 301 308 B-Procedure-Name

- NCT03865810 316 317 O
Endoscopic NCT03865810 319 329 B-Procedure-Name
procedures NCT03865810 330 340 I-Procedure-Name

- NCT03865810 348 349 O
Non NCT03865810 351 354 O
- NCT03865810 355 356 O
oncological NCT03865810 357 368 B-Procedure-Name
gastric NCT03865810 369 376 I-Procedure-Name
surgery NCT03865810 377 384 I-Procedure-Name

- NCT03865810 392 393 O
Patients NCT03865810 395 403 O
who NCT03865810 404 407 O
refuse NCT03865810 408 414 O
to NCT03865810 415 417 O
participate NCT03865810 418 429 O

Inclusion NCT03868449 0 9 O
Criteria NCT03868449 10 18 O
: NCT03868449 19 20 O

- NCT03868449 24 25 O
patients NCT03868449 27 35 O
with NCT03868449 36 40 O
common NCT03868449 41 47 O
hand NCT03868449 48 52 O
conditions NCT03868449 53 63 B-Condition-Name

Exclusion NCT03868449 64 73 O
Criteria NCT03868449 74 82 O
: NCT03868449 83 84 O

- NCT03868449 87 88 O

Inclusion NCT03868878 0 9 O
Criteria NCT03868878 10 18 O
: NCT03868878 19 20 O

- NCT03868878 24 25 O
age NCT03868878 27 30 O
greater NCT03868878 31 38 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868878 39 43 I-Eq-Operator___Eq-Operator-Value:GT
60 NCT03868878 45 47 B-Eq-Value
years NCT03868878 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03868878 53 54 O

- NCT03868878 57 58 O
is NCT03868878 60 62 O
not NCT03868878 63 66 O
engaged NCT03868878 67 74 O
in NCT03868878 75 77 O
physical NCT03868878 78 86 B-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03868878 87 95 I-Observation-Name___Observation-Type-Value:social-habit
programs NCT03868878 96 104 O
for NCT03868878 105 108 O
at NCT03868878 109 111 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868878 112 117 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03868878 118 121 B-Eq-Value
year NCT03868878 122 126 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03868878 126 127 O

- NCT03868878 130 131 O
do NCT03868878 133 135 O
not NCT03868878 136 139 O
present NCT03868878 140 147 O
severe NCT03868878 148 154 B-Severity___Severity-Value:severe
cardiovascular NCT03868878 155 169 B-Condition-Name
disease NCT03868878 170 177 I-Condition-Name
, NCT03868878 178 179 O
kidney NCT03868878 180 186 B-Condition-Name
disease NCT03868878 187 194 I-Condition-Name
, NCT03868878 195 196 O
liver NCT03868878 197 202 B-Condition-Name
disease NCT03868878 203 210 I-Condition-Name
or NCT03868878 211 213 O
limiting NCT03868878 214 222 O
cognitive NCT03868878 223 232 O
or NCT03868878 233 235 O
neuromuscular NCT03868878 236 249 O
disease NCT03868878 250 257 B-Condition-Name
and NCT03868878 258 261 O
; NCT03868878 261 262 O

- NCT03868878 265 266 O
does NCT03868878 268 272 O
not NCT03868878 273 276 O
present NCT03868878 277 284 O
visual NCT03868878 285 291 O
or NCT03868878 292 294 O
auditory NCT03868878 295 303 O
inability NCT03868878 304 313 B-Condition-Name
. NCT03868878 314 315 O

Exclusion NCT03868878 317 326 O
Criteria NCT03868878 327 335 O
: NCT03868878 336 337 O

- NCT03868878 341 342 O
failing NCT03868878 344 351 O
to NCT03868878 352 354 O
perform NCT03868878 355 362 O
any NCT03868878 363 366 O
of NCT03868878 367 369 O
the NCT03868878 370 373 O
evaluations NCT03868878 374 385 O
suggested NCT03868878 386 395 O
during NCT03868878 396 402 O
the NCT03868878 403 406 O
intervention NCT03868878 407 419 O
protocol NCT03868878 420 428 O
and NCT03868878 429 432 O
; NCT03868878 432 433 O

- NCT03868878 436 437 O
absence NCT03868878 439 446 O
in NCT03868878 447 449 O
five NCT03868878 450 454 B-Eq-Value
or NCT03868878 455 457 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03868878 458 462 I-Eq-Operator___Eq-Operator-Value:GTEQ
Capoeira NCT03868878 463 471 B-Procedure-Name
training NCT03868878 472 480 I-Procedure-Name
sessions NCT03868878 481 489 I-Procedure-Name
. NCT03868878 490 491 O

Inclusion NCT03868111 0 9 O
Criteria NCT03868111 10 18 O
: NCT03868111 19 20 O

- NCT03868111 24 25 O
Patients NCT03868111 27 35 O
aged NCT03868111 36 40 O
between NCT03868111 41 48 B-Eq-Operator___Eq-Operator-Value:BETWEEN
19 NCT03868111 50 52 B-Eq-Value
and NCT03868111 53 56 O
65 NCT03868111 58 60 B-Eq-Value
years NCT03868111 61 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03868111 69 70 O
Patients NCT03868111 72 80 O
with NCT03868111 81 85 O
American NCT03868111 86 94 B-Condition-Name
Society NCT03868111 95 102 I-Condition-Name
of NCT03868111 103 105 I-Condition-Name
Anesthesiologists NCT03868111 106 123 I-Condition-Name
physical NCT03868111 124 132 O
status NCT03868111 133 139 O
I NCT03868111 140 141 B-Eq-Value
or NCT03868111 142 144 O
II NCT03868111 145 147 B-Eq-Value

- NCT03868111 150 151 O
Patients NCT03868111 153 161 O
scheduled NCT03868111 162 171 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03868111 172 175 O
elective NCT03868111 176 184 O
laparoscopic NCT03868111 185 197 B-Procedure-Name
cholecystectomy NCT03868111 198 213 I-Procedure-Name
under NCT03868111 214 219 O
balanced NCT03868111 220 228 O
general NCT03868111 229 236 B-Procedure-Name
anesthesia NCT03868111 237 247 I-Procedure-Name
for NCT03868111 248 251 O
benign NCT03868111 252 258 B-Condition-Name
cholecystic NCT03868111 259 270 I-Condition-Name
diseases NCT03868111 271 279 I-Condition-Name

- NCT03868111 282 283 O
Patients NCT03868111 285 293 O
obtaining NCT03868111 294 303 O
written NCT03868111 304 311 O
informed NCT03868111 312 320 O
consent NCT03868111 321 328 O

Exclusion NCT03868111 329 338 O
Criteria NCT03868111 339 347 O
: NCT03868111 348 349 O

- NCT03868111 353 354 O
Patients NCT03868111 356 364 O
with NCT03868111 365 369 O
asthma NCT03868111 370 376 B-Condition-Name
or NCT03868111 377 379 O
hypertension NCT03868111 380 392 B-Condition-Name

- NCT03868111 395 396 O
Patients NCT03868111 398 406 O
with NCT03868111 407 411 O
an NCT03868111 412 414 O
inability NCT03868111 415 424 O
to NCT03868111 425 427 O
express NCT03868111 428 435 O
their NCT03868111 436 441 O
pain NCT03868111 442 446 B-Condition-Name
accurately NCT03868111 447 457 O

- NCT03868111 460 461 O
Patients NCT03868111 463 471 O
with NCT03868111 472 476 O
an NCT03868111 477 479 O
inability NCT03868111 480 489 O
to NCT03868111 490 492 O
understand NCT03868111 493 503 O
the NCT03868111 504 507 O
pain NCT03868111 508 512 B-Observation-Name___Observation-Type-Value:measurement
scale NCT03868111 513 518 I-Observation-Name___Observation-Type-Value:measurement

- NCT03868111 521 522 O
Patients NCT03868111 524 532 O
with NCT03868111 533 537 O
chronic NCT03868111 538 545 O
abdominal NCT03868111 546 555 O
pain NCT03868111 556 560 B-Condition-Name
or NCT03868111 561 563 O
chronic NCT03868111 564 571 O
pain NCT03868111 572 576 B-Condition-Name
syndrome NCT03868111 577 585 I-Condition-Name

- NCT03868111 588 589 O
Patients NCT03868111 591 599 O
who NCT03868111 600 603 O
required NCT03868111 604 612 O
to NCT03868111 613 615 O
convert NCT03868111 616 623 B-Stability___Stability-Value:change
to NCT03868111 624 626 O
laparotomy NCT03868111 627 637 B-Procedure-Name
from NCT03868111 638 642 O
laparoscopic NCT03868111 643 655 B-Procedure-Name
surgery NCT03868111 656 663 I-Procedure-Name

- NCT03868111 666 667 O
Patients NCT03868111 669 677 O
who NCT03868111 678 681 O
required NCT03868111 682 690 O
to NCT03868111 691 693 O
receive NCT03868111 694 701 O
incidental NCT03868111 702 712 O
lower NCT03868111 713 718 O
abdominal NCT03868111 719 728 B-Procedure-Name
procedures NCT03868111 729 739 I-Procedure-Name
owing NCT03868111 740 745 O
to NCT03868111 746 748 O
adhesion NCT03868111 749 757 B-Condition-Name
, NCT03868111 758 759 O
injury NCT03868111 760 766 B-Condition-Name
, NCT03868111 767 768 O
or NCT03868111 769 771 O
other NCT03868111 772 777 O
incidental NCT03868111 778 788 B-Condition-Name
findings NCT03868111 789 797 I-Condition-Name
at NCT03868111 798 800 O
the NCT03868111 801 804 O
lower NCT03868111 805 810 O
abdominal NCT03868111 811 820 O
cavity NCT03868111 821 827 O

- NCT03868111 830 831 O
Patients NCT03868111 833 841 O
with NCT03868111 842 846 O
a NCT03868111 847 848 O
history NCT03868111 849 856 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868111 857 859 O
drug NCT03868111 860 864 O
or NCT03868111 865 867 O
alcohol NCT03868111 868 875 O
abuse NCT03868111 876 881 B-Condition-Name

- NCT03868111 884 885 O
Pregnant NCT03868111 887 895 B-Condition-Name
women NCT03868111 896 901 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

Patient NCT03869541 0 7 O
participants NCT03869541 8 20 O
: NCT03869541 21 22 O

Inclusion NCT03869541 24 33 O
Criteria NCT03869541 34 42 O
: NCT03869541 43 44 O

- NCT03869541 48 49 O
Patients NCT03869541 51 59 O
admitted NCT03869541 60 68 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03869541 69 71 O
the NCT03869541 72 75 O
ICU NCT03869541 76 79 B-Location___Location-Value:hospital
who NCT03869541 80 83 O
are NCT03869541 84 87 O
receiving NCT03869541 88 97 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
vasoactive NCT03869541 98 108 B-Drug-Name
drugs NCT03869541 109 114 I-Drug-Name
. NCT03869541 115 116 O

- NCT03869541 120 121 O
Age NCT03869541 123 126 O
greater NCT03869541 127 134 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03869541 135 139 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03869541 140 142 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03869541 143 148 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03869541 149 151 O
18 NCT03869541 153 155 B-Eq-Value
years NCT03869541 156 161 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869541 162 165 O
. NCT03869541 166 167 O

- NCT03869541 171 172 O
Expected NCT03869541 174 182 O
to NCT03869541 183 185 O
remain NCT03869541 186 192 B-Stability___Stability-Value:stable
admitted NCT03869541 193 201 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03869541 202 204 O
the NCT03869541 205 208 O
ICU NCT03869541 209 212 B-Location___Location-Value:unit
for NCT03869541 213 216 O
at NCT03869541 217 219 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869541 220 225 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03869541 227 229 B-Eq-Value
hours NCT03869541 230 235 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
post NCT03869541 236 240 O
- NCT03869541 241 242 O
enrolment NCT03869541 243 252 O
. NCT03869541 253 254 O

Exclusion NCT03869541 256 265 O
Criteria NCT03869541 266 274 O
: NCT03869541 275 276 O

- NCT03869541 280 281 O
Any NCT03869541 283 286 O
patient NCT03869541 287 294 O
who NCT03869541 295 298 O
is NCT03869541 299 301 O
expected NCT03869541 302 310 O
to NCT03869541 311 313 O
die NCT03869541 314 317 O
imminently NCT03869541 318 328 O
, NCT03869541 329 330 O
as NCT03869541 331 333 O
per NCT03869541 334 337 O
clinical NCT03869541 338 346 O
opinion NCT03869541 347 354 O
. NCT03869541 355 356 O

- NCT03869541 360 361 O
Any NCT03869541 363 366 O
patient NCT03869541 367 374 O
where NCT03869541 375 380 O
mobilization NCT03869541 381 393 B-Procedure-Name
is NCT03869541 394 396 O
contraindicated NCT03869541 397 412 O
by NCT03869541 413 415 O
the NCT03869541 416 419 O
nature NCT03869541 420 426 O
of NCT03869541 427 429 O
their NCT03869541 430 435 O
existing NCT03869541 436 444 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
injuries NCT03869541 445 453 B-Condition-Name
. NCT03869541 454 455 O

- NCT03869541 459 460 O
Where NCT03869541 462 467 O
it NCT03869541 468 470 O
is NCT03869541 471 473 O
clear NCT03869541 474 479 O
from NCT03869541 480 484 O
the NCT03869541 485 488 O
medical NCT03869541 489 496 O
records NCT03869541 497 504 O
that NCT03869541 505 509 O
participants NCT03869541 510 522 O
are NCT03869541 523 526 O
prisoners NCT03869541 527 536 B-Observation-Name
or NCT03869541 537 539 O
offenders NCT03869541 540 549 O
on NCT03869541 550 552 B-Observation-Name
probation NCT03869541 553 562 I-Observation-Name
. NCT03869541 563 564 O

- NCT03869541 568 569 O
Patients NCT03869541 571 579 O
with NCT03869541 580 584 O
neuromuscular NCT03869541 585 598 B-Condition-Name
disease NCT03869541 599 606 I-Condition-Name
or NCT03869541 607 609 O
acute NCT03869541 610 615 B-Severity___Severity-Value:severe
brain NCT03869541 616 621 O
injury NCT03869541 622 628 B-Condition-Name
or NCT03869541 629 631 O
spinal NCT03869541 632 638 O
cord NCT03869541 639 643 O
injury NCT03869541 644 650 B-Condition-Name
. NCT03869541 651 652 O

- NCT03869541 656 657 O
If NCT03869541 659 661 O
the NCT03869541 662 665 O
patient NCT03869541 666 673 O
and NCT03869541 674 677 O
/ NCT03869541 678 679 O
or NCT03869541 680 682 O
their NCT03869541 683 688 O
consultee NCT03869541 689 698 O
is NCT03869541 699 701 O
unable NCT03869541 702 708 O
to NCT03869541 709 711 O
speak NCT03869541 712 717 O
English NCT03869541 718 725 B-Language
. NCT03869541 726 727 O

Clinicians NCT03869541 729 739 O
participating NCT03869541 740 753 O
in NCT03869541 754 756 O
a NCT03869541 757 758 O
survey NCT03869541 759 765 O
on NCT03869541 766 768 O
hypothetical NCT03869541 769 781 O
randomization NCT03869541 782 795 O
of NCT03869541 796 798 O
patient NCT03869541 799 806 O
participants NCT03869541 807 819 O
: NCT03869541 820 821 O

Inclusion NCT03869541 823 832 O
criteria NCT03869541 833 841 O
: NCT03869541 842 843 O

- NCT03869541 847 848 O
Clinicians NCT03869541 850 860 O
who NCT03869541 861 864 O
work NCT03869541 865 869 O
in NCT03869541 870 872 O
the NCT03869541 873 876 O
intensive NCT03869541 877 886 B-Location___Location-Value:unit
care NCT03869541 887 891 I-Location___Location-Value:unit
unit NCT03869541 892 896 I-Location___Location-Value:unit
where NCT03869541 897 902 O
a NCT03869541 903 904 O
patient NCT03869541 905 912 O
participant NCT03869541 913 924 O
has NCT03869541 925 928 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
been NCT03869541 929 933 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
admitted NCT03869541 934 942 B-Encounter-Type___Encounter-Type-Value:inpatient
. NCT03869541 943 944 O

Exclusion NCT03869541 946 955 O
criteria NCT03869541 956 964 O
: NCT03869541 965 966 O

- NCT03869541 970 971 O
None NCT03869541 973 977 O
. NCT03869541 978 979 O

Clinician NCT03869541 981 990 O
participants NCT03869541 991 1003 O
in NCT03869541 1004 1006 O
the NCT03869541 1007 1010 O
survey NCT03869541 1011 1017 O
on NCT03869541 1018 1020 O
the NCT03869541 1021 1024 O
feasibility NCT03869541 1025 1036 O
of NCT03869541 1037 1039 O
the NCT03869541 1040 1043 O
ICU NCT03869541 1044 1047 B-Location___Location-Value:unit
physical NCT03869541 1048 1056 B-Procedure-Name
rehabilitation NCT03869541 1057 1071 I-Procedure-Name
adverse NCT03869541 1072 1079 O
event NCT03869541 1080 1085 O
tool NCT03869541 1086 1090 O
: NCT03869541 1091 1092 O

Inclusion NCT03869541 1094 1103 O
criteria NCT03869541 1104 1112 O
: NCT03869541 1113 1114 O

- NCT03869541 1118 1119 O
An NCT03869541 1121 1123 O
ICU NCT03869541 1124 1127 B-Location___Location-Value:unit
clinician NCT03869541 1128 1137 O
at NCT03869541 1138 1140 O
the NCT03869541 1141 1144 O
research NCT03869541 1145 1153 O
site NCT03869541 1154 1158 O
. NCT03869541 1159 1160 O

- NCT03869541 1164 1165 O
Has NCT03869541 1167 1170 O
used NCT03869541 1171 1175 O
the NCT03869541 1176 1179 O
ICU NCT03869541 1180 1183 B-Location___Location-Value:unit
physical NCT03869541 1184 1192 B-Observation-Name
rehabilitation NCT03869541 1193 1207 I-Observation-Name
adverse NCT03869541 1208 1215 I-Observation-Name
event NCT03869541 1216 1221 I-Observation-Name
tool NCT03869541 1222 1226 I-Observation-Name
as NCT03869541 1227 1229 O
part NCT03869541 1230 1234 O
of NCT03869541 1235 1237 O
this NCT03869541 1238 1242 O
research NCT03869541 1243 1251 O
study NCT03869541 1252 1257 O
. NCT03869541 1258 1259 O

Exclusion NCT03869541 1261 1270 O
criteria NCT03869541 1271 1279 O
: NCT03869541 1280 1281 O

- NCT03869541 1285 1286 O
None NCT03869541 1288 1292 O
. NCT03869541 1293 1294 O


Inclusion NCT03868176 0 9 O
Criteria NCT03868176 10 18 O
: NCT03868176 19 20 O

- NCT03868176 24 25 O
Patient NCT03868176 27 34 O
with NCT03868176 35 39 O
germ NCT03868176 40 44 O
cell NCT03868176 45 49 O
tumor NCT03868176 50 55 B-Condition-Name
. NCT03868176 56 57 O

- NCT03868176 61 62 O
Patient NCT03868176 64 71 O
with NCT03868176 72 76 O
a NCT03868176 77 78 O
mobile NCT03868176 79 85 O
phone NCT03868176 86 91 O
. NCT03868176 92 93 O

- NCT03868176 97 98 O
Patient NCT03868176 100 107 O
on NCT03868176 108 110 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surveillance NCT03868176 111 123 B-Procedure-Name
. NCT03868176 124 125 O

Exclusion NCT03868176 127 136 O
Criteria NCT03868176 137 145 O
: NCT03868176 146 147 O

- NCT03868176 151 152 O
Testicular NCT03868176 154 164 O
cancer NCT03868176 165 171 B-Condition-Name
without NCT03868176 172 179 O
germ NCT03868176 180 184 O
cell NCT03868176 185 189 O
component NCT03868176 190 199 O
. NCT03868176 200 201 O

- NCT03868176 205 206 O
Prior NCT03868176 208 213 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03868176 214 221 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868176 222 224 O
other NCT03868176 225 230 O
malignancy NCT03868176 231 241 B-Condition-Name
except NCT03868176 242 248 O
for NCT03868176 249 252 O
: NCT03868176 253 254 O
cutaneous NCT03868176 255 264 B-Condition-Name
cancers NCT03868176 265 272 I-Condition-Name
excluding NCT03868176 273 282 O
melanoma NCT03868176 283 291 B-Condition-Name
, NCT03868176 292 293 O
superficial NCT03868176 294 305 O
bladder NCT03868176 306 313 O
tumor NCT03868176 314 319 B-Condition-Name
, NCT03868176 320 321 O
localized NCT03868176 322 331 O
prostate NCT03868176 332 340 O
cancer NCT03868176 341 347 B-Condition-Name
with NCT03868176 348 352 O
undetectable NCT03868176 353 365 B-Polarity___Polarity-Value:negative
PSA NCT03868176 366 369 B-Observation-Name___Observation-Type-Value:lab
. NCT03868176 370 371 O

- NCT03868176 375 376 O
Cognitive NCT03868176 378 387 B-Condition-Name
condition NCT03868176 388 397 I-Condition-Name
that NCT03868176 398 402 O
would NCT03868176 403 408 O
preclude NCT03868176 409 417 O
patient NCT03868176 418 425 O
's NCT03868176 425 427 O
understanding NCT03868176 428 441 O
and NCT03868176 442 445 O
completion NCT03868176 446 456 O
of NCT03868176 457 459 O
study NCT03868176 460 465 O
procedures NCT03868176 466 476 O
. NCT03868176 477 478 O

Inclusion NCT03864016 0 9 O
Criteria NCT03864016 10 18 O
: NCT03864016 19 20 O

- NCT03864016 24 25 O
Person NCT03864016 27 33 O
who NCT03864016 34 37 O
has NCT03864016 38 41 O
given NCT03864016 42 47 O
written NCT03864016 48 55 O
consent NCT03864016 56 63 O

- NCT03864016 66 67 O
Adult NCT03864016 69 74 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patient NCT03864016 75 82 O

- NCT03864016 85 86 O
Patient NCT03864016 88 95 O
undergoing NCT03864016 96 106 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
coronary NCT03864016 107 115 B-Procedure-Name
artery NCT03864016 116 122 I-Procedure-Name
bypass NCT03864016 123 129 I-Procedure-Name
surgery NCT03864016 130 137 I-Procedure-Name
with NCT03864016 138 142 O
CEC NCT03864016 143 146 B-Procedure-Name
, NCT03864016 147 148 O
with NCT03864016 149 153 O
or NCT03864016 154 156 O
without NCT03864016 157 164 O
valve NCT03864016 165 170 B-Procedure-Name
surgery NCT03864016 171 178 I-Procedure-Name
, NCT03864016 179 180 O
by NCT03864016 181 183 O
sternotomy NCT03864016 184 194 B-Procedure-Name
. NCT03864016 195 196 O

- NCT03864016 200 201 O
ASA NCT03864016 203 206 B-Condition-Name
< NCT03864016 207 208 B-Eq-Operator___Eq-Operator-Value:LT
4 NCT03864016 210 211 B-Eq-Value
. NCT03864016 211 212 O

Exclusion NCT03864016 214 223 O
Criteria NCT03864016 224 232 O
: NCT03864016 233 234 O

- NCT03864016 238 239 O
Person NCT03864016 241 247 O
not NCT03864016 248 251 O
affiliated NCT03864016 252 262 O
to NCT03864016 263 265 O
the NCT03864016 266 269 O
national NCT03864016 270 278 B-Insurance
health NCT03864016 279 285 I-Insurance
insurance NCT03864016 286 295 I-Insurance
system NCT03864016 296 302 O

- NCT03864016 305 306 O
Person NCT03864016 308 314 O
subject NCT03864016 315 322 O
to NCT03864016 323 325 O
legal NCT03864016 326 331 B-Observation-Name
protection NCT03864016 332 342 I-Observation-Name
( NCT03864016 343 344 O
curatorship NCT03864016 345 356 B-Observation-Name
, NCT03864016 357 358 O
guardianship NCT03864016 359 371 B-Observation-Name
) NCT03864016 372 373 O

- NCT03864016 377 378 O
Person NCT03864016 380 386 O
who NCT03864016 387 390 O
has NCT03864016 391 394 O
been NCT03864016 395 399 O
deemed NCT03864016 400 406 O
mentally NCT03864016 407 415 B-Condition-Name
incompetent NCT03864016 416 427 I-Condition-Name

- NCT03864016 430 431 O
Pregnant NCT03864016 433 441 B-Condition-Name
, NCT03864016 442 443 O
parturient NCT03864016 444 454 B-Condition-Name
or NCT03864016 455 457 O
breastfeeding NCT03864016 458 471 B-Condition-Name
woman NCT03864016 472 477 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03864016 480 481 O
Adult NCT03864016 483 488 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
unable NCT03864016 489 495 O
or NCT03864016 496 498 O
unwilling NCT03864016 499 508 O
to NCT03864016 509 511 O
provide NCT03864016 512 519 O
consent NCT03864016 520 527 O

- NCT03864016 530 531 O
Patient NCT03864016 533 540 O
with NCT03864016 541 545 O
pre NCT03864016 546 549 O
operative NCT03864016 550 559 B-Procedure-Name
cognitive NCT03864016 560 569 B-Condition-Name
dysfunction NCT03864016 570 581 I-Condition-Name
( NCT03864016 582 583 O
MMS NCT03864016 584 587 B-Observation-Name___Observation-Type-Value:clinical-score
< NCT03864016 588 589 B-Eq-Operator___Eq-Operator-Value:LT
13 NCT03864016 591 593 B-Eq-Value
) NCT03864016 594 595 O
( NCT03864016 596 597 O
APPENDIX NCT03864016 598 606 O
6 NCT03864016 608 609 O
) NCT03864016 610 611 O
, NCT03864016 613 614 O

- NCT03864016 618 619 O
Patient NCT03864016 621 628 O
with NCT03864016 629 633 O
morphine NCT03864016 634 642 B-Drug-Name
intolerance NCT03864016 643 654 B-Condition-Name
, NCT03864016 655 656 O

- NCT03864016 660 661 O
Patient NCT03864016 663 670 O
on NCT03864016 671 673 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
long NCT03864016 674 678 O
- NCT03864016 679 680 O
term NCT03864016 681 685 O
opioid NCT03864016 686 692 B-Drug-Name
treatment NCT03864016 693 702 O
, NCT03864016 703 704 O

- NCT03864016 708 709 O
Emergency NCT03864016 711 720 O
surgery NCT03864016 721 728 B-Procedure-Name
, NCT03864016 729 730 O

- NCT03864016 734 735 O
Eye NCT03864016 737 740 B-Condition-Name
disease NCT03864016 741 748 I-Condition-Name
, NCT03864016 749 750 O
corneal NCT03864016 751 758 O
injury NCT03864016 759 765 B-Condition-Name
, NCT03864016 766 767 O
or NCT03864016 768 770 O
wearing NCT03864016 771 778 O
contact NCT03864016 779 786 B-Procedure-Name
lenses NCT03864016 787 793 I-Procedure-Name
, NCT03864016 794 795 O
a NCT03864016 796 797 O
neurological NCT03864016 798 810 B-Condition-Name
disease NCT03864016 811 818 I-Condition-Name
that NCT03864016 819 823 O
can NCT03864016 824 827 O
influence NCT03864016 828 837 B-Stability___Stability-Value:change
the NCT03864016 838 841 O
pupillary NCT03864016 842 851 B-Condition-Name
reflex NCT03864016 852 858 I-Condition-Name
, NCT03864016 859 860 O

- NCT03864016 864 865 O
Refusal NCT03864016 867 874 O
to NCT03864016 875 877 O
participate NCT03864016 878 889 O

Inclusion NCT03867279 0 9 O
Criteria NCT03867279 10 18 O
: NCT03867279 19 20 O

- NCT03867279 24 25 O
From NCT03867279 27 31 O
18 NCT03867279 33 35 B-Eq-Value
to NCT03867279 36 38 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03867279 40 42 B-Eq-Value
years NCT03867279 43 48 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867279 49 52 O

- NCT03867279 55 56 O
Male NCT03867279 58 62 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03867279 65 66 O
That NCT03867279 68 72 O
they NCT03867279 73 77 O
be NCT03867279 78 80 O
weight NCT03867279 81 87 B-Observation-Name___Observation-Type-Value:social-habit
lifters NCT03867279 88 95 I-Observation-Name___Observation-Type-Value:social-habit
with NCT03867279 96 100 O
at NCT03867279 101 103 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867279 104 109 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03867279 110 113 B-Eq-Value
year NCT03867279 114 118 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03867279 119 121 O
experience NCT03867279 122 132 O

- NCT03867279 135 136 O
That NCT03867279 138 142 O
they NCT03867279 143 147 O
do NCT03867279 148 150 O
not NCT03867279 151 154 O
present NCT03867279 155 162 O
musculoskeletal NCT03867279 163 178 O
injury NCT03867279 179 185 B-Condition-Name
or NCT03867279 186 188 O
pathology NCT03867279 189 198 B-Condition-Name
in NCT03867279 199 201 O
the NCT03867279 202 205 O
three NCT03867279 206 211 B-Eq-Value
months NCT03867279 212 218 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03867279 219 224 O
to NCT03867279 225 227 O
the NCT03867279 228 231 O
beginning NCT03867279 232 241 O
of NCT03867279 242 244 O
the NCT03867279 245 248 O
study NCT03867279 249 254 O

Exclusion NCT03867279 255 264 O
Criteria NCT03867279 265 273 O
: NCT03867279 274 275 O

- NCT03867279 279 280 O
Can NCT03867279 282 285 O
not NCT03867279 286 289 O
be NCT03867279 290 292 O
present NCT03867279 293 300 O
during NCT03867279 301 307 O
the NCT03867279 308 311 O
6 NCT03867279 313 314 B-Eq-Value
weeks NCT03867279 315 320 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03867279 321 323 O
the NCT03867279 324 327 O
intervention NCT03867279 328 340 O
and NCT03867279 341 344 O
the NCT03867279 345 348 O
evaluations NCT03867279 349 360 O
will NCT03867279 361 365 O
be NCT03867279 366 368 O
excluded NCT03867279 369 377 O

- NCT03867279 380 381 O
Under NCT03867279 383 388 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pharmacological NCT03867279 389 404 B-Procedure-Name
treatment NCT03867279 405 414 I-Procedure-Name

- NCT03867279 417 418 O
Who NCT03867279 420 423 O
are NCT03867279 424 427 O
performing NCT03867279 428 438 O
another NCT03867279 439 446 O
physiotherapy NCT03867279 447 460 B-Procedure-Name
study NCT03867279 461 466 O

- NCT03867279 469 470 O
Not NCT03867279 472 475 O
sign NCT03867279 476 480 O
the NCT03867279 481 484 O
informed NCT03867279 485 493 O
consent NCT03867279 494 501 O
document NCT03867279 502 510 O
. NCT03867279 511 512 O

Inclusion NCT03864770 0 9 O
Criteria NCT03864770 10 18 O
: NCT03864770 19 20 O

1 NCT03864770 25 26 O
. NCT03864770 26 27 O
≥ NCT03864770 29 30 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03864770 32 34 B-Eq-Value
y NCT03864770 35 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
/ NCT03864770 37 38 O
o NCT03864770 39 40 O
patients NCT03864770 41 49 O
with NCT03864770 50 54 O
NLCs NCT03864770 55 59 B-Condition-Name
: NCT03864770 60 61 O
( NCT03864770 62 63 O
1 NCT03864770 65 66 O
) NCT03864770 67 68 O
4 NCT03864770 70 71 B-Eq-Value
times NCT03864770 72 77 O
/ NCT03864770 78 79 O
week NCT03864770 80 84 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03864770 85 86 O
last NCT03864770 87 91 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03864770 93 94 B-Eq-Value
weeks NCT03864770 95 100 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03864770 100 101 O
( NCT03864770 102 103 O
2 NCT03864770 105 106 O
) NCT03864770 107 108 O
Occurred NCT03864770 109 117 O
in NCT03864770 118 120 O
nighttime NCT03864770 121 130 O
or NCT03864770 131 133 O
resting NCT03864770 134 141 O
time NCT03864770 142 146 O
of NCT03864770 147 149 O
daytime NCT03864770 150 157 O

2 NCT03864770 161 162 O
. NCT03864770 162 163 O
Patients NCT03864770 165 173 O
with NCT03864770 174 178 O
MTrPs NCT03864770 179 184 B-Condition-Name
on NCT03864770 185 187 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
gastrocnemius NCT03864770 188 201 B-Drug-Name
( NCT03864770 202 203 O
According NCT03864770 204 213 O
to NCT03864770 214 216 O
the NCT03864770 217 220 O
diagnostic NCT03864770 221 231 O
criteria NCT03864770 232 240 O
proposed NCT03864770 241 249 O
by NCT03864770 250 252 O
Simons NCT03864770 253 259 O
& NCT03864770 260 261 O
Travell NCT03864770 262 269 O
) NCT03864770 270 271 O

Exclusion NCT03864770 273 282 O
Criteria NCT03864770 283 291 O
: NCT03864770 292 293 O

1 NCT03864770 298 299 O
. NCT03864770 299 300 O
( NCT03864770 302 303 O
1 NCT03864770 305 306 O
) NCT03864770 307 308 O
Taking NCT03864770 309 315 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03864770 316 326 O
for NCT03864770 327 330 O
leg NCT03864770 331 334 O
cramps NCT03864770 335 341 B-Condition-Name
( NCT03864770 342 343 O
eg NCT03864770 344 346 O
. NCT03864770 347 348 O
Quinine NCT03864770 350 357 B-Drug-Name
, NCT03864770 358 359 O
Magnesium NCT03864770 360 369 B-Drug-Name
oxide NCT03864770 370 375 I-Drug-Name
) NCT03864770 376 377 O
; NCT03864770 378 379 O
( NCT03864770 380 381 O
2 NCT03864770 383 384 O
) NCT03864770 385 386 O
Other NCT03864770 387 392 O
drugs NCT03864770 393 398 O
that NCT03864770 399 403 O
affect NCT03864770 404 410 B-Stability___Stability-Value:change
research NCT03864770 411 419 O
and NCT03864770 420 423 O
evaluation NCT03864770 424 434 O
( NCT03864770 435 436 O
eg NCT03864770 437 439 O
. NCT03864770 440 441 O
diuretics NCT03864770 443 452 B-Drug-Name
, NCT03864770 453 454 O
statins NCT03864770 455 462 B-Drug-Name
, NCT03864770 463 464 O
calcium NCT03864770 465 472 B-Drug-Name
channel NCT03864770 473 480 I-Drug-Name
blockers NCT03864770 481 489 I-Drug-Name
, NCT03864770 490 491 O
anticonvulsants NCT03864770 492 507 B-Drug-Name
) NCT03864770 508 509 O

2 NCT03864770 514 515 O
. NCT03864770 515 516 O
Congenital NCT03864770 518 528 B-Condition-Name
lower NCT03864770 529 534 I-Condition-Name
limb NCT03864770 535 539 I-Condition-Name
musculoskeletal NCT03864770 540 555 I-Condition-Name
diseases NCT03864770 556 564 I-Condition-Name
, NCT03864770 565 566 O
Lower NCT03864770 567 572 O
limb NCT03864770 573 577 O
or NCT03864770 578 580 O
spine NCT03864770 581 586 O
surgery NCT03864770 587 594 B-Procedure-Name

3 NCT03864770 598 599 O
. NCT03864770 599 600 O
Uncommunicated NCT03864770 602 616 B-Condition-Name
or NCT03864770 617 619 O
cognitive NCT03864770 620 629 B-Condition-Name
impaired NCT03864770 630 638 I-Condition-Name

4 NCT03864770 642 643 O
. NCT03864770 643 644 O
Patients NCT03864770 646 654 O
refused NCT03864770 655 662 O
to NCT03864770 663 665 O
be NCT03864770 666 668 O
recruited NCT03864770 669 678 O

Inclusion NCT03868189 0 9 O
Criteria NCT03868189 10 18 O
: NCT03868189 19 20 O

- NCT03868189 24 25 O
Patient NCT03868189 27 34 O
requiring NCT03868189 35 44 O
an NCT03868189 45 47 O
electroneuromyogram NCT03868189 48 67 B-Procedure-Name
whose NCT03868189 68 73 O
indication NCT03868189 74 84 O
allows NCT03868189 85 91 O
the NCT03868189 92 95 O
application NCT03868189 96 107 O
of NCT03868189 108 110 O
a NCT03868189 111 112 O
standard NCT03868189 113 121 O
protocol NCT03868189 122 130 O
of NCT03868189 131 133 O
examination NCT03868189 134 145 B-Procedure-Name
. NCT03868189 146 147 O

- NCT03868189 151 152 O
Patient NCT03868189 154 161 O
that NCT03868189 162 166 O
has NCT03868189 167 170 O
given NCT03868189 171 176 O
his NCT03868189 177 180 O
/ NCT03868189 181 182 O
her NCT03868189 183 186 O
free NCT03868189 187 191 O
and NCT03868189 192 195 O
informed NCT03868189 196 204 O
consent NCT03868189 205 212 O
. NCT03868189 213 214 O

- NCT03868189 218 219 O
Patient NCT03868189 221 228 O
that NCT03868189 229 233 O
signed NCT03868189 234 240 O
the NCT03868189 241 244 O
consent NCT03868189 245 252 O
form NCT03868189 253 257 O
. NCT03868189 258 259 O

- NCT03868189 263 264 O
Patient NCT03868189 266 273 O
with NCT03868189 274 278 O
an NCT03868189 279 281 O
health NCT03868189 282 288 B-Insurance
insurance NCT03868189 289 298 I-Insurance
plan NCT03868189 299 303 I-Insurance
. NCT03868189 304 305 O

- NCT03868189 309 310 O
The NCT03868189 312 315 O
patient NCT03868189 316 323 O
is NCT03868189 324 326 O
at NCT03868189 327 329 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868189 330 335 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868189 337 339 B-Eq-Value
years NCT03868189 340 345 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03868189 346 349 O
( NCT03868189 350 351 O
≥ NCT03868189 353 354 B-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03868189 356 357 O
. NCT03868189 359 360 O

- NCT03868189 364 365 O
he NCT03868189 367 369 O
patient NCT03868189 370 377 O
is NCT03868189 378 380 O
under NCT03868189 381 386 B-Eq-Operator___Eq-Operator-Value:LT
80 NCT03868189 388 390 B-Eq-Value
years NCT03868189 391 396 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03868189 397 400 O
( NCT03868189 401 402 O
≤ NCT03868189 404 405 B-Eq-Operator___Eq-Operator-Value:LTEQ
) NCT03868189 407 408 O
. NCT03868189 410 411 O

Exclusion NCT03868189 413 422 O
Criteria NCT03868189 423 431 O
: NCT03868189 432 433 O

- NCT03868189 437 438 O
Patient NCT03868189 440 447 O
with NCT03868189 448 452 O
symptoms NCT03868189 453 461 O
of NCT03868189 462 464 O
neuropathy NCT03868189 465 475 B-Condition-Name
during NCT03868189 476 482 O
the NCT03868189 483 486 O
screening NCT03868189 487 496 O
. NCT03868189 497 498 O

- NCT03868189 502 503 O
Patient NCT03868189 505 512 O
whose NCT03868189 513 518 O
Neurological NCT03868189 519 531 B-Observation-Name___Observation-Type-Value:clinical-score
severity NCT03868189 532 540 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03868189 541 546 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03868189 547 548 O
NSS NCT03868189 549 552 B-Observation-Name
) NCT03868189 553 554 O
score NCT03868189 555 560 O
is NCT03868189 561 563 O
≥ NCT03868189 564 565 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03868189 567 568 O
. NCT03868189 568 569 O

- NCT03868189 573 574 O
Patient NCT03868189 576 583 O
whose NCT03868189 584 589 O
neurological NCT03868189 590 602 B-Procedure-Name
examination NCT03868189 603 614 I-Procedure-Name
is NCT03868189 615 617 O
abnormal NCT03868189 618 626 B-Polarity___Polarity-Value:abnormal
and NCT03868189 627 630 O
suggestive NCT03868189 631 641 O
of NCT03868189 642 644 O
neuropathy NCT03868189 645 655 B-Condition-Name
. NCT03868189 656 657 O

- NCT03868189 661 662 O
Patient NCT03868189 664 671 O
presenting NCT03868189 672 682 O
a NCT03868189 683 684 O
pathology NCT03868189 685 694 B-Condition-Name
that NCT03868189 695 699 O
could NCT03868189 700 705 O
cause NCT03868189 706 711 O
neuropathy NCT03868189 712 722 B-Condition-Name
( NCT03868189 723 724 O
e NCT03868189 725 726 O
. NCT03868189 727 728 O
g NCT03868189 729 730 O
. NCT03868189 731 732 O
diabetes NCT03868189 734 742 B-Condition-Name
, NCT03868189 743 744 O
renal NCT03868189 745 750 B-Condition-Name
failure NCT03868189 751 758 I-Condition-Name
, NCT03868189 759 760 O
etc NCT03868189 761 764 O
. NCT03868189 765 766 O
) NCT03868189 767 768 O
. NCT03868189 770 771 O

- NCT03868189 775 776 O
Patient NCT03868189 778 785 O
already NCT03868189 786 793 O
participating NCT03868189 794 807 O
in NCT03868189 808 810 O
a NCT03868189 811 812 O
category NCT03868189 813 821 O
1 NCT03868189 823 824 O
research NCT03868189 825 833 O
study NCT03868189 834 839 O
( NCT03868189 840 841 O
Jardé NCT03868189 842 847 O
law NCT03868189 848 851 O
) NCT03868189 852 853 O
. NCT03868189 855 856 O

- NCT03868189 860 861 O
Patient NCT03868189 863 870 O
in NCT03868189 871 873 O
an NCT03868189 874 876 O
exclusion NCT03868189 877 886 O
period NCT03868189 887 893 O
determined NCT03868189 894 904 O
by NCT03868189 905 907 O
another NCT03868189 908 915 O
study NCT03868189 916 921 O
. NCT03868189 922 923 O

- NCT03868189 927 928 O
Patient NCT03868189 930 937 O
under NCT03868189 938 943 O
the NCT03868189 944 947 O
protection NCT03868189 948 958 B-Observation-Name
of NCT03868189 959 961 I-Observation-Name
justice NCT03868189 962 969 I-Observation-Name
, NCT03868189 970 971 O
under NCT03868189 972 977 B-Observation-Name
guardianship NCT03868189 978 990 I-Observation-Name
or NCT03868189 991 993 O
under NCT03868189 994 999 O
curatorship NCT03868189 1000 1011 B-Observation-Name
. NCT03868189 1012 1013 O

- NCT03868189 1017 1018 O
Patient NCT03868189 1020 1027 O
refusing NCT03868189 1028 1036 O
to NCT03868189 1037 1039 O
sign NCT03868189 1040 1044 O
the NCT03868189 1045 1048 O
consent NCT03868189 1049 1056 O
form NCT03868189 1057 1061 O
. NCT03868189 1062 1063 O

- NCT03868189 1067 1068 O
Patient NCT03868189 1070 1077 O
for NCT03868189 1078 1081 O
which NCT03868189 1082 1087 O
it NCT03868189 1088 1090 O
is NCT03868189 1091 1093 O
impossible NCT03868189 1094 1104 O
to NCT03868189 1105 1107 O
provide NCT03868189 1108 1115 O
information NCT03868189 1116 1127 O
about NCT03868189 1128 1133 O
the NCT03868189 1134 1137 O
study NCT03868189 1138 1143 O
. NCT03868189 1144 1145 O

- NCT03868189 1149 1150 O
Pregnant NCT03868189 1152 1160 B-Condition-Name
patient NCT03868189 1161 1168 O
, NCT03868189 1169 1170 O
parturient NCT03868189 1171 1181 B-Condition-Name
, NCT03868189 1182 1183 O
or NCT03868189 1184 1186 O
breastfeeding NCT03868189 1187 1200 B-Condition-Name
. NCT03868189 1201 1202 O

Inclusion NCT03867721 0 9 O
Criteria NCT03867721 10 18 O
: NCT03867721 19 20 O

- NCT03867721 24 25 O
All NCT03867721 27 30 O
individuals NCT03867721 31 42 O
affected NCT03867721 43 51 O
by NCT03867721 52 54 O
NMDs NCT03867721 55 59 B-Condition-Name
attending NCT03867721 60 69 O
our NCT03867721 70 73 O
Centre NCT03867721 74 80 B-Location___Location-Value:clinic
for NCT03867721 81 84 I-Location___Location-Value:clinic
Home NCT03867721 85 89 I-Location___Location-Value:clinic
Mechanical NCT03867721 90 100 I-Location___Location-Value:clinic
Ventilation NCT03867721 101 112 I-Location___Location-Value:clinic
between NCT03867721 113 120 B-Eq-Operator___Eq-Operator-Value:BETWEEN
January NCT03867721 121 128 B-Eq-Value
2015 NCT03867721 130 134 I-Eq-Value
and NCT03867721 135 138 O
December NCT03867721 139 147 B-Eq-Value
2018 NCT03867721 149 153 I-Eq-Value
who NCT03867721 154 157 O
required NCT03867721 158 166 O
daytime NCT03867721 167 174 O
MPV NCT03867721 175 178 B-Procedure-Name
as NCT03867721 179 181 O
an NCT03867721 182 184 O
extension NCT03867721 185 194 O
of NCT03867721 195 197 O
nocturnal NCT03867721 198 207 O
NIV NCT03867721 208 211 B-Procedure-Name

Exclusion NCT03867721 212 221 O
Criteria NCT03867721 222 230 O
: NCT03867721 231 232 O

- NCT03867721 236 237 O
Patients NCT03867721 239 247 O
with NCT03867721 248 252 O
no NCT03867721 253 255 O
need NCT03867721 256 260 O
for NCT03867721 261 264 O
daytime NCT03867721 265 272 O
ventilation NCT03867721 273 284 B-Procedure-Name

- NCT03867721 287 288 O
patients NCT03867721 290 298 O
with NCT03867721 299 303 O
ineffective NCT03867721 304 315 O
NIV NCT03867721 316 319 B-Procedure-Name
during NCT03867721 320 326 O
sleep NCT03867721 327 332 B-Observation-Name
as NCT03867721 333 335 O
assessed NCT03867721 336 344 O
by NCT03867721 345 347 O
the NCT03867721 348 351 O
measurement NCT03867721 352 363 O
of NCT03867721 364 366 O
TcCO NCT03867721 367 371 B-Observation-Name
2 NCT03867721 372 373 I-Observation-Name
> NCT03867721 374 375 B-Eq-Operator___Eq-Operator-Value:GT
49 NCT03867721 377 379 B-Eq-Value
mmHg NCT03867721 380 384 B-Eq-Unit
( NCT03867721 385 386 O
S NCT03867721 387 388 O
) NCT03867721 389 390 O

- NCT03867721 394 395 O
patients NCT03867721 397 405 O
with NCT03867721 406 410 O
uncontrollable NCT03867721 411 425 O
oral NCT03867721 426 430 B-Condition-Name
leaks NCT03867721 431 436 I-Condition-Name
with NCT03867721 437 441 O
MPV NCT03867721 442 445 B-Procedure-Name
or NCT03867721 446 448 O
episode NCT03867721 449 456 O
of NCT03867721 457 459 O
acute NCT03867721 460 465 B-Severity___Severity-Value:severe
respiratory NCT03867721 466 477 B-Condition-Name
infection NCT03867721 478 487 I-Condition-Name
during NCT03867721 488 494 O
the NCT03867721 495 498 O
trials NCT03867721 499 505 O

Inclusion NCT03860714 0 9 O
Criteria NCT03860714 10 18 O
: NCT03860714 19 20 O

- NCT03860714 24 25 O
Non NCT03860714 27 30 O
- NCT03860714 31 32 O
cardiac NCT03860714 33 40 O
surgery NCT03860714 41 48 B-Procedure-Name
patients NCT03860714 49 57 O
; NCT03860714 57 58 O

- NCT03860714 66 67 O
Age NCT03860714 69 72 O
is NCT03860714 73 75 O
greater NCT03860714 76 83 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03860714 84 88 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03860714 89 91 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03860714 92 97 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03860714 98 100 O
60 NCT03860714 102 104 B-Eq-Value
years NCT03860714 105 110 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03860714 111 114 O
; NCT03860714 114 115 O
③ NCT03860714 116 117 O
Han NCT03860714 118 121 B-Ethnicity
Nationality NCT03860714 122 133 I-Ethnicity
, NCT03860714 134 135 O
mother NCT03860714 136 142 O
tongue NCT03860714 143 149 O
is NCT03860714 150 152 O
chinese NCT03860714 153 160 B-Language
; NCT03860714 160 161 O
④ NCT03860714 162 163 O
The NCT03860714 164 167 O
MMSE NCT03860714 168 172 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03860714 173 178 O
: NCT03860714 179 180 O
Illiteracy NCT03860714 181 191 O
is NCT03860714 192 194 O
greater NCT03860714 195 202 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03860714 203 207 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03860714 208 210 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03860714 211 216 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03860714 217 219 O
17 NCT03860714 221 223 B-Eq-Value
points NCT03860714 224 230 B-Eq-Unit
, NCT03860714 231 232 O
primary NCT03860714 233 240 B-Observation-Name
school NCT03860714 241 247 I-Observation-Name
is NCT03860714 248 250 O
greater NCT03860714 251 258 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03860714 259 263 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03860714 264 266 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03860714 267 272 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03860714 273 275 O
20 NCT03860714 277 279 B-Eq-Value
points NCT03860714 280 286 B-Eq-Unit
, NCT03860714 287 288 O
higher NCT03860714 289 295 B-Observation-Name
secondary NCT03860714 296 305 I-Observation-Name
school NCT03860714 306 312 I-Observation-Name
is NCT03860714 313 315 O
more NCT03860714 316 320 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03860714 321 325 I-Eq-Operator___Eq-Operator-Value:GT
24 NCT03860714 327 329 B-Eq-Value
points NCT03860714 330 336 B-Eq-Unit
; NCT03860714 336 337 O
⑤The NCT03860714 338 342 O
people NCT03860714 343 349 O
signed NCT03860714 350 356 O
informed NCT03860714 357 365 O
consent NCT03860714 366 373 O
. NCT03860714 374 375 O

Exclusion NCT03860714 377 386 O
Criteria NCT03860714 387 395 O
: NCT03860714 396 397 O

- NCT03860714 401 402 O
The NCT03860714 404 407 O
diagnosis NCT03860714 408 417 O
of NCT03860714 418 420 O
pre NCT03860714 421 424 O
operative NCT03860714 425 434 B-Procedure-Name
delirium NCT03860714 435 443 B-Condition-Name
； NCT03860714 443 444 O

- NCT03860714 452 453 O
The NCT03860714 455 458 O
diagnosis NCT03860714 459 468 O
Unstable NCT03860714 469 477 B-Stability___Stability-Value:change
hypertension NCT03860714 478 490 B-Condition-Name
（ NCT03860714 491 492 O
Such NCT03860714 493 497 O
as NCT03860714 498 500 O
： NCT03860714 501 502 O
pheochromocytoma NCT03860714 503 519 B-Condition-Name
or NCT03860714 520 522 O
aortic NCT03860714 523 529 B-Condition-Name
dissection NCT03860714 530 540 I-Condition-Name
） NCT03860714 540 541 O
； NCT03860714 541 542 O
③ NCT03860714 543 544 O
Severe NCT03860714 545 551 B-Severity___Severity-Value:severe
chronic NCT03860714 552 559 O
obstructive NCT03860714 560 571 B-Condition-Name
pulmonary NCT03860714 572 581 I-Condition-Name
disease NCT03860714 582 589 I-Condition-Name
or NCT03860714 590 592 O
congestive NCT03860714 593 603 B-Condition-Name
heart NCT03860714 604 609 I-Condition-Name
failure NCT03860714 610 617 I-Condition-Name
； NCT03860714 617 618 O
④ NCT03860714 619 620 O
Severe NCT03860714 621 627 B-Severity___Severity-Value:severe
liver NCT03860714 628 633 O
and NCT03860714 634 637 O
kidney NCT03860714 638 644 O
dysfunction NCT03860714 645 656 B-Condition-Name
; NCT03860714 656 657 O

Inclusion NCT03865693 0 9 O
Criteria NCT03865693 10 18 O
: NCT03865693 19 20 O

- NCT03865693 24 25 O
Burn NCT03865693 27 31 B-Condition-Name
patients NCT03865693 32 40 O

- NCT03865693 43 44 O
severe NCT03865693 46 52 B-Severity___Severity-Value:severe
neuropatic NCT03865693 53 63 O
pain NCT03865693 64 68 B-Condition-Name
rated NCT03865693 69 74 O
at NCT03865693 75 77 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865693 78 83 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03865693 85 86 B-Eq-Value
on NCT03865693 87 89 O
the NCT03865693 90 93 O
10 NCT03865693 95 97 B-Observation-Name___Observation-Type-Value:measurement
- NCT03865693 98 99 I-Observation-Name___Observation-Type-Value:measurement
point NCT03865693 100 105 I-Observation-Name___Observation-Type-Value:measurement
numerical NCT03865693 106 115 I-Observation-Name___Observation-Type-Value:measurement
rating NCT03865693 116 122 I-Observation-Name___Observation-Type-Value:measurement
scale NCT03865693 123 128 I-Observation-Name___Observation-Type-Value:measurement
( NCT03865693 129 130 O
NRS NCT03865693 131 134 B-Observation-Name
) NCT03865693 135 136 O

Exclusion NCT03865693 138 147 O
Criteria NCT03865693 148 156 O
: NCT03865693 157 158 O

- NCT03865693 162 163 O
cardiac NCT03865693 165 172 B-Condition-Name
arrest NCT03865693 173 179 I-Condition-Name
history NCT03865693 180 187 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

- NCT03865693 190 191 O
history NCT03865693 193 200 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865693 201 203 O
neurologi NCT03865693 204 213 B-Condition-Name
disease NCT03865693 214 221 I-Condition-Name
or NCT03865693 222 224 O
brain NCT03865693 225 230 O
surgery NCT03865693 231 238 B-Procedure-Name

- NCT03865693 241 242 O
unstable NCT03865693 244 252 B-Stability___Stability-Value:change
heart NCT03865693 253 258 B-Condition-Name
disease NCT03865693 259 266 I-Condition-Name
or NCT03865693 267 269 O
presence NCT03865693 270 278 O
of NCT03865693 279 281 O
a NCT03865693 282 283 O
cardiac NCT03865693 284 291 B-Procedure-Name
pacemaker NCT03865693 292 301 I-Procedure-Name

- NCT03865693 304 305 O
pain NCT03865693 307 311 B-Condition-Name
resulting NCT03865693 312 321 O
from NCT03865693 322 326 O
other NCT03865693 327 332 O
causes NCT03865693 333 339 O
like NCT03865693 340 344 O
as NCT03865693 345 347 O
neuromuscular NCT03865693 348 361 B-Condition-Name
diseases NCT03865693 362 370 I-Condition-Name

- NCT03865693 373 374 O
psychiatric NCT03865693 376 387 B-Condition-Name
disorder NCT03865693 388 396 I-Condition-Name

- NCT03865693 399 400 O
diabetes NCT03865693 402 410 B-Condition-Name
mellitus NCT03865693 411 419 I-Condition-Name

- NCT03865693 422 423 O
abnormal NCT03865693 425 433 B-Polarity___Polarity-Value:abnormal
renal NCT03865693 434 439 B-Condition-Name
function NCT03865693 440 448 I-Condition-Name

- NCT03865693 451 452 O
contraindication NCT03865693 454 470 O
for NCT03865693 471 474 O
MRI NCT03865693 475 478 B-Procedure-Name
, NCT03865693 479 480 O
or NCT03865693 481 483 O
pregnancy NCT03865693 484 493 B-Condition-Name
. NCT03865693 494 495 O

Inclusion NCT03868956 0 9 O
Criteria NCT03868956 10 18 O
: NCT03868956 19 20 O

- NCT03868956 24 25 O
Age NCT03868956 27 30 O
> NCT03868956 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03868956 34 35 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868956 37 39 B-Eq-Value
years NCT03868956 40 45 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03868956 48 49 O
Known NCT03868956 51 56 O
history NCT03868956 57 64 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868956 65 67 O
objectively NCT03868956 68 79 O
documented NCT03868956 80 90 O
deep NCT03868956 91 95 B-Condition-Name
vein NCT03868956 96 100 I-Condition-Name
thrombosis NCT03868956 101 111 I-Condition-Name
of NCT03868956 112 114 O
the NCT03868956 115 118 O
lower NCT03868956 119 124 O
limb NCT03868956 125 129 O
( NCT03868956 130 131 O
with NCT03868956 132 136 O
or NCT03868956 137 139 O
without NCT03868956 140 147 O
pulmonary NCT03868956 148 157 B-Condition-Name
embolism NCT03868956 158 166 I-Condition-Name
) NCT03868956 167 168 O

- NCT03868956 172 173 O
Out NCT03868956 175 178 B-Encounter-Type___Encounter-Type-Value:outpatient
- NCT03868956 179 180 I-Encounter-Type___Encounter-Type-Value:outpatient
patients NCT03868956 181 189 I-Encounter-Type___Encounter-Type-Value:outpatient
referred NCT03868956 190 198 O
for NCT03868956 199 202 O
clinically NCT03868956 203 213 O
suspected NCT03868956 214 223 O
acute NCT03868956 224 229 B-Severity___Severity-Value:severe
recurrent NCT03868956 230 239 O
ipsilateral NCT03868956 240 251 O
DVT NCT03868956 252 255 B-Condition-Name
of NCT03868956 256 258 O
the NCT03868956 259 262 O
lower NCT03868956 263 268 O
limb NCT03868956 269 273 O
i NCT03868956 274 275 O
. NCT03868956 276 277 O
e NCT03868956 278 279 O
. NCT03868956 280 281 O
the NCT03868956 283 286 O
occurrence NCT03868956 287 297 O
of NCT03868956 298 300 O
new NCT03868956 301 304 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
symptoms NCT03868956 305 313 O
and NCT03868956 314 317 O
signs NCT03868956 318 323 O
of NCT03868956 324 326 O
DVT NCT03868956 327 330 B-Condition-Name
or NCT03868956 331 333 O
the NCT03868956 334 337 O
increase NCT03868956 338 346 B-Polarity___Polarity-Value:high
of NCT03868956 347 349 O
symptoms NCT03868956 350 358 O
and NCT03868956 359 362 O
signs NCT03868956 363 368 O
in NCT03868956 369 371 O
patients NCT03868956 372 380 O
with NCT03868956 381 385 O
post NCT03868956 386 390 B-Condition-Name
- NCT03868956 391 392 I-Condition-Name
thrombotic NCT03868956 393 403 I-Condition-Name
syndrome NCT03868956 404 412 I-Condition-Name

- NCT03868956 415 416 O
Patients NCT03868956 418 426 O
covered NCT03868956 427 434 O
by NCT03868956 435 437 O
social NCT03868956 438 444 O
security NCT03868956 445 453 O
or NCT03868956 454 456 O
equivalent NCT03868956 457 467 O
regimen NCT03868956 468 475 O

- NCT03868956 478 479 O
Signed NCT03868956 481 487 O
and NCT03868956 488 491 O
dated NCT03868956 492 497 O
informed NCT03868956 498 506 O
consent NCT03868956 507 514 O

Exclusion NCT03868956 515 524 O
Criteria NCT03868956 525 533 O
: NCT03868956 534 535 O

- NCT03868956 539 540 O
Known NCT03868956 542 547 O
current NCT03868956 548 555 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnancy NCT03868956 556 565 B-Condition-Name

- NCT03868956 568 569 O
Any NCT03868956 571 574 O
condition NCT03868956 575 584 O
, NCT03868956 585 586 O
which NCT03868956 587 592 O
, NCT03868956 593 594 O
in NCT03868956 595 597 O
the NCT03868956 598 601 O
opinion NCT03868956 602 609 O
of NCT03868956 610 612 O
the NCT03868956 613 616 O
investigator NCT03868956 617 629 O
may NCT03868956 630 633 O
prevent NCT03868956 634 641 O
him NCT03868956 642 645 O
from NCT03868956 646 650 O
performing NCT03868956 651 661 O
the NCT03868956 662 665 O
colour NCT03868956 666 672 B-Procedure-Name
doppler NCT03868956 673 680 I-Procedure-Name
ultrasound NCT03868956 681 691 I-Procedure-Name
test NCT03868956 692 696 I-Procedure-Name
( NCT03868956 697 698 O
plaster NCT03868956 699 706 B-Condition-Name
cast NCT03868956 707 711 I-Condition-Name
, NCT03868956 712 713 O
inaccessible NCT03868956 714 726 O
vein NCT03868956 727 731 B-Condition-Name
segment NCT03868956 732 739 I-Condition-Name
after NCT03868956 740 745 O
abdominal NCT03868956 746 755 O
or NCT03868956 756 758 O
pelvic NCT03868956 759 765 O
surgery NCT03868956 766 773 B-Procedure-Name
, NCT03868956 774 775 O
or NCT03868956 776 778 O
other NCT03868956 779 784 O
causes NCT03868956 785 791 O
that NCT03868956 792 796 O
may NCT03868956 797 800 O
lead NCT03868956 801 805 B-Stability___Stability-Value:change
to NCT03868956 806 808 I-Stability___Stability-Value:change
a NCT03868956 809 810 O
technically NCT03868956 811 822 O
inadequate NCT03868956 823 833 O
CDUS NCT03868956 834 838 O
) NCT03868956 839 840 O

- NCT03868956 844 845 O
Delay NCT03868956 847 852 O
from NCT03868956 853 857 O
onset NCT03868956 858 863 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03868956 864 866 O
symptoms NCT03868956 867 875 O
to NCT03868956 876 878 O
inclusion NCT03868956 879 888 O
of NCT03868956 889 891 O
more NCT03868956 892 896 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868956 897 901 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03868956 903 905 B-Eq-Value
days NCT03868956 906 910 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03868956 913 914 O
Therapeutic NCT03868956 916 927 B-Procedure-Name
anticoagulation NCT03868956 928 943 I-Procedure-Name
for NCT03868956 944 947 O
more NCT03868956 948 952 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868956 953 957 I-Eq-Operator___Eq-Operator-Value:GT
48 NCT03868956 959 961 B-Eq-Value
hours NCT03868956 962 967 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
in NCT03868956 968 970 O
the NCT03868956 971 974 O
two NCT03868956 975 978 B-Eq-Value
days NCT03868956 979 983 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03868956 984 989 O
to NCT03868956 990 992 O
consent NCT03868956 993 1000 O

- NCT03868956 1003 1004 O
Prophylactic NCT03868956 1006 1018 B-Procedure-Name
anticoagulation NCT03868956 1019 1034 I-Procedure-Name
for NCT03868956 1035 1038 O
more NCT03868956 1039 1043 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868956 1044 1048 I-Eq-Operator___Eq-Operator-Value:GT
48 NCT03868956 1050 1052 B-Eq-Value
hours NCT03868956 1053 1058 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
in NCT03868956 1059 1061 O
the NCT03868956 1062 1065 O
two NCT03868956 1066 1069 B-Eq-Value
days NCT03868956 1070 1074 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03868956 1075 1080 O
to NCT03868956 1081 1083 O
consent NCT03868956 1084 1091 O

- NCT03868956 1094 1095 O
Clinical NCT03868956 1097 1105 O
symptoms NCT03868956 1106 1114 O
of NCT03868956 1115 1117 O
pulmonary NCT03868956 1118 1127 B-Condition-Name
embolism NCT03868956 1128 1136 I-Condition-Name

- NCT03868956 1139 1140 O
Life NCT03868956 1142 1146 B-Observation-Name
expectancy NCT03868956 1147 1157 I-Observation-Name
less NCT03868956 1158 1162 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868956 1163 1167 I-Eq-Operator___Eq-Operator-Value:LT
3 NCT03868956 1169 1170 B-Eq-Value
months NCT03868956 1171 1177 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03868956 1180 1181 O
Patient NCT03868956 1183 1190 O
unable NCT03868956 1191 1197 O
to NCT03868956 1198 1200 O
adhere NCT03868956 1201 1207 O
to NCT03868956 1208 1210 O
protocol NCT03868956 1211 1219 O
or NCT03868956 1220 1222 O
follow NCT03868956 1223 1229 O
- NCT03868956 1230 1231 O
up NCT03868956 1232 1234 O
visits NCT03868956 1235 1241 O
and NCT03868956 1242 1245 O
contacts NCT03868956 1246 1254 O

- NCT03868956 1257 1258 O
Participants NCT03868956 1260 1272 O
under NCT03868956 1273 1278 O
legal NCT03868956 1279 1284 B-Observation-Name
guardianship NCT03868956 1285 1297 I-Observation-Name
or NCT03868956 1298 1300 O
incapacitation NCT03868956 1301 1315 B-Condition-Name

- NCT03868956 1318 1319 O
Patient NCT03868956 1321 1328 O
already NCT03868956 1329 1336 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
enrolled NCT03868956 1337 1345 O
in NCT03868956 1346 1348 O
a NCT03868956 1349 1350 O
deep NCT03868956 1351 1355 B-Condition-Name
vein NCT03868956 1356 1360 I-Condition-Name
thrombosis NCT03868956 1361 1371 I-Condition-Name
( NCT03868956 1372 1373 O
DVT NCT03868956 1374 1377 B-Condition-Name
) NCT03868956 1378 1379 O
diagnostic NCT03868956 1380 1390 O
research NCT03868956 1391 1399 O

Inclusion NCT03864822 0 9 O
Criteria NCT03864822 10 18 O
: NCT03864822 19 20 O

- NCT03864822 24 25 O
Otherwise NCT03864822 27 36 O
healthy NCT03864822 37 44 B-Condition-Name
men NCT03864822 45 48 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03864822 49 52 O
women NCT03864822 53 58 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03864822 61 62 O
Aged NCT03864822 64 68 O
18 NCT03864822 70 72 B-Eq-Value
- NCT03864822 73 74 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03864822 76 78 B-Eq-Value
years NCT03864822 79 84 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864822 87 88 O
Continuous NCT03864822 90 100 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pain NCT03864822 101 105 B-Condition-Name
( NCT03864822 106 107 O
> NCT03864822 109 110 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03864822 112 113 B-Eq-Value
days NCT03864822 114 118 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
pain NCT03864822 119 123 B-Condition-Name
/ NCT03864822 124 125 O
week NCT03864822 126 130 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03864822 131 132 O
episode NCT03864822 133 140 O
lasting NCT03864822 141 148 O
at NCT03864822 149 151 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864822 152 157 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03864822 159 160 B-Eq-Value
months NCT03864822 161 167 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03864822 168 169 O
sufficient NCT03864822 170 180 O
to NCT03864822 181 183 O
limit NCT03864822 184 189 B-Stability___Stability-Value:change
daily NCT03864822 190 195 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
activities NCT03864822 196 206 B-Observation-Name___Observation-Type-Value:social-habit

- NCT03864822 209 210 O
Pain NCT03864822 212 216 B-Condition-Name
in NCT03864822 217 219 O
the NCT03864822 220 223 O
region NCT03864822 224 230 O
posteriorly NCT03864822 231 242 O
between NCT03864822 243 250 O
the NCT03864822 251 254 O
inferior NCT03864822 255 263 O
border NCT03864822 264 270 O
of NCT03864822 271 273 O
the NCT03864822 274 277 O
12 NCT03864822 279 281 O
th NCT03864822 282 284 O
rib NCT03864822 285 288 O
and NCT03864822 289 292 O
the NCT03864822 293 296 O
lower NCT03864822 297 302 O
gluteal NCT03864822 303 310 O
fold NCT03864822 311 315 O
( NCT03864822 316 317 O
low NCT03864822 318 321 O
back NCT03864822 322 326 O
pain NCT03864822 327 331 B-Condition-Name
) NCT03864822 332 333 O
at NCT03864822 334 336 O
the NCT03864822 337 340 O
time NCT03864822 341 345 O
of NCT03864822 346 348 O
recruitment NCT03864822 349 360 O

- NCT03864822 363 364 O
Able NCT03864822 366 370 O
to NCT03864822 371 373 O
speak NCT03864822 374 379 O
, NCT03864822 380 381 O
read NCT03864822 382 386 O
and NCT03864822 387 390 O
understand NCT03864822 391 401 O
English NCT03864822 402 409 B-Language

Exclusion NCT03864822 410 419 O
Criteria NCT03864822 420 428 O
: NCT03864822 429 430 O

- NCT03864822 434 435 O
Pregnancy NCT03864822 437 446 B-Condition-Name

- NCT03864822 449 450 O
Low NCT03864822 452 455 O
back NCT03864822 456 460 O
pain NCT03864822 461 465 B-Condition-Name
associated NCT03864822 466 476 O
with NCT03864822 477 481 O
menstruation NCT03864822 482 494 B-Condition-Name

- NCT03864822 497 498 O
Currently NCT03864822 500 509 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
seeking NCT03864822 510 517 O
active NCT03864822 518 524 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03864822 525 534 O
for NCT03864822 535 538 O
low NCT03864822 539 542 O
back NCT03864822 543 547 O
pain NCT03864822 548 552 B-Condition-Name

- NCT03864822 555 556 O
Red NCT03864822 558 561 O
flags NCT03864822 562 567 O
symptoms NCT03864822 568 576 O
( NCT03864822 577 578 O
i NCT03864822 579 580 O
. NCT03864822 581 582 O
e NCT03864822 583 584 O
. NCT03864822 585 586 O
fever NCT03864822 588 593 B-Condition-Name
, NCT03864822 594 595 O
malaise NCT03864822 596 603 B-Condition-Name
, NCT03864822 604 605 O
progressive NCT03864822 606 617 O
neurologic NCT03864822 618 628 B-Condition-Name
deficit NCT03864822 629 636 I-Condition-Name
, NCT03864822 637 638 O
significant NCT03864822 639 650 B-Severity___Severity-Value:severe
trauma NCT03864822 651 657 B-Condition-Name
, NCT03864822 658 659 O
prolonged NCT03864822 660 669 O
corticosteroid NCT03864822 670 684 B-Drug-Name
use NCT03864822 685 688 O
or NCT03864822 689 691 O
osteoporosis NCT03864822 692 704 B-Condition-Name
, NCT03864822 705 706 O
pain NCT03864822 707 711 B-Condition-Name
worst NCT03864822 712 717 O
at NCT03864822 718 720 O
night NCT03864822 721 726 O
, NCT03864822 727 728 O
urinary NCT03864822 729 736 O
or NCT03864822 737 739 O
faecal NCT03864822 740 746 O
incontinence NCT03864822 747 759 B-Condition-Name
, NCT03864822 760 761 O
or NCT03864822 762 764 O
unintended NCT03864822 765 775 O
weight NCT03864822 776 782 B-Condition-Name
loss NCT03864822 783 787 I-Condition-Name
) NCT03864822 788 789 O

- NCT03864822 793 794 O
Drug NCT03864822 796 800 B-Condition-Name
addiction NCT03864822 801 810 I-Condition-Name
defined NCT03864822 811 818 O
as NCT03864822 819 821 O
the NCT03864822 822 825 O
use NCT03864822 826 829 O
of NCT03864822 830 832 O
cannabis NCT03864822 833 841 B-Drug-Name
, NCT03864822 842 843 O
opioids NCT03864822 844 851 B-Drug-Name
or NCT03864822 852 854 O
other NCT03864822 855 860 O
drugs NCT03864822 861 866 O

- NCT03864822 869 870 O
Current NCT03864822 872 879 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03864822 880 882 O
previous NCT03864822 883 891 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
neurologic NCT03864822 892 902 O
, NCT03864822 903 904 O
musculoskeletal NCT03864822 905 920 O
, NCT03864822 921 922 O
mental NCT03864822 923 929 O
, NCT03864822 930 931 O
or NCT03864822 932 934 O
other NCT03864822 935 940 O
illnesses NCT03864822 941 950 B-Condition-Name
which NCT03864822 951 956 O
may NCT03864822 957 960 O
affect NCT03864822 961 967 B-Stability___Stability-Value:change
the NCT03864822 968 971 O
trial NCT03864822 972 977 O

- NCT03864822 980 981 O
Current NCT03864822 983 990 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03864822 991 993 O
previous NCT03864822 994 1002 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
chronic NCT03864822 1003 1010 O
or NCT03864822 1011 1013 O
recurrent NCT03864822 1014 1023 O
pain NCT03864822 1024 1028 B-Condition-Name
condition NCT03864822 1029 1038 I-Condition-Name
other NCT03864822 1039 1044 O
than NCT03864822 1045 1049 O
low NCT03864822 1050 1053 O
back NCT03864822 1054 1058 O
pain NCT03864822 1059 1063 B-Condition-Name

- NCT03864822 1066 1067 O
Current NCT03864822 1069 1076 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
regular NCT03864822 1077 1084 O
use NCT03864822 1085 1088 O
of NCT03864822 1089 1091 O
analgesic NCT03864822 1092 1101 B-Drug-Name
medication NCT03864822 1102 1112 I-Drug-Name
or NCT03864822 1113 1115 O
other NCT03864822 1116 1121 O
medication NCT03864822 1122 1132 O
which NCT03864822 1133 1138 O
may NCT03864822 1139 1142 O
affect NCT03864822 1143 1149 B-Stability___Stability-Value:change
the NCT03864822 1150 1153 O
trial NCT03864822 1154 1159 O

- NCT03864822 1162 1163 O
Lack NCT03864822 1165 1169 O
of NCT03864822 1170 1172 O
ability NCT03864822 1173 1180 O
to NCT03864822 1181 1183 O
cooperate NCT03864822 1184 1193 O

Inclusion NCT03862274 0 9 O
Criteria NCT03862274 10 18 O
: NCT03862274 19 20 O

- NCT03862274 24 25 O
Patients NCT03862274 27 35 O
that NCT03862274 36 40 O
have NCT03862274 41 45 O
a NCT03862274 46 47 O
TPP NCT03862274 48 51 O
1 NCT03862274 52 53 O
enzyme NCT03862274 54 60 B-Condition-Name
deficiency NCT03862274 61 71 I-Condition-Name

- NCT03862274 74 75 O
Patients NCT03862274 77 85 O
have NCT03862274 86 90 O
confirmed NCT03862274 91 100 O
molecular NCT03862274 101 110 B-Procedure-Name
diagnosis NCT03862274 111 120 O
of NCT03862274 121 123 O
pathogenic NCT03862274 124 134 B-Condition-Name
variants NCT03862274 135 143 I-Condition-Name
in NCT03862274 144 146 O
the NCT03862274 147 150 O
TPP NCT03862274 151 154 O
1 NCT03862274 155 156 O
gene NCT03862274 157 161 O

- NCT03862274 164 165 O
Patients NCT03862274 167 175 O
that NCT03862274 176 180 O
are NCT03862274 181 184 O
enrolled NCT03862274 185 193 O
in NCT03862274 194 196 O
post NCT03862274 197 201 O
- NCT03862274 202 203 O
marketing NCT03862274 204 213 O
studies NCT03862274 214 221 O
will NCT03862274 222 226 O
be NCT03862274 227 229 O
allowed NCT03862274 230 237 O
to NCT03862274 238 240 O
enroll NCT03862274 241 247 O
into NCT03862274 248 252 O
the NCT03862274 253 256 O
current NCT03862274 257 264 O
study NCT03862274 265 270 O

Exclusion NCT03862274 271 280 O
Criteria NCT03862274 281 289 O
: NCT03862274 290 291 O

- NCT03862274 295 296 O
Patients NCT03862274 298 306 O
without NCT03862274 307 314 O
a NCT03862274 315 316 O
diagnosis NCT03862274 317 326 O
of NCT03862274 327 329 O
CLN NCT03862274 330 333 B-Condition-Name
2 NCT03862274 334 335 I-Condition-Name
and NCT03862274 336 339 O
deficiency NCT03862274 340 350 B-Condition-Name
of NCT03862274 351 353 O
TPP NCT03862274 354 357 O
1 NCT03862274 358 359 O

- NCT03862274 362 363 O
Patients NCT03862274 365 373 O
that NCT03862274 374 378 O
are NCT03862274 379 382 O
currently NCT03862274 383 392 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
enrolled NCT03862274 393 401 O
as NCT03862274 402 404 O
part NCT03862274 405 409 O
of NCT03862274 410 412 O
a NCT03862274 413 414 O
larger NCT03862274 415 421 O
multi NCT03862274 422 427 O
- NCT03862274 428 429 O
center NCT03862274 430 436 O
clinical NCT03862274 437 445 O
trial NCT03862274 446 451 O

Inclusion NCT03860311 0 9 O
Criteria NCT03860311 10 18 O
: NCT03860311 19 20 O

- NCT03860311 24 25 O
Age NCT03860311 27 30 O
8 NCT03860311 32 33 B-Eq-Value
yr NCT03860311 34 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
- NCT03860311 37 38 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03860311 40 42 B-Eq-Value
yrs NCT03860311 43 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03860311 49 50 O
Female NCT03860311 52 58 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03860311 61 62 O
Likely NCT03860311 64 70 O
to NCT03860311 71 73 O
have NCT03860311 74 78 O
order NCT03860311 79 84 O
placed NCT03860311 85 91 O
for NCT03860311 92 95 O
transabdominal NCT03860311 96 110 B-Procedure-Name
pelvic NCT03860311 111 117 I-Procedure-Name
ultrasound NCT03860311 118 128 I-Procedure-Name
/ NCT03860311 129 130 O
ovarian NCT03860311 131 138 O
ultrasound NCT03860311 139 149 B-Procedure-Name

- NCT03860311 152 153 O
No NCT03860311 155 157 O
history NCT03860311 158 165 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860311 166 168 O
pelvic NCT03860311 169 175 O
or NCT03860311 176 178 O
bladder NCT03860311 179 186 O
reconstructive NCT03860311 187 201 B-Procedure-Name
surgery NCT03860311 202 209 I-Procedure-Name

Exclusion NCT03860311 210 219 O
Criteria NCT03860311 220 228 O
: NCT03860311 229 230 O

- NCT03860311 234 235 O
Pregnancy NCT03860311 237 246 B-Condition-Name
( NCT03860311 247 248 O
known NCT03860311 249 254 O
) NCT03860311 255 256 O

- NCT03860311 260 261 O
Critically NCT03860311 263 273 B-Severity___Severity-Value:severe
ill NCT03860311 274 277 B-Condition-Name
patients NCT03860311 278 286 O

- NCT03860311 289 290 O
Patients NCT03860311 292 300 O
with NCT03860311 301 305 O
known NCT03860311 306 311 O
renal NCT03860311 312 317 O
or NCT03860311 318 320 O
genitourinary NCT03860311 321 334 O
structural NCT03860311 335 345 O
abnormalities NCT03860311 346 359 B-Condition-Name
or NCT03860311 360 362 O
prior NCT03860311 363 368 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pelvic NCT03860311 369 375 O
/ NCT03860311 376 377 O
genitourinary NCT03860311 378 391 O
surgery NCT03860311 392 399 B-Procedure-Name

- NCT03860311 402 403 O
Chronic NCT03860311 405 412 O
renal NCT03860311 413 418 B-Condition-Name
disease NCT03860311 419 426 I-Condition-Name

- NCT03860311 429 430 O
Patients NCT03860311 432 440 O
presenting NCT03860311 441 451 O
outside NCT03860311 452 459 O
the NCT03860311 460 463 O
defined NCT03860311 464 471 O
treatment NCT03860311 472 481 O
windows NCT03860311 482 489 O

Inclusion NCT03868995 0 9 O
Criteria NCT03868995 10 18 O
: NCT03868995 19 20 O

1 NCT03868995 25 26 O
. NCT03868995 26 27 O
20 NCT03868995 30 32 B-Eq-Value
- NCT03868995 33 34 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03868995 36 38 B-Eq-Value
age NCT03868995 39 42 O

2 NCT03868995 46 47 O
. NCT03868995 47 48 O
Chronic NCT03868995 50 57 O
ankle NCT03868995 58 63 O
sprain NCT03868995 64 70 B-Condition-Name
more NCT03868995 71 75 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868995 76 80 I-Eq-Operator___Eq-Operator-Value:GT
3 NCT03868995 82 83 B-Eq-Value
months NCT03868995 84 90 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
with NCT03868995 91 95 O
chronic NCT03868995 96 103 O
ankle NCT03868995 104 109 O
pain NCT03868995 110 114 B-Condition-Name
or NCT03868995 115 117 O
instability NCT03868995 118 129 O
sensation NCT03868995 130 139 B-Condition-Name

3 NCT03868995 143 144 O
. NCT03868995 144 145 O
Ultrasound NCT03868995 147 157 B-Procedure-Name
diagnosed NCT03868995 158 167 O
anterior NCT03868995 168 176 O
talofibular NCT03868995 177 188 O
ligament NCT03868995 189 197 B-Condition-Name
sprain NCT03868995 198 204 I-Condition-Name

Exclusion NCT03868995 205 214 O
Criteria NCT03868995 215 223 O
: NCT03868995 224 225 O

1 NCT03868995 230 231 O
. NCT03868995 231 232 O
Acute NCT03868995 234 239 B-Severity___Severity-Value:severe
ankle NCT03868995 240 245 O
sprain NCT03868995 246 252 B-Condition-Name
less NCT03868995 253 257 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868995 258 262 I-Eq-Operator___Eq-Operator-Value:LT
3 NCT03868995 264 265 B-Eq-Value
months NCT03868995 266 272 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

2 NCT03868995 276 277 O
. NCT03868995 277 278 O
Lower NCT03868995 280 285 O
limb NCT03868995 286 290 O
fracture NCT03868995 291 299 B-Condition-Name
history NCT03868995 300 307 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

3 NCT03868995 311 312 O
. NCT03868995 312 313 O
Cognitive NCT03868995 315 324 B-Condition-Name
impairment NCT03868995 325 335 I-Condition-Name

4 NCT03868995 339 340 O
. NCT03868995 340 341 O
Other NCT03868995 343 348 O
neurological NCT03868995 349 361 O
or NCT03868995 362 364 O
muscular NCT03868995 365 373 O
disorders NCT03868995 374 383 B-Condition-Name

5 NCT03868995 387 388 O
. NCT03868995 388 389 O
Sever NCT03868995 391 396 O
pain NCT03868995 397 401 B-Condition-Name
could NCT03868995 402 407 O
not NCT03868995 408 411 O
tolerate NCT03868995 412 420 O
examination NCT03868995 421 432 B-Procedure-Name

Inclusion NCT03861741 0 9 O
Criteria NCT03861741 10 18 O
: NCT03861741 19 20 O

1 NCT03861741 25 26 O
. NCT03861741 26 27 O
NS NCT03861741 29 31 B-Condition-Name
- NCT03861741 32 33 I-Condition-Name
TAD NCT03861741 34 37 I-Condition-Name
probands NCT03861741 38 46 O
operated NCT03861741 47 55 B-Procedure-Name
on NCT03861741 56 58 O
( NCT03861741 59 60 O
n NCT03861741 61 62 O
= NCT03861741 63 64 O
16 NCT03861741 66 68 O
) NCT03861741 69 70 O
. NCT03861741 72 73 O

2 NCT03861741 78 79 O
. NCT03861741 79 80 O
FDR NCT03861741 82 85 B-Condition-Name
and NCT03861741 86 89 O
SDR NCT03861741 90 93 B-Condition-Name
, NCT03861741 94 95 O
aged NCT03861741 96 100 O
16 NCT03861741 102 104 B-Eq-Value
and NCT03861741 105 108 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03861741 109 114 I-Eq-Operator___Eq-Operator-Value:GTEQ
: NCT03861741 115 116 O

1 NCT03861741 126 127 O
. NCT03861741 127 128 O
At NCT03861741 130 132 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861741 133 138 I-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03861741 139 142 B-Eq-Value
relatives NCT03861741 143 152 O
willing NCT03861741 153 160 O
to NCT03861741 161 163 O
participate NCT03861741 164 175 O
in NCT03861741 176 178 O
the NCT03861741 179 182 O
screening NCT03861741 183 192 O
programme NCT03861741 193 202 O
. NCT03861741 203 204 O

2 NCT03861741 214 215 O
. NCT03861741 215 216 O
Relatives NCT03861741 218 227 O
able NCT03861741 228 232 O
to NCT03861741 233 235 O
understand NCT03861741 236 246 O
English NCT03861741 247 254 B-Language
. NCT03861741 255 256 O

Exclusion NCT03861741 258 267 O
Criteria NCT03861741 268 276 O
: NCT03861741 277 278 O

1 NCT03861741 283 284 O
. NCT03861741 284 285 O
Probands NCT03861741 287 295 O
with NCT03861741 296 300 O
syndromic NCT03861741 301 310 B-Condition-Name
aortopathies NCT03861741 311 323 I-Condition-Name
, NCT03861741 324 325 O
including NCT03861741 326 335 O
Marfan NCT03861741 336 342 B-Condition-Name
Syndrome NCT03861741 343 351 I-Condition-Name
, NCT03861741 352 353 O
Loeys NCT03861741 354 359 B-Condition-Name
- NCT03861741 360 361 I-Condition-Name
Dietz NCT03861741 362 367 I-Condition-Name
Syndrome NCT03861741 368 376 I-Condition-Name
, NCT03861741 377 378 O
Ehlers NCT03861741 379 385 B-Condition-Name
- NCT03861741 386 387 I-Condition-Name
Danlos NCT03861741 388 394 I-Condition-Name
Syndrome NCT03861741 395 403 I-Condition-Name
, NCT03861741 404 405 O
Shprintzen NCT03861741 406 416 B-Condition-Name
- NCT03861741 417 418 I-Condition-Name
Goldberg NCT03861741 419 427 I-Condition-Name
syndrome NCT03861741 428 436 I-Condition-Name
, NCT03861741 437 438 O
aneurysm NCT03861741 439 447 B-Condition-Name
- NCT03861741 448 449 I-Condition-Name
osteoarthritis NCT03861741 450 464 I-Condition-Name
syndrome NCT03861741 465 473 I-Condition-Name
, NCT03861741 474 475 O
arterial NCT03861741 476 484 B-Condition-Name
tortuosity NCT03861741 485 495 I-Condition-Name
syndrome NCT03861741 496 504 I-Condition-Name
, NCT03861741 505 506 O
and NCT03861741 507 510 O
cutis NCT03861741 511 516 B-Condition-Name
laxa NCT03861741 517 521 I-Condition-Name
syndrome NCT03861741 522 530 I-Condition-Name
. NCT03861741 531 532 O

2 NCT03861741 537 538 O
. NCT03861741 538 539 O
Probands NCT03861741 541 549 O
with NCT03861741 550 554 O
aortic NCT03861741 555 561 B-Condition-Name
lesions NCT03861741 562 569 I-Condition-Name
associated NCT03861741 570 580 O
with NCT03861741 581 585 O
trauma NCT03861741 586 592 B-Condition-Name
and NCT03861741 593 596 O
infections NCT03861741 597 607 B-Condition-Name
. NCT03861741 608 609 O

3 NCT03861741 614 615 O
. NCT03861741 615 616 O
Probands NCT03861741 618 626 O
/ NCT03861741 627 628 O
relatives NCT03861741 629 638 O
unable NCT03861741 639 645 O
to NCT03861741 646 648 O
give NCT03861741 649 653 O
informed NCT03861741 654 662 O
consent NCT03861741 663 670 O

Inclusion NCT03862248 0 9 O
Criteria NCT03862248 10 18 O
: NCT03862248 19 20 O

- NCT03862248 24 25 O
All NCT03862248 27 30 O
newly NCT03862248 31 36 O
registered NCT03862248 37 47 O
patients NCT03862248 48 56 O
with NCT03862248 57 61 O
smear NCT03862248 62 67 O
- NCT03862248 68 69 O
positive NCT03862248 70 78 B-Polarity___Polarity-Value:positive
recurrent NCT03862248 79 88 O
pulmonary NCT03862248 89 98 O
TB NCT03862248 99 101 B-Condition-Name

- NCT03862248 104 105 O
Adults NCT03862248 107 113 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
as NCT03862248 114 116 O
well NCT03862248 117 121 O
as NCT03862248 122 124 O
children NCT03862248 125 133 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
( NCT03862248 134 135 O
no NCT03862248 136 138 O
age NCT03862248 139 142 O
limit NCT03862248 143 148 O
) NCT03862248 149 150 O

- NCT03862248 154 155 O
Able NCT03862248 157 161 O
and NCT03862248 162 165 O
willing NCT03862248 166 173 O
to NCT03862248 174 176 O
provide NCT03862248 177 184 O
written NCT03862248 185 192 O
informed NCT03862248 193 201 O
consent NCT03862248 202 209 O

Exclusion NCT03862248 210 219 O
Criteria NCT03862248 220 228 O
: NCT03862248 229 230 O

- NCT03862248 234 235 O
Patients NCT03862248 237 245 O
transferred NCT03862248 246 257 B-Encounter-Type___Encounter-Type-Value:transfer
to NCT03862248 258 260 O
a NCT03862248 261 262 O
health NCT03862248 263 269 B-Location___Location-Value:hospital
facility NCT03862248 270 278 I-Location___Location-Value:hospital
not NCT03862248 279 282 O
supported NCT03862248 283 292 O
by NCT03862248 293 295 O
Damien NCT03862248 296 302 O
Foundation NCT03862248 303 313 O
will NCT03862248 314 318 O
be NCT03862248 319 321 O
excluded NCT03862248 322 330 O
. NCT03862248 331 332 O
This NCT03862248 334 338 O
includes NCT03862248 339 347 O
patients NCT03862248 348 356 O
diagnosed NCT03862248 357 366 O
with NCT03862248 367 371 O
HIV NCT03862248 372 375 B-Condition-Name
/ NCT03862248 376 377 O
TB NCT03862248 378 380 B-Condition-Name
- NCT03862248 381 382 O
coinfection NCT03862248 383 394 B-Condition-Name
. NCT03862248 395 396 O

Inclusion NCT03862937 0 9 O
Criteria NCT03862937 10 18 O
: NCT03862937 19 20 O

- NCT03862937 24 25 O
Be NCT03862937 27 29 O
60 NCT03862937 31 33 B-Eq-Value
or NCT03862937 34 36 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03862937 37 42 I-Eq-Operator___Eq-Operator-Value:GTEQ
, NCT03862937 43 44 O
and NCT03862937 45 48 O
in NCT03862937 49 51 O
the NCT03862937 52 55 O
case NCT03862937 56 60 O
of NCT03862937 61 63 O
women NCT03862937 64 69 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03862937 70 71 O
they NCT03862937 72 76 O
must NCT03862937 77 81 O
be NCT03862937 82 84 O
postmenopausal NCT03862937 85 99 B-Condition-Name
( NCT03862937 100 101 O
interruption NCT03862937 102 114 O
of NCT03862937 115 117 O
menstruation NCT03862937 118 130 B-Condition-Name
for NCT03862937 131 134 O
more NCT03862937 135 139 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862937 140 144 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03862937 145 148 B-Eq-Value
year NCT03862937 149 153 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03862937 154 155 O
. NCT03862937 157 158 O

- NCT03862937 162 163 O
Have NCT03862937 165 169 O
not NCT03862937 170 173 O
participated NCT03862937 174 186 O
in NCT03862937 187 189 O
any NCT03862937 190 193 O
systematic NCT03862937 194 204 O
exercise NCT03862937 205 213 B-Procedure-Name
program NCT03862937 214 221 I-Procedure-Name
for NCT03862937 222 225 O
at NCT03862937 226 228 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862937 229 234 I-Eq-Operator___Eq-Operator-Value:GTEQ
six NCT03862937 235 238 B-Eq-Value
months NCT03862937 239 245 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03862937 246 251 O
to NCT03862937 252 254 O
the NCT03862937 255 258 O
start NCT03862937 259 264 O
of NCT03862937 265 267 O
this NCT03862937 268 272 O
project NCT03862937 273 280 O
. NCT03862937 281 282 O

- NCT03862937 286 287 O
To NCT03862937 289 291 O
have NCT03862937 292 296 O
a NCT03862937 297 298 O
body NCT03862937 299 303 B-Observation-Name___Observation-Type-Value:vital
mass NCT03862937 304 308 I-Observation-Name___Observation-Type-Value:vital
index NCT03862937 309 314 I-Observation-Name___Observation-Type-Value:vital
( NCT03862937 315 316 O
BMI NCT03862937 317 320 B-Observation-Name___Observation-Type-Value:vital
) NCT03862937 321 322 O
between NCT03862937 323 330 B-Eq-Operator___Eq-Operator-Value:BETWEEN
22 NCT03862937 332 334 B-Eq-Value
and NCT03862937 335 338 O
30 NCT03862937 340 342 B-Eq-Value
kg NCT03862937 343 345 B-Eq-Unit
/ NCT03862937 346 347 O
m NCT03862937 348 349 B-Eq-Unit
2 NCT03862937 350 351 I-Eq-Unit
. NCT03862937 351 352 O

- NCT03862937 356 357 O
Are NCT03862937 359 362 O
not NCT03862937 363 366 O
cardiopathic NCT03862937 367 379 B-Condition-Name
, NCT03862937 380 381 O
diabetic NCT03862937 382 390 B-Condition-Name
or NCT03862937 391 393 O
have NCT03862937 394 398 O
any NCT03862937 399 402 O
other NCT03862937 403 408 O
metabolic NCT03862937 409 418 B-Condition-Name
disease NCT03862937 419 426 I-Condition-Name
. NCT03862937 427 428 O

- NCT03862937 432 433 O
Do NCT03862937 435 437 O
not NCT03862937 438 441 O
present NCT03862937 442 449 O
joint NCT03862937 450 455 B-Condition-Name
problems NCT03862937 456 464 I-Condition-Name
or NCT03862937 465 467 O
any NCT03862937 468 471 O
other NCT03862937 472 477 O
injury NCT03862937 478 484 B-Condition-Name
that NCT03862937 485 489 O
prevents NCT03862937 490 498 O
the NCT03862937 499 502 O
proper NCT03862937 503 509 O
execution NCT03862937 510 519 O
of NCT03862937 520 522 O
the NCT03862937 523 526 O
exercises NCT03862937 527 536 B-Observation-Name___Observation-Type-Value:social-habit
of NCT03862937 537 539 O
the NCT03862937 540 543 O
training NCT03862937 544 552 B-Procedure-Name
routine NCT03862937 553 560 I-Procedure-Name
. NCT03862937 561 562 O

- NCT03862937 566 567 O
Non NCT03862937 569 572 O
- NCT03862937 573 574 O
smoker NCT03862937 575 581 B-Condition-Name
or NCT03862937 582 584 O
have NCT03862937 585 589 O
quit NCT03862937 590 594 B-Condition-Name
smoking NCT03862937 595 602 I-Condition-Name
for NCT03862937 603 606 O
at NCT03862937 607 609 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862937 610 615 I-Eq-Operator___Eq-Operator-Value:GTEQ
five NCT03862937 616 620 B-Eq-Value
years NCT03862937 621 626 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
ago NCT03862937 627 630 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
. NCT03862937 631 632 O

- NCT03862937 636 637 O
Release NCT03862937 639 646 O
of NCT03862937 647 649 O
the NCT03862937 650 653 O
doctor NCT03862937 654 660 O
( NCT03862937 661 662 O
medical NCT03862937 663 670 O
certificate NCT03862937 671 682 O
) NCT03862937 683 684 O
to NCT03862937 685 687 O
perform NCT03862937 688 695 O
the NCT03862937 696 699 O
physical NCT03862937 700 708 B-Observation-Name___Observation-Type-Value:social-habit
exercises NCT03862937 709 718 I-Observation-Name___Observation-Type-Value:social-habit
. NCT03862937 719 720 O

Exclusion NCT03862937 722 731 O
Criteria NCT03862937 732 740 O
: NCT03862937 741 742 O

- NCT03862937 746 747 O
Do NCT03862937 749 751 O
not NCT03862937 752 755 O
participate NCT03862937 756 767 O
in NCT03862937 768 770 O
at NCT03862937 771 773 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862937 774 779 I-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03862937 781 783 B-Eq-Value
training NCT03862937 784 792 B-Procedure-Name
sessions NCT03862937 793 801 I-Procedure-Name
or NCT03862937 802 804 O
miss NCT03862937 805 809 O
more NCT03862937 810 814 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862937 815 819 I-Eq-Operator___Eq-Operator-Value:GT
three NCT03862937 820 825 B-Eq-Value
consecutive NCT03862937 826 837 O
training NCT03862937 838 846 B-Procedure-Name
sessions NCT03862937 847 855 I-Procedure-Name
. NCT03862937 856 857 O

Inclusion NCT03869645 0 9 O
Criteria NCT03869645 10 18 O
: NCT03869645 19 20 O

- NCT03869645 24 25 O
Patients NCT03869645 27 35 O
who NCT03869645 36 39 O
are NCT03869645 40 43 O
> NCT03869645 44 45 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03869645 47 49 B-Eq-Value
years NCT03869645 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869645 56 58 O
age NCT03869645 59 62 O

- NCT03869645 65 66 O
Patients NCT03869645 68 76 O
with NCT03869645 77 81 O
clinical NCT03869645 82 90 O
signs NCT03869645 91 96 O
, NCT03869645 97 98 O
symptoms NCT03869645 99 107 O
and NCT03869645 108 111 O
presentation NCT03869645 112 124 O
consistent NCT03869645 125 135 O
with NCT03869645 136 140 O
acute NCT03869645 141 146 B-Severity___Severity-Value:severe
thrombosis NCT03869645 147 157 B-Condition-Name
; NCT03869645 157 158 O
onset NCT03869645 159 164 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03869645 165 167 O
symptoms NCT03869645 168 176 O
< NCT03869645 177 178 B-Eq-Operator___Eq-Operator-Value:LT
14 NCT03869645 180 182 B-Eq-Value
days NCT03869645 183 187 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03869645 190 191 O
Patients NCT03869645 193 201 O
cleared NCT03869645 202 209 O
medically NCT03869645 210 219 O
for NCT03869645 220 223 O
invasive NCT03869645 224 232 B-Procedure-Name
endovenous NCT03869645 233 243 I-Procedure-Name
procedures NCT03869645 244 254 I-Procedure-Name

Exclusion NCT03869645 255 264 O
Criteria NCT03869645 265 273 O
: NCT03869645 274 275 O

- NCT03869645 279 280 O
Patients NCT03869645 282 290 O
with NCT03869645 291 295 O
IVC NCT03869645 296 299 B-Procedure-Name
filter NCT03869645 300 306 I-Procedure-Name
in NCT03869645 307 309 O
area NCT03869645 310 314 O
to NCT03869645 315 317 O
be NCT03869645 318 320 O
treated NCT03869645 321 328 O

- NCT03869645 331 332 O
Patients NCT03869645 334 342 O
who NCT03869645 343 346 O
are NCT03869645 347 350 O
< NCT03869645 351 352 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03869645 354 356 B-Eq-Value
years NCT03869645 357 362 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869645 363 365 O
age NCT03869645 366 369 O
. NCT03869645 370 371 O

- NCT03869645 375 376 O
Known NCT03869645 378 383 O
anaphylactic NCT03869645 384 396 B-Condition-Name
reaction NCT03869645 397 405 I-Condition-Name
of NCT03869645 406 408 O
radiographic NCT03869645 409 421 B-Drug-Name
contrast NCT03869645 422 430 I-Drug-Name
agents NCT03869645 431 437 I-Drug-Name
that NCT03869645 438 442 O
can NCT03869645 443 446 O
not NCT03869645 446 449 O
be NCT03869645 450 452 O
pre NCT03869645 453 456 O
- NCT03869645 457 458 O
treated NCT03869645 459 466 O

- NCT03869645 469 470 O
Imaging NCT03869645 472 479 B-Procedure-Name
evidence NCT03869645 480 488 O
or NCT03869645 489 491 O
other NCT03869645 492 497 O
evidence NCT03869645 498 506 O
that NCT03869645 507 511 O
suggests NCT03869645 512 520 O
the NCT03869645 521 524 O
participant NCT03869645 525 536 O
is NCT03869645 537 539 O
not NCT03869645 540 543 O
appropriate NCT03869645 544 555 O
for NCT03869645 556 559 O
mechanical NCT03869645 560 570 B-Procedure-Name
thrombectomy NCT03869645 571 583 I-Procedure-Name
intervention NCT03869645 584 596 I-Procedure-Name

- NCT03869645 599 600 O
Female NCT03869645 602 608 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03869645 609 612 O
is NCT03869645 613 615 O
pregnant NCT03869645 616 624 B-Condition-Name
or NCT03869645 625 627 O
nursing NCT03869645 628 635 B-Condition-Name

- NCT03869645 638 639 O
Concurrent NCT03869645 641 651 O
participation NCT03869645 652 665 O
in NCT03869645 666 668 O
another NCT03869645 669 676 O
investigational NCT03869645 677 692 O
drug NCT03869645 693 697 O
or NCT03869645 698 700 O
device NCT03869645 701 707 O
treatment NCT03869645 708 717 O
study NCT03869645 718 723 O

Inclusion NCT03865043 0 9 O
criteria NCT03865043 10 18 O
: NCT03865043 19 20 O

- NCT03865043 24 25 O
Patients NCT03865043 27 35 O
undergoing NCT03865043 36 46 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03865043 47 48 O
TAVI NCT03865043 49 53 B-Procedure-Name
at NCT03865043 54 56 O
Montpellier NCT03865043 57 68 B-Location___Location-Value:hospital
University NCT03865043 69 79 I-Location___Location-Value:hospital
Hospital NCT03865043 80 88 I-Location___Location-Value:hospital

- NCT03865043 91 92 O
Since NCT03865043 94 99 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
November NCT03865043 100 108 B-Eq-Value
2017 NCT03865043 110 114 I-Eq-Value

- NCT03865043 118 119 O
With NCT03865043 121 125 O
implantation NCT03865043 126 138 B-Procedure-Name
of NCT03865043 139 141 O
a NCT03865043 142 143 O
COREVALVE NCT03865043 144 153 O
or NCT03865043 154 156 O
EDWARDS NCT03865043 157 164 O

- NCT03865043 167 168 O
By NCT03865043 170 172 O
femoral NCT03865043 173 180 B-Procedure-Name
approach NCT03865043 181 189 I-Procedure-Name

Exclusion NCT03865043 190 199 O
criteria NCT03865043 200 208 O
: NCT03865043 209 210 O

- NCT03865043 214 215 O
Minor NCT03865043 217 222 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
patient NCT03865043 223 230 O

- NCT03865043 233 234 O
Patient NCT03865043 236 243 O
unable NCT03865043 244 250 O
to NCT03865043 251 253 O
give NCT03865043 254 258 O
consent NCT03865043 259 266 O
for NCT03865043 267 270 O
reasons NCT03865043 271 278 O
of NCT03865043 279 281 O
understanding NCT03865043 282 295 O
or NCT03865043 296 298 O
language NCT03865043 299 307 B-Condition-Name
barrier NCT03865043 308 315 I-Condition-Name

Inclusion NCT03865862 0 9 O
Criteria NCT03865862 10 18 O
: NCT03865862 19 20 O

- NCT03865862 24 25 O
Volleyball NCT03865862 27 37 B-Observation-Name___Observation-Type-Value:social-habit
players NCT03865862 38 45 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03865862 48 49 O
Federated NCT03865862 51 60 O
that NCT03865862 61 65 O
at NCT03865862 66 68 O
the NCT03865862 69 72 O
time NCT03865862 73 77 O
of NCT03865862 78 80 O
the NCT03865862 81 84 O
study NCT03865862 85 90 O
compete NCT03865862 91 98 O
in NCT03865862 99 101 O
clubs NCT03865862 102 107 O
of NCT03865862 108 110 O
the NCT03865862 111 114 O
Community NCT03865862 115 124 B-Location___Location-Value:residence
of NCT03865862 125 127 I-Location___Location-Value:residence
Madrid NCT03865862 128 134 I-Location___Location-Value:residence

- NCT03865862 137 138 O
Over NCT03865862 140 144 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03865862 146 148 B-Eq-Value
years NCT03865862 149 154 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03865862 155 158 O
. NCT03865862 159 160 O

Exclusion NCT03865862 162 171 O
Criteria NCT03865862 172 180 O
: NCT03865862 181 182 O

- NCT03865862 186 187 O
Present NCT03865862 189 196 O
a NCT03865862 197 198 O
medical NCT03865862 199 206 O
diagnosis NCT03865862 207 216 O
of NCT03865862 217 219 O
injury NCT03865862 220 226 B-Condition-Name
or NCT03865862 227 229 O
illness NCT03865862 230 237 B-Condition-Name

- NCT03865862 240 241 O
Have NCT03865862 243 247 O
suffered NCT03865862 248 256 O
a NCT03865862 257 258 O
knee NCT03865862 259 263 O
injury NCT03865862 264 270 B-Condition-Name
in NCT03865862 271 273 O
the NCT03865862 274 277 O
6 NCT03865862 279 280 B-Eq-Value
months NCT03865862 281 287 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03865862 288 293 O
to NCT03865862 294 296 O
the NCT03865862 297 300 O
study NCT03865862 301 306 O

- NCT03865862 309 310 O
Doing NCT03865862 312 317 O
some NCT03865862 318 322 O
pharmacological NCT03865862 323 338 O
or NCT03865862 339 341 O
physiotherapy NCT03865862 342 355 B-Procedure-Name
treatment NCT03865862 356 365 I-Procedure-Name
external NCT03865862 366 374 O
to NCT03865862 375 377 O
the NCT03865862 378 381 O
study NCT03865862 382 387 O

- NCT03865862 390 391 O
Not NCT03865862 393 396 O
signed NCT03865862 397 403 O
the NCT03865862 404 407 O
informed NCT03865862 408 416 O
consent NCT03865862 417 424 O
document NCT03865862 425 433 O
. NCT03865862 434 435 O

Inclusion NCT03862664 0 9 O
Criteria NCT03862664 10 18 O
: NCT03862664 19 20 O

- NCT03862664 24 25 O
Excellent NCT03862664 27 36 B-Polarity___Polarity-Value:normal
general NCT03862664 37 44 O
physical NCT03862664 45 53 O
and NCT03862664 54 57 O
mental NCT03862664 58 64 O
condition NCT03862664 65 74 B-Condition-Name
, NCT03862664 75 76 O

- NCT03862664 80 81 O
Free NCT03862664 83 87 O
of NCT03862664 88 90 O
chronic NCT03862664 91 98 O
disease NCT03862664 99 106 B-Condition-Name
or NCT03862664 107 109 O

- NCT03862664 112 113 O
Previous NCT03862664 115 123 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
major NCT03862664 124 129 B-Severity___Severity-Value:severe
abdominal NCT03862664 130 139 B-Procedure-Name
surgery NCT03862664 140 147 I-Procedure-Name
, NCT03862664 148 149 O

- NCT03862664 153 154 O
Body NCT03862664 156 160 B-Observation-Name___Observation-Type-Value:vital
mass NCT03862664 161 165 I-Observation-Name___Observation-Type-Value:vital
index NCT03862664 166 171 I-Observation-Name___Observation-Type-Value:vital
( NCT03862664 172 173 O
BMI NCT03862664 174 177 B-Observation-Name___Observation-Type-Value:vital
) NCT03862664 178 179 O
< NCT03862664 180 181 B-Eq-Operator___Eq-Operator-Value:LT
28 NCT03862664 183 185 B-Eq-Value
, NCT03862664 186 187 O

- NCT03862664 192 193 O
ABO NCT03862664 195 198 B-Observation-Name___Observation-Type-Value:lab
blood NCT03862664 199 204 I-Observation-Name___Observation-Type-Value:lab
group NCT03862664 205 210 O
identical NCT03862664 211 220 O
to NCT03862664 221 223 O
recipients NCT03862664 224 234 O
and NCT03862664 235 238 O

- NCT03862664 241 242 O
Negative NCT03862664 244 252 B-Polarity___Polarity-Value:negative
for NCT03862664 253 256 O
hepatitis NCT03862664 257 266 B-Condition-Name
B NCT03862664 267 268 O
, NCT03862664 269 270 O
C NCT03862664 271 272 O
and NCT03862664 273 276 O
human NCT03862664 277 282 B-Condition-Name
immunodeficiency NCT03862664 283 299 I-Condition-Name
viruses NCT03862664 300 307 I-Condition-Name
( NCT03862664 308 309 O
HIV NCT03862664 310 313 B-Condition-Name
) NCT03862664 314 315 O
. NCT03862664 317 318 O

Exclusion NCT03862664 320 329 O
Criteria NCT03862664 330 338 O
: NCT03862664 339 340 O

- NCT03862664 344 345 O
ASA NCT03862664 347 350 B-Condition-Name
physical NCT03862664 351 359 O
status NCT03862664 360 366 O
> NCT03862664 367 368 B-Eq-Operator___Eq-Operator-Value:GT
II NCT03862664 369 371 B-Eq-Value
, NCT03862664 372 373 O

- NCT03862664 377 378 O
BMI NCT03862664 380 383 B-Observation-Name___Observation-Type-Value:vital
> NCT03862664 384 385 B-Eq-Operator___Eq-Operator-Value:GT
28 NCT03862664 387 389 B-Eq-Value
, NCT03862664 390 391 O

- NCT03862664 396 397 O
Psychiatric NCT03862664 399 410 O
or NCT03862664 411 413 O
mental NCT03862664 414 420 O
retardation NCT03862664 421 432 B-Condition-Name
, NCT03862664 433 434 O

- NCT03862664 438 439 O
pregnant NCT03862664 441 449 B-Condition-Name
and NCT03862664 450 453 O
nursing NCT03862664 454 461 B-Condition-Name
women NCT03862664 462 467 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
or NCT03862664 468 470 O

- NCT03862664 473 474 O
Patients NCT03862664 476 484 O
with NCT03862664 485 489 O
significant NCT03862664 490 501 B-Severity___Severity-Value:severe
laboratory NCT03862664 502 512 B-Observation-Name___Observation-Type-Value:lab
abnormalities NCT03862664 513 526 B-Polarity___Polarity-Value:abnormal

Inclusion NCT03867708 0 9 O
Criteria NCT03867708 10 18 O
: NCT03867708 19 20 O

- NCT03867708 24 25 O
Patients NCT03867708 27 35 O
with NCT03867708 36 40 O
suitable NCT03867708 41 49 O
indication NCT03867708 50 60 O
for NCT03867708 61 64 O
ASD NCT03867708 65 68 B-Condition-Name
closure NCT03867708 69 76 B-Procedure-Name
according NCT03867708 77 86 O
to NCT03867708 87 89 O
recent NCT03867708 90 96 O
guidelines NCT03867708 97 107 O
: NCT03867708 108 109 O

1 NCT03867708 119 120 O
. NCT03867708 120 121 O
Impaired NCT03867708 123 131 B-Condition-Name
functional NCT03867708 132 142 I-Condition-Name
capacity NCT03867708 143 151 I-Condition-Name
. NCT03867708 152 153 O

2 NCT03867708 163 164 O
. NCT03867708 164 165 O
Right NCT03867708 167 172 O
atrial NCT03867708 173 179 O
and NCT03867708 180 183 O
/ NCT03867708 184 185 O
or NCT03867708 186 188 O
RV NCT03867708 189 191 O
enlargement NCT03867708 192 203 B-Condition-Name
. NCT03867708 204 205 O

3 NCT03867708 215 216 O
. NCT03867708 216 217 O
Left NCT03867708 219 223 O
- NCT03867708 224 225 O
to NCT03867708 226 228 O
- NCT03867708 229 230 O
right NCT03867708 231 236 O
shunt NCT03867708 237 242 B-Condition-Name
with NCT03867708 243 247 O
[ NCT03867708 248 249 O
Qp NCT03867708 250 252 B-Observation-Name___Observation-Type-Value:measurement
: NCT03867708 253 254 I-Observation-Name___Observation-Type-Value:measurement
Qs NCT03867708 255 257 I-Observation-Name___Observation-Type-Value:measurement
] NCT03867708 258 259 O
≥ NCT03867708 260 261 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.5 NCT03867708 263 266 B-Eq-Value
: NCT03867708 267 268 O
1 NCT03867708 270 271 B-Eq-Value
. NCT03867708 271 272 O

4 NCT03867708 282 283 O
. NCT03867708 283 284 O
Paradoxical NCT03867708 286 297 B-Condition-Name
embolism NCT03867708 298 306 I-Condition-Name
. NCT03867708 307 308 O

- NCT03867708 312 313 O
Patients NCT03867708 315 323 O
with NCT03867708 324 328 O
isolated NCT03867708 329 337 O
secundum NCT03867708 338 346 O
ASD NCT03867708 347 350 B-Condition-Name
with NCT03867708 351 355 O
sufficient NCT03867708 356 366 B-Polarity___Polarity-Value:normal
rims NCT03867708 367 371 B-Observation-Name
suitable NCT03867708 372 380 O
for NCT03867708 381 384 O
device NCT03867708 385 391 B-Procedure-Name
closure NCT03867708 392 399 I-Procedure-Name
. NCT03867708 400 401 O

Exclusion NCT03867708 403 412 O
Criteria NCT03867708 413 421 O
: NCT03867708 422 423 O

- NCT03867708 427 428 O
Small NCT03867708 430 435 O
ASD NCT03867708 436 439 B-Condition-Name
with NCT03867708 440 444 O
Qp NCT03867708 445 447 B-Observation-Name___Observation-Type-Value:measurement
/ NCT03867708 448 449 I-Observation-Name___Observation-Type-Value:measurement
Qs NCT03867708 450 452 I-Observation-Name___Observation-Type-Value:measurement
< NCT03867708 453 454 B-Eq-Operator___Eq-Operator-Value:LT
1.5 NCT03867708 456 459 B-Eq-Value
: NCT03867708 460 461 O
1 NCT03867708 463 464 B-Eq-Value
or NCT03867708 465 467 O
no NCT03867708 468 470 O
signs NCT03867708 471 476 O
of NCT03867708 477 479 O
RV NCT03867708 480 482 B-Condition-Name
volume NCT03867708 483 489 I-Condition-Name
overload NCT03867708 490 498 I-Condition-Name

- NCT03867708 501 502 O
A NCT03867708 504 505 O
single NCT03867708 506 512 B-Eq-Value
defect NCT03867708 513 519 B-Condition-Name
too NCT03867708 520 523 O
large NCT03867708 524 529 O
for NCT03867708 530 533 O
closure NCT03867708 534 541 B-Procedure-Name
( NCT03867708 542 543 O
> NCT03867708 545 546 B-Eq-Operator___Eq-Operator-Value:GT
38 NCT03867708 548 550 B-Eq-Value
mm NCT03867708 551 553 B-Eq-Unit
) NCT03867708 554 555 O

- NCT03867708 559 560 O
Multiple NCT03867708 562 570 B-Eq-Operator___Eq-Operator-Value:GT
ASDs NCT03867708 571 575 B-Condition-Name
unsuitable NCT03867708 576 586 O
for NCT03867708 587 590 O
percutaneous NCT03867708 591 603 B-Procedure-Name
closure NCT03867708 604 611 I-Procedure-Name
. NCT03867708 612 613 O

- NCT03867708 617 618 O
Anterior NCT03867708 620 628 O
, NCT03867708 629 630 O
posterior NCT03867708 631 640 O
, NCT03867708 641 642 O
superior NCT03867708 643 651 O
, NCT03867708 652 653 O
or NCT03867708 654 656 O
inferior NCT03867708 657 665 O
rim NCT03867708 666 669 B-Observation-Name
< NCT03867708 670 671 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03867708 673 674 B-Eq-Value
mm NCT03867708 675 677 B-Eq-Unit
. NCT03867708 678 679 O

- NCT03867708 683 684 O
Abnormal NCT03867708 686 694 B-Polarity___Polarity-Value:abnormal
pulmonary NCT03867708 695 704 B-Condition-Name
venous NCT03867708 705 711 I-Condition-Name
drainage NCT03867708 712 720 I-Condition-Name
. NCT03867708 721 722 O

- NCT03867708 726 727 O
Associated NCT03867708 729 739 O
structural NCT03867708 740 750 O
heart NCT03867708 751 756 B-Condition-Name
disease NCT03867708 757 764 I-Condition-Name
requiring NCT03867708 765 774 O
cardiac NCT03867708 775 782 B-Procedure-Name
surgery NCT03867708 783 790 I-Procedure-Name
. NCT03867708 791 792 O

- NCT03867708 796 797 O
ASD NCT03867708 799 802 B-Condition-Name
with NCT03867708 803 807 O
severe NCT03867708 808 814 B-Severity___Severity-Value:severe
pulmonary NCT03867708 815 824 B-Condition-Name
arterial NCT03867708 825 833 I-Condition-Name
hypertension NCT03867708 834 846 I-Condition-Name
and NCT03867708 847 850 O
bidirectional NCT03867708 851 864 O
or NCT03867708 865 867 O
right NCT03867708 868 873 O
- NCT03867708 874 875 O
to NCT03867708 876 878 O
- NCT03867708 879 880 O
left NCT03867708 881 885 O
shunting NCT03867708 886 894 B-Condition-Name
. NCT03867708 895 896 O

- NCT03867708 900 901 O
Intracardiac NCT03867708 903 915 B-Condition-Name
thrombi NCT03867708 916 923 I-Condition-Name
diagnosed NCT03867708 924 933 O
by NCT03867708 934 936 O
echocardiography NCT03867708 937 953 B-Procedure-Name
. NCT03867708 954 955 O

Inclusion NCT03860701 0 9 O
Criteria NCT03860701 10 18 O
: NCT03860701 19 20 O

- NCT03860701 24 25 O
Patients NCT03860701 27 35 O
with NCT03860701 36 40 O
NEC NCT03860701 41 44 B-Condition-Name
( NCT03860701 45 46 O
stages NCT03860701 47 53 B-Eq-Unit
I NCT03860701 54 55 B-Eq-Value
- NCT03860701 56 57 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03860701 58 61 B-Eq-Value
Bell NCT03860701 62 66 O
's NCT03860701 66 68 O
Classification NCT03860701 69 83 O
) NCT03860701 84 85 O

- NCT03860701 89 90 O
Weight NCT03860701 92 98 B-Observation-Name___Observation-Type-Value:vital
greater NCT03860701 99 106 B-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03860701 107 109 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03860701 110 115 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03860701 116 118 B-Eq-Operator___Eq-Operator-Value:BETWEEN
750 NCT03860701 120 123 B-Eq-Value
g NCT03860701 124 125 B-Eq-Unit
. NCT03860701 126 127 I-Eq-Unit

- NCT03860701 131 132 O
Gestational NCT03860701 134 145 B-Observation-Name___Observation-Type-Value:measurement
age NCT03860701 146 149 I-Observation-Name___Observation-Type-Value:measurement
< NCT03860701 150 151 B-Eq-Operator___Eq-Operator-Value:LT
36 NCT03860701 153 155 B-Eq-Value
weeks NCT03860701 156 161 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03860701 162 163 O

- NCT03860701 167 168 O
Patients NCT03860701 170 178 O
whose NCT03860701 179 184 O
parents NCT03860701 185 192 O
consent NCT03860701 193 200 O
to NCT03860701 201 203 O
participate NCT03860701 204 215 O
in NCT03860701 216 218 O
the NCT03860701 219 222 O
study NCT03860701 223 228 O
. NCT03860701 229 230 O

Exclusion NCT03860701 232 241 O
Criteria NCT03860701 242 250 O
: NCT03860701 251 252 O

- NCT03860701 256 257 O
Patients NCT03860701 259 267 O
with NCT03860701 268 272 O
major NCT03860701 273 278 B-Severity___Severity-Value:severe
congenital NCT03860701 279 289 B-Condition-Name
anomalies NCT03860701 290 299 I-Condition-Name

- NCT03860701 302 303 O
No NCT03860701 305 307 O
antecedent NCT03860701 308 318 O
of NCT03860701 319 321 O
limb NCT03860701 322 326 O
ischemia NCT03860701 327 335 B-Condition-Name
/ NCT03860701 336 337 O
limb NCT03860701 338 342 O
thrombotic NCT03860701 343 353 B-Condition-Name
events NCT03860701 354 360 I-Condition-Name
. NCT03860701 361 362 O

- NCT03860701 366 367 O
No NCT03860701 369 371 O
antecedent NCT03860701 372 382 O
diagnosis NCT03860701 383 392 O
of NCT03860701 393 395 O
occlusive NCT03860701 396 405 O
arterial NCT03860701 406 414 O
or NCT03860701 415 417 O
venous NCT03860701 418 424 O
thrombosis NCT03860701 425 435 B-Condition-Name

- NCT03860701 438 439 O
Hemodynamic NCT03860701 441 452 B-Condition-Name
instability NCT03860701 453 464 B-Stability___Stability-Value:change

Inclusion NCT03867734 0 9 O
Criteria NCT03867734 10 18 O
: NCT03867734 19 20 O

- NCT03867734 24 25 O
Persons NCT03867734 27 34 O
diagnosed NCT03867734 35 44 O
with NCT03867734 45 49 O
pharyngeal NCT03867734 50 60 O
gonorrhea NCT03867734 61 70 B-Condition-Name
or NCT03867734 71 73 O
gonococcal NCT03867734 74 84 O
urethritis NCT03867734 85 95 B-Condition-Name
who NCT03867734 96 99 O
are NCT03867734 100 103 O
undergoing NCT03867734 104 114 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pharyngeal NCT03867734 115 125 B-Procedure-Name
gonorrhea NCT03867734 126 135 I-Procedure-Name
testing NCT03867734 136 143 I-Procedure-Name
, NCT03867734 144 145 O
who NCT03867734 146 149 O
are NCT03867734 150 153 O
not NCT03867734 154 157 O
yet NCT03867734 158 161 O
treated NCT03867734 162 169 O
. NCT03867734 170 171 O

Exclusion NCT03867734 173 182 O
Criteria NCT03867734 183 191 O
: NCT03867734 192 193 O

- NCT03867734 197 198 O
Age NCT03867734 200 203 O
less NCT03867734 204 208 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867734 209 213 I-Eq-Operator___Eq-Operator-Value:LT
16 NCT03867734 215 217 B-Eq-Value
years NCT03867734 218 223 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867734 226 227 O
Receipt NCT03867734 229 236 O
of NCT03867734 237 239 O
antibiotics NCT03867734 240 251 B-Drug-Name
in NCT03867734 252 254 O
≤ NCT03867734 255 256 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03867734 258 260 B-Eq-Value
days NCT03867734 261 265 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03867734 268 269 O
Known NCT03867734 271 276 O
allergy NCT03867734 277 284 O
to NCT03867734 285 287 O
aztreonam NCT03867734 288 297 B-Drug-Name

- NCT03867734 300 301 O
History NCT03867734 303 310 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867734 311 313 O
renal NCT03867734 314 319 B-Condition-Name
disease NCT03867734 320 327 I-Condition-Name
( NCT03867734 328 329 O
including NCT03867734 330 339 O
diagnosis NCT03867734 340 349 O
of NCT03867734 350 352 O
solitary NCT03867734 353 361 B-Condition-Name
kidney NCT03867734 362 368 I-Condition-Name
, NCT03867734 369 370 O
chronic NCT03867734 371 378 O
renal NCT03867734 379 384 B-Condition-Name
insufficiency NCT03867734 385 398 I-Condition-Name
, NCT03867734 399 400 O
renal NCT03867734 401 406 B-Condition-Name
cell NCT03867734 407 411 I-Condition-Name
carcinoma NCT03867734 412 421 I-Condition-Name
etc NCT03867734 422 425 O
. NCT03867734 426 427 O
) NCT03867734 428 429 O

- NCT03867734 433 434 O
Concurrent NCT03867734 436 446 O
infection NCT03867734 447 456 B-Condition-Name
with NCT03867734 457 461 O
syphilis NCT03867734 462 470 B-Condition-Name
or NCT03867734 471 473 O
chlamydia NCT03867734 474 483 B-Condition-Name

- NCT03867734 486 487 O
Pregnancy NCT03867734 489 498 B-Condition-Name
and NCT03867734 499 502 O
/ NCT03867734 503 504 O
or NCT03867734 505 507 O
nursing NCT03867734 508 515 B-Condition-Name

- NCT03867734 518 519 O
Unable NCT03867734 521 527 O
to NCT03867734 528 530 O
return NCT03867734 531 537 O
for NCT03867734 538 541 O
a NCT03867734 542 543 O
follow NCT03867734 544 550 O
- NCT03867734 551 552 O
up NCT03867734 553 555 O
visit NCT03867734 556 561 O
4 NCT03867734 563 564 B-Eq-Value
- NCT03867734 565 566 B-Eq-Operator___Eq-Operator-Value:BETWEEN
7 NCT03867734 568 569 B-Eq-Value
days NCT03867734 570 574 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
( NCT03867734 575 576 O
+ NCT03867734 578 579 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
/ NCT03867734 581 582 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
- NCT03867734 584 585 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
1 NCT03867734 587 588 B-Eq-Value
day NCT03867734 589 592 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03867734 593 594 O
. NCT03867734 596 597 O

- NCT03867734 601 602 O
Study NCT03867734 604 609 O
team NCT03867734 610 614 O
's NCT03867734 614 616 O
discretion NCT03867734 617 627 O

Inclusion NCT03861806 0 9 O
Criteria NCT03861806 10 18 O
: NCT03861806 19 20 O

- NCT03861806 24 25 O
Unilateral NCT03861806 27 37 O
ischemic NCT03861806 38 46 O
stroke NCT03861806 47 53 B-Condition-Name
with NCT03861806 54 58 O
residual NCT03861806 59 67 O
arm NCT03861806 68 71 O
weakness NCT03861806 72 80 B-Condition-Name
( NCT03861806 81 82 O
Fugl NCT03861806 83 87 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03861806 88 89 I-Observation-Name___Observation-Type-Value:clinical-score
Meyer NCT03861806 90 95 I-Observation-Name___Observation-Type-Value:clinical-score
Upper NCT03861806 96 101 I-Observation-Name___Observation-Type-Value:clinical-score
Limb NCT03861806 102 106 I-Observation-Name___Observation-Type-Value:clinical-score
< NCT03861806 107 108 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03861806 110 112 B-Eq-Value
) NCT03861806 113 114 O
more NCT03861806 115 119 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03861806 120 124 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03861806 126 127 B-Eq-Value
months NCT03861806 128 134 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03861806 135 140 O
to NCT03861806 141 143 O
enrollment NCT03861806 144 154 O
. NCT03861806 155 156 O

- NCT03861806 160 161 O
Ability NCT03861806 163 170 O
to NCT03861806 171 173 O
give NCT03861806 174 178 O
informed NCT03861806 179 187 O
consent NCT03861806 188 195 O
and NCT03861806 196 199 O
understand NCT03861806 200 210 O
the NCT03861806 211 214 O
tasks NCT03861806 215 220 O
involved NCT03861806 221 229 O
. NCT03861806 230 231 O

- NCT03861806 235 236 O
Age NCT03861806 238 241 O
over NCT03861806 242 246 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03861806 248 250 B-Eq-Value
years NCT03861806 251 256 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03861806 257 258 O

Exclusion NCT03861806 260 269 O
Criteria NCT03861806 270 278 O
: NCT03861806 279 280 O

- NCT03861806 284 285 O
Hemorrhagic NCT03861806 287 298 O
Stroke NCT03861806 299 305 B-Condition-Name

- NCT03861806 308 309 O
Contraindications NCT03861806 311 328 O
to NCT03861806 329 331 O
TMS NCT03861806 332 335 B-Drug-Name
: NCT03861806 336 337 O
history NCT03861806 338 345 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861806 346 348 O
seizure NCT03861806 349 356 B-Condition-Name
/ NCT03861806 357 358 O
epilepsy NCT03861806 359 367 B-Condition-Name
, NCT03861806 368 369 O
pacemaker NCT03861806 370 379 B-Procedure-Name
, NCT03861806 380 381 O
other NCT03861806 382 387 O
neurological NCT03861806 388 400 B-Condition-Name
disorders NCT03861806 401 410 I-Condition-Name
, NCT03861806 411 412 O
brain NCT03861806 413 418 B-Procedure-Name
surgery NCT03861806 419 426 I-Procedure-Name
, NCT03861806 427 428 O
metal NCT03861806 429 434 B-Procedure-Name
implant NCT03861806 435 442 O
/ NCT03861806 443 444 O
fragment NCT03861806 445 453 O
in NCT03861806 454 456 O
the NCT03861806 457 460 O
head NCT03861806 461 465 O
, NCT03861806 466 467 O
pregnancy NCT03861806 468 477 B-Condition-Name

- NCT03861806 480 481 O
Taking NCT03861806 483 489 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medications NCT03861806 490 501 O
or NCT03861806 502 504 O
substances NCT03861806 505 515 O
that NCT03861806 516 520 O
are NCT03861806 521 524 O
known NCT03861806 525 530 O
to NCT03861806 531 533 O
affect NCT03861806 534 540 B-Stability___Stability-Value:change
PAS NCT03861806 541 544 O
- NCT03861806 545 546 O
induced NCT03861806 547 554 O
plasticity NCT03861806 555 565 B-Condition-Name
within NCT03861806 566 572 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861806 573 576 O
past NCT03861806 577 581 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03861806 583 584 B-Eq-Value
months NCT03861806 585 591 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
: NCT03861806 592 593 O
selective NCT03861806 594 603 O
serotonin NCT03861806 604 613 B-Drug-Name
reuptake NCT03861806 614 622 I-Drug-Name
inhibitors NCT03861806 623 633 I-Drug-Name
, NCT03861806 634 635 O
dopamine NCT03861806 636 644 B-Drug-Name
, NCT03861806 645 646 O
dopamine NCT03861806 647 655 B-Drug-Name
agonists NCT03861806 656 664 I-Drug-Name
, NCT03861806 665 666 O
haloperidol NCT03861806 667 678 B-Drug-Name
, NCT03861806 679 680 O
lithium NCT03861806 681 688 B-Drug-Name
, NCT03861806 689 690 O
acetylcholinesterase NCT03861806 691 711 B-Drug-Name
inhibitors NCT03861806 712 722 I-Drug-Name
, NCT03861806 723 724 O
beta NCT03861806 725 729 B-Drug-Name
- NCT03861806 730 731 I-Drug-Name
blockers NCT03861806 732 740 I-Drug-Name
, NCT03861806 741 742 O
nimodipine NCT03861806 743 753 B-Drug-Name
, NCT03861806 754 755 O
levetiracetam NCT03861806 756 769 B-Drug-Name
, NCT03861806 770 771 O
ethosuximide NCT03861806 772 784 B-Drug-Name
, NCT03861806 785 786 O
benzodiazepines NCT03861806 787 802 B-Drug-Name
, NCT03861806 803 804 O
baclofen NCT03861806 805 813 B-Drug-Name
, NCT03861806 814 815 O
nicotine NCT03861806 816 824 B-Drug-Name

- NCT03861806 827 828 O
Peripheral NCT03861806 830 840 O
neuropathy NCT03861806 841 851 B-Condition-Name
or NCT03861806 852 854 O
history NCT03861806 855 862 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861806 863 865 O
nerve NCT03861806 866 871 O
injury NCT03861806 872 878 B-Condition-Name
in NCT03861806 879 881 O
the NCT03861806 882 885 O
paretic NCT03861806 886 893 O
upper NCT03861806 894 899 O
limb NCT03861806 900 904 O
. NCT03861806 905 906 O

- NCT03861806 910 911 O
Social NCT03861806 913 919 O
and NCT03861806 920 923 O
/ NCT03861806 924 925 O
or NCT03861806 926 928 O
personal NCT03861806 929 937 O
circumstances NCT03861806 938 951 O
that NCT03861806 952 956 O
interfere NCT03861806 957 966 B-Stability___Stability-Value:change
with NCT03861806 967 971 O
ability NCT03861806 972 979 O
to NCT03861806 980 982 O
return NCT03861806 983 989 O
for NCT03861806 990 993 O
all NCT03861806 994 997 O
study NCT03861806 998 1003 O
visits NCT03861806 1004 1010 O
. NCT03861806 1011 1012 O

Inclusion NCT03863977 0 9 O
Criteria NCT03863977 10 18 O
: NCT03863977 19 20 O

- NCT03863977 24 25 O
Patients NCT03863977 27 35 O
' NCT03863977 35 36 O
age NCT03863977 37 40 O
from NCT03863977 41 45 O
18 NCT03863977 47 49 B-Eq-Value
to NCT03863977 50 52 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03863977 54 56 B-Eq-Value
years NCT03863977 57 62 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863977 63 66 O
, NCT03863977 67 68 O

- NCT03863977 72 73 O
physical NCT03863977 75 83 O
status NCT03863977 84 90 O
ASA NCT03863977 91 94 B-Condition-Name
I NCT03863977 95 96 B-Eq-Value
- NCT03863977 97 98 B-Eq-Operator___Eq-Operator-Value:BETWEEN
II NCT03863977 99 101 B-Eq-Value
( NCT03863977 102 103 O
by NCT03863977 104 106 O
the NCT03863977 107 110 O
American NCT03863977 111 119 B-Condition-Name
Society NCT03863977 120 127 I-Condition-Name
of NCT03863977 128 130 I-Condition-Name
Anesthesiologists NCT03863977 131 148 I-Condition-Name
) NCT03863977 149 150 O
, NCT03863977 152 153 O

- NCT03863977 157 158 O
Elective NCT03863977 160 168 O
unilateral NCT03863977 169 179 O
open NCT03863977 180 184 O
inguinal NCT03863977 185 193 B-Procedure-Name
hernia NCT03863977 194 200 I-Procedure-Name
repair NCT03863977 201 207 I-Procedure-Name
, NCT03863977 208 209 O

- NCT03863977 213 214 O
Under NCT03863977 216 221 O
spinal NCT03863977 222 228 B-Procedure-Name
anesthesia NCT03863977 229 239 I-Procedure-Name

Exclusion NCT03863977 240 249 O
Criteria NCT03863977 250 258 O
: NCT03863977 259 260 O

- NCT03863977 264 265 O
age NCT03863977 267 270 O
< NCT03863977 271 272 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03863977 274 276 B-Eq-Value
or NCT03863977 277 279 O
> NCT03863977 280 281 B-Eq-Operator___Eq-Operator-Value:GT
60 NCT03863977 283 285 B-Eq-Value
, NCT03863977 286 287 O

- NCT03863977 292 293 O
American NCT03863977 295 303 B-Condition-Name
society NCT03863977 304 311 I-Condition-Name
of NCT03863977 312 314 I-Condition-Name
anesthesiologist NCT03863977 315 331 I-Condition-Name
( NCT03863977 332 333 O
ASA NCT03863977 334 337 B-Condition-Name
) NCT03863977 338 339 O
class NCT03863977 340 345 O
III NCT03863977 346 349 B-Eq-Value
- NCT03863977 350 351 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IV NCT03863977 352 354 B-Eq-Value
, NCT03863977 355 356 O

- NCT03863977 360 361 O
known NCT03863977 363 368 O
allergy NCT03863977 369 376 O
to NCT03863977 377 379 O
amino NCT03863977 380 385 B-Drug-Name
amide NCT03863977 386 391 I-Drug-Name
local NCT03863977 392 397 I-Drug-Name
anesthetics NCT03863977 398 409 I-Drug-Name
, NCT03863977 410 411 O

- NCT03863977 415 416 O
skin NCT03863977 418 422 O
infection NCT03863977 423 432 B-Condition-Name
and NCT03863977 433 436 O
diseases NCT03863977 437 445 B-Condition-Name
at NCT03863977 446 448 O
site NCT03863977 449 453 O
of NCT03863977 454 456 O
injection NCT03863977 457 466 B-Procedure-Name
. NCT03863977 467 468 O

- NCT03863977 472 473 O
coagulation NCT03863977 475 486 B-Condition-Name
disorders NCT03863977 487 496 I-Condition-Name
, NCT03863977 497 498 O

- NCT03863977 502 503 O
patients NCT03863977 505 513 O
with NCT03863977 514 518 O
body NCT03863977 519 523 B-Observation-Name___Observation-Type-Value:vital
mass NCT03863977 524 528 I-Observation-Name___Observation-Type-Value:vital
index NCT03863977 529 534 I-Observation-Name___Observation-Type-Value:vital
( NCT03863977 535 536 O
BMI NCT03863977 537 540 B-Observation-Name___Observation-Type-Value:vital
) NCT03863977 541 542 O
> NCT03863977 543 544 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03863977 546 548 B-Eq-Value
kg NCT03863977 549 551 B-Eq-Unit
/ NCT03863977 552 553 O
m NCT03863977 554 555 B-Eq-Unit
2 NCT03863977 556 557 I-Eq-Unit
, NCT03863977 558 559 O

- NCT03863977 564 565 O
scrotal NCT03863977 567 574 O
hernias NCT03863977 575 582 B-Condition-Name
, NCT03863977 583 584 O

For NCT03869255 0 3 O
community NCT03869255 4 13 O
patients NCT03869255 14 22 O
: NCT03869255 23 24 O

Inclusion NCT03869255 26 35 O
Criteria NCT03869255 36 44 O
: NCT03869255 45 46 O

- NCT03869255 50 51 O
the NCT03869255 53 56 O
selection NCT03869255 57 66 O
criteria NCT03869255 67 75 O
for NCT03869255 76 79 O
blood NCT03869255 80 85 B-Observation-Name___Observation-Type-Value:social-habit
donation NCT03869255 86 94 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03869255 97 98 O
age NCT03869255 100 103 O
≥ NCT03869255 104 105 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03869255 107 109 B-Eq-Value
years NCT03869255 110 115 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869255 116 119 O

- NCT03869255 122 123 O
No NCT03869255 125 127 O
refusal NCT03869255 128 135 O
of NCT03869255 136 138 O
the NCT03869255 139 142 O
person NCT03869255 143 149 O

Exclusion NCT03869255 150 159 O
Criteria NCT03869255 160 168 O
: NCT03869255 169 170 O

- NCT03869255 174 175 O
None NCT03869255 177 181 O

For NCT03869255 182 185 O
hospitalized NCT03869255 186 198 B-Encounter-Type___Encounter-Type-Value:inpatient
patients NCT03869255 199 207 O
: NCT03869255 208 209 O

Inclusion NCT03869255 211 220 O
Criteria NCT03869255 221 229 O
: NCT03869255 230 231 O

- NCT03869255 235 236 O
age NCT03869255 238 241 O
≥ NCT03869255 242 243 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03869255 245 247 B-Eq-Value
years NCT03869255 248 253 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869255 254 257 O

- NCT03869255 260 261 O
hospitalization NCT03869255 263 278 B-Encounter-Type___Encounter-Type-Value:inpatient
in NCT03869255 279 281 O
one NCT03869255 282 285 O
of NCT03869255 286 288 O
the NCT03869255 289 292 O
services NCT03869255 293 301 O
participating NCT03869255 302 315 O
in NCT03869255 316 318 O
the NCT03869255 319 322 O
study NCT03869255 323 328 O

- NCT03869255 331 332 O
no NCT03869255 334 336 O
refusal NCT03869255 337 344 O
of NCT03869255 345 347 O
the NCT03869255 348 351 O
person NCT03869255 352 358 O

Exclusion NCT03869255 359 368 O
Criteria NCT03869255 369 377 O
: NCT03869255 378 379 O

- NCT03869255 383 384 O
None NCT03869255 386 390 O

Inclusion NCT03864003 0 9 O
Criteria NCT03864003 10 18 O
: NCT03864003 19 20 O

- NCT03864003 24 25 O
Bilateral NCT03864003 27 36 O
hearing NCT03864003 37 44 B-Condition-Name
loss NCT03864003 45 49 I-Condition-Name
within NCT03864003 50 56 O
the NCT03864003 57 60 O
fitting NCT03864003 61 68 O
range NCT03864003 69 74 O
of NCT03864003 75 77 O
study NCT03864003 78 83 O
hearing NCT03864003 84 91 B-Procedure-Name
aids NCT03864003 92 96 I-Procedure-Name

Exclusion NCT03864003 97 106 O
Criteria NCT03864003 107 115 O
: NCT03864003 116 117 O

- NCT03864003 121 122 O
Medically NCT03864003 124 133 O
unqualified NCT03864003 134 145 O
to NCT03864003 146 148 O
receive NCT03864003 149 156 O
hearing NCT03864003 157 164 B-Procedure-Name
aids NCT03864003 165 169 I-Procedure-Name

- NCT03864003 172 173 O
Current NCT03864003 175 182 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hearing NCT03864003 183 190 B-Procedure-Name
aid NCT03864003 191 194 I-Procedure-Name
user NCT03864003 195 199 O

- NCT03864003 202 203 O
Cognitively NCT03864003 205 216 B-Condition-Name
impaired NCT03864003 217 225 I-Condition-Name

Inclusion NCT03868163 0 9 O
Criteria NCT03868163 10 18 O
: NCT03868163 19 20 O

- NCT03868163 24 25 O
Treatment NCT03868163 27 36 O
- NCT03868163 37 38 O
naïve NCT03868163 39 44 O
or NCT03868163 45 47 O
- NCT03868163 48 49 O
pegIFN NCT03868163 50 56 B-Drug-Name
( NCT03868163 57 58 O
or NCT03868163 59 61 O
IFN NCT03868163 62 65 B-Drug-Name
) NCT03868163 66 67 O
, NCT03868163 69 70 O
and NCT03868163 71 74 O
/ NCT03868163 75 76 O
or NCT03868163 77 79 O
Ribavirin NCT03868163 80 89 B-Drug-Name
( NCT03868163 90 91 O
RBV NCT03868163 92 95 B-Drug-Name
) NCT03868163 96 97 O
and NCT03868163 98 101 O
/ NCT03868163 102 103 O
or NCT03868163 104 106 O
sofosbuvir NCT03868163 107 117 B-Drug-Name
( NCT03868163 118 119 O
PRS NCT03868163 120 123 B-Drug-Name
) NCT03868163 124 125 O
experienced NCT03868163 126 137 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
with NCT03868163 138 142 O
confirmed NCT03868163 143 152 O
CHC NCT03868163 153 156 B-Condition-Name
, NCT03868163 157 158 O
genotypes NCT03868163 159 168 O
1 NCT03868163 170 171 O
, NCT03868163 172 173 O
2 NCT03868163 175 176 O
, NCT03868163 177 178 O
3 NCT03868163 180 181 O
, NCT03868163 182 183 O
4 NCT03868163 185 186 O
, NCT03868163 187 188 O
5 NCT03868163 190 191 O
, NCT03868163 192 193 O
or NCT03868163 194 196 O
6 NCT03868163 198 199 O
, NCT03868163 200 201 O
with NCT03868163 202 206 O
or NCT03868163 207 209 O
without NCT03868163 210 217 O
compensated NCT03868163 218 229 O
cirrhosis NCT03868163 230 239 B-Condition-Name
, NCT03868163 240 241 O
receiving NCT03868163 242 251 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
combination NCT03868163 252 263 B-Procedure-Name
therapy NCT03868163 264 271 I-Procedure-Name
with NCT03868163 272 276 O
the NCT03868163 277 280 O
all NCT03868163 281 284 O
oral NCT03868163 285 289 B-Drug-Name
GLE NCT03868163 290 293 I-Drug-Name
/ NCT03868163 294 295 O
PIB NCT03868163 296 299 B-Drug-Name
regimen NCT03868163 300 307 O
according NCT03868163 308 317 O
to NCT03868163 318 320 O
standard NCT03868163 321 329 O
of NCT03868163 330 332 O
care NCT03868163 333 337 O
, NCT03868163 338 339 O
international NCT03868163 340 353 O
guidelines NCT03868163 354 364 O
and NCT03868163 365 368 O
in NCT03868163 369 371 O
line NCT03868163 372 376 O
with NCT03868163 377 381 O
the NCT03868163 382 385 O
current NCT03868163 386 393 O
local NCT03868163 394 399 O
label NCT03868163 400 405 O
. NCT03868163 406 407 O

- NCT03868163 411 412 O
May NCT03868163 414 417 O
be NCT03868163 418 420 O
enrolled NCT03868163 421 429 O
up NCT03868163 430 432 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03868163 433 435 I-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03868163 437 438 B-Eq-Value
weeks NCT03868163 439 444 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03868163 445 450 O
treatment NCT03868163 451 460 O
initiation NCT03868163 461 471 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
. NCT03868163 472 473 O

- NCT03868163 477 478 O
Patients NCT03868163 480 488 O
must NCT03868163 489 493 O
voluntarily NCT03868163 494 505 O
sign NCT03868163 506 510 O
and NCT03868163 511 514 O
date NCT03868163 515 519 O
Informed NCT03868163 520 528 O
Consent NCT03868163 529 536 O
Form NCT03868163 537 541 O
prior NCT03868163 542 547 O
to NCT03868163 548 550 O
inclusion NCT03868163 551 560 O
into NCT03868163 561 565 O
the NCT03868163 566 569 O
study NCT03868163 570 575 O
. NCT03868163 576 577 O

- NCT03868163 581 582 O
Patient NCT03868163 584 591 O
must NCT03868163 592 596 O
not NCT03868163 597 600 O
be NCT03868163 601 603 O
participating NCT03868163 604 617 O
or NCT03868163 618 620 O
intending NCT03868163 621 630 O
to NCT03868163 631 633 O
participate NCT03868163 634 645 O
in NCT03868163 646 648 O
a NCT03868163 649 650 O
concurrent NCT03868163 651 661 O
interventional NCT03868163 662 676 O
therapeutic NCT03868163 677 688 B-Procedure-Name
trial NCT03868163 689 694 O
. NCT03868163 695 696 O

Exclusion NCT03868163 698 707 O
Criteria NCT03868163 708 716 O
: NCT03868163 717 718 O

- NCT03868163 722 723 O
None NCT03868163 725 729 O
. NCT03868163 730 731 O

Inclusion NCT03868605 0 9 O
Criteria NCT03868605 10 18 O
: NCT03868605 19 20 O

- NCT03868605 24 25 O
age NCT03868605 27 30 O
≥ NCT03868605 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868605 34 36 B-Eq-Value
years NCT03868605 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03868605 45 46 O
colorectal NCT03868605 48 58 O
lesions NCT03868605 59 66 B-Condition-Name
of NCT03868605 67 69 O
10 NCT03868605 71 73 B-Eq-Value
- NCT03868605 74 75 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03868605 77 79 B-Eq-Value
mm NCT03868605 80 82 B-Eq-Unit
size NCT03868605 83 87 O
with NCT03868605 88 92 O
positive NCT03868605 93 101 B-Polarity___Polarity-Value:positive
non NCT03868605 102 105 O
- NCT03868605 106 107 O
lifting NCT03868605 108 115 O
sign NCT03868605 116 120 B-Condition-Name

- NCT03868605 123 124 O
signed NCT03868605 126 132 O
informed NCT03868605 133 141 O
consent NCT03868605 142 149 O
with NCT03868605 150 154 O
the NCT03868605 155 158 O
study NCT03868605 159 164 O
and NCT03868605 165 168 O
with NCT03868605 169 173 O
colonoscopy NCT03868605 174 185 B-Procedure-Name

Exclusion NCT03868605 186 195 O
Criteria NCT03868605 196 204 O
: NCT03868605 205 206 O

- NCT03868605 210 211 O
age NCT03868605 213 216 O
< NCT03868605 217 218 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03868605 220 222 B-Eq-Value
years NCT03868605 223 228 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03868605 231 232 O
lesions NCT03868605 234 241 B-Condition-Name
> NCT03868605 242 243 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03868605 245 247 B-Eq-Value
mm NCT03868605 248 250 B-Eq-Unit

- NCT03868605 253 254 O
pedunculated NCT03868605 256 268 B-Condition-Name
polyps NCT03868605 269 275 I-Condition-Name

- NCT03868605 278 279 O
colorectal NCT03868605 281 291 B-Condition-Name
stenosis NCT03868605 292 300 I-Condition-Name

- NCT03868605 303 304 O
colonoscopy NCT03868605 306 317 B-Procedure-Name
contraindication NCT03868605 318 334 O

- NCT03868605 337 338 O
severe NCT03868605 340 346 B-Severity___Severity-Value:severe
acute NCT03868605 347 352 I-Severity___Severity-Value:severe
inflammatory NCT03868605 353 365 B-Condition-Name
bowel NCT03868605 366 371 I-Condition-Name
disease NCT03868605 372 379 I-Condition-Name

- NCT03868605 382 383 O
severe NCT03868605 385 391 B-Severity___Severity-Value:severe
comorbidities NCT03868605 392 405 B-Condition-Name

- NCT03868605 408 409 O
patient NCT03868605 411 418 O
not NCT03868605 419 422 O
able NCT03868605 423 427 O
to NCT03868605 428 430 O
sign NCT03868605 431 435 O
the NCT03868605 436 439 O
informed NCT03868605 440 448 O
consent NCT03868605 449 456 O

Inclusion NCT03860259 0 9 O
Criteria NCT03860259 10 18 O
: NCT03860259 19 20 O

1 NCT03860259 25 26 O
. NCT03860259 26 27 O
Subject NCT03860259 29 36 O
is NCT03860259 37 39 O
greater NCT03860259 40 47 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03860259 48 52 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03860259 54 56 B-Eq-Value
years NCT03860259 57 62 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03860259 63 65 O
age NCT03860259 66 69 O

2 NCT03860259 73 74 O
. NCT03860259 74 75 O
Subject NCT03860259 77 84 O
is NCT03860259 85 87 O
willing NCT03860259 88 95 O
and NCT03860259 96 99 O
able NCT03860259 100 104 O
to NCT03860259 105 107 O
provide NCT03860259 108 115 O
informed NCT03860259 116 124 O
consent NCT03860259 125 132 O

3 NCT03860259 136 137 O
. NCT03860259 137 138 O
Subject NCT03860259 140 147 O
is NCT03860259 148 150 O
scheduled NCT03860259 151 160 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03860259 161 163 O
undergo NCT03860259 164 171 O
elective NCT03860259 172 180 O
rotator NCT03860259 181 188 B-Procedure-Name
cuff NCT03860259 189 193 I-Procedure-Name
surgery NCT03860259 194 201 I-Procedure-Name

4 NCT03860259 205 206 O
. NCT03860259 206 207 O
Subject NCT03860259 209 216 O
has NCT03860259 217 220 O
consented NCT03860259 221 230 O
to NCT03860259 231 233 O
an NCT03860259 234 236 O
interscalene NCT03860259 237 249 B-Procedure-Name
block NCT03860259 250 255 I-Procedure-Name

Exclusion NCT03860259 256 265 O
Criteria NCT03860259 266 274 O
: NCT03860259 275 276 O

1 NCT03860259 281 282 O
. NCT03860259 282 283 O
Opioid NCT03860259 285 291 B-Condition-Name
dependence NCT03860259 292 302 I-Condition-Name

2 NCT03860259 306 307 O
. NCT03860259 307 308 O
Any NCT03860259 310 313 O
subject NCT03860259 314 321 O
diagnosed NCT03860259 322 331 O
with NCT03860259 332 336 O
a NCT03860259 337 338 O
chronic NCT03860259 339 346 O
pain NCT03860259 347 351 B-Condition-Name
condition NCT03860259 352 361 I-Condition-Name
which NCT03860259 362 367 O
daily NCT03860259 368 373 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
opioid NCT03860259 374 380 B-Drug-Name
use NCT03860259 381 384 O
is NCT03860259 385 387 O
needed NCT03860259 388 394 O

3 NCT03860259 398 399 O
. NCT03860259 399 400 O
Anatomical NCT03860259 402 412 B-Condition-Name
malformation NCT03860259 413 425 I-Condition-Name
, NCT03860259 426 427 O
which NCT03860259 428 433 O
in NCT03860259 434 436 O
the NCT03860259 437 440 O
investigator NCT03860259 441 453 O
's NCT03860259 453 455 O
opinion NCT03860259 456 463 O
may NCT03860259 464 467 O
interfere NCT03860259 468 477 B-Stability___Stability-Value:change
with NCT03860259 478 482 O
the NCT03860259 483 486 O
placement NCT03860259 487 496 O
of NCT03860259 497 499 O
the NCT03860259 500 503 O
nerve NCT03860259 504 509 B-Procedure-Name
block NCT03860259 510 515 I-Procedure-Name

4 NCT03860259 519 520 O
. NCT03860259 520 521 O
Raynaud NCT03860259 523 530 B-Condition-Name
's NCT03860259 530 532 I-Condition-Name
disease NCT03860259 533 540 I-Condition-Name
diagnosis NCT03860259 541 550 O

5 NCT03860259 554 555 O
. NCT03860259 555 556 O
Vasculopathy NCT03860259 558 570 B-Condition-Name

6 NCT03860259 574 575 O
. NCT03860259 575 576 O
Patient NCT03860259 578 585 O
refusal NCT03860259 586 593 O

Inclusion NCT03869554 0 9 O
Criteria NCT03869554 10 18 O
: NCT03869554 19 20 O

- NCT03869554 24 25 O
Adult NCT03869554 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patient NCT03869554 33 40 O
( NCT03869554 41 42 O
> NCT03869554 44 45 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03869554 47 49 B-Eq-Value
years NCT03869554 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869554 56 59 O
) NCT03869554 60 61 O

- NCT03869554 65 66 O
Obtaining NCT03869554 68 77 O
consent NCT03869554 78 85 O
to NCT03869554 86 88 O
participate NCT03869554 89 100 O
in NCT03869554 101 103 O
the NCT03869554 104 107 O
study NCT03869554 108 113 O

- NCT03869554 116 117 O
Patients NCT03869554 119 127 O
whose NCT03869554 128 133 O
clinical NCT03869554 134 142 O
presentation NCT03869554 143 155 O
meets NCT03869554 156 161 O
at NCT03869554 162 164 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869554 165 170 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03869554 171 174 B-Eq-Value
of NCT03869554 175 177 O
the NCT03869554 178 181 O
following NCT03869554 182 191 O
criteria NCT03869554 192 200 O
: NCT03869554 201 202 O

- NCT03869554 211 212 O
Undetermined NCT03869554 214 226 O
nephropathy NCT03869554 227 238 B-Condition-Name
despite NCT03869554 239 246 O
renal NCT03869554 247 252 B-Procedure-Name
biopsy NCT03869554 253 259 I-Procedure-Name
, NCT03869554 260 261 O

- NCT03869554 270 271 O
Nephroangiosclerosis NCT03869554 273 293 B-Condition-Name
as NCT03869554 294 296 O
the NCT03869554 297 300 O
predominant NCT03869554 301 312 O
lesion NCT03869554 313 319 B-Condition-Name

- NCT03869554 327 328 O
Chronic NCT03869554 330 337 O
tubulointerstitial NCT03869554 338 356 O
nephropathy NCT03869554 357 368 B-Condition-Name
, NCT03869554 369 370 O

- NCT03869554 379 380 O
Glomerulosclerosis NCT03869554 382 400 B-Condition-Name
, NCT03869554 401 402 O

- NCT03869554 411 412 O
Segmental NCT03869554 414 423 O
and NCT03869554 424 427 O
focal NCT03869554 428 433 O
hyalinosis NCT03869554 434 444 B-Condition-Name
. NCT03869554 445 446 O

- NCT03869554 455 456 O
Optically NCT03869554 458 467 O
normal NCT03869554 468 474 B-Polarity___Polarity-Value:normal
kidney NCT03869554 475 481 O
or NCT03869554 482 484 O
seat NCT03869554 485 489 O
of NCT03869554 490 492 O
minimal NCT03869554 493 500 O
lesions NCT03869554 501 508 B-Condition-Name

Exclusion NCT03869554 509 518 O
Criteria NCT03869554 519 527 O
: NCT03869554 528 529 O

- NCT03869554 533 534 O
Patient NCT03869554 536 543 O
who NCT03869554 544 547 O
has NCT03869554 548 551 O
already NCT03869554 552 559 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
been NCT03869554 560 564 O
screened NCT03869554 565 573 B-Procedure-Name
for NCT03869554 574 577 O
Fabry NCT03869554 578 583 B-Condition-Name
Disease NCT03869554 584 591 I-Condition-Name

- NCT03869554 594 595 O
At NCT03869554 597 599 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869554 600 605 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03869554 606 609 B-Eq-Value
of NCT03869554 610 612 O
the NCT03869554 613 616 O
following NCT03869554 617 626 O
criteria NCT03869554 627 635 O
: NCT03869554 636 637 O

- NCT03869554 646 647 O
Nephrotic NCT03869554 649 658 B-Condition-Name
syndrome NCT03869554 659 667 I-Condition-Name
and NCT03869554 668 671 O
/ NCT03869554 672 673 O
or NCT03869554 674 676 O
Glomerular NCT03869554 677 687 O
nephropathy NCT03869554 688 699 B-Condition-Name

- NCT03869554 707 708 O
Histological NCT03869554 710 722 B-Procedure-Name
diagnosis NCT03869554 723 732 O
of NCT03869554 733 735 O
certain NCT03869554 736 743 O
nephropathies NCT03869554 744 757 B-Condition-Name
( NCT03869554 758 759 O
specific NCT03869554 760 768 O
kidney NCT03869554 769 775 O
lesions NCT03869554 776 783 B-Condition-Name
) NCT03869554 784 785 O

Inclusion NCT03865420 0 9 O
Criteria NCT03865420 10 18 O
: NCT03865420 19 20 O

- NCT03865420 24 25 O
Men NCT03865420 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03865420 31 33 O
women NCT03865420 34 39 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03865420 40 42 O
any NCT03865420 43 46 O
race NCT03865420 47 51 O
or NCT03865420 52 54 O
ethnicity NCT03865420 55 64 O
aged NCT03865420 65 69 O
18 NCT03865420 71 73 B-Eq-Value
or NCT03865420 74 76 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865420 77 82 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03865420 85 86 O
No NCT03865420 88 90 O
symptoms NCT03865420 91 99 O
of NCT03865420 100 102 O
ALS NCT03865420 103 106 B-Condition-Name
or NCT03865420 107 109 O
fronto NCT03865420 110 116 O
- NCT03865420 117 118 O
temporal NCT03865420 119 127 O
dementia NCT03865420 128 136 B-Condition-Name
at NCT03865420 137 139 O
enrollment NCT03865420 140 150 O

- NCT03865420 153 154 O
Have NCT03865420 156 160 O
a NCT03865420 161 162 O
first NCT03865420 163 168 O
degree NCT03865420 169 175 O
relative NCT03865420 176 184 O
who NCT03865420 185 188 O
had NCT03865420 189 192 O
an NCT03865420 193 195 O
ALS NCT03865420 196 199 B-Condition-Name
- NCT03865420 200 201 O
spectrum NCT03865420 202 210 O
diagnosis NCT03865420 211 220 O
with NCT03865420 221 225 O
a NCT03865420 226 227 O
confirmed NCT03865420 228 237 O
ALS NCT03865420 238 241 B-Condition-Name
- NCT03865420 242 243 I-Condition-Name
spectrum NCT03865420 244 252 I-Condition-Name
gene NCT03865420 253 257 I-Condition-Name
mutation NCT03865420 258 266 I-Condition-Name
; NCT03865420 266 267 O
or NCT03865420 268 270 O
already NCT03865420 271 278 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
have NCT03865420 279 283 O
had NCT03865420 284 287 O
genetic NCT03865420 288 295 B-Procedure-Name
testing NCT03865420 296 303 I-Procedure-Name
and NCT03865420 304 307 O
have NCT03865420 308 312 O
tested NCT03865420 313 319 B-Observation-Name___Observation-Type-Value:lab
positive NCT03865420 320 328 B-Polarity___Polarity-Value:positive
for NCT03865420 329 332 O
an NCT03865420 333 335 O
ALS NCT03865420 336 339 B-Condition-Name
- NCT03865420 340 341 I-Condition-Name
spectrum NCT03865420 342 350 I-Condition-Name
gene NCT03865420 351 355 I-Condition-Name
mutation NCT03865420 356 364 I-Condition-Name
. NCT03865420 365 366 O

- NCT03865420 370 371 O
Willing NCT03865420 373 380 O
to NCT03865420 381 383 O
undergo NCT03865420 384 391 O
genetic NCT03865420 392 399 B-Procedure-Name
testing NCT03865420 400 407 I-Procedure-Name
with NCT03865420 408 412 O
option NCT03865420 413 419 O
of NCT03865420 420 422 O
whether NCT03865420 423 430 O
or NCT03865420 431 433 O
not NCT03865420 434 437 O
to NCT03865420 438 440 O
learn NCT03865420 441 446 O
results NCT03865420 447 454 O

- NCT03865420 457 458 O
Willing NCT03865420 460 467 O
to NCT03865420 468 470 O
travel NCT03865420 471 477 O
to NCT03865420 478 480 O
Columbia NCT03865420 481 489 B-Location___Location-Value:hospital
University NCT03865420 490 500 I-Location___Location-Value:hospital
Irving NCT03865420 501 507 I-Location___Location-Value:hospital
Medical NCT03865420 508 515 I-Location___Location-Value:hospital
Center NCT03865420 516 522 I-Location___Location-Value:hospital
( NCT03865420 523 524 O
CUIMC NCT03865420 525 530 B-Location___Location-Value:hospital
) NCT03865420 531 532 O
every NCT03865420 533 538 O
6 NCT03865420 540 541 B-Eq-Value
- NCT03865420 542 543 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03865420 545 547 B-Eq-Value
months NCT03865420 548 554 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
for NCT03865420 555 558 O
study NCT03865420 559 564 O
procedures NCT03865420 565 575 O

- NCT03865420 578 579 O
Capable NCT03865420 581 588 O
of NCT03865420 589 591 O
providing NCT03865420 592 601 O
informed NCT03865420 602 610 O
consent NCT03865420 611 618 O
and NCT03865420 619 622 O
following NCT03865420 623 632 O
study NCT03865420 633 638 O
procedures NCT03865420 639 649 O
, NCT03865420 650 651 O
or NCT03865420 652 654 O
has NCT03865420 655 658 O
a NCT03865420 659 660 O
legally NCT03865420 661 668 O
authorized NCT03865420 669 679 O
representative NCT03865420 680 694 O
who NCT03865420 695 698 O
is NCT03865420 699 701 O
able NCT03865420 702 706 O
to NCT03865420 707 709 O
consent NCT03865420 710 717 O
for NCT03865420 718 721 O
the NCT03865420 722 725 O
subject NCT03865420 726 733 O
. NCT03865420 734 735 O

Exclusion NCT03865420 737 746 O
Criteria NCT03865420 747 755 O
: NCT03865420 756 757 O

- NCT03865420 761 762 O
Known NCT03865420 764 769 O
HIV NCT03865420 770 773 B-Condition-Name

- NCT03865420 776 777 O
Known NCT03865420 779 784 O
hepatitis NCT03865420 785 794 B-Condition-Name
B NCT03865420 795 796 I-Condition-Name

- NCT03865420 799 800 O
Known NCT03865420 802 807 O
hepatitis NCT03865420 808 817 B-Condition-Name
C NCT03865420 818 819 I-Condition-Name

Inclusion NCT03863938 0 9 O
Criteria NCT03863938 10 18 O
: NCT03863938 19 20 O

- NCT03863938 24 25 O
Healthy NCT03863938 27 34 B-Condition-Name
adult NCT03863938 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
males NCT03863938 41 46 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
aged NCT03863938 47 51 O
≥ NCT03863938 52 53 B-Eq-Operator___Eq-Operator-Value:GTEQ
19 NCT03863938 55 57 B-Eq-Value
years NCT03863938 58 63 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03863938 64 67 O
≤ NCT03863938 68 69 B-Eq-Operator___Eq-Operator-Value:LTEQ
50 NCT03863938 71 73 B-Eq-Value
years NCT03863938 74 79 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863938 82 83 O
Body NCT03863938 85 89 B-Observation-Name___Observation-Type-Value:vital
weight NCT03863938 90 96 I-Observation-Name___Observation-Type-Value:vital
of NCT03863938 97 99 O
≥ NCT03863938 100 101 B-Eq-Operator___Eq-Operator-Value:GTEQ
55.0 NCT03863938 103 107 B-Eq-Value
kg NCT03863938 108 110 B-Eq-Unit
and NCT03863938 111 114 O
≤ NCT03863938 115 116 B-Eq-Operator___Eq-Operator-Value:LTEQ
90.0 NCT03863938 118 122 B-Eq-Value
kg NCT03863938 123 125 B-Eq-Unit
, NCT03863938 126 127 O
with NCT03863938 128 132 O
body NCT03863938 133 137 B-Observation-Name___Observation-Type-Value:vital
mass NCT03863938 138 142 I-Observation-Name___Observation-Type-Value:vital
index NCT03863938 143 148 I-Observation-Name___Observation-Type-Value:vital
( NCT03863938 149 150 O
BMI NCT03863938 151 154 B-Observation-Name___Observation-Type-Value:vital
) NCT03863938 155 156 O
of NCT03863938 157 159 O
≥ NCT03863938 160 161 B-Eq-Operator___Eq-Operator-Value:GTEQ
18.0 NCT03863938 163 167 B-Eq-Value
kg NCT03863938 168 170 B-Eq-Unit
/ NCT03863938 171 172 O
m NCT03863938 173 174 B-Eq-Unit
2 NCT03863938 175 176 I-Eq-Unit
and NCT03863938 177 180 O
≤ NCT03863938 181 182 B-Eq-Operator___Eq-Operator-Value:LTEQ
27.0 NCT03863938 184 188 B-Eq-Value
kg NCT03863938 189 191 B-Eq-Unit
/ NCT03863938 192 193 O
m NCT03863938 194 195 B-Eq-Unit
2 NCT03863938 196 197 I-Eq-Unit
at NCT03863938 198 200 O
the NCT03863938 201 204 O
time NCT03863938 205 209 O
of NCT03863938 210 212 O
screening NCT03863938 213 222 O

- NCT03863938 225 226 O
Helicobacter NCT03863938 228 240 B-Organism-Name
pylori NCT03863938 241 247 I-Organism-Name
negative NCT03863938 248 256 B-Polarity___Polarity-Value:positive

Exclusion NCT03863938 257 266 O
Criteria NCT03863938 267 275 O
: NCT03863938 276 277 O

- NCT03863938 281 282 O
Presence NCT03863938 284 292 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03863938 293 295 O
history NCT03863938 296 303 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863938 304 306 O
clinically NCT03863938 307 317 O
significant NCT03863938 318 329 B-Severity___Severity-Value:severe
diseases NCT03863938 330 338 B-Condition-Name

- NCT03863938 341 342 O
Presence NCT03863938 344 352 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03863938 353 355 O
history NCT03863938 356 363 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863938 364 366 O
gastrointestinal NCT03863938 367 383 B-Condition-Name
disorder NCT03863938 384 392 I-Condition-Name
( NCT03863938 393 394 O
gastric NCT03863938 395 402 B-Condition-Name
ulcer NCT03863938 403 408 I-Condition-Name
, NCT03863938 409 410 O
GERD NCT03863938 411 415 B-Condition-Name
, NCT03863938 416 417 O
Crohn NCT03863938 418 423 B-Condition-Name
's NCT03863938 423 425 I-Condition-Name
disease NCT03863938 426 433 I-Condition-Name
, NCT03863938 434 435 O
etc NCT03863938 436 439 O
. NCT03863938 440 441 O
) NCT03863938 442 443 O

- NCT03863938 447 448 O
Hypersensitivity NCT03863938 450 466 B-Condition-Name
to NCT03863938 467 469 O
drugs NCT03863938 470 475 O
containing NCT03863938 476 486 O
study NCT03863938 487 492 O
drug NCT03863938 493 497 O
or NCT03863938 498 500 O
proton NCT03863938 501 507 B-Drug-Name
pump NCT03863938 508 512 I-Drug-Name
inhibitor NCT03863938 513 522 I-Drug-Name
and NCT03863938 523 526 O
other NCT03863938 527 532 O
drugs NCT03863938 533 538 O
( NCT03863938 539 540 O
aspirin NCT03863938 541 548 B-Drug-Name
, NCT03863938 549 550 O
antibiotics NCT03863938 551 562 B-Drug-Name
, NCT03863938 563 564 O
etc NCT03863938 565 568 O
. NCT03863938 569 570 O
) NCT03863938 571 572 O
or NCT03863938 573 575 O
history NCT03863938 576 583 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863938 584 586 O
clinically NCT03863938 587 597 O
significant NCT03863938 598 609 B-Severity___Severity-Value:severe
hypersensitivity NCT03863938 610 626 B-Condition-Name

- NCT03863938 629 630 O
Serologic NCT03863938 632 641 B-Observation-Name___Observation-Type-Value:lab
test NCT03863938 642 646 I-Observation-Name___Observation-Type-Value:lab
positive NCT03863938 647 655 B-Polarity___Polarity-Value:positive

- NCT03863938 658 659 O
Abnormal NCT03863938 661 669 B-Polarity___Polarity-Value:abnormal
obstacle NCT03863938 670 678 B-Stability___Stability-Value:change
to NCT03863938 679 681 O
insertion NCT03863938 682 691 B-Procedure-Name
and NCT03863938 692 695 O
maintenance NCT03863938 696 707 O
of NCT03863938 708 710 O
pH NCT03863938 711 713 B-Procedure-Name
meter NCT03863938 714 719 I-Procedure-Name
catheter NCT03863938 720 728 I-Procedure-Name

- NCT03863938 731 732 O
History NCT03863938 734 741 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863938 742 744 O
drug NCT03863938 745 749 B-Condition-Name
abuse NCT03863938 750 755 I-Condition-Name

- NCT03863938 758 759 O
Excessive NCT03863938 761 770 B-Polarity___Polarity-Value:high
caffeine NCT03863938 771 779 B-Drug-Name
intake NCT03863938 780 786 O
or NCT03863938 787 789 O
persistent NCT03863938 790 800 O
alcohol NCT03863938 801 808 B-Drug-Name
intake NCT03863938 809 815 O

- NCT03863938 818 819 O
Not NCT03863938 821 824 O
use NCT03863938 825 828 O
of NCT03863938 829 831 O
a NCT03863938 832 833 O
medically NCT03863938 834 843 O
acceptable NCT03863938 844 854 O
method NCT03863938 855 861 O
of NCT03863938 862 864 O
contraception NCT03863938 865 878 B-Procedure-Name

Inclusion NCT03863509 0 9 O
Criteria NCT03863509 10 18 O
: NCT03863509 19 20 O

- NCT03863509 24 25 O
able NCT03863509 27 31 O
to NCT03863509 32 34 O
read NCT03863509 35 39 O
and NCT03863509 40 43 O
write NCT03863509 44 49 O
English NCT03863509 50 57 B-Language

- NCT03863509 60 61 O
no NCT03863509 63 65 O
plans NCT03863509 66 71 O
to NCT03863509 72 74 O
quit NCT03863509 75 79 O
smoking NCT03863509 80 87 B-Condition-Name
and NCT03863509 88 91 O
/ NCT03863509 92 93 O
or NCT03863509 94 96 O
e NCT03863509 97 98 B-Drug-Name
- NCT03863509 99 100 I-Drug-Name
cig NCT03863509 101 104 I-Drug-Name
use NCT03863509 105 108 O
in NCT03863509 109 111 O
the NCT03863509 112 115 O
next NCT03863509 116 120 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
month NCT03863509 121 126 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863509 129 130 O
not NCT03863509 132 135 O
using NCT03863509 136 141 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cigars NCT03863509 142 148 B-Drug-Name
/ NCT03863509 149 150 O
smokeless NCT03863509 151 160 B-Drug-Name
/ NCT03863509 161 162 O
snus NCT03863509 163 167 B-Drug-Name
tobacco NCT03863509 168 175 I-Drug-Name
> NCT03863509 176 177 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03863509 179 180 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03863509 182 183 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03863509 185 186 B-Eq-Value
time NCT03863509 187 191 O
per NCT03863509 192 195 O
week NCT03863509 196 200 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03863509 203 204 O
having NCT03863509 206 212 O
a NCT03863509 213 214 O
stable NCT03863509 215 221 B-Stability___Stability-Value:stable
pattern NCT03863509 222 229 O
of NCT03863509 230 232 O
current NCT03863509 233 240 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
product NCT03863509 241 248 O
use NCT03863509 249 252 O

- NCT03863509 255 256 O
able NCT03863509 258 262 B-Condition-Name
to NCT03863509 263 265 I-Condition-Name
walk NCT03863509 266 270 I-Condition-Name
at NCT03863509 271 273 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863509 274 279 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03863509 281 282 B-Eq-Value
blocks NCT03863509 283 289 B-Eq-Unit
without NCT03863509 290 297 O
assistance NCT03863509 298 308 O
or NCT03863509 309 311 O
stopping NCT03863509 312 320 O

- NCT03863509 323 324 O
Specific NCT03863509 326 334 O
to NCT03863509 335 337 O
Exclusive NCT03863509 338 347 O
Smokers NCT03863509 348 355 B-Condition-Name
: NCT03863509 356 357 O

- NCT03863509 366 367 O
smokes NCT03863509 369 375 B-Condition-Name
daily NCT03863509 376 381 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03863509 389 390 O
> NCT03863509 392 393 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03863509 395 396 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03863509 398 399 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03863509 401 402 B-Eq-Value
cigs NCT03863509 403 407 B-Drug-Name
/ NCT03863509 408 409 O
day NCT03863509 410 413 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
for NCT03863509 414 417 O
last NCT03863509 418 422 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03863509 424 425 B-Eq-Value
months NCT03863509 426 432 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863509 440 441 O
< NCT03863509 443 444 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03863509 446 447 B-Eq-Value
uses NCT03863509 448 452 O
E NCT03863509 453 454 B-Observation-Name___Observation-Type-Value:lab
- NCT03863509 455 456 I-Observation-Name___Observation-Type-Value:lab
cigs NCT03863509 457 461 I-Observation-Name___Observation-Type-Value:lab
in NCT03863509 462 464 O
lifetime NCT03863509 465 473 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime

- NCT03863509 481 482 O
> NCT03863509 484 485 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03863509 487 488 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03863509 490 491 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03863509 493 494 B-Eq-Value
ppm NCT03863509 495 498 B-Eq-Unit
carbon NCT03863509 499 505 B-Observation-Name___Observation-Type-Value:lab
monoxide NCT03863509 506 514 I-Observation-Name___Observation-Type-Value:lab
( NCT03863509 515 516 O
CO NCT03863509 517 519 B-Observation-Name
) NCT03863509 520 521 O

- NCT03863509 530 531 O
Cotinine NCT03863509 533 541 B-Observation-Name___Observation-Type-Value:lab
> NCT03863509 542 543 B-Eq-Operator___Eq-Operator-Value:GT
100 NCT03863509 545 548 B-Eq-Value
ng NCT03863509 549 551 B-Eq-Unit
/ NCT03863509 552 553 O
ml NCT03863509 554 556 B-Eq-Unit

- NCT03863509 559 560 O
Specific NCT03863509 562 570 O
to NCT03863509 571 573 O
Exclusive NCT03863509 574 583 O
E NCT03863509 584 585 B-Drug-Name
- NCT03863509 586 587 I-Drug-Name
cig NCT03863509 588 591 I-Drug-Name
users NCT03863509 592 597 O
: NCT03863509 598 599 O

- NCT03863509 608 609 O
< NCT03863509 611 612 B-Eq-Operator___Eq-Operator-Value:LTEQ
/ NCT03863509 614 615 I-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03863509 617 618 I-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03863509 620 621 B-Eq-Value
days NCT03863509 622 626 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
per NCT03863509 627 630 O
month NCT03863509 631 636 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
cigarette NCT03863509 637 646 B-Drug-Name
use NCT03863509 647 650 O
for NCT03863509 651 654 O
last NCT03863509 655 659 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03863509 661 662 B-Eq-Value
months NCT03863509 663 669 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863509 677 678 O
> NCT03863509 680 681 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03863509 683 684 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03863509 686 687 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03863509 689 690 B-Eq-Value
days NCT03863509 691 695 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
per NCT03863509 696 699 O
week NCT03863509 700 704 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
E NCT03863509 705 706 B-Drug-Name
- NCT03863509 707 708 I-Drug-Name
cig NCT03863509 709 712 I-Drug-Name
use NCT03863509 713 716 O
for NCT03863509 717 720 O
last NCT03863509 721 725 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863509 727 728 B-Eq-Value
months NCT03863509 729 735 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863509 743 744 O
< NCT03863509 746 747 B-Eq-Operator___Eq-Operator-Value:LTEQ
/ NCT03863509 749 750 I-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03863509 752 753 I-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03863509 755 756 B-Eq-Value
ppm NCT03863509 757 760 B-Eq-Unit
CO NCT03863509 761 763 B-Observation-Name

- NCT03863509 771 772 O
Cotinine NCT03863509 774 782 B-Observation-Name___Observation-Type-Value:lab
> NCT03863509 783 784 B-Eq-Operator___Eq-Operator-Value:GT
100 NCT03863509 786 789 B-Eq-Value
ng NCT03863509 790 792 B-Eq-Unit
/ NCT03863509 793 794 O
ml NCT03863509 795 797 B-Eq-Unit

- NCT03863509 800 801 O
Specific NCT03863509 803 811 O
to NCT03863509 812 814 O
Dual NCT03863509 815 819 O
users NCT03863509 820 825 O

- NCT03863509 833 834 O
> NCT03863509 836 837 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03863509 839 840 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03863509 842 843 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03863509 845 846 B-Eq-Value
cigs NCT03863509 847 851 B-Drug-Name
/ NCT03863509 852 853 O
day NCT03863509 854 857 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
for NCT03863509 858 861 O
last NCT03863509 862 866 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03863509 868 869 B-Eq-Value
months NCT03863509 870 876 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863509 884 885 O
> NCT03863509 887 888 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03863509 890 891 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03863509 893 894 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03863509 896 897 B-Eq-Value
days NCT03863509 898 902 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
per NCT03863509 903 906 O
week NCT03863509 907 911 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
E NCT03863509 912 913 B-Drug-Name
- NCT03863509 914 915 I-Drug-Name
cig NCT03863509 916 919 I-Drug-Name
use NCT03863509 920 923 O
for NCT03863509 924 927 O
last NCT03863509 928 932 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863509 934 935 B-Eq-Value
months NCT03863509 936 942 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863509 950 951 O
> NCT03863509 953 954 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03863509 956 957 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03863509 959 960 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03863509 962 963 B-Eq-Value
ppm NCT03863509 964 967 B-Eq-Unit
CO NCT03863509 968 970 B-Observation-Name

- NCT03863509 978 979 O
Continine NCT03863509 981 990 B-Observation-Name___Observation-Type-Value:lab
> NCT03863509 991 992 B-Eq-Operator___Eq-Operator-Value:GT
100 NCT03863509 994 997 B-Eq-Value
ng NCT03863509 998 1000 B-Eq-Unit
/ NCT03863509 1001 1002 O
ml NCT03863509 1003 1005 B-Eq-Unit

- NCT03863509 1008 1009 O
Specific NCT03863509 1011 1019 O
to NCT03863509 1020 1022 O
Never NCT03863509 1023 1028 O
- NCT03863509 1029 1030 O
users NCT03863509 1031 1036 O

- NCT03863509 1044 1045 O
< NCT03863509 1047 1048 B-Eq-Operator___Eq-Operator-Value:LT
100 NCT03863509 1050 1053 B-Eq-Value
cigarettes NCT03863509 1054 1064 B-Drug-Name
in NCT03863509 1065 1067 O
a NCT03863509 1068 1069 O
lifetime NCT03863509 1070 1078 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
, NCT03863509 1079 1080 O
none NCT03863509 1081 1085 B-Eq-Value
for NCT03863509 1086 1089 O
> NCT03863509 1090 1091 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03863509 1093 1094 B-Eq-Value
years NCT03863509 1095 1100 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863509 1108 1109 O
< NCT03863509 1111 1112 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03863509 1114 1115 B-Eq-Value
E NCT03863509 1116 1117 B-Drug-Name
- NCT03863509 1118 1119 I-Drug-Name
cig NCT03863509 1120 1123 I-Drug-Name
uses NCT03863509 1124 1128 O
in NCT03863509 1129 1131 O
a NCT03863509 1132 1133 O
lifetime NCT03863509 1134 1142 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime

- NCT03863509 1150 1151 O
< NCT03863509 1153 1154 B-Eq-Operator___Eq-Operator-Value:LTEQ
/ NCT03863509 1156 1157 I-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03863509 1159 1160 I-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03863509 1162 1163 B-Eq-Value
ppm NCT03863509 1164 1167 B-Eq-Unit
CO NCT03863509 1168 1170 B-Observation-Name

- NCT03863509 1178 1179 O
Continine NCT03863509 1181 1190 B-Observation-Name___Observation-Type-Value:lab
< NCT03863509 1191 1192 B-Eq-Operator___Eq-Operator-Value:LT
100 NCT03863509 1194 1197 B-Eq-Value
ng NCT03863509 1198 1200 B-Eq-Unit
/ NCT03863509 1201 1202 O
ml NCT03863509 1203 1205 B-Eq-Unit

Exclusion NCT03863509 1206 1215 O
Criteria NCT03863509 1216 1224 O
: NCT03863509 1225 1226 O

- NCT03863509 1230 1231 O
current NCT03863509 1233 1240 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03863509 1241 1244 O
of NCT03863509 1245 1247 O
a NCT03863509 1248 1249 O
smoking NCT03863509 1250 1257 B-Drug-Name
cessation NCT03863509 1258 1267 I-Drug-Name
medication NCT03863509 1268 1278 I-Drug-Name

- NCT03863509 1281 1282 O
women NCT03863509 1284 1289 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03863509 1290 1293 O
are NCT03863509 1294 1297 O
pregnant NCT03863509 1298 1306 B-Condition-Name
or NCT03863509 1307 1309 O
plan NCT03863509 1310 1314 O
to NCT03863509 1315 1317 O
get NCT03863509 1318 1321 O
pregnant NCT03863509 1322 1330 B-Condition-Name
in NCT03863509 1331 1333 O
the NCT03863509 1334 1337 O
coming NCT03863509 1338 1344 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
month NCT03863509 1345 1350 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863509 1353 1354 O
women NCT03863509 1356 1361 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03863509 1362 1365 O
might NCT03863509 1366 1371 O
be NCT03863509 1372 1374 O
pregnant NCT03863509 1375 1383 B-Condition-Name

- NCT03863509 1386 1387 O
incarcerated NCT03863509 1389 1401 B-Observation-Name
individuals NCT03863509 1402 1413 O

- NCT03863509 1416 1417 O
history NCT03863509 1419 1426 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863509 1427 1429 O
sarcoidosis NCT03863509 1430 1441 B-Condition-Name
in NCT03863509 1442 1444 O
past NCT03863509 1445 1449 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03863509 1451 1452 B-Eq-Value
years NCT03863509 1453 1458 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03863509 1459 1460 O
or NCT03863509 1461 1463 O
active NCT03863509 1464 1470 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
interstitial NCT03863509 1471 1483 O
lung NCT03863509 1484 1488 O
/ NCT03863509 1489 1490 O
pulmonary NCT03863509 1491 1500 O
fibrosis NCT03863509 1501 1509 B-Condition-Name

Inclusion NCT03860766 0 9 O
Criteria NCT03860766 10 18 O
: NCT03860766 19 20 O

- NCT03860766 24 25 O
Handball NCT03860766 27 35 B-Observation-Name
players NCT03860766 36 43 I-Observation-Name
; NCT03860766 43 44 O

- NCT03860766 47 48 O
Healthy NCT03860766 50 57 B-Condition-Name
; NCT03860766 57 58 O

- NCT03860766 61 62 O
Participation NCT03860766 64 77 O
of NCT03860766 78 80 O
at NCT03860766 81 83 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03860766 84 89 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03860766 90 93 B-Eq-Value
official NCT03860766 94 102 B-Observation-Name
match NCT03860766 103 108 I-Observation-Name
in NCT03860766 109 111 O
the NCT03860766 112 115 O
last NCT03860766 116 120 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03860766 121 125 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03860766 126 129 O
attend NCT03860766 130 136 O
70 NCT03860766 138 140 B-Eq-Value
% NCT03860766 141 142 B-Eq-Unit
of NCT03860766 143 145 O
the NCT03860766 146 149 O
team NCT03860766 150 154 B-Observation-Name
's NCT03860766 154 156 I-Observation-Name
activities NCT03860766 157 167 I-Observation-Name
during NCT03860766 168 174 O
the NCT03860766 175 178 O
current NCT03860766 179 186 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
season NCT03860766 187 193 O
. NCT03860766 194 195 O

Exclusion NCT03860766 197 206 O
Criteria NCT03860766 207 215 O
: NCT03860766 216 217 O

- NCT03860766 221 222 O
musculoskeletal NCT03860766 224 239 O
injury NCT03860766 240 246 B-Condition-Name
in NCT03860766 247 249 O
the NCT03860766 250 253 O
last NCT03860766 254 258 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03860766 259 264 B-Eq-Value
months NCT03860766 265 271 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03860766 271 272 O

- NCT03860766 275 276 O
cardiovascular NCT03860766 278 292 B-Condition-Name
diseases NCT03860766 293 301 I-Condition-Name
; NCT03860766 301 302 O

- NCT03860766 305 306 O
use NCT03860766 308 311 O
of NCT03860766 312 314 O
anabolic NCT03860766 315 323 O
, NCT03860766 324 325 O
anti NCT03860766 326 330 O
- NCT03860766 331 332 O
inflammatory NCT03860766 333 345 O
and NCT03860766 346 349 O
analgesic NCT03860766 350 359 O
drugs NCT03860766 360 365 B-Drug-Name
72 NCT03860766 367 369 B-Eq-Value
hours NCT03860766 370 375 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
before NCT03860766 376 382 O
the NCT03860766 383 386 O
evaluations NCT03860766 387 398 O
; NCT03860766 398 399 O

- NCT03860766 402 403 O
use NCT03860766 405 408 O
of NCT03860766 409 411 O
alcohol NCT03860766 412 419 B-Drug-Name
and NCT03860766 420 423 O
illicit NCT03860766 424 431 B-Drug-Name
drugs NCT03860766 432 437 I-Drug-Name
during NCT03860766 438 444 O
the NCT03860766 445 448 O
collection NCT03860766 449 459 O
period NCT03860766 460 466 O
; NCT03860766 466 467 O

Inclusion NCT03866317 0 9 O
Criteria NCT03866317 10 18 O
: NCT03866317 19 20 O

1 NCT03866317 25 26 O
. NCT03866317 26 27 O
Male NCT03866317 29 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03866317 34 36 O
female NCT03866317 37 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subject NCT03866317 44 51 O
18 NCT03866317 53 55 B-Eq-Value
years NCT03866317 56 61 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866317 62 64 O
age NCT03866317 65 68 O
or NCT03866317 69 71 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03866317 72 77 I-Eq-Operator___Eq-Operator-Value:GTEQ

2 NCT03866317 81 82 O
. NCT03866317 82 83 O
Subjects NCT03866317 85 93 O
with NCT03866317 94 98 O
moderate NCT03866317 99 107 B-Severity___Severity-Value:moderate
to NCT03866317 108 110 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03866317 111 117 B-Severity___Severity-Value:severe
DLE NCT03866317 118 121 B-Condition-Name
with NCT03866317 122 126 O
at NCT03866317 127 129 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866317 130 135 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03866317 136 139 B-Eq-Value
active NCT03866317 140 146 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
discoid NCT03866317 147 154 O
target NCT03866317 155 161 O
lesion NCT03866317 162 168 B-Condition-Name
( NCT03866317 169 170 O
0.5 NCT03866317 172 175 B-Eq-Value
- NCT03866317 176 177 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1.0 NCT03866317 179 182 B-Eq-Value
cm NCT03866317 183 185 B-Eq-Unit
2 NCT03866317 186 187 I-Eq-Unit
) NCT03866317 188 189 O
, NCT03866317 191 192 O
with NCT03866317 193 197 O
CLASI NCT03866317 198 203 B-Observation-Name
≥ NCT03866317 204 205 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03866317 207 208 B-Eq-Value
. NCT03866317 208 209 O

3 NCT03866317 214 215 O
. NCT03866317 215 216 O
Willingness NCT03866317 218 229 O
of NCT03866317 230 232 O
subject NCT03866317 233 240 O
to NCT03866317 241 243 O
follow NCT03866317 244 250 O
all NCT03866317 251 254 O
study NCT03866317 255 260 O
procedures NCT03866317 261 271 O

4 NCT03866317 275 276 O
. NCT03866317 276 277 O
Willingness NCT03866317 279 290 O
to NCT03866317 291 293 O
avoid NCT03866317 294 299 O
excessive NCT03866317 300 309 O
exposure NCT03866317 310 318 O
of NCT03866317 319 321 O
diseased NCT03866317 322 330 B-Condition-Name
areas NCT03866317 331 336 O
to NCT03866317 337 339 O
natural NCT03866317 340 347 O
or NCT03866317 348 350 O
artificial NCT03866317 351 361 O
sunlight NCT03866317 362 370 O

Exclusion NCT03866317 371 380 O
Criteria NCT03866317 381 389 O
: NCT03866317 390 391 O

1 NCT03866317 396 397 O
. NCT03866317 397 398 O
Pregnancy NCT03866317 400 409 B-Condition-Name
or NCT03866317 410 412 O
breast NCT03866317 413 419 B-Condition-Name
feeding NCT03866317 420 427 I-Condition-Name

2 NCT03866317 431 432 O
. NCT03866317 432 433 O
Any NCT03866317 435 438 O
condition NCT03866317 439 448 O
or NCT03866317 449 451 O
therapy NCT03866317 452 459 B-Procedure-Name
that NCT03866317 460 464 O
in NCT03866317 465 467 O
the NCT03866317 468 471 O
investigator NCT03866317 472 484 O
's NCT03866317 484 486 O
opinion NCT03866317 487 494 O
may NCT03866317 495 498 O
pose NCT03866317 499 503 B-Stability___Stability-Value:change
a NCT03866317 504 505 O
risk NCT03866317 506 510 O
to NCT03866317 511 513 O
the NCT03866317 514 517 O
subject NCT03866317 518 525 O
or NCT03866317 526 528 O
that NCT03866317 529 533 O
could NCT03866317 534 539 O
interfere NCT03866317 540 549 B-Stability___Stability-Value:change
with NCT03866317 550 554 O
any NCT03866317 555 558 O
evaluation NCT03866317 559 569 O
in NCT03866317 570 572 O
the NCT03866317 573 576 O
study NCT03866317 577 582 O

3 NCT03866317 586 587 O
. NCT03866317 587 588 O
Systemic NCT03866317 590 598 O
Lupus NCT03866317 599 604 B-Condition-Name
Erythematosus NCT03866317 605 618 I-Condition-Name
( NCT03866317 619 620 O
SLE NCT03866317 621 624 B-Condition-Name
) NCT03866317 625 626 O
as NCT03866317 627 629 O
defined NCT03866317 630 637 O
by NCT03866317 638 640 O
ACR NCT03866317 641 644 O
criteria NCT03866317 645 653 O

4 NCT03866317 657 658 O
. NCT03866317 658 659 O
Known NCT03866317 661 666 O
hypersensitivity NCT03866317 667 683 B-Condition-Name
to NCT03866317 684 686 O
any NCT03866317 687 690 O
of NCT03866317 691 693 O
the NCT03866317 694 697 O
constituents NCT03866317 698 710 O
or NCT03866317 711 713 O
excipients NCT03866317 714 724 O
of NCT03866317 725 727 O
the NCT03866317 728 731 O
investigational NCT03866317 732 747 O
product NCT03866317 748 755 O

5 NCT03866317 759 760 O
. NCT03866317 760 761 O
Use NCT03866317 763 766 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03866317 767 769 O
any NCT03866317 770 773 O
prescription NCT03866317 774 786 O
or NCT03866317 787 789 O
non NCT03866317 790 793 O
- NCT03866317 794 795 O
prescription NCT03866317 796 808 O
medication NCT03866317 809 819 O
that NCT03866317 820 824 O
could NCT03866317 825 830 O
interfere NCT03866317 831 840 B-Stability___Stability-Value:change
with NCT03866317 841 845 O
efficacy NCT03866317 846 854 B-Procedure-Name
evaluations NCT03866317 855 866 I-Procedure-Name
in NCT03866317 867 869 O
the NCT03866317 870 873 O
study NCT03866317 874 879 O

6 NCT03866317 883 884 O
. NCT03866317 884 885 O
Change NCT03866317 887 893 B-Stability___Stability-Value:change
in NCT03866317 894 896 O
use NCT03866317 897 900 O
of NCT03866317 901 903 O
systemic NCT03866317 904 912 O
DLE NCT03866317 913 916 B-Procedure-Name
therapy NCT03866317 917 924 I-Procedure-Name
, NCT03866317 925 926 O
e NCT03866317 927 928 O
. NCT03866317 929 930 O
g NCT03866317 931 932 O
. NCT03866317 933 934 O
systemic NCT03866317 936 944 B-Drug-Name
corticosteroids NCT03866317 945 960 I-Drug-Name
, NCT03866317 961 962 O
cyclosporine NCT03866317 963 975 B-Drug-Name
A NCT03866317 976 977 I-Drug-Name
, NCT03866317 978 979 O
azathioprine NCT03866317 980 992 B-Drug-Name
, NCT03866317 993 994 O
mycophenolate NCT03866317 995 1008 B-Drug-Name
mofetil NCT03866317 1009 1016 I-Drug-Name
, NCT03866317 1017 1018 O
in NCT03866317 1019 1021 O
the NCT03866317 1022 1025 O
past NCT03866317 1026 1030 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
1 NCT03866317 1032 1033 B-Eq-Value
month NCT03866317 1034 1039 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03866317 1040 1041 O

7 NCT03866317 1046 1047 O
. NCT03866317 1047 1048 O
Use NCT03866317 1050 1053 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03866317 1054 1056 O
systemic NCT03866317 1057 1065 O
pain NCT03866317 1066 1070 B-Condition-Name
medications NCT03866317 1071 1082 O
, NCT03866317 1083 1084 O
e NCT03866317 1085 1086 O
. NCT03866317 1087 1088 O
g NCT03866317 1089 1090 O
. NCT03866317 1091 1092 O
oxycodone NCT03866317 1094 1103 B-Drug-Name
in NCT03866317 1104 1106 O
the NCT03866317 1107 1110 O
past NCT03866317 1111 1115 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03866317 1117 1118 B-Eq-Value
weeks NCT03866317 1119 1124 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

8 NCT03866317 1128 1129 O
. NCT03866317 1129 1130 O
Participation NCT03866317 1132 1145 O
in NCT03866317 1146 1148 O
another NCT03866317 1149 1156 O
clinical NCT03866317 1157 1165 O
research NCT03866317 1166 1174 O
study NCT03866317 1175 1180 O
with NCT03866317 1181 1185 O
an NCT03866317 1186 1188 O
investigational NCT03866317 1189 1204 O
drug NCT03866317 1205 1209 O
within NCT03866317 1210 1216 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03866317 1218 1219 B-Eq-Value
weeks NCT03866317 1220 1225 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03866317 1226 1232 O
this NCT03866317 1233 1237 O
study NCT03866317 1238 1243 O

9 NCT03866317 1247 1248 O
. NCT03866317 1248 1249 O
Use NCT03866317 1251 1254 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03866317 1255 1257 O
immune NCT03866317 1258 1264 B-Drug-Name
- NCT03866317 1265 1266 I-Drug-Name
suppressant NCT03866317 1267 1278 I-Drug-Name
or NCT03866317 1279 1281 O
other NCT03866317 1282 1287 O
biological NCT03866317 1288 1298 B-Procedure-Name
treatment NCT03866317 1299 1308 I-Procedure-Name

10 NCT03866317 1311 1313 O
. NCT03866317 1313 1314 O
Starting NCT03866317 1316 1324 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antimalarial NCT03866317 1325 1337 B-Drug-Name
medicine NCT03866317 1338 1346 I-Drug-Name
after NCT03866317 1347 1352 O
enrolling NCT03866317 1353 1362 O
in NCT03866317 1363 1365 O
the NCT03866317 1366 1369 O
study NCT03866317 1370 1375 O
. NCT03866317 1376 1377 O
Subjects NCT03866317 1379 1387 O
who NCT03866317 1388 1391 O
are NCT03866317 1392 1395 O
already NCT03866317 1396 1403 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
on NCT03866317 1404 1406 O
a NCT03866317 1407 1408 O
stable NCT03866317 1409 1415 B-Stability___Stability-Value:stable
dose NCT03866317 1416 1420 O
of NCT03866317 1421 1423 O
antimalarial NCT03866317 1424 1436 B-Drug-Name
before NCT03866317 1437 1443 O
enrollment NCT03866317 1444 1454 O
, NCT03866317 1455 1456 O
may NCT03866317 1457 1460 O
continue NCT03866317 1461 1469 O
the NCT03866317 1470 1473 O
same NCT03866317 1474 1478 O
dose NCT03866317 1479 1483 O
. NCT03866317 1484 1485 O

11 NCT03866317 1489 1491 O
. NCT03866317 1491 1492 O
An NCT03866317 1494 1496 O
ongoing NCT03866317 1497 1504 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03866317 1505 1514 B-Condition-Name
. NCT03866317 1515 1516 O

Inclusion NCT03863535 0 9 O
Criteria NCT03863535 10 18 O
: NCT03863535 19 20 O

Type NCT03863535 22 26 O
II NCT03863535 27 29 O
diabetic NCT03863535 30 38 B-Condition-Name
patients NCT03863535 39 47 O
, NCT03863535 48 49 O
18 NCT03863535 51 53 B-Eq-Value
years NCT03863535 54 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03863535 60 63 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03863535 64 69 I-Eq-Operator___Eq-Operator-Value:GTEQ
, NCT03863535 70 71 O
were NCT03863535 72 76 O
included NCT03863535 77 85 O
if NCT03863535 86 88 O
the NCT03863535 89 92 O
participants NCT03863535 93 105 O
had NCT03863535 106 109 O
: NCT03863535 110 111 O

1 NCT03863535 116 117 O
. NCT03863535 117 118 O
severe NCT03863535 120 126 B-Severity___Severity-Value:severe
non NCT03863535 127 130 O
- NCT03863535 131 132 O
PDR NCT03863535 133 136 B-Condition-Name
in NCT03863535 137 139 O
either NCT03863535 140 146 O
eyes NCT03863535 147 151 O
with NCT03863535 152 156 O
/ NCT03863535 157 158 O
without NCT03863535 159 166 O
diabetic NCT03863535 167 175 B-Condition-Name
macular NCT03863535 176 183 I-Condition-Name
edema NCT03863535 184 189 I-Condition-Name
; NCT03863535 189 190 O

2 NCT03863535 194 195 O
. NCT03863535 195 196 O
ETDRS NCT03863535 198 203 O
letters NCT03863535 204 211 O
- NCT03863535 212 213 O
measured NCT03863535 214 222 O
best NCT03863535 223 227 B-Observation-Name___Observation-Type-Value:measurement
- NCT03863535 228 229 I-Observation-Name___Observation-Type-Value:measurement
corrected NCT03863535 230 239 I-Observation-Name___Observation-Type-Value:measurement
visual NCT03863535 240 246 I-Observation-Name___Observation-Type-Value:measurement
acuity NCT03863535 247 253 I-Observation-Name___Observation-Type-Value:measurement
( NCT03863535 254 255 O
BCVA NCT03863535 256 260 B-Observation-Name
) NCT03863535 261 262 O
ranging NCT03863535 263 270 O
from NCT03863535 271 275 O
20 NCT03863535 277 279 B-Eq-Value
/ NCT03863535 280 281 I-Eq-Value
40 NCT03863535 283 285 I-Eq-Value
to NCT03863535 286 288 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03863535 290 292 B-Eq-Value
/ NCT03863535 293 294 I-Eq-Value
320 NCT03863535 296 299 I-Eq-Value
Snellen NCT03863535 300 307 O
equivalent NCT03863535 308 318 O
; NCT03863535 318 319 O

3 NCT03863535 328 329 O
. NCT03863535 329 330 O
no NCT03863535 332 334 O
previous NCT03863535 335 343 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03863535 344 353 O
( NCT03863535 354 355 O
of NCT03863535 356 358 O
any NCT03863535 359 362 O
type NCT03863535 363 367 O
) NCT03863535 368 369 O
in NCT03863535 370 372 O
either NCT03863535 373 379 O
eye NCT03863535 380 383 O
. NCT03863535 384 385 O

Exclusion NCT03863535 387 396 O
Criteria NCT03863535 397 405 O
: NCT03863535 406 407 O

1 NCT03863535 412 413 O
. NCT03863535 413 414 O
history NCT03863535 416 423 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863535 424 426 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
prior NCT03863535 427 432 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
laser NCT03863535 433 438 B-Procedure-Name
treatment NCT03863535 439 448 I-Procedure-Name
or NCT03863535 449 451 O
vitrectomy NCT03863535 452 462 B-Procedure-Name
in NCT03863535 463 465 O
the NCT03863535 466 469 O
study NCT03863535 470 475 O
eye NCT03863535 476 479 O
; NCT03863535 479 480 O

2 NCT03863535 484 485 O
. NCT03863535 485 486 O
history NCT03863535 488 495 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863535 496 498 O
thromboembolic NCT03863535 499 513 B-Condition-Name
event NCT03863535 514 519 I-Condition-Name
- NCT03863535 520 521 O
including NCT03863535 522 531 O
myocardial NCT03863535 532 542 B-Condition-Name
infarction NCT03863535 543 553 I-Condition-Name
or NCT03863535 554 556 O
cerebral NCT03863535 557 565 B-Condition-Name
vascular NCT03863535 566 574 I-Condition-Name
accident NCT03863535 575 583 I-Condition-Name
; NCT03863535 583 584 O

3 NCT03863535 588 589 O
. NCT03863535 589 590 O
major NCT03863535 592 597 B-Severity___Severity-Value:severe
surgery NCT03863535 598 605 B-Procedure-Name
within NCT03863535 606 612 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863535 613 616 O
prior NCT03863535 617 622 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03863535 624 625 B-Eq-Value
months NCT03863535 626 632 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03863535 633 635 O
planned NCT03863535 636 643 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
within NCT03863535 644 650 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863535 651 654 O
next NCT03863535 655 659 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
28 NCT03863535 661 663 B-Eq-Value
days NCT03863535 664 668 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
; NCT03863535 668 669 O

4 NCT03863535 673 674 O
. NCT03863535 674 675 O
history NCT03863535 677 684 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863535 685 687 O
glaucoma NCT03863535 688 696 B-Condition-Name
or NCT03863535 697 699 O
ocular NCT03863535 700 706 O
hypertension NCT03863535 707 719 B-Condition-Name
; NCT03863535 719 720 O

5 NCT03863535 724 725 O
. NCT03863535 725 726 O
loss NCT03863535 728 732 B-Condition-Name
of NCT03863535 733 735 I-Condition-Name
vision NCT03863535 736 742 I-Condition-Name
as NCT03863535 743 745 O
a NCT03863535 746 747 O
result NCT03863535 748 754 O
of NCT03863535 755 757 O
other NCT03863535 758 763 O
causes NCT03863535 764 770 O
; NCT03863535 770 771 O

6 NCT03863535 775 776 O
. NCT03863535 776 777 O
history NCT03863535 779 786 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863535 787 789 O
systemic NCT03863535 790 798 O
corticosteroid NCT03863535 799 813 B-Procedure-Name
therapy NCT03863535 814 821 I-Procedure-Name
within NCT03863535 822 828 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863535 829 832 O
last NCT03863535 833 837 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863535 839 840 B-Eq-Value
months NCT03863535 841 847 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03863535 847 848 O

7 NCT03863535 852 853 O
. NCT03863535 853 854 O
severe NCT03863535 856 862 B-Severity___Severity-Value:severe
systemic NCT03863535 863 871 O
disease NCT03863535 872 879 B-Condition-Name
other NCT03863535 880 885 O
than NCT03863535 886 890 O
diabetes NCT03863535 891 899 B-Condition-Name
mellitus NCT03863535 900 908 I-Condition-Name
; NCT03863535 908 909 O

8 NCT03863535 913 914 O
. NCT03863535 914 915 O
known NCT03863535 917 922 O
coagulation NCT03863535 923 934 B-Condition-Name
abnormalities NCT03863535 935 948 B-Polarity___Polarity-Value:abnormal
or NCT03863535 949 951 O
current NCT03863535 952 959 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03863535 960 963 O
of NCT03863535 964 966 O
anticoagulative NCT03863535 967 982 B-Drug-Name
medication NCT03863535 983 993 I-Drug-Name
other NCT03863535 994 999 O
than NCT03863535 1000 1004 O
aspirin NCT03863535 1005 1012 B-Drug-Name

9 NCT03863535 1016 1017 O
. NCT03863535 1017 1018 O
any NCT03863535 1020 1023 O
condition NCT03863535 1024 1033 O
that NCT03863535 1034 1038 O
could NCT03863535 1039 1044 O
affect NCT03863535 1045 1051 B-Stability___Stability-Value:change
followup NCT03863535 1052 1060 O
or NCT03863535 1061 1063 O
documentation NCT03863535 1064 1077 B-Observation-Name
( NCT03863535 1078 1079 O
including NCT03863535 1080 1089 O
preretinal NCT03863535 1090 1100 O
or NCT03863535 1101 1103 O
vitreous NCT03863535 1104 1112 O
hemorrhage NCT03863535 1113 1123 B-Condition-Name
) NCT03863535 1124 1125 O
. NCT03863535 1127 1128 O


Inclusion NCT03868306 0 9 O
Criteria NCT03868306 10 18 O
: NCT03868306 19 20 O

- NCT03868306 24 25 O
All NCT03868306 27 30 O
patients NCT03868306 31 39 O
with NCT03868306 40 44 O
microcytic NCT03868306 45 55 B-Condition-Name
hypochromic NCT03868306 56 67 I-Condition-Name
anemia NCT03868306 68 74 I-Condition-Name
( NCT03868306 75 76 O
according NCT03868306 77 86 O
to NCT03868306 87 89 O
WHO NCT03868306 90 93 O
, NCT03868306 94 95 O
MCV NCT03868306 96 99 B-Observation-Name___Observation-Type-Value:lab
less NCT03868306 100 104 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868306 105 109 I-Eq-Operator___Eq-Operator-Value:LT
80 NCT03868306 111 113 B-Eq-Value
fl NCT03868306 114 116 B-Eq-Unit
and NCT03868306 117 120 O
HB NCT03868306 121 123 B-Observation-Name___Observation-Type-Value:lab
level NCT03868306 124 129 O
below NCT03868306 130 135 B-Eq-Operator___Eq-Operator-Value:LT
the NCT03868306 136 139 O
lower NCT03868306 140 145 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03868306 146 151 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03868306 152 154 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03868306 155 161 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
value NCT03868306 162 167 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
specified NCT03868306 168 177 O
by NCT03868306 178 180 O
age NCT03868306 181 184 O
and NCT03868306 185 188 O
gender NCT03868306 189 195 O
. NCT03868306 197 198 O

Exclusion NCT03868306 200 209 O
Criteria NCT03868306 210 218 O
: NCT03868306 219 220 O

- NCT03868306 224 225 O
Beta NCT03868306 227 231 B-Condition-Name
thalassemia NCT03868306 232 243 I-Condition-Name
major NCT03868306 244 249 I-Condition-Name
patients NCT03868306 250 258 O
. NCT03868306 260 261 O

- NCT03868306 265 266 O
Chronic NCT03868306 268 275 O
diseases NCT03868306 276 284 B-Condition-Name
or NCT03868306 285 287 O
infections NCT03868306 288 298 B-Condition-Name
. NCT03868306 300 301 O

- NCT03868306 305 306 O
Lead NCT03868306 308 312 B-Condition-Name
poisoning NCT03868306 313 322 I-Condition-Name
. NCT03868306 324 325 O

- NCT03868306 329 330 O
Sideroblastic NCT03868306 332 345 B-Condition-Name
anaemia NCT03868306 346 353 I-Condition-Name
. NCT03868306 355 356 O

Inclusion NCT03867747 0 9 O
Criteria NCT03867747 10 18 O
: NCT03867747 19 20 O

- NCT03867747 24 25 O
Patients NCT03867747 27 35 O
with NCT03867747 36 40 O
structural NCT03867747 41 51 O
heart NCT03867747 52 57 B-Condition-Name
disease NCT03867747 58 65 I-Condition-Name
and NCT03867747 66 69 O
implantable NCT03867747 70 81 B-Procedure-Name
cardioverter NCT03867747 82 94 I-Procedure-Name
defibrillator NCT03867747 95 108 I-Procedure-Name
( NCT03867747 109 110 O
ICD NCT03867747 111 114 B-Procedure-Name
) NCT03867747 115 116 O

- NCT03867747 120 121 O
Age NCT03867747 123 126 O
> NCT03867747 127 128 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03867747 130 132 B-Eq-Value
years NCT03867747 133 138 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867747 141 142 O
either NCT03867747 144 150 O

1 NCT03867747 159 160 O
. NCT03867747 160 161 O
Recurring NCT03867747 163 172 O
symptomatic NCT03867747 173 184 O
monomorphic NCT03867747 185 196 B-Condition-Name
ventricular NCT03867747 197 208 I-Condition-Name
tachycardia NCT03867747 209 220 I-Condition-Name
that NCT03867747 221 225 O
requires NCT03867747 226 234 O
ICD NCT03867747 235 238 B-Procedure-Name
intervention NCT03867747 239 251 I-Procedure-Name
( NCT03867747 252 253 O
e NCT03867747 254 255 O
. NCT03867747 256 257 O
g NCT03867747 258 259 O
. NCT03867747 260 261 O
shock NCT03867747 263 268 O
or NCT03867747 269 271 O
anti NCT03867747 272 276 O
- NCT03867747 277 278 O
tachycardia NCT03867747 279 290 O
stimulation NCT03867747 291 302 B-Procedure-Name
) NCT03867747 303 304 O
. NCT03867747 306 307 O
At NCT03867747 309 311 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867747 312 317 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03867747 319 320 B-Eq-Value
episodes NCT03867747 321 329 O
within NCT03867747 330 336 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867747 337 340 O
3 NCT03867747 342 343 B-Eq-Value
months NCT03867747 344 350 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03867747 351 356 O
to NCT03867747 357 359 O
inclusion NCT03867747 360 369 O
or NCT03867747 370 372 O

2 NCT03867747 381 382 O
. NCT03867747 382 383 O
induction NCT03867747 385 394 O
of NCT03867747 395 397 O
symptomatic NCT03867747 398 409 O
monomorphic NCT03867747 410 421 B-Condition-Name
ventricular NCT03867747 422 433 I-Condition-Name
tachycardia NCT03867747 434 445 I-Condition-Name
that NCT03867747 446 450 O
requires NCT03867747 451 459 O
ICD NCT03867747 460 463 B-Procedure-Name
intervention NCT03867747 464 476 I-Procedure-Name
( NCT03867747 477 478 O
e NCT03867747 479 480 O
. NCT03867747 481 482 O
g NCT03867747 483 484 O
. NCT03867747 485 486 O
shock NCT03867747 488 493 O
or NCT03867747 494 496 O
anti NCT03867747 497 501 O
- NCT03867747 502 503 O
tachycardia NCT03867747 504 515 O
stimulation NCT03867747 516 527 B-Procedure-Name
) NCT03867747 528 529 O
. NCT03867747 531 532 O
Induction NCT03867747 534 543 O
triggered NCT03867747 544 553 O
by NCT03867747 554 556 O
ICD NCT03867747 557 560 B-Procedure-Name
or NCT03867747 561 563 O
during NCT03867747 564 570 O
electrophysiology NCT03867747 571 588 B-Procedure-Name
studies NCT03867747 589 596 I-Procedure-Name
( NCT03867747 597 598 O
EPS NCT03867747 599 602 B-Procedure-Name
) NCT03867747 603 604 O
or NCT03867747 605 607 O
both NCT03867747 608 612 O
, NCT03867747 613 614 O
a NCT03867747 615 616 O
) NCT03867747 617 618 O
and NCT03867747 619 622 O
b NCT03867747 623 624 O
) NCT03867747 625 626 O

- NCT03867747 630 631 O
Refractory NCT03867747 633 643 O
to NCT03867747 644 646 O
antiarrhythmic NCT03867747 647 661 B-Procedure-Name
combination NCT03867747 662 673 I-Procedure-Name
therapy NCT03867747 674 681 I-Procedure-Name

- NCT03867747 684 685 O
Beside NCT03867747 687 693 O
the NCT03867747 694 697 O
cardiac NCT03867747 698 705 B-Condition-Name
conditions NCT03867747 706 716 I-Condition-Name
: NCT03867747 717 718 O
No NCT03867747 719 721 O
competing NCT03867747 722 731 O
illness NCT03867747 732 739 B-Condition-Name
that NCT03867747 740 744 O
would NCT03867747 745 750 O
additionally NCT03867747 751 763 O
limit NCT03867747 764 769 B-Stability___Stability-Value:change
the NCT03867747 770 773 O
life NCT03867747 774 778 B-Observation-Name
expectancy NCT03867747 779 789 I-Observation-Name
to NCT03867747 790 792 O
less NCT03867747 793 797 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867747 798 802 I-Eq-Operator___Eq-Operator-Value:LT
6 NCT03867747 804 805 B-Eq-Value
months NCT03867747 806 812 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03867747 815 816 O
No NCT03867747 818 820 O
prior NCT03867747 821 826 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiation NCT03867747 827 836 B-Procedure-Name
therapy NCT03867747 837 844 I-Procedure-Name
in NCT03867747 845 847 O
the NCT03867747 848 851 O
thorax NCT03867747 852 858 O
area NCT03867747 859 863 O

- NCT03867747 866 867 O
No NCT03867747 869 871 O
pregnancy NCT03867747 872 881 B-Condition-Name
and NCT03867747 882 885 O
no NCT03867747 886 888 O
active NCT03867747 889 895 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
breastfeeding NCT03867747 896 909 B-Condition-Name

- NCT03867747 912 913 O
Ability NCT03867747 915 922 O
to NCT03867747 923 925 O
consent NCT03867747 926 933 O
and NCT03867747 934 937 O
consent NCT03867747 938 945 O
to NCT03867747 946 948 O
study NCT03867747 949 954 O
participation NCT03867747 955 968 O

Exclusion NCT03867747 969 978 O
Criteria NCT03867747 979 987 O
: NCT03867747 988 989 O

- NCT03867747 993 994 O
ICD NCT03867747 996 999 B-Condition-Name
electrode NCT03867747 1000 1009 I-Condition-Name
malfunction NCT03867747 1010 1021 I-Condition-Name
of NCT03867747 1022 1024 O
ICD NCT03867747 1025 1028 B-Procedure-Name
readings NCT03867747 1029 1037 O
outside NCT03867747 1038 1045 B-Polarity___Polarity-Value:abnormal
reference NCT03867747 1046 1055 I-Polarity___Polarity-Value:abnormal
range NCT03867747 1056 1061 I-Polarity___Polarity-Value:abnormal

- NCT03867747 1064 1065 O
Lack NCT03867747 1067 1071 O
of NCT03867747 1072 1074 O
evidence NCT03867747 1075 1083 O
of NCT03867747 1084 1086 O
a NCT03867747 1087 1088 O
myocardial NCT03867747 1089 1099 B-Condition-Name
scar NCT03867747 1100 1104 I-Condition-Name
( NCT03867747 1105 1106 O
Computer NCT03867747 1107 1115 B-Procedure-Name
tomography NCT03867747 1116 1126 I-Procedure-Name
or NCT03867747 1127 1129 O
magnetic NCT03867747 1130 1138 B-Procedure-Name
resonance NCT03867747 1139 1148 I-Procedure-Name
tomography NCT03867747 1149 1159 I-Procedure-Name
for NCT03867747 1160 1163 O
MRI NCT03867747 1164 1167 B-Procedure-Name
- NCT03867747 1168 1169 O
capable NCT03867747 1170 1177 O
ICD NCT03867747 1178 1181 B-Procedure-Name
aggregates NCT03867747 1182 1192 I-Procedure-Name
or NCT03867747 1193 1195 O
electrophysiological NCT03867747 1196 1216 B-Observation-Name___Observation-Type-Value:measurement
measurement NCT03867747 1217 1228 I-Observation-Name___Observation-Type-Value:measurement
) NCT03867747 1229 1230 O

- NCT03867747 1234 1235 O
No NCT03867747 1237 1239 O
possible NCT03867747 1240 1248 O
induction NCT03867747 1249 1258 O
of NCT03867747 1259 1261 O
symptomatic NCT03867747 1262 1273 O
monomorphic NCT03867747 1274 1285 O
ventricular NCT03867747 1286 1297 B-Condition-Name
tachycardia NCT03867747 1298 1309 I-Condition-Name
non NCT03867747 1310 1313 O
- NCT03867747 1314 1315 O
persistent NCT03867747 1316 1326 O
or NCT03867747 1327 1329 O
persistent NCT03867747 1330 1340 O
with NCT03867747 1341 1345 O
delivery NCT03867747 1346 1354 O
of NCT03867747 1355 1357 O
ICD NCT03867747 1358 1361 B-Procedure-Name
therapies NCT03867747 1362 1371 I-Procedure-Name
such NCT03867747 1372 1376 O
as NCT03867747 1377 1379 O
antitachycardic NCT03867747 1380 1395 B-Procedure-Name
pacing NCT03867747 1396 1402 I-Procedure-Name
or NCT03867747 1403 1405 O
shock NCT03867747 1406 1411 B-Procedure-Name

- NCT03867747 1414 1415 O
Contraindication NCT03867747 1417 1433 O
to NCT03867747 1434 1436 O
radiosurgery NCT03867747 1437 1449 B-Procedure-Name
( NCT03867747 1450 1451 O
e NCT03867747 1452 1453 O
. NCT03867747 1454 1455 O
g NCT03867747 1456 1457 O
. NCT03867747 1458 1459 O
precise NCT03867747 1461 1468 O
target NCT03867747 1469 1475 B-Observation-Name___Observation-Type-Value:measurement
volume NCT03867747 1476 1482 I-Observation-Name___Observation-Type-Value:measurement
definition NCT03867747 1483 1493 I-Observation-Name___Observation-Type-Value:measurement
not NCT03867747 1494 1497 O
possible NCT03867747 1498 1506 O
due NCT03867747 1507 1510 O
to NCT03867747 1511 1513 O
image NCT03867747 1514 1519 B-Observation-Name
artifacts NCT03867747 1520 1529 I-Observation-Name
created NCT03867747 1530 1537 O
from NCT03867747 1538 1542 O
a NCT03867747 1543 1544 O
left NCT03867747 1545 1549 B-Procedure-Name
ventricular NCT03867747 1550 1561 I-Procedure-Name
assist NCT03867747 1562 1568 I-Procedure-Name
device NCT03867747 1569 1575 I-Procedure-Name
[ NCT03867747 1576 1577 O
LVAD NCT03867747 1578 1582 B-Procedure-Name
] NCT03867747 1583 1584 O
) NCT03867747 1586 1587 O

- NCT03867747 1591 1592 O
Inability NCT03867747 1594 1603 O
to NCT03867747 1604 1606 O
consent NCT03867747 1607 1614 O
or NCT03867747 1615 1617 O
missing NCT03867747 1618 1625 O
or NCT03867747 1626 1628 O
withdrawn NCT03867747 1629 1638 O
consent NCT03867747 1639 1646 O

Inclusion NCT03865030 0 9 O
Criteria NCT03865030 10 18 O
: NCT03865030 19 20 O

- NCT03865030 24 25 O
Psoriatic NCT03865030 27 36 B-Condition-Name
patients NCT03865030 37 45 O
that NCT03865030 46 50 O
are NCT03865030 51 54 O
treated NCT03865030 55 62 O
in NCT03865030 63 65 O
our NCT03865030 66 69 O
institute NCT03865030 70 79 B-Location___Location-Value:hospital
. NCT03865030 80 81 O

Exclusion NCT03865030 83 92 O
Criteria NCT03865030 93 101 O
: NCT03865030 102 103 O

- NCT03865030 107 108 O
Patients NCT03865030 110 118 O
suffering NCT03865030 119 128 O
from NCT03865030 129 133 O
cardiovascular NCT03865030 134 148 B-Condition-Name
diseases NCT03865030 149 157 I-Condition-Name
( NCT03865030 158 159 O
peripheral NCT03865030 160 170 B-Condition-Name
vascular NCT03865030 171 179 I-Condition-Name
disease NCT03865030 180 187 I-Condition-Name
, NCT03865030 188 189 O
congestive NCT03865030 190 200 B-Condition-Name
heart NCT03865030 201 206 I-Condition-Name
failure NCT03865030 207 214 I-Condition-Name
, NCT03865030 215 216 O
status NCT03865030 217 223 O
post NCT03865030 224 228 O
cerebrovascular NCT03865030 229 244 B-Condition-Name
accident NCT03865030 245 253 I-Condition-Name
) NCT03865030 254 255 O
. NCT03865030 257 258 O

- NCT03865030 262 263 O
Conditions NCT03865030 265 275 O
that NCT03865030 276 280 O
are NCT03865030 281 284 O
harmful NCT03865030 285 292 B-Condition-Name
to NCT03865030 293 295 I-Condition-Name
the NCT03865030 296 299 I-Condition-Name
inner NCT03865030 300 305 I-Condition-Name
ear NCT03865030 306 309 I-Condition-Name
( NCT03865030 310 311 O
chronic NCT03865030 312 319 O
renal NCT03865030 320 325 B-Condition-Name
failure NCT03865030 326 333 I-Condition-Name
, NCT03865030 334 335 O
history NCT03865030 336 343 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865030 344 346 O
noise NCT03865030 347 352 B-Condition-Name
exposure NCT03865030 353 361 I-Condition-Name
, NCT03865030 362 363 O
usage NCT03865030 364 369 O
of NCT03865030 370 372 O
ototoxic NCT03865030 373 381 B-Drug-Name
drugs NCT03865030 382 387 I-Drug-Name
, NCT03865030 388 389 O
chronic NCT03865030 390 397 O
otitis NCT03865030 398 404 B-Condition-Name
media NCT03865030 405 410 I-Condition-Name
, NCT03865030 411 412 O
ear NCT03865030 413 416 B-Procedure-Name
surgery NCT03865030 417 424 I-Procedure-Name
in NCT03865030 425 427 O
the NCT03865030 428 431 O
past NCT03865030 432 436 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
, NCT03865030 437 438 O
significant NCT03865030 439 450 B-Severity___Severity-Value:severe
head NCT03865030 451 455 O
trauma NCT03865030 456 462 B-Condition-Name
in NCT03865030 463 465 O
the NCT03865030 466 469 O
past NCT03865030 470 474 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
, NCT03865030 475 476 O
ear NCT03865030 477 480 B-Condition-Name
drum NCT03865030 481 485 I-Condition-Name
perforation NCT03865030 486 497 I-Condition-Name
) NCT03865030 498 499 O
. NCT03865030 501 502 O

- NCT03865030 506 507 O
participant NCT03865030 509 520 O
that NCT03865030 521 525 O
complains NCT03865030 526 535 O
of NCT03865030 536 538 O
vertigo NCT03865030 539 546 B-Condition-Name
/ NCT03865030 547 548 O
dizziness NCT03865030 549 558 B-Condition-Name
/ NCT03865030 559 560 O
unsteadiness NCT03865030 561 573 B-Condition-Name
. NCT03865030 574 575 O

- NCT03865030 579 580 O
Participant NCT03865030 582 593 O
who NCT03865030 594 597 O
is NCT03865030 598 600 O
/ NCT03865030 601 602 O
was NCT03865030 603 606 O
suffering NCT03865030 607 616 O
from NCT03865030 617 621 O
known NCT03865030 622 627 O
inner NCT03865030 628 633 B-Condition-Name
ear NCT03865030 634 637 I-Condition-Name
disease NCT03865030 638 645 I-Condition-Name
: NCT03865030 646 647 O
meniere NCT03865030 648 655 B-Condition-Name
disease NCT03865030 656 663 I-Condition-Name
, NCT03865030 664 665 O
acoustic NCT03865030 666 674 B-Condition-Name
neurinoma NCT03865030 675 684 I-Condition-Name
, NCT03865030 685 686 O
vestibular NCT03865030 687 697 B-Condition-Name
neuronitis NCT03865030 698 708 I-Condition-Name
. NCT03865030 709 710 O

Inclusion NCT03868514 0 9 O
Criteria NCT03868514 10 18 O
: NCT03868514 19 20 O

Age NCT03868514 22 25 O
[ NCT03868514 26 27 O
≥ NCT03868514 29 30 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868514 32 34 B-Eq-Value
] NCT03868514 35 36 O

Indications NCT03868514 38 49 O
of NCT03868514 50 52 O
breast NCT03868514 53 59 B-Procedure-Name
reconstruction NCT03868514 60 74 I-Procedure-Name
: NCT03868514 75 76 O
histologically NCT03868514 77 91 B-Procedure-Name
confirmed NCT03868514 92 101 O
breast NCT03868514 102 108 O
cancer NCT03868514 109 115 B-Condition-Name
, NCT03868514 116 117 O
precancerous NCT03868514 118 130 O
lesions NCT03868514 131 138 B-Condition-Name
( NCT03868514 139 140 O
DCIS NCT03868514 141 145 B-Condition-Name
, NCT03868514 146 147 O
LCIS NCT03868514 148 152 B-Condition-Name
) NCT03868514 153 154 O
, NCT03868514 156 157 O
mutation NCT03868514 158 166 B-Condition-Name
carrier NCT03868514 167 174 I-Condition-Name
with NCT03868514 175 179 O
increased NCT03868514 180 189 B-Polarity___Polarity-Value:high
breast NCT03868514 190 196 O
cancer NCT03868514 197 203 B-Condition-Name
risk NCT03868514 204 208 O
, NCT03868514 209 210 O
strong NCT03868514 211 217 O
family NCT03868514 218 224 O
history NCT03868514 225 232 O
( NCT03868514 233 234 O
lifetime NCT03868514 235 243 O
risk NCT03868514 244 248 O
> NCT03868514 249 250 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03868514 252 254 B-Eq-Value
% NCT03868514 255 256 B-Eq-Unit
) NCT03868514 258 259 O

The NCT03868514 261 264 O
patient NCT03868514 265 272 O
is NCT03868514 273 275 O
capable NCT03868514 276 283 O
to NCT03868514 284 286 O
realise NCT03868514 287 294 O
the NCT03868514 295 298 O
nature NCT03868514 299 305 O
, NCT03868514 306 307 O
aims NCT03868514 308 312 O
and NCT03868514 313 316 O
possible NCT03868514 317 325 O
consequences NCT03868514 326 338 O
of NCT03868514 339 341 O
the NCT03868514 342 345 O
clinical NCT03868514 346 354 O
trial NCT03868514 355 360 O
( NCT03868514 361 362 O
MPG NCT03868514 363 366 O
§ NCT03868514 367 368 O
20.2.1 NCT03868514 369 375 O
) NCT03868514 376 377 O

Patient NCT03868514 379 386 O
information NCT03868514 387 398 O
has NCT03868514 399 402 O
been NCT03868514 403 407 O
provided NCT03868514 408 416 O
and NCT03868514 417 420 O
all NCT03868514 421 424 O
written NCT03868514 425 432 O
consents NCT03868514 433 441 O
of NCT03868514 442 444 O
the NCT03868514 445 448 O
patient NCT03868514 449 456 O
are NCT03868514 457 460 O
available NCT03868514 461 470 O

Exclusion NCT03868514 471 480 O
Criteria NCT03868514 481 489 O
: NCT03868514 490 491 O

Metastatic NCT03868514 493 503 O
breast NCT03868514 504 510 O
cancer NCT03868514 511 517 B-Condition-Name

Patient NCT03868514 518 525 O
with NCT03868514 526 530 O
known NCT03868514 531 536 O
contraindications NCT03868514 537 554 O
against NCT03868514 555 562 O
mesh NCT03868514 563 567 O
- NCT03868514 568 569 O
assisted NCT03868514 570 578 O
or NCT03868514 579 581 O
plastic NCT03868514 582 589 O
- NCT03868514 590 591 O
reconstructive NCT03868514 592 606 O
breast NCT03868514 607 613 B-Procedure-Name
surgery NCT03868514 614 621 I-Procedure-Name
according NCT03868514 622 631 O
to NCT03868514 632 634 O
the NCT03868514 635 638 O
instruction NCT03868514 639 650 O
for NCT03868514 651 654 O
use NCT03868514 655 658 O

Patient NCT03868514 659 666 O
is NCT03868514 667 669 O
kept NCT03868514 670 674 O
in NCT03868514 675 677 O
an NCT03868514 678 680 O
institution NCT03868514 681 692 B-Observation-Name
under NCT03868514 693 698 I-Observation-Name
judicial NCT03868514 699 707 I-Observation-Name
or NCT03868514 708 710 O
official NCT03868514 711 719 O
orders NCT03868514 720 726 O
( NCT03868514 727 728 O
MPG NCT03868514 729 732 O
§ NCT03868514 733 734 O
20.3 NCT03868514 735 739 O
) NCT03868514 740 741 O

Participate NCT03868514 743 754 O
in NCT03868514 755 757 O
another NCT03868514 758 765 O
operative NCT03868514 766 775 O
clinical NCT03868514 776 784 O
trial NCT03868514 785 790 O
, NCT03868514 791 792 O
if NCT03868514 793 795 O
it NCT03868514 796 798 O
relates NCT03868514 799 806 O
to NCT03868514 807 809 O
the NCT03868514 810 813 O
area NCT03868514 814 818 O
of NCT03868514 819 821 O
reconstructive NCT03868514 822 836 B-Procedure-Name
breast NCT03868514 837 843 I-Procedure-Name
surgery NCT03868514 844 851 I-Procedure-Name
and NCT03868514 852 855 O
/ NCT03868514 856 857 O
or NCT03868514 858 860 O
influences NCT03868514 861 871 B-Stability___Stability-Value:change
the NCT03868514 872 875 O
primary NCT03868514 876 883 O
endpoint NCT03868514 884 892 O
of NCT03868514 893 895 O
the NCT03868514 896 899 O
clinical NCT03868514 900 908 O
trial NCT03868514 909 914 O


Inclusion NCT03863327 0 9 O
Criteria NCT03863327 10 18 O
: NCT03863327 19 20 O

- NCT03863327 24 25 O
Recorded NCT03863327 27 35 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
EKG NCT03863327 36 39 B-Procedure-Name
prior NCT03863327 40 45 O
to NCT03863327 46 48 O
cardiac NCT03863327 49 56 B-Procedure-Name
catheterization NCT03863327 57 72 I-Procedure-Name

Exclusion NCT03863327 73 82 O
Criteria NCT03863327 83 91 O
: NCT03863327 92 93 O

- NCT03863327 97 98 O
Absence NCT03863327 100 107 O
of NCT03863327 108 110 O
documented NCT03863327 111 121 O
EKG NCT03863327 122 125 B-Procedure-Name
prior NCT03863327 126 131 O
to NCT03863327 132 134 O
cardiac NCT03863327 135 142 B-Procedure-Name
catheterization NCT03863327 143 158 I-Procedure-Name

Inclusion NCT03863496 0 9 O
Criteria NCT03863496 10 18 O
: NCT03863496 19 20 O

- NCT03863496 24 25 O
Signed NCT03863496 27 33 O
and NCT03863496 34 37 O
dated NCT03863496 38 43 O
informed NCT03863496 44 52 O
consent NCT03863496 53 60 O
for NCT03863496 61 64 O
participation NCT03863496 65 78 O
in NCT03863496 79 81 O
the NCT03863496 82 85 O
study NCT03863496 86 91 O
( NCT03863496 92 93 O
separate NCT03863496 94 102 O
informed NCT03863496 103 111 O
consents NCT03863496 112 120 O
for NCT03863496 121 124 O
child NCT03863496 125 130 O
and NCT03863496 131 134 O
parents NCT03863496 135 142 O
/ NCT03863496 143 144 O
caregivers NCT03863496 145 155 O
) NCT03863496 156 157 O
, NCT03863496 159 160 O
obtained NCT03863496 161 169 O
before NCT03863496 170 176 O
conducting NCT03863496 177 187 O
any NCT03863496 188 191 O
study NCT03863496 192 197 O
procedures NCT03863496 198 208 O

- NCT03863496 211 212 O
Verified NCT03863496 214 222 O
and NCT03863496 223 226 O
documented NCT03863496 227 237 O
diagnosis NCT03863496 238 247 O
( NCT03863496 248 249 O
neuromuscular NCT03863496 250 263 B-Condition-Name
desease NCT03863496 264 271 I-Condition-Name
, NCT03863496 272 273 O
NMD NCT03863496 274 277 B-Condition-Name
) NCT03863496 278 279 O
with NCT03863496 280 284 O
the NCT03863496 285 288 O
results NCT03863496 289 296 O
of NCT03863496 297 299 O
neurologic NCT03863496 300 310 B-Procedure-Name
examination NCT03863496 311 322 I-Procedure-Name

- NCT03863496 325 326 O
Deformity NCT03863496 328 337 B-Condition-Name
of NCT03863496 338 340 O
thoracic NCT03863496 341 349 O
and NCT03863496 350 353 O
/ NCT03863496 354 355 O
or NCT03863496 356 358 O
lumbar NCT03863496 359 365 O
spine NCT03863496 366 371 O
associated NCT03863496 372 382 O
with NCT03863496 383 387 O
NMD NCT03863496 388 391 B-Condition-Name
, NCT03863496 392 393 O
which NCT03863496 394 399 O
requires NCT03863496 400 408 O
surgical NCT03863496 409 417 B-Procedure-Name
intervention NCT03863496 418 430 I-Procedure-Name

Exclusion NCT03863496 431 440 O
Criteria NCT03863496 441 449 O
: NCT03863496 450 451 O

- NCT03863496 455 456 O
Patient NCT03863496 458 465 O
unwillingness NCT03863496 466 479 O
or NCT03863496 480 482 O
inability NCT03863496 483 492 O
to NCT03863496 493 495 O
follow NCT03863496 496 502 O
study NCT03863496 503 508 O
procedures NCT03863496 509 519 O

- NCT03863496 522 523 O
Absence NCT03863496 525 532 O
of NCT03863496 533 535 O
signed NCT03863496 536 542 O
and NCT03863496 543 546 O
dated NCT03863496 547 552 O
informed NCT03863496 553 561 O
consent NCT03863496 562 569 O
for NCT03863496 570 573 O
participation NCT03863496 574 587 O
in NCT03863496 588 590 O
the NCT03863496 591 594 O
study NCT03863496 595 600 O
( NCT03863496 601 602 O
as NCT03863496 603 605 O
for NCT03863496 606 609 O
child NCT03863496 610 615 O
and NCT03863496 616 619 O
for NCT03863496 620 623 O
parents NCT03863496 624 631 O
/ NCT03863496 632 633 O
caregivers NCT03863496 634 644 O
) NCT03863496 645 646 O

- NCT03863496 650 651 O
Patient NCT03863496 653 660 O
participation NCT03863496 661 674 O
in NCT03863496 675 677 O
another NCT03863496 678 685 O
clinical NCT03863496 686 694 O
study NCT03863496 695 700 O
, NCT03863496 701 702 O
which NCT03863496 703 708 O
can NCT03863496 709 712 O
influence NCT03863496 713 722 B-Stability___Stability-Value:change
the NCT03863496 723 726 O
results NCT03863496 727 734 O
of NCT03863496 735 737 O
this NCT03863496 738 742 O
study NCT03863496 743 748 O

- NCT03863496 751 752 O
Left NCT03863496 754 758 B-Observation-Name___Observation-Type-Value:measurement
ventricle NCT03863496 759 768 I-Observation-Name___Observation-Type-Value:measurement
ejection NCT03863496 769 777 I-Observation-Name___Observation-Type-Value:measurement
fraction NCT03863496 778 786 I-Observation-Name___Observation-Type-Value:measurement
less NCT03863496 787 791 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03863496 792 796 I-Eq-Operator___Eq-Operator-Value:LT
40 NCT03863496 798 800 B-Eq-Value
% NCT03863496 801 802 B-Eq-Unit
by NCT03863496 803 805 O
echocardiography NCT03863496 806 822 B-Procedure-Name

- NCT03863496 825 826 O
FEV NCT03863496 828 831 B-Observation-Name___Observation-Type-Value:measurement
> NCT03863496 832 833 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03863496 835 837 B-Eq-Value

- NCT03863496 841 842 O
Life NCT03863496 844 848 B-Observation-Name
expectancy NCT03863496 849 859 I-Observation-Name
< NCT03863496 860 861 B-Eq-Operator___Eq-Operator-Value:LT
12 NCT03863496 863 865 B-Eq-Value
months NCT03863496 866 872 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863496 875 876 O
Liver NCT03863496 878 883 B-Condition-Name
insufficiency NCT03863496 884 897 I-Condition-Name
: NCT03863496 898 899 O
ALT NCT03863496 900 903 B-Observation-Name___Observation-Type-Value:lab
, NCT03863496 904 905 O
AST NCT03863496 906 909 B-Observation-Name___Observation-Type-Value:lab
and NCT03863496 910 913 O
total NCT03863496 914 919 B-Observation-Name___Observation-Type-Value:lab
bilirubin NCT03863496 920 929 I-Observation-Name___Observation-Type-Value:lab
twice NCT03863496 930 935 B-Eq-Value
higher NCT03863496 936 942 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863496 943 947 I-Eq-Operator___Eq-Operator-Value:GT
normal NCT03863496 948 954 B-Eq-Unit___Eq-Unit-Value:ref-range-normal

- NCT03863496 957 958 O
Kidney NCT03863496 960 966 B-Condition-Name
insufficiency NCT03863496 967 980 I-Condition-Name
( NCT03863496 981 982 O
creatinine NCT03863496 983 993 B-Observation-Name___Observation-Type-Value:lab
clearance NCT03863496 994 1003 I-Observation-Name___Observation-Type-Value:lab
< NCT03863496 1004 1005 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03863496 1007 1009 B-Eq-Value
ml NCT03863496 1010 1012 B-Eq-Unit
/ NCT03863496 1013 1014 O
min NCT03863496 1015 1018 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
) NCT03863496 1019 1020 O

- NCT03863496 1024 1025 O
Concomitant NCT03863496 1027 1038 O
diseases NCT03863496 1039 1047 B-Condition-Name
, NCT03863496 1048 1049 O
which NCT03863496 1050 1055 O
preclude NCT03863496 1056 1064 O
patient NCT03863496 1065 1072 O
participation NCT03863496 1073 1086 O
in NCT03863496 1087 1089 O
this NCT03863496 1090 1094 O
study NCT03863496 1095 1100 O
according NCT03863496 1101 1110 O
to NCT03863496 1111 1113 O
doctor NCT03863496 1114 1120 O
's NCT03863496 1120 1122 O
opinion NCT03863496 1123 1130 O

Inclusion NCT03866707 0 9 O
Criteria NCT03866707 10 18 O
: NCT03866707 19 20 O

- NCT03866707 24 25 O
Childhood NCT03866707 27 36 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
cancer NCT03866707 37 43 B-Condition-Name
survivors NCT03866707 44 53 O
age NCT03866707 54 57 O
1 NCT03866707 59 60 B-Eq-Value
- NCT03866707 61 62 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03866707 64 66 B-Eq-Value
years NCT03866707 67 72 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866707 73 76 O
who NCT03866707 77 80 O
received NCT03866707 81 89 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
intensive NCT03866707 90 99 O
treatment NCT03866707 100 109 O
which NCT03866707 110 115 O
included NCT03866707 116 124 O
anthracycline NCT03866707 125 138 B-Drug-Name
and NCT03866707 139 142 O
/ NCT03866707 143 144 O
or NCT03866707 145 147 O
alkylating NCT03866707 148 158 B-Drug-Name
agent NCT03866707 159 164 I-Drug-Name
chemotherapy NCT03866707 165 177 B-Procedure-Name
. NCT03866707 178 179 O

- NCT03866707 183 184 O
Diseases NCT03866707 186 194 B-Condition-Name
which NCT03866707 195 200 O
will NCT03866707 201 205 O
be NCT03866707 206 208 O
eligible NCT03866707 209 217 O
include NCT03866707 218 225 O
, NCT03866707 226 227 O
high NCT03866707 228 232 B-Polarity___Polarity-Value:high
risk NCT03866707 233 237 O
or NCT03866707 238 240 O
very NCT03866707 241 245 O
high NCT03866707 246 250 B-Polarity___Polarity-Value:high
risk NCT03866707 251 255 O
acute NCT03866707 256 261 B-Severity___Severity-Value:severe
lymphoblastic NCT03866707 262 275 B-Condition-Name
leukemia NCT03866707 276 284 I-Condition-Name
, NCT03866707 285 286 O
acute NCT03866707 287 292 B-Severity___Severity-Value:severe
myeloid NCT03866707 293 300 B-Condition-Name
leukemia NCT03866707 301 309 I-Condition-Name
, NCT03866707 310 311 O
Hodgkin NCT03866707 312 319 B-Condition-Name
lymphoma NCT03866707 320 328 I-Condition-Name
, NCT03866707 329 330 O
non NCT03866707 331 334 O
- NCT03866707 335 336 O
Hodgkin NCT03866707 337 344 O
lymphoma NCT03866707 345 353 B-Condition-Name
, NCT03866707 354 355 O
sarcomas NCT03866707 356 364 B-Condition-Name
. NCT03866707 365 366 O

Healthy NCT03866707 368 375 B-Condition-Name
controls NCT03866707 376 384 O
: NCT03866707 385 386 O

• NCT03866707 388 389 O
Healthy NCT03866707 390 397 B-Condition-Name
controls NCT03866707 398 406 O
are NCT03866707 407 410 O
defined NCT03866707 411 418 O
as NCT03866707 419 421 O
children NCT03866707 422 430 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
ages NCT03866707 431 435 O
1 NCT03866707 437 438 B-Eq-Value
- NCT03866707 439 440 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03866707 442 444 B-Eq-Value
years NCT03866707 445 450 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866707 451 454 O
who NCT03866707 455 458 O
are NCT03866707 459 462 O
free NCT03866707 463 467 O
from NCT03866707 468 472 O
diseases NCT03866707 473 481 B-Condition-Name
or NCT03866707 482 484 O
medical NCT03866707 485 492 O
conditions NCT03866707 493 503 O
that NCT03866707 504 508 O
might NCT03866707 509 514 O
be NCT03866707 515 517 O
affected NCT03866707 518 526 B-Stability___Stability-Value:change
by NCT03866707 527 529 O
or NCT03866707 530 532 O
have NCT03866707 533 537 O
an NCT03866707 538 540 O
impact NCT03866707 541 547 B-Stability___Stability-Value:change
on NCT03866707 548 550 O
this NCT03866707 551 555 O
research NCT03866707 556 564 O
study NCT03866707 565 570 O
. NCT03866707 571 572 O
Healthy NCT03866707 574 581 B-Condition-Name
controls NCT03866707 582 590 O
will NCT03866707 591 595 O
be NCT03866707 596 598 O
matched NCT03866707 599 606 O
with NCT03866707 607 611 O
patients NCT03866707 612 620 O
for NCT03866707 621 624 O
age NCT03866707 625 628 O
, NCT03866707 629 630 O
sex NCT03866707 631 634 O
, NCT03866707 635 636 O
ethnicity NCT03866707 637 646 O
, NCT03866707 647 648 O
geographic NCT03866707 649 659 O
region NCT03866707 660 666 O
, NCT03866707 667 668 O
and NCT03866707 669 672 O
tanner NCT03866707 673 679 O
stage NCT03866707 680 685 O
, NCT03866707 686 687 O
since NCT03866707 688 693 O
it NCT03866707 694 696 O
is NCT03866707 697 699 O
known NCT03866707 700 705 O
that NCT03866707 706 710 O
these NCT03866707 711 716 O
factors NCT03866707 717 724 O
can NCT03866707 725 728 O
affect NCT03866707 729 735 B-Stability___Stability-Value:change
the NCT03866707 736 739 O
epigenetic NCT03866707 740 750 B-Observation-Name
signature NCT03866707 751 760 I-Observation-Name
of NCT03866707 761 763 O
an NCT03866707 764 766 O
individual NCT03866707 767 777 O
. NCT03866707 778 779 O
Controls NCT03866707 781 789 O
will NCT03866707 790 794 O
already NCT03866707 795 802 O
be NCT03866707 803 805 O
having NCT03866707 806 812 O
blood NCT03866707 813 818 B-Observation-Specimen
drawn NCT03866707 819 824 O
as NCT03866707 825 827 O
part NCT03866707 828 832 O
of NCT03866707 833 835 O
their NCT03866707 836 841 O
routine NCT03866707 842 849 B-Procedure-Name
care NCT03866707 850 854 I-Procedure-Name
. NCT03866707 855 856 O

Exclusion NCT03866707 858 867 O
Criteria NCT03866707 868 876 O
: NCT03866707 877 878 O

Cancer NCT03866707 880 886 B-Condition-Name
survivors NCT03866707 887 896 O
: NCT03866707 897 898 O

• NCT03866707 900 901 O
Patients NCT03866707 902 910 O
who NCT03866707 911 914 O
have NCT03866707 915 919 O
received NCT03866707 920 928 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03866707 929 930 O
bone NCT03866707 931 935 B-Procedure-Name
marrow NCT03866707 936 942 I-Procedure-Name
transplant NCT03866707 943 953 I-Procedure-Name
will NCT03866707 954 958 O
not NCT03866707 959 962 O
be NCT03866707 963 965 O
eligible NCT03866707 966 974 O
. NCT03866707 975 976 O

Healthy NCT03866707 978 985 B-Condition-Name
controls NCT03866707 986 994 O
: NCT03866707 995 996 O

• NCT03866707 998 999 O
Age NCT03866707 1000 1003 O
, NCT03866707 1004 1005 O
sex NCT03866707 1006 1009 O
, NCT03866707 1010 1011 O
ethnicity NCT03866707 1012 1021 O
, NCT03866707 1022 1023 O
geographic NCT03866707 1024 1034 O
region NCT03866707 1035 1041 O
, NCT03866707 1042 1043 O
and NCT03866707 1044 1047 O
tanner NCT03866707 1048 1054 O
stage NCT03866707 1055 1060 O
matched NCT03866707 1061 1068 O
controls NCT03866707 1069 1077 O
with NCT03866707 1078 1082 O
any NCT03866707 1083 1086 O
acute NCT03866707 1087 1092 B-Severity___Severity-Value:severe
or NCT03866707 1093 1095 O
chronic NCT03866707 1096 1103 O
disease NCT03866707 1104 1111 B-Condition-Name
will NCT03866707 1112 1116 O
be NCT03866707 1117 1119 O
excluded NCT03866707 1120 1128 O
. NCT03866707 1129 1130 O


Inclusion NCT03860376 0 9 O
Criteria NCT03860376 10 18 O
: NCT03860376 19 20 O

- NCT03860376 24 25 O
Patients NCT03860376 27 35 O
aged NCT03860376 36 40 O
21 NCT03860376 42 44 B-Eq-Value
years NCT03860376 45 50 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03860376 51 53 B-Eq-Operator___Eq-Operator-Value:LTEQ
younger NCT03860376 54 61 I-Eq-Operator___Eq-Operator-Value:LTEQ
at NCT03860376 62 64 O
the NCT03860376 65 68 O
time NCT03860376 69 73 O
of NCT03860376 74 76 O
enrollment NCT03860376 77 87 O
on NCT03860376 88 90 O
this NCT03860376 91 95 O
study NCT03860376 96 101 O
of NCT03860376 102 104 O
any NCT03860376 105 108 O
gender NCT03860376 109 115 O
, NCT03860376 116 117 O
race NCT03860376 118 122 O
or NCT03860376 123 125 O
ethnicity NCT03860376 126 135 O
. NCT03860376 136 137 O

- NCT03860376 146 147 O
Subjects NCT03860376 149 157 O
with NCT03860376 158 162 O
suspected NCT03860376 163 172 O
or NCT03860376 173 175 O
confirmed NCT03860376 176 185 O
diagnosis NCT03860376 186 195 O
of NCT03860376 196 198 O
recurrent NCT03860376 199 208 O
or NCT03860376 209 211 O
refractory NCT03860376 212 222 O
cancer NCT03860376 223 229 B-Condition-Name

- NCT03860376 237 238 O
Subjects NCT03860376 240 248 O
who NCT03860376 249 252 O
are NCT03860376 253 256 O
scheduled NCT03860376 257 266 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03860376 267 270 O
or NCT03860376 271 273 O
have NCT03860376 274 278 O
recently NCT03860376 279 287 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
had NCT03860376 288 291 O
biopsy NCT03860376 292 298 B-Procedure-Name
or NCT03860376 299 301 O
tumor NCT03860376 302 307 B-Condition-Name
excised NCT03860376 308 315 B-Procedure-Name
( NCT03860376 316 317 O
solid NCT03860376 318 323 O
tumors NCT03860376 324 330 B-Condition-Name
) NCT03860376 331 332 O
or NCT03860376 333 335 O
bone NCT03860376 336 340 O
marrow NCT03860376 341 347 O
aspirate NCT03860376 348 356 B-Procedure-Name
( NCT03860376 357 358 O
blood NCT03860376 359 364 O
cancers NCT03860376 365 372 B-Condition-Name
) NCT03860376 373 374 O

- NCT03860376 383 384 O
Subjects NCT03860376 386 394 O
willing NCT03860376 395 402 O
to NCT03860376 403 405 O
have NCT03860376 406 410 O
a NCT03860376 411 412 O
blood NCT03860376 413 418 B-Observation-Specimen
draw NCT03860376 419 423 O
or NCT03860376 424 426 O
buccal NCT03860376 427 433 B-Procedure-Name
swab NCT03860376 434 438 I-Procedure-Name
done NCT03860376 439 443 O
for NCT03860376 444 447 O
the NCT03860376 448 451 O
purposes NCT03860376 452 460 O
of NCT03860376 461 463 O
genetic NCT03860376 464 471 O
testing NCT03860376 472 479 O

- NCT03860376 487 488 O
Subjects NCT03860376 490 498 O
or NCT03860376 499 501 O
their NCT03860376 502 507 O
parents NCT03860376 508 515 O
or NCT03860376 516 518 O
legal NCT03860376 519 524 O
guardians NCT03860376 525 534 O
willing NCT03860376 535 542 O
to NCT03860376 543 545 O
sign NCT03860376 546 550 O
informed NCT03860376 551 559 O
consent NCT03860376 560 567 O

- NCT03860376 575 576 O
Subjects NCT03860376 578 586 O
aged NCT03860376 587 591 O
7 NCT03860376 593 594 B-Eq-Value
to NCT03860376 595 597 B-Eq-Operator___Eq-Operator-Value:BETWEEN
17 NCT03860376 599 601 B-Eq-Value
willing NCT03860376 602 609 O
to NCT03860376 610 612 O
sign NCT03860376 613 617 O
assent NCT03860376 618 624 O

Exclusion NCT03860376 625 634 O
Criteria NCT03860376 635 643 O
: NCT03860376 644 645 O

- NCT03860376 649 650 O
Subjects NCT03860376 652 660 O
who NCT03860376 661 664 O
do NCT03860376 665 667 O
not NCT03860376 668 671 O
have NCT03860376 672 676 O
malignant NCT03860376 677 686 B-Condition-Name
tissue NCT03860376 687 693 I-Condition-Name
available NCT03860376 694 703 O
and NCT03860376 704 707 O
accessible NCT03860376 708 718 O

- NCT03860376 721 722 O
The NCT03860376 724 727 O
amount NCT03860376 728 734 O
of NCT03860376 735 737 O
excised NCT03860376 738 745 B-Procedure-Name
malignant NCT03860376 746 755 B-Condition-Name
tissue NCT03860376 756 762 I-Condition-Name
is NCT03860376 763 765 O
not NCT03860376 766 769 O
sufficient NCT03860376 770 780 O
for NCT03860376 781 784 O
the NCT03860376 785 788 O
ex NCT03860376 789 791 O
vivo NCT03860376 792 796 O
drug NCT03860376 797 801 B-Procedure-Name
testing NCT03860376 802 809 I-Procedure-Name
and NCT03860376 810 813 O
/ NCT03860376 814 815 O
or NCT03860376 816 818 O
genetic NCT03860376 819 826 B-Procedure-Name
profiling NCT03860376 827 836 I-Procedure-Name
. NCT03860376 837 838 O

- NCT03860376 842 843 O
Patients NCT03860376 845 853 O
with NCT03860376 854 858 O
newly NCT03860376 859 864 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnosed NCT03860376 865 874 O
tumors NCT03860376 875 881 B-Condition-Name
and NCT03860376 882 885 O
tumors NCT03860376 886 892 B-Condition-Name
that NCT03860376 893 897 O
have NCT03860376 898 902 O
high NCT03860376 903 907 B-Polarity___Polarity-Value:high
( NCT03860376 908 909 O
> NCT03860376 911 912 B-Eq-Operator___Eq-Operator-Value:GT
90 NCT03860376 914 916 B-Eq-Value
% NCT03860376 917 918 B-Eq-Unit
) NCT03860376 920 921 O
cure NCT03860376 922 926 B-Observation-Name
rate NCT03860376 927 931 I-Observation-Name
with NCT03860376 932 936 O
safe NCT03860376 937 941 O
standard NCT03860376 942 950 B-Procedure-Name
therapy NCT03860376 951 958 I-Procedure-Name
. NCT03860376 959 960 O

Inclusion NCT03869346 0 9 O
Criteria NCT03869346 10 18 O
: NCT03869346 19 20 O

- NCT03869346 24 25 O
American NCT03869346 27 35 B-Condition-Name
Society NCT03869346 36 43 I-Condition-Name
of NCT03869346 44 46 I-Condition-Name
Anesthesiologists NCT03869346 47 64 I-Condition-Name
Grade NCT03869346 65 70 B-Eq-Unit
Ⅰ NCT03869346 71 72 B-Eq-Value
－ NCT03869346 73 74 O
II NCT03869346 75 77 B-Eq-Value
, NCT03869346 78 79 O
Patients NCT03869346 80 88 O
undergo NCT03869346 89 96 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03869346 97 105 O
surgery NCT03869346 106 113 B-Procedure-Name
for NCT03869346 114 117 O
benign NCT03869346 118 124 O
Reproductive NCT03869346 125 137 B-Condition-Name
diseases NCT03869346 138 146 I-Condition-Name
( NCT03869346 147 148 O
including NCT03869346 149 158 O
laparoscopic NCT03869346 159 171 B-Procedure-Name
ovarian NCT03869346 172 179 I-Procedure-Name
cyst NCT03869346 180 184 I-Procedure-Name
removal NCT03869346 185 192 I-Procedure-Name
, NCT03869346 193 194 O
laparoscopic NCT03869346 195 207 B-Procedure-Name
tubal NCT03869346 208 213 I-Procedure-Name
ligation NCT03869346 214 222 I-Procedure-Name
, NCT03869346 223 224 O
laparoscopic NCT03869346 225 237 B-Procedure-Name
tubal NCT03869346 238 243 I-Procedure-Name
drainage NCT03869346 244 252 I-Procedure-Name
, NCT03869346 253 254 O
laparoscopic NCT03869346 255 267 B-Procedure-Name
salpingoplasty NCT03869346 268 282 I-Procedure-Name
, NCT03869346 283 284 O
etc NCT03869346 285 288 O
. NCT03869346 289 290 O
) NCT03869346 291 292 O
or NCT03869346 293 295 O
breast NCT03869346 296 302 B-Condition-Name
disease NCT03869346 303 310 I-Condition-Name
. NCT03869346 311 312 O

- NCT03869346 316 317 O
Aged NCT03869346 319 323 O
18 NCT03869346 325 327 B-Eq-Value
- NCT03869346 328 329 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03869346 331 333 B-Eq-Value
years NCT03869346 334 339 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03869346 342 343 O
Body NCT03869346 345 349 B-Observation-Name___Observation-Type-Value:vital
Mass NCT03869346 350 354 I-Observation-Name___Observation-Type-Value:vital
Index NCT03869346 355 360 I-Observation-Name___Observation-Type-Value:vital
18 NCT03869346 362 364 B-Eq-Value
- NCT03869346 365 366 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03869346 368 370 B-Eq-Value
kg NCT03869346 371 373 B-Eq-Unit
/ NCT03869346 374 375 O
m NCT03869346 376 377 B-Eq-Unit
2 NCT03869346 378 379 I-Eq-Unit
, NCT03869346 380 381 O
body NCT03869346 383 387 B-Observation-Name___Observation-Type-Value:vital
weight NCT03869346 388 394 I-Observation-Name___Observation-Type-Value:vital
40 NCT03869346 396 398 B-Eq-Value
- NCT03869346 399 400 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03869346 402 404 B-Eq-Value
kilograms NCT03869346 405 414 B-Eq-Unit

- NCT03869346 417 418 O
Agreed NCT03869346 420 426 O
to NCT03869346 427 429 O
participate NCT03869346 430 441 O
the NCT03869346 442 445 O
research NCT03869346 446 454 O

Exclusion NCT03869346 455 464 O
Criteria NCT03869346 465 473 O
: NCT03869346 474 475 O

- NCT03869346 479 480 O
Difficult NCT03869346 482 491 B-Condition-Name
airway NCT03869346 492 498 I-Condition-Name

- NCT03869346 501 502 O
upper NCT03869346 504 509 B-Condition-Name
respiratory NCT03869346 510 521 I-Condition-Name
tract NCT03869346 522 527 I-Condition-Name
infection NCT03869346 528 537 I-Condition-Name
within NCT03869346 538 544 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03869346 546 547 B-Eq-Value
weeks NCT03869346 548 553 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03869346 556 557 O
history NCT03869346 559 566 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869346 567 569 O
allergy NCT03869346 570 577 O
or NCT03869346 578 580 O
long NCT03869346 581 585 O
- NCT03869346 586 587 O
term NCT03869346 588 592 O
use NCT03869346 593 596 O
of NCT03869346 597 599 O
propofol NCT03869346 600 608 B-Drug-Name
and NCT03869346 609 612 O
opioids NCT03869346 613 620 B-Drug-Name

- NCT03869346 623 624 O
self NCT03869346 626 630 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03869346 631 632 I-Observation-Name___Observation-Type-Value:clinical-score
rating NCT03869346 633 639 I-Observation-Name___Observation-Type-Value:clinical-score
anxiety NCT03869346 640 647 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03869346 648 653 I-Observation-Name___Observation-Type-Value:clinical-score
before NCT03869346 654 660 O
operation NCT03869346 661 670 B-Procedure-Name
indicates NCT03869346 671 680 O
anxiety NCT03869346 681 688 B-Condition-Name

- NCT03869346 691 692 O
pregnancy NCT03869346 694 703 B-Condition-Name
or NCT03869346 704 706 O
lactation NCT03869346 707 716 B-Condition-Name
. NCT03869346 717 718 O

Inclusion NCT03860389 0 9 O
Criteria NCT03860389 10 18 O
: NCT03860389 19 20 O

- NCT03860389 24 25 O
Diagnosis NCT03860389 27 36 O
of NCT03860389 37 39 O
autism NCT03860389 40 46 B-Condition-Name
spectrum NCT03860389 47 55 I-Condition-Name
disorder NCT03860389 56 64 I-Condition-Name

Exclusion NCT03860389 65 74 O
Criteria NCT03860389 75 83 O
: NCT03860389 84 85 O

- NCT03860389 89 90 O
Any NCT03860389 92 95 O
medical NCT03860389 96 103 O
condition NCT03860389 104 113 O
which NCT03860389 114 119 O
excludes NCT03860389 120 128 O
the NCT03860389 129 132 O
child NCT03860389 133 138 O
from NCT03860389 139 143 O
partaking NCT03860389 144 153 O
in NCT03860389 154 156 O
exercise NCT03860389 157 165 B-Observation-Name___Observation-Type-Value:social-habit

Inclusion NCT03868475 0 9 O
Criteria NCT03868475 10 18 O
: NCT03868475 19 20 O

- NCT03868475 24 25 O
Women NCT03868475 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
over NCT03868475 33 37 B-Eq-Operator___Eq-Operator-Value:GT
age NCT03868475 38 41 O
18 NCT03868475 43 45 B-Eq-Value
with NCT03868475 46 50 O
a NCT03868475 51 52 O
core NCT03868475 53 57 O
biopsy NCT03868475 58 64 B-Procedure-Name
proven NCT03868475 65 71 O
borderline NCT03868475 72 82 O
or NCT03868475 83 85 O
high NCT03868475 86 90 B-Polarity___Polarity-Value:high
- NCT03868475 91 92 O
risk NCT03868475 93 97 O
breast NCT03868475 98 104 B-Condition-Name
lesion NCT03868475 105 111 I-Condition-Name
that NCT03868475 112 116 O
requires NCT03868475 117 125 O
further NCT03868475 126 133 O
excision NCT03868475 134 142 B-Procedure-Name
for NCT03868475 143 146 O
management NCT03868475 147 157 O
based NCT03868475 158 163 O
on NCT03868475 164 166 O
the NCT03868475 167 170 O
surgeon NCT03868475 171 178 B-Provider-Type
's NCT03868475 178 180 O
assessment NCT03868475 181 191 O

- NCT03868475 194 195 O
Informed NCT03868475 197 205 O
consent NCT03868475 206 213 O
must NCT03868475 214 218 O
be NCT03868475 219 221 O
obtained NCT03868475 222 230 O
. NCT03868475 231 232 O

Exclusion NCT03868475 234 243 O
Criteria NCT03868475 244 252 O
: NCT03868475 253 254 O

- NCT03868475 258 259 O
Women NCT03868475 261 266 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03868475 267 270 O
are NCT03868475 271 274 O
considered NCT03868475 275 285 O
high NCT03868475 286 290 B-Polarity___Polarity-Value:high
- NCT03868475 291 292 O
risk NCT03868475 293 297 O
based NCT03868475 298 303 O
on NCT03868475 304 306 O
a NCT03868475 307 308 O
greater NCT03868475 309 316 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868475 317 321 I-Eq-Operator___Eq-Operator-Value:GT
25 NCT03868475 323 325 B-Eq-Value
% NCT03868475 326 327 B-Eq-Unit
lifetime NCT03868475 328 336 O
risk NCT03868475 337 341 O
of NCT03868475 342 344 O
breast NCT03868475 345 351 O
cancer NCT03868475 352 358 B-Condition-Name
as NCT03868475 359 361 O
per NCT03868475 362 365 O
the NCT03868475 366 369 O
IBIS NCT03868475 370 374 O
( NCT03868475 375 376 O
International NCT03868475 377 390 O
Breast NCT03868475 391 397 O
Cancer NCT03868475 398 404 O
Intervention NCT03868475 405 417 O
Study NCT03868475 418 423 O
) NCT03868475 424 425 O
Breast NCT03868475 426 432 B-Observation-Name___Observation-Type-Value:clinical-score
Cancer NCT03868475 433 439 I-Observation-Name___Observation-Type-Value:clinical-score
Risk NCT03868475 440 444 I-Observation-Name___Observation-Type-Value:clinical-score
Evaluation NCT03868475 445 455 I-Observation-Name___Observation-Type-Value:clinical-score
Tool NCT03868475 456 460 I-Observation-Name___Observation-Type-Value:clinical-score

- NCT03868475 463 464 O
Pathology NCT03868475 466 475 B-Condition-Name
that NCT03868475 476 480 O
is NCT03868475 481 483 O
felt NCT03868475 484 488 O
to NCT03868475 489 491 O
be NCT03868475 492 494 O
discordant NCT03868475 495 505 O
with NCT03868475 506 510 O
imaging NCT03868475 511 518 B-Procedure-Name

- NCT03868475 521 522 O
Extensive NCT03868475 524 533 B-Severity___Severity-Value:severe
calcifications NCT03868475 534 548 B-Condition-Name
extending NCT03868475 549 558 O
more NCT03868475 559 563 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868475 564 568 I-Eq-Operator___Eq-Operator-Value:GT
20 NCT03868475 570 572 B-Eq-Value
mm NCT03868475 573 575 B-Eq-Unit
and NCT03868475 576 579 O
/ NCT03868475 580 581 O
or NCT03868475 582 584 O
masses NCT03868475 585 591 B-Condition-Name
greater NCT03868475 592 599 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868475 600 604 I-Eq-Operator___Eq-Operator-Value:GT
30 NCT03868475 606 608 B-Eq-Value
mm NCT03868475 609 611 B-Eq-Unit

- NCT03868475 614 615 O
The NCT03868475 617 620 O
following NCT03868475 621 630 O
lesions NCT03868475 631 638 B-Condition-Name
will NCT03868475 639 643 O
be NCT03868475 644 646 O
excluded NCT03868475 647 655 O
based NCT03868475 656 661 O
on NCT03868475 662 664 O
their NCT03868475 665 670 O
increased NCT03868475 671 680 B-Polarity___Polarity-Value:high
risk NCT03868475 681 685 O
of NCT03868475 686 688 O
upstaging NCT03868475 689 698 B-Condition-Name
; NCT03868475 698 699 O
lesions NCT03868475 700 707 B-Condition-Name
( NCT03868475 708 709 O
other NCT03868475 710 715 O
than NCT03868475 716 720 O
fibroadenomas NCT03868475 721 734 B-Condition-Name
, NCT03868475 735 736 O
phyllodes NCT03868475 737 746 B-Condition-Name
and NCT03868475 747 750 O
papillomas NCT03868475 751 761 B-Condition-Name
) NCT03868475 762 763 O
that NCT03868475 764 768 O
are NCT03868475 769 772 O
associated NCT03868475 773 783 O
with NCT03868475 784 788 O
a NCT03868475 789 790 O
palpable NCT03868475 791 799 B-Condition-Name
mass NCT03868475 800 804 I-Condition-Name
, NCT03868475 805 806 O
ADH NCT03868475 807 810 B-Condition-Name
( NCT03868475 811 812 O
atypical NCT03868475 813 821 B-Condition-Name
ductal NCT03868475 822 828 I-Condition-Name
hyperplasia NCT03868475 829 840 I-Condition-Name
) NCT03868475 841 842 O
with NCT03868475 843 847 O
high NCT03868475 848 852 B-Polarity___Polarity-Value:high
- NCT03868475 853 854 O
risk NCT03868475 855 859 O
features NCT03868475 860 868 O
( NCT03868475 869 870 O
ADH NCT03868475 871 874 B-Condition-Name
with NCT03868475 875 879 O
zonal NCT03868475 880 885 B-Condition-Name
necrosis NCT03868475 886 894 I-Condition-Name
, NCT03868475 895 896 O
significant NCT03868475 897 908 B-Severity___Severity-Value:severe
cytological NCT03868475 909 920 B-Condition-Name
atypia NCT03868475 921 927 I-Condition-Name
or NCT03868475 928 930 O
more NCT03868475 931 935 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868475 936 940 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03868475 942 943 B-Eq-Value
foci NCT03868475 944 948 B-Condition-Name
) NCT03868475 949 950 O
, NCT03868475 952 953 O
LCIS NCT03868475 954 958 B-Condition-Name
( NCT03868475 959 960 O
lobular NCT03868475 961 968 O
carcinoma NCT03868475 969 978 B-Condition-Name
in NCT03868475 979 981 O
situ NCT03868475 982 986 O
) NCT03868475 987 988 O
with NCT03868475 989 993 O
high NCT03868475 994 998 B-Polarity___Polarity-Value:high
- NCT03868475 999 1000 O
risk NCT03868475 1001 1005 O
features NCT03868475 1006 1014 O
( NCT03868475 1015 1016 O
associated NCT03868475 1017 1027 O
with NCT03868475 1028 1032 O
ADH NCT03868475 1033 1036 B-Condition-Name
, NCT03868475 1037 1038 O
pleomorphic NCT03868475 1039 1050 B-Condition-Name
LCIS NCT03868475 1051 1055 I-Condition-Name
, NCT03868475 1056 1057 O
zonal NCT03868475 1058 1063 B-Condition-Name
necrosis NCT03868475 1064 1072 I-Condition-Name
and NCT03868475 1073 1076 O
> NCT03868475 1077 1078 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03868475 1080 1081 B-Eq-Value
foci NCT03868475 1082 1086 B-Condition-Name
) NCT03868475 1087 1088 O
or NCT03868475 1089 1091 O
discordant NCT03868475 1092 1102 O
with NCT03868475 1103 1107 O
imaging NCT03868475 1108 1115 B-Procedure-Name
, NCT03868475 1116 1117 O
papilloma NCT03868475 1118 1127 B-Condition-Name
with NCT03868475 1128 1132 O
atypia NCT03868475 1133 1139 O
, NCT03868475 1140 1141 O
and NCT03868475 1142 1145 O
spindle NCT03868475 1146 1153 O
cell NCT03868475 1154 1158 O
lesion NCT03868475 1159 1165 B-Condition-Name
( NCT03868475 1166 1167 O
especially NCT03868475 1168 1178 O
if NCT03868475 1179 1181 O
there NCT03868475 1182 1187 O
is NCT03868475 1188 1190 O
atypia NCT03868475 1191 1197 O
) NCT03868475 1198 1199 O
. NCT03868475 1201 1202 O

- NCT03868475 1206 1207 O
Lesions NCT03868475 1209 1216 B-Condition-Name
that NCT03868475 1217 1221 O
are NCT03868475 1222 1225 O
suspicious NCT03868475 1226 1236 O
for NCT03868475 1237 1240 O
borderline NCT03868475 1241 1251 O
or NCT03868475 1252 1254 O
malignant NCT03868475 1255 1264 O
Phyllodes NCT03868475 1265 1274 B-Condition-Name
, NCT03868475 1275 1276 O
DCIS NCT03868475 1277 1281 B-Condition-Name
( NCT03868475 1282 1283 O
ductal NCT03868475 1284 1290 B-Condition-Name
carcinoma NCT03868475 1291 1300 I-Condition-Name
in NCT03868475 1301 1303 O
situ NCT03868475 1304 1308 O
) NCT03868475 1309 1310 O
, NCT03868475 1312 1313 O
invasive NCT03868475 1314 1322 O
mammary NCT03868475 1323 1330 O
carcinoma NCT03868475 1331 1340 B-Condition-Name
, NCT03868475 1341 1342 O
or NCT03868475 1343 1345 O
encapsulated NCT03868475 1346 1358 O
papillary NCT03868475 1359 1368 O
carcinoma NCT03868475 1369 1378 B-Condition-Name

- NCT03868475 1381 1382 O
Any NCT03868475 1384 1387 O
lesion NCT03868475 1388 1394 B-Condition-Name
that NCT03868475 1395 1399 O
either NCT03868475 1400 1406 O
the NCT03868475 1407 1410 O
radiologist NCT03868475 1411 1422 B-Provider-Type
, NCT03868475 1423 1424 O
pathologist NCT03868475 1425 1436 B-Provider-Type
or NCT03868475 1437 1439 O
surgeon NCT03868475 1440 1447 B-Provider-Type
feels NCT03868475 1448 1453 O
is NCT03868475 1454 1456 O
not NCT03868475 1457 1460 O
amenable NCT03868475 1461 1469 O
to NCT03868475 1470 1472 O
VAPE NCT03868475 1473 1477 B-Procedure-Name
or NCT03868475 1478 1480 O
surgical NCT03868475 1481 1489 B-Procedure-Name
excision NCT03868475 1490 1498 I-Procedure-Name

Inclusion NCT03867292 0 9 O
Criteria NCT03867292 10 18 O
: NCT03867292 19 20 O

- NCT03867292 24 25 O
Padel NCT03867292 27 32 B-Observation-Name___Observation-Type-Value:social-habit
players NCT03867292 33 40 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03867292 43 44 O
With NCT03867292 46 50 O
federal NCT03867292 51 58 O
sheet NCT03867292 59 64 O

- NCT03867292 67 68 O
Male NCT03867292 70 74 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03867292 77 78 O
Over NCT03867292 80 84 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03867292 86 88 B-Eq-Value
years NCT03867292 89 94 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867292 97 98 O
Currently NCT03867292 100 109 O
participate NCT03867292 110 121 O
in NCT03867292 122 124 O
regional NCT03867292 125 133 O
and NCT03867292 134 137 O
/ NCT03867292 138 139 O
or NCT03867292 140 142 O
national NCT03867292 143 151 O
competitions NCT03867292 152 164 O

Exclusion NCT03867292 165 174 O
Criteria NCT03867292 175 183 O
: NCT03867292 184 185 O

- NCT03867292 189 190 O
Present NCT03867292 192 199 O
a NCT03867292 200 201 O
medical NCT03867292 202 209 O
diagnosis NCT03867292 210 219 O
of NCT03867292 220 222 O
musculoskeletal NCT03867292 223 238 O
pathology NCT03867292 239 248 B-Condition-Name

- NCT03867292 251 252 O
Not NCT03867292 254 257 O
signed NCT03867292 258 264 O
the NCT03867292 265 268 O
informed NCT03867292 269 277 O
consent NCT03867292 278 285 O
document NCT03867292 286 294 O
. NCT03867292 295 296 O

Inclusion NCT03865056 0 9 O
Criteria NCT03865056 10 18 O
: NCT03865056 19 20 O

1 NCT03865056 25 26 O
. NCT03865056 26 27 O
Hypoxemia NCT03865056 29 38 B-Condition-Name
defined NCT03865056 39 46 O
by NCT03865056 47 49 O
a NCT03865056 50 51 O
ratio NCT03865056 52 57 O
of NCT03865056 58 60 O
the NCT03865056 61 64 O
partial NCT03865056 65 72 B-Observation-Name___Observation-Type-Value:measurement
pressure NCT03865056 73 81 I-Observation-Name___Observation-Type-Value:measurement
of NCT03865056 82 84 I-Observation-Name___Observation-Type-Value:measurement
arterial NCT03865056 85 93 I-Observation-Name___Observation-Type-Value:measurement
oxygen NCT03865056 94 100 I-Observation-Name___Observation-Type-Value:measurement
to NCT03865056 101 103 I-Observation-Name___Observation-Type-Value:measurement
the NCT03865056 104 107 I-Observation-Name___Observation-Type-Value:measurement
fraction NCT03865056 108 116 I-Observation-Name___Observation-Type-Value:measurement
of NCT03865056 117 119 I-Observation-Name___Observation-Type-Value:measurement
inspired NCT03865056 120 128 I-Observation-Name___Observation-Type-Value:measurement
oxygen NCT03865056 129 135 I-Observation-Name___Observation-Type-Value:measurement
( NCT03865056 136 137 O
PaO NCT03865056 138 141 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03865056 142 143 I-Observation-Name___Observation-Type-Value:measurement
: NCT03865056 144 145 I-Observation-Name___Observation-Type-Value:measurement
FiO NCT03865056 146 149 I-Observation-Name___Observation-Type-Value:measurement
2 NCT03865056 150 151 I-Observation-Name___Observation-Type-Value:measurement
) NCT03865056 152 153 O
≤ NCT03865056 154 155 B-Eq-Operator___Eq-Operator-Value:LTEQ
300 NCT03865056 157 160 B-Eq-Value
while NCT03865056 161 166 O
the NCT03865056 167 170 O
patient NCT03865056 171 178 O
is NCT03865056 179 181 O
breathing NCT03865056 182 191 B-Observation-Name
oxygen NCT03865056 192 198 I-Observation-Name
through NCT03865056 199 206 O
NHF NCT03865056 207 210 B-Procedure-Name
for NCT03865056 211 214 O
at NCT03865056 215 217 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865056 218 223 I-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03865056 225 227 B-Eq-Value
minutes NCT03865056 228 235 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
; NCT03865056 235 236 O

2 NCT03865056 240 241 O
. NCT03865056 241 242 O
Respiratory NCT03865056 244 255 B-Observation-Name___Observation-Type-Value:vital
rate NCT03865056 256 260 I-Observation-Name___Observation-Type-Value:vital
> NCT03865056 261 262 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03865056 264 266 B-Eq-Value
breaths NCT03865056 267 274 B-Observation-Name___Observation-Type-Value:measurement
/ NCT03865056 275 276 O
minute NCT03865056 277 283 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
; NCT03865056 283 284 O

3 NCT03865056 288 289 O
. NCT03865056 289 290 O
Partial NCT03865056 292 299 B-Observation-Name___Observation-Type-Value:measurement
pressure NCT03865056 300 308 I-Observation-Name___Observation-Type-Value:measurement
of NCT03865056 309 311 I-Observation-Name___Observation-Type-Value:measurement
arterial NCT03865056 312 320 I-Observation-Name___Observation-Type-Value:measurement
carbon NCT03865056 321 327 I-Observation-Name___Observation-Type-Value:measurement
dioxide NCT03865056 328 335 I-Observation-Name___Observation-Type-Value:measurement
( NCT03865056 336 337 O
PaCO NCT03865056 338 342 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03865056 343 344 I-Observation-Name___Observation-Type-Value:measurement
) NCT03865056 345 346 O
≤ NCT03865056 347 348 B-Eq-Operator___Eq-Operator-Value:LTEQ
45 NCT03865056 350 352 B-Eq-Value
mmHg NCT03865056 353 357 B-Eq-Unit
; NCT03865056 357 358 O

4 NCT03865056 362 363 O
. NCT03865056 363 364 O
Absence NCT03865056 366 373 O
of NCT03865056 374 376 O
clinical NCT03865056 377 385 O
history NCT03865056 386 393 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865056 394 396 O
underlying NCT03865056 397 407 O
chronic NCT03865056 408 415 O
respiratory NCT03865056 416 427 B-Condition-Name
failure NCT03865056 428 435 I-Condition-Name
. NCT03865056 436 437 O

Exclusion NCT03865056 439 448 O
Criteria NCT03865056 449 457 O
: NCT03865056 458 459 O

1 NCT03865056 464 465 O
. NCT03865056 465 466 O
Lack NCT03865056 468 472 O
of NCT03865056 473 475 O
consent NCT03865056 476 483 O
; NCT03865056 483 484 O

2 NCT03865056 488 489 O
. NCT03865056 489 490 O
Age NCT03865056 492 495 O
< NCT03865056 496 497 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03865056 499 501 B-Eq-Value
years NCT03865056 502 507 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03865056 507 508 O

3 NCT03865056 512 513 O
. NCT03865056 513 514 O
Invasive NCT03865056 516 524 O
mechanical NCT03865056 525 535 B-Procedure-Name
ventilation NCT03865056 536 547 I-Procedure-Name
for NCT03865056 548 551 O
> NCT03865056 552 553 B-Eq-Operator___Eq-Operator-Value:GT
48 NCT03865056 555 557 B-Eq-Value
hours NCT03865056 558 563 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
in NCT03865056 564 566 O
the NCT03865056 567 570 O
same NCT03865056 571 575 O
hospital NCT03865056 576 584 B-Location___Location-Value:hospital
admission NCT03865056 585 594 B-Encounter-Type___Encounter-Type-Value:inpatient

4 NCT03865056 598 599 O
. NCT03865056 599 600 O
Immediate NCT03865056 602 611 O
need NCT03865056 612 616 O
for NCT03865056 617 620 O
intubation NCT03865056 621 631 B-Procedure-Name
; NCT03865056 631 632 O

5 NCT03865056 636 637 O
. NCT03865056 637 638 O
Previous NCT03865056 640 648 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
inclusion NCT03865056 649 658 O
in NCT03865056 659 661 O
the NCT03865056 662 665 O
present NCT03865056 666 673 O
study NCT03865056 674 679 O
; NCT03865056 679 680 O

6 NCT03865056 684 685 O
. NCT03865056 685 686 O
Systolic NCT03865056 688 696 B-Observation-Name___Observation-Type-Value:vital
arterial NCT03865056 697 705 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03865056 706 714 I-Observation-Name___Observation-Type-Value:vital
< NCT03865056 715 716 B-Eq-Operator___Eq-Operator-Value:LT
90 NCT03865056 718 720 B-Eq-Value
mmHg NCT03865056 721 725 B-Eq-Unit
after NCT03865056 726 731 O
optimal NCT03865056 732 739 O
fluid NCT03865056 740 745 B-Procedure-Name
therapy NCT03865056 746 753 I-Procedure-Name
; NCT03865056 753 754 O

7 NCT03865056 758 759 O
. NCT03865056 759 760 O
Cardiogenic NCT03865056 762 773 B-Condition-Name
pulmonary NCT03865056 774 783 I-Condition-Name
edema NCT03865056 784 789 I-Condition-Name
; NCT03865056 789 790 O

8 NCT03865056 794 795 O
. NCT03865056 795 796 O
Glasgow NCT03865056 798 805 B-Observation-Name___Observation-Type-Value:clinical-score
Coma NCT03865056 806 810 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03865056 811 816 I-Observation-Name___Observation-Type-Value:clinical-score
< NCT03865056 817 818 B-Eq-Operator___Eq-Operator-Value:LT
12 NCT03865056 820 822 B-Eq-Value
; NCT03865056 823 824 O

9 NCT03865056 828 829 O
. NCT03865056 829 830 O
Imminent NCT03865056 832 840 O
death NCT03865056 841 846 O
; NCT03865056 846 847 O

10 NCT03865056 850 852 O
. NCT03865056 852 853 O
Contraindications NCT03865056 855 872 O
to NCT03865056 873 875 O
noninvasive NCT03865056 876 887 B-Procedure-Name
ventilation NCT03865056 888 899 I-Procedure-Name
; NCT03865056 899 900 O

11 NCT03865056 903 905 O
. NCT03865056 905 906 O
Tracheostomy NCT03865056 908 920 B-Procedure-Name
. NCT03865056 921 922 O

Inclusion NCT03868228 0 9 O
Criteria NCT03868228 10 18 O
: NCT03868228 19 20 O

1 NCT03868228 25 26 O
. NCT03868228 26 27 O
Patients NCT03868228 29 37 O
with NCT03868228 38 42 O
CPM NCT03868228 43 46 B-Condition-Name
with NCT03868228 47 51 O
expected NCT03868228 52 60 O
life NCT03868228 61 65 B-Observation-Name
expectancy NCT03868228 66 76 I-Observation-Name
of NCT03868228 77 79 O
> NCT03868228 80 81 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03868228 83 84 B-Eq-Value
months NCT03868228 85 91 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03868228 92 93 O

2 NCT03868228 98 99 O
. NCT03868228 99 100 O
ECOG NCT03868228 102 106 B-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03868228 107 112 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03868228 113 115 I-Observation-Name___Observation-Type-Value:clinical-score
Performance NCT03868228 116 127 I-Observation-Name___Observation-Type-Value:clinical-score
Status NCT03868228 128 134 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03868228 135 136 O
PS NCT03868228 137 139 B-Observation-Name
) NCT03868228 140 141 O
scores NCT03868228 142 148 O
0 NCT03868228 150 151 B-Eq-Value
or NCT03868228 152 154 O
1 NCT03868228 156 157 B-Eq-Value
. NCT03868228 157 158 O

3 NCT03868228 163 164 O
. NCT03868228 164 165 O
15 NCT03868228 168 170 O
mile NCT03868228 171 175 O
catchment NCT03868228 176 185 O
area NCT03868228 186 190 O
to NCT03868228 191 193 O
facilitate NCT03868228 194 204 O
overseeing NCT03868228 205 215 O
systemic NCT03868228 216 224 O
chemotherapy NCT03868228 225 237 B-Procedure-Name
administration NCT03868228 238 252 O

4 NCT03868228 256 257 O
. NCT03868228 257 258 O
Concomitant NCT03868228 260 271 O
systemic NCT03868228 272 280 O
chemotherapy NCT03868228 281 293 B-Procedure-Name
regimens NCT03868228 294 302 O
with NCT03868228 303 307 O
FOLFIRI NCT03868228 308 315 B-Drug-Name
, NCT03868228 316 317 O
FOLFOX NCT03868228 318 324 B-Drug-Name
, NCT03868228 325 326 O
Mitomycin NCT03868228 327 336 B-Drug-Name
C NCT03868228 337 338 I-Drug-Name
& NCT03868228 339 340 O

Fluorouracil NCT03868228 346 358 B-Drug-Name
, NCT03868228 359 360 O
Capecitabine NCT03868228 361 373 B-Drug-Name
( NCT03868228 374 375 O
excluding NCT03868228 376 385 O
Lonsurf NCT03868228 386 393 B-Drug-Name
) NCT03868228 394 395 O
or NCT03868228 396 398 O
without NCT03868228 399 406 O
systemic NCT03868228 407 415 O
chemotherapy NCT03868228 416 428 B-Procedure-Name
if NCT03868228 429 431 O
no NCT03868228 432 434 O
systemic NCT03868228 435 443 O
options NCT03868228 444 451 O
available NCT03868228 452 461 O
to NCT03868228 462 464 O
patient NCT03868228 465 472 O

5 NCT03868228 476 477 O
. NCT03868228 477 478 O
Neutrophil NCT03868228 480 490 B-Observation-Name___Observation-Type-Value:lab
count NCT03868228 491 496 I-Observation-Name___Observation-Type-Value:lab
on NCT03868228 497 499 O
or NCT03868228 500 502 O
just NCT03868228 503 507 O
before NCT03868228 508 514 O
chemotherapy NCT03868228 515 527 B-Procedure-Name
due NCT03868228 528 531 O
date NCT03868228 532 536 O
of NCT03868228 537 539 O
> NCT03868228 540 541 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03868228 543 546 B-Eq-Value

Exclusion NCT03868228 548 557 O
Criteria NCT03868228 558 566 O
: NCT03868228 567 568 O

1 NCT03868228 573 574 O
. NCT03868228 574 575 O
Age NCT03868228 577 580 O
< NCT03868228 581 582 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03868228 584 586 B-Eq-Value

2 NCT03868228 591 592 O
. NCT03868228 592 593 O
MDT NCT03868228 595 598 B-Condition-Name
decision NCT03868228 599 607 O
that NCT03868228 608 612 O
patient NCT03868228 613 620 O
not NCT03868228 621 624 O
suitable NCT03868228 625 633 O
for NCT03868228 634 637 O
PIPAC NCT03868228 638 643 B-Procedure-Name

3 NCT03868228 647 648 O
. NCT03868228 648 649 O
Decision NCT03868228 651 659 O
by NCT03868228 660 662 O
Pre NCT03868228 663 666 B-Procedure-Name
operative NCT03868228 667 676 I-Procedure-Name
Assessment NCT03868228 677 687 I-Procedure-Name
Department NCT03868228 688 698 O
or NCT03868228 699 701 O
Consultant NCT03868228 702 712 O
Anaesthetist NCT03868228 713 725 B-Provider-Type
that NCT03868228 726 730 O
patient NCT03868228 731 738 O
not NCT03868228 739 742 O
fit NCT03868228 743 746 O
for NCT03868228 747 750 O
general NCT03868228 751 758 B-Procedure-Name
anaesthesia NCT03868228 759 770 I-Procedure-Name
and NCT03868228 771 774 O
/ NCT03868228 775 776 O
or NCT03868228 777 779 O
laparoscopy NCT03868228 780 791 B-Procedure-Name

4 NCT03868228 795 796 O
. NCT03868228 796 797 O
Clinically NCT03868228 799 809 O
evident NCT03868228 810 817 B-Condition-Name
gross NCT03868228 818 823 I-Condition-Name
ascites NCT03868228 824 831 I-Condition-Name

5 NCT03868228 835 836 O
. NCT03868228 836 837 O
Bowel NCT03868228 839 844 B-Condition-Name
obstruction NCT03868228 845 856 I-Condition-Name

6 NCT03868228 860 861 O
. NCT03868228 861 862 O
Bevacizumab NCT03868228 864 875 B-Drug-Name
as NCT03868228 876 878 O
part NCT03868228 879 883 O
of NCT03868228 884 886 O
systemic NCT03868228 887 895 O
chemotherapy NCT03868228 896 908 B-Procedure-Name
regime NCT03868228 909 915 O
- NCT03868228 916 917 O
time NCT03868228 918 922 O
from NCT03868228 923 927 O
chemotherapy NCT03868228 928 940 B-Procedure-Name
to NCT03868228 941 943 O
surgery NCT03868228 944 951 B-Procedure-Name
would NCT03868228 952 957 O
be NCT03868228 958 960 O
too NCT03868228 961 964 O
long NCT03868228 965 969 O
for NCT03868228 970 973 O
PIPAC NCT03868228 974 979 B-Procedure-Name
to NCT03868228 980 982 O
be NCT03868228 983 985 O
feasible NCT03868228 986 994 O

7 NCT03868228 998 999 O
. NCT03868228 999 1000 O
Previous NCT03868228 1002 1010 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
bone NCT03868228 1011 1015 B-Condition-Name
marrow NCT03868228 1016 1022 I-Condition-Name
suppression NCT03868228 1023 1034 I-Condition-Name
due NCT03868228 1035 1038 O
to NCT03868228 1039 1041 O
chemotherapy NCT03868228 1042 1054 B-Procedure-Name
given NCT03868228 1055 1060 O
risk NCT03868228 1061 1065 O
of NCT03868228 1066 1068 O
post NCT03868228 1069 1073 O
- NCT03868228 1074 1075 O
operative NCT03868228 1076 1085 B-Procedure-Name
neutropenia NCT03868228 1086 1097 B-Condition-Name

Key NCT03866577 0 3 O
Criteria NCT03866577 4 12 O
for NCT03866577 13 16 O
Healthy NCT03866577 17 24 B-Condition-Name
Volunteers NCT03866577 25 35 O
: NCT03866577 36 37 O
Subject NCT03866577 38 45 O
must NCT03866577 46 50 O
be NCT03866577 51 53 O
between NCT03866577 54 61 B-Eq-Operator___Eq-Operator-Value:BETWEEN
the NCT03866577 62 65 O
ages NCT03866577 66 70 O
of NCT03866577 71 73 O
18 NCT03866577 75 77 B-Eq-Value
and NCT03866577 78 81 O
55 NCT03866577 83 85 B-Eq-Value
years NCT03866577 86 91 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03866577 91 92 O

healthy NCT03866577 93 100 B-Condition-Name
as NCT03866577 101 103 O
indicated NCT03866577 104 113 O
by NCT03866577 114 116 O
medical NCT03866577 117 124 B-Procedure-Name
history NCT03866577 125 132 I-Procedure-Name
, NCT03866577 133 134 O
physical NCT03866577 135 143 B-Procedure-Name
examination NCT03866577 144 155 I-Procedure-Name
, NCT03866577 156 157 O
vital NCT03866577 158 163 B-Observation-Name___Observation-Type-Value:vital
signs NCT03866577 164 169 I-Observation-Name___Observation-Type-Value:vital
, NCT03866577 170 171 O
clinical NCT03866577 172 180 O
laboratory NCT03866577 181 191 B-Observation-Name___Observation-Type-Value:lab
tests NCT03866577 192 197 I-Observation-Name___Observation-Type-Value:lab
, NCT03866577 198 199 O
and NCT03866577 200 203 O
12 NCT03866577 205 207 B-Procedure-Name
- NCT03866577 208 209 I-Procedure-Name
lead NCT03866577 210 214 I-Procedure-Name
electrocardiogram NCT03866577 215 232 I-Procedure-Name
, NCT03866577 233 234 O
and NCT03866577 235 238 O
all NCT03866577 239 242 O
abnormal NCT03866577 243 251 B-Polarity___Polarity-Value:abnormal
findings NCT03866577 252 260 O
are NCT03866577 261 264 O
assessed NCT03866577 265 273 O
as NCT03866577 274 276 O
not NCT03866577 277 280 O
clinically NCT03866577 281 291 O
significant NCT03866577 292 303 B-Severity___Severity-Value:severe
by NCT03866577 304 306 O
the NCT03866577 307 310 O
Investigator NCT03866577 311 323 O
; NCT03866577 323 324 O
not NCT03866577 325 328 O
pregnant NCT03866577 329 337 B-Condition-Name
or NCT03866577 338 340 O
breastfeeding NCT03866577 341 354 B-Condition-Name
; NCT03866577 354 355 O
and NCT03866577 356 359 O
no NCT03866577 360 362 O
other NCT03866577 363 368 O
clinically NCT03866577 369 379 O
relevant NCT03866577 380 388 O
abnormalities NCT03866577 389 402 B-Condition-Name
currently NCT03866577 403 412 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03866577 413 415 O
in NCT03866577 416 418 O
their NCT03866577 419 424 O
history NCT03866577 425 432 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
that NCT03866577 433 437 O
the NCT03866577 438 441 O
Investigator NCT03866577 442 454 O
would NCT03866577 455 460 O
deem NCT03866577 461 465 O
them NCT03866577 466 470 O
ineligible NCT03866577 471 481 O
to NCT03866577 482 484 O
participate NCT03866577 485 496 O
. NCT03866577 497 498 O

Key NCT03866577 500 503 O
Criteria NCT03866577 504 512 O
for NCT03866577 513 516 O
Immune NCT03866577 517 523 B-Condition-Name
Thrombocytopenic NCT03866577 524 540 I-Condition-Name
Purpura NCT03866577 541 548 I-Condition-Name
( NCT03866577 549 550 O
ITP NCT03866577 551 554 B-Condition-Name
) NCT03866577 555 556 O
Patients NCT03866577 557 565 O
: NCT03866577 566 567 O
Patient NCT03866577 568 575 O
must NCT03866577 576 580 O
be NCT03866577 581 583 O
between NCT03866577 584 591 B-Eq-Operator___Eq-Operator-Value:BETWEEN
the NCT03866577 592 595 O
ages NCT03866577 596 600 O
of NCT03866577 601 603 O
18 NCT03866577 605 607 B-Eq-Value
to NCT03866577 608 610 B-Eq-Operator___Eq-Operator-Value:BETWEEN
64 NCT03866577 612 614 B-Eq-Value
years NCT03866577 615 620 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03866577 621 624 O
diagnosed NCT03866577 625 634 O
with NCT03866577 635 639 O
ITP NCT03866577 640 643 B-Condition-Name
at NCT03866577 644 646 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866577 647 652 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03866577 654 655 B-Eq-Value
months NCT03866577 656 662 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03866577 663 668 O
to NCT03866577 669 671 O
screening NCT03866577 672 681 O
, NCT03866577 682 683 O
stable NCT03866577 684 690 B-Stability___Stability-Value:stable
maintenance NCT03866577 691 702 B-Procedure-Name
therapy NCT03866577 703 710 I-Procedure-Name
for NCT03866577 711 714 O
at NCT03866577 715 717 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866577 718 723 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03866577 725 726 B-Eq-Value
weeks NCT03866577 727 732 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03866577 733 738 O
to NCT03866577 739 741 O
the NCT03866577 742 745 O
first NCT03866577 746 751 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
study NCT03866577 752 757 O
visit NCT03866577 758 763 O
, NCT03866577 764 765 O
not NCT03866577 766 769 O
pregnant NCT03866577 770 778 B-Condition-Name
or NCT03866577 779 781 O
breastfeeding NCT03866577 782 795 B-Condition-Name
, NCT03866577 796 797 O
and NCT03866577 798 801 O
no NCT03866577 802 804 O
other NCT03866577 805 810 O
clinically NCT03866577 811 821 O
relevant NCT03866577 822 830 O
abnormalities NCT03866577 831 844 B-Condition-Name
currently NCT03866577 845 854 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03866577 855 857 O
in NCT03866577 858 860 O
their NCT03866577 861 866 O
history NCT03866577 867 874 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
that NCT03866577 875 879 O
the NCT03866577 880 883 O
Investigator NCT03866577 884 896 O
would NCT03866577 897 902 O
deem NCT03866577 903 907 O
them NCT03866577 908 912 O
ineligible NCT03866577 913 923 O
to NCT03866577 924 926 O
participate NCT03866577 927 938 O
. NCT03866577 939 940 O


Inclusion NCT03865095 0 9 O
Criteria NCT03865095 10 18 O
: NCT03865095 19 20 O

- NCT03865095 24 25 O
age NCT03865095 27 30 O
≥ NCT03865095 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03865095 34 36 B-Eq-Value
years NCT03865095 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03865095 45 46 O
mechanical NCT03865095 48 58 B-Procedure-Name
ventilation NCT03865095 59 70 I-Procedure-Name
expected NCT03865095 71 79 O
for NCT03865095 80 83 O
at NCT03865095 84 86 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865095 87 92 I-Eq-Operator___Eq-Operator-Value:GTEQ
48 NCT03865095 94 96 B-Eq-Value
hours NCT03865095 97 102 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

Exclusion NCT03865095 103 112 O
Criteria NCT03865095 113 121 O
: NCT03865095 122 123 O

- NCT03865095 127 128 O
Clinical NCT03865095 130 138 B-Observation-Name___Observation-Type-Value:clinical-score
Frailty NCT03865095 139 146 I-Observation-Name___Observation-Type-Value:clinical-score
Score NCT03865095 147 152 I-Observation-Name___Observation-Type-Value:clinical-score
above NCT03865095 153 158 B-Eq-Operator___Eq-Operator-Value:GT
7 NCT03865095 160 161 B-Eq-Value
prior NCT03865095 162 167 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
admission NCT03865095 168 177 B-Encounter-Type___Encounter-Type-Value:inpatient

- NCT03865095 180 181 O
neuromuscular NCT03865095 183 196 B-Condition-Name
disease NCT03865095 197 204 I-Condition-Name
in NCT03865095 205 207 O
previous NCT03865095 208 216 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
medical NCT03865095 217 224 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03865095 225 232 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

- NCT03865095 235 236 O
amputated NCT03865095 238 247 B-Condition-Name
lower NCT03865095 248 253 O
extremities NCT03865095 254 265 O

- NCT03865095 268 269 O
trauma NCT03865095 271 277 B-Condition-Name
of NCT03865095 278 280 O
lower NCT03865095 281 286 O
extremities NCT03865095 287 298 O
involving NCT03865095 299 308 O
tights NCT03865095 309 315 O

- NCT03865095 318 319 O
age NCT03865095 321 324 O
under NCT03865095 325 330 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03865095 332 334 B-Eq-Value
years NCT03865095 335 340 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03865095 343 344 O
inability NCT03865095 346 355 O
to NCT03865095 356 358 O
perform NCT03865095 359 366 O
ultrasound NCT03865095 367 377 B-Procedure-Name
examination NCT03865095 378 389 I-Procedure-Name

- NCT03865095 392 393 O
death NCT03865095 395 400 O
or NCT03865095 401 403 O
discharge NCT03865095 404 413 B-Encounter-Type___Encounter-Type-Value:discharge
prior NCT03865095 414 419 O
completion NCT03865095 420 430 O
of NCT03865095 431 433 O
protocol NCT03865095 434 442 O

- NCT03865095 445 446 O
full NCT03865095 448 452 B-Procedure-Name
verticalization NCT03865095 453 468 I-Procedure-Name
prior NCT03865095 469 474 O
completion NCT03865095 475 485 O
of NCT03865095 486 488 O
protocol NCT03865095 489 497 O

Inclusion NCT03867682 0 9 O
Criteria NCT03867682 10 18 O
: NCT03867682 19 20 O

1 NCT03867682 25 26 O
. NCT03867682 26 27 O
Refractory NCT03867682 29 39 O
or NCT03867682 40 42 O
relapsed NCT03867682 43 51 O
AML NCT03867682 52 55 B-Condition-Name
which NCT03867682 56 61 O
will NCT03867682 62 66 O
include NCT03867682 67 74 O
: NCT03867682 75 76 O

1 NCT03867682 86 87 O
. NCT03867682 87 88 O
Refractory NCT03867682 90 100 B-Condition-Name
disease NCT03867682 101 108 I-Condition-Name
will NCT03867682 109 113 O
be NCT03867682 114 116 O
defined NCT03867682 117 124 O
as NCT03867682 125 127 O
at NCT03867682 128 130 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867682 131 136 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03867682 138 139 B-Eq-Value
prior NCT03867682 140 145 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03867682 146 155 O
with NCT03867682 156 160 O
no NCT03867682 161 163 O
remission NCT03867682 164 173 B-Condition-Name
. NCT03867682 174 175 O

2 NCT03867682 185 186 O
. NCT03867682 186 187 O
Relapsed NCT03867682 189 197 B-Condition-Name
disease NCT03867682 198 205 I-Condition-Name
will NCT03867682 206 210 O
be NCT03867682 211 213 O
defined NCT03867682 214 221 O
as NCT03867682 222 224 O
5 NCT03867682 226 227 B-Eq-Value
% NCT03867682 228 229 B-Eq-Unit
or NCT03867682 230 232 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03867682 233 237 I-Eq-Operator___Eq-Operator-Value:GTEQ
blasts NCT03867682 238 244 B-Observation-Name___Observation-Type-Value:lab
in NCT03867682 245 247 O
bone NCT03867682 248 252 B-Observation-Specimen
marrow NCT03867682 253 259 I-Observation-Specimen
seen NCT03867682 260 264 O
after NCT03867682 265 270 O
remission NCT03867682 271 280 B-Condition-Name
. NCT03867682 281 282 O

3 NCT03867682 292 293 O
. NCT03867682 293 294 O
Patients NCT03867682 296 304 O
with NCT03867682 305 309 O
AML NCT03867682 310 313 B-Condition-Name
arising NCT03867682 314 321 O
from NCT03867682 322 326 O
myelodysplastic NCT03867682 327 342 B-Condition-Name
syndromes NCT03867682 343 352 I-Condition-Name
( NCT03867682 353 354 O
including NCT03867682 355 364 O
CMML NCT03867682 365 369 B-Condition-Name
) NCT03867682 370 371 O
or NCT03867682 372 374 O
myeloproliferative NCT03867682 375 393 B-Condition-Name
neoplasms NCT03867682 394 403 I-Condition-Name
( NCT03867682 404 405 O
secondary NCT03867682 406 415 O
AML NCT03867682 416 419 B-Condition-Name
, NCT03867682 420 421 O
ts NCT03867682 422 424 B-Condition-Name
- NCT03867682 425 426 I-Condition-Name
AML NCT03867682 427 430 I-Condition-Name
) NCT03867682 431 432 O
are NCT03867682 433 436 O
also NCT03867682 437 441 O
eligible NCT03867682 442 450 O
. NCT03867682 451 452 O

2 NCT03867682 457 458 O
. NCT03867682 458 459 O
Circulating NCT03867682 461 472 B-Observation-Name___Observation-Type-Value:lab
blast NCT03867682 473 478 I-Observation-Name___Observation-Type-Value:lab
count NCT03867682 479 484 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03867682 485 486 B-Eq-Operator___Eq-Operator-Value:LTEQ
200 NCT03867682 488 491 B-Eq-Value
/ NCT03867682 492 493 O
μL NCT03867682 494 496 B-Eq-Unit
within NCT03867682 497 503 B-Eq-Operator___Eq-Operator-Value:LTEQ
10 NCT03867682 505 507 B-Eq-Value
days NCT03867682 508 512 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03867682 513 518 O
to NCT03867682 519 521 O
first NCT03867682 522 527 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
cycle NCT03867682 528 533 O
of NCT03867682 534 536 O
treatment NCT03867682 537 546 O
. NCT03867682 547 548 O
Hydroxyurea NCT03867682 550 561 B-Drug-Name
should NCT03867682 562 568 O
be NCT03867682 569 571 O
used NCT03867682 572 576 O
to NCT03867682 577 579 O
keep NCT03867682 580 584 O
the NCT03867682 585 588 O
peripheral NCT03867682 589 599 B-Observation-Name___Observation-Type-Value:lab
blast NCT03867682 600 605 I-Observation-Name___Observation-Type-Value:lab
count NCT03867682 606 611 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03867682 612 613 B-Eq-Operator___Eq-Operator-Value:LTEQ
200 NCT03867682 615 618 B-Eq-Value
/ NCT03867682 619 620 O
μL NCT03867682 621 623 B-Eq-Unit
until NCT03867682 624 629 O
the NCT03867682 630 633 O
first NCT03867682 634 639 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
day NCT03867682 640 643 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03867682 644 646 O
protocol NCT03867682 647 655 O
treatment NCT03867682 656 665 O
, NCT03867682 666 667 O
to NCT03867682 668 670 O
the NCT03867682 671 674 O
extent NCT03867682 675 681 O
that NCT03867682 682 686 O
this NCT03867682 687 691 O
is NCT03867682 692 694 O
possible NCT03867682 695 703 O

3 NCT03867682 707 708 O
. NCT03867682 708 709 O
ECOG NCT03867682 711 715 B-Observation-Name
≤ NCT03867682 716 717 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03867682 719 720 B-Eq-Value

4 NCT03867682 725 726 O
. NCT03867682 726 727 O
Estimated NCT03867682 729 738 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03867682 739 749 I-Observation-Name___Observation-Type-Value:lab
clearance NCT03867682 750 759 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03867682 760 761 B-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03867682 763 765 B-Eq-Value
mL NCT03867682 766 768 B-Eq-Unit
/ NCT03867682 769 770 O
min NCT03867682 771 774 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

5 NCT03867682 778 779 O
. NCT03867682 779 780 O
AST NCT03867682 782 785 B-Observation-Name___Observation-Type-Value:lab
and NCT03867682 786 789 O
ALT NCT03867682 790 793 B-Observation-Name___Observation-Type-Value:lab
≤ NCT03867682 794 795 B-Eq-Operator___Eq-Operator-Value:LTEQ
3.0 NCT03867682 797 800 B-Eq-Value
x NCT03867682 801 802 O
ULN NCT03867682 803 806 B-Eq-Unit

6 NCT03867682 810 811 O
. NCT03867682 811 812 O
Bilirubin NCT03867682 814 823 B-Observation-Name___Observation-Type-Value:lab
≤ NCT03867682 824 825 B-Eq-Operator___Eq-Operator-Value:LTEQ
3.0 NCT03867682 827 830 B-Eq-Value
x NCT03867682 831 832 O
ULN NCT03867682 833 836 B-Eq-Unit

Exclusion NCT03867682 837 846 O
Criteria NCT03867682 847 855 O
: NCT03867682 856 857 O

1 NCT03867682 862 863 O
. NCT03867682 863 864 O
Active NCT03867682 866 872 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
CNS NCT03867682 873 876 O
Leukemia NCT03867682 877 885 B-Condition-Name
. NCT03867682 886 887 O

2 NCT03867682 892 893 O
. NCT03867682 893 894 O
Known NCT03867682 896 901 O
HIV NCT03867682 902 905 B-Condition-Name
infection NCT03867682 906 915 I-Condition-Name
or NCT03867682 916 918 O
known NCT03867682 919 924 O
hepatitis NCT03867682 925 934 O
B NCT03867682 935 936 O
or NCT03867682 937 939 O
hepatitis NCT03867682 940 949 O
C NCT03867682 950 951 O
infection NCT03867682 952 961 B-Condition-Name
( NCT03867682 962 963 O
with NCT03867682 964 968 O
a NCT03867682 969 970 O
detectable NCT03867682 971 981 B-Polarity___Polarity-Value:positive
viral NCT03867682 982 987 B-Observation-Name___Observation-Type-Value:lab
load NCT03867682 988 992 I-Observation-Name___Observation-Type-Value:lab
) NCT03867682 993 994 O
. NCT03867682 996 997 O

3 NCT03867682 1002 1003 O
. NCT03867682 1003 1004 O
Participant NCT03867682 1006 1017 O
has NCT03867682 1018 1021 O
received NCT03867682 1022 1030 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
strong NCT03867682 1031 1037 B-Polarity___Polarity-Value:high
and NCT03867682 1038 1041 O
/ NCT03867682 1042 1043 O
or NCT03867682 1044 1046 O
moderate NCT03867682 1047 1055 B-Polarity___Polarity-Value:medium
CYP NCT03867682 1056 1059 B-Drug-Name
3A NCT03867682 1060 1062 I-Drug-Name
inducers NCT03867682 1063 1071 I-Drug-Name
within NCT03867682 1072 1078 B-Eq-Operator___Eq-Operator-Value:LTEQ
7 NCT03867682 1080 1081 B-Eq-Value
days NCT03867682 1082 1086 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03867682 1087 1092 O
to NCT03867682 1093 1095 O
the NCT03867682 1096 1099 O
initiation NCT03867682 1100 1110 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03867682 1111 1113 O
study NCT03867682 1114 1119 O
treatment NCT03867682 1120 1129 O
. NCT03867682 1130 1131 O

4 NCT03867682 1136 1137 O
. NCT03867682 1137 1138 O
Have NCT03867682 1140 1144 O
received NCT03867682 1145 1153 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
prior NCT03867682 1154 1159 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiation NCT03867682 1160 1169 B-Procedure-Name
to NCT03867682 1170 1172 O
maximally NCT03867682 1173 1182 O
tolerated NCT03867682 1183 1192 O
levels NCT03867682 1193 1199 O
to NCT03867682 1200 1202 O
any NCT03867682 1203 1206 O
critical NCT03867682 1207 1215 B-Severity___Severity-Value:severe
normal NCT03867682 1216 1222 B-Polarity___Polarity-Value:normal
organ NCT03867682 1223 1228 O
. NCT03867682 1229 1230 O

5 NCT03867682 1235 1236 O
. NCT03867682 1236 1237 O
Clinically NCT03867682 1239 1249 O
significant NCT03867682 1250 1261 B-Severity___Severity-Value:severe
cardiac NCT03867682 1262 1269 B-Condition-Name
disease NCT03867682 1270 1277 I-Condition-Name
. NCT03867682 1278 1279 O

6 NCT03867682 1284 1285 O
. NCT03867682 1285 1286 O
Active NCT03867682 1288 1294 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
, NCT03867682 1295 1296 O
uncontrolled NCT03867682 1297 1309 O
serious NCT03867682 1310 1317 B-Severity___Severity-Value:severe
infection NCT03867682 1318 1327 B-Condition-Name
. NCT03867682 1328 1329 O

7 NCT03867682 1334 1335 O
. NCT03867682 1335 1336 O
Have NCT03867682 1338 1342 O
other NCT03867682 1343 1348 O
non NCT03867682 1349 1352 O
- NCT03867682 1353 1354 O
myeloid NCT03867682 1355 1362 O
malignancy NCT03867682 1363 1373 B-Condition-Name
within NCT03867682 1374 1380 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03867682 1382 1383 B-Eq-Value
years NCT03867682 1384 1389 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03867682 1390 1392 O
entry NCT03867682 1393 1398 O
( NCT03867682 1399 1400 O
with NCT03867682 1401 1405 O
exceptions NCT03867682 1406 1416 O
) NCT03867682 1417 1418 O
. NCT03867682 1420 1421 O

8 NCT03867682 1426 1427 O
. NCT03867682 1427 1428 O
Psychiatric NCT03867682 1430 1441 B-Condition-Name
disorder NCT03867682 1442 1450 I-Condition-Name
that NCT03867682 1451 1455 O
would NCT03867682 1456 1461 O
preclude NCT03867682 1462 1470 O
study NCT03867682 1471 1476 O
participation NCT03867682 1477 1490 O

9 NCT03867682 1494 1495 O
. NCT03867682 1495 1496 O
Previous NCT03867682 1498 1506 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
solid NCT03867682 1507 1512 O
organ NCT03867682 1513 1518 B-Procedure-Name
transplant NCT03867682 1519 1529 I-Procedure-Name
( NCT03867682 1530 1531 O
prior NCT03867682 1532 1537 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03867682 1538 1547 O
with NCT03867682 1548 1552 O
SCT NCT03867682 1553 1556 B-Procedure-Name
is NCT03867682 1557 1559 O
allowed NCT03867682 1560 1567 O
but NCT03867682 1568 1571 O
not NCT03867682 1572 1575 O
if NCT03867682 1576 1578 O
patient NCT03867682 1579 1586 O
has NCT03867682 1587 1590 O
GVHD NCT03867682 1591 1595 B-Condition-Name
or NCT03867682 1596 1598 O
is NCT03867682 1599 1601 O
still NCT03867682 1602 1607 O
receiving NCT03867682 1608 1617 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
immunosuppression NCT03867682 1618 1635 B-Procedure-Name
/ NCT03867682 1636 1637 O
GVHD NCT03867682 1638 1642 B-Procedure-Name
therapy NCT03867682 1643 1650 I-Procedure-Name
) NCT03867682 1651 1652 O
. NCT03867682 1654 1655 O

Inclusion NCT03861754 0 9 O
Criteria NCT03861754 10 18 O
: NCT03861754 19 20 O

- NCT03861754 24 25 O
Body NCT03861754 27 31 B-Observation-Name___Observation-Type-Value:vital
mass NCT03861754 32 36 I-Observation-Name___Observation-Type-Value:vital
Index NCT03861754 37 42 I-Observation-Name___Observation-Type-Value:vital
> NCT03861754 43 44 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03861754 46 48 B-Eq-Value

- NCT03861754 52 53 O
Age NCT03861754 55 58 O
18 NCT03861754 60 62 B-Eq-Value
- NCT03861754 63 64 B-Eq-Operator___Eq-Operator-Value:BETWEEN
64 NCT03861754 66 68 B-Eq-Value

Exclusion NCT03861754 70 79 O
Criteria NCT03861754 80 88 O
: NCT03861754 89 90 O

- NCT03861754 94 95 O
Pregnancy NCT03861754 97 106 B-Condition-Name

- NCT03861754 109 110 O
Health NCT03861754 112 118 O
reasons NCT03861754 119 126 O
preventing NCT03861754 127 137 O
exercise NCT03861754 138 146 B-Observation-Name___Observation-Type-Value:social-habit
and NCT03861754 147 150 O
exercise NCT03861754 151 159 B-Procedure-Name
test NCT03861754 160 164 I-Procedure-Name

- NCT03861754 167 168 O
Medication NCT03861754 170 180 O
preventing NCT03861754 181 191 O
exercise NCT03861754 192 200 B-Observation-Name___Observation-Type-Value:social-habit
and NCT03861754 201 204 O
exercise NCT03861754 205 213 B-Procedure-Name
test NCT03861754 214 218 I-Procedure-Name

- NCT03861754 221 222 O
Previously NCT03861754 224 234 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosed NCT03861754 235 244 O
diabetes NCT03861754 245 253 B-Condition-Name

Inclusion NCT03862261 0 9 O
Criteria NCT03862261 10 18 O
: NCT03862261 19 20 O

- NCT03862261 24 25 O
Children NCT03862261 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
< NCT03862261 36 37 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03862261 39 40 B-Eq-Value
years NCT03862261 41 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862261 47 50 O
. NCT03862261 51 52 O

- NCT03862261 56 57 O
Presumptive NCT03862261 59 70 O
pulmonary NCT03862261 71 80 O
or NCT03862261 81 83 O
extra NCT03862261 84 89 O
- NCT03862261 90 91 O
pulmonary NCT03862261 92 101 O
TB NCT03862261 102 104 B-Condition-Name
case NCT03862261 105 109 O
: NCT03862261 110 111 O
symptoms NCT03862261 112 120 O
or NCT03862261 121 123 O
clinical NCT03862261 124 132 O
signs NCT03862261 133 138 O
suggestive NCT03862261 139 149 O
of NCT03862261 150 152 O
active NCT03862261 153 159 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
TB NCT03862261 160 162 B-Condition-Name
disease NCT03862261 163 170 I-Condition-Name
. NCT03862261 171 172 O

- NCT03862261 176 177 O
Other NCT03862261 179 184 O
infectious NCT03862261 185 195 B-Condition-Name
diseases NCT03862261 196 204 I-Condition-Name
are NCT03862261 205 208 O
not NCT03862261 209 212 O
suspected NCT03862261 213 222 O
or NCT03862261 223 225 O
have NCT03862261 226 230 O
already NCT03862261 231 238 O
been NCT03862261 239 243 O
ruled NCT03862261 244 249 O
out NCT03862261 250 253 O
. NCT03862261 254 255 O

- NCT03862261 259 260 O
Commitment NCT03862261 262 272 O
to NCT03862261 273 275 O
take NCT03862261 276 280 O
treatment NCT03862261 281 290 O
in NCT03862261 291 293 O
the NCT03862261 294 297 O
clinic NCT03862261 298 304 B-Location___Location-Value:clinic
of NCT03862261 305 307 O
enrolment NCT03862261 308 317 O
or NCT03862261 318 320 O
another NCT03862261 321 328 O
INPUT NCT03862261 329 334 O
study NCT03862261 335 340 O
site NCT03862261 341 345 O
. NCT03862261 346 347 O

- NCT03862261 351 352 O
Parental NCT03862261 354 362 O
/ NCT03862261 363 364 O
caregiver NCT03862261 365 374 O
consent NCT03862261 375 382 O
for NCT03862261 383 386 O
the NCT03862261 387 390 O
child NCT03862261 391 396 O
to NCT03862261 397 399 O
participate NCT03862261 400 411 O
in NCT03862261 412 414 O
the NCT03862261 415 418 O
study NCT03862261 419 424 O
. NCT03862261 425 426 O

Exclusion NCT03862261 428 437 O
Criteria NCT03862261 438 446 O
: NCT03862261 447 448 O

- NCT03862261 452 453 O
Children NCT03862261 455 463 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
who NCT03862261 464 467 O
are NCT03862261 468 471 O
TB NCT03862261 472 474 B-Condition-Name
contacts NCT03862261 475 483 O
but NCT03862261 484 487 O
without NCT03862261 488 495 O
symptoms NCT03862261 496 504 O
or NCT03862261 505 507 O
signs NCT03862261 508 513 O
of NCT03862261 514 516 O
active NCT03862261 517 523 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
TB NCT03862261 524 526 B-Condition-Name

Inclusion NCT03861637 0 9 O
Criteria NCT03861637 10 18 O
: NCT03861637 19 20 O

- NCT03861637 24 25 O
Patients NCT03861637 27 35 O
who NCT03861637 36 39 O
fulfilled NCT03861637 40 49 O
the NCT03861637 50 53 O
following NCT03861637 54 63 O
criteria NCT03861637 64 72 O
were NCT03861637 73 77 O
included NCT03861637 78 86 O
in NCT03861637 87 89 O
the NCT03861637 90 93 O
study NCT03861637 94 99 O
: NCT03861637 100 101 O

- NCT03861637 105 106 O
Adult NCT03861637 108 113 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
renal NCT03861637 114 119 B-Procedure-Name
transplant NCT03861637 120 130 I-Procedure-Name
patients NCT03861637 131 139 O
( NCT03861637 140 141 O
≥ NCT03861637 143 144 B-Eq-Operator___Eq-Operator-Value:GTEQ
21 NCT03861637 146 148 B-Eq-Value
years NCT03861637 149 154 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03861637 155 156 O
, NCT03861637 158 159 O

- NCT03861637 163 164 O
Informed NCT03861637 166 174 O
consent NCT03861637 175 182 O
, NCT03861637 183 184 O

- NCT03861637 188 189 O
Stable NCT03861637 191 197 B-Stability___Stability-Value:stable
maintenance NCT03861637 198 209 O
subcutaneous NCT03861637 210 222 O
ESA NCT03861637 223 226 B-Procedure-Name
therapy NCT03861637 227 234 I-Procedure-Name
with NCT03861637 235 239 O
constant NCT03861637 240 248 B-Stability___Stability-Value:stable
dose NCT03861637 249 253 O
interval NCT03861637 254 262 O
during NCT03861637 263 269 O
the NCT03861637 270 273 O
last NCT03861637 274 278 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03861637 280 281 B-Eq-Value
months NCT03861637 282 288 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03861637 289 290 O

- NCT03861637 294 295 O
Haemoglobin NCT03861637 297 308 B-Observation-Name___Observation-Type-Value:lab
( NCT03861637 309 310 O
Hb NCT03861637 311 313 B-Observation-Name___Observation-Type-Value:lab
) NCT03861637 314 315 O
≥ NCT03861637 316 317 B-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03861637 319 321 B-Eq-Value
mg NCT03861637 322 324 B-Eq-Unit
/ NCT03861637 325 326 O
dL NCT03861637 327 329 B-Eq-Unit
( NCT03861637 330 331 O
Hct NCT03861637 332 335 B-Observation-Name___Observation-Type-Value:lab
32 NCT03861637 337 339 B-Eq-Value
% NCT03861637 340 341 B-Eq-Unit
) NCT03861637 343 344 O
, NCT03861637 346 347 O

- NCT03861637 351 352 O
Transferrin NCT03861637 354 365 B-Observation-Name___Observation-Type-Value:lab
saturation NCT03861637 366 376 I-Observation-Name___Observation-Type-Value:lab
( NCT03861637 377 378 O
TSAT NCT03861637 379 383 B-Observation-Name___Observation-Type-Value:lab
) NCT03861637 384 385 O
≥ NCT03861637 386 387 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03861637 389 391 B-Eq-Value
% NCT03861637 392 393 B-Eq-Unit
( NCT03861637 394 395 O
during NCT03861637 396 402 O
the NCT03861637 403 406 O
screening NCT03861637 407 416 O
phase NCT03861637 417 422 O
) NCT03861637 423 424 O
, NCT03861637 426 427 O

- NCT03861637 431 432 O
and NCT03861637 434 437 O
serum NCT03861637 438 443 B-Observation-Name___Observation-Type-Value:lab
ferritin NCT03861637 444 452 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03861637 453 454 B-Eq-Operator___Eq-Operator-Value:GTEQ
100 NCT03861637 456 459 B-Eq-Value
ng NCT03861637 460 462 B-Eq-Unit
/ NCT03861637 463 464 O
mL NCT03861637 465 467 B-Eq-Unit

Exclusion NCT03861637 468 477 O
Criteria NCT03861637 478 486 O
: NCT03861637 487 488 O

We NCT03861637 490 492 O
excluded NCT03861637 493 501 O
patients NCT03861637 502 510 O
with NCT03861637 511 515 O
the NCT03861637 516 519 O
following NCT03861637 520 529 O
criteria NCT03861637 530 538 O
: NCT03861637 539 540 O

- NCT03861637 544 545 O
Acute NCT03861637 547 552 B-Severity___Severity-Value:severe
or NCT03861637 553 555 O
chronic NCT03861637 556 563 O
bleeding NCT03861637 564 572 B-Condition-Name
, NCT03861637 573 574 O
or NCT03861637 575 577 O
erythrocyte NCT03861637 578 589 B-Procedure-Name
transfusion NCT03861637 590 601 I-Procedure-Name
, NCT03861637 602 603 O
within NCT03861637 604 610 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861637 611 614 O
preceding NCT03861637 615 624 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
8 NCT03861637 626 627 B-Eq-Value
weeks NCT03861637 628 633 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03861637 634 635 O
change NCT03861637 637 643 B-Stability___Stability-Value:change
in NCT03861637 644 646 O
Hb NCT03861637 647 649 B-Observation-Name___Observation-Type-Value:lab
level NCT03861637 650 655 O
≥ NCT03861637 656 657 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03861637 659 660 B-Eq-Value
g NCT03861637 661 662 B-Eq-Unit
/ NCT03861637 663 664 O
dL NCT03861637 665 667 B-Eq-Unit
during NCT03861637 668 674 O
screening NCT03861637 675 684 O
phase NCT03861637 685 690 O
, NCT03861637 691 692 O

- NCT03861637 696 697 O
Hemolytic NCT03861637 699 708 B-Condition-Name
anemia NCT03861637 709 715 I-Condition-Name
, NCT03861637 716 717 O

- NCT03861637 721 722 O
Recent NCT03861637 724 730 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
infection NCT03861637 731 740 B-Condition-Name
or NCT03861637 741 743 O
rejection NCT03861637 744 753 B-Condition-Name
, NCT03861637 754 755 O

- NCT03861637 759 760 O
Diastolic NCT03861637 762 771 B-Observation-Name___Observation-Type-Value:vital
blood NCT03861637 772 777 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03861637 778 786 I-Observation-Name___Observation-Type-Value:vital
> NCT03861637 787 788 B-Eq-Operator___Eq-Operator-Value:GT
100 NCT03861637 790 793 B-Eq-Value
mmHg NCT03861637 794 798 B-Eq-Unit
or NCT03861637 799 801 O
discontinuation NCT03861637 802 817 O
of NCT03861637 818 820 O
ESA NCT03861637 821 824 B-Procedure-Name
due NCT03861637 825 828 O
to NCT03861637 829 831 O
hypertension NCT03861637 832 844 B-Condition-Name
in NCT03861637 845 847 O
the NCT03861637 848 851 O
6 NCT03861637 853 854 B-Eq-Value
months NCT03861637 855 861 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03861637 862 867 O
to NCT03861637 868 870 O
study NCT03861637 871 876 O
, NCT03861637 877 878 O

- NCT03861637 882 883 O
Vitamin NCT03861637 885 892 O
B NCT03861637 893 894 O
12 NCT03861637 895 897 O
or NCT03861637 898 900 O
folic NCT03861637 901 906 O
acid NCT03861637 907 911 O
deficiency NCT03861637 912 922 B-Condition-Name
, NCT03861637 923 924 O

- NCT03861637 928 929 O
Uncontrolled NCT03861637 931 943 O
or NCT03861637 944 946 O
secondary NCT03861637 947 956 O
hyperparathyroidism NCT03861637 957 976 B-Condition-Name
, NCT03861637 977 978 O

- NCT03861637 982 983 O
Acute NCT03861637 985 990 B-Severity___Severity-Value:severe
or NCT03861637 991 993 O
chronic NCT03861637 994 1001 O
systemic NCT03861637 1002 1010 B-Condition-Name
inflammatory NCT03861637 1011 1023 I-Condition-Name
disease NCT03861637 1024 1031 I-Condition-Name
and NCT03861637 1032 1035 O
/ NCT03861637 1036 1037 O
or NCT03861637 1038 1040 O
C NCT03861637 1041 1042 B-Observation-Name___Observation-Type-Value:lab
- NCT03861637 1043 1044 I-Observation-Name___Observation-Type-Value:lab
reactive NCT03861637 1045 1053 I-Observation-Name___Observation-Type-Value:lab
protein NCT03861637 1054 1061 I-Observation-Name___Observation-Type-Value:lab
( NCT03861637 1062 1063 O
CRP NCT03861637 1064 1067 B-Observation-Name
) NCT03861637 1068 1069 O
> NCT03861637 1070 1071 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03861637 1073 1075 B-Eq-Value
mg NCT03861637 1076 1078 B-Eq-Unit
/ NCT03861637 1079 1080 O
L NCT03861637 1081 1082 B-Eq-Unit
, NCT03861637 1083 1084 O

- NCT03861637 1088 1089 O
Hemodialysis NCT03861637 1091 1103 B-Procedure-Name
due NCT03861637 1104 1107 O
to NCT03861637 1108 1110 O
failure NCT03861637 1111 1118 O
of NCT03861637 1119 1121 O
a NCT03861637 1122 1123 O
kidney NCT03861637 1124 1130 B-Procedure-Name
transplant NCT03861637 1131 1141 I-Procedure-Name
, NCT03861637 1142 1143 O

- NCT03861637 1147 1148 O
and NCT03861637 1150 1153 O
malignancy NCT03861637 1154 1164 B-Condition-Name


Inclusion NCT03864029 0 9 O
Criteria NCT03864029 10 18 O
: NCT03864029 19 20 O

- NCT03864029 24 25 O
Willing NCT03864029 27 34 O
and NCT03864029 35 38 O
able NCT03864029 39 43 O
to NCT03864029 44 46 O
provide NCT03864029 47 54 O
informed NCT03864029 55 63 O
consent NCT03864029 64 71 O
( NCT03864029 72 73 O
unless NCT03864029 74 80 O
exemption NCT03864029 81 90 O
of NCT03864029 91 93 O
obtaining NCT03864029 94 103 O
consent NCT03864029 104 111 O
is NCT03864029 112 114 O
obtained NCT03864029 115 123 O
as NCT03864029 124 126 O
per NCT03864029 127 130 O
local NCT03864029 131 136 O
regulation NCT03864029 137 147 O
) NCT03864029 148 149 O
. NCT03864029 151 152 O
Assent NCT03864029 154 160 O
( NCT03864029 161 162 O
if NCT03864029 163 165 O
required NCT03864029 166 174 O
defined NCT03864029 175 182 O
by NCT03864029 183 185 O
local NCT03864029 186 191 O
regulation NCT03864029 192 202 O
and NCT03864029 203 206 O
requirement NCT03864029 207 218 O
) NCT03864029 219 220 O
should NCT03864029 221 227 O
also NCT03864029 228 232 O
be NCT03864029 233 235 O
obtained NCT03864029 236 244 O
from NCT03864029 245 249 O
the NCT03864029 250 253 O
subject NCT03864029 254 261 O
and NCT03864029 262 265 O
the NCT03864029 266 269 O
legal NCT03864029 270 275 O
authorized NCT03864029 276 286 O
representative NCT03864029 287 301 O
. NCT03864029 302 303 O

- NCT03864029 307 308 O
Diagnosed NCT03864029 310 319 O
with NCT03864029 320 324 O
BH NCT03864029 325 327 B-Condition-Name
4 NCT03864029 328 329 I-Condition-Name
deficiency NCT03864029 330 340 I-Condition-Name
per NCT03864029 341 344 O
local NCT03864029 345 350 O
practice NCT03864029 351 359 O
. NCT03864029 360 361 O

- NCT03864029 365 366 O
KUVAN NCT03864029 368 373 B-Drug-Name
® NCT03864029 373 374 O
was NCT03864029 375 378 O
taken NCT03864029 379 384 O
at NCT03864029 385 387 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864029 388 393 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03864029 395 396 B-Eq-Value
dose NCT03864029 397 401 B-Eq-Unit
to NCT03864029 402 404 O
treat NCT03864029 405 410 O
HPA NCT03864029 411 414 B-Condition-Name
caused NCT03864029 415 421 O
by NCT03864029 422 424 O
BH NCT03864029 425 427 B-Condition-Name
4 NCT03864029 428 429 I-Condition-Name
deficiency NCT03864029 430 440 I-Condition-Name
during NCT03864029 441 447 O
the NCT03864029 448 451 O
period NCT03864029 452 458 O
of NCT03864029 459 461 O
observation NCT03864029 462 473 O
. NCT03864029 474 475 O

- NCT03864029 479 480 O
Baseline NCT03864029 482 490 O
Phe NCT03864029 491 494 B-Observation-Name___Observation-Type-Value:lab
concentration NCT03864029 495 508 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03864029 509 510 B-Eq-Operator___Eq-Operator-Value:GTEQ
450 NCT03864029 512 515 B-Eq-Value
µmol NCT03864029 516 520 B-Eq-Unit
/ NCT03864029 521 522 O
L NCT03864029 523 524 B-Eq-Unit

Exclusion NCT03864029 525 534 O
Criteria NCT03864029 535 543 O
: NCT03864029 544 545 O

- NCT03864029 549 550 O
Subject NCT03864029 552 559 O
diagnosed NCT03864029 560 569 O
to NCT03864029 570 572 O
have NCT03864029 573 577 O
Phenylketonuria NCT03864029 578 593 B-Condition-Name
( NCT03864029 594 595 O
PKU NCT03864029 596 599 B-Condition-Name
) NCT03864029 600 601 O

- NCT03864029 605 606 O
Has NCT03864029 608 611 O
any NCT03864029 612 615 O
condition NCT03864029 616 625 O
that NCT03864029 626 630 O
, NCT03864029 631 632 O
in NCT03864029 633 635 O
the NCT03864029 636 639 O
view NCT03864029 640 644 O
of NCT03864029 645 647 O
the NCT03864029 648 651 O
Investigator NCT03864029 652 664 O
, NCT03864029 665 666 O
the NCT03864029 667 670 O
medical NCT03864029 671 678 O
record NCT03864029 679 685 O
of NCT03864029 686 688 O
the NCT03864029 689 692 O
subject NCT03864029 693 700 O
in NCT03864029 701 703 O
the NCT03864029 704 707 O
duration NCT03864029 708 716 O
of NCT03864029 717 719 O
observation NCT03864029 720 731 O
is NCT03864029 732 734 O
not NCT03864029 735 738 O
reliable NCT03864029 739 747 O
, NCT03864029 748 749 O
or NCT03864029 750 752 O
not NCT03864029 753 756 O
accessible NCT03864029 757 767 O
. NCT03864029 768 769 O

Inclusion NCT03869294 0 9 O
Criteria NCT03869294 10 18 O
: NCT03869294 19 20 O

- NCT03869294 24 25 O
1 NCT03869294 28 29 O
. NCT03869294 29 30 O
Histologically NCT03869294 31 45 B-Procedure-Name
confirmed NCT03869294 46 55 O
pancreatic NCT03869294 56 66 B-Condition-Name
adenocarcinoma NCT03869294 67 81 I-Condition-Name
2 NCT03869294 83 84 O
. NCT03869294 84 85 O
Locally NCT03869294 86 93 O
advanced NCT03869294 94 102 O
or NCT03869294 103 105 O
metastatic NCT03869294 106 116 O
PC NCT03869294 117 119 B-Condition-Name
3 NCT03869294 121 122 O
. NCT03869294 122 123 O
Chemotherapy NCT03869294 124 136 B-Procedure-Name
- NCT03869294 137 138 O
naïve NCT03869294 139 144 O
4 NCT03869294 146 147 O
. NCT03869294 147 148 O
ECOG NCT03869294 149 153 B-Observation-Name___Observation-Type-Value:clinical-score
performance NCT03869294 154 165 I-Observation-Name___Observation-Type-Value:clinical-score
status NCT03869294 166 172 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03869294 173 175 O
0 NCT03869294 177 178 B-Eq-Value
or NCT03869294 179 181 O
1 NCT03869294 183 184 B-Eq-Value
5 NCT03869294 186 187 O
. NCT03869294 187 188 O
An NCT03869294 190 192 O
adequate NCT03869294 193 201 B-Polarity___Polarity-Value:normal
bone NCT03869294 202 206 O
marrow NCT03869294 207 213 O
, NCT03869294 214 215 O
liver NCT03869294 216 221 O
function NCT03869294 222 230 B-Condition-Name
and NCT03869294 231 234 O
kidney NCT03869294 235 241 O
function NCT03869294 242 250 B-Condition-Name

Exclusion NCT03869294 251 260 O
Criteria NCT03869294 261 269 O
: NCT03869294 270 271 O

- NCT03869294 275 276 O
1 NCT03869294 279 280 O
. NCT03869294 280 281 O
Age NCT03869294 282 285 O
≥ NCT03869294 286 287 B-Eq-Operator___Eq-Operator-Value:GTEQ
80 NCT03869294 289 291 B-Eq-Value
years NCT03869294 292 297 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
2 NCT03869294 299 300 O
. NCT03869294 300 301 O
Brain NCT03869294 302 307 O
metastasis NCT03869294 308 318 B-Condition-Name
3 NCT03869294 320 321 O
. NCT03869294 321 322 O
With NCT03869294 323 327 O
other NCT03869294 328 333 O
malignancies NCT03869294 334 346 B-Condition-Name
4 NCT03869294 348 349 O
. NCT03869294 349 350 O
Chronic NCT03869294 351 358 O
diarrhea NCT03869294 359 367 B-Condition-Name
, NCT03869294 368 369 O
cardiac NCT03869294 370 377 B-Condition-Name
disease NCT03869294 378 385 I-Condition-Name
, NCT03869294 386 387 O
pregnancy NCT03869294 388 397 B-Condition-Name
or NCT03869294 398 400 O
breast NCT03869294 401 407 B-Condition-Name
feeding NCT03869294 408 415 I-Condition-Name

Inclusion NCT03863236 0 9 O
Criteria NCT03863236 10 18 O
: NCT03863236 19 20 O

- NCT03863236 24 25 O
18 NCT03863236 28 30 B-Eq-Value
years NCT03863236 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03863236 37 39 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03863236 40 45 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03863236 48 49 O
Primary NCT03863236 51 58 O
colon NCT03863236 59 64 O
adenocarcinoma NCT03863236 65 79 B-Condition-Name

- NCT03863236 82 83 O
Curative NCT03863236 85 93 B-Procedure-Name
operation NCT03863236 94 103 I-Procedure-Name
is NCT03863236 104 106 O
possible NCT03863236 107 115 O

- NCT03863236 118 119 O
Patient NCT03863236 121 128 O
has NCT03863236 129 132 O
a NCT03863236 133 134 O
life NCT03863236 135 139 B-Observation-Name
expectancy NCT03863236 140 150 I-Observation-Name
of NCT03863236 151 153 O
at NCT03863236 154 156 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863236 157 162 I-Eq-Operator___Eq-Operator-Value:GTEQ
12 NCT03863236 164 166 B-Eq-Value
months NCT03863236 167 173 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863236 176 177 O
Patient NCT03863236 179 186 O
signs NCT03863236 187 192 O
the NCT03863236 193 196 O
informed NCT03863236 197 205 O
consent NCT03863236 206 213 O
and NCT03863236 214 217 O
agrees NCT03863236 218 224 O
to NCT03863236 225 227 O
attend NCT03863236 228 234 O
all NCT03863236 235 238 O
study NCT03863236 239 244 O
visits NCT03863236 245 251 O

Exclusion NCT03863236 252 261 O
Criteria NCT03863236 262 270 O
: NCT03863236 271 272 O

- NCT03863236 276 277 O
Recurrent NCT03863236 279 288 O
colon NCT03863236 289 294 O
adenocarcinoma NCT03863236 295 309 B-Condition-Name

- NCT03863236 312 313 O
Metastatic NCT03863236 315 325 B-Condition-Name
disease NCT03863236 326 333 I-Condition-Name

- NCT03863236 336 337 O
Cancer NCT03863236 339 345 B-Condition-Name
that NCT03863236 346 350 O
will NCT03863236 351 355 O
require NCT03863236 356 363 O
multiorgan NCT03863236 364 374 B-Procedure-Name
resection NCT03863236 375 384 I-Procedure-Name

- NCT03863236 387 388 O
Pregnant NCT03863236 390 398 B-Condition-Name
or NCT03863236 399 401 O
suspected NCT03863236 402 411 O
pregnancy NCT03863236 412 421 B-Condition-Name

- NCT03863236 424 425 O
Patient NCT03863236 427 434 O
with NCT03863236 435 439 O
a NCT03863236 440 441 O
comorbid NCT03863236 442 450 B-Condition-Name
illness NCT03863236 451 458 I-Condition-Name
or NCT03863236 459 461 O
condition NCT03863236 462 471 O
that NCT03863236 472 476 O
would NCT03863236 477 482 O
preclude NCT03863236 483 491 O
the NCT03863236 492 495 O
use NCT03863236 496 499 O
of NCT03863236 500 502 O
surgery NCT03863236 503 510 B-Procedure-Name
( NCT03863236 511 512 O
ASA NCT03863236 513 516 B-Condition-Name
5 NCT03863236 518 519 B-Eq-Value
) NCT03863236 520 521 O
. NCT03863236 523 524 O

- NCT03863236 528 529 O
Patients NCT03863236 531 539 O
with NCT03863236 540 544 O
concurrent NCT03863236 545 555 O
or NCT03863236 556 558 O
previous NCT03863236 559 567 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
malignant NCT03863236 568 577 B-Condition-Name
tumors NCT03863236 578 584 I-Condition-Name
within NCT03863236 585 591 B-Eq-Operator___Eq-Operator-Value:LTEQ
5 NCT03863236 593 594 B-Eq-Value
years NCT03863236 595 600 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
before NCT03863236 601 607 O
the NCT03863236 608 611 O
study NCT03863236 612 617 O
enrollment NCT03863236 618 628 O

- NCT03863236 631 632 O
Patient NCT03863236 634 641 O
undergoing NCT03863236 642 652 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
emergency NCT03863236 653 662 O
procedures NCT03863236 663 673 O

- NCT03863236 676 677 O
Dialysis NCT03863236 679 687 B-Procedure-Name

- NCT03863236 690 691 O
Liver NCT03863236 693 698 B-Condition-Name
dysfunction NCT03863236 699 710 I-Condition-Name
, NCT03863236 711 712 O
child NCT03863236 713 718 B-Condition-Name
pugh NCT03863236 719 723 I-Condition-Name
B NCT03863236 724 725 B-Eq-Value
or NCT03863236 726 728 B-Eq-Operator___Eq-Operator-Value:LTEQ
worse NCT03863236 729 734 I-Eq-Operator___Eq-Operator-Value:LTEQ

- NCT03863236 737 738 O
NRS NCT03863236 740 743 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03863236 744 749 B-Eq-Unit
< NCT03863236 750 751 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03863236 753 754 B-Eq-Value
or NCT03863236 755 757 O
> NCT03863236 758 759 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03863236 761 762 B-Eq-Value

- NCT03863236 766 767 O
BMI NCT03863236 769 772 B-Observation-Name___Observation-Type-Value:vital
under NCT03863236 773 778 B-Eq-Operator___Eq-Operator-Value:LT
18.5 NCT03863236 780 784 B-Eq-Value

- NCT03863236 788 789 O
Weight NCT03863236 791 797 B-Observation-Name___Observation-Type-Value:measurement
loss NCT03863236 798 802 I-Observation-Name___Observation-Type-Value:measurement
15 NCT03863236 804 806 B-Eq-Value
% NCT03863236 807 808 B-Eq-Unit
or NCT03863236 809 811 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03863236 812 816 I-Eq-Operator___Eq-Operator-Value:GTEQ
past NCT03863236 817 821 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03863236 823 824 B-Eq-Value
months NCT03863236 825 831 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863236 834 835 O
Serum NCT03863236 837 842 B-Observation-Name___Observation-Type-Value:lab
albumin NCT03863236 843 850 I-Observation-Name___Observation-Type-Value:lab
less NCT03863236 851 855 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03863236 856 860 I-Eq-Operator___Eq-Operator-Value:LT
30 NCT03863236 862 864 B-Eq-Value
without NCT03863236 865 872 O
liver NCT03863236 873 878 O
or NCT03863236 879 881 O
renal NCT03863236 882 887 O
dysfunction NCT03863236 888 899 B-Condition-Name

- NCT03863236 902 903 O
Chronic NCT03863236 905 912 B-Condition-Name
malnutrition NCT03863236 913 925 I-Condition-Name
: NCT03863236 926 927 O
short NCT03863236 928 933 B-Condition-Name
bowel NCT03863236 934 939 I-Condition-Name
syndrome NCT03863236 940 948 I-Condition-Name
, NCT03863236 949 950 O
previous NCT03863236 951 959 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
gastrectomy NCT03863236 960 971 B-Condition-Name
, NCT03863236 972 973 O
pancreatic NCT03863236 974 984 B-Condition-Name
dysfunction NCT03863236 985 996 I-Condition-Name

- NCT03863236 999 1000 O
Language NCT03863236 1002 1010 B-Condition-Name
barrier NCT03863236 1011 1018 I-Condition-Name
or NCT03863236 1019 1021 O
other NCT03863236 1022 1027 O
reasons NCT03863236 1028 1035 O
why NCT03863236 1036 1039 O
informed NCT03863236 1040 1048 O
consent NCT03863236 1049 1056 O
is NCT03863236 1057 1059 O
not NCT03863236 1060 1063 O
possible NCT03863236 1064 1072 O

Inclusion NCT03865121 0 9 O
criteria NCT03865121 10 18 O
: NCT03865121 19 20 O

- NCT03865121 24 25 O
Subjects NCT03865121 27 35 O
over NCT03865121 36 40 B-Eq-Operator___Eq-Operator-Value:GT
60 NCT03865121 42 44 B-Eq-Value
years NCT03865121 45 50 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865121 51 53 O
age NCT03865121 54 57 O
with NCT03865121 58 62 O
a NCT03865121 63 64 O
clinical NCT03865121 65 73 O
diagnosis NCT03865121 74 83 O
of NCT03865121 84 86 O
Parkinson NCT03865121 87 96 B-Condition-Name
's NCT03865121 96 98 I-Condition-Name
disease NCT03865121 99 106 I-Condition-Name

- NCT03865121 109 110 O
Stages NCT03865121 112 118 O
of NCT03865121 119 121 O
the NCT03865121 122 125 O
disease NCT03865121 126 133 O
2 NCT03865121 135 136 B-Eq-Value
- NCT03865121 137 138 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03865121 140 141 B-Eq-Value
of NCT03865121 142 144 O
Hoehn NCT03865121 145 150 O
and NCT03865121 151 154 O
Yahr NCT03865121 155 159 O

- NCT03865121 162 163 O
Not NCT03865121 165 168 O
exposed NCT03865121 169 176 B-Condition-Name
to NCT03865121 177 179 I-Condition-Name
tobacco NCT03865121 180 187 I-Condition-Name
during NCT03865121 188 194 O
any NCT03865121 195 198 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
stage NCT03865121 199 204 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
of NCT03865121 205 207 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
their NCT03865121 208 213 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
life NCT03865121 214 218 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime

- NCT03865121 221 222 O
No NCT03865121 224 226 O
history NCT03865121 227 234 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865121 235 237 O
lung NCT03865121 238 242 B-Condition-Name
diseases NCT03865121 243 251 I-Condition-Name

- NCT03865121 254 255 O
No NCT03865121 257 259 O
laboratory NCT03865121 260 270 B-Observation-Name___Observation-Type-Value:lab
abnormalities NCT03865121 271 284 B-Polarity___Polarity-Value:abnormal

- NCT03865121 287 288 O
No NCT03865121 290 292 O
history NCT03865121 293 300 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865121 301 303 O
adverse NCT03865121 304 311 B-Condition-Name
reactions NCT03865121 312 321 I-Condition-Name
to NCT03865121 322 324 O
nicotine NCT03865121 325 333 B-Drug-Name

- NCT03865121 336 337 O
Able NCT03865121 339 343 O
to NCT03865121 344 346 O
use NCT03865121 347 350 O
nicotine NCT03865121 351 359 B-Drug-Name
nasal NCT03865121 360 365 I-Drug-Name
spray NCT03865121 366 371 I-Drug-Name

- NCT03865121 374 375 O
Residents NCT03865121 377 386 O
of NCT03865121 387 389 O
Mexico NCT03865121 390 396 B-Location___Location-Value:residence
City NCT03865121 397 401 I-Location___Location-Value:residence
able NCT03865121 402 406 O
to NCT03865121 407 409 O
attend NCT03865121 410 416 O
for NCT03865121 417 420 O
evaluations NCT03865121 421 432 O

- NCT03865121 435 436 O
Under NCT03865121 438 443 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
current NCT03865121 444 451 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03865121 452 461 O
with NCT03865121 462 466 O
levodopa NCT03865121 467 475 B-Drug-Name
at NCT03865121 476 478 O
a NCT03865121 479 480 O
stable NCT03865121 481 487 B-Stability___Stability-Value:stable
dose NCT03865121 488 492 O

- NCT03865121 495 496 O
Not NCT03865121 498 501 O
currently NCT03865121 502 511 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
receiving NCT03865121 512 521 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03865121 522 523 O
monoamine NCT03865121 524 533 B-Drug-Name
oxidase NCT03865121 534 541 I-Drug-Name
inhibitor NCT03865121 542 551 I-Drug-Name
treatment NCT03865121 552 561 O

Exclusion NCT03865121 562 571 O
Criteria NCT03865121 572 580 O

- NCT03865121 583 584 O
Unable NCT03865121 586 592 O
to NCT03865121 593 595 O
complete NCT03865121 596 604 O
follow NCT03865121 605 611 O
- NCT03865121 612 613 O
up NCT03865121 614 616 O
protocol NCT03865121 617 625 O

- NCT03865121 628 629 O
Drug NCT03865121 631 635 O
adverse NCT03865121 636 643 B-Condition-Name
reaction NCT03865121 644 652 I-Condition-Name

- NCT03865121 655 656 O
Death NCT03865121 658 663 O

Inclusion NCT03867656 0 9 O
Criteria NCT03867656 10 18 O
: NCT03867656 19 20 O

- NCT03867656 24 25 O
Male NCT03867656 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03867656 34 35 O
Age NCT03867656 37 40 O
25 NCT03867656 42 44 B-Eq-Value
to NCT03867656 45 47 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03867656 49 51 B-Eq-Value
years NCT03867656 52 57 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867656 58 61 O
. NCT03867656 62 63 O

- NCT03867656 67 68 O
Type NCT03867656 70 74 O
2 NCT03867656 76 77 O
diabetes NCT03867656 78 86 B-Condition-Name
. NCT03867656 87 88 O

- NCT03867656 92 93 O
In NCT03867656 95 97 O
Metformin NCT03867656 98 107 B-Drug-Name
or NCT03867656 108 110 O
sulfonylureas NCT03867656 111 124 B-Drug-Name

Exclusion NCT03867656 125 134 O
Criteria NCT03867656 135 143 O
: NCT03867656 144 145 O

- NCT03867656 149 150 O
Treatment NCT03867656 152 161 O
with NCT03867656 162 166 O
other NCT03867656 167 172 O
antidiabetics NCT03867656 173 186 B-Drug-Name

- NCT03867656 189 190 O
Osteopososis NCT03867656 192 204 B-Condition-Name
or NCT03867656 205 207 O
gastrointestinal NCT03867656 208 224 O
disease NCT03867656 225 232 B-Condition-Name

- NCT03867656 235 236 O
Smoking NCT03867656 238 245 B-Condition-Name

- NCT03867656 248 249 O
Long NCT03867656 251 255 O
term NCT03867656 256 260 O
steroid NCT03867656 261 268 B-Drug-Name
treatment NCT03867656 269 278 O

- NCT03867656 281 282 O
Weight NCT03867656 284 290 B-Observation-Name___Observation-Type-Value:vital
change NCT03867656 291 297 B-Stability___Stability-Value:change
more NCT03867656 298 302 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867656 303 307 I-Eq-Operator___Eq-Operator-Value:GT
3 NCT03867656 309 310 B-Eq-Value
kg NCT03867656 311 313 B-Eq-Unit
within NCT03867656 314 320 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867656 321 324 O
last NCT03867656 325 329 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03867656 331 332 B-Eq-Value
months NCT03867656 333 339 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03867656 340 341 O

- NCT03867656 345 346 O
Overweight NCT03867656 348 358 B-Condition-Name
or NCT03867656 359 361 O
intestinal NCT03867656 362 372 O
surgery NCT03867656 373 380 B-Procedure-Name

Inclusion NCT03863418 0 9 O
Criteria NCT03863418 10 18 O
: NCT03863418 19 20 O

- NCT03863418 24 25 O
Children NCT03863418 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
aged NCT03863418 36 40 O
6 NCT03863418 42 43 B-Eq-Value
- NCT03863418 44 45 B-Eq-Operator___Eq-Operator-Value:BETWEEN
36 NCT03863418 47 49 B-Eq-Value
months NCT03863418 50 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863418 59 60 O
diagnosis NCT03863418 62 71 O
of NCT03863418 72 74 O
Atopic NCT03863418 75 81 B-Condition-Name
Dermatitis NCT03863418 82 92 I-Condition-Name
according NCT03863418 93 102 O
to NCT03863418 103 105 O
SCORAD NCT03863418 106 112 B-Observation-Name___Observation-Type-Value:clinical-score
index NCT03863418 113 118 I-Observation-Name___Observation-Type-Value:clinical-score

Exclusion NCT03863418 119 128 O
Criteria NCT03863418 129 137 O

- NCT03863418 140 141 O
Age NCT03863418 143 146 O
< NCT03863418 147 148 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03863418 150 151 B-Eq-Value
months NCT03863418 152 158 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863418 161 162 O
age NCT03863418 164 167 O
> NCT03863418 168 169 B-Eq-Operator___Eq-Operator-Value:GT
36 NCT03863418 171 173 B-Eq-Value
months NCT03863418 174 180 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03863418 181 182 O

- NCT03863418 186 187 O
skin NCT03863418 189 193 O
infections NCT03863418 194 204 B-Condition-Name
, NCT03863418 205 206 O

- NCT03863418 210 211 O
ichthyosis NCT03863418 213 223 B-Condition-Name
, NCT03863418 224 225 O

- NCT03863418 229 230 O
food NCT03863418 232 236 B-Allergy-Name
allergies NCT03863418 237 246 O
, NCT03863418 247 248 O

- NCT03863418 252 253 O
other NCT03863418 255 260 O
allergic NCT03863418 261 269 B-Condition-Name
diseases NCT03863418 270 278 I-Condition-Name
, NCT03863418 279 280 O

- NCT03863418 284 285 O
chronic NCT03863418 287 294 O
systemic NCT03863418 295 303 O
diseases NCT03863418 304 312 B-Condition-Name
, NCT03863418 313 314 O

- NCT03863418 318 319 O
congenital NCT03863418 321 331 B-Condition-Name
cardiac NCT03863418 332 339 I-Condition-Name
defects NCT03863418 340 347 I-Condition-Name
, NCT03863418 348 349 O

- NCT03863418 353 354 O
active NCT03863418 356 362 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
tuberculosis NCT03863418 363 375 B-Condition-Name
, NCT03863418 376 377 O

- NCT03863418 381 382 O
autoimmune NCT03863418 384 394 B-Condition-Name
diseases NCT03863418 395 403 I-Condition-Name
, NCT03863418 404 405 O

- NCT03863418 409 410 O
immunodeficiency NCT03863418 412 428 B-Condition-Name
, NCT03863418 429 430 O

- NCT03863418 434 435 O
chronic NCT03863418 437 444 O
inflammatory NCT03863418 445 457 B-Condition-Name
bowel NCT03863418 458 463 I-Condition-Name
diseases NCT03863418 464 472 I-Condition-Name
, NCT03863418 473 474 O

- NCT03863418 478 479 O
celiac NCT03863418 481 487 B-Condition-Name
disease NCT03863418 488 495 I-Condition-Name
, NCT03863418 496 497 O

- NCT03863418 501 502 O
cystic NCT03863418 504 510 B-Condition-Name
fibrosis NCT03863418 511 519 I-Condition-Name
, NCT03863418 520 521 O

- NCT03863418 525 526 O
metabolic NCT03863418 528 537 B-Condition-Name
diseases NCT03863418 538 546 I-Condition-Name
, NCT03863418 547 548 O

- NCT03863418 552 553 O
malignancy NCT03863418 555 565 B-Condition-Name
, NCT03863418 566 567 O

- NCT03863418 571 572 O
chronic NCT03863418 574 581 O
pulmonary NCT03863418 582 591 B-Condition-Name
diseases NCT03863418 592 600 I-Condition-Name
, NCT03863418 601 602 O

- NCT03863418 606 607 O
malformations NCT03863418 609 622 B-Condition-Name
of NCT03863418 623 625 O
the NCT03863418 626 629 O
gastrointestinal NCT03863418 630 646 O
and NCT03863418 647 650 O
/ NCT03863418 651 652 O
or NCT03863418 653 655 O
respiratory NCT03863418 656 667 O
tract NCT03863418 668 673 O
, NCT03863418 674 675 O

- NCT03863418 679 680 O
administration NCT03863418 682 696 O
of NCT03863418 697 699 O
prebiotics NCT03863418 700 710 B-Drug-Name
/ NCT03863418 711 712 O
probiotics NCT03863418 713 723 B-Drug-Name
/ NCT03863418 724 725 O
symbiotic NCT03863418 726 735 O
/ NCT03863418 736 737 O
systemic NCT03863418 738 746 O
immunomodulators NCT03863418 747 763 B-Drug-Name
during NCT03863418 764 770 O
the NCT03863418 771 774 O
4 NCT03863418 776 777 B-Eq-Value
weeks NCT03863418 778 783 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03863418 784 790 O
enrolment NCT03863418 791 800 O
, NCT03863418 801 802 O

- NCT03863418 806 807 O
treatments NCT03863418 809 819 O
with NCT03863418 820 824 O
topical NCT03863418 825 832 B-Drug-Name
immunomodulators NCT03863418 833 849 I-Drug-Name
( NCT03863418 850 851 O
Tacrolimus NCT03863418 852 862 B-Drug-Name
or NCT03863418 863 865 O
Pimecrolimus NCT03863418 866 878 B-Drug-Name
) NCT03863418 879 880 O
over NCT03863418 881 885 O
the NCT03863418 886 889 O
three NCT03863418 890 895 B-Eq-Value
months NCT03863418 896 902 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03863418 903 908 O
to NCT03863418 909 911 O
enrolment NCT03863418 912 921 O
; NCT03863418 921 922 O

- NCT03863418 925 926 O
use NCT03863418 928 931 O
of NCT03863418 932 934 O
corticosteroids NCT03863418 935 950 B-Drug-Name
or NCT03863418 951 953 O
calcineurin NCT03863418 954 965 B-Drug-Name
antagonists NCT03863418 966 977 I-Drug-Name
or NCT03863418 978 980 O
phototherapy NCT03863418 981 993 B-Procedure-Name
in NCT03863418 994 996 O
the NCT03863418 997 1000 O
previous NCT03863418 1001 1009 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
4 NCT03863418 1011 1012 B-Eq-Value
weeks NCT03863418 1013 1018 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03863418 1019 1020 O

- NCT03863418 1024 1025 O
use NCT03863418 1027 1030 O
of NCT03863418 1031 1033 O
systemic NCT03863418 1034 1042 O
antibiotics NCT03863418 1043 1054 B-Drug-Name
or NCT03863418 1055 1057 O
anti NCT03863418 1058 1062 O
- NCT03863418 1063 1064 O
mycotic NCT03863418 1065 1072 B-Condition-Name
drugs NCT03863418 1073 1078 O
during NCT03863418 1079 1085 O
4 NCT03863418 1087 1088 B-Eq-Value
weeks NCT03863418 1089 1094 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03863418 1095 1101 O
study NCT03863418 1102 1107 O
entry NCT03863418 1108 1113 O
; NCT03863418 1113 1114 O

- NCT03863418 1117 1118 O
investigator NCT03863418 1120 1132 O
's NCT03863418 1132 1134 O
uncertainty NCT03863418 1135 1146 O
about NCT03863418 1147 1152 O
the NCT03863418 1153 1156 O
willingness NCT03863418 1157 1168 O
or NCT03863418 1169 1171 O
ability NCT03863418 1172 1179 O
of NCT03863418 1180 1182 O
the NCT03863418 1183 1186 O
subject NCT03863418 1187 1194 O
to NCT03863418 1195 1197 O
comply NCT03863418 1198 1204 O
with NCT03863418 1205 1209 O
the NCT03863418 1210 1213 O
protocol NCT03863418 1214 1222 O
requirements NCT03863418 1223 1235 O
; NCT03863418 1235 1236 O

- NCT03863418 1239 1240 O
participation NCT03863418 1242 1255 O
in NCT03863418 1256 1258 O
any NCT03863418 1259 1262 O
other NCT03863418 1263 1268 O
studies NCT03863418 1269 1276 O
involving NCT03863418 1277 1286 O
investigational NCT03863418 1287 1302 O
or NCT03863418 1303 1305 O
marketed NCT03863418 1306 1314 O
products NCT03863418 1315 1323 O
concomitantly NCT03863418 1324 1337 O
or NCT03863418 1338 1340 O
within NCT03863418 1341 1347 B-Eq-Operator___Eq-Operator-Value:LTEQ
two NCT03863418 1348 1351 B-Eq-Value
weeks NCT03863418 1352 1357 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03863418 1358 1363 O
to NCT03863418 1364 1366 O
entry NCT03863418 1367 1372 O
into NCT03863418 1373 1377 O
the NCT03863418 1378 1381 O
study NCT03863418 1382 1387 O
; NCT03863418 1387 1388 O

- NCT03863418 1391 1392 O
hypersensitivity NCT03863418 1394 1410 B-Condition-Name
to NCT03863418 1411 1413 O
components NCT03863418 1414 1424 O
contained NCT03863418 1425 1434 O
in NCT03863418 1435 1437 O
study NCT03863418 1438 1443 O
product NCT03863418 1444 1451 O
. NCT03863418 1452 1453 O

Inclusion NCT03867695 0 9 O
criteria NCT03867695 10 18 O
: NCT03867695 19 20 O

- NCT03867695 24 25 O
All NCT03867695 27 30 O
patients NCT03867695 31 39 O
undergoing NCT03867695 40 50 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
lobectomy NCT03867695 51 60 B-Procedure-Name
VATS NCT03867695 61 65 I-Procedure-Name

- NCT03867695 68 69 O
Older NCT03867695 71 76 O
> NCT03867695 77 78 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03867695 80 82 B-Eq-Value
years NCT03867695 83 88 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867695 91 92 O
Patients NCT03867695 94 102 O
who NCT03867695 103 106 O
meet NCT03867695 107 111 O
criteria NCT03867695 112 120 O
of NCT03867695 121 123 O
ASA NCT03867695 124 127 B-Condition-Name
1 NCT03867695 129 130 B-Eq-Value
to NCT03867695 131 133 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03867695 135 136 B-Eq-Value
class NCT03867695 137 142 B-Eq-Unit

Exclusion NCT03867695 143 152 O
criteria NCT03867695 153 161 O
: NCT03867695 162 163 O

- NCT03867695 167 168 O
Patient NCT03867695 170 177 O
's NCT03867695 177 179 O
refusal NCT03867695 180 187 O
to NCT03867695 188 190 O
participate NCT03867695 191 202 O
in NCT03867695 203 205 O
the NCT03867695 206 209 O
study NCT03867695 210 215 O

- NCT03867695 218 219 O
Psychiatric NCT03867695 221 232 B-Condition-Name
disorder NCT03867695 233 241 I-Condition-Name
( NCT03867695 242 243 O
impossibility NCT03867695 244 257 O
to NCT03867695 258 260 O
collect NCT03867695 261 268 O
the NCT03867695 269 272 O
informed NCT03867695 273 281 O
consent NCT03867695 282 289 O
) NCT03867695 290 291 O

- NCT03867695 295 296 O
Patient NCT03867695 298 305 O
under NCT03867695 306 311 O
juridical NCT03867695 312 321 B-Observation-Name
protection NCT03867695 322 332 I-Observation-Name

- NCT03867695 335 336 O
On NCT03867695 338 340 O
going NCT03867695 341 346 O
an NCT03867695 347 349 O
other NCT03867695 350 355 O
study NCT03867695 356 361 O

- NCT03867695 364 365 O
Non NCT03867695 367 370 O
balanced NCT03867695 371 379 O
epilepsy NCT03867695 380 388 B-Condition-Name

- NCT03867695 391 392 O
3 NCT03867695 395 396 B-Eq-Value
grade NCT03867695 397 402 B-Eq-Unit
auriculo NCT03867695 403 411 O
- NCT03867695 412 413 O
ventricular NCT03867695 414 425 O
heart NCT03867695 426 431 B-Condition-Name
block NCT03867695 432 437 I-Condition-Name
without NCT03867695 438 445 O
pacing NCT03867695 446 452 O

- NCT03867695 455 456 O
Severe NCT03867695 458 464 B-Severity___Severity-Value:severe
hepatocellular NCT03867695 465 479 B-Condition-Name
insufficiency NCT03867695 480 493 I-Condition-Name

- NCT03867695 496 497 O
Anti NCT03867695 499 503 B-Procedure-Name
arrhythmic NCT03867695 504 514 I-Procedure-Name
treatment NCT03867695 515 524 I-Procedure-Name
: NCT03867695 525 526 O
class NCT03867695 527 532 B-Eq-Unit
III NCT03867695 533 536 B-Eq-Value
of NCT03867695 537 539 O
the NCT03867695 540 543 O
Vaughan NCT03867695 544 551 O
William NCT03867695 552 559 O
's NCT03867695 559 561 O
classification NCT03867695 562 576 O

- NCT03867695 579 580 O
Pregnant NCT03867695 582 590 B-Condition-Name
patient NCT03867695 591 598 O
or NCT03867695 599 601 O
/ NCT03867695 602 603 O
and NCT03867695 604 607 O
breastfeeding NCT03867695 608 621 B-Condition-Name

- NCT03867695 624 625 O
History NCT03867695 627 634 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867695 635 637 O
opioid NCT03867695 638 644 B-Condition-Name
abuse NCT03867695 645 650 I-Condition-Name

- NCT03867695 653 654 O
Allergy NCT03867695 656 663 O
to NCT03867695 664 666 O
local NCT03867695 667 672 B-Drug-Name
anesthetic NCT03867695 673 683 I-Drug-Name
drug NCT03867695 684 688 I-Drug-Name
or NCT03867695 689 691 O
opioids NCT03867695 692 699 B-Drug-Name

Inclusion NCT03860688 0 9 O
Criteria NCT03860688 10 18 O
: NCT03860688 19 20 O

- NCT03860688 24 25 O
Men NCT03860688 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03860688 31 34 O
women NCT03860688 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03860688 41 42 O
aged NCT03860688 43 47 O
18 NCT03860688 49 51 B-Eq-Value
to NCT03860688 52 54 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03860688 56 58 B-Eq-Value
years NCT03860688 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03860688 65 66 O

- NCT03860688 70 71 O
Body NCT03860688 73 77 B-Observation-Name___Observation-Type-Value:vital
mass NCT03860688 78 82 I-Observation-Name___Observation-Type-Value:vital
index NCT03860688 83 88 I-Observation-Name___Observation-Type-Value:vital
20 NCT03860688 90 92 B-Eq-Value
to NCT03860688 93 95 B-Eq-Operator___Eq-Operator-Value:BETWEEN
27 NCT03860688 97 99 B-Eq-Value
kg NCT03860688 100 102 B-Eq-Unit
/ NCT03860688 103 104 O
m NCT03860688 105 106 B-Eq-Unit
2 NCT03860688 107 108 I-Eq-Unit

Exclusion NCT03860688 109 118 O
Criteria NCT03860688 119 127 O
: NCT03860688 128 129 O

1 NCT03860688 134 135 O
. NCT03860688 135 136 O
Patients NCT03860688 138 146 O
with NCT03860688 147 151 O
active NCT03860688 152 158 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
inflammatory NCT03860688 159 171 B-Condition-Name
bowel NCT03860688 172 177 I-Condition-Name
disease NCT03860688 178 185 I-Condition-Name

2 NCT03860688 189 190 O
. NCT03860688 190 191 O
Patients NCT03860688 193 201 O
with NCT03860688 202 206 O
pre NCT03860688 207 210 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03860688 211 212 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03860688 213 221 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Celiac NCT03860688 222 228 B-Condition-Name
disease NCT03860688 229 236 I-Condition-Name
, NCT03860688 237 238 O
exocrine NCT03860688 239 247 B-Condition-Name
pancreatic NCT03860688 248 258 I-Condition-Name
insufficiency NCT03860688 259 272 I-Condition-Name
or NCT03860688 273 275 O
small NCT03860688 276 281 B-Condition-Name
bowel NCT03860688 282 287 I-Condition-Name
malabsorption NCT03860688 288 301 I-Condition-Name

3 NCT03860688 305 306 O
. NCT03860688 306 307 O
Patients NCT03860688 309 317 O
with NCT03860688 318 322 O
active NCT03860688 323 329 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
bowel NCT03860688 330 335 B-Condition-Name
malignancy NCT03860688 336 346 I-Condition-Name

4 NCT03860688 350 351 O
. NCT03860688 351 352 O
Patients NCT03860688 354 362 O
with NCT03860688 363 367 O
diabetes NCT03860688 368 376 B-Condition-Name
mellitus NCT03860688 377 385 I-Condition-Name
or NCT03860688 386 388 O
known NCT03860688 389 394 O
/ NCT03860688 395 396 O
suspected NCT03860688 397 406 O
motility NCT03860688 407 415 B-Condition-Name
disorders NCT03860688 416 425 I-Condition-Name
of NCT03860688 426 428 O
the NCT03860688 429 432 O
gut NCT03860688 433 436 O

5 NCT03860688 440 441 O
. NCT03860688 441 442 O
Patients NCT03860688 444 452 O
with NCT03860688 453 457 O
decompensated NCT03860688 458 471 O
liver NCT03860688 472 477 B-Condition-Name
disease NCT03860688 478 485 I-Condition-Name

6 NCT03860688 489 490 O
. NCT03860688 490 491 O
Patients NCT03860688 493 501 O
on NCT03860688 502 504 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
ezetimibe NCT03860688 505 514 B-Drug-Name
or NCT03860688 515 517 O
bile NCT03860688 518 522 B-Drug-Name
acid NCT03860688 523 527 I-Drug-Name
sequestrants NCT03860688 528 540 I-Drug-Name

7 NCT03860688 544 545 O
. NCT03860688 545 546 O
Patients NCT03860688 548 556 O
who NCT03860688 557 560 O
are NCT03860688 561 564 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnant NCT03860688 565 573 B-Condition-Name
or NCT03860688 574 576 O
breastfeeding NCT03860688 577 590 B-Condition-Name
. NCT03860688 591 592 O

8 NCT03860688 597 598 O
. NCT03860688 598 599 O
Patients NCT03860688 601 609 O
with NCT03860688 610 614 O
renal NCT03860688 615 620 B-Condition-Name
disease NCT03860688 621 628 I-Condition-Name
. NCT03860688 629 630 O

9 NCT03860688 635 636 O
. NCT03860688 636 637 O
Patients NCT03860688 639 647 O
on NCT03860688 648 650 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
benzodiazepine NCT03860688 651 665 B-Drug-Name
. NCT03860688 666 667 O

10 NCT03860688 671 673 O
. NCT03860688 673 674 O
Unstable NCT03860688 676 684 B-Stability___Stability-Value:change
cardiac NCT03860688 685 692 O
or NCT03860688 693 695 O
respiratory NCT03860688 696 707 O
disease NCT03860688 708 715 B-Condition-Name

11 NCT03860688 718 720 O
. NCT03860688 720 721 O
Any NCT03860688 723 726 O
changes NCT03860688 727 734 B-Stability___Stability-Value:change
to NCT03860688 735 737 O
medication NCT03860688 738 748 O
in NCT03860688 749 751 O
the NCT03860688 752 755 O
preceding NCT03860688 756 765 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03860688 766 771 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

12 NCT03860688 774 776 O
. NCT03860688 776 777 O
Patients NCT03860688 779 787 O
with NCT03860688 788 792 O
hypersensitive NCT03860688 793 807 B-Condition-Name
to NCT03860688 808 810 O
Revestive NCT03860688 811 820 B-Drug-Name
or NCT03860688 821 823 O
any NCT03860688 824 827 O
ingredient NCT03860688 828 838 O
, NCT03860688 839 840 O
active NCT03860688 841 847 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03860688 848 850 O
a NCT03860688 851 852 O
history NCT03860688 853 860 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860688 861 863 O
the NCT03860688 864 867 O
drug NCT03860688 868 872 O
within NCT03860688 873 879 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860688 880 883 O
last NCT03860688 884 888 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03860688 890 891 B-Eq-Value
years NCT03860688 892 897 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

13 NCT03860688 900 902 O
. NCT03860688 902 903 O
Patients NCT03860688 905 913 O
with NCT03860688 914 918 O
GI NCT03860688 919 921 B-Condition-Name
malignancy NCT03860688 922 932 I-Condition-Name
( NCT03860688 933 934 O
GI NCT03860688 935 937 O
tract NCT03860688 938 943 O
, NCT03860688 944 945 O
hepatobiliary NCT03860688 946 959 O
, NCT03860688 960 961 O
pancreatic NCT03860688 962 972 O
) NCT03860688 973 974 O

Inclusion NCT03869684 0 9 O
Criteria NCT03869684 10 18 O
: NCT03869684 19 20 O

- NCT03869684 24 25 O
Must NCT03869684 27 31 O
agree NCT03869684 32 37 O
to NCT03869684 38 40 O
sign NCT03869684 41 45 O
informed NCT03869684 46 54 O
consent NCT03869684 55 62 O
form NCT03869684 63 67 O
, NCT03869684 68 69 O
and NCT03869684 70 73 O
to NCT03869684 74 76 O
comply NCT03869684 77 83 O
with NCT03869684 84 88 O
protocol NCT03869684 89 97 O
requirements NCT03869684 98 110 O
, NCT03869684 111 112 O
including NCT03869684 113 122 O
study NCT03869684 123 128 O
visits NCT03869684 129 135 O
. NCT03869684 136 137 O

- NCT03869684 141 142 O
Must NCT03869684 144 148 O
have NCT03869684 149 153 O
clear NCT03869684 154 159 O
optic NCT03869684 160 165 B-Observation-Name
media NCT03869684 166 171 I-Observation-Name
in NCT03869684 172 174 O
the NCT03869684 175 178 O
study NCT03869684 179 184 O
eye NCT03869684 185 188 O
that NCT03869684 189 193 O
is NCT03869684 194 196 O
capable NCT03869684 197 204 O
of NCT03869684 205 207 O
producing NCT03869684 208 217 O
high NCT03869684 218 222 O
- NCT03869684 223 224 O
quality NCT03869684 225 232 O
fundus NCT03869684 233 239 B-Observation-Name
images NCT03869684 240 246 I-Observation-Name
. NCT03869684 247 248 O

Exclusion NCT03869684 250 259 O
Criteria NCT03869684 260 268 O
: NCT03869684 269 270 O

- NCT03869684 274 275 O
Has NCT03869684 277 280 O
active NCT03869684 281 287 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
CNV NCT03869684 288 291 B-Condition-Name
due NCT03869684 292 295 O
to NCT03869684 296 298 O
causes NCT03869684 299 305 O
other NCT03869684 306 311 O
than NCT03869684 312 316 O
AMD NCT03869684 317 320 B-Condition-Name
in NCT03869684 321 323 O
the NCT03869684 324 327 O
study NCT03869684 328 333 O
eye NCT03869684 334 337 O
. NCT03869684 338 339 O

- NCT03869684 343 344 O
Has NCT03869684 346 349 O
retinal NCT03869684 350 357 B-Condition-Name
vascular NCT03869684 358 366 I-Condition-Name
disease NCT03869684 367 374 I-Condition-Name
or NCT03869684 375 377 O
retinal NCT03869684 378 385 B-Condition-Name
degeneration NCT03869684 386 398 I-Condition-Name
other NCT03869684 399 404 O
than NCT03869684 405 409 O
AMD NCT03869684 410 413 B-Condition-Name
in NCT03869684 414 416 O
the NCT03869684 417 420 O
study NCT03869684 421 426 O
eye NCT03869684 427 430 O
. NCT03869684 431 432 O

- NCT03869684 436 437 O
Has NCT03869684 439 442 O
had NCT03869684 443 446 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
intraocular NCT03869684 447 458 B-Procedure-Name
surgery NCT03869684 459 466 I-Procedure-Name
, NCT03869684 467 468 O
cataract NCT03869684 469 477 B-Procedure-Name
surgery NCT03869684 478 485 I-Procedure-Name
or NCT03869684 486 488 O
LASIK NCT03869684 489 494 B-Procedure-Name
surgery NCT03869684 495 502 I-Procedure-Name
on NCT03869684 503 505 O
the NCT03869684 506 509 O
study NCT03869684 510 515 O
eye NCT03869684 516 519 O
within NCT03869684 520 526 B-Eq-Operator___Eq-Operator-Value:LTEQ
90 NCT03869684 528 530 B-Eq-Value
days NCT03869684 531 535 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03869684 536 541 O
to NCT03869684 542 544 O
the NCT03869684 545 548 O
study NCT03869684 549 554 O
. NCT03869684 555 556 O

- NCT03869684 565 566 O
Has NCT03869684 568 571 O
had NCT03869684 572 575 O
yttrium NCT03869684 576 583 B-Procedure-Name
aluminum NCT03869684 584 592 I-Procedure-Name
garnet NCT03869684 593 599 I-Procedure-Name
( NCT03869684 600 601 O
YAG NCT03869684 602 605 B-Procedure-Name
) NCT03869684 606 607 O
laser NCT03869684 608 613 B-Procedure-Name
capsulotomy NCT03869684 614 625 I-Procedure-Name
on NCT03869684 626 628 O
the NCT03869684 629 632 O
study NCT03869684 633 638 O
eye NCT03869684 639 642 O
within NCT03869684 643 649 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03869684 651 653 B-Eq-Value
days NCT03869684 654 658 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03869684 659 664 O
to NCT03869684 665 667 O
the NCT03869684 668 671 O
study NCT03869684 672 677 O
. NCT03869684 678 679 O

- NCT03869684 683 684 O
Has NCT03869684 686 689 O
active NCT03869684 690 696 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
inflammation NCT03869684 697 709 B-Condition-Name
, NCT03869684 710 711 O
infection NCT03869684 712 721 B-Condition-Name
, NCT03869684 722 723 O
or NCT03869684 724 726 O
other NCT03869684 727 732 O
severe NCT03869684 733 739 B-Severity___Severity-Value:severe
ocular NCT03869684 740 746 B-Condition-Name
disease NCT03869684 747 754 I-Condition-Name
in NCT03869684 755 757 O
either NCT03869684 758 764 O
eye NCT03869684 765 768 O
. NCT03869684 769 770 O

- NCT03869684 774 775 O
Has NCT03869684 777 780 O
aphakia NCT03869684 781 788 B-Condition-Name
in NCT03869684 789 791 O
the NCT03869684 792 795 O
study NCT03869684 796 801 O
eye NCT03869684 802 805 O
. NCT03869684 806 807 O

- NCT03869684 811 812 O
Has NCT03869684 814 817 O
uncontrolled NCT03869684 818 830 O
glaucoma NCT03869684 831 839 B-Condition-Name
or NCT03869684 840 842 O
a NCT03869684 843 844 O
history NCT03869684 845 852 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869684 853 855 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
previous NCT03869684 856 864 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
glaucoma NCT03869684 865 873 B-Procedure-Name
filter NCT03869684 874 880 I-Procedure-Name
surgery NCT03869684 881 888 I-Procedure-Name
in NCT03869684 889 891 O
either NCT03869684 892 898 O
eye NCT03869684 899 902 O
. NCT03869684 903 904 O

- NCT03869684 908 909 O
Is NCT03869684 911 913 O
a NCT03869684 914 915 O
contact NCT03869684 916 923 B-Procedure-Name
lens NCT03869684 924 928 I-Procedure-Name
wearer NCT03869684 929 935 O
and NCT03869684 936 939 O
is NCT03869684 940 942 O
unable NCT03869684 943 949 O
to NCT03869684 950 952 O
discontinue NCT03869684 953 964 O
their NCT03869684 965 970 O
use NCT03869684 971 974 O
in NCT03869684 975 977 O
both NCT03869684 978 982 O
eyes NCT03869684 983 987 O
for NCT03869684 988 991 O
the NCT03869684 992 995 O
duration NCT03869684 996 1004 O
of NCT03869684 1005 1007 O
the NCT03869684 1008 1011 O
study NCT03869684 1012 1017 O
. NCT03869684 1018 1019 O

- NCT03869684 1023 1024 O
Has NCT03869684 1026 1029 O
a NCT03869684 1030 1031 O
serious NCT03869684 1032 1039 B-Severity___Severity-Value:severe
allergy NCT03869684 1040 1047 O
to NCT03869684 1048 1050 O
, NCT03869684 1051 1052 O
or NCT03869684 1053 1055 O
experienced NCT03869684 1056 1067 O
a NCT03869684 1068 1069 O
prior NCT03869684 1070 1075 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
significant NCT03869684 1076 1087 B-Severity___Severity-Value:severe
adverse NCT03869684 1088 1095 B-Condition-Name
reaction NCT03869684 1096 1104 I-Condition-Name
to NCT03869684 1105 1107 O
fluorescein NCT03869684 1108 1119 B-Procedure-Name
angiography NCT03869684 1120 1131 I-Procedure-Name
( NCT03869684 1132 1133 O
FA NCT03869684 1134 1136 B-Procedure-Name
) NCT03869684 1137 1138 O
or NCT03869684 1139 1141 O
indocyanine NCT03869684 1142 1153 B-Procedure-Name
green NCT03869684 1154 1159 I-Procedure-Name
angiography NCT03869684 1160 1171 I-Procedure-Name
( NCT03869684 1172 1173 O
ICGA NCT03869684 1174 1178 B-Procedure-Name
) NCT03869684 1179 1180 O
. NCT03869684 1182 1183 O

- NCT03869684 1187 1188 O
Has NCT03869684 1190 1193 O
participated NCT03869684 1194 1206 O
in NCT03869684 1207 1209 O
any NCT03869684 1210 1213 O
other NCT03869684 1214 1219 O
clinical NCT03869684 1220 1228 O
trial NCT03869684 1229 1234 O
and NCT03869684 1235 1238 O
/ NCT03869684 1239 1240 O
or NCT03869684 1241 1243 O
has NCT03869684 1244 1247 O
taken NCT03869684 1248 1253 O
any NCT03869684 1254 1257 O
investigational NCT03869684 1258 1273 O
drug NCT03869684 1274 1278 O
or NCT03869684 1279 1281 O
product NCT03869684 1282 1289 O
within NCT03869684 1290 1296 B-Eq-Operator___Eq-Operator-Value:LTEQ
90 NCT03869684 1298 1300 B-Eq-Value
days NCT03869684 1301 1305 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03869684 1306 1311 O
to NCT03869684 1312 1314 O
the NCT03869684 1315 1318 O
study NCT03869684 1319 1324 O
. NCT03869684 1325 1326 O

Other NCT03869684 1328 1333 O
protocol NCT03869684 1334 1342 O
- NCT03869684 1343 1344 O
defined NCT03869684 1345 1352 O
inclusion NCT03869684 1353 1362 O
/ NCT03869684 1363 1364 O
exclusion NCT03869684 1365 1374 O
criteria NCT03869684 1375 1383 O
could NCT03869684 1384 1389 O
apply NCT03869684 1390 1395 O
. NCT03869684 1396 1397 O


Inclusion NCT03865914 0 9 O
Criteria NCT03865914 10 18 O
: NCT03865914 19 20 O

- NCT03865914 24 25 O
Age NCT03865914 27 30 O
≥ NCT03865914 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03865914 34 36 B-Eq-Value
, NCT03865914 37 38 O
male NCT03865914 39 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03865914 44 46 O
female NCT03865914 47 53 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03865914 56 57 O
Clinical NCT03865914 59 67 O
diagnosed NCT03865914 68 77 O
as NCT03865914 78 80 O
type NCT03865914 81 85 O
2 NCT03865914 87 88 O
diabetes NCT03865914 89 97 B-Condition-Name
mellitus NCT03865914 98 106 I-Condition-Name

- NCT03865914 109 110 O
The NCT03865914 112 115 O
presence NCT03865914 116 124 O
of NCT03865914 125 127 O
renal NCT03865914 128 133 B-Condition-Name
impairment NCT03865914 134 144 I-Condition-Name
including NCT03865914 145 154 O
: NCT03865914 155 156 O
microalbuminuria NCT03865914 157 173 B-Condition-Name
or NCT03865914 174 176 O
overt NCT03865914 177 182 O
proteinuria NCT03865914 183 194 B-Condition-Name
or NCT03865914 195 197 O
renal NCT03865914 198 203 O
insufficiency NCT03865914 204 217 B-Condition-Name

- NCT03865914 220 221 O
The NCT03865914 223 226 O
renal NCT03865914 227 232 O
biopsy NCT03865914 233 239 B-Procedure-Name
was NCT03865914 240 243 O
performed NCT03865914 244 253 O
with NCT03865914 254 258 O
complete NCT03865914 259 267 O
renal NCT03865914 268 273 B-Condition-Name
pathological NCT03865914 274 286 I-Condition-Name
diagnosis NCT03865914 287 296 O

- NCT03865914 299 300 O
Obtaining NCT03865914 302 311 O
the NCT03865914 312 315 O
signed NCT03865914 316 322 O
informed NCT03865914 323 331 O
consent NCT03865914 332 339 O
from NCT03865914 340 344 O
patients NCT03865914 345 353 O

Exclusion NCT03865914 354 363 O
Criteria NCT03865914 364 372 O
: NCT03865914 373 374 O

- NCT03865914 378 379 O
The NCT03865914 381 384 O
history NCT03865914 385 392 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865914 393 395 O
the NCT03865914 396 399 O
disease NCT03865914 400 407 O
was NCT03865914 408 411 O
not NCT03865914 412 415 O
complete NCT03865914 416 424 O

- NCT03865914 427 428 O
Clinical NCT03865914 430 438 O
diagnosed NCT03865914 439 448 O
as NCT03865914 449 451 O
other NCT03865914 452 457 O
secondary NCT03865914 458 467 O
renal NCT03865914 468 473 B-Condition-Name
diseases NCT03865914 474 482 I-Condition-Name

- NCT03865914 485 486 O
Patients NCT03865914 488 496 O
with NCT03865914 497 501 O
hereditary NCT03865914 502 512 O
kidney NCT03865914 513 519 B-Condition-Name
disease NCT03865914 520 527 I-Condition-Name

- NCT03865914 530 531 O
Autoimmune NCT03865914 533 543 B-Condition-Name
diseases NCT03865914 544 552 I-Condition-Name

- NCT03865914 555 556 O
Patients NCT03865914 558 566 O
with NCT03865914 567 571 O
malignant NCT03865914 572 581 B-Condition-Name
tumor NCT03865914 582 587 I-Condition-Name
were NCT03865914 588 592 O
expected NCT03865914 593 601 O
to NCT03865914 602 604 O
survive NCT03865914 605 612 O
less NCT03865914 613 617 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03865914 618 622 I-Eq-Operator___Eq-Operator-Value:LT
6 NCT03865914 624 625 B-Eq-Value
months NCT03865914 626 632 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03865914 635 636 O
Pregnancy NCT03865914 638 647 B-Condition-Name
and NCT03865914 648 651 O
lactation NCT03865914 652 661 B-Condition-Name

Inclusion NCT03863626 0 9 O
Criteria NCT03863626 10 18 O
: NCT03863626 19 20 O

- NCT03863626 24 25 O
Age NCT03863626 27 30 O
more NCT03863626 31 35 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863626 36 40 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03863626 42 44 B-Eq-Value
years NCT03863626 45 50 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03863626 51 52 O

- NCT03863626 56 57 O
Chronic NCT03863626 59 66 O
heart NCT03863626 67 72 B-Condition-Name
failure NCT03863626 73 80 I-Condition-Name
prior NCT03863626 81 86 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03863626 87 96 O
, NCT03863626 97 98 O
based NCT03863626 99 104 O
on NCT03863626 105 107 O
signs NCT03863626 108 113 O
and NCT03863626 114 117 O
or NCT03863626 118 120 O
symptoms NCT03863626 121 129 O
of NCT03863626 130 132 O
heart NCT03863626 133 138 B-Condition-Name
failure NCT03863626 139 146 I-Condition-Name
, NCT03863626 147 148 O
presenting NCT03863626 149 159 B-Condition-Type___Condition-Type-Value:admitting
with NCT03863626 160 164 O
acute NCT03863626 165 170 B-Severity___Severity-Value:severe
decompensation NCT03863626 171 185 B-Condition-Name
as NCT03863626 186 188 O
judged NCT03863626 189 195 O
by NCT03863626 196 198 O
the NCT03863626 199 202 O
physician NCT03863626 203 212 B-Provider-Role
to NCT03863626 213 215 O
require NCT03863626 216 223 O
hospitalization NCT03863626 224 239 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03863626 240 243 O
IV NCT03863626 244 246 B-Drug-Name
diuretics NCT03863626 247 256 I-Drug-Name

Exclusion NCT03863626 257 266 O
Criteria NCT03863626 267 275 O
: NCT03863626 276 277 O

- NCT03863626 281 282 O
Refusal NCT03863626 284 291 O
to NCT03863626 292 294 O
participate NCT03863626 295 306 O
in NCT03863626 307 309 O
the NCT03863626 310 313 O
study NCT03863626 314 319 O
. NCT03863626 320 321 O

- NCT03863626 325 326 O
Allergy NCT03863626 328 335 O
to NCT03863626 336 338 O
IV NCT03863626 339 341 B-Drug-Name
frusemide NCT03863626 342 351 I-Drug-Name
. NCT03863626 352 353 O

- NCT03863626 357 358 O
Severe NCT03863626 360 366 B-Severity___Severity-Value:severe
renal NCT03863626 367 372 B-Condition-Name
impairment NCT03863626 373 383 I-Condition-Name
defined NCT03863626 384 391 O
as NCT03863626 392 394 O
eGFR NCT03863626 395 399 B-Observation-Name___Observation-Type-Value:lab
< NCT03863626 400 401 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03863626 403 405 B-Eq-Value
ml NCT03863626 406 408 B-Eq-Unit
/ NCT03863626 409 410 O
m NCT03863626 411 412 B-Eq-Unit
. NCT03863626 413 414 O

- NCT03863626 418 419 O
Cardiogenic NCT03863626 421 432 B-Condition-Name
shock NCT03863626 433 438 I-Condition-Name
or NCT03863626 439 441 O
hemodynamic NCT03863626 442 453 B-Condition-Name
instability NCT03863626 454 465 B-Stability___Stability-Value:change
judged NCT03863626 466 472 O
by NCT03863626 473 475 O
the NCT03863626 476 479 O
treating NCT03863626 480 488 O
physician NCT03863626 489 498 O
to NCT03863626 499 501 O
be NCT03863626 502 504 O
unsuitable NCT03863626 505 515 O
to NCT03863626 516 518 O
participate NCT03863626 519 530 O
. NCT03863626 531 532 O

Inclusion NCT03863197 0 9 O
Criteria NCT03863197 10 18 O
: NCT03863197 19 20 O

- NCT03863197 24 25 O
Confirmed NCT03863197 27 36 O
diagnosis NCT03863197 37 46 O
of NCT03863197 47 49 O
SCP NCT03863197 50 53 B-Condition-Name

- NCT03863197 56 57 O
Aged NCT03863197 59 63 O
5 NCT03863197 65 66 B-Eq-Value
- NCT03863197 67 68 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03863197 70 72 B-Eq-Value
years NCT03863197 73 78 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863197 81 82 O
GMFCS NCT03863197 84 89 B-Observation-Name___Observation-Type-Value:clinical-score
levels NCT03863197 90 96 B-Eq-Unit
I NCT03863197 97 98 B-Eq-Value
- NCT03863197 99 100 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03863197 101 104 B-Eq-Value
( NCT03863197 105 106 O
GMFCS NCT03863197 107 112 B-Observation-Name___Observation-Type-Value:clinical-score
= NCT03863197 113 114 B-Eq-Operator___Eq-Operator-Value:EQ
Gross NCT03863197 115 120 B-Observation-Name___Observation-Type-Value:clinical-score
Motor NCT03863197 121 126 I-Observation-Name___Observation-Type-Value:clinical-score
Function NCT03863197 127 135 I-Observation-Name___Observation-Type-Value:clinical-score
Classification NCT03863197 136 150 I-Observation-Name___Observation-Type-Value:clinical-score
Score NCT03863197 151 156 I-Observation-Name___Observation-Type-Value:clinical-score
, NCT03863197 157 158 O
expressing NCT03863197 159 169 O
the NCT03863197 170 173 O
overall NCT03863197 174 181 O
functional NCT03863197 182 192 B-Condition-Name
level NCT03863197 193 198 I-Condition-Name
of NCT03863197 199 201 I-Condition-Name
impairment NCT03863197 202 212 I-Condition-Name
) NCT03863197 213 214 O

- NCT03863197 218 219 O
Sufficient NCT03863197 221 231 O
cooperation NCT03863197 232 243 O
to NCT03863197 244 246 O
comprehend NCT03863197 247 257 O
and NCT03863197 258 261 O
complete NCT03863197 262 270 O
the NCT03863197 271 274 O
test NCT03863197 275 279 B-Procedure-Name
procedure NCT03863197 280 289 I-Procedure-Name

Exclusion NCT03863197 290 299 O
Criteria NCT03863197 300 308 O
: NCT03863197 309 310 O

- NCT03863197 314 315 O
Non NCT03863197 317 320 O
- NCT03863197 321 322 O
ambulatory NCT03863197 323 333 B-Condition-Name

- NCT03863197 336 337 O
Botulinum NCT03863197 339 348 B-Drug-Name
toxin NCT03863197 349 354 I-Drug-Name
A NCT03863197 355 356 I-Drug-Name
injections NCT03863197 357 367 B-Procedure-Name
six NCT03863197 368 371 B-Eq-Value
months NCT03863197 372 378 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03863197 379 384 O
to NCT03863197 385 387 O
enrollment NCT03863197 388 398 O

- NCT03863197 401 402 O
Lower NCT03863197 404 409 O
limb NCT03863197 410 414 O
surgery NCT03863197 415 422 B-Procedure-Name
two NCT03863197 423 426 B-Eq-Value
years NCT03863197 427 432 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
prior NCT03863197 433 438 O
to NCT03863197 439 441 O
enrollment NCT03863197 442 452 O

- NCT03863197 455 456 O
Presence NCT03863197 458 466 O
of NCT03863197 467 469 O
ataxia NCT03863197 470 476 B-Condition-Name
or NCT03863197 477 479 O
dystonia NCT03863197 480 488 B-Condition-Name

- NCT03863197 491 492 O
Cognitive NCT03863197 494 503 B-Condition-Name
problems NCT03863197 504 512 I-Condition-Name
that NCT03863197 513 517 O
impede NCT03863197 518 524 B-Stability___Stability-Value:change
measurements NCT03863197 525 537 B-Observation-Name___Observation-Type-Value:measurement

- NCT03863197 540 541 O
Severe NCT03863197 543 549 B-Severity___Severity-Value:severe
co NCT03863197 550 552 B-Condition-Name
- NCT03863197 553 554 I-Condition-Name
morbidities NCT03863197 555 566 I-Condition-Name
( NCT03863197 567 568 O
severe NCT03863197 569 575 B-Severity___Severity-Value:severe
epilepsy NCT03863197 576 584 B-Condition-Name
, NCT03863197 585 586 O
non NCT03863197 587 590 O
- NCT03863197 591 592 O
correctable NCT03863197 593 604 O
visual NCT03863197 605 611 B-Condition-Name
impairment NCT03863197 612 622 I-Condition-Name
, NCT03863197 623 624 O
autism NCT03863197 625 631 B-Condition-Name
spectrum NCT03863197 632 640 I-Condition-Name
disorders NCT03863197 641 650 I-Condition-Name
, NCT03863197 651 652 O
mental NCT03863197 653 659 B-Condition-Name
problems NCT03863197 660 668 I-Condition-Name
that NCT03863197 669 673 O
prevent NCT03863197 674 681 O
comprehensiveness NCT03863197 682 699 B-Stability___Stability-Value:change
of NCT03863197 700 702 O
the NCT03863197 703 706 O
tasks NCT03863197 707 712 O
) NCT03863197 713 714 O

Inclusion NCT03864809 0 9 O
Criteria NCT03864809 10 18 O
: NCT03864809 19 20 O

- NCT03864809 23 24 O
patients NCT03864809 25 33 O
with NCT03864809 34 38 O
Psoriasis NCT03864809 39 48 B-Condition-Name
and NCT03864809 49 52 O
Patients NCT03864809 53 61 O
with NCT03864809 62 66 O
A NCT03864809 67 68 O
topic NCT03864809 69 74 B-Condition-Name
dermatitis NCT03864809 75 85 I-Condition-Name

Exclusion NCT03864809 86 95 O
Criteria NCT03864809 96 104 O
: NCT03864809 105 106 O

- NCT03864809 110 111 O
All NCT03864809 113 116 O
patient NCT03864809 117 124 O
have NCT03864809 125 129 O
another NCT03864809 130 137 O
dermatological NCT03864809 138 152 B-Condition-Name
disease NCT03864809 153 160 I-Condition-Name

Inclusion NCT03868969 0 9 O
Criteria NCT03868969 10 18 O
: NCT03868969 19 20 O

- NCT03868969 24 25 O
clinical NCT03868969 27 35 O
suspicion NCT03868969 36 45 O
of NCT03868969 46 48 O
urinary NCT03868969 49 56 B-Condition-Name
tract NCT03868969 57 62 I-Condition-Name
infection NCT03868969 63 72 I-Condition-Name
( NCT03868969 73 74 O
UTI NCT03868969 75 78 B-Condition-Name
) NCT03868969 79 80 O
defined NCT03868969 81 88 O
by NCT03868969 89 91 O
the NCT03868969 92 95 O
presence NCT03868969 96 104 O
of NCT03868969 105 107 O
at NCT03868969 108 110 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868969 111 116 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03868969 117 120 B-Eq-Value
of NCT03868969 121 123 O
these NCT03868969 124 129 O
signs NCT03868969 130 135 O
: NCT03868969 136 137 O
fever NCT03868969 138 143 B-Condition-Name
> NCT03868969 144 145 B-Eq-Operator___Eq-Operator-Value:GT
38 NCT03868969 147 149 B-Eq-Value
° NCT03868969 150 151 B-Eq-Unit
C NCT03868969 151 152 I-Eq-Unit
and NCT03868969 153 156 O
/ NCT03868969 157 158 O
or NCT03868969 159 161 O
sus NCT03868969 162 165 O
- NCT03868969 166 167 O
pubic NCT03868969 168 173 O
pain NCT03868969 174 178 B-Condition-Name
and NCT03868969 179 182 O
/ NCT03868969 183 184 O
or NCT03868969 185 187 O
dysuria NCT03868969 188 195 B-Condition-Name
and NCT03868969 196 199 O
/ NCT03868969 200 201 O
or NCT03868969 202 204 O
pollakiuria NCT03868969 205 216 B-Condition-Name
and NCT03868969 217 220 O
/ NCT03868969 221 222 O
or NCT03868969 223 225 O
urinary NCT03868969 226 233 O
burns NCT03868969 234 239 B-Condition-Name
and NCT03868969 240 243 O
/ NCT03868969 244 245 O
or NCT03868969 246 248 O
macroscopic NCT03868969 249 260 O
hematuria NCT03868969 261 270 B-Condition-Name
and NCT03868969 271 274 O
/ NCT03868969 275 276 O
or NCT03868969 277 279 O
acute NCT03868969 280 285 B-Severity___Severity-Value:severe
urinary NCT03868969 286 293 B-Condition-Name
retention NCT03868969 294 303 I-Condition-Name
and NCT03868969 304 307 O
/ NCT03868969 308 309 O
or NCT03868969 310 312 O
pain NCT03868969 313 317 B-Condition-Name
with NCT03868969 318 322 O
the NCT03868969 323 326 O
rectal NCT03868969 327 333 B-Procedure-Name
examination NCT03868969 334 345 I-Procedure-Name
and NCT03868969 346 349 O
/ NCT03868969 350 351 O
or NCT03868969 352 354 O
confusion NCT03868969 355 364 B-Condition-Name

- NCT03868969 367 368 O
And NCT03868969 370 373 O
urinary NCT03868969 374 381 B-Observation-Name___Observation-Type-Value:lab
analysis NCT03868969 382 390 I-Observation-Name___Observation-Type-Value:lab
with NCT03868969 391 395 O
leukocyturia NCT03868969 396 408 B-Condition-Name
> NCT03868969 409 410 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03868969 412 414 B-Eq-Value
/ NCT03868969 415 416 O
mm NCT03868969 417 419 B-Eq-Unit
3 NCT03868969 420 421 I-Eq-Unit
, NCT03868969 422 423 O
bacteriuria NCT03868969 424 435 B-Condition-Name
> NCT03868969 436 437 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03868969 439 441 B-Eq-Value
^ NCT03868969 442 443 I-Eq-Value
3 NCT03868969 444 445 I-Eq-Value
CFU NCT03868969 446 449 B-Eq-Unit
/ NCT03868969 450 451 O
mL NCT03868969 452 454 B-Eq-Unit
with NCT03868969 455 459 O
ESBL NCT03868969 460 464 O
producing NCT03868969 465 474 O
enterobacteriaceae NCT03868969 475 493 B-Condition-Name
and NCT03868969 494 497 O
resistance NCT03868969 498 508 B-Condition-Name
associated NCT03868969 509 519 O
with NCT03868969 520 524 O
fluoroquinolones NCT03868969 525 541 B-Drug-Name
( NCT03868969 542 543 O
FQ NCT03868969 544 546 B-Drug-Name
) NCT03868969 547 548 O
and NCT03868969 549 552 O
cotrimoxazole NCT03868969 553 566 B-Drug-Name
( NCT03868969 567 568 O
CTX NCT03868969 569 572 B-Drug-Name
) NCT03868969 573 574 O
but NCT03868969 575 578 O
sensitive NCT03868969 579 588 B-Condition-Name
to NCT03868969 589 591 O
fosfomycin NCT03868969 592 602 B-Drug-Name
. NCT03868969 603 604 O

Exclusion NCT03868969 606 615 O
Criteria NCT03868969 616 624 O
: NCT03868969 625 626 O

- NCT03868969 630 631 O
allergy NCT03868969 633 640 O
to NCT03868969 641 643 O
fosfomycin NCT03868969 644 654 B-Drug-Name
and NCT03868969 655 658 O
/ NCT03868969 659 660 O
or NCT03868969 661 663 O
trometamol NCT03868969 664 674 B-Drug-Name

- NCT03868969 677 678 O
Presence NCT03868969 680 688 O
of NCT03868969 689 691 O
material NCT03868969 692 700 B-Condition-Name
in NCT03868969 701 703 O
the NCT03868969 704 707 O
urinary NCT03868969 708 715 O
tract NCT03868969 716 721 O

- NCT03868969 724 725 O
Severe NCT03868969 727 733 B-Severity___Severity-Value:severe
immunosuppression NCT03868969 734 751 B-Condition-Name

- NCT03868969 754 755 O
Chronic NCT03868969 757 764 O
prostatitis NCT03868969 765 776 B-Condition-Name

- NCT03868969 779 780 O
Prostate NCT03868969 782 790 B-Condition-Name
abscess NCT03868969 791 798 I-Condition-Name

- NCT03868969 801 802 O
Acute NCT03868969 804 809 B-Severity___Severity-Value:severe
pyelonephritis NCT03868969 810 824 B-Condition-Name

- NCT03868969 827 828 O
Hemodynamic NCT03868969 830 841 B-Condition-Name
instability NCT03868969 842 853 B-Stability___Stability-Value:change

- NCT03868969 856 857 O
Chronic NCT03868969 859 866 B-Condition-Name
renal NCT03868969 867 872 I-Condition-Name
failure NCT03868969 873 880 I-Condition-Name
( NCT03868969 881 882 O
clearance NCT03868969 883 892 B-Observation-Name
< NCT03868969 893 894 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03868969 896 898 B-Eq-Value
mL NCT03868969 899 901 B-Eq-Unit
/ NCT03868969 902 903 O
min NCT03868969 904 907 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
) NCT03868969 908 909 O

- NCT03868969 913 914 O
Prior NCT03868969 916 921 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
antibiotic NCT03868969 922 932 B-Procedure-Name
therapy NCT03868969 933 940 I-Procedure-Name
, NCT03868969 941 942 O
with NCT03868969 943 947 O
an NCT03868969 948 950 O
antibiotic NCT03868969 951 961 B-Drug-Name
sensitive NCT03868969 962 971 B-Condition-Name
on NCT03868969 972 974 O
the NCT03868969 975 978 O
antibiotic NCT03868969 979 989 B-Observation-Name___Observation-Type-Value:lab
susceptibility NCT03868969 990 1004 I-Observation-Name___Observation-Type-Value:lab
test NCT03868969 1005 1009 I-Observation-Name___Observation-Type-Value:lab
except NCT03868969 1010 1016 O
: NCT03868969 1017 1018 O
amoxicillin NCT03868969 1019 1030 B-Drug-Name
- NCT03868969 1031 1032 O
clavulanic NCT03868969 1033 1043 B-Drug-Name
acid NCT03868969 1044 1048 I-Drug-Name
, NCT03868969 1049 1050 O
cefixime NCT03868969 1051 1059 B-Drug-Name
, NCT03868969 1060 1061 O
nitrofurantoin NCT03868969 1062 1076 B-Drug-Name
. NCT03868969 1077 1078 O

- NCT03868969 1082 1083 O
Co NCT03868969 1085 1087 O
- NCT03868969 1088 1089 O
treatment NCT03868969 1090 1099 O
with NCT03868969 1100 1104 O
metoclopramide NCT03868969 1105 1119 B-Drug-Name

Inclusion NCT03864835 0 9 O
Criteria NCT03864835 10 18 O

•Enrollment NCT03864835 19 30 O
and NCT03864835 31 34 O
completion NCT03864835 35 45 O
of NCT03864835 46 48 O
IRB NCT03864835 49 52 O
study NCT03864835 53 58 O
# NCT03864835 59 60 O
00011797 NCT03864835 62 70 O

Exclusion NCT03864835 72 81 O
Criteria NCT03864835 82 90 O

- NCT03864835 93 94 O
Inability NCT03864835 96 105 O
to NCT03864835 106 108 O
provide NCT03864835 109 116 O
informed NCT03864835 117 125 O
consent NCT03864835 126 133 O

- NCT03864835 136 137 O
Institutionalized NCT03864835 139 156 B-Observation-Name
/ NCT03864835 157 158 O
prisoner NCT03864835 159 167 B-Observation-Name

- NCT03864835 170 171 O
Non NCT03864835 173 176 O
- NCT03864835 177 178 O
English NCT03864835 179 186 B-Language
- NCT03864835 187 188 O
speaking NCT03864835 189 197 O
patients NCT03864835 198 206 O
due NCT03864835 207 210 O
to NCT03864835 211 213 O
unavailability NCT03864835 214 228 O
of NCT03864835 229 231 O
translators NCT03864835 232 243 O
for NCT03864835 244 247 O
all NCT03864835 248 251 O
visits NCT03864835 252 258 O
/ NCT03864835 259 260 O
sessions NCT03864835 261 269 O

Inclusion NCT03866005 0 9 O
Criteria NCT03866005 10 18 O
: NCT03866005 19 20 O

- NCT03866005 24 25 O
Diagnosed NCT03866005 27 36 O
diabetes NCT03866005 37 45 B-Condition-Name
mellitus NCT03866005 46 54 I-Condition-Name
and NCT03866005 55 58 O
treatment NCT03866005 59 68 O
- NCT03866005 69 70 O
naïve NCT03866005 71 76 O
CI NCT03866005 77 79 B-Condition-Name
- NCT03866005 80 81 I-Condition-Name
DME NCT03866005 82 85 I-Condition-Name
requiring NCT03866005 86 95 O
anti NCT03866005 96 100 O
- NCT03866005 101 102 O
VEGF NCT03866005 103 107 B-Condition-Name
therapy NCT03866005 108 115 B-Procedure-Name
per NCT03866005 116 119 O
retinal NCT03866005 120 127 B-Provider-Type
specialist NCT03866005 128 138 I-Provider-Type
's NCT03866005 138 140 O
customary NCT03866005 141 150 O
treatment NCT03866005 151 160 O
regimen NCT03866005 161 168 O
will NCT03866005 169 173 O
be NCT03866005 174 176 O
recruited NCT03866005 177 186 O
to NCT03866005 187 189 O
participate NCT03866005 190 201 O
in NCT03866005 202 204 O
the NCT03866005 205 208 O
study NCT03866005 209 214 O
. NCT03866005 215 216 O
CI NCT03866005 218 220 B-Condition-Name
- NCT03866005 221 222 I-Condition-Name
DME NCT03866005 223 226 I-Condition-Name
will NCT03866005 227 231 O
be NCT03866005 232 234 O
defined NCT03866005 235 242 O
as NCT03866005 243 245 O
a NCT03866005 246 247 O
central NCT03866005 248 255 B-Observation-Name___Observation-Type-Value:measurement
subfield NCT03866005 256 264 I-Observation-Name___Observation-Type-Value:measurement
thickness NCT03866005 265 274 I-Observation-Name___Observation-Type-Value:measurement
( NCT03866005 275 276 O
CST NCT03866005 277 280 B-Observation-Name
) NCT03866005 281 282 O
> NCT03866005 283 284 B-Eq-Operator___Eq-Operator-Value:GT
300 NCT03866005 286 289 B-Eq-Value
microns NCT03866005 290 297 B-Eq-Unit
on NCT03866005 298 300 O
spectral NCT03866005 301 309 O
domain NCT03866005 310 316 O
optical NCT03866005 317 324 B-Procedure-Name
coherence NCT03866005 325 334 I-Procedure-Name
tomography NCT03866005 335 345 I-Procedure-Name
( NCT03866005 346 347 O
SD NCT03866005 348 350 B-Procedure-Name
- NCT03866005 351 352 I-Procedure-Name
OCT NCT03866005 353 356 I-Procedure-Name
) NCT03866005 357 358 O
or NCT03866005 359 361 O
CST NCT03866005 362 365 B-Observation-Name
> NCT03866005 366 367 B-Eq-Operator___Eq-Operator-Value:GT
250 NCT03866005 369 372 B-Eq-Value
microns NCT03866005 373 380 B-Eq-Unit
with NCT03866005 381 385 O
definite NCT03866005 386 394 O
intra NCT03866005 395 400 O
- NCT03866005 401 402 O
retinal NCT03866005 403 410 O
cystic NCT03866005 411 417 B-Condition-Name
fluid NCT03866005 418 423 I-Condition-Name
accumulation NCT03866005 424 436 I-Condition-Name
. NCT03866005 437 438 O
Additional NCT03866005 440 450 O
inclusion NCT03866005 451 460 O
criteria NCT03866005 461 469 O
are NCT03866005 470 473 O
age NCT03866005 474 477 O
> NCT03866005 478 479 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03866005 481 483 B-Eq-Value
years NCT03866005 484 489 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03866005 490 491 O
and NCT03866005 492 495 O
ability NCT03866005 496 503 O
to NCT03866005 504 506 O
give NCT03866005 507 511 O
informed NCT03866005 512 520 O
consent NCT03866005 521 528 O
. NCT03866005 529 530 O

Exclusion NCT03866005 532 541 O
Criteria NCT03866005 542 550 O
: NCT03866005 551 552 O

- NCT03866005 556 557 O
Age NCT03866005 559 562 O
< NCT03866005 563 564 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03866005 566 568 B-Eq-Value
years NCT03866005 569 574 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03866005 575 576 O
inability NCT03866005 577 586 O
to NCT03866005 587 589 O
give NCT03866005 590 594 O
informed NCT03866005 595 603 O
consent NCT03866005 604 611 O
, NCT03866005 612 613 O
evidence NCT03866005 614 622 O
of NCT03866005 623 625 O
proliferative NCT03866005 626 639 B-Condition-Name
diabetic NCT03866005 640 648 I-Condition-Name
retinopathy NCT03866005 649 660 I-Condition-Name
, NCT03866005 661 662 O
evidence NCT03866005 663 671 O
of NCT03866005 672 674 O
other NCT03866005 675 680 O
serious NCT03866005 681 688 B-Severity___Severity-Value:severe
ocular NCT03866005 689 695 B-Condition-Name
disease NCT03866005 696 703 I-Condition-Name
( NCT03866005 704 705 O
age NCT03866005 706 709 O
- NCT03866005 710 711 O
related NCT03866005 712 719 O
macular NCT03866005 720 727 B-Condition-Name
degeneration NCT03866005 728 740 I-Condition-Name
, NCT03866005 741 742 O
glaucoma NCT03866005 743 751 B-Condition-Name
, NCT03866005 752 753 O
significant NCT03866005 754 765 B-Severity___Severity-Value:severe
media NCT03866005 766 771 B-Condition-Name
opacity NCT03866005 772 779 I-Condition-Name
) NCT03866005 780 781 O
, NCT03866005 783 784 O
history NCT03866005 785 792 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866005 793 795 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
previous NCT03866005 796 804 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
intraocular NCT03866005 805 816 B-Procedure-Name
surgery NCT03866005 817 824 I-Procedure-Name
, NCT03866005 825 826 O
including NCT03866005 827 836 O
macular NCT03866005 837 844 O
or NCT03866005 845 847 O
panretinal NCT03866005 848 858 O
photocoagulation NCT03866005 859 875 B-Procedure-Name
( NCT03866005 876 877 O
except NCT03866005 878 884 O
uncomplicated NCT03866005 885 898 O
cataract NCT03866005 899 907 O
or NCT03866005 908 910 O
keratorefractive NCT03866005 911 927 O
surgery NCT03866005 928 935 B-Procedure-Name
more NCT03866005 936 940 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866005 941 945 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03866005 947 948 B-Eq-Value
months NCT03866005 949 955 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03866005 956 961 O
to NCT03866005 962 964 O
enrollment NCT03866005 965 975 O
) NCT03866005 976 977 O
, NCT03866005 979 980 O
pregnant NCT03866005 981 989 B-Condition-Name
and NCT03866005 990 993 O
nursing NCT03866005 994 1001 B-Condition-Name
women NCT03866005 1002 1007 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03866005 1008 1009 O
known NCT03866005 1010 1015 O
sensitivity NCT03866005 1016 1027 B-Condition-Name
to NCT03866005 1028 1030 O
any NCT03866005 1031 1034 O
of NCT03866005 1035 1037 O
the NCT03866005 1038 1041 O
supplement NCT03866005 1042 1052 O
ingredients NCT03866005 1053 1064 O
. NCT03866005 1065 1066 O

Inclusion NCT03868982 0 9 O
Criteria NCT03868982 10 18 O
: NCT03868982 19 20 O

- NCT03868982 24 25 O
Diagnosis NCT03868982 27 36 O
of NCT03868982 37 39 O
ARDS NCT03868982 40 44 B-Condition-Name
by NCT03868982 45 47 O
Berlin NCT03868982 48 54 O
definition NCT03868982 55 65 O

- NCT03868982 68 69 O
P NCT03868982 71 72 B-Observation-Name___Observation-Type-Value:measurement
/ NCT03868982 73 74 I-Observation-Name___Observation-Type-Value:measurement
F NCT03868982 75 76 I-Observation-Name___Observation-Type-Value:measurement
ratio NCT03868982 77 82 I-Observation-Name___Observation-Type-Value:measurement
between NCT03868982 83 90 B-Eq-Operator___Eq-Operator-Value:BETWEEN
100 NCT03868982 92 95 B-Eq-Value
- NCT03868982 96 97 B-Eq-Operator___Eq-Operator-Value:BETWEEN
300 NCT03868982 99 102 B-Eq-Value

- NCT03868982 106 107 O
Completed NCT03868982 109 118 O
the NCT03868982 119 122 O
case NCT03868982 123 127 O
enrollement NCT03868982 128 139 O
within NCT03868982 140 146 B-Eq-Operator___Eq-Operator-Value:LTEQ
48 NCT03868982 148 150 B-Eq-Value
hours NCT03868982 151 156 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

Exclusion NCT03868982 157 166 O
Criteria NCT03868982 167 175 O
: NCT03868982 176 177 O

- NCT03868982 181 182 O
Less NCT03868982 184 188 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868982 189 193 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03868982 195 197 B-Eq-Value
years NCT03868982 198 203 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03868982 204 207 O

- NCT03868982 210 211 O
Pregnancy NCT03868982 213 222 B-Condition-Name

- NCT03868982 225 226 O
Participants NCT03868982 228 240 O
with NCT03868982 241 245 O
tracheostomy NCT03868982 246 258 B-Procedure-Name

- NCT03868982 261 262 O
Unable NCT03868982 264 270 O
to NCT03868982 271 273 O
insert NCT03868982 274 280 O
the NCT03868982 281 284 O
NG NCT03868982 285 287 B-Procedure-Name
- NCT03868982 288 289 I-Procedure-Name
tube NCT03868982 290 294 I-Procedure-Name

Inclusion NCT03865524 0 9 O
Criteria NCT03865524 10 18 O
: NCT03865524 19 20 O

- NCT03865524 24 25 O
Men NCT03865524 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03865524 31 34 O
women NCT03865524 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
over NCT03865524 41 45 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03865524 47 49 B-Eq-Value
years NCT03865524 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03865524 56 59 O
. NCT03865524 60 61 O

- NCT03865524 65 66 O
Written NCT03865524 68 75 O
informed NCT03865524 76 84 O
consent NCT03865524 85 92 O
according NCT03865524 93 102 O
to NCT03865524 103 105 O
ICH NCT03865524 106 109 O
/ NCT03865524 110 111 O
GCP NCT03865524 112 115 O
and NCT03865524 116 119 O
Spanish NCT03865524 120 127 O
legislation NCT03865524 128 139 O
, NCT03865524 140 141 O
obtained NCT03865524 142 150 O
before NCT03865524 151 157 O
any NCT03865524 158 161 O
study NCT03865524 162 167 O
procedure NCT03865524 168 177 O
. NCT03865524 178 179 O

- NCT03865524 183 184 O
Patient NCT03865524 186 193 O
with NCT03865524 194 198 O
a NCT03865524 199 200 O
BMI NCT03865524 201 204 B-Observation-Name___Observation-Type-Value:vital
equal NCT03865524 205 210 B-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03865524 211 213 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03865524 214 216 I-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03865524 217 224 I-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03865524 225 229 I-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03865524 231 233 B-Eq-Value
Kg NCT03865524 234 236 B-Eq-Unit
/ NCT03865524 237 238 O
m NCT03865524 239 240 B-Eq-Unit
2 NCT03865524 241 242 I-Eq-Unit

- NCT03865524 245 246 O
Patients NCT03865524 248 256 O
with NCT03865524 257 261 O
clinical NCT03865524 262 270 O
and NCT03865524 271 274 O
radiological NCT03865524 275 287 B-Procedure-Name
criteria NCT03865524 288 296 O
of NCT03865524 297 299 O
knee NCT03865524 300 304 O
osteoarthritis NCT03865524 305 319 B-Condition-Name
. NCT03865524 320 321 O

- NCT03865524 325 326 O
Patients NCT03865524 328 336 O
with NCT03865524 337 341 O
indication NCT03865524 342 352 O
for NCT03865524 353 356 O
primary NCT03865524 357 364 O
TKA NCT03865524 365 368 B-Condition-Name
according NCT03865524 369 378 O
to NCT03865524 379 381 O
medical NCT03865524 382 389 O
criteria NCT03865524 390 398 O
. NCT03865524 399 400 O

Exclusion NCT03865524 402 411 O
Criteria NCT03865524 412 420 O
: NCT03865524 421 422 O

- NCT03865524 426 427 O
Pregnancy NCT03865524 429 438 B-Condition-Name
or NCT03865524 439 441 O
lactation NCT03865524 442 451 B-Condition-Name
. NCT03865524 452 453 O

- NCT03865524 457 458 O
Inability NCT03865524 460 469 O
to NCT03865524 470 472 O
give NCT03865524 473 477 O
informed NCT03865524 478 486 O
consent NCT03865524 487 494 O
in NCT03865524 495 497 O
the NCT03865524 498 501 O
absence NCT03865524 502 509 O
of NCT03865524 510 512 O
a NCT03865524 513 514 O
legal NCT03865524 515 520 O
representative NCT03865524 521 535 O
. NCT03865524 536 537 O

- NCT03865524 541 542 O
Subjects NCT03865524 544 552 O
that NCT03865524 553 557 O
are NCT03865524 558 561 O
participating NCT03865524 562 575 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
in NCT03865524 576 578 O
a NCT03865524 579 580 O
study NCT03865524 581 586 O
with NCT03865524 587 591 O
medicines NCT03865524 592 601 O
or NCT03865524 602 604 O
other NCT03865524 605 610 O
medical NCT03865524 611 618 B-Procedure-Name
devices NCT03865524 619 626 I-Procedure-Name
. NCT03865524 627 628 O

- NCT03865524 632 633 O
Those NCT03865524 635 640 O
who NCT03865524 641 644 O
show NCT03865524 645 649 O
inability NCT03865524 650 659 O
to NCT03865524 660 662 O
follow NCT03865524 663 669 O
the NCT03865524 670 673 O
instructions NCT03865524 674 686 O
or NCT03865524 687 689 O
collaborate NCT03865524 690 701 O
during NCT03865524 702 708 O
the NCT03865524 709 712 O
development NCT03865524 713 724 O
of NCT03865524 725 727 O
the NCT03865524 728 731 O
study NCT03865524 732 737 O
. NCT03865524 738 739 O

- NCT03865524 743 744 O
If NCT03865524 746 748 O
in NCT03865524 749 751 O
the NCT03865524 752 755 O
opinion NCT03865524 756 763 O
of NCT03865524 764 766 O
the NCT03865524 767 770 O
researcher NCT03865524 771 781 O
there NCT03865524 782 787 O
are NCT03865524 788 791 O
findings NCT03865524 792 800 O
in NCT03865524 801 803 O
the NCT03865524 804 807 O
physical NCT03865524 808 816 B-Procedure-Name
examination NCT03865524 817 828 I-Procedure-Name
, NCT03865524 829 830 O
abnormalities NCT03865524 831 844 B-Condition-Name
in NCT03865524 845 847 O
the NCT03865524 848 851 O
results NCT03865524 852 859 O
of NCT03865524 860 862 O
the NCT03865524 863 866 O
clinical NCT03865524 867 875 O
analyzes NCT03865524 876 884 O
or NCT03865524 885 887 O
other NCT03865524 888 893 O
medical NCT03865524 894 901 O
, NCT03865524 902 903 O
social NCT03865524 904 910 O
or NCT03865524 911 913 O
psychosocial NCT03865524 914 926 O
factors NCT03865524 927 934 O
that NCT03865524 935 939 O
could NCT03865524 940 945 O
have NCT03865524 946 950 O
a NCT03865524 951 952 O
negative NCT03865524 953 961 B-Polarity___Polarity-Value:negative
influence NCT03865524 962 971 B-Stability___Stability-Value:change

- NCT03865524 974 975 O
Having NCT03865524 977 983 O
had NCT03865524 984 987 O
a NCT03865524 988 989 O
previous NCT03865524 990 998 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgical NCT03865524 999 1007 B-Procedure-Name
procedure NCT03865524 1008 1017 I-Procedure-Name
on NCT03865524 1018 1020 O
or NCT03865524 1021 1023 O
around NCT03865524 1024 1030 O
the NCT03865524 1031 1034 O
knee NCT03865524 1035 1039 O
in NCT03865524 1040 1042 O
the NCT03865524 1043 1046 O
last NCT03865524 1047 1051 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
12 NCT03865524 1053 1055 B-Eq-Value
months NCT03865524 1056 1062 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
( NCT03865524 1063 1064 O
such NCT03865524 1065 1069 O
as NCT03865524 1070 1072 O
proximal NCT03865524 1073 1081 B-Procedure-Name
tibial NCT03865524 1082 1088 I-Procedure-Name
osteotomy NCT03865524 1089 1098 I-Procedure-Name
, NCT03865524 1099 1100 O
femoral NCT03865524 1101 1108 B-Procedure-Name
osteotomy NCT03865524 1109 1118 I-Procedure-Name
, NCT03865524 1119 1120 O
open NCT03865524 1121 1125 B-Procedure-Name
reduction NCT03865524 1126 1135 I-Procedure-Name
and NCT03865524 1136 1139 O
internal NCT03865524 1140 1148 B-Procedure-Name
fixation NCT03865524 1149 1157 I-Procedure-Name
for NCT03865524 1158 1161 O
a NCT03865524 1162 1163 O
fracture NCT03865524 1164 1172 B-Condition-Name
, NCT03865524 1173 1174 O
patellectomy NCT03865524 1175 1187 B-Procedure-Name
or NCT03865524 1188 1190 O
patellar NCT03865524 1191 1199 B-Procedure-Name
realignment NCT03865524 1200 1211 I-Procedure-Name
) NCT03865524 1212 1213 O
. NCT03865524 1215 1216 O

- NCT03865524 1220 1221 O
Need NCT03865524 1223 1227 O
a NCT03865524 1228 1229 O
simultaneous NCT03865524 1230 1242 O
bilateral NCT03865524 1243 1252 O
TKA NCT03865524 1253 1256 B-Procedure-Name
. NCT03865524 1257 1258 O

- NCT03865524 1262 1263 O
Have NCT03865524 1265 1269 O
a NCT03865524 1270 1271 O
varus NCT03865524 1272 1277 B-Observation-Name___Observation-Type-Value:measurement
angle NCT03865524 1278 1283 I-Observation-Name___Observation-Type-Value:measurement
or NCT03865524 1284 1286 O
valgus NCT03865524 1287 1293 B-Observation-Name___Observation-Type-Value:measurement
≥ NCT03865524 1294 1295 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03865524 1297 1299 B-Eq-Value
° NCT03865524 1300 1301 B-Eq-Unit
. NCT03865524 1302 1303 O

- NCT03865524 1307 1308 O
Total NCT03865524 1310 1315 B-Procedure-Name
revision NCT03865524 1316 1324 I-Procedure-Name
knee NCT03865524 1325 1329 I-Procedure-Name
arthroplasty NCT03865524 1330 1342 I-Procedure-Name
. NCT03865524 1343 1344 O

Inclusion NCT03867864 0 9 O
Criteria NCT03867864 10 18 O
: NCT03867864 19 20 O

- NCT03867864 24 25 O
Registered NCT03867864 27 37 O
nurses NCT03867864 38 44 B-Provider-Role
, NCT03867864 45 46 O
working NCT03867864 47 54 O
in NCT03867864 55 57 O
intensive NCT03867864 58 67 B-Location___Location-Value:unit
care NCT03867864 68 72 I-Location___Location-Value:unit
units NCT03867864 73 78 I-Location___Location-Value:unit
( NCT03867864 79 80 O
ICU NCT03867864 81 84 B-Location___Location-Value:unit
) NCT03867864 85 86 O
or NCT03867864 87 89 O
department NCT03867864 90 100 B-Location___Location-Value:emergency-dept
of NCT03867864 101 103 I-Location___Location-Value:emergency-dept
emergency NCT03867864 104 113 I-Location___Location-Value:emergency-dept
( NCT03867864 114 115 O
ED NCT03867864 116 118 B-Location___Location-Value:emergency-dept
) NCT03867864 119 120 O
. NCT03867864 122 123 O

- NCT03867864 127 128 O
The NCT03867864 130 133 O
frequency NCT03867864 134 143 O
of NCT03867864 144 146 O
headaches NCT03867864 147 156 B-Condition-Name
more NCT03867864 157 161 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867864 162 166 I-Eq-Operator___Eq-Operator-Value:GT
three NCT03867864 167 172 B-Eq-Value
times NCT03867864 173 178 O
per NCT03867864 179 182 O
month NCT03867864 183 188 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03867864 189 190 O

- NCT03867864 194 195 O
The NCT03867864 197 200 O
type NCT03867864 201 205 O
of NCT03867864 206 208 O
headache NCT03867864 209 217 B-Condition-Name
is NCT03867864 218 220 O
migraine NCT03867864 221 229 B-Condition-Name
or NCT03867864 230 232 O
frequent NCT03867864 233 241 O
episodic NCT03867864 242 250 O
tension NCT03867864 251 258 O
- NCT03867864 259 260 O
type NCT03867864 261 265 O
headache NCT03867864 266 274 B-Condition-Name
, NCT03867864 275 276 O
which NCT03867864 277 282 O
is NCT03867864 283 285 O
defined NCT03867864 286 293 O
by NCT03867864 294 296 O
the NCT03867864 297 300 O
Headache NCT03867864 301 309 O
Classification NCT03867864 310 324 O
Committee NCT03867864 325 334 O
of NCT03867864 335 337 O
the NCT03867864 338 341 O
International NCT03867864 342 355 O
Headache NCT03867864 356 364 O
Society NCT03867864 365 372 O
. NCT03867864 373 374 O
If NCT03867864 376 378 O
the NCT03867864 379 382 O
symptoms NCT03867864 383 391 O
of NCT03867864 392 394 O
a NCT03867864 395 396 O
headache NCT03867864 397 405 B-Condition-Name
can NCT03867864 406 409 O
not NCT03867864 409 412 O
be NCT03867864 413 415 O
defined NCT03867864 416 423 O
, NCT03867864 424 425 O
the NCT03867864 426 429 O
investigator NCT03867864 430 442 O
will NCT03867864 443 447 O
refer NCT03867864 448 453 B-Encounter-Type___Encounter-Type-Value:referral
the NCT03867864 454 457 O
potential NCT03867864 458 467 O
participant NCT03867864 468 479 O
to NCT03867864 480 482 O
a NCT03867864 483 484 O
neurologist NCT03867864 485 496 B-Provider-Type
for NCT03867864 497 500 O
further NCT03867864 501 508 O
diagnosis NCT03867864 509 518 O
. NCT03867864 519 520 O

Exclusion NCT03867864 522 531 O
Criteria NCT03867864 532 540 O
: NCT03867864 541 542 O

- NCT03867864 546 547 O
Current NCT03867864 549 556 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
user NCT03867864 557 561 O
of NCT03867864 562 564 O
other NCT03867864 565 570 O
kinds NCT03867864 571 576 O
of NCT03867864 577 579 O
essential NCT03867864 580 589 B-Drug-Name
oils NCT03867864 590 594 I-Drug-Name
( NCT03867864 595 596 O
e NCT03867864 597 598 O
. NCT03867864 599 600 O
g NCT03867864 601 602 O
. NCT03867864 603 604 O
, NCT03867864 605 606 O
the NCT03867864 607 610 O
external NCT03867864 611 619 O
application NCT03867864 620 631 O
on NCT03867864 632 634 O
skin NCT03867864 635 639 O
, NCT03867864 640 641 O
sniffing NCT03867864 642 650 O
) NCT03867864 651 652 O
, NCT03867864 654 655 O
and NCT03867864 656 659 O
do NCT03867864 660 662 O
not NCT03867864 663 666 O
willing NCT03867864 667 674 O
to NCT03867864 675 677 O
temporarily NCT03867864 678 689 O
suspend NCT03867864 690 697 O
for NCT03867864 698 701 O
nine NCT03867864 702 706 B-Eq-Value
weeks NCT03867864 707 712 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03867864 713 714 O

- NCT03867864 718 719 O
Having NCT03867864 721 727 O
sensitive NCT03867864 728 737 B-Condition-Name
responses NCT03867864 738 747 I-Condition-Name
to NCT03867864 748 750 O
the NCT03867864 751 754 O
essential NCT03867864 755 764 B-Drug-Name
oil NCT03867864 765 768 I-Drug-Name
. NCT03867864 769 770 O

- NCT03867864 774 775 O
Pregnancy NCT03867864 777 786 B-Condition-Name
or NCT03867864 787 789 O
preparing NCT03867864 790 799 O
for NCT03867864 800 803 O
pregnancy NCT03867864 804 813 B-Condition-Name
. NCT03867864 814 815 O

- NCT03867864 819 820 O
Breastfeeding NCT03867864 822 835 B-Condition-Name
. NCT03867864 836 837 O

- NCT03867864 841 842 O
The NCT03867864 844 847 O
type NCT03867864 848 852 O
of NCT03867864 853 855 O
headache NCT03867864 856 864 B-Condition-Name
was NCT03867864 865 868 O
neither NCT03867864 869 876 O
migraine NCT03867864 877 885 B-Condition-Name
nor NCT03867864 886 889 O
frequent NCT03867864 890 898 O
episodic NCT03867864 899 907 O
tension NCT03867864 908 915 O
- NCT03867864 916 917 O
type NCT03867864 918 922 O
headache NCT03867864 923 931 B-Condition-Name
after NCT03867864 932 937 O
diagnosed NCT03867864 938 947 O
by NCT03867864 948 950 O
the NCT03867864 951 954 O
neurologist NCT03867864 955 966 B-Provider-Type
. NCT03867864 967 968 O

- NCT03867864 972 973 O
With NCT03867864 975 979 O
hepatic NCT03867864 980 987 O
or NCT03867864 988 990 O
renal NCT03867864 991 996 O
diseases NCT03867864 997 1005 B-Condition-Name
. NCT03867864 1006 1007 O

- NCT03867864 1011 1012 O
taking NCT03867864 1014 1020 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medicine NCT03867864 1021 1029 O
for NCT03867864 1030 1033 O
long NCT03867864 1034 1038 O
- NCT03867864 1039 1040 O
term NCT03867864 1041 1045 O
( NCT03867864 1046 1047 O
such NCT03867864 1048 1052 O
as NCT03867864 1053 1055 O
Aspirin NCT03867864 1056 1063 B-Drug-Name
, NCT03867864 1064 1065 O
anti NCT03867864 1066 1070 B-Drug-Name
- NCT03867864 1071 1072 I-Drug-Name
coagulant NCT03867864 1073 1082 I-Drug-Name
, NCT03867864 1083 1084 O
medication NCT03867864 1085 1095 O
for NCT03867864 1096 1099 O
mental NCT03867864 1100 1106 B-Condition-Name
disorders NCT03867864 1107 1116 I-Condition-Name
, NCT03867864 1117 1118 O
contraceptives NCT03867864 1119 1133 O
, NCT03867864 1134 1135 O
etc NCT03867864 1136 1139 O
. NCT03867864 1140 1141 O
) NCT03867864 1142 1143 O
. NCT03867864 1145 1146 O

Inclusion NCT03865901 0 9 O
Criteria NCT03865901 10 18 O
: NCT03865901 19 20 O

1 NCT03865901 25 26 O
. NCT03865901 26 27 O
Women NCT03865901 29 34 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
18 NCT03865901 36 38 B-Eq-Value
years NCT03865901 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865901 45 47 O
age NCT03865901 48 51 O
or NCT03865901 52 54 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865901 55 60 I-Eq-Operator___Eq-Operator-Value:GTEQ
at NCT03865901 61 63 O
enrollment NCT03865901 64 74 O

2 NCT03865901 78 79 O
. NCT03865901 79 80 O
Has NCT03865901 82 85 O
an NCT03865901 86 88 O
established NCT03865901 89 100 O
viable NCT03865901 101 107 O
singleton NCT03865901 108 117 O
pregnancy NCT03865901 118 127 B-Condition-Name

3 NCT03865901 131 132 O
. NCT03865901 132 133 O
Is NCT03865901 135 137 O
recommended NCT03865901 138 149 O
for NCT03865901 150 153 O
routine NCT03865901 154 161 O
GDM NCT03865901 162 165 B-Procedure-Name
screening NCT03865901 166 175 I-Procedure-Name
between NCT03865901 176 183 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03865901 185 187 B-Eq-Value
- NCT03865901 188 189 B-Eq-Operator___Eq-Operator-Value:BETWEEN
28 NCT03865901 191 193 B-Eq-Value
weeks NCT03865901 194 199 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
gestation NCT03865901 200 209 B-Observation-Name___Observation-Type-Value:measurement

4 NCT03865901 213 214 O
. NCT03865901 214 215 O
Has NCT03865901 217 220 O
confirmed NCT03865901 221 230 O
gestational NCT03865901 231 242 B-Observation-Name___Observation-Type-Value:measurement
age NCT03865901 243 246 I-Observation-Name___Observation-Type-Value:measurement
of NCT03865901 247 249 O
24 NCT03865901 251 253 B-Eq-Value
- NCT03865901 254 255 B-Eq-Operator___Eq-Operator-Value:BETWEEN
28 NCT03865901 257 259 B-Eq-Value
weeks NCT03865901 260 265 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
at NCT03865901 266 268 O
the NCT03865901 269 272 O
Screening NCT03865901 273 282 O
Visit NCT03865901 283 288 O

5 NCT03865901 292 293 O
. NCT03865901 293 294 O
Is NCT03865901 296 298 O
willing NCT03865901 299 306 O
and NCT03865901 307 310 O
able NCT03865901 311 315 O
to NCT03865901 316 318 O
provide NCT03865901 319 326 O
documentation NCT03865901 327 340 O
of NCT03865901 341 343 O
informed NCT03865901 344 352 O
consent NCT03865901 353 360 O

Exclusion NCT03865901 361 370 O
Criteria NCT03865901 371 379 O
: NCT03865901 380 381 O

1 NCT03865901 386 387 O
. NCT03865901 387 388 O
Has NCT03865901 390 393 O
diabetes NCT03865901 394 402 B-Condition-Name
before NCT03865901 403 409 O
pregnancy NCT03865901 410 419 B-Condition-Name
or NCT03865901 420 422 O
has NCT03865901 423 426 O
already NCT03865901 427 434 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
been NCT03865901 435 439 O
diagnosed NCT03865901 440 449 O
with NCT03865901 450 454 O
GDM NCT03865901 455 458 B-Condition-Name

2 NCT03865901 462 463 O
. NCT03865901 463 464 O
Has NCT03865901 466 469 O
contraindications NCT03865901 470 487 O
for NCT03865901 488 491 O
drinking NCT03865901 492 500 O
oral NCT03865901 501 505 O
glucose NCT03865901 506 513 B-Drug-Name
solution NCT03865901 514 522 O
up NCT03865901 523 525 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03865901 526 528 I-Eq-Operator___Eq-Operator-Value:LTEQ
100 NCT03865901 530 533 B-Eq-Value
g NCT03865901 534 535 B-Eq-Unit
of NCT03865901 536 538 O
sugar NCT03865901 539 544 B-Eq-Unit

3 NCT03865901 548 549 O
. NCT03865901 549 550 O
Is NCT03865901 552 554 O
taking NCT03865901 555 561 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
metformin NCT03865901 562 571 B-Drug-Name
for NCT03865901 572 575 O
any NCT03865901 576 579 O
reason NCT03865901 580 586 O

4 NCT03865901 590 591 O
. NCT03865901 591 592 O
Has NCT03865901 594 597 O
any NCT03865901 598 601 O
concomitant NCT03865901 602 613 O
illness NCT03865901 614 621 B-Condition-Name
, NCT03865901 622 623 O
disease NCT03865901 624 631 B-Condition-Name
or NCT03865901 632 634 O
condition NCT03865901 635 644 O
that NCT03865901 645 649 O
, NCT03865901 650 651 O
in NCT03865901 652 654 O
the NCT03865901 655 658 O
clinical NCT03865901 659 667 O
judgment NCT03865901 668 676 O
of NCT03865901 677 679 O
the NCT03865901 680 683 O
investigator NCT03865901 684 696 O
, NCT03865901 697 698 O
is NCT03865901 699 701 O
likely NCT03865901 702 708 O
to NCT03865901 709 711 O
prevent NCT03865901 712 719 B-Stability___Stability-Value:change
the NCT03865901 720 723 O
subject NCT03865901 724 731 O
from NCT03865901 732 736 O
complying NCT03865901 737 746 O
with NCT03865901 747 751 O
any NCT03865901 752 755 O
aspect NCT03865901 756 762 O
of NCT03865901 763 765 O
the NCT03865901 766 769 O
protocol NCT03865901 770 778 O
, NCT03865901 779 780 O
or NCT03865901 781 783 O
that NCT03865901 784 788 O
may NCT03865901 789 792 O
put NCT03865901 793 796 O
the NCT03865901 797 800 O
subject NCT03865901 801 808 O
at NCT03865901 809 811 O
unacceptable NCT03865901 812 824 O
risk NCT03865901 825 829 O

Inclusion NCT03860662 0 9 O
Criteria NCT03860662 10 18 O
: NCT03860662 19 20 O

- NCT03860662 24 25 O
Being NCT03860662 27 32 O
between NCT03860662 33 40 B-Eq-Operator___Eq-Operator-Value:BETWEEN
the NCT03860662 41 44 O
ages NCT03860662 45 49 O
of NCT03860662 50 52 O
18 NCT03860662 54 56 B-Eq-Value
- NCT03860662 57 58 O
60 NCT03860662 60 62 B-Eq-Value

- NCT03860662 66 67 O
To NCT03860662 69 71 O
accept NCT03860662 72 78 O
voluntary NCT03860662 79 88 O
participation NCT03860662 89 102 O
in NCT03860662 103 105 O
the NCT03860662 106 109 O
study NCT03860662 110 115 O

- NCT03860662 118 119 O
Spastic NCT03860662 121 128 B-Condition-Name
Hemiplegia NCT03860662 129 139 I-Condition-Name
( NCT03860662 140 141 O
Modified NCT03860662 142 150 B-Observation-Name___Observation-Type-Value:clinical-score
Ashworth NCT03860662 151 159 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03860662 160 165 I-Observation-Name___Observation-Type-Value:clinical-score
2 NCT03860662 167 168 B-Eq-Value
and NCT03860662 169 172 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03860662 173 178 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03860662 179 180 O

Exclusion NCT03860662 182 191 O
Criteria NCT03860662 192 200 O
: NCT03860662 201 202 O

- NCT03860662 206 207 O
Pregnant NCT03860662 209 217 B-Condition-Name
women NCT03860662 218 223 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03860662 224 225 O
breastfeeding NCT03860662 226 239 B-Condition-Name
and NCT03860662 240 243 O
younger NCT03860662 244 251 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03860662 252 256 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03860662 258 260 B-Eq-Value
years NCT03860662 261 266 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03860662 269 270 O
To NCT03860662 272 274 O
have NCT03860662 275 279 O
medication NCT03860662 280 290 O
and NCT03860662 291 294 O
substance NCT03860662 295 304 B-Condition-Name
use NCT03860662 305 308 I-Condition-Name
causing NCT03860662 309 316 O
neuropathy NCT03860662 317 327 B-Condition-Name
in NCT03860662 328 330 O
the NCT03860662 331 334 O
history NCT03860662 335 342 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860662 343 345 O
the NCT03860662 346 349 O
disease NCT03860662 350 357 B-Condition-Name
and NCT03860662 358 361 O
/ NCT03860662 362 363 O
or NCT03860662 364 366 O
neuropathy NCT03860662 367 377 B-Condition-Name

- NCT03860662 380 381 O
Companies NCT03860662 383 392 O
that NCT03860662 393 397 O
have NCT03860662 398 402 O
received NCT03860662 403 411 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
botulinum NCT03860662 412 421 B-Procedure-Name
toxin NCT03860662 422 427 I-Procedure-Name
injection NCT03860662 428 437 I-Procedure-Name
therapy NCT03860662 438 445 I-Procedure-Name
and NCT03860662 446 449 O
/ NCT03860662 450 451 O
or NCT03860662 452 454 O
oral NCT03860662 455 459 O
antispastic NCT03860662 460 471 B-Procedure-Name
therapy NCT03860662 472 479 I-Procedure-Name
within NCT03860662 480 486 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860662 487 490 O
last NCT03860662 491 495 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03860662 497 498 B-Eq-Value
months NCT03860662 499 505 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03860662 508 509 O
Have NCT03860662 511 515 O
a NCT03860662 516 517 O
history NCT03860662 518 525 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860662 526 528 O
allergies NCT03860662 529 538 O
and NCT03860662 539 542 O
hypersensitivity NCT03860662 543 559 B-Condition-Name
to NCT03860662 560 562 O
usability NCT03860662 563 572 O
drug NCT03860662 573 577 O

- NCT03860662 580 581 O
Injection NCT03860662 583 592 B-Procedure-Name
treatment NCT03860662 593 602 I-Procedure-Name
planned NCT03860662 603 610 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
purification NCT03860662 611 623 B-Procedure-Name
hematoma NCT03860662 624 632 I-Procedure-Name
, NCT03860662 633 634 O
cleaning NCT03860662 635 643 O
or NCT03860662 644 646 O
skin NCT03860662 647 651 O
lesion NCT03860662 652 658 B-Condition-Name
to NCT03860662 659 661 O
be NCT03860662 662 664 O

Inclusion NCT03866213 0 9 O
Criteria NCT03866213 10 18 O
: NCT03866213 19 20 O

- NCT03866213 24 25 O
The NCT03866213 27 30 O
patient NCT03866213 31 38 O
is NCT03866213 39 41 O
currently NCT03866213 42 51 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
being NCT03866213 52 57 O
treated NCT03866213 58 65 O
at NCT03866213 66 68 O
Queen NCT03866213 69 74 B-Location___Location-Value:hospital
Elizabeth NCT03866213 75 84 I-Location___Location-Value:hospital
Central NCT03866213 85 92 I-Location___Location-Value:hospital
Hospital NCT03866213 93 101 I-Location___Location-Value:hospital
or NCT03866213 102 104 O
Kamuzu NCT03866213 105 111 B-Location___Location-Value:hospital
Central NCT03866213 112 119 I-Location___Location-Value:hospital
Hospital NCT03866213 120 128 I-Location___Location-Value:hospital
in NCT03866213 129 131 O
the NCT03866213 132 135 O
neonatal NCT03866213 136 144 B-Location___Location-Value:unit
ward NCT03866213 145 149 I-Location___Location-Value:unit
. NCT03866213 150 151 O

- NCT03866213 155 156 O
The NCT03866213 158 161 O
patient NCT03866213 162 169 O
is NCT03866213 170 172 O
less NCT03866213 173 177 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03866213 178 182 I-Eq-Operator___Eq-Operator-Value:LT
28 NCT03866213 184 186 B-Eq-Value
days NCT03866213 187 191 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
old NCT03866213 192 195 O
( NCT03866213 196 197 O
neonate NCT03866213 198 205 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
) NCT03866213 206 207 O
. NCT03866213 209 210 O

- NCT03866213 214 215 O
The NCT03866213 217 220 O
patient NCT03866213 221 228 O
is NCT03866213 229 231 O
deemed NCT03866213 232 238 O
to NCT03866213 239 241 O
be NCT03866213 242 244 O
at NCT03866213 245 247 O
risk NCT03866213 248 252 O
for NCT03866213 253 256 O
jaundice NCT03866213 257 265 B-Condition-Name
or NCT03866213 266 268 O
the NCT03866213 269 272 O
patient NCT03866213 273 280 O
is NCT03866213 281 283 O
undergoing NCT03866213 284 294 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
blue NCT03866213 295 299 O
light NCT03866213 300 305 O
phototherapy NCT03866213 306 318 B-Procedure-Name
for NCT03866213 319 322 O
treatment NCT03866213 323 332 O
of NCT03866213 333 335 O
jaundice NCT03866213 336 344 B-Condition-Name
. NCT03866213 345 346 O

- NCT03866213 350 351 O
The NCT03866213 353 356 O
patient NCT03866213 357 364 O
's NCT03866213 364 366 O
parent NCT03866213 367 373 O
or NCT03866213 374 376 O
guardian NCT03866213 377 385 O
has NCT03866213 386 389 O
provided NCT03866213 390 398 O
informed NCT03866213 399 407 O
consent NCT03866213 408 415 O
for NCT03866213 416 419 O
their NCT03866213 420 425 O
child NCT03866213 426 431 O
to NCT03866213 432 434 O
participate NCT03866213 435 446 O
. NCT03866213 447 448 O

Exclusion NCT03866213 450 459 O
Criteria NCT03866213 460 468 O
: NCT03866213 469 470 O

- NCT03866213 474 475 O
Parent NCT03866213 477 483 O
or NCT03866213 484 486 O
guardian NCT03866213 487 495 O
is NCT03866213 496 498 O
unable NCT03866213 499 505 O
or NCT03866213 506 508 O
unwilling NCT03866213 509 518 O
to NCT03866213 519 521 O
provide NCT03866213 522 529 O
informed NCT03866213 530 538 O
consent NCT03866213 539 546 O
. NCT03866213 547 548 O

- NCT03866213 552 553 O
The NCT03866213 555 558 O
patient NCT03866213 559 566 O
is NCT03866213 567 569 O
unable NCT03866213 570 576 O
to NCT03866213 577 579 O
receive NCT03866213 580 587 O
a NCT03866213 588 589 O
blood NCT03866213 590 595 B-Observation-Specimen
draw NCT03866213 596 600 I-Observation-Specimen
/ NCT03866213 601 602 O
heel NCT03866213 603 607 B-Observation-Specimen
stick NCT03866213 608 613 I-Observation-Specimen
as NCT03866213 614 616 O
determined NCT03866213 617 627 O
by NCT03866213 628 630 O
their NCT03866213 631 636 O
clinician NCT03866213 637 646 O
. NCT03866213 647 648 O

Inclusion NCT03865732 0 9 O
Criteria NCT03865732 10 18 O
: NCT03865732 19 20 O

- NCT03865732 24 25 O
Molecular NCT03865732 27 36 B-Procedure-Name
confirmation NCT03865732 37 49 O
of NCT03865732 50 52 O
a NCT03865732 53 54 O
pathogenic NCT03865732 55 65 O
or NCT03865732 66 68 O
likely NCT03865732 69 75 O
pathogenic NCT03865732 76 86 O
PCDH NCT03865732 87 91 B-Condition-Name
19 NCT03865732 92 94 I-Condition-Name
variant NCT03865732 95 102 I-Condition-Name

- NCT03865732 105 106 O
Failure NCT03865732 108 115 O
to NCT03865732 116 118 O
control NCT03865732 119 126 B-Stability___Stability-Value:stable
seizures NCT03865732 127 135 B-Condition-Name
despite NCT03865732 136 143 O
2 NCT03865732 145 146 B-Eq-Value
or NCT03865732 147 149 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03865732 150 154 I-Eq-Operator___Eq-Operator-Value:GTEQ
anti NCT03865732 155 159 O
- NCT03865732 160 161 O
seizure NCT03865732 162 169 B-Condition-Name
medications NCT03865732 170 181 O

- NCT03865732 184 185 O
12 NCT03865732 188 190 B-Eq-Value
seizures NCT03865732 191 199 B-Condition-Name
over NCT03865732 200 204 O
a NCT03865732 205 206 O
12 NCT03865732 208 210 B-Eq-Value
- NCT03865732 211 212 O
week NCT03865732 213 217 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
period NCT03865732 218 224 O
of NCT03865732 225 227 O
primary NCT03865732 228 235 B-Condition-Name
seizure NCT03865732 236 243 I-Condition-Name
types NCT03865732 244 249 O
prior NCT03865732 250 255 O
to NCT03865732 256 258 O
screening NCT03865732 259 268 O

- NCT03865732 271 272 O
On NCT03865732 274 276 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03865732 277 278 O
stable NCT03865732 279 285 B-Stability___Stability-Value:stable
regimen NCT03865732 286 293 O
of NCT03865732 294 296 O
anti NCT03865732 297 301 O
- NCT03865732 302 303 O
seizure NCT03865732 304 311 B-Condition-Name
treatments NCT03865732 312 322 O
( NCT03865732 323 324 O
Vagus NCT03865732 325 330 B-Procedure-Name
nerve NCT03865732 331 336 I-Procedure-Name
stimulator NCT03865732 337 347 I-Procedure-Name
, NCT03865732 348 349 O
ketogenic NCT03865732 350 359 B-Observation-Name___Observation-Type-Value:social-habit
diet NCT03865732 360 364 I-Observation-Name___Observation-Type-Value:social-habit
, NCT03865732 365 366 O
and NCT03865732 367 370 O
modified NCT03865732 371 379 O
Atkins NCT03865732 380 386 B-Observation-Name___Observation-Type-Value:social-habit
diet NCT03865732 387 391 I-Observation-Name___Observation-Type-Value:social-habit
should NCT03865732 392 398 O
be NCT03865732 399 401 O
unchanged NCT03865732 402 411 B-Stability___Stability-Value:stable
for NCT03865732 412 415 O
3 NCT03865732 417 418 B-Eq-Value
months NCT03865732 419 425 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03865732 426 431 O
to NCT03865732 432 434 O
screening NCT03865732 435 444 O
) NCT03865732 445 446 O

Exclusion NCT03865732 448 457 O
Criteria NCT03865732 458 466 O
: NCT03865732 467 468 O

- NCT03865732 472 473 O
Previous NCT03865732 475 483 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
exposure NCT03865732 484 492 O
to NCT03865732 493 495 O
ganaxolone NCT03865732 496 506 B-Drug-Name

- NCT03865732 509 510 O
> NCT03865732 512 513 B-Eq-Operator___Eq-Operator-Value:GT
8 NCT03865732 515 516 B-Eq-Value
consecutive NCT03865732 517 528 O
weeks NCT03865732 529 534 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03865732 535 537 O
seizure NCT03865732 538 545 B-Condition-Name
freedom NCT03865732 546 553 O
during NCT03865732 554 560 O
the NCT03865732 561 564 O
12 NCT03865732 566 568 B-Eq-Value
weeks NCT03865732 569 574 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03865732 575 580 O
to NCT03865732 581 583 O
screening NCT03865732 584 593 O

- NCT03865732 596 597 O
Concurrent NCT03865732 599 609 O
use NCT03865732 610 613 O
of NCT03865732 614 616 O
strong NCT03865732 617 623 B-Drug-Name
inducers NCT03865732 624 632 I-Drug-Name
or NCT03865732 633 635 O
inhibitors NCT03865732 636 646 B-Drug-Name
of NCT03865732 647 649 O
CYP NCT03865732 650 653 O
3A NCT03865732 654 656 O
4 NCT03865732 657 658 O
/ NCT03865732 659 660 O
5 NCT03865732 662 663 O
/ NCT03865732 664 665 O
7 NCT03865732 667 668 O
is NCT03865732 669 671 O
not NCT03865732 672 675 O
permitted NCT03865732 676 685 O

- NCT03865732 688 689 O
Use NCT03865732 691 694 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03865732 695 697 O
tetrahydrocannabinol NCT03865732 698 718 B-Drug-Name
( NCT03865732 719 720 O
THC NCT03865732 721 724 B-Drug-Name
) NCT03865732 725 726 O
or NCT03865732 727 729 O
non NCT03865732 730 733 O
- NCT03865732 734 735 O
approved NCT03865732 736 744 O
cannabidiol NCT03865732 745 756 B-Drug-Name
( NCT03865732 757 758 O
CBD NCT03865732 759 762 B-Drug-Name
) NCT03865732 763 764 O
is NCT03865732 765 767 O
prohibited NCT03865732 768 778 O
during NCT03865732 779 785 O
the NCT03865732 786 789 O
double NCT03865732 790 796 O
- NCT03865732 797 798 O
blind NCT03865732 799 804 O
phase NCT03865732 805 810 O

- NCT03865732 813 814 O
Exposure NCT03865732 816 824 O
to NCT03865732 825 827 O
any NCT03865732 828 831 O
other NCT03865732 832 837 O
investigational NCT03865732 838 853 O
drug NCT03865732 854 858 O
within NCT03865732 859 865 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03865732 867 869 B-Eq-Value
days NCT03865732 870 874 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
or NCT03865732 875 877 O
fewer NCT03865732 878 883 B-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03865732 884 888 I-Eq-Operator___Eq-Operator-Value:LTEQ
5 NCT03865732 890 891 B-Eq-Value
half NCT03865732 892 896 B-Eq-Unit
- NCT03865732 897 898 I-Eq-Unit
lives NCT03865732 899 904 I-Eq-Unit
prior NCT03865732 905 910 O
to NCT03865732 911 913 O
screening NCT03865732 914 923 O

Inclusion NCT03867643 0 9 O
Criteria NCT03867643 10 18 O
: NCT03867643 19 20 O

- NCT03867643 24 25 O
Children NCT03867643 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
who NCT03867643 36 39 O
are NCT03867643 40 43 O
6 NCT03867643 45 46 B-Eq-Value
- NCT03867643 47 48 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03867643 50 52 B-Eq-Value
years NCT03867643 53 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867643 59 62 O
， NCT03867643 63 64 O
in NCT03867643 65 67 O
Chongqing NCT03867643 68 77 B-Location___Location-Value:residence

- NCT03867643 80 81 O
After NCT03867643 83 88 O
birth NCT03867643 89 94 O
, NCT03867643 95 96 O
three NCT03867643 97 102 B-Eq-Value
injections NCT03867643 103 113 B-Procedure-Name
of NCT03867643 114 116 O
Hep NCT03867643 117 120 B-Drug-Name
B NCT03867643 121 122 I-Drug-Name
were NCT03867643 123 127 O
inoculated NCT03867643 128 138 O
in NCT03867643 139 141 O
time NCT03867643 142 146 O
according NCT03867643 147 156 O
to NCT03867643 157 159 O
the NCT03867643 160 163 O
procedure NCT03867643 164 173 O
of NCT03867643 174 176 O
0 NCT03867643 178 179 B-Eq-Value
, NCT03867643 180 181 O
1 NCT03867643 183 184 B-Eq-Value
and NCT03867643 185 188 O
6 NCT03867643 190 191 B-Eq-Value
months NCT03867643 192 198 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
（ NCT03867643 199 200 O
The NCT03867643 201 204 O
vaccination NCT03867643 205 216 O
certificate NCT03867643 217 228 O
record NCT03867643 229 235 O
） NCT03867643 235 236 O

- NCT03867643 239 240 O
No NCT03867643 242 244 O
HBV NCT03867643 245 248 B-Immunization-Name
booster NCT03867643 249 256 I-Immunization-Name
vaccine NCT03867643 257 264 I-Immunization-Name
given NCT03867643 265 270 O
since NCT03867643 271 276 O
primary NCT03867643 277 284 O
HBV NCT03867643 285 288 B-Immunization-Name
immunization NCT03867643 289 301 I-Immunization-Name

- NCT03867643 304 305 O
Children NCT03867643 307 315 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
or NCT03867643 316 318 O
guardian NCT03867643 319 327 O
knew NCT03867643 328 332 O
and NCT03867643 333 336 O
agreed NCT03867643 337 343 O
to NCT03867643 344 346 O
accept NCT03867643 347 353 O
the NCT03867643 354 357 O
study NCT03867643 358 363 O

- NCT03867643 366 367 O
Follow NCT03867643 369 375 O
- NCT03867643 376 377 O
up NCT03867643 378 380 O
study NCT03867643 381 386 O
and NCT03867643 387 390 O
blood NCT03867643 391 396 B-Observation-Specimen
collection NCT03867643 397 407 O
after NCT03867643 408 413 O
vaccination NCT03867643 414 425 O
can NCT03867643 426 429 O
be NCT03867643 430 432 O
accepted NCT03867643 433 441 O

Exclusion NCT03867643 442 451 O
Criteria NCT03867643 452 460 O
: NCT03867643 461 462 O

- NCT03867643 466 467 O
Unwilling NCT03867643 469 478 O
or NCT03867643 479 481 O
impossible NCT03867643 482 492 O
to NCT03867643 493 495 O
participate NCT03867643 496 507 O
in NCT03867643 508 510 O
this NCT03867643 511 515 O
research NCT03867643 516 524 O
project NCT03867643 525 532 O
; NCT03867643 532 533 O

- NCT03867643 536 537 O
Have NCT03867643 539 543 O
a NCT03867643 544 545 O
history NCT03867643 546 553 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867643 554 556 O
allergy NCT03867643 557 564 O
or NCT03867643 565 567 O
have NCT03867643 568 572 O
had NCT03867643 573 576 O
a NCT03867643 577 578 O
serious NCT03867643 579 586 B-Severity___Severity-Value:severe
vaccine NCT03867643 587 594 O
reaction NCT03867643 595 603 B-Condition-Name

- NCT03867643 606 607 O
Have NCT03867643 609 613 O
immune NCT03867643 614 620 B-Condition-Name
impairment NCT03867643 621 631 I-Condition-Name
diseases NCT03867643 632 640 I-Condition-Name
and NCT03867643 641 644 O
appear NCT03867643 645 651 O
immune NCT03867643 652 658 B-Condition-Name
impairment NCT03867643 659 669 I-Condition-Name
; NCT03867643 669 670 O

- NCT03867643 673 674 O
Immunosuppressive NCT03867643 676 693 B-Procedure-Name
treatment NCT03867643 694 703 I-Procedure-Name
, NCT03867643 704 705 O
receive NCT03867643 706 713 O
any NCT03867643 714 717 O
injection NCT03867643 718 727 O
or NCT03867643 728 730 O
oral NCT03867643 731 735 O
administration NCT03867643 736 750 O
of NCT03867643 751 753 O
cortisone NCT03867643 754 763 B-Drug-Name
or NCT03867643 764 766 O
cancer NCT03867643 767 773 B-Condition-Name
chemotherapy NCT03867643 774 786 B-Procedure-Name
; NCT03867643 786 787 O

- NCT03867643 790 791 O
Any NCT03867643 793 796 O
kind NCT03867643 797 801 O
of NCT03867643 802 804 O
vaccine NCT03867643 805 812 O
or NCT03867643 813 815 O
any NCT03867643 816 819 O
kind NCT03867643 820 824 O
of NCT03867643 825 827 O
observation NCT03867643 828 839 O
drug NCT03867643 840 844 O
has NCT03867643 845 848 O
been NCT03867643 849 853 O
vaccinated NCT03867643 854 864 O
in NCT03867643 865 867 O
the NCT03867643 868 871 O
past NCT03867643 872 876 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
four NCT03867643 877 881 B-Eq-Value
weeks NCT03867643 882 887 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03867643 887 888 O

- NCT03867643 891 892 O
Any NCT03867643 894 897 O
acute NCT03867643 898 903 B-Severity___Severity-Value:severe
disease NCT03867643 904 911 B-Condition-Name
or NCT03867643 912 914 O
other NCT03867643 915 920 O
infection NCT03867643 921 930 B-Condition-Name
requiring NCT03867643 931 940 O
antibiotic NCT03867643 941 951 B-Drug-Name
or NCT03867643 952 954 O
antiviral NCT03867643 955 964 B-Drug-Name
treatment NCT03867643 965 974 O
in NCT03867643 975 977 O
the NCT03867643 978 981 O
past NCT03867643 982 986 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
four NCT03867643 987 991 B-Eq-Value
weeks NCT03867643 992 997 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03867643 997 998 O

- NCT03867643 1001 1002 O
Fever NCT03867643 1004 1009 B-Condition-Name
symptoms NCT03867643 1010 1018 O
occurred NCT03867643 1019 1027 O
in NCT03867643 1028 1030 O
the NCT03867643 1031 1034 O
past NCT03867643 1035 1039 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
week NCT03867643 1040 1044 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03867643 1045 1046 O
axillary NCT03867643 1047 1055 O
temperature NCT03867643 1056 1067 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03867643 1068 1069 B-Eq-Operator___Eq-Operator-Value:GTEQ
38 NCT03867643 1071 1073 B-Eq-Value
℃ NCT03867643 1074 1075 B-Eq-Unit
) NCT03867643 1076 1077 O

- NCT03867643 1081 1082 O
Blood NCT03867643 1084 1089 B-Procedure-Name
transfusion NCT03867643 1090 1101 I-Procedure-Name
experience NCT03867643 1102 1112 O
; NCT03867643 1112 1113 O

- NCT03867643 1116 1117 O
Has NCT03867643 1119 1122 O
a NCT03867643 1123 1124 O
history NCT03867643 1125 1132 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867643 1133 1135 O
more NCT03867643 1136 1140 O
serious NCT03867643 1141 1148 B-Severity___Severity-Value:severe
infectious NCT03867643 1149 1159 B-Condition-Name
diseases NCT03867643 1160 1168 I-Condition-Name
( NCT03867643 1169 1170 O
five NCT03867643 1171 1175 O
types NCT03867643 1176 1181 O
of NCT03867643 1182 1184 O
hepatitis NCT03867643 1185 1194 B-Condition-Name
, NCT03867643 1195 1196 O
AIDS NCT03867643 1197 1201 B-Condition-Name
, NCT03867643 1202 1203 O
syphilis NCT03867643 1204 1212 B-Condition-Name
, NCT03867643 1213 1214 O
gonorrhea NCT03867643 1215 1224 B-Condition-Name
, NCT03867643 1225 1226 O
etc NCT03867643 1227 1230 O
. NCT03867643 1231 1232 O
) NCT03867643 1234 1235 O
; NCT03867643 1236 1237 O

- NCT03867643 1240 1241 O
Hepatitis NCT03867643 1243 1252 B-Condition-Name
B NCT03867643 1253 1254 I-Condition-Name
infection NCT03867643 1255 1264 O
or NCT03867643 1265 1267 O
carriers NCT03867643 1268 1276 O
( NCT03867643 1277 1278 O
lineal NCT03867643 1279 1285 O
relationship NCT03867643 1286 1298 O
) NCT03867643 1299 1300 O
; NCT03867643 1301 1302 O

- NCT03867643 1305 1306 O
Abnormal NCT03867643 1308 1316 B-Polarity___Polarity-Value:abnormal
physical NCT03867643 1317 1325 B-Procedure-Name
examination NCT03867643 1326 1337 I-Procedure-Name

Inclusion NCT03863431 0 9 O
Criteria NCT03863431 10 18 O
: NCT03863431 19 20 O

- NCT03863431 24 25 O
18 NCT03863431 28 30 B-Eq-Value
- NCT03863431 31 32 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03863431 34 36 B-Eq-Value
years NCT03863431 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863431 45 46 O
BMI NCT03863431 48 51 B-Observation-Name___Observation-Type-Value:vital
= NCT03863431 52 53 B-Eq-Operator___Eq-Operator-Value:EQ
18.5 NCT03863431 55 59 B-Eq-Value
- NCT03863431 60 61 B-Eq-Operator___Eq-Operator-Value:BETWEEN
29.9 NCT03863431 63 67 B-Eq-Value
kg NCT03863431 68 70 B-Eq-Unit
/ NCT03863431 71 72 O
m NCT03863431 73 74 B-Eq-Unit
2 NCT03863431 75 76 I-Eq-Unit

- NCT03863431 79 80 O
Male NCT03863431 82 86 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03863431 87 89 O
female NCT03863431 90 96 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03863431 99 100 O
Physically NCT03863431 102 112 B-Observation-Name___Observation-Type-Value:social-habit
active NCT03863431 113 119 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03863431 120 121 O
> NCT03863431 123 124 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03863431 126 127 B-Eq-Value
x NCT03863431 128 129 O
30 NCT03863431 131 133 B-Eq-Value
min NCT03863431 134 137 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
moderate NCT03863431 138 146 O
exercise NCT03863431 147 155 O
per NCT03863431 156 159 O
week NCT03863431 160 164 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03863431 165 166 O

- NCT03863431 170 171 O
Non NCT03863431 173 176 O
- NCT03863431 177 178 O
smoker NCT03863431 179 185 B-Condition-Name
( NCT03863431 186 187 O
including NCT03863431 188 197 O
the NCT03863431 198 201 O
use NCT03863431 202 205 O
of NCT03863431 206 208 O
vaporisers NCT03863431 209 219 B-Drug-Name
and NCT03863431 220 223 O
e NCT03863431 224 225 B-Drug-Name
- NCT03863431 226 227 I-Drug-Name
cigarettes NCT03863431 228 238 I-Drug-Name
) NCT03863431 239 240 O

- NCT03863431 244 245 O
Healthy NCT03863431 247 254 B-Condition-Name
( NCT03863431 255 256 O
determined NCT03863431 257 267 O
by NCT03863431 268 270 O
the NCT03863431 271 274 O
School NCT03863431 275 281 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
's NCT03863431 281 283 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
standard NCT03863431 284 292 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
health NCT03863431 293 299 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
questionnaire NCT03863431 300 313 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03863431 314 315 O

- NCT03863431 319 320 O
No NCT03863431 322 324 O
cardiometabolic NCT03863431 325 340 O
or NCT03863431 341 343 O
inflammatory NCT03863431 344 356 O
illness NCT03863431 357 364 B-Condition-Name

Exclusion NCT03863431 365 374 O
Criteria NCT03863431 375 383 O
: NCT03863431 384 385 O

- NCT03863431 389 390 O
Outside NCT03863431 392 399 O
of NCT03863431 400 402 O
age NCT03863431 403 406 O
- NCT03863431 407 408 O
range NCT03863431 409 414 O

- NCT03863431 417 418 O
Outside NCT03863431 420 427 O
BMI NCT03863431 428 431 B-Observation-Name___Observation-Type-Value:vital
range NCT03863431 432 437 B-Eq-Unit___Eq-Unit-Value:ref-range-normal

- NCT03863431 440 441 O
Inactive NCT03863431 443 451 B-Observation-Name___Observation-Type-Value:social-habit
( NCT03863431 452 453 O
< NCT03863431 455 456 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03863431 458 459 B-Eq-Value
x NCT03863431 460 461 O
30 NCT03863431 463 465 B-Eq-Value
min NCT03863431 466 469 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
moderate NCT03863431 470 478 O
exercise NCT03863431 479 487 O
per NCT03863431 488 491 O
week NCT03863431 492 496 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03863431 497 498 O

- NCT03863431 502 503 O
Smoker NCT03863431 505 511 B-Condition-Name

- NCT03863431 514 515 O
Taking NCT03863431 517 523 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03863431 524 534 O

- NCT03863431 537 538 O
History NCT03863431 540 547 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863431 548 550 O
cardiometabolic NCT03863431 551 566 O
or NCT03863431 567 569 O
inflammatory NCT03863431 570 582 O
illness NCT03863431 583 590 B-Condition-Name

- NCT03863431 593 594 O
Vegetarian NCT03863431 596 606 B-Condition-Name
/ NCT03863431 607 608 O
vegan NCT03863431 609 614 B-Condition-Name
( NCT03863431 615 616 O
as NCT03863431 617 619 O
the NCT03863431 620 623 O
high NCT03863431 624 628 O
- NCT03863431 629 630 O
fat NCT03863431 631 634 O
diet NCT03863431 635 639 O
is NCT03863431 640 642 O
based NCT03863431 643 648 O
on NCT03863431 649 651 O
animal NCT03863431 652 658 O
fats NCT03863431 659 663 O
) NCT03863431 664 665 O

- NCT03863431 669 670 O
Other NCT03863431 672 677 O
dietary NCT03863431 678 685 B-Condition-Name
restrictions NCT03863431 686 698 I-Condition-Name
which NCT03863431 699 704 O
prevent NCT03863431 705 712 O
consumption NCT03863431 713 724 O
of NCT03863431 725 727 O
the NCT03863431 728 731 O
experimental NCT03863431 732 744 B-Procedure-Name
diet NCT03863431 745 749 I-Procedure-Name

- NCT03863431 752 753 O
Consumption NCT03863431 755 766 O
of NCT03863431 767 769 O
probiotics NCT03863431 770 780 B-Drug-Name
within NCT03863431 781 787 B-Eq-Operator___Eq-Operator-Value:LTEQ
last NCT03863431 788 792 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863431 794 795 B-Eq-Value
months NCT03863431 796 802 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
( NCT03863431 803 804 O
these NCT03863431 805 810 O
influence NCT03863431 811 820 O
the NCT03863431 821 824 O
gut NCT03863431 825 828 O
microbiota NCT03863431 829 839 O
) NCT03863431 840 841 O

- NCT03863431 845 846 O
Participation NCT03863431 848 861 O
in NCT03863431 862 864 O
another NCT03863431 865 872 O
clinical NCT03863431 873 881 O
trial NCT03863431 882 887 O

- NCT03863431 890 891 O
Those NCT03863431 893 898 O
with NCT03863431 899 903 O
known NCT03863431 904 909 O
or NCT03863431 910 912 O
suspected NCT03863431 913 922 O
food NCT03863431 923 927 B-Condition-Name
intolerances NCT03863431 928 940 I-Condition-Name
, NCT03863431 941 942 O
allergies NCT03863431 943 952 O
or NCT03863431 953 955 O
hypersensitivity NCT03863431 956 972 B-Condition-Name

- NCT03863431 975 976 O
Women NCT03863431 978 983 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03863431 984 987 O
are NCT03863431 988 991 O
known NCT03863431 992 997 O
to NCT03863431 998 1000 O
be NCT03863431 1001 1003 O
pregnant NCT03863431 1004 1012 B-Condition-Name
or NCT03863431 1013 1015 O
who NCT03863431 1016 1019 O
are NCT03863431 1020 1023 O
intending NCT03863431 1024 1033 O
to NCT03863431 1034 1036 O
become NCT03863431 1037 1043 O
pregnant NCT03863431 1044 1052 B-Condition-Name
over NCT03863431 1053 1057 O
the NCT03863431 1058 1061 O
course NCT03863431 1062 1068 O
of NCT03863431 1069 1071 O
the NCT03863431 1072 1075 O
study NCT03863431 1076 1081 O

Inclusion NCT03865875 0 9 O
Criteria NCT03865875 10 18 O

- NCT03865875 21 22 O
Adults NCT03865875 24 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
age NCT03865875 31 34 O
18 NCT03865875 36 38 B-Eq-Value
years NCT03865875 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03865875 45 47 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865875 48 53 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03865875 54 55 O

- NCT03865875 59 60 O
Diagnosed NCT03865875 62 71 O
within NCT03865875 72 78 B-Eq-Operator___Eq-Operator-Value:LTEQ
8 NCT03865875 80 81 B-Eq-Value
weeks NCT03865875 82 87 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
with NCT03865875 88 92 O
upfront NCT03865875 93 100 O
resectable NCT03865875 101 111 O
, NCT03865875 112 113 O
borderline NCT03865875 114 124 O
resectable NCT03865875 125 135 O
, NCT03865875 136 137 O
or NCT03865875 138 140 O
locally NCT03865875 141 148 O
advanced NCT03865875 149 157 O
unresectable NCT03865875 158 170 O
PDAC NCT03865875 171 175 B-Condition-Name
as NCT03865875 176 178 O
defined NCT03865875 179 186 O
by NCT03865875 187 189 O
the NCT03865875 190 193 O
National NCT03865875 194 202 O
Comprehensive NCT03865875 203 216 O
Cancer NCT03865875 217 223 O
Network NCT03865875 224 231 O
( NCT03865875 232 233 O
NCCN NCT03865875 234 238 O
) NCT03865875 239 240 O
. NCT03865875 242 243 O

- NCT03865875 247 248 O
Planning NCT03865875 250 258 O
to NCT03865875 259 261 O
undergo NCT03865875 262 269 O
TNT NCT03865875 270 273 B-Procedure-Name
at NCT03865875 274 276 O
MGH NCT03865875 277 280 B-Location___Location-Value:hospital
. NCT03865875 281 282 O

- NCT03865875 286 287 O
Planning NCT03865875 289 297 O
to NCT03865875 298 300 O
receive NCT03865875 301 308 O
modified NCT03865875 309 317 O
FOLFIRINOX NCT03865875 318 328 B-Drug-Name
for NCT03865875 329 332 O
neoadjuvant NCT03865875 333 344 O
chemotherapy NCT03865875 345 357 B-Procedure-Name
. NCT03865875 358 359 O

- NCT03865875 363 364 O
Planning NCT03865875 366 374 O
to NCT03865875 375 377 O
undergo NCT03865875 378 385 O
surgical NCT03865875 386 394 B-Procedure-Name
resection NCT03865875 395 404 I-Procedure-Name
of NCT03865875 405 407 O
PDAC NCT03865875 408 412 B-Condition-Name
at NCT03865875 413 415 O
MGH NCT03865875 416 419 B-Location___Location-Value:hospital
. NCT03865875 420 421 O

- NCT03865875 425 426 O
Verbal NCT03865875 428 434 O
fluency NCT03865875 435 442 O
in NCT03865875 443 445 O
English NCT03865875 446 453 B-Language
. NCT03865875 454 455 O

Exclusion NCT03865875 457 466 O
Criteria NCT03865875 467 475 O

- NCT03865875 478 479 O
Metastatic NCT03865875 481 491 B-Condition-Name
disease NCT03865875 492 499 I-Condition-Name
. NCT03865875 500 501 O

- NCT03865875 505 506 O
Previous NCT03865875 508 516 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03865875 517 526 O
for NCT03865875 527 530 O
pancreas NCT03865875 531 539 O
adenocarcinoma NCT03865875 540 554 B-Condition-Name
and NCT03865875 555 558 O
no NCT03865875 559 561 O
prior NCT03865875 562 567 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
therapy NCT03865875 568 575 B-Procedure-Name
for NCT03865875 576 579 O
any NCT03865875 580 583 O
cancer NCT03865875 584 590 B-Condition-Name
within NCT03865875 591 597 B-Eq-Operator___Eq-Operator-Value:LTEQ
5 NCT03865875 599 600 B-Eq-Value
years NCT03865875 601 606 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03865875 607 608 O

- NCT03865875 612 613 O
Known NCT03865875 615 620 O
history NCT03865875 621 628 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865875 629 631 O
cognitive NCT03865875 632 641 O
or NCT03865875 642 644 O
psychologic NCT03865875 645 656 O
impairment NCT03865875 657 667 B-Condition-Name
. NCT03865875 668 669 O

- NCT03865875 673 674 O
Known NCT03865875 676 681 O
history NCT03865875 682 689 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865875 690 692 O
physical NCT03865875 693 701 B-Condition-Name
impairment NCT03865875 702 712 I-Condition-Name
such NCT03865875 713 717 O
as NCT03865875 718 720 O
immobility NCT03865875 721 731 B-Condition-Name
, NCT03865875 732 733 O
use NCT03865875 734 737 O
of NCT03865875 738 740 O
walking NCT03865875 741 748 B-Procedure-Name
aids NCT03865875 749 753 I-Procedure-Name
, NCT03865875 754 755 O
or NCT03865875 756 758 O
required NCT03865875 759 767 O
wheelchair NCT03865875 768 778 B-Procedure-Name
use NCT03865875 779 782 I-Procedure-Name
. NCT03865875 783 784 O

- NCT03865875 788 789 O
Known NCT03865875 791 796 O
history NCT03865875 797 804 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865875 805 807 O
the NCT03865875 808 811 O
following NCT03865875 812 821 O
orthopedic NCT03865875 822 832 B-Condition-Name
comorbidities NCT03865875 833 846 I-Condition-Name
: NCT03865875 847 848 O
advanced NCT03865875 849 857 B-Severity___Severity-Value:severe
osteoarthritis NCT03865875 858 872 B-Condition-Name
or NCT03865875 873 875 O
rheumatoid NCT03865875 876 886 O
arthritis NCT03865875 887 896 B-Condition-Name
, NCT03865875 897 898 O
mobility NCT03865875 899 907 O
- NCT03865875 908 909 O
limiting NCT03865875 910 918 O
amputations NCT03865875 919 930 B-Condition-Name
, NCT03865875 931 932 O
orthopedic NCT03865875 933 943 O
injuries NCT03865875 944 952 B-Condition-Name
, NCT03865875 953 954 O
or NCT03865875 955 957 O
widespread NCT03865875 958 968 B-Severity___Severity-Value:severe
chronic NCT03865875 969 976 O
pain NCT03865875 977 981 B-Condition-Name
( NCT03865875 982 983 O
e NCT03865875 984 985 O
. NCT03865875 986 987 O
g NCT03865875 988 989 O
. NCT03865875 990 991 O
fibromyalgia NCT03865875 993 1005 B-Condition-Name
) NCT03865875 1006 1007 O
. NCT03865875 1009 1010 O

- NCT03865875 1014 1015 O
Known NCT03865875 1017 1022 O
history NCT03865875 1023 1030 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865875 1031 1033 O
the NCT03865875 1034 1037 O
following NCT03865875 1038 1047 O
pulmonary NCT03865875 1048 1057 O
comorbidities NCT03865875 1058 1071 B-Condition-Name
: NCT03865875 1072 1073 O
severe NCT03865875 1074 1080 B-Severity___Severity-Value:severe
chronic NCT03865875 1081 1088 O
obstructive NCT03865875 1089 1100 B-Condition-Name
pulmonary NCT03865875 1101 1110 I-Condition-Name
disease NCT03865875 1111 1118 I-Condition-Name
( NCT03865875 1119 1120 O
COPD NCT03865875 1121 1125 B-Condition-Name
) NCT03865875 1126 1127 O
defined NCT03865875 1128 1135 O
as NCT03865875 1136 1138 O
FEV NCT03865875 1139 1142 B-Observation-Name___Observation-Type-Value:lab
1 NCT03865875 1143 1144 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03865875 1145 1146 B-Eq-Operator___Eq-Operator-Value:LTEQ
50 NCT03865875 1148 1150 B-Eq-Value
% NCT03865875 1151 1152 B-Eq-Unit
, NCT03865875 1154 1155 O
emphysema NCT03865875 1156 1165 B-Condition-Name
, NCT03865875 1166 1167 O
interstitial NCT03865875 1168 1180 B-Condition-Name
lung NCT03865875 1181 1185 I-Condition-Name
disease NCT03865875 1186 1193 I-Condition-Name
, NCT03865875 1194 1195 O
and NCT03865875 1196 1199 O
/ NCT03865875 1200 1201 O
or NCT03865875 1202 1204 O
use NCT03865875 1205 1208 O
of NCT03865875 1209 1211 O
supplemental NCT03865875 1212 1224 B-Procedure-Name
oxygen NCT03865875 1225 1231 I-Procedure-Name
. NCT03865875 1232 1233 O

- NCT03865875 1237 1238 O
Known NCT03865875 1240 1245 O
history NCT03865875 1246 1253 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865875 1254 1256 O
the NCT03865875 1257 1260 O
following NCT03865875 1261 1270 O
cardiovascular NCT03865875 1271 1285 B-Condition-Name
comorbidities NCT03865875 1286 1299 I-Condition-Name
: NCT03865875 1300 1301 O
uncontrolled NCT03865875 1302 1314 O
hypertension NCT03865875 1315 1327 B-Condition-Name
, NCT03865875 1328 1329 O
severe NCT03865875 1330 1336 B-Severity___Severity-Value:severe
congestive NCT03865875 1337 1347 B-Condition-Name
heart NCT03865875 1348 1353 I-Condition-Name
failure NCT03865875 1354 1361 I-Condition-Name
( NCT03865875 1362 1363 O
NYHA NCT03865875 1364 1368 B-Condition-Name
Class NCT03865875 1369 1374 B-Eq-Unit
IV NCT03865875 1375 1377 B-Eq-Value
) NCT03865875 1378 1379 O
, NCT03865875 1381 1382 O
and NCT03865875 1383 1386 O
/ NCT03865875 1387 1388 O
or NCT03865875 1389 1391 O
myocardial NCT03865875 1392 1402 B-Condition-Name
infarction NCT03865875 1403 1413 I-Condition-Name
within NCT03865875 1414 1420 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865875 1421 1424 O
last NCT03865875 1425 1429 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03865875 1431 1432 B-Eq-Value
months NCT03865875 1433 1439 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03865875 1440 1441 O

- NCT03865875 1445 1446 O
Inability NCT03865875 1448 1457 O
to NCT03865875 1458 1460 O
tolerate NCT03865875 1461 1469 O
diet NCT03865875 1470 1474 B-Observation-Name___Observation-Type-Value:social-habit
through NCT03865875 1475 1482 O
routine NCT03865875 1483 1490 O
oral NCT03865875 1491 1495 O
routes NCT03865875 1496 1502 O
and NCT03865875 1503 1506 O
/ NCT03865875 1507 1508 O
or NCT03865875 1509 1511 O
patients NCT03865875 1512 1520 O
with NCT03865875 1521 1525 O
strict NCT03865875 1526 1532 O
nutritional NCT03865875 1533 1544 B-Condition-Name
restrictions NCT03865875 1545 1557 I-Condition-Name
, NCT03865875 1558 1559 O
allergies NCT03865875 1560 1569 O
, NCT03865875 1570 1571 O
and NCT03865875 1572 1575 O
/ NCT03865875 1576 1577 O
or NCT03865875 1578 1580 O
dietary NCT03865875 1581 1588 B-Observation-Name___Observation-Type-Value:social-habit
preferences NCT03865875 1589 1600 I-Observation-Name___Observation-Type-Value:social-habit
. NCT03865875 1601 1602 O

Inclusion NCT03860064 0 9 O
Criteria NCT03860064 10 18 O
: NCT03860064 19 20 O

- NCT03860064 24 25 O
18 NCT03860064 28 30 B-Eq-Value
- NCT03860064 31 32 B-Eq-Operator___Eq-Operator-Value:BETWEEN
35 NCT03860064 34 36 B-Eq-Value
- NCT03860064 37 38 O
year NCT03860064 39 43 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
- NCT03860064 44 45 O
old NCT03860064 46 49 O
women NCT03860064 50 55 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03860064 58 59 O
BMI NCT03860064 61 64 B-Observation-Name___Observation-Type-Value:vital
: NCT03860064 65 66 O
> NCT03860064 67 68 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03860064 70 72 B-Eq-Value
and NCT03860064 73 76 O
< NCT03860064 77 78 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03860064 80 82 B-Eq-Value
kg NCT03860064 83 85 B-Eq-Unit
/ NCT03860064 86 87 O
m NCT03860064 88 89 B-Eq-Unit
2 NCT03860064 90 91 I-Eq-Unit

- NCT03860064 94 95 O
Normal NCT03860064 97 103 B-Polarity___Polarity-Value:normal
female NCT03860064 104 110 O
karyotype NCT03860064 111 120 B-Condition-Name

- NCT03860064 123 124 O
Normal NCT03860064 126 132 B-Polarity___Polarity-Value:normal
uterus NCT03860064 133 139 B-Condition-Name
and NCT03860064 140 143 O
ovaries NCT03860064 144 151 B-Condition-Name
at NCT03860064 152 154 O
transvaginal NCT03860064 155 167 B-Procedure-Name
ultrasound NCT03860064 168 178 I-Procedure-Name

Exclusion NCT03860064 179 188 O
Criteria NCT03860064 189 197 O
: NCT03860064 198 199 O

- NCT03860064 203 204 O
> NCT03860064 206 207 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03860064 209 211 B-Eq-Value
years NCT03860064 212 217 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03860064 220 221 O
PCO NCT03860064 223 226 B-Condition-Name
syndrome NCT03860064 227 235 I-Condition-Name
carriers NCT03860064 236 244 O

- NCT03860064 247 248 O
Null NCT03860064 250 254 O
follicle NCT03860064 255 263 B-Condition-Name
aspiration NCT03860064 264 274 I-Condition-Name

- NCT03860064 277 278 O
History NCT03860064 280 287 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860064 288 290 O
chemotherapy NCT03860064 291 303 B-Procedure-Name
or NCT03860064 304 306 O
radiotherapy NCT03860064 307 319 B-Procedure-Name

Inclusion NCT03865108 0 9 O
Criteria NCT03865108 10 18 O
: NCT03865108 19 20 O

- NCT03865108 24 25 O
Singleton NCT03865108 27 36 O
gestation NCT03865108 37 46 B-Condition-Name
. NCT03865108 47 48 O

- NCT03865108 57 58 O
Twin NCT03865108 60 64 O
gestation NCT03865108 65 74 B-Condition-Name
reduced NCT03865108 75 82 B-Stability___Stability-Value:change
to NCT03865108 83 85 I-Stability___Stability-Value:change
singleton NCT03865108 86 95 O
either NCT03865108 96 102 O
spontaneously NCT03865108 103 116 O
or NCT03865108 117 119 O
therapeutically NCT03865108 120 135 B-Procedure-Name
, NCT03865108 136 137 O
is NCT03865108 138 140 O
not NCT03865108 141 144 O
eligible NCT03865108 145 153 O
unless NCT03865108 154 160 O
the NCT03865108 161 164 O
reduction NCT03865108 165 174 O
occurred NCT03865108 175 183 O
before NCT03865108 184 190 O
13 NCT03865108 192 194 B-Eq-Value
weeks NCT03865108 195 200 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
6 NCT03865108 202 203 B-Eq-Value
days NCT03865108 204 208 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
project NCT03865108 209 216 O
gestational NCT03865108 217 228 B-Observation-Name___Observation-Type-Value:measurement
age NCT03865108 229 232 I-Observation-Name___Observation-Type-Value:measurement
. NCT03865108 233 234 O

- NCT03865108 243 244 O
Higher NCT03865108 246 252 O
order NCT03865108 253 258 O
multifetal NCT03865108 259 269 O
gestations NCT03865108 270 280 B-Condition-Name
reduced NCT03865108 281 288 B-Stability___Stability-Value:change
to NCT03865108 289 291 I-Stability___Stability-Value:change
singletons NCT03865108 292 302 O
are NCT03865108 303 306 O
not NCT03865108 307 310 O
eligible NCT03865108 311 319 O
. NCT03865108 320 321 O

- NCT03865108 325 326 O
Gestational NCT03865108 328 339 B-Observation-Name___Observation-Type-Value:measurement
age NCT03865108 340 343 I-Observation-Name___Observation-Type-Value:measurement
at NCT03865108 344 346 O
randomization NCT03865108 347 360 O
between NCT03865108 361 368 B-Eq-Operator___Eq-Operator-Value:BETWEEN
16 NCT03865108 370 372 B-Eq-Value
weeks NCT03865108 373 378 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
0 NCT03865108 380 381 B-Eq-Value
days NCT03865108 382 386 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
and NCT03865108 387 390 O
23 NCT03865108 392 394 B-Eq-Value
weeks NCT03865108 395 400 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
6 NCT03865108 402 403 B-Eq-Value
days NCT03865108 404 408 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
based NCT03865108 409 414 O
on NCT03865108 415 417 O
clinical NCT03865108 418 426 O
information NCT03865108 427 438 O
and NCT03865108 439 442 O
evaluation NCT03865108 443 453 O
of NCT03865108 454 456 O
the NCT03865108 457 460 O
earliest NCT03865108 461 469 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
ultrasound NCT03865108 470 480 B-Procedure-Name
as NCT03865108 481 483 O
described NCT03865108 484 493 O
in NCT03865108 494 496 O
Gestational NCT03865108 497 508 B-Observation-Name___Observation-Type-Value:measurement
Age NCT03865108 509 512 I-Observation-Name___Observation-Type-Value:measurement
. NCT03865108 513 514 O

- NCT03865108 518 519 O
Cervical NCT03865108 521 529 B-Observation-Name___Observation-Type-Value:measurement
length NCT03865108 530 536 I-Observation-Name___Observation-Type-Value:measurement
on NCT03865108 537 539 O
transvaginal NCT03865108 540 552 B-Procedure-Name
examination NCT03865108 553 564 I-Procedure-Name
of NCT03865108 565 567 O
less NCT03865108 568 572 B-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03865108 573 577 I-Eq-Operator___Eq-Operator-Value:LTEQ
or NCT03865108 578 580 I-Eq-Operator___Eq-Operator-Value:LTEQ
equal NCT03865108 581 586 I-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03865108 587 589 O
20 NCT03865108 591 593 B-Eq-Value
mm NCT03865108 594 596 B-Eq-Unit
within NCT03865108 597 603 B-Eq-Operator___Eq-Operator-Value:LTEQ
10 NCT03865108 605 607 B-Eq-Value
days NCT03865108 608 612 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03865108 613 618 O
to NCT03865108 619 621 O
randomization NCT03865108 622 635 O
by NCT03865108 636 638 O
a NCT03865108 639 640 O
study NCT03865108 641 646 O
certified NCT03865108 647 656 O
sonographer NCT03865108 657 668 B-Provider-Role
. NCT03865108 669 670 O
There NCT03865108 672 677 O
is NCT03865108 678 680 O
no NCT03865108 681 683 O
lower NCT03865108 684 689 O
cervical NCT03865108 690 698 B-Observation-Name___Observation-Type-Value:measurement
length NCT03865108 699 705 I-Observation-Name___Observation-Type-Value:measurement
threshold NCT03865108 706 715 O
. NCT03865108 716 717 O

Exclusion NCT03865108 719 728 O
Criteria NCT03865108 729 737 O
: NCT03865108 738 739 O

- NCT03865108 743 744 O
Women NCT03865108 746 751 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03865108 752 755 O
are NCT03865108 756 759 O
ineligible NCT03865108 760 770 O
for NCT03865108 771 774 O
the NCT03865108 775 778 O
TOPS NCT03865108 779 783 O
trial NCT03865108 784 789 O
. NCT03865108 790 791 O

Inclusion NCT03865134 0 9 O
Criteria NCT03865134 10 18 O
: NCT03865134 19 20 O

- NCT03865134 24 25 O
Age NCT03865134 27 30 O
range NCT03865134 31 36 O
between NCT03865134 37 44 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03865134 46 47 B-Eq-Value
- NCT03865134 48 49 B-Eq-Operator___Eq-Operator-Value:BETWEEN
6 NCT03865134 51 52 B-Eq-Value
years NCT03865134 53 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865134 59 61 O
age NCT03865134 62 65 O

- NCT03865134 68 69 O
Gestational NCT03865134 71 82 B-Observation-Name___Observation-Type-Value:measurement
age NCT03865134 83 86 I-Observation-Name___Observation-Type-Value:measurement
range NCT03865134 87 92 O
26 NCT03865134 94 96 B-Eq-Value
- NCT03865134 97 98 B-Eq-Operator___Eq-Operator-Value:BETWEEN
34 NCT03865134 100 102 B-Eq-Value
. NCT03865134 102 103 O
be NCT03865134 105 107 O
between NCT03865134 108 115 B-Eq-Operator___Eq-Operator-Value:BETWEEN
weeks NCT03865134 116 121 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03865134 124 125 O
To NCT03865134 127 129 O
be NCT03865134 130 132 O
diagnosed NCT03865134 133 142 O
with NCT03865134 143 147 O
retinopathy NCT03865134 148 159 B-Condition-Name
of NCT03865134 160 162 I-Condition-Name
prematurity NCT03865134 163 174 I-Condition-Name

- NCT03865134 177 178 O
Neurological NCT03865134 180 192 O
, NCT03865134 193 194 O
hereditary NCT03865134 195 205 O
and NCT03865134 206 209 O
not NCT03865134 210 213 O
having NCT03865134 214 220 O
metabolic NCT03865134 221 230 O
disease NCT03865134 231 238 B-Condition-Name

- NCT03865134 241 242 O
Compliance NCT03865134 244 254 O
with NCT03865134 255 259 O
visual NCT03865134 260 266 B-Procedure-Name
examinations NCT03865134 267 279 I-Procedure-Name
and NCT03865134 280 283 O
physiotherapy NCT03865134 284 297 B-Procedure-Name
evaluations NCT03865134 298 309 I-Procedure-Name

- NCT03865134 312 313 O
To NCT03865134 315 317 O
be NCT03865134 318 320 O
children NCT03865134 321 329 O
and NCT03865134 330 333 O
parents NCT03865134 334 341 O
who NCT03865134 342 345 O
agree NCT03865134 346 351 O
to NCT03865134 352 354 O
participate NCT03865134 355 366 O
in NCT03865134 367 369 O
the NCT03865134 370 373 O
study NCT03865134 374 379 O

Exclusion NCT03865134 380 389 O
Criteria NCT03865134 390 398 O
: NCT03865134 399 400 O

- NCT03865134 404 405 O
To NCT03865134 407 409 O
be NCT03865134 410 412 O
a NCT03865134 413 414 O
child NCT03865134 415 420 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
who NCT03865134 421 424 O
does NCT03865134 425 429 O
not NCT03865134 430 433 O
comply NCT03865134 434 440 O
with NCT03865134 441 445 O
Optical NCT03865134 446 453 B-Procedure-Name
Kohlerans NCT03865134 454 463 I-Procedure-Name
Tomography NCT03865134 464 474 I-Procedure-Name
( NCT03865134 475 476 O
OCT NCT03865134 477 480 B-Procedure-Name
) NCT03865134 481 482 O

- NCT03865134 486 487 O
Not NCT03865134 489 492 O
participating NCT03865134 493 506 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03865134 507 509 O
one NCT03865134 510 513 B-Eq-Value
or NCT03865134 514 516 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03865134 517 521 I-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03865134 522 524 O
the NCT03865134 525 528 O
eye NCT03865134 529 532 B-Procedure-Name
examination NCT03865134 533 544 I-Procedure-Name
or NCT03865134 545 547 O
physiotherapy NCT03865134 548 561 B-Procedure-Name
assessments NCT03865134 562 573 I-Procedure-Name

- NCT03865134 576 577 O
Being NCT03865134 579 584 O
children NCT03865134 585 593 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
and NCT03865134 594 597 O
parents NCT03865134 598 605 O
who NCT03865134 606 609 O
do NCT03865134 610 612 O
not NCT03865134 613 616 O
agree NCT03865134 617 622 O
to NCT03865134 623 625 O
participate NCT03865134 626 637 O
in NCT03865134 638 640 O
the NCT03865134 641 644 O
study NCT03865134 645 650 O

Inclusion NCT03863223 0 9 O
Criteria NCT03863223 10 18 O
: NCT03863223 19 20 O

1 NCT03863223 25 26 O
. NCT03863223 26 27 O
HER NCT03863223 29 32 O
2 NCT03863223 33 34 O
positive NCT03863223 35 43 B-Polarity___Polarity-Value:positive
recurrent NCT03863223 44 53 O
or NCT03863223 54 56 O
metastasis NCT03863223 57 67 O
breast NCT03863223 68 74 O
cancer NCT03863223 75 81 B-Condition-Name
. NCT03863223 82 83 O

2 NCT03863223 88 89 O
. NCT03863223 89 90 O
Patients NCT03863223 92 100 O
with NCT03863223 101 105 O
measurable NCT03863223 106 116 O
disease NCT03863223 117 124 B-Condition-Name
are NCT03863223 125 128 O
eligible NCT03863223 129 137 O
. NCT03863223 138 139 O

3 NCT03863223 144 145 O
. NCT03863223 145 146 O
Eastern NCT03863223 148 155 B-Observation-Name___Observation-Type-Value:clinical-score
Cooperative NCT03863223 156 167 I-Observation-Name___Observation-Type-Value:clinical-score
Oncology NCT03863223 168 176 I-Observation-Name___Observation-Type-Value:clinical-score
Group NCT03863223 177 182 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03863223 183 184 O
ECOG NCT03863223 185 189 B-Observation-Name
) NCT03863223 190 191 O
performance NCT03863223 192 203 O
status NCT03863223 204 210 O
0 NCT03863223 212 213 B-Eq-Value
or NCT03863223 214 216 O
1 NCT03863223 218 219 B-Eq-Value
. NCT03863223 219 220 O

4 NCT03863223 225 226 O
. NCT03863223 226 227 O
Adequate NCT03863223 229 237 B-Polarity___Polarity-Value:normal
organ NCT03863223 238 243 B-Condition-Name
function NCT03863223 244 252 I-Condition-Name
. NCT03863223 253 254 O

5 NCT03863223 259 260 O
. NCT03863223 260 261 O
Signed NCT03863223 263 269 O
, NCT03863223 270 271 O
written NCT03863223 272 279 O
inform NCT03863223 280 286 O
consent NCT03863223 287 294 O
obtained NCT03863223 295 303 O
prior NCT03863223 304 309 O
to NCT03863223 310 312 O
any NCT03863223 313 316 O
study NCT03863223 317 322 O
procedure NCT03863223 323 332 O
. NCT03863223 333 334 O

Exclusion NCT03863223 336 345 O
Criteria NCT03863223 346 354 O
: NCT03863223 355 356 O

1 NCT03863223 361 362 O
. NCT03863223 362 363 O
History NCT03863223 365 372 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863223 373 375 O
anti NCT03863223 376 380 O
- NCT03863223 381 382 O
cancer NCT03863223 383 389 B-Condition-Name
therapy NCT03863223 390 397 B-Procedure-Name
for NCT03863223 398 401 O
MBC NCT03863223 402 405 B-Condition-Name
（ NCT03863223 406 407 O
with NCT03863223 408 412 O
the NCT03863223 413 416 O
exception NCT03863223 417 426 O
of NCT03863223 427 429 O
one NCT03863223 430 433 B-Eq-Value
prior NCT03863223 434 439 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
hormonal NCT03863223 440 448 B-Procedure-Name
regimen NCT03863223 449 456 I-Procedure-Name
for NCT03863223 457 460 O
MBC NCT03863223 461 464 B-Condition-Name
） NCT03863223 464 465 O
. NCT03863223 466 467 O

2 NCT03863223 472 473 O
. NCT03863223 473 474 O
History NCT03863223 476 483 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863223 484 486 O
HER NCT03863223 487 490 O
tyrosine NCT03863223 491 499 B-Drug-Name
kinase NCT03863223 500 506 I-Drug-Name
inhibitors NCT03863223 507 517 I-Drug-Name
or NCT03863223 518 520 O
monoclonal NCT03863223 521 531 B-Drug-Name
antibody NCT03863223 532 540 I-Drug-Name
for NCT03863223 541 544 O
breast NCT03863223 545 551 O
cancer NCT03863223 552 558 B-Condition-Name
in NCT03863223 559 561 O
any NCT03863223 562 565 O
treatment NCT03863223 566 575 O
setting NCT03863223 576 583 O
， NCT03863223 584 585 O
except NCT03863223 586 592 O
trastuzumab NCT03863223 593 604 B-Drug-Name
used NCT03863223 605 609 O
in NCT03863223 610 612 O
the NCT03863223 613 616 O
neo NCT03863223 617 620 O
- NCT03863223 621 622 O
adjuvant NCT03863223 623 631 O
or NCT03863223 632 634 O
adjuvant NCT03863223 635 643 O
setting NCT03863223 644 651 O
. NCT03863223 652 653 O

3 NCT03863223 658 659 O
. NCT03863223 659 660 O
Assessed NCT03863223 662 670 O
by NCT03863223 671 673 O
the NCT03863223 674 677 O
investigator NCT03863223 678 690 O
to NCT03863223 691 693 O
be NCT03863223 694 696 O
unable NCT03863223 697 703 O
receive NCT03863223 704 711 O
systemic NCT03863223 712 720 O
chemotherapy NCT03863223 721 733 B-Procedure-Name
. NCT03863223 734 735 O

4 NCT03863223 740 741 O
. NCT03863223 741 742 O
History NCT03863223 744 751 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863223 752 754 O
other NCT03863223 755 760 O
malignancy NCT03863223 761 771 B-Condition-Name
within NCT03863223 772 778 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863223 779 782 O
last NCT03863223 783 787 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03863223 789 790 B-Eq-Value
years NCT03863223 791 796 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
， NCT03863223 797 798 O
except NCT03863223 799 805 O
for NCT03863223 806 809 O
carcinoma NCT03863223 810 819 B-Condition-Name
in NCT03863223 820 822 O
situ NCT03863223 823 827 O
of NCT03863223 828 830 O
cervix NCT03863223 831 837 O
， NCT03863223 838 839 O
basal NCT03863223 840 845 O
cell NCT03863223 846 850 O
carcinoma NCT03863223 851 860 O
or NCT03863223 861 863 O
squamous NCT03863223 864 872 O
cell NCT03863223 873 877 O
carcinoma NCT03863223 878 887 B-Condition-Name
of NCT03863223 888 890 O
the NCT03863223 891 894 O
skin NCT03863223 895 899 O
that NCT03863223 900 904 O
has NCT03863223 905 908 O
been NCT03863223 909 913 O
previously NCT03863223 914 924 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treated NCT03863223 925 932 O
with NCT03863223 933 937 O
curative NCT03863223 938 946 O
intent NCT03863223 947 953 O
. NCT03863223 954 955 O

5 NCT03863223 960 961 O
. NCT03863223 961 962 O
Pregnant NCT03863223 964 972 B-Condition-Name
or NCT03863223 973 975 O
lactating NCT03863223 976 985 B-Condition-Name
women NCT03863223 986 991 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
， NCT03863223 992 993 O
or NCT03863223 994 996 O
for NCT03863223 997 1000 O
women NCT03863223 1001 1006 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03863223 1007 1009 O
childbearing NCT03863223 1010 1022 B-Condition-Name
potential NCT03863223 1023 1032 O
unwilling NCT03863223 1033 1042 O
to NCT03863223 1043 1045 O
use NCT03863223 1046 1049 O
a NCT03863223 1050 1051 O
highly NCT03863223 1052 1058 O
- NCT03863223 1059 1060 O
effective NCT03863223 1061 1070 O
contraception NCT03863223 1071 1084 B-Procedure-Name
during NCT03863223 1085 1091 O
of NCT03863223 1092 1094 O
the NCT03863223 1095 1098 O
study NCT03863223 1099 1104 O
treatment NCT03863223 1105 1114 O
and NCT03863223 1115 1118 O
for NCT03863223 1119 1122 O
at NCT03863223 1123 1125 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863223 1126 1131 I-Eq-Operator___Eq-Operator-Value:GTEQ
7 NCT03863223 1133 1134 B-Eq-Value
months NCT03863223 1135 1141 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03863223 1142 1147 O
the NCT03863223 1148 1151 O
last NCT03863223 1152 1156 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
dose NCT03863223 1157 1161 O
of NCT03863223 1162 1164 O
study NCT03863223 1165 1170 O
treatment NCT03863223 1171 1180 O
. NCT03863223 1181 1182 O

Inclusion NCT03867045 0 9 O
Criteria NCT03867045 10 18 O
: NCT03867045 19 20 O

Patients NCT03867045 22 30 O
> NCT03867045 31 32 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03867045 34 36 B-Eq-Value
years NCT03867045 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03867045 43 45 O
age NCT03867045 46 49 O
Patients NCT03867045 50 58 O
planning NCT03867045 59 67 O
to NCT03867045 68 70 O
start NCT03867045 71 76 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
treatment NCT03867045 77 86 O
with NCT03867045 87 91 O
cabozantinib NCT03867045 92 104 B-Procedure-Name
therapy NCT03867045 105 112 I-Procedure-Name
for NCT03867045 113 116 O
renal NCT03867045 117 122 O
cancer NCT03867045 123 129 B-Condition-Name
. NCT03867045 130 131 O

Technology NCT03867045 133 143 O
requirement NCT03867045 144 155 O
: NCT03867045 156 157 O
The NCT03867045 158 161 O
patient NCT03867045 162 169 O
will NCT03867045 170 174 O
need NCT03867045 175 179 O
to NCT03867045 180 182 O
have NCT03867045 183 187 O
home NCT03867045 188 192 O
wireless NCT03867045 193 201 O
internet NCT03867045 202 210 O
access NCT03867045 211 217 O
for NCT03867045 218 221 O
use NCT03867045 222 225 O
of NCT03867045 226 228 O
the NCT03867045 229 232 O
software NCT03867045 233 241 O
and NCT03867045 242 245 O
technology NCT03867045 246 256 O
in NCT03867045 257 259 O
this NCT03867045 260 264 O
study NCT03867045 265 270 O
. NCT03867045 271 272 O
The NCT03867045 274 277 O
patient NCT03867045 278 285 O
will NCT03867045 286 290 O
need NCT03867045 291 295 O
to NCT03867045 296 298 O
already NCT03867045 299 306 O
have NCT03867045 307 311 O
or NCT03867045 312 314 O
be NCT03867045 315 317 O
willing NCT03867045 318 325 O
to NCT03867045 326 328 O
set NCT03867045 329 332 O
up NCT03867045 333 335 O
a NCT03867045 336 337 O
Duke NCT03867045 338 342 O
MyChart NCT03867045 343 350 O
account NCT03867045 351 358 O
. NCT03867045 359 360 O

Exclusion NCT03867045 362 371 O
Criteria NCT03867045 372 380 O
: NCT03867045 381 382 O

Non NCT03867045 384 387 O
- NCT03867045 388 389 O
English NCT03867045 390 397 B-Language
Speaking NCT03867045 398 406 O
. NCT03867045 407 408 O
Any NCT03867045 410 413 O
patient NCT03867045 414 421 O
who NCT03867045 422 425 O
is NCT03867045 426 428 O
not NCT03867045 429 432 O
able NCT03867045 433 437 O
to NCT03867045 438 440 O
comprehend NCT03867045 441 451 O
and NCT03867045 452 455 O
operate NCT03867045 456 463 O
the NCT03867045 464 467 O
technology NCT03867045 468 478 O
at NCT03867045 479 481 O
the NCT03867045 482 485 O
discretion NCT03867045 486 496 O
of NCT03867045 497 499 O
the NCT03867045 500 503 O
enrolling NCT03867045 504 513 O
provider NCT03867045 514 522 O
. NCT03867045 523 524 O


Inclusion NCT03869281 0 9 O
Criteria NCT03869281 10 18 O
( NCT03869281 19 20 O
PTA NCT03869281 21 24 O
group NCT03869281 25 30 O
) NCT03869281 31 32 O

- NCT03869281 36 37 O
T NCT03869281 39 40 B-Condition-Name
1D NCT03869281 41 43 I-Condition-Name
patients NCT03869281 44 52 O
who NCT03869281 53 56 O
received NCT03869281 57 65 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
their NCT03869281 66 71 O
first NCT03869281 72 77 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
PTA NCT03869281 78 81 B-Procedure-Name
, NCT03869281 82 83 O
or NCT03869281 84 86 O
second NCT03869281 87 93 B-Eq-Value
PTA NCT03869281 94 97 B-Procedure-Name
only NCT03869281 98 102 O
if NCT03869281 103 105 O
their NCT03869281 106 111 O
first NCT03869281 112 117 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
graft NCT03869281 118 123 B-Procedure-Name
was NCT03869281 124 127 O
explanted NCT03869281 128 137 O
within NCT03869281 138 144 B-Eq-Operator___Eq-Operator-Value:LTEQ
a NCT03869281 145 146 O
week NCT03869281 147 151 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03869281 152 153 O
between NCT03869281 154 161 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03869281 163 164 B-Eq-Value
January NCT03869281 165 172 I-Eq-Value
2005 NCT03869281 174 178 I-Eq-Value
and NCT03869281 179 182 O
31 NCT03869281 184 186 B-Eq-Value
December NCT03869281 187 195 I-Eq-Value
2017 NCT03869281 197 201 I-Eq-Value

- NCT03869281 205 206 O
age NCT03869281 208 211 O
≥ NCT03869281 212 213 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03869281 215 217 B-Eq-Value
and NCT03869281 218 221 O
< NCT03869281 222 223 B-Eq-Operator___Eq-Operator-Value:LT
65 NCT03869281 225 227 B-Eq-Value
years NCT03869281 228 233 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03869281 236 237 O
willingness NCT03869281 239 250 O
to NCT03869281 251 253 O
participate NCT03869281 254 265 O
in NCT03869281 266 268 O
this NCT03869281 269 273 O
observational NCT03869281 274 287 O
study NCT03869281 288 293 O

Inclusion NCT03869281 294 303 O
Criteria NCT03869281 304 312 O
( NCT03869281 313 314 O
control NCT03869281 315 322 O
group NCT03869281 323 328 O
) NCT03869281 329 330 O

- NCT03869281 334 335 O
Type NCT03869281 337 341 O
1 NCT03869281 343 344 O
diabetes NCT03869281 345 353 B-Condition-Name

- NCT03869281 356 357 O
age NCT03869281 359 362 O
≥ NCT03869281 363 364 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03869281 366 368 B-Eq-Value
years NCT03869281 369 374 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03869281 375 378 O
< NCT03869281 379 380 B-Eq-Operator___Eq-Operator-Value:LT
65 NCT03869281 382 384 B-Eq-Value
years NCT03869281 385 390 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03869281 393 394 O
willingness NCT03869281 396 407 O
to NCT03869281 408 410 O
participate NCT03869281 411 422 O
in NCT03869281 423 425 O
this NCT03869281 426 430 O
observational NCT03869281 431 444 O
study NCT03869281 445 450 O

- NCT03869281 453 454 O
minimum NCT03869281 456 463 B-Eq-Operator___Eq-Operator-Value:GTEQ
disease NCT03869281 464 471 B-Condition-Name
duration NCT03869281 472 480 O
of NCT03869281 481 483 O
5 NCT03869281 485 486 B-Eq-Value
years NCT03869281 487 492 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03869281 495 496 O
brittle NCT03869281 498 505 B-Condition-Name
diabetes NCT03869281 506 514 I-Condition-Name
, NCT03869281 515 516 O
as NCT03869281 517 519 O
defined NCT03869281 520 527 O
by NCT03869281 528 530 O
the NCT03869281 531 534 O
occurrence NCT03869281 535 545 O
of NCT03869281 546 548 O
frequent NCT03869281 549 557 O
acute NCT03869281 558 563 B-Severity___Severity-Value:severe
complications NCT03869281 564 577 B-Condition-Name
( NCT03869281 578 579 O
ketoacidosis NCT03869281 580 592 B-Condition-Name
or NCT03869281 593 595 O
severe NCT03869281 596 602 B-Severity___Severity-Value:severe
hypoglycaemic NCT03869281 603 616 B-Condition-Name
episodes NCT03869281 617 625 O
requiring NCT03869281 626 635 O
third NCT03869281 636 641 B-Procedure-Name
- NCT03869281 642 643 I-Procedure-Name
part NCT03869281 644 648 I-Procedure-Name
assistance NCT03869281 649 659 I-Procedure-Name
or NCT03869281 660 662 O
unawareness NCT03869281 663 674 B-Condition-Name
despite NCT03869281 675 682 O
well NCT03869281 683 687 O
- NCT03869281 688 689 O
conducted NCT03869281 690 699 O
intensive NCT03869281 700 709 O
insulin NCT03869281 710 717 B-Procedure-Name
therapy NCT03869281 718 725 I-Procedure-Name
) NCT03869281 726 727 O

- NCT03869281 731 732 O
presence NCT03869281 734 742 O
of NCT03869281 743 745 O
at NCT03869281 746 748 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869281 749 754 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03869281 755 758 B-Eq-Value
diabetes NCT03869281 759 767 B-Condition-Name
- NCT03869281 768 769 O
related NCT03869281 770 777 O
complication NCT03869281 778 790 B-Condition-Name
( NCT03869281 791 792 O
either NCT03869281 793 799 O
neuropathy NCT03869281 800 810 B-Condition-Name
, NCT03869281 811 812 O
retinopathy NCT03869281 813 824 B-Condition-Name
, NCT03869281 825 826 O
subclinical NCT03869281 827 838 O
nephropathy NCT03869281 839 850 B-Condition-Name
) NCT03869281 851 852 O
. NCT03869281 854 855 O

Exclusion NCT03869281 857 866 O
Criteria NCT03869281 867 875 O
( NCT03869281 876 877 O
both NCT03869281 878 882 O
groups NCT03869281 883 889 O
) NCT03869281 890 891 O

- NCT03869281 895 896 O
conditions NCT03869281 898 908 O
other NCT03869281 909 914 O
than NCT03869281 915 919 O
T NCT03869281 920 921 B-Condition-Name
1D NCT03869281 922 924 I-Condition-Name
known NCT03869281 925 930 O
to NCT03869281 931 933 O
affect NCT03869281 934 940 B-Stability___Stability-Value:change
bone NCT03869281 941 945 B-Condition-Name
health NCT03869281 946 952 I-Condition-Name
( NCT03869281 953 954 O
i NCT03869281 955 956 O
. NCT03869281 957 958 O
e NCT03869281 959 960 O
. NCT03869281 961 962 O
, NCT03869281 963 964 O
non NCT03869281 965 968 O
- NCT03869281 969 970 O
compensated NCT03869281 971 982 O
hypothyroidism NCT03869281 983 997 B-Condition-Name
, NCT03869281 998 999 O
hyperthyroidism NCT03869281 1000 1015 B-Condition-Name
, NCT03869281 1016 1017 O
hyperparathyroidism NCT03869281 1018 1037 B-Condition-Name
, NCT03869281 1038 1039 O
inflammatory NCT03869281 1040 1052 B-Condition-Name
bowel NCT03869281 1053 1058 I-Condition-Name
disease NCT03869281 1059 1066 I-Condition-Name
, NCT03869281 1067 1068 O
malignancy NCT03869281 1069 1079 B-Condition-Name
, NCT03869281 1080 1081 O
rheumatoid NCT03869281 1082 1092 B-Condition-Name
arthritis NCT03869281 1093 1102 I-Condition-Name
, NCT03869281 1103 1104 O
hypogonadism NCT03869281 1105 1117 B-Condition-Name
, NCT03869281 1118 1119 O
severe NCT03869281 1120 1126 B-Severity___Severity-Value:severe
chronic NCT03869281 1127 1134 O
obstructive NCT03869281 1135 1146 B-Condition-Name
pulmonary NCT03869281 1147 1156 I-Condition-Name
disease NCT03869281 1157 1164 I-Condition-Name
, NCT03869281 1165 1166 O
hepatic NCT03869281 1167 1174 B-Condition-Name
insufficiency NCT03869281 1175 1188 I-Condition-Name
, NCT03869281 1189 1190 O
alcohol NCT03869281 1191 1198 B-Observation-Name___Observation-Type-Value:social-habit
intake NCT03869281 1199 1205 I-Observation-Name___Observation-Type-Value:social-habit
≥ NCT03869281 1206 1207 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03869281 1209 1210 B-Eq-Value
units NCT03869281 1211 1216 B-Eq-Unit
/ NCT03869281 1217 1218 O
day NCT03869281 1219 1222 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03869281 1223 1224 O
, NCT03869281 1226 1227 O

- NCT03869281 1231 1232 O
use NCT03869281 1234 1237 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03869281 1238 1240 O
drugs NCT03869281 1241 1246 O
that NCT03869281 1247 1251 O
can NCT03869281 1252 1255 O
affect NCT03869281 1256 1262 B-Stability___Stability-Value:change
bone NCT03869281 1263 1267 B-Condition-Name
metabolism NCT03869281 1268 1278 I-Condition-Name
( NCT03869281 1279 1280 O
e NCT03869281 1281 1282 O
. NCT03869281 1283 1284 O
g NCT03869281 1285 1286 O
. NCT03869281 1287 1288 O
, NCT03869281 1289 1290 O
bisphosphonates NCT03869281 1291 1306 B-Drug-Name
, NCT03869281 1307 1308 O
anticonvulsants NCT03869281 1309 1324 B-Drug-Name
, NCT03869281 1325 1326 O
hormone NCT03869281 1327 1334 B-Procedure-Name
replacement NCT03869281 1335 1346 I-Procedure-Name
therapy NCT03869281 1347 1354 I-Procedure-Name
) NCT03869281 1355 1356 O
other NCT03869281 1357 1362 O
than NCT03869281 1363 1367 O
glucocorticoids NCT03869281 1368 1383 B-Drug-Name
and NCT03869281 1384 1387 O
immunosuppressants NCT03869281 1388 1406 B-Drug-Name

- NCT03869281 1409 1410 O
recipients NCT03869281 1412 1422 O
of NCT03869281 1423 1425 O
simultaneous NCT03869281 1426 1438 O
pancreas NCT03869281 1439 1447 B-Procedure-Name
kidney NCT03869281 1448 1454 I-Procedure-Name
transplantation NCT03869281 1455 1470 I-Procedure-Name
, NCT03869281 1471 1472 O
pancreatic NCT03869281 1473 1483 B-Procedure-Name
islet NCT03869281 1484 1489 I-Procedure-Name
transplantation NCT03869281 1490 1505 I-Procedure-Name
, NCT03869281 1506 1507 O
multiple NCT03869281 1508 1516 O
PTAs NCT03869281 1517 1521 B-Procedure-Name
, NCT03869281 1522 1523 O
other NCT03869281 1524 1529 O
transplants NCT03869281 1530 1541 B-Procedure-Name

- NCT03869281 1544 1545 O
BMI NCT03869281 1547 1550 B-Observation-Name___Observation-Type-Value:vital
< NCT03869281 1551 1552 B-Eq-Operator___Eq-Operator-Value:LT
18.5 NCT03869281 1554 1558 B-Eq-Value
or NCT03869281 1559 1561 O
≥ NCT03869281 1562 1563 B-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03869281 1565 1567 B-Eq-Value
kg NCT03869281 1568 1570 B-Eq-Unit
/ NCT03869281 1571 1572 O
m NCT03869281 1573 1574 B-Eq-Unit
2 NCT03869281 1575 1576 I-Eq-Unit

Inclusion NCT03866824 0 9 O
Criteria NCT03866824 10 18 O
: NCT03866824 19 20 O

Men NCT03866824 22 25 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03866824 26 29 O
women NCT03866824 30 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
aged NCT03866824 36 40 O
20 NCT03866824 42 44 B-Eq-Value
to NCT03866824 45 47 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03866824 49 51 B-Eq-Value

- NCT03866824 55 56 O
MDD NCT03866824 58 61 B-Condition-Name
diagnosis NCT03866824 62 71 O
objected NCT03866824 72 80 O
to NCT03866824 81 83 O
MRI NCT03866824 84 87 B-Procedure-Name
( NCT03866824 88 89 O
grade NCT03866824 90 95 B-Eq-Unit
II NCT03866824 96 98 B-Eq-Value
/ NCT03866824 99 100 O
III NCT03866824 101 104 B-Eq-Value
) NCT03866824 105 106 O

- NCT03866824 110 111 O
Joint NCT03866824 113 118 O
pain NCT03866824 119 123 B-Condition-Name
for NCT03866824 124 127 O
more NCT03866824 128 132 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866824 133 137 I-Eq-Operator___Eq-Operator-Value:GT
3 NCT03866824 139 140 B-Eq-Value
month NCT03866824 141 146 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03866824 149 150 O
Absence NCT03866824 152 159 O
of NCT03866824 160 162 O
bone NCT03866824 163 167 O
lesion NCT03866824 168 174 B-Condition-Name
or NCT03866824 175 177 O
moderate NCT03866824 178 186 B-Severity___Severity-Value:moderate
knee NCT03866824 187 191 O
osteoarthritis NCT03866824 192 206 B-Condition-Name
stage NCT03866824 207 212 B-Eq-Unit
< NCT03866824 213 214 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03866824 216 217 B-Eq-Value
on NCT03866824 218 220 O
the NCT03866824 221 224 O
Kellgren NCT03866824 225 233 B-Observation-Name___Observation-Type-Value:clinical-score
Laurence NCT03866824 234 242 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03866824 243 248 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03866824 249 250 O
objectified NCT03866824 251 262 O
on NCT03866824 263 265 O
radiography NCT03866824 266 277 B-Procedure-Name
in NCT03866824 278 280 O
schuss NCT03866824 281 287 O
) NCT03866824 288 289 O
in NCT03866824 290 292 O
the NCT03866824 293 296 O
6 NCT03866824 298 299 B-Eq-Value
months NCT03866824 300 306 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03866824 307 312 O
to NCT03866824 313 315 O
inclusion NCT03866824 316 325 O

- NCT03866824 328 329 O
Axial NCT03866824 331 336 B-Condition-Name
deformity NCT03866824 337 346 I-Condition-Name
of NCT03866824 347 349 O
the NCT03866824 350 353 O
lower NCT03866824 354 359 O
limbs NCT03866824 360 365 O
less NCT03866824 366 370 B-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03866824 371 375 I-Eq-Operator___Eq-Operator-Value:LTEQ
or NCT03866824 376 378 I-Eq-Operator___Eq-Operator-Value:LTEQ
equal NCT03866824 379 384 I-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03866824 385 387 O
5 NCT03866824 389 390 B-Eq-Value
° NCT03866824 391 392 B-Eq-Unit

- NCT03866824 395 396 O
Signed NCT03866824 398 404 O
consent NCT03866824 405 412 O
signed NCT03866824 413 419 O
by NCT03866824 420 422 O
the NCT03866824 423 426 O
patient NCT03866824 427 434 O

- NCT03866824 437 438 O
Ability NCT03866824 440 447 O
to NCT03866824 448 450 O
perform NCT03866824 451 458 O
procedures NCT03866824 459 469 O
as NCT03866824 470 472 O
part NCT03866824 473 477 O
of NCT03866824 478 480 O
the NCT03866824 481 484 O
follow NCT03866824 485 491 O
- NCT03866824 492 493 O
up NCT03866824 494 496 O
( NCT03866824 497 498 O
walk NCT03866824 499 503 B-Observation-Name___Observation-Type-Value:social-habit
50 NCT03866824 505 507 B-Eq-Value
steps NCT03866824 508 513 B-Eq-Unit
on NCT03866824 514 516 O
a NCT03866824 517 518 O
flat NCT03866824 519 523 O
surface NCT03866824 524 531 O
and NCT03866824 532 535 O
up NCT03866824 536 538 O
/ NCT03866824 539 540 O
down NCT03866824 541 545 O
stairs NCT03866824 546 552 O
) NCT03866824 553 554 O
. NCT03866824 556 557 O

- NCT03866824 561 562 O
Be NCT03866824 564 566 O
affiliated NCT03866824 567 577 O
to NCT03866824 578 580 O
a NCT03866824 581 582 O
health NCT03866824 583 589 O
insurance NCT03866824 590 599 O
scheme NCT03866824 600 606 O

Exclusion NCT03866824 607 616 O
Criteria NCT03866824 617 625 O
: NCT03866824 626 627 O

- NCT03866824 631 632 O
Axial NCT03866824 634 639 B-Condition-Name
deformity NCT03866824 640 649 I-Condition-Name
> NCT03866824 650 651 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03866824 653 654 B-Eq-Value
° NCT03866824 655 656 B-Eq-Unit

- NCT03866824 659 660 O
Ligament NCT03866824 662 670 B-Condition-Name
instability NCT03866824 671 682 I-Condition-Name

- NCT03866824 685 686 O
Major NCT03866824 688 693 B-Severity___Severity-Value:severe
injuries NCT03866824 694 702 B-Condition-Name
or NCT03866824 703 705 O
surgery NCT03866824 706 713 B-Procedure-Name
of NCT03866824 714 716 O
the NCT03866824 717 720 O
target NCT03866824 721 727 O
knee NCT03866824 728 732 O
or NCT03866824 733 735 O
lateral NCT03866824 736 743 O
contralateral NCT03866824 744 757 O
knee NCT03866824 758 762 O
in NCT03866824 763 765 O
the NCT03866824 766 769 O
12 NCT03866824 771 773 B-Eq-Value
months NCT03866824 774 780 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
preceding NCT03866824 781 790 O
the NCT03866824 791 794 O
inclusion NCT03866824 795 804 O
visit NCT03866824 805 810 O

- NCT03866824 813 814 O
Ligament NCT03866824 816 824 B-Procedure-Name
reconstruction NCT03866824 825 839 I-Procedure-Name
in NCT03866824 840 842 O
the NCT03866824 843 846 O
12 NCT03866824 848 850 B-Eq-Value
months NCT03866824 851 857 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03866824 858 863 O
to NCT03866824 864 866 O
the NCT03866824 867 870 O
inclusion NCT03866824 871 880 O
visit NCT03866824 881 886 O

- NCT03866824 889 890 O
Need NCT03866824 892 896 O
a NCT03866824 897 898 O
cane NCT03866824 899 903 O
or NCT03866824 904 906 O
assistance NCT03866824 907 917 O
to NCT03866824 918 920 O
move NCT03866824 921 925 B-Condition-Name

- NCT03866824 928 929 O
BMI NCT03866824 931 934 B-Observation-Name___Observation-Type-Value:vital
> NCT03866824 935 936 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03866824 938 940 B-Eq-Value

- NCT03866824 944 945 O
Thrombocytopenia NCT03866824 947 963 B-Condition-Name
< NCT03866824 964 965 B-Eq-Operator___Eq-Operator-Value:LT
150 NCT03866824 967 970 B-Eq-Value
G NCT03866824 971 972 B-Eq-Unit
/ NCT03866824 973 974 O
L NCT03866824 975 976 B-Eq-Unit

- NCT03866824 979 980 O
Thrombocytosis NCT03866824 982 996 B-Condition-Name
> NCT03866824 997 998 B-Eq-Operator___Eq-Operator-Value:GT
450 NCT03866824 1000 1003 B-Eq-Value
G NCT03866824 1004 1005 B-Eq-Unit
/ NCT03866824 1006 1007 O
L NCT03866824 1008 1009 B-Eq-Unit

Inclusion NCT03866603 0 9 O
Criteria NCT03866603 10 18 O
: NCT03866603 19 20 O

- NCT03866603 24 25 O
Informed NCT03866603 27 35 O
consent NCT03866603 36 43 O
is NCT03866603 44 46 O
obtained NCT03866603 47 55 O
from NCT03866603 56 60 O
the NCT03866603 61 64 O
participant NCT03866603 65 76 O
. NCT03866603 77 78 O

- NCT03866603 82 83 O
The NCT03866603 85 88 O
participant NCT03866603 89 100 O
is NCT03866603 101 103 O
clinically NCT03866603 104 114 O
diagnosed NCT03866603 115 124 O
with NCT03866603 125 129 O
Parkinson NCT03866603 130 139 B-Condition-Name
's NCT03866603 139 141 I-Condition-Name
disease NCT03866603 142 149 I-Condition-Name
or NCT03866603 150 152 O
the NCT03866603 153 156 O
individual NCT03866603 157 167 O
is NCT03866603 168 170 O
a NCT03866603 171 172 O
family NCT03866603 173 179 O
member NCT03866603 180 186 O
of NCT03866603 187 189 O
a NCT03866603 190 191 O
participant NCT03866603 192 203 O
with NCT03866603 204 208 O
LRRK NCT03866603 209 213 O
2 NCT03866603 214 215 O
parkinsonism NCT03866603 216 228 B-Condition-Name
or NCT03866603 229 231 O
is NCT03866603 232 234 O
a NCT03866603 235 236 O
member NCT03866603 237 243 O
of NCT03866603 244 246 O
a NCT03866603 247 248 O
high NCT03866603 249 253 B-Polarity___Polarity-Value:high
risk NCT03866603 254 258 O
population NCT03866603 259 269 O
with NCT03866603 270 274 O
an NCT03866603 275 277 O
early NCT03866603 278 283 O
PD NCT03866603 284 286 B-Condition-Name
onset NCT03866603 287 292 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
. NCT03866603 293 294 O

- NCT03866603 298 299 O
The NCT03866603 301 304 O
participant NCT03866603 305 316 O
is NCT03866603 317 319 O
equal NCT03866603 320 325 B-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03866603 326 328 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03866603 329 331 I-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03866603 332 337 I-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03866603 338 342 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03866603 344 346 B-Eq-Value
years NCT03866603 347 352 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866603 353 356 O
. NCT03866603 357 358 O

Exclusion NCT03866603 360 369 O
Criteria NCT03866603 370 378 O
: NCT03866603 379 380 O

- NCT03866603 384 385 O
Inability NCT03866603 387 396 O
to NCT03866603 397 399 O
provide NCT03866603 400 407 O
informed NCT03866603 408 416 O
consent NCT03866603 417 424 O
. NCT03866603 425 426 O

- NCT03866603 430 431 O
The NCT03866603 433 436 O
participant NCT03866603 437 448 O
is NCT03866603 449 451 O
not NCT03866603 452 455 O
suffering NCT03866603 456 465 O
from NCT03866603 466 470 O
Parkinson NCT03866603 471 480 B-Condition-Name
's NCT03866603 480 482 I-Condition-Name
disease NCT03866603 483 490 I-Condition-Name
or NCT03866603 491 493 O
the NCT03866603 494 497 O
individual NCT03866603 498 508 O
is NCT03866603 509 511 O
not NCT03866603 512 515 O
a NCT03866603 516 517 O
family NCT03866603 518 524 O
member NCT03866603 525 531 O
of NCT03866603 532 534 O
a NCT03866603 535 536 O
participant NCT03866603 537 548 O
with NCT03866603 549 553 O
LRRK NCT03866603 554 558 O
2 NCT03866603 559 560 O
parkinsonism NCT03866603 561 573 B-Condition-Name
or NCT03866603 574 576 O
is NCT03866603 577 579 O
not NCT03866603 580 583 O
a NCT03866603 584 585 O
member NCT03866603 586 592 O
of NCT03866603 593 595 O
a NCT03866603 596 597 O
high NCT03866603 598 602 B-Polarity___Polarity-Value:high
risk NCT03866603 603 607 O
population NCT03866603 608 618 O
. NCT03866603 619 620 O

- NCT03866603 624 625 O
The NCT03866603 627 630 O
participant NCT03866603 631 642 O
is NCT03866603 643 645 O
younger NCT03866603 646 653 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03866603 654 658 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03866603 660 662 B-Eq-Value
years NCT03866603 663 668 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866603 669 672 O
. NCT03866603 673 674 O

- NCT03866603 678 679 O
Previously NCT03866603 681 691 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
enrolled NCT03866603 692 700 O
in NCT03866603 701 703 O
the NCT03866603 704 707 O
study NCT03866603 708 713 O
. NCT03866603 714 715 O

- NCT03866603 719 720 O
Participant NCT03866603 722 733 O
in NCT03866603 734 736 B-Observation-Name
custody NCT03866603 737 744 I-Observation-Name
. NCT03866603 745 746 O

Inclusion NCT03866941 0 9 O
Criteria NCT03866941 10 18 O
: NCT03866941 19 20 O

1 NCT03866941 25 26 O
. NCT03866941 26 27 O
All NCT03866941 29 32 O
the NCT03866941 33 36 O
cases NCT03866941 37 42 O
with NCT03866941 43 47 O
the NCT03866941 48 51 O
primary NCT03866941 52 59 O
diagnosis NCT03866941 60 69 O
of NCT03866941 70 72 O
acute NCT03866941 73 78 B-Severity___Severity-Value:severe
or NCT03866941 79 81 O
chronic NCT03866941 82 89 O
synthetic NCT03866941 90 99 B-Condition-Name
cannabinoids NCT03866941 100 112 I-Condition-Name
toxicity NCT03866941 113 121 I-Condition-Name
will NCT03866941 122 126 O
be NCT03866941 127 129 O
included NCT03866941 130 138 O
in NCT03866941 139 141 O
the NCT03866941 142 145 O
study NCT03866941 146 151 O
. NCT03866941 152 153 O

2 NCT03866941 158 159 O
. NCT03866941 159 160 O
Willing NCT03866941 162 169 O
and NCT03866941 170 173 O
able NCT03866941 174 178 O
to NCT03866941 179 181 O
comply NCT03866941 182 188 O
with NCT03866941 189 193 O
the NCT03866941 194 197 O
study NCT03866941 198 203 O
procedures NCT03866941 204 214 O
and NCT03866941 215 218 O
provide NCT03866941 219 226 O
written NCT03866941 227 234 O
informed NCT03866941 235 243 O
consent NCT03866941 244 251 O
to NCT03866941 252 254 O
participate NCT03866941 255 266 O
in NCT03866941 267 269 O
the NCT03866941 270 273 O
study NCT03866941 274 279 O
. NCT03866941 280 281 O

Exclusion NCT03866941 283 292 O
Criteria NCT03866941 293 301 O
: NCT03866941 302 303 O

- NCT03866941 307 308 O
1 NCT03866941 311 312 O
- NCT03866941 313 314 O
Patients NCT03866941 315 323 O
with NCT03866941 324 328 O
a NCT03866941 329 330 O
history NCT03866941 331 338 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866941 339 341 O
any NCT03866941 342 345 O
chronic NCT03866941 346 353 O
disease NCT03866941 354 361 B-Condition-Name
( NCT03866941 362 363 O
renal NCT03866941 364 369 O
and NCT03866941 370 373 O
hepatic NCT03866941 374 381 O
) NCT03866941 382 383 O
. NCT03866941 385 386 O
2 NCT03866941 389 390 O
- NCT03866941 391 392 O
Patients NCT03866941 393 401 O
refuse NCT03866941 402 408 O
to NCT03866941 409 411 O
participate NCT03866941 412 423 O
in NCT03866941 424 426 O
the NCT03866941 427 430 O
study NCT03866941 431 436 O
. NCT03866941 437 438 O
3 NCT03866941 441 442 O
- NCT03866941 443 444 O
Abuse NCT03866941 445 450 B-Condition-Name
to NCT03866941 451 453 O
other NCT03866941 454 459 O
drugs NCT03866941 460 465 O
. NCT03866941 466 467 O

Inclusion NCT03864159 0 9 O
Criteria NCT03864159 10 18 O
: NCT03864159 19 20 O

- NCT03864159 24 25 O
Age NCT03864159 27 30 O
between NCT03864159 31 38 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03864159 40 42 B-Eq-Value
to NCT03864159 43 45 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03864159 47 49 B-Eq-Value
years NCT03864159 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864159 58 59 O
Amateur NCT03864159 61 68 B-Observation-Name___Observation-Type-Value:social-habit
basketball NCT03864159 69 79 I-Observation-Name___Observation-Type-Value:social-habit
players NCT03864159 80 87 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03864159 90 91 O
Belong NCT03864159 93 99 O
to NCT03864159 100 102 O
the NCT03864159 103 106 O
Celeste NCT03864159 107 114 O
club NCT03864159 115 119 O

- NCT03864159 122 123 O
Not NCT03864159 125 128 O
having NCT03864159 129 135 O
any NCT03864159 136 139 O
injury NCT03864159 140 146 B-Condition-Name
to NCT03864159 147 149 O
the NCT03864159 150 153 O
hamstring NCT03864159 154 163 O
musculature NCT03864159 164 175 O
at NCT03864159 176 178 O
the NCT03864159 179 182 O
time NCT03864159 183 187 O
of NCT03864159 188 190 O
the NCT03864159 191 194 O
study NCT03864159 195 200 O

Exclusion NCT03864159 201 210 O
Criteria NCT03864159 211 219 O
: NCT03864159 220 221 O

- NCT03864159 225 226 O
At NCT03864159 228 230 O
the NCT03864159 231 234 O
time NCT03864159 235 239 O
of NCT03864159 240 242 O
the NCT03864159 243 246 O
study NCT03864159 247 252 O
they NCT03864159 253 257 O
are NCT03864159 258 261 O
included NCT03864159 262 270 O
in NCT03864159 271 273 O
a NCT03864159 274 275 O
program NCT03864159 276 283 B-Procedure-Name
of NCT03864159 284 286 I-Procedure-Name
individualized NCT03864159 287 301 I-Procedure-Name
strength NCT03864159 302 310 I-Procedure-Name
training NCT03864159 311 319 I-Procedure-Name
in NCT03864159 320 322 O
lower NCT03864159 323 328 O
limbs NCT03864159 329 334 O

- NCT03864159 337 338 O
Subjects NCT03864159 340 348 O
with NCT03864159 349 353 O
alterations NCT03864159 354 365 B-Condition-Name
in NCT03864159 366 368 O
venous NCT03864159 369 375 O
return NCT03864159 376 382 O
or NCT03864159 383 385 O
congenital NCT03864159 386 396 O
coagulopathies NCT03864159 397 411 B-Condition-Name

- NCT03864159 414 415 O
Subjects NCT03864159 417 425 O
who NCT03864159 426 429 O
present NCT03864159 430 437 O
hypermobility NCT03864159 438 451 B-Condition-Name

- NCT03864159 454 455 O
Not NCT03864159 457 460 O
signed NCT03864159 461 467 O
the NCT03864159 468 471 O
informed NCT03864159 472 480 O
consent NCT03864159 481 488 O
document NCT03864159 489 497 O

Inclusion NCT03866772 0 9 O
Criteria NCT03866772 10 18 O
: NCT03866772 19 20 O

- NCT03866772 24 25 O
unfavourable NCT03866772 27 39 B-Condition-Name
cervix NCT03866772 40 46 I-Condition-Name
( NCT03866772 47 48 O
Bishop NCT03866772 49 55 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03866772 56 61 I-Observation-Name___Observation-Type-Value:clinical-score
≤ NCT03866772 62 63 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03866772 65 66 B-Eq-Value
) NCT03866772 67 68 O
, NCT03866772 70 71 O

- NCT03866772 75 76 O
indication NCT03866772 78 88 O
for NCT03866772 89 92 O
induction NCT03866772 93 102 B-Procedure-Name
of NCT03866772 103 105 I-Procedure-Name
labor NCT03866772 106 111 I-Procedure-Name
( NCT03866772 112 113 O
medical NCT03866772 114 121 O
or NCT03866772 122 124 O
obstetrical NCT03866772 125 136 O
) NCT03866772 137 138 O
, NCT03866772 140 141 O

- NCT03866772 145 146 O
37 NCT03866772 149 151 B-Eq-Value
completed NCT03866772 152 161 O
gestational NCT03866772 162 173 B-Observation-Name___Observation-Type-Value:measurement
weeks NCT03866772 174 179 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03866772 180 181 O

- NCT03866772 185 186 O
vertex NCT03866772 188 194 B-Condition-Name
presentation NCT03866772 195 207 I-Condition-Name
, NCT03866772 208 209 O

- NCT03866772 213 214 O
singleton NCT03866772 216 225 O
pregnancy NCT03866772 226 235 B-Condition-Name

- NCT03866772 238 239 O
intact NCT03866772 241 247 B-Condition-Name
membranes NCT03866772 248 257 I-Condition-Name
. NCT03866772 258 259 O

Exclusion NCT03866772 261 270 O
Criteria NCT03866772 271 279 O
: NCT03866772 280 281 O

- NCT03866772 285 286 O
previous NCT03866772 288 296 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cesarean NCT03866772 297 305 B-Procedure-Name
delivery NCT03866772 306 314 I-Procedure-Name

- NCT03866772 317 318 O
previous NCT03866772 320 328 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
uterine NCT03866772 329 336 B-Procedure-Name
surgery NCT03866772 337 344 I-Procedure-Name
( NCT03866772 345 346 O
eg NCT03866772 347 349 O
: NCT03866772 350 351 O
myomectomy NCT03866772 352 362 B-Procedure-Name
) NCT03866772 363 364 O

- NCT03866772 368 369 O
noncephalic NCT03866772 371 382 B-Condition-Name
presentation NCT03866772 383 395 I-Condition-Name

- NCT03866772 398 399 O
multiple NCT03866772 401 409 B-Eq-Operator___Eq-Operator-Value:GT
pregnancy NCT03866772 410 419 B-Condition-Name

- NCT03866772 422 423 O
pre NCT03866772 425 428 B-Condition-Name
- NCT03866772 429 430 I-Condition-Name
eclampsia NCT03866772 431 440 I-Condition-Name
with NCT03866772 441 445 O
severe NCT03866772 446 452 B-Severity___Severity-Value:severe
features NCT03866772 453 461 O

- NCT03866772 464 465 O
oligohydramnios NCT03866772 467 482 B-Condition-Name
( NCT03866772 483 484 O
Maximal NCT03866772 485 492 B-Observation-Name___Observation-Type-Value:measurement
vertical NCT03866772 493 501 I-Observation-Name___Observation-Type-Value:measurement
pocket NCT03866772 502 508 I-Observation-Name___Observation-Type-Value:measurement
≤ NCT03866772 509 510 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03866772 512 513 B-Eq-Value
) NCT03866772 514 515 O

- NCT03866772 519 520 O
estimated NCT03866772 522 531 O
fetal NCT03866772 532 537 O
weight NCT03866772 538 544 B-Observation-Name___Observation-Type-Value:vital
< NCT03866772 545 546 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03866772 548 550 B-Eq-Value
% NCT03866772 551 552 B-Eq-Unit
percentile NCT03866772 553 563 B-Eq-Unit

- NCT03866772 566 567 O
any NCT03866772 569 572 O
contraindication NCT03866772 573 589 O
to NCT03866772 590 592 O
Vaginal NCT03866772 593 600 B-Procedure-Name
delivery NCT03866772 601 609 I-Procedure-Name

Inclusion NCT03866564 0 9 O
Criteria NCT03866564 10 18 O
: NCT03866564 19 20 O

- NCT03866564 24 25 O
Age NCT03866564 27 30 O
24 NCT03866564 32 34 B-Eq-Value
- NCT03866564 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03866564 38 40 B-Eq-Value

- NCT03866564 44 45 O
Former NCT03866564 47 53 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
professional NCT03866564 54 66 B-Observation-Name___Observation-Type-Value:social-habit
football NCT03866564 67 75 I-Observation-Name___Observation-Type-Value:social-habit
play NCT03866564 76 80 I-Observation-Name___Observation-Type-Value:social-habit
from NCT03866564 81 85 O
1960 NCT03866564 87 91 B-Eq-Value
to NCT03866564 92 94 B-Eq-Operator___Eq-Operator-Value:BETWEEN
present NCT03866564 95 102 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
. NCT03866564 103 104 O

- NCT03866564 108 109 O
Prior NCT03866564 111 116 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
completed NCT03866564 117 126 O
the NCT03866564 127 130 O
first NCT03866564 131 136 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
Health NCT03866564 137 143 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
and NCT03866564 144 147 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Wellness NCT03866564 148 156 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03866564 157 170 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03866564 171 172 O
Q NCT03866564 173 174 B-Observation-Name
1 NCT03866564 175 176 I-Observation-Name
) NCT03866564 177 178 O

- NCT03866564 182 183 O
" NCT03866564 185 186 O
Healthy NCT03866564 186 193 O
" NCT03866564 193 194 O
subjects NCT03866564 195 203 O
: NCT03866564 204 205 O
ability NCT03866564 206 213 O
to NCT03866564 214 216 O
give NCT03866564 217 221 O
informed NCT03866564 222 230 O
consent NCT03866564 231 238 O
, NCT03866564 239 240 O
comply NCT03866564 241 247 O
with NCT03866564 248 252 O
study NCT03866564 253 258 O
procedures NCT03866564 259 269 O
, NCT03866564 270 271 O
and NCT03866564 272 275 O
have NCT03866564 276 280 O
a NCT03866564 281 282 O
Telephone NCT03866564 283 292 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03866564 293 294 I-Observation-Name___Observation-Type-Value:clinical-score
Montreal NCT03866564 295 303 I-Observation-Name___Observation-Type-Value:clinical-score
Cognitive NCT03866564 304 313 I-Observation-Name___Observation-Type-Value:clinical-score
Assessment NCT03866564 314 324 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03866564 325 326 O
T NCT03866564 327 328 B-Observation-Name
- NCT03866564 329 330 I-Observation-Name
MoCA NCT03866564 331 335 I-Observation-Name
) NCT03866564 336 337 O
score NCT03866564 338 343 O
of NCT03866564 344 346 O
> NCT03866564 347 348 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03866564 350 352 B-Eq-Value
. NCT03866564 352 353 O

- NCT03866564 357 358 O
" NCT03866564 360 361 O
Afflicted NCT03866564 361 370 O
" NCT03866564 370 371 O
participants NCT03866564 372 384 O
: NCT03866564 385 386 O
must NCT03866564 387 391 O
meet NCT03866564 392 396 O
criteria NCT03866564 397 405 O
for NCT03866564 406 409 O
at NCT03866564 410 412 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866564 413 418 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03866564 419 422 B-Eq-Value
of NCT03866564 423 425 O
the NCT03866564 426 429 O
following NCT03866564 430 439 O
subjective NCT03866564 440 450 B-Condition-Name
afflictions NCT03866564 451 462 I-Condition-Name
based NCT03866564 463 468 O
on NCT03866564 469 471 O
Q NCT03866564 472 473 B-Observation-Name
1 NCT03866564 474 475 I-Observation-Name
responses NCT03866564 476 485 O
: NCT03866564 486 487 O
1 NCT03866564 489 490 O
) NCT03866564 491 492 O
Cardiovascular NCT03866564 493 507 B-Condition-Name
Dysfunction NCT03866564 508 519 I-Condition-Name
, NCT03866564 520 521 O
2 NCT03866564 523 524 O
) NCT03866564 525 526 O
Neurocognitive NCT03866564 527 541 B-Condition-Name
Disease NCT03866564 542 549 I-Condition-Name
, NCT03866564 550 551 O
3 NCT03866564 553 554 O
) NCT03866564 555 556 O
Chronic NCT03866564 557 564 O
Pain NCT03866564 565 569 B-Condition-Name
, NCT03866564 570 571 O
and NCT03866564 572 575 O
/ NCT03866564 576 577 O
or NCT03866564 578 580 O
4 NCT03866564 582 583 O
) NCT03866564 584 585 O
Sleep NCT03866564 586 591 B-Condition-Name
Apnea NCT03866564 592 597 I-Condition-Name

- NCT03866564 600 601 O
" NCT03866564 603 604 O
Afflicted NCT03866564 604 613 O
" NCT03866564 613 614 O
participants NCT03866564 615 627 O
must NCT03866564 628 632 O
be NCT03866564 633 635 O
able NCT03866564 636 640 O
to NCT03866564 641 643 O
give NCT03866564 644 648 O
informed NCT03866564 649 657 O
consent NCT03866564 658 665 O
or NCT03866564 666 668 O
have NCT03866564 669 673 O
a NCT03866564 674 675 O
legal NCT03866564 676 681 O
guardian NCT03866564 682 690 O
present NCT03866564 691 698 O
to NCT03866564 699 701 O
provide NCT03866564 702 709 O
informed NCT03866564 710 718 O
consent NCT03866564 719 726 O
( NCT03866564 727 728 O
if NCT03866564 729 731 O
participants NCT03866564 732 744 O
demonstrate NCT03866564 745 756 O
on NCT03866564 757 759 O
T NCT03866564 760 761 B-Observation-Name
- NCT03866564 762 763 I-Observation-Name
MoCA NCT03866564 764 768 I-Observation-Name
score NCT03866564 769 774 B-Eq-Unit
< NCT03866564 775 776 B-Eq-Operator___Eq-Operator-Value:LT
19 NCT03866564 778 780 B-Eq-Value
) NCT03866564 781 782 O
and NCT03866564 783 786 O
to NCT03866564 787 789 O
comply NCT03866564 790 796 O
with NCT03866564 797 801 O
study NCT03866564 802 807 O
procedures NCT03866564 808 818 O
. NCT03866564 819 820 O

Exclusion NCT03866564 822 831 O
Criteria NCT03866564 832 840 O
: NCT03866564 841 842 O

- NCT03866564 846 847 O
Prior NCT03866564 849 854 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
metallic NCT03866564 855 863 B-Procedure-Name
device NCT03866564 864 870 I-Procedure-Name
implants NCT03866564 871 879 I-Procedure-Name
such NCT03866564 880 884 O
as NCT03866564 885 887 O
cardiac NCT03866564 888 895 B-Procedure-Name
pacemakers NCT03866564 896 906 I-Procedure-Name
/ NCT03866564 907 908 O
defibrillators NCT03866564 909 923 B-Procedure-Name
or NCT03866564 924 926 O
perfusion NCT03866564 927 936 B-Procedure-Name
pumps NCT03866564 937 942 I-Procedure-Name
that NCT03866564 943 947 O
can NCT03866564 948 951 O
not NCT03866564 951 954 O
be NCT03866564 955 957 O
removed NCT03866564 958 965 O
. NCT03866564 966 967 O

- NCT03866564 971 972 O
Ferromagnetic NCT03866564 974 987 B-Procedure-Name
implants NCT03866564 988 996 I-Procedure-Name
or NCT03866564 997 999 O
objects NCT03866564 1000 1007 B-Procedure-Name
that NCT03866564 1008 1012 O
can NCT03866564 1013 1016 O
not NCT03866564 1016 1019 O
be NCT03866564 1020 1022 O
removed NCT03866564 1023 1030 O
such NCT03866564 1031 1035 O
as NCT03866564 1036 1038 O
aneurysm NCT03866564 1039 1047 B-Procedure-Name
clips NCT03866564 1048 1053 I-Procedure-Name
, NCT03866564 1054 1055 O
surgical NCT03866564 1056 1064 B-Procedure-Name
clips NCT03866564 1065 1070 I-Procedure-Name
, NCT03866564 1071 1072 O
prostheses NCT03866564 1073 1083 B-Procedure-Name
, NCT03866564 1084 1085 O
artificial NCT03866564 1086 1096 B-Procedure-Name
hearts NCT03866564 1097 1103 I-Procedure-Name
, NCT03866564 1104 1105 O
valves NCT03866564 1106 1112 B-Procedure-Name
with NCT03866564 1113 1117 O
steel NCT03866564 1118 1123 O
parts NCT03866564 1124 1129 O
, NCT03866564 1130 1131 O
metal NCT03866564 1132 1137 B-Condition-Name
fragments NCT03866564 1138 1147 I-Condition-Name
, NCT03866564 1148 1149 O
shrapnel NCT03866564 1150 1158 B-Condition-Name
, NCT03866564 1159 1160 O
tattoos NCT03866564 1161 1168 B-Condition-Name
near NCT03866564 1169 1173 O
the NCT03866564 1174 1177 O
eye NCT03866564 1178 1181 O
, NCT03866564 1182 1183 O
or NCT03866564 1184 1186 O
steel NCT03866564 1187 1192 B-Procedure-Name
implants NCT03866564 1193 1201 O
or NCT03866564 1202 1204 O
jewelry NCT03866564 1205 1212 O

- NCT03866564 1215 1216 O
Body NCT03866564 1218 1222 B-Observation-Name___Observation-Type-Value:vital
weight NCT03866564 1223 1229 I-Observation-Name___Observation-Type-Value:vital
> NCT03866564 1230 1231 B-Eq-Operator___Eq-Operator-Value:GT
450 NCT03866564 1233 1236 B-Eq-Value
lbs NCT03866564 1237 1240 B-Eq-Unit

- NCT03866564 1243 1244 O
Inability NCT03866564 1246 1255 O
to NCT03866564 1256 1258 O
complete NCT03866564 1259 1267 O
the NCT03866564 1268 1271 O
telephone NCT03866564 1272 1281 B-Procedure-Name
screener NCT03866564 1282 1290 I-Procedure-Name

- NCT03866564 1293 1294 O
Low NCT03866564 1296 1299 B-Polarity___Polarity-Value:low
T NCT03866564 1300 1301 B-Observation-Name
- NCT03866564 1302 1303 I-Observation-Name
MoCA NCT03866564 1304 1308 I-Observation-Name
score NCT03866564 1309 1314 O
( NCT03866564 1315 1316 O
< NCT03866564 1318 1319 B-Eq-Operator___Eq-Operator-Value:LT
20 NCT03866564 1321 1323 B-Eq-Value
) NCT03866564 1324 1325 O
and NCT03866564 1326 1329 O
absence NCT03866564 1330 1337 O
of NCT03866564 1338 1340 O
an NCT03866564 1341 1343 O
available NCT03866564 1344 1353 O
legal NCT03866564 1354 1359 O
guardian NCT03866564 1360 1368 O
who NCT03866564 1369 1372 O
can NCT03866564 1373 1376 O
accompany NCT03866564 1377 1386 O
the NCT03866564 1387 1390 O
participant NCT03866564 1391 1402 O
through NCT03866564 1403 1410 O
all NCT03866564 1411 1414 O
phases NCT03866564 1415 1421 O
of NCT03866564 1422 1424 O
the NCT03866564 1425 1428 O
study NCT03866564 1429 1434 O
. NCT03866564 1435 1436 O

- NCT03866564 1440 1441 O
Significant NCT03866564 1443 1454 B-Severity___Severity-Value:severe
behavioral NCT03866564 1455 1465 O
or NCT03866564 1466 1468 O
functional NCT03866564 1469 1479 O
disability NCT03866564 1480 1490 B-Condition-Name
due NCT03866564 1491 1494 O
to NCT03866564 1495 1497 O
cognitive NCT03866564 1498 1507 B-Condition-Name
impairment NCT03866564 1508 1518 I-Condition-Name

Inclusion NCT03869125 0 9 O
Criteria NCT03869125 10 18 O
: NCT03869125 19 20 O

- NCT03869125 24 25 O
Obstructive NCT03869125 27 38 B-Condition-Name
sleep NCT03869125 39 44 I-Condition-Name
apnoea NCT03869125 45 51 I-Condition-Name
syndrome NCT03869125 52 60 I-Condition-Name

Exclusion NCT03869125 61 70 O
Criteria NCT03869125 71 79 O
: NCT03869125 80 81 O

- NCT03869125 85 86 O
Non NCT03869125 88 91 O
- NCT03869125 92 93 O
compliance NCT03869125 94 104 O
of NCT03869125 105 107 O
patients NCT03869125 108 116 O
with NCT03869125 117 121 O
blood NCT03869125 122 127 B-Procedure-Name
pressure NCT03869125 128 136 I-Procedure-Name
monitoring NCT03869125 137 147 I-Procedure-Name

Inclusion NCT03864367 0 9 O
Criteria NCT03864367 10 18 O
: NCT03864367 19 20 O

- NCT03864367 24 25 O
55 NCT03864367 28 30 B-Eq-Value
and NCT03864367 31 34 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03864367 35 40 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03864367 43 44 O
distal NCT03864367 46 52 O
femur NCT03864367 53 58 O
fracture NCT03864367 59 67 B-Condition-Name

- NCT03864367 70 71 O
able NCT03864367 73 77 B-Condition-Name
to NCT03864367 78 80 I-Condition-Name
walk NCT03864367 81 85 I-Condition-Name
prior NCT03864367 86 91 O
to NCT03864367 92 94 O
fracture NCT03864367 95 103 B-Condition-Name

Exclusion NCT03864367 104 113 O
Criteria NCT03864367 114 122 O
: NCT03864367 123 124 O

- NCT03864367 128 129 O
patients NCT03864367 131 139 O
unable NCT03864367 140 146 B-Condition-Name
to NCT03864367 147 149 I-Condition-Name
walk NCT03864367 150 154 I-Condition-Name
without NCT03864367 155 162 O
any NCT03864367 163 166 O
assistive NCT03864367 167 176 B-Procedure-Name
devices NCT03864367 177 184 I-Procedure-Name
post NCT03864367 185 189 O
- NCT03864367 190 191 O
injury NCT03864367 192 198 B-Condition-Name

- NCT03864367 201 202 O
patients NCT03864367 204 212 O
too NCT03864367 213 216 O
medically NCT03864367 217 226 O
unstable NCT03864367 227 235 B-Stability___Stability-Value:change
to NCT03864367 236 238 O
participate NCT03864367 239 250 O
in NCT03864367 251 253 O
physical NCT03864367 254 262 B-Procedure-Name
therapy NCT03864367 263 270 I-Procedure-Name

Inclusion NCT03863795 0 9 O
Criteria NCT03863795 10 18 O
: NCT03863795 19 20 O

- NCT03863795 24 25 O
United NCT03863795 27 33 B-Location___Location-Value:residence
States NCT03863795 34 40 I-Location___Location-Value:residence
( NCT03863795 41 42 O
US NCT03863795 43 45 B-Location___Location-Value:residence
) NCT03863795 46 47 O
adult NCT03863795 48 53 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
smokers NCT03863795 54 61 B-Condition-Name
. NCT03863795 62 63 O

Smokers NCT03863795 65 72 B-Condition-Name
recruited NCT03863795 73 82 O
through NCT03863795 83 90 O
Amazon NCT03863795 91 97 O
Mechanical NCT03863795 98 108 O
Turk NCT03863795 109 113 O

Inclusion NCT03866161 0 9 O
Criteria NCT03866161 10 18 O
: NCT03866161 19 20 O

- NCT03866161 24 25 O
Newly NCT03866161 27 32 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnosed NCT03866161 33 42 O
obstructive NCT03866161 43 54 B-Condition-Name
sleep NCT03866161 55 60 I-Condition-Name
apnea NCT03866161 61 66 I-Condition-Name
indicated NCT03866161 67 76 O
for NCT03866161 77 80 O
positive NCT03866161 81 89 B-Polarity___Polarity-Value:positive
airway NCT03866161 90 96 B-Procedure-Name
pressure NCT03866161 97 105 I-Procedure-Name
therapy NCT03866161 106 113 I-Procedure-Name
, NCT03866161 114 115 O
i NCT03866161 116 117 O
. NCT03866161 118 119 O
e NCT03866161 120 121 O
. NCT03866161 122 123 O
Apnea NCT03866161 125 130 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03866161 131 132 I-Observation-Name___Observation-Type-Value:clinical-score
Hypopnea NCT03866161 133 141 I-Observation-Name___Observation-Type-Value:clinical-score
index NCT03866161 142 147 I-Observation-Name___Observation-Type-Value:clinical-score
AHI NCT03866161 148 151 B-Observation-Name
> NCT03866161 152 153 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03866161 155 157 B-Eq-Value

Exclusion NCT03866161 159 168 O
Criteria NCT03866161 169 177 O
: NCT03866161 178 179 O

- NCT03866161 183 184 O
Psychiatric NCT03866161 186 197 B-Procedure-Name
treatment NCT03866161 198 207 I-Procedure-Name

- NCT03866161 210 211 O
Treatment NCT03866161 213 222 O
with NCT03866161 223 227 O
psychoactive NCT03866161 228 240 B-Drug-Name
drugs NCT03866161 241 246 I-Drug-Name

Inclusion NCT03863743 0 9 O
Criteria NCT03863743 10 18 O
: NCT03863743 19 20 O

- NCT03863743 24 25 O
ASA NCT03863743 27 30 B-Condition-Name
grade NCT03863743 31 36 B-Eq-Unit
I NCT03863743 37 38 B-Eq-Value
- NCT03863743 39 40 O
III NCT03863743 41 44 B-Eq-Value

- NCT03863743 47 48 O
BMI NCT03863743 50 53 B-Observation-Name___Observation-Type-Value:vital
under NCT03863743 54 59 B-Eq-Operator___Eq-Operator-Value:LT
36 NCT03863743 61 63 B-Eq-Value
kg NCT03863743 64 66 B-Eq-Unit
/ NCT03863743 67 68 O
m^ NCT03863743 69 71 B-Eq-Unit
2 NCT03863743 72 73 I-Eq-Unit

- NCT03863743 77 78 O
Scheduled NCT03863743 80 89 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
surgery NCT03863743 90 97 B-Procedure-Name
for NCT03863743 98 101 O
primary NCT03863743 102 109 O
total NCT03863743 110 115 O
hip NCT03863743 116 119 O
or NCT03863743 120 122 O
knee NCT03863743 123 127 O
replacement NCT03863743 128 139 B-Procedure-Name

- NCT03863743 142 143 O
Age NCT03863743 145 148 O
18 NCT03863743 150 152 B-Eq-Value
+ NCT03863743 153 154 B-Eq-Operator___Eq-Operator-Value:GT
years NCT03863743 155 160 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03863743 161 170 O
Criteria NCT03863743 171 179 O
: NCT03863743 180 181 O

- NCT03863743 185 186 O
Contraindications NCT03863743 188 205 O
or NCT03863743 206 208 O
failure NCT03863743 209 216 O
of NCT03863743 217 219 O
neuraxial NCT03863743 220 229 B-Procedure-Name
anesthesia NCT03863743 230 240 I-Procedure-Name

- NCT03863743 243 244 O
Patients NCT03863743 246 254 O
must NCT03863743 255 259 O
not NCT03863743 260 263 O
be NCT03863743 264 266 O
outpatient NCT03863743 267 277 B-Encounter-Type___Encounter-Type-Value:outpatient
total NCT03863743 278 283 O
hip NCT03863743 284 287 O
or NCT03863743 288 290 O
knee NCT03863743 291 295 O
procedure NCT03863743 296 305 B-Procedure-Name

- NCT03863743 308 309 O
Known NCT03863743 311 316 O
intercurrent NCT03863743 317 329 O
UTI NCT03863743 330 333 B-Condition-Name
, NCT03863743 334 335 O
incontinence NCT03863743 336 348 B-Condition-Name
, NCT03863743 349 350 O
or NCT03863743 351 353 O
urinary NCT03863743 354 361 B-Condition-Name
retention NCT03863743 362 371 I-Condition-Name
not NCT03863743 372 375 O
addressed NCT03863743 376 385 O
by NCT03863743 386 388 O
pre NCT03863743 389 392 O
- NCT03863743 393 394 O
operative NCT03863743 395 404 B-Procedure-Name
urologic NCT03863743 405 413 B-Procedure-Name
consultation NCT03863743 414 426 O
and NCT03863743 427 430 O
correction NCT03863743 431 441 O

- NCT03863743 444 445 O
Pregnancy NCT03863743 447 456 B-Condition-Name

- NCT03863743 459 460 O
Current NCT03863743 462 469 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
nicotine NCT03863743 470 478 B-Drug-Name
, NCT03863743 479 480 O
alcohol NCT03863743 481 488 O
or NCT03863743 489 491 O
drug NCT03863743 492 496 O
abusers NCT03863743 497 504 B-Condition-Name

- NCT03863743 507 508 O
Pre NCT03863743 510 513 O
- NCT03863743 514 515 O
operative NCT03863743 516 525 B-Procedure-Name
narcotic NCT03863743 526 534 B-Drug-Name
use NCT03863743 535 538 O
( NCT03863743 539 540 O
any NCT03863743 541 544 O
narcotic NCT03863743 545 553 B-Drug-Name
consumption NCT03863743 554 565 O
within NCT03863743 566 572 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03863743 574 575 B-Eq-Value
days NCT03863743 576 580 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03863743 581 586 O
to NCT03863743 587 589 O
surgery NCT03863743 590 597 B-Procedure-Name
) NCT03863743 598 599 O

- NCT03863743 603 604 O
Post NCT03863743 606 610 O
- NCT03863743 611 612 O
operative NCT03863743 613 622 B-Procedure-Name
parenteral NCT03863743 623 633 O
narcotic NCT03863743 634 642 B-Drug-Name
administration NCT03863743 643 657 O

- NCT03863743 660 661 O
Allergy NCT03863743 663 670 O
or NCT03863743 671 673 O
intolerance NCT03863743 674 685 B-Condition-Name
to NCT03863743 686 688 O
liposomal NCT03863743 689 698 B-Drug-Name
bupivacaine NCT03863743 699 710 B-Drug-Name
, NCT03863743 711 712 O
bupivacaine NCT03863743 713 724 B-Drug-Name
, NCT03863743 725 726 O
celecoxib NCT03863743 727 736 B-Drug-Name
, NCT03863743 737 738 O
dexamethasone NCT03863743 739 752 B-Drug-Name
and NCT03863743 753 756 O
/ NCT03863743 757 758 O
or NCT03863743 759 761 O
pregabalin NCT03863743 762 772 B-Drug-Name

Minimum NCT03862105 0 7 B-Eq-Operator___Eq-Operator-Value:GTEQ
Age NCT03862105 8 11 O
: NCT03862105 12 13 O
18 NCT03862105 15 17 B-Eq-Value
Years NCT03862105 18 23 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
Maximum NCT03862105 24 31 B-Eq-Operator___Eq-Operator-Value:LTEQ
Age NCT03862105 32 35 O
: NCT03862105 36 37 O
99 NCT03862105 39 41 B-Eq-Value
Years NCT03862105 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
Sex NCT03862105 48 51 O
: NCT03862105 52 53 O
All NCT03862105 54 57 O
Gender NCT03862105 58 64 O
Based NCT03862105 65 70 O
: NCT03862105 71 72 O
No NCT03862105 73 75 O

Criteria NCT03862105 76 84 O
: NCT03862105 85 86 O
Inclusion NCT03862105 87 96 O
Criteria NCT03862105 97 105 O
: NCT03862105 106 107 O

- NCT03862105 111 112 O
Male NCT03862105 114 118 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03862105 119 121 O
female NCT03862105 122 128 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03862105 129 137 O
with NCT03862105 138 142 O
invasive NCT03862105 143 151 O
bladder NCT03862105 152 159 O
cancer NCT03862105 160 166 B-Condition-Name
scheduled NCT03862105 167 176 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03862105 177 180 O
radical NCT03862105 181 188 B-Procedure-Name
cystectomy NCT03862105 189 199 I-Procedure-Name
at NCT03862105 200 202 O
UNC NCT03862105 203 206 B-Location___Location-Value:hospital
within NCT03862105 207 213 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03862105 214 217 O
next NCT03862105 218 222 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
30 NCT03862105 224 226 B-Eq-Value
days NCT03862105 227 231 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03862105 234 235 O
English NCT03862105 237 244 B-Language
- NCT03862105 245 246 O
speaking NCT03862105 247 255 O

- NCT03862105 258 259 O
Ability NCT03862105 261 268 O
to NCT03862105 269 271 O
access NCT03862105 272 278 O
the NCT03862105 279 282 O
Internet NCT03862105 283 291 O
( NCT03862105 292 293 O
either NCT03862105 294 300 O
themselves NCT03862105 301 311 O
or NCT03862105 312 314 O
with NCT03862105 315 319 O
assistance NCT03862105 320 330 O
from NCT03862105 331 335 O
their NCT03862105 336 341 O
caregiver NCT03862105 342 351 O
) NCT03862105 352 353 O

- NCT03862105 357 358 O
Ability NCT03862105 360 367 O
to NCT03862105 368 370 O
read NCT03862105 371 375 O

- NCT03862105 378 379 O
Ability NCT03862105 381 388 O
to NCT03862105 389 391 O
provide NCT03862105 392 399 O
informed NCT03862105 400 408 O
consent NCT03862105 409 416 O
. NCT03862105 417 418 O

Exclusion NCT03862105 420 429 O
Criteria NCT03862105 430 438 O
: NCT03862105 439 440 O

- NCT03862105 444 445 O
Inability NCT03862105 447 456 O
to NCT03862105 457 459 O
read NCT03862105 460 464 O

- NCT03862105 467 468 O
Inability NCT03862105 470 479 O
to NCT03862105 480 482 O
provide NCT03862105 483 490 O
informed NCT03862105 491 499 O
consent NCT03862105 500 507 O

- NCT03862105 510 511 O
Severe NCT03862105 513 519 B-Severity___Severity-Value:severe
psychiatric NCT03862105 520 531 B-Condition-Name
illness NCT03862105 532 539 I-Condition-Name

- NCT03862105 542 543 O
Cystectomy NCT03862105 545 555 B-Procedure-Name
surgery NCT03862105 556 563 I-Procedure-Name
without NCT03862105 564 571 O
cancer NCT03862105 572 578 B-Condition-Name
diagnosis NCT03862105 579 588 O

- NCT03862105 591 592 O
Non NCT03862105 594 597 O
- NCT03862105 598 599 O
English NCT03862105 600 607 B-Language
speaking NCT03862105 608 616 O

Inclusion NCT03862677 0 9 O
Criteria NCT03862677 10 18 O
: NCT03862677 19 20 O

- NCT03862677 24 25 O
Patients NCT03862677 27 35 O
with NCT03862677 36 40 O
( NCT03862677 41 42 O
suspicion NCT03862677 43 52 O
of NCT03862677 53 55 O
) NCT03862677 56 57 O
primary NCT03862677 58 65 O
or NCT03862677 66 68 O
recurrent NCT03862677 69 78 O
EOC NCT03862677 79 82 B-Condition-Name
with NCT03862677 83 87 O
an NCT03862677 88 90 O
indication NCT03862677 91 101 O
for NCT03862677 102 105 O
surgery NCT03862677 106 113 B-Procedure-Name
, NCT03862677 114 115 O
chemotherapy NCT03862677 116 128 B-Procedure-Name
and NCT03862677 129 132 O
/ NCT03862677 133 134 O
or NCT03862677 135 137 O
immunotherapy NCT03862677 138 151 B-Procedure-Name
. NCT03862677 152 153 O

- NCT03862677 157 158 O
Age NCT03862677 160 163 O
≥ NCT03862677 164 165 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03862677 167 169 B-Eq-Value
years NCT03862677 170 175 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03862677 176 177 O

- NCT03862677 181 182 O
WHO NCT03862677 184 187 B-Observation-Name___Observation-Type-Value:clinical-score
performance NCT03862677 188 199 I-Observation-Name___Observation-Type-Value:clinical-score
status NCT03862677 200 206 I-Observation-Name___Observation-Type-Value:clinical-score
0 NCT03862677 208 209 B-Eq-Value
- NCT03862677 210 211 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03862677 213 214 B-Eq-Value
. NCT03862677 214 215 O

- NCT03862677 219 220 O
Accessible NCT03862677 222 232 O
for NCT03862677 233 236 O
treatment NCT03862677 237 246 O
and NCT03862677 247 250 O
follow NCT03862677 251 257 O
- NCT03862677 258 259 O
up NCT03862677 260 262 O
. NCT03862677 263 264 O

- NCT03862677 268 269 O
Written NCT03862677 271 278 O
informed NCT03862677 279 287 O
consent NCT03862677 288 295 O
. NCT03862677 296 297 O

Exclusion NCT03862677 299 308 O
Criteria NCT03862677 309 317 O
: NCT03862677 318 319 O

- NCT03862677 323 324 O
Other NCT03862677 326 331 O
active NCT03862677 332 338 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
malignancy NCT03862677 339 349 B-Condition-Name
in NCT03862677 350 352 O
past NCT03862677 353 357 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03862677 359 360 B-Eq-Value
years NCT03862677 361 366 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
prior NCT03862677 367 372 O
to NCT03862677 373 375 O
entry NCT03862677 376 381 O
into NCT03862677 382 386 O
the NCT03862677 387 390 O
study NCT03862677 391 396 O
, NCT03862677 397 398 O
except NCT03862677 399 405 O
for NCT03862677 406 409 O
treated NCT03862677 410 417 O
non NCT03862677 418 421 O
- NCT03862677 422 423 O
melanoma NCT03862677 424 432 O
skin NCT03862677 433 437 O
cancer NCT03862677 438 444 B-Condition-Name
. NCT03862677 445 446 O

- NCT03862677 450 451 O
Any NCT03862677 453 456 O
known NCT03862677 457 462 O
severe NCT03862677 463 469 B-Severity___Severity-Value:severe
infection NCT03862677 470 479 B-Condition-Name
like NCT03862677 480 484 O
HIV NCT03862677 485 488 B-Condition-Name
, NCT03862677 489 490 O
hepatitis NCT03862677 491 500 B-Condition-Name
A NCT03862677 501 502 O
, NCT03862677 503 504 O
B NCT03862677 505 506 O
and NCT03862677 507 510 O
C NCT03862677 511 512 O
. NCT03862677 513 514 O

- NCT03862677 518 519 O
Receiving NCT03862677 521 530 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
immune NCT03862677 531 537 B-Procedure-Name
suppressive NCT03862677 538 549 I-Procedure-Name
treatment NCT03862677 550 559 I-Procedure-Name
. NCT03862677 560 561 O

- NCT03862677 565 566 O
Medical NCT03862677 568 575 O
or NCT03862677 576 578 O
psychological NCT03862677 579 592 O
condition NCT03862677 593 602 B-Condition-Name
which NCT03862677 603 608 O
in NCT03862677 609 611 O
the NCT03862677 612 615 O
opinion NCT03862677 616 623 O
of NCT03862677 624 626 O
the NCT03862677 627 630 O
investigator NCT03862677 631 643 O
would NCT03862677 644 649 O
not NCT03862677 650 653 O
permit NCT03862677 654 660 O
the NCT03862677 661 664 O
patient NCT03862677 665 672 O
to NCT03862677 673 675 O
complete NCT03862677 676 684 O
the NCT03862677 685 688 O
study NCT03862677 689 694 O
or NCT03862677 695 697 O
sign NCT03862677 698 702 O
meaningful NCT03862677 703 713 O
informed NCT03862677 714 722 O
consent NCT03862677 723 730 O
. NCT03862677 731 732 O

Inclusion NCT03860909 0 9 O
Criteria NCT03860909 10 18 O
: NCT03860909 19 20 O

- NCT03860909 24 25 O
Female NCT03860909 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03860909 34 42 O
who NCT03860909 43 46 O
have NCT03860909 47 51 O
symptoms NCT03860909 52 60 O
consistent NCT03860909 61 71 O
with NCT03860909 72 76 O
endometriosis NCT03860909 77 90 B-Condition-Name
such NCT03860909 91 95 O
as NCT03860909 96 98 O
pelvic NCT03860909 99 105 O
pain NCT03860909 106 110 B-Condition-Name
, NCT03860909 111 112 O
dysmenorrhea NCT03860909 113 125 B-Condition-Name
, NCT03860909 126 127 O
deep NCT03860909 128 132 B-Condition-Name
dyspareunia NCT03860909 133 144 I-Condition-Name
, NCT03860909 145 146 O
and NCT03860909 147 150 O
infertility NCT03860909 151 162 B-Condition-Name

Exclusion NCT03860909 163 172 O
Criteria NCT03860909 173 181 O
: NCT03860909 182 183 O

- NCT03860909 187 188 O
The NCT03860909 190 193 O
common NCT03860909 194 200 O
contraindication NCT03860909 201 217 O
to NCT03860909 218 220 O
MRI NCT03860909 221 224 B-Procedure-Name
, NCT03860909 225 226 O
peacemaker NCT03860909 227 237 B-Procedure-Name
, NCT03860909 238 239 O
metallic NCT03860909 240 248 B-Condition-Name
foreign NCT03860909 249 256 I-Condition-Name
bodies NCT03860909 257 263 I-Condition-Name
, NCT03860909 264 265 O
and NCT03860909 266 269 O
claustrophobia NCT03860909 270 284 B-Condition-Name

Inclusion NCT03869905 0 9 O
Criteria NCT03869905 10 18 O
: NCT03869905 19 20 O

- NCT03869905 24 25 O
Ulcerative NCT03869905 27 37 B-Condition-Name
colitis NCT03869905 38 45 I-Condition-Name
with NCT03869905 46 50 O
confirmed NCT03869905 51 60 O
diagnosis NCT03869905 61 70 O
by NCT03869905 71 73 O
histology NCT03869905 74 83 B-Procedure-Name
and NCT03869905 84 87 O
endoscopy NCT03869905 88 97 B-Procedure-Name
AND NCT03869905 98 101 O
in NCT03869905 102 104 O
stable NCT03869905 105 111 B-Stability___Stability-Value:stable
remission NCT03869905 112 121 B-Condition-Name
for NCT03869905 122 125 O
3 NCT03869905 127 128 B-Eq-Value
months NCT03869905 129 135 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03869905 136 138 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03869905 139 143 I-Eq-Operator___Eq-Operator-Value:GTEQ
without NCT03869905 144 151 O
therapy NCT03869905 152 159 B-Procedure-Name
or NCT03869905 160 162 O
with NCT03869905 163 167 O
a NCT03869905 168 169 O
maintenance NCT03869905 170 181 B-Procedure-Name
therapy NCT03869905 182 189 I-Procedure-Name
( NCT03869905 190 191 O
except NCT03869905 192 198 O
steroids NCT03869905 199 207 B-Drug-Name
and NCT03869905 208 211 O
antibiotics NCT03869905 212 223 B-Drug-Name
for NCT03869905 224 227 O
3 NCT03869905 229 230 B-Eq-Value
months NCT03869905 231 237 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03869905 238 239 O

- NCT03869905 243 244 O
A NCT03869905 246 247 O
negative NCT03869905 248 256 B-Polarity___Polarity-Value:negative
pregnancy NCT03869905 257 266 B-Observation-Name___Observation-Type-Value:lab
test NCT03869905 267 271 I-Observation-Name___Observation-Type-Value:lab

Exclusion NCT03869905 272 281 O
Criteria NCT03869905 282 290 O
: NCT03869905 291 292 O

- NCT03869905 296 297 O
No NCT03869905 299 301 O
history NCT03869905 302 309 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03869905 310 312 O
diagnosis NCT03869905 313 322 O
of NCT03869905 323 325 O
any NCT03869905 326 329 O
of NCT03869905 330 332 O
the NCT03869905 333 336 O
following NCT03869905 337 346 O
conditions NCT03869905 347 357 O
: NCT03869905 358 359 O
Chron NCT03869905 360 365 B-Condition-Name
's NCT03869905 365 367 I-Condition-Name
disease NCT03869905 368 375 I-Condition-Name
, NCT03869905 376 377 O
bleeding NCT03869905 378 386 B-Condition-Name
disorders NCT03869905 387 396 I-Condition-Name
, NCT03869905 397 398 O
gastrointestinal NCT03869905 399 415 O
or NCT03869905 416 418 O
colonic NCT03869905 419 426 O
malignancy NCT03869905 427 437 B-Condition-Name
, NCT03869905 438 439 O
Kidney NCT03869905 440 446 B-Condition-Name
disease NCT03869905 447 454 I-Condition-Name
, NCT03869905 455 456 O
including NCT03869905 457 466 O
kidney NCT03869905 467 473 B-Condition-Name
" NCT03869905 474 475 I-Condition-Name
stones NCT03869905 475 481 I-Condition-Name
" NCT03869905 481 482 I-Condition-Name
or NCT03869905 483 485 O
hypercalcemia NCT03869905 486 499 B-Condition-Name
, NCT03869905 500 501 O
Coagulopathy NCT03869905 502 514 B-Condition-Name
/ NCT03869905 515 516 O
hereditary NCT03869905 517 527 O
hemorrhagic NCT03869905 528 539 B-Condition-Name
disorders NCT03869905 540 549 I-Condition-Name
/ NCT03869905 550 551 O
or NCT03869905 552 554 O
receiving NCT03869905 555 564 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
therapeutic NCT03869905 565 576 B-Procedure-Name
doses NCT03869905 577 582 O
of NCT03869905 583 585 O
Coumadin NCT03869905 586 594 B-Drug-Name
or NCT03869905 595 597 O
heparin NCT03869905 598 605 B-Drug-Name
. NCT03869905 606 607 O

- NCT03869905 611 612 O
Ingested NCT03869905 614 622 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
certain NCT03869905 623 630 O
medications NCT03869905 631 642 O
( NCT03869905 643 644 O
Calcium NCT03869905 645 652 B-Drug-Name
, NCT03869905 653 654 O
Vitamin NCT03869905 655 662 B-Drug-Name
D NCT03869905 663 664 I-Drug-Name
, NCT03869905 665 666 O
fiber NCT03869905 667 672 B-Drug-Name
supplements NCT03869905 673 684 I-Drug-Name
and NCT03869905 685 688 O
Non NCT03869905 689 692 B-Drug-Name
- NCT03869905 693 694 I-Drug-Name
steroidal NCT03869905 695 704 I-Drug-Name
anti NCT03869905 705 709 I-Drug-Name
- NCT03869905 710 711 I-Drug-Name
inflammatory NCT03869905 712 724 I-Drug-Name
drugs NCT03869905 725 730 I-Drug-Name
- NCT03869905 731 732 O
NSAIDs NCT03869905 733 739 B-Drug-Name
) NCT03869905 740 741 O
within NCT03869905 742 748 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03869905 750 752 B-Eq-Value
days NCT03869905 753 757 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03869905 758 760 O
study NCT03869905 761 766 O
start NCT03869905 767 772 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
. NCT03869905 773 774 O

Inclusion NCT03862703 0 9 O
Criteria NCT03862703 10 18 O
: NCT03862703 19 20 O

1 NCT03862703 25 26 O
. NCT03862703 26 27 O
must NCT03862703 29 33 O
be NCT03862703 34 36 O
at NCT03862703 37 39 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862703 40 45 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03862703 47 49 B-Eq-Value
years NCT03862703 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862703 56 59 O
. NCT03862703 60 61 O

2 NCT03862703 66 67 O
. NCT03862703 67 68 O
fulfil NCT03862703 70 76 O
the NCT03862703 77 80 O
DSM NCT03862703 81 84 O
- NCT03862703 85 86 O
5 NCT03862703 88 89 O
PTSD NCT03862703 90 94 B-Condition-Name
diagnosis NCT03862703 95 104 O
criteria NCT03862703 105 113 O
. NCT03862703 114 115 O

3 NCT03862703 120 121 O
. NCT03862703 121 122 O
be NCT03862703 124 126 O
referred NCT03862703 127 135 O
to NCT03862703 136 138 O
PTSD NCT03862703 139 143 B-Condition-Name
care NCT03862703 144 148 B-Procedure-Name
package NCT03862703 149 156 I-Procedure-Name
treatment NCT03862703 157 166 I-Procedure-Name
( NCT03862703 167 168 O
Danske NCT03862703 169 175 O
regioner NCT03862703 176 184 O
, NCT03862703 185 186 O
pakkeforløb NCT03862703 187 198 O
for NCT03862703 199 202 O
PTSD NCT03862703 203 207 O
, NCT03862703 208 209 O
2017 NCT03862703 211 215 O
) NCT03862703 216 217 O

4 NCT03862703 226 227 O
. NCT03862703 227 228 O
have NCT03862703 230 234 O
access NCT03862703 235 241 O
to NCT03862703 242 244 O
a NCT03862703 245 246 O
smartphone NCT03862703 247 257 O
with NCT03862703 258 262 O
iOS NCT03862703 263 266 O
( NCT03862703 267 268 O
version NCT03862703 269 276 O
10 NCT03862703 278 280 O
or NCT03862703 281 283 O
higher NCT03862703 284 290 O
) NCT03862703 291 292 O
or NCT03862703 293 295 O
Android NCT03862703 296 303 O
( NCT03862703 304 305 O
version NCT03862703 306 313 O
5.0.1 NCT03862703 315 320 O
. NCT03862703 320 321 O
or NCT03862703 323 325 O
higher NCT03862703 326 332 O
) NCT03862703 333 334 O

5 NCT03862703 339 340 O
. NCT03862703 340 341 O
provide NCT03862703 343 350 O
informed NCT03862703 351 359 O
consent NCT03862703 360 367 O
. NCT03862703 368 369 O

Exclusion NCT03862703 371 380 O
Criteria NCT03862703 381 389 O
: NCT03862703 390 391 O

1 NCT03862703 396 397 O
. NCT03862703 397 398 O
suicidal NCT03862703 400 408 B-Condition-Name
risk NCT03862703 409 413 O

2 NCT03862703 417 418 O
. NCT03862703 418 419 O
ongoing NCT03862703 421 428 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
episode NCT03862703 429 436 O
of NCT03862703 437 439 O
bipolar NCT03862703 440 447 B-Condition-Name
disease NCT03862703 448 455 I-Condition-Name
or NCT03862703 456 458 O
psychotic NCT03862703 459 468 B-Condition-Name
disorder NCT03862703 469 477 I-Condition-Name

3 NCT03862703 481 482 O
. NCT03862703 482 483 O
current NCT03862703 485 492 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
abuse NCT03862703 493 498 B-Condition-Name
of NCT03862703 499 501 O
alcohol NCT03862703 502 509 O
or NCT03862703 510 512 O
drugs NCT03862703 513 518 O

4 NCT03862703 522 523 O
. NCT03862703 523 524 O
inability NCT03862703 526 535 O
to NCT03862703 536 538 O
understand NCT03862703 539 549 O
and NCT03862703 550 553 O
/ NCT03862703 554 555 O
or NCT03862703 556 558 O
read NCT03862703 559 563 O
Danish NCT03862703 564 570 B-Language

5 NCT03862703 574 575 O
. NCT03862703 575 576 O
concurrent NCT03862703 578 588 O
psychiatric NCT03862703 589 600 O
or NCT03862703 601 603 O
psychological NCT03862703 604 617 O
treatment NCT03862703 618 627 O
of NCT03862703 628 630 O
PTSD NCT03862703 631 635 B-Condition-Name
outside NCT03862703 636 643 O
of NCT03862703 644 646 O
MHS NCT03862703 647 650 B-Procedure-Name
- NCT03862703 651 652 I-Procedure-Name
CRD NCT03862703 653 656 I-Procedure-Name
. NCT03862703 657 658 O


Inclusion NCT03863353 0 9 O
Criteria NCT03863353 10 18 O
: NCT03863353 19 20 O

- NCT03863353 24 25 O
Undergoing NCT03863353 27 37 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
an NCT03863353 38 40 O
elective NCT03863353 41 49 O
surgical NCT03863353 50 58 B-Procedure-Name
procedure NCT03863353 59 68 I-Procedure-Name
for NCT03863353 69 72 O
which NCT03863353 73 78 O
it NCT03863353 79 81 O
is NCT03863353 82 84 O
expected NCT03863353 85 93 O
they NCT03863353 94 98 O
will NCT03863353 99 103 O
receive NCT03863353 104 111 O
a NCT03863353 112 113 O
prescription NCT03863353 114 126 O
pain NCT03863353 127 131 B-Condition-Name
medicine NCT03863353 132 140 O
for NCT03863353 141 144 O
management NCT03863353 145 155 O
of NCT03863353 156 158 O
pain NCT03863353 159 163 B-Condition-Name
during NCT03863353 164 170 O
recovery NCT03863353 171 179 B-Observation-Name
at NCT03863353 180 182 O
home NCT03863353 183 187 B-Location___Location-Value:residence
. NCT03863353 188 189 O

Exclusion NCT03863353 191 200 O
Criteria NCT03863353 201 209 O
: NCT03863353 210 211 O

- NCT03863353 215 216 O
Undergoing NCT03863353 218 228 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
non NCT03863353 229 232 O
- NCT03863353 233 234 O
elective NCT03863353 235 243 O
procedure NCT03863353 244 253 B-Procedure-Name

- NCT03863353 256 257 O
Cognitive NCT03863353 259 268 B-Condition-Name
impairment NCT03863353 269 279 I-Condition-Name
precluding NCT03863353 280 290 O
self NCT03863353 291 295 O
- NCT03863353 296 297 O
reporting NCT03863353 298 307 O
of NCT03863353 308 310 O
pain NCT03863353 311 315 B-Condition-Name

- NCT03863353 318 319 O
Hematologic NCT03863353 321 332 O
/ NCT03863353 333 334 O
oncologic NCT03863353 335 344 O
condition NCT03863353 345 354 B-Condition-Name

- NCT03863353 357 358 O
Liver NCT03863353 360 365 O
of NCT03863353 366 368 O
kidney NCT03863353 369 375 O
conditions NCT03863353 376 386 B-Condition-Name
precluding NCT03863353 387 397 O
usual NCT03863353 398 403 O
analgesic NCT03863353 404 413 B-Drug-Name
prescription NCT03863353 414 426 I-Drug-Name
patters NCT03863353 427 434 I-Drug-Name
( NCT03863353 435 436 O
opioid NCT03863353 437 443 B-Drug-Name
plus NCT03863353 444 448 O
a NCT03863353 449 450 O
non NCT03863353 451 454 O
- NCT03863353 455 456 O
opioid NCT03863353 457 463 B-Drug-Name
) NCT03863353 464 465 O

- NCT03863353 469 470 O
Use NCT03863353 472 475 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03863353 476 478 O
opioids NCT03863353 479 486 B-Drug-Name
for NCT03863353 487 490 O
prolonged NCT03863353 491 500 O
pain NCT03863353 501 505 B-Condition-Name
pre NCT03863353 506 509 O
- NCT03863353 510 511 O
operatively NCT03863353 512 523 B-Procedure-Name
( NCT03863353 524 525 O
< NCT03863353 527 528 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03863353 530 531 B-Eq-Value
weeks NCT03863353 532 537 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03863353 538 539 O

Inclusion NCT03860896 0 9 O
Criteria NCT03860896 10 18 O
: NCT03860896 19 20 O

- NCT03860896 24 25 O
Patients NCT03860896 27 35 O
aged NCT03860896 36 40 O
18 NCT03860896 42 44 B-Eq-Value
- NCT03860896 45 46 B-Eq-Operator___Eq-Operator-Value:BETWEEN
74 NCT03860896 48 50 B-Eq-Value
, NCT03860896 51 52 O
receiving NCT03860896 53 62 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
therapy NCT03860896 63 70 B-Procedure-Name
for NCT03860896 71 74 O
active NCT03860896 75 81 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
ulcerative NCT03860896 82 92 B-Condition-Name
colitis NCT03860896 93 100 I-Condition-Name
confirmed NCT03860896 101 110 O
by NCT03860896 111 113 O
Mayo NCT03860896 114 118 B-Observation-Name___Observation-Type-Value:clinical-score
Score NCT03860896 119 124 I-Observation-Name___Observation-Type-Value:clinical-score
assessment NCT03860896 125 135 I-Observation-Name___Observation-Type-Value:clinical-score
, NCT03860896 136 137 O
and NCT03860896 138 141 O
evidence NCT03860896 142 150 O
of NCT03860896 151 153 O
colonic NCT03860896 154 161 B-Condition-Name
inflammation NCT03860896 162 174 I-Condition-Name
. NCT03860896 175 176 O

Exclusion NCT03860896 178 187 O
Criteria NCT03860896 188 196 O
: NCT03860896 197 198 O

- NCT03860896 202 203 O
Evidence NCT03860896 205 213 O
of NCT03860896 214 216 O
Crohn NCT03860896 217 222 B-Condition-Name
's NCT03860896 222 224 I-Condition-Name
disease NCT03860896 225 232 I-Condition-Name
, NCT03860896 233 234 O
indeterminate NCT03860896 235 248 B-Condition-Name
colitis NCT03860896 249 256 I-Condition-Name
, NCT03860896 257 258 O
or NCT03860896 259 261 O
presence NCT03860896 262 270 O
of NCT03860896 271 273 O
bacterial NCT03860896 274 283 O
or NCT03860896 284 286 O
parasitic NCT03860896 287 296 O
infection NCT03860896 297 306 B-Condition-Name
. NCT03860896 307 308 O

- NCT03860896 312 313 O
Patients NCT03860896 315 323 O
receiving NCT03860896 324 333 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
biologic NCT03860896 334 342 B-Drug-Name
agents NCT03860896 343 349 I-Drug-Name
and NCT03860896 350 353 O
experimental NCT03860896 354 366 B-Drug-Name
agents NCT03860896 367 373 I-Drug-Name
are NCT03860896 374 377 O
excluded NCT03860896 378 386 O
. NCT03860896 387 388 O

Inclusion NCT03862924 0 9 O
Criteria NCT03862924 10 18 O
: NCT03862924 19 20 O

- NCT03862924 24 25 O
diagnosed NCT03862924 27 36 O
with NCT03862924 37 41 O
and NCT03862924 42 45 O
engaged NCT03862924 46 53 O
in NCT03862924 54 56 O
care NCT03862924 57 61 O
for NCT03862924 62 65 O
HIV NCT03862924 66 69 B-Condition-Name
( NCT03862924 70 71 O
defined NCT03862924 72 79 O
as NCT03862924 80 82 O
at NCT03862924 83 85 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862924 86 91 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03862924 92 95 B-Eq-Value
HIV NCT03862924 96 99 B-Location___Location-Value:clinic
clinic NCT03862924 100 106 I-Location___Location-Value:clinic
medical NCT03862924 107 114 B-Encounter-Type___Encounter-Type-Value:outpatient
appointment NCT03862924 115 126 I-Encounter-Type___Encounter-Type-Value:outpatient
within NCT03862924 127 133 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03862924 134 137 O
past NCT03862924 138 142 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03862924 143 146 B-Eq-Value
month NCT03862924 147 152 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
period NCT03862924 153 159 O
) NCT03862924 160 161 O

- NCT03862924 165 166 O
at NCT03862924 168 170 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862924 171 176 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03862924 178 180 B-Eq-Value
years NCT03862924 181 186 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03862924 187 189 O
age NCT03862924 190 193 O

- NCT03862924 196 197 O
smoke NCT03862924 199 204 B-Condition-Name
at NCT03862924 205 207 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862924 208 213 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03862924 215 216 B-Eq-Value
cigarettes NCT03862924 217 227 B-Eq-Unit
per NCT03862924 228 231 O
day NCT03862924 232 235 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
for NCT03862924 236 239 O
longer NCT03862924 240 246 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862924 247 251 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03862924 252 255 B-Eq-Value
year NCT03862924 256 260 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862924 263 264 O
exhaled NCT03862924 266 273 B-Observation-Name___Observation-Type-Value:measurement
carbon NCT03862924 274 280 I-Observation-Name___Observation-Type-Value:measurement
monoxide NCT03862924 281 289 I-Observation-Name___Observation-Type-Value:measurement
( NCT03862924 290 291 O
CO NCT03862924 292 294 B-Observation-Name
) NCT03862924 295 296 O
level NCT03862924 297 302 O
greater NCT03862924 303 310 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862924 311 315 I-Eq-Operator___Eq-Operator-Value:GT
5 NCT03862924 317 318 B-Eq-Value
at NCT03862924 319 321 O
BL NCT03862924 322 324 O

Exclusion NCT03862924 325 334 O
Criteria NCT03862924 335 343 O
: NCT03862924 344 345 O

- NCT03862924 349 350 O
intention NCT03862924 352 361 O
to NCT03862924 362 364 O
quit NCT03862924 365 369 B-Condition-Name
smoking NCT03862924 370 377 I-Condition-Name
in NCT03862924 378 380 O
the NCT03862924 381 384 O
next NCT03862924 385 389 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
30 NCT03862924 391 393 B-Eq-Value
days NCT03862924 394 398 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03862924 401 402 O
currently NCT03862924 404 413 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
using NCT03862924 414 419 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pharmacotherapy NCT03862924 420 435 B-Procedure-Name
for NCT03862924 436 439 O
smoking NCT03862924 440 447 B-Procedure-Name
cessation NCT03862924 448 457 I-Procedure-Name

- NCT03862924 460 461 O
currently NCT03862924 463 472 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
using NCT03862924 473 478 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
electronic NCT03862924 479 489 O
cigarettes NCT03862924 490 500 B-Drug-Name
more NCT03862924 501 505 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862924 506 510 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03862924 512 513 B-Eq-Value
days NCT03862924 514 518 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
/ NCT03862924 519 520 O
week NCT03862924 521 525 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03862924 528 529 O
unstable NCT03862924 531 539 B-Stability___Stability-Value:change
medical NCT03862924 540 547 O
or NCT03862924 548 550 O
psychiatric NCT03862924 551 562 O
condition NCT03862924 563 572 B-Condition-Name
( NCT03862924 573 574 O
defined NCT03862924 575 582 O
as NCT03862924 583 585 O
hospitalization NCT03862924 586 601 B-Encounter-Type___Encounter-Type-Value:inpatient
) NCT03862924 602 603 O

- NCT03862924 607 608 O
medical NCT03862924 610 617 O
contraindications NCT03862924 618 635 O
to NCT03862924 636 638 O
nicotine NCT03862924 639 647 B-Drug-Name
( NCT03862924 648 649 O
unstable NCT03862924 650 658 B-Stability___Stability-Value:change
angina NCT03862924 659 665 B-Condition-Name
, NCT03862924 666 667 O
uncontrolled NCT03862924 668 680 O
hypertension NCT03862924 681 693 B-Condition-Name
, NCT03862924 694 695 O
or NCT03862924 696 698 O
recent NCT03862924 699 705 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
cardiovascular NCT03862924 706 720 B-Condition-Name
event NCT03862924 721 726 I-Condition-Name
, NCT03862924 727 728 O
including NCT03862924 729 738 O
hospitalization NCT03862924 739 754 B-Encounter-Type___Encounter-Type-Value:inpatient
) NCT03862924 755 756 O

- NCT03862924 760 761 O
psychotic NCT03862924 763 772 B-Condition-Name
symptoms NCT03862924 773 781 O

- NCT03862924 784 785 O
substance NCT03862924 787 796 B-Condition-Name
use NCT03862924 797 800 I-Condition-Name
disorder NCT03862924 801 809 I-Condition-Name
other NCT03862924 810 815 O
than NCT03862924 816 820 O
nicotine NCT03862924 821 829 B-Condition-Name
dependence NCT03862924 830 840 I-Condition-Name

- NCT03862924 843 844 O
past NCT03862924 846 850 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03862924 851 852 O
month NCT03862924 853 858 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
suicidal NCT03862924 859 867 B-Condition-Name
ideation NCT03862924 868 876 I-Condition-Name
or NCT03862924 877 879 O
past NCT03862924 880 884 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03862924 885 886 O
year NCT03862924 887 891 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
suicide NCT03862924 892 899 B-Condition-Name
attempt NCT03862924 900 907 I-Condition-Name

- NCT03862924 910 911 O
pregnant NCT03862924 913 921 B-Condition-Name
or NCT03862924 922 924 O
nursing NCT03862924 925 932 B-Condition-Name
. NCT03862924 933 934 O

Inclusion NCT03861975 0 9 O
Criteria NCT03861975 10 18 O
: NCT03861975 19 20 O

- NCT03861975 24 25 O
Participants NCT03861975 27 39 O
must NCT03861975 40 44 O
have NCT03861975 45 49 O
histologically NCT03861975 50 64 O
or NCT03861975 65 67 O
cytologically NCT03861975 68 81 B-Procedure-Name
confirmed NCT03861975 82 91 O
invasive NCT03861975 92 100 O
or NCT03861975 101 103 O
in NCT03861975 104 106 O
- NCT03861975 107 108 O
situ NCT03861975 109 113 O
carcinoma NCT03861975 114 123 B-Condition-Name
of NCT03861975 124 126 O
the NCT03861975 127 130 O
breast NCT03861975 131 137 O
and NCT03861975 138 141 O
will NCT03861975 142 146 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03861975 147 154 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
unilateral NCT03861975 155 165 O
breast NCT03861975 166 172 O
cancer NCT03861975 173 179 B-Condition-Name
surgery NCT03861975 180 187 B-Procedure-Name

- NCT03861975 190 191 O
Willingness NCT03861975 193 204 O
to NCT03861975 205 207 O
complete NCT03861975 208 216 O
SEI NCT03861975 217 220 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03861975 221 222 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
BCLE NCT03861975 223 227 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03861975 228 241 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire

- NCT03861975 244 245 O
Age NCT03861975 247 250 O
> NCT03861975 251 252 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03861975 254 256 B-Eq-Value
years NCT03861975 257 262 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03861975 263 264 O

- NCT03861975 268 269 O
Ability NCT03861975 271 278 O
to NCT03861975 279 281 O
understand NCT03861975 282 292 O
and NCT03861975 293 296 O
the NCT03861975 297 300 O
willingness NCT03861975 301 312 O
to NCT03861975 313 315 O
verbally NCT03861975 316 324 O
consent NCT03861975 325 332 O
to NCT03861975 333 335 O
the NCT03861975 336 339 O
trial NCT03861975 340 345 O

Exclusion NCT03861975 346 355 O
Criteria NCT03861975 356 364 O
: NCT03861975 365 366 O

- NCT03861975 370 371 O
History NCT03861975 373 380 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861975 381 383 O
primary NCT03861975 384 391 O
lymphedema NCT03861975 392 402 B-Condition-Name
. NCT03861975 403 404 O

- NCT03861975 408 409 O
Any NCT03861975 411 414 O
patient NCT03861975 415 422 O
with NCT03861975 423 427 O
a NCT03861975 428 429 O
current NCT03861975 430 437 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
case NCT03861975 438 442 O
of NCT03861975 443 445 O
cellulitis NCT03861975 446 456 B-Condition-Name
. NCT03861975 457 458 O

- NCT03861975 462 463 O
Participants NCT03861975 465 477 O
with NCT03861975 478 482 O
known NCT03861975 483 488 O
brain NCT03861975 489 494 O
metastases NCT03861975 495 505 B-Condition-Name
should NCT03861975 506 512 O
be NCT03861975 513 515 O
excluded NCT03861975 516 524 O
from NCT03861975 525 529 O
this NCT03861975 530 534 O
clinical NCT03861975 535 543 O
trial NCT03861975 544 549 O
because NCT03861975 550 557 O
of NCT03861975 558 560 O
their NCT03861975 561 566 O
poor NCT03861975 567 571 B-Condition-Name
prognosis NCT03861975 572 581 I-Condition-Name
and NCT03861975 582 585 O
because NCT03861975 586 593 O
they NCT03861975 594 598 O
often NCT03861975 599 604 O
develop NCT03861975 605 612 O
progressive NCT03861975 613 624 O
neurologic NCT03861975 625 635 B-Condition-Name
dysfunction NCT03861975 636 647 I-Condition-Name
that NCT03861975 648 652 O
would NCT03861975 653 658 O
confound NCT03861975 659 667 B-Stability___Stability-Value:change
the NCT03861975 668 671 O
evaluation NCT03861975 672 682 B-Procedure-Name
of NCT03861975 683 685 O
neurologic NCT03861975 686 696 O
and NCT03861975 697 700 O
other NCT03861975 701 706 O
adverse NCT03861975 707 714 B-Condition-Name
events NCT03861975 715 721 I-Condition-Name
. NCT03861975 722 723 O

- NCT03861975 727 728 O
Uncontrolled NCT03861975 730 742 O
intercurrent NCT03861975 743 755 B-Condition-Name
illness NCT03861975 756 763 I-Condition-Name
including NCT03861975 764 773 O
, NCT03861975 774 775 O
but NCT03861975 776 779 O
not NCT03861975 780 783 O
limited NCT03861975 784 791 O
to NCT03861975 792 794 O
, NCT03861975 795 796 O
ongoing NCT03861975 797 804 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03861975 805 807 O
active NCT03861975 808 814 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03861975 815 824 B-Condition-Name
, NCT03861975 825 826 O
symptomatic NCT03861975 827 838 O
congestive NCT03861975 839 849 B-Condition-Name
heart NCT03861975 850 855 I-Condition-Name
failure NCT03861975 856 863 I-Condition-Name
, NCT03861975 864 865 O
unstable NCT03861975 866 874 B-Stability___Stability-Value:change
angina NCT03861975 875 881 B-Condition-Name
pectoris NCT03861975 882 890 I-Condition-Name
, NCT03861975 891 892 O
cardiac NCT03861975 893 900 B-Condition-Name
arrhythmia NCT03861975 901 911 I-Condition-Name
, NCT03861975 912 913 O
or NCT03861975 914 916 O
psychiatric NCT03861975 917 928 O
illness NCT03861975 929 936 B-Condition-Name
/ NCT03861975 937 938 O
social NCT03861975 939 945 B-Observation-Name___Observation-Type-Value:social-habit
situations NCT03861975 946 956 I-Observation-Name___Observation-Type-Value:social-habit
that NCT03861975 957 961 O
would NCT03861975 962 967 O
limit NCT03861975 968 973 B-Stability___Stability-Value:change
compliance NCT03861975 974 984 O
with NCT03861975 985 989 O
study NCT03861975 990 995 O
requirements NCT03861975 996 1008 O
. NCT03861975 1009 1010 O

- NCT03861975 1014 1015 O
Participants NCT03861975 1017 1029 O
unable NCT03861975 1030 1036 O
to NCT03861975 1037 1039 O
abduct NCT03861975 1040 1046 B-Condition-Name
upper NCT03861975 1047 1052 O
- NCT03861975 1053 1054 O
extremity NCT03861975 1055 1064 O
perpendicular NCT03861975 1065 1078 O
to NCT03861975 1079 1081 O
body NCT03861975 1082 1086 O
or NCT03861975 1087 1089 O
to NCT03861975 1090 1092 O
stand NCT03861975 1093 1098 B-Observation-Name
comfortably NCT03861975 1099 1110 B-Polarity___Polarity-Value:normal
without NCT03861975 1111 1118 O
aid NCT03861975 1119 1122 O
for NCT03861975 1123 1126 O
several NCT03861975 1127 1134 B-Eq-Operator___Eq-Operator-Value:GT
minutes NCT03861975 1135 1142 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
, NCT03861975 1143 1144 O
both NCT03861975 1145 1149 O
of NCT03861975 1150 1152 O
which NCT03861975 1153 1158 O
are NCT03861975 1159 1162 O
necessary NCT03861975 1163 1172 O
to NCT03861975 1173 1175 O
perform NCT03861975 1176 1183 O
a NCT03861975 1184 1185 O
LymphaTech NCT03861975 1186 1196 B-Procedure-Name
Scan NCT03861975 1197 1201 I-Procedure-Name

Inclusion NCT03861949 0 9 O
Criteria NCT03861949 10 18 O
: NCT03861949 19 20 O

- NCT03861949 24 25 O
adult NCT03861949 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03861949 33 41 O
of NCT03861949 42 44 O
ASA NCT03861949 45 48 B-Condition-Name
physical NCT03861949 49 57 O
status NCT03861949 58 64 B-Eq-Unit
I NCT03861949 65 66 B-Eq-Value
and NCT03861949 67 70 O
II NCT03861949 71 73 B-Eq-Value
undergoing NCT03861949 74 84 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surgery NCT03861949 85 92 B-Procedure-Name
under NCT03861949 93 98 O
general NCT03861949 99 106 B-Procedure-Name
anaesthesia NCT03861949 107 118 I-Procedure-Name

Exclusion NCT03861949 119 128 O
Criteria NCT03861949 129 137 O
: NCT03861949 138 139 O

- NCT03861949 143 144 O
anticipated NCT03861949 146 157 O
difficult NCT03861949 158 167 O
mask NCT03861949 168 172 B-Procedure-Name
ventilation NCT03861949 173 184 I-Procedure-Name
/ NCT03861949 185 186 O
intubation NCT03861949 187 197 B-Procedure-Name

- NCT03861949 200 201 O
individuals NCT03861949 203 214 O
with NCT03861949 215 219 O
significant NCT03861949 220 231 B-Severity___Severity-Value:severe
cardiorespiratory NCT03861949 232 249 O
or NCT03861949 250 252 O
cerebrovascular NCT03861949 253 268 O
disease NCT03861949 269 276 B-Condition-Name

- NCT03861949 279 280 O
pregnant NCT03861949 282 290 B-Condition-Name
ladies NCT03861949 291 297 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03861949 300 301 O
patient NCT03861949 303 310 O
with NCT03861949 311 315 O
history NCT03861949 316 323 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861949 324 326 O
epilepsy NCT03861949 327 335 B-Condition-Name

- NCT03861949 338 339 O
body NCT03861949 341 345 B-Observation-Name___Observation-Type-Value:vital
mass NCT03861949 346 350 I-Observation-Name___Observation-Type-Value:vital
index NCT03861949 351 356 I-Observation-Name___Observation-Type-Value:vital
> NCT03861949 357 358 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03861949 360 362 B-Eq-Value
kg NCT03861949 363 365 B-Eq-Unit
/ NCT03861949 366 367 O
m NCT03861949 368 369 B-Eq-Unit
2 NCT03861949 370 371 I-Eq-Unit

- NCT03861949 374 375 O
hemoglobin NCT03861949 377 387 B-Observation-Name___Observation-Type-Value:lab
< NCT03861949 388 389 B-Eq-Operator___Eq-Operator-Value:LT
8 NCT03861949 391 392 B-Eq-Value
gm NCT03861949 393 395 B-Eq-Unit
/ NCT03861949 396 397 O
dL NCT03861949 398 400 B-Eq-Unit

- NCT03861949 403 404 O
patients NCT03861949 406 414 O
who NCT03861949 415 418 O
were NCT03861949 419 423 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
non NCT03861949 424 427 O
- NCT03861949 428 429 O
ambulant NCT03861949 430 438 B-Condition-Name
for NCT03861949 439 442 O
> NCT03861949 443 444 B-Eq-Operator___Eq-Operator-Value:GT
24 NCT03861949 446 448 B-Eq-Value
h NCT03861949 449 450 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
, NCT03861949 451 452 O
having NCT03861949 453 459 O
SpO NCT03861949 460 463 B-Observation-Name___Observation-Type-Value:vital
2 NCT03861949 464 465 I-Observation-Name___Observation-Type-Value:vital
< NCT03861949 466 467 B-Eq-Operator___Eq-Operator-Value:LT
97 NCT03861949 469 471 B-Eq-Value
% NCT03861949 472 473 B-Eq-Unit
while NCT03861949 474 479 O
breathing NCT03861949 480 489 B-Observation-Name
in NCT03861949 490 492 O
room NCT03861949 493 497 O
air NCT03861949 498 501 O

- NCT03861949 504 505 O
phobia NCT03861949 507 513 B-Condition-Name
to NCT03861949 514 516 O
facemask NCT03861949 517 525 O
. NCT03861949 526 527 O

Inclusion NCT03867929 0 9 O
Criteria NCT03867929 10 18 O
: NCT03867929 19 20 O

- NCT03867929 24 25 O
presence NCT03867929 27 35 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 36 38 O
erectile NCT03867929 39 47 B-Condition-Name
dysfunction NCT03867929 48 59 I-Condition-Name

Exclusion NCT03867929 60 69 O
Criteria NCT03867929 70 78 O
: NCT03867929 79 80 O

- NCT03867929 84 85 O
Presence NCT03867929 87 95 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 96 98 O
uncontrolled NCT03867929 99 111 O
diabetes NCT03867929 112 120 B-Condition-Name
mellitus NCT03867929 121 129 I-Condition-Name
, NCT03867929 130 131 O

- NCT03867929 135 136 O
Presence NCT03867929 138 146 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 147 149 O
uncontrolled NCT03867929 150 162 O
hypertension NCT03867929 163 175 B-Condition-Name
, NCT03867929 176 177 O

- NCT03867929 181 182 O
Presence NCT03867929 184 192 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 193 195 O
uncontrolled NCT03867929 196 208 O
lipid NCT03867929 209 214 B-Condition-Name
metabolism NCT03867929 215 225 I-Condition-Name
disorders NCT03867929 226 235 I-Condition-Name
, NCT03867929 236 237 O

- NCT03867929 241 242 O
Presence NCT03867929 244 252 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 253 255 O
neurological NCT03867929 256 268 B-Condition-Name
diseases NCT03867929 269 277 I-Condition-Name
, NCT03867929 278 279 O

- NCT03867929 283 284 O
Presence NCT03867929 286 294 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 295 297 O
heamatological NCT03867929 298 312 B-Condition-Name
diseases NCT03867929 313 321 I-Condition-Name
, NCT03867929 322 323 O

- NCT03867929 327 328 O
Urinary NCT03867929 330 337 B-Condition-Name
tract NCT03867929 338 343 I-Condition-Name
infection NCT03867929 344 353 I-Condition-Name
, NCT03867929 354 355 O

- NCT03867929 359 360 O
Diagnosis NCT03867929 362 371 O
of NCT03867929 372 374 O
any NCT03867929 375 378 O
malignencies NCT03867929 379 391 B-Condition-Name
, NCT03867929 392 393 O

- NCT03867929 397 398 O
Chronic NCT03867929 400 407 O
kidney NCT03867929 408 414 B-Condition-Name
failure NCT03867929 415 422 I-Condition-Name
, NCT03867929 423 424 O

- NCT03867929 428 429 O
Presence NCT03867929 431 439 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 440 442 O
metabolic NCT03867929 443 452 B-Condition-Name
syndrome NCT03867929 453 461 I-Condition-Name
, NCT03867929 462 463 O

- NCT03867929 467 468 O
Presence NCT03867929 470 478 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03867929 479 481 O
psychiatric NCT03867929 482 493 B-Condition-Name
diseases NCT03867929 494 502 I-Condition-Name
and NCT03867929 503 506 O
/ NCT03867929 507 508 O
or NCT03867929 509 511 O
medical NCT03867929 512 519 O
treatment NCT03867929 520 529 O
, NCT03867929 530 531 O

- NCT03867929 535 536 O
Smoking NCT03867929 538 545 B-Condition-Name
, NCT03867929 546 547 O

- NCT03867929 551 552 O
History NCT03867929 554 561 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867929 562 564 O
pelvic NCT03867929 565 571 B-Procedure-Name
surgery NCT03867929 572 579 I-Procedure-Name
, NCT03867929 580 581 O
cardiac NCT03867929 582 589 B-Procedure-Name
surgery NCT03867929 590 597 I-Procedure-Name
and NCT03867929 598 601 O
pelvic NCT03867929 602 608 O
radiotherapy NCT03867929 609 621 B-Procedure-Name

Inclusion NCT03865680 0 9 O
Criteria NCT03865680 10 18 O
: NCT03865680 19 20 O

- NCT03865680 24 25 O
Healthy NCT03865680 27 34 B-Condition-Name
children NCT03865680 35 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03865680 44 48 O
no NCT03865680 49 51 O
systemic NCT03865680 52 60 O
diseases NCT03865680 61 69 B-Condition-Name
. NCT03865680 70 71 O

- NCT03865680 75 76 O
High NCT03865680 78 82 B-Polarity___Polarity-Value:high
caries NCT03865680 83 89 B-Condition-Name
risk NCT03865680 90 94 O
children NCT03865680 95 103 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03865680 104 108 O
the NCT03865680 109 112 O
presence NCT03865680 113 121 O
of NCT03865680 122 124 O
at NCT03865680 125 127 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865680 128 133 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03865680 134 137 B-Eq-Value
visible NCT03865680 138 145 O
active NCT03865680 146 152 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
WSL NCT03865680 153 156 B-Condition-Name
in NCT03865680 157 159 O
primary NCT03865680 160 167 O
teeth NCT03865680 168 173 O
with NCT03865680 174 178 O
ICDAS NCT03865680 179 184 B-Observation-Name___Observation-Type-Value:clinical-score
II NCT03865680 185 187 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03865680 188 193 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03865680 194 196 O
1 NCT03865680 198 199 B-Eq-Value
, NCT03865680 200 201 O
2 NCT03865680 202 203 B-Eq-Value
or NCT03865680 204 206 O
3 NCT03865680 208 209 B-Eq-Value

- NCT03865680 213 214 O
Completion NCT03865680 216 226 O
of NCT03865680 227 229 O
a NCT03865680 230 231 O
parental NCT03865680 232 240 O
consent NCT03865680 241 248 O
to NCT03865680 249 251 O
participate NCT03865680 252 263 O
in NCT03865680 264 266 O
the NCT03865680 267 270 O
study NCT03865680 271 276 O
. NCT03865680 277 278 O

Exclusion NCT03865680 280 289 O
Criteria NCT03865680 290 298 O
: NCT03865680 299 300 O

- NCT03865680 304 305 O
Selected NCT03865680 307 315 O
tooth NCT03865680 316 321 O
with NCT03865680 322 326 O
cavitated NCT03865680 327 336 B-Condition-Name
lesion NCT03865680 337 343 I-Condition-Name
. NCT03865680 344 345 O

- NCT03865680 349 350 O
Selected NCT03865680 352 360 O
tooth NCT03865680 361 366 O
with NCT03865680 367 371 O
enamel NCT03865680 372 378 B-Condition-Name
defects NCT03865680 379 386 I-Condition-Name
. NCT03865680 387 388 O

- NCT03865680 392 393 O
Participants NCT03865680 395 407 O
allergic NCT03865680 408 416 O
to NCT03865680 417 419 O
milk NCT03865680 420 424 B-Allergy-Name
products NCT03865680 425 433 O
. NCT03865680 434 435 O

Inclusion NCT03869086 0 9 O
Criteria NCT03869086 10 18 O
: NCT03869086 19 20 O

- NCT03869086 24 25 O
BMI NCT03869086 27 30 B-Observation-Name___Observation-Type-Value:vital
> NCT03869086 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03869086 34 35 I-Eq-Operator___Eq-Operator-Value:GTEQ
25 NCT03869086 37 39 B-Eq-Value
kg NCT03869086 40 42 B-Eq-Unit
/ NCT03869086 43 44 O
m NCT03869086 45 46 B-Eq-Unit
2 NCT03869086 47 48 I-Eq-Unit

- NCT03869086 51 52 O
Adults NCT03869086 54 60 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
aged NCT03869086 61 65 O
50 NCT03869086 67 69 B-Eq-Value
- NCT03869086 70 71 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03869086 73 75 B-Eq-Value
years NCT03869086 76 81 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869086 82 85 O

- NCT03869086 88 89 O
Successful NCT03869086 91 101 O
biochemical NCT03869086 102 113 O
, NCT03869086 114 115 O
haematological NCT03869086 116 130 O
, NCT03869086 131 132 O
and NCT03869086 133 136 O
urinalysis NCT03869086 137 147 O
assessment NCT03869086 148 158 B-Procedure-Name
at NCT03869086 159 161 O
screening NCT03869086 162 171 O

Exclusion NCT03869086 172 181 O
Criteria NCT03869086 182 190 O
: NCT03869086 191 192 O

- NCT03869086 196 197 O
Current NCT03869086 199 206 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
smokers NCT03869086 207 214 B-Condition-Name
, NCT03869086 215 216 O
or NCT03869086 217 219 O
ex NCT03869086 220 222 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03869086 223 224 O
smokers NCT03869086 225 232 B-Condition-Name
ceasing NCT03869086 233 240 O
< NCT03869086 241 242 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03869086 244 245 B-Eq-Value
months NCT03869086 246 252 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
ago NCT03869086 253 256 O

- NCT03869086 259 260 O
existing NCT03869086 262 270 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03869086 271 273 O
significant NCT03869086 274 285 B-Severity___Severity-Value:severe
past NCT03869086 286 290 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
medical NCT03869086 291 298 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03869086 299 306 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869086 307 309 O
vascular NCT03869086 310 318 B-Condition-Name
disease NCT03869086 319 326 I-Condition-Name
or NCT03869086 327 329 O
medical NCT03869086 330 337 O
conditions NCT03869086 338 348 O
likely NCT03869086 349 355 O
to NCT03869086 356 358 O
affect NCT03869086 359 365 B-Stability___Stability-Value:change
the NCT03869086 366 369 O
study NCT03869086 370 375 O
measures NCT03869086 376 384 O

- NCT03869086 387 388 O
Fructose NCT03869086 390 398 O
or NCT03869086 399 401 O
lactose NCT03869086 402 409 O
intolerant NCT03869086 410 420 B-Condition-Name
subjects NCT03869086 421 429 O
or NCT03869086 430 432 O
known NCT03869086 433 438 O
allergies NCT03869086 439 448 O
to NCT03869086 449 451 O
intervention NCT03869086 452 464 O
treatments NCT03869086 465 475 O

- NCT03869086 478 479 O
Those NCT03869086 481 486 O
unprepared NCT03869086 487 497 O
to NCT03869086 498 500 O
adhere NCT03869086 501 507 O
to NCT03869086 508 510 O
dietary NCT03869086 511 518 B-Procedure-Name
instructions NCT03869086 519 531 I-Procedure-Name

- NCT03869086 534 535 O
Parallel NCT03869086 537 545 O
participation NCT03869086 546 559 O
in NCT03869086 560 562 O
another NCT03869086 563 570 O
research NCT03869086 571 579 O
project NCT03869086 580 587 O
involving NCT03869086 588 597 O
dietary NCT03869086 598 605 B-Procedure-Name
intervention NCT03869086 606 618 I-Procedure-Name
and NCT03869086 619 622 O
/ NCT03869086 623 624 O
or NCT03869086 625 627 O
sampling NCT03869086 628 636 B-Procedure-Name
of NCT03869086 637 639 O
biological NCT03869086 640 650 O
fluids NCT03869086 651 657 O
/ NCT03869086 658 659 O
material NCT03869086 660 668 O

- NCT03869086 671 672 O
Those NCT03869086 674 679 O
on NCT03869086 680 682 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
therapeutic NCT03869086 683 694 B-Procedure-Name
diets NCT03869086 695 700 I-Procedure-Name
or NCT03869086 701 703 O
having NCT03869086 704 710 O
experienced NCT03869086 711 722 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
substantial NCT03869086 723 734 B-Severity___Severity-Value:severe
weight NCT03869086 735 741 B-Condition-Name
loss NCT03869086 742 746 I-Condition-Name
within NCT03869086 747 753 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03869086 755 756 B-Eq-Value
months NCT03869086 757 763 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03869086 764 766 O
screening NCT03869086 767 776 O
. NCT03869086 777 778 O

- NCT03869086 782 783 O
Those NCT03869086 785 790 O
taking NCT03869086 791 797 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
flavonoid NCT03869086 798 807 B-Drug-Name
, NCT03869086 808 809 O
nitrate NCT03869086 810 817 B-Drug-Name
/ NCT03869086 818 819 O
nitrite NCT03869086 820 827 B-Drug-Name
containing NCT03869086 828 838 I-Drug-Name
or NCT03869086 839 841 O
fish NCT03869086 842 846 O
oil NCT03869086 847 850 O
containing NCT03869086 851 861 O
supplements NCT03869086 862 873 B-Drug-Name
( NCT03869086 874 875 O
and NCT03869086 876 879 O
unwilling NCT03869086 880 889 O
to NCT03869086 890 892 O
cease NCT03869086 893 898 O
intake NCT03869086 899 905 O
during NCT03869086 906 912 O
, NCT03869086 913 914 O
and NCT03869086 915 918 O
1 NCT03869086 920 921 B-Eq-Value
month NCT03869086 922 927 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
preceding NCT03869086 928 937 O
the NCT03869086 938 941 O
trial NCT03869086 942 947 O
) NCT03869086 948 949 O
or NCT03869086 950 952 O
unwilling NCT03869086 953 962 O
to NCT03869086 963 965 O
maintain NCT03869086 966 974 B-Stability___Stability-Value:stable
existing NCT03869086 975 983 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
intake NCT03869086 984 990 O
of NCT03869086 991 993 O
other NCT03869086 994 999 O
supplements NCT03869086 1000 1011 B-Drug-Name
. NCT03869086 1012 1013 O

- NCT03869086 1017 1018 O
Prescribed NCT03869086 1020 1030 O
hypoglycaemic NCT03869086 1031 1044 B-Drug-Name
, NCT03869086 1045 1046 O
anti NCT03869086 1047 1051 B-Drug-Name
- NCT03869086 1052 1053 I-Drug-Name
hypertensive NCT03869086 1054 1066 I-Drug-Name
, NCT03869086 1067 1068 O
vasodilator NCT03869086 1069 1080 B-Drug-Name
or NCT03869086 1081 1083 O
hormone NCT03869086 1084 1091 B-Procedure-Name
replacement NCT03869086 1092 1103 I-Procedure-Name
therapy NCT03869086 1104 1111 I-Procedure-Name
( NCT03869086 1112 1113 O
HRT NCT03869086 1114 1117 B-Procedure-Name
) NCT03869086 1118 1119 O
medication NCT03869086 1120 1130 O
. NCT03869086 1131 1132 O

- NCT03869086 1136 1137 O
Unsatisfactory NCT03869086 1139 1153 O
biochemical NCT03869086 1154 1165 O
, NCT03869086 1166 1167 O
haematological NCT03869086 1168 1182 O
or NCT03869086 1183 1185 O
urinary NCT03869086 1186 1193 O
results NCT03869086 1194 1201 B-Observation-Name
or NCT03869086 1202 1204 O
measurements NCT03869086 1205 1217 B-Observation-Name___Observation-Type-Value:measurement
considered NCT03869086 1218 1228 O
to NCT03869086 1229 1231 O
be NCT03869086 1232 1234 O
counter NCT03869086 1235 1242 B-Stability___Stability-Value:change
indicative NCT03869086 1243 1253 I-Stability___Stability-Value:change
for NCT03869086 1254 1257 O
the NCT03869086 1258 1261 O
study NCT03869086 1262 1267 O

- NCT03869086 1270 1271 O
Undiagnosed NCT03869086 1273 1284 O
hypertension NCT03869086 1285 1297 B-Condition-Name
( NCT03869086 1298 1299 O
elicited NCT03869086 1300 1308 O
at NCT03869086 1309 1311 O
screening NCT03869086 1312 1321 O
; NCT03869086 1321 1322 O
i NCT03869086 1323 1324 O
. NCT03869086 1325 1326 O
e NCT03869086 1327 1328 O
. NCT03869086 1329 1330 O
≥ NCT03869086 1332 1333 B-Eq-Operator___Eq-Operator-Value:GTEQ
180 NCT03869086 1335 1338 B-Eq-Value
/ NCT03869086 1339 1340 O
110 NCT03869086 1342 1345 B-Eq-Value
mmHg NCT03869086 1346 1350 B-Eq-Unit
) NCT03869086 1351 1352 O
at NCT03869086 1353 1355 O
a NCT03869086 1356 1357 O
level NCT03869086 1358 1363 O
requiring NCT03869086 1364 1373 O
immediate NCT03869086 1374 1383 O
referral NCT03869086 1384 1392 O
back NCT03869086 1393 1397 O
to NCT03869086 1398 1400 O
general NCT03869086 1401 1408 B-Provider-Role
practitioner NCT03869086 1409 1421 I-Provider-Role
for NCT03869086 1422 1425 O
follow NCT03869086 1426 1432 O
- NCT03869086 1433 1434 O
up NCT03869086 1435 1437 O

Inclusion NCT03864549 0 9 O
Criteria NCT03864549 10 18 O
: NCT03864549 19 20 O

- NCT03864549 24 25 O
Pregnant NCT03864549 27 35 B-Condition-Name
women NCT03864549 36 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03864549 42 45 O
were NCT03864549 46 50 O
diagnosed NCT03864549 51 60 O
with NCT03864549 61 65 O
GDM NCT03864549 66 69 B-Condition-Name
from NCT03864549 70 74 O
13 NCT03864549 76 78 B-Eq-Value
to NCT03864549 79 81 B-Eq-Operator___Eq-Operator-Value:BETWEEN
32.6 NCT03864549 83 87 B-Eq-Value
gestational NCT03864549 88 99 B-Observation-Name___Observation-Type-Value:measurement
weeks NCT03864549 100 105 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03864549 108 109 O
18 NCT03864549 112 114 B-Eq-Value
years NCT03864549 115 120 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03864549 121 124 O
and NCT03864549 125 128 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03864549 129 134 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03864549 137 138 O
Singleton NCT03864549 140 149 O
pregnancy NCT03864549 150 159 B-Condition-Name

Exclusion NCT03864549 160 169 O
Criteria NCT03864549 170 178 O
: NCT03864549 179 180 O

- NCT03864549 184 185 O
Women NCT03864549 187 192 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864549 193 197 O
pre NCT03864549 198 201 O
- NCT03864549 202 203 O
gestational NCT03864549 204 215 O
diabetes NCT03864549 216 224 B-Condition-Name
mellitus NCT03864549 225 233 I-Condition-Name

- NCT03864549 236 237 O
GDM NCT03864549 239 242 B-Condition-Name
diagnosed NCT03864549 243 252 O
≥ NCT03864549 253 254 B-Eq-Operator___Eq-Operator-Value:GTEQ
33 NCT03864549 256 258 B-Eq-Value
gestational NCT03864549 259 270 B-Observation-Name___Observation-Type-Value:measurement
weeks NCT03864549 271 276 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03864549 279 280 O
Women NCT03864549 282 287 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
using NCT03864549 288 293 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
prophylactic NCT03864549 294 306 B-Procedure-Name
antimicrobial NCT03864549 307 320 I-Procedure-Name
treatment NCT03864549 321 330 I-Procedure-Name

- NCT03864549 333 334 O
Immunocompromised NCT03864549 336 353 B-Condition-Name
women NCT03864549 354 359 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03864549 362 363 O
Multiple NCT03864549 365 373 B-Eq-Operator___Eq-Operator-Value:GT
pregnancy NCT03864549 374 383 B-Condition-Name

- NCT03864549 386 387 O
Women NCT03864549 389 394 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
taking NCT03864549 395 401 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
oral NCT03864549 402 406 O
probiotic NCT03864549 407 416 B-Drug-Name
products NCT03864549 417 425 I-Drug-Name
who NCT03864549 426 429 O
refuse NCT03864549 430 436 O
to NCT03864549 437 439 O
stop NCT03864549 440 444 O
the NCT03864549 445 448 O
consumption NCT03864549 449 460 O
( NCT03864549 461 462 O
food NCT03864549 463 467 O
- NCT03864549 468 469 O
containing NCT03864549 470 480 O
probiotics NCT03864549 481 491 B-Drug-Name
is NCT03864549 492 494 O
not NCT03864549 495 498 O
considered NCT03864549 499 509 O
an NCT03864549 510 512 O
exclusion NCT03864549 513 522 O
criterion NCT03864549 523 532 O
) NCT03864549 533 534 O
. NCT03864549 536 537 O

Inclusion NCT03869723 0 9 O
Criteria NCT03869723 10 18 O
: NCT03869723 19 20 O

- NCT03869723 24 25 O
Patients NCT03869723 27 35 O
who NCT03869723 36 39 O
underwent NCT03869723 40 49 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
fibula NCT03869723 50 56 B-Procedure-Name
free NCT03869723 57 61 I-Procedure-Name
flap NCT03869723 62 66 I-Procedure-Name
for NCT03869723 67 70 O
mandibular NCT03869723 71 81 B-Procedure-Name
reconstruction NCT03869723 82 96 I-Procedure-Name

- NCT03869723 99 100 O
Patient NCT03869723 102 109 O
≥ NCT03869723 110 111 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03869723 113 115 B-Eq-Value
years NCT03869723 116 121 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869723 122 125 O

- NCT03869723 128 129 O
patient NCT03869723 131 138 O
alive NCT03869723 139 144 O
6 NCT03869723 146 147 B-Eq-Value
months NCT03869723 148 154 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03869723 155 160 O
completion NCT03869723 161 171 O
of NCT03869723 172 174 O
treatment NCT03869723 175 184 O

Exclusion NCT03869723 185 194 O
Criteria NCT03869723 195 203 O
: NCT03869723 204 205 O

- NCT03869723 209 210 O
Patient NCT03869723 212 219 O
without NCT03869723 220 227 O
post NCT03869723 228 232 O
- NCT03869723 233 234 O
operative NCT03869723 235 244 B-Procedure-Name
scan NCT03869723 245 249 B-Procedure-Name
evaluation NCT03869723 250 260 I-Procedure-Name

- NCT03869723 263 264 O
Patient NCT03869723 266 273 O
with NCT03869723 274 278 O
a NCT03869723 279 280 O
chirurgical NCT03869723 281 292 B-Procedure-Name
contraindication NCT03869723 293 309 O

- NCT03869723 312 313 O
Pregnant NCT03869723 315 323 B-Condition-Name
or NCT03869723 324 326 O
nursing NCT03869723 327 334 B-Condition-Name
woman NCT03869723 335 340 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03869723 343 344 O
Adult NCT03869723 346 351 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
requiring NCT03869723 352 361 B-Observation-Name
protection NCT03869723 362 372 I-Observation-Name
( NCT03869723 373 374 O
guardianship NCT03869723 375 387 B-Observation-Name
, NCT03869723 388 389 O
supervision NCT03869723 390 401 B-Observation-Name
) NCT03869723 402 403 O

Inclusion NCT03861182 0 9 O
Criteria NCT03861182 10 18 O
: NCT03861182 19 20 O

Adult NCT03861182 22 27 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
Healthy NCT03861182 28 35 B-Condition-Name
Volunteers NCT03861182 36 46 O
: NCT03861182 47 48 O

- NCT03861182 51 52 O
Over NCT03861182 53 57 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03861182 59 61 B-Eq-Value
years NCT03861182 62 67 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03861182 68 70 O
age NCT03861182 71 74 O

Neonates NCT03861182 75 83 B-Condition-Name
: NCT03861182 84 85 O

- NCT03861182 89 90 O
Aged NCT03861182 92 96 O
between NCT03861182 97 104 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1 NCT03861182 106 107 B-Eq-Value
h NCT03861182 108 109 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03861182 110 112 O
life NCT03861182 113 117 O
and NCT03861182 118 121 O
28 NCT03861182 123 125 B-Eq-Value
days NCT03861182 126 130 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03861182 131 133 O
life NCT03861182 134 138 O

- NCT03861182 141 142 O
Born NCT03861182 144 148 O
beyond NCT03861182 149 155 B-Eq-Operator___Eq-Operator-Value:GT
33 NCT03861182 157 159 B-Eq-Value
Week NCT03861182 160 164 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03861182 165 167 O
Amenorrhea NCT03861182 168 178 B-Condition-Name
+ NCT03861182 179 180 O
1 NCT03861182 182 183 B-Eq-Value
day NCT03861182 184 187 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
and NCT03861182 188 191 O
2 NCT03861182 193 194 B-Eq-Value
kg NCT03861182 195 197 B-Eq-Unit
of NCT03861182 198 200 O
birth NCT03861182 201 206 B-Observation-Name___Observation-Type-Value:vital
weight NCT03861182 207 213 I-Observation-Name___Observation-Type-Value:vital

- NCT03861182 216 217 O
Hospitalized NCT03861182 219 231 B-Encounter-Type___Encounter-Type-Value:inpatient
in NCT03861182 232 234 O
the NCT03861182 235 238 O
medical NCT03861182 239 246 B-Location___Location-Value:unit
- NCT03861182 247 248 I-Location___Location-Value:unit
surgical NCT03861182 249 257 I-Location___Location-Value:unit
centre NCT03861182 258 264 I-Location___Location-Value:unit
of NCT03861182 265 267 I-Location___Location-Value:unit
Pediatrics NCT03861182 268 278 I-Location___Location-Value:unit
of NCT03861182 279 281 O
the NCT03861182 282 285 O
hospital NCT03861182 286 294 B-Location___Location-Value:hospital
of NCT03861182 295 297 I-Location___Location-Value:hospital
Strasbourg NCT03861182 298 308 I-Location___Location-Value:hospital

- NCT03861182 311 312 O
For NCT03861182 314 317 O
whom NCT03861182 318 322 O
a NCT03861182 323 324 O
blood NCT03861182 325 330 B-Observation-Name___Observation-Type-Value:lab
sample NCT03861182 331 337 I-Observation-Name___Observation-Type-Value:lab
was NCT03861182 338 341 O
prescribed NCT03861182 342 352 O
as NCT03861182 353 355 O
part NCT03861182 356 360 O
of NCT03861182 361 363 O
their NCT03861182 364 369 O
routine NCT03861182 370 377 O
care NCT03861182 378 382 O

Exclusion NCT03861182 383 392 O
Criteria NCT03861182 393 401 O
: NCT03861182 402 403 O

Adult NCT03861182 405 410 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
Healthy NCT03861182 411 418 B-Condition-Name
Volunteers NCT03861182 419 429 O
: NCT03861182 430 431 O

- NCT03861182 435 436 O
Systemic NCT03861182 438 446 O
inflammatory NCT03861182 447 459 B-Condition-Name
disease NCT03861182 460 467 I-Condition-Name

- NCT03861182 470 471 O
Transient NCT03861182 473 482 B-Condition-Name
inflammatory NCT03861182 483 495 I-Condition-Name
state NCT03861182 496 501 I-Condition-Name

- NCT03861182 504 505 O
Any NCT03861182 507 510 O
drug NCT03861182 511 515 O
that NCT03861182 516 520 O
modifies NCT03861182 521 529 B-Stability___Stability-Value:change
the NCT03861182 530 533 O
coagulation NCT03861182 534 545 B-Condition-Name
cascade NCT03861182 546 553 I-Condition-Name
during NCT03861182 554 560 O
the NCT03861182 561 564 O
48 NCT03861182 566 568 B-Eq-Value
h NCT03861182 569 570 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
preceding NCT03861182 571 580 O
the NCT03861182 581 584 O
sampling NCT03861182 585 593 O

Neonates NCT03861182 594 602 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
: NCT03861182 603 604 O

- NCT03861182 608 609 O
Risk NCT03861182 611 615 O
of NCT03861182 616 618 O
anemia NCT03861182 619 625 B-Condition-Name
< NCT03861182 626 627 B-Eq-Operator___Eq-Operator-Value:LT
7 NCT03861182 629 630 B-Eq-Value
g NCT03861182 631 632 I-Eq-Value
/ NCT03861182 633 634 O
DL NCT03861182 635 637 B-Eq-Unit

- NCT03861182 640 641 O
Current NCT03861182 643 650 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
anticoagulant NCT03861182 651 664 B-Drug-Name
treatment NCT03861182 665 674 O

Inclusion NCT03866148 0 9 O
Criteria NCT03866148 10 18 O
: NCT03866148 19 20 O

- NCT03866148 24 25 O
Patients NCT03866148 27 35 O
with NCT03866148 36 40 O
moderate NCT03866148 41 49 B-Severity___Severity-Value:moderate
to NCT03866148 50 52 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03866148 53 59 B-Severity___Severity-Value:severe
sleep NCT03866148 60 65 B-Condition-Name
apnoea NCT03866148 66 72 I-Condition-Name
who NCT03866148 73 76 O
require NCT03866148 77 84 O
CPAP NCT03866148 85 89 B-Procedure-Name
as NCT03866148 90 92 O
standard NCT03866148 93 101 O
care NCT03866148 102 106 O
( NCT03866148 107 108 O
AHI NCT03866148 109 112 B-Observation-Name
> NCT03866148 113 114 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03866148 116 118 B-Eq-Value
) NCT03866148 119 120 O

- NCT03866148 124 125 O
Patients NCT03866148 127 135 O
between NCT03866148 136 143 B-Eq-Operator___Eq-Operator-Value:BETWEEN
the NCT03866148 144 147 O
age NCT03866148 148 151 O
of NCT03866148 152 154 O
18 NCT03866148 156 158 B-Eq-Value
and NCT03866148 159 162 O
75 NCT03866148 164 166 B-Eq-Value

Exclusion NCT03866148 168 177 O
Criteria NCT03866148 178 186 O
: NCT03866148 187 188 O

- NCT03866148 192 193 O
Patients NCT03866148 195 203 O
with NCT03866148 204 208 O
a NCT03866148 209 210 O
diagnosis NCT03866148 211 220 O
of NCT03866148 221 223 O
atrial NCT03866148 224 230 B-Condition-Name
fibrillation NCT03866148 231 243 I-Condition-Name
( NCT03866148 244 245 O
AF NCT03866148 246 248 B-Condition-Name
) NCT03866148 249 250 O
, NCT03866148 252 253 O
atrial NCT03866148 254 260 B-Condition-Name
flutter NCT03866148 261 268 I-Condition-Name
and NCT03866148 269 272 O
/ NCT03866148 273 274 O
or NCT03866148 275 277 O
ventricular NCT03866148 278 289 B-Condition-Name
tachycardia NCT03866148 290 301 I-Condition-Name
( NCT03866148 302 303 O
VT NCT03866148 304 306 B-Condition-Name
) NCT03866148 307 308 O

- NCT03866148 312 313 O
Patients NCT03866148 315 323 O
with NCT03866148 324 328 O
an NCT03866148 329 331 O
ILR NCT03866148 332 335 B-Procedure-Name
already NCT03866148 336 343 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03866148 344 346 O
- NCT03866148 347 348 O
situ NCT03866148 349 353 O
or NCT03866148 354 356 O
an NCT03866148 357 359 O
established NCT03866148 360 371 O
indication NCT03866148 372 382 O
for NCT03866148 383 386 O
ILR NCT03866148 387 390 B-Procedure-Name

- NCT03866148 393 394 O
Patients NCT03866148 396 404 O
with NCT03866148 405 409 O
a NCT03866148 410 411 O
palliative NCT03866148 412 422 B-Condition-Name
diagnosis NCT03866148 423 432 O
i NCT03866148 433 434 O
. NCT03866148 435 436 O
e NCT03866148 437 438 O
. NCT03866148 439 440 O
life NCT03866148 442 446 B-Observation-Name
expectancy NCT03866148 447 457 I-Observation-Name
less NCT03866148 458 462 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03866148 463 467 I-Eq-Operator___Eq-Operator-Value:LT
3 NCT03866148 469 470 B-Eq-Value
years NCT03866148 471 476 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866148 479 480 O
Patients NCT03866148 482 490 O
who NCT03866148 491 494 O
lack NCT03866148 495 499 B-Condition-Name
capacity NCT03866148 500 508 I-Condition-Name

Inclusion NCT03863756 0 9 O
Criteria NCT03863756 10 18 O
: NCT03863756 19 20 O

- NCT03863756 24 25 O
Patients NCT03863756 27 35 O
with NCT03863756 36 40 O
Spondyloarthritis NCT03863756 41 58 B-Condition-Name
( NCT03863756 59 60 O
SpA NCT03863756 61 64 B-Condition-Name
) NCT03863756 65 66 O
meeting NCT03863756 67 74 O
the NCT03863756 75 78 O
criteria NCT03863756 79 87 O
of NCT03863756 88 90 O
Amor NCT03863756 91 95 O
and NCT03863756 96 99 O
/ NCT03863756 100 101 O
or NCT03863756 102 104 O
Assessement NCT03863756 105 116 O
of NCT03863756 117 119 O
spondyloarthritis NCT03863756 120 137 O
International NCT03863756 138 151 O
Society NCT03863756 152 159 O
( NCT03863756 160 161 O
ASAS NCT03863756 162 166 O
) NCT03863756 167 168 O

- NCT03863756 172 173 O
Indication NCT03863756 175 185 O
of NCT03863756 186 188 O
standard NCT03863756 189 197 B-Procedure-Name
radiography NCT03863756 198 209 I-Procedure-Name
for NCT03863756 210 213 O
the NCT03863756 214 217 O
follow NCT03863756 218 224 O
- NCT03863756 225 226 O
up NCT03863756 227 229 O
of NCT03863756 230 232 O
the NCT03863756 233 236 O
patients NCT03863756 237 245 O
. NCT03863756 246 247 O

Exclusion NCT03863756 249 258 O
Criteria NCT03863756 259 267 O
: NCT03863756 268 269 O

- NCT03863756 273 274 O
the NCT03863756 276 279 O
presence NCT03863756 280 288 O
of NCT03863756 289 291 O
a NCT03863756 292 293 O
contraindication NCT03863756 294 310 O
to NCT03863756 311 313 O
the NCT03863756 314 317 O
performance NCT03863756 318 329 O
of NCT03863756 330 332 O
conventional NCT03863756 333 345 B-Procedure-Name
radiography NCT03863756 346 357 I-Procedure-Name
( NCT03863756 358 359 O
CR NCT03863756 360 362 B-Procedure-Name
) NCT03863756 363 364 O
or NCT03863756 365 367 O
EOS NCT03863756 368 371 B-Procedure-Name
imaging NCT03863756 372 379 I-Procedure-Name

- NCT03863756 382 383 O
any NCT03863756 385 388 O
disease NCT03863756 389 396 B-Condition-Name
affecting NCT03863756 397 406 B-Stability___Stability-Value:change
cognition NCT03863756 407 416 B-Condition-Name

- NCT03863756 419 420 O
Patients NCT03863756 422 430 O
who NCT03863756 431 434 O
have NCT03863756 435 439 O
had NCT03863756 440 443 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgery NCT03863756 444 451 B-Procedure-Name
on NCT03863756 452 454 O
the NCT03863756 455 458 O
spine NCT03863756 459 464 O
and NCT03863756 465 468 O
/ NCT03863756 469 470 O
or NCT03863756 471 473 O
hip NCT03863756 474 477 O
. NCT03863756 478 479 O

Inclusion NCT03864991 0 9 O
Criteria NCT03864991 10 18 O
: NCT03864991 19 20 O

- NCT03864991 24 25 O
Patient NCT03864991 27 34 O
diagnosed NCT03864991 35 44 O
with NCT03864991 45 49 O
T NCT03864991 50 51 B-Condition-Name
1D NCT03864991 52 54 I-Condition-Name
> NCT03864991 55 56 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03864991 58 59 B-Eq-Value
months NCT03864991 60 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03864991 69 70 O
Patient NCT03864991 72 79 O
's NCT03864991 79 81 O
age NCT03864991 82 85 O
≥ NCT03864991 86 87 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03864991 89 91 B-Eq-Value
years NCT03864991 92 97 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864991 100 101 O
Patient NCT03864991 103 110 O
or NCT03864991 111 113 O
any NCT03864991 114 117 O
one NCT03864991 118 121 O
of NCT03864991 122 124 O
the NCT03864991 125 128 O
family NCT03864991 129 135 O
member NCT03864991 136 142 O
like NCT03864991 143 147 O
father NCT03864991 148 154 O
, NCT03864991 155 156 O
mother NCT03864991 157 163 O
or NCT03864991 164 166 O
sibling NCT03864991 167 174 O
using NCT03864991 175 180 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
smart NCT03864991 181 186 O
phone NCT03864991 187 192 O
. NCT03864991 193 194 O

- NCT03864991 198 199 O
Patient NCT03864991 201 208 O
or NCT03864991 209 211 O
any NCT03864991 212 215 O
one NCT03864991 216 219 O
of NCT03864991 220 222 O
the NCT03864991 223 226 O
family NCT03864991 227 233 O
member NCT03864991 234 240 O
know NCT03864991 241 245 O
how NCT03864991 246 249 O
to NCT03864991 250 252 O
use NCT03864991 253 256 O
( NCT03864991 257 258 O
receive NCT03864991 259 266 O
calls NCT03864991 267 272 O
or NCT03864991 273 275 O
read NCT03864991 276 280 O
text NCT03864991 281 285 O
message NCT03864991 286 293 O
) NCT03864991 294 295 O
a NCT03864991 296 297 O
smart NCT03864991 298 303 O
phone NCT03864991 304 309 O
. NCT03864991 310 311 O

Exclusion NCT03864991 313 322 O
Criteria NCT03864991 323 331 O
: NCT03864991 332 333 O

- NCT03864991 337 338 O
Patient NCT03864991 340 347 O
on NCT03864991 348 350 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
insulin NCT03864991 351 358 B-Drug-Name
pump NCT03864991 359 363 O

- NCT03864991 366 367 O
Pregnant NCT03864991 369 377 B-Condition-Name
females NCT03864991 378 385 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03864991 386 387 O

- NCT03864991 391 392 O
Patient NCT03864991 394 401 O
with NCT03864991 402 406 O
neurodevelopmental NCT03864991 407 425 B-Condition-Name
delay NCT03864991 426 431 I-Condition-Name
or NCT03864991 432 434 O
thalassemia NCT03864991 435 446 B-Condition-Name

- NCT03864991 449 450 O
Patient NCT03864991 452 459 O
currently NCT03864991 460 469 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
using NCT03864991 470 475 O
any NCT03864991 476 479 O
kind NCT03864991 480 484 O
of NCT03864991 485 487 O
authentic NCT03864991 488 497 O
e NCT03864991 498 499 B-Procedure-Name
- NCT03864991 500 501 I-Procedure-Name
device NCT03864991 502 508 I-Procedure-Name
for NCT03864991 509 512 O
step NCT03864991 513 517 B-Observation-Name___Observation-Type-Value:social-habit
count NCT03864991 518 523 I-Observation-Name___Observation-Type-Value:social-habit
or NCT03864991 524 526 O
physical NCT03864991 527 535 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03864991 536 544 I-Observation-Name___Observation-Type-Value:social-habit
. NCT03864991 545 546 O

Inclusion NCT03867240 0 9 O
Criteria NCT03867240 10 18 O
: NCT03867240 19 20 O

- NCT03867240 24 25 O
Be NCT03867240 27 29 O
aged NCT03867240 30 34 O
10 NCT03867240 36 38 B-Eq-Value
- NCT03867240 39 40 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03867240 42 44 B-Eq-Value
years NCT03867240 45 50 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
at NCT03867240 51 53 O
the NCT03867240 54 57 O
time NCT03867240 58 62 O
of NCT03867240 63 65 O
surgery NCT03867240 66 73 B-Procedure-Name

- NCT03867240 76 77 O
Have NCT03867240 79 83 O
a NCT03867240 84 85 O
diagnosis NCT03867240 86 95 O
of NCT03867240 96 98 O
idiopathic NCT03867240 99 109 B-Condition-Name
scoliosis NCT03867240 110 119 I-Condition-Name
and NCT03867240 120 123 O
/ NCT03867240 124 125 O
or NCT03867240 126 128 O
kyphosis NCT03867240 129 137 B-Condition-Name

- NCT03867240 140 141 O
Be NCT03867240 143 145 O
undergoing NCT03867240 146 156 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03867240 157 165 O
posterior NCT03867240 166 175 B-Procedure-Name
spinal NCT03867240 176 182 I-Procedure-Name
fusion NCT03867240 183 189 I-Procedure-Name

- NCT03867240 192 193 O
Have NCT03867240 195 199 O
only NCT03867240 200 204 O
mild NCT03867240 205 209 B-Severity___Severity-Value:mild
systemic NCT03867240 210 218 B-Condition-Name
disease NCT03867240 219 226 I-Condition-Name

Exclusion NCT03867240 227 236 O
Criteria NCT03867240 237 245 O
: NCT03867240 246 247 O

- NCT03867240 251 252 O
A NCT03867240 254 255 O
diagnosis NCT03867240 256 265 O
of NCT03867240 266 268 O
neuromuscular NCT03867240 269 282 B-Condition-Name
scoliosis NCT03867240 283 292 I-Condition-Name
and NCT03867240 293 296 O
/ NCT03867240 297 298 O
or NCT03867240 299 301 O
kyphosis NCT03867240 302 310 B-Condition-Name

- NCT03867240 313 314 O
A NCT03867240 316 317 O
diagnosis NCT03867240 318 327 O
of NCT03867240 328 330 O
chronic NCT03867240 331 338 O
pain NCT03867240 339 343 B-Condition-Name

- NCT03867240 346 347 O
Used NCT03867240 349 353 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
opioids NCT03867240 354 361 B-Drug-Name
in NCT03867240 362 364 O
the NCT03867240 365 368 O
past NCT03867240 369 373 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03867240 375 376 B-Eq-Value
months NCT03867240 377 383 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03867240 386 387 O
Developmental NCT03867240 389 402 B-Condition-Name
delay NCT03867240 403 408 I-Condition-Name

- NCT03867240 411 412 O
Liver NCT03867240 414 419 O
or NCT03867240 420 422 O
kidney NCT03867240 423 429 O
disease NCT03867240 430 437 B-Condition-Name

- NCT03867240 440 441 O
Obstructive NCT03867240 443 454 B-Condition-Name
sleep NCT03867240 455 460 I-Condition-Name
apnea NCT03867240 461 466 I-Condition-Name

- NCT03867240 469 470 O
Body NCT03867240 472 476 B-Observation-Name___Observation-Type-Value:vital
mass NCT03867240 477 481 I-Observation-Name___Observation-Type-Value:vital
index NCT03867240 482 487 I-Observation-Name___Observation-Type-Value:vital
> NCT03867240 488 489 B-Eq-Operator___Eq-Operator-Value:GT
40 NCT03867240 491 493 B-Eq-Value

- NCT03867240 497 498 O
Be NCT03867240 500 502 O
pregnant NCT03867240 503 511 B-Condition-Name
or NCT03867240 512 514 O
breastfeeding NCT03867240 515 528 B-Condition-Name

Inclusion NCT03867526 0 9 O
Criteria NCT03867526 10 18 O
: NCT03867526 19 20 O

- NCT03867526 24 25 O
Informed NCT03867526 27 35 O
consent NCT03867526 36 43 O
will NCT03867526 44 48 O
be NCT03867526 49 51 O
obtained NCT03867526 52 60 O
from NCT03867526 61 65 O
the NCT03867526 66 69 O
patient NCT03867526 70 77 O
or NCT03867526 78 80 O
the NCT03867526 81 84 O
parents NCT03867526 85 92 O
before NCT03867526 93 99 O
any NCT03867526 100 103 O
study NCT03867526 104 109 O
related NCT03867526 110 117 O
procedures NCT03867526 118 128 O
. NCT03867526 129 130 O

- NCT03867526 134 135 O
Patients NCT03867526 137 145 O
of NCT03867526 146 148 O
both NCT03867526 149 153 O
genders NCT03867526 154 161 O
older NCT03867526 162 167 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867526 168 172 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03867526 174 175 B-Eq-Value
months NCT03867526 176 182 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03867526 183 186 O
younger NCT03867526 187 194 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867526 195 199 I-Eq-Operator___Eq-Operator-Value:LT
80 NCT03867526 201 203 B-Eq-Value
years NCT03867526 204 209 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867526 212 213 O
The NCT03867526 215 218 O
patient NCT03867526 219 226 O
has NCT03867526 227 230 O
a NCT03867526 231 232 O
diagnosis NCT03867526 233 242 O
of NCT03867526 243 245 O
Wilson NCT03867526 246 252 B-Condition-Name
dis NCT03867526 253 256 I-Condition-Name
- NCT03867526 257 258 I-Condition-Name
ease NCT03867526 259 263 I-Condition-Name

Exclusion NCT03867526 264 273 O
Criteria NCT03867526 274 282 O
: NCT03867526 283 284 O

- NCT03867526 288 289 O
No NCT03867526 291 293 O
Informed NCT03867526 294 302 O
consent NCT03867526 303 310 O
from NCT03867526 311 315 O
the NCT03867526 316 319 O
patient NCT03867526 320 327 O
or NCT03867526 328 330 O
the NCT03867526 331 334 O
parents NCT03867526 335 342 O
before NCT03867526 343 349 O
any NCT03867526 350 353 O
study NCT03867526 354 359 O
related NCT03867526 360 367 O
procedures NCT03867526 368 378 O

- NCT03867526 381 382 O
Patients NCT03867526 384 392 O
of NCT03867526 393 395 O
both NCT03867526 396 400 O
genders NCT03867526 401 408 O
younger NCT03867526 409 416 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867526 417 421 I-Eq-Operator___Eq-Operator-Value:LT
6 NCT03867526 423 424 B-Eq-Value
months NCT03867526 425 431 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03867526 432 435 O
older NCT03867526 436 441 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867526 442 446 I-Eq-Operator___Eq-Operator-Value:GT
80 NCT03867526 448 450 B-Eq-Value
years NCT03867526 451 456 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867526 459 460 O
No NCT03867526 462 464 O
diagnosis NCT03867526 465 474 O
of NCT03867526 475 477 O
Wilson NCT03867526 478 484 B-Condition-Name
disease NCT03867526 485 492 I-Condition-Name

Inclusion NCT03868826 0 9 O
Criteria NCT03868826 10 18 O
: NCT03868826 19 20 O

- NCT03868826 24 25 O
Patients NCT03868826 27 35 O
eligible NCT03868826 36 44 O
for NCT03868826 45 48 O
treatment NCT03868826 49 58 O
of NCT03868826 59 61 O
hamstring NCT03868826 62 71 B-Condition-Name
avulsion NCT03868826 72 80 I-Condition-Name

Exclusion NCT03868826 81 90 O
Criteria NCT03868826 91 99 O
: NCT03868826 100 101 O

- NCT03868826 105 106 O
Conditions NCT03868826 108 118 O
that NCT03868826 119 123 O
contraindicate NCT03868826 124 138 O
muscle NCT03868826 139 145 B-Procedure-Name
strength NCT03868826 146 154 I-Procedure-Name
testing NCT03868826 155 162 I-Procedure-Name
e NCT03868826 163 164 O
. NCT03868826 165 166 O
g NCT03868826 167 168 O
. NCT03868826 169 170 O
cancer NCT03868826 172 178 B-Condition-Name
and NCT03868826 179 182 O
neurological NCT03868826 183 195 B-Condition-Name
conditions NCT03868826 196 206 I-Condition-Name

- NCT03868826 209 210 O
Patients NCT03868826 212 220 O
that NCT03868826 221 225 O
do NCT03868826 226 228 O
not NCT03868826 229 232 O
speak NCT03868826 233 238 O
or NCT03868826 239 241 O
understand NCT03868826 242 252 O
Danish NCT03868826 253 259 B-Language

Inclusion NCT03866837 0 9 O
Criteria NCT03866837 10 18 O
: NCT03866837 19 20 O

- NCT03866837 24 25 O
vaginal NCT03866837 27 34 B-Procedure-Name
delivery NCT03866837 35 43 I-Procedure-Name

- NCT03866837 46 47 O
an NCT03866837 49 51 O
infant NCT03866837 52 58 O
age NCT03866837 59 62 O
of NCT03866837 63 65 B-Eq-Operator___Eq-Operator-Value:EQ
6 NCT03866837 67 68 B-Eq-Value
months NCT03866837 69 75 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
( NCT03866837 76 77 O
± NCT03866837 79 80 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
3 NCT03866837 82 83 B-Eq-Value
weeks NCT03866837 84 89 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03866837 90 91 O

- NCT03866837 95 96 O
mother NCT03866837 98 104 O
≥ NCT03866837 105 106 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03866837 108 110 B-Eq-Value
years NCT03866837 111 116 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866837 117 119 O
age NCT03866837 120 123 O

- NCT03866837 126 127 O
infant NCT03866837 129 135 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
still NCT03866837 136 141 O
breastfeeding NCT03866837 142 155 B-Condition-Name

- NCT03866837 158 159 O
anticipated NCT03866837 161 172 O
residence NCT03866837 173 182 O
in NCT03866837 183 185 O
the NCT03866837 186 189 O
area NCT03866837 190 194 O
for NCT03866837 195 198 O
the NCT03866837 199 202 O
study NCT03866837 203 208 O
duration NCT03866837 209 217 O
. NCT03866837 218 219 O

Exclusion NCT03866837 221 230 O
Criteria NCT03866837 231 239 O
: NCT03866837 240 241 O

- NCT03866837 245 246 O
inability NCT03866837 248 257 O
to NCT03866837 258 260 O
provide NCT03866837 261 268 O
informed NCT03866837 269 277 O
consent NCT03866837 278 285 O

- NCT03866837 288 289 O
hemoglobin NCT03866837 291 301 B-Observation-Name___Observation-Type-Value:lab
< NCT03866837 302 303 B-Eq-Operator___Eq-Operator-Value:LT
70 NCT03866837 305 307 B-Eq-Value
g NCT03866837 308 309 B-Eq-Unit
/ NCT03866837 310 311 O
L NCT03866837 312 313 B-Eq-Unit

- NCT03866837 316 317 O
Z NCT03866837 319 320 B-Observation-Name___Observation-Type-Value:measurement
scores NCT03866837 321 327 I-Observation-Name___Observation-Type-Value:measurement
for NCT03866837 328 331 I-Observation-Name___Observation-Type-Value:measurement
weight NCT03866837 332 338 I-Observation-Name___Observation-Type-Value:measurement
- NCT03866837 339 340 I-Observation-Name___Observation-Type-Value:measurement
for NCT03866837 341 344 I-Observation-Name___Observation-Type-Value:measurement
- NCT03866837 345 346 I-Observation-Name___Observation-Type-Value:measurement
age NCT03866837 347 350 I-Observation-Name___Observation-Type-Value:measurement
( NCT03866837 351 352 O
WAZ NCT03866837 353 356 B-Observation-Name
) NCT03866837 357 358 O
or NCT03866837 359 361 O
weight NCT03866837 362 368 B-Observation-Name___Observation-Type-Value:measurement
- NCT03866837 369 370 I-Observation-Name___Observation-Type-Value:measurement
for NCT03866837 371 374 I-Observation-Name___Observation-Type-Value:measurement
- NCT03866837 375 376 I-Observation-Name___Observation-Type-Value:measurement
height NCT03866837 377 383 I-Observation-Name___Observation-Type-Value:measurement
( NCT03866837 384 385 O
WHZ NCT03866837 386 389 B-Observation-Name
) NCT03866837 390 391 O
< NCT03866837 392 393 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03866837 395 396 B-Eq-Value
, NCT03866837 397 398 O

- NCT03866837 403 404 O
any NCT03866837 406 409 O
maternal NCT03866837 410 418 O
or NCT03866837 419 421 O
infant NCT03866837 422 428 O
chronic NCT03866837 429 436 O
illness NCT03866837 437 444 B-Condition-Name

- NCT03866837 447 448 O
administration NCT03866837 450 464 O
of NCT03866837 465 467 O
any NCT03866837 468 471 O
infant NCT03866837 472 478 O
vitamin NCT03866837 479 486 O
or NCT03866837 487 489 O
mineral NCT03866837 490 497 O
supplements NCT03866837 498 509 B-Drug-Name
for NCT03866837 510 513 O
the NCT03866837 514 517 O
past NCT03866837 518 522 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03866837 524 525 B-Eq-Value
months NCT03866837 526 532 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03866837 535 536 O
any NCT03866837 538 541 O
history NCT03866837 542 549 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866837 550 552 O
infant NCT03866837 553 559 O
antibiotic NCT03866837 560 570 B-Drug-Name
treatment NCT03866837 571 580 O
. NCT03866837 581 582 O

Inclusion NCT03864952 0 9 O
Criteria NCT03864952 10 18 O
: NCT03864952 19 20 O

- NCT03864952 24 25 O
three NCT03864952 27 32 B-Eq-Value
months NCT03864952 33 39 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03864952 40 46 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
, NCT03864952 47 48 O
having NCT03864952 49 55 O
been NCT03864952 56 60 O
infected NCT03864952 61 69 B-Condition-Name
with NCT03864952 70 74 O
a NCT03864952 75 76 O
documented NCT03864952 77 87 O
pathogen NCT03864952 88 96 B-Condition-Name

- NCT03864952 99 100 O
this NCT03864952 102 106 O
infection NCT03864952 107 116 O
must NCT03864952 117 121 O
have NCT03864952 122 126 O
been NCT03864952 127 131 O
clinically NCT03864952 132 142 O
obvious NCT03864952 143 150 O

- NCT03864952 153 154 O
the NCT03864952 156 159 O
patient NCT03864952 160 167 O
must NCT03864952 168 172 O
have NCT03864952 173 177 O
dental NCT03864952 178 184 B-Condition-Name
calculus NCT03864952 185 193 I-Condition-Name

Exclusion NCT03864952 194 203 O
Criteria NCT03864952 204 212 O
: NCT03864952 213 214 O

- NCT03864952 218 219 O
to NCT03864952 221 223 O
be NCT03864952 224 226 O
under NCT03864952 227 232 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03864952 234 236 B-Eq-Value
years NCT03864952 237 242 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03864952 243 246 O

- NCT03864952 249 250 O
to NCT03864952 252 254 O
be NCT03864952 255 257 O
incapable NCT03864952 258 267 O
to NCT03864952 268 270 O
consenting NCT03864952 271 281 O

- NCT03864952 284 285 O
a NCT03864952 287 288 O
tartar NCT03864952 289 295 B-Procedure-Name
removal NCT03864952 296 303 I-Procedure-Name
since NCT03864952 304 309 O
the NCT03864952 310 313 O
infection NCT03864952 314 323 O

Inclusion NCT03869047 0 9 O
Criteria NCT03869047 10 18 O
: NCT03869047 19 20 O

- NCT03869047 24 25 O
physical NCT03869047 27 35 O
status NCT03869047 36 42 O
American NCT03869047 43 51 B-Condition-Name
Society NCT03869047 52 59 I-Condition-Name
of NCT03869047 60 62 I-Condition-Name
Anesthesiologist NCT03869047 63 79 I-Condition-Name
( NCT03869047 80 81 O
ASA NCT03869047 82 85 B-Condition-Name
) NCT03869047 86 87 O
I NCT03869047 88 89 B-Eq-Value
or NCT03869047 90 92 O
II NCT03869047 93 95 B-Eq-Value

Exclusion NCT03869047 96 105 O
Criteria NCT03869047 106 114 O
: NCT03869047 115 116 O

- NCT03869047 120 121 O
Patients NCT03869047 123 131 O
refusal NCT03869047 132 139 O

- NCT03869047 142 143 O
A NCT03869047 145 146 O
body NCT03869047 147 151 B-Observation-Name___Observation-Type-Value:vital
mass NCT03869047 152 156 I-Observation-Name___Observation-Type-Value:vital
index NCT03869047 157 162 I-Observation-Name___Observation-Type-Value:vital
( NCT03869047 163 164 O
BMI NCT03869047 165 168 B-Observation-Name___Observation-Type-Value:vital
) NCT03869047 169 170 O
> NCT03869047 171 172 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03869047 174 176 B-Eq-Value
kg NCT03869047 177 179 B-Eq-Unit
/ NCT03869047 180 181 O
m NCT03869047 182 183 B-Eq-Unit
2 NCT03869047 184 185 I-Eq-Unit

- NCT03869047 188 189 O
ASA NCT03869047 191 194 B-Condition-Name
physical NCT03869047 195 203 O
status NCT03869047 204 210 O
> NCT03869047 211 212 B-Eq-Operator___Eq-Operator-Value:GT
II NCT03869047 213 215 B-Eq-Value

- NCT03869047 218 219 O
major NCT03869047 221 226 B-Severity___Severity-Value:severe
illnesses NCT03869047 227 236 B-Condition-Name
( NCT03869047 237 238 O
e NCT03869047 239 240 O
. NCT03869047 241 242 O
g NCT03869047 243 244 O
. NCT03869047 245 246 O
, NCT03869047 247 248 O
cardiac NCT03869047 249 256 O
, NCT03869047 257 258 O
respiratory NCT03869047 259 270 O
, NCT03869047 271 272 O
renal NCT03869047 273 278 O
, NCT03869047 279 280 O
hepatic NCT03869047 281 288 O
or NCT03869047 289 291 O
neurological NCT03869047 292 304 O
) NCT03869047 305 306 O

- NCT03869047 310 311 O
Coagulation NCT03869047 313 324 B-Condition-Name
abnormalities NCT03869047 325 338 B-Polarity___Polarity-Value:abnormal

- NCT03869047 341 342 O
Infection NCT03869047 344 353 B-Condition-Name
at NCT03869047 354 356 O
the NCT03869047 357 360 O
injection NCT03869047 361 370 B-Procedure-Name
site NCT03869047 371 375 O

- NCT03869047 378 379 O
Allergy NCT03869047 381 388 O
or NCT03869047 389 391 O
contraindications NCT03869047 392 409 O
to NCT03869047 410 412 O
the NCT03869047 413 416 O
drugs NCT03869047 417 422 O
used NCT03869047 423 427 O
in NCT03869047 428 430 O
the NCT03869047 431 434 O
study NCT03869047 435 440 O

- NCT03869047 443 444 O
History NCT03869047 446 453 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869047 454 456 O
drug NCT03869047 457 461 B-Condition-Name
addiction NCT03869047 462 471 I-Condition-Name
or NCT03869047 472 474 O
alcohol NCT03869047 475 482 B-Condition-Name
abuse NCT03869047 483 488 I-Condition-Name

- NCT03869047 491 492 O
A NCT03869047 494 495 O
psychiatric NCT03869047 496 507 B-Condition-Name
illness NCT03869047 508 515 I-Condition-Name
, NCT03869047 516 517 O
or NCT03869047 518 520 O
mental NCT03869047 521 527 B-Condition-Name
retardation NCT03869047 528 539 I-Condition-Name
interfering NCT03869047 540 551 B-Stability___Stability-Value:change
with NCT03869047 552 556 O
the NCT03869047 557 560 O
evaluation NCT03869047 561 571 O
of NCT03869047 572 574 O
pain NCT03869047 575 579 B-Observation-Name___Observation-Type-Value:measurement
scores NCT03869047 580 586 I-Observation-Name___Observation-Type-Value:measurement
or NCT03869047 587 589 O
PCA NCT03869047 590 593 B-Procedure-Name
programs NCT03869047 594 602 I-Procedure-Name
. NCT03869047 604 605 O

Inclusion NCT03865641 0 9 O
Criteria NCT03865641 10 18 O
: NCT03865641 19 20 O

- NCT03865641 24 25 O
The NCT03865641 27 30 O
patients NCT03865641 31 39 O
' NCT03865641 39 40 O
burn NCT03865641 41 45 B-Condition-Name
scars NCT03865641 46 51 I-Condition-Name
had NCT03865641 52 55 O
re NCT03865641 56 58 O
- NCT03865641 59 60 O
epithelialized NCT03865641 61 75 O
after NCT03865641 76 81 O
aseptic NCT03865641 82 89 B-Procedure-Name
care NCT03865641 90 94 I-Procedure-Name
or NCT03865641 95 97 O
skin NCT03865641 98 102 B-Procedure-Name
graft NCT03865641 103 108 I-Procedure-Name
. NCT03865641 109 110 O
We NCT03865641 112 114 O
included NCT03865641 115 123 O
patients NCT03865641 124 132 O
aged NCT03865641 133 137 O
≥ NCT03865641 138 139 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03865641 141 143 B-Eq-Value
years NCT03865641 144 149 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
with NCT03865641 150 154 O
a NCT03865641 155 156 O
deep NCT03865641 157 161 O
partial NCT03865641 162 169 O
- NCT03865641 170 171 O
thickness NCT03865641 172 181 O
( NCT03865641 182 183 O
second NCT03865641 184 190 O
- NCT03865641 191 192 O
degree NCT03865641 193 199 O
) NCT03865641 200 201 O
burn NCT03865641 202 206 B-Condition-Name
or NCT03865641 207 209 O
a NCT03865641 210 211 O
full NCT03865641 212 216 O
thickness NCT03865641 217 226 O
( NCT03865641 227 228 O
third NCT03865641 229 234 O
- NCT03865641 235 236 O
degree NCT03865641 237 243 O
) NCT03865641 244 245 O
burn NCT03865641 246 250 B-Condition-Name
to NCT03865641 251 253 O
their NCT03865641 254 259 O
hands NCT03865641 260 265 O
, NCT03865641 266 267 O
with NCT03865641 268 272 O
joint NCT03865641 273 278 B-Condition-Name
contracture NCT03865641 279 290 I-Condition-Name
( NCT03865641 291 292 O
hand NCT03865641 293 297 O
and NCT03865641 298 301 O
wrist NCT03865641 302 307 O
) NCT03865641 308 309 O
, NCT03865641 311 312 O
having NCT03865641 313 319 O
been NCT03865641 320 324 O
transferred NCT03865641 325 336 B-Encounter-Type___Encounter-Type-Value:transfer
to NCT03865641 337 339 O
the NCT03865641 340 343 O
rehabilitation NCT03865641 344 358 B-Location___Location-Value:unit
department NCT03865641 359 369 I-Location___Location-Value:unit
after NCT03865641 370 375 O
acute NCT03865641 376 381 B-Severity___Severity-Value:severe
burn NCT03865641 382 386 B-Condition-Name
treatment NCT03865641 387 396 B-Procedure-Name
, NCT03865641 397 398 O
and NCT03865641 399 402 O
less NCT03865641 403 407 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03865641 408 412 I-Eq-Operator___Eq-Operator-Value:LT
6 NCT03865641 414 415 B-Eq-Value
months NCT03865641 416 422 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
since NCT03865641 423 428 O
the NCT03865641 429 432 O
onset NCT03865641 433 438 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03865641 439 441 O
the NCT03865641 442 445 O
burn NCT03865641 446 450 O
injury NCT03865641 451 457 B-Condition-Name
. NCT03865641 458 459 O

Exclusion NCT03865641 461 470 O
Criteria NCT03865641 471 479 O
: NCT03865641 480 481 O

- NCT03865641 485 486 O
patients NCT03865641 488 496 O
who NCT03865641 497 500 O
had NCT03865641 501 504 O
fourth NCT03865641 505 511 O
- NCT03865641 512 513 O
degree NCT03865641 514 520 O
burns NCT03865641 521 526 B-Condition-Name
( NCT03865641 527 528 O
involving NCT03865641 529 538 O
muscles NCT03865641 539 546 O
, NCT03865641 547 548 O
tendons NCT03865641 549 556 O
, NCT03865641 557 558 O
and NCT03865641 559 562 O
bone NCT03865641 563 567 O
injuries NCT03865641 568 576 B-Condition-Name
) NCT03865641 577 578 O
, NCT03865641 580 581 O
musculoskeletal NCT03865641 582 597 B-Condition-Name
diseases NCT03865641 598 606 I-Condition-Name
( NCT03865641 607 608 O
fracture NCT03865641 609 617 B-Condition-Name
, NCT03865641 618 619 O
amputation NCT03865641 620 630 B-Condition-Name
, NCT03865641 631 632 O
rheumatoid NCT03865641 633 643 B-Condition-Name
arthritis NCT03865641 644 653 I-Condition-Name
, NCT03865641 654 655 O
and NCT03865641 656 659 O
degenerative NCT03865641 660 672 B-Condition-Name
joint NCT03865641 673 678 I-Condition-Name
diseases NCT03865641 679 687 I-Condition-Name
) NCT03865641 688 689 O
in NCT03865641 690 692 O
the NCT03865641 693 696 O
burned NCT03865641 697 703 O
hand NCT03865641 704 708 O
, NCT03865641 709 710 O
or NCT03865641 711 713 O
neurological NCT03865641 714 726 B-Condition-Name
diseases NCT03865641 727 735 I-Condition-Name
( NCT03865641 736 737 O
such NCT03865641 738 742 O
as NCT03865641 743 745 O
peripheral NCT03865641 746 756 B-Condition-Name
nerve NCT03865641 757 762 I-Condition-Name
disorders NCT03865641 763 772 I-Condition-Name
) NCT03865641 773 774 O
, NCT03865641 776 777 O
preexisting NCT03865641 778 789 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
physical NCT03865641 790 798 O
and NCT03865641 799 802 O
psychologic NCT03865641 803 814 O
disability NCT03865641 815 825 B-Condition-Name
( NCT03865641 826 827 O
severe NCT03865641 828 834 B-Severity___Severity-Value:severe
aphasia NCT03865641 835 842 B-Condition-Name
and NCT03865641 843 846 O
cognitive NCT03865641 847 856 B-Condition-Name
impairment NCT03865641 857 867 I-Condition-Name
that NCT03865641 868 872 O
could NCT03865641 873 878 O
influence NCT03865641 879 888 B-Stability___Stability-Value:change
the NCT03865641 889 892 O
intervention NCT03865641 893 905 O
) NCT03865641 906 907 O
, NCT03865641 909 910 O
and NCT03865641 911 914 O
severe NCT03865641 915 921 B-Severity___Severity-Value:severe
pain NCT03865641 922 926 B-Condition-Name
impeding NCT03865641 927 935 B-Stability___Stability-Value:change
hand NCT03865641 936 940 B-Procedure-Name
rehabilitation NCT03865641 941 955 I-Procedure-Name
. NCT03865641 956 957 O

Inclusion NCT03868371 0 9 O
Criteria NCT03868371 10 18 O
: NCT03868371 19 20 O

- NCT03868371 24 25 O
≥ NCT03868371 27 28 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868371 30 32 B-Eq-Value
years NCT03868371 33 38 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03868371 39 41 O
age NCT03868371 42 45 O

- NCT03868371 48 49 O
Currently NCT03868371 51 60 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treated NCT03868371 61 68 O
with NCT03868371 69 73 O
peritoneal NCT03868371 74 84 B-Procedure-Name
dialysis NCT03868371 85 93 I-Procedure-Name
( NCT03868371 94 95 O
APD NCT03868371 96 99 B-Procedure-Name
or NCT03868371 100 102 O
CAPD NCT03868371 103 107 B-Procedure-Name
) NCT03868371 108 109 O

- NCT03868371 113 114 O
Serum NCT03868371 116 121 B-Observation-Name___Observation-Type-Value:lab
ionized NCT03868371 122 129 I-Observation-Name___Observation-Type-Value:lab
calcium NCT03868371 130 137 I-Observation-Name___Observation-Type-Value:lab
between NCT03868371 138 145 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1.10 NCT03868371 147 151 B-Eq-Value
and NCT03868371 152 155 O
1.40 NCT03868371 157 161 B-Eq-Value
mmol NCT03868371 162 166 B-Eq-Unit
/ NCT03868371 167 168 O
L NCT03868371 169 170 B-Eq-Unit
for NCT03868371 171 174 O
> NCT03868371 175 176 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03868371 178 179 B-Eq-Value
months NCT03868371 180 186 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03868371 189 190 O
Plasma NCT03868371 192 198 B-Observation-Name___Observation-Type-Value:lab
phosphate NCT03868371 199 208 I-Observation-Name___Observation-Type-Value:lab
between NCT03868371 209 216 B-Eq-Operator___Eq-Operator-Value:BETWEEN
0.7 NCT03868371 218 221 B-Eq-Value
and NCT03868371 222 225 O
3.0 NCT03868371 227 230 B-Eq-Value
mmol NCT03868371 231 235 B-Eq-Unit
/ NCT03868371 236 237 O
L NCT03868371 238 239 B-Eq-Unit
for NCT03868371 240 243 O
> NCT03868371 244 245 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03868371 247 248 B-Eq-Value
months NCT03868371 249 255 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Exclusion NCT03868371 256 265 O
Criteria NCT03868371 266 274 O
: NCT03868371 275 276 O

- NCT03868371 280 281 O
Earlier NCT03868371 283 290 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
parathyroidectomized NCT03868371 291 311 B-Condition-Name

- NCT03868371 314 315 O
Other NCT03868371 317 322 O
conditions NCT03868371 323 333 O
, NCT03868371 334 335 O
which NCT03868371 336 341 O
hinders NCT03868371 342 349 B-Stability___Stability-Value:change
the NCT03868371 350 353 O
participation NCT03868371 354 367 O
in NCT03868371 368 370 O
the NCT03868371 371 374 O
trial NCT03868371 375 380 O

Inclusion NCT03867903 0 9 O
Criteria NCT03867903 10 18 O
: NCT03867903 19 20 O

- NCT03867903 24 25 O
Study NCT03867903 27 32 O
participants NCT03867903 33 45 O
will NCT03867903 46 50 O
be NCT03867903 51 53 O
infants NCT03867903 54 61 O
( NCT03867903 62 63 O
and NCT03867903 64 67 O
their NCT03867903 68 73 O
parents NCT03867903 74 81 O
) NCT03867903 82 83 O
who NCT03867903 84 87 O
have NCT03867903 88 92 O
undergone NCT03867903 93 102 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cardiac NCT03867903 103 110 B-Procedure-Name
surgery NCT03867903 111 118 I-Procedure-Name
at NCT03867903 119 121 O
Children NCT03867903 122 130 B-Location___Location-Value:hospital
's NCT03867903 130 132 I-Location___Location-Value:hospital
Mercy NCT03867903 133 138 I-Location___Location-Value:hospital
Kansas NCT03867903 139 145 I-Location___Location-Value:hospital
City NCT03867903 146 150 I-Location___Location-Value:hospital
in NCT03867903 151 153 O
the NCT03867903 154 157 O
first NCT03867903 158 163 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
six NCT03867903 164 167 B-Eq-Value
weeks NCT03867903 168 173 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03867903 174 176 O
life NCT03867903 177 181 O
and NCT03867903 182 185 O
are NCT03867903 186 189 O
currently NCT03867903 190 199 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
less NCT03867903 200 204 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867903 205 209 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03867903 211 213 B-Eq-Value
months NCT03867903 214 220 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03867903 221 223 O
age NCT03867903 224 227 O
at NCT03867903 228 230 O
the NCT03867903 231 234 O
time NCT03867903 235 239 O
of NCT03867903 240 242 O
being NCT03867903 243 248 O
approached NCT03867903 249 259 O
for NCT03867903 260 263 O
participation NCT03867903 264 277 O
in NCT03867903 278 280 O
this NCT03867903 281 285 O
study NCT03867903 286 291 O
. NCT03867903 292 293 O

Exclusion NCT03867903 295 304 O
Criteria NCT03867903 305 313 O
: NCT03867903 314 315 O

- NCT03867903 319 320 O
• NCT03867903 322 323 O
Families NCT03867903 324 332 O
without NCT03867903 333 340 O
access NCT03867903 341 347 O
to NCT03867903 348 350 O
a NCT03867903 351 352 O
personal NCT03867903 353 361 O
device NCT03867903 362 368 O
for NCT03867903 369 372 O
download NCT03867903 373 381 O
( NCT03867903 382 383 O
no NCT03867903 384 386 O
devices NCT03867903 387 394 O
will NCT03867903 395 399 O
be NCT03867903 400 402 O
provided NCT03867903 403 411 O
) NCT03867903 412 413 O

- NCT03867903 422 423 O
Children NCT03867903 425 433 O
who NCT03867903 434 437 O
are NCT03867903 438 441 O
deceased NCT03867903 442 450 O
prior NCT03867903 451 456 O
to NCT03867903 457 459 O
the NCT03867903 460 463 O
family NCT03867903 464 470 O
being NCT03867903 471 476 O
approached NCT03867903 477 487 O
for NCT03867903 488 491 O
study NCT03867903 492 497 O
participation NCT03867903 498 511 O

- NCT03867903 519 520 O
Neonates NCT03867903 522 530 O
that NCT03867903 531 535 O
are NCT03867903 536 539 O
considered NCT03867903 540 550 O
non NCT03867903 551 554 B-Condition-Name
- NCT03867903 555 556 I-Condition-Name
viable NCT03867903 557 563 I-Condition-Name
, NCT03867903 564 565 O
or NCT03867903 566 568 O
have NCT03867903 569 573 O
the NCT03867903 574 577 O
potential NCT03867903 578 587 O
to NCT03867903 588 590 O
be NCT03867903 591 593 O
non NCT03867903 594 597 B-Condition-Name
- NCT03867903 598 599 I-Condition-Name
viable NCT03867903 600 606 I-Condition-Name

- NCT03867903 614 615 O
Spanish NCT03867903 617 624 B-Language
- NCT03867903 625 626 O
only NCT03867903 627 631 O
speaking NCT03867903 632 640 O
families NCT03867903 641 649 O

Exclude NCT03867903 650 657 O
special NCT03867903 658 665 O
populations NCT03867903 666 677 O
: NCT03867903 678 679 O

• NCT03867903 681 682 O
Wards NCT03867903 683 688 B-Observation-Name
of NCT03867903 689 691 I-Observation-Name
the NCT03867903 692 695 I-Observation-Name
state NCT03867903 696 701 I-Observation-Name

Inclusion NCT03860922 0 9 O
Criteria NCT03860922 10 18 O
: NCT03860922 19 20 O

- NCT03860922 24 25 O
patients NCT03860922 27 35 O
in NCT03860922 36 38 O
different NCT03860922 39 48 O
age NCT03860922 49 52 O
groups NCT03860922 53 59 O
and NCT03860922 60 63 O
both NCT03860922 64 68 O
sex NCT03860922 69 72 O
referred NCT03860922 73 81 O
from NCT03860922 82 86 O
orthopedic NCT03860922 87 97 B-Location___Location-Value:clinic
outpatient NCT03860922 98 108 B-Encounter-Type___Encounter-Type-Value:outpatient
clinic NCT03860922 109 115 B-Location___Location-Value:clinic
with NCT03860922 116 120 O
chronic NCT03860922 121 128 O
ankle NCT03860922 129 134 O
pain NCT03860922 135 139 B-Condition-Name
and NCT03860922 140 143 O
suspected NCT03860922 144 153 O
clinically NCT03860922 154 164 O
to NCT03860922 165 167 O
have NCT03860922 168 172 O
impingement NCT03860922 173 184 B-Condition-Name
syndrome NCT03860922 185 193 I-Condition-Name
. NCT03860922 194 195 O

Exclusion NCT03860922 197 206 O
Criteria NCT03860922 207 215 O
: NCT03860922 216 217 O

1 NCT03860922 222 223 O
. NCT03860922 223 224 O
Inflammatory NCT03860922 226 238 B-Condition-Name
arthritis NCT03860922 239 248 I-Condition-Name
of NCT03860922 249 251 O
ankle NCT03860922 252 257 O
joint NCT03860922 258 263 O
, NCT03860922 264 265 O
infection NCT03860922 266 275 B-Condition-Name
in NCT03860922 276 278 O
ankle NCT03860922 279 284 O
joint NCT03860922 285 290 O
, NCT03860922 291 292 O
neoplasm NCT03860922 293 301 O
around NCT03860922 302 308 O
ankle NCT03860922 309 314 O
joint NCT03860922 315 320 O
. NCT03860922 321 322 O

2 NCT03860922 327 328 O
. NCT03860922 328 329 O
Patients NCT03860922 331 339 O
with NCT03860922 340 344 O
contraindications NCT03860922 345 362 O
for NCT03860922 363 366 O
MRI NCT03860922 367 370 B-Procedure-Name
, NCT03860922 371 372 O
e NCT03860922 373 374 O
. NCT03860922 375 376 O
g NCT03860922 377 378 O
. NCT03860922 379 380 O
an NCT03860922 382 384 O
implanted NCT03860922 385 394 B-Procedure-Name
magnetic NCT03860922 395 403 I-Procedure-Name
device NCT03860922 404 410 I-Procedure-Name
, NCT03860922 411 412 O
pacemakers NCT03860922 413 423 B-Procedure-Name
or NCT03860922 424 426 O
claustrophobia NCT03860922 427 441 B-Condition-Name
. NCT03860922 442 443 O

Inclusion NCT03868774 0 9 O
Criteria NCT03868774 10 18 O
: NCT03868774 19 20 O

1 NCT03868774 25 26 O
. NCT03868774 26 27 O
Moderate NCT03868774 29 37 B-Severity___Severity-Value:moderate
- NCT03868774 38 39 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03868774 40 46 B-Severity___Severity-Value:severe
uni NCT03868774 47 50 O
- NCT03868774 51 52 O
and NCT03868774 53 56 O
bipolar NCT03868774 57 64 O
depression NCT03868774 65 75 B-Condition-Name
according NCT03868774 76 85 O
to NCT03868774 86 88 O
the NCT03868774 89 92 O
International NCT03868774 93 106 O
Classification NCT03868774 107 121 O
of NCT03868774 122 124 O
Diseases NCT03868774 125 133 O
( NCT03868774 134 135 O
ICD NCT03868774 136 139 O
- NCT03868774 140 141 O
10 NCT03868774 143 145 O
) NCT03868774 146 147 O

2 NCT03868774 152 153 O
. NCT03868774 153 154 O
A NCT03868774 156 157 O
Hamilton NCT03868774 158 166 B-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03868774 167 172 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03868774 173 178 O
( NCT03868774 179 180 O
HDS NCT03868774 181 184 B-Observation-Name
- NCT03868774 185 186 I-Observation-Name
17 NCT03868774 188 190 I-Observation-Name
) NCT03868774 191 192 O
of NCT03868774 193 195 O
≥ NCT03868774 196 197 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868774 199 201 B-Eq-Value
and NCT03868774 202 205 O
/ NCT03868774 206 207 O
or NCT03868774 208 210 O
a NCT03868774 211 212 O
sub NCT03868774 213 216 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03868774 217 218 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03868774 219 224 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03868774 225 226 O
HDSS NCT03868774 227 231 B-Observation-Name
) NCT03868774 232 233 O
score NCT03868774 234 239 O
of NCT03868774 240 242 O
≥ NCT03868774 243 244 B-Eq-Operator___Eq-Operator-Value:GTEQ
9 NCT03868774 246 247 B-Eq-Value
within NCT03868774 248 254 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03868774 256 258 B-Eq-Value
- NCT03868774 259 260 B-Eq-Operator___Eq-Operator-Value:BETWEEN
48 NCT03868774 262 264 B-Eq-Value
hours NCT03868774 265 270 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
before NCT03868774 271 277 O
the NCT03868774 278 281 O
first NCT03868774 282 287 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
treatment NCT03868774 288 297 O

Exclusion NCT03868774 298 307 O
Criteria NCT03868774 308 316 O
: NCT03868774 317 318 O

1 NCT03868774 323 324 O
. NCT03868774 324 325 O
Organic NCT03868774 327 334 O
brain NCT03868774 335 340 B-Condition-Name
disease NCT03868774 341 348 I-Condition-Name
. NCT03868774 349 350 O

2 NCT03868774 355 356 O
. NCT03868774 356 357 O
Epileptic NCT03868774 359 368 B-Condition-Name
seizure NCT03868774 369 376 I-Condition-Name
< NCT03868774 377 378 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03868774 380 381 B-Eq-Value
years NCT03868774 382 387 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

3 NCT03868774 391 392 O
. NCT03868774 392 393 O
Patients NCT03868774 395 403 O
with NCT03868774 404 408 O
implanted NCT03868774 409 418 B-Procedure-Name
metal NCT03868774 419 424 I-Procedure-Name
parts NCT03868774 425 430 I-Procedure-Name
in NCT03868774 431 433 O
the NCT03868774 434 437 O
brain NCT03868774 438 443 O
or NCT03868774 444 446 O
chest NCT03868774 447 452 O

4 NCT03868774 456 457 O
. NCT03868774 457 458 O
Patients NCT03868774 460 468 O
with NCT03868774 469 473 O
pacemaker NCT03868774 474 483 B-Procedure-Name

5 NCT03868774 487 488 O
. NCT03868774 488 489 O
Medical NCT03868774 491 498 O
diseases NCT03868774 499 507 B-Condition-Name
with NCT03868774 508 512 O
cerebral NCT03868774 513 521 B-Condition-Name
impact NCT03868774 522 528 B-Stability___Stability-Value:change

6 NCT03868774 532 533 O
. NCT03868774 533 534 O
Serious NCT03868774 536 543 B-Severity___Severity-Value:severe
suicidal NCT03868774 544 552 B-Condition-Name
danger NCT03868774 553 559 O


Inclusion NCT03861988 0 9 O
Criteria NCT03861988 10 18 O
: NCT03861988 19 20 O

- NCT03861988 24 25 O
Patient NCT03861988 27 34 O
presenting NCT03861988 35 45 O
for NCT03861988 46 49 O
primary NCT03861988 50 57 O
total NCT03861988 58 63 B-Procedure-Name
joint NCT03861988 64 69 I-Procedure-Name
arthroplasty NCT03861988 70 82 I-Procedure-Name

- NCT03861988 85 86 O
Major NCT03861988 88 93 B-Severity___Severity-Value:severe
Depressive NCT03861988 94 104 B-Condition-Name
Disorder NCT03861988 105 113 I-Condition-Name

Exclusion NCT03861988 114 123 O
Criteria NCT03861988 124 132 O
: NCT03861988 133 134 O

- NCT03861988 138 139 O
Pregnant NCT03861988 141 149 B-Condition-Name
of NCT03861988 150 152 O
breastfeeding NCT03861988 153 166 B-Condition-Name
women NCT03861988 167 172 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

Inclusion NCT03864172 0 9 O
Criteria NCT03864172 10 18 O

- NCT03864172 21 22 O
Screened NCT03864172 24 32 O
to NCT03864172 33 35 O
be NCT03864172 36 38 O
generally NCT03864172 39 48 O
healthy NCT03864172 49 56 B-Condition-Name
as NCT03864172 57 59 O
determined NCT03864172 60 70 O
by NCT03864172 71 73 O
standard NCT03864172 74 82 B-Procedure-Name
medical NCT03864172 83 90 I-Procedure-Name
assessment NCT03864172 91 101 I-Procedure-Name
on NCT03864172 102 104 O
physical NCT03864172 105 113 O
and NCT03864172 114 117 O
mental NCT03864172 118 124 O
health NCT03864172 125 131 O

- NCT03864172 134 135 O
Tanner NCT03864172 137 143 B-Condition-Name
stage NCT03864172 144 149 B-Eq-Unit
2 NCT03864172 151 152 B-Eq-Value
based NCT03864172 153 158 O
on NCT03864172 159 161 O
breast NCT03864172 162 168 B-Condition-Name
development NCT03864172 169 180 I-Condition-Name
for NCT03864172 181 184 O
girls NCT03864172 185 190 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:girl
, NCT03864172 191 192 O
and NCT03864172 193 196 O
pubic NCT03864172 197 202 B-Condition-Name
hair NCT03864172 203 207 I-Condition-Name
in NCT03864172 208 210 O
boys NCT03864172 211 215 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:boy
. NCT03864172 216 217 O
Girls NCT03864172 219 224 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:girl
will NCT03864172 225 229 O
have NCT03864172 230 234 O
to NCT03864172 235 237 O
be NCT03864172 238 240 O
premenarcheal NCT03864172 241 254 B-Condition-Name

- NCT03864172 257 258 O
Having NCT03864172 260 266 O
obtained NCT03864172 267 275 O
his NCT03864172 276 279 O
/ NCT03864172 280 281 O
her NCT03864172 282 285 O
informed NCT03864172 286 294 O
consent NCT03864172 295 302 O
and NCT03864172 303 306 O
parents NCT03864172 307 314 O
or NCT03864172 315 317 O
legal NCT03864172 318 323 O
guardians NCT03864172 324 333 O
consent NCT03864172 334 341 O

Exclusion NCT03864172 342 351 O
Criteria NCT03864172 352 360 O
: NCT03864172 361 362 O

- NCT03864172 366 367 O
History NCT03864172 369 376 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864172 377 379 O
serious NCT03864172 380 387 B-Severity___Severity-Value:severe
medical NCT03864172 388 395 O
conditions NCT03864172 396 406 O
such NCT03864172 407 411 O
as NCT03864172 412 414 O
intestinal NCT03864172 415 425 O
or NCT03864172 426 428 O
severe NCT03864172 429 435 B-Severity___Severity-Value:severe
metabolic NCT03864172 436 445 B-Condition-Name
diseases NCT03864172 446 454 I-Condition-Name
, NCT03864172 455 456 O
disorders NCT03864172 457 466 B-Condition-Name
such NCT03864172 467 471 O
as NCT03864172 472 474 O
diabetes NCT03864172 475 483 B-Condition-Name
, NCT03864172 484 485 O
renal NCT03864172 486 491 O
, NCT03864172 492 493 O
hepatic NCT03864172 494 501 O
or NCT03864172 502 504 O
pancreatic NCT03864172 505 515 O
diseases NCT03864172 516 524 B-Condition-Name
, NCT03864172 525 526 O
disorders NCT03864172 527 536 B-Condition-Name
, NCT03864172 537 538 O
ulcer NCT03864172 539 544 B-Condition-Name
, NCT03864172 545 546 O
hyperthyroidism NCT03864172 547 562 B-Condition-Name
, NCT03864172 563 564 O
malignance NCT03864172 565 575 B-Condition-Name
, NCT03864172 576 577 O
chronic NCT03864172 578 585 O
malnutrition NCT03864172 586 598 B-Condition-Name
, NCT03864172 599 600 O
anaemia NCT03864172 601 608 B-Condition-Name

- NCT03864172 611 612 O
History NCT03864172 614 621 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03864172 622 624 O
on NCT03864172 625 627 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
therapy NCT03864172 628 635 B-Procedure-Name
with NCT03864172 636 640 O
medication NCT03864172 641 651 O
known NCT03864172 652 657 O
to NCT03864172 658 660 O
interfere NCT03864172 661 670 B-Stability___Stability-Value:change
with NCT03864172 671 675 O
bone NCT03864172 676 680 B-Condition-Name
metabolism NCT03864172 681 691 I-Condition-Name
such NCT03864172 692 696 O
as NCT03864172 697 699 O
steroids NCT03864172 700 708 B-Drug-Name
, NCT03864172 709 710 O
hormones NCT03864172 711 719 B-Drug-Name
, NCT03864172 720 721 O
diuretics NCT03864172 722 731 B-Drug-Name
, NCT03864172 732 733 O
cortisone NCT03864172 734 743 B-Drug-Name
or NCT03864172 744 746 O
anti NCT03864172 747 751 O
- NCT03864172 752 753 O
seizure NCT03864172 754 761 B-Condition-Name
medication NCT03864172 762 772 O

- NCT03864172 775 776 O
Taking NCT03864172 778 784 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
regularly NCT03864172 785 794 O
any NCT03864172 795 798 O
nutritional NCT03864172 799 810 B-Drug-Name
supplements NCT03864172 811 822 I-Drug-Name
and NCT03864172 823 826 O
unwilling NCT03864172 827 836 O
to NCT03864172 837 839 O
stop NCT03864172 840 844 O
for NCT03864172 845 848 O
the NCT03864172 849 852 O
study NCT03864172 853 858 O

Inclusion NCT03864614 0 9 O
Criteria NCT03864614 10 18 O
: NCT03864614 19 20 O

1 NCT03864614 25 26 O
. NCT03864614 26 27 O
Subject NCT03864614 29 36 O
has NCT03864614 37 40 O
a NCT03864614 41 42 O
diagnosis NCT03864614 43 52 O
of NCT03864614 53 55 O
MDD NCT03864614 56 59 B-Condition-Name
as NCT03864614 60 62 O
diagnosed NCT03864614 63 72 O
by NCT03864614 73 75 O
SCID NCT03864614 76 80 O
- NCT03864614 81 82 O
5 NCT03864614 84 85 O
- NCT03864614 86 87 O
CT NCT03864614 88 90 O
, NCT03864614 91 92 O
with NCT03864614 93 97 O
symptoms NCT03864614 98 106 O
that NCT03864614 107 111 O
have NCT03864614 112 116 O
been NCT03864614 117 121 O
present NCT03864614 122 129 O
for NCT03864614 130 133 O
at NCT03864614 134 136 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864614 137 142 I-Eq-Operator___Eq-Operator-Value:GTEQ
a NCT03864614 143 144 O
4 NCT03864614 146 147 B-Eq-Value
- NCT03864614 148 149 O
week NCT03864614 150 154 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
period NCT03864614 155 161 O
. NCT03864614 162 163 O

2 NCT03864614 168 169 O
. NCT03864614 169 170 O
Subject NCT03864614 172 179 O
is NCT03864614 180 182 O
in NCT03864614 183 185 O
good NCT03864614 186 190 B-Condition-Name
physical NCT03864614 191 199 I-Condition-Name
health NCT03864614 200 206 I-Condition-Name
and NCT03864614 207 210 O
has NCT03864614 211 214 O
no NCT03864614 215 217 O
clinically NCT03864614 218 228 O
significant NCT03864614 229 240 B-Severity___Severity-Value:severe
findings NCT03864614 241 249 O
, NCT03864614 250 251 O
as NCT03864614 252 254 O
determined NCT03864614 255 265 O
by NCT03864614 266 268 O
the NCT03864614 269 272 O
Investigator NCT03864614 273 285 O
, NCT03864614 286 287 O
on NCT03864614 288 290 O
physical NCT03864614 291 299 B-Procedure-Name
examination NCT03864614 300 311 I-Procedure-Name
, NCT03864614 312 313 O
12 NCT03864614 315 317 B-Procedure-Name
- NCT03864614 318 319 I-Procedure-Name
lead NCT03864614 320 324 I-Procedure-Name
ECG NCT03864614 325 328 I-Procedure-Name
, NCT03864614 329 330 O
or NCT03864614 331 333 O
clinical NCT03864614 334 342 O
laboratory NCT03864614 343 353 B-Observation-Name___Observation-Type-Value:lab
tests NCT03864614 354 359 I-Observation-Name___Observation-Type-Value:lab
. NCT03864614 360 361 O

Exclusion NCT03864614 363 372 O
Criteria NCT03864614 373 381 O
: NCT03864614 382 383 O

1 NCT03864614 388 389 O
. NCT03864614 389 390 O
Subject NCT03864614 392 399 O
has NCT03864614 400 403 O
attempted NCT03864614 404 413 B-Condition-Name
suicide NCT03864614 414 421 I-Condition-Name
associated NCT03864614 422 432 O
with NCT03864614 433 437 O
the NCT03864614 438 441 O
current NCT03864614 442 449 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
episode NCT03864614 450 457 O
of NCT03864614 458 460 O
MDD NCT03864614 461 464 B-Condition-Name
. NCT03864614 465 466 O

2 NCT03864614 471 472 O
. NCT03864614 472 473 O
Subject NCT03864614 475 482 O
has NCT03864614 483 486 O
a NCT03864614 487 488 O
medical NCT03864614 489 496 O
history NCT03864614 497 504 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864614 505 507 O
bipolar NCT03864614 508 515 B-Condition-Name
disorder NCT03864614 516 524 I-Condition-Name
, NCT03864614 525 526 O
schizophrenia NCT03864614 527 540 B-Condition-Name
, NCT03864614 541 542 O
and NCT03864614 543 546 O
/ NCT03864614 547 548 O
or NCT03864614 549 551 O
schizoaffective NCT03864614 552 567 B-Condition-Name
disorder NCT03864614 568 576 I-Condition-Name
. NCT03864614 577 578 O

3 NCT03864614 583 584 O
. NCT03864614 584 585 O
Subject NCT03864614 587 594 O
has NCT03864614 595 598 O
had NCT03864614 599 602 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
vagus NCT03864614 603 608 B-Procedure-Name
nerve NCT03864614 609 614 I-Procedure-Name
stimulation NCT03864614 615 626 I-Procedure-Name
, NCT03864614 627 628 O
electroconvulsive NCT03864614 629 646 B-Procedure-Name
therapy NCT03864614 647 654 I-Procedure-Name
, NCT03864614 655 656 O
or NCT03864614 657 659 O
has NCT03864614 660 663 O
taken NCT03864614 664 669 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ketamine NCT03864614 670 678 B-Drug-Name
( NCT03864614 679 680 O
including NCT03864614 681 690 O
esketamine NCT03864614 691 701 B-Drug-Name
) NCT03864614 702 703 O
within NCT03864614 704 710 O
the NCT03864614 711 714 O
current NCT03864614 715 722 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
major NCT03864614 723 728 B-Severity___Severity-Value:severe
depressive NCT03864614 729 739 B-Condition-Name
episode NCT03864614 740 747 I-Condition-Name
. NCT03864614 748 749 O

Inclusion NCT03861585 0 9 O
Criteria NCT03861585 10 18 O
: NCT03861585 19 20 O

- NCT03861585 24 25 O
Children NCT03861585 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
between NCT03861585 36 43 B-Eq-Operator___Eq-Operator-Value:BETWEEN
7 NCT03861585 45 46 B-Eq-Value
and NCT03861585 47 50 O
12 NCT03861585 52 54 B-Eq-Value
years NCT03861585 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861585 61 64 O
… NCT03861585 64 65 O
…… NCT03861585 65 67 O
…… NCT03861585 67 69 O
…… NCT03861585 69 71 O
…… NCT03861585 71 73 O
…… NCT03861585 73 75 O
. NCT03861585 76 77 O

- NCT03861585 81 82 O
Normal NCT03861585 84 90 B-Polarity___Polarity-Value:normal
or NCT03861585 91 93 O
corrected NCT03861585 94 103 O
visual NCT03861585 104 110 B-Condition-Name
acuity NCT03861585 111 117 I-Condition-Name
… NCT03861585 118 119 O
… NCT03861585 119 120 O
… NCT03861585 120 121 O
… NCT03861585 121 122 O
…… NCT03861585 122 124 O
…… NCT03861585 124 126 O
…… NCT03861585 126 128 O
…… NCT03861585 128 130 O
. NCT03861585 131 132 O

- NCT03861585 136 137 O
ADHD NCT03861585 139 143 B-Condition-Name
diagnostic NCT03861585 144 154 O
given NCT03861585 155 160 O
by NCT03861585 161 163 O
a NCT03861585 164 165 O
doctor NCT03861585 166 172 O
according NCT03861585 173 182 O
to NCT03861585 183 185 O
DSM NCT03861585 186 189 O
5 NCT03861585 191 192 O
criteria NCT03861585 193 201 O
( NCT03861585 202 203 O
Diagnostic NCT03861585 204 214 O
and NCT03861585 215 218 O
Statistical NCT03861585 219 230 O
Manual NCT03861585 231 237 O
of NCT03861585 238 240 O
Mental NCT03861585 241 247 O
Disorders NCT03861585 248 257 O
) NCT03861585 258 259 O

- NCT03861585 263 264 O
Free NCT03861585 266 270 O
from NCT03861585 271 275 O
drug NCT03861585 276 280 O
treatment NCT03861585 281 290 O
until NCT03861585 291 296 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
24 NCT03861585 298 300 B-Eq-Value
hours NCT03861585 301 306 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
before NCT03861585 307 313 O
the NCT03861585 314 317 O
experiment NCT03861585 318 328 O
session NCT03861585 329 336 O
… NCT03861585 336 337 O
…… NCT03861585 337 339 O
…… NCT03861585 339 341 O
…… NCT03861585 341 343 O
…… NCT03861585 343 345 O
. NCT03861585 346 347 O

- NCT03861585 351 352 O
Affiliation NCT03861585 354 365 O
to NCT03861585 366 368 O
a NCT03861585 369 370 O
social NCT03861585 371 377 O
security NCT03861585 378 386 O
system NCT03861585 387 393 O
…… NCT03861585 393 395 O
…… NCT03861585 395 397 O
…… NCT03861585 397 399 O
…… NCT03861585 399 401 O
. NCT03861585 402 403 O

- NCT03861585 407 408 O
Signature NCT03861585 410 419 O
of NCT03861585 420 422 O
the NCT03861585 423 426 O
authorization NCT03861585 427 440 O
documents NCT03861585 441 450 O
from NCT03861585 451 455 O
one NCT03861585 456 459 O
parent NCT03861585 460 466 O
or NCT03861585 467 469 O
the NCT03861585 470 473 O
holder NCT03861585 474 480 O
of NCT03861585 481 483 O
parental NCT03861585 484 492 O
authority NCT03861585 493 502 O

Exclusion NCT03861585 503 512 O
Criteria NCT03861585 513 521 O
: NCT03861585 522 523 O

- NCT03861585 526 527 O
History NCT03861585 528 535 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861585 536 538 O
neurological NCT03861585 539 551 B-Condition-Name
troubles NCT03861585 552 560 I-Condition-Name
, NCT03861585 561 562 O
dysphasia NCT03861585 563 572 B-Condition-Name
, NCT03861585 573 574 O
autistic NCT03861585 575 583 B-Condition-Name
spectrum NCT03861585 584 592 I-Condition-Name
disorder NCT03861585 593 601 I-Condition-Name
, NCT03861585 602 603 O
intellectual NCT03861585 604 616 B-Condition-Name
disabilities NCT03861585 617 629 I-Condition-Name


Inclusion NCT03863392 0 9 O
Criteria NCT03863392 10 18 O
: NCT03863392 19 20 O

- NCT03863392 24 25 O
Primigravida NCT03863392 27 39 B-Condition-Name
or NCT03863392 40 42 O
Primipara NCT03863392 43 52 B-Condition-Name

- NCT03863392 55 56 O
Pregnancy NCT03863392 58 67 B-Condition-Name
between NCT03863392 68 75 B-Eq-Operator___Eq-Operator-Value:BETWEEN
36 NCT03863392 77 79 B-Eq-Value
and NCT03863392 80 83 O
42 NCT03863392 85 87 B-Eq-Value
weeks NCT03863392 88 93 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03863392 94 96 O
gestation NCT03863392 97 106 B-Observation-Name___Observation-Type-Value:measurement
. NCT03863392 107 108 O

- NCT03863392 112 113 O
A NCT03863392 115 116 O
live NCT03863392 117 121 O
singleton NCT03863392 122 131 B-Condition-Name
fetus NCT03863392 132 137 I-Condition-Name
in NCT03863392 138 140 O
cephalic NCT03863392 141 149 O
presentation NCT03863392 150 162 O
. NCT03863392 163 164 O

- NCT03863392 168 169 O
No NCT03863392 171 173 O
history NCT03863392 174 181 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863392 182 184 O
uterine NCT03863392 185 192 B-Procedure-Name
surgery NCT03863392 193 200 I-Procedure-Name
. NCT03863392 201 202 O

- NCT03863392 206 207 O
Clinically NCT03863392 209 219 O
adequate NCT03863392 220 228 B-Polarity___Polarity-Value:normal
pelvis NCT03863392 229 235 B-Condition-Name
. NCT03863392 236 237 O

- NCT03863392 241 242 O
Modified NCT03863392 244 252 O
Bishop NCT03863392 253 259 B-Observation-Name___Observation-Type-Value:clinical-score
's NCT03863392 259 261 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03863392 262 267 I-Observation-Name___Observation-Type-Value:clinical-score
< NCT03863392 268 269 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03863392 271 272 B-Eq-Value
. NCT03863392 272 273 O

- NCT03863392 277 278 O
Reactive NCT03863392 280 288 B-Polarity___Polarity-Value:reactive
Non NCT03863392 289 292 B-Procedure-Name
stress NCT03863392 293 299 I-Procedure-Name
test NCT03863392 300 304 I-Procedure-Name
( NCT03863392 305 306 O
NST NCT03863392 307 310 B-Procedure-Name
) NCT03863392 311 312 O
. NCT03863392 314 315 O

Exclusion NCT03863392 317 326 O
Criteria NCT03863392 327 335 O
: NCT03863392 336 337 O

- NCT03863392 341 342 O
•Known NCT03863392 344 350 O
hypersensitivity NCT03863392 351 367 B-Condition-Name
or NCT03863392 368 370 O
contraindications NCT03863392 371 388 O
to NCT03863392 389 391 O
oral NCT03863392 392 396 O
misoprostol NCT03863392 397 408 B-Drug-Name
( NCT03863392 409 410 O
uterine NCT03863392 411 418 B-Procedure-Name
surgery NCT03863392 419 426 I-Procedure-Name
) NCT03863392 427 428 O
. NCT03863392 430 431 O

- NCT03863392 440 441 O
Any NCT03863392 443 446 O
antenatal NCT03863392 447 456 O
medical NCT03863392 457 464 O
complications NCT03863392 465 478 B-Condition-Name
. NCT03863392 479 480 O

- NCT03863392 489 490 O
A NCT03863392 492 493 O
situation NCT03863392 494 503 O
requiring NCT03863392 504 513 O
LSCS NCT03863392 514 518 B-Procedure-Name
( NCT03863392 519 520 O
Maternal NCT03863392 521 529 O
or NCT03863392 530 532 O
Fetal NCT03863392 533 538 O
) NCT03863392 539 540 O
e NCT03863392 541 542 O
. NCT03863392 543 544 O
g NCT03863392 545 546 O
: NCT03863392 547 548 O
fetal NCT03863392 549 554 B-Condition-Name
distress NCT03863392 555 563 I-Condition-Name

- NCT03863392 571 572 O
Non NCT03863392 574 577 B-Polarity___Polarity-Value:non-reactive
- NCT03863392 578 579 I-Polarity___Polarity-Value:non-reactive
reactive NCT03863392 580 588 I-Polarity___Polarity-Value:non-reactive
NST NCT03863392 589 592 B-Procedure-Name
. NCT03863392 593 594 O

- NCT03863392 603 604 O
Patient NCT03863392 606 613 O
's NCT03863392 613 615 O
refusal NCT03863392 616 623 O
to NCT03863392 624 626 O
give NCT03863392 627 631 O
consent NCT03863392 632 639 O

Inclusion NCT03860857 0 9 O
Criteria NCT03860857 10 18 O
: NCT03860857 19 20 O

1 NCT03860857 25 26 O
. NCT03860857 26 27 O
Between NCT03860857 29 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
the NCT03860857 37 40 O
ages NCT03860857 41 45 O
of NCT03860857 46 48 O
60 NCT03860857 50 52 B-Eq-Value
and NCT03860857 53 56 O
85 NCT03860857 58 60 B-Eq-Value
; NCT03860857 61 62 O

2 NCT03860857 66 67 O
. NCT03860857 67 68 O
Speaks NCT03860857 70 76 O
fluent NCT03860857 77 83 O
English NCT03860857 84 91 B-Language
; NCT03860857 91 92 O

3 NCT03860857 96 97 O
. NCT03860857 97 98 O
Visual NCT03860857 100 106 O
and NCT03860857 107 110 O
auditory NCT03860857 111 119 O
acuity NCT03860857 120 126 B-Condition-Name
adequate NCT03860857 127 135 O
for NCT03860857 136 139 O
neuropsychological NCT03860857 140 158 O
and NCT03860857 159 162 O
computerized NCT03860857 163 175 O
testing NCT03860857 176 183 B-Procedure-Name
; NCT03860857 183 184 O

4 NCT03860857 188 189 O
. NCT03860857 189 190 O
Good NCT03860857 192 196 B-Polarity___Polarity-Value:normal
general NCT03860857 197 204 B-Condition-Name
health NCT03860857 205 211 I-Condition-Name
with NCT03860857 212 216 O
no NCT03860857 217 219 O
disease NCT03860857 220 227 B-Condition-Name
( NCT03860857 228 229 O
s NCT03860857 230 231 O
) NCT03860857 232 233 O
expected NCT03860857 234 242 O
to NCT03860857 243 245 O
interfere NCT03860857 246 255 B-Stability___Stability-Value:change
with NCT03860857 256 260 O
the NCT03860857 261 264 O
study NCT03860857 265 270 O
; NCT03860857 270 271 O

5 NCT03860857 275 276 O
. NCT03860857 276 277 O
Willing NCT03860857 279 286 O
and NCT03860857 287 290 O
able NCT03860857 291 295 O
to NCT03860857 296 298 O
participate NCT03860857 299 310 O
for NCT03860857 311 314 O
the NCT03860857 315 318 O
duration NCT03860857 319 327 O
of NCT03860857 328 330 O
the NCT03860857 331 334 O
study NCT03860857 335 340 O
and NCT03860857 341 344 O
in NCT03860857 345 347 O
all NCT03860857 348 351 O
study NCT03860857 352 357 O
procedures NCT03860857 358 368 O
including NCT03860857 369 378 O
MRI NCT03860857 379 382 B-Procedure-Name
and NCT03860857 383 386 O
PET NCT03860857 387 390 B-Procedure-Name
; NCT03860857 390 391 O

6 NCT03860857 395 396 O
. NCT03860857 396 397 O
Normal NCT03860857 399 405 B-Polarity___Polarity-Value:normal
cognition NCT03860857 406 415 B-Condition-Name
defined NCT03860857 416 423 O
as NCT03860857 424 426 O
a NCT03860857 427 428 O
Clinical NCT03860857 429 437 B-Observation-Name___Observation-Type-Value:clinical-score
Dementia NCT03860857 438 446 I-Observation-Name___Observation-Type-Value:clinical-score
Rating NCT03860857 447 453 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03860857 454 456 O
0 NCT03860857 458 459 B-Eq-Value
and NCT03860857 460 463 O
a NCT03860857 464 465 O
Mini NCT03860857 466 470 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03860857 471 472 I-Observation-Name___Observation-Type-Value:clinical-score
Mental NCT03860857 473 479 I-Observation-Name___Observation-Type-Value:clinical-score
State NCT03860857 480 485 I-Observation-Name___Observation-Type-Value:clinical-score
Examination NCT03860857 486 497 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03860857 498 503 B-Eq-Unit
of NCT03860857 504 506 O
27 NCT03860857 508 510 B-Eq-Value
or NCT03860857 511 513 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03860857 514 520 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03860857 521 522 O

Exclusion NCT03860857 524 533 O
Criteria NCT03860857 534 542 O
: NCT03860857 543 544 O

1 NCT03860857 549 550 O
. NCT03860857 550 551 O
Significant NCT03860857 553 564 B-Severity___Severity-Value:severe
co NCT03860857 565 567 O
- NCT03860857 568 569 O
morbid NCT03860857 570 576 O
neurologic NCT03860857 577 587 B-Condition-Name
disease NCT03860857 588 595 I-Condition-Name
such NCT03860857 596 600 O
as NCT03860857 601 603 O
Parkinson NCT03860857 604 613 B-Condition-Name
's NCT03860857 613 615 I-Condition-Name
disease NCT03860857 616 623 I-Condition-Name
, NCT03860857 624 625 O
multiple NCT03860857 626 634 B-Condition-Name
sclerosis NCT03860857 635 644 I-Condition-Name
, NCT03860857 645 646 O
brain NCT03860857 647 652 B-Condition-Name
cyst NCT03860857 653 657 I-Condition-Name
, NCT03860857 658 659 O
tumor NCT03860857 660 665 B-Condition-Name
or NCT03860857 666 668 O
aneurysm NCT03860857 669 677 B-Condition-Name
; NCT03860857 677 678 O

2 NCT03860857 682 683 O
. NCT03860857 683 684 O
Major NCT03860857 686 691 B-Severity___Severity-Value:severe
health NCT03860857 692 698 O
conditions NCT03860857 699 709 O
such NCT03860857 710 714 O
as NCT03860857 715 717 O
uncontrolled NCT03860857 718 730 O
diabetes NCT03860857 731 739 B-Condition-Name
mellitus NCT03860857 740 748 I-Condition-Name
, NCT03860857 749 750 O
uncontrolled NCT03860857 751 763 O
hypertension NCT03860857 764 776 B-Condition-Name
, NCT03860857 777 778 O
nutritional NCT03860857 779 790 B-Condition-Name
deficiency NCT03860857 791 801 I-Condition-Name
or NCT03860857 802 804 O
uncontrolled NCT03860857 805 817 O
thyroid NCT03860857 818 825 B-Condition-Name
disease NCT03860857 826 833 I-Condition-Name
; NCT03860857 833 834 O

3 NCT03860857 838 839 O
. NCT03860857 839 840 O
Significant NCT03860857 842 853 B-Severity___Severity-Value:severe
psychiatric NCT03860857 854 865 B-Condition-Name
disorders NCT03860857 866 875 I-Condition-Name
such NCT03860857 876 880 O
as NCT03860857 881 883 O
schizophrenia NCT03860857 884 897 B-Condition-Name
, NCT03860857 898 899 O
bipolar NCT03860857 900 907 B-Condition-Name
disorder NCT03860857 908 916 I-Condition-Name
, NCT03860857 917 918 O
anxiety NCT03860857 919 926 B-Condition-Name
disorder NCT03860857 927 935 I-Condition-Name
, NCT03860857 936 937 O
major NCT03860857 938 943 B-Severity___Severity-Value:severe
depressive NCT03860857 944 954 B-Condition-Name
disorder NCT03860857 955 963 I-Condition-Name
, NCT03860857 964 965 O
or NCT03860857 966 968 O
attention NCT03860857 969 978 B-Condition-Name
- NCT03860857 979 980 I-Condition-Name
deficit NCT03860857 981 988 I-Condition-Name
hyperactivity NCT03860857 989 1002 I-Condition-Name
disorder NCT03860857 1003 1011 I-Condition-Name
; NCT03860857 1011 1012 O

4 NCT03860857 1016 1017 O
. NCT03860857 1017 1018 O
ADRC NCT03860857 1020 1024 O
consensus NCT03860857 1025 1034 O
diagnosis NCT03860857 1035 1044 O
of NCT03860857 1045 1047 O
dementia NCT03860857 1048 1056 B-Condition-Name
or NCT03860857 1057 1059 O
mild NCT03860857 1060 1064 B-Severity___Severity-Value:mild
cognitive NCT03860857 1065 1074 B-Condition-Name
impairment NCT03860857 1075 1085 I-Condition-Name
; NCT03860857 1085 1086 O

5 NCT03860857 1090 1091 O
. NCT03860857 1091 1092 O
Cognitive NCT03860857 1094 1103 B-Condition-Name
impairment NCT03860857 1104 1114 I-Condition-Name
when NCT03860857 1115 1119 O
tested NCT03860857 1120 1126 O
at NCT03860857 1127 1129 O
baseline NCT03860857 1130 1138 O
( NCT03860857 1139 1140 O
defined NCT03860857 1141 1148 O
as NCT03860857 1149 1151 O
a NCT03860857 1152 1153 O
score NCT03860857 1154 1159 O
on NCT03860857 1160 1162 O
any NCT03860857 1163 1166 O
neuropsychological NCT03860857 1167 1185 B-Observation-Name___Observation-Type-Value:clinical-score
test NCT03860857 1186 1190 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03860857 1191 1193 O
1.5 NCT03860857 1195 1198 B-Eq-Value
SDs NCT03860857 1199 1202 B-Eq-Unit
or NCT03860857 1203 1205 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03860857 1206 1210 I-Eq-Operator___Eq-Operator-Value:GTEQ
outside NCT03860857 1211 1218 O
the NCT03860857 1219 1222 O
age NCT03860857 1223 1226 O
norm NCT03860857 1227 1231 O
) NCT03860857 1232 1233 O
; NCT03860857 1234 1235 O

6 NCT03860857 1239 1240 O
. NCT03860857 1240 1241 O
Alcohol NCT03860857 1243 1250 O
or NCT03860857 1251 1253 O
substance NCT03860857 1254 1263 O
abuse NCT03860857 1264 1269 B-Condition-Name
or NCT03860857 1270 1272 O
dependence NCT03860857 1273 1283 B-Condition-Name
within NCT03860857 1284 1290 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860857 1291 1294 O
past NCT03860857 1295 1299 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03860857 1301 1302 B-Eq-Value
years NCT03860857 1303 1308 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03860857 1309 1310 O
DSM NCT03860857 1311 1314 O
- NCT03860857 1315 1316 O
IV NCT03860857 1317 1319 O
criteria NCT03860857 1320 1328 O
) NCT03860857 1329 1330 O
; NCT03860857 1331 1332 O

7 NCT03860857 1336 1337 O
. NCT03860857 1337 1338 O
MRI NCT03860857 1340 1343 B-Procedure-Name
contraindications NCT03860857 1344 1361 O
, NCT03860857 1362 1363 O
e NCT03860857 1364 1365 O
. NCT03860857 1366 1367 O
g NCT03860857 1368 1369 O
. NCT03860857 1370 1371 O
pacemakers NCT03860857 1373 1383 B-Procedure-Name
, NCT03860857 1384 1385 O
aneurysm NCT03860857 1386 1394 B-Procedure-Name
clips NCT03860857 1395 1400 I-Procedure-Name
, NCT03860857 1401 1402 O
artificial NCT03860857 1403 1413 B-Procedure-Name
heart NCT03860857 1414 1419 I-Procedure-Name
valves NCT03860857 1420 1426 I-Procedure-Name
, NCT03860857 1427 1428 O
ear NCT03860857 1429 1432 B-Procedure-Name
implants NCT03860857 1433 1441 I-Procedure-Name
, NCT03860857 1442 1443 O
metal NCT03860857 1444 1449 B-Condition-Name
fragments NCT03860857 1450 1459 I-Condition-Name
or NCT03860857 1460 1462 O
foreign NCT03860857 1463 1470 O
objects NCT03860857 1471 1478 B-Condition-Name
in NCT03860857 1479 1481 O
the NCT03860857 1482 1485 O
eyes NCT03860857 1486 1490 O
, NCT03860857 1491 1492 O
skin NCT03860857 1493 1497 O
or NCT03860857 1498 1500 O
body NCT03860857 1501 1505 O
. NCT03860857 1506 1507 O
Females NCT03860857 1509 1516 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03860857 1517 1520 O
are NCT03860857 1521 1524 O
pregnant NCT03860857 1525 1533 B-Condition-Name
or NCT03860857 1534 1536 O
trying NCT03860857 1537 1543 O
to NCT03860857 1544 1546 O
get NCT03860857 1547 1550 O
pregnant NCT03860857 1551 1559 B-Condition-Name
are NCT03860857 1560 1563 O
also NCT03860857 1564 1568 O
excluded NCT03860857 1569 1577 O
; NCT03860857 1577 1578 O

8 NCT03860857 1582 1583 O
. NCT03860857 1583 1584 O
PET NCT03860857 1586 1589 B-Procedure-Name
contraindications NCT03860857 1590 1607 O
, NCT03860857 1608 1609 O
e NCT03860857 1610 1611 O
. NCT03860857 1612 1613 O
g NCT03860857 1614 1615 O
. NCT03860857 1616 1617 O
significant NCT03860857 1619 1630 B-Severity___Severity-Value:severe
prior NCT03860857 1631 1636 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiation NCT03860857 1637 1646 B-Condition-Name
exposure NCT03860857 1647 1655 I-Condition-Name
and NCT03860857 1656 1659 O
pregnancy NCT03860857 1660 1669 B-Condition-Name
. NCT03860857 1670 1671 O

Inclusion NCT03861546 0 9 O
Criteria NCT03861546 10 18 O
: NCT03861546 19 20 O

1 NCT03861546 25 26 O
. NCT03861546 26 27 O
age NCT03861546 29 32 O
> NCT03861546 33 34 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03861546 36 38 B-Eq-Value
years NCT03861546 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03861546 44 45 O

2 NCT03861546 49 50 O
. NCT03861546 50 51 O
confirmed NCT03861546 53 62 O
diagnosis NCT03861546 63 72 O
of NCT03861546 73 75 O
prediabetes NCT03861546 76 87 B-Condition-Name
or NCT03861546 88 90 O
T NCT03861546 91 92 B-Condition-Name
2D NCT03861546 93 95 I-Condition-Name
( NCT03861546 96 97 O
documented NCT03861546 98 108 O
A NCT03861546 109 110 B-Observation-Name___Observation-Type-Value:lab
1c NCT03861546 111 113 I-Observation-Name___Observation-Type-Value:lab
of NCT03861546 114 116 O
≥ NCT03861546 117 118 B-Eq-Operator___Eq-Operator-Value:GTEQ
5.7 NCT03861546 120 123 B-Eq-Value
% NCT03861546 124 125 B-Eq-Unit
, NCT03861546 127 128 O
2 NCT03861546 130 131 B-Observation-Name___Observation-Type-Value:lab
- NCT03861546 132 133 I-Observation-Name___Observation-Type-Value:lab
hour NCT03861546 134 138 I-Observation-Name___Observation-Type-Value:lab
post NCT03861546 139 143 I-Observation-Name___Observation-Type-Value:lab
- NCT03861546 144 145 I-Observation-Name___Observation-Type-Value:lab
load NCT03861546 146 150 I-Observation-Name___Observation-Type-Value:lab
glucose NCT03861546 151 158 I-Observation-Name___Observation-Type-Value:lab
of NCT03861546 159 161 O
> NCT03861546 162 163 B-Eq-Operator___Eq-Operator-Value:GT
140 NCT03861546 165 168 B-Eq-Value
, NCT03861546 169 170 O
or NCT03861546 171 173 O
FBG NCT03861546 174 177 B-Observation-Name
of NCT03861546 178 180 O
> NCT03861546 181 182 B-Eq-Operator___Eq-Operator-Value:GT
100 NCT03861546 184 187 B-Eq-Value
) NCT03861546 188 189 O
; NCT03861546 190 191 O

3 NCT03861546 195 196 O
. NCT03861546 196 197 O
a NCT03861546 199 200 O
family NCT03861546 201 207 O
member NCT03861546 208 214 O
or NCT03861546 215 217 O
peer NCT03861546 218 222 O
willing NCT03861546 223 230 O
to NCT03861546 231 233 O
participate NCT03861546 234 245 O
and NCT03861546 246 249 O
attend NCT03861546 250 256 O
all NCT03861546 257 260 O
sessions NCT03861546 261 269 B-Procedure-Name
as NCT03861546 270 272 O
a NCT03861546 273 274 O
social NCT03861546 275 281 O
influencer NCT03861546 282 292 O
; NCT03861546 292 293 O

4 NCT03861546 297 298 O
. NCT03861546 298 299 O
proficiency NCT03861546 301 312 O
in NCT03861546 313 315 O
English NCT03861546 316 323 B-Language
of NCT03861546 324 326 O
at NCT03861546 327 329 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861546 330 335 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03861546 336 339 B-Eq-Value
member NCT03861546 340 346 O
of NCT03861546 347 349 O
each NCT03861546 350 354 O
dyad NCT03861546 355 359 O
, NCT03861546 360 361 O

5 NCT03861546 366 367 O
. NCT03861546 367 368 O
willingness NCT03861546 370 381 O
to NCT03861546 382 384 O
provide NCT03861546 385 392 O
written NCT03861546 393 400 O
consent NCT03861546 401 408 O
. NCT03861546 409 410 O

Exclusion NCT03861546 412 421 O
Criteria NCT03861546 422 430 O
: NCT03861546 431 432 O

1 NCT03861546 437 438 O
. NCT03861546 438 439 O
type NCT03861546 441 445 O
1 NCT03861546 447 448 O
diabetes NCT03861546 449 457 B-Condition-Name
or NCT03861546 458 460 O
diabetes NCT03861546 461 469 B-Condition-Name
secondary NCT03861546 470 479 O
to NCT03861546 480 482 O
other NCT03861546 483 488 O
conditions NCT03861546 489 499 O
( NCT03861546 500 501 O
e NCT03861546 502 503 O
. NCT03861546 504 505 O
g NCT03861546 506 507 O
. NCT03861546 508 509 O
steroid NCT03861546 511 518 B-Drug-Name
- NCT03861546 519 520 O
induced NCT03861546 521 528 O
, NCT03861546 529 530 O
pancreatic NCT03861546 531 541 O
insufficiency NCT03861546 542 555 B-Condition-Name
, NCT03861546 556 557 O
or NCT03861546 558 560 O
chemotherapy NCT03861546 561 573 B-Procedure-Name
- NCT03861546 574 575 O
induced NCT03861546 576 583 O
) NCT03861546 584 585 O
; NCT03861546 586 587 O

2 NCT03861546 591 592 O
. NCT03861546 592 593 O
malignancy NCT03861546 595 605 B-Condition-Name
or NCT03861546 606 608 O
life NCT03861546 609 613 O
- NCT03861546 614 615 O
threatening NCT03861546 616 627 O
illness NCT03861546 628 635 O
with NCT03861546 636 640 O
life NCT03861546 641 645 B-Observation-Name
expectancy NCT03861546 646 656 I-Observation-Name
of NCT03861546 657 659 O
< NCT03861546 660 661 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03861546 663 664 B-Eq-Value
years NCT03861546 665 670 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03861546 670 671 O

3 NCT03861546 675 676 O
. NCT03861546 676 677 O
end NCT03861546 679 682 O
- NCT03861546 683 684 O
stage NCT03861546 685 690 O
disease NCT03861546 691 698 B-Condition-Name
or NCT03861546 699 701 O
serious NCT03861546 702 709 B-Severity___Severity-Value:severe
illness NCT03861546 710 717 B-Condition-Name
that NCT03861546 718 722 O
prohibits NCT03861546 723 732 O
participation NCT03861546 733 746 O
( NCT03861546 747 748 O
e NCT03861546 749 750 O
. NCT03861546 751 752 O
g NCT03861546 753 754 O
. NCT03861546 755 756 O
end NCT03861546 758 761 O
- NCT03861546 762 763 O
stage NCT03861546 764 769 O
renal NCT03861546 770 775 B-Condition-Name
disease NCT03861546 776 783 I-Condition-Name
or NCT03861546 784 786 O
class NCT03861546 787 792 B-Eq-Unit
IV NCT03861546 793 795 B-Eq-Value
congestive NCT03861546 796 806 B-Condition-Name
heart NCT03861546 807 812 I-Condition-Name
failure NCT03861546 813 820 I-Condition-Name
) NCT03861546 821 822 O
; NCT03861546 823 824 O

4 NCT03861546 828 829 O
. NCT03861546 829 830 O
inability NCT03861546 832 841 O
to NCT03861546 842 844 O
perform NCT03861546 845 852 O
unsupervised NCT03861546 853 865 O
physical NCT03861546 866 874 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03861546 875 883 I-Observation-Name___Observation-Type-Value:social-habit
; NCT03861546 883 884 O

5 NCT03861546 888 889 O
. NCT03861546 889 890 O
pregnancy NCT03861546 892 901 B-Condition-Name
; NCT03861546 901 902 O

6 NCT03861546 906 907 O
. NCT03861546 907 908 O
diagnosed NCT03861546 910 919 O
cognitive NCT03861546 920 929 B-Condition-Name
deficits NCT03861546 930 938 I-Condition-Name
or NCT03861546 939 941 O
limited NCT03861546 942 949 B-Polarity___Polarity-Value:low
decision NCT03861546 950 958 B-Condition-Name
- NCT03861546 959 960 I-Condition-Name
making NCT03861546 961 967 I-Condition-Name
capacity NCT03861546 968 976 I-Condition-Name
; NCT03861546 976 977 O

7 NCT03861546 981 982 O
. NCT03861546 982 983 O
alcohol NCT03861546 985 992 O
or NCT03861546 993 995 O
substance NCT03861546 996 1005 O
abuse NCT03861546 1006 1011 B-Condition-Name
; NCT03861546 1011 1012 O

8 NCT03861546 1016 1017 O
. NCT03861546 1017 1018 O
homelessness NCT03861546 1020 1032 B-Condition-Name
or NCT03861546 1033 1035 O
no NCT03861546 1036 1038 O
fixed NCT03861546 1039 1044 B-Location___Location-Value:residence
address NCT03861546 1045 1052 I-Location___Location-Value:residence
. NCT03861546 1053 1054 O

Inclusion NCT03863379 0 9 O
Criteria NCT03863379 10 18 O
: NCT03863379 19 20 O

Persons NCT03863379 22 29 O
with NCT03863379 30 34 O

- NCT03863379 37 38 O
stroke NCT03863379 40 46 B-Condition-Name
/ NCT03863379 47 48 O
cerebrovascular NCT03863379 49 64 B-Condition-Name
disease NCT03863379 65 72 I-Condition-Name

- NCT03863379 75 76 O
traumatic NCT03863379 78 87 B-Condition-Name
brain NCT03863379 88 93 I-Condition-Name
injury NCT03863379 94 100 I-Condition-Name

- NCT03863379 103 104 O
multiple NCT03863379 106 114 B-Condition-Name
sclerosis NCT03863379 115 124 I-Condition-Name

- NCT03863379 127 128 O
spinal NCT03863379 130 136 O
cord NCT03863379 137 141 O
injuries NCT03863379 142 150 B-Condition-Name
( NCT03863379 151 152 O
including NCT03863379 153 162 O
spinal NCT03863379 163 169 O
cord NCT03863379 170 174 O
lesions NCT03863379 175 182 B-Condition-Name
i NCT03863379 183 184 O
. NCT03863379 185 186 O
e NCT03863379 187 188 O
. NCT03863379 189 190 O
myelopathies NCT03863379 192 204 B-Condition-Name
etc NCT03863379 205 208 O
. NCT03863379 209 210 O
) NCT03863379 211 212 O

Exclusion NCT03863379 214 223 O
Criteria NCT03863379 224 232 O
: NCT03863379 233 234 O

Persons NCT03863379 236 243 O
with NCT03863379 244 248 O

- NCT03863379 251 252 O
heterotopic NCT03863379 254 265 B-Condition-Name
ossifications NCT03863379 266 279 I-Condition-Name
, NCT03863379 280 281 O

- NCT03863379 285 286 O
chronic NCT03863379 288 295 O
administration NCT03863379 296 310 O
of NCT03863379 311 313 O
drugs NCT03863379 314 319 O
, NCT03863379 320 321 O
which NCT03863379 322 327 O
promote NCT03863379 328 335 B-Stability___Stability-Value:change
fat NCT03863379 336 339 B-Condition-Name
increase NCT03863379 340 348 B-Polarity___Polarity-Value:high

- NCT03863379 351 352 O
chronic NCT03863379 354 361 O
administration NCT03863379 362 376 O
of NCT03863379 377 379 O
drugs NCT03863379 380 385 O
, NCT03863379 386 387 O
which NCT03863379 388 393 O
promote NCT03863379 394 401 B-Stability___Stability-Value:change
bone NCT03863379 402 406 O
or NCT03863379 407 409 O
muscle NCT03863379 410 416 O
loss NCT03863379 417 421 B-Condition-Name

- NCT03863379 424 425 O
co NCT03863379 427 429 O
- NCT03863379 430 431 O
existing NCT03863379 432 440 O
other NCT03863379 441 446 O
diseases NCT03863379 447 455 B-Condition-Name
such NCT03863379 456 460 O
as NCT03863379 461 463 O
: NCT03863379 464 465 O
endocrinopathies NCT03863379 466 482 B-Condition-Name
, NCT03863379 483 484 O
muscular NCT03863379 485 493 B-Condition-Name
dystrophies NCT03863379 494 505 I-Condition-Name
, NCT03863379 506 507 O
non NCT03863379 508 511 O
- NCT03863379 512 513 O
alcoholic NCT03863379 514 523 O
fatty NCT03863379 524 529 B-Condition-Name
liver NCT03863379 530 535 I-Condition-Name
disease NCT03863379 536 543 I-Condition-Name
. NCT03863379 544 545 O

Inclusion NCT03861208 0 9 O
Criteria NCT03861208 10 18 O
: NCT03861208 19 20 O

- NCT03861208 24 25 O
healthy NCT03861208 27 34 B-Condition-Name
children NCT03861208 35 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child

Exclusion NCT03861208 44 53 O
Criteria NCT03861208 54 62 O
: NCT03861208 63 64 O

- NCT03861208 68 69 O
no NCT03861208 71 73 O
food NCT03861208 74 78 B-Allergy-Name
allergies NCT03861208 79 88 O

- NCT03861208 91 92 O
no NCT03861208 94 96 O
medications NCT03861208 97 108 O
that NCT03861208 109 113 O
affect NCT03861208 114 120 B-Stability___Stability-Value:change
behavior NCT03861208 121 129 B-Condition-Name
/ NCT03861208 130 131 O
learning NCT03861208 132 140 B-Condition-Name
/ NCT03861208 141 142 O
appetite NCT03861208 143 151 B-Condition-Name

Inclusion NCT03860116 0 9 O
Criteria NCT03860116 10 18 O
: NCT03860116 19 20 O

- NCT03860116 24 25 O
1 NCT03860116 28 29 O
. NCT03860116 29 30 O
diagnosed NCT03860116 32 41 O
as NCT03860116 42 44 O
HIV NCT03860116 45 48 B-Condition-Name
positive NCT03860116 49 57 B-Polarity___Polarity-Value:positive
; NCT03860116 57 58 O

- NCT03860116 61 62 O
2 NCT03860116 65 66 O
. NCT03860116 66 67 O
initiate NCT03860116 69 77 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
antiretroviral NCT03860116 78 92 B-Procedure-Name
therapy NCT03860116 93 100 I-Procedure-Name
on NCT03860116 101 103 O
the NCT03860116 104 107 O
day NCT03860116 108 111 O
of NCT03860116 112 114 O
recruitment NCT03860116 115 126 O
; NCT03860116 126 127 O

- NCT03860116 130 131 O
3 NCT03860116 134 135 O
. NCT03860116 135 136 O
was NCT03860116 138 141 O
infected NCT03860116 142 150 B-Condition-Name
through NCT03860116 151 158 O
male NCT03860116 159 163 O
same NCT03860116 164 168 B-Condition-Name
- NCT03860116 169 170 I-Condition-Name
sex NCT03860116 171 174 I-Condition-Name
behavior NCT03860116 175 183 I-Condition-Name
; NCT03860116 183 184 O

- NCT03860116 187 188 O
4 NCT03860116 191 192 O
. NCT03860116 192 193 O
has NCT03860116 195 198 O
access NCT03860116 199 205 O
to NCT03860116 206 208 O
internet NCT03860116 209 217 O
on NCT03860116 218 220 O
a NCT03860116 221 222 O
personal NCT03860116 223 231 O
mobile NCT03860116 232 238 O
phone NCT03860116 239 244 O
; NCT03860116 244 245 O

- NCT03860116 248 249 O
5 NCT03860116 252 253 O
. NCT03860116 253 254 O
has NCT03860116 256 259 O
a NCT03860116 260 261 O
Wechat NCT03860116 262 268 O
account NCT03860116 269 276 O
and NCT03860116 277 280 O
use NCT03860116 281 284 O
it NCT03860116 285 287 O
daily NCT03860116 288 293 O
; NCT03860116 293 294 O

- NCT03860116 297 298 O
6 NCT03860116 301 302 O
. NCT03860116 302 303 O
willing NCT03860116 305 312 O
to NCT03860116 313 315 O
provide NCT03860116 316 323 O
written NCT03860116 324 331 O
informed NCT03860116 332 340 O
consent NCT03860116 341 348 O
; NCT03860116 348 349 O

Exclusion NCT03860116 350 359 O
Criteria NCT03860116 360 368 O
: NCT03860116 369 370 O

- NCT03860116 374 375 O
1 NCT03860116 378 379 O
. NCT03860116 379 380 O
under NCT03860116 382 387 O
severe NCT03860116 388 394 B-Severity___Severity-Value:severe
physical NCT03860116 395 403 O
or NCT03860116 404 406 O
mental NCT03860116 407 413 O
condition NCT03860116 414 423 B-Condition-Name
which NCT03860116 424 429 O
precludes NCT03860116 430 439 O
study NCT03860116 440 445 O
participation NCT03860116 446 459 O
; NCT03860116 459 460 O

- NCT03860116 463 464 O
2 NCT03860116 467 468 O
. NCT03860116 468 469 O
being NCT03860116 471 476 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
an NCT03860116 477 479 O
inpatient NCT03860116 480 489 B-Encounter-Type___Encounter-Type-Value:inpatient
of NCT03860116 490 492 O
the NCT03860116 493 496 O
hospital NCT03860116 497 505 B-Location___Location-Value:hospital
; NCT03860116 505 506 O

Inclusion NCT03862846 0 9 O
Criteria NCT03862846 10 18 O
: NCT03862846 19 20 O

- NCT03862846 24 25 O
Subjects NCT03862846 27 35 O
must NCT03862846 36 40 O
give NCT03862846 41 45 O
written NCT03862846 46 53 O
, NCT03862846 54 55 O
signed NCT03862846 56 62 O
and NCT03862846 63 66 O
dated NCT03862846 67 72 O
informed NCT03862846 73 81 O
consent NCT03862846 82 89 O

- NCT03862846 92 93 O
Confirmed NCT03862846 95 104 O
diagnosis NCT03862846 105 114 O
of NCT03862846 115 117 O
PMM NCT03862846 118 121 B-Condition-Name
according NCT03862846 122 131 O
to NCT03862846 132 134 O
the NCT03862846 135 138 O
2016 NCT03862846 140 144 O
Rome NCT03862846 145 149 O
Consensus NCT03862846 150 159 O
recommendations NCT03862846 160 175 O

- NCT03862846 178 179 O
Confirmed NCT03862846 181 190 O
mitochondrial NCT03862846 191 204 B-Condition-Name
mutation NCT03862846 205 213 I-Condition-Name
with NCT03862846 214 218 O
evidence NCT03862846 219 227 O
of NCT03862846 228 230 O
myopathy NCT03862846 231 239 B-Condition-Name

- NCT03862846 242 243 O
Able NCT03862846 245 249 O
to NCT03862846 250 252 O
remain NCT03862846 253 259 O
on NCT03862846 260 262 O
stable NCT03862846 263 269 B-Stability___Stability-Value:stable
medication NCT03862846 270 280 O
throughout NCT03862846 281 291 O
the NCT03862846 292 295 O
study NCT03862846 296 301 O

Exclusion NCT03862846 302 311 O
Criteria NCT03862846 312 320 O
: NCT03862846 321 322 O

- NCT03862846 326 327 O
Documented NCT03862846 329 339 O
evidence NCT03862846 340 348 O
of NCT03862846 349 351 O
ongoing NCT03862846 352 359 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
rhabdomyolysis NCT03862846 360 374 B-Condition-Name

- NCT03862846 377 378 O
Subjects NCT03862846 380 388 O
with NCT03862846 389 393 O
motor NCT03862846 394 399 B-Condition-Name
abnormalities NCT03862846 400 413 I-Condition-Name
other NCT03862846 414 419 O
than NCT03862846 420 424 O
related NCT03862846 425 432 O
to NCT03862846 433 435 O
mitochondrial NCT03862846 436 449 B-Condition-Name
disease NCT03862846 450 457 I-Condition-Name

- NCT03862846 460 461 O
Treatment NCT03862846 463 472 O
with NCT03862846 473 477 O
an NCT03862846 478 480 O
investigational NCT03862846 481 496 O
drug NCT03862846 497 501 O
within NCT03862846 502 508 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03862846 510 511 B-Eq-Value
months NCT03862846 512 518 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03862846 519 524 O
to NCT03862846 525 527 O
Day NCT03862846 528 531 O
1 NCT03862846 533 534 O

- NCT03862846 538 539 O
Hospitalised NCT03862846 541 553 B-Encounter-Type___Encounter-Type-Value:inpatient
within NCT03862846 554 560 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03862846 562 563 B-Eq-Value
months NCT03862846 564 570 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03862846 571 576 O
to NCT03862846 577 579 O
screening NCT03862846 580 589 O
for NCT03862846 590 593 O
any NCT03862846 594 597 O
major NCT03862846 598 603 B-Severity___Severity-Value:severe
medical NCT03862846 604 611 O
condition NCT03862846 612 621 O

- NCT03862846 624 625 O
Pregnant NCT03862846 627 635 B-Condition-Name
or NCT03862846 636 638 O
nursing NCT03862846 639 646 B-Condition-Name
females NCT03862846 647 654 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

Inclusion NCT03867916 0 9 O
Criteria NCT03867916 10 18 O
: NCT03867916 19 20 O

- NCT03867916 24 25 O
FOR NCT03867916 27 30 O
INTERVIEWS NCT03867916 31 41 O
AND NCT03867916 42 45 O
FOCUS NCT03867916 46 51 O
GROUPS NCT03867916 52 58 O
: NCT03867916 59 60 O
Cancer NCT03867916 61 67 B-Condition-Name
patients NCT03867916 68 76 O
: NCT03867916 77 78 O
Self NCT03867916 79 83 O
- NCT03867916 84 85 O
identifies NCT03867916 86 96 O
as NCT03867916 97 99 O
Asian NCT03867916 100 105 B-Ethnicity
American NCT03867916 106 114 I-Ethnicity
, NCT03867916 115 116 O
lives NCT03867916 117 122 O
in NCT03867916 123 125 O
San NCT03867916 126 129 B-Location___Location-Value:residence
Francisco NCT03867916 130 139 I-Location___Location-Value:residence
, NCT03867916 140 141 O
speaks NCT03867916 142 148 O
English NCT03867916 149 156 B-Language
, NCT03867916 157 158 O
Mandarin NCT03867916 159 167 B-Language
, NCT03867916 168 169 O
Cantonese NCT03867916 170 179 B-Language
, NCT03867916 180 181 O
or NCT03867916 182 184 O
Vietnamese NCT03867916 185 195 B-Language
, NCT03867916 196 197 O
has NCT03867916 198 201 O
a NCT03867916 202 203 O
history NCT03867916 204 211 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867916 212 214 O
cancer NCT03867916 215 221 B-Condition-Name
of NCT03867916 222 224 O
any NCT03867916 225 228 O
kind NCT03867916 229 233 O

- NCT03867916 236 237 O
FOR NCT03867916 239 242 O
INTERVIEWS NCT03867916 243 253 O
AND NCT03867916 254 257 O
FOCUS NCT03867916 258 263 O
GROUPS NCT03867916 264 270 O
: NCT03867916 271 272 O
Caregivers NCT03867916 273 283 O
: NCT03867916 284 285 O
any NCT03867916 286 289 O
person NCT03867916 290 296 O
who NCT03867916 297 300 O
has NCT03867916 301 304 O
provided NCT03867916 305 313 O
care NCT03867916 314 318 O
to NCT03867916 319 321 O
an NCT03867916 322 324 O
Asian NCT03867916 325 330 B-Ethnicity
American NCT03867916 331 339 I-Ethnicity
cancer NCT03867916 340 346 B-Condition-Name
patient NCT03867916 347 354 O

- NCT03867916 357 358 O
FOR NCT03867916 360 363 O
INTERVIEWS NCT03867916 364 374 O
AND NCT03867916 375 378 O
FOCUS NCT03867916 379 384 O
GROUPS NCT03867916 385 391 O
: NCT03867916 392 393 O
Health NCT03867916 394 400 O
professionals NCT03867916 401 414 O
: NCT03867916 415 416 O
physicians NCT03867916 417 427 B-Provider-Role
and NCT03867916 428 431 O
other NCT03867916 432 437 O
health NCT03867916 438 444 O
professionals NCT03867916 445 458 O
who NCT03867916 459 462 O
provide NCT03867916 463 470 O
care NCT03867916 471 475 O
to NCT03867916 476 478 O
Asian NCT03867916 479 484 B-Ethnicity
American NCT03867916 485 493 I-Ethnicity
patients NCT03867916 494 502 O
with NCT03867916 503 507 O
cancer NCT03867916 508 514 B-Condition-Name

- NCT03867916 517 518 O
FOR NCT03867916 520 523 O
PILOT NCT03867916 524 529 O
AND NCT03867916 530 533 O
FULL NCT03867916 534 538 O
IMPLEMENTATION NCT03867916 539 553 O
: NCT03867916 554 555 O
Self NCT03867916 556 560 O
- NCT03867916 561 562 O
identifies NCT03867916 563 573 O
as NCT03867916 574 576 O
Asian NCT03867916 577 582 B-Ethnicity
American NCT03867916 583 591 I-Ethnicity
, NCT03867916 592 593 O
lives NCT03867916 594 599 O
in NCT03867916 600 602 O
San NCT03867916 603 606 B-Location___Location-Value:residence
Francisco NCT03867916 607 616 I-Location___Location-Value:residence
, NCT03867916 617 618 O
speaks NCT03867916 619 625 O
English NCT03867916 626 633 B-Language
, NCT03867916 634 635 O
Mandarin NCT03867916 636 644 B-Language
, NCT03867916 645 646 O
Cantonese NCT03867916 647 656 B-Language
, NCT03867916 657 658 O
or NCT03867916 659 661 O
Vietnamese NCT03867916 662 672 B-Language
, NCT03867916 673 674 O
has NCT03867916 675 678 O
stage NCT03867916 679 684 B-Eq-Unit
I NCT03867916 685 686 B-Eq-Value
- NCT03867916 687 688 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03867916 689 692 B-Eq-Value
colorectal NCT03867916 693 703 O
, NCT03867916 704 705 O
lung NCT03867916 706 710 O
, NCT03867916 711 712 O
or NCT03867916 713 715 O
liver NCT03867916 716 721 O
cancer NCT03867916 722 728 B-Condition-Name
, NCT03867916 729 730 O
has NCT03867916 731 734 O
not NCT03867916 735 738 O
yet NCT03867916 739 742 O
undergone NCT03867916 743 752 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03867916 753 762 O

- NCT03867916 765 766 O
FOR NCT03867916 768 771 O
PILOT NCT03867916 772 777 O
AND NCT03867916 778 781 O
FULL NCT03867916 782 786 O
IMPLEMENTATION NCT03867916 787 801 O
: NCT03867916 802 803 O
Is NCT03867916 804 806 O
willing NCT03867916 807 814 O
to NCT03867916 815 817 O
stay NCT03867916 818 822 O
in NCT03867916 823 825 O
the NCT03867916 826 829 O
study NCT03867916 830 835 O
for NCT03867916 836 839 O
six NCT03867916 840 843 B-Eq-Value
months NCT03867916 844 850 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Exclusion NCT03867916 851 860 O
Criteria NCT03867916 861 869 O
: NCT03867916 870 871 O

- NCT03867916 875 876 O
Any NCT03867916 878 881 O
medical NCT03867916 882 889 O
or NCT03867916 890 892 O
psychological NCT03867916 893 906 O
conditions NCT03867916 907 917 O
precluding NCT03867916 918 928 O
informed NCT03867916 929 937 O
consent NCT03867916 938 945 O

Inclusion NCT03864562 0 9 O
Criteria NCT03864562 10 18 O
: NCT03864562 19 20 O

- NCT03864562 24 25 O
White NCT03864562 27 32 B-Ethnicity
European NCT03864562 33 41 I-Ethnicity
or NCT03864562 42 44 O
black NCT03864562 45 50 B-Ethnicity
African NCT03864562 51 58 I-Ethnicity
/ NCT03864562 59 60 O
Caribbean NCT03864562 61 70 B-Ethnicity
heritage NCT03864562 71 79 I-Ethnicity

- NCT03864562 82 83 O
BMI NCT03864562 85 88 B-Observation-Name___Observation-Type-Value:vital
> NCT03864562 89 90 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03864562 92 94 B-Eq-Value
kg NCT03864562 95 97 B-Eq-Unit
/ NCT03864562 98 99 O
m NCT03864562 100 101 B-Eq-Unit
2 NCT03864562 102 103 I-Eq-Unit

- NCT03864562 106 107 O
Ability NCT03864562 109 116 O
to NCT03864562 117 119 O
give NCT03864562 120 124 O
written NCT03864562 125 132 O
informed NCT03864562 133 141 O
consent NCT03864562 142 149 O

- NCT03864562 152 153 O
English NCT03864562 155 162 B-Language
speaking NCT03864562 163 171 O

Exclusion NCT03864562 172 181 O
Criteria NCT03864562 182 190 O
: NCT03864562 191 192 O

- NCT03864562 196 197 O
Any NCT03864562 199 202 O
significant NCT03864562 203 214 B-Severity___Severity-Value:severe
medical NCT03864562 215 222 O
condition NCT03864562 223 232 O

- NCT03864562 235 236 O
Uncontrolled NCT03864562 238 250 O
hypertension NCT03864562 251 263 B-Condition-Name

- NCT03864562 266 267 O
Alcohol NCT03864562 269 276 B-Observation-Name___Observation-Type-Value:social-habit
consumption NCT03864562 277 288 I-Observation-Name___Observation-Type-Value:social-habit
> NCT03864562 289 290 B-Eq-Operator___Eq-Operator-Value:GT
14 NCT03864562 292 294 B-Eq-Value
units NCT03864562 295 300 B-Eq-Unit
/ NCT03864562 301 302 O
week NCT03864562 303 307 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03864562 310 311 O
Random NCT03864562 313 319 O
blood NCT03864562 320 325 B-Observation-Name___Observation-Type-Value:lab
Glucose NCT03864562 326 333 I-Observation-Name___Observation-Type-Value:lab
concentration NCT03864562 334 347 I-Observation-Name___Observation-Type-Value:lab
above NCT03864562 348 353 B-Eq-Operator___Eq-Operator-Value:GT
7.8 NCT03864562 355 358 B-Eq-Value
mmol NCT03864562 359 363 B-Eq-Unit
/ NCT03864562 364 365 O
l NCT03864562 366 367 B-Eq-Unit

- NCT03864562 370 371 O
Hemoglobin NCT03864562 373 383 B-Observation-Name___Observation-Type-Value:lab
A NCT03864562 384 385 I-Observation-Name___Observation-Type-Value:lab
1c NCT03864562 386 388 I-Observation-Name___Observation-Type-Value:lab
( NCT03864562 389 390 O
HbA NCT03864562 391 394 B-Observation-Name___Observation-Type-Value:lab
1c NCT03864562 395 397 I-Observation-Name___Observation-Type-Value:lab
) NCT03864562 398 399 O
> NCT03864562 400 401 B-Eq-Operator___Eq-Operator-Value:GT
47 NCT03864562 403 405 B-Eq-Value
mmol NCT03864562 406 410 B-Eq-Unit
/ NCT03864562 411 412 O
mol NCT03864562 413 416 B-Eq-Unit
( NCT03864562 417 418 O
> NCT03864562 420 421 B-Eq-Operator___Eq-Operator-Value:GT
6.4 NCT03864562 423 426 B-Eq-Value
% NCT03864562 427 428 B-Eq-Unit
) NCT03864562 430 431 O

- NCT03864562 435 436 O
Use NCT03864562 438 441 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03864562 442 444 O
regular NCT03864562 445 452 O
medication NCT03864562 453 463 O
, NCT03864562 464 465 O
( NCT03864562 466 467 O
oral NCT03864562 468 472 B-Drug-Name
contraceptive NCT03864562 473 486 I-Drug-Name
pill NCT03864562 487 491 I-Drug-Name
or NCT03864562 492 494 O
antihypertensive NCT03864562 495 511 B-Drug-Name
medication NCT03864562 512 522 I-Drug-Name
are NCT03864562 523 526 O
acceptable NCT03864562 527 537 O
if NCT03864562 538 540 O
use NCT03864562 541 544 O
has NCT03864562 545 548 O
been NCT03864562 549 553 O
for NCT03864562 554 557 O
> NCT03864562 558 559 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03864562 561 562 B-Eq-Value
months NCT03864562 563 569 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03864562 570 571 O

- NCT03864562 575 576 O
History NCT03864562 578 585 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864562 586 588 O
Irritable NCT03864562 589 598 B-Condition-Name
Bowel NCT03864562 599 604 I-Condition-Name
Syndrome NCT03864562 605 613 I-Condition-Name
, NCT03864562 614 615 O
food NCT03864562 616 620 B-Condition-Name
intolerances NCT03864562 621 633 I-Condition-Name
or NCT03864562 634 636 O
any NCT03864562 637 640 O
gastrointestinal NCT03864562 641 657 B-Condition-Name
disorders NCT03864562 658 667 I-Condition-Name

- NCT03864562 670 671 O
Previous NCT03864562 673 681 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
bariatric NCT03864562 682 691 B-Procedure-Name
surgery NCT03864562 692 699 I-Procedure-Name
, NCT03864562 700 701 O
or NCT03864562 702 704 O
gastrointestinal NCT03864562 705 721 B-Procedure-Name
surgery NCT03864562 722 729 I-Procedure-Name
which NCT03864562 730 735 O
may NCT03864562 736 739 O
affect NCT03864562 740 746 B-Stability___Stability-Value:change
normal NCT03864562 747 753 B-Polarity___Polarity-Value:normal
function NCT03864562 754 762 B-Condition-Name
( NCT03864562 763 764 O
e NCT03864562 765 766 O
. NCT03864562 767 768 O
g NCT03864562 769 770 O
. NCT03864562 771 772 O
bowel NCT03864562 774 779 B-Procedure-Name
resection NCT03864562 780 789 I-Procedure-Name
) NCT03864562 790 791 O

Inclusion NCT03868358 0 9 O
Criteria NCT03868358 10 18 O
: NCT03868358 19 20 O

- NCT03868358 24 25 O
Patients NCT03868358 27 35 O
met NCT03868358 36 39 O
diagnostic NCT03868358 40 50 O
criteria NCT03868358 51 59 O
for NCT03868358 60 63 O
schizophrenia NCT03868358 64 77 B-Condition-Name
or NCT03868358 78 80 O
schizoaffective NCT03868358 81 96 B-Condition-Name
disorder NCT03868358 97 105 I-Condition-Name
using NCT03868358 106 111 O
the NCT03868358 112 115 O
Structural NCT03868358 116 126 O
Clinical NCT03868358 127 135 O
Interview NCT03868358 136 145 O
for NCT03868358 146 149 O
Diagnostic NCT03868358 150 160 O
and NCT03868358 161 164 O
Statistical NCT03868358 165 176 O
Manual NCT03868358 177 183 O
Diploma NCT03868358 184 191 O
in NCT03868358 192 194 O
Social NCT03868358 195 201 O
Medicine NCT03868358 202 210 O
( NCT03868358 211 212 O
DSM NCT03868358 213 216 O
) NCT03868358 217 218 O
- NCT03868358 220 221 O
IV NCT03868358 222 224 O
( NCT03868358 225 226 O
SCID NCT03868358 227 231 O
, NCT03868358 232 233 O
Version NCT03868358 234 241 O
2.0 NCT03868358 243 246 O
) NCT03868358 247 248 O
. NCT03868358 250 251 O

- NCT03868358 255 256 O
Patients NCT03868358 258 266 O
remain NCT03868358 267 273 O
their NCT03868358 274 279 O
psychotropic NCT03868358 280 292 B-Drug-Name
medication NCT03868358 293 303 I-Drug-Name
at NCT03868358 304 306 O
steady NCT03868358 307 313 B-Stability___Stability-Value:stable
dosages NCT03868358 314 321 O
for NCT03868358 322 325 O
at NCT03868358 326 328 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868358 329 334 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03868358 336 337 B-Eq-Value
weeks NCT03868358 338 343 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03868358 344 349 O
to NCT03868358 350 352 O
study NCT03868358 353 358 O
entry NCT03868358 359 364 O
and NCT03868358 365 368 O
for NCT03868358 369 372 O
the NCT03868358 373 376 O
duration NCT03868358 377 385 O
of NCT03868358 386 388 O
the NCT03868358 389 392 O
trial NCT03868358 393 398 O
. NCT03868358 399 400 O

- NCT03868358 404 405 O
Verbal NCT03868358 407 413 B-Observation-Name___Observation-Type-Value:measurement
intelligence NCT03868358 414 426 I-Observation-Name___Observation-Type-Value:measurement
quotient NCT03868358 427 435 I-Observation-Name___Observation-Type-Value:measurement
> NCT03868358 436 437 B-Eq-Operator___Eq-Operator-Value:GT
85 NCT03868358 439 441 B-Eq-Value
as NCT03868358 442 444 O
measured NCT03868358 445 453 O
by NCT03868358 454 456 O
using NCT03868358 457 462 O
a NCT03868358 463 464 O
Chinese NCT03868358 465 472 O
version NCT03868358 473 480 O
of NCT03868358 481 483 O
the NCT03868358 484 487 O
National NCT03868358 488 496 B-Observation-Name
Adult NCT03868358 497 502 I-Observation-Name
Reading NCT03868358 503 510 I-Observation-Name
Test NCT03868358 511 515 I-Observation-Name
. NCT03868358 516 517 O

Exclusion NCT03868358 519 528 O
Criteria NCT03868358 529 537 O
: NCT03868358 538 539 O

- NCT03868358 543 544 O
History NCT03868358 546 553 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868358 554 556 O
significant NCT03868358 557 568 B-Severity___Severity-Value:severe
head NCT03868358 569 573 O
trauma NCT03868358 574 580 B-Condition-Name
or NCT03868358 581 583 O
neurological NCT03868358 584 596 B-Condition-Name
disorders NCT03868358 597 606 I-Condition-Name

- NCT03868358 609 610 O
Alcohol NCT03868358 612 619 O
or NCT03868358 620 622 O
drug NCT03868358 623 627 O
abuse NCT03868358 628 633 B-Condition-Name
Focal NCT03868358 634 639 B-Condition-Name
brain NCT03868358 640 645 I-Condition-Name
lesions NCT03868358 646 653 I-Condition-Name
on NCT03868358 654 656 O
T NCT03868358 657 658 O
1 NCT03868358 659 660 O
- NCT03868358 661 662 O
or NCT03868358 663 665 O
T NCT03868358 666 667 O
2 NCT03868358 668 669 O
- NCT03868358 670 671 O
weighted NCT03868358 672 680 O
fluid NCT03868358 681 686 O
- NCT03868358 687 688 O
attenuated NCT03868358 689 699 O
inversion NCT03868358 700 709 O
- NCT03868358 710 711 O
recovery NCT03868358 712 720 O
magnetic NCT03868358 721 729 B-Procedure-Name
resonance NCT03868358 730 739 I-Procedure-Name
images NCT03868358 740 746 I-Procedure-Name

- NCT03868358 749 750 O
a NCT03868358 752 753 O
prior NCT03868358 754 759 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03868358 760 767 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868358 768 770 O
a NCT03868358 771 772 O
seizure NCT03868358 773 780 B-Condition-Name
not NCT03868358 781 784 O
induced NCT03868358 785 792 O
by NCT03868358 793 795 O
drug NCT03868358 796 800 B-Condition-Name
withdrawal NCT03868358 801 811 I-Condition-Name
, NCT03868358 812 813 O
first NCT03868358 814 819 O
degree NCT03868358 820 826 O
relative NCT03868358 827 835 O
with NCT03868358 836 840 O
epilepsy NCT03868358 841 849 B-Condition-Name
, NCT03868358 850 851 O
significant NCT03868358 852 863 B-Severity___Severity-Value:severe
neurological NCT03868358 864 876 B-Condition-Name
illness NCT03868358 877 884 I-Condition-Name
or NCT03868358 885 887 O
head NCT03868358 888 892 O
trauma NCT03868358 893 899 B-Condition-Name
, NCT03868358 900 901 O
endocrine NCT03868358 902 911 B-Condition-Name
disease NCT03868358 912 919 I-Condition-Name
, NCT03868358 920 921 O
such NCT03868358 922 926 O
as NCT03868358 927 929 O
thyroid NCT03868358 930 937 B-Condition-Name
disease NCT03868358 938 945 I-Condition-Name
, NCT03868358 946 947 O
significant NCT03868358 948 959 B-Severity___Severity-Value:severe
unstable NCT03868358 960 968 B-Stability___Stability-Value:change
medical NCT03868358 969 976 O
condition NCT03868358 977 986 O
, NCT03868358 987 988 O
recent NCT03868358 989 995 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
aggression NCT03868358 996 1006 B-Condition-Name
or NCT03868358 1007 1009 O
other NCT03868358 1010 1015 O
forms NCT03868358 1016 1021 O
of NCT03868358 1022 1024 O
behavioral NCT03868358 1025 1035 B-Condition-Name
dyscontrol NCT03868358 1036 1046 I-Condition-Name

- NCT03868358 1049 1050 O
left NCT03868358 1052 1056 B-Condition-Name
- NCT03868358 1057 1058 I-Condition-Name
handedness NCT03868358 1059 1069 I-Condition-Name
, NCT03868358 1070 1071 O
pregnancy NCT03868358 1072 1081 B-Condition-Name

- NCT03868358 1084 1085 O
estimated NCT03868358 1087 1096 B-Observation-Name___Observation-Type-Value:measurement
intelligence NCT03868358 1097 1109 I-Observation-Name___Observation-Type-Value:measurement
quotient NCT03868358 1110 1118 I-Observation-Name___Observation-Type-Value:measurement
< NCT03868358 1119 1120 B-Eq-Operator___Eq-Operator-Value:LT
80 NCT03868358 1122 1124 B-Eq-Value

- NCT03868358 1128 1129 O
current NCT03868358 1131 1138 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
alcohol NCT03868358 1139 1146 O
or NCT03868358 1147 1149 O
drug NCT03868358 1150 1154 O
abuse NCT03868358 1155 1160 B-Condition-Name

- NCT03868358 1163 1164 O
inability NCT03868358 1166 1175 O
to NCT03868358 1176 1178 O
provide NCT03868358 1179 1186 O
informed NCT03868358 1187 1195 O
consent NCT03868358 1196 1203 O
. NCT03868358 1204 1205 O

- NCT03868358 1209 1210 O
Hamilton NCT03868358 1212 1220 B-Observation-Name___Observation-Type-Value:clinical-score
Anxiety NCT03868358 1221 1228 I-Observation-Name___Observation-Type-Value:clinical-score
Rating NCT03868358 1229 1235 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03868358 1236 1241 I-Observation-Name___Observation-Type-Value:clinical-score
or NCT03868358 1242 1244 O
the NCT03868358 1245 1248 O
Hamilton NCT03868358 1249 1257 B-Observation-Name___Observation-Type-Value:clinical-score
Depression NCT03868358 1258 1268 I-Observation-Name___Observation-Type-Value:clinical-score
Rating NCT03868358 1269 1275 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03868358 1276 1281 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03868358 1282 1287 B-Eq-Unit
> NCT03868358 1288 1289 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03868358 1291 1293 B-Eq-Value

Inclusion NCT03861195 0 9 O
Criteria NCT03861195 10 18 O
: NCT03861195 19 20 O

- NCT03861195 24 25 O
age NCT03861195 27 30 O
≥ NCT03861195 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03861195 34 36 B-Eq-Value
years NCT03861195 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861195 45 46 O
BMI NCT03861195 48 51 B-Observation-Name___Observation-Type-Value:vital
≤ NCT03861195 52 53 B-Eq-Operator___Eq-Operator-Value:LTEQ
40 NCT03861195 55 57 B-Eq-Value
kg NCT03861195 58 60 B-Eq-Unit
/ NCT03861195 61 62 O
m NCT03861195 63 64 B-Eq-Unit
2 NCT03861195 65 66 I-Eq-Unit

- NCT03861195 69 70 O
indication NCT03861195 72 82 O
for NCT03861195 83 86 O
hysterectomy NCT03861195 87 99 B-Procedure-Name
for NCT03861195 100 103 O
benign NCT03861195 104 110 B-Condition-Name
disease NCT03861195 111 118 I-Condition-Name
or NCT03861195 119 121 O
prophylactic NCT03861195 122 134 B-Procedure-Name
surgery NCT03861195 135 142 I-Procedure-Name
due NCT03861195 143 146 O
to NCT03861195 147 149 O
hereditary NCT03861195 150 160 O
cancer NCT03861195 161 167 B-Condition-Name

- NCT03861195 170 171 O
indication NCT03861195 173 183 O
for NCT03861195 184 187 O
radical NCT03861195 188 195 B-Procedure-Name
hysterectomy NCT03861195 196 208 I-Procedure-Name
and NCT03861195 209 212 O
/ NCT03861195 213 214 O
or NCT03861195 215 217 O
pelvic NCT03861195 218 224 O
- NCT03861195 225 226 O
/ NCT03861195 228 229 O
para NCT03861195 230 234 O
- NCT03861195 235 236 O
aortic NCT03861195 237 243 O
( NCT03861195 244 245 O
sentinel NCT03861195 246 254 O
- NCT03861195 255 256 O
node NCT03861195 257 261 O
) NCT03861195 262 263 O
lymphadenectomy NCT03861195 264 279 B-Procedure-Name
for NCT03861195 280 283 O
cervical NCT03861195 284 292 O
cancer NCT03861195 293 299 B-Condition-Name

- NCT03861195 302 303 O
indication NCT03861195 305 315 O
for NCT03861195 316 319 O
modified NCT03861195 320 328 O
radical NCT03861195 329 336 O
hysterectomy NCT03861195 337 349 B-Procedure-Name
and NCT03861195 350 353 O
/ NCT03861195 354 355 O
or NCT03861195 356 358 O
pelvic NCT03861195 359 365 O
- NCT03861195 366 367 O
/ NCT03861195 369 370 O
para NCT03861195 371 375 O
- NCT03861195 376 377 O
aortic NCT03861195 378 384 O
( NCT03861195 385 386 O
sentinel NCT03861195 387 395 O
- NCT03861195 396 397 O
node NCT03861195 398 402 O
) NCT03861195 403 404 O
lymphadenectomy NCT03861195 405 420 B-Procedure-Name
for NCT03861195 421 424 O
endometrial NCT03861195 425 436 O
cancer NCT03861195 437 443 B-Condition-Name

- NCT03861195 446 447 O
size NCT03861195 449 453 B-Observation-Name___Observation-Type-Value:measurement
of NCT03861195 454 456 O
uterus NCT03861195 457 463 O
and NCT03861195 464 467 O
vagina NCT03861195 468 474 O
allows NCT03861195 475 481 O
for NCT03861195 482 485 O
retrieval NCT03861195 486 495 B-Procedure-Name
by NCT03861195 496 498 O
the NCT03861195 499 502 O
vaginal NCT03861195 503 510 O
route NCT03861195 511 516 O
in NCT03861195 517 519 O
cancer NCT03861195 520 526 B-Condition-Name
patients NCT03861195 527 535 O

- NCT03861195 538 539 O
written NCT03861195 541 548 O
informed NCT03861195 549 557 O
consent NCT03861195 558 565 O

Exclusion NCT03861195 566 575 O
Criteria NCT03861195 576 584 O
: NCT03861195 585 586 O

- NCT03861195 590 591 O
known NCT03861195 593 598 O
extensive NCT03861195 599 608 O
intra NCT03861195 609 614 O
- NCT03861195 615 616 O
abdominal NCT03861195 617 626 O
adhesions NCT03861195 627 636 B-Condition-Name

- NCT03861195 639 640 O
anaesthesiological NCT03861195 642 660 O
contraindications NCT03861195 661 678 O
to NCT03861195 679 681 O
laparoscopy NCT03861195 682 693 B-Procedure-Name

- NCT03861195 696 697 O
women NCT03861195 699 704 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03861195 705 709 O
pacemaker NCT03861195 710 719 B-Procedure-Name
or NCT03861195 720 722 O
other NCT03861195 723 728 O
implants NCT03861195 729 737 B-Procedure-Name
where NCT03861195 738 743 O
electrosurgery NCT03861195 744 758 B-Procedure-Name
is NCT03861195 759 761 O
to NCT03861195 762 764 O
be NCT03861195 765 767 O
avoided NCT03861195 768 775 O

- NCT03861195 778 779 O
women NCT03861195 781 786 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03861195 787 791 O
known NCT03861195 792 797 O
defects NCT03861195 798 805 B-Condition-Name
of NCT03861195 806 808 I-Condition-Name
the NCT03861195 809 812 I-Condition-Name
hemostasis NCT03861195 813 823 I-Condition-Name

- NCT03861195 826 827 O
pregnancy NCT03861195 829 838 B-Condition-Name

- NCT03861195 841 842 O
other NCT03861195 844 849 O
internal NCT03861195 850 858 O
or NCT03861195 859 861 O
anatomical NCT03861195 862 872 O
criteria NCT03861195 873 881 O
that NCT03861195 882 886 O
preclude NCT03861195 887 895 O
a NCT03861195 896 897 O
minimal NCT03861195 898 905 B-Procedure-Name
invasive NCT03861195 906 914 I-Procedure-Name
approach NCT03861195 915 923 I-Procedure-Name

- NCT03861195 926 927 O
inability NCT03861195 929 938 O
to NCT03861195 939 941 O
understand NCT03861195 942 952 O
patient NCT03861195 953 960 O
information NCT03861195 961 972 O

Inclusion NCT03861156 0 9 O
Criteria NCT03861156 10 18 O
: NCT03861156 19 20 O

- NCT03861156 24 25 O
Aged NCT03861156 27 31 O
at NCT03861156 32 34 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861156 35 40 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03861156 42 44 B-Eq-Value
years NCT03861156 45 50 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03861156 51 52 O

- NCT03861156 56 57 O
Histologically NCT03861156 59 73 O
or NCT03861156 74 76 O
cytologically NCT03861156 77 90 B-Procedure-Name
proven NCT03861156 91 97 O
diagnosis NCT03861156 98 107 O
of NCT03861156 108 110 O
NSCLC NCT03861156 111 116 B-Condition-Name
that NCT03861156 117 121 O
is NCT03861156 122 124 O
locally NCT03861156 125 132 O
advanced NCT03861156 133 141 O
or NCT03861156 142 144 O
metastatic NCT03861156 145 155 O
. NCT03861156 156 157 O

- NCT03861156 161 162 O
Radiological NCT03861156 164 176 B-Procedure-Name
documentation NCT03861156 177 190 O
of NCT03861156 191 193 O
disease NCT03861156 194 201 B-Condition-Name
progression NCT03861156 202 213 I-Condition-Name
while NCT03861156 214 219 O
on NCT03861156 220 222 O
a NCT03861156 223 224 O
previous NCT03861156 225 233 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
continuous NCT03861156 234 244 O
treatment NCT03861156 245 254 O
with NCT03861156 255 259 O
an NCT03861156 260 262 O
first NCT03861156 263 268 O
or NCT03861156 269 271 O
second NCT03861156 272 278 O
generation NCT03861156 279 289 O
of NCT03861156 290 292 O
EGFR NCT03861156 293 297 B-Drug-Name
TKI NCT03861156 298 301 I-Drug-Name
e NCT03861156 302 303 O
. NCT03861156 304 305 O
g NCT03861156 306 307 O
. NCT03861156 308 309 O
gefitinib NCT03861156 311 320 B-Drug-Name
or NCT03861156 321 323 O
erlotinib NCT03861156 324 333 B-Drug-Name
. NCT03861156 334 335 O

- NCT03861156 339 340 O
patients NCT03861156 342 350 O
must NCT03861156 351 355 O
also NCT03861156 356 360 O
have NCT03861156 361 365 O
confirmation NCT03861156 366 378 O
of NCT03861156 379 381 O
tumour NCT03861156 382 388 B-Condition-Name
T NCT03861156 389 390 I-Condition-Name
790 NCT03861156 391 394 I-Condition-Name
M NCT03861156 395 396 I-Condition-Name
mutation NCT03861156 397 405 I-Condition-Name
status NCT03861156 406 412 O
( NCT03861156 413 414 O
confirmed NCT03861156 415 424 O
positive NCT03861156 425 433 B-Polarity___Polarity-Value:positive
) NCT03861156 434 435 O
after NCT03861156 436 441 O
disease NCT03861156 442 449 B-Condition-Name
progression NCT03861156 450 461 I-Condition-Name
on NCT03861156 462 464 O
the NCT03861156 465 468 O
prior NCT03861156 469 474 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
EGFR NCT03861156 475 479 B-Drug-Name
TKI NCT03861156 480 483 I-Drug-Name
. NCT03861156 484 485 O

- NCT03861156 489 490 O
Eastern NCT03861156 492 499 B-Observation-Name___Observation-Type-Value:clinical-score
cooperative NCT03861156 500 511 I-Observation-Name___Observation-Type-Value:clinical-score
oncology NCT03861156 512 520 I-Observation-Name___Observation-Type-Value:clinical-score
group NCT03861156 521 526 I-Observation-Name___Observation-Type-Value:clinical-score
performance NCT03861156 527 538 I-Observation-Name___Observation-Type-Value:clinical-score
status NCT03861156 539 545 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03861156 546 547 O
ECOG NCT03861156 548 552 B-Observation-Name
PS NCT03861156 553 555 O
) NCT03861156 556 557 O
of NCT03861156 558 560 O
0 NCT03861156 562 563 B-Eq-Value
- NCT03861156 564 565 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1 NCT03861156 567 568 B-Eq-Value
. NCT03861156 568 569 O

- NCT03861156 573 574 O
a NCT03861156 576 577 O
minimum NCT03861156 578 585 B-Eq-Operator___Eq-Operator-Value:GTEQ
life NCT03861156 586 590 B-Observation-Name
expectancy NCT03861156 591 601 I-Observation-Name
of NCT03861156 602 604 O
12 NCT03861156 606 608 B-Eq-Value
weeks NCT03861156 609 614 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03861156 615 616 O

- NCT03861156 620 621 O
At NCT03861156 623 625 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861156 626 631 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03861156 632 635 B-Eq-Value
lesion NCT03861156 636 642 B-Condition-Name
, NCT03861156 643 644 O
not NCT03861156 645 648 O
previously NCT03861156 649 659 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
irradiated NCT03861156 660 670 B-Procedure-Name
during NCT03861156 671 677 O
the NCT03861156 678 681 O
study NCT03861156 682 687 O
screening NCT03861156 688 697 O
period NCT03861156 698 704 O
, NCT03861156 705 706 O
that NCT03861156 707 711 O
can NCT03861156 712 715 O
be NCT03861156 716 718 O
accurately NCT03861156 719 729 O
measured NCT03861156 730 738 B-Observation-Name___Observation-Type-Value:measurement
at NCT03861156 739 741 O
baseline NCT03861156 742 750 O
according NCT03861156 751 760 O
to NCT03861156 761 763 O
RECIST NCT03861156 764 770 O
1.1 NCT03861156 772 775 O
. NCT03861156 775 776 O

- NCT03861156 780 781 O
Agree NCT03861156 783 788 O
to NCT03861156 789 791 O
use NCT03861156 792 795 O
routine NCT03861156 796 803 O
adequate NCT03861156 804 812 O
and NCT03861156 813 816 O
effective NCT03861156 817 826 O
contraceptive NCT03861156 827 840 B-Procedure-Name
measures NCT03861156 841 849 O
during NCT03861156 850 856 O
the NCT03861156 857 860 O
entire NCT03861156 861 867 O
study NCT03861156 868 873 O
period NCT03861156 874 880 O
and NCT03861156 881 884 O
within NCT03861156 885 891 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03861156 893 894 B-Eq-Value
weeks NCT03861156 895 900 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03861156 901 906 O
the NCT03861156 907 910 O
last NCT03861156 911 915 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
dose NCT03861156 916 920 O
pre NCT03861156 921 924 B-Condition-Name
- NCT03861156 925 926 I-Condition-Name
menopausal NCT03861156 927 937 I-Condition-Name
fertility NCT03861156 938 947 I-Condition-Name
possible NCT03861156 948 956 O
; NCT03861156 956 957 O
Female NCT03861156 958 964 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03861156 965 973 O
need NCT03861156 974 978 O
to NCT03861156 979 981 O
exclude NCT03861156 982 989 O
pregnancy NCT03861156 990 999 B-Condition-Name
( NCT03861156 1000 1001 O
ie NCT03861156 1002 1004 O
negative NCT03861156 1005 1013 B-Polarity___Polarity-Value:negative
pregnancy NCT03861156 1014 1023 B-Observation-Name___Observation-Type-Value:lab
test NCT03861156 1024 1028 I-Observation-Name___Observation-Type-Value:lab
) NCT03861156 1029 1030 O
and NCT03861156 1031 1034 O
in NCT03861156 1035 1037 O
non NCT03861156 1038 1041 O
- NCT03861156 1042 1043 O
lactation NCT03861156 1044 1053 B-Condition-Name
period NCT03861156 1054 1060 O
. NCT03861156 1061 1062 O

Exclusion NCT03861156 1064 1073 O
Criteria NCT03861156 1074 1082 O
: NCT03861156 1083 1084 O

- NCT03861156 1088 1089 O
Treatment NCT03861156 1091 1100 O
with NCT03861156 1101 1105 O
a NCT03861156 1106 1107 O
first NCT03861156 1108 1113 O
or NCT03861156 1114 1116 O
second NCT03861156 1117 1123 O
generation NCT03861156 1124 1134 O
of NCT03861156 1135 1137 O
EGFR NCT03861156 1138 1142 B-Drug-Name
- NCT03861156 1143 1144 I-Drug-Name
TKI NCT03861156 1145 1148 I-Drug-Name
within NCT03861156 1149 1155 B-Eq-Operator___Eq-Operator-Value:LTEQ
7 NCT03861156 1157 1158 B-Eq-Value
days NCT03861156 1159 1163 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03861156 1164 1166 O
study NCT03861156 1167 1172 O
entry NCT03861156 1173 1178 O
; NCT03861156 1178 1179 O
previous NCT03861156 1180 1188 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03861156 1189 1198 O
with NCT03861156 1199 1203 O
a NCT03861156 1204 1205 O
third NCT03861156 1206 1211 O
generation NCT03861156 1212 1222 O
of NCT03861156 1223 1225 O
EGFR NCT03861156 1226 1230 B-Drug-Name
- NCT03861156 1231 1232 I-Drug-Name
TKI NCT03861156 1233 1236 I-Drug-Name
. NCT03861156 1237 1238 O

- NCT03861156 1242 1243 O
Unresolved NCT03861156 1245 1255 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
toxicities NCT03861156 1256 1266 B-Condition-Name
from NCT03861156 1267 1271 O
prior NCT03861156 1272 1277 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
therapy NCT03861156 1278 1285 B-Procedure-Name
. NCT03861156 1286 1287 O

- NCT03861156 1291 1292 O
Unstable NCT03861156 1294 1302 B-Stability___Stability-Value:change
spinal NCT03861156 1303 1309 B-Condition-Name
cord NCT03861156 1310 1314 I-Condition-Name
compression NCT03861156 1315 1326 I-Condition-Name
/ NCT03861156 1327 1328 O
brain NCT03861156 1329 1334 O
metastases NCT03861156 1335 1345 B-Condition-Name
. NCT03861156 1346 1347 O

- NCT03861156 1351 1352 O
Severe NCT03861156 1354 1360 B-Severity___Severity-Value:severe
/ NCT03861156 1361 1362 O
uncontrolled NCT03861156 1363 1375 O
systemic NCT03861156 1376 1384 O
diseases NCT03861156 1385 1393 B-Condition-Name
, NCT03861156 1394 1395 O
including NCT03861156 1396 1405 O
uncontrolled NCT03861156 1406 1418 O
hypertension NCT03861156 1419 1431 B-Condition-Name
, NCT03861156 1432 1433 O
bleeding NCT03861156 1434 1442 B-Condition-Name
diatheses NCT03861156 1443 1452 I-Condition-Name
or NCT03861156 1453 1455 O
infection NCT03861156 1456 1465 B-Condition-Name
. NCT03861156 1466 1467 O

- NCT03861156 1471 1472 O
QTcF NCT03861156 1474 1478 B-Observation-Name___Observation-Type-Value:measurement
> NCT03861156 1479 1480 B-Eq-Operator___Eq-Operator-Value:GT
470 NCT03861156 1482 1485 B-Eq-Value
msec NCT03861156 1486 1490 B-Eq-Unit
during NCT03861156 1491 1497 O
the NCT03861156 1498 1501 O
screening NCT03861156 1502 1511 O
period NCT03861156 1512 1518 O
. NCT03861156 1519 1520 O

- NCT03861156 1524 1525 O
Severe NCT03861156 1527 1533 B-Severity___Severity-Value:severe
respiratory NCT03861156 1534 1545 B-Condition-Name
diseases NCT03861156 1546 1554 I-Condition-Name
such NCT03861156 1555 1559 O
as NCT03861156 1560 1562 O
interstitial NCT03861156 1563 1575 B-Condition-Name
lung NCT03861156 1576 1580 I-Condition-Name
disease NCT03861156 1581 1588 I-Condition-Name
, NCT03861156 1589 1590 O
severe NCT03861156 1591 1597 B-Severity___Severity-Value:severe
asthma NCT03861156 1598 1604 B-Condition-Name
, NCT03861156 1605 1606 O
pulmonary NCT03861156 1607 1616 B-Condition-Name
embolism NCT03861156 1617 1625 I-Condition-Name
, NCT03861156 1626 1627 O
etc NCT03861156 1628 1631 O
. NCT03861156 1632 1633 O

- NCT03861156 1637 1638 O
previous NCT03861156 1640 1648 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03861156 1649 1658 O
with NCT03861156 1659 1663 O
2 NCT03861156 1665 1666 B-Eq-Value
or NCT03861156 1667 1669 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03861156 1670 1674 I-Eq-Operator___Eq-Operator-Value:GTEQ
lines NCT03861156 1675 1680 O
of NCT03861156 1681 1683 O
Chemotherapy NCT03861156 1684 1696 B-Procedure-Name
or NCT03861156 1697 1699 O
immunotherapy NCT03861156 1700 1713 B-Procedure-Name
. NCT03861156 1714 1715 O

Inclusion NCT03861624 0 9 O
Criteria NCT03861624 10 18 O
: NCT03861624 19 20 O

1 NCT03861624 25 26 O
. NCT03861624 26 27 O
Skeletal NCT03861624 29 37 B-Condition-Name
maturity NCT03861624 38 46 I-Condition-Name

2 NCT03861624 50 51 O
. NCT03861624 51 52 O
AO NCT03861624 54 56 B-Eq-Value
/ NCT03861624 57 58 O
OTA NCT03861624 59 62 B-Eq-Value
42 NCT03861624 64 66 I-Eq-Value
open NCT03861624 67 71 O
tibia NCT03861624 72 77 O
fractures NCT03861624 78 87 B-Condition-Name

3 NCT03861624 91 92 O
. NCT03861624 92 93 O
Wound NCT03861624 95 100 B-Condition-Name
primarily NCT03861624 101 110 O
closeable NCT03861624 111 120 O
( NCT03861624 121 122 O
no NCT03861624 123 125 O
flap NCT03861624 126 130 O
or NCT03861624 131 133 O
delay NCT03861624 134 139 O
in NCT03861624 140 142 O
closure NCT03861624 143 150 B-Procedure-Name
due NCT03861624 151 154 O
to NCT03861624 155 157 O
contamination NCT03861624 158 171 B-Condition-Name
needed NCT03861624 172 178 O
) NCT03861624 179 180 O

4 NCT03861624 185 186 O
. NCT03861624 186 187 O
Palpable NCT03861624 189 197 O
pedal NCT03861624 198 203 B-Observation-Name___Observation-Type-Value:vital
pulses NCT03861624 204 210 I-Observation-Name___Observation-Type-Value:vital
( NCT03861624 211 212 O
no NCT03861624 213 215 O
vascular NCT03861624 216 224 B-Condition-Name
injury NCT03861624 225 231 I-Condition-Name
sustained NCT03861624 232 241 O
) NCT03861624 242 243 O

5 NCT03861624 248 249 O
. NCT03861624 249 250 O
Presentation NCT03861624 252 264 O
within NCT03861624 265 271 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03861624 273 275 B-Eq-Value
hours NCT03861624 276 281 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
from NCT03861624 282 286 O
injury NCT03861624 287 293 B-Condition-Name

Exclusion NCT03861624 294 303 O
Criteria NCT03861624 304 312 O
: NCT03861624 313 314 O

1 NCT03861624 319 320 O
. NCT03861624 320 321 O
Current NCT03861624 323 330 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
injury NCT03861624 331 337 B-Condition-Name
is NCT03861624 338 340 O
a NCT03861624 341 342 O
pathologic NCT03861624 343 353 O
fracture NCT03861624 354 362 B-Condition-Name

2 NCT03861624 366 367 O
. NCT03861624 367 368 O
Sustained NCT03861624 370 379 O
bilateral NCT03861624 380 389 O
tibia NCT03861624 390 395 O
fracture NCT03861624 396 404 B-Condition-Name

3 NCT03861624 408 409 O
. NCT03861624 409 410 O
Sustained NCT03861624 412 421 O
comminuted NCT03861624 422 432 O
femur NCT03861624 433 438 O
fracture NCT03861624 439 447 B-Condition-Name

4 NCT03861624 451 452 O
. NCT03861624 452 453 O
Sustained NCT03861624 455 464 O
severe NCT03861624 465 471 B-Severity___Severity-Value:severe
Traumatic NCT03861624 472 481 B-Condition-Name
Brain NCT03861624 482 487 I-Condition-Name
Injury NCT03861624 488 494 I-Condition-Name
( NCT03861624 495 496 O
GCS NCT03861624 497 500 B-Observation-Name___Observation-Type-Value:clinical-score
< NCT03861624 501 502 B-Eq-Operator___Eq-Operator-Value:LT
12 NCT03861624 504 506 B-Eq-Value
) NCT03861624 507 508 O
* NCT03861624 509 510 O
* NCT03861624 510 511 O
* NCT03861624 511 512 O

5 NCT03861624 516 517 O
. NCT03861624 517 518 O
Sustained NCT03861624 520 529 O
severe NCT03861624 530 536 B-Severity___Severity-Value:severe
spinal NCT03861624 537 543 O
cord NCT03861624 544 548 O
injury NCT03861624 549 555 B-Condition-Name
( NCT03861624 556 557 O
lower NCT03861624 558 563 O
extremity NCT03861624 564 573 O
paresis NCT03861624 574 581 B-Condition-Name
/ NCT03861624 582 583 O
paralysis NCT03861624 584 593 B-Condition-Name
) NCT03861624 594 595 O

6 NCT03861624 600 601 O
. NCT03861624 601 602 O
Sustained NCT03861624 604 613 O
severe NCT03861624 614 620 B-Severity___Severity-Value:severe
burns NCT03861624 621 626 B-Condition-Name
( NCT03861624 627 628 O
> NCT03861624 630 631 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03861624 633 635 B-Eq-Value
% NCT03861624 636 637 B-Eq-Unit
total NCT03861624 638 643 B-Observation-Name___Observation-Type-Value:measurement
body NCT03861624 644 648 I-Observation-Name___Observation-Type-Value:measurement
surface NCT03861624 649 656 I-Observation-Name___Observation-Type-Value:measurement
area NCT03861624 657 661 I-Observation-Name___Observation-Type-Value:measurement
( NCT03861624 662 663 O
TBSA NCT03861624 664 668 B-Observation-Name
) NCT03861624 669 670 O
or NCT03861624 671 673 O
> NCT03861624 674 675 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03861624 677 678 B-Eq-Value
% NCT03861624 679 680 B-Eq-Unit
TBSA NCT03861624 681 685 B-Observation-Name
with NCT03861624 686 690 O
full NCT03861624 691 695 O
thickness NCT03861624 696 705 O
or NCT03861624 706 708 O
circumferential NCT03861624 709 724 O
injury NCT03861624 725 731 B-Condition-Name
) NCT03861624 732 733 O

7 NCT03861624 738 739 O
. NCT03861624 739 740 O
Prior NCT03861624 742 747 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ipsilateral NCT03861624 748 759 O
leg NCT03861624 760 763 O
injury NCT03861624 764 770 B-Condition-Name
requiring NCT03861624 771 780 O
surgery NCT03861624 781 788 B-Procedure-Name

8 NCT03861624 792 793 O
. NCT03861624 793 794 O
Prior NCT03861624 796 801 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03861624 802 804 O
current NCT03861624 805 812 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
lower NCT03861624 813 818 O
limb NCT03861624 819 823 O
deformity NCT03861624 824 833 B-Condition-Name
or NCT03861624 834 836 O
abnormality NCT03861624 837 848 B-Condition-Name

9 NCT03861624 852 853 O
. NCT03861624 853 854 O
Unable NCT03861624 856 862 O
to NCT03861624 863 865 O
complete NCT03861624 866 874 O
follow NCT03861624 875 881 O
- NCT03861624 882 883 O
up NCT03861624 884 886 O
visits NCT03861624 887 893 O

Inclusion NCT03863769 0 9 O
Criteria NCT03863769 10 18 O
: NCT03863769 19 20 O

- NCT03863769 24 25 O
Age NCT03863769 27 30 O
greater NCT03863769 31 38 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863769 39 43 I-Eq-Operator___Eq-Operator-Value:GT
48 NCT03863769 45 47 B-Eq-Value
years NCT03863769 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863769 54 57 O

- NCT03863769 60 61 O
Patient NCT03863769 63 70 O
has NCT03863769 71 74 O
leg NCT03863769 75 78 O
or NCT03863769 79 81 O
buttock NCT03863769 82 89 O
pain NCT03863769 90 94 B-Condition-Name
while NCT03863769 95 100 O
walking NCT03863769 101 108 B-Observation-Name

- NCT03863769 111 112 O
Patient NCT03863769 114 121 O
feels NCT03863769 122 127 O
relief NCT03863769 128 134 O
of NCT03863769 135 137 O
symptoms NCT03863769 138 146 O
with NCT03863769 147 151 O
bending NCT03863769 152 159 O
( NCT03863769 160 161 O
flexing NCT03863769 162 169 O
) NCT03863769 170 171 O
forward NCT03863769 172 179 O

- NCT03863769 182 183 O
Patient NCT03863769 185 192 O
feels NCT03863769 193 198 O
relief NCT03863769 199 205 O
when NCT03863769 206 210 O
using NCT03863769 211 216 O
a NCT03863769 217 218 O
shopping NCT03863769 219 227 O
cart NCT03863769 228 232 O
of NCT03863769 233 235 O
bicycle NCT03863769 236 243 O

- NCT03863769 246 247 O
Patient NCT03863769 249 256 O
has NCT03863769 257 260 O
motor NCT03863769 261 266 O
or NCT03863769 267 269 O
sensory NCT03863769 270 277 O
disturbance NCT03863769 278 289 B-Condition-Name
while NCT03863769 290 295 O
walking NCT03863769 296 303 B-Observation-Name

- NCT03863769 306 307 O
Patient NCT03863769 309 316 O
has NCT03863769 317 320 O
normal NCT03863769 321 327 B-Polarity___Polarity-Value:normal
and NCT03863769 328 331 O
symmetrical NCT03863769 332 343 O
foot NCT03863769 344 348 B-Observation-Name
pulses NCT03863769 349 355 I-Observation-Name

- NCT03863769 358 359 O
Patient NCT03863769 361 368 O
has NCT03863769 369 372 O
lower NCT03863769 373 378 O
extremity NCT03863769 379 388 O
weakness NCT03863769 389 397 B-Condition-Name

- NCT03863769 400 401 O
Patient NCT03863769 403 410 O
has NCT03863769 411 414 O
low NCT03863769 415 418 O
back NCT03863769 419 423 O
pain NCT03863769 424 428 B-Condition-Name

- NCT03863769 431 432 O
Duration NCT03863769 434 442 O
of NCT03863769 443 445 O
symptoms NCT03863769 446 454 O
and NCT03863769 455 458 O
signs NCT03863769 459 464 O
for NCT03863769 465 468 O
more NCT03863769 469 473 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863769 474 478 I-Eq-Operator___Eq-Operator-Value:GT
1 NCT03863769 480 481 B-Eq-Value
month NCT03863769 482 487 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863769 490 491 O
Able NCT03863769 493 497 B-Condition-Name
to NCT03863769 498 500 I-Condition-Name
stand NCT03863769 501 506 O
and NCT03863769 507 510 O
walk NCT03863769 511 515 O
without NCT03863769 516 523 O
assistive NCT03863769 524 533 B-Procedure-Name
devices NCT03863769 534 541 I-Procedure-Name
for NCT03863769 542 545 O
at NCT03863769 546 548 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863769 549 554 I-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03863769 556 558 B-Eq-Value
minutes NCT03863769 559 566 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

- NCT03863769 569 570 O
Able NCT03863769 572 576 O
to NCT03863769 577 579 O
give NCT03863769 580 584 O
written NCT03863769 585 592 O
informed NCT03863769 593 601 O
consent NCT03863769 602 609 O
and NCT03863769 610 613 O
complete NCT03863769 614 622 O
interviews NCT03863769 623 633 O
and NCT03863769 634 637 O
questionnaires NCT03863769 638 652 O
in NCT03863769 653 655 O
English NCT03863769 656 663 B-Language

Exclusion NCT03863769 664 673 O
Criteria NCT03863769 674 682 O
: NCT03863769 683 684 O

- NCT03863769 688 689 O
Complicated NCT03863769 691 702 O
spinal NCT03863769 703 709 O
pain NCT03863769 710 714 B-Condition-Name
due NCT03863769 715 718 O
to NCT03863769 719 721 O
fracture NCT03863769 722 730 B-Condition-Name
, NCT03863769 731 732 O
tumor NCT03863769 733 738 B-Condition-Name
, NCT03863769 739 740 O
infection NCT03863769 741 750 B-Condition-Name
, NCT03863769 751 752 O
or NCT03863769 753 755 O
severe NCT03863769 756 762 B-Severity___Severity-Value:severe
spondyloarthropathy NCT03863769 763 782 B-Condition-Name

- NCT03863769 785 786 O
Has NCT03863769 788 791 O
other NCT03863769 792 797 O
severe NCT03863769 798 804 B-Severity___Severity-Value:severe
co NCT03863769 805 807 B-Condition-Name
- NCT03863769 808 809 I-Condition-Name
morbidities NCT03863769 810 821 I-Condition-Name
, NCT03863769 822 823 O
including NCT03863769 824 833 O
progressive NCT03863769 834 845 O
neurological NCT03863769 846 858 B-Condition-Name
deficit NCT03863769 859 866 I-Condition-Name

- NCT03863769 869 870 O
Other NCT03863769 872 877 O
serious NCT03863769 878 885 B-Severity___Severity-Value:severe
pathologies NCT03863769 886 897 B-Condition-Name
of NCT03863769 898 900 O
the NCT03863769 901 904 O
locomotor NCT03863769 905 914 O
system NCT03863769 915 921 O

- NCT03863769 924 925 O
No NCT03863769 927 929 O
correspondence NCT03863769 930 944 O
availability NCT03863769 945 957 O
through NCT03863769 958 965 O
email NCT03863769 966 971 O

- NCT03863769 974 975 O
Inability NCT03863769 977 986 O
to NCT03863769 987 989 O
read NCT03863769 990 994 O
/ NCT03863769 995 996 O
comprehend NCT03863769 997 1007 O
English NCT03863769 1008 1015 B-Language

- NCT03863769 1018 1019 O
Compensation NCT03863769 1021 1033 O
or NCT03863769 1034 1036 O
seeking NCT03863769 1037 1044 O
compensation NCT03863769 1045 1057 O
from NCT03863769 1058 1062 O
a NCT03863769 1063 1064 O
third NCT03863769 1065 1070 O
- NCT03863769 1071 1072 O
party NCT03863769 1073 1078 O
liability NCT03863769 1079 1088 O
or NCT03863769 1089 1091 O
workers NCT03863769 1092 1099 O
' NCT03863769 1099 1100 O
compensation NCT03863769 1101 1113 O

- NCT03863769 1116 1117 O
Previous NCT03863769 1119 1127 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
spinal NCT03863769 1128 1134 B-Procedure-Name
manipulation NCT03863769 1135 1147 I-Procedure-Name
within NCT03863769 1148 1154 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863769 1155 1158 O
past NCT03863769 1159 1163 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03863769 1164 1169 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03866200 0 9 O
Criteria NCT03866200 10 18 O
: NCT03866200 19 20 O

- NCT03866200 24 25 O
The NCT03866200 27 30 O
diagnosis NCT03866200 31 40 O
of NCT03866200 41 43 O
pseudoachondroplasia NCT03866200 44 64 B-Condition-Name
is NCT03866200 65 67 O
based NCT03866200 68 73 O
on NCT03866200 74 76 O
clinical NCT03866200 77 85 B-Procedure-Name
assessment NCT03866200 86 96 I-Procedure-Name
either NCT03866200 97 103 O
in NCT03866200 104 106 O
person NCT03866200 107 113 O
or NCT03866200 114 116 O
by NCT03866200 117 119 O
photographic NCT03866200 120 132 O
review NCT03866200 133 139 O
by NCT03866200 140 142 O
skeletal NCT03866200 143 151 B-Provider-Type
dysplasia NCT03866200 152 161 I-Provider-Type
specialist NCT03866200 162 172 I-Provider-Type
( NCT03866200 173 174 O
JTH NCT03866200 175 178 O
) NCT03866200 179 180 O
, NCT03866200 182 183 O

- NCT03866200 187 188 O
Healthy NCT03866200 190 197 B-Condition-Name
beyond NCT03866200 198 204 O
pseudoachondroplasia NCT03866200 205 225 B-Condition-Name
associated NCT03866200 226 236 O
complications NCT03866200 237 250 B-Condition-Name
, NCT03866200 251 252 O

Exclusion NCT03866200 254 263 O
Criteria NCT03866200 264 272 O
: NCT03866200 273 274 O

- NCT03866200 278 279 O
Current NCT03866200 281 288 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03866200 289 292 O
of NCT03866200 293 295 O
resveratrol NCT03866200 296 307 B-Drug-Name

- NCT03866200 310 311 O
Current NCT03866200 313 320 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03866200 321 324 O
of NCT03866200 325 327 O
blood NCT03866200 328 333 B-Drug-Name
thinners NCT03866200 334 342 I-Drug-Name
, NCT03866200 343 344 O
lovastatin NCT03866200 345 355 B-Drug-Name
, NCT03866200 356 357 O
ketoconazole NCT03866200 358 370 B-Drug-Name
, NCT03866200 371 372 O
itraconazole NCT03866200 373 385 B-Drug-Name
, NCT03866200 386 387 O
fexofenadine NCT03866200 388 400 B-Drug-Name
and NCT03866200 401 404 O
triazolam NCT03866200 405 414 B-Drug-Name
. NCT03866200 415 416 O

- NCT03866200 420 421 O
Other NCT03866200 423 428 O
non NCT03866200 429 432 O
- NCT03866200 433 434 O
pseudoachondroplasia NCT03866200 435 455 B-Condition-Name
related NCT03866200 456 463 O
health NCT03866200 464 470 O
conditions NCT03866200 471 481 O
, NCT03866200 482 483 O
e NCT03866200 484 485 O
. NCT03866200 486 487 O
g NCT03866200 488 489 O
. NCT03866200 490 491 O
cancers NCT03866200 493 500 B-Condition-Name
. NCT03866200 501 502 O

- NCT03866200 506 507 O
Pregnancy NCT03866200 509 518 B-Condition-Name
or NCT03866200 519 521 O
breastfeeding NCT03866200 522 535 B-Condition-Name
. NCT03866200 536 537 O
Women NCT03866200 539 544 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
must NCT03866200 545 549 O
use NCT03866200 550 553 O
adequate NCT03866200 554 562 O
contraception NCT03866200 563 576 B-Procedure-Name
during NCT03866200 577 583 O
the NCT03866200 584 587 O
study NCT03866200 588 593 O
. NCT03866200 594 595 O

- NCT03866200 599 600 O
Participation NCT03866200 602 615 O
in NCT03866200 616 618 O
another NCT03866200 619 626 O
clinical NCT03866200 627 635 O
study NCT03866200 636 641 O
and NCT03866200 642 645 O
/ NCT03866200 646 647 O
or NCT03866200 648 650 O
using NCT03866200 651 656 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
investigational NCT03866200 657 672 O
agents NCT03866200 673 679 O
. NCT03866200 680 681 O

- NCT03866200 685 686 O
Use NCT03866200 688 691 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03866200 692 694 O
Non NCT03866200 695 698 B-Drug-Name
- NCT03866200 699 700 I-Drug-Name
steroid NCT03866200 701 708 I-Drug-Name
anti NCT03866200 709 713 I-Drug-Name
- NCT03866200 714 715 I-Drug-Name
inflammatory NCT03866200 716 728 I-Drug-Name
( NCT03866200 729 730 O
NSAIDs NCT03866200 731 737 B-Drug-Name
) NCT03866200 738 739 O
or NCT03866200 740 742 O
aspirin NCT03866200 743 750 B-Drug-Name
. NCT03866200 751 752 O

- NCT03866200 756 757 O
Current NCT03866200 759 766 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03866200 767 770 O
of NCT03866200 771 773 O
Alfentanil NCT03866200 774 784 B-Drug-Name
, NCT03866200 785 786 O
Cyclosporine NCT03866200 787 799 B-Drug-Name
, NCT03866200 800 801 O
Dihydroergotamine NCT03866200 802 819 B-Drug-Name
, NCT03866200 820 821 O
Dofetilide NCT03866200 822 832 B-Drug-Name
, NCT03866200 833 834 O
Ergotamine NCT03866200 835 845 B-Drug-Name
, NCT03866200 846 847 O
Fentanyl NCT03866200 848 856 B-Drug-Name
, NCT03866200 857 858 O
Flibanserin NCT03866200 859 870 B-Drug-Name
, NCT03866200 871 872 O
Oxycodone NCT03866200 873 882 B-Drug-Name
, NCT03866200 883 884 O
Pimavanserin NCT03866200 885 897 B-Drug-Name
, NCT03866200 898 899 O
Pimozide NCT03866200 900 908 B-Drug-Name
, NCT03866200 909 910 O
Quinidine NCT03866200 911 920 B-Drug-Name
, NCT03866200 921 922 O
Saquinavir NCT03866200 923 933 B-Drug-Name
, NCT03866200 934 935 O
Sirolimus NCT03866200 936 945 B-Drug-Name
, NCT03866200 946 947 O
Tacrolimus NCT03866200 948 958 B-Drug-Name
, NCT03866200 959 960 O
Temsirolimus NCT03866200 961 973 B-Drug-Name
, NCT03866200 974 975 O
Theophylline NCT03866200 976 988 B-Drug-Name
, NCT03866200 989 990 O
Tizanidine NCT03866200 991 1001 B-Drug-Name
, NCT03866200 1002 1003 O
Thioridazine NCT03866200 1004 1016 B-Drug-Name
, NCT03866200 1017 1018 O
Fosphenytoin NCT03866200 1019 1031 B-Drug-Name
, NCT03866200 1032 1033 O
Phenytoin NCT03866200 1034 1043 B-Drug-Name
or NCT03866200 1044 1046 O
Warfarin NCT03866200 1047 1055 B-Drug-Name
. NCT03866200 1056 1057 O

- NCT03866200 1061 1062 O
Baseline NCT03866200 1064 1072 O
level NCT03866200 1073 1078 O
of NCT03866200 1079 1081 O
pain NCT03866200 1082 1086 B-Condition-Name
of NCT03866200 1087 1089 O
2 NCT03866200 1091 1092 B-Eq-Value
or NCT03866200 1093 1095 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03866200 1096 1102 I-Eq-Operator___Eq-Operator-Value:GTEQ
on NCT03866200 1103 1105 O
10 NCT03866200 1107 1109 O
point NCT03866200 1110 1115 O
scale NCT03866200 1116 1121 O
. NCT03866200 1122 1123 O

- NCT03866200 1127 1128 O
Platelet NCT03866200 1130 1138 B-Observation-Name___Observation-Type-Value:lab
count NCT03866200 1139 1144 I-Observation-Name___Observation-Type-Value:lab
below NCT03866200 1145 1150 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03866200 1152 1154 B-Eq-Value
, NCT03866200 1155 1156 I-Eq-Value
000 NCT03866200 1157 1160 I-Eq-Value
per NCT03866200 1161 1164 O
ul NCT03866200 1165 1167 B-Eq-Unit
on NCT03866200 1168 1170 O
baseline NCT03866200 1171 1179 O
complete NCT03866200 1180 1188 B-Observation-Name___Observation-Type-Value:lab
blood NCT03866200 1189 1194 I-Observation-Name___Observation-Type-Value:lab
count NCT03866200 1195 1200 I-Observation-Name___Observation-Type-Value:lab
( NCT03866200 1201 1202 O
CBC NCT03866200 1203 1206 B-Observation-Name
) NCT03866200 1207 1208 O
. NCT03866200 1210 1211 O

Inclusion NCT03862066 0 9 O
Criteria NCT03862066 10 18 O
: NCT03862066 19 20 O

- NCT03862066 24 25 O
Newly NCT03862066 27 32 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnosed NCT03862066 33 42 O
histologically NCT03862066 43 57 O
proven NCT03862066 58 64 O
locoregional NCT03862066 65 77 O
oral NCT03862066 78 82 O
squamous NCT03862066 83 91 O
cell NCT03862066 92 96 O
carcinoma NCT03862066 97 106 B-Condition-Name
( NCT03862066 107 108 O
OSCC NCT03862066 109 113 B-Condition-Name
) NCT03862066 114 115 O
without NCT03862066 116 123 O
evidence NCT03862066 124 132 O
of NCT03862066 133 135 O
distant NCT03862066 136 143 O
metastases NCT03862066 144 154 B-Condition-Name
. NCT03862066 155 156 O
OSCC NCT03862066 158 162 B-Condition-Name
includes NCT03862066 163 171 O
the NCT03862066 172 175 O
subsites NCT03862066 176 184 O
of NCT03862066 185 187 O
oral NCT03862066 188 192 O
tongue NCT03862066 193 199 O
, NCT03862066 200 201 O
floor NCT03862066 202 207 O
of NCT03862066 208 210 O
mouth NCT03862066 211 216 O
, NCT03862066 217 218 O
gingiva NCT03862066 219 226 O
, NCT03862066 227 228 O
retromolar NCT03862066 229 239 O
trigone NCT03862066 240 247 O
and NCT03862066 248 251 O
buccal NCT03862066 252 258 O
mucosa NCT03862066 259 265 O
OR NCT03862066 266 268 O
Recurrent NCT03862066 269 278 O
or NCT03862066 279 281 O
persistent NCT03862066 282 292 O
histologically NCT03862066 293 307 O
proven NCT03862066 308 314 O
locoregional NCT03862066 315 327 O
OSCC NCT03862066 328 332 B-Condition-Name
that NCT03862066 333 337 O
was NCT03862066 338 341 O
initially NCT03862066 342 351 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
treated NCT03862066 352 359 O
with NCT03862066 360 364 O
surgery NCT03862066 365 372 B-Procedure-Name
alone NCT03862066 373 378 O
. NCT03862066 379 380 O

- NCT03862066 384 385 O
must NCT03862066 387 391 O
be NCT03862066 392 394 O
eligible NCT03862066 395 403 O
for NCT03862066 404 407 O
surgical NCT03862066 408 416 B-Procedure-Name
resection NCT03862066 417 426 I-Procedure-Name

- NCT03862066 429 430 O
greater NCT03862066 432 439 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862066 440 444 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03862066 446 448 B-Eq-Value
years NCT03862066 449 454 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03862066 455 457 O
age NCT03862066 458 461 O

Exclusion NCT03862066 462 471 O
Criteria NCT03862066 472 480 O
: NCT03862066 481 482 O

- NCT03862066 486 487 O
prior NCT03862066 489 494 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
immunotherapy NCT03862066 495 508 B-Procedure-Name
or NCT03862066 509 511 O
treatment NCT03862066 512 521 O
with NCT03862066 522 526 O
another NCT03862066 527 534 O
anti NCT03862066 535 539 B-Drug-Name
PD NCT03862066 540 542 I-Drug-Name
- NCT03862066 543 544 I-Drug-Name
1 NCT03862066 546 547 I-Drug-Name
agent NCT03862066 548 553 I-Drug-Name
besides NCT03862066 554 561 O
nivolumab NCT03862066 562 571 B-Drug-Name

- NCT03862066 574 575 O
prior NCT03862066 577 582 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
chemotherapy NCT03862066 583 595 B-Procedure-Name
including NCT03862066 596 605 O
cetuximab NCT03862066 606 615 B-Drug-Name
or NCT03862066 616 618 O
radiation NCT03862066 619 628 B-Procedure-Name
therapy NCT03862066 629 636 I-Procedure-Name

- NCT03862066 639 640 O
concomitant NCT03862066 642 653 O
malignancies NCT03862066 654 666 B-Condition-Name
except NCT03862066 667 673 O
cutaneous NCT03862066 674 683 O
squamous NCT03862066 684 692 O
cell NCT03862066 693 697 O
carcinoma NCT03862066 698 707 B-Condition-Name
or NCT03862066 708 710 O
basal NCT03862066 711 716 O
cell NCT03862066 717 721 O
carcinoma NCT03862066 722 731 B-Condition-Name

- NCT03862066 734 735 O
unresectable NCT03862066 737 749 O
primary NCT03862066 750 757 O
tumor NCT03862066 758 763 B-Condition-Name
or NCT03862066 764 766 O
regional NCT03862066 767 775 B-Condition-Name
disease NCT03862066 776 783 I-Condition-Name
or NCT03862066 784 786 O
distant NCT03862066 787 794 O
metastases NCT03862066 795 805 B-Condition-Name


Inclusion NCT03860103 0 9 O
Criteria NCT03860103 10 18 O
: NCT03860103 19 20 O

- NCT03860103 24 25 O
Patient NCT03860103 27 34 O
who NCT03860103 35 38 O
accepted NCT03860103 39 47 O
to NCT03860103 48 50 O
participate NCT03860103 51 62 O
in NCT03860103 63 65 O
the NCT03860103 66 69 O
study NCT03860103 70 75 O

- NCT03860103 78 79 O
Woman NCT03860103 81 86 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
over NCT03860103 87 91 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03860103 93 95 B-Eq-Value
years NCT03860103 96 101 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03860103 102 105 O

- NCT03860103 108 109 O
Affiliated NCT03860103 111 121 O
to NCT03860103 122 124 O
a NCT03860103 125 126 O
social NCT03860103 127 133 O
security NCT03860103 134 142 O
scheme NCT03860103 143 149 O

- NCT03860103 152 153 O
Mono NCT03860103 155 159 O
- NCT03860103 160 161 O
fetal NCT03860103 162 167 O
pregnancy NCT03860103 168 177 B-Condition-Name

- NCT03860103 180 181 O
Patients NCT03860103 183 191 O
with NCT03860103 192 196 O
normal NCT03860103 197 203 B-Polarity___Polarity-Value:normal
pregnancy NCT03860103 204 213 B-Condition-Name
between NCT03860103 214 221 B-Eq-Operator___Eq-Operator-Value:BETWEEN
11 NCT03860103 223 225 B-Eq-Value
and NCT03860103 226 229 O
42 NCT03860103 231 233 B-Eq-Value
weeks NCT03860103 234 239 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03860103 240 242 O
amenorrhea NCT03860103 243 253 B-Condition-Name

- NCT03860103 256 257 O
Patients NCT03860103 259 267 O
hospitalized NCT03860103 268 280 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03860103 281 284 O
preeclampsia NCT03860103 285 297 B-Condition-Name
and NCT03860103 298 301 O
/ NCT03860103 302 303 O
or NCT03860103 304 306 O
intrauterine NCT03860103 307 319 B-Condition-Name
growth NCT03860103 320 326 I-Condition-Name
retardation NCT03860103 327 338 I-Condition-Name
, NCT03860103 339 340 O
beyond NCT03860103 341 347 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03860103 349 351 B-Eq-Value
weeks NCT03860103 352 357 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03860103 358 360 O
amenorrhea NCT03860103 361 371 B-Condition-Name

Exclusion NCT03860103 372 381 O
Criteria NCT03860103 382 390 O
: NCT03860103 391 392 O

- NCT03860103 396 397 O
Minors NCT03860103 399 405 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
, NCT03860103 406 407 O
adults NCT03860103 408 414 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
under NCT03860103 415 420 B-Observation-Name
guardianship NCT03860103 421 433 I-Observation-Name
, NCT03860103 434 435 O
protected NCT03860103 436 445 B-Observation-Name
persons NCT03860103 446 453 I-Observation-Name

- NCT03860103 456 457 O
Not NCT03860103 459 462 O
affiliated NCT03860103 463 473 O
to NCT03860103 474 476 O
a NCT03860103 477 478 O
social NCT03860103 479 485 O
security NCT03860103 486 494 O
scheme NCT03860103 495 501 O

- NCT03860103 504 505 O
Multiple NCT03860103 507 515 B-Eq-Operator___Eq-Operator-Value:GT
pregnancy NCT03860103 516 525 B-Condition-Name

Inclusion NCT03861221 0 9 O
Criteria NCT03861221 10 18 O
: NCT03861221 19 20 O

- NCT03861221 24 25 O
Female NCT03861221 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03861221 34 35 O
older NCT03861221 36 41 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03861221 42 46 I-Eq-Operator___Eq-Operator-Value:GT
35 NCT03861221 48 50 B-Eq-Value
years NCT03861221 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03861221 57 58 O
Already NCT03861221 60 67 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
have NCT03861221 68 72 O
mammography NCT03861221 73 84 B-Procedure-Name
, NCT03861221 85 86 O
or NCT03861221 87 89 O
other NCT03861221 90 95 O
standard NCT03861221 96 104 B-Procedure-Name
exams NCT03861221 105 110 I-Procedure-Name
( NCT03861221 111 112 O
ultrasound NCT03861221 113 123 B-Procedure-Name
, NCT03861221 124 125 O
MRI NCT03861221 126 129 B-Procedure-Name
, NCT03861221 130 131 O
etc NCT03861221 132 135 O
) NCT03861221 136 137 O
. NCT03861221 139 140 O
Could NCT03861221 142 147 O
participate NCT03861221 148 159 O
this NCT03861221 160 164 O
trial NCT03861221 165 170 O
within NCT03861221 171 177 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03861221 179 180 B-Eq-Value
weeks NCT03861221 181 186 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03861221 187 192 O
mammography NCT03861221 193 204 B-Procedure-Name
. NCT03861221 205 206 O
Have NCT03861221 208 212 O
the NCT03861221 213 216 O
ability NCT03861221 217 224 O
of NCT03861221 225 227 O
consent NCT03861221 228 235 O
inform NCT03861221 236 242 O
. NCT03861221 243 244 O

Exclusion NCT03861221 246 255 O
Criteria NCT03861221 256 264 O
: NCT03861221 265 266 O

- NCT03861221 270 271 O
During NCT03861221 273 279 O
pregnancy NCT03861221 280 289 B-Condition-Name
or NCT03861221 290 292 O
lactation NCT03861221 293 302 B-Condition-Name
period NCT03861221 303 309 O
. NCT03861221 310 311 O
Patients NCT03861221 313 321 O
that NCT03861221 322 326 O
may NCT03861221 327 330 O
not NCT03861221 331 334 O
be NCT03861221 335 337 O
capable NCT03861221 338 345 B-Observation-Name
of NCT03861221 346 348 I-Observation-Name
prone NCT03861221 349 354 I-Observation-Name
position NCT03861221 355 363 I-Observation-Name
, NCT03861221 364 365 O
such NCT03861221 366 370 O
as NCT03861221 371 373 O
patients NCT03861221 374 382 O
with NCT03861221 383 387 O
scapulohumeral NCT03861221 388 402 B-Condition-Name
periarthritis NCT03861221 403 416 I-Condition-Name
, NCT03861221 417 418 O
cardiac NCT03861221 419 426 B-Procedure-Name
pacemaker NCT03861221 427 436 I-Procedure-Name
or NCT03861221 437 439 O
have NCT03861221 440 444 O
recent NCT03861221 445 451 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
cardiac NCT03861221 452 459 B-Procedure-Name
surgery NCT03861221 460 467 I-Procedure-Name
. NCT03861221 468 469 O

Lymphoma NCT03861221 471 479 B-Condition-Name
patients NCT03861221 480 488 O
that NCT03861221 489 493 O
under NCT03861221 494 499 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
therapy NCT03861221 500 507 B-Procedure-Name
. NCT03861221 508 509 O
Severe NCT03861221 511 517 B-Severity___Severity-Value:severe
scoliosis NCT03861221 518 527 B-Condition-Name
. NCT03861221 528 529 O

Inclusion NCT03867877 0 9 O
Criteria NCT03867877 10 18 O
: NCT03867877 19 20 O

- NCT03867877 24 25 O
Hoehn NCT03867877 27 32 B-Condition-Name
& NCT03867877 33 34 I-Condition-Name
Yahr NCT03867877 35 39 I-Condition-Name
Classification NCT03867877 40 54 I-Condition-Name
of NCT03867877 55 57 I-Condition-Name
Disability NCT03867877 58 68 I-Condition-Name
, NCT03867877 69 70 O
stage NCT03867877 71 76 B-Eq-Unit
1 NCT03867877 78 79 B-Eq-Value
- NCT03867877 80 81 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03867877 83 84 B-Eq-Value

- NCT03867877 88 89 O
can NCT03867877 91 94 B-Condition-Name
ambulate NCT03867877 95 103 I-Condition-Name
with NCT03867877 104 108 O
or NCT03867877 109 111 O
without NCT03867877 112 119 O
an NCT03867877 120 122 O
assistive NCT03867877 123 132 B-Procedure-Name
device NCT03867877 133 139 I-Procedure-Name
for NCT03867877 140 143 O
at NCT03867877 144 146 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867877 147 152 I-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03867877 154 156 B-Eq-Value
feet NCT03867877 157 161 B-Eq-Unit

- NCT03867877 164 165 O
able NCT03867877 167 171 O
to NCT03867877 172 174 O
get NCT03867877 175 178 B-Observation-Name
up NCT03867877 179 181 I-Observation-Name
and NCT03867877 182 185 I-Observation-Name
down NCT03867877 186 190 I-Observation-Name
from NCT03867877 191 195 I-Observation-Name
the NCT03867877 196 199 I-Observation-Name
floor NCT03867877 200 205 I-Observation-Name
with NCT03867877 206 210 O
minimal NCT03867877 211 218 O
assistance NCT03867877 219 229 O

- NCT03867877 232 233 O
has NCT03867877 235 238 O
a NCT03867877 239 240 O
score NCT03867877 241 246 O
of NCT03867877 247 249 O
24 NCT03867877 251 253 B-Eq-Value
or NCT03867877 254 256 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03867877 257 262 I-Eq-Operator___Eq-Operator-Value:GTEQ
on NCT03867877 263 265 O
the NCT03867877 266 269 O
Folstein NCT03867877 270 278 B-Observation-Name___Observation-Type-Value:clinical-score
Mini NCT03867877 279 283 I-Observation-Name___Observation-Type-Value:clinical-score
- NCT03867877 284 285 I-Observation-Name___Observation-Type-Value:clinical-score
Mental NCT03867877 286 292 I-Observation-Name___Observation-Type-Value:clinical-score
State NCT03867877 293 298 I-Observation-Name___Observation-Type-Value:clinical-score
Exam NCT03867877 299 303 I-Observation-Name___Observation-Type-Value:clinical-score

Exclusion NCT03867877 304 313 O
Criteria NCT03867877 314 322 O
: NCT03867877 323 324 O

- NCT03867877 328 329 O
Greater NCT03867877 331 338 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867877 339 343 I-Eq-Operator___Eq-Operator-Value:GT
Stage NCT03867877 344 349 B-Eq-Unit
3 NCT03867877 351 352 B-Eq-Value
on NCT03867877 353 355 O
the NCT03867877 356 359 O
Hoehn NCT03867877 360 365 B-Condition-Name
& NCT03867877 366 367 I-Condition-Name
Yahr NCT03867877 368 372 I-Condition-Name
Classification NCT03867877 373 387 I-Condition-Name
of NCT03867877 388 390 I-Condition-Name
Disability NCT03867877 391 401 I-Condition-Name

- NCT03867877 404 405 O
decline NCT03867877 407 414 B-Polarity___Polarity-Value:low
in NCT03867877 415 417 O
immune NCT03867877 418 424 B-Condition-Name
function NCT03867877 425 433 I-Condition-Name
such NCT03867877 434 438 O
as NCT03867877 439 441 O
pneumonia NCT03867877 442 451 B-Condition-Name
or NCT03867877 452 454 O
systemic NCT03867877 455 463 O
infection NCT03867877 464 473 B-Condition-Name

- NCT03867877 476 477 O
progressive NCT03867877 479 490 B-Condition-Name
degenerative NCT03867877 491 503 I-Condition-Name
disease NCT03867877 504 511 I-Condition-Name
besides NCT03867877 512 519 O
PD NCT03867877 520 522 B-Condition-Name

- NCT03867877 525 526 O
spinal NCT03867877 528 534 B-Procedure-Name
fusion NCT03867877 535 541 I-Procedure-Name
or NCT03867877 542 544 O
other NCT03867877 545 550 O
orthopedic NCT03867877 551 561 B-Procedure-Name
surgery NCT03867877 562 569 I-Procedure-Name
in NCT03867877 570 572 O
the NCT03867877 573 576 O
past NCT03867877 577 581 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03867877 582 585 B-Eq-Value
months NCT03867877 586 592 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03867877 595 596 O
mental NCT03867877 598 604 B-Condition-Name
disease NCT03867877 605 612 I-Condition-Name
/ NCT03867877 613 614 O
psychosis NCT03867877 615 624 B-Condition-Name
such NCT03867877 625 629 O
as NCT03867877 630 632 O
dementia NCT03867877 633 641 B-Condition-Name

- NCT03867877 644 645 O
greater NCT03867877 647 654 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867877 655 659 I-Eq-Operator___Eq-Operator-Value:GT
minimal NCT03867877 660 667 B-Observation-Name
assistance NCT03867877 668 678 I-Observation-Name
required NCT03867877 679 687 O
for NCT03867877 688 691 O
gait NCT03867877 692 696 O
and NCT03867877 697 700 O
transfers NCT03867877 701 710 O

- NCT03867877 713 714 O
inability NCT03867877 716 725 O
to NCT03867877 726 728 O
make NCT03867877 729 733 O
regular NCT03867877 734 741 O
time NCT03867877 742 746 O
commitments NCT03867877 747 758 O
to NCT03867877 759 761 O
the NCT03867877 762 765 O
scheduled NCT03867877 766 775 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
training NCT03867877 776 784 B-Procedure-Name
sessions NCT03867877 785 793 I-Procedure-Name

- NCT03867877 796 797 O
participation NCT03867877 799 812 O
in NCT03867877 813 815 O
resistance NCT03867877 816 826 B-Observation-Name___Observation-Type-Value:social-habit
training NCT03867877 827 835 I-Observation-Name___Observation-Type-Value:social-habit
on NCT03867877 836 838 O
a NCT03867877 839 840 O
regular NCT03867877 841 848 O
basis NCT03867877 849 854 O
within NCT03867877 855 861 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867877 862 865 O
past NCT03867877 866 870 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03867877 871 874 B-Eq-Value
months NCT03867877 875 881 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03867877 884 885 O
inability NCT03867877 887 896 O
to NCT03867877 897 899 O
provide NCT03867877 900 907 O
consent NCT03867877 908 915 O

- NCT03867877 918 919 O
pregnancy NCT03867877 921 930 B-Condition-Name

- NCT03867877 933 934 O
a NCT03867877 936 937 O
prisoner NCT03867877 938 946 B-Observation-Name

Inclusion NCT03860467 0 9 O
Criteria NCT03860467 10 18 O
: NCT03860467 19 20 O

- NCT03860467 24 25 O
admitted NCT03860467 27 35 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03860467 36 38 O
the NCT03860467 39 42 O
ICU NCT03860467 43 46 B-Location___Location-Value:unit
at NCT03860467 47 49 O
the NCT03860467 50 53 O
University NCT03860467 54 64 B-Location___Location-Value:hospital
Hospital NCT03860467 65 73 I-Location___Location-Value:hospital
Basel NCT03860467 74 79 I-Location___Location-Value:hospital

- NCT03860467 82 83 O
suffered NCT03860467 85 93 O
from NCT03860467 94 98 O
one NCT03860467 99 102 B-Eq-Value
or NCT03860467 103 105 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03860467 106 110 I-Eq-Operator___Eq-Operator-Value:GTEQ
epileptic NCT03860467 111 120 B-Condition-Name
seizures NCT03860467 121 129 I-Condition-Name
( NCT03860467 130 131 O
detected NCT03860467 132 140 O
clinically NCT03860467 141 151 O
and NCT03860467 152 155 O
/ NCT03860467 156 157 O
or NCT03860467 158 160 O
by NCT03860467 161 163 O
EEG NCT03860467 164 167 B-Procedure-Name
) NCT03860467 168 169 O
during NCT03860467 170 176 O
their NCT03860467 177 182 O
ICU NCT03860467 183 186 B-Location___Location-Value:unit
- NCT03860467 187 188 O
stay NCT03860467 189 193 B-Encounter-Type___Encounter-Type-Value:inpatient

Exclusion NCT03860467 194 203 O
Criteria NCT03860467 204 212 O
: NCT03860467 213 214 O

- NCT03860467 218 219 O
patients NCT03860467 221 229 O
with NCT03860467 230 234 O
epileptic NCT03860467 235 244 B-Condition-Name
seizures NCT03860467 245 253 I-Condition-Name
transforming NCT03860467 254 266 B-Stability___Stability-Value:change
into NCT03860467 267 271 O
Status NCT03860467 272 278 B-Condition-Name
epilepticus NCT03860467 279 290 I-Condition-Name
( NCT03860467 291 292 O
SE NCT03860467 293 295 B-Condition-Name
) NCT03860467 296 297 O

Inclusion NCT03865251 0 9 O
Criteria NCT03865251 10 18 O
: NCT03865251 19 20 O

- NCT03865251 24 25 O
Undertake NCT03865251 27 36 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
regular NCT03865251 37 44 O
exercise NCT03865251 45 53 B-Observation-Name___Observation-Type-Value:social-habit
at NCT03865251 54 56 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865251 57 62 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03865251 64 65 B-Eq-Value
times NCT03865251 66 71 O
a NCT03865251 72 73 O
week NCT03865251 74 78 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
with NCT03865251 79 83 O
accumulation NCT03865251 84 96 O
of NCT03865251 97 99 O
150 NCT03865251 101 104 B-Eq-Value
min NCT03865251 105 108 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
per NCT03865251 109 112 O
week NCT03865251 113 117 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03865251 120 121 O
Age NCT03865251 123 126 O
between NCT03865251 127 134 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03865251 136 138 B-Eq-Value
and NCT03865251 139 142 O
30 NCT03865251 144 146 B-Eq-Value
years NCT03865251 147 152 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03865251 153 156 O

Exclusion NCT03865251 157 166 O
Criteria NCT03865251 167 175 O
: NCT03865251 176 177 O

- NCT03865251 181 182 O
History NCT03865251 184 191 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865251 192 194 O
severe NCT03865251 195 201 B-Severity___Severity-Value:severe
neuromuscular NCT03865251 202 215 O
injury NCT03865251 216 222 B-Condition-Name

- NCT03865251 225 226 O
Current NCT03865251 228 235 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
lower NCT03865251 236 241 O
extremity NCT03865251 242 251 O
injury NCT03865251 252 258 B-Condition-Name

- NCT03865251 261 262 O
Current NCT03865251 264 271 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
neurological NCT03865251 272 284 B-Condition-Name
diseases NCT03865251 285 293 I-Condition-Name

Inclusion NCT03865537 0 9 O
Criteria NCT03865537 10 18 O
: NCT03865537 19 20 O

- NCT03865537 24 25 O
Any NCT03865537 27 30 O
patient NCT03865537 31 38 O
≥ NCT03865537 39 40 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03865537 42 44 B-Eq-Value
who NCT03865537 45 48 O
presents NCT03865537 49 57 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
for NCT03865537 58 61 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03865537 62 63 O
colonoscopy NCT03865537 64 75 B-Procedure-Name
and NCT03865537 76 79 O
who NCT03865537 80 83 O
does NCT03865537 84 88 O
not NCT03865537 89 92 O
have NCT03865537 93 97 O
criteria NCT03865537 98 106 O
for NCT03865537 107 110 O
exclusion NCT03865537 111 120 O

- NCT03865537 123 124 O
Patients NCT03865537 126 134 O
with NCT03865537 135 139 O
a NCT03865537 140 141 O
≥ NCT03865537 142 143 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03865537 145 147 B-Eq-Value
mm NCT03865537 148 150 B-Eq-Unit
non NCT03865537 151 154 O
- NCT03865537 155 156 O
pedunculated NCT03865537 157 169 O
colorectal NCT03865537 170 180 O
polyp NCT03865537 181 186 B-Condition-Name

Exclusion NCT03865537 187 196 O
Criteria NCT03865537 197 205 O
: NCT03865537 206 207 O

- NCT03865537 211 212 O
Pedunculated NCT03865537 214 226 O
polyps NCT03865537 227 233 B-Condition-Name
( NCT03865537 234 235 O
as NCT03865537 236 238 O
defined NCT03865537 239 246 O
by NCT03865537 247 249 O
Paris NCT03865537 250 255 O
Classification NCT03865537 256 270 O
type NCT03865537 271 275 O
Ip NCT03865537 276 278 O
) NCT03865537 279 280 O

- NCT03865537 284 285 O
Suspected NCT03865537 287 296 O
adenocarcinoma NCT03865537 297 311 B-Condition-Name
with NCT03865537 312 316 O
deep NCT03865537 317 321 O
submucosal NCT03865537 322 332 O
invasion NCT03865537 333 341 O

- NCT03865537 344 345 O
Patients NCT03865537 347 355 O
with NCT03865537 356 360 O
ulcerated NCT03865537 361 370 O
depressed NCT03865537 371 380 O
lesions NCT03865537 381 388 B-Condition-Name
( NCT03865537 389 390 O
as NCT03865537 391 393 O
defined NCT03865537 394 401 O
by NCT03865537 402 404 O
Paris NCT03865537 405 410 O
Classification NCT03865537 411 425 O
type NCT03865537 426 430 O
III NCT03865537 431 434 O
) NCT03865537 435 436 O
or NCT03865537 437 439 O
confirmed NCT03865537 440 449 O
adenocarcinoma NCT03865537 450 464 B-Condition-Name

- NCT03865537 467 468 O
Patients NCT03865537 470 478 O
with NCT03865537 479 483 O
inflammatory NCT03865537 484 496 B-Condition-Name
bowel NCT03865537 497 502 I-Condition-Name
disease NCT03865537 503 510 I-Condition-Name

- NCT03865537 513 514 O
Patients NCT03865537 516 524 O
who NCT03865537 525 528 O
are NCT03865537 529 532 O
receiving NCT03865537 533 542 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
an NCT03865537 543 545 O
emergency NCT03865537 546 555 O
colonoscopy NCT03865537 556 567 B-Procedure-Name

- NCT03865537 570 571 O
Poor NCT03865537 573 577 B-Condition-Name
general NCT03865537 578 585 I-Condition-Name
health NCT03865537 586 592 I-Condition-Name
( NCT03865537 593 594 O
ASA NCT03865537 595 598 B-Condition-Name
class NCT03865537 599 604 O
> NCT03865537 605 606 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03865537 608 609 B-Eq-Value
) NCT03865537 610 611 O

- NCT03865537 615 616 O
Patients NCT03865537 618 626 O
with NCT03865537 627 631 O
coagulopathy NCT03865537 632 644 B-Condition-Name
with NCT03865537 645 649 O
an NCT03865537 650 652 O
elevated NCT03865537 653 661 B-Polarity___Polarity-Value:high
INR NCT03865537 662 665 B-Observation-Name___Observation-Type-Value:lab
≥ NCT03865537 666 667 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.5 NCT03865537 669 672 B-Eq-Value
, NCT03865537 673 674 O
or NCT03865537 675 677 O
platelets NCT03865537 678 687 B-Observation-Name___Observation-Type-Value:lab
< NCT03865537 688 689 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03865537 691 693 B-Eq-Value

- NCT03865537 697 698 O
Inadequate NCT03865537 700 710 B-Condition-Name
bowel NCT03865537 711 716 I-Condition-Name
preparation NCT03865537 717 728 I-Condition-Name
( NCT03865537 729 730 O
Boston NCT03865537 731 737 B-Observation-Name___Observation-Type-Value:clinical-score
Bowel NCT03865537 738 743 I-Observation-Name___Observation-Type-Value:clinical-score
Prep NCT03865537 744 748 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03865537 749 754 I-Observation-Name___Observation-Type-Value:clinical-score
, NCT03865537 755 756 O
total NCT03865537 757 762 O
score NCT03865537 763 768 O
≤ NCT03865537 769 770 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03865537 772 773 B-Eq-Value
) NCT03865537 774 775 O

- NCT03865537 779 780 O
Pregnancy NCT03865537 782 791 B-Condition-Name


Inclusion NCT03868761 0 9 O
Criteria NCT03868761 10 18 O
: NCT03868761 19 20 O

1 NCT03868761 25 26 O
. NCT03868761 26 27 O
Males NCT03868761 29 34 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
& NCT03868761 35 36 O
females NCT03868761 37 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
aged NCT03868761 45 49 O
13 NCT03868761 51 53 B-Eq-Value
- NCT03868761 54 55 B-Eq-Operator___Eq-Operator-Value:BETWEEN
17 NCT03868761 57 59 B-Eq-Value
years NCT03868761 60 65 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
directly NCT03868761 66 74 O
impacted NCT03868761 75 83 B-Stability___Stability-Value:change
by NCT03868761 84 86 O
the NCT03868761 87 90 O
2017 NCT03868761 92 96 O
wildfires NCT03868761 97 106 O
having NCT03868761 107 113 O
lost NCT03868761 114 118 B-Observation-Name
their NCT03868761 119 124 I-Observation-Name
home NCT03868761 125 129 I-Observation-Name
or NCT03868761 130 132 O
been NCT03868761 133 137 O
temporarily NCT03868761 138 149 B-Observation-Name
displaced NCT03868761 150 159 I-Observation-Name

2 NCT03868761 163 164 O
. NCT03868761 164 165 O
Screen NCT03868761 167 173 O
positive NCT03868761 174 182 B-Polarity___Polarity-Value:positive
for NCT03868761 183 186 O
PTSD NCT03868761 187 191 B-Condition-Name
( NCT03868761 192 193 O
Child NCT03868761 194 199 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Trauma NCT03868761 200 206 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Screening NCT03868761 207 216 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03868761 217 230 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
= NCT03868761 231 232 B-Eq-Operator___Eq-Operator-Value:EQ
5 NCT03868761 234 235 B-Eq-Value
or NCT03868761 236 238 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03868761 239 245 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03868761 246 247 O

3 NCT03868761 252 253 O
. NCT03868761 253 254 O
Have NCT03868761 256 260 O
regular NCT03868761 261 268 O
access NCT03868761 269 275 O
to NCT03868761 276 278 O
a NCT03868761 279 280 O
smart NCT03868761 281 286 O
phone NCT03868761 287 292 O
and NCT03868761 293 296 O
a NCT03868761 297 298 O
computer NCT03868761 299 307 O

4 NCT03868761 311 312 O
. NCT03868761 312 313 O
Have NCT03868761 315 319 O
a NCT03868761 320 321 O
personal NCT03868761 322 330 O
email NCT03868761 331 336 O
address NCT03868761 337 344 O

5 NCT03868761 348 349 O
. NCT03868761 349 350 O
Speak NCT03868761 352 357 O
and NCT03868761 358 361 O
read NCT03868761 362 366 O
English NCT03868761 367 374 B-Language
fluently NCT03868761 375 383 O

6 NCT03868761 387 388 O
. NCT03868761 388 389 O
Have NCT03868761 391 395 O
parental NCT03868761 396 404 O
consent NCT03868761 405 412 O

Exclusion NCT03868761 413 422 O
Criteria NCT03868761 423 431 O
: NCT03868761 432 433 O

1 NCT03868761 438 439 O
. NCT03868761 439 440 O
A NCT03868761 442 443 O
positive NCT03868761 444 452 B-Polarity___Polarity-Value:positive
self NCT03868761 453 457 O
- NCT03868761 458 459 O
reported NCT03868761 460 468 O
history NCT03868761 469 476 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868761 477 479 O
psychosis NCT03868761 480 489 B-Condition-Name
, NCT03868761 490 491 O
bipolar NCT03868761 492 499 B-Condition-Name
, NCT03868761 500 501 O
or NCT03868761 502 504 O
schizophrenia NCT03868761 505 518 B-Condition-Name

2 NCT03868761 522 523 O
. NCT03868761 523 524 O
Serious NCT03868761 526 533 B-Severity___Severity-Value:severe
self NCT03868761 534 538 O
- NCT03868761 539 540 O
reported NCT03868761 541 549 O
physical NCT03868761 550 558 B-Condition-Name
health NCT03868761 559 565 I-Condition-Name
concerns NCT03868761 566 574 I-Condition-Name
necessitating NCT03868761 575 588 O
surgery NCT03868761 589 596 B-Procedure-Name
or NCT03868761 597 599 O
with NCT03868761 600 604 O
prognosis NCT03868761 605 614 B-Observation-Name
< NCT03868761 615 616 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03868761 618 619 B-Eq-Value
months NCT03868761 620 626 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

3 NCT03868761 635 636 O
. NCT03868761 636 637 O
A NCT03868761 639 640 O
positive NCT03868761 641 649 B-Polarity___Polarity-Value:positive
screen NCT03868761 650 656 O
for NCT03868761 657 660 O
a NCT03868761 661 662 O
current NCT03868761 663 670 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Substance NCT03868761 671 680 B-Condition-Name
User NCT03868761 681 685 I-Condition-Name
Disorder NCT03868761 686 694 I-Condition-Name
( NCT03868761 695 696 O
CRAFFT NCT03868761 697 703 B-Observation-Name
= NCT03868761 704 705 B-Eq-Operator___Eq-Operator-Value:EQ
2 NCT03868761 707 708 B-Eq-Value
or NCT03868761 709 711 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03868761 712 718 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03868761 719 720 O

4 NCT03868761 725 726 O
. NCT03868761 726 727 O
Current NCT03868761 729 736 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
self NCT03868761 737 741 O
- NCT03868761 742 743 O
reported NCT03868761 744 752 O
suicidal NCT03868761 753 761 B-Condition-Name
ideation NCT03868761 762 770 I-Condition-Name

5 NCT03868761 774 775 O
. NCT03868761 775 776 O
Self NCT03868761 778 782 O
- NCT03868761 783 784 O
reported NCT03868761 785 793 O
pregnancy NCT03868761 794 803 B-Condition-Name

6 NCT03868761 807 808 O
. NCT03868761 808 809 O
Self NCT03868761 811 815 O
- NCT03868761 816 817 O
reported NCT03868761 818 826 O
less NCT03868761 827 831 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868761 832 836 I-Eq-Operator___Eq-Operator-Value:LT
four NCT03868761 837 841 B-Eq-Value
weeks NCT03868761 842 847 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03868761 848 850 O
stable NCT03868761 851 857 B-Stability___Stability-Value:stable
prescription NCT03868761 858 870 O
medication NCT03868761 871 881 O
for NCT03868761 882 885 O
anxiety NCT03868761 886 893 B-Condition-Name
, NCT03868761 894 895 O
anti NCT03868761 896 900 B-Drug-Name
- NCT03868761 901 902 I-Drug-Name
depressant NCT03868761 903 913 I-Drug-Name
, NCT03868761 914 915 O
and NCT03868761 916 919 O
sleep NCT03868761 920 925 B-Condition-Name
promoting NCT03868761 926 935 O
medications NCT03868761 936 947 O
prior NCT03868761 948 953 O
to NCT03868761 954 956 O
the NCT03868761 957 960 O
screening NCT03868761 961 970 O
assessment NCT03868761 971 981 O


Inclusion NCT03861962 0 9 O
Criteria NCT03861962 10 18 O
: NCT03861962 19 20 O

- NCT03861962 24 25 O
patients NCT03861962 27 35 O
( NCT03861962 36 37 O
adults NCT03861962 38 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
and NCT03861962 45 48 O
children NCT03861962 49 57 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
) NCT03861962 58 59 O

- NCT03861962 63 64 O
patients NCT03861962 66 74 O
recipients NCT03861962 75 85 O
in NCT03861962 86 88 O
France NCT03861962 89 95 B-Location___Location-Value:residence
from NCT03861962 96 100 O
2008 NCT03861962 102 106 B-Eq-Value
to NCT03861962 107 109 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2015 NCT03861962 111 115 B-Eq-Value
of NCT03861962 116 118 O
a NCT03861962 119 120 O
first NCT03861962 121 126 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
kidney NCT03861962 127 133 O
transplant NCT03861962 134 144 B-Procedure-Name
/ NCT03861962 145 146 O
heart NCT03861962 147 152 O
/ NCT03861962 153 154 O
lung NCT03861962 155 159 O
/ NCT03861962 160 161 O
liver NCT03861962 162 167 O
donor NCT03861962 168 173 O
living NCT03861962 174 180 O
or NCT03861962 181 183 O
deceased NCT03861962 184 192 O
, NCT03861962 193 194 O
non NCT03861962 195 198 O
- NCT03861962 199 200 O
immunized NCT03861962 201 210 O
anti NCT03861962 211 215 O
- NCT03861962 216 217 O
HLA NCT03861962 218 221 B-Condition-Name
before NCT03861962 222 228 O
the NCT03861962 229 232 O
transplant NCT03861962 233 243 B-Procedure-Name

- NCT03861962 246 247 O
patients NCT03861962 249 257 O
having NCT03861962 258 264 O
preserved NCT03861962 265 274 O
their NCT03861962 275 280 O
graft NCT03861962 281 286 B-Procedure-Name
> NCT03861962 287 288 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03861962 290 291 B-Eq-Value
years NCT03861962 292 297 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861962 300 301 O
having NCT03861962 303 309 O
agreed NCT03861962 310 316 O
to NCT03861962 317 319 O
the NCT03861962 320 323 O
use NCT03861962 324 327 O
for NCT03861962 328 331 O
research NCT03861962 332 340 O
purposes NCT03861962 341 349 O
in NCT03861962 350 352 O
transplantation NCT03861962 353 368 B-Procedure-Name
of NCT03861962 369 371 O
the NCT03861962 372 375 O
remains NCT03861962 376 383 O
of NCT03861962 384 386 O
the NCT03861962 387 390 O
DNA NCT03861962 391 394 B-Observation-Name___Observation-Type-Value:lab
and NCT03861962 395 398 O
serum NCT03861962 399 404 B-Observation-Name___Observation-Type-Value:lab
samples NCT03861962 405 412 I-Observation-Name___Observation-Type-Value:lab
taken NCT03861962 413 418 O
as NCT03861962 419 421 O
part NCT03861962 422 426 O
of NCT03861962 427 429 O
the NCT03861962 430 433 O
care NCT03861962 434 438 O
of NCT03861962 439 441 O
which NCT03861962 442 447 O
the NCT03861962 448 451 O
remains NCT03861962 452 459 O
are NCT03861962 460 463 O
available NCT03861962 464 473 O

Exclusion NCT03861962 474 483 O
Criteria NCT03861962 484 492 O
: NCT03861962 493 494 O

- NCT03861962 498 499 O
no NCT03861962 501 503 O
inclusion NCT03861962 504 513 O
if NCT03861962 514 516 O
one NCT03861962 517 520 O
of NCT03861962 521 523 O
the NCT03861962 524 527 O
inclusion NCT03861962 528 537 O
criteria NCT03861962 538 546 O
is NCT03861962 547 549 O
not NCT03861962 550 553 O
met NCT03861962 554 557 O

Inclusion NCT03864198 0 9 O
Criteria NCT03864198 10 18 O
: NCT03864198 19 20 O

- NCT03864198 24 25 O
male NCT03864198 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
18 NCT03864198 33 35 B-Eq-Value
- NCT03864198 36 37 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03864198 39 41 B-Eq-Value
years NCT03864198 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864198 50 51 O
oligozoospermia NCT03864198 53 68 B-Condition-Name
: NCT03864198 69 70 O
< NCT03864198 71 72 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03864198 74 75 B-Eq-Value
million NCT03864198 76 83 I-Eq-Value
spermatozoa NCT03864198 84 95 B-Observation-Name___Observation-Type-Value:lab
/ NCT03864198 96 97 O
mL NCT03864198 98 100 B-Eq-Unit
; NCT03864198 100 101 O

- NCT03864198 104 105 O
asthenozoospermia NCT03864198 107 124 B-Condition-Name
: NCT03864198 125 126 O
< NCT03864198 127 128 B-Eq-Operator___Eq-Operator-Value:LT
32 NCT03864198 130 132 B-Eq-Value
% NCT03864198 133 134 B-Eq-Unit
progressive NCT03864198 135 146 B-Observation-Name___Observation-Type-Value:lab
motile NCT03864198 147 153 I-Observation-Name___Observation-Type-Value:lab
spermatozoa NCT03864198 154 165 I-Observation-Name___Observation-Type-Value:lab
; NCT03864198 165 166 O

- NCT03864198 169 170 O
teratozoospermia NCT03864198 172 188 B-Condition-Name
: NCT03864198 189 190 O
< NCT03864198 191 192 B-Eq-Operator___Eq-Operator-Value:LT
4 NCT03864198 194 195 B-Eq-Value
% NCT03864198 196 197 B-Eq-Unit
normal NCT03864198 198 204 B-Polarity___Polarity-Value:normal
forms NCT03864198 205 210 B-Observation-Name
. NCT03864198 211 212 O

Exclusion NCT03864198 214 223 O
Criteria NCT03864198 224 232 O
: NCT03864198 233 234 O

- NCT03864198 238 239 O
azoospermia NCT03864198 241 252 B-Condition-Name

- NCT03864198 255 256 O
smoke NCT03864198 258 263 B-Condition-Name

- NCT03864198 266 267 O
use NCT03864198 269 272 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
drugs NCT03864198 273 278 O

- NCT03864198 281 282 O
use NCT03864198 284 287 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
drugs NCT03864198 288 293 O
with NCT03864198 294 298 O
proven NCT03864198 299 305 O
fertility NCT03864198 306 315 B-Condition-Name
toxicity NCT03864198 316 324 I-Condition-Name

- NCT03864198 327 328 O
exposition NCT03864198 330 340 O
to NCT03864198 341 343 O
any NCT03864198 344 347 O
environmental NCT03864198 348 361 O
or NCT03864198 362 364 O
occupational NCT03864198 365 377 O
toxic NCT03864198 378 383 O
substances NCT03864198 384 394 B-Drug-Name

- NCT03864198 397 398 O
exposition NCT03864198 400 410 O
to NCT03864198 411 413 O
radiation NCT03864198 414 423 B-Procedure-Name
or NCT03864198 424 426 O
heat NCT03864198 427 431 O

- NCT03864198 434 435 O
orchitis NCT03864198 437 445 B-Condition-Name
secondary NCT03864198 446 455 O
to NCT03864198 456 458 O
mumps NCT03864198 459 464 B-Condition-Name

- NCT03864198 467 468 O
sexually NCT03864198 470 478 B-Condition-Name
transmitted NCT03864198 479 490 I-Condition-Name
diseases NCT03864198 491 499 I-Condition-Name

- NCT03864198 502 503 O
history NCT03864198 505 512 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864198 513 515 O
cryptorchidism NCT03864198 516 530 B-Condition-Name

- NCT03864198 533 534 O
previous NCT03864198 536 544 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
testicular NCT03864198 545 555 B-Procedure-Name
torsion NCT03864198 556 563 I-Procedure-Name

- NCT03864198 566 567 O
genitourinary NCT03864198 569 582 B-Condition-Name
anomalies NCT03864198 583 592 I-Condition-Name

- NCT03864198 595 596 O
alterations NCT03864198 598 609 B-Procedure-Name
of NCT03864198 610 612 O
the NCT03864198 613 616 O
epididymis NCT03864198 617 627 O
or NCT03864198 628 630 O
deferens NCT03864198 631 639 O

- NCT03864198 642 643 O
inguinal NCT03864198 645 653 B-Procedure-Name
surgery NCT03864198 654 661 I-Procedure-Name

Inclusion NCT03868631 0 9 O
Criteria NCT03868631 10 18 O
: NCT03868631 19 20 O

- NCT03868631 24 25 O
non NCT03868631 27 30 O
- NCT03868631 31 32 O
smoking NCT03868631 33 40 B-Condition-Name

- NCT03868631 43 44 O
body NCT03868631 46 50 B-Observation-Name___Observation-Type-Value:vital
mass NCT03868631 51 55 I-Observation-Name___Observation-Type-Value:vital
index NCT03868631 56 61 I-Observation-Name___Observation-Type-Value:vital
( NCT03868631 62 63 O
BMI NCT03868631 64 67 B-Observation-Name___Observation-Type-Value:vital
) NCT03868631 68 69 O
18.5 NCT03868631 71 75 B-Eq-Value
- NCT03868631 76 77 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24.9 NCT03868631 79 83 B-Eq-Value

- NCT03868631 87 88 O
recreationally NCT03868631 90 104 B-Observation-Name___Observation-Type-Value:social-habit
active NCT03868631 105 111 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present

Exclusion NCT03868631 112 121 O
Criteria NCT03868631 122 130 O
: NCT03868631 131 132 O

- NCT03868631 136 137 O
participated NCT03868631 139 151 O
in NCT03868631 152 154 O
structured NCT03868631 155 165 O
weight NCT03868631 166 172 B-Observation-Name___Observation-Type-Value:social-habit
training NCT03868631 173 181 I-Observation-Name___Observation-Type-Value:social-habit
during NCT03868631 182 188 O
the NCT03868631 189 192 O
previous NCT03868631 193 201 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
12 NCT03868631 203 205 B-Eq-Value
month NCT03868631 206 211 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03868631 214 215 O
vegetarian NCT03868631 217 227 B-Condition-Name
or NCT03868631 228 230 O
vegan NCT03868631 231 236 B-Condition-Name

- NCT03868631 239 240 O
presence NCT03868631 242 250 O
of NCT03868631 251 253 O
chronic NCT03868631 254 261 O
disease NCT03868631 262 269 B-Condition-Name

- NCT03868631 272 273 O
pregnant NCT03868631 275 283 B-Condition-Name
, NCT03868631 284 285 O
postpartum NCT03868631 286 296 B-Condition-Name
up NCT03868631 297 299 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03868631 300 302 I-Eq-Operator___Eq-Operator-Value:LTEQ
six NCT03868631 303 306 B-Eq-Value
months NCT03868631 307 313 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03868631 314 315 O
lactating NCT03868631 316 325 B-Condition-Name
, NCT03868631 326 327 O
or NCT03868631 328 330 O
intention NCT03868631 331 340 O
to NCT03868631 341 343 O
become NCT03868631 344 350 O
pregnant NCT03868631 351 359 B-Condition-Name

- NCT03868631 362 363 O
allergy NCT03868631 365 372 O
to NCT03868631 373 375 O
whey NCT03868631 376 380 B-Allergy-Name
or NCT03868631 381 383 O
soy NCT03868631 384 387 B-Allergy-Name

- NCT03868631 390 391 O
changes NCT03868631 393 400 B-Stability___Stability-Value:change
in NCT03868631 401 403 O
body NCT03868631 404 408 B-Observation-Name___Observation-Type-Value:vital
weight NCT03868631 409 415 I-Observation-Name___Observation-Type-Value:vital
more NCT03868631 416 420 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868631 421 425 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03868631 427 429 B-Eq-Value
pounds NCT03868631 430 436 B-Eq-Unit
in NCT03868631 437 439 O
the NCT03868631 440 443 O
past NCT03868631 444 448 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03868631 449 454 B-Eq-Value
months NCT03868631 455 461 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03865329 0 9 O
Criteria NCT03865329 10 18 O

- NCT03865329 21 22 O
COPD NCT03865329 24 28 B-Condition-Name
related NCT03865329 29 36 O
hospitalization NCT03865329 37 52 B-Encounter-Type___Encounter-Type-Value:inpatient
and NCT03865329 53 56 O
eligible NCT03865329 57 65 O
for NCT03865329 66 69 O
PR NCT03865329 70 72 B-Procedure-Name

- NCT03865329 75 76 O
Exclusion NCT03865329 78 87 O
Criteria NCT03865329 88 96 O

- NCT03865329 99 100 O
Inability NCT03865329 102 111 B-Condition-Name
to NCT03865329 112 114 I-Condition-Name
walk NCT03865329 115 119 I-Condition-Name
( NCT03865329 120 121 O
orthopedic NCT03865329 122 132 O
- NCT03865329 133 134 O
neurologic NCT03865329 135 145 O
problems NCT03865329 146 154 B-Condition-Name
or NCT03865329 155 157 O
confined NCT03865329 158 166 B-Condition-Name
to NCT03865329 167 169 I-Condition-Name
bed NCT03865329 170 173 I-Condition-Name
) NCT03865329 174 175 O

Inclusion NCT03865498 0 9 O
Criteria NCT03865498 10 18 O
: NCT03865498 19 20 O

- NCT03865498 24 25 O
18 NCT03865498 28 30 B-Eq-Value
years NCT03865498 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865498 37 39 O
age NCT03865498 40 43 O
or NCT03865498 44 46 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865498 47 52 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03865498 55 56 O
Black NCT03865498 58 63 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03865498 64 66 O
Hispanic NCT03865498 67 75 B-Ethnicity
, NCT03865498 76 77 O
living NCT03865498 78 84 O
in NCT03865498 85 87 O
the NCT03865498 88 91 O
U NCT03865498 92 93 B-Location___Location-Value:residence
. NCT03865498 94 95 I-Location___Location-Value:residence
S NCT03865498 96 97 I-Location___Location-Value:residence
. NCT03865498 98 99 I-Location___Location-Value:residence
including NCT03865498 101 110 O
the NCT03865498 111 114 O
U NCT03865498 115 116 B-Location___Location-Value:residence
. NCT03865498 117 118 I-Location___Location-Value:residence
S NCT03865498 119 120 I-Location___Location-Value:residence
. NCT03865498 121 122 I-Location___Location-Value:residence
territories NCT03865498 124 135 I-Location___Location-Value:residence

- NCT03865498 138 139 O
a NCT03865498 141 142 O
dementia NCT03865498 143 151 B-Condition-Name
caregiver NCT03865498 152 161 O
with NCT03865498 162 166 O
any NCT03865498 167 170 O
duration NCT03865498 171 179 O
, NCT03865498 180 181 O
able NCT03865498 182 186 O
to NCT03865498 187 189 O
speak NCT03865498 190 195 O
English NCT03865498 196 203 B-Language
or NCT03865498 204 206 O
Spanish NCT03865498 207 214 B-Language
/ NCT03865498 215 216 O
bilingual NCT03865498 217 226 O

- NCT03865498 229 230 O
must NCT03865498 232 236 O
agree NCT03865498 237 242 O
to NCT03865498 243 245 O
terms NCT03865498 246 251 O
of NCT03865498 252 254 O
conditions NCT03865498 255 265 O
of NCT03865498 266 268 O
use NCT03865498 269 272 O
and NCT03865498 273 276 O
privacy NCT03865498 277 284 O
policy NCT03865498 285 291 O
and NCT03865498 292 295 O
rules NCT03865498 296 301 O
of NCT03865498 302 304 O
one NCT03865498 305 308 O
of NCT03865498 309 311 O
the NCT03865498 312 315 O
two NCT03865498 316 319 O
dementia NCT03865498 320 328 O
caregiver NCT03865498 329 338 O
network NCT03865498 339 346 O
( NCT03865498 347 348 O
Hispanic NCT03865498 349 357 O
@dcnh NCT03865498 358 363 O
, NCT03865498 364 365 O
Black NCT03865498 366 371 O
@dcnaab NCT03865498 372 379 O
) NCT03865498 380 381 O
, NCT03865498 383 384 O
the NCT03865498 385 388 O
Twitter NCT03865498 389 396 O
user NCT03865498 397 401 O
agreement NCT03865498 402 411 O
of NCT03865498 412 414 O
the NCT03865498 415 418 O
terms NCT03865498 419 424 O
of NCT03865498 425 427 O
service NCT03865498 428 435 O
, NCT03865498 436 437 O
Twitter NCT03865498 438 445 O
privacy NCT03865498 446 453 O
policy NCT03865498 454 460 O
and NCT03865498 461 464 O
Twitter NCT03865498 465 472 O
rules NCT03865498 473 478 O
including NCT03865498 479 488 O
intellectual NCT03865498 489 501 O
property NCT03865498 502 510 O
, NCT03865498 511 512 O
violence NCT03865498 513 521 B-Condition-Name
, NCT03865498 522 523 O
misconduct NCT03865498 524 534 B-Condition-Name
, NCT03865498 535 536 O
abuse NCT03865498 537 542 B-Condition-Name
behavior NCT03865498 543 551 I-Condition-Name
, NCT03865498 552 553 O
private NCT03865498 554 561 O
information NCT03865498 562 573 O
and NCT03865498 574 577 O
spam NCT03865498 578 582 O
and NCT03865498 583 586 O
security NCT03865498 587 595 O

- NCT03865498 598 599 O
use NCT03865498 601 604 O
a NCT03865498 605 606 O
smartphone NCT03865498 607 617 O
or NCT03865498 618 620 O
a NCT03865498 621 622 O
feature NCT03865498 623 630 O
phone NCT03865498 631 636 O
( NCT03865498 637 638 O
i NCT03865498 639 640 O
. NCT03865498 641 642 O
e NCT03865498 643 644 O
. NCT03865498 645 646 O
, NCT03865498 647 648 O
a NCT03865498 649 650 O
cell NCT03865498 651 655 O
phone NCT03865498 656 661 O
with NCT03865498 662 666 O
text NCT03865498 667 671 O
messaging NCT03865498 672 681 O
) NCT03865498 682 683 O

Exclusion NCT03865498 685 694 O
Criteria NCT03865498 695 703 O
: NCT03865498 704 705 O

- NCT03865498 709 710 O
do NCT03865498 712 714 O
not NCT03865498 715 718 O
have NCT03865498 719 723 O
de NCT03865498 724 726 O
- NCT03865498 727 728 O
identified NCT03865498 729 739 O
Twitter NCT03865498 740 747 O
account NCT03865498 748 755 O
, NCT03865498 756 757 O
children NCT03865498 758 766 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
, NCT03865498 767 768 O
not NCT03865498 769 772 O
a NCT03865498 773 774 O
dementia NCT03865498 775 783 B-Condition-Name
family NCT03865498 784 790 O
caregiver NCT03865498 791 800 O

Inclusion NCT03860090 0 9 O
Criteria NCT03860090 10 18 O
: NCT03860090 19 20 O

- NCT03860090 24 25 O
Patients NCT03860090 27 35 O
with NCT03860090 36 40 O
a NCT03860090 41 42 O
endovenous NCT03860090 43 53 B-Procedure-Name
pacemaker NCT03860090 54 63 I-Procedure-Name
or NCT03860090 64 66 O
defibrillator NCT03860090 67 80 B-Procedure-Name
indication NCT03860090 81 91 O
. NCT03860090 92 93 O

Exclusion NCT03860090 95 104 O
Criteria NCT03860090 105 113 O
: NCT03860090 114 115 O

- NCT03860090 119 120 O
Pre NCT03860090 122 125 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03860090 126 127 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03860090 128 136 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ipsilateral NCT03860090 137 148 B-Procedure-Name
pacing NCT03860090 149 155 I-Procedure-Name
electrode NCT03860090 156 165 I-Procedure-Name
. NCT03860090 166 167 O

- NCT03860090 171 172 O
Previous NCT03860090 174 182 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ipsilateral NCT03860090 183 194 B-Condition-Name
lymphadenectomy NCT03860090 195 210 I-Condition-Name
. NCT03860090 211 212 O

- NCT03860090 216 217 O
Indication NCT03860090 219 229 O
of NCT03860090 230 232 O
cardiac NCT03860090 233 240 B-Procedure-Name
resynchronization NCT03860090 241 258 I-Procedure-Name
therapy NCT03860090 259 266 I-Procedure-Name
. NCT03860090 267 268 O

For NCT03869671 0 3 O
all NCT03869671 4 7 O
phases NCT03869671 8 14 O
: NCT03869671 15 16 O

Inclusion NCT03869671 18 27 O
Criteria NCT03869671 28 36 O
: NCT03869671 37 38 O

- NCT03869671 42 43 O
An NCT03869671 45 47 O
adult NCT03869671 48 53 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
PWID NCT03869671 54 58 B-Condition-Name

- NCT03869671 61 62 O
Self NCT03869671 64 68 O
report NCT03869671 69 75 O
of NCT03869671 76 78 O
any NCT03869671 79 82 O
high NCT03869671 83 87 B-Polarity___Polarity-Value:high
risk NCT03869671 88 92 O
behaviors NCT03869671 93 102 O
for NCT03869671 103 106 O
HIV NCT03869671 107 110 B-Condition-Name
( NCT03869671 111 112 O
past NCT03869671 113 117 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03869671 118 119 O
month NCT03869671 120 125 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
receptive NCT03869671 126 135 O
syringe NCT03869671 136 143 B-Condition-Name
sharing NCT03869671 144 151 I-Condition-Name
, NCT03869671 152 153 O
transactional NCT03869671 154 167 B-Condition-Name
sex NCT03869671 168 171 I-Condition-Name
, NCT03869671 172 173 O
condomless NCT03869671 174 184 O
sex NCT03869671 185 188 B-Condition-Name
with NCT03869671 189 193 O
an NCT03869671 194 196 O
HIV NCT03869671 197 200 O
- NCT03869671 201 202 O
infected NCT03869671 203 211 O
or NCT03869671 212 214 O
unknown NCT03869671 215 222 O
status NCT03869671 223 229 O
partner NCT03869671 230 237 O
) NCT03869671 238 239 O

Exclusion NCT03869671 241 250 O
Criteria NCT03869671 251 259 O
: NCT03869671 260 261 O

- NCT03869671 265 266 O
Unable NCT03869671 268 274 O
or NCT03869671 275 277 O
unwilling NCT03869671 278 287 O
to NCT03869671 288 290 O
provide NCT03869671 291 298 O
informed NCT03869671 299 307 O
consent NCT03869671 308 315 O

For NCT03869671 316 319 O
Phase NCT03869671 320 325 O
3 NCT03869671 327 328 O
( NCT03869671 329 330 O
the NCT03869671 331 334 O
RCT NCT03869671 335 338 O
pilot NCT03869671 339 344 O
) NCT03869671 345 346 O
: NCT03869671 348 349 O

Inclusion NCT03869671 351 360 O
Criteria NCT03869671 361 369 O
: NCT03869671 370 371 O

- NCT03869671 375 376 O
Clinically NCT03869671 378 388 O
eligible NCT03869671 389 397 O
for NCT03869671 398 401 O
PrEP NCT03869671 402 406 B-Procedure-Name
( NCT03869671 407 408 O
confirmed NCT03869671 409 418 O
HIV NCT03869671 419 422 B-Condition-Name
- NCT03869671 423 424 O
uninfected NCT03869671 425 435 O
status NCT03869671 436 442 O
, NCT03869671 443 444 O
adequate NCT03869671 445 453 B-Polarity___Polarity-Value:normal
renal NCT03869671 454 459 B-Observation-Name___Observation-Type-Value:lab
function NCT03869671 460 468 I-Observation-Name___Observation-Type-Value:lab
[ NCT03869671 469 470 O
estimated NCT03869671 471 480 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03869671 481 491 I-Observation-Name___Observation-Type-Value:lab
clearance NCT03869671 492 501 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03869671 502 503 B-Eq-Operator___Eq-Operator-Value:GTEQ
60 NCT03869671 505 507 B-Eq-Value
ml NCT03869671 508 510 B-Eq-Unit
/ NCT03869671 511 512 O
min NCT03869671 513 516 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
] NCT03869671 517 518 O
, NCT03869671 520 521 O
and NCT03869671 522 525 O
documented NCT03869671 526 536 O
hepatitis NCT03869671 537 546 B-Condition-Name
B NCT03869671 547 548 I-Condition-Name
virus NCT03869671 549 554 I-Condition-Name
[ NCT03869671 555 556 O
HBV NCT03869671 557 560 B-Condition-Name
] NCT03869671 561 562 O
status NCT03869671 563 569 O
) NCT03869671 570 571 O

Inclusion NCT03864341 0 9 O
Criteria NCT03864341 10 18 O
: NCT03864341 19 20 O

- NCT03864341 24 25 O
Be NCT03864341 27 29 O
a NCT03864341 30 31 O
patient NCT03864341 32 39 O
in NCT03864341 40 42 O
the NCT03864341 43 46 O
Bellevue NCT03864341 47 55 B-Location___Location-Value:hospital
Hospital NCT03864341 56 64 I-Location___Location-Value:hospital
Center NCT03864341 65 71 I-Location___Location-Value:hospital
ED NCT03864341 72 74 I-Location___Location-Value:hospital
. NCT03864341 75 76 O

- NCT03864341 80 81 O
Be NCT03864341 83 85 O
≥ NCT03864341 86 87 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03864341 89 91 I-Eq-Operator___Eq-Operator-Value:GTEQ
years NCT03864341 92 97 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03864341 98 101 O
. NCT03864341 102 103 O

- NCT03864341 107 108 O
Screen NCT03864341 110 116 O
positive NCT03864341 117 125 B-Polarity___Polarity-Value:positive
for NCT03864341 126 129 O
homelessness NCT03864341 130 142 B-Condition-Name
risk NCT03864341 143 147 O
using NCT03864341 148 153 O
a NCT03864341 154 155 O
homelessness NCT03864341 156 168 B-Observation-Name
risk NCT03864341 169 173 I-Observation-Name
screening NCT03864341 174 183 I-Observation-Name
tool NCT03864341 184 188 I-Observation-Name
( NCT03864341 189 190 O
HRST NCT03864341 191 195 B-Observation-Name
) NCT03864341 196 197 O
. NCT03864341 199 200 O

- NCT03864341 204 205 O
Screen NCT03864341 207 213 O
positive NCT03864341 214 222 B-Polarity___Polarity-Value:positive
for NCT03864341 223 226 O
unhealthy NCT03864341 227 236 O
alcohol NCT03864341 237 244 O
or NCT03864341 245 247 O
drug NCT03864341 248 252 O
use NCT03864341 253 256 B-Condition-Name
. NCT03864341 257 258 O

- NCT03864341 262 263 O
Able NCT03864341 265 269 O
to NCT03864341 270 272 O
provide NCT03864341 273 280 O
consent NCT03864341 281 288 O
. NCT03864341 289 290 O

Exclusion NCT03864341 292 301 O
Criteria NCT03864341 302 310 O
: NCT03864341 311 312 O

- NCT03864341 316 317 O
Medically NCT03864341 319 328 O
( NCT03864341 329 330 O
e NCT03864341 331 332 O
. NCT03864341 333 334 O
g NCT03864341 335 336 O
. NCT03864341 337 338 O
, NCT03864341 339 340 O
critically NCT03864341 341 351 B-Condition-Name
ill NCT03864341 352 355 I-Condition-Name
) NCT03864341 356 357 O
or NCT03864341 358 360 O
psychiatrically NCT03864341 361 376 O
unstable NCT03864341 377 385 B-Condition-Name
. NCT03864341 386 387 O

- NCT03864341 391 392 O
Unable NCT03864341 394 400 O
to NCT03864341 401 403 O
provide NCT03864341 404 411 O
informed NCT03864341 412 420 O
consent NCT03864341 421 428 O
for NCT03864341 429 432 O
other NCT03864341 433 438 O
reason NCT03864341 439 445 O
( NCT03864341 446 447 O
e NCT03864341 448 449 O
. NCT03864341 450 451 O
g NCT03864341 452 453 O
. NCT03864341 454 455 O
, NCT03864341 456 457 O
cognitive NCT03864341 458 467 B-Condition-Name
deficit NCT03864341 468 475 I-Condition-Name
, NCT03864341 476 477 O
profound NCT03864341 478 486 B-Condition-Name
intoxication NCT03864341 487 499 I-Condition-Name
) NCT03864341 500 501 O
. NCT03864341 503 504 O

- NCT03864341 508 509 O
Incarcerated NCT03864341 511 523 B-Observation-Name
or NCT03864341 524 526 O
in NCT03864341 527 529 O
police NCT03864341 530 536 B-Observation-Name
custody NCT03864341 537 544 I-Observation-Name
. NCT03864341 545 546 O

- NCT03864341 550 551 O
Unable NCT03864341 553 559 O
to NCT03864341 560 562 O
understand NCT03864341 563 573 O
and NCT03864341 574 577 O
speak NCT03864341 578 583 O
English NCT03864341 584 591 B-Language
. NCT03864341 592 593 O

- NCT03864341 597 598 O
Lives NCT03864341 600 605 O
outside NCT03864341 606 613 O
NYC NCT03864341 614 617 B-Location___Location-Value:residence
and NCT03864341 618 621 O
/ NCT03864341 622 623 O
or NCT03864341 624 626 O
can NCT03864341 627 630 O
not NCT03864341 630 633 O
give NCT03864341 634 638 O
a NCT03864341 639 640 O
NYC NCT03864341 641 644 B-Location___Location-Value:residence
ZIP NCT03864341 645 648 O
code NCT03864341 649 653 O
. NCT03864341 654 655 O

- NCT03864341 659 660 O
Already NCT03864341 662 669 O
homeless NCT03864341 670 678 B-Condition-Name
( NCT03864341 679 680 O
residing NCT03864341 681 689 O
in NCT03864341 690 692 O
a NCT03864341 693 694 O
shelter NCT03864341 695 702 B-Location___Location-Value:residence
or NCT03864341 703 705 O
on NCT03864341 706 708 O
the NCT03864341 709 712 O
streets NCT03864341 713 720 B-Location___Location-Value:residence
) NCT03864341 721 722 O
. NCT03864341 724 725 O

- NCT03864341 729 730 O
Does NCT03864341 732 736 O
not NCT03864341 737 740 O
have NCT03864341 741 745 O
a NCT03864341 746 747 O
telephone NCT03864341 748 757 O
where NCT03864341 758 763 O
can NCT03864341 764 767 O
be NCT03864341 768 770 O
reached NCT03864341 771 778 O
for NCT03864341 779 782 O
follow NCT03864341 783 789 O
- NCT03864341 790 791 O
up NCT03864341 792 794 O
. NCT03864341 795 796 O

- NCT03864341 800 801 O
Has NCT03864341 803 806 O
already NCT03864341 807 814 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
received NCT03864341 815 823 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
specialized NCT03864341 824 835 O
peer NCT03864341 836 840 O
navigator NCT03864341 841 850 O
/ NCT03864341 851 852 O
addiction NCT03864341 853 862 O
social NCT03864341 863 869 B-Procedure-Name
worker NCT03864341 870 876 I-Procedure-Name
services NCT03864341 877 885 I-Procedure-Name
during NCT03864341 886 892 O
current NCT03864341 893 900 O
ED NCT03864341 901 903 B-Encounter-Type___Encounter-Type-Value:emergency
visit NCT03864341 904 909 I-Encounter-Type___Encounter-Type-Value:emergency
. NCT03864341 910 911 O

- NCT03864341 915 916 O
Has NCT03864341 918 921 O
already NCT03864341 922 929 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participated NCT03864341 930 942 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03864341 943 945 O
the NCT03864341 946 949 O
study NCT03864341 950 955 O
. NCT03864341 956 957 O

Inclusion NCT03867890 0 9 O
Criteria NCT03867890 10 18 O
: NCT03867890 19 20 O

- NCT03867890 24 25 O
walk NCT03867890 27 31 B-Observation-Name___Observation-Type-Value:social-habit
or NCT03867890 32 34 O
run NCT03867890 35 38 B-Observation-Name___Observation-Type-Value:social-habit
at NCT03867890 39 41 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867890 42 47 I-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03867890 49 51 B-Eq-Value
kilometres NCT03867890 52 62 B-Eq-Unit
per NCT03867890 63 66 O
week NCT03867890 67 71 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03867890 74 75 O
maintain NCT03867890 77 85 B-Observation-Name
a NCT03867890 86 87 O
minimal NCT03867890 88 95 B-Eq-Operator___Eq-Operator-Value:GTEQ
distance NCT03867890 96 104 O
of NCT03867890 105 107 O
ten NCT03867890 108 111 B-Eq-Value
kilometres NCT03867890 112 122 B-Eq-Unit
per NCT03867890 123 126 O
week NCT03867890 127 131 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03867890 132 133 O
for NCT03867890 134 137 O
a NCT03867890 138 139 O
period NCT03867890 140 146 O
of NCT03867890 147 149 O
24 NCT03867890 151 153 B-Eq-Value
weeks NCT03867890 154 159 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03867890 162 163 O
wear NCT03867890 165 169 B-Observation-Name___Observation-Type-Value:social-habit
one NCT03867890 170 173 B-Eq-Value
and NCT03867890 174 177 O
the NCT03867890 178 181 O
same NCT03867890 182 186 O
pair NCT03867890 187 191 O
of NCT03867890 192 194 O
shoes NCT03867890 195 200 O
during NCT03867890 201 207 O
walking NCT03867890 208 215 B-Observation-Name___Observation-Type-Value:social-habit
/ NCT03867890 216 217 O
running NCT03867890 218 225 B-Observation-Name___Observation-Type-Value:social-habit
activities NCT03867890 226 236 O
during NCT03867890 237 243 O
this NCT03867890 244 248 O
period NCT03867890 249 255 O

Exclusion NCT03867890 256 265 O
Criteria NCT03867890 266 274 O
: NCT03867890 275 276 O

- NCT03867890 280 281 O
systemic NCT03867890 283 291 B-Condition-Name
disease NCT03867890 292 299 I-Condition-Name
, NCT03867890 300 301 O
cardiac NCT03867890 302 309 B-Condition-Name
problems NCT03867890 310 318 I-Condition-Name
or NCT03867890 319 321 O
diabetes NCT03867890 322 330 B-Condition-Name

- NCT03867890 333 334 O
complaints NCT03867890 336 346 B-Condition-Name
at NCT03867890 347 349 O
the NCT03867890 350 353 O
lower NCT03867890 354 359 O
extremities NCT03867890 360 371 O
in NCT03867890 372 374 O
the NCT03867890 375 378 O
last NCT03867890 379 383 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
two NCT03867890 384 387 B-Eq-Value
weeks NCT03867890 388 393 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03867890 394 395 O

- NCT03867890 399 400 O
surgery NCT03867890 402 409 B-Procedure-Name
at NCT03867890 410 412 O
the NCT03867890 413 416 O
lower NCT03867890 417 422 O
extremities NCT03867890 423 434 O
in NCT03867890 435 437 O
the NCT03867890 438 441 O
last NCT03867890 442 446 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03867890 447 452 B-Eq-Value
years NCT03867890 453 458 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Inclusion NCT03860480 0 9 O
Criteria NCT03860480 10 18 O
: NCT03860480 19 20 O

• NCT03860480 22 23 O
Patients NCT03860480 24 32 O
> NCT03860480 33 34 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03860480 36 38 B-Eq-Value
years NCT03860480 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03860480 45 48 O
with NCT03860480 49 53 O
to NCT03860480 54 56 O
ASA NCT03860480 57 60 B-Condition-Name
status NCT03860480 61 67 O
I NCT03860480 68 69 B-Eq-Value
- NCT03860480 70 71 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03860480 72 75 B-Eq-Value
, NCT03860480 76 77 O
undergoing NCT03860480 78 88 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
VATS NCT03860480 89 93 B-Procedure-Name
for NCT03860480 94 97 O
lobectomy NCT03860480 98 107 B-Procedure-Name
or NCT03860480 108 110 O
wedge NCT03860480 111 116 B-Procedure-Name
. NCT03860480 117 118 O

Non NCT03860480 120 123 O
- NCT03860480 124 125 O
inclusion NCT03860480 126 135 O
Criteria NCT03860480 136 144 O
: NCT03860480 145 146 O

- NCT03860480 150 151 O
< NCT03860480 153 154 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03860480 156 158 B-Eq-Value
years NCT03860480 159 164 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03860480 165 168 O

- NCT03860480 171 172 O
BMI NCT03860480 174 177 B-Observation-Name___Observation-Type-Value:vital
> NCT03860480 178 179 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03860480 181 183 B-Eq-Value

- NCT03860480 187 188 O
Chronic NCT03860480 190 197 O
pain NCT03860480 198 202 B-Condition-Name
history NCT03860480 203 210 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
with NCT03860480 211 215 O
regular NCT03860480 216 223 O
opioid NCT03860480 224 230 B-Drug-Name
and NCT03860480 231 234 O
/ NCT03860480 235 236 O
or NCT03860480 237 239 O
gabapentinoids NCT03860480 240 254 B-Drug-Name
use NCT03860480 255 258 O
during NCT03860480 259 265 O
the NCT03860480 266 269 O
2 NCT03860480 271 272 B-Eq-Value
weeks NCT03860480 273 278 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03860480 279 285 O
surgery NCT03860480 286 293 B-Procedure-Name

- NCT03860480 296 297 O
Regular NCT03860480 299 306 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
marijuana NCT03860480 307 316 B-Drug-Name
use NCT03860480 317 320 O

- NCT03860480 323 324 O
History NCT03860480 326 333 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860480 334 336 O
thoracic NCT03860480 337 345 B-Procedure-Name
surgery NCT03860480 346 353 I-Procedure-Name
on NCT03860480 354 356 O
the NCT03860480 357 360 O
operated NCT03860480 361 369 O
side NCT03860480 370 374 O

- NCT03860480 377 378 O
Epidural NCT03860480 380 388 B-Procedure-Name
analgesia NCT03860480 389 398 I-Procedure-Name
preferred NCT03860480 399 408 O
due NCT03860480 409 412 O
to NCT03860480 413 415 O
an NCT03860480 416 418 O
anticipated NCT03860480 419 430 O
high NCT03860480 431 435 B-Polarity___Polarity-Value:high
risk NCT03860480 436 440 O
of NCT03860480 441 443 O
conversion NCT03860480 444 454 O
to NCT03860480 455 457 O
thoracotomy NCT03860480 458 469 B-Procedure-Name

- NCT03860480 472 473 O
Unable NCT03860480 475 481 B-Condition-Name
to NCT03860480 482 484 I-Condition-Name
communicate NCT03860480 485 496 I-Condition-Name
with NCT03860480 497 501 O
the NCT03860480 502 505 O
investigators NCT03860480 506 519 O

- NCT03860480 522 523 O
Receiving NCT03860480 525 534 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
anticoagulation NCT03860480 535 550 B-Procedure-Name
or NCT03860480 551 553 O
experiencing NCT03860480 554 566 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03860480 567 570 O
bleeding NCT03860480 571 579 B-Condition-Name
disorder NCT03860480 580 588 I-Condition-Name

- NCT03860480 591 592 O
Surgery NCT03860480 594 601 B-Procedure-Name
for NCT03860480 602 605 O
empyema NCT03860480 606 613 B-Condition-Name
and NCT03860480 614 617 O
sympathectomy NCT03860480 618 631 B-Procedure-Name

- NCT03860480 634 635 O
Known NCT03860480 637 642 O
allergy NCT03860480 643 650 O
to NCT03860480 651 653 O
local NCT03860480 654 659 B-Procedure-Name
anesthetics NCT03860480 660 671 I-Procedure-Name
, NCT03860480 672 673 O
fentanyl NCT03860480 674 682 B-Drug-Name
or NCT03860480 683 685 O
hydromorphone NCT03860480 686 699 B-Drug-Name

- NCT03860480 702 703 O
Active NCT03860480 705 711 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03860480 712 721 B-Condition-Name
at NCT03860480 722 724 O
injection NCT03860480 725 734 O
sites NCT03860480 735 740 O

- NCT03860480 743 744 O
Preexisting NCT03860480 746 757 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
neurological NCT03860480 758 770 B-Condition-Name
deficit NCT03860480 771 778 I-Condition-Name
or NCT03860480 779 781 O
psychiatric NCT03860480 782 793 B-Condition-Name
illness NCT03860480 794 801 I-Condition-Name

- NCT03860480 804 805 O
Severe NCT03860480 807 813 B-Severity___Severity-Value:severe
cardiovascular NCT03860480 814 828 B-Condition-Name
disease NCT03860480 829 836 I-Condition-Name

- NCT03860480 839 840 O
Liver NCT03860480 842 847 B-Condition-Name
failure NCT03860480 848 855 I-Condition-Name

- NCT03860480 858 859 O
Renal NCT03860480 861 866 B-Condition-Name
failure NCT03860480 867 874 I-Condition-Name
( NCT03860480 875 876 O
estimated NCT03860480 877 886 B-Observation-Name___Observation-Type-Value:lab
glomerular NCT03860480 887 897 I-Observation-Name___Observation-Type-Value:lab
filtration NCT03860480 898 908 I-Observation-Name___Observation-Type-Value:lab
rate NCT03860480 909 913 I-Observation-Name___Observation-Type-Value:lab
< NCT03860480 914 915 B-Eq-Operator___Eq-Operator-Value:LT
15 NCT03860480 917 919 B-Eq-Value
mL NCT03860480 920 922 B-Eq-Unit
/ NCT03860480 923 924 I-Eq-Unit
min NCT03860480 925 928 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
/ NCT03860480 929 930 O
1.73 NCT03860480 932 936 B-Eq-Unit
m NCT03860480 937 938 I-Eq-Unit
2 NCT03860480 939 940 I-Eq-Unit
) NCT03860480 941 942 O

- NCT03860480 946 947 O
Pregnancy NCT03860480 949 958 B-Condition-Name

Exclusion NCT03860480 959 968 O
Criteria NCT03860480 969 977 O
: NCT03860480 978 979 O

- NCT03860480 983 984 O
Peri NCT03860480 986 990 O
operative NCT03860480 991 1000 B-Procedure-Name
conversion NCT03860480 1001 1011 O
to NCT03860480 1012 1014 O
thoracotomy NCT03860480 1015 1026 B-Procedure-Name

- NCT03860480 1029 1030 O
Severe NCT03860480 1032 1038 B-Severity___Severity-Value:severe
intra NCT03860480 1039 1044 O
- NCT03860480 1045 1046 O
or NCT03860480 1047 1049 O
post NCT03860480 1050 1054 O
operative NCT03860480 1055 1064 B-Procedure-Name
bleeding NCT03860480 1065 1073 B-Condition-Name

- NCT03860480 1076 1077 O
Patients NCT03860480 1079 1087 O
requiring NCT03860480 1088 1097 O
post NCT03860480 1098 1102 O
operative NCT03860480 1103 1112 B-Procedure-Name
mechanical NCT03860480 1113 1123 B-Procedure-Name
ventilation NCT03860480 1124 1135 I-Procedure-Name

- NCT03860480 1138 1139 O
Technical NCT03860480 1141 1150 O
inability NCT03860480 1151 1160 O
to NCT03860480 1161 1163 O
proceed NCT03860480 1164 1171 O
with NCT03860480 1172 1176 O
the NCT03860480 1177 1180 O
blocks NCT03860480 1181 1187 O

Inclusion NCT03868787 0 9 O
Criteria NCT03868787 10 18 O
: NCT03868787 19 20 O

1 NCT03868787 25 26 O
. NCT03868787 26 27 O
Women NCT03868787 29 34 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
≥ NCT03868787 35 36 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868787 38 40 B-Eq-Value
years NCT03868787 41 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03868787 47 49 O
age NCT03868787 50 53 O

2 NCT03868787 57 58 O
. NCT03868787 58 59 O
Gestational NCT03868787 61 72 B-Observation-Name
age NCT03868787 73 76 I-Observation-Name
between NCT03868787 77 84 B-Eq-Operator___Eq-Operator-Value:BETWEEN
14 NCT03868787 86 88 B-Eq-Value
weeks NCT03868787 89 94 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
and NCT03868787 95 98 O
23 NCT03868787 100 102 B-Eq-Value
weeks NCT03868787 103 108 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
6 NCT03868787 110 111 B-Eq-Value
days NCT03868787 112 116 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

3 NCT03868787 120 121 O
. NCT03868787 121 122 O
Willing NCT03868787 124 131 O
and NCT03868787 132 135 O
able NCT03868787 136 140 O
to NCT03868787 141 143 O
sign NCT03868787 144 148 O
an NCT03868787 149 151 O
informed NCT03868787 152 160 O
consent NCT03868787 161 168 O
in NCT03868787 169 171 O
English NCT03868787 172 179 B-Language

4 NCT03868787 183 184 O
. NCT03868787 184 185 O
No NCT03868787 187 189 O
contraindications NCT03868787 190 207 O
to NCT03868787 208 210 O
TENS NCT03868787 211 215 B-Procedure-Name

Exclusion NCT03868787 216 225 O
Criteria NCT03868787 226 234 O
: NCT03868787 235 236 O

1 NCT03868787 241 242 O
. NCT03868787 242 243 O
Incarceration NCT03868787 245 258 B-Observation-Name

2 NCT03868787 262 263 O
. NCT03868787 263 264 O
Preterm NCT03868787 266 273 B-Condition-Name
Premature NCT03868787 274 283 I-Condition-Name
Rupture NCT03868787 284 291 I-Condition-Name
of NCT03868787 292 294 O
Membranes NCT03868787 295 304 O
or NCT03868787 305 307 O
evidence NCT03868787 308 316 O
of NCT03868787 317 319 O
intra NCT03868787 320 325 O
- NCT03868787 326 327 O
amniotic NCT03868787 328 336 O
infection NCT03868787 337 346 B-Condition-Name

3 NCT03868787 350 351 O
. NCT03868787 351 352 O
Presence NCT03868787 354 362 O
of NCT03868787 363 365 O
implanted NCT03868787 366 375 B-Procedure-Name
cardiac NCT03868787 376 383 I-Procedure-Name
device NCT03868787 384 390 I-Procedure-Name

4 NCT03868787 394 395 O
. NCT03868787 395 396 O
Lack NCT03868787 398 402 O
of NCT03868787 403 405 O
sensation NCT03868787 406 415 B-Condition-Name
to NCT03868787 416 418 I-Condition-Name
touch NCT03868787 419 424 I-Condition-Name
on NCT03868787 425 427 O
area NCT03868787 428 432 O
of NCT03868787 433 435 O
electrode NCT03868787 436 445 B-Procedure-Name
placement NCT03868787 446 455 I-Procedure-Name

5 NCT03868787 459 460 O
. NCT03868787 460 461 O
Prior NCT03868787 463 468 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
TENS NCT03868787 469 473 B-Procedure-Name
use NCT03868787 474 477 O

6 NCT03868787 481 482 O
. NCT03868787 482 483 O
Opioid NCT03868787 485 491 B-Condition-Name
dependence NCT03868787 492 502 I-Condition-Name

Inclusion NCT03860324 0 9 O
Criteria NCT03860324 10 18 O
: NCT03860324 19 20 O

- NCT03860324 24 25 O
Surgical NCT03860324 27 35 O
plan NCT03860324 36 40 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03860324 41 44 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
total NCT03860324 45 50 B-Procedure-Name
hip NCT03860324 51 54 I-Procedure-Name
replacement NCT03860324 55 66 I-Procedure-Name

- NCT03860324 69 70 O
Signing NCT03860324 72 79 O
of NCT03860324 80 82 O
consent NCT03860324 83 90 O
form NCT03860324 91 95 O
to NCT03860324 96 98 O
participate NCT03860324 99 110 O
in NCT03860324 111 113 O
the NCT03860324 114 117 O
study NCT03860324 118 123 O

Exclusion NCT03860324 124 133 O
Criteria NCT03860324 134 142 O
: NCT03860324 143 144 O

- NCT03860324 148 149 O
Patient NCT03860324 151 158 O
refusal NCT03860324 159 166 O

- NCT03860324 169 170 O
BMI NCT03860324 172 175 B-Observation-Name___Observation-Type-Value:vital
> NCT03860324 176 177 B-Eq-Operator___Eq-Operator-Value:GT
40 NCT03860324 179 181 B-Eq-Value
kg NCT03860324 182 184 B-Eq-Unit
/ NCT03860324 185 186 O
m NCT03860324 187 188 B-Eq-Unit
2 NCT03860324 189 190 I-Eq-Unit

- NCT03860324 193 194 O
Surgical NCT03860324 196 204 O
plan NCT03860324 205 209 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03860324 210 213 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
revision NCT03860324 214 222 O
of NCT03860324 223 225 O
hip NCT03860324 226 229 B-Procedure-Name
replacement NCT03860324 230 241 I-Procedure-Name

- NCT03860324 244 245 O
Patient NCT03860324 247 254 O
unable NCT03860324 255 261 O
to NCT03860324 262 264 O
quantify NCT03860324 265 273 O
pain NCT03860324 274 278 B-Condition-Name
level NCT03860324 279 284 O

- NCT03860324 287 288 O
Chronic NCT03860324 290 297 O
kidney NCT03860324 298 304 B-Condition-Name
disease NCT03860324 305 312 I-Condition-Name
with NCT03860324 313 317 O
a NCT03860324 318 319 O
Glomerular NCT03860324 320 330 B-Observation-Name___Observation-Type-Value:lab
Filtration NCT03860324 331 341 I-Observation-Name___Observation-Type-Value:lab
Rate NCT03860324 342 346 I-Observation-Name___Observation-Type-Value:lab
< NCT03860324 347 348 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03860324 350 352 B-Eq-Value
ml NCT03860324 353 355 B-Eq-Unit
/ NCT03860324 356 357 O
min NCT03860324 358 361 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

- NCT03860324 364 365 O
Previously NCT03860324 367 377 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
medicated NCT03860324 378 387 O
with NCT03860324 388 392 O
opioids NCT03860324 393 400 B-Drug-Name

- NCT03860324 403 404 O
Patient NCT03860324 406 413 O
unable NCT03860324 414 420 O
to NCT03860324 421 423 O
perform NCT03860324 424 431 O
the NCT03860324 432 435 O
surgery NCT03860324 436 443 B-Procedure-Name
with NCT03860324 444 448 O
spinal NCT03860324 449 455 B-Procedure-Name
block NCT03860324 456 461 I-Procedure-Name

- NCT03860324 464 465 O
Allergy NCT03860324 467 474 O
to NCT03860324 475 477 O
local NCT03860324 478 483 B-Procedure-Name
anesthetics NCT03860324 484 495 I-Procedure-Name

- NCT03860324 498 499 O
Infection NCT03860324 501 510 B-Condition-Name
in NCT03860324 511 513 O
the NCT03860324 514 517 O
site NCT03860324 518 522 O
of NCT03860324 523 525 O
the NCT03860324 526 529 O
Erector NCT03860324 530 537 O
Spinae NCT03860324 538 544 O
Plane NCT03860324 545 550 O
or NCT03860324 551 553 O
Fascia NCT03860324 554 560 O
Iliaca NCT03860324 561 567 O
block NCT03860324 568 573 O

- NCT03860324 576 577 O
Allergy NCT03860324 579 586 O
or NCT03860324 587 589 O
contraindication NCT03860324 590 606 O
to NCT03860324 607 609 O
the NCT03860324 610 613 O
use NCT03860324 614 617 O
of NCT03860324 618 620 O
morphine NCT03860324 621 629 B-Drug-Name

Inclusion NCT03863639 0 9 O
Criteria NCT03863639 10 18 O
: NCT03863639 19 20 O
Severe NCT03863639 21 27 B-Severity___Severity-Value:severe
Pre NCT03863639 28 31 B-Condition-Name
- NCT03863639 32 33 I-Condition-Name
Eclampsia NCT03863639 34 43 I-Condition-Name
defined NCT03863639 44 51 O
by NCT03863639 52 54 O

- NCT03863639 57 58 O
Symptoms NCT03863639 60 68 O
of NCT03863639 69 71 O
central NCT03863639 72 79 B-Condition-Name
nervous NCT03863639 80 87 I-Condition-Name
system NCT03863639 88 94 I-Condition-Name
dysfunction NCT03863639 95 106 I-Condition-Name
( NCT03863639 107 108 O
New NCT03863639 109 112 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
onset NCT03863639 113 118 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
cerebral NCT03863639 119 127 O
or NCT03863639 128 130 O
visual NCT03863639 131 137 O
disturbance NCT03863639 138 149 B-Condition-Name
, NCT03863639 150 151 O
such NCT03863639 152 156 O
as NCT03863639 157 159 O
: NCT03863639 160 161 O
Photopsia NCT03863639 162 171 B-Condition-Name
, NCT03863639 172 173 O
scotomata NCT03863639 174 183 B-Condition-Name
, NCT03863639 184 185 O
cortical NCT03863639 186 194 B-Condition-Name
blindness NCT03863639 195 204 I-Condition-Name
, NCT03863639 205 206 O
retinal NCT03863639 207 214 B-Condition-Name
vasospasm NCT03863639 215 224 I-Condition-Name
) NCT03863639 225 226 O

- NCT03863639 230 231 O
Severe NCT03863639 233 239 B-Severity___Severity-Value:severe
headache NCT03863639 240 248 B-Condition-Name
( NCT03863639 249 250 O
ie NCT03863639 251 253 O
, NCT03863639 254 255 O
incapacitating NCT03863639 256 270 B-Condition-Name
, NCT03863639 271 272 O
" NCT03863639 273 274 O
the NCT03863639 274 277 O
worst NCT03863639 278 283 B-Severity___Severity-Value:severe
headache NCT03863639 284 292 B-Condition-Name
I NCT03863639 293 294 O
've NCT03863639 294 297 O
ever NCT03863639 298 302 O
had NCT03863639 303 306 O
" NCT03863639 306 307 O
) NCT03863639 308 309 O
or NCT03863639 310 312 O
headache NCT03863639 313 321 B-Condition-Name
that NCT03863639 322 326 O
persists NCT03863639 327 335 O
and NCT03863639 336 339 O
progresses NCT03863639 340 350 O
despite NCT03863639 351 358 O
analgesic NCT03863639 359 368 B-Procedure-Name
therapy NCT03863639 369 376 I-Procedure-Name

- NCT03863639 379 380 O
Altered NCT03863639 382 389 B-Condition-Name
mental NCT03863639 390 396 I-Condition-Name
status NCT03863639 397 403 I-Condition-Name

- NCT03863639 406 407 O
Hepatic NCT03863639 409 416 B-Condition-Name
abnormality NCT03863639 417 428 B-Polarity___Polarity-Value:abnormal
( NCT03863639 429 430 O
Severe NCT03863639 431 437 B-Severity___Severity-Value:severe
persistent NCT03863639 438 448 O
right NCT03863639 449 454 O
upper NCT03863639 455 460 O
quadrant NCT03863639 461 469 O
or NCT03863639 470 472 O
epigastric NCT03863639 473 483 O
pain NCT03863639 484 488 B-Condition-Name
unresponsive NCT03863639 489 501 O
to NCT03863639 502 504 O
medication NCT03863639 505 515 O
and NCT03863639 516 519 O
not NCT03863639 520 523 O
accounted NCT03863639 524 533 O
for NCT03863639 534 537 O
by NCT03863639 538 540 O
an NCT03863639 541 543 O
alternative NCT03863639 544 555 O
diagnosis NCT03863639 556 565 O
or NCT03863639 566 568 O
serum NCT03863639 569 574 B-Observation-Name___Observation-Type-Value:lab
transaminase NCT03863639 575 587 I-Observation-Name___Observation-Type-Value:lab
concentration NCT03863639 588 601 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03863639 602 603 B-Eq-Operator___Eq-Operator-Value:GTEQ
twice NCT03863639 604 609 B-Eq-Value
normal NCT03863639 610 616 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
, NCT03863639 617 618 O
or NCT03863639 619 621 O
both NCT03863639 622 626 O
) NCT03863639 627 628 O

- NCT03863639 632 633 O
Severe NCT03863639 635 641 B-Severity___Severity-Value:severe
blood NCT03863639 642 647 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03863639 648 656 I-Observation-Name___Observation-Type-Value:vital
elevation NCT03863639 657 666 B-Polarity___Polarity-Value:high
( NCT03863639 667 668 O
Systolic NCT03863639 669 677 B-Observation-Name___Observation-Type-Value:vital
blood NCT03863639 678 683 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03863639 684 692 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03863639 693 694 B-Eq-Operator___Eq-Operator-Value:GTEQ
160 NCT03863639 696 699 B-Eq-Value
mmHg NCT03863639 700 704 B-Eq-Unit
or NCT03863639 705 707 O
diastolic NCT03863639 708 717 B-Observation-Name___Observation-Type-Value:vital
blood NCT03863639 718 723 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03863639 724 732 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03863639 733 734 B-Eq-Operator___Eq-Operator-Value:GTEQ
110 NCT03863639 736 739 B-Eq-Value
mmHg NCT03863639 740 744 B-Eq-Unit
on NCT03863639 745 747 O
two NCT03863639 748 751 B-Eq-Value
occasions NCT03863639 752 761 B-Eq-Unit
at NCT03863639 762 764 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863639 765 770 I-Eq-Operator___Eq-Operator-Value:GTEQ
four NCT03863639 771 775 B-Eq-Value
hours NCT03863639 776 781 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
apart NCT03863639 782 787 O
while NCT03863639 788 793 O
the NCT03863639 794 797 O
patient NCT03863639 798 805 O
is NCT03863639 806 808 O
on NCT03863639 809 811 O
bedrest NCT03863639 812 819 O
( NCT03863639 820 821 O
unless NCT03863639 822 828 O
the NCT03863639 829 832 O
patient NCT03863639 833 840 O
is NCT03863639 841 843 O
on NCT03863639 844 846 O
antihypertensive NCT03863639 847 863 B-Procedure-Name
therapy NCT03863639 864 871 I-Procedure-Name
) NCT03863639 872 873 O
) NCT03863639 875 876 O

- NCT03863639 880 881 O
Thrombocytopenia NCT03863639 883 899 B-Condition-Name
( NCT03863639 900 901 O
< NCT03863639 903 904 B-Eq-Operator___Eq-Operator-Value:LT
100 NCT03863639 906 909 B-Eq-Value
, NCT03863639 910 911 I-Eq-Value
000 NCT03863639 912 915 I-Eq-Value
platelets NCT03863639 916 925 B-Observation-Name___Observation-Type-Value:lab
/ NCT03863639 926 927 O
microL NCT03863639 928 934 B-Eq-Unit
) NCT03863639 935 936 O

- NCT03863639 940 941 O
Renal NCT03863639 943 948 B-Condition-Name
abnormality NCT03863639 949 960 B-Polarity___Polarity-Value:abnormal
( NCT03863639 961 962 O
Progressive NCT03863639 963 974 B-Condition-Name
renal NCT03863639 975 980 I-Condition-Name
insufficiency NCT03863639 981 994 I-Condition-Name
( NCT03863639 995 996 O
serum NCT03863639 997 1002 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03863639 1003 1013 I-Observation-Name___Observation-Type-Value:lab
> NCT03863639 1014 1015 B-Eq-Operator___Eq-Operator-Value:GT
1.1 NCT03863639 1017 1020 B-Eq-Value
mg NCT03863639 1021 1023 B-Eq-Unit
/ NCT03863639 1024 1025 O
dL NCT03863639 1026 1028 B-Eq-Unit
or NCT03863639 1029 1031 O
doubling NCT03863639 1032 1040 B-Eq-Value
of NCT03863639 1041 1043 O
serum NCT03863639 1044 1049 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03863639 1050 1060 I-Observation-Name___Observation-Type-Value:lab
concentration NCT03863639 1061 1074 I-Observation-Name___Observation-Type-Value:lab
in NCT03863639 1075 1077 O
the NCT03863639 1078 1081 O
absence NCT03863639 1082 1089 O
of NCT03863639 1090 1092 O
other NCT03863639 1093 1098 O
renal NCT03863639 1099 1104 B-Condition-Name
disease NCT03863639 1105 1112 I-Condition-Name
) NCT03863639 1113 1114 O
) NCT03863639 1116 1117 O

- NCT03863639 1121 1122 O
Pulmonary NCT03863639 1124 1133 B-Condition-Name
edema NCT03863639 1134 1139 I-Condition-Name

15 NCT03863639 1146 1148 O
English NCT03863639 1149 1156 B-Language
- NCT03863639 1157 1158 O
speaking NCT03863639 1159 1167 O
pregnant NCT03863639 1168 1176 B-Condition-Name
controls NCT03863639 1177 1185 O
with NCT03863639 1186 1190 O
uncomplicated NCT03863639 1191 1204 O
pregnancy NCT03863639 1205 1214 B-Condition-Name
matched NCT03863639 1215 1222 O
by NCT03863639 1223 1225 O
age NCT03863639 1226 1229 O
and NCT03863639 1230 1233 O
gestational NCT03863639 1234 1245 B-Observation-Name
age NCT03863639 1246 1249 I-Observation-Name
will NCT03863639 1250 1254 O
be NCT03863639 1255 1257 O
enrolled NCT03863639 1258 1266 O
from NCT03863639 1267 1271 O
the NCT03863639 1272 1275 O
antenatal NCT03863639 1276 1285 B-Location___Location-Value:clinic
clinic NCT03863639 1286 1292 I-Location___Location-Value:clinic
or NCT03863639 1293 1295 O
the NCT03863639 1296 1299 O
labor NCT03863639 1300 1305 B-Location___Location-Value:unit
ward NCT03863639 1306 1310 I-Location___Location-Value:unit
. NCT03863639 1311 1312 O

Exclusion NCT03863639 1314 1323 O
Criteria NCT03863639 1324 1332 O
: NCT03863639 1333 1334 O

- NCT03863639 1338 1339 O
History NCT03863639 1341 1348 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863639 1349 1351 O
symptomatic NCT03863639 1352 1363 O
cerebrovascular NCT03863639 1364 1379 B-Condition-Name
disease NCT03863639 1380 1387 I-Condition-Name
with NCT03863639 1388 1392 O
substantial NCT03863639 1393 1404 B-Severity___Severity-Value:severe
residual NCT03863639 1405 1413 B-Condition-Name
deficit NCT03863639 1414 1421 I-Condition-Name

- NCT03863639 1424 1425 O
History NCT03863639 1427 1434 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863639 1435 1437 O
alcoholism NCT03863639 1438 1448 B-Condition-Name

- NCT03863639 1451 1452 O
History NCT03863639 1454 1461 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863639 1462 1464 O
psychiatric NCT03863639 1465 1476 B-Condition-Name
illness NCT03863639 1477 1484 I-Condition-Name

- NCT03863639 1487 1488 O
History NCT03863639 1490 1497 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863639 1498 1500 O
claustrophobia NCT03863639 1501 1515 B-Condition-Name

- NCT03863639 1518 1519 O
Renal NCT03863639 1521 1526 B-Condition-Name
failure NCT03863639 1527 1534 I-Condition-Name
( NCT03863639 1535 1536 O
creatinine NCT03863639 1537 1547 B-Observation-Name___Observation-Type-Value:lab
> NCT03863639 1548 1549 B-Eq-Operator___Eq-Operator-Value:GT
2.0 NCT03863639 1551 1554 B-Eq-Value
mg NCT03863639 1555 1557 B-Eq-Unit
/ NCT03863639 1558 1559 O
dl NCT03863639 1560 1562 B-Eq-Unit
) NCT03863639 1563 1564 O

- NCT03863639 1568 1569 O
Patients NCT03863639 1571 1579 O
with NCT03863639 1580 1584 O
less NCT03863639 1585 1589 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03863639 1590 1594 I-Eq-Operator___Eq-Operator-Value:LT
a NCT03863639 1595 1596 O
7 NCT03863639 1598 1599 B-Eq-Value
th NCT03863639 1600 1602 I-Eq-Value
grade NCT03863639 1603 1608 B-Eq-Unit
education NCT03863639 1609 1618 B-Observation-Name
or NCT03863639 1619 1621 O
unable NCT03863639 1622 1628 B-Condition-Name
to NCT03863639 1629 1631 I-Condition-Name
read NCT03863639 1632 1636 I-Condition-Name
and NCT03863639 1637 1640 O
thus NCT03863639 1641 1645 O
unable NCT03863639 1646 1652 O
complete NCT03863639 1653 1661 O
the NCT03863639 1662 1665 O
neuropsychological NCT03863639 1666 1684 B-Procedure-Name
testing NCT03863639 1685 1692 I-Procedure-Name

- NCT03863639 1695 1696 O
Patients NCT03863639 1698 1706 O
with NCT03863639 1707 1711 O
bodily NCT03863639 1712 1718 B-Procedure-Name
implants NCT03863639 1719 1727 I-Procedure-Name
unsafe NCT03863639 1728 1734 O
for NCT03863639 1735 1738 O
MRI NCT03863639 1739 1742 B-Procedure-Name
use NCT03863639 1743 1746 O

Inclusion NCT03867305 0 9 O
Criteria NCT03867305 10 18 O
: NCT03867305 19 20 O

- NCT03867305 24 25 O
Patient NCT03867305 27 34 O
requiring NCT03867305 35 44 O
a NCT03867305 45 46 O
first NCT03867305 47 52 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
total NCT03867305 53 58 B-Procedure-Name
knee NCT03867305 59 63 I-Procedure-Name
prosthesis NCT03867305 64 74 I-Procedure-Name
( NCT03867305 75 76 O
scheduled NCT03867305 77 86 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
between NCT03867305 87 94 B-Eq-Operator___Eq-Operator-Value:BETWEEN
Tuesday NCT03867305 95 102 B-Eq-Value
and NCT03867305 103 106 O
Friday NCT03867305 107 113 B-Eq-Value
) NCT03867305 114 115 O
. NCT03867305 117 118 O

- NCT03867305 122 123 O
Patient NCT03867305 125 132 O
that NCT03867305 133 137 O
has NCT03867305 138 141 O
given NCT03867305 142 147 O
his NCT03867305 148 151 O
/ NCT03867305 152 153 O
her NCT03867305 154 157 O
free NCT03867305 158 162 O
and NCT03867305 163 166 O
informed NCT03867305 167 175 O
consent NCT03867305 176 183 O
and NCT03867305 184 187 O
signed NCT03867305 188 194 O
the NCT03867305 195 198 O
consent NCT03867305 199 206 O
form NCT03867305 207 211 O
. NCT03867305 212 213 O

- NCT03867305 217 218 O
The NCT03867305 220 223 O
patient NCT03867305 224 231 O
must NCT03867305 232 236 O
be NCT03867305 237 239 O
a NCT03867305 240 241 O
member NCT03867305 242 248 O
or NCT03867305 249 251 O
beneficiary NCT03867305 252 263 O
of NCT03867305 264 266 O
a NCT03867305 267 268 O
health NCT03867305 269 275 B-Insurance
insurance NCT03867305 276 285 I-Insurance
plan NCT03867305 286 290 I-Insurance

- NCT03867305 293 294 O
The NCT03867305 296 299 O
patient NCT03867305 300 307 O
is NCT03867305 308 310 O
at NCT03867305 311 313 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867305 314 319 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03867305 321 323 B-Eq-Value
years NCT03867305 324 329 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867305 330 333 O
( NCT03867305 334 335 O
≥ NCT03867305 337 338 O
) NCT03867305 340 341 O
and NCT03867305 342 345 O
under NCT03867305 346 351 B-Eq-Operator___Eq-Operator-Value:LT
90 NCT03867305 353 355 B-Eq-Value
years NCT03867305 356 361 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867305 362 365 O
( NCT03867305 366 367 O
< NCT03867305 369 370 O
) NCT03867305 372 373 O
. NCT03867305 375 376 O

Exclusion NCT03867305 378 387 O
Criteria NCT03867305 388 396 O
: NCT03867305 397 398 O

- NCT03867305 402 403 O
The NCT03867305 405 408 O
subject NCT03867305 409 416 O
is NCT03867305 417 419 O
in NCT03867305 420 422 O
a NCT03867305 423 424 O
period NCT03867305 425 431 O
of NCT03867305 432 434 O
exclusion NCT03867305 435 444 O
determined NCT03867305 445 455 O
by NCT03867305 456 458 O
a NCT03867305 459 460 O
previous NCT03867305 461 469 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
study NCT03867305 470 475 O
( NCT03867305 476 477 O
therapeutic NCT03867305 478 489 B-Procedure-Name
study NCT03867305 490 495 O
) NCT03867305 496 497 O

- NCT03867305 501 502 O
The NCT03867305 504 507 O
subject NCT03867305 508 515 O
refuses NCT03867305 516 523 O
to NCT03867305 524 526 O
sign NCT03867305 527 531 O
the NCT03867305 532 535 O
consent NCT03867305 536 543 O

- NCT03867305 546 547 O
It NCT03867305 549 551 O
is NCT03867305 552 554 O
impossible NCT03867305 555 565 O
to NCT03867305 566 568 O
give NCT03867305 569 573 O
the NCT03867305 574 577 O
subject NCT03867305 578 585 O
informed NCT03867305 586 594 O
information NCT03867305 595 606 O

- NCT03867305 609 610 O
The NCT03867305 612 615 O
patient NCT03867305 616 623 O
is NCT03867305 624 626 O
under NCT03867305 627 632 B-Observation-Name
safeguard NCT03867305 633 642 I-Observation-Name
of NCT03867305 643 645 I-Observation-Name
justice NCT03867305 646 653 I-Observation-Name
or NCT03867305 654 656 O
state NCT03867305 657 662 B-Observation-Name
guardianship NCT03867305 663 675 I-Observation-Name

- NCT03867305 678 679 O
The NCT03867305 681 684 O
patient NCT03867305 685 692 O
is NCT03867305 693 695 O
pregnant NCT03867305 696 704 B-Condition-Name
or NCT03867305 705 707 O
breastfeeding NCT03867305 708 721 B-Condition-Name

- NCT03867305 724 725 O
The NCT03867305 727 730 O
patient NCT03867305 731 738 O
is NCT03867305 739 741 O
allergic NCT03867305 742 750 O
to NCT03867305 751 753 O
latex NCT03867305 754 759 B-Allergy-Name
bandages NCT03867305 760 768 I-Allergy-Name
. NCT03867305 769 770 O

- NCT03867305 774 775 O
The NCT03867305 777 780 O
subject NCT03867305 781 788 O
has NCT03867305 789 792 O
contralateral NCT03867305 793 806 B-Condition-Name
amputation NCT03867305 807 817 I-Condition-Name
, NCT03867305 818 819 O
pressure NCT03867305 820 828 B-Condition-Name
ulcers NCT03867305 829 835 I-Condition-Name
, NCT03867305 836 837 O
severe NCT03867305 838 844 B-Severity___Severity-Value:severe
Obstructive NCT03867305 845 856 B-Condition-Name
Arteriopathy NCT03867305 857 869 I-Condition-Name
of NCT03867305 870 872 O
Lower NCT03867305 873 878 O
Limbs NCT03867305 879 884 O
, NCT03867305 885 886 O
lymphoedema NCT03867305 887 898 O
or NCT03867305 899 901 O
thromboembolic NCT03867305 902 916 B-Condition-Name
event NCT03867305 917 922 I-Condition-Name
of NCT03867305 923 925 O
the NCT03867305 926 929 O
lower NCT03867305 930 935 O
limb NCT03867305 936 940 O
( NCT03867305 941 942 O
ipsilateral NCT03867305 943 954 O
and NCT03867305 955 958 O
/ NCT03867305 959 960 O
or NCT03867305 961 963 O
contralateral NCT03867305 964 977 O
/ NCT03867305 978 979 O
superficial NCT03867305 980 991 O
or NCT03867305 992 994 O
deep NCT03867305 995 999 O
or NCT03867305 1000 1002 O
detected NCT03867305 1003 1011 O
by NCT03867305 1012 1014 O
post NCT03867305 1015 1019 O
operative NCT03867305 1020 1029 B-Procedure-Name
Doppler NCT03867305 1030 1037 B-Procedure-Name
) NCT03867305 1038 1039 O
. NCT03867305 1041 1042 O

- NCT03867305 1046 1047 O
The NCT03867305 1049 1052 O
subject NCT03867305 1053 1060 O
has NCT03867305 1061 1064 O
chronic NCT03867305 1065 1072 O
or NCT03867305 1073 1075 O
active NCT03867305 1076 1082 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
wounds NCT03867305 1083 1089 B-Condition-Name
or NCT03867305 1090 1092 O
any NCT03867305 1093 1096 O
cause NCT03867305 1097 1102 O
that NCT03867305 1103 1107 O
hinders NCT03867305 1108 1115 B-Stability___Stability-Value:change
normal NCT03867305 1116 1122 B-Polarity___Polarity-Value:normal
rehabilitation NCT03867305 1123 1137 B-Procedure-Name
or NCT03867305 1138 1140 O
the NCT03867305 1141 1144 O
application NCT03867305 1145 1156 O
of NCT03867305 1157 1159 O
a NCT03867305 1160 1161 O
bandage NCT03867305 1162 1169 B-Procedure-Name
. NCT03867305 1170 1171 O

- NCT03867305 1175 1176 O
patient NCT03867305 1178 1185 O
with NCT03867305 1186 1190 O
a NCT03867305 1191 1192 O
stroke NCT03867305 1193 1199 B-Condition-Name
/ NCT03867305 1200 1201 O
Disabling NCT03867305 1202 1211 O
Neurological NCT03867305 1212 1224 B-Condition-Name
Pathology NCT03867305 1225 1234 I-Condition-Name
, NCT03867305 1235 1236 O
Chronic NCT03867305 1237 1244 O
Immunological NCT03867305 1245 1258 B-Condition-Name
Pathology NCT03867305 1259 1268 I-Condition-Name
/ NCT03867305 1269 1270 O
Systemic NCT03867305 1271 1279 O
Disease NCT03867305 1280 1287 B-Condition-Name
. NCT03867305 1288 1289 O

- NCT03867305 1293 1294 O
patient NCT03867305 1296 1303 O
with NCT03867305 1304 1308 O
Hepatic NCT03867305 1309 1316 B-Condition-Name
insufficiency NCT03867305 1317 1330 I-Condition-Name
. NCT03867305 1331 1332 O

- NCT03867305 1336 1337 O
patient NCT03867305 1339 1346 O
with NCT03867305 1347 1351 O
Venous NCT03867305 1352 1358 B-Condition-Name
insufficiency NCT03867305 1359 1372 I-Condition-Name
( NCT03867305 1373 1374 O
stages NCT03867305 1375 1381 O
3 NCT03867305 1383 1384 B-Eq-Value
and NCT03867305 1385 1388 O
4 NCT03867305 1390 1391 B-Eq-Value
) NCT03867305 1392 1393 O
. NCT03867305 1395 1396 O

- NCT03867305 1400 1401 O
The NCT03867305 1403 1406 O
patient NCT03867305 1407 1414 O
is NCT03867305 1415 1417 O
on NCT03867305 1418 1420 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
dialysis NCT03867305 1421 1429 B-Procedure-Name
. NCT03867305 1430 1431 O

- NCT03867305 1435 1436 O
The NCT03867305 1438 1441 O
subject NCT03867305 1442 1449 O
has NCT03867305 1450 1453 O
cognitive NCT03867305 1454 1463 O
or NCT03867305 1464 1466 O
behavioral NCT03867305 1467 1477 O
disorders NCT03867305 1478 1487 B-Condition-Name
( NCT03867305 1488 1489 O
Parkinson NCT03867305 1490 1499 B-Condition-Name
's NCT03867305 1499 1501 I-Condition-Name
disease NCT03867305 1502 1509 I-Condition-Name
, NCT03867305 1510 1511 O
cerebellar NCT03867305 1512 1522 B-Condition-Name
syndrome NCT03867305 1523 1531 I-Condition-Name
, NCT03867305 1532 1533 O
opposition NCT03867305 1534 1544 B-Condition-Name
, NCT03867305 1545 1546 O
agitation NCT03867305 1547 1556 B-Condition-Name
, NCT03867305 1557 1558 O
dementia NCT03867305 1559 1567 B-Condition-Name
) NCT03867305 1568 1569 O
. NCT03867305 1571 1572 O

- NCT03867305 1576 1577 O
The NCT03867305 1579 1582 O
subject NCT03867305 1583 1590 O
has NCT03867305 1591 1594 O
a NCT03867305 1595 1596 O
history NCT03867305 1597 1604 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867305 1605 1607 O
knee NCT03867305 1608 1612 B-Procedure-Name
surgery NCT03867305 1613 1620 I-Procedure-Name
. NCT03867305 1621 1622 O

Inclusion NCT03864354 0 9 O
Criteria NCT03864354 10 18 O
: NCT03864354 19 20 O

- NCT03864354 24 25 O
18 NCT03864354 28 30 B-Eq-Value
years NCT03864354 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03864354 37 39 O
age NCT03864354 40 43 O
or NCT03864354 44 46 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03864354 47 52 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03864354 55 56 O
previously NCT03864354 58 68 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosed NCT03864354 69 78 O
with NCT03864354 79 83 O
asthma NCT03864354 84 90 B-Condition-Name

Exclusion NCT03864354 91 100 O
Criteria NCT03864354 101 109 O
: NCT03864354 110 111 O

- NCT03864354 115 116 O
Current NCT03864354 118 125 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
smoker NCT03864354 126 132 B-Condition-Name

- NCT03864354 135 136 O
Diagnosed NCT03864354 138 147 O
with NCT03864354 148 152 O
any NCT03864354 153 156 O
other NCT03864354 157 162 O
respiratory NCT03864354 163 174 B-Condition-Name
disease NCT03864354 175 182 I-Condition-Name
besides NCT03864354 183 190 O
asthma NCT03864354 191 197 B-Condition-Name

- NCT03864354 200 201 O
Receiving NCT03864354 203 212 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
OMM NCT03864354 213 216 B-Drug-Name
from NCT03864354 217 221 O
a NCT03864354 222 223 O
licensed NCT03864354 224 232 O
physician NCT03864354 233 242 B-Provider-Role
, NCT03864354 243 244 O
chiropractic NCT03864354 245 257 B-Procedure-Name
treatment NCT03864354 258 267 I-Procedure-Name
, NCT03864354 268 269 O
or NCT03864354 270 272 O
massage NCT03864354 273 280 B-Procedure-Name
therapy NCT03864354 281 288 I-Procedure-Name
for NCT03864354 289 292 O
30 NCT03864354 294 296 B-Eq-Value
days NCT03864354 297 301 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03864354 302 307 O
to NCT03864354 308 310 O
and NCT03864354 311 314 O
during NCT03864354 315 321 O
the NCT03864354 322 325 O
study NCT03864354 326 331 O

Inclusion NCT03864432 0 9 O
Criteria NCT03864432 10 18 O
: NCT03864432 19 20 O

- NCT03864432 24 25 O
Healthy NCT03864432 27 34 B-Condition-Name
male NCT03864432 35 39 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03864432 40 43 O
female NCT03864432 44 50 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subjects NCT03864432 51 59 O
( NCT03864432 60 61 O
aged NCT03864432 62 66 O
19 NCT03864432 68 70 B-Eq-Value
~ NCT03864432 71 72 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03864432 74 76 B-Eq-Value
years NCT03864432 77 82 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
at NCT03864432 83 85 O
the NCT03864432 86 89 O
time NCT03864432 90 94 O
of NCT03864432 95 97 O
screening NCT03864432 98 107 O
) NCT03864432 108 109 O

- NCT03864432 113 114 O
Subjects NCT03864432 116 124 O
weighing NCT03864432 125 133 B-Observation-Name___Observation-Type-Value:vital
between NCT03864432 134 141 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03864432 143 145 B-Eq-Value
kg NCT03864432 146 148 B-Eq-Unit
( NCT03864432 149 150 O
inclusive NCT03864432 151 160 O
) NCT03864432 161 162 O
and NCT03864432 163 166 O
90 NCT03864432 168 170 B-Eq-Value
kg NCT03864432 171 173 B-Eq-Unit
( NCT03864432 174 175 O
exclusive NCT03864432 176 185 O
) NCT03864432 186 187 O
, NCT03864432 189 190 O
and NCT03864432 191 194 O
having NCT03864432 195 201 O
a NCT03864432 202 203 O
body NCT03864432 204 208 B-Observation-Name___Observation-Type-Value:vital
mass NCT03864432 209 213 I-Observation-Name___Observation-Type-Value:vital
index NCT03864432 214 219 I-Observation-Name___Observation-Type-Value:vital
( NCT03864432 220 221 O
BMI NCT03864432 222 225 B-Observation-Name___Observation-Type-Value:vital
) NCT03864432 226 227 O
of NCT03864432 228 230 O
17.1 NCT03864432 232 236 B-Eq-Value
～ NCT03864432 237 238 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25.8 NCT03864432 239 243 B-Eq-Value
( NCT03864432 244 245 O
inclusive NCT03864432 246 255 O
of NCT03864432 256 258 O
limits NCT03864432 259 265 O
) NCT03864432 266 267 O
. NCT03864432 269 270 O

- NCT03864432 274 275 O
Subjects NCT03864432 277 285 O
with NCT03864432 286 290 O
a NCT03864432 291 292 O
fasting NCT03864432 293 300 B-Observation-Name___Observation-Type-Value:lab
plasma NCT03864432 301 307 I-Observation-Name___Observation-Type-Value:lab
glucose NCT03864432 308 315 I-Observation-Name___Observation-Type-Value:lab
( NCT03864432 316 317 O
FPG NCT03864432 318 321 B-Observation-Name
) NCT03864432 322 323 O
of NCT03864432 324 326 O
70 NCT03864432 328 330 B-Eq-Value
～ NCT03864432 331 332 B-Eq-Operator___Eq-Operator-Value:BETWEEN
110 NCT03864432 333 336 B-Eq-Value
mg NCT03864432 337 339 B-Eq-Unit
/ NCT03864432 340 341 O
dL NCT03864432 342 344 B-Eq-Unit
( NCT03864432 345 346 O
inclusive NCT03864432 347 356 O
of NCT03864432 357 359 O
limits NCT03864432 360 366 O
) NCT03864432 367 368 O
at NCT03864432 369 371 O
the NCT03864432 372 375 O
time NCT03864432 376 380 O
of NCT03864432 381 383 O
screening NCT03864432 384 393 O

- NCT03864432 396 397 O
Subjects NCT03864432 399 407 O
who NCT03864432 408 411 O
are NCT03864432 412 415 O
willing NCT03864432 416 423 O
to NCT03864432 424 426 O
participate NCT03864432 427 438 O
in NCT03864432 439 441 O
the NCT03864432 442 445 O
entire NCT03864432 446 452 O
study NCT03864432 453 458 O
cycle NCT03864432 459 464 O
and NCT03864432 465 468 O
comply NCT03864432 469 475 O
with NCT03864432 476 480 O
the NCT03864432 481 484 O
study NCT03864432 485 490 O
protocol NCT03864432 491 499 O
( NCT03864432 500 501 O
including NCT03864432 502 511 O
contraception NCT03864432 512 525 O
) NCT03864432 526 527 O
. NCT03864432 529 530 O
Subjects NCT03864432 532 540 O
who NCT03864432 541 544 O
can NCT03864432 545 548 O
sign NCT03864432 549 553 O
the NCT03864432 554 557 O
written NCT03864432 558 565 O
Informed NCT03864432 566 574 O
Consent NCT03864432 575 582 O
Form NCT03864432 583 587 O
after NCT03864432 588 593 O
being NCT03864432 594 599 O
informed NCT03864432 600 608 O
of NCT03864432 609 611 O
the NCT03864432 612 615 O
study NCT03864432 616 621 O
procedures NCT03864432 622 632 O
. NCT03864432 633 634 O

Exclusion NCT03864432 636 645 O
Criteria NCT03864432 646 654 O
: NCT03864432 655 656 O

- NCT03864432 660 661 O
Those NCT03864432 663 668 O
with NCT03864432 669 673 O
a NCT03864432 674 675 O
history NCT03864432 676 683 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864432 684 686 O
allergies NCT03864432 687 696 O
including NCT03864432 697 706 O
drug NCT03864432 707 711 O
allergies NCT03864432 712 721 O
( NCT03864432 722 723 O
aspirin NCT03864432 724 731 B-Drug-Name
, NCT03864432 732 733 O
antibiotics NCT03864432 734 745 B-Drug-Name
, NCT03864432 746 747 O
etc NCT03864432 748 751 O
. NCT03864432 752 753 O
) NCT03864432 754 755 O
, NCT03864432 757 758 O
or NCT03864432 759 761 O
other NCT03864432 762 767 O
clinically NCT03864432 768 778 O
significant NCT03864432 779 790 B-Severity___Severity-Value:severe
allergies NCT03864432 791 800 O
. NCT03864432 801 802 O

- NCT03864432 806 807 O
Those NCT03864432 809 814 O
with NCT03864432 815 819 O
diseases NCT03864432 820 828 B-Condition-Name
of NCT03864432 829 831 O
the NCT03864432 832 835 O
liver NCT03864432 836 841 O
( NCT03864432 842 843 O
including NCT03864432 844 853 O
carriers NCT03864432 854 862 O
of NCT03864432 863 865 O
hepatitis NCT03864432 866 875 B-Condition-Name
virus NCT03864432 876 881 I-Condition-Name
) NCT03864432 882 883 O
, NCT03864432 885 886 O
kidney NCT03864432 887 893 O
, NCT03864432 894 895 O
respiratory NCT03864432 896 907 O
system NCT03864432 908 914 O
, NCT03864432 915 916 O
endocrine NCT03864432 917 926 O
system NCT03864432 927 933 O
, NCT03864432 934 935 O
nervous NCT03864432 936 943 O
system NCT03864432 944 950 O
or NCT03864432 951 953 O
immune NCT03864432 954 960 O
system NCT03864432 961 967 O
. NCT03864432 968 969 O
Those NCT03864432 971 976 O
with NCT03864432 977 981 O
a NCT03864432 982 983 O
medical NCT03864432 984 991 O
history NCT03864432 992 999 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864432 1000 1002 O
hematology NCT03864432 1003 1013 O
/ NCT03864432 1014 1015 O
oncology NCT03864432 1016 1024 O
, NCT03864432 1025 1026 O
psychiatry NCT03864432 1027 1037 O
or NCT03864432 1038 1040 O
cardiovascular NCT03864432 1041 1055 O
diseases NCT03864432 1056 1064 B-Condition-Name
. NCT03864432 1065 1066 O

- NCT03864432 1070 1071 O
Those NCT03864432 1073 1078 O
with NCT03864432 1079 1083 O
a NCT03864432 1084 1085 O
medical NCT03864432 1086 1093 O
history NCT03864432 1094 1101 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864432 1102 1104 O
gastrointestinal NCT03864432 1105 1121 B-Condition-Name
diseases NCT03864432 1122 1130 I-Condition-Name
( NCT03864432 1131 1132 O
ulcers NCT03864432 1133 1139 B-Condition-Name
, NCT03864432 1140 1141 O
Crohn NCT03864432 1142 1147 B-Condition-Name
's NCT03864432 1147 1149 I-Condition-Name
disease NCT03864432 1150 1157 I-Condition-Name
, NCT03864432 1158 1159 O
etc NCT03864432 1160 1163 O
. NCT03864432 1164 1165 O
) NCT03864432 1166 1167 O
or NCT03864432 1168 1170 O
surgery NCT03864432 1171 1178 B-Procedure-Name
( NCT03864432 1179 1180 O
excluding NCT03864432 1181 1190 O
simple NCT03864432 1191 1197 O
appendectomy NCT03864432 1198 1210 B-Procedure-Name
or NCT03864432 1211 1213 O
hernia NCT03864432 1214 1220 B-Procedure-Name
repair NCT03864432 1221 1227 I-Procedure-Name
) NCT03864432 1228 1229 O
, NCT03864432 1231 1232 O
and NCT03864432 1233 1236 O
these NCT03864432 1237 1242 O
situations NCT03864432 1243 1253 O
can NCT03864432 1254 1257 O
affect NCT03864432 1258 1264 B-Stability___Stability-Value:change
the NCT03864432 1265 1268 O
absorption NCT03864432 1269 1279 B-Condition-Name
of NCT03864432 1280 1282 O
the NCT03864432 1283 1286 O
study NCT03864432 1287 1292 O
drug NCT03864432 1293 1297 O
. NCT03864432 1298 1299 O

Inclusion NCT03868397 0 9 O
Criteria NCT03868397 10 18 O
: NCT03868397 19 20 O

- NCT03868397 24 25 O
older NCT03868397 27 32 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868397 33 37 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03868397 39 41 B-Eq-Value
years NCT03868397 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03868397 50 51 O
And NCT03868397 53 56 O
signed NCT03868397 57 63 O
informed NCT03868397 64 72 O
consent NCT03868397 73 80 O

- NCT03868397 83 84 O
And NCT03868397 86 89 O
planned NCT03868397 90 97 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
either NCT03868397 98 104 O
a NCT03868397 105 106 O
) NCT03868397 107 108 O
liver NCT03868397 109 114 B-Procedure-Name
transplantation NCT03868397 115 130 I-Procedure-Name
as NCT03868397 131 133 O
a NCT03868397 134 135 O
recipient NCT03868397 136 145 O
; NCT03868397 145 146 O
or NCT03868397 147 149 O
b NCT03868397 150 151 O
) NCT03868397 152 153 O
liver NCT03868397 154 159 B-Procedure-Name
transplantation NCT03868397 160 175 I-Procedure-Name
as NCT03868397 176 178 O
a NCT03868397 179 180 O
donor NCT03868397 181 186 O

Exclusion NCT03868397 187 196 O
Criteria NCT03868397 197 205 O
: NCT03868397 206 207 O

- NCT03868397 211 212 O
any NCT03868397 214 217 O
absolute NCT03868397 218 226 O
/ NCT03868397 227 228 O
relative NCT03868397 229 237 O
contraindication NCT03868397 238 254 O
of NCT03868397 255 257 O
contrast NCT03868397 258 266 O
- NCT03868397 267 268 O
enhanced NCT03868397 269 277 O
MRI NCT03868397 278 281 B-Procedure-Name

Inclusion NCT03869710 0 9 O
Criteria NCT03869710 10 18 O
: NCT03869710 19 20 O

- NCT03869710 24 25 O
Chronic NCT03869710 27 34 O
neck NCT03869710 35 39 O
pain NCT03869710 40 44 B-Condition-Name

- NCT03869710 47 48 O
Chronic NCT03869710 50 57 O
head NCT03869710 58 62 O
pain NCT03869710 63 67 B-Condition-Name

Exclusion NCT03869710 68 77 O
Criteria NCT03869710 78 86 O
: NCT03869710 87 88 O

- NCT03869710 92 93 O
previous NCT03869710 95 103 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgery NCT03869710 104 111 B-Procedure-Name
of NCT03869710 112 114 O
neck NCT03869710 115 119 O
and NCT03869710 120 123 O
head NCT03869710 124 128 O

- NCT03869710 131 132 O
Body NCT03869710 134 138 B-Observation-Name___Observation-Type-Value:vital
Mass NCT03869710 139 143 I-Observation-Name___Observation-Type-Value:vital
Index NCT03869710 144 149 I-Observation-Name___Observation-Type-Value:vital
> NCT03869710 150 151 B-Eq-Operator___Eq-Operator-Value:GT
39 NCT03869710 153 155 B-Eq-Value
, NCT03869710 156 157 I-Eq-Value
99 NCT03869710 158 160 I-Eq-Value

- NCT03869710 164 165 O
politrauma NCT03869710 167 177 B-Condition-Name
patients NCT03869710 178 186 O

- NCT03869710 189 190 O
pregnancy NCT03869710 192 201 B-Condition-Name

- NCT03869710 204 205 O
neck NCT03869710 207 211 O
and NCT03869710 212 215 O
head NCT03869710 216 220 O
infections NCT03869710 221 231 B-Condition-Name

Inclusion NCT03864744 0 9 O
Criteria NCT03864744 10 18 O
: NCT03864744 19 20 O

- NCT03864744 24 25 O
Subject NCT03864744 27 34 O
scheduled NCT03864744 35 44 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03864744 45 48 O
total NCT03864744 49 54 B-Procedure-Name
pancreatectomy NCT03864744 55 69 I-Procedure-Name
or NCT03864744 70 72 O
pancreaticoduodenectomy NCT03864744 73 96 B-Procedure-Name

- NCT03864744 99 100 O
Informed NCT03864744 102 110 O
consent NCT03864744 111 118 O
signed NCT03864744 119 125 O
prior NCT03864744 126 131 O
to NCT03864744 132 134 O
any NCT03864744 135 138 O
study NCT03864744 139 144 O
- NCT03864744 145 146 O
related NCT03864744 147 154 O
procedure NCT03864744 155 164 O

Exclusion NCT03864744 165 174 O
Criteria NCT03864744 175 183 O
: NCT03864744 184 185 O

- NCT03864744 189 190 O
Known NCT03864744 192 197 O
liver NCT03864744 198 203 B-Condition-Name
disease NCT03864744 204 211 I-Condition-Name
before NCT03864744 212 218 O
total NCT03864744 219 224 B-Procedure-Name
pancreatectomy NCT03864744 225 239 I-Procedure-Name
or NCT03864744 240 242 O
pancreaticoduodenectomy NCT03864744 243 266 B-Procedure-Name
( NCT03864744 267 268 O
excluding NCT03864744 269 278 O
NAFLD NCT03864744 279 284 B-Condition-Name
) NCT03864744 285 286 O

- NCT03864744 290 291 O
Severe NCT03864744 293 299 B-Severity___Severity-Value:severe
co NCT03864744 300 302 B-Condition-Name
- NCT03864744 303 304 I-Condition-Name
morbid NCT03864744 305 311 I-Condition-Name
disease NCT03864744 312 319 I-Condition-Name
( NCT03864744 320 321 O
besides NCT03864744 322 329 O
from NCT03864744 330 334 O
the NCT03864744 335 338 O
indication NCT03864744 339 349 O
for NCT03864744 350 353 O
the NCT03864744 354 357 O
pancreas NCT03864744 358 366 B-Procedure-Name
surgery NCT03864744 367 374 I-Procedure-Name
) NCT03864744 375 376 O

- NCT03864744 380 381 O
Pregnancy NCT03864744 383 392 B-Condition-Name

- NCT03864744 395 396 O
Any NCT03864744 398 401 O
condition NCT03864744 402 411 O
that NCT03864744 412 416 O
the NCT03864744 417 420 O
investigator NCT03864744 421 433 O
feels NCT03864744 434 439 O
would NCT03864744 440 445 O
interfere NCT03864744 446 455 B-Stability___Stability-Value:change
with NCT03864744 456 460 O
the NCT03864744 461 464 O
safety NCT03864744 465 471 O
of NCT03864744 472 474 O
the NCT03864744 475 478 O
trial NCT03864744 479 484 O
participation NCT03864744 485 498 O
or NCT03864744 499 501 O
the NCT03864744 502 505 O
safety NCT03864744 506 512 O
of NCT03864744 513 515 O
the NCT03864744 516 519 O
subject NCT03864744 520 527 O

- NCT03864744 530 531 O
Metastatic NCT03864744 533 543 B-Condition-Name
disease NCT03864744 544 551 I-Condition-Name

Percutaneous NCT03864744 552 564 O
liver NCT03864744 565 570 B-Procedure-Name
biopsy NCT03864744 571 577 I-Procedure-Name
exclusion NCT03864744 578 587 O
criteria NCT03864744 588 596 O
( NCT03864744 597 598 O
to NCT03864744 599 601 O
be NCT03864744 602 604 O
evaluated NCT03864744 605 614 B-Procedure-Name
before NCT03864744 615 621 O
last NCT03864744 622 626 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
visit NCT03864744 627 632 O
) NCT03864744 633 634 O

- NCT03864744 638 639 O
MR NCT03864744 641 643 B-Procedure-Name
spectroscopy NCT03864744 644 656 I-Procedure-Name
demonstrating NCT03864744 657 670 O
lipid NCT03864744 671 676 B-Observation-Name___Observation-Type-Value:lab
content NCT03864744 677 684 I-Observation-Name___Observation-Type-Value:lab
< NCT03864744 685 686 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03864744 688 689 B-Eq-Value
% NCT03864744 690 691 B-Eq-Unit

- NCT03864744 695 696 O
Haemoglobin NCT03864744 698 709 B-Observation-Name___Observation-Type-Value:lab
< NCT03864744 710 711 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03864744 713 714 B-Eq-Value
mmol NCT03864744 715 719 B-Eq-Unit
/ NCT03864744 720 721 O
L NCT03864744 722 723 B-Eq-Unit

- NCT03864744 726 727 O
INR NCT03864744 729 732 B-Observation-Name___Observation-Type-Value:lab
> NCT03864744 733 734 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03864744 736 739 B-Eq-Value

- NCT03864744 743 744 O
Trombocytes NCT03864744 746 757 B-Observation-Name___Observation-Type-Value:lab
< NCT03864744 758 759 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03864744 761 763 B-Eq-Value
× NCT03864744 764 765 B-Eq-Unit
109 NCT03864744 767 770 B-Eq-Value
/ NCT03864744 771 772 O
L NCT03864744 773 774 B-Eq-Unit

- NCT03864744 777 778 O
Skin NCT03864744 780 784 O
infection NCT03864744 785 794 B-Condition-Name
in NCT03864744 795 797 O
area NCT03864744 798 802 O
where NCT03864744 803 808 O
biopsy NCT03864744 809 815 B-Procedure-Name
will NCT03864744 816 820 O
be NCT03864744 821 823 O
sampled NCT03864744 824 831 O

Inclusion NCT03868618 0 9 O
Criteria NCT03868618 10 18 O
: NCT03868618 19 20 O

- NCT03868618 24 25 O
Body NCT03868618 27 31 B-Observation-Name___Observation-Type-Value:vital
mass NCT03868618 32 36 I-Observation-Name___Observation-Type-Value:vital
index NCT03868618 37 42 I-Observation-Name___Observation-Type-Value:vital
( NCT03868618 43 44 O
BMI NCT03868618 45 48 B-Observation-Name___Observation-Type-Value:vital
) NCT03868618 49 50 O
limitations NCT03868618 51 62 O

- NCT03868618 65 66 O
Likely NCT03868618 68 74 O
suffer NCT03868618 75 81 O
from NCT03868618 82 86 O
moderate NCT03868618 87 95 B-Severity___Severity-Value:moderate
to NCT03868618 96 98 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03868618 99 105 B-Severity___Severity-Value:severe
OSA NCT03868618 106 109 B-Condition-Name
based NCT03868618 110 115 O
on NCT03868618 116 118 O
history NCT03868618 119 126 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
and NCT03868618 127 130 O
physical NCT03868618 131 139 B-Procedure-Name

- NCT03868618 142 143 O
Has NCT03868618 145 148 O
either NCT03868618 149 155 O
not NCT03868618 156 159 O
tolerated NCT03868618 160 169 O
, NCT03868618 170 171 O
has NCT03868618 172 175 O
failed NCT03868618 176 182 O
or NCT03868618 183 185 O
refused NCT03868618 186 193 O
positive NCT03868618 194 202 B-Procedure-Name
airway NCT03868618 203 209 I-Procedure-Name
pressure NCT03868618 210 218 I-Procedure-Name
( NCT03868618 219 220 O
PAP NCT03868618 221 224 B-Procedure-Name
) NCT03868618 225 226 O
treatments NCT03868618 227 237 O

- NCT03868618 240 241 O
Willing NCT03868618 243 250 O
and NCT03868618 251 254 O
capable NCT03868618 255 262 O
of NCT03868618 263 265 O
providing NCT03868618 266 275 O
informed NCT03868618 276 284 O
consent NCT03868618 285 292 O

Exclusion NCT03868618 293 302 O
Criteria NCT03868618 303 311 O
: NCT03868618 312 313 O

- NCT03868618 317 318 O
Inadequately NCT03868618 320 332 O
treated NCT03868618 333 340 O
sleep NCT03868618 341 346 B-Condition-Name
disorders NCT03868618 347 356 I-Condition-Name
other NCT03868618 357 362 O
than NCT03868618 363 367 O
OSA NCT03868618 368 371 B-Condition-Name

- NCT03868618 374 375 O
Significant NCT03868618 377 388 B-Severity___Severity-Value:severe
co NCT03868618 389 391 B-Condition-Name
- NCT03868618 392 393 I-Condition-Name
morbidities NCT03868618 394 405 I-Condition-Name
that NCT03868618 406 410 O
contraindicates NCT03868618 411 426 O
surgery NCT03868618 427 434 B-Procedure-Name
or NCT03868618 435 437 O
general NCT03868618 438 445 B-Procedure-Name
anesthesia NCT03868618 446 456 I-Procedure-Name

Inclusion NCT03866421 0 9 O
Criteria NCT03866421 10 18 O
( NCT03866421 19 20 O
kidney NCT03866421 21 27 B-Procedure-Name
transplanted NCT03866421 28 40 I-Procedure-Name
patients NCT03866421 41 49 O
) NCT03866421 50 51 O
: NCT03866421 53 54 O

- NCT03866421 58 59 O
Outpatient NCT03866421 61 71 B-Encounter-Type___Encounter-Type-Value:inpatient
at NCT03866421 72 74 O
the NCT03866421 75 78 O
department NCT03866421 79 89 B-Location___Location-Value:clinic
of NCT03866421 90 92 I-Location___Location-Value:clinic
nephrology NCT03866421 93 103 I-Location___Location-Value:clinic
at NCT03866421 104 106 O
either NCT03866421 107 113 O
Rigshospitalet NCT03866421 114 128 B-Location___Location-Value:hospital
or NCT03866421 129 131 O
Herlev NCT03866421 132 138 B-Location___Location-Value:hospital
Hospital NCT03866421 139 147 I-Location___Location-Value:hospital
scheduled NCT03866421 148 157 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03866421 158 161 O
a NCT03866421 162 163 O
kidney NCT03866421 164 170 B-Procedure-Name
transplantation NCT03866421 171 186 I-Procedure-Name
with NCT03866421 187 191 O
a NCT03866421 192 193 O
living NCT03866421 194 200 B-Observation-Name
donor NCT03866421 201 206 I-Observation-Name

- NCT03866421 209 210 O
Impaired NCT03866421 212 220 B-Condition-Name
glucose NCT03866421 221 228 I-Condition-Name
tolerance NCT03866421 229 238 I-Condition-Name
: NCT03866421 239 240 O
fasting NCT03866421 241 248 O
glucose NCT03866421 249 256 B-Observation-Name___Observation-Type-Value:lab
concentration NCT03866421 257 270 I-Observation-Name___Observation-Type-Value:lab
< NCT03866421 271 272 B-Eq-Operator___Eq-Operator-Value:LT
7 NCT03866421 274 275 B-Eq-Value
, NCT03866421 276 277 I-Eq-Value
0 NCT03866421 278 279 I-Eq-Value
mmol NCT03866421 280 284 B-Eq-Unit
/ NCT03866421 285 286 I-Eq-Unit
l NCT03866421 287 288 B-Eq-Unit
and NCT03866421 289 292 O
a NCT03866421 293 294 O
2 NCT03866421 296 297 B-Observation-Name___Observation-Type-Value:lab
- NCT03866421 298 299 I-Observation-Name___Observation-Type-Value:lab
hour NCT03866421 300 304 I-Observation-Name___Observation-Type-Value:lab
glucose NCT03866421 305 312 I-Observation-Name___Observation-Type-Value:lab
load NCT03866421 313 317 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03866421 318 319 B-Eq-Operator___Eq-Operator-Value:GTEQ
7 NCT03866421 321 322 B-Eq-Value
, NCT03866421 323 324 I-Eq-Value
8 NCT03866421 325 326 I-Eq-Value
mmol NCT03866421 327 331 B-Eq-Unit
/ NCT03866421 332 333 I-Eq-Unit
l NCT03866421 334 335 B-Eq-Unit
and NCT03866421 336 339 O
< NCT03866421 340 341 B-Eq-Operator___Eq-Operator-Value:LT
11 NCT03866421 343 345 B-Eq-Value
, NCT03866421 346 347 I-Eq-Value
1 NCT03866421 348 349 I-Eq-Value
mmol NCT03866421 350 354 B-Eq-Unit
/ NCT03866421 355 356 I-Eq-Unit
l NCT03866421 357 358 B-Eq-Unit
OR NCT03866421 359 361 O
Impaired NCT03866421 362 370 B-Condition-Name
fasting NCT03866421 371 378 I-Condition-Name
glycaemia NCT03866421 379 388 I-Condition-Name
: NCT03866421 389 390 O
Fasting NCT03866421 391 398 O
blood NCT03866421 399 404 B-Observation-Name___Observation-Type-Value:lab
glucose NCT03866421 405 412 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03866421 413 414 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03866421 416 417 B-Eq-Value
, NCT03866421 418 419 I-Eq-Value
1 NCT03866421 420 421 I-Eq-Value
mmol NCT03866421 422 426 B-Eq-Unit
/ NCT03866421 427 428 O
l NCT03866421 429 430 B-Eq-Unit
and NCT03866421 431 434 O
< NCT03866421 435 436 B-Eq-Operator___Eq-Operator-Value:LT
7 NCT03866421 438 439 B-Eq-Value
, NCT03866421 440 441 I-Eq-Value
0 NCT03866421 442 443 I-Eq-Value
mmol NCT03866421 444 448 B-Eq-Unit
/ NCT03866421 449 450 I-Eq-Unit
l NCT03866421 451 452 B-Eq-Unit
and NCT03866421 453 456 O
a NCT03866421 457 458 O
2 NCT03866421 460 461 B-Observation-Name___Observation-Type-Value:lab
- NCT03866421 462 463 I-Observation-Name___Observation-Type-Value:lab
hour NCT03866421 464 468 I-Observation-Name___Observation-Type-Value:lab
glucose NCT03866421 469 476 I-Observation-Name___Observation-Type-Value:lab
load NCT03866421 477 481 I-Observation-Name___Observation-Type-Value:lab
< NCT03866421 482 483 B-Eq-Operator___Eq-Operator-Value:LT
7 NCT03866421 485 486 B-Eq-Value
, NCT03866421 487 488 I-Eq-Value
8 NCT03866421 489 490 I-Eq-Value
mmol NCT03866421 491 495 B-Eq-Unit
/ NCT03866421 496 497 I-Eq-Unit
l NCT03866421 498 499 B-Eq-Unit
OR NCT03866421 500 502 O
Normal NCT03866421 503 509 B-Polarity___Polarity-Value:normal
glucose NCT03866421 510 517 B-Condition-Name
tolerance NCT03866421 518 527 I-Condition-Name
: NCT03866421 528 529 O
fasting NCT03866421 530 537 O
glucose NCT03866421 538 545 B-Observation-Name___Observation-Type-Value:lab
concentration NCT03866421 546 559 I-Observation-Name___Observation-Type-Value:lab
< NCT03866421 560 561 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03866421 563 564 B-Eq-Value
, NCT03866421 565 566 I-Eq-Value
1 NCT03866421 567 568 I-Eq-Value
mmol NCT03866421 569 573 B-Eq-Unit
/ NCT03866421 574 575 I-Eq-Unit
l NCT03866421 576 577 B-Eq-Unit
and NCT03866421 578 581 O
a NCT03866421 582 583 O
2 NCT03866421 585 586 B-Observation-Name___Observation-Type-Value:lab
- NCT03866421 587 588 I-Observation-Name___Observation-Type-Value:lab
hour NCT03866421 589 593 I-Observation-Name___Observation-Type-Value:lab
glucose NCT03866421 594 601 I-Observation-Name___Observation-Type-Value:lab
load NCT03866421 602 606 I-Observation-Name___Observation-Type-Value:lab
< NCT03866421 607 608 B-Eq-Operator___Eq-Operator-Value:LT
7 NCT03866421 610 611 B-Eq-Value
, NCT03866421 612 613 I-Eq-Value
8 NCT03866421 614 615 I-Eq-Value
mmol NCT03866421 616 620 B-Eq-Unit
/ NCT03866421 621 622 I-Eq-Unit
l NCT03866421 623 624 B-Eq-Unit
. NCT03866421 625 626 O

Inclusion NCT03866421 628 637 O
criteria NCT03866421 638 646 O
( NCT03866421 647 648 O
control NCT03866421 649 656 O
group NCT03866421 657 662 O
) NCT03866421 663 664 O
: NCT03866421 666 667 O

- NCT03866421 671 672 O
Normal NCT03866421 674 680 B-Polarity___Polarity-Value:normal
kidney NCT03866421 681 687 B-Condition-Name
function NCT03866421 688 696 I-Condition-Name

- NCT03866421 699 700 O
Normal NCT03866421 702 708 B-Polarity___Polarity-Value:normal
glucose NCT03866421 709 716 B-Condition-Name
tolerance NCT03866421 717 726 I-Condition-Name

Exclusion NCT03866421 727 736 O
Criteria NCT03866421 737 745 O
: NCT03866421 746 747 O

- NCT03866421 751 752 O
End NCT03866421 754 757 O
stage NCT03866421 758 763 O
liver NCT03866421 764 769 B-Condition-Name
disease NCT03866421 770 777 I-Condition-Name
as NCT03866421 778 780 O
diagnosed NCT03866421 781 790 O
by NCT03866421 791 793 O
MELD NCT03866421 794 798 O
( NCT03866421 799 800 O
model NCT03866421 801 806 O
for NCT03866421 807 810 O
end NCT03866421 811 814 O
stage NCT03866421 815 820 O
liver NCT03866421 821 826 O
disease NCT03866421 827 834 O
) NCT03866421 835 836 O
criteria NCT03866421 837 845 O
OR NCT03866421 846 848 O

- NCT03866421 851 852 O
At NCT03866421 854 856 O
the NCT03866421 857 860 O
waiting NCT03866421 861 868 O
list NCT03866421 869 873 O
for NCT03866421 874 877 O
liver NCT03866421 878 883 B-Procedure-Name
transplantation NCT03866421 884 899 I-Procedure-Name
OR NCT03866421 900 902 O

- NCT03866421 905 906 O
Daily NCT03866421 908 913 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
alcohol NCT03866421 914 921 B-Observation-Name___Observation-Type-Value:social-habit
intake NCT03866421 922 928 I-Observation-Name___Observation-Type-Value:social-habit
above NCT03866421 929 934 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03866421 936 938 B-Eq-Value
g NCT03866421 939 940 B-Eq-Unit
and NCT03866421 941 944 O
30 NCT03866421 946 948 B-Eq-Value
g NCT03866421 949 950 B-Eq-Unit
for NCT03866421 951 954 O
women NCT03866421 955 960 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
and NCT03866421 961 964 O
men NCT03866421 965 968 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
respectively NCT03866421 969 981 O
OR NCT03866421 982 984 O

- NCT03866421 987 988 O
Known NCT03866421 990 995 O
hepatitis NCT03866421 996 1005 B-Condition-Name
A NCT03866421 1006 1007 O
, NCT03866421 1008 1009 O
B NCT03866421 1010 1011 O
or NCT03866421 1012 1014 O
C NCT03866421 1015 1016 O
or NCT03866421 1017 1019 O
hepatocellular NCT03866421 1020 1034 O
carcinoma NCT03866421 1035 1044 B-Condition-Name
or NCT03866421 1045 1047 O
other NCT03866421 1048 1053 O
known NCT03866421 1054 1059 O
liver NCT03866421 1060 1065 B-Condition-Name
disease NCT03866421 1066 1073 I-Condition-Name
OR NCT03866421 1074 1076 O

- NCT03866421 1079 1080 O
Pregnancy NCT03866421 1082 1091 B-Condition-Name
OR NCT03866421 1092 1094 O

- NCT03866421 1097 1098 O
Weight NCT03866421 1100 1106 B-Observation-Name___Observation-Type-Value:vital
> NCT03866421 1107 1108 B-Eq-Operator___Eq-Operator-Value:GT
130 NCT03866421 1110 1113 B-Eq-Value
kg NCT03866421 1114 1116 B-Eq-Unit
OR NCT03866421 1117 1119 O

- NCT03866421 1122 1123 O
Implanted NCT03866421 1125 1134 B-Procedure-Name
pacemaker NCT03866421 1135 1144 I-Procedure-Name

Inclusion NCT03863821 0 9 O
Criteria NCT03863821 10 18 O
: NCT03863821 19 20 O

- NCT03863821 24 25 O
Mild NCT03863821 27 31 B-Severity___Severity-Value:severe
COPD NCT03863821 32 36 B-Condition-Name
with NCT03863821 37 41 O
performed NCT03863821 42 51 O
pulmonary NCT03863821 52 61 B-Observation-Name___Observation-Type-Value:lab
function NCT03863821 62 70 I-Observation-Name___Observation-Type-Value:lab
test NCT03863821 71 75 I-Observation-Name___Observation-Type-Value:lab

Exclusion NCT03863821 76 85 O
Criteria NCT03863821 86 94 O
: NCT03863821 95 96 O

- NCT03863821 100 101 O
Left NCT03863821 103 107 O
- NCT03863821 108 109 O
side NCT03863821 110 114 O
heart NCT03863821 115 120 B-Condition-Name
failure NCT03863821 121 128 I-Condition-Name

- NCT03863821 131 132 O
COPD NCT03863821 134 138 B-Condition-Name
exacerbation NCT03863821 139 151 B-Stability___Stability-Value:change
within NCT03863821 152 158 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03863821 160 161 B-Eq-Value
month NCT03863821 162 167 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863821 170 171 O
Diagnosed NCT03863821 173 182 O
neuromuscular NCT03863821 183 196 B-Condition-Name
disease NCT03863821 197 204 I-Condition-Name

- NCT03863821 207 208 O
Unable NCT03863821 210 216 O
to NCT03863821 217 219 O
perform NCT03863821 220 227 O
6 NCT03863821 229 230 B-Observation-Name
- NCT03863821 231 232 I-Observation-Name
MWT NCT03863821 233 236 I-Observation-Name

Inclusion NCT03865277 0 9 O
Criteria NCT03865277 10 18 O
: NCT03865277 19 20 O

- NCT03865277 24 25 O
Age NCT03865277 27 30 O
: NCT03865277 31 32 O
older NCT03865277 33 38 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03865277 39 43 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03865277 45 47 B-Eq-Value
years NCT03865277 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03865277 56 57 O
WHO NCT03865277 59 62 O
( NCT03865277 63 64 O
ECOG NCT03865277 65 69 B-Observation-Name
) NCT03865277 70 71 O
performance NCT03865277 72 83 O
status NCT03865277 84 90 O
0 NCT03865277 92 93 B-Eq-Value
- NCT03865277 94 95 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03865277 97 98 B-Eq-Value

- NCT03865277 102 103 O
Histological NCT03865277 105 117 O
proven NCT03865277 118 124 O
HNSCC NCT03865277 125 130 B-Condition-Name

- NCT03865277 133 134 O
HPV NCT03865277 136 139 B-Condition-Name
negative NCT03865277 140 148 B-Polarity___Polarity-Value:negative
tumors NCT03865277 149 155 O
or NCT03865277 156 158 O
HPV NCT03865277 159 162 B-Condition-Name
positive NCT03865277 163 171 B-Polarity___Polarity-Value:positive
tumors NCT03865277 172 178 O

- NCT03865277 181 182 O
Stage NCT03865277 184 189 B-Eq-Unit
III NCT03865277 190 193 B-Eq-Value
, NCT03865277 194 195 O
IVA NCT03865277 196 199 O
or NCT03865277 200 202 O
IVB NCT03865277 203 206 O
HNSCC NCT03865277 207 212 B-Condition-Name
according NCT03865277 213 222 O
to NCT03865277 223 225 O
UICC NCT03865277 226 230 O
and NCT03865277 231 234 O
AJCC NCT03865277 235 239 O
guidelines NCT03865277 240 250 O

- NCT03865277 253 254 O
Tumor NCT03865277 256 261 B-Condition-Name
classified NCT03865277 262 272 O
as NCT03865277 273 275 O
irresectable NCT03865277 276 288 O
or NCT03865277 289 291 O
patient NCT03865277 292 299 O
inoperable NCT03865277 300 310 O
or NCT03865277 311 313 O
patient NCT03865277 314 321 O
refused NCT03865277 322 329 O
surgery NCT03865277 330 337 B-Procedure-Name

- NCT03865277 340 341 O
Tumor NCT03865277 343 348 B-Condition-Name
extension NCT03865277 349 358 O
and NCT03865277 359 362 O
localization NCT03865277 363 375 O
suitable NCT03865277 376 384 O
for NCT03865277 385 388 O
radiochemotherapy NCT03865277 389 406 B-Procedure-Name
with NCT03865277 407 411 O
curative NCT03865277 412 420 O
intent NCT03865277 421 427 O

- NCT03865277 430 431 O
Simultaneous NCT03865277 433 445 O
standard NCT03865277 446 454 O
chemotherapy NCT03865277 455 467 B-Procedure-Name
with NCT03865277 468 472 O
cisplatin NCT03865277 473 482 B-Drug-Name
applicable NCT03865277 483 493 O
( NCT03865277 494 495 O
no NCT03865277 496 498 O
contra NCT03865277 499 505 O
- NCT03865277 506 507 O
indications NCT03865277 508 519 O
) NCT03865277 520 521 O

- NCT03865277 525 526 O
Dental NCT03865277 528 534 B-Procedure-Name
examination NCT03865277 535 546 O
and NCT03865277 547 550 O
- NCT03865277 551 552 O
treatment NCT03865277 553 562 O
before NCT03865277 563 569 O
start NCT03865277 570 575 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03865277 576 578 O
therapy NCT03865277 579 586 B-Procedure-Name

- NCT03865277 589 590 O
For NCT03865277 592 595 O
women NCT03865277 596 601 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03865277 602 606 O
childbearing NCT03865277 607 619 B-Condition-Name
potential NCT03865277 620 629 I-Condition-Name
and NCT03865277 630 633 O
men NCT03865277 634 637 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
in NCT03865277 638 640 O
reproductive NCT03865277 641 653 B-Condition-Name
ages NCT03865277 654 658 I-Condition-Name
adequate NCT03865277 659 667 B-Polarity___Polarity-Value:normal
contraception NCT03865277 668 681 B-Procedure-Name
. NCT03865277 682 683 O

- NCT03865277 687 688 O
Ability NCT03865277 690 697 O
of NCT03865277 698 700 O
subject NCT03865277 701 708 O
to NCT03865277 709 711 O
understand NCT03865277 712 722 O
character NCT03865277 723 732 O
and NCT03865277 733 736 O
individual NCT03865277 737 747 O
consequences NCT03865277 748 760 O
of NCT03865277 761 763 O
the NCT03865277 764 767 O
clinical NCT03865277 768 776 O
trial NCT03865277 777 782 O

- NCT03865277 785 786 O
Written NCT03865277 788 795 O
informed NCT03865277 796 804 O
consent NCT03865277 805 812 O
( NCT03865277 813 814 O
must NCT03865277 815 819 O
be NCT03865277 820 822 O
available NCT03865277 823 832 O
before NCT03865277 833 839 O
enrolment NCT03865277 840 849 O
in NCT03865277 850 852 O
the NCT03865277 853 856 O
trial NCT03865277 857 862 O
) NCT03865277 863 864 O

Exclusion NCT03865277 866 875 O
Criteria NCT03865277 876 884 O
: NCT03865277 885 886 O

- NCT03865277 890 891 O
Refusal NCT03865277 893 900 O
of NCT03865277 901 903 O
the NCT03865277 904 907 O
patients NCT03865277 908 916 O
to NCT03865277 917 919 O
take NCT03865277 920 924 O
part NCT03865277 925 929 O
in NCT03865277 930 932 O
the NCT03865277 933 936 O
trial NCT03865277 937 942 O

- NCT03865277 945 946 O
Presence NCT03865277 948 956 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03865277 957 959 O
distant NCT03865277 960 967 O
metastases NCT03865277 968 978 B-Condition-Name
( NCT03865277 979 980 O
UICC NCT03865277 981 985 B-Condition-Name
stage NCT03865277 986 991 B-Eq-Unit
IVC NCT03865277 992 995 B-Eq-Value
) NCT03865277 996 997 O

- NCT03865277 1001 1002 O
Previous NCT03865277 1004 1012 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiotherapy NCT03865277 1013 1025 B-Procedure-Name
in NCT03865277 1026 1028 O
the NCT03865277 1029 1032 O
head NCT03865277 1033 1037 O
and NCT03865277 1038 1041 O
neck NCT03865277 1042 1046 O
region NCT03865277 1047 1053 O

- NCT03865277 1056 1057 O
Second NCT03865277 1059 1065 B-Eq-Value
malignancy NCT03865277 1066 1076 B-Condition-Name
that NCT03865277 1077 1081 O
is NCT03865277 1082 1084 O
likely NCT03865277 1085 1091 O
to NCT03865277 1092 1094 O
require NCT03865277 1095 1102 O
treatment NCT03865277 1103 1112 O
during NCT03865277 1113 1119 O
the NCT03865277 1120 1123 O
trial NCT03865277 1124 1129 O
intervention NCT03865277 1130 1142 O
or NCT03865277 1143 1145 O
follow NCT03865277 1146 1152 O
- NCT03865277 1153 1154 O
up NCT03865277 1155 1157 O
period NCT03865277 1158 1164 O
or NCT03865277 1165 1167 O
that NCT03865277 1168 1172 O
, NCT03865277 1173 1174 O
in NCT03865277 1175 1177 O
the NCT03865277 1178 1181 O
opinion NCT03865277 1182 1189 O
of NCT03865277 1190 1192 O
the NCT03865277 1193 1196 O
physician NCT03865277 1197 1206 O
, NCT03865277 1207 1208 O
has NCT03865277 1209 1212 O
a NCT03865277 1213 1214 O
considerable NCT03865277 1215 1227 B-Severity___Severity-Value:severe
risk NCT03865277 1228 1232 O
of NCT03865277 1233 1235 O
recurrence NCT03865277 1236 1246 O
or NCT03865277 1247 1249 O
metastases NCT03865277 1250 1260 B-Condition-Name
within NCT03865277 1261 1267 O
the NCT03865277 1268 1271 O
follow NCT03865277 1272 1278 O
- NCT03865277 1279 1280 O
up NCT03865277 1281 1283 O
period NCT03865277 1284 1290 O

- NCT03865277 1293 1294 O
Serious NCT03865277 1296 1303 B-Severity___Severity-Value:severe
disease NCT03865277 1304 1311 B-Condition-Name
or NCT03865277 1312 1314 O
medical NCT03865277 1315 1322 O
condition NCT03865277 1323 1332 O
with NCT03865277 1333 1337 O
life NCT03865277 1338 1342 B-Observation-Name
expectancy NCT03865277 1343 1353 I-Observation-Name
of NCT03865277 1354 1356 O
less NCT03865277 1357 1361 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03865277 1362 1366 I-Eq-Operator___Eq-Operator-Value:LT
one NCT03865277 1367 1370 B-Eq-Value
year NCT03865277 1371 1375 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03865277 1378 1379 O
Participation NCT03865277 1381 1394 O
in NCT03865277 1395 1397 O
competing NCT03865277 1398 1407 O
interventional NCT03865277 1408 1422 O
trial NCT03865277 1423 1428 O
on NCT03865277 1429 1431 O
cancer NCT03865277 1432 1438 B-Condition-Name
treatment NCT03865277 1439 1448 O

- NCT03865277 1451 1452 O
Patients NCT03865277 1454 1462 O
who NCT03865277 1463 1466 O
are NCT03865277 1467 1470 O
not NCT03865277 1471 1474 O
suitable NCT03865277 1475 1483 O
for NCT03865277 1484 1487 O
radiochemotherapy NCT03865277 1488 1505 B-Procedure-Name

- NCT03865277 1508 1509 O
Pregnant NCT03865277 1511 1519 B-Condition-Name
or NCT03865277 1520 1522 O
lactating NCT03865277 1523 1532 B-Condition-Name
women NCT03865277 1533 1538 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03865277 1541 1542 O
Patients NCT03865277 1544 1552 O
not NCT03865277 1553 1556 O
able NCT03865277 1557 1561 O
to NCT03865277 1562 1564 O
understand NCT03865277 1565 1575 O
the NCT03865277 1576 1579 O
character NCT03865277 1580 1589 O
and NCT03865277 1590 1593 O
individual NCT03865277 1594 1604 O
consequences NCT03865277 1605 1617 O
of NCT03865277 1618 1620 O
the NCT03865277 1621 1624 O
trial NCT03865277 1625 1630 O

- NCT03865277 1633 1634 O
Nasopharyngeal NCT03865277 1636 1650 B-Condition-Name
Carcinomas NCT03865277 1651 1661 I-Condition-Name

Inclusion NCT03866018 0 9 O
Criteria NCT03866018 10 18 O
: NCT03866018 19 20 O

- NCT03866018 24 25 O
Male NCT03866018 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03866018 32 34 O
Female NCT03866018 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
≥ NCT03866018 42 43 B-Eq-Operator___Eq-Operator-Value:GTEQ
60 NCT03866018 45 47 B-Eq-Value
years NCT03866018 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866018 54 57 O

- NCT03866018 60 61 O
MMSE NCT03866018 63 67 B-Observation-Name
score NCT03866018 68 73 O
between NCT03866018 74 81 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03866018 83 84 B-Eq-Value
and NCT03866018 85 88 O
26 NCT03866018 90 92 B-Eq-Value
/ NCT03866018 93 94 O
30 NCT03866018 96 98 B-Eq-Value

- NCT03866018 102 103 O
Diagnosis NCT03866018 105 114 O
of NCT03866018 115 117 O
minor NCT03866018 118 123 B-Severity___Severity-Value:mild
to NCT03866018 124 126 O
major NCT03866018 127 132 B-Severity___Severity-Value:severe
NeuroCognitive NCT03866018 133 147 B-Condition-Name
Disorder NCT03866018 148 156 I-Condition-Name
of NCT03866018 157 159 O
the NCT03866018 160 163 O
Alzheimer NCT03866018 164 173 B-Condition-Name
type NCT03866018 174 178 O
or NCT03866018 179 181 O
multiple NCT03866018 182 190 B-Eq-Operator___Eq-Operator-Value:GT
etiology NCT03866018 191 199 B-Condition-Name
; NCT03866018 199 200 O

- NCT03866018 203 204 O
Subject NCT03866018 206 213 O
without NCT03866018 214 221 O
a NCT03866018 222 223 O
major NCT03866018 224 229 B-Severity___Severity-Value:severe
hearing NCT03866018 230 237 O
or NCT03866018 238 240 O
visual NCT03866018 241 247 O
impairment NCT03866018 248 258 B-Condition-Name
; NCT03866018 258 259 O

- NCT03866018 262 263 O
Subject NCT03866018 265 272 O
not NCT03866018 273 276 O
presenting NCT03866018 277 287 O
any NCT03866018 288 291 O
contraindications NCT03866018 292 309 O
to NCT03866018 310 312 O
the NCT03866018 313 316 O
practice NCT03866018 317 325 O
of NCT03866018 326 328 O
adapted NCT03866018 329 336 O
physical NCT03866018 337 345 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03866018 346 354 I-Observation-Name___Observation-Type-Value:social-habit
; NCT03866018 354 355 O

- NCT03866018 358 359 O
Subject NCT03866018 361 368 O
affiliated NCT03866018 369 379 O
to NCT03866018 380 382 O
Social NCT03866018 383 389 O
Security NCT03866018 390 398 O
System NCT03866018 399 405 O
; NCT03866018 405 406 O

- NCT03866018 409 410 O
Signing NCT03866018 412 419 O
informed NCT03866018 420 428 O
consent NCT03866018 429 436 O

Exclusion NCT03866018 437 446 O
Criteria NCT03866018 447 455 O
: NCT03866018 456 457 O

- NCT03866018 461 462 O
< NCT03866018 464 465 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03866018 467 469 B-Eq-Value
years NCT03866018 470 475 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866018 478 479 O
Medical NCT03866018 481 488 O
indications NCT03866018 489 500 O
: NCT03866018 501 502 O
Recent NCT03866018 503 509 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
or NCT03866018 510 512 O
unstable NCT03866018 513 521 B-Stability___Stability-Value:change
cardiovascular NCT03866018 522 536 B-Condition-Name
events NCT03866018 537 543 I-Condition-Name
: NCT03866018 544 545 O
ECG NCT03866018 546 549 B-Procedure-Name
changes NCT03866018 550 557 B-Stability___Stability-Value:change
, NCT03866018 558 559 O
unstable NCT03866018 560 568 B-Stability___Stability-Value:change
angina NCT03866018 569 575 B-Condition-Name
, NCT03866018 576 577 O
uncontrolled NCT03866018 578 590 O
arrhythmia NCT03866018 591 601 B-Condition-Name
, NCT03866018 602 603 O
3 NCT03866018 605 606 O
rd NCT03866018 607 609 O
degree NCT03866018 610 616 O
BAV NCT03866018 617 620 B-Condition-Name
, NCT03866018 621 622 O
acute NCT03866018 623 628 B-Severity___Severity-Value:severe
heart NCT03866018 629 634 B-Condition-Name
failure NCT03866018 635 642 I-Condition-Name
. NCT03866018 643 644 O

- NCT03866018 648 649 O
MMSE NCT03866018 651 655 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03866018 656 661 B-Eq-Unit
< NCT03866018 662 663 B-Eq-Operator___Eq-Operator-Value:LT
4 NCT03866018 665 666 B-Eq-Value

- NCT03866018 670 671 O
Subject NCT03866018 673 680 O
already NCT03866018 681 688 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
engaged NCT03866018 689 696 O
in NCT03866018 697 699 O
appropriate NCT03866018 700 711 O
physical NCT03866018 712 720 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03866018 721 729 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03866018 732 733 O
Subject NCT03866018 735 742 O
with NCT03866018 743 747 O
a NCT03866018 748 749 O
perceptual NCT03866018 750 760 B-Condition-Name
disorder NCT03866018 761 769 I-Condition-Name
( NCT03866018 770 771 O
AMD NCT03866018 772 775 B-Condition-Name
, NCT03866018 776 777 O
deafness NCT03866018 778 786 B-Condition-Name
. NCT03866018 787 788 O
. NCT03866018 789 790 O
. NCT03866018 791 792 O
) NCT03866018 793 794 O

- NCT03866018 798 799 O
Subject NCT03866018 801 808 O
with NCT03866018 809 813 O
a NCT03866018 814 815 O
motor NCT03866018 816 821 B-Condition-Name
disability NCT03866018 822 832 I-Condition-Name

- NCT03866018 835 836 O
Subject NCT03866018 838 845 O
under NCT03866018 846 851 B-Observation-Name
guardianship NCT03866018 852 864 I-Observation-Name
, NCT03866018 865 866 O
curatorship NCT03866018 867 878 B-Observation-Name
or NCT03866018 879 881 O
safeguard NCT03866018 882 891 B-Observation-Name
of NCT03866018 892 894 I-Observation-Name
justice NCT03866018 895 902 I-Observation-Name

- NCT03866018 905 906 O
Persons NCT03866018 908 915 O
deprived NCT03866018 916 924 B-Observation-Name
of NCT03866018 925 927 I-Observation-Name
their NCT03866018 928 933 I-Observation-Name
liberty NCT03866018 934 941 I-Observation-Name
( NCT03866018 942 943 O
administrative NCT03866018 944 958 O
or NCT03866018 959 961 O
judicial NCT03866018 962 970 O
) NCT03866018 971 972 O

Inclusion NCT03867474 0 9 O
Criteria NCT03867474 10 18 O
: NCT03867474 19 20 O

- NCT03867474 24 25 O
Inclusion NCT03867474 27 36 O
criteria NCT03867474 37 45 O
for NCT03867474 46 49 O
study NCT03867474 50 55 O
participants NCT03867474 56 68 O
include NCT03867474 69 76 O
: NCT03867474 77 78 O
( NCT03867474 79 80 O
1 NCT03867474 82 83 O
) NCT03867474 84 85 O
age NCT03867474 86 89 O
≥ NCT03867474 90 91 B-Eq-Operator___Eq-Operator-Value:GTEQ
60 NCT03867474 93 95 B-Eq-Value
years NCT03867474 96 101 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03867474 101 102 O
( NCT03867474 103 104 O
2 NCT03867474 106 107 O
) NCT03867474 108 109 O
English NCT03867474 110 117 B-Language
fluency NCT03867474 118 125 O
; NCT03867474 125 126 O
( NCT03867474 127 128 O
3 NCT03867474 130 131 O
) NCT03867474 132 133 O
living NCT03867474 134 140 B-Observation-Name___Observation-Type-Value:social-habit
independently NCT03867474 141 154 I-Observation-Name___Observation-Type-Value:social-habit
in NCT03867474 155 157 O
the NCT03867474 158 161 O
community NCT03867474 162 171 O
; NCT03867474 171 172 O
( NCT03867474 173 174 O
4 NCT03867474 176 177 O
) NCT03867474 178 179 O
self NCT03867474 180 184 O
- NCT03867474 185 186 O
reported NCT03867474 187 195 O
demographic NCT03867474 196 207 O
information NCT03867474 208 219 O
that NCT03867474 220 224 O
includes NCT03867474 225 233 O
either NCT03867474 234 240 O
the NCT03867474 241 244 O
label NCT03867474 245 250 O
of NCT03867474 251 253 O
SCD NCT03867474 254 257 B-Condition-Name
or NCT03867474 258 260 O
MCI NCT03867474 261 264 B-Condition-Name

Exclusion NCT03867474 265 274 O
Criteria NCT03867474 275 283 O
: NCT03867474 284 285 O

- NCT03867474 289 290 O
( NCT03867474 292 293 O
1 NCT03867474 295 296 O
) NCT03867474 297 298 O
history NCT03867474 299 306 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867474 307 309 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
prior NCT03867474 310 315 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participation NCT03867474 316 329 O
in NCT03867474 330 332 O
any NCT03867474 333 336 O
MBSR NCT03867474 337 341 O
or NCT03867474 342 344 O
other NCT03867474 345 350 O
mindfulness NCT03867474 351 362 O
- NCT03867474 363 364 O
based NCT03867474 365 370 O
interventions NCT03867474 371 384 B-Procedure-Name
, NCT03867474 385 386 O
or NCT03867474 387 389 O
participation NCT03867474 390 403 O
in NCT03867474 404 406 O
regular NCT03867474 407 414 O
( NCT03867474 415 416 O
weekly NCT03867474 417 423 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03867474 424 425 O
mindfulness NCT03867474 426 437 O
or NCT03867474 438 440 O
yoga NCT03867474 441 445 O
practice NCT03867474 446 454 B-Observation-Name___Observation-Type-Value:social-habit
; NCT03867474 454 455 O
( NCT03867474 456 457 O
2 NCT03867474 459 460 O
) NCT03867474 461 462 O
low NCT03867474 463 466 B-Polarity___Polarity-Value:low
mood NCT03867474 467 471 B-Condition-Name
as NCT03867474 472 474 O
indicated NCT03867474 475 484 O
by NCT03867474 485 487 O
a NCT03867474 488 489 O
5 NCT03867474 491 492 B-Eq-Value
or NCT03867474 493 495 B-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03867474 496 503 I-Eq-Operator___Eq-Operator-Value:GTEQ
on NCT03867474 504 506 O
the NCT03867474 507 510 O
Geriatric NCT03867474 511 520 B-Observation-Name___Observation-Type-Value:clinical-score
Depression NCT03867474 521 531 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03867474 532 537 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03867474 538 539 O
GDS NCT03867474 540 543 B-Observation-Name
) NCT03867474 544 545 O
( NCT03867474 546 547 O
3 NCT03867474 549 550 O
) NCT03867474 551 552 O
alcoholism NCT03867474 553 563 B-Condition-Name
and NCT03867474 564 567 O
/ NCT03867474 568 569 O
or NCT03867474 570 572 O
other NCT03867474 573 578 O
substance NCT03867474 579 588 B-Condition-Name
abuse NCT03867474 589 594 I-Condition-Name
defined NCT03867474 595 602 O
in NCT03867474 603 605 O
the NCT03867474 606 609 O
Diagnostic NCT03867474 610 620 O
and NCT03867474 621 624 O
Statistical NCT03867474 625 636 O
Manual NCT03867474 637 643 O
of NCT03867474 644 646 O
Mental NCT03867474 647 653 O
Disorders NCT03867474 654 663 O
, NCT03867474 664 665 O
Fifth NCT03867474 666 671 O
Edition NCT03867474 672 679 O
( NCT03867474 680 681 O
DSM NCT03867474 682 685 O
- NCT03867474 686 687 O
V NCT03867474 688 689 O
) NCT03867474 690 691 O
( NCT03867474 692 693 O
American NCT03867474 694 702 O
Psychiatric NCT03867474 703 714 O
Association NCT03867474 715 726 O
, NCT03867474 727 728 O
2013 NCT03867474 730 734 O
; NCT03867474 735 736 O
Kiefer NCT03867474 737 743 O
, NCT03867474 744 745 O
Israel NCT03867474 746 752 O
, NCT03867474 753 754 O
& NCT03867474 755 756 O
Martino NCT03867474 757 764 O
, NCT03867474 765 766 O
2016 NCT03867474 768 772 O
) NCT03867474 773 774 O
; NCT03867474 775 776 O
( NCT03867474 777 778 O
4 NCT03867474 780 781 O
) NCT03867474 782 783 O
Montreal NCT03867474 784 792 B-Observation-Name___Observation-Type-Value:clinical-score
Cognitive NCT03867474 793 802 I-Observation-Name___Observation-Type-Value:clinical-score
Assessment NCT03867474 803 813 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03867474 814 815 O
MoCA NCT03867474 816 820 B-Observation-Name
) NCT03867474 821 822 O
of NCT03867474 823 825 O
23 NCT03867474 827 829 B-Eq-Value
( NCT03867474 830 831 O
+ NCT03867474 833 834 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
/ NCT03867474 836 837 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
- NCT03867474 839 840 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
4 NCT03867474 842 843 B-Eq-Value
) NCT03867474 844 845 O
( NCT03867474 846 847 O
Clarnette NCT03867474 848 857 O
, NCT03867474 858 859 O
O'Caoimh NCT03867474 860 868 O
, NCT03867474 869 870 O
Antony NCT03867474 871 877 O
, NCT03867474 878 879 O
Svendrovski NCT03867474 880 891 O
, NCT03867474 892 893 O
& NCT03867474 894 895 O
Molloy NCT03867474 896 902 O
, NCT03867474 903 904 O
2017 NCT03867474 906 910 O
; NCT03867474 911 912 O
O'Caoimh NCT03867474 913 921 O
, NCT03867474 922 923 O
Timmons NCT03867474 924 931 O
, NCT03867474 932 933 O
& NCT03867474 934 935 O
Molloy NCT03867474 936 942 O
, NCT03867474 943 944 O
2016 NCT03867474 946 950 O
) NCT03867474 951 952 O
or NCT03867474 953 955 O
under NCT03867474 956 961 O
; NCT03867474 961 962 O
and NCT03867474 963 966 O
( NCT03867474 967 968 O
5 NCT03867474 970 971 O
) NCT03867474 972 973 O
if NCT03867474 974 976 O
participating NCT03867474 977 990 O
in NCT03867474 991 993 O
other NCT03867474 994 999 O
concurrent NCT03867474 1000 1010 O
group NCT03867474 1011 1016 O
( NCT03867474 1017 1018 O
s NCT03867474 1019 1020 O
) NCT03867474 1021 1022 O
e NCT03867474 1023 1024 O
. NCT03867474 1025 1026 O
g NCT03867474 1027 1028 O
. NCT03867474 1029 1030 O
cognitive NCT03867474 1032 1041 B-Procedure-Name
behavioural NCT03867474 1042 1053 I-Procedure-Name
therapy NCT03867474 1054 1061 I-Procedure-Name
( NCT03867474 1062 1063 O
CBT NCT03867474 1064 1067 B-Procedure-Name
) NCT03867474 1068 1069 O
or NCT03867474 1070 1072 O
memory NCT03867474 1073 1079 B-Procedure-Name
training NCT03867474 1080 1088 I-Procedure-Name
programs NCT03867474 1089 1097 I-Procedure-Name
in NCT03867474 1098 1100 O
the NCT03867474 1101 1104 O
community NCT03867474 1105 1114 O
, NCT03867474 1115 1116 O
while NCT03867474 1117 1122 O
in NCT03867474 1123 1125 O
the NCT03867474 1126 1129 O
study NCT03867474 1130 1135 O
. NCT03867474 1136 1137 O


Inclusion NCT03864380 0 9 O
Criteria NCT03864380 10 18 O
: NCT03864380 19 20 O

- NCT03864380 24 25 O
Person NCT03864380 27 33 O
registered NCT03864380 34 44 O
at NCT03864380 45 47 O
the NCT03864380 48 51 O
2019 NCT03864380 53 57 O
Paris NCT03864380 58 63 O
Marathon NCT03864380 64 72 O

Exclusion NCT03864380 73 82 O
Criteria NCT03864380 83 91 O
: NCT03864380 92 93 O

- NCT03864380 97 98 O
Ophthalmological NCT03864380 100 116 B-Condition-Name
disorders NCT03864380 117 126 I-Condition-Name
making NCT03864380 127 133 B-Stability___Stability-Value:change
access NCT03864380 134 140 B-Observation-Name
to NCT03864380 141 143 O
the NCT03864380 144 147 O
fundus NCT03864380 148 154 O
impossible NCT03864380 155 165 O
for NCT03864380 166 169 O
both NCT03864380 170 174 O
eyes NCT03864380 175 179 O

Inclusion NCT03860870 0 9 O
Criteria NCT03860870 10 18 O
: NCT03860870 19 20 O

- NCT03860870 24 25 O
Healthy NCT03860870 27 34 B-Condition-Name

- NCT03860870 37 38 O
Male NCT03860870 40 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03860870 47 48 O
18 NCT03860870 51 53 B-Eq-Value
- NCT03860870 54 55 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03860870 57 59 B-Eq-Value
years NCT03860870 60 65 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03860870 66 68 O
age NCT03860870 69 72 O

- NCT03860870 75 76 O
No NCT03860870 78 80 O
known NCT03860870 81 86 O
contraindications NCT03860870 87 104 O
for NCT03860870 105 108 O
anabolic NCT03860870 109 117 B-Drug-Name
drugs NCT03860870 118 123 I-Drug-Name
( NCT03860870 124 125 O
e NCT03860870 126 127 O
. NCT03860870 128 129 O
g NCT03860870 130 131 O
. NCT03860870 132 133 O
cancer NCT03860870 135 141 B-Condition-Name
) NCT03860870 142 143 O

Exclusion NCT03860870 145 154 O
Criteria NCT03860870 155 163 O
: NCT03860870 164 165 O

- NCT03860870 169 170 O
Abnormal NCT03860870 172 180 B-Polarity___Polarity-Value:abnormal
ECG NCT03860870 181 184 B-Procedure-Name

- NCT03860870 187 188 O
Steroid NCT03860870 190 197 B-Condition-Name
abuse NCT03860870 198 203 I-Condition-Name

- NCT03860870 206 207 O
Ongoing NCT03860870 209 216 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03860870 217 220 O
of NCT03860870 221 223 O
prescription NCT03860870 224 236 O
medication NCT03860870 237 247 O

- NCT03860870 250 251 O
heavy NCT03860870 253 258 B-Severity___Severity-Value:severe
resistance NCT03860870 259 269 B-Observation-Name___Observation-Type-Value:social-habit
training NCT03860870 270 278 I-Observation-Name___Observation-Type-Value:social-habit
more NCT03860870 279 283 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03860870 284 288 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03860870 290 291 B-Eq-Value
times NCT03860870 292 297 O
weekly NCT03860870 298 304 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03860870 307 308 O
Disease NCT03860870 310 317 B-Condition-Name
deemed NCT03860870 318 324 O
by NCT03860870 325 327 O
the NCT03860870 328 331 O
MD NCT03860870 332 334 O
to NCT03860870 335 337 O
infer NCT03860870 338 343 B-Stability___Stability-Value:change
a NCT03860870 344 345 O
risk NCT03860870 346 350 O
to NCT03860870 351 353 O
participate NCT03860870 354 365 O
in NCT03860870 366 368 O
the NCT03860870 369 372 O
trial NCT03860870 373 378 O

Inclusion NCT03868592 0 9 O
Criteria NCT03868592 10 18 O
: NCT03868592 19 20 O

- NCT03868592 24 25 O
BMI NCT03868592 27 30 B-Observation-Name___Observation-Type-Value:vital
40 NCT03868592 32 34 B-Eq-Value
- NCT03868592 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03868592 38 40 B-Eq-Value
kg NCT03868592 41 43 B-Eq-Unit
/ NCT03868592 44 45 O
m NCT03868592 46 47 B-Eq-Unit
2 NCT03868592 48 49 I-Eq-Unit
. NCT03868592 49 50 O

- NCT03868592 54 55 O
Mo NCT03868592 57 59 O
active NCT03868592 60 66 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
physical NCT03868592 67 75 B-Condition-Name
illness NCT03868592 76 83 I-Condition-Name
that NCT03868592 84 88 O
would NCT03868592 89 94 O
interfere NCT03868592 95 104 B-Stability___Stability-Value:change
with NCT03868592 105 109 O
mobility NCT03868592 110 118 B-Condition-Name
or NCT03868592 119 121 O
weight NCT03868592 122 128 B-Condition-Name
loss NCT03868592 129 133 I-Condition-Name
after NCT03868592 134 139 O
bariatric NCT03868592 140 149 B-Procedure-Name
surgery NCT03868592 150 157 I-Procedure-Name

Exclusion NCT03868592 158 167 O
Criteria NCT03868592 168 176 O
: NCT03868592 177 178 O

- NCT03868592 182 183 O
Type NCT03868592 185 189 O
1 NCT03868592 191 192 O
or NCT03868592 193 195 O
Type NCT03868592 196 200 O
2 NCT03868592 202 203 O
Diabetes NCT03868592 204 212 B-Condition-Name
diagnosis NCT03868592 213 222 O
or NCT03868592 223 225 O
fasting NCT03868592 226 233 O
plasma NCT03868592 234 240 B-Observation-Name___Observation-Type-Value:lab
glucose NCT03868592 241 248 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03868592 249 250 B-Eq-Operator___Eq-Operator-Value:GTEQ
126 NCT03868592 252 255 B-Eq-Value
mg NCT03868592 256 258 B-Eq-Unit
/ NCT03868592 259 260 O
dL NCT03868592 261 263 B-Eq-Unit

- NCT03868592 266 267 O
Active NCT03868592 269 275 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
coronary NCT03868592 276 284 B-Condition-Name
artery NCT03868592 285 291 I-Condition-Name
disease NCT03868592 292 299 I-Condition-Name

- NCT03868592 302 303 O
Participation NCT03868592 305 318 O
in NCT03868592 319 321 O
structured NCT03868592 322 332 B-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03868592 333 341 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03868592 342 343 O
> NCT03868592 345 346 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03868592 348 349 B-Eq-Value
times NCT03868592 350 355 O
per NCT03868592 356 359 O
week NCT03868592 360 364 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
for NCT03868592 365 368 O
30 NCT03868592 370 372 B-Eq-Value
minutes NCT03868592 373 380 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
or NCT03868592 381 383 B-Eq-Operator___Eq-Operator-Value:GTEQ
longer NCT03868592 384 390 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03868592 391 392 O

- NCT03868592 396 397 O
Smoking NCT03868592 399 406 B-Condition-Name

- NCT03868592 409 410 O
Medications NCT03868592 412 423 O
known NCT03868592 424 429 O
to NCT03868592 430 432 O
affect NCT03868592 433 439 B-Stability___Stability-Value:change
adipose NCT03868592 440 447 B-Condition-Name
tissue NCT03868592 448 454 I-Condition-Name
metabolism NCT03868592 455 465 I-Condition-Name
( NCT03868592 466 467 O
e NCT03868592 468 469 O
. NCT03868592 470 471 O
g NCT03868592 472 473 O
. NCT03868592 474 475 O
, NCT03868592 476 477 O
beta NCT03868592 478 482 B-Drug-Name
blockers NCT03868592 483 491 I-Drug-Name
, NCT03868592 492 493 O
corticosteroids NCT03868592 494 509 B-Drug-Name
) NCT03868592 510 511 O

- NCT03868592 515 516 O
Renal NCT03868592 518 523 B-Condition-Name
insufficiency NCT03868592 524 537 I-Condition-Name
( NCT03868592 538 539 O
serum NCT03868592 540 545 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03868592 546 556 I-Observation-Name___Observation-Type-Value:lab
> NCT03868592 557 558 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03868592 560 563 B-Eq-Value
mg NCT03868592 564 566 B-Eq-Unit
/ NCT03868592 567 568 O
dl NCT03868592 569 571 B-Eq-Unit
) NCT03868592 572 573 O

- NCT03868592 577 578 O
Chronic NCT03868592 580 587 O
active NCT03868592 588 594 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
liver NCT03868592 595 600 B-Condition-Name
disease NCT03868592 601 608 I-Condition-Name
( NCT03868592 609 610 O
Bilirubin NCT03868592 611 620 B-Observation-Name___Observation-Type-Value:lab
> NCT03868592 621 622 B-Eq-Operator___Eq-Operator-Value:GT
17 NCT03868592 624 626 B-Eq-Value
mmol NCT03868592 627 631 B-Eq-Unit
/ NCT03868592 632 633 O
L NCT03868592 634 635 B-Eq-Unit
, NCT03868592 636 637 O
AST NCT03868592 638 641 B-Observation-Name___Observation-Type-Value:lab
> NCT03868592 642 643 B-Eq-Operator___Eq-Operator-Value:GT
144 NCT03868592 645 648 B-Eq-Value
IU NCT03868592 649 651 B-Eq-Unit
/ NCT03868592 652 653 O
L NCT03868592 654 655 B-Eq-Unit
, NCT03868592 656 657 O
or NCT03868592 658 660 O
ALT NCT03868592 661 664 B-Observation-Name
> NCT03868592 665 666 B-Eq-Operator___Eq-Operator-Value:GT
165 NCT03868592 668 671 B-Eq-Value
IU NCT03868592 672 674 B-Eq-Unit
/ NCT03868592 675 676 O
L NCT03868592 677 678 B-Eq-Unit
) NCT03868592 679 680 O

- NCT03868592 684 685 O
Pregnancy NCT03868592 687 696 B-Condition-Name
or NCT03868592 697 699 O
breastfeeding NCT03868592 700 713 B-Condition-Name
. NCT03868592 714 715 O

Inclusion NCT03866226 0 9 O
Criteria NCT03866226 10 18 O
: NCT03866226 19 20 O

1 NCT03866226 25 26 O
. NCT03866226 26 27 O
Signed NCT03866226 29 35 O
written NCT03866226 36 43 O
informed NCT03866226 44 52 O
consent NCT03866226 53 60 O

2 NCT03866226 64 65 O
. NCT03866226 65 66 O
Age NCT03866226 68 71 O
18 NCT03866226 73 75 B-Eq-Value
- NCT03866226 76 77 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03866226 79 81 B-Eq-Value
years NCT03866226 82 87 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

3 NCT03866226 91 92 O
. NCT03866226 92 93 O
Capable NCT03866226 95 102 O
of NCT03866226 103 105 O
understanding NCT03866226 106 119 O
the NCT03866226 120 123 O
test NCT03866226 124 128 B-Procedure-Name
and NCT03866226 129 132 O
cooperating NCT03866226 133 144 O
with NCT03866226 145 149 O
the NCT03866226 150 153 O
questionnaire NCT03866226 154 167 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
. NCT03866226 168 169 O

Exclusion NCT03866226 171 180 O
Criteria NCT03866226 181 189 O
: NCT03866226 190 191 O

1 NCT03866226 196 197 O
. NCT03866226 197 198 O
History NCT03866226 200 207 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866226 208 210 O
psychosis NCT03866226 211 220 B-Condition-Name
, NCT03866226 221 222 O
including NCT03866226 223 232 O
schizophrenia NCT03866226 233 246 B-Condition-Name
, NCT03866226 247 248 O
bipolar NCT03866226 249 256 B-Condition-Name
disorder NCT03866226 257 265 I-Condition-Name
, NCT03866226 266 267 O
depression NCT03866226 268 278 B-Condition-Name
, NCT03866226 279 280 O
anxiety NCT03866226 281 288 B-Condition-Name
, NCT03866226 289 290 O
obsessive NCT03866226 291 300 B-Condition-Name
- NCT03866226 301 302 I-Condition-Name
compulsive NCT03866226 303 313 I-Condition-Name
disorder NCT03866226 314 322 I-Condition-Name
, NCT03866226 323 324 O
phobia NCT03866226 325 331 B-Condition-Name
, NCT03866226 332 333 O
somatoform NCT03866226 334 344 B-Condition-Name
disorder NCT03866226 345 353 I-Condition-Name
, NCT03866226 354 355 O
stress NCT03866226 356 362 B-Condition-Name
- NCT03866226 363 364 I-Condition-Name
related NCT03866226 365 372 I-Condition-Name
disorders NCT03866226 373 382 I-Condition-Name

2 NCT03866226 386 387 O
. NCT03866226 387 388 O
History NCT03866226 390 397 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866226 398 400 O
insomnia NCT03866226 401 409 B-Condition-Name
, NCT03866226 410 411 O
currently NCT03866226 412 421 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
with NCT03866226 422 426 O
medication NCT03866226 427 437 O

3 NCT03866226 441 442 O
. NCT03866226 442 443 O
History NCT03866226 445 452 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866226 453 455 O
obstructive NCT03866226 456 467 B-Condition-Name
sleep NCT03866226 468 473 I-Condition-Name
apnea NCT03866226 474 479 I-Condition-Name
( NCT03866226 480 481 O
OSA NCT03866226 482 485 B-Condition-Name
) NCT03866226 486 487 O

4 NCT03866226 492 493 O
. NCT03866226 493 494 O
History NCT03866226 496 503 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866226 504 506 O
other NCT03866226 507 512 O
sleep NCT03866226 513 518 B-Condition-Name
disorders NCT03866226 519 528 I-Condition-Name
, NCT03866226 529 530 O
including NCT03866226 531 540 O
narcolepsy NCT03866226 541 551 B-Condition-Name
/ NCT03866226 552 553 O
hypersomnias NCT03866226 554 566 B-Condition-Name
, NCT03866226 567 568 O
circadian NCT03866226 569 578 B-Condition-Name
rhythm NCT03866226 579 585 I-Condition-Name
sleep NCT03866226 586 591 I-Condition-Name
disorder NCT03866226 592 600 I-Condition-Name
, NCT03866226 601 602 O
parasomnias NCT03866226 603 614 B-Condition-Name
, NCT03866226 615 616 O
sleep NCT03866226 617 622 O
- NCT03866226 623 624 O
related NCT03866226 625 632 O
dyskinesia NCT03866226 633 643 B-Condition-Name

5 NCT03866226 647 648 O
. NCT03866226 648 649 O
History NCT03866226 651 658 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866226 659 661 O
heart NCT03866226 662 667 B-Condition-Name
failure NCT03866226 668 675 I-Condition-Name
, NCT03866226 676 677 O
that NCT03866226 678 682 O
is NCT03866226 683 685 O
New NCT03866226 686 689 B-Condition-Name
York NCT03866226 690 694 I-Condition-Name
heart NCT03866226 695 700 I-Condition-Name
association NCT03866226 701 712 I-Condition-Name
( NCT03866226 713 714 O
NYHA NCT03866226 715 719 B-Condition-Name
) NCT03866226 720 721 O
Class NCT03866226 722 727 B-Eq-Unit
Ⅲ NCT03866226 728 729 B-Eq-Value
- NCT03866226 730 731 B-Eq-Operator___Eq-Operator-Value:BETWEEN
Ⅳ NCT03866226 732 733 B-Eq-Value

6 NCT03866226 737 738 O
. NCT03866226 738 739 O
History NCT03866226 741 748 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866226 749 751 O
atrial NCT03866226 752 758 B-Condition-Name
fibrillation NCT03866226 759 771 I-Condition-Name
and NCT03866226 772 775 O
frequent NCT03866226 776 784 O
atrial NCT03866226 785 791 O
or NCT03866226 792 794 O
ventricular NCT03866226 795 806 O
extrasystoles NCT03866226 807 820 B-Condition-Name

7 NCT03866226 824 825 O
. NCT03866226 825 826 O
Ongoing NCT03866226 828 835 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03866226 836 845 O
or NCT03866226 846 848 O
alcohol NCT03866226 849 856 O
abuse NCT03866226 857 862 B-Condition-Name

8 NCT03866226 866 867 O
. NCT03866226 867 868 O
Currently NCT03866226 870 879 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
receiving NCT03866226 880 889 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
sedative NCT03866226 890 898 B-Drug-Name
hypnotic NCT03866226 899 907 I-Drug-Name
medication NCT03866226 908 918 I-Drug-Name
within NCT03866226 919 925 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03866226 927 928 B-Eq-Value
week NCT03866226 929 933 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

9 NCT03866226 937 938 O
. NCT03866226 938 939 O
Pregnant NCT03866226 941 949 B-Condition-Name
women NCT03866226 950 955 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

10 NCT03866226 958 960 O
. NCT03866226 960 961 O
Ongoing NCT03866226 963 970 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
involvement NCT03866226 971 982 O
in NCT03866226 983 985 O
night NCT03866226 986 991 B-Observation-Name
- NCT03866226 992 993 I-Observation-Name
shift NCT03866226 994 999 I-Observation-Name
work NCT03866226 1000 1004 I-Observation-Name
( NCT03866226 1005 1006 O
22 NCT03866226 1008 1010 B-Eq-Value
: NCT03866226 1011 1012 I-Eq-Value
00 NCT03866226 1014 1016 I-Eq-Value
- NCT03866226 1017 1018 B-Eq-Operator___Eq-Operator-Value:BETWEEN
6 NCT03866226 1020 1021 B-Eq-Value
: NCT03866226 1022 1023 I-Eq-Value
00 NCT03866226 1025 1027 I-Eq-Value
) NCT03866226 1028 1029 O
within NCT03866226 1030 1036 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03866226 1038 1039 B-Eq-Value
week NCT03866226 1040 1044 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

11 NCT03866226 1047 1049 O
. NCT03866226 1049 1050 O
Ongoing NCT03866226 1052 1059 O
need NCT03866226 1060 1064 O
of NCT03866226 1065 1067 O
care NCT03866226 1068 1072 B-Procedure-Name
of NCT03866226 1073 1075 O
families NCT03866226 1076 1084 O
at NCT03866226 1085 1087 O
home NCT03866226 1088 1092 O
that NCT03866226 1093 1097 O
wake NCT03866226 1098 1102 B-Condition-Name
during NCT03866226 1103 1109 I-Condition-Name
the NCT03866226 1110 1113 I-Condition-Name
night NCT03866226 1114 1119 I-Condition-Name
within NCT03866226 1120 1126 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03866226 1128 1129 B-Eq-Value
week NCT03866226 1130 1134 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

12 NCT03866226 1137 1139 O
. NCT03866226 1139 1140 O
Incomprehensible NCT03866226 1142 1158 O
or NCT03866226 1159 1161 O
unwilling NCT03866226 1162 1171 O
to NCT03866226 1172 1174 O
fill NCT03866226 1175 1179 O
in NCT03866226 1180 1182 O
informed NCT03866226 1183 1191 O
consent NCT03866226 1192 1199 O
or NCT03866226 1200 1202 O
questionnaire NCT03866226 1203 1216 O

Inclusion NCT03868579 0 9 O
Criteria NCT03868579 10 18 O
: NCT03868579 19 20 O

- NCT03868579 24 25 O
Patients NCT03868579 27 35 O
who NCT03868579 36 39 O
will NCT03868579 40 44 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03868579 45 52 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
pleuroscopy NCT03868579 53 64 B-Procedure-Name
with NCT03868579 65 69 O
biopsy NCT03868579 70 76 B-Procedure-Name

Exclusion NCT03868579 77 86 O
Criteria NCT03868579 87 95 O
: NCT03868579 96 97 O

- NCT03868579 101 102 O
Patients NCT03868579 104 112 O
with NCT03868579 113 117 O
known NCT03868579 118 123 O
malignant NCT03868579 124 133 O
pleural NCT03868579 134 141 B-Condition-Name
effusion NCT03868579 142 150 I-Condition-Name

- NCT03868579 153 154 O
Inability NCT03868579 156 165 O
or NCT03868579 166 168 O
unwillingness NCT03868579 169 182 O
to NCT03868579 183 185 O
give NCT03868579 186 190 O
informed NCT03868579 191 199 O
consent NCT03868579 200 207 O

Resident NCT03861429 0 8 O
Inclusion NCT03861429 9 18 O
Criteria NCT03861429 19 27 O
: NCT03861429 28 29 O

- NCT03861429 33 34 O
Identified NCT03861429 36 46 O
as NCT03861429 47 49 O
having NCT03861429 50 56 O
Alzheimer NCT03861429 57 66 B-Condition-Name
's NCT03861429 66 68 I-Condition-Name
or NCT03861429 69 71 O
related NCT03861429 72 79 O
dementia NCT03861429 80 88 B-Condition-Name

- NCT03861429 91 92 O
Mild NCT03861429 94 98 B-Severity___Severity-Value:mild
to NCT03861429 99 101 B-Eq-Operator___Eq-Operator-Value:BETWEEN
moderate NCT03861429 102 110 B-Severity___Severity-Value:moderate
cognitive NCT03861429 111 120 B-Condition-Name
impairment NCT03861429 121 131 I-Condition-Name
( NCT03861429 132 133 O
BIMS NCT03861429 134 138 B-Observation-Name
= NCT03861429 139 140 B-Eq-Operator___Eq-Operator-Value:EQ
8 NCT03861429 142 143 B-Eq-Value
- NCT03861429 144 145 B-Eq-Operator___Eq-Operator-Value:BETWEEN
15 NCT03861429 147 149 B-Eq-Value
, NCT03861429 150 151 O
( NCT03861429 152 153 O
MDS NCT03861429 154 157 B-Observation-Code
C NCT03861429 158 159 I-Observation-Code
0500 NCT03861429 160 164 I-Observation-Code
) NCT03861429 165 166 O
( NCT03861429 167 168 O
nursing NCT03861429 169 176 B-Location___Location-Value:residence
home NCT03861429 177 181 I-Location___Location-Value:residence
residents NCT03861429 182 191 O
only NCT03861429 192 196 O
) NCT03861429 197 198 O

- NCT03861429 202 203 O
Makes NCT03861429 205 210 B-Observation-Name
Self NCT03861429 211 215 I-Observation-Name
Understood NCT03861429 216 226 I-Observation-Name
= NCT03861429 227 228 B-Eq-Operator___Eq-Operator-Value:EQ
< NCT03861429 229 230 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03861429 232 233 B-Eq-Value
( NCT03861429 234 235 O
MDS NCT03861429 236 239 B-Observation-Code
B NCT03861429 240 241 I-Observation-Code
0700 NCT03861429 242 246 I-Observation-Code
) NCT03861429 247 248 O
/ NCT03861429 250 251 O
present NCT03861429 252 259 O
in NCT03861429 260 262 O
medical NCT03861429 263 270 O
record NCT03861429 271 277 O

- NCT03861429 280 281 O
Understood NCT03861429 283 293 B-Observation-Name
By NCT03861429 294 296 I-Observation-Name
Others NCT03861429 297 303 I-Observation-Name
= NCT03861429 304 305 B-Eq-Operator___Eq-Operator-Value:EQ
< NCT03861429 306 307 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03861429 309 310 B-Eq-Value
( NCT03861429 311 312 O
MDS NCT03861429 313 316 B-Observation-Code
B NCT03861429 317 318 I-Observation-Code
0800 NCT03861429 319 323 I-Observation-Code
) NCT03861429 324 325 O
/ NCT03861429 327 328 O
present NCT03861429 329 336 O
in NCT03861429 337 339 O
medical NCT03861429 340 347 O
record NCT03861429 348 354 O

- NCT03861429 357 358 O
Reside NCT03861429 360 366 O
at NCT03861429 367 369 O
the NCT03861429 370 373 O
facility NCT03861429 374 382 B-Location___Location-Value:hospital
at NCT03861429 383 385 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03861429 386 391 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03861429 393 394 B-Eq-Value
weeks NCT03861429 395 400 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
identified NCT03861429 401 411 O
as NCT03861429 412 414 O
a NCT03861429 415 416 O
long NCT03861429 417 421 B-Observation-Name
- NCT03861429 422 423 I-Observation-Name
term NCT03861429 424 428 I-Observation-Name
resident NCT03861429 429 437 I-Observation-Name

- NCT03861429 440 441 O
Age NCT03861429 443 446 O
> NCT03861429 447 448 B-Eq-Operator___Eq-Operator-Value:GT
65 NCT03861429 450 452 B-Eq-Value
years NCT03861429 453 458 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861429 461 462 O
Speaks NCT03861429 464 470 O
English NCT03861429 471 478 B-Language

Family NCT03861429 479 485 O
Inclusion NCT03861429 486 495 O
Criteria NCT03861429 496 504 O
: NCT03861429 505 506 O

- NCT03861429 510 511 O
Speaks NCT03861429 513 519 O
English NCT03861429 520 527 B-Language

- NCT03861429 530 531 O
Willing NCT03861429 533 540 O
and NCT03861429 541 544 O
able NCT03861429 545 549 O
to NCT03861429 550 552 O
watch NCT03861429 553 558 O
the NCT03861429 559 562 O
videos NCT03861429 563 569 O

- NCT03861429 572 573 O
Willing NCT03861429 575 582 O
to NCT03861429 583 585 O
complete NCT03861429 586 594 O
short NCT03861429 595 600 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
surveys NCT03861429 601 608 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
. NCT03861429 609 610 O
Being NCT03861429 612 617 O
unable NCT03861429 618 624 O
to NCT03861429 625 627 O
attend NCT03861429 628 634 O
care NCT03861429 635 639 O
conference NCT03861429 640 650 O
to NCT03861429 651 653 O
view NCT03861429 654 658 O
the NCT03861429 659 662 O
video NCT03861429 663 668 O
( NCT03861429 669 670 O
e NCT03861429 671 672 O
. NCT03861429 673 674 O
g NCT03861429 675 676 O
. NCT03861429 677 678 O
due NCT03861429 680 683 O
to NCT03861429 684 686 O
distance NCT03861429 687 695 O
) NCT03861429 696 697 O
will NCT03861429 698 702 O
not NCT03861429 703 706 O
exclude NCT03861429 707 714 O
family NCT03861429 715 721 O
from NCT03861429 722 726 O
participating NCT03861429 727 740 O
. NCT03861429 741 742 O

Staff NCT03861429 744 749 O
Inclusion NCT03861429 750 759 O
Criteria NCT03861429 760 768 O
: NCT03861429 769 770 O

- NCT03861429 774 775 O
Speaks NCT03861429 777 783 O
English NCT03861429 784 791 B-Language

- NCT03861429 794 795 O
Willing NCT03861429 797 804 O
to NCT03861429 805 807 O
watch NCT03861429 808 813 O
the NCT03861429 814 817 O
videos NCT03861429 818 824 O

- NCT03861429 827 828 O
Willing NCT03861429 830 837 O
to NCT03861429 838 840 O
complete NCT03861429 841 849 O
short NCT03861429 850 855 O
surveys NCT03861429 856 863 O

Resident NCT03861429 864 872 O
Exclusion NCT03861429 873 882 O
Criteria NCT03861429 883 891 O
: NCT03861429 892 893 O

- NCT03861429 897 898 O
Limited NCT03861429 900 907 B-Polarity___Polarity-Value:low
communication NCT03861429 908 921 B-Condition-Name
capacity NCT03861429 922 930 I-Condition-Name
( NCT03861429 931 932 O
e NCT03861429 933 934 O
. NCT03861429 935 936 O
g NCT03861429 937 938 O
. NCT03861429 939 940 O
aphasia NCT03861429 942 949 B-Condition-Name
) NCT03861429 950 951 O

- NCT03861429 955 956 O
Comatose NCT03861429 958 966 B-Condition-Name

- NCT03861429 969 970 O
Cognitively NCT03861429 972 983 B-Condition-Name
intact NCT03861429 984 990 I-Condition-Name

- NCT03861429 993 994 O
Severe NCT03861429 996 1002 B-Severity___Severity-Value:severe
cognitive NCT03861429 1003 1012 B-Condition-Name
impairment NCT03861429 1013 1023 I-Condition-Name

Inclusion NCT03867058 0 9 O
Criteria NCT03867058 10 18 O
: NCT03867058 19 20 O

- NCT03867058 24 25 O
Native NCT03867058 27 33 O
speakers NCT03867058 34 42 O
of NCT03867058 43 45 O
English NCT03867058 46 53 B-Language

- NCT03867058 56 57 O
Cochlear NCT03867058 59 67 B-Procedure-Name
Nucleus NCT03867058 68 75 I-Procedure-Name
cochlear NCT03867058 76 84 I-Procedure-Name
implant NCT03867058 85 92 I-Procedure-Name
users NCT03867058 93 98 O
or NCT03867058 99 101 O
Advanced NCT03867058 102 110 B-Procedure-Name
Bionics NCT03867058 111 118 I-Procedure-Name
users NCT03867058 119 124 O

- NCT03867058 127 128 O
Postlingually NCT03867058 130 143 O
deafened NCT03867058 144 152 B-Condition-Name

- NCT03867058 155 156 O
Has NCT03867058 158 161 O
had NCT03867058 162 165 O
device NCT03867058 166 172 B-Procedure-Name
experience NCT03867058 173 183 O
for NCT03867058 184 187 O
at NCT03867058 188 190 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867058 191 196 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03867058 197 200 B-Eq-Value
year NCT03867058 201 205 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867058 208 209 O
Can NCT03867058 211 214 O
be NCT03867058 215 217 O
child NCT03867058 218 223 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
or NCT03867058 224 226 O
adult NCT03867058 227 232 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
at NCT03867058 233 235 O
the NCT03867058 236 239 O
time NCT03867058 240 244 O
of NCT03867058 245 247 O
enrollment NCT03867058 248 258 O

Exclusion NCT03867058 259 268 O
Criteria NCT03867058 269 277 O
: NCT03867058 278 279 O

- NCT03867058 283 284 O
None NCT03867058 286 290 O

Inclusion NCT03868800 0 9 O
Criteria NCT03868800 10 18 O
: NCT03868800 19 20 O

- NCT03868800 24 25 O
Estimated NCT03868800 27 36 B-Observation-Name___Observation-Type-Value:lab
glomerular NCT03868800 37 47 I-Observation-Name___Observation-Type-Value:lab
filtration NCT03868800 48 58 I-Observation-Name___Observation-Type-Value:lab
rate NCT03868800 59 63 I-Observation-Name___Observation-Type-Value:lab
below NCT03868800 64 69 B-Eq-Operator___Eq-Operator-Value:LT
20 NCT03868800 71 73 B-Eq-Value
ml NCT03868800 74 76 B-Eq-Unit
/ NCT03868800 77 78 O
min NCT03868800 79 82 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

- NCT03868800 85 86 O
A NCT03868800 88 89 O
clinical NCT03868800 90 98 O
judgement NCT03868800 99 108 O
made NCT03868800 109 113 O
by NCT03868800 114 116 O
the NCT03868800 117 120 O
contact NCT03868800 121 128 O
nurse NCT03868800 129 134 O
and NCT03868800 135 138 O
the NCT03868800 139 142 O
contact NCT03868800 143 150 O
physician NCT03868800 151 160 O

Exclusion NCT03868800 161 170 O
Criteria NCT03868800 171 179 O
: NCT03868800 180 181 O

- NCT03868800 185 186 O
Conservative NCT03868800 188 200 B-Procedure-Name
care NCT03868800 201 205 I-Procedure-Name

- NCT03868800 208 209 O
A NCT03868800 211 212 O
set NCT03868800 213 216 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
date NCT03868800 217 221 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03868800 222 225 O
a NCT03868800 226 227 O
transplantation NCT03868800 228 243 B-Procedure-Name
with NCT03868800 244 248 O
a NCT03868800 249 250 O
living NCT03868800 251 257 O
donor NCT03868800 258 263 O

- NCT03868800 266 267 O
Not NCT03868800 269 272 O
able NCT03868800 273 277 O
to NCT03868800 278 280 O
participate NCT03868800 281 292 O
due NCT03868800 293 296 O
to NCT03868800 297 299 O
cognitive NCT03868800 300 309 B-Condition-Name
impairment NCT03868800 310 320 I-Condition-Name

Inclusion NCT03866811 0 9 O
Criteria NCT03866811 10 18 O
: NCT03866811 19 20 O

- NCT03866811 24 25 O
female NCT03866811 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
emergency NCT03866811 34 43 B-Encounter-Type___Encounter-Type-Value:emergency
department NCT03866811 44 54 I-Encounter-Type___Encounter-Type-Value:emergency
patient NCT03866811 55 62 O

- NCT03866811 65 66 O
age NCT03866811 68 71 O
14 NCT03866811 73 75 B-Eq-Value
- NCT03866811 76 77 B-Eq-Operator___Eq-Operator-Value:BETWEEN
19 NCT03866811 79 81 B-Eq-Value
years NCT03866811 82 87 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866811 90 91 O
sexually NCT03866811 93 101 B-Condition-Name
active NCT03866811 102 108 I-Condition-Name
with NCT03866811 109 113 O
males NCT03866811 114 119 O
in NCT03866811 120 122 O
the NCT03866811 123 126 O
past NCT03866811 127 131 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03866811 133 134 B-Eq-Value
months NCT03866811 135 141 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Exclusion NCT03866811 142 151 O
Criteria NCT03866811 152 160 O
: NCT03866811 161 162 O

- NCT03866811 166 167 O
currently NCT03866811 169 178 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
using NCT03866811 179 184 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03866811 185 188 O
effective NCT03866811 189 198 O
form NCT03866811 199 203 O
of NCT03866811 204 206 O
contraception NCT03866811 207 220 B-Procedure-Name

- NCT03866811 223 224 O
do NCT03866811 226 228 O
not NCT03866811 229 232 O
own NCT03866811 233 236 O
a NCT03866811 237 238 O
mobile NCT03866811 239 245 O
phone NCT03866811 246 251 O
with NCT03866811 252 256 O
texting NCT03866811 257 264 O

- NCT03866811 267 268 O
are NCT03866811 270 273 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnant NCT03866811 274 282 B-Condition-Name

- NCT03866811 285 286 O
are NCT03866811 288 291 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
too NCT03866811 292 295 O
ill NCT03866811 296 299 B-Condition-Name
for NCT03866811 300 303 O
participation NCT03866811 304 317 O
per NCT03866811 318 321 O
the NCT03866811 322 325 O
attending NCT03866811 326 335 B-Provider-Role
physician NCT03866811 336 345 I-Provider-Role

- NCT03866811 348 349 O
are NCT03866811 351 354 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cognitively NCT03866811 355 366 B-Condition-Name
impaired NCT03866811 367 375 I-Condition-Name

- NCT03866811 378 379 O
do NCT03866811 381 383 O
not NCT03866811 384 387 O
live NCT03866811 388 392 O
locally NCT03866811 393 400 B-Location___Location-Value:residence

- NCT03866811 403 404 O
do NCT03866811 406 408 O
not NCT03866811 409 412 O
speak NCT03866811 413 418 O
English NCT03866811 419 426 B-Language

- NCT03866811 429 430 O
want NCT03866811 432 436 O
to NCT03866811 437 439 O
" NCT03866811 440 441 O
become NCT03866811 441 447 O
pregnant NCT03866811 448 456 B-Condition-Name
in NCT03866811 457 459 O
the NCT03866811 460 463 O
next NCT03866811 464 468 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
year NCT03866811 469 473 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
" NCT03866811 473 474 O

Inclusion NCT03865459 0 9 O
Criteria NCT03865459 10 18 O
: NCT03865459 19 20 O

- NCT03865459 24 25 O
age NCT03865459 27 30 O
> NCT03865459 31 32 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03865459 34 36 B-Eq-Value
years NCT03865459 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03865459 45 46 O
female NCT03865459 48 54 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
gender NCT03865459 55 61 O

- NCT03865459 64 65 O
rigid NCT03865459 67 72 O
cystoscopy NCT03865459 73 83 B-Procedure-Name
for NCT03865459 84 87 O
the NCT03865459 88 91 O
first NCT03865459 92 97 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
time NCT03865459 98 102 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time

Exclusion NCT03865459 103 112 O
Criteria NCT03865459 113 121 O
: NCT03865459 122 123 O

- NCT03865459 127 128 O
presence NCT03865459 130 138 O
of NCT03865459 139 141 O
any NCT03865459 142 145 O
contraindication NCT03865459 146 162 O
for NCT03865459 163 166 O
cystoscopy NCT03865459 167 177 B-Procedure-Name
( NCT03865459 178 179 O
such NCT03865459 180 184 O
as NCT03865459 185 187 O
lidocaine NCT03865459 188 197 B-Drug-Name
allergy NCT03865459 198 205 O
, NCT03865459 206 207 O
urinary NCT03865459 208 215 B-Condition-Name
tract NCT03865459 216 221 I-Condition-Name
infection NCT03865459 222 231 I-Condition-Name
, NCT03865459 232 233 O
and NCT03865459 234 237 O
urethra NCT03865459 238 245 O
- NCT03865459 246 247 O
related NCT03865459 248 255 O
anatomical NCT03865459 256 266 B-Condition-Name
disorders NCT03865459 267 276 I-Condition-Name
) NCT03865459 277 278 O

- NCT03865459 282 283 O
any NCT03865459 285 288 O
analgesic NCT03865459 289 298 B-Drug-Name
used NCT03865459 299 303 O
24 NCT03865459 305 307 B-Eq-Value
hours NCT03865459 308 313 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
before NCT03865459 314 320 O
cystoscopy NCT03865459 321 331 B-Procedure-Name

- NCT03865459 334 335 O
manipulations NCT03865459 337 350 B-Procedure-Name
such NCT03865459 351 355 O
as NCT03865459 356 358 O
Double NCT03865459 359 365 B-Procedure-Name
- NCT03865459 366 367 I-Procedure-Name
J NCT03865459 368 369 I-Procedure-Name
stent NCT03865459 370 375 I-Procedure-Name
placement NCT03865459 376 385 O
or NCT03865459 386 388 O
removal NCT03865459 389 396 O
, NCT03865459 397 398 O
and NCT03865459 399 402 O
/ NCT03865459 403 404 O
or NCT03865459 405 407 O
bladder NCT03865459 408 415 O
biopsy NCT03865459 416 422 B-Procedure-Name
. NCT03865459 423 424 O

Inclusion NCT03865303 0 9 O
Criteria NCT03865303 10 18 O

- NCT03865303 21 22 O
For NCT03865303 24 27 O
EMR NCT03865303 28 31 O
review NCT03865303 32 38 O
all NCT03865303 39 42 O
adults NCT03865303 43 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
admitted NCT03865303 50 58 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03865303 59 61 O
the NCT03865303 62 65 O
hospital NCT03865303 66 74 B-Location___Location-Value:hospital
ages NCT03865303 75 79 O
18 NCT03865303 81 83 B-Eq-Value
and NCT03865303 84 87 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865303 88 93 I-Eq-Operator___Eq-Operator-Value:GTEQ
with NCT03865303 94 98 O
research NCT03865303 99 107 O
authorization NCT03865303 108 121 O

- NCT03865303 124 125 O
For NCT03865303 127 130 O
survey NCT03865303 131 137 O
- NCT03865303 138 139 O
clinicians NCT03865303 140 150 O
including NCT03865303 151 160 O
physicians NCT03865303 161 171 B-Provider-Role
, NCT03865303 172 173 O
advanced NCT03865303 174 182 B-Provider-Role
care NCT03865303 183 187 I-Provider-Role
practitioners NCT03865303 188 201 I-Provider-Role

- NCT03865303 204 205 O
For NCT03865303 207 210 O
focus NCT03865303 211 216 O
groups NCT03865303 217 223 O
and NCT03865303 224 227 O
interviews NCT03865303 228 238 O
- NCT03865303 239 240 O
clinicians NCT03865303 241 251 O
including NCT03865303 252 261 O
physicians NCT03865303 262 272 B-Provider-Role
, NCT03865303 273 274 O
advanced NCT03865303 275 283 B-Provider-Role
care NCT03865303 284 288 I-Provider-Role
practitioners NCT03865303 289 302 I-Provider-Role

Exclusion NCT03865303 303 312 O
Criteria NCT03865303 313 321 O

- NCT03865303 324 325 O
Age NCT03865303 327 330 O
< NCT03865303 331 332 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03865303 334 336 B-Eq-Value
years NCT03865303 337 342 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03865303 343 346 O

- NCT03865303 349 350 O
No NCT03865303 352 354 O
research NCT03865303 355 363 O
authorization NCT03865303 364 377 O

- NCT03865303 380 381 O
Refusal NCT03865303 383 390 O
to NCT03865303 391 393 O
give NCT03865303 394 398 O
consent NCT03865303 399 406 O

Inclusion NCT03867266 0 9 O
criteria NCT03867266 10 18 O
: NCT03867266 19 20 O

- NCT03867266 24 25 O
paroxysmal NCT03867266 27 37 O
, NCT03867266 38 39 O
persistent NCT03867266 40 50 O
and NCT03867266 51 54 O
/ NCT03867266 55 56 O
or NCT03867266 57 59 O
long NCT03867266 60 64 O
standing NCT03867266 65 73 O
atrial NCT03867266 74 80 B-Condition-Name
flutter NCT03867266 81 88 I-Condition-Name
even NCT03867266 89 93 O
in NCT03867266 94 96 O
the NCT03867266 97 100 O
presence NCT03867266 101 109 O
of NCT03867266 110 112 O
structural NCT03867266 113 123 O
heart NCT03867266 124 129 B-Condition-Name
disease NCT03867266 130 137 I-Condition-Name

- NCT03867266 140 141 O
Informed NCT03867266 143 151 O
consent NCT03867266 152 159 O
form NCT03867266 160 164 O

- NCT03867266 167 168 O
Age NCT03867266 170 173 O
equal NCT03867266 174 179 B-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03867266 180 182 I-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03867266 183 188 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03867266 190 192 B-Eq-Value
years NCT03867266 193 198 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867266 201 202 O
Skilled NCT03867266 204 211 O
and NCT03867266 212 215 O
willing NCT03867266 216 223 O
to NCT03867266 224 226 O
comply NCT03867266 227 233 O
with NCT03867266 234 238 O
all NCT03867266 239 242 O
tests NCT03867266 243 248 B-Procedure-Name
and NCT03867266 249 252 O
follow NCT03867266 253 259 O
up NCT03867266 260 262 O
requirements NCT03867266 263 275 O

- NCT03867266 278 279 O
Patients NCT03867266 281 289 O
that NCT03867266 290 294 O
, NCT03867266 295 296 O
in NCT03867266 297 299 O
the NCT03867266 300 303 O
context NCT03867266 304 311 O
of NCT03867266 312 314 O
ablation NCT03867266 315 323 B-Procedure-Name
for NCT03867266 324 327 O
fibrillation NCT03867266 328 340 B-Condition-Name
atrial NCT03867266 341 347 I-Condition-Name
, NCT03867266 348 349 O
should NCT03867266 350 356 O
also NCT03867266 357 361 O
undergo NCT03867266 362 369 O
to NCT03867266 370 372 O
typical NCT03867266 373 380 O
flutter NCT03867266 381 388 B-Procedure-Name
ablation NCT03867266 389 397 I-Procedure-Name
: NCT03867266 398 399 O
in NCT03867266 400 402 O
this NCT03867266 403 407 O
case NCT03867266 408 412 O
the NCT03867266 413 416 O
data NCT03867266 417 421 O
collected NCT03867266 422 431 O
will NCT03867266 432 436 O
be NCT03867266 437 439 O
those NCT03867266 440 445 O
related NCT03867266 446 453 O
to NCT03867266 454 456 O
typical NCT03867266 457 464 O
flutter NCT03867266 465 472 B-Procedure-Name
ablation NCT03867266 473 481 I-Procedure-Name
. NCT03867266 482 483 O

Exclusion NCT03867266 485 494 O
Criteria NCT03867266 495 503 O
: NCT03867266 504 505 O

- NCT03867266 509 510 O
Previous NCT03867266 512 520 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ablation NCT03867266 521 529 B-Procedure-Name
for NCT03867266 530 533 O
atrial NCT03867266 534 540 B-Condition-Name
flutter NCT03867266 541 548 I-Condition-Name

- NCT03867266 551 552 O
Atrial NCT03867266 554 560 B-Condition-Name
flutter NCT03867266 561 568 I-Condition-Name
secondary NCT03867266 569 578 O
to NCT03867266 579 581 O
electrolyte NCT03867266 582 593 B-Condition-Name
imbalance NCT03867266 594 603 I-Condition-Name
, NCT03867266 604 605 O
thyroid NCT03867266 606 613 B-Condition-Name
disease NCT03867266 614 621 I-Condition-Name
or NCT03867266 622 624 O
to NCT03867266 625 627 O
a NCT03867266 628 629 O
reversible NCT03867266 630 640 O
or NCT03867266 641 643 O
non NCT03867266 644 647 O
- NCT03867266 648 649 O
cardiac NCT03867266 650 657 O
cause NCT03867266 658 663 O

- NCT03867266 666 667 O
severe NCT03867266 669 675 B-Severity___Severity-Value:severe
anemia NCT03867266 676 682 B-Condition-Name
, NCT03867266 683 684 O

- NCT03867266 688 689 O
sepsis NCT03867266 691 697 B-Condition-Name
in NCT03867266 698 700 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
progress NCT03867266 701 709 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present

- NCT03867266 712 713 O
Bypass NCT03867266 715 721 B-Procedure-Name
procedure NCT03867266 722 731 I-Procedure-Name
with NCT03867266 732 736 O
coronary NCT03867266 737 745 O
arterial NCT03867266 746 754 O
artery NCT03867266 755 761 O
in NCT03867266 762 764 O
the NCT03867266 765 768 O
last NCT03867266 769 773 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03867266 774 779 B-Eq-Value
months NCT03867266 780 786 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03867266 789 790 O
Pending NCT03867266 792 799 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
cardiac NCT03867266 800 807 B-Procedure-Name
transplantation NCT03867266 808 823 I-Procedure-Name
or NCT03867266 824 826 O
other NCT03867266 827 832 O
cardiac NCT03867266 833 840 B-Procedure-Name
surgery NCT03867266 841 848 I-Procedure-Name

- NCT03867266 851 852 O
Pregnant NCT03867266 854 862 B-Condition-Name
or NCT03867266 863 865 O
breastfeeding NCT03867266 866 879 B-Condition-Name
women NCT03867266 880 885 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03867266 888 889 O
Acute NCT03867266 891 896 B-Severity___Severity-Value:severe
disease NCT03867266 897 904 B-Condition-Name
or NCT03867266 905 907 O
active NCT03867266 908 914 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
systemic NCT03867266 915 923 O
infection NCT03867266 924 933 B-Condition-Name
or NCT03867266 934 936 O
sepsis NCT03867266 937 943 B-Condition-Name

- NCT03867266 946 947 O
Documented NCT03867266 949 959 O
left NCT03867266 960 964 O
atrial NCT03867266 965 971 B-Condition-Name
thrombus NCT03867266 972 980 I-Condition-Name

- NCT03867266 983 984 O
Unstable NCT03867266 986 994 B-Stability___Stability-Value:change
angina NCT03867266 995 1001 B-Condition-Name

- NCT03867266 1004 1005 O
Uncontrolled NCT03867266 1007 1019 O
heart NCT03867266 1020 1025 B-Condition-Name
failure NCT03867266 1026 1033 I-Condition-Name

- NCT03867266 1036 1037 O
Life NCT03867266 1039 1043 B-Observation-Name
expectancy NCT03867266 1044 1054 I-Observation-Name
of NCT03867266 1055 1057 O
less NCT03867266 1058 1062 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867266 1063 1067 I-Eq-Operator___Eq-Operator-Value:LT
12 NCT03867266 1069 1071 B-Eq-Value
months NCT03867266 1072 1078 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03867266 1081 1082 O
Registration NCT03867266 1084 1096 O
in NCT03867266 1097 1099 O
any NCT03867266 1100 1103 O
other NCT03867266 1104 1109 O
study NCT03867266 1110 1115 O
evaluating NCT03867266 1116 1126 O
another NCT03867266 1127 1134 O
device NCT03867266 1135 1141 O
or NCT03867266 1142 1144 O
medication NCT03867266 1145 1155 O

- NCT03867266 1158 1159 O
Presence NCT03867266 1161 1169 O
of NCT03867266 1170 1172 O
intramural NCT03867266 1173 1183 B-Condition-Name
thrombi NCT03867266 1184 1191 I-Condition-Name
, NCT03867266 1192 1193 O
tumor NCT03867266 1194 1199 B-Condition-Name
or NCT03867266 1200 1202 O
other NCT03867266 1203 1208 O
anomalies NCT03867266 1209 1218 B-Condition-Name
that NCT03867266 1219 1223 O
preclude NCT03867266 1224 1232 O
the NCT03867266 1233 1236 O
introduction NCT03867266 1237 1249 O
of NCT03867266 1250 1252 O
the NCT03867266 1253 1256 O
catheter NCT03867266 1257 1265 B-Procedure-Name
into NCT03867266 1266 1270 O
the NCT03867266 1271 1274 O
vein NCT03867266 1275 1279 O
system NCT03867266 1280 1286 O

Inclusion NCT03867500 0 9 O
criteria NCT03867500 10 18 O
: NCT03867500 19 20 O

- NCT03867500 24 25 O
Women NCT03867500 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
and NCT03867500 33 36 O
Men NCT03867500 37 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
( NCT03867500 41 42 O
Women NCT03867500 43 48 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
premenopausal NCT03867500 49 62 B-Condition-Name
) NCT03867500 63 64 O

- NCT03867500 68 69 O
BMI NCT03867500 71 74 B-Observation-Name___Observation-Type-Value:vital
29 NCT03867500 76 78 B-Eq-Value
- NCT03867500 79 80 B-Eq-Operator___Eq-Operator-Value:BETWEEN
37 NCT03867500 82 84 B-Eq-Value

- NCT03867500 88 89 O
Weight NCT03867500 91 97 B-Observation-Name___Observation-Type-Value:vital
stable NCT03867500 98 104 B-Stability___Stability-Value:stable

- NCT03867500 107 108 O
Not NCT03867500 110 113 O
pregnant NCT03867500 114 122 B-Condition-Name
/ NCT03867500 123 124 O
nursing NCT03867500 125 132 B-Condition-Name

Exclusion NCT03867500 133 142 O
criteria NCT03867500 143 151 O
: NCT03867500 152 153 O

- NCT03867500 157 158 O
Ischemic NCT03867500 160 168 B-Condition-Name
heart NCT03867500 169 174 I-Condition-Name
disease NCT03867500 175 182 I-Condition-Name

- NCT03867500 185 186 O
Atherosclerotic NCT03867500 188 203 B-Condition-Name
valvular NCT03867500 204 212 I-Condition-Name
disease NCT03867500 213 220 I-Condition-Name

- NCT03867500 223 224 O
Smokers NCT03867500 226 233 B-Condition-Name
( NCT03867500 234 235 O
> NCT03867500 237 238 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03867500 240 242 B-Eq-Value
cigarettes NCT03867500 243 253 B-Eq-Unit
per NCT03867500 254 257 O
week NCT03867500 258 262 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03867500 263 264 O

- NCT03867500 268 269 O
Bilateral NCT03867500 271 280 O
oophorectomy NCT03867500 281 293 B-Procedure-Name

- NCT03867500 296 297 O
Concomitant NCT03867500 299 310 O
use NCT03867500 311 314 O
of NCT03867500 315 317 O
medications NCT03867500 318 329 O
that NCT03867500 330 334 O
can NCT03867500 335 338 O
alter NCT03867500 339 344 B-Stability___Stability-Value:change
serum NCT03867500 345 350 B-Observation-Name___Observation-Type-Value:lab
lipid NCT03867500 351 356 I-Observation-Name___Observation-Type-Value:lab
profile NCT03867500 357 364 I-Observation-Name___Observation-Type-Value:lab
: NCT03867500 365 366 O

- NCT03867500 375 376 O
High NCT03867500 378 382 B-Polarity___Polarity-Value:high
dose NCT03867500 383 387 O
fish NCT03867500 388 392 B-Drug-Name
oil NCT03867500 393 396 I-Drug-Name
( NCT03867500 397 398 O
> NCT03867500 400 401 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03867500 403 404 B-Eq-Value
g NCT03867500 405 406 B-Eq-Unit
per NCT03867500 407 410 O
day NCT03867500 411 414 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03867500 415 416 O
, NCT03867500 418 419 O

- NCT03867500 428 429 O
STATINS NCT03867500 431 438 B-Drug-Name
( NCT03867500 439 440 O
if NCT03867500 441 443 O
yes NCT03867500 444 447 O
hold NCT03867500 448 452 O
for NCT03867500 453 456 O
6 NCT03867500 458 459 B-Eq-Value
weeks NCT03867500 460 465 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
and NCT03867500 466 469 O
receive NCT03867500 470 477 O
PCP NCT03867500 478 481 B-Provider-Role
's NCT03867500 481 483 O
approval NCT03867500 484 492 B-Observation-Name
) NCT03867500 493 494 O
, NCT03867500 496 497 O

- NCT03867500 506 507 O
Niacin NCT03867500 509 515 B-Drug-Name

- NCT03867500 523 524 O
Fibrates NCT03867500 526 534 B-Drug-Name

- NCT03867500 542 543 O
thiazolidinediones NCT03867500 545 563 B-Drug-Name

- NCT03867500 571 572 O
Beta NCT03867500 574 578 B-Drug-Name
- NCT03867500 579 580 I-Drug-Name
blockers NCT03867500 581 589 I-Drug-Name

- NCT03867500 597 598 O
Atypical NCT03867500 600 608 O
antipsychotics NCT03867500 609 623 B-Drug-Name

- NCT03867500 626 627 O
Lidocaine NCT03867500 629 638 B-Drug-Name
or NCT03867500 639 641 O
Niacin NCT03867500 642 648 B-Drug-Name
/ NCT03867500 649 650 O
Niaspan NCT03867500 651 658 B-Drug-Name
allergy NCT03867500 659 666 O

- NCT03867500 669 670 O
Subjects NCT03867500 672 680 O
with NCT03867500 681 685 O
1.5 NCT03867500 687 690 B-Eq-Value
times NCT03867500 691 696 O
upper NCT03867500 697 702 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03867500 703 708 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03867500 709 711 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03867500 712 718 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03867500 719 721 O
serum NCT03867500 722 727 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03867500 728 738 I-Observation-Name___Observation-Type-Value:lab
, NCT03867500 739 740 O
Alkaline NCT03867500 741 749 B-Observation-Name___Observation-Type-Value:lab
phosphatase NCT03867500 750 761 I-Observation-Name___Observation-Type-Value:lab
, NCT03867500 762 763 O
Aspartate NCT03867500 764 773 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03867500 774 790 I-Observation-Name___Observation-Type-Value:lab
( NCT03867500 791 792 O
AST NCT03867500 793 796 B-Observation-Name___Observation-Type-Value:lab
) NCT03867500 797 798 O
, NCT03867500 800 801 O
Alanine NCT03867500 802 809 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03867500 810 826 I-Observation-Name___Observation-Type-Value:lab
( NCT03867500 827 828 O
ALT NCT03867500 829 832 B-Observation-Name___Observation-Type-Value:lab
) NCT03867500 833 834 O
unless NCT03867500 835 841 O
participant NCT03867500 842 853 O
has NCT03867500 854 857 O
fatty NCT03867500 858 863 B-Condition-Name
liver NCT03867500 864 869 I-Condition-Name
disease NCT03867500 870 877 I-Condition-Name
, NCT03867500 878 879 O
Total NCT03867500 880 885 B-Observation-Name___Observation-Type-Value:lab
bilirubin NCT03867500 886 895 I-Observation-Name___Observation-Type-Value:lab
( NCT03867500 896 897 O
unless NCT03867500 898 904 O
the NCT03867500 905 908 O
patient NCT03867500 909 916 O
has NCT03867500 917 920 O
documented NCT03867500 921 931 O
Gilbert NCT03867500 932 939 B-Condition-Name
's NCT03867500 939 941 I-Condition-Name
syndrome NCT03867500 942 950 I-Condition-Name
) NCT03867500 951 952 O

Inclusion NCT03865316 0 9 O
Criteria NCT03865316 10 18 O
: NCT03865316 19 20 O

- NCT03865316 24 25 O
Patients NCT03865316 27 35 O
18 NCT03865316 37 39 B-Eq-Value
years NCT03865316 40 45 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03865316 46 49 O
and NCT03865316 50 53 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865316 54 59 I-Eq-Operator___Eq-Operator-Value:GTEQ
at NCT03865316 60 62 O
the NCT03865316 63 66 O
time NCT03865316 67 71 O
of NCT03865316 72 74 O
consent NCT03865316 75 82 O
. NCT03865316 83 84 O

- NCT03865316 88 89 O
ASA NCT03865316 91 94 B-Condition-Name
status NCT03865316 95 101 O
I NCT03865316 102 103 B-Eq-Value
, NCT03865316 104 105 O
II NCT03865316 106 108 B-Eq-Value
, NCT03865316 109 110 O
or NCT03865316 111 113 O
III NCT03865316 114 117 B-Eq-Value
. NCT03865316 118 119 O

- NCT03865316 123 124 O
English NCT03865316 126 133 B-Language
- NCT03865316 134 135 O
speaking NCT03865316 136 144 O
subjects NCT03865316 145 153 O
. NCT03865316 154 155 O

- NCT03865316 159 160 O
Scheduled NCT03865316 162 171 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03865316 172 175 O
surgical NCT03865316 176 184 O
and NCT03865316 185 188 O
non NCT03865316 189 192 O
- NCT03865316 193 194 O
surgical NCT03865316 195 203 O
procedures NCT03865316 204 214 B-Procedure-Name
scheduled NCT03865316 215 224 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
under NCT03865316 225 230 O
general NCT03865316 231 238 B-Procedure-Name
anesthesia NCT03865316 239 249 I-Procedure-Name
( NCT03865316 250 251 O
Common NCT03865316 252 258 O
procedures NCT03865316 259 269 O
include NCT03865316 270 277 O
but NCT03865316 278 281 O
are NCT03865316 282 285 O
not NCT03865316 286 289 O
restricted NCT03865316 290 300 O
to NCT03865316 301 303 O
tonsillectomy NCT03865316 304 317 B-Procedure-Name
, NCT03865316 318 319 O
adenoidectomy NCT03865316 320 333 B-Procedure-Name
, NCT03865316 334 335 O
urological NCT03865316 336 346 B-Procedure-Name
procedures NCT03865316 347 357 I-Procedure-Name
, NCT03865316 358 359 O
dental NCT03865316 360 366 B-Procedure-Name
rehabilitation NCT03865316 367 381 I-Procedure-Name
, NCT03865316 382 383 O
orthopedic NCT03865316 384 394 B-Procedure-Name
procedures NCT03865316 395 405 I-Procedure-Name
, NCT03865316 406 407 O
biopsies NCT03865316 408 416 B-Procedure-Name
, NCT03865316 417 418 O
audiogram NCT03865316 419 428 B-Procedure-Name
, NCT03865316 429 430 O
nuclear NCT03865316 431 438 B-Procedure-Name
scans NCT03865316 439 444 I-Procedure-Name
, NCT03865316 445 446 O
gastroscopy NCT03865316 447 458 B-Procedure-Name
, NCT03865316 459 460 O
colonoscopy NCT03865316 461 472 B-Procedure-Name
, NCT03865316 473 474 O
etc NCT03865316 475 478 O
. NCT03865316 479 480 O
) NCT03865316 481 482 O
. NCT03865316 484 485 O

Exclusion NCT03865316 487 496 O
Criteria NCT03865316 497 505 O
: NCT03865316 506 507 O

- NCT03865316 511 512 O
Any NCT03865316 514 517 O
deformities NCT03865316 518 529 B-Condition-Name
or NCT03865316 530 532 O
devices NCT03865316 533 540 B-Procedure-Name
that NCT03865316 541 545 O
may NCT03865316 546 549 O
prevent NCT03865316 550 557 O
application NCT03865316 558 569 O
of NCT03865316 570 572 O
EEG NCT03865316 573 576 B-Procedure-Name
Sensor NCT03865316 577 583 I-Procedure-Name
to NCT03865316 584 586 O
forehead NCT03865316 587 595 O
with NCT03865316 596 600 O
a NCT03865316 601 602 O
proper NCT03865316 603 609 O
fit NCT03865316 610 613 O
. NCT03865316 614 615 O

- NCT03865316 619 620 O
Subjects NCT03865316 622 630 O
who NCT03865316 631 634 O
are NCT03865316 635 638 O
developmentally NCT03865316 639 654 B-Condition-Name
delayed NCT03865316 655 662 I-Condition-Name
. NCT03865316 663 664 O

- NCT03865316 668 669 O
Subjects NCT03865316 671 679 O
deemed NCT03865316 680 686 O
not NCT03865316 687 690 O
suitable NCT03865316 691 699 O
for NCT03865316 700 703 O
study NCT03865316 704 709 O
at NCT03865316 710 712 O
the NCT03865316 713 716 O
discretion NCT03865316 717 727 O
of NCT03865316 728 730 O
the NCT03865316 731 734 O
investigator NCT03865316 735 747 O
. NCT03865316 748 749 O

Inclusion NCT03863015 0 9 O
Criteria NCT03863015 10 18 O
: NCT03863015 19 20 O

Each NCT03863015 22 26 O
of NCT03863015 27 29 O
the NCT03863015 30 33 O
following NCT03863015 34 43 O
criteria NCT03863015 44 52 O
must NCT03863015 53 57 O
be NCT03863015 58 60 O
fulfilled NCT03863015 61 70 O
for NCT03863015 71 74 O
a NCT03863015 75 76 O
subject NCT03863015 77 84 O
to NCT03863015 85 87 O
be NCT03863015 88 90 O
eligible NCT03863015 91 99 O
: NCT03863015 100 101 O

1 NCT03863015 106 107 O
. NCT03863015 107 108 O
Age NCT03863015 110 113 O
≥ NCT03863015 114 115 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863015 117 119 B-Eq-Value
years NCT03863015 120 125 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

2 NCT03863015 129 130 O
. NCT03863015 130 131 O
OHCA NCT03863015 133 137 B-Condition-Name
of NCT03863015 138 140 O
a NCT03863015 141 142 O
presumed NCT03863015 143 151 O
cardiac NCT03863015 152 159 B-Condition-Name
cause NCT03863015 160 165 I-Condition-Name

3 NCT03863015 169 170 O
. NCT03863015 170 171 O
Unconsciousness NCT03863015 173 188 B-Condition-Name
upon NCT03863015 189 193 O
admission NCT03863015 194 203 B-Encounter-Type___Encounter-Type-Value:inpatient
, NCT03863015 204 205 O
i NCT03863015 206 207 O
. NCT03863015 208 209 O
e NCT03863015 210 211 O
. NCT03863015 212 213 O
a NCT03863015 215 216 O
GCS NCT03863015 217 220 B-Observation-Name
< NCT03863015 221 222 B-Eq-Operator___Eq-Operator-Value:LT
9 NCT03863015 224 225 B-Eq-Value

4 NCT03863015 230 231 O
. NCT03863015 231 232 O
Sustained NCT03863015 234 243 B-Severity___Severity-Value:severe
ROSC NCT03863015 244 248 B-Condition-Name
for NCT03863015 249 252 O
more NCT03863015 253 257 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863015 258 262 I-Eq-Operator___Eq-Operator-Value:GT
20 NCT03863015 264 266 B-Eq-Value
minutes NCT03863015 267 274 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

Exclusion NCT03863015 275 284 O
Criteria NCT03863015 285 293 O
: NCT03863015 294 295 O

None NCT03863015 297 301 O
of NCT03863015 302 304 O
the NCT03863015 305 308 O
following NCT03863015 309 318 O
criteria NCT03863015 319 327 O
must NCT03863015 328 332 O
be NCT03863015 333 335 O
fulfilled NCT03863015 336 345 O
for NCT03863015 346 349 O
a NCT03863015 350 351 O
subject NCT03863015 352 359 O
to NCT03863015 360 362 O
be NCT03863015 363 365 O
eligible NCT03863015 366 374 O
: NCT03863015 375 376 O

1 NCT03863015 381 382 O
. NCT03863015 382 383 O
Consciousness NCT03863015 385 398 B-Condition-Name
upon NCT03863015 399 403 O
admission NCT03863015 404 413 B-Encounter-Type___Encounter-Type-Value:inpatient
, NCT03863015 414 415 O
i NCT03863015 416 417 O
. NCT03863015 418 419 O
e NCT03863015 420 421 O
. NCT03863015 422 423 O
a NCT03863015 425 426 O
GCS NCT03863015 427 430 B-Observation-Name
≥ NCT03863015 431 432 B-Eq-Operator___Eq-Operator-Value:GTEQ
9 NCT03863015 434 435 B-Eq-Value

2 NCT03863015 440 441 O
. NCT03863015 441 442 O
Presumed NCT03863015 444 452 O
non NCT03863015 453 456 O
- NCT03863015 457 458 O
cardiac NCT03863015 459 466 O
cause NCT03863015 467 472 O
of NCT03863015 473 475 O
arrest NCT03863015 476 482 B-Condition-Name

3 NCT03863015 486 487 O
. NCT03863015 487 488 O
Unwitnessed NCT03863015 490 501 B-Condition-Name
asystole NCT03863015 502 510 I-Condition-Name

4 NCT03863015 514 515 O
. NCT03863015 515 516 O
Suspected NCT03863015 518 527 O
or NCT03863015 528 530 O
confirmed NCT03863015 531 540 O
intracranial NCT03863015 541 553 B-Condition-Name
bleeding NCT03863015 554 562 I-Condition-Name
or NCT03863015 563 565 O
stroke NCT03863015 566 572 B-Condition-Name

5 NCT03863015 576 577 O
. NCT03863015 577 578 O
Pregnancy NCT03863015 580 589 B-Condition-Name
, NCT03863015 590 591 O
or NCT03863015 592 594 O
females NCT03863015 595 602 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
in NCT03863015 603 605 O
fertile NCT03863015 606 613 B-Condition-Name
age NCT03863015 614 617 I-Condition-Name
, NCT03863015 618 619 O
unless NCT03863015 620 626 O
a NCT03863015 627 628 O
negative NCT03863015 629 637 B-Polarity___Polarity-Value:negative
serum NCT03863015 638 643 B-Observation-Name___Observation-Type-Value:lab
HCG NCT03863015 644 647 I-Observation-Name___Observation-Type-Value:lab
can NCT03863015 648 651 O
rule NCT03863015 652 656 O
out NCT03863015 657 660 O
pregnancy NCT03863015 661 670 B-Condition-Name
within NCT03863015 671 677 O
the NCT03863015 678 681 O
inclusion NCT03863015 682 691 O
window NCT03863015 692 698 O
. NCT03863015 699 700 O

6 NCT03863015 705 706 O
. NCT03863015 706 707 O
Temperature NCT03863015 709 720 B-Observation-Name___Observation-Type-Value:vital
on NCT03863015 721 723 O
admission NCT03863015 724 733 B-Encounter-Type___Encounter-Type-Value:inpatient
< NCT03863015 734 735 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03863015 737 739 B-Eq-Value
° NCT03863015 740 741 B-Eq-Unit
C NCT03863015 741 742 I-Eq-Unit

7 NCT03863015 746 747 O
. NCT03863015 747 748 O
Persistent NCT03863015 750 760 O
cardiogenic NCT03863015 761 772 B-Condition-Name
shock NCT03863015 773 778 I-Condition-Name
* NCT03863015 778 779 O
that NCT03863015 780 784 O
is NCT03863015 785 787 O
not NCT03863015 788 791 O
reversed NCT03863015 792 800 O
within NCT03863015 801 807 O
the NCT03863015 808 811 O
inclusion NCT03863015 812 821 O
window NCT03863015 822 828 O

8 NCT03863015 832 833 O
. NCT03863015 833 834 O
Known NCT03863015 836 841 O
disease NCT03863015 842 849 B-Condition-Name
making NCT03863015 850 856 O
180 NCT03863015 858 861 B-Eq-Value
day NCT03863015 862 865 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
survival NCT03863015 866 874 O
unlikely NCT03863015 875 883 O

9 NCT03863015 887 888 O
. NCT03863015 888 889 O
Known NCT03863015 891 896 O
limitations NCT03863015 897 908 O
in NCT03863015 909 911 O
therapy NCT03863015 912 919 B-Procedure-Name

10 NCT03863015 922 924 O
. NCT03863015 924 925 O
Known NCT03863015 927 932 O
pre NCT03863015 933 936 O
- NCT03863015 937 938 O
arrest NCT03863015 939 945 B-Condition-Name
Cerebral NCT03863015 946 954 B-Observation-Name___Observation-Type-Value:clinical-score
Performance NCT03863015 955 966 I-Observation-Name___Observation-Type-Value:clinical-score
Category NCT03863015 967 975 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03863015 976 978 O
3 NCT03863015 980 981 B-Eq-Value
to NCT03863015 982 984 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03863015 986 987 B-Eq-Value

11 NCT03863015 991 993 O
. NCT03863015 993 994 O
> NCT03863015 996 997 B-Eq-Operator___Eq-Operator-Value:GT
240 NCT03863015 999 1002 B-Eq-Value
minutes NCT03863015 1003 1010 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
from NCT03863015 1011 1015 O
ROSC NCT03863015 1016 1020 B-Observation-Name
to NCT03863015 1021 1023 O
randomization NCT03863015 1024 1037 O

Inclusion NCT03860246 0 9 O
Criteria NCT03860246 10 18 O
: NCT03860246 19 20 O

Nursing NCT03860246 22 29 B-Location___Location-Value:residence
home NCT03860246 30 34 I-Location___Location-Value:residence
residents NCT03860246 35 44 O
with NCT03860246 45 49 O
≥ NCT03860246 50 51 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03860246 53 54 B-Eq-Value
of NCT03860246 55 57 O
the NCT03860246 58 61 O
following NCT03860246 62 71 O
risk NCT03860246 72 76 O
factors NCT03860246 77 84 O
for NCT03860246 85 88 O
atrial NCT03860246 89 95 B-Condition-Name
fibrillation NCT03860246 96 108 I-Condition-Name
: NCT03860246 109 110 O

- NCT03860246 114 115 O
age NCT03860246 117 120 O
≥ NCT03860246 121 122 B-Eq-Operator___Eq-Operator-Value:GTEQ
75 NCT03860246 124 126 B-Eq-Value
years NCT03860246 127 132 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03860246 135 136 O
female NCT03860246 138 144 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
sex NCT03860246 145 148 O

- NCT03860246 151 152 O
obstructive NCT03860246 154 165 B-Condition-Name
sleep NCT03860246 166 171 I-Condition-Name
apnea NCT03860246 172 177 I-Condition-Name

- NCT03860246 180 181 O
peripheral NCT03860246 183 193 B-Condition-Name
vascular NCT03860246 194 202 I-Condition-Name
disease NCT03860246 203 210 I-Condition-Name

- NCT03860246 213 214 O
diabetes NCT03860246 216 224 B-Condition-Name
mellitus NCT03860246 225 233 I-Condition-Name

- NCT03860246 236 237 O
obesity NCT03860246 239 246 B-Condition-Name
( NCT03860246 247 248 O
body NCT03860246 249 253 B-Observation-Name___Observation-Type-Value:vital
mass NCT03860246 254 258 I-Observation-Name___Observation-Type-Value:vital
index NCT03860246 259 264 I-Observation-Name___Observation-Type-Value:vital
[ NCT03860246 265 266 O
BMI NCT03860246 267 270 B-Observation-Name___Observation-Type-Value:vital
] NCT03860246 271 272 O
> NCT03860246 273 274 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03860246 276 278 B-Eq-Value
kg NCT03860246 279 281 B-Eq-Unit
/ NCT03860246 282 283 O
m NCT03860246 284 285 B-Eq-Unit
2 NCT03860246 286 287 I-Eq-Unit
) NCT03860246 288 289 O

- NCT03860246 293 294 O
hypertension NCT03860246 296 308 B-Condition-Name

- NCT03860246 311 312 O
congestive NCT03860246 314 324 B-Condition-Name
heart NCT03860246 325 330 I-Condition-Name
failure NCT03860246 331 338 I-Condition-Name

Exclusion NCT03860246 339 348 O
Criteria NCT03860246 349 357 O
: NCT03860246 358 359 O

- NCT03860246 363 364 O
prior NCT03860246 366 371 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03860246 372 381 O
of NCT03860246 382 384 O
AF NCT03860246 385 387 B-Condition-Name

- NCT03860246 390 391 O
continuous NCT03860246 393 403 O
rhythm NCT03860246 404 410 B-Procedure-Name
monitoring NCT03860246 411 421 I-Procedure-Name
over NCT03860246 422 426 O
the NCT03860246 427 430 O
past NCT03860246 431 435 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03860246 436 440 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03860246 443 444 O
pacemaker NCT03860246 446 455 B-Procedure-Name
or NCT03860246 456 458 O
implantable NCT03860246 459 470 B-Procedure-Name
cardioverter NCT03860246 471 483 I-Procedure-Name
defibrillator NCT03860246 484 497 I-Procedure-Name
in NCT03860246 498 500 O
situ NCT03860246 501 505 O

Inclusion NCT03861819 0 9 O
Criteria NCT03861819 10 18 O
: NCT03861819 19 20 O

- NCT03861819 24 25 O
Ages NCT03861819 27 31 O
18 NCT03861819 33 35 B-Eq-Value
- NCT03861819 36 37 B-Eq-Operator___Eq-Operator-Value:BETWEEN
59 NCT03861819 39 41 B-Eq-Value

- NCT03861819 45 46 O
Histologically NCT03861819 48 62 O
confirmed NCT03861819 63 72 O
nonalcoholic NCT03861819 73 85 B-Condition-Name
steatohepatitis NCT03861819 86 101 I-Condition-Name
and NCT03861819 102 105 O
fibrosis NCT03861819 106 114 B-Condition-Name
( NCT03861819 115 116 O
stage NCT03861819 117 122 B-Eq-Unit
1 NCT03861819 124 125 B-Eq-Value
- NCT03861819 126 127 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03861819 129 130 B-Eq-Value
) NCT03861819 131 132 O
from NCT03861819 133 137 O
liver NCT03861819 138 143 B-Procedure-Name
biopsy NCT03861819 144 150 I-Procedure-Name

- NCT03861819 153 154 O
Able NCT03861819 156 160 O
to NCT03861819 161 163 O
row NCT03861819 164 167 O
on NCT03861819 168 170 O
an NCT03861819 171 173 O
indoor NCT03861819 174 180 B-Observation-Name___Observation-Type-Value:social-habit
rowing NCT03861819 181 187 I-Observation-Name___Observation-Type-Value:social-habit
apparatus NCT03861819 188 197 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03861819 200 201 O
Not NCT03861819 203 206 O
participating NCT03861819 207 220 O
in NCT03861819 221 223 O
regular NCT03861819 224 231 O
physical NCT03861819 232 240 B-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03861819 241 249 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03861819 250 251 O
more NCT03861819 252 256 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03861819 257 261 I-Eq-Operator___Eq-Operator-Value:GT
60 NCT03861819 263 265 B-Eq-Value
minutes NCT03861819 266 273 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
of NCT03861819 274 276 O
moderate NCT03861819 277 285 B-Severity___Severity-Value:moderate
intensity NCT03861819 286 295 O
or NCT03861819 296 298 O
30 NCT03861819 300 302 B-Eq-Value
minutes NCT03861819 303 310 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
of NCT03861819 311 313 O
vigorous NCT03861819 314 322 B-Severity___Severity-Value:severe
intensity NCT03861819 323 332 I-Severity___Severity-Value:severe
exercise NCT03861819 333 341 B-Observation-Name___Observation-Type-Value:social-habit
per NCT03861819 342 345 O
week NCT03861819 346 350 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03861819 351 352 O

- NCT03861819 356 357 O
Not NCT03861819 359 362 O
actively NCT03861819 363 371 O
trying NCT03861819 372 378 O
to NCT03861819 379 381 O
lose NCT03861819 382 386 B-Condition-Name
weight NCT03861819 387 393 I-Condition-Name
through NCT03861819 394 401 O
a NCT03861819 402 403 O
dietary NCT03861819 404 411 B-Observation-Name___Observation-Type-Value:social-habit
approach NCT03861819 412 420 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03861819 423 424 O
No NCT03861819 426 428 O
absolute NCT03861819 429 437 O
contra NCT03861819 438 444 O
- NCT03861819 445 446 O
indications NCT03861819 447 458 O
to NCT03861819 459 461 O
exercise NCT03861819 462 470 B-Observation-Name___Observation-Type-Value:social-habit
: NCT03861819 471 472 O
recent NCT03861819 473 479 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
( NCT03861819 480 481 O
< NCT03861819 483 484 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03861819 486 487 B-Eq-Value
months NCT03861819 488 494 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03861819 495 496 O
acute NCT03861819 497 502 B-Severity___Severity-Value:severe
cardiac NCT03861819 503 510 B-Condition-Name
event NCT03861819 511 516 I-Condition-Name
unstable NCT03861819 517 525 B-Stability___Stability-Value:change
angina NCT03861819 526 532 B-Condition-Name
, NCT03861819 533 534 O
uncontrolled NCT03861819 535 547 O
dysrhythmias NCT03861819 548 560 B-Condition-Name
causing NCT03861819 561 568 O
symptoms NCT03861819 569 577 O
or NCT03861819 578 580 O
hemodynamic NCT03861819 581 592 O
compromise NCT03861819 593 603 B-Condition-Name
, NCT03861819 604 605 O
symptomatic NCT03861819 606 617 O
aortic NCT03861819 618 624 B-Condition-Name
stenosis NCT03861819 625 633 I-Condition-Name
, NCT03861819 634 635 O
uncontrolled NCT03861819 636 648 O
symptomatic NCT03861819 649 660 O
heart NCT03861819 661 666 B-Condition-Name
failure NCT03861819 667 674 I-Condition-Name
, NCT03861819 675 676 O
acute NCT03861819 677 682 B-Severity___Severity-Value:severe
pulmonary NCT03861819 683 692 B-Condition-Name
embolus NCT03861819 693 700 I-Condition-Name
, NCT03861819 701 702 O
acute NCT03861819 703 708 B-Severity___Severity-Value:severe
myocarditis NCT03861819 709 720 B-Condition-Name
or NCT03861819 721 723 O
pericarditis NCT03861819 724 736 B-Condition-Name
, NCT03861819 737 738 O
suspected NCT03861819 739 748 O
or NCT03861819 749 751 O
known NCT03861819 752 757 O
dissecting NCT03861819 758 768 B-Condition-Name
aneurism NCT03861819 769 777 I-Condition-Name
and NCT03861819 778 781 O
acute NCT03861819 782 787 B-Severity___Severity-Value:severe
systemic NCT03861819 788 796 O
infection NCT03861819 797 806 B-Condition-Name

- NCT03861819 809 810 O
No NCT03861819 812 814 O
other NCT03861819 815 820 O
form NCT03861819 821 825 O
of NCT03861819 826 828 O
chronic NCT03861819 829 836 O
liver NCT03861819 837 842 B-Condition-Name
disease NCT03861819 843 850 I-Condition-Name
( NCT03861819 851 852 O
as NCT03861819 853 855 O
confirmed NCT03861819 856 865 O
by NCT03861819 866 868 O
serology NCT03861819 869 877 B-Procedure-Name
and NCT03861819 878 881 O
histology NCT03861819 882 891 B-Procedure-Name
) NCT03861819 892 893 O

- NCT03861819 897 898 O
No NCT03861819 900 902 O
liver NCT03861819 903 908 B-Condition-Name
cirrhosis NCT03861819 909 918 I-Condition-Name
( NCT03861819 919 920 O
stage NCT03861819 921 926 B-Eq-Unit
4 NCT03861819 928 929 B-Eq-Value
fibrosis NCT03861819 930 938 B-Condition-Name
on NCT03861819 939 941 O
liver NCT03861819 942 947 B-Procedure-Name
biopsy NCT03861819 948 954 I-Procedure-Name
) NCT03861819 955 956 O
or NCT03861819 957 959 O
a NCT03861819 960 961 O
clinical NCT03861819 962 970 O
diagnosis NCT03861819 971 980 O
of NCT03861819 981 983 O
cirrhosis NCT03861819 984 993 B-Condition-Name
as NCT03861819 994 996 O
ascertained NCT03861819 997 1008 O
by NCT03861819 1009 1011 O
a NCT03861819 1012 1013 O
hepatologist NCT03861819 1014 1026 B-Provider-Type

- NCT03861819 1029 1030 O
No NCT03861819 1032 1034 O
coronary NCT03861819 1035 1043 B-Condition-Name
artery NCT03861819 1044 1050 I-Condition-Name
disease NCT03861819 1051 1058 I-Condition-Name
or NCT03861819 1059 1061 O
chronic NCT03861819 1062 1069 O
obstructive NCT03861819 1070 1081 B-Condition-Name
pulmonary NCT03861819 1082 1091 I-Condition-Name
disease NCT03861819 1092 1099 I-Condition-Name
. NCT03861819 1100 1101 O

- NCT03861819 1105 1106 O
No NCT03861819 1108 1110 O
diagnosis NCT03861819 1111 1120 O
of NCT03861819 1121 1123 O
malignancy NCT03861819 1124 1134 B-Condition-Name
( NCT03861819 1135 1136 O
except NCT03861819 1137 1143 O
non NCT03861819 1144 1147 O
- NCT03861819 1148 1149 O
melanoma NCT03861819 1150 1158 O
skin NCT03861819 1159 1163 O
cancer NCT03861819 1164 1170 B-Condition-Name
) NCT03861819 1171 1172 O

- NCT03861819 1176 1177 O
No NCT03861819 1179 1181 O
past NCT03861819 1182 1186 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03861819 1187 1189 O
present NCT03861819 1190 1197 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
history NCT03861819 1198 1205 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03861819 1206 1208 O
portal NCT03861819 1209 1215 B-Condition-Name
hypertension NCT03861819 1216 1228 I-Condition-Name
( NCT03861819 1229 1230 O
esophageal NCT03861819 1231 1241 O
varices NCT03861819 1242 1249 B-Condition-Name
, NCT03861819 1250 1251 O
ascites NCT03861819 1252 1259 B-Condition-Name
, NCT03861819 1260 1261 O
hepatic NCT03861819 1262 1269 B-Condition-Name
encephalopathy NCT03861819 1270 1284 I-Condition-Name
) NCT03861819 1285 1286 O

- NCT03861819 1290 1291 O
No NCT03861819 1293 1295 O
use NCT03861819 1296 1299 O
of NCT03861819 1300 1302 O
immunosuppression NCT03861819 1303 1320 B-Drug-Name
or NCT03861819 1321 1323 O
chronic NCT03861819 1324 1331 O
nonsteroidal NCT03861819 1332 1344 B-Drug-Name
anti NCT03861819 1345 1349 I-Drug-Name
- NCT03861819 1350 1351 I-Drug-Name
inflammatory NCT03861819 1352 1364 I-Drug-Name
medication NCT03861819 1365 1375 I-Drug-Name

- NCT03861819 1378 1379 O
No NCT03861819 1381 1383 B-Eq-Operator___Eq-Operator-Value:LTEQ
more NCT03861819 1384 1388 I-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03861819 1389 1393 I-Eq-Operator___Eq-Operator-Value:LTEQ
14 NCT03861819 1395 1397 B-Eq-Value
drinks NCT03861819 1398 1404 B-Eq-Unit
per NCT03861819 1405 1408 O
week NCT03861819 1409 1413 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03861819 1414 1415 O
if NCT03861819 1416 1418 O
male NCT03861819 1419 1423 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
) NCT03861819 1424 1425 O
or NCT03861819 1426 1428 O
7 NCT03861819 1430 1431 B-Eq-Value
drinks NCT03861819 1432 1438 B-Eq-Unit
a NCT03861819 1439 1440 O
week NCT03861819 1441 1445 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03861819 1446 1447 O
if NCT03861819 1448 1450 O
female NCT03861819 1451 1457 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
) NCT03861819 1458 1459 O
in NCT03861819 1460 1462 O
the NCT03861819 1463 1466 O
last NCT03861819 1467 1471 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03861819 1473 1474 B-Eq-Value
years NCT03861819 1475 1480 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861819 1483 1484 O
Cognitively NCT03861819 1486 1497 O
able NCT03861819 1498 1502 O
to NCT03861819 1503 1505 O
provide NCT03861819 1506 1513 O
consent NCT03861819 1514 1521 O

- NCT03861819 1524 1525 O
Able NCT03861819 1527 1531 O
to NCT03861819 1532 1534 O
read NCT03861819 1535 1539 O
, NCT03861819 1540 1541 O
write NCT03861819 1542 1547 O
, NCT03861819 1548 1549 O
and NCT03861819 1550 1553 O
understand NCT03861819 1554 1564 O
English NCT03861819 1565 1572 B-Language

- NCT03861819 1575 1576 O
Transportation NCT03861819 1578 1592 O
to NCT03861819 1593 1595 O
the NCT03861819 1596 1599 O
exercise NCT03861819 1600 1608 O
and NCT03861819 1609 1612 O
testing NCT03861819 1613 1620 O
facility NCT03861819 1621 1629 O

Inclusion NCT03867071 0 9 O
Criteria NCT03867071 10 18 O
: NCT03867071 19 20 O

- NCT03867071 24 25 O
Patients NCT03867071 27 35 O
between NCT03867071 36 43 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03867071 45 47 B-Eq-Value
to NCT03867071 48 50 O
65 NCT03867071 52 54 B-Eq-Value
years NCT03867071 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867071 61 64 O

- NCT03867071 67 68 O
Patient NCT03867071 70 77 O
with NCT03867071 78 82 O
an NCT03867071 83 85 O
ASA NCT03867071 86 89 B-Condition-Name
1 NCT03867071 91 92 B-Eq-Value
or NCT03867071 93 95 O
2 NCT03867071 97 98 B-Eq-Value
( NCT03867071 99 100 O
ASA NCT03867071 101 104 O
1 NCT03867071 106 107 O
corresponding NCT03867071 108 121 O
to NCT03867071 122 124 O
a NCT03867071 125 126 O
patient NCT03867071 127 134 O
in NCT03867071 135 137 O
perfect NCT03867071 138 145 O
health NCT03867071 146 152 O
and NCT03867071 153 156 O
ASA NCT03867071 157 160 O
2 NCT03867071 162 163 O
to NCT03867071 164 166 O
a NCT03867071 167 168 O
patient NCT03867071 169 176 O
with NCT03867071 177 181 O
moderate NCT03867071 182 190 O
involvement NCT03867071 191 202 O
and NCT03867071 203 206 O
well NCT03867071 207 211 O
controlled NCT03867071 212 222 O
organ NCT03867071 223 228 O
function NCT03867071 229 237 O
) NCT03867071 238 239 O

- NCT03867071 243 244 O
patient NCT03867071 246 253 O
presenting NCT03867071 254 264 O
at NCT03867071 265 267 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867071 268 273 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03867071 274 277 B-Eq-Value
of NCT03867071 278 280 O
the NCT03867071 281 284 O
following NCT03867071 285 294 O
fractures NCT03867071 295 304 B-Condition-Name
: NCT03867071 305 306 O
Basin NCT03867071 307 312 O
and NCT03867071 313 316 O
/ NCT03867071 317 318 O
or NCT03867071 319 321 O
femur NCT03867071 322 327 O
with NCT03867071 328 332 O
surgical NCT03867071 333 341 B-Procedure-Name
indication NCT03867071 342 352 O
, NCT03867071 353 354 O
associated NCT03867071 355 365 O
or NCT03867071 366 368 O
not NCT03867071 369 372 O
with NCT03867071 373 377 O
other NCT03867071 378 383 O
fractures NCT03867071 384 393 B-Condition-Name
. NCT03867071 394 395 O

- NCT03867071 399 400 O
patient NCT03867071 402 409 O
with NCT03867071 410 414 O
hemoglobin NCT03867071 415 425 B-Observation-Name___Observation-Type-Value:lab
between NCT03867071 426 433 B-Eq-Operator___Eq-Operator-Value:BETWEEN
9 NCT03867071 435 436 B-Eq-Value
and NCT03867071 437 440 O
13 NCT03867071 442 444 B-Eq-Value
g NCT03867071 445 446 B-Eq-Unit
/ NCT03867071 447 448 O
dl NCT03867071 449 451 B-Eq-Unit
at NCT03867071 452 454 O
the NCT03867071 455 458 O
time NCT03867071 459 463 O
of NCT03867071 464 466 O
admission NCT03867071 467 476 B-Encounter-Type___Encounter-Type-Value:inpatient
on NCT03867071 477 479 O
trauma NCT03867071 480 486 B-Location___Location-Value:unit
department NCT03867071 487 497 I-Location___Location-Value:unit

Exclusion NCT03867071 498 507 O
Criteria NCT03867071 508 516 O
: NCT03867071 517 518 O

- NCT03867071 522 523 O
patient NCT03867071 525 532 O
with NCT03867071 533 537 O
contraindication NCT03867071 538 554 O
to NCT03867071 555 557 O
synthetic NCT03867071 558 567 B-Procedure-Name
erythropoietin NCT03867071 568 582 I-Procedure-Name

- NCT03867071 585 586 O
Patient NCT03867071 588 595 O
with NCT03867071 596 600 O
intravenous NCT03867071 601 612 B-Procedure-Name
iron NCT03867071 613 617 I-Procedure-Name
contraindication NCT03867071 618 634 O

- NCT03867071 637 638 O
pregnant NCT03867071 640 648 B-Condition-Name
patient NCT03867071 649 656 O
or NCT03867071 657 659 O
with NCT03867071 660 664 O
a NCT03867071 665 666 O
risk NCT03867071 667 671 O
of NCT03867071 672 674 O
pregnancy NCT03867071 675 684 B-Condition-Name

- NCT03867071 687 688 O
patient NCT03867071 690 697 O
who NCT03867071 698 701 O
has NCT03867071 702 705 O
not NCT03867071 706 709 O
given NCT03867071 710 715 O
his NCT03867071 716 719 O
consent NCT03867071 720 727 O
or NCT03867071 728 730 O
does NCT03867071 731 735 O
not NCT03867071 736 739 O
understand NCT03867071 740 750 O
the NCT03867071 751 754 O
protocol NCT03867071 755 763 O

- NCT03867071 766 767 O
Patient NCT03867071 769 776 O
with NCT03867071 777 781 O
hemodynamic NCT03867071 782 793 B-Condition-Name
instability NCT03867071 794 805 B-Stability___Stability-Value:change

- NCT03867071 808 809 O
patient NCT03867071 811 818 O
participating NCT03867071 819 832 O
in NCT03867071 833 835 O
another NCT03867071 836 843 O
research NCT03867071 844 852 O
protocol NCT03867071 853 861 O
for NCT03867071 862 865 O
less NCT03867071 866 870 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867071 871 875 I-Eq-Operator___Eq-Operator-Value:LT
3 NCT03867071 877 878 B-Eq-Value
months NCT03867071 879 885 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03867071 886 887 O


Inclusion NCT03862690 0 9 O
Criteria NCT03862690 10 18 O
: NCT03862690 19 20 O

- NCT03862690 24 25 O
Signed NCT03862690 27 33 O
consent NCT03862690 34 41 O
obtained NCT03862690 42 50 O
before NCT03862690 51 57 O
any NCT03862690 58 61 O
study NCT03862690 62 67 O
- NCT03862690 68 69 O
related NCT03862690 70 77 O
activities NCT03862690 78 88 O
( NCT03862690 89 90 O
study NCT03862690 91 96 O
- NCT03862690 97 98 O
related NCT03862690 99 106 O
activities NCT03862690 107 117 O
are NCT03862690 118 121 O
any NCT03862690 122 125 O
procedure NCT03862690 126 135 O
related NCT03862690 136 143 O
to NCT03862690 144 146 O
recording NCT03862690 147 156 O
of NCT03862690 157 159 O
data NCT03862690 160 164 O
according NCT03862690 165 174 O
to NCT03862690 175 177 O
the NCT03862690 178 181 O
protocol NCT03862690 182 190 O
) NCT03862690 191 192 O

- NCT03862690 196 197 O
The NCT03862690 199 202 O
decision NCT03862690 203 211 O
to NCT03862690 212 214 O
initiate NCT03862690 215 223 O
treatment NCT03862690 224 233 O
with NCT03862690 234 238 O
commercially NCT03862690 239 251 O
available NCT03862690 252 261 O
NovoMix NCT03862690 262 269 B-Drug-Name
® NCT03862690 269 270 I-Drug-Name
30 NCT03862690 272 274 I-Drug-Name
has NCT03862690 275 278 O
been NCT03862690 279 283 O
made NCT03862690 284 288 O
by NCT03862690 289 291 O
the NCT03862690 292 295 O
patient NCT03862690 296 303 O
and NCT03862690 304 307 O
the NCT03862690 308 311 O
treating NCT03862690 312 320 O
physician NCT03862690 321 330 O
before NCT03862690 331 337 O
and NCT03862690 338 341 O
independently NCT03862690 342 355 O
from NCT03862690 356 360 O
the NCT03862690 361 364 O
decision NCT03862690 365 373 O
to NCT03862690 374 376 O
include NCT03862690 377 384 O
the NCT03862690 385 388 O
patient NCT03862690 389 396 O
in NCT03862690 397 399 O
this NCT03862690 400 404 O
study NCT03862690 405 410 O

- NCT03862690 413 414 O
Male NCT03862690 416 420 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03862690 421 423 O
female NCT03862690 424 430 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03862690 431 432 O
greater NCT03862690 433 440 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03862690 441 445 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03862690 446 448 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03862690 449 454 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03862690 455 457 O
19 NCT03862690 459 461 B-Eq-Value
years NCT03862690 462 467 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
at NCT03862690 468 470 O
the NCT03862690 471 474 O
time NCT03862690 475 479 O
of NCT03862690 480 482 O
signing NCT03862690 483 490 O
informed NCT03862690 491 499 O
consent NCT03862690 500 507 O

- NCT03862690 510 511 O
Diagnosed NCT03862690 513 522 O
with NCT03862690 523 527 O
type NCT03862690 528 532 O
2 NCT03862690 534 535 O
diabetes NCT03862690 536 544 B-Condition-Name
and NCT03862690 545 548 O
treated NCT03862690 549 556 O
with NCT03862690 557 561 O
basal NCT03862690 562 567 B-Drug-Name
insulin NCT03862690 568 575 I-Drug-Name
plus NCT03862690 576 580 O
1 NCT03862690 582 583 B-Eq-Value
- NCT03862690 584 585 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03862690 587 588 B-Eq-Value
bolus NCT03862690 589 594 O
insulin NCT03862690 595 602 O
injections NCT03862690 603 613 O
per NCT03862690 614 617 O
day NCT03862690 618 621 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
for NCT03862690 622 625 O
at NCT03862690 626 628 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862690 629 634 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03862690 636 638 B-Eq-Value
weeks NCT03862690 639 644 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03862690 645 650 O
to NCT03862690 651 653 O
informed NCT03862690 654 662 O
consent NCT03862690 663 670 O

- NCT03862690 673 674 O
Available NCT03862690 676 685 O
and NCT03862690 686 689 O
documented NCT03862690 690 700 O
HbA NCT03862690 701 704 B-Observation-Name___Observation-Type-Value:lab
1c NCT03862690 705 707 I-Observation-Name___Observation-Type-Value:lab
value NCT03862690 708 713 O
less NCT03862690 714 718 B-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03862690 719 723 I-Eq-Operator___Eq-Operator-Value:LTEQ
or NCT03862690 724 726 I-Eq-Operator___Eq-Operator-Value:LTEQ
equal NCT03862690 727 732 I-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03862690 733 735 O
12 NCT03862690 737 739 B-Eq-Value
weeks NCT03862690 740 745 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03862690 746 751 O
to NCT03862690 752 754 O
initiation NCT03862690 755 765 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03862690 766 768 O
NovoMix NCT03862690 769 776 B-Drug-Name
® NCT03862690 776 777 I-Drug-Name
30 NCT03862690 779 781 I-Drug-Name
treatment NCT03862690 782 791 O

Exclusion NCT03862690 792 801 O
Criteria NCT03862690 802 810 O
: NCT03862690 811 812 O

- NCT03862690 816 817 O
Previous NCT03862690 819 827 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participation NCT03862690 828 841 O
in NCT03862690 842 844 O
this NCT03862690 845 849 O
study NCT03862690 850 855 O
. NCT03862690 856 857 O
Participation NCT03862690 859 872 O
is NCT03862690 873 875 O
defined NCT03862690 876 883 O
as NCT03862690 884 886 O
having NCT03862690 887 893 O
given NCT03862690 894 899 O
informed NCT03862690 900 908 O
consent NCT03862690 909 916 O
in NCT03862690 917 919 O
this NCT03862690 920 924 O
study NCT03862690 925 930 O

- NCT03862690 933 934 O
Mental NCT03862690 936 942 B-Condition-Name
incapacity NCT03862690 943 953 I-Condition-Name
, NCT03862690 954 955 O
unwillingness NCT03862690 956 969 O
or NCT03862690 970 972 O
language NCT03862690 973 981 B-Condition-Name
barriers NCT03862690 982 990 I-Condition-Name
precluding NCT03862690 991 1001 O
adequate NCT03862690 1002 1010 O
understanding NCT03862690 1011 1024 O
or NCT03862690 1025 1027 O
cooperation NCT03862690 1028 1039 O

- NCT03862690 1042 1043 O
Participation NCT03862690 1045 1058 O
in NCT03862690 1059 1061 O
any NCT03862690 1062 1065 O
clinical NCT03862690 1066 1074 O
trial NCT03862690 1075 1080 O
of NCT03862690 1081 1083 O
an NCT03862690 1084 1086 O
approved NCT03862690 1087 1095 O
or NCT03862690 1096 1098 O
non NCT03862690 1099 1102 O
- NCT03862690 1103 1104 O
approved NCT03862690 1105 1113 O
investigational NCT03862690 1114 1129 O
medicinal NCT03862690 1130 1139 O
product NCT03862690 1140 1147 O
within NCT03862690 1148 1154 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03862690 1156 1158 B-Eq-Value
weeks NCT03862690 1159 1164 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03862690 1165 1170 O
to NCT03862690 1171 1173 O
initiation NCT03862690 1174 1184 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03862690 1185 1187 O
NovoMix NCT03862690 1188 1195 B-Drug-Name
® NCT03862690 1195 1196 I-Drug-Name
30 NCT03862690 1198 1200 I-Drug-Name
treatment NCT03862690 1201 1210 O
. NCT03862690 1211 1212 O
Clinical NCT03862690 1214 1222 O
trials NCT03862690 1223 1229 O
do NCT03862690 1230 1232 O
not NCT03862690 1233 1236 O
include NCT03862690 1237 1244 O
non NCT03862690 1245 1248 O
- NCT03862690 1249 1250 O
interventional NCT03862690 1251 1265 O
studies NCT03862690 1266 1273 O

- NCT03862690 1276 1277 O
Hypersensitivity NCT03862690 1279 1295 B-Condition-Name
to NCT03862690 1296 1298 O
NovoMix NCT03862690 1299 1306 B-Drug-Name
® NCT03862690 1306 1307 I-Drug-Name
30 NCT03862690 1309 1311 I-Drug-Name
or NCT03862690 1312 1314 O
to NCT03862690 1315 1317 O
any NCT03862690 1318 1321 O
of NCT03862690 1322 1324 O
the NCT03862690 1325 1328 O
excipients NCT03862690 1329 1339 O

- NCT03862690 1342 1343 O
Pregnancy NCT03862690 1345 1354 B-Condition-Name
or NCT03862690 1355 1357 O
intention NCT03862690 1358 1367 O
of NCT03862690 1368 1370 O
becoming NCT03862690 1371 1379 O
pregnant NCT03862690 1380 1388 B-Condition-Name

Inclusion NCT03865706 0 9 O
Criteria NCT03865706 10 18 O
: NCT03865706 19 20 O

1 NCT03865706 25 26 O
. NCT03865706 26 27 O
Hospitalized NCT03865706 29 41 B-Encounter-Type___Encounter-Type-Value:inpatient
in NCT03865706 42 44 O
an NCT03865706 45 47 O
eligible NCT03865706 48 56 O
medical NCT03865706 57 64 O
ICU NCT03865706 65 68 B-Location___Location-Value:unit

2 NCT03865706 72 73 O
. NCT03865706 73 74 O
Age NCT03865706 76 79 O
≥ NCT03865706 80 81 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03865706 83 85 B-Eq-Value
years NCT03865706 86 91 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03865706 92 95 O
at NCT03865706 96 98 O
the NCT03865706 99 102 O
time NCT03865706 103 107 O
of NCT03865706 108 110 O
hospitalization NCT03865706 111 126 B-Encounter-Type___Encounter-Type-Value:inpatient

3 NCT03865706 130 131 O
. NCT03865706 131 132 O
With NCT03865706 134 138 O
sepsis NCT03865706 139 145 B-Condition-Name
as NCT03865706 146 148 O
defined NCT03865706 149 156 O
by NCT03865706 157 159 O
the NCT03865706 160 163 O
Sepsis NCT03865706 164 170 O
- NCT03865706 171 172 O
3 NCT03865706 174 175 O
( NCT03865706 176 177 O
2016 NCT03865706 179 183 O
) NCT03865706 184 185 O
consensus NCT03865706 186 195 O
as NCT03865706 196 198 O
a NCT03865706 199 200 O
known NCT03865706 201 206 O
or NCT03865706 207 209 O
suspected NCT03865706 210 219 O
infection NCT03865706 220 229 B-Condition-Name
with NCT03865706 230 234 O
a NCT03865706 235 236 O
SOFA NCT03865706 237 241 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03865706 242 247 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03865706 248 250 O
≥ NCT03865706 251 252 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03865706 254 255 B-Eq-Value
points NCT03865706 256 262 O
above NCT03865706 263 268 B-Eq-Operator___Eq-Operator-Value:GT
baseline NCT03865706 269 277 B-Eq-Unit___Eq-Unit-Value:ref-range-normal

4 NCT03865706 281 282 O
. NCT03865706 282 283 O
Received NCT03865706 285 293 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
broad NCT03865706 294 299 O
- NCT03865706 300 301 O
spectrum NCT03865706 302 310 O
antibiotics NCT03865706 311 322 B-Drug-Name
within NCT03865706 323 329 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03865706 330 333 O
last NCT03865706 334 338 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
24 NCT03865706 340 342 B-Eq-Value
hours NCT03865706 343 348 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03865706 349 351 O
ordered NCT03865706 352 359 O
and NCT03865706 360 363 O
pending NCT03865706 364 371 O
administration NCT03865706 372 386 O

5 NCT03865706 390 391 O
. NCT03865706 391 392 O
Able NCT03865706 394 398 O
to NCT03865706 399 401 O
complete NCT03865706 402 410 O
enrollment NCT03865706 411 421 O
within NCT03865706 422 428 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03865706 430 431 B-Eq-Value
hours NCT03865706 432 437 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03865706 438 440 O
ICU NCT03865706 441 444 B-Location___Location-Value:unit
admission NCT03865706 445 454 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03865706 455 458 O
administration NCT03865706 459 473 O
of NCT03865706 474 476 O
the NCT03865706 477 480 O
intervention NCT03865706 481 493 O
within NCT03865706 494 500 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03865706 502 503 B-Eq-Value
hours NCT03865706 504 509 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03865706 510 512 O
ICU NCT03865706 513 516 B-Location___Location-Value:unit
admission NCT03865706 517 526 B-Encounter-Type___Encounter-Type-Value:inpatient

Exclusion NCT03865706 527 536 O
Criteria NCT03865706 537 545 O
: NCT03865706 546 547 O

1 NCT03865706 552 553 O
. NCT03865706 553 554 O
Inability NCT03865706 556 565 O
to NCT03865706 566 568 O
receive NCT03865706 569 576 O
oral NCT03865706 577 581 O
or NCT03865706 582 584 O
enteric NCT03865706 585 592 O
fluids NCT03865706 593 599 B-Procedure-Name

2 NCT03865706 603 604 O
. NCT03865706 604 605 O
Inulin NCT03865706 607 613 B-Drug-Name
allergy NCT03865706 614 621 O

3 NCT03865706 625 626 O
. NCT03865706 626 627 O
Hyponatremia NCT03865706 629 641 B-Condition-Name
( NCT03865706 642 643 O
serum NCT03865706 644 649 B-Observation-Name___Observation-Type-Value:lab
sodium NCT03865706 650 656 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03865706 657 658 B-Eq-Operator___Eq-Operator-Value:LTEQ
128 NCT03865706 660 663 B-Eq-Value
mEq NCT03865706 664 667 B-Eq-Unit
/ NCT03865706 668 669 O
L NCT03865706 670 671 B-Eq-Unit
) NCT03865706 672 673 O

4 NCT03865706 678 679 O
. NCT03865706 679 680 O
Immunosuppression NCT03865706 682 699 B-Condition-Name
, NCT03865706 700 701 O
defined NCT03865706 702 709 O
as NCT03865706 710 712 O
history NCT03865706 713 720 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865706 721 723 O
solid NCT03865706 724 729 B-Procedure-Name
organ NCT03865706 730 735 I-Procedure-Name
transplant NCT03865706 736 746 I-Procedure-Name
or NCT03865706 747 749 O
as NCT03865706 750 752 O
receipt NCT03865706 753 760 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865706 761 763 O
ablative NCT03865706 764 772 B-Procedure-Name
chemotherapy NCT03865706 773 785 I-Procedure-Name
, NCT03865706 786 787 O
steroids NCT03865706 788 796 B-Drug-Name
at NCT03865706 797 799 O
the NCT03865706 800 803 O
equivalent NCT03865706 804 814 O
of NCT03865706 815 817 O
≥ NCT03865706 818 819 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03865706 821 822 B-Eq-Value
mg NCT03865706 823 825 B-Eq-Unit
/ NCT03865706 826 827 O
day NCT03865706 828 831 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prednisone NCT03865706 832 842 B-Drug-Name
, NCT03865706 843 844 O
antimetabolites NCT03865706 845 860 B-Drug-Name
, NCT03865706 861 862 O
anti NCT03865706 863 867 B-Drug-Name
- NCT03865706 868 869 I-Drug-Name
TNFα NCT03865706 870 874 I-Drug-Name
agents NCT03865706 875 881 I-Drug-Name
, NCT03865706 882 883 O
calcineurin NCT03865706 884 895 B-Drug-Name
inhibitors NCT03865706 896 906 I-Drug-Name
, NCT03865706 907 908 O
or NCT03865706 909 911 O
mycophenolate NCT03865706 912 925 B-Drug-Name

5 NCT03865706 929 930 O
. NCT03865706 930 931 O
Surgery NCT03865706 933 940 B-Procedure-Name
involving NCT03865706 941 950 O
the NCT03865706 951 954 O
intestinal NCT03865706 955 965 O
lumen NCT03865706 966 971 O
within NCT03865706 972 978 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03865706 980 982 B-Eq-Value
days NCT03865706 983 987 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
or NCT03865706 988 990 O
known NCT03865706 991 996 O
intestinal NCT03865706 997 1007 B-Condition-Name
strictures NCT03865706 1008 1018 I-Condition-Name

6 NCT03865706 1022 1023 O
. NCT03865706 1023 1024 O
Do NCT03865706 1026 1028 B-Observation-Name
Not NCT03865706 1029 1032 I-Observation-Name
Resuscitate NCT03865706 1033 1044 I-Observation-Name
( NCT03865706 1045 1046 O
DNR NCT03865706 1047 1050 B-Observation-Name
) NCT03865706 1051 1052 O
or NCT03865706 1053 1055 O
Do NCT03865706 1056 1058 B-Observation-Name
Not NCT03865706 1059 1062 I-Observation-Name
Intubate NCT03865706 1063 1071 I-Observation-Name
( NCT03865706 1072 1073 O
DNI NCT03865706 1074 1077 B-Observation-Name
) NCT03865706 1078 1079 O
status NCT03865706 1080 1086 O
, NCT03865706 1087 1088 O
or NCT03865706 1089 1091 O
" NCT03865706 1092 1093 O
no NCT03865706 1093 1095 B-Observation-Name
escalation NCT03865706 1096 1106 I-Observation-Name
of NCT03865706 1107 1109 I-Observation-Name
care NCT03865706 1110 1114 I-Observation-Name
" NCT03865706 1114 1115 O
orders NCT03865706 1116 1122 O

7 NCT03865706 1126 1127 O
. NCT03865706 1127 1128 O
Lack NCT03865706 1130 1134 O
capacity NCT03865706 1135 1143 O
for NCT03865706 1144 1147 O
consent NCT03865706 1148 1155 O
and NCT03865706 1156 1159 O
no NCT03865706 1160 1162 O
appropriate NCT03865706 1163 1174 O
Legally NCT03865706 1175 1182 O
Authorized NCT03865706 1183 1193 O
Representative NCT03865706 1194 1208 O
( NCT03865706 1209 1210 O
LAR NCT03865706 1211 1214 O
) NCT03865706 1215 1216 O


Inclusion NCT03863405 0 9 O
Criteria NCT03863405 10 18 O
: NCT03863405 19 20 O

- NCT03863405 24 25 O
Patients NCT03863405 27 35 O
older NCT03863405 36 41 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863405 42 46 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03863405 48 50 B-Eq-Value
years NCT03863405 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03863405 57 58 O
of NCT03863405 59 61 O
both NCT03863405 62 66 O
sexes NCT03863405 67 72 O
) NCT03863405 73 74 O
diagnosed NCT03863405 75 84 O
with NCT03863405 85 89 O
rheumatoid NCT03863405 90 100 B-Condition-Name
arthritis NCT03863405 101 110 I-Condition-Name
according NCT03863405 111 120 O
to NCT03863405 121 123 O
ACR NCT03863405 124 127 O
/ NCT03863405 128 129 O
EULAR NCT03863405 130 135 O
2010 NCT03863405 137 141 O
criteria NCT03863405 142 150 O
. NCT03863405 152 153 O

- NCT03863405 157 158 O
Patients NCT03863405 160 168 O
with NCT03863405 169 173 O
moderate NCT03863405 174 182 B-Severity___Severity-Value:moderate
to NCT03863405 183 185 B-Eq-Operator___Eq-Operator-Value:BETWEEN
high NCT03863405 186 190 B-Severity___Severity-Value:severe
disease NCT03863405 191 198 B-Condition-Name
activity NCT03863405 199 207 I-Condition-Name
( NCT03863405 208 209 O
DAS NCT03863405 210 213 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03863405 214 215 I-Observation-Name___Observation-Type-Value:clinical-score
28 NCT03863405 217 219 I-Observation-Name___Observation-Type-Value:clinical-score
. NCT03863405 221 222 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03863405 224 229 I-Observation-Name___Observation-Type-Value:clinical-score
greater NCT03863405 230 237 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863405 238 242 I-Eq-Operator___Eq-Operator-Value:GT
3.2 NCT03863405 244 247 B-Eq-Value
) NCT03863405 248 249 O

- NCT03863405 253 254 O
Patients NCT03863405 256 264 O
received NCT03863405 265 273 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
the NCT03863405 274 277 O
standard NCT03863405 278 286 B-Procedure-Name
therapy NCT03863405 287 294 I-Procedure-Name
( NCT03863405 295 296 O
i NCT03863405 297 298 O
. NCT03863405 299 300 O
e NCT03863405 301 302 O
. NCT03863405 303 304 O
one NCT03863405 306 309 B-Eq-Value
or NCT03863405 310 312 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03863405 313 317 I-Eq-Operator___Eq-Operator-Value:GTEQ
conventional NCT03863405 318 330 O
DMARDs NCT03863405 331 337 B-Drug-Name
) NCT03863405 338 339 O
for NCT03863405 340 343 O
at NCT03863405 344 346 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863405 347 352 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03863405 353 358 B-Eq-Value
months NCT03863405 359 365 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03863405 366 367 O

Exclusion NCT03863405 369 378 O
Criteria NCT03863405 379 387 O
: NCT03863405 388 389 O

- NCT03863405 393 394 O
Known NCT03863405 396 401 O
hypersensitivity NCT03863405 402 418 B-Condition-Name
to NCT03863405 419 421 O
metformin NCT03863405 422 431 B-Drug-Name
. NCT03863405 432 433 O

- NCT03863405 437 438 O
Patients NCT03863405 440 448 O
who NCT03863405 449 452 O
have NCT03863405 453 457 O
a NCT03863405 458 459 O
prior NCT03863405 460 465 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03863405 466 475 O
with NCT03863405 476 480 O
diabetes NCT03863405 481 489 B-Condition-Name
mellitus NCT03863405 490 498 I-Condition-Name
. NCT03863405 499 500 O

- NCT03863405 504 505 O
Patients NCT03863405 507 515 O
receive NCT03863405 516 523 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
metformin NCT03863405 524 533 B-Drug-Name
for NCT03863405 534 537 O
any NCT03863405 538 541 O
other NCT03863405 542 547 O
indications NCT03863405 548 559 O
. NCT03863405 560 561 O

- NCT03863405 565 566 O
Patients NCT03863405 568 576 O
with NCT03863405 577 581 O
congestive NCT03863405 582 592 B-Condition-Name
heart NCT03863405 593 598 I-Condition-Name
failure NCT03863405 599 606 I-Condition-Name
. NCT03863405 607 608 O

- NCT03863405 612 613 O
Patients NCT03863405 615 623 O
with NCT03863405 624 628 O
a NCT03863405 629 630 O
history NCT03863405 631 638 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863405 639 641 O
myocardial NCT03863405 642 652 B-Condition-Name
infarction NCT03863405 653 663 I-Condition-Name
. NCT03863405 664 665 O

- NCT03863405 669 670 O
Patients NCT03863405 672 680 O
with NCT03863405 681 685 O
severe NCT03863405 686 692 B-Severity___Severity-Value:severe
anemia NCT03863405 693 699 B-Condition-Name
. NCT03863405 700 701 O

- NCT03863405 705 706 O
Patients NCT03863405 708 716 O
with NCT03863405 717 721 O
active NCT03863405 722 728 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infections NCT03863405 729 739 B-Condition-Name
or NCT03863405 740 742 O
other NCT03863405 743 748 O
inflammatory NCT03863405 749 761 B-Condition-Name
diseases NCT03863405 762 770 I-Condition-Name
. NCT03863405 771 772 O

- NCT03863405 776 777 O
Patients NCT03863405 779 787 O
receiving NCT03863405 788 797 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
biological NCT03863405 798 808 B-Procedure-Name
therapy NCT03863405 809 816 I-Procedure-Name
. NCT03863405 817 818 O

- NCT03863405 822 823 O
Pregnancy NCT03863405 825 834 B-Condition-Name
or NCT03863405 835 837 O
lactation NCT03863405 838 847 B-Condition-Name
. NCT03863405 848 849 O

- NCT03863405 853 854 O
Patients NCT03863405 856 864 O
with NCT03863405 865 869 O
impaired NCT03863405 870 878 B-Condition-Name
liver NCT03863405 879 884 I-Condition-Name
functions NCT03863405 885 894 I-Condition-Name
. NCT03863405 895 896 O

- NCT03863405 900 901 O
Patients NCT03863405 903 911 O
with NCT03863405 912 916 O
impaired NCT03863405 917 925 B-Condition-Name
kidney NCT03863405 926 932 I-Condition-Name
functions NCT03863405 933 942 I-Condition-Name
( NCT03863405 943 944 O
serum NCT03863405 945 950 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03863405 951 961 I-Observation-Name___Observation-Type-Value:lab
concentrations NCT03863405 962 976 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03863405 977 978 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.5 NCT03863405 980 983 B-Eq-Value
and NCT03863405 984 987 O
≥ NCT03863405 988 989 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.4 NCT03863405 991 994 B-Eq-Value
mg NCT03863405 995 997 B-Eq-Unit
/ NCT03863405 998 999 O
dL NCT03863405 1000 1002 B-Eq-Unit
in NCT03863405 1003 1005 O
males NCT03863405 1006 1011 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03863405 1012 1015 O
females NCT03863405 1016 1023 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
respectively NCT03863405 1024 1036 O
) NCT03863405 1037 1038 O
. NCT03863405 1040 1041 O

- NCT03863405 1045 1046 O
Patients NCT03863405 1048 1056 O
with NCT03863405 1057 1061 O
malignancies NCT03863405 1062 1074 B-Condition-Name
. NCT03863405 1075 1076 O

Inclusion NCT03868020 0 9 O
Criteria NCT03868020 10 18 O
: NCT03868020 19 20 O

- NCT03868020 24 25 O
Adults NCT03868020 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
with NCT03868020 34 38 O
biopsy NCT03868020 39 45 B-Procedure-Name
proven NCT03868020 46 52 O
metastatic NCT03868020 53 63 O
cervical NCT03868020 64 72 O
nodal NCT03868020 73 78 O
squamous NCT03868020 79 87 O
cell NCT03868020 88 92 O
carcinoma NCT03868020 93 102 B-Condition-Name

- NCT03868020 105 106 O
CT NCT03868020 108 110 B-Procedure-Name
of NCT03868020 111 113 O
the NCT03868020 114 117 O
neck NCT03868020 118 122 O
with NCT03868020 123 127 O
contrast NCT03868020 128 136 O
that NCT03868020 137 141 O
does NCT03868020 142 146 O
not NCT03868020 147 150 O
confidently NCT03868020 151 162 O
identify NCT03868020 163 171 O
a NCT03868020 172 173 O
primary NCT03868020 174 181 O
oropharyngeal NCT03868020 182 195 O
site NCT03868020 196 200 O
of NCT03868020 201 203 O
disease NCT03868020 204 211 O

- NCT03868020 214 215 O
Planned NCT03868020 217 224 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
standard NCT03868020 225 233 O
of NCT03868020 234 236 O
care NCT03868020 237 241 O
18 NCT03868020 243 245 O
F NCT03868020 246 247 O
- NCT03868020 248 249 O
FDG NCT03868020 250 253 O
PET NCT03868020 254 257 B-Procedure-Name
CT NCT03868020 258 260 I-Procedure-Name
examination NCT03868020 261 272 I-Procedure-Name

- NCT03868020 275 276 O
Planned NCT03868020 278 285 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
standard NCT03868020 286 294 O
of NCT03868020 295 297 O
care NCT03868020 298 302 B-Procedure-Name
exam NCT03868020 303 307 I-Procedure-Name
under NCT03868020 308 313 O
anesthesia NCT03868020 314 324 B-Procedure-Name
with NCT03868020 325 329 O
oropharyngeal NCT03868020 330 343 B-Procedure-Name
surgical NCT03868020 344 352 I-Procedure-Name
biopsy NCT03868020 353 359 I-Procedure-Name

Exclusion NCT03868020 360 369 O
Criteria NCT03868020 370 378 O
: NCT03868020 379 380 O

- NCT03868020 384 385 O
Pregnant NCT03868020 387 395 B-Condition-Name
women NCT03868020 396 401 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03868020 404 405 O
Known NCT03868020 407 412 O
allergy NCT03868020 413 420 O
to NCT03868020 421 423 O
FDG NCT03868020 424 427 B-Drug-Name
, NCT03868020 428 429 O
fluciclovine NCT03868020 430 442 B-Drug-Name
, NCT03868020 443 444 O
or NCT03868020 445 447 O
iodine NCT03868020 448 454 O
- NCT03868020 455 456 O
based NCT03868020 457 462 O
contrast NCT03868020 463 471 B-Drug-Name
agents NCT03868020 472 478 I-Drug-Name

- NCT03868020 481 482 O
Severe NCT03868020 484 490 B-Severity___Severity-Value:severe
renal NCT03868020 491 496 B-Condition-Name
dysfunction NCT03868020 497 508 I-Condition-Name
( NCT03868020 509 510 O
glomerular NCT03868020 511 521 B-Observation-Name___Observation-Type-Value:lab
filtrate NCT03868020 522 530 I-Observation-Name___Observation-Type-Value:lab
rate NCT03868020 531 535 I-Observation-Name___Observation-Type-Value:lab
[ NCT03868020 536 537 O
within NCT03868020 538 544 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03868020 546 548 B-Eq-Value
days NCT03868020 549 553 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
] NCT03868020 554 555 O
less NCT03868020 556 560 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868020 561 565 I-Eq-Operator___Eq-Operator-Value:LT
30 NCT03868020 567 569 B-Eq-Value
) NCT03868020 570 571 O

- NCT03868020 575 576 O
Inability NCT03868020 578 587 B-Condition-Name
to NCT03868020 588 590 I-Condition-Name
tolerate NCT03868020 591 599 I-Condition-Name
lying NCT03868020 600 605 I-Condition-Name
supine NCT03868020 606 612 I-Condition-Name
, NCT03868020 613 614 O
relatively NCT03868020 615 625 O
motionless NCT03868020 626 636 O
for NCT03868020 637 640 O
up NCT03868020 641 643 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03868020 644 646 I-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03868020 648 649 B-Eq-Value
hour NCT03868020 650 654 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

Inclusion NCT03863613 0 9 O
Criteria NCT03863613 10 18 O
: NCT03863613 19 20 O

- NCT03863613 24 25 O
Women NCT03863613 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03863613 33 37 O
a NCT03863613 38 39 O
twin NCT03863613 40 44 O
pregnancy NCT03863613 45 54 B-Condition-Name
( NCT03863613 55 56 O
mono NCT03863613 57 61 O
- NCT03863613 62 63 O
and NCT03863613 64 67 O
di NCT03863613 68 70 O
- NCT03863613 71 72 O
chorionic NCT03863613 73 82 O
) NCT03863613 83 84 O

- NCT03863613 88 89 O
16 NCT03863613 92 94 B-Eq-Value
0 NCT03863613 96 97 I-Eq-Value
/ NCT03863613 98 99 I-Eq-Value
7 NCT03863613 101 102 I-Eq-Value
to NCT03863613 103 105 B-Eq-Operator___Eq-Operator-Value:BETWEEN
22 NCT03863613 107 109 B-Eq-Value
0 NCT03863613 111 112 I-Eq-Value
/ NCT03863613 113 114 I-Eq-Value
7 NCT03863613 116 117 I-Eq-Value
weeks NCT03863613 118 123 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03863613 124 126 O
gestation NCT03863613 127 136 B-Observation-Name

- NCT03863613 139 140 O
Maternal NCT03863613 142 150 O
age NCT03863613 151 154 O
≥ NCT03863613 155 156 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863613 158 160 B-Eq-Value
yrs NCT03863613 161 164 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863613 167 168 O
Cervical NCT03863613 170 178 B-Observation-Name___Observation-Type-Value:measurement
length NCT03863613 179 185 I-Observation-Name___Observation-Type-Value:measurement
≤ NCT03863613 186 187 B-Eq-Operator___Eq-Operator-Value:LTEQ
28 NCT03863613 189 191 B-Eq-Value
mm NCT03863613 192 194 B-Eq-Unit

- NCT03863613 197 198 O
Informed NCT03863613 200 208 O
consent NCT03863613 209 216 O

- NCT03863613 219 220 O
Not NCT03863613 222 225 O
participating NCT03863613 226 239 O
in NCT03863613 240 242 O
another NCT03863613 243 250 O
preterm NCT03863613 251 258 O
birth NCT03863613 259 264 O
study NCT03863613 265 270 O
at NCT03863613 271 273 O
the NCT03863613 274 277 O
same NCT03863613 278 282 O
time NCT03863613 283 287 O

Exclusion NCT03863613 288 297 O
Criteria NCT03863613 298 306 O
: NCT03863613 307 308 O

- NCT03863613 312 313 O
Uterine NCT03863613 315 322 B-Condition-Name
anomalies NCT03863613 323 332 I-Condition-Name

- NCT03863613 335 336 O
Cervical NCT03863613 338 346 B-Condition-Name
dilation NCT03863613 347 355 I-Condition-Name
with NCT03863613 356 360 O
visible NCT03863613 361 368 O
amniotic NCT03863613 369 377 B-Condition-Name
membranes NCT03863613 378 387 I-Condition-Name
or NCT03863613 388 390 O
amniotic NCT03863613 391 399 B-Condition-Name
membranes NCT03863613 400 409 I-Condition-Name
prolapsed NCT03863613 410 419 I-Condition-Name
into NCT03863613 420 424 O
the NCT03863613 425 428 O
vagina NCT03863613 429 435 O

- NCT03863613 438 439 O
Twin NCT03863613 441 445 O
- NCT03863613 446 447 O
to NCT03863613 448 450 O
- NCT03863613 451 452 O
twin NCT03863613 453 457 O
transfusion NCT03863613 458 469 B-Condition-Name
syndrome NCT03863613 470 478 I-Condition-Name

- NCT03863613 481 482 O
Stillbirth NCT03863613 484 494 B-Condition-Name
or NCT03863613 495 497 O
major NCT03863613 498 503 B-Severity___Severity-Value:severe
congenital NCT03863613 504 514 B-Condition-Name
abnormalities NCT03863613 515 528 I-Condition-Name
in NCT03863613 529 531 O
any NCT03863613 532 535 O
of NCT03863613 536 538 O
the NCT03863613 539 542 O
fetus NCT03863613 543 548 O

- NCT03863613 551 552 O
Severe NCT03863613 554 560 B-Severity___Severity-Value:severe
vaginal NCT03863613 561 568 B-Condition-Name
discharge NCT03863613 569 578 I-Condition-Name

- NCT03863613 581 582 O
Acute NCT03863613 584 589 B-Severity___Severity-Value:severe
vaginitis NCT03863613 590 599 B-Condition-Name
or NCT03863613 600 602 O
cervicitis NCT03863613 603 613 B-Condition-Name

- NCT03863613 616 617 O
Vaginal NCT03863613 619 626 O
bleeding NCT03863613 627 635 B-Condition-Name

- NCT03863613 638 639 O
Placental NCT03863613 641 650 B-Condition-Name
preavia NCT03863613 651 658 I-Condition-Name

- NCT03863613 661 662 O
Vasa NCT03863613 664 668 B-Condition-Name
preavia NCT03863613 669 676 I-Condition-Name

- NCT03863613 679 680 O
Premature NCT03863613 682 691 O
rupture NCT03863613 692 699 B-Condition-Name
of NCT03863613 700 702 I-Condition-Name
membranes NCT03863613 703 712 I-Condition-Name

- NCT03863613 715 716 O
Premature NCT03863613 718 727 O
labor NCT03863613 728 733 B-Condition-Name
with NCT03863613 734 738 O
/ NCT03863613 739 740 O
without NCT03863613 741 748 O
ruptured NCT03863613 749 757 B-Condition-Name
membrane NCT03863613 758 766 I-Condition-Name

- NCT03863613 769 770 O
Suspicion NCT03863613 772 781 O
of NCT03863613 782 784 O
chorioamnionitis NCT03863613 785 801 B-Condition-Name

- NCT03863613 804 805 O
Cerclage NCT03863613 807 815 B-Condition-Name
in NCT03863613 816 818 I-Condition-Name
place NCT03863613 819 824 I-Condition-Name
or NCT03863613 825 827 O
unable NCT03863613 828 834 O
to NCT03863613 835 837 O
undergo NCT03863613 838 845 O
cervical NCT03863613 846 854 B-Procedure-Name
cerclage NCT03863613 855 863 O
or NCT03863613 864 866 O
pessary NCT03863613 867 874 O

Inclusion NCT03867461 0 9 O
Criteria NCT03867461 10 18 O
: NCT03867461 19 20 O

- NCT03867461 24 25 O
Adults NCT03867461 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
determined NCT03867461 34 44 O
to NCT03867461 45 47 O
be NCT03867461 48 50 O
candidates NCT03867461 51 61 O
for NCT03867461 62 65 O
venous NCT03867461 66 72 B-Procedure-Name
sinus NCT03867461 73 78 I-Procedure-Name
stenting NCT03867461 79 87 I-Procedure-Name

Inclusion NCT03866031 0 9 O
Criteria NCT03866031 10 18 O
: NCT03866031 19 20 O

1 NCT03866031 25 26 O
. NCT03866031 26 27 O
the NCT03866031 29 32 O
patient NCT03866031 33 40 O
should NCT03866031 41 47 O
be NCT03866031 48 50 O
completely NCT03866031 51 61 O
edentulous NCT03866031 62 72 B-Condition-Name
for NCT03866031 73 76 O
at NCT03866031 77 79 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866031 80 85 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03866031 87 88 B-Eq-Value
months NCT03866031 89 95 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03866031 96 97 O

2 NCT03866031 102 103 O
. NCT03866031 103 104 O
first NCT03866031 106 111 O
class NCT03866031 112 117 O
jaw NCT03866031 118 121 O
relation NCT03866031 122 130 O
. NCT03866031 131 132 O

3 NCT03866031 137 138 O
. NCT03866031 138 139 O
adequate NCT03866031 141 149 B-Polarity___Polarity-Value:normal
bone NCT03866031 150 154 B-Condition-Name
for NCT03866031 155 158 O
an NCT03866031 159 161 O
implant NCT03866031 162 169 B-Procedure-Name
length NCT03866031 170 176 O
of NCT03866031 177 179 O
at NCT03866031 180 182 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866031 183 188 I-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03866031 190 192 B-Eq-Value
mm NCT03866031 193 195 B-Eq-Unit
and NCT03866031 196 199 O
diameter NCT03866031 200 208 O
of NCT03866031 209 211 O
at NCT03866031 212 214 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866031 215 220 I-Eq-Operator___Eq-Operator-Value:GTEQ
2.75 NCT03866031 222 226 B-Eq-Value
mm NCT03866031 227 229 B-Eq-Unit
. NCT03866031 230 231 O

4 NCT03866031 236 237 O
. NCT03866031 237 238 O
the NCT03866031 240 243 O
patients NCT03866031 244 252 O
should NCT03866031 253 259 O
be NCT03866031 260 262 O
able NCT03866031 263 267 O
to NCT03866031 268 270 O
speak NCT03866031 271 276 O
and NCT03866031 277 280 O
write NCT03866031 281 286 O
in NCT03866031 287 289 O
arabic NCT03866031 290 296 B-Language
. NCT03866031 297 298 O

Exclusion NCT03866031 300 309 O
Criteria NCT03866031 310 318 O
: NCT03866031 319 320 O

1 NCT03866031 323 324 O
) NCT03866031 325 326 O
patients NCT03866031 327 335 O
who NCT03866031 336 339 O
received NCT03866031 340 348 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiotherapy NCT03866031 349 361 B-Procedure-Name
to NCT03866031 362 364 O
the NCT03866031 365 368 O
head NCT03866031 369 373 O
or NCT03866031 374 376 O
neck NCT03866031 377 381 O
region NCT03866031 382 388 O
for NCT03866031 389 392 O
tumors NCT03866031 393 399 B-Condition-Name
. NCT03866031 400 401 O
( NCT03866031 403 404 O
2 NCT03866031 406 407 O
) NCT03866031 408 409 O
a NCT03866031 410 411 O
history NCT03866031 412 419 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866031 420 422 O
chemotherapy NCT03866031 423 435 B-Procedure-Name
. NCT03866031 436 437 O
( NCT03866031 439 440 O
3 NCT03866031 442 443 O
) NCT03866031 444 445 O
patients NCT03866031 446 454 O
on NCT03866031 455 457 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
long NCT03866031 458 462 O
- NCT03866031 463 464 O
term NCT03866031 465 469 O
steroids NCT03866031 470 478 B-Drug-Name
, NCT03866031 479 480 O
or NCT03866031 481 483 O
bisphosphonates NCT03866031 484 499 B-Drug-Name
. NCT03866031 500 501 O
( NCT03866031 503 504 O
4 NCT03866031 506 507 O
) NCT03866031 508 509 O
heavy NCT03866031 510 515 B-Severity___Severity-Value:severe
smokers NCT03866031 516 523 B-Condition-Name
. NCT03866031 524 525 O

( NCT03866031 528 529 O
5 NCT03866031 531 532 O
) NCT03866031 533 534 O
patients NCT03866031 535 543 O
with NCT03866031 544 548 O
physical NCT03866031 549 557 O
and NCT03866031 558 561 O
mental NCT03866031 562 568 O
dis NCT03866031 569 572 B-Condition-Name
- NCT03866031 573 574 I-Condition-Name
abilities NCT03866031 575 584 I-Condition-Name
that NCT03866031 585 589 O
interfere NCT03866031 590 599 B-Stability___Stability-Value:change
with NCT03866031 600 604 O
the NCT03866031 605 608 O
maintenance NCT03866031 609 620 O
of NCT03866031 621 623 O
implants NCT03866031 624 632 B-Procedure-Name
. NCT03866031 633 634 O

( NCT03866031 637 638 O
6 NCT03866031 640 641 O
) NCT03866031 642 643 O
uncontrolled NCT03866031 644 656 O
systematic NCT03866031 657 667 O
disease NCT03866031 668 675 B-Condition-Name
that NCT03866031 676 680 O
could NCT03866031 681 686 O
compromise NCT03866031 687 697 B-Stability___Stability-Value:change
implant NCT03866031 698 705 B-Procedure-Name
surgery NCT03866031 706 713 I-Procedure-Name
. NCT03866031 714 715 O
( NCT03866031 717 718 O
7 NCT03866031 720 721 O
) NCT03866031 722 723 O
extreme NCT03866031 724 731 B-Severity___Severity-Value:severe
bruxism NCT03866031 732 739 B-Condition-Name
. NCT03866031 740 741 O
( NCT03866031 743 744 O
8 NCT03866031 746 747 O
) NCT03866031 748 749 O
infectious NCT03866031 750 760 B-Condition-Name
disease NCT03866031 761 768 I-Condition-Name
. NCT03866031 769 770 O
( NCT03866031 772 773 O
9 NCT03866031 775 776 O
) NCT03866031 777 778 O
temporomandibular NCT03866031 779 796 B-Condition-Name
joint NCT03866031 797 802 I-Condition-Name
dysfunction NCT03866031 803 814 I-Condition-Name
. NCT03866031 815 816 O


Inclusion NCT03860454 0 9 O
Criteria NCT03860454 10 18 O
: NCT03860454 19 20 O

- NCT03860454 24 25 O
LMNA NCT03860454 27 31 B-Condition-Name
+ NCT03860454 32 33 B-Polarity___Polarity-Value:positive
cases NCT03860454 34 39 O
with NCT03860454 40 44 O
pathogenic NCT03860454 45 55 B-Condition-Name
LMNA NCT03860454 56 60 I-Condition-Name
mutations NCT03860454 61 70 I-Condition-Name
for NCT03860454 71 74 O
LMNA NCT03860454 75 79 B-Condition-Name
+ NCT03860454 80 81 B-Polarity___Polarity-Value:positive
and NCT03860454 82 85 O
heart NCT03860454 86 91 B-Observation-Specimen
myocardial NCT03860454 92 102 I-Observation-Specimen
samples NCT03860454 103 110 I-Observation-Specimen
from NCT03860454 111 115 O
the NCT03860454 116 119 O
explanted NCT03860454 120 129 O
hearts NCT03860454 130 136 O
of NCT03860454 137 139 O
LMNA NCT03860454 140 144 B-Condition-Name
+ NCT03860454 145 146 B-Polarity___Polarity-Value:positive
patients NCT03860454 147 155 O
who NCT03860454 156 159 O
are NCT03860454 160 163 O
scheduled NCT03860454 164 173 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03860454 174 176 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03860454 177 184 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
clinically NCT03860454 185 195 O
indicated NCT03860454 196 205 O
heart NCT03860454 206 211 B-Procedure-Name
transplantation NCT03860454 212 227 I-Procedure-Name
at NCT03860454 228 230 O
the NCT03860454 231 234 O
Papworth NCT03860454 235 243 B-Location___Location-Value:hospital
Hospital NCT03860454 244 252 I-Location___Location-Value:hospital
NHS NCT03860454 253 256 O
Trust NCT03860454 257 262 O
. NCT03860454 263 264 O

- NCT03860454 268 269 O
DCMWT NCT03860454 271 276 B-Condition-Name
cases NCT03860454 277 282 O
: NCT03860454 283 284 O
patients NCT03860454 285 293 O
with NCT03860454 294 298 O
heart NCT03860454 299 304 B-Condition-Name
muscle NCT03860454 305 311 I-Condition-Name
failure NCT03860454 312 319 I-Condition-Name
but NCT03860454 320 323 O
with NCT03860454 324 328 O
wild NCT03860454 329 333 O
- NCT03860454 334 335 O
type NCT03860454 336 340 O
lamin NCT03860454 341 346 B-Condition-Name
gene NCT03860454 347 351 I-Condition-Name
. NCT03860454 352 353 O
Heart NCT03860454 355 360 B-Observation-Specimen
myocardial NCT03860454 361 371 I-Observation-Specimen
samples NCT03860454 372 379 I-Observation-Specimen
from NCT03860454 380 384 O
the NCT03860454 385 388 O
explanted NCT03860454 389 398 O
hearts NCT03860454 399 405 O
of NCT03860454 406 408 O
DCMWT NCT03860454 409 414 B-Condition-Name
patients NCT03860454 415 423 O
who NCT03860454 424 427 O
are NCT03860454 428 431 O
scheduled NCT03860454 432 441 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03860454 442 444 O
undergo NCT03860454 445 452 O
clinically NCT03860454 453 463 O
indicated NCT03860454 464 473 O
heart NCT03860454 474 479 B-Procedure-Name
transplantation NCT03860454 480 495 I-Procedure-Name
at NCT03860454 496 498 O
the NCT03860454 499 502 O
Papworth NCT03860454 503 511 B-Location___Location-Value:hospital
Hospital NCT03860454 512 520 I-Location___Location-Value:hospital
NHS NCT03860454 521 524 O
Trust NCT03860454 525 530 O
. NCT03860454 531 532 O

- NCT03860454 536 537 O
HV NCT03860454 539 541 O
( NCT03860454 542 543 O
controls NCT03860454 544 552 O
) NCT03860454 553 554 O
: NCT03860454 556 557 O
matched NCT03860454 558 565 O
to NCT03860454 566 568 O
cases NCT03860454 569 574 O
. NCT03860454 575 576 O

Exclusion NCT03860454 578 587 O
Criteria NCT03860454 588 596 O
: NCT03860454 597 598 O

- NCT03860454 602 603 O
Needle NCT03860454 605 611 B-Condition-Name
- NCT03860454 612 613 I-Condition-Name
phobia NCT03860454 614 620 I-Condition-Name
that NCT03860454 621 625 O
would NCT03860454 626 631 O
preclude NCT03860454 632 640 O
blood NCT03860454 641 646 B-Procedure-Name
- NCT03860454 647 648 I-Procedure-Name
letting NCT03860454 649 656 I-Procedure-Name

- NCT03860454 659 660 O
Participants NCT03860454 662 674 O
unwilling NCT03860454 675 684 O
to NCT03860454 685 687 O
consent NCT03860454 688 695 O

- NCT03860454 698 699 O
Patients NCT03860454 701 709 O
that NCT03860454 710 714 O
have NCT03860454 715 719 O
a NCT03860454 720 721 O
conventional NCT03860454 722 734 O
contraindication NCT03860454 735 751 O
for NCT03860454 752 755 O
cardiac NCT03860454 756 763 B-Procedure-Name
magnetic NCT03860454 764 772 I-Procedure-Name
resonance NCT03860454 773 782 I-Procedure-Name
imaging NCT03860454 783 790 I-Procedure-Name
( NCT03860454 791 792 O
MRI NCT03860454 793 796 B-Procedure-Name
) NCT03860454 797 798 O
. NCT03860454 800 801 O

- NCT03860454 805 806 O
Patients NCT03860454 808 816 O
that NCT03860454 817 821 O
have NCT03860454 822 826 O
had NCT03860454 827 830 O
a NCT03860454 831 832 O
blood NCT03860454 833 838 B-Procedure-Name
transfusion NCT03860454 839 850 I-Procedure-Name
within NCT03860454 851 857 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860454 858 861 O
last NCT03860454 862 866 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03860454 867 872 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03860454 873 876 O
patients NCT03860454 877 885 O
having NCT03860454 886 892 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
haemodialysis NCT03860454 893 906 B-Procedure-Name
will NCT03860454 907 911 O
be NCT03860454 912 914 O
excluded NCT03860454 915 923 O
. NCT03860454 924 925 O

Inclusion NCT03869515 0 9 O
Criteria NCT03869515 10 18 O
: NCT03869515 19 20 O

- NCT03869515 24 25 O
The NCT03869515 27 30 O
chILD NCT03869515 31 36 B-Condition-Name
syndrome NCT03869515 37 45 I-Condition-Name
exists NCT03869515 46 52 O
when NCT03869515 53 57 O
a NCT03869515 58 59 O
child NCT03869515 60 65 O
with NCT03869515 66 70 O
DLD NCT03869515 71 74 B-Condition-Name
has NCT03869515 75 78 O
had NCT03869515 79 82 O
the NCT03869515 83 86 O
common NCT03869515 87 93 O
causes NCT03869515 94 100 O
of NCT03869515 101 103 O
DLD NCT03869515 104 107 B-Condition-Name
excluded NCT03869515 108 116 O
as NCT03869515 117 119 O
the NCT03869515 120 123 O
primary NCT03869515 124 131 O
diagnosis NCT03869515 132 141 O
and NCT03869515 142 145 O
has NCT03869515 146 149 O
at NCT03869515 150 152 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869515 153 158 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03869515 159 164 B-Eq-Value
of NCT03869515 165 167 O
the NCT03869515 168 171 O
following NCT03869515 172 181 O
four NCT03869515 182 186 B-Eq-Value
criteria NCT03869515 187 195 O
: NCT03869515 196 197 O
( NCT03869515 198 199 O
1 NCT03869515 201 202 O
) NCT03869515 203 204 O
respiratory NCT03869515 205 216 B-Condition-Name
symptoms NCT03869515 217 225 O
( NCT03869515 226 227 O
e NCT03869515 228 229 O
. NCT03869515 230 231 O
g NCT03869515 232 233 O
. NCT03869515 234 235 O
, NCT03869515 236 237 O
cough NCT03869515 238 243 B-Condition-Name
, NCT03869515 244 245 O
rapid NCT03869515 246 251 O
and NCT03869515 252 255 O
/ NCT03869515 256 257 O
or NCT03869515 258 260 O
difficult NCT03869515 261 270 O
breathing NCT03869515 271 280 B-Condition-Name
, NCT03869515 281 282 O
or NCT03869515 283 285 O
exercise NCT03869515 286 294 B-Condition-Name
intolerance NCT03869515 295 306 I-Condition-Name
) NCT03869515 307 308 O
; NCT03869515 309 310 O
( NCT03869515 311 312 O
2 NCT03869515 314 315 O
) NCT03869515 316 317 O
respiratory NCT03869515 318 329 B-Condition-Name
signs NCT03869515 330 335 O
( NCT03869515 336 337 O
e NCT03869515 338 339 O
. NCT03869515 340 341 O
g NCT03869515 342 343 O
. NCT03869515 344 345 O
, NCT03869515 346 347 O
resting NCT03869515 348 355 B-Condition-Name
tachypnea NCT03869515 356 365 I-Condition-Name
, NCT03869515 366 367 O
adventitious NCT03869515 368 380 B-Condition-Name
sounds NCT03869515 381 387 I-Condition-Name
, NCT03869515 388 389 O
retractions NCT03869515 390 401 B-Condition-Name
, NCT03869515 402 403 O
digital NCT03869515 404 411 B-Condition-Name
clubbing NCT03869515 412 420 I-Condition-Name
, NCT03869515 421 422 O
failure NCT03869515 423 430 B-Condition-Name
to NCT03869515 431 433 I-Condition-Name
thrive NCT03869515 434 440 I-Condition-Name
, NCT03869515 441 442 O
or NCT03869515 443 445 O
respiratory NCT03869515 446 457 B-Condition-Name
fail NCT03869515 458 462 I-Condition-Name
- NCT03869515 463 464 I-Condition-Name
ure NCT03869515 465 468 I-Condition-Name
) NCT03869515 469 470 O
; NCT03869515 471 472 O
( NCT03869515 473 474 O
3 NCT03869515 476 477 O
) NCT03869515 478 479 O
hypoxemia NCT03869515 480 489 B-Condition-Name
; NCT03869515 489 490 O
and NCT03869515 491 494 O
( NCT03869515 495 496 O
4 NCT03869515 498 499 O
) NCT03869515 500 501 O
diffuse NCT03869515 502 509 B-Condition-Name
abnormalities NCT03869515 510 523 I-Condition-Name
on NCT03869515 524 526 O
CXR NCT03869515 527 530 B-Procedure-Name
or NCT03869515 531 533 O
a NCT03869515 534 535 O
CT NCT03869515 536 538 B-Procedure-Name
scan NCT03869515 539 543 I-Procedure-Name
. NCT03869515 544 545 O

Exclusion NCT03869515 547 556 O
Criteria NCT03869515 557 565 O
: NCT03869515 566 567 O

- NCT03869515 571 572 O
These NCT03869515 574 579 O
include NCT03869515 580 587 O
cystic NCT03869515 588 594 B-Condition-Name
fibrosis NCT03869515 595 603 I-Condition-Name
, NCT03869515 604 605 O
congenital NCT03869515 606 616 O
or NCT03869515 617 619 O
acquired NCT03869515 620 628 O
immunodeficiency NCT03869515 629 645 B-Condition-Name
, NCT03869515 646 647 O
congenital NCT03869515 648 658 B-Condition-Name
heart NCT03869515 659 664 I-Condition-Name
disease NCT03869515 665 672 I-Condition-Name
, NCT03869515 673 674 O
bronchopulmonary NCT03869515 675 691 B-Condition-Name
dysplasia NCT03869515 692 701 I-Condition-Name
, NCT03869515 702 703 O
pulmonary NCT03869515 704 713 B-Condition-Name
infection NCT03869515 714 723 I-Condition-Name
, NCT03869515 724 725 O
primary NCT03869515 726 733 O
ciliary NCT03869515 734 741 O
dyskinesia NCT03869515 742 752 B-Condition-Name
presenting NCT03869515 753 763 B-Condition-Type___Condition-Type-Value:admitting
with NCT03869515 764 768 O
newborn NCT03869515 769 776 B-Condition-Name
respiratory NCT03869515 777 788 I-Condition-Name
distress NCT03869515 789 797 I-Condition-Name
and NCT03869515 798 801 O
recurrent NCT03869515 802 811 O
aspiration NCT03869515 812 822 B-Condition-Name
. NCT03869515 823 824 O

Inclusion NCT03864757 0 9 O
Criteria NCT03864757 10 18 O
: NCT03864757 19 20 O

- NCT03864757 24 25 O
Male NCT03864757 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03864757 32 35 O
female NCT03864757 36 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03864757 43 51 O
between NCT03864757 52 59 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03864757 61 63 B-Eq-Value
and NCT03864757 64 67 O
80 NCT03864757 69 71 B-Eq-Value
years NCT03864757 72 77 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864757 80 81 O
Diagnosed NCT03864757 83 92 O
with NCT03864757 93 97 O
permanent NCT03864757 98 107 O
UVFP NCT03864757 108 112 B-Condition-Name
and NCT03864757 113 116 O
insufficient NCT03864757 117 129 O
glottal NCT03864757 130 137 B-Condition-Name
closure NCT03864757 138 145 I-Condition-Name
and NCT03864757 146 149 O
planned NCT03864757 150 157 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
type NCT03864757 158 162 O
I NCT03864757 163 164 O
thyroplasty NCT03864757 165 176 B-Procedure-Name
with NCT03864757 177 181 O
conventional NCT03864757 182 194 B-Procedure-Name
implant NCT03864757 195 202 I-Procedure-Name

- NCT03864757 205 206 O
Ability NCT03864757 208 215 O
to NCT03864757 216 218 O
co NCT03864757 219 221 O
- NCT03864757 222 223 O
operate NCT03864757 224 231 O
with NCT03864757 232 236 O
the NCT03864757 237 240 O
investigator NCT03864757 241 253 O
and NCT03864757 254 257 O
to NCT03864757 258 260 O
comply NCT03864757 261 267 O
with NCT03864757 268 272 O
the NCT03864757 273 276 O
requirements NCT03864757 277 289 O
of NCT03864757 290 292 O
the NCT03864757 293 296 O
entire NCT03864757 297 303 O
study NCT03864757 304 309 O

Exclusion NCT03864757 310 319 O
Criteria NCT03864757 320 328 O
: NCT03864757 329 330 O

- NCT03864757 334 335 O
Any NCT03864757 337 340 O
other NCT03864757 341 346 O
significant NCT03864757 347 358 B-Severity___Severity-Value:severe
disease NCT03864757 359 366 B-Condition-Name
or NCT03864757 367 369 O
disorder NCT03864757 370 378 B-Condition-Name
which NCT03864757 379 384 O
, NCT03864757 385 386 O
in NCT03864757 387 389 O
the NCT03864757 390 393 O
opinion NCT03864757 394 401 O
of NCT03864757 402 404 O
the NCT03864757 405 408 O
investigator NCT03864757 409 421 O
, NCT03864757 422 423 O
may NCT03864757 424 427 O
either NCT03864757 428 434 O
put NCT03864757 435 438 O
the NCT03864757 439 442 O
participant NCT03864757 443 454 O
at NCT03864757 455 457 O
risk NCT03864757 458 462 O
because NCT03864757 463 470 O
of NCT03864757 471 473 O
participation NCT03864757 474 487 O
in NCT03864757 488 490 O
the NCT03864757 491 494 O
clinical NCT03864757 495 503 O
investigation NCT03864757 504 517 O
may NCT03864757 518 521 O
influence NCT03864757 522 531 B-Stability___Stability-Value:change
the NCT03864757 532 535 O
result NCT03864757 536 542 O
of NCT03864757 543 545 O
the NCT03864757 546 549 O
clinical NCT03864757 550 558 O
investigation NCT03864757 559 572 O
, NCT03864757 573 574 O
or NCT03864757 575 577 O
the NCT03864757 578 581 O
participant NCT03864757 582 593 O
's NCT03864757 593 595 O
ability NCT03864757 596 603 O
to NCT03864757 604 606 O
participate NCT03864757 607 618 O
in NCT03864757 619 621 O
the NCT03864757 622 625 O
clinical NCT03864757 626 634 O
investigation NCT03864757 635 648 O

- NCT03864757 651 652 O
Scheduled NCT03864757 654 663 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
elective NCT03864757 664 672 O
surgery NCT03864757 673 680 B-Procedure-Name
or NCT03864757 681 683 O
other NCT03864757 684 689 O
procedures NCT03864757 690 700 O
requiring NCT03864757 701 710 O
general NCT03864757 711 718 B-Procedure-Name
anaesthesia NCT03864757 719 730 I-Procedure-Name
during NCT03864757 731 737 O
clinical NCT03864757 738 746 O
investigation NCT03864757 747 760 O

- NCT03864757 763 764 O
Had NCT03864757 766 769 O
medialization NCT03864757 770 783 B-Procedure-Name
thyroplasty NCT03864757 784 795 I-Procedure-Name
before NCT03864757 796 802 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

- NCT03864757 805 806 O
Had NCT03864757 808 811 O
injection NCT03864757 812 821 O
medialization NCT03864757 822 835 B-Procedure-Name
laryngoplasty NCT03864757 836 849 I-Procedure-Name
in NCT03864757 850 852 O
the NCT03864757 853 856 O
past NCT03864757 857 861 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
two NCT03864757 862 865 B-Eq-Value
years NCT03864757 866 871 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03864757 872 873 O

- NCT03864757 877 878 O
Presence NCT03864757 880 888 O
of NCT03864757 889 891 O
structural NCT03864757 892 902 O
vocal NCT03864757 903 908 O
fold NCT03864757 909 913 O
lesions NCT03864757 914 921 B-Condition-Name
such NCT03864757 922 926 O
as NCT03864757 927 929 O
polyp NCT03864757 930 935 B-Condition-Name
or NCT03864757 936 938 O
nodules NCT03864757 939 946 B-Condition-Name

- NCT03864757 949 950 O
Status NCT03864757 952 958 O
post NCT03864757 959 963 O
total NCT03864757 964 969 B-Procedure-Name
cordectomy NCT03864757 970 980 I-Procedure-Name

- NCT03864757 983 984 O
Previous NCT03864757 986 994 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
laryngeal NCT03864757 995 1004 B-Procedure-Name
framework NCT03864757 1005 1014 I-Procedure-Name
surgery NCT03864757 1015 1022 I-Procedure-Name
( NCT03864757 1023 1024 O
any NCT03864757 1025 1028 O
type NCT03864757 1029 1033 O
of NCT03864757 1034 1036 O
thyroplasty NCT03864757 1037 1048 B-Procedure-Name
, NCT03864757 1049 1050 O
arytenoid NCT03864757 1051 1060 B-Procedure-Name
adduction NCT03864757 1061 1070 I-Procedure-Name
) NCT03864757 1071 1072 O

- NCT03864757 1076 1077 O
Significant NCT03864757 1079 1090 B-Severity___Severity-Value:severe
non NCT03864757 1091 1094 O
- NCT03864757 1095 1096 O
laryngeal NCT03864757 1097 1106 O
speech NCT03864757 1107 1113 O
abnormality NCT03864757 1114 1125 B-Condition-Name
( NCT03864757 1126 1127 O
severe NCT03864757 1128 1134 B-Severity___Severity-Value:severe
dysarthria NCT03864757 1135 1145 B-Condition-Name
determined NCT03864757 1146 1156 O
by NCT03864757 1157 1159 O
a NCT03864757 1160 1161 O
panel NCT03864757 1162 1167 O
of NCT03864757 1168 1170 O
trained NCT03864757 1171 1178 O
speech NCT03864757 1179 1185 B-Provider-Type
therapists NCT03864757 1186 1196 I-Provider-Type
) NCT03864757 1197 1198 O

- NCT03864757 1202 1203 O
Severe NCT03864757 1205 1211 B-Severity___Severity-Value:severe
coagulopathy NCT03864757 1212 1224 B-Condition-Name

Inclusion NCT03862326 0 9 O
Criteria NCT03862326 10 18 O
: NCT03862326 19 20 O

Diaper NCT03862326 22 28 O
grant NCT03862326 29 34 O

- NCT03862326 37 38 O
Urinary NCT03862326 40 47 B-Condition-Name
incontinency NCT03862326 48 60 I-Condition-Name

- NCT03862326 64 65 O
Living NCT03862326 67 73 O
in NCT03862326 74 76 O
own NCT03862326 77 80 O
home NCT03862326 81 85 O
in NCT03862326 86 88 O
Aalborg NCT03862326 89 96 B-Location___Location-Value:residence
Municipality NCT03862326 97 109 O

Exclusion NCT03862326 110 119 O
Criteria NCT03862326 120 128 O
: NCT03862326 129 130 O

- NCT03862326 134 135 O
Dementia NCT03862326 137 145 O

- NCT03862326 149 150 O
Inability NCT03862326 152 161 O
to NCT03862326 162 164 O
transport NCT03862326 165 174 O
herself NCT03862326 175 182 O
to NCT03862326 183 185 O
the NCT03862326 186 189 O
training NCT03862326 190 198 O
facility NCT03862326 199 207 O

- NCT03862326 211 212 O
neurological NCT03862326 214 226 B-Condition-Name
diseases NCT03862326 227 235 I-Condition-Name

- NCT03862326 239 240 O
inability NCT03862326 242 251 O
to NCT03862326 252 254 O
understand NCT03862326 255 265 O
Danish NCT03862326 266 272 B-Language
or NCT03862326 273 275 O
bring NCT03862326 276 281 O
a NCT03862326 282 283 O
translator NCT03862326 284 294 O


Inclusion NCT03863951 0 9 O
Criteria NCT03863951 10 18 O
: NCT03863951 19 20 O

- NCT03863951 24 25 O
diagnosed NCT03863951 27 36 O
with NCT03863951 37 41 O
the NCT03863951 42 45 O
first NCT03863951 46 51 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
ever NCT03863951 52 56 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
acute NCT03863951 57 62 B-Severity___Severity-Value:severe
ischemic NCT03863951 63 71 O
stroke NCT03863951 72 78 B-Condition-Name
occurring NCT03863951 79 88 O
within NCT03863951 89 95 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03863951 97 98 B-Eq-Value
weeks NCT03863951 99 104 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
and NCT03863951 105 108 O
were NCT03863951 109 113 O
confirmed NCT03863951 114 123 O
by NCT03863951 124 126 O
CT NCT03863951 127 129 B-Procedure-Name
or NCT03863951 130 132 O
MRI NCT03863951 133 136 B-Procedure-Name
, NCT03863951 137 138 O

- NCT03863951 142 143 O
has NCT03863951 145 148 O
no NCT03863951 149 151 O
history NCT03863951 152 159 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863951 160 162 O
depression NCT03863951 163 173 B-Condition-Name
or NCT03863951 174 176 O
use NCT03863951 177 180 O
of NCT03863951 181 183 O
antidepressants NCT03863951 184 199 B-Drug-Name
or NCT03863951 200 202 O
antipsychotics NCT03863951 203 217 B-Drug-Name
, NCT03863951 218 219 O

- NCT03863951 223 224 O
were NCT03863951 226 230 O
competent NCT03863951 231 240 O
to NCT03863951 241 243 O
consent NCT03863951 244 251 O
to NCT03863951 252 254 O
take NCT03863951 255 259 O
part NCT03863951 260 264 O
in NCT03863951 265 267 O
this NCT03863951 268 272 O
research NCT03863951 273 281 O
. NCT03863951 282 283 O

Exclusion NCT03863951 285 294 O
Criteria NCT03863951 295 303 O
: NCT03863951 304 305 O

- NCT03863951 309 310 O
significant NCT03863951 312 323 B-Severity___Severity-Value:severe
acute NCT03863951 324 329 I-Severity___Severity-Value:severe
or NCT03863951 330 332 O
severe NCT03863951 333 339 B-Severity___Severity-Value:severe
illness NCT03863951 340 347 B-Condition-Name
such NCT03863951 348 352 O
as NCT03863951 353 355 O
infection NCT03863951 356 365 B-Condition-Name
, NCT03863951 366 367 O
heart NCT03863951 368 373 B-Condition-Name
failure NCT03863951 374 381 I-Condition-Name
and NCT03863951 382 385 O
tumor NCT03863951 386 391 B-Condition-Name
, NCT03863951 392 393 O

- NCT03863951 397 398 O
previous NCT03863951 400 408 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03863951 409 418 O
of NCT03863951 419 421 O
depression NCT03863951 422 432 B-Condition-Name
or NCT03863951 433 435 O
other NCT03863951 436 441 O
mental NCT03863951 442 448 B-Condition-Name
disorder NCT03863951 449 457 I-Condition-Name
or NCT03863951 458 460 O
who NCT03863951 461 464 O
had NCT03863951 465 468 O
recently NCT03863951 469 477 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
accepted NCT03863951 478 486 O
antidepressants NCT03863951 487 502 B-Drug-Name
or NCT03863951 503 505 O
antipsychotics NCT03863951 506 520 B-Drug-Name
, NCT03863951 521 522 O

- NCT03863951 526 527 O
antibiotics NCT03863951 529 540 B-Drug-Name
in NCT03863951 541 543 O
the NCT03863951 544 547 O
last NCT03863951 548 552 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
two NCT03863951 553 556 B-Eq-Value
weeks NCT03863951 557 562 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03863951 563 564 O

- NCT03863951 568 569 O
severe NCT03863951 571 577 B-Severity___Severity-Value:severe
aphasia NCT03863951 578 585 B-Condition-Name
or NCT03863951 586 588 O
dysarthria NCT03863951 589 599 B-Condition-Name
, NCT03863951 600 601 O
irritable NCT03863951 602 611 B-Condition-Name
bowel NCT03863951 612 617 I-Condition-Name
syndrome NCT03863951 618 626 I-Condition-Name
, NCT03863951 627 628 O
asthma NCT03863951 629 635 B-Condition-Name
, NCT03863951 636 637 O
and NCT03863951 638 641 O
pregnant NCT03863951 642 650 B-Condition-Name
or NCT03863951 651 653 O
lactating NCT03863951 654 663 B-Condition-Name
women NCT03863951 664 669 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03863951 670 671 O

- NCT03863951 675 676 O
a NCT03863951 678 679 O
previous NCT03863951 680 688 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03863951 689 696 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863951 697 699 O
neurological NCT03863951 700 712 B-Condition-Name
illness NCT03863951 713 720 I-Condition-Name
including NCT03863951 721 730 O
AD NCT03863951 731 733 B-Condition-Name
and NCT03863951 734 737 O
PD NCT03863951 738 740 B-Condition-Name
， NCT03863951 741 742 O

- NCT03863951 746 747 O
Inflammatory NCT03863951 749 761 B-Condition-Name
bowel NCT03863951 762 767 I-Condition-Name
disease NCT03863951 768 775 I-Condition-Name
， NCT03863951 776 777 O

Inclusion NCT03863548 0 9 O
Criteria NCT03863548 10 18 O
: NCT03863548 19 20 O

- NCT03863548 24 25 O
person NCT03863548 27 33 O
who NCT03863548 34 37 O
has NCT03863548 38 41 O
expressed NCT03863548 42 51 O
willingness NCT03863548 52 63 O
to NCT03863548 64 66 O
participate NCT03863548 67 78 O

- NCT03863548 81 82 O
person NCT03863548 84 90 O
over NCT03863548 91 95 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03863548 97 99 B-Eq-Value
years NCT03863548 100 105 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03863548 106 108 O
age NCT03863548 109 112 O

- NCT03863548 115 116 O
person NCT03863548 118 124 O
with NCT03863548 125 129 O
a NCT03863548 130 131 O
retinal NCT03863548 132 139 B-Condition-Name
- NCT03863548 140 141 I-Condition-Name
vitreous NCT03863548 142 150 I-Condition-Name
condition NCT03863548 151 160 I-Condition-Name
requiring NCT03863548 161 170 O
scheduled NCT03863548 171 180 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
surgery NCT03863548 181 188 B-Procedure-Name
( NCT03863548 189 190 O
epi NCT03863548 191 194 B-Procedure-Name
- NCT03863548 195 196 I-Procedure-Name
retinal NCT03863548 197 204 I-Procedure-Name
membrane NCT03863548 205 213 I-Procedure-Name
surgery NCT03863548 214 221 I-Procedure-Name
, NCT03863548 222 223 O
vitreous NCT03863548 224 232 B-Procedure-Name
traction NCT03863548 233 241 I-Procedure-Name
surgery NCT03863548 242 249 I-Procedure-Name
, NCT03863548 250 251 O
macular NCT03863548 252 259 B-Procedure-Name
hole NCT03863548 260 264 I-Procedure-Name
surgery NCT03863548 265 272 I-Procedure-Name
) NCT03863548 273 274 O
. NCT03863548 276 277 O

Exclusion NCT03863548 279 288 O
Criteria NCT03863548 289 297 O
: NCT03863548 298 299 O

- NCT03863548 303 304 O
person NCT03863548 306 312 O
subject NCT03863548 313 320 O
to NCT03863548 321 323 O
legal NCT03863548 324 329 B-Observation-Name
protection NCT03863548 330 340 I-Observation-Name
( NCT03863548 341 342 O
curatorship NCT03863548 343 354 O
, NCT03863548 355 356 O
guardianship NCT03863548 357 369 O
) NCT03863548 370 371 O

- NCT03863548 375 376 O
person NCT03863548 378 384 O
deemed NCT03863548 385 391 O
mentally NCT03863548 392 400 B-Condition-Name
incompetent NCT03863548 401 412 I-Condition-Name

- NCT03863548 415 416 O
pregnant NCT03863548 418 426 B-Condition-Name
, NCT03863548 427 428 O
parturient NCT03863548 429 439 B-Condition-Name
or NCT03863548 440 442 O
breastfeeding NCT03863548 443 456 B-Condition-Name
woman NCT03863548 457 462 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03863548 465 466 O
adult NCT03863548 468 473 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
unwilling NCT03863548 474 483 O
or NCT03863548 484 486 O
unable NCT03863548 487 493 O
to NCT03863548 494 496 O
consent NCT03863548 497 504 O

- NCT03863548 507 508 O
patient NCT03863548 510 517 O
who NCT03863548 518 521 O
has NCT03863548 522 525 O
already NCT03863548 526 533 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participated NCT03863548 534 546 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03863548 547 549 O
the NCT03863548 550 553 O
study NCT03863548 554 559 O

- NCT03863548 562 563 O
person NCT03863548 565 571 O
with NCT03863548 572 576 O
a NCT03863548 577 578 O
physical NCT03863548 579 587 O
or NCT03863548 588 590 O
mental NCT03863548 591 597 O
disability NCT03863548 598 608 B-Condition-Name
that NCT03863548 609 613 O
does NCT03863548 614 618 O
not NCT03863548 619 622 O
allow NCT03863548 623 628 O
participation NCT03863548 629 642 O
. NCT03863548 643 644 O

- NCT03863548 648 649 O
a NCT03863548 651 652 O
person NCT03863548 653 659 O
who NCT03863548 660 663 O
has NCT03863548 664 667 O
participated NCT03863548 668 680 O
in NCT03863548 681 683 O
any NCT03863548 684 687 O
study NCT03863548 688 693 O
of NCT03863548 694 696 O
an NCT03863548 697 699 O
experimental NCT03863548 700 712 O
medical NCT03863548 713 720 O
product NCT03863548 721 728 O
within NCT03863548 729 735 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863548 736 739 O
previous NCT03863548 740 748 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863548 750 751 B-Eq-Value
months NCT03863548 752 758 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863548 761 762 O
person NCT03863548 764 770 O
who NCT03863548 771 774 O
experiences NCT03863548 775 786 O
any NCT03863548 787 790 O
of NCT03863548 791 793 O
the NCT03863548 794 797 O
following NCT03863548 798 807 O
during NCT03863548 808 814 O
the NCT03863548 815 818 O
ophthalmological NCT03863548 819 835 B-Procedure-Name
examination NCT03863548 836 847 I-Procedure-Name
: NCT03863548 848 849 O

- NCT03863548 858 859 O
severe NCT03863548 861 867 B-Severity___Severity-Value:severe
or NCT03863548 868 870 O
proliferating NCT03863548 871 884 O
diabetic NCT03863548 885 893 B-Condition-Name
retinopathy NCT03863548 894 905 I-Condition-Name

- NCT03863548 913 914 O
intra NCT03863548 916 921 O
- NCT03863548 922 923 O
vitreal NCT03863548 924 931 O
hemorrhage NCT03863548 932 942 B-Condition-Name

- NCT03863548 950 951 O
tractional NCT03863548 953 963 B-Condition-Name
retinal NCT03863548 964 971 I-Condition-Name
detachment NCT03863548 972 982 I-Condition-Name

- NCT03863548 990 991 O
subretinal NCT03863548 993 1003 O
or NCT03863548 1004 1006 O
retrohyaloidal NCT03863548 1007 1021 O
hematoma NCT03863548 1022 1030 B-Condition-Name
. NCT03863548 1031 1032 O

Inclusion NCT03866356 0 9 O
Criteria NCT03866356 10 18 O
: NCT03866356 19 20 O

- NCT03866356 24 25 O
The NCT03866356 27 30 O
inclusion NCT03866356 31 40 O
criteria NCT03866356 41 49 O
were NCT03866356 50 54 O
being NCT03866356 55 60 O
female NCT03866356 61 67 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03866356 68 69 O
≥ NCT03866356 70 71 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03866356 73 75 B-Eq-Value
years NCT03866356 76 81 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03866356 82 83 O
having NCT03866356 84 90 O
an NCT03866356 91 93 O
initial NCT03866356 94 101 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnosis NCT03866356 102 111 O
of NCT03866356 112 114 O
SI NCT03866356 115 117 B-Condition-Name
, NCT03866356 118 119 O
being NCT03866356 120 125 O
literate NCT03866356 126 134 B-Condition-Name
, NCT03866356 135 136 O
having NCT03866356 137 143 O
no NCT03866356 144 146 O
sensory NCT03866356 147 154 B-Condition-Name
disorder NCT03866356 155 163 I-Condition-Name
affecting NCT03866356 164 173 B-Stability___Stability-Value:change
communication NCT03866356 174 187 B-Condition-Name
, NCT03866356 188 189 O
and NCT03866356 190 193 O
agreeing NCT03866356 194 202 O
to NCT03866356 203 205 O
participate NCT03866356 206 217 O
in NCT03866356 218 220 O
the NCT03866356 221 224 O
research NCT03866356 225 233 O

Exclusion NCT03866356 234 243 O
Criteria NCT03866356 244 252 O
: NCT03866356 253 254 O

- NCT03866356 258 259 O
The NCT03866356 261 264 O
exclusion NCT03866356 265 274 O
criteria NCT03866356 275 283 O
were NCT03866356 284 288 O
pregnancy NCT03866356 289 298 B-Condition-Name
, NCT03866356 299 300 O
presence NCT03866356 301 309 O
of NCT03866356 310 312 O
a NCT03866356 313 314 O
urinary NCT03866356 315 322 B-Condition-Name
tract NCT03866356 323 328 I-Condition-Name
infection NCT03866356 329 338 I-Condition-Name
and NCT03866356 339 342 O
previous NCT03866356 343 351 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03866356 352 361 O
for NCT03866356 362 365 O
SI NCT03866356 366 368 B-Condition-Name
. NCT03866356 369 370 O
The NCT03866356 372 375 O
removal NCT03866356 376 383 O
criteria NCT03866356 384 392 O
were NCT03866356 393 397 O
patient NCT03866356 398 405 O
non NCT03866356 406 409 O
- NCT03866356 410 411 O
compliance NCT03866356 412 422 O
with NCT03866356 423 427 O
the NCT03866356 428 431 O
protocol NCT03866356 432 440 O
, NCT03866356 441 442 O
failure NCT03866356 443 450 O
in NCT03866356 451 453 O
contacting NCT03866356 454 464 O
the NCT03866356 465 468 O
patient NCT03866356 469 476 O
and NCT03866356 477 480 O
the NCT03866356 481 484 O
patient NCT03866356 485 492 O
's NCT03866356 492 494 O
wish NCT03866356 495 499 O
to NCT03866356 500 502 O
withdraw NCT03866356 503 511 O
from NCT03866356 512 516 O
the NCT03866356 517 520 O
study NCT03866356 521 526 O
. NCT03866356 527 528 O

Inclusion NCT03862118 0 9 O
Criteria NCT03862118 10 18 O
: NCT03862118 19 20 O

- NCT03862118 24 25 O
•Both NCT03862118 27 32 O
sexes NCT03862118 33 38 O
will NCT03862118 39 43 O
be NCT03862118 44 46 O
included NCT03862118 47 55 O
. NCT03862118 56 57 O

- NCT03862118 66 67 O
Age NCT03862118 69 72 O
( NCT03862118 73 74 O
20 NCT03862118 76 78 B-Eq-Value
- NCT03862118 79 80 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03862118 82 84 B-Eq-Value
) NCT03862118 85 86 O

- NCT03862118 95 96 O
Patient NCT03862118 98 105 O
with NCT03862118 106 110 O
Fitzpatrick NCT03862118 111 122 B-Condition-Name
skin NCT03862118 123 127 I-Condition-Name
types NCT03862118 128 133 O
III NCT03862118 134 137 B-Eq-Value
- NCT03862118 138 139 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IV NCT03862118 140 142 B-Eq-Value

Exclusion NCT03862118 143 152 O
Criteria NCT03862118 153 161 O
: NCT03862118 162 163 O

- NCT03862118 167 168 O
• NCT03862118 170 171 O
Patients NCT03862118 172 180 O
with NCT03862118 181 185 O
known NCT03862118 186 191 O
platelet NCT03862118 192 200 B-Condition-Name
dysfunction NCT03862118 201 212 I-Condition-Name
syndrome NCT03862118 213 221 I-Condition-Name
, NCT03862118 222 223 O
critical NCT03862118 224 232 B-Severity___Severity-Value:severe
thrombocytopenia NCT03862118 233 249 B-Condition-Name
( NCT03862118 250 251 O
< NCT03862118 253 254 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03862118 256 258 B-Eq-Value
, NCT03862118 259 260 I-Eq-Value
000 NCT03862118 261 264 I-Eq-Value
/ NCT03862118 265 266 O
ul NCT03862118 267 269 B-Eq-Unit
) NCT03862118 270 271 O
, NCT03862118 273 274 O
any NCT03862118 275 278 O
hemodynamic NCT03862118 279 290 B-Condition-Name
instability NCT03862118 291 302 I-Condition-Name
. NCT03862118 303 304 O

- NCT03862118 313 314 O
Patients NCT03862118 316 324 O
with NCT03862118 325 329 O
chronic NCT03862118 330 337 O
medical NCT03862118 338 345 O
illness NCT03862118 346 353 O
( NCT03862118 354 355 O
e NCT03862118 356 357 O
. NCT03862118 358 359 O
g NCT03862118 360 361 O
. NCT03862118 362 363 O
diabetes NCT03862118 365 373 B-Condition-Name
, NCT03862118 374 375 O
chronic NCT03862118 376 383 O
infections NCT03862118 384 394 B-Condition-Name
, NCT03862118 395 396 O
and NCT03862118 397 400 O
blood NCT03862118 401 406 O
dyscrasias NCT03862118 407 417 B-Condition-Name
) NCT03862118 418 419 O
. NCT03862118 421 422 O

- NCT03862118 431 432 O
Patients NCT03862118 434 442 O
with NCT03862118 443 447 O
local NCT03862118 448 453 O
inflammatory NCT03862118 454 466 O
skin NCT03862118 467 471 B-Condition-Name
disorders NCT03862118 472 481 I-Condition-Name
or NCT03862118 482 484 O
active NCT03862118 485 491 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
herpes NCT03862118 492 498 B-Condition-Name
infection NCT03862118 499 508 I-Condition-Name
at NCT03862118 509 511 O
the NCT03862118 512 515 O
site NCT03862118 516 520 O
of NCT03862118 521 523 O
the NCT03862118 524 527 O
procedure NCT03862118 528 537 O
. NCT03862118 538 539 O

- NCT03862118 548 549 O
Patients NCT03862118 551 559 O
on NCT03862118 560 562 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
consistent NCT03862118 563 573 O
use NCT03862118 574 577 O
of NCT03862118 578 580 O
anti NCT03862118 581 585 B-Drug-Name
- NCT03862118 586 587 I-Drug-Name
coagulants NCT03862118 588 598 I-Drug-Name
or NCT03862118 599 601 O
non NCT03862118 602 605 B-Drug-Name
- NCT03862118 606 607 I-Drug-Name
steroidal NCT03862118 608 617 I-Drug-Name
anti NCT03862118 618 622 I-Drug-Name
- NCT03862118 623 624 I-Drug-Name
inflammatory NCT03862118 625 637 I-Drug-Name
drugs NCT03862118 638 643 I-Drug-Name
( NCT03862118 644 645 O
NSAID NCT03862118 646 651 B-Drug-Name
) NCT03862118 652 653 O
within NCT03862118 654 660 B-Eq-Operator___Eq-Operator-Value:LTEQ
48 NCT03862118 662 664 B-Eq-Value
hours NCT03862118 665 670 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03862118 671 673 O
procedure NCT03862118 674 683 O
. NCT03862118 684 685 O

- NCT03862118 694 695 O
Haemoglobin NCT03862118 697 708 B-Observation-Name___Observation-Type-Value:lab
level NCT03862118 709 714 O
< NCT03862118 715 716 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03862118 718 720 B-Eq-Value
g NCT03862118 721 722 B-Eq-Unit
/ NCT03862118 723 724 O
dl NCT03862118 725 727 B-Eq-Unit
were NCT03862118 728 732 O
also NCT03862118 733 737 O
excluded NCT03862118 738 746 O
. NCT03862118 747 748 O

- NCT03862118 757 758 O
Patients NCT03862118 760 768 O
with NCT03862118 769 773 O
cancer NCT03862118 774 780 B-Condition-Name
- NCT03862118 781 782 O
especially NCT03862118 783 793 O
hematopoietic NCT03862118 794 807 O
or NCT03862118 808 810 O
of NCT03862118 811 813 O
bone NCT03862118 814 818 O
. NCT03862118 819 820 O

- NCT03862118 829 830 O
Pregnant NCT03862118 832 840 B-Condition-Name
females NCT03862118 841 848 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
. NCT03862118 849 850 O

- NCT03862118 859 860 O
Patients NCT03862118 862 870 O
with NCT03862118 871 875 O
corticosteroids NCT03862118 876 891 B-Drug-Name
injection NCT03862118 892 901 O
at NCT03862118 902 904 O
treatment NCT03862118 905 914 O
site NCT03862118 915 919 O
within NCT03862118 920 926 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03862118 928 929 B-Eq-Value
month NCT03862118 930 935 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03862118 936 938 O
systemic NCT03862118 939 947 O
use NCT03862118 948 951 O
of NCT03862118 952 954 O
corticosteroids NCT03862118 955 970 B-Drug-Name
within NCT03862118 971 977 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03862118 979 980 B-Eq-Value
weeks NCT03862118 981 986 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03862118 987 988 O

Inclusion NCT03861377 0 9 O
Criteria NCT03861377 10 18 O
: NCT03861377 19 20 O

- NCT03861377 24 25 O
Gynecological NCT03861377 27 40 B-Procedure-Name
procedure NCT03861377 41 50 I-Procedure-Name

- NCT03861377 53 54 O
Age NCT03861377 56 59 O
18 NCT03861377 61 63 B-Eq-Value
- NCT03861377 64 65 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03861377 67 69 B-Eq-Value
years NCT03861377 70 75 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861377 78 79 O
General NCT03861377 81 88 B-Procedure-Name
anesthesia NCT03861377 89 99 I-Procedure-Name
planned NCT03861377 100 107 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future

- NCT03861377 110 111 O
Systolic NCT03861377 113 121 B-Observation-Name___Observation-Type-Value:vital
blood NCT03861377 122 127 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03861377 128 136 I-Observation-Name___Observation-Type-Value:vital
< NCT03861377 137 138 B-Eq-Operator___Eq-Operator-Value:LT
150 NCT03861377 140 143 B-Eq-Value
mmHg NCT03861377 144 148 B-Eq-Unit
, NCT03861377 149 150 O
HR NCT03861377 151 153 B-Observation-Name___Observation-Type-Value:vital
< NCT03861377 154 155 B-Eq-Operator___Eq-Operator-Value:LT
100 NCT03861377 157 160 B-Eq-Value
beats NCT03861377 161 166 B-Eq-Unit
/ NCT03861377 167 168 O
min NCT03861377 169 172 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

Exclusion NCT03861377 173 182 O
Criteria NCT03861377 183 191 O
: NCT03861377 192 193 O

- NCT03861377 197 198 O
Pre NCT03861377 200 203 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03861377 204 205 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03861377 206 214 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
hypertension NCT03861377 215 227 B-Condition-Name

- NCT03861377 230 231 O
Diabetes NCT03861377 233 241 B-Condition-Name

- NCT03861377 244 245 O
Ischemic NCT03861377 247 255 O
heart NCT03861377 256 261 B-Condition-Name
disease NCT03861377 262 269 I-Condition-Name
or NCT03861377 270 272 O
cerebrovascular NCT03861377 273 288 B-Condition-Name
disease NCT03861377 289 296 I-Condition-Name

- NCT03861377 299 300 O
Heart NCT03861377 302 307 B-Condition-Name
valve NCT03861377 308 313 I-Condition-Name
disease NCT03861377 314 321 I-Condition-Name

- NCT03861377 324 325 O
Verified NCT03861377 327 335 O
cardiac NCT03861377 336 343 B-Condition-Name
arrhythmia NCT03861377 344 354 I-Condition-Name
other NCT03861377 355 360 O
than NCT03861377 361 365 O
extrasystoles NCT03861377 366 379 B-Condition-Name

- NCT03861377 382 383 O
Verified NCT03861377 385 393 O
anaemia NCT03861377 394 401 B-Condition-Name
with NCT03861377 402 406 O
hemoglobin NCT03861377 407 417 B-Observation-Name___Observation-Type-Value:lab
level NCT03861377 418 423 O
below NCT03861377 424 429 B-Eq-Operator___Eq-Operator-Value:GT
9.0 NCT03861377 431 434 B-Eq-Value
gr NCT03861377 435 437 B-Eq-Unit
/ NCT03861377 438 439 O
dl NCT03861377 440 442 B-Eq-Unit
. NCT03861377 443 444 O

- NCT03861377 448 449 O
Kidney NCT03861377 451 457 O
or NCT03861377 458 460 O
hepatic NCT03861377 461 468 O
disease NCT03861377 469 476 B-Condition-Name

- NCT03861377 479 480 O
Hypersensitivity NCT03861377 482 498 B-Condition-Name
for NCT03861377 499 502 O
propofol NCT03861377 503 511 B-Drug-Name
, NCT03861377 512 513 O
soya NCT03861377 514 518 O
, NCT03861377 519 520 O
eggs NCT03861377 521 525 O
or NCT03861377 526 528 O
peanuts NCT03861377 529 536 O

- NCT03861377 539 540 O
Pregnancy NCT03861377 542 551 B-Condition-Name

- NCT03861377 554 555 O
Poor NCT03861377 557 561 B-Condition-Name
health NCT03861377 562 568 I-Condition-Name
state NCT03861377 569 574 O

- NCT03861377 577 578 O
Illicit NCT03861377 580 587 B-Condition-Name
substance NCT03861377 588 597 I-Condition-Name
use NCT03861377 598 601 I-Condition-Name

- NCT03861377 604 605 O
BMI NCT03861377 607 610 B-Observation-Name___Observation-Type-Value:vital
< NCT03861377 611 612 B-Eq-Operator___Eq-Operator-Value:LT
20 NCT03861377 614 616 B-Eq-Value
or NCT03861377 617 619 O
> NCT03861377 620 621 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03861377 623 625 B-Eq-Value
kg NCT03861377 626 628 B-Eq-Unit
/ NCT03861377 629 630 O
m NCT03861377 631 632 B-Eq-Unit
2 NCT03861377 633 634 I-Eq-Unit

Inclusion NCT03869918 0 9 O
Criteria NCT03869918 10 18 O
: NCT03869918 19 20 O

1 NCT03869918 25 26 O
. NCT03869918 26 27 O
female NCT03869918 29 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

2 NCT03869918 39 40 O
. NCT03869918 40 41 O
age NCT03869918 43 46 O
60 NCT03869918 48 50 B-Eq-Value
+ NCT03869918 51 52 B-Eq-Operator___Eq-Operator-Value:GTEQ
years NCT03869918 53 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

3 NCT03869918 62 63 O
. NCT03869918 63 64 O
community NCT03869918 66 75 B-Location___Location-Value:residence
dwelling NCT03869918 76 84 I-Location___Location-Value:residence

4 NCT03869918 88 89 O
. NCT03869918 89 90 O
Moderate NCT03869918 92 100 B-Severity___Severity-Value:moderate
to NCT03869918 101 103 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03869918 104 110 B-Severity___Severity-Value:severe
UUI NCT03869918 111 114 B-Condition-Name
( NCT03869918 115 116 O
as NCT03869918 117 119 O
measured NCT03869918 120 128 O
by NCT03869918 129 131 O
International NCT03869918 132 145 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Consultation NCT03869918 146 158 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
on NCT03869918 159 161 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Incontinence NCT03869918 162 174 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03869918 175 188 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Short NCT03869918 189 194 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Form NCT03869918 195 199 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03869918 200 201 O

5 NCT03869918 206 207 O
. NCT03869918 207 208 O
low NCT03869918 210 213 B-Polarity___Polarity-Value:low
physical NCT03869918 214 222 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03869918 223 231 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03869918 232 233 O
Physical NCT03869918 234 242 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Activity NCT03869918 243 251 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Staging NCT03869918 252 259 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
questionnaire NCT03869918 260 273 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03869918 274 275 O

6 NCT03869918 280 281 O
. NCT03869918 281 282 O
cognitively NCT03869918 284 295 B-Condition-Name
able NCT03869918 296 300 O
to NCT03869918 301 303 O
complete NCT03869918 304 312 O
the NCT03869918 313 316 O
study NCT03869918 317 322 O
( NCT03869918 323 324 O
in NCT03869918 325 327 O
opinion NCT03869918 328 335 O
of NCT03869918 336 338 O
the NCT03869918 339 342 O
referring NCT03869918 343 352 O
provider NCT03869918 353 361 O
) NCT03869918 362 363 O
Women NCT03869918 364 369 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
currently NCT03869918 370 379 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
on NCT03869918 380 382 O
anti NCT03869918 383 387 B-Drug-Name
- NCT03869918 388 389 I-Drug-Name
cholinergic NCT03869918 390 401 I-Drug-Name
medication NCT03869918 402 412 I-Drug-Name
for NCT03869918 413 416 O
urinary NCT03869918 417 424 B-Condition-Name
incontinence NCT03869918 425 437 I-Condition-Name
will NCT03869918 438 442 O
be NCT03869918 443 445 O
allowed NCT03869918 446 453 O
if NCT03869918 454 456 O
they NCT03869918 457 461 O
meet NCT03869918 462 466 O
the NCT03869918 467 470 O
above NCT03869918 471 476 O
criteria NCT03869918 477 485 O
. NCT03869918 486 487 O

Exclusion NCT03869918 489 498 O
Criteria NCT03869918 499 507 O
: NCT03869918 508 509 O

1 NCT03869918 514 515 O
. NCT03869918 515 516 O
cognitive NCT03869918 518 527 B-Condition-Name
impairment NCT03869918 528 538 I-Condition-Name
( NCT03869918 539 540 O
in NCT03869918 541 543 O
opinion NCT03869918 544 551 O
of NCT03869918 552 554 O
the NCT03869918 555 558 O
referring NCT03869918 559 568 O
provider NCT03869918 569 577 O
) NCT03869918 578 579 O

2 NCT03869918 584 585 O
. NCT03869918 585 586 O
unable NCT03869918 588 594 O
to NCT03869918 595 597 O
provide NCT03869918 598 605 O
informed NCT03869918 606 614 O
consent NCT03869918 615 622 O
or NCT03869918 623 625 O
communicate NCT03869918 626 637 O
in NCT03869918 638 640 O
English NCT03869918 641 648 B-Language

3 NCT03869918 652 653 O
. NCT03869918 653 654 O
desire NCT03869918 656 662 O
for NCT03869918 663 666 O
surgical NCT03869918 667 675 B-Procedure-Name
management NCT03869918 676 686 I-Procedure-Name

4 NCT03869918 690 691 O
. NCT03869918 691 692 O
osteoporosis NCT03869918 694 706 B-Condition-Name

5 NCT03869918 710 711 O
. NCT03869918 711 712 O
lack NCT03869918 714 718 O
of NCT03869918 719 721 O
medical NCT03869918 722 729 O
clearance NCT03869918 730 739 O
from NCT03869918 740 744 O
the NCT03869918 745 748 O
physician NCT03869918 749 758 B-Provider-Role
. NCT03869918 759 760 O

Inclusion NCT03868384 0 9 O
Criteria NCT03868384 10 18 O
: NCT03868384 19 20 O

- NCT03868384 24 25 O
Patients NCT03868384 27 35 O
with NCT03868384 36 40 O
hypertension NCT03868384 41 53 B-Condition-Name
and NCT03868384 54 57 O
taking NCT03868384 58 64 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antihypertensive NCT03868384 65 81 B-Drug-Name
drugs NCT03868384 82 87 I-Drug-Name
more NCT03868384 88 92 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868384 93 97 I-Eq-Operator___Eq-Operator-Value:GT
1 NCT03868384 99 100 B-Eq-Value
year NCT03868384 101 105 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03868384 106 115 O
Criteria NCT03868384 116 124 O
: NCT03868384 125 126 O

- NCT03868384 130 131 O
Secondary NCT03868384 133 142 O
hypertension NCT03868384 143 155 B-Condition-Name

- NCT03868384 158 159 O
Hypertensive NCT03868384 161 173 B-Condition-Name
emergency NCT03868384 174 183 B-Encounter-Type___Encounter-Type-Value:emergency
and NCT03868384 184 187 O
urgency NCT03868384 188 195 B-Encounter-Type___Encounter-Type-Value:emergency

- NCT03868384 198 199 O
Severe NCT03868384 201 207 B-Severity___Severity-Value:severe
heart NCT03868384 208 213 B-Condition-Name
failure NCT03868384 214 221 I-Condition-Name
( NCT03868384 222 223 O
NYHA NCT03868384 224 228 B-Condition-Name
III NCT03868384 229 232 B-Eq-Value
and NCT03868384 233 236 O
IV NCT03868384 237 239 B-Eq-Value
) NCT03868384 240 241 O

- NCT03868384 245 246 O
Angina NCT03868384 248 254 B-Condition-Name
with NCT03868384 255 259 O
6 NCT03868384 261 262 B-Eq-Value
months NCT03868384 263 269 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03868384 272 273 O
Myocardial NCT03868384 275 285 B-Condition-Name
infarction NCT03868384 286 296 I-Condition-Name
within NCT03868384 297 303 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03868384 305 306 B-Eq-Value
months NCT03868384 307 313 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03868384 316 317 O
Peripheral NCT03868384 319 329 B-Condition-Name
artery NCT03868384 330 336 I-Condition-Name
disease NCT03868384 337 344 I-Condition-Name
within NCT03868384 345 351 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03868384 353 354 B-Eq-Value
months NCT03868384 355 361 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03868384 364 365 O
Significant NCT03868384 367 378 B-Severity___Severity-Value:severe
arrhythmia NCT03868384 379 389 B-Condition-Name
( NCT03868384 390 391 O
i NCT03868384 392 393 O
. NCT03868384 394 395 O
e NCT03868384 396 397 O
. NCT03868384 398 399 O
ventricular NCT03868384 401 412 B-Condition-Name
tachycardia NCT03868384 413 424 I-Condition-Name
and NCT03868384 425 428 O
fibrillation NCT03868384 429 441 B-Condition-Name
, NCT03868384 442 443 O
atrial NCT03868384 444 450 B-Condition-Name
fibrillation NCT03868384 451 463 I-Condition-Name
, NCT03868384 464 465 O
atrial NCT03868384 466 472 B-Condition-Name
flutter NCT03868384 473 480 I-Condition-Name
) NCT03868384 481 482 O

- NCT03868384 486 487 O
Pregnancy NCT03868384 489 498 B-Condition-Name

- NCT03868384 501 502 O
Night NCT03868384 504 509 B-Observation-Name
labor NCT03868384 510 515 I-Observation-Name
, NCT03868384 516 517 O
shift NCT03868384 518 523 B-Observation-Name
worker NCT03868384 524 530 I-Observation-Name

- NCT03868384 533 534 O
Those NCT03868384 536 541 O
who NCT03868384 542 545 O
are NCT03868384 546 549 O
currently NCT03868384 550 559 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
participating NCT03868384 560 573 O
in NCT03868384 574 576 O
other NCT03868384 577 582 O
clinical NCT03868384 583 591 O
studies NCT03868384 592 599 O

- NCT03868384 602 603 O
Those NCT03868384 605 610 O
who NCT03868384 611 614 O
have NCT03868384 615 619 O
taken NCT03868384 620 625 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
other NCT03868384 626 631 O
clinical NCT03868384 632 640 O
trial NCT03868384 641 646 O
drugs NCT03868384 647 652 O
within NCT03868384 653 659 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03868384 660 663 O
past NCT03868384 664 668 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03868384 669 674 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03868384 677 678 O
According NCT03868384 680 689 O
to NCT03868384 690 692 O
the NCT03868384 693 696 O
opinion NCT03868384 697 704 O
of NCT03868384 705 707 O
the NCT03868384 708 711 O
researcher NCT03868384 712 722 O
, NCT03868384 723 724 O
those NCT03868384 725 730 O
who NCT03868384 731 734 O
have NCT03868384 735 739 O
or NCT03868384 740 742 O
may NCT03868384 743 746 O
have NCT03868384 747 751 O
a NCT03868384 752 753 O
disease NCT03868384 754 761 B-Condition-Name
that NCT03868384 762 766 O
may NCT03868384 767 770 O
interfere NCT03868384 771 780 B-Stability___Stability-Value:change
with NCT03868384 781 785 O
the NCT03868384 786 789 O
completion NCT03868384 790 800 O
of NCT03868384 801 803 O
the NCT03868384 804 807 O
study NCT03868384 808 813 O

- NCT03868384 816 817 O
History NCT03868384 819 826 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868384 827 829 O
drug NCT03868384 830 834 O
or NCT03868384 835 837 O
alcohol NCT03868384 838 845 O
dependence NCT03868384 846 856 B-Condition-Name
within NCT03868384 857 863 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03868384 865 866 B-Eq-Value
months NCT03868384 867 873 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03861559 0 9 O
Criteria NCT03861559 10 18 O
: NCT03861559 19 20 O

- NCT03861559 24 25 O
Has NCT03861559 27 30 O
a NCT03861559 31 32 O
2 NCT03861559 34 35 B-Eq-Value
- NCT03861559 36 37 O
year NCT03861559 38 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
history NCT03861559 43 50 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861559 51 53 O
seasonal NCT03861559 54 62 O
allergic NCT03861559 63 71 B-Condition-Name
rhinitis NCT03861559 72 80 I-Condition-Name

- NCT03861559 83 84 O
Has NCT03861559 86 89 O
a NCT03861559 90 91 O
positive NCT03861559 92 100 B-Polarity___Polarity-Value:positive
skin NCT03861559 101 105 B-Observation-Name___Observation-Type-Value:lab
test NCT03861559 106 110 I-Observation-Name___Observation-Type-Value:lab
response NCT03861559 111 119 O
to NCT03861559 120 122 O
a NCT03861559 123 124 O
local NCT03861559 125 130 O
seasonal NCT03861559 131 139 O
allergen NCT03861559 140 148 O
( NCT03861559 149 150 O
current NCT03861559 151 158 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
, NCT03861559 159 160 O
or NCT03861559 161 163 O
performed NCT03861559 164 173 O
in NCT03861559 174 176 O
investigator NCT03861559 177 189 O
's NCT03861559 189 191 O
office NCT03861559 192 198 O
within NCT03861559 199 205 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861559 206 209 O
past NCT03861559 210 214 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03861559 215 219 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03861559 220 221 O

- NCT03861559 225 226 O
Is NCT03861559 228 230 O
in NCT03861559 231 233 O
good NCT03861559 234 238 B-Condition-Name
health NCT03861559 239 245 I-Condition-Name
and NCT03861559 246 249 O
free NCT03861559 250 254 O
of NCT03861559 255 257 O
any NCT03861559 258 261 O
unstable NCT03861559 262 270 B-Stability___Stability-Value:change
, NCT03861559 271 272 O
clinically NCT03861559 273 283 O
- NCT03861559 284 285 O
significant NCT03861559 286 297 B-Severity___Severity-Value:severe
disease NCT03861559 298 305 B-Condition-Name
, NCT03861559 306 307 O
other NCT03861559 308 313 O
than NCT03861559 314 318 O
allergic NCT03861559 319 327 B-Condition-Name
rhinitis NCT03861559 328 336 I-Condition-Name
, NCT03861559 337 338 O
that NCT03861559 339 343 O
would NCT03861559 344 349 O
interfere NCT03861559 350 359 B-Stability___Stability-Value:change
with NCT03861559 360 364 O
the NCT03861559 365 368 O
study NCT03861559 369 374 O
schedule NCT03861559 375 383 O
or NCT03861559 384 386 O
evaluation NCT03861559 387 397 O
of NCT03861559 398 400 O
seasonal NCT03861559 401 409 O
allergic NCT03861559 410 418 B-Condition-Name
rhinitis NCT03861559 419 427 I-Condition-Name

Exclusion NCT03861559 428 437 O
Criteria NCT03861559 438 446 O
: NCT03861559 447 448 O

- NCT03861559 452 453 O
Women NCT03861559 455 460 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03861559 461 464 O
are NCT03861559 465 468 O
pregnant NCT03861559 469 477 B-Condition-Name
or NCT03861559 478 480 O
breastfeeding NCT03861559 481 494 B-Condition-Name

- NCT03861559 497 498 O
Women NCT03861559 500 505 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03861559 506 508 O
childbearing NCT03861559 509 521 B-Condition-Name
potential NCT03861559 522 531 I-Condition-Name
who NCT03861559 532 535 O
are NCT03861559 536 539 O
not NCT03861559 540 543 O
using NCT03861559 544 549 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
an NCT03861559 550 552 O
acceptable NCT03861559 553 563 O
form NCT03861559 564 568 O
of NCT03861559 569 571 O
birth NCT03861559 572 577 B-Procedure-Name
control NCT03861559 578 585 I-Procedure-Name

- NCT03861559 588 589 O
Has NCT03861559 591 594 O
asthma NCT03861559 595 601 B-Condition-Name
that NCT03861559 602 606 O
requires NCT03861559 607 615 O
therapy NCT03861559 616 623 B-Procedure-Name
with NCT03861559 624 628 O
inhaled NCT03861559 629 636 O
or NCT03861559 637 639 O
systemic NCT03861559 640 648 O
corticosteroids NCT03861559 649 664 B-Drug-Name
, NCT03861559 665 666 O
cromolyn NCT03861559 667 675 B-Drug-Name
, NCT03861559 676 677 O
or NCT03861559 678 680 O
nedocromil NCT03861559 681 691 B-Drug-Name

- NCT03861559 694 695 O
Has NCT03861559 697 700 O
significant NCT03861559 701 712 B-Severity___Severity-Value:severe
renal NCT03861559 713 718 O
, NCT03861559 719 720 O
hepatic NCT03861559 721 728 O
, NCT03861559 729 730 O
neurologic NCT03861559 731 741 O
, NCT03861559 742 743 O
cardiovascular NCT03861559 744 758 O
, NCT03861559 759 760 O
hematologic NCT03861559 761 772 O
, NCT03861559 773 774 O
metabolic NCT03861559 775 784 O
, NCT03861559 785 786 O
cerebrovascular NCT03861559 787 802 O
, NCT03861559 803 804 O
respiratory NCT03861559 805 816 O
, NCT03861559 817 818 O
gastrointestinal NCT03861559 819 835 O
, NCT03861559 836 837 O
or NCT03861559 838 840 O
other NCT03861559 841 846 O
significant NCT03861559 847 858 B-Severity___Severity-Value:severe
medical NCT03861559 859 866 O
illness NCT03861559 867 874 O
or NCT03861559 875 877 O
disorder NCT03861559 878 886 B-Condition-Name
which NCT03861559 887 892 O
, NCT03861559 893 894 O
in NCT03861559 895 897 O
the NCT03861559 898 901 O
judgment NCT03861559 902 910 O
of NCT03861559 911 913 O
the NCT03861559 914 917 O
investigator NCT03861559 918 930 O
, NCT03861559 931 932 O
could NCT03861559 933 938 O
interfere NCT03861559 939 948 B-Stability___Stability-Value:change
with NCT03861559 949 953 O
the NCT03861559 954 957 O
study NCT03861559 958 963 O
, NCT03861559 964 965 O
or NCT03861559 966 968 O
required NCT03861559 969 977 O
treatment NCT03861559 978 987 O
which NCT03861559 988 993 O
might NCT03861559 994 999 O
interfere NCT03861559 1000 1009 B-Stability___Stability-Value:change
with NCT03861559 1010 1014 O
the NCT03861559 1015 1018 O
study NCT03861559 1019 1024 O

- NCT03861559 1027 1028 O
Is NCT03861559 1030 1032 O
on NCT03861559 1033 1035 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
immunotherapy NCT03861559 1036 1049 B-Procedure-Name
with NCT03861559 1050 1054 O
the NCT03861559 1055 1058 O
exception NCT03861559 1059 1068 O
of NCT03861559 1069 1071 O
maintenance NCT03861559 1072 1083 B-Procedure-Name
therapy NCT03861559 1084 1091 I-Procedure-Name

- NCT03861559 1094 1095 O
Has NCT03861559 1097 1100 O
a NCT03861559 1101 1102 O
clinically NCT03861559 1103 1113 O
significant NCT03861559 1114 1125 B-Severity___Severity-Value:severe
upper NCT03861559 1126 1131 O
respiratory NCT03861559 1132 1143 O
or NCT03861559 1144 1146 O
sinus NCT03861559 1147 1152 O
infection NCT03861559 1153 1162 B-Condition-Name

- NCT03861559 1165 1166 O
Has NCT03861559 1168 1171 O
used NCT03861559 1172 1176 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
an NCT03861559 1177 1179 O
investigational NCT03861559 1180 1195 O
drug NCT03861559 1196 1200 O
within NCT03861559 1201 1207 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861559 1208 1211 O
previous NCT03861559 1212 1220 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
30 NCT03861559 1222 1224 B-Eq-Value
days NCT03861559 1225 1229 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03861559 1232 1233 O
Has NCT03861559 1235 1238 O
nasal NCT03861559 1239 1244 O
structural NCT03861559 1245 1255 O
abnormalities NCT03861559 1256 1269 B-Condition-Name
, NCT03861559 1270 1271 O
including NCT03861559 1272 1281 O
large NCT03861559 1282 1287 O
nasal NCT03861559 1288 1293 B-Condition-Name
polyps NCT03861559 1294 1300 I-Condition-Name
and NCT03861559 1301 1304 O
marked NCT03861559 1305 1311 O
septal NCT03861559 1312 1318 B-Condition-Name
deviation NCT03861559 1319 1328 I-Condition-Name
, NCT03861559 1329 1330 O
that NCT03861559 1331 1335 O
significantly NCT03861559 1336 1349 O
interfere NCT03861559 1350 1359 B-Stability___Stability-Value:change
with NCT03861559 1360 1364 O
nasal NCT03861559 1365 1370 B-Condition-Name
air NCT03861559 1371 1374 I-Condition-Name
flow NCT03861559 1375 1379 I-Condition-Name

- NCT03861559 1382 1383 O
Has NCT03861559 1385 1388 O
a NCT03861559 1389 1390 O
history NCT03861559 1391 1398 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861559 1399 1401 O
multiple NCT03861559 1402 1410 B-Eq-Operator___Eq-Operator-Value:GT
drug NCT03861559 1411 1415 O
allergies NCT03861559 1416 1425 O
or NCT03861559 1426 1428 O
an NCT03861559 1429 1431 O
allergy NCT03861559 1432 1439 O
to NCT03861559 1440 1442 O
antihistamines NCT03861559 1443 1457 B-Drug-Name
or NCT03861559 1458 1460 O
corticoids NCT03861559 1461 1471 B-Drug-Name

- NCT03861559 1474 1475 O
Has NCT03861559 1477 1480 O
dependence NCT03861559 1481 1491 O
upon NCT03861559 1492 1496 O
nasal NCT03861559 1497 1502 O
, NCT03861559 1503 1504 O
oral NCT03861559 1505 1509 O
or NCT03861559 1510 1512 O
ocular NCT03861559 1513 1519 O
decongestants NCT03861559 1520 1533 B-Drug-Name
, NCT03861559 1534 1535 O
or NCT03861559 1536 1538 O
nasal NCT03861559 1539 1544 B-Drug-Name
topical NCT03861559 1545 1552 I-Drug-Name
antihistamines NCT03861559 1553 1567 I-Drug-Name
, NCT03861559 1568 1569 O
in NCT03861559 1570 1572 O
the NCT03861559 1573 1576 O
opinion NCT03861559 1577 1584 O
of NCT03861559 1585 1587 O
the NCT03861559 1588 1591 O
investigator NCT03861559 1592 1604 O

- NCT03861559 1607 1608 O
Has NCT03861559 1610 1613 O
rhinitis NCT03861559 1614 1622 B-Condition-Name
medicamentosa NCT03861559 1623 1636 I-Condition-Name

- NCT03861559 1639 1640 O
Is NCT03861559 1642 1644 O
using NCT03861559 1645 1650 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03861559 1651 1653 O
any NCT03861559 1654 1657 O
chronic NCT03861559 1658 1665 O
medication NCT03861559 1666 1676 O
which NCT03861559 1677 1682 O
could NCT03861559 1683 1688 O
affect NCT03861559 1689 1695 B-Stability___Stability-Value:change
the NCT03861559 1696 1699 O
course NCT03861559 1700 1706 O
of NCT03861559 1707 1709 O
seasonal NCT03861559 1710 1718 O
allergic NCT03861559 1719 1727 B-Condition-Name
rhinitis NCT03861559 1728 1736 I-Condition-Name

Inclusion NCT03863366 0 9 O
Criteria NCT03863366 10 18 O
: NCT03863366 19 20 O

- NCT03863366 24 25 O
Male NCT03863366 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03863366 32 34 O
female NCT03863366 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03863366 44 45 O
Aged NCT03863366 47 51 O
18 NCT03863366 53 55 B-Eq-Value
- NCT03863366 56 57 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03863366 59 61 B-Eq-Value
years NCT03863366 62 67 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863366 70 71 O
Willing NCT03863366 73 80 O
and NCT03863366 81 84 O
able NCT03863366 85 89 O
to NCT03863366 90 92 O
give NCT03863366 93 97 O
informed NCT03863366 98 106 O
consent NCT03863366 107 114 O
for NCT03863366 115 118 O
participation NCT03863366 119 132 O
in NCT03863366 133 135 O
the NCT03863366 136 139 O
study NCT03863366 140 145 O

- NCT03863366 148 149 O
Sufficiently NCT03863366 151 163 O
fluent NCT03863366 164 170 O
English NCT03863366 171 178 B-Language
to NCT03863366 179 181 O
understand NCT03863366 182 192 O
and NCT03863366 193 196 O
complete NCT03863366 197 205 O
the NCT03863366 206 209 O
task NCT03863366 210 214 O

Exclusion NCT03863366 215 224 O
Criteria NCT03863366 225 233 O
: NCT03863366 234 235 O

- NCT03863366 239 240 O
Current NCT03863366 242 249 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
usage NCT03863366 250 255 O
of NCT03863366 256 258 O
psychoactive NCT03863366 259 271 B-Drug-Name
medication NCT03863366 272 282 I-Drug-Name
( NCT03863366 283 284 O
except NCT03863366 285 291 O
the NCT03863366 292 295 O
contraceptive NCT03863366 296 309 B-Drug-Name
pill NCT03863366 310 314 I-Drug-Name
, NCT03863366 315 316 O
the NCT03863366 317 320 O
Depo NCT03863366 321 325 B-Drug-Name
- NCT03863366 326 327 I-Drug-Name
Provera NCT03863366 328 335 I-Drug-Name
injection NCT03863366 336 345 O
or NCT03863366 346 348 O
the NCT03863366 349 352 O
progesterone NCT03863366 353 365 B-Procedure-Name
implant NCT03863366 366 373 I-Procedure-Name
) NCT03863366 374 375 O

- NCT03863366 379 380 O
Any NCT03863366 382 385 O
past NCT03863366 386 390 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03863366 391 393 O
current NCT03863366 394 401 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Axis NCT03863366 402 406 O
1 NCT03863366 408 409 O
DSM NCT03863366 410 413 O
- NCT03863366 414 415 O
IV NCT03863366 416 418 O
psychiatric NCT03863366 419 430 B-Condition-Name
disorder NCT03863366 431 439 I-Condition-Name

- NCT03863366 442 443 O
Significant NCT03863366 445 456 B-Severity___Severity-Value:severe
medical NCT03863366 457 464 O
condition NCT03863366 465 474 O

- NCT03863366 477 478 O
Current NCT03863366 480 487 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03863366 488 490 O
past NCT03863366 491 495 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
gastro NCT03863366 496 502 O
- NCT03863366 503 504 O
intestinal NCT03863366 505 515 O
disorder NCT03863366 516 524 B-Condition-Name
or NCT03863366 525 527 O
irritable NCT03863366 528 537 B-Condition-Name
bowel NCT03863366 538 543 I-Condition-Name
syndrome NCT03863366 544 552 I-Condition-Name

- NCT03863366 555 556 O
Current NCT03863366 558 565 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnancy NCT03863366 566 575 B-Condition-Name
or NCT03863366 576 578 O
breastfeeding NCT03863366 579 592 B-Condition-Name

- NCT03863366 595 596 O
Known NCT03863366 598 603 O
lactate NCT03863366 604 611 B-Condition-Name
deficiency NCT03863366 612 622 I-Condition-Name
or NCT03863366 623 625 O
any NCT03863366 626 629 O
other NCT03863366 630 635 O
problem NCT03863366 636 643 B-Condition-Name
absorbing NCT03863366 644 653 I-Condition-Name
lactose NCT03863366 654 661 O
, NCT03863366 662 663 O
galactose NCT03863366 664 673 O
or NCT03863366 674 676 O
glucose NCT03863366 677 684 O

- NCT03863366 687 688 O
Current NCT03863366 690 697 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03863366 698 700 O
past NCT03863366 701 705 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03863366 706 713 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863366 714 716 O
drug NCT03863366 717 721 O
or NCT03863366 722 724 O
alcohol NCT03863366 725 732 O
dependency NCT03863366 733 743 B-Condition-Name

- NCT03863366 746 747 O
Participation NCT03863366 749 762 O
in NCT03863366 763 765 O
a NCT03863366 766 767 O
psychological NCT03863366 768 781 O
or NCT03863366 782 784 O
medical NCT03863366 785 792 O
study NCT03863366 793 798 O
involving NCT03863366 799 808 O
the NCT03863366 809 812 O
use NCT03863366 813 816 O
of NCT03863366 817 819 O
medication NCT03863366 820 830 O
within NCT03863366 831 837 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03863366 838 841 O
last NCT03863366 842 846 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863366 848 849 B-Eq-Value
months NCT03863366 850 856 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863366 859 860 O
Previous NCT03863366 862 870 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participation NCT03863366 871 884 O
in NCT03863366 885 887 O
a NCT03863366 888 889 O
study NCT03863366 890 895 O
using NCT03863366 896 901 O
the NCT03863366 902 905 O
same NCT03863366 906 910 O
, NCT03863366 911 912 O
or NCT03863366 913 915 O
similar NCT03863366 916 923 O
, NCT03863366 924 925 O
emotional NCT03863366 926 935 B-Procedure-Name
processing NCT03863366 936 946 I-Procedure-Name
tasks NCT03863366 947 952 I-Procedure-Name

- NCT03863366 955 956 O
Smoker NCT03863366 958 964 B-Condition-Name
> NCT03863366 965 966 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03863366 968 969 B-Eq-Value
cigarettes NCT03863366 970 980 B-Eq-Unit
per NCT03863366 981 984 O
day NCT03863366 985 988 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03863366 991 992 O
Typically NCT03863366 994 1003 O
drinks NCT03863366 1004 1010 B-Observation-Name___Observation-Type-Value:social-habit
> NCT03863366 1011 1012 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03863366 1014 1015 B-Eq-Value
caffeinated NCT03863366 1016 1027 B-Eq-Unit
drinks NCT03863366 1028 1034 I-Eq-Unit
per NCT03863366 1035 1038 O
day NCT03863366 1039 1042 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

Inclusion NCT03862534 0 9 O
Criteria NCT03862534 10 18 O
: NCT03862534 19 20 O

- NCT03862534 24 25 O
Age NCT03862534 27 30 O
≥ NCT03862534 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03862534 34 36 I-Eq-Operator___Eq-Operator-Value:GTEQ
years NCT03862534 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862534 45 46 O
No NCT03862534 48 50 O
systemic NCT03862534 51 59 O
diseases NCT03862534 60 68 B-Condition-Name
or NCT03862534 69 71 O
pregnancy NCT03862534 72 81 B-Condition-Name
. NCT03862534 82 83 O

- NCT03862534 87 88 O
Self NCT03862534 90 94 O
- NCT03862534 95 96 O
reported NCT03862534 97 105 O
smoking NCT03862534 106 113 B-Condition-Name
≤ NCT03862534 114 115 B-Eq-Operator___Eq-Operator-Value:LTEQ
10 NCT03862534 117 119 B-Eq-Value
cigarettes NCT03862534 120 130 B-Eq-Unit
/ NCT03862534 131 132 O
day NCT03862534 133 136 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
. NCT03862534 137 138 O

- NCT03862534 142 143 O
Full NCT03862534 145 149 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03862534 150 151 I-Observation-Name___Observation-Type-Value:clinical-score
mouth NCT03862534 152 157 I-Observation-Name___Observation-Type-Value:clinical-score
plaque NCT03862534 158 164 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03862534 165 170 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03862534 171 172 O
FMPS NCT03862534 173 177 B-Observation-Name
) NCT03862534 178 179 O
and NCT03862534 180 183 O
full NCT03862534 184 188 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03862534 189 190 I-Observation-Name___Observation-Type-Value:clinical-score
mouth NCT03862534 191 196 I-Observation-Name___Observation-Type-Value:clinical-score
bleeding NCT03862534 197 205 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03862534 206 211 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03862534 212 213 O
FMBS NCT03862534 214 218 B-Observation-Name
) NCT03862534 219 220 O
≤ NCT03862534 221 222 B-Eq-Operator___Eq-Operator-Value:LTEQ
10 NCT03862534 224 226 B-Eq-Value
% NCT03862534 227 228 B-Eq-Unit
( NCT03862534 229 230 O
measured NCT03862534 231 239 O
at NCT03862534 240 242 O
four NCT03862534 243 247 B-Eq-Value
sites NCT03862534 248 253 O
per NCT03862534 254 257 O
tooth NCT03862534 258 263 B-Eq-Unit
) NCT03862534 264 265 O
. NCT03862534 267 268 O

- NCT03862534 272 273 O
Presence NCT03862534 275 283 O
of NCT03862534 284 286 O
single NCT03862534 287 293 B-Eq-Value
RT NCT03862534 294 296 O
1 NCT03862534 297 298 O
buccal NCT03862534 299 305 O
gingival NCT03862534 306 314 B-Condition-Name
recessions NCT03862534 315 325 I-Condition-Name
≥ NCT03862534 326 327 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03862534 329 330 B-Eq-Value
mm NCT03862534 331 333 B-Eq-Unit
of NCT03862534 334 336 O
depth NCT03862534 337 342 O
located NCT03862534 343 350 O
in NCT03862534 351 353 O
the NCT03862534 354 357 O
anterior NCT03862534 358 366 O
area NCT03862534 367 371 O
of NCT03862534 372 374 O
the NCT03862534 375 378 O
upper NCT03862534 379 384 O
jaw NCT03862534 385 388 O
( NCT03862534 389 390 O
central NCT03862534 391 398 O
and NCT03862534 399 402 O
lateral NCT03862534 403 410 O
incisors NCT03862534 411 419 O
, NCT03862534 420 421 O
canine NCT03862534 422 428 O
, NCT03862534 429 430 O
first NCT03862534 431 436 O
and NCT03862534 437 440 O
second NCT03862534 441 447 O
pre NCT03862534 448 451 O
- NCT03862534 452 453 O
molars NCT03862534 454 460 O
, NCT03862534 461 462 O
first NCT03862534 463 468 O
molar NCT03862534 469 474 O
) NCT03862534 475 476 O
and NCT03862534 477 480 O
associated NCT03862534 481 491 O
with NCT03862534 492 496 O
aesthetic NCT03862534 497 506 B-Condition-Name
complains NCT03862534 507 516 I-Condition-Name
and NCT03862534 517 520 O
or NCT03862534 521 523 O
dental NCT03862534 524 530 B-Condition-Name
sensitivity NCT03862534 531 542 I-Condition-Name
. NCT03862534 543 544 O

- NCT03862534 548 549 O
Presence NCT03862534 551 559 O
of NCT03862534 560 562 O
NCCL NCT03862534 563 567 B-Condition-Name
associated NCT03862534 568 578 O
with NCT03862534 579 583 O
recession NCT03862534 584 593 B-Condition-Name

- NCT03862534 596 597 O
No NCT03862534 599 601 O
history NCT03862534 602 609 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862534 610 612 O
mucogingival NCT03862534 613 625 O
or NCT03862534 626 628 O
periodontal NCT03862534 629 640 O
surgery NCT03862534 641 648 B-Procedure-Name
at NCT03862534 649 651 O
experimental NCT03862534 652 664 O
sites NCT03862534 665 670 O
. NCT03862534 671 672 O

Exclusion NCT03862534 674 683 O
Criteria NCT03862534 684 692 O
: NCT03862534 693 694 O

- NCT03862534 698 699 O
Prosthetic NCT03862534 701 711 B-Condition-Name
crown NCT03862534 712 717 I-Condition-Name
at NCT03862534 718 720 O
experimental NCT03862534 721 733 O
teeth NCT03862534 734 739 O
. NCT03862534 740 741 O

- NCT03862534 745 746 O
Gingival NCT03862534 748 756 B-Condition-Name
recessions NCT03862534 757 767 I-Condition-Name
presenting NCT03862534 768 778 O
minimal NCT03862534 779 786 O
amount NCT03862534 787 793 O
( NCT03862534 794 795 O
< NCT03862534 797 798 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03862534 800 801 B-Eq-Value
mm NCT03862534 802 804 B-Eq-Unit
) NCT03862534 805 806 O
of NCT03862534 807 809 O
apico NCT03862534 810 815 B-Condition-Name
- NCT03862534 816 817 I-Condition-Name
coronal NCT03862534 818 825 I-Condition-Name
keratinized NCT03862534 826 837 I-Condition-Name
tissue NCT03862534 838 844 I-Condition-Name
( NCT03862534 845 846 O
KT NCT03862534 847 849 B-Condition-Name
) NCT03862534 850 851 O
extension NCT03862534 852 861 O
apical NCT03862534 862 868 O
to NCT03862534 869 871 O
recession NCT03862534 872 881 O
area NCT03862534 882 886 O
. NCT03862534 887 888 O

Inclusion NCT03869307 0 9 O
Criteria NCT03869307 10 18 O
: NCT03869307 19 20 O

- NCT03869307 24 25 O
Men NCT03869307 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03869307 31 34 O
women NCT03869307 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
aged NCT03869307 41 45 O
18 NCT03869307 47 49 B-Eq-Value
- NCT03869307 50 51 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03869307 53 55 B-Eq-Value

- NCT03869307 59 60 O
Generalized NCT03869307 62 73 O
HSD NCT03869307 74 77 B-Condition-Name
( NCT03869307 78 79 O
G NCT03869307 80 81 B-Condition-Name
- NCT03869307 82 83 I-Condition-Name
HSD NCT03869307 84 87 I-Condition-Name
) NCT03869307 88 89 O
defined NCT03869307 90 97 O
with NCT03869307 98 102 O
Beighton NCT03869307 103 111 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03869307 112 117 I-Observation-Name___Observation-Type-Value:clinical-score
cut NCT03869307 118 121 O
- NCT03869307 122 123 O
off NCT03869307 124 127 O
≥ NCT03869307 128 129 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03869307 131 132 B-Eq-Value
for NCT03869307 133 136 O
women NCT03869307 137 142 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
up NCT03869307 143 145 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03869307 146 148 I-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03869307 149 152 O
age NCT03869307 153 156 O
of NCT03869307 157 159 O
50 NCT03869307 161 163 B-Eq-Value
years NCT03869307 164 169 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03869307 170 173 O
≥ NCT03869307 174 175 B-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03869307 177 178 B-Eq-Value
for NCT03869307 179 182 O
those NCT03869307 183 188 O
above NCT03869307 189 194 B-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03869307 196 198 B-Eq-Value
years NCT03869307 199 204 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03869307 205 208 O
all NCT03869307 209 212 O
men NCT03869307 213 216 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
, NCT03869307 217 218 O
or NCT03869307 219 221 O
Historical NCT03869307 222 232 O
HSD NCT03869307 233 236 B-Condition-Name
( NCT03869307 237 238 O
H NCT03869307 239 240 B-Condition-Name
- NCT03869307 241 242 I-Condition-Name
HSD NCT03869307 243 246 I-Condition-Name
) NCT03869307 247 248 O
if NCT03869307 249 251 O
the NCT03869307 252 255 O
Beighton NCT03869307 256 264 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03869307 265 270 I-Observation-Name___Observation-Type-Value:clinical-score
was NCT03869307 271 274 O
1 NCT03869307 276 277 B-Eq-Value
point NCT03869307 278 283 O
below NCT03869307 284 289 B-Eq-Operator___Eq-Operator-Value:LT
the NCT03869307 290 293 O
age NCT03869307 294 297 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
and NCT03869307 298 301 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
sex NCT03869307 302 305 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
- NCT03869307 306 307 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
specific NCT03869307 308 316 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
cut NCT03869307 317 320 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
- NCT03869307 321 322 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
off NCT03869307 323 326 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
AND NCT03869307 327 330 O
the NCT03869307 331 334 O
five NCT03869307 335 339 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03869307 340 341 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
part NCT03869307 342 346 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
questionnaire NCT03869307 347 360 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03869307 361 362 O
5 NCT03869307 364 365 B-Observation-Name
PQ NCT03869307 366 368 I-Observation-Name
) NCT03869307 369 370 O
was NCT03869307 371 374 O
positive NCT03869307 375 383 B-Polarity___Polarity-Value:positive
( NCT03869307 384 385 O
= NCT03869307 387 388 O
at NCT03869307 389 391 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869307 392 397 I-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03869307 398 401 B-Eq-Value
positive NCT03869307 402 410 B-Polarity___Polarity-Value:positive
items NCT03869307 411 416 O
) NCT03869307 417 418 O
. NCT03869307 420 421 O

- NCT03869307 425 426 O
Present NCT03869307 428 435 O
with NCT03869307 436 440 O
one NCT03869307 441 444 B-Eq-Value
or NCT03869307 445 447 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03869307 448 452 I-Eq-Operator___Eq-Operator-Value:GTEQ
secondary NCT03869307 453 462 O
symptomatic NCT03869307 463 474 O
musculoskeletal NCT03869307 475 490 B-Condition-Name
manifestations NCT03869307 491 505 I-Condition-Name
, NCT03869307 506 507 O
defined NCT03869307 508 515 O
as NCT03869307 516 518 O
either NCT03869307 519 525 O

1 NCT03869307 534 535 O
. NCT03869307 535 536 O
musculoskeletal NCT03869307 538 553 O
pain NCT03869307 554 558 B-Condition-Name
in NCT03869307 559 561 O
minimum NCT03869307 562 569 B-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03869307 570 573 B-Eq-Value
shoulder NCT03869307 574 582 O
for NCT03869307 583 586 O
at NCT03869307 587 589 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869307 590 595 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03869307 596 601 B-Eq-Value
months NCT03869307 602 608 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03869307 609 612 O
/ NCT03869307 613 614 O
or NCT03869307 615 617 O

2 NCT03869307 626 627 O
. NCT03869307 627 628 O
recurrent NCT03869307 630 639 O
joint NCT03869307 640 645 O
dislocations NCT03869307 646 658 B-Condition-Name
or NCT03869307 659 661 O
joint NCT03869307 662 667 O
instability NCT03869307 668 679 B-Condition-Name
without NCT03869307 680 687 O
a NCT03869307 688 689 O
reported NCT03869307 690 698 O
history NCT03869307 699 706 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869307 707 709 O
trauma NCT03869307 710 716 B-Condition-Name
defined NCT03869307 717 724 O
as NCT03869307 725 727 O
either NCT03869307 728 734 O
a NCT03869307 735 736 O
) NCT03869307 737 738 O
minimum NCT03869307 739 746 B-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03869307 747 752 B-Eq-Value
atraumatic NCT03869307 753 763 O
dislocations NCT03869307 764 776 B-Condition-Name
in NCT03869307 777 779 O
same NCT03869307 780 784 O
shoulder NCT03869307 785 793 O
, NCT03869307 794 795 O
b NCT03869307 796 797 O
) NCT03869307 798 799 O
minimum NCT03869307 800 807 B-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03869307 808 811 B-Eq-Value
atraumatic NCT03869307 812 822 O
dislocations NCT03869307 823 835 B-Condition-Name
in NCT03869307 836 838 O
two NCT03869307 839 842 O
different NCT03869307 843 852 O
joints NCT03869307 853 859 O
( NCT03869307 860 861 O
minimum NCT03869307 862 869 B-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03869307 870 873 B-Eq-Value
in NCT03869307 874 876 O
the NCT03869307 877 880 O
shoulder NCT03869307 881 889 O
) NCT03869307 890 891 O
occurring NCT03869307 892 901 O
at NCT03869307 902 904 O
different NCT03869307 905 914 O
times NCT03869307 915 920 O
, NCT03869307 921 922 O
or NCT03869307 923 925 O
c NCT03869307 926 927 O
) NCT03869307 928 929 O
medical NCT03869307 930 937 O
confirmation NCT03869307 938 950 O
of NCT03869307 951 953 O
joint NCT03869307 954 959 O
instability NCT03869307 960 971 B-Condition-Name
in NCT03869307 972 974 O
minimum NCT03869307 975 982 B-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03869307 983 986 B-Eq-Value
joints NCT03869307 987 993 B-Eq-Unit
( NCT03869307 994 995 O
minimum NCT03869307 996 1003 B-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03869307 1004 1007 B-Eq-Value
in NCT03869307 1008 1010 O
the NCT03869307 1011 1014 O
shoulder NCT03869307 1015 1023 O
) NCT03869307 1024 1025 O
not NCT03869307 1026 1029 O
related NCT03869307 1030 1037 O
to NCT03869307 1038 1040 O
trauma NCT03869307 1041 1047 B-Condition-Name
. NCT03869307 1048 1049 O

Exclusion NCT03869307 1051 1060 O
Criteria NCT03869307 1061 1069 O
: NCT03869307 1070 1071 O

- NCT03869307 1075 1076 O
Clinically NCT03869307 1078 1088 O
suspected NCT03869307 1089 1098 O
referred NCT03869307 1099 1107 O
pain NCT03869307 1108 1112 B-Condition-Name
from NCT03869307 1113 1117 O
the NCT03869307 1118 1121 O
cervical NCT03869307 1122 1130 O
spine NCT03869307 1131 1136 O

- NCT03869307 1139 1140 O
Systemic NCT03869307 1142 1150 O
inflammatory NCT03869307 1151 1163 B-Condition-Name
rheumatic NCT03869307 1164 1173 I-Condition-Name
diseases NCT03869307 1174 1182 I-Condition-Name

- NCT03869307 1185 1186 O
Connective NCT03869307 1188 1198 B-Condition-Name
tissue NCT03869307 1199 1205 I-Condition-Name
diseases NCT03869307 1206 1214 I-Condition-Name
( NCT03869307 1215 1216 O
e NCT03869307 1217 1218 O
. NCT03869307 1219 1220 O
g NCT03869307 1221 1222 O
. NCT03869307 1223 1224 O
Marfans NCT03869307 1226 1233 B-Condition-Name
, NCT03869307 1234 1235 O
Stickler NCT03869307 1236 1244 B-Condition-Name
's NCT03869307 1244 1246 I-Condition-Name
or NCT03869307 1247 1249 O
Loeys NCT03869307 1250 1255 B-Condition-Name
Dietz NCT03869307 1256 1261 I-Condition-Name
syndromes NCT03869307 1262 1271 I-Condition-Name
, NCT03869307 1272 1273 O
Ehlers NCT03869307 1274 1280 B-Condition-Name
- NCT03869307 1281 1282 I-Condition-Name
Danlos NCT03869307 1283 1289 I-Condition-Name
Syndromes NCT03869307 1290 1299 I-Condition-Name
except NCT03869307 1300 1306 O
hypermobile NCT03869307 1307 1318 O
type NCT03869307 1319 1323 O
) NCT03869307 1324 1325 O

- NCT03869307 1329 1330 O
Neurological NCT03869307 1332 1344 B-Condition-Name
diseases NCT03869307 1345 1353 I-Condition-Name

- NCT03869307 1356 1357 O
Pregnancy NCT03869307 1359 1368 B-Condition-Name
or NCT03869307 1369 1371 O
childbirth NCT03869307 1372 1382 B-Condition-Name
within NCT03869307 1383 1389 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03869307 1390 1393 O
past NCT03869307 1394 1398 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03869307 1399 1403 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03869307 1404 1406 O
planning NCT03869307 1407 1415 O
to NCT03869307 1416 1418 O
get NCT03869307 1419 1422 O
pregnant NCT03869307 1423 1431 B-Condition-Name
during NCT03869307 1432 1438 O
the NCT03869307 1439 1442 O
study NCT03869307 1443 1448 O
period NCT03869307 1449 1455 O

- NCT03869307 1458 1459 O
Shoulder NCT03869307 1461 1469 O
surgery NCT03869307 1470 1477 B-Procedure-Name
within NCT03869307 1478 1484 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03869307 1485 1488 O
past NCT03869307 1489 1493 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03869307 1494 1498 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03869307 1501 1502 O
Steroid NCT03869307 1504 1511 B-Procedure-Name
injection NCT03869307 1512 1521 I-Procedure-Name
in NCT03869307 1522 1524 O
the NCT03869307 1525 1528 O
affected NCT03869307 1529 1537 O
shoulder NCT03869307 1538 1546 O
within NCT03869307 1547 1553 B-Eq-Operator___Eq-Operator-Value:LTEQ
three NCT03869307 1554 1559 B-Eq-Value
months NCT03869307 1560 1566 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03869307 1569 1570 O
Inability NCT03869307 1572 1581 O
to NCT03869307 1582 1584 O
speak NCT03869307 1585 1590 O
and NCT03869307 1591 1594 O
understand NCT03869307 1595 1605 O
Danish NCT03869307 1606 1612 B-Language
. NCT03869307 1613 1614 O

- NCT03869307 1618 1619 O
Unable NCT03869307 1621 1627 O
to NCT03869307 1628 1630 O
comply NCT03869307 1631 1637 O
with NCT03869307 1638 1642 O
protocol NCT03869307 1643 1651 O

Inclusion NCT03863158 0 9 O
Criteria NCT03863158 10 18 O
: NCT03863158 19 20 O

- NCT03863158 24 25 O
Patients NCT03863158 27 35 O
presenting NCT03863158 36 46 B-Condition-Type___Condition-Type-Value:admitting
acute NCT03863158 47 52 B-Severity___Severity-Value:severe
myocardial NCT03863158 53 63 B-Condition-Name
infarction NCT03863158 64 74 I-Condition-Name
with NCT03863158 75 79 O
hemodynamic NCT03863158 80 91 B-Condition-Name
stability NCT03863158 92 101 B-Stability___Stability-Value:stable
at NCT03863158 102 104 O
the NCT03863158 105 108 O
diagnosis NCT03863158 109 118 O

- NCT03863158 121 122 O
Patients NCT03863158 124 132 O
undergoing NCT03863158 133 143 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
coronary NCT03863158 144 152 B-Procedure-Name
artery NCT03863158 153 159 I-Procedure-Name
bypass NCT03863158 160 166 I-Procedure-Name
in NCT03863158 167 169 O
Dijon NCT03863158 170 175 B-Location___Location-Value:hospital
University NCT03863158 176 186 I-Location___Location-Value:hospital
hospital NCT03863158 187 195 I-Location___Location-Value:hospital

Exclusion NCT03863158 196 205 O
Criteria NCT03863158 206 214 O
: NCT03863158 215 216 O

- NCT03863158 220 221 O
Patients NCT03863158 223 231 O
with NCT03863158 232 236 O
Acute NCT03863158 237 242 B-Severity___Severity-Value:severe
pulmonary NCT03863158 243 252 B-Condition-Name
oedema NCT03863158 253 259 I-Condition-Name

- NCT03863158 262 263 O
Patients NCT03863158 265 273 O
with NCT03863158 274 278 O
cardiorespiratory NCT03863158 279 296 B-Condition-Name
arrest NCT03863158 297 303 I-Condition-Name
before NCT03863158 304 310 O
coronary NCT03863158 311 319 B-Procedure-Name
angiography NCT03863158 320 331 I-Procedure-Name

- NCT03863158 334 335 O
hemodynamically NCT03863158 337 352 B-Condition-Name
unstable NCT03863158 353 361 B-Stability___Stability-Value:change
patient NCT03863158 362 369 O
at NCT03863158 370 372 O
diagnosis NCT03863158 373 382 O

- NCT03863158 385 386 O
patients NCT03863158 388 396 O
requiring NCT03863158 397 406 O
combined NCT03863158 407 415 O
surgery NCT03863158 416 423 B-Procedure-Name

- NCT03863158 426 427 O
patients NCT03863158 429 437 O
with NCT03863158 438 442 O
unstable NCT03863158 443 451 B-Stability___Stability-Value:change
angina NCT03863158 452 458 B-Condition-Name

Inclusion NCT03866746 0 9 O
Criteria NCT03866746 10 18 O
: NCT03866746 19 20 O

- NCT03866746 24 25 O
older NCT03866746 27 32 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866746 33 37 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03866746 39 41 B-Eq-Value
years NCT03866746 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866746 48 51 O

- NCT03866746 54 55 O
diagnosed NCT03866746 57 66 O
with NCT03866746 67 71 O
DME NCT03866746 72 75 B-Condition-Name
with NCT03866746 76 80 O
central NCT03866746 81 88 B-Observation-Name___Observation-Type-Value:measurement
macular NCT03866746 89 96 I-Observation-Name___Observation-Type-Value:measurement
thickness NCT03866746 97 106 I-Observation-Name___Observation-Type-Value:measurement
( NCT03866746 107 108 O
CMT NCT03866746 109 112 B-Observation-Name
) NCT03866746 113 114 O
more NCT03866746 115 119 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866746 120 124 I-Eq-Operator___Eq-Operator-Value:GT
250 NCT03866746 126 129 B-Eq-Value
µm NCT03866746 130 132 B-Eq-Unit
measured NCT03866746 133 141 O
by NCT03866746 142 144 O
OCT NCT03866746 145 148 B-Procedure-Name

- NCT03866746 151 152 O
best NCT03866746 154 158 B-Observation-Name___Observation-Type-Value:measurement
corrected NCT03866746 159 168 I-Observation-Name___Observation-Type-Value:measurement
visual NCT03866746 169 175 I-Observation-Name___Observation-Type-Value:measurement
acuity NCT03866746 176 182 I-Observation-Name___Observation-Type-Value:measurement
( NCT03866746 183 184 O
BCVA NCT03866746 185 189 B-Observation-Name
) NCT03866746 190 191 O
between NCT03866746 192 199 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03866746 201 203 B-Eq-Value
/ NCT03866746 204 205 I-Eq-Value
400 NCT03866746 207 210 I-Eq-Value
and NCT03866746 211 214 O
20 NCT03866746 216 218 B-Eq-Value
/ NCT03866746 219 220 I-Eq-Value
40 NCT03866746 222 224 I-Eq-Value
. NCT03866746 224 225 O

Exclusion NCT03866746 227 236 O
Criteria NCT03866746 237 245 O
: NCT03866746 246 247 O

- NCT03866746 251 252 O
patients NCT03866746 254 262 O
with NCT03866746 263 267 O
intra NCT03866746 268 273 O
- NCT03866746 274 275 O
ocular NCT03866746 276 282 O
surgery NCT03866746 283 290 B-Procedure-Name
as NCT03866746 291 293 O
cataract NCT03866746 294 302 B-Procedure-Name
surgery NCT03866746 303 310 I-Procedure-Name
within NCT03866746 311 317 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03866746 319 320 B-Eq-Value
months NCT03866746 321 327 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03866746 330 331 O
prior NCT03866746 333 338 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
intravitreal NCT03866746 339 351 B-Procedure-Name
injection NCT03866746 352 361 I-Procedure-Name
of NCT03866746 362 364 O
any NCT03866746 365 368 O
drug NCT03866746 369 373 O
within NCT03866746 374 380 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03866746 381 384 O
preceding NCT03866746 385 394 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03866746 396 397 B-Eq-Value
months NCT03866746 398 404 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03866746 407 408 O
panretinal NCT03866746 410 420 B-Procedure-Name
photocoagulation NCT03866746 421 437 I-Procedure-Name
( NCT03866746 438 439 O
PRP NCT03866746 440 443 B-Procedure-Name
) NCT03866746 444 445 O
within NCT03866746 446 452 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03866746 453 456 O
former NCT03866746 457 463 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
4 NCT03866746 465 466 B-Eq-Value
months NCT03866746 467 473 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03866746 474 475 O

- NCT03866746 479 480 O
Patients NCT03866746 482 490 O
with NCT03866746 491 495 O
previous NCT03866746 496 504 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
macular NCT03866746 505 512 B-Procedure-Name
laser NCT03866746 513 518 I-Procedure-Name

- NCT03866746 521 522 O
patients NCT03866746 524 532 O
with NCT03866746 533 537 O
vitreo NCT03866746 538 544 B-Condition-Name
- NCT03866746 545 546 I-Condition-Name
macular NCT03866746 547 554 I-Condition-Name
traction NCT03866746 555 563 I-Condition-Name
( NCT03866746 564 565 O
VMT NCT03866746 566 569 B-Condition-Name
) NCT03866746 570 571 O
syndrome NCT03866746 572 580 O

- NCT03866746 583 584 O
severe NCT03866746 586 592 B-Severity___Severity-Value:severe
glaucoma NCT03866746 593 601 B-Condition-Name

- NCT03866746 604 605 O
other NCT03866746 607 612 O
retinal NCT03866746 613 620 B-Condition-Name
vascular NCT03866746 621 629 I-Condition-Name
diseases NCT03866746 630 638 I-Condition-Name

- NCT03866746 641 642 O
conditions NCT03866746 644 654 O
that NCT03866746 655 659 O
impede NCT03866746 660 666 B-Stability___Stability-Value:change
the NCT03866746 667 670 O
OCT NCT03866746 671 674 B-Procedure-Name
interpretation NCT03866746 675 689 O

Inclusion NCT03860337 0 9 O
Criteria NCT03860337 10 18 O
: NCT03860337 19 20 O

- NCT03860337 23 24 O

Exclusion NCT03860337 26 35 O
Criteria NCT03860337 36 44 O
: NCT03860337 45 46 O

- NCT03860337 50 51 O
pregnant NCT03860337 53 61 B-Condition-Name
or NCT03860337 62 64 O
lactating NCT03860337 65 74 B-Condition-Name
. NCT03860337 75 76 O

Inclusion NCT03862508 0 9 O
Criteria NCT03862508 10 18 O
: NCT03862508 19 20 O

- NCT03862508 24 25 O
Height NCT03862508 27 33 B-Observation-Name
jumpers NCT03862508 34 41 I-Observation-Name

- NCT03862508 44 45 O
Age NCT03862508 47 50 O
between NCT03862508 51 58 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03862508 60 62 B-Eq-Value
and NCT03862508 63 66 O
40 NCT03862508 68 70 B-Eq-Value
years NCT03862508 71 76 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862508 79 80 O
Currently NCT03862508 82 91 O
participate NCT03862508 92 103 O
in NCT03862508 104 106 O
the NCT03862508 107 110 O
competitive NCT03862508 111 122 O
field NCT03862508 123 128 O

Exclusion NCT03862508 129 138 O
Criteria NCT03862508 139 147 O
: NCT03862508 148 149 O

- NCT03862508 153 154 O
Present NCT03862508 156 163 O
medical NCT03862508 164 171 O
diagnosis NCT03862508 172 181 O
of NCT03862508 182 184 O
musculoskeletal NCT03862508 185 200 O
pathology NCT03862508 201 210 B-Condition-Name

- NCT03862508 213 214 O
Who NCT03862508 216 219 O
have NCT03862508 220 224 O
not NCT03862508 225 228 O
had NCT03862508 229 232 O
musculoskeletal NCT03862508 233 248 O
injuries NCT03862508 249 257 B-Condition-Name
in NCT03862508 258 260 O
the NCT03862508 261 264 O
last NCT03862508 265 269 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03862508 270 275 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03862508 278 279 O
Not NCT03862508 281 284 O
signed NCT03862508 285 291 O
the NCT03862508 292 295 O
informed NCT03862508 296 304 O
consent NCT03862508 305 312 O
document NCT03862508 313 321 O
. NCT03862508 322 323 O

Inclusion NCT03860493 0 9 O
Criteria NCT03860493 10 18 O
: NCT03860493 19 20 O

1 NCT03860493 25 26 O
. NCT03860493 26 27 O
Patients NCT03860493 29 37 O
of NCT03860493 38 40 O
both NCT03860493 41 45 O
genders NCT03860493 46 53 O

2 NCT03860493 57 58 O
. NCT03860493 58 59 O
Minimum NCT03860493 61 68 B-Eq-Operator___Eq-Operator-Value:GTEQ
age NCT03860493 69 72 O
: NCT03860493 73 74 O
18 NCT03860493 76 78 B-Eq-Value
years NCT03860493 79 84 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03860493 85 88 O

3 NCT03860493 92 93 O
. NCT03860493 93 94 O
Spoken NCT03860493 96 102 O
and NCT03860493 103 106 O
written NCT03860493 107 114 O
command NCT03860493 115 122 O
of NCT03860493 123 125 O
the NCT03860493 126 129 O
language NCT03860493 130 138 O
spoken NCT03860493 139 145 O
in NCT03860493 146 148 O
the NCT03860493 149 152 O
country NCT03860493 153 160 O
's NCT03860493 160 162 O
center NCT03860493 163 169 O

4 NCT03860493 173 174 O
. NCT03860493 174 175 O
Ability NCT03860493 177 184 O
to NCT03860493 185 187 O
understand NCT03860493 188 198 O
and NCT03860493 199 202 O
follow NCT03860493 203 209 O
the NCT03860493 210 213 O
study NCT03860493 214 219 O
procedures NCT03860493 220 230 O
and NCT03860493 231 234 O
sign NCT03860493 235 239 O
the NCT03860493 240 243 O
informed NCT03860493 244 252 O
consent NCT03860493 253 260 O

5 NCT03860493 264 265 O
. NCT03860493 265 266 O
open NCT03860493 268 272 O
surgical NCT03860493 273 281 B-Procedure-Name
porcedures NCT03860493 282 292 I-Procedure-Name

Exclusion NCT03860493 293 302 O
Criteria NCT03860493 303 311 O
: NCT03860493 312 313 O

1 NCT03860493 318 319 O
. NCT03860493 319 320 O
Known NCT03860493 322 327 O
allergies NCT03860493 328 337 O
to NCT03860493 338 340 O
iodides NCT03860493 341 348 B-Drug-Name

2 NCT03860493 352 353 O
. NCT03860493 353 354 O
Known NCT03860493 356 361 O
history NCT03860493 362 369 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860493 370 372 O
coagulopathy NCT03860493 373 385 B-Condition-Name

3 NCT03860493 389 390 O
. NCT03860493 390 391 O
Women NCT03860493 393 398 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03860493 399 402 O
are NCT03860493 403 406 O
pregnant NCT03860493 407 415 B-Condition-Name
or NCT03860493 416 418 O
breastfeeding NCT03860493 419 432 B-Condition-Name
, NCT03860493 433 434 O
or NCT03860493 435 437 O
for NCT03860493 438 441 O
whom NCT03860493 442 446 O
possibility NCT03860493 447 458 O
of NCT03860493 459 461 O
pregnancy NCT03860493 462 471 B-Condition-Name
was NCT03860493 472 475 O
not NCT03860493 476 479 O
ruled NCT03860493 480 485 O
out NCT03860493 486 489 O

Inclusion NCT03863171 0 9 O
Criteria NCT03863171 10 18 O
: NCT03863171 19 20 O

- NCT03863171 24 25 O
Ocular NCT03863171 27 33 B-Condition-Name
ischemia NCT03863171 34 42 I-Condition-Name
syndrome NCT03863171 43 51 I-Condition-Name
group NCT03863171 52 57 O
: NCT03863171 58 59 O
Patients NCT03863171 60 68 O
diagnosed NCT03863171 69 78 O
with NCT03863171 79 83 O
ocular NCT03863171 84 90 B-Condition-Name
ischemia NCT03863171 91 99 I-Condition-Name
syndrome NCT03863171 100 108 I-Condition-Name
; NCT03863171 108 109 O

- NCT03863171 112 113 O
Age NCT03863171 115 118 O
- NCT03863171 119 120 O
related NCT03863171 121 128 O
macular NCT03863171 129 136 B-Condition-Name
degeneration NCT03863171 137 149 I-Condition-Name
group NCT03863171 150 155 O
( NCT03863171 156 157 O
Control NCT03863171 158 165 O
group NCT03863171 166 171 O
) NCT03863171 172 173 O
: NCT03863171 175 176 O
Patients NCT03863171 177 185 O
diagnosed NCT03863171 186 195 O
with NCT03863171 196 200 O
age NCT03863171 201 204 O
- NCT03863171 205 206 O
related NCT03863171 207 214 O
macular NCT03863171 215 222 B-Condition-Name
degeneration NCT03863171 223 235 I-Condition-Name
; NCT03863171 235 236 O

- NCT03863171 239 240 O
Age NCT03863171 242 245 O
: NCT03863171 246 247 O
50 NCT03863171 249 251 B-Eq-Value
- NCT03863171 252 253 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03863171 255 257 B-Eq-Value
years NCT03863171 258 263 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03863171 263 264 O

- NCT03863171 267 268 O
Sex NCT03863171 270 273 O
: NCT03863171 274 275 O
all NCT03863171 276 279 O
; NCT03863171 279 280 O

- NCT03863171 283 284 O
Patients NCT03863171 286 294 O
signed NCT03863171 295 301 O
written NCT03863171 302 309 O
informed NCT03863171 310 318 O
consent NCT03863171 319 326 O
. NCT03863171 327 328 O

Exclusion NCT03863171 330 339 O
Criteria NCT03863171 340 348 O
: NCT03863171 349 350 O

- NCT03863171 354 355 O
Fundus NCT03863171 357 363 B-Procedure-Name
fluorescein NCT03863171 364 375 I-Procedure-Name
angiography NCT03863171 376 387 I-Procedure-Name
( NCT03863171 388 389 O
FFA NCT03863171 390 393 B-Procedure-Name
) NCT03863171 394 395 O
clear NCT03863171 396 401 O
images NCT03863171 402 408 O
can NCT03863171 409 412 O
not NCT03863171 412 415 O
be NCT03863171 416 418 O
obtained NCT03863171 419 427 O
due NCT03863171 428 431 O
to NCT03863171 432 434 O
refractive NCT03863171 435 445 B-Condition-Name
media NCT03863171 446 451 I-Condition-Name
problems NCT03863171 452 460 I-Condition-Name
( NCT03863171 461 462 O
such NCT03863171 463 467 O
as NCT03863171 468 470 O
corneal NCT03863171 471 478 B-Condition-Name
leukoplakia NCT03863171 479 490 I-Condition-Name
, NCT03863171 491 492 O
severe NCT03863171 493 499 B-Severity___Severity-Value:severe
cataract NCT03863171 500 508 B-Condition-Name
, NCT03863171 509 510 O
vitreous NCT03863171 511 519 B-Condition-Name
hemorrhage NCT03863171 520 530 I-Condition-Name
, NCT03863171 531 532 O
etc NCT03863171 533 536 O
. NCT03863171 537 538 O
) NCT03863171 539 540 O
; NCT03863171 541 542 O

- NCT03863171 545 546 O
Patients NCT03863171 548 556 O
with NCT03863171 557 561 O
contraindications NCT03863171 562 579 O
for NCT03863171 580 583 O
FFA NCT03863171 584 587 B-Procedure-Name
; NCT03863171 587 588 O

- NCT03863171 591 592 O
Patients NCT03863171 594 602 O
was NCT03863171 603 606 O
unable NCT03863171 607 613 O
to NCT03863171 614 616 O
perform NCT03863171 617 624 O
magnetic NCT03863171 625 633 B-Procedure-Name
resonance NCT03863171 634 643 I-Procedure-Name
rmaging NCT03863171 644 651 I-Procedure-Name
( NCT03863171 652 653 O
MRI NCT03863171 654 657 B-Procedure-Name
) NCT03863171 658 659 O
test NCT03863171 660 664 O
; NCT03863171 664 665 O

- NCT03863171 668 669 O
Patients NCT03863171 671 679 O
with NCT03863171 680 684 O
history NCT03863171 685 692 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863171 693 695 O
bleeding NCT03863171 696 704 B-Condition-Name
and NCT03863171 705 708 O
cerebral NCT03863171 709 717 B-Condition-Name
infarction NCT03863171 718 728 I-Condition-Name
; NCT03863171 728 729 O

- NCT03863171 732 733 O
Patients NCT03863171 735 743 O
with NCT03863171 744 748 O
a NCT03863171 749 750 O
history NCT03863171 751 758 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863171 759 761 O
surgery NCT03863171 762 769 B-Procedure-Name
within NCT03863171 770 776 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03863171 778 779 B-Eq-Value
months NCT03863171 780 786 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03863171 786 787 O

- NCT03863171 790 791 O
Patients NCT03863171 793 801 O
who NCT03863171 802 805 O
had NCT03863171 806 809 O
participated NCT03863171 810 822 O
in NCT03863171 823 825 O
other NCT03863171 826 831 O
clinical NCT03863171 832 840 O
trials NCT03863171 841 847 O
within NCT03863171 848 854 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03863171 856 857 B-Eq-Value
months NCT03863171 858 864 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03863171 864 865 O

- NCT03863171 868 869 O
Patients NCT03863171 871 879 O
who NCT03863171 880 883 O
disagree NCT03863171 884 892 O
and NCT03863171 893 896 O
refuse NCT03863171 897 903 O
to NCT03863171 904 906 O
participate NCT03863171 907 918 O
in NCT03863171 919 921 O
the NCT03863171 922 925 O
trial NCT03863171 926 931 O
. NCT03863171 932 933 O

Inclusion NCT03862521 0 9 O
criteria NCT03862521 10 18 O

- NCT03862521 21 22 O
Prepubertal NCT03862521 24 35 B-Condition-Name
children NCT03862521 36 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
2 NCT03862521 46 47 B-Eq-Value
to NCT03862521 48 50 B-Eq-Operator___Eq-Operator-Value:BETWEEN
< NCT03862521 51 52 B-Eq-Operator___Eq-Operator-Value:LT
12 NCT03862521 54 56 B-Eq-Value
years NCT03862521 57 62 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862521 63 66 O
( NCT03862521 67 68 O
i NCT03862521 69 70 O
. NCT03862521 71 72 O
e NCT03862521 73 74 O
. NCT03862521 75 76 O
, NCT03862521 77 78 O
before NCT03862521 79 85 O
12 NCT03862521 87 89 O
th NCT03862521 90 92 O
birthday NCT03862521 93 101 O
) NCT03862521 102 103 O

- NCT03862521 107 108 O
Type NCT03862521 110 114 O
1 NCT03862521 116 117 O
diabetes NCT03862521 118 126 B-Condition-Name
for NCT03862521 127 130 O
at NCT03862521 131 133 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862521 134 139 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03862521 141 142 B-Eq-Value
months NCT03862521 143 149 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03862521 152 153 O
Patients NCT03862521 155 163 O
must NCT03862521 164 168 O
be NCT03862521 169 171 O
using NCT03862521 172 177 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
insulin NCT03862521 178 185 B-Procedure-Name
pump NCT03862521 186 190 I-Procedure-Name
therapy NCT03862521 191 198 I-Procedure-Name

- NCT03862521 201 202 O
Not NCT03862521 204 207 O
presently NCT03862521 208 217 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
on NCT03862521 218 220 O
low NCT03862521 221 224 B-Polarity___Polarity-Value:low
carbohydrate NCT03862521 225 237 O
diet NCT03862521 238 242 B-Observation-Name___Observation-Type-Value:social-habit

Exclusion NCT03862521 243 252 O
criteria NCT03862521 253 261 O

- NCT03862521 264 265 O
On NCT03862521 267 269 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
low NCT03862521 270 273 B-Polarity___Polarity-Value:low
or NCT03862521 274 276 O
very NCT03862521 277 281 B-Polarity___Polarity-Value:low
low NCT03862521 282 285 I-Polarity___Polarity-Value:low
carbohydrate NCT03862521 286 298 O
diet NCT03862521 299 303 B-Observation-Name___Observation-Type-Value:social-habit

- NCT03862521 306 307 O
History NCT03862521 309 316 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862521 317 319 O
endocrine NCT03862521 320 329 O
or NCT03862521 330 332 O
metabolic NCT03862521 333 342 O
disorder NCT03862521 343 351 B-Condition-Name
that NCT03862521 352 356 O
could NCT03862521 357 362 O
affect NCT03862521 363 369 B-Stability___Stability-Value:change
counter NCT03862521 370 377 B-Condition-Name
- NCT03862521 378 379 I-Condition-Name
regulation NCT03862521 380 390 I-Condition-Name
( NCT03862521 391 392 O
well NCT03862521 393 397 B-Stability___Stability-Value:stable
- NCT03862521 398 399 I-Stability___Stability-Value:stable
controlled NCT03862521 400 410 I-Stability___Stability-Value:stable
hypothyroidism NCT03862521 411 425 B-Condition-Name
is NCT03862521 426 428 O
acceptable NCT03862521 429 439 O
if NCT03862521 440 442 O
on NCT03862521 443 445 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
stable NCT03862521 446 452 B-Stability___Stability-Value:stable
dose NCT03862521 453 457 O
of NCT03862521 458 460 O
l NCT03862521 461 462 B-Drug-Name
- NCT03862521 463 464 I-Drug-Name
thyroxine NCT03862521 465 474 I-Drug-Name
for NCT03862521 475 478 O
≥ NCT03862521 479 480 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03862521 482 483 B-Eq-Value
months NCT03862521 484 490 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03862521 491 492 O

- NCT03862521 496 497 O
History NCT03862521 499 506 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862521 507 509 O
metabolic NCT03862521 510 519 B-Condition-Name
disorder NCT03862521 520 528 I-Condition-Name
affection NCT03862521 529 538 B-Stability___Stability-Value:change
lipid NCT03862521 539 544 B-Condition-Name
metabolism NCT03862521 545 555 I-Condition-Name

- NCT03862521 558 559 O
Severe NCT03862521 561 567 B-Severity___Severity-Value:severe
hypoglycemic NCT03862521 568 580 B-Condition-Name
event NCT03862521 581 586 I-Condition-Name
in NCT03862521 587 589 O
past NCT03862521 590 594 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03862521 596 597 B-Eq-Value
months NCT03862521 598 604 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03862092 0 9 O
Criteria NCT03862092 10 18 O
: NCT03862092 19 20 O

- NCT03862092 24 25 O
Patients NCT03862092 27 35 O
aged NCT03862092 36 40 O
≥ NCT03862092 41 42 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03862092 44 46 B-Eq-Value
, NCT03862092 47 48 O
and NCT03862092 49 52 O
< NCT03862092 53 54 B-Eq-Operator___Eq-Operator-Value:LT
80 NCT03862092 56 58 B-Eq-Value
years NCT03862092 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862092 67 68 O
ER NCT03862092 70 72 B-Encounter-Type___Encounter-Type-Value:emergency
- NCT03862092 73 74 I-Encounter-Type___Encounter-Type-Value:emergency
visit NCT03862092 75 80 I-Encounter-Type___Encounter-Type-Value:emergency
patients NCT03862092 81 89 O
with NCT03862092 90 94 O
acute NCT03862092 95 100 B-Severity___Severity-Value:severe
abdominal NCT03862092 101 110 O
pain NCT03862092 111 115 B-Condition-Name

- NCT03862092 123 124 O
NRS NCT03862092 126 129 B-Observation-Name
≥ NCT03862092 130 131 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03862092 133 134 B-Eq-Value

- NCT03862092 143 144 O
Unresponsive NCT03862092 146 158 B-Condition-Name
to NCT03862092 159 161 O
gastrointestinal NCT03862092 162 178 B-Drug-Name
motility NCT03862092 179 187 I-Drug-Name
drug NCT03862092 188 192 I-Drug-Name
, NCT03862092 193 194 O
antacid NCT03862092 195 202 B-Drug-Name

Exclusion NCT03862092 203 212 O
Criteria NCT03862092 213 221 O
: NCT03862092 222 223 O

- NCT03862092 227 228 O
Unwilling NCT03862092 230 239 O
or NCT03862092 240 242 O
unable NCT03862092 243 249 O
to NCT03862092 250 252 O
give NCT03862092 253 257 O
informed NCT03862092 258 266 O
consent NCT03862092 267 274 O

- NCT03862092 277 278 O
Patients NCT03862092 280 288 O
who NCT03862092 289 292 O
take NCT03862092 293 297 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antiviral NCT03862092 298 307 B-Drug-Name
agents NCT03862092 308 314 I-Drug-Name
( NCT03862092 315 316 O
acyclovir NCT03862092 317 326 B-Drug-Name
, NCT03862092 327 328 O
valacyclovir NCT03862092 329 341 B-Drug-Name
, NCT03862092 342 343 O
famciclovir NCT03862092 344 355 B-Drug-Name
, NCT03862092 356 357 O
ganciclovir NCT03862092 358 369 B-Drug-Name
, NCT03862092 370 371 O
valganciclovir NCT03862092 372 386 B-Drug-Name
, NCT03862092 387 388 O
foscarnet NCT03862092 389 398 B-Drug-Name
. NCT03862092 399 400 O
. NCT03862092 401 402 O
. NCT03862092 403 404 O
) NCT03862092 405 406 O

- NCT03862092 410 411 O
Patients NCT03862092 413 421 O
complaining NCT03862092 422 433 O
abdominal NCT03862092 434 443 O
pain NCT03862092 444 448 B-Condition-Name
with NCT03862092 449 453 O
NRS NCT03862092 454 457 B-Observation-Name
≤ NCT03862092 458 459 B-Eq-Operator___Eq-Operator-Value:LTEQ
5 NCT03862092 461 462 B-Eq-Value
or NCT03862092 463 465 O
improved NCT03862092 466 474 O
symptom NCT03862092 475 482 B-Condition-Name
by NCT03862092 483 485 O
gastrointestinal NCT03862092 486 502 B-Drug-Name
motility NCT03862092 503 511 I-Drug-Name
drug NCT03862092 512 516 I-Drug-Name
, NCT03862092 517 518 O
antacid NCT03862092 519 526 B-Drug-Name

Inclusion NCT03869879 0 9 O
Criteria NCT03869879 10 18 O
: NCT03869879 19 20 O

- NCT03869879 24 25 O
60 NCT03869879 28 30 B-Eq-Value
- NCT03869879 31 32 B-Eq-Operator___Eq-Operator-Value:BETWEEN
89 NCT03869879 34 36 B-Eq-Value
years NCT03869879 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869879 43 46 O

- NCT03869879 49 50 O
gait NCT03869879 52 56 B-Condition-Name
disturbances NCT03869879 57 69 I-Condition-Name
requiring NCT03869879 70 79 O
physical NCT03869879 80 88 B-Procedure-Name
therapy NCT03869879 89 96 I-Procedure-Name

Exclusion NCT03869879 97 106 O
Criteria NCT03869879 107 115 O
: NCT03869879 116 117 O

- NCT03869879 121 122 O
unable NCT03869879 124 130 O
to NCT03869879 131 133 O
follow NCT03869879 134 140 O
instructions NCT03869879 141 153 O
( NCT03869879 154 155 O
up NCT03869879 156 158 O
to NCT03869879 159 161 O
the NCT03869879 162 165 O
practitioner NCT03869879 166 178 O
's NCT03869879 178 180 O
judgement NCT03869879 181 190 O
) NCT03869879 191 192 O

Inclusion NCT03862079 0 9 O
Criteria NCT03862079 10 18 O
: NCT03862079 19 20 O

- NCT03862079 24 25 O
Patients NCT03862079 27 35 O
who NCT03862079 36 39 O
are NCT03862079 40 43 O
day NCT03862079 44 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
- NCT03862079 48 49 B-Eq-Value
10 NCT03862079 51 53 I-Eq-Value
pre NCT03862079 54 57 O
- NCT03862079 58 59 O
to NCT03862079 60 62 B-Eq-Operator___Eq-Operator-Value:BETWEEN
day NCT03862079 63 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
+ NCT03862079 67 68 O
30 NCT03862079 70 72 B-Eq-Value
post NCT03862079 73 77 O
- NCT03862079 78 79 O
allogeneic NCT03862079 80 90 B-Procedure-Name
hematopoietic NCT03862079 91 104 I-Procedure-Name
cell NCT03862079 105 109 I-Procedure-Name
transplant NCT03862079 110 120 I-Procedure-Name
( NCT03862079 121 122 O
AHCT NCT03862079 123 127 B-Procedure-Name
) NCT03862079 128 129 O
from NCT03862079 130 134 O
any NCT03862079 135 138 O
donor NCT03862079 139 144 O
or NCT03862079 145 147 O
graft NCT03862079 148 153 O
source NCT03862079 154 160 O
and NCT03862079 161 164 O
for NCT03862079 165 168 O
any NCT03862079 169 172 O
conditioning NCT03862079 173 185 B-Procedure-Name
regimen NCT03862079 186 193 I-Procedure-Name

- NCT03862079 196 197 O
Patients NCT03862079 199 207 O
who NCT03862079 208 211 O
have NCT03862079 212 216 O
received NCT03862079 217 225 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03862079 226 235 O
with NCT03862079 236 240 O
meropenem NCT03862079 241 250 B-Drug-Name
or NCT03862079 251 253 O
piperacillin NCT03862079 254 266 B-Drug-Name
- NCT03862079 267 268 I-Drug-Name
tazobactam NCT03862079 269 279 I-Drug-Name
( NCT03862079 280 281 O
pip NCT03862079 282 285 B-Drug-Name
- NCT03862079 286 287 I-Drug-Name
tazo NCT03862079 288 292 I-Drug-Name
) NCT03862079 293 294 O
intravenously NCT03862079 295 308 O
( NCT03862079 309 310 O
IV NCT03862079 311 313 O
) NCT03862079 314 315 O
( NCT03862079 316 317 O
of NCT03862079 318 320 O
at NCT03862079 321 323 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862079 324 329 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03862079 331 333 B-Eq-Value
hours NCT03862079 334 339 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
duration NCT03862079 340 348 O
) NCT03862079 349 350 O
in NCT03862079 351 353 O
past NCT03862079 354 358 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
7 NCT03862079 360 361 B-Eq-Value
days NCT03862079 362 366 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03862079 369 370 O
Controlled NCT03862079 372 382 O
infection NCT03862079 383 392 B-Condition-Name
defined NCT03862079 393 400 O
as NCT03862079 401 403 O
hemodynamically NCT03862079 404 419 B-Condition-Name
stable NCT03862079 420 426 B-Stability___Stability-Value:stable
and NCT03862079 427 430 O
not NCT03862079 431 434 O
requiring NCT03862079 435 444 O
supplemental NCT03862079 445 457 B-Procedure-Name
oxygen NCT03862079 458 464 I-Procedure-Name
of NCT03862079 465 467 O
more NCT03862079 468 472 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862079 473 477 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03862079 479 480 B-Eq-Value
liters NCT03862079 481 487 B-Eq-Unit
via NCT03862079 488 491 O
nasal NCT03862079 492 497 O
cannula NCT03862079 498 505 O

- NCT03862079 508 509 O
Patients NCT03862079 511 519 O
who NCT03862079 520 523 O
are NCT03862079 524 527 O
able NCT03862079 528 532 O
to NCT03862079 533 535 O
take NCT03862079 536 540 O
oral NCT03862079 541 545 B-Drug-Name
medications NCT03862079 546 557 I-Drug-Name
in NCT03862079 558 560 O
suspension NCT03862079 561 571 O
form NCT03862079 572 576 O

- NCT03862079 579 580 O
Patients NCT03862079 582 590 O
who NCT03862079 591 594 O
are NCT03862079 595 598 O
able NCT03862079 599 603 O
to NCT03862079 604 606 O
provide NCT03862079 607 614 O
informed NCT03862079 615 623 O
consent NCT03862079 624 631 O
( NCT03862079 632 633 O
IC NCT03862079 634 636 O
) NCT03862079 637 638 O
and NCT03862079 639 642 O
comply NCT03862079 643 649 O
with NCT03862079 650 654 O
all NCT03862079 655 658 O
study NCT03862079 659 664 O
visits NCT03862079 665 671 O
and NCT03862079 672 675 O
procedures NCT03862079 676 686 O

Exclusion NCT03862079 687 696 O
Criteria NCT03862079 697 705 O
: NCT03862079 706 707 O

- NCT03862079 711 712 O
Patients NCT03862079 714 722 O
who NCT03862079 723 726 O
are NCT03862079 727 730 O
anticipated NCT03862079 731 742 O
to NCT03862079 743 745 O
require NCT03862079 746 753 O
continued NCT03862079 754 763 O
broad NCT03862079 764 769 O
spectrum NCT03862079 770 778 O
antibiotics NCT03862079 779 790 B-Drug-Name
with NCT03862079 791 795 O
meropenem NCT03862079 796 805 B-Drug-Name
or NCT03862079 806 808 O
pip NCT03862079 809 812 B-Drug-Name
- NCT03862079 813 814 I-Drug-Name
tazo NCT03862079 815 819 I-Drug-Name
IV NCT03862079 820 822 O
for NCT03862079 823 826 O
> NCT03862079 827 828 B-Eq-Operator___Eq-Operator-Value:GT
96 NCT03862079 830 832 B-Eq-Value
hours NCT03862079 833 838 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
post NCT03862079 839 843 O
- NCT03862079 844 845 O
engraftment NCT03862079 846 857 B-Procedure-Name
such NCT03862079 858 862 O
as NCT03862079 863 865 O
for NCT03862079 866 869 O
known NCT03862079 870 875 O
, NCT03862079 876 877 O
documented NCT03862079 878 888 O
infections NCT03862079 889 899 B-Condition-Name
necessitating NCT03862079 900 913 O
prolonged NCT03862079 914 923 O
treatment NCT03862079 924 933 O

- NCT03862079 936 937 O
Patients NCT03862079 939 947 O
with NCT03862079 948 952 O
a NCT03862079 953 954 O
prior NCT03862079 955 960 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
documented NCT03862079 961 971 O
infection NCT03862079 972 981 B-Condition-Name
with NCT03862079 982 986 O
mycormycetes NCT03862079 987 999 B-Organism-Name

- NCT03862079 1002 1003 O
Patients NCT03862079 1005 1013 O
who NCT03862079 1014 1017 O
are NCT03862079 1018 1021 O
greater NCT03862079 1022 1029 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862079 1030 1034 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03862079 1036 1037 B-Eq-Value
days NCT03862079 1038 1042 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
from NCT03862079 1043 1047 O
time NCT03862079 1048 1052 O
of NCT03862079 1053 1055 O
neutrophil NCT03862079 1056 1066 B-Procedure-Name
engraftment NCT03862079 1067 1078 I-Procedure-Name
post NCT03862079 1079 1083 O
AHCT NCT03862079 1084 1088 B-Procedure-Name

- NCT03862079 1091 1092 O
Patients NCT03862079 1094 1102 O
with NCT03862079 1103 1107 O
active NCT03862079 1108 1114 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
enteric NCT03862079 1115 1122 O
infections NCT03862079 1123 1133 B-Condition-Name

- NCT03862079 1136 1137 O
Patients NCT03862079 1139 1147 O
with NCT03862079 1148 1152 O
acute NCT03862079 1153 1158 B-Severity___Severity-Value:severe
GVHD NCT03862079 1159 1163 B-Condition-Name
> NCT03862079 1164 1165 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03862079 1167 1168 I-Eq-Operator___Eq-Operator-Value:GTEQ
grade NCT03862079 1169 1174 B-Eq-Unit
II NCT03862079 1175 1177 B-Eq-Value

- NCT03862079 1180 1181 O
Patients NCT03862079 1183 1191 O
unwilling NCT03862079 1192 1201 O
or NCT03862079 1202 1204 O
unable NCT03862079 1205 1211 O
to NCT03862079 1212 1214 O
undergo NCT03862079 1215 1222 O
the NCT03862079 1223 1226 O
FMT NCT03862079 1227 1230 B-Procedure-Name
via NCT03862079 1231 1234 O
retention NCT03862079 1235 1244 B-Procedure-Name
enema NCT03862079 1245 1250 I-Procedure-Name
procedure NCT03862079 1251 1260 I-Procedure-Name

- NCT03862079 1263 1264 O
Patients NCT03862079 1266 1274 O
who NCT03862079 1275 1278 O
have NCT03862079 1279 1283 O
received NCT03862079 1284 1292 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03862079 1293 1302 O
with NCT03862079 1303 1307 O
an NCT03862079 1308 1310 O
investigational NCT03862079 1311 1326 O
agent NCT03862079 1327 1332 O
within NCT03862079 1333 1339 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03862079 1341 1342 B-Eq-Value
weeks NCT03862079 1343 1348 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03862079 1349 1351 O
enrollment NCT03862079 1352 1362 O

- NCT03862079 1365 1366 O
Patients NCT03862079 1368 1376 O
unable NCT03862079 1377 1383 O
to NCT03862079 1384 1386 O
tolerate NCT03862079 1387 1395 O
oral NCT03862079 1396 1400 B-Procedure-Name
decontamination NCT03862079 1401 1416 I-Procedure-Name
regimen NCT03862079 1417 1424 O
of NCT03862079 1425 1427 O
pip NCT03862079 1428 1431 B-Drug-Name
- NCT03862079 1432 1433 I-Drug-Name
tazo NCT03862079 1434 1438 I-Drug-Name
and NCT03862079 1439 1442 O
nystatin NCT03862079 1443 1451 B-Drug-Name
due NCT03862079 1452 1455 O
to NCT03862079 1456 1458 O
prior NCT03862079 1459 1464 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
allergy NCT03862079 1465 1472 O
or NCT03862079 1473 1475 O
intolerance NCT03862079 1476 1487 B-Condition-Name
of NCT03862079 1488 1490 O
these NCT03862079 1491 1496 O
medications NCT03862079 1497 1508 O

- NCT03862079 1511 1512 O
Patients NCT03862079 1514 1522 O
with NCT03862079 1523 1527 O
any NCT03862079 1528 1531 O
medical NCT03862079 1532 1539 O
or NCT03862079 1540 1542 O
psychological NCT03862079 1543 1556 O
condition NCT03862079 1557 1566 O
that NCT03862079 1567 1571 O
, NCT03862079 1572 1573 O
in NCT03862079 1574 1576 O
the NCT03862079 1577 1580 O
opinion NCT03862079 1581 1588 O
of NCT03862079 1589 1591 O
the NCT03862079 1592 1595 O
investigator NCT03862079 1596 1608 O
, NCT03862079 1609 1610 O
might NCT03862079 1611 1616 O
interfere NCT03862079 1617 1626 B-Stability___Stability-Value:change
with NCT03862079 1627 1631 O
the NCT03862079 1632 1635 O
subject NCT03862079 1636 1643 O
's NCT03862079 1643 1645 O
participation NCT03862079 1646 1659 O
in NCT03862079 1660 1662 O
the NCT03862079 1663 1666 O
trial NCT03862079 1667 1672 O
, NCT03862079 1673 1674 O
pose NCT03862079 1675 1679 O
any NCT03862079 1680 1683 O
additional NCT03862079 1684 1694 O
risk NCT03862079 1695 1699 O
for NCT03862079 1700 1703 O
the NCT03862079 1704 1707 O
subject NCT03862079 1708 1715 O
, NCT03862079 1716 1717 O
or NCT03862079 1718 1720 O
confound NCT03862079 1721 1729 B-Stability___Stability-Value:change
the NCT03862079 1730 1733 O
assessments NCT03862079 1734 1745 O
of NCT03862079 1746 1748 O
the NCT03862079 1749 1752 O
subject NCT03862079 1753 1760 O

Inclusion NCT03863561 0 9 O
Criteria NCT03863561 10 18 O
: NCT03863561 19 20 O

- NCT03863561 24 25 O
Diagnosis NCT03863561 27 36 O
of NCT03863561 37 39 O
type NCT03863561 40 44 O
1 NCT03863561 46 47 O
or NCT03863561 48 50 O
type NCT03863561 51 55 O
2 NCT03863561 57 58 O
diabetes NCT03863561 59 67 B-Condition-Name

- NCT03863561 70 71 O
Age NCT03863561 73 76 O
≥ NCT03863561 77 78 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863561 80 82 B-Eq-Value
years NCT03863561 83 88 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863561 91 92 O
Ability NCT03863561 94 101 O
to NCT03863561 102 104 O
read NCT03863561 105 109 O
English NCT03863561 110 117 B-Language

- NCT03863561 120 121 O
Duration NCT03863561 123 131 O
of NCT03863561 132 134 O
diabetes NCT03863561 135 143 B-Condition-Name
≥ NCT03863561 144 145 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03863561 147 148 B-Eq-Value
months NCT03863561 149 155 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
( NCT03863561 156 157 O
DSME NCT03863561 158 162 O
cohort NCT03863561 163 169 O
only NCT03863561 170 174 O
) NCT03863561 175 176 O

- NCT03863561 180 181 O
A NCT03863561 183 184 B-Observation-Name___Observation-Type-Value:lab
1C NCT03863561 185 187 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03863561 188 189 B-Eq-Operator___Eq-Operator-Value:GTEQ
8.0 NCT03863561 191 194 B-Eq-Value
% NCT03863561 195 196 B-Eq-Unit
( NCT03863561 197 198 O
DSME NCT03863561 199 203 O
cohort NCT03863561 204 210 O
only NCT03863561 211 215 O
) NCT03863561 216 217 O

Exclusion NCT03863561 219 228 O
Criteria NCT03863561 229 237 O
: NCT03863561 238 239 O

- NCT03863561 242 243 O

Inclusion NCT03862131 0 9 O
Criteria NCT03862131 10 18 O
: NCT03862131 19 20 O

- NCT03862131 24 25 O
Participant NCT03862131 27 38 O
in NCT03862131 39 41 O
the NCT03862131 42 45 O
SURVIVE NCT03862131 46 53 O
registry NCT03862131 54 62 O

- NCT03862131 65 66 O
Signed NCT03862131 68 74 O
informed NCT03862131 75 83 O
consent NCT03862131 84 91 O
form NCT03862131 92 96 O
for NCT03862131 97 100 O
PROACT NCT03862131 101 107 O

- NCT03862131 110 111 O
Histological NCT03862131 113 125 O
diagnosis NCT03862131 126 135 O
of NCT03862131 136 138 O
early NCT03862131 139 144 O
or NCT03862131 145 147 O
metastatic NCT03862131 148 158 O
breast NCT03862131 159 165 O
cancer NCT03862131 166 172 B-Condition-Name
, NCT03862131 173 174 O
lymphoma NCT03862131 175 183 B-Condition-Name
, NCT03862131 184 185 O
sarcoma NCT03862131 186 193 B-Condition-Name
, NCT03862131 194 195 O
leukemia NCT03862131 196 204 B-Condition-Name
, NCT03862131 205 206 O
myeloma NCT03862131 207 214 B-Condition-Name
, NCT03862131 215 216 O
or NCT03862131 217 219 O
lung NCT03862131 220 224 O
cancer NCT03862131 225 231 B-Condition-Name
( NCT03862131 232 233 O
patients NCT03862131 234 242 O
with NCT03862131 243 247 O
treated NCT03862131 248 255 O
and NCT03862131 256 259 O
clinically NCT03862131 260 270 O
stable NCT03862131 271 277 B-Stability___Stability-Value:stable
brain NCT03862131 278 283 O
metastasis NCT03862131 284 294 B-Condition-Name
are NCT03862131 295 298 O
acceptable NCT03862131 299 309 O
) NCT03862131 310 311 O

- NCT03862131 315 316 O
Scheduled NCT03862131 318 327 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03862131 328 330 O
receive NCT03862131 331 338 O
anti NCT03862131 339 343 O
- NCT03862131 344 345 O
cancer NCT03862131 346 352 B-Condition-Name
therapy NCT03862131 353 360 B-Procedure-Name
( NCT03862131 361 362 O
radiation NCT03862131 363 372 B-Procedure-Name
therapy NCT03862131 373 380 I-Procedure-Name
is NCT03862131 381 383 O
permitted NCT03862131 384 393 O
) NCT03862131 394 395 O

Exclusion NCT03862131 397 406 O
Criteria NCT03862131 407 415 O
: NCT03862131 416 417 O

- NCT03862131 421 422 O
Contraindication NCT03862131 424 440 O
to NCT03862131 441 443 O
magnetic NCT03862131 444 452 B-Procedure-Name
resonance NCT03862131 453 462 I-Procedure-Name
imaging NCT03862131 463 470 I-Procedure-Name
( NCT03862131 471 472 O
MRI NCT03862131 473 476 B-Procedure-Name
) NCT03862131 477 478 O

- NCT03862131 482 483 O
Unable NCT03862131 485 491 O
to NCT03862131 492 494 O
comply NCT03862131 495 501 O
with NCT03862131 502 506 O
study NCT03862131 507 512 O
investigations NCT03862131 513 527 O
( NCT03862131 528 529 O
in NCT03862131 530 532 O
the NCT03862131 533 536 O
judgment NCT03862131 537 545 O
of NCT03862131 546 548 O
the NCT03862131 549 552 O
investigator NCT03862131 553 565 O
) NCT03862131 566 567 O

- NCT03862131 571 572 O
Life NCT03862131 574 578 B-Observation-Name
expectancy NCT03862131 579 589 I-Observation-Name
less NCT03862131 590 594 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03862131 595 599 I-Eq-Operator___Eq-Operator-Value:LT
1 NCT03862131 601 602 B-Eq-Value
year NCT03862131 603 607 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Inclusion NCT03864965 0 9 O
Criteria NCT03864965 10 18 O
: NCT03864965 19 20 O

- NCT03864965 24 25 O
Patients NCT03864965 27 35 O
having NCT03864965 36 42 O
mild NCT03864965 43 47 B-Severity___Severity-Value:mild
cognitive NCT03864965 48 57 B-Condition-Name
impairment NCT03864965 58 68 I-Condition-Name
( NCT03864965 69 70 O
MCI NCT03864965 71 74 B-Condition-Name
) NCT03864965 75 76 O
or NCT03864965 77 79 O
very NCT03864965 80 84 O
mild NCT03864965 85 89 B-Severity___Severity-Value:mild
to NCT03864965 90 92 B-Eq-Operator___Eq-Operator-Value:BETWEEN
mild NCT03864965 93 97 B-Severity___Severity-Value:mild
dementia NCT03864965 98 106 B-Condition-Name
( NCT03864965 107 108 O
CDR NCT03864965 109 112 B-Observation-Name
0.5 NCT03864965 114 117 B-Eq-Value
- NCT03864965 118 119 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1 NCT03864965 121 122 B-Eq-Value
) NCT03864965 123 124 O
. NCT03864965 126 127 O

Exclusion NCT03864965 129 138 O
Criteria NCT03864965 139 147 O
: NCT03864965 148 149 O

- NCT03864965 153 154 O
Patients NCT03864965 156 164 O
with NCT03864965 165 169 O
moderate NCT03864965 170 178 B-Severity___Severity-Value:moderate
to NCT03864965 179 181 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03864965 182 188 B-Severity___Severity-Value:severe
dementia NCT03864965 189 197 B-Condition-Name
( NCT03864965 198 199 O
CDR NCT03864965 200 203 B-Observation-Name
2 NCT03864965 205 206 B-Eq-Value
- NCT03864965 207 208 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03864965 210 211 B-Eq-Value
) NCT03864965 212 213 O
. NCT03864965 215 216 O


Inclusion NCT03862482 0 9 O
Criteria NCT03862482 10 18 O
: NCT03862482 19 20 O

- NCT03862482 24 25 O
non NCT03862482 27 30 O
- NCT03862482 31 32 O
smoker NCT03862482 33 39 B-Condition-Name

- NCT03862482 42 43 O
no NCT03862482 45 47 O
temporomandibular NCT03862482 48 65 B-Condition-Name
joint NCT03862482 66 71 I-Condition-Name
( NCT03862482 72 73 O
TMJ NCT03862482 74 77 B-Condition-Name
) NCT03862482 78 79 O
disorder NCT03862482 80 88 O
or NCT03862482 89 91 O
facial NCT03862482 92 98 O
pain NCT03862482 99 103 B-Condition-Name

- NCT03862482 106 107 O
having NCT03862482 109 115 O
partcipated NCT03862482 116 127 O
in NCT03862482 128 130 O
the NCT03862482 131 134 O
original NCT03862482 135 143 O
study NCT03862482 144 149 O
( NCT03862482 150 151 O
1993 NCT03862482 153 157 B-Eq-Value
- NCT03862482 158 159 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1996 NCT03862482 161 165 B-Eq-Value
) NCT03862482 166 167 O
at NCT03862482 168 170 O
which NCT03862482 171 176 O
time NCT03862482 177 181 O
the NCT03862482 182 185 O
mnimum NCT03862482 186 192 B-Eq-Operator___Eq-Operator-Value:GTEQ
participate NCT03862482 193 204 O
age NCT03862482 205 208 O
was NCT03862482 209 212 O
25 NCT03862482 214 216 B-Eq-Value
years NCT03862482 217 222 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03862482 223 226 O
the NCT03862482 227 230 O
maximum NCT03862482 231 238 B-Eq-Operator___Eq-Operator-Value:LTEQ
56 NCT03862482 240 242 B-Eq-Value
years NCT03862482 243 248 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03862482 249 250 O

Exclusion NCT03862482 252 261 O
Criteria NCT03862482 262 270 O
: NCT03862482 271 272 O

- NCT03862482 276 277 O
refusal NCT03862482 279 286 O
to NCT03862482 287 289 O
sign NCT03862482 290 294 O
informed NCT03862482 295 303 O
consent NCT03862482 304 311 O
documents NCT03862482 312 321 O
. NCT03862482 322 323 O

Inclusion NCT03862469 0 9 O
Criteria NCT03862469 10 18 O
: NCT03862469 19 20 O

- NCT03862469 24 25 O
Female NCT03862469 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03862469 36 37 O
Aged NCT03862469 39 43 O
18 NCT03862469 45 47 B-Eq-Value
- NCT03862469 48 49 B-Eq-Operator___Eq-Operator-Value:BETWEEN
35 NCT03862469 51 53 B-Eq-Value
years NCT03862469 54 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03862469 60 61 O
established NCT03862469 62 73 O
by NCT03862469 74 76 O
visual NCT03862469 77 83 B-Procedure-Name
inspection NCT03862469 84 94 I-Procedure-Name
of NCT03862469 95 97 O
a NCT03862469 98 99 O
government NCT03862469 100 110 O
- NCT03862469 111 112 O
issued NCT03862469 113 119 O
ID NCT03862469 120 122 O

- NCT03862469 125 126 O
Average NCT03862469 128 135 O
menstrual NCT03862469 136 145 B-Observation-Name
cycle NCT03862469 146 151 I-Observation-Name
21 NCT03862469 153 155 B-Eq-Value
- NCT03862469 156 157 B-Eq-Operator___Eq-Operator-Value:BETWEEN
35 NCT03862469 159 161 B-Eq-Value
days NCT03862469 162 166 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03862469 169 170 O
Access NCT03862469 172 178 O
to NCT03862469 179 181 O
smartphone NCT03862469 182 192 O
with NCT03862469 193 197 O
working NCT03862469 198 205 O
camera NCT03862469 206 212 O
for NCT03862469 213 216 O
daily NCT03862469 217 222 O
use NCT03862469 223 226 O
of NCT03862469 227 229 O
the NCT03862469 230 233 O
PreMom NCT03862469 234 240 O
application NCT03862469 241 252 O

Exclusion NCT03862469 253 262 O
Criteria NCT03862469 263 271 O
: NCT03862469 272 273 O

- NCT03862469 277 278 O
Lifetime NCT03862469 280 288 O
DSM NCT03862469 289 292 B-Condition-Name
- NCT03862469 293 294 I-Condition-Name
5 NCT03862469 296 297 I-Condition-Name
Axis NCT03862469 298 302 I-Condition-Name
1 NCT03862469 304 305 I-Condition-Name
disorder NCT03862469 306 314 I-Condition-Name
( NCT03862469 315 316 O
except NCT03862469 317 323 O
anxiety NCT03862469 324 331 B-Condition-Name
and NCT03862469 332 335 O
depression NCT03862469 336 346 B-Condition-Name
) NCT03862469 347 348 O
, NCT03862469 350 351 O
as NCT03862469 352 354 O
documented NCT03862469 355 365 O
in NCT03862469 366 368 O
the NCT03862469 369 372 O
Mental NCT03862469 373 379 B-Procedure-Name
Health NCT03862469 380 386 I-Procedure-Name
Interview NCT03862469 387 396 I-Procedure-Name

- NCT03862469 399 400 O
Current NCT03862469 402 409 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
DSM NCT03862469 410 413 B-Condition-Name
- NCT03862469 414 415 I-Condition-Name
5 NCT03862469 417 418 I-Condition-Name
Axis NCT03862469 419 423 I-Condition-Name
depressive NCT03862469 424 434 I-Condition-Name
or NCT03862469 435 437 O
anxiety NCT03862469 438 445 B-Condition-Name
disorder NCT03862469 446 454 I-Condition-Name
, NCT03862469 455 456 O
as NCT03862469 457 459 O
documented NCT03862469 460 470 O
in NCT03862469 471 473 O
the NCT03862469 474 477 O
Mental NCT03862469 478 484 B-Procedure-Name
Health NCT03862469 485 491 I-Procedure-Name
Interview NCT03862469 492 501 I-Procedure-Name

- NCT03862469 504 505 O
Positive NCT03862469 507 515 B-Polarity___Polarity-Value:positive
urine NCT03862469 516 521 B-Observation-Name___Observation-Type-Value:lab
drug NCT03862469 522 526 I-Observation-Name___Observation-Type-Value:lab
screen NCT03862469 527 533 I-Observation-Name___Observation-Type-Value:lab
test NCT03862469 534 538 I-Observation-Name___Observation-Type-Value:lab

- NCT03862469 541 542 O
Breath NCT03862469 544 550 B-Observation-Name___Observation-Type-Value:lab
alcohol NCT03862469 551 558 I-Observation-Name___Observation-Type-Value:lab
concentration NCT03862469 559 572 I-Observation-Name___Observation-Type-Value:lab
> NCT03862469 573 574 B-Eq-Operator___Eq-Operator-Value:GT
0.00 NCT03862469 576 580 B-Eq-Value
% NCT03862469 581 582 B-Eq-Unit

- NCT03862469 586 587 O
Self NCT03862469 589 593 O
- NCT03862469 594 595 O
reported NCT03862469 596 604 O
smoker NCT03862469 605 611 B-Condition-Name
or NCT03862469 612 614 O
carbon NCT03862469 615 621 B-Observation-Name___Observation-Type-Value:lab
monoxide NCT03862469 622 630 I-Observation-Name___Observation-Type-Value:lab
concentration NCT03862469 631 644 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03862469 645 646 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03862469 648 649 B-Eq-Value
ppm NCT03862469 650 653 B-Eq-Unit

- NCT03862469 656 657 O
Irregular NCT03862469 659 668 B-Condition-Name
menstrual NCT03862469 669 678 I-Condition-Name
cycle NCT03862469 679 684 I-Condition-Name

- NCT03862469 687 688 O
Current NCT03862469 690 697 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnancy NCT03862469 698 707 B-Condition-Name
( NCT03862469 708 709 O
urine NCT03862469 710 715 B-Observation-Name___Observation-Type-Value:lab
test NCT03862469 716 720 I-Observation-Name___Observation-Type-Value:lab
- NCT03862469 721 722 O
verified NCT03862469 723 731 O
) NCT03862469 732 733 O
or NCT03862469 734 736 O
lactation NCT03862469 737 746 B-Condition-Name
, NCT03862469 747 748 O
or NCT03862469 749 751 O
a NCT03862469 752 753 O
plan NCT03862469 754 758 O
to NCT03862469 759 761 O
become NCT03862469 762 768 O
pregnant NCT03862469 769 777 B-Condition-Name

- NCT03862469 780 781 O
Moderate NCT03862469 783 791 B-Severity___Severity-Value:moderate
or NCT03862469 792 794 B-Eq-Operator___Eq-Operator-Value:BETWEEN
high NCT03862469 795 799 B-Polarity___Polarity-Value:high
suicide NCT03862469 800 807 B-Condition-Name
risk NCT03862469 808 812 O

- NCT03862469 815 816 O
Shipley NCT03862469 818 825 B-Observation-Name___Observation-Type-Value:clinical-score
IQ NCT03862469 826 828 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03862469 829 830 O
vocabulary NCT03862469 831 841 B-Observation-Name
standard NCT03862469 842 850 I-Observation-Name
score NCT03862469 851 856 I-Observation-Name
) NCT03862469 857 858 O
> NCT03862469 859 860 B-Eq-Operator___Eq-Operator-Value:GT
80 NCT03862469 862 864 B-Eq-Value

- NCT03862469 868 869 O
Prescription NCT03862469 871 883 O
medications NCT03862469 884 895 O

Inclusion NCT03869528 0 9 O
Criteria NCT03869528 10 18 O
: NCT03869528 19 20 O

- NCT03869528 24 25 O
All NCT03869528 27 30 O
adults NCT03869528 31 37 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
≥ NCT03869528 38 39 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03869528 41 43 B-Eq-Value
yrs NCT03869528 44 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869528 48 50 O
age NCT03869528 51 54 O
undergoing NCT03869528 55 65 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
flexible NCT03869528 66 74 O
bronchoscopy NCT03869528 75 87 B-Procedure-Name

Exclusion NCT03869528 88 97 O
Criteria NCT03869528 98 106 O
: NCT03869528 107 108 O

- NCT03869528 112 113 O
Uncontrolled NCT03869528 115 127 O
hypertension NCT03869528 128 140 B-Condition-Name
Systolic NCT03869528 141 149 B-Observation-Name___Observation-Type-Value:vital
Blood NCT03869528 150 155 I-Observation-Name___Observation-Type-Value:vital
Pressure NCT03869528 156 164 I-Observation-Name___Observation-Type-Value:vital
> NCT03869528 165 166 B-Eq-Operator___Eq-Operator-Value:GT
180 NCT03869528 168 171 B-Eq-Value
mm NCT03869528 172 174 B-Eq-Unit
Hg NCT03869528 175 177 I-Eq-Unit

- NCT03869528 180 181 O
Symptomatic NCT03869528 183 194 O
coronary NCT03869528 195 203 B-Condition-Name
artery NCT03869528 204 210 I-Condition-Name
disease NCT03869528 211 218 I-Condition-Name

- NCT03869528 221 222 O
Pregnancy NCT03869528 224 233 B-Condition-Name

- NCT03869528 236 237 O
Not NCT03869528 239 242 O
giving NCT03869528 243 249 O
informed NCT03869528 250 258 O
consent NCT03869528 259 266 O
for NCT03869528 267 270 O
the NCT03869528 271 274 O
procedure NCT03869528 275 284 O

- NCT03869528 287 288 O
Hypoxemia NCT03869528 290 299 B-Condition-Name
( NCT03869528 300 301 O
oxygen NCT03869528 302 308 B-Observation-Name___Observation-Type-Value:vital
saturation NCT03869528 309 319 I-Observation-Name___Observation-Type-Value:vital
[ NCT03869528 320 321 O
by NCT03869528 322 324 O
pulse NCT03869528 325 330 B-Procedure-Name
oximetry NCT03869528 331 339 I-Procedure-Name
] NCT03869528 340 341 O
< NCT03869528 342 343 B-Eq-Operator___Eq-Operator-Value:LT
92 NCT03869528 345 347 B-Eq-Value
% NCT03869528 348 349 B-Eq-Unit
with NCT03869528 350 354 O
Fio NCT03869528 355 358 B-Observation-Name___Observation-Type-Value:vital
2 NCT03869528 359 360 I-Observation-Name___Observation-Type-Value:vital
of NCT03869528 361 363 O
≥ NCT03869528 364 365 B-Eq-Operator___Eq-Operator-Value:GTEQ
0.3 NCT03869528 367 370 B-Eq-Value

- NCT03869528 374 375 O
Bronchoscopy NCT03869528 377 389 B-Procedure-Name
performed NCT03869528 390 399 O
through NCT03869528 400 407 O
an NCT03869528 408 410 O
artificial NCT03869528 411 421 B-Procedure-Name
airway NCT03869528 422 428 I-Procedure-Name

Inclusion NCT03868150 0 9 O
Criteria NCT03868150 10 18 O
: NCT03868150 19 20 O

- NCT03868150 24 25 O
Patients NCT03868150 27 35 O
scheduled NCT03868150 36 45 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03868150 46 49 O
first NCT03868150 50 55 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
- NCT03868150 56 57 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
time NCT03868150 58 62 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
non NCT03868150 63 66 O
- NCT03868150 67 68 O
emergent NCT03868150 69 77 O
open NCT03868150 78 82 B-Procedure-Name
- NCT03868150 83 84 I-Procedure-Name
heart NCT03868150 85 90 I-Procedure-Name
surgery NCT03868150 91 98 I-Procedure-Name
for NCT03868150 99 102 O
coronary NCT03868150 103 111 B-Procedure-Name
artery NCT03868150 112 118 I-Procedure-Name
bypass NCT03868150 119 125 I-Procedure-Name
graft NCT03868150 126 131 I-Procedure-Name
( NCT03868150 132 133 O
CABG NCT03868150 134 138 B-Procedure-Name
) NCT03868150 139 140 O
revascularization NCT03868150 141 158 O
, NCT03868150 159 160 O
valvular NCT03868150 161 169 B-Procedure-Name
repair NCT03868150 170 176 O
or NCT03868150 177 179 O
replacement NCT03868150 180 191 O
, NCT03868150 192 193 O
combined NCT03868150 194 202 O
CABG NCT03868150 203 207 B-Procedure-Name
with NCT03868150 208 212 O
valve NCT03868150 213 218 B-Procedure-Name
repair NCT03868150 219 225 O
or NCT03868150 226 228 O
replacement NCT03868150 229 240 O
, NCT03868150 241 242 O
or NCT03868150 243 245 O
valve NCT03868150 246 251 B-Procedure-Name
sparing NCT03868150 252 259 I-Procedure-Name
aortic NCT03868150 260 266 I-Procedure-Name
root NCT03868150 267 271 I-Procedure-Name
repair NCT03868150 272 278 I-Procedure-Name

- NCT03868150 281 282 O
Normal NCT03868150 284 290 B-Polarity___Polarity-Value:normal
sinus NCT03868150 291 296 B-Condition-Name
rhythm NCT03868150 297 303 I-Condition-Name

- NCT03868150 306 307 O
No NCT03868150 309 311 O
documented NCT03868150 312 322 O
history NCT03868150 323 330 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868150 331 333 O
atrial NCT03868150 334 340 B-Condition-Name
fibrillation NCT03868150 341 353 I-Condition-Name

Exclusion NCT03868150 354 363 O
Criteria NCT03868150 364 372 O
: NCT03868150 373 374 O

- NCT03868150 378 379 O
Prior NCT03868150 381 386 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgical NCT03868150 387 395 B-Procedure-Name
procedures NCT03868150 396 406 I-Procedure-Name
involving NCT03868150 407 416 O
heart NCT03868150 417 422 B-Procedure-Name
surgery NCT03868150 423 430 I-Procedure-Name
and NCT03868150 431 434 O
cardiopulmonary NCT03868150 435 450 B-Procedure-Name
bypass NCT03868150 451 457 I-Procedure-Name

- NCT03868150 460 461 O
Any NCT03868150 463 466 O
prior NCT03868150 467 472 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
documented NCT03868150 473 483 O
history NCT03868150 484 491 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868150 492 494 O
atrial NCT03868150 495 501 B-Condition-Name
fibrillation NCT03868150 502 514 I-Condition-Name
, NCT03868150 515 516 O
atrial NCT03868150 517 523 B-Condition-Name
flutter NCT03868150 524 531 I-Condition-Name
or NCT03868150 532 534 O
atrial NCT03868150 535 541 B-Condition-Name
tachycardia NCT03868150 542 553 I-Condition-Name
lasting NCT03868150 554 561 O
longer NCT03868150 562 568 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868150 569 573 I-Eq-Operator___Eq-Operator-Value:GT
30 NCT03868150 575 577 B-Eq-Value
seconds NCT03868150 578 585 B-Eq-Unit

- NCT03868150 588 589 O
Prior NCT03868150 591 596 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03868150 597 604 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868150 605 607 O
Amiodarone NCT03868150 608 618 B-Drug-Name
treatment NCT03868150 619 628 O
for NCT03868150 629 632 O
the NCT03868150 633 636 O
management NCT03868150 637 647 O
of NCT03868150 648 650 O
supraventricular NCT03868150 651 667 O
tachy NCT03868150 668 673 B-Condition-Name
- NCT03868150 674 675 I-Condition-Name
arrhythmias NCT03868150 676 687 I-Condition-Name

- NCT03868150 690 691 O
Patients NCT03868150 693 701 O
requiring NCT03868150 702 711 O
surgical NCT03868150 712 720 B-Procedure-Name
treatment NCT03868150 721 730 I-Procedure-Name
of NCT03868150 731 733 O
atrial NCT03868150 734 740 B-Condition-Name
arrhythmias NCT03868150 741 752 I-Condition-Name
such NCT03868150 753 757 O
as NCT03868150 758 760 O
pulmonary NCT03868150 761 770 B-Procedure-Name
vein NCT03868150 771 775 I-Procedure-Name
isolation NCT03868150 776 785 I-Procedure-Name
or NCT03868150 786 788 O
Maze NCT03868150 789 793 B-Procedure-Name
procedure NCT03868150 794 803 I-Procedure-Name
. NCT03868150 804 805 O

Inclusion NCT03867539 0 9 O
Criteria NCT03867539 10 18 O
: NCT03867539 19 20 O

- NCT03867539 24 25 O
carpal NCT03867539 27 33 B-Condition-Name
tunnel NCT03867539 34 40 I-Condition-Name
syndrome NCT03867539 41 49 I-Condition-Name
diagnosed NCT03867539 50 59 O
either NCT03867539 60 66 O
by NCT03867539 67 69 O
physical NCT03867539 70 78 B-Procedure-Name
exam NCT03867539 79 83 I-Procedure-Name
or NCT03867539 84 86 O
EMG NCT03867539 87 90 B-Procedure-Name

- NCT03867539 93 94 O
age NCT03867539 96 99 O
> NCT03867539 100 101 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03867539 103 105 B-Eq-Value
. NCT03867539 105 106 O

Exclusion NCT03867539 108 117 O
Criteria NCT03867539 118 126 O
: NCT03867539 127 128 O

- NCT03867539 132 133 O
allergy NCT03867539 135 142 O
to NCT03867539 143 145 O
bupivacaine NCT03867539 146 157 B-Drug-Name

- NCT03867539 160 161 O
pre NCT03867539 163 166 O
- NCT03867539 167 168 O
operative NCT03867539 169 178 B-Procedure-Name
opioid NCT03867539 179 185 B-Drug-Name
usage NCT03867539 186 191 O
within NCT03867539 192 198 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867539 199 202 O
last NCT03867539 203 207 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
six NCT03867539 208 211 B-Eq-Value
months NCT03867539 212 218 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03867539 221 222 O
patients NCT03867539 224 232 O
allergic NCT03867539 233 241 O
to NCT03867539 242 244 O
Percocet NCT03867539 245 253 B-Drug-Name
or NCT03867539 254 256 O
acetaminophen NCT03867539 257 270 B-Drug-Name

- NCT03867539 273 274 O
patients NCT03867539 276 284 O
taking NCT03867539 285 291 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
tricyclic NCT03867539 292 301 B-Drug-Name
antidepressants NCT03867539 302 317 I-Drug-Name
( NCT03867539 318 319 O
interaction NCT03867539 320 331 B-Stability___Stability-Value:change
with NCT03867539 332 336 O
bupivacaine NCT03867539 337 348 B-Drug-Name
) NCT03867539 349 350 O

- NCT03867539 354 355 O
vulnerable NCT03867539 357 367 B-Observation-Name
populations NCT03867539 368 379 I-Observation-Name
( NCT03867539 380 381 O
prisoners NCT03867539 382 391 B-Observation-Name
or NCT03867539 392 394 O
pregnant NCT03867539 395 403 B-Condition-Name
women NCT03867539 404 409 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
) NCT03867539 410 411 O

Inclusion NCT03862287 0 9 O
Criteria NCT03862287 10 18 O
: NCT03862287 19 20 O

- NCT03862287 24 25 O
ASA NCT03862287 27 30 B-Condition-Name
I NCT03862287 31 32 B-Eq-Value
- NCT03862287 33 34 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03862287 35 38 B-Eq-Value
male NCT03862287 39 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03862287 44 47 O
female NCT03862287 48 54 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03862287 55 63 O
aged NCT03862287 64 68 O
between NCT03862287 69 76 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03862287 78 80 B-Eq-Value
to NCT03862287 81 83 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03862287 85 87 B-Eq-Value
years NCT03862287 88 93 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862287 94 97 O
, NCT03862287 98 99 O
who NCT03862287 100 103 O
will NCT03862287 104 108 O
receive NCT03862287 109 116 O
spinal NCT03862287 117 123 B-Procedure-Name
anesthesia NCT03862287 124 134 I-Procedure-Name
for NCT03862287 135 138 O
surgeries NCT03862287 139 148 B-Procedure-Name
lasting NCT03862287 149 156 O
less NCT03862287 157 161 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03862287 162 166 I-Eq-Operator___Eq-Operator-Value:LT
one NCT03862287 167 170 B-Eq-Value
hour NCT03862287 171 175 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
. NCT03862287 176 177 O

Exclusion NCT03862287 179 188 O
Criteria NCT03862287 189 197 O
: NCT03862287 198 199 O

- NCT03862287 203 204 O
Patients NCT03862287 206 214 O
younger NCT03862287 215 222 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03862287 223 227 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03862287 229 231 B-Eq-Value
years NCT03862287 232 237 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862287 238 241 O
. NCT03862287 242 243 O

- NCT03862287 247 248 O
ASA NCT03862287 250 253 B-Condition-Name
physical NCT03862287 254 262 O
status NCT03862287 263 269 O
> NCT03862287 270 271 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03862287 273 274 B-Eq-Value
. NCT03862287 274 275 O

- NCT03862287 279 280 O
Immunosuppression NCT03862287 282 299 B-Condition-Name
or NCT03862287 300 302 O
high NCT03862287 303 307 B-Polarity___Polarity-Value:high
risk NCT03862287 308 312 O
of NCT03862287 313 315 O
infection NCT03862287 316 325 B-Condition-Name
. NCT03862287 326 327 O

- NCT03862287 331 332 O
Contraindications NCT03862287 334 351 O
to NCT03862287 352 354 O
receiving NCT03862287 355 364 O
spinal NCT03862287 365 371 B-Procedure-Name
anesthesia NCT03862287 372 382 I-Procedure-Name
( NCT03862287 383 384 O
e NCT03862287 385 386 O
. NCT03862287 387 388 O
g NCT03862287 389 390 O
. NCT03862287 391 392 O
coagulation NCT03862287 394 405 B-Condition-Name
impairment NCT03862287 406 416 I-Condition-Name
) NCT03862287 417 418 O
. NCT03862287 420 421 O

- NCT03862287 425 426 O
Patients NCT03862287 428 436 O
with NCT03862287 437 441 O
psychosis NCT03862287 442 451 B-Condition-Name

- NCT03862287 454 455 O
Patients NCT03862287 457 465 O
with NCT03862287 466 470 O
preexisting NCT03862287 471 482 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
back NCT03862287 483 487 B-Condition-Name
pain NCT03862287 488 492 I-Condition-Name
. NCT03862287 493 494 O

- NCT03862287 498 499 O
Patients NCT03862287 501 509 O
with NCT03862287 510 514 O
cognitive NCT03862287 515 524 B-Condition-Name
impairment NCT03862287 525 535 I-Condition-Name

- NCT03862287 538 539 O
Allergies NCT03862287 541 550 O
to NCT03862287 551 553 O
local NCT03862287 554 559 B-Procedure-Name
anesthetics NCT03862287 560 571 I-Procedure-Name
, NCT03862287 572 573 O
analgesics NCT03862287 574 584 B-Drug-Name
or NCT03862287 585 587 O
any NCT03862287 588 591 O
medication NCT03862287 592 602 O
used NCT03862287 603 607 O
in NCT03862287 608 610 O
the NCT03862287 611 614 O
study NCT03862287 615 620 O
. NCT03862287 621 622 O

- NCT03862287 626 627 O
Patients NCT03862287 629 637 O
with NCT03862287 638 642 O
chronic NCT03862287 643 650 O
regular NCT03862287 651 658 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
opioid NCT03862287 659 665 B-Drug-Name
usage NCT03862287 666 671 O

- NCT03862287 674 675 O
Presence NCT03862287 677 685 O
of NCT03862287 686 688 O
preexisting NCT03862287 689 700 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
neurological NCT03862287 701 713 B-Condition-Name
symptoms NCT03862287 714 722 O
. NCT03862287 723 724 O

Inclusion NCT03863600 0 9 O
Criteria NCT03863600 10 18 O
: NCT03863600 19 20 O

- NCT03863600 24 25 O
Residing NCT03863600 27 35 O
in NCT03863600 36 38 O
rural NCT03863600 39 44 B-Location___Location-Value:residence
village NCT03863600 45 52 I-Location___Location-Value:residence

- NCT03863600 55 56 O
Registered NCT03863600 58 68 O
for NCT03863600 69 72 O
pregnancy NCT03863600 73 82 B-Condition-Name
care NCT03863600 83 87 O
at NCT03863600 88 90 O
the NCT03863600 91 94 O
villages NCT03863600 95 103 B-Location___Location-Value:clinic
governmental NCT03863600 104 116 I-Location___Location-Value:clinic
clinic NCT03863600 117 123 I-Location___Location-Value:clinic

- NCT03863600 126 127 O
With NCT03863600 129 133 O
singleton NCT03863600 134 143 O
pregnancy NCT03863600 144 153 B-Condition-Name

- NCT03863600 156 157 O
Gave NCT03863600 159 163 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
birth NCT03863600 164 169 O
the NCT03863600 170 173 O
last NCT03863600 174 178 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
one NCT03863600 179 182 B-Eq-Value
to NCT03863600 183 185 B-Eq-Operator___Eq-Operator-Value:BETWEEN
six NCT03863600 186 189 B-Eq-Value
month NCT03863600 190 195 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Exclusion NCT03863600 196 205 O
Criteria NCT03863600 206 214 O
: NCT03863600 215 216 O

- NCT03863600 220 221 O
Residing NCT03863600 223 231 O
in NCT03863600 232 234 O
urban NCT03863600 235 240 B-Location___Location-Value:residence
areas NCT03863600 241 246 I-Location___Location-Value:residence

- NCT03863600 249 250 O
With NCT03863600 252 256 O
multiple NCT03863600 257 265 B-Eq-Operator___Eq-Operator-Value:GT
pregnancy NCT03863600 266 275 B-Condition-Name

- NCT03863600 278 279 O
Not NCT03863600 281 284 O
registered NCT03863600 285 295 O
for NCT03863600 296 299 O
antenatal NCT03863600 300 309 B-Procedure-Name
care NCT03863600 310 314 I-Procedure-Name
at NCT03863600 315 317 O
the NCT03863600 318 321 O
local NCT03863600 322 327 B-Location___Location-Value:clinic
governmental NCT03863600 328 340 I-Location___Location-Value:clinic
clinic NCT03863600 341 347 I-Location___Location-Value:clinic

Inclusion NCT03868033 0 9 O
Criteria NCT03868033 10 18 O
: NCT03868033 19 20 O

1 NCT03868033 25 26 O
. NCT03868033 26 27 O
Postmenopausal NCT03868033 29 43 B-Condition-Name
women NCT03868033 44 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

2 NCT03868033 53 54 O
. NCT03868033 54 55 O
Men NCT03868033 57 60 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
> NCT03868033 61 62 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03868033 64 66 B-Eq-Value
- NCT03868033 67 68 O
year NCT03868033 69 73 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
- NCT03868033 74 75 O
old NCT03868033 76 79 O

3 NCT03868033 83 84 O
. NCT03868033 84 85 O
After NCT03868033 87 92 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Denosumab NCT03868033 93 102 B-Drug-Name
treatment NCT03868033 103 112 O
≥ NCT03868033 113 114 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03868033 116 117 B-Eq-Value
years NCT03868033 118 123 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
due NCT03868033 124 127 O
to NCT03868033 128 130 O
osteoporosis NCT03868033 131 143 B-Condition-Name

Exclusion NCT03868033 144 153 O
Criteria NCT03868033 154 162 O
: NCT03868033 163 164 O

1 NCT03868033 169 170 O
. NCT03868033 170 171 O
secondary NCT03868033 173 182 O
osteoporosis NCT03868033 183 195 B-Condition-Name

2 NCT03868033 199 200 O
. NCT03868033 200 201 O
metabolic NCT03868033 203 212 B-Condition-Name
bone NCT03868033 213 217 I-Condition-Name
disease NCT03868033 218 225 I-Condition-Name

3 NCT03868033 229 230 O
. NCT03868033 230 231 O
cancer NCT03868033 233 239 B-Condition-Name
history NCT03868033 240 247 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

4 NCT03868033 251 252 O
. NCT03868033 252 253 O
continuous NCT03868033 255 265 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
steroid NCT03868033 266 273 B-Procedure-Name
therapy NCT03868033 274 281 I-Procedure-Name

5 NCT03868033 285 286 O
. NCT03868033 286 287 O
hormone NCT03868033 289 296 B-Procedure-Name
replacement NCT03868033 297 308 I-Procedure-Name
therapy NCT03868033 309 316 I-Procedure-Name

6 NCT03868033 320 321 O
. NCT03868033 321 322 O
ever NCT03868033 324 328 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:anytime
used NCT03868033 329 333 O
any NCT03868033 334 337 O
other NCT03868033 338 343 O
kind NCT03868033 344 348 O
of NCT03868033 349 351 O
anti NCT03868033 352 356 B-Procedure-Name
- NCT03868033 357 358 I-Procedure-Name
resorptive NCT03868033 359 369 I-Procedure-Name
treatment NCT03868033 370 379 I-Procedure-Name

6 NCT03868033 383 384 O
. NCT03868033 384 385 O
estimated NCT03868033 387 396 B-Observation-Name___Observation-Type-Value:lab
Glomerular NCT03868033 397 407 I-Observation-Name___Observation-Type-Value:lab
filtration NCT03868033 408 418 I-Observation-Name___Observation-Type-Value:lab
rate NCT03868033 419 423 I-Observation-Name___Observation-Type-Value:lab
< NCT03868033 424 425 B-Eq-Operator___Eq-Operator-Value:LT
35 NCT03868033 427 429 B-Eq-Value
mL NCT03868033 430 432 B-Eq-Unit
/ NCT03868033 433 434 O
min NCT03868033 435 438 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

7 NCT03868033 443 444 O
. NCT03868033 444 445 O
allergy NCT03868033 447 454 O
to NCT03868033 455 457 O
Zoledronic NCT03868033 458 468 B-Drug-Name
acid NCT03868033 469 473 I-Drug-Name

8 NCT03868033 477 478 O
. NCT03868033 478 479 O
hypocalcaemia NCT03868033 481 494 B-Condition-Name

9 NCT03868033 499 500 O
. NCT03868033 500 501 O
any NCT03868033 503 506 O
contraindications NCT03868033 507 524 O
to NCT03868033 525 527 O
use NCT03868033 528 531 O
Zoledronic NCT03868033 532 542 B-Drug-Name
acid NCT03868033 543 547 I-Drug-Name


Inclusion NCT03869463 0 9 O
Criteria NCT03869463 10 18 O
: NCT03869463 19 20 O

1 NCT03869463 25 26 O
. NCT03869463 26 27 O
Age NCT03869463 29 32 O
18 NCT03869463 34 36 B-Eq-Value
- NCT03869463 37 38 B-Eq-Operator___Eq-Operator-Value:BETWEEN
29 NCT03869463 40 42 B-Eq-Value
. NCT03869463 42 43 O

2 NCT03869463 48 49 O
. NCT03869463 49 50 O
Current NCT03869463 52 59 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnosis NCT03869463 60 69 O
of NCT03869463 70 72 O
MDD NCT03869463 73 76 B-Condition-Name
/ NCT03869463 77 78 O
persistent NCT03869463 79 89 O
depressive NCT03869463 90 100 B-Condition-Name
disorder NCT03869463 101 109 I-Condition-Name
or NCT03869463 110 112 O
HDRS NCT03869463 113 117 B-Observation-Name
greater NCT03869463 118 125 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03869463 126 130 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03869463 131 133 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03869463 134 139 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03869463 140 142 O
12 NCT03869463 144 146 B-Eq-Value
. NCT03869463 146 147 O
3 NCT03869463 150 151 O
. NCT03869463 151 152 O
Daily NCT03869463 154 159 O
access NCT03869463 160 166 O
to NCT03869463 167 169 O
smartphone NCT03869463 170 180 O
or NCT03869463 181 183 O
tablet NCT03869463 184 190 O
with NCT03869463 191 195 O
internet NCT03869463 196 204 O
connection NCT03869463 205 215 O
for NCT03869463 216 219 O
the NCT03869463 220 223 O
study NCT03869463 224 229 O
duration NCT03869463 230 238 O
. NCT03869463 239 240 O

4 NCT03869463 243 244 O
. NCT03869463 244 245 O
Willing NCT03869463 247 254 O
and NCT03869463 255 258 O
able NCT03869463 259 263 O
to NCT03869463 264 266 O
complete NCT03869463 267 275 O
MRI NCT03869463 276 279 B-Procedure-Name
, NCT03869463 280 281 O
mood NCT03869463 282 286 O
, NCT03869463 287 288 O
and NCT03869463 289 292 O
neuropsychological NCT03869463 293 311 O
testing NCT03869463 312 319 B-Procedure-Name
. NCT03869463 320 321 O
5 NCT03869463 324 325 O
. NCT03869463 325 326 O
IQ NCT03869463 328 330 B-Observation-Name
> NCT03869463 331 332 B-Eq-Operator___Eq-Operator-Value:GT
85 NCT03869463 334 336 B-Eq-Value
. NCT03869463 336 337 O

Exclusion NCT03869463 339 348 O
Criteria NCT03869463 349 357 O
: NCT03869463 358 359 O

1 NCT03869463 364 365 O
. NCT03869463 365 366 O
Lacks NCT03869463 368 373 O
English NCT03869463 374 381 B-Language
- NCT03869463 382 383 O
speaking NCT03869463 384 392 O
ability NCT03869463 393 400 O
as NCT03869463 401 403 O
determined NCT03869463 404 414 O
by NCT03869463 415 417 O
self NCT03869463 418 422 O
- NCT03869463 423 424 O
report NCT03869463 425 431 O
and NCT03869463 432 435 O
clinical NCT03869463 436 444 O
evaluation NCT03869463 445 455 O
. NCT03869463 456 457 O

2 NCT03869463 462 463 O
. NCT03869463 463 464 O
Evidence NCT03869463 466 474 O
of NCT03869463 475 477 O
schizophrenia NCT03869463 478 491 B-Condition-Name
, NCT03869463 492 493 O
schizoaffective NCT03869463 494 509 B-Condition-Name
disorder NCT03869463 510 518 I-Condition-Name
, NCT03869463 519 520 O
psychosis NCT03869463 521 530 B-Condition-Name
, NCT03869463 531 532 O
bipolar NCT03869463 533 540 B-Condition-Name
I NCT03869463 541 542 B-Eq-Value
and NCT03869463 543 546 O
II NCT03869463 547 549 B-Eq-Value
disorder NCT03869463 550 558 O
. NCT03869463 559 560 O

3 NCT03869463 565 566 O
. NCT03869463 566 567 O
Active NCT03869463 569 575 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
suicidal NCT03869463 576 584 B-Condition-Name
ideation NCT03869463 585 593 I-Condition-Name
, NCT03869463 594 595 O
intent NCT03869463 596 602 O
, NCT03869463 603 604 O
or NCT03869463 605 607 O
plan NCT03869463 608 612 O
, NCT03869463 613 614 O
or NCT03869463 615 617 O
past NCT03869463 618 622 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
attempt NCT03869463 623 630 O
within NCT03869463 631 637 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03869463 639 640 B-Eq-Value
year NCT03869463 641 645 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03869463 646 647 O

4 NCT03869463 652 653 O
. NCT03869463 653 654 O
Severe NCT03869463 656 662 B-Severity___Severity-Value:severe
depression NCT03869463 663 673 B-Condition-Name
( NCT03869463 674 675 O
HDRS NCT03869463 676 680 B-Observation-Name
> NCT03869463 681 682 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03869463 684 686 B-Eq-Value
) NCT03869463 687 688 O
. NCT03869463 690 691 O

5 NCT03869463 696 697 O
. NCT03869463 697 698 O
Neurological NCT03869463 700 712 B-Condition-Name
disorder NCT03869463 713 721 I-Condition-Name
( NCT03869463 722 723 O
epilepsy NCT03869463 724 732 B-Condition-Name
, NCT03869463 733 734 O
multiple NCT03869463 735 743 B-Condition-Name
sclerosis NCT03869463 744 753 I-Condition-Name
, NCT03869463 754 755 O
traumatic NCT03869463 756 765 B-Condition-Name
brain NCT03869463 766 771 I-Condition-Name
injury NCT03869463 772 778 I-Condition-Name
, NCT03869463 779 780 O
clinical NCT03869463 781 789 O
stroke NCT03869463 790 796 B-Condition-Name
) NCT03869463 797 798 O
. NCT03869463 800 801 O

6 NCT03869463 806 807 O
. NCT03869463 807 808 O
Use NCT03869463 810 813 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03869463 814 816 O
medications NCT03869463 817 828 O
known NCT03869463 829 834 O
to NCT03869463 835 837 O
have NCT03869463 838 842 O
negative NCT03869463 843 851 O
impact NCT03869463 852 858 B-Stability___Stability-Value:change
on NCT03869463 859 861 O
cognition NCT03869463 862 871 B-Condition-Name
( NCT03869463 872 873 O
benzodiazepines NCT03869463 874 889 B-Drug-Name
and NCT03869463 890 893 O
lorazepam NCT03869463 894 903 B-Drug-Name
equivalents NCT03869463 904 915 O
> NCT03869463 916 917 B-Eq-Operator___Eq-Operator-Value:GT
1 NCT03869463 919 920 B-Eq-Value
mg NCT03869463 921 923 B-Eq-Unit
daily NCT03869463 924 929 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
, NCT03869463 930 931 O
narcotics NCT03869463 932 941 B-Drug-Name
, NCT03869463 942 943 O
anticholinergics NCT03869463 944 960 B-Drug-Name
) NCT03869463 961 962 O
. NCT03869463 964 965 O

7 NCT03869463 970 971 O
. NCT03869463 971 972 O
History NCT03869463 974 981 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869463 982 984 O
alcohol NCT03869463 985 992 O
or NCT03869463 993 995 O
drug NCT03869463 996 1000 O
abuse NCT03869463 1001 1006 B-Condition-Name
or NCT03869463 1007 1009 O
dependence NCT03869463 1010 1020 O
within NCT03869463 1021 1027 B-Eq-Operator___Eq-Operator-Value:LTEQ
past NCT03869463 1028 1032 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03869463 1033 1037 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03869463 1038 1039 O

8 NCT03869463 1044 1045 O
. NCT03869463 1045 1046 O
Acute NCT03869463 1048 1053 B-Severity___Severity-Value:severe
, NCT03869463 1054 1055 O
severe NCT03869463 1056 1062 B-Severity___Severity-Value:severe
, NCT03869463 1063 1064 O
unstable NCT03869463 1065 1073 B-Stability___Stability-Value:change
medical NCT03869463 1074 1081 O
illness NCT03869463 1082 1089 O
. NCT03869463 1090 1091 O
For NCT03869463 1093 1096 O
cancer NCT03869463 1097 1103 B-Condition-Name
, NCT03869463 1104 1105 O
acutely NCT03869463 1106 1113 B-Severity___Severity-Value:severe
ill NCT03869463 1114 1117 B-Condition-Name
patients NCT03869463 1118 1126 O
( NCT03869463 1127 1128 O
including NCT03869463 1129 1138 O
those NCT03869463 1139 1144 O
with NCT03869463 1145 1149 O
metastases NCT03869463 1150 1160 B-Condition-Name
) NCT03869463 1161 1162 O
are NCT03869463 1163 1166 O
excluded NCT03869463 1167 1175 O
, NCT03869463 1176 1177 O
but NCT03869463 1178 1181 O
past NCT03869463 1182 1186 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03869463 1187 1194 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869463 1195 1197 O
successfully NCT03869463 1198 1210 O
treated NCT03869463 1211 1218 O
cancer NCT03869463 1219 1225 B-Condition-Name
does NCT03869463 1226 1230 O
not NCT03869463 1231 1234 O
result NCT03869463 1235 1241 O
in NCT03869463 1242 1244 O
exclusion NCT03869463 1245 1254 O
. NCT03869463 1255 1256 O

9 NCT03869463 1261 1262 O
. NCT03869463 1262 1263 O
Regular NCT03869463 1265 1272 O
online NCT03869463 1273 1279 O
brain NCT03869463 1280 1285 O
training NCT03869463 1286 1294 B-Observation-Name___Observation-Type-Value:social-habit
or NCT03869463 1295 1297 O
regular NCT03869463 1298 1305 O
player NCT03869463 1306 1312 O
of NCT03869463 1313 1315 O
non NCT03869463 1316 1319 O
- NCT03869463 1320 1321 O
fluency NCT03869463 1322 1329 O
verbal NCT03869463 1330 1336 B-Observation-Name___Observation-Type-Value:social-habit
games NCT03869463 1337 1342 I-Observation-Name___Observation-Type-Value:social-habit
, NCT03869463 1343 1344 O
defined NCT03869463 1345 1352 O
as NCT03869463 1353 1355 O
doing NCT03869463 1356 1361 O
these NCT03869463 1362 1367 O
procedures NCT03869463 1368 1378 O
at NCT03869463 1379 1381 O
a NCT03869463 1382 1383 O
frequency NCT03869463 1384 1393 O
of NCT03869463 1394 1396 O
twice NCT03869463 1397 1402 B-Eq-Value
weekly NCT03869463 1403 1409 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
or NCT03869463 1410 1412 B-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03869463 1413 1420 I-Eq-Operator___Eq-Operator-Value:GTEQ
during NCT03869463 1421 1427 O
the NCT03869463 1428 1431 O
year NCT03869463 1432 1436 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
prior NCT03869463 1437 1442 O
to NCT03869463 1443 1445 O
screening NCT03869463 1446 1455 O
. NCT03869463 1456 1457 O

Inclusion NCT03861598 0 9 O
Criteria NCT03861598 10 18 O
: NCT03861598 19 20 O

- NCT03861598 24 25 O
Grade NCT03861598 27 32 B-Eq-Unit
IV NCT03861598 33 35 B-Eq-Value
Glioblastoma NCT03861598 36 48 B-Condition-Name
, NCT03861598 49 50 O
receiving NCT03861598 51 60 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
chemotherapy NCT03861598 61 73 B-Procedure-Name
with NCT03861598 74 78 O
or NCT03861598 79 81 O
without NCT03861598 82 89 O
TTfields NCT03861598 90 98 B-Drug-Name
. NCT03861598 99 100 O

- NCT03861598 104 105 O
Progressive NCT03861598 107 118 O
or NCT03861598 119 121 O
recurrent NCT03861598 122 131 O
disease NCT03861598 132 139 B-Condition-Name
requiring NCT03861598 140 149 O
second NCT03861598 150 156 B-Procedure-Name
line NCT03861598 157 161 I-Procedure-Name
treatment NCT03861598 162 171 I-Procedure-Name

- NCT03861598 174 175 O
evidence NCT03861598 177 185 O
of NCT03861598 186 188 O
progression NCT03861598 189 200 B-Condition-Name
of NCT03861598 201 203 I-Condition-Name
disease NCT03861598 204 211 I-Condition-Name
by NCT03861598 212 214 O
brain NCT03861598 215 220 B-Procedure-Name
MRI NCT03861598 221 224 I-Procedure-Name
and NCT03861598 225 228 O
are NCT03861598 229 232 O
planned NCT03861598 233 240 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03861598 241 243 O
receive NCT03861598 244 251 O
chemotherapy NCT03861598 252 264 B-Procedure-Name

Exclusion NCT03861598 265 274 O
Criteria NCT03861598 275 283 O
: NCT03861598 284 285 O

- NCT03861598 289 290 O
Current NCT03861598 292 299 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03861598 300 303 O
of NCT03861598 304 306 O
another NCT03861598 307 314 O
beta NCT03861598 315 319 B-Drug-Name
blocker NCT03861598 320 327 I-Drug-Name
that NCT03861598 328 332 O
can NCT03861598 333 336 O
not NCT03861598 336 339 O
be NCT03861598 340 342 O
switched NCT03861598 343 351 B-Stability___Stability-Value:change
to NCT03861598 352 354 I-Stability___Stability-Value:change
carvedilol NCT03861598 355 365 B-Drug-Name
at NCT03861598 366 368 O
the NCT03861598 369 372 O
onset NCT03861598 373 378 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03861598 379 381 O
the NCT03861598 382 385 O
trial NCT03861598 386 391 O
. NCT03861598 392 393 O

- NCT03861598 397 398 O
Systolic NCT03861598 400 408 B-Observation-Name___Observation-Type-Value:vital
blood NCT03861598 409 414 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03861598 415 423 I-Observation-Name___Observation-Type-Value:vital
< NCT03861598 424 425 B-Eq-Operator___Eq-Operator-Value:LT
90 NCT03861598 427 429 B-Eq-Value
mmHg NCT03861598 430 434 B-Eq-Unit
and NCT03861598 435 438 O
/ NCT03861598 439 440 O
or NCT03861598 441 443 O
heart NCT03861598 444 449 B-Observation-Name___Observation-Type-Value:vital
rate NCT03861598 450 454 I-Observation-Name___Observation-Type-Value:vital
< NCT03861598 455 456 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03861598 458 460 B-Eq-Value
bpm NCT03861598 461 464 B-Eq-Unit
without NCT03861598 465 472 O
hypertensive NCT03861598 473 485 B-Condition-Name
medications NCT03861598 486 497 O

- NCT03861598 500 501 O
Allergy NCT03861598 503 510 O
to NCT03861598 511 513 O
beta NCT03861598 514 518 B-Drug-Name
blockers NCT03861598 519 527 I-Drug-Name

- NCT03861598 530 531 O
Severe NCT03861598 533 539 B-Severity___Severity-Value:severe
or NCT03861598 540 542 O
uncontrolled NCT03861598 543 555 O
asthma NCT03861598 556 562 B-Condition-Name
or NCT03861598 563 565 O
COPD NCT03861598 566 570 B-Condition-Name
( NCT03861598 571 572 O
chronic NCT03861598 573 580 B-Condition-Name
obstructive NCT03861598 581 592 I-Condition-Name
pulmonary NCT03861598 593 602 I-Condition-Name
disease NCT03861598 603 610 I-Condition-Name
) NCT03861598 611 612 O

Inclusion NCT03861104 0 9 O
Criteria NCT03861104 10 18 O
: NCT03861104 19 20 O

- NCT03861104 24 25 O
patients NCT03861104 27 35 O
who NCT03861104 36 39 O
will NCT03861104 40 44 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03861104 45 52 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
septoplasty NCT03861104 53 64 B-Procedure-Name
/ NCT03861104 65 66 O
septorhinoplasty NCT03861104 67 83 B-Procedure-Name
procedures NCT03861104 84 94 I-Procedure-Name

- NCT03861104 97 98 O
patients NCT03861104 100 108 O
who NCT03861104 109 112 O
will NCT03861104 113 117 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
receive NCT03861104 118 125 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
nasal NCT03861104 126 131 B-Procedure-Name
packing NCT03861104 132 139 I-Procedure-Name
at NCT03861104 140 142 O
their NCT03861104 143 148 O
septoplasty NCT03861104 149 160 B-Procedure-Name
septorhinoplasty NCT03861104 161 177 I-Procedure-Name
procedures NCT03861104 178 188 I-Procedure-Name

Exclusion NCT03861104 189 198 O
Criteria NCT03861104 199 207 O
: NCT03861104 208 209 O

- NCT03861104 213 214 O
patients NCT03861104 216 224 O
who NCT03861104 225 228 O
will NCT03861104 229 233 O
not NCT03861104 234 237 O
want NCT03861104 238 242 O
to NCT03861104 243 245 O
participate NCT03861104 246 257 O
to NCT03861104 258 260 O
the NCT03861104 261 264 O
study NCT03861104 265 270 O

- NCT03861104 273 274 O
revision NCT03861104 276 284 O
surgeries NCT03861104 285 294 B-Procedure-Name

- NCT03861104 297 298 O
if NCT03861104 300 302 O
the NCT03861104 303 306 O
patient NCT03861104 307 314 O
is NCT03861104 315 317 O
taking NCT03861104 318 324 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antidepressants NCT03861104 325 340 B-Drug-Name
during NCT03861104 341 347 O
the NCT03861104 348 351 O
last NCT03861104 352 356 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03861104 358 359 B-Eq-Value
months NCT03861104 360 366 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03861104 369 370 O
if NCT03861104 372 374 O
the NCT03861104 375 378 O
patient NCT03861104 379 386 O
has NCT03861104 387 390 O
a NCT03861104 391 392 O
history NCT03861104 393 400 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861104 401 403 O
a NCT03861104 404 405 O
disease NCT03861104 406 413 B-Condition-Name
that NCT03861104 414 418 O
can NCT03861104 419 422 O
affect NCT03861104 423 429 B-Stability___Stability-Value:change
anxiety NCT03861104 430 437 B-Condition-Name
levels NCT03861104 438 444 O

- NCT03861104 447 448 O
if NCT03861104 450 452 O
patient NCT03861104 453 460 O
wants NCT03861104 461 466 O
to NCT03861104 467 469 O
be NCT03861104 470 472 O
excluded NCT03861104 473 481 O
from NCT03861104 482 486 O
the NCT03861104 487 490 O
study NCT03861104 491 496 O

Inclusion NCT03861676 0 9 O
Criteria NCT03861676 10 18 O
: NCT03861676 19 20 O

- NCT03861676 24 25 O
Adenocarcinoma NCT03861676 27 41 B-Condition-Name
of NCT03861676 42 44 O
the NCT03861676 45 48 O
prostate NCT03861676 49 57 O

- NCT03861676 60 61 O
Performance NCT03861676 63 74 B-Observation-Name___Observation-Type-Value:clinical-score
Status NCT03861676 75 81 I-Observation-Name___Observation-Type-Value:clinical-score
< NCT03861676 82 83 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03861676 85 86 B-Eq-Value

- NCT03861676 90 91 O
Clinical NCT03861676 93 101 O
stages NCT03861676 102 108 O
( NCT03861676 109 110 O
not NCT03861676 111 114 O
radiographic NCT03861676 115 127 O
stage NCT03861676 128 133 O
) NCT03861676 134 135 O
T NCT03861676 136 137 B-Eq-Value
1c NCT03861676 138 140 I-Eq-Value
- NCT03861676 141 142 B-Eq-Operator___Eq-Operator-Value:BETWEEN
T NCT03861676 143 144 B-Eq-Value
2a NCT03861676 145 147 I-Eq-Value
, NCT03861676 148 149 O
Nx NCT03861676 150 152 O
or NCT03861676 153 155 O
N NCT03861676 156 157 B-Eq-Value
0 NCT03861676 158 159 I-Eq-Value
, NCT03861676 160 161 O
Mx NCT03861676 162 164 B-Eq-Value
or NCT03861676 165 167 O
M NCT03861676 168 169 B-Eq-Value
0 NCT03861676 170 171 I-Eq-Value

- NCT03861676 174 175 O
Gleason NCT03861676 177 184 B-Observation-Name___Observation-Type-Value:clinical-score
6 NCT03861676 186 187 B-Eq-Value
- NCT03861676 188 189 B-Eq-Operator___Eq-Operator-Value:BETWEEN
7 NCT03861676 191 192 B-Eq-Value
cancer NCT03861676 193 199 B-Condition-Name

- NCT03861676 202 203 O
Prostate NCT03861676 205 213 B-Observation-Name___Observation-Type-Value:measurement
volume NCT03861676 214 220 I-Observation-Name___Observation-Type-Value:measurement
< NCT03861676 221 222 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03861676 224 226 B-Eq-Value
cc NCT03861676 227 229 B-Eq-Unit
( NCT03861676 230 231 O
if NCT03861676 232 234 O
MRI NCT03861676 235 238 B-Procedure-Name
and NCT03861676 239 242 O
TRUS NCT03861676 243 247 B-Procedure-Name
have NCT03861676 248 252 O
conflicting NCT03861676 253 264 O
values NCT03861676 265 271 O
, NCT03861676 272 273 O
then NCT03861676 274 278 O
MRI NCT03861676 279 282 B-Procedure-Name
value NCT03861676 283 288 O
will NCT03861676 289 293 O
be NCT03861676 294 296 O
utilized NCT03861676 297 305 O
) NCT03861676 306 307 O

- NCT03861676 311 312 O
International NCT03861676 314 327 B-Observation-Name___Observation-Type-Value:clinical-score
Prostate NCT03861676 328 336 I-Observation-Name___Observation-Type-Value:clinical-score
symptom NCT03861676 337 344 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03861676 345 350 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03861676 351 352 O
IPSS NCT03861676 353 357 B-Observation-Name
) NCT03861676 358 359 O
20 NCT03861676 361 363 B-Eq-Value
or NCT03861676 364 366 B-Eq-Operator___Eq-Operator-Value:LTEQ
less NCT03861676 367 371 I-Eq-Operator___Eq-Operator-Value:LTEQ

- NCT03861676 374 375 O
Ability NCT03861676 377 384 O
to NCT03861676 385 387 O
undergo NCT03861676 388 395 O
DCF NCT03861676 396 399 B-Procedure-Name
- NCT03861676 400 401 I-Procedure-Name
Pyl NCT03861676 402 405 I-Procedure-Name
PSMA NCT03861676 406 410 I-Procedure-Name
PET NCT03861676 411 414 I-Procedure-Name
as NCT03861676 415 417 O
part NCT03861676 418 422 O
of NCT03861676 423 425 O
pre NCT03861676 426 429 O
treatment NCT03861676 430 439 O
staging NCT03861676 440 447 O

- NCT03861676 450 451 O
Signed NCT03861676 453 459 O
study NCT03861676 460 465 O
- NCT03861676 466 467 O
specific NCT03861676 468 476 O
consent NCT03861676 477 484 O
form NCT03861676 485 489 O
prior NCT03861676 490 495 O
to NCT03861676 496 498 O
registration NCT03861676 499 511 O

Exclusion NCT03861676 512 521 O
Criteria NCT03861676 522 530 O
: NCT03861676 531 532 O

- NCT03861676 536 537 O
Prior NCT03861676 539 544 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03861676 545 552 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861676 553 555 O
pelvic NCT03861676 556 562 O
radiation NCT03861676 563 572 B-Procedure-Name
therapy NCT03861676 573 580 I-Procedure-Name

- NCT03861676 583 584 O
Major NCT03861676 586 591 B-Severity___Severity-Value:severe
medical NCT03861676 592 599 O
or NCT03861676 600 602 O
psychiatric NCT03861676 603 614 O
illness NCT03861676 615 622 B-Condition-Name
which NCT03861676 623 628 O
, NCT03861676 629 630 O
in NCT03861676 631 633 O
the NCT03861676 634 637 O
investigator NCT03861676 638 650 O
's NCT03861676 650 652 O
opinion NCT03861676 653 660 O
, NCT03861676 661 662 O
would NCT03861676 663 668 O
prevent NCT03861676 669 676 O
completion NCT03861676 677 687 O
of NCT03861676 688 690 O
treatment NCT03861676 691 700 O
and NCT03861676 701 704 O
would NCT03861676 705 710 O
interfere NCT03861676 711 720 B-Stability___Stability-Value:change
with NCT03861676 721 725 O
follow NCT03861676 726 732 O
up NCT03861676 733 735 O
. NCT03861676 736 737 O

- NCT03861676 741 742 O
Implanted NCT03861676 744 753 B-Procedure-Name
device NCT03861676 754 760 O
or NCT03861676 761 763 O
apparatus NCT03861676 764 773 O
which NCT03861676 774 779 O
obstruct NCT03861676 780 788 O
visibility NCT03861676 789 799 O
of NCT03861676 800 802 O
the NCT03861676 803 806 O
implanted NCT03861676 807 816 O
sources NCT03861676 817 824 O
on NCT03861676 825 827 O
fluoroscopy NCT03861676 828 839 B-Procedure-Name

- NCT03861676 842 843 O
Metallic NCT03861676 845 853 B-Procedure-Name
implants NCT03861676 854 862 I-Procedure-Name
, NCT03861676 863 864 O
claustrophobia NCT03861676 865 879 B-Condition-Name
not NCT03861676 880 883 O
amenable NCT03861676 884 892 O
to NCT03861676 893 895 O
medication NCT03861676 896 906 O
, NCT03861676 907 908 O
or NCT03861676 909 911 O
known NCT03861676 912 917 O
contraindications NCT03861676 918 935 O
to NCT03861676 936 938 O
undergoing NCT03861676 939 949 O
MR NCT03861676 950 952 B-Procedure-Name
scanning NCT03861676 953 961 I-Procedure-Name

- NCT03861676 964 965 O
History NCT03861676 967 974 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861676 975 977 O
other NCT03861676 978 983 O
malignancy NCT03861676 984 994 B-Condition-Name
diagnosed NCT03861676 995 1004 O
within NCT03861676 1005 1011 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861676 1012 1015 O
past NCT03861676 1016 1020 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03861676 1022 1023 B-Eq-Value
years NCT03861676 1024 1029 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Inclusion NCT03864068 0 9 O
Criteria NCT03864068 10 18 O
: NCT03864068 19 20 O

- NCT03864068 24 25 O
Women NCT03864068 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 33 37 O
chronic NCT03864068 38 45 O
anovulation NCT03864068 46 57 B-Condition-Name
or NCT03864068 58 60 O
oligomenorrhea NCT03864068 61 75 B-Condition-Name
defined NCT03864068 76 83 O
as NCT03864068 84 86 O
spontaneous NCT03864068 87 98 B-Condition-Name
intermenstrual NCT03864068 99 113 I-Condition-Name
periods NCT03864068 114 121 I-Condition-Name
of NCT03864068 122 124 O
greater NCT03864068 125 132 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03864068 133 137 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03864068 138 140 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03864068 141 146 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03864068 147 149 O
45 NCT03864068 151 153 B-Eq-Value
days NCT03864068 154 158 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
or NCT03864068 159 161 O
a NCT03864068 162 163 O
total NCT03864068 164 169 O
of NCT03864068 170 172 O
less NCT03864068 173 177 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03864068 178 182 I-Eq-Operator___Eq-Operator-Value:LT
or NCT03864068 183 185 B-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03864068 186 191 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03864068 192 194 O
8 NCT03864068 196 197 B-Eq-Value
menses NCT03864068 198 204 B-Observation-Name
per NCT03864068 205 208 O
year NCT03864068 209 213 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03864068 214 215 O

- NCT03864068 219 220 O
Women NCT03864068 222 227 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 228 232 O
Hyperandrogenism NCT03864068 233 249 B-Condition-Name
defined NCT03864068 250 257 O
as NCT03864068 258 260 O
a NCT03864068 261 262 O
total NCT03864068 263 268 B-Observation-Name___Observation-Type-Value:lab
testosterone NCT03864068 269 281 I-Observation-Name___Observation-Type-Value:lab
greater NCT03864068 282 289 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03864068 290 294 I-Eq-Operator___Eq-Operator-Value:GT
50 NCT03864068 296 298 B-Eq-Value
ng NCT03864068 299 301 B-Eq-Unit
/ NCT03864068 302 303 O
dL NCT03864068 304 306 B-Eq-Unit
or NCT03864068 307 309 O
a NCT03864068 310 311 O
free NCT03864068 312 316 B-Observation-Name___Observation-Type-Value:lab
androgen NCT03864068 317 325 I-Observation-Name___Observation-Type-Value:lab
index NCT03864068 326 331 I-Observation-Name___Observation-Type-Value:lab
greater NCT03864068 332 339 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03864068 340 344 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03864068 346 348 B-Eq-Value
. NCT03864068 348 349 O

- NCT03864068 353 354 O
Women NCT03864068 356 361 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 362 366 O
Polycystic NCT03864068 367 377 B-Condition-Name
Ovaries NCT03864068 378 385 I-Condition-Name
on NCT03864068 386 388 O
Ultrasound NCT03864068 389 399 B-Procedure-Name
defined NCT03864068 400 407 O
as NCT03864068 408 410 O
either NCT03864068 411 417 O
12 NCT03864068 419 421 B-Eq-Value
or NCT03864068 422 424 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03864068 425 429 I-Eq-Operator___Eq-Operator-Value:GTEQ
follicles NCT03864068 430 439 B-Observation-Name___Observation-Type-Value:measurement
measuring NCT03864068 440 449 I-Observation-Name___Observation-Type-Value:measurement
2 NCT03864068 451 452 B-Eq-Value
- NCT03864068 453 454 B-Eq-Operator___Eq-Operator-Value:BETWEEN
9 NCT03864068 456 457 B-Eq-Value
mm NCT03864068 458 460 B-Eq-Unit
in NCT03864068 461 463 O
diameter NCT03864068 464 472 O
or NCT03864068 473 475 O
increased NCT03864068 476 485 B-Polarity___Polarity-Value:high
ovarian NCT03864068 486 493 B-Observation-Name___Observation-Type-Value:measurement
volume NCT03864068 494 500 I-Observation-Name___Observation-Type-Value:measurement
greater NCT03864068 501 508 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03864068 509 513 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03864068 515 517 B-Eq-Value
cm NCT03864068 518 520 B-Eq-Unit
. NCT03864068 521 522 O

Exclusion NCT03864068 524 533 O
Criteria NCT03864068 534 542 O
: NCT03864068 543 544 O

- NCT03864068 548 549 O
Women NCT03864068 551 556 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 557 561 O
Hyperprolactinemia NCT03864068 562 580 B-Condition-Name
defined NCT03864068 581 588 O
as NCT03864068 589 591 O
2 NCT03864068 593 594 B-Eq-Value
prolactin NCT03864068 595 604 B-Observation-Name___Observation-Type-Value:lab
levels NCT03864068 605 611 I-Observation-Name___Observation-Type-Value:lab
at NCT03864068 612 614 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864068 615 620 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03864068 621 624 B-Eq-Value
week NCT03864068 625 629 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
apart NCT03864068 630 635 O
greater NCT03864068 636 643 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03864068 644 648 I-Eq-Operator___Eq-Operator-Value:GT
30 NCT03864068 650 652 B-Eq-Value
ng NCT03864068 653 655 B-Eq-Unit
/ NCT03864068 656 657 O
mL NCT03864068 658 660 B-Eq-Unit
. NCT03864068 661 662 I-Eq-Unit

- NCT03864068 666 667 O
Women NCT03864068 669 674 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 675 679 O
known NCT03864068 680 685 O
21 NCT03864068 687 689 B-Condition-Name
- NCT03864068 690 691 I-Condition-Name
hydroxylase NCT03864068 692 703 I-Condition-Name
deficiency NCT03864068 704 714 I-Condition-Name
or NCT03864068 715 717 O
other NCT03864068 718 723 O
enzyme NCT03864068 724 730 B-Condition-Name
deficiency NCT03864068 731 741 I-Condition-Name
leading NCT03864068 742 749 O
to NCT03864068 750 752 O
the NCT03864068 753 756 O
congenital NCT03864068 757 767 B-Condition-Name
adrenal NCT03864068 768 775 I-Condition-Name
hyperplasia NCT03864068 776 787 I-Condition-Name
. NCT03864068 788 789 O

- NCT03864068 793 794 O
Women NCT03864068 796 801 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 802 806 O
elevated NCT03864068 807 815 B-Polarity___Polarity-Value:high
FSH NCT03864068 816 819 B-Observation-Name___Observation-Type-Value:lab
levels NCT03864068 820 826 I-Observation-Name___Observation-Type-Value:lab
greater NCT03864068 827 834 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03864068 835 839 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03864068 841 843 B-Eq-Value
mIU NCT03864068 844 847 B-Eq-Unit
/ NCT03864068 848 849 O
mL NCT03864068 850 852 B-Eq-Unit
. NCT03864068 853 854 I-Eq-Unit

- NCT03864068 858 859 O
Women NCT03864068 861 866 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 867 871 O
uncorrected NCT03864068 872 883 O
thyroid NCT03864068 884 891 B-Condition-Name
disease NCT03864068 892 899 I-Condition-Name
as NCT03864068 900 902 O
per NCT03864068 903 906 O
ASRM NCT03864068 907 911 O
guidelines NCT03864068 912 922 O
for NCT03864068 923 926 O
nonpregnant NCT03864068 927 938 O
subjects NCT03864068 939 947 O
( NCT03864068 948 949 O
TSH NCT03864068 950 953 B-Observation-Name___Observation-Type-Value:lab
less NCT03864068 954 958 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03864068 959 963 I-Eq-Operator___Eq-Operator-Value:LT
0.45 NCT03864068 965 969 B-Eq-Value
mIU NCT03864068 970 973 B-Eq-Unit
/ NCT03864068 974 975 O
mL NCT03864068 976 978 B-Eq-Unit
or NCT03864068 979 981 O
greater NCT03864068 982 989 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03864068 990 994 I-Eq-Operator___Eq-Operator-Value:GT
4.5 NCT03864068 996 999 B-Eq-Value
MIU NCT03864068 1000 1003 B-Eq-Unit
/ NCT03864068 1004 1005 O
mL NCT03864068 1006 1008 B-Eq-Unit
) NCT03864068 1009 1010 O
. NCT03864068 1012 1013 O

- NCT03864068 1017 1018 O
Women NCT03864068 1020 1025 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 1026 1030 O
a NCT03864068 1031 1032 O
suspected NCT03864068 1033 1042 O
adrenal NCT03864068 1043 1050 O
or NCT03864068 1051 1053 O
ovarian NCT03864068 1054 1061 O
tumor NCT03864068 1062 1067 B-Condition-Name
secreting NCT03864068 1068 1077 O
androgens NCT03864068 1078 1087 O

- NCT03864068 1090 1091 O
Women NCT03864068 1093 1098 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 1099 1103 O
Cushing NCT03864068 1104 1111 B-Condition-Name
's NCT03864068 1111 1113 I-Condition-Name
syndrome NCT03864068 1114 1122 I-Condition-Name

- NCT03864068 1125 1126 O
Women NCT03864068 1128 1133 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
on NCT03864068 1134 1136 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
confounding NCT03864068 1137 1148 O
medications NCT03864068 1149 1160 O
which NCT03864068 1161 1166 O
affect NCT03864068 1167 1173 B-Stability___Stability-Value:change
ovarian NCT03864068 1174 1181 B-Condition-Name
function NCT03864068 1182 1190 I-Condition-Name
including NCT03864068 1191 1200 O
metformin NCT03864068 1201 1210 B-Drug-Name
, NCT03864068 1211 1212 O
hormonal NCT03864068 1213 1221 B-Drug-Name
contraceptives NCT03864068 1222 1236 I-Drug-Name
or NCT03864068 1237 1239 O
other NCT03864068 1240 1245 O
medications NCT03864068 1246 1257 O
for NCT03864068 1258 1261 O
type NCT03864068 1262 1266 B-Condition-Name
2 NCT03864068 1268 1269 I-Condition-Name
diabetes NCT03864068 1270 1278 I-Condition-Name

- NCT03864068 1281 1282 O
Women NCT03864068 1284 1289 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03864068 1290 1294 O
medical NCT03864068 1295 1302 O
conditions NCT03864068 1303 1313 O
that NCT03864068 1314 1318 O
are NCT03864068 1319 1322 O
contraindications NCT03864068 1323 1340 O
to NCT03864068 1341 1343 O
OTC NCT03864068 1344 1347 B-Drug-Name
inositol NCT03864068 1348 1356 I-Drug-Name
or NCT03864068 1357 1359 O
previous NCT03864068 1360 1368 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
allergic NCT03864068 1369 1377 O
reactions NCT03864068 1378 1387 O
to NCT03864068 1388 1390 O
the NCT03864068 1391 1394 O
supplement NCT03864068 1395 1405 O
or NCT03864068 1406 1408 O
to NCT03864068 1409 1411 O
the NCT03864068 1412 1415 O
placebo NCT03864068 1416 1423 B-Drug-Name
maltodextrin NCT03864068 1424 1436 I-Drug-Name
or NCT03864068 1437 1439 O
inulin NCT03864068 1440 1446 B-Drug-Name
. NCT03864068 1447 1448 O

Patient NCT03869216 0 7 O
Inclusion NCT03869216 8 17 O
Criteria NCT03869216 18 26 O
: NCT03869216 27 28 O

- NCT03869216 32 33 O
Receiving NCT03869216 35 44 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
care NCT03869216 45 49 O
at NCT03869216 50 52 O
the NCT03869216 53 56 O
clinical NCT03869216 57 65 B-Location___Location-Value:clinic
sites NCT03869216 66 71 I-Location___Location-Value:clinic

- NCT03869216 74 75 O
Identify NCT03869216 77 85 O
as NCT03869216 86 88 O
African NCT03869216 89 96 B-Ethnicity
American NCT03869216 97 105 I-Ethnicity
male NCT03869216 106 110 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03869216 113 114 O
Ages NCT03869216 116 120 O
40 NCT03869216 122 124 B-Eq-Value
- NCT03869216 125 126 B-Eq-Operator___Eq-Operator-Value:BETWEEN
69 NCT03869216 128 130 B-Eq-Value
years NCT03869216 131 136 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03869216 137 140 O

- NCT03869216 143 144 O
Provider NCT03869216 146 154 O
- NCT03869216 155 156 O
estimated NCT03869216 157 166 O
life NCT03869216 167 171 B-Observation-Name
expectancy NCT03869216 172 182 I-Observation-Name
of NCT03869216 183 185 O
at NCT03869216 186 188 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869216 189 194 I-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03869216 196 198 B-Eq-Value
years NCT03869216 199 204 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Patient NCT03869216 205 212 O
Exclusion NCT03869216 213 222 O
Criteria NCT03869216 223 231 O
: NCT03869216 232 233 O

- NCT03869216 237 238 O
Personal NCT03869216 240 248 O
history NCT03869216 249 256 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869216 257 259 O
prostate NCT03869216 260 268 O
cancer NCT03869216 269 275 B-Condition-Name
at NCT03869216 276 278 O
the NCT03869216 279 282 O
time NCT03869216 283 287 O
of NCT03869216 288 290 O
consent NCT03869216 291 298 O

- NCT03869216 301 302 O
Cognitive NCT03869216 304 313 B-Condition-Name
impairment NCT03869216 314 324 I-Condition-Name
that NCT03869216 325 329 O
would NCT03869216 330 335 O
interfere NCT03869216 336 345 B-Stability___Stability-Value:change
with NCT03869216 346 350 O
participation NCT03869216 351 364 O
in NCT03869216 365 367 O
the NCT03869216 368 371 O
study NCT03869216 372 377 O

- NCT03869216 380 381 O
Unable NCT03869216 383 389 O
to NCT03869216 390 392 O
complete NCT03869216 393 401 O
any NCT03869216 402 405 O
aspect NCT03869216 406 412 O
of NCT03869216 413 415 O
the NCT03869216 416 419 O
intervention NCT03869216 420 432 O
within NCT03869216 433 439 O
the NCT03869216 440 443 O
specified NCT03869216 444 453 O
time NCT03869216 454 458 O
limit NCT03869216 459 464 O

Inclusion NCT03861845 0 9 O
Criteria NCT03861845 10 18 O
: NCT03861845 19 20 O

- NCT03861845 24 25 O
18 NCT03861845 28 30 B-Eq-Value
years NCT03861845 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03861845 37 39 O
age NCT03861845 40 43 O
or NCT03861845 44 46 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03861845 47 52 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03861845 55 56 O
speak NCT03861845 58 63 O
English NCT03861845 64 71 B-Language

- NCT03861845 74 75 O
be NCT03861845 77 79 O
prescribed NCT03861845 80 90 O
to NCT03861845 91 93 O
take NCT03861845 94 98 O
two NCT03861845 99 102 B-Eq-Value
or NCT03861845 103 105 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03861845 106 110 I-Eq-Operator___Eq-Operator-Value:GTEQ
medications NCT03861845 111 122 O
per NCT03861845 123 126 O
day NCT03861845 127 130 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
, NCT03861845 131 132 O
and NCT03861845 133 136 O
manage NCT03861845 137 143 O
their NCT03861845 144 149 O
own NCT03861845 150 153 O
medications NCT03861845 154 165 O
. NCT03861845 166 167 O

Exclusion NCT03861845 169 178 O
Criteria NCT03861845 179 187 O
: NCT03861845 188 189 O

- NCT03861845 193 194 O
have NCT03861845 196 200 O
a NCT03861845 201 202 O
significant NCT03861845 203 214 B-Severity___Severity-Value:severe
cognitive NCT03861845 215 224 B-Condition-Name
impairment NCT03861845 225 235 I-Condition-Name

- NCT03861845 238 239 O
unwilling NCT03861845 241 250 O
to NCT03861845 251 253 O
use NCT03861845 254 257 O
a NCT03861845 258 259 O
novel NCT03861845 260 265 B-Procedure-Name
pillbox NCT03861845 266 273 I-Procedure-Name

- NCT03861845 276 277 O
unable NCT03861845 279 285 O
to NCT03861845 286 288 O
meet NCT03861845 289 293 O
with NCT03861845 294 298 O
the NCT03861845 299 302 O
research NCT03861845 303 311 O
team NCT03861845 312 316 O

Inclusion NCT03860597 0 9 O
Criteria NCT03860597 10 18 O
: NCT03860597 19 20 O

- NCT03860597 24 25 O
diagnosis NCT03860597 27 36 O
of NCT03860597 37 39 O
schizophrenia NCT03860597 40 53 B-Condition-Name
OR NCT03860597 54 56 O
schizoaffective NCT03860597 57 72 B-Condition-Name
- NCT03860597 73 74 I-Condition-Name
depressed NCT03860597 75 84 I-Condition-Name
OR NCT03860597 85 87 O
healthy NCT03860597 88 95 B-Condition-Name
subjects NCT03860597 96 104 O

- NCT03860597 107 108 O
ages NCT03860597 110 114 O
18 NCT03860597 116 118 B-Eq-Value
- NCT03860597 119 120 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03860597 122 124 B-Eq-Value
for NCT03860597 125 128 O
all NCT03860597 129 132 O
subjects NCT03860597 133 141 O

- NCT03860597 144 145 O
double NCT03860597 147 153 O
barrier NCT03860597 154 161 O
contraception NCT03860597 162 175 B-Procedure-Name
for NCT03860597 176 179 O
all NCT03860597 180 183 O
subjects NCT03860597 184 192 O

- NCT03860597 195 196 O
not NCT03860597 198 201 O
pregnant NCT03860597 202 210 B-Condition-Name
for NCT03860597 211 214 O
all NCT03860597 215 218 O
subjects NCT03860597 219 227 O

Exclusion NCT03860597 228 237 O
Criteria NCT03860597 238 246 O
: NCT03860597 247 248 O

- NCT03860597 252 253 O
DSM NCT03860597 255 258 B-Condition-Name
- NCT03860597 259 260 I-Condition-Name
IV NCT03860597 261 263 I-Condition-Name
Axis NCT03860597 264 268 I-Condition-Name
I NCT03860597 269 270 B-Eq-Value
or NCT03860597 271 273 O
II NCT03860597 274 276 B-Eq-Value
Diagnosis NCT03860597 277 286 O
for NCT03860597 287 290 O
for NCT03860597 291 294 O
healthy NCT03860597 295 302 B-Condition-Name
subjects NCT03860597 303 311 O

- NCT03860597 314 315 O
MEM NCT03860597 317 320 B-Condition-Name
or NCT03860597 321 323 O
amantadine NCT03860597 324 334 B-Drug-Name
for NCT03860597 335 338 O
patients NCT03860597 339 347 O

- NCT03860597 350 351 O
current NCT03860597 353 360 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03860597 361 370 B-Condition-Name
abuse NCT03860597 371 376 I-Condition-Name
for NCT03860597 377 380 O
all NCT03860597 381 384 O
subjects NCT03860597 385 393 O

- NCT03860597 396 397 O
current NCT03860597 399 406 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
recreational NCT03860597 407 419 B-Condition-Name
drug NCT03860597 420 424 I-Condition-Name
use NCT03860597 425 428 I-Condition-Name
for NCT03860597 429 432 O
all NCT03860597 433 436 O
subjects NCT03860597 437 445 O

- NCT03860597 448 449 O
history NCT03860597 451 458 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860597 459 461 O
other NCT03860597 462 467 O
significant NCT03860597 468 479 B-Severity___Severity-Value:severe
medical NCT03860597 480 487 B-Condition-Name
illness NCT03860597 488 495 I-Condition-Name
( NCT03860597 496 497 O
e NCT03860597 498 499 O
. NCT03860597 500 501 O
g NCT03860597 502 503 O
. NCT03860597 504 505 O
cancer NCT03860597 507 513 B-Condition-Name
, NCT03860597 514 515 O
diabetes NCT03860597 516 524 B-Condition-Name
, NCT03860597 525 526 O
heart NCT03860597 527 532 B-Condition-Name
disease NCT03860597 533 540 I-Condition-Name
, NCT03860597 541 542 O
HIV NCT03860597 543 546 B-Condition-Name
, NCT03860597 547 548 O
seizures NCT03860597 549 557 B-Condition-Name
) NCT03860597 558 559 O
for NCT03860597 560 563 O
all NCT03860597 564 567 O
subjects NCT03860597 568 576 O

- NCT03860597 579 580 O
open NCT03860597 582 586 O
head NCT03860597 587 591 O
injury NCT03860597 592 598 B-Condition-Name
or NCT03860597 599 601 O
closed NCT03860597 602 608 O
head NCT03860597 609 613 O
injury NCT03860597 614 620 B-Condition-Name
with NCT03860597 621 625 O
loss NCT03860597 626 630 B-Condition-Name
of NCT03860597 631 633 I-Condition-Name
consciousness NCT03860597 634 647 I-Condition-Name
> NCT03860597 648 649 B-Eq-Operator___Eq-Operator-Value:GT
1 NCT03860597 651 652 B-Eq-Value
min NCT03860597 653 656 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
for NCT03860597 657 660 O
all NCT03860597 661 664 O
subjects NCT03860597 665 673 O

- NCT03860597 676 677 O
hearing NCT03860597 679 686 O
or NCT03860597 687 689 O
visual NCT03860597 690 696 O
impairment NCT03860597 697 707 B-Condition-Name
for NCT03860597 708 711 O
all NCT03860597 712 715 O
subjects NCT03860597 716 724 O

- NCT03860597 727 728 O
pregnancy NCT03860597 730 739 B-Condition-Name
for NCT03860597 740 743 O
all NCT03860597 744 747 O
subjects NCT03860597 748 756 O

- NCT03860597 759 760 O
dementia NCT03860597 762 770 B-Condition-Name
for NCT03860597 771 774 O
all NCT03860597 775 778 O
subjects NCT03860597 779 787 O

- NCT03860597 790 791 O
mental NCT03860597 793 799 B-Condition-Name
retardation NCT03860597 800 811 I-Condition-Name
for NCT03860597 812 815 O
all NCT03860597 816 819 O
subjects NCT03860597 820 828 O

Inclusion NCT03861689 0 9 O
Criteria NCT03861689 10 18 O
: NCT03861689 19 20 O

- NCT03861689 24 25 O
Age NCT03861689 27 30 O
≥ NCT03861689 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03861689 34 36 B-Eq-Value
years NCT03861689 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861689 43 46 O

- NCT03861689 49 50 O
Confirmed NCT03861689 52 61 O
diagnosis NCT03861689 62 71 O
of NCT03861689 72 74 O
perianal NCT03861689 75 83 O
Crohn NCT03861689 84 89 B-Condition-Name
's NCT03861689 89 91 I-Condition-Name
disease NCT03861689 92 99 I-Condition-Name

- NCT03861689 102 103 O
On NCT03861689 105 107 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
biologics NCT03861689 108 117 B-Drug-Name
or NCT03861689 118 120 O
will NCT03861689 121 125 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
start NCT03861689 126 131 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
biologics NCT03861689 132 141 B-Drug-Name

Exclusion NCT03861689 142 151 O
Criteria NCT03861689 152 160 O
: NCT03861689 161 162 O

- NCT03861689 166 167 O
Patients NCT03861689 169 177 O
who NCT03861689 178 181 O
have NCT03861689 182 186 O
perianal NCT03861689 187 195 B-Condition-Name
fistula NCT03861689 196 203 I-Condition-Name
due NCT03861689 204 207 O
to NCT03861689 208 210 O
causes NCT03861689 211 217 O
other NCT03861689 218 223 O
than NCT03861689 224 228 O
Crohn NCT03861689 229 234 B-Condition-Name
's NCT03861689 234 236 I-Condition-Name
disease NCT03861689 237 244 I-Condition-Name

- NCT03861689 247 248 O
Fistulation NCT03861689 250 261 B-Condition-Name
into NCT03861689 262 266 O
other NCT03861689 267 272 O
organs NCT03861689 273 279 O
, NCT03861689 280 281 O
including NCT03861689 282 291 O
bladder NCT03861689 292 299 O
and NCT03861689 300 303 O
intestine NCT03861689 304 313 O

- NCT03861689 316 317 O
Patients NCT03861689 319 327 O
who NCT03861689 328 331 O
have NCT03861689 332 336 O
allergic NCT03861689 337 345 O
reaction NCT03861689 346 354 O
/ NCT03861689 355 356 O
contraindications NCT03861689 357 374 O
to NCT03861689 375 377 O
anti NCT03861689 378 382 B-Drug-Name
- NCT03861689 383 384 I-Drug-Name
TNF NCT03861689 385 388 I-Drug-Name

- NCT03861689 391 392 O
Patients NCT03861689 394 402 O
who NCT03861689 403 406 O
have NCT03861689 407 411 O
active NCT03861689 412 418 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cancer NCT03861689 419 425 B-Condition-Name

- NCT03861689 428 429 O
Patients NCT03861689 431 439 O
who NCT03861689 440 443 O
have NCT03861689 444 448 O
contraindications NCT03861689 449 466 O
for NCT03861689 467 470 O
MRI NCT03861689 471 474 B-Procedure-Name

- NCT03861689 477 478 O
Known NCT03861689 480 485 O
pregnancy NCT03861689 486 495 B-Condition-Name

For NCT03861689 496 499 O
patients NCT03861689 500 508 O
who NCT03861689 509 512 O
refuse NCT03861689 513 519 O
to NCT03861689 520 522 O
participate NCT03861689 523 534 O
in NCT03861689 535 537 O
the NCT03861689 538 541 O
tight NCT03861689 542 547 O
monitoring NCT03861689 548 558 O
arm NCT03861689 559 562 O
, NCT03861689 563 564 O
they NCT03861689 565 569 O
will NCT03861689 570 574 O
be NCT03861689 575 577 O
consented NCT03861689 578 587 O
and NCT03861689 588 591 O
recruited NCT03861689 592 601 O
to NCT03861689 602 604 O
the NCT03861689 605 608 O
control NCT03861689 609 616 O
arm NCT03861689 617 620 O
for NCT03861689 621 624 O
comparison NCT03861689 625 635 O
. NCT03861689 636 637 O


Inclusion NCT03865160 0 9 O
Criteria NCT03865160 10 18 O
: NCT03865160 19 20 O

- NCT03865160 24 25 O
Children NCT03865160 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
aged NCT03865160 36 40 O
6 NCT03865160 42 43 B-Eq-Value
- NCT03865160 44 45 B-Eq-Operator___Eq-Operator-Value:BETWEEN
11 NCT03865160 47 49 B-Eq-Value
years NCT03865160 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
with NCT03865160 56 60 O
- NCT03865160 61 62 B-Eq-Value
1 NCT03865160 64 65 I-Eq-Value
- NCT03865160 66 67 O
to NCT03865160 68 70 B-Eq-Operator___Eq-Operator-Value:BETWEEN
- NCT03865160 71 72 B-Eq-Value
10 NCT03865160 74 76 I-Eq-Value
diopters NCT03865160 77 85 B-Eq-Unit
( NCT03865160 86 87 O
D NCT03865160 88 89 B-Eq-Unit
) NCT03865160 90 91 O
myopia NCT03865160 92 98 B-Condition-Name

Exclusion NCT03865160 99 108 O
Criteria NCT03865160 109 117 O
: NCT03865160 118 119 O

- NCT03865160 123 124 O
Any NCT03865160 126 129 O
organic NCT03865160 130 137 B-Condition-Name
eye NCT03865160 138 141 I-Condition-Name
disease NCT03865160 142 149 I-Condition-Name
, NCT03865160 150 151 O
strabismus NCT03865160 152 162 B-Condition-Name
, NCT03865160 163 164 O
astigmatism NCT03865160 165 176 B-Condition-Name
and NCT03865160 177 180 O
/ NCT03865160 181 182 O
or NCT03865160 183 185 O
anisometropia NCT03865160 186 199 B-Condition-Name
> NCT03865160 200 201 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03865160 203 206 B-Eq-Value
D NCT03865160 207 208 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
, NCT03865160 209 210 O
prematurity NCT03865160 211 222 B-Condition-Name
, NCT03865160 223 224 O
use NCT03865160 225 228 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03865160 229 231 O
mono NCT03865160 232 236 O
- NCT03865160 237 238 O
/ NCT03865160 239 240 O
multifocal NCT03865160 241 251 O
contact NCT03865160 252 259 B-Procedure-Name
lenses NCT03865160 260 266 I-Procedure-Name
, NCT03865160 267 268 O
pre NCT03865160 269 272 O
- NCT03865160 273 274 O
treatment NCT03865160 275 284 O
with NCT03865160 285 289 O
atropine NCT03865160 290 298 B-Drug-Name

Inclusion NCT03861312 0 9 O
Criteria NCT03861312 10 18 O
: NCT03861312 19 20 O

- NCT03861312 24 25 O
The NCT03861312 27 30 O
inclusion NCT03861312 31 40 O
criteria NCT03861312 41 49 O
were NCT03861312 50 54 O
as NCT03861312 55 57 O
follows NCT03861312 58 65 O
: NCT03861312 66 67 O
a NCT03861312 68 69 O
) NCT03861312 70 71 O
men NCT03861312 72 75 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03861312 76 79 O
women NCT03861312 80 85 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
aged NCT03861312 86 90 O
between NCT03861312 91 98 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03861312 100 102 B-Eq-Value
- NCT03861312 103 104 O
and NCT03861312 105 108 O
65 NCT03861312 110 112 B-Eq-Value
- NCT03861312 113 114 O
years NCT03861312 115 120 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
b NCT03861312 121 122 O
) NCT03861312 123 124 O
medical NCT03861312 125 132 O
diagnosis NCT03861312 133 142 O
of NCT03861312 143 145 O
Non NCT03861312 146 149 O
- NCT03861312 150 151 O
Specific NCT03861312 152 160 O
Chronic NCT03861312 161 168 O
Neck NCT03861312 169 173 O
Pain NCT03861312 174 178 B-Condition-Name
with NCT03861312 179 183 O
more NCT03861312 184 188 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03861312 189 193 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03861312 195 196 B-Eq-Value
months NCT03861312 197 203 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03861312 204 206 O
evolution NCT03861312 207 216 O
of NCT03861312 217 219 O
neck NCT03861312 220 224 O
pain NCT03861312 225 229 B-Condition-Name
. NCT03861312 230 231 O

Exclusion NCT03861312 233 242 O
Criteria NCT03861312 243 251 O
: NCT03861312 252 253 O

- NCT03861312 257 258 O
Exclusion NCT03861312 260 269 O
criteria NCT03861312 270 278 O
included NCT03861312 279 287 O
the NCT03861312 288 291 O
following NCT03861312 292 301 O
: NCT03861312 302 303 O
a NCT03861312 304 305 O
) NCT03861312 306 307 O
patients NCT03861312 308 316 O
with NCT03861312 317 321 O
rheumatic NCT03861312 322 331 B-Condition-Name
diseases NCT03861312 332 340 I-Condition-Name
, NCT03861312 341 342 O
cervical NCT03861312 343 351 B-Condition-Name
hernia NCT03861312 352 358 I-Condition-Name
, NCT03861312 359 360 O
cervical NCT03861312 361 369 B-Condition-Name
whiplash NCT03861312 370 378 I-Condition-Name
syndrome NCT03861312 379 387 I-Condition-Name
, NCT03861312 388 389 O
neck NCT03861312 390 394 O
surgeries NCT03861312 395 404 B-Procedure-Name
or NCT03861312 405 407 O
history NCT03861312 408 415 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861312 416 418 O
arthrodesis NCT03861312 419 430 B-Procedure-Name
, NCT03861312 431 432 O
b NCT03861312 433 434 O
) NCT03861312 435 436 O
systemic NCT03861312 437 445 O
diseases NCT03861312 446 454 B-Condition-Name
, NCT03861312 455 456 O
c NCT03861312 457 458 O
) NCT03861312 459 460 O
vision NCT03861312 461 467 O
, NCT03861312 468 469 O
hearing NCT03861312 470 477 O
or NCT03861312 478 480 O
vestibular NCT03861312 481 491 O
problems NCT03861312 492 500 B-Condition-Name
, NCT03861312 501 502 O
d NCT03861312 503 504 O
) NCT03861312 505 506 O
Severe NCT03861312 507 513 B-Severity___Severity-Value:severe
trauma NCT03861312 514 520 B-Condition-Name
or NCT03861312 521 523 O
traffic NCT03861312 524 531 B-Condition-Name
accident NCT03861312 532 540 I-Condition-Name
which NCT03861312 541 546 O
has NCT03861312 547 550 O
had NCT03861312 551 554 O
an NCT03861312 555 557 O
impact NCT03861312 558 564 B-Stability___Stability-Value:change
on NCT03861312 565 567 O
the NCT03861312 568 571 O
cervical NCT03861312 572 580 O
area NCT03861312 581 585 O
. NCT03861312 586 587 O

Inclusion NCT03869996 0 9 O
Criteria NCT03869996 10 18 O
: NCT03869996 19 20 O

- NCT03869996 24 25 O
patients NCT03869996 27 35 O
affected NCT03869996 36 44 O
by NCT03869996 45 47 O
knee NCT03869996 48 52 O
osteoarthritis NCT03869996 53 67 B-Condition-Name
, NCT03869996 68 69 O
eligible NCT03869996 70 78 O
for NCT03869996 79 82 O
primary NCT03869996 83 90 O
total NCT03869996 91 96 B-Procedure-Name
knee NCT03869996 97 101 I-Procedure-Name
arthroplasty NCT03869996 102 114 I-Procedure-Name

- NCT03869996 117 118 O
BMI NCT03869996 120 123 B-Observation-Name___Observation-Type-Value:vital
< NCT03869996 124 125 B-Eq-Operator___Eq-Operator-Value:LT
32 NCT03869996 127 129 B-Eq-Value

- NCT03869996 133 134 O
Time NCT03869996 136 140 B-Observation-Name
up NCT03869996 141 143 I-Observation-Name
ang NCT03869996 144 147 I-Observation-Name
go NCT03869996 148 150 I-Observation-Name
test NCT03869996 151 155 I-Observation-Name
< NCT03869996 156 157 B-Eq-Operator___Eq-Operator-Value:LTEQ
/ NCT03869996 159 160 I-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03869996 162 163 I-Eq-Operator___Eq-Operator-Value:LTEQ
12 NCT03869996 165 167 B-Eq-Value
seconds NCT03869996 168 175 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:second

- NCT03869996 178 179 O
American NCT03869996 181 189 B-Condition-Name
Society NCT03869996 190 197 I-Condition-Name
of NCT03869996 198 200 I-Condition-Name
Anesthesiologists NCT03869996 201 218 I-Condition-Name
physical NCT03869996 219 227 O
status NCT03869996 228 234 O
classification NCT03869996 235 249 O
system NCT03869996 250 256 O
( NCT03869996 257 258 O
ASA NCT03869996 259 262 B-Condition-Name
) NCT03869996 263 264 O
< NCT03869996 265 266 B-Eq-Operator___Eq-Operator-Value:LTEQ
/ NCT03869996 268 269 I-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03869996 271 272 I-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03869996 274 275 B-Eq-Value

- NCT03869996 279 280 O
pre NCT03869996 282 285 O
operative NCT03869996 286 295 B-Procedure-Name
hemoglobin NCT03869996 296 306 B-Observation-Name___Observation-Type-Value:lab
( NCT03869996 307 308 O
HB NCT03869996 309 311 B-Observation-Name
) NCT03869996 312 313 O
> NCT03869996 314 315 B-Eq-Operator___Eq-Operator-Value:GT
13 NCT03869996 317 319 B-Eq-Value
g NCT03869996 320 321 B-Eq-Unit
/ NCT03869996 322 323 O
dl NCT03869996 324 326 B-Eq-Unit

- NCT03869996 329 330 O
patients NCT03869996 332 340 O
eligible NCT03869996 341 349 O
for NCT03869996 350 353 O
spinal NCT03869996 354 360 B-Procedure-Name
anesthesia NCT03869996 361 371 I-Procedure-Name

- NCT03869996 374 375 O
presence NCT03869996 377 385 O
of NCT03869996 386 388 O
a NCT03869996 389 390 O
care NCT03869996 391 395 O
- NCT03869996 396 397 O
giver NCT03869996 398 403 O

Exclusion NCT03869996 404 413 O
Criteria NCT03869996 414 422 O
: NCT03869996 423 424 O

- NCT03869996 428 429 O
psychiatric NCT03869996 431 442 B-Condition-Name
diseases NCT03869996 443 451 I-Condition-Name

- NCT03869996 454 455 O
pre NCT03869996 457 460 O
operative NCT03869996 461 470 B-Procedure-Name
use NCT03869996 471 474 O
of NCT03869996 475 477 O
crutches NCT03869996 478 486 B-Procedure-Name

- NCT03869996 489 490 O
ASA NCT03869996 492 495 B-Condition-Name
> NCT03869996 496 497 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03869996 499 500 B-Eq-Value

- NCT03869996 504 505 O
pre NCT03869996 507 510 O
operative NCT03869996 511 520 B-Procedure-Name
HB NCT03869996 521 523 B-Observation-Name___Observation-Type-Value:lab
< NCT03869996 524 525 B-Eq-Operator___Eq-Operator-Value:LT
13 NCT03869996 527 529 B-Eq-Value
g NCT03869996 530 531 B-Eq-Unit
/ NCT03869996 532 533 O
dl NCT03869996 534 536 B-Eq-Unit

Inclusion NCT03864874 0 9 O
Criteria NCT03864874 10 18 O
: NCT03864874 19 20 O

- NCT03864874 24 25 O
Patient NCT03864874 27 34 O
candidate NCT03864874 35 44 O
to NCT03864874 45 47 O
pulmonary NCT03864874 48 57 B-Procedure-Name
metastasectomy NCT03864874 58 72 I-Procedure-Name
with NCT03864874 73 77 O
curative NCT03864874 78 86 O
intent NCT03864874 87 93 O
by NCT03864874 94 96 O
mean NCT03864874 97 101 O
of NCT03864874 102 104 O
both NCT03864874 105 109 O
major NCT03864874 110 115 B-Severity___Severity-Value:severe
anatomical NCT03864874 116 126 O
or NCT03864874 127 129 O
limited NCT03864874 130 137 O
resection NCT03864874 138 147 B-Procedure-Name
; NCT03864874 147 148 O

- NCT03864874 151 152 O
Age NCT03864874 154 157 O
> NCT03864874 158 159 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03864874 161 163 B-Eq-Value
years NCT03864874 164 169 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03864874 170 171 O

Exclusion NCT03864874 173 182 O
Criteria NCT03864874 183 191 O
: NCT03864874 192 193 O

- NCT03864874 197 198 O
Patients NCT03864874 200 208 O
with NCT03864874 209 213 O
widespread NCT03864874 214 224 B-Severity___Severity-Value:severe
metastatic NCT03864874 225 235 B-Condition-Name
disease NCT03864874 236 243 I-Condition-Name
where NCT03864874 244 249 O
surgical NCT03864874 250 258 B-Procedure-Name
resection NCT03864874 259 268 I-Procedure-Name
is NCT03864874 269 271 O
performed NCT03864874 272 281 O
only NCT03864874 282 286 O
for NCT03864874 287 290 O
diagnostic NCT03864874 291 301 O
purposes NCT03864874 302 310 O
; NCT03864874 310 311 O

- NCT03864874 314 315 O
History NCT03864874 317 324 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864874 325 327 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
previous NCT03864874 328 336 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
intrapleural NCT03864874 337 349 B-Procedure-Name
talc NCT03864874 350 354 I-Procedure-Name
injection NCT03864874 355 364 I-Procedure-Name
; NCT03864874 364 365 O

- NCT03864874 368 369 O
Any NCT03864874 371 374 O
anatomical NCT03864874 375 385 O
or NCT03864874 386 388 O
pathological NCT03864874 389 401 O
condition NCT03864874 402 411 B-Condition-Name
( NCT03864874 412 413 O
eg NCT03864874 414 416 O
. NCT03864874 417 418 O
diffuse NCT03864874 420 427 B-Condition-Name
adhesions NCT03864874 428 437 I-Condition-Name
, NCT03864874 438 439 O
severe NCT03864874 440 446 B-Severity___Severity-Value:severe
emphysema NCT03864874 447 456 B-Condition-Name
) NCT03864874 457 458 O
that NCT03864874 459 463 O
may NCT03864874 464 467 O
interfere NCT03864874 468 477 B-Stability___Stability-Value:change
with NCT03864874 478 482 O
execution NCT03864874 483 492 O
of NCT03864874 493 495 O
ultrasonographic NCT03864874 496 512 B-Procedure-Name
investigation NCT03864874 513 526 I-Procedure-Name
; NCT03864874 526 527 O

- NCT03864874 530 531 O
Incomplete NCT03864874 533 543 O
lung NCT03864874 544 548 B-Condition-Name
exclusion NCT03864874 549 558 I-Condition-Name
during NCT03864874 559 565 O
surgical NCT03864874 566 574 B-Procedure-Name
procedure NCT03864874 575 584 I-Procedure-Name
. NCT03864874 585 586 O

Inclusion NCT03869411 0 9 O
Criteria NCT03869411 10 18 O
: NCT03869411 19 20 O

- NCT03869411 24 25 O
Diabetes NCT03869411 27 35 O
group NCT03869411 36 41 O
: NCT03869411 42 43 O
1 NCT03869411 45 46 O
) NCT03869411 47 48 O
Age NCT03869411 49 52 O
between NCT03869411 53 60 B-Eq-Operator___Eq-Operator-Value:BETWEEN
30 NCT03869411 62 64 B-Eq-Value
- NCT03869411 65 66 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03869411 68 70 B-Eq-Value
years NCT03869411 71 76 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869411 77 79 O
old NCT03869411 80 83 O
, NCT03869411 84 85 O
2 NCT03869411 87 88 O
) NCT03869411 89 90 O
type NCT03869411 91 95 O
2 NCT03869411 97 98 O
diabetes NCT03869411 99 107 B-Condition-Name
. NCT03869411 108 109 O

- NCT03869411 113 114 O
Healthy NCT03869411 116 123 B-Condition-Name
control NCT03869411 124 131 O
group NCT03869411 132 137 O
: NCT03869411 138 139 O
1 NCT03869411 141 142 O
) NCT03869411 143 144 O
Age NCT03869411 145 148 O
between NCT03869411 149 156 B-Eq-Operator___Eq-Operator-Value:BETWEEN
30 NCT03869411 158 160 B-Eq-Value
- NCT03869411 161 162 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03869411 164 166 B-Eq-Value
years NCT03869411 167 172 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869411 173 175 O
old NCT03869411 176 179 O
, NCT03869411 180 181 O
2 NCT03869411 183 184 O
) NCT03869411 185 186 O
without NCT03869411 187 194 O
diabetes NCT03869411 195 203 B-Condition-Name

Exclusion NCT03869411 204 213 O
Criteria NCT03869411 214 222 O
: NCT03869411 223 224 O

- NCT03869411 228 229 O
history NCT03869411 231 238 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869411 239 241 O
moderate NCT03869411 242 250 B-Severity___Severity-Value:moderate
- NCT03869411 251 252 O
severe NCT03869411 253 259 B-Severity___Severity-Value:severe
somatic NCT03869411 260 267 O
or NCT03869411 268 270 O
autonomic NCT03869411 271 280 O
neuropathy NCT03869411 281 291 B-Condition-Name
, NCT03869411 292 293 O
cardiovascular NCT03869411 294 308 B-Condition-Name
disease NCT03869411 309 316 I-Condition-Name
, NCT03869411 317 318 O
preproliferative NCT03869411 319 335 O
or NCT03869411 336 338 O
proliferative NCT03869411 339 352 O
retinopathy NCT03869411 353 364 B-Condition-Name
, NCT03869411 365 366 O
and NCT03869411 367 370 O
chronic NCT03869411 371 378 O
renal NCT03869411 379 384 B-Condition-Name
failure NCT03869411 385 392 I-Condition-Name

- NCT03869411 395 396 O
unable NCT03869411 398 404 O
to NCT03869411 405 407 O
perform NCT03869411 408 415 O
the NCT03869411 416 419 O
programs NCT03869411 420 428 O
or NCT03869411 429 431 O
assessments NCT03869411 432 443 O

- NCT03869411 446 447 O
other NCT03869411 449 454 O
systematic NCT03869411 455 465 O
diseases NCT03869411 466 474 B-Condition-Name

1 NCT03866044 1 2 O
. NCT03866044 2 3 O
Parkinson NCT03866044 5 14 B-Condition-Name
's NCT03866044 14 16 I-Condition-Name
Disease NCT03866044 17 24 I-Condition-Name
( NCT03866044 25 26 O
PD NCT03866044 27 29 B-Condition-Name
) NCT03866044 30 31 O
group NCT03866044 32 37 O
Inclusion NCT03866044 38 47 O
criteria NCT03866044 48 56 O
: NCT03866044 57 58 O

- NCT03866044 67 68 O
Aged NCT03866044 70 74 O
18 NCT03866044 76 78 B-Eq-Value
or NCT03866044 79 81 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03866044 82 86 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03866044 87 88 O

- NCT03866044 97 98 O
Clinically NCT03866044 100 110 O
established NCT03866044 111 122 O
or NCT03866044 123 125 O
probable NCT03866044 126 134 O
PD NCT03866044 135 137 B-Condition-Name
according NCT03866044 138 147 O
to NCT03866044 148 150 O
the NCT03866044 151 154 O
Movement NCT03866044 155 163 O
Disorder NCT03866044 164 172 O
Society NCT03866044 173 180 O
Clinical NCT03866044 181 189 O
Diagnostic NCT03866044 190 200 O
Criteria NCT03866044 201 209 O
for NCT03866044 210 213 O
Parkinson NCT03866044 214 223 O
's NCT03866044 223 225 O
Disease NCT03866044 226 233 O

- NCT03866044 241 242 O
Signed NCT03866044 244 250 O
informed NCT03866044 251 259 O
consent NCT03866044 260 267 O
Exclusion NCT03866044 268 277 O
criteria NCT03866044 278 286 O
: NCT03866044 287 288 O

- NCT03866044 297 298 O
Pregnancy NCT03866044 300 309 B-Condition-Name
or NCT03866044 310 312 O
breastfeeding NCT03866044 313 326 B-Condition-Name

- NCT03866044 334 335 O
History NCT03866044 337 344 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866044 345 347 O
other NCT03866044 348 353 O
neurologic NCT03866044 354 364 O
or NCT03866044 365 367 O
psychiatric NCT03866044 368 379 O
disease NCT03866044 380 387 B-Condition-Name

- NCT03866044 395 396 O
Pacemaker NCT03866044 398 407 B-Procedure-Name
or NCT03866044 408 410 O
other NCT03866044 411 416 O
implanted NCT03866044 417 426 B-Procedure-Name
electronic NCT03866044 427 437 I-Procedure-Name
devices NCT03866044 438 445 I-Procedure-Name

- NCT03866044 453 454 O
Claustrophobia NCT03866044 456 470 B-Condition-Name

2 NCT03866044 474 475 O
. NCT03866044 475 476 O
Healthy NCT03866044 478 485 B-Condition-Name
participants NCT03866044 486 498 O
age NCT03866044 499 502 O
- NCT03866044 503 504 O
and NCT03866044 505 508 O
sex NCT03866044 509 512 O
- NCT03866044 513 514 O
matched NCT03866044 515 522 O
to NCT03866044 523 525 O
the NCT03866044 526 529 O
PD NCT03866044 530 532 B-Condition-Name
group NCT03866044 533 538 O
: NCT03866044 539 540 O

Inclusion NCT03866044 542 551 O
criteria NCT03866044 552 560 O
: NCT03866044 561 562 O

- NCT03866044 566 567 O
Age NCT03866044 569 572 O
- NCT03866044 573 574 O
and NCT03866044 575 578 O
sex NCT03866044 579 582 O
- NCT03866044 583 584 O
matched NCT03866044 585 592 O
to NCT03866044 593 595 O
PD NCT03866044 596 598 B-Condition-Name
group NCT03866044 599 604 O
( NCT03866044 605 606 O
aged NCT03866044 607 611 O
18 NCT03866044 613 615 B-Eq-Value
or NCT03866044 616 618 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03866044 619 623 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03866044 624 625 O

- NCT03866044 629 630 O
Signed NCT03866044 632 638 O
informed NCT03866044 639 647 O
consent NCT03866044 648 655 O

Exclusion NCT03866044 656 665 O
criteria NCT03866044 666 674 O
: NCT03866044 675 676 O

- NCT03866044 680 681 O
Pregnancy NCT03866044 683 692 B-Condition-Name
or NCT03866044 693 695 O
breastfeeding NCT03866044 696 709 B-Condition-Name

- NCT03866044 712 713 O
History NCT03866044 715 722 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866044 723 725 O
neurologic NCT03866044 726 736 O
or NCT03866044 737 739 O
psychiatric NCT03866044 740 751 O
disease NCT03866044 752 759 B-Condition-Name

- NCT03866044 762 763 O
Pacemaker NCT03866044 765 774 B-Procedure-Name
or NCT03866044 775 777 O
other NCT03866044 778 783 O
implanted NCT03866044 784 793 B-Procedure-Name
electronic NCT03866044 794 804 I-Procedure-Name
devices NCT03866044 805 812 I-Procedure-Name

- NCT03866044 815 816 O
Claustrophobia NCT03866044 818 832 B-Condition-Name

Inclusion NCT03864653 0 9 O
Criteria NCT03864653 10 18 O
: NCT03864653 19 20 O

- NCT03864653 24 25 O
Currently NCT03864653 27 36 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
enrolled NCT03864653 37 45 O
within NCT03864653 46 52 O
the NCT03864653 53 56 O
" NCT03864653 57 58 O
Getting NCT03864653 58 65 O
Off NCT03864653 66 69 O
" NCT03864653 69 70 O
( NCT03864653 71 72 O
AKA NCT03864653 73 76 O
, NCT03864653 77 78 O
" NCT03864653 79 80 O
Friends NCT03864653 80 87 O
Getting NCT03864653 88 95 O
Off NCT03864653 96 99 O
" NCT03864653 99 100 O
) NCT03864653 101 102 O
outpatient NCT03864653 103 113 B-Encounter-Type___Encounter-Type-Value:outpatient
methamphetamine NCT03864653 114 129 B-Drug-Name
treatment NCT03864653 130 139 B-Procedure-Name
program NCT03864653 140 147 I-Procedure-Name
at NCT03864653 148 150 O
Friends NCT03864653 151 158 O
Community NCT03864653 159 168 O
Center NCT03864653 169 175 O
, NCT03864653 176 177 O
Los NCT03864653 178 181 B-Location___Location-Value:residence
Angeles NCT03864653 182 189 I-Location___Location-Value:residence
, NCT03864653 190 191 I-Location___Location-Value:residence
CA NCT03864653 192 194 I-Location___Location-Value:residence
, NCT03864653 195 196 I-Location___Location-Value:residence
USA NCT03864653 197 200 I-Location___Location-Value:residence
. NCT03864653 201 202 O

- NCT03864653 206 207 O
and NCT03864653 209 212 O
; NCT03864653 212 213 O
within NCT03864653 214 220 B-Eq-Operator___Eq-Operator-Value:LTEQ
two NCT03864653 221 224 B-Eq-Value
weeks NCT03864653 225 230 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03864653 231 233 O
initial NCT03864653 234 241 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
enrollment NCT03864653 242 252 O
into NCT03864653 253 257 O
the NCT03864653 258 261 O
" NCT03864653 262 263 O
Getting NCT03864653 263 270 O
Off NCT03864653 271 274 O
" NCT03864653 274 275 O
program NCT03864653 276 283 O
. NCT03864653 284 285 O

Exclusion NCT03864653 287 296 O
Criteria NCT03864653 297 305 O
: NCT03864653 306 307 O

- NCT03864653 311 312 O
Not NCT03864653 314 317 O
currently NCT03864653 318 327 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
enrolled NCT03864653 328 336 O
within NCT03864653 337 343 O
the NCT03864653 344 347 O
" NCT03864653 348 349 O
Getting NCT03864653 349 356 O
Off NCT03864653 357 360 O
" NCT03864653 360 361 O
program NCT03864653 362 369 O
. NCT03864653 370 371 O

- NCT03864653 375 376 O
or NCT03864653 378 380 O
; NCT03864653 380 381 O
more NCT03864653 382 386 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03864653 387 391 I-Eq-Operator___Eq-Operator-Value:GT
two NCT03864653 392 395 B-Eq-Value
weeks NCT03864653 396 401 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
post NCT03864653 402 406 O
- NCT03864653 407 408 O
enrollment NCT03864653 409 419 O
in NCT03864653 420 422 O
the NCT03864653 423 426 O
" NCT03864653 427 428 O
Getting NCT03864653 428 435 O
Off NCT03864653 436 439 O
" NCT03864653 439 440 O
program NCT03864653 441 448 O
. NCT03864653 449 450 O

Inclusion NCT03861065 0 9 O
Criteria NCT03861065 10 18 O
: NCT03861065 19 20 O

- NCT03861065 24 25 O
Patients NCT03861065 27 35 O
with NCT03861065 36 40 O
high NCT03861065 41 45 B-Polarity___Polarity-Value:high
risk NCT03861065 46 50 O
class NCT03861065 51 56 B-Eq-Unit
II NCT03861065 57 59 B-Eq-Value
, NCT03861065 60 61 O
class NCT03861065 62 67 B-Eq-Unit
III NCT03861065 68 71 B-Eq-Value
, NCT03861065 72 73 O
class NCT03861065 74 79 B-Eq-Unit
IV NCT03861065 80 82 B-Eq-Value
abdominal NCT03861065 83 92 O
wounds NCT03861065 93 99 B-Condition-Name

- NCT03861065 102 103 O
Undergoing NCT03861065 105 115 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
laparotomy NCT03861065 116 126 B-Procedure-Name
for NCT03861065 127 130 O
gynecologic NCT03861065 131 142 B-Condition-Name
related NCT03861065 143 150 I-Condition-Name
disorders NCT03861065 151 160 I-Condition-Name

- NCT03861065 163 164 O
Patients NCT03861065 166 174 O
undergoing NCT03861065 175 185 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
laparotomy NCT03861065 186 196 B-Procedure-Name
for NCT03861065 197 200 O
both NCT03861065 201 205 O
benign NCT03861065 206 212 O
and NCT03861065 213 216 O
malignant NCT03861065 217 226 O
diagnoses NCT03861065 227 236 B-Condition-Name
will NCT03861065 237 241 O
be NCT03861065 242 244 O
included NCT03861065 245 253 O
in NCT03861065 254 256 O
this NCT03861065 257 261 O
study NCT03861065 262 267 O

Exclusion NCT03861065 268 277 O
Criteria NCT03861065 278 286 O
: NCT03861065 287 288 O

- NCT03861065 292 293 O
Pregnancy NCT03861065 295 304 B-Condition-Name

- NCT03861065 307 308 O
Allergy NCT03861065 310 317 O
to NCT03861065 318 320 O
triclosan NCT03861065 321 330 B-Drug-Name

- NCT03861065 333 334 O
Patients NCT03861065 336 344 O
undergoing NCT03861065 345 355 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
HIPEC NCT03861065 356 361 B-Procedure-Name

Inclusion NCT03866291 0 9 O
Criteria NCT03866291 10 18 O
: NCT03866291 19 20 O

- NCT03866291 24 25 O
Travellers NCT03866291 27 37 O
diarrhoea NCT03866291 38 47 B-Condition-Name

- NCT03866291 50 51 O
foreign NCT03866291 53 60 B-Location___Location-Value:residence
traveller NCT03866291 61 70 O

Exclusion NCT03866291 71 80 O
Criteria NCT03866291 81 89 O
: NCT03866291 90 91 O

- NCT03866291 95 96 O
foreign NCT03866291 98 105 B-Location___Location-Value:residence
traveller NCT03866291 106 115 O
but NCT03866291 116 119 O
no NCT03866291 120 122 O
symptoms NCT03866291 123 131 O

Inclusion NCT03867825 0 9 O
Criteria NCT03867825 10 18 O
: NCT03867825 19 20 O

- NCT03867825 24 25 O
Newborn NCT03867825 27 34 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
infants NCT03867825 35 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant

Exclusion NCT03867825 43 52 O
Criteria NCT03867825 53 61 O
: NCT03867825 62 63 O

- NCT03867825 67 68 O
Infants NCT03867825 70 77 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
> NCT03867825 78 79 B-Eq-Operator___Eq-Operator-Value:GT
1 NCT03867825 81 82 B-Eq-Value
month NCT03867825 83 88 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03867825 89 91 O
age NCT03867825 92 95 O

Inclusion NCT03868280 0 9 O
Criteria NCT03868280 10 18 O
: NCT03868280 19 20 O

- NCT03868280 24 25 O
Mid NCT03868280 27 30 O
shaft NCT03868280 31 36 O
or NCT03868280 37 39 O
subtrochanteric NCT03868280 40 55 O
femur NCT03868280 56 61 O
fracture NCT03868280 62 70 B-Condition-Name
appropriate NCT03868280 71 82 O
for NCT03868280 83 86 O
antegrade NCT03868280 87 96 B-Procedure-Name
fixation NCT03868280 97 105 I-Procedure-Name

- NCT03868280 108 109 O
Surgeon NCT03868280 111 118 B-Provider-Type
agreement NCT03868280 119 128 O
for NCT03868280 129 132 O
participation NCT03868280 133 146 O
in NCT03868280 147 149 O
study NCT03868280 150 155 O

- NCT03868280 158 159 O
Ability NCT03868280 161 168 O
to NCT03868280 169 171 O
obtain NCT03868280 172 178 O
peri NCT03868280 179 183 B-Procedure-Name
operative NCT03868280 184 193 I-Procedure-Name
imaging NCT03868280 194 201 I-Procedure-Name
( NCT03868280 202 203 O
CT NCT03868280 204 206 B-Procedure-Name
scans NCT03868280 207 212 I-Procedure-Name
) NCT03868280 213 214 O

- NCT03868280 218 219 O
Provision NCT03868280 221 230 O
of NCT03868280 231 233 O
informed NCT03868280 234 242 O
consent NCT03868280 243 250 O

Exclusion NCT03868280 251 260 O
Criteria NCT03868280 261 269 O
: NCT03868280 270 271 O

- NCT03868280 275 276 O
Inability NCT03868280 278 287 O
to NCT03868280 288 290 O
provide NCT03868280 291 298 O
informed NCT03868280 299 307 O
consent NCT03868280 308 315 O
( NCT03868280 316 317 O
e NCT03868280 318 319 O
. NCT03868280 320 321 O
g NCT03868280 322 323 O
. NCT03868280 324 325 O
cognitive NCT03868280 327 336 B-Condition-Name
disability NCT03868280 337 347 I-Condition-Name
, NCT03868280 348 349 O
language NCT03868280 350 358 B-Condition-Name
barrier NCT03868280 359 366 I-Condition-Name
) NCT03868280 367 368 O

- NCT03868280 372 373 O
Bilateral NCT03868280 375 384 O
Femoral NCT03868280 385 392 O
Fractures NCT03868280 393 402 B-Condition-Name

- NCT03868280 405 406 O
Inability NCT03868280 408 417 O
or NCT03868280 418 420 O
lack NCT03868280 421 425 O
of NCT03868280 426 428 O
willingness NCT03868280 429 440 O
to NCT03868280 441 443 O
attend NCT03868280 444 450 O
follow NCT03868280 451 457 O
up NCT03868280 458 460 O

- NCT03868280 463 464 O
Ipsilateral NCT03868280 466 477 O
tibial NCT03868280 478 484 B-Condition-Name
fracture NCT03868280 485 493 I-Condition-Name

- NCT03868280 496 497 O
Ipsilateral NCT03868280 499 510 O
femoral NCT03868280 511 518 O
neck NCT03868280 519 523 O
fracture NCT03868280 524 532 B-Condition-Name

- NCT03868280 535 536 O
Ipsilateral NCT03868280 538 549 O
acetabular NCT03868280 550 560 O
fracture NCT03868280 561 569 B-Condition-Name

- NCT03868280 572 573 O
Pregnant NCT03868280 575 583 B-Condition-Name
or NCT03868280 584 586 O
breastfeeding NCT03868280 587 600 B-Condition-Name

- NCT03868280 603 604 O
Contraindications NCT03868280 606 623 O
to NCT03868280 624 626 O
CT NCT03868280 627 629 B-Procedure-Name
imaging NCT03868280 630 637 I-Procedure-Name
including NCT03868280 638 647 O
impaired NCT03868280 648 656 B-Condition-Name
kidney NCT03868280 657 663 I-Condition-Name
/ NCT03868280 664 665 O
liver NCT03868280 666 671 B-Condition-Name
function NCT03868280 672 680 I-Condition-Name
, NCT03868280 681 682 O
or NCT03868280 683 685 O
lack NCT03868280 686 690 O
of NCT03868280 691 693 O
timely NCT03868280 694 700 O
availability NCT03868280 701 713 O

- NCT03868280 716 717 O
Periprosthetic NCT03868280 719 733 O
fracture NCT03868280 734 742 B-Condition-Name

- NCT03868280 745 746 O
Pathologic NCT03868280 748 758 O
fracture NCT03868280 759 767 B-Condition-Name

- NCT03868280 770 771 O
Significant NCT03868280 773 784 B-Severity___Severity-Value:severe
delirium NCT03868280 785 793 B-Condition-Name
or NCT03868280 794 796 O
dementia NCT03868280 797 805 B-Condition-Name

Inclusion NCT03860623 0 9 O
Criteria NCT03860623 10 18 O
: NCT03860623 19 20 O

- NCT03860623 24 25 O
BMI NCT03860623 27 30 B-Observation-Name___Observation-Type-Value:vital
30 NCT03860623 32 34 B-Eq-Value
- NCT03860623 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03860623 38 40 B-Eq-Value
kg NCT03860623 41 43 B-Eq-Unit
/ NCT03860623 44 45 O
m NCT03860623 46 47 B-Eq-Unit
2 NCT03860623 48 49 I-Eq-Unit

- NCT03860623 52 53 O
BMI NCT03860623 55 58 B-Observation-Name___Observation-Type-Value:vital
18 NCT03860623 60 62 B-Eq-Value
- NCT03860623 63 64 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03860623 66 68 B-Eq-Value
kg NCT03860623 69 71 B-Eq-Unit
/ NCT03860623 72 73 O
m NCT03860623 74 75 B-Eq-Unit
2 NCT03860623 76 77 I-Eq-Unit
; NCT03860623 77 78 O
those NCT03860623 79 84 O
with NCT03860623 85 89 O
BMI NCT03860623 90 93 B-Observation-Name___Observation-Type-Value:vital
up NCT03860623 94 96 B-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03860623 97 99 I-Eq-Operator___Eq-Operator-Value:GTEQ
28 NCT03860623 101 103 B-Eq-Value
kg NCT03860623 104 106 B-Eq-Unit
/ NCT03860623 107 108 O
m NCT03860623 109 110 B-Eq-Unit
2 NCT03860623 111 112 I-Eq-Unit
will NCT03860623 113 117 O
be NCT03860623 118 120 O
included NCT03860623 121 129 O
if NCT03860623 130 132 O
waist NCT03860623 133 138 B-Observation-Name___Observation-Type-Value:measurement
circumference NCT03860623 139 152 I-Observation-Name___Observation-Type-Value:measurement
is NCT03860623 153 155 O
< NCT03860623 156 157 B-Eq-Operator___Eq-Operator-Value:LT
96 NCT03860623 159 161 B-Eq-Value
cm NCT03860623 162 164 B-Eq-Unit
. NCT03860623 165 166 O

- NCT03860623 170 171 O
Males NCT03860623 173 178 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03860623 181 182 O
Aged NCT03860623 184 188 O
18 NCT03860623 190 192 B-Eq-Value
- NCT03860623 193 194 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03860623 196 198 B-Eq-Value
yrs NCT03860623 199 202 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03860623 203 212 O
Criteria NCT03860623 213 221 O
: NCT03860623 222 223 O

- NCT03860623 227 228 O
Acute NCT03860623 230 235 B-Severity___Severity-Value:severe
illness NCT03860623 236 243 B-Condition-Name
in NCT03860623 244 246 O
the NCT03860623 247 250 O
preceding NCT03860623 251 260 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03860623 262 263 B-Eq-Value
weeks NCT03860623 264 269 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03860623 272 273 O
Taking NCT03860623 275 281 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
regular NCT03860623 282 289 O
medication NCT03860623 290 300 O

- NCT03860623 303 304 O
History NCT03860623 306 313 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860623 314 316 O
deep NCT03860623 317 321 B-Condition-Name
vein NCT03860623 322 326 I-Condition-Name
thrombosis NCT03860623 327 337 I-Condition-Name
or NCT03860623 338 340 O
clotting NCT03860623 341 349 B-Condition-Name
disorders NCT03860623 350 359 I-Condition-Name

- NCT03860623 362 363 O
Hypertension NCT03860623 365 377 B-Condition-Name

- NCT03860623 380 381 O
Diabetes NCT03860623 383 391 B-Condition-Name

- NCT03860623 394 395 O
Any NCT03860623 397 400 O
clinically NCT03860623 401 411 O
significant NCT03860623 412 423 B-Severity___Severity-Value:severe
findings NCT03860623 424 432 O
at NCT03860623 433 435 O
screening NCT03860623 436 445 O

- NCT03860623 448 449 O
History NCT03860623 451 458 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860623 459 461 O
substance NCT03860623 462 471 B-Condition-Name
abuse NCT03860623 472 477 I-Condition-Name

- NCT03860623 480 481 O
Demonstrating NCT03860623 483 496 O
factors NCT03860623 497 504 O
precluding NCT03860623 505 515 O
safe NCT03860623 516 520 O
MRI NCT03860623 521 524 B-Procedure-Name

- NCT03860623 527 528 O
History NCT03860623 530 537 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860623 538 540 O
gastrointestinal NCT03860623 541 557 B-Condition-Name
motility NCT03860623 558 566 I-Condition-Name
disorders NCT03860623 567 576 I-Condition-Name
( NCT03860623 577 578 O
e NCT03860623 579 580 O
. NCT03860623 581 582 O
g NCT03860623 583 584 O
. NCT03860623 585 586 O
gastroesophageal NCT03860623 588 604 B-Condition-Name
reflux NCT03860623 605 611 I-Condition-Name
disease NCT03860623 612 619 I-Condition-Name
- NCT03860623 620 621 O
irritable NCT03860623 622 631 B-Condition-Name
bowel NCT03860623 632 637 I-Condition-Name
syndrome NCT03860623 638 646 I-Condition-Name
, NCT03860623 647 648 O
gastroparesis NCT03860623 649 662 B-Condition-Name
, NCT03860623 663 664 O
sphincter NCT03860623 665 674 B-Condition-Name
of NCT03860623 675 677 I-Condition-Name
Oddi NCT03860623 678 682 I-Condition-Name
dysfunction NCT03860623 683 694 I-Condition-Name
, NCT03860623 695 696 O
etc NCT03860623 697 700 O
. NCT03860623 701 702 O
) NCT03860623 703 704 O

- NCT03860623 708 709 O
Previous NCT03860623 711 719 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
thoracic NCT03860623 720 728 O
or NCT03860623 729 731 O
abdominal NCT03860623 732 741 O
surgery NCT03860623 742 749 B-Procedure-Name
. NCT03860623 750 751 O

- NCT03860623 755 756 O
Those NCT03860623 758 763 O
who NCT03860623 764 767 O
report NCT03860623 768 774 O
having NCT03860623 775 781 O
≤ NCT03860623 782 783 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03860623 785 786 B-Eq-Value
bowel NCT03860623 787 792 B-Observation-Name
movements NCT03860623 793 802 I-Observation-Name
/ NCT03860623 803 804 O
week NCT03860623 805 809 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
or NCT03860623 810 812 O
> NCT03860623 813 814 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03860623 816 817 B-Eq-Value
/ NCT03860623 818 819 O
day NCT03860623 820 823 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
. NCT03860623 824 825 O

Inclusion NCT03866252 0 9 O
Criteria NCT03866252 10 18 O
: NCT03866252 19 20 O

- NCT03866252 24 25 O
Major NCT03866252 27 32 B-Severity___Severity-Value:severe
Depressive NCT03866252 33 43 B-Condition-Name
Disorder NCT03866252 44 52 I-Condition-Name
according NCT03866252 53 62 O
to NCT03866252 63 65 O
Diagnostic NCT03866252 66 76 O
and NCT03866252 77 80 O
Statistical NCT03866252 81 92 O
Manual NCT03866252 93 99 O
of NCT03866252 100 102 O
Mental NCT03866252 103 109 O
Disorders NCT03866252 110 119 O
( NCT03866252 120 121 O
DSM NCT03866252 122 125 O
- NCT03866252 126 127 O
V NCT03866252 128 129 O
) NCT03866252 130 131 O

- NCT03866252 135 136 O
> NCT03866252 138 139 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03866252 141 143 B-Eq-Value
years NCT03866252 144 149 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866252 152 153 O
Sufficient NCT03866252 155 165 O
understanding NCT03866252 166 179 O
of NCT03866252 180 182 O
the NCT03866252 183 186 O
German NCT03866252 187 193 B-Language
language NCT03866252 194 202 O

Exclusion NCT03866252 203 212 O
Criteria NCT03866252 213 221 O
: NCT03866252 222 223 O

- NCT03866252 227 228 O
< NCT03866252 230 231 B-Eq-Operator___Eq-Operator-Value:LT
25 NCT03866252 233 235 B-Eq-Value
years NCT03866252 236 241 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866252 244 245 O
Concomitant NCT03866252 247 258 O
diagnosis NCT03866252 259 268 O
of NCT03866252 269 271 O
past NCT03866252 272 276 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03866252 277 279 O
present NCT03866252 280 287 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
psychotic NCT03866252 288 297 B-Condition-Name
disorder NCT03866252 298 306 I-Condition-Name

- NCT03866252 309 310 O
Concomitant NCT03866252 312 323 O
diagnosis NCT03866252 324 333 O
of NCT03866252 334 336 O
past NCT03866252 337 341 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03866252 342 344 O
present NCT03866252 345 352 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
bipolar NCT03866252 353 360 B-Condition-Name
disorder NCT03866252 361 369 I-Condition-Name

- NCT03866252 372 373 O
First NCT03866252 375 380 O
degree NCT03866252 381 387 O
relative NCT03866252 388 396 O
with NCT03866252 397 401 O
a NCT03866252 402 403 O
psychotic NCT03866252 404 413 B-Condition-Name
disorder NCT03866252 414 422 I-Condition-Name

- NCT03866252 425 426 O
Unable NCT03866252 428 434 O
or NCT03866252 435 437 O
unwilling NCT03866252 438 447 O
to NCT03866252 448 450 O
discontinue NCT03866252 451 462 O
antidepressant NCT03866252 463 477 B-Drug-Name
medication NCT03866252 478 488 I-Drug-Name

- NCT03866252 491 492 O
Pregnancy NCT03866252 494 503 B-Condition-Name
or NCT03866252 504 506 O
breastfeeding NCT03866252 507 520 B-Condition-Name

- NCT03866252 523 524 O
Known NCT03866252 526 531 O
hypersensitivity NCT03866252 532 548 B-Condition-Name
to NCT03866252 549 551 O
LSD NCT03866252 552 555 B-Drug-Name

- NCT03866252 558 559 O
Somatic NCT03866252 561 568 B-Condition-Name
disorders NCT03866252 569 578 I-Condition-Name
including NCT03866252 579 588 O
central NCT03866252 589 596 B-Condition-Name
nervous NCT03866252 597 604 I-Condition-Name
system NCT03866252 605 611 I-Condition-Name
( NCT03866252 612 613 O
CNS NCT03866252 614 617 B-Condition-Name
) NCT03866252 618 619 O
involvement NCT03866252 620 631 O

- NCT03866252 634 635 O
Known NCT03866252 637 642 O
or NCT03866252 643 645 O
suspected NCT03866252 646 655 O
non NCT03866252 656 659 O
- NCT03866252 660 661 O
compliance NCT03866252 662 672 O
, NCT03866252 673 674 O
drug NCT03866252 675 679 O
or NCT03866252 680 682 O
alcohol NCT03866252 683 690 O
abuse NCT03866252 691 696 B-Condition-Name

- NCT03866252 699 700 O
Metal NCT03866252 702 707 B-Procedure-Name
implants NCT03866252 708 716 I-Procedure-Name

- NCT03866252 719 720 O
Weight NCT03866252 722 728 B-Observation-Name___Observation-Type-Value:vital
< NCT03866252 729 730 B-Eq-Operator___Eq-Operator-Value:LT
42 NCT03866252 732 734 B-Eq-Value
kg NCT03866252 735 737 B-Eq-Unit

- NCT03866252 740 741 O
Suicide NCT03866252 743 750 B-Condition-Name
risk NCT03866252 751 755 O
or NCT03866252 756 758 O
very NCT03866252 759 763 O
likely NCT03866252 764 770 O
to NCT03866252 771 773 O
require NCT03866252 774 781 O
psychiatric NCT03866252 782 793 B-Condition-Name
hospitalisation NCT03866252 794 809 B-Encounter-Type___Encounter-Type-Value:inpatient

Inclusion NCT03863470 0 9 O
Criteria NCT03863470 10 18 O
: NCT03863470 19 20 O

- NCT03863470 24 25 O
Age NCT03863470 27 30 O
≥ NCT03863470 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863470 34 36 B-Eq-Value
years NCT03863470 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863470 43 46 O
; NCT03863470 46 47 O
AND NCT03863470 48 51 O

- NCT03863470 54 55 O
Admission NCT03863470 57 66 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03863470 67 69 O
1 NCT03863470 71 72 O
of NCT03863470 73 75 O
12 NCT03863470 77 79 O
participating NCT03863470 80 93 O
ICUs NCT03863470 94 98 B-Location___Location-Value:unit
; NCT03863470 98 99 O
AND NCT03863470 100 103 O

- NCT03863470 106 107 O
Continuous NCT03863470 109 119 O
mechanical NCT03863470 120 130 B-Procedure-Name
ventilation NCT03863470 131 142 I-Procedure-Name
for NCT03863470 143 146 O
≥ NCT03863470 147 148 B-Eq-Operator___Eq-Operator-Value:GTEQ
48 NCT03863470 150 152 B-Eq-Value
hours NCT03863470 153 158 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
( NCT03863470 159 160 O
without NCT03863470 161 168 O
interruption NCT03863470 169 181 O
) NCT03863470 182 183 O
; NCT03863470 184 185 O
AND NCT03863470 186 189 O

- NCT03863470 192 193 O
Baseline NCT03863470 195 203 O
independent NCT03863470 204 215 B-Condition-Name
ambulatory NCT03863470 216 226 I-Condition-Name
status NCT03863470 227 233 O

Exclusion NCT03863470 234 243 O
Criteria NCT03863470 244 252 O
: NCT03863470 253 254 O

- NCT03863470 258 259 O
Admitting NCT03863470 261 270 O
diagnosis NCT03863470 271 280 O
of NCT03863470 281 283 O
any NCT03863470 284 287 O
of NCT03863470 288 290 O
the NCT03863470 291 294 O
following NCT03863470 295 304 O
conditions NCT03863470 305 315 O
: NCT03863470 316 317 O

- NCT03863470 326 327 O
Cardiopulmonary NCT03863470 329 344 B-Condition-Name
arrest NCT03863470 345 351 I-Condition-Name

- NCT03863470 359 360 O
Raised NCT03863470 362 368 B-Polarity___Polarity-Value:high
intracranial NCT03863470 369 381 B-Condition-Name
pressure NCT03863470 382 390 I-Condition-Name

- NCT03863470 398 399 O
Acute NCT03863470 401 406 B-Severity___Severity-Value:severe
neurological NCT03863470 407 419 O
admission NCT03863470 420 429 B-Condition-Type___Condition-Type-Value:admitting
diagnosis NCT03863470 430 439 B-Condition-Name

- NCT03863470 447 448 O
Subarachnoid NCT03863470 450 462 B-Condition-Name
hemorrhage NCT03863470 463 473 I-Condition-Name

- NCT03863470 481 482 O
Ischemic NCT03863470 484 492 O
stroke NCT03863470 493 499 B-Condition-Name

Inclusion NCT03862183 0 9 O
Criteria NCT03862183 10 18 O
: NCT03862183 19 20 O

1 NCT03862183 25 26 O
. NCT03862183 26 27 O
Outpatients NCT03862183 29 40 B-Encounter-Type___Encounter-Type-Value:outpatient
from NCT03862183 41 45 O
departments NCT03862183 46 57 O
of NCT03862183 58 60 O
Cardiology NCT03862183 61 71 B-Provider-Type
, NCT03862183 72 73 O
Endocrinology NCT03862183 74 87 B-Provider-Type
, NCT03862183 88 89 O
Nephrology NCT03862183 90 100 B-Provider-Type
, NCT03862183 101 102 O
Neurology NCT03862183 103 112 B-Provider-Type
, NCT03862183 113 114 O
Geriatrics NCT03862183 115 125 B-Provider-Type
or NCT03862183 126 128 O
General NCT03862183 129 136 B-Provider-Type
Internal NCT03862183 137 145 I-Provider-Type
Medicine NCT03862183 146 154 I-Provider-Type
. NCT03862183 155 156 O

2 NCT03862183 161 162 O
. NCT03862183 162 163 O
Diagnosed NCT03862183 165 174 O
as NCT03862183 175 177 O
hypertension NCT03862183 178 190 B-Condition-Name
. NCT03862183 191 192 O
Diagnostic NCT03862183 194 204 O
criteria NCT03862183 205 213 O
: NCT03862183 214 215 O
1 NCT03862183 217 218 O
) NCT03862183 219 220 O
The NCT03862183 221 224 O
office NCT03862183 225 231 O
BP NCT03862183 232 234 B-Observation-Name___Observation-Type-Value:vital
measured NCT03862183 235 243 O
at NCT03862183 244 246 O
the NCT03862183 247 250 O
day NCT03862183 251 254 O
of NCT03862183 255 257 O
visit NCT03862183 258 263 O
and NCT03862183 264 267 O
at NCT03862183 268 270 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862183 271 276 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03862183 277 280 B-Eq-Value
time NCT03862183 281 285 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
before NCT03862183 286 292 O
that NCT03862183 293 297 O
day NCT03862183 298 301 O
were NCT03862183 302 306 O
above NCT03862183 307 312 B-Eq-Operator___Eq-Operator-Value:GT
the NCT03862183 313 316 O
cut NCT03862183 317 320 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
- NCT03862183 321 322 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
off NCT03862183 323 326 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
values NCT03862183 327 333 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
( NCT03862183 334 335 O
≥ NCT03862183 336 337 B-Eq-Operator___Eq-Operator-Value:GTEQ
140 NCT03862183 339 342 B-Eq-Value
mmHg NCT03862183 343 347 B-Eq-Unit
SBP NCT03862183 348 351 B-Observation-Name___Observation-Type-Value:vital
and NCT03862183 352 355 O
/ NCT03862183 356 357 O
or NCT03862183 358 360 O
≥ NCT03862183 361 362 B-Eq-Operator___Eq-Operator-Value:GTEQ
90 NCT03862183 364 366 B-Eq-Value
mmHg NCT03862183 367 371 B-Eq-Unit
DBP NCT03862183 372 375 B-Observation-Name___Observation-Type-Value:vital
) NCT03862183 376 377 O
; NCT03862183 378 379 O
2 NCT03862183 381 382 O
) NCT03862183 383 384 O
for NCT03862183 385 388 O
patients NCT03862183 389 397 O
with NCT03862183 398 402 O
normal NCT03862183 403 409 B-Polarity___Polarity-Value:normal
BP NCT03862183 410 412 B-Observation-Name___Observation-Type-Value:vital
at NCT03862183 413 415 O
the NCT03862183 416 419 O
day NCT03862183 420 423 O
of NCT03862183 424 426 O
visit NCT03862183 427 432 O
, NCT03862183 433 434 O
they NCT03862183 435 439 O
should NCT03862183 440 446 O
have NCT03862183 447 451 O
already NCT03862183 452 459 O
been NCT03862183 460 464 O
given NCT03862183 465 470 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pre NCT03862183 471 474 O
- NCT03862183 475 476 O
treatment NCT03862183 477 486 O
with NCT03862183 487 491 O
antihypertensive NCT03862183 492 508 B-Drug-Name
drugs NCT03862183 509 514 I-Drug-Name
≥ NCT03862183 515 516 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03862183 518 519 B-Eq-Value
weeks NCT03862183 520 525 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03862183 526 527 O

3 NCT03862183 532 533 O
. NCT03862183 533 534 O
Voluntary NCT03862183 536 545 O
participation NCT03862183 546 559 O
. NCT03862183 560 561 O

Exclusion NCT03862183 563 572 O
Criteria NCT03862183 573 581 O
: NCT03862183 582 583 O

1 NCT03862183 588 589 O
. NCT03862183 589 590 O
Patients NCT03862183 592 600 O
aged NCT03862183 601 605 O
< NCT03862183 606 607 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03862183 609 611 B-Eq-Value
years NCT03862183 612 617 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03862183 618 621 O
. NCT03862183 622 623 O

2 NCT03862183 628 629 O
. NCT03862183 629 630 O
Patients NCT03862183 632 640 O
without NCT03862183 641 648 O
a NCT03862183 649 650 O
definite NCT03862183 651 659 O
diagnosis NCT03862183 660 669 O
of NCT03862183 670 672 O
hypertension NCT03862183 673 685 B-Condition-Name
（ NCT03862183 686 687 O
for NCT03862183 688 691 O
instance NCT03862183 692 700 O
, NCT03862183 701 702 O
if NCT03862183 703 705 O
the NCT03862183 706 709 O
patient NCT03862183 710 717 O
has NCT03862183 718 721 O
been NCT03862183 722 726 O
taking NCT03862183 727 733 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antihypertensive NCT03862183 734 750 B-Drug-Name
drugs NCT03862183 751 756 I-Drug-Name
irregularly NCT03862183 757 768 O
, NCT03862183 769 770 O
it NCT03862183 771 773 O
is NCT03862183 774 776 O
difficult NCT03862183 777 786 O
to NCT03862183 787 789 O
confirm NCT03862183 790 797 O
the NCT03862183 798 801 O
diagnosis NCT03862183 802 811 O
of NCT03862183 812 814 O
hypertension NCT03862183 815 827 B-Condition-Name
） NCT03862183 827 828 O
. NCT03862183 829 830 O

3 NCT03862183 835 836 O
. NCT03862183 836 837 O
Patients NCT03862183 839 847 O
with NCT03862183 848 852 O
a NCT03862183 853 854 O
definite NCT03862183 855 863 O
diagnosis NCT03862183 864 873 O
of NCT03862183 874 876 O
secondary NCT03862183 877 886 O
hypertension NCT03862183 887 899 B-Condition-Name
. NCT03862183 900 901 O

4 NCT03862183 906 907 O
. NCT03862183 907 908 O
Patients NCT03862183 910 918 O
are NCT03862183 919 922 O
diagnosed NCT03862183 923 932 O
dyslipidemia NCT03862183 933 945 B-Condition-Name
with NCT03862183 946 950 O
clear NCT03862183 951 956 O
cause NCT03862183 957 962 O
, NCT03862183 963 964 O
such NCT03862183 965 969 O
as NCT03862183 970 972 O
nephrotic NCT03862183 973 982 B-Condition-Name
syndrome NCT03862183 983 991 I-Condition-Name
, NCT03862183 992 993 O
severe NCT03862183 994 1000 B-Severity___Severity-Value:severe
hypothyroidism NCT03862183 1001 1015 B-Condition-Name
, NCT03862183 1016 1017 O
terminal NCT03862183 1018 1026 B-Eq-Value
stage NCT03862183 1027 1032 B-Eq-Unit
of NCT03862183 1033 1035 O
malignancy NCT03862183 1036 1046 B-Condition-Name
, NCT03862183 1047 1048 O
etc NCT03862183 1049 1052 O
. NCT03862183 1053 1054 O

5 NCT03862183 1059 1060 O
. NCT03862183 1060 1061 O
Patients NCT03862183 1063 1071 O
are NCT03862183 1072 1075 O
diagnosed NCT03862183 1076 1085 O
end NCT03862183 1086 1089 B-Eq-Value
- NCT03862183 1090 1091 O
stage NCT03862183 1092 1097 B-Eq-Unit
renal NCT03862183 1098 1103 B-Condition-Name
disease NCT03862183 1104 1111 I-Condition-Name
, NCT03862183 1112 1113 O
hemodialysis NCT03862183 1114 1126 B-Procedure-Name
, NCT03862183 1127 1128 O
and NCT03862183 1129 1132 O
peritoneal NCT03862183 1133 1143 B-Procedure-Name
dialysis NCT03862183 1144 1152 I-Procedure-Name
patients NCT03862183 1153 1161 O
. NCT03862183 1162 1163 O

6 NCT03862183 1168 1169 O
. NCT03862183 1169 1170 O
Patients NCT03862183 1172 1180 O
diagnosed NCT03862183 1181 1190 O
with NCT03862183 1191 1195 O
mental NCT03862183 1196 1202 B-Condition-Name
abnormalities NCT03862183 1203 1216 I-Condition-Name
who NCT03862183 1217 1220 O
are NCT03862183 1221 1224 O
unable NCT03862183 1225 1231 O
to NCT03862183 1232 1234 O
complete NCT03862183 1235 1243 O
the NCT03862183 1244 1247 O
questionnaire NCT03862183 1248 1261 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
. NCT03862183 1262 1263 O

7 NCT03862183 1268 1269 O
. NCT03862183 1269 1270 O
Patients NCT03862183 1272 1280 O
have NCT03862183 1281 1285 O
once NCT03862183 1286 1290 O
participated NCT03862183 1291 1303 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03862183 1304 1306 O
this NCT03862183 1307 1311 O
research NCT03862183 1312 1320 O
during NCT03862183 1321 1327 O
this NCT03862183 1328 1332 O
study NCT03862183 1333 1338 O
cycle NCT03862183 1339 1344 O
（ NCT03862183 1345 1346 O
to NCT03862183 1347 1349 O
avoid NCT03862183 1350 1355 O
repeated NCT03862183 1356 1364 O
participation NCT03862183 1365 1378 O
） NCT03862183 1378 1379 O
. NCT03862183 1380 1381 O

Inclusion NCT03860025 0 9 O
Criteria NCT03860025 10 18 O
: NCT03860025 19 20 O

- NCT03860025 24 25 O
patients NCT03860025 27 35 O
with NCT03860025 36 40 O
one NCT03860025 41 44 B-Eq-Value
or NCT03860025 45 47 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03860025 48 52 I-Eq-Operator___Eq-Operator-Value:GTEQ
events NCT03860025 53 59 O
of NCT03860025 60 62 O
hip NCT03860025 63 66 B-Condition-Name
dislocation NCT03860025 67 78 I-Condition-Name
after NCT03860025 79 84 O
a NCT03860025 85 86 O
primary NCT03860025 87 94 O
THA NCT03860025 95 98 B-Procedure-Name

- NCT03860025 101 102 O
controls NCT03860025 104 112 O
with NCT03860025 113 117 O
a NCT03860025 118 119 O
primary NCT03860025 120 127 O
THA NCT03860025 128 131 B-Procedure-Name
without NCT03860025 132 139 O
events NCT03860025 140 146 O
of NCT03860025 147 149 O
hip NCT03860025 150 153 B-Condition-Name
dislocation NCT03860025 154 165 I-Condition-Name

Exclusion NCT03860025 166 175 O
Criteria NCT03860025 176 184 O
: NCT03860025 185 186 O

- NCT03860025 189 190 O

Inclusion NCT03863262 0 9 O
Criteria NCT03863262 10 18 O
: NCT03863262 19 20 O

- NCT03863262 24 25 O
Registered NCT03863262 27 37 O
patients NCT03863262 38 46 O
at NCT03863262 47 49 O
Eric NCT03863262 50 54 O
Williams NCT03863262 55 63 O
Medical NCT03863262 64 71 O
Sciences NCT03863262 72 80 O
Complex NCT03863262 81 88 O
in NCT03863262 89 91 O
any NCT03863262 92 95 O
of NCT03863262 96 98 O
the NCT03863262 99 102 O
cardiology NCT03863262 103 113 B-Location___Location-Value:clinic
outpatient NCT03863262 114 124 I-Location___Location-Value:clinic
clinics NCT03863262 125 132 I-Location___Location-Value:clinic
. NCT03863262 133 134 O
This NCT03863262 136 140 O
was NCT03863262 141 144 O
confirmed NCT03863262 145 154 O
by NCT03863262 155 157 O
matching NCT03863262 158 166 O
patients NCT03863262 167 175 O
with NCT03863262 176 180 O
their NCT03863262 181 186 O
registration NCT03863262 187 199 O
numbers NCT03863262 200 207 O
on NCT03863262 208 210 O
the NCT03863262 211 214 O
cardiology NCT03863262 215 225 B-Location___Location-Value:clinic
outpatient NCT03863262 226 236 I-Location___Location-Value:clinic
clinic NCT03863262 237 243 I-Location___Location-Value:clinic
appointment NCT03863262 244 255 O
listings NCT03863262 256 264 O
. NCT03863262 265 266 O
These NCT03863262 268 273 O
lists NCT03863262 274 279 O
are NCT03863262 280 283 O
made NCT03863262 284 288 O
prior NCT03863262 289 294 O
to NCT03863262 295 297 O
each NCT03863262 298 302 O
cardiology NCT03863262 303 313 O
clinic NCT03863262 314 320 O
that NCT03863262 321 325 O
is NCT03863262 326 328 O
scheduled NCT03863262 329 338 O
every NCT03863262 339 344 O
week NCT03863262 345 349 O
on NCT03863262 350 352 O
Mondays NCT03863262 353 360 O
, NCT03863262 361 362 O
Tuesdays NCT03863262 363 371 O
, NCT03863262 372 373 O
Wednesdays NCT03863262 374 384 O
, NCT03863262 385 386 O
Thursdays NCT03863262 387 396 O
and NCT03863262 397 400 O
Fridays NCT03863262 401 408 O
. NCT03863262 409 410 O

- NCT03863262 414 415 O
Patients NCT03863262 417 425 O
who NCT03863262 426 429 O
were NCT03863262 430 434 O
18 NCT03863262 436 438 B-Eq-Value
years NCT03863262 439 444 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863262 445 448 O

Exclusion NCT03863262 449 458 O
Criteria NCT03863262 459 467 O
: NCT03863262 468 469 O

- NCT03863262 473 474 O
Patients NCT03863262 476 484 O
less NCT03863262 485 489 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03863262 490 494 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03863262 496 498 B-Eq-Value
years NCT03863262 499 504 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863262 505 508 O

- NCT03863262 511 512 O
Those NCT03863262 514 519 O
who NCT03863262 520 523 O
did NCT03863262 524 527 O
not NCT03863262 528 531 O
give NCT03863262 532 536 O
informed NCT03863262 537 545 O
consent NCT03863262 546 553 O
to NCT03863262 554 556 O
participate NCT03863262 557 568 O
in NCT03863262 569 571 O
the NCT03863262 572 575 O
study NCT03863262 576 581 O

- NCT03863262 584 585 O
Patients NCT03863262 587 595 O
who NCT03863262 596 599 O
were NCT03863262 600 604 O
not NCT03863262 605 608 O
registered NCT03863262 609 619 O
patients NCT03863262 620 628 O
of NCT03863262 629 631 O
the NCT03863262 632 635 O
cardiology NCT03863262 636 646 B-Location___Location-Value:clinic
outpatient NCT03863262 647 657 I-Location___Location-Value:clinic
clinics NCT03863262 658 665 I-Location___Location-Value:clinic
at NCT03863262 666 668 O
Eric NCT03863262 669 673 B-Location___Location-Value:hospital
Williams NCT03863262 674 682 I-Location___Location-Value:hospital
Medical NCT03863262 683 690 I-Location___Location-Value:hospital
Sciences NCT03863262 691 699 I-Location___Location-Value:hospital
Complex NCT03863262 700 707 I-Location___Location-Value:hospital
along NCT03863262 708 713 O

- NCT03863262 716 717 O
Patients NCT03863262 719 727 O
who NCT03863262 728 731 O
were NCT03863262 732 736 O
acutely NCT03863262 737 744 B-Severity___Severity-Value:severe
unwell NCT03863262 745 751 B-Condition-Name
requiring NCT03863262 752 761 O
hospital NCT03863262 762 770 B-Location___Location-Value:hospital
admission NCT03863262 771 780 B-Encounter-Type___Encounter-Type-Value:inpatient

Inclusion NCT03866681 0 9 O
Criteria NCT03866681 10 18 O
: NCT03866681 19 20 O

- NCT03866681 24 25 O
age NCT03866681 27 30 O
18 NCT03866681 32 34 B-Eq-Value
- NCT03866681 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03866681 38 40 B-Eq-Value
years NCT03866681 41 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866681 49 50 O
diagnosed NCT03866681 52 61 O
with NCT03866681 62 66 O
PNH NCT03866681 67 70 B-Condition-Name
and NCT03866681 71 74 O
no NCT03866681 75 77 O
thrombosis NCT03866681 78 88 B-Condition-Name

- NCT03866681 91 92 O
ineffective NCT03866681 94 105 O
, NCT03866681 106 107 O
relapsed NCT03866681 108 116 O
or NCT03866681 117 119 O
intolerant NCT03866681 120 130 B-Condition-Name
to NCT03866681 131 133 O
conventional NCT03866681 134 146 O
treatment NCT03866681 147 156 O
( NCT03866681 157 158 O
eg NCT03866681 159 161 O
glucocorticoids NCT03866681 162 177 B-Drug-Name
, NCT03866681 178 179 O
• NCT03866681 180 181 O
• NCT03866681 182 183 O
iron NCT03866681 184 188 B-Drug-Name
, NCT03866681 189 190 O
folic NCT03866681 191 196 B-Drug-Name
acid NCT03866681 197 201 I-Drug-Name
, NCT03866681 202 203 O
androgen NCT03866681 204 212 B-Drug-Name
, NCT03866681 213 214 O
etc NCT03866681 215 218 O
. NCT03866681 219 220 O
) NCT03866681 221 222 O

- NCT03866681 226 227 O
not NCT03866681 229 232 O
available NCT03866681 233 242 O
for NCT03866681 243 246 O
hematopoietic NCT03866681 247 260 B-Procedure-Name
stem NCT03866681 261 265 I-Procedure-Name
cell NCT03866681 266 270 I-Procedure-Name
transplantation NCT03866681 271 286 I-Procedure-Name

- NCT03866681 289 290 O
ECOG NCT03866681 292 296 B-Observation-Name
≤ NCT03866681 297 298 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03866681 300 301 B-Eq-Value

- NCT03866681 305 306 O
agreed NCT03866681 308 314 O
to NCT03866681 315 317 O
sign NCT03866681 318 322 O
the NCT03866681 323 326 O
consent NCT03866681 327 334 O
forms NCT03866681 335 340 O

Exclusion NCT03866681 341 350 O
Criteria NCT03866681 351 359 O
: NCT03866681 360 361 O

- NCT03866681 365 366 O
severe NCT03866681 368 374 B-Severity___Severity-Value:severe
heart NCT03866681 375 380 O
, NCT03866681 381 382 O
liver NCT03866681 383 388 O
and NCT03866681 389 392 O
kidney NCT03866681 393 399 O
dysfunction NCT03866681 400 411 B-Condition-Name

- NCT03866681 414 415 O
combined NCT03866681 417 425 O
with NCT03866681 426 430 O
thrombotic NCT03866681 431 441 O
complications NCT03866681 442 455 B-Condition-Name

- NCT03866681 458 459 O
people NCT03866681 461 467 O
who NCT03866681 468 471 O
are NCT03866681 472 475 O
pregnant NCT03866681 476 484 B-Condition-Name
and NCT03866681 485 488 O
breastfeeding NCT03866681 489 502 B-Condition-Name

- NCT03866681 505 506 O
history NCT03866681 508 515 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866681 516 518 O
other NCT03866681 519 524 O
immunosuppressive NCT03866681 525 542 B-Drug-Name
agents NCT03866681 543 549 I-Drug-Name
in NCT03866681 550 552 O
recent NCT03866681 553 559 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
3 NCT03866681 561 562 B-Eq-Value
months NCT03866681 563 569 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03866681 572 573 O
Patients NCT03866681 575 583 O
who NCT03866681 584 587 O
are NCT03866681 588 591 O
not NCT03866681 592 595 O
eligible NCT03866681 596 604 O
to NCT03866681 605 607 O
participate NCT03866681 608 619 O
in NCT03866681 620 622 O
this NCT03866681 623 627 O
trial NCT03866681 628 633 O
due NCT03866681 634 637 O
to NCT03866681 638 640 O
any NCT03866681 641 644 O
reason NCT03866681 645 651 O
based NCT03866681 652 657 O
• NCT03866681 658 659 O
• NCT03866681 660 661 O
• NCT03866681 662 663 O
on NCT03866681 664 666 O
the NCT03866681 667 670 O
consideration NCT03866681 671 684 O
of NCT03866681 685 687 O
investigator NCT03866681 688 700 O

Inclusion NCT03864900 0 9 O
Criteria NCT03864900 10 18 O
: NCT03864900 19 20 O

1 NCT03864900 25 26 O
. NCT03864900 26 27 O
≥ NCT03864900 29 30 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03864900 32 34 B-Eq-Value
years NCT03864900 35 40 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03864900 41 43 O
age NCT03864900 44 47 O

2 NCT03864900 51 52 O
. NCT03864900 52 53 O
fluent NCT03864900 55 61 O
in NCT03864900 62 64 O
Mandarin NCT03864900 65 73 B-Language
or NCT03864900 74 76 O
Taiwanese NCT03864900 77 86 B-Language

3 NCT03864900 90 91 O
. NCT03864900 91 92 O
diagnosed NCT03864900 94 103 O
with NCT03864900 104 108 O
AF NCT03864900 109 111 B-Condition-Name

4 NCT03864900 115 116 O
. NCT03864900 116 117 O
treated NCT03864900 119 126 O
with NCT03864900 127 131 O
warfarin NCT03864900 132 140 B-Drug-Name
or NCT03864900 141 143 O
NOACs NCT03864900 144 149 B-Drug-Name
for NCT03864900 150 153 O
anticoagulation NCT03864900 154 169 B-Procedure-Name
. NCT03864900 170 171 O

Exclusion NCT03864900 173 182 O
Criteria NCT03864900 183 191 O
: NCT03864900 192 193 O

1 NCT03864900 198 199 O
. NCT03864900 199 200 O
diagnosed NCT03864900 202 211 O
with NCT03864900 212 216 O
psychological NCT03864900 217 230 B-Condition-Name
diseases NCT03864900 231 239 I-Condition-Name

2 NCT03864900 243 244 O
. NCT03864900 244 245 O
diagnosed NCT03864900 247 256 O
with NCT03864900 257 261 O
uncontrolled NCT03864900 262 274 O
hypertension NCT03864900 275 287 B-Condition-Name

3 NCT03864900 291 292 O
. NCT03864900 292 293 O
diagnosed NCT03864900 295 304 O
with NCT03864900 305 309 O
the NCT03864900 310 313 O
New NCT03864900 314 317 B-Condition-Name
York NCT03864900 318 322 I-Condition-Name
Heart NCT03864900 323 328 I-Condition-Name
Association NCT03864900 329 340 I-Condition-Name
( NCT03864900 341 342 O
NYHA NCT03864900 343 347 B-Condition-Name
) NCT03864900 348 349 O
grade NCT03864900 350 355 B-Eq-Unit
VI NCT03864900 356 358 B-Eq-Value
heart NCT03864900 359 364 B-Condition-Name
failure NCT03864900 365 372 I-Condition-Name

4 NCT03864900 376 377 O
. NCT03864900 377 378 O
implanted NCT03864900 380 389 O
with NCT03864900 390 394 O
a NCT03864900 395 396 O
cardiac NCT03864900 397 404 B-Procedure-Name
pacemaker NCT03864900 405 414 I-Procedure-Name

5 NCT03864900 418 419 O
. NCT03864900 419 420 O
had NCT03864900 422 425 O
a NCT03864900 426 427 O
cardiac NCT03864900 428 435 B-Procedure-Name
surgery NCT03864900 436 443 I-Procedure-Name
in NCT03864900 444 446 O
the NCT03864900 447 450 O
past NCT03864900 451 455 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03864900 456 461 B-Eq-Value
months NCT03864900 462 468 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

6 NCT03864900 472 473 O
. NCT03864900 473 474 O
hospitalized NCT03864900 476 488 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03864900 489 492 O
AF NCT03864900 493 495 B-Condition-Name
in NCT03864900 496 498 O
the NCT03864900 499 502 O
past NCT03864900 503 507 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03864900 508 513 B-Eq-Value
months NCT03864900 514 520 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03864900 521 522 O

Inclusion NCT03866642 0 9 O
Criteria NCT03866642 10 18 O
: NCT03866642 19 20 O

- NCT03866642 24 25 O
Ankle NCT03866642 27 32 O
arthritis NCT03866642 33 42 B-Condition-Name
treated NCT03866642 43 50 O
with NCT03866642 51 55 O
Cadence NCT03866642 56 63 O
Total NCT03866642 64 69 B-Procedure-Name
Ankle NCT03866642 70 75 I-Procedure-Name
Replacement NCT03866642 76 87 I-Procedure-Name
system NCT03866642 88 94 I-Procedure-Name

Exclusion NCT03866642 95 104 O
Criteria NCT03866642 105 113 O
: NCT03866642 114 115 O

- NCT03866642 119 120 O
Under NCT03866642 122 127 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03866642 129 131 B-Eq-Value
years NCT03866642 132 137 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866642 138 140 O
age NCT03866642 141 144 O

Inclusion NCT03860233 0 9 O
Criteria NCT03860233 10 18 O
: NCT03860233 19 20 O

- NCT03860233 24 25 O
Men NCT03860233 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03860233 31 33 O
women NCT03860233 34 39 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
18 NCT03860233 41 43 B-Eq-Value
years NCT03860233 44 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03860233 50 52 O
age NCT03860233 53 56 O
or NCT03860233 57 59 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03860233 60 65 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03860233 66 67 O

Exclusion NCT03860233 69 78 O
Criteria NCT03860233 79 87 O
: NCT03860233 88 89 O

- NCT03860233 93 94 O
subjects NCT03860233 96 104 O
not NCT03860233 105 108 O
willing NCT03860233 109 116 O
to NCT03860233 117 119 O
or NCT03860233 120 122 O
otherwise NCT03860233 123 132 O
unable NCT03860233 133 139 O
to NCT03860233 140 142 O
use NCT03860233 143 146 O
CPAP NCT03860233 147 151 B-Procedure-Name
for NCT03860233 152 155 O
treatment NCT03860233 156 165 O
of NCT03860233 166 168 O
OSA NCT03860233 169 172 B-Condition-Name
. NCT03860233 173 174 O

- NCT03860233 178 179 O
Presence NCT03860233 181 189 O
of NCT03860233 190 192 O
other NCT03860233 193 198 O
sleep NCT03860233 199 204 B-Condition-Name
disorders NCT03860233 205 214 I-Condition-Name

- NCT03860233 217 218 O
Pregnant NCT03860233 220 228 B-Condition-Name
or NCT03860233 229 231 O
breastfeeding NCT03860233 232 245 B-Condition-Name
women NCT03860233 246 251 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03860233 254 255 O
Women NCT03860233 257 262 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03860233 263 265 O
child NCT03860233 266 271 B-Condition-Name
- NCT03860233 272 273 I-Condition-Name
bearing NCT03860233 274 281 I-Condition-Name
age NCT03860233 282 285 I-Condition-Name
( NCT03860233 286 287 O
WOCBA NCT03860233 288 293 B-Condition-Name
) NCT03860233 294 295 O
not NCT03860233 296 299 O
willing NCT03860233 300 307 O
or NCT03860233 308 310 O
unable NCT03860233 311 317 O
to NCT03860233 318 320 O
use NCT03860233 321 324 O
an NCT03860233 325 327 O
accepted NCT03860233 328 336 O
method NCT03860233 337 343 O
to NCT03860233 344 346 O
avoid NCT03860233 347 352 O
pregnancy NCT03860233 353 362 B-Condition-Name
for NCT03860233 363 366 O
the NCT03860233 367 370 O
entire NCT03860233 371 377 O
duration NCT03860233 378 386 O
of NCT03860233 387 389 O
the NCT03860233 390 393 O
study NCT03860233 394 399 O

- NCT03860233 402 403 O
Prisoners NCT03860233 405 414 B-Observation-Name
or NCT03860233 415 417 O
subjects NCT03860233 418 426 O
who NCT03860233 427 430 O
are NCT03860233 431 434 O
involuntarily NCT03860233 435 448 B-Observation-Name
incarcerated NCT03860233 449 461 I-Observation-Name

- NCT03860233 464 465 O
Subjects NCT03860233 467 475 O
who NCT03860233 476 479 O
are NCT03860233 480 483 O
compulsorily NCT03860233 484 496 B-Observation-Name
detain NCT03860233 497 503 I-Observation-Name
or NCT03860233 504 506 O
treatment NCT03860233 507 516 O
of NCT03860233 517 519 O
either NCT03860233 520 526 O
a NCT03860233 527 528 O
psychiatric NCT03860233 529 540 O
or NCT03860233 541 543 O
physical NCT03860233 544 552 O
( NCT03860233 553 554 O
i NCT03860233 555 556 O
. NCT03860233 557 558 O
e NCT03860233 559 560 O
. NCT03860233 561 562 O
infectious NCT03860233 564 574 B-Condition-Name
disease NCT03860233 575 582 I-Condition-Name
) NCT03860233 583 584 O
illness NCT03860233 585 592 B-Condition-Name

- NCT03860233 595 596 O
Patients NCT03860233 598 606 O
unable NCT03860233 607 613 O
to NCT03860233 614 616 O
give NCT03860233 617 621 O
consent NCT03860233 622 629 O
because NCT03860233 630 637 O
of NCT03860233 638 640 O
a NCT03860233 641 642 O
language NCT03860233 643 651 B-Condition-Name
barrier NCT03860233 652 659 I-Condition-Name
, NCT03860233 660 661 O
or NCT03860233 662 664 O
other NCT03860233 665 670 O
reason NCT03860233 671 677 O
. NCT03860233 678 679 O

Inclusion NCT03864055 0 9 O
Criteria NCT03864055 10 18 O
: NCT03864055 19 20 O

- NCT03864055 24 25 O
age NCT03864055 27 30 O
of NCT03864055 31 33 O
18 NCT03864055 35 37 B-Eq-Value
years NCT03864055 38 43 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03864055 44 46 B-Eq-Operator___Eq-Operator-Value:LTEQ
younger NCT03864055 47 54 I-Eq-Operator___Eq-Operator-Value:LTEQ

- NCT03864055 57 58 O
both NCT03864055 60 64 O
sexes NCT03864055 65 70 O
are NCT03864055 71 74 O
included NCT03864055 75 83 O

- NCT03864055 86 87 O
a NCT03864055 89 90 O
clinical NCT03864055 91 99 O
or NCT03864055 100 102 O
radiological NCT03864055 103 115 B-Procedure-Name
finding NCT03864055 116 123 O
of NCT03864055 124 126 O
mastoiditis NCT03864055 127 138 B-Condition-Name
in NCT03864055 139 141 O
the NCT03864055 142 145 O
patient NCT03864055 146 153 O
's NCT03864055 153 155 O
file NCT03864055 156 160 O

- NCT03864055 163 164 O
Documentation NCT03864055 166 179 O
of NCT03864055 180 182 O
CSVT NCT03864055 183 187 B-Condition-Name
in NCT03864055 188 190 O
an NCT03864055 191 193 O
imaging NCT03864055 194 201 B-Procedure-Name
study NCT03864055 202 207 I-Procedure-Name
, NCT03864055 208 209 O
either NCT03864055 210 216 O
CT NCT03864055 217 219 B-Procedure-Name
or NCT03864055 220 222 O
MRI NCT03864055 223 226 B-Procedure-Name
. NCT03864055 227 228 O

Patient NCT03864055 230 237 O
's NCT03864055 237 239 O
exclusion NCT03864055 240 249 O
criteria NCT03864055 250 258 O

- NCT03864055 261 262 O
age NCT03864055 264 267 O
above NCT03864055 268 273 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03864055 275 277 B-Eq-Value
years NCT03864055 278 283 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864055 286 287 O
lack NCT03864055 289 293 O
of NCT03864055 294 296 O
a NCT03864055 297 298 O
clinical NCT03864055 299 307 O
or NCT03864055 308 310 O
radiological NCT03864055 311 323 B-Procedure-Name
finding NCT03864055 324 331 O
of NCT03864055 332 334 O
mastoiditis NCT03864055 335 346 B-Condition-Name
in NCT03864055 347 349 O
the NCT03864055 350 353 O
patient NCT03864055 354 361 O
's NCT03864055 361 363 O
file NCT03864055 364 368 O

- NCT03864055 371 372 O
Lack NCT03864055 374 378 O
of NCT03864055 379 381 O
documentation NCT03864055 382 395 O
of NCT03864055 396 398 O
CSVT NCT03864055 399 403 B-Condition-Name
in NCT03864055 404 406 O
an NCT03864055 407 409 O
imaging NCT03864055 410 417 B-Procedure-Name
study NCT03864055 418 423 I-Procedure-Name
, NCT03864055 424 425 O
either NCT03864055 426 432 O
CT NCT03864055 433 435 B-Procedure-Name
or NCT03864055 436 438 O
MRI NCT03864055 439 442 B-Procedure-Name
. NCT03864055 443 444 O

- NCT03864055 448 449 O
previous NCT03864055 451 459 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
unprovoked NCT03864055 460 470 O
venous NCT03864055 471 477 B-Condition-Name
thromboembolism NCT03864055 478 493 I-Condition-Name
event NCT03864055 494 499 O
. NCT03864055 500 501 O

Inclusion NCT03869203 0 9 O
Criteria NCT03869203 10 18 O
: NCT03869203 19 20 O

- NCT03869203 24 25 O
1 NCT03869203 28 29 O
. NCT03869203 29 30 O
elective NCT03869203 32 40 O
total NCT03869203 41 46 B-Procedure-Name
knee NCT03869203 47 51 I-Procedure-Name
arthroplasty NCT03869203 52 64 I-Procedure-Name
for NCT03869203 65 68 O
degenerative NCT03869203 69 81 O
osteoarthritis NCT03869203 82 96 B-Condition-Name

- NCT03869203 99 100 O
2 NCT03869203 103 104 O
. NCT03869203 104 105 O
elective NCT03869203 107 115 O
total NCT03869203 116 121 B-Procedure-Name
hip NCT03869203 122 125 I-Procedure-Name
arthroplasty NCT03869203 126 138 I-Procedure-Name
for NCT03869203 139 142 O
osteoarthritis NCT03869203 143 157 B-Condition-Name
of NCT03869203 158 160 O
osteonecrosis NCT03869203 161 174 B-Condition-Name
of NCT03869203 175 177 I-Condition-Name
femoral NCT03869203 178 185 I-Condition-Name
head NCT03869203 186 190 I-Condition-Name

Exclusion NCT03869203 191 200 O
Criteria NCT03869203 201 209 O
: NCT03869203 210 211 O

- NCT03869203 215 216 O
1 NCT03869203 219 220 O
. NCT03869203 220 221 O
ASA NCT03869203 223 226 B-Condition-Name
class NCT03869203 227 232 B-Eq-Unit
> NCT03869203 233 234 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03869203 236 237 B-Eq-Value

- NCT03869203 241 242 O
2 NCT03869203 245 246 O
. NCT03869203 246 247 O
severe NCT03869203 249 255 B-Severity___Severity-Value:severe
medical NCT03869203 256 263 B-Condition-Name
comorbidities NCT03869203 264 277 I-Condition-Name

- NCT03869203 280 281 O
3 NCT03869203 284 285 O
. NCT03869203 285 286 O
inflammatory NCT03869203 288 300 B-Condition-Name
arthritis NCT03869203 301 310 I-Condition-Name
including NCT03869203 311 320 O
rheumatoid NCT03869203 321 331 B-Condition-Name
arthritis NCT03869203 332 341 I-Condition-Name

- NCT03869203 344 345 O
4 NCT03869203 348 349 O
. NCT03869203 349 350 O
severe NCT03869203 352 358 B-Severity___Severity-Value:severe
instability NCT03869203 359 370 B-Condition-Name
of NCT03869203 371 373 O
knee NCT03869203 374 378 O
or NCT03869203 379 381 O
hip NCT03869203 382 385 O

- NCT03869203 388 389 O
5 NCT03869203 392 393 O
. NCT03869203 393 394 O
revision NCT03869203 396 404 O
surgery NCT03869203 405 412 B-Procedure-Name

Inclusion NCT03869502 0 9 O
Criteria NCT03869502 10 18 O
: NCT03869502 19 20 O

- NCT03869502 24 25 O
Age NCT03869502 27 30 O
> NCT03869502 31 32 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03869502 34 36 B-Eq-Value
years NCT03869502 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03869502 45 46 O
Diagnosis NCT03869502 48 57 O
of NCT03869502 58 60 O
BCR‐ABL NCT03869502 61 68 B-Condition-Name
positive NCT03869502 69 77 B-Polarity___Polarity-Value:positive
CML NCT03869502 78 81 O
blast NCT03869502 82 87 O
crisis NCT03869502 88 94 O
according NCT03869502 95 104 O
to NCT03869502 105 107 O
the NCT03869502 108 111 O
WHO NCT03869502 112 115 O
criteria NCT03869502 116 124 O
: NCT03869502 125 126 O

- NCT03869502 135 136 O
Blasts NCT03869502 138 144 B-Observation-Name___Observation-Type-Value:lab
20 NCT03869502 146 148 B-Eq-Value
% NCT03869502 149 150 B-Eq-Unit
or NCT03869502 151 153 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03869502 154 158 I-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03869502 159 161 O
peripheral NCT03869502 162 172 O
blood NCT03869502 173 178 O
white NCT03869502 179 184 O
cells NCT03869502 185 190 O
or NCT03869502 191 193 O
bone NCT03869502 194 198 O
marrow NCT03869502 199 205 O
cells NCT03869502 206 211 O
or NCT03869502 212 214 O

- NCT03869502 222 223 O
Extramedullary NCT03869502 225 239 O
blast NCT03869502 240 245 B-Condition-Name
proliferation NCT03869502 246 259 I-Condition-Name
or NCT03869502 260 262 O

- NCT03869502 270 271 O
Large NCT03869502 273 278 O
foci NCT03869502 279 283 O
or NCT03869502 284 286 O
clusters NCT03869502 287 295 O
of NCT03869502 296 298 O
blasts NCT03869502 299 305 B-Condition-Name
in NCT03869502 306 308 O
bone NCT03869502 309 313 B-Procedure-Name
marrow NCT03869502 314 320 I-Procedure-Name
biopsy NCT03869502 321 327 I-Procedure-Name

Exclusion NCT03869502 328 337 O
Criteria NCT03869502 338 346 O
: NCT03869502 347 348 O

- NCT03869502 352 353 O
Lack NCT03869502 355 359 O
of NCT03869502 360 362 O
informed NCT03869502 363 371 O
consent NCT03869502 372 379 O

Inclusion NCT03862443 0 9 O
Criteria NCT03862443 10 18 O
for NCT03862443 19 22 O
Parent NCT03862443 23 29 O
/ NCT03862443 30 31 O
Caregiver NCT03862443 32 41 O
: NCT03862443 42 43 O

- NCT03862443 47 48 O
Provide NCT03862443 50 57 O
signed NCT03862443 58 64 O
and NCT03862443 65 68 O
dated NCT03862443 69 74 O
informed NCT03862443 75 83 O
consent NCT03862443 84 91 O
form NCT03862443 92 96 O
in NCT03862443 97 99 O
English NCT03862443 100 107 B-Language
or NCT03862443 108 110 O
Spanish NCT03862443 111 118 B-Language
. NCT03862443 119 120 O

- NCT03862443 124 125 O
Agree NCT03862443 127 132 O
to NCT03862443 133 135 O
comply NCT03862443 136 142 O
with NCT03862443 143 147 O
all NCT03862443 148 151 O
study NCT03862443 152 157 O
procedures NCT03862443 158 168 O
and NCT03862443 169 172 O
be NCT03862443 173 175 O
available NCT03862443 176 185 O
for NCT03862443 186 189 O
the NCT03862443 190 193 O
duration NCT03862443 194 202 O
of NCT03862443 203 205 O
the NCT03862443 206 209 O
study NCT03862443 210 215 O
visit NCT03862443 216 221 O
. NCT03862443 222 223 O

- NCT03862443 227 228 O
Male NCT03862443 230 234 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03862443 235 237 O
female NCT03862443 238 244 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03862443 245 246 O
aged NCT03862443 247 251 O
18 NCT03862443 253 255 B-Eq-Value
and NCT03862443 256 259 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03862443 260 265 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03862443 266 267 O

- NCT03862443 271 272 O
Speak NCT03862443 274 279 O
, NCT03862443 280 281 O
read NCT03862443 282 286 O
, NCT03862443 287 288 O
and NCT03862443 289 292 O
write NCT03862443 293 298 O
either NCT03862443 299 305 O
English NCT03862443 306 313 B-Language
or NCT03862443 314 316 O
Spanish NCT03862443 317 324 B-Language
. NCT03862443 325 326 O

- NCT03862443 330 331 O
Be NCT03862443 333 335 O
a NCT03862443 336 337 O
parent NCT03862443 338 344 O
or NCT03862443 345 347 O
caregiver NCT03862443 348 357 O
of NCT03862443 358 360 O
a NCT03862443 361 362 O
child NCT03862443 363 368 O
at NCT03862443 369 371 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862443 372 377 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03862443 379 380 B-Eq-Value
months NCT03862443 381 387 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
old NCT03862443 388 391 O
but NCT03862443 392 395 O
less NCT03862443 396 400 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03862443 401 405 I-Eq-Operator___Eq-Operator-Value:LT
3.5 NCT03862443 407 410 B-Eq-Value
years NCT03862443 411 416 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03862443 417 418 O
42 NCT03862443 420 422 B-Eq-Value
months NCT03862443 423 429 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03862443 430 431 O
, NCT03862443 433 434 O
with NCT03862443 435 439 O
at NCT03862443 440 442 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862443 443 448 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03862443 450 451 B-Eq-Value
fully NCT03862443 452 457 O
erupted NCT03862443 458 465 O
teeth NCT03862443 466 471 B-Condition-Name
and NCT03862443 472 475 O
enrolled NCT03862443 476 484 O
in NCT03862443 485 487 O
, NCT03862443 488 489 O
or NCT03862443 490 492 O
waitlisted NCT03862443 493 503 O
for NCT03862443 504 507 O
, NCT03862443 508 509 O
one NCT03862443 510 513 O
of NCT03862443 514 516 O
the NCT03862443 517 520 O
three NCT03862443 521 526 O
participating NCT03862443 527 540 O
Los NCT03862443 541 544 O
Angeles NCT03862443 545 552 O
County NCT03862443 553 559 O
EHS NCT03862443 560 563 O
home NCT03862443 564 568 O
visit NCT03862443 569 574 O
programs NCT03862443 575 583 O
. NCT03862443 584 585 O

- NCT03862443 589 590 O
Not NCT03862443 592 595 O
be NCT03862443 596 598 O
planning NCT03862443 599 607 O
to NCT03862443 608 610 O
move NCT03862443 611 615 B-Observation-Name
residence NCT03862443 616 625 O
for NCT03862443 626 629 O
the NCT03862443 630 633 O
next NCT03862443 634 638 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
6 NCT03862443 640 641 B-Eq-Value
months NCT03862443 642 648 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
outside NCT03862443 649 656 O
the NCT03862443 657 660 O
greater NCT03862443 661 668 B-Location___Location-Value:residence
Los NCT03862443 669 672 I-Location___Location-Value:residence
Angeles NCT03862443 673 680 I-Location___Location-Value:residence
area NCT03862443 681 685 I-Location___Location-Value:residence
. NCT03862443 686 687 O

- NCT03862443 691 692 O
Own NCT03862443 694 697 O
a NCT03862443 698 699 O
smartphone NCT03862443 700 710 O
with NCT03862443 711 715 O
the NCT03862443 716 719 O
Google NCT03862443 720 726 O
Play NCT03862443 727 731 O
or NCT03862443 732 734 O
iTunes NCT03862443 735 741 O
store NCT03862443 742 747 O
and NCT03862443 748 751 O
be NCT03862443 752 754 O
willing NCT03862443 755 762 O
to NCT03862443 763 765 O
download NCT03862443 766 774 O
the NCT03862443 775 778 O
smart NCT03862443 779 784 O
powered NCT03862443 785 792 O
TB NCT03862443 793 795 O
app NCT03862443 796 799 O

- NCT03862443 802 803 O
Be NCT03862443 805 807 O
willing NCT03862443 808 815 O
to NCT03862443 816 818 O
be NCT03862443 819 821 O
contacted NCT03862443 822 831 O
via NCT03862443 832 835 O
text NCT03862443 836 840 O
- NCT03862443 841 842 O
messaging NCT03862443 843 852 O
( NCT03862443 853 854 O
SMS NCT03862443 855 858 O
) NCT03862443 859 860 O
for NCT03862443 861 864 O
study NCT03862443 865 870 O
related NCT03862443 871 878 O
notifications NCT03862443 879 892 O
, NCT03862443 893 894 O
such NCT03862443 895 899 O
as NCT03862443 900 902 O
incentives NCT03862443 903 913 O
earned NCT03862443 914 920 O
or NCT03862443 921 923 O
reminders NCT03862443 924 933 O
to NCT03862443 934 936 O
sync NCT03862443 937 941 O
the NCT03862443 942 945 O
TB NCT03862443 946 948 O

Exclusion NCT03862443 949 958 O
Criteria NCT03862443 959 967 O
: NCT03862443 968 969 O

- NCT03862443 973 974 O
Known NCT03862443 976 981 O
allergic NCT03862443 982 990 O
reaction NCT03862443 991 999 O
to NCT03862443 1000 1002 O
components NCT03862443 1003 1013 O
of NCT03862443 1014 1016 O
the NCT03862443 1017 1020 O
study NCT03862443 1021 1026 O
product NCT03862443 1027 1034 O
( NCT03862443 1035 1036 O
s NCT03862443 1037 1038 O
) NCT03862443 1039 1040 O
. NCT03862443 1042 1043 O

- NCT03862443 1047 1048 O
Uncooperative NCT03862443 1050 1063 B-Condition-Name
or NCT03862443 1064 1066 O
behaviorally NCT03862443 1067 1079 B-Condition-Name
unsuited NCT03862443 1080 1088 I-Condition-Name
( NCT03862443 1089 1090 O
assessed NCT03862443 1091 1099 O
during NCT03862443 1100 1106 O
a NCT03862443 1107 1108 O
TB NCT03862443 1109 1111 B-Procedure-Name
prophylaxis NCT03862443 1112 1123 I-Procedure-Name
at NCT03862443 1124 1126 O
the NCT03862443 1127 1130 O
initial NCT03862443 1131 1138 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
baseline NCT03862443 1139 1147 O
study NCT03862443 1148 1153 O
visit NCT03862443 1154 1159 O
) NCT03862443 1160 1161 O
. NCT03862443 1163 1164 O

- NCT03862443 1168 1169 O
A NCT03862443 1171 1172 O
sibling NCT03862443 1173 1180 O
of NCT03862443 1181 1183 O
a NCT03862443 1184 1185 O
child NCT03862443 1186 1191 O
already NCT03862443 1192 1199 O
enrolled NCT03862443 1200 1208 O
in NCT03862443 1209 1211 O
the NCT03862443 1212 1215 O
study NCT03862443 1216 1221 O
( NCT03862443 1222 1223 O
the NCT03862443 1224 1227 O
family NCT03862443 1228 1234 O
's NCT03862443 1234 1236 O
oldest NCT03862443 1237 1243 O
child NCT03862443 1244 1249 O
in NCT03862443 1250 1252 O
the NCT03862443 1253 1256 O
eligible NCT03862443 1257 1265 O
age NCT03862443 1266 1269 O
range NCT03862443 1270 1275 O
will NCT03862443 1276 1280 O
be NCT03862443 1281 1283 O
the NCT03862443 1284 1287 O
study NCT03862443 1288 1293 O
child NCT03862443 1294 1299 O
) NCT03862443 1300 1301 O
. NCT03862443 1303 1304 O

- NCT03862443 1308 1309 O
Enrolled NCT03862443 1311 1319 O
in NCT03862443 1320 1322 O
foster NCT03862443 1323 1329 B-Observation-Name
care NCT03862443 1330 1334 I-Observation-Name
. NCT03862443 1335 1336 O

- NCT03862443 1340 1341 O
Anything NCT03862443 1343 1351 O
else NCT03862443 1352 1356 O
that NCT03862443 1357 1361 O
would NCT03862443 1362 1367 O
place NCT03862443 1368 1373 O
him NCT03862443 1374 1377 O
/ NCT03862443 1378 1379 O
her NCT03862443 1380 1383 O
at NCT03862443 1384 1386 O
increased NCT03862443 1387 1396 B-Polarity___Polarity-Value:high
health NCT03862443 1397 1403 O
risk NCT03862443 1404 1408 O
or NCT03862443 1409 1411 O
preclude NCT03862443 1412 1420 O
the NCT03862443 1421 1424 O
individual NCT03862443 1425 1435 O
's NCT03862443 1435 1437 O
full NCT03862443 1438 1442 O
compliance NCT03862443 1443 1453 O
with NCT03862443 1454 1458 O
or NCT03862443 1459 1461 O
completion NCT03862443 1462 1472 O
of NCT03862443 1473 1475 O
the NCT03862443 1476 1479 O
study NCT03862443 1480 1485 O
. NCT03862443 1486 1487 O

Inclusion NCT03868813 0 9 O
Criteria NCT03868813 10 18 O
: NCT03868813 19 20 O

Health NCT03868813 22 28 O
Coaches NCT03868813 29 36 O
Group NCT03868813 37 42 O
: NCT03868813 43 44 O

( NCT03868813 47 48 O
i NCT03868813 49 50 O
) NCT03868813 51 52 O
age NCT03868813 53 56 O
between NCT03868813 57 64 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03868813 66 68 B-Eq-Value
and NCT03868813 69 72 O
80 NCT03868813 74 76 B-Eq-Value
years NCT03868813 77 82 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03868813 83 84 O
ii NCT03868813 85 87 O
) NCT03868813 88 89 O
fluent NCT03868813 90 96 O
in NCT03868813 97 99 O
English NCT03868813 100 107 B-Language
( NCT03868813 108 109 O
iii NCT03868813 110 113 O
) NCT03868813 114 115 O
work NCT03868813 116 120 O
in NCT03868813 121 123 O
or NCT03868813 124 126 O
carry NCT03868813 127 132 O
expertise NCT03868813 133 142 O
in NCT03868813 143 145 O
physical NCT03868813 146 154 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03868813 155 163 I-Observation-Name___Observation-Type-Value:social-habit
, NCT03868813 164 165 O
nutrition NCT03868813 166 175 B-Condition-Name
/ NCT03868813 176 177 O
diet NCT03868813 178 182 B-Observation-Name___Observation-Type-Value:social-habit
or NCT03868813 183 185 O
health NCT03868813 186 192 B-Condition-Name
behavior NCT03868813 193 201 I-Condition-Name
. NCT03868813 202 203 O

People NCT03868813 205 211 O
with NCT03868813 212 216 O
Diabetes NCT03868813 217 225 O
Group NCT03868813 226 231 O
( NCT03868813 232 233 O
Patient NCT03868813 234 241 O
/ NCT03868813 242 243 O
Caregiver NCT03868813 244 253 O
Dyads NCT03868813 254 259 O
) NCT03868813 260 261 O
: NCT03868813 263 264 O

( NCT03868813 267 268 O
i NCT03868813 269 270 O
) NCT03868813 271 272 O
age NCT03868813 273 276 O
between NCT03868813 277 284 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03868813 286 288 B-Eq-Value
and NCT03868813 289 292 O
80 NCT03868813 294 296 B-Eq-Value
years NCT03868813 297 302 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03868813 303 304 O
ii NCT03868813 305 307 O
) NCT03868813 308 309 O
fluent NCT03868813 310 316 O
in NCT03868813 317 319 O
English NCT03868813 320 327 B-Language
( NCT03868813 328 329 O
iii NCT03868813 330 333 O
) NCT03868813 334 335 O
have NCT03868813 336 340 O
Type NCT03868813 341 345 O
- NCT03868813 346 347 O
II NCT03868813 348 350 O
diabetes NCT03868813 351 359 B-Condition-Name
. NCT03868813 360 361 O

Exclusion NCT03868813 363 372 O
Criteria NCT03868813 373 381 O
: NCT03868813 382 383 O

None NCT03868813 385 389 O


Inclusion NCT03864224 0 9 O
Criteria NCT03864224 10 18 O
: NCT03864224 19 20 O

- NCT03864224 24 25 O
Patients NCT03864224 27 35 O
must NCT03864224 36 40 O
have NCT03864224 41 45 O
persistent NCT03864224 46 56 O
low NCT03864224 57 60 O
back NCT03864224 61 65 O
pain NCT03864224 66 70 B-Condition-Name
of NCT03864224 71 73 O
at NCT03864224 74 76 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864224 77 82 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03864224 84 85 B-Eq-Value
month NCT03864224 86 91 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
's NCT03864224 91 93 O
duration NCT03864224 94 102 O
. NCT03864224 103 104 O

Exclusion NCT03864224 106 115 O
Criteria NCT03864224 116 124 O
: NCT03864224 125 126 O

- NCT03864224 130 131 O
Participating NCT03864224 133 146 O
currently NCT03864224 147 156 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
in NCT03864224 157 159 O
a NCT03864224 160 161 O
supervised NCT03864224 162 172 O
exercise NCT03864224 173 181 O
or NCT03864224 182 184 O
rehabilitation NCT03864224 185 199 O
program NCT03864224 200 207 B-Procedure-Name
or NCT03864224 208 210 O
enrolled NCT03864224 211 219 O
in NCT03864224 220 222 O
another NCT03864224 223 230 O
interventional NCT03864224 231 245 O
clinical NCT03864224 246 254 O
trial NCT03864224 255 260 O
. NCT03864224 261 262 O

- NCT03864224 266 267 O
Patients NCT03864224 269 277 O
with NCT03864224 278 282 O
nerve NCT03864224 283 288 B-Condition-Name
root NCT03864224 289 293 I-Condition-Name
involvement NCT03864224 294 305 I-Condition-Name
, NCT03864224 306 307 O
suspected NCT03864224 308 317 O
serious NCT03864224 318 325 B-Severity___Severity-Value:severe
pathology NCT03864224 326 335 B-Condition-Name
, NCT03864224 336 337 O
unstable NCT03864224 338 346 B-Stability___Stability-Value:change
trauma NCT03864224 347 353 B-Condition-Name
to NCT03864224 354 356 O
the NCT03864224 357 360 O
spine NCT03864224 361 366 O
, NCT03864224 367 368 O
aspects NCT03864224 369 376 O
of NCT03864224 377 379 O
pregnancy NCT03864224 380 389 B-Condition-Name
or NCT03864224 390 392 O
other NCT03864224 393 398 O
conditions NCT03864224 399 409 O
that NCT03864224 410 414 O
would NCT03864224 415 420 O
prevent NCT03864224 421 428 O
participation NCT03864224 429 442 O
or NCT03864224 443 445 O
disallow NCT03864224 446 454 O
trial NCT03864224 455 460 O
completion NCT03864224 461 471 O
within NCT03864224 472 478 O
the NCT03864224 479 482 O
prescribed NCT03864224 483 493 O
time NCT03864224 494 498 O
period NCT03864224 499 505 O
. NCT03864224 506 507 O

- NCT03864224 511 512 O
Persons NCT03864224 514 521 O
with NCT03864224 522 526 O
conditions NCT03864224 527 537 O
that NCT03864224 538 542 O
require NCT03864224 543 550 O
a NCT03864224 551 552 O
specialist NCT03864224 553 563 O
consult NCT03864224 564 571 O
are NCT03864224 572 575 O
suspected NCT03864224 576 585 O
of NCT03864224 586 588 O
needing NCT03864224 589 596 O
a NCT03864224 597 598 O
specialist NCT03864224 599 609 O
consult NCT03864224 610 617 O
, NCT03864224 618 619 O
or NCT03864224 620 622 O
have NCT03864224 623 627 O
conditions NCT03864224 628 638 O
that NCT03864224 639 643 O
would NCT03864224 644 649 O
be NCT03864224 650 652 O
aggravated NCT03864224 653 663 B-Stability___Stability-Value:change
or NCT03864224 664 666 O
worsened NCT03864224 667 675 B-Stability___Stability-Value:change
if NCT03864224 676 678 O
treated NCT03864224 679 686 O
by NCT03864224 687 689 O
the NCT03864224 690 693 O
interventions NCT03864224 694 707 O
in NCT03864224 708 710 O
this NCT03864224 711 715 O
study NCT03864224 716 721 O
. NCT03864224 722 723 O

Inclusion NCT03868436 0 9 O
Criteria NCT03868436 10 18 O
: NCT03868436 19 20 O

1 NCT03868436 25 26 O
. NCT03868436 26 27 O
Conscious NCT03868436 29 38 O
adult NCT03868436 39 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03868436 45 53 O
: NCT03868436 54 55 O
≥ NCT03868436 56 57 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868436 59 61 B-Eq-Value
years NCT03868436 62 67 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03868436 68 70 O
age NCT03868436 71 74 O

2 NCT03868436 78 79 O
. NCT03868436 79 80 O
Moderate NCT03868436 82 90 B-Severity___Severity-Value:moderate
to NCT03868436 91 93 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03868436 94 100 B-Severity___Severity-Value:severe
pain NCT03868436 101 105 B-Condition-Name
associated NCT03868436 106 116 O
with NCT03868436 117 121 O
trauma NCT03868436 122 128 B-Condition-Name
( NCT03868436 129 130 O
NRS NCT03868436 131 134 B-Observation-Name
0 NCT03868436 135 136 I-Observation-Name
- NCT03868436 137 138 I-Observation-Name
10 NCT03868436 140 142 I-Observation-Name
≥ NCT03868436 143 144 B-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03868436 146 147 B-Eq-Value
) NCT03868436 148 149 O
which NCT03868436 150 155 O
is NCT03868436 156 158 O
unlikely NCT03868436 159 167 O
to NCT03868436 168 170 O
require NCT03868436 171 178 O
surgery NCT03868436 179 186 B-Procedure-Name
/ NCT03868436 187 188 O
hospitalization NCT03868436 189 204 B-Encounter-Type___Encounter-Type-Value:inpatient
, NCT03868436 205 206 O
such NCT03868436 207 211 O
as NCT03868436 212 214 O

- NCT03868436 222 223 O
Musculoskeletal NCT03868436 225 240 O
injuries NCT03868436 241 249 B-Condition-Name
and NCT03868436 250 253 O
physical NCT03868436 254 262 O
wounds NCT03868436 263 269 B-Condition-Name

- NCT03868436 277 278 O
Fractures NCT03868436 280 289 B-Condition-Name

- NCT03868436 297 298 O
Lacerations NCT03868436 300 311 B-Condition-Name

- NCT03868436 319 320 O
Burns NCT03868436 322 327 B-Condition-Name

- NCT03868436 335 336 O
Dislocations NCT03868436 338 350 O

- NCT03868436 358 359 O
Contusions NCT03868436 361 371 B-Condition-Name

- NCT03868436 379 380 O
Injury NCT03868436 382 388 B-Condition-Name
due NCT03868436 389 392 O
to NCT03868436 393 395 O
foreign NCT03868436 396 403 B-Condition-Name
bodies NCT03868436 404 410 I-Condition-Name

3 NCT03868436 414 415 O
. NCT03868436 415 416 O
Patient NCT03868436 418 425 O
( NCT03868436 426 427 O
and NCT03868436 428 431 O
/ NCT03868436 432 433 O
or NCT03868436 434 436 O
patient NCT03868436 437 444 O
's NCT03868436 444 446 O
authorized NCT03868436 447 457 O
legal NCT03868436 458 463 O
representative NCT03868436 464 478 O
) NCT03868436 479 480 O
should NCT03868436 481 487 O
understand NCT03868436 488 498 O
the NCT03868436 499 502 O
nature NCT03868436 503 509 O
of NCT03868436 510 512 O
the NCT03868436 513 516 O
study NCT03868436 517 522 O
and NCT03868436 523 526 O
provide NCT03868436 527 534 O
written NCT03868436 535 542 O
informed NCT03868436 543 551 O
consent NCT03868436 552 559 O

4 NCT03868436 563 564 O
. NCT03868436 564 565 O
Patient NCT03868436 567 574 O
is NCT03868436 575 577 O
able NCT03868436 578 582 O
to NCT03868436 583 585 O
follow NCT03868436 586 592 O
all NCT03868436 593 596 O
study NCT03868436 597 602 O
requirements NCT03868436 603 615 O
and NCT03868436 616 619 O
procedures NCT03868436 620 630 O
and NCT03868436 631 634 O
complete NCT03868436 635 643 O
required NCT03868436 644 652 O
questionnaires NCT03868436 653 667 O

Exclusion NCT03868436 668 677 O
Criteria NCT03868436 678 686 O
: NCT03868436 687 688 O

1 NCT03868436 693 694 O
. NCT03868436 694 695 O
Multi NCT03868436 697 702 B-Condition-Name
- NCT03868436 703 704 I-Condition-Name
level NCT03868436 705 710 I-Condition-Name
trauma NCT03868436 711 717 I-Condition-Name

2 NCT03868436 721 722 O
. NCT03868436 722 723 O
Women NCT03868436 725 730 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03868436 731 733 O
child NCT03868436 734 739 B-Condition-Name
bearing NCT03868436 740 747 I-Condition-Name
potential NCT03868436 748 757 I-Condition-Name
who NCT03868436 758 761 O
are NCT03868436 762 765 O
pregnant NCT03868436 766 774 B-Condition-Name
or NCT03868436 775 777 O
peri NCT03868436 778 782 B-Condition-Name
partum NCT03868436 783 789 I-Condition-Name
, NCT03868436 790 791 O
including NCT03868436 792 801 O
labour NCT03868436 802 808 B-Condition-Name

3 NCT03868436 812 813 O
. NCT03868436 813 814 O
An NCT03868436 816 818 O
altered NCT03868436 819 826 B-Condition-Name
level NCT03868436 827 832 I-Condition-Name
of NCT03868436 833 835 I-Condition-Name
consciousness NCT03868436 836 849 I-Condition-Name
, NCT03868436 850 851 O
due NCT03868436 852 855 O
to NCT03868436 856 858 O
any NCT03868436 859 862 O
cause NCT03868436 863 868 O
, NCT03868436 869 870 O
including NCT03868436 871 880 O
head NCT03868436 881 885 O
injury NCT03868436 886 892 B-Condition-Name
, NCT03868436 893 894 O
drugs NCT03868436 895 900 B-Drug-Name
, NCT03868436 901 902 O
or NCT03868436 903 905 O
alcohol NCT03868436 906 913 B-Drug-Name

4 NCT03868436 917 918 O
. NCT03868436 918 919 O
Clinically NCT03868436 921 931 O
significant NCT03868436 932 943 B-Severity___Severity-Value:severe
renal NCT03868436 944 949 B-Condition-Name
impairment NCT03868436 950 960 I-Condition-Name

5 NCT03868436 964 965 O
. NCT03868436 965 966 O
A NCT03868436 968 969 O
history NCT03868436 970 977 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868436 978 980 O
liver NCT03868436 981 986 B-Condition-Name
dysfunction NCT03868436 987 998 I-Condition-Name
after NCT03868436 999 1004 O
previous NCT03868436 1005 1013 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
MEOF NCT03868436 1014 1018 B-Drug-Name
use NCT03868436 1019 1022 O
or NCT03868436 1023 1025 O
other NCT03868436 1026 1031 O
halogenated NCT03868436 1032 1043 B-Drug-Name
anesthetics NCT03868436 1044 1055 I-Drug-Name

6 NCT03868436 1059 1060 O
. NCT03868436 1060 1061 O
Hypersensitivity NCT03868436 1063 1079 B-Condition-Name
to NCT03868436 1080 1082 O
MEOF NCT03868436 1083 1087 B-Drug-Name
or NCT03868436 1088 1090 O
other NCT03868436 1091 1096 O
halogenated NCT03868436 1097 1108 B-Drug-Name
anesthetics NCT03868436 1109 1120 I-Drug-Name
, NCT03868436 1121 1122 O
or NCT03868436 1123 1125 O
to NCT03868436 1126 1128 O
butylated NCT03868436 1129 1138 B-Drug-Name
hydroxytoluene NCT03868436 1139 1153 I-Drug-Name

7 NCT03868436 1157 1158 O
. NCT03868436 1158 1159 O
Known NCT03868436 1161 1166 O
or NCT03868436 1167 1169 O
genetically NCT03868436 1170 1181 O
susceptible NCT03868436 1182 1193 O
to NCT03868436 1194 1196 O
malignant NCT03868436 1197 1206 O
hyperthermia NCT03868436 1207 1219 B-Condition-Name
or NCT03868436 1220 1222 O
a NCT03868436 1223 1224 O
history NCT03868436 1225 1232 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868436 1233 1235 O
severe NCT03868436 1236 1242 B-Severity___Severity-Value:severe
adverse NCT03868436 1243 1250 B-Condition-Name
reactions NCT03868436 1251 1260 I-Condition-Name
in NCT03868436 1261 1263 O
either NCT03868436 1264 1270 O
patient NCT03868436 1271 1278 O
or NCT03868436 1279 1281 O
relatives NCT03868436 1282 1291 O

8 NCT03868436 1295 1296 O
. NCT03868436 1296 1297 O
Exacerbation NCT03868436 1299 1311 B-Stability___Stability-Value:change
of NCT03868436 1312 1314 O
an NCT03868436 1315 1317 O
underlying NCT03868436 1318 1328 O
condition NCT03868436 1329 1338 O
( NCT03868436 1339 1340 O
i NCT03868436 1341 1342 O
. NCT03868436 1343 1344 O
e NCT03868436 1345 1346 O
. NCT03868436 1347 1348 O
, NCT03868436 1349 1350 O
chronic NCT03868436 1351 1358 O
pain NCT03868436 1359 1363 B-Condition-Name
) NCT03868436 1364 1365 O

9 NCT03868436 1370 1371 O
. NCT03868436 1371 1372 O
Clinically NCT03868436 1374 1384 O
evident NCT03868436 1385 1392 O
or NCT03868436 1393 1395 O
potential NCT03868436 1396 1405 O
hemodynamic NCT03868436 1406 1417 B-Condition-Name
instability NCT03868436 1418 1429 B-Stability___Stability-Value:change
as NCT03868436 1430 1432 O
per NCT03868436 1433 1436 O
the NCT03868436 1437 1440 O
opinion NCT03868436 1441 1448 O
of NCT03868436 1449 1451 O
the NCT03868436 1452 1455 O
investigator NCT03868436 1456 1468 O

10 NCT03868436 1471 1473 O
. NCT03868436 1473 1474 O
Clinically NCT03868436 1476 1486 O
evident NCT03868436 1487 1494 B-Severity___Severity-Value:severe
respiratory NCT03868436 1495 1506 B-Condition-Name
impairment NCT03868436 1507 1517 I-Condition-Name
as NCT03868436 1518 1520 O
per NCT03868436 1521 1524 O
the NCT03868436 1525 1528 O
opinion NCT03868436 1529 1536 O
of NCT03868436 1537 1539 O
the NCT03868436 1540 1543 O
investigator NCT03868436 1544 1556 O

11 NCT03868436 1559 1561 O
. NCT03868436 1561 1562 O
Prior NCT03868436 1564 1569 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03868436 1570 1579 O
with NCT03868436 1580 1584 O
PENTHROX NCT03868436 1585 1593 B-Drug-Name
within NCT03868436 1594 1600 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03868436 1602 1603 B-Eq-Value
months NCT03868436 1604 1610 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03869112 0 9 O
Criteria NCT03869112 10 18 O
: NCT03869112 19 20 O

- NCT03869112 24 25 O
Participant NCT03869112 27 38 O
is NCT03869112 39 41 O
willing NCT03869112 42 49 O
and NCT03869112 50 53 O
able NCT03869112 54 58 O
to NCT03869112 59 61 O
give NCT03869112 62 66 O
informed NCT03869112 67 75 O
consent NCT03869112 76 83 O
for NCT03869112 84 87 O
participation NCT03869112 88 101 O
in NCT03869112 102 104 O
the NCT03869112 105 108 O
study NCT03869112 109 114 O

- NCT03869112 117 118 O
Male NCT03869112 120 124 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03869112 125 127 O
Female NCT03869112 128 134 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03869112 135 136 O
aged NCT03869112 137 141 O
40 NCT03869112 143 145 B-Eq-Value
years NCT03869112 146 151 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
to NCT03869112 152 154 B-Eq-Operator___Eq-Operator-Value:BETWEEN
85 NCT03869112 156 158 B-Eq-Value
years NCT03869112 159 164 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03869112 165 166 O

- NCT03869112 170 171 O
Diagnosed NCT03869112 173 182 O
with NCT03869112 183 187 O
COPD NCT03869112 188 192 B-Condition-Name

- NCT03869112 195 196 O
Able NCT03869112 198 202 O
( NCT03869112 203 204 O
in NCT03869112 205 207 O
the NCT03869112 208 211 O
Investigators NCT03869112 212 225 O
opinion NCT03869112 226 233 O
) NCT03869112 234 235 O
and NCT03869112 236 239 O
willing NCT03869112 240 247 O
to NCT03869112 248 250 O
comply NCT03869112 251 257 O
with NCT03869112 258 262 O
all NCT03869112 263 266 O
study NCT03869112 267 272 O
requirements NCT03869112 273 285 O
. NCT03869112 286 287 O

- NCT03869112 291 292 O
Participant NCT03869112 294 305 O
is NCT03869112 306 308 O
willing NCT03869112 309 316 O
to NCT03869112 317 319 O
attend NCT03869112 320 326 O
visits NCT03869112 327 333 O
at NCT03869112 334 336 O
baseline NCT03869112 337 345 O
and NCT03869112 346 349 O
8 NCT03869112 351 352 B-Eq-Value
weeks NCT03869112 353 358 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03869112 359 360 O
sub NCT03869112 361 364 O
- NCT03869112 365 366 O
group NCT03869112 367 372 O
: NCT03869112 373 374 O
baseline NCT03869112 375 383 O
, NCT03869112 384 385 O
8 NCT03869112 387 388 O
weeks NCT03869112 389 394 O
) NCT03869112 395 396 O

- NCT03869112 404 405 O
Able NCT03869112 407 411 O
to NCT03869112 412 414 O
read NCT03869112 415 419 O
and NCT03869112 420 423 O
understand NCT03869112 424 434 O
English NCT03869112 435 442 B-Language

Exclusion NCT03869112 443 452 O
Criteria NCT03869112 453 461 O
: NCT03869112 462 463 O

- NCT03869112 467 468 O
Age NCT03869112 470 473 O
< NCT03869112 474 475 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03869112 477 479 B-Eq-Value

- NCT03869112 483 484 O
Attended NCT03869112 486 494 O
a NCT03869112 495 496 O
pulmonary NCT03869112 497 506 B-Procedure-Name
rehabilitation NCT03869112 507 521 I-Procedure-Name
programme NCT03869112 522 531 O
or NCT03869112 532 534 O
participating NCT03869112 535 548 O
in NCT03869112 549 551 O
a NCT03869112 552 553 O
physical NCT03869112 554 562 B-Procedure-Name
activity NCT03869112 563 571 I-Procedure-Name
intervention NCT03869112 572 584 I-Procedure-Name
study NCT03869112 585 590 O
in NCT03869112 591 593 O
current NCT03869112 594 601 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
time NCT03869112 602 606 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03869112 607 609 O
in NCT03869112 610 612 O
the NCT03869112 613 616 O
last NCT03869112 617 621 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03869112 623 624 B-Eq-Value
months NCT03869112 625 631 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03869112 632 633 O

- NCT03869112 637 638 O
Any NCT03869112 640 643 O
other NCT03869112 644 649 O
significant NCT03869112 650 661 B-Severity___Severity-Value:severe
diseases NCT03869112 662 670 B-Condition-Name
or NCT03869112 671 673 O
disorders NCT03869112 674 683 B-Condition-Name
that NCT03869112 684 688 O
are NCT03869112 689 692 O
a NCT03869112 693 694 O
contraindication NCT03869112 695 711 O
to NCT03869112 712 714 O
be NCT03869112 715 717 O
enrolled NCT03869112 718 726 O
in NCT03869112 727 729 O
a NCT03869112 730 731 O
pulmonary NCT03869112 732 741 B-Procedure-Name
rehabilitation NCT03869112 742 756 I-Procedure-Name
programme NCT03869112 757 766 O
. NCT03869112 767 768 O


Inclusion NCT03861572 0 9 O
Criteria NCT03861572 10 18 O
: NCT03861572 19 20 O

- NCT03861572 24 25 O
Participants NCT03861572 27 39 O
will NCT03861572 40 44 O
be NCT03861572 45 47 O
male NCT03861572 48 52 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03861572 53 56 O
female NCT03861572 57 63 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subjects NCT03861572 64 72 O
who NCT03861572 73 76 O
suffered NCT03861572 77 85 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
total NCT03861572 86 91 O
acute NCT03861572 92 97 B-Severity___Severity-Value:severe
Achilles NCT03861572 98 106 B-Condition-Name
tendon NCT03861572 107 113 I-Condition-Name
rupture NCT03861572 114 121 I-Condition-Name
, NCT03861572 122 123 O
and NCT03861572 124 127 O
which NCT03861572 128 133 O
underwent NCT03861572 134 143 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgical NCT03861572 144 152 B-Procedure-Name
repair NCT03861572 153 159 I-Procedure-Name
. NCT03861572 160 161 O
In NCT03861572 163 165 O
addition NCT03861572 166 174 O
, NCT03861572 175 176 O
to NCT03861572 177 179 O
participate NCT03861572 180 191 O
in NCT03861572 192 194 O
this NCT03861572 195 199 O
study NCT03861572 200 205 O
all NCT03861572 206 209 O
volunteers NCT03861572 210 220 O
will NCT03861572 221 225 O
need NCT03861572 226 230 O
to NCT03861572 231 233 O
present NCT03861572 234 241 O
medical NCT03861572 242 249 O
and NCT03861572 250 253 O
/ NCT03861572 254 255 O
or NCT03861572 256 258 O
physiotherapeutic NCT03861572 259 276 O
release NCT03861572 277 284 O
for NCT03861572 285 288 O
physical NCT03861572 289 297 O
/ NCT03861572 298 299 O
sports NCT03861572 300 306 O
activities NCT03861572 307 317 O
practice NCT03861572 318 326 O
. NCT03861572 327 328 O

Exclusion NCT03861572 330 339 O
Criteria NCT03861572 340 348 O
: NCT03861572 349 350 O

- NCT03861572 354 355 O
Volunteers NCT03861572 357 367 O
that NCT03861572 368 372 O
did NCT03861572 373 376 O
not NCT03861572 377 380 O
have NCT03861572 381 385 O
Achilles NCT03861572 386 394 B-Procedure-Name
tendon NCT03861572 395 401 I-Procedure-Name
surgical NCT03861572 402 410 I-Procedure-Name
reconstruction NCT03861572 411 425 I-Procedure-Name
, NCT03861572 426 427 O
that NCT03861572 428 432 O
did NCT03861572 433 436 O
not NCT03861572 437 440 O
present NCT03861572 441 448 O
medical NCT03861572 449 456 O
and NCT03861572 457 460 O
/ NCT03861572 461 462 O
or NCT03861572 463 465 O
physiotherapeutic NCT03861572 466 483 O
release NCT03861572 484 491 B-Observation-Name
for NCT03861572 492 495 O
physical NCT03861572 496 504 O
/ NCT03861572 505 506 O
sports NCT03861572 507 513 O
activities NCT03861572 514 524 O
, NCT03861572 525 526 O
who NCT03861572 527 530 O
have NCT03861572 531 535 O
participated NCT03861572 536 548 O
in NCT03861572 549 551 O
strength NCT03861572 552 560 B-Procedure-Name
training NCT03861572 561 569 I-Procedure-Name
program NCT03861572 570 577 I-Procedure-Name
for NCT03861572 578 581 O
the NCT03861572 582 585 O
plantar NCT03861572 586 593 O
flexors NCT03861572 594 601 O
in NCT03861572 602 604 O
the NCT03861572 605 608 O
last NCT03861572 609 613 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03861572 615 616 B-Eq-Value
months NCT03861572 617 623 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03861572 624 625 O
patients NCT03861572 626 634 O
with NCT03861572 635 639 O
diabetic NCT03861572 640 648 B-Condition-Name
diseases NCT03861572 649 657 I-Condition-Name
, NCT03861572 658 659 O
as NCT03861572 660 662 O
well NCT03861572 663 667 O
as NCT03861572 668 670 O
those NCT03861572 671 676 O
with NCT03861572 677 681 O
difficulty NCT03861572 682 692 O
for NCT03861572 693 696 O
understanding NCT03861572 697 710 O
and NCT03861572 711 714 O
/ NCT03861572 715 716 O
or NCT03861572 717 719 O
executing NCT03861572 720 729 O
the NCT03861572 730 733 O
test NCT03861572 734 738 O
and NCT03861572 739 742 O
training NCT03861572 743 751 O
protocols NCT03861572 752 761 O
in NCT03861572 762 764 O
the NCT03861572 765 768 O
isokinetic NCT03861572 769 779 O
dynamometer NCT03861572 780 791 O
will NCT03861572 792 796 O
be NCT03861572 797 799 O
excluded NCT03861572 800 808 O
. NCT03861572 809 810 O

Inclusion NCT03864393 0 9 O
Criteria NCT03864393 10 18 O
: NCT03864393 19 20 O

- NCT03864393 24 25 O
18 NCT03864393 28 30 B-Eq-Value
years NCT03864393 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03864393 37 39 O
age NCT03864393 40 43 O
or NCT03864393 44 46 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03864393 47 52 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03864393 55 56 O
diagnosis NCT03864393 58 67 O
of NCT03864393 68 70 O
idiopathic NCT03864393 71 81 O
Parkinson NCT03864393 82 91 B-Condition-Name
's NCT03864393 91 93 I-Condition-Name
Disease NCT03864393 94 101 I-Condition-Name
, NCT03864393 102 103 O
mild NCT03864393 104 108 B-Severity___Severity-Value:mild
to NCT03864393 109 111 B-Eq-Operator___Eq-Operator-Value:BETWEEN
moderate NCT03864393 112 120 B-Severity___Severity-Value:moderate
( NCT03864393 121 122 O
Hoehn NCT03864393 123 128 B-Observation-Name___Observation-Type-Value:clinical-score
and NCT03864393 129 132 I-Observation-Name___Observation-Type-Value:clinical-score
Yahr NCT03864393 133 137 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03864393 138 143 I-Observation-Name___Observation-Type-Value:clinical-score
less NCT03864393 144 148 B-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03864393 149 153 I-Eq-Operator___Eq-Operator-Value:LTEQ
or NCT03864393 154 156 I-Eq-Operator___Eq-Operator-Value:LTEQ
equal NCT03864393 157 162 I-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03864393 163 165 O
3 NCT03864393 167 168 B-Eq-Value
) NCT03864393 169 170 O

- NCT03864393 174 175 O
speaks NCT03864393 177 183 O
English NCT03864393 184 191 B-Language

- NCT03864393 194 195 O
able NCT03864393 197 201 B-Condition-Name
to NCT03864393 202 204 I-Condition-Name
ambulate NCT03864393 205 213 I-Condition-Name
without NCT03864393 214 221 O
requiring NCT03864393 222 231 O
an NCT03864393 232 234 O
assistive NCT03864393 235 244 B-Procedure-Name
device NCT03864393 245 251 I-Procedure-Name

Exclusion NCT03864393 252 261 O
Criteria NCT03864393 262 270 O
: NCT03864393 271 272 O

- NCT03864393 276 277 O
neurological NCT03864393 279 291 B-Condition-Name
disease NCT03864393 292 299 I-Condition-Name
diagnosis NCT03864393 300 309 O
other NCT03864393 310 315 O
than NCT03864393 316 320 O
PD NCT03864393 321 323 B-Condition-Name

- NCT03864393 326 327 O
uncontrolled NCT03864393 329 341 O
cardiovascular NCT03864393 342 356 O
, NCT03864393 357 358 O
pulmonary NCT03864393 359 368 O
, NCT03864393 369 370 O
neurological NCT03864393 371 383 O
, NCT03864393 384 385 O
or NCT03864393 386 388 O
metabolic NCT03864393 389 398 O
disease NCT03864393 399 406 B-Condition-Name
which NCT03864393 407 412 O
may NCT03864393 413 416 O
impact NCT03864393 417 423 B-Stability___Stability-Value:change
the NCT03864393 424 427 O
ability NCT03864393 428 435 O
to NCT03864393 436 438 O
exercise NCT03864393 439 447 B-Observation-Name___Observation-Type-Value:social-habit
or NCT03864393 448 450 O
in NCT03864393 451 453 O
which NCT03864393 454 459 O
exercise NCT03864393 460 468 B-Observation-Name___Observation-Type-Value:social-habit
is NCT03864393 469 471 O
contraindicated NCT03864393 472 487 O

- NCT03864393 490 491 O
any NCT03864393 493 496 O
medications NCT03864393 497 508 O
, NCT03864393 509 510 O
such NCT03864393 511 515 O
as NCT03864393 516 518 O
beta NCT03864393 519 523 B-Drug-Name
- NCT03864393 524 525 I-Drug-Name
blockers NCT03864393 526 534 I-Drug-Name
, NCT03864393 535 536 O
that NCT03864393 537 541 O
may NCT03864393 542 545 O
alter NCT03864393 546 551 B-Stability___Stability-Value:change
HR NCT03864393 552 554 B-Observation-Name___Observation-Type-Value:vital
or NCT03864393 555 557 O
metabolic NCT03864393 558 567 B-Observation-Name
data NCT03864393 568 572 I-Observation-Name

- NCT03864393 575 576 O
cognitive NCT03864393 578 587 O
or NCT03864393 588 590 O
psychiatric NCT03864393 591 602 O
impairment NCT03864393 603 613 B-Condition-Name
precluding NCT03864393 614 624 O
informed NCT03864393 625 633 O
consent NCT03864393 634 641 O
or NCT03864393 642 644 O
ability NCT03864393 645 652 O
to NCT03864393 653 655 O
following NCT03864393 656 665 O
instructions NCT03864393 666 678 O

- NCT03864393 681 682 O
mini NCT03864393 684 688 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03864393 689 690 I-Observation-Name___Observation-Type-Value:clinical-score
Mental NCT03864393 691 697 I-Observation-Name___Observation-Type-Value:clinical-score
State NCT03864393 698 703 I-Observation-Name___Observation-Type-Value:clinical-score
Examination NCT03864393 704 715 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03864393 716 721 O
< NCT03864393 722 723 B-Eq-Operator___Eq-Operator-Value:LT
24 NCT03864393 725 727 B-Eq-Value

- NCT03864393 731 732 O
pregnancy NCT03864393 734 743 B-Condition-Name

Inclusion NCT03866590 0 9 O
Criteria NCT03866590 10 18 O
: NCT03866590 19 20 O

- NCT03866590 24 25 O
Informed NCT03866590 27 35 O
consent NCT03866590 36 43 O
is NCT03866590 44 46 O
obtained NCT03866590 47 55 O
from NCT03866590 56 60 O
the NCT03866590 61 64 O
participant NCT03866590 65 76 O
or NCT03866590 77 79 O
its NCT03866590 80 83 O
legal NCT03866590 84 89 O
representatives NCT03866590 90 105 O

- NCT03866590 108 109 O
The NCT03866590 111 114 O
participant NCT03866590 115 126 O
is NCT03866590 127 129 O
older NCT03866590 130 135 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866590 136 140 I-Eq-Operator___Eq-Operator-Value:GT
14 NCT03866590 142 144 B-Eq-Value
years NCT03866590 145 150 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03866590 151 154 O
younger NCT03866590 155 162 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03866590 163 167 I-Eq-Operator___Eq-Operator-Value:LT
25 NCT03866590 169 171 B-Eq-Value
years NCT03866590 172 177 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866590 178 181 O

- NCT03866590 184 185 O
The NCT03866590 187 190 O
patient NCT03866590 191 198 O
exhibits NCT03866590 199 207 O
chronic NCT03866590 208 215 O
anaemia NCT03866590 216 223 B-Condition-Name
or NCT03866590 224 226 O
cholelithiasis NCT03866590 227 241 B-Condition-Name
or NCT03866590 242 244 O
cholecystitis NCT03866590 245 258 B-Condition-Name
of NCT03866590 259 261 O
undetermined NCT03866590 262 274 O
aetiology NCT03866590 275 284 O
or NCT03866590 285 287 O
The NCT03866590 288 291 O
patient NCT03866590 292 299 O
has NCT03866590 300 303 O
a NCT03866590 304 305 O
high NCT03866590 306 310 B-Polarity___Polarity-Value:high
- NCT03866590 311 312 O
grade NCT03866590 313 318 O
PKD NCT03866590 319 322 B-Condition-Name
suspicion NCT03866590 323 332 O
due NCT03866590 333 336 O
to NCT03866590 337 339 O
any NCT03866590 340 343 O
clinical NCT03866590 344 352 O
item NCT03866590 353 357 O
or NCT03866590 358 360 O
The NCT03866590 361 364 O
patient NCT03866590 365 372 O
is NCT03866590 373 375 O
diagnosed NCT03866590 376 385 O
biochemically NCT03866590 386 399 B-Procedure-Name
and NCT03866590 400 403 O
/ NCT03866590 404 405 O
or NCT03866590 406 408 O
genetically NCT03866590 409 420 B-Procedure-Name
with NCT03866590 421 425 O
PKD NCT03866590 426 429 B-Condition-Name

Exclusion NCT03866590 430 439 O
Criteria NCT03866590 440 448 O
: NCT03866590 449 450 O

- NCT03866590 454 455 O
Inability NCT03866590 457 466 O
to NCT03866590 467 469 O
provide NCT03866590 470 477 O
informed NCT03866590 478 486 O
consent NCT03866590 487 494 O

- NCT03866590 497 498 O
The NCT03866590 500 503 O
patient NCT03866590 504 511 O
does NCT03866590 512 516 O
not NCT03866590 517 520 O
suffer NCT03866590 521 527 O
from NCT03866590 528 532 O
chronic NCT03866590 533 540 O
anaemia NCT03866590 541 548 B-Condition-Name
or NCT03866590 549 551 O
cholelithiasis NCT03866590 552 566 B-Condition-Name
or NCT03866590 567 569 O
cholecystitis NCT03866590 570 583 B-Condition-Name

- NCT03866590 586 587 O
The NCT03866590 589 592 O
aetiology NCT03866590 593 602 O
of NCT03866590 603 605 O
chronic NCT03866590 606 613 O
anaemia NCT03866590 614 621 B-Condition-Name
or NCT03866590 622 624 O
cholelithiasis NCT03866590 625 639 B-Condition-Name
or NCT03866590 640 642 O
cholecystitis NCT03866590 643 656 B-Condition-Name
is NCT03866590 657 659 O
determined NCT03866590 660 670 O
and NCT03866590 671 674 O
is NCT03866590 675 677 O
not NCT03866590 678 681 O
due NCT03866590 682 685 O
to NCT03866590 686 688 O
PKD NCT03866590 689 692 B-Condition-Name

- NCT03866590 695 696 O
The NCT03866590 698 701 O
participant NCT03866590 702 713 O
is NCT03866590 714 716 O
younger NCT03866590 717 724 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03866590 725 729 I-Eq-Operator___Eq-Operator-Value:LT
14 NCT03866590 731 733 B-Eq-Value
years NCT03866590 734 739 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03866590 740 742 O
older NCT03866590 743 748 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866590 749 753 I-Eq-Operator___Eq-Operator-Value:GT
25 NCT03866590 755 757 B-Eq-Value
years NCT03866590 758 763 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866590 764 767 O

- NCT03866590 770 771 O
Previously NCT03866590 773 783 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
enrolled NCT03866590 784 792 O
in NCT03866590 793 795 O
the NCT03866590 796 799 O
study NCT03866590 800 805 O

Inclusion NCT03869476 0 9 O
Criteria NCT03869476 10 18 O
: NCT03869476 19 20 O

- NCT03869476 24 25 O
Adult NCT03869476 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03869476 33 34 O
18 NCT03869476 36 38 B-Eq-Value
years NCT03869476 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869476 45 47 O
age NCT03869476 48 51 O
or NCT03869476 52 54 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03869476 55 60 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03869476 61 62 O
with NCT03869476 63 67 O
the NCT03869476 68 71 O
diagnosis NCT03869476 72 81 O
of NCT03869476 82 84 O
essential NCT03869476 85 94 O
thrombocytosis NCT03869476 95 109 B-Condition-Name
, NCT03869476 110 111 O
prefibrotic NCT03869476 112 123 B-Condition-Name
myelofibrosis NCT03869476 124 137 I-Condition-Name
or NCT03869476 138 140 O
overt NCT03869476 141 146 O
myelofibrosis NCT03869476 147 160 B-Condition-Name
according NCT03869476 161 170 O
to NCT03869476 171 173 O
WHO NCT03869476 174 177 O
2016 NCT03869476 179 183 O
criteria NCT03869476 184 192 O
; NCT03869476 192 193 O

- NCT03869476 196 197 O
Patient NCT03869476 199 206 O
who NCT03869476 207 210 O
has NCT03869476 211 214 O
not NCT03869476 215 218 O
received NCT03869476 219 227 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
specific NCT03869476 228 236 O
treatment NCT03869476 237 246 O
for NCT03869476 247 250 O
neoplasms NCT03869476 251 260 B-Condition-Name
; NCT03869476 260 261 O

- NCT03869476 264 265 O
Patient NCT03869476 267 274 O
who NCT03869476 275 278 O
has NCT03869476 279 282 O
signed NCT03869476 283 289 O
the NCT03869476 290 293 O
consent NCT03869476 294 301 O
to NCT03869476 302 304 O
participate NCT03869476 305 316 O
in NCT03869476 317 319 O
the NCT03869476 320 323 O
study NCT03869476 324 329 O
; NCT03869476 329 330 O

- NCT03869476 333 334 O
Patient NCT03869476 336 343 O
who NCT03869476 344 347 O
has NCT03869476 348 351 O
consented NCT03869476 352 361 O
to NCT03869476 362 364 O
be NCT03869476 365 367 O
included NCT03869476 368 376 O
in NCT03869476 377 379 O
the NCT03869476 380 383 O
" NCT03869476 384 385 O
Malignant NCT03869476 385 394 O
Haemopathies NCT03869476 395 407 O
" NCT03869476 407 408 O
collection NCT03869476 409 419 O
at NCT03869476 420 422 O
the NCT03869476 423 426 O
University NCT03869476 427 437 B-Location___Location-Value:hospital
Hospital NCT03869476 438 446 I-Location___Location-Value:hospital
of NCT03869476 447 449 I-Location___Location-Value:hospital
Angers NCT03869476 450 456 I-Location___Location-Value:hospital
or NCT03869476 457 459 O
Brest NCT03869476 460 465 B-Location___Location-Value:hospital
and NCT03869476 466 469 O
for NCT03869476 470 473 O
whom NCT03869476 474 478 O
the NCT03869476 479 482 O
samples NCT03869476 483 490 O
necessary NCT03869476 491 500 O
for NCT03869476 501 504 O
the NCT03869476 505 508 O
study NCT03869476 509 514 O
are NCT03869476 515 518 O
available NCT03869476 519 528 O
in NCT03869476 529 531 O
the NCT03869476 532 535 O
biocollection NCT03869476 536 549 O
. NCT03869476 550 551 O

Exclusion NCT03869476 553 562 O
Criteria NCT03869476 563 571 O
: NCT03869476 572 573 O

- NCT03869476 577 578 O
Patient NCT03869476 580 587 O
with NCT03869476 588 592 O
another NCT03869476 593 600 O
hematologic NCT03869476 601 612 B-Condition-Name
neoplasm NCT03869476 613 621 I-Condition-Name
or NCT03869476 622 624 O
progressive NCT03869476 625 636 O
cancer NCT03869476 637 643 B-Condition-Name
at NCT03869476 644 646 O
the NCT03869476 647 650 O
time NCT03869476 651 655 O
of NCT03869476 656 658 O
diagnosis NCT03869476 659 668 O
; NCT03869476 668 669 O

- NCT03869476 672 673 O
Patient NCT03869476 675 682 O
with NCT03869476 683 687 O
a NCT03869476 688 689 O
diagnosis NCT03869476 690 699 O
of NCT03869476 700 702 O
secondary NCT03869476 703 712 O
myelofibrosis NCT03869476 713 726 B-Condition-Name
; NCT03869476 726 727 O

- NCT03869476 730 731 O
Pregnant NCT03869476 733 741 B-Condition-Name
or NCT03869476 742 744 O
breastfeeding NCT03869476 745 758 B-Condition-Name
woman NCT03869476 759 764 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
; NCT03869476 764 765 O

- NCT03869476 768 769 O
Person NCT03869476 771 777 O
prived NCT03869476 778 784 B-Observation-Name
of NCT03869476 785 787 I-Observation-Name
liberty NCT03869476 788 795 I-Observation-Name
by NCT03869476 796 798 O
judicial NCT03869476 799 807 O
or NCT03869476 808 810 O
administrative NCT03869476 811 825 O
decision NCT03869476 826 834 O
; NCT03869476 834 835 O

- NCT03869476 838 839 O
Person NCT03869476 841 847 O
subject NCT03869476 848 855 O
to NCT03869476 856 858 O
a NCT03869476 859 860 O
legal NCT03869476 861 866 B-Observation-Name
protection NCT03869476 867 877 I-Observation-Name
measure NCT03869476 878 885 I-Observation-Name
; NCT03869476 885 886 O

Inclusion NCT03869489 0 9 O
Criteria NCT03869489 10 18 O
: NCT03869489 19 20 O

- NCT03869489 24 25 O
Normal NCT03869489 27 33 B-Polarity___Polarity-Value:normal
hearing NCT03869489 34 41 B-Condition-Name
and NCT03869489 42 45 O
vision NCT03869489 46 52 B-Condition-Name

Exclusion NCT03869489 53 62 O
Criteria NCT03869489 63 71 O
: NCT03869489 72 73 O

- NCT03869489 77 78 O
Left NCT03869489 80 84 B-Condition-Name
- NCT03869489 85 86 I-Condition-Name
handedness NCT03869489 87 97 I-Condition-Name

- NCT03869489 100 101 O
History NCT03869489 103 110 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869489 111 113 O
seizure NCT03869489 114 121 B-Condition-Name
, NCT03869489 122 123 O
head NCT03869489 124 128 O
injury NCT03869489 129 135 B-Condition-Name
( NCT03869489 136 137 O
including NCT03869489 138 147 O
neurosurgery NCT03869489 148 160 B-Procedure-Name
) NCT03869489 161 162 O
, NCT03869489 164 165 O
brain NCT03869489 166 171 O
injury NCT03869489 172 178 B-Condition-Name
, NCT03869489 179 180 O
diagnosis NCT03869489 181 190 O
or NCT03869489 191 193 O
a NCT03869489 194 195 O
neurological NCT03869489 196 208 O
or NCT03869489 209 211 O
psychiatric NCT03869489 212 223 O
disorder NCT03869489 224 232 B-Condition-Name
, NCT03869489 233 234 O
metal NCT03869489 235 240 B-Condition-Name
in NCT03869489 241 243 I-Condition-Name
the NCT03869489 244 247 I-Condition-Name
head NCT03869489 248 252 I-Condition-Name
, NCT03869489 253 254 O
sensitive NCT03869489 255 264 B-Condition-Name
scalp NCT03869489 265 270 I-Condition-Name

- NCT03869489 273 274 O
History NCT03869489 276 283 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869489 284 286 O
anxiolytic NCT03869489 287 297 B-Drug-Name
and NCT03869489 298 301 O
/ NCT03869489 302 303 O
or NCT03869489 304 306 O
antidepressant NCT03869489 307 321 B-Drug-Name
medications NCT03869489 322 333 I-Drug-Name

- NCT03869489 336 337 O
Participation NCT03869489 339 352 O
in NCT03869489 353 355 O
Experiment NCT03869489 356 366 O
# NCT03869489 367 368 O
1 NCT03869489 369 370 O
or NCT03869489 371 373 O
Experiment NCT03869489 374 384 O
# NCT03869489 385 386 O
2 NCT03869489 387 388 O
of NCT03869489 389 391 O
the NCT03869489 392 395 O
larger NCT03869489 396 402 O
study NCT03869489 403 408 O

Inclusion NCT03863210 0 9 O
Criteria NCT03863210 10 18 O
: NCT03863210 19 20 O

- NCT03863210 24 25 O
female NCT03863210 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
sex NCT03863210 34 37 O

- NCT03863210 40 41 O
age NCT03863210 43 46 O
45 NCT03863210 48 50 B-Eq-Value
to NCT03863210 51 53 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03863210 55 57 B-Eq-Value
years NCT03863210 58 63 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03863210 66 67 O
one NCT03863210 69 72 B-Eq-Value
or NCT03863210 73 75 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03863210 76 80 I-Eq-Operator___Eq-Operator-Value:GTEQ
CV NCT03863210 81 83 B-Condition-Name
risk NCT03863210 84 88 O
factors NCT03863210 89 96 O
[ NCT03863210 97 98 O
overweight NCT03863210 99 109 B-Condition-Name
or NCT03863210 110 112 O
obesity NCT03863210 113 120 B-Condition-Name
, NCT03863210 121 122 O
i NCT03863210 123 124 O
. NCT03863210 125 126 O
e NCT03863210 128 129 O
. NCT03863210 130 131 O
body NCT03863210 133 137 B-Observation-Name___Observation-Type-Value:vital
mass NCT03863210 138 142 I-Observation-Name___Observation-Type-Value:vital
index NCT03863210 143 148 I-Observation-Name___Observation-Type-Value:vital
( NCT03863210 149 150 O
BMI NCT03863210 151 154 B-Observation-Name___Observation-Type-Value:vital
) NCT03863210 155 156 O
≥ NCT03863210 157 158 B-Eq-Operator___Eq-Operator-Value:GTEQ
25 NCT03863210 160 162 B-Eq-Value
kg NCT03863210 163 165 B-Eq-Unit
/ NCT03863210 166 167 O
m NCT03863210 168 169 B-Eq-Unit
2 NCT03863210 170 171 I-Eq-Unit
, NCT03863210 172 173 O
and NCT03863210 174 177 O
/ NCT03863210 178 179 O
or NCT03863210 180 182 O
central NCT03863210 183 190 O
obesity NCT03863210 191 198 B-Condition-Name
- NCT03863210 199 200 O
waist NCT03863210 201 206 B-Observation-Name___Observation-Type-Value:measurement
circumference NCT03863210 207 220 I-Observation-Name___Observation-Type-Value:measurement
≥ NCT03863210 221 222 B-Eq-Operator___Eq-Operator-Value:GTEQ
88 NCT03863210 224 226 B-Eq-Value
cm NCT03863210 227 229 B-Eq-Unit
, NCT03863210 230 231 O
high NCT03863210 232 236 B-Polarity___Polarity-Value:high
blood NCT03863210 237 242 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03863210 243 251 I-Observation-Name___Observation-Type-Value:vital
( NCT03863210 252 253 O
systolic NCT03863210 254 262 B-Observation-Name___Observation-Type-Value:vital
blood NCT03863210 263 268 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03863210 269 277 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03863210 278 279 B-Eq-Operator___Eq-Operator-Value:GTEQ
140 NCT03863210 281 284 B-Eq-Value
mm NCT03863210 285 287 B-Eq-Unit
Hg NCT03863210 288 290 I-Eq-Unit
and NCT03863210 291 294 O
/ NCT03863210 295 296 O
or NCT03863210 297 299 O
diastolic NCT03863210 300 309 B-Observation-Name___Observation-Type-Value:vital
blood NCT03863210 310 315 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03863210 316 324 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03863210 325 326 B-Eq-Operator___Eq-Operator-Value:GTEQ
90 NCT03863210 328 330 B-Eq-Value
mm NCT03863210 331 333 B-Eq-Unit
Hg NCT03863210 334 336 I-Eq-Unit
) NCT03863210 337 338 O
, NCT03863210 340 341 O
high NCT03863210 342 346 B-Polarity___Polarity-Value:high
blood NCT03863210 347 352 B-Observation-Name___Observation-Type-Value:lab
cholesterol NCT03863210 353 364 I-Observation-Name___Observation-Type-Value:lab
( NCT03863210 365 366 O
≥ NCT03863210 368 369 B-Eq-Operator___Eq-Operator-Value:GTEQ
5.2 NCT03863210 371 374 B-Eq-Value
mmol NCT03863210 375 379 B-Eq-Unit
/ NCT03863210 380 381 O
L NCT03863210 382 383 B-Eq-Unit
) NCT03863210 384 385 O
and NCT03863210 386 389 O
active NCT03863210 390 396 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
smoking NCT03863210 397 404 B-Condition-Name
] NCT03863210 405 406 O

- NCT03863210 410 411 O
participants NCT03863210 413 425 O
on NCT03863210 426 428 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
antihypertensive NCT03863210 429 445 B-Procedure-Name
therapy NCT03863210 446 453 I-Procedure-Name
were NCT03863210 454 458 O
also NCT03863210 459 463 O
included NCT03863210 464 472 O
in NCT03863210 473 475 O
the NCT03863210 476 479 O
study NCT03863210 480 485 O

Exclusion NCT03863210 486 495 O
Criteria NCT03863210 496 504 O
: NCT03863210 505 506 O

- NCT03863210 510 511 O
current NCT03863210 513 520 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cardiovascular NCT03863210 521 535 B-Condition-Name
disease NCT03863210 536 543 I-Condition-Name
( NCT03863210 544 545 O
CVD NCT03863210 546 549 B-Condition-Name
) NCT03863210 550 551 O
( NCT03863210 552 553 O
ischemic NCT03863210 554 562 B-Condition-Name
heart NCT03863210 563 568 I-Condition-Name
disease NCT03863210 569 576 I-Condition-Name
, NCT03863210 577 578 O
peripheral NCT03863210 579 589 B-Condition-Name
artery NCT03863210 590 596 I-Condition-Name
disease NCT03863210 597 604 I-Condition-Name
, NCT03863210 605 606 O
and NCT03863210 607 610 O
stroke NCT03863210 611 617 B-Condition-Name
) NCT03863210 618 619 O

- NCT03863210 623 624 O
malignant NCT03863210 626 635 B-Condition-Name
diseases NCT03863210 636 644 I-Condition-Name

- NCT03863210 647 648 O
serious NCT03863210 650 657 B-Severity___Severity-Value:severe
systemic NCT03863210 658 666 O
or NCT03863210 667 669 O
mental NCT03863210 670 676 O
diseases NCT03863210 677 685 B-Condition-Name

Inclusion NCT03868345 0 9 O
Criteria NCT03868345 10 18 O
: NCT03868345 19 20 O

1 NCT03868345 25 26 O
. NCT03868345 26 27 O
male NCT03868345 29 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03868345 34 36 O
female NCT03868345 37 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03868345 44 45 O
age NCT03868345 46 49 O
21 NCT03868345 51 53 B-Eq-Value
or NCT03868345 54 56 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03868345 57 62 I-Eq-Operator___Eq-Operator-Value:GTEQ
, NCT03868345 63 64 O

2 NCT03868345 69 70 O
. NCT03868345 70 71 O
diagnosed NCT03868345 73 82 O
with NCT03868345 83 87 O
definite NCT03868345 88 96 O
, NCT03868345 97 98 O
probable NCT03868345 99 107 O
, NCT03868345 108 109 O
or NCT03868345 110 112 O
possible NCT03868345 113 121 O
ALS NCT03868345 122 125 B-Condition-Name
according NCT03868345 126 135 O
to NCT03868345 136 138 O
the NCT03868345 139 142 O
modified NCT03868345 143 151 O
El NCT03868345 152 154 O
Escorial NCT03868345 155 163 O
Criteria NCT03868345 164 172 O
, NCT03868345 173 174 O

3 NCT03868345 179 180 O
. NCT03868345 180 181 O
a NCT03868345 183 184 O
score NCT03868345 185 190 O
of NCT03868345 191 193 O
2 NCT03868345 195 196 B-Eq-Value
or NCT03868345 197 199 B-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03868345 200 207 I-Eq-Operator___Eq-Operator-Value:GTEQ
on NCT03868345 208 210 O
the NCT03868345 211 214 O
speech NCT03868345 215 221 B-Observation-Name___Observation-Type-Value:clinical-score
question NCT03868345 222 230 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03868345 231 233 I-Observation-Name___Observation-Type-Value:clinical-score
the NCT03868345 234 237 I-Observation-Name___Observation-Type-Value:clinical-score
ALSFRS NCT03868345 238 244 I-Observation-Name___Observation-Type-Value:clinical-score
- NCT03868345 245 246 I-Observation-Name___Observation-Type-Value:clinical-score
R NCT03868345 247 248 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03868345 249 250 O
i NCT03868345 251 252 O
. NCT03868345 253 254 O
e NCT03868345 255 256 O
. NCT03868345 257 258 O
speech NCT03868345 260 266 B-Condition-Name
is NCT03868345 267 269 O
intelligible NCT03868345 270 282 O
with NCT03868345 283 287 O
occasional NCT03868345 288 298 O
repetition NCT03868345 299 309 O
) NCT03868345 310 311 O
, NCT03868345 313 314 O

4 NCT03868345 319 320 O
. NCT03868345 320 321 O
continuous NCT03868345 323 333 O
internet NCT03868345 334 342 O
access NCT03868345 343 349 O
at NCT03868345 350 352 O
home NCT03868345 353 357 O
, NCT03868345 358 359 O

5 NCT03868345 364 365 O
. NCT03868345 365 366 O
willingness NCT03868345 368 379 O
and NCT03868345 380 383 O
medical NCT03868345 384 391 O
ability NCT03868345 392 399 O
to NCT03868345 400 402 O
comply NCT03868345 403 409 O
with NCT03868345 410 414 O
scheduled NCT03868345 415 424 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
visits NCT03868345 425 431 O
and NCT03868345 432 435 O
study NCT03868345 436 441 O
procedures NCT03868345 442 452 O
, NCT03868345 453 454 O

6 NCT03868345 459 460 O
. NCT03868345 460 461 O
ability NCT03868345 463 470 O
to NCT03868345 471 473 O
understand NCT03868345 474 484 O
the NCT03868345 485 488 O
purpose NCT03868345 489 496 O
and NCT03868345 497 500 O
risks NCT03868345 501 506 O
of NCT03868345 507 509 O
the NCT03868345 510 513 O
study NCT03868345 514 519 O
and NCT03868345 520 523 O
provide NCT03868345 524 531 O
signed NCT03868345 532 538 O
and NCT03868345 539 542 O
dated NCT03868345 543 548 O
informed NCT03868345 549 557 O
consent NCT03868345 558 565 O
and NCT03868345 566 569 O
authorization NCT03868345 570 583 O
to NCT03868345 584 586 O
use NCT03868345 587 590 O
protected NCT03868345 591 600 O
health NCT03868345 601 607 O
information NCT03868345 608 619 O
( NCT03868345 620 621 O
PHI NCT03868345 622 625 O
) NCT03868345 626 627 O
in NCT03868345 628 630 O
accordance NCT03868345 631 641 O
with NCT03868345 642 646 O
national NCT03868345 647 655 O
and NCT03868345 656 659 O
local NCT03868345 660 665 O
subject NCT03868345 666 673 O
privacy NCT03868345 674 681 O
regulations NCT03868345 682 693 O
, NCT03868345 694 695 O

7 NCT03868345 700 701 O
. NCT03868345 701 702 O
geographic NCT03868345 704 714 O
accessibility NCT03868345 715 728 O
to NCT03868345 729 731 O
study NCT03868345 732 737 O
site NCT03868345 738 742 O
, NCT03868345 743 744 O

8 NCT03868345 749 750 O
. NCT03868345 750 751 O
for NCT03868345 753 756 O
the NCT03868345 757 760 O
25 NCT03868345 762 764 O
participants NCT03868345 765 777 O
in NCT03868345 778 780 O
Group NCT03868345 781 786 O
1 NCT03868345 788 789 O
, NCT03868345 790 791 O
NO NCT03868345 792 794 O
noted NCT03868345 795 800 O
symptoms NCT03868345 801 809 O
of NCT03868345 810 812 O
frontotemporal NCT03868345 813 827 B-Condition-Name
cognitive NCT03868345 828 837 I-Condition-Name
dysfunction NCT03868345 838 849 I-Condition-Name
, NCT03868345 850 851 O
and NCT03868345 852 855 O

9 NCT03868345 859 860 O
. NCT03868345 860 861 O
for NCT03868345 863 866 O
the NCT03868345 867 870 O
25 NCT03868345 872 874 O
participants NCT03868345 875 887 O
in NCT03868345 888 890 O
Group NCT03868345 891 896 O
2 NCT03868345 898 899 O
, NCT03868345 900 901 O
MUST NCT03868345 902 906 O
have NCT03868345 907 911 O
cognitive NCT03868345 912 921 B-Condition-Name
symptoms NCT03868345 922 930 O
as NCT03868345 931 933 O
noted NCT03868345 934 939 O
either NCT03868345 940 946 O
by NCT03868345 947 949 O
themselves NCT03868345 950 960 O
or NCT03868345 961 963 O
a NCT03868345 964 965 O
caregiver NCT03868345 966 975 O
. NCT03868345 976 977 O

Exclusion NCT03868345 979 988 O
Criteria NCT03868345 989 997 O
: NCT03868345 998 999 O

1 NCT03868345 1004 1005 O
. NCT03868345 1005 1006 O
unwilling NCT03868345 1008 1017 O
or NCT03868345 1018 1020 O
unable NCT03868345 1021 1027 O
to NCT03868345 1028 1030 O
comply NCT03868345 1031 1037 O
with NCT03868345 1038 1042 O
the NCT03868345 1043 1046 O
requirements NCT03868345 1047 1059 O
of NCT03868345 1060 1062 O
this NCT03868345 1063 1067 O
protocol NCT03868345 1068 1076 O
, NCT03868345 1077 1078 O
including NCT03868345 1079 1088 O
the NCT03868345 1089 1092 O
presence NCT03868345 1093 1101 O
of NCT03868345 1102 1104 O
any NCT03868345 1105 1108 O
condition NCT03868345 1109 1118 O
( NCT03868345 1119 1120 O
physical NCT03868345 1121 1129 O
, NCT03868345 1130 1131 O
mental NCT03868345 1132 1138 O
, NCT03868345 1139 1140 O
or NCT03868345 1141 1143 O
social NCT03868345 1144 1150 O
) NCT03868345 1151 1152 O
that NCT03868345 1153 1157 O
is NCT03868345 1158 1160 O
likely NCT03868345 1161 1167 O
to NCT03868345 1168 1170 O
affect NCT03868345 1171 1177 B-Stability___Stability-Value:change
the NCT03868345 1178 1181 O
participant NCT03868345 1182 1193 O
's NCT03868345 1193 1195 O
ability NCT03868345 1196 1203 O
to NCT03868345 1204 1206 O
comply NCT03868345 1207 1213 O
with NCT03868345 1214 1218 O
the NCT03868345 1219 1222 O
protocol NCT03868345 1223 1231 O
, NCT03868345 1232 1233 O
and NCT03868345 1234 1237 O

2 NCT03868345 1241 1242 O
. NCT03868345 1242 1243 O
any NCT03868345 1245 1248 O
other NCT03868345 1249 1254 O
reasons NCT03868345 1255 1262 O
that NCT03868345 1263 1267 O
, NCT03868345 1268 1269 O
in NCT03868345 1270 1272 O
the NCT03868345 1273 1276 O
opinion NCT03868345 1277 1284 O
of NCT03868345 1285 1287 O
the NCT03868345 1288 1291 O
PI NCT03868345 1292 1294 O
, NCT03868345 1295 1296 O
cause NCT03868345 1297 1302 O
the NCT03868345 1303 1306 O
candidate NCT03868345 1307 1316 O
to NCT03868345 1317 1319 O
be NCT03868345 1320 1322 O
deemed NCT03868345 1323 1329 O
unsuitable NCT03868345 1330 1340 O
for NCT03868345 1341 1344 O
entry NCT03868345 1345 1350 O
into NCT03868345 1351 1355 O
the NCT03868345 1356 1359 O
study NCT03868345 1360 1365 O
. NCT03868345 1366 1367 O

Inclusion NCT03862898 0 9 O
Criteria NCT03862898 10 18 O
: NCT03862898 19 20 O

- NCT03862898 24 25 O
patients NCT03862898 27 35 O
with NCT03862898 36 40 O
lumbar NCT03862898 41 47 O
pain NCT03862898 48 52 B-Condition-Name
present NCT03862898 53 60 O
for NCT03862898 61 64 O
more NCT03862898 65 69 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862898 70 74 I-Eq-Operator___Eq-Operator-Value:GT
12 NCT03862898 76 78 B-Eq-Value
weeks NCT03862898 79 84 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03862898 85 86 O

- NCT03862898 90 91 O
pain NCT03862898 93 97 B-Condition-Name
during NCT03862898 98 104 O
changing NCT03862898 105 113 B-Observation-Name
of NCT03862898 114 116 I-Observation-Name
the NCT03862898 117 120 I-Observation-Name
position NCT03862898 121 129 I-Observation-Name
, NCT03862898 130 131 O

- NCT03862898 135 136 O
radicular NCT03862898 138 147 O
pain NCT03862898 148 152 B-Condition-Name
. NCT03862898 153 154 O

Exclusion NCT03862898 156 165 O
Criteria NCT03862898 166 174 O
: NCT03862898 175 176 O

- NCT03862898 180 181 O
Cauda NCT03862898 183 188 B-Condition-Name
equina NCT03862898 189 195 I-Condition-Name
syndrome NCT03862898 196 204 I-Condition-Name
, NCT03862898 205 206 O

- NCT03862898 210 211 O
ankylosing NCT03862898 213 223 B-Condition-Name
spondylitis NCT03862898 224 235 I-Condition-Name
, NCT03862898 236 237 O

- NCT03862898 241 242 O
thoracic NCT03862898 244 252 B-Condition-Name
deformities NCT03862898 253 264 I-Condition-Name
( NCT03862898 265 266 O
pectus NCT03862898 267 273 B-Condition-Name
carinatum NCT03862898 274 283 I-Condition-Name
, NCT03862898 284 285 O
excavatum NCT03862898 286 295 B-Condition-Name
) NCT03862898 296 297 O
, NCT03862898 299 300 O

- NCT03862898 304 305 O
spina NCT03862898 307 312 B-Condition-Name
bifida NCT03862898 313 319 I-Condition-Name
, NCT03862898 320 321 O

- NCT03862898 325 326 O
fractures NCT03862898 328 337 B-Condition-Name
, NCT03862898 338 339 O

- NCT03862898 343 344 O
post NCT03862898 346 350 O
- NCT03862898 351 352 O
operative NCT03862898 353 362 B-Procedure-Name
spinal NCT03862898 363 369 B-Condition-Name
conditions NCT03862898 370 380 I-Condition-Name
, NCT03862898 381 382 O

- NCT03862898 386 387 O
diabetes NCT03862898 389 397 B-Condition-Name
, NCT03862898 398 399 O

- NCT03862898 403 404 O
inflammatory NCT03862898 406 418 B-Condition-Name
processes NCT03862898 419 428 I-Condition-Name
, NCT03862898 429 430 O

- NCT03862898 434 435 O
tumors NCT03862898 437 443 B-Condition-Name
, NCT03862898 444 445 O

- NCT03862898 449 450 O
pregnancy NCT03862898 452 461 B-Condition-Name
. NCT03862898 462 463 O

Inclusion NCT03869073 0 9 O
Criteria NCT03869073 10 18 O
: NCT03869073 19 20 O

- NCT03869073 24 25 O
Signed NCT03869073 27 33 O
informed NCT03869073 34 42 O
consent NCT03869073 43 50 O

- NCT03869073 53 54 O
At NCT03869073 56 58 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869073 59 64 I-Eq-Operator___Eq-Operator-Value:GTEQ
19 NCT03869073 66 68 B-Eq-Value
years NCT03869073 69 74 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869073 75 77 O
age NCT03869073 78 81 O

- NCT03869073 84 85 O
Known NCT03869073 87 92 O
or NCT03869073 93 95 O
suspected NCT03869073 96 105 O
infection NCT03869073 106 115 B-Condition-Name

- NCT03869073 118 119 O
AND NCT03869073 121 124 O
one NCT03869073 125 128 B-Eq-Value
or NCT03869073 129 131 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03869073 132 136 I-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03869073 137 139 O
the NCT03869073 140 143 O
following NCT03869073 144 153 O
organ NCT03869073 154 159 B-Condition-Name
dysfunctions NCT03869073 160 172 I-Condition-Name
judged NCT03869073 173 179 O
due NCT03869073 180 183 O
to NCT03869073 184 186 O
sepsis NCT03869073 187 193 B-Condition-Name
: NCT03869073 194 195 O

1 NCT03869073 205 206 O
. NCT03869073 206 207 O
Cardiovascular NCT03869073 209 223 O
- NCT03869073 224 225 O
refractory NCT03869073 226 236 O
hypotension NCT03869073 237 248 B-Condition-Name
( NCT03869073 249 250 O
a NCT03869073 251 252 O
systolic NCT03869073 253 261 B-Observation-Name___Observation-Type-Value:vital
blood NCT03869073 262 267 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03869073 268 276 I-Observation-Name___Observation-Type-Value:vital
( NCT03869073 277 278 O
SBP NCT03869073 279 282 B-Observation-Name
) NCT03869073 283 284 O
< NCT03869073 285 286 B-Eq-Operator___Eq-Operator-Value:LT
90 NCT03869073 288 290 B-Eq-Value
mm NCT03869073 291 293 B-Eq-Unit
Hg NCT03869073 294 296 I-Eq-Unit
or NCT03869073 297 299 O
mean NCT03869073 300 304 B-Observation-Name___Observation-Type-Value:measurement
arterial NCT03869073 305 313 I-Observation-Name___Observation-Type-Value:measurement
pressure NCT03869073 314 322 I-Observation-Name___Observation-Type-Value:measurement
( NCT03869073 323 324 O
MAP NCT03869073 325 328 B-Observation-Name
) NCT03869073 329 330 O
< NCT03869073 331 332 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03869073 334 336 B-Eq-Value
mm NCT03869073 337 339 B-Eq-Unit
Hg NCT03869073 340 342 I-Eq-Unit
despite NCT03869073 343 350 O
an NCT03869073 351 353 O
IV NCT03869073 354 356 B-Observation-Name___Observation-Type-Value:measurement
fluid NCT03869073 357 362 I-Observation-Name___Observation-Type-Value:measurement
challenge NCT03869073 363 372 I-Observation-Name___Observation-Type-Value:measurement
of NCT03869073 373 375 O
at NCT03869073 376 378 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03869073 379 384 I-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03869073 386 388 B-Eq-Value
ml NCT03869073 389 391 B-Eq-Unit
/ NCT03869073 392 393 O
kg NCT03869073 394 396 B-Eq-Unit
fluids NCT03869073 397 403 O
) NCT03869073 404 405 O
, NCT03869073 407 408 O
or NCT03869073 409 411 O
use NCT03869073 412 415 O
of NCT03869073 416 418 O
vasopressor NCT03869073 419 430 B-Procedure-Name
( NCT03869073 431 432 I-Procedure-Name
s NCT03869073 433 434 I-Procedure-Name
) NCT03869073 435 436 O
to NCT03869073 437 439 O
maintain NCT03869073 440 448 O
SAP NCT03869073 449 452 B-Observation-Name
> NCT03869073 453 454 B-Eq-Operator___Eq-Operator-Value:GT
90 NCT03869073 456 458 B-Eq-Value
mm NCT03869073 459 461 B-Eq-Unit
Hg NCT03869073 462 464 I-Eq-Unit
or NCT03869073 465 467 O
MAP NCT03869073 468 471 B-Observation-Name
> NCT03869073 472 473 B-Eq-Operator___Eq-Operator-Value:GT
60 NCT03869073 475 477 B-Eq-Value
mm NCT03869073 478 480 B-Eq-Unit
Hg NCT03869073 481 483 I-Eq-Unit
, NCT03869073 484 485 O
or NCT03869073 486 488 O
; NCT03869073 488 489 O

2 NCT03869073 498 499 O
. NCT03869073 499 500 O
Respiratory NCT03869073 502 513 B-Condition-Name
: NCT03869073 514 515 O
PaO NCT03869073 516 519 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03869073 520 521 I-Observation-Name___Observation-Type-Value:measurement
/ NCT03869073 522 523 O
FiO NCT03869073 524 527 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03869073 528 529 I-Observation-Name___Observation-Type-Value:measurement
< NCT03869073 530 531 B-Eq-Operator___Eq-Operator-Value:LT
300 NCT03869073 533 536 B-Eq-Value
or NCT03869073 537 539 O
PaO NCT03869073 540 543 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03869073 544 545 I-Observation-Name___Observation-Type-Value:measurement
/ NCT03869073 546 547 O
FiO NCT03869073 548 551 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03869073 552 553 I-Observation-Name___Observation-Type-Value:measurement
< NCT03869073 554 555 B-Eq-Operator___Eq-Operator-Value:LT
200 NCT03869073 557 560 B-Eq-Value
if NCT03869073 561 563 O
lung NCT03869073 564 568 O
is NCT03869073 569 571 O
the NCT03869073 572 575 O
only NCT03869073 576 580 O
organ NCT03869073 581 586 O
dysfunction NCT03869073 587 598 B-Condition-Name
or NCT03869073 599 601 O
SaO NCT03869073 602 605 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03869073 606 607 I-Observation-Name___Observation-Type-Value:measurement
: NCT03869073 608 609 O
FiO NCT03869073 610 613 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03869073 614 615 I-Observation-Name___Observation-Type-Value:measurement
150 NCT03869073 617 620 B-Eq-Value

Exclusion NCT03869073 622 631 O
Criteria NCT03869073 632 640 O
: NCT03869073 641 642 O

- NCT03869073 646 647 O
Known NCT03869073 649 654 O
pregnancy NCT03869073 655 664 B-Condition-Name

- NCT03869073 667 668 O
Underlying NCT03869073 670 680 O
severe NCT03869073 681 687 B-Severity___Severity-Value:severe
congestive NCT03869073 688 698 B-Condition-Name
heart NCT03869073 699 704 I-Condition-Name
failure NCT03869073 705 712 I-Condition-Name
( NCT03869073 713 714 O
New NCT03869073 715 718 B-Condition-Name
York NCT03869073 719 723 I-Condition-Name
Heart NCT03869073 724 729 I-Condition-Name
Association NCT03869073 730 741 I-Condition-Name
( NCT03869073 742 743 O
NYHA NCT03869073 744 748 B-Condition-Name
) NCT03869073 749 750 O
IV NCT03869073 751 753 B-Eq-Value
) NCT03869073 754 755 O
, NCT03869073 757 758 O
severe NCT03869073 759 765 B-Severity___Severity-Value:severe
COPD NCT03869073 766 770 B-Condition-Name
( NCT03869073 771 772 O
need NCT03869073 773 777 O
for NCT03869073 778 781 O
chronic NCT03869073 782 789 B-Procedure-Name
oxygen NCT03869073 790 796 I-Procedure-Name
or NCT03869073 797 799 O
mechanical NCT03869073 800 810 B-Procedure-Name
ventilation NCT03869073 811 822 I-Procedure-Name
) NCT03869073 823 824 O
, NCT03869073 826 827 O
severe NCT03869073 828 834 B-Severity___Severity-Value:severe
liver NCT03869073 835 840 B-Condition-Name
disease NCT03869073 841 848 I-Condition-Name
( NCT03869073 849 850 O
Child NCT03869073 851 856 B-Condition-Name
- NCT03869073 857 858 I-Condition-Name
Pugh NCT03869073 859 863 I-Condition-Name
Class NCT03869073 864 869 B-Eq-Unit
C NCT03869073 870 871 B-Eq-Value
) NCT03869073 872 873 O
, NCT03869073 875 876 O
cancer NCT03869073 877 883 B-Condition-Name
requiring NCT03869073 884 893 O
chemotherapy NCT03869073 894 906 B-Procedure-Name
, NCT03869073 907 908 O
or NCT03869073 909 911 O
transplantation NCT03869073 912 927 B-Procedure-Name
( NCT03869073 928 929 O
bone NCT03869073 930 934 O
marrow NCT03869073 935 941 O
, NCT03869073 942 943 O
heart NCT03869073 944 949 O
, NCT03869073 950 951 O
lung NCT03869073 952 956 O
, NCT03869073 957 958 O
liver NCT03869073 959 964 O
, NCT03869073 965 966 O
pancreas NCT03869073 967 975 O
, NCT03869073 976 977 O
or NCT03869073 978 980 O
small NCT03869073 981 986 O
bowel NCT03869073 987 992 O
) NCT03869073 993 994 O
in NCT03869073 995 997 O
the NCT03869073 998 1001 O
past NCT03869073 1002 1006 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03869073 1008 1009 B-Eq-Value
months NCT03869073 1010 1016 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03869073 1017 1019 O
likely NCT03869073 1020 1026 O
within NCT03869073 1027 1033 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03869073 1034 1037 O
next NCT03869073 1038 1042 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
6 NCT03869073 1044 1045 B-Eq-Value
months NCT03869073 1046 1052 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03869073 1055 1056 O
Previous NCT03869073 1058 1066 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
episode NCT03869073 1067 1074 O
of NCT03869073 1075 1077 O
sepsis NCT03869073 1078 1084 B-Condition-Name
during NCT03869073 1085 1091 O
that NCT03869073 1092 1096 O
hospital NCT03869073 1097 1105 B-Location___Location-Value:hospital
admission NCT03869073 1106 1115 B-Encounter-Type___Encounter-Type-Value:inpatient

- NCT03869073 1118 1119 O
Absolute NCT03869073 1121 1129 B-Observation-Name___Observation-Type-Value:lab
Neutrophil NCT03869073 1130 1140 I-Observation-Name___Observation-Type-Value:lab
Count NCT03869073 1141 1146 I-Observation-Name___Observation-Type-Value:lab
< NCT03869073 1147 1148 B-Eq-Operator___Eq-Operator-Value:LT
500 NCT03869073 1150 1153 B-Eq-Value
/ NCT03869073 1154 1155 O
mm³ NCT03869073 1156 1159 B-Eq-Unit

- NCT03869073 1162 1163 O
CD NCT03869073 1165 1167 B-Observation-Name___Observation-Type-Value:lab
4 NCT03869073 1168 1169 I-Observation-Name___Observation-Type-Value:lab
count NCT03869073 1170 1175 I-Observation-Name___Observation-Type-Value:lab
< NCT03869073 1176 1177 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03869073 1179 1181 B-Eq-Value
/ NCT03869073 1182 1183 O
mm³ NCT03869073 1184 1187 B-Eq-Unit

- NCT03869073 1190 1191 O
Treating NCT03869073 1193 1201 O
physician NCT03869073 1202 1211 O
deems NCT03869073 1212 1217 O
aggressive NCT03869073 1218 1228 O
care NCT03869073 1229 1233 O
unsuitable NCT03869073 1234 1244 O
( NCT03869073 1245 1246 O
i NCT03869073 1247 1248 O
. NCT03869073 1249 1250 O
e NCT03869073 1251 1252 O
. NCT03869073 1253 1254 O
no NCT03869073 1256 1258 O
commitment NCT03869073 1259 1269 O
to NCT03869073 1270 1272 O
active NCT03869073 1273 1279 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
care NCT03869073 1280 1284 O
) NCT03869073 1285 1286 O

- NCT03869073 1290 1291 O
Participation NCT03869073 1293 1306 O
in NCT03869073 1307 1309 O
another NCT03869073 1310 1317 O
interventional NCT03869073 1318 1332 O
drug NCT03869073 1333 1337 O
study NCT03869073 1338 1343 O
within NCT03869073 1344 1350 B-Eq-Operator___Eq-Operator-Value:LTEQ
previous NCT03869073 1351 1359 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
1 NCT03869073 1361 1362 B-Eq-Value
month NCT03869073 1363 1368 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03869073 1371 1372 O
Allergic NCT03869073 1374 1382 O
to NCT03869073 1383 1385 O
the NCT03869073 1386 1389 O
study NCT03869073 1390 1395 O
drug NCT03869073 1396 1400 O
or NCT03869073 1401 1403 O
any NCT03869073 1404 1407 O
of NCT03869073 1408 1410 O
its NCT03869073 1411 1414 O
components NCT03869073 1415 1425 O

- NCT03869073 1428 1429 O
Lactation NCT03869073 1431 1440 B-Condition-Name

- NCT03869073 1443 1444 O
Have NCT03869073 1446 1450 O
signed NCT03869073 1451 1457 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03869073 1458 1459 O
Do NCT03869073 1460 1462 B-Observation-Name
No NCT03869073 1463 1465 I-Observation-Name
Resuscitate NCT03869073 1466 1477 I-Observation-Name
( NCT03869073 1478 1479 O
DNR NCT03869073 1480 1483 B-Observation-Name
) NCT03869073 1484 1485 O
Form NCT03869073 1486 1490 O

Inclusion NCT03864796 0 9 O
Criteria NCT03864796 10 18 O
: NCT03864796 19 20 O

- NCT03864796 24 25 O
newly NCT03864796 27 32 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnosed NCT03864796 33 42 O
primary NCT03864796 43 50 O
immune NCT03864796 51 57 O
thrombocytopenic NCT03864796 58 74 B-Condition-Name
patients NCT03864796 75 83 O

Exclusion NCT03864796 84 93 O
Criteria NCT03864796 94 102 O
: NCT03864796 103 104 O

- NCT03864796 108 109 O
We NCT03864796 111 113 O
will NCT03864796 114 118 O
exclude NCT03864796 119 126 O
patients NCT03864796 127 135 O
with NCT03864796 136 140 O
any NCT03864796 141 144 O
other NCT03864796 145 150 O
possible NCT03864796 151 159 O
cause NCT03864796 160 165 O
of NCT03864796 166 168 O
thrombocytopenia NCT03864796 169 185 B-Condition-Name
either NCT03864796 186 192 O
immune NCT03864796 193 199 O
or NCT03864796 200 202 O
non NCT03864796 203 206 O
immune NCT03864796 207 213 O
as NCT03864796 214 216 O
: NCT03864796 217 218 O

- NCT03864796 222 223 O
Patients NCT03864796 225 233 O
with NCT03864796 234 238 O
diabetes NCT03864796 239 247 B-Condition-Name

- NCT03864796 250 251 O
HCV NCT03864796 253 256 B-Condition-Name

- NCT03864796 259 260 O
other NCT03864796 262 267 O
autoimmune NCT03864796 268 278 B-Condition-Name
disease NCT03864796 279 286 I-Condition-Name
( NCT03864796 287 288 O
as NCT03864796 289 291 O
SLE NCT03864796 292 295 B-Condition-Name
or NCT03864796 296 298 O
RA NCT03864796 299 301 B-Condition-Name
) NCT03864796 302 303 O

- NCT03864796 307 308 O
Chronic NCT03864796 310 317 O
Liver NCT03864796 318 323 O
or NCT03864796 324 326 O
kidney NCT03864796 327 333 O
disease NCT03864796 334 341 B-Condition-Name

Inclusion NCT03862495 0 9 O
Criteria NCT03862495 10 18 O
: NCT03862495 19 20 O

1 NCT03862495 25 26 O
. NCT03862495 26 27 O
pregnant NCT03862495 29 37 B-Condition-Name
women NCT03862495 38 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
on NCT03862495 44 46 O
their NCT03862495 47 52 O
first NCT03862495 53 58 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
visit NCT03862495 59 64 O
to NCT03862495 65 67 O
the NCT03862495 68 71 O
hospital NCT03862495 72 80 B-Location___Location-Value:hospital
( NCT03862495 81 82 O
regardless NCT03862495 83 93 O
of NCT03862495 94 96 O
gestational NCT03862495 97 108 B-Observation-Name
age NCT03862495 109 112 I-Observation-Name
) NCT03862495 113 114 O
; NCT03862495 115 116 O

2 NCT03862495 120 121 O
. NCT03862495 121 122 O
aged NCT03862495 124 128 O
18 NCT03862495 130 132 B-Eq-Value
or NCT03862495 133 135 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03862495 136 141 I-Eq-Operator___Eq-Operator-Value:GTEQ
; NCT03862495 141 142 O

3 NCT03862495 146 147 O
. NCT03862495 147 148 O
agree NCT03862495 150 155 O
to NCT03862495 156 158 O
participate NCT03862495 159 170 O
and NCT03862495 171 174 O
sign NCT03862495 175 179 O
an NCT03862495 180 182 O
informed NCT03862495 183 191 O
consent NCT03862495 192 199 O
. NCT03862495 200 201 O

Exclusion NCT03862495 203 212 O
Criteria NCT03862495 213 221 O
: NCT03862495 222 223 O

1 NCT03862495 228 229 O
. NCT03862495 229 230 O
systemic NCT03862495 232 240 O
or NCT03862495 241 243 O
topical NCT03862495 244 251 O
vaginal NCT03862495 252 259 O
antibiotics NCT03862495 260 271 B-Drug-Name
use NCT03862495 272 275 O
within NCT03862495 276 282 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03862495 284 285 B-Eq-Value
weeks NCT03862495 286 291 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03862495 292 297 O
to NCT03862495 298 300 O
the NCT03862495 301 304 O
first NCT03862495 305 310 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
perinatal NCT03862495 311 320 O
visit NCT03862495 321 326 O
; NCT03862495 326 327 O

2 NCT03862495 331 332 O
. NCT03862495 332 333 O
comorbidities NCT03862495 335 348 B-Condition-Name
that NCT03862495 349 353 O
are NCT03862495 354 357 O
known NCT03862495 358 363 O
to NCT03862495 364 366 O
be NCT03862495 367 369 O
related NCT03862495 370 377 O
to NCT03862495 378 380 O
adverse NCT03862495 381 388 B-Condition-Name
pregnancy NCT03862495 389 398 I-Condition-Name
outcomes NCT03862495 399 407 I-Condition-Name
( NCT03862495 408 409 O
e NCT03862495 410 411 O
. NCT03862495 412 413 O
g NCT03862495 414 415 O
. NCT03862495 416 417 O
, NCT03862495 418 419 O
diabetes NCT03862495 420 428 B-Condition-Name
and NCT03862495 429 432 O
hypertension NCT03862495 433 445 B-Condition-Name
) NCT03862495 446 447 O
; NCT03862495 448 449 O

3 NCT03862495 453 454 O
. NCT03862495 454 455 O
diagnosed NCT03862495 457 466 O
adverse NCT03862495 467 474 B-Condition-Name
pregnancy NCT03862495 475 484 I-Condition-Name
outcomes NCT03862495 485 493 I-Condition-Name
at NCT03862495 494 496 O
recruitment NCT03862495 497 508 O
( NCT03862495 509 510 O
e NCT03862495 511 512 O
. NCT03862495 513 514 O
g NCT03862495 515 516 O
. NCT03862495 517 518 O
, NCT03862495 519 520 O
stillbirth NCT03862495 521 531 B-Condition-Name
) NCT03862495 532 533 O
; NCT03862495 534 535 O
Women NCT03862495 536 541 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03862495 542 546 O
a NCT03862495 547 548 O
previous NCT03862495 549 557 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03862495 558 565 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862495 566 568 O
CT NCT03862495 569 571 B-Procedure-Name
or NCT03862495 572 574 O
NG NCT03862495 575 577 B-Procedure-Name
and NCT03862495 578 581 O
women NCT03862495 582 587 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03862495 588 592 O
a NCT03862495 593 594 O
prior NCT03862495 595 600 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
adverse NCT03862495 601 608 B-Condition-Name
outcome NCT03862495 609 616 I-Condition-Name
will NCT03862495 617 621 O
not NCT03862495 622 625 O
be NCT03862495 626 628 O
excluded NCT03862495 629 637 O
. NCT03862495 638 639 O
Instead NCT03862495 641 648 O
, NCT03862495 649 650 O
the NCT03862495 651 654 O
investigators NCT03862495 655 668 O
will NCT03862495 669 673 O
conduct NCT03862495 674 681 O
sub NCT03862495 682 685 O
- NCT03862495 686 687 O
analysis NCT03862495 688 696 O
and NCT03862495 697 700 O
check NCT03862495 701 706 O
whether NCT03862495 707 714 O
the NCT03862495 715 718 O
intervention NCT03862495 719 731 O
has NCT03862495 732 735 O
different NCT03862495 736 745 O
effects NCT03862495 746 753 O
on NCT03862495 754 756 O
different NCT03862495 757 766 O
groups NCT03862495 767 773 O
of NCT03862495 774 776 O
pregnant NCT03862495 777 785 O
women NCT03862495 786 791 O
. NCT03862495 792 793 O

Inclusion NCT03861611 0 9 O
Criteria NCT03861611 10 18 O
: NCT03861611 19 20 O

- NCT03861611 24 25 O
Men NCT03861611 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03861611 31 33 O
women NCT03861611 34 39 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
age NCT03861611 40 43 O
18 NCT03861611 45 47 B-Eq-Value
- NCT03861611 48 49 B-Eq-Operator___Eq-Operator-Value:BETWEEN
64 NCT03861611 51 53 B-Eq-Value
. NCT03861611 53 54 O

- NCT03861611 58 59 O
Present NCT03861611 61 68 B-Condition-Type___Condition-Type-Value:admitting
to NCT03861611 69 71 O
ED NCT03861611 72 74 B-Encounter-Type___Encounter-Type-Value:emergency
primary NCT03861611 75 82 O
for NCT03861611 83 86 O
management NCT03861611 87 97 O
of NCT03861611 98 100 O
Low NCT03861611 101 104 B-Condition-Name
Back NCT03861611 105 109 I-Condition-Name
Pain NCT03861611 110 114 I-Condition-Name
( NCT03861611 115 116 O
LBP NCT03861611 117 120 B-Condition-Name
) NCT03861611 121 122 O

- NCT03861611 126 127 O
Functionally NCT03861611 129 141 O
impairing NCT03861611 142 151 O
back NCT03861611 152 156 B-Condition-Name
pain NCT03861611 157 161 I-Condition-Name
: NCT03861611 162 163 O
A NCT03861611 164 165 O
baseline NCT03861611 166 174 O
score NCT03861611 175 180 O
of NCT03861611 181 183 O
greater NCT03861611 184 191 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03861611 192 196 I-Eq-Operator___Eq-Operator-Value:GT
5 NCT03861611 198 199 B-Eq-Value
on NCT03861611 200 202 O
the NCT03861611 203 206 O
Roland NCT03861611 207 213 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03861611 214 215 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Morris NCT03861611 216 222 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Disability NCT03861611 223 233 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03861611 234 247 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire

- NCT03861611 250 251 O
Musculoskeletal NCT03861611 253 268 B-Condition-Name
etiology NCT03861611 269 277 I-Condition-Name
of NCT03861611 278 280 O
low NCT03861611 281 284 O
back NCT03861611 285 289 O
. NCT03861611 290 291 O

- NCT03861611 295 296 O
Non NCT03861611 298 301 O
- NCT03861611 302 303 O
radicular NCT03861611 304 313 O
pain NCT03861611 314 318 B-Condition-Name
. NCT03861611 319 320 O

- NCT03861611 324 325 O
Pain NCT03861611 327 331 B-Condition-Name
duration NCT03861611 332 340 O
< NCT03861611 341 342 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03861611 344 345 B-Eq-Value
weeks NCT03861611 346 351 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03861611 352 353 O
336 NCT03861611 355 358 B-Eq-Value
hours NCT03861611 359 364 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
) NCT03861611 365 366 O
. NCT03861611 368 369 O

- NCT03861611 373 374 O
Non NCT03861611 376 379 O
- NCT03861611 380 381 O
traumatic NCT03861611 382 391 O
LBP NCT03861611 392 395 B-Condition-Name

- NCT03861611 398 399 O
Participant NCT03861611 401 412 O
is NCT03861611 413 415 O
to NCT03861611 416 418 O
be NCT03861611 419 421 O
discharged NCT03861611 422 432 B-Encounter-Type___Encounter-Type-Value:discharge
home NCT03861611 433 437 B-Location___Location-Value:residence
. NCT03861611 438 439 O

Exclusion NCT03861611 441 450 O
Criteria NCT03861611 451 459 O
: NCT03861611 460 461 O

- NCT03861611 465 466 O
Flank NCT03861611 468 473 O
pain NCT03861611 474 478 B-Condition-Name
, NCT03861611 479 480 O
that NCT03861611 481 485 O
is NCT03861611 486 488 O
pain NCT03861611 489 493 B-Condition-Name
originating NCT03861611 494 505 O
from NCT03861611 506 510 O
tissues NCT03861611 511 518 O
lateral NCT03861611 519 526 O
to NCT03861611 527 529 O
the NCT03861611 530 533 O
paraspinal NCT03861611 534 544 O
muscles NCT03861611 545 552 O
. NCT03861611 553 554 O

- NCT03861611 558 559 O
Not NCT03861611 561 564 O
available NCT03861611 565 574 O
for NCT03861611 575 578 O
follow NCT03861611 579 585 O
- NCT03861611 586 587 O
up NCT03861611 588 590 O

- NCT03861611 593 594 O
Pregnant NCT03861611 596 604 B-Condition-Name

- NCT03861611 607 608 O
Chronic NCT03861611 610 617 O
pain NCT03861611 618 622 B-Condition-Name
syndrome NCT03861611 623 631 I-Condition-Name

- NCT03861611 634 635 O
Allergic NCT03861611 637 645 O
to NCT03861611 646 648 O
or NCT03861611 649 651 O
intolerant NCT03861611 652 662 B-Condition-Name
of NCT03861611 663 665 O
investigational NCT03861611 666 681 O
medications NCT03861611 682 693 O

- NCT03861611 696 697 O
Contra NCT03861611 699 705 O
- NCT03861611 706 707 O
indications NCT03861611 708 719 O
to NCT03861611 720 722 O
investigational NCT03861611 723 738 O
medications NCT03861611 739 750 O

Inclusion NCT03862456 0 9 O
Criteria NCT03862456 10 18 O
: NCT03862456 19 20 O

- NCT03862456 24 25 O
Diagnosis NCT03862456 27 36 O
of NCT03862456 37 39 O
periodontitis NCT03862456 40 53 B-Condition-Name
( NCT03862456 54 55 O
stages NCT03862456 56 62 B-Eq-Unit
III NCT03862456 63 66 B-Eq-Value
or NCT03862456 67 69 O
IV NCT03862456 70 72 B-Eq-Value
) NCT03862456 73 74 O
that NCT03862456 75 79 O
may NCT03862456 80 83 O
require NCT03862456 84 91 O
periodontal NCT03862456 92 103 B-Procedure-Name
surgery NCT03862456 104 111 I-Procedure-Name

- NCT03862456 114 115 O
Have NCT03862456 117 121 O
at NCT03862456 122 124 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862456 125 130 I-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03862456 132 134 B-Eq-Value
teeth NCT03862456 135 140 B-Condition-Name
in NCT03862456 141 143 O
function NCT03862456 144 152 O
, NCT03862456 153 154 O
excluding NCT03862456 155 164 O
third NCT03862456 165 170 O
molars NCT03862456 171 177 O
. NCT03862456 178 179 O

- NCT03862456 183 184 O
Present NCT03862456 186 193 O
locations NCT03862456 194 203 O
with NCT03862456 204 208 O
probing NCT03862456 209 216 B-Observation-Name___Observation-Type-Value:measurement
depth NCT03862456 217 222 I-Observation-Name___Observation-Type-Value:measurement
( NCT03862456 223 224 O
PS NCT03862456 225 227 B-Observation-Name
) NCT03862456 228 229 O
> NCT03862456 231 232 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03862456 234 235 B-Eq-Value
mm NCT03862456 236 238 B-Eq-Unit
in NCT03862456 239 241 O
at NCT03862456 242 244 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862456 245 250 I-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03862456 252 254 B-Eq-Value
% NCT03862456 255 256 B-Eq-Unit
of NCT03862456 257 259 O
the NCT03862456 260 263 O
teeth NCT03862456 264 269 B-Condition-Name
. NCT03862456 270 271 O

- NCT03862456 275 276 O
Present NCT03862456 278 285 O
radiographic NCT03862456 286 298 B-Procedure-Name
evidence NCT03862456 299 307 O
of NCT03862456 308 310 O
moderate NCT03862456 311 319 B-Severity___Severity-Value:moderate
- NCT03862456 320 321 O
severe NCT03862456 322 328 B-Severity___Severity-Value:severe
bone NCT03862456 329 333 B-Condition-Name
loss NCT03862456 334 338 I-Condition-Name
in NCT03862456 339 341 O
at NCT03862456 342 344 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862456 345 350 I-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03862456 352 354 B-Eq-Value
% NCT03862456 355 356 B-Eq-Unit
of NCT03862456 357 359 O
the NCT03862456 360 363 O
dentition NCT03862456 364 373 B-Procedure-Name
. NCT03862456 374 375 O

- NCT03862456 379 380 O
Detection NCT03862456 382 391 O
of NCT03862456 392 394 O
P NCT03862456 395 396 O
. NCT03862456 397 398 O
gingivalis NCT03862456 400 410 O
in NCT03862456 411 413 O
subgingival NCT03862456 414 425 B-Observation-Specimen
samples NCT03862456 426 433 I-Observation-Specimen
taken NCT03862456 434 439 O
at NCT03862456 440 442 O
the NCT03862456 443 446 O
screening NCT03862456 447 456 O
visit NCT03862456 457 462 O
as NCT03862456 463 465 O
well NCT03862456 466 470 O
as NCT03862456 471 473 O
in NCT03862456 474 476 O
the NCT03862456 477 480 O
post NCT03862456 481 485 O
- NCT03862456 486 487 O
scaling NCT03862456 488 495 O
and NCT03862456 496 499 O
root NCT03862456 500 504 O
planning NCT03862456 505 513 O
visit NCT03862456 514 519 O
and NCT03862456 520 523 O
processed NCT03862456 524 533 O
by NCT03862456 534 536 O
culture NCT03862456 537 544 O
. NCT03862456 545 546 O

- NCT03862456 550 551 O
Systemically NCT03862456 553 565 O
healthy NCT03862456 566 573 B-Condition-Name
patients NCT03862456 574 582 O
. NCT03862456 583 584 O

Exclusion NCT03862456 586 595 O
Criteria NCT03862456 596 604 O
: NCT03862456 605 606 O

- NCT03862456 610 611 O
Pregnant NCT03862456 613 621 B-Condition-Name
or NCT03862456 622 624 O
lactating NCT03862456 625 634 B-Condition-Name
women NCT03862456 635 640 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
. NCT03862456 641 642 O

- NCT03862456 646 647 O
Presenting NCT03862456 649 659 O
systemic NCT03862456 660 668 O
pathology NCT03862456 669 678 B-Condition-Name
and NCT03862456 679 682 O
/ NCT03862456 683 684 O
or NCT03862456 685 687 O
taking NCT03862456 688 694 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03862456 695 705 O
that NCT03862456 706 710 O
may NCT03862456 711 714 O
affect NCT03862456 715 721 B-Stability___Stability-Value:change
the NCT03862456 722 725 O
periodontal NCT03862456 726 737 B-Condition-Name
situation NCT03862456 738 747 I-Condition-Name
and NCT03862456 748 751 O
/ NCT03862456 752 753 O
or NCT03862456 754 756 O
patients NCT03862456 757 765 O
requiring NCT03862456 766 775 O
antibiotic NCT03862456 776 786 B-Procedure-Name
prophylaxis NCT03862456 787 798 I-Procedure-Name
. NCT03862456 799 800 O

- NCT03862456 804 805 O
Have NCT03862456 807 811 O
received NCT03862456 812 820 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
systemic NCT03862456 821 829 O
antimicrobial NCT03862456 830 843 B-Procedure-Name
treatment NCT03862456 844 853 I-Procedure-Name
in NCT03862456 854 856 O
the NCT03862456 857 860 O
previous NCT03862456 861 869 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03862456 871 872 B-Eq-Value
months NCT03862456 873 879 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03862456 880 881 O

- NCT03862456 885 886 O
Have NCT03862456 888 892 O
received NCT03862456 893 901 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
periodontal NCT03862456 902 913 B-Procedure-Name
treatment NCT03862456 914 923 I-Procedure-Name
in NCT03862456 924 926 O
the NCT03862456 927 930 O
6 NCT03862456 932 933 B-Eq-Value
months NCT03862456 934 940 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03862456 941 946 O
to NCT03862456 947 949 O
the NCT03862456 950 953 O
beginning NCT03862456 954 963 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03862456 964 966 O
the NCT03862456 967 970 O
study NCT03862456 971 976 O
. NCT03862456 977 978 O

- NCT03862456 982 983 O
Patients NCT03862456 985 993 O
allergic NCT03862456 994 1002 O
to NCT03862456 1003 1005 O
metronidazole NCT03862456 1006 1019 B-Drug-Name
, NCT03862456 1020 1021 O
or NCT03862456 1022 1024 O
to NCT03862456 1025 1027 O
any NCT03862456 1028 1031 O
of NCT03862456 1032 1034 O
the NCT03862456 1035 1038 O
components NCT03862456 1039 1049 O
of NCT03862456 1050 1052 O
commercial NCT03862456 1053 1063 O
formulations NCT03862456 1064 1076 O
thereof NCT03862456 1077 1084 O
( NCT03862456 1085 1086 O
Flagyl NCT03862456 1087 1093 B-Drug-Name
® NCT03862456 1093 1094 O
) NCT03862456 1095 1096 O
. NCT03862456 1098 1099 O

- NCT03862456 1103 1104 O
Patients NCT03862456 1106 1114 O
allergic NCT03862456 1115 1123 O
to NCT03862456 1124 1126 O
azithromycin NCT03862456 1127 1139 B-Drug-Name
, NCT03862456 1140 1141 O
or NCT03862456 1142 1144 O
to NCT03862456 1145 1147 O
any NCT03862456 1148 1151 O
of NCT03862456 1152 1154 O
the NCT03862456 1155 1158 O
components NCT03862456 1159 1169 O
of NCT03862456 1170 1172 O
commercial NCT03862456 1173 1183 O
formulations NCT03862456 1184 1196 O
thereof NCT03862456 1197 1204 O
( NCT03862456 1205 1206 O
Zithromax NCT03862456 1207 1216 B-Drug-Name
® NCT03862456 1216 1217 O
) NCT03862456 1218 1219 O
. NCT03862456 1221 1222 O

- NCT03862456 1226 1227 O
Patients NCT03862456 1229 1237 O
who NCT03862456 1238 1241 O
refuse NCT03862456 1242 1248 O
to NCT03862456 1249 1251 O
sign NCT03862456 1252 1256 O
the NCT03862456 1257 1260 O
informed NCT03862456 1261 1269 O
consent NCT03862456 1270 1277 O
. NCT03862456 1278 1279 O

Inclusion NCT03867617 0 9 O
Criteria NCT03867617 10 18 O
: NCT03867617 19 20 O

- NCT03867617 24 25 O
Patient NCT03867617 27 34 O
has NCT03867617 35 38 O
provided NCT03867617 39 47 O
written NCT03867617 48 55 O
informed NCT03867617 56 64 O
consent NCT03867617 65 72 O
. NCT03867617 73 74 O

- NCT03867617 78 79 O
Patient NCT03867617 81 88 O
is NCT03867617 89 91 O
18 NCT03867617 93 95 B-Eq-Value
years NCT03867617 96 101 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03867617 102 104 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03867617 105 110 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03867617 111 112 O

- NCT03867617 116 117 O
Patient NCT03867617 119 126 O
is NCT03867617 127 129 O
a NCT03867617 130 131 O
planned NCT03867617 132 139 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
recipient NCT03867617 140 149 O
of NCT03867617 150 152 O
a NCT03867617 153 154 O
living NCT03867617 155 161 O
donor NCT03867617 162 167 O
kidney NCT03867617 168 174 B-Procedure-Name
transplant NCT03867617 175 185 I-Procedure-Name
. NCT03867617 186 187 O

- NCT03867617 191 192 O
Patient NCT03867617 194 201 O
is NCT03867617 202 204 O
a NCT03867617 205 206 O
planned NCT03867617 207 214 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
recipient NCT03867617 215 224 O
of NCT03867617 225 227 O
an NCT03867617 228 230 O
ABO NCT03867617 231 234 O
blood NCT03867617 235 240 O
group NCT03867617 241 246 O
- NCT03867617 247 248 O
compatible NCT03867617 249 259 O
kidney NCT03867617 260 266 B-Procedure-Name
graft NCT03867617 267 272 I-Procedure-Name
. NCT03867617 273 274 O

- NCT03867617 278 279 O
Patient NCT03867617 281 288 O
is NCT03867617 289 291 O
a NCT03867617 292 293 O
planned NCT03867617 294 301 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
recipient NCT03867617 302 311 O
of NCT03867617 312 314 O
a NCT03867617 315 316 O
kidney NCT03867617 317 323 B-Procedure-Name
graft NCT03867617 324 329 I-Procedure-Name
from NCT03867617 330 334 O
a NCT03867617 335 336 O
donor NCT03867617 337 342 O
that NCT03867617 343 347 O
is NCT03867617 348 350 O
not NCT03867617 351 354 O
HLA NCT03867617 355 358 B-Condition-Name
( NCT03867617 359 360 O
human NCT03867617 361 366 B-Condition-Name
leukocyte NCT03867617 367 376 I-Condition-Name
antigen NCT03867617 377 384 I-Condition-Name
) NCT03867617 385 386 O
- NCT03867617 388 389 O
identical NCT03867617 390 399 O
. NCT03867617 400 401 O

- NCT03867617 405 406 O
Patient NCT03867617 408 415 O
is NCT03867617 416 418 O
negative NCT03867617 419 427 B-Polarity___Polarity-Value:negative
for NCT03867617 428 431 O
DSA NCT03867617 432 435 B-Condition-Name
( NCT03867617 436 437 O
donor NCT03867617 438 443 B-Condition-Name
- NCT03867617 444 445 I-Condition-Name
specific NCT03867617 446 454 I-Condition-Name
antibodies NCT03867617 455 465 I-Condition-Name
) NCT03867617 466 467 O
. NCT03867617 469 470 O

- NCT03867617 474 475 O
WOCBP NCT03867617 477 482 B-Condition-Name
( NCT03867617 483 484 O
women NCT03867617 485 490 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03867617 491 493 O
child NCT03867617 494 499 B-Condition-Name
- NCT03867617 500 501 I-Condition-Name
bearing NCT03867617 502 509 I-Condition-Name
potential NCT03867617 510 519 I-Condition-Name
) NCT03867617 520 521 O
must NCT03867617 522 526 O
have NCT03867617 527 531 O
a NCT03867617 532 533 O
negative NCT03867617 534 542 B-Polarity___Polarity-Value:negative
pregnancy NCT03867617 543 552 B-Observation-Name___Observation-Type-Value:lab
test NCT03867617 553 557 I-Observation-Name___Observation-Type-Value:lab
at NCT03867617 558 560 O
inclusion NCT03867617 561 570 O
. NCT03867617 571 572 O

- NCT03867617 576 577 O
WOCBP NCT03867617 579 584 B-Condition-Name
must NCT03867617 585 589 O
be NCT03867617 590 592 O
using NCT03867617 593 598 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
an NCT03867617 599 601 O
adequate NCT03867617 602 610 O
method NCT03867617 611 617 O
of NCT03867617 618 620 O
contraception NCT03867617 621 634 B-Procedure-Name
to NCT03867617 635 637 O
avoid NCT03867617 638 643 O
pregnancy NCT03867617 644 653 B-Condition-Name
throughout NCT03867617 654 664 O
the NCT03867617 665 668 O
study NCT03867617 669 674 O
and NCT03867617 675 678 O
for NCT03867617 679 682 O
up NCT03867617 683 685 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03867617 686 688 I-Eq-Operator___Eq-Operator-Value:LTEQ
12 NCT03867617 690 692 B-Eq-Value
weeks NCT03867617 693 698 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03867617 699 704 O
the NCT03867617 705 708 O
study NCT03867617 709 714 O
in NCT03867617 715 717 O
such NCT03867617 718 722 O
a NCT03867617 723 724 O
manner NCT03867617 725 731 O
that NCT03867617 732 736 O
the NCT03867617 737 740 O
risk NCT03867617 741 745 O
of NCT03867617 746 748 O
pregnancy NCT03867617 749 758 B-Condition-Name
is NCT03867617 759 761 O
minimized NCT03867617 762 771 B-Polarity___Polarity-Value:low
. NCT03867617 772 773 O

Exclusion NCT03867617 775 784 O
Criteria NCT03867617 785 793 O
: NCT03867617 794 795 O

- NCT03867617 799 800 O
Patient NCT03867617 802 809 O
is NCT03867617 810 812 O
EBV NCT03867617 813 816 B-Condition-Name
( NCT03867617 817 818 O
epstein NCT03867617 819 826 B-Condition-Name
barr NCT03867617 827 831 I-Condition-Name
virus NCT03867617 832 837 I-Condition-Name
) NCT03867617 838 839 O
- NCT03867617 841 842 O
negative NCT03867617 843 851 B-Polarity___Polarity-Value:negative
on NCT03867617 852 854 O
serology NCT03867617 855 863 B-Observation-Name___Observation-Type-Value:lab
. NCT03867617 864 865 O

- NCT03867617 869 870 O
Patient NCT03867617 872 879 O
is NCT03867617 880 882 O
HIV NCT03867617 883 886 B-Condition-Name
- NCT03867617 887 888 O
positive NCT03867617 889 897 B-Polarity___Polarity-Value:positive
or NCT03867617 898 900 O
suffering NCT03867617 901 910 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
from NCT03867617 911 915 O
chronic NCT03867617 916 923 O
viral NCT03867617 924 929 O
hepatitis NCT03867617 930 939 B-Condition-Name
. NCT03867617 940 941 O

- NCT03867617 945 946 O
Patient NCT03867617 948 955 O
is NCT03867617 956 958 O
CMV NCT03867617 959 962 B-Condition-Name
( NCT03867617 963 964 O
cytomegalo NCT03867617 965 975 B-Condition-Name
virus NCT03867617 976 981 I-Condition-Name
) NCT03867617 982 983 O
- NCT03867617 985 986 O
negative NCT03867617 987 995 B-Polarity___Polarity-Value:negative
and NCT03867617 996 999 O
receiving NCT03867617 1000 1009 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03867617 1010 1011 O
kidney NCT03867617 1012 1018 O
from NCT03867617 1019 1023 O
a NCT03867617 1024 1025 O
CMV NCT03867617 1026 1029 B-Condition-Name
- NCT03867617 1030 1031 O
positive NCT03867617 1032 1040 B-Polarity___Polarity-Value:positive
donor NCT03867617 1041 1046 O
. NCT03867617 1047 1048 O

- NCT03867617 1052 1053 O
Positive NCT03867617 1055 1063 B-Polarity___Polarity-Value:positive
T NCT03867617 1064 1065 B-Observation-Name___Observation-Type-Value:lab
- NCT03867617 1066 1067 I-Observation-Name___Observation-Type-Value:lab
cell NCT03867617 1068 1072 I-Observation-Name___Observation-Type-Value:lab
lymphocytotoxic NCT03867617 1073 1088 I-Observation-Name___Observation-Type-Value:lab
cross NCT03867617 1089 1094 I-Observation-Name___Observation-Type-Value:lab
match NCT03867617 1095 1100 I-Observation-Name___Observation-Type-Value:lab
. NCT03867617 1101 1102 O

- NCT03867617 1106 1107 O
Patient NCT03867617 1109 1116 O
with NCT03867617 1117 1121 O
prior NCT03867617 1122 1127 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
kidney NCT03867617 1128 1134 B-Procedure-Name
transplant NCT03867617 1135 1145 I-Procedure-Name
or NCT03867617 1146 1148 O
non NCT03867617 1149 1152 O
- NCT03867617 1153 1154 O
renal NCT03867617 1155 1160 O
solid NCT03867617 1161 1166 B-Procedure-Name
organ NCT03867617 1167 1172 I-Procedure-Name
transplant NCT03867617 1173 1183 I-Procedure-Name
. NCT03867617 1184 1185 O

- NCT03867617 1189 1190 O
Patient NCT03867617 1192 1199 O
has NCT03867617 1200 1203 O
a NCT03867617 1204 1205 O
known NCT03867617 1206 1211 O
contraindication NCT03867617 1212 1228 O
to NCT03867617 1229 1231 O
any NCT03867617 1232 1235 O
of NCT03867617 1236 1238 O
the NCT03867617 1239 1242 O
protocol NCT03867617 1243 1251 O
- NCT03867617 1252 1253 O
specified NCT03867617 1254 1263 O
treatments NCT03867617 1264 1274 O
. NCT03867617 1275 1276 O

- NCT03867617 1280 1281 O
Patient NCT03867617 1283 1290 O
had NCT03867617 1291 1294 O
been NCT03867617 1295 1299 O
diagnosed NCT03867617 1300 1309 O
with NCT03867617 1310 1314 O
a NCT03867617 1315 1316 O
malignancy NCT03867617 1317 1327 B-Condition-Name
within NCT03867617 1328 1334 B-Eq-Operator___Eq-Operator-Value:LTEQ
5 NCT03867617 1336 1337 B-Eq-Value
years NCT03867617 1338 1343 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
prior NCT03867617 1344 1349 O
to NCT03867617 1350 1352 O
study NCT03867617 1353 1358 O
entry NCT03867617 1359 1364 O
, NCT03867617 1365 1366 O
excluding NCT03867617 1367 1376 O
non NCT03867617 1377 1380 O
- NCT03867617 1381 1382 O
metastatic NCT03867617 1383 1393 O
basal NCT03867617 1394 1399 O
or NCT03867617 1400 1402 O
squamous NCT03867617 1403 1411 O
cell NCT03867617 1412 1416 O
carcinoma NCT03867617 1417 1426 B-Condition-Name
of NCT03867617 1427 1429 O
the NCT03867617 1430 1433 O
skin NCT03867617 1434 1438 O
. NCT03867617 1439 1440 O

- NCT03867617 1444 1445 O
Female NCT03867617 1447 1453 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03867617 1454 1462 O
who NCT03867617 1463 1466 O
are NCT03867617 1467 1470 O
breast NCT03867617 1471 1477 B-Condition-Name
- NCT03867617 1478 1479 I-Condition-Name
feeding NCT03867617 1480 1487 I-Condition-Name
. NCT03867617 1488 1489 O

- NCT03867617 1493 1494 O
Female NCT03867617 1496 1502 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03867617 1503 1511 O
with NCT03867617 1512 1516 O
a NCT03867617 1517 1518 O
positive NCT03867617 1519 1527 B-Polarity___Polarity-Value:positive
pregnancy NCT03867617 1528 1537 B-Observation-Name___Observation-Type-Value:lab
test NCT03867617 1538 1542 I-Observation-Name___Observation-Type-Value:lab
. NCT03867617 1543 1544 O

Inclusion NCT03869606 0 9 O
Criteria NCT03869606 10 18 O
: NCT03869606 19 20 O

- NCT03869606 24 25 O
Patients NCT03869606 27 35 O
11 NCT03869606 37 39 B-Eq-Value
to NCT03869606 40 42 B-Eq-Operator___Eq-Operator-Value:BETWEEN
no NCT03869606 43 45 I-Eq-Operator___Eq-Operator-Value:BETWEEN
older NCT03869606 46 51 I-Eq-Operator___Eq-Operator-Value:BETWEEN
than NCT03869606 52 56 I-Eq-Operator___Eq-Operator-Value:BETWEEN
17 NCT03869606 58 60 B-Eq-Value
years NCT03869606 61 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869606 67 69 O
age NCT03869606 70 73 O

Exclusion NCT03869606 74 83 O
Criteria NCT03869606 84 92 O
: NCT03869606 93 94 O

- NCT03869606 98 99 O
severed NCT03869606 101 108 B-Severity___Severity-Value:severe
developmental NCT03869606 109 122 B-Condition-Name
delay NCT03869606 123 128 I-Condition-Name
, NCT03869606 129 130 O

- NCT03869606 134 135 O
orthopedic NCT03869606 137 147 B-Procedure-Name
patients NCT03869606 148 156 O
with NCT03869606 157 161 O
leg NCT03869606 162 165 O
injuries NCT03869606 166 174 B-Condition-Name

- NCT03869606 177 178 O
injury NCT03869606 180 186 B-Condition-Name
that NCT03869606 187 191 O
would NCT03869606 192 197 O
prevent NCT03869606 198 205 O
passive NCT03869606 206 213 O
leg NCT03869606 214 217 O
elevation NCT03869606 218 227 B-Procedure-Name
. NCT03869606 228 229 O

- NCT03869606 233 234 O
severe NCT03869606 236 242 B-Severity___Severity-Value:severe
aortic NCT03869606 243 249 B-Condition-Name
insufficiency NCT03869606 250 263 I-Condition-Name
, NCT03869606 264 265 O

- NCT03869606 269 270 O
severe NCT03869606 272 278 B-Severity___Severity-Value:severe
anatomic NCT03869606 279 287 B-Condition-Name
abnormalities NCT03869606 288 301 I-Condition-Name
of NCT03869606 302 304 O
the NCT03869606 305 308 O
thoracic NCT03869606 309 317 O
aorta NCT03869606 318 323 O

- NCT03869606 326 327 O
patients NCT03869606 329 337 O
with NCT03869606 338 342 O
external NCT03869606 343 351 B-Procedure-Name
cardiac NCT03869606 352 359 I-Procedure-Name
pacemakers NCT03869606 360 370 I-Procedure-Name
. NCT03869606 371 372 O
close NCT03869606 374 379 O

Inclusion NCT03861299 0 9 O
Criteria NCT03861299 10 18 O
: NCT03861299 19 20 O

1 NCT03861299 25 26 O
. NCT03861299 26 27 O
Age NCT03861299 29 32 O
≥ NCT03861299 33 34 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03861299 36 38 B-Eq-Value
years NCT03861299 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03861299 45 48 O
≤ NCT03861299 49 50 B-Eq-Operator___Eq-Operator-Value:LTEQ
90 NCT03861299 52 54 B-Eq-Value
years NCT03861299 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

2 NCT03861299 64 65 O
. NCT03861299 65 66 O
Tumor NCT03861299 68 73 B-Condition-Name
diagnosed NCT03861299 74 83 O
as NCT03861299 84 86 O
Glioblastoma NCT03861299 87 99 O
Multiforme NCT03861299 100 110 O
on NCT03861299 111 113 O
MRI NCT03861299 114 117 B-Procedure-Name
with NCT03861299 118 122 O
distinct NCT03861299 123 131 O
ring NCT03861299 132 136 O
- NCT03861299 137 138 O
like NCT03861299 139 143 O
pattern NCT03861299 144 151 O
of NCT03861299 152 154 O
contrast NCT03861299 155 163 B-Procedure-Name
enhancement NCT03861299 164 175 I-Procedure-Name
with NCT03861299 176 180 O
thick NCT03861299 181 186 O
irregular NCT03861299 187 196 O
walls NCT03861299 197 202 O
and NCT03861299 203 206 O
a NCT03861299 207 208 O
core NCT03861299 209 213 O
area NCT03861299 214 218 O
reduced NCT03861299 219 226 O
signal NCT03861299 227 233 O
suggestive NCT03861299 234 244 O
of NCT03861299 245 247 O
tumour NCT03861299 248 254 B-Condition-Name
necrosis NCT03861299 255 263 I-Condition-Name
as NCT03861299 264 266 O
assessed NCT03861299 267 275 O
by NCT03861299 276 278 O
the NCT03861299 279 282 O
surgeon NCT03861299 283 290 B-Provider-Type

3 NCT03861299 294 295 O
. NCT03861299 295 296 O
Tumors NCT03861299 298 304 B-Condition-Name
situated NCT03861299 305 313 O
in NCT03861299 314 316 O
or NCT03861299 317 319 O
near NCT03861299 320 324 O
eloquent NCT03861299 325 333 O
areas NCT03861299 334 339 O
; NCT03861299 339 340 O
motor NCT03861299 341 346 O
cortex NCT03861299 347 353 O
, NCT03861299 354 355 O
sensory NCT03861299 356 363 O
cortex NCT03861299 364 370 O
, NCT03861299 371 372 O
subcortical NCT03861299 373 384 O
pyramidal NCT03861299 385 394 O
tract NCT03861299 395 400 O
or NCT03861299 401 403 O
speech NCT03861299 404 410 O
areas NCT03861299 411 416 O
as NCT03861299 417 419 O
indicated NCT03861299 420 429 O
on NCT03861299 430 432 O
MRI NCT03861299 433 436 B-Procedure-Name
( NCT03861299 437 438 O
Sawaya NCT03861299 439 445 B-Condition-Name
Grading NCT03861299 446 453 B-Eq-Unit
II NCT03861299 454 456 B-Eq-Value
and NCT03861299 457 460 O
II NCT03861299 461 463 B-Eq-Value
) NCT03861299 464 465 O

4 NCT03861299 470 471 O
. NCT03861299 471 472 O
The NCT03861299 474 477 O
tumor NCT03861299 478 483 B-Condition-Name
is NCT03861299 484 486 O
suitable NCT03861299 487 495 O
for NCT03861299 496 499 O
resection NCT03861299 500 509 B-Procedure-Name
( NCT03861299 510 511 O
according NCT03861299 512 521 O
to NCT03861299 522 524 O
neurosurgeon NCT03861299 525 537 B-Provider-Type
) NCT03861299 538 539 O

5 NCT03861299 544 545 O
. NCT03861299 545 546 O
Karnofsky NCT03861299 548 557 B-Observation-Name___Observation-Type-Value:clinical-score
performance NCT03861299 558 569 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03861299 570 575 I-Observation-Name___Observation-Type-Value:clinical-score
80 NCT03861299 577 579 B-Eq-Value
or NCT03861299 580 582 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03861299 583 587 I-Eq-Operator___Eq-Operator-Value:GTEQ

6 NCT03861299 591 592 O
. NCT03861299 592 593 O
Written NCT03861299 595 602 O
Informed NCT03861299 603 611 O
consent NCT03861299 612 619 O

Exclusion NCT03861299 620 629 O
Criteria NCT03861299 630 638 O
: NCT03861299 639 640 O

1 NCT03861299 645 646 O
. NCT03861299 646 647 O
Tumors NCT03861299 649 655 B-Condition-Name
of NCT03861299 656 658 O
the NCT03861299 659 662 O
cerebellum NCT03861299 663 673 O
, NCT03861299 674 675 O
brain NCT03861299 676 681 O
stem NCT03861299 682 686 O
or NCT03861299 687 689 O
midline NCT03861299 690 697 O

2 NCT03861299 701 702 O
. NCT03861299 702 703 O
Multifocal NCT03861299 705 715 O
contrast NCT03861299 716 724 O
enhancing NCT03861299 725 734 O
lesions NCT03861299 735 742 B-Condition-Name

3 NCT03861299 746 747 O
. NCT03861299 747 748 O
Substantial NCT03861299 750 761 B-Severity___Severity-Value:severe
non NCT03861299 762 765 O
- NCT03861299 766 767 O
contrast NCT03861299 768 776 O
enhancing NCT03861299 777 786 O
tumor NCT03861299 787 792 B-Condition-Name
areas NCT03861299 793 798 O
suggesting NCT03861299 799 809 O
low NCT03861299 810 813 B-Polarity___Polarity-Value:low
grade NCT03861299 814 819 I-Polarity___Polarity-Value:low
gliomas NCT03861299 820 827 B-Condition-Name
with NCT03861299 828 832 O
malignant NCT03861299 833 842 O
transformation NCT03861299 843 857 O

4 NCT03861299 861 862 O
. NCT03861299 862 863 O
Medical NCT03861299 865 872 O
reasons NCT03861299 873 880 O
precluding NCT03861299 881 891 O
MRI NCT03861299 892 895 B-Procedure-Name
( NCT03861299 896 897 O
eg NCT03861299 898 900 O
, NCT03861299 901 902 O
pacemaker NCT03861299 903 912 B-Procedure-Name
) NCT03861299 913 914 O

5 NCT03861299 919 920 O
. NCT03861299 920 921 O
Inability NCT03861299 923 932 O
to NCT03861299 933 935 O
give NCT03861299 936 940 O
consent NCT03861299 941 948 O
because NCT03861299 949 956 O
of NCT03861299 957 959 O
or NCT03861299 960 962 O
language NCT03861299 963 971 B-Condition-Name
barrier NCT03861299 972 979 I-Condition-Name

6 NCT03861299 983 984 O
. NCT03861299 984 985 O
Psychiatric NCT03861299 987 998 B-Condition-Name
history NCT03861299 999 1006 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

7 NCT03861299 1010 1011 O
. NCT03861299 1011 1012 O
Previous NCT03861299 1014 1022 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
brain NCT03861299 1023 1028 O
tumour NCT03861299 1029 1035 B-Condition-Name
surgery NCT03861299 1036 1043 B-Procedure-Name

8 NCT03861299 1047 1048 O
. NCT03861299 1048 1049 O
Previous NCT03861299 1051 1059 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
low NCT03861299 1060 1063 B-Polarity___Polarity-Value:low
- NCT03861299 1064 1065 I-Polarity___Polarity-Value:low
grade NCT03861299 1066 1071 I-Polarity___Polarity-Value:low
glioma NCT03861299 1072 1078 B-Condition-Name
. NCT03861299 1079 1080 O

9 NCT03861299 1085 1086 O
. NCT03861299 1086 1087 O
Second NCT03861299 1089 1095 B-Eq-Value
primary NCT03861299 1096 1103 O
malignancy NCT03861299 1104 1114 B-Condition-Name
within NCT03861299 1115 1121 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861299 1122 1125 O
past NCT03861299 1126 1130 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03861299 1132 1133 B-Eq-Value
years NCT03861299 1134 1139 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
with NCT03861299 1140 1144 O
the NCT03861299 1145 1148 O
exception NCT03861299 1149 1158 O
of NCT03861299 1159 1161 O
adequately NCT03861299 1162 1172 O
treated NCT03861299 1173 1180 O
in NCT03861299 1181 1183 O
situ NCT03861299 1184 1188 O
carcinoma NCT03861299 1189 1198 B-Condition-Name
of NCT03861299 1199 1201 O
any NCT03861299 1202 1205 O
organ NCT03861299 1206 1211 O
or NCT03861299 1212 1214 O
basal NCT03861299 1215 1220 O
cell NCT03861299 1221 1225 O
carcinoma NCT03861299 1226 1235 B-Condition-Name
of NCT03861299 1236 1238 O
the NCT03861299 1239 1242 O
skin NCT03861299 1243 1247 O
. NCT03861299 1248 1249 O

10 NCT03861299 1253 1255 O
. NCT03861299 1255 1256 O
Severe NCT03861299 1258 1264 B-Severity___Severity-Value:severe
aphasia NCT03861299 1265 1272 B-Condition-Name
or NCT03861299 1273 1275 O
dysphasia NCT03861299 1276 1285 B-Condition-Name

Inclusion NCT03864120 0 9 O
Criteria NCT03864120 10 18 O
: NCT03864120 19 20 O

1 NCT03864120 25 26 O
. NCT03864120 26 27 O
Age NCT03864120 29 32 O
> NCT03864120 33 34 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03864120 36 38 B-Eq-Value
years NCT03864120 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

2 NCT03864120 48 49 O
. NCT03864120 49 50 O
on NCT03864120 52 54 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
PD NCT03864120 55 57 B-Condition-Name
treatment NCT03864120 58 67 O
for NCT03864120 68 71 O
at NCT03864120 72 74 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864120 75 80 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03864120 81 84 B-Eq-Value
month NCT03864120 85 90 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

3 NCT03864120 94 95 O
. NCT03864120 95 96 O
signed NCT03864120 98 104 O
the NCT03864120 105 108 O
consent NCT03864120 109 116 O

Exclusion NCT03864120 117 126 O
Criteria NCT03864120 127 135 O
: NCT03864120 136 137 O

1 NCT03864120 142 143 O
. NCT03864120 143 144 O
Peritonitis NCT03864120 146 157 B-Condition-Name
or NCT03864120 158 160 O
recovery NCT03864120 161 169 O
from NCT03864120 170 174 O
peritonitis NCT03864120 175 186 B-Condition-Name
for NCT03864120 187 190 O
less NCT03864120 191 195 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03864120 196 200 I-Eq-Operator___Eq-Operator-Value:LT
one NCT03864120 201 204 B-Eq-Value
month NCT03864120 205 210 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03864120 211 212 O

2 NCT03864120 217 218 O
. NCT03864120 218 219 O
On NCT03864120 221 223 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03864120 224 227 O
intra NCT03864120 228 233 O
peritoneal NCT03864120 234 244 B-Procedure-Name
treatment NCT03864120 245 254 I-Procedure-Name
apart NCT03864120 255 260 O
from NCT03864120 261 265 O
peritoneal NCT03864120 266 276 B-Procedure-Name
dialysis NCT03864120 277 285 I-Procedure-Name
. NCT03864120 286 287 O

3 NCT03864120 292 293 O
. NCT03864120 293 294 O
Evidence NCT03864120 296 304 O
of NCT03864120 305 307 O
decompensated NCT03864120 308 321 O
liver NCT03864120 322 327 O
cirrhosis NCT03864120 328 337 B-Condition-Name
or NCT03864120 338 340 O
heart NCT03864120 341 346 B-Condition-Name
failure NCT03864120 347 354 I-Condition-Name
. NCT03864120 355 356 O

4 NCT03864120 361 362 O
. NCT03864120 362 363 O
Evidence NCT03864120 365 373 O
of NCT03864120 374 376 O
extra NCT03864120 377 382 O
peritoneal NCT03864120 383 393 B-Condition-Name
leakage NCT03864120 394 401 I-Condition-Name
, NCT03864120 402 403 O
eg NCT03864120 404 406 O
. NCT03864120 407 408 O
leakage NCT03864120 410 417 B-Condition-Name
to NCT03864120 418 420 O
thoracic NCT03864120 421 429 O
cavity NCT03864120 430 436 O
, NCT03864120 437 438 O
post NCT03864120 439 443 O
peritoneal NCT03864120 444 454 B-Procedure-Name
, NCT03864120 455 456 O
hernia NCT03864120 457 463 B-Condition-Name
. NCT03864120 464 465 O

Inclusion NCT03864861 0 9 O
Criteria NCT03864861 10 18 O
: NCT03864861 19 20 O

- NCT03864861 24 25 O
All NCT03864861 27 30 O
adult NCT03864861 31 36 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03864861 37 45 O
( NCT03864861 46 47 O
aged NCT03864861 48 52 O
≥ NCT03864861 53 54 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03864861 56 58 I-Eq-Operator___Eq-Operator-Value:GTEQ
years NCT03864861 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03864861 65 66 O
undergoing NCT03864861 67 77 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03864861 78 86 O
bariatric NCT03864861 87 96 B-Procedure-Name
surgery NCT03864861 97 104 I-Procedure-Name
and NCT03864861 105 108 O
by NCT03864861 109 111 O
any NCT03864861 112 115 O
approach NCT03864861 116 124 O
( NCT03864861 125 126 O
Includes NCT03864861 127 135 O
surgery NCT03864861 136 143 B-Procedure-Name
with NCT03864861 144 148 O
laparoscopic NCT03864861 149 161 B-Procedure-Name
, NCT03864861 162 163 O
assisted NCT03864861 164 172 O
laparoscopic NCT03864861 173 185 B-Procedure-Name
approach NCT03864861 186 194 I-Procedure-Name
or NCT03864861 195 197 O
open NCT03864861 198 202 B-Procedure-Name
approach NCT03864861 203 211 I-Procedure-Name
) NCT03864861 212 213 O
in NCT03864861 214 216 O
a NCT03864861 217 218 O
participating NCT03864861 219 232 O
hospital NCT03864861 233 241 B-Location___Location-Value:hospital
during NCT03864861 242 248 O
the NCT03864861 249 252 O
30 NCT03864861 254 256 B-Eq-Value
- NCT03864861 257 258 O
day NCT03864861 259 262 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
cohort NCT03864861 263 269 O
period NCT03864861 270 276 O
with NCT03864861 277 281 O
a NCT03864861 282 283 O
planned NCT03864861 284 291 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
overnight NCT03864861 292 301 O
stay NCT03864861 302 306 O
. NCT03864861 307 308 O

Exclusion NCT03864861 310 319 O
Criteria NCT03864861 320 328 O
: NCT03864861 329 330 O

- NCT03864861 334 335 O
Patients NCT03864861 337 345 O
undergoing NCT03864861 346 356 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
emergency NCT03864861 357 366 O
surgery NCT03864861 367 374 B-Procedure-Name

- NCT03864861 382 383 O
Endoscopic NCT03864861 385 395 B-Procedure-Name
procedures NCT03864861 396 406 I-Procedure-Name

- NCT03864861 414 415 O
Patients NCT03864861 417 425 O
under NCT03864861 426 431 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03864861 433 435 B-Eq-Value
years NCT03864861 436 441 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03864861 442 444 O
age NCT03864861 445 448 O

- NCT03864861 456 457 O
Patients NCT03864861 459 467 O
with NCT03864861 468 472 O
previous NCT03864861 473 481 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
bariatric NCT03864861 482 491 B-Procedure-Name
surgery NCT03864861 492 499 I-Procedure-Name
who NCT03864861 500 503 O
undergo NCT03864861 504 511 O
revision NCT03864861 512 520 B-Procedure-Name
surgery NCT03864861 521 528 I-Procedure-Name

- NCT03864861 536 537 O
Patients NCT03864861 539 547 O
who NCT03864861 548 551 O
refuse NCT03864861 552 558 O
to NCT03864861 559 561 O
participate NCT03864861 562 573 O

Inclusion NCT03868137 0 9 O
Criteria NCT03868137 10 18 O
: NCT03868137 19 20 O

- NCT03868137 24 25 O
Age NCT03868137 27 30 O
≥ NCT03868137 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868137 34 36 B-Eq-Value

- NCT03868137 40 41 O
Female NCT03868137 43 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03868137 52 53 O
Able NCT03868137 55 59 O
to NCT03868137 60 62 O
provide NCT03868137 63 70 O
informed NCT03868137 71 79 O
consent NCT03868137 80 87 O

- NCT03868137 90 91 O
English NCT03868137 93 100 B-Language
speaking NCT03868137 101 109 O

- NCT03868137 112 113 O
Able NCT03868137 115 119 O
to NCT03868137 120 122 O
provide NCT03868137 123 130 O
telephone NCT03868137 131 140 O
and NCT03868137 141 144 O
address NCT03868137 145 152 O
contact NCT03868137 153 160 O
information NCT03868137 161 172 O

- NCT03868137 175 176 O
Able NCT03868137 178 182 O
and NCT03868137 183 186 O
willing NCT03868137 187 194 O
to NCT03868137 195 197 O
receive NCT03868137 198 205 O
HIPAA NCT03868137 206 211 O
compliant NCT03868137 212 221 O
telephone NCT03868137 222 231 O
texts NCT03868137 232 237 O
and NCT03868137 238 241 O
phone NCT03868137 242 247 O
messages NCT03868137 248 256 O

- NCT03868137 259 260 O
Stable NCT03868137 262 268 B-Stability___Stability-Value:stable
( NCT03868137 269 270 O
the NCT03868137 271 274 O
same NCT03868137 275 279 O
) NCT03868137 280 281 O
address NCT03868137 282 289 B-Location___Location-Value:residence
and NCT03868137 290 293 I-Location___Location-Value:residence
phone NCT03868137 294 299 I-Location___Location-Value:residence
number NCT03868137 300 306 I-Location___Location-Value:residence
within NCT03868137 307 313 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03868137 314 317 O
last NCT03868137 318 322 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03868137 324 325 B-Eq-Value
months NCT03868137 326 332 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03868137 333 334 O

Exclusion NCT03868137 336 345 O
Criteria NCT03868137 346 354 O
: NCT03868137 355 356 O

- NCT03868137 360 361 O
Contraindications NCT03868137 363 380 O
to NCT03868137 381 383 O
IUD NCT03868137 384 387 B-Procedure-Name
insertion NCT03868137 388 397 I-Procedure-Name
( NCT03868137 398 399 O
active NCT03868137 400 406 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pelvic NCT03868137 407 413 O
infection NCT03868137 414 423 B-Condition-Name
, NCT03868137 424 425 O
current NCT03868137 426 433 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnancy NCT03868137 434 443 B-Condition-Name
) NCT03868137 444 445 O

- NCT03868137 449 450 O
Contraindications NCT03868137 452 469 O
to NCT03868137 470 472 O
NSAIDs NCT03868137 473 479 B-Drug-Name
( NCT03868137 480 481 O
allergy NCT03868137 482 489 O
, NCT03868137 490 491 O
history NCT03868137 492 499 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868137 500 502 O
asthma NCT03868137 503 509 B-Condition-Name
, NCT03868137 510 511 O
history NCT03868137 512 519 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868137 520 522 O
aspirin NCT03868137 523 530 B-Drug-Name
allergy NCT03868137 531 538 O
, NCT03868137 539 540 O
history NCT03868137 541 548 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868137 549 551 O
kidney NCT03868137 552 558 B-Condition-Name
disease NCT03868137 559 566 I-Condition-Name
, NCT03868137 567 568 O
history NCT03868137 569 576 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868137 577 579 O
stomach NCT03868137 580 587 O
ulcer NCT03868137 588 593 B-Condition-Name
, NCT03868137 594 595 O
history NCT03868137 596 603 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868137 604 606 O
active NCT03868137 607 613 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
GI NCT03868137 614 616 O
bleeding NCT03868137 617 625 B-Condition-Name
, NCT03868137 626 627 O
history NCT03868137 628 635 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868137 636 638 O
liver NCT03868137 639 644 B-Condition-Name
disease NCT03868137 645 652 I-Condition-Name
) NCT03868137 653 654 O

- NCT03868137 658 659 O
Not NCT03868137 661 664 O
undergoing NCT03868137 665 675 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03868137 676 679 O
other NCT03868137 680 685 O
concurrent NCT03868137 686 696 O
office NCT03868137 697 703 O
procedures NCT03868137 704 714 O

Inclusion NCT03865407 0 9 O
Criteria NCT03865407 10 18 O
: NCT03865407 19 20 O

- NCT03865407 24 25 O
Chronic NCT03865407 27 34 O
Kidney NCT03865407 35 41 B-Condition-Name
Disease NCT03865407 42 49 I-Condition-Name
stage NCT03865407 50 55 B-Eq-Unit
1 NCT03865407 57 58 B-Eq-Value
- NCT03865407 59 60 B-Eq-Operator___Eq-Operator-Value:BETWEEN
5 NCT03865407 62 63 B-Eq-Value

- NCT03865407 67 68 O
Hyperuricemic NCT03865407 70 83 B-Condition-Name
( NCT03865407 84 85 O
UA NCT03865407 86 88 B-Observation-Name___Observation-Type-Value:lab
> NCT03865407 89 90 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03865407 92 93 I-Eq-Operator___Eq-Operator-Value:GTEQ
5.5 NCT03865407 95 98 B-Eq-Value
mg NCT03865407 99 101 B-Eq-Unit
/ NCT03865407 102 103 O
dL NCT03865407 104 106 B-Eq-Unit
) NCT03865407 107 108 O

Exclusion NCT03865407 110 119 O
Criteria NCT03865407 120 128 O
: NCT03865407 129 130 O

- NCT03865407 134 135 O
Contraindication NCT03865407 137 153 O
to NCT03865407 154 156 O
Allopurinol NCT03865407 157 168 B-Drug-Name

- NCT03865407 171 172 O
Elevated NCT03865407 174 182 B-Polarity___Polarity-Value:high
baseline NCT03865407 183 191 O
liver NCT03865407 192 197 B-Observation-Name___Observation-Type-Value:lab
function NCT03865407 198 206 I-Observation-Name___Observation-Type-Value:lab
tests NCT03865407 207 212 I-Observation-Name___Observation-Type-Value:lab

- NCT03865407 215 216 O
Receiving NCT03865407 218 227 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
acute NCT03865407 228 233 B-Severity___Severity-Value:severe
or NCT03865407 234 236 O
chronic NCT03865407 237 244 O
dialysis NCT03865407 245 253 B-Procedure-Name

- NCT03865407 256 257 O
Primary NCT03865407 259 266 O
metabolic NCT03865407 267 276 B-Condition-Name
disorder NCT03865407 277 285 I-Condition-Name

- NCT03865407 288 289 O
Sickle NCT03865407 291 297 B-Condition-Name
cell NCT03865407 298 302 I-Condition-Name
disease NCT03865407 303 310 I-Condition-Name

- NCT03865407 313 314 O
Autosomal NCT03865407 316 325 O
Dominant NCT03865407 326 334 O
Polycystic NCT03865407 335 345 B-Condition-Name
Kidney NCT03865407 346 352 I-Condition-Name
Disease NCT03865407 353 360 I-Condition-Name

- NCT03865407 363 364 O
Cystinosis NCT03865407 366 376 B-Condition-Name

- NCT03865407 379 380 O
Bartter NCT03865407 382 389 O
or NCT03865407 390 392 O
Gitelman NCT03865407 393 401 O
Disease NCT03865407 402 409 B-Condition-Name

- NCT03865407 412 413 O
Pregnant NCT03865407 415 423 B-Condition-Name
or NCT03865407 424 426 O
nursing NCT03865407 427 434 B-Condition-Name

Inclusion NCT03866668 0 9 O
Criteria NCT03866668 10 18 O
: NCT03866668 19 20 O

- NCT03866668 24 25 O
outpatients NCT03866668 27 38 B-Encounter-Type___Encounter-Type-Value:outpatient
2 NCT03866668 40 41 B-Eq-Value
to NCT03866668 42 44 B-Eq-Operator___Eq-Operator-Value:BETWEEN
6 NCT03866668 46 47 B-Eq-Value
years NCT03866668 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866668 54 56 O
age NCT03866668 57 60 O
; NCT03866668 60 61 O

- NCT03866668 64 65 O
males NCT03866668 67 72 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03866668 73 76 O
females NCT03866668 77 84 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03866668 85 88 O
are NCT03866668 89 92 O
physically NCT03866668 93 103 O
healthy NCT03866668 104 111 B-Condition-Name
; NCT03866668 111 112 O

- NCT03866668 115 116 O
diagnosis NCT03866668 118 127 O
of NCT03866668 128 130 O
autism NCT03866668 131 137 B-Condition-Name
spectrum NCT03866668 138 146 I-Condition-Name
disorder NCT03866668 147 155 I-Condition-Name
based NCT03866668 156 161 O
on NCT03866668 162 164 O
clinical NCT03866668 165 173 O
evaluation NCT03866668 174 184 O
and NCT03866668 185 188 O
DSM NCT03866668 189 192 O
- NCT03866668 193 194 O
5 NCT03866668 196 197 O
criteria NCT03866668 198 206 O
, NCT03866668 207 208 O
and NCT03866668 209 212 O
confirmed NCT03866668 213 222 O
using NCT03866668 223 228 O
the NCT03866668 229 232 O
Autism NCT03866668 233 239 O
Diagnostic NCT03866668 240 250 O
Interview NCT03866668 251 260 O
- NCT03866668 261 262 O
Revised NCT03866668 263 270 O
, NCT03866668 271 272 O
and NCT03866668 273 276 O
the NCT03866668 277 280 O
Autism NCT03866668 281 287 O
Diagnostic NCT03866668 288 298 O
Observation NCT03866668 299 310 O
Schedule NCT03866668 311 319 O
; NCT03866668 319 320 O

- NCT03866668 323 324 O
care NCT03866668 326 330 O
provider NCT03866668 331 339 O
who NCT03866668 340 343 O
could NCT03866668 344 349 O
reliably NCT03866668 350 358 O
bring NCT03866668 359 364 O
subject NCT03866668 365 372 O
to NCT03866668 373 375 O
clinic NCT03866668 376 382 B-Location___Location-Value:clinic
visits NCT03866668 383 389 B-Encounter-Type___Encounter-Type-Value:outpatient
, NCT03866668 390 391 O
could NCT03866668 392 397 O
provide NCT03866668 398 405 O
trustworthy NCT03866668 406 417 O
ratings NCT03866668 418 425 O
, NCT03866668 426 427 O
and NCT03866668 428 431 O
interacted NCT03866668 432 442 O
with NCT03866668 443 447 O
subject NCT03866668 448 455 O
on NCT03866668 456 458 O
a NCT03866668 459 460 O
regular NCT03866668 461 468 O
basis NCT03866668 469 474 O
; NCT03866668 474 475 O

- NCT03866668 478 479 O
ability NCT03866668 481 488 O
of NCT03866668 489 491 O
subject NCT03866668 492 499 O
to NCT03866668 500 502 O
swallow NCT03866668 503 510 O
the NCT03866668 511 514 O
compound NCT03866668 515 523 O
; NCT03866668 523 524 O

- NCT03866668 527 528 O
stable NCT03866668 530 536 B-Stability___Stability-Value:stable
concomitant NCT03866668 537 548 O
medications NCT03866668 549 560 O
for NCT03866668 561 564 O
at NCT03866668 565 567 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03866668 568 573 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03866668 575 576 B-Eq-Value
weeks NCT03866668 577 582 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03866668 583 584 O
4 NCT03866668 586 587 B-Eq-Value
weeks NCT03866668 588 593 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
if NCT03866668 594 596 O
patient NCT03866668 597 604 O
took NCT03866668 605 609 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
fluoxetine NCT03866668 610 620 B-Drug-Name
) NCT03866668 621 622 O
; NCT03866668 623 624 O

- NCT03866668 627 628 O
no NCT03866668 630 632 O
planned NCT03866668 633 640 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
changes NCT03866668 641 648 B-Stability___Stability-Value:change
in NCT03866668 649 651 O
psychosocial NCT03866668 652 664 B-Procedure-Name
interventions NCT03866668 665 678 I-Procedure-Name
during NCT03866668 679 685 O
the NCT03866668 686 689 O
open NCT03866668 690 694 O
- NCT03866668 695 696 O
label NCT03866668 697 702 O
trial NCT03866668 703 708 O
. NCT03866668 709 710 O

Exclusion NCT03866668 712 721 O
Criteria NCT03866668 722 730 O
: NCT03866668 731 732 O

- NCT03866668 736 737 O
DSM NCT03866668 739 742 O
- NCT03866668 743 744 O
5 NCT03866668 746 747 O
diagnosis NCT03866668 748 757 O
of NCT03866668 758 760 O
schizophrenia NCT03866668 761 774 B-Condition-Name
, NCT03866668 775 776 O
schizoaffective NCT03866668 777 792 B-Condition-Name
disorder NCT03866668 793 801 I-Condition-Name
, NCT03866668 802 803 O
or NCT03866668 804 806 O
psychotic NCT03866668 807 816 B-Condition-Name
disorder NCT03866668 817 825 I-Condition-Name
not NCT03866668 826 829 O
otherwise NCT03866668 830 839 O
specified NCT03866668 840 849 O
; NCT03866668 849 850 O

- NCT03866668 853 854 O
prior NCT03866668 856 861 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
adequate NCT03866668 862 870 O
trial NCT03866668 871 876 O
of NCT03866668 877 879 O
Esomeprazole NCT03866668 880 892 B-Drug-Name
; NCT03866668 892 893 O

- NCT03866668 896 897 O
active NCT03866668 899 905 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medical NCT03866668 906 913 O
problems NCT03866668 914 922 O
such NCT03866668 923 927 O
as NCT03866668 928 930 O
unstable NCT03866668 931 939 B-Stability___Stability-Value:change
seizures NCT03866668 940 948 B-Condition-Name
, NCT03866668 949 950 O
or NCT03866668 951 953 O
significant NCT03866668 954 965 B-Severity___Severity-Value:severe
physical NCT03866668 966 974 B-Condition-Name
illness NCT03866668 975 982 I-Condition-Name
( NCT03866668 983 984 O
e NCT03866668 985 986 O
. NCT03866668 987 988 O
g NCT03866668 989 990 O
. NCT03866668 991 992 O
, NCT03866668 993 994 O
serious NCT03866668 995 1002 B-Severity___Severity-Value:severe
liver NCT03866668 1003 1008 O
or NCT03866668 1009 1011 O
renal NCT03866668 1012 1017 O
pathology NCT03866668 1018 1027 B-Condition-Name
) NCT03866668 1028 1029 O
. NCT03866668 1031 1032 O

Inclusion NCT03864731 0 9 O
Criteria NCT03864731 10 18 O
: NCT03864731 19 20 O

- NCT03864731 24 25 O
Unilateral NCT03864731 27 37 O
and NCT03864731 38 41 O
/ NCT03864731 42 43 O
or NCT03864731 44 46 O
bilateral NCT03864731 47 56 O
conductive NCT03864731 57 67 B-Condition-Name
hearing NCT03864731 68 75 I-Condition-Name
loss NCT03864731 76 80 I-Condition-Name
( NCT03864731 81 82 O
CHL NCT03864731 83 86 B-Condition-Name
) NCT03864731 87 88 O

- NCT03864731 92 93 O
Conductive NCT03864731 95 105 O
hearing NCT03864731 106 113 B-Condition-Name
loss NCT03864731 114 118 I-Condition-Name
> NCT03864731 119 120 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03864731 122 124 B-Eq-Value
decibel NCT03864731 125 132 B-Eq-Unit
on NCT03864731 133 135 O
average NCT03864731 136 143 O

- NCT03864731 146 147 O
Subjective NCT03864731 149 159 O
benefit NCT03864731 160 167 O
from NCT03864731 168 172 O
the NCT03864731 173 176 O
device NCT03864731 177 183 O

- NCT03864731 186 187 O
Subjects NCT03864731 189 197 O
aged NCT03864731 198 202 O
13 NCT03864731 204 206 B-Eq-Value
years NCT03864731 207 212 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03864731 213 215 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03864731 216 221 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03864731 224 225 O
Capable NCT03864731 227 234 O
of NCT03864731 235 237 O
the NCT03864731 238 241 O
German NCT03864731 242 248 B-Language
language NCT03864731 249 257 O

- NCT03864731 260 261 O
Willingness NCT03864731 263 274 O
and NCT03864731 275 278 O
ability NCT03864731 279 286 O
to NCT03864731 287 289 O
perform NCT03864731 290 297 O
all NCT03864731 298 301 O
tests NCT03864731 302 307 O
required NCT03864731 308 316 O
for NCT03864731 317 320 O
the NCT03864731 321 324 O
study NCT03864731 325 330 O

- NCT03864731 333 334 O
Signed NCT03864731 336 342 O
, NCT03864731 343 344 O
and NCT03864731 345 348 O
dated NCT03864731 349 354 O
informed NCT03864731 355 363 O
consent NCT03864731 364 371 O
before NCT03864731 372 378 O
the NCT03864731 379 382 O
start NCT03864731 383 388 O
of NCT03864731 389 391 O
any NCT03864731 392 395 O
study NCT03864731 396 401 O
specific NCT03864731 402 410 O
procedure NCT03864731 411 420 O

Exclusion NCT03864731 421 430 O
Criteria NCT03864731 431 439 O
: NCT03864731 440 441 O

- NCT03864731 445 446 O
Pregnancy NCT03864731 448 457 B-Condition-Name
or NCT03864731 458 460 O
breastfeeding NCT03864731 461 474 B-Condition-Name

- NCT03864731 477 478 O
Patient NCT03864731 480 487 O
uses NCT03864731 488 492 O
a NCT03864731 493 494 O
hearing NCT03864731 495 502 B-Condition-Name
aid NCT03864731 503 506 I-Condition-Name
or NCT03864731 507 509 O
plans NCT03864731 510 515 O
to NCT03864731 516 518 O
acquire NCT03864731 519 526 O
a NCT03864731 527 528 O
hearing NCT03864731 529 536 B-Condition-Name
aid NCT03864731 537 540 I-Condition-Name

- NCT03864731 543 544 O
Patient NCT03864731 546 553 O
is NCT03864731 554 556 O
intolerant NCT03864731 557 567 O
of NCT03864731 568 570 O
the NCT03864731 571 574 O
materials NCT03864731 575 584 O
as NCT03864731 585 587 O
described NCT03864731 588 597 O
by NCT03864731 598 600 O
Manufacturer NCT03864731 601 613 O

- NCT03864731 616 617 O
Patient NCT03864731 619 626 O
presents NCT03864731 627 635 O
with NCT03864731 636 640 O
a NCT03864731 641 642 O
skin NCT03864731 643 647 O
or NCT03864731 648 650 O
scalp NCT03864731 651 656 O
condition NCT03864731 657 666 B-Condition-Name
that NCT03864731 667 671 O
may NCT03864731 672 675 O
preclude NCT03864731 676 684 O
the NCT03864731 685 688 O
attachment NCT03864731 689 699 B-Procedure-Name
of NCT03864731 700 702 I-Procedure-Name
the NCT03864731 703 706 I-Procedure-Name
adhesive NCT03864731 707 715 I-Procedure-Name
adapter NCT03864731 716 723 I-Procedure-Name
. NCT03864731 724 725 O

- NCT03864731 729 730 O
Patient NCT03864731 732 739 O
can NCT03864731 740 743 O
not NCT03864731 743 746 O
perform NCT03864731 747 754 O
the NCT03864731 755 758 O
audiological NCT03864731 759 771 B-Procedure-Name
tests NCT03864731 772 777 I-Procedure-Name
or NCT03864731 778 780 O
is NCT03864731 781 783 O
unable NCT03864731 784 790 O
to NCT03864731 791 793 O
fill NCT03864731 794 798 O
out NCT03864731 799 802 O
the NCT03864731 803 806 O
questionnaires NCT03864731 807 821 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
. NCT03864731 822 823 O

- NCT03864731 827 828 O
Patient NCT03864731 830 837 O
presents NCT03864731 838 846 O
with NCT03864731 847 851 O
retrocochlear NCT03864731 852 865 B-Condition-Name
, NCT03864731 866 867 O
or NCT03864731 868 870 O
central NCT03864731 871 878 O
auditory NCT03864731 879 887 B-Condition-Name
disorder NCT03864731 888 896 I-Condition-Name
. NCT03864731 897 898 O

- NCT03864731 902 903 O
any NCT03864731 905 908 O
physical NCT03864731 909 917 O
, NCT03864731 918 919 O
psychological NCT03864731 920 933 O
, NCT03864731 934 935 O
or NCT03864731 936 938 O
emotional NCT03864731 939 948 O
disorder NCT03864731 949 957 B-Condition-Name
that NCT03864731 958 962 O
would NCT03864731 963 968 O
interfere NCT03864731 969 978 B-Stability___Stability-Value:change
with NCT03864731 979 983 O
the NCT03864731 984 987 O
ability NCT03864731 988 995 O
to NCT03864731 996 998 O
perform NCT03864731 999 1006 O
on NCT03864731 1007 1009 O
test NCT03864731 1010 1014 B-Observation-Name
and NCT03864731 1015 1018 O
rehabilitation NCT03864731 1019 1033 B-Procedure-Name
procedures NCT03864731 1034 1044 I-Procedure-Name

Inclusion NCT03869567 0 9 O
Criteria NCT03869567 10 18 O
: NCT03869567 19 20 O

- NCT03869567 24 25 O
all NCT03869567 27 30 O
patients NCT03869567 31 39 O
with NCT03869567 40 44 O
cerebral NCT03869567 45 53 B-Condition-Name
thrombectomy NCT03869567 54 66 I-Condition-Name

- NCT03869567 69 70 O
Adults NCT03869567 72 78 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult

- NCT03869567 81 82 O
Patients NCT03869567 84 92 O
able NCT03869567 93 97 O
to NCT03869567 98 100 O
express NCT03869567 101 108 O
consent NCT03869567 109 116 O

- NCT03869567 119 120 O
Signed NCT03869567 122 128 O
written NCT03869567 129 136 O
informed NCT03869567 137 145 O
consent NCT03869567 146 153 O
form NCT03869567 154 158 O

- NCT03869567 161 162 O
Covered NCT03869567 164 171 O
by NCT03869567 172 174 O
national NCT03869567 175 183 B-Insurance
health NCT03869567 184 190 I-Insurance
insurance NCT03869567 191 200 I-Insurance

Exclusion NCT03869567 201 210 O
Criteria NCT03869567 211 219 O
: NCT03869567 220 221 O

- NCT03869567 225 226 O
minors NCT03869567 228 234 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child

- NCT03869567 237 238 O
pregnancy NCT03869567 240 249 B-Condition-Name
or NCT03869567 250 252 O
beast NCT03869567 253 258 B-Condition-Name
feeding NCT03869567 259 266 I-Condition-Name

- NCT03869567 269 270 O
patient NCT03869567 272 279 O
deprived NCT03869567 280 288 B-Observation-Name
of NCT03869567 289 291 I-Observation-Name
liberty NCT03869567 292 299 I-Observation-Name
by NCT03869567 300 302 O
administrative NCT03869567 303 317 O
or NCT03869567 318 320 O
judicial NCT03869567 321 329 O
decision NCT03869567 330 338 O
or NCT03869567 339 341 O
placed NCT03869567 342 348 O
under NCT03869567 349 354 O
judicial NCT03869567 355 363 B-Observation-Name
protection NCT03869567 364 374 I-Observation-Name
( NCT03869567 375 376 O
guardianship NCT03869567 377 389 O
or NCT03869567 390 392 O
supervision NCT03869567 393 404 O
) NCT03869567 405 406 O

- NCT03869567 410 411 O
obstruction NCT03869567 413 424 O
to NCT03869567 425 427 O
participate NCT03869567 428 439 O

- NCT03869567 442 443 O
non NCT03869567 445 448 O
covered NCT03869567 449 456 O
by NCT03869567 457 459 O
national NCT03869567 460 468 B-Insurance
health NCT03869567 469 475 I-Insurance
insurance NCT03869567 476 485 I-Insurance

Inclusion NCT03864094 0 9 O
Criteria NCT03864094 10 18 O
: NCT03864094 19 20 O

- NCT03864094 24 25 O
Healthy NCT03864094 27 34 B-Condition-Name
women NCT03864094 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03864094 43 44 O
Age NCT03864094 46 49 O
18 NCT03864094 51 53 B-Eq-Value
- NCT03864094 54 55 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03864094 57 59 B-Eq-Value
years NCT03864094 60 65 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864094 68 69 O
Gynecological NCT03864094 71 84 B-Procedure-Name
procedures NCT03864094 85 95 I-Procedure-Name

- NCT03864094 98 99 O
General NCT03864094 101 108 B-Procedure-Name
anesthesia NCT03864094 109 119 I-Procedure-Name

Exclusion NCT03864094 120 129 O
Criteria NCT03864094 130 138 O
: NCT03864094 139 140 O

- NCT03864094 144 145 O
Pre NCT03864094 147 150 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03864094 151 152 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03864094 153 161 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
hypertension NCT03864094 162 174 B-Condition-Name

- NCT03864094 177 178 O
Diabetes NCT03864094 180 188 B-Condition-Name
for NCT03864094 189 192 O
several NCT03864094 193 200 B-Eq-Operator___Eq-Operator-Value:GT
years NCT03864094 201 206 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864094 209 210 O
Ischemic NCT03864094 212 220 O
heart NCT03864094 221 226 B-Condition-Name
disease NCT03864094 227 234 I-Condition-Name

- NCT03864094 237 238 O
Cerebrovascular NCT03864094 240 255 B-Condition-Name
disease NCT03864094 256 263 I-Condition-Name

- NCT03864094 266 267 O
Heart NCT03864094 269 274 B-Condition-Name
valve NCT03864094 275 280 I-Condition-Name
disease NCT03864094 281 288 I-Condition-Name

- NCT03864094 291 292 O
Verified NCT03864094 294 302 O
cardiac NCT03864094 303 310 B-Condition-Name
arrhythmia NCT03864094 311 321 I-Condition-Name

- NCT03864094 324 325 O
Anaemia NCT03864094 327 334 B-Condition-Name

- NCT03864094 337 338 O
Kidney NCT03864094 340 346 O
or NCT03864094 347 349 O
hepatic NCT03864094 350 357 O
disease NCT03864094 358 365 B-Condition-Name

- NCT03864094 368 369 O
Hypersensitivity NCT03864094 371 387 B-Condition-Name
for NCT03864094 388 391 O
soya NCT03864094 392 396 O
, NCT03864094 397 398 O
eggs NCT03864094 399 403 O
or NCT03864094 404 406 O
peanuts NCT03864094 407 414 O

- NCT03864094 417 418 O
Pregnancy NCT03864094 420 429 B-Condition-Name

- NCT03864094 432 433 O
Poor NCT03864094 435 439 B-Condition-Name
health NCT03864094 440 446 I-Condition-Name
state NCT03864094 447 452 O

- NCT03864094 455 456 O
Illicit NCT03864094 458 465 B-Condition-Name
substance NCT03864094 466 475 I-Condition-Name
use NCT03864094 476 479 O

- NCT03864094 482 483 O
BMI NCT03864094 485 488 B-Observation-Name___Observation-Type-Value:vital
< NCT03864094 489 490 B-Eq-Operator___Eq-Operator-Value:LT
20 NCT03864094 492 494 B-Eq-Value
or NCT03864094 495 497 O
> NCT03864094 498 499 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03864094 501 503 B-Eq-Value
kg NCT03864094 504 506 B-Eq-Unit
/ NCT03864094 507 508 O
m NCT03864094 509 510 B-Eq-Unit
2 NCT03864094 511 512 I-Eq-Unit

- NCT03864094 515 516 O
SBP NCT03864094 518 521 B-Observation-Name___Observation-Type-Value:vital
> NCT03864094 522 523 B-Eq-Operator___Eq-Operator-Value:GT
150 NCT03864094 525 528 B-Eq-Value
mmHg NCT03864094 529 533 B-Eq-Unit

- NCT03864094 536 537 O
HR NCT03864094 539 541 B-Observation-Name___Observation-Type-Value:vital
> NCT03864094 542 543 B-Eq-Operator___Eq-Operator-Value:GT
100 NCT03864094 545 548 B-Eq-Value
beats NCT03864094 549 554 B-Eq-Unit
/ NCT03864094 555 556 O
min NCT03864094 557 560 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

Inclusion NCT03867760 0 9 O
Criteria NCT03867760 10 18 O
: NCT03867760 19 20 O

- NCT03867760 24 25 O
self NCT03867760 27 31 O
- NCT03867760 32 33 O
reporting NCT03867760 34 43 O
moderate NCT03867760 44 52 B-Severity___Severity-Value:moderate
or NCT03867760 53 55 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03867760 56 62 I-Eq-Operator___Eq-Operator-Value:GTEQ
pain NCT03867760 63 67 B-Condition-Name
on NCT03867760 68 70 O
average NCT03867760 71 78 O
during NCT03867760 79 85 O
the NCT03867760 86 89 O
last NCT03867760 90 94 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
week NCT03867760 95 99 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03867760 100 101 O
> NCT03867760 103 104 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03867760 106 107 B-Eq-Value
on NCT03867760 108 110 O
a NCT03867760 111 112 O
0 NCT03867760 114 115 O
- NCT03867760 116 117 O
10 NCT03867760 119 121 O
pain NCT03867760 122 126 B-Observation-Name___Observation-Type-Value:clinical-score
intensity NCT03867760 127 136 I-Observation-Name___Observation-Type-Value:clinical-score
numeric NCT03867760 137 144 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03867760 145 150 I-Observation-Name___Observation-Type-Value:clinical-score
) NCT03867760 151 152 O

- NCT03867760 156 157 O
self NCT03867760 159 163 O
- NCT03867760 164 165 O
reporting NCT03867760 166 175 O
experiencing NCT03867760 176 188 O
pain NCT03867760 189 193 B-Condition-Name
at NCT03867760 194 196 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867760 197 202 I-Eq-Operator___Eq-Operator-Value:GTEQ
half NCT03867760 203 207 B-Eq-Value
of NCT03867760 208 210 O
the NCT03867760 211 214 O
days NCT03867760 215 219 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
in NCT03867760 220 222 O
the NCT03867760 223 226 O
past NCT03867760 227 231 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
4 NCT03867760 233 234 B-Eq-Value
weeks NCT03867760 235 240 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03867760 243 244 O
self NCT03867760 246 250 O
- NCT03867760 251 252 O
reporting NCT03867760 253 262 O
chronic NCT03867760 263 270 O
pain NCT03867760 271 275 B-Condition-Name
related NCT03867760 276 283 O
to NCT03867760 284 286 O
cancer NCT03867760 287 293 B-Condition-Name
or NCT03867760 294 296 O
its NCT03867760 297 300 O
treatment NCT03867760 301 310 O

- NCT03867760 313 314 O
completed NCT03867760 316 325 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
active NCT03867760 326 332 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cancer NCT03867760 333 339 B-Condition-Name
treatment NCT03867760 340 349 O
other NCT03867760 350 355 O
than NCT03867760 356 360 O
maintenance NCT03867760 361 372 B-Procedure-Name
therapy NCT03867760 373 380 I-Procedure-Name

- NCT03867760 383 384 O
being NCT03867760 386 391 O
> NCT03867760 392 393 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03867760 395 397 B-Eq-Value
years NCT03867760 398 403 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03867760 404 406 O
age NCT03867760 407 410 O

- NCT03867760 413 414 O
functional NCT03867760 416 426 O
fluency NCT03867760 427 434 O
in NCT03867760 435 437 O
English NCT03867760 438 445 B-Language

- NCT03867760 448 449 O
mentally NCT03867760 451 459 O
and NCT03867760 460 463 O
physically NCT03867760 464 474 O
able NCT03867760 475 479 O
to NCT03867760 480 482 O
participate NCT03867760 483 494 O
and NCT03867760 495 498 O
complete NCT03867760 499 507 O
surveys NCT03867760 508 515 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire

Exclusion NCT03867760 516 525 O
Criteria NCT03867760 526 534 O
: NCT03867760 535 536 O

• NCT03867760 538 539 O
has NCT03867760 540 543 O
a NCT03867760 544 545 O
psychiatric NCT03867760 546 557 B-Condition-Name
condition NCT03867760 558 567 I-Condition-Name
or NCT03867760 568 570 O
symptoms NCT03867760 571 579 O
( NCT03867760 580 581 O
i NCT03867760 582 583 O
. NCT03867760 584 585 O
e NCT03867760 586 587 O
. NCT03867760 588 589 O
, NCT03867760 590 591 O
diagnosis NCT03867760 592 601 O
of NCT03867760 602 604 O
paranoid NCT03867760 605 613 B-Condition-Name
schizophrenia NCT03867760 614 627 I-Condition-Name
or NCT03867760 628 630 O
active NCT03867760 631 637 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
paranoid NCT03867760 638 646 B-Condition-Name
delusional NCT03867760 647 657 I-Condition-Name
thoughts NCT03867760 658 666 I-Condition-Name
, NCT03867760 667 668 O
as NCT03867760 669 671 O
determined NCT03867760 672 682 O
via NCT03867760 683 686 O
a NCT03867760 687 688 O
telephone NCT03867760 689 698 O
or NCT03867760 699 701 O
in NCT03867760 702 704 O
- NCT03867760 705 706 O
person NCT03867760 707 713 O
screening NCT03867760 714 723 B-Procedure-Name
assessment NCT03867760 724 734 I-Procedure-Name
) NCT03867760 735 736 O
that NCT03867760 737 741 O
would NCT03867760 742 747 O
interfere NCT03867760 748 757 B-Stability___Stability-Value:change
with NCT03867760 758 762 O
study NCT03867760 763 768 O
participation NCT03867760 769 782 O
. NCT03867760 783 784 O

Exclusion NCT03867760 786 795 O
Criteria NCT03867760 796 804 O
for NCT03867760 805 808 O
Optional NCT03867760 809 817 O
EEG NCT03867760 818 821 O
Measurement NCT03867760 822 833 O
: NCT03867760 834 835 O

- NCT03867760 839 840 O
a NCT03867760 842 843 O
history NCT03867760 844 851 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867760 852 854 O
seizure NCT03867760 855 862 B-Condition-Name
condition NCT03867760 863 872 I-Condition-Name
within NCT03867760 873 879 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867760 880 883 O
last NCT03867760 884 888 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03867760 889 893 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03867760 896 897 O
a NCT03867760 899 900 O
significant NCT03867760 901 912 B-Severity___Severity-Value:severe
brain NCT03867760 913 918 O
injury NCT03867760 919 925 B-Condition-Name
or NCT03867760 926 928 O
skull NCT03867760 929 934 O
defect NCT03867760 935 941 B-Condition-Name

- NCT03867760 944 945 O
a NCT03867760 947 948 O
history NCT03867760 949 956 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867760 957 959 O
brain NCT03867760 960 965 O
cancer NCT03867760 966 972 B-Condition-Name
. NCT03867760 973 974 O


Inclusion NCT03865836 0 9 O
Criteria NCT03865836 10 18 O
: NCT03865836 19 20 O

1 NCT03865836 25 26 O
. NCT03865836 26 27 O
Subject NCT03865836 29 36 O
must NCT03865836 37 41 O
have NCT03865836 42 46 O
a NCT03865836 47 48 O
diagnosis NCT03865836 49 58 O
of NCT03865836 59 61 O
LOPD NCT03865836 62 66 B-Condition-Name
based NCT03865836 67 72 O
on NCT03865836 73 75 O
documentation NCT03865836 76 89 O
of NCT03865836 90 92 O
one NCT03865836 93 96 B-Eq-Value
of NCT03865836 97 99 O
the NCT03865836 100 103 O
following NCT03865836 104 113 O
: NCT03865836 114 115 O

1 NCT03865836 125 126 O
. NCT03865836 126 127 O
deficiency NCT03865836 129 139 B-Condition-Name
of NCT03865836 140 142 O
GAA NCT03865836 143 146 O
enzyme NCT03865836 147 153 O

2 NCT03865836 162 163 O
. NCT03865836 163 164 O
GAA NCT03865836 166 169 B-Procedure-Name
genotyping NCT03865836 170 180 I-Procedure-Name

2 NCT03865836 184 185 O
. NCT03865836 185 186 O
Subject NCT03865836 188 195 O
must NCT03865836 196 200 O
provide NCT03865836 201 208 O
signed NCT03865836 209 215 O
informed NCT03865836 216 224 O
consent NCT03865836 225 232 O
prior NCT03865836 233 238 O
to NCT03865836 239 241 O
any NCT03865836 242 245 O
study NCT03865836 246 251 O
- NCT03865836 252 253 O
related NCT03865836 254 261 O
procedures NCT03865836 262 272 O
being NCT03865836 273 278 O
performed NCT03865836 279 288 O
. NCT03865836 289 290 O

Exclusion NCT03865836 292 301 O
Criteria NCT03865836 302 310 O
: NCT03865836 311 312 O

1 NCT03865836 317 318 O
. NCT03865836 318 319 O
Subject NCT03865836 321 328 O
is NCT03865836 329 331 O
eligible NCT03865836 332 340 O
for NCT03865836 341 344 O
enrollment NCT03865836 345 355 O
in NCT03865836 356 358 O
an NCT03865836 359 361 O
ongoing NCT03865836 362 369 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
clinical NCT03865836 370 378 O
trial NCT03865836 379 384 O
using NCT03865836 385 390 O
ATB NCT03865836 391 394 B-Drug-Name
200 NCT03865836 395 398 I-Drug-Name
/ NCT03865836 399 400 O
AT NCT03865836 401 403 B-Drug-Name
2221 NCT03865836 404 408 I-Drug-Name
. NCT03865836 408 409 O

2 NCT03865836 414 415 O
. NCT03865836 415 416 O
Subject NCT03865836 418 425 O
, NCT03865836 426 427 O
if NCT03865836 428 430 O
female NCT03865836 431 437 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03865836 438 439 O
is NCT03865836 440 442 O
pregnant NCT03865836 443 451 B-Condition-Name
or NCT03865836 452 454 O
breastfeeding NCT03865836 455 468 B-Condition-Name
at NCT03865836 469 471 O
screening NCT03865836 472 481 O
. NCT03865836 482 483 O

3 NCT03865836 488 489 O
. NCT03865836 489 490 O
Subject NCT03865836 492 499 O
, NCT03865836 500 501 O
whether NCT03865836 502 509 O
male NCT03865836 510 514 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03865836 515 517 O
female NCT03865836 518 524 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03865836 525 526 O
is NCT03865836 527 529 O
planning NCT03865836 530 538 O
to NCT03865836 539 541 O
conceive NCT03865836 542 550 B-Condition-Name
a NCT03865836 551 552 I-Condition-Name
child NCT03865836 553 558 I-Condition-Name
during NCT03865836 559 565 O
the NCT03865836 566 569 O
study NCT03865836 570 575 O
. NCT03865836 576 577 O

Inclusion NCT03868241 0 9 O
Criteria NCT03868241 10 18 O
: NCT03868241 19 20 O

- NCT03868241 24 25 O
All NCT03868241 27 30 O
patients NCT03868241 31 39 O
admitted NCT03868241 40 48 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03868241 49 51 O
the NCT03868241 52 55 O
intensive NCT03868241 56 65 B-Location___Location-Value:unit
care NCT03868241 66 70 I-Location___Location-Value:unit
unit NCT03868241 71 75 I-Location___Location-Value:unit
which NCT03868241 76 81 O
will NCT03868241 82 86 O
require NCT03868241 87 94 O
simultaneous NCT03868241 95 107 O
insertion NCT03868241 108 117 B-Procedure-Name
of NCT03868241 118 120 I-Procedure-Name
all NCT03868241 121 124 I-Procedure-Name
three NCT03868241 125 130 I-Procedure-Name
devices NCT03868241 131 138 I-Procedure-Name
( NCT03868241 139 140 O
endotracheal NCT03868241 141 153 B-Procedure-Name
tube NCT03868241 154 158 I-Procedure-Name
, NCT03868241 159 160 O
central NCT03868241 161 168 B-Procedure-Name
venous NCT03868241 169 175 I-Procedure-Name
catheter NCT03868241 176 184 I-Procedure-Name
and NCT03868241 185 188 O
urinary NCT03868241 189 196 B-Procedure-Name
catheter NCT03868241 197 205 I-Procedure-Name
) NCT03868241 206 207 O
due NCT03868241 208 211 O
to NCT03868241 212 214 O
illness NCT03868241 215 222 O
severity NCT03868241 223 231 B-Severity___Severity-Value:severe
as NCT03868241 232 234 O
defined NCT03868241 235 242 O
by NCT03868241 243 245 O
the NCT03868241 246 249 O
attending NCT03868241 250 259 B-Provider-Role
physician NCT03868241 260 269 I-Provider-Role
. NCT03868241 270 271 O

Exclusion NCT03868241 273 282 O
Criteria NCT03868241 283 291 O
: NCT03868241 292 293 O

- NCT03868241 297 298 O
Patients NCT03868241 300 308 O
admitted NCT03868241 309 317 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03868241 318 320 O
the NCT03868241 321 324 O
intensive NCT03868241 325 334 B-Location___Location-Value:unit
care NCT03868241 335 339 I-Location___Location-Value:unit
unit NCT03868241 340 344 I-Location___Location-Value:unit
for NCT03868241 345 348 O
more NCT03868241 349 353 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868241 354 358 I-Eq-Operator___Eq-Operator-Value:GT
48 NCT03868241 360 362 B-Eq-Value
hours NCT03868241 363 368 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03868241 369 371 O
admitted NCT03868241 372 380 B-Encounter-Type___Encounter-Type-Value:inpatient
in NCT03868241 381 383 O
the NCT03868241 384 387 O
hospital NCT03868241 388 396 B-Location___Location-Value:hospital
for NCT03868241 397 400 O
more NCT03868241 401 405 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868241 406 410 I-Eq-Operator___Eq-Operator-Value:GT
seven NCT03868241 411 416 B-Eq-Value
days NCT03868241 417 421 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03868241 424 425 O
Presence NCT03868241 427 435 O
of NCT03868241 436 438 O
any NCT03868241 439 442 O
of NCT03868241 443 445 O
the NCT03868241 446 449 O
invasive NCT03868241 450 458 B-Procedure-Name
devices NCT03868241 459 466 I-Procedure-Name
( NCT03868241 467 468 O
endotracheal NCT03868241 469 481 B-Procedure-Name
tube NCT03868241 482 486 I-Procedure-Name
, NCT03868241 487 488 O
central NCT03868241 489 496 B-Procedure-Name
venous NCT03868241 497 503 I-Procedure-Name
catheter NCT03868241 504 512 I-Procedure-Name
or NCT03868241 513 515 O
urinary NCT03868241 516 523 B-Procedure-Name
catheters NCT03868241 524 533 I-Procedure-Name
) NCT03868241 534 535 O
before NCT03868241 536 542 O
randomization NCT03868241 543 556 O
and NCT03868241 557 560 O
absence NCT03868241 561 568 O
of NCT03868241 569 571 O
the NCT03868241 572 575 O
intention NCT03868241 576 585 O
to NCT03868241 586 588 O
exchange NCT03868241 589 597 B-Stability___Stability-Value:change
the NCT03868241 598 601 O
devices NCT03868241 602 609 O
; NCT03868241 609 610 O

- NCT03868241 613 614 O
Previous NCT03868241 616 624 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
use NCT03868241 625 628 O
of NCT03868241 629 631 O
any NCT03868241 632 635 O
type NCT03868241 636 640 O
of NCT03868241 641 643 O
coated NCT03868241 644 650 B-Procedure-Name
devices NCT03868241 651 658 I-Procedure-Name
; NCT03868241 658 659 O

- NCT03868241 662 663 O
Age NCT03868241 665 668 O
< NCT03868241 669 670 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03868241 672 674 B-Eq-Value
years NCT03868241 675 680 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03868241 680 681 O

- NCT03868241 684 685 O
Known NCT03868241 687 692 O
pregnancy NCT03868241 693 702 B-Condition-Name

- NCT03868241 705 706 O
Known NCT03868241 708 713 O
allergy NCT03868241 714 721 O
to NCT03868241 722 724 O
gold NCT03868241 725 729 B-Allergy-Name
, NCT03868241 730 731 O
silver NCT03868241 732 738 B-Allergy-Name
and NCT03868241 739 742 O
palladium NCT03868241 743 752 B-Allergy-Name
; NCT03868241 752 753 O

- NCT03868241 756 757 O
Suspected NCT03868241 759 768 O
or NCT03868241 769 771 O
confirmed NCT03868241 772 781 O
brain NCT03868241 782 787 O
death NCT03868241 788 793 O
; NCT03868241 793 794 O

- NCT03868241 797 798 O
Previously NCT03868241 800 810 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
enrolled NCT03868241 811 819 O
in NCT03868241 820 822 O
the NCT03868241 823 826 O
study NCT03868241 827 832 O

Newly NCT03868241 833 838 O
added NCT03868241 839 844 O
exclusion NCT03868241 845 854 O
criteria NCT03868241 855 863 O
in NCT03868241 864 866 O
version NCT03868241 867 874 O
2.0 NCT03868241 876 879 O
: NCT03868241 880 881 O

- NCT03868241 885 886 O
Severe NCT03868241 888 894 B-Severity___Severity-Value:severe
chronic NCT03868241 895 902 O
pulmonary NCT03868241 903 912 B-Condition-Name
obstructive NCT03868241 913 924 I-Condition-Name
disease NCT03868241 925 932 I-Condition-Name
which NCT03868241 933 938 O
may NCT03868241 939 942 O
limit NCT03868241 943 948 B-Stability___Stability-Value:change
catheter NCT03868241 949 957 B-Procedure-Name
site NCT03868241 958 962 I-Procedure-Name
selection NCT03868241 963 972 O

- NCT03868241 975 976 O
Previous NCT03868241 978 986 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
irradiation NCT03868241 987 998 B-Procedure-Name
and NCT03868241 999 1002 O
/ NCT03868241 1003 1004 O
or NCT03868241 1005 1007 O
thrombosis NCT03868241 1008 1018 B-Condition-Name
in NCT03868241 1019 1021 O
site NCT03868241 1022 1026 O
selected NCT03868241 1027 1035 O
for NCT03868241 1036 1039 O
catheter NCT03868241 1040 1048 B-Procedure-Name
insertion NCT03868241 1049 1058 I-Procedure-Name

Inclusion NCT03863314 0 9 O
Criteria NCT03863314 10 18 O
: NCT03863314 19 20 O

- NCT03863314 24 25 O
Greater NCT03863314 27 34 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863314 35 39 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03863314 41 43 B-Eq-Value
years NCT03863314 44 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03863314 50 52 O
age NCT03863314 53 56 O

- NCT03863314 59 60 O
Personnel NCT03863314 62 71 O
working NCT03863314 72 79 O
or NCT03863314 80 82 O
volunteering NCT03863314 83 95 O
at NCT03863314 96 98 O
Lucile NCT03863314 99 105 B-Location___Location-Value:hospital
Packard NCT03863314 106 113 I-Location___Location-Value:hospital
Children NCT03863314 114 122 I-Location___Location-Value:hospital
's NCT03863314 122 124 I-Location___Location-Value:hospital
Hospital NCT03863314 125 133 I-Location___Location-Value:hospital
( NCT03863314 134 135 O
LPCH NCT03863314 136 140 B-Location___Location-Value:hospital
) NCT03863314 141 142 O
or NCT03863314 143 145 O
Stanford NCT03863314 146 154 B-Location___Location-Value:hospital
Health NCT03863314 155 161 I-Location___Location-Value:hospital
Care NCT03863314 162 166 I-Location___Location-Value:hospital
( NCT03863314 167 168 O
SHC NCT03863314 169 172 B-Location___Location-Value:hospital
) NCT03863314 173 174 O
facilities NCT03863314 175 185 O

Exclusion NCT03863314 186 195 O
Criteria NCT03863314 196 204 O
: NCT03863314 205 206 O

- NCT03863314 210 211 O
Patients NCT03863314 213 221 O
who NCT03863314 222 225 O
do NCT03863314 226 228 O
not NCT03863314 229 232 O
consent NCT03863314 233 240 O

- NCT03863314 243 244 O
Are NCT03863314 246 249 O
currently NCT03863314 250 259 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03863314 260 266 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
beta NCT03863314 267 271 B-Drug-Name
blockers NCT03863314 272 280 I-Drug-Name
or NCT03863314 281 283 O
other NCT03863314 284 289 O
chronotropic NCT03863314 290 302 B-Drug-Name
heart NCT03863314 303 308 I-Drug-Name
medication NCT03863314 309 319 I-Drug-Name
( NCT03863314 320 321 I-Drug-Name
s NCT03863314 322 323 I-Drug-Name
) NCT03863314 324 325 O

- NCT03863314 329 330 O
Have NCT03863314 332 336 O
a NCT03863314 337 338 O
history NCT03863314 339 346 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863314 347 349 O
severe NCT03863314 350 356 B-Severity___Severity-Value:severe
motion NCT03863314 357 363 B-Condition-Name
sickness NCT03863314 364 372 I-Condition-Name

- NCT03863314 375 376 O
Currently NCT03863314 378 387 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
have NCT03863314 388 392 O
nausea NCT03863314 393 399 B-Condition-Name

- NCT03863314 402 403 O
Currently NCT03863314 405 414 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
experiencing NCT03863314 415 427 O
seizures NCT03863314 428 436 B-Condition-Name

- NCT03863314 439 440 O
Are NCT03863314 442 445 O
clinically NCT03863314 446 456 O
unstable NCT03863314 457 465 B-Stability___Stability-Value:change

Inclusion NCT03868527 0 9 O
Criteria NCT03868527 10 18 O
: NCT03868527 19 20 O

- NCT03868527 23 24 O
Patients NCT03868527 25 33 O
followed NCT03868527 34 42 O
for NCT03868527 43 46 O
hematological NCT03868527 47 60 B-Condition-Name
diseases NCT03868527 61 69 I-Condition-Name
in NCT03868527 70 72 O
Lyon NCT03868527 73 77 B-Location___Location-Value:hospital
Sud NCT03868527 78 81 I-Location___Location-Value:hospital
Hospital NCT03868527 82 90 I-Location___Location-Value:hospital

Exclusion NCT03868527 91 100 O
Criteria NCT03868527 101 109 O
: NCT03868527 110 111 O

- NCT03868527 114 115 O
Patients NCT03868527 116 124 O
who NCT03868527 125 128 O
does NCT03868527 129 133 O
n't NCT03868527 133 136 O
have NCT03868527 137 141 O
hematological NCT03868527 142 155 B-Condition-Name
diseases NCT03868527 156 164 I-Condition-Name

Inclusion NCT03865771 0 9 O
Criteria NCT03865771 10 18 O
: NCT03865771 19 20 O

Principal NCT03865771 22 31 O
: NCT03865771 32 33 O

- NCT03865771 37 38 O
normal NCT03865771 40 46 B-Polarity___Polarity-Value:normal
psychomotor NCT03865771 47 58 B-Condition-Name
development NCT03865771 59 70 I-Condition-Name

- NCT03865771 73 74 O
informed NCT03865771 76 84 O
consent NCT03865771 85 92 O
signed NCT03865771 93 99 O
by NCT03865771 100 102 O
both NCT03865771 103 107 O
parents NCT03865771 108 115 O
and NCT03865771 116 119 O
subject NCT03865771 120 127 O
if NCT03865771 128 130 O
able NCT03865771 131 135 O

- NCT03865771 138 139 O
affiliated NCT03865771 141 151 O
to NCT03865771 152 154 O
social NCT03865771 155 161 O
security NCT03865771 162 170 O
regimen NCT03865771 171 178 O

Specific NCT03865771 179 187 O

Patients NCT03865771 188 196 O
from NCT03865771 197 201 O
" NCT03865771 202 203 O
severe NCT03865771 203 209 O
" NCT03865771 209 210 O
and NCT03865771 211 214 O
" NCT03865771 215 216 O
benign NCT03865771 216 222 O
" NCT03865771 222 223 O
groups NCT03865771 224 230 O
: NCT03865771 231 232 O

- NCT03865771 236 237 O
focal NCT03865771 239 244 O
age NCT03865771 245 248 O
related NCT03865771 249 256 O
epilepsy NCT03865771 257 265 B-Condition-Name
: NCT03865771 266 267 O
BECTS NCT03865771 268 273 B-Condition-Name
, NCT03865771 274 275 O
ABPE NCT03865771 276 280 B-Condition-Name
, NCT03865771 281 282 O
ECSWS NCT03865771 283 288 B-Condition-Name
( NCT03865771 289 290 O
ILAE NCT03865771 291 295 O
criteria NCT03865771 296 304 O
) NCT03865771 305 306 O

- NCT03865771 310 311 O
children NCT03865771 313 321 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
hospitalized NCT03865771 322 334 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03865771 335 338 O
their NCT03865771 339 344 O
follow NCT03865771 345 351 O
- NCT03865771 352 353 O
up NCT03865771 354 356 O

- NCT03865771 359 360 O
normal NCT03865771 362 368 B-Polarity___Polarity-Value:normal
neuroimaging NCT03865771 369 381 B-Procedure-Name

Control NCT03865771 382 389 O
group NCT03865771 390 395 O

- NCT03865771 397 398 O
children NCT03865771 399 407 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
hospitalized NCT03865771 408 420 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03865771 421 424 O
a NCT03865771 425 426 O
non NCT03865771 427 430 O
neurologic NCT03865771 431 441 B-Condition-Name
disease NCT03865771 442 449 I-Condition-Name

Exclusion NCT03865771 450 459 O
Criteria NCT03865771 460 468 O
: NCT03865771 469 470 O

Principal NCT03865771 472 481 O
: NCT03865771 482 483 O

Psychiatric NCT03865771 485 496 B-Condition-Name
trouble NCT03865771 497 504 I-Condition-Name
( NCT03865771 505 506 O
DSM NCT03865771 507 510 O
V NCT03865771 511 512 O
) NCT03865771 513 514 O
Sensorial NCT03865771 515 524 B-Condition-Name
trouble NCT03865771 525 532 I-Condition-Name
without NCT03865771 533 540 O
correction NCT03865771 541 551 O
Poor NCT03865771 552 556 O
command NCT03865771 557 564 O
of NCT03865771 565 567 O
French NCT03865771 568 574 B-Language
language NCT03865771 575 583 O
Minor NCT03865771 584 589 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
under NCT03865771 590 595 O
care NCT03865771 596 600 O

Specific NCT03865771 601 609 O

Patients NCT03865771 610 618 O
from NCT03865771 619 623 O
" NCT03865771 624 625 O
severe NCT03865771 625 631 O
" NCT03865771 631 632 O
and NCT03865771 633 636 O
" NCT03865771 637 638 O
benign NCT03865771 638 644 O
" NCT03865771 644 645 O
groups NCT03865771 646 652 O
: NCT03865771 653 654 O

- NCT03865771 658 659 O
degenerative NCT03865771 661 673 B-Condition-Name
disease NCT03865771 674 681 I-Condition-Name

- NCT03865771 684 685 O
abnormal NCT03865771 687 695 B-Polarity___Polarity-Value:abnormal
neuroimaging NCT03865771 696 708 B-Procedure-Name

- NCT03865771 711 712 O
mental NCT03865771 714 720 B-Condition-Name
deficiency NCT03865771 721 731 I-Condition-Name

Control NCT03865771 732 739 O
group NCT03865771 740 745 O

- NCT03865771 748 749 O
neurologic NCT03865771 751 761 B-Condition-Name
trouble NCT03865771 762 769 I-Condition-Name

- NCT03865771 772 773 O
abnormal NCT03865771 775 783 B-Polarity___Polarity-Value:abnormal
sleep NCT03865771 784 789 B-Procedure-Name
EEG NCT03865771 790 793 I-Procedure-Name

- NCT03865771 796 797 O
intellectual NCT03865771 799 811 B-Condition-Name
deficiency NCT03865771 812 822 I-Condition-Name


Inclusion NCT03862963 0 9 O
Criteria NCT03862963 10 18 O
: NCT03862963 19 20 O

- NCT03862963 24 25 O
Resident NCT03862963 27 35 O
of NCT03862963 36 38 O
the NCT03862963 39 42 O
Republic NCT03862963 43 51 B-Location___Location-Value:residence
of NCT03862963 52 54 I-Location___Location-Value:residence
Marshall NCT03862963 55 63 I-Location___Location-Value:residence
Islands NCT03862963 64 71 I-Location___Location-Value:residence

- NCT03862963 74 75 O
Aged NCT03862963 77 81 O
18 NCT03862963 83 85 B-Eq-Value
- NCT03862963 86 87 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03862963 89 91 B-Eq-Value
years NCT03862963 92 97 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862963 100 101 O
HbA NCT03862963 103 106 B-Observation-Name___Observation-Type-Value:lab
1c NCT03862963 107 109 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03862963 110 111 B-Eq-Operator___Eq-Operator-Value:GTEQ
8.0 NCT03862963 113 116 B-Eq-Value
% NCT03862963 117 118 B-Eq-Unit
or NCT03862963 119 121 O
diagnosed NCT03862963 122 131 O
with NCT03862963 132 136 O
T NCT03862963 137 138 B-Condition-Name
2D NCT03862963 139 141 I-Condition-Name
and NCT03862963 142 145 O
taking NCT03862963 146 152 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diabetes NCT03862963 153 161 B-Condition-Name
medication NCT03862963 162 172 O

- NCT03862963 175 176 O
Medical NCT03862963 178 185 O
clearance NCT03862963 186 195 O
to NCT03862963 196 198 O
participate NCT03862963 199 210 O
from NCT03862963 211 215 O
Diabetes NCT03862963 216 224 B-Location___Location-Value:clinic
Wellness NCT03862963 225 233 I-Location___Location-Value:clinic
Center NCT03862963 234 240 I-Location___Location-Value:clinic
( NCT03862963 241 242 O
DWC NCT03862963 243 246 B-Location
) NCT03862963 247 248 O
physicians NCT03862963 249 259 B-Provider-Role
. NCT03862963 260 261 O

Exclusion NCT03862963 263 272 O
Criteria NCT03862963 273 281 O
: NCT03862963 282 283 O

- NCT03862963 287 288 O
Recent NCT03862963 290 296 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
( NCT03862963 297 298 O
≤ NCT03862963 300 301 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03862963 303 304 I-Eq-Operator___Eq-Operator-Value:LTEQ
months NCT03862963 305 311 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03862963 312 313 O
change NCT03862963 314 320 B-Stability___Stability-Value:change
in NCT03862963 321 323 O
a NCT03862963 324 325 O
diabetes NCT03862963 326 334 B-Condition-Name
- NCT03862963 335 336 O
related NCT03862963 337 344 O
medication NCT03862963 345 355 O
dosage NCT03862963 356 362 O

- NCT03862963 365 366 O
A NCT03862963 368 369 O
physical NCT03862963 370 378 O
or NCT03862963 379 381 O
medical NCT03862963 382 389 O
condition NCT03862963 390 399 O
that NCT03862963 400 404 O
would NCT03862963 405 410 O
impede NCT03862963 411 417 B-Stability___Stability-Value:change
participation NCT03862963 418 431 O
in NCT03862963 432 434 O
the NCT03862963 435 438 O
lifestyle NCT03862963 439 448 B-Procedure-Name
intervention NCT03862963 449 461 I-Procedure-Name
( NCT03862963 462 463 O
e NCT03862963 464 465 O
. NCT03862963 466 467 O
g NCT03862963 468 469 O
. NCT03862963 470 471 O
, NCT03862963 472 473 O
wheel NCT03862963 474 479 B-Condition-Name
- NCT03862963 480 481 I-Condition-Name
chair NCT03862963 482 487 I-Condition-Name
bound NCT03862963 488 493 I-Condition-Name
, NCT03862963 494 495 O
unstable NCT03862963 496 504 B-Stability___Stability-Value:change
angina NCT03862963 505 511 B-Condition-Name
) NCT03862963 512 513 O

- NCT03862963 517 518 O
Evidence NCT03862963 520 528 O
of NCT03862963 529 531 O
significant NCT03862963 532 543 B-Severity___Severity-Value:severe
coronary NCT03862963 544 552 B-Condition-Name
heart NCT03862963 553 558 I-Condition-Name
disease NCT03862963 559 566 I-Condition-Name

- NCT03862963 569 570 O
Previous NCT03862963 572 580 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participation NCT03862963 581 594 O
in NCT03862963 595 597 O
an NCT03862963 598 600 O
intensive NCT03862963 601 610 O
lifestyle NCT03862963 611 620 B-Procedure-Name
intervention NCT03862963 621 633 I-Procedure-Name

Inclusion NCT03864484 0 9 O
Criteria NCT03864484 10 18 O
: NCT03864484 19 20 O

- NCT03864484 24 25 O
40 NCT03864484 28 30 B-Eq-Value
years NCT03864484 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03864484 37 40 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03864484 41 46 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03864484 49 50 O
Males NCT03864484 52 57 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03864484 58 61 O
females NCT03864484 62 69 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03864484 72 73 O
Center NCT03864484 75 81 B-Observation-Name___Observation-Type-Value:clinical-score
for NCT03864484 82 85 I-Observation-Name___Observation-Type-Value:clinical-score
Epidemiologic NCT03864484 86 99 I-Observation-Name___Observation-Type-Value:clinical-score
Studies NCT03864484 100 107 I-Observation-Name___Observation-Type-Value:clinical-score
Depression NCT03864484 108 118 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03864484 119 124 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03864484 125 130 O
≥ NCT03864484 131 132 B-Eq-Operator___Eq-Operator-Value:GTEQ
16 NCT03864484 134 136 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03864484 140 141 O
Mini NCT03864484 143 147 B-Observation-Name___Observation-Type-Value:clinical-score
Mental NCT03864484 148 154 I-Observation-Name___Observation-Type-Value:clinical-score
State NCT03864484 155 160 I-Observation-Name___Observation-Type-Value:clinical-score
Examination NCT03864484 161 172 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03864484 173 178 I-Observation-Name___Observation-Type-Value:clinical-score
≥ NCT03864484 179 180 B-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03864484 182 184 B-Eq-Value

- NCT03864484 188 189 O
First NCT03864484 191 196 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
stroke NCT03864484 197 203 B-Condition-Name

- NCT03864484 206 207 O
Native NCT03864484 209 215 O
language NCT03864484 216 224 O
is NCT03864484 225 227 O
Japanese NCT03864484 228 236 B-Language

- NCT03864484 239 240 O
Written NCT03864484 242 249 O
informed NCT03864484 250 258 O
consent NCT03864484 259 266 O
prior NCT03864484 267 272 O
to NCT03864484 273 275 O
participation NCT03864484 276 289 O

Exclusion NCT03864484 290 299 O
Criteria NCT03864484 300 308 O
: NCT03864484 309 310 O

- NCT03864484 314 315 O
Major NCT03864484 317 322 B-Severity___Severity-Value:severe
depressive NCT03864484 323 333 B-Condition-Name
disorder NCT03864484 334 342 I-Condition-Name
before NCT03864484 343 349 O
onset NCT03864484 350 355 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03864484 356 358 O
stroke NCT03864484 359 365 B-Condition-Name

- NCT03864484 368 369 O
Bilateral NCT03864484 371 380 O
hemiplegia NCT03864484 381 391 B-Condition-Name

- NCT03864484 394 395 O
Vision NCT03864484 397 403 O
or NCT03864484 404 406 O
hearing NCT03864484 407 414 O
deficits NCT03864484 415 423 B-Condition-Name
that NCT03864484 424 428 O
negatively NCT03864484 429 439 B-Polarity___Polarity-Value:negative
impact NCT03864484 440 446 B-Stability___Stability-Value:change
everyday NCT03864484 447 455 B-Observation-Name
life NCT03864484 456 460 I-Observation-Name

- NCT03864484 463 464 O
Severe NCT03864484 466 472 B-Severity___Severity-Value:severe
aphasia NCT03864484 473 480 B-Condition-Name

- NCT03864484 483 484 O
Severe NCT03864484 486 492 B-Severity___Severity-Value:severe
unilateral NCT03864484 493 503 O
spatial NCT03864484 504 511 B-Condition-Name
neglect NCT03864484 512 519 I-Condition-Name

- NCT03864484 522 523 O
Diagnosis NCT03864484 525 534 O
of NCT03864484 535 537 O
neurodegenerative NCT03864484 538 555 B-Condition-Name
disease NCT03864484 556 563 I-Condition-Name
such NCT03864484 564 568 O
as NCT03864484 569 571 O
Parkinson NCT03864484 572 581 B-Condition-Name
's NCT03864484 581 583 I-Condition-Name
disease NCT03864484 584 591 I-Condition-Name
or NCT03864484 592 594 O
multiple NCT03864484 595 603 O
system NCT03864484 604 610 O
atrophy NCT03864484 611 618 B-Condition-Name

- NCT03864484 621 622 O
Current NCT03864484 624 631 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
life NCT03864484 632 636 O
- NCT03864484 637 638 O
threatening NCT03864484 639 650 O
severe NCT03864484 651 657 B-Severity___Severity-Value:severe
organ NCT03864484 658 663 B-Condition-Name
failure NCT03864484 664 671 I-Condition-Name
, NCT03864484 672 673 O
musculoskeletal NCT03864484 674 689 B-Condition-Name
disorders NCT03864484 690 699 I-Condition-Name
, NCT03864484 700 701 O
or NCT03864484 702 704 O
cancer NCT03864484 705 711 B-Condition-Name

Inclusion NCT03867370 0 9 O
Criteria NCT03867370 10 18 O
: NCT03867370 19 20 O

1 NCT03867370 25 26 O
. NCT03867370 26 27 O
Confirmed NCT03867370 29 38 O
by NCT03867370 39 41 O
histopathological NCT03867370 42 59 B-Procedure-Name
or NCT03867370 60 62 O
cytological NCT03867370 63 74 B-Procedure-Name
examination NCT03867370 75 86 I-Procedure-Name
; NCT03867370 86 87 O

2 NCT03867370 91 92 O
. NCT03867370 92 93 O
The NCT03867370 95 98 O
criteria NCT03867370 99 107 O
for NCT03867370 108 111 O
resectability NCT03867370 112 125 O
is NCT03867370 126 128 O
met NCT03867370 129 132 O

3 NCT03867370 136 137 O
. NCT03867370 137 138 O
Has NCT03867370 140 143 O
at NCT03867370 144 146 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867370 147 152 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03867370 153 156 B-Eq-Value
evaluable NCT03867370 157 166 O
lesion NCT03867370 167 173 B-Condition-Name
according NCT03867370 174 183 O
to NCT03867370 184 186 O
the NCT03867370 187 190 O
RECIST NCT03867370 191 197 O
1.1 NCT03867370 199 202 O
standard NCT03867370 203 211 O
and NCT03867370 212 215 O
has NCT03867370 216 219 O
not NCT03867370 220 223 O
received NCT03867370 224 232 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
local NCT03867370 233 238 O
treatment NCT03867370 239 248 O

Exclusion NCT03867370 249 258 O
Criteria NCT03867370 259 267 O
: NCT03867370 268 269 O

1 NCT03867370 274 275 O
. NCT03867370 275 276 O
Patients NCT03867370 278 286 O
who NCT03867370 287 290 O
previously NCT03867370 291 301 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
received NCT03867370 302 310 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
anti NCT03867370 311 315 B-Drug-Name
- NCT03867370 316 317 I-Drug-Name
programmed NCT03867370 318 328 I-Drug-Name
death NCT03867370 329 334 I-Drug-Name
receptor NCT03867370 335 343 I-Drug-Name
- NCT03867370 344 345 I-Drug-Name
1 NCT03867370 347 348 I-Drug-Name
( NCT03867370 349 350 O
PD NCT03867370 351 353 B-Drug-Name
- NCT03867370 354 355 I-Drug-Name
1 NCT03867370 357 358 I-Drug-Name
) NCT03867370 359 360 O
antibody NCT03867370 361 369 O
, NCT03867370 370 371 O
anti NCT03867370 372 376 B-Drug-Name
- NCT03867370 377 378 I-Drug-Name
programmed NCT03867370 379 389 I-Drug-Name
death NCT03867370 390 395 I-Drug-Name
ligand NCT03867370 396 402 I-Drug-Name
- NCT03867370 403 404 I-Drug-Name
1 NCT03867370 406 407 I-Drug-Name
( NCT03867370 408 409 O
PD NCT03867370 410 412 B-Drug-Name
- NCT03867370 413 414 I-Drug-Name
L NCT03867370 415 416 I-Drug-Name
1 NCT03867370 417 418 I-Drug-Name
) NCT03867370 419 420 O
antibody NCT03867370 421 429 O
, NCT03867370 430 431 O
anti NCT03867370 432 436 B-Drug-Name
- NCT03867370 437 438 I-Drug-Name
programmed NCT03867370 439 449 I-Drug-Name
death NCT03867370 450 455 I-Drug-Name
ligand NCT03867370 456 462 I-Drug-Name
- NCT03867370 463 464 I-Drug-Name
2 NCT03867370 466 467 I-Drug-Name
( NCT03867370 468 469 O
PD NCT03867370 470 472 B-Drug-Name
- NCT03867370 473 474 I-Drug-Name
L NCT03867370 475 476 I-Drug-Name
2 NCT03867370 477 478 I-Drug-Name
) NCT03867370 479 480 O
antibody NCT03867370 481 489 O
or NCT03867370 490 492 O
anti NCT03867370 493 497 B-Drug-Name
- NCT03867370 498 499 I-Drug-Name
cytotoxic NCT03867370 500 509 I-Drug-Name
T NCT03867370 510 511 I-Drug-Name
lymphocyte NCT03867370 512 522 I-Drug-Name
- NCT03867370 523 524 I-Drug-Name
associated NCT03867370 525 535 I-Drug-Name
antigen NCT03867370 536 543 I-Drug-Name
- NCT03867370 544 545 I-Drug-Name
4 NCT03867370 547 548 I-Drug-Name
( NCT03867370 549 550 O
CTLA NCT03867370 551 555 B-Drug-Name
- NCT03867370 556 557 I-Drug-Name
4 NCT03867370 559 560 I-Drug-Name
) NCT03867370 561 562 O
antibodies NCT03867370 563 573 O
, NCT03867370 574 575 O
including NCT03867370 576 585 O
those NCT03867370 586 591 O
who NCT03867370 592 595 O
have NCT03867370 596 600 O
participated NCT03867370 601 613 O
in NCT03867370 614 616 O
a NCT03867370 617 618 O
JS NCT03867370 619 621 O
001 NCT03867370 622 625 O
clinical NCT03867370 626 634 O
study NCT03867370 635 640 O
; NCT03867370 640 641 O

2 NCT03867370 645 646 O
. NCT03867370 646 647 O
Patients NCT03867370 649 657 O
who NCT03867370 658 661 O
previously NCT03867370 662 672 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
received NCT03867370 673 681 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
any NCT03867370 682 685 O
TACE NCT03867370 686 690 B-Procedure-Name
, NCT03867370 691 692 O
radiofrequency NCT03867370 693 707 B-Procedure-Name
ablation NCT03867370 708 716 I-Procedure-Name
and NCT03867370 717 720 O
other NCT03867370 721 726 O
liver NCT03867370 727 732 O
cancer NCT03867370 733 739 B-Condition-Name
treatments NCT03867370 740 750 O
; NCT03867370 750 751 O

3 NCT03867370 755 756 O
. NCT03867370 756 757 O
Patients NCT03867370 759 767 O
with NCT03867370 768 772 O
a NCT03867370 773 774 O
history NCT03867370 775 782 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867370 783 785 O
gastroesophageal NCT03867370 786 802 B-Condition-Name
varices NCT03867370 803 810 I-Condition-Name
or NCT03867370 811 813 O
active NCT03867370 814 820 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cardia NCT03867370 821 827 B-Condition-Name
ulcers NCT03867370 828 834 I-Condition-Name
associated NCT03867370 835 845 O
with NCT03867370 846 850 O
a NCT03867370 851 852 O
high NCT03867370 853 857 B-Polarity___Polarity-Value:high
risk NCT03867370 858 862 O
of NCT03867370 863 865 O
bleeding NCT03867370 866 874 B-Condition-Name
; NCT03867370 874 875 O

4 NCT03867370 879 880 O
. NCT03867370 880 881 O
Patients NCT03867370 883 891 O
who NCT03867370 892 895 O
have NCT03867370 896 900 O
upper NCT03867370 901 906 O
gastrointestinal NCT03867370 907 923 O
hemorrhage NCT03867370 924 934 B-Condition-Name
within NCT03867370 935 941 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03867370 943 944 B-Eq-Value
year NCT03867370 945 949 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03867370 949 950 O

5 NCT03867370 954 955 O
. NCT03867370 955 956 O
Patients NCT03867370 958 966 O
known NCT03867370 967 972 O
to NCT03867370 973 975 O
have NCT03867370 976 980 O
fibrous NCT03867370 981 988 O
layer NCT03867370 989 994 O
HCC NCT03867370 995 998 B-Condition-Name
, NCT03867370 999 1000 O
sarcomatoid NCT03867370 1001 1012 O
HCC NCT03867370 1013 1016 B-Condition-Name
or NCT03867370 1017 1019 O
mixed NCT03867370 1020 1025 O
cholangiocarcinoma NCT03867370 1026 1044 B-Condition-Name
and NCT03867370 1045 1048 O
HCC NCT03867370 1049 1052 B-Condition-Name
; NCT03867370 1052 1053 O
Other NCT03867370 1054 1059 O
protocol NCT03867370 1060 1068 O
defined NCT03867370 1069 1076 O
inclusion NCT03867370 1077 1086 O
/ NCT03867370 1087 1088 O
exclusion NCT03867370 1089 1098 O
criteria NCT03867370 1099 1107 O
could NCT03867370 1108 1113 O
apply NCT03867370 1114 1119 O

Inclusion NCT03861715 0 9 O
Criteria NCT03861715 10 18 O
: NCT03861715 19 20 O

- NCT03861715 24 25 O
age NCT03861715 27 30 O
20 NCT03861715 32 34 B-Eq-Value
- NCT03861715 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
34 NCT03861715 38 40 B-Eq-Value
years NCT03861715 41 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03861715 46 47 O

- NCT03861715 50 51 O
body NCT03861715 53 57 B-Observation-Name___Observation-Type-Value:vital
mass NCT03861715 58 62 I-Observation-Name___Observation-Type-Value:vital
index NCT03861715 63 68 I-Observation-Name___Observation-Type-Value:vital
( NCT03861715 69 70 O
BMI NCT03861715 71 74 B-Observation-Name___Observation-Type-Value:vital
) NCT03861715 75 76 O
18 NCT03861715 78 80 B-Eq-Value
- NCT03861715 81 82 B-Eq-Operator___Eq-Operator-Value:BETWEEN
29 NCT03861715 84 86 B-Eq-Value
kg NCT03861715 87 89 B-Eq-Unit
/ NCT03861715 90 91 O
m NCT03861715 92 93 B-Eq-Unit
2 NCT03861715 94 95 I-Eq-Unit
; NCT03861715 95 96 O

- NCT03861715 99 100 O
regular NCT03861715 102 109 B-Polarity___Polarity-Value:normal
menstrual NCT03861715 110 119 B-Condition-Name
cycle NCT03861715 120 125 I-Condition-Name
of NCT03861715 126 128 O
26 NCT03861715 130 132 B-Eq-Value
- NCT03861715 133 134 B-Eq-Operator___Eq-Operator-Value:BETWEEN
35 NCT03861715 136 138 B-Eq-Value
days NCT03861715 139 143 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
, NCT03861715 144 145 O

- NCT03861715 149 150 O
AMH NCT03861715 152 155 B-Observation-Name___Observation-Type-Value:lab
levels NCT03861715 156 162 O
age NCT03861715 163 166 O
appropriate NCT03861715 167 178 O
( NCT03861715 179 180 O
≥ NCT03861715 182 183 B-Eq-Operator___Eq-Operator-Value:GTEQ
2.3 NCT03861715 185 188 B-Eq-Value
ng NCT03861715 189 191 B-Eq-Unit
/ NCT03861715 192 193 O
ml NCT03861715 194 196 B-Eq-Unit
) NCT03861715 197 198 O

- NCT03861715 202 203 O
early NCT03861715 205 210 O
follicular NCT03861715 211 221 O
- NCT03861715 222 223 O
phase NCT03861715 224 229 O
serum NCT03861715 230 235 B-Observation-Name___Observation-Type-Value:lab
concentration NCT03861715 236 249 I-Observation-Name___Observation-Type-Value:lab
of NCT03861715 250 252 I-Observation-Name___Observation-Type-Value:lab
FSH NCT03861715 253 256 I-Observation-Name___Observation-Type-Value:lab
within NCT03861715 257 263 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03861715 264 270 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
limits NCT03861715 271 277 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
( NCT03861715 278 279 O
1 NCT03861715 281 282 B-Eq-Value
- NCT03861715 283 284 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03861715 286 288 B-Eq-Value
IU NCT03861715 289 291 B-Eq-Unit
/ NCT03861715 292 293 O
l NCT03861715 294 295 B-Eq-Unit
) NCT03861715 296 297 O
. NCT03861715 299 300 O

Exclusion NCT03861715 302 311 O
Criteria NCT03861715 312 320 O
: NCT03861715 321 322 O

- NCT03861715 326 327 O
women NCT03861715 329 334 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03861715 335 339 O
diabetes NCT03861715 340 348 B-Condition-Name
and NCT03861715 349 352 O
other NCT03861715 353 358 O
metabolic NCT03861715 359 368 B-Condition-Name
disease NCT03861715 369 376 I-Condition-Name

- NCT03861715 379 380 O
women NCT03861715 382 387 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03861715 388 392 O
hereditary NCT03861715 393 403 O
genetic NCT03861715 404 411 B-Condition-Name
diseases NCT03861715 412 420 I-Condition-Name
; NCT03861715 420 421 O

- NCT03861715 424 425 O
women NCT03861715 427 432 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03861715 433 437 O
heart NCT03861715 438 443 B-Condition-Name
disease NCT03861715 444 451 I-Condition-Name
, NCT03861715 452 453 O
QT NCT03861715 454 456 B-Condition-Name
prolongation NCT03861715 457 469 I-Condition-Name
, NCT03861715 470 471 O
heart NCT03861715 472 477 B-Condition-Name
failure NCT03861715 478 485 I-Condition-Name

- NCT03861715 488 489 O
elevated NCT03861715 491 499 B-Polarity___Polarity-Value:high
liver NCT03861715 500 505 B-Condition-Name
enzymes NCT03861715 506 513 I-Condition-Name
, NCT03861715 514 515 O
liver NCT03861715 516 521 B-Condition-Name
failure NCT03861715 522 529 I-Condition-Name
, NCT03861715 530 531 O
hepatitis NCT03861715 532 541 B-Condition-Name

- NCT03861715 544 545 O
women NCT03861715 547 552 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03861715 553 557 O
inflammatory NCT03861715 558 570 O
or NCT03861715 571 573 O
autoimmune NCT03861715 574 584 O
disease NCT03861715 585 592 B-Condition-Name

- NCT03861715 595 596 O
abnormal NCT03861715 598 606 B-Polarity___Polarity-Value:abnormal
karyotype NCT03861715 607 616 B-Condition-Name
; NCT03861715 616 617 O

- NCT03861715 620 621 O
endometriosis NCT03861715 623 636 B-Condition-Name
stage NCT03861715 637 642 B-Eq-Unit
III NCT03861715 643 646 B-Eq-Value
/ NCT03861715 647 648 O
IV NCT03861715 649 651 B-Eq-Value
; NCT03861715 651 652 O

- NCT03861715 655 656 O
history NCT03861715 658 665 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03861715 666 668 O
recurrent NCT03861715 669 678 B-Condition-Name
miscarriage NCT03861715 679 690 I-Condition-Name
; NCT03861715 690 691 O

- NCT03861715 694 695 O
severe NCT03861715 697 703 B-Severity___Severity-Value:severe
OHSS NCT03861715 704 708 B-Condition-Name
in NCT03861715 709 711 O
a NCT03861715 712 713 O
previous NCT03861715 714 722 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
stimulation NCT03861715 723 734 B-Procedure-Name
cycle NCT03861715 735 740 I-Procedure-Name
or NCT03861715 741 743 O
any NCT03861715 744 747 O
contraindication NCT03861715 748 764 O
for NCT03861715 765 768 O
the NCT03861715 769 772 O
use NCT03861715 773 776 O
of NCT03861715 777 779 O
gonadotrophins NCT03861715 780 794 B-Drug-Name
. NCT03861715 795 796 O

Inclusion NCT03866720 0 9 O
Criteria NCT03866720 10 18 O
: NCT03866720 19 20 O

- NCT03866720 24 25 O
Body NCT03866720 27 31 B-Observation-Name___Observation-Type-Value:vital
mass NCT03866720 32 36 I-Observation-Name___Observation-Type-Value:vital
index NCT03866720 37 42 I-Observation-Name___Observation-Type-Value:vital
18.5 NCT03866720 44 48 B-Eq-Value
- NCT03866720 49 50 B-Eq-Operator___Eq-Operator-Value:BETWEEN
29.9 NCT03866720 52 56 B-Eq-Value
kg NCT03866720 57 59 B-Eq-Unit
∙ NCT03866720 60 61 O
m NCT03866720 62 63 B-Eq-Unit
- NCT03866720 64 65 I-Eq-Unit
2 NCT03866720 67 68 I-Eq-Unit

- NCT03866720 72 73 O
Age NCT03866720 75 78 O
18 NCT03866720 80 82 B-Eq-Value
- NCT03866720 83 84 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03866720 86 88 B-Eq-Value
years NCT03866720 89 94 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866720 97 98 O
Able NCT03866720 100 104 O
and NCT03866720 105 108 O
willing NCT03866720 109 116 O
to NCT03866720 117 119 O
provide NCT03866720 120 127 O
informed NCT03866720 128 136 O
consent NCT03866720 137 144 O
and NCT03866720 145 148 O
safely NCT03866720 149 155 O
comply NCT03866720 156 162 O
with NCT03866720 163 167 O
study NCT03866720 168 173 O
procedures NCT03866720 174 184 O

- NCT03866720 187 188 O
Females NCT03866720 190 197 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
to NCT03866720 198 200 O
maintain NCT03866720 201 209 O
record NCT03866720 210 216 O
of NCT03866720 217 219 O
regular NCT03866720 220 227 O
menstrual NCT03866720 228 237 B-Procedure-Name
cycle NCT03866720 238 243 I-Procedure-Name
phase NCT03866720 244 249 I-Procedure-Name
or NCT03866720 250 252 O
contraceptive NCT03866720 253 266 B-Procedure-Name
use NCT03866720 267 270 O

- NCT03866720 273 274 O
No NCT03866720 276 278 O
anticipated NCT03866720 279 290 O
changes NCT03866720 291 298 B-Stability___Stability-Value:change
in NCT03866720 299 301 O
diet NCT03866720 302 306 B-Observation-Name___Observation-Type-Value:social-habit
/ NCT03866720 307 308 O
physical NCT03866720 309 317 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03866720 318 326 I-Observation-Name___Observation-Type-Value:social-habit
during NCT03866720 327 333 O
the NCT03866720 334 337 O
study NCT03866720 338 343 O
( NCT03866720 344 345 O
e NCT03866720 346 347 O
. NCT03866720 348 349 O
g NCT03866720 350 351 O
. NCT03866720 352 353 O
holidays NCT03866720 355 363 O
or NCT03866720 364 366 O
diet NCT03866720 367 371 B-Observation-Name___Observation-Type-Value:social-habit
plans NCT03866720 372 377 O
) NCT03866720 378 379 O

- NCT03866720 383 384 O
Inclusive NCT03866720 386 395 O
to NCT03866720 396 398 O
all NCT03866720 399 402 O
breakfast NCT03866720 403 412 O
habits NCT03866720 413 419 O
( NCT03866720 420 421 O
e NCT03866720 422 423 O
. NCT03866720 424 425 O
g NCT03866720 426 427 O
. NCT03866720 428 429 O
regular NCT03866720 431 438 O
skipper NCT03866720 439 446 O
/ NCT03866720 447 448 O
consumer NCT03866720 449 457 O
) NCT03866720 458 459 O

Exclusion NCT03866720 461 470 O
Criteria NCT03866720 471 479 O
: NCT03866720 480 481 O

- NCT03866720 485 486 O
Any NCT03866720 488 491 O
reported NCT03866720 492 500 O
condition NCT03866720 501 510 O
or NCT03866720 511 513 O
behaviour NCT03866720 514 523 O
deemed NCT03866720 524 530 O
either NCT03866720 531 537 O
to NCT03866720 538 540 O
pose NCT03866720 541 545 O
undue NCT03866720 546 551 O
personal NCT03866720 552 560 O
risk NCT03866720 561 565 O
to NCT03866720 566 568 O
the NCT03866720 569 572 O
participant NCT03866720 573 584 O
or NCT03866720 585 587 O
introduce NCT03866720 588 597 B-Stability___Stability-Value:change
bias NCT03866720 598 602 O

- NCT03866720 605 606 O
Any NCT03866720 608 611 O
diagnosed NCT03866720 612 621 O
metabolic NCT03866720 622 631 B-Condition-Name
disease NCT03866720 632 639 I-Condition-Name
( NCT03866720 640 641 O
e NCT03866720 642 643 O
. NCT03866720 644 645 O
g NCT03866720 646 647 O
. NCT03866720 648 649 O
type NCT03866720 651 655 O
1 NCT03866720 657 658 O
or NCT03866720 659 661 O
type NCT03866720 662 666 O
2 NCT03866720 668 669 O
diabetes NCT03866720 670 678 B-Condition-Name
) NCT03866720 679 680 O

- NCT03866720 684 685 O
Any NCT03866720 687 690 O
reported NCT03866720 691 699 O
use NCT03866720 700 703 O
of NCT03866720 704 706 O
substances NCT03866720 707 717 O
which NCT03866720 718 723 O
may NCT03866720 724 727 O
pose NCT03866720 728 732 B-Stability___Stability-Value:change
undue NCT03866720 733 738 O
personal NCT03866720 739 747 O
risk NCT03866720 748 752 O
to NCT03866720 753 755 O
the NCT03866720 756 759 O
participants NCT03866720 760 772 O
or NCT03866720 773 775 O
introduce NCT03866720 776 785 B-Stability___Stability-Value:change
bias NCT03866720 786 790 O
into NCT03866720 791 795 O
the NCT03866720 796 799 O
experiment NCT03866720 800 810 O
( NCT03866720 811 812 O
e NCT03866720 813 814 O
. NCT03866720 815 816 O
g NCT03866720 817 818 O
. NCT03866720 819 820 O
smoking NCT03866720 822 829 B-Condition-Name
/ NCT03866720 830 831 O
substance NCT03866720 832 841 B-Condition-Name
abuse NCT03866720 842 847 I-Condition-Name
) NCT03866720 848 849 O

- NCT03866720 853 854 O
Lifestyle NCT03866720 856 865 O
not NCT03866720 866 869 O
conforming NCT03866720 870 880 O
to NCT03866720 881 883 O
standard NCT03866720 884 892 B-Polarity___Polarity-Value:normal
sleep NCT03866720 893 898 B-Condition-Name
- NCT03866720 899 900 I-Condition-Name
wake NCT03866720 901 905 I-Condition-Name
cycle NCT03866720 906 911 I-Condition-Name
( NCT03866720 912 913 O
e NCT03866720 914 915 O
. NCT03866720 916 917 O
g NCT03866720 918 919 O
. NCT03866720 920 921 O
shift NCT03866720 923 928 B-Observation-Name
worker NCT03866720 929 935 I-Observation-Name
) NCT03866720 936 937 O

- NCT03866720 941 942 O
Any NCT03866720 944 947 O
reported NCT03866720 948 956 O
recent NCT03866720 957 963 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
( NCT03866720 964 965 O
< NCT03866720 967 968 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03866720 970 971 B-Eq-Value
months NCT03866720 972 978 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03866720 979 980 O
change NCT03866720 981 987 B-Stability___Stability-Value:change
in NCT03866720 988 990 O
body NCT03866720 991 995 B-Observation-Name___Observation-Type-Value:vital
mass NCT03866720 996 1000 I-Observation-Name___Observation-Type-Value:vital
( NCT03866720 1001 1002 O
± NCT03866720 1004 1005 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
3 NCT03866720 1007 1008 B-Eq-Value
% NCT03866720 1009 1010 B-Eq-Unit
) NCT03866720 1012 1013 O

Inclusion NCT03864692 0 9 O
Criteria NCT03864692 10 18 O
: NCT03864692 19 20 O

- NCT03864692 24 25 O
singleton NCT03864692 27 36 O
parturient NCT03864692 37 47 B-Condition-Name

- NCT03864692 50 51 O
planned NCT03864692 53 60 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03864692 61 64 O
elective NCT03864692 65 73 O
LSCS NCT03864692 74 78 B-Procedure-Name
under NCT03864692 79 84 O
spinal NCT03864692 85 91 B-Procedure-Name
anesthesia NCT03864692 92 102 I-Procedure-Name

Exclusion NCT03864692 103 112 O
Criteria NCT03864692 113 121 O
: NCT03864692 122 123 O

- NCT03864692 127 128 O
gestational NCT03864692 130 141 B-Observation-Name___Observation-Type-Value:measurement
age NCT03864692 142 145 I-Observation-Name___Observation-Type-Value:measurement
< NCT03864692 146 147 B-Eq-Operator___Eq-Operator-Value:LT
36 NCT03864692 149 151 B-Eq-Value
weeks NCT03864692 152 157 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03864692 160 161 O
emergency NCT03864692 163 172 O
cases NCT03864692 173 178 O

- NCT03864692 181 182 O
placenta NCT03864692 184 192 B-Condition-Name
previa NCT03864692 193 199 I-Condition-Name
, NCT03864692 200 201 O
pre NCT03864692 202 205 B-Condition-Name
- NCT03864692 206 207 I-Condition-Name
eclampsia NCT03864692 208 217 I-Condition-Name

- NCT03864692 220 221 O
BMI NCT03864692 223 226 B-Observation-Name___Observation-Type-Value:vital
> NCT03864692 227 228 B-Eq-Operator___Eq-Operator-Value:GTEQ
40 NCT03864692 230 232 B-Eq-Value

- NCT03864692 236 237 O
Reynauld NCT03864692 239 247 B-Condition-Name
disease NCT03864692 248 255 I-Condition-Name

- NCT03864692 258 259 O
patient NCT03864692 261 268 O
refusal NCT03864692 269 276 O

- NCT03864692 279 280 O
cardiovascular NCT03864692 282 296 B-Condition-Name
disease NCT03864692 297 304 I-Condition-Name

Inclusion NCT03868917 0 9 O
Criteria NCT03868917 10 18 O
: NCT03868917 19 20 O

- NCT03868917 24 25 O
Scheduled NCT03868917 27 36 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03868917 37 40 O
elective NCT03868917 41 49 O
thoracotomy NCT03868917 50 61 B-Procedure-Name

- NCT03868917 64 65 O
ASA NCT03868917 67 70 B-Condition-Name
status NCT03868917 71 77 O
1 NCT03868917 79 80 B-Eq-Value
, NCT03868917 81 82 O
2 NCT03868917 83 84 B-Eq-Value

Exclusion NCT03868917 86 95 O
Criteria NCT03868917 96 104 O
: NCT03868917 105 106 O

- NCT03868917 110 111 O
Inability NCT03868917 113 122 O
to NCT03868917 123 125 O
provide NCT03868917 126 133 O
adequate NCT03868917 134 142 O
informed NCT03868917 143 151 O
consent NCT03868917 152 159 O

- NCT03868917 162 163 O
Any NCT03868917 165 168 O
contraindication NCT03868917 169 185 O
to NCT03868917 186 188 O
the NCT03868917 189 192 O
placement NCT03868917 193 202 O
of NCT03868917 203 205 O
thoracic NCT03868917 206 214 B-Procedure-Name
paravertebral NCT03868917 215 228 I-Procedure-Name
catheters NCT03868917 229 238 I-Procedure-Name

- NCT03868917 241 242 O
Unstable NCT03868917 244 252 B-Stability___Stability-Value:change
vertebral NCT03868917 253 262 O
and NCT03868917 263 266 O
transverse NCT03868917 267 277 O
process NCT03868917 278 285 O
fractures NCT03868917 286 295 B-Condition-Name

- NCT03868917 298 299 O
Any NCT03868917 301 304 O
chronic NCT03868917 305 312 O
painful NCT03868917 313 320 B-Condition-Name
conditions NCT03868917 321 331 I-Condition-Name
or NCT03868917 332 334 O
pre NCT03868917 335 338 O
operative NCT03868917 339 348 B-Procedure-Name
opioid NCT03868917 349 355 B-Drug-Name
use NCT03868917 356 359 O
Any NCT03868917 360 363 O
chronic NCT03868917 364 371 O
painful NCT03868917 372 379 B-Condition-Name
conditions NCT03868917 380 390 I-Condition-Name
or NCT03868917 391 393 O
pre NCT03868917 394 397 O
operative NCT03868917 398 407 B-Procedure-Name
opioid NCT03868917 408 414 B-Drug-Name
use NCT03868917 415 418 O

- NCT03868917 421 422 O
Coagulation NCT03868917 424 435 B-Condition-Name
abnormalities NCT03868917 436 449 I-Condition-Name
or NCT03868917 450 452 O
expectation NCT03868917 453 464 O
to NCT03868917 465 467 O
be NCT03868917 468 470 O
on NCT03868917 471 473 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
therapeutic NCT03868917 474 485 B-Drug-Name
anticoagulants NCT03868917 486 500 I-Drug-Name
post NCT03868917 501 505 O
operatively NCT03868917 506 517 B-Procedure-Name

- NCT03868917 520 521 O
Allergy NCT03868917 523 530 O
to NCT03868917 531 533 O
any NCT03868917 534 537 O
of NCT03868917 538 540 O
the NCT03868917 541 544 O
drugs NCT03868917 545 550 O
/ NCT03868917 551 552 O
agents NCT03868917 553 559 O
used NCT03868917 560 564 O
in NCT03868917 565 567 O
study NCT03868917 568 573 O
protocol NCT03868917 574 582 O

- NCT03868917 585 586 O
Altered NCT03868917 588 595 B-Condition-Name
mental NCT03868917 596 602 I-Condition-Name
status NCT03868917 603 609 I-Condition-Name
or NCT03868917 610 612 O
emergency NCT03868917 613 622 O
surgery NCT03868917 623 630 B-Procedure-Name

- NCT03868917 633 634 O
Comorbid NCT03868917 636 644 B-Condition-Name
conditions NCT03868917 645 655 I-Condition-Name
such NCT03868917 656 660 O
as NCT03868917 661 663 O
sepsis NCT03868917 664 670 B-Condition-Name
, NCT03868917 671 672 O
unstable NCT03868917 673 681 B-Stability___Stability-Value:change
angina NCT03868917 682 688 B-Condition-Name
, NCT03868917 689 690 O
congestive NCT03868917 691 701 B-Condition-Name
heart NCT03868917 702 707 I-Condition-Name
failure NCT03868917 708 715 I-Condition-Name

Inclusion NCT03862547 0 9 O
Criteria NCT03862547 10 18 O
: NCT03862547 19 20 O

- NCT03862547 24 25 O
men NCT03862547 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
with NCT03862547 31 35 O
DE NCT03862547 36 38 B-Condition-Name
and NCT03862547 39 42 O
metabolic NCT03862547 43 52 B-Condition-Name
syndrome NCT03862547 53 61 I-Condition-Name

Exclusion NCT03862547 62 71 O
Criteria NCT03862547 72 80 O
: NCT03862547 81 82 O

- NCT03862547 86 87 O
men NCT03862547 89 92 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
with NCT03862547 93 97 O
DE NCT03862547 98 100 B-Condition-Name
without NCT03862547 101 108 O
metabolic NCT03862547 109 118 B-Condition-Name
syndrome NCT03862547 119 127 I-Condition-Name

Inclusion NCT03860350 0 9 O
Criteria NCT03860350 10 18 O
: NCT03860350 19 20 O

- NCT03860350 24 25 O
CAC NCT03860350 27 30 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03860350 31 36 I-Observation-Name___Observation-Type-Value:clinical-score
> NCT03860350 37 38 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03860350 40 42 B-Eq-Value

- NCT03860350 46 47 O
Framingham NCT03860350 49 59 B-Observation-Name___Observation-Type-Value:measurement
risk NCT03860350 60 64 I-Observation-Name___Observation-Type-Value:measurement
score NCT03860350 65 70 I-Observation-Name___Observation-Type-Value:measurement
( NCT03860350 71 72 O
10 NCT03860350 74 76 B-Eq-Value
% NCT03860350 77 78 B-Eq-Unit
or NCT03860350 79 81 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03860350 82 87 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03860350 88 89 O

- NCT03860350 93 94 O
Subjects NCT03860350 96 104 O
are NCT03860350 105 108 O
required NCT03860350 109 117 O
to NCT03860350 118 120 O
be NCT03860350 121 123 O
on NCT03860350 124 126 O
stable NCT03860350 127 133 B-Stability___Stability-Value:stable
concomitant NCT03860350 134 145 O
medications NCT03860350 146 157 O
for NCT03860350 158 161 O
at NCT03860350 162 164 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03860350 165 170 I-Eq-Operator___Eq-Operator-Value:GTEQ
12 NCT03860350 172 174 B-Eq-Value
weeks NCT03860350 175 180 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03860350 181 186 O
to NCT03860350 187 189 O
randomization NCT03860350 190 203 O

- NCT03860350 206 207 O
Subjects NCT03860350 209 217 O
with NCT03860350 218 222 O
diabetic NCT03860350 223 231 B-Condition-Name
must NCT03860350 232 236 O
have NCT03860350 237 241 O
HbA NCT03860350 242 245 B-Observation-Name___Observation-Type-Value:lab
1C NCT03860350 246 248 I-Observation-Name___Observation-Type-Value:lab
< NCT03860350 249 250 B-Eq-Operator___Eq-Operator-Value:LT
8.0 NCT03860350 252 255 B-Eq-Value
, NCT03860350 256 257 O
and NCT03860350 258 261 O
stable NCT03860350 262 268 B-Stability___Stability-Value:stable
HbA NCT03860350 269 272 B-Observation-Name___Observation-Type-Value:lab
1C NCT03860350 273 275 I-Observation-Name___Observation-Type-Value:lab
level NCT03860350 276 281 O
variation NCT03860350 282 291 O
range NCT03860350 292 297 O
within NCT03860350 298 304 B-Eq-Operator___Eq-Operator-Value:LTEQ
0.5 NCT03860350 306 309 B-Eq-Value
% NCT03860350 310 311 B-Eq-Unit
for NCT03860350 312 315 O
three NCT03860350 316 321 B-Eq-Value
months NCT03860350 322 328 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03860350 329 330 O

Exclusion NCT03860350 332 341 O
Criteria NCT03860350 342 350 O
: NCT03860350 351 352 O

- NCT03860350 356 357 O
Hypersensitivity NCT03860350 359 375 B-Condition-Name
to NCT03860350 376 378 O
AGE NCT03860350 379 382 B-Procedure-Name
therapy NCT03860350 383 390 I-Procedure-Name
, NCT03860350 391 392 O

- NCT03860350 396 397 O
Unstable NCT03860350 399 407 B-Stability___Stability-Value:change
medical NCT03860350 408 415 O
, NCT03860350 416 417 O
psychiatric NCT03860350 418 429 O
, NCT03860350 430 431 O
or NCT03860350 432 434 O
substance NCT03860350 435 444 O
abuse NCT03860350 445 450 O
disorder NCT03860350 451 459 B-Condition-Name
that NCT03860350 460 464 O
may NCT03860350 465 468 O
interfere NCT03860350 469 478 B-Stability___Stability-Value:change
with NCT03860350 479 483 O
continuation NCT03860350 484 496 O
in NCT03860350 497 499 O
the NCT03860350 500 503 O
study NCT03860350 504 509 O
, NCT03860350 510 511 O

- NCT03860350 515 516 O
Weight NCT03860350 518 524 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03860350 525 526 B-Eq-Operator___Eq-Operator-Value:GTEQ
325 NCT03860350 528 531 B-Eq-Value
pounds NCT03860350 532 538 B-Eq-Unit
, NCT03860350 539 540 O

- NCT03860350 544 545 O
Bleeding NCT03860350 547 555 B-Condition-Name
disorder NCT03860350 556 564 I-Condition-Name
, NCT03860350 565 566 O

- NCT03860350 570 571 O
History NCT03860350 573 580 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860350 581 583 O
myocardial NCT03860350 584 594 B-Condition-Name
infarction NCT03860350 595 605 I-Condition-Name
, NCT03860350 606 607 O

- NCT03860350 611 612 O
Stroke NCT03860350 614 620 B-Condition-Name

- NCT03860350 623 624 O
Life NCT03860350 626 630 O
- NCT03860350 631 632 O
threatening NCT03860350 633 644 O
arrhythmia NCT03860350 645 655 B-Condition-Name
within NCT03860350 656 662 B-Eq-Operator___Eq-Operator-Value:LTEQ
prior NCT03860350 663 668 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03860350 670 671 B-Eq-Value
months NCT03860350 672 678 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03860350 679 680 O

- NCT03860350 684 685 O
Resting NCT03860350 687 694 O
hypotension NCT03860350 695 706 B-Condition-Name
( NCT03860350 707 708 O
systolic NCT03860350 709 717 B-Observation-Name___Observation-Type-Value:vital
< NCT03860350 718 719 B-Eq-Operator___Eq-Operator-Value:LT
90 NCT03860350 721 723 B-Eq-Value
mmHg NCT03860350 724 728 B-Eq-Unit
) NCT03860350 729 730 O
or NCT03860350 731 733 O
hypertension NCT03860350 734 746 B-Condition-Name
( NCT03860350 747 748 O
resting NCT03860350 749 756 O
blood NCT03860350 757 762 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03860350 763 771 I-Observation-Name___Observation-Type-Value:vital
> NCT03860350 772 773 B-Eq-Operator___Eq-Operator-Value:GT
170 NCT03860350 775 778 B-Eq-Value
/ NCT03860350 779 780 O
110 NCT03860350 782 785 B-Eq-Value
) NCT03860350 786 787 O

- NCT03860350 791 792 O
Heart NCT03860350 794 799 B-Condition-Name
failure NCT03860350 800 807 I-Condition-Name
NYHA NCT03860350 808 812 B-Condition-Name
class NCT03860350 813 818 I-Condition-Name
III NCT03860350 819 822 B-Eq-Value
or NCT03860350 823 825 O
IV NCT03860350 826 828 B-Eq-Value
, NCT03860350 829 830 O

- NCT03860350 834 835 O
History NCT03860350 837 844 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860350 845 847 O
malignancy NCT03860350 848 858 B-Condition-Name
within NCT03860350 859 865 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860350 866 869 O
last NCT03860350 870 874 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03860350 876 877 B-Eq-Value
years NCT03860350 878 883 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03860350 884 885 O
other NCT03860350 886 891 O
than NCT03860350 892 896 O
skin NCT03860350 897 901 O
cancer NCT03860350 902 908 B-Condition-Name
) NCT03860350 909 910 O
or NCT03860350 911 913 O
evidence NCT03860350 914 922 O
of NCT03860350 923 925 O
active NCT03860350 926 932 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cancer NCT03860350 933 939 B-Condition-Name
which NCT03860350 940 945 O
would NCT03860350 946 951 O
require NCT03860350 952 959 O
concomitant NCT03860350 960 971 O
cancer NCT03860350 972 978 B-Procedure-Name
chemotherapy NCT03860350 979 991 I-Procedure-Name

- NCT03860350 994 995 O
Serum NCT03860350 997 1002 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03860350 1003 1013 I-Observation-Name___Observation-Type-Value:lab
> NCT03860350 1014 1015 B-Eq-Operator___Eq-Operator-Value:GT
1.4 NCT03860350 1017 1020 B-Eq-Value
mg NCT03860350 1021 1023 B-Eq-Unit
/ NCT03860350 1024 1025 O
dl NCT03860350 1026 1028 B-Eq-Unit

- NCT03860350 1031 1032 O
Triglycerides NCT03860350 1034 1047 B-Observation-Name___Observation-Type-Value:lab
> NCT03860350 1048 1049 B-Eq-Operator___Eq-Operator-Value:GT
400 NCT03860350 1051 1054 B-Eq-Value
at NCT03860350 1055 1057 O
baseline NCT03860350 1058 1066 O
visit NCT03860350 1067 1072 O

- NCT03860350 1075 1076 O
Diabetic NCT03860350 1078 1086 B-Condition-Name
subjects NCT03860350 1087 1095 O
with NCT03860350 1096 1100 O
HbA NCT03860350 1101 1104 B-Observation-Name___Observation-Type-Value:lab
1C NCT03860350 1105 1107 I-Observation-Name___Observation-Type-Value:lab
> NCT03860350 1108 1109 B-Eq-Operator___Eq-Operator-Value:GT
8 NCT03860350 1111 1112 B-Eq-Value
% NCT03860350 1113 1114 B-Eq-Unit
, NCT03860350 1116 1117 O

- NCT03860350 1121 1122 O
Drug NCT03860350 1124 1128 O
or NCT03860350 1129 1131 O
alcohol NCT03860350 1132 1139 O
abuse NCT03860350 1140 1145 B-Condition-Name

- NCT03860350 1148 1149 O
Conditions NCT03860350 1151 1161 O
interfering NCT03860350 1162 1173 B-Stability___Stability-Value:change
with NCT03860350 1174 1178 O
accurate NCT03860350 1179 1187 O
assessment NCT03860350 1188 1198 O
of NCT03860350 1199 1201 O
coronary NCT03860350 1202 1210 B-Condition-Name
calcification NCT03860350 1211 1224 I-Condition-Name
( NCT03860350 1225 1226 O
metal NCT03860350 1227 1232 B-Condition-Name
clips NCT03860350 1233 1238 I-Condition-Name
, NCT03860350 1239 1240 O
bypass NCT03860350 1241 1247 B-Procedure-Name
patients NCT03860350 1248 1256 O
, NCT03860350 1257 1258 O
intracoronary NCT03860350 1259 1272 B-Procedure-Name
stents NCT03860350 1273 1279 I-Procedure-Name
) NCT03860350 1280 1281 O
and NCT03860350 1282 1285 O
drug NCT03860350 1286 1290 B-Condition-Name
absorption NCT03860350 1291 1301 I-Condition-Name
( NCT03860350 1302 1303 O
partial NCT03860350 1304 1311 B-Procedure-Name
ileal NCT03860350 1312 1317 I-Procedure-Name
bypass NCT03860350 1318 1324 I-Procedure-Name
or NCT03860350 1325 1327 O
malabsorption NCT03860350 1328 1341 B-Condition-Name
syndrome NCT03860350 1342 1350 I-Condition-Name
) NCT03860350 1351 1352 O
. NCT03860350 1354 1355 O

- NCT03860350 1359 1360 O
Current NCT03860350 1362 1369 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03860350 1370 1373 O
of NCT03860350 1374 1376 O
anticoagulants NCT03860350 1377 1391 B-Drug-Name
( NCT03860350 1392 1393 O
except NCT03860350 1394 1400 O
for NCT03860350 1401 1404 O
antiplatelet NCT03860350 1405 1417 B-Drug-Name
agents NCT03860350 1418 1424 I-Drug-Name
) NCT03860350 1425 1426 O

- NCT03860350 1430 1431 O
Chronic NCT03860350 1433 1440 O
renal NCT03860350 1441 1446 B-Condition-Name
failure NCT03860350 1447 1454 I-Condition-Name

- NCT03860350 1457 1458 O
Liver NCT03860350 1460 1465 B-Condition-Name
failure NCT03860350 1466 1473 I-Condition-Name

- NCT03860350 1476 1477 O
Hematological NCT03860350 1479 1492 O
or NCT03860350 1493 1495 O
biochemical NCT03860350 1496 1507 O
values NCT03860350 1508 1514 B-Observation-Name___Observation-Type-Value:lab
at NCT03860350 1515 1517 O
baseline NCT03860350 1518 1526 O
visit NCT03860350 1527 1532 O
outside NCT03860350 1533 1540 B-Polarity___Polarity-Value:abnormal
the NCT03860350 1541 1544 I-Polarity___Polarity-Value:abnormal
reference NCT03860350 1545 1554 I-Polarity___Polarity-Value:abnormal
ranges NCT03860350 1555 1561 I-Polarity___Polarity-Value:abnormal
considered NCT03860350 1562 1572 O
as NCT03860350 1573 1575 O
clinically NCT03860350 1576 1586 O
significant NCT03860350 1587 1598 B-Severity___Severity-Value:severe
. NCT03860350 1599 1600 O

Inclusion NCT03862235 0 9 O
Criteria NCT03862235 10 18 O
: NCT03862235 19 20 O

- NCT03862235 24 25 O
Anabolic NCT03862235 27 35 B-Drug-Name
androgenic NCT03862235 36 46 I-Drug-Name
steroids NCT03862235 47 55 I-Drug-Name
users NCT03862235 56 61 O
and NCT03862235 62 65 O
Anabolic NCT03862235 66 74 B-Drug-Name
androgenic NCT03862235 75 85 I-Drug-Name
steroids NCT03862235 86 94 I-Drug-Name
nonusers NCT03862235 95 103 O
groups NCT03862235 104 110 O
had NCT03862235 111 114 O
been NCT03862235 115 119 O
involved NCT03862235 120 128 O
in NCT03862235 129 131 O
strength NCT03862235 132 140 B-Observation-Name___Observation-Type-Value:social-habit
training NCT03862235 141 149 I-Observation-Name___Observation-Type-Value:social-habit
for NCT03862235 150 153 O
at NCT03862235 154 156 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862235 157 162 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03862235 164 165 B-Eq-Value
years NCT03862235 166 171 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03862235 171 172 O

- NCT03862235 175 176 O
Anabolic NCT03862235 178 186 B-Drug-Name
androgenic NCT03862235 187 197 I-Drug-Name
steroids NCT03862235 198 206 I-Drug-Name
users NCT03862235 207 212 O
should NCT03862235 213 219 O
be NCT03862235 220 222 O
self NCT03862235 223 227 O
- NCT03862235 228 229 O
administering NCT03862235 230 243 O
anabolic NCT03862235 244 252 B-Drug-Name
androgenic NCT03862235 253 263 I-Drug-Name
steroids NCT03862235 264 272 I-Drug-Name
in NCT03862235 273 275 O
periodic NCT03862235 276 284 O
cycles NCT03862235 285 291 O
lasting NCT03862235 292 299 O
from NCT03862235 300 304 O
8 NCT03862235 306 307 B-Eq-Value
to NCT03862235 308 310 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03862235 312 314 B-Eq-Value
weeks NCT03862235 315 320 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
for NCT03862235 321 324 O
at NCT03862235 325 327 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862235 328 333 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03862235 335 336 B-Eq-Value
years NCT03862235 337 342 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
with NCT03862235 343 347 O
2 NCT03862235 349 350 B-Eq-Value
- NCT03862235 351 352 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03862235 354 355 B-Eq-Value
cycles NCT03862235 356 362 B-Eq-Unit
per NCT03862235 363 366 O
year NCT03862235 367 371 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03862235 371 372 O

- NCT03862235 375 376 O
All NCT03862235 378 381 O
anabolic NCT03862235 382 390 B-Drug-Name
androgenic NCT03862235 391 401 I-Drug-Name
steroids NCT03862235 402 410 I-Drug-Name
users NCT03862235 411 416 O
were NCT03862235 417 421 O
on NCT03862235 422 424 O
a NCT03862235 425 426 O
cycle NCT03862235 427 432 O
over NCT03862235 433 437 O
the NCT03862235 438 441 O
course NCT03862235 442 448 O
of NCT03862235 449 451 O
the NCT03862235 452 455 O
study NCT03862235 456 461 O
; NCT03862235 461 462 O

- NCT03862235 465 466 O
Sedentary NCT03862235 468 477 O
control NCT03862235 478 485 O
group NCT03862235 486 491 O
: NCT03862235 492 493 O
sedentary NCT03862235 494 503 B-Condition-Name
men NCT03862235 504 507 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
without NCT03862235 508 515 O
cardiovascular NCT03862235 516 530 B-Condition-Name
disease NCT03862235 531 538 I-Condition-Name
. NCT03862235 539 540 O

Exclusion NCT03862235 542 551 O
Criteria NCT03862235 552 560 O
: NCT03862235 561 562 O

- NCT03862235 566 567 O
Smoking NCT03862235 569 576 B-Condition-Name
; NCT03862235 576 577 O

- NCT03862235 580 581 O
Alcohol NCT03862235 583 590 B-Observation-Name___Observation-Type-Value:social-habit
consumption NCT03862235 591 602 I-Observation-Name___Observation-Type-Value:social-habit
; NCT03862235 602 603 O

- NCT03862235 606 607 O
Use NCT03862235 609 612 O
of NCT03862235 613 615 O
diuretics NCT03862235 616 625 B-Drug-Name
and NCT03862235 626 629 O
/ NCT03862235 630 631 O
or NCT03862235 632 634 O
antihypertensive NCT03862235 635 651 B-Drug-Name
medications NCT03862235 652 663 I-Drug-Name
; NCT03862235 663 664 O

- NCT03862235 667 668 O
Liver NCT03862235 670 675 O
and NCT03862235 676 679 O
kidney NCT03862235 680 686 O
disease NCT03862235 687 694 B-Condition-Name

Inclusion NCT03862209 0 9 O
Criteria NCT03862209 10 18 O
: NCT03862209 19 20 O

Adults NCT03862209 22 28 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03862209 29 30 O
ages NCT03862209 31 35 O
18 NCT03862209 37 39 B-Eq-Value
- NCT03862209 40 41 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03862209 43 45 B-Eq-Value
) NCT03862209 46 47 O
, NCT03862209 49 50 O
current NCT03862209 51 58 O
service NCT03862209 59 66 O
users NCT03862209 67 72 O
, NCT03862209 73 74 O
with NCT03862209 75 79 O
severe NCT03862209 80 86 B-Severity___Severity-Value:severe
and NCT03862209 87 90 O
enduring NCT03862209 91 99 O
mental NCT03862209 100 106 B-Condition-Name
ill NCT03862209 107 110 I-Condition-Name
- NCT03862209 111 112 I-Condition-Name
health NCT03862209 113 119 I-Condition-Name
, NCT03862209 120 121 O
which NCT03862209 122 127 O
, NCT03862209 128 129 O
for NCT03862209 130 133 O
clinical NCT03862209 134 142 O
purposes NCT03862209 143 151 O
, NCT03862209 152 153 O
typically NCT03862209 154 163 O
relates NCT03862209 164 171 O
to NCT03862209 172 174 O
diagnostic NCT03862209 175 185 O
categories NCT03862209 186 196 O
of NCT03862209 197 199 O
bipolar NCT03862209 200 207 B-Condition-Name
disorder NCT03862209 208 216 I-Condition-Name
, NCT03862209 217 218 O
severe NCT03862209 219 225 B-Severity___Severity-Value:severe
depression NCT03862209 226 236 B-Condition-Name
, NCT03862209 237 238 O
or NCT03862209 239 241 O
schizophrenia NCT03862209 242 255 B-Condition-Name
. NCT03862209 256 257 O
We NCT03862209 259 261 O
use NCT03862209 262 265 O
the NCT03862209 266 269 O
following NCT03862209 270 279 O
definition NCT03862209 280 290 O
for NCT03862209 291 294 O
SMI NCT03862209 295 298 B-Condition-Name
: NCT03862209 299 300 O

- NCT03862209 304 305 O
Presence NCT03862209 307 315 O
of NCT03862209 316 318 O
a NCT03862209 319 320 O
psychiatric NCT03862209 321 332 B-Condition-Name
disorder NCT03862209 333 341 I-Condition-Name
that NCT03862209 342 346 O
requires NCT03862209 347 355 O
care NCT03862209 356 360 O
and NCT03862209 361 364 O
treatment NCT03862209 365 374 O
( NCT03862209 375 376 O
so NCT03862209 377 379 O
, NCT03862209 380 381 O
they NCT03862209 382 386 O
are NCT03862209 387 390 O
NOT NCT03862209 391 394 O
in NCT03862209 395 397 O
symptom NCT03862209 398 405 O
remission NCT03862209 406 415 O
) NCT03862209 416 417 O

- NCT03862209 421 422 O
Has NCT03862209 424 427 O
severe NCT03862209 428 434 B-Severity___Severity-Value:severe
limitations NCT03862209 435 446 B-Condition-Name
in NCT03862209 447 449 O
social NCT03862209 450 456 O
and NCT03862209 457 460 O
community NCT03862209 461 470 O
functioning NCT03862209 471 482 O
( NCT03862209 483 484 O
i NCT03862209 485 486 O
. NCT03862209 487 488 O
e NCT03862209 489 490 O
. NCT03862209 491 492 O
they NCT03862209 494 498 O
are NCT03862209 499 502 O
not NCT03862209 503 506 O
in NCT03862209 507 509 O
functional NCT03862209 510 520 O
remission NCT03862209 521 530 O
) NCT03862209 531 532 O

- NCT03862209 536 537 O
These NCT03862209 539 544 O
problems NCT03862209 545 553 O
are NCT03862209 554 557 O
not NCT03862209 558 561 O
transient NCT03862209 562 571 O
( NCT03862209 572 573 O
e NCT03862209 574 575 O
. NCT03862209 576 577 O
g NCT03862209 578 579 O
. NCT03862209 580 581 O
temporary NCT03862209 583 592 O
, NCT03862209 593 594 O
one NCT03862209 595 598 O
- NCT03862209 599 600 O
off NCT03862209 601 604 O
) NCT03862209 605 606 O
in NCT03862209 607 609 O
nature NCT03862209 610 616 O
( NCT03862209 617 618 O
They NCT03862209 619 623 O
are NCT03862209 624 627 O
systematic NCT03862209 628 638 O
and NCT03862209 639 642 O
long NCT03862209 643 647 O
- NCT03862209 648 649 O
term NCT03862209 650 654 O
) NCT03862209 655 656 O

- NCT03862209 660 661 O
Coordinated NCT03862209 663 674 B-Procedure-Name
care NCT03862209 675 679 I-Procedure-Name
provided NCT03862209 680 688 O
by NCT03862209 689 691 O
care NCT03862209 692 696 O
networks NCT03862209 697 705 O
or NCT03862209 706 708 O
teams NCT03862209 709 714 O
is NCT03862209 715 717 O
needed NCT03862209 718 724 O
to NCT03862209 725 727 O
implement NCT03862209 728 737 O
the NCT03862209 738 741 O
treatment NCT03862209 742 751 O
plan NCT03862209 752 756 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future

Exclusion NCT03862209 757 766 O
Criteria NCT03862209 767 775 O
: NCT03862209 776 777 O

Exclusion NCT03862209 779 788 O
criteria NCT03862209 789 797 O
at NCT03862209 798 800 O
the NCT03862209 801 804 O
patient NCT03862209 805 812 O
level NCT03862209 813 818 O
includes NCT03862209 819 827 O
patients NCT03862209 828 836 O
who NCT03862209 837 840 O
do NCT03862209 841 843 O
not NCT03862209 844 847 O
consent NCT03862209 848 855 O
to NCT03862209 856 858 O
their NCT03862209 859 864 O
data NCT03862209 865 869 O
being NCT03862209 870 875 O
collected NCT03862209 876 885 O
who NCT03862209 886 889 O
are NCT03862209 890 893 O
part NCT03862209 894 898 O
of NCT03862209 899 901 O
the NCT03862209 902 905 O
intervention NCT03862209 906 918 O
or NCT03862209 919 921 O
control NCT03862209 922 929 O
conditions NCT03862209 930 940 O
, NCT03862209 941 942 O
those NCT03862209 943 948 O
who NCT03862209 949 952 O
are NCT03862209 953 956 O
under NCT03862209 957 962 B-Eq-Operator___Eq-Operator-Value:LT
the NCT03862209 963 966 O
age NCT03862209 967 970 O
of NCT03862209 971 973 O
18 NCT03862209 975 977 B-Eq-Value
at NCT03862209 978 980 O
the NCT03862209 981 984 O
start NCT03862209 985 990 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03862209 991 993 O
the NCT03862209 994 997 O
study NCT03862209 998 1003 O
. NCT03862209 1004 1005 O


Inclusion NCT03862976 0 9 O
Criteria NCT03862976 10 18 O
: NCT03862976 19 20 O

- NCT03862976 24 25 O
Women NCT03862976 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03862976 33 37 O
singleton NCT03862976 38 47 O
gestation NCT03862976 48 57 B-Condition-Name

- NCT03862976 60 61 O
18 NCT03862976 64 66 B-Eq-Value
years NCT03862976 67 72 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
to NCT03862976 73 75 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03862976 77 79 B-Eq-Value
years NCT03862976 80 85 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03862976 88 89 O
High NCT03862976 91 95 B-Polarity___Polarity-Value:high
risk NCT03862976 96 100 O
pregnancies NCT03862976 101 112 B-Condition-Name
: NCT03862976 113 114 O
DM NCT03862976 115 117 B-Condition-Name
, NCT03862976 118 119 O
or NCT03862976 120 122 O
GDM NCT03862976 123 126 B-Condition-Name
, NCT03862976 127 128 O
or NCT03862976 129 131 O
hypertension NCT03862976 132 144 B-Condition-Name
, NCT03862976 145 146 O
or NCT03862976 147 149 O
preeclampsia NCT03862976 150 162 B-Condition-Name

Exclusion NCT03862976 163 172 O
Criteria NCT03862976 173 181 O
: NCT03862976 182 183 O

- NCT03862976 186 187 O
IUGR NCT03862976 188 192 B-Condition-Name

Inclusion NCT03865758 0 9 O
Criteria NCT03865758 10 18 O
: NCT03865758 19 20 O

- NCT03865758 24 25 O
Probable NCT03865758 27 35 O
dementia NCT03865758 36 44 B-Condition-Name
indicated NCT03865758 45 54 O
by NCT03865758 55 57 O
prior NCT03865758 58 63 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosis NCT03865758 64 73 O
and NCT03865758 74 77 O
/ NCT03865758 78 79 O
or NCT03865758 80 82 O
a NCT03865758 83 84 O
score NCT03865758 85 90 O
of NCT03865758 91 93 O
23 NCT03865758 95 97 B-Eq-Value
or NCT03865758 98 100 B-Eq-Operator___Eq-Operator-Value:GTEQ
less NCT03865758 101 105 I-Eq-Operator___Eq-Operator-Value:GTEQ
on NCT03865758 106 108 O
the NCT03865758 109 112 O
Brief NCT03865758 113 118 B-Observation-Name___Observation-Type-Value:clinical-score
Alzheimer NCT03865758 119 128 I-Observation-Name___Observation-Type-Value:clinical-score
Screen NCT03865758 129 135 I-Observation-Name___Observation-Type-Value:clinical-score
. NCT03865758 136 137 O

Exclusion NCT03865758 139 148 O
Criteria NCT03865758 149 157 O
: NCT03865758 158 159 O

- NCT03865758 163 164 O
No NCT03865758 166 168 O
evidence NCT03865758 169 177 O
of NCT03865758 178 180 O
dementia NCT03865758 181 189 B-Condition-Name

Inclusion NCT03862989 0 9 O
Criteria NCT03862989 10 18 O
: NCT03862989 19 20 O

- NCT03862989 24 25 O
post NCT03862989 27 31 O
- NCT03862989 32 33 O
myocardial NCT03862989 34 44 B-Condition-Name
infarction NCT03862989 45 55 I-Condition-Name
ventricular NCT03862989 56 67 B-Condition-Name
tachycardia NCT03862989 68 79 I-Condition-Name
diagnosis NCT03862989 80 89 O

- NCT03862989 92 93 O
scheduled NCT03862989 95 104 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03862989 105 107 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03862989 108 115 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
radiofrequency NCT03862989 116 130 B-Procedure-Name
catheter NCT03862989 131 139 I-Procedure-Name
ablation NCT03862989 140 148 I-Procedure-Name
as NCT03862989 149 151 O
either NCT03862989 152 158 O
emergency NCT03862989 159 168 O
or NCT03862989 169 171 O
elective NCT03862989 172 180 O
case NCT03862989 181 185 O

Exclusion NCT03862989 186 195 O
Criteria NCT03862989 196 204 O
: NCT03862989 205 206 O

- NCT03862989 210 211 O
Unable NCT03862989 213 219 O
to NCT03862989 220 222 O
perform NCT03862989 223 230 O
pace NCT03862989 231 235 B-Procedure-Name
mapping NCT03862989 236 243 I-Procedure-Name
during NCT03862989 244 250 O
ablation NCT03862989 251 259 B-Procedure-Name
procedure NCT03862989 260 269 I-Procedure-Name

- NCT03862989 272 273 O
Unable NCT03862989 275 281 O
to NCT03862989 282 284 O
terminate NCT03862989 285 294 O
VT NCT03862989 295 297 O
thus NCT03862989 298 302 O
unable NCT03862989 303 309 O
to NCT03862989 310 312 O
provide NCT03862989 313 320 O
data NCT03862989 321 325 O
regarding NCT03862989 326 335 O
successful NCT03862989 336 346 O
ablation NCT03862989 347 355 B-Procedure-Name
lesion NCT03862989 356 362 I-Procedure-Name
sites NCT03862989 363 368 O

- NCT03862989 371 372 O
Intracardiac NCT03862989 374 386 B-Condition-Name
thrombus NCT03862989 387 395 I-Condition-Name

Inclusion NCT03868254 0 9 O
Criteria NCT03868254 10 18 O
: NCT03868254 19 20 O

- NCT03868254 24 25 O
Eye NCT03868254 27 30 O
treated NCT03868254 31 38 O
with NCT03868254 39 43 O
XEN NCT03868254 44 47 O
45 NCT03868254 49 51 O
Gel NCT03868254 52 55 B-Procedure-Name
Stent NCT03868254 56 61 I-Procedure-Name
for NCT03868254 62 65 O
primary NCT03868254 66 73 O
open NCT03868254 74 78 O
angle NCT03868254 79 84 O
glaucoma NCT03868254 85 93 B-Condition-Name
as NCT03868254 94 96 O
a NCT03868254 97 98 O
standalone NCT03868254 99 109 O
procedure NCT03868254 110 119 O
or NCT03868254 120 122 O
in NCT03868254 123 125 O
combination NCT03868254 126 137 O
with NCT03868254 138 142 O
phacoemulsification NCT03868254 143 162 B-Procedure-Name

- NCT03868254 165 166 O
XEN NCT03868254 168 171 O
45 NCT03868254 173 175 O
Gel NCT03868254 176 179 B-Procedure-Name
Stent NCT03868254 180 185 I-Procedure-Name
was NCT03868254 186 189 O
implanted NCT03868254 190 199 O
between NCT03868254 200 207 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1 NCT03868254 209 210 B-Eq-Value
January NCT03868254 211 218 I-Eq-Value
2014 NCT03868254 220 224 I-Eq-Value
and NCT03868254 225 228 O
1 NCT03868254 230 231 B-Eq-Value
October NCT03868254 232 239 I-Eq-Value
2015 NCT03868254 241 245 I-Eq-Value

Exclusion NCT03868254 247 256 O
Criteria NCT03868254 257 265 O

- NCT03868254 268 269 O
None NCT03868254 271 275 O

Inclusion NCT03865823 0 9 O
Criteria NCT03865823 10 18 O
: NCT03865823 19 20 O

- NCT03865823 24 25 O
Patient NCT03865823 27 34 O
over NCT03865823 35 39 O
the NCT03865823 40 43 O
age NCT03865823 44 47 O
of NCT03865823 48 50 O
18 NCT03865823 52 54 B-Eq-Value
, NCT03865823 55 56 O
patient NCT03865823 57 64 O
with NCT03865823 65 69 O
an NCT03865823 70 72 O
anus NCT03865823 73 77 O
fistula NCT03865823 78 85 B-Condition-Name
with NCT03865823 86 90 O
indication NCT03865823 91 101 O
for NCT03865823 102 105 O
surgical NCT03865823 106 114 B-Procedure-Name
treatment NCT03865823 115 124 I-Procedure-Name

Exclusion NCT03865823 125 134 O
Criteria NCT03865823 135 143 O
: NCT03865823 144 145 O

- NCT03865823 149 150 O
Cutaneous NCT03865823 152 161 B-Condition-Name
Suppuration NCT03865823 162 173 I-Condition-Name
, NCT03865823 174 175 O
without NCT03865823 176 183 O
fistula NCT03865823 184 191 B-Condition-Name
( NCT03865823 192 193 O
e NCT03865823 194 195 O
. NCT03865823 196 197 O
g NCT03865823 198 199 O
. NCT03865823 200 201 O
, NCT03865823 202 203 O
Verneuil NCT03865823 204 212 B-Condition-Name
disease NCT03865823 213 220 I-Condition-Name
, NCT03865823 221 222 O
boil NCT03865823 223 227 B-Condition-Name
) NCT03865823 228 229 O

Inclusion NCT03869957 0 9 O
Criteria NCT03869957 10 18 O
: NCT03869957 19 20 O

- NCT03869957 24 25 O
Patients NCT03869957 27 35 O
admitted NCT03869957 36 44 O
in NCT03869957 45 47 O
the NCT03869957 48 51 O
non NCT03869957 52 55 O
- NCT03869957 56 57 O
critical NCT03869957 58 66 B-Location___Location-Value:unit
areas NCT03869957 67 72 I-Location___Location-Value:unit
of NCT03869957 73 75 O
the NCT03869957 76 79 O
Instituto NCT03869957 80 89 B-Location___Location-Value:hospital
Nacional NCT03869957 90 98 I-Location___Location-Value:hospital
de NCT03869957 99 101 I-Location___Location-Value:hospital
Ciencias NCT03869957 102 110 I-Location___Location-Value:hospital
Médicas NCT03869957 111 118 I-Location___Location-Value:hospital
y NCT03869957 119 120 I-Location___Location-Value:hospital
Nutrición NCT03869957 121 130 I-Location___Location-Value:hospital
Salvador NCT03869957 131 139 I-Location___Location-Value:hospital
Zubirán NCT03869957 140 147 I-Location___Location-Value:hospital
( NCT03869957 148 149 O
INCMNSZ NCT03869957 150 157 B-Location
) NCT03869957 158 159 O
with NCT03869957 160 164 O
a NCT03869957 165 166 O
nutritional NCT03869957 167 178 B-Condition-Name
risk NCT03869957 179 183 O
between NCT03869957 184 191 B-Eq-Operator___Eq-Operator-Value:BETWEEN
January NCT03869957 192 199 B-Eq-Value
2019 NCT03869957 201 205 I-Eq-Value
and NCT03869957 206 209 O
July NCT03869957 210 214 B-Eq-Value
2020 NCT03869957 216 220 I-Eq-Value
will NCT03869957 221 225 O
be NCT03869957 226 228 O
considered NCT03869957 229 239 O
eligible NCT03869957 240 248 O
. NCT03869957 249 250 O

- NCT03869957 254 255 O
Patients NCT03869957 257 265 O
with NCT03869957 266 270 O
recent NCT03869957 271 277 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
diagnosis NCT03869957 278 287 O
of NCT03869957 288 290 O
IF NCT03869957 291 293 B-Condition-Name
type NCT03869957 294 298 O
II NCT03869957 299 301 O
( NCT03869957 302 303 O
an NCT03869957 304 306 O
evolution NCT03869957 307 316 O
> NCT03869957 317 318 B-Eq-Operator___Eq-Operator-Value:GT
28 NCT03869957 320 322 B-Eq-Value
days NCT03869957 323 327 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03869957 328 329 O
originate NCT03869957 330 339 O
from NCT03869957 340 344 O
various NCT03869957 345 352 O
gastrointestinal NCT03869957 353 369 O
or NCT03869957 370 372 O
systemic NCT03869957 373 381 O
diseases NCT03869957 382 390 B-Condition-Name
( NCT03869957 391 392 O
short NCT03869957 393 398 O
bowel NCT03869957 399 404 O
, NCT03869957 405 406 O
intestinal NCT03869957 407 417 O
fistula NCT03869957 418 425 O
, NCT03869957 426 427 O
intestinal NCT03869957 428 438 O
dysmotility NCT03869957 439 450 O
, NCT03869957 451 452 O
mechanical NCT03869957 453 463 O
obstruction NCT03869957 464 475 O
, NCT03869957 476 477 O
and NCT03869957 478 481 O
extensive NCT03869957 482 491 O
small NCT03869957 492 497 O
bowel NCT03869957 498 503 O
mucosal NCT03869957 504 511 O
disease NCT03869957 512 519 B-Condition-Name
) NCT03869957 520 521 O
. NCT03869957 523 524 O

Exclusion NCT03869957 531 540 O
Criteria NCT03869957 541 549 O
: NCT03869957 550 551 O

- NCT03869957 555 556 O
Patients NCT03869957 558 566 O
with NCT03869957 567 571 O
contraindications NCT03869957 572 589 O
for NCT03869957 590 593 O
PN NCT03869957 594 596 B-Procedure-Name

- NCT03869957 599 600 O
Patients NCT03869957 602 610 O
with NCT03869957 611 615 O
known NCT03869957 616 621 O
allergies NCT03869957 622 631 O
to NCT03869957 632 634 O
the NCT03869957 635 638 O
components NCT03869957 639 649 O
of NCT03869957 650 652 O
the NCT03869957 653 656 O
PN NCT03869957 657 659 B-Procedure-Name
formula NCT03869957 660 667 O

- NCT03869957 670 671 O
Severe NCT03869957 673 679 B-Severity___Severity-Value:severe
liver NCT03869957 680 685 O
or NCT03869957 686 688 O
renal NCT03869957 689 694 O
insufficiency NCT03869957 695 708 B-Condition-Name

- NCT03869957 711 712 O
Uncontrolled NCT03869957 714 726 B-Stability___Stability-Value:change
diabetes NCT03869957 727 735 B-Condition-Name
mellitus NCT03869957 736 744 I-Condition-Name

- NCT03869957 747 748 O
Certain NCT03869957 750 757 O
acute NCT03869957 758 763 B-Severity___Severity-Value:severe
and NCT03869957 764 767 O
life NCT03869957 768 772 O
- NCT03869957 773 774 O
threatening NCT03869957 775 786 O
conditions NCT03869957 787 797 O

- NCT03869957 800 801 O
Immunological NCT03869957 803 816 B-Condition-Name
diseases NCT03869957 817 825 I-Condition-Name
( NCT03869957 826 827 O
such NCT03869957 828 832 O
as NCT03869957 833 835 O
autoimmune NCT03869957 836 846 B-Condition-Name
diseases NCT03869957 847 855 I-Condition-Name
, NCT03869957 856 857 O
human NCT03869957 858 863 B-Condition-Name
immunodeficiency NCT03869957 864 880 I-Condition-Name
virus NCT03869957 881 886 I-Condition-Name
infection NCT03869957 887 896 I-Condition-Name
, NCT03869957 897 898 O
cancer NCT03869957 899 905 B-Condition-Name
, NCT03869957 906 907 O
etc NCT03869957 908 911 O
. NCT03869957 912 913 O
) NCT03869957 914 915 O

- NCT03869957 919 920 O
Those NCT03869957 922 927 O
that NCT03869957 928 932 O
take NCT03869957 933 937 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
immunosuppressant NCT03869957 938 955 B-Drug-Name
medications NCT03869957 956 967 I-Drug-Name

- NCT03869957 970 971 O
Severe NCT03869957 973 979 B-Severity___Severity-Value:severe
hemorrhagic NCT03869957 980 991 B-Condition-Name
disorders NCT03869957 992 1001 I-Condition-Name

- NCT03869957 1004 1005 O
Pregnant NCT03869957 1007 1015 B-Condition-Name
or NCT03869957 1016 1018 O
lactating NCT03869957 1019 1028 B-Condition-Name


Inclusion NCT03863249 0 9 O
Criteria NCT03863249 10 18 O
: NCT03863249 19 20 O

1 NCT03863249 25 26 O
. NCT03863249 26 27 O
Subjects NCT03863249 29 37 O
of NCT03863249 38 40 O
40 NCT03863249 42 44 B-Eq-Value
- NCT03863249 45 46 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03863249 48 50 B-Eq-Value
years NCT03863249 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03863249 57 58 O

2 NCT03863249 63 64 O
. NCT03863249 64 65 O
No NCT03863249 67 69 O
smokers NCT03863249 70 77 B-Condition-Name
or NCT03863249 78 80 O
smokers NCT03863249 81 88 B-Condition-Name
of NCT03863249 89 91 O
less NCT03863249 92 96 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03863249 97 101 I-Eq-Operator___Eq-Operator-Value:LT
10 NCT03863249 103 105 B-Eq-Value
cigarettes NCT03863249 106 116 B-Eq-Unit
a NCT03863249 117 118 O
day NCT03863249 119 122 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
. NCT03863249 123 124 O

3 NCT03863249 129 130 O
. NCT03863249 130 131 O
Patients NCT03863249 133 141 O
with NCT03863249 142 146 O
periodontitis NCT03863249 147 160 B-Condition-Name
stages NCT03863249 161 167 B-Eq-Unit
III NCT03863249 168 171 B-Eq-Value
and NCT03863249 172 175 O
IV NCT03863249 176 178 B-Eq-Value
grades NCT03863249 179 185 B-Eq-Unit
A NCT03863249 186 187 B-Eq-Value
- NCT03863249 188 189 B-Eq-Operator___Eq-Operator-Value:BETWEEN
B NCT03863249 190 191 B-Eq-Value
. NCT03863249 192 193 O

4 NCT03863249 198 199 O
. NCT03863249 199 200 O
Presence NCT03863249 202 210 O
of NCT03863249 211 213 O
20 NCT03863249 215 217 B-Eq-Value
natural NCT03863249 218 225 O
teeth NCT03863249 226 231 B-Condition-Name
, NCT03863249 232 233 O
including NCT03863249 234 243 O
at NCT03863249 244 246 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863249 247 252 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03863249 253 258 B-Eq-Value
molar NCT03863249 259 264 O
teeth NCT03863249 265 270 B-Condition-Name
. NCT03863249 271 272 O

5 NCT03863249 277 278 O
. NCT03863249 278 279 O
Presence NCT03863249 281 289 O
of NCT03863249 290 292 O
at NCT03863249 293 295 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863249 296 301 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03863249 303 304 B-Eq-Value
sites NCT03863249 305 310 B-Eq-Unit
with NCT03863249 311 315 O
at NCT03863249 316 318 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863249 319 324 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03863249 326 327 B-Eq-Value
mm NCT03863249 328 330 B-Eq-Unit
probing NCT03863249 331 338 B-Observation-Name___Observation-Type-Value:measurement
depth NCT03863249 339 344 I-Observation-Name___Observation-Type-Value:measurement
. NCT03863249 345 346 O

6 NCT03863249 351 352 O
. NCT03863249 352 353 O
Good NCT03863249 355 359 B-Polarity___Polarity-Value:normal
general NCT03863249 360 367 B-Condition-Name
health NCT03863249 368 374 I-Condition-Name

Exclusion NCT03863249 375 384 O
Criteria NCT03863249 385 393 O
: NCT03863249 394 395 O

1 NCT03863249 400 401 O
. NCT03863249 401 402 O
Smokers NCT03863249 404 411 B-Condition-Name
of NCT03863249 412 414 O
more NCT03863249 415 419 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863249 420 424 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03863249 426 428 B-Eq-Value
cigarettes NCT03863249 429 439 B-Eq-Unit
a NCT03863249 440 441 O
day NCT03863249 442 445 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
. NCT03863249 446 447 O

2 NCT03863249 452 453 O
. NCT03863249 453 454 O
Patients NCT03863249 456 464 O
who NCT03863249 465 468 O
have NCT03863249 469 473 O
received NCT03863249 474 482 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
periodontal NCT03863249 483 494 B-Procedure-Name
treatment NCT03863249 495 504 I-Procedure-Name
in NCT03863249 505 507 O
the NCT03863249 508 511 O
previous NCT03863249 512 520 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
12 NCT03863249 522 524 B-Eq-Value
months NCT03863249 525 531 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03863249 532 533 O

3 NCT03863249 538 539 O
. NCT03863249 539 540 O
Patients NCT03863249 542 550 O
who NCT03863249 551 554 O
have NCT03863249 555 559 O
used NCT03863249 560 564 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
antibiotics NCT03863249 565 576 B-Drug-Name
in NCT03863249 577 579 O
the NCT03863249 580 583 O
last NCT03863249 584 588 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03863249 590 591 B-Eq-Value
months NCT03863249 592 598 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03863249 599 600 O

4 NCT03863249 605 606 O
. NCT03863249 606 607 O
Routine NCT03863249 609 616 O
use NCT03863249 617 620 O
of NCT03863249 621 623 O
oral NCT03863249 624 628 B-Drug-Name
antiseptics NCT03863249 629 640 I-Drug-Name
and NCT03863249 641 644 O
/ NCT03863249 645 646 O
or NCT03863249 647 649 O
during NCT03863249 650 656 O
the NCT03863249 657 660 O
previous NCT03863249 661 669 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03863249 671 672 B-Eq-Value
months NCT03863249 673 679 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03863249 680 681 O

5 NCT03863249 686 687 O
. NCT03863249 687 688 O
Systemic NCT03863249 690 698 O
conditions NCT03863249 699 709 O
that NCT03863249 710 714 O
required NCT03863249 715 723 O
antibiotic NCT03863249 724 734 B-Drug-Name
premedication NCT03863249 735 748 I-Drug-Name
. NCT03863249 749 750 O

6 NCT03863249 755 756 O
. NCT03863249 756 757 O
Women NCT03863249 759 764 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
pregnant NCT03863249 765 773 B-Condition-Name
or NCT03863249 774 776 O
nursing NCT03863249 777 784 B-Condition-Name
. NCT03863249 785 786 O

7 NCT03863249 791 792 O
. NCT03863249 792 793 O
Medications NCT03863249 795 806 O
that NCT03863249 807 811 O
could NCT03863249 812 817 O
influence NCT03863249 818 827 B-Stability___Stability-Value:change
the NCT03863249 828 831 O
outcome NCT03863249 832 839 O
of NCT03863249 840 842 O
periodontal NCT03863249 843 854 B-Procedure-Name
therapy NCT03863249 855 862 I-Procedure-Name
. NCT03863249 863 864 O

8 NCT03863249 869 870 O
. NCT03863249 870 871 O
Any NCT03863249 873 876 O
known NCT03863249 877 882 O
allergies NCT03863249 883 892 O
to NCT03863249 893 895 O
the NCT03863249 896 899 O
test NCT03863249 900 904 O
antimicrobial NCT03863249 905 918 B-Drug-Name
agents NCT03863249 919 925 I-Drug-Name
. NCT03863249 926 927 O

9 NCT03863249 932 933 O
. NCT03863249 933 934 O
Diabetics NCT03863249 936 945 B-Condition-Name
. NCT03863249 946 947 O

Inclusion NCT03862625 0 9 O
Criteria NCT03862625 10 18 O
: NCT03862625 19 20 O

- NCT03862625 24 25 O
the NCT03862625 27 30 O
participant NCT03862625 31 42 O
6 NCT03862625 44 45 B-Eq-Value
to NCT03862625 46 48 B-Eq-Operator___Eq-Operator-Value:BETWEEN
15 NCT03862625 50 52 B-Eq-Value
years NCT03862625 53 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03862625 59 61 O
age NCT03862625 62 65 O
during NCT03862625 66 72 O
inclusion NCT03862625 73 82 O

- NCT03862625 85 86 O
the NCT03862625 88 91 O
participant NCT03862625 92 103 O
is NCT03862625 104 106 O
diagnosed NCT03862625 107 116 O
as NCT03862625 117 119 O
cerebral NCT03862625 120 128 B-Condition-Name
palsy NCT03862625 129 134 I-Condition-Name
by NCT03862625 135 137 O
a NCT03862625 138 139 O
specialist NCT03862625 140 150 O

- NCT03862625 153 154 O
the NCT03862625 156 159 O
participant NCT03862625 160 171 O
's NCT03862625 171 173 O
Cobb NCT03862625 174 178 B-Observation-Name___Observation-Type-Value:measurement
angle NCT03862625 179 184 I-Observation-Name___Observation-Type-Value:measurement
is NCT03862625 185 187 O
between NCT03862625 188 195 B-Eq-Operator___Eq-Operator-Value:BETWEEN
10 NCT03862625 197 199 B-Eq-Value
- NCT03862625 200 201 O
40 NCT03862625 203 205 B-Eq-Value
degrees NCT03862625 206 213 B-Eq-Unit
. NCT03862625 214 215 O
( NCT03862625 217 218 O
Cobb NCT03862625 219 223 B-Observation-Name___Observation-Type-Value:measurement
angle NCT03862625 224 229 I-Observation-Name___Observation-Type-Value:measurement
above NCT03862625 230 235 B-Eq-Operator___Eq-Operator-Value:GT
40 NCT03862625 237 239 B-Eq-Value
degrees NCT03862625 240 247 B-Eq-Unit
and NCT03862625 248 251 O
patients NCT03862625 252 260 O
whose NCT03862625 261 266 O
parents NCT03862625 267 274 O
have NCT03862625 275 279 O
not NCT03862625 280 283 O
accepted NCT03862625 284 292 O
the NCT03862625 293 296 O
operation NCT03862625 297 306 B-Procedure-Name
) NCT03862625 307 308 O

- NCT03862625 312 313 O
There NCT03862625 315 320 O
is NCT03862625 321 323 O
no NCT03862625 324 326 O
history NCT03862625 327 334 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862625 335 337 O
operation NCT03862625 338 347 B-Procedure-Name
due NCT03862625 348 351 O
to NCT03862625 352 354 O
scoliosis NCT03862625 355 364 B-Condition-Name
or NCT03862625 365 367 O
the NCT03862625 368 371 O
decision NCT03862625 372 380 O
of NCT03862625 381 383 O
the NCT03862625 384 387 O
operation NCT03862625 388 397 B-Procedure-Name
has NCT03862625 398 401 O
not NCT03862625 402 405 O
been NCT03862625 406 410 O
accepted NCT03862625 411 419 O
by NCT03862625 420 422 O
the NCT03862625 423 426 O
patients NCT03862625 427 435 O
and NCT03862625 436 439 O
their NCT03862625 440 445 O
parents NCT03862625 446 453 O

- NCT03862625 456 457 O
the NCT03862625 459 462 O
participant NCT03862625 463 474 O
is NCT03862625 475 477 O
Gross NCT03862625 478 483 B-Observation-Name
Motor NCT03862625 484 489 I-Observation-Name
Function NCT03862625 490 498 I-Observation-Name
Classification NCT03862625 499 513 I-Observation-Name
System NCT03862625 514 520 I-Observation-Name
Level NCT03862625 521 526 O
4 NCT03862625 528 529 B-Eq-Value
or NCT03862625 530 532 O
5 NCT03862625 534 535 B-Eq-Value

- NCT03862625 539 540 O
Lack NCT03862625 542 546 B-Condition-Name
of NCT03862625 547 549 I-Condition-Name
contracture NCT03862625 550 561 I-Condition-Name
to NCT03862625 562 564 O
prevent NCT03862625 565 572 O
sitting NCT03862625 573 580 B-Observation-Name
in NCT03862625 581 583 O
the NCT03862625 584 587 O
lower NCT03862625 588 593 O
extremity NCT03862625 594 603 O

- NCT03862625 606 607 O
Parents NCT03862625 609 616 O
agree NCT03862625 617 622 O
to NCT03862625 623 625 O
participate NCT03862625 626 637 O
in NCT03862625 638 640 O
the NCT03862625 641 644 O
intensive NCT03862625 645 654 O
therapy NCT03862625 655 662 B-Procedure-Name
program NCT03862625 663 670 O
and NCT03862625 671 674 O
stop NCT03862625 675 679 O
the NCT03862625 680 683 O
therapeutic NCT03862625 684 695 B-Procedure-Name
interventions NCT03862625 696 709 I-Procedure-Name
for NCT03862625 710 713 O
scoliosis NCT03862625 714 723 B-Condition-Name
and NCT03862625 724 727 O
lower NCT03862625 728 733 O
extremities NCT03862625 734 745 O
during NCT03862625 746 752 O
the NCT03862625 753 756 O
3 NCT03862625 758 759 B-Eq-Value
- NCT03862625 760 761 O
month NCT03862625 762 767 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
follow NCT03862625 768 774 O
- NCT03862625 775 776 O
up NCT03862625 777 779 O
period NCT03862625 780 786 O

Exclusion NCT03862625 787 796 O
Criteria NCT03862625 797 805 O
: NCT03862625 806 807 O

- NCT03862625 811 812 O
Having NCT03862625 814 820 O
a NCT03862625 821 822 O
history NCT03862625 823 830 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862625 831 833 O
operation NCT03862625 834 843 B-Procedure-Name
due NCT03862625 844 847 O
to NCT03862625 848 850 O
scoliosis NCT03862625 851 860 B-Condition-Name

- NCT03862625 863 864 O
The NCT03862625 866 869 O
deformity NCT03862625 870 879 B-Condition-Name
in NCT03862625 880 882 O
the NCT03862625 883 886 O
spine NCT03862625 887 892 O
is NCT03862625 893 895 O
rigid NCT03862625 896 901 O

- NCT03862625 904 905 O
If NCT03862625 907 909 O
the NCT03862625 910 913 O
curvature NCT03862625 914 923 B-Observation-Name___Observation-Type-Value:measurement
measured NCT03862625 924 932 O
in NCT03862625 933 935 O
the NCT03862625 936 939 O
spine NCT03862625 940 945 O
is NCT03862625 946 948 O
less NCT03862625 949 953 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03862625 954 958 I-Eq-Operator___Eq-Operator-Value:LT
10 NCT03862625 960 962 B-Eq-Value
degrees NCT03862625 963 970 B-Eq-Unit
or NCT03862625 971 973 O
more NCT03862625 974 978 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03862625 979 983 I-Eq-Operator___Eq-Operator-Value:GT
40 NCT03862625 985 987 B-Eq-Value
degrees NCT03862625 988 995 B-Eq-Unit
in NCT03862625 996 998 O
the NCT03862625 999 1002 O
patients NCT03862625 1003 1011 O
whose NCT03862625 1012 1017 O
operation NCT03862625 1018 1027 B-Procedure-Name
decision NCT03862625 1028 1036 O
is NCT03862625 1037 1039 O
accepted NCT03862625 1040 1048 O
by NCT03862625 1049 1051 O
the NCT03862625 1052 1055 O
family NCT03862625 1056 1062 O

- NCT03862625 1065 1066 O
Having NCT03862625 1068 1074 O
a NCT03862625 1075 1076 O
seating NCT03862625 1077 1084 B-Condition-Name
modification NCT03862625 1085 1097 I-Condition-Name
applied NCT03862625 1098 1105 O
at NCT03862625 1106 1108 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862625 1109 1114 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03862625 1116 1117 B-Eq-Value
year NCT03862625 1118 1122 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
before NCT03862625 1123 1129 O
being NCT03862625 1130 1135 O
included NCT03862625 1136 1144 O
in NCT03862625 1145 1147 O
the NCT03862625 1148 1151 O
study NCT03862625 1152 1157 O

- NCT03862625 1160 1161 O
Having NCT03862625 1163 1169 O
a NCT03862625 1170 1171 O
spasticity NCT03862625 1172 1182 B-Condition-Name
and NCT03862625 1183 1186 O
contracture NCT03862625 1187 1198 B-Condition-Name
to NCT03862625 1199 1201 O
prevent NCT03862625 1202 1209 O
sitting NCT03862625 1210 1217 B-Observation-Name
in NCT03862625 1218 1220 O
the NCT03862625 1221 1224 O
hip NCT03862625 1225 1228 O
and NCT03862625 1229 1232 O
knee NCT03862625 1233 1237 O
joint NCT03862625 1238 1243 O

- NCT03862625 1246 1247 O
Having NCT03862625 1249 1255 O
a NCT03862625 1256 1257 O
pressure NCT03862625 1258 1266 B-Condition-Name
ulcer NCT03862625 1267 1272 I-Condition-Name
to NCT03862625 1273 1275 O
prevent NCT03862625 1276 1283 O
the NCT03862625 1284 1287 O
patient NCT03862625 1288 1295 O
from NCT03862625 1296 1300 O
sitting NCT03862625 1301 1308 B-Observation-Name

- NCT03862625 1311 1312 O
the NCT03862625 1314 1317 O
participant NCT03862625 1318 1329 O
has NCT03862625 1330 1333 O
comorbidity NCT03862625 1334 1345 B-Condition-Name
that NCT03862625 1346 1350 O
is NCT03862625 1351 1353 O
not NCT03862625 1354 1357 O
related NCT03862625 1358 1365 O
about NCT03862625 1366 1371 O
cerebral NCT03862625 1372 1380 B-Condition-Name
palsy NCT03862625 1381 1386 I-Condition-Name

- NCT03862625 1389 1390 O
Having NCT03862625 1392 1398 O
epileptic NCT03862625 1399 1408 B-Condition-Name
seizures NCT03862625 1409 1417 I-Condition-Name
not NCT03862625 1418 1421 O
controlled NCT03862625 1422 1432 B-Stability___Stability-Value:stable

- NCT03862625 1435 1436 O
Having NCT03862625 1438 1444 O
bone NCT03862625 1445 1449 B-Procedure-Name
operations NCT03862625 1450 1460 I-Procedure-Name
for NCT03862625 1461 1464 O
hip NCT03862625 1465 1468 O
joints NCT03862625 1469 1475 O

Inclusion NCT03863275 0 9 O
Criteria NCT03863275 10 18 O
: NCT03863275 19 20 O

- NCT03863275 24 25 O
Boys NCT03863275 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:boy
and NCT03863275 32 35 O
girls NCT03863275 36 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:girl
from NCT03863275 42 46 O
7 NCT03863275 48 49 B-Eq-Value
to NCT03863275 50 52 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03863275 54 56 B-Eq-Value
years NCT03863275 57 62 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863275 63 66 O
with NCT03863275 67 71 O
class NCT03863275 72 77 B-Eq-Unit
II NCT03863275 78 80 B-Eq-Value
skeletal NCT03863275 81 89 B-Condition-Name
classification NCT03863275 90 104 I-Condition-Name
attending NCT03863275 105 114 O
a NCT03863275 115 116 O
consultation NCT03863275 117 129 O
in NCT03863275 130 132 O
the NCT03863275 133 136 O
dental NCT03863275 137 143 B-Location___Location-Value:clinic
clinic NCT03863275 144 150 I-Location___Location-Value:clinic
of NCT03863275 151 153 O
the NCT03863275 154 157 O
UNICIEO NCT03863275 158 165 O
foundation NCT03863275 166 176 O
, NCT03863275 177 178 O
to NCT03863275 179 181 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
be NCT03863275 182 184 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
fitted NCT03863275 185 191 O
with NCT03863275 192 196 O
myofunctional NCT03863275 197 210 B-Procedure-Name
apparatus NCT03863275 211 220 I-Procedure-Name
type NCT03863275 221 225 O
Sn NCT03863275 226 228 O
1 NCT03863275 229 230 O

Exclusion NCT03863275 231 240 O
Criteria NCT03863275 241 249 O
: NCT03863275 250 251 O

- NCT03863275 255 256 O
Patients NCT03863275 258 266 O
who NCT03863275 267 270 O
have NCT03863275 271 275 O
had NCT03863275 276 279 O
previous NCT03863275 280 288 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
orthopedic NCT03863275 289 299 B-Procedure-Name
treatment NCT03863275 300 309 I-Procedure-Name

- NCT03863275 312 313 O
Patients NCT03863275 315 323 O
with NCT03863275 324 328 O
signs NCT03863275 329 334 O
of NCT03863275 335 337 O
condyle NCT03863275 338 345 O
injuries NCT03863275 346 354 B-Condition-Name

- NCT03863275 357 358 O
Patients NCT03863275 360 368 O
of NCT03863275 369 371 O
Pierre NCT03863275 372 378 O
Robin NCT03863275 379 384 O
or NCT03863275 385 387 O
any NCT03863275 388 391 O
form NCT03863275 392 396 O
of NCT03863275 397 399 O
cleft NCT03863275 400 405 B-Condition-Name

- NCT03863275 408 409 O
Patients NCT03863275 411 419 O
with NCT03863275 420 424 O
syndromes NCT03863275 425 434 B-Condition-Name
that NCT03863275 435 439 O
associate NCT03863275 440 449 O
craniofacial NCT03863275 450 462 B-Condition-Name
anomalies NCT03863275 463 472 I-Condition-Name
and NCT03863275 473 476 O
muscle NCT03863275 477 483 B-Condition-Name
alterations NCT03863275 484 495 I-Condition-Name
. NCT03863275 496 497 O

Inclusion NCT03861884 0 9 O
Criteria NCT03861884 10 18 O
: NCT03861884 19 20 O

1 NCT03861884 25 26 O
. NCT03861884 26 27 O
Ability NCT03861884 29 36 O
to NCT03861884 37 39 O
give NCT03861884 40 44 O
informed NCT03861884 45 53 O
consent NCT03861884 54 61 O
. NCT03861884 62 63 O

2 NCT03861884 68 69 O
. NCT03861884 69 70 O
Either NCT03861884 72 78 O
pathological NCT03861884 79 91 B-Procedure-Name
, NCT03861884 92 93 O
genetic NCT03861884 94 101 B-Procedure-Name
or NCT03861884 102 104 O
imaging NCT03861884 105 112 B-Procedure-Name
biomarker NCT03861884 113 122 O
evidence NCT03861884 123 131 O
to NCT03861884 132 134 O
suggest NCT03861884 135 142 O
Fronto NCT03861884 143 149 B-Condition-Name
- NCT03861884 150 151 I-Condition-Name
temporal NCT03861884 152 160 I-Condition-Name
Lobar NCT03861884 161 166 I-Condition-Name
Degeneration NCT03861884 167 179 I-Condition-Name
, NCT03861884 180 181 O
Alzheimer NCT03861884 182 191 B-Condition-Name
's NCT03861884 191 193 I-Condition-Name
Disease NCT03861884 194 201 I-Condition-Name
or NCT03861884 202 204 O
Vascular NCT03861884 205 213 O
Cognitive NCT03861884 214 223 B-Condition-Name
Impairment NCT03861884 224 234 I-Condition-Name
, NCT03861884 235 236 O
or NCT03861884 237 239 O
defined NCT03861884 240 247 O
clinical NCT03861884 248 256 O
diagnoses NCT03861884 257 266 O
. NCT03861884 267 268 O

Exclusion NCT03861884 270 279 O
Criteria NCT03861884 280 288 O
: NCT03861884 289 290 O

1 NCT03861884 295 296 O
. NCT03861884 296 297 O
Lack NCT03861884 299 303 B-Condition-Name
of NCT03861884 304 306 I-Condition-Name
mental NCT03861884 307 313 I-Condition-Name
capacity NCT03861884 314 322 I-Condition-Name
to NCT03861884 323 325 O
consent NCT03861884 326 333 O
to NCT03861884 334 336 O
study NCT03861884 337 342 O
involvement NCT03861884 343 354 O
. NCT03861884 355 356 O

2 NCT03861884 361 362 O
. NCT03861884 362 363 O
Not NCT03861884 365 368 O
speaking NCT03861884 369 377 O
English NCT03861884 378 385 B-Language
before NCT03861884 386 392 O
age NCT03861884 393 396 O
5 NCT03861884 398 399 B-Eq-Value
years NCT03861884 400 405 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03861884 406 407 O

3 NCT03861884 412 413 O
. NCT03861884 413 414 O
Learning NCT03861884 416 424 B-Condition-Name
disability NCT03861884 425 435 I-Condition-Name
. NCT03861884 436 437 O

4 NCT03861884 442 443 O
. NCT03861884 443 444 O
MRI NCT03861884 446 449 B-Procedure-Name
contraindications NCT03861884 450 467 O

Inclusion NCT03866655 0 9 O
Criteria NCT03866655 10 18 O
: NCT03866655 19 20 O

- NCT03866655 24 25 O
female NCT03866655 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03866655 36 37 O
adult NCT03866655 39 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03866655 45 46 O
age NCT03866655 47 50 O
18 NCT03866655 52 54 B-Eq-Value
years NCT03866655 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03866655 61 63 B-Eq-Operator___Eq-Operator-Value:GTEQ
over NCT03866655 64 68 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03866655 69 70 O

- NCT03866655 74 75 O
newly NCT03866655 77 82 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnosed NCT03866655 83 92 O

- NCT03866655 95 96 O
early NCT03866655 98 103 O
breast NCT03866655 104 110 O
cancer NCT03866655 111 117 B-Condition-Name

- NCT03866655 120 121 O
first NCT03866655 123 128 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
primary NCT03866655 129 136 O
cancer NCT03866655 137 143 B-Condition-Name
diagnosis NCT03866655 144 153 O

- NCT03866655 156 157 O
under NCT03866655 159 164 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03866655 165 174 O
at NCT03866655 175 177 O
one NCT03866655 178 181 O
of NCT03866655 182 184 O
the NCT03866655 185 188 O
participating NCT03866655 189 202 B-Location
sites NCT03866655 203 208 I-Location
. NCT03866655 209 210 O

Exclusion NCT03866655 212 221 O
Criteria NCT03866655 222 230 O
: NCT03866655 231 232 O

- NCT03866655 236 237 O
have NCT03866655 239 243 O
started NCT03866655 244 251 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
anti NCT03866655 252 256 O
- NCT03866655 257 258 O
cancer NCT03866655 259 265 B-Condition-Name
treatment NCT03866655 266 275 O

- NCT03866655 278 279 O
private NCT03866655 281 288 O
patients NCT03866655 289 297 O

- NCT03866655 300 301 O
unable NCT03866655 303 309 O
to NCT03866655 310 312 O
read NCT03866655 313 317 O
or NCT03866655 318 320 O
write NCT03866655 321 326 O
in NCT03866655 327 329 O
English NCT03866655 330 337 B-Language

- NCT03866655 340 341 O
significant NCT03866655 343 354 B-Severity___Severity-Value:severe
cognitive NCT03866655 355 364 B-Condition-Name
impairment NCT03866655 365 375 I-Condition-Name

- NCT03866655 378 379 O
poor NCT03866655 381 385 B-Condition-Name
mental NCT03866655 386 392 I-Condition-Name
health NCT03866655 393 399 I-Condition-Name

- NCT03866655 402 403 O
do NCT03866655 405 407 O
not NCT03866655 408 411 O
have NCT03866655 412 416 O
access NCT03866655 417 423 O
to NCT03866655 424 426 O
the NCT03866655 427 430 O
internet NCT03866655 431 439 O

- NCT03866655 442 443 O
confirmed NCT03866655 445 454 O
metastatic NCT03866655 455 465 B-Condition-Name
disease NCT03866655 466 473 I-Condition-Name

Inclusion NCT03864718 0 9 O
Criteria NCT03864718 10 18 O
: NCT03864718 19 20 O

- NCT03864718 24 25 O
complex NCT03864718 27 34 O
anal NCT03864718 35 39 B-Condition-Name
fistula NCT03864718 40 47 I-Condition-Name
according NCT03864718 48 57 O
to NCT03864718 58 60 O
Parks NCT03864718 61 66 O
classification NCT03864718 67 81 O

Exclusion NCT03864718 82 91 O
Criteria NCT03864718 92 100 O
: NCT03864718 101 102 O

- NCT03864718 106 107 O
Non NCT03864718 109 112 O
cryptoglandular NCT03864718 113 128 B-Condition-Name
fistulas NCT03864718 129 137 I-Condition-Name

- NCT03864718 140 141 O
acute NCT03864718 143 148 B-Severity___Severity-Value:severe
sepsis NCT03864718 149 155 B-Condition-Name

- NCT03864718 158 159 O
inflammatory NCT03864718 161 173 B-Condition-Name
bowel NCT03864718 174 179 I-Condition-Name
diseases NCT03864718 180 188 I-Condition-Name

- NCT03864718 191 192 O
simple NCT03864718 194 200 B-Condition-Name
fistulas NCT03864718 201 209 I-Condition-Name
( NCT03864718 210 211 O
defined NCT03864718 212 219 O
as NCT03864718 220 222 O
subcutaneous NCT03864718 223 235 O
, NCT03864718 236 237 O
intersphincteric NCT03864718 238 254 O
and NCT03864718 255 258 O
low NCT03864718 259 262 O
transsphincteric NCT03864718 263 279 O
fistula NCT03864718 280 287 B-Condition-Name
) NCT03864718 288 289 O

- NCT03864718 293 294 O
pregnant NCT03864718 296 304 B-Condition-Name
patients NCT03864718 305 313 O

- NCT03864718 316 317 O
ASA NCT03864718 319 322 B-Condition-Name
IV NCT03864718 323 325 B-Eq-Value

- NCT03864718 328 329 O
patients NCT03864718 331 339 O
< NCT03864718 340 341 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03864718 343 345 B-Eq-Value

- NCT03864718 349 350 O
immunocompromised NCT03864718 352 369 B-Condition-Name

- NCT03864718 372 373 O
patients NCT03864718 375 383 O
who NCT03864718 384 387 O
refused NCT03864718 388 395 O
consent NCT03864718 396 403 O
. NCT03864718 404 405 O

Inclusion NCT03868644 0 9 O
Criteria NCT03868644 10 18 O
: NCT03868644 19 20 O

- NCT03868644 23 24 O
Youth NCT03868644 25 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
previously NCT03868644 31 41 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participated NCT03868644 42 54 O
in NCT03868644 55 57 O
an NCT03868644 58 60 O
earlier NCT03868644 61 68 O
study NCT03868644 69 74 O
by NCT03868644 75 77 O
Duflo NCT03868644 78 83 O
, NCT03868644 84 85 O
Dupas NCT03868644 86 91 O
and NCT03868644 92 95 O
Kremer NCT03868644 96 102 O
in NCT03868644 103 105 O
328 NCT03868644 107 110 O
primary NCT03868644 111 118 O
schools NCT03868644 119 126 O
in NCT03868644 127 129 O
the NCT03868644 130 133 O
same NCT03868644 134 138 O
study NCT03868644 139 144 O
site NCT03868644 145 149 O
in NCT03868644 150 152 O
Western NCT03868644 153 160 B-Location___Location-Value:residence
Province NCT03868644 161 169 I-Location___Location-Value:residence
, NCT03868644 170 171 I-Location___Location-Value:residence
Kenya NCT03868644 172 177 I-Location___Location-Value:residence
who NCT03868644 178 181 O
consent NCT03868644 182 189 O
to NCT03868644 190 192 O

participate NCT03868644 193 204 O
. NCT03868644 205 206 O

Exclusion NCT03868644 208 217 O
Criteria NCT03868644 218 226 O
: NCT03868644 227 228 O

- NCT03868644 231 232 O
Youth NCT03868644 233 238 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
sampled NCT03868644 239 246 O
for NCT03868644 247 250 O
the NCT03868644 251 254 O
study NCT03868644 255 260 O
who NCT03868644 261 264 O
do NCT03868644 265 267 O
not NCT03868644 268 271 O
consent NCT03868644 272 279 O
to NCT03868644 280 282 O
participate NCT03868644 283 294 O
. NCT03868644 295 296 O

Inclusion NCT03863847 0 9 O
Criteria NCT03863847 10 18 O
: NCT03863847 19 20 O

- NCT03863847 24 25 O
Patients NCT03863847 27 35 O
suffering NCT03863847 36 45 O
from NCT03863847 46 50 O
chronic NCT03863847 51 58 O
pain NCT03863847 59 63 B-Condition-Name
due NCT03863847 64 67 O
to NCT03863847 68 70 O
tennis NCT03863847 71 77 B-Condition-Name
elbow NCT03863847 78 83 I-Condition-Name
for NCT03863847 84 87 O
at NCT03863847 88 90 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03863847 91 96 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03863847 98 99 B-Eq-Value
months NCT03863847 100 106 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863847 109 110 O
A NCT03863847 112 113 O
clinical NCT03863847 114 122 O
diagnosis NCT03863847 123 132 O
of NCT03863847 133 135 O
chronic NCT03863847 136 143 O
lateral NCT03863847 144 151 B-Condition-Name
epicondylalgia NCT03863847 152 166 I-Condition-Name
, NCT03863847 167 168 O

- NCT03863847 172 173 O
Pain NCT03863847 175 179 B-Condition-Name
associated NCT03863847 180 190 O
with NCT03863847 191 195 O
functional NCT03863847 196 206 B-Observation-Name
activities NCT03863847 207 217 I-Observation-Name
such NCT03863847 218 222 O
as NCT03863847 223 225 O
gripping NCT03863847 226 234 B-Observation-Name
and NCT03863847 235 238 O
pain NCT03863847 239 243 B-Condition-Name
with NCT03863847 244 248 O
resisted NCT03863847 249 257 B-Observation-Name
contraction NCT03863847 258 269 I-Observation-Name
of NCT03863847 270 272 O
the NCT03863847 273 276 O
wrist NCT03863847 277 282 O
extensors NCT03863847 283 292 O
or NCT03863847 293 295 O
extensor NCT03863847 296 304 O
carpi NCT03863847 305 310 O
radialis NCT03863847 311 319 B-Condition-Name
brevis NCT03863847 320 326 I-Condition-Name
, NCT03863847 327 328 O
or NCT03863847 329 331 O
with NCT03863847 332 336 O
passive NCT03863847 337 344 B-Observation-Name
stretching NCT03863847 345 355 I-Observation-Name
of NCT03863847 356 358 O
the NCT03863847 359 362 O
wrist NCT03863847 363 368 O
extensors NCT03863847 369 378 O
. NCT03863847 379 380 O

Exclusion NCT03863847 382 391 O
Criteria NCT03863847 392 400 O
: NCT03863847 401 402 O

- NCT03863847 406 407 O
Clinical NCT03863847 409 417 O
diagnosis NCT03863847 418 427 O
of NCT03863847 428 430 O
chronic NCT03863847 431 438 O
lateral NCT03863847 439 446 B-Condition-Name
epicondylalgia NCT03863847 447 461 I-Condition-Name
on NCT03863847 462 464 O
both NCT03863847 465 469 O
sides NCT03863847 470 475 O
, NCT03863847 476 477 O
cervicothoracic NCT03863847 478 493 O
spinal NCT03863847 494 500 O
pathology NCT03863847 501 510 B-Condition-Name
, NCT03863847 511 512 O
other NCT03863847 513 518 O
upper NCT03863847 519 524 O
limb NCT03863847 525 529 O
musculoskeletal NCT03863847 530 545 B-Condition-Name
disorders NCT03863847 546 555 I-Condition-Name
or NCT03863847 556 558 O
neurological NCT03863847 559 571 B-Condition-Name
disorders NCT03863847 572 581 I-Condition-Name

- NCT03863847 584 585 O
Pregnancy NCT03863847 587 596 B-Condition-Name

- NCT03863847 599 600 O
Drug NCT03863847 602 606 B-Condition-Name
addiction NCT03863847 607 616 I-Condition-Name
defined NCT03863847 617 624 O
as NCT03863847 625 627 O
the NCT03863847 628 631 O
use NCT03863847 632 635 O
of NCT03863847 636 638 O
cannabis NCT03863847 639 647 B-Drug-Name
, NCT03863847 648 649 O
opioids NCT03863847 650 657 B-Drug-Name
or NCT03863847 658 660 O
other NCT03863847 661 666 O
drugs NCT03863847 667 672 O

- NCT03863847 675 676 O
Previous NCT03863847 678 686 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03863847 687 689 O
current NCT03863847 690 697 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
neurologic NCT03863847 698 708 O
, NCT03863847 709 710 O
musculoskeletal NCT03863847 711 726 O
or NCT03863847 727 729 O
mental NCT03863847 730 736 O
illnesses NCT03863847 737 746 B-Condition-Name
defined NCT03863847 747 754 O
as NCT03863847 755 757 O
an NCT03863847 758 760 O
on NCT03863847 761 763 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
- NCT03863847 764 765 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
going NCT03863847 766 771 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
systemic NCT03863847 772 780 O
condition NCT03863847 781 790 O

- NCT03863847 793 794 O
Lack NCT03863847 796 800 O
of NCT03863847 801 803 O
ability NCT03863847 804 811 B-Condition-Name
to NCT03863847 812 814 I-Condition-Name
cooperate NCT03863847 815 824 I-Condition-Name

- NCT03863847 827 828 O
Current NCT03863847 830 837 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03863847 838 841 O
of NCT03863847 842 844 O
medications NCT03863847 845 856 O
that NCT03863847 857 861 O
may NCT03863847 862 865 O
affect NCT03863847 866 872 B-Stability___Stability-Value:change
the NCT03863847 873 876 O
trial NCT03863847 877 882 O
e NCT03863847 883 884 O
. NCT03863847 885 886 O
g NCT03863847 887 888 O
. NCT03863847 889 890 O
analgesics NCT03863847 892 902 B-Drug-Name
, NCT03863847 903 904 O
anti NCT03863847 905 909 B-Drug-Name
- NCT03863847 910 911 I-Drug-Name
inflammatory NCT03863847 912 924 I-Drug-Name
drugs NCT03863847 925 930 I-Drug-Name

- NCT03863847 933 934 O
Consumption NCT03863847 936 947 O
of NCT03863847 948 950 O
alcohol NCT03863847 951 958 B-Drug-Name
, NCT03863847 959 960 O
caffeine NCT03863847 961 969 B-Drug-Name
, NCT03863847 970 971 O
nicotine NCT03863847 972 980 B-Drug-Name
or NCT03863847 981 983 O
painkillers NCT03863847 984 995 B-Drug-Name
throughout NCT03863847 996 1006 O
the NCT03863847 1007 1010 O
study NCT03863847 1011 1016 O
period NCT03863847 1017 1023 O

- NCT03863847 1026 1027 O
Past NCT03863847 1029 1033 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03863847 1034 1041 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863847 1042 1044 O
chronic NCT03863847 1045 1052 O
pain NCT03863847 1053 1057 B-Condition-Name
, NCT03863847 1058 1059 O
neurological NCT03863847 1060 1072 O
or NCT03863847 1073 1075 O
psychiatric NCT03863847 1076 1087 O
conditions NCT03863847 1088 1098 O

- NCT03863847 1101 1102 O
Participation NCT03863847 1104 1117 O
in NCT03863847 1118 1120 O
other NCT03863847 1121 1126 O
pain NCT03863847 1127 1131 B-Condition-Name
trials NCT03863847 1132 1138 O
throughout NCT03863847 1139 1149 O
the NCT03863847 1150 1153 O
study NCT03863847 1154 1159 O
period NCT03863847 1160 1166 O
and NCT03863847 1167 1170 O
one NCT03863847 1171 1174 B-Eq-Value
month NCT03863847 1175 1180 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03863847 1181 1186 O
to NCT03863847 1187 1189 O
participation NCT03863847 1190 1203 O

- NCT03863847 1206 1207 O
Participation NCT03863847 1209 1222 O
in NCT03863847 1223 1225 O
more NCT03863847 1226 1230 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03863847 1231 1235 I-Eq-Operator___Eq-Operator-Value:GT
two NCT03863847 1236 1239 B-Eq-Value
sessions NCT03863847 1240 1248 O
of NCT03863847 1249 1251 O
muscle NCT03863847 1252 1258 B-Observation-Name___Observation-Type-Value:social-habit
training NCT03863847 1259 1267 I-Observation-Name___Observation-Type-Value:social-habit
exercises NCT03863847 1268 1277 O
per NCT03863847 1278 1281 O
week NCT03863847 1282 1286 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
involving NCT03863847 1287 1296 O
the NCT03863847 1297 1300 O
upper NCT03863847 1301 1306 O
limb NCT03863847 1307 1311 O
and NCT03863847 1312 1315 O
/ NCT03863847 1316 1317 O
or NCT03863847 1318 1320 O
lower NCT03863847 1321 1326 O
back NCT03863847 1327 1331 O

- NCT03863847 1334 1335 O
Evidence NCT03863847 1337 1345 O
of NCT03863847 1346 1348 O
other NCT03863847 1349 1354 O
sources NCT03863847 1355 1362 O
of NCT03863847 1363 1365 O
elbow NCT03863847 1366 1371 O
pain NCT03863847 1372 1376 B-Condition-Name
such NCT03863847 1377 1381 O
as NCT03863847 1382 1384 O
exacerbation NCT03863847 1385 1397 B-Stability___Stability-Value:change
of NCT03863847 1398 1400 O
pain NCT03863847 1401 1405 B-Condition-Name
with NCT03863847 1406 1410 O
neck NCT03863847 1411 1415 B-Observation-Name
movement NCT03863847 1416 1424 I-Observation-Name
or NCT03863847 1425 1427 O
manual NCT03863847 1428 1434 O
examination NCT03863847 1435 1446 B-Procedure-Name

- NCT03863847 1449 1450 O
Sensory NCT03863847 1452 1459 B-Condition-Name
disturbances NCT03863847 1460 1472 I-Condition-Name

- NCT03863847 1475 1476 O
History NCT03863847 1478 1485 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03863847 1486 1488 O
fractures NCT03863847 1489 1498 B-Condition-Name

- NCT03863847 1501 1502 O
Elbow NCT03863847 1504 1509 B-Procedure-Name
surgery NCT03863847 1510 1517 I-Procedure-Name

- NCT03863847 1520 1521 O
Contraindications NCT03863847 1523 1540 O
to NCT03863847 1541 1543 O
the NCT03863847 1544 1547 O
use NCT03863847 1548 1551 O
of NCT03863847 1552 1554 O
TMS NCT03863847 1555 1558 B-Procedure-Name

Inclusion NCT03868735 0 9 O
Criteria NCT03868735 10 18 O
: NCT03868735 19 20 O

- NCT03868735 24 25 O
Orally NCT03868735 27 33 O
intubated NCT03868735 34 43 B-Procedure-Name
patient NCT03868735 44 51 O
with NCT03868735 52 56 O
endotracheal NCT03868735 57 69 B-Procedure-Name
tube NCT03868735 70 74 I-Procedure-Name

- NCT03868735 77 78 O
Mechanically NCT03868735 80 92 B-Procedure-Name
ventilated NCT03868735 93 103 I-Procedure-Name
less NCT03868735 104 108 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868735 109 113 I-Eq-Operator___Eq-Operator-Value:LT
24 NCT03868735 115 117 B-Eq-Value
hours NCT03868735 118 123 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
prior NCT03868735 124 129 O
to NCT03868735 130 132 O
enrollment NCT03868735 133 143 O

Exclusion NCT03868735 144 153 O
Criteria NCT03868735 154 162 O
: NCT03868735 163 164 O

- NCT03868735 168 169 O
Less NCT03868735 171 175 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868735 176 180 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03868735 182 184 B-Eq-Value
years NCT03868735 185 190 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03868735 191 194 O

- NCT03868735 197 198 O
Tracheostomy NCT03868735 200 212 B-Procedure-Name
tube NCT03868735 213 217 I-Procedure-Name

- NCT03868735 220 221 O
Extracorporeal NCT03868735 223 237 B-Procedure-Name
membrane NCT03868735 238 246 I-Procedure-Name
oxygenation NCT03868735 247 258 I-Procedure-Name

- NCT03868735 261 262 O
Transfer NCT03868735 264 272 B-Encounter-Type___Encounter-Type-Value:transfer
from NCT03868735 273 277 O
outside NCT03868735 278 285 O
hospital NCT03868735 286 294 B-Location___Location-Value:hospital
with NCT03868735 295 299 O
more NCT03868735 300 304 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03868735 305 309 I-Eq-Operator___Eq-Operator-Value:GT
24 NCT03868735 311 313 B-Eq-Value
hours NCT03868735 314 319 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03868735 320 322 O
mechanical NCT03868735 323 333 B-Procedure-Name
ventilation NCT03868735 334 345 I-Procedure-Name

Inclusion NCT03869359 0 9 O
Criteria NCT03869359 10 18 O
: NCT03869359 19 20 O

- NCT03869359 24 25 O
Adult NCT03869359 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03869359 33 41 O
with NCT03869359 42 46 O
IBS NCT03869359 47 50 B-Condition-Name
according NCT03869359 51 60 O
to NCT03869359 61 63 O
Rome NCT03869359 64 68 O
IV NCT03869359 69 71 O
criteria NCT03869359 72 80 O

Exclusion NCT03869359 81 90 O
Criteria NCT03869359 91 99 O
: NCT03869359 100 101 O

- NCT03869359 105 106 O
allergy NCT03869359 108 115 O
or NCT03869359 116 118 O
documented NCT03869359 119 129 O
intolerance NCT03869359 130 141 B-Condition-Name
to NCT03869359 142 144 O
food NCT03869359 145 149 B-Allergy-Name
, NCT03869359 150 151 O

- NCT03869359 155 156 O
severe NCT03869359 158 164 B-Severity___Severity-Value:severe
cardiovascular NCT03869359 165 179 O
, NCT03869359 180 181 O
hepatic NCT03869359 182 189 O
, NCT03869359 190 191 O
neurological NCT03869359 192 204 O
or NCT03869359 205 207 O
psychiatric NCT03869359 208 219 O
disease NCT03869359 220 227 B-Condition-Name

- NCT03869359 230 231 O
serious NCT03869359 233 240 B-Severity___Severity-Value:severe
gastrointestinal NCT03869359 241 257 B-Condition-Name
disease NCT03869359 258 265 I-Condition-Name
: NCT03869359 266 267 O
including NCT03869359 268 277 O
celiac NCT03869359 278 284 B-Condition-Name
disease NCT03869359 285 292 I-Condition-Name
and NCT03869359 293 296 O
inflammatory NCT03869359 297 309 B-Condition-Name
bowel NCT03869359 310 315 I-Condition-Name
diseases NCT03869359 316 324 I-Condition-Name
( NCT03869359 325 326 O
IBD NCT03869359 327 330 B-Condition-Name
) NCT03869359 331 332 O
, NCT03869359 334 335 O

- NCT03869359 339 340 O
diabetes NCT03869359 342 350 B-Condition-Name

- NCT03869359 353 354 O
bowel NCT03869359 356 361 B-Condition-Name
dysfunction NCT03869359 362 373 I-Condition-Name
related NCT03869359 374 381 O
to NCT03869359 382 384 O
previous NCT03869359 385 393 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgery NCT03869359 394 401 B-Procedure-Name

- NCT03869359 404 405 O
pregnant NCT03869359 407 415 B-Condition-Name
or NCT03869359 416 418 O
lactating NCT03869359 419 428 B-Condition-Name
women NCT03869359 429 434 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03869359 437 438 O
usage NCT03869359 440 445 O
of NCT03869359 446 448 O
antibiotics NCT03869359 449 460 B-Drug-Name
within NCT03869359 461 467 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03869359 469 470 B-Eq-Value
weeks NCT03869359 471 476 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03869359 477 483 O
inclusion NCT03869359 484 493 O

- NCT03869359 496 497 O
strict NCT03869359 499 505 O
avoidance NCT03869359 506 515 O
of NCT03869359 516 518 O
foods NCT03869359 519 524 O

Inclusion NCT03864133 0 9 O
Criteria NCT03864133 10 18 O
: NCT03864133 19 20 O

- NCT03864133 24 25 O
Adults NCT03864133 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
age NCT03864133 34 37 O
55 NCT03864133 39 41 B-Eq-Value
- NCT03864133 42 43 B-Eq-Operator___Eq-Operator-Value:BETWEEN
90 NCT03864133 45 47 B-Eq-Value
years NCT03864133 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
with NCT03864133 54 58 O
visual NCT03864133 59 65 O
significant NCT03864133 66 77 B-Severity___Severity-Value:severe
cataracts NCT03864133 78 87 B-Condition-Name
in NCT03864133 88 90 O
one NCT03864133 91 94 O
or NCT03864133 95 97 O
both NCT03864133 98 102 O
eyes NCT03864133 103 107 O
. NCT03864133 108 109 O

- NCT03864133 113 114 O
Healthy NCT03864133 116 123 B-Condition-Name
individuals NCT03864133 124 135 O
able NCT03864133 136 140 O
to NCT03864133 141 143 O
tolerate NCT03864133 144 152 O
outpatient NCT03864133 153 163 B-Encounter-Type___Encounter-Type-Value:outpatient
cataract NCT03864133 164 172 B-Procedure-Name
surgery NCT03864133 173 180 I-Procedure-Name
under NCT03864133 181 186 O
local NCT03864133 187 192 B-Procedure-Name
anesthesia NCT03864133 193 203 I-Procedure-Name
via NCT03864133 204 207 O
either NCT03864133 208 214 O
phacoemulsification NCT03864133 215 234 B-Procedure-Name
and NCT03864133 235 238 O
/ NCT03864133 239 240 O
or NCT03864133 241 243 O
femtosecond NCT03864133 244 255 O
assisted NCT03864133 256 264 O
cataract NCT03864133 265 273 B-Procedure-Name
surgery NCT03864133 274 281 I-Procedure-Name
. NCT03864133 282 283 O
Well NCT03864133 285 289 B-Stability___Stability-Value:stable
- NCT03864133 290 291 I-Stability___Stability-Value:stable
controlled NCT03864133 292 302 I-Stability___Stability-Value:stable
diabetes NCT03864133 303 311 B-Condition-Name
, NCT03864133 312 313 O
hypertension NCT03864133 314 326 B-Condition-Name
will NCT03864133 327 331 O
be NCT03864133 332 334 O
included NCT03864133 335 343 O
. NCT03864133 344 345 O

- NCT03864133 349 350 O
Females NCT03864133 352 359 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03864133 360 362 O
childbearing NCT03864133 363 375 B-Condition-Name
potential NCT03864133 376 385 O
must NCT03864133 386 390 O
agree NCT03864133 391 396 O
to NCT03864133 397 399 O
use NCT03864133 400 403 O
a NCT03864133 404 405 O
reliable NCT03864133 406 414 O
method NCT03864133 415 421 O
of NCT03864133 422 424 O
birth NCT03864133 425 430 B-Procedure-Name
control NCT03864133 431 438 I-Procedure-Name
while NCT03864133 439 444 O
participating NCT03864133 445 458 O
in NCT03864133 459 461 O
this NCT03864133 462 466 O
study NCT03864133 467 472 O
. NCT03864133 473 474 O
Reliable NCT03864133 476 484 O
methods NCT03864133 485 492 O
of NCT03864133 493 495 O
birth NCT03864133 496 501 B-Procedure-Name
control NCT03864133 502 509 I-Procedure-Name
are NCT03864133 510 513 O
: NCT03864133 514 515 O
abstinence NCT03864133 516 526 B-Condition-Name
, NCT03864133 527 528 O
oral NCT03864133 529 533 B-Drug-Name
contraceptives NCT03864133 534 548 I-Drug-Name
, NCT03864133 549 550 O
intrauterine NCT03864133 551 563 B-Procedure-Name
device NCT03864133 564 570 I-Procedure-Name
( NCT03864133 571 572 O
IUD NCT03864133 573 576 B-Procedure-Name
) NCT03864133 577 578 O
, NCT03864133 580 581 O
DepoProvera NCT03864133 582 593 B-Procedure-Name
, NCT03864133 594 595 O
tubal NCT03864133 596 601 B-Procedure-Name
ligation NCT03864133 602 610 I-Procedure-Name
or NCT03864133 611 613 O
vasectomy NCT03864133 614 623 B-Procedure-Name
of NCT03864133 624 626 O
the NCT03864133 627 630 O
partner NCT03864133 631 638 O
( NCT03864133 639 640 O
with NCT03864133 641 645 O
confirmed NCT03864133 646 655 O
negative NCT03864133 656 664 B-Polarity___Polarity-Value:negative
sperm NCT03864133 665 670 B-Observation-Name___Observation-Type-Value:lab
counts NCT03864133 671 677 I-Observation-Name___Observation-Type-Value:lab
) NCT03864133 678 679 O
in NCT03864133 680 682 O
monogamous NCT03864133 683 693 B-Condition-Name
relationship NCT03864133 694 706 I-Condition-Name
( NCT03864133 707 708 O
same NCT03864133 709 713 O
partner NCT03864133 714 721 O
) NCT03864133 722 723 O
. NCT03864133 725 726 O
An NCT03864133 728 730 O
acceptable NCT03864133 731 741 O
, NCT03864133 742 743 O
although NCT03864133 744 752 O
less NCT03864133 753 757 O
reliable NCT03864133 758 766 O
, NCT03864133 767 768 O
method NCT03864133 769 775 O
involves NCT03864133 776 784 O
the NCT03864133 785 788 O
careful NCT03864133 789 796 O
use NCT03864133 797 800 O
of NCT03864133 801 803 O
condoms NCT03864133 804 811 B-Procedure-Name
and NCT03864133 812 815 O
spermicidal NCT03864133 816 827 B-Procedure-Name
foam NCT03864133 828 832 O
or NCT03864133 833 835 O
gel NCT03864133 836 839 O
and NCT03864133 840 843 O
/ NCT03864133 844 845 O
or NCT03864133 846 848 O
cervical NCT03864133 849 857 B-Procedure-Name
cap NCT03864133 858 861 O
or NCT03864133 862 864 O
sponge NCT03864133 865 871 O
. NCT03864133 872 873 O
A NCT03864133 875 876 O
pregnancy NCT03864133 877 886 B-Observation-Name___Observation-Type-Value:lab
test NCT03864133 887 891 I-Observation-Name___Observation-Type-Value:lab
is NCT03864133 892 894 O
required NCT03864133 895 903 O
at NCT03864133 904 906 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03864133 907 912 I-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03864133 914 916 B-Eq-Value
days NCT03864133 917 921 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
from NCT03864133 922 926 O
the NCT03864133 927 930 O
last NCT03864133 931 935 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
normal NCT03864133 936 942 B-Polarity___Polarity-Value:normal
menstrual NCT03864133 943 952 B-Condition-Name
period NCT03864133 953 959 I-Condition-Name
, NCT03864133 960 961 O
if NCT03864133 962 964 O
the NCT03864133 965 968 O
patient NCT03864133 969 976 O
is NCT03864133 977 979 O
a NCT03864133 980 981 O
sexually NCT03864133 982 990 B-Condition-Name
active NCT03864133 991 997 I-Condition-Name
female NCT03864133 998 1004 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03864133 1005 1007 O
childbearing NCT03864133 1008 1020 B-Condition-Name
potential NCT03864133 1021 1030 I-Condition-Name
. NCT03864133 1031 1032 O

Exclusion NCT03864133 1034 1043 O
Criteria NCT03864133 1044 1052 O
: NCT03864133 1053 1054 O

- NCT03864133 1058 1059 O
Allergy NCT03864133 1061 1068 O
to NCT03864133 1069 1071 O
Phenylephrine NCT03864133 1072 1085 B-Drug-Name
or NCT03864133 1086 1088 O
NSAIDs NCT03864133 1089 1095 B-Drug-Name
. NCT03864133 1096 1097 O

- NCT03864133 1101 1102 O
Inability NCT03864133 1104 1113 O
to NCT03864133 1114 1116 O
sit NCT03864133 1117 1120 B-Observation-Name
steady NCT03864133 1121 1127 O
and NCT03864133 1128 1131 O
upright NCT03864133 1132 1139 O
for NCT03864133 1140 1143 O
the NCT03864133 1144 1147 O
Optical NCT03864133 1148 1155 B-Procedure-Name
Coherence NCT03864133 1156 1165 I-Procedure-Name
Tomography NCT03864133 1166 1176 I-Procedure-Name
( NCT03864133 1177 1178 O
OCT NCT03864133 1179 1182 B-Procedure-Name
) NCT03864133 1183 1184 O
. NCT03864133 1186 1187 O

- NCT03864133 1191 1192 O
Complications NCT03864133 1194 1207 O
during NCT03864133 1208 1214 O
surgery NCT03864133 1215 1222 B-Procedure-Name
, NCT03864133 1223 1224 O
including NCT03864133 1225 1234 O
posterior NCT03864133 1235 1244 O
capsular NCT03864133 1245 1253 B-Condition-Name
rupture NCT03864133 1254 1261 I-Condition-Name
, NCT03864133 1262 1263 O
vitreous NCT03864133 1264 1272 B-Condition-Name
loss NCT03864133 1273 1277 I-Condition-Name
, NCT03864133 1278 1279 O
zonular NCT03864133 1280 1287 B-Procedure-Name
dialysis NCT03864133 1288 1296 I-Procedure-Name
, NCT03864133 1297 1298 O
or NCT03864133 1299 1301 O
iris NCT03864133 1302 1306 O
trauma NCT03864133 1307 1313 B-Condition-Name
. NCT03864133 1314 1315 O

- NCT03864133 1319 1320 O
Macular NCT03864133 1322 1329 B-Observation-Name___Observation-Type-Value:measurement
thickness NCT03864133 1330 1339 I-Observation-Name___Observation-Type-Value:measurement
above NCT03864133 1340 1345 B-Eq-Operator___Eq-Operator-Value:GT
300 NCT03864133 1347 1350 B-Eq-Value
microns NCT03864133 1351 1358 B-Eq-Unit
at NCT03864133 1359 1361 O
baseline NCT03864133 1362 1370 O

- NCT03864133 1373 1374 O
Currently NCT03864133 1376 1385 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03864133 1386 1392 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03864133 1393 1394 O
prostaglandin NCT03864133 1395 1408 B-Drug-Name
analogue NCT03864133 1409 1417 I-Drug-Name

- NCT03864133 1420 1421 O
Presence NCT03864133 1423 1431 O
of NCT03864133 1432 1434 O
an NCT03864133 1435 1437 O
epiretinal NCT03864133 1438 1448 B-Condition-Name
membrane NCT03864133 1449 1457 I-Condition-Name
on NCT03864133 1458 1460 O
the NCT03864133 1461 1464 O
pre NCT03864133 1465 1468 O
operative NCT03864133 1469 1478 O
OCT NCT03864133 1479 1482 B-Procedure-Name
. NCT03864133 1483 1484 O

- NCT03864133 1488 1489 O
Retained NCT03864133 1491 1499 O
lens NCT03864133 1500 1504 B-Condition-Name
fragment NCT03864133 1505 1513 I-Condition-Name
post NCT03864133 1514 1518 O
- NCT03864133 1519 1520 O
operatively NCT03864133 1521 1532 B-Procedure-Name
. NCT03864133 1533 1534 O

- NCT03864133 1538 1539 O
Inability NCT03864133 1541 1550 O
to NCT03864133 1551 1553 O
return NCT03864133 1554 1560 O
for NCT03864133 1561 1564 O
follow NCT03864133 1565 1571 O
appointments NCT03864133 1572 1584 O

- NCT03864133 1587 1588 O
Female NCT03864133 1590 1596 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
patients NCT03864133 1597 1605 O
who NCT03864133 1606 1609 O
are NCT03864133 1610 1613 O
pregnant NCT03864133 1614 1622 B-Condition-Name
, NCT03864133 1623 1624 O
lactating NCT03864133 1625 1634 B-Condition-Name
or NCT03864133 1635 1637 O
planning NCT03864133 1638 1646 O
to NCT03864133 1647 1649 O
become NCT03864133 1650 1656 O
pregnant NCT03864133 1657 1665 B-Condition-Name
during NCT03864133 1666 1672 O
the NCT03864133 1673 1676 O
course NCT03864133 1677 1683 O
of NCT03864133 1684 1686 O
treatment NCT03864133 1687 1696 O
. NCT03864133 1697 1698 O

Inclusion NCT03868709 0 9 O
Criteria NCT03868709 10 18 O
: NCT03868709 19 20 O

1 NCT03868709 25 26 O
. NCT03868709 26 27 O
Age NCT03868709 29 32 O
of NCT03868709 33 35 O
50 NCT03868709 37 39 B-Eq-Value
years NCT03868709 40 45 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03868709 46 48 B-Eq-Operator___Eq-Operator-Value:GTEQ
over NCT03868709 49 53 I-Eq-Operator___Eq-Operator-Value:GTEQ
; NCT03868709 53 54 O

2 NCT03868709 58 59 O
. NCT03868709 59 60 O
Scheduled NCT03868709 62 71 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03868709 72 74 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03868709 75 82 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
open NCT03868709 83 87 O
or NCT03868709 88 90 O
laparoscope NCT03868709 91 102 O
assisted NCT03868709 103 111 O
upper NCT03868709 112 117 O
abdominal NCT03868709 118 127 O
or NCT03868709 128 130 O
intrathoracic NCT03868709 131 144 O
surgery NCT03868709 145 152 B-Procedure-Name
; NCT03868709 152 153 O

3 NCT03868709 157 158 O
. NCT03868709 158 159 O
The NCT03868709 161 164 O
expected NCT03868709 165 173 O
duration NCT03868709 174 182 O
of NCT03868709 183 185 O
surgery NCT03868709 186 193 B-Procedure-Name
is NCT03868709 194 196 O
2 NCT03868709 198 199 B-Eq-Value
hours NCT03868709 200 205 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03868709 206 208 B-Eq-Operator___Eq-Operator-Value:GTEQ
longer NCT03868709 209 215 I-Eq-Operator___Eq-Operator-Value:GTEQ
; NCT03868709 215 216 O

4 NCT03868709 220 221 O
. NCT03868709 221 222 O
Identified NCT03868709 224 234 O
at NCT03868709 235 237 O
high NCT03868709 238 242 B-Polarity___Polarity-Value:high
risk NCT03868709 243 247 O
of NCT03868709 248 250 O
PPCs NCT03868709 251 255 B-Condition-Name
according NCT03868709 256 265 O
to NCT03868709 266 268 O
the NCT03868709 269 272 O
ARISCAT NCT03868709 273 280 B-Observation-Name___Observation-Type-Value:clinical-score
risk NCT03868709 281 285 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03868709 286 291 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03868709 292 293 O
ARISCAT NCT03868709 294 301 B-Observation-Name___Observation-Type-Value:clinical-score
predictive NCT03868709 302 312 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03868709 313 318 I-Observation-Name___Observation-Type-Value:clinical-score
≥ NCT03868709 319 320 B-Eq-Operator___Eq-Operator-Value:GTEQ
45 NCT03868709 322 324 B-Eq-Value
) NCT03868709 325 326 O
. NCT03868709 328 329 O

Exclusion NCT03868709 331 340 O
Criteria NCT03868709 341 349 O
: NCT03868709 350 351 O

1 NCT03868709 356 357 O
. NCT03868709 357 358 O
American NCT03868709 360 368 B-Condition-Name
Society NCT03868709 369 376 I-Condition-Name
of NCT03868709 377 379 I-Condition-Name
Anesthesiologists NCT03868709 380 397 I-Condition-Name
( NCT03868709 398 399 O
ASA NCT03868709 400 403 B-Condition-Name
) NCT03868709 404 405 O
physical NCT03868709 406 414 O
classification NCT03868709 415 429 B-Eq-Unit
≥ NCT03868709 430 431 B-Eq-Operator___Eq-Operator-Value:GTEQ
IV NCT03868709 432 434 B-Eq-Value
or NCT03868709 435 437 O
the NCT03868709 438 441 O
expected NCT03868709 442 450 B-Observation-Name
survival NCT03868709 451 459 I-Observation-Name
duration NCT03868709 460 468 O
≤ NCT03868709 469 470 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03868709 472 474 B-Eq-Value
h NCT03868709 475 476 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
; NCT03868709 476 477 O

2 NCT03868709 481 482 O
. NCT03868709 482 483 O
Pre NCT03868709 485 488 O
operative NCT03868709 489 498 B-Procedure-Name
history NCT03868709 499 506 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868709 507 509 O
prostatic NCT03868709 510 519 B-Condition-Name
hypertrophy NCT03868709 520 531 I-Condition-Name
or NCT03868709 532 534 O
glaucoma NCT03868709 535 543 B-Condition-Name
; NCT03868709 543 544 O

3 NCT03868709 548 549 O
. NCT03868709 549 550 O
History NCT03868709 552 559 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868709 560 562 O
myocardial NCT03868709 563 573 B-Condition-Name
infarction NCT03868709 574 584 I-Condition-Name
, NCT03868709 585 586 O
severe NCT03868709 587 593 B-Severity___Severity-Value:severe
heart NCT03868709 594 599 B-Condition-Name
dysfunction NCT03868709 600 611 I-Condition-Name
( NCT03868709 612 613 O
New NCT03868709 614 617 B-Condition-Name
York NCT03868709 618 622 I-Condition-Name
Heart NCT03868709 623 628 I-Condition-Name
Association NCT03868709 629 640 I-Condition-Name
functional NCT03868709 641 651 I-Condition-Name
classification NCT03868709 652 666 O
≥ NCT03868709 667 668 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03868709 670 671 B-Eq-Value
) NCT03868709 672 673 O
or NCT03868709 674 676 O
tachyarrhythmia NCT03868709 677 692 B-Condition-Name
within NCT03868709 693 699 B-Eq-Operator___Eq-Operator-Value:LTEQ
one NCT03868709 700 703 B-Eq-Value
year NCT03868709 704 708 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03868709 708 709 O

4 NCT03868709 713 714 O
. NCT03868709 714 715 O
Inhalation NCT03868709 717 727 O
of NCT03868709 728 730 O
β NCT03868709 731 732 B-Drug-Name
2 NCT03868709 733 734 I-Drug-Name
- NCT03868709 735 736 I-Drug-Name
receptor NCT03868709 737 745 I-Drug-Name
activator NCT03868709 746 755 I-Drug-Name
, NCT03868709 756 757 O
M NCT03868709 758 759 B-Drug-Name
- NCT03868709 760 761 I-Drug-Name
receptor NCT03868709 762 770 I-Drug-Name
blockers NCT03868709 771 779 I-Drug-Name
and NCT03868709 780 783 O
/ NCT03868709 784 785 O
or NCT03868709 786 788 O
glucocorticoids NCT03868709 789 804 B-Drug-Name
within NCT03868709 805 811 B-Eq-Operator___Eq-Operator-Value:LTEQ
one NCT03868709 812 815 B-Eq-Value
month NCT03868709 816 821 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03868709 822 828 O
surgery NCT03868709 829 836 B-Procedure-Name
; NCT03868709 836 837 O

5 NCT03868709 841 842 O
. NCT03868709 842 843 O
Severe NCT03868709 845 851 B-Severity___Severity-Value:severe
renal NCT03868709 852 857 B-Condition-Name
dysfunction NCT03868709 858 869 I-Condition-Name
( NCT03868709 870 871 O
requirement NCT03868709 872 883 O
of NCT03868709 884 886 O
renal NCT03868709 887 892 B-Procedure-Name
replacement NCT03868709 893 904 I-Procedure-Name
therapy NCT03868709 905 912 I-Procedure-Name
) NCT03868709 913 914 O
or NCT03868709 915 917 O
severe NCT03868709 918 924 B-Severity___Severity-Value:severe
hepatic NCT03868709 925 932 B-Condition-Name
dysfunction NCT03868709 933 944 I-Condition-Name
( NCT03868709 945 946 O
Child NCT03868709 947 952 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03868709 953 954 I-Observation-Name___Observation-Type-Value:clinical-score
Pugh NCT03868709 955 959 I-Observation-Name___Observation-Type-Value:clinical-score
grade NCT03868709 960 965 B-Eq-Unit
C NCT03868709 966 967 B-Eq-Value
) NCT03868709 968 969 O
; NCT03868709 970 971 O

6 NCT03868709 975 976 O
. NCT03868709 976 977 O
History NCT03868709 979 986 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868709 987 989 O
acute NCT03868709 990 995 B-Severity___Severity-Value:severe
stroke NCT03868709 996 1002 B-Condition-Name
within NCT03868709 1003 1009 B-Eq-Operator___Eq-Operator-Value:LTEQ
three NCT03868709 1010 1015 B-Eq-Value
months NCT03868709 1016 1022 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03868709 1023 1029 O
surgery NCT03868709 1030 1037 B-Procedure-Name
; NCT03868709 1037 1038 O

7 NCT03868709 1042 1043 O
. NCT03868709 1043 1044 O
Refuse NCT03868709 1046 1052 O
to NCT03868709 1053 1055 O
participate NCT03868709 1056 1067 O
in NCT03868709 1068 1070 O
the NCT03868709 1071 1074 O
study NCT03868709 1075 1080 O
or NCT03868709 1081 1083 O
unable NCT03868709 1084 1090 O
to NCT03868709 1091 1093 O
cooperate NCT03868709 1094 1103 O
with NCT03868709 1104 1108 O
the NCT03868709 1109 1112 O
inhalation NCT03868709 1113 1123 B-Procedure-Name
therapy NCT03868709 1124 1131 I-Procedure-Name
; NCT03868709 1131 1132 O

8 NCT03868709 1136 1137 O
. NCT03868709 1137 1138 O
Participation NCT03868709 1140 1153 O
in NCT03868709 1154 1156 O
other NCT03868709 1157 1162 O
clinical NCT03868709 1163 1171 O
trial NCT03868709 1172 1177 O
during NCT03868709 1178 1184 O
the NCT03868709 1185 1188 O
last NCT03868709 1189 1193 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03868709 1194 1199 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03868709 1200 1202 O
within NCT03868709 1203 1209 O
the NCT03868709 1210 1213 O
six NCT03868709 1214 1217 B-Eq-Value
half NCT03868709 1218 1222 B-Eq-Unit
- NCT03868709 1223 1224 I-Eq-Unit
life NCT03868709 1225 1229 I-Eq-Unit
periods NCT03868709 1230 1237 O
of NCT03868709 1238 1240 O
the NCT03868709 1241 1244 O
study NCT03868709 1245 1250 O
drug NCT03868709 1251 1255 O
used NCT03868709 1256 1260 O
in NCT03868709 1261 1263 O
the NCT03868709 1264 1267 O
last NCT03868709 1268 1272 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
trial NCT03868709 1273 1278 O
. NCT03868709 1279 1280 O

Inclusion NCT03860194 0 9 O
Criteria NCT03860194 10 18 O
: NCT03860194 19 20 O

- NCT03860194 24 25 O
Older NCT03860194 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:elderly
adults NCT03860194 33 39 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:elderly
( NCT03860194 40 41 O
≥ NCT03860194 43 44 B-Eq-Operator___Eq-Operator-Value:GTEQ
65 NCT03860194 46 48 B-Eq-Value
years NCT03860194 49 54 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03860194 55 56 O

- NCT03860194 60 61 O
Subject NCT03860194 63 70 O
has NCT03860194 71 74 O
lower NCT03860194 75 80 B-Observation-Name___Observation-Type-Value:measurement
appendicular NCT03860194 81 93 I-Observation-Name___Observation-Type-Value:measurement
muscle NCT03860194 94 100 I-Observation-Name___Observation-Type-Value:measurement
mass NCT03860194 101 105 I-Observation-Name___Observation-Type-Value:measurement
index NCT03860194 106 111 I-Observation-Name___Observation-Type-Value:measurement
( NCT03860194 112 113 O
AMMI NCT03860194 114 118 B-Observation-Name
) NCT03860194 119 120 O
( NCT03860194 121 122 O
< NCT03860194 124 125 B-Eq-Operator___Eq-Operator-Value:LT
7 NCT03860194 127 128 B-Eq-Value
kg NCT03860194 129 131 B-Eq-Unit
/ NCT03860194 132 133 O
m^ NCT03860194 134 136 B-Eq-Unit
2 NCT03860194 137 138 I-Eq-Unit
in NCT03860194 139 141 O
men NCT03860194 142 145 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
; NCT03860194 145 146 O
< NCT03860194 147 148 B-Eq-Operator___Eq-Operator-Value:LT
5.7 NCT03860194 150 153 B-Eq-Value
kg NCT03860194 154 156 B-Eq-Unit
/ NCT03860194 157 158 O
m^ NCT03860194 159 161 B-Eq-Unit
2 NCT03860194 162 163 I-Eq-Unit
in NCT03860194 164 166 O
women NCT03860194 167 172 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
) NCT03860194 173 174 O
using NCT03860194 175 180 O
Bioelectrical NCT03860194 181 194 B-Procedure-Name
impedance NCT03860194 195 204 I-Procedure-Name
analysis NCT03860194 205 213 I-Procedure-Name
( NCT03860194 214 215 O
BIA NCT03860194 216 219 O
, NCT03860194 220 221 O
TANITA NCT03860194 222 228 O
BC NCT03860194 229 231 O
- NCT03860194 232 233 O
418 NCT03860194 235 238 O
® NCT03860194 239 240 O
, NCT03860194 241 242 O
Tokyo NCT03860194 243 248 O
, NCT03860194 249 250 O
Japan NCT03860194 251 256 O
) NCT03860194 257 258 O

- NCT03860194 262 263 O
Subject NCT03860194 265 272 O
has NCT03860194 273 276 O
lower NCT03860194 277 282 B-Observation-Name___Observation-Type-Value:measurement
handgrip NCT03860194 283 291 I-Observation-Name___Observation-Type-Value:measurement
strength NCT03860194 292 300 I-Observation-Name___Observation-Type-Value:measurement
( NCT03860194 301 302 O
< NCT03860194 304 305 B-Eq-Operator___Eq-Operator-Value:LT
26 NCT03860194 307 309 B-Eq-Value
kg NCT03860194 310 312 B-Eq-Unit
in NCT03860194 313 315 O
men NCT03860194 316 319 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
; NCT03860194 319 320 O
< NCT03860194 321 322 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03860194 324 326 B-Eq-Value
kg NCT03860194 327 329 B-Eq-Unit
in NCT03860194 330 332 O
women NCT03860194 333 338 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
) NCT03860194 339 340 O
using NCT03860194 341 346 O
dynamometer NCT03860194 347 358 B-Procedure-Name
( NCT03860194 359 360 O
CAMRY NCT03860194 361 366 O
® NCT03860194 366 367 O
, NCT03860194 368 369 O
Zhongshan NCT03860194 370 379 O
, NCT03860194 380 381 O
Guangdong NCT03860194 382 391 O
) NCT03860194 392 393 O
or NCT03860194 394 396 O
slowly NCT03860194 397 403 B-Polarity___Polarity-Value:low
gait NCT03860194 404 408 B-Observation-Name___Observation-Type-Value:measurement
speed NCT03860194 409 414 I-Observation-Name___Observation-Type-Value:measurement
( NCT03860194 415 416 O
< NCT03860194 418 419 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03860194 421 422 B-Eq-Value
m NCT03860194 423 424 B-Eq-Unit
/ NCT03860194 425 426 O
s NCT03860194 427 428 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:second
) NCT03860194 429 430 O

Exclusion NCT03860194 432 441 O
Criteria NCT03860194 442 450 O
: NCT03860194 451 452 O

- NCT03860194 456 457 O
Subject NCT03860194 459 466 O
's NCT03860194 466 468 O
life NCT03860194 469 473 B-Observation-Name
expectancy NCT03860194 474 484 I-Observation-Name
was NCT03860194 485 488 O
shorter NCT03860194 489 496 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03860194 497 501 I-Eq-Operator___Eq-Operator-Value:LT
6 NCT03860194 503 504 B-Eq-Value
months NCT03860194 505 511 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03860194 514 515 O
Nursing NCT03860194 517 524 B-Location___Location-Value:residence
home NCT03860194 525 529 I-Location___Location-Value:residence
resident NCT03860194 530 538 O

- NCT03860194 541 542 O
Subject NCT03860194 544 551 O
has NCT03860194 552 555 O
the NCT03860194 556 559 O
history NCT03860194 560 567 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860194 568 570 O
kidney NCT03860194 571 577 B-Condition-Name
failure NCT03860194 578 585 I-Condition-Name

- NCT03860194 588 589 O
Subject NCT03860194 591 598 O
has NCT03860194 599 602 O
the NCT03860194 603 606 O
history NCT03860194 607 614 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860194 615 617 O
liver NCT03860194 618 623 B-Condition-Name
failure NCT03860194 624 631 I-Condition-Name

- NCT03860194 634 635 O
Subject NCT03860194 637 644 O
has NCT03860194 645 648 O
the NCT03860194 649 652 O
history NCT03860194 653 660 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860194 661 663 O
diabetes NCT03860194 664 672 B-Condition-Name
mellitus NCT03860194 673 681 I-Condition-Name

- NCT03860194 684 685 O
Subject NCT03860194 687 694 O
has NCT03860194 695 698 O
resistance NCT03860194 699 709 B-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03860194 710 718 I-Observation-Name___Observation-Type-Value:social-habit
habit NCT03860194 719 724 O
. NCT03860194 725 726 O

Inclusion NCT03867604 0 9 O
Criteria NCT03867604 10 18 O
: NCT03867604 19 20 O

- NCT03867604 24 25 O
20 NCT03867604 28 30 B-Eq-Value
- NCT03867604 31 32 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03867604 34 36 B-Eq-Value
years NCT03867604 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867604 43 46 O

- NCT03867604 49 50 O
diagnosed NCT03867604 52 61 O
as NCT03867604 62 64 O
a NCT03867604 65 66 O
myofascial NCT03867604 67 77 B-Condition-Name
pain NCT03867604 78 82 I-Condition-Name
syndrome NCT03867604 83 91 I-Condition-Name
at NCT03867604 92 94 O
upper NCT03867604 95 100 O
trapezium NCT03867604 101 110 O
muscle NCT03867604 111 117 O

- NCT03867604 120 121 O
trigger NCT03867604 123 130 B-Condition-Name
point NCT03867604 131 136 I-Condition-Name

- NCT03867604 139 140 O
taut NCT03867604 142 146 B-Condition-Name
band NCT03867604 147 151 I-Condition-Name

- NCT03867604 154 155 O
refer NCT03867604 157 162 O
pain NCT03867604 163 167 B-Condition-Name
while NCT03867604 168 173 O
taut NCT03867604 174 178 B-Condition-Name
band NCT03867604 179 183 I-Condition-Name
irritation NCT03867604 184 194 I-Condition-Name

Exclusion NCT03867604 195 204 O
Criteria NCT03867604 205 213 O
: NCT03867604 214 215 O

- NCT03867604 219 220 O
Cognitive NCT03867604 222 231 B-Condition-Name
impairment NCT03867604 232 242 I-Condition-Name
. NCT03867604 243 244 O

- NCT03867604 248 249 O
Post NCT03867604 251 255 O
operation NCT03867604 256 265 B-Procedure-Name
at NCT03867604 266 268 O
neck NCT03867604 269 273 O
and NCT03867604 274 277 O
shoulder NCT03867604 278 286 O
. NCT03867604 287 288 O

- NCT03867604 292 293 O
Nerve NCT03867604 295 300 B-Condition-Name
compression NCT03867604 301 312 I-Condition-Name
at NCT03867604 313 315 O
cervical NCT03867604 316 324 O
region NCT03867604 325 331 O
. NCT03867604 332 333 O

- NCT03867604 337 338 O
Could NCT03867604 340 345 O
not NCT03867604 346 349 O
receive NCT03867604 350 357 O
injection NCT03867604 358 367 B-Procedure-Name
therapy NCT03867604 368 375 I-Procedure-Name
, NCT03867604 376 377 O
history NCT03867604 378 385 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867604 386 388 O
fainting NCT03867604 389 397 B-Condition-Name
during NCT03867604 398 404 O
needling NCT03867604 405 413 B-Procedure-Name

Inclusion NCT03861507 0 9 O
Criteria NCT03861507 10 18 O
: NCT03861507 19 20 O

- NCT03861507 24 25 O
Male NCT03861507 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
, NCT03861507 32 33 O
aged NCT03861507 34 38 O
18 NCT03861507 40 42 B-Eq-Value
years NCT03861507 43 48 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03861507 49 51 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03861507 52 57 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03861507 60 61 O
Willing NCT03861507 63 70 O
to NCT03861507 71 73 O
provide NCT03861507 74 81 O
written NCT03861507 82 89 O
consent NCT03861507 90 97 O

- NCT03861507 100 101 O
Pathologically NCT03861507 103 117 B-Procedure-Name
confirmed NCT03861507 118 127 O
prostate NCT03861507 128 136 O
cancer NCT03861507 137 143 B-Condition-Name
on NCT03861507 144 146 O
previous NCT03861507 147 155 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
biopsy NCT03861507 156 162 B-Procedure-Name

- NCT03861507 165 166 O
Suitable NCT03861507 168 176 O
for NCT03861507 177 180 O
and NCT03861507 181 184 O
consenting NCT03861507 185 195 O
to NCT03861507 196 198 O
high NCT03861507 199 203 O
- NCT03861507 204 205 O
dose NCT03861507 206 210 O
- NCT03861507 211 212 O
rate NCT03861507 213 217 O
brachytherapy NCT03861507 218 231 B-Procedure-Name
for NCT03861507 232 235 O
treatment NCT03861507 236 245 O
as NCT03861507 246 248 O
standard NCT03861507 249 257 O
of NCT03861507 258 260 O
care NCT03861507 261 265 O
. NCT03861507 266 267 O

Exclusion NCT03861507 269 278 O
Criteria NCT03861507 279 287 O
: NCT03861507 288 289 O

- NCT03861507 293 294 O
• NCT03861507 296 297 O
Previous NCT03861507 298 306 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiotherapy NCT03861507 307 319 B-Procedure-Name
to NCT03861507 320 322 O
the NCT03861507 323 326 O
prostate NCT03861507 327 335 B-Condition-Name

Inclusion NCT03860584 0 9 O
Criteria NCT03860584 10 18 O
: NCT03860584 19 20 O

- NCT03860584 24 25 O
Serum NCT03860584 27 32 B-Observation-Name___Observation-Type-Value:lab
Glucose NCT03860584 33 40 I-Observation-Name___Observation-Type-Value:lab
100 NCT03860584 42 45 B-Eq-Value
- NCT03860584 46 47 B-Eq-Operator___Eq-Operator-Value:BETWEEN
126 NCT03860584 49 52 B-Eq-Value
mg NCT03860584 53 55 B-Eq-Unit
/ NCT03860584 56 57 O
dl NCT03860584 58 60 B-Eq-Unit

- NCT03860584 63 64 O
Waist NCT03860584 66 71 B-Observation-Name___Observation-Type-Value:measurement
C NCT03860584 72 73 I-Observation-Name___Observation-Type-Value:measurement
> NCT03860584 74 75 B-Eq-Operator___Eq-Operator-Value:GT
89 NCT03860584 77 79 B-Eq-Value
/ NCT03860584 80 81 O
102 NCT03860584 83 86 B-Eq-Value
cm NCT03860584 87 89 B-Eq-Unit
; NCT03860584 89 90 O
F NCT03860584 91 92 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
/ NCT03860584 93 94 O
M NCT03860584 95 96 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03860584 99 100 O
Serum NCT03860584 102 107 B-Observation-Name___Observation-Type-Value:lab
HDL NCT03860584 108 111 I-Observation-Name___Observation-Type-Value:lab
- NCT03860584 112 113 I-Observation-Name___Observation-Type-Value:lab
C NCT03860584 114 115 I-Observation-Name___Observation-Type-Value:lab
: NCT03860584 116 117 O
< NCT03860584 118 119 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03860584 121 123 B-Eq-Value
/ NCT03860584 124 125 O
40 NCT03860584 127 129 B-Eq-Value
mg NCT03860584 130 132 B-Eq-Unit
/ NCT03860584 133 134 O
dl NCT03860584 135 137 B-Eq-Unit
; NCT03860584 137 138 O
F NCT03860584 139 140 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
/ NCT03860584 141 142 O
M NCT03860584 143 144 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03860584 147 148 O
Serum NCT03860584 150 155 B-Observation-Name___Observation-Type-Value:lab
TG NCT03860584 156 158 I-Observation-Name___Observation-Type-Value:lab
: NCT03860584 159 160 O
> NCT03860584 161 162 B-Eq-Operator___Eq-Operator-Value:GT
150 NCT03860584 164 167 B-Eq-Value
mg NCT03860584 168 170 B-Eq-Unit
/ NCT03860584 171 172 O
dl NCT03860584 173 175 B-Eq-Unit

- NCT03860584 178 179 O
BP NCT03860584 181 183 B-Observation-Name___Observation-Type-Value:vital
> NCT03860584 184 185 B-Eq-Operator___Eq-Operator-Value:GT
130 NCT03860584 187 190 B-Eq-Value
/ NCT03860584 191 192 O
85 NCT03860584 194 196 B-Eq-Value
mmHg NCT03860584 197 201 B-Eq-Unit

- NCT03860584 204 205 O
Serum NCT03860584 207 212 B-Observation-Name___Observation-Type-Value:lab
Endotoxin NCT03860584 213 222 I-Observation-Name___Observation-Type-Value:lab
> NCT03860584 223 224 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03860584 226 228 B-Eq-Value
EU NCT03860584 229 231 B-Eq-Unit
/ NCT03860584 232 233 O
ml NCT03860584 234 236 B-Eq-Unit

Exclusion NCT03860584 237 246 O
Criteria NCT03860584 247 255 O
: NCT03860584 256 257 O

- NCT03860584 261 262 O
Unstable NCT03860584 264 272 B-Stability___Stability-Value:change
body NCT03860584 273 277 B-Observation-Name___Observation-Type-Value:vital
mass NCT03860584 278 282 I-Observation-Name___Observation-Type-Value:vital
( NCT03860584 283 284 O
± NCT03860584 286 287 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
2 NCT03860584 289 290 B-Eq-Value
kg NCT03860584 291 293 B-Eq-Unit
over NCT03860584 294 298 O
prior NCT03860584 299 304 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03860584 306 307 B-Eq-Value
- NCT03860584 308 309 O
mo NCT03860584 310 312 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03860584 313 314 O

- NCT03860584 318 319 O
Vegetarian NCT03860584 321 331 B-Condition-Name

- NCT03860584 334 335 O
Food NCT03860584 337 341 B-Allergy-Name
allergies NCT03860584 342 351 O
or NCT03860584 352 354 O
lactose NCT03860584 355 362 B-Condition-Name
intolerance NCT03860584 363 374 I-Condition-Name

- NCT03860584 377 378 O
User NCT03860584 380 384 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03860584 385 387 O
dietary NCT03860584 388 395 B-Drug-Name
supplements NCT03860584 396 407 I-Drug-Name
or NCT03860584 408 410 O
probiotics NCT03860584 411 421 B-Drug-Name
( NCT03860584 422 423 O
within NCT03860584 424 430 B-Eq-Operator___Eq-Operator-Value:LTEQ
past NCT03860584 431 435 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
1 NCT03860584 437 438 B-Eq-Value
- NCT03860584 439 440 O
mo NCT03860584 441 443 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03860584 444 445 O

- NCT03860584 449 450 O
Pregnancy NCT03860584 452 461 B-Condition-Name
, NCT03860584 462 463 O
lactation NCT03860584 464 473 B-Condition-Name
, NCT03860584 474 475 O
changes NCT03860584 476 483 B-Stability___Stability-Value:change
in NCT03860584 484 486 O
birth NCT03860584 487 492 B-Procedure-Name
control NCT03860584 493 500 I-Procedure-Name
( NCT03860584 501 502 O
within NCT03860584 503 509 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03860584 511 512 B-Eq-Value
- NCT03860584 513 514 O
mo NCT03860584 515 517 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03860584 518 519 O

- NCT03860584 523 524 O
Any NCT03860584 526 529 O
gastrointestinal NCT03860584 530 546 B-Condition-Name
disorders NCT03860584 547 556 I-Condition-Name

- NCT03860584 559 560 O
Chronic NCT03860584 562 569 O
diarrhea NCT03860584 570 578 B-Condition-Name

- NCT03860584 581 582 O
Smoker NCT03860584 584 590 B-Condition-Name

- NCT03860584 593 594 O
Excess NCT03860584 596 602 B-Polarity___Polarity-Value:high
alcohol NCT03860584 603 610 B-Observation-Name___Observation-Type-Value:social-habit
( NCT03860584 611 612 O
> NCT03860584 614 615 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03860584 617 618 B-Eq-Value
drinks NCT03860584 619 625 B-Eq-Unit
/ NCT03860584 626 627 O
d NCT03860584 628 629 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03860584 630 631 O

- NCT03860584 635 636 O
Excess NCT03860584 638 644 B-Polarity___Polarity-Value:high
aerobic NCT03860584 645 652 B-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03860584 653 661 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03860584 662 663 O
> NCT03860584 665 666 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03860584 668 669 B-Eq-Value
h NCT03860584 670 671 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
/ NCT03860584 672 673 O
wk NCT03860584 674 676 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03860584 677 678 O

- NCT03860584 682 683 O
Recent NCT03860584 685 691 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
antibiotic NCT03860584 692 702 B-Drug-Name
or NCT03860584 703 705 O
anti NCT03860584 706 710 B-Drug-Name
- NCT03860584 711 712 I-Drug-Name
inflammatory NCT03860584 713 725 I-Drug-Name
agent NCT03860584 726 731 I-Drug-Name
use NCT03860584 732 735 O

- NCT03860584 738 739 O
BP NCT03860584 741 743 B-Observation-Name___Observation-Type-Value:vital
> NCT03860584 744 745 B-Eq-Operator___Eq-Operator-Value:GT
140 NCT03860584 747 750 B-Eq-Value
/ NCT03860584 751 752 O
90 NCT03860584 754 756 B-Eq-Value
mmHg NCT03860584 757 761 B-Eq-Unit

Inclusion NCT03860220 0 9 O
Criteria NCT03860220 10 18 O
: NCT03860220 19 20 O

- NCT03860220 24 25 O
145 NCT03860220 28 31 B-Eq-Value
mmHg NCT03860220 32 36 B-Eq-Unit
≤ NCT03860220 37 38 B-Eq-Operator___Eq-Operator-Value:LTEQ
msSBP NCT03860220 39 44 B-Observation-Name___Observation-Type-Value:vital
≤ NCT03860220 45 46 B-Eq-Operator___Eq-Operator-Value:LTEQ
190 NCT03860220 48 51 B-Eq-Value
mmHg NCT03860220 52 56 B-Eq-Unit

- NCT03860220 59 60 O
Triglycerides NCT03860220 62 75 B-Observation-Name___Observation-Type-Value:lab
< NCT03860220 76 77 B-Eq-Operator___Eq-Operator-Value:LT
500 NCT03860220 79 82 B-Eq-Value
mg NCT03860220 83 85 B-Eq-Unit
/ NCT03860220 86 87 O
dL NCT03860220 88 90 B-Eq-Unit

- NCT03860220 93 94 O
LDL NCT03860220 96 99 B-Observation-Name___Observation-Type-Value:lab
- NCT03860220 100 101 I-Observation-Name___Observation-Type-Value:lab
C NCT03860220 102 103 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03860220 104 105 B-Eq-Operator___Eq-Operator-Value:LTEQ
250 NCT03860220 107 110 B-Eq-Value
mg NCT03860220 111 113 B-Eq-Unit
/ NCT03860220 114 115 O
dL NCT03860220 116 118 B-Eq-Unit

Exclusion NCT03860220 119 128 O
Criteria NCT03860220 129 137 O
: NCT03860220 138 139 O

- NCT03860220 143 144 O
sSBP NCT03860220 146 150 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03860220 151 152 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03860220 154 156 B-Eq-Value
mmHg NCT03860220 157 161 B-Eq-Unit
and NCT03860220 162 165 O
sDBP NCT03860220 166 170 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03860220 171 172 B-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03860220 174 176 B-Eq-Value
mmHg NCT03860220 177 181 B-Eq-Temporal-Unit

- NCT03860220 184 185 O
symptomatic NCT03860220 187 198 O
orthostatic NCT03860220 199 210 O
hypotension NCT03860220 211 222 B-Condition-Name
and NCT03860220 223 226 O
secondary NCT03860220 227 236 O
/ NCT03860220 237 238 O
iatrogenic NCT03860220 239 249 O
hypertension NCT03860220 250 262 B-Condition-Name
and NCT03860220 263 266 O
dyslipidemia NCT03860220 267 279 B-Condition-Name

- NCT03860220 282 283 O
history NCT03860220 285 292 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860220 293 295 O
moderate NCT03860220 296 304 B-Severity___Severity-Value:moderate
to NCT03860220 305 307 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03860220 308 314 B-Severity___Severity-Value:severe
cerebral NCT03860220 315 323 B-Condition-Name
ischemia NCT03860220 324 332 I-Condition-Name
, NCT03860220 333 334 O
cerebral NCT03860220 335 343 B-Condition-Name
hemorrhage NCT03860220 344 354 I-Condition-Name
, NCT03860220 355 356 O
transient NCT03860220 357 366 B-Condition-Name
ischemic NCT03860220 367 375 I-Condition-Name
attack NCT03860220 376 382 I-Condition-Name
, NCT03860220 383 384 O
myocardial NCT03860220 385 395 B-Condition-Name
infarction NCT03860220 396 406 I-Condition-Name
, NCT03860220 407 408 O
or NCT03860220 409 411 O
unstable NCT03860220 412 420 B-Stability___Stability-Value:change
angina NCT03860220 421 427 B-Condition-Name
in NCT03860220 428 430 O
the NCT03860220 431 434 O
past NCT03860220 435 439 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03860220 441 442 B-Eq-Value
months NCT03860220 443 449 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03860220 449 450 O
severe NCT03860220 451 457 B-Severity___Severity-Value:severe
heart NCT03860220 458 463 B-Condition-Name
failure NCT03860220 464 471 I-Condition-Name
( NCT03860220 472 473 O
New NCT03860220 474 477 B-Condition-Name
York NCT03860220 478 482 I-Condition-Name
Heart NCT03860220 483 488 I-Condition-Name
Association NCT03860220 489 500 I-Condition-Name
functional NCT03860220 501 511 O
class NCT03860220 512 517 B-Eq-Unit
III NCT03860220 518 521 B-Eq-Value
and NCT03860220 522 525 O
IV NCT03860220 526 528 B-Eq-Value
) NCT03860220 529 530 O

- NCT03860220 534 535 O
hypersensitivity NCT03860220 537 553 B-Condition-Name
to NCT03860220 554 556 O
telmisartan NCT03860220 557 568 B-Drug-Name
or NCT03860220 569 571 O
rosuvastatin NCT03860220 572 584 B-Drug-Name

- NCT03860220 587 588 O
history NCT03860220 590 597 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860220 598 600 O
angioedema NCT03860220 601 611 B-Condition-Name
after NCT03860220 612 617 O
treatment NCT03860220 618 627 O
with NCT03860220 628 632 O
angiotensin NCT03860220 633 644 B-Drug-Name
- NCT03860220 645 646 I-Drug-Name
converting NCT03860220 647 657 I-Drug-Name
enzyme NCT03860220 658 664 I-Drug-Name
inhibitors NCT03860220 665 675 I-Drug-Name
or NCT03860220 676 678 O
ARBs NCT03860220 679 683 B-Drug-Name
; NCT03860220 683 684 O
creatinine NCT03860220 685 695 B-Observation-Name___Observation-Type-Value:lab
phosphokinase NCT03860220 696 709 I-Observation-Name___Observation-Type-Value:lab
levels NCT03860220 710 716 O
≥ NCT03860220 717 718 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03860220 720 721 B-Eq-Value
times NCT03860220 722 727 O
the NCT03860220 728 731 O
upper NCT03860220 732 737 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03860220 738 743 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03860220 744 746 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03860220 747 753 I-Eq-Unit___Eq-Unit-Value:ref-range-normal

- NCT03860220 756 757 O
estimated NCT03860220 759 768 B-Observation-Name___Observation-Type-Value:lab
glomerular NCT03860220 769 779 I-Observation-Name___Observation-Type-Value:lab
filtration NCT03860220 780 790 I-Observation-Name___Observation-Type-Value:lab
rate NCT03860220 791 795 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03860220 796 797 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03860220 799 801 B-Eq-Value
mL NCT03860220 802 804 B-Eq-Unit
/ NCT03860220 805 806 O
min NCT03860220 807 810 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
; NCT03860220 810 811 O
aspartate NCT03860220 812 821 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03860220 822 838 I-Observation-Name___Observation-Type-Value:lab
and NCT03860220 839 842 O
alanine NCT03860220 843 850 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03860220 851 867 I-Observation-Name___Observation-Type-Value:lab
levels NCT03860220 868 874 O
≥ NCT03860220 875 876 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03860220 878 879 B-Eq-Value
times NCT03860220 880 885 O
the NCT03860220 886 889 O
upper NCT03860220 890 895 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03860220 896 901 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03860220 902 904 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03860220 905 911 I-Eq-Unit___Eq-Unit-Value:ref-range-normal

- NCT03860220 914 915 O
potassium NCT03860220 917 926 B-Observation-Name___Observation-Type-Value:lab
levels NCT03860220 927 933 O
> NCT03860220 934 935 B-Eq-Operator___Eq-Operator-Value:GT
5.5 NCT03860220 937 940 B-Eq-Value
mmol NCT03860220 941 945 B-Eq-Unit
/ NCT03860220 946 947 O
L NCT03860220 948 949 B-Eq-Unit
; NCT03860220 949 950 O
or NCT03860220 951 953 O
any NCT03860220 954 957 O
diseases NCT03860220 958 966 B-Condition-Name
that NCT03860220 967 971 O
could NCT03860220 972 977 O
affect NCT03860220 978 984 B-Stability___Stability-Value:change
the NCT03860220 985 988 O
results NCT03860220 989 996 O
of NCT03860220 997 999 O
the NCT03860220 1000 1003 O
study NCT03860220 1004 1009 O
. NCT03860220 1010 1011 O

Inclusion NCT03866889 0 9 O
Criteria NCT03866889 10 18 O
: NCT03866889 19 20 O

- NCT03866889 24 25 O
Military NCT03866889 27 35 B-Observation-Name
personnel NCT03866889 36 45 I-Observation-Name
belonging NCT03866889 46 55 O
to NCT03866889 56 58 O
the NCT03866889 59 62 O
Military NCT03866889 63 71 O
Emergency NCT03866889 72 81 O
Unit NCT03866889 82 86 O

- NCT03866889 89 90 O
male NCT03866889 92 96 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03866889 99 100 O
With NCT03866889 102 106 O
an NCT03866889 107 109 O
age NCT03866889 110 113 O
of NCT03866889 114 116 O
25 NCT03866889 118 120 B-Eq-Value
to NCT03866889 121 123 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03866889 125 127 B-Eq-Value
years NCT03866889 128 133 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866889 136 137 O
No NCT03866889 139 141 O
history NCT03866889 142 149 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03866889 150 152 O
musculoskeletal NCT03866889 153 168 O
injury NCT03866889 169 175 B-Condition-Name
in NCT03866889 176 178 O
the NCT03866889 179 182 O
3 NCT03866889 184 185 B-Eq-Value
months NCT03866889 186 192 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03866889 193 198 O
to NCT03866889 199 201 O
the NCT03866889 202 205 O
study NCT03866889 206 211 O

Exclusion NCT03866889 212 221 O
Criteria NCT03866889 222 230 O
: NCT03866889 231 232 O

- NCT03866889 236 237 O
Present NCT03866889 239 246 O
a NCT03866889 247 248 O
diagnosis NCT03866889 249 258 O
of NCT03866889 259 261 O
injury NCT03866889 262 268 B-Condition-Name
in NCT03866889 269 271 O
the NCT03866889 272 275 O
period NCT03866889 276 282 O
prior NCT03866889 283 288 O
to NCT03866889 289 291 O
or NCT03866889 292 294 O
during NCT03866889 295 301 O
the NCT03866889 302 305 O
study NCT03866889 306 311 O

- NCT03866889 314 315 O
Who NCT03866889 317 320 O
are NCT03866889 321 324 O
receiving NCT03866889 325 334 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03866889 335 336 O
physiotherapy NCT03866889 337 350 B-Procedure-Name
intervention NCT03866889 351 363 I-Procedure-Name
at NCT03866889 364 366 O
the NCT03866889 367 370 O
time NCT03866889 371 375 O
of NCT03866889 376 378 O
the NCT03866889 379 382 O
study NCT03866889 383 388 O

- NCT03866889 391 392 O
Not NCT03866889 394 397 O
signed NCT03866889 398 404 O
the NCT03866889 405 408 O
informed NCT03866889 409 417 O
consent NCT03866889 418 425 O
document NCT03866889 426 434 O

Inclusion NCT03863067 0 9 O
Criteria NCT03863067 10 18 O
: NCT03863067 19 20 O

- NCT03863067 24 25 O
Patient NCT03863067 27 34 O
with NCT03863067 35 39 O
indication NCT03863067 40 50 O
for NCT03863067 51 54 O
epiduroscopy NCT03863067 55 67 B-Procedure-Name
in NCT03863067 68 70 O
the NCT03863067 71 74 O
usual NCT03863067 75 80 O
clinical NCT03863067 81 89 O
practice NCT03863067 90 98 O

- NCT03863067 101 102 O
Neurogenic NCT03863067 104 114 B-Condition-Name
claudication NCT03863067 115 127 I-Condition-Name

- NCT03863067 130 131 O
Lumbar NCT03863067 133 139 O
pain NCT03863067 140 144 B-Condition-Name
for NCT03863067 145 148 O
more NCT03863067 149 153 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03863067 154 158 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03863067 160 161 B-Eq-Value
months NCT03863067 162 168 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03863067 171 172 O
Numerical NCT03863067 174 183 B-Observation-Name
rating NCT03863067 184 190 I-Observation-Name
scale NCT03863067 191 196 I-Observation-Name
> NCT03863067 197 198 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03863067 200 201 B-Eq-Value

- NCT03863067 205 206 O
No NCT03863067 208 210 O
response NCT03863067 211 219 B-Stability___Stability-Value:change
with NCT03863067 220 224 O
medical NCT03863067 225 232 O
treatment NCT03863067 233 242 O

- NCT03863067 245 246 O
No NCT03863067 248 250 O
response NCT03863067 251 259 B-Stability___Stability-Value:change
with NCT03863067 260 264 O
other NCT03863067 265 270 O
interventional NCT03863067 271 285 O
treatment NCT03863067 286 295 O
: NCT03863067 296 297 O
epidurolysis NCT03863067 298 310 B-Procedure-Name

Exclusion NCT03863067 311 320 O
Criteria NCT03863067 321 329 O
: NCT03863067 330 331 O

- NCT03863067 335 336 O
Psychiatric NCT03863067 338 349 B-Condition-Name
disorders NCT03863067 350 359 I-Condition-Name

- NCT03863067 362 363 O
Opioid NCT03863067 365 371 B-Condition-Name
addiction NCT03863067 372 381 I-Condition-Name

- NCT03863067 384 385 O
Acute NCT03863067 387 392 B-Severity___Severity-Value:severe
organic NCT03863067 393 400 B-Condition-Name
disease NCT03863067 401 408 I-Condition-Name

- NCT03863067 411 412 O
Severe NCT03863067 414 420 B-Severity___Severity-Value:severe
chronic NCT03863067 421 428 O
organic NCT03863067 429 436 B-Condition-Name
disease NCT03863067 437 444 I-Condition-Name

- NCT03863067 447 448 O
Vasculo NCT03863067 450 457 B-Condition-Name
- NCT03863067 458 459 I-Condition-Name
cerebral NCT03863067 460 468 I-Condition-Name
disease NCT03863067 469 476 I-Condition-Name

- NCT03863067 479 480 O
Coagulation NCT03863067 482 493 B-Condition-Name
alterations NCT03863067 494 505 I-Condition-Name

- NCT03863067 508 509 O
Ofthalmologic NCT03863067 511 524 B-Condition-Name
disease NCT03863067 525 532 I-Condition-Name

- NCT03863067 535 536 O
Allergic NCT03863067 538 546 O

- NCT03863067 549 550 O
Infections NCT03863067 552 562 B-Condition-Name

- NCT03863067 565 566 O
Impossibility NCT03863067 568 581 O
to NCT03863067 582 584 O
understand NCT03863067 585 595 O
the NCT03863067 596 599 O
procedure NCT03863067 600 609 B-Procedure-Name

key NCT03867201 0 3 O
inclusion NCT03867201 4 13 O
Criteria NCT03867201 14 22 O
: NCT03867201 23 24 O

1 NCT03867201 29 30 O
. NCT03867201 30 31 O
History NCT03867201 33 40 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867201 41 43 O
at NCT03867201 44 46 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03867201 47 52 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03867201 54 55 B-Eq-Value
attacks NCT03867201 56 63 O
of NCT03867201 64 66 O
migraine NCT03867201 67 75 B-Condition-Name

2 NCT03867201 79 80 O
. NCT03867201 80 81 O
≥ NCT03867201 83 84 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03867201 86 88 B-Eq-Value
headache NCT03867201 89 97 B-Condition-Name
days NCT03867201 98 102 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03867201 103 105 O
which NCT03867201 106 111 O
≥ NCT03867201 112 113 B-Eq-Operator___Eq-Operator-Value:GTEQ
8 NCT03867201 115 116 B-Eq-Value
headache NCT03867201 117 125 B-Condition-Name
days NCT03867201 126 130 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
meet NCT03867201 131 135 O
criteria NCT03867201 136 144 O
as NCT03867201 145 147 O
migraine NCT03867201 148 156 B-Condition-Name
days NCT03867201 157 161 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
during NCT03867201 162 168 O
the NCT03867201 169 172 O
baseline NCT03867201 173 181 O
period NCT03867201 182 188 O

3 NCT03867201 192 193 O
. NCT03867201 193 194 O
> NCT03867201 196 197 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03867201 199 200 I-Eq-Operator___Eq-Operator-Value:GTEQ
80 NCT03867201 202 204 B-Eq-Value
% NCT03867201 205 206 B-Eq-Unit
diary NCT03867201 207 212 B-Observation-Name
compliance NCT03867201 213 223 I-Observation-Name
during NCT03867201 224 230 O
the NCT03867201 231 234 O
baseline NCT03867201 235 243 O
period NCT03867201 244 250 O

Key NCT03867201 251 254 O
exclusion NCT03867201 255 264 O
Criteria NCT03867201 265 273 O
: NCT03867201 274 275 O

1 NCT03867201 280 281 O
. NCT03867201 281 282 O
Older NCT03867201 284 289 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03867201 290 294 I-Eq-Operator___Eq-Operator-Value:GT
50 NCT03867201 296 298 B-Eq-Value
years NCT03867201 299 304 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03867201 305 307 O
age NCT03867201 308 311 O
at NCT03867201 312 314 O
migraine NCT03867201 315 323 B-Condition-Name
onset NCT03867201 324 329 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time

2 NCT03867201 333 334 O
. NCT03867201 334 335 O
History NCT03867201 337 344 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867201 345 347 O
cluster NCT03867201 348 355 O
or NCT03867201 356 358 O
hemiplegic NCT03867201 359 369 O
headache NCT03867201 370 378 B-Condition-Name

3 NCT03867201 382 383 O
. NCT03867201 383 384 O
Evidence NCT03867201 386 394 O
of NCT03867201 395 397 O
seizure NCT03867201 398 405 B-Condition-Name
or NCT03867201 406 408 O
major NCT03867201 409 414 B-Severity___Severity-Value:severe
psychiatric NCT03867201 415 426 B-Condition-Name
disorder NCT03867201 427 435 I-Condition-Name

4 NCT03867201 439 440 O
. NCT03867201 440 441 O
Cardiac NCT03867201 443 450 O
or NCT03867201 451 453 O
active NCT03867201 454 460 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hepatic NCT03867201 461 468 B-Condition-Name
disease NCT03867201 469 476 I-Condition-Name

5 NCT03867201 480 481 O
. NCT03867201 481 482 O
Pregnant NCT03867201 484 492 B-Condition-Name
or NCT03867201 493 495 O
nursing NCT03867201 496 503 B-Condition-Name

Inclusion NCT03864913 0 9 O
Criteria NCT03864913 10 18 O
: NCT03864913 19 20 O

- NCT03864913 24 25 O
Testosterone NCT03864913 27 39 B-Condition-Name
naive NCT03864913 40 45 I-Condition-Name

- NCT03864913 48 49 O
Transgender NCT03864913 51 62 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:transgender
male NCT03864913 63 67 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03864913 70 71 O
14 NCT03864913 74 76 B-Eq-Value
- NCT03864913 77 78 B-Eq-Operator___Eq-Operator-Value:BETWEEN
19 NCT03864913 80 82 B-Eq-Value
years NCT03864913 83 88 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03864913 89 92 O

Exclusion NCT03864913 93 102 O
Criteria NCT03864913 103 111 O
: NCT03864913 112 113 O

- NCT03864913 117 118 O
Transgender NCT03864913 120 131 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:transgender
males NCT03864913 132 137 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
who NCT03864913 138 141 O
have NCT03864913 142 146 O
received NCT03864913 147 155 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
testosterone NCT03864913 156 168 B-Procedure-Name
therapy NCT03864913 169 176 I-Procedure-Name
in NCT03864913 177 179 O
the NCT03864913 180 183 O
past NCT03864913 184 188 B-Eq-Operator___Eq-Operator-Value:GTEQ

Inclusion NCT03868683 0 9 O
Criteria NCT03868683 10 18 O
: NCT03868683 19 20 O

- NCT03868683 24 25 O
Chinese NCT03868683 27 34 B-Ethnicity
ethnicity NCT03868683 35 44 O

- NCT03868683 47 48 O
Age NCT03868683 50 53 O
≥ NCT03868683 54 55 B-Eq-Operator___Eq-Operator-Value:GTEQ
21 NCT03868683 57 59 B-Eq-Value
and NCT03868683 60 63 O
≤ NCT03868683 64 65 B-Eq-Operator___Eq-Operator-Value:LTEQ
60 NCT03868683 67 69 B-Eq-Value
years NCT03868683 70 75 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03868683 78 79 O
Body NCT03868683 81 85 B-Observation-Name___Observation-Type-Value:vital
mass NCT03868683 86 90 I-Observation-Name___Observation-Type-Value:vital
index NCT03868683 91 96 I-Observation-Name___Observation-Type-Value:vital
between NCT03868683 97 104 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18.5 NCT03868683 106 110 B-Eq-Value
to NCT03868683 111 113 O
25 NCT03868683 115 117 B-Eq-Value
kg NCT03868683 118 120 B-Eq-Unit
/ NCT03868683 121 122 O
m NCT03868683 123 124 B-Eq-Unit
2 NCT03868683 125 126 I-Eq-Unit

- NCT03868683 129 130 O
Normal NCT03868683 132 138 B-Polarity___Polarity-Value:normal
blood NCT03868683 139 144 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03868683 145 153 I-Observation-Name___Observation-Type-Value:vital
< NCT03868683 154 155 B-Eq-Operator___Eq-Operator-Value:LT
140 NCT03868683 157 160 B-Eq-Value
/ NCT03868683 161 162 O
90 NCT03868683 164 166 B-Eq-Value
mmHg NCT03868683 167 171 B-Eq-Unit

- NCT03868683 174 175 O
Fasting NCT03868683 177 184 O
blood NCT03868683 185 190 B-Observation-Name___Observation-Type-Value:lab
glucose NCT03868683 191 198 I-Observation-Name___Observation-Type-Value:lab
< NCT03868683 199 200 B-Eq-Operator___Eq-Operator-Value:LT
6.0 NCT03868683 202 205 B-Eq-Value
mmol NCT03868683 206 210 B-Eq-Unit
/ NCT03868683 211 212 O
L NCT03868683 213 214 B-Eq-Unit

- NCT03868683 217 218 O
In NCT03868683 220 222 O
general NCT03868683 223 230 O
good NCT03868683 231 235 B-Condition-Name
health NCT03868683 236 242 I-Condition-Name

Exclusion NCT03868683 243 252 O
Criteria NCT03868683 253 261 O
: NCT03868683 262 263 O

- NCT03868683 267 268 O
Current NCT03868683 270 277 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Smoker NCT03868683 278 284 B-Condition-Name

- NCT03868683 287 288 O
have NCT03868683 290 294 O
any NCT03868683 295 298 O
metabolic NCT03868683 299 308 B-Condition-Name
diseases NCT03868683 309 317 I-Condition-Name
( NCT03868683 318 319 O
such NCT03868683 320 324 O
as NCT03868683 325 327 O
diabetes NCT03868683 328 336 B-Condition-Name
, NCT03868683 337 338 O
hypertension NCT03868683 339 351 B-Condition-Name
etc NCT03868683 352 355 O
) NCT03868683 356 357 O

- NCT03868683 361 362 O
have NCT03868683 364 368 O
known NCT03868683 369 374 O
glucose NCT03868683 375 382 B-Condition-Name
- NCT03868683 383 384 I-Condition-Name
6 NCT03868683 386 387 I-Condition-Name
- NCT03868683 388 389 I-Condition-Name
phosphate NCT03868683 390 399 I-Condition-Name
dehydrogenase NCT03868683 400 413 I-Condition-Name
deficiency NCT03868683 414 424 I-Condition-Name
( NCT03868683 425 426 O
G NCT03868683 427 428 B-Condition-Name
6PD NCT03868683 429 432 I-Condition-Name
deficiency NCT03868683 433 443 I-Condition-Name
) NCT03868683 444 445 O

- NCT03868683 449 450 O
having NCT03868683 452 458 O
medical NCT03868683 459 466 O
conditions NCT03868683 467 477 O
and NCT03868683 478 481 O
/ NCT03868683 482 483 O
or NCT03868683 484 486 O
taking NCT03868683 487 493 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medications NCT03868683 494 505 O
known NCT03868683 506 511 O
to NCT03868683 512 514 O
affect NCT03868683 515 521 B-Stability___Stability-Value:change
glycaemia NCT03868683 522 531 B-Condition-Name
( NCT03868683 532 533 O
glucocorticoids NCT03868683 534 549 B-Drug-Name
, NCT03868683 550 551 O
thyroid NCT03868683 552 559 B-Drug-Name
hormones NCT03868683 560 568 I-Drug-Name
, NCT03868683 569 570 O
thiazide NCT03868683 571 579 B-Drug-Name
diuretics NCT03868683 580 589 I-Drug-Name
) NCT03868683 590 591 O

- NCT03868683 595 596 O
have NCT03868683 598 602 O
intolerances NCT03868683 603 615 B-Condition-Name
or NCT03868683 616 618 O
allergies NCT03868683 619 628 O
to NCT03868683 629 631 O
any NCT03868683 632 635 O
foods NCT03868683 636 641 B-Allergy-Name

- NCT03868683 644 645 O
partake NCT03868683 647 654 O
in NCT03868683 655 657 O
sports NCT03868683 658 664 B-Observation-Name___Observation-Type-Value:social-habit
at NCT03868683 665 667 O
the NCT03868683 668 671 O
competitive NCT03868683 672 683 O
and NCT03868683 684 687 O
/ NCT03868683 688 689 O
or NCT03868683 690 692 O
endurance NCT03868683 693 702 O
levels NCT03868683 703 709 O

- NCT03868683 712 713 O
intentionally NCT03868683 715 728 O
restrict NCT03868683 729 737 O
food NCT03868683 738 742 B-Condition-Name
intake NCT03868683 743 749 I-Condition-Name

Inclusion NCT03866876 0 9 O
Criteria NCT03866876 10 18 O
: NCT03866876 19 20 O

- NCT03866876 24 25 O
All NCT03866876 27 30 O
birth NCT03866876 31 36 O
more NCT03866876 37 41 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866876 42 46 I-Eq-Operator___Eq-Operator-Value:GT
37 NCT03866876 48 50 B-Eq-Value
weeks NCT03866876 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03866876 57 59 O
amenorrhea NCT03866876 60 70 B-Condition-Name
at NCT03866876 71 73 O
the NCT03866876 74 77 O
maternity NCT03866876 78 87 B-Location___Location-Value:unit
ward NCT03866876 88 92 I-Location___Location-Value:unit
of NCT03866876 93 95 O
the NCT03866876 96 99 O
hospital NCT03866876 100 108 B-Location___Location-Value:hospital
Femme NCT03866876 109 114 I-Location___Location-Value:hospital
- NCT03866876 115 116 I-Location___Location-Value:hospital
Mère NCT03866876 117 121 I-Location___Location-Value:hospital
- NCT03866876 122 123 I-Location___Location-Value:hospital
Enfant NCT03866876 124 130 I-Location___Location-Value:hospital

- NCT03866876 133 134 O
from NCT03866876 136 140 O
1 NCT03866876 142 143 B-Eq-Value
st NCT03866876 144 146 I-Eq-Value
of NCT03866876 147 149 I-Eq-Value
january NCT03866876 150 157 I-Eq-Value
2000 NCT03866876 159 163 I-Eq-Value
to NCT03866876 164 166 B-Eq-Operator___Eq-Operator-Value:BETWEEN
31 NCT03866876 168 170 B-Eq-Value
december NCT03866876 171 179 I-Eq-Value
2016 NCT03866876 181 185 I-Eq-Value

Exclusion NCT03866876 187 196 O
Criteria NCT03866876 197 205 O
: NCT03866876 206 207 O

- NCT03866876 211 212 O
Infants NCT03866876 214 221 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
born NCT03866876 222 226 O
out NCT03866876 227 230 O
of NCT03866876 231 233 O
the NCT03866876 234 237 O
hospital NCT03866876 238 246 B-Location___Location-Value:hospital
and NCT03866876 247 250 O
secondarily NCT03866876 251 262 B-Encounter-Type___Encounter-Type-Value:transfer
hospitalized NCT03866876 263 275 I-Encounter-Type___Encounter-Type-Value:transfer
in NCT03866876 276 278 O
the NCT03866876 279 282 O
hospital NCT03866876 283 291 B-Location___Location-Value:hospital
Femme NCT03866876 292 297 I-Location___Location-Value:hospital
- NCT03866876 298 299 I-Location___Location-Value:hospital
Mère NCT03866876 300 304 I-Location___Location-Value:hospital
- NCT03866876 305 306 I-Location___Location-Value:hospital
Enfant NCT03866876 307 313 I-Location___Location-Value:hospital

- NCT03866876 316 317 O
Children NCT03866876 319 327 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03866876 328 332 O
congenital NCT03866876 333 343 B-Condition-Name
anomalies NCT03866876 344 353 I-Condition-Name
or NCT03866876 354 356 O
without NCT03866876 357 364 O
valid NCT03866876 365 370 O
arterial NCT03866876 371 379 O
and NCT03866876 380 383 O
venous NCT03866876 384 390 O
umbilical NCT03866876 391 400 B-Observation-Specimen
cord NCT03866876 401 405 I-Observation-Specimen
samples NCT03866876 406 413 O

Inclusion NCT03866447 0 9 O
Criteria NCT03866447 10 18 O
: NCT03866447 19 20 O

1 NCT03866447 25 26 O
. NCT03866447 26 27 O
Patients NCT03866447 29 37 O
with NCT03866447 38 42 O
Acne NCT03866447 43 47 B-Condition-Name
of NCT03866447 48 50 O
any NCT03866447 51 54 O
grade NCT03866447 55 60 O
. NCT03866447 61 62 O

2 NCT03866447 67 68 O
. NCT03866447 68 69 O
Patients NCT03866447 71 79 O
between NCT03866447 80 87 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03866447 89 91 B-Eq-Value
and NCT03866447 92 95 O
45 NCT03866447 97 99 B-Eq-Value
years NCT03866447 100 105 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03866447 106 109 O
. NCT03866447 110 111 O

Exclusion NCT03866447 113 122 O
Criteria NCT03866447 123 131 O
: NCT03866447 132 133 O

1 NCT03866447 138 139 O
. NCT03866447 139 140 O
Patients NCT03866447 142 150 O
below NCT03866447 151 156 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03866447 158 160 B-Eq-Value
and NCT03866447 161 164 O
above NCT03866447 165 170 B-Eq-Operator___Eq-Operator-Value:GT
45 NCT03866447 172 174 B-Eq-Value
years NCT03866447 175 180 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03866447 181 182 O

2 NCT03866447 187 188 O
. NCT03866447 188 189 O
Patients NCT03866447 191 199 O
with NCT03866447 200 204 O
any NCT03866447 205 208 O
concomitant NCT03866447 209 220 O
Dermatologic NCT03866447 221 233 O
or NCT03866447 234 236 O
systemic NCT03866447 237 245 O
illness NCT03866447 246 253 B-Condition-Name

3 NCT03866447 257 258 O
. NCT03866447 258 259 O
Patients NCT03866447 261 269 O
on NCT03866447 270 272 O
any NCT03866447 273 276 O
topical NCT03866447 277 284 O
or NCT03866447 285 287 O
systemic NCT03866447 288 296 O
medication NCT03866447 297 307 O
within NCT03866447 308 314 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03866447 316 317 B-Eq-Value
weeks NCT03866447 318 323 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03866447 324 330 O
enrollment NCT03866447 331 341 O
. NCT03866447 342 343 O

4 NCT03866447 348 349 O
. NCT03866447 349 350 O
Pregnancy NCT03866447 352 361 B-Condition-Name
. NCT03866447 362 363 O

Inclusion NCT03867981 0 9 O
Criteria NCT03867981 10 18 O
: NCT03867981 19 20 O

- NCT03867981 24 25 O
Age NCT03867981 27 30 O
18 NCT03867981 32 34 B-Eq-Value
- NCT03867981 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03867981 38 40 B-Eq-Value

- NCT03867981 44 45 O
BMI NCT03867981 47 50 B-Observation-Name___Observation-Type-Value:vital
: NCT03867981 51 52 O
25 NCT03867981 54 56 B-Eq-Value
- NCT03867981 57 58 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03867981 60 62 B-Eq-Value
kg NCT03867981 63 65 B-Eq-Unit
/ NCT03867981 66 67 O
m NCT03867981 68 69 B-Eq-Unit
2 NCT03867981 70 71 I-Eq-Unit

- NCT03867981 74 75 O
Regular NCT03867981 77 84 O
internet NCT03867981 85 93 O
access NCT03867981 94 100 O

Exclusion NCT03867981 101 110 O
Criteria NCT03867981 111 119 O
: NCT03867981 120 121 O

- NCT03867981 125 126 O
Currently NCT03867981 128 137 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnant NCT03867981 138 146 B-Condition-Name
, NCT03867981 147 148 O
< NCT03867981 149 150 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03867981 152 153 B-Eq-Value
months NCT03867981 154 160 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
post NCT03867981 161 165 B-Condition-Name
- NCT03867981 166 167 I-Condition-Name
partum NCT03867981 168 174 I-Condition-Name
, NCT03867981 175 176 O
nursing NCT03867981 177 184 B-Condition-Name
, NCT03867981 185 186 O
or NCT03867981 187 189 O
planning NCT03867981 190 198 O
to NCT03867981 199 201 O
become NCT03867981 202 208 O
pregnant NCT03867981 209 217 B-Condition-Name
within NCT03867981 218 224 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03867981 225 228 O
next NCT03867981 229 233 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
12 NCT03867981 235 237 B-Eq-Value
months NCT03867981 238 244 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03867981 245 246 O

- NCT03867981 250 251 O
Current NCT03867981 253 260 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
enrollment NCT03867981 261 271 O
in NCT03867981 272 274 O
a NCT03867981 275 276 O
commercial NCT03867981 277 287 O
weight NCT03867981 288 294 B-Procedure-Name
loss NCT03867981 295 299 I-Procedure-Name
program NCT03867981 300 307 I-Procedure-Name
or NCT03867981 308 310 O
other NCT03867981 311 316 O
weight NCT03867981 317 323 B-Procedure-Name
loss NCT03867981 324 328 I-Procedure-Name
research NCT03867981 329 337 O
study NCT03867981 338 343 O

- NCT03867981 346 347 O
Currently NCT03867981 349 358 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03867981 359 365 O
weight NCT03867981 366 372 B-Procedure-Name
loss NCT03867981 373 377 I-Procedure-Name
medications NCT03867981 378 389 O

- NCT03867981 392 393 O
Previously NCT03867981 395 405 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
had NCT03867981 406 409 O
bariatric NCT03867981 410 419 B-Procedure-Name
surgery NCT03867981 420 427 I-Procedure-Name

- NCT03867981 430 431 O
Inability NCT03867981 433 442 B-Condition-Name
to NCT03867981 443 445 I-Condition-Name
walk NCT03867981 446 450 I-Condition-Name
2 NCT03867981 452 453 O
blocks NCT03867981 454 460 O
without NCT03867981 461 468 O
stopping NCT03867981 469 477 O

- NCT03867981 480 481 O
Any NCT03867981 483 486 O
medical NCT03867981 487 494 O
condition NCT03867981 495 504 O
for NCT03867981 505 508 O
which NCT03867981 509 514 O
weight NCT03867981 515 521 B-Procedure-Name
loss NCT03867981 522 526 I-Procedure-Name
, NCT03867981 527 528 O
dietary NCT03867981 529 536 B-Procedure-Name
restriction NCT03867981 537 548 I-Procedure-Name
, NCT03867981 549 550 O
or NCT03867981 551 553 O
physical NCT03867981 554 562 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03867981 563 571 I-Observation-Name___Observation-Type-Value:social-habit
is NCT03867981 572 574 O
contraindicated NCT03867981 575 590 O

Inclusion NCT03865628 0 9 O
Criteria NCT03865628 10 18 O
: NCT03865628 19 20 O

- NCT03865628 24 25 O
Singleton NCT03865628 27 36 O
pregnancy NCT03865628 37 46 B-Condition-Name

- NCT03865628 49 50 O
Estimation NCT03865628 52 62 O
of NCT03865628 63 65 O
the NCT03865628 66 69 O
fetal NCT03865628 70 75 O
weight NCT03865628 76 82 B-Observation-Name___Observation-Type-Value:vital
less NCT03865628 83 87 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03865628 88 92 I-Eq-Operator___Eq-Operator-Value:LT
estimation NCT03865628 93 103 O
the NCT03865628 104 107 O
10 NCT03865628 109 111 B-Eq-Value
th NCT03865628 112 114 I-Eq-Value
percentile NCT03865628 115 125 B-Eq-Unit

Exclusion NCT03865628 126 135 O
Criteria NCT03865628 136 144 O
: NCT03865628 145 146 O

- NCT03865628 150 151 O
Refusal NCT03865628 153 160 O
of NCT03865628 161 163 O
parents NCT03865628 164 171 O

- NCT03865628 174 175 O
Fetal NCT03865628 177 182 O
and NCT03865628 183 186 O
vascular NCT03865628 187 195 O
malformations NCT03865628 196 209 B-Condition-Name

- NCT03865628 212 213 O
Fetal NCT03865628 215 220 B-Condition-Name
anemia NCT03865628 221 227 I-Condition-Name

Inclusions NCT03864536 0 10 O
: NCT03864536 11 12 O

- NCT03864536 16 17 O
Must NCT03864536 19 23 O
be NCT03864536 24 26 O
African NCT03864536 27 34 B-Ethnicity
American NCT03864536 35 43 I-Ethnicity

- NCT03864536 46 47 O
Must NCT03864536 49 53 O
be NCT03864536 54 56 O
age NCT03864536 57 60 O
50 NCT03864536 62 64 B-Eq-Value
to NCT03864536 65 67 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03864536 69 71 B-Eq-Value

- NCT03864536 75 76 O
Must NCT03864536 78 82 O
have NCT03864536 83 87 O
a NCT03864536 88 89 O
working NCT03864536 90 97 O
cell NCT03864536 98 102 O
phone NCT03864536 103 108 O
with NCT03864536 109 113 O
unlimited NCT03864536 114 123 O
texting NCT03864536 124 131 O

- NCT03864536 134 135 O
Must NCT03864536 137 141 O
be NCT03864536 142 144 O
ambulatory NCT03864536 145 155 B-Condition-Name

Exclusions NCT03864536 156 166 O
: NCT03864536 167 168 O

- NCT03864536 172 173 O
No NCT03864536 175 177 O
neurological NCT03864536 178 190 O
( NCT03864536 191 192 O
including NCT03864536 193 202 O
dementia NCT03864536 203 211 B-Condition-Name
diagnosis NCT03864536 212 221 O
) NCT03864536 222 223 O
or NCT03864536 224 226 O
severe NCT03864536 227 233 B-Severity___Severity-Value:severe
psychiatric NCT03864536 234 245 O
( NCT03864536 246 247 O
e NCT03864536 248 249 O
. NCT03864536 250 251 O
g NCT03864536 252 253 O
. NCT03864536 254 255 O
, NCT03864536 256 257 O
schizophrenia NCT03864536 258 271 B-Condition-Name
or NCT03864536 272 274 O
bipolar NCT03864536 275 282 B-Condition-Name
disorder NCT03864536 283 291 I-Condition-Name
) NCT03864536 292 293 O
disorders NCT03864536 294 303 B-Condition-Name

- NCT03864536 306 307 O
No NCT03864536 309 311 O
insomnia NCT03864536 312 320 B-Condition-Name

- NCT03864536 323 324 O
Telephone NCT03864536 326 335 B-Observation-Name___Observation-Type-Value:clinical-score
Interview NCT03864536 336 345 I-Observation-Name___Observation-Type-Value:clinical-score
for NCT03864536 346 349 I-Observation-Name___Observation-Type-Value:clinical-score
Cognitive NCT03864536 350 359 I-Observation-Name___Observation-Type-Value:clinical-score
Status NCT03864536 360 366 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03864536 367 368 O
TICS NCT03864536 369 373 B-Observation-Name
) NCT03864536 374 375 O
score NCT03864536 376 381 O
≤ NCT03864536 382 383 B-Eq-Operator___Eq-Operator-Value:LTEQ
20 NCT03864536 385 387 B-Eq-Value

Inclusion NCT03867942 0 9 O
Criteria NCT03867942 10 18 O
: NCT03867942 19 20 O

- NCT03867942 24 25 O
Age NCT03867942 27 30 O
: NCT03867942 31 32 O
19 NCT03867942 34 36 B-Eq-Value
~ NCT03867942 37 38 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03867942 40 42 B-Eq-Value

- NCT03867942 46 47 O
Body NCT03867942 49 53 B-Observation-Name___Observation-Type-Value:vital
weight NCT03867942 54 60 I-Observation-Name___Observation-Type-Value:vital
: NCT03867942 61 62 O
55 NCT03867942 64 66 B-Eq-Value
kg NCT03867942 67 69 B-Eq-Unit
or NCT03867942 70 72 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03867942 73 79 I-Eq-Operator___Eq-Operator-Value:GTEQ
( NCT03867942 80 81 O
female NCT03867942 82 88 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
: NCT03867942 89 90 O
50 NCT03867942 92 94 B-Eq-Value
kg NCT03867942 95 97 B-Eq-Unit
or NCT03867942 98 100 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03867942 101 107 I-Eq-Operator___Eq-Operator-Value:GTEQ
) NCT03867942 108 109 O
and NCT03867942 110 113 O
BMI NCT03867942 114 117 B-Observation-Name___Observation-Type-Value:vital
18 NCT03867942 119 121 B-Eq-Value
~ NCT03867942 122 123 B-Eq-Operator___Eq-Operator-Value:BETWEEN
27 NCT03867942 125 127 O
kg NCT03867942 128 130 B-Eq-Unit
/ NCT03867942 131 132 O
m NCT03867942 133 134 B-Eq-Unit
2 NCT03867942 135 136 I-Eq-Unit

- NCT03867942 139 140 O
SBP NCT03867942 142 145 B-Observation-Name___Observation-Type-Value:vital
90 NCT03867942 147 149 B-Eq-Value
~ NCT03867942 150 151 B-Eq-Operator___Eq-Operator-Value:BETWEEN
150 NCT03867942 153 156 B-Eq-Value
mmHg NCT03867942 157 161 B-Eq-Unit
, NCT03867942 162 163 O
DBP NCT03867942 164 167 B-Observation-Name___Observation-Type-Value:vital
60 NCT03867942 169 171 B-Eq-Value
- NCT03867942 172 173 B-Eq-Operator___Eq-Operator-Value:BETWEEN
95 NCT03867942 175 177 B-Eq-Value
mmHg NCT03867942 178 182 B-Eq-Unit

- NCT03867942 185 186 O
Fasting NCT03867942 188 195 O
glucose NCT03867942 196 203 B-Observation-Name___Observation-Type-Value:lab
70 NCT03867942 205 207 B-Eq-Value
~ NCT03867942 208 209 B-Eq-Operator___Eq-Operator-Value:BETWEEN
120 NCT03867942 211 214 B-Eq-Value
mg NCT03867942 215 217 B-Eq-Unit
/ NCT03867942 218 219 O
dL NCT03867942 220 222 B-Eq-Unit

- NCT03867942 225 226 O
Infertility NCT03867942 228 239 B-Condition-Name

1 NCT03867942 248 249 O
. NCT03867942 249 250 O
Surgically NCT03867942 252 262 O
infertile NCT03867942 263 272 B-Condition-Name

2 NCT03867942 281 282 O
. NCT03867942 282 283 O
To NCT03867942 285 287 O
prevent NCT03867942 288 295 O
pregnancy NCT03867942 296 305 B-Condition-Name
, NCT03867942 306 307 O
participants NCT03867942 308 320 O
who NCT03867942 321 324 O
agreed NCT03867942 325 331 O
using NCT03867942 332 337 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
2 NCT03867942 339 340 B-Eq-Value
or NCT03867942 341 343 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03867942 344 348 I-Eq-Operator___Eq-Operator-Value:GTEQ
contraceptive NCT03867942 349 362 B-Procedure-Name
methods NCT03867942 363 370 I-Procedure-Name
. NCT03867942 371 372 O
Such NCT03867942 374 378 O
as NCT03867942 379 381 O

- NCT03867942 384 385 O
Barrier NCT03867942 387 394 B-Procedure-Name
methods NCT03867942 395 402 I-Procedure-Name
: NCT03867942 403 404 O
Condom NCT03867942 405 411 B-Procedure-Name
, NCT03867942 412 413 O
Diaphragm NCT03867942 414 423 B-Condition-Name
, NCT03867942 424 425 O
Cervical NCT03867942 426 434 B-Procedure-Name
cap NCT03867942 435 438 I-Procedure-Name
( NCT03867942 439 440 O
Pessary NCT03867942 441 448 B-Procedure-Name
) NCT03867942 449 450 O
, NCT03867942 452 453 O
Spermicide NCT03867942 454 464 B-Procedure-Name

- NCT03867942 467 468 O
Hormonal NCT03867942 470 478 B-Procedure-Name
methods NCT03867942 479 486 I-Procedure-Name
: NCT03867942 487 488 O
Pills NCT03867942 489 494 O
, NCT03867942 495 496 O
Injection NCT03867942 497 506 B-Procedure-Name
( NCT03867942 507 508 O
Depot NCT03867942 509 514 O
) NCT03867942 515 516 O
, NCT03867942 518 519 O
Skin NCT03867942 520 524 B-Procedure-Name
patch NCT03867942 525 530 I-Procedure-Name
, NCT03867942 531 532 O
Hormonal NCT03867942 533 541 B-Procedure-Name
implant NCT03867942 542 549 I-Procedure-Name
( NCT03867942 550 551 O
Implanon NCT03867942 552 560 O
) NCT03867942 561 562 O
, NCT03867942 564 565 O
Vaginal NCT03867942 566 573 B-Procedure-Name
ring NCT03867942 574 578 I-Procedure-Name

- NCT03867942 581 582 O
Intrauterine NCT03867942 584 596 B-Procedure-Name
Devices NCT03867942 597 604 I-Procedure-Name
( NCT03867942 605 606 O
IUDs NCT03867942 607 611 B-Procedure-Name
) NCT03867942 612 613 O
: NCT03867942 615 616 O
Cooper NCT03867942 617 623 O
IUD NCT03867942 624 627 B-Procedure-Name
( NCT03867942 628 629 O
Loop NCT03867942 630 634 O
) NCT03867942 635 636 O
, NCT03867942 638 639 O
Hormonal NCT03867942 640 648 O
IUD NCT03867942 649 652 B-Procedure-Name
( NCT03867942 653 654 O
Mirena NCT03867942 655 661 O
) NCT03867942 662 663 O

- NCT03867942 667 668 O
Natural NCT03867942 670 677 B-Procedure-Name
methods NCT03867942 678 685 I-Procedure-Name
: NCT03867942 686 687 O
Basic NCT03867942 688 693 O
body NCT03867942 694 698 B-Observation-Name___Observation-Type-Value:vital
temperature NCT03867942 699 710 I-Observation-Name___Observation-Type-Value:vital
, NCT03867942 711 712 O
Ovulation NCT03867942 713 722 B-Condition-Name
period NCT03867942 723 729 I-Condition-Name
, NCT03867942 730 731 O
Coitus NCT03867942 732 738 B-Procedure-Name
interruptus NCT03867942 739 750 I-Procedure-Name
, NCT03867942 751 752 O
Abstinent NCT03867942 753 762 B-Condition-Name

- NCT03867942 765 766 O
People NCT03867942 768 774 O
who NCT03867942 775 778 O
perfectly NCT03867942 779 788 O
understood NCT03867942 789 799 O
clinical NCT03867942 800 808 O
trial NCT03867942 809 814 O
and NCT03867942 815 818 O
independently NCT03867942 819 832 O
decided NCT03867942 833 840 O
to NCT03867942 841 843 O
participate NCT03867942 844 855 O
in NCT03867942 856 858 O
clinical NCT03867942 859 867 O
trial NCT03867942 868 873 O
. NCT03867942 874 875 O

- NCT03867942 879 880 O
People NCT03867942 882 888 O
who NCT03867942 889 892 O
will NCT03867942 893 897 O
be NCT03867942 898 900 O
able NCT03867942 901 905 O
to NCT03867942 906 908 O
collect NCT03867942 909 916 O
blood NCT03867942 917 922 B-Observation-Specimen
sample NCT03867942 923 929 O
during NCT03867942 930 936 O
clinical NCT03867942 937 945 O
trial NCT03867942 946 951 O
period NCT03867942 952 958 O
. NCT03867942 959 960 O

- NCT03867942 964 965 O
People NCT03867942 967 973 O
who NCT03867942 974 977 O
are NCT03867942 978 981 O
suitable NCT03867942 982 990 O
to NCT03867942 991 993 O
participate NCT03867942 994 1005 O
clinical NCT03867942 1006 1014 O
trial NCT03867942 1015 1020 O
by NCT03867942 1021 1023 O
physical NCT03867942 1024 1032 B-Procedure-Name
examination NCT03867942 1033 1044 I-Procedure-Name
, NCT03867942 1045 1046 O
lab NCT03867942 1047 1050 B-Observation-Name___Observation-Type-Value:lab
test NCT03867942 1051 1055 I-Observation-Name___Observation-Type-Value:lab
and NCT03867942 1056 1059 O
medical NCT03867942 1060 1067 B-Procedure-Name
examination NCT03867942 1068 1079 I-Procedure-Name
by NCT03867942 1080 1082 O
interview NCT03867942 1083 1092 O
. NCT03867942 1093 1094 O

Exclusion NCT03867942 1096 1105 O
Criteria NCT03867942 1106 1114 O
: NCT03867942 1115 1116 O

- NCT03867942 1120 1121 O
Genetic NCT03867942 1123 1130 B-Condition-Name
problems NCT03867942 1131 1139 I-Condition-Name
such NCT03867942 1140 1144 O
as NCT03867942 1145 1147 O
galactose NCT03867942 1148 1157 B-Condition-Name
intolerance NCT03867942 1158 1169 I-Condition-Name
, NCT03867942 1170 1171 O
Lapp NCT03867942 1172 1176 B-Condition-Name
lacatase NCT03867942 1177 1185 I-Condition-Name
deficiency NCT03867942 1186 1196 I-Condition-Name
, NCT03867942 1197 1198 O
glucose NCT03867942 1199 1206 B-Condition-Name
- NCT03867942 1207 1208 I-Condition-Name
galactose NCT03867942 1209 1218 I-Condition-Name
malabsorption NCT03867942 1219 1232 I-Condition-Name

- NCT03867942 1235 1236 O
Clinically NCT03867942 1238 1248 O
significant NCT03867942 1249 1260 B-Severity___Severity-Value:severe
disease NCT03867942 1261 1268 B-Condition-Name
such NCT03867942 1269 1273 O
as NCT03867942 1274 1276 O
liver NCT03867942 1277 1282 O
, NCT03867942 1283 1284 O
kidney NCT03867942 1285 1291 O
, NCT03867942 1292 1293 O
digestive NCT03867942 1294 1303 O
, NCT03867942 1304 1305 O
pulmonary NCT03867942 1306 1315 O
, NCT03867942 1316 1317 O
endocrine NCT03867942 1318 1327 O
system NCT03867942 1328 1334 O
, NCT03867942 1335 1336 O
cardiovascular NCT03867942 1337 1351 O
disease NCT03867942 1352 1359 B-Condition-Name
etc NCT03867942 1360 1363 O
. NCT03867942 1364 1365 O

- NCT03867942 1369 1370 O
People NCT03867942 1372 1378 O
who NCT03867942 1379 1382 O
have NCT03867942 1383 1387 O
gastrointestinal NCT03867942 1388 1404 B-Condition-Name
disease NCT03867942 1405 1412 I-Condition-Name
or NCT03867942 1413 1415 O
history NCT03867942 1416 1423 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867942 1424 1426 O
surgery NCT03867942 1427 1434 B-Procedure-Name
which NCT03867942 1435 1440 O
would NCT03867942 1441 1446 O
affect NCT03867942 1447 1453 B-Stability___Stability-Value:change
absorption NCT03867942 1454 1464 B-Condition-Name
of NCT03867942 1465 1467 O
drug NCT03867942 1468 1472 B-Drug-Name
. NCT03867942 1473 1474 O

- NCT03867942 1478 1479 O
History NCT03867942 1481 1488 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867942 1489 1491 O
clinically NCT03867942 1492 1502 O
significant NCT03867942 1503 1514 B-Severity___Severity-Value:severe
drug NCT03867942 1515 1519 O
induced NCT03867942 1520 1527 O
hyper NCT03867942 1528 1533 B-Condition-Name
- NCT03867942 1534 1535 I-Condition-Name
sensitive NCT03867942 1536 1545 I-Condition-Name
reaction NCT03867942 1546 1554 I-Condition-Name
or NCT03867942 1555 1557 O
drug NCT03867942 1558 1562 O
related NCT03867942 1563 1570 O
muscular NCT03867942 1571 1579 B-Condition-Name
disease NCT03867942 1580 1587 I-Condition-Name

Inclusion NCT03865199 0 9 O
Criteria NCT03865199 10 18 O
: NCT03865199 19 20 O

- NCT03865199 24 25 O
Women NCT03865199 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
aged NCT03865199 33 37 O
18 NCT03865199 39 41 B-Eq-Value
or NCT03865199 42 44 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03865199 45 50 I-Eq-Operator___Eq-Operator-Value:GTEQ
undergoing NCT03865199 51 61 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medical NCT03865199 62 69 O
or NCT03865199 70 72 O
surgical NCT03865199 73 81 O
abortion NCT03865199 82 90 B-Procedure-Name
at NCT03865199 91 93 O
Planned NCT03865199 94 101 B-Location___Location-Value:clinic
Parenthood NCT03865199 102 112 I-Location___Location-Value:clinic
of NCT03865199 113 115 I-Location___Location-Value:clinic
Illinois NCT03865199 116 124 I-Location___Location-Value:clinic
( NCT03865199 125 126 O
PPIL NCT03865199 127 131 B-Location
) NCT03865199 132 133 O
will NCT03865199 134 138 O
be NCT03865199 139 141 O
eligible NCT03865199 142 150 O
for NCT03865199 151 154 O
inclusion NCT03865199 155 164 O
. NCT03865199 165 166 O
Inclusion NCT03865199 168 177 O
criteria NCT03865199 178 186 O
include NCT03865199 187 194 O
having NCT03865199 195 201 O
an NCT03865199 202 204 O
intrauterine NCT03865199 205 217 O
pregnancy NCT03865199 218 227 B-Condition-Name
, NCT03865199 228 229 O
having NCT03865199 230 236 O
a NCT03865199 237 238 O
smart NCT03865199 239 244 O
phone NCT03865199 245 250 O
to NCT03865199 251 253 O
be NCT03865199 254 256 O
able NCT03865199 257 261 O
to NCT03865199 262 264 O
follow NCT03865199 265 271 O
- NCT03865199 272 273 O
up NCT03865199 274 276 O
by NCT03865199 277 279 O
text NCT03865199 280 284 O
message NCT03865199 285 292 O
2 NCT03865199 294 295 B-Eq-Value
- NCT03865199 296 297 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03865199 299 300 B-Eq-Value
weeks NCT03865199 301 306 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03865199 307 312 O
the NCT03865199 313 316 O
clinic NCT03865199 317 323 B-Encounter-Type___Encounter-Type-Value:outpatient
appointment NCT03865199 324 335 I-Encounter-Type___Encounter-Type-Value:outpatient
, NCT03865199 336 337 O
having NCT03865199 338 344 O
no NCT03865199 345 347 O
contraindications NCT03865199 348 365 O
to NCT03865199 366 368 O
an NCT03865199 369 371 O
outpatient NCT03865199 372 382 B-Encounter-Type___Encounter-Type-Value:outpatient
medication NCT03865199 383 393 O
or NCT03865199 394 396 O
surgical NCT03865199 397 405 O
abortion NCT03865199 406 414 B-Procedure-Name
that NCT03865199 415 419 O
same NCT03865199 420 424 O
day NCT03865199 425 428 O
, NCT03865199 429 430 O
and NCT03865199 431 434 O
not NCT03865199 435 438 O
meeting NCT03865199 439 446 O
any NCT03865199 447 450 O
exclusion NCT03865199 451 460 O
criteria NCT03865199 461 469 O
. NCT03865199 470 471 O

Exclusion NCT03865199 473 482 O
Criteria NCT03865199 483 491 O
: NCT03865199 492 493 O

- NCT03865199 497 498 O
Exclusion NCT03865199 500 509 O
criteria NCT03865199 510 518 O
will NCT03865199 519 523 O
include NCT03865199 524 531 O
non NCT03865199 532 535 O
- NCT03865199 536 537 O
English NCT03865199 538 545 B-Language
speaking NCT03865199 546 554 O
, NCT03865199 555 556 O
no NCT03865199 557 559 O
working NCT03865199 560 567 O
telephone NCT03865199 568 577 O
, NCT03865199 578 579 O
and NCT03865199 580 583 O
less NCT03865199 584 588 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03865199 589 593 I-Eq-Operator___Eq-Operator-Value:LT
5 NCT03865199 595 596 B-Eq-Value
th NCT03865199 597 599 I-Eq-Value
grade NCT03865199 600 605 B-Eq-Unit
education NCT03865199 606 615 B-Observation-Name
level NCT03865199 616 621 I-Observation-Name
. NCT03865199 622 623 O

Inclusion NCT03860142 0 9 O
Criteria NCT03860142 10 18 O
: NCT03860142 19 20 O

- NCT03860142 24 25 O
Children NCT03860142 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
whose NCT03860142 36 41 O
age NCT03860142 42 45 O
≥ NCT03860142 46 47 B-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03860142 49 51 B-Eq-Value
months NCT03860142 52 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03860142 59 62 O
≤ NCT03860142 63 64 B-Eq-Operator___Eq-Operator-Value:LTEQ
36 NCT03860142 66 68 B-Eq-Value
months NCT03860142 69 75 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03860142 78 79 O
Full NCT03860142 81 85 O
- NCT03860142 86 87 O
term NCT03860142 88 92 O
or NCT03860142 93 95 O
prematurely NCT03860142 96 107 O
born NCT03860142 108 112 O
( NCT03860142 113 114 O
< NCT03860142 116 117 B-Eq-Operator___Eq-Operator-Value:LT
33 NCT03860142 119 121 B-Eq-Value
SA NCT03860142 122 124 B-Observation-Name
) NCT03860142 125 126 O
at NCT03860142 127 129 O
Nice NCT03860142 130 134 B-Location___Location-Value:hospital
University NCT03860142 135 145 I-Location___Location-Value:hospital
Hospital NCT03860142 146 154 I-Location___Location-Value:hospital

Exclusion NCT03860142 155 164 O
Criteria NCT03860142 165 173 O
: NCT03860142 174 175 O

- NCT03860142 179 180 O
Children NCT03860142 182 190 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03860142 191 195 O
congenital NCT03860142 196 206 B-Condition-Name
pathologies NCT03860142 207 218 I-Condition-Name
( NCT03860142 219 220 O
with NCT03860142 221 225 O
malformations NCT03860142 226 239 B-Condition-Name
in NCT03860142 240 242 O
the NCT03860142 243 246 O
oro NCT03860142 247 250 O
- NCT03860142 251 252 O
facial NCT03860142 253 259 O
sphere NCT03860142 260 266 O
) NCT03860142 267 268 O

- NCT03860142 272 273 O
Children NCT03860142 275 283 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03860142 284 288 O
neurological NCT03860142 289 301 O
and NCT03860142 302 305 O
developmental NCT03860142 306 319 O
pathologies NCT03860142 320 331 B-Condition-Name
unrelated NCT03860142 332 341 O
to NCT03860142 342 344 O
prematurity NCT03860142 345 356 B-Condition-Name

- NCT03860142 359 360 O
Children NCT03860142 362 370 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03860142 371 375 O
ENT NCT03860142 376 379 B-Condition-Name
deformities NCT03860142 380 391 I-Condition-Name

- NCT03860142 394 395 O
Parental NCT03860142 397 405 O
langage NCT03860142 406 413 B-Condition-Name
barrier NCT03860142 414 421 I-Condition-Name

Inclusion NCT03862755 0 9 O
Criteria NCT03862755 10 18 O
: NCT03862755 19 20 O

- NCT03862755 24 25 O
Lung NCT03862755 27 31 B-Procedure-Name
surgical NCT03862755 32 40 I-Procedure-Name
patients NCT03862755 41 49 O
who NCT03862755 50 53 O
were NCT03862755 54 58 O
sent NCT03862755 59 63 O
to NCT03862755 64 66 O
thoracic NCT03862755 67 75 O
post NCT03862755 76 80 O
operative NCT03862755 81 90 B-Procedure-Name
intensive NCT03862755 91 100 B-Location___Location-Value:unit
care NCT03862755 101 105 I-Location___Location-Value:unit
unit NCT03862755 106 110 I-Location___Location-Value:unit
( NCT03862755 111 112 O
ICU NCT03862755 113 116 B-Location___Location-Value:unit
) NCT03862755 117 118 O
ward NCT03862755 119 123 O
right NCT03862755 124 129 O
after NCT03862755 130 135 O
surgery NCT03862755 136 143 B-Procedure-Name
and NCT03862755 144 147 O
stayed NCT03862755 148 154 O
in NCT03862755 155 157 O
ICU NCT03862755 158 161 B-Location___Location-Value:unit
for NCT03862755 162 165 O
at NCT03862755 166 168 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862755 169 174 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03862755 176 178 B-Eq-Value
hours NCT03862755 179 184 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
. NCT03862755 185 186 O

Exclusion NCT03862755 188 197 O
Criteria NCT03862755 198 206 O
: NCT03862755 207 208 O

- NCT03862755 212 213 O
Cases NCT03862755 215 220 O
received NCT03862755 221 229 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
inferior NCT03862755 230 238 B-Procedure-Name
vena NCT03862755 239 243 I-Procedure-Name
filter NCT03862755 244 250 I-Procedure-Name
and NCT03862755 251 254 O
anti NCT03862755 255 259 B-Procedure-Name
- NCT03862755 260 261 I-Procedure-Name
coagulation NCT03862755 262 273 I-Procedure-Name
treatment NCT03862755 274 283 I-Procedure-Name
history NCT03862755 284 291 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
. NCT03862755 292 293 O

Inclusion NCT03862027 0 9 O
Criteria NCT03862027 10 18 O
: NCT03862027 19 20 O

- NCT03862027 24 25 O
Adult NCT03862027 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03862027 33 41 O
( NCT03862027 42 43 O
age NCT03862027 44 47 O
> NCT03862027 48 49 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03862027 51 52 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03862027 54 55 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03862027 57 59 B-Eq-Value
) NCT03862027 60 61 O
admitted NCT03862027 62 70 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03862027 71 73 O
the NCT03862027 74 77 O
Neuro NCT03862027 78 83 B-Location___Location-Value:unit
ICU NCT03862027 84 87 I-Location___Location-Value:unit
of NCT03862027 88 90 O
UNC NCT03862027 91 94 B-Location___Location-Value:unit
Hospital NCT03862027 95 103 I-Location___Location-Value:unit
requiring NCT03862027 104 113 O
mechanical NCT03862027 114 124 B-Procedure-Name
ventilation NCT03862027 125 136 I-Procedure-Name
and NCT03862027 137 140 O
with NCT03862027 141 145 O
ICP NCT03862027 146 149 B-Procedure-Name
monitoring NCT03862027 150 160 I-Procedure-Name
in NCT03862027 161 163 O
place NCT03862027 164 169 O
. NCT03862027 170 171 O

Exclusion NCT03862027 173 182 O
Criteria NCT03862027 183 191 O
: NCT03862027 192 193 O

1 NCT03862027 198 199 O
. NCT03862027 199 200 O
Pneumothorax NCT03862027 202 214 B-Condition-Name
or NCT03862027 215 217 O
pneumomediastinum NCT03862027 218 235 B-Condition-Name

2 NCT03862027 239 240 O
. NCT03862027 240 241 O
Life NCT03862027 243 247 B-Observation-Name
expectancy NCT03862027 248 258 I-Observation-Name
< NCT03862027 259 260 B-Eq-Operator___Eq-Operator-Value:LT
24 NCT03862027 262 264 B-Eq-Value
hours NCT03862027 265 270 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03862027 271 273 O
expected NCT03862027 274 282 O
to NCT03862027 283 285 O
require NCT03862027 286 293 O
mechanical NCT03862027 294 304 B-Procedure-Name
ventilation NCT03862027 305 316 I-Procedure-Name
for NCT03862027 317 320 O
< NCT03862027 321 322 B-Eq-Operator___Eq-Operator-Value:LT
24 NCT03862027 324 326 B-Eq-Value
hours NCT03862027 327 332 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

3 NCT03862027 336 337 O
. NCT03862027 337 338 O
Condition NCT03862027 340 349 O
that NCT03862027 350 354 O
precludes NCT03862027 355 364 O
placement NCT03862027 365 374 O
of NCT03862027 375 377 O
an NCT03862027 378 380 O
esophageal NCT03862027 381 391 B-Procedure-Name
balloon NCT03862027 392 399 I-Procedure-Name
[ NCT03862027 400 401 O
esophageal NCT03862027 402 412 O
or NCT03862027 413 415 O
nasopharyngeal NCT03862027 416 430 O
pathology NCT03862027 431 440 B-Condition-Name
preventing NCT03862027 441 451 O
insertion NCT03862027 452 461 O
of NCT03862027 462 464 O
the NCT03862027 465 468 O
esophageal NCT03862027 469 479 B-Procedure-Name
balloon NCT03862027 480 487 I-Procedure-Name
catheter NCT03862027 488 496 I-Procedure-Name
( NCT03862027 497 498 O
esophageal NCT03862027 499 509 B-Condition-Name
ulcerations NCT03862027 510 521 I-Condition-Name
, NCT03862027 522 523 O
tumors NCT03862027 524 530 B-Condition-Name
, NCT03862027 531 532 O
diverticulitis NCT03862027 533 547 B-Condition-Name
, NCT03862027 548 549 O
bleeding NCT03862027 550 558 B-Condition-Name
varices NCT03862027 559 566 I-Condition-Name
or NCT03862027 567 569 O
in NCT03862027 570 572 O
patients NCT03862027 573 581 O
with NCT03862027 582 586 O
sinusitis NCT03862027 587 596 B-Condition-Name
, NCT03862027 597 598 O
epistaxis NCT03862027 599 608 B-Condition-Name
or NCT03862027 609 611 O
recent NCT03862027 612 618 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
nasopharyngeal NCT03862027 619 633 B-Procedure-Name
surgery NCT03862027 634 641 I-Procedure-Name
) NCT03862027 642 643 O
, NCT03862027 645 646 O
severe NCT03862027 647 653 B-Severity___Severity-Value:severe
thrombocytopenia NCT03862027 654 670 B-Condition-Name
( NCT03862027 671 672 O
platelet NCT03862027 673 681 B-Observation-Name___Observation-Type-Value:lab
count NCT03862027 682 687 I-Observation-Name___Observation-Type-Value:lab
< NCT03862027 688 689 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03862027 691 693 B-Eq-Value
) NCT03862027 694 695 O
or NCT03862027 696 698 O
coagulopathy NCT03862027 699 711 B-Condition-Name
( NCT03862027 712 713 O
INR NCT03862027 714 717 B-Observation-Name___Observation-Type-Value:lab
> NCT03862027 718 719 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03862027 721 722 B-Eq-Value
or NCT03862027 723 725 O
on NCT03862027 726 728 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
oral NCT03862027 729 733 B-Drug-Name
anticoagulants NCT03862027 734 748 I-Drug-Name
) NCT03862027 749 750 O
. NCT03862027 752 753 O

4 NCT03862027 758 759 O
. NCT03862027 759 760 O
Pre NCT03862027 762 765 O
- NCT03862027 766 767 O
enrollment NCT03862027 768 778 O
ICP NCT03862027 779 782 B-Observation-Name___Observation-Type-Value:lab
> NCT03862027 783 784 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03862027 786 788 B-Eq-Value
mm NCT03862027 789 791 B-Eq-Unit
Hg NCT03862027 792 794 I-Eq-Unit

5 NCT03862027 798 799 O
. NCT03862027 799 800 O
Pre NCT03862027 802 805 O
- NCT03862027 806 807 O
enrollment NCT03862027 808 818 O
CPP NCT03862027 819 822 B-Observation-Name___Observation-Type-Value:lab
< NCT03862027 823 824 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03862027 826 828 B-Eq-Value
mm NCT03862027 829 831 B-Eq-Unit
Hg NCT03862027 832 834 I-Eq-Unit

6 NCT03862027 838 839 O
. NCT03862027 839 840 O
Planned NCT03862027 842 849 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
change NCT03862027 850 856 B-Stability___Stability-Value:change
in NCT03862027 857 859 O
the NCT03862027 860 863 O
external NCT03862027 864 872 B-Procedure-Name
ventricular NCT03862027 873 884 I-Procedure-Name
drain NCT03862027 885 890 I-Procedure-Name
set NCT03862027 891 894 O
point NCT03862027 895 900 O
during NCT03862027 901 907 O
the NCT03862027 908 911 O
pre NCT03862027 912 915 O
- NCT03862027 916 917 O
intervention NCT03862027 918 930 B-Procedure-Name
, NCT03862027 931 932 O
intervention NCT03862027 933 945 B-Procedure-Name
or NCT03862027 946 948 O
post NCT03862027 949 953 O
- NCT03862027 954 955 O
intervention NCT03862027 956 968 B-Procedure-Name
periods NCT03862027 969 976 O

7 NCT03862027 980 981 O
. NCT03862027 981 982 O
Incarceration NCT03862027 984 997 B-Observation-Name

8 NCT03862027 1001 1002 O
. NCT03862027 1002 1003 O
Variation NCT03862027 1005 1014 B-Stability___Stability-Value:change
in NCT03862027 1015 1017 O
ICP NCT03862027 1018 1021 B-Observation-Name___Observation-Type-Value:lab
of NCT03862027 1022 1024 O
> NCT03862027 1025 1026 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03862027 1028 1029 B-Eq-Value
cm NCT03862027 1030 1032 B-Eq-Unit
H NCT03862027 1033 1034 B-Eq-Unit
2O NCT03862027 1035 1037 I-Eq-Unit
in NCT03862027 1038 1040 O
the NCT03862027 1041 1044 O
hour NCT03862027 1045 1049 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
prior NCT03862027 1050 1055 O
to NCT03862027 1056 1058 O
intervention NCT03862027 1059 1071 B-Procedure-Name
. NCT03862027 1072 1073 O

Subjects NCT03860181 0 8 O
will NCT03860181 9 13 O
be NCT03860181 14 16 O
included NCT03860181 17 25 O
if NCT03860181 26 28 O
: NCT03860181 29 30 O

- NCT03860181 34 35 O
They NCT03860181 37 41 O
are NCT03860181 42 45 O
18 NCT03860181 47 49 B-Eq-Value
years NCT03860181 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03860181 56 58 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03860181 59 64 I-Eq-Operator___Eq-Operator-Value:GTEQ
; NCT03860181 64 65 O

- NCT03860181 68 69 O
They NCT03860181 71 75 O
are NCT03860181 76 79 O
undergoing NCT03860181 80 90 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
primary NCT03860181 91 98 O
total NCT03860181 99 104 B-Procedure-Name
shoulder NCT03860181 105 113 I-Procedure-Name
arthroplasty NCT03860181 114 126 I-Procedure-Name
by NCT03860181 127 129 O
the NCT03860181 130 133 O
principal NCT03860181 134 143 O
and NCT03860181 144 147 O
co NCT03860181 148 150 O
- NCT03860181 151 152 O
investigator NCT03860181 153 165 O
. NCT03860181 166 167 O

- NCT03860181 171 172 O
They NCT03860181 174 178 O
are NCT03860181 179 182 O
willing NCT03860181 183 190 O
and NCT03860181 191 194 O
have NCT03860181 195 199 O
the NCT03860181 200 203 O
capacity NCT03860181 204 212 O
to NCT03860181 213 215 O
provide NCT03860181 216 223 O
informed NCT03860181 224 232 O
consent NCT03860181 233 240 O
; NCT03860181 240 241 O

- NCT03860181 244 245 O
They NCT03860181 247 251 O
expect NCT03860181 252 258 O
to NCT03860181 259 261 O
continue NCT03860181 262 270 O
their NCT03860181 271 276 O
post NCT03860181 277 281 O
- NCT03860181 282 283 O
operative NCT03860181 284 293 B-Procedure-Name
follow NCT03860181 294 300 O
up NCT03860181 301 303 O
care NCT03860181 304 308 O
with NCT03860181 309 313 O
their NCT03860181 314 319 O
operating NCT03860181 320 329 O
surgeons NCT03860181 330 338 O
at NCT03860181 339 341 O
Medical NCT03860181 342 349 B-Location___Location-Value:hospital
University NCT03860181 350 360 I-Location___Location-Value:hospital
of NCT03860181 361 363 I-Location___Location-Value:hospital
South NCT03860181 364 369 I-Location___Location-Value:hospital
Carolina NCT03860181 370 378 I-Location___Location-Value:hospital
( NCT03860181 379 380 O
MUSC NCT03860181 381 385 B-Location
) NCT03860181 386 387 O
. NCT03860181 389 390 O

Subjects NCT03860181 392 400 O
will NCT03860181 401 405 O
be NCT03860181 406 408 O
excluded NCT03860181 409 417 O
if NCT03860181 418 420 O
: NCT03860181 421 422 O

- NCT03860181 426 427 O
They NCT03860181 429 433 O
have NCT03860181 434 438 O
a NCT03860181 439 440 O
unique NCT03860181 441 447 O
, NCT03860181 448 449 O
identifying NCT03860181 450 461 O
tattoo NCT03860181 462 468 B-Condition-Name
or NCT03860181 469 471 O
skin NCT03860181 472 476 B-Condition-Name
marking NCT03860181 477 484 I-Condition-Name
within NCT03860181 485 491 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03860181 493 494 B-Eq-Value
inches NCT03860181 495 501 B-Eq-Unit
of NCT03860181 502 504 O
intended NCT03860181 505 513 O
site NCT03860181 514 518 O
of NCT03860181 519 521 O
surgical NCT03860181 522 530 B-Procedure-Name
incision NCT03860181 531 539 I-Procedure-Name

- NCT03860181 542 543 O
They NCT03860181 545 549 O
self NCT03860181 550 554 O
- NCT03860181 555 556 O
report NCT03860181 557 563 O
a NCT03860181 564 565 O
known NCT03860181 566 571 O
hypersensitivity NCT03860181 572 588 B-Condition-Name
to NCT03860181 589 591 O
cyanoacrylate NCT03860181 592 605 B-Drug-Name
, NCT03860181 606 607 O
formaldehyde NCT03860181 608 620 B-Drug-Name
, NCT03860181 621 622 O
benzalkonium NCT03860181 623 635 B-Drug-Name
chloride NCT03860181 636 644 I-Drug-Name
, NCT03860181 645 646 O
or NCT03860181 647 649 O
pressure NCT03860181 650 658 B-Condition-Name
sensitive NCT03860181 659 668 I-Condition-Name
adhesive NCT03860181 669 677 I-Condition-Name
; NCT03860181 677 678 O

- NCT03860181 681 682 O
They NCT03860181 684 688 O
self NCT03860181 689 693 O
- NCT03860181 694 695 O
report NCT03860181 696 702 O
or NCT03860181 703 705 O
have NCT03860181 706 710 O
a NCT03860181 711 712 O
documented NCT03860181 713 723 O
prior NCT03860181 724 729 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ipsilateral NCT03860181 730 741 O
shoulder NCT03860181 742 750 B-Procedure-Name
arthroplasty NCT03860181 751 763 I-Procedure-Name
or NCT03860181 764 766 O
other NCT03860181 767 772 O
open NCT03860181 773 777 O
ispilateral NCT03860181 778 789 O
shoulder NCT03860181 790 798 B-Procedure-Name
surgery NCT03860181 799 806 I-Procedure-Name
utilizing NCT03860181 807 816 O
the NCT03860181 817 820 O
delto NCT03860181 821 826 O
- NCT03860181 827 828 O
pectoral NCT03860181 829 837 O
approach NCT03860181 838 846 O
; NCT03860181 846 847 O

- NCT03860181 850 851 O
Their NCT03860181 853 858 O
medical NCT03860181 859 866 O
record NCT03860181 867 873 O
shows NCT03860181 874 879 O
that NCT03860181 880 884 O
they NCT03860181 885 889 O
are NCT03860181 890 893 O
HIV NCT03860181 894 897 B-Condition-Name
positive NCT03860181 898 906 B-Polarity___Polarity-Value:positive
or NCT03860181 907 909 O
otherwise NCT03860181 910 919 O
immunocompromised NCT03860181 920 937 B-Condition-Name
; NCT03860181 937 938 O

- NCT03860181 941 942 O
Their NCT03860181 944 949 O
medical NCT03860181 950 957 O
record NCT03860181 958 964 O
shows NCT03860181 965 970 O
a NCT03860181 971 972 O
skin NCT03860181 973 977 O
abnormality NCT03860181 978 989 B-Condition-Name
or NCT03860181 990 992 O
dermatological NCT03860181 993 1007 B-Condition-Name
condition NCT03860181 1008 1017 I-Condition-Name
which NCT03860181 1018 1023 O
affects NCT03860181 1024 1031 B-Stability___Stability-Value:change
skin NCT03860181 1032 1036 B-Condition-Name
healing NCT03860181 1037 1044 I-Condition-Name
; NCT03860181 1044 1045 O

- NCT03860181 1048 1049 O
They NCT03860181 1051 1055 O
report NCT03860181 1056 1062 O
a NCT03860181 1063 1064 O
personal NCT03860181 1065 1073 O
or NCT03860181 1074 1076 O
family NCT03860181 1077 1083 O
history NCT03860181 1084 1091 O
of NCT03860181 1092 1094 O
significant NCT03860181 1095 1106 O
keloid NCT03860181 1107 1113 O
or NCT03860181 1114 1116 O
significant NCT03860181 1117 1128 B-Severity___Severity-Value:severe
hypertrophic NCT03860181 1129 1141 B-Condition-Name
scar NCT03860181 1142 1146 I-Condition-Name
formations NCT03860181 1147 1157 I-Condition-Name
, NCT03860181 1158 1159 O
or NCT03860181 1160 1162 O
other NCT03860181 1163 1168 O
problems NCT03860181 1169 1177 B-Condition-Name
with NCT03860181 1178 1182 I-Condition-Name
wound NCT03860181 1183 1188 I-Condition-Name
healing NCT03860181 1189 1196 I-Condition-Name
. NCT03860181 1197 1198 O

Inclusion NCT03867188 0 9 O
Criteria NCT03867188 10 18 O
: NCT03867188 19 20 O

- NCT03867188 24 25 O
Patients NCT03867188 27 35 O
with NCT03867188 36 40 O
a NCT03867188 41 42 O
soft NCT03867188 43 47 O
tissue NCT03867188 48 54 O
sarcoma NCT03867188 55 62 B-Condition-Name
of NCT03867188 63 65 O
the NCT03867188 66 69 O
thigh NCT03867188 70 75 O

- NCT03867188 78 79 O
Must NCT03867188 81 85 O
have NCT03867188 86 90 O
sufficient NCT03867188 91 101 B-Polarity___Polarity-Value:normal
health NCT03867188 102 108 B-Condition-Name
to NCT03867188 109 111 O
withstand NCT03867188 112 121 O
the NCT03867188 122 125 O
physical NCT03867188 126 134 O
demands NCT03867188 135 142 O
of NCT03867188 143 145 O
surgery NCT03867188 146 153 B-Procedure-Name

- NCT03867188 156 157 O
≥ NCT03867188 159 160 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03867188 162 164 B-Eq-Value
years NCT03867188 165 170 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867188 171 174 O

- NCT03867188 177 178 O
ECOG NCT03867188 180 184 B-Observation-Name___Observation-Type-Value:clinical-score
performance NCT03867188 185 196 I-Observation-Name___Observation-Type-Value:clinical-score
status NCT03867188 197 203 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03867188 204 206 O
≤ NCT03867188 207 208 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03867188 210 211 B-Eq-Value

- NCT03867188 215 216 O
Ability NCT03867188 218 225 O
to NCT03867188 226 228 O
understand NCT03867188 229 239 O
and NCT03867188 240 243 O
the NCT03867188 244 247 O
willingness NCT03867188 248 259 O
to NCT03867188 260 262 O
sign NCT03867188 263 267 O
an NCT03867188 268 270 O
IRB NCT03867188 271 274 O
- NCT03867188 275 276 O
approved NCT03867188 277 285 O
informed NCT03867188 286 294 O
consent NCT03867188 295 302 O
document NCT03867188 303 311 O
( NCT03867188 312 313 O
either NCT03867188 314 320 O
directly NCT03867188 321 329 O
or NCT03867188 330 332 O
via NCT03867188 333 336 O
a NCT03867188 337 338 O
legally NCT03867188 339 346 O
authorized NCT03867188 347 357 O
representative NCT03867188 358 372 O
) NCT03867188 373 374 O

Exclusion NCT03867188 376 385 O
Criteria NCT03867188 386 394 O
: NCT03867188 395 396 O

- NCT03867188 400 401 O
History NCT03867188 403 410 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867188 411 413 O
clinically NCT03867188 414 424 O
significant NCT03867188 425 436 B-Severity___Severity-Value:severe
medical NCT03867188 437 444 O
conditions NCT03867188 445 455 O
including NCT03867188 456 465 O
: NCT03867188 466 467 O
Cardiovascular NCT03867188 468 482 O
: NCT03867188 483 484 O
Atrial NCT03867188 485 491 B-Condition-Name
Fibrillation NCT03867188 492 504 I-Condition-Name
, NCT03867188 505 506 O
Ventricular NCT03867188 507 518 B-Condition-Name
Fibrillation NCT03867188 519 531 I-Condition-Name
, NCT03867188 532 533 O
Significant NCT03867188 534 545 B-Severity___Severity-Value:severe
Coronary NCT03867188 546 554 B-Condition-Name
Artery NCT03867188 555 561 I-Condition-Name
Disease NCT03867188 562 569 I-Condition-Name
. NCT03867188 570 571 O
Hepatic NCT03867188 573 580 O
: NCT03867188 581 582 O
Viral NCT03867188 583 588 O
or NCT03867188 589 591 O
Autoimmune NCT03867188 592 602 O
Hepatitis NCT03867188 603 612 B-Condition-Name
, NCT03867188 613 614 O
Cirrhosis NCT03867188 615 624 B-Condition-Name
of NCT03867188 625 627 O
the NCT03867188 628 631 O
Liver NCT03867188 632 637 O
, NCT03867188 638 639 O
Liver NCT03867188 640 645 O
Metabolism NCT03867188 646 656 B-Condition-Name
Disorders NCT03867188 657 666 I-Condition-Name
. NCT03867188 667 668 O
Renal NCT03867188 670 675 O
: NCT03867188 676 677 O
Any NCT03867188 678 681 O
form NCT03867188 682 686 O
of NCT03867188 687 689 O
renal NCT03867188 690 695 B-Condition-Name
impairment NCT03867188 696 706 I-Condition-Name
. NCT03867188 707 708 O
EXPAREL NCT03867188 710 717 B-Drug-Name
® NCT03867188 717 718 O
is NCT03867188 719 721 O
cleared NCT03867188 722 729 O
by NCT03867188 730 732 O
the NCT03867188 733 736 O
kidneys NCT03867188 737 744 O
, NCT03867188 745 746 O
thus NCT03867188 747 751 O
any NCT03867188 752 755 O
form NCT03867188 756 760 O
of NCT03867188 761 763 O
renal NCT03867188 764 769 B-Condition-Name
impairment NCT03867188 770 780 I-Condition-Name
could NCT03867188 781 786 O
lead NCT03867188 787 791 O
to NCT03867188 792 794 O
an NCT03867188 795 797 O
adverse NCT03867188 798 805 B-Condition-Name
reaction NCT03867188 806 814 I-Condition-Name
. NCT03867188 815 816 O

- NCT03867188 820 821 O
Medical NCT03867188 823 830 O
condition NCT03867188 831 840 O
( NCT03867188 841 842 O
s NCT03867188 843 844 O
) NCT03867188 845 846 O
or NCT03867188 847 849 O
concurrent NCT03867188 850 860 O
surgery NCT03867188 861 868 B-Procedure-Name
that NCT03867188 869 873 O
may NCT03867188 874 877 O
have NCT03867188 878 882 O
required NCT03867188 883 891 O
analgesic NCT03867188 892 901 B-Procedure-Name
treatment NCT03867188 902 911 I-Procedure-Name
in NCT03867188 912 914 O
the NCT03867188 915 918 O
post NCT03867188 919 923 O
operative NCT03867188 924 933 B-Procedure-Name
period NCT03867188 934 940 O
for NCT03867188 941 944 O
pain NCT03867188 945 949 B-Condition-Name
that NCT03867188 950 954 O
was NCT03867188 955 958 O
not NCT03867188 959 962 O
strictly NCT03867188 963 971 O
related NCT03867188 972 979 O
to NCT03867188 980 982 O
the NCT03867188 983 986 O
study NCT03867188 987 992 O
surgery NCT03867188 993 1000 B-Procedure-Name
. NCT03867188 1001 1002 O

- NCT03867188 1006 1007 O
Any NCT03867188 1009 1012 O
clinically NCT03867188 1013 1023 O
significant NCT03867188 1024 1035 O
event NCT03867188 1036 1041 O
or NCT03867188 1042 1044 O
condition NCT03867188 1045 1054 O
discovered NCT03867188 1055 1065 O
during NCT03867188 1066 1072 O
surgery NCT03867188 1073 1080 B-Procedure-Name
that NCT03867188 1081 1085 O
may NCT03867188 1086 1089 O
have NCT03867188 1090 1094 O
complicated NCT03867188 1095 1106 O
the NCT03867188 1107 1110 O
patient NCT03867188 1111 1118 O
's NCT03867188 1118 1120 O
post NCT03867188 1121 1125 O
surgical NCT03867188 1126 1134 B-Procedure-Name
course NCT03867188 1135 1141 O
such NCT03867188 1142 1146 O
as NCT03867188 1147 1149 O
vascular NCT03867188 1150 1158 O
or NCT03867188 1159 1161 O
nerve NCT03867188 1162 1167 O
involvement NCT03867188 1168 1179 B-Condition-Name
that NCT03867188 1180 1184 O
was NCT03867188 1185 1188 O
unknown NCT03867188 1189 1196 O
before NCT03867188 1197 1203 O
surgery NCT03867188 1204 1211 B-Procedure-Name
. NCT03867188 1212 1213 O

- NCT03867188 1217 1218 O
History NCT03867188 1220 1227 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867188 1228 1230 O
allergic NCT03867188 1231 1239 O
reactions NCT03867188 1240 1249 O
attributed NCT03867188 1250 1260 O
to NCT03867188 1261 1263 O
compounds NCT03867188 1264 1273 O
of NCT03867188 1274 1276 O
similar NCT03867188 1277 1284 O
chemical NCT03867188 1285 1293 O
or NCT03867188 1294 1296 O
biologic NCT03867188 1297 1305 O
composition NCT03867188 1306 1317 O
to NCT03867188 1318 1320 O
liposomal NCT03867188 1321 1330 B-Drug-Name
bupivacaine NCT03867188 1331 1342 I-Drug-Name
. NCT03867188 1343 1344 O

- NCT03867188 1348 1349 O
Pregnant NCT03867188 1351 1359 B-Condition-Name
women NCT03867188 1360 1365 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
are NCT03867188 1366 1369 O
excluded NCT03867188 1370 1378 O
from NCT03867188 1379 1383 O
this NCT03867188 1384 1388 O
study NCT03867188 1389 1394 O
because NCT03867188 1395 1402 O
EXPAREL NCT03867188 1403 1410 B-Drug-Name
has NCT03867188 1411 1414 O
the NCT03867188 1415 1418 O
potential NCT03867188 1419 1428 O
for NCT03867188 1429 1432 O
teratogenic NCT03867188 1433 1444 O
or NCT03867188 1445 1447 O
abortifacient NCT03867188 1448 1461 O
effects NCT03867188 1462 1469 B-Condition-Name
. NCT03867188 1470 1471 O
Because NCT03867188 1473 1480 O
there NCT03867188 1481 1486 O
is NCT03867188 1487 1489 O
an NCT03867188 1490 1492 O
unknown NCT03867188 1493 1500 O
but NCT03867188 1501 1504 O
potential NCT03867188 1505 1514 O
risk NCT03867188 1515 1519 O
for NCT03867188 1520 1523 O
adverse NCT03867188 1524 1531 B-Condition-Name
events NCT03867188 1532 1538 I-Condition-Name
in NCT03867188 1539 1541 O
nursing NCT03867188 1542 1549 B-Condition-Name
infants NCT03867188 1550 1557 O
secondary NCT03867188 1558 1567 O
to NCT03867188 1568 1570 O
treatment NCT03867188 1571 1580 O
of NCT03867188 1581 1583 O
the NCT03867188 1584 1587 O
mother NCT03867188 1588 1594 O
with NCT03867188 1595 1599 O
EXPAREL NCT03867188 1600 1607 B-Drug-Name
, NCT03867188 1608 1609 O
breastfeeding NCT03867188 1610 1623 B-Condition-Name
should NCT03867188 1624 1630 O
be NCT03867188 1631 1633 O
discontinued NCT03867188 1634 1646 O
if NCT03867188 1647 1649 O
the NCT03867188 1650 1653 O
mother NCT03867188 1654 1660 O
is NCT03867188 1661 1663 O
treated NCT03867188 1664 1671 O
with NCT03867188 1672 1676 O
EXPAREL NCT03867188 1677 1684 B-Drug-Name
. NCT03867188 1685 1686 O

Inclusion NCT03865953 0 9 O
Criteria NCT03865953 10 18 O
: NCT03865953 19 20 O

1 NCT03865953 25 26 O
. NCT03865953 26 27 O
Clinical NCT03865953 29 37 O
diagnosis NCT03865953 38 47 O
of NCT03865953 48 50 O
post NCT03865953 51 55 B-Condition-Name
herpetic NCT03865953 56 64 I-Condition-Name
neuralgia NCT03865953 65 74 I-Condition-Name
, NCT03865953 75 76 O
with NCT03865953 77 81 O
pain NCT03865953 82 86 B-Condition-Name
persisting NCT03865953 87 97 O
for NCT03865953 98 101 O
at NCT03865953 102 104 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865953 105 110 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03865953 112 113 B-Eq-Value
months NCT03865953 114 120 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03865953 121 126 O
the NCT03865953 127 130 O
onset NCT03865953 131 136 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03865953 137 139 O
herpes NCT03865953 140 146 B-Condition-Name
zoster NCT03865953 147 153 I-Condition-Name
rash NCT03865953 154 158 I-Condition-Name
OR NCT03865953 159 161 O

2 NCT03865953 165 166 O
. NCT03865953 166 167 O
Clinical NCT03865953 169 177 O
diagnosis NCT03865953 178 187 O
of NCT03865953 188 190 O
distal NCT03865953 191 197 O
painful NCT03865953 198 205 O
polyneuropathy NCT03865953 206 220 B-Condition-Name
due NCT03865953 221 224 O
to NCT03865953 225 227 O
Type NCT03865953 228 232 O
I NCT03865953 233 234 O
or NCT03865953 235 237 O
Type NCT03865953 238 242 O
II NCT03865953 243 245 O
diabetes NCT03865953 246 254 B-Condition-Name
mellitus NCT03865953 255 263 I-Condition-Name
with NCT03865953 264 268 O
: NCT03865953 269 270 O

1 NCT03865953 280 281 O
. NCT03865953 281 282 O
symmetrical NCT03865953 284 295 O
, NCT03865953 296 297 O
bilateral NCT03865953 298 307 O
pain NCT03865953 308 312 B-Condition-Name
in NCT03865953 313 315 O
the NCT03865953 316 319 O
lower NCT03865953 320 325 O
extremities NCT03865953 326 337 O
for NCT03865953 338 341 O
at NCT03865953 342 344 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865953 345 350 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03865953 352 353 B-Eq-Value
months NCT03865953 354 360 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03865953 361 364 O

2 NCT03865953 373 374 O
. NCT03865953 374 375 O
diabetes NCT03865953 377 385 B-Condition-Name
under NCT03865953 386 391 B-Stability___Stability-Value:stable
control NCT03865953 392 399 I-Stability___Stability-Value:stable
for NCT03865953 400 403 O
at NCT03865953 404 406 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865953 407 412 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03865953 414 415 B-Eq-Value
months NCT03865953 416 422 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03865953 423 428 O
to NCT03865953 429 431 O
randomisation NCT03865953 432 445 O
, NCT03865953 446 447 O
as NCT03865953 448 450 O
indicated NCT03865953 451 460 O
by NCT03865953 461 463 O
a NCT03865953 464 465 O
glycated NCT03865953 466 474 B-Observation-Name___Observation-Type-Value:lab
haemoglobin NCT03865953 475 486 I-Observation-Name___Observation-Type-Value:lab
level NCT03865953 487 492 I-Observation-Name___Observation-Type-Value:lab
( NCT03865953 493 494 O
HbA NCT03865953 495 498 B-Observation-Name___Observation-Type-Value:lab
1c NCT03865953 499 501 I-Observation-Name___Observation-Type-Value:lab
) NCT03865953 502 503 O
of NCT03865953 504 506 O
≤ NCT03865953 507 508 B-Eq-Operator___Eq-Operator-Value:LTEQ
11 NCT03865953 510 512 B-Eq-Value
% NCT03865953 513 514 B-Eq-Unit
( NCT03865953 515 516 O
97 NCT03865953 518 520 B-Eq-Value
mmol NCT03865953 521 525 B-Eq-Unit
/ NCT03865953 526 527 O
mol NCT03865953 528 531 B-Eq-Unit
) NCT03865953 532 533 O
and NCT03865953 534 537 O
on NCT03865953 538 540 O
a NCT03865953 541 542 O
stable NCT03865953 543 549 B-Stability___Stability-Value:stable
dose NCT03865953 550 554 O
of NCT03865953 555 557 O
insulin NCT03865953 558 565 B-Drug-Name
or NCT03865953 566 568 O
oral NCT03865953 569 573 O
diabetic NCT03865953 574 582 B-Condition-Name
medication NCT03865953 583 593 O
for NCT03865953 594 597 O
3 NCT03865953 599 600 B-Eq-Value
months NCT03865953 601 607 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03865953 608 613 O
to NCT03865953 614 616 O
screening NCT03865953 617 626 O
, NCT03865953 627 628 O
and NCT03865953 629 632 O

3 NCT03865953 641 642 O
. NCT03865953 642 643 O
no NCT03865953 645 647 O
change NCT03865953 648 654 B-Stability___Stability-Value:change
in NCT03865953 655 657 O
diabetic NCT03865953 658 666 B-Condition-Name
medication NCT03865953 667 677 O
planned NCT03865953 678 685 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03865953 686 689 O
the NCT03865953 690 693 O
duration NCT03865953 694 702 O
of NCT03865953 703 705 O
the NCT03865953 706 709 O
study NCT03865953 710 715 O

3 NCT03865953 719 720 O
. NCT03865953 720 721 O
Positive NCT03865953 723 731 B-Polarity___Polarity-Value:positive
sensory NCT03865953 732 739 B-Condition-Name
symptoms NCT03865953 740 748 I-Condition-Name
( NCT03865953 749 750 O
mechanical NCT03865953 751 761 O
or NCT03865953 762 764 O
thermal NCT03865953 765 772 O
) NCT03865953 773 774 O
associated NCT03865953 775 785 O
with NCT03865953 786 790 O
neuropathic NCT03865953 791 802 O
pain NCT03865953 803 807 B-Condition-Name
, NCT03865953 808 809 O
confirmed NCT03865953 810 819 O
by NCT03865953 820 822 O
: NCT03865953 823 824 O

1 NCT03865953 834 835 O
. NCT03865953 835 836 O
painDETECT NCT03865953 838 848 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
questionnaire NCT03865953 849 862 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03865953 863 864 O
PD NCT03865953 865 867 B-Observation-Name
- NCT03865953 868 869 I-Observation-Name
Q NCT03865953 870 871 I-Observation-Name
) NCT03865953 872 873 O
and NCT03865953 874 877 O

2 NCT03865953 886 887 O
. NCT03865953 887 888 O
Clinical NCT03865953 890 898 O
assessment NCT03865953 899 909 B-Procedure-Name
, NCT03865953 910 911 O
showing NCT03865953 912 919 O
signs NCT03865953 920 925 O
of NCT03865953 926 928 O
neuropathic NCT03865953 929 940 O
pain NCT03865953 941 945 B-Condition-Name
in NCT03865953 946 948 O
either NCT03865953 949 955 O
a NCT03865953 956 957 O
dermatomal NCT03865953 958 968 O
( NCT03865953 969 970 O
PHN NCT03865953 971 974 B-Condition-Name
) NCT03865953 975 976 O
or NCT03865953 977 979 O
distal NCT03865953 980 986 O
symmetrical NCT03865953 987 998 B-Condition-Name
distribution NCT03865953 999 1011 I-Condition-Name
( NCT03865953 1012 1013 O
DPN NCT03865953 1014 1017 B-Condition-Name
) NCT03865953 1018 1019 O

8 NCT03865953 1022 1023 O
. NCT03865953 1023 1024 O
An NCT03865953 1026 1028 O
average NCT03865953 1029 1036 O
daily NCT03865953 1037 1042 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
pain NCT03865953 1043 1047 B-Observation-Name___Observation-Type-Value:measurement
score NCT03865953 1048 1053 I-Observation-Name___Observation-Type-Value:measurement
on NCT03865953 1054 1056 O
the NCT03865953 1057 1060 O
NPRS NCT03865953 1061 1065 B-Observation-Name
of NCT03865953 1066 1068 O
at NCT03865953 1069 1071 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03865953 1072 1077 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03865953 1079 1080 B-Eq-Value
and NCT03865953 1081 1084 O
no NCT03865953 1085 1087 O
more NCT03865953 1088 1092 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03865953 1093 1097 I-Eq-Operator___Eq-Operator-Value:GT
8 NCT03865953 1099 1100 B-Eq-Value
in NCT03865953 1101 1103 O
the NCT03865953 1104 1107 O
last NCT03865953 1108 1112 O
five NCT03865953 1113 1117 O
diary NCT03865953 1118 1123 O
entries NCT03865953 1124 1131 O
before NCT03865953 1132 1138 O
randomisation NCT03865953 1139 1152 O

Exclusion NCT03865953 1153 1162 O
Criteria NCT03865953 1163 1171 O
: NCT03865953 1172 1173 O

1 NCT03865953 1178 1179 O
. NCT03865953 1179 1180 O
Presence NCT03865953 1182 1190 O
of NCT03865953 1191 1193 O
moderate NCT03865953 1194 1202 B-Severity___Severity-Value:moderate
to NCT03865953 1203 1205 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03865953 1206 1212 B-Severity___Severity-Value:severe
pain NCT03865953 1213 1217 B-Condition-Name
from NCT03865953 1218 1222 O
other NCT03865953 1223 1228 O
causes NCT03865953 1229 1235 O
that NCT03865953 1236 1240 O
may NCT03865953 1241 1244 O
confound NCT03865953 1245 1253 B-Stability___Stability-Value:change
assessment NCT03865953 1254 1264 O
or NCT03865953 1265 1267 O
self NCT03865953 1268 1272 O
- NCT03865953 1273 1274 O
evaluation NCT03865953 1275 1285 O
of NCT03865953 1286 1288 O
NP NCT03865953 1289 1291 O
. NCT03865953 1292 1293 O

2 NCT03865953 1298 1299 O
. NCT03865953 1299 1300 O
Subjects NCT03865953 1302 1310 O
with NCT03865953 1311 1315 O
both NCT03865953 1316 1320 O
DPN NCT03865953 1321 1324 B-Condition-Name
and NCT03865953 1325 1328 O
PHN NCT03865953 1329 1332 B-Condition-Name


Inclusion NCT03869827 0 9 O
Criteria NCT03869827 10 18 O
: NCT03869827 19 20 O

- NCT03869827 24 25 O
All NCT03869827 27 30 O
birth NCT03869827 31 36 O
between NCT03869827 37 44 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03869827 46 48 B-Eq-Value
+ NCT03869827 49 50 O
0 NCT03869827 52 53 B-Eq-Value
weeks NCT03869827 54 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03869827 60 62 O
amenorrhea NCT03869827 63 73 B-Condition-Name
and NCT03869827 74 77 O
36 NCT03869827 79 81 B-Eq-Value
+ NCT03869827 82 83 O
6 NCT03869827 85 86 B-Eq-Value
weeks NCT03869827 87 92 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03869827 93 95 O
amenorrhea NCT03869827 96 106 B-Condition-Name

- NCT03869827 109 110 O
with NCT03869827 112 116 O
isolated NCT03869827 117 125 O
intrauterine NCT03869827 126 138 B-Condition-Name
growth NCT03869827 139 145 I-Condition-Name
restriction NCT03869827 146 157 I-Condition-Name
at NCT03869827 158 160 O
the NCT03869827 161 164 O
maternity NCT03869827 165 174 B-Location___Location-Value:unit
ward NCT03869827 175 179 I-Location___Location-Value:unit
of NCT03869827 180 182 O
the NCT03869827 183 186 O
hospital NCT03869827 187 195 B-Location___Location-Value:hospital
Femme NCT03869827 196 201 I-Location___Location-Value:hospital
- NCT03869827 202 203 I-Location___Location-Value:hospital
Mère NCT03869827 204 208 I-Location___Location-Value:hospital
- NCT03869827 209 210 I-Location___Location-Value:hospital
Enfant NCT03869827 211 217 I-Location___Location-Value:hospital

- NCT03869827 220 221 O
from NCT03869827 223 227 O
1 NCT03869827 229 230 B-Eq-Value
st NCT03869827 231 233 I-Eq-Value
of NCT03869827 234 236 I-Eq-Value
january NCT03869827 237 244 I-Eq-Value
2011 NCT03869827 246 250 I-Eq-Value
to NCT03869827 251 253 B-Eq-Operator___Eq-Operator-Value:BETWEEN
31 NCT03869827 255 257 B-Eq-Value
december NCT03869827 258 266 I-Eq-Value
2016 NCT03869827 268 272 I-Eq-Value
. NCT03869827 272 273 O

Inclusion NCT03869827 275 284 O
Criteria NCT03869827 285 293 O
for NCT03869827 294 297 O
control NCT03869827 298 305 O
group NCT03869827 306 311 O
: NCT03869827 312 313 O

- NCT03869827 317 318 O
All NCT03869827 320 323 O
birth NCT03869827 324 329 O
between NCT03869827 330 337 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03869827 339 341 B-Eq-Value
+ NCT03869827 342 343 O
0 NCT03869827 345 346 B-Eq-Value
weeks NCT03869827 347 352 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03869827 353 355 O
amenorrhea NCT03869827 356 366 B-Condition-Name
and NCT03869827 367 370 O
36 NCT03869827 372 374 B-Eq-Value
+ NCT03869827 375 376 O
6 NCT03869827 378 379 B-Eq-Value
weeks NCT03869827 380 385 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03869827 386 388 O
amenorrhea NCT03869827 389 399 B-Condition-Name

- NCT03869827 402 403 O
without NCT03869827 405 412 O
isolated NCT03869827 413 421 O
intrauterine NCT03869827 422 434 B-Condition-Name
growth NCT03869827 435 441 I-Condition-Name
restriction NCT03869827 442 453 I-Condition-Name
at NCT03869827 454 456 O
the NCT03869827 457 460 O
maternity NCT03869827 461 470 B-Location___Location-Value:unit
ward NCT03869827 471 475 I-Location___Location-Value:unit
of NCT03869827 476 478 O
the NCT03869827 479 482 O
hospital NCT03869827 483 491 B-Location___Location-Value:hospital
Femme NCT03869827 492 497 I-Location___Location-Value:hospital
- NCT03869827 498 499 I-Location___Location-Value:hospital
Mère NCT03869827 500 504 I-Location___Location-Value:hospital
- NCT03869827 505 506 I-Location___Location-Value:hospital
Enfant NCT03869827 507 513 I-Location___Location-Value:hospital

- NCT03869827 516 517 O
from NCT03869827 519 523 O
1 NCT03869827 525 526 B-Eq-Value
st NCT03869827 527 529 I-Eq-Value
of NCT03869827 530 532 I-Eq-Value
january NCT03869827 533 540 I-Eq-Value
2011 NCT03869827 542 546 I-Eq-Value
to NCT03869827 547 549 B-Eq-Operator___Eq-Operator-Value:BETWEEN
31 NCT03869827 551 553 B-Eq-Value
december NCT03869827 554 562 I-Eq-Value
2016 NCT03869827 564 568 I-Eq-Value
. NCT03869827 568 569 O

Exclusion NCT03869827 571 580 O
Criteria NCT03869827 581 589 O
: NCT03869827 590 591 O

- NCT03869827 595 596 O
Infants NCT03869827 598 605 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
born NCT03869827 606 610 O
out NCT03869827 611 614 O
of NCT03869827 615 617 O
the NCT03869827 618 621 O
hospital NCT03869827 622 630 B-Location___Location-Value:hospital
and NCT03869827 631 634 O
secondarily NCT03869827 635 646 B-Encounter-Type___Encounter-Type-Value:transfer
hospitalized NCT03869827 647 659 I-Encounter-Type___Encounter-Type-Value:transfer
in NCT03869827 660 662 O
our NCT03869827 663 666 O
department NCT03869827 667 677 B-Location___Location-Value:unit

- NCT03869827 680 681 O
unaccompanied NCT03869827 683 696 O
pregnancies NCT03869827 697 708 B-Condition-Name

- NCT03869827 711 712 O
multiple NCT03869827 714 722 B-Eq-Operator___Eq-Operator-Value:GT
pregnancies NCT03869827 723 734 B-Condition-Name

- NCT03869827 737 738 O
children NCT03869827 740 748 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03869827 749 753 O
malformations NCT03869827 754 767 B-Condition-Name
or NCT03869827 768 770 O
genetic NCT03869827 771 778 B-Condition-Name
abnormalities NCT03869827 779 792 I-Condition-Name
, NCT03869827 793 794 O

- NCT03869827 798 799 O
medical NCT03869827 801 808 B-Procedure-Name
termination NCT03869827 809 820 I-Procedure-Name
of NCT03869827 821 823 I-Procedure-Name
pregnancy NCT03869827 824 833 I-Procedure-Name

- NCT03869827 836 837 O
fetal NCT03869827 839 844 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
deaths NCT03869827 845 851 O
in NCT03869827 852 854 O
utero NCT03869827 855 860 O

Inclusion NCT03866057 0 9 O
criteria NCT03866057 10 18 O
: NCT03866057 19 20 O

- NCT03866057 24 25 O
age NCT03866057 27 30 O
18 NCT03866057 32 34 B-Eq-Value
- NCT03866057 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
90 NCT03866057 38 40 B-Eq-Value

- NCT03866057 44 45 O
acute NCT03866057 47 52 B-Severity___Severity-Value:severe
ischemic NCT03866057 53 61 O
or NCT03866057 62 64 O
hemorrhagic NCT03866057 65 76 O
stroke NCT03866057 77 83 B-Condition-Name
( NCT03866057 84 85 O
within NCT03866057 86 92 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03866057 94 96 B-Eq-Value
days NCT03866057 97 101 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03866057 102 103 O

- NCT03866057 107 108 O
consent NCT03866057 110 117 O
to NCT03866057 118 120 O
participate NCT03866057 121 132 O
and NCT03866057 133 136 O
to NCT03866057 137 139 O
anonymous NCT03866057 140 149 O
processing NCT03866057 150 160 O
of NCT03866057 161 163 O
data NCT03866057 164 168 O
. NCT03866057 169 170 O

Additional NCT03866057 172 182 O
inclusion NCT03866057 183 192 O
criteria NCT03866057 193 201 O
for NCT03866057 202 205 O
Sub NCT03866057 206 209 O
- NCT03866057 210 211 O
project NCT03866057 212 219 O
Neurophysiological NCT03866057 220 238 O
Markers NCT03866057 239 246 O
: NCT03866057 247 248 O

- NCT03866057 251 252 O
signing NCT03866057 253 260 O
of NCT03866057 261 263 O
informed NCT03866057 264 272 O
consent NCT03866057 273 280 O
for NCT03866057 281 284 O
the NCT03866057 285 288 O
participation NCT03866057 289 302 O
in NCT03866057 303 305 O
the NCT03866057 306 309 O
sub NCT03866057 310 313 O
- NCT03866057 314 315 O
project NCT03866057 316 323 O
. NCT03866057 324 325 O

Additional NCT03866057 327 337 O
inclusion NCT03866057 338 347 O
criteria NCT03866057 348 356 O
for NCT03866057 357 360 O
Epigenetic NCT03866057 361 371 O
subproject NCT03866057 372 382 O
: NCT03866057 383 384 O

- NCT03866057 387 388 O
signing NCT03866057 389 396 O
of NCT03866057 397 399 O
informed NCT03866057 400 408 O
consent NCT03866057 409 416 O
for NCT03866057 417 420 O
participation NCT03866057 421 434 O
in NCT03866057 435 437 O
the NCT03866057 438 441 O
subproject NCT03866057 442 452 O
. NCT03866057 453 454 O

Exclusion NCT03866057 456 465 O
Criteria NCT03866057 466 474 O
: NCT03866057 475 476 O

- NCT03866057 479 480 O
Stroke NCT03866057 481 487 B-Condition-Name
occurred NCT03866057 488 496 O
more NCT03866057 497 501 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866057 502 506 I-Eq-Operator___Eq-Operator-Value:GT
30 NCT03866057 508 510 B-Eq-Value
days NCT03866057 511 515 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
after NCT03866057 516 521 O
the NCT03866057 522 525 O
transfer NCT03866057 526 534 B-Encounter-Type___Encounter-Type-Value:transfer
to NCT03866057 535 537 O
intensive NCT03866057 538 547 B-Location___Location-Value:unit
rehabilitation NCT03866057 548 562 I-Location___Location-Value:unit

Additional NCT03866057 563 573 O
exclusion NCT03866057 574 583 O
criteria NCT03866057 584 592 O
for NCT03866057 593 596 O
Epigenetic NCT03866057 597 607 O
subproject NCT03866057 608 618 O
( NCT03866057 619 620 O
for NCT03866057 621 624 O
retrospective NCT03866057 625 638 O
analysis NCT03866057 639 647 O
) NCT03866057 648 649 O
: NCT03866057 651 652 O

- NCT03866057 656 657 O
history NCT03866057 659 666 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03866057 667 669 O
major NCT03866057 670 675 B-Severity___Severity-Value:severe
psychiatric NCT03866057 676 687 B-Condition-Name
disorder NCT03866057 688 696 I-Condition-Name
or NCT03866057 697 699 O
recent NCT03866057 700 706 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
exacerbation NCT03866057 707 719 B-Condition-Name

- NCT03866057 722 723 O
global NCT03866057 725 731 B-Condition-Name
aphasia NCT03866057 732 739 I-Condition-Name

- NCT03866057 742 743 O
refusal NCT03866057 745 752 O
of NCT03866057 753 755 O
the NCT03866057 756 759 O
patient NCT03866057 760 767 O
to NCT03866057 768 770 O
participate NCT03866057 771 782 O
in NCT03866057 783 785 O
the NCT03866057 786 789 O
study NCT03866057 790 795 O
. NCT03866057 796 797 O

Inclusion NCT03864640 0 9 O
Criteria NCT03864640 10 18 O
: NCT03864640 19 20 O

- NCT03864640 24 25 O
Adult NCT03864640 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03864640 33 41 O
with NCT03864640 42 46 O
colorectal NCT03864640 47 57 O
cancer NCT03864640 58 64 B-Condition-Name
. NCT03864640 65 66 O

Exclusion NCT03864640 68 77 O
Criteria NCT03864640 78 86 O
: NCT03864640 87 88 O

- NCT03864640 92 93 O
Patients NCT03864640 95 103 O
reluctant NCT03864640 104 113 O
to NCT03864640 114 116 O
participate NCT03864640 117 128 O
in NCT03864640 129 131 O
the NCT03864640 132 135 O
study NCT03864640 136 141 O
. NCT03864640 142 143 O

Inclusion NCT03868046 0 9 O
Criteria NCT03868046 10 18 O
: NCT03868046 19 20 O

1 NCT03868046 25 26 O
. NCT03868046 26 27 O
Initiation NCT03868046 29 39 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03868046 40 42 O
treatment NCT03868046 43 52 O
with NCT03868046 53 57 O
a NCT03868046 58 59 O
single NCT03868046 60 66 B-Eq-Value
ICI NCT03868046 67 70 B-Procedure-Name
or NCT03868046 71 73 O
a NCT03868046 74 75 O
combination NCT03868046 76 87 B-Eq-Operator___Eq-Operator-Value:GT
of NCT03868046 88 90 O
ICIs NCT03868046 91 95 B-Procedure-Name
. NCT03868046 96 97 O

2 NCT03868046 102 103 O
. NCT03868046 103 104 O
Acceptation NCT03868046 106 117 O
of NCT03868046 118 120 O
an NCT03868046 121 123 O
informed NCT03868046 124 132 O
consent NCT03868046 133 140 O
. NCT03868046 141 142 O

Exclusion NCT03868046 144 153 O
Criteria NCT03868046 154 162 O
: NCT03868046 163 164 O

1 NCT03868046 169 170 O
. NCT03868046 170 171 O
Life NCT03868046 173 177 B-Observation-Name
expectancy NCT03868046 178 188 I-Observation-Name
lower NCT03868046 189 194 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03868046 195 199 I-Eq-Operator___Eq-Operator-Value:LT
3 NCT03868046 201 202 B-Eq-Value
months NCT03868046 203 209 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
from NCT03868046 210 214 O
the NCT03868046 215 218 O
initiation NCT03868046 219 229 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03868046 230 232 O
treatment NCT03868046 233 242 O
with NCT03868046 243 247 O
ICIs NCT03868046 248 252 B-Procedure-Name
. NCT03868046 253 254 O

2 NCT03868046 259 260 O
. NCT03868046 260 261 O
Proven NCT03868046 263 269 O
hypersensitivity NCT03868046 270 286 B-Condition-Name
or NCT03868046 287 289 O
previous NCT03868046 290 298 O
allergic NCT03868046 299 307 O
anaphylactic NCT03868046 308 320 B-Condition-Name
reaction NCT03868046 321 329 I-Condition-Name
induced NCT03868046 330 337 O
by NCT03868046 338 340 O
a NCT03868046 341 342 O
specific NCT03868046 343 351 O
ICI NCT03868046 352 355 B-Procedure-Name
. NCT03868046 356 357 O

3 NCT03868046 362 363 O
. NCT03868046 363 364 O
Active NCT03868046 366 372 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
autoimmune NCT03868046 373 383 B-Condition-Name
disease NCT03868046 384 391 I-Condition-Name
with NCT03868046 392 396 O
severe NCT03868046 397 403 B-Severity___Severity-Value:severe
involvement NCT03868046 404 415 O
. NCT03868046 416 417 O

4 NCT03868046 422 423 O
. NCT03868046 423 424 O
Eastern NCT03868046 426 433 B-Observation-Name___Observation-Type-Value:clinical-score
Cooperative NCT03868046 434 445 I-Observation-Name___Observation-Type-Value:clinical-score
Oncology NCT03868046 446 454 I-Observation-Name___Observation-Type-Value:clinical-score
Group NCT03868046 455 460 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03868046 461 462 O
ECOG NCT03868046 463 467 B-Observation-Name___Observation-Type-Value:clinical-score
) NCT03868046 468 469 O
performance NCT03868046 470 481 O
status NCT03868046 482 488 O
≥ NCT03868046 489 490 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03868046 492 493 B-Eq-Value
. NCT03868046 493 494 O

5 NCT03868046 499 500 O
. NCT03868046 500 501 O
Ongoing NCT03868046 503 510 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
immunosuppressive NCT03868046 511 528 B-Procedure-Name
therapy NCT03868046 529 536 I-Procedure-Name
: NCT03868046 537 538 O
prednisone NCT03868046 539 549 B-Drug-Name
at NCT03868046 550 552 O
doses NCT03868046 553 558 O
> NCT03868046 559 560 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03868046 562 564 B-Eq-Value
mg NCT03868046 565 567 B-Eq-Unit
/ NCT03868046 568 569 O
day NCT03868046 570 573 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
or NCT03868046 574 576 O
equivalent NCT03868046 577 587 O
( NCT03868046 588 589 O
> NCT03868046 591 592 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03868046 594 597 B-Eq-Value
mg NCT03868046 598 600 B-Eq-Unit
/ NCT03868046 601 602 O
day NCT03868046 603 606 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03868046 607 609 O
dexamethasone NCT03868046 610 623 B-Drug-Name
) NCT03868046 624 625 O
, NCT03868046 627 628 O
and NCT03868046 629 632 O
/ NCT03868046 633 634 O
or NCT03868046 635 637 O
any NCT03868046 638 641 O
dose NCT03868046 642 646 O
of NCT03868046 647 649 O
azathioprine NCT03868046 650 662 B-Drug-Name
, NCT03868046 663 664 O
methotrexate NCT03868046 665 677 B-Drug-Name
, NCT03868046 678 679 O
mycophenolate NCT03868046 680 693 B-Drug-Name
, NCT03868046 694 695 O
cyclophosphamide NCT03868046 696 712 B-Drug-Name
, NCT03868046 713 714 O
leflunomide NCT03868046 715 726 B-Drug-Name
, NCT03868046 727 728 O
rituximab NCT03868046 729 738 B-Drug-Name
, NCT03868046 739 740 O
anti NCT03868046 741 745 B-Drug-Name
- NCT03868046 746 747 I-Drug-Name
tumor NCT03868046 748 753 I-Drug-Name
necrosis NCT03868046 754 762 I-Drug-Name
factor NCT03868046 763 769 I-Drug-Name
drugs NCT03868046 770 775 I-Drug-Name
( NCT03868046 776 777 O
infliximab NCT03868046 778 788 B-Drug-Name
, NCT03868046 789 790 O
etanercept NCT03868046 791 801 B-Drug-Name
, NCT03868046 802 803 O
adalimumab NCT03868046 804 814 B-Drug-Name
, NCT03868046 815 816 O
golimumab NCT03868046 817 826 B-Drug-Name
) NCT03868046 827 828 O
, NCT03868046 830 831 O
belimumab NCT03868046 832 841 B-Drug-Name
and NCT03868046 842 845 O
abatacept NCT03868046 846 855 B-Drug-Name
. NCT03868046 856 857 O

Inclusion NCT03865576 0 9 O
Criteria NCT03865576 10 18 O
: NCT03865576 19 20 O

- NCT03865576 24 25 O
ICU NCT03865576 27 30 B-Encounter-Type___Encounter-Type-Value:icu
patients NCT03865576 31 39 O
suspected NCT03865576 40 49 O
of NCT03865576 50 52 O
having NCT03865576 53 59 O
an NCT03865576 60 62 O
abnormality NCT03865576 63 74 B-Polarity___Polarity-Value:abnormal
of NCT03865576 75 77 O
ICP NCT03865576 78 81 B-Condition-Name
undergoing NCT03865576 82 92 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
monitoring NCT03865576 93 103 B-Procedure-Name
with NCT03865576 104 108 O
commercially NCT03865576 109 121 O
- NCT03865576 122 123 O
available NCT03865576 124 133 O
, NCT03865576 134 135 O
FDA NCT03865576 136 139 O
- NCT03865576 140 141 O
approved NCT03865576 142 150 O
instrumentation NCT03865576 151 166 O
. NCT03865576 167 168 O

Exclusion NCT03865576 170 179 O
Criteria NCT03865576 180 188 O
: NCT03865576 189 190 O

History NCT03865576 192 199 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03865576 200 202 O
: NCT03865576 203 204 O

- NCT03865576 208 209 O
Glaucoma NCT03865576 211 219 B-Condition-Name
or NCT03865576 220 222 O
optic NCT03865576 223 228 O
hypertension NCT03865576 229 241 B-Condition-Name

- NCT03865576 244 245 O
Severe NCT03865576 247 253 B-Severity___Severity-Value:severe
orbital NCT03865576 254 261 O
or NCT03865576 262 264 O
ophthalmic NCT03865576 265 275 O
injury NCT03865576 276 282 B-Condition-Name

- NCT03865576 285 286 O
Orbital NCT03865576 288 295 O
or NCT03865576 296 298 O
intraocular NCT03865576 299 310 O
surgery NCT03865576 311 318 B-Procedure-Name
that NCT03865576 319 323 O
might NCT03865576 324 329 O
interfere NCT03865576 330 339 B-Stability___Stability-Value:change
with NCT03865576 340 344 O
orbital NCT03865576 345 352 B-Condition-Name
compliance NCT03865576 353 363 I-Condition-Name

- NCT03865576 366 367 O
Congenital NCT03865576 369 379 B-Condition-Name
malformations NCT03865576 380 393 I-Condition-Name
of NCT03865576 394 396 O
the NCT03865576 397 400 O
eye NCT03865576 401 404 O
and NCT03865576 405 408 O
/ NCT03865576 409 410 O
or NCT03865576 411 413 O
orbit NCT03865576 414 419 O
that NCT03865576 420 424 O
might NCT03865576 425 430 O
interfere NCT03865576 431 440 B-Stability___Stability-Value:change
with NCT03865576 441 445 O
orbital NCT03865576 446 453 B-Condition-Name
compliance NCT03865576 454 464 I-Condition-Name
or NCT03865576 465 467 O
orbital NCT03865576 468 475 B-Condition-Name
vascular NCT03865576 476 484 I-Condition-Name
anatomy NCT03865576 485 492 I-Condition-Name

Inclusion NCT03861923 0 9 O
Criteria NCT03861923 10 18 O
: NCT03861923 19 20 O

- NCT03861923 24 25 O
Primary NCT03861923 27 34 O
complaint NCT03861923 35 44 O
of NCT03861923 45 47 O
shoulder NCT03861923 48 56 O
pain NCT03861923 57 61 B-Condition-Name
and NCT03861923 62 65 O
stiffness NCT03861923 66 75 B-Condition-Name

- NCT03861923 78 79 O
Gradual NCT03861923 81 88 O
onset NCT03861923 89 94 O
of NCT03861923 95 97 O
symptoms NCT03861923 98 106 O

- NCT03861923 109 110 O
Glenohumeral NCT03861923 112 124 B-Observation-Name___Observation-Type-Value:measurement
passive NCT03861923 125 132 I-Observation-Name___Observation-Type-Value:measurement
range NCT03861923 133 138 I-Observation-Name___Observation-Type-Value:measurement
of NCT03861923 139 141 I-Observation-Name___Observation-Type-Value:measurement
motion NCT03861923 142 148 I-Observation-Name___Observation-Type-Value:measurement
limited NCT03861923 149 156 B-Polarity___Polarity-Value:low
in NCT03861923 157 159 O
multiple NCT03861923 160 168 O
directions NCT03861923 169 179 O

- NCT03861923 182 183 O
Glenohumeral NCT03861923 185 197 B-Observation-Name___Observation-Type-Value:measurement
passive NCT03861923 198 205 I-Observation-Name___Observation-Type-Value:measurement
range NCT03861923 206 211 I-Observation-Name___Observation-Type-Value:measurement
of NCT03861923 212 214 I-Observation-Name___Observation-Type-Value:measurement
motion NCT03861923 215 221 I-Observation-Name___Observation-Type-Value:measurement
decreases NCT03861923 222 231 B-Polarity___Polarity-Value:low
as NCT03861923 232 234 O
the NCT03861923 235 238 O
humerus NCT03861923 239 246 O
is NCT03861923 247 249 O
abducted NCT03861923 250 258 B-Observation-Name
from NCT03861923 259 263 O
45 NCT03861923 265 267 B-Eq-Value
degrees NCT03861923 268 275 B-Eq-Unit
to NCT03861923 276 278 B-Eq-Operator___Eq-Operator-Value:BETWEEN
90 NCT03861923 280 282 B-Eq-Value
degrees NCT03861923 283 290 B-Eq-Unit

- NCT03861923 293 294 O
Age NCT03861923 296 299 O
18 NCT03861923 301 303 B-Eq-Value
to NCT03861923 304 306 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03861923 308 310 B-Eq-Value
years NCT03861923 311 316 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861923 319 320 O
Reports NCT03861923 322 329 O
pain NCT03861923 330 334 B-Condition-Name
with NCT03861923 335 339 O
normal NCT03861923 340 346 O
activity NCT03861923 347 355 O
greater NCT03861923 356 363 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03861923 364 368 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03861923 369 371 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03861923 372 377 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03861923 378 380 O
2 NCT03861923 382 383 B-Eq-Value
/ NCT03861923 384 385 O
10 NCT03861923 387 389 B-Eq-Unit
on NCT03861923 390 392 O
the NCT03861923 393 396 O
numeric NCT03861923 397 404 O
pain NCT03861923 405 409 B-Observation-Name___Observation-Type-Value:measurement
rating NCT03861923 410 416 I-Observation-Name___Observation-Type-Value:measurement
scale NCT03861923 417 422 I-Observation-Name___Observation-Type-Value:measurement

- NCT03861923 425 426 O
Read NCT03861923 428 432 O
and NCT03861923 433 436 O
speak NCT03861923 437 442 O
English NCT03861923 443 450 B-Language

Exclusion NCT03861923 451 460 O
Criteria NCT03861923 461 469 O
: NCT03861923 470 471 O

- NCT03861923 475 476 O
Signs NCT03861923 478 483 O
or NCT03861923 484 486 O
symptoms NCT03861923 487 495 O
of NCT03861923 496 498 O
cervical NCT03861923 499 507 B-Condition-Name
radiculopathy NCT03861923 508 521 I-Condition-Name
, NCT03861923 522 523 O
radiculitis NCT03861923 524 535 B-Condition-Name
, NCT03861923 536 537 O
or NCT03861923 538 540 O
referral NCT03861923 541 549 B-Condition-Name
from NCT03861923 550 554 O
the NCT03861923 555 558 O
cervical NCT03861923 559 567 O
spine NCT03861923 568 573 O

- NCT03861923 576 577 O
Clinical NCT03861923 579 587 O
evidence NCT03861923 588 596 O
as NCT03861923 597 599 O
determined NCT03861923 600 610 O
in NCT03861923 611 613 O
the NCT03861923 614 617 O
examination NCT03861923 618 629 B-Procedure-Name
of NCT03861923 630 632 O
an NCT03861923 633 635 O
alternative NCT03861923 636 647 O
shoulder NCT03861923 648 656 O
diagnosis NCT03861923 657 666 B-Condition-Name

- NCT03861923 669 670 O
Normal NCT03861923 672 678 B-Polarity___Polarity-Value:normal
passive NCT03861923 679 686 O
shoulder NCT03861923 687 695 O
range NCT03861923 696 701 B-Observation-Name
of NCT03861923 702 704 I-Observation-Name
motion NCT03861923 705 711 I-Observation-Name

- NCT03861923 714 715 O
Known NCT03861923 717 722 O
radiographic NCT03861923 723 735 B-Procedure-Name
evidence NCT03861923 736 744 O
of NCT03861923 745 747 O
glenohumeral NCT03861923 748 760 O
osteoarthritis NCT03861923 761 775 B-Condition-Name

- NCT03861923 778 779 O
Known NCT03861923 781 786 O
neurologic NCT03861923 787 797 B-Condition-Name
disease NCT03861923 798 805 I-Condition-Name

- NCT03861923 808 809 O
Received NCT03861923 811 819 O
dry NCT03861923 820 823 B-Procedure-Name
needling NCT03861923 824 832 I-Procedure-Name
or NCT03861923 833 835 O
acupuncture NCT03861923 836 847 B-Procedure-Name
within NCT03861923 848 854 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03861923 855 858 O
past NCT03861923 859 863 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03861923 865 866 B-Eq-Value
months NCT03861923 867 873 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03861923 876 877 O
Fear NCT03861923 879 883 B-Condition-Name
of NCT03861923 884 886 I-Condition-Name
needling NCT03861923 887 895 I-Condition-Name

- NCT03861923 898 899 O
Currently NCT03861923 901 910 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
being NCT03861923 911 916 O
treated NCT03861923 917 924 O
with NCT03861923 925 929 O
anticoagulant NCT03861923 930 943 B-Drug-Name
medication NCT03861923 944 954 I-Drug-Name

- NCT03861923 957 958 O
Shoulder NCT03861923 960 968 B-Observation-Name___Observation-Type-Value:clinical-score
pain NCT03861923 969 973 I-Observation-Name___Observation-Type-Value:clinical-score
and NCT03861923 974 977 I-Observation-Name___Observation-Type-Value:clinical-score
disability NCT03861923 978 988 I-Observation-Name___Observation-Type-Value:clinical-score
index NCT03861923 989 994 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03861923 995 996 O
SPADI NCT03861923 997 1002 B-Observation-Name
) NCT03861923 1003 1004 O
score NCT03861923 1005 1010 O
less NCT03861923 1011 1015 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03861923 1016 1020 I-Eq-Operator___Eq-Operator-Value:LT
10 NCT03861923 1022 1024 B-Eq-Value
% NCT03861923 1025 1026 B-Eq-Unit
or NCT03861923 1027 1029 O
greater NCT03861923 1030 1037 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03861923 1038 1042 I-Eq-Operator___Eq-Operator-Value:GT
90 NCT03861923 1044 1046 B-Eq-Value
% NCT03861923 1047 1048 B-Eq-Unit

Inclusion NCT03865589 0 9 O
Criteria NCT03865589 10 18 O
: NCT03865589 19 20 O

- NCT03865589 24 25 O
Any NCT03865589 27 30 O
patient NCT03865589 31 38 O
undergoing NCT03865589 39 49 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03865589 50 51 O
myeloablative NCT03865589 52 65 B-Procedure-Name
conditioning NCT03865589 66 78 I-Procedure-Name
regimen NCT03865589 79 86 O
for NCT03865589 87 90 O
HCT NCT03865589 91 94 B-Condition-Name
between NCT03865589 95 102 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03865589 104 105 B-Eq-Value
/ NCT03865589 106 107 I-Eq-Value
1 NCT03865589 109 110 I-Eq-Value
/ NCT03865589 111 112 I-Eq-Value
2019 NCT03865589 114 118 I-Eq-Value
and NCT03865589 119 122 O
12 NCT03865589 124 126 B-Eq-Value
/ NCT03865589 127 128 I-Eq-Value
31 NCT03865589 130 132 I-Eq-Value
/ NCT03865589 133 134 I-Eq-Value
2120 NCT03865589 136 140 I-Eq-Value
defined NCT03865589 141 148 O
as NCT03865589 149 151 O
one NCT03865589 152 155 B-Eq-Value
of NCT03865589 156 158 O
the NCT03865589 159 162 O
following NCT03865589 163 172 O
: NCT03865589 173 174 O

- NCT03865589 183 184 O
TBI NCT03865589 186 189 B-Observation-Name___Observation-Type-Value:lab
> NCT03865589 190 191 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03865589 193 194 I-Eq-Operator___Eq-Operator-Value:GTEQ
1200 NCT03865589 196 200 B-Eq-Value
cGy NCT03865589 201 204 B-Eq-Unit
( NCT03865589 205 206 O
fractionated NCT03865589 207 219 O
) NCT03865589 220 221 O

- NCT03865589 230 231 O
Cyclophosphamide NCT03865589 233 249 B-Drug-Name
+ NCT03865589 250 251 O
TBI NCT03865589 252 255 B-Observation-Name___Observation-Type-Value:lab
( NCT03865589 256 257 O
> NCT03865589 259 260 B-Eq-Operator___Eq-Operator-Value:GT
500 NCT03865589 262 265 B-Eq-Value
cGy NCT03865589 266 269 B-Eq-Unit
( NCT03865589 270 271 O
single NCT03865589 272 278 O
) NCT03865589 279 280 O
or NCT03865589 281 283 O
> NCT03865589 284 285 B-Eq-Operator___Eq-Operator-Value:GT
800 NCT03865589 287 290 B-Eq-Value
cGy NCT03865589 291 294 B-Eq-Unit
( NCT03865589 295 296 O
fractionated NCT03865589 297 309 O
) NCT03865589 310 311 O
) NCT03865589 313 314 O

- NCT03865589 323 324 O
Cyclophosphamide NCT03865589 326 342 B-Drug-Name
+ NCT03865589 343 344 O
Etoposide NCT03865589 345 354 B-Drug-Name
+ NCT03865589 355 356 O
TBI NCT03865589 357 360 B-Observation-Name___Observation-Type-Value:lab
( NCT03865589 361 362 O
> NCT03865589 364 365 B-Eq-Operator___Eq-Operator-Value:GT
500 NCT03865589 367 370 B-Eq-Value
cGy NCT03865589 371 374 B-Eq-Unit
( NCT03865589 375 376 O
single NCT03865589 377 383 O
) NCT03865589 384 385 O
or NCT03865589 386 388 O
> NCT03865589 389 390 B-Eq-Operator___Eq-Operator-Value:GT
800 NCT03865589 392 395 B-Eq-Value
cGy NCT03865589 396 399 B-Eq-Unit
( NCT03865589 400 401 O
fractionated NCT03865589 402 414 O
) NCT03865589 415 416 O
) NCT03865589 418 419 O

- NCT03865589 428 429 O
Cyclophosphamide NCT03865589 431 447 B-Drug-Name
+ NCT03865589 448 449 O
Thiotepa NCT03865589 450 458 B-Drug-Name
+ NCT03865589 459 460 O
TBI NCT03865589 461 464 B-Observation-Name___Observation-Type-Value:lab
( NCT03865589 465 466 O
> NCT03865589 468 469 B-Eq-Operator___Eq-Operator-Value:GT
500 NCT03865589 471 474 B-Eq-Value
cGy NCT03865589 475 478 B-Eq-Unit
( NCT03865589 479 480 O
single NCT03865589 481 487 O
) NCT03865589 488 489 O
or NCT03865589 490 492 O
> NCT03865589 493 494 B-Eq-Operator___Eq-Operator-Value:GT
800 NCT03865589 496 499 B-Eq-Value
cGy NCT03865589 500 503 B-Eq-Unit
( NCT03865589 504 505 O
fractionated NCT03865589 506 518 O
) NCT03865589 519 520 O
) NCT03865589 522 523 O

- NCT03865589 532 533 O
Busulfan NCT03865589 535 543 B-Drug-Name
( NCT03865589 544 545 O
Total NCT03865589 546 551 O
dose NCT03865589 552 556 O
> NCT03865589 557 558 B-Eq-Operator___Eq-Operator-Value:GT
7.2 NCT03865589 560 563 B-Eq-Value
mg NCT03865589 564 566 B-Eq-Unit
/ NCT03865589 567 568 O
kg NCT03865589 569 571 B-Eq-Unit
IV NCT03865589 572 574 O
or NCT03865589 575 577 O
> NCT03865589 578 579 B-Eq-Operator___Eq-Operator-Value:GT
9.0 NCT03865589 581 584 B-Eq-Value
mg NCT03865589 585 587 B-Eq-Unit
/ NCT03865589 588 589 O
kg NCT03865589 590 592 B-Eq-Unit
orally NCT03865589 593 599 O
) NCT03865589 600 601 O
+ NCT03865589 602 603 O
Cyclophosphamide NCT03865589 604 620 B-Drug-Name

- NCT03865589 628 629 O
Busulfan NCT03865589 631 639 B-Drug-Name
( NCT03865589 640 641 O
Total NCT03865589 642 647 O
dose NCT03865589 648 652 O
> NCT03865589 653 654 B-Eq-Operator___Eq-Operator-Value:GT
7.2 NCT03865589 656 659 B-Eq-Value
mg NCT03865589 660 662 B-Eq-Unit
/ NCT03865589 663 664 O
kg NCT03865589 665 667 B-Eq-Unit
IV NCT03865589 668 670 O
or NCT03865589 671 673 O
> NCT03865589 674 675 B-Eq-Operator___Eq-Operator-Value:GT
9.0 NCT03865589 677 680 B-Eq-Value
mg NCT03865589 681 683 B-Eq-Unit
/ NCT03865589 684 685 O
kg NCT03865589 686 688 B-Eq-Unit
orally NCT03865589 689 695 O
) NCT03865589 696 697 O
+ NCT03865589 698 699 O
Melphalan NCT03865589 700 709 B-Drug-Name

- NCT03865589 717 718 O
Busulfan NCT03865589 720 728 B-Drug-Name
( NCT03865589 729 730 O
Total NCT03865589 731 736 O
dose NCT03865589 737 741 O
> NCT03865589 742 743 B-Eq-Operator___Eq-Operator-Value:GT
7.2 NCT03865589 745 748 B-Eq-Value
mg NCT03865589 749 751 B-Eq-Unit
/ NCT03865589 752 753 O
kg NCT03865589 754 756 B-Eq-Unit
IV NCT03865589 757 759 O
or NCT03865589 760 762 O
> NCT03865589 763 764 B-Eq-Operator___Eq-Operator-Value:GT
9.0 NCT03865589 766 769 B-Eq-Value
mg NCT03865589 770 772 B-Eq-Unit
/ NCT03865589 773 774 O
kg NCT03865589 775 777 B-Eq-Unit
orally NCT03865589 778 784 O
) NCT03865589 785 786 O
+ NCT03865589 787 788 O
Thiotepa NCT03865589 789 797 B-Drug-Name

- NCT03865589 805 806 O
NOTE NCT03865589 808 812 O
: NCT03865589 813 814 O
Busulfan NCT03865589 815 823 B-Drug-Name
cumulative NCT03865589 824 834 B-Observation-Name___Observation-Type-Value:lab
plasma NCT03865589 835 841 I-Observation-Name___Observation-Type-Value:lab
AUC NCT03865589 842 845 I-Observation-Name___Observation-Type-Value:lab
of NCT03865589 846 848 O
> NCT03865589 849 850 B-Eq-Operator___Eq-Operator-Value:GT
75 NCT03865589 852 854 B-Eq-Value
mg NCT03865589 855 857 B-Eq-Unit
/ NCT03865589 858 859 O
L NCT03865589 860 861 B-Eq-Unit
per NCT03865589 862 865 O
hour NCT03865589 866 870 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03865589 871 873 O
> NCT03865589 874 875 B-Eq-Operator___Eq-Operator-Value:GT
18270 NCT03865589 877 882 B-Eq-Value
microMolar NCT03865589 883 893 B-Eq-Unit
per NCT03865589 894 897 O
minute NCT03865589 898 904 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
could NCT03865589 905 910 O
be NCT03865589 911 913 O
used NCT03865589 914 918 O
in NCT03865589 919 921 O
the NCT03865589 922 925 O
preceding NCT03865589 926 935 O
criteria NCT03865589 936 944 O
in NCT03865589 945 947 O
lieu NCT03865589 948 952 O
of NCT03865589 953 955 O
the NCT03865589 956 959 O
mg NCT03865589 960 962 O
/ NCT03865589 963 964 O
kg NCT03865589 965 967 O
doses NCT03865589 968 973 O
. NCT03865589 974 975 O

OR NCT03865589 977 979 O

2 NCT03865589 981 982 O
. NCT03865589 982 983 O
Any NCT03865589 985 988 O
patient NCT03865589 989 996 O
who NCT03865589 997 1000 O
has NCT03865589 1001 1004 O
a NCT03865589 1005 1006 O
myeloablative NCT03865589 1007 1020 B-Procedure-Name
conditioning NCT03865589 1021 1033 I-Procedure-Name
regimen NCT03865589 1034 1041 O
( NCT03865589 1042 1043 O
as NCT03865589 1044 1046 O
defined NCT03865589 1047 1054 O
by NCT03865589 1055 1057 O
the NCT03865589 1058 1061 O
local NCT03865589 1062 1067 O
HSCT NCT03865589 1068 1072 O
team NCT03865589 1073 1077 O
) NCT03865589 1078 1079 O
that NCT03865589 1080 1084 O
includes NCT03865589 1085 1093 O
sirolimus NCT03865589 1094 1103 B-Drug-Name
and NCT03865589 1104 1107 O
tacrolimus NCT03865589 1108 1118 B-Drug-Name
for NCT03865589 1119 1122 O
GVHD NCT03865589 1123 1127 B-Condition-Name
prophylaxis NCT03865589 1128 1139 B-Procedure-Name
. NCT03865589 1140 1141 O

OR NCT03865589 1143 1145 O

3 NCT03865589 1147 1148 O
. NCT03865589 1148 1149 O
Any NCT03865589 1151 1154 O
patient NCT03865589 1155 1162 O
who NCT03865589 1163 1166 O
is NCT03865589 1167 1169 O
high NCT03865589 1170 1174 B-Polarity___Polarity-Value:high
risk NCT03865589 1175 1179 O
for NCT03865589 1180 1183 O
SOS NCT03865589 1184 1187 B-Condition-Name
irrespective NCT03865589 1188 1200 O
of NCT03865589 1201 1203 O
conditioning NCT03865589 1204 1216 O
regimen NCT03865589 1217 1224 O
: NCT03865589 1225 1226 O

Neuroblastoma NCT03865589 1228 1241 B-Condition-Name
, NCT03865589 1242 1243 O
HLH NCT03865589 1244 1247 B-Condition-Name
, NCT03865589 1248 1249 O
Osteopetrosis NCT03865589 1250 1263 B-Condition-Name
, NCT03865589 1264 1265 O
Thalassemia NCT03865589 1266 1277 B-Condition-Name
, NCT03865589 1278 1279 O
treatment NCT03865589 1280 1289 O
with NCT03865589 1290 1294 O
inotuzumab NCT03865589 1295 1305 B-Drug-Name
or NCT03865589 1306 1308 O
gemtuzumab NCT03865589 1309 1319 B-Drug-Name
within NCT03865589 1320 1326 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03865589 1328 1329 B-Eq-Value
months NCT03865589 1330 1336 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03865589 1337 1342 O
to NCT03865589 1343 1345 O
HSCT NCT03865589 1346 1350 B-Procedure-Name
admission NCT03865589 1351 1360 B-Encounter-Type___Encounter-Type-Value:inpatient
, NCT03865589 1361 1362 O
2 NCT03865589 1364 1365 B-Eq-Value
nd NCT03865589 1366 1368 I-Eq-Value
HSCT NCT03865589 1369 1373 B-Procedure-Name
if NCT03865589 1374 1376 O
it NCT03865589 1377 1379 O
is NCT03865589 1380 1382 O
myeloablative NCT03865589 1383 1396 O
and NCT03865589 1397 1400 O
within NCT03865589 1401 1407 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03865589 1409 1410 B-Eq-Value
months NCT03865589 1411 1417 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03865589 1418 1420 O
prior NCT03865589 1421 1426 O
, NCT03865589 1427 1428 O
iron NCT03865589 1429 1433 B-Condition-Name
overload NCT03865589 1434 1442 I-Condition-Name
, NCT03865589 1443 1444 O
steatohepatitis NCT03865589 1445 1460 B-Condition-Name
, NCT03865589 1461 1462 O
active NCT03865589 1463 1469 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
inflammatory NCT03865589 1470 1482 O
or NCT03865589 1483 1485 O
infection NCT03865589 1486 1495 O
hepatitis NCT03865589 1496 1505 B-Condition-Name
or NCT03865589 1506 1508 O
any NCT03865589 1509 1512 O
other NCT03865589 1513 1518 O
condition NCT03865589 1519 1528 O
which NCT03865589 1529 1534 O
puts NCT03865589 1535 1539 B-Stability___Stability-Value:change
the NCT03865589 1540 1543 O
patient NCT03865589 1544 1551 O
at NCT03865589 1552 1554 O
a NCT03865589 1555 1556 O
higher NCT03865589 1557 1563 B-Polarity___Polarity-Value:high
risk NCT03865589 1564 1568 O
of NCT03865589 1569 1571 O
developing NCT03865589 1572 1582 O
SOS NCT03865589 1583 1586 B-Condition-Name
. NCT03865589 1587 1588 O

Exclusion NCT03865589 1590 1599 O
Criteria NCT03865589 1600 1608 O
: NCT03865589 1609 1610 O

- NCT03865589 1614 1615 O
Any NCT03865589 1617 1620 O
patient NCT03865589 1621 1628 O
who NCT03865589 1629 1632 O
has NCT03865589 1633 1636 O
contraindication NCT03865589 1637 1653 O
to NCT03865589 1654 1656 O
US NCT03865589 1657 1659 B-Procedure-Name
SWE NCT03865589 1660 1663 I-Procedure-Name
( NCT03865589 1664 1665 O
e NCT03865589 1666 1667 O
. NCT03865589 1668 1669 O
g NCT03865589 1670 1671 O
. NCT03865589 1672 1673 O
unable NCT03865589 1675 1681 B-Condition-Name
to NCT03865589 1682 1684 I-Condition-Name
hold NCT03865589 1685 1689 I-Condition-Name
still NCT03865589 1690 1695 I-Condition-Name
) NCT03865589 1696 1697 O


Inclusion NCT03866902 0 9 O
criteria NCT03866902 10 18 O
for NCT03866902 19 22 O
mothers NCT03866902 23 30 O
will NCT03866902 31 35 O
be NCT03866902 36 38 O
: NCT03866902 39 40 O

- NCT03866902 44 45 O
age NCT03866902 47 50 O
18 NCT03866902 52 54 B-Eq-Value
years NCT03866902 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03866902 61 63 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03866902 64 69 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03866902 72 73 O
self NCT03866902 75 79 O
- NCT03866902 80 81 O
identification NCT03866902 82 96 O
as NCT03866902 97 99 O
Hispanic NCT03866902 100 108 B-Ethnicity

- NCT03866902 111 112 O
limited NCT03866902 114 121 O
English NCT03866902 122 129 B-Language
proficiency NCT03866902 130 141 O
; NCT03866902 141 142 O
little NCT03866902 143 149 O
acculturation NCT03866902 150 163 B-Observation-Name
, NCT03866902 164 165 O
as NCT03866902 166 168 O
measured NCT03866902 169 177 O
by NCT03866902 178 180 O
the NCT03866902 181 184 O
Short NCT03866902 185 190 B-Observation-Name___Observation-Type-Value:clinical-score
Acculturation NCT03866902 191 204 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03866902 205 210 I-Observation-Name___Observation-Type-Value:clinical-score
for NCT03866902 211 214 I-Observation-Name___Observation-Type-Value:clinical-score
Hispanics NCT03866902 215 224 I-Observation-Name___Observation-Type-Value:clinical-score
with NCT03866902 225 229 O
a NCT03866902 230 231 O
score NCT03866902 232 237 O
from NCT03866902 238 242 O
1.00 NCT03866902 244 248 B-Eq-Value
to NCT03866902 249 251 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2.99 NCT03866902 253 257 B-Eq-Value

- NCT03866902 261 262 O
ability NCT03866902 264 271 O
to NCT03866902 272 274 O
understand NCT03866902 275 285 O
spoken NCT03866902 286 292 O
Spanish NCT03866902 293 300 B-Language

- NCT03866902 303 304 O
a NCT03866902 306 307 O
BMI NCT03866902 308 311 B-Observation-Name___Observation-Type-Value:vital
> NCT03866902 312 313 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03866902 315 317 B-Eq-Value
kg NCT03866902 318 320 B-Eq-Unit
/ NCT03866902 321 322 O
m² NCT03866902 323 325 B-Eq-Unit

- NCT03866902 328 329 O
residence NCT03866902 331 340 O
with NCT03866902 341 345 O
the NCT03866902 346 349 O
child NCT03866902 350 355 O

- NCT03866902 358 359 O
consent NCT03866902 361 368 O
to NCT03866902 369 371 O
join NCT03866902 372 376 O
the NCT03866902 377 380 O
study NCT03866902 381 386 O
and NCT03866902 387 390 O
consent NCT03866902 391 398 O
for NCT03866902 399 402 O
their NCT03866902 403 408 O
child NCT03866902 409 414 O
to NCT03866902 415 417 O
join NCT03866902 418 422 O
the NCT03866902 423 426 O
study NCT03866902 427 432 O
. NCT03866902 433 434 O

Inclusion NCT03866902 436 445 O
criteria NCT03866902 446 454 O
for NCT03866902 455 458 O
children NCT03866902 459 467 O
will NCT03866902 468 472 O
be NCT03866902 473 475 O
: NCT03866902 476 477 O

- NCT03866902 481 482 O
age NCT03866902 484 487 O
3 NCT03866902 489 490 B-Eq-Value
- NCT03866902 491 492 B-Eq-Operator___Eq-Operator-Value:BETWEEN
5 NCT03866902 494 495 B-Eq-Value
years NCT03866902 496 501 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866902 504 505 O
ability NCT03866902 507 514 O
to NCT03866902 515 517 O
understand NCT03866902 518 528 O
spoken NCT03866902 529 535 O
Spanish NCT03866902 536 543 B-Language

- NCT03866902 546 547 O
a NCT03866902 549 550 O
BMI NCT03866902 551 554 B-Observation-Name___Observation-Type-Value:vital
> NCT03866902 555 556 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03866902 558 560 B-Eq-Value
th NCT03866902 561 563 I-Eq-Value
percentile NCT03866902 564 574 B-Eq-Unit
for NCT03866902 575 578 O
age NCT03866902 579 582 O
and NCT03866902 583 586 O
gender NCT03866902 587 593 O

Exclusion NCT03866902 594 603 O
criteria NCT03866902 604 612 O
for NCT03866902 613 616 O
mothers NCT03866902 617 624 O
will NCT03866902 625 629 O
be NCT03866902 630 632 O
: NCT03866902 633 634 O

- NCT03866902 638 639 O
heart NCT03866902 641 646 B-Condition-Name
murmur NCT03866902 647 653 I-Condition-Name

- NCT03866902 656 657 O
congenital NCT03866902 659 669 B-Condition-Name
heart NCT03866902 670 675 I-Condition-Name
disease NCT03866902 676 683 I-Condition-Name

- NCT03866902 686 687 O
family NCT03866902 689 695 O
history NCT03866902 696 703 O
of NCT03866902 704 706 O
sudden NCT03866902 707 713 B-Condition-Name
death NCT03866902 714 719 I-Condition-Name

- NCT03866902 722 723 O
difficulty NCT03866902 725 735 O
exercising NCT03866902 736 746 B-Observation-Name___Observation-Type-Value:social-habit

- NCT03866902 749 750 O
psychological NCT03866902 752 765 B-Condition-Name
problems NCT03866902 766 774 I-Condition-Name

Inclusion NCT03862807 0 9 O
Criteria NCT03862807 10 18 O
: NCT03862807 19 20 O

- NCT03862807 24 25 O
Received NCT03862807 27 35 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
liver NCT03862807 36 41 B-Procedure-Name
transplant NCT03862807 42 52 I-Procedure-Name
for NCT03862807 53 56 O
treatment NCT03862807 57 66 O
of NCT03862807 67 69 O
hATTR NCT03862807 70 75 O
amyloidosis NCT03862807 76 87 B-Condition-Name
≥ NCT03862807 88 89 B-Eq-Operator___Eq-Operator-Value:GTEQ
12 NCT03862807 91 93 B-Eq-Value
months NCT03862807 94 100 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03862807 101 107 O
study NCT03862807 108 113 O
start NCT03862807 114 119 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time

- NCT03862807 122 123 O
Has NCT03862807 125 128 O
increase NCT03862807 129 137 B-Polarity___Polarity-Value:high
in NCT03862807 138 140 O
polyneuropathy NCT03862807 141 155 B-Condition-Name
disability NCT03862807 156 166 I-Condition-Name
( NCT03862807 167 168 O
PND NCT03862807 169 172 B-Condition-Name
) NCT03862807 173 174 O
score NCT03862807 175 180 O
after NCT03862807 181 186 O
liver NCT03862807 187 192 B-Procedure-Name
transplant NCT03862807 193 203 I-Procedure-Name

- NCT03862807 206 207 O
Has NCT03862807 209 212 O
received NCT03862807 213 221 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
stable NCT03862807 222 228 B-Stability___Stability-Value:stable
immunosuppressive NCT03862807 229 246 B-Procedure-Name
regimen NCT03862807 247 254 I-Procedure-Name
with NCT03862807 255 259 O
≤ NCT03862807 260 261 B-Eq-Operator___Eq-Operator-Value:LTEQ
10 NCT03862807 263 265 B-Eq-Value
mg NCT03862807 266 268 B-Eq-Unit
/ NCT03862807 269 270 O
day NCT03862807 271 274 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03862807 275 277 O
prednisone NCT03862807 278 288 B-Drug-Name
for NCT03862807 289 292 O
at NCT03862807 293 295 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03862807 296 301 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03862807 303 304 B-Eq-Value
months NCT03862807 305 311 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03862807 312 318 O
study NCT03862807 319 324 O
start NCT03862807 325 330 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time

- NCT03862807 333 334 O
Has NCT03862807 336 339 O
Karnofsky NCT03862807 340 349 B-Observation-Name___Observation-Type-Value:clinical-score
Performance NCT03862807 350 361 I-Observation-Name___Observation-Type-Value:clinical-score
Status NCT03862807 362 368 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03862807 369 370 O
KPS NCT03862807 371 374 B-Observation-Name
) NCT03862807 375 376 O
of NCT03862807 377 379 O
≥ NCT03862807 380 381 B-Eq-Operator___Eq-Operator-Value:GTEQ
70 NCT03862807 383 385 B-Eq-Value
% NCT03862807 386 387 B-Eq-Unit

- NCT03862807 391 392 O
Has NCT03862807 394 397 O
vitamin NCT03862807 398 405 B-Observation-Name___Observation-Type-Value:lab
A NCT03862807 406 407 I-Observation-Name___Observation-Type-Value:lab
level NCT03862807 408 413 I-Observation-Name___Observation-Type-Value:lab
greater NCT03862807 414 421 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03862807 422 426 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03862807 427 429 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03862807 430 435 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03862807 436 438 O
lower NCT03862807 439 444 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03862807 445 450 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03862807 451 453 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03862807 454 460 I-Eq-Unit___Eq-Unit-Value:ref-range-normal

Exclusion NCT03862807 461 470 O
Criteria NCT03862807 471 479 O
: NCT03862807 480 481 O

- NCT03862807 485 486 O
Has NCT03862807 488 491 O
previously NCT03862807 492 502 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
received NCT03862807 503 511 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
inotersen NCT03862807 512 521 B-Drug-Name
or NCT03862807 522 524 O
patisiran NCT03862807 525 534 B-Drug-Name

- NCT03862807 537 538 O
Has NCT03862807 540 543 O
clinically NCT03862807 544 554 O
significant NCT03862807 555 566 B-Severity___Severity-Value:severe
liver NCT03862807 567 572 B-Observation-Name___Observation-Type-Value:lab
function NCT03862807 573 581 I-Observation-Name___Observation-Type-Value:lab
test NCT03862807 582 586 I-Observation-Name___Observation-Type-Value:lab
abnormalities NCT03862807 587 600 B-Polarity___Polarity-Value:abnormal

- NCT03862807 603 604 O
Has NCT03862807 606 609 O
known NCT03862807 610 615 O
portal NCT03862807 616 622 B-Condition-Name
hypertension NCT03862807 623 635 I-Condition-Name
with NCT03862807 636 640 O
ascites NCT03862807 641 648 B-Condition-Name

- NCT03862807 651 652 O
Has NCT03862807 654 657 O
estimated NCT03862807 658 667 B-Observation-Name___Observation-Type-Value:lab
glomerular NCT03862807 668 678 I-Observation-Name___Observation-Type-Value:lab
filtration NCT03862807 679 689 I-Observation-Name___Observation-Type-Value:lab
rate NCT03862807 690 694 I-Observation-Name___Observation-Type-Value:lab
( NCT03862807 695 696 O
eGFR NCT03862807 697 701 B-Observation-Name___Observation-Type-Value:lab
) NCT03862807 702 703 O
≤ NCT03862807 704 705 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03862807 707 709 B-Eq-Value
mL NCT03862807 710 712 B-Eq-Unit
/ NCT03862807 713 714 O
min NCT03862807 715 718 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
/ NCT03862807 719 720 O
1.73 NCT03862807 722 726 B-Eq-Unit
m^ NCT03862807 727 729 I-Eq-Unit
2 NCT03862807 730 731 I-Eq-Unit

- NCT03862807 735 736 O
Has NCT03862807 738 741 O
known NCT03862807 742 747 O
leptomeningeal NCT03862807 748 762 O
amyloidosis NCT03862807 763 774 B-Condition-Name

- NCT03862807 777 778 O
Has NCT03862807 780 783 O
infection NCT03862807 784 793 B-Condition-Name
with NCT03862807 794 798 O
hepatitis NCT03862807 799 808 B-Condition-Name
B NCT03862807 809 810 I-Condition-Name
, NCT03862807 811 812 O
hepatitis NCT03862807 813 822 B-Condition-Name
C NCT03862807 823 824 I-Condition-Name
or NCT03862807 825 827 O
human NCT03862807 828 833 B-Condition-Name
immunodeficiency NCT03862807 834 850 I-Condition-Name
virus NCT03862807 851 856 I-Condition-Name
( NCT03862807 857 858 O
HIV NCT03862807 859 862 B-Condition-Name
) NCT03862807 863 864 O

- NCT03862807 868 869 O
Has NCT03862807 871 874 O
New NCT03862807 875 878 B-Condition-Name
York NCT03862807 879 883 I-Condition-Name
Heart NCT03862807 884 889 I-Condition-Name
Association NCT03862807 890 901 I-Condition-Name
heart NCT03862807 902 907 I-Condition-Name
failure NCT03862807 908 915 I-Condition-Name
classification NCT03862807 916 930 O
of NCT03862807 931 933 O
> NCT03862807 934 935 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03862807 937 938 B-Eq-Value

- NCT03862807 942 943 O
Is NCT03862807 945 947 O
wheelchair NCT03862807 948 958 B-Condition-Name
bound NCT03862807 959 964 I-Condition-Name
or NCT03862807 965 967 O
bedridden NCT03862807 968 977 B-Condition-Name

- NCT03862807 980 981 O
Has NCT03862807 983 986 O
received NCT03862807 987 995 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
organ NCT03862807 996 1001 B-Procedure-Name
transplants NCT03862807 1002 1013 I-Procedure-Name
other NCT03862807 1014 1019 O
than NCT03862807 1020 1024 O
liver NCT03862807 1025 1030 B-Procedure-Name
transplant NCT03862807 1031 1041 I-Procedure-Name

- NCT03862807 1044 1045 O
Will NCT03862807 1047 1051 O
be NCT03862807 1052 1054 O
using NCT03862807 1055 1060 O
an NCT03862807 1061 1063 O
other NCT03862807 1064 1069 O
tetramer NCT03862807 1070 1078 B-Procedure-Name
stabilizer NCT03862807 1079 1089 I-Procedure-Name
during NCT03862807 1090 1096 O
the NCT03862807 1097 1100 O
study NCT03862807 1101 1106 O

Inclusion NCT03860792 0 9 O
Criteria NCT03860792 10 18 O
: NCT03860792 19 20 O

- NCT03860792 24 25 O
Diagnosis NCT03860792 27 36 O
of NCT03860792 37 39 O
AD NCT03860792 40 42 B-Condition-Name
by NCT03860792 43 45 O
current NCT03860792 46 53 O
McKhann NCT03860792 54 61 O
et NCT03860792 62 64 O
al NCT03860792 65 67 O
. NCT03860792 68 69 O
criteria NCT03860792 71 79 O

- NCT03860792 82 83 O
CDR NCT03860792 85 88 B-Observation-Name___Observation-Type-Value:clinical-score
global NCT03860792 89 95 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03860792 96 101 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03860792 102 104 O
0.5 NCT03860792 106 109 B-Eq-Value
or NCT03860792 110 112 O
1 NCT03860792 114 115 B-Eq-Value

- NCT03860792 119 120 O
Agreed NCT03860792 122 128 O
cooperation NCT03860792 129 140 O
from NCT03860792 141 145 O
an NCT03860792 146 148 O
appropriate NCT03860792 149 160 O
study NCT03860792 161 166 O
partner NCT03860792 167 174 O

- NCT03860792 177 178 O
Speaks NCT03860792 180 186 O
English NCT03860792 187 194 B-Language
as NCT03860792 195 197 O
primary NCT03860792 198 205 O
language NCT03860792 206 214 O

- NCT03860792 217 218 O
Age NCT03860792 220 223 O
50 NCT03860792 225 227 B-Eq-Value
to NCT03860792 228 230 B-Eq-Operator___Eq-Operator-Value:BETWEEN
90 NCT03860792 232 234 B-Eq-Value

- NCT03860792 238 239 O
No NCT03860792 241 243 O
medication NCT03860792 244 254 O
changes NCT03860792 255 262 B-Stability___Stability-Value:change
within NCT03860792 263 269 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860792 270 273 O
past NCT03860792 274 278 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
30 NCT03860792 280 282 B-Eq-Value
days NCT03860792 283 287 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

Exclusion NCT03860792 288 297 O
Criteria NCT03860792 298 306 O
: NCT03860792 307 308 O

- NCT03860792 312 313 O
Resides NCT03860792 315 322 O
in NCT03860792 323 325 O
a NCT03860792 326 327 O
nursing NCT03860792 328 335 B-Location___Location-Value:residence
home NCT03860792 336 340 I-Location___Location-Value:residence
or NCT03860792 341 343 O
dementia NCT03860792 344 352 B-Location___Location-Value:unit
special NCT03860792 353 360 I-Location___Location-Value:unit
care NCT03860792 361 365 I-Location___Location-Value:unit
unit NCT03860792 366 370 I-Location___Location-Value:unit
, NCT03860792 371 372 O
or NCT03860792 373 375 O
can NCT03860792 376 379 O
not NCT03860792 379 382 O
control NCT03860792 383 390 B-Stability___Stability-Value:stable
diet NCT03860792 391 395 B-Procedure-Name

- NCT03860792 398 399 O
A NCT03860792 401 402 O
potentially NCT03860792 403 414 O
confounding NCT03860792 415 426 B-Stability___Stability-Value:change
serious NCT03860792 427 434 B-Severity___Severity-Value:severe
medical NCT03860792 435 442 O
risk NCT03860792 443 447 O
including NCT03860792 448 457 O
insulin NCT03860792 458 465 B-Drug-Name
- NCT03860792 466 467 O
requiring NCT03860792 468 477 O
diabetes NCT03860792 478 486 B-Condition-Name
, NCT03860792 487 488 O
cancer NCT03860792 489 495 B-Condition-Name
requiring NCT03860792 496 505 O
chemotherapy NCT03860792 506 518 B-Procedure-Name
or NCT03860792 519 521 O
radiation NCT03860792 522 531 B-Procedure-Name
within NCT03860792 532 538 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860792 539 542 O
past NCT03860792 543 547 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03860792 549 550 B-Eq-Value
years NCT03860792 551 556 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03860792 557 558 O
or NCT03860792 559 561 O
a NCT03860792 562 563 O
recent NCT03860792 564 570 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
cardiac NCT03860792 571 578 B-Condition-Name
event NCT03860792 579 584 I-Condition-Name
( NCT03860792 585 586 O
i NCT03860792 587 588 O
. NCT03860792 589 590 O
e NCT03860792 591 592 O
. NCT03860792 593 594 O
heart NCT03860792 596 601 B-Condition-Name
attack NCT03860792 602 608 I-Condition-Name
, NCT03860792 609 610 O
angioplasty NCT03860792 611 622 B-Procedure-Name
, NCT03860792 623 624 O
etc NCT03860792 625 628 O
. NCT03860792 629 630 O
) NCT03860792 631 632 O

- NCT03860792 636 637 O
Participating NCT03860792 639 652 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
in NCT03860792 653 655 O
another NCT03860792 656 663 O
clinical NCT03860792 664 672 O
trial NCT03860792 673 678 O
or NCT03860792 679 681 O
using NCT03860792 682 687 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
an NCT03860792 688 690 O
investigational NCT03860792 691 706 O
drug NCT03860792 707 711 O
or NCT03860792 712 714 O
therapy NCT03860792 715 722 B-Procedure-Name
within NCT03860792 723 729 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03860792 731 733 B-Eq-Value
days NCT03860792 734 738 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03860792 739 741 O
the NCT03860792 742 745 O
Screening NCT03860792 746 755 O
Visit NCT03860792 756 761 O

- NCT03860792 764 765 O
A NCT03860792 767 768 O
history NCT03860792 769 776 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860792 777 779 O
renal NCT03860792 780 785 B-Condition-Name
stones NCT03860792 786 792 I-Condition-Name

Inclusion NCT03860779 0 9 O
Criteria NCT03860779 10 18 O
: NCT03860779 19 20 O

- NCT03860779 24 25 O
Age NCT03860779 27 30 O
above NCT03860779 31 36 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03860779 38 40 B-Eq-Value

- NCT03860779 44 45 O
ASA NCT03860779 47 50 B-Condition-Name
classification NCT03860779 51 65 O
I NCT03860779 66 67 B-Eq-Value
to NCT03860779 68 70 B-Eq-Operator___Eq-Operator-Value:BETWEEN
II NCT03860779 71 73 B-Eq-Value

- NCT03860779 76 77 O
Indication NCT03860779 79 89 O
for NCT03860779 90 93 O
colonoscopy NCT03860779 94 105 B-Procedure-Name
with NCT03860779 106 110 O
propofol NCT03860779 111 119 B-Drug-Name
sedation NCT03860779 120 128 B-Procedure-Name

- NCT03860779 131 132 O
Written NCT03860779 134 141 O
informed NCT03860779 142 150 O
consent NCT03860779 151 158 O

Exclusion NCT03860779 159 168 O
Criteria NCT03860779 169 177 O
: NCT03860779 178 179 O

- NCT03860779 183 184 O
Pregnancy NCT03860779 186 195 B-Condition-Name

Inclusion NCT03869749 0 9 O
Criteria NCT03869749 10 18 O
: NCT03869749 19 20 O

- NCT03869749 24 25 O
two NCT03869749 27 30 B-Eq-Value
parents NCT03869749 31 38 O
in NCT03869749 39 41 O
the NCT03869749 42 45 O
home NCT03869749 46 50 O

- NCT03869749 53 54 O
an NCT03869749 56 58 O
adolescent NCT03869749 59 69 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
who NCT03869749 70 73 O
is NCT03869749 74 76 O
between NCT03869749 77 84 B-Eq-Operator___Eq-Operator-Value:BETWEEN
14 NCT03869749 86 88 B-Eq-Value
and NCT03869749 89 92 O
18 NCT03869749 94 96 B-Eq-Value
years NCT03869749 97 102 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869749 103 105 O
age NCT03869749 106 109 O

- NCT03869749 112 113 O
marital NCT03869749 115 122 B-Observation-Name
distress NCT03869749 123 131 I-Observation-Name

- NCT03869749 134 135 O
youth NCT03869749 137 142 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
reports NCT03869749 143 150 O
of NCT03869749 151 153 O
stress NCT03869749 154 160 B-Condition-Name
or NCT03869749 161 163 O
anxiety NCT03869749 164 171 B-Condition-Name

Exclusion NCT03869749 172 181 O
Criteria NCT03869749 182 190 O
: NCT03869749 191 192 O

- NCT03869749 196 197 O
two NCT03869749 199 202 B-Eq-Value
parents NCT03869749 203 210 O
in NCT03869749 211 213 O
the NCT03869749 214 217 O
home NCT03869749 218 222 O
, NCT03869749 223 224 O
but NCT03869749 225 228 O
they NCT03869749 229 233 O
are NCT03869749 234 237 O
pursuing NCT03869749 238 246 O
legal NCT03869749 247 252 B-Observation-Name
divorce NCT03869749 253 260 I-Observation-Name
or NCT03869749 261 263 O
separation NCT03869749 264 274 B-Observation-Name

- NCT03869749 277 278 O
parents NCT03869749 280 287 O
are NCT03869749 288 291 O
not NCT03869749 292 295 O
willing NCT03869749 296 303 O
to NCT03869749 304 306 O
receive NCT03869749 307 314 O
marital NCT03869749 315 322 O
education NCT03869749 323 332 B-Procedure-Name
/ NCT03869749 333 334 O
support NCT03869749 335 342 B-Procedure-Name

- NCT03869749 345 346 O
adolescents NCT03869749 348 359 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
are NCT03869749 360 363 O
clinically NCT03869749 364 374 O
depressed NCT03869749 375 384 B-Condition-Name
or NCT03869749 385 387 O
report NCT03869749 388 394 O
suicidal NCT03869749 395 403 B-Condition-Name
ideation NCT03869749 404 412 I-Condition-Name
at NCT03869749 413 415 O
baseline NCT03869749 416 424 O

Inclusion NCT03865173 0 9 O
Criteria NCT03865173 10 18 O
: NCT03865173 19 20 O

- NCT03865173 24 25 O
Patient NCT03865173 27 34 O
being NCT03865173 35 40 O
over NCT03865173 41 45 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03865173 47 49 B-Eq-Value
years NCT03865173 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865173 56 58 O
age NCT03865173 59 62 O
living NCT03865173 63 69 O
in NCT03865173 70 72 O
metropolitan NCT03865173 73 85 B-Location___Location-Value:residence
France NCT03865173 86 92 I-Location___Location-Value:residence
; NCT03865173 92 93 O

- NCT03865173 96 97 O
Patient NCT03865173 99 106 O
with NCT03865173 107 111 O
recent NCT03865173 112 118 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
stroke NCT03865173 119 125 B-Condition-Name
( NCT03865173 126 127 O
not NCT03865173 128 131 O
before NCT03865173 132 138 B-Eq-Operator___Eq-Operator-Value:LT
2019 NCT03865173 140 144 B-Eq-Value
) NCT03865173 145 146 O
whose NCT03865173 147 152 O
diagnosis NCT03865173 153 162 O
confirmed NCT03865173 163 172 O
by NCT03865173 173 175 O
a NCT03865173 176 177 O
neuro NCT03865173 178 183 B-Provider-Type
- NCT03865173 184 185 I-Provider-Type
vascular NCT03865173 186 194 I-Provider-Type
physician NCT03865173 195 204 B-Provider-Role
; NCT03865173 204 205 O

- NCT03865173 208 209 O
Patient NCT03865173 211 218 O
managed NCT03865173 219 226 O
for NCT03865173 227 230 O
stroke NCT03865173 231 237 B-Condition-Name
in NCT03865173 238 240 O
one NCT03865173 241 244 O
of NCT03865173 245 247 O
the NCT03865173 248 251 O
13 NCT03865173 253 255 O
participating NCT03865173 256 269 O
hospitals NCT03865173 270 279 B-Location___Location-Value:hospital
of NCT03865173 280 282 I-Location___Location-Value:hospital
the NCT03865173 283 286 I-Location___Location-Value:hospital
Aquitaine NCT03865173 287 296 I-Location___Location-Value:hospital
region NCT03865173 297 303 I-Location___Location-Value:hospital
; NCT03865173 303 304 O

- NCT03865173 307 308 O
Patient NCT03865173 310 317 O
giving NCT03865173 318 324 O
consent NCT03865173 325 332 O
to NCT03865173 333 335 O
participate NCT03865173 336 347 O
to NCT03865173 348 350 O
PAPASéPA NCT03865173 351 359 O
; NCT03865173 359 360 O

- NCT03865173 363 364 O
Patient NCT03865173 366 373 O
to NCT03865173 374 376 O
be NCT03865173 377 379 O
alive NCT03865173 380 385 B-Observation-Name
at NCT03865173 386 388 O
the NCT03865173 389 392 O
end NCT03865173 393 396 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
of NCT03865173 397 399 O
the NCT03865173 400 403 O
acute NCT03865173 404 409 O
management NCT03865173 410 420 O
hospital NCT03865173 421 429 B-Encounter-Type___Encounter-Type-Value:inpatient
stay NCT03865173 430 434 I-Encounter-Type___Encounter-Type-Value:inpatient

Exclusion NCT03865173 435 444 O
Criteria NCT03865173 445 453 O
: NCT03865173 454 455 O

- NCT03865173 459 460 O
Patient NCT03865173 462 469 O
refuse NCT03865173 470 476 O
to NCT03865173 477 479 O
participate NCT03865173 480 491 O
to NCT03865173 492 494 O
PAPASéPA NCT03865173 495 503 O

- NCT03865173 506 507 O
Patient NCT03865173 509 516 O
died NCT03865173 517 521 O
during NCT03865173 522 528 O
the NCT03865173 529 532 O
initial NCT03865173 533 540 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
stay NCT03865173 541 545 O

Inclusion NCT03868319 0 9 O
Criteria NCT03868319 10 18 O
: NCT03868319 19 20 O

- NCT03868319 24 25 O
scheduled NCT03868319 27 36 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03868319 37 40 O
elective NCT03868319 41 49 O
RARC NCT03868319 50 54 B-Procedure-Name

Exclusion NCT03868319 55 64 O
Criteria NCT03868319 65 73 O
: NCT03868319 74 75 O

- NCT03868319 79 80 O
history NCT03868319 82 89 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868319 90 92 O
lung NCT03868319 93 97 O
surgery NCT03868319 98 105 B-Procedure-Name

- NCT03868319 108 109 O
patients NCT03868319 111 119 O
' NCT03868319 119 120 O
refusal NCT03868319 121 128 O
or NCT03868319 129 131 O
inability NCT03868319 132 141 O
to NCT03868319 142 144 O
give NCT03868319 145 149 O
informed NCT03868319 150 158 O
consent NCT03868319 159 166 O

Inclusion NCT03867994 0 9 O
Criteria NCT03867994 10 18 O
: NCT03867994 19 20 O

- NCT03867994 24 25 O
Patients NCT03867994 27 35 O
aged NCT03867994 36 40 O
between NCT03867994 41 48 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03867994 50 52 B-Eq-Value
and NCT03867994 53 56 O
70 NCT03867994 58 60 B-Eq-Value
years NCT03867994 61 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03867994 67 68 O

- NCT03867994 72 73 O
Serum NCT03867994 75 80 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03867994 81 91 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03867994 92 93 B-Eq-Operator___Eq-Operator-Value:LTEQ
1.5 NCT03867994 95 98 B-Eq-Value
mg NCT03867994 99 101 B-Eq-Unit
/ NCT03867994 102 103 O
dL NCT03867994 104 106 B-Eq-Unit
. NCT03867994 107 108 O

- NCT03867994 112 113 O
Using NCT03867994 115 120 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03867994 121 122 O
moderate NCT03867994 123 131 B-Severity___Severity-Value:moderate
dose NCT03867994 132 136 O
of NCT03867994 137 139 O
atorvastatin NCT03867994 140 152 B-Drug-Name
( NCT03867994 153 154 O
40 NCT03867994 156 158 B-Eq-Value
mg NCT03867994 159 161 B-Eq-Unit
or NCT03867994 162 164 O
equivalent NCT03867994 165 175 O
dose NCT03867994 176 180 O
of NCT03867994 181 183 O
other NCT03867994 184 189 O
statins NCT03867994 190 197 B-Drug-Name
) NCT03867994 198 199 O
. NCT03867994 201 202 O

- NCT03867994 206 207 O
Moderate NCT03867994 209 217 B-Severity___Severity-Value:moderate
to NCT03867994 218 220 B-Eq-Operator___Eq-Operator-Value:BETWEEN
high NCT03867994 221 225 B-Severity___Severity-Value:severe
- NCT03867994 226 227 O
risk NCT03867994 228 232 O
for NCT03867994 233 236 O
CIN NCT03867994 237 240 B-Condition-Name
. NCT03867994 241 242 O

Exclusion NCT03867994 244 253 O
Criteria NCT03867994 254 262 O
: NCT03867994 263 264 O

- NCT03867994 268 269 O
Patients NCT03867994 271 279 O
suffering NCT03867994 280 289 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
from NCT03867994 290 294 O
ST NCT03867994 295 297 O
- NCT03867994 298 299 O
segment NCT03867994 300 307 O
elevation NCT03867994 308 317 O
myocardial NCT03867994 318 328 B-Condition-Name
infarction NCT03867994 329 339 I-Condition-Name
( NCT03867994 340 341 O
STEMI NCT03867994 342 347 B-Condition-Name
) NCT03867994 348 349 O

- NCT03867994 353 354 O
Patients NCT03867994 356 364 O
need NCT03867994 365 369 O
for NCT03867994 370 373 O
immediate NCT03867994 374 383 O
cardiac NCT03867994 384 391 B-Procedure-Name
catheterization NCT03867994 392 407 I-Procedure-Name

- NCT03867994 410 411 O
Elevated NCT03867994 413 421 B-Polarity___Polarity-Value:high
liver NCT03867994 422 427 B-Condition-Name
enzymes NCT03867994 428 435 I-Condition-Name
( NCT03867994 436 437 O
Aspartate NCT03867994 438 447 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03867994 448 464 I-Observation-Name___Observation-Type-Value:lab
( NCT03867994 465 466 O
AST NCT03867994 467 470 B-Observation-Name___Observation-Type-Value:lab
) NCT03867994 471 472 O
and NCT03867994 473 476 O
Alanine NCT03867994 477 484 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03867994 485 501 I-Observation-Name___Observation-Type-Value:lab
( NCT03867994 502 503 O
ALT NCT03867994 504 507 B-Observation-Name___Observation-Type-Value:lab
) NCT03867994 508 509 O
three NCT03867994 510 515 B-Eq-Value
times NCT03867994 516 521 O
the NCT03867994 522 525 O
upper NCT03867994 526 531 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03867994 532 537 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03867994 538 540 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03867994 541 547 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
) NCT03867994 548 549 O
. NCT03867994 551 552 O

- NCT03867994 556 557 O
Active NCT03867994 559 565 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03867994 566 575 B-Condition-Name
. NCT03867994 576 577 O

- NCT03867994 581 582 O
Any NCT03867994 584 587 O
contraindication NCT03867994 588 604 O
to NCT03867994 605 607 O
carvedilol NCT03867994 608 618 B-Drug-Name
, NCT03867994 619 620 O
or NCT03867994 621 623 O
atorvastatin NCT03867994 624 636 B-Drug-Name
. NCT03867994 637 638 O

- NCT03867994 642 643 O
Patients NCT03867994 645 653 O
on NCT03867994 654 656 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
regular NCT03867994 657 664 O
use NCT03867994 665 668 O
of NCT03867994 669 671 O
vitamins NCT03867994 672 680 B-Drug-Name
, NCT03867994 681 682 O
minerals NCT03867994 683 691 B-Drug-Name
. NCT03867994 692 693 O

- NCT03867994 697 698 O
Using NCT03867994 700 705 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03867994 706 716 O
with NCT03867994 717 721 O
antioxidant NCT03867994 722 733 O
properties NCT03867994 734 744 O
e NCT03867994 745 746 O
. NCT03867994 747 748 O
g NCT03867994 749 750 O
. NCT03867994 751 752 O
, NCT03867994 753 754 O
beta NCT03867994 755 759 B-Drug-Name
- NCT03867994 760 761 I-Drug-Name
carotene NCT03867994 762 770 I-Drug-Name
, NCT03867994 771 772 O
vitamin NCT03867994 773 780 B-Drug-Name
E NCT03867994 781 782 I-Drug-Name
, NCT03867994 783 784 O
vitamin NCT03867994 785 792 B-Drug-Name
C NCT03867994 793 794 I-Drug-Name
, NCT03867994 795 796 O
selenium NCT03867994 797 805 B-Drug-Name
, NCT03867994 806 807 O
theophylline NCT03867994 808 820 B-Drug-Name
or NCT03867994 821 823 O
N NCT03867994 824 825 B-Drug-Name
- NCT03867994 826 827 I-Drug-Name
acetyl NCT03867994 828 834 I-Drug-Name
cysteine NCT03867994 835 843 I-Drug-Name
7 NCT03867994 845 846 B-Eq-Value
days NCT03867994 847 851 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03867994 852 857 O
to NCT03867994 858 860 O
CC NCT03867994 861 863 B-Procedure-Name
. NCT03867994 864 865 O

- NCT03867994 869 870 O
Hemodynamically NCT03867994 872 887 B-Condition-Name
unstable NCT03867994 888 896 B-Stability___Stability-Value:change
patients NCT03867994 897 905 O
( NCT03867994 906 907 O
defined NCT03867994 908 915 O
as NCT03867994 916 918 O
abnormal NCT03867994 919 927 B-Polarity___Polarity-Value:abnormal
or NCT03867994 928 930 O
unstable NCT03867994 931 939 B-Stability___Stability-Value:change
blood NCT03867994 940 945 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03867994 946 954 I-Observation-Name___Observation-Type-Value:vital
, NCT03867994 955 956 O
especially NCT03867994 957 967 O
hypotension NCT03867994 968 979 B-Condition-Name
( NCT03867994 980 981 O
blood NCT03867994 982 987 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03867994 988 996 I-Observation-Name___Observation-Type-Value:vital
less NCT03867994 997 1001 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867994 1002 1006 I-Eq-Operator___Eq-Operator-Value:LT
90 NCT03867994 1008 1010 B-Eq-Value
/ NCT03867994 1011 1012 O
60 NCT03867994 1014 1016 B-Eq-Value
mm NCT03867994 1017 1019 B-Eq-Unit
Hg NCT03867994 1020 1022 I-Eq-Unit
) NCT03867994 1023 1024 O
. NCT03867994 1026 1027 O

- NCT03867994 1031 1032 O
Patients NCT03867994 1034 1042 O
who NCT03867994 1043 1046 O
required NCT03867994 1047 1055 O
dialysis NCT03867994 1056 1064 B-Procedure-Name
. NCT03867994 1065 1066 O

- NCT03867994 1070 1071 O
Pregnancy NCT03867994 1073 1082 B-Condition-Name
. NCT03867994 1083 1084 O

- NCT03867994 1088 1089 O
Using NCT03867994 1091 1096 O
of NCT03867994 1097 1099 O
carvedilol NCT03867994 1100 1110 B-Drug-Name
in NCT03867994 1111 1113 O
the NCT03867994 1114 1117 O
past NCT03867994 1118 1122 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03867994 1123 1128 B-Eq-Value
months NCT03867994 1129 1135 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03867994 1136 1137 O

- NCT03867994 1141 1142 O
Using NCT03867994 1144 1149 O
a NCT03867994 1150 1151 O
nephrotoxic NCT03867994 1152 1163 B-Drug-Name
agent NCT03867994 1164 1169 I-Drug-Name
in NCT03867994 1170 1172 O
the NCT03867994 1173 1176 O
past NCT03867994 1177 1181 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
48 NCT03867994 1183 1185 B-Eq-Value
hours NCT03867994 1186 1191 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03867994 1192 1194 O
exposure NCT03867994 1195 1203 O
to NCT03867994 1204 1206 O
a NCT03867994 1207 1208 O
contrast NCT03867994 1209 1217 B-Procedure-Name
agent NCT03867994 1218 1223 I-Procedure-Name
in NCT03867994 1224 1226 O
the NCT03867994 1227 1230 O
past NCT03867994 1231 1235 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
7 NCT03867994 1237 1238 B-Eq-Value
days NCT03867994 1239 1243 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03867994 1244 1249 O
to NCT03867994 1250 1252 O
cardiac NCT03867994 1253 1260 B-Procedure-Name
catheterization NCT03867994 1261 1276 I-Procedure-Name
. NCT03867994 1277 1278 O

Inclusion NCT03869775 0 9 O
Criteria NCT03869775 10 18 O
: NCT03869775 19 20 O

- NCT03869775 24 25 O
the NCT03869775 27 30 O
patient NCT03869775 31 38 O
will NCT03869775 39 43 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
be NCT03869775 44 46 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
operated NCT03869775 47 55 B-Procedure-Name
with NCT03869775 56 60 O
spinal NCT03869775 61 67 B-Procedure-Name
anesthesia NCT03869775 68 78 I-Procedure-Name

- NCT03869775 81 82 O
over NCT03869775 84 88 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03869775 90 92 B-Eq-Value
years NCT03869775 93 98 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03869775 101 102 O
no NCT03869775 104 106 O
additional NCT03869775 107 117 O
disease NCT03869775 118 125 B-Condition-Name
and NCT03869775 126 129 O
only NCT03869775 130 134 O
DM NCT03869775 135 137 B-Condition-Name

Exclusion NCT03869775 138 147 O
Criteria NCT03869775 148 156 O
: NCT03869775 157 158 O

- NCT03869775 162 163 O
patients NCT03869775 165 173 O
with NCT03869775 174 178 O
additional NCT03869775 179 189 O
disease NCT03869775 190 197 B-Condition-Name

- NCT03869775 200 201 O
patients NCT03869775 203 211 O
under NCT03869775 212 217 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03869775 219 221 B-Eq-Value
years NCT03869775 222 227 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03869775 228 230 O
age NCT03869775 231 234 O

- NCT03869775 237 238 O
patients NCT03869775 240 248 O
contraindicated NCT03869775 249 264 O
in NCT03869775 265 267 O
spinal NCT03869775 268 274 B-Procedure-Name
anesthesia NCT03869775 275 285 I-Procedure-Name

Inclusion NCT03866863 0 9 O
Criteria NCT03866863 10 18 O
: NCT03866863 19 20 O

- NCT03866863 24 25 O
All NCT03866863 27 30 O
birth NCT03866863 31 36 O
more NCT03866863 37 41 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866863 42 46 I-Eq-Operator___Eq-Operator-Value:GT
24 NCT03866863 48 50 B-Eq-Value
+ NCT03866863 51 52 O
0 NCT03866863 54 55 O
weeks NCT03866863 56 61 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03866863 62 64 O
amenorrhea NCT03866863 65 75 B-Condition-Name
at NCT03866863 76 78 O
the NCT03866863 79 82 O
maternity NCT03866863 83 92 B-Location___Location-Value:unit
ward NCT03866863 93 97 I-Location___Location-Value:unit
of NCT03866863 98 100 O
the NCT03866863 101 104 O
hospital NCT03866863 105 113 B-Location___Location-Value:hospital
Femme NCT03866863 114 119 I-Location___Location-Value:hospital
- NCT03866863 120 121 I-Location___Location-Value:hospital
Mère NCT03866863 122 126 I-Location___Location-Value:hospital
- NCT03866863 127 128 I-Location___Location-Value:hospital
Enfant NCT03866863 129 135 I-Location___Location-Value:hospital

- NCT03866863 138 139 O
from NCT03866863 141 145 O
1 NCT03866863 147 148 B-Eq-Value
st NCT03866863 149 151 I-Eq-Value
of NCT03866863 152 154 I-Eq-Value
january NCT03866863 155 162 I-Eq-Value
2011 NCT03866863 164 168 I-Eq-Value
to NCT03866863 169 171 B-Eq-Operator___Eq-Operator-Value:BETWEEN
31 NCT03866863 173 175 B-Eq-Value
december NCT03866863 176 184 I-Eq-Value
2017 NCT03866863 186 190 I-Eq-Value
. NCT03866863 190 191 O

Exclusion NCT03866863 193 202 O
Criteria NCT03866863 203 211 O
: NCT03866863 212 213 O

- NCT03866863 217 218 O
Infants NCT03866863 220 227 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
born NCT03866863 228 232 O
out NCT03866863 233 236 O
of NCT03866863 237 239 O
the NCT03866863 240 243 O
hospital NCT03866863 244 252 B-Location___Location-Value:hospital
and NCT03866863 253 256 O
secondarily NCT03866863 257 268 B-Encounter-Type___Encounter-Type-Value:transfer
hospitalized NCT03866863 269 281 I-Encounter-Type___Encounter-Type-Value:transfer
in NCT03866863 282 284 O
the NCT03866863 285 288 O
hospital NCT03866863 289 297 B-Location___Location-Value:hospital
Femme NCT03866863 298 303 I-Location___Location-Value:hospital
- NCT03866863 304 305 I-Location___Location-Value:hospital
Mère NCT03866863 306 310 I-Location___Location-Value:hospital
- NCT03866863 311 312 I-Location___Location-Value:hospital
Enfant NCT03866863 313 319 I-Location___Location-Value:hospital
. NCT03866863 321 322 O

- NCT03866863 326 327 O
Multiple NCT03866863 329 337 B-Eq-Operator___Eq-Operator-Value:GT
pregnancies NCT03866863 338 349 B-Condition-Name
, NCT03866863 350 351 O

- NCT03866863 355 356 O
children NCT03866863 358 366 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03866863 367 371 O
congenital NCT03866863 372 382 B-Condition-Name
fetal NCT03866863 383 388 I-Condition-Name
anomalies NCT03866863 389 398 I-Condition-Name

- NCT03866863 401 402 O
pregnancies NCT03866863 404 415 B-Condition-Name
without NCT03866863 416 423 O
first NCT03866863 424 429 O
trimester NCT03866863 430 439 O
ultrasound NCT03866863 440 450 B-Procedure-Name
( NCT03866863 451 452 O
to NCT03866863 453 455 O
date NCT03866863 456 460 O
the NCT03866863 461 464 O
pregnancy NCT03866863 465 474 B-Condition-Name
) NCT03866863 475 476 O

Inclusion NCT03868696 0 9 O
Criteria NCT03868696 10 18 O
: NCT03868696 19 20 O

- NCT03868696 24 25 O
Adults NCT03868696 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
with NCT03868696 34 38 O
Colles NCT03868696 39 45 O
' NCT03868696 45 46 O
type NCT03868696 47 51 O
fractures NCT03868696 52 61 B-Condition-Name
of NCT03868696 62 64 O
the NCT03868696 65 68 O
distal NCT03868696 69 75 O
radius NCT03868696 76 82 O
undergoing NCT03868696 83 93 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
fracture NCT03868696 94 102 B-Procedure-Name
manipulation NCT03868696 103 115 I-Procedure-Name
in NCT03868696 116 118 O
the NCT03868696 119 122 O
ED NCT03868696 123 125 B-Location___Location-Value:emergency-dept

- NCT03868696 128 129 O
UDiReCT NCT03868696 131 138 O
Trial NCT03868696 139 144 O
trained NCT03868696 145 152 O
staff NCT03868696 153 158 O
available NCT03868696 159 168 O

Exclusion NCT03868696 169 178 O
Criteria NCT03868696 179 187 O
: NCT03868696 188 189 O

- NCT03868696 193 194 O
Age NCT03868696 196 199 O
under NCT03868696 200 205 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03868696 207 209 B-Eq-Value

- NCT03868696 213 214 O
Volar NCT03868696 216 221 O
displaced NCT03868696 222 231 O
( NCT03868696 232 233 O
Smith NCT03868696 234 239 O
's NCT03868696 239 241 O
) NCT03868696 242 243 O
type NCT03868696 244 248 O
fractures NCT03868696 249 258 B-Condition-Name
( NCT03868696 259 260 O
well NCT03868696 261 265 O
established NCT03868696 266 277 O
as NCT03868696 278 280 O
being NCT03868696 281 286 O
unstable NCT03868696 287 295 B-Stability___Stability-Value:change
and NCT03868696 296 299 O
requiring NCT03868696 300 309 O
surgical NCT03868696 310 318 B-Procedure-Name
treatment NCT03868696 319 328 I-Procedure-Name
) NCT03868696 329 330 O

- NCT03868696 334 335 O
Unable NCT03868696 337 343 O
or NCT03868696 344 346 O
unwilling NCT03868696 347 356 O
to NCT03868696 357 359 O
give NCT03868696 360 364 O
informed NCT03868696 365 373 O
consent NCT03868696 374 381 O

- NCT03868696 384 385 O
Unable NCT03868696 387 393 O
or NCT03868696 394 396 O
unwilling NCT03868696 397 406 O
to NCT03868696 407 409 O
be NCT03868696 410 412 O
followed NCT03868696 413 421 O
up NCT03868696 422 424 O
( NCT03868696 425 426 O
e NCT03868696 427 428 O
. NCT03868696 429 430 O
g NCT03868696 431 432 O
. NCT03868696 433 434 O
orthopaedic NCT03868696 436 447 B-Provider-Type
follow NCT03868696 448 454 O
up NCT03868696 455 457 O
in NCT03868696 458 460 O
another NCT03868696 461 468 O
region NCT03868696 469 475 B-Location
) NCT03868696 476 477 O

- NCT03868696 481 482 O
Major NCT03868696 484 489 B-Severity___Severity-Value:severe
trauma NCT03868696 490 496 B-Condition-Name
with NCT03868696 497 501 O
other NCT03868696 502 507 O
injuries NCT03868696 508 516 B-Condition-Name
and NCT03868696 517 520 O
ISS NCT03868696 521 524 B-Observation-Name___Observation-Type-Value:clinical-score
( NCT03868696 525 526 O
Injury NCT03868696 527 533 B-Observation-Name___Observation-Type-Value:clinical-score
Severity NCT03868696 534 542 I-Observation-Name___Observation-Type-Value:clinical-score
Score NCT03868696 543 548 I-Observation-Name___Observation-Type-Value:clinical-score
) NCT03868696 549 550 O
> NCT03868696 551 552 B-Eq-Operator___Eq-Operator-Value:GT
16 NCT03868696 554 556 B-Eq-Value

- NCT03868696 560 561 O
Urgent NCT03868696 563 569 O
manipulation NCT03868696 570 582 B-Procedure-Name
required NCT03868696 583 591 O
due NCT03868696 592 595 O
to NCT03868696 596 598 O
neurovascular NCT03868696 599 612 O
or NCT03868696 613 615 O
skin NCT03868696 616 620 O
compromise NCT03868696 621 631 B-Condition-Name

- NCT03868696 634 635 O
Open NCT03868696 637 641 O
fractures NCT03868696 642 651 B-Condition-Name
or NCT03868696 652 654 O
those NCT03868696 655 660 O
with NCT03868696 661 665 O
associated NCT03868696 666 676 O
nerve NCT03868696 677 682 O
or NCT03868696 683 685 O
tendon NCT03868696 686 692 O
involvement NCT03868696 693 704 O
( NCT03868696 705 706 O
affect NCT03868696 707 713 O
functional NCT03868696 714 724 O
outcome NCT03868696 725 732 O
) NCT03868696 733 734 O

- NCT03868696 738 739 O
Prisoners NCT03868696 741 750 B-Observation-Name

Inclusion NCT03867214 0 9 O
Criteria NCT03867214 10 18 O
: NCT03867214 19 20 O

- NCT03867214 24 25 O
Adult NCT03867214 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03867214 33 41 O
who NCT03867214 42 45 O
plan NCT03867214 46 50 O
to NCT03867214 51 53 O
undergo NCT03867214 54 61 O
simultaneous NCT03867214 62 74 O
primary NCT03867214 75 82 O
total NCT03867214 83 88 B-Procedure-Name
knee NCT03867214 89 93 I-Procedure-Name
arthroplasty NCT03867214 94 106 I-Procedure-Name
on NCT03867214 107 109 O
bilateral NCT03867214 110 119 O
knee NCT03867214 120 124 O
joint NCT03867214 125 130 O
with NCT03867214 131 135 O
a NCT03867214 136 137 O
diagnosis NCT03867214 138 147 O
of NCT03867214 148 150 O
osteoarthritis NCT03867214 151 165 B-Condition-Name
or NCT03867214 166 168 O
aseptic NCT03867214 169 176 B-Condition-Name
bone NCT03867214 177 181 I-Condition-Name
necrosis NCT03867214 182 190 I-Condition-Name
, NCT03867214 191 192 O
but NCT03867214 193 196 O
not NCT03867214 197 200 O
of NCT03867214 201 203 O
rheumatoid NCT03867214 204 214 B-Condition-Name
arthritis NCT03867214 215 224 I-Condition-Name
; NCT03867214 224 225 O

- NCT03867214 228 229 O
All NCT03867214 231 234 O
patients NCT03867214 235 243 O
who NCT03867214 244 247 O
have NCT03867214 248 252 O
normal NCT03867214 253 259 B-Polarity___Polarity-Value:normal
pre NCT03867214 260 263 O
operative NCT03867214 264 273 B-Procedure-Name
platelet NCT03867214 274 282 B-Observation-Name___Observation-Type-Value:lab
count NCT03867214 283 288 I-Observation-Name___Observation-Type-Value:lab
, NCT03867214 289 290 O
normal NCT03867214 291 297 B-Polarity___Polarity-Value:normal
prothrombin NCT03867214 298 309 B-Observation-Name___Observation-Type-Value:lab
time NCT03867214 310 314 I-Observation-Name___Observation-Type-Value:lab
, NCT03867214 315 316 O
normal NCT03867214 317 323 B-Polarity___Polarity-Value:normal
partial NCT03867214 324 331 B-Observation-Name___Observation-Type-Value:lab
thromboplastin NCT03867214 332 346 I-Observation-Name___Observation-Type-Value:lab
time NCT03867214 347 351 I-Observation-Name___Observation-Type-Value:lab
, NCT03867214 352 353 O
and NCT03867214 354 357 O
normal NCT03867214 358 364 B-Polarity___Polarity-Value:normal
international NCT03867214 365 378 B-Observation-Name___Observation-Type-Value:lab
normalized NCT03867214 379 389 I-Observation-Name___Observation-Type-Value:lab
ratio NCT03867214 390 395 I-Observation-Name___Observation-Type-Value:lab
; NCT03867214 395 396 O

- NCT03867214 399 400 O
The NCT03867214 402 405 O
use NCT03867214 406 409 O
of NCT03867214 410 412 O
only NCT03867214 413 417 O
balanced NCT03867214 418 426 B-Drug-Name
electrolyte NCT03867214 427 438 I-Drug-Name
solutions NCT03867214 439 448 I-Drug-Name
and NCT03867214 449 452 O
/ NCT03867214 453 454 O
or NCT03867214 455 457 O
albumin NCT03867214 458 465 B-Observation-Name___Observation-Type-Value:lab
for NCT03867214 466 469 O
plasma NCT03867214 470 476 B-Procedure-Name
volume NCT03867214 477 483 I-Procedure-Name
restitution NCT03867214 484 495 I-Procedure-Name
. NCT03867214 496 497 O

Exclusion NCT03867214 499 508 O
Criteria NCT03867214 509 517 O
: NCT03867214 518 519 O

- NCT03867214 523 524 O
Allergy NCT03867214 526 533 O
to NCT03867214 534 536 O
tranexamic NCT03867214 537 547 B-Drug-Name
acid NCT03867214 548 552 I-Drug-Name
; NCT03867214 552 553 O

- NCT03867214 556 557 O
Receiving NCT03867214 559 568 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
warfarin NCT03867214 569 577 B-Drug-Name
or NCT03867214 578 580 O
heparin NCT03867214 581 588 B-Drug-Name
; NCT03867214 588 589 O
had NCT03867214 590 593 O
a NCT03867214 594 595 O
history NCT03867214 596 603 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867214 604 606 O
hemophilia NCT03867214 607 617 B-Condition-Name
, NCT03867214 618 619 O
deep NCT03867214 620 624 B-Condition-Name
venous NCT03867214 625 631 I-Condition-Name
thrombosis NCT03867214 632 642 I-Condition-Name
, NCT03867214 643 644 O
pulmonary NCT03867214 645 654 B-Condition-Name
embolism NCT03867214 655 663 I-Condition-Name
, NCT03867214 664 665 O
or NCT03867214 666 668 O
renal NCT03867214 669 674 B-Condition-Name
impairment NCT03867214 675 685 I-Condition-Name
; NCT03867214 685 686 O
or NCT03867214 687 689 O
were NCT03867214 690 694 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pregnant NCT03867214 695 703 B-Condition-Name
; NCT03867214 703 704 O

- NCT03867214 707 708 O
Patients NCT03867214 710 718 O
with NCT03867214 719 723 O
any NCT03867214 724 727 O
cardiovascular NCT03867214 728 742 B-Condition-Name
problems NCT03867214 743 751 I-Condition-Name
( NCT03867214 752 753 O
such NCT03867214 754 758 O
as NCT03867214 759 761 O
myocardiac NCT03867214 762 772 B-Condition-Name
infarction NCT03867214 773 783 I-Condition-Name
history NCT03867214 784 791 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
, NCT03867214 792 793 O
atrial NCT03867214 794 800 B-Condition-Name
fibrillation NCT03867214 801 813 I-Condition-Name
, NCT03867214 814 815 O
angina NCT03867214 816 822 B-Condition-Name
) NCT03867214 823 824 O
; NCT03867214 825 826 O

- NCT03867214 829 830 O
Patients NCT03867214 832 840 O
with NCT03867214 841 845 O
thromboembolic NCT03867214 846 860 B-Condition-Name
disorders NCT03867214 861 870 I-Condition-Name
, NCT03867214 871 872 O
or NCT03867214 873 875 O
those NCT03867214 876 881 O
exhibiting NCT03867214 882 892 O
a NCT03867214 893 894 O
deteriorating NCT03867214 895 908 B-Polarity___Polarity-Value:low
general NCT03867214 909 916 B-Condition-Name
condition NCT03867214 917 926 I-Condition-Name
; NCT03867214 926 927 O

- NCT03867214 930 931 O
Pre NCT03867214 933 936 O
operative NCT03867214 937 946 B-Procedure-Name
anemia NCT03867214 947 953 B-Condition-Name
( NCT03867214 954 955 O
a NCT03867214 956 957 O
hemoglobin NCT03867214 958 968 B-Observation-Name___Observation-Type-Value:lab
value NCT03867214 969 974 O
of NCT03867214 975 977 O
< NCT03867214 978 979 B-Eq-Operator___Eq-Operator-Value:LT
11 NCT03867214 981 983 B-Eq-Value
g NCT03867214 984 985 B-Eq-Unit
/ NCT03867214 986 987 O
dL NCT03867214 988 990 B-Eq-Unit
in NCT03867214 991 993 O
females NCT03867214 994 1001 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
and NCT03867214 1002 1005 O
< NCT03867214 1006 1007 O
12 NCT03867214 1009 1011 B-Eq-Value
g NCT03867214 1012 1013 B-Eq-Unit
/ NCT03867214 1014 1015 O
dL NCT03867214 1016 1018 B-Eq-Unit
in NCT03867214 1019 1021 O
males NCT03867214 1022 1027 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
) NCT03867214 1028 1029 O
, NCT03867214 1031 1032 O
refusal NCT03867214 1033 1040 O
of NCT03867214 1041 1043 O
blood NCT03867214 1044 1049 B-Procedure-Name
products NCT03867214 1050 1058 I-Procedure-Name
; NCT03867214 1058 1059 O

- NCT03867214 1062 1063 O
Pre NCT03867214 1065 1068 O
operative NCT03867214 1069 1078 B-Procedure-Name
use NCT03867214 1079 1082 O
of NCT03867214 1083 1085 O
anticoagulant NCT03867214 1086 1099 B-Procedure-Name
therapy NCT03867214 1100 1107 I-Procedure-Name
within NCT03867214 1108 1114 B-Eq-Operator___Eq-Operator-Value:LTEQ
five NCT03867214 1115 1119 B-Eq-Value
days NCT03867214 1120 1124 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
before NCT03867214 1125 1131 O
surgery NCT03867214 1132 1139 B-Procedure-Name
, NCT03867214 1140 1141 O
fibrinolytic NCT03867214 1142 1154 B-Condition-Name
disorders NCT03867214 1155 1164 I-Condition-Name
requiring NCT03867214 1165 1174 O
intraoperative NCT03867214 1175 1189 O
antifibrinolytic NCT03867214 1190 1206 B-Procedure-Name
treatment NCT03867214 1207 1216 I-Procedure-Name
, NCT03867214 1217 1218 O
coagulopathy NCT03867214 1219 1231 B-Condition-Name
( NCT03867214 1232 1233 O
as NCT03867214 1234 1236 O
identified NCT03867214 1237 1247 O
by NCT03867214 1248 1250 O
a NCT03867214 1251 1252 O
pre NCT03867214 1253 1256 O
operative NCT03867214 1257 1266 B-Procedure-Name
platelet NCT03867214 1267 1275 B-Observation-Name___Observation-Type-Value:lab
count NCT03867214 1276 1281 I-Observation-Name___Observation-Type-Value:lab
of NCT03867214 1282 1284 O
< NCT03867214 1285 1286 B-Eq-Operator___Eq-Operator-Value:LT
150 NCT03867214 1288 1291 B-Eq-Value
, NCT03867214 1292 1293 I-Eq-Value
000 NCT03867214 1294 1297 I-Eq-Value
/ NCT03867214 1298 1299 O
mm NCT03867214 1300 1302 B-Eq-Unit
3 NCT03867214 1303 1304 I-Eq-Unit
, NCT03867214 1305 1306 O
an NCT03867214 1307 1309 O
international NCT03867214 1310 1323 B-Observation-Name___Observation-Type-Value:lab
normalized NCT03867214 1324 1334 I-Observation-Name___Observation-Type-Value:lab
ratio NCT03867214 1335 1340 I-Observation-Name___Observation-Type-Value:lab
of NCT03867214 1341 1343 O
> NCT03867214 1344 1345 B-Eq-Operator___Eq-Operator-Value:GT
1.4 NCT03867214 1347 1350 O
, NCT03867214 1351 1352 O
or NCT03867214 1353 1355 O
a NCT03867214 1356 1357 O
prolonged NCT03867214 1358 1367 B-Polarity___Polarity-Value:abnormal
partial NCT03867214 1368 1375 B-Observation-Name___Observation-Type-Value:lab
thromboplastin NCT03867214 1376 1390 I-Observation-Name___Observation-Type-Value:lab
time NCT03867214 1391 1395 I-Observation-Name___Observation-Type-Value:lab
[ NCT03867214 1396 1397 O
> NCT03867214 1399 1400 B-Eq-Operator___Eq-Operator-Value:GT
1.4 NCT03867214 1402 1405 B-Eq-Value
times NCT03867214 1406 1411 O
normal NCT03867214 1412 1418 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
] NCT03867214 1419 1420 O
) NCT03867214 1422 1423 O
. NCT03867214 1425 1426 O

Inclusion NCT03862378 0 9 O
Criteria NCT03862378 10 18 O
: NCT03862378 19 20 O

- NCT03862378 24 25 O
Planned NCT03862378 27 34 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
surgery NCT03862378 35 42 B-Procedure-Name
for NCT03862378 43 46 O
gastric NCT03862378 47 54 O
or NCT03862378 55 57 O
colorectal NCT03862378 58 68 O
cancer NCT03862378 69 75 B-Condition-Name
with NCT03862378 76 80 O
primary NCT03862378 81 88 O
anastomosis NCT03862378 89 100 B-Procedure-Name
. NCT03862378 101 102 O

- NCT03862378 106 107 O
Inform NCT03862378 109 115 O
consent NCT03862378 116 123 O
signed NCT03862378 124 130 O
before NCT03862378 131 137 O
surgery NCT03862378 138 145 B-Procedure-Name
. NCT03862378 146 147 O

Exclusion NCT03862378 149 158 O
Criteria NCT03862378 159 167 O
: NCT03862378 168 169 O

- NCT03862378 173 174 O
No NCT03862378 176 178 O
drainage NCT03862378 179 187 B-Procedure-Name
tube NCT03862378 188 192 I-Procedure-Name
placed NCT03862378 193 199 O
. NCT03862378 200 201 O

Inclusion NCT03861117 0 9 O
Criteria NCT03861117 10 18 O
: NCT03861117 19 20 O

- NCT03861117 24 25 O
Patient NCT03861117 27 34 O
18 NCT03861117 36 38 B-Eq-Value
years NCT03861117 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03861117 45 48 O
or NCT03861117 49 51 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03861117 52 56 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03861117 59 60 O
Intubated NCT03861117 62 71 B-Procedure-Name
and NCT03861117 72 75 O
ventilated NCT03861117 76 86 B-Procedure-Name
in NCT03861117 87 89 O
intensive NCT03861117 90 99 B-Location___Location-Value:unit
care NCT03861117 100 104 I-Location___Location-Value:unit
unit NCT03861117 105 109 I-Location___Location-Value:unit
for NCT03861117 110 113 O
more NCT03861117 114 118 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03861117 119 123 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03861117 125 127 B-Eq-Value
hours NCT03861117 128 133 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

- NCT03861117 136 137 O
Patient NCT03861117 139 146 O
ready NCT03861117 147 152 O
for NCT03861117 153 156 O
weaning NCT03861117 157 164 B-Procedure-Name
evaluation NCT03861117 165 175 I-Procedure-Name

- NCT03861117 178 179 O
Failure NCT03861117 181 188 O
of NCT03861117 189 191 O
a NCT03861117 192 193 O
first NCT03861117 194 199 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
T NCT03861117 200 201 O
- NCT03861117 202 203 O
piece NCT03861117 204 209 O
SBT NCT03861117 210 213 B-Procedure-Name

Exclusion NCT03861117 214 223 O
Criteria NCT03861117 224 232 O
: NCT03861117 233 234 O

- NCT03861117 238 239 O
Chronic NCT03861117 241 248 O
neuromuscular NCT03861117 249 262 B-Condition-Name
disease NCT03861117 263 270 I-Condition-Name

- NCT03861117 273 274 O
Guillain NCT03861117 276 284 B-Condition-Name
- NCT03861117 285 286 I-Condition-Name
Barré NCT03861117 287 292 I-Condition-Name
Syndrome NCT03861117 293 301 I-Condition-Name

- NCT03861117 304 305 O
Central NCT03861117 307 314 B-Condition-Name
nervous NCT03861117 315 322 I-Condition-Name
system NCT03861117 323 329 I-Condition-Name
disease NCT03861117 330 337 I-Condition-Name
with NCT03861117 338 342 O
consciousness NCT03861117 343 356 B-Condition-Name
disorder NCT03861117 357 365 I-Condition-Name

- NCT03861117 368 369 O
Tracheostomy NCT03861117 371 383 B-Procedure-Name

- NCT03861117 386 387 O
Chronic NCT03861117 389 396 O
disease NCT03861117 397 404 B-Condition-Name
with NCT03861117 405 409 O
life NCT03861117 410 414 B-Observation-Name
expectancy NCT03861117 415 425 I-Observation-Name
less NCT03861117 426 430 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03861117 431 435 I-Eq-Operator___Eq-Operator-Value:LT
1 NCT03861117 437 438 B-Eq-Value
year NCT03861117 439 443 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03861117 446 447 O
Pregnancy NCT03861117 449 458 B-Condition-Name
, NCT03861117 459 460 O
breast NCT03861117 461 467 B-Condition-Name
feeding NCT03861117 468 475 I-Condition-Name

- NCT03861117 478 479 O
Withholding NCT03861117 481 492 O
life NCT03861117 493 497 B-Procedure-Name
support NCT03861117 498 505 I-Procedure-Name
regarding NCT03861117 506 515 O
a NCT03861117 516 517 O
reintubation NCT03861117 518 530 B-Procedure-Name

- NCT03861117 533 534 O
Prisoner NCT03861117 536 544 B-Observation-Name
or NCT03861117 545 547 O
patient NCT03861117 548 555 O
interned NCT03861117 556 564 O
in NCT03861117 565 567 O
psychiatric NCT03861117 568 579 B-Location___Location-Value:hospital
hospital NCT03861117 580 588 I-Location___Location-Value:hospital

- NCT03861117 591 592 O
Guardianship NCT03861117 594 606 B-Observation-Name

- NCT03861117 609 610 O
Language NCT03861117 612 620 B-Condition-Name
barrier NCT03861117 621 628 I-Condition-Name

- NCT03861117 631 632 O
Lack NCT03861117 634 638 O
of NCT03861117 639 641 O
medical NCT03861117 642 649 B-Insurance
insurance NCT03861117 650 659 I-Insurance

- NCT03861117 662 663 O
Lack NCT03861117 665 669 O
of NCT03861117 670 672 O
the NCT03861117 673 676 O
patient NCT03861117 677 684 O
's NCT03861117 684 686 O
consent NCT03861117 687 694 O
( NCT03861117 695 696 O
or NCT03861117 697 699 O
of NCT03861117 700 702 O
the NCT03861117 703 706 O
next NCT03861117 707 711 O
of NCT03861117 712 714 O
kin NCT03861117 715 718 O
where NCT03861117 719 724 O
appropriate NCT03861117 725 736 O
) NCT03861117 737 738 O

- NCT03861117 742 743 O
Patient NCT03861117 745 752 O
under NCT03861117 753 758 O
an NCT03861117 759 761 O
exclusion NCT03861117 762 771 O
period NCT03861117 772 778 O
after NCT03861117 779 784 O
enrollment NCT03861117 785 795 O
in NCT03861117 796 798 O
another NCT03861117 799 806 O
research NCT03861117 807 815 O
study NCT03861117 816 821 O

Inclusion NCT03866122 0 9 O
Criteria NCT03866122 10 18 O
: NCT03866122 19 20 O

- NCT03866122 24 25 O
The NCT03866122 27 30 O
subject NCT03866122 31 38 O
is NCT03866122 39 41 O
currently NCT03866122 42 51 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
being NCT03866122 52 57 O
treated NCT03866122 58 65 O
at NCT03866122 66 68 O
QECH NCT03866122 69 73 B-Location___Location-Value:hospital
in NCT03866122 74 76 O
the NCT03866122 77 80 O
neonatal NCT03866122 81 89 O
or NCT03866122 90 92 O
KMC NCT03866122 93 96 O
ward NCT03866122 97 101 B-Location___Location-Value:unit
. NCT03866122 102 103 O

- NCT03866122 107 108 O
Study NCT03866122 110 115 O
devices NCT03866122 116 123 O
are NCT03866122 124 127 O
available NCT03866122 128 137 O
for NCT03866122 138 141 O
use NCT03866122 142 145 O
. NCT03866122 146 147 O

- NCT03866122 151 152 O
The NCT03866122 154 157 O
subject NCT03866122 158 165 O
's NCT03866122 165 167 O
caregiver NCT03866122 168 177 O
has NCT03866122 178 181 O
provided NCT03866122 182 190 O
informed NCT03866122 191 199 O
consent NCT03866122 200 207 O
for NCT03866122 208 211 O
their NCT03866122 212 217 O
child NCT03866122 218 223 O
to NCT03866122 224 226 O
participate NCT03866122 227 238 O
. NCT03866122 239 240 O

Exclusion NCT03866122 242 251 O
Criteria NCT03866122 252 260 O
: NCT03866122 261 262 O

- NCT03866122 266 267 O
At NCT03866122 269 271 O
the NCT03866122 272 275 O
clinician NCT03866122 276 285 O
's NCT03866122 285 287 O
discretion NCT03866122 288 298 O
for NCT03866122 299 302 O
any NCT03866122 303 306 O
reason NCT03866122 307 313 O
including NCT03866122 314 323 O
, NCT03866122 324 325 O
but NCT03866122 326 329 O
not NCT03866122 330 333 O
limited NCT03866122 334 341 O
to NCT03866122 342 344 O
: NCT03866122 345 346 O

- NCT03866122 350 351 O
potential NCT03866122 353 362 O
for NCT03866122 363 366 O
skin NCT03866122 367 371 O
irritation NCT03866122 372 382 B-Condition-Name

- NCT03866122 385 386 O
Cough NCT03866122 388 393 B-Condition-Name

- NCT03866122 396 397 O
other NCT03866122 399 404 O
condition NCT03866122 405 414 O
that NCT03866122 415 419 O
may NCT03866122 420 423 O
preclude NCT03866122 424 432 O
use NCT03866122 433 436 O
of NCT03866122 437 439 O
the NCT03866122 440 443 O
temperature NCT03866122 444 455 B-Procedure-Name
belt NCT03866122 456 460 I-Procedure-Name

- NCT03866122 463 464 O
concurrent NCT03866122 466 476 O
treatments NCT03866122 477 487 O
that NCT03866122 488 492 O
may NCT03866122 493 496 O
require NCT03866122 497 504 O
increased NCT03866122 505 514 B-Polarity___Polarity-Value:high
patient NCT03866122 515 522 B-Procedure-Name
care NCT03866122 523 527 I-Procedure-Name

Inclusion NCT03866096 0 9 O
Criteria NCT03866096 10 18 O
: NCT03866096 19 20 O

- NCT03866096 24 25 O
Volleyball NCT03866096 27 37 B-Observation-Name___Observation-Type-Value:social-habit
players NCT03866096 38 45 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03866096 48 49 O
Female NCT03866096 51 57 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03866096 60 61 O
From NCT03866096 63 67 O
18 NCT03866096 69 71 B-Eq-Value
to NCT03866096 72 74 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03866096 76 78 B-Eq-Value
years NCT03866096 79 84 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866096 87 88 O
With NCT03866096 90 94 O
more NCT03866096 95 99 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866096 100 104 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03866096 105 108 B-Eq-Value
year NCT03866096 109 113 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866096 114 116 O
sports NCT03866096 117 123 B-Observation-Name___Observation-Type-Value:social-habit
practice NCT03866096 124 132 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03866096 135 136 O
Currently NCT03866096 138 147 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
participate NCT03866096 148 159 O
in NCT03866096 160 162 O
amateur NCT03866096 163 170 O
industry NCT03866096 171 179 O
competitions NCT03866096 180 192 O

Exclusion NCT03866096 193 202 O
Criteria NCT03866096 203 211 O
: NCT03866096 212 213 O

- NCT03866096 217 218 O
Present NCT03866096 220 227 O
a NCT03866096 228 229 O
medical NCT03866096 230 237 O
diagnosis NCT03866096 238 247 O
of NCT03866096 248 250 O
musculoskeletal NCT03866096 251 266 O
injury NCT03866096 267 273 B-Condition-Name
at NCT03866096 274 276 O
the NCT03866096 277 280 O
time NCT03866096 281 285 O
of NCT03866096 286 288 O
beginning NCT03866096 289 298 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
the NCT03866096 299 302 O
study NCT03866096 303 308 O

- NCT03866096 311 312 O
Receive NCT03866096 314 321 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03866096 322 323 O
physiotherapy NCT03866096 324 337 B-Procedure-Name
treatment NCT03866096 338 347 I-Procedure-Name
unrelated NCT03866096 348 357 O
to NCT03866096 358 360 O
the NCT03866096 361 364 O
study NCT03866096 365 370 O

- NCT03866096 373 374 O
Have NCT03866096 376 380 O
suffered NCT03866096 381 389 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
neurological NCT03866096 390 402 B-Condition-Name
pathology NCT03866096 403 412 I-Condition-Name
in NCT03866096 413 415 O
the NCT03866096 416 419 O
last NCT03866096 420 424 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03866096 426 427 B-Eq-Value
months NCT03866096 428 434 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03866096 437 438 O
Have NCT03866096 440 444 O
some NCT03866096 445 449 O
type NCT03866096 450 454 O
of NCT03866096 455 457 O
auditory NCT03866096 458 466 O
or NCT03866096 467 469 O
vestibular NCT03866096 470 480 O
disorder NCT03866096 481 489 B-Condition-Name

- NCT03866096 492 493 O
Not NCT03866096 495 498 O
signed NCT03866096 499 505 O
the NCT03866096 506 509 O
informed NCT03866096 510 518 O
consent NCT03866096 519 526 O
. NCT03866096 527 528 O

Inclusion NCT03866733 0 9 O
Criteria NCT03866733 10 18 O
: NCT03866733 19 20 O

- NCT03866733 24 25 O
elective NCT03866733 27 35 O
cardiac NCT03866733 36 43 B-Procedure-Name
surgery NCT03866733 44 51 I-Procedure-Name
. NCT03866733 52 53 O

- NCT03866733 57 58 O
age NCT03866733 60 63 O
18 NCT03866733 65 67 B-Eq-Value
- NCT03866733 68 69 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03866733 71 73 B-Eq-Value
years NCT03866733 74 79 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03866733 80 81 O

- NCT03866733 85 86 O
patients NCT03866733 88 96 O
with NCT03866733 97 101 O
median NCT03866733 102 108 B-Procedure-Name
sternotomy NCT03866733 109 119 I-Procedure-Name
. NCT03866733 120 121 O

- NCT03866733 125 126 O
body NCT03866733 128 132 B-Observation-Name___Observation-Type-Value:vital
mass NCT03866733 133 137 I-Observation-Name___Observation-Type-Value:vital
index NCT03866733 138 143 I-Observation-Name___Observation-Type-Value:vital
< NCT03866733 144 145 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03866733 147 149 B-Eq-Value
kg NCT03866733 150 152 B-Eq-Unit
. NCT03866733 153 154 O
m NCT03866733 155 156 B-Eq-Unit
2 NCT03866733 157 158 I-Eq-Unit
. NCT03866733 158 159 O

- NCT03866733 163 164 O
left NCT03866733 166 170 B-Observation-Name___Observation-Type-Value:measurement
ventricular NCT03866733 171 182 I-Observation-Name___Observation-Type-Value:measurement
ejection NCT03866733 183 191 I-Observation-Name___Observation-Type-Value:measurement
fraction NCT03866733 192 200 I-Observation-Name___Observation-Type-Value:measurement
> NCT03866733 201 202 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03866733 204 206 B-Eq-Value
% NCT03866733 207 208 B-Eq-Unit
. NCT03866733 210 211 O

Exclusion NCT03866733 213 222 O
Criteria NCT03866733 223 231 O
: NCT03866733 232 233 O

- NCT03866733 237 238 O
signiﬁcant NCT03866733 240 250 B-Severity___Severity-Value:severe
aortic NCT03866733 251 257 B-Condition-Name
stenosis NCT03866733 258 266 I-Condition-Name
. NCT03866733 267 268 O

- NCT03866733 272 273 O
left NCT03866733 275 279 O
main NCT03866733 280 284 O
coronary NCT03866733 285 293 B-Condition-Name
artery NCT03866733 294 300 I-Condition-Name
disease NCT03866733 301 308 I-Condition-Name
. NCT03866733 309 310 O

- NCT03866733 314 315 O
patient NCT03866733 317 324 O
on NCT03866733 325 327 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
anti NCT03866733 328 332 B-Drug-Name
- NCT03866733 333 334 I-Drug-Name
coagulants NCT03866733 335 345 I-Drug-Name
0 NCT03866733 346 347 I-Drug-Name

- NCT03866733 350 351 O
pre NCT03866733 353 356 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03866733 357 358 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03866733 359 367 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
respiratory NCT03866733 368 379 O
, NCT03866733 380 381 O
neurological NCT03866733 382 394 O
, NCT03866733 395 396 O
or NCT03866733 397 399 O
renal NCT03866733 400 405 O
disease NCT03866733 406 413 B-Condition-Name
. NCT03866733 414 415 O

- NCT03866733 419 420 O
CSF NCT03866733 422 425 B-Procedure-Name
or NCT03866733 426 428 O
blood NCT03866733 429 434 B-Procedure-Name
tap NCT03866733 435 438 I-Procedure-Name
during NCT03866733 439 445 O
the NCT03866733 446 449 O
procedure NCT03866733 450 459 O
. NCT03866733 460 461 O

- NCT03866733 465 466 O
failure NCT03866733 468 475 O
to NCT03866733 476 478 O
thread NCT03866733 479 485 O
the NCT03866733 486 489 O
catheter NCT03866733 490 498 B-Procedure-Name
. NCT03866733 499 500 O

- NCT03866733 504 505 O
anomalies NCT03866733 507 516 B-Condition-Name
of NCT03866733 517 519 O
vertebral NCT03866733 520 529 O
column NCT03866733 530 536 O
. NCT03866733 537 538 O

Inclusion NCT03869372 0 9 O
Criteria NCT03869372 10 18 O
: NCT03869372 19 20 O

- NCT03869372 24 25 O
Adults NCT03869372 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
between NCT03869372 34 41 B-Eq-Operator___Eq-Operator-Value:BETWEEN
age NCT03869372 42 45 O
18 NCT03869372 47 49 B-Eq-Value
and NCT03869372 50 53 O
75 NCT03869372 55 57 B-Eq-Value

- NCT03869372 61 62 O
Participants NCT03869372 64 76 O
without NCT03869372 77 84 O
a NCT03869372 85 86 O
history NCT03869372 87 94 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869372 95 97 O
gastrointestinal NCT03869372 98 114 B-Condition-Name
disorders NCT03869372 115 124 I-Condition-Name
( NCT03869372 125 126 O
control NCT03869372 127 134 O
group NCT03869372 135 140 O
) NCT03869372 141 142 O

- NCT03869372 146 147 O
Participants NCT03869372 149 161 O
with NCT03869372 162 166 O
functional NCT03869372 167 177 O
dyspepsia NCT03869372 178 187 B-Condition-Name
( NCT03869372 188 189 O
FD NCT03869372 190 192 O
group NCT03869372 193 198 O
) NCT03869372 199 200 O

- NCT03869372 204 205 O
Participants NCT03869372 207 219 O
with NCT03869372 220 224 O
moderate NCT03869372 225 233 B-Severity___Severity-Value:moderate
- NCT03869372 234 235 O
to NCT03869372 236 238 B-Eq-Operator___Eq-Operator-Value:BETWEEN
- NCT03869372 239 240 O
severe NCT03869372 241 247 B-Severity___Severity-Value:severe
irritable NCT03869372 248 257 B-Condition-Name
bowel NCT03869372 258 263 I-Condition-Name
syndrome NCT03869372 264 272 I-Condition-Name
( NCT03869372 273 274 O
defined NCT03869372 275 282 O
by NCT03869372 283 285 O
IBS NCT03869372 286 289 B-Observation-Name___Observation-Type-Value:clinical-score
symptom NCT03869372 290 297 I-Observation-Name___Observation-Type-Value:clinical-score
severity NCT03869372 298 306 I-Observation-Name___Observation-Type-Value:clinical-score
scores NCT03869372 307 313 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03869372 314 315 O
IBS NCT03869372 316 319 B-Observation-Name
- NCT03869372 320 321 I-Observation-Name
SSS NCT03869372 322 325 I-Observation-Name
) NCT03869372 326 327 O
greater NCT03869372 328 335 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03869372 336 340 I-Eq-Operator___Eq-Operator-Value:GT
250 NCT03869372 342 345 B-Eq-Value
) NCT03869372 346 347 O
( NCT03869372 348 349 O
IBS NCT03869372 350 353 O
group NCT03869372 354 359 O
) NCT03869372 360 361 O

Exclusion NCT03869372 363 372 O
Criteria NCT03869372 373 381 O
: NCT03869372 382 383 O

- NCT03869372 387 388 O
history NCT03869372 390 397 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869372 398 400 O
myocardial NCT03869372 401 411 B-Condition-Name
infarction NCT03869372 412 422 I-Condition-Name
, NCT03869372 423 424 O
supplemental NCT03869372 425 437 B-Procedure-Name
oxygen NCT03869372 438 444 I-Procedure-Name
requirement NCT03869372 445 456 O
, NCT03869372 457 458 O
or NCT03869372 459 461 O
diabetes NCT03869372 462 470 B-Condition-Name

- NCT03869372 473 474 O
history NCT03869372 476 483 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869372 484 486 O
chronic NCT03869372 487 494 O
gastrointestinal NCT03869372 495 511 B-Condition-Name
symptoms NCT03869372 512 520 O
( NCT03869372 521 522 O
for NCT03869372 523 526 O
healthy NCT03869372 527 534 O
control NCT03869372 535 542 O
population NCT03869372 543 553 O
only NCT03869372 554 558 O
) NCT03869372 559 560 O

- NCT03869372 564 565 O
history NCT03869372 567 574 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869372 575 577 O
gastric NCT03869372 578 585 B-Procedure-Name
surgery NCT03869372 586 593 I-Procedure-Name

- NCT03869372 596 597 O
psychosis NCT03869372 599 608 B-Condition-Name
or NCT03869372 609 611 O
altered NCT03869372 612 619 B-Condition-Name
cognitive NCT03869372 620 629 I-Condition-Name
status NCT03869372 630 636 I-Condition-Name

- NCT03869372 639 640 O
history NCT03869372 642 649 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869372 650 652 O
head NCT03869372 653 657 O
injury NCT03869372 658 664 B-Condition-Name
, NCT03869372 665 666 O
metal NCT03869372 667 672 B-Condition-Name
in NCT03869372 673 675 I-Condition-Name
the NCT03869372 676 679 I-Condition-Name
skull NCT03869372 680 685 I-Condition-Name
, NCT03869372 686 687 O
stroke NCT03869372 688 694 B-Condition-Name
, NCT03869372 695 696 O
or NCT03869372 697 699 O
a NCT03869372 700 701 O
history NCT03869372 702 709 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869372 710 712 O
seizures NCT03869372 713 721 B-Condition-Name

- NCT03869372 724 725 O
implantable NCT03869372 727 738 B-Procedure-Name
devices NCT03869372 739 746 I-Procedure-Name
, NCT03869372 747 748 O
such NCT03869372 749 753 O
as NCT03869372 754 756 O
a NCT03869372 757 758 O
pacemaker NCT03869372 759 768 B-Procedure-Name
or NCT03869372 769 771 O
nerve NCT03869372 772 777 B-Procedure-Name
stimulator NCT03869372 778 788 I-Procedure-Name

- NCT03869372 791 792 O
current NCT03869372 794 801 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03869372 802 805 O
of NCT03869372 806 808 O
the NCT03869372 809 812 O
following NCT03869372 813 822 O
medications NCT03869372 823 834 O
or NCT03869372 835 837 O
use NCT03869372 838 841 O
of NCT03869372 842 844 O
substances NCT03869372 845 855 O
which NCT03869372 856 861 O
are NCT03869372 862 865 O
known NCT03869372 866 871 O
to NCT03869372 872 874 O
lower NCT03869372 875 880 B-Polarity___Polarity-Value:low
the NCT03869372 881 884 O
seizure NCT03869372 885 892 B-Condition-Name
threshold NCT03869372 893 902 O
: NCT03869372 903 904 O
amitriptyline NCT03869372 905 918 B-Drug-Name
( NCT03869372 919 920 O
Elavil NCT03869372 921 927 B-Drug-Name
) NCT03869372 928 929 O
, NCT03869372 931 932 O
nortriptyline NCT03869372 933 946 B-Drug-Name
( NCT03869372 947 948 O
Pamelor NCT03869372 949 956 B-Drug-Name
) NCT03869372 957 958 O
, NCT03869372 960 961 O
imipramine NCT03869372 962 972 B-Drug-Name
( NCT03869372 973 974 O
Tofranil NCT03869372 975 983 B-Drug-Name
) NCT03869372 984 985 O
, NCT03869372 987 988 O
doxepin NCT03869372 989 996 B-Drug-Name
( NCT03869372 997 998 O
Sinequan NCT03869372 999 1007 B-Drug-Name
) NCT03869372 1008 1009 O
, NCT03869372 1011 1012 O
clozapine NCT03869372 1013 1022 B-Drug-Name
( NCT03869372 1023 1024 O
Clozaril NCT03869372 1025 1033 B-Drug-Name
) NCT03869372 1034 1035 O
, NCT03869372 1037 1038 O
chlorpromazine NCT03869372 1039 1053 B-Drug-Name
( NCT03869372 1054 1055 O
Thorazine NCT03869372 1056 1065 B-Drug-Name
) NCT03869372 1066 1067 O
, NCT03869372 1069 1070 O
amphetamines NCT03869372 1071 1083 B-Drug-Name
or NCT03869372 1084 1086 O
methamphetamine NCT03869372 1087 1102 B-Drug-Name
, NCT03869372 1103 1104 O
Ecstasy NCT03869372 1105 1112 B-Drug-Name
, NCT03869372 1113 1114 O
Ketamine NCT03869372 1115 1123 B-Drug-Name
, NCT03869372 1124 1125 O
Angel NCT03869372 1126 1131 B-Drug-Name
Dust NCT03869372 1132 1136 I-Drug-Name
/ NCT03869372 1137 1138 O
phencyclidine NCT03869372 1139 1152 B-Drug-Name
( NCT03869372 1153 1154 O
PCP NCT03869372 1155 1158 B-Drug-Name
) NCT03869372 1159 1160 O
, NCT03869372 1162 1163 O
cocaine NCT03869372 1164 1171 B-Drug-Name
, NCT03869372 1172 1173 O
or NCT03869372 1174 1176 O
3 NCT03869372 1178 1179 B-Eq-Value
or NCT03869372 1180 1182 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03869372 1183 1187 I-Eq-Operator___Eq-Operator-Value:GTEQ
alcoholic NCT03869372 1188 1197 B-Drug-Name
drinks NCT03869372 1198 1204 I-Drug-Name
per NCT03869372 1205 1208 O
day NCT03869372 1209 1212 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03869372 1215 1216 O
pregnancy NCT03869372 1218 1227 B-Condition-Name

Inclusion NCT03865979 0 9 O
Criteria NCT03865979 10 18 O
: NCT03865979 19 20 O

- NCT03865979 24 25 O
Subjects NCT03865979 27 35 O
with NCT03865979 36 40 O
stroke NCT03865979 41 47 B-Condition-Name
symptoms NCT03865979 48 56 O
who NCT03865979 57 60 O
undergo NCT03865979 61 68 O
CT NCT03865979 69 71 B-Procedure-Name
brain NCT03865979 72 77 I-Procedure-Name
imaging NCT03865979 78 85 I-Procedure-Name
. NCT03865979 86 87 O

Exclusion NCT03865979 89 98 O
Criteria NCT03865979 99 107 O
: NCT03865979 108 109 O

- NCT03865979 113 114 O
Subjects NCT03865979 116 124 O
with NCT03865979 125 129 O
poor NCT03865979 130 134 O
or NCT03865979 135 137 O
incomplete NCT03865979 138 148 O
CT NCT03865979 149 151 B-Procedure-Name
brain NCT03865979 152 157 I-Procedure-Name
imaging NCT03865979 158 165 I-Procedure-Name
. NCT03865979 166 167 O

Inclusion NCT03864497 0 9 O
Criteria NCT03864497 10 18 O
: NCT03864497 19 20 O

• NCT03864497 22 23 O
Liver NCT03864497 24 29 B-Procedure-Name
transplantation NCT03864497 30 45 I-Procedure-Name
candidates NCT03864497 46 56 O
with NCT03864497 57 61 O
one NCT03864497 62 65 O
or NCT03864497 66 68 O
more NCT03864497 69 73 O
of NCT03864497 74 76 O
the NCT03864497 77 80 O
following NCT03864497 81 90 O
: NCT03864497 91 92 O

- NCT03864497 96 97 O
inability NCT03864497 99 108 O
to NCT03864497 109 111 O
perform NCT03864497 112 119 O
> NCT03864497 120 121 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03864497 123 124 B-Eq-Value
METs NCT03864497 125 129 B-Observation-Name___Observation-Type-Value:measurement
by NCT03864497 130 132 O
history NCT03864497 133 140 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past

- NCT03864497 143 144 O
insulin NCT03864497 146 153 O
- NCT03864497 154 155 O
treated NCT03864497 156 163 O
diabetes NCT03864497 164 172 B-Condition-Name
mellitus NCT03864497 173 181 I-Condition-Name

- NCT03864497 184 185 O
serum NCT03864497 187 192 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03864497 193 203 I-Observation-Name___Observation-Type-Value:lab
> NCT03864497 204 205 B-Eq-Operator___Eq-Operator-Value:GT
152 NCT03864497 207 210 B-Eq-Value
μmol NCT03864497 211 215 B-Eq-Unit
/ NCT03864497 216 217 O
l NCT03864497 218 219 B-Eq-Unit

- NCT03864497 222 223 O
history NCT03864497 225 232 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03864497 233 235 O
MI NCT03864497 236 238 B-Condition-Name
, NCT03864497 239 240 O
PCI NCT03864497 241 244 B-Procedure-Name
or NCT03864497 245 247 O
CABG NCT03864497 248 252 B-Procedure-Name

- NCT03864497 255 256 O
stable NCT03864497 258 264 B-Condition-Name
angina NCT03864497 265 271 I-Condition-Name

- NCT03864497 274 275 O
cerebrovascular NCT03864497 277 292 B-Condition-Name
disease NCT03864497 293 300 I-Condition-Name

- NCT03864497 303 304 O
peripheral NCT03864497 306 316 B-Condition-Name
vascular NCT03864497 317 325 I-Condition-Name
disease NCT03864497 326 333 I-Condition-Name

Exclusion NCT03864497 334 343 O
Criteria NCT03864497 344 352 O
: NCT03864497 353 354 O

- NCT03864497 358 359 O
Age NCT03864497 361 364 O
< NCT03864497 365 366 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03864497 368 370 B-Eq-Value
years NCT03864497 371 376 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03864497 379 380 O
Pregnancy NCT03864497 382 391 B-Condition-Name

- NCT03864497 394 395 O
Contraindication NCT03864497 397 413 O
to NCT03864497 414 416 O
liver NCT03864497 417 422 B-Procedure-Name
transplantation NCT03864497 423 438 I-Procedure-Name

Inclusion NCT03865004 0 9 O
Criteria NCT03865004 10 18 O
: NCT03865004 19 20 O
Renal NCT03865004 21 26 B-Condition-Name
colic NCT03865004 27 32 I-Condition-Name
patients NCT03865004 33 41 O
- NCT03865004 42 43 O

Exclusion NCT03865004 45 54 O
Criteria NCT03865004 55 63 O
: NCT03865004 64 65 O
Not NCT03865004 66 69 O
renal NCT03865004 70 75 B-Condition-Name
colic NCT03865004 76 81 I-Condition-Name
patients NCT03865004 82 90 O

- NCT03865004 92 93 O

Inclusion NCT03860168 0 9 O
Criteria NCT03860168 10 18 O
for NCT03860168 19 22 O
Participating NCT03860168 23 36 O
Units NCT03860168 37 42 O
: NCT03860168 43 44 O

- NCT03860168 48 49 O
Participating NCT03860168 51 64 O
PICUs NCT03860168 65 70 O
must NCT03860168 71 75 O
be NCT03860168 76 78 O
a NCT03860168 79 80 O
separate NCT03860168 81 89 O
physical NCT03860168 90 98 O
space NCT03860168 99 104 O
dedicated NCT03860168 105 114 O
to NCT03860168 115 117 O
the NCT03860168 118 121 O
care NCT03860168 122 126 O
of NCT03860168 127 129 O
critically NCT03860168 130 140 B-Condition-Name
ill NCT03860168 141 144 I-Condition-Name
infants NCT03860168 145 152 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
and NCT03860168 153 156 O
children NCT03860168 157 165 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
, NCT03860168 166 167 O
with NCT03860168 168 172 O
the NCT03860168 173 176 O
ability NCT03860168 177 184 O
to NCT03860168 185 187 O
provide NCT03860168 188 195 O
mechanical NCT03860168 196 206 B-Procedure-Name
ventilation NCT03860168 207 218 I-Procedure-Name
. NCT03860168 219 220 O

- NCT03860168 224 225 O
Not NCT03860168 227 230 O
implemented NCT03860168 231 242 O
a NCT03860168 243 244 O
PICU NCT03860168 245 249 O
mobility NCT03860168 250 258 O
protocol NCT03860168 259 267 O
and NCT03860168 268 271 O
would NCT03860168 272 277 O
commit NCT03860168 278 284 O
to NCT03860168 285 287 O
not NCT03860168 288 291 O
implementing NCT03860168 292 304 O
a NCT03860168 305 306 O
mobility NCT03860168 307 315 O
protocol NCT03860168 316 324 O
until NCT03860168 325 330 O
the NCT03860168 331 334 O
randomized NCT03860168 335 345 O
time NCT03860168 346 350 O
of NCT03860168 351 353 O
unit NCT03860168 354 358 O
implementation NCT03860168 359 373 O
. NCT03860168 374 375 O

Inclusion NCT03860168 377 386 O
Criteria NCT03860168 387 395 O
for NCT03860168 396 399 O
Patients NCT03860168 400 408 O
: NCT03860168 409 410 O

All NCT03860168 412 415 O
patients NCT03860168 416 424 O
admitted NCT03860168 425 433 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03860168 434 436 O
the NCT03860168 437 440 O
PICUs NCT03860168 441 446 B-Location___Location-Value:unit
regardless NCT03860168 447 457 O
of NCT03860168 458 460 O
length NCT03860168 461 467 O
of NCT03860168 468 470 O
stay NCT03860168 471 475 O
will NCT03860168 476 480 O
receive NCT03860168 481 488 O
the NCT03860168 489 492 O
unit NCT03860168 493 497 O
- NCT03860168 498 499 O
based NCT03860168 500 505 O
PICU NCT03860168 506 510 O
Up NCT03860168 511 513 O
! NCT03860168 513 514 O
intervention NCT03860168 515 527 B-Procedure-Name
, NCT03860168 528 529 O
which NCT03860168 530 535 O
includes NCT03860168 536 544 O
criteria NCT03860168 545 553 O
for NCT03860168 554 557 O
no NCT03860168 558 560 O
mobilization NCT03860168 561 573 B-Procedure-Name
based NCT03860168 574 579 O
on NCT03860168 580 582 O
specific NCT03860168 583 591 O
clinical NCT03860168 592 600 O
factors NCT03860168 601 608 O
( NCT03860168 609 610 O
i NCT03860168 611 612 O
. NCT03860168 613 614 O
e NCT03860168 615 616 O
. NCT03860168 617 618 O
open NCT03860168 620 624 B-Condition-Name
chest NCT03860168 625 630 I-Condition-Name
, NCT03860168 631 632 O
surgeon NCT03860168 633 640 B-Condition-Name
request NCT03860168 641 648 I-Condition-Name
) NCT03860168 649 650 O
. NCT03860168 652 653 O
10 NCT03860168 654 656 O
For NCT03860168 657 660 O
inclusion NCT03860168 661 670 O
in NCT03860168 671 673 O
data NCT03860168 674 678 O
analysis NCT03860168 679 687 O
, NCT03860168 688 689 O

patients NCT03860168 691 699 O
will NCT03860168 700 704 O
be NCT03860168 705 707 O
eligible NCT03860168 708 716 O
if NCT03860168 717 719 O

- NCT03860168 722 723 O
Admitted NCT03860168 725 733 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03860168 734 736 O
the NCT03860168 737 740 O
participating NCT03860168 741 754 O
PICU NCT03860168 755 759 B-Location___Location-Value:unit
≥ NCT03860168 760 761 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03860168 763 764 B-Eq-Value
days NCT03860168 765 769 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
. NCT03860168 770 771 O

Exclusion NCT03860168 773 782 O
Criteria NCT03860168 783 791 O
for NCT03860168 792 795 O
Patients NCT03860168 796 804 O
: NCT03860168 805 806 O

- NCT03860168 810 811 O
Patients NCT03860168 813 821 O
with NCT03860168 822 826 O
an NCT03860168 827 829 O
active NCT03860168 830 836 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
do NCT03860168 837 839 B-Observation-Name
- NCT03860168 840 841 I-Observation-Name
not NCT03860168 842 845 I-Observation-Name
- NCT03860168 846 847 I-Observation-Name
resuscitate NCT03860168 848 859 I-Observation-Name
( NCT03860168 860 861 O
DNR NCT03860168 862 865 B-Observation-Name
) NCT03860168 866 867 O
order NCT03860168 868 873 O
will NCT03860168 874 878 O
be NCT03860168 879 881 O
excluded NCT03860168 882 890 O
. NCT03860168 891 892 O


Inclusion NCT03869164 0 9 O
Criteria NCT03869164 10 18 O
: NCT03869164 19 20 O

1 NCT03869164 25 26 O
. NCT03869164 26 27 O
age NCT03869164 29 32 O
older NCT03869164 33 38 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03869164 39 43 I-Eq-Operator___Eq-Operator-Value:GT
60 NCT03869164 45 47 B-Eq-Value
years NCT03869164 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03869164 53 54 O

2 NCT03869164 58 59 O
. NCT03869164 59 60 O
moderate NCT03869164 62 70 B-Severity___Severity-Value:moderate
to NCT03869164 71 73 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03869164 74 80 B-Severity___Severity-Value:severe
or NCT03869164 81 83 O
severe NCT03869164 84 90 B-Severity___Severity-Value:severe
mitral NCT03869164 91 97 B-Condition-Name
regurgitation NCT03869164 98 111 I-Condition-Name
; NCT03869164 111 112 O

3 NCT03869164 116 117 O
. NCT03869164 117 118 O
symptoms NCT03869164 120 128 O
( NCT03869164 129 130 O
New NCT03869164 131 134 B-Condition-Name
York NCT03869164 135 139 I-Condition-Name
Heart NCT03869164 140 145 I-Condition-Name
Association NCT03869164 146 157 I-Condition-Name
[ NCT03869164 158 159 O
NYHA NCT03869164 160 164 B-Condition-Name
] NCT03869164 165 166 O
cardiac NCT03869164 167 174 O
function NCT03869164 175 183 O
class NCT03869164 184 189 O
≥ NCT03869164 190 191 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03869164 193 194 B-Eq-Value
) NCT03869164 195 196 O
related NCT03869164 197 204 O
to NCT03869164 205 207 O
MR NCT03869164 208 210 B-Condition-Name
; NCT03869164 210 211 O

4 NCT03869164 215 216 O
. NCT03869164 216 217 O
the NCT03869164 219 222 O
primary NCT03869164 223 230 O
regurgitant NCT03869164 231 242 O
jet NCT03869164 243 246 O
originated NCT03869164 247 257 O
from NCT03869164 258 262 O
malcoaptation NCT03869164 263 276 B-Condition-Name
of NCT03869164 277 279 O
the NCT03869164 280 283 O
A NCT03869164 284 285 O
2 NCT03869164 286 287 O
and NCT03869164 288 291 O
P NCT03869164 292 293 O
2 NCT03869164 294 295 O
scallops NCT03869164 296 304 O
of NCT03869164 305 307 O
the NCT03869164 308 311 O
mitral NCT03869164 312 318 O
valve NCT03869164 319 324 O
; NCT03869164 324 325 O

5 NCT03869164 329 330 O
. NCT03869164 330 331 O
high NCT03869164 333 337 B-Polarity___Polarity-Value:high
risk NCT03869164 338 342 O
for NCT03869164 343 346 O
surgery NCT03869164 347 354 B-Procedure-Name
according NCT03869164 355 364 O
the NCT03869164 365 368 O
MVARC NCT03869164 369 374 O
criteria NCT03869164 375 383 O
; NCT03869164 383 384 O

6 NCT03869164 388 389 O
. NCT03869164 389 390 O
providing NCT03869164 392 401 O
signed NCT03869164 402 408 O
informed NCT03869164 409 417 O
consent NCT03869164 418 425 O
. NCT03869164 426 427 O

Exclusion NCT03869164 429 438 O
Criteria NCT03869164 439 447 O
: NCT03869164 448 449 O

1 NCT03869164 454 455 O
. NCT03869164 455 456 O
acute NCT03869164 458 463 B-Severity___Severity-Value:severe
myocardial NCT03869164 464 474 B-Condition-Name
infarction NCT03869164 475 485 I-Condition-Name
in NCT03869164 486 488 O
the NCT03869164 489 492 O
prior NCT03869164 493 498 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
4 NCT03869164 500 501 B-Eq-Value
weeks NCT03869164 502 507 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03869164 508 510 O
the NCT03869164 511 514 O
intended NCT03869164 515 523 O
treatment NCT03869164 524 533 O
; NCT03869164 533 534 O

2 NCT03869164 538 539 O
. NCT03869164 539 540 O
any NCT03869164 542 545 O
interventional NCT03869164 546 560 O
or NCT03869164 561 563 O
surgical NCT03869164 564 572 O
cardiac NCT03869164 573 580 B-Procedure-Name
procedure NCT03869164 581 590 I-Procedure-Name
performed NCT03869164 591 600 O
within NCT03869164 601 607 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03869164 609 611 B-Eq-Value
days NCT03869164 612 616 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03869164 617 622 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
; NCT03869164 622 623 O

3 NCT03869164 627 628 O
. NCT03869164 628 629 O
the NCT03869164 631 634 O
need NCT03869164 635 639 O
for NCT03869164 640 643 O
any NCT03869164 644 647 O
other NCT03869164 648 653 O
cardiac NCT03869164 654 661 B-Procedure-Name
surgery NCT03869164 662 669 I-Procedure-Name
; NCT03869164 669 670 O

4 NCT03869164 674 675 O
. NCT03869164 675 676 O
echocardiographic NCT03869164 678 695 B-Procedure-Name
evidence NCT03869164 696 704 O
of NCT03869164 705 707 O
intracardiac NCT03869164 708 720 B-Condition-Name
mass NCT03869164 721 725 O
, NCT03869164 726 727 O
thrombus NCT03869164 728 736 O
, NCT03869164 737 738 O
or NCT03869164 739 741 O
vegetation NCT03869164 742 752 O
; NCT03869164 752 753 O

5 NCT03869164 757 758 O
. NCT03869164 758 759 O
life NCT03869164 761 765 B-Observation-Name
expectancy NCT03869164 766 776 I-Observation-Name
within NCT03869164 777 783 B-Eq-Operator___Eq-Operator-Value:LTEQ
12 NCT03869164 785 787 B-Eq-Value
months NCT03869164 788 794 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03869164 794 795 O

6 NCT03869164 799 800 O
. NCT03869164 800 801 O
moderate NCT03869164 803 811 B-Severity___Severity-Value:moderate
or NCT03869164 812 814 O
severe NCT03869164 815 821 B-Severity___Severity-Value:severe
aortic NCT03869164 822 828 B-Condition-Name
stenosis NCT03869164 829 837 O
or NCT03869164 838 840 O
regurgitation NCT03869164 841 854 O
; NCT03869164 854 855 O

7 NCT03869164 859 860 O
. NCT03869164 860 861 O
mitral NCT03869164 863 869 B-Observation-Name___Observation-Type-Value:measurement
valve NCT03869164 870 875 I-Observation-Name___Observation-Type-Value:measurement
orifice NCT03869164 876 883 I-Observation-Name___Observation-Type-Value:measurement
area NCT03869164 884 888 I-Observation-Name___Observation-Type-Value:measurement
< NCT03869164 889 890 B-Eq-Operator___Eq-Operator-Value:LT
3.5 NCT03869164 892 895 B-Eq-Value
cm NCT03869164 896 898 B-Eq-Unit
2 NCT03869164 899 900 I-Eq-Unit
; NCT03869164 900 901 O

8 NCT03869164 905 906 O
. NCT03869164 906 907 O
untreated NCT03869164 909 918 O
significant NCT03869164 919 930 B-Severity___Severity-Value:severe
coronary NCT03869164 931 939 B-Condition-Name
stenosis NCT03869164 940 948 I-Condition-Name
; NCT03869164 948 949 O

9 NCT03869164 953 954 O
. NCT03869164 954 955 O
history NCT03869164 957 964 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03869164 965 967 O
mitral NCT03869164 968 974 B-Condition-Name
valvuloplasty NCT03869164 975 988 I-Condition-Name
; NCT03869164 988 989 O

10 NCT03869164 992 994 O
. NCT03869164 994 995 O
Infective NCT03869164 997 1006 B-Condition-Name
endocarditis NCT03869164 1007 1019 I-Condition-Name
and NCT03869164 1020 1023 O
rheumatic NCT03869164 1024 1033 B-Condition-Name
heart NCT03869164 1034 1039 I-Condition-Name
disease NCT03869164 1040 1047 I-Condition-Name
; NCT03869164 1047 1048 O

11 NCT03869164 1051 1053 O
. NCT03869164 1053 1054 O
untreated NCT03869164 1056 1065 O
cardiogenic NCT03869164 1066 1077 B-Condition-Name
shock NCT03869164 1078 1083 I-Condition-Name
, NCT03869164 1084 1085 O
acute NCT03869164 1086 1091 B-Severity___Severity-Value:severe
pulmonary NCT03869164 1092 1101 B-Condition-Name
congestion NCT03869164 1102 1112 I-Condition-Name
; NCT03869164 1112 1113 O

12 NCT03869164 1116 1118 O
. NCT03869164 1118 1119 O
unfavored NCT03869164 1121 1130 O
mitral NCT03869164 1131 1137 B-Condition-Name
valve NCT03869164 1138 1143 I-Condition-Name
anatomy NCT03869164 1144 1151 I-Condition-Name
that NCT03869164 1152 1156 O
may NCT03869164 1157 1160 O
preclude NCT03869164 1161 1169 O
device NCT03869164 1170 1176 B-Procedure-Name
implantation NCT03869164 1177 1189 I-Procedure-Name
including NCT03869164 1190 1199 O
: NCT03869164 1200 1201 O

calcification NCT03869164 1208 1221 O
or NCT03869164 1222 1224 O
significant NCT03869164 1225 1236 B-Severity___Severity-Value:severe
cleft NCT03869164 1237 1242 B-Condition-Name
in NCT03869164 1243 1245 O
area NCT03869164 1246 1250 O
of NCT03869164 1251 1253 O
the NCT03869164 1254 1257 O
A NCT03869164 1258 1259 O
2 NCT03869164 1260 1261 O
and NCT03869164 1262 1265 O
/ NCT03869164 1266 1267 O
or NCT03869164 1268 1270 O
P NCT03869164 1271 1272 O
2 NCT03869164 1273 1274 O
scallops NCT03869164 1275 1283 O
, NCT03869164 1284 1285 O
significant NCT03869164 1286 1297 B-Severity___Severity-Value:severe
regurgitation NCT03869164 1298 1311 B-Condition-Name
beyond NCT03869164 1312 1318 O
A NCT03869164 1319 1320 O
2 NCT03869164 1321 1322 O
or NCT03869164 1323 1325 O
P NCT03869164 1326 1327 O
2 NCT03869164 1328 1329 O
scallops NCT03869164 1330 1338 O
and NCT03869164 1339 1342 O
short NCT03869164 1343 1348 B-Observation-Name___Observation-Type-Value:measurement
posterior NCT03869164 1349 1358 I-Observation-Name___Observation-Type-Value:measurement
leaflet NCT03869164 1359 1366 I-Observation-Name___Observation-Type-Value:measurement
( NCT03869164 1367 1368 O
< NCT03869164 1370 1371 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03869164 1373 1375 B-Eq-Value
mm NCT03869164 1376 1378 B-Eq-Unit
) NCT03869164 1379 1380 O
. NCT03869164 1382 1383 O

13 NCT03869164 1387 1389 O
. NCT03869164 1389 1390 O
Other NCT03869164 1392 1397 O
clinical NCT03869164 1398 1406 O
trials NCT03869164 1407 1413 O
that NCT03869164 1414 1418 O
the NCT03869164 1419 1422 O
subjects NCT03869164 1423 1431 O
participated NCT03869164 1432 1444 O
in NCT03869164 1445 1447 O
have NCT03869164 1448 1452 O
not NCT03869164 1453 1456 O
reached NCT03869164 1457 1464 O
the NCT03869164 1465 1468 O
end NCT03869164 1469 1472 O
point NCT03869164 1473 1478 O
. NCT03869164 1479 1480 O

Inclusion NCT03922828 0 9 O
Criteria NCT03922828 10 18 O
: NCT03922828 19 20 O

- NCT03922828 24 25 O
The NCT03922828 27 30 O
subject NCT03922828 31 38 O
must NCT03922828 39 43 O
meet NCT03922828 44 48 O
all NCT03922828 49 52 O
of NCT03922828 53 55 O
the NCT03922828 56 59 O
following NCT03922828 60 69 O
inclusion NCT03922828 70 79 O
criteria NCT03922828 80 88 O
to NCT03922828 89 91 O
participate NCT03922828 92 103 O
in NCT03922828 104 106 O
this NCT03922828 107 111 O
study NCT03922828 112 117 O
. NCT03922828 118 119 O

1 NCT03922828 129 130 O
. NCT03922828 130 131 O
Evidence NCT03922828 133 141 O
of NCT03922828 142 144 O
lung NCT03922828 145 149 B-Condition-Name
nodule NCT03922828 150 156 I-Condition-Name
on NCT03922828 157 159 O
chest NCT03922828 160 165 B-Procedure-Name
radiograph NCT03922828 166 176 I-Procedure-Name
or NCT03922828 177 179 O
Computed NCT03922828 180 188 B-Procedure-Name
Tomography NCT03922828 189 199 I-Procedure-Name
regardless NCT03922828 200 210 O
of NCT03922828 211 213 O
underlying NCT03922828 214 224 O
aetiology NCT03922828 225 234 O

2 NCT03922828 243 244 O
. NCT03922828 244 245 O
Age NCT03922828 247 250 O
> NCT03922828 251 252 B-Eq-Operator___Eq-Operator-Value:GT
21 NCT03922828 254 256 B-Eq-Value
years NCT03922828 257 262 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03922828 263 266 O

3 NCT03922828 275 276 O
. NCT03922828 276 277 O
Ability NCT03922828 279 286 O
to NCT03922828 287 289 O
provide NCT03922828 290 297 O
informed NCT03922828 298 306 O
consent NCT03922828 307 314 O

Exclusion NCT03922828 315 324 O
Criteria NCT03922828 325 333 O
: NCT03922828 334 335 O

- NCT03922828 339 340 O
Subjects NCT03922828 342 350 O
who NCT03922828 351 354 O
no NCT03922828 355 357 O
radiographic NCT03922828 358 370 B-Procedure-Name
evidence NCT03922828 371 379 O
of NCT03922828 380 382 O
lung NCT03922828 383 387 B-Condition-Name
nodules NCT03922828 388 395 I-Condition-Name
or NCT03922828 396 398 O
who NCT03922828 399 402 O
are NCT03922828 403 406 O
unwilling NCT03922828 407 416 O
/ NCT03922828 417 418 O
unable NCT03922828 419 425 O
to NCT03922828 426 428 O
provide NCT03922828 429 436 O
informed NCT03922828 437 445 O
consent NCT03922828 446 453 O

Inclusion NCT03926455 0 9 O
Criteria NCT03926455 10 18 O
: NCT03926455 19 20 O

- NCT03926455 24 25 O
Healthy NCT03926455 27 34 O
adult NCT03926455 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
men NCT03926455 41 44 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03926455 45 47 O
women NCT03926455 48 53 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03926455 54 57 O
are NCT03926455 58 61 O
not NCT03926455 62 65 O
pregnant NCT03926455 66 74 B-Condition-Name
or NCT03926455 75 77 O
planning NCT03926455 78 86 O
to NCT03926455 87 89 O
become NCT03926455 90 96 O
pregnant NCT03926455 97 105 B-Condition-Name
during NCT03926455 106 112 O
study NCT03926455 113 118 O
duration NCT03926455 119 127 O
aged NCT03926455 128 132 O
18 NCT03926455 134 136 B-Eq-Value
to NCT03926455 137 139 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03926455 141 143 B-Eq-Value
years NCT03926455 144 149 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03926455 150 151 O

- NCT03926455 155 156 O
Clinical NCT03926455 158 166 O
laboratory NCT03926455 167 177 B-Observation-Name___Observation-Type-Value:lab
parameters NCT03926455 178 188 I-Observation-Name___Observation-Type-Value:lab
within NCT03926455 189 195 O
normal NCT03926455 196 202 B-Polarity___Polarity-Value:normal
laboratory NCT03926455 203 213 O
limits NCT03926455 214 220 O
or NCT03926455 221 223 O
not NCT03926455 224 227 O
found NCT03926455 228 233 O
to NCT03926455 234 236 O
be NCT03926455 237 239 O
clinically NCT03926455 240 250 O
significant NCT03926455 251 262 O
by NCT03926455 263 265 O
the NCT03926455 266 269 O
PI NCT03926455 270 272 O

Exclusion NCT03926455 273 282 O
Criteria NCT03926455 283 291 O
: NCT03926455 292 293 O

- NCT03926455 297 298 O
Relevant NCT03926455 300 308 O
history NCT03926455 309 316 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926455 317 319 O
physical NCT03926455 320 328 O
or NCT03926455 329 331 O
psychiatric NCT03926455 332 343 O
illness NCT03926455 344 351 B-Condition-Name
or NCT03926455 352 354 O
medical NCT03926455 355 362 B-Condition-Name
disorder NCT03926455 363 371 I-Condition-Name
that NCT03926455 372 376 O
required NCT03926455 377 385 O
treatment NCT03926455 386 395 O
. NCT03926455 396 397 O

- NCT03926455 401 402 O
Known NCT03926455 404 409 O
or NCT03926455 410 412 O
suspected NCT03926455 413 422 O
hypersensitivity NCT03926455 423 439 B-Condition-Name
to NCT03926455 440 442 O
investigational NCT03926455 443 458 O
product NCT03926455 459 466 O

- NCT03926455 469 470 O
Immunocompromised NCT03926455 472 489 B-Condition-Name
subjects NCT03926455 490 498 O

- NCT03926455 501 502 O
Previous NCT03926455 504 512 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
Typhoid NCT03926455 513 520 B-Procedure-Name
vaccination NCT03926455 521 532 I-Procedure-Name
or NCT03926455 533 535 O
elevated NCT03926455 536 544 B-Polarity___Polarity-Value:high
anti NCT03926455 545 549 B-Observation-Name___Observation-Type-Value:lab
- NCT03926455 550 551 I-Observation-Name___Observation-Type-Value:lab
Vi NCT03926455 552 554 I-Observation-Name___Observation-Type-Value:lab
antibodies NCT03926455 555 565 I-Observation-Name___Observation-Type-Value:lab
at NCT03926455 566 568 O
screening NCT03926455 569 578 O

- NCT03926455 581 582 O
Known NCT03926455 584 589 O
history NCT03926455 590 597 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926455 598 600 O
Typhoid NCT03926455 601 608 B-Condition-Name
infection NCT03926455 609 618 I-Condition-Name
in NCT03926455 619 621 O
the NCT03926455 622 625 O
previous NCT03926455 626 634 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03926455 636 637 B-Eq-Value
months NCT03926455 638 644 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03926455 647 648 O
Positive NCT03926455 650 658 B-Polarity___Polarity-Value:positive
HIV NCT03926455 659 662 B-Condition-Name
, NCT03926455 663 664 O
HBsAg NCT03926455 665 670 B-Condition-Name
, NCT03926455 671 672 O
or NCT03926455 673 675 O
HCV NCT03926455 676 679 B-Condition-Name
screen NCT03926455 680 686 O

- NCT03926455 689 690 O
Any NCT03926455 692 695 O
other NCT03926455 696 701 O
condition NCT03926455 702 711 O
or NCT03926455 712 714 O
abnormality NCT03926455 715 726 B-Condition-Name
that NCT03926455 727 731 O
, NCT03926455 732 733 O
in NCT03926455 734 736 O
the NCT03926455 737 740 O
opinion NCT03926455 741 748 O
of NCT03926455 749 751 O
the NCT03926455 752 755 O
Investigator NCT03926455 756 768 O
, NCT03926455 769 770 O
may NCT03926455 771 774 O
compromise NCT03926455 775 785 B-Stability___Stability-Value:change
the NCT03926455 786 789 O
safety NCT03926455 790 796 B-Observation-Name
of NCT03926455 797 799 O
the NCT03926455 800 803 O
patients NCT03926455 804 812 O

Inclusion NCT03928444 0 9 O
Criteria NCT03928444 10 18 O
: NCT03928444 19 20 O

- NCT03928444 24 25 O
Clinically NCT03928444 27 37 O
diagnosed NCT03928444 38 47 O
facial NCT03928444 48 54 B-Condition-Name
skin NCT03928444 55 59 I-Condition-Name
aging NCT03928444 60 65 I-Condition-Name
. NCT03928444 66 67 O

- NCT03928444 71 72 O
Glogau NCT03928444 74 80 B-Condition-Name
photoaging NCT03928444 81 91 I-Condition-Name
score NCT03928444 92 97 B-Eq-Unit
II NCT03928444 98 100 B-Eq-Value
and NCT03928444 101 104 O
III NCT03928444 105 108 B-Eq-Value
. NCT03928444 109 110 O

- NCT03928444 114 115 O
Body NCT03928444 117 121 B-Observation-Name___Observation-Type-Value:vital
mass NCT03928444 122 126 I-Observation-Name___Observation-Type-Value:vital
index NCT03928444 127 132 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03928444 133 134 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03928444 136 138 B-Eq-Value
with NCT03928444 139 143 O
adequate NCT03928444 144 152 O
abdominal NCT03928444 153 162 O
or NCT03928444 163 165 O
other NCT03928444 166 171 O
subcutaneous NCT03928444 172 184 O
adipose NCT03928444 185 192 B-Observation-Name
tissue NCT03928444 193 199 I-Observation-Name
accessible NCT03928444 200 210 O
for NCT03928444 211 214 O
lipoaspiration NCT03928444 215 229 B-Procedure-Name
. NCT03928444 230 231 O

Exclusion NCT03928444 233 242 O
Criteria NCT03928444 243 251 O
: NCT03928444 252 253 O

- NCT03928444 257 258 O
History NCT03928444 260 267 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928444 268 270 O
keloid NCT03928444 271 277 B-Condition-Name
formation NCT03928444 278 287 I-Condition-Name
. NCT03928444 288 289 O

- NCT03928444 293 294 O
Any NCT03928444 296 299 O
coincidental NCT03928444 300 312 O
chronic NCT03928444 313 320 O
illness NCT03928444 321 328 B-Condition-Name
( NCT03928444 329 330 O
e NCT03928444 331 332 O
. NCT03928444 333 334 O
g NCT03928444 335 336 O
. NCT03928444 337 338 O
metabolic NCT03928444 340 349 O
, NCT03928444 350 351 O
autoimmune NCT03928444 352 362 O
or NCT03928444 363 365 O
endocrinal NCT03928444 366 376 O
) NCT03928444 377 378 O
or NCT03928444 379 381 O
malignancy NCT03928444 382 392 B-Condition-Name
. NCT03928444 393 394 O

- NCT03928444 398 399 O
Any NCT03928444 401 404 O
bleeding NCT03928444 405 413 O
or NCT03928444 414 416 O
coagulation NCT03928444 417 428 O
disorder NCT03928444 429 437 B-Condition-Name
or NCT03928444 438 440 O
recent NCT03928444 441 447 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03928444 448 451 O
of NCT03928444 452 454 O
anticoagulant NCT03928444 455 468 B-Drug-Name
therapy NCT03928444 469 476 I-Drug-Name
. NCT03928444 477 478 O

- NCT03928444 482 483 O
Active NCT03928444 485 491 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03928444 492 501 B-Condition-Name
. NCT03928444 502 503 O

- NCT03928444 507 508 O
History NCT03928444 510 517 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928444 518 520 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
any NCT03928444 521 524 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
previous NCT03928444 525 533 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
aesthetic NCT03928444 534 543 B-Procedure-Name
procedure NCT03928444 544 553 I-Procedure-Name
on NCT03928444 554 556 O
the NCT03928444 557 560 O
face NCT03928444 561 565 O
within NCT03928444 566 572 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03928444 573 576 O
past NCT03928444 577 581 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03928444 583 584 B-Eq-Value
months NCT03928444 585 591 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03928444 592 593 O

- NCT03928444 597 598 O
History NCT03928444 600 607 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928444 608 610 O
intake NCT03928444 611 617 O
of NCT03928444 618 620 O
anti NCT03928444 621 625 O
- NCT03928444 626 627 O
aging NCT03928444 628 633 O
systemic NCT03928444 634 642 O
or NCT03928444 643 645 O
topical NCT03928444 646 653 O
medications NCT03928444 654 665 B-Drug-Name
within NCT03928444 666 672 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03928444 673 676 O
previous NCT03928444 677 685 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03928444 687 688 B-Eq-Value
months NCT03928444 689 695 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03928444 696 697 O

Inclusion NCT03924518 0 9 O
Criteria NCT03924518 10 18 O
( NCT03924518 19 20 O
Only NCT03924518 21 25 O
patients NCT03924518 26 34 O
who NCT03924518 35 38 O
fully NCT03924518 39 44 O
meet NCT03924518 45 49 O
the NCT03924518 50 53 O
following NCT03924518 54 63 O
criteria NCT03924518 64 72 O
are NCT03924518 73 76 O
eligible NCT03924518 77 85 O
to NCT03924518 86 88 O

participate NCT03924518 89 100 O
in NCT03924518 101 103 O
the NCT03924518 104 107 O
trial NCT03924518 108 113 O
) NCT03924518 114 115 O
: NCT03924518 117 118 O

- NCT03924518 122 123 O
Meets NCT03924518 125 130 O
the NCT03924518 131 134 O
diagnostic NCT03924518 135 145 O
criteria NCT03924518 146 154 O
for NCT03924518 155 158 O
sepsis NCT03924518 159 165 B-Condition-Name
- NCT03924518 166 167 O
3 NCT03924518 169 170 B-Eq-Value
developed NCT03924518 171 180 O
by NCT03924518 181 183 O
the NCT03924518 184 187 O
American NCT03924518 188 196 O
Society NCT03924518 197 204 O
of NCT03924518 205 207 O
Critical NCT03924518 208 216 O
Care NCT03924518 217 221 O
Medicine NCT03924518 222 230 O
( NCT03924518 231 232 O
SCCM NCT03924518 233 237 O
) NCT03924518 238 239 O
/ NCT03924518 241 242 O
European NCT03924518 243 251 O
Critical NCT03924518 252 260 O
Care NCT03924518 261 265 O
Medicine NCT03924518 266 274 O
Association NCT03924518 275 286 O
( NCT03924518 287 288 O
ESICM NCT03924518 289 294 O
) NCT03924518 295 296 O

- NCT03924518 300 301 O
Age NCT03924518 303 306 O
≥ NCT03924518 307 308 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03924518 310 312 B-Eq-Value
years NCT03924518 313 318 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03924518 319 322 O
and NCT03924518 323 326 O
age NCT03924518 327 330 O
≤ NCT03924518 331 332 B-Eq-Operator___Eq-Operator-Value:LTEQ
80 NCT03924518 334 336 B-Eq-Value
years NCT03924518 337 342 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03924518 343 346 O
. NCT03924518 347 348 O

- NCT03924518 352 353 O
Procalcitonin NCT03924518 355 368 B-Observation-Name___Observation-Type-Value:lab
≥ NCT03924518 369 370 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03924518 372 373 B-Eq-Value
ng NCT03924518 374 376 B-Eq-Unit
/ NCT03924518 377 378 O
ml NCT03924518 379 381 B-Eq-Unit

Exclusion NCT03924518 382 391 O
Criteria NCT03924518 392 400 O
: NCT03924518 401 402 O

- NCT03924518 406 407 O
Age NCT03924518 409 412 O
＜ NCT03924518 413 414 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03924518 416 418 B-Eq-Value
years NCT03924518 419 424 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03924518 425 426 O
or NCT03924518 427 429 O
age NCT03924518 430 433 O
＞ NCT03924518 434 435 B-Eq-Operator___Eq-Operator-Value:GT
80 NCT03924518 437 439 B-Eq-Value
years NCT03924518 440 445 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03924518 446 447 O

- NCT03924518 451 452 O
Pregnancy NCT03924518 454 463 B-Condition-Name
or NCT03924518 464 466 O
lactating NCT03924518 467 476 B-Condition-Name

- NCT03924518 479 480 O
A NCT03924518 482 483 O
solid NCT03924518 484 489 O
- NCT03924518 490 491 O
organ NCT03924518 492 497 O
or NCT03924518 498 500 O
bone NCT03924518 501 505 O
marrow NCT03924518 506 512 O
transplant NCT03924518 513 523 B-Procedure-Name
patients NCT03924518 524 532 O
. NCT03924518 533 534 O

- NCT03924518 538 539 O
Patients NCT03924518 541 549 O
with NCT03924518 550 554 O
myocardial NCT03924518 555 565 B-Condition-Name
infarction NCT03924518 566 576 I-Condition-Name
within NCT03924518 577 583 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03924518 584 587 O
past NCT03924518 588 592 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03924518 594 595 B-Eq-Value
months NCT03924518 596 602 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03924518 603 604 O

- NCT03924518 608 609 O
Advanced NCT03924518 611 619 B-Condition-Name
pulmonary NCT03924518 620 629 I-Condition-Name
fibrosis NCT03924518 630 638 I-Condition-Name
. NCT03924518 640 641 O

- NCT03924518 645 646 O
Patients NCT03924518 648 656 O
with NCT03924518 657 661 O
cardiopulmonary NCT03924518 662 677 B-Condition-Name
resuscitation NCT03924518 678 691 I-Condition-Name
before NCT03924518 692 698 O
enrollment NCT03924518 699 709 O
. NCT03924518 710 711 O

- NCT03924518 715 716 O
HIV NCT03924518 718 721 B-Condition-Name
- NCT03924518 722 723 O
positive NCT03924518 724 732 B-Polarity___Polarity-Value:positive
patients NCT03924518 733 741 O
. NCT03924518 742 743 O

- NCT03924518 747 748 O
granulocyte NCT03924518 750 761 B-Condition-Name
- NCT03924518 762 763 I-Condition-Name
deficient NCT03924518 764 773 I-Condition-Name
patients NCT03924518 774 782 O
. NCT03924518 783 784 O

- NCT03924518 788 789 O
blood NCT03924518 791 796 O
/ NCT03924518 797 798 O
lymphatic NCT03924518 799 808 O
system NCT03924518 809 815 O
tumors NCT03924518 816 822 B-Condition-Name
are NCT03924518 823 826 O
not NCT03924518 827 830 O
remission NCT03924518 831 840 O
. NCT03924518 841 842 O

- NCT03924518 846 847 O
patients NCT03924518 849 857 O
with NCT03924518 858 862 O
limited NCT03924518 863 870 B-Observation-Name
care NCT03924518 871 875 I-Observation-Name
( NCT03924518 876 877 O
lack NCT03924518 878 882 O
of NCT03924518 883 885 O
commitment NCT03924518 886 896 O
to NCT03924518 897 899 O
full NCT03924518 900 904 O
， NCT03924518 905 906 O
aggressive NCT03924518 907 917 O
life NCT03924518 918 922 B-Procedure-Name
support NCT03924518 923 930 I-Procedure-Name
) NCT03924518 931 932 O
. NCT03924518 934 935 O

- NCT03924518 939 940 O
patients NCT03924518 942 950 O
with NCT03924518 951 955 O
long NCT03924518 956 960 O
- NCT03924518 961 962 O
term NCT03924518 963 967 O
use NCT03924518 968 971 O
of NCT03924518 972 974 O
immunosuppressive NCT03924518 975 992 B-Drug-Name
drugs NCT03924518 993 998 I-Drug-Name
or NCT03924518 999 1001 O
with NCT03924518 1002 1006 O
immunodeficiency NCT03924518 1007 1023 B-Condition-Name
. NCT03924518 1024 1025 O

- NCT03924518 1029 1030 O
patients NCT03924518 1032 1040 O
with NCT03924518 1041 1045 O
advanced NCT03924518 1046 1054 B-Condition-Name
tumors NCT03924518 1055 1061 I-Condition-Name
. NCT03924518 1062 1063 O

- NCT03924518 1067 1068 O
patients NCT03924518 1070 1078 O
combined NCT03924518 1079 1087 O
with NCT03924518 1088 1092 O
non NCT03924518 1093 1096 O
- NCT03924518 1097 1098 O
infectious NCT03924518 1099 1109 B-Condition-Name
factors NCT03924518 1110 1117 I-Condition-Name
leading NCT03924518 1118 1125 O
to NCT03924518 1126 1128 O
the NCT03924518 1129 1132 O
death NCT03924518 1133 1138 O
( NCT03924518 1139 1140 O
uncontrollable NCT03924518 1141 1155 B-Condition-Name
major NCT03924518 1156 1161 I-Condition-Name
bleeding NCT03924518 1162 1170 I-Condition-Name
, NCT03924518 1171 1172 O
brain NCT03924518 1173 1178 B-Condition-Name
hernia NCT03924518 1179 1185 B-Condition-Name
, NCT03924518 1186 1187 O
etc NCT03924518 1188 1191 O
. NCT03924518 1192 1193 O
) NCT03924518 1194 1195 O
. NCT03924518 1197 1198 O

- NCT03924518 1202 1203 O
surgically NCT03924518 1205 1215 O
unresolved NCT03924518 1216 1226 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03924518 1227 1236 B-Condition-Name
sources NCT03924518 1237 1244 O
( NCT03924518 1245 1246 O
such NCT03924518 1247 1251 O
as NCT03924518 1252 1254 O
some NCT03924518 1255 1259 O
intraperitoneal NCT03924518 1260 1275 B-Condition-Name
infection NCT03924518 1276 1285 I-Condition-Name
etc NCT03924518 1286 1289 O
. NCT03924518 1290 1291 O
) NCT03924518 1292 1293 O

- NCT03924518 1297 1298 O
patients NCT03924518 1300 1308 O
allergic NCT03924518 1309 1317 O
to NCT03924518 1318 1320 O
granisetron NCT03924518 1321 1332 B-Allergy-Name
. NCT03924518 1333 1334 O

- NCT03924518 1338 1339 O
patients NCT03924518 1341 1349 O
with NCT03924518 1350 1354 O
intestinal NCT03924518 1355 1365 B-Condition-Name
obstruction NCT03924518 1366 1377 I-Condition-Name
. NCT03924518 1378 1379 O

Inclusion NCT03926858 0 9 O
Criteria NCT03926858 10 18 O
: NCT03926858 19 20 O

- NCT03926858 24 25 O
18 NCT03926858 28 30 B-Eq-Value
years NCT03926858 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03926858 37 39 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03926858 40 45 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03926858 48 49 O
Undergoing NCT03926858 51 61 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
general NCT03926858 62 69 O
or NCT03926858 70 72 O
regional NCT03926858 73 81 O
anesthesia NCT03926858 82 92 B-Procedure-Name

- NCT03926858 95 96 O
Hospitalized NCT03926858 98 110 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03926858 111 114 O
at NCT03926858 115 117 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926858 118 123 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03926858 125 127 B-Eq-Value
hours NCT03926858 128 133 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
after NCT03926858 134 139 O
surgery NCT03926858 140 147 B-Procedure-Name

- NCT03926858 150 151 O
Able NCT03926858 153 157 O
to NCT03926858 158 160 O
give NCT03926858 161 165 O
informed NCT03926858 166 174 O
consent NCT03926858 175 182 O

- NCT03926858 185 186 O
Able NCT03926858 188 192 O
to NCT03926858 193 195 O
read NCT03926858 196 200 O
and NCT03926858 201 204 O
write NCT03926858 205 210 O

Exclusion NCT03926858 211 220 O
Criteria NCT03926858 221 229 O
: NCT03926858 230 231 O

- NCT03926858 235 236 O
Existing NCT03926858 238 246 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnoses NCT03926858 247 256 O
of NCT03926858 257 259 O
psychiatric NCT03926858 260 271 O
or NCT03926858 272 274 O
neurologic NCT03926858 275 285 O
pathology NCT03926858 286 295 B-Condition-Name

- NCT03926858 298 299 O
A NCT03926858 301 302 O
history NCT03926858 303 310 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926858 311 313 O
substance NCT03926858 314 323 B-Condition-Name
abuse NCT03926858 324 329 I-Condition-Name

- NCT03926858 332 333 O
Admitted NCT03926858 335 343 O
to NCT03926858 344 346 O
ICU NCT03926858 347 350 B-Encounter-Type___Encounter-Type-Value:icu
after NCT03926858 351 356 O
surgery NCT03926858 357 364 B-Procedure-Name

Inclusion NCT03925389 0 9 O
Criteria NCT03925389 10 18 O
: NCT03925389 19 20 O

- NCT03925389 24 25 O
at NCT03925389 27 29 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03925389 30 35 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03925389 37 39 B-Eq-Value
years NCT03925389 40 45 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03925389 46 49 O

- NCT03925389 52 53 O
Patients NCT03925389 55 63 O
eligible NCT03925389 64 72 O
for NCT03925389 73 76 O
external NCT03925389 77 85 B-Procedure-Name
septorhinoplasty NCT03925389 86 102 I-Procedure-Name
: NCT03925389 103 104 O
patients NCT03925389 105 113 O
seen NCT03925389 114 118 O
in NCT03925389 119 121 O
consultation NCT03925389 122 134 O
because NCT03925389 135 142 O
of NCT03925389 143 145 O
nasal NCT03925389 146 151 B-Condition-Name
obstruction NCT03925389 152 163 I-Condition-Name
were NCT03925389 164 168 O
evaluated NCT03925389 169 178 O
. NCT03925389 179 180 O
Patients NCT03925389 182 190 O
who NCT03925389 191 194 O
had NCT03925389 195 198 O
symptoms NCT03925389 199 207 O
of NCT03925389 208 210 O
nasal NCT03925389 211 216 B-Condition-Name
obstruction NCT03925389 217 228 I-Condition-Name
for NCT03925389 229 232 O
at NCT03925389 233 235 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03925389 236 241 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03925389 243 244 B-Eq-Value
year NCT03925389 245 249 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
that NCT03925389 250 254 O
were NCT03925389 255 259 O
the NCT03925389 260 263 O
result NCT03925389 264 270 O
of NCT03925389 271 273 O
an NCT03925389 274 276 O
identifiable NCT03925389 277 289 O
anatomical NCT03925389 290 300 B-Condition-Name
cause NCT03925389 301 306 I-Condition-Name
such NCT03925389 307 311 O
as NCT03925389 312 314 O
septal NCT03925389 315 321 B-Condition-Name
deviation NCT03925389 322 331 I-Condition-Name
, NCT03925389 332 333 O
turbinate NCT03925389 334 343 B-Condition-Name
hypertrophy NCT03925389 344 355 I-Condition-Name
, NCT03925389 356 357 O
internal NCT03925389 358 366 B-Condition-Name
valve NCT03925389 367 372 I-Condition-Name
collapse NCT03925389 373 381 I-Condition-Name
, NCT03925389 382 383 O
or NCT03925389 384 386 O
external NCT03925389 387 395 B-Condition-Name
valve NCT03925389 396 401 I-Condition-Name
collapse NCT03925389 402 410 I-Condition-Name
were NCT03925389 411 415 O
included NCT03925389 416 424 O
in NCT03925389 425 427 O
the NCT03925389 428 431 O
study NCT03925389 432 437 O
. NCT03925389 438 439 O

Exclusion NCT03925389 441 450 O
Criteria NCT03925389 451 459 O
: NCT03925389 460 461 O

- NCT03925389 465 466 O
< NCT03925389 468 469 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03925389 471 473 B-Eq-Value
years NCT03925389 474 479 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03925389 482 483 O
mental NCT03925389 485 491 O
or NCT03925389 492 494 O
physical NCT03925389 495 503 O
incapacity NCT03925389 504 514 B-Condition-Name
to NCT03925389 515 517 O
answer NCT03925389 518 524 O
the NCT03925389 525 528 O
questionnaires NCT03925389 529 543 O

- NCT03925389 546 547 O
nasal NCT03925389 549 554 B-Condition-Name
fracture NCT03925389 555 563 I-Condition-Name
or NCT03925389 564 566 O
surgery NCT03925389 567 574 B-Procedure-Name
in NCT03925389 575 577 O
the NCT03925389 578 581 O
past NCT03925389 582 586 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03925389 587 591 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03925389 594 595 O
nasal NCT03925389 597 602 O
cocaine NCT03925389 603 610 B-Drug-Name
use NCT03925389 611 614 O
in NCT03925389 615 617 O
the NCT03925389 618 621 O
past NCT03925389 622 626 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03925389 627 631 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Inclusion NCT03923920 0 9 O
Criteria NCT03923920 10 18 O
: NCT03923920 19 20 O

- NCT03923920 24 25 O
Age NCT03923920 27 30 O
≥ NCT03923920 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03923920 34 36 B-Eq-Value
years NCT03923920 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923920 45 46 O
Undergoing NCT03923920 48 58 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surgical NCT03923920 59 67 B-Procedure-Name
intervention NCT03923920 68 80 I-Procedure-Name
for NCT03923920 81 84 O
non NCT03923920 85 88 O
- NCT03923920 89 90 O
congenital NCT03923920 91 101 O
spinal NCT03923920 102 108 B-Condition-Name
stenosis NCT03923920 109 117 I-Condition-Name
and NCT03923920 118 121 O
/ NCT03923920 122 123 O
or NCT03923920 124 126 O
spondyloarthropathy NCT03923920 127 146 B-Condition-Name

- NCT03923920 149 150 O
Able NCT03923920 152 156 O
to NCT03923920 157 159 O
consent NCT03923920 160 167 O

Exclusion NCT03923920 168 177 O
Criteria NCT03923920 178 186 O
: NCT03923920 187 188 O

- NCT03923920 192 193 O
History NCT03923920 195 202 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03923920 203 205 O
congenital NCT03923920 206 216 B-Condition-Name
spinal NCT03923920 217 223 I-Condition-Name
stenosis NCT03923920 224 232 I-Condition-Name
or NCT03923920 233 235 O
congenital NCT03923920 236 246 B-Condition-Name
spondyloarthropathy NCT03923920 247 266 I-Condition-Name

Inclusion NCT03928691 0 9 O
criteria NCT03928691 10 18 O
: NCT03928691 19 20 O

pregnant NCT03928691 22 30 B-Condition-Name
women NCT03928691 31 36 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
34 NCT03928691 38 40 B-Eq-Value
weeks NCT03928691 41 46 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
or NCT03928691 47 49 B-Eq-Operator___Eq-Operator-Value:LTEQ
less NCT03928691 50 54 I-Eq-Operator___Eq-Operator-Value:LTEQ
admitted NCT03928691 55 63 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03928691 64 66 O
Women NCT03928691 67 72 B-Location___Location-Value:hospital
's NCT03928691 72 74 I-Location___Location-Value:hospital
Health NCT03928691 75 81 I-Location___Location-Value:hospital
Hospital NCT03928691 82 90 I-Location___Location-Value:hospital
with NCT03928691 91 95 O
a NCT03928691 96 97 O
diagnosis NCT03928691 98 107 O
of NCT03928691 108 110 O
: NCT03928691 111 112 O

- NCT03928691 116 117 O
sever NCT03928691 119 124 B-Severity___Severity-Value:severe
preeclampsia NCT03928691 125 137 B-Condition-Name
. NCT03928691 138 139 O
It NCT03928691 141 143 O
is NCT03928691 144 146 O
defined NCT03928691 147 154 O
as NCT03928691 155 157 O
1 NCT03928691 159 160 O
- NCT03928691 161 162 O
blood NCT03928691 163 168 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03928691 169 177 I-Observation-Name___Observation-Type-Value:vital
160 NCT03928691 179 182 B-Eq-Value
/ NCT03928691 183 184 O
110 NCT03928691 186 189 B-Eq-Value
mmHg NCT03928691 190 194 B-Eq-Unit
or NCT03928691 195 197 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03928691 198 202 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03928691 204 205 O
- NCT03928691 206 207 O
proteinurea NCT03928691 208 219 B-Observation-Name___Observation-Type-Value:lab
( NCT03928691 220 221 O
+ NCT03928691 223 224 O
3 NCT03928691 226 227 B-Eq-Value
or NCT03928691 228 230 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03928691 231 235 I-Eq-Operator___Eq-Operator-Value:GTEQ
by NCT03928691 236 238 O
dipstick NCT03928691 239 247 O
) NCT03928691 248 249 O
3 NCT03928691 251 252 B-Condition-Name
- NCT03928691 253 254 I-Condition-Name
HELLP NCT03928691 255 260 I-Condition-Name
syndrome NCT03928691 261 269 I-Condition-Name

- NCT03928691 272 273 O
threatened NCT03928691 275 285 O
preterm NCT03928691 286 293 B-Condition-Name
labour NCT03928691 294 300 I-Condition-Name
that NCT03928691 301 305 O
will NCT03928691 306 310 O
receive NCT03928691 311 318 O
Magnesium NCT03928691 319 328 B-Drug-Name
Sulphate NCT03928691 329 337 I-Drug-Name
either NCT03928691 338 344 O
for NCT03928691 345 348 O
tocolysis NCT03928691 349 358 O
or NCT03928691 359 361 O
neuroprotection NCT03928691 362 377 O
. NCT03928691 378 379 O

Exclusion NCT03928691 381 390 O
criteria NCT03928691 391 399 O
: NCT03928691 400 401 O

- NCT03928691 404 405 O
women NCT03928691 406 411 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03928691 412 416 O
more NCT03928691 417 421 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03928691 422 426 I-Eq-Operator___Eq-Operator-Value:GT
34 NCT03928691 428 430 B-Eq-Value
weeks NCT03928691 431 436 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
gestation NCT03928691 437 446 B-Observation-Name
and NCT03928691 447 450 O
with NCT03928691 451 455 O
any NCT03928691 456 459 O
contraindication NCT03928691 460 476 O
for NCT03928691 477 480 O
Magnesium NCT03928691 481 490 B-Drug-Name
Sulphate NCT03928691 491 499 I-Drug-Name
intake NCT03928691 500 506 O
like NCT03928691 507 511 O
severe NCT03928691 512 518 B-Severity
renal NCT03928691 519 524 B-Condition-Name
impairment NCT03928691 525 535 I-Condition-Name
or NCT03928691 536 538 O
myasthenia NCT03928691 539 549 B-Condition-Name
gravis NCT03928691 550 556 I-Condition-Name
. NCT03928691 557 558 O


Inclusion NCT03922425 0 9 O
Criteria NCT03922425 10 18 O
: NCT03922425 19 20 O

- NCT03922425 24 25 O
Age NCT03922425 27 30 O
18 NCT03922425 32 34 B-Eq-Value
- NCT03922425 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03922425 38 40 B-Eq-Value

- NCT03922425 44 45 O
Current NCT03922425 47 54 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
service NCT03922425 55 62 O
users NCT03922425 63 68 O
, NCT03922425 69 70 O
with NCT03922425 71 75 O
severe NCT03922425 76 82 B-Severity___Severity-Value:severe
and NCT03922425 83 86 O
enduring NCT03922425 87 95 O
mental NCT03922425 96 102 B-Condition-Name
disorder NCT03922425 103 111 I-Condition-Name
, NCT03922425 112 113 O

- NCT03922425 117 118 O
Severe NCT03922425 120 126 B-Severity___Severity-Value:severe
Mental NCT03922425 127 133 B-Condition-Name
Illnesses NCT03922425 134 143 I-Condition-Name
- NCT03922425 144 145 O
bipolar NCT03922425 146 153 B-Condition-Name
disorder NCT03922425 154 162 I-Condition-Name
, NCT03922425 163 164 O
severe NCT03922425 165 171 B-Condition-Name
depression NCT03922425 172 182 I-Condition-Name
, NCT03922425 183 184 O
or NCT03922425 185 187 O
schizophrenia NCT03922425 188 201 B-Condition-Name

Exclusion NCT03922425 202 211 O
Criteria NCT03922425 212 220 O
: NCT03922425 221 222 O

- NCT03922425 226 227 O
Patients NCT03922425 229 237 O
who NCT03922425 238 241 O
do NCT03922425 242 244 O
not NCT03922425 245 248 O
consent NCT03922425 249 256 O
to NCT03922425 257 259 O
their NCT03922425 260 265 O
data NCT03922425 266 270 O
being NCT03922425 271 276 O
collected NCT03922425 277 286 O

- NCT03922425 289 290 O
Patients NCT03922425 292 300 O
with NCT03922425 301 305 O
acute NCT03922425 306 311 B-Severity___Severity-Value:severe
somatic NCT03922425 312 319 B-Condition-Name
disorders NCT03922425 320 329 I-Condition-Name

- NCT03922425 332 333 O
Patients NCT03922425 335 343 O
who NCT03922425 344 347 O
are NCT03922425 348 351 O
under NCT03922425 352 357 B-Eq-Operator___Eq-Operator-Value:LT
the NCT03922425 358 361 O
age NCT03922425 362 365 O
of NCT03922425 366 368 O
18 NCT03922425 370 372 B-Eq-Value
at NCT03922425 373 375 O
the NCT03922425 376 379 O
start NCT03922425 380 385 O
of NCT03922425 386 388 O
the NCT03922425 389 392 O
study NCT03922425 393 398 O
. NCT03922425 399 400 O

Inclusion NCT03921892 0 9 O
Criteria NCT03921892 10 18 O
: NCT03921892 19 20 O

- NCT03921892 24 25 O
age NCT03921892 27 30 O
15 NCT03921892 32 34 B-Eq-Value
to NCT03921892 35 37 B-Eq-Operator___Eq-Operator-Value:BETWEEN
21 NCT03921892 39 41 B-Eq-Value
, NCT03921892 42 43 O

- NCT03921892 48 49 O
be NCT03921892 51 53 O
able NCT03921892 54 58 O
to NCT03921892 59 61 O
read NCT03921892 62 66 O
and NCT03921892 67 70 O
understand NCT03921892 71 81 O
English NCT03921892 82 89 B-Language
( NCT03921892 90 91 O
as NCT03921892 92 94 O
determined NCT03921892 95 105 O
by NCT03921892 106 108 O
having NCT03921892 109 115 O
the NCT03921892 116 119 O
individual NCT03921892 120 130 O
read NCT03921892 131 135 O
a NCT03921892 136 137 O
brief NCT03921892 138 143 O
, NCT03921892 144 145 O
eighth NCT03921892 146 152 O
grade NCT03921892 153 158 O
reading NCT03921892 159 166 O
level NCT03921892 167 172 O
paragraph NCT03921892 173 182 O
) NCT03921892 183 184 O
, NCT03921892 186 187 O

- NCT03921892 191 192 O
able NCT03921892 194 198 O
to NCT03921892 199 201 O
begin NCT03921892 202 207 O
the NCT03921892 208 211 O
intervention NCT03921892 212 224 O
within NCT03921892 225 231 B-Eq-Operator___Eq-Operator-Value:LTEQ
six NCT03921892 232 235 B-Eq-Value
weeks NCT03921892 236 241 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03921892 242 244 O
their NCT03921892 245 250 O
infant NCT03921892 251 257 O
's NCT03921892 257 259 O
birth NCT03921892 260 265 O
, NCT03921892 266 267 O

- NCT03921892 271 272 O
be NCT03921892 274 276 O
able NCT03921892 277 281 O
to NCT03921892 282 284 O
participate NCT03921892 285 296 O
in NCT03921892 297 299 O
an NCT03921892 300 302 O
intervention NCT03921892 303 315 O
over NCT03921892 316 320 B-Eq-Operator___Eq-Operator-Value:GT
two NCT03921892 321 324 B-Eq-Value
weeks NCT03921892 325 330 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
, NCT03921892 331 332 O
requiring NCT03921892 333 342 O
approximately NCT03921892 343 356 O
a NCT03921892 357 358 O
12 NCT03921892 360 362 O
- NCT03921892 363 364 O
hour NCT03921892 365 369 O
time NCT03921892 370 374 O
commitment NCT03921892 375 385 O
: NCT03921892 386 387 O
either NCT03921892 388 394 O
in NCT03921892 395 397 O
- NCT03921892 398 399 O
person NCT03921892 400 406 O
on NCT03921892 407 409 O
two NCT03921892 410 413 O
Saturdays NCT03921892 414 423 O
for NCT03921892 424 427 O
six NCT03921892 428 431 O
hours NCT03921892 432 437 O
each NCT03921892 438 442 O
, NCT03921892 443 444 O
or NCT03921892 445 447 O
a NCT03921892 448 449 O
self NCT03921892 450 454 O
- NCT03921892 455 456 O
paced NCT03921892 457 462 O
content NCT03921892 463 470 O
of NCT03921892 471 473 O
videos NCT03921892 474 480 O
and NCT03921892 481 484 O
resource NCT03921892 485 493 O
materials NCT03921892 494 503 O
over NCT03921892 504 508 O
two NCT03921892 509 512 O
weeks NCT03921892 513 518 O
, NCT03921892 519 520 O

- NCT03921892 524 525 O
own NCT03921892 527 530 O
or NCT03921892 531 533 O
have NCT03921892 534 538 O
access NCT03921892 539 545 O
to NCT03921892 546 548 O
a NCT03921892 549 550 O
device NCT03921892 551 557 O
with NCT03921892 558 562 O
internet NCT03921892 563 571 O
access NCT03921892 572 578 O
and NCT03921892 579 582 O

- NCT03921892 585 586 O
have NCT03921892 588 592 O
a NCT03921892 593 594 O
working NCT03921892 595 602 O
e NCT03921892 603 604 O
- NCT03921892 605 606 O
mail NCT03921892 607 611 O
address NCT03921892 612 619 O
. NCT03921892 620 621 O

Exclusion NCT03921892 623 632 O
Criteria NCT03921892 633 641 O
: NCT03921892 642 643 O

- NCT03921892 647 648 O
Any NCT03921892 650 653 O
condition NCT03921892 654 663 O
that NCT03921892 664 668 O
might NCT03921892 669 674 O
prevent NCT03921892 675 682 O
the NCT03921892 683 686 O
father NCT03921892 687 693 O
's NCT03921892 693 695 O
infant NCT03921892 696 702 O
from NCT03921892 703 707 O
reaching NCT03921892 708 716 O
normal NCT03921892 717 723 B-Polarity___Polarity-Value:normal
developmental NCT03921892 724 737 B-Observation-Name
milestones NCT03921892 738 748 I-Observation-Name
will NCT03921892 749 753 O
participation NCT03921892 754 767 O
, NCT03921892 768 769 O
including NCT03921892 770 779 O
congenital NCT03921892 780 790 B-Condition-Name
malformations NCT03921892 791 804 I-Condition-Name
or NCT03921892 805 807 O
prematurity NCT03921892 808 819 B-Condition-Name
requiring NCT03921892 820 829 O
prolonged NCT03921892 830 839 O
/ NCT03921892 840 841 O
ongoing NCT03921892 842 849 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infant NCT03921892 850 856 O
hospitalization NCT03921892 857 872 B-Encounter-Type___Encounter-Type-Value:inpatient
. NCT03921892 873 874 O


Inclusion NCT03924726 0 9 O
Criteria NCT03924726 10 18 O
: NCT03924726 19 20 O

- NCT03924726 24 25 O
Aged NCT03924726 27 31 O
18 NCT03924726 33 35 B-Eq-Value
years NCT03924726 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03924726 42 45 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03924726 46 51 I-Eq-Operator___Eq-Operator-Value:GTEQ
at NCT03924726 52 54 O
the NCT03924726 55 58 O
start NCT03924726 59 64 O
of NCT03924726 65 67 O
the NCT03924726 68 71 O
treatment NCT03924726 72 81 O
. NCT03924726 82 83 O

- NCT03924726 87 88 O
Molar NCT03924726 90 95 B-Condition-Name
relationship NCT03924726 96 108 I-Condition-Name
either NCT03924726 109 115 O
Class NCT03924726 116 121 B-Eq-Unit
I NCT03924726 122 123 B-Eq-Value
, NCT03924726 124 125 O
< NCT03924726 126 127 B-Eq-Operator___Eq-Operator-Value:LT
½ NCT03924726 128 129 B-Eq-Value
unit NCT03924726 130 134 B-Eq-Unit
Class NCT03924726 135 140 I-Eq-Unit
II NCT03924726 141 143 I-Eq-Unit
or NCT03924726 144 146 O
Class NCT03924726 147 152 B-Eq-Unit
III NCT03924726 153 156 B-Eq-Value
. NCT03924726 157 158 O

- NCT03924726 162 163 O
Extraction NCT03924726 165 175 B-Procedure-Name
of NCT03924726 176 178 I-Procedure-Name
all NCT03924726 179 182 I-Procedure-Name
four NCT03924726 183 187 I-Procedure-Name
first NCT03924726 188 193 I-Procedure-Name
premolar NCT03924726 194 202 I-Procedure-Name
teeth NCT03924726 203 208 I-Procedure-Name
as NCT03924726 209 211 O
part NCT03924726 212 216 O
of NCT03924726 217 219 O
orthodontic NCT03924726 220 231 B-Procedure-Name
treatment NCT03924726 232 241 I-Procedure-Name
. NCT03924726 242 243 O

- NCT03924726 247 248 O
Maximum NCT03924726 250 257 B-Procedure-Name
anchorage NCT03924726 258 267 I-Procedure-Name
required NCT03924726 268 276 O
using NCT03924726 277 282 O
mini NCT03924726 283 287 B-Procedure-Name
- NCT03924726 288 289 I-Procedure-Name
implant NCT03924726 290 297 I-Procedure-Name
. NCT03924726 298 299 O

- NCT03924726 303 304 O
No NCT03924726 306 308 O
systemic NCT03924726 309 317 B-Condition-Name
disease NCT03924726 318 325 I-Condition-Name
. NCT03924726 326 327 O

- NCT03924726 331 332 O
Good NCT03924726 334 338 O
oral NCT03924726 339 343 O
hygiene NCT03924726 344 351 O
. NCT03924726 352 353 O

- NCT03924726 357 358 O
No NCT03924726 360 362 O
periodontal NCT03924726 363 374 B-Condition-Name
disease NCT03924726 375 382 I-Condition-Name
. NCT03924726 383 384 O

Exclusion NCT03924726 386 395 O
Criteria NCT03924726 396 404 O
: NCT03924726 405 406 O

- NCT03924726 410 411 O
Significant NCT03924726 413 424 O
vertical NCT03924726 425 433 B-Condition-Name
skeletal NCT03924726 434 442 I-Condition-Name
discrepancies NCT03924726 443 456 I-Condition-Name
. NCT03924726 457 458 O

- NCT03924726 462 463 O
Systemic NCT03924726 465 473 B-Condition-Name
diseases NCT03924726 474 482 I-Condition-Name
requiring NCT03924726 483 492 O
long NCT03924726 493 497 O
- NCT03924726 498 499 O
term NCT03924726 500 504 O
antibiotic NCT03924726 505 515 B-Drug-Name
use NCT03924726 516 519 O
, NCT03924726 520 521 O
phenytoin NCT03924726 522 531 B-Drug-Name
, NCT03924726 532 533 O
cyclosporin NCT03924726 534 545 B-Drug-Name
, NCT03924726 546 547 O
anti NCT03924726 548 552 B-Drug-Name
- NCT03924726 553 554 I-Drug-Name
inflammatory NCT03924726 555 567 I-Drug-Name
drugs NCT03924726 568 573 I-Drug-Name
, NCT03924726 574 575 O
bisphosphonates NCT03924726 576 591 B-Drug-Name
, NCT03924726 592 593 O
systemic NCT03924726 594 602 B-Drug-Name
corticosteroids NCT03924726 603 618 I-Drug-Name
or NCT03924726 619 621 O
calcium NCT03924726 622 629 B-Drug-Name
channel NCT03924726 630 637 I-Drug-Name
blockers NCT03924726 638 646 I-Drug-Name
. NCT03924726 647 648 O

- NCT03924726 652 653 O
Poor NCT03924726 655 659 B-Condition-Name
oral NCT03924726 660 664 I-Condition-Name
hygiene NCT03924726 665 672 I-Condition-Name
. NCT03924726 673 674 O

- NCT03924726 678 679 O
Active NCT03924726 681 687 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
periodontal NCT03924726 688 699 B-Condition-Name
disease NCT03924726 700 707 I-Condition-Name
. NCT03924726 708 709 O


Inclusion NCT03923049 0 9 O
Criteria NCT03923049 10 18 O
: NCT03923049 19 20 O

1 NCT03923049 23 24 O
. NCT03923049 24 25 O
Subjects NCT03923049 26 34 O
older NCT03923049 35 40 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03923049 41 45 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03923049 47 49 B-Eq-Value
years NCT03923049 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03923049 56 58 O
age NCT03923049 59 62 O
with NCT03923049 63 67 O
high NCT03923049 68 72 B-Polarity___Polarity-Value:high
suspicion NCT03923049 73 82 O
of NCT03923049 83 85 O
cardiac NCT03923049 86 93 B-Condition-Name
sarcoidosis NCT03923049 94 105 I-Condition-Name
and NCT03923049 106 109 O
/ NCT03923049 110 111 O
or NCT03923049 112 114 O

biopsy NCT03923049 115 121 B-Procedure-Name
proven NCT03923049 122 128 O
extracardiac NCT03923049 129 141 B-Condition-Name
sarcoidosis NCT03923049 142 153 I-Condition-Name
and NCT03923049 154 157 O
/ NCT03923049 158 159 O
or NCT03923049 160 162 O
positive NCT03923049 163 171 B-Polarity___Polarity-Value:positive
HRS NCT03923049 172 175 B-Condition-Name
criteria NCT03923049 176 184 O
will NCT03923049 185 189 O
be NCT03923049 190 192 O
enrolled NCT03923049 193 201 O
. NCT03923049 202 203 O

Exclusion NCT03923049 205 214 O
Criteria NCT03923049 215 223 O
: NCT03923049 224 225 O

1 NCT03923049 230 231 O
. NCT03923049 231 232 O
Coronary NCT03923049 234 242 B-Condition-Name
artery NCT03923049 243 249 I-Condition-Name
disease NCT03923049 250 257 I-Condition-Name

2 NCT03923049 261 262 O
. NCT03923049 262 263 O
Insulin NCT03923049 265 272 O
dependent NCT03923049 273 282 O
diabetes NCT03923049 283 291 B-Condition-Name

3 NCT03923049 295 296 O
. NCT03923049 296 297 O
Claustrophobia NCT03923049 299 313 B-Condition-Name

4 NCT03923049 317 318 O
. NCT03923049 318 319 O
Pregnancy NCT03923049 321 330 B-Condition-Name
/ NCT03923049 331 332 O
nursing NCT03923049 333 340 B-Condition-Name

5 NCT03923049 344 345 O
. NCT03923049 345 346 O
Presence NCT03923049 348 356 O
of NCT03923049 357 359 O
pacemaker NCT03923049 360 369 B-Procedure-Name
or NCT03923049 370 372 O
automatic NCT03923049 373 382 B-Procedure-Name
implantable NCT03923049 383 394 I-Procedure-Name
cardioverter NCT03923049 395 407 I-Procedure-Name
- NCT03923049 408 409 I-Procedure-Name
defibrillator NCT03923049 410 423 I-Procedure-Name

6 NCT03923049 427 428 O
. NCT03923049 428 429 O
Impaired NCT03923049 431 439 B-Condition-Name
renal NCT03923049 440 445 I-Condition-Name
function NCT03923049 446 454 I-Condition-Name
( NCT03923049 455 456 O
estimated NCT03923049 457 466 B-Observation-Name___Observation-Type-Value:lab
glomerular NCT03923049 467 477 I-Observation-Name___Observation-Type-Value:lab
filtration NCT03923049 478 488 I-Observation-Name___Observation-Type-Value:lab
rate NCT03923049 489 493 I-Observation-Name___Observation-Type-Value:lab
< NCT03923049 494 495 B-Eq-Operator___Eq-Operator-Value:LT
45 NCT03923049 497 499 B-Eq-Value
ml NCT03923049 500 502 B-Eq-Unit
/ NCT03923049 503 504 O
min NCT03923049 505 508 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
/ NCT03923049 509 510 O
1.73 NCT03923049 512 516 B-Eq-Value
m NCT03923049 517 518 B-Eq-Unit
2 NCT03923049 519 520 I-Eq-Unit
) NCT03923049 521 522 O
will NCT03923049 523 527 O
be NCT03923049 528 530 O
excluded NCT03923049 531 539 O
. NCT03923049 540 541 O

7 NCT03923049 546 547 O
. NCT03923049 547 548 O
Inability NCT03923049 550 559 O
to NCT03923049 560 562 O
undergo NCT03923049 563 570 O
PET NCT03923049 571 574 B-Procedure-Name
/ NCT03923049 575 576 O
MRI NCT03923049 577 580 B-Procedure-Name
due NCT03923049 581 584 O
to NCT03923049 585 587 O
any NCT03923049 588 591 O
other NCT03923049 592 597 O
condition NCT03923049 598 607 O
. NCT03923049 608 609 O

Inclusion NCT03920540 0 9 O
Criteria NCT03920540 10 18 O
: NCT03920540 19 20 O

- NCT03920540 24 25 O
Patients NCT03920540 27 35 O
diagnosed NCT03920540 36 45 O
with NCT03920540 46 50 O
Hunter NCT03920540 51 57 B-Condition-Name
syndrome NCT03920540 58 66 I-Condition-Name

- NCT03920540 69 70 O
Male NCT03920540 72 76 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
at NCT03920540 77 79 O
the NCT03920540 80 83 O
age NCT03920540 84 87 O
of NCT03920540 88 90 O
≥ NCT03920540 91 92 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03920540 94 95 B-Eq-Value

- NCT03920540 99 100 O
Adequate NCT03920540 102 110 O
abilities NCT03920540 111 120 O
( NCT03920540 121 122 O
including NCT03920540 123 132 O
6 NCT03920540 134 135 B-Observation-Name
- NCT03920540 136 137 I-Observation-Name
MWT NCT03920540 138 141 I-Observation-Name
) NCT03920540 142 143 O
to NCT03920540 144 146 O
participate NCT03920540 147 158 O
in NCT03920540 159 161 O
this NCT03920540 162 166 O
study NCT03920540 167 172 O
in NCT03920540 173 175 O
the NCT03920540 176 179 O
opinion NCT03920540 180 187 O
of NCT03920540 188 190 O
the NCT03920540 191 194 O
investigator NCT03920540 195 207 O
. NCT03920540 208 209 O

- NCT03920540 213 214 O
Voluntarily NCT03920540 216 227 O
signed NCT03920540 228 234 O
written NCT03920540 235 242 O
informed NCT03920540 243 251 O
consent NCT03920540 252 259 O
to NCT03920540 260 262 O
participation NCT03920540 263 276 O
in NCT03920540 277 279 O
this NCT03920540 280 284 O
study NCT03920540 285 290 O

- NCT03920540 293 294 O
Consent NCT03920540 296 303 O
to NCT03920540 304 306 O
contraception NCT03920540 307 320 B-Procedure-Name

Exclusion NCT03920540 321 330 O
Criteria NCT03920540 331 339 O
: NCT03920540 340 341 O

- NCT03920540 345 346 O
Prior NCT03920540 348 353 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03920540 354 363 O
with NCT03920540 364 368 O
iduronate NCT03920540 369 378 B-Drug-Name
- NCT03920540 379 380 I-Drug-Name
2 NCT03920540 382 383 I-Drug-Name
- NCT03920540 384 385 I-Drug-Name
sulfatase NCT03920540 386 395 I-Drug-Name
ERT NCT03920540 396 399 I-Drug-Name

- NCT03920540 402 403 O
History NCT03920540 405 412 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920540 413 415 O
bronchotomy NCT03920540 416 427 B-Procedure-Name
, NCT03920540 428 429 O
bone NCT03920540 430 434 B-Procedure-Name
marrow NCT03920540 435 441 I-Procedure-Name
trasplanation NCT03920540 442 455 I-Procedure-Name
, NCT03920540 456 457 O
or NCT03920540 458 460 O
cord NCT03920540 461 465 B-Procedure-Name
blood NCT03920540 466 471 I-Procedure-Name
transplanation NCT03920540 472 486 I-Procedure-Name
. NCT03920540 487 488 O

- NCT03920540 492 493 O
Known NCT03920540 495 500 O
hypersensitivity NCT03920540 501 517 B-Condition-Name
reactions NCT03920540 518 527 O
to NCT03920540 528 530 O
any NCT03920540 531 534 O
of NCT03920540 535 537 O
the NCT03920540 538 541 O
components NCT03920540 542 552 O
of NCT03920540 553 555 O
the NCT03920540 556 559 O
invetigational NCT03920540 560 574 O
product NCT03920540 575 582 O

- NCT03920540 585 586 O
Prior NCT03920540 588 593 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03920540 594 596 O
planned NCT03920540 597 604 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
administration NCT03920540 605 619 O
of NCT03920540 620 622 O
other NCT03920540 623 628 O
investigational NCT03920540 629 644 O
products NCT03920540 645 653 O
within NCT03920540 654 660 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03920540 662 664 B-Eq-Value
days NCT03920540 665 669 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
before NCT03920540 670 676 O
treatment NCT03920540 677 686 O
with NCT03920540 687 691 O
the NCT03920540 692 695 O
investigational NCT03920540 696 711 O
product NCT03920540 712 719 O
in NCT03920540 720 722 O
this NCT03920540 723 727 O
study NCT03920540 728 733 O
or NCT03920540 734 736 O
duirng NCT03920540 737 743 O
this NCT03920540 744 748 O
study NCT03920540 749 754 O
. NCT03920540 755 756 O

- NCT03920540 760 761 O
Unable NCT03920540 763 769 O
to NCT03920540 770 772 O
perform NCT03920540 773 780 O
6 NCT03920540 782 783 B-Observation-Name
- NCT03920540 784 785 I-Observation-Name
MWT NCT03920540 786 789 I-Observation-Name
. NCT03920540 790 791 O

- NCT03920540 795 796 O
Female NCT03920540 798 804 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

Inclusion NCT03921138 0 9 O
Criteria NCT03921138 10 18 O
: NCT03921138 19 20 O

- NCT03921138 24 25 O
patients NCT03921138 27 35 O
who NCT03921138 36 39 O
underwent NCT03921138 40 49 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
benign NCT03921138 50 56 O
laparoscopic NCT03921138 57 69 B-Procedure-Name
hysterectomy NCT03921138 70 82 I-Procedure-Name
with NCT03921138 83 87 O
systematic NCT03921138 88 98 B-Procedure-Name
salpingectomy NCT03921138 99 112 I-Procedure-Name

Exclusion NCT03921138 113 122 O
Criteria NCT03921138 123 131 O
: NCT03921138 132 133 O

- NCT03921138 137 138 O
Hysterectomy NCT03921138 140 152 B-Procedure-Name
in NCT03921138 153 155 O
a NCT03921138 156 157 O
context NCT03921138 158 165 O
of NCT03921138 166 168 O
gynecologic NCT03921138 169 180 B-Condition-Name
cancer NCT03921138 181 187 I-Condition-Name

- NCT03921138 190 191 O
Hysterectomy NCT03921138 193 205 B-Procedure-Name
not NCT03921138 206 209 O
carried NCT03921138 210 217 O
out NCT03921138 218 221 O
using NCT03921138 222 227 O
laparoscopy NCT03921138 228 239 B-Procedure-Name

- NCT03921138 242 243 O
Fimbriated NCT03921138 245 255 B-Condition-Name
end NCT03921138 256 259 I-Condition-Name
missing NCT03921138 260 267 O
or NCT03921138 268 270 O
damaged NCT03921138 271 278 O
or NCT03921138 279 281 O
impossible NCT03921138 282 292 O
for NCT03921138 293 296 O
pathologist NCT03921138 297 308 O
to NCT03921138 309 311 O
analyze NCT03921138 312 319 O

Inclusion NCT03928652 0 9 O
Criteria NCT03928652 10 18 O
: NCT03928652 19 20 O

1 NCT03928652 25 26 O
. NCT03928652 26 27 O
Colon NCT03928652 29 34 O
or NCT03928652 35 37 O
rectal NCT03928652 38 44 O
cancer NCT03928652 45 51 B-Condition-Name
diagnosed NCT03928652 52 61 O
by NCT03928652 62 64 O
endoscopic NCT03928652 65 75 B-Procedure-Name
biopsy NCT03928652 76 82 I-Procedure-Name
histopathology NCT03928652 83 97 I-Procedure-Name
; NCT03928652 97 98 O

2 NCT03928652 102 103 O
. NCT03928652 103 104 O
Complete NCT03928652 106 114 O
sample NCT03928652 115 121 B-Observation-Name___Observation-Type-Value:lab
information NCT03928652 122 133 O
, NCT03928652 134 135 O
including NCT03928652 136 145 O
sample NCT03928652 146 152 O
number NCT03928652 153 159 O
, NCT03928652 160 161 O
gender NCT03928652 162 168 O
, NCT03928652 169 170 O
age NCT03928652 171 174 O
and NCT03928652 175 178 O
clinical NCT03928652 179 187 O
molecular NCT03928652 188 197 O
diagnostic NCT03928652 198 208 O
information NCT03928652 209 220 O
, NCT03928652 221 222 O
etc NCT03928652 223 226 O
. NCT03928652 227 228 O
; NCT03928652 229 230 O

3 NCT03928652 234 235 O
. NCT03928652 235 236 O
Sufficient NCT03928652 238 248 O
surgical NCT03928652 249 257 B-Observation-Name___Observation-Type-Value:lab
tissue NCT03928652 258 264 I-Observation-Name___Observation-Type-Value:lab
samples NCT03928652 265 272 B-Observation-Specimen
are NCT03928652 273 276 O
available NCT03928652 277 286 O
for NCT03928652 287 290 O
testing NCT03928652 291 298 B-Observation-Name
; NCT03928652 298 299 O

4 NCT03928652 303 304 O
. NCT03928652 304 305 O
untreated NCT03928652 307 316 O
colon NCT03928652 317 322 O
or NCT03928652 323 325 O
rectal NCT03928652 326 332 O
cancer NCT03928652 333 339 B-Condition-Name
patients NCT03928652 340 348 O
; NCT03928652 348 349 O

5 NCT03928652 353 354 O
. NCT03928652 354 355 O
Patient NCT03928652 357 364 O
able NCT03928652 365 369 O
to NCT03928652 370 372 O
understand NCT03928652 373 383 O
and NCT03928652 384 387 O
sign NCT03928652 388 392 O
written NCT03928652 393 400 O
informed NCT03928652 401 409 O
consent NCT03928652 410 417 O

6 NCT03928652 421 422 O
. NCT03928652 422 423 O
No NCT03928652 425 427 O
evidence NCT03928652 428 436 O
of NCT03928652 437 439 O
distant NCT03928652 440 447 B-Condition-Name
metastasis NCT03928652 448 458 I-Condition-Name
( NCT03928652 459 460 O
M NCT03928652 461 462 B-Condition-Code
0 NCT03928652 463 464 I-Condition-Code
) NCT03928652 465 466 O

Exclusion NCT03928652 468 477 O
Criteria NCT03928652 478 486 O
: NCT03928652 487 488 O

1 NCT03928652 493 494 O
. NCT03928652 494 495 O
Previously NCT03928652 497 507 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treated NCT03928652 508 515 O
CRC NCT03928652 516 519 B-Condition-Name
, NCT03928652 520 521 O
including NCT03928652 522 531 O
cytotoxic NCT03928652 532 541 B-Drug-Name
drug NCT03928652 542 546 I-Drug-Name
therapy NCT03928652 547 554 I-Drug-Name
, NCT03928652 555 556 O
targeted NCT03928652 557 565 B-Procedure-Name
drug NCT03928652 566 570 I-Procedure-Name
therapy NCT03928652 571 578 I-Procedure-Name
, NCT03928652 579 580 O
etc NCT03928652 581 584 O
. NCT03928652 585 586 O
; NCT03928652 587 588 O

2 NCT03928652 592 593 O
. NCT03928652 593 594 O
Other NCT03928652 596 601 O
malignant NCT03928652 602 611 B-Condition-Name
tumors NCT03928652 612 618 I-Condition-Name
; NCT03928652 618 619 O

3 NCT03928652 623 624 O
. NCT03928652 624 625 O
Pregnant NCT03928652 627 635 B-Condition-Name
women NCT03928652 636 641 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
; NCT03928652 641 642 O

4 NCT03928652 646 647 O
. NCT03928652 647 648 O
Hereditary NCT03928652 650 660 O
colorectal NCT03928652 661 671 B-Condition-Name
cancer NCT03928652 672 678 I-Condition-Name
linked NCT03928652 679 685 O
to NCT03928652 686 688 O
familial NCT03928652 689 697 B-Condition-Name
colonic NCT03928652 698 705 I-Condition-Name
polyposis NCT03928652 706 715 I-Condition-Name
or NCT03928652 716 718 O
Lynch NCT03928652 719 724 B-Condition-Name
syndrome NCT03928652 725 733 I-Condition-Name

Inclusion NCT03925376 0 9 O
Criteria NCT03925376 10 18 O
: NCT03925376 19 20 O

- NCT03925376 24 25 O
Patients NCT03925376 27 35 O
undergoing NCT03925376 36 46 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
redo NCT03925376 47 51 O
cardiac NCT03925376 52 59 B-Procedure-Name
surgery NCT03925376 60 67 I-Procedure-Name

Exclusion NCT03925376 68 77 O
Criteria NCT03925376 78 86 O
: NCT03925376 87 88 O

- NCT03925376 92 93 O
Age NCT03925376 95 98 O
< NCT03925376 99 100 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03925376 102 104 B-Eq-Value
years NCT03925376 105 110 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03925376 110 111 O

- NCT03925376 114 115 O
Patients NCT03925376 117 125 O
with NCT03925376 126 130 O
a NCT03925376 131 132 O
DNR NCT03925376 133 136 B-Observation-Name
order NCT03925376 137 142 I-Observation-Name
or NCT03925376 143 145 O
" NCT03925376 146 147 B-Observation-Name
do NCT03925376 147 149 I-Observation-Name
not NCT03925376 150 153 I-Observation-Name
escalate NCT03925376 154 162 I-Observation-Name
care NCT03925376 163 167 I-Observation-Name
" NCT03925376 167 168 I-Observation-Name
order NCT03925376 169 174 I-Observation-Name
. NCT03925376 175 176 O

Inclusion NCT03923075 0 9 O
Criteria NCT03923075 10 18 O
: NCT03923075 19 20 O

- NCT03923075 24 25 O
children NCT03923075 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
underoing NCT03923075 36 45 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03923075 46 54 O
surgery NCT03923075 55 62 B-Procedure-Name
under NCT03923075 63 68 O
general NCT03923075 69 76 B-Procedure-Name
anaesthsia NCT03923075 77 87 I-Procedure-Name

- NCT03923075 90 91 O
age NCT03923075 93 96 O
4 NCT03923075 98 99 B-Eq-Value
- NCT03923075 100 101 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03923075 103 105 B-Eq-Value
years NCT03923075 106 111 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03923075 112 115 O

- NCT03923075 118 119 O
ASA NCT03923075 121 124 B-Condition-Name
I NCT03923075 125 126 B-Eq-Value
- NCT03923075 127 128 B-Eq-Operator___Eq-Operator-Value:BETWEEN
II NCT03923075 129 131 B-Eq-Value

Exclusion NCT03923075 132 141 O
Criteria NCT03923075 142 150 O
: NCT03923075 151 152 O

- NCT03923075 156 157 O
patient NCT03923075 159 166 O
or NCT03923075 167 169 O
parent NCT03923075 170 176 O
refusal NCT03923075 177 184 O

- NCT03923075 187 188 O
Mallampati NCT03923075 190 200 B-Observation-Name
score NCT03923075 201 206 I-Observation-Name
> NCT03923075 207 208 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03923075 210 211 B-Eq-Value

- NCT03923075 215 216 O
BMI NCT03923075 218 221 B-Observation-Name___Observation-Type-Value:vital
> NCT03923075 222 223 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03923075 225 227 B-Eq-Value

- NCT03923075 231 232 O
severe NCT03923075 234 240 B-Severity___Severity-Value:severe
systemic NCT03923075 241 249 O
cardiac NCT03923075 250 257 B-Condition-Name
disease NCT03923075 258 265 I-Condition-Name

- NCT03923075 268 269 O
neuromuscular NCT03923075 271 284 B-Condition-Name
disease NCT03923075 285 292 I-Condition-Name

- NCT03923075 295 296 O
recent NCT03923075 298 304 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
respiratory NCT03923075 305 316 B-Condition-Name
infection NCT03923075 317 326 I-Condition-Name

- NCT03923075 329 330 O
drug NCT03923075 332 336 O
allergy NCT03923075 337 344 O

Inclusion NCT03929809 0 9 O
Criteria NCT03929809 10 18 O
: NCT03929809 19 20 O

1 NCT03929809 25 26 O
. NCT03929809 26 27 O
Participants NCT03929809 29 41 O
will NCT03929809 42 46 O
be NCT03929809 47 49 O
adults NCT03929809 50 56 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
who NCT03929809 57 60 O
utilize NCT03929809 61 68 O
English NCT03929809 69 76 B-Language
as NCT03929809 77 79 O
their NCT03929809 80 85 O
primary NCT03929809 86 93 O
language NCT03929809 94 102 O
. NCT03929809 103 104 O

2 NCT03929809 109 110 O
. NCT03929809 110 111 O
Unilateral NCT03929809 113 123 O
severe NCT03929809 124 130 B-Severity___Severity-Value:severe
to NCT03929809 131 133 O
profound NCT03929809 134 142 B-Condition-Name
sensorineural NCT03929809 143 156 I-Condition-Name
hearing NCT03929809 157 164 I-Condition-Name
loss NCT03929809 165 169 I-Condition-Name
for NCT03929809 170 173 O
a NCT03929809 174 175 O
duration NCT03929809 176 184 O
of NCT03929809 185 187 O
at NCT03929809 188 190 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929809 191 196 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03929809 198 199 B-Eq-Value
months NCT03929809 200 206 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
( NCT03929809 207 208 O
to NCT03929809 209 211 O
ensure NCT03929809 212 218 O
stability NCT03929809 219 228 O
of NCT03929809 229 231 O
hearing NCT03929809 232 239 B-Condition-Name
loss NCT03929809 240 244 I-Condition-Name
) NCT03929809 245 246 O
, NCT03929809 248 249 O
but NCT03929809 250 253 O
no NCT03929809 254 256 O
greater NCT03929809 257 264 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929809 265 269 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03929809 271 273 B-Eq-Value
years NCT03929809 274 279 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03929809 280 281 O

3 NCT03929809 286 287 O
. NCT03929809 287 288 O
Contralateral NCT03929809 290 303 B-Condition-Name
ear NCT03929809 304 307 I-Condition-Name
with NCT03929809 308 312 O
normal NCT03929809 313 319 B-Polarity___Polarity-Value:normal
, NCT03929809 320 321 O
or NCT03929809 322 324 O
near NCT03929809 325 329 B-Polarity___Polarity-Value:normal
- NCT03929809 330 331 I-Polarity___Polarity-Value:normal
normal NCT03929809 332 338 I-Polarity___Polarity-Value:normal
, NCT03929809 339 340 O
hearing NCT03929809 341 348 B-Condition-Name
. NCT03929809 349 350 O

4 NCT03929809 355 356 O
. NCT03929809 356 357 O
Poorer NCT03929809 359 365 B-Condition-Name
ear NCT03929809 366 369 I-Condition-Name
( NCT03929809 370 371 O
ear NCT03929809 372 375 O
to NCT03929809 376 378 O
be NCT03929809 379 381 O
implanted NCT03929809 382 391 B-Procedure-Name
) NCT03929809 392 393 O
: NCT03929809 395 396 O
severe NCT03929809 397 403 B-Severity___Severity-Value:severe
to NCT03929809 404 406 O
profound NCT03929809 407 415 B-Condition-Name
sensorineural NCT03929809 416 429 I-Condition-Name
hearing NCT03929809 430 437 I-Condition-Name
loss NCT03929809 438 442 I-Condition-Name
, NCT03929809 443 444 O
defined NCT03929809 445 452 O
as NCT03929809 453 455 O
pure NCT03929809 456 460 B-Observation-Name
- NCT03929809 461 462 I-Observation-Name
tone NCT03929809 463 467 I-Observation-Name
thresholds NCT03929809 468 478 I-Observation-Name
70 NCT03929809 480 482 B-Eq-Value
dB NCT03929809 483 485 B-Eq-Unit
HL NCT03929809 486 488 I-Eq-Unit
or NCT03929809 489 491 B-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03929809 492 499 I-Eq-Operator___Eq-Operator-Value:GTEQ
for NCT03929809 500 503 O
the NCT03929809 504 507 O
frequencies NCT03929809 508 519 O
500 NCT03929809 521 524 O
, NCT03929809 525 526 O
1000 NCT03929809 528 532 O
, NCT03929809 533 534 O

2000 NCT03929809 543 547 O
, NCT03929809 548 549 O
3000 NCT03929809 551 555 O
, NCT03929809 556 557 O
and NCT03929809 558 561 O
4000 NCT03929809 563 567 O
Hz NCT03929809 568 570 O
with NCT03929809 571 575 O
monosyllabic NCT03929809 576 588 B-Condition-Name
word NCT03929809 589 593 I-Condition-Name
understanding NCT03929809 594 607 I-Condition-Name
, NCT03929809 608 609 O
as NCT03929809 610 612 O
measured NCT03929809 613 621 O
using NCT03929809 622 627 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
the NCT03929809 628 631 O
CNC NCT03929809 632 635 B-Observation-Name
Word NCT03929809 636 640 I-Observation-Name
Test NCT03929809 641 645 I-Observation-Name
at NCT03929809 646 648 O
60 NCT03929809 650 652 B-Eq-Value
dBA NCT03929809 653 656 B-Eq-Unit
under NCT03929809 657 662 O
earphones NCT03929809 663 672 O
, NCT03929809 673 674 O
less NCT03929809 675 679 B-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03929809 680 684 I-Eq-Operator___Eq-Operator-Value:LTEQ
or NCT03929809 685 687 I-Eq-Operator___Eq-Operator-Value:LTEQ
equal NCT03929809 688 693 I-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03929809 694 696 O
20 NCT03929809 698 700 B-Eq-Value
% NCT03929809 701 702 B-Eq-Unit

5 NCT03929809 707 708 O
. NCT03929809 708 709 O
Better NCT03929809 711 717 B-Condition-Name
ear NCT03929809 718 721 I-Condition-Name
( NCT03929809 722 723 O
contralateral NCT03929809 724 737 B-Condition-Name
ear NCT03929809 738 741 I-Condition-Name
) NCT03929809 742 743 O
: NCT03929809 745 746 O
normal NCT03929809 747 753 B-Polarity___Polarity-Value:normal
or NCT03929809 754 756 O
near NCT03929809 757 761 B-Polarity___Polarity-Value:normal
- NCT03929809 762 763 I-Polarity___Polarity-Value:normal
normal NCT03929809 764 770 I-Polarity___Polarity-Value:normal
hearing NCT03929809 771 778 B-Condition-Name
defined NCT03929809 779 786 O
as NCT03929809 787 789 O
pure NCT03929809 790 794 B-Observation-Name
- NCT03929809 795 796 I-Observation-Name
tone NCT03929809 797 801 I-Observation-Name
thresholds NCT03929809 802 812 I-Observation-Name
no NCT03929809 813 815 O
poorer NCT03929809 816 822 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03929809 823 827 I-Eq-Operator___Eq-Operator-Value:LT
30 NCT03929809 829 831 B-Eq-Value
dB NCT03929809 832 834 B-Eq-Unit
HL NCT03929809 835 837 I-Eq-Unit
at NCT03929809 838 840 O
250 NCT03929809 842 845 O
, NCT03929809 846 847 O
500 NCT03929809 849 852 O
, NCT03929809 853 854 O
1000 NCT03929809 856 860 O
, NCT03929809 861 862 O
2000 NCT03929809 864 868 O
, NCT03929809 869 870 O
and NCT03929809 871 874 O
3000 NCT03929809 876 880 O
Hz NCT03929809 881 883 O
and NCT03929809 884 887 O
no NCT03929809 888 890 O
poorer NCT03929809 891 897 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03929809 898 902 I-Eq-Operator___Eq-Operator-Value:LT
40 NCT03929809 904 906 B-Eq-Value
dB NCT03929809 907 909 B-Eq-Unit
HL NCT03929809 910 912 I-Eq-Unit
at NCT03929809 913 915 O
4000 NCT03929809 917 921 O
Hz NCT03929809 922 924 O
with NCT03929809 925 929 O
monosyllabic NCT03929809 930 942 B-Condition-Name
word NCT03929809 943 947 I-Condition-Name
understanding NCT03929809 948 961 I-Condition-Name
, NCT03929809 962 963 O
as NCT03929809 964 966 O
measured NCT03929809 967 975 O
using NCT03929809 976 981 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
the NCT03929809 982 985 O
CNC NCT03929809 986 989 B-Observation-Name
Word NCT03929809 990 994 I-Observation-Name
Test NCT03929809 995 999 I-Observation-Name
at NCT03929809 1000 1002 O
60 NCT03929809 1004 1006 B-Eq-Value
dBA NCT03929809 1007 1010 B-Eq-Unit
under NCT03929809 1011 1016 O
earphones NCT03929809 1017 1026 O
, NCT03929809 1027 1028 O
of NCT03929809 1029 1031 O
greater NCT03929809 1032 1039 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03929809 1040 1044 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03929809 1045 1047 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03929809 1048 1053 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03929809 1054 1056 O
85 NCT03929809 1058 1060 B-Eq-Value
% NCT03929809 1061 1062 B-Eq-Unit
. NCT03929809 1064 1065 O

6 NCT03929809 1070 1071 O
. NCT03929809 1071 1072 O
Willingness NCT03929809 1074 1085 O
to NCT03929809 1086 1088 O
comply NCT03929809 1089 1095 O
with NCT03929809 1096 1100 O
all NCT03929809 1101 1104 O
study NCT03929809 1105 1110 O
requirements NCT03929809 1111 1123 O
. NCT03929809 1124 1125 O

7 NCT03929809 1130 1131 O
. NCT03929809 1131 1132 O
Patent NCT03929809 1134 1140 B-Condition-Name
cochlea NCT03929809 1141 1148 I-Condition-Name
and NCT03929809 1149 1152 O
normal NCT03929809 1153 1159 B-Polarity___Polarity-Value:normal
cochlear NCT03929809 1160 1168 B-Condition-Name
anatomy NCT03929809 1169 1176 I-Condition-Name
. NCT03929809 1177 1178 O

Exclusion NCT03929809 1180 1189 O
Criteria NCT03929809 1190 1198 O
: NCT03929809 1199 1200 O

1 NCT03929809 1205 1206 O
. NCT03929809 1206 1207 O
Medical NCT03929809 1209 1216 O
or NCT03929809 1217 1219 O
psychological NCT03929809 1220 1233 O
conditions NCT03929809 1234 1244 B-Condition-Name
that NCT03929809 1245 1249 O
contraindicate NCT03929809 1250 1264 O
undergoing NCT03929809 1265 1275 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surgery NCT03929809 1276 1283 B-Procedure-Name
. NCT03929809 1284 1285 O

2 NCT03929809 1290 1291 O
. NCT03929809 1291 1292 O
Ossification NCT03929809 1294 1306 B-Condition-Name
or NCT03929809 1307 1309 O
any NCT03929809 1310 1313 O
other NCT03929809 1314 1319 O
cochlear NCT03929809 1320 1328 B-Condition-Name
anomaly NCT03929809 1329 1336 I-Condition-Name
that NCT03929809 1337 1341 O
might NCT03929809 1342 1347 O
prevent NCT03929809 1348 1355 O
complete NCT03929809 1356 1364 O
insertion NCT03929809 1365 1374 B-Procedure-Name
of NCT03929809 1375 1377 I-Procedure-Name
the NCT03929809 1378 1381 I-Procedure-Name
electrode NCT03929809 1382 1391 I-Procedure-Name
array NCT03929809 1392 1397 I-Procedure-Name
. NCT03929809 1398 1399 O

3 NCT03929809 1404 1405 O
. NCT03929809 1405 1406 O
Unrealistic NCT03929809 1408 1419 O
expectations NCT03929809 1420 1432 O
on NCT03929809 1433 1435 O
the NCT03929809 1436 1439 O
part NCT03929809 1440 1444 O
of NCT03929809 1445 1447 O
the NCT03929809 1448 1451 O
candidate NCT03929809 1452 1461 O
and NCT03929809 1462 1465 O
/ NCT03929809 1466 1467 O
or NCT03929809 1468 1470 O
candidate NCT03929809 1471 1480 O
's NCT03929809 1480 1482 O
family NCT03929809 1483 1489 O
, NCT03929809 1490 1491 O
regarding NCT03929809 1492 1501 O
the NCT03929809 1502 1505 O
possible NCT03929809 1506 1514 O
benefits NCT03929809 1515 1523 O
, NCT03929809 1524 1525 O
risks NCT03929809 1526 1531 O
, NCT03929809 1532 1533 O
and NCT03929809 1534 1537 O
limitations NCT03929809 1538 1549 O
that NCT03929809 1550 1554 O
are NCT03929809 1555 1558 O
inherent NCT03929809 1559 1567 O
to NCT03929809 1568 1570 O
the NCT03929809 1571 1574 O
surgical NCT03929809 1575 1583 B-Procedure-Name
procedure NCT03929809 1584 1593 I-Procedure-Name
( NCT03929809 1594 1595 O
s NCT03929809 1596 1597 O
) NCT03929809 1598 1599 O
and NCT03929809 1600 1603 O
prosthetic NCT03929809 1604 1614 B-Condition-Name
devices NCT03929809 1615 1622 I-Condition-Name
. NCT03929809 1623 1624 O

4 NCT03929809 1629 1630 O
. NCT03929809 1630 1631 O
Unwillingness NCT03929809 1633 1646 O
or NCT03929809 1647 1649 O
inability NCT03929809 1650 1659 O
of NCT03929809 1660 1662 O
the NCT03929809 1663 1666 O
candidate NCT03929809 1667 1676 O
to NCT03929809 1677 1679 O
comply NCT03929809 1680 1686 O
with NCT03929809 1687 1691 O
all NCT03929809 1692 1695 O
investigational NCT03929809 1696 1711 O
requirements NCT03929809 1712 1724 O
. NCT03929809 1725 1726 O

5 NCT03929809 1731 1732 O
. NCT03929809 1732 1733 O
Active NCT03929809 1735 1741 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
middle NCT03929809 1742 1748 O
ear NCT03929809 1749 1752 O
infection NCT03929809 1753 1762 B-Condition-Name
. NCT03929809 1763 1764 O

6 NCT03929809 1769 1770 O
. NCT03929809 1770 1771 O
Tinnitus NCT03929809 1773 1781 B-Condition-Name
primary NCT03929809 1782 1789 O
motivation NCT03929809 1790 1800 O
for NCT03929809 1801 1804 O
implantation NCT03929809 1805 1817 B-Procedure-Name
. NCT03929809 1818 1819 O

Inclusion NCT03924336 0 9 O
Criteria NCT03924336 10 18 O
: NCT03924336 19 20 O

- NCT03924336 24 25 O
Stage NCT03924336 27 32 B-Eq-Unit
III NCT03924336 33 36 B-Eq-Value
periodontitis NCT03924336 37 50 B-Condition-Name
patient NCT03924336 51 58 O
having NCT03924336 59 65 O
at NCT03924336 66 68 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03924336 69 74 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03924336 75 78 B-Eq-Value
tooth NCT03924336 79 84 B-Eq-Unit
with NCT03924336 85 89 O
2 NCT03924336 91 92 O
- NCT03924336 93 94 O
wall NCT03924336 95 99 O
, NCT03924336 100 101 O
3 NCT03924336 103 104 O
- NCT03924336 105 106 O
wall NCT03924336 107 111 O
, NCT03924336 112 113 O
or NCT03924336 114 116 O
combined NCT03924336 117 125 O
2 NCT03924336 127 128 O
- NCT03924336 129 130 O
to NCT03924336 131 133 O
3 NCT03924336 135 136 O
- NCT03924336 137 138 O
wall NCT03924336 139 143 O
intraosseous NCT03924336 144 156 B-Observation-Name
defect NCT03924336 157 163 I-Observation-Name
≥ NCT03924336 164 165 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03924336 167 168 B-Eq-Value
mm NCT03924336 169 171 B-Eq-Unit
in NCT03924336 172 174 O
depth NCT03924336 175 180 O
( NCT03924336 181 182 O
assessed NCT03924336 183 191 O
by NCT03924336 192 194 O
bone NCT03924336 195 199 B-Procedure-Name
sounding NCT03924336 200 208 I-Procedure-Name
, NCT03924336 209 210 O
radiographic NCT03924336 211 223 B-Procedure-Name
examination NCT03924336 224 235 I-Procedure-Name
) NCT03924336 236 237 O
with NCT03924336 238 242 O
clinical NCT03924336 243 251 B-Observation-Name
attachment NCT03924336 252 262 I-Observation-Name
level NCT03924336 263 268 I-Observation-Name
( NCT03924336 269 270 O
CAL NCT03924336 271 274 B-Observation-Name
) NCT03924336 275 276 O
≥ NCT03924336 277 278 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03924336 280 281 B-Eq-Value
mm NCT03924336 282 284 B-Eq-Unit
and NCT03924336 285 288 O
pocket NCT03924336 289 295 B-Observation-Name
depth NCT03924336 296 301 I-Observation-Name
( NCT03924336 302 303 O
PD NCT03924336 304 306 B-Observation-Name
) NCT03924336 307 308 O
≥ NCT03924336 309 310 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03924336 312 313 B-Eq-Value
mm NCT03924336 314 316 B-Eq-Unit
. NCT03924336 317 318 O

- NCT03924336 322 323 O
Defect NCT03924336 325 331 B-Condition-Name
not NCT03924336 332 335 O
extending NCT03924336 336 345 O
to NCT03924336 346 348 O
a NCT03924336 349 350 O
root NCT03924336 351 355 O
furcation NCT03924336 356 365 O
area NCT03924336 366 370 O

- NCT03924336 373 374 O
Vital NCT03924336 376 381 O
teeth NCT03924336 382 387 O

- NCT03924336 390 391 O
Non NCT03924336 393 396 O
- NCT03924336 397 398 O
smokers NCT03924336 399 406 B-Condition-Name
. NCT03924336 407 408 O

- NCT03924336 412 413 O
No NCT03924336 415 417 O
history NCT03924336 418 425 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924336 426 428 O
intake NCT03924336 429 435 O
of NCT03924336 436 438 O
antibiotics NCT03924336 439 450 B-Drug-Name
or NCT03924336 451 453 O
other NCT03924336 454 459 O
medications NCT03924336 460 471 O
affecting NCT03924336 472 481 B-Stability___Stability-Value:change
the NCT03924336 482 485 O
periodontium NCT03924336 486 498 B-Condition-Name
in NCT03924336 499 501 O
the NCT03924336 502 505 O
previous NCT03924336 506 514 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03924336 516 517 B-Eq-Value
months NCT03924336 518 524 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03924336 525 526 O

- NCT03924336 530 531 O
No NCT03924336 533 535 O
periodontal NCT03924336 536 547 B-Procedure-Name
therapy NCT03924336 548 555 I-Procedure-Name
carried NCT03924336 556 563 O
out NCT03924336 564 567 O
in NCT03924336 568 570 O
the NCT03924336 571 574 O
past NCT03924336 575 579 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03924336 581 582 B-Eq-Value
months NCT03924336 583 589 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03924336 590 591 O

- NCT03924336 595 596 O
Able NCT03924336 598 602 O
to NCT03924336 603 605 O
sign NCT03924336 606 610 O
an NCT03924336 611 613 O
informed NCT03924336 614 622 O
consent NCT03924336 623 630 O
form NCT03924336 631 635 O
. NCT03924336 636 637 O

- NCT03924336 641 642 O
Patients NCT03924336 644 652 O
age NCT03924336 653 656 O
between NCT03924336 657 664 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03924336 666 668 B-Eq-Value
and NCT03924336 669 672 O
50 NCT03924336 674 676 B-Eq-Value
years NCT03924336 677 682 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03924336 683 686 O
. NCT03924336 687 688 O

- NCT03924336 692 693 O
Patients NCT03924336 695 703 O
who NCT03924336 704 707 O
are NCT03924336 708 711 O
cooperative NCT03924336 712 723 O
, NCT03924336 724 725 O
motivated NCT03924336 726 735 O
, NCT03924336 736 737 O
and NCT03924336 738 741 O
hygiene NCT03924336 742 749 O
conscious NCT03924336 750 759 O
. NCT03924336 760 761 O

- NCT03924336 765 766 O
Systemically NCT03924336 768 780 O
free NCT03924336 781 785 O
according NCT03924336 786 795 O
to NCT03924336 796 798 O
Cornell NCT03924336 799 806 O
Medical NCT03924336 807 814 O
Index NCT03924336 815 820 O
( NCT03924336 821 822 O
Broadbent NCT03924336 823 832 O
, NCT03924336 833 834 O
1951 NCT03924336 836 840 O
) NCT03924336 841 842 O
. NCT03924336 844 845 O

Exclusion NCT03924336 847 856 O
Criteria NCT03924336 857 865 O
: NCT03924336 866 867 O

- NCT03924336 871 872 O
Pregnancy NCT03924336 874 883 B-Condition-Name
or NCT03924336 884 886 O
breast NCT03924336 887 893 B-Condition-Name
feeding NCT03924336 894 901 I-Condition-Name

- NCT03924336 904 905 O
The NCT03924336 907 910 O
presence NCT03924336 911 919 O
of NCT03924336 920 922 O
an NCT03924336 923 925 O
orthodontic NCT03924336 926 937 B-Condition-Name
appliance NCT03924336 938 947 I-Condition-Name

- NCT03924336 950 951 O
Teeth NCT03924336 953 958 B-Condition-Name
mobility NCT03924336 959 967 I-Condition-Name
greater NCT03924336 968 975 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03924336 976 980 I-Eq-Operator___Eq-Operator-Value:GT
grade NCT03924336 981 986 B-Eq-Unit
I NCT03924336 987 988 B-Eq-Value

Inclusion NCT03920150 0 9 O
Criteria NCT03920150 10 18 O
: NCT03920150 19 20 O

- NCT03920150 24 25 O
vitamin NCT03920150 27 34 B-Condition-Name
D NCT03920150 35 36 I-Condition-Name
deficiency NCT03920150 37 47 I-Condition-Name
by NCT03920150 48 50 O
serum NCT03920150 51 56 B-Observation-Name___Observation-Type-Value:lab
level NCT03920150 57 62 I-Observation-Name___Observation-Type-Value:lab
< NCT03920150 63 64 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03920150 66 68 B-Eq-Value
nmol NCT03920150 69 73 B-Eq-Unit
/ NCT03920150 74 75 O
l NCT03920150 76 77 B-Eq-Unit

Exclusion NCT03920150 78 87 O
Criteria NCT03920150 88 96 O
: NCT03920150 97 98 O

- NCT03920150 102 103 O
hypercalcaemia NCT03920150 105 119 B-Condition-Name

Inclusion NCT03922009 0 9 O
Criteria NCT03922009 10 18 O
: NCT03922009 19 20 O

1 NCT03922009 25 26 O
. NCT03922009 26 27 O
population NCT03922009 29 39 O
: NCT03922009 40 41 O
acceptance NCT03922009 42 52 O
of NCT03922009 53 55 O
lower NCT03922009 56 61 B-Condition-Name
extremity NCT03922009 62 71 I-Condition-Name
fractures NCT03922009 72 81 I-Condition-Name
in NCT03922009 82 84 O
patients NCT03922009 85 93 O
with NCT03922009 94 98 O
spinal NCT03922009 99 105 B-Procedure-Name
anesthesia NCT03922009 106 116 I-Procedure-Name
. NCT03922009 117 118 O

2 NCT03922009 123 124 O
. NCT03922009 124 125 O
Anesthesia NCT03922009 127 137 B-Condition-Name
classification NCT03922009 138 152 I-Condition-Name
( NCT03922009 153 154 O
ASA NCT03922009 155 158 B-Condition-Name
) NCT03922009 159 160 O
: NCT03922009 162 163 O
I NCT03922009 164 165 B-Eq-Value
- NCT03922009 166 167 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03922009 168 171 B-Eq-Value
. NCT03922009 172 173 O

3 NCT03922009 178 179 O
. NCT03922009 179 180 O
Age NCT03922009 182 185 O
: NCT03922009 186 187 O
20 NCT03922009 189 191 B-Eq-Value
years NCT03922009 192 197 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03922009 198 201 O
to NCT03922009 202 204 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03922009 206 208 B-Eq-Value
years NCT03922009 209 214 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03922009 215 217 O
age NCT03922009 218 221 O
. NCT03922009 222 223 O

Exclusion NCT03922009 225 234 O
Criteria NCT03922009 235 243 O
: NCT03922009 244 245 O

1 NCT03922009 250 251 O
. NCT03922009 251 252 O
Mental NCT03922009 254 260 B-Condition-Name
illness NCT03922009 261 268 I-Condition-Name
and NCT03922009 269 272 O
taking NCT03922009 273 279 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
related NCT03922009 280 287 O
drugs NCT03922009 288 293 O
. NCT03922009 294 295 O

2 NCT03922009 300 301 O
. NCT03922009 301 302 O
Visually NCT03922009 304 312 B-Condition-Name
impaired NCT03922009 313 321 I-Condition-Name
and NCT03922009 322 325 O
hearing NCT03922009 326 333 B-Condition-Name
impaired NCT03922009 334 342 I-Condition-Name
. NCT03922009 343 344 O

3 NCT03922009 349 350 O
. NCT03922009 350 351 O
Being NCT03922009 353 358 O
unable NCT03922009 359 365 B-Condition-Name
to NCT03922009 366 368 I-Condition-Name
communicate NCT03922009 369 380 I-Condition-Name
or NCT03922009 381 383 O
illiterate NCT03922009 384 394 B-Condition-Name
. NCT03922009 395 396 O

4 NCT03922009 401 402 O
. NCT03922009 402 403 O
The NCT03922009 405 408 O
condition NCT03922009 409 418 O
changes NCT03922009 419 426 B-Stability___Stability-Value:change
or NCT03922009 427 429 O
is NCT03922009 430 432 O
critical NCT03922009 433 441 B-Severity___Severity-Value:severe
, NCT03922009 442 443 O
and NCT03922009 444 447 O
the NCT03922009 448 451 O
intensive NCT03922009 452 461 B-Encounter-Type___Encounter-Type-Value:icu
care NCT03922009 462 466 I-Encounter-Type___Encounter-Type-Value:icu
unit NCT03922009 467 471 I-Encounter-Type___Encounter-Type-Value:icu
is NCT03922009 472 474 O
admitted NCT03922009 475 483 O
after NCT03922009 484 489 O
the NCT03922009 490 493 O
operation NCT03922009 494 503 B-Procedure-Name
. NCT03922009 504 505 O

5 NCT03922009 510 511 O
. NCT03922009 511 512 O
Contact NCT03922009 514 521 O
isolation NCT03922009 522 531 O
. NCT03922009 532 533 O

6 NCT03922009 538 539 O
. NCT03922009 539 540 O
Trauma NCT03922009 542 548 B-Condition-Name
of NCT03922009 549 551 O
the NCT03922009 552 555 O
head NCT03922009 556 560 O
and NCT03922009 561 564 O
wounds NCT03922009 565 571 B-Condition-Name
on NCT03922009 572 574 O
the NCT03922009 575 578 O
head NCT03922009 579 583 O
. NCT03922009 584 585 O

7 NCT03922009 590 591 O
. NCT03922009 591 592 O
History NCT03922009 594 601 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03922009 602 604 O
motion NCT03922009 605 611 B-Condition-Name
sickness NCT03922009 612 620 I-Condition-Name
and NCT03922009 621 624 O
vertigo NCT03922009 625 632 B-Condition-Name
. NCT03922009 633 634 O

Inclusion NCT03925766 0 9 O
Criteria NCT03925766 10 18 O
: NCT03925766 19 20 O

- NCT03925766 24 25 O
Patient NCT03925766 27 34 O
with NCT03925766 35 39 O
altered NCT03925766 40 47 O
Roux NCT03925766 48 52 B-Procedure-Name
en NCT03925766 53 55 I-Procedure-Name
Y NCT03925766 56 57 I-Procedure-Name
Gastric NCT03925766 58 65 I-Procedure-Name
Bypass NCT03925766 66 72 I-Procedure-Name
anatomy NCT03925766 73 80 O

Exclusion NCT03925766 81 90 O
Criteria NCT03925766 91 99 O
: NCT03925766 100 101 O

- NCT03925766 105 106 O
Patients NCT03925766 108 116 O
without NCT03925766 117 124 O
Roux NCT03925766 125 129 B-Procedure-Name
en NCT03925766 130 132 I-Procedure-Name
Y NCT03925766 133 134 I-Procedure-Name
Gastric NCT03925766 135 142 I-Procedure-Name
Bypass NCT03925766 143 149 I-Procedure-Name
anatomy NCT03925766 150 157 O

Inclusion NCT03923465 0 9 O
Criteria NCT03923465 10 18 O
: NCT03923465 19 20 O

- NCT03923465 24 25 O
Systemically NCT03923465 27 39 O
healthy NCT03923465 40 47 B-Condition-Name

- NCT03923465 50 51 O
Clinical NCT03923465 53 61 O
diagnosis NCT03923465 62 71 O
of NCT03923465 72 74 O
advanced NCT03923465 75 83 B-Severity___Severity-Value:severe
periodontitis NCT03923465 84 97 B-Condition-Name

- NCT03923465 100 101 O
Having NCT03923465 103 109 O
one NCT03923465 110 113 B-Eq-Value
isolated NCT03923465 114 122 B-Condition-Name
intrabony NCT03923465 123 132 I-Condition-Name
defect NCT03923465 133 139 I-Condition-Name
with NCT03923465 140 144 O
probing NCT03923465 145 152 B-Observation-Name___Observation-Type-Value:measurement
depth NCT03923465 153 158 I-Observation-Name___Observation-Type-Value:measurement
( NCT03923465 159 160 O
PD NCT03923465 161 163 B-Observation-Name
) NCT03923465 164 165 O
≥ NCT03923465 166 167 B-Eq-Operator___Eq-Operator-Value:GTEQ
7 NCT03923465 169 170 B-Eq-Value
mm NCT03923465 171 173 B-Eq-Unit
, NCT03923465 174 175 O
clinical NCT03923465 176 184 B-Observation-Name
attachment NCT03923465 185 195 I-Observation-Name
level NCT03923465 196 201 I-Observation-Name
( NCT03923465 202 203 O
CAL NCT03923465 204 207 B-Observation-Name
) NCT03923465 208 209 O
≥ NCT03923465 210 211 B-Eq-Operator___Eq-Operator-Value:GTEQ
8 NCT03923465 213 214 B-Eq-Value
mm NCT03923465 215 217 B-Eq-Unit
and NCT03923465 218 221 O
at NCT03923465 222 224 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03923465 225 230 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03923465 232 233 B-Eq-Value
mm NCT03923465 234 236 B-Eq-Unit
intrabony NCT03923465 237 246 B-Observation-Name
component NCT03923465 247 256 I-Observation-Name
involving NCT03923465 257 266 O
predominantly NCT03923465 267 280 O
the NCT03923465 281 284 O
interproximal NCT03923465 285 298 O
area NCT03923465 299 303 O
of NCT03923465 304 306 O
the NCT03923465 307 310 O
affected NCT03923465 311 319 O
tooth NCT03923465 320 325 O
. NCT03923465 326 327 O

- NCT03923465 331 332 O
Full NCT03923465 334 338 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03923465 339 340 I-Observation-Name___Observation-Type-Value:clinical-score
mouth NCT03923465 341 346 I-Observation-Name___Observation-Type-Value:clinical-score
plaque NCT03923465 347 353 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03923465 354 359 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03923465 360 361 O
FMPS NCT03923465 362 366 B-Observation-Name
) NCT03923465 367 368 O
≤ NCT03923465 369 370 B-Eq-Operator___Eq-Operator-Value:LTEQ
20 NCT03923465 372 374 B-Eq-Value
% NCT03923465 375 376 B-Eq-Unit
. NCT03923465 378 379 O

- NCT03923465 383 384 O
Full NCT03923465 386 390 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03923465 391 392 I-Observation-Name___Observation-Type-Value:clinical-score
mouth NCT03923465 393 398 I-Observation-Name___Observation-Type-Value:clinical-score
bleeding NCT03923465 399 407 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03923465 408 413 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03923465 414 415 O
FMBS NCT03923465 416 420 B-Observation-Name
) NCT03923465 421 422 O
≤ NCT03923465 423 424 B-Eq-Operator___Eq-Operator-Value:LTEQ
20 NCT03923465 426 428 B-Eq-Value
% NCT03923465 429 430 B-Eq-Unit
. NCT03923465 432 433 O

Exclusion NCT03923465 435 444 O
Criteria NCT03923465 445 453 O
: NCT03923465 454 455 O

- NCT03923465 459 460 O
Smokers NCT03923465 462 469 O

- NCT03923465 472 473 O
Patients NCT03923465 475 483 O
with NCT03923465 484 488 O
known NCT03923465 489 494 O
systemic NCT03923465 495 503 O
diseases NCT03923465 504 512 B-Condition-Name
such NCT03923465 513 517 O
as NCT03923465 518 520 O
diabetes NCT03923465 521 529 B-Condition-Name
and NCT03923465 530 533 O
cardiovascular NCT03923465 534 548 B-Condition-Name
diseases NCT03923465 549 557 I-Condition-Name
or NCT03923465 558 560 O
using NCT03923465 561 566 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medications NCT03923465 567 578 O
that NCT03923465 579 583 O
affect NCT03923465 584 590 O
periodontal NCT03923465 591 602 B-Condition-Name
tissues NCT03923465 603 610 I-Condition-Name
, NCT03923465 611 612 O
pregnant NCT03923465 613 621 B-Condition-Name
or NCT03923465 622 624 O
lactating NCT03923465 625 634 B-Condition-Name
women NCT03923465 635 640 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03923465 643 644 O
One NCT03923465 646 649 B-Condition-Name
- NCT03923465 650 651 I-Condition-Name
wall NCT03923465 652 656 I-Condition-Name
intrabony NCT03923465 657 666 I-Condition-Name
defects NCT03923465 667 674 I-Condition-Name

- NCT03923465 677 678 O
Defects NCT03923465 680 687 B-Condition-Name
that NCT03923465 688 692 O
involve NCT03923465 693 700 O
buccal NCT03923465 701 707 O
and NCT03923465 708 711 O
lingual NCT03923465 712 719 O
sites NCT03923465 720 725 O

- NCT03923465 728 729 O
Presence NCT03923465 731 739 O
of NCT03923465 740 742 O
inadequate NCT03923465 743 753 O
endodontic NCT03923465 754 764 B-Procedure-Name
treatment NCT03923465 765 774 I-Procedure-Name
and NCT03923465 775 778 O
/ NCT03923465 779 780 O
or NCT03923465 781 783 O
restoration NCT03923465 784 795 B-Procedure-Name
in NCT03923465 796 798 I-Procedure-Name
the NCT03923465 799 802 I-Procedure-Name
relevant NCT03923465 803 811 I-Procedure-Name
teeth NCT03923465 812 817 I-Procedure-Name
. NCT03923465 818 819 O

Inclusion NCT03862352 0 9 O
Criteria NCT03862352 10 18 O
: NCT03862352 19 20 O

- NCT03862352 24 25 O
Any NCT03862352 27 30 O
coronary NCT03862352 31 39 B-Procedure-Name
artery NCT03862352 40 46 I-Procedure-Name
perforation NCT03862352 47 58 I-Procedure-Name
during NCT03862352 59 65 O
percutaneous NCT03862352 66 78 B-Procedure-Name
coronary NCT03862352 79 87 I-Procedure-Name
intervention NCT03862352 88 100 I-Procedure-Name

Exclusion NCT03862352 101 110 O
Criteria NCT03862352 111 119 O
: NCT03862352 120 121 O

- NCT03862352 125 126 O
Nil NCT03862352 128 131 O

Inclusion NCT03860545 0 9 O
Criteria NCT03860545 10 18 O
: NCT03860545 19 20 O

- NCT03860545 24 25 O
a NCT03860545 27 28 O
planned NCT03860545 29 36 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
operation NCT03860545 37 46 O
of NCT03860545 47 49 O
coronary NCT03860545 50 58 B-Procedure-Name
artery NCT03860545 59 65 I-Procedure-Name
bypass NCT03860545 66 72 I-Procedure-Name
grafting NCT03860545 73 81 I-Procedure-Name
with NCT03860545 82 86 O
the NCT03860545 87 90 O
use NCT03860545 91 94 O
of NCT03860545 95 97 O
cardiopulmonary NCT03860545 98 113 B-Procedure-Name
bypass NCT03860545 114 120 I-Procedure-Name

Exclusion NCT03860545 121 130 O
Criteria NCT03860545 131 139 O
: NCT03860545 140 141 O

- NCT03860545 145 146 O
emergency NCT03860545 148 157 B-Encounter-Type___Encounter-Type-Value:emergency
operations NCT03860545 158 168 B-Procedure-Name
or NCT03860545 169 171 O
re NCT03860545 172 174 B-Procedure-Name
- NCT03860545 175 176 I-Procedure-Name
operations NCT03860545 177 187 I-Procedure-Name
; NCT03860545 187 188 O

- NCT03860545 191 192 O
a NCT03860545 194 195 O
known NCT03860545 196 201 O
pathology NCT03860545 202 211 B-Condition-Name
of NCT03860545 212 214 I-Condition-Name
the NCT03860545 215 218 I-Condition-Name
urinary NCT03860545 219 226 I-Condition-Name
tract NCT03860545 227 232 I-Condition-Name
or NCT03860545 233 235 O
renal NCT03860545 236 241 B-Condition-Name
failure NCT03860545 242 249 I-Condition-Name
; NCT03860545 249 250 O

- NCT03860545 253 254 O
chronic NCT03860545 256 263 O
use NCT03860545 264 267 O
of NCT03860545 268 270 O
the NCT03860545 271 274 O
following NCT03860545 275 284 O
medications NCT03860545 285 296 O
: NCT03860545 297 298 O
iron NCT03860545 299 303 B-Drug-Name
, NCT03860545 304 305 O
non NCT03860545 306 309 B-Drug-Name
- NCT03860545 310 311 I-Drug-Name
steroidal NCT03860545 312 321 I-Drug-Name
anti NCT03860545 322 326 I-Drug-Name
- NCT03860545 327 328 I-Drug-Name
inflammatory NCT03860545 329 341 I-Drug-Name
drugs NCT03860545 342 347 I-Drug-Name
( NCT03860545 348 349 O
NSAIDs NCT03860545 350 356 B-Drug-Name
) NCT03860545 357 358 O
, NCT03860545 360 361 O
immunosuppression NCT03860545 362 379 B-Drug-Name
, NCT03860545 380 381 O
or NCT03860545 382 384 O
steroids NCT03860545 385 393 B-Drug-Name
in NCT03860545 394 396 O
the NCT03860545 397 400 O
pre NCT03860545 401 404 O
operative NCT03860545 405 414 O
period NCT03860545 415 421 O
; NCT03860545 421 422 O

- NCT03860545 425 426 O
polycythemia NCT03860545 428 440 B-Condition-Name
, NCT03860545 441 442 O
porphyria NCT03860545 443 452 B-Condition-Name
or NCT03860545 453 455 O
pathological NCT03860545 456 468 B-Condition-Name
hemoglobin NCT03860545 469 479 I-Condition-Name
species NCT03860545 480 487 I-Condition-Name
in NCT03860545 488 490 I-Condition-Name
anamnesis NCT03860545 491 500 I-Condition-Name
; NCT03860545 500 501 O

- NCT03860545 504 505 O
pre NCT03860545 507 510 O
operative NCT03860545 511 520 O
signs NCT03860545 521 526 O
of NCT03860545 527 529 O
hepatic NCT03860545 530 537 B-Condition-Name
failure NCT03860545 538 545 I-Condition-Name
; NCT03860545 545 546 O

- NCT03860545 549 550 O
active NCT03860545 552 558 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
autoimmune NCT03860545 559 569 O
or NCT03860545 570 572 O
neoplastic NCT03860545 573 583 O
diseases NCT03860545 584 592 B-Condition-Name
, NCT03860545 593 594 O
active NCT03860545 595 601 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03860545 602 611 B-Condition-Name
; NCT03860545 611 612 O

- NCT03860545 615 616 O
anticipated NCT03860545 618 629 O
significant NCT03860545 630 641 B-Severity___Severity-Value:severe
bleeding NCT03860545 642 650 B-Condition-Name
( NCT03860545 651 652 O
anti NCT03860545 653 657 B-Drug-Name
- NCT03860545 658 659 I-Drug-Name
platelet NCT03860545 660 668 I-Drug-Name
agents NCT03860545 669 675 I-Drug-Name
) NCT03860545 676 677 O
, NCT03860545 679 680 O
suggesting NCT03860545 681 691 O
the NCT03860545 692 695 O
use NCT03860545 696 699 O
of NCT03860545 700 702 O
blood NCT03860545 703 708 B-Drug-Name
- NCT03860545 709 710 I-Drug-Name
derived NCT03860545 711 718 I-Drug-Name
products NCT03860545 719 727 I-Drug-Name
during NCT03860545 728 734 O
the NCT03860545 735 738 O
operation NCT03860545 739 748 B-Procedure-Name
and NCT03860545 749 752 O
afterward NCT03860545 753 762 O

- NCT03860545 765 766 O
acute NCT03860545 768 773 B-Condition-Name
myocardial NCT03860545 774 784 I-Condition-Name
infarction NCT03860545 785 795 I-Condition-Name
after NCT03860545 796 801 O
operation NCT03860545 802 811 B-Procedure-Name

Inclusion NCT03868657 0 9 O
Criteria NCT03868657 10 18 O
: NCT03868657 19 20 O

- NCT03868657 24 25 O
Healthy NCT03868657 27 34 O
men NCT03868657 35 38 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03868657 39 42 O
women NCT03868657 43 48 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03868657 51 52 O
Age NCT03868657 54 57 O
≥ NCT03868657 58 59 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03868657 61 63 B-Eq-Value
and NCT03868657 64 67 B-Eq-Operator___Eq-Operator-Value:BETWEEN
≤ NCT03868657 68 69 B-Eq-Operator___Eq-Operator-Value:LTEQ
40 NCT03868657 71 73 B-Eq-Value
years NCT03868657 74 79 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03868657 82 83 O
BMI NCT03868657 85 88 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03868657 89 90 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868657 92 94 B-Eq-Value
, NCT03868657 95 96 I-Eq-Value
5 NCT03868657 97 98 I-Eq-Value
and NCT03868657 99 102 B-Eq-Operator___Eq-Operator-Value:BETWEEN
≤ NCT03868657 103 104 B-Eq-Operator___Eq-Operator-Value:LTEQ
27 NCT03868657 106 108 B-Eq-Value
, NCT03868657 109 110 I-Eq-Value
5 NCT03868657 111 112 I-Eq-Value

Exclusion NCT03868657 114 123 O
Criteria NCT03868657 124 132 O
: NCT03868657 133 134 O

- NCT03868657 138 139 O
Chronic NCT03868657 141 148 B-Condition-Name
diseases NCT03868657 149 157 I-Condition-Name
( NCT03868657 158 159 O
cardiac NCT03868657 160 167 O
, NCT03868657 168 169 O
metabolic NCT03868657 170 179 O
, NCT03868657 180 181 O
liver NCT03868657 182 187 O
) NCT03868657 188 189 O
including NCT03868657 190 199 O
a NCT03868657 200 201 O
family NCT03868657 202 208 O
history NCT03868657 209 216 O
of NCT03868657 217 219 O
congenital NCT03868657 220 230 B-Condition-Name
Long NCT03868657 231 235 I-Condition-Name
QT NCT03868657 236 238 I-Condition-Name
syndrome NCT03868657 239 247 I-Condition-Name
. NCT03868657 248 249 O

- NCT03868657 253 254 O
QTc NCT03868657 256 259 B-Observation-Name___Observation-Type-Value:measurement
values NCT03868657 260 266 O
> NCT03868657 267 268 B-Eq-Operator___Eq-Operator-Value:GT
440 NCT03868657 270 273 B-Eq-Value
ms NCT03868657 274 276 B-Eq-Unit
( NCT03868657 277 278 O
men NCT03868657 279 282 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
) NCT03868657 283 284 O
and NCT03868657 285 288 O
> NCT03868657 289 290 B-Eq-Operator___Eq-Operator-Value:GT
450 NCT03868657 292 295 B-Eq-Value
ms NCT03868657 296 298 B-Eq-Unit
( NCT03868657 299 300 O
women NCT03868657 301 306 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
) NCT03868657 307 308 O

- NCT03868657 312 313 O
Clinical NCT03868657 315 323 O
important NCT03868657 324 333 O
and NCT03868657 334 337 O
/ NCT03868657 338 339 O
or NCT03868657 340 342 O
symptomatic NCT03868657 343 354 O
bradycardia NCT03868657 355 366 B-Condition-Name

- NCT03868657 369 370 O
Regular NCT03868657 372 379 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03868657 380 390 O
( NCT03868657 391 392 O
contraceptive NCT03868657 393 406 B-Drug-Name
pills NCT03868657 407 412 I-Drug-Name
allowed NCT03868657 413 420 O
) NCT03868657 421 422 O

- NCT03868657 426 427 O
Pregnancy NCT03868657 429 438 B-Condition-Name
and NCT03868657 439 442 O
breastfeeding NCT03868657 443 456 B-Condition-Name

Inclusion NCT03862391 0 9 O
Criteria NCT03862391 10 18 O
: NCT03862391 19 20 O

- NCT03862391 24 25 O
ASA NCT03862391 27 30 B-Condition-Name
physical NCT03862391 31 39 I-Condition-Name
status NCT03862391 40 46 I-Condition-Name
1 NCT03862391 48 49 B-Eq-Value
and NCT03862391 50 53 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03862391 55 56 B-Eq-Value
, NCT03862391 57 58 O
underwent NCT03862391 59 68 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
gynicological NCT03862391 69 82 B-Procedure-Name
laparotomic NCT03862391 83 94 I-Procedure-Name
surgery NCT03862391 95 102 I-Procedure-Name
under NCT03862391 103 108 O
general NCT03862391 109 116 B-Procedure-Name
anesthesia NCT03862391 117 127 I-Procedure-Name
, NCT03862391 128 129 O
followed NCT03862391 130 138 O
up NCT03862391 139 141 O
in NCT03862391 142 144 O
PACU NCT03862391 145 149 B-Location___Location-Value:unit
( NCT03862391 150 151 O
post NCT03862391 152 156 B-Location___Location-Value:unit
operative NCT03862391 157 166 I-Location___Location-Value:unit
care NCT03862391 167 171 I-Location___Location-Value:unit
unit NCT03862391 172 176 I-Location___Location-Value:unit
) NCT03862391 177 178 O

Exclusion NCT03862391 180 189 O
Criteria NCT03862391 190 198 O
: NCT03862391 199 200 O

- NCT03862391 204 205 O
ASA NCT03862391 207 210 B-Condition-Name
3 NCT03862391 212 213 B-Eq-Value
or NCT03862391 214 216 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03862391 218 219 B-Eq-Value
, NCT03862391 220 221 O
mental NCT03862391 222 228 B-Condition-Name
retardation NCT03862391 229 240 I-Condition-Name
, NCT03862391 241 242 O
psychiatric NCT03862391 243 254 B-Condition-Name
disease NCT03862391 255 262 I-Condition-Name
, NCT03862391 263 264 O
history NCT03862391 265 272 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862391 273 275 O
malignant NCT03862391 276 285 B-Condition-Name
hyperthermia NCT03862391 286 298 I-Condition-Name
in NCT03862391 299 301 O
patient NCT03862391 302 309 O
or NCT03862391 310 312 O
her NCT03862391 313 316 O
family NCT03862391 317 323 O
, NCT03862391 324 325 O
neurological NCT03862391 326 338 B-Condition-Name
disease NCT03862391 339 346 I-Condition-Name
, NCT03862391 347 348 O
morbid NCT03862391 349 355 B-Condition-Name
obesity NCT03862391 356 363 I-Condition-Name
, NCT03862391 364 365 O
history NCT03862391 366 373 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03862391 374 376 O
asthma NCT03862391 377 383 B-Condition-Name
and NCT03862391 384 387 O
follow NCT03862391 388 394 O
- NCT03862391 395 396 O
up NCT03862391 397 399 O
in NCT03862391 400 402 O
the NCT03862391 403 406 O
intensive NCT03862391 407 416 B-Location___Location-Value:unit
care NCT03862391 417 421 I-Location___Location-Value:unit
unit NCT03862391 422 426 I-Location___Location-Value:unit
. NCT03862391 427 428 O

Inclusion NCT03863925 0 9 O
Criteria NCT03863925 10 18 O
: NCT03863925 19 20 O

- NCT03863925 24 25 O
Age NCT03863925 27 30 O
between NCT03863925 31 38 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03863925 40 42 B-Eq-Value
years NCT03863925 43 48 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863925 49 52 O
and NCT03863925 53 56 O
65 NCT03863925 58 60 B-Eq-Value
years NCT03863925 61 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863925 67 70 O

- NCT03863925 73 74 O
Diagnosis NCT03863925 76 85 O
of NCT03863925 86 88 O
major NCT03863925 89 94 O
depressive NCT03863925 95 105 B-Condition-Name
disorder NCT03863925 106 114 I-Condition-Name
, NCT03863925 115 116 O
bipolar NCT03863925 117 124 B-Condition-Name
disorder NCT03863925 125 133 I-Condition-Name
, NCT03863925 134 135 O
and NCT03863925 136 139 O
schizophrenia NCT03863925 140 153 B-Condition-Name
, NCT03863925 154 155 O
compatible NCT03863925 156 166 O
with NCT03863925 167 171 O
SCID NCT03863925 172 176 O
for NCT03863925 177 180 O
DSM NCT03863925 181 184 O
- NCT03863925 185 186 O
5 NCT03863925 188 189 O
, NCT03863925 190 191 O
with NCT03863925 192 196 O
clinical NCT03863925 197 205 O
necessity NCT03863925 206 215 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
of NCT03863925 216 218 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
ECT NCT03863925 219 222 B-Procedure-Name
under NCT03863925 223 228 O
a NCT03863925 229 230 O
psychiatrist NCT03863925 231 243 O
's NCT03863925 243 245 O
evaluation NCT03863925 246 256 O
and NCT03863925 257 260 O
decision NCT03863925 261 269 O

- NCT03863925 272 273 O
Patients NCT03863925 275 283 O
with NCT03863925 284 288 O
adequate NCT03863925 289 297 B-Condition-Name
visual NCT03863925 298 304 I-Condition-Name
acuity NCT03863925 305 311 I-Condition-Name
and NCT03863925 312 315 O
auditory NCT03863925 316 324 B-Condition-Name
acuity NCT03863925 325 331 I-Condition-Name
without NCT03863925 332 339 O
or NCT03863925 340 342 O
with NCT03863925 343 347 O
correction NCT03863925 348 358 O

- NCT03863925 361 362 O
Patients NCT03863925 364 372 O
or NCT03863925 373 375 O
patients NCT03863925 376 384 O
' NCT03863925 384 385 O
legal NCT03863925 386 391 O
representative NCT03863925 392 406 O
signing NCT03863925 407 414 O
up NCT03863925 415 417 O
the NCT03863925 418 421 O
informed NCT03863925 422 430 O
consent NCT03863925 431 438 O

Exclusion NCT03863925 439 448 O
Criteria NCT03863925 449 457 O
: NCT03863925 458 459 O

- NCT03863925 463 464 O
Patients NCT03863925 466 474 O
already NCT03863925 475 482 O
diagnosed NCT03863925 483 492 O
with NCT03863925 493 497 O
neurocognitive NCT03863925 498 512 B-Condition-Name
disorder NCT03863925 513 521 I-Condition-Name

- NCT03863925 524 525 O
Patients NCT03863925 527 535 O
with NCT03863925 536 540 O
contraindications NCT03863925 541 558 O
to NCT03863925 559 561 O
ECT NCT03863925 562 565 B-Procedure-Name
, NCT03863925 566 567 O
including NCT03863925 568 577 O
myocardial NCT03863925 578 588 B-Condition-Name
infarction NCT03863925 589 599 I-Condition-Name
, NCT03863925 600 601 O
cerebrovascular NCT03863925 602 617 B-Condition-Name
disease NCT03863925 618 625 I-Condition-Name
, NCT03863925 626 627 O
elevated NCT03863925 628 636 B-Condition-Name
intracranial NCT03863925 637 649 I-Condition-Name
pressure NCT03863925 650 658 I-Condition-Name
, NCT03863925 659 660 O
intracranial NCT03863925 661 673 B-Condition-Name
angiomas NCT03863925 674 682 I-Condition-Name
, NCT03863925 683 684 O
untreated NCT03863925 685 694 O
bony NCT03863925 695 699 B-Condition-Name
fractures NCT03863925 700 709 I-Condition-Name
, NCT03863925 710 711 O
cervical NCT03863925 712 720 B-Condition-Name
spine NCT03863925 721 726 I-Condition-Name
injury NCT03863925 727 733 I-Condition-Name
, NCT03863925 734 735 O
pheochromocytoma NCT03863925 736 752 B-Condition-Name
, NCT03863925 753 754 O
heart NCT03863925 755 760 B-Condition-Name
failure NCT03863925 761 768 I-Condition-Name
, NCT03863925 769 770 O
sever NCT03863925 771 776 B-Severity___Severity-Value:severe
valvular NCT03863925 777 785 B-Condition-Name
disease NCT03863925 786 793 I-Condition-Name
, NCT03863925 794 795 O
deep NCT03863925 796 800 B-Condition-Name
vein NCT03863925 801 805 I-Condition-Name
thrombosis NCT03863925 806 816 I-Condition-Name
, NCT03863925 817 818 O
etc NCT03863925 819 822 O
. NCT03863925 823 824 O

- NCT03863925 828 829 O
Patients NCT03863925 831 839 O
with NCT03863925 840 844 O
untreated NCT03863925 845 854 O
substance NCT03863925 855 864 B-Condition-Name
abuse NCT03863925 865 870 I-Condition-Name
, NCT03863925 871 872 O
including NCT03863925 873 882 O
alcohol NCT03863925 883 890 B-Drug-Name
and NCT03863925 891 894 O
illegal NCT03863925 895 902 B-Drug-Name
drugs NCT03863925 903 908 I-Drug-Name

- NCT03863925 911 912 O
Patients NCT03863925 914 922 O
with NCT03863925 923 927 O
unspecified NCT03863925 928 939 O
psychiatric NCT03863925 940 951 B-Condition-Name
disorders NCT03863925 952 961 I-Condition-Name

- NCT03863925 964 965 O
Patients NCT03863925 967 975 O
unable NCT03863925 976 982 O
to NCT03863925 983 985 O
cooperate NCT03863925 986 995 O

Inclusion NCT03860753 0 9 O
Criteria NCT03860753 10 18 O
: NCT03860753 19 20 O

- NCT03860753 24 25 O
treatment NCT03860753 27 36 O
- NCT03860753 37 38 O
seeking NCT03860753 39 46 O
individuals NCT03860753 47 58 O
diagnosed NCT03860753 59 68 O
with NCT03860753 69 73 O
AUD NCT03860753 74 77 B-Condition-Name
diagnostic NCT03860753 78 88 O
statistical NCT03860753 89 100 O
manual NCT03860753 101 107 O
5 NCT03860753 109 110 O
( NCT03860753 111 112 O
DSM NCT03860753 113 116 O
- NCT03860753 117 118 O
5 NCT03860753 120 121 O
) NCT03860753 122 123 O

- NCT03860753 127 128 O
fluent NCT03860753 130 136 O
in NCT03860753 137 139 O
English NCT03860753 140 147 B-Language

- NCT03860753 150 151 O
past NCT03860753 153 157 B-Eq-Operator___Eq-Operator-Value:LTEQ
month NCT03860753 158 163 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
excessive NCT03860753 164 173 B-Polarity___Polarity-Value:high
alcohol NCT03860753 174 181 B-Observation-Name___Observation-Type-Value:social-habit
use NCT03860753 182 185 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03860753 186 187 O
> NCT03860753 189 190 B-Eq-Operator___Eq-Operator-Value:GT
7 NCT03860753 192 193 B-Eq-Value
drinks NCT03860753 194 200 B-Eq-Unit
/ NCT03860753 201 202 O
week NCT03860753 203 207 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
for NCT03860753 208 211 O
woman NCT03860753 212 217 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03860753 218 219 O
> NCT03860753 220 221 B-Eq-Operator___Eq-Operator-Value:GT
14 NCT03860753 223 225 B-Eq-Value
drinks NCT03860753 226 232 B-Eq-Unit
/ NCT03860753 233 234 O
week NCT03860753 235 239 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
for NCT03860753 240 243 O
men NCT03860753 244 247 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
, NCT03860753 248 249 O
> NCT03860753 250 251 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03860753 253 254 B-Eq-Value
drinks NCT03860753 255 261 B-Eq-Value
/ NCT03860753 262 263 O
occasion NCT03860753 264 272 B-Eq-Unit
for NCT03860753 273 276 O
women NCT03860753 277 282 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
> NCT03860753 283 284 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03860753 286 287 B-Eq-Value
drinks NCT03860753 288 294 B-Eq-Unit
/ NCT03860753 295 296 O
occasion NCT03860753 297 305 B-Eq-Unit
for NCT03860753 306 309 O
men NCT03860753 310 313 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
) NCT03860753 314 315 O
14 NCT03860753 317 319 O

- NCT03860753 323 324 O
baseline NCT03860753 326 334 O
Hamilton NCT03860753 335 343 B-Observation-Name___Observation-Type-Value:clinical-score
Anxiety NCT03860753 344 351 I-Observation-Name___Observation-Type-Value:clinical-score
Rating NCT03860753 352 358 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03860753 359 364 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03860753 365 366 O
HAM NCT03860753 367 370 B-Observation-Name
- NCT03860753 371 372 I-Observation-Name
A NCT03860753 373 374 I-Observation-Name
) NCT03860753 375 376 O
or NCT03860753 377 379 O
Perceived NCT03860753 380 389 B-Observation-Name___Observation-Type-Value:clinical-score
Stress NCT03860753 390 396 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03860753 397 402 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03860753 403 404 O
PSS NCT03860753 405 408 B-Observation-Name
) NCT03860753 409 410 O
core NCT03860753 411 415 O
indicative NCT03860753 416 426 O
of NCT03860753 427 429 O
mild NCT03860753 430 434 B-Severity___Severity-Value:mild
to NCT03860753 435 437 O
moderate NCT03860753 438 446 B-Severity___Severity-Value:moderate
anxiety NCT03860753 447 454 B-Condition-Name
( NCT03860753 455 456 O
score NCT03860753 457 462 B-Eq-Unit
8 NCT03860753 464 465 B-Eq-Value
to NCT03860753 466 468 B-Eq-Operator___Eq-Operator-Value:BETWEEN
23 NCT03860753 470 472 B-Eq-Value
) NCT03860753 473 474 O
or NCT03860753 475 477 O
moderate NCT03860753 478 486 B-Severity___Severity-Value:moderate
stress NCT03860753 487 493 B-Condition-Name
( NCT03860753 494 495 O
score NCT03860753 496 501 B-Eq-Unit
14 NCT03860753 503 505 B-Eq-Value
to NCT03860753 506 508 B-Eq-Operator___Eq-Operator-Value:BETWEEN
26 NCT03860753 510 512 B-Eq-Value
) NCT03860753 513 514 O
, NCT03860753 516 517 O
respectively NCT03860753 518 530 O

- NCT03860753 533 534 O
increase NCT03860753 536 544 B-Polarity___Polarity-Value:high
in NCT03860753 545 547 O
alcohol NCT03860753 548 555 B-Condition-Name
craving NCT03860753 556 563 I-Condition-Name
following NCT03860753 564 573 O
the NCT03860753 574 577 O
baseline NCT03860753 578 586 O
stress NCT03860753 587 593 O
reactivity NCT03860753 594 604 O
assessment NCT03860753 605 615 O
. NCT03860753 616 617 O

Exclusion NCT03860753 619 628 O
Criteria NCT03860753 629 637 O
: NCT03860753 638 639 O

- NCT03860753 643 644 O
Individuals NCT03860753 646 657 O
will NCT03860753 658 662 O
be NCT03860753 663 665 O
excluded NCT03860753 666 674 O
for NCT03860753 675 678 O
exhibiting NCT03860753 679 689 O
severe NCT03860753 690 696 B-Severity___Severity-Value:severe
scores NCT03860753 697 703 O
on NCT03860753 704 706 O
the NCT03860753 707 710 O
HAM NCT03860753 711 714 B-Observation-Name
- NCT03860753 715 716 I-Observation-Name
A NCT03860753 717 718 I-Observation-Name
, NCT03860753 719 720 O
PSS NCT03860753 721 724 B-Observation-Name
, NCT03860753 725 726 O
or NCT03860753 727 729 O
post NCT03860753 730 734 B-Condition-Name
- NCT03860753 735 736 I-Condition-Name
traumatic NCT03860753 737 746 I-Condition-Name
( NCT03860753 747 748 O
PTSD NCT03860753 749 753 B-Condition-Name
) NCT03860753 754 755 O
checklist NCT03860753 756 765 B-Observation-Name
( NCT03860753 766 767 O
PCL NCT03860753 768 771 B-Observation-Name
- NCT03860753 772 773 I-Observation-Name
5 NCT03860753 775 776 I-Observation-Name
) NCT03860753 777 778 O
at NCT03860753 779 781 O
the NCT03860753 782 785 O
discretion NCT03860753 786 796 O
of NCT03860753 797 799 O
the NCT03860753 800 803 O
admitting NCT03860753 804 813 O
physician NCT03860753 814 823 O

- NCT03860753 826 827 O
physical NCT03860753 829 837 O
dependence NCT03860753 838 848 B-Condition-Name
on NCT03860753 849 851 I-Condition-Name
alcohol NCT03860753 852 859 I-Condition-Name
Alcohol NCT03860753 860 867 B-Observation-Name
Use NCT03860753 868 871 I-Observation-Name
Disorders NCT03860753 872 881 I-Observation-Name
Inventory NCT03860753 882 891 I-Observation-Name
( NCT03860753 892 893 O
AUDIT NCT03860753 894 899 B-Observation-Name
) NCT03860753 900 901 O
score NCT03860753 902 907 O
indicative NCT03860753 908 918 O
of NCT03860753 919 921 O
severe NCT03860753 922 928 B-Severity___Severity-Value:severe
alcohol NCT03860753 929 936 B-Condition-Name
dependence NCT03860753 937 947 I-Condition-Name
( NCT03860753 948 949 O
≥ NCT03860753 951 952 B-Eq-Operator___Eq-Operator-Value:GTEQ
13 NCT03860753 954 956 B-Eq-Value
for NCT03860753 957 960 O
women NCT03860753 961 966 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03860753 967 968 O
≥ NCT03860753 969 970 B-Eq-Operator___Eq-Operator-Value:GTEQ
15 NCT03860753 972 974 B-Eq-Value
for NCT03860753 975 978 O
men NCT03860753 979 982 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
) NCT03860753 983 984 O

- NCT03860753 988 989 O
greater NCT03860753 991 998 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03860753 999 1003 I-Eq-Operator___Eq-Operator-Value:GT
mild NCT03860753 1004 1008 B-Severity___Severity-Value:mild
substance NCT03860753 1009 1018 B-Condition-Name
use NCT03860753 1019 1022 I-Condition-Name
disorder NCT03860753 1023 1031 I-Condition-Name
on NCT03860753 1032 1034 O
drugs NCT03860753 1035 1040 O
other NCT03860753 1041 1046 O
than NCT03860753 1047 1051 O
alcohol NCT03860753 1052 1059 B-Drug-Name
, NCT03860753 1060 1061 O
nicotine NCT03860753 1062 1070 B-Drug-Name
, NCT03860753 1071 1072 O
and NCT03860753 1073 1076 O
marijuana NCT03860753 1077 1086 B-Drug-Name

- NCT03860753 1089 1090 O
contraindications NCT03860753 1092 1109 O
for NCT03860753 1110 1113 O
taking NCT03860753 1114 1120 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pioglitazone NCT03860753 1121 1133 B-Drug-Name
; NCT03860753 1133 1134 O
medical NCT03860753 1135 1142 O
conditions NCT03860753 1143 1153 O
contraindicating NCT03860753 1154 1170 O
pioglitazone NCT03860753 1171 1183 B-Drug-Name
pharmacotherapy NCT03860753 1184 1199 O
or NCT03860753 1200 1202 O
taking NCT03860753 1203 1209 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
contraindicated NCT03860753 1210 1225 O
medications NCT03860753 1226 1237 O

- NCT03860753 1240 1241 O
be NCT03860753 1243 1245 O
pregnant NCT03860753 1246 1254 B-Condition-Name
, NCT03860753 1255 1256 O
nursing NCT03860753 1257 1264 B-Condition-Name
, NCT03860753 1265 1266 O
or NCT03860753 1267 1269 O
planning NCT03860753 1270 1278 O
on NCT03860753 1279 1281 O
becoming NCT03860753 1282 1290 O
pregnant NCT03860753 1291 1299 B-Condition-Name
during NCT03860753 1300 1306 O
the NCT03860753 1307 1310 O
course NCT03860753 1311 1317 O
of NCT03860753 1318 1320 O
the NCT03860753 1321 1324 O
study NCT03860753 1325 1330 O

- NCT03860753 1333 1334 O
have NCT03860753 1336 1340 O
any NCT03860753 1341 1344 O
other NCT03860753 1345 1350 O
illness NCT03860753 1351 1358 O
, NCT03860753 1359 1360 O
condition NCT03860753 1361 1370 O
, NCT03860753 1371 1372 O
or NCT03860753 1373 1375 O
use NCT03860753 1376 1379 O
of NCT03860753 1380 1382 O
medications NCT03860753 1383 1394 O
, NCT03860753 1395 1396 O
which NCT03860753 1397 1402 O
in NCT03860753 1403 1405 O
the NCT03860753 1406 1409 O
opinion NCT03860753 1410 1417 O
of NCT03860753 1418 1420 O
the NCT03860753 1421 1424 O
PI NCT03860753 1425 1427 O
and NCT03860753 1428 1431 O
/ NCT03860753 1432 1433 O
or NCT03860753 1434 1436 O
admitting NCT03860753 1437 1446 O
physician NCT03860753 1447 1456 O
would NCT03860753 1457 1462 O
preclude NCT03860753 1463 1471 O
safe NCT03860753 1472 1476 O
and NCT03860753 1477 1480 O
/ NCT03860753 1481 1482 O
or NCT03860753 1483 1485 O
successful NCT03860753 1486 1496 O
completion NCT03860753 1497 1507 O
of NCT03860753 1508 1510 O
the NCT03860753 1511 1514 O
study NCT03860753 1515 1520 O
. NCT03860753 1521 1522 O


Inclusion NCT03867955 0 9 O
Criteria NCT03867955 10 18 O
: NCT03867955 19 20 O

- NCT03867955 24 25 O
Majors NCT03867955 27 33 O
patients NCT03867955 34 42 O

- NCT03867955 45 46 O
Score NCT03867955 48 53 O
American NCT03867955 54 62 B-Condition-Name
Society NCT03867955 63 70 I-Condition-Name
of NCT03867955 71 73 I-Condition-Name
Anesthesiologists NCT03867955 74 91 I-Condition-Name
( NCT03867955 92 93 O
ASA NCT03867955 94 97 B-Condition-Name
) NCT03867955 98 99 O
1 NCT03867955 101 102 B-Eq-Value
or NCT03867955 103 105 O
2 NCT03867955 107 108 B-Eq-Value

- NCT03867955 112 113 O
Managed NCT03867955 115 122 O
in NCT03867955 123 125 O
the NCT03867955 126 129 O
operating NCT03867955 130 139 O
theater NCT03867955 140 147 O
of NCT03867955 148 150 O
the NCT03867955 151 154 O
University NCT03867955 155 165 B-Location___Location-Value:hospital
Hospital NCT03867955 166 174 I-Location___Location-Value:hospital
of NCT03867955 175 177 I-Location___Location-Value:hospital
Saint NCT03867955 178 183 I-Location___Location-Value:hospital
- NCT03867955 184 185 I-Location___Location-Value:hospital
Etienne NCT03867955 186 193 I-Location___Location-Value:hospital
for NCT03867955 194 197 O
a NCT03867955 198 199 O
neurosurgical NCT03867955 200 213 B-Procedure-Name
intervention NCT03867955 214 226 I-Procedure-Name
. NCT03867955 227 228 O

Exclusion NCT03867955 230 239 O
Criteria NCT03867955 240 248 O
: NCT03867955 249 250 O

- NCT03867955 254 255 O
Single NCT03867955 257 263 O
or NCT03867955 264 266 O
bilateral NCT03867955 267 276 O
eye NCT03867955 277 280 B-Procedure-Name
surgery NCT03867955 281 288 I-Procedure-Name
modifying NCT03867955 289 298 O
the NCT03867955 299 302 O
possibilities NCT03867955 303 316 O
of NCT03867955 317 319 O
variation NCT03867955 320 329 O
of NCT03867955 330 332 O
the NCT03867955 333 336 O
pupillary NCT03867955 337 346 O
diameter NCT03867955 347 355 O

- NCT03867955 358 359 O
Having NCT03867955 361 367 O
been NCT03867955 368 372 O
asleep NCT03867955 373 379 O
under NCT03867955 380 385 O
general NCT03867955 386 393 B-Procedure-Name
anesthesia NCT03867955 394 404 I-Procedure-Name
in NCT03867955 405 407 O
the NCT03867955 408 411 O
7 NCT03867955 413 414 B-Eq-Value
days NCT03867955 415 419 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03867955 420 425 O
to NCT03867955 426 428 O
the NCT03867955 429 432 O
current NCT03867955 433 440 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surgery NCT03867955 441 448 B-Procedure-Name

- NCT03867955 451 452 O
History NCT03867955 454 461 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867955 462 464 O
Parkinson NCT03867955 465 474 B-Condition-Name
's NCT03867955 474 476 I-Condition-Name
disease NCT03867955 477 484 I-Condition-Name
, NCT03867955 485 486 O
insulin NCT03867955 487 494 O
- NCT03867955 495 496 O
dependent NCT03867955 497 506 O
or NCT03867955 507 509 O
non NCT03867955 510 513 O
- NCT03867955 514 515 O
insulin NCT03867955 516 523 O
- NCT03867955 524 525 O
dependent NCT03867955 526 535 O
diabetes NCT03867955 536 544 B-Condition-Name
at NCT03867955 545 547 O
a NCT03867955 548 549 O
dysautonomic NCT03867955 550 562 O
stage NCT03867955 563 568 O
or NCT03867955 569 571 O
chronic NCT03867955 572 579 O
alcoholism NCT03867955 580 590 B-Condition-Name
at NCT03867955 591 593 O
a NCT03867955 594 595 O
dysautonomous NCT03867955 596 609 O
stage NCT03867955 610 615 O

Inclusion NCT03860974 0 9 O
Criteria NCT03860974 10 18 O
: NCT03860974 19 20 O

- NCT03860974 24 25 O
undergoing NCT03860974 27 37 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
unilateral NCT03860974 38 48 O
or NCT03860974 49 51 O
bilateral NCT03860974 52 61 O
breast NCT03860974 62 68 B-Procedure-Name
surgery NCT03860974 69 76 I-Procedure-Name
with NCT03860974 77 81 O
at NCT03860974 82 84 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03860974 85 90 I-Eq-Operator___Eq-Operator-Value:GTEQ
moderate NCT03860974 91 99 B-Eq-Value
post NCT03860974 100 104 O
operative NCT03860974 105 114 O
pain NCT03860974 115 119 B-Observation-Name
anticipated NCT03860974 120 131 O

- NCT03860974 134 135 O
analgesic NCT03860974 137 146 B-Drug-Name
plan NCT03860974 147 151 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
includes NCT03860974 152 160 O
a NCT03860974 161 162 O
single NCT03860974 163 169 B-Procedure-Name
- NCT03860974 170 171 I-Procedure-Name
injection NCT03860974 172 181 I-Procedure-Name
peripheral NCT03860974 182 192 I-Procedure-Name
nerve NCT03860974 193 198 I-Procedure-Name
block NCT03860974 199 204 I-Procedure-Name
( NCT03860974 205 206 O
s NCT03860974 207 208 O
) NCT03860974 209 210 O

- NCT03860974 214 215 O
age NCT03860974 217 220 O
18 NCT03860974 222 224 B-Eq-Value
years NCT03860974 225 230 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03860974 231 233 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03860974 234 239 I-Eq-Operator___Eq-Operator-Value:GTEQ

Exclusion NCT03860974 240 249 O
Criteria NCT03860974 250 258 O
: NCT03860974 259 260 O

- NCT03860974 264 265 O
morbid NCT03860974 267 273 B-Condition-Name
obesity NCT03860974 274 281 I-Condition-Name
as NCT03860974 282 284 O
defined NCT03860974 285 292 O
by NCT03860974 293 295 O
a NCT03860974 296 297 O
body NCT03860974 298 302 B-Observation-Name___Observation-Type-Value:vital
mass NCT03860974 303 307 I-Observation-Name___Observation-Type-Value:vital
index NCT03860974 308 313 I-Observation-Name___Observation-Type-Value:vital
> NCT03860974 314 315 B-Eq-Operator___Eq-Operator-Value:GT
40 NCT03860974 317 319 B-Eq-Value
( NCT03860974 320 321 O
BMI NCT03860974 322 325 O
= NCT03860974 326 327 O
weight NCT03860974 328 334 O
in NCT03860974 335 337 O
kg NCT03860974 338 340 O
/ NCT03860974 341 342 O
[ NCT03860974 343 344 O
height NCT03860974 345 351 O
in NCT03860974 352 354 O
meters NCT03860974 355 361 O
] NCT03860974 362 363 O
2 NCT03860974 365 366 O
) NCT03860974 367 368 O

- NCT03860974 372 373 O
renal NCT03860974 375 380 B-Condition-Name
insufficiency NCT03860974 381 394 I-Condition-Name
( NCT03860974 395 396 O
pre NCT03860974 397 400 O
operative NCT03860974 401 410 O
creatinine NCT03860974 411 421 B-Observation-Name___Observation-Type-Value:lab
> NCT03860974 422 423 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03860974 425 428 B-Eq-Value
mg NCT03860974 429 431 B-Eq-Unit
/ NCT03860974 432 433 O
dL NCT03860974 434 436 B-Eq-Unit
) NCT03860974 437 438 O

- NCT03860974 442 443 O
chronic NCT03860974 445 452 O
opioid NCT03860974 453 459 B-Drug-Name
use NCT03860974 460 463 O
( NCT03860974 464 465 O
daily NCT03860974 466 471 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
use NCT03860974 472 475 O
within NCT03860974 476 482 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03860974 483 486 O
2 NCT03860974 488 489 B-Eq-Value
weeks NCT03860974 490 495 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03860974 496 501 O
to NCT03860974 502 504 O
surgery NCT03860974 505 512 B-Procedure-Name
and NCT03860974 513 516 O
duration NCT03860974 517 525 O
of NCT03860974 526 528 O
use NCT03860974 529 532 O
> NCT03860974 533 534 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03860974 536 537 B-Eq-Value
weeks NCT03860974 538 543 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03860974 544 545 O

- NCT03860974 549 550 O
history NCT03860974 552 559 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03860974 560 562 O
opioid NCT03860974 563 569 B-Condition-Name
abuse NCT03860974 570 575 I-Condition-Name

- NCT03860974 578 579 O
any NCT03860974 581 584 O
comorbidity NCT03860974 585 596 B-Condition-Name
which NCT03860974 597 602 O
results NCT03860974 603 610 O
in NCT03860974 611 613 O
moderate NCT03860974 614 622 B-Severity___Severity-Value:moderate
or NCT03860974 623 625 O
severe NCT03860974 626 632 B-Severity___Severity-Value:severe
functional NCT03860974 633 643 B-Condition-Name
limitation NCT03860974 644 654 I-Condition-Name
inability NCT03860974 655 664 I-Condition-Name
to NCT03860974 665 667 I-Condition-Name
communicate NCT03860974 668 679 I-Condition-Name
with NCT03860974 680 684 O
the NCT03860974 685 688 O
investigators NCT03860974 689 702 O
or NCT03860974 703 705 O
hospital NCT03860974 706 714 O
staff NCT03860974 715 720 O

- NCT03860974 723 724 O
pregnancy NCT03860974 726 735 B-Condition-Name

- NCT03860974 738 739 O
planned NCT03860974 741 748 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
regional NCT03860974 749 757 B-Drug-Name
analgesic NCT03860974 758 767 I-Drug-Name
with NCT03860974 768 772 O
perineural NCT03860974 773 783 B-Procedure-Name
catheter NCT03860974 784 792 I-Procedure-Name
placement NCT03860974 793 802 I-Procedure-Name

- NCT03860974 805 806 O
incarceration NCT03860974 808 821 B-Observation-Name


Inclusion NCT03869788 0 9 O
Criteria NCT03869788 10 18 O
: NCT03869788 19 20 O

- NCT03869788 24 25 O
vague NCT03869788 27 32 O
gastrointestinal NCT03869788 33 49 B-Condition-Name
disturbances NCT03869788 50 62 I-Condition-Name
. NCT03869788 63 64 O

- NCT03869788 68 69 O
intermittent NCT03869788 71 83 O
eosinophilia NCT03869788 84 96 B-Condition-Name
. NCT03869788 97 98 O

- NCT03869788 102 103 O
biliary NCT03869788 105 112 B-Condition-Name
obstruction NCT03869788 113 124 I-Condition-Name
. NCT03869788 125 126 O

- NCT03869788 130 131 O
biliary NCT03869788 133 140 B-Condition-Name
colic NCT03869788 141 146 I-Condition-Name
pain NCT03869788 147 151 I-Condition-Name
. NCT03869788 152 153 O

- NCT03869788 157 158 O
intermittent NCT03869788 160 172 O
jaundice NCT03869788 173 181 B-Condition-Name
. NCT03869788 182 183 O

- NCT03869788 187 188 O
right NCT03869788 190 195 B-Condition-Name
upper NCT03869788 196 201 I-Condition-Name
- NCT03869788 202 203 I-Condition-Name
quadrant NCT03869788 204 212 I-Condition-Name
abdominal NCT03869788 213 222 I-Condition-Name
tenderness NCT03869788 223 233 I-Condition-Name
. NCT03869788 234 235 O

Exclusion NCT03869788 237 246 O
Criteria NCT03869788 247 255 O
: NCT03869788 256 257 O

- NCT03869788 261 262 O
no NCT03869788 264 266 O
exclusion NCT03869788 267 276 O
Criteria NCT03869788 277 285 O

Inclusion NCT03862742 0 9 O
Criteria NCT03862742 10 18 O
: NCT03862742 19 20 O

- NCT03862742 24 25 O
≥ NCT03862742 27 28 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03862742 30 32 B-Eq-Value
years NCT03862742 33 38 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03862742 39 41 O
age NCT03862742 42 45 O

- NCT03862742 48 49 O
Own NCT03862742 51 54 O
an NCT03862742 55 57 O
iOS NCT03862742 58 61 O
or NCT03862742 62 64 O
Android NCT03862742 65 72 O
device NCT03862742 73 79 O

Exclusion NCT03862742 80 89 O
Criteria NCT03862742 90 98 O
: NCT03862742 99 100 O

- NCT03862742 104 105 O
Inability NCT03862742 107 116 O
to NCT03862742 117 119 O
give NCT03862742 120 124 O
informed NCT03862742 125 133 O
consent NCT03862742 134 141 O

- NCT03862742 144 145 O
< NCT03862742 147 148 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03862742 150 152 B-Eq-Value
years NCT03862742 153 158 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03862742 159 161 O
age NCT03862742 162 165 O

- NCT03862742 168 169 O
Inability NCT03862742 171 180 O
to NCT03862742 181 183 O
understand NCT03862742 184 194 O
written NCT03862742 195 202 O
English NCT03862742 203 210 B-Language
language NCT03862742 211 219 O

- NCT03862742 222 223 O
Hypertensive NCT03862742 225 237 B-Condition-Name
urgency NCT03862742 238 245 O
or NCT03862742 246 248 O
emergency NCT03862742 249 258 O
as NCT03862742 259 261 O
an NCT03862742 262 264 O
admission NCT03862742 265 274 B-Condition-Type___Condition-Type-Value:admitting
diagnosis NCT03862742 275 284 O

Inclusion NCT03862781 0 9 O
Criteria NCT03862781 10 18 O
: NCT03862781 19 20 O

- NCT03862781 24 25 O
Eligible NCT03862781 27 35 O
patients NCT03862781 36 44 O
are NCT03862781 45 48 O
those NCT03862781 49 54 O
over NCT03862781 55 59 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03862781 61 63 B-Eq-Value
years NCT03862781 64 69 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03862781 70 72 O
age NCT03862781 73 76 O
who NCT03862781 77 80 O
are NCT03862781 81 84 O
regularly NCT03862781 85 94 O
scheduled NCT03862781 95 104 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03862781 105 107 O
undergo NCT03862781 108 115 O
a NCT03862781 116 117 O
right NCT03862781 118 123 B-Procedure-Name
hemicolectomy NCT03862781 124 137 I-Procedure-Name
via NCT03862781 138 141 O
a NCT03862781 142 143 O
minimally NCT03862781 144 153 B-Procedure-Name
invasive NCT03862781 154 162 I-Procedure-Name
approach NCT03862781 163 171 I-Procedure-Name
( NCT03862781 172 173 O
robotic NCT03862781 174 181 O
or NCT03862781 182 184 O
laparoscopic NCT03862781 185 197 O
) NCT03862781 198 199 O
with NCT03862781 200 204 O
the NCT03862781 205 208 O
creation NCT03862781 209 217 O
of NCT03862781 218 220 O
an NCT03862781 221 223 O
anastomosis NCT03862781 224 235 B-Procedure-Name
. NCT03862781 236 237 O
Right NCT03862781 239 244 B-Procedure-Name
colectomy NCT03862781 245 254 I-Procedure-Name
will NCT03862781 255 259 O
be NCT03862781 260 262 O
defined NCT03862781 263 270 O
as NCT03862781 271 273 O
removal NCT03862781 274 281 B-Procedure-Name
of NCT03862781 282 284 I-Procedure-Name
the NCT03862781 285 288 I-Procedure-Name
ascending NCT03862781 289 298 I-Procedure-Name
colon NCT03862781 299 304 I-Procedure-Name
, NCT03862781 305 306 O
ligation NCT03862781 307 315 B-Procedure-Name
of NCT03862781 316 318 I-Procedure-Name
the NCT03862781 319 322 I-Procedure-Name
ileocolic NCT03862781 323 332 I-Procedure-Name
artery NCT03862781 333 339 I-Procedure-Name
and NCT03862781 340 343 I-Procedure-Name
vein NCT03862781 344 348 I-Procedure-Name
, NCT03862781 349 350 O
+ NCT03862781 351 352 O
/ NCT03862781 354 355 O
- NCT03862781 357 358 O
removal NCT03862781 359 366 B-Procedure-Name
of NCT03862781 367 369 I-Procedure-Name
the NCT03862781 370 373 I-Procedure-Name
terminal NCT03862781 374 382 I-Procedure-Name
ileum NCT03862781 383 388 I-Procedure-Name
, NCT03862781 389 390 O
+ NCT03862781 391 392 O
/ NCT03862781 394 395 O
- NCT03862781 397 398 O
removal NCT03862781 399 406 B-Procedure-Name
of NCT03862781 407 409 I-Procedure-Name
the NCT03862781 410 413 I-Procedure-Name
proximal NCT03862781 414 422 I-Procedure-Name
transverse NCT03862781 423 433 I-Procedure-Name
colon NCT03862781 434 439 I-Procedure-Name
, NCT03862781 440 441 O
and NCT03862781 442 445 O
+ NCT03862781 446 447 O
/ NCT03862781 449 450 O
- NCT03862781 452 453 O
removal NCT03862781 454 461 B-Procedure-Name
of NCT03862781 462 464 I-Procedure-Name
the NCT03862781 465 468 I-Procedure-Name
right NCT03862781 469 474 I-Procedure-Name
branch NCT03862781 475 481 I-Procedure-Name
of NCT03862781 482 484 I-Procedure-Name
the NCT03862781 485 488 I-Procedure-Name
middle NCT03862781 489 495 I-Procedure-Name
colic NCT03862781 496 501 I-Procedure-Name
artery NCT03862781 502 508 I-Procedure-Name
and NCT03862781 509 512 I-Procedure-Name
vein NCT03862781 513 517 I-Procedure-Name
. NCT03862781 518 519 O

Exclusion NCT03862781 521 530 O
Criteria NCT03862781 531 539 O
: NCT03862781 540 541 O

- NCT03862781 545 546 O
Pregnant NCT03862781 548 556 B-Condition-Name
women NCT03862781 557 562 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03862781 565 566 O
Additional NCT03862781 568 578 O
colon NCT03862781 579 584 B-Procedure-Name
resection NCT03862781 585 594 I-Procedure-Name
is NCT03862781 595 597 O
planned NCT03862781 598 605 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
( NCT03862781 606 607 O
i NCT03862781 608 609 O
. NCT03862781 610 611 O
e NCT03862781 612 613 O
. NCT03862781 614 615 O
left NCT03862781 617 621 B-Procedure-Name
colectomy NCT03862781 622 631 I-Procedure-Name
or NCT03862781 632 634 O
proctectomy NCT03862781 635 646 B-Procedure-Name
) NCT03862781 647 648 O

- NCT03862781 652 653 O
Vulnerable NCT03862781 655 665 B-Observation-Name
populations NCT03862781 666 677 I-Observation-Name
such NCT03862781 678 682 O
as NCT03862781 683 685 O
prisoners NCT03862781 686 695 B-Observation-Name
or NCT03862781 696 698 O
adults NCT03862781 699 705 O
unable NCT03862781 706 712 O
to NCT03862781 713 715 O
give NCT03862781 716 720 O
consent NCT03862781 721 728 O

- NCT03862781 731 732 O
If NCT03862781 734 736 O
the NCT03862781 737 740 O
scheduled NCT03862781 741 750 O
surgery NCT03862781 751 758 B-Procedure-Name
is NCT03862781 759 761 O
planned NCT03862781 762 769 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
at NCT03862781 770 772 O
Butterworth NCT03862781 773 784 B-Location___Location-Value:hospital
hospital NCT03862781 785 793 I-Location___Location-Value:hospital
( NCT03862781 794 795 O
as NCT03862781 796 798 O
to NCT03862781 799 801 O
standardize NCT03862781 802 813 O
the NCT03862781 814 817 O
nursing NCT03862781 818 825 O
care NCT03862781 826 830 O
received NCT03862781 831 839 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
post NCT03862781 840 844 O
operatively NCT03862781 845 856 O
) NCT03862781 857 858 O

- NCT03862781 862 863 O
Emergent NCT03862781 865 873 O
cases NCT03862781 874 879 O

Patients NCT03862781 880 888 O
will NCT03862781 889 893 O
be NCT03862781 894 896 O
excluded NCT03862781 897 905 O
from NCT03862781 906 910 O
the NCT03862781 911 914 O
study NCT03862781 915 920 O
intra NCT03862781 921 926 O
- NCT03862781 927 928 O
operatively NCT03862781 929 940 O
if NCT03862781 941 943 O
: NCT03862781 944 945 O

- NCT03862781 949 950 O
The NCT03862781 952 955 O
procedure NCT03862781 956 965 O
is NCT03862781 966 968 O
converted NCT03862781 969 978 B-Stability___Stability-Value:change
to NCT03862781 979 981 O
an NCT03862781 982 984 O
open NCT03862781 985 989 B-Procedure-Name
resection NCT03862781 990 999 I-Procedure-Name

- NCT03862781 1002 1003 O
If NCT03862781 1005 1007 O
a NCT03862781 1008 1009 O
loop NCT03862781 1010 1014 B-Procedure-Name
ileostomy NCT03862781 1015 1024 I-Procedure-Name
is NCT03862781 1025 1027 O
performed NCT03862781 1028 1037 O
in NCT03862781 1038 1040 O
addition NCT03862781 1041 1049 O
to NCT03862781 1050 1052 O
the NCT03862781 1053 1056 O
right NCT03862781 1057 1062 B-Procedure-Name
colectomy NCT03862781 1063 1072 I-Procedure-Name

Inclusion NCT03863886 0 9 O
Criteria NCT03863886 10 18 O
: NCT03863886 19 20 O

- NCT03863886 24 25 O
Adults NCT03863886 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03863886 34 42 O
≥ NCT03863886 43 44 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03863886 46 48 B-Eq-Value
years NCT03863886 49 54 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03863886 55 57 O
age NCT03863886 58 61 O
with NCT03863886 62 66 O
CD NCT03863886 67 69 B-Condition-Name
with NCT03863886 70 74 O
at NCT03863886 75 77 O
least NCT03863886 78 83 O
colonic NCT03863886 84 91 B-Condition-Name
involvement NCT03863886 92 103 I-Condition-Name
, NCT03863886 104 105 O
UC NCT03863886 106 108 B-Condition-Name
, NCT03863886 109 110 O
or NCT03863886 111 113 O
non NCT03863886 114 117 O
- NCT03863886 118 119 O
IBD NCT03863886 120 123 B-Condition-Name
controls NCT03863886 124 132 O
who NCT03863886 133 136 O
have NCT03863886 137 141 O
been NCT03863886 142 146 O
referred NCT03863886 147 155 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03863886 156 159 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
colonoscopy NCT03863886 160 171 B-Procedure-Name
for NCT03863886 172 175 O
clinical NCT03863886 176 184 O
reasons NCT03863886 185 192 O
. NCT03863886 193 194 O
The NCT03863886 196 199 O
clinical NCT03863886 200 208 O
reasons NCT03863886 209 216 O
may NCT03863886 217 220 O
include NCT03863886 221 228 O
colorectal NCT03863886 229 239 B-Procedure-Name
cancer NCT03863886 240 246 I-Procedure-Name
screening NCT03863886 247 256 I-Procedure-Name
, NCT03863886 257 258 O
surveillance NCT03863886 259 271 B-Observation-Name
, NCT03863886 272 273 O
diagnostic NCT03863886 274 284 O
for NCT03863886 285 288 O
CD NCT03863886 289 291 B-Condition-Name
or NCT03863886 292 294 O
UC NCT03863886 295 297 B-Condition-Name
flare NCT03863886 298 303 O
, NCT03863886 304 305 O
or NCT03863886 306 308 O
gastrointestinal NCT03863886 309 325 B-Condition-Name
symptoms NCT03863886 326 334 O
. NCT03863886 335 336 O

Exclusion NCT03863886 338 347 O
Criteria NCT03863886 348 356 O
: NCT03863886 357 358 O

- NCT03863886 362 363 O
Pregnant NCT03863886 365 373 B-Condition-Name
patients NCT03863886 374 382 O
. NCT03863886 383 384 O

- NCT03863886 388 389 O
Patients NCT03863886 391 399 O
with NCT03863886 400 404 O
known NCT03863886 405 410 O
current NCT03863886 411 418 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
colorectal NCT03863886 419 429 O
cancer NCT03863886 430 436 B-Condition-Name
, NCT03863886 437 438 O
infectious NCT03863886 439 449 B-Condition-Name
colitis NCT03863886 450 457 I-Condition-Name
, NCT03863886 458 459 O
diverticulitis NCT03863886 460 474 B-Condition-Name
, NCT03863886 475 476 O
or NCT03863886 477 479 O
microscopic NCT03863886 480 491 B-Condition-Name
colitis NCT03863886 492 499 I-Condition-Name
. NCT03863886 500 501 O

- NCT03863886 505 506 O
Patients NCT03863886 508 516 O
who NCT03863886 517 520 O
have NCT03863886 521 525 O
undergone NCT03863886 526 535 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgery NCT03863886 536 543 B-Procedure-Name
involving NCT03863886 544 553 O
the NCT03863886 554 557 O
cecum NCT03863886 558 563 O
or NCT03863886 564 566 O
rectum NCT03863886 567 573 O
. NCT03863886 574 575 O

Inclusion NCT03866083 0 9 O
Criteria NCT03866083 10 18 O
: NCT03866083 19 20 O

- NCT03866083 23 24 O
Critically NCT03866083 25 35 B-Severity___Severity-Value:severe
ill NCT03866083 36 39 O
cirrhotics NCT03866083 40 50 B-Condition-Name
with NCT03866083 51 55 O
early NCT03866083 56 61 O
onset NCT03866083 62 67 O
septic NCT03866083 68 74 B-Condition-Name
shock NCT03866083 75 80 I-Condition-Name
( NCT03866083 81 82 O
< NCT03866083 84 85 B-Eq-Operator___Eq-Operator-Value:LT
24 NCT03866083 87 89 B-Eq-Value
hours NCT03866083 90 95 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
) NCT03866083 96 97 O
with NCT03866083 98 102 O
norepinephrine NCT03866083 103 117 B-Drug-Name

of NCT03866083 118 120 O
more NCT03866083 121 125 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866083 126 130 I-Eq-Operator___Eq-Operator-Value:GT
10 NCT03866083 132 134 B-Eq-Value
ug NCT03866083 135 137 B-Eq-Unit
/ NCT03866083 138 139 O
min NCT03866083 140 143 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
and NCT03866083 144 147 O
lactate NCT03866083 148 155 B-Observation-Name___Observation-Type-Value:lab
> NCT03866083 156 157 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03866083 159 160 B-Eq-Value
mmol NCT03866083 161 165 B-Eq-Unit
/ NCT03866083 166 167 O
L NCT03866083 168 169 B-Eq-Unit
. NCT03866083 170 171 O

Exclusion NCT03866083 173 182 O
Criteria NCT03866083 183 191 O
: NCT03866083 192 193 O

- NCT03866083 197 198 O
Patients NCT03866083 200 208 O
with NCT03866083 209 213 O
age NCT03866083 214 217 O
less NCT03866083 218 222 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03866083 223 227 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03866083 229 231 B-Eq-Value
years NCT03866083 232 237 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03866083 240 241 O
Severe NCT03866083 243 249 B-Severity___Severity-Value:severe
known NCT03866083 250 255 O
cardiopulmonary NCT03866083 256 271 B-Condition-Name
disease NCT03866083 272 279 I-Condition-Name
( NCT03866083 280 281 O
structural NCT03866083 282 292 O
or NCT03866083 293 295 O
valvular NCT03866083 296 304 O
heart NCT03866083 305 310 B-Condition-Name
disease NCT03866083 311 318 I-Condition-Name
, NCT03866083 319 320 O
coronary NCT03866083 321 329 B-Condition-Name
artery NCT03866083 330 336 I-Condition-Name
disease NCT03866083 337 344 I-Condition-Name
, NCT03866083 345 346 O
COPD NCT03866083 347 351 B-Condition-Name
) NCT03866083 352 353 O

- NCT03866083 357 358 O
Severe NCT03866083 360 366 B-Severity___Severity-Value:severe
coagulopathy NCT03866083 367 379 B-Condition-Name
platelets NCT03866083 380 389 B-Observation-Name___Observation-Type-Value:lab
< NCT03866083 390 391 B-Eq-Operator___Eq-Operator-Value:LT
20 NCT03866083 393 395 B-Eq-Value
, NCT03866083 396 397 I-Eq-Value
000 NCT03866083 398 401 I-Eq-Value
and NCT03866083 402 405 O
INR NCT03866083 406 409 B-Observation-Name___Observation-Type-Value:lab
> NCT03866083 410 411 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03866083 413 414 B-Eq-Value

- NCT03866083 418 419 O
Active NCT03866083 421 427 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Bleed NCT03866083 428 433 B-Condition-Name
( NCT03866083 434 435 O
Mucosal NCT03866083 436 443 O
or NCT03866083 444 446 O
variceal NCT03866083 447 455 O
) NCT03866083 456 457 O

- NCT03866083 461 462 O
Pregnancy NCT03866083 464 473 B-Condition-Name

- NCT03866083 476 477 O
Chronic NCT03866083 479 486 O
kidney NCT03866083 487 493 B-Condition-Name
disease NCT03866083 494 501 I-Condition-Name

- NCT03866083 504 505 O
Extremely NCT03866083 507 516 O
moribund NCT03866083 517 525 O
patients NCT03866083 526 534 O
with NCT03866083 535 539 O
an NCT03866083 540 542 O
expected NCT03866083 543 551 O
life NCT03866083 552 556 B-Observation-Name
expectancy NCT03866083 557 567 I-Observation-Name
of NCT03866083 568 570 O
less NCT03866083 571 575 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03866083 576 580 I-Eq-Operator___Eq-Operator-Value:LT
24 NCT03866083 582 584 B-Eq-Value
hours NCT03866083 585 590 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

- NCT03866083 593 594 O
Failure NCT03866083 596 603 O
to NCT03866083 604 606 O
give NCT03866083 607 611 O
informed NCT03866083 612 620 O
consent NCT03866083 621 628 O
from NCT03866083 629 633 O
family NCT03866083 634 640 O
members NCT03866083 641 648 O
. NCT03866083 649 650 O

- NCT03866083 654 655 O
Hemodynamic NCT03866083 657 668 B-Condition-Name
instability NCT03866083 669 680 I-Condition-Name
requiring NCT03866083 681 690 O
very NCT03866083 691 695 O
high NCT03866083 696 700 B-Polarity___Polarity-Value:high
dose NCT03866083 701 705 O
of NCT03866083 706 708 O
vasopressors NCT03866083 709 721 B-Drug-Name
, NCT03866083 722 723 O
late NCT03866083 724 728 O
presentation NCT03866083 729 741 O
or NCT03866083 742 744 O
spontaneous NCT03866083 745 756 O
reversal NCT03866083 757 765 O
of NCT03866083 766 768 O
shock NCT03866083 769 774 B-Condition-Name

- NCT03866083 777 778 O
Patient NCT03866083 780 787 O
enrolled NCT03866083 788 796 O
in NCT03866083 797 799 O
other NCT03866083 800 805 O
clinical NCT03866083 806 814 O
trials NCT03866083 815 821 O

Inclusion NCT03868904 0 9 O
Criteria NCT03868904 10 18 O
: NCT03868904 19 20 O

- NCT03868904 24 25 O
Participant NCT03868904 27 38 O
in NCT03868904 39 41 O
TransMedics NCT03868904 42 53 O
OCS NCT03868904 54 57 O
Lung NCT03868904 58 62 O
System NCT03868904 63 69 O
INSPIRE NCT03868904 70 77 O
trial NCT03868904 78 83 O

Exclusion NCT03868904 84 93 O
Criteria NCT03868904 94 102 O
: NCT03868904 103 104 O

- NCT03868904 108 109 O
None NCT03868904 111 115 O

Inclusion NCT03866915 0 9 O
Criteria NCT03866915 10 18 O
: NCT03866915 19 20 O

- NCT03866915 24 25 O
All NCT03866915 27 30 O
patients NCT03866915 31 39 O
older NCT03866915 40 45 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03866915 46 50 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03866915 52 54 B-Eq-Value
years NCT03866915 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
undergoing NCT03866915 61 71 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03866915 72 80 O
surgery NCT03866915 81 88 B-Procedure-Name
that NCT03866915 89 93 O
receive NCT03866915 94 101 O
a NCT03866915 102 103 O
pre NCT03866915 104 107 O
operative NCT03866915 108 117 O
visit NCT03866915 118 123 O
by NCT03866915 124 126 O
anesthesiologists NCT03866915 127 144 B-Provider-Type
. NCT03866915 145 146 O

Exclusion NCT03866915 148 157 O
Criteria NCT03866915 158 166 O
: NCT03866915 167 168 O

- NCT03866915 172 173 O
Patients NCT03866915 175 183 O
undergoing NCT03866915 184 194 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
emergency NCT03866915 195 204 B-Procedure-Name
surgery NCT03866915 205 212 I-Procedure-Name

- NCT03866915 220 221 O
Patients NCT03866915 223 231 O
under NCT03866915 232 237 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03866915 239 241 B-Eq-Value
years NCT03866915 242 247 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03866915 248 250 O
age NCT03866915 251 254 O

- NCT03866915 262 263 O
Patients NCT03866915 265 273 O
who NCT03866915 274 277 O
refuse NCT03866915 278 284 O
to NCT03866915 285 287 O
participate NCT03866915 288 299 O

- NCT03866915 307 308 O
Patients NCT03866915 310 318 O
unable NCT03866915 319 325 O
to NCT03866915 326 328 O
perform NCT03866915 329 336 O
the NCT03866915 337 340 O
6 NCT03866915 342 343 B-Observation-Name
MWT NCT03866915 344 347 I-Observation-Name

- NCT03866915 355 356 O
Claudication NCT03866915 358 370 B-Condition-Name
of NCT03866915 371 373 I-Condition-Name
the NCT03866915 374 377 I-Condition-Name
lower NCT03866915 378 383 I-Condition-Name
extremities NCT03866915 384 395 I-Condition-Name
and NCT03866915 396 399 O
inability NCT03866915 400 409 O
to NCT03866915 410 412 O
maintain NCT03866915 413 421 O
a NCT03866915 422 423 O
constant NCT03866915 424 432 B-Stability___Stability-Value:stable
pace NCT03866915 433 437 B-Observation-Name
of NCT03866915 438 440 I-Observation-Name
walking NCT03866915 441 448 I-Observation-Name
on NCT03866915 449 451 O
level NCT03866915 452 457 O
ground NCT03866915 458 464 O

Inclusion NCT03869398 0 9 O
Criteria NCT03869398 10 18 O
: NCT03869398 19 20 O

- NCT03869398 24 25 O
All NCT03869398 27 30 O
patients NCT03869398 31 39 O
, NCT03869398 40 41 O
age NCT03869398 42 45 O
> NCT03869398 46 47 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03869398 49 51 B-Eq-Value
, NCT03869398 52 53 O
undergoing NCT03869398 54 64 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
total NCT03869398 65 70 B-Procedure-Name
thyroidectomy NCT03869398 71 84 I-Procedure-Name
are NCT03869398 85 88 O
eligible NCT03869398 89 97 O
. NCT03869398 98 99 O

Exclusion NCT03869398 101 110 O
Criteria NCT03869398 111 119 O
: NCT03869398 120 121 O

- NCT03869398 125 126 O
partial NCT03869398 128 135 B-Procedure-Name
thyroidectomy NCT03869398 136 149 I-Procedure-Name
, NCT03869398 150 151 O
lobectomy NCT03869398 152 161 B-Procedure-Name
, NCT03869398 162 163 O
or NCT03869398 164 166 O
concurrent NCT03869398 167 177 O
parathyroidectomy NCT03869398 178 195 B-Procedure-Name
. NCT03869398 196 197 O

Inclusion NCT03867968 0 9 O
Criteria NCT03867968 10 18 O
: NCT03867968 19 20 O

- NCT03867968 24 25 O
Adult NCT03867968 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
18 NCT03867968 34 36 B-Eq-Value
years NCT03867968 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867968 43 46 O
or NCT03867968 47 49 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03867968 50 55 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03867968 58 59 O
Have NCT03867968 61 65 O
a NCT03867968 66 67 O
child NCT03867968 68 73 O
age NCT03867968 74 77 O
3 NCT03867968 79 80 B-Eq-Value
- NCT03867968 81 82 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03867968 84 86 B-Eq-Value
that NCT03867968 87 91 O
was NCT03867968 92 95 O
hospitalized NCT03867968 96 108 B-Encounter-Type___Encounter-Type-Value:inpatient
overnight NCT03867968 109 118 O
with NCT03867968 119 123 O
a NCT03867968 124 125 O
traumatic NCT03867968 126 135 B-Condition-Name
brain NCT03867968 136 141 I-Condition-Name
injury NCT03867968 142 148 I-Condition-Name
( NCT03867968 149 150 O
TBI NCT03867968 151 154 B-Condition-Name
) NCT03867968 155 156 O
. NCT03867968 158 159 O

- NCT03867968 163 164 O
Involved NCT03867968 166 174 O
in NCT03867968 175 177 O
the NCT03867968 178 181 O
care NCT03867968 182 186 O
and NCT03867968 187 190 O
support NCT03867968 191 198 O
of NCT03867968 199 201 O
the NCT03867968 202 205 O
child NCT03867968 206 211 O
with NCT03867968 212 216 O
the NCT03867968 217 220 O
TBI NCT03867968 221 224 B-Condition-Name
. NCT03867968 225 226 O

- NCT03867968 230 231 O
Live NCT03867968 233 237 O
in NCT03867968 238 240 O
the NCT03867968 241 244 O
same NCT03867968 245 249 O
household NCT03867968 250 259 O
as NCT03867968 260 262 O
child NCT03867968 263 268 O
with NCT03867968 269 273 O
a NCT03867968 274 275 O
TBI NCT03867968 276 279 B-Condition-Name
. NCT03867968 280 281 O

- NCT03867968 285 286 O
The NCT03867968 288 291 O
child NCT03867968 292 297 O
with NCT03867968 298 302 O
the NCT03867968 303 306 O
TBI NCT03867968 307 310 B-Condition-Name
is NCT03867968 311 313 O
able NCT03867968 314 318 O
to NCT03867968 319 321 O
follow NCT03867968 322 328 O
simple NCT03867968 329 335 O
instructions NCT03867968 336 348 O
such NCT03867968 349 353 O
as NCT03867968 354 356 O
" NCT03867968 357 358 O
please NCT03867968 358 364 O
eat NCT03867968 365 368 O
your NCT03867968 369 373 O
toast NCT03867968 374 379 O
. NCT03867968 380 381 O
" NCT03867968 382 383 O

Exclusion NCT03867968 384 393 O
Criteria NCT03867968 394 402 O
: NCT03867968 403 404 O

- NCT03867968 408 409 O
Does NCT03867968 411 415 O
not NCT03867968 416 419 O
speak NCT03867968 420 425 O
and NCT03867968 426 429 O
read NCT03867968 430 434 O
English NCT03867968 435 442 B-Language
. NCT03867968 443 444 O

- NCT03867968 448 449 O
Does NCT03867968 451 455 O
not NCT03867968 456 459 O
have NCT03867968 460 464 O
high NCT03867968 465 469 O
speed NCT03867968 470 475 O
Internet NCT03867968 476 484 O
access NCT03867968 485 491 O
. NCT03867968 492 493 O

- NCT03867968 497 498 O
Not NCT03867968 500 503 O
US NCT03867968 504 506 B-Location___Location-Value:residence
resident NCT03867968 507 515 O

Inclusion NCT03866486 0 9 O
Criteria NCT03866486 10 18 O
: NCT03866486 19 20 O

- NCT03866486 24 25 O
1 NCT03866486 28 29 O
. NCT03866486 29 30 O
The NCT03866486 32 35 O
patients NCT03866486 36 44 O
who NCT03866486 45 48 O
enrolled NCT03866486 49 57 O
in NCT03866486 58 60 O
the NCT03866486 61 64 O
XPL NCT03866486 65 68 O
- NCT03866486 69 70 O
IVUS NCT03866486 71 75 O
study NCT03866486 76 81 O
. NCT03866486 82 83 O

- NCT03866486 87 88 O
2 NCT03866486 91 92 O
. NCT03866486 92 93 O
Provision NCT03866486 95 104 O
of NCT03866486 105 107 O
informed NCT03866486 108 116 O
consent NCT03866486 117 124 O

Exclusion NCT03866486 125 134 O
Criteria NCT03866486 135 143 O
: NCT03866486 144 145 O

- NCT03866486 149 150 O
1 NCT03866486 153 154 O
. NCT03866486 154 155 O
This NCT03866486 157 161 O
observational NCT03866486 162 175 O
study NCT03866486 176 181 O
does NCT03866486 182 186 O
not NCT03866486 187 190 O
have NCT03866486 191 195 O
any NCT03866486 196 199 O
specific NCT03866486 200 208 O
exclusion NCT03866486 209 218 O
criteria NCT03866486 219 227 O
. NCT03866486 228 229 O

Inclusion NCT03868332 0 9 O
Criteria NCT03868332 10 18 O
: NCT03868332 19 20 O

Patients NCT03868332 22 30 O
who NCT03868332 31 34 O
are NCT03868332 35 38 O
diagnosed NCT03868332 39 48 O
as NCT03868332 49 51 O
ulcerative NCT03868332 52 62 B-Condition-Name
colitis NCT03868332 63 70 I-Condition-Name
/ NCT03868332 71 72 O
Crhon NCT03868332 73 78 B-Condition-Name
s NCT03868332 79 80 I-Condition-Name
disease NCT03868332 81 88 I-Condition-Name
however NCT03868332 89 96 O
in NCT03868332 97 99 O
activity NCT03868332 100 108 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03868332 109 111 O

in NCT03868332 112 114 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
remission NCT03868332 115 124 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
attending NCT03868332 125 134 O
the NCT03868332 135 138 O
the NCT03868332 139 142 O
outpatient NCT03868332 143 153 B-Encounter-Type___Encounter-Type-Value:outpatient
clinics NCT03868332 154 161 B-Location___Location-Value:clinic
and NCT03868332 162 165 O
inpatient NCT03868332 166 175 B-Encounter-Type___Encounter-Type-Value:inpatient
of NCT03868332 176 178 O
gastroenterology NCT03868332 179 195 B-Location___Location-Value:unit
units NCT03868332 196 201 I-Location___Location-Value:unit

of NCT03868332 202 204 O
Internal NCT03868332 205 213 O
medicine NCT03868332 214 222 O
department NCT03868332 223 233 O

Exclusion NCT03868332 234 243 O
Criteria NCT03868332 244 252 O
: NCT03868332 253 254 O

- NCT03868332 258 259 O
Previous NCT03868332 261 269 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03868332 270 277 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868332 278 280 O
hypertension NCT03868332 281 293 B-Condition-Name
, NCT03868332 294 295 O
diabetes NCT03868332 296 304 B-Condition-Name
mellitus NCT03868332 305 313 I-Condition-Name
, NCT03868332 314 315 O
Dyslipidemia NCT03868332 316 328 B-Condition-Name

- NCT03868332 331 332 O
Previous NCT03868332 334 342 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03868332 343 350 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03868332 351 353 O
cardiovascular NCT03868332 354 368 O
or NCT03868332 369 371 O
cerebrovascular NCT03868332 372 387 O
events NCT03868332 388 394 B-Condition-Name

- NCT03868332 397 398 O
Autoimmune NCT03868332 400 410 O
, NCT03868332 411 412 O
Neoplastic NCT03868332 413 423 O
diseases NCT03868332 424 432 B-Condition-Name

- NCT03868332 435 436 O
Thromboembolic NCT03868332 438 452 B-Condition-Name
diseases NCT03868332 453 461 I-Condition-Name

Inclusion NCT03867773 0 9 O
Criteria NCT03867773 10 18 O
: NCT03867773 19 20 O

- NCT03867773 24 25 O
Male NCT03867773 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03867773 32 34 O
female NCT03867773 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
; NCT03867773 41 42 O

- NCT03867773 45 46 O
body NCT03867773 48 52 B-Observation-Name___Observation-Type-Value:vital
mass NCT03867773 53 57 I-Observation-Name___Observation-Type-Value:vital
index NCT03867773 58 63 I-Observation-Name___Observation-Type-Value:vital
( NCT03867773 64 65 O
BMI NCT03867773 66 69 B-Observation-Name___Observation-Type-Value:vital
) NCT03867773 70 71 O
between NCT03867773 72 79 B-Eq-Operator___Eq-Operator-Value:BETWEEN
30.0 NCT03867773 81 85 B-Eq-Value
and NCT03867773 86 89 O
49.9 NCT03867773 91 95 B-Eq-Value
kg NCT03867773 96 98 B-Eq-Unit
/ NCT03867773 99 100 O
m NCT03867773 101 102 B-Eq-Unit
2 NCT03867773 103 104 I-Eq-Unit
; NCT03867773 104 105 O

- NCT03867773 108 109 O
age NCT03867773 111 114 O
between NCT03867773 115 122 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03867773 124 126 B-Eq-Value
and NCT03867773 127 130 O
65 NCT03867773 132 134 B-Eq-Value
years NCT03867773 135 140 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03867773 140 141 O
sedentary NCT03867773 142 151 B-Observation-Name___Observation-Type-Value:social-habit
( NCT03867773 152 153 O
light NCT03867773 154 159 B-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03867773 160 168 I-Observation-Name___Observation-Type-Value:social-habit
less NCT03867773 169 173 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03867773 174 178 I-Eq-Operator___Eq-Operator-Value:LT
1 NCT03867773 180 181 B-Eq-Value
h NCT03867773 182 183 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
per NCT03867773 184 187 O
week NCT03867773 188 192 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03867773 193 194 O
or NCT03867773 195 197 O
moderately NCT03867773 198 208 B-Observation-Name___Observation-Type-Value:social-habit
active NCT03867773 209 215 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03867773 216 217 O
moderate NCT03867773 218 226 B-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03867773 227 235 I-Observation-Name___Observation-Type-Value:social-habit
1 NCT03867773 237 238 B-Eq-Value
to NCT03867773 239 241 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03867773 243 244 B-Eq-Value
h NCT03867773 245 246 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
per NCT03867773 247 250 O
week NCT03867773 251 255 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03867773 256 257 O
; NCT03867773 258 259 O

- NCT03867773 262 263 O
weight NCT03867773 265 271 B-Observation-Name___Observation-Type-Value:vital
stable NCT03867773 272 278 B-Stability___Stability-Value:stable
for NCT03867773 279 282 O
> NCT03867773 283 284 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03867773 286 287 B-Eq-Value
months NCT03867773 288 294 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03867773 295 300 O
to NCT03867773 301 303 O
the NCT03867773 304 307 O
beginning NCT03867773 308 317 O
of NCT03867773 318 320 O
the NCT03867773 321 324 O
study NCT03867773 325 330 O
( NCT03867773 331 332 O
gain NCT03867773 333 337 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
or NCT03867773 338 340 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
loss NCT03867773 341 345 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
< NCT03867773 346 347 B-Eq-Operator___Eq-Operator-Value:LT
4 NCT03867773 349 350 B-Eq-Value
kg NCT03867773 351 353 B-Eq-Unit
) NCT03867773 354 355 O
; NCT03867773 356 357 O

- NCT03867773 360 361 O
able NCT03867773 363 367 O
to NCT03867773 368 370 O
give NCT03867773 371 375 O
written NCT03867773 376 383 O
informed NCT03867773 384 392 O
consent NCT03867773 393 400 O

Exclusion NCT03867773 401 410 O
Criteria NCT03867773 411 419 O
: NCT03867773 420 421 O

- NCT03867773 425 426 O
Smoker NCT03867773 428 434 B-Condition-Name
; NCT03867773 434 435 O
diabetic NCT03867773 436 444 B-Condition-Name
; NCT03867773 444 445 O

- NCT03867773 448 449 O
history NCT03867773 451 458 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867773 459 461 O
alcohol NCT03867773 462 469 B-Condition-Name
dependance NCT03867773 470 480 I-Condition-Name
( NCT03867773 481 482 O
score NCT03867773 483 488 B-Eq-Unit
> NCT03867773 489 490 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03867773 492 494 B-Eq-Value
from NCT03867773 495 499 O
Alcohol NCT03867773 500 507 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
and NCT03867773 508 511 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Health NCT03867773 512 518 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03867773 519 532 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
8 NCT03867773 534 535 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03867773 536 537 O
; NCT03867773 538 539 O

- NCT03867773 542 543 O
taking NCT03867773 545 551 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
weight NCT03867773 552 558 B-Drug-Name
loss NCT03867773 559 563 I-Drug-Name
medications NCT03867773 564 575 I-Drug-Name
; NCT03867773 575 576 O

- NCT03867773 579 580 O
taking NCT03867773 582 588 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03867773 589 599 B-Drug-Name
that NCT03867773 600 604 O
requires NCT03867773 605 613 O
eating NCT03867773 614 620 B-Observation-Name___Observation-Type-Value:social-habit
food NCT03867773 621 625 I-Observation-Name___Observation-Type-Value:social-habit
before NCT03867773 626 632 O
( NCT03867773 633 634 O
or NCT03867773 635 637 O
with NCT03867773 638 642 O
) NCT03867773 643 644 O
the NCT03867773 645 648 O
medication NCT03867773 649 659 O
; NCT03867773 659 660 O
history NCT03867773 661 668 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03867773 669 671 O
eating NCT03867773 672 678 B-Condition-Name
disorders NCT03867773 679 688 I-Condition-Name
; NCT03867773 688 689 O

- NCT03867773 692 693 O
night NCT03867773 695 700 O
- NCT03867773 701 702 O
shift NCT03867773 703 708 O
workers NCT03867773 709 716 O
; NCT03867773 716 717 O

- NCT03867773 720 721 O
perimenopausal NCT03867773 723 737 B-Condition-Name
; NCT03867773 737 738 O

- NCT03867773 741 742 O
pregnant NCT03867773 744 752 B-Condition-Name
women NCT03867773 753 758 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

Inclusion NCT03865602 0 9 O
Criteria NCT03865602 10 18 O
: NCT03865602 19 20 O

1 NCT03865602 25 26 O
. NCT03865602 26 27 O
Admitted NCT03865602 29 37 O
from NCT03865602 38 42 O
the NCT03865602 43 46 O
emergency NCT03865602 47 56 B-Encounter-Type___Encounter-Type-Value:emergency
department NCT03865602 57 67 O
to NCT03865602 68 70 O
inpatient NCT03865602 71 80 B-Encounter-Type___Encounter-Type-Value:inpatient
or NCT03865602 81 83 O
observation NCT03865602 84 95 B-Encounter-Type___Encounter-Type-Value:observation
status NCT03865602 96 102 O
at NCT03865602 103 105 O
one NCT03865602 106 109 O
of NCT03865602 110 112 O
: NCT03865602 113 114 O

Carolinas NCT03865602 121 130 B-Location___Location-Value:hospital
Medical NCT03865602 131 138 I-Location___Location-Value:hospital
Center NCT03865602 139 145 I-Location___Location-Value:hospital
, NCT03865602 146 147 O
Carolinas NCT03865602 148 157 B-Location___Location-Value:hospital
Medical NCT03865602 158 165 I-Location___Location-Value:hospital
Center NCT03865602 166 172 I-Location___Location-Value:hospital
- NCT03865602 173 174 I-Location___Location-Value:hospital
Mercy NCT03865602 175 180 I-Location___Location-Value:hospital
, NCT03865602 181 182 O
or NCT03865602 183 185 O
Atrium NCT03865602 186 192 B-Location___Location-Value:hospital
Health NCT03865602 193 199 I-Location___Location-Value:hospital
Northeast NCT03865602 200 209 I-Location___Location-Value:hospital
; NCT03865602 209 210 O

2 NCT03865602 214 215 O
. NCT03865602 215 216 O
≥ NCT03865602 218 219 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03865602 221 223 B-Eq-Value
years NCT03865602 224 229 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03865602 230 232 O
age NCT03865602 233 236 O
upon NCT03865602 237 241 O
admission NCT03865602 242 251 B-Encounter-Type___Encounter-Type-Value:inpatient
; NCT03865602 251 252 O

3 NCT03865602 256 257 O
. NCT03865602 257 258 O
oral NCT03865602 260 264 O
/ NCT03865602 265 266 O
parenteral NCT03865602 267 277 O
antibiotic NCT03865602 278 288 B-Drug-Name
or NCT03865602 289 291 O
bacterial NCT03865602 292 301 B-Observation-Name___Observation-Type-Value:lab
culture NCT03865602 302 309 I-Observation-Name___Observation-Type-Value:lab
order NCT03865602 310 315 O
within NCT03865602 316 322 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03865602 324 326 B-Eq-Value
hours NCT03865602 327 332 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03865602 333 335 O
emergency NCT03865602 336 345 B-Encounter-Type___Encounter-Type-Value:emergency
department NCT03865602 346 356 O
presentation NCT03865602 357 369 O
and NCT03865602 370 373 O

1 NCT03865602 382 383 O
. NCT03865602 383 384 O
culture NCT03865602 386 393 B-Observation-Name___Observation-Type-Value:lab
drawn NCT03865602 394 399 O
first NCT03865602 400 405 O
, NCT03865602 406 407 O
antibiotics NCT03865602 408 419 B-Drug-Name
ordered NCT03865602 420 427 O
within NCT03865602 428 434 B-Eq-Operator___Eq-Operator-Value:LTEQ
48 NCT03865602 436 438 B-Eq-Value
hours NCT03865602 439 444 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
or NCT03865602 445 447 O

2 NCT03865602 456 457 O
. NCT03865602 457 458 O
antibiotics NCT03865602 460 471 B-Drug-Name
ordered NCT03865602 472 479 O
first NCT03865602 480 485 O
, NCT03865602 486 487 O
culture NCT03865602 488 495 B-Observation-Name___Observation-Type-Value:lab
ordered NCT03865602 496 503 O
within NCT03865602 504 510 B-Eq-Operator___Eq-Operator-Value:LTEQ
48 NCT03865602 512 514 B-Eq-Value
hours NCT03865602 515 520 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
( NCT03865602 521 522 O
adapted NCT03865602 523 530 O
from NCT03865602 531 535 O
criteria NCT03865602 536 544 O
applied NCT03865602 545 552 O
in NCT03865602 553 555 O
development NCT03865602 556 567 O
of NCT03865602 568 570 O
the NCT03865602 571 574 O
Third NCT03865602 575 580 O
International NCT03865602 581 594 O
Consensus NCT03865602 595 604 O
Definitions NCT03865602 605 616 O
for NCT03865602 617 620 O
Sepsis NCT03865602 621 627 O
and NCT03865602 628 631 O
Septic NCT03865602 632 638 O
Shock NCT03865602 639 644 O
) NCT03865602 645 646 O

4 NCT03865602 651 652 O
. NCT03865602 652 653 O
deemed NCT03865602 655 661 O
as NCT03865602 662 664 O
high NCT03865602 665 669 O
- NCT03865602 670 671 O
risk NCT03865602 672 676 O
for NCT03865602 677 680 O
30 NCT03865602 682 684 B-Eq-Value
- NCT03865602 685 686 O
day NCT03865602 687 690 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
readmission NCT03865602 691 702 B-Encounter-Type___Encounter-Type-Value:readmission
( NCT03865602 703 704 O
i NCT03865602 705 706 O
. NCT03865602 707 708 O
e NCT03865602 709 710 O
. NCT03865602 711 712 O
, NCT03865602 713 714 O
≥ NCT03865602 715 716 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03865602 718 720 B-Eq-Value
% NCT03865602 721 722 B-Eq-Unit
) NCT03865602 724 725 O
or NCT03865602 726 728 O
30 NCT03865602 730 732 B-Eq-Value
- NCT03865602 733 734 O
day NCT03865602 735 738 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
mortality NCT03865602 739 748 O
( NCT03865602 749 750 O
i NCT03865602 751 752 O
. NCT03865602 753 754 O
e NCT03865602 755 756 O
. NCT03865602 757 758 O
, NCT03865602 759 760 O
≥ NCT03865602 761 762 B-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03865602 764 766 B-Eq-Value
% NCT03865602 767 768 B-Eq-Unit
) NCT03865602 770 771 O
using NCT03865602 772 777 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
risk NCT03865602 778 782 B-Observation-Name
- NCT03865602 783 784 I-Observation-Name
scoring NCT03865602 785 792 I-Observation-Name
models NCT03865602 793 799 I-Observation-Name

5 NCT03865602 803 804 O
. NCT03865602 804 805 O
not NCT03865602 807 810 O
discharged NCT03865602 811 821 B-Encounter-Type___Encounter-Type-Value:discharge
at NCT03865602 822 824 O
the NCT03865602 825 828 O
time NCT03865602 829 833 O
of NCT03865602 834 836 O
patient NCT03865602 837 844 O
list NCT03865602 845 849 O
generation NCT03865602 850 860 O

Exclusion NCT03865602 861 870 O
Criteria NCT03865602 871 879 O
: NCT03865602 880 881 O

1 NCT03865602 886 887 O
. NCT03865602 887 888 O
prior NCT03865602 890 895 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
randomization NCT03865602 896 909 O
to NCT03865602 910 912 O
either NCT03865602 913 919 O
STAR NCT03865602 920 924 O
or NCT03865602 925 927 O
usual NCT03865602 928 933 O
care NCT03865602 934 938 O
study NCT03865602 939 944 O
arms NCT03865602 945 949 O
; NCT03865602 949 950 O

2 NCT03865602 954 955 O
. NCT03865602 955 956 O
not NCT03865602 958 961 O
a NCT03865602 962 963 O
North NCT03865602 964 969 B-Location___Location-Value:residence
Carolina NCT03865602 970 978 I-Location___Location-Value:residence
resident NCT03865602 979 987 O
or NCT03865602 988 990 O
residence NCT03865602 991 1000 O
> NCT03865602 1001 1002 B-Eq-Operator___Eq-Operator-Value:GT
2.5 NCT03865602 1004 1007 B-Eq-Value
- NCT03865602 1008 1009 O
hour NCT03865602 1010 1014 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
drive NCT03865602 1015 1020 B-Observation-Name
time NCT03865602 1021 1025 I-Observation-Name
from NCT03865602 1026 1030 O
treating NCT03865602 1031 1039 O
hospital NCT03865602 1040 1048 B-Location___Location-Value:hospital
; NCT03865602 1048 1049 O

3 NCT03865602 1053 1054 O
. NCT03865602 1054 1055 O
the NCT03865602 1057 1060 O
only NCT03865602 1061 1065 O
antibiotic NCT03865602 1066 1076 B-Drug-Name
associated NCT03865602 1077 1087 O
with NCT03865602 1088 1092 O
patient NCT03865602 1093 1100 O
is NCT03865602 1101 1103 O
administered NCT03865602 1104 1116 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03865602 1117 1119 O
the NCT03865602 1120 1123 O
operating NCT03865602 1124 1133 B-Location___Location-Value:room
room NCT03865602 1134 1138 I-Location___Location-Value:room
as NCT03865602 1139 1141 O
this NCT03865602 1142 1146 O
likely NCT03865602 1147 1153 O
represents NCT03865602 1154 1164 O
pre NCT03865602 1165 1168 O
- NCT03865602 1169 1170 O
operative NCT03865602 1171 1180 O
infection NCT03865602 1181 1190 B-Condition-Name
prophylaxis NCT03865602 1191 1202 O
and NCT03865602 1203 1206 O
not NCT03865602 1207 1210 O
presumed NCT03865602 1211 1219 O
infection NCT03865602 1220 1229 B-Condition-Name
; NCT03865602 1229 1230 O

4 NCT03865602 1234 1235 O
. NCT03865602 1235 1236 O
patients NCT03865602 1238 1246 O
transferred NCT03865602 1247 1258 B-Encounter-Type___Encounter-Type-Value:transfer
from NCT03865602 1259 1263 O
other NCT03865602 1264 1269 O
acute NCT03865602 1270 1275 B-Location___Location-Value:hospital
care NCT03865602 1276 1280 I-Location___Location-Value:hospital
hospitals NCT03865602 1281 1290 I-Location___Location-Value:hospital
; NCT03865602 1290 1291 O

5 NCT03865602 1295 1296 O
. NCT03865602 1296 1297 O
patients NCT03865602 1299 1307 O
with NCT03865602 1308 1312 O
a NCT03865602 1313 1314 O
change NCT03865602 1315 1321 O
in NCT03865602 1322 1324 O
code NCT03865602 1325 1329 B-Observation-Name
status NCT03865602 1330 1336 I-Observation-Name
( NCT03865602 1337 1338 O
i NCT03865602 1339 1340 O
. NCT03865602 1341 1342 O
e NCT03865602 1343 1344 O
. NCT03865602 1345 1346 O
, NCT03865602 1347 1348 O
do NCT03865602 1349 1351 B-Observation-Name
not NCT03865602 1352 1355 I-Observation-Name
resuscitate NCT03865602 1356 1367 I-Observation-Name
, NCT03865602 1368 1369 O
do NCT03865602 1370 1372 B-Observation-Name
not NCT03865602 1373 1376 I-Observation-Name
intubate NCT03865602 1377 1385 I-Observation-Name
) NCT03865602 1386 1387 O
within NCT03865602 1388 1394 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03865602 1396 1398 B-Eq-Value
hours NCT03865602 1399 1404 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
after NCT03865602 1405 1410 O
admission NCT03865602 1411 1420 B-Encounter-Type___Encounter-Type-Value:inpatient
due NCT03865602 1421 1424 O
to NCT03865602 1425 1427 O
the NCT03865602 1428 1431 O
general NCT03865602 1432 1439 O
assumption NCT03865602 1440 1450 O
of NCT03865602 1451 1453 O
increased NCT03865602 1454 1463 O
risk NCT03865602 1464 1468 O
of NCT03865602 1469 1471 O
exposure NCT03865602 1472 1480 O
to NCT03865602 1481 1483 O
less NCT03865602 1484 1488 O
aggressive NCT03865602 1489 1499 O
treatment NCT03865602 1500 1509 O
; NCT03865602 1509 1510 O

6 NCT03865602 1514 1515 O
. NCT03865602 1515 1516 O
patients NCT03865602 1518 1526 O
with NCT03865602 1527 1531 O
infection NCT03865602 1532 1541 B-Condition-Name
ruled NCT03865602 1542 1547 O
out NCT03865602 1548 1551 O
during NCT03865602 1552 1558 O
the NCT03865602 1559 1562 O
index NCT03865602 1563 1568 O
hospitalization NCT03865602 1569 1584 B-Encounter-Type___Encounter-Type-Value:inpatient
. NCT03865602 1585 1586 O


Inclusion NCT03864939 0 9 O
Criteria NCT03864939 10 18 O
: NCT03864939 19 20 O

- NCT03864939 24 25 O
patients NCT03864939 27 35 O
with NCT03864939 36 40 O
localized NCT03864939 41 50 O
prostate NCT03864939 51 59 O
cancer NCT03864939 60 66 B-Condition-Name

- NCT03864939 69 70 O
indication NCT03864939 72 82 O
for NCT03864939 83 86 O
radical NCT03864939 87 94 B-Procedure-Name
prostatectomy NCT03864939 95 108 I-Procedure-Name

- NCT03864939 111 112 O
no NCT03864939 114 116 O
other NCT03864939 117 122 O
treatment NCT03864939 123 132 O
of NCT03864939 133 135 O
prostate NCT03864939 136 144 O
cancer NCT03864939 145 151 B-Condition-Name

- NCT03864939 154 155 O
availability NCT03864939 157 169 O
to NCT03864939 170 172 O
informed NCT03864939 173 181 O
consent NCT03864939 182 189 O

Exclusion NCT03864939 190 199 O
Criteria NCT03864939 200 208 O
: NCT03864939 209 210 O

- NCT03864939 214 215 O
pre NCT03864939 217 220 O
operative NCT03864939 221 230 O
incontinence NCT03864939 231 243 B-Condition-Name
( NCT03864939 244 245 O
24 NCT03864939 247 249 B-Observation-Name
hrs NCT03864939 250 253 I-Observation-Name
pad NCT03864939 254 257 I-Observation-Name
- NCT03864939 258 259 I-Observation-Name
test NCT03864939 260 264 I-Observation-Name
) NCT03864939 265 266 O

- NCT03864939 270 271 O
pre NCT03864939 273 276 O
operative NCT03864939 277 286 O
erectile NCT03864939 287 295 B-Condition-Name
dysfunction NCT03864939 296 307 I-Condition-Name
( NCT03864939 308 309 O
IIEF NCT03864939 310 314 B-Observation-Name
- NCT03864939 315 316 O
5 NCT03864939 318 319 B-Eq-Value
< NCT03864939 320 321 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03864939 323 325 B-Eq-Value
) NCT03864939 326 327 O

- NCT03864939 331 332 O
metastasized NCT03864939 334 346 O
or NCT03864939 347 349 O
locally NCT03864939 350 357 O
advanced NCT03864939 358 366 O
prostate NCT03864939 367 375 O
cancer NCT03864939 376 382 B-Condition-Name
in NCT03864939 383 385 O
pre NCT03864939 386 389 O
operative NCT03864939 390 399 O
assessment NCT03864939 400 410 B-Observation-Name

- NCT03864939 413 414 O
previous NCT03864939 416 424 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiation NCT03864939 425 434 B-Procedure-Name
of NCT03864939 435 437 O
pelvis NCT03864939 438 444 O

- NCT03864939 447 448 O
previous NCT03864939 450 458 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
prostate NCT03864939 459 467 O
cancer NCT03864939 468 474 B-Condition-Name
therapy NCT03864939 475 482 B-Procedure-Name

- NCT03864939 485 486 O
psychiatric NCT03864939 488 499 B-Condition-Name
disease NCT03864939 500 507 I-Condition-Name

- NCT03864939 510 511 O
participation NCT03864939 513 526 O
at NCT03864939 527 529 O
another NCT03864939 530 537 O
study NCT03864939 538 543 O

Inclusion NCT03868865 0 9 O
Criteria NCT03868865 10 18 O
: NCT03868865 19 20 O

- NCT03868865 24 25 O
curative NCT03868865 27 35 B-Condition-Name
malignancy NCT03868865 36 46 I-Condition-Name
( NCT03868865 47 48 O
breast NCT03868865 49 55 O
cancer NCT03868865 56 62 B-Condition-Name
of NCT03868865 63 65 O
TNM NCT03868865 66 69 O
( NCT03868865 70 71 O
T NCT03868865 72 73 O
: NCT03868865 74 75 O
primary NCT03868865 76 83 O
tumor NCT03868865 84 89 O
, NCT03868865 90 91 O
N NCT03868865 92 93 O
: NCT03868865 94 95 O
regional NCT03868865 96 104 O
nodes NCT03868865 105 110 O
, NCT03868865 111 112 O
M NCT03868865 113 114 O
: NCT03868865 115 116 O
metastasis NCT03868865 117 127 O
) NCT03868865 128 129 O
staging NCT03868865 130 137 B-Eq-Unit
I NCT03868865 138 139 B-Eq-Value
- NCT03868865 140 141 O
III NCT03868865 142 145 B-Eq-Value
) NCT03868865 146 147 O

- NCT03868865 151 152 O
receiving NCT03868865 154 163 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
chemotherapy NCT03868865 164 176 B-Procedure-Name

- NCT03868865 179 180 O
at NCT03868865 182 184 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03868865 185 190 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03868865 192 194 B-Eq-Value
years NCT03868865 195 200 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03868865 201 204 O

- NCT03868865 207 208 O
written NCT03868865 210 217 O
informed NCT03868865 218 226 O
consent NCT03868865 227 234 O

- NCT03868865 237 238 O
willing NCT03868865 240 247 O
and NCT03868865 248 251 O
physically NCT03868865 252 262 O
/ NCT03868865 263 264 O
mentally NCT03868865 265 273 O
able NCT03868865 274 278 O
to NCT03868865 279 281 O
participate NCT03868865 282 293 O
in NCT03868865 294 296 O
a NCT03868865 297 298 O
six NCT03868865 299 302 B-Eq-Value
hours NCT03868865 303 308 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
day NCT03868865 309 312 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
care NCT03868865 313 317 B-Observation-Name
clinic NCT03868865 318 324 I-Observation-Name
program NCT03868865 325 332 I-Observation-Name
eleven NCT03868865 333 339 B-Eq-Value
times NCT03868865 340 345 O
during NCT03868865 346 352 O
chemotherapy NCT03868865 353 365 B-Procedure-Name
. NCT03868865 366 367 O

Exclusion NCT03868865 369 378 O
Criteria NCT03868865 379 387 O
: NCT03868865 388 389 O

- NCT03868865 393 394 O
insufficient NCT03868865 396 408 O
knowledge NCT03868865 409 418 O
of NCT03868865 419 421 O
the NCT03868865 422 425 O
German NCT03868865 426 432 B-Language
language NCT03868865 433 441 O

- NCT03868865 444 445 O
physical NCT03868865 447 455 O
or NCT03868865 456 458 O
mental NCT03868865 459 465 O
disabilities NCT03868865 466 478 B-Condition-Name
resulting NCT03868865 479 488 O
in NCT03868865 489 491 O
ineligibility NCT03868865 492 505 O
for NCT03868865 506 509 O
participation NCT03868865 510 523 O
in NCT03868865 524 526 O
the NCT03868865 527 530 O
program NCT03868865 531 538 O
or NCT03868865 539 541 O
filling NCT03868865 542 549 O
out NCT03868865 550 553 O
the NCT03868865 554 557 O
questionnaires NCT03868865 558 572 O
. NCT03868865 573 574 O


Inclusion NCT03867565 0 9 O
Criteria NCT03867565 10 18 O
: NCT03867565 19 20 O

- NCT03867565 24 25 O
Minor NCT03867565 27 32 B-Condition-Name
burn NCT03867565 33 37 I-Condition-Name
, NCT03867565 38 39 O
TBSA NCT03867565 40 44 B-Observation-Name
< NCT03867565 45 46 B-Eq-Operator___Eq-Operator-Value:LT
20 NCT03867565 48 50 B-Eq-Value
% NCT03867565 51 52 B-Eq-Unit

- NCT03867565 56 57 O
Age NCT03867565 59 62 O
≥ NCT03867565 63 64 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03867565 66 68 B-Eq-Value
years NCT03867565 69 74 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03867565 75 78 O

- NCT03867565 81 82 O
Understands NCT03867565 84 95 O
Swedish NCT03867565 96 103 B-Language
or NCT03867565 104 106 O
English NCT03867565 107 114 B-Language
verbally NCT03867565 115 123 O
and NCT03867565 124 127 O
in NCT03867565 128 130 O
writing NCT03867565 131 138 O

- NCT03867565 141 142 O
Mentally NCT03867565 144 152 B-Condition-Name
adequate NCT03867565 153 161 I-Condition-Name

- NCT03867565 164 165 O
Oral NCT03867565 167 171 O
and NCT03867565 172 175 O
written NCT03867565 176 183 O
informed NCT03867565 184 192 O
consent NCT03867565 193 200 O
. NCT03867565 201 202 O

Exclusion NCT03867565 204 213 O
Criteria NCT03867565 214 222 O
: NCT03867565 223 224 O

- NCT03867565 228 229 O
Patients NCT03867565 231 239 O
deemed NCT03867565 240 246 O
not NCT03867565 247 250 O
to NCT03867565 251 253 O
be NCT03867565 254 256 O
able NCT03867565 257 261 O
to NCT03867565 262 264 O
complete NCT03867565 265 273 O
study NCT03867565 274 279 O
protocol NCT03867565 280 288 O
. NCT03867565 289 290 O

- NCT03867565 294 295 O
TBSA NCT03867565 297 301 B-Observation-Name
< NCT03867565 302 303 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03867565 305 306 B-Eq-Value
% NCT03867565 307 308 B-Eq-Unit
. NCT03867565 310 311 O

Inclusion NCT03868124 0 9 O
Criteria NCT03868124 10 18 O
: NCT03868124 19 20 O

- NCT03868124 24 25 O
Diagnosed NCT03868124 27 36 O
with NCT03868124 37 41 O
open NCT03868124 42 46 O
- NCT03868124 47 48 O
angle NCT03868124 49 54 O
glaucoma NCT03868124 55 63 B-Condition-Name
or NCT03868124 64 66 O
ocular NCT03868124 67 73 O
hypertension NCT03868124 74 86 B-Condition-Name

- NCT03868124 89 90 O
C NCT03868124 92 93 B-Observation-Name
/ NCT03868124 94 95 I-Observation-Name
D NCT03868124 96 97 I-Observation-Name
ratio NCT03868124 98 103 I-Observation-Name
≤ NCT03868124 104 105 B-Eq-Operator___Eq-Operator-Value:LTEQ
0.8 NCT03868124 107 110 B-Eq-Value

- NCT03868124 114 115 O
Zero NCT03868124 117 121 B-Eq-Value
to NCT03868124 122 124 B-Eq-Operator___Eq-Operator-Value:BETWEEN
two NCT03868124 125 128 B-Eq-Value
pre NCT03868124 129 132 O
operative NCT03868124 133 142 O
ocular NCT03868124 143 149 B-Drug-Name
hypotensive NCT03868124 150 161 I-Drug-Name
medications NCT03868124 162 173 I-Drug-Name

Exclusion NCT03868124 174 183 O
Criteria NCT03868124 184 192 O
: NCT03868124 193 194 O

- NCT03868124 198 199 O
Active NCT03868124 201 207 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
corneal NCT03868124 208 215 B-Condition-Name
inflammation NCT03868124 216 228 I-Condition-Name
or NCT03868124 229 231 O
edema NCT03868124 232 237 B-Condition-Name

- NCT03868124 240 241 O
Retinal NCT03868124 243 250 B-Condition-Name
disorders NCT03868124 251 260 I-Condition-Name
not NCT03868124 261 264 O
associated NCT03868124 265 275 O
with NCT03868124 276 280 O
glaucoma NCT03868124 281 289 B-Condition-Name

Inclusion NCT03863717 0 9 O
Criteria NCT03863717 10 18 O
: NCT03863717 19 20 O

- NCT03863717 24 25 O
Diagnosis NCT03863717 27 36 O
of NCT03863717 37 39 O
COPD NCT03863717 40 44 B-Condition-Name
confirmed NCT03863717 45 54 O
by NCT03863717 55 57 O
clinical NCT03863717 58 66 B-Observation-Name
examination NCT03863717 67 78 I-Observation-Name
and NCT03863717 79 82 O
a NCT03863717 83 84 O
pulmonary NCT03863717 85 94 B-Observation-Name___Observation-Type-Value:lab
function NCT03863717 95 103 I-Observation-Name___Observation-Type-Value:lab
test NCT03863717 104 108 I-Observation-Name___Observation-Type-Value:lab

- NCT03863717 111 112 O
Stable NCT03863717 114 120 B-Stability___Stability-Value:stable
clinical NCT03863717 121 129 O
condition NCT03863717 130 139 O
( NCT03863717 140 141 O
without NCT03863717 142 149 O
recent NCT03863717 150 156 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
respiratory NCT03863717 157 168 B-Condition-Name
system NCT03863717 169 175 I-Condition-Name
infections NCT03863717 176 186 I-Condition-Name
or NCT03863717 187 189 O
any NCT03863717 190 193 O
exacerbation NCT03863717 194 206 B-Stability___Stability-Value:change
of NCT03863717 207 209 O
the NCT03863717 210 213 O
disease NCT03863717 214 221 O
) NCT03863717 222 223 O

- NCT03863717 227 228 O
Patients NCT03863717 230 238 O
must NCT03863717 239 243 O
be NCT03863717 244 246 O
willing NCT03863717 247 254 O
to NCT03863717 255 257 O
re NCT03863717 258 260 O
evaluate NCT03863717 261 269 O
at NCT03863717 270 272 O
the NCT03863717 273 276 O
end NCT03863717 277 280 O
of NCT03863717 281 283 O
the NCT03863717 284 287 O
study NCT03863717 288 293 O

- NCT03863717 296 297 O
Patients NCT03863717 299 307 O
must NCT03863717 308 312 O
be NCT03863717 313 315 O
willing NCT03863717 316 323 O
to NCT03863717 324 326 O
give NCT03863717 327 331 O
written NCT03863717 332 339 O
consent NCT03863717 340 347 O
for NCT03863717 348 351 O
their NCT03863717 352 357 O
participation NCT03863717 358 371 O
in NCT03863717 372 374 O
the NCT03863717 375 378 O
study NCT03863717 379 384 O

Exclusion NCT03863717 385 394 O
Criteria NCT03863717 395 403 O
: NCT03863717 404 405 O

- NCT03863717 409 410 O
Age NCT03863717 412 415 O
< NCT03863717 416 417 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03863717 419 421 B-Eq-Value
years NCT03863717 422 427 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03863717 428 431 O

- NCT03863717 434 435 O
Unstable NCT03863717 437 445 B-Stability___Stability-Value:change
cardiac NCT03863717 446 453 B-Condition-Name
disease NCT03863717 454 461 I-Condition-Name

- NCT03863717 464 465 O
Musculoskeletal NCT03863717 467 482 O
and NCT03863717 483 486 O
neurological NCT03863717 487 499 O
diseases NCT03863717 500 508 B-Condition-Name
that NCT03863717 509 513 O
could NCT03863717 514 519 O
affect NCT03863717 520 526 O
exercise NCT03863717 527 535 O
performance NCT03863717 536 547 O
or NCT03863717 548 550 O
preclude NCT03863717 551 559 O
exercise NCT03863717 560 568 O

- NCT03863717 571 572 O
Patients NCT03863717 574 582 O
of NCT03863717 583 585 O
COPD NCT03863717 586 590 B-Condition-Name
final NCT03863717 591 596 O
stage NCT03863717 597 602 O
or NCT03863717 603 605 O
other NCT03863717 606 611 O
serious NCT03863717 612 619 B-Severity___Severity-Value:severe
disease NCT03863717 620 627 B-Condition-Name
final NCT03863717 628 633 O
stage NCT03863717 634 639 O

- NCT03863717 642 643 O
Significant NCT03863717 645 656 O
cognitive NCT03863717 657 666 O
or NCT03863717 667 669 O
psychiatric NCT03863717 670 681 O
impairment NCT03863717 682 692 B-Condition-Name
that NCT03863717 693 697 O
would NCT03863717 698 703 O
lead NCT03863717 704 708 O
to NCT03863717 709 711 O
an NCT03863717 712 714 O
inability NCT03863717 715 724 B-Condition-Name
to NCT03863717 725 727 I-Condition-Name
follow NCT03863717 728 734 I-Condition-Name
simple NCT03863717 735 741 I-Condition-Name
commands NCT03863717 742 750 I-Condition-Name
in NCT03863717 751 753 O
a NCT03863717 754 755 O
group NCT03863717 756 761 O
setting NCT03863717 762 769 O

Inclusion NCT03866135 0 9 O
Criteria NCT03866135 10 18 O
: NCT03866135 19 20 O

- NCT03866135 24 25 O
Patients NCT03866135 27 35 O
diagnosed NCT03866135 36 45 O
as NCT03866135 46 48 O
AS NCT03866135 49 51 B-Condition-Name
according NCT03866135 52 61 O
to NCT03866135 62 64 O
the NCT03866135 65 68 O
modified NCT03866135 69 77 O
New NCT03866135 78 81 O
York NCT03866135 82 86 O
diagnostic NCT03866135 87 97 O
criteria NCT03866135 98 106 O
were NCT03866135 107 111 O
included NCT03866135 112 120 O

Exclusion NCT03866135 121 130 O
Criteria NCT03866135 131 139 O
: NCT03866135 140 141 O

- NCT03866135 145 146 O
Patients NCT03866135 148 156 O
previously NCT03866135 157 167 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
diagnosed NCT03866135 168 177 O
with NCT03866135 178 182 O
OP NCT03866135 183 185 B-Condition-Name
, NCT03866135 186 187 O

- NCT03866135 191 192 O
Patients NCT03866135 194 202 O
previously NCT03866135 203 213 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treated NCT03866135 214 221 O
with NCT03866135 222 226 O
OP NCT03866135 227 229 B-Condition-Name
, NCT03866135 230 231 O

- NCT03866135 235 236 O
Patients NCT03866135 238 246 O
with NCT03866135 247 251 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
bone NCT03866135 252 256 B-Condition-Name
fractures NCT03866135 257 266 I-Condition-Name
previously NCT03866135 267 277 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
associated NCT03866135 278 288 O
with NCT03866135 289 293 O
OP NCT03866135 294 296 B-Condition-Name
, NCT03866135 297 298 O

- NCT03866135 302 303 O
Those NCT03866135 305 310 O
using NCT03866135 311 316 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
drugs NCT03866135 317 322 B-Drug-Name
that NCT03866135 323 327 O
affect NCT03866135 328 334 B-Stability___Stability-Value:change
bone NCT03866135 335 339 B-Condition-Name
metabolism NCT03866135 340 350 I-Condition-Name
, NCT03866135 351 352 O
metabolic NCT03866135 353 362 B-Condition-Name
bone NCT03866135 363 367 I-Condition-Name
diseases NCT03866135 368 376 I-Condition-Name
( NCT03866135 377 378 O
Paget NCT03866135 379 384 B-Condition-Name
's NCT03866135 384 386 I-Condition-Name
disease NCT03866135 387 394 I-Condition-Name
, NCT03866135 395 396 O
osteomalacia NCT03866135 397 409 B-Condition-Name
, NCT03866135 410 411 O
hyperparathyroidism NCT03866135 412 431 B-Condition-Name
) NCT03866135 432 433 O
, NCT03866135 435 436 O

- NCT03866135 440 441 O
Diabetes NCT03866135 443 451 B-Condition-Name
mellitus NCT03866135 452 460 I-Condition-Name
, NCT03866135 461 462 O

- NCT03866135 466 467 O
Hypothyroidism NCT03866135 469 483 B-Condition-Name
, NCT03866135 484 485 O
hyperthyroidism NCT03866135 486 501 B-Condition-Name
, NCT03866135 502 503 O

- NCT03866135 507 508 O
Patients NCT03866135 510 518 O
with NCT03866135 519 523 O
kidney NCT03866135 524 530 O
, NCT03866135 531 532 O
liver NCT03866135 533 538 O
and NCT03866135 539 542 O
intestinal NCT03866135 543 553 O
diseases NCT03866135 554 562 B-Condition-Name
, NCT03866135 563 564 O

- NCT03866135 568 569 O
Those NCT03866135 571 576 O
using NCT03866135 577 582 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
corticosteroids NCT03866135 583 598 B-Drug-Name


- NCT03921515 1 2 O
INCLUSION NCT03921515 4 13 O
CRITERIA NCT03921515 14 22 O
: NCT03921515 23 24 O

1 NCT03921515 34 35 O
. NCT03921515 35 36 O
Meets NCT03921515 38 43 O
one NCT03921515 44 47 O
of NCT03921515 48 50 O
the NCT03921515 51 54 O
following NCT03921515 55 64 O
: NCT03921515 65 66 O

1 NCT03921515 81 82 O
. NCT03921515 82 83 O
has NCT03921515 85 88 O
documentation NCT03921515 89 102 O
of NCT03921515 103 105 O
HIES NCT03921515 106 110 B-Condition-Name
or NCT03921515 111 113 O
CGD NCT03921515 114 117 B-Condition-Name
( NCT03921515 118 119 O
patient NCT03921515 120 127 O
populations NCT03921515 128 139 O
) NCT03921515 140 141 O
; NCT03921515 142 143 O
or NCT03921515 144 146 O

2 NCT03921515 160 161 O
. NCT03921515 161 162 O
does NCT03921515 164 168 O
not NCT03921515 169 172 O
have NCT03921515 173 177 O
clinically NCT03921515 178 188 O
apparent NCT03921515 189 197 O
evidence NCT03921515 198 206 O
of NCT03921515 207 209 O
an NCT03921515 210 212 O
immune NCT03921515 213 219 B-Condition-Name
defect NCT03921515 220 226 I-Condition-Name
or NCT03921515 227 229 O
history NCT03921515 230 237 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921515 238 240 O
invasive NCT03921515 241 249 O
or NCT03921515 250 252 O
recurrent NCT03921515 253 262 O
S NCT03921515 263 264 B-Organism-Name
. NCT03921515 265 266 I-Organism-Name
aureus NCT03921515 268 274 I-Organism-Name
infections NCT03921515 275 285 B-Condition-Name
( NCT03921515 286 287 O
healthy NCT03921515 288 295 B-Condition-Name
volunteers NCT03921515 296 306 O
) NCT03921515 307 308 O
. NCT03921515 310 311 O

2 NCT03921515 321 322 O
. NCT03921515 322 323 O
Between NCT03921515 325 332 O
the NCT03921515 333 336 O
following NCT03921515 337 346 O
age NCT03921515 347 350 O
limits NCT03921515 351 357 O
( NCT03921515 358 359 O
inclusive NCT03921515 360 369 O
) NCT03921515 370 371 O
: NCT03921515 373 374 O

1 NCT03921515 389 390 O
. NCT03921515 390 391 O
18 NCT03921515 394 396 B-Eq-Value
and NCT03921515 397 400 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03921515 402 404 B-Eq-Value
years NCT03921515 405 410 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03921515 411 414 O
for NCT03921515 415 418 O
healthy NCT03921515 419 426 B-Condition-Name
volunteers NCT03921515 427 437 O
; NCT03921515 437 438 O

2 NCT03921515 452 453 O
. NCT03921515 453 454 O
7 NCT03921515 457 458 B-Eq-Value
and NCT03921515 459 462 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03921515 464 466 B-Eq-Value
years NCT03921515 467 472 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03921515 473 476 O
for NCT03921515 477 480 O
patients NCT03921515 481 489 O
with NCT03921515 490 494 O
CGD NCT03921515 495 498 B-Condition-Name
; NCT03921515 498 499 O

3 NCT03921515 513 514 O
. NCT03921515 514 515 O
18 NCT03921515 518 520 B-Eq-Value
and NCT03921515 521 524 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03921515 526 528 B-Eq-Value
years NCT03921515 529 534 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03921515 535 538 O
for NCT03921515 539 542 O
patients NCT03921515 543 551 O
with NCT03921515 552 556 O
HIES NCT03921515 557 561 B-Condition-Name
. NCT03921515 562 563 O

3 NCT03921515 573 574 O
. NCT03921515 574 575 O
Willing NCT03921515 577 584 O
to NCT03921515 585 587 O
allow NCT03921515 588 593 B-Observation-Name
storage NCT03921515 594 601 I-Observation-Name
of NCT03921515 602 604 O
blood NCT03921515 605 610 O
, NCT03921515 611 612 O
RNA NCT03921515 613 616 O
, NCT03921515 617 618 O
bacterial NCT03921515 619 628 O
and NCT03921515 629 632 O
fungal NCT03921515 633 639 O
cultures NCT03921515 640 648 O
, NCT03921515 649 650 O
and NCT03921515 651 654 O
other NCT03921515 655 660 O
tissue NCT03921515 661 667 O
samples NCT03921515 668 675 O
for NCT03921515 676 679 O
future NCT03921515 680 686 O
research NCT03921515 687 695 O
. NCT03921515 696 697 O

4 NCT03921515 707 708 O
. NCT03921515 708 709 O
Able NCT03921515 711 715 O
to NCT03921515 716 718 O
provide NCT03921515 719 726 O
informed NCT03921515 727 735 O
consent NCT03921515 736 743 O
. NCT03921515 744 745 O

EXCLUSION NCT03921515 747 756 O
CRITERIA NCT03921515 757 765 O
: NCT03921515 766 767 O

The NCT03921515 769 772 O
following NCT03921515 773 782 O
exclusion NCT03921515 783 792 O
criteria NCT03921515 793 801 O
apply NCT03921515 802 807 O
to NCT03921515 808 810 O
all NCT03921515 811 814 O
subjects NCT03921515 815 823 O
: NCT03921515 824 825 O

1 NCT03921515 830 831 O
. NCT03921515 831 832 O
For NCT03921515 834 837 O
individuals NCT03921515 838 849 O
undergoing NCT03921515 850 860 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
blister NCT03921515 861 868 O
or NCT03921515 869 871 O
skin NCT03921515 872 876 O
biopsy NCT03921515 877 883 B-Procedure-Name
procedures NCT03921515 884 894 I-Procedure-Name
, NCT03921515 895 896 O
history NCT03921515 897 904 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921515 905 907 O
keloid NCT03921515 908 914 B-Condition-Name
formation NCT03921515 915 924 I-Condition-Name
. NCT03921515 925 926 O

2 NCT03921515 931 932 O
. NCT03921515 932 933 O
Current NCT03921515 935 942 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03921515 943 945 O
prior NCT03921515 946 951 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
( NCT03921515 952 953 O
within NCT03921515 954 960 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03921515 962 963 B-Eq-Value
months NCT03921515 964 970 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03921515 971 972 O
anticoagulant NCT03921515 973 986 O
or NCT03921515 987 989 O
anti NCT03921515 990 994 O
- NCT03921515 995 996 O
platelet NCT03921515 997 1005 O
therapy NCT03921515 1006 1013 B-Procedure-Name
( NCT03921515 1014 1015 O
other NCT03921515 1016 1021 O
than NCT03921515 1022 1026 O
aspirin NCT03921515 1027 1034 B-Drug-Name
or NCT03921515 1035 1037 O
non NCT03921515 1038 1041 B-Drug-Name
- NCT03921515 1042 1043 I-Drug-Name
steroidal NCT03921515 1044 1053 I-Drug-Name
anti NCT03921515 1054 1058 I-Drug-Name
- NCT03921515 1059 1060 I-Drug-Name
inflammatory NCT03921515 1061 1073 I-Drug-Name
drugs NCT03921515 1074 1079 I-Drug-Name
[ NCT03921515 1080 1081 O
NSAIDs NCT03921515 1082 1088 B-Drug-Name
] NCT03921515 1089 1090 O
) NCT03921515 1092 1093 O
. NCT03921515 1095 1096 O

3 NCT03921515 1101 1102 O
. NCT03921515 1102 1103 O
Current NCT03921515 1105 1112 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03921515 1113 1115 O
prior NCT03921515 1116 1121 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
( NCT03921515 1122 1123 O
within NCT03921515 1124 1130 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03921515 1132 1133 B-Eq-Value
months NCT03921515 1134 1140 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03921515 1141 1142 O
use NCT03921515 1143 1146 O
of NCT03921515 1147 1149 O
immunomodulatory NCT03921515 1150 1166 B-Drug-Name
drugs NCT03921515 1167 1172 I-Drug-Name
( NCT03921515 1173 1174 O
e NCT03921515 1175 1176 O
. NCT03921515 1177 1178 O
g NCT03921515 1179 1180 O
. NCT03921515 1181 1182 O
, NCT03921515 1183 1184 O
chemotherapy NCT03921515 1185 1197 B-Procedure-Name
, NCT03921515 1198 1199 O
steroids NCT03921515 1200 1208 B-Drug-Name
) NCT03921515 1209 1210 O
, NCT03921515 1212 1213 O
except NCT03921515 1214 1220 O
if NCT03921515 1221 1223 O
approved NCT03921515 1224 1232 O
by NCT03921515 1233 1235 O
the NCT03921515 1236 1239 O
principal NCT03921515 1240 1249 O
investigator NCT03921515 1250 1262 O
. NCT03921515 1263 1264 O

4 NCT03921515 1269 1270 O
. NCT03921515 1270 1271 O
Pregnancy NCT03921515 1273 1282 B-Condition-Name
. NCT03921515 1283 1284 O

5 NCT03921515 1289 1290 O
. NCT03921515 1290 1291 O
Any NCT03921515 1293 1296 O
condition NCT03921515 1297 1306 O
that NCT03921515 1307 1311 O
, NCT03921515 1312 1313 O
in NCT03921515 1314 1316 O
the NCT03921515 1317 1320 O
opinion NCT03921515 1321 1328 O
of NCT03921515 1329 1331 O
the NCT03921515 1332 1335 O
investigator NCT03921515 1336 1348 O
, NCT03921515 1349 1350 O
contraindicates NCT03921515 1351 1366 O
participation NCT03921515 1367 1380 O
in NCT03921515 1381 1383 O
the NCT03921515 1384 1387 O
study NCT03921515 1388 1393 O
. NCT03921515 1394 1395 O

Healthy NCT03924479 0 7 B-Observation-Name
subjects NCT03924479 8 16 O
: NCT03924479 17 18 O
Adults NCT03924479 19 25 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03924479 26 27 O
≥ NCT03924479 29 30 B-Eq-Operator___Eq-Operator-Value:GTEQ
21 NCT03924479 32 34 B-Eq-Value
years NCT03924479 35 40 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03924479 41 43 O
age NCT03924479 44 47 O
) NCT03924479 48 49 O
in NCT03924479 50 52 O
the NCT03924479 53 56 O
absence NCT03924479 57 64 O
of NCT03924479 65 67 O
a NCT03924479 68 69 O
history NCT03924479 70 77 O
of NCT03924479 78 80 O
HFpEF NCT03924479 81 86 B-Condition-Name
or NCT03924479 87 89 O
HFrEF NCT03924479 90 95 B-Condition-Name
, NCT03924479 96 97 O
pulmonary NCT03924479 98 107 O
, NCT03924479 108 109 O
neurologic NCT03924479 110 120 O
, NCT03924479 121 122 O
orthopedic NCT03924479 123 133 O
, NCT03924479 134 135 O
or NCT03924479 136 138 O
other NCT03924479 139 144 O
diseases NCT03924479 145 153 B-Condition-Name
affecting NCT03924479 154 163 I-Condition-Name
the NCT03924479 164 167 I-Condition-Name
neuromuscular NCT03924479 168 181 I-Condition-Name
system NCT03924479 182 188 I-Condition-Name
. NCT03924479 189 190 O

Controls NCT03924479 192 200 O
will NCT03924479 201 205 O
be NCT03924479 206 208 O
matched NCT03924479 209 216 O
for NCT03924479 217 220 O
age NCT03924479 221 224 O
and NCT03924479 225 228 O
sex NCT03924479 229 232 O
. NCT03924479 233 234 O

All NCT03924479 236 239 O
HFpEF NCT03924479 240 245 B-Condition-Name
patients NCT03924479 246 254 O
will NCT03924479 255 259 O
be NCT03924479 260 262 O
managed NCT03924479 263 270 O
by NCT03924479 271 273 O
their NCT03924479 274 279 O
primary NCT03924479 280 287 O
care NCT03924479 288 292 O
physician NCT03924479 293 302 O
or NCT03924479 303 305 O
cardiologist NCT03924479 306 318 O
with NCT03924479 319 323 O
additional NCT03924479 324 334 O
review NCT03924479 335 341 O
and NCT03924479 342 345 O
oversight NCT03924479 346 355 O
by NCT03924479 356 358 O
Dr NCT03924479 359 361 O
. NCT03924479 362 363 O
Borlaug NCT03924479 365 372 O
( NCT03924479 373 374 O
Co NCT03924479 375 377 O
- NCT03924479 378 379 O
Investigator NCT03924479 380 392 O
) NCT03924479 393 394 O
prior NCT03924479 395 400 O
to NCT03924479 401 403 O
enrollment NCT03924479 404 414 O
to NCT03924479 415 417 O
ensure NCT03924479 418 424 O
adequacy NCT03924479 425 433 O
of NCT03924479 434 436 O
inclusion NCT03924479 437 446 O
and NCT03924479 447 450 O
exclusion NCT03924479 451 460 O
criteria NCT03924479 461 469 O
and NCT03924479 470 473 O
that NCT03924479 474 478 O
participation NCT03924479 479 492 O
in NCT03924479 493 495 O
exercise NCT03924479 496 504 O
testing NCT03924479 505 512 O
and NCT03924479 513 516 O
resistance NCT03924479 517 527 O
exercise NCT03924479 528 536 O
training NCT03924479 537 545 O
is NCT03924479 546 548 O
safe NCT03924479 549 553 O
. NCT03924479 554 555 O

Inclusion NCT03924479 557 566 O
Criteria NCT03924479 567 575 O
for NCT03924479 576 579 O
HFpEF NCT03924479 580 585 O
, NCT03924479 586 587 O
includes NCT03924479 588 596 O
: NCT03924479 597 598 O

- NCT03924479 602 603 O
Clinical NCT03924479 605 613 O
diagnosis NCT03924479 614 623 O
of NCT03924479 624 626 O
HFpEF NCT03924479 627 632 B-Condition-Name
. NCT03924479 633 634 O

- NCT03924479 638 639 O
Patients NCT03924479 641 649 O
with NCT03924479 650 654 O
a NCT03924479 655 656 O
history NCT03924479 657 664 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
stable NCT03924479 665 671 B-Stability___Stability-Value:stable
( NCT03924479 672 673 O
no NCT03924479 674 676 O
medication NCT03924479 677 687 O
changes NCT03924479 688 695 B-Stability___Stability-Value:change
in NCT03924479 696 698 O
past NCT03924479 699 703 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03924479 705 706 B-Eq-Value
weeks NCT03924479 707 712 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03924479 713 714 O
w NCT03924479 715 716 O
/ NCT03924479 717 718 O
duration NCT03924479 719 727 O
of NCT03924479 728 730 O
diagnosis NCT03924479 731 740 O
> NCT03924479 741 742 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03924479 744 745 B-Eq-Value
months NCT03924479 746 752 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03924479 753 754 O
. NCT03924479 756 757 O

- NCT03924479 761 762 O
New NCT03924479 764 767 B-Condition-Name
York NCT03924479 768 772 I-Condition-Name
Heart NCT03924479 773 778 I-Condition-Name
Association NCT03924479 779 790 I-Condition-Name
class NCT03924479 791 796 B-Eq-Unit
I NCT03924479 797 798 B-Eq-Value
- NCT03924479 799 800 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03924479 801 804 B-Eq-Value
. NCT03924479 805 806 O

- NCT03924479 810 811 O
Current NCT03924479 813 820 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
non NCT03924479 821 824 O
- NCT03924479 825 826 O
smokers NCT03924479 827 834 B-Condition-Name
with NCT03924479 835 839 O
< NCT03924479 840 841 B-Eq-Operator___Eq-Operator-Value:LT
15 NCT03924479 843 845 B-Eq-Value
pack NCT03924479 846 850 B-Eq-Unit
year NCT03924479 851 855 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
history NCT03924479 856 863 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
. NCT03924479 864 865 O

- NCT03924479 869 870 O
Non NCT03924479 872 875 O
- NCT03924479 876 877 O
pregnant NCT03924479 878 886 B-Condition-Name
women NCT03924479 887 892 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03924479 893 894 O
and NCT03924479 895 898 O
individuals NCT03924479 899 910 O
who NCT03924479 911 914 O
are NCT03924479 915 918 O
able NCT03924479 919 923 B-Observation-Name___Observation-Type-Value:social-habit
to NCT03924479 924 926 I-Observation-Name___Observation-Type-Value:social-habit
exercise NCT03924479 927 935 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03924479 936 937 O
i NCT03924479 938 939 O
. NCT03924479 940 941 O
e NCT03924479 942 943 O
. NCT03924479 944 945 O
without NCT03924479 947 954 O
orthopedic NCT03924479 955 965 B-Condition-Name
limitations NCT03924479 966 977 I-Condition-Name
or NCT03924479 978 980 O
neuromuscular NCT03924479 981 994 B-Condition-Name
disorders NCT03924479 995 1004 I-Condition-Name
) NCT03924479 1005 1006 O
. NCT03924479 1008 1009 O

Exclusion NCT03924479 1011 1020 O
Criteria NCT03924479 1021 1029 O
for NCT03924479 1030 1033 O
all NCT03924479 1034 1037 O
subjects NCT03924479 1038 1046 O
, NCT03924479 1047 1048 O
includes NCT03924479 1049 1057 O
: NCT03924479 1058 1059 O

- NCT03924479 1063 1064 O
history NCT03924479 1066 1073 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924479 1074 1076 O
dangerous NCT03924479 1077 1086 B-Severity___Severity-Value:severe
arrhythmias NCT03924479 1087 1098 B-Condition-Name

- NCT03924479 1101 1102 O
body NCT03924479 1104 1108 B-Observation-Name___Observation-Type-Value:vital
mass NCT03924479 1109 1113 I-Observation-Name___Observation-Type-Value:vital
index NCT03924479 1114 1119 I-Observation-Name___Observation-Type-Value:vital
> NCT03924479 1120 1121 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03924479 1123 1125 B-Eq-Value
kg NCT03924479 1126 1128 B-Eq-Unit
/ NCT03924479 1129 1130 O
m NCT03924479 1131 1132 B-Eq-Unit
2 NCT03924479 1133 1134 I-Eq-Unit

- NCT03924479 1137 1138 O
current NCT03924479 1140 1147 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
smokers NCT03924479 1148 1155 B-Condition-Name
and NCT03924479 1156 1159 O
/ NCT03924479 1160 1161 O
or NCT03924479 1162 1164 O
smoking NCT03924479 1165 1172 B-Observation-Name___Observation-Type-Value:social-habit
history NCT03924479 1173 1180 I-Observation-Name___Observation-Type-Value:social-habit
> NCT03924479 1181 1182 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03924479 1184 1186 B-Eq-Value
pack NCT03924479 1187 1191 B-Eq-Unit
years NCT03924479 1192 1197 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03924479 1200 1201 O
pregnant NCT03924479 1203 1211 B-Condition-Name
women NCT03924479 1212 1217 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03924479 1220 1221 O
uremia NCT03924479 1223 1229 B-Condition-Name
, NCT03924479 1230 1231 O
history NCT03924479 1232 1239 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924479 1240 1242 O
allergy NCT03924479 1243 1250 O
to NCT03924479 1251 1253 O
iodides NCT03924479 1254 1261 B-Allergy-Name

- NCT03924479 1264 1265 O
impaired NCT03924479 1267 1275 B-Condition-Name
renal NCT03924479 1276 1281 I-Condition-Name
function NCT03924479 1282 1290 I-Condition-Name

- NCT03924479 1293 1294 O
creatinine NCT03924479 1296 1306 B-Observation-Name___Observation-Type-Value:lab
value NCT03924479 1307 1312 O
greater NCT03924479 1313 1320 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03924479 1321 1325 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03924479 1326 1328 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03924479 1329 1334 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03924479 1335 1337 I-Eq-Operator___Eq-Operator-Value:GTEQ
1.3 NCT03924479 1339 1342 B-Eq-Value
mg NCT03924479 1343 1345 B-Eq-Unit
/ NCT03924479 1346 1347 O
dL NCT03924479 1348 1350 B-Eq-Unit
( NCT03924479 1351 1352 O
via NCT03924479 1353 1356 O
clinical NCT03924479 1357 1365 O
record NCT03924479 1366 1372 O
within NCT03924479 1373 1379 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03924479 1380 1383 O
past NCT03924479 1384 1388 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03924479 1390 1391 B-Eq-Value
months NCT03924479 1392 1398 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03924479 1399 1400 O

- NCT03924479 1404 1405 O
diagnosis NCT03924479 1407 1416 O
of NCT03924479 1417 1419 O
liver NCT03924479 1420 1425 B-Condition-Name
disease NCT03924479 1426 1433 I-Condition-Name

- NCT03924479 1436 1437 O
individuals NCT03924479 1439 1450 O
who NCT03924479 1451 1454 O
are NCT03924479 1455 1458 O
not NCT03924479 1459 1462 O
able NCT03924479 1463 1467 O
to NCT03924479 1468 1470 O
engage NCT03924479 1471 1477 O
in NCT03924479 1478 1480 O
exercise NCT03924479 1481 1489 B-Observation-Name___Observation-Type-Value:social-habit


Inclusion NCT03926520 0 9 O
Criteria NCT03926520 10 18 O
: NCT03926520 19 20 O

1 NCT03926520 25 26 O
. NCT03926520 26 27 O
Diagnosis NCT03926520 29 38 O
of NCT03926520 39 41 O
Alzheimer NCT03926520 42 51 B-Condition-Name
's NCT03926520 51 53 I-Condition-Name
Dementia NCT03926520 54 62 I-Condition-Name
according NCT03926520 63 72 O
to NCT03926520 73 75 O
NIA NCT03926520 76 79 O
- NCT03926520 80 81 O
AA NCT03926520 82 84 O
Criteria NCT03926520 85 93 O
for NCT03926520 94 97 O
dementia NCT03926520 98 106 O
[ NCT03926520 107 108 O
55 NCT03926520 110 112 O
] NCT03926520 113 114 O

2 NCT03926520 119 120 O
. NCT03926520 120 121 O
MMSE NCT03926520 123 127 B-Observation-Name
< NCT03926520 128 129 B-Eq-Operator___Eq-Operator-Value:LT
15 NCT03926520 131 133 B-Eq-Value

3 NCT03926520 138 139 O
. NCT03926520 139 140 O
Cohen NCT03926520 142 147 B-Observation-Name
- NCT03926520 148 149 I-Observation-Name
Mansfield NCT03926520 150 159 I-Observation-Name
Agitation NCT03926520 160 169 I-Observation-Name
Inventory NCT03926520 170 179 I-Observation-Name
Short NCT03926520 180 185 I-Observation-Name
Version NCT03926520 186 193 I-Observation-Name
( NCT03926520 194 195 O
CMAI NCT03926520 196 200 B-Observation-Name
) NCT03926520 201 202 O
score NCT03926520 203 208 O
of NCT03926520 209 211 O
≥ NCT03926520 212 213 B-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03926520 215 216 B-Eq-Value
on NCT03926520 217 219 O
at NCT03926520 220 222 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926520 223 228 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03926520 229 232 B-Eq-Value
item NCT03926520 233 237 B-Eq-Unit
, NCT03926520 238 239 O
a NCT03926520 240 241 O
score NCT03926520 242 247 O
of NCT03926520 248 250 O
3 NCT03926520 252 253 B-Eq-Value
on NCT03926520 254 256 O
at NCT03926520 257 259 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926520 260 265 I-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03926520 266 269 B-Eq-Unit
items NCT03926520 270 275 I-Eq-Unit
, NCT03926520 276 277 O
or NCT03926520 278 280 O
a NCT03926520 281 282 O
score NCT03926520 283 288 O
of NCT03926520 289 291 O
2 NCT03926520 293 294 B-Eq-Value
on NCT03926520 295 297 O
at NCT03926520 298 300 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926520 301 306 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03926520 307 312 B-Eq-Unit
items NCT03926520 313 318 I-Eq-Unit
. NCT03926520 319 320 O

4 NCT03926520 325 326 O
. NCT03926520 326 327 O
At NCT03926520 329 331 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926520 332 337 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03926520 338 341 B-Eq-Unit
failed NCT03926520 342 348 O
pharmacological NCT03926520 349 364 O
intervention NCT03926520 365 377 O
to NCT03926520 378 380 O
manage NCT03926520 381 387 O
behavioral NCT03926520 388 398 B-Condition-Name
symptoms NCT03926520 399 407 O

5 NCT03926520 411 412 O
. NCT03926520 412 413 O
Medically NCT03926520 415 424 O
stable NCT03926520 425 431 B-Stability___Stability-Value:stable
for NCT03926520 432 435 O
safe NCT03926520 436 440 O
administration NCT03926520 441 455 O
of NCT03926520 456 458 O
ECT NCT03926520 459 462 B-Procedure-Name
verified NCT03926520 463 471 O
by NCT03926520 472 474 O
standard NCT03926520 475 483 B-Procedure-Name
physical NCT03926520 484 492 I-Procedure-Name
examination NCT03926520 493 504 I-Procedure-Name
, NCT03926520 505 506 O
urinalysis NCT03926520 507 517 B-Observation-Name___Observation-Type-Value:lab
and NCT03926520 518 521 O
serum NCT03926520 522 527 B-Observation-Name___Observation-Type-Value:lab
chemistries NCT03926520 528 539 I-Observation-Name___Observation-Type-Value:lab

6 NCT03926520 543 544 O
. NCT03926520 544 545 O
Comprehension NCT03926520 547 560 O
of NCT03926520 561 563 O
English NCT03926520 564 571 B-Language
language NCT03926520 572 580 O

7 NCT03926520 584 585 O
. NCT03926520 585 586 O
Authorized NCT03926520 588 598 O
legal NCT03926520 599 604 O
representative NCT03926520 605 619 O
able NCT03926520 620 624 O
and NCT03926520 625 628 O
willing NCT03926520 629 636 O
to NCT03926520 637 639 O
give NCT03926520 640 644 O
informed NCT03926520 645 653 O
consent NCT03926520 654 661 O

8 NCT03926520 665 666 O
. NCT03926520 666 667 O
Age NCT03926520 669 672 O
55 NCT03926520 674 676 B-Eq-Value
- NCT03926520 677 678 B-Eq-Operator___Eq-Operator-Value:BETWEEN
89 NCT03926520 680 682 B-Eq-Value
years NCT03926520 683 688 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03926520 689 692 O
( NCT03926520 693 694 O
inclusive NCT03926520 695 704 O
) NCT03926520 705 706 O

Exclusion NCT03926520 708 717 O
Criteria NCT03926520 718 726 O
: NCT03926520 727 728 O

1 NCT03926520 733 734 O
. NCT03926520 734 735 O
Current NCT03926520 737 744 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnosis NCT03926520 745 754 O
of NCT03926520 755 757 O
co NCT03926520 758 760 B-Condition-Name
- NCT03926520 761 762 I-Condition-Name
morbid NCT03926520 763 769 I-Condition-Name
delirium NCT03926520 770 778 I-Condition-Name
, NCT03926520 779 780 O
measured NCT03926520 781 789 O
by NCT03926520 790 792 O
the NCT03926520 793 796 O
Confusion NCT03926520 797 806 B-Observation-Name___Observation-Type-Value:measurement
Assessment NCT03926520 807 817 I-Observation-Name___Observation-Type-Value:measurement
Measure NCT03926520 818 825 I-Observation-Name___Observation-Type-Value:measurement
( NCT03926520 826 827 O
CAM NCT03926520 828 831 B-Observation-Name
) NCT03926520 832 833 O
and NCT03926520 834 837 O
by NCT03926520 838 840 O
clinical NCT03926520 841 849 O
diagnosis NCT03926520 850 859 O

2 NCT03926520 863 864 O
. NCT03926520 864 865 O
Diagnosis NCT03926520 867 876 O
of NCT03926520 877 879 O
Non NCT03926520 880 883 O
- NCT03926520 884 885 O
AD NCT03926520 886 888 B-Condition-Name
Dementia NCT03926520 889 897 B-Condition-Name

3 NCT03926520 901 902 O
. NCT03926520 902 903 O
Lifetime NCT03926520 905 913 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03926520 914 916 O
current NCT03926520 917 924 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnosis NCT03926520 925 934 O
of NCT03926520 935 937 O
Schizophrenia NCT03926520 938 951 B-Condition-Name
, NCT03926520 952 953 O
Bipolar NCT03926520 954 961 B-Condition-Name
Disorder NCT03926520 962 970 I-Condition-Name
or NCT03926520 971 973 O
Schizoaffective NCT03926520 974 989 B-Condition-Name
Disorder NCT03926520 990 998 I-Condition-Name

4 NCT03926520 1002 1003 O
. NCT03926520 1003 1004 O
Current NCT03926520 1006 1013 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
episode NCT03926520 1014 1021 O
of NCT03926520 1022 1024 O
Major NCT03926520 1025 1030 O
Depressive NCT03926520 1031 1041 B-Condition-Name
Disorder NCT03926520 1042 1050 I-Condition-Name
( NCT03926520 1051 1052 O
MDD NCT03926520 1053 1056 B-Condition-Name
) NCT03926520 1057 1058 O

5 NCT03926520 1063 1064 O
. NCT03926520 1064 1065 O
Active NCT03926520 1067 1073 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03926520 1074 1083 B-Condition-Name
use NCT03926520 1084 1087 I-Condition-Name
disorder NCT03926520 1088 1096 I-Condition-Name
within NCT03926520 1097 1103 B-Eq-Operator___Eq-Operator-Value:LTEQ
past NCT03926520 1104 1108 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03926520 1110 1111 B-Eq-Value
months NCT03926520 1112 1118 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

6 NCT03926520 1122 1123 O
. NCT03926520 1123 1124 O
Treatment NCT03926520 1126 1135 O
with NCT03926520 1136 1140 O
ECT NCT03926520 1141 1144 B-Procedure-Name
or NCT03926520 1145 1147 O
other NCT03926520 1148 1153 O
neurostimulation NCT03926520 1154 1170 B-Procedure-Name
therapies NCT03926520 1171 1180 I-Procedure-Name
( NCT03926520 1181 1182 O
e NCT03926520 1183 1184 O
. NCT03926520 1185 1186 O
g NCT03926520 1187 1188 O
. NCT03926520 1189 1190 O
, NCT03926520 1191 1192 O
TMS NCT03926520 1193 1196 B-Procedure-Name
or NCT03926520 1197 1199 O
vagal NCT03926520 1200 1205 B-Procedure-Name
nerve NCT03926520 1206 1211 I-Procedure-Name
stimulation NCT03926520 1212 1223 I-Procedure-Name
) NCT03926520 1224 1225 O
within NCT03926520 1226 1232 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03926520 1233 1236 O
past NCT03926520 1237 1241 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03926520 1243 1244 B-Eq-Value
months NCT03926520 1245 1251 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03924492 0 9 O
Criteria NCT03924492 10 18 O
: NCT03924492 19 20 O

1 NCT03924492 25 26 O
. NCT03924492 26 27 O
Subject NCT03924492 29 36 O
has NCT03924492 37 40 O
signed NCT03924492 41 47 O
an NCT03924492 48 50 O
informed NCT03924492 51 59 O
consent NCT03924492 60 67 O
form NCT03924492 68 72 O
prior NCT03924492 73 78 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
to NCT03924492 79 81 O
any NCT03924492 82 85 O
study NCT03924492 86 91 O
- NCT03924492 92 93 O
specific NCT03924492 94 102 O
procedures NCT03924492 103 113 O
being NCT03924492 114 119 O
performed NCT03924492 120 129 O

2 NCT03924492 133 134 O
. NCT03924492 134 135 O
Subject NCT03924492 137 144 O
is NCT03924492 145 147 O
an NCT03924492 148 150 O
ambulatory NCT03924492 151 161 B-Condition-Name
female NCT03924492 162 168 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
at NCT03924492 169 171 B-Eq-Operator___Eq-Operator-Value:LTEQ
least NCT03924492 172 177 I-Eq-Operator___Eq-Operator-Value:LTEQ
18 NCT03924492 179 181 B-Eq-Value
years NCT03924492 182 187 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03924492 188 190 O
age NCT03924492 191 194 O

3 NCT03924492 198 199 O
. NCT03924492 199 200 O
Subject NCT03924492 202 209 O
agrees NCT03924492 210 216 O
to NCT03924492 217 219 O
adhere NCT03924492 220 226 O
to NCT03924492 227 229 O
the NCT03924492 230 233 O
study NCT03924492 234 239 O
requirements NCT03924492 240 252 O

4 NCT03924492 256 257 O
. NCT03924492 257 258 O
Subject NCT03924492 260 267 O
agrees NCT03924492 268 274 O
not NCT03924492 275 278 O
to NCT03924492 279 281 O
be NCT03924492 282 284 O
the NCT03924492 285 288 O
primary NCT03924492 289 296 B-Observation-Name
caregiver NCT03924492 297 306 I-Observation-Name
of NCT03924492 307 309 O
any NCT03924492 310 313 O
dependents NCT03924492 314 324 O
during NCT03924492 325 331 O
the NCT03924492 332 335 O
infusion NCT03924492 336 344 B-Procedure-Name

5 NCT03924492 348 349 O
. NCT03924492 349 350 O
Subject NCT03924492 352 359 O
must NCT03924492 360 364 O
have NCT03924492 365 369 O
a NCT03924492 370 371 O
negative NCT03924492 372 380 B-Polarity___Polarity-Value:negative
pregnancy NCT03924492 381 390 B-Observation-Name
test NCT03924492 391 395 I-Observation-Name
on NCT03924492 396 398 O
Day NCT03924492 399 402 O
1 NCT03924492 404 405 O
prior NCT03924492 406 411 O
to NCT03924492 412 414 O
the NCT03924492 415 418 O
start NCT03924492 419 424 O
of NCT03924492 425 427 O
the NCT03924492 428 431 O
ZULRESSO NCT03924492 432 440 B-Procedure-Name
infusion NCT03924492 441 449 I-Procedure-Name

6 NCT03924492 453 454 O
. NCT03924492 454 455 O
Subject NCT03924492 457 464 O
has NCT03924492 465 468 O
a NCT03924492 469 470 O
current NCT03924492 471 478 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnosis NCT03924492 479 488 O
of NCT03924492 489 491 O
PPD NCT03924492 492 495 B-Condition-Name
, NCT03924492 496 497 O
as NCT03924492 498 500 O
assessed NCT03924492 501 509 O
by NCT03924492 510 512 O
the NCT03924492 513 516 O
Investigator NCT03924492 517 529 O

Exclusion NCT03924492 530 539 O
Criteria NCT03924492 540 548 O
: NCT03924492 549 550 O

1 NCT03924492 555 556 O
. NCT03924492 556 557 O
Subject NCT03924492 559 566 O
has NCT03924492 567 570 O
end NCT03924492 571 574 O
stage NCT03924492 575 580 O
renal NCT03924492 581 586 B-Condition-Name
disease NCT03924492 587 594 I-Condition-Name

2 NCT03924492 598 599 O
. NCT03924492 599 600 O
Subject NCT03924492 602 609 O
has NCT03924492 610 613 O
a NCT03924492 614 615 O
known NCT03924492 616 621 O
allergy NCT03924492 622 629 O
to NCT03924492 630 632 O
progesterone NCT03924492 633 645 B-Drug-Name
or NCT03924492 646 648 O
allopregnanolone NCT03924492 649 665 B-Drug-Name

Inclusion NCT03925571 0 9 O
Criteria NCT03925571 10 18 O
: NCT03925571 19 20 O

- NCT03925571 24 25 O
Majors NCT03925571 27 33 O
aged NCT03925571 34 38 O
between NCT03925571 39 46 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03925571 48 50 B-Eq-Value
and NCT03925571 51 54 O
55 NCT03925571 56 58 B-Eq-Value
years NCT03925571 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03925571 65 66 O
with NCT03925571 67 71 O
an NCT03925571 72 74 O
appropriate NCT03925571 75 86 O
hearing NCT03925571 87 94 O
and NCT03925571 95 98 O
able NCT03925571 99 103 O
to NCT03925571 104 106 O
use NCT03925571 107 110 O
Music NCT03925571 111 116 O
- NCT03925571 117 118 O
Care NCT03925571 119 123 O
© NCT03925571 123 124 O
( NCT03925571 125 126 O
selection NCT03925571 127 136 O
of NCT03925571 137 139 O
the NCT03925571 140 143 O
playlist NCT03925571 144 152 O
via NCT03925571 153 156 O
internet NCT03925571 157 165 O
access NCT03925571 166 172 O
) NCT03925571 173 174 O
, NCT03925571 176 177 O

- NCT03925571 181 182 O
Needing NCT03925571 184 191 O
treatment NCT03925571 192 201 O
in NCT03925571 202 204 O
odontology NCT03925571 205 215 O
- NCT03925571 216 217 O
periodontal NCT03925571 218 229 O
surgery NCT03925571 230 237 B-Procedure-Name
( NCT03925571 238 239 O
coronary NCT03925571 240 248 B-Procedure-Name
elongation NCT03925571 249 259 I-Procedure-Name
or NCT03925571 260 262 O
sanitation NCT03925571 263 273 B-Procedure-Name
surgery NCT03925571 274 281 I-Procedure-Name
or NCT03925571 282 284 O
muco NCT03925571 285 289 B-Procedure-Name
- NCT03925571 290 291 I-Procedure-Name
gingival NCT03925571 292 300 I-Procedure-Name
surgery NCT03925571 301 308 I-Procedure-Name
) NCT03925571 309 310 O
or NCT03925571 311 313 O
implantary NCT03925571 314 324 B-Procedure-Name
surgery NCT03925571 325 332 I-Procedure-Name
( NCT03925571 333 334 O
placement NCT03925571 335 344 B-Procedure-Name
of NCT03925571 345 347 I-Procedure-Name
an NCT03925571 348 350 I-Procedure-Name
unit NCT03925571 351 355 I-Procedure-Name
implant NCT03925571 356 363 O
or NCT03925571 364 366 O
two NCT03925571 367 370 O
implant NCT03925571 371 378 O
in NCT03925571 379 381 O
the NCT03925571 382 385 O
same NCT03925571 386 390 O
localization NCT03925571 391 403 O
) NCT03925571 404 405 O
, NCT03925571 407 408 O

- NCT03925571 412 413 O
Oral NCT03925571 415 419 O
and NCT03925571 420 423 O
dated NCT03925571 424 429 O
consent NCT03925571 430 437 O
, NCT03925571 438 439 O

- NCT03925571 443 444 O
Agreeing NCT03925571 446 454 O
to NCT03925571 455 457 O
be NCT03925571 458 460 O
contacted NCT03925571 461 470 O
via NCT03925571 471 474 O
phone NCT03925571 475 480 O
at NCT03925571 481 483 O
J NCT03925571 484 485 O
+ NCT03925571 486 487 O
1 NCT03925571 489 490 O
and NCT03925571 491 494 O
to NCT03925571 495 497 O
fill NCT03925571 498 502 O
follow NCT03925571 503 509 O
- NCT03925571 510 511 O
up NCT03925571 512 514 O
study NCT03925571 515 520 O
documents NCT03925571 521 530 O
, NCT03925571 531 532 O

- NCT03925571 536 537 O
Profiting NCT03925571 539 548 O
of NCT03925571 549 551 O
social NCT03925571 552 558 O
security NCT03925571 559 567 O
or NCT03925571 568 570 O
CMU NCT03925571 571 574 O
. NCT03925571 575 576 O

Exclusion NCT03925571 578 587 O
Criteria NCT03925571 588 596 O
: NCT03925571 597 598 O

- NCT03925571 602 603 O
Patients NCT03925571 605 613 O
with NCT03925571 614 618 O
a NCT03925571 619 620 O
long NCT03925571 621 625 O
- NCT03925571 626 627 O
term NCT03925571 628 632 O
taking NCT03925571 633 639 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03925571 640 642 O
anxiolytic NCT03925571 643 653 B-Drug-Name
or NCT03925571 654 656 O
analgesic NCT03925571 657 666 B-Drug-Name
, NCT03925571 667 668 O

- NCT03925571 672 673 O
Regular NCT03925571 675 682 O
consumer NCT03925571 683 691 O
of NCT03925571 692 694 O
soft NCT03925571 695 699 B-Drug-Name
drug NCT03925571 700 704 I-Drug-Name
( NCT03925571 705 706 O
cannabis NCT03925571 707 715 B-Drug-Name
) NCT03925571 716 717 O
or NCT03925571 718 720 O
hard NCT03925571 721 725 B-Drug-Name
drug NCT03925571 726 730 I-Drug-Name
( NCT03925571 731 732 O
opioid NCT03925571 733 739 B-Drug-Name
) NCT03925571 740 741 O
, NCT03925571 743 744 O

- NCT03925571 748 749 O
Patient NCT03925571 751 758 O
with NCT03925571 759 763 O
medical NCT03925571 764 771 O
history NCT03925571 772 779 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925571 780 782 O
psychiatry NCT03925571 783 793 B-Procedure-Name
( NCT03925571 794 795 O
mental NCT03925571 796 802 B-Condition-Name
harm NCT03925571 803 807 I-Condition-Name
) NCT03925571 808 809 O
, NCT03925571 811 812 O
hearing NCT03925571 813 820 B-Condition-Name
problem NCT03925571 821 828 I-Condition-Name
, NCT03925571 829 830 O
cognitive NCT03925571 831 840 O
and NCT03925571 841 844 O
behavioural NCT03925571 845 856 O
impairment NCT03925571 857 867 B-Condition-Name
( NCT03925571 868 869 O
claustrophobia NCT03925571 870 884 B-Condition-Name
) NCT03925571 885 886 O
, NCT03925571 888 889 O
sensory NCT03925571 890 897 B-Condition-Name
disabilities NCT03925571 898 910 I-Condition-Name
, NCT03925571 911 912 O

- NCT03925571 916 917 O
Patient NCT03925571 919 926 O
with NCT03925571 927 931 O
problems NCT03925571 932 940 O
of NCT03925571 941 943 O
hemostasis NCT03925571 944 954 B-Procedure-Name
, NCT03925571 955 956 O

- NCT03925571 960 961 O
Majors NCT03925571 963 969 O
under NCT03925571 970 975 O
trusteeship NCT03925571 976 987 O
or NCT03925571 988 990 O
guardianship NCT03925571 991 1003 O
, NCT03925571 1004 1005 O

- NCT03925571 1009 1010 O
Pregnant NCT03925571 1012 1020 B-Condition-Name
women NCT03925571 1021 1026 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
or NCT03925571 1027 1029 O
lactating NCT03925571 1030 1039 B-Condition-Name
, NCT03925571 1040 1041 O

- NCT03925571 1045 1046 O
Minors NCT03925571 1048 1054 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
, NCT03925571 1055 1056 O

- NCT03925571 1060 1061 O
Protected NCT03925571 1063 1072 B-Observation-Name
person NCT03925571 1073 1079 I-Observation-Name
, NCT03925571 1080 1081 O
deprived NCT03925571 1082 1090 O
of NCT03925571 1091 1093 O
freedom NCT03925571 1094 1101 O
or NCT03925571 1102 1104 O
under NCT03925571 1105 1110 O
justice NCT03925571 1111 1118 O
safeguard NCT03925571 1119 1128 O
, NCT03925571 1129 1130 O

- NCT03925571 1134 1135 O
Profiting NCT03925571 1137 1146 O
of NCT03925571 1147 1149 O
a NCT03925571 1150 1151 O
medical NCT03925571 1152 1159 O
help NCT03925571 1160 1164 O
from NCT03925571 1165 1169 O
government NCT03925571 1170 1180 O
( NCT03925571 1181 1182 O
AME NCT03925571 1183 1186 O
) NCT03925571 1187 1188 O
, NCT03925571 1190 1191 O

- NCT03925571 1195 1196 O
Not NCT03925571 1198 1201 O
contactable NCT03925571 1202 1213 O
after NCT03925571 1214 1219 O
care NCT03925571 1220 1224 O
, NCT03925571 1225 1226 O

- NCT03925571 1230 1231 O
Patient NCT03925571 1233 1240 O
with NCT03925571 1241 1245 O
hepatic NCT03925571 1246 1253 B-Condition-Name
impairment NCT03925571 1254 1264 I-Condition-Name
, NCT03925571 1265 1266 O

- NCT03925571 1270 1271 O
Patient NCT03925571 1273 1280 O
with NCT03925571 1281 1285 O
dry NCT03925571 1286 1289 B-Condition-Name
mouth NCT03925571 1290 1295 I-Condition-Name
, NCT03925571 1296 1297 O

- NCT03925571 1301 1302 O
Patient NCT03925571 1304 1311 O
relevant NCT03925571 1312 1320 O
a NCT03925571 1321 1322 O
suboptimal NCT03925571 1323 1333 B-Condition-Name
hearing NCT03925571 1334 1341 I-Condition-Name
incompatible NCT03925571 1342 1354 O
with NCT03925571 1355 1359 O
musicotherapy NCT03925571 1360 1373 O
or NCT03925571 1374 1376 O
inability NCT03925571 1377 1386 O
to NCT03925571 1387 1389 O
use NCT03925571 1390 1393 O
Music NCT03925571 1394 1399 O
- NCT03925571 1400 1401 O
care NCT03925571 1402 1406 O
® NCT03925571 1406 1407 O
. NCT03925571 1408 1409 O

Inclusion NCT03926078 0 9 O
criteria NCT03926078 10 18 O
: NCT03926078 19 20 O

- NCT03926078 24 25 O
All NCT03926078 27 30 O
patients NCT03926078 31 39 O
that NCT03926078 40 44 O
visit NCT03926078 45 50 O
the NCT03926078 51 54 O
Zuyderland NCT03926078 55 65 B-Location___Location-Value:hospital
Medical NCT03926078 66 73 I-Location___Location-Value:hospital
Centre NCT03926078 74 80 I-Location___Location-Value:hospital
outpatient NCT03926078 81 91 B-Encounter-Type___Encounter-Type-Value:outpatient
clinic NCT03926078 92 98 B-Location___Location-Value:clinic
for NCT03926078 99 102 O
evaluation NCT03926078 103 113 O
of NCT03926078 114 116 O
their NCT03926078 117 122 O
pectus NCT03926078 123 129 B-Condition-Name
excavatum NCT03926078 130 139 I-Condition-Name
. NCT03926078 140 141 O

- NCT03926078 145 146 O
No NCT03926078 148 150 O
age NCT03926078 151 154 O
restrictions NCT03926078 155 167 O
were NCT03926078 168 172 O
imposed NCT03926078 173 180 O
, NCT03926078 181 182 O
however NCT03926078 183 190 O
, NCT03926078 191 192 O
to NCT03926078 193 195 O
be NCT03926078 196 198 O
eligible NCT03926078 199 207 O
, NCT03926078 208 209 O
it NCT03926078 210 212 O
was NCT03926078 213 216 O
mandatory NCT03926078 217 226 O
to NCT03926078 227 229 O
be NCT03926078 230 232 O
able NCT03926078 233 237 O
to NCT03926078 238 240 O
stand NCT03926078 241 246 O
still NCT03926078 247 252 O
in NCT03926078 253 255 O
and NCT03926078 256 259 O
upright NCT03926078 260 267 O
position NCT03926078 268 276 O
for NCT03926078 277 280 O
60 NCT03926078 282 284 O
seconds NCT03926078 285 292 O
. NCT03926078 293 294 O

Exclusion NCT03926078 296 305 O
criteria NCT03926078 306 314 O
: NCT03926078 315 316 O

- NCT03926078 319 320 O
Patients NCT03926078 321 329 O
that NCT03926078 330 334 O
suffer NCT03926078 335 341 O
from NCT03926078 342 346 O
any NCT03926078 347 350 O
form NCT03926078 351 355 O
of NCT03926078 356 358 O
light NCT03926078 359 364 B-Condition-Name
hypersensitivity NCT03926078 365 381 I-Condition-Name
or NCT03926078 382 384 O
epilepsy NCT03926078 385 393 B-Condition-Name
were NCT03926078 394 398 O
not NCT03926078 399 402 O

considered NCT03926078 403 413 O
while NCT03926078 414 419 O
3 NCT03926078 421 422 O
D NCT03926078 423 424 O
optical NCT03926078 425 432 O
surface NCT03926078 433 440 O
images NCT03926078 441 447 O
were NCT03926078 448 452 O
acquired NCT03926078 453 461 O
with NCT03926078 462 466 O
the NCT03926078 467 470 O
use NCT03926078 471 474 O
of NCT03926078 475 477 O
structured NCT03926078 478 488 O
, NCT03926078 489 490 O

flashing NCT03926078 492 500 O
light NCT03926078 501 506 O
. NCT03926078 507 508 O

Inclusion NCT03923114 0 9 O
Criteria NCT03923114 10 18 O
: NCT03923114 19 20 O

Patients NCT03923114 22 30 O
with NCT03923114 31 35 O
treatment NCT03923114 36 45 B-Observation-Name
response NCT03923114 46 54 I-Observation-Name
: NCT03923114 55 56 O

- NCT03923114 60 61 O
Age NCT03923114 63 66 O
≥ NCT03923114 67 68 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03923114 70 72 B-Eq-Value
years NCT03923114 73 78 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923114 81 82 O
Subject NCT03923114 84 91 O
is NCT03923114 92 94 O
diagnosed NCT03923114 95 104 O
with NCT03923114 105 109 O
type NCT03923114 110 114 B-Condition-Name
2 NCT03923114 116 117 I-Condition-Name
diabetes NCT03923114 118 126 I-Condition-Name

- NCT03923114 129 130 O
Subject NCT03923114 132 139 O
showed NCT03923114 140 146 O
response NCT03923114 147 155 B-Observation-Name
to NCT03923114 156 158 O
GLP NCT03923114 159 162 B-Procedure-Name
- NCT03923114 163 164 I-Procedure-Name
1 NCT03923114 166 167 I-Procedure-Name
RA NCT03923114 168 170 I-Procedure-Name
treatment NCT03923114 171 180 I-Procedure-Name

- NCT03923114 183 184 O
Ability NCT03923114 186 193 O
to NCT03923114 194 196 O
sign NCT03923114 197 201 O
informed NCT03923114 202 210 O
consent NCT03923114 211 218 O

Patients NCT03923114 219 227 O
without NCT03923114 228 235 O
treatment NCT03923114 236 245 B-Observation-Name
response NCT03923114 246 254 I-Observation-Name
: NCT03923114 255 256 O

- NCT03923114 260 261 O
Age NCT03923114 263 266 O
≥ NCT03923114 267 268 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03923114 270 272 B-Eq-Value
years NCT03923114 273 278 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923114 281 282 O
Subject NCT03923114 284 291 O
is NCT03923114 292 294 O
diagnosed NCT03923114 295 304 O
with NCT03923114 305 309 O
type NCT03923114 310 314 B-Condition-Name
2 NCT03923114 316 317 I-Condition-Name
diabetes NCT03923114 318 326 I-Condition-Name

- NCT03923114 329 330 O
Subject NCT03923114 332 339 O
showed NCT03923114 340 346 O
no NCT03923114 347 349 O
response NCT03923114 350 358 B-Observation-Name
to NCT03923114 359 361 O
GLP NCT03923114 362 365 B-Procedure-Name
- NCT03923114 366 367 I-Procedure-Name
1 NCT03923114 369 370 I-Procedure-Name
RA NCT03923114 371 373 I-Procedure-Name
treatment NCT03923114 374 383 I-Procedure-Name

- NCT03923114 386 387 O
Ability NCT03923114 389 396 O
to NCT03923114 397 399 O
sign NCT03923114 400 404 O
informed NCT03923114 405 413 O
consent NCT03923114 414 421 O

Exclusion NCT03923114 422 431 O
Criteria NCT03923114 432 440 O
: NCT03923114 441 442 O

- NCT03923114 446 447 O
Liver NCT03923114 449 454 B-Condition-Name
disease NCT03923114 455 462 I-Condition-Name

- NCT03923114 465 466 O
Renal NCT03923114 468 473 B-Condition-Name
disease NCT03923114 474 481 I-Condition-Name

- NCT03923114 484 485 O
Pregnancy NCT03923114 487 496 B-Condition-Name
or NCT03923114 497 499 O
the NCT03923114 500 503 O
wish NCT03923114 504 508 O
to NCT03923114 509 511 O
become NCT03923114 512 518 O
pregnant NCT03923114 519 527 B-Condition-Name
within NCT03923114 528 534 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03923114 536 537 B-Eq-Value
months NCT03923114 538 544 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03923114 545 550 O
the NCT03923114 551 554 O
study NCT03923114 555 560 O

- NCT03923114 563 564 O
Breastfeeding NCT03923114 566 579 B-Condition-Name

- NCT03923114 582 583 O
Age NCT03923114 585 588 O
< NCT03923114 589 590 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03923114 592 594 B-Eq-Value
years NCT03923114 595 600 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923114 603 604 O
Pituitary NCT03923114 606 615 B-Condition-Name
disorder NCT03923114 616 624 I-Condition-Name

- NCT03923114 627 628 O
Inability NCT03923114 630 639 O
to NCT03923114 640 642 O
sign NCT03923114 643 647 O
informed NCT03923114 648 656 O
consent NCT03923114 657 664 O

- NCT03923114 667 668 O
Exclusion NCT03923114 670 679 O
criteria NCT03923114 680 688 O
for NCT03923114 689 692 O
MR NCT03923114 693 695 O
: NCT03923114 696 697 O

- NCT03923114 706 707 O
Fragments NCT03923114 709 718 O
, NCT03923114 719 720 O
clips NCT03923114 721 726 O
or NCT03923114 727 729 O
devices NCT03923114 730 737 O
in NCT03923114 738 740 O
brain NCT03923114 741 746 B-Condition-Name
, NCT03923114 747 748 O
eyes NCT03923114 749 753 O
, NCT03923114 754 755 O
spinal NCT03923114 756 762 O
canal NCT03923114 763 768 O

- NCT03923114 776 777 O
Implantable NCT03923114 779 790 B-Procedure-Name
defibrillator NCT03923114 791 804 I-Procedure-Name
or NCT03923114 805 807 O
pacemaker NCT03923114 808 817 B-Procedure-Name
( NCT03923114 818 819 O
wires NCT03923114 820 825 O
) NCT03923114 826 827 O

- NCT03923114 836 837 O
Mandibular NCT03923114 839 849 B-Procedure-Name
magnetic NCT03923114 850 858 I-Procedure-Name
implants NCT03923114 859 867 I-Procedure-Name

- NCT03923114 875 876 O
Neurostimulator NCT03923114 878 893 B-Procedure-Name
, NCT03923114 894 895 O
bladder NCT03923114 896 903 B-Procedure-Name
stimulator NCT03923114 904 914 I-Procedure-Name
, NCT03923114 915 916 O
non NCT03923114 917 920 B-Procedure-Name
- NCT03923114 921 922 I-Procedure-Name
removable NCT03923114 923 932 I-Procedure-Name
insulin NCT03923114 933 940 I-Procedure-Name
pump NCT03923114 941 945 I-Procedure-Name

- NCT03923114 953 954 O
Metal NCT03923114 956 961 B-Procedure-Name
tissue NCT03923114 962 968 I-Procedure-Name
- NCT03923114 969 970 I-Procedure-Name
expander NCT03923114 971 979 I-Procedure-Name
in NCT03923114 980 982 I-Procedure-Name
chest NCT03923114 983 988 I-Procedure-Name

- NCT03923114 996 997 O
Cochlear NCT03923114 999 1007 B-Procedure-Name
implant NCT03923114 1008 1015 I-Procedure-Name

- NCT03923114 1023 1024 O
Ossicular NCT03923114 1026 1035 B-Procedure-Name
replacement NCT03923114 1036 1047 I-Procedure-Name
prosthesis NCT03923114 1048 1058 I-Procedure-Name

Inclusion NCT03921918 0 9 O
Criteria NCT03921918 10 18 O
: NCT03921918 19 20 O

1 NCT03921918 25 26 O
. NCT03921918 26 27 O
Subject NCT03921918 29 36 O
≥ NCT03921918 37 38 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03921918 40 42 B-Eq-Value
years NCT03921918 43 48 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03921918 49 52 O

2 NCT03921918 56 57 O
. NCT03921918 57 58 O
Infant NCT03921918 60 66 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
is NCT03921918 67 69 O
≥ NCT03921918 70 71 B-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03921918 73 74 B-Eq-Value
and NCT03921918 75 78 O
≤ NCT03921918 79 80 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03921918 82 83 B-Eq-Value
month NCT03921918 84 89 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
old NCT03921918 90 93 O

3 NCT03921918 97 98 O
. NCT03921918 98 99 O
Subject NCT03921918 101 108 O
and NCT03921918 109 112 O
baby NCT03921918 113 117 O
are NCT03921918 118 121 O
healthy NCT03921918 122 129 B-Condition-Name
according NCT03921918 130 139 O
to NCT03921918 140 142 O
self NCT03921918 143 147 O
- NCT03921918 148 149 O
declaration NCT03921918 150 161 O
in NCT03921918 162 164 O
the NCT03921918 165 168 O
" NCT03921918 169 170 O
Mother NCT03921918 170 176 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
and NCT03921918 177 180 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
infant NCT03921918 181 187 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
health NCT03921918 188 194 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
questionnaire NCT03921918 195 208 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
" NCT03921918 208 209 O

4 NCT03921918 213 214 O
. NCT03921918 214 215 O
Subject NCT03921918 217 224 O
is NCT03921918 225 227 O
predominantly NCT03921918 228 241 O
breastfeeding NCT03921918 242 255 B-Condition-Name
( NCT03921918 256 257 O
80 NCT03921918 259 261 B-Eq-Value
% NCT03921918 262 263 B-Eq-Unit
of NCT03921918 264 266 O
all NCT03921918 267 270 O
feeds NCT03921918 271 276 O
, NCT03921918 277 278 O
i NCT03921918 279 280 O
. NCT03921918 281 282 O
e NCT03921918 283 284 O
. NCT03921918 285 286 O
≤ NCT03921918 288 289 B-Eq-Operator___Eq-Operator-Value:LTEQ
150 NCT03921918 291 294 B-Eq-Value
ml NCT03921918 295 297 B-Eq-Unit
formula NCT03921918 298 305 O
/ NCT03921918 306 307 O
day NCT03921918 308 311 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
or NCT03921918 312 314 O
equal NCT03921918 315 320 O
representative NCT03921918 321 335 O
amount NCT03921918 336 342 O
of NCT03921918 343 345 O
solid NCT03921918 346 351 O
food NCT03921918 352 356 O
) NCT03921918 357 358 O

5 NCT03921918 363 364 O
. NCT03921918 364 365 O
The NCT03921918 367 370 O
subject NCT03921918 371 378 O
agrees NCT03921918 379 385 O
to NCT03921918 386 388 O
pump NCT03921918 389 393 B-Observation-Name
or NCT03921918 394 396 O
feed NCT03921918 397 401 B-Observation-Name
the NCT03921918 402 405 O
last NCT03921918 406 410 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
time NCT03921918 411 415 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
a NCT03921918 416 417 O
minimum NCT03921918 418 425 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03921918 426 428 O
2 NCT03921918 430 431 B-Eq-Value
hours NCT03921918 432 437 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
( NCT03921918 438 439 O
hr NCT03921918 440 442 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
) NCT03921918 443 444 O
before NCT03921918 445 451 O
the NCT03921918 452 455 O
start NCT03921918 456 461 O
of NCT03921918 462 464 O
the NCT03921918 465 468 O
pumping NCT03921918 469 476 O
session NCT03921918 477 484 O
at NCT03921918 485 487 O
the NCT03921918 488 491 O
study NCT03921918 492 497 O
site NCT03921918 498 502 O

6 NCT03921918 506 507 O
. NCT03921918 507 508 O
The NCT03921918 510 513 O
subject NCT03921918 514 521 O
agrees NCT03921918 522 528 O
to NCT03921918 529 531 O
photographs NCT03921918 532 543 B-Observation-Name
/ NCT03921918 544 545 I-Observation-Name
3 NCT03921918 547 548 I-Observation-Name
D NCT03921918 549 550 I-Observation-Name
scan NCT03921918 551 555 I-Observation-Name
of NCT03921918 556 558 O
the NCT03921918 559 562 O
breast NCT03921918 563 569 O
and NCT03921918 570 573 O
upper NCT03921918 574 579 O
body NCT03921918 580 584 O
( NCT03921918 585 586 O
no NCT03921918 587 589 O
face NCT03921918 590 594 O
) NCT03921918 595 596 O
, NCT03921918 598 599 O

7 NCT03921918 604 605 O
. NCT03921918 605 606 O
The NCT03921918 608 611 O
subject NCT03921918 612 619 O
agrees NCT03921918 620 626 O
to NCT03921918 627 629 O
a NCT03921918 630 631 O
video NCT03921918 632 637 B-Observation-Name
while NCT03921918 638 643 O
pumping NCT03921918 644 651 B-Observation-Name

8 NCT03921918 655 656 O
. NCT03921918 656 657 O
The NCT03921918 659 662 O
subject NCT03921918 663 670 O
signs NCT03921918 671 676 O
the NCT03921918 677 680 O
informed NCT03921918 681 689 O
consent NCT03921918 690 697 O
documentation NCT03921918 698 711 O

9 NCT03921918 715 716 O
. NCT03921918 716 717 O
Subject NCT03921918 719 726 O
agrees NCT03921918 727 733 O
that NCT03921918 734 738 O
a NCT03921918 739 740 O
maximum NCT03921918 741 748 B-Eq-Operator___Eq-Operator-Value:LTEQ
of NCT03921918 749 751 O
2 NCT03921918 753 754 B-Eq-Value
male NCT03921918 755 759 B-Eq-Unit
team NCT03921918 760 764 I-Eq-Unit
members NCT03921918 765 772 I-Eq-Unit
can NCT03921918 773 776 O
be NCT03921918 777 779 O
present NCT03921918 780 787 B-Observation-Name
in NCT03921918 788 790 I-Observation-Name
the NCT03921918 791 794 I-Observation-Name
room NCT03921918 795 799 I-Observation-Name
to NCT03921918 800 802 O
conduct NCT03921918 803 810 O
the NCT03921918 811 814 O
usability NCT03921918 815 824 O
part NCT03921918 825 829 O
of NCT03921918 830 832 O
the NCT03921918 833 836 O
study NCT03921918 837 842 O

10 NCT03921918 845 847 O
. NCT03921918 847 848 O
The NCT03921918 850 853 O
mother NCT03921918 854 860 O
accepts NCT03921918 861 868 O
that NCT03921918 869 873 O
the NCT03921918 874 877 O
pumped NCT03921918 878 884 O
milk NCT03921918 885 889 O
in NCT03921918 890 892 O
visit NCT03921918 893 898 O
2 NCT03921918 900 901 O
must NCT03921918 902 906 O
be NCT03921918 907 909 O
donated NCT03921918 910 917 O
to NCT03921918 918 920 O
the NCT03921918 921 924 O
study NCT03921918 925 930 O
i NCT03921918 931 932 O
. NCT03921918 933 934 O
e NCT03921918 935 936 O
. NCT03921918 937 938 O
can NCT03921918 940 943 O
not NCT03921918 943 946 O
be NCT03921918 947 949 O
fed NCT03921918 950 953 O
to NCT03921918 954 956 O
the NCT03921918 957 960 O
baby NCT03921918 961 965 O

Exclusion NCT03921918 966 975 O
Criteria NCT03921918 976 984 O
: NCT03921918 985 986 O

1 NCT03921918 991 992 O
. NCT03921918 992 993 O
The NCT03921918 995 998 O
subject NCT03921918 999 1006 O
has NCT03921918 1007 1010 O
a NCT03921918 1011 1012 O
nipple NCT03921918 1013 1019 B-Observation-Name___Observation-Type-Value:measurement
size NCT03921918 1020 1024 I-Observation-Name___Observation-Type-Value:measurement
≥ NCT03921918 1025 1026 B-Eq-Operator___Eq-Operator-Value:GTEQ
21 NCT03921918 1028 1030 B-Eq-Value
mm NCT03921918 1031 1033 B-Eq-Unit

2 NCT03921918 1037 1038 O
. NCT03921918 1038 1039 O
Mastitis NCT03921918 1041 1049 B-Condition-Name
( NCT03921918 1050 1051 O
any NCT03921918 1052 1055 O
breast NCT03921918 1056 1062 O
within NCT03921918 1063 1069 B-Eq-Operator___Eq-Operator-Value:LTEQ
two NCT03921918 1070 1073 B-Eq-Value
weeks NCT03921918 1074 1079 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03921918 1080 1085 O
to NCT03921918 1086 1088 O
enrolment NCT03921918 1089 1098 O
) NCT03921918 1099 1100 O

3 NCT03921918 1105 1106 O
. NCT03921918 1106 1107 O
Engorgement NCT03921918 1109 1120 B-Condition-Name
( NCT03921918 1121 1122 O
any NCT03921918 1123 1126 O
breast NCT03921918 1127 1133 O
within NCT03921918 1134 1140 B-Eq-Operator___Eq-Operator-Value:LTEQ
two NCT03921918 1141 1144 B-Eq-Value
weeks NCT03921918 1145 1150 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03921918 1151 1156 O
to NCT03921918 1157 1159 O
enrolment NCT03921918 1160 1169 O
) NCT03921918 1170 1171 O
. NCT03921918 1173 1174 O

4 NCT03921918 1179 1180 O
. NCT03921918 1180 1181 O
Case NCT03921918 1183 1187 O
of NCT03921918 1188 1190 O
current NCT03921918 1191 1198 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03921918 1199 1208 B-Condition-Name
as NCT03921918 1209 1211 O
self NCT03921918 1212 1216 O
- NCT03921918 1217 1218 O
declared NCT03921918 1219 1227 O
in NCT03921918 1228 1230 O
the NCT03921918 1231 1234 O
Mother NCT03921918 1235 1241 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
and NCT03921918 1242 1245 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
infant NCT03921918 1246 1252 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
health NCT03921918 1253 1259 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
questionnaire NCT03921918 1260 1273 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire

Inclusion NCT03923699 0 9 O
Criteria NCT03923699 10 18 O
: NCT03923699 19 20 O

- NCT03923699 24 25 O
All NCT03923699 27 30 O
patients NCT03923699 31 39 O
18 NCT03923699 41 43 B-Eq-Value
years NCT03923699 44 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03923699 50 52 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03923699 53 58 I-Eq-Operator___Eq-Operator-Value:GTEQ
undergoing NCT03923699 59 69 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surgery NCT03923699 70 77 B-Procedure-Name
at NCT03923699 78 80 O
Barnes NCT03923699 81 87 B-Location___Location-Value:hospital
Jewish NCT03923699 88 94 I-Location___Location-Value:hospital
Hospital NCT03923699 95 103 I-Location___Location-Value:hospital
in NCT03923699 104 106 O
St NCT03923699 107 109 B-Location
. NCT03923699 110 111 I-Location
Louis NCT03923699 113 118 I-Location
, NCT03923699 119 120 I-Location
MO NCT03923699 121 123 I-Location

Exclusion NCT03923699 124 133 O
Criteria NCT03923699 134 142 O
: NCT03923699 143 144 O

- NCT03923699 147 148 O

Inclusion NCT03920384 0 9 O
Criteria NCT03920384 10 18 O
: NCT03920384 19 20 O

- NCT03920384 24 25 O
Are NCT03920384 27 30 O
aged NCT03920384 31 35 O
16 NCT03920384 37 39 B-Eq-Value
or NCT03920384 40 42 B-Eq-Operator___Eq-Operator-Value:GTEQ
over NCT03920384 43 47 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03920384 50 51 O
Are NCT03920384 53 56 O
competent NCT03920384 57 66 O
and NCT03920384 67 70 O
willing NCT03920384 71 78 O
to NCT03920384 79 81 O
provide NCT03920384 82 89 O
written NCT03920384 90 97 O
, NCT03920384 98 99 O
informed NCT03920384 100 108 O
consent NCT03920384 109 116 O

- NCT03920384 119 120 O
Are NCT03920384 122 125 O
experiencing NCT03920384 126 138 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
delusions NCT03920384 139 148 B-Condition-Name
( NCT03920384 149 150 O
A NCT03920384 151 152 O
score NCT03920384 153 158 B-Eq-Unit
of NCT03920384 159 161 O
≥ NCT03920384 162 163 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03920384 165 166 B-Eq-Value
on NCT03920384 167 169 O
PANSS NCT03920384 170 175 B-Observation-Name
item NCT03920384 176 180 O
P NCT03920384 181 182 O
1 NCT03920384 183 184 O
, NCT03920384 185 186 O
P NCT03920384 187 188 O
5 NCT03920384 189 190 O
or NCT03920384 191 193 O
P NCT03920384 194 195 O
6 NCT03920384 196 197 O
) NCT03920384 198 199 O

Exclusion NCT03920384 201 210 O
Criteria NCT03920384 211 219 O
: NCT03920384 220 221 O

- NCT03920384 225 226 O
Significant NCT03920384 228 239 B-Severity___Severity-Value:severe
developmental NCT03920384 240 253 B-Condition-Name
disability NCT03920384 254 264 I-Condition-Name

- NCT03920384 267 268 O
Currently NCT03920384 270 279 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
receiving NCT03920384 280 289 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03920384 290 292 O
have NCT03920384 293 297 O
received NCT03920384 298 306 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
CBTp NCT03920384 307 311 B-Procedure-Name
in NCT03920384 312 314 O
the NCT03920384 315 318 O
last NCT03920384 319 323 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03920384 325 326 B-Eq-Value
months NCT03920384 327 333 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03920384 336 337 O
Significant NCT03920384 339 350 O
difficulty NCT03920384 351 361 O
with NCT03920384 362 366 O
the NCT03920384 367 370 O
English NCT03920384 371 378 B-Language
language NCT03920384 379 387 I-Language

Inclusion NCT03925363 0 9 O
Criteria NCT03925363 10 18 O
: NCT03925363 19 20 O

- NCT03925363 24 25 O
Previous NCT03925363 27 35 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
participants NCT03925363 36 48 O
in NCT03925363 49 51 O
healthy NCT03925363 52 59 O
aging NCT03925363 60 65 O
initiative NCT03925363 66 76 O
. NCT03925363 77 78 O

Exclusion NCT03925363 80 89 O
Criteria NCT03925363 90 98 O
: NCT03925363 99 100 O

- NCT03925363 104 105 O
Not NCT03925363 107 110 O
able NCT03925363 111 115 B-Condition-Name
to NCT03925363 116 118 I-Condition-Name
walk NCT03925363 119 123 I-Condition-Name
or NCT03925363 124 126 O
previous NCT03925363 127 135 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
medical NCT03925363 136 143 O
diagnoses NCT03925363 144 153 O
that NCT03925363 154 158 O
severely NCT03925363 159 167 B-Severity___Severity-Value:severe
limits NCT03925363 168 174 O
the NCT03925363 175 178 O
possibility NCT03925363 179 190 O
to NCT03925363 191 193 O
exercise NCT03925363 194 202 B-Observation-Name___Observation-Type-Value:social-habit
. NCT03925363 203 204 O

Inclusion NCT03926130 0 9 O
Criteria NCT03926130 10 18 O
: NCT03926130 19 20 O

- NCT03926130 24 25 O
Diagnosis NCT03926130 27 36 O
of NCT03926130 37 39 O
CD NCT03926130 40 42 B-Condition-Name
for NCT03926130 43 46 O
at NCT03926130 47 49 B-Eq-Operator___Eq-Operator-Value:LTEQ
least NCT03926130 50 55 I-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03926130 57 58 B-Eq-Value
months NCT03926130 59 65 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03926130 66 71 O
to NCT03926130 72 74 O
baseline NCT03926130 75 83 O

- NCT03926130 86 87 O
Confirmed NCT03926130 89 98 O
diagnosis NCT03926130 99 108 O
of NCT03926130 109 111 O
moderate NCT03926130 112 120 B-Severity___Severity-Value:moderate
to NCT03926130 121 123 O
severe NCT03926130 124 130 B-Severity___Severity-Value:severe
CD NCT03926130 131 133 B-Condition-Name
as NCT03926130 134 136 O
assessed NCT03926130 137 145 O
by NCT03926130 146 148 O
SF NCT03926130 149 151 B-Observation-Name
, NCT03926130 152 153 O
AP NCT03926130 154 156 B-Observation-Name
score NCT03926130 157 162 I-Observation-Name
, NCT03926130 163 164 O
and NCT03926130 165 168 O
SES NCT03926130 169 172 B-Observation-Name
- NCT03926130 173 174 I-Observation-Name
CD NCT03926130 175 177 I-Observation-Name

- NCT03926130 180 181 O
Demonstrated NCT03926130 183 195 O
intolerance NCT03926130 196 207 B-Condition-Name
, NCT03926130 208 209 O
loss NCT03926130 210 214 B-Condition-Name
of NCT03926130 215 217 I-Condition-Name
response NCT03926130 218 226 I-Condition-Name
or NCT03926130 227 229 O
inadequate NCT03926130 230 240 B-Condition-Name
response NCT03926130 241 249 I-Condition-Name
to NCT03926130 250 252 O
conventional NCT03926130 253 265 O
or NCT03926130 266 268 O
to NCT03926130 269 271 O
biologic NCT03926130 272 280 O
therapy NCT03926130 281 288 B-Procedure-Name
for NCT03926130 289 292 O
CD NCT03926130 293 295 B-Condition-Name

- NCT03926130 298 299 O
If NCT03926130 301 303 O
female NCT03926130 304 310 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03926130 311 312 O
subject NCT03926130 313 320 O
must NCT03926130 321 325 O
meet NCT03926130 326 330 O
the NCT03926130 331 334 O
contraception NCT03926130 335 348 B-Procedure-Name
recommendations NCT03926130 349 364 O

Exclusion NCT03926130 365 374 O
Criteria NCT03926130 375 383 O
: NCT03926130 384 385 O

- NCT03926130 389 390 O
Have NCT03926130 392 396 O
a NCT03926130 397 398 O
current NCT03926130 399 406 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnosis NCT03926130 407 416 O
of NCT03926130 417 419 O
ulcerative NCT03926130 420 430 B-Condition-Name
colitis NCT03926130 431 438 I-Condition-Name
, NCT03926130 439 440 O
inflammatory NCT03926130 441 453 B-Condition-Name
bowel NCT03926130 454 459 I-Condition-Name
disease NCT03926130 460 467 I-Condition-Name
- NCT03926130 468 469 I-Condition-Name
unclassified NCT03926130 470 482 I-Condition-Name
( NCT03926130 483 484 O
IBD NCT03926130 485 488 B-Condition-Name
- NCT03926130 489 490 I-Condition-Name
U NCT03926130 491 492 I-Condition-Name
) NCT03926130 493 494 O
( NCT03926130 495 496 O
formerly NCT03926130 497 505 O
known NCT03926130 506 511 O
as NCT03926130 512 514 O
indeterminate NCT03926130 515 528 B-Condition-Name
colitis NCT03926130 529 536 I-Condition-Name
) NCT03926130 537 538 O
, NCT03926130 540 541 O
abdominal NCT03926130 542 551 O
or NCT03926130 552 554 O
perianal NCT03926130 555 563 O
abscess NCT03926130 564 571 B-Condition-Name
or NCT03926130 572 574 O
short NCT03926130 575 580 B-Condition-Name
bowel NCT03926130 581 586 I-Condition-Name
syndrome NCT03926130 587 595 I-Condition-Name

- NCT03926130 598 599 O
Have NCT03926130 601 605 O
a NCT03926130 606 607 O
stoma NCT03926130 608 613 B-Procedure-Name
or NCT03926130 614 616 O
ostomy NCT03926130 617 623 B-Procedure-Name

- NCT03926130 626 627 O
Have NCT03926130 629 633 O
had NCT03926130 634 637 O
a NCT03926130 638 639 O
bowel NCT03926130 640 645 B-Procedure-Name
resection NCT03926130 646 655 I-Procedure-Name
within NCT03926130 656 662 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03926130 664 665 B-Eq-Value
months NCT03926130 666 672 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03926130 673 674 O
or NCT03926130 675 677 O
any NCT03926130 678 681 O
kind NCT03926130 682 686 O
of NCT03926130 687 689 O
intra NCT03926130 690 695 O
- NCT03926130 696 697 O
abdominal NCT03926130 698 707 O
or NCT03926130 708 710 O
extra NCT03926130 711 716 O
abdominal NCT03926130 717 726 O
surgery NCT03926130 727 734 B-Procedure-Name
within NCT03926130 735 741 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03926130 743 744 B-Eq-Value
months NCT03926130 745 751 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03926130 752 754 O
baseline NCT03926130 755 763 O

- NCT03926130 766 767 O
Have NCT03926130 769 773 O
ever NCT03926130 774 778 O
received NCT03926130 779 787 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
any NCT03926130 788 791 O
monoclonal NCT03926130 792 802 B-Procedure-Name
antibodies NCT03926130 803 813 I-Procedure-Name
binding NCT03926130 814 821 I-Procedure-Name
IL NCT03926130 822 824 I-Procedure-Name
- NCT03926130 825 826 I-Procedure-Name
23 NCT03926130 828 830 I-Procedure-Name

Inclusion NCT03926871 0 9 O
Criteria NCT03926871 10 18 O
: NCT03926871 19 20 O

To NCT03926871 22 24 O
Novato NCT03926871 25 31 O
workers NCT03926871 32 39 O

- NCT03926871 42 43 O
1 NCT03926871 46 47 B-Eq-Value
to NCT03926871 48 50 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03926871 52 53 B-Eq-Value
days NCT03926871 54 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
in NCT03926871 59 61 O
the NCT03926871 62 65 O
company NCT03926871 66 73 O

- NCT03926871 76 77 O
Not NCT03926871 79 82 O
have NCT03926871 83 87 O
previous NCT03926871 88 96 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
experience NCT03926871 97 107 O
in NCT03926871 108 110 O
a NCT03926871 111 112 O
frigorifico NCT03926871 113 124 O
, NCT03926871 125 126 O
or NCT03926871 127 129 O
butcher NCT03926871 130 137 O
's NCT03926871 137 139 O
shop NCT03926871 140 144 O

- NCT03926871 147 148 O
Not NCT03926871 150 153 O
have NCT03926871 154 158 O
prior NCT03926871 159 164 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
knowledge NCT03926871 165 174 O
of NCT03926871 175 177 O
the NCT03926871 178 181 O
activity NCT03926871 182 190 O
. NCT03926871 191 192 O
To NCT03926871 194 196 O
experienced NCT03926871 197 208 O
workers NCT03926871 209 216 O

- NCT03926871 219 220 O
Work NCT03926871 222 226 O
on NCT03926871 227 229 O
the NCT03926871 230 233 O
task NCT03926871 234 238 O
for NCT03926871 239 242 O
more NCT03926871 243 247 O
than NCT03926871 248 252 O
six NCT03926871 253 256 O
months NCT03926871 257 263 O

- NCT03926871 266 267 O
Be NCT03926871 269 271 O
present NCT03926871 272 279 O
in NCT03926871 280 282 O
company NCT03926871 283 290 O
during NCT03926871 291 297 O
the NCT03926871 298 301 O
study NCT03926871 302 307 O
period NCT03926871 308 314 O

Exclusion NCT03926871 315 324 O
Criteria NCT03926871 325 333 O
: NCT03926871 334 335 O

For NCT03926871 337 340 O
all NCT03926871 341 344 O
workers NCT03926871 345 352 O

- NCT03926871 355 356 O
Had NCT03926871 358 361 O
already NCT03926871 362 369 O
received NCT03926871 370 378 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ergonomic NCT03926871 379 388 O
training NCT03926871 389 397 O
( NCT03926871 398 399 O
general NCT03926871 400 407 O
guidelines NCT03926871 408 418 O
and NCT03926871 419 422 O
postural NCT03926871 423 431 O
adjustments NCT03926871 432 443 O
) NCT03926871 444 445 O

- NCT03926871 449 450 O
Pregnant NCT03926871 452 460 B-Condition-Name
women NCT03926871 461 466 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03926871 469 470 O
People NCT03926871 472 478 O
with NCT03926871 479 483 O
disabilities NCT03926871 484 496 B-Condition-Name
. NCT03926871 497 498 O

Inclusion NCT03928860 0 9 O
Criteria NCT03928860 10 18 O
: NCT03928860 19 20 O

- NCT03928860 24 25 O
Patients NCT03928860 27 35 O
with NCT03928860 36 40 O
at NCT03928860 41 43 B-Eq-Operator___Eq-Operator-Value:LTEQ
least NCT03928860 44 49 I-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03928860 51 52 B-Eq-Value
months NCT03928860 53 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03928860 60 62 O
clinical NCT03928860 63 71 O
onset NCT03928860 72 77 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03928860 78 80 O
peripheral NCT03928860 81 91 B-Condition-Name
vascular NCT03928860 92 100 I-Condition-Name
disease NCT03928860 101 108 I-Condition-Name

- NCT03928860 111 112 O
Patients NCT03928860 114 122 O
with NCT03928860 123 127 O
ABI NCT03928860 128 131 B-Observation-Name
between NCT03928860 132 139 O
0.4 NCT03928860 141 144 B-Eq-Value
- NCT03928860 145 146 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1.4 NCT03928860 148 151 B-Eq-Value

- NCT03928860 155 156 O
Patients NCT03928860 158 166 O
up NCT03928860 167 169 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03928860 170 172 I-Eq-Operator___Eq-Operator-Value:LTEQ
Stage NCT03928860 173 178 B-Eq-Unit
2 NCT03928860 180 181 B-Eq-Value
b NCT03928860 182 183 I-Eq-Value
according NCT03928860 184 193 O
to NCT03928860 194 196 O
the NCT03928860 197 200 O
Fontaine NCT03928860 201 209 B-Condition-Name
classification NCT03928860 210 224 I-Condition-Name
system NCT03928860 225 231 I-Condition-Name

Exclusion NCT03928860 232 241 O
Criteria NCT03928860 242 250 O
: NCT03928860 251 252 O

- NCT03928860 256 257 O
Patients NCT03928860 259 267 O
undergoing NCT03928860 268 278 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
vascular NCT03928860 279 287 O
or NCT03928860 288 290 O
endovascular NCT03928860 291 303 O
surgery NCT03928860 304 311 B-Procedure-Name
in NCT03928860 312 314 O
the NCT03928860 315 318 O
last NCT03928860 319 323 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03928860 325 326 B-Eq-Value
months NCT03928860 327 333 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03928860 336 337 O
Patients NCT03928860 339 347 O
with NCT03928860 348 352 O
unstable NCT03928860 353 361 B-Condition-Name
angina NCT03928860 362 368 I-Condition-Name

- NCT03928860 371 372 O
Patients NCT03928860 374 382 O
with NCT03928860 383 387 O
myocardial NCT03928860 388 398 B-Condition-Name
infarction NCT03928860 399 409 I-Condition-Name
( NCT03928860 410 411 O
MI NCT03928860 412 414 B-Condition-Name
) NCT03928860 415 416 O

- NCT03928860 420 421 O
Patients NCT03928860 423 431 O
with NCT03928860 432 436 O
stroke NCT03928860 437 443 B-Condition-Name

- NCT03928860 446 447 O
Patients NCT03928860 449 457 O
with NCT03928860 458 462 O
heart NCT03928860 463 468 B-Condition-Name
failure NCT03928860 469 476 I-Condition-Name

- NCT03928860 479 480 O
Patients NCT03928860 482 490 O
with NCT03928860 491 495 O
significant NCT03928860 496 507 B-Severity___Severity-Value:severe
liver NCT03928860 508 513 O
or NCT03928860 514 516 O
renal NCT03928860 517 522 O
failure NCT03928860 523 530 B-Condition-Name
( NCT03928860 531 532 O
ie NCT03928860 533 535 O
, NCT03928860 536 537 O
dialysis NCT03928860 538 546 B-Procedure-Name
) NCT03928860 547 548 O

- NCT03928860 552 553 O
Acute NCT03928860 555 560 B-Severity___Severity-Value:severe
infectious NCT03928860 561 571 B-Condition-Name
diseases NCT03928860 572 580 I-Condition-Name

- NCT03928860 583 584 O
Patients NCT03928860 586 594 O
with NCT03928860 595 599 O
neoplasia NCT03928860 600 609 B-Condition-Name

Inclusion NCT03921307 0 9 O
Criteria NCT03921307 10 18 O
: NCT03921307 19 20 O

- NCT03921307 24 25 O
Healthy NCT03921307 27 34 B-Condition-Name
periodontal NCT03921307 35 46 I-Condition-Name
tissue NCT03921307 47 53 I-Condition-Name
Adequate NCT03921307 54 62 O
root NCT03921307 63 67 B-Procedure-Name
canal NCT03921307 68 73 I-Procedure-Name
treatment NCT03921307 74 83 I-Procedure-Name

Exclusion NCT03921307 84 93 O
Criteria NCT03921307 94 102 O
: NCT03921307 103 104 O

- NCT03921307 108 109 O
Parafunctional NCT03921307 111 125 B-Condition-Name
habits NCT03921307 126 132 I-Condition-Name

Inclusion NCT03926468 0 9 O
Criteria NCT03926468 10 18 O
: NCT03926468 19 20 O

- NCT03926468 24 25 O
histologically NCT03926468 27 41 O
confirmed NCT03926468 42 51 O
head NCT03926468 52 56 O
and NCT03926468 57 60 O
neck NCT03926468 61 65 O
squamous NCT03926468 66 74 B-Condition-Name
cell NCT03926468 75 79 I-Condition-Name
carcinoma NCT03926468 80 89 I-Condition-Name
( NCT03926468 90 91 O
HNSCC NCT03926468 92 97 B-Condition-Name
) NCT03926468 98 99 O

- NCT03926468 103 104 O
WHO NCT03926468 106 109 B-Observation-Name___Observation-Type-Value:clinical-score
performance NCT03926468 110 121 I-Observation-Name___Observation-Type-Value:clinical-score
status NCT03926468 122 128 I-Observation-Name___Observation-Type-Value:clinical-score
0 NCT03926468 130 131 B-Eq-Value
- NCT03926468 132 133 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2 NCT03926468 135 136 B-Eq-Value

- NCT03926468 140 141 O
clinical NCT03926468 143 151 O
stage NCT03926468 152 157 B-Eq-Unit
III NCT03926468 158 161 B-Eq-Value
patients NCT03926468 162 170 O
with NCT03926468 171 175 O
bulky NCT03926468 176 181 O
T NCT03926468 182 183 O
3 NCT03926468 184 185 O
primary NCT03926468 186 193 O
+ NCT03926468 194 195 O
/ NCT03926468 197 198 O
- NCT03926468 200 201 O
neck NCT03926468 202 206 O
metastasis NCT03926468 207 217 B-Condition-Name

- NCT03926468 220 221 O
all NCT03926468 223 226 O
stage NCT03926468 227 232 B-Eq-Unit
IV NCT03926468 233 235 B-Eq-Value
patients NCT03926468 236 244 O

- NCT03926468 247 248 O
referral NCT03926468 250 258 O
to NCT03926468 259 261 O
definitive NCT03926468 262 272 O
radiotherapy NCT03926468 273 285 B-Procedure-Name
or NCT03926468 286 288 O
chemoradiotherapy NCT03926468 289 306 B-Procedure-Name
or NCT03926468 307 309 O
multimodality NCT03926468 310 323 B-Procedure-Name
treatment NCT03926468 324 333 I-Procedure-Name

Exclusion NCT03926468 334 343 O
Criteria NCT03926468 344 352 O
: NCT03926468 353 354 O

- NCT03926468 358 359 O
patients NCT03926468 361 369 O
who NCT03926468 370 373 O
are NCT03926468 374 377 O
not NCT03926468 378 381 O
able NCT03926468 382 386 O
to NCT03926468 387 389 O
sign NCT03926468 390 394 O
written NCT03926468 395 402 O
informed NCT03926468 403 411 O
consent NCT03926468 412 419 O

Inclusion NCT03923504 0 9 O
Criteria NCT03923504 10 18 O
: NCT03923504 19 20 O

- NCT03923504 24 25 O
Ability NCT03923504 27 34 O
to NCT03923504 35 37 O
read NCT03923504 38 42 O
and NCT03923504 43 46 O
understand NCT03923504 47 57 O
and NCT03923504 58 61 O
willing NCT03923504 62 69 O
to NCT03923504 70 72 O
sign NCT03923504 73 77 O
a NCT03923504 78 79 O
written NCT03923504 80 87 O
informed NCT03923504 88 96 O
consent NCT03923504 97 104 O
form NCT03923504 105 109 O
. NCT03923504 110 111 O

- NCT03923504 115 116 O
Diagnosis NCT03923504 118 127 O
of NCT03923504 128 130 O
stage NCT03923504 131 136 B-Eq-Unit
I NCT03923504 137 138 B-Eq-Value
- NCT03923504 139 140 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IV NCT03923504 141 143 B-Eq-Value
non NCT03923504 144 147 O
- NCT03923504 148 149 O
or NCT03923504 150 152 O
Hodgkin NCT03923504 153 160 O
lymphoma NCT03923504 161 169 B-Condition-Name
and NCT03923504 170 173 O
expect NCT03923504 174 180 O
to NCT03923504 181 183 O
receive NCT03923504 184 191 O
an NCT03923504 192 194 O
anthracycline NCT03923504 195 208 B-Drug-Name
based NCT03923504 209 214 O
chemotherapeutic NCT03923504 215 231 B-Drug-Name
regimen NCT03923504 232 239 I-Drug-Name
. NCT03923504 240 241 O

- NCT03923504 245 246 O
Capacity NCT03923504 248 256 B-Observation-Name___Observation-Type-Value:social-habit
to NCT03923504 257 259 I-Observation-Name___Observation-Type-Value:social-habit
walk NCT03923504 260 264 I-Observation-Name___Observation-Type-Value:social-habit
at NCT03923504 265 267 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03923504 268 273 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03923504 275 276 B-Eq-Value
city NCT03923504 277 281 B-Eq-Unit
blocks NCT03923504 282 288 I-Eq-Unit
on NCT03923504 289 291 O
a NCT03923504 292 293 O
flat NCT03923504 294 298 O
surface NCT03923504 299 306 O

Exclusion NCT03923504 307 316 O
Criteria NCT03923504 317 325 O
: NCT03923504 326 327 O

- NCT03923504 331 332 O
Contraindications NCT03923504 334 351 O
for NCT03923504 352 355 O
MRI NCT03923504 356 359 B-Procedure-Name

- NCT03923504 362 363 O
Contraindications NCT03923504 365 382 O
for NCT03923504 383 386 O
exercise NCT03923504 387 395 B-Observation-Name___Observation-Type-Value:social-habit
training NCT03923504 396 404 O
or NCT03923504 405 407 O
testing NCT03923504 408 415 O

- NCT03923504 418 419 O
Active NCT03923504 421 427 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Pregnancy NCT03923504 428 437 B-Condition-Name

- NCT03923504 440 441 O
Subjects NCT03923504 443 451 O
with NCT03923504 452 456 O
claustrophobia NCT03923504 457 471 B-Condition-Name

- NCT03923504 474 475 O
Inability NCT03923504 477 486 O
to NCT03923504 487 489 O
provide NCT03923504 490 497 O
informed NCT03923504 498 506 O
consent NCT03923504 507 514 O

Inclusion NCT03924531 0 9 O
Criteria NCT03924531 10 18 O
: NCT03924531 19 20 O

- NCT03924531 24 25 O
over NCT03924531 27 31 B-Eq-Operator___Eq-Operator-Value:GT
21 NCT03924531 33 35 B-Eq-Value
years NCT03924531 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03924531 42 44 O
age NCT03924531 45 48 O

- NCT03924531 51 52 O
able NCT03924531 54 58 O
to NCT03924531 59 61 O
understand NCT03924531 62 72 O
and NCT03924531 73 76 O
speak NCT03924531 77 82 O
English NCT03924531 83 90 B-Language

- NCT03924531 93 94 O
self NCT03924531 96 100 O
- NCT03924531 101 102 O
report NCT03924531 103 109 O
of NCT03924531 110 112 O
having NCT03924531 113 119 O
difficulty NCT03924531 120 130 O
with NCT03924531 131 135 O
a NCT03924531 136 137 O
healthy NCT03924531 138 145 B-Observation-Name
diet NCT03924531 146 150 I-Observation-Name
and NCT03924531 151 154 O
engaging NCT03924531 155 163 O
in NCT03924531 164 166 O
regular NCT03924531 167 174 B-Observation-Name___Observation-Type-Value:social-habit
physical NCT03924531 175 183 I-Observation-Name___Observation-Type-Value:social-habit
activity NCT03924531 184 192 I-Observation-Name___Observation-Type-Value:social-habit
. NCT03924531 193 194 O

Exclusion NCT03924531 196 205 O
Criteria NCT03924531 206 214 O
: NCT03924531 215 216 O

- NCT03924531 220 221 O
On NCT03924531 223 225 O
chemotherapy NCT03924531 226 238 B-Procedure-Name
for NCT03924531 239 242 O
cancer NCT03924531 243 249 B-Procedure-Name
treatment NCT03924531 250 259 I-Procedure-Name

- NCT03924531 262 263 O
Current NCT03924531 265 272 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03924531 273 282 B-Condition-Name
abuse NCT03924531 283 288 I-Condition-Name
disorder NCT03924531 289 297 I-Condition-Name
( NCT03924531 298 299 O
i NCT03924531 300 301 O
. NCT03924531 302 303 O
e NCT03924531 304 305 O
. NCT03924531 306 307 O
, NCT03924531 308 309 O
drugs NCT03924531 310 315 B-Drug-Name
, NCT03924531 316 317 O
alcohol NCT03924531 318 325 B-Drug-Name
) NCT03924531 326 327 O
. NCT03924531 329 330 O

- NCT03924531 334 335 O
Current NCT03924531 337 344 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnoses NCT03924531 345 354 O
of NCT03924531 355 357 O
Post NCT03924531 358 362 B-Condition-Name
- NCT03924531 363 364 I-Condition-Name
traumatic NCT03924531 365 374 I-Condition-Name
stress NCT03924531 375 381 I-Condition-Name
disorders NCT03924531 382 391 I-Condition-Name
, NCT03924531 392 393 O
severe NCT03924531 394 400 B-Severity___Severity-Value:severe
anxiety NCT03924531 401 408 B-Condition-Name
, NCT03924531 409 410 O
or NCT03924531 411 413 O
severe NCT03924531 414 420 B-Severity___Severity-Value:severe
depression NCT03924531 421 431 B-Condition-Name
. NCT03924531 432 433 O

- NCT03924531 437 438 O
On NCT03924531 440 442 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hemodialysis NCT03924531 443 455 B-Procedure-Name
. NCT03924531 456 457 O

- NCT03924531 461 462 O
Pregnant NCT03924531 464 472 B-Condition-Name
. NCT03924531 473 474 O
( NCT03924531 476 477 O
Pregnant NCT03924531 478 486 B-Condition-Name
women NCT03924531 487 492 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
may NCT03924531 493 496 O
develop NCT03924531 497 504 O
Preeclampsia NCT03924531 505 517 B-Condition-Name
, NCT03924531 518 519 O
which NCT03924531 520 525 O
is NCT03924531 526 528 O
a NCT03924531 529 530 O
pregnancy NCT03924531 531 540 B-Condition-Name
complication NCT03924531 541 553 I-Condition-Name
characterized NCT03924531 554 567 O
by NCT03924531 568 570 O
high NCT03924531 571 575 B-Condition-Name
blood NCT03924531 576 581 I-Condition-Name
pressure NCT03924531 582 590 I-Condition-Name
) NCT03924531 591 592 O

Inclusion NCT03922815 0 9 O
Criteria NCT03922815 10 18 O
: NCT03922815 19 20 O

- NCT03922815 24 25 O
written NCT03922815 27 34 O
consent NCT03922815 35 42 O
to NCT03922815 43 45 O
participate NCT03922815 46 57 O
in NCT03922815 58 60 O
the NCT03922815 61 64 O
study NCT03922815 65 70 O

- NCT03922815 73 74 O
written NCT03922815 76 83 O
consent NCT03922815 84 91 O
to NCT03922815 92 94 O
undergo NCT03922815 95 102 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
deep NCT03922815 103 107 B-Procedure-Name
sedation NCT03922815 108 116 I-Procedure-Name
for NCT03922815 117 120 O
colonoscopic NCT03922815 121 133 B-Procedure-Name
procedure NCT03922815 134 143 I-Procedure-Name

- NCT03922815 146 147 O
general NCT03922815 149 156 O
heath NCT03922815 157 162 O
condition NCT03922815 163 172 O
I NCT03922815 173 174 B-Eq-Value
- NCT03922815 175 176 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03922815 177 180 B-Eq-Value
of NCT03922815 181 183 O
American NCT03922815 184 192 B-Condition-Name
Society NCT03922815 193 200 I-Condition-Name
of NCT03922815 201 203 I-Condition-Name
Anaesthesiology NCT03922815 204 219 I-Condition-Name

Exclusion NCT03922815 220 229 O
Criteria NCT03922815 230 238 O
: NCT03922815 239 240 O

- NCT03922815 244 245 O
necessity NCT03922815 247 256 O
of NCT03922815 257 259 O
administration NCT03922815 260 274 O
of NCT03922815 275 277 O
vasoactive NCT03922815 278 288 B-Drug-Name
drugs NCT03922815 289 294 I-Drug-Name
influencing NCT03922815 295 306 B-Stability___Stability-Value:change
SPI NCT03922815 307 310 B-Procedure-Name
monitoring NCT03922815 311 321 I-Procedure-Name

- NCT03922815 324 325 O
pregnancy NCT03922815 327 336 B-Condition-Name

- NCT03922815 339 340 O
anatomical NCT03922815 342 352 B-Condition-Name
malformation NCT03922815 353 365 I-Condition-Name
that NCT03922815 366 370 O
make NCT03922815 371 375 B-Stability___Stability-Value:change
monitoring NCT03922815 376 386 B-Procedure-Name
using NCT03922815 387 392 I-Procedure-Name
SE NCT03922815 393 395 I-Procedure-Name
sensor NCT03922815 396 402 I-Procedure-Name
impossible NCT03922815 403 413 O

- NCT03922815 416 417 O
general NCT03922815 419 426 B-Condition-Name
atherosclerosis NCT03922815 427 442 I-Condition-Name
, NCT03922815 443 444 O
heart NCT03922815 445 450 B-Condition-Name
rhythm NCT03922815 451 457 I-Condition-Name
disturbances NCT03922815 458 470 I-Condition-Name
impairing NCT03922815 471 480 O
SPI NCT03922815 481 484 B-Procedure-Name
monitoring NCT03922815 485 495 I-Procedure-Name

- NCT03922815 498 499 O
chronic NCT03922815 501 508 O
medication NCT03922815 509 519 O
using NCT03922815 520 525 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
opioid NCT03922815 526 532 B-Drug-Name
drugs NCT03922815 533 538 I-Drug-Name
leading NCT03922815 539 546 O
to NCT03922815 547 549 O
resistancy NCT03922815 550 560 B-Condition-Name
to NCT03922815 561 563 I-Condition-Name
opioids NCT03922815 564 571 I-Condition-Name
. NCT03922815 572 573 O

Inclusion NCT03921931 0 9 O
Criteria NCT03921931 10 18 O
: NCT03921931 19 20 O

- NCT03921931 24 25 O
men NCT03921931 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03921931 31 34 O
women NCT03921931 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
aged NCT03921931 41 45 O
over NCT03921931 46 50 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03921931 52 54 B-Eq-Value
years NCT03921931 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03921931 63 64 O
signed NCT03921931 66 72 O
informed NCT03921931 73 81 O
consent NCT03921931 82 89 O
form NCT03921931 90 94 O

- NCT03921931 97 98 O
ametropia NCT03921931 100 109 B-Observation-Name
below NCT03921931 110 115 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03921931 117 118 B-Eq-Value
diopters NCT03921931 119 127 B-Eq-Unit

- NCT03921931 130 131 O
ability NCT03921931 133 140 O
and NCT03921931 141 144 O
willingness NCT03921931 145 156 O
to NCT03921931 157 159 O
follow NCT03921931 160 166 O
instructions NCT03921931 167 179 O

for NCT03921931 180 183 O
healthy NCT03921931 184 191 B-Observation-Name
volunteers NCT03921931 192 202 O
: NCT03921931 203 204 O

- NCT03921931 208 209 O
normal NCT03921931 211 217 B-Polarity___Polarity-Value:normal
ophthalmologic NCT03921931 218 232 B-Observation-Name
findings NCT03921931 233 241 I-Observation-Name

for NCT03921931 242 245 O
primary NCT03921931 246 253 O
open NCT03921931 254 258 O
angle NCT03921931 259 264 O
glaucoma NCT03921931 265 273 B-Condition-Name
patients NCT03921931 274 282 O
( NCT03921931 283 284 O
POAG NCT03921931 285 289 B-Condition-Name
) NCT03921931 290 291 O
: NCT03921931 293 294 O

- NCT03921931 298 299 O
diagnosed NCT03921931 301 310 O
POAG NCT03921931 311 315 B-Condition-Name

- NCT03921931 318 319 O
MD NCT03921931 321 323 B-Observation-Name
< NCT03921931 324 325 B-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03921931 327 328 I-Eq-Operator___Eq-Operator-Value:LTEQ
10 NCT03921931 330 332 B-Eq-Value
dB NCT03921931 333 335 B-Eq-Unit

for NCT03921931 336 339 O
age NCT03921931 340 343 O
- NCT03921931 344 345 O
related NCT03921931 346 353 O
macular NCT03921931 354 361 B-Condition-Name
degeneration NCT03921931 362 374 I-Condition-Name
( NCT03921931 375 376 O
AMD NCT03921931 377 380 B-Condition-Name
) NCT03921931 381 382 O
: NCT03921931 384 385 O

- NCT03921931 389 390 O
diagnosed NCT03921931 392 401 O
dry NCT03921931 402 405 O
AMD NCT03921931 406 409 B-Condition-Name

- NCT03921931 412 413 O
diagnosed NCT03921931 415 424 O
stage NCT03921931 425 430 B-Eq-Unit
II NCT03921931 431 433 B-Eq-Value
or NCT03921931 434 436 O
stage NCT03921931 437 442 B-Eq-Unit
III NCT03921931 443 446 B-Eq-Value
AMD NCT03921931 447 450 B-Condition-Name

Exclusion NCT03921931 451 460 O
Criteria NCT03921931 461 469 O
: NCT03921931 470 471 O

- NCT03921931 475 476 O
Presence NCT03921931 478 486 O
of NCT03921931 487 489 O
any NCT03921931 490 493 O
abnormalities NCT03921931 494 507 B-Condition-Name
preventing NCT03921931 508 518 O
reliable NCT03921931 519 527 B-Stability___Stability-Value:stable
measurements NCT03921931 528 540 O

- NCT03921931 543 544 O
Ocular NCT03921931 546 552 B-Condition-Name
inflammation NCT03921931 553 565 I-Condition-Name
and NCT03921931 566 569 O
ocular NCT03921931 570 576 B-Condition-Name
disease NCT03921931 577 584 I-Condition-Name
interfering NCT03921931 585 596 O
with NCT03921931 597 601 O
the NCT03921931 602 605 O
study NCT03921931 606 611 O
aims NCT03921931 612 616 O

- NCT03921931 619 620 O
Use NCT03921931 622 625 O
of NCT03921931 626 628 O
photosensitizing NCT03921931 629 645 B-Drug-Name
medication NCT03921931 646 656 I-Drug-Name
( NCT03921931 657 658 O
phototoxic NCT03921931 659 669 B-Drug-Name
drugs NCT03921931 670 675 I-Drug-Name
, NCT03921931 676 677 O
photoallergic NCT03921931 678 691 B-Drug-Name
drugs NCT03921931 692 697 I-Drug-Name
) NCT03921931 698 699 O
in NCT03921931 700 702 O
the NCT03921931 703 706 O
3 NCT03921931 708 709 B-Eq-Value
months NCT03921931 710 716 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
preceding NCT03921931 717 726 O
the NCT03921931 727 730 O
study NCT03921931 731 736 O

- NCT03921931 739 740 O
Presence NCT03921931 742 750 O
of NCT03921931 751 753 O
any NCT03921931 754 757 O
condition NCT03921931 758 767 O
with NCT03921931 768 772 O
the NCT03921931 773 776 O
possibility NCT03921931 777 788 O
of NCT03921931 789 791 O
causing NCT03921931 792 799 O
photosensitivity NCT03921931 800 816 B-Condition-Name
, NCT03921931 817 818 O
including NCT03921931 819 828 O
systemic NCT03921931 829 837 B-Condition-Name
lupus NCT03921931 838 843 I-Condition-Name
erythematosus NCT03921931 844 857 I-Condition-Name
SLE NCT03921931 858 861 B-Condition-Name
, NCT03921931 862 863 O
Porphyria NCT03921931 864 873 B-Condition-Name
, NCT03921931 874 875 O
Vitiligo NCT03921931 876 884 B-Condition-Name
, NCT03921931 885 886 O
Xeroderma NCT03921931 887 896 B-Condition-Name
Pigmentosum NCT03921931 897 908 I-Condition-Name
and NCT03921931 909 912 O
Albinism NCT03921931 913 921 B-Condition-Name

- NCT03921931 924 925 O
Presence NCT03921931 927 935 O
of NCT03921931 936 938 O
any NCT03921931 939 942 O
form NCT03921931 943 947 O
of NCT03921931 948 950 O
epilepsy NCT03921931 951 959 B-Condition-Name

- NCT03921931 962 963 O
Ocular NCT03921931 965 971 B-Procedure-Name
surgery NCT03921931 972 979 I-Procedure-Name
in NCT03921931 980 982 O
the NCT03921931 983 986 O
3 NCT03921931 988 989 B-Eq-Value
months NCT03921931 990 996 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
preceding NCT03921931 997 1006 O
the NCT03921931 1007 1010 O
study NCT03921931 1011 1016 O

- NCT03921931 1019 1020 O
Pregnancy NCT03921931 1022 1031 B-Condition-Name
, NCT03921931 1032 1033 O
planned NCT03921931 1034 1041 O
pregnancy NCT03921931 1042 1051 B-Condition-Name
or NCT03921931 1052 1054 O
lactating NCT03921931 1055 1064 B-Condition-Name

- NCT03921931 1067 1068 O
Any NCT03921931 1070 1073 O
medical NCT03921931 1074 1081 O
or NCT03921931 1082 1084 O
surgical NCT03921931 1085 1093 B-Procedure-Name
history NCT03921931 1094 1101 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
, NCT03921931 1102 1103 O
disorder NCT03921931 1104 1112 B-Condition-Name
or NCT03921931 1113 1115 O
disease NCT03921931 1116 1123 B-Condition-Name
such NCT03921931 1124 1128 O
as NCT03921931 1129 1131 O
acute NCT03921931 1132 1137 O
or NCT03921931 1138 1140 O
chronic NCT03921931 1141 1148 O
severe NCT03921931 1149 1155 B-Severity___Severity-Value:severe
organic NCT03921931 1156 1163 B-Condition-Name
disease NCT03921931 1164 1171 I-Condition-Name

Inclusion NCT03926910 0 9 O
Criteria NCT03926910 10 18 O
: NCT03926910 19 20 O

- NCT03926910 24 25 O
Over NCT03926910 27 31 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03926910 33 35 B-Eq-Value
years NCT03926910 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03926910 42 45 O
, NCT03926910 46 47 O

- NCT03926910 51 52 O
Programmed NCT03926910 54 64 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03926910 65 68 O
cardiac NCT03926910 69 76 B-Procedure-Name
surgery NCT03926910 77 84 I-Procedure-Name
with NCT03926910 85 89 O
the NCT03926910 90 93 O
need NCT03926910 94 98 O
for NCT03926910 99 102 O
invasive NCT03926910 103 111 B-Procedure-Name
hemodynamic NCT03926910 112 123 I-Procedure-Name
monitoring NCT03926910 124 134 I-Procedure-Name
( NCT03926910 135 136 O
pulmonary NCT03926910 137 146 B-Procedure-Name
artery NCT03926910 147 153 I-Procedure-Name
catheter NCT03926910 154 162 I-Procedure-Name
) NCT03926910 163 164 O
according NCT03926910 165 174 O
to NCT03926910 175 177 O
the NCT03926910 178 181 O
recommendations NCT03926910 182 197 O
: NCT03926910 198 199 O

- NCT03926910 208 209 O
Euroscore NCT03926910 211 220 O
with NCT03926910 221 225 O
predicted NCT03926910 226 235 B-Observation-Name
mortality NCT03926910 236 245 I-Observation-Name
> NCT03926910 246 247 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03926910 249 251 B-Eq-Value
% NCT03926910 252 253 B-Eq-Unit

- NCT03926910 262 263 O
Left NCT03926910 265 269 B-Observation-Name___Observation-Type-Value:measurement
ventricular NCT03926910 270 281 I-Observation-Name___Observation-Type-Value:measurement
ejection NCT03926910 282 290 I-Observation-Name___Observation-Type-Value:measurement
fraction NCT03926910 291 299 I-Observation-Name___Observation-Type-Value:measurement
( NCT03926910 300 301 O
LVEF NCT03926910 302 306 B-Observation-Name___Observation-Type-Value:measurement
) NCT03926910 307 308 O
< NCT03926910 309 310 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03926910 312 314 B-Eq-Value
% NCT03926910 315 316 B-Eq-Unit

- NCT03926910 325 326 O
Left NCT03926910 328 332 B-Observation-Name___Observation-Type-Value:measurement
ventricular NCT03926910 333 344 I-Observation-Name___Observation-Type-Value:measurement
ejection NCT03926910 345 353 I-Observation-Name___Observation-Type-Value:measurement
fraction NCT03926910 354 362 I-Observation-Name___Observation-Type-Value:measurement
( NCT03926910 363 364 O
LVEF NCT03926910 365 369 B-Observation-Name___Observation-Type-Value:measurement
) NCT03926910 370 371 O
< NCT03926910 372 373 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03926910 375 377 B-Eq-Value
% NCT03926910 378 379 B-Eq-Unit
for NCT03926910 380 383 O
mitral NCT03926910 384 390 B-Condition-Name
insufficiency NCT03926910 391 404 I-Condition-Name

- NCT03926910 412 413 O
pulmonary NCT03926910 415 424 B-Condition-Name
artery NCT03926910 425 431 I-Condition-Name
hypertension NCT03926910 432 444 I-Condition-Name
( NCT03926910 445 446 O
PAH NCT03926910 447 450 B-Condition-Name
) NCT03926910 451 452 O
> NCT03926910 454 455 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03926910 457 459 B-Eq-Value
mmHg NCT03926910 460 464 B-Eq-Unit

- NCT03926910 472 473 O
Tricuspid NCT03926910 475 484 B-Condition-Name
insufficiency NCT03926910 485 498 I-Condition-Name
> NCT03926910 499 500 B-Eq-Operator___Eq-Operator-Value:GT
3.4 NCT03926910 502 505 B-Eq-Value
m NCT03926910 506 507 B-Eq-Unit
/ NCT03926910 508 509 O
s NCT03926910 510 511 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:second

- NCT03926910 519 520 O
Tricuspid NCT03926910 522 531 B-Observation-Name___Observation-Type-Value:measurement
annular NCT03926910 532 539 I-Observation-Name___Observation-Type-Value:measurement
plane NCT03926910 540 545 I-Observation-Name___Observation-Type-Value:measurement
systolic NCT03926910 546 554 I-Observation-Name___Observation-Type-Value:measurement
excursion NCT03926910 555 564 I-Observation-Name___Observation-Type-Value:measurement
( NCT03926910 565 566 O
TAPSE NCT03926910 567 572 B-Observation-Name___Observation-Type-Value:measurement
) NCT03926910 573 574 O
< NCT03926910 575 576 B-Eq-Operator___Eq-Operator-Value:LT
16 NCT03926910 578 580 B-Eq-Value
mm NCT03926910 581 583 B-Eq-Unit

- NCT03926910 591 592 O
Dilatation NCT03926910 594 604 B-Condition-Name
of NCT03926910 605 607 I-Condition-Name
the NCT03926910 608 611 I-Condition-Name
inferior NCT03926910 612 620 I-Condition-Name
vena NCT03926910 621 625 I-Condition-Name
cava NCT03926910 626 630 I-Condition-Name
under NCT03926910 631 636 I-Condition-Name
respiratory NCT03926910 637 648 I-Condition-Name
collapse NCT03926910 649 657 I-Condition-Name

- NCT03926910 660 661 O
Sinus NCT03926910 663 668 B-Condition-Name
rhythm NCT03926910 669 675 I-Condition-Name
in NCT03926910 676 678 O
immediate NCT03926910 679 688 O
post NCT03926910 689 693 O
operative NCT03926910 694 703 O
period NCT03926910 704 710 O
, NCT03926910 711 712 O

- NCT03926910 716 717 O
Sedated NCT03926910 719 726 B-Procedure-Name
with NCT03926910 727 731 O
mechanical NCT03926910 732 742 B-Procedure-Name
ventilation NCT03926910 743 754 I-Procedure-Name
, NCT03926910 755 756 O

- NCT03926910 760 761 O
Having NCT03926910 763 769 O
given NCT03926910 770 775 O
their NCT03926910 776 781 O
written NCT03926910 782 789 O
participation NCT03926910 790 803 O
consent NCT03926910 804 811 O
in NCT03926910 812 814 O
accordance NCT03926910 815 825 O
with NCT03926910 826 830 O
the NCT03926910 831 834 O
regulations NCT03926910 835 846 O
, NCT03926910 847 848 O

- NCT03926910 852 853 O
Benefiting NCT03926910 855 865 O
from NCT03926910 866 870 O
a NCT03926910 871 872 O
social NCT03926910 873 879 O
security NCT03926910 880 888 O

Exclusion NCT03926910 889 898 O
Criteria NCT03926910 899 907 O
: NCT03926910 908 909 O

- NCT03926910 913 914 O
Pregnant NCT03926910 916 924 B-Condition-Name
or NCT03926910 925 927 O
lactating NCT03926910 928 937 B-Condition-Name
women NCT03926910 938 943 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03926910 944 945 O

- NCT03926910 949 950 O
Patient NCT03926910 952 959 O
under NCT03926910 960 965 B-Observation-Name
guardianship NCT03926910 966 978 I-Observation-Name
, NCT03926910 979 980 O
Under NCT03926910 981 986 O
curatorship NCT03926910 987 998 O
or NCT03926910 999 1001 O
court NCT03926910 1002 1007 O
of NCT03926910 1008 1010 O
justice NCT03926910 1011 1018 O
, NCT03926910 1019 1020 O

- NCT03926910 1024 1025 O
Discomfort NCT03926910 1027 1037 B-Condition-Name
to NCT03926910 1038 1040 I-Condition-Name
communication NCT03926910 1041 1054 I-Condition-Name
or NCT03926910 1055 1057 O
neuropsychic NCT03926910 1058 1070 B-Condition-Name
disorders NCT03926910 1071 1080 I-Condition-Name
, NCT03926910 1081 1082 O
Inability NCT03926910 1083 1092 O
to NCT03926910 1093 1095 O
understand NCT03926910 1096 1106 O
, NCT03926910 1107 1108 O
to NCT03926910 1109 1111 O
read NCT03926910 1112 1116 O
or NCT03926910 1117 1119 O
to NCT03926910 1120 1122 O
write NCT03926910 1123 1128 O
the NCT03926910 1129 1132 O
French NCT03926910 1133 1139 B-Language
language NCT03926910 1140 1148 O
, NCT03926910 1149 1150 O

- NCT03926910 1154 1155 O
Patients NCT03926910 1157 1165 O
for NCT03926910 1166 1169 O
whom NCT03926910 1170 1174 O
a NCT03926910 1175 1176 O
fluids NCT03926910 1177 1183 B-Condition-Name
overload NCT03926910 1184 1192 I-Condition-Name
seems NCT03926910 1193 1198 O
obvious NCT03926910 1199 1206 O
to NCT03926910 1207 1209 O
the NCT03926910 1210 1213 O
intensivist NCT03926910 1214 1225 O
and NCT03926910 1226 1229 O
for NCT03926910 1230 1233 O
whom NCT03926910 1234 1238 O
a NCT03926910 1239 1240 O
crystalloids NCT03926910 1241 1253 B-Procedure-Name
filling NCT03926910 1254 1261 I-Procedure-Name
would NCT03926910 1262 1267 O
be NCT03926910 1268 1270 O
contraindicated NCT03926910 1271 1286 O
, NCT03926910 1287 1288 O

- NCT03926910 1292 1293 O
Patients NCT03926910 1295 1303 O
for NCT03926910 1304 1307 O
whom NCT03926910 1308 1312 O
respiratory NCT03926910 1313 1324 O
changes NCT03926910 1325 1332 O
in NCT03926910 1333 1335 O
pulse NCT03926910 1336 1341 B-Observation-Name
pressure NCT03926910 1342 1350 I-Observation-Name
( NCT03926910 1351 1352 O
ΔPP NCT03926910 1353 1356 B-Observation-Name
) NCT03926910 1357 1358 O
measurement NCT03926910 1359 1370 O
is NCT03926910 1371 1373 O
not NCT03926910 1374 1377 O
validated NCT03926910 1378 1387 O
: NCT03926910 1388 1389 O
patients NCT03926910 1390 1398 O
with NCT03926910 1399 1403 O
spontaneous NCT03926910 1404 1415 B-Condition-Name
ventilation NCT03926910 1416 1427 I-Condition-Name
, NCT03926910 1428 1429 O
atrial NCT03926910 1430 1436 B-Condition-Name
fibrillation NCT03926910 1437 1449 I-Condition-Name
, NCT03926910 1450 1451 O
non NCT03926910 1452 1455 B-Condition-Name
- NCT03926910 1456 1457 I-Condition-Name
sedated NCT03926910 1458 1465 I-Condition-Name

Inclusion NCT03925558 0 9 O
Criteria NCT03925558 10 18 O
: NCT03925558 19 20 O

- NCT03925558 23 24 O
Full NCT03925558 25 29 O
term NCT03925558 30 34 O
healthy NCT03925558 35 42 B-Condition-Name
infant NCT03925558 43 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
aged NCT03925558 50 54 O
3 NCT03925558 56 57 B-Eq-Value
- NCT03925558 58 59 B-Eq-Operator___Eq-Operator-Value:BETWEEN
95 NCT03925558 61 63 B-Eq-Value
days NCT03925558 64 68 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

Exclusion NCT03925558 69 78 O
Criteria NCT03925558 79 87 O
: NCT03925558 88 89 O

- NCT03925558 93 94 O
Prematurity NCT03925558 96 107 B-Condition-Name

- NCT03925558 110 111 O
Low NCT03925558 113 116 B-Polarity___Polarity-Value:low
birth NCT03925558 117 122 B-Observation-Name___Observation-Type-Value:vital
weight NCT03925558 123 129 I-Observation-Name___Observation-Type-Value:vital

- NCT03925558 132 133 O
Congenital NCT03925558 135 145 B-Condition-Name
anomalies NCT03925558 146 155 I-Condition-Name

- NCT03925558 158 159 O
Chronic NCT03925558 161 168 B-Condition-Name
disease NCT03925558 169 176 I-Condition-Name

- NCT03925558 179 180 O
Failure NCT03925558 182 189 B-Condition-Name
to NCT03925558 190 192 I-Condition-Name
thrive NCT03925558 193 199 I-Condition-Name

- NCT03925558 202 203 O
Allergy NCT03925558 205 212 O
or NCT03925558 213 215 O
atopic NCT03925558 216 222 B-Condition-Name
disease NCT03925558 223 230 I-Condition-Name

- NCT03925558 233 234 O
Recent NCT03925558 236 242 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
exposure NCT03925558 243 251 O
to NCT03925558 252 254 O
antibiotics NCT03925558 255 266 B-Drug-Name

Inclusion NCT03928054 0 9 O
Criteria NCT03928054 10 18 O
: NCT03928054 19 20 O

- NCT03928054 24 25 O
Patients NCT03928054 27 35 O
with NCT03928054 36 40 O
both NCT03928054 41 45 O
sexes NCT03928054 46 51 O
from NCT03928054 52 56 O
40 NCT03928054 58 60 B-Eq-Value
to NCT03928054 61 63 B-Eq-Operator___Eq-Operator-Value:BETWEEN
80 NCT03928054 65 67 B-Eq-Value
years NCT03928054 68 73 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03928054 74 77 O

- NCT03928054 80 81 O
who NCT03928054 83 86 O
underwent NCT03928054 87 96 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
imaging NCT03928054 97 104 B-Procedure-Name
examination NCT03928054 105 116 I-Procedure-Name
evidencing NCT03928054 117 127 O
grade NCT03928054 128 133 B-Eq-Unit
II NCT03928054 134 136 B-Eq-Value
or NCT03928054 137 139 O
III NCT03928054 140 143 B-Eq-Value
knee NCT03928054 144 148 B-Condition-Name
osteoarthritis NCT03928054 149 163 I-Condition-Name
according NCT03928054 164 173 O
to NCT03928054 174 176 O
the NCT03928054 177 180 O
Kellgren NCT03928054 181 189 O
and NCT03928054 190 193 O
Lawrence NCT03928054 194 202 O
classification NCT03928054 203 217 O

- NCT03928054 220 221 O
who NCT03928054 223 226 O
were NCT03928054 227 231 O
referred NCT03928054 232 240 B-Encounter-Type___Encounter-Type-Value:referral
to NCT03928054 241 243 O
the NCT03928054 244 247 O
physiotherapy NCT03928054 248 261 B-Provider-Type
service NCT03928054 262 269 I-Provider-Type
by NCT03928054 270 272 O
a NCT03928054 273 274 O
physician NCT03928054 275 284 O
. NCT03928054 285 286 O

Exclusion NCT03928054 288 297 O
Criteria NCT03928054 298 306 O
: NCT03928054 307 308 O

- NCT03928054 312 313 O
Patients NCT03928054 315 323 O
who NCT03928054 324 327 O
are NCT03928054 328 331 O
unable NCT03928054 332 338 O
to NCT03928054 339 341 O
walk NCT03928054 342 346 B-Condition-Name

- NCT03928054 349 350 O
with NCT03928054 352 356 O
a NCT03928054 357 358 O
history NCT03928054 359 366 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928054 367 369 O
cancer NCT03928054 370 376 B-Condition-Name

- NCT03928054 379 380 O
associated NCT03928054 382 392 O
neurological NCT03928054 393 405 B-Condition-Name
diseases NCT03928054 406 414 I-Condition-Name

- NCT03928054 417 418 O
morbid NCT03928054 420 426 B-Condition-Name
obesity NCT03928054 427 434 I-Condition-Name

Inclusion NCT03923101 0 9 O
Criteria NCT03923101 10 18 O
: NCT03923101 19 20 O

- NCT03923101 24 25 O
All NCT03923101 27 30 O
Keratoconus NCT03923101 31 42 B-Condition-Name
patients NCT03923101 43 51 O
presenting NCT03923101 52 62 O
in NCT03923101 63 65 O
the NCT03923101 66 69 O
department NCT03923101 70 80 B-Location___Location-Value:clinic
of NCT03923101 81 83 I-Location___Location-Value:clinic
ophthalmology NCT03923101 84 97 I-Location___Location-Value:clinic
, NCT03923101 98 99 O
Saarland NCT03923101 100 108 B-Location___Location-Value:hospital
University NCT03923101 109 119 I-Location___Location-Value:hospital
Medical NCT03923101 120 127 I-Location___Location-Value:hospital
Center NCT03923101 128 134 I-Location___Location-Value:hospital
, NCT03923101 135 136 O
Homburg NCT03923101 137 144 B-Location___Location-Value:residence
, NCT03923101 145 146 I-Location___Location-Value:residence
Saarland NCT03923101 147 155 I-Location___Location-Value:residence
, NCT03923101 156 157 I-Location___Location-Value:residence
Germany NCT03923101 158 165 I-Location___Location-Value:residence
. NCT03923101 166 167 O

Exclusion NCT03923101 169 178 O
Criteria NCT03923101 179 187 O
: NCT03923101 188 189 O

- NCT03923101 193 194 O
Patients NCT03923101 196 204 O
without NCT03923101 205 212 O
Keratoconus NCT03923101 213 224 B-Condition-Name
. NCT03923101 225 226 O

Inclusion NCT03926247 0 9 O
Criteria NCT03926247 10 18 O
: NCT03926247 19 20 O

- NCT03926247 24 25 O
Mexican NCT03926247 27 34 B-Ethnicity
immigrant NCT03926247 35 44 O

- NCT03926247 47 48 O
Residing NCT03926247 50 58 O
in NCT03926247 59 61 O
Bernalillo NCT03926247 62 72 B-Location___Location-Value:residence
County NCT03926247 73 79 I-Location___Location-Value:residence
, NCT03926247 80 81 I-Location___Location-Value:residence
New NCT03926247 82 85 I-Location___Location-Value:residence
Mexico NCT03926247 86 92 I-Location___Location-Value:residence

Exclusion NCT03926247 93 102 O
Criteria NCT03926247 103 111 O
: NCT03926247 112 113 O

- NCT03926247 117 118 O
Severe NCT03926247 120 126 B-Severity___Severity-Value:severe
cognitive NCT03926247 127 136 B-Condition-Name
functioning NCT03926247 137 148 I-Condition-Name
problems NCT03926247 149 157 I-Condition-Name

- NCT03926247 160 161 O
Imminent NCT03926247 163 171 B-Severity___Severity-Value:severe
suicide NCT03926247 172 179 B-Condition-Name
risk NCT03926247 180 184 O

- NCT03926247 187 188 O
Mental NCT03926247 190 196 B-Condition-Name
illness NCT03926247 197 204 I-Condition-Name
that NCT03926247 205 209 O
is NCT03926247 210 212 O
so NCT03926247 213 215 O
severe NCT03926247 216 222 B-Severity___Severity-Value:severe
as NCT03926247 223 225 O
to NCT03926247 226 228 O
impede NCT03926247 229 235 O
participation NCT03926247 236 249 O
in NCT03926247 250 252 O
a NCT03926247 253 254 O
group NCT03926247 255 260 O
and NCT03926247 261 264 O
that NCT03926247 265 269 O
warrants NCT03926247 270 278 O
immediate NCT03926247 279 288 O
individual NCT03926247 289 299 O
treatment NCT03926247 300 309 O

Inclusion NCT03921502 0 9 O
Criteria NCT03921502 10 18 O
: NCT03921502 19 20 O

- NCT03921502 24 25 O
Symptomatic NCT03921502 27 38 B-Condition-Name
choledocholithiasis NCT03921502 39 58 I-Condition-Name
( NCT03921502 59 60 O
choledocholithiasis NCT03921502 61 80 B-Condition-Name
demonstrated NCT03921502 81 93 O
radiologically NCT03921502 94 108 B-Procedure-Name
or NCT03921502 109 111 O
highly NCT03921502 112 118 B-Polarity___Polarity-Value:high
suspected NCT03921502 119 128 O
by NCT03921502 129 131 O
clinical NCT03921502 132 140 O
data NCT03921502 141 145 O
( NCT03921502 146 147 O
acute NCT03921502 148 153 B-Condition-Name
cholangitis NCT03921502 154 165 I-Condition-Name
or NCT03921502 166 168 O
obstructive NCT03921502 169 180 B-Condition-Name
jaundice NCT03921502 181 189 I-Condition-Name
) NCT03921502 190 191 O
, NCT03921502 193 194 O
analytical NCT03921502 195 205 O
and NCT03921502 206 209 O
imaging NCT03921502 210 217 O
according NCT03921502 218 227 O
to NCT03921502 228 230 O
the NCT03921502 231 234 O
criteria NCT03921502 235 243 O
of NCT03921502 244 246 O
high NCT03921502 247 251 B-Polarity___Polarity-Value:high
probability NCT03921502 252 263 O
of NCT03921502 264 266 O
choledocholithiasis NCT03921502 267 286 B-Condition-Name
established NCT03921502 287 298 O
in NCT03921502 299 301 O
the NCT03921502 302 305 O
clinical NCT03921502 306 314 O
guidelines NCT03921502 315 325 O
( NCT03921502 326 327 O
ASGE NCT03921502 328 332 O
Guide NCT03921502 333 338 O
) NCT03921502 339 340 O
. NCT03921502 342 343 O

- NCT03921502 347 348 O
Discarded NCT03921502 350 359 O
for NCT03921502 360 363 O
surgical NCT03921502 364 372 B-Procedure-Name
treatment NCT03921502 373 382 I-Procedure-Name
due NCT03921502 383 386 O
to NCT03921502 387 389 O
age NCT03921502 390 393 O
, NCT03921502 394 395 O
comorbidity NCT03921502 396 407 O
or NCT03921502 408 410 O
refusal NCT03921502 411 418 B-Observation-Name
of NCT03921502 419 421 O
the NCT03921502 422 425 O
patient NCT03921502 426 433 O
. NCT03921502 434 435 O

- NCT03921502 439 440 O
Age NCT03921502 442 445 O
> NCT03921502 446 447 B-Eq-Operator___Eq-Operator-Value:GT
75 NCT03921502 449 451 B-Eq-Value
years NCT03921502 452 457 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03921502 458 467 O
Criteria NCT03921502 468 476 O
: NCT03921502 477 478 O

- NCT03921502 482 483 O
Charlson NCT03921502 485 493 B-Observation-Name___Observation-Type-Value:clinical-score
comorbidity NCT03921502 494 505 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03921502 506 511 I-Observation-Name___Observation-Type-Value:clinical-score
adjusted NCT03921502 512 520 O
to NCT03921502 521 523 O
age NCT03921502 524 527 O
< NCT03921502 528 529 B-Eq-Operator___Eq-Operator-Value:LT
4 NCT03921502 531 532 B-Eq-Value
. NCT03921502 532 533 O

- NCT03921502 537 538 O
Prior NCT03921502 540 545 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ERCP NCT03921502 546 550 B-Procedure-Name
. NCT03921502 551 552 O

- NCT03921502 556 557 O
Previous NCT03921502 559 567 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
episodes NCT03921502 568 576 O
of NCT03921502 577 579 O
cholangitis NCT03921502 580 591 B-Condition-Name
, NCT03921502 592 593 O
pancreatitis NCT03921502 594 606 B-Condition-Name
or NCT03921502 607 609 O
lithiasic NCT03921502 610 619 B-Condition-Name
cholecystitis NCT03921502 620 633 I-Condition-Name
. NCT03921502 634 635 O

- NCT03921502 639 640 O
Hepatobiliary NCT03921502 642 655 B-Procedure-Name
surgery NCT03921502 656 663 I-Procedure-Name
or NCT03921502 664 666 O
previous NCT03921502 667 675 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
superior NCT03921502 676 684 B-Condition-Name
digestive NCT03921502 685 694 I-Condition-Name
tract NCT03921502 695 700 I-Condition-Name
. NCT03921502 701 702 O

- NCT03921502 706 707 O
Ascitis NCT03921502 709 716 O
. NCT03921502 717 718 O

- NCT03921502 722 723 O
Inability NCT03921502 725 734 O
to NCT03921502 735 737 O
tolerate NCT03921502 738 746 O
sedation NCT03921502 747 755 B-Procedure-Name
of NCT03921502 756 758 I-Procedure-Name
endoscopy NCT03921502 759 768 I-Procedure-Name
, NCT03921502 769 770 O
perforation NCT03921502 771 782 B-Condition-Name
of NCT03921502 783 785 I-Condition-Name
the NCT03921502 786 789 I-Condition-Name
digestive NCT03921502 790 799 I-Condition-Name
tract NCT03921502 800 805 I-Condition-Name
or NCT03921502 806 808 O
other NCT03921502 809 814 O
contraindication NCT03921502 815 831 O
to NCT03921502 832 834 O
endoscopy NCT03921502 835 844 B-Procedure-Name
. NCT03921502 845 846 O

- NCT03921502 850 851 O
Coagulopathy NCT03921502 853 865 B-Condition-Name
with NCT03921502 866 870 O
INR NCT03921502 871 874 B-Observation-Name___Observation-Type-Value:lab
( NCT03921502 875 876 O
international NCT03921502 877 890 B-Observation-Name___Observation-Type-Value:lab
normalized NCT03921502 891 901 I-Observation-Name___Observation-Type-Value:lab
ratio NCT03921502 902 907 I-Observation-Name___Observation-Type-Value:lab
) NCT03921502 908 909 O
> NCT03921502 910 911 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03921502 913 916 B-Eq-Value
not NCT03921502 917 920 O
correctable NCT03921502 921 932 O
or NCT03921502 933 935 O
thrombocytopenia NCT03921502 936 952 B-Condition-Name
< NCT03921502 953 954 B-Eq-Operator___Eq-Operator-Value:LT
50000 NCT03921502 956 961 B-Eq-Value
/ NCT03921502 962 963 O
mm NCT03921502 964 966 B-Eq-Unit
3 NCT03921502 967 968 I-Eq-Unit
not NCT03921502 969 972 O
correctable NCT03921502 973 984 O
. NCT03921502 985 986 O

- NCT03921502 990 991 O
Other NCT03921502 993 998 O
diagnoses NCT03921502 999 1008 O
at NCT03921502 1009 1011 O
admission NCT03921502 1012 1021 B-Condition-Type___Condition-Type-Value:admitting|Encounter-Type___Encounter-Type-Value:inpatient
( NCT03921502 1022 1023 O
acute NCT03921502 1024 1029 B-Condition-Name
cholecystitis NCT03921502 1030 1043 I-Condition-Name
, NCT03921502 1044 1045 O
acute NCT03921502 1046 1051 B-Condition-Name
pancreatitis NCT03921502 1052 1064 I-Condition-Name
, NCT03921502 1065 1066 O
biliopancreatic NCT03921502 1067 1082 B-Condition-Name
neoplasia NCT03921502 1083 1092 I-Condition-Name
) NCT03921502 1093 1094 O
. NCT03921502 1096 1097 O

- NCT03921502 1101 1102 O
Hemodynamic NCT03921502 1104 1115 B-Condition-Name
instability NCT03921502 1116 1127 I-Condition-Name
. NCT03921502 1128 1129 O

- NCT03921502 1133 1134 O
Urgent NCT03921502 1136 1142 B-Procedure-Name
procedure NCT03921502 1143 1152 I-Procedure-Name
performed NCT03921502 1153 1162 O
after NCT03921502 1163 1168 O
hours NCT03921502 1169 1174 O

- NCT03921502 1177 1178 O
No NCT03921502 1180 1182 O
availability NCT03921502 1183 1195 O
of NCT03921502 1196 1198 O
expert NCT03921502 1199 1205 O
material NCT03921502 1206 1214 O
/ NCT03921502 1215 1216 O
endoscopist NCT03921502 1217 1228 O
in NCT03921502 1229 1231 O
drainage NCT03921502 1232 1240 O
. NCT03921502 1241 1242 O

- NCT03921502 1246 1247 O
Anatomical NCT03921502 1249 1259 O
impossibility NCT03921502 1260 1273 O
of NCT03921502 1274 1276 O
performing NCT03921502 1277 1287 O
biliary NCT03921502 1288 1295 B-Procedure-Name
drainage NCT03921502 1296 1304 I-Procedure-Name
( NCT03921502 1305 1306 O
absence NCT03921502 1307 1314 O
of NCT03921502 1315 1317 O
vesicular NCT03921502 1318 1327 B-Condition-Name
distension NCT03921502 1328 1338 I-Condition-Name
, NCT03921502 1339 1340 O
contact NCT03921502 1341 1348 B-Condition-Name
between NCT03921502 1349 1356 O
gallbladder NCT03921502 1357 1368 O
and NCT03921502 1369 1372 O
stomach NCT03921502 1373 1380 O
or NCT03921502 1381 1383 O
duodenum NCT03921502 1384 1392 O
, NCT03921502 1393 1394 O
contact NCT03921502 1395 1402 B-Observation-Name___Observation-Type-Value:measurement
area NCT03921502 1403 1407 I-Observation-Name___Observation-Type-Value:measurement
< NCT03921502 1408 1409 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03921502 1411 1413 B-Eq-Value
mm NCT03921502 1414 1416 B-Eq-Unit
) NCT03921502 1417 1418 O
. NCT03921502 1420 1421 O

- NCT03921502 1425 1426 O
Baseline NCT03921502 1428 1436 O
ECOG NCT03921502 1437 1441 B-Observation-Name
( NCT03921502 1442 1443 O
Easthern NCT03921502 1444 1452 B-Observation-Name
Cooperative NCT03921502 1453 1464 I-Observation-Name
Oncology NCT03921502 1465 1473 I-Observation-Name
Group NCT03921502 1474 1479 I-Observation-Name
) NCT03921502 1480 1481 O
> NCT03921502 1482 1483 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03921502 1484 1485 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03921502 1487 1488 B-Eq-Value

- NCT03921502 1492 1493 O
Expectancy NCT03921502 1495 1505 B-Observation-Name
of NCT03921502 1506 1508 I-Observation-Name
survival NCT03921502 1509 1517 I-Observation-Name
< NCT03921502 1518 1519 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03921502 1521 1522 B-Eq-Value
months NCT03921502 1523 1529 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03921502 1530 1531 O

- NCT03921502 1535 1536 O
Refusal NCT03921502 1538 1545 O
to NCT03921502 1546 1548 O
participate NCT03921502 1549 1560 O
. NCT03921502 1561 1562 O

- NCT03921502 1566 1567 O
Distance NCT03921502 1569 1577 B-Observation-Name
between NCT03921502 1578 1585 O
the NCT03921502 1586 1589 O
gallbladder NCT03921502 1590 1601 O
and NCT03921502 1602 1605 O
upper NCT03921502 1606 1611 O
digestive NCT03921502 1612 1621 O
tract NCT03921502 1622 1627 O
> NCT03921502 1628 1629 B-Eq-Operator___Eq-Operator-Value:GT
1 NCT03921502 1631 1632 B-Eq-Value
cm NCT03921502 1633 1635 B-Eq-Unit
, NCT03921502 1636 1637 O
scleroatrophic NCT03921502 1638 1652 B-Condition-Name
vesicle NCT03921502 1653 1660 I-Condition-Name
, NCT03921502 1661 1662 O
lack NCT03921502 1663 1667 O
of NCT03921502 1668 1670 O
stable NCT03921502 1671 1677 B-Observation-Name
acoustic NCT03921502 1678 1686 I-Observation-Name
window NCT03921502 1687 1693 I-Observation-Name
for NCT03921502 1694 1697 I-Observation-Name
drainage NCT03921502 1698 1706 I-Observation-Name

- NCT03921502 1709 1710 O
ERCP NCT03921502 1712 1716 B-Condition-Name
failed NCT03921502 1717 1723 O
( NCT03921502 1724 1725 O
inhability NCT03921502 1726 1736 O
to NCT03921502 1737 1739 O
dain NCT03921502 1740 1744 B-Condition-Name
common NCT03921502 1745 1751 I-Condition-Name
bile NCT03921502 1752 1756 I-Condition-Name
duct NCT03921502 1757 1761 I-Condition-Name
) NCT03921502 1762 1763 O

Inclusion NCT03920813 0 9 O
Criteria NCT03920813 10 18 O
: NCT03920813 19 20 O

- NCT03920813 24 25 O
Patients NCT03920813 27 35 O
have NCT03920813 36 40 O
been NCT03920813 41 45 O
diagnosed NCT03920813 46 55 O
with NCT03920813 56 60 O
Acute NCT03920813 61 66 B-Condition-Name
Lymphoblastic NCT03920813 67 80 I-Condition-Name
Leukemia NCT03920813 81 89 I-Condition-Name

- NCT03920813 92 93 O
Childhood NCT03920813 95 104 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
patients NCT03920813 105 113 O
who NCT03920813 114 117 O
were NCT03920813 118 122 O
undergoing NCT03920813 123 133 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
chemotherapy NCT03920813 134 146 B-Procedure-Name
or NCT03920813 147 149 O
continuous NCT03920813 150 160 O
follow NCT03920813 161 167 B-Encounter-Type___Encounter-Type-Value:outpatient
- NCT03920813 168 169 I-Encounter-Type___Encounter-Type-Value:outpatient
up NCT03920813 170 172 I-Encounter-Type___Encounter-Type-Value:outpatient
after NCT03920813 173 178 O
completion NCT03920813 179 189 O
of NCT03920813 190 192 O
chemotherapy NCT03920813 193 205 B-Procedure-Name

- NCT03920813 208 209 O
Patients NCT03920813 211 219 O
received NCT03920813 220 228 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
the NCT03920813 229 232 O
phase NCT03920813 233 238 O
of NCT03920813 239 241 O
maintenance NCT03920813 242 253 B-Procedure-Name
therapy NCT03920813 254 261 I-Procedure-Name
that NCT03920813 262 266 O
included NCT03920813 267 275 O
oral NCT03920813 276 280 O
6 NCT03920813 282 283 B-Drug-Name
- NCT03920813 284 285 I-Drug-Name
MP NCT03920813 286 288 I-Drug-Name
( NCT03920813 289 290 O
> NCT03920813 292 293 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03920813 295 296 B-Eq-Value
weeks NCT03920813 297 302 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03920813 303 304 O
and NCT03920813 305 308 O
completion NCT03920813 309 319 O
of NCT03920813 320 322 O
≥ NCT03920813 323 324 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03920813 326 327 B-Eq-Value
months NCT03920813 328 334 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
according NCT03920813 335 344 O
to NCT03920813 345 347 O
the NCT03920813 348 351 O
CCLG NCT03920813 352 356 O
( NCT03920813 357 358 O
Chinese NCT03920813 359 366 O
Children NCT03920813 367 375 O
's NCT03920813 375 377 O
Leukemia NCT03920813 378 386 O
Group NCT03920813 387 392 O
) NCT03920813 393 394 O
protocol NCT03920813 395 403 O
- NCT03920813 404 405 O
ALL NCT03920813 406 409 O
2015 NCT03920813 411 415 O

Exclusion NCT03920813 417 426 O
Criteria NCT03920813 427 435 O
: NCT03920813 436 437 O

- NCT03920813 441 442 O
Patients NCT03920813 444 452 O
with NCT03920813 453 457 O
high NCT03920813 458 462 B-Polarity___Polarity-Value:high
- NCT03920813 463 464 O
risk NCT03920813 465 469 O
ALL NCT03920813 470 473 B-Condition-Name
( NCT03920813 474 475 O
presence NCT03920813 476 484 O
of NCT03920813 485 487 O
higher NCT03920813 488 494 O
- NCT03920813 495 496 O
risk NCT03920813 497 501 O
features NCT03920813 502 510 O
: NCT03920813 511 512 O
MRD NCT03920813 513 516 B-Observation-Name
≥ NCT03920813 517 518 B-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03920813 520 521 B-Eq-Value
% NCT03920813 522 523 B-Eq-Unit
at NCT03920813 524 526 O
46 NCT03920813 528 530 O
day NCT03920813 531 534 O
, NCT03920813 535 536 O
or NCT03920813 537 539 O
age NCT03920813 540 543 O
< NCT03920813 544 545 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03920813 547 548 B-Eq-Value
month NCT03920813 549 554 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03920813 555 558 O
white NCT03920813 559 564 B-Observation-Name___Observation-Type-Value:lab
blood NCT03920813 565 570 I-Observation-Name___Observation-Type-Value:lab
cell NCT03920813 571 575 I-Observation-Name___Observation-Type-Value:lab
( NCT03920813 576 577 O
WBC NCT03920813 578 581 B-Observation-Name___Observation-Type-Value:lab
) NCT03920813 582 583 O
count NCT03920813 584 589 O
≥ NCT03920813 590 591 B-Eq-Operator___Eq-Operator-Value:GTEQ
300 NCT03920813 593 596 B-Eq-Value
× NCT03920813 597 598 B-Eq-Unit
109 NCT03920813 599 602 I-Eq-Unit
/ NCT03920813 603 604 O
L NCT03920813 605 606 B-Eq-Unit
with NCT03920813 607 611 O
translocations NCT03920813 612 626 O
t NCT03920813 627 628 O
( NCT03920813 629 630 O
9 NCT03920813 632 633 O
; NCT03920813 634 635 O
22 NCT03920813 636 638 O
) NCT03920813 639 640 O
( NCT03920813 641 642 O
q NCT03920813 643 644 O
34 NCT03920813 645 647 O
; NCT03920813 648 649 O
q NCT03920813 649 650 O
11 NCT03920813 651 653 O
) NCT03920813 654 655 O
[ NCT03920813 656 657 O
BCR NCT03920813 658 661 O
- NCT03920813 662 663 O
ABL NCT03920813 664 667 O
] NCT03920813 668 669 O
, NCT03920813 671 672 O
t NCT03920813 673 674 O
( NCT03920813 675 676 O
4 NCT03920813 678 679 O
; NCT03920813 680 681 O
11 NCT03920813 682 684 O
) NCT03920813 685 686 O
( NCT03920813 687 688 O
q NCT03920813 689 690 O
21 NCT03920813 691 693 O
; NCT03920813 694 695 O
q NCT03920813 695 696 O
23 NCT03920813 697 699 O
) NCT03920813 700 701 O
[ NCT03920813 702 703 O
AF NCT03920813 704 706 O
4 NCT03920813 707 708 O
/ NCT03920813 709 710 O
MLL NCT03920813 711 714 O
] NCT03920813 715 716 O
, NCT03920813 718 719 O
t NCT03920813 720 721 O
( NCT03920813 722 723 O
1 NCT03920813 725 726 O
; NCT03920813 727 728 O
19 NCT03920813 729 731 O
) NCT03920813 732 733 O
( NCT03920813 734 735 O
q NCT03920813 736 737 O
23 NCT03920813 738 740 O
; NCT03920813 741 742 O
p NCT03920813 742 743 O
13 NCT03920813 744 746 O
) NCT03920813 747 748 O
[ NCT03920813 749 750 O
E NCT03920813 751 752 O
2A NCT03920813 753 755 O
- NCT03920813 756 757 O
PBX NCT03920813 758 761 O
1 NCT03920813 762 763 O
] NCT03920813 764 765 O
or NCT03920813 766 768 O
other NCT03920813 769 774 O
MLL NCT03920813 775 778 O
- NCT03920813 779 780 O
rearrangements NCT03920813 781 795 O
) NCT03920813 796 797 O
were NCT03920813 798 802 O
removed NCT03920813 803 810 O

Inclusion NCT03927417 0 9 O
Criteria NCT03927417 10 18 O
: NCT03927417 19 20 O

• NCT03927417 22 23 O
Couples NCT03927417 24 31 O
with NCT03927417 32 36 O
primary NCT03927417 37 44 O
/ NCT03927417 45 46 O
secondary NCT03927417 47 56 O
infertility NCT03927417 57 68 B-Condition-Name
who NCT03927417 69 72 O
are NCT03927417 73 76 O
planned NCT03927417 77 84 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03927417 85 87 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03927417 88 95 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
IVF NCT03927417 96 99 B-Procedure-Name
/ NCT03927417 100 101 O
ICSI NCT03927417 102 106 B-Procedure-Name

treatment NCT03927417 107 116 O
in NCT03927417 117 119 O
one NCT03927417 120 123 O
of NCT03927417 124 126 O
the NCT03927417 127 130 O
above NCT03927417 131 136 O
mentioned NCT03927417 137 146 O
centers NCT03927417 147 154 O
and NCT03927417 155 158 O
who NCT03927417 159 162 O
agree NCT03927417 163 168 O
to NCT03927417 169 171 O
take NCT03927417 172 176 O
part NCT03927417 177 181 O
in NCT03927417 182 184 O
this NCT03927417 185 189 O
study NCT03927417 190 195 O
. NCT03927417 196 197 O

Exclusion NCT03927417 199 208 O
Criteria NCT03927417 209 217 O
: NCT03927417 218 219 O

- NCT03927417 223 224 O
Couples NCT03927417 226 233 O
planned NCT03927417 234 241 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03927417 242 245 O
oocyte NCT03927417 246 252 O
and NCT03927417 253 256 O
sperm NCT03927417 257 262 O
donation NCT03927417 263 271 B-Observation-Name

- NCT03927417 274 275 O
Couples NCT03927417 277 284 O
in NCT03927417 285 287 O
whom NCT03927417 288 292 O
the NCT03927417 293 296 O
female NCT03927417 297 303 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
partner NCT03927417 304 311 O
has NCT03927417 312 315 O
a NCT03927417 316 317 O
history NCT03927417 318 325 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927417 326 328 O
: NCT03927417 329 330 O

- NCT03927417 334 335 O
Chemotherapy NCT03927417 337 349 B-Procedure-Name
or NCT03927417 350 352 O
radiation NCT03927417 353 362 B-Procedure-Name
which NCT03927417 363 368 O
impacts NCT03927417 369 376 O
the NCT03927417 377 380 O
ovarian NCT03927417 381 388 O
reserve NCT03927417 389 396 O

- NCT03927417 399 400 O
Surgery NCT03927417 402 409 B-Procedure-Name
at NCT03927417 410 412 O
the NCT03927417 413 416 O
ovaries NCT03927417 417 424 O
/ NCT03927417 425 426 O
adnex NCT03927417 427 432 O
region NCT03927417 433 439 O

- NCT03927417 442 443 O
Tubal NCT03927417 445 450 B-Procedure-Name
ligation NCT03927417 451 459 I-Procedure-Name

- NCT03927417 462 463 O
Reversal NCT03927417 465 473 B-Procedure-Name
of NCT03927417 474 476 I-Procedure-Name
tubal NCT03927417 477 482 I-Procedure-Name
ligation NCT03927417 483 491 I-Procedure-Name

- NCT03927417 494 495 O
Endometriosis NCT03927417 497 510 B-Condition-Name

- NCT03927417 513 514 O
Couples NCT03927417 516 523 O
in NCT03927417 524 526 O
whom NCT03927417 527 531 O
the NCT03927417 532 535 O
male NCT03927417 536 540 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
partner NCT03927417 541 548 O
has NCT03927417 549 552 O
a NCT03927417 553 554 O
history NCT03927417 555 562 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927417 563 565 O
: NCT03927417 566 567 O

- NCT03927417 571 572 O
Chemotherapy NCT03927417 574 586 B-Procedure-Name
/ NCT03927417 587 588 O
Radiation NCT03927417 589 598 B-Procedure-Name
which NCT03927417 599 604 O
impacts NCT03927417 605 612 B-Stability___Stability-Value:change
the NCT03927417 613 616 O
semen NCT03927417 617 622 B-Condition-Name
result NCT03927417 623 629 O

- NCT03927417 632 633 O
Surgery NCT03927417 635 642 B-Procedure-Name
at NCT03927417 643 645 O
the NCT03927417 646 649 O
testicles NCT03927417 650 659 O

- NCT03927417 662 663 O
Vasectomy NCT03927417 665 674 B-Procedure-Name

- NCT03927417 677 678 O
Surgery NCT03927417 680 687 B-Procedure-Name
for NCT03927417 688 691 I-Procedure-Name
reversal NCT03927417 692 700 I-Procedure-Name
of NCT03927417 701 703 I-Procedure-Name
vasectomy NCT03927417 704 713 I-Procedure-Name

Inclusion NCT03928730 0 9 O
Criteria NCT03928730 10 18 O
: NCT03928730 19 20 O

- NCT03928730 24 25 O
All NCT03928730 27 30 O
with NCT03928730 31 35 O
oral NCT03928730 36 40 O
and NCT03928730 41 44 O
/ NCT03928730 45 46 O
or NCT03928730 47 49 O
maxillofacial NCT03928730 50 63 O
swelling NCT03928730 64 72 B-Condition-Name
, NCT03928730 73 74 O

Exclusion NCT03928730 76 85 O
Criteria NCT03928730 86 94 O
: NCT03928730 95 96 O

- NCT03928730 100 101 O
Any NCT03928730 103 106 O
other NCT03928730 107 112 O
swellings NCT03928730 113 122 B-Condition-Name
that NCT03928730 123 127 O
were NCT03928730 128 132 O
caused NCT03928730 133 139 O
by NCT03928730 140 142 O
trauma NCT03928730 143 149 B-Condition-Name
and NCT03928730 150 153 O
/ NCT03928730 154 155 O
or NCT03928730 156 158 O
fracture NCT03928730 159 167 B-Condition-Name
, NCT03928730 168 169 O
extended NCT03928730 170 178 O
below NCT03928730 179 184 O
the NCT03928730 185 188 O
neck NCT03928730 189 193 O
or NCT03928730 194 196 O
patient NCT03928730 197 204 O
reluctant NCT03928730 205 214 O
to NCT03928730 215 217 O
undergo NCT03928730 218 225 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
US NCT03928730 226 228 B-Procedure-Name
were NCT03928730 229 233 O
excluded NCT03928730 234 242 O
from NCT03928730 243 247 O
the NCT03928730 248 251 O
study NCT03928730 252 257 O
. NCT03928730 258 259 O

Inclusion NCT03929406 0 9 O
Criteria NCT03929406 10 18 O
: NCT03929406 19 20 O

- NCT03929406 24 25 O
Eligible NCT03929406 27 35 O
patients NCT03929406 36 44 O
for NCT03929406 45 48 O
deep NCT03929406 49 53 B-Procedure-Name
brain NCT03929406 54 59 I-Procedure-Name
stimulation NCT03929406 60 71 I-Procedure-Name
surgery NCT03929406 72 79 I-Procedure-Name

- NCT03929406 82 83 O
Patients NCT03929406 85 93 O
affiliated NCT03929406 94 104 O
to NCT03929406 105 107 O
social NCT03929406 108 114 O
security NCT03929406 115 123 O
or NCT03929406 124 126 O
benefiting NCT03929406 127 137 O
of NCT03929406 138 140 O
a NCT03929406 141 142 O
similar NCT03929406 143 150 O
insurance NCT03929406 151 160 O
scheme NCT03929406 161 167 O

- NCT03929406 170 171 O
Patients NCT03929406 173 181 O
having NCT03929406 182 188 O
signed NCT03929406 189 195 O
a NCT03929406 196 197 O
consent NCT03929406 198 205 O
to NCT03929406 206 208 O
participate NCT03929406 209 220 O
to NCT03929406 221 223 O
the NCT03929406 224 227 O
study NCT03929406 228 233 O

Exclusion NCT03929406 234 243 O
Criteria NCT03929406 244 252 O
: NCT03929406 253 254 O

- NCT03929406 258 259 O
Patient NCT03929406 261 268 O
not NCT03929406 269 272 O
eligible NCT03929406 273 281 O
for NCT03929406 282 285 O
deep NCT03929406 286 290 B-Procedure-Name
brain NCT03929406 291 296 I-Procedure-Name
stimulation NCT03929406 297 308 I-Procedure-Name
surgery NCT03929406 309 316 I-Procedure-Name

- NCT03929406 319 320 O
Pregnant NCT03929406 322 330 B-Condition-Name
women NCT03929406 331 336 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
or NCT03929406 337 339 O
nursing NCT03929406 340 347 B-Condition-Name
mothers NCT03929406 348 355 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03929406 358 359 O
Persons NCT03929406 361 368 O
deprived NCT03929406 369 377 B-Observation-Name
of NCT03929406 378 380 I-Observation-Name
liberty NCT03929406 381 388 I-Observation-Name
by NCT03929406 389 391 O
judicial NCT03929406 392 400 O
or NCT03929406 401 403 O
administrative NCT03929406 404 418 O
decision NCT03929406 419 427 O

- NCT03929406 430 431 O
Persons NCT03929406 433 440 O
unable NCT03929406 441 447 O
to NCT03929406 448 450 O
express NCT03929406 451 458 O
their NCT03929406 459 464 O
consent NCT03929406 465 472 O
or NCT03929406 473 475 O
legally NCT03929406 476 483 B-Observation-Name
protected NCT03929406 484 493 I-Observation-Name

- NCT03929406 496 497 O
Persons NCT03929406 499 506 O
in NCT03929406 507 509 O
period NCT03929406 510 516 O
of NCT03929406 517 519 O
disqualification NCT03929406 520 536 O
for NCT03929406 537 540 O
another NCT03929406 541 548 O
interventional NCT03929406 549 563 O
research NCT03929406 564 572 O

Inclusion NCT03920436 0 9 O
Criteria NCT03920436 10 18 O
: NCT03920436 19 20 O

- NCT03920436 24 25 O
19 NCT03920436 28 30 B-Eq-Value
years NCT03920436 31 36 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03920436 37 40 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03920436 41 46 I-Eq-Operator___Eq-Operator-Value:GTEQ

Exclusion NCT03920436 47 56 O
Criteria NCT03920436 57 65 O
: NCT03920436 66 67 O

- NCT03920436 71 72 O
aspartate NCT03920436 74 83 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03920436 84 100 I-Observation-Name___Observation-Type-Value:lab
( NCT03920436 101 102 O
AST NCT03920436 103 106 B-Observation-Name___Observation-Type-Value:lab
) NCT03920436 107 108 O
or NCT03920436 109 111 O
alanine NCT03920436 112 119 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03920436 120 136 I-Observation-Name___Observation-Type-Value:lab
( NCT03920436 137 138 O
ALT NCT03920436 139 142 B-Observation-Name___Observation-Type-Value:lab
) NCT03920436 143 144 O
more NCT03920436 145 149 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03920436 150 154 I-Eq-Operator___Eq-Operator-Value:GTEQ
twice NCT03920436 155 160 B-Eq-Value
the NCT03920436 161 164 O
highest NCT03920436 165 172 B-Eq-Unit___Eq-Unit-Value:ref-range-high
reference NCT03920436 173 182 I-Eq-Unit___Eq-Unit-Value:ref-range-high
value NCT03920436 183 188 I-Eq-Unit___Eq-Unit-Value:ref-range-high

- NCT03920436 191 192 O
serum NCT03920436 194 199 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03920436 200 210 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03920436 211 212 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.5 NCT03920436 214 217 B-Eq-Value
mg NCT03920436 218 220 B-Eq-Unit
/ NCT03920436 221 222 O
dL NCT03920436 223 225 B-Eq-Unit
) NCT03920436 226 227 O

- NCT03920436 231 232 O
uncontrolled NCT03920436 234 246 O
diabetes NCT03920436 247 255 B-Condition-Name
mellitus NCT03920436 256 264 I-Condition-Name
( NCT03920436 265 266 O
a NCT03920436 267 268 O
fasting NCT03920436 269 276 B-Observation-Name___Observation-Type-Value:lab
glucose NCT03920436 277 284 I-Observation-Name___Observation-Type-Value:lab
of NCT03920436 285 287 O
> NCT03920436 288 289 B-Eq-Operator___Eq-Operator-Value:GT
160 NCT03920436 291 294 B-Eq-Value
mg NCT03920436 295 297 B-Eq-Unit
/ NCT03920436 298 299 O
dL NCT03920436 300 302 B-Eq-Unit
) NCT03920436 303 304 O

- NCT03920436 308 309 O
uncontrolled NCT03920436 311 323 O
hypertension NCT03920436 324 336 B-Condition-Name
( NCT03920436 337 338 O
BP NCT03920436 339 341 B-Observation-Name___Observation-Type-Value:vital
> NCT03920436 342 343 B-Eq-Operator___Eq-Operator-Value:GT
160 NCT03920436 345 348 B-Eq-Value
/ NCT03920436 349 350 O
100 NCT03920436 352 355 B-Eq-Value
mmHg NCT03920436 356 360 B-Eq-Unit
) NCT03920436 361 362 O

- NCT03920436 366 367 O
severe NCT03920436 369 375 B-Severity___Severity-Value:severe
gastrointestinal NCT03920436 376 392 B-Condition-Name
symptoms NCT03920436 393 401 O

- NCT03920436 404 405 O
alcohol NCT03920436 407 414 B-Observation-Name___Observation-Type-Value:social-habit
abuser NCT03920436 415 421 I-Observation-Name___Observation-Type-Value:social-habit

- NCT03920436 424 425 O
pregnant NCT03920436 427 435 B-Condition-Name
or NCT03920436 436 438 O
lactating NCT03920436 439 448 B-Condition-Name
women NCT03920436 449 454 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03920436 457 458 O
allergic NCT03920436 460 468 O
to NCT03920436 469 471 O
the NCT03920436 472 475 O
ingredient NCT03920436 476 486 O
involved NCT03920436 487 495 O

- NCT03920436 498 499 O
cardiocebrovascular NCT03920436 501 520 B-Condition-Name
diseases NCT03920436 521 529 I-Condition-Name
or NCT03920436 530 532 O
any NCT03920436 533 536 O
cancer NCT03920436 537 543 B-Condition-Name
during NCT03920436 544 550 O
the NCT03920436 551 554 O
six NCT03920436 555 558 B-Eq-Value
months NCT03920436 559 565 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03920436 566 571 O
to NCT03920436 572 574 O
study NCT03920436 575 580 O

- NCT03920436 583 584 O
smoker NCT03920436 586 592 B-Condition-Name

Inclusion NCT03924687 0 9 O
Criteria NCT03924687 10 18 O
: NCT03924687 19 20 O

- NCT03924687 24 25 O
being NCT03924687 27 32 O
18 NCT03924687 34 36 B-Eq-Value
years NCT03924687 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03924687 43 45 O
age NCT03924687 46 49 O
or NCT03924687 50 52 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03924687 53 58 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03924687 61 62 O
having NCT03924687 64 70 O
suffered NCT03924687 71 79 O
from NCT03924687 80 84 O
daily NCT03924687 85 90 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
pain NCT03924687 91 95 B-Condition-Name
for NCT03924687 96 99 O
more NCT03924687 100 104 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03924687 105 109 I-Eq-Operator___Eq-Operator-Value:GT
three NCT03924687 110 115 B-Eq-Value
months NCT03924687 116 122 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03924687 125 126 O
having NCT03924687 128 134 O
reading NCT03924687 135 142 O
and NCT03924687 143 146 O
writing NCT03924687 147 154 O
abilities NCT03924687 155 164 O
in NCT03924687 165 167 O
French NCT03924687 168 174 B-Language
equivalent NCT03924687 175 185 O
or NCT03924687 186 188 O
superior NCT03924687 189 197 O
to NCT03924687 198 200 O
grade NCT03924687 201 206 O
8 NCT03924687 208 209 O

- NCT03924687 213 214 O
having NCT03924687 216 222 O
access NCT03924687 223 229 O
to NCT03924687 230 232 O
Internet NCT03924687 233 241 O
at NCT03924687 242 244 O
home NCT03924687 245 249 O
and NCT03924687 250 253 O
having NCT03924687 254 260 O
a NCT03924687 261 262 O
valid NCT03924687 263 268 O
e NCT03924687 269 270 O
- NCT03924687 271 272 O
mail NCT03924687 273 277 O
address NCT03924687 278 285 O

- NCT03924687 288 289 O
not NCT03924687 291 294 O
having NCT03924687 295 301 O
previously NCT03924687 302 312 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
completed NCT03924687 313 322 O
an NCT03924687 323 325 O
ACT NCT03924687 326 329 B-Procedure-Name
- NCT03924687 330 331 I-Procedure-Name
type NCT03924687 332 336 I-Procedure-Name
psychotherapy NCT03924687 337 350 I-Procedure-Name
, NCT03924687 351 352 O
not NCT03924687 353 356 O
having NCT03924687 357 363 O
practiced NCT03924687 364 373 B-Observation-Name
mindfulness NCT03924687 374 385 I-Observation-Name
meditation NCT03924687 386 396 I-Observation-Name
regularly NCT03924687 397 406 O
and NCT03924687 407 410 O
not NCT03924687 411 414 O
having NCT03924687 415 421 O
read NCT03924687 422 426 O
a NCT03924687 427 428 O
bibliotherapy NCT03924687 429 442 B-Procedure-Name
on NCT03924687 443 445 I-Procedure-Name
ACT NCT03924687 446 449 I-Procedure-Name
for NCT03924687 450 453 O
pain NCT03924687 454 458 B-Condition-Name

- NCT03924687 461 462 O
having NCT03924687 464 470 O
stable NCT03924687 471 477 B-Stability___Stability-Value:stable
medication NCT03924687 478 488 O
for NCT03924687 489 492 O
at NCT03924687 493 495 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03924687 496 501 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03924687 502 505 B-Eq-Value
month NCT03924687 506 511 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03924687 512 513 O
if NCT03924687 514 516 O
applicable NCT03924687 517 527 O
. NCT03924687 528 529 O

Exclusion NCT03924687 531 540 O
Criteria NCT03924687 541 549 O
: NCT03924687 550 551 O

- NCT03924687 554 555 O

Inclusion NCT03921099 0 9 O
Criteria NCT03921099 10 18 O
: NCT03921099 19 20 O

- NCT03921099 24 25 O
Adults NCT03921099 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
who NCT03921099 34 37 O
are NCT03921099 38 41 O
critically NCT03921099 42 52 B-Severity___Severity-Value:severe
ill NCT03921099 53 56 O
and NCT03921099 57 60 O
with NCT03921099 61 65 O
MRSA NCT03921099 66 70 B-Condition-Name
infection NCT03921099 71 80 I-Condition-Name
suspection NCT03921099 81 91 O
. NCT03921099 92 93 O

Exclusion NCT03921099 95 104 O
Criteria NCT03921099 105 113 O
: NCT03921099 114 115 O

1 NCT03921099 120 121 O
. NCT03921099 121 122 O
Pregnancy NCT03921099 124 133 B-Condition-Name
or NCT03921099 134 136 O
breast NCT03921099 137 143 B-Condition-Name
feeding NCT03921099 144 151 I-Condition-Name
. NCT03921099 152 153 O

2 NCT03921099 158 159 O
. NCT03921099 159 160 O
Known NCT03921099 162 167 O
allergy NCT03921099 168 175 O
to NCT03921099 176 178 O
either NCT03921099 179 185 O
vancomycin NCT03921099 186 196 B-Drug-Name
or NCT03921099 197 199 O
ascorbic NCT03921099 200 208 B-Drug-Name
acid NCT03921099 209 213 I-Drug-Name
. NCT03921099 214 215 O

3 NCT03921099 220 221 O
. NCT03921099 221 222 O
Base NCT03921099 224 228 O
line NCT03921099 229 233 O
serum NCT03921099 234 239 B-Observation-Name___Observation-Type-Value:lab
creatinine NCT03921099 240 250 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03921099 251 252 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03921099 254 255 B-Eq-Value
mg NCT03921099 256 258 B-Eq-Unit
/ NCT03921099 259 260 O
dl NCT03921099 261 263 B-Eq-Unit
. NCT03921099 264 265 O

4 NCT03921099 270 271 O
. NCT03921099 271 272 O
Patients NCT03921099 274 282 O
receiving NCT03921099 283 292 O
other NCT03921099 293 298 O
nephrotoxic NCT03921099 299 310 B-Drug-Name
drug NCT03921099 311 315 I-Drug-Name
( NCT03921099 316 317 O
e NCT03921099 318 319 O
. NCT03921099 320 321 O
g NCT03921099 322 323 O
. NCT03921099 324 325 O
, NCT03921099 326 327 O
aminoglycosides NCT03921099 328 343 B-Drug-Name
, NCT03921099 344 345 O
amphotericin NCT03921099 346 358 B-Drug-Name
B NCT03921099 359 360 I-Drug-Name
, NCT03921099 361 362 O
cisplatin NCT03921099 363 372 B-Drug-Name
or NCT03921099 373 375 O
calcinurine NCT03921099 376 387 B-Drug-Name
inhibitors NCT03921099 388 398 I-Drug-Name
) NCT03921099 399 400 O
. NCT03921099 402 403 O

5 NCT03921099 408 409 O
. NCT03921099 409 410 O
Anticepated NCT03921099 412 423 O
administration NCT03921099 424 438 O
of NCT03921099 439 441 O
contrast NCT03921099 442 450 B-Drug-Name
medium NCT03921099 451 457 I-Drug-Name
within NCT03921099 458 464 B-Eq-Operator___Eq-Operator-Value:LTEQ
7 NCT03921099 466 467 B-Eq-Value
days NCT03921099 468 472 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
. NCT03921099 473 474 O

6 NCT03921099 479 480 O
. NCT03921099 480 481 O
Patients NCT03921099 483 491 O
suffering NCT03921099 492 501 O
from NCT03921099 502 506 O
some NCT03921099 507 511 O
underlying NCT03921099 512 522 O
diseases NCT03921099 523 531 B-Condition-Name
( NCT03921099 532 533 O
e NCT03921099 534 535 O
. NCT03921099 536 537 O
g NCT03921099 538 539 O
. NCT03921099 540 541 O
, NCT03921099 542 543 O
cancer NCT03921099 544 550 B-Condition-Name
, NCT03921099 551 552 O
HIV NCT03921099 553 556 B-Condition-Name
infection NCT03921099 557 566 I-Condition-Name
, NCT03921099 567 568 O
systemic NCT03921099 569 577 B-Condition-Name
lupus NCT03921099 578 583 I-Condition-Name
erythematoses NCT03921099 584 597 I-Condition-Name
, NCT03921099 598 599 O
or NCT03921099 600 602 O
urinary NCT03921099 603 610 B-Condition-Name
tract NCT03921099 611 616 I-Condition-Name
stones NCT03921099 617 623 I-Condition-Name
) NCT03921099 624 625 O
. NCT03921099 627 628 O

7 NCT03921099 633 634 O
. NCT03921099 634 635 O
Unlikelyhood NCT03921099 637 649 O
of NCT03921099 650 652 O
receiving NCT03921099 653 662 O
the NCT03921099 663 666 O
study NCT03921099 667 672 O
medications NCT03921099 673 684 O
for NCT03921099 685 688 O
at NCT03921099 689 691 B-Eq-Operator___Eq-Operator-Value:LTEQ
least NCT03921099 692 697 I-Eq-Operator___Eq-Operator-Value:LTEQ
72 NCT03921099 699 701 B-Eq-Value
hours NCT03921099 702 707 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

Inclusion NCT03925610 0 9 O
Criteria NCT03925610 10 18 O
: NCT03925610 19 20 O

- NCT03925610 24 25 O
Body NCT03925610 27 31 B-Observation-Name___Observation-Type-Value:vital
mass NCT03925610 32 36 I-Observation-Name___Observation-Type-Value:vital
index NCT03925610 37 42 I-Observation-Name___Observation-Type-Value:vital
( NCT03925610 43 44 O
BMI NCT03925610 45 48 B-Observation-Name___Observation-Type-Value:vital
) NCT03925610 49 50 O
equal NCT03925610 51 56 B-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03925610 57 59 I-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03925610 60 67 I-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03925610 68 72 I-Eq-Operator___Eq-Operator-Value:GTEQ
35 NCT03925610 74 76 B-Eq-Value
kg NCT03925610 77 79 B-Eq-Unit
/ NCT03925610 80 81 O
m NCT03925610 82 83 B-Eq-Unit
2 NCT03925610 84 85 I-Eq-Unit
. NCT03925610 85 86 O

- NCT03925610 90 91 O
American NCT03925610 93 101 B-Condition-Name
Society NCT03925610 102 109 I-Condition-Name
of NCT03925610 110 112 I-Condition-Name
Anesthesiologists NCT03925610 113 130 I-Condition-Name
( NCT03925610 131 132 O
ASA NCT03925610 133 136 B-Condition-Name
) NCT03925610 137 138 O
physical NCT03925610 139 147 O
status NCT03925610 148 154 B-Eq-Unit
I NCT03925610 155 156 B-Eq-Value
- NCT03925610 157 158 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03925610 159 162 B-Eq-Value
patients NCT03925610 163 171 O
. NCT03925610 172 173 O

- NCT03925610 177 178 O
Scheduled NCT03925610 180 189 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
to NCT03925610 190 192 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03925610 193 200 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
laparoscopic NCT03925610 201 213 B-Procedure-Name
roux NCT03925610 214 218 I-Procedure-Name
- NCT03925610 219 220 I-Procedure-Name
en NCT03925610 221 223 I-Procedure-Name
- NCT03925610 224 225 I-Procedure-Name
Y NCT03925610 226 227 I-Procedure-Name
gastric NCT03925610 228 235 I-Procedure-Name
bypass NCT03925610 236 242 I-Procedure-Name
or NCT03925610 243 245 O
gastric NCT03925610 246 253 B-Procedure-Name
sleeve NCT03925610 254 260 I-Procedure-Name
placement NCT03925610 261 270 I-Procedure-Name
surgery NCT03925610 271 278 I-Procedure-Name
for NCT03925610 279 282 O
weight NCT03925610 283 289 B-Condition-Name
loss NCT03925610 290 294 I-Condition-Name
. NCT03925610 295 296 O

Exclusion NCT03925610 298 307 O
Criteria NCT03925610 308 316 O
: NCT03925610 317 318 O

- NCT03925610 322 323 O
Chronic NCT03925610 325 332 B-Condition-Name
obstructive NCT03925610 333 344 I-Condition-Name
pulmonary NCT03925610 345 354 I-Condition-Name
disorder NCT03925610 355 363 I-Condition-Name
( NCT03925610 364 365 O
COPD NCT03925610 366 370 B-Condition-Name
) NCT03925610 371 372 O
. NCT03925610 374 375 O

- NCT03925610 379 380 O
Treatment NCT03925610 382 391 O
with NCT03925610 392 396 O
continuous NCT03925610 397 407 B-Procedure-Name
positive NCT03925610 408 416 I-Procedure-Name
airway NCT03925610 417 423 I-Procedure-Name
pressure NCT03925610 424 432 I-Procedure-Name
( NCT03925610 433 434 O
CPAP NCT03925610 435 439 B-Procedure-Name
) NCT03925610 440 441 O
in NCT03925610 442 444 O
the NCT03925610 445 448 O
past NCT03925610 449 453 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03925610 454 459 B-Eq-Value
months NCT03925610 460 466 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03925610 467 468 O

- NCT03925610 472 473 O
Severe NCT03925610 475 481 B-Severity___Severity-Value:severe
neurological NCT03925610 482 494 O
, NCT03925610 495 496 O
cardiopulmonary NCT03925610 497 512 O
, NCT03925610 513 514 O
psychiatric NCT03925610 515 526 O
, NCT03925610 527 528 O
or NCT03925610 529 531 O
untreated NCT03925610 532 541 O
thyroid NCT03925610 542 549 O
disorder NCT03925610 550 558 B-Condition-Name
. NCT03925610 559 560 O

- NCT03925610 564 565 O
Chronic NCT03925610 567 574 B-Condition-Name
pain NCT03925610 575 579 I-Condition-Name
condition NCT03925610 580 589 I-Condition-Name
that NCT03925610 590 594 O
was NCT03925610 595 598 O
being NCT03925610 599 604 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treated NCT03925610 605 612 O
with NCT03925610 613 617 O
opioids NCT03925610 618 625 B-Drug-Name
. NCT03925610 626 627 O

- NCT03925610 631 632 O
Patients NCT03925610 634 642 O
with NCT03925610 643 647 O
a NCT03925610 648 649 O
hematocrit NCT03925610 650 660 B-Observation-Name___Observation-Type-Value:lab
lower NCT03925610 661 666 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03925610 667 671 I-Eq-Operator___Eq-Operator-Value:LT
35 NCT03925610 673 675 B-Eq-Value
% NCT03925610 676 677 B-Eq-Unit
. NCT03925610 679 680 O

Inclusion NCT03921476 0 9 O
Criteria NCT03921476 10 18 O
: NCT03921476 19 20 O

Female NCT03921476 22 28 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subjects NCT03921476 29 37 O
between NCT03921476 38 45 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03921476 47 49 B-Eq-Value
and NCT03921476 50 53 O
65 NCT03921476 55 57 B-Eq-Value
years NCT03921476 58 63 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921476 64 66 O
age NCT03921476 67 70 O
currently NCT03921476 71 80 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03921476 81 87 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
spironolactone NCT03921476 88 102 B-Drug-Name
for NCT03921476 103 106 O
a NCT03921476 107 108 O
diagnosis NCT03921476 109 118 O
of NCT03921476 119 121 O
acne NCT03921476 122 126 B-Condition-Name
vulgaris NCT03921476 127 135 I-Condition-Name

OR NCT03921476 136 138 O

Female NCT03921476 139 145 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subjects NCT03921476 146 154 O
between NCT03921476 155 162 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03921476 164 166 B-Eq-Value
and NCT03921476 167 170 O
65 NCT03921476 172 174 B-Eq-Value
years NCT03921476 175 180 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921476 181 183 O
age NCT03921476 184 187 O
currently NCT03921476 188 197 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03921476 198 204 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
oral NCT03921476 205 209 B-Drug-Name
antibiotics NCT03921476 210 221 I-Drug-Name
for NCT03921476 222 225 O
a NCT03921476 226 227 O
diagnosis NCT03921476 228 237 O
of NCT03921476 238 240 O
acne NCT03921476 241 245 B-Condition-Name
vulgaris NCT03921476 246 254 I-Condition-Name

AND NCT03921476 255 258 O
Subjects NCT03921476 259 267 O
able NCT03921476 268 272 O
to NCT03921476 273 275 O
complete NCT03921476 276 284 O
an NCT03921476 285 287 O
online NCT03921476 288 294 O
survey NCT03921476 295 301 O
in NCT03921476 302 304 O
English NCT03921476 305 312 B-Language

Exclusion NCT03921476 313 322 O
Criteria NCT03921476 323 331 O
: NCT03921476 332 333 O

Subjects NCT03921476 335 343 O
less NCT03921476 344 348 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03921476 349 353 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03921476 355 357 B-Eq-Value
years NCT03921476 358 363 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921476 364 366 O
age NCT03921476 367 370 O
or NCT03921476 371 373 O
older NCT03921476 374 379 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03921476 380 384 I-Eq-Operator___Eq-Operator-Value:GT
65 NCT03921476 386 388 B-Eq-Value
years NCT03921476 389 394 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921476 395 397 O
age NCT03921476 398 401 O
Subjects NCT03921476 402 410 O
that NCT03921476 411 415 O
have NCT03921476 416 420 O
ever NCT03921476 421 425 O
been NCT03921476 426 430 O
diagnosed NCT03921476 431 440 O
with NCT03921476 441 445 O
any NCT03921476 446 449 O
mood NCT03921476 450 454 B-Condition-Name
disorder NCT03921476 455 463 I-Condition-Name
by NCT03921476 464 466 O
a NCT03921476 467 468 O
clinician NCT03921476 469 478 O
prior NCT03921476 479 484 O
to NCT03921476 485 487 O
starting NCT03921476 488 496 O
spironolactone NCT03921476 497 511 B-Drug-Name
( NCT03921476 512 513 O
history NCT03921476 514 521 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921476 522 524 O
mood NCT03921476 525 529 B-Condition-Name
disorder NCT03921476 530 538 I-Condition-Name
or NCT03921476 539 541 O
current NCT03921476 542 549 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
mood NCT03921476 550 554 B-Condition-Name
disorder NCT03921476 555 563 I-Condition-Name
) NCT03921476 564 565 O
Subjects NCT03921476 566 574 O
taking NCT03921476 575 581 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hormonal NCT03921476 582 590 B-Drug-Name
contraception NCT03921476 591 604 I-Drug-Name
( NCT03921476 605 606 O
including NCT03921476 607 616 O
but NCT03921476 617 620 O
not NCT03921476 621 624 O
limited NCT03921476 625 632 O
to NCT03921476 633 635 O
oral NCT03921476 636 640 B-Drug-Name
contraceptive NCT03921476 641 654 I-Drug-Name
pills NCT03921476 655 660 I-Drug-Name
) NCT03921476 661 662 O
for NCT03921476 663 666 O
a NCT03921476 667 668 O
duration NCT03921476 669 677 O
of NCT03921476 678 680 O
less NCT03921476 681 685 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03921476 686 690 I-Eq-Operator___Eq-Operator-Value:LT
6 NCT03921476 692 693 B-Eq-Value
months NCT03921476 694 700 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
Subjects NCT03921476 701 709 O
that NCT03921476 710 714 O
have NCT03921476 715 719 O
ever NCT03921476 720 724 O
been NCT03921476 725 729 O
diagnosed NCT03921476 730 739 O
with NCT03921476 740 744 O
any NCT03921476 745 748 O
type NCT03921476 749 753 O
of NCT03921476 754 756 O
sexual NCT03921476 757 763 B-Condition-Name
dysfunction NCT03921476 764 775 I-Condition-Name
prior NCT03921476 776 781 O
to NCT03921476 782 784 O
starting NCT03921476 785 793 O
spironolactone NCT03921476 794 808 B-Drug-Name
Subjects NCT03921476 809 817 O
not NCT03921476 818 821 O
able NCT03921476 822 826 O
to NCT03921476 827 829 O
complete NCT03921476 830 838 O
an NCT03921476 839 841 O
online NCT03921476 842 848 O
survey NCT03921476 849 855 O
in NCT03921476 856 858 O
English NCT03921476 859 866 B-Language
Subjects NCT03921476 867 875 O
taking NCT03921476 876 882 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
oral NCT03921476 883 887 B-Drug-Name
isotretinoin NCT03921476 888 900 I-Drug-Name
for NCT03921476 901 904 O
a NCT03921476 905 906 O
diagnosis NCT03921476 907 916 O
of NCT03921476 917 919 O
acne NCT03921476 920 924 B-Condition-Name
Subjects NCT03921476 925 933 O
that NCT03921476 934 938 O
are NCT03921476 939 942 O
currently NCT03921476 943 952 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnant NCT03921476 953 961 B-Condition-Name


Inclusion NCT03929770 0 9 O
Criteria NCT03929770 10 18 O
: NCT03929770 19 20 O

- NCT03929770 24 25 O
The NCT03929770 27 30 O
patients NCT03929770 31 39 O
who NCT03929770 40 43 O
need NCT03929770 44 48 O
to NCT03929770 49 51 O
Swan NCT03929770 52 56 B-Procedure-Name
- NCT03929770 57 58 I-Procedure-Name
Ganz NCT03929770 59 63 I-Procedure-Name
catheterization NCT03929770 64 79 I-Procedure-Name
for NCT03929770 80 83 O
heart NCT03929770 84 89 B-Procedure-Name
surgeries NCT03929770 90 99 I-Procedure-Name

Exclusion NCT03929770 100 109 O
Criteria NCT03929770 110 118 O
: NCT03929770 119 120 O

- NCT03929770 124 125 O
Who NCT03929770 127 130 O
does NCT03929770 131 135 O
n't NCT03929770 135 138 O
agree NCT03929770 139 144 O
to NCT03929770 145 147 O
enroll NCT03929770 148 154 O

- NCT03929770 157 158 O
Who NCT03929770 160 163 O
has NCT03929770 164 167 O
thrombus NCT03929770 168 176 B-Condition-Name
in NCT03929770 177 179 I-Condition-Name
the NCT03929770 180 183 I-Condition-Name
heart NCT03929770 184 189 O
or NCT03929770 190 192 O
the NCT03929770 193 196 O
vena NCT03929770 197 201 O
cavas NCT03929770 202 207 O
. NCT03929770 208 209 O

Inclusion NCT03926325 0 9 O
Criteria NCT03926325 10 18 O
: NCT03926325 19 20 O

1 NCT03926325 25 26 O
. NCT03926325 26 27 O
OHCA NCT03926325 29 33 O
: NCT03926325 34 35 O
Every NCT03926325 36 41 O
patient NCT03926325 42 49 O
who NCT03926325 50 53 O
suffered NCT03926325 54 62 O
a NCT03926325 63 64 O
cardiac NCT03926325 65 72 B-Condition-Name
arrest NCT03926325 73 79 I-Condition-Name
that NCT03926325 80 84 O
occurred NCT03926325 85 93 O
in NCT03926325 94 96 O
any NCT03926325 97 100 O
location NCT03926325 101 109 B-Location
other NCT03926325 110 115 O
than NCT03926325 116 120 O
a NCT03926325 121 122 O
hospital NCT03926325 123 131 B-Location___Location-Value:hospital
, NCT03926325 132 133 O
and NCT03926325 134 137 O
was NCT03926325 138 141 O
attended NCT03926325 142 150 O
and NCT03926325 151 154 O
/ NCT03926325 155 156 O
or NCT03926325 157 159 O
treated NCT03926325 160 167 O
by NCT03926325 168 170 O
an NCT03926325 171 173 O
EMS NCT03926325 174 177 O
. NCT03926325 178 179 O

2 NCT03926325 184 185 O
. NCT03926325 185 186 O
IHCA NCT03926325 188 192 O
: NCT03926325 193 194 O
Every NCT03926325 195 200 O
patient NCT03926325 201 208 O
who NCT03926325 209 212 O
suffered NCT03926325 213 221 O
a NCT03926325 222 223 O
cardiac NCT03926325 224 231 B-Condition-Name
arrest NCT03926325 232 238 I-Condition-Name
in NCT03926325 239 241 O
hospital NCT03926325 242 250 B-Location___Location-Value:hospital
. NCT03926325 251 252 O

3 NCT03926325 257 258 O
. NCT03926325 258 259 O
the NCT03926325 261 264 O
representative NCT03926325 265 279 O
population NCT03926325 280 290 O
- NCT03926325 291 292 O
based NCT03926325 293 298 O
survey NCT03926325 299 305 O
: NCT03926325 306 307 O
Every NCT03926325 308 313 O
patient NCT03926325 314 321 O
who NCT03926325 322 325 O
suffered NCT03926325 326 334 O
a NCT03926325 335 336 O
cardiac NCT03926325 337 344 B-Condition-Name
arrest NCT03926325 345 351 I-Condition-Name
in NCT03926325 352 354 O
the NCT03926325 355 358 O
selected NCT03926325 359 367 O
cities NCT03926325 368 374 O
or NCT03926325 375 377 O
suburbs NCT03926325 378 385 O
. NCT03926325 386 387 O

Exclusion NCT03926325 389 398 O
Criteria NCT03926325 399 407 O
: NCT03926325 408 409 O

1 NCT03926325 414 415 O
. NCT03926325 415 416 O
OHCA NCT03926325 418 422 O
: NCT03926325 423 424 O
1 NCT03926325 426 427 O
) NCT03926325 428 429 O
The NCT03926325 430 433 O
out NCT03926325 434 437 O
- NCT03926325 438 439 O
of NCT03926325 440 442 O
- NCT03926325 443 444 O
hospital NCT03926325 445 453 B-Location___Location-Value:hospital
cardiac NCT03926325 454 461 B-Condition-Name
arrest NCT03926325 462 468 I-Condition-Name
patients NCT03926325 469 477 O
who NCT03926325 478 481 O
were NCT03926325 482 486 O
taken NCT03926325 487 492 O
to NCT03926325 493 495 O
the NCT03926325 496 499 O
hospital NCT03926325 500 508 O
by NCT03926325 509 511 O
their NCT03926325 512 517 O
family NCT03926325 518 524 O
members NCT03926325 525 532 O
; NCT03926325 532 533 O
2 NCT03926325 535 536 O
) NCT03926325 537 538 O
Bystanders NCT03926325 539 549 O
suspected NCT03926325 550 559 O
cardiac NCT03926325 560 567 B-Condition-Name
arrest NCT03926325 568 574 I-Condition-Name
, NCT03926325 575 576 O
but NCT03926325 577 580 O
the NCT03926325 581 584 O
ROSC NCT03926325 585 589 O
was NCT03926325 590 593 O
achieved NCT03926325 594 602 O
without NCT03926325 603 610 O
defibrillation NCT03926325 611 625 B-Procedure-Name
or NCT03926325 626 628 O
resuscitation NCT03926325 629 642 B-Procedure-Name
by NCT03926325 643 645 O
EMS NCT03926325 646 649 O
. NCT03926325 650 651 O

2 NCT03926325 656 657 O
. NCT03926325 657 658 O
IHCA NCT03926325 660 664 O
: NCT03926325 665 666 O
The NCT03926325 667 670 O
patient NCT03926325 671 678 O
who NCT03926325 679 682 O
suffered NCT03926325 683 691 O
a NCT03926325 692 693 O
cardiac NCT03926325 694 701 B-Condition-Name
arrest NCT03926325 702 708 I-Condition-Name
that NCT03926325 709 713 O
occurred NCT03926325 714 722 O
out NCT03926325 723 726 O
- NCT03926325 727 728 O
of NCT03926325 729 731 O
- NCT03926325 732 733 O
hospital NCT03926325 734 742 B-Location___Location-Value:hospital
and NCT03926325 743 746 O
then NCT03926325 747 751 O
transferred NCT03926325 752 763 B-Encounter-Type___Encounter-Type-Value:transfer
to NCT03926325 764 766 O
the NCT03926325 767 770 O
hospital NCT03926325 771 779 B-Location___Location-Value:hospital
. NCT03926325 780 781 O

Inclusion NCT03924297 0 9 O
Criteria NCT03924297 10 18 O
: NCT03924297 19 20 O

- NCT03924297 24 25 O
Patients NCT03924297 27 35 O
who NCT03924297 36 39 O
have NCT03924297 40 44 O
seen NCT03924297 45 49 O
the NCT03924297 50 53 O
study NCT03924297 54 59 O
PI NCT03924297 60 62 O
( NCT03924297 63 64 O
Remy NCT03924297 65 69 O
Coeytaux NCT03924297 70 78 O
, NCT03924297 79 80 O
MD NCT03924297 81 83 O
, NCT03924297 84 85 O
PhD NCT03924297 86 89 O
) NCT03924297 90 91 O
for NCT03924297 92 95 O
an NCT03924297 96 98 O
integrative NCT03924297 99 110 O
medicine NCT03924297 111 119 O
consultation NCT03924297 120 132 B-Encounter-Type___Encounter-Type-Value:outpatient
between NCT03924297 133 140 B-Eq-Operator___Eq-Operator-Value:BETWEEN
September NCT03924297 141 150 B-Eq-Value
1 NCT03924297 152 153 I-Eq-Value
, NCT03924297 154 155 I-Eq-Value
2018 NCT03924297 157 161 I-Eq-Value
and NCT03924297 162 165 O
April NCT03924297 166 171 B-Eq-Value
30 NCT03924297 173 175 I-Eq-Value
, NCT03924297 176 177 I-Eq-Value
2019 NCT03924297 179 183 I-Eq-Value
and NCT03924297 184 187 O
who NCT03924297 188 191 O
report NCT03924297 192 198 O
having NCT03924297 199 205 O
been NCT03924297 206 210 O
diagnoses NCT03924297 211 220 O
with NCT03924297 221 225 O
PTSD NCT03924297 226 230 B-Condition-Name
or NCT03924297 231 233 O
who NCT03924297 234 237 O
believe NCT03924297 238 245 O
they NCT03924297 246 250 O
may NCT03924297 251 254 O
have NCT03924297 255 259 O
PTSD NCT03924297 260 264 B-Condition-Name
or NCT03924297 265 267 O
PTSD NCT03924297 268 272 B-Condition-Name
- NCT03924297 273 274 O
related NCT03924297 275 282 O
symptoms NCT03924297 283 291 O
are NCT03924297 292 295 O
eligible NCT03924297 296 304 O
to NCT03924297 305 307 O
participate NCT03924297 308 319 O
. NCT03924297 320 321 O

Exclusion NCT03924297 323 332 O
Criteria NCT03924297 333 341 O
: NCT03924297 342 343 O

- NCT03924297 347 348 O
No NCT03924297 350 352 O
exclusion NCT03924297 353 362 O
criteria NCT03924297 363 371 O

Inclusion NCT03926481 0 9 O
Criteria NCT03926481 10 18 O
: NCT03926481 19 20 O

- NCT03926481 24 25 O
English NCT03926481 27 34 B-Language
Speaking NCT03926481 35 43 O

- NCT03926481 46 47 O
Age NCT03926481 49 52 O
≥ NCT03926481 53 54 B-Eq-Operator___Eq-Operator-Value:GTEQ
65 NCT03926481 56 58 B-Eq-Value
years NCT03926481 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03926481 67 68 O
Body NCT03926481 70 74 O
Composition NCT03926481 75 86 O
Body NCT03926481 87 91 B-Observation-Name___Observation-Type-Value:measurement
Fat NCT03926481 92 95 I-Observation-Name___Observation-Type-Value:measurement
> NCT03926481 96 97 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03926481 99 101 B-Eq-Value
% NCT03926481 102 103 B-Eq-Unit
for NCT03926481 104 107 O
Men NCT03926481 108 111 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03926481 114 115 O
Body NCT03926481 117 121 O
Composition NCT03926481 122 133 O
Body NCT03926481 134 138 B-Observation-Name___Observation-Type-Value:measurement
Fat NCT03926481 139 142 I-Observation-Name___Observation-Type-Value:measurement
> NCT03926481 143 144 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03926481 146 148 B-Eq-Value
% NCT03926481 149 150 B-Eq-Unit
for NCT03926481 151 154 O
Women NCT03926481 155 160 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03926481 163 164 O
Participating NCT03926481 166 179 O
in NCT03926481 180 182 O
the NCT03926481 183 186 O
Dartmouth NCT03926481 187 196 B-Location___Location-Value:clinic
Hitchcock NCT03926481 197 206 I-Location___Location-Value:clinic
Weight NCT03926481 207 213 I-Location___Location-Value:clinic
and NCT03926481 214 217 I-Location___Location-Value:clinic
Wellness NCT03926481 218 226 I-Location___Location-Value:clinic
Center NCT03926481 227 233 I-Location___Location-Value:clinic
( NCT03926481 234 235 O
WWC NCT03926481 236 239 B-Location___Location-Value:clinic
) NCT03926481 240 241 O
Healthy NCT03926481 242 249 O
Lifestyle NCT03926481 250 259 O
Program NCT03926481 260 267 O
( NCT03926481 268 269 O
HLP NCT03926481 270 273 O
) NCT03926481 274 275 O

- NCT03926481 279 280 O
Willing NCT03926481 282 289 O
and NCT03926481 290 293 O
able NCT03926481 294 298 O
to NCT03926481 299 301 O
give NCT03926481 302 306 O
informed NCT03926481 307 315 O
consent NCT03926481 316 323 O

Exclusion NCT03926481 324 333 O
Criteria NCT03926481 334 342 O
: NCT03926481 343 344 O

- NCT03926481 348 349 O
Unable NCT03926481 351 357 O
to NCT03926481 358 360 O
perform NCT03926481 361 368 O
measures NCT03926481 369 377 O

- NCT03926481 380 381 O
Individuals NCT03926481 383 394 O
unwilling NCT03926481 395 404 O
/ NCT03926481 405 406 O
unable NCT03926481 407 413 O
to NCT03926481 414 416 O
provide NCT03926481 417 424 O
consent NCT03926481 425 432 O

- NCT03926481 435 436 O
Severe NCT03926481 438 444 B-Severity___Severity-Value:severe
mental NCT03926481 445 451 O
or NCT03926481 452 454 O
life NCT03926481 455 459 O
- NCT03926481 460 461 O
threatening NCT03926481 462 473 O
illness NCT03926481 474 481 O

- NCT03926481 484 485 O
History NCT03926481 487 494 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926481 495 497 O
bariatric NCT03926481 498 507 B-Procedure-Name
surgery NCT03926481 508 515 I-Procedure-Name

Inclusion NCT03920033 0 9 O
Criteria NCT03920033 10 18 O
: NCT03920033 19 20 O

- NCT03920033 24 25 O
Pathologically NCT03920033 27 41 B-Procedure-Name
confirmed NCT03920033 42 51 O
intermediate NCT03920033 52 64 B-Polarity___Polarity-Value:medium
- NCT03920033 65 66 O
or NCT03920033 67 69 O
high NCT03920033 70 74 B-Polarity___Polarity-Value:high
- NCT03920033 75 76 O
risk NCT03920033 77 81 O
prostate NCT03920033 82 90 B-Condition-Name
cancer NCT03920033 91 97 I-Condition-Name

- NCT03920033 100 101 O
Biochemical NCT03920033 103 114 O
recurrence NCT03920033 115 125 O
after NCT03920033 126 131 O
radical NCT03920033 132 139 B-Procedure-Name
prostatectomy NCT03920033 140 153 I-Procedure-Name
( NCT03920033 154 155 O
Definition NCT03920033 156 166 O
: NCT03920033 167 168 O
Serial NCT03920033 169 175 O
elevation NCT03920033 176 185 B-Polarity___Polarity-Value:high
of NCT03920033 186 188 O
PSA NCT03920033 189 192 B-Observation-Name___Observation-Type-Value:lab
over NCT03920033 193 197 B-Eq-Operator___Eq-Operator-Value:GT
0.2 NCT03920033 199 202 B-Eq-Value
ng NCT03920033 203 205 B-Eq-Unit
/ NCT03920033 206 207 O
mL NCT03920033 208 210 B-Eq-Unit
and NCT03920033 211 214 O
< NCT03920033 215 216 B-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03920033 218 219 I-Eq-Operator___Eq-Operator-Value:LTEQ
1.0 NCT03920033 221 224 B-Eq-Value
ng NCT03920033 225 227 B-Eq-Unit
/ NCT03920033 228 229 O
mL NCT03920033 230 232 B-Eq-Unit
) NCT03920033 233 234 O

- NCT03920033 238 239 O
ECOG NCT03920033 241 245 B-Observation-Name___Observation-Type-Value:clinical-score
performance NCT03920033 246 257 I-Observation-Name___Observation-Type-Value:clinical-score
status NCT03920033 258 264 I-Observation-Name___Observation-Type-Value:clinical-score
0 NCT03920033 266 267 B-Eq-Value
- NCT03920033 268 269 B-Eq-Operator___Eq-Operator-Value:BETWEEN
1 NCT03920033 271 272 B-Eq-Value

- NCT03920033 276 277 O
Appropriate NCT03920033 279 290 O
values NCT03920033 291 297 O
of NCT03920033 298 300 O
blood NCT03920033 301 306 O
tests NCT03920033 307 312 O
within NCT03920033 313 319 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03920033 321 322 B-Eq-Value
months NCT03920033 323 329 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03920033 330 335 O
enrollment NCT03920033 336 346 O
Absolute NCT03920033 347 355 B-Observation-Name___Observation-Type-Value:lab
neutrophil NCT03920033 356 366 I-Observation-Name___Observation-Type-Value:lab
count NCT03920033 367 372 I-Observation-Name___Observation-Type-Value:lab
( NCT03920033 373 374 O
ANC NCT03920033 375 378 B-Observation-Name___Observation-Type-Value:lab
) NCT03920033 379 380 O
≥ NCT03920033 381 382 B-Eq-Operator___Eq-Operator-Value:GTEQ
1500 NCT03920033 384 388 B-Eq-Value
cells NCT03920033 389 394 B-Eq-Unit
/ NCT03920033 395 396 O
mm NCT03920033 397 399 B-Eq-Unit
3 NCT03920033 400 401 I-Eq-Unit
Platelets NCT03920033 402 411 B-Observation-Name___Observation-Type-Value:lab
≥ NCT03920033 412 413 B-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03920033 415 417 B-Eq-Value
, NCT03920033 418 419 I-Eq-Value
000 NCT03920033 420 423 I-Eq-Value
cells NCT03920033 424 429 B-Eq-Unit
/ NCT03920033 430 431 O
mm NCT03920033 432 434 B-Eq-Unit
3 NCT03920033 435 436 I-Eq-Unit
Hemoglobin NCT03920033 437 447 B-Observation-Name___Observation-Type-Value:lab
≥ NCT03920033 448 449 B-Eq-Operator___Eq-Operator-Value:GTEQ
8.0 NCT03920033 451 454 B-Eq-Value
g NCT03920033 455 456 B-Eq-Unit
/ NCT03920033 457 458 O
dl NCT03920033 459 461 B-Eq-Unit

- NCT03920033 464 465 O
Appropriate NCT03920033 467 478 O
values NCT03920033 479 485 O
of NCT03920033 486 488 O
kidney NCT03920033 489 495 B-Observation-Name___Observation-Type-Value:lab
function NCT03920033 496 504 I-Observation-Name___Observation-Type-Value:lab
within NCT03920033 505 511 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03920033 513 514 B-Eq-Value
months NCT03920033 515 521 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03920033 522 527 O
enrollment NCT03920033 528 538 O
Creatinine NCT03920033 539 549 B-Observation-Name___Observation-Type-Value:lab
< NCT03920033 550 551 B-Eq-Operator___Eq-Operator-Value:LT
2.0 NCT03920033 553 556 B-Eq-Value
ng NCT03920033 557 559 B-Eq-Unit
/ NCT03920033 560 561 O
dL NCT03920033 562 564 B-Eq-Unit

- NCT03920033 567 568 O
Appropriate NCT03920033 570 581 O
values NCT03920033 582 588 O
of NCT03920033 589 591 O
liver NCT03920033 592 597 B-Observation-Name___Observation-Type-Value:lab
function NCT03920033 598 606 I-Observation-Name___Observation-Type-Value:lab
within NCT03920033 607 613 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03920033 615 616 B-Eq-Value
months NCT03920033 617 623 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
after NCT03920033 624 629 O
enrollment NCT03920033 630 640 O
total NCT03920033 641 646 B-Observation-Name___Observation-Type-Value:lab
bilirubin NCT03920033 647 656 I-Observation-Name___Observation-Type-Value:lab
< NCT03920033 657 658 B-Eq-Operator___Eq-Operator-Value:LT
1.5 NCT03920033 660 663 B-Eq-Value
X NCT03920033 664 665 O
maximum NCT03920033 666 673 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03920033 674 680 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
value NCT03920033 681 686 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
alanine NCT03920033 687 694 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03920033 695 711 I-Observation-Name___Observation-Type-Value:lab
or NCT03920033 712 714 O
aspartate NCT03920033 715 724 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03920033 725 741 I-Observation-Name___Observation-Type-Value:lab
< NCT03920033 742 743 B-Eq-Operator___Eq-Operator-Value:LT
2.5 NCT03920033 745 748 B-Eq-Value
X NCT03920033 749 750 O
maximum NCT03920033 751 758 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03920033 759 765 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
value NCT03920033 766 771 I-Eq-Unit___Eq-Unit-Value:ref-range-normal

Exclusion NCT03920033 772 781 O
Criteria NCT03920033 782 790 O
: NCT03920033 791 792 O

- NCT03920033 796 797 O
Clinically NCT03920033 799 809 O
gross NCT03920033 810 815 B-Condition-Name
recurrent NCT03920033 816 825 I-Condition-Name
tumor NCT03920033 826 831 I-Condition-Name

- NCT03920033 834 835 O
Presence NCT03920033 837 845 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03920033 846 848 O
distant NCT03920033 849 856 O
metastasis NCT03920033 857 867 B-Condition-Name

- NCT03920033 870 871 O
Presence NCT03920033 873 881 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03920033 882 884 O
pelvic NCT03920033 885 891 O
LN NCT03920033 892 894 O
metastasis NCT03920033 895 905 B-Condition-Name

- NCT03920033 908 909 O
History NCT03920033 911 918 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920033 919 921 O
pelvic NCT03920033 922 928 O
irradiation NCT03920033 929 940 B-Procedure-Name

- NCT03920033 943 944 O
History NCT03920033 946 953 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920033 954 956 O
cryotherapy NCT03920033 957 968 B-Procedure-Name
or NCT03920033 969 971 O
brachytherapy NCT03920033 972 985 B-Procedure-Name
for NCT03920033 986 989 O
prostate NCT03920033 990 998 O
cancer NCT03920033 999 1005 B-Condition-Name

- NCT03920033 1008 1009 O
Double NCT03920033 1011 1017 B-Eq-Value
primary NCT03920033 1018 1025 O
cancer NCT03920033 1026 1032 B-Condition-Name
other NCT03920033 1033 1038 O
than NCT03920033 1039 1043 O
skin NCT03920033 1044 1048 O
/ NCT03920033 1049 1050 O
thyroid NCT03920033 1051 1058 O
cancer NCT03920033 1059 1065 B-Condition-Name

- NCT03920033 1068 1069 O
Combined NCT03920033 1071 1079 O
serious NCT03920033 1080 1087 B-Severity___Severity-Value:severe
morbidity NCT03920033 1088 1097 B-Condition-Name


Inclusion NCT03921463 0 9 O
Criteria NCT03921463 10 18 O
: NCT03921463 19 20 O

- NCT03921463 24 25 O
1 NCT03921463 28 29 O
) NCT03921463 30 31 O
Age NCT03921463 32 35 O
: NCT03921463 36 37 O
20 NCT03921463 39 41 B-Eq-Value
~ NCT03921463 42 43 B-Eq-Operator___Eq-Operator-Value:BETWEEN
35 NCT03921463 45 47 O
years NCT03921463 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03921463 54 57 O
; NCT03921463 57 58 O
2 NCT03921463 60 61 O
) NCT03921463 62 63 O
first NCT03921463 64 69 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
parturients NCT03921463 70 81 B-Condition-Name
registered NCT03921463 82 92 O
in NCT03921463 93 95 O
the NCT03921463 96 99 O
obstetrics NCT03921463 100 110 B-Location___Location-Value:hospital
department NCT03921463 111 121 I-Location___Location-Value:hospital
of NCT03921463 122 124 I-Location___Location-Value:hospital
our NCT03921463 125 128 I-Location___Location-Value:hospital
hospital NCT03921463 129 137 I-Location___Location-Value:hospital
; NCT03921463 137 138 O
3 NCT03921463 140 141 O
) NCT03921463 142 143 O
no NCT03921463 144 146 O
medical NCT03921463 147 154 O
complications NCT03921463 155 168 O
before NCT03921463 169 175 O
pregnancy NCT03921463 176 185 B-Condition-Name
, NCT03921463 186 187 O
no NCT03921463 188 190 O
UI NCT03921463 191 193 B-Condition-Name
and NCT03921463 194 197 O
POP NCT03921463 198 201 B-Condition-Name
( NCT03921463 202 203 O
according NCT03921463 204 213 O
to NCT03921463 214 216 O
the NCT03921463 217 220 O
standard NCT03921463 221 229 B-Observation-Name
of NCT03921463 230 232 I-Observation-Name
POP NCT03921463 233 236 I-Observation-Name
- NCT03921463 237 238 I-Observation-Name
Q NCT03921463 239 240 I-Observation-Name
stage NCT03921463 241 246 I-Observation-Name
) NCT03921463 247 248 O
; NCT03921463 249 250 O
4 NCT03921463 252 253 O
) NCT03921463 254 255 O
no NCT03921463 256 258 O
obstetric NCT03921463 259 268 B-Condition-Name
complications NCT03921463 269 282 I-Condition-Name
; NCT03921463 282 283 O
5 NCT03921463 285 286 O
) NCT03921463 287 288 O
the NCT03921463 289 292 O
patients NCT03921463 293 301 O
agreed NCT03921463 302 308 O
to NCT03921463 309 311 O
conduct NCT03921463 312 319 O
the NCT03921463 320 323 O
study NCT03921463 324 329 O
and NCT03921463 330 333 O
signed NCT03921463 334 340 O
the NCT03921463 341 344 O
informed NCT03921463 345 353 O
consent NCT03921463 354 361 O
. NCT03921463 362 363 O

Exclusion NCT03921463 365 374 O
Criteria NCT03921463 375 383 O
: NCT03921463 384 385 O

- NCT03921463 389 390 O
1 NCT03921463 393 394 O
) NCT03921463 395 396 O
patients NCT03921463 397 405 O
with NCT03921463 406 410 O
uncontrolled NCT03921463 411 423 O
epilepsy NCT03921463 424 432 B-Condition-Name
, NCT03921463 433 434 O
central NCT03921463 435 442 B-Condition-Name
nervous NCT03921463 443 450 I-Condition-Name
system NCT03921463 451 457 I-Condition-Name
diseases NCT03921463 458 466 I-Condition-Name
or NCT03921463 467 469 O
mental NCT03921463 470 476 B-Condition-Name
disorders NCT03921463 477 486 I-Condition-Name
, NCT03921463 487 488 O
whose NCT03921463 489 494 O
clinical NCT03921463 495 503 O
severity NCT03921463 504 512 O
shall NCT03921463 513 518 O
be NCT03921463 519 521 O
determined NCT03921463 522 532 O
by NCT03921463 533 535 O
the NCT03921463 536 539 O
researcher NCT03921463 540 550 O
to NCT03921463 551 553 O
affect NCT03921463 554 560 O
clinical NCT03921463 561 569 O
research NCT03921463 570 578 O
compliance NCT03921463 579 589 O
; NCT03921463 589 590 O
2 NCT03921463 592 593 O
) NCT03921463 594 595 O
follow NCT03921463 596 602 O
up NCT03921463 603 605 O
the NCT03921463 606 609 O
patients NCT03921463 610 618 O
with NCT03921463 619 623 O
difficulty NCT03921463 624 634 O
. NCT03921463 635 636 O

Inclusion NCT03923738 0 9 O
Criteria NCT03923738 10 18 O
: NCT03923738 19 20 O

- NCT03923738 24 25 O
Diagnosis NCT03923738 27 36 O
of NCT03923738 37 39 O
GCA NCT03923738 40 43 B-Condition-Name
as NCT03923738 44 46 O
classified NCT03923738 47 57 O
according NCT03923738 58 67 O
to NCT03923738 68 70 O
protocol NCT03923738 71 79 O
- NCT03923738 80 81 O
specified NCT03923738 82 91 O
criteria NCT03923738 92 100 O
; NCT03923738 100 101 O

- NCT03923738 104 105 O
Participants NCT03923738 107 119 O
entering NCT03923738 120 128 O
Period NCT03923738 129 135 O
1 NCT03923738 137 138 O
must NCT03923738 139 143 O
be NCT03923738 144 146 O
receiving NCT03923738 147 156 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03923738 157 166 O
with NCT03923738 167 171 O
TCZ NCT03923738 172 175 B-Drug-Name
8 NCT03923738 177 178 B-Eq-Value
mg NCT03923738 179 181 B-Eq-Unit
/ NCT03923738 182 183 O
kg NCT03923738 184 186 B-Eq-Unit
IV NCT03923738 187 189 O
Q NCT03923738 190 191 B-Eq-Temporal-Unit
4W NCT03923738 192 194 I-Eq-Temporal-Unit
. NCT03923738 195 196 O

Exclusion NCT03923738 198 207 O
Criteria NCT03923738 208 216 O
: NCT03923738 217 218 O

- NCT03923738 222 223 O
Treatment NCT03923738 225 234 O
with NCT03923738 235 239 O
any NCT03923738 240 243 O
other NCT03923738 244 249 O
investigational NCT03923738 250 265 O
agent NCT03923738 266 271 O
besides NCT03923738 272 279 O
TCZ NCT03923738 280 283 B-Drug-Name
within NCT03923738 284 290 B-Eq-Operator___Eq-Operator-Value:LTEQ
12 NCT03923738 292 294 B-Eq-Value
weeks NCT03923738 295 300 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
( NCT03923738 301 302 O
or NCT03923738 303 305 O
5 NCT03923738 307 308 B-Eq-Value
half NCT03923738 309 313 B-Eq-Unit
- NCT03923738 314 315 I-Eq-Unit
lives NCT03923738 316 321 I-Eq-Unit
of NCT03923738 322 324 O
the NCT03923738 325 328 O
investigational NCT03923738 329 344 O
drug NCT03923738 345 349 O
, NCT03923738 350 351 O
whichever NCT03923738 352 361 O
is NCT03923738 362 364 O
longer NCT03923738 365 371 O
) NCT03923738 372 373 O
prior NCT03923738 374 379 O
to NCT03923738 380 382 O
screening NCT03923738 383 392 O
; NCT03923738 392 393 O

- NCT03923738 396 397 O
Evidence NCT03923738 399 407 O
of NCT03923738 408 410 O
serious NCT03923738 411 418 B-Severity___Severity-Value:severe
uncontrolled NCT03923738 419 431 O
disease NCT03923738 432 439 B-Condition-Name
; NCT03923738 439 440 O

- NCT03923738 443 444 O
Known NCT03923738 446 451 O
active NCT03923738 452 458 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
current NCT03923738 459 466 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03923738 467 469 O
history NCT03923738 470 477 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03923738 478 480 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
recurrent NCT03923738 481 490 O
bacterial NCT03923738 491 500 O
, NCT03923738 501 502 O
viral NCT03923738 503 508 O
, NCT03923738 509 510 O
fungal NCT03923738 511 517 O
, NCT03923738 518 519 O
mycobacterial NCT03923738 520 533 O
, NCT03923738 534 535 O
or NCT03923738 536 538 O
other NCT03923738 539 544 O
infections NCT03923738 545 555 B-Condition-Name
; NCT03923738 555 556 O

- NCT03923738 559 560 O
Active NCT03923738 562 568 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
TB NCT03923738 569 571 B-Condition-Name
requiring NCT03923738 572 581 O
treatment NCT03923738 582 591 O
within NCT03923738 592 598 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03923738 599 602 O
previous NCT03923738 603 611 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03923738 613 614 B-Eq-Value
years NCT03923738 615 620 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03923738 621 622 O

Inclusion NCT03923062 0 9 O
Criteria NCT03923062 10 18 O
: NCT03923062 19 20 O

- NCT03923062 24 25 O
- NCT03923062 27 28 O
Subjects NCT03923062 29 37 O
presented NCT03923062 38 47 O
with NCT03923062 48 52 O
melasma NCT03923062 53 60 B-Condition-Name
. NCT03923062 61 62 O

- NCT03923062 66 67 O
Age NCT03923062 69 72 O
20 NCT03923062 74 76 B-Eq-Value
- NCT03923062 77 78 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03923062 80 82 B-Eq-Value
years NCT03923062 83 88 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03923062 89 92 O
. NCT03923062 93 94 O

- NCT03923062 98 99 O
Melasma NCT03923062 101 108 B-Condition-Name
persisting NCT03923062 109 119 O
for NCT03923062 120 123 O
more NCT03923062 124 128 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03923062 129 133 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03923062 135 136 B-Eq-Value
months NCT03923062 137 143 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
that NCT03923062 144 148 O
has NCT03923062 149 152 O
failed NCT03923062 153 159 O
to NCT03923062 160 162 O
respond NCT03923062 163 170 O
to NCT03923062 171 173 O
conventional NCT03923062 174 186 B-Procedure-Name
treatment NCT03923062 187 196 I-Procedure-Name
with NCT03923062 197 201 O
hydroquinone NCT03923062 202 214 B-Drug-Name
or NCT03923062 215 217 O
other NCT03923062 218 223 O
topical NCT03923062 224 231 B-Drug-Name
lightening NCT03923062 232 242 I-Drug-Name
agents NCT03923062 243 249 I-Drug-Name
. NCT03923062 250 251 O

Exclusion NCT03923062 253 262 O
Criteria NCT03923062 263 271 O
: NCT03923062 272 273 O

- NCT03923062 277 278 O
- NCT03923062 280 281 O
History NCT03923062 282 289 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03923062 290 292 O
photosensitivity NCT03923062 293 309 B-Condition-Name
, NCT03923062 310 311 O
keloids NCT03923062 312 319 B-Condition-Name
, NCT03923062 320 321 O
hypertrophic NCT03923062 322 334 B-Condition-Name
scarring NCT03923062 335 343 I-Condition-Name
and NCT03923062 344 347 O
post NCT03923062 348 352 B-Condition-Name
- NCT03923062 353 354 I-Condition-Name
inflammatory NCT03923062 355 367 I-Condition-Name
hyperpigmentation NCT03923062 368 385 I-Condition-Name
. NCT03923062 386 387 O

- NCT03923062 391 392 O
Pregnancy NCT03923062 394 403 B-Condition-Name
and NCT03923062 404 407 O
lactation NCT03923062 408 417 B-Condition-Name
. NCT03923062 418 419 O

- NCT03923062 423 424 O
Subjects NCT03923062 426 434 O
with NCT03923062 435 439 O
local NCT03923062 440 445 B-Condition-Name
inflammatory NCT03923062 446 458 I-Condition-Name
skin NCT03923062 459 463 I-Condition-Name
disorder NCT03923062 464 472 I-Condition-Name
or NCT03923062 473 475 O
active NCT03923062 476 482 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
herpes NCT03923062 483 489 B-Condition-Name
infection NCT03923062 490 499 I-Condition-Name
at NCT03923062 500 502 O
the NCT03923062 503 506 O
site NCT03923062 507 511 O
of NCT03923062 512 514 O
procedure NCT03923062 515 524 B-Procedure-Name
. NCT03923062 525 526 O

- NCT03923062 530 531 O
Subjects NCT03923062 533 541 O
with NCT03923062 542 546 O
history NCT03923062 547 554 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03923062 555 557 O
medical NCT03923062 558 565 B-Condition-Name
diseases NCT03923062 566 574 I-Condition-Name
which NCT03923062 575 580 O
contraindicate NCT03923062 581 595 O
cryosurgery NCT03923062 596 607 B-Procedure-Name
such NCT03923062 608 612 O
as NCT03923062 613 615 O
; NCT03923062 615 616 O
cold NCT03923062 617 621 B-Condition-Name
intolerance NCT03923062 622 633 I-Condition-Name
, NCT03923062 634 635 O
cold NCT03923062 636 640 B-Condition-Name
urticaria NCT03923062 641 650 I-Condition-Name
, NCT03923062 651 652 O
Raynaud`s NCT03923062 653 662 B-Condition-Name
disease NCT03923062 663 670 I-Condition-Name
and NCT03923062 671 674 O
history NCT03923062 675 682 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03923062 683 685 O
allergic NCT03923062 686 694 O
reactions NCT03923062 695 704 O
to NCT03923062 705 707 O
cryosurgery NCT03923062 708 719 B-Procedure-Name
. NCT03923062 720 721 O

Inclusion NCT03928080 0 9 O
Criteria NCT03928080 10 18 O
: NCT03928080 19 20 O

- NCT03928080 24 25 O
Aged NCT03928080 27 31 O
18 NCT03928080 33 35 B-Eq-Value
and NCT03928080 36 39 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03928080 40 45 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03928080 46 47 O

- NCT03928080 51 52 O
Having NCT03928080 54 60 O
the NCT03928080 61 64 O
ability NCT03928080 65 72 O
to NCT03928080 73 75 O
learn NCT03928080 76 81 O
the NCT03928080 82 85 O
standard NCT03928080 86 94 O
toothbrushing NCT03928080 95 108 O
method NCT03928080 109 115 O
with NCT03928080 116 120 O
artificial NCT03928080 121 131 O
intelligence NCT03928080 132 144 O
powered NCT03928080 145 152 O
toothbrush NCT03928080 153 163 O
. NCT03928080 164 165 O

- NCT03928080 169 170 O
Ability NCT03928080 172 179 O
and NCT03928080 180 183 O
willingness NCT03928080 184 195 O
to NCT03928080 196 198 O
give NCT03928080 199 203 O
written NCT03928080 204 211 O
informed NCT03928080 212 220 O
consent NCT03928080 221 228 O
. NCT03928080 229 230 O

Exclusion NCT03928080 232 241 O
Criteria NCT03928080 242 250 O
: NCT03928080 251 252 O

- NCT03928080 256 257 O
Edentulous NCT03928080 259 269 B-Condition-Name
mouth NCT03928080 270 275 I-Condition-Name
. NCT03928080 276 277 O

- NCT03928080 281 282 O
Pregnant NCT03928080 284 292 B-Condition-Name
females NCT03928080 293 300 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
. NCT03928080 301 302 O

- NCT03928080 306 307 O
Having NCT03928080 309 315 O
received NCT03928080 316 324 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
professional NCT03928080 325 337 O
periodontal NCT03928080 338 349 B-Procedure-Name
treatment NCT03928080 350 359 I-Procedure-Name
( NCT03928080 360 361 O
other NCT03928080 362 367 O
than NCT03928080 368 372 O
supragingival NCT03928080 373 386 B-Procedure-Name
cleaning NCT03928080 387 395 I-Procedure-Name
) NCT03928080 396 397 O
within NCT03928080 398 404 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03928080 405 408 O
previous NCT03928080 409 417 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
12 NCT03928080 419 421 B-Eq-Value
months NCT03928080 422 428 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03928080 429 430 O

- NCT03928080 434 435 O
Having NCT03928080 437 443 O
received NCT03928080 444 452 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
antibiotic NCT03928080 453 463 B-Drug-Name
medication NCT03928080 464 474 I-Drug-Name
within NCT03928080 475 481 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03928080 482 485 O
previous NCT03928080 486 494 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03928080 496 497 B-Eq-Value
months NCT03928080 498 504 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03928080 505 506 O

Inclusion NCT03920423 0 9 O
Criteria NCT03920423 10 18 O
: NCT03920423 19 20 O

- NCT03920423 24 25 O
requirement NCT03920423 27 38 O
of NCT03920423 39 41 O
radial NCT03920423 42 48 B-Procedure-Name
arterial NCT03920423 49 57 I-Procedure-Name
catheterization NCT03920423 58 73 I-Procedure-Name
during NCT03920423 74 80 O
peri NCT03920423 81 85 O
operative NCT03920423 86 95 B-Procedure-Name
period NCT03920423 96 102 O

- NCT03920423 105 106 O
within NCT03920423 108 114 O
cardiac NCT03920423 115 122 B-Condition-Name
- NCT03920423 123 124 I-Condition-Name
vascular NCT03920423 125 133 I-Condition-Name
disease NCT03920423 134 141 I-Condition-Name

- NCT03920423 144 145 O
written NCT03920423 147 154 O
consent NCT03920423 155 162 O

Exclusion NCT03920423 163 172 O
Criteria NCT03920423 173 181 O
: NCT03920423 182 183 O

- NCT03920423 187 188 O
contraindication NCT03920423 190 206 O
to NCT03920423 207 209 O
radial NCT03920423 210 216 B-Procedure-Name
arterial NCT03920423 217 225 I-Procedure-Name
catheterization NCT03920423 226 241 I-Procedure-Name

- NCT03920423 244 245 O
abnormal NCT03920423 247 255 B-Condition-Name
artery NCT03920423 256 262 I-Condition-Name
evaluated NCT03920423 263 272 O
by NCT03920423 273 275 O
ultrasonography NCT03920423 276 291 B-Procedure-Name

Inclusion NCT03923894 0 9 O
Criteria NCT03923894 10 18 O
: NCT03923894 19 20 O

- NCT03923894 24 25 O
Adult NCT03923894 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
men NCT03923894 33 36 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03923894 37 40 O
women NCT03923894 41 46 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
over NCT03923894 47 51 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03923894 53 55 B-Eq-Value
years NCT03923894 56 61 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923894 64 65 O
After NCT03923894 67 72 O
fully NCT03923894 73 78 O
hearing NCT03923894 79 86 O
and NCT03923894 87 90 O
fully NCT03923894 91 96 O
understanding NCT03923894 97 110 O
this NCT03923894 111 115 O
clinical NCT03923894 116 124 O
trials NCT03923894 125 131 O
, NCT03923894 132 133 O
those NCT03923894 134 139 O
who NCT03923894 140 143 O
agree NCT03923894 144 149 O
to NCT03923894 150 152 O
voluntarily NCT03923894 153 164 O
decide NCT03923894 165 171 O
to NCT03923894 172 174 O
participate NCT03923894 175 186 O
and NCT03923894 187 190 O
to NCT03923894 191 193 O
comply NCT03923894 194 200 O
with NCT03923894 201 205 O
the NCT03923894 206 209 O
notice NCT03923894 210 216 O

Exclusion NCT03923894 217 226 O
Criteria NCT03923894 227 235 O
: NCT03923894 236 237 O

- NCT03923894 241 242 O
If NCT03923894 244 246 O
screening NCT03923894 247 256 O
shows NCT03923894 257 262 O
that NCT03923894 263 267 O
the NCT03923894 268 271 O
white NCT03923894 272 277 B-Observation-Name___Observation-Type-Value:lab
blood NCT03923894 278 283 I-Observation-Name___Observation-Type-Value:lab
cell NCT03923894 284 288 I-Observation-Name___Observation-Type-Value:lab
( NCT03923894 289 290 O
WBC NCT03923894 291 294 B-Observation-Name___Observation-Type-Value:lab
) NCT03923894 295 296 O
is NCT03923894 297 299 O
less NCT03923894 300 304 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03923894 305 309 I-Eq-Operator___Eq-Operator-Value:LT
3000 NCT03923894 311 315 B-Eq-Value
/ NCT03923894 316 317 O
㎕ NCT03923894 318 319 B-Eq-Unit
or NCT03923894 320 322 O
more NCT03923894 323 327 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03923894 328 332 I-Eq-Operator___Eq-Operator-Value:GT
8000 NCT03923894 334 338 B-Eq-Value
/ NCT03923894 339 340 O
㎕ NCT03923894 341 342 B-Eq-Unit

- NCT03923894 345 346 O
Those NCT03923894 348 353 O
who NCT03923894 354 357 O
received NCT03923894 358 366 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
influenza NCT03923894 367 376 B-Immunization-Name
vaccination NCT03923894 377 388 I-Immunization-Name
within NCT03923894 389 395 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03923894 397 398 B-Eq-Value
months NCT03923894 399 405 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03923894 406 412 O
the NCT03923894 413 416 O
screening NCT03923894 417 426 O

- NCT03923894 429 430 O
Those NCT03923894 432 437 O
who NCT03923894 438 441 O
have NCT03923894 442 446 O
a NCT03923894 447 448 O
body NCT03923894 449 453 B-Observation-Name___Observation-Type-Value:vital
mass NCT03923894 454 458 I-Observation-Name___Observation-Type-Value:vital
index NCT03923894 459 464 I-Observation-Name___Observation-Type-Value:vital
( NCT03923894 465 466 O
BMI NCT03923894 467 470 B-Observation-Name___Observation-Type-Value:vital
) NCT03923894 471 472 O
of NCT03923894 473 475 O
less NCT03923894 476 480 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03923894 481 485 I-Eq-Operator___Eq-Operator-Value:LT
18.5 NCT03923894 487 491 B-Eq-Value
kg NCT03923894 492 494 B-Eq-Unit
/ NCT03923894 495 496 O
m NCT03923894 497 498 B-Eq-Unit
2 NCT03923894 499 500 I-Eq-Unit
or NCT03923894 501 503 O
greater NCT03923894 504 511 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03923894 512 516 I-Eq-Operator___Eq-Operator-Value:GT
35 NCT03923894 518 520 B-Eq-Value
kg NCT03923894 521 523 B-Eq-Unit
/ NCT03923894 524 525 O
m NCT03923894 526 527 B-Eq-Unit
2 NCT03923894 528 529 I-Eq-Unit
at NCT03923894 530 532 O
the NCT03923894 533 536 O
screening NCT03923894 537 546 O

- NCT03923894 549 550 O
Those NCT03923894 552 557 O
who NCT03923894 558 561 O
have NCT03923894 562 566 O
a NCT03923894 567 568 O
clinically NCT03923894 569 579 O
significant NCT03923894 580 591 O
acute NCT03923894 592 597 B-Severity___Severity-Value:severe
or NCT03923894 598 600 O
chronic NCT03923894 601 608 O
cardiovascular NCT03923894 609 623 B-Condition-Name
system NCT03923894 624 630 I-Condition-Name
, NCT03923894 631 632 O
endocrine NCT03923894 633 642 B-Condition-Name
system NCT03923894 643 649 I-Condition-Name
, NCT03923894 650 651 O
immune NCT03923894 652 658 B-Condition-Name
system NCT03923894 659 665 I-Condition-Name
, NCT03923894 666 667 O
respiratory NCT03923894 668 679 B-Condition-Name
system NCT03923894 680 686 I-Condition-Name
, NCT03923894 687 688 O
liver NCT03923894 689 694 B-Condition-Name
biliary NCT03923894 695 702 I-Condition-Name
system NCT03923894 703 709 I-Condition-Name
, NCT03923894 710 711 O
kidney NCT03923894 712 718 O
and NCT03923894 719 722 O
urinary NCT03923894 723 730 O
system NCT03923894 731 737 B-Condition-Name
, NCT03923894 738 739 O
neuropsychiatry NCT03923894 740 755 B-Condition-Name
, NCT03923894 756 757 O
musculoskeletal NCT03923894 758 773 B-Condition-Name
system NCT03923894 774 780 I-Condition-Name
, NCT03923894 781 782 O
inflammatory NCT03923894 783 795 B-Condition-Name
and NCT03923894 796 799 O
hematologic NCT03923894 800 811 B-Condition-Name

- NCT03923894 814 815 O
Those NCT03923894 817 822 O
who NCT03923894 823 826 O
take NCT03923894 827 831 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03923894 832 833 O
medication NCT03923894 834 844 B-Drug-Name
or NCT03923894 845 847 O
health NCT03923894 848 854 B-Drug-Name
function NCT03923894 855 863 I-Drug-Name
food NCT03923894 864 868 I-Drug-Name
that NCT03923894 869 873 O
affects NCT03923894 874 881 B-Stability___Stability-Value:change
your NCT03923894 882 886 O
promotion NCT03923894 887 896 B-Condition-Name
of NCT03923894 897 899 I-Condition-Name
immunity NCT03923894 900 908 I-Condition-Name
within NCT03923894 909 915 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03923894 917 918 B-Eq-Value
month NCT03923894 919 924 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03923894 925 930 O
to NCT03923894 931 933 O
the NCT03923894 934 937 O
screening NCT03923894 938 947 O

- NCT03923894 950 951 O
Those NCT03923894 953 958 O
who NCT03923894 959 962 O
have NCT03923894 963 967 O
received NCT03923894 968 976 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
antipsychotic NCT03923894 977 990 B-Drug-Name
medication NCT03923894 991 1001 I-Drug-Name
within NCT03923894 1002 1008 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03923894 1010 1011 B-Eq-Value
months NCT03923894 1012 1018 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03923894 1019 1025 O
screening NCT03923894 1026 1035 O

- NCT03923894 1038 1039 O
Those NCT03923894 1041 1046 O
who NCT03923894 1047 1050 O
alcoholic NCT03923894 1051 1060 O
or NCT03923894 1061 1063 O
drug NCT03923894 1064 1068 O
abuse NCT03923894 1069 1074 B-Condition-Name
suspected NCT03923894 1075 1084 O

- NCT03923894 1087 1088 O
Those NCT03923894 1090 1095 O
who NCT03923894 1096 1099 O
participated NCT03923894 1100 1112 B-Observation-Name
in NCT03923894 1113 1115 I-Observation-Name
other NCT03923894 1116 1121 I-Observation-Name
clinical NCT03923894 1122 1130 I-Observation-Name
trials NCT03923894 1131 1137 I-Observation-Name
within NCT03923894 1138 1144 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03923894 1146 1147 B-Eq-Value
months NCT03923894 1148 1154 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03923894 1155 1161 O
screening NCT03923894 1162 1171 O

- NCT03923894 1174 1175 O
Laboratory NCT03923894 1177 1187 O
test NCT03923894 1188 1192 O
by NCT03923894 1193 1195 O
show NCT03923894 1196 1200 O
the NCT03923894 1201 1204 O
following NCT03923894 1205 1214 O
results NCT03923894 1215 1222 O

- NCT03923894 1230 1231 O
Aspartate NCT03923894 1233 1242 B-Observation-Name___Observation-Type-Value:lab
Transaminase NCT03923894 1243 1255 I-Observation-Name___Observation-Type-Value:lab
( NCT03923894 1256 1257 O
AST NCT03923894 1258 1261 B-Observation-Name___Observation-Type-Value:lab
) NCT03923894 1262 1263 O
, NCT03923894 1265 1266 O
Alanine NCT03923894 1267 1274 B-Observation-Name___Observation-Type-Value:lab
Transaminase NCT03923894 1275 1287 I-Observation-Name___Observation-Type-Value:lab
( NCT03923894 1288 1289 O
ALT NCT03923894 1290 1293 B-Observation-Name___Observation-Type-Value:lab
) NCT03923894 1294 1295 O
> NCT03923894 1296 1297 B-Eq-Operator___Eq-Operator-Value:GT
Reference NCT03923894 1298 1307 O
range NCT03923894 1308 1313 O
3 NCT03923894 1315 1316 B-Eq-Value
times NCT03923894 1317 1322 O
upper NCT03923894 1323 1328 B-Eq-Unit___Eq-Unit-Value:ref-range-high
limit NCT03923894 1329 1334 I-Eq-Unit___Eq-Unit-Value:ref-range-high

- NCT03923894 1342 1343 O
Serum NCT03923894 1345 1350 B-Observation-Name___Observation-Type-Value:lab
Creatinine NCT03923894 1351 1361 I-Observation-Name___Observation-Type-Value:lab
> NCT03923894 1362 1363 B-Eq-Operator___Eq-Operator-Value:GT
2.0 NCT03923894 1365 1368 B-Eq-Value
mg NCT03923894 1369 1371 B-Eq-Unit
/ NCT03923894 1372 1373 O
dL NCT03923894 1374 1376 B-Eq-Unit

- NCT03923894 1379 1380 O
Pregnancy NCT03923894 1382 1391 B-Condition-Name
or NCT03923894 1392 1394 O
breast NCT03923894 1395 1401 B-Condition-Name
feeding NCT03923894 1402 1409 I-Condition-Name

- NCT03923894 1412 1413 O
Those NCT03923894 1415 1420 O
who NCT03923894 1421 1424 O
does NCT03923894 1425 1429 O
n't NCT03923894 1429 1432 O
accept NCT03923894 1433 1439 O
the NCT03923894 1440 1443 O
implementation NCT03923894 1444 1458 O
of NCT03923894 1459 1461 O
appropriate NCT03923894 1462 1473 O
contraception NCT03923894 1474 1487 B-Drug-Name
of NCT03923894 1488 1490 O
a NCT03923894 1491 1492 O
childbearing NCT03923894 1493 1505 B-Condition-Name
woman NCT03923894 1506 1511 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03923894 1514 1515 O
Principal NCT03923894 1517 1526 O
Investigator NCT03923894 1527 1539 O
judged NCT03923894 1540 1546 O
inappropriate NCT03923894 1547 1560 O
for NCT03923894 1561 1564 O
participation NCT03923894 1565 1578 O
in NCT03923894 1579 1581 O
study NCT03923894 1582 1587 O
because NCT03923894 1588 1595 O
of NCT03923894 1596 1598 O
Laboratory NCT03923894 1599 1609 O
test NCT03923894 1610 1614 O
result NCT03923894 1615 1621 O
, NCT03923894 1622 1623 O
etc NCT03923894 1624 1627 O
. NCT03923894 1628 1629 O


Inclusion NCT03920345 0 9 O
Criteria NCT03920345 10 18 O
: NCT03920345 19 20 O

Subject NCT03920345 22 29 O
age NCT03920345 30 33 O
18 NCT03920345 35 37 B-Eq-Value
- NCT03920345 38 39 B-Eq-Operator___Eq-Operator-Value:BETWEEN
85 NCT03920345 41 43 B-Eq-Value
years NCT03920345 44 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03920345 49 50 O

- NCT03920345 53 54 O
SIJ NCT03920345 56 59 B-Condition-Name
arthropathy NCT03920345 60 71 I-Condition-Name
and NCT03920345 72 75 O
chronic NCT03920345 76 83 B-Condition-Name
lower NCT03920345 84 89 I-Condition-Name
back NCT03920345 90 94 I-Condition-Name
pain NCT03920345 95 99 I-Condition-Name
( NCT03920345 100 101 O
CLBP NCT03920345 102 106 B-Condition-Name
) NCT03920345 107 108 O
; NCT03920345 109 110 O

- NCT03920345 113 114 O
Patient NCT03920345 116 123 O
to NCT03920345 124 126 O
undergo NCT03920345 127 134 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
endoscopic NCT03920345 135 145 B-Procedure-Name
electrothermic NCT03920345 146 160 I-Procedure-Name
ablation NCT03920345 161 169 I-Procedure-Name
of NCT03920345 170 172 O
spinal NCT03920345 173 179 B-Condition-Name
levels NCT03920345 180 186 I-Condition-Name
S NCT03920345 187 188 B-Eq-Value
1 NCT03920345 189 190 I-Eq-Value
- NCT03920345 191 192 B-Eq-Operator___Eq-Operator-Value:BETWEEN
S NCT03920345 193 194 B-Eq-Value
3 NCT03920345 195 196 I-Eq-Value
. NCT03920345 196 197 O
The NCT03920345 199 202 O
L NCT03920345 203 204 O
4 NCT03920345 205 206 O
- NCT03920345 207 208 O
L NCT03920345 209 210 O
5 NCT03920345 211 212 O
and NCT03920345 213 216 O
/ NCT03920345 217 218 O
or NCT03920345 219 221 O
L NCT03920345 222 223 O
5 NCT03920345 224 225 O
- NCT03920345 226 227 O
S NCT03920345 228 229 O
1 NCT03920345 230 231 O
facet NCT03920345 232 237 B-Procedure-Name
joint NCT03920345 238 243 I-Procedure-Name
can NCT03920345 244 247 O
be NCT03920345 248 250 O
included NCT03920345 251 259 O
in NCT03920345 260 262 O
the NCT03920345 263 266 O
ablation NCT03920345 267 275 B-Procedure-Name
per NCT03920345 276 279 O
doctor NCT03920345 280 286 O
discretion NCT03920345 287 297 O
. NCT03920345 298 299 O

- NCT03920345 303 304 O
Correct NCT03920345 306 313 B-Polarity___Polarity-Value:normal
spinal NCT03920345 314 320 B-Condition-Name
levels NCT03920345 321 327 I-Condition-Name
( NCT03920345 328 329 O
ranging NCT03920345 330 337 O
L NCT03920345 338 339 B-Eq-Value
4 NCT03920345 340 341 I-Eq-Value
- NCT03920345 342 343 B-Eq-Operator___Eq-Operator-Value:BETWEEN
S NCT03920345 344 345 B-Eq-Value
3 NCT03920345 346 347 I-Eq-Value
) NCT03920345 348 349 O
to NCT03920345 350 352 O
be NCT03920345 353 355 O
treated NCT03920345 356 363 O
have NCT03920345 364 368 O
been NCT03920345 369 373 O
confirmed NCT03920345 374 383 O
by NCT03920345 384 386 O
1 NCT03920345 388 389 O
) NCT03920345 390 391 O
diagnostic NCT03920345 392 402 B-Procedure-Name
SIJ NCT03920345 403 406 I-Procedure-Name
injection NCT03920345 407 416 I-Procedure-Name
, NCT03920345 417 418 O
followed NCT03920345 419 427 O
by NCT03920345 428 430 O
2 NCT03920345 432 433 O
) NCT03920345 434 435 O
diagnostic NCT03920345 436 446 O
Medial NCT03920345 447 453 O
/ NCT03920345 454 455 O
Lateral NCT03920345 456 463 O
Branch NCT03920345 464 470 B-Condition-Name
Block NCT03920345 471 476 I-Condition-Name
at NCT03920345 477 479 O
the NCT03920345 480 483 O
applicable NCT03920345 484 494 O
levels NCT03920345 495 501 O
. NCT03920345 502 503 O

- NCT03920345 507 508 O
The NCT03920345 510 513 O
subject NCT03920345 514 521 O
is NCT03920345 522 524 O
likely NCT03920345 525 531 O
to NCT03920345 532 534 O
follow NCT03920345 535 541 B-Observation-Name
standard NCT03920345 542 550 I-Observation-Name
of NCT03920345 551 553 I-Observation-Name
care NCT03920345 554 558 I-Observation-Name
post NCT03920345 559 563 O
- NCT03920345 564 565 O
operative NCT03920345 566 575 O
follow NCT03920345 576 582 O
- NCT03920345 583 584 O
up NCT03920345 585 587 O
for NCT03920345 588 591 O
at NCT03920345 592 594 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03920345 595 600 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03920345 602 604 B-Eq-Value
months NCT03920345 605 611 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03920345 612 613 O

Exclusion NCT03920345 615 624 O
Criteria NCT03920345 625 633 O
: NCT03920345 634 635 O

Patients NCT03920345 637 645 O
receiving NCT03920345 646 655 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
additional NCT03920345 656 666 O
invasive NCT03920345 667 675 B-Procedure-Name
back NCT03920345 676 680 I-Procedure-Name
surgery NCT03920345 681 688 I-Procedure-Name
after NCT03920345 689 694 O
the NCT03920345 695 698 O
study NCT03920345 699 704 O
treatment NCT03920345 705 714 O
. NCT03920345 715 716 O

- NCT03920345 720 721 O
Inability NCT03920345 723 732 O
to NCT03920345 733 735 O
complete NCT03920345 736 744 O
follow NCT03920345 745 751 O
- NCT03920345 752 753 O
up NCT03920345 754 756 O
visits NCT03920345 757 763 B-Encounter-Type___Encounter-Type-Value:outpatient
or NCT03920345 764 766 O
required NCT03920345 767 775 O
questionnaires NCT03920345 776 790 O
. NCT03920345 791 792 O

- NCT03920345 796 797 O
Non NCT03920345 799 802 O
- NCT03920345 803 804 O
compliant NCT03920345 805 814 O
patients NCT03920345 815 823 O

- NCT03920345 826 827 O
Difficult NCT03920345 829 838 O
or NCT03920345 839 841 O
impossible NCT03920345 842 852 O
communication NCT03920345 853 866 B-Condition-Name
with NCT03920345 867 871 O
the NCT03920345 872 875 O
patient NCT03920345 876 883 O

- NCT03920345 886 887 O
Breastfeeding NCT03920345 889 902 B-Condition-Name
, NCT03920345 903 904 O
pregnant NCT03920345 905 913 B-Condition-Name
or NCT03920345 914 916 O
patients NCT03920345 917 925 O
who NCT03920345 926 929 O
plan NCT03920345 930 934 O
a NCT03920345 935 936 O
pregnancy NCT03920345 937 946 B-Condition-Name
while NCT03920345 947 952 O
participating NCT03920345 953 966 O
in NCT03920345 967 969 O
the NCT03920345 970 973 O
study NCT03920345 974 979 O

- NCT03920345 982 983 O
Systemic NCT03920345 985 993 O
neurological NCT03920345 994 1006 B-Condition-Name
disorders NCT03920345 1007 1016 I-Condition-Name
with NCT03920345 1017 1021 O
mobility NCT03920345 1022 1030 B-Condition-Name
limitations NCT03920345 1031 1042 I-Condition-Name
( NCT03920345 1043 1044 O
e NCT03920345 1045 1046 O
. NCT03920345 1047 1048 O
g NCT03920345 1049 1050 O
. NCT03920345 1051 1052 O
advanced NCT03920345 1054 1062 B-Severity___Severity-Value:severe
Parkinson NCT03920345 1063 1072 B-Condition-Name
's NCT03920345 1072 1074 I-Condition-Name
disease NCT03920345 1075 1082 I-Condition-Name
or NCT03920345 1083 1085 O
multiple NCT03920345 1086 1094 B-Condition-Name
sclerosis NCT03920345 1095 1104 I-Condition-Name
) NCT03920345 1105 1106 O

- NCT03920345 1110 1111 O
Patients NCT03920345 1113 1121 O
with NCT03920345 1122 1126 O
incompatibilities NCT03920345 1127 1144 O
or NCT03920345 1145 1147 O
known NCT03920345 1148 1153 O
limitations NCT03920345 1154 1165 O
that NCT03920345 1166 1170 O
make NCT03920345 1171 1175 O
participation NCT03920345 1176 1189 O
impossible NCT03920345 1190 1200 O

- NCT03920345 1203 1204 O
Patients NCT03920345 1206 1214 O
after NCT03920345 1215 1220 O
stabilization NCT03920345 1221 1234 O
with NCT03920345 1235 1239 O
implants NCT03920345 1240 1248 B-Condition-Name
on NCT03920345 1249 1251 O
thoracic NCT03920345 1252 1260 O
or NCT03920345 1261 1263 O
lumbar NCT03920345 1264 1270 O
spine NCT03920345 1271 1276 O
. NCT03920345 1277 1278 O

- NCT03920345 1282 1283 O
Inability NCT03920345 1285 1294 O
to NCT03920345 1295 1297 O
provide NCT03920345 1298 1305 O
informed NCT03920345 1306 1314 O
consent NCT03920345 1315 1322 O
without NCT03920345 1323 1330 O
a NCT03920345 1331 1332 O
legally NCT03920345 1333 1340 O
authorized NCT03920345 1341 1351 O
representative NCT03920345 1352 1366 O
. NCT03920345 1367 1368 O


Inclusion NCT03927833 0 9 O
Criteria NCT03927833 10 18 O
: NCT03927833 19 20 O

1 NCT03927833 25 26 O
. NCT03927833 26 27 O
Infants NCT03927833 29 36 O
is NCT03927833 37 39 O
inborn NCT03927833 40 46 B-Condition-Name

2 NCT03927833 50 51 O
. NCT03927833 51 52 O
Infant NCT03927833 54 60 O
is NCT03927833 61 63 O
≤ NCT03927833 64 65 B-Eq-Operator___Eq-Operator-Value:LTEQ
750 NCT03927833 67 70 B-Eq-Value
grams NCT03927833 71 76 B-Eq-Unit
at NCT03927833 77 79 O
birth NCT03927833 80 85 O
and NCT03927833 86 89 O
/ NCT03927833 90 91 O
or NCT03927833 92 94 O
< NCT03927833 95 96 B-Eq-Operator___Eq-Operator-Value:LT
27 NCT03927833 98 100 B-Eq-Value
weeks NCT03927833 101 106 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
gestation NCT03927833 107 116 B-Observation-Name___Observation-Type-Value:measurement
at NCT03927833 117 119 O
birth NCT03927833 120 125 O
by NCT03927833 126 128 O
best NCT03927833 129 133 O
OB NCT03927833 134 136 O
estimate NCT03927833 137 145 O

3 NCT03927833 149 150 O
. NCT03927833 150 151 O
Infant NCT03927833 153 159 O
is NCT03927833 160 162 O
12 NCT03927833 164 166 B-Eq-Value
- NCT03927833 167 168 B-Eq-Operator___Eq-Operator-Value:BETWEEN
36 NCT03927833 170 172 B-Eq-Value
hours NCT03927833 173 178 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03927833 179 181 O
age NCT03927833 182 185 O
. NCT03927833 186 187 O

Exclusion NCT03927833 189 198 O
Criteria NCT03927833 199 207 O
: NCT03927833 208 209 O

1 NCT03927833 214 215 O
. NCT03927833 215 216 O
Unable NCT03927833 218 224 O
to NCT03927833 225 227 O
enroll NCT03927833 228 234 O
infant NCT03927833 235 241 O
by NCT03927833 242 244 B-Eq-Operator___Eq-Operator-Value:LTEQ
36 NCT03927833 246 248 B-Eq-Value
hours NCT03927833 249 254 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03927833 255 257 O
age NCT03927833 258 261 O

2 NCT03927833 265 266 O
. NCT03927833 266 267 O
Previous NCT03927833 269 277 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
phototherapy NCT03927833 278 290 B-Procedure-Name

3 NCT03927833 294 295 O
. NCT03927833 295 296 O
Known NCT03927833 298 303 O
hemolytic NCT03927833 304 313 B-Condition-Name
disease NCT03927833 314 321 I-Condition-Name

4 NCT03927833 325 326 O
. NCT03927833 326 327 O
TSB NCT03927833 329 332 B-Observation-Name___Observation-Type-Value:lab
reported NCT03927833 333 341 O
as NCT03927833 342 344 O
> NCT03927833 345 346 B-Eq-Operator___Eq-Operator-Value:GT
6.0 NCT03927833 348 351 B-Eq-Value
mg NCT03927833 352 354 B-Eq-Unit
/ NCT03927833 355 356 O
dL NCT03927833 357 359 B-Eq-Unit
before NCT03927833 360 366 O
12 NCT03927833 368 370 B-Eq-Value
hours NCT03927833 371 376 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
age NCT03927833 377 380 O

5 NCT03927833 384 385 O
. NCT03927833 385 386 O
Major NCT03927833 388 393 B-Condition-Name
anomaly NCT03927833 394 401 I-Condition-Name

6 NCT03927833 405 406 O
. NCT03927833 406 407 O
Overt NCT03927833 409 414 B-Condition-Name
nonbacterial NCT03927833 415 427 I-Condition-Name
infection NCT03927833 428 437 I-Condition-Name

7 NCT03927833 441 442 O
. NCT03927833 442 443 O
Infant NCT03927833 445 451 O
is NCT03927833 452 454 O
likely NCT03927833 455 461 O
to NCT03927833 462 464 O
expire NCT03927833 465 471 O
soon NCT03927833 472 476 O
: NCT03927833 477 478 O
Limiting NCT03927833 479 487 O
or NCT03927833 488 490 O
withdrawal NCT03927833 491 501 O
of NCT03927833 502 504 O
intensive NCT03927833 505 514 B-Encounter-Type___Encounter-Type-Value:icu
care NCT03927833 515 519 I-Encounter-Type___Encounter-Type-Value:icu
is NCT03927833 520 522 O
being NCT03927833 523 528 O
recommended NCT03927833 529 540 O
to NCT03927833 541 543 O
the NCT03927833 544 547 O
parents NCT03927833 548 555 O
, NCT03927833 556 557 O
the NCT03927833 558 561 O
parents NCT03927833 562 569 O
are NCT03927833 570 573 O
requesting NCT03927833 574 584 O
withdrawal NCT03927833 585 595 O
of NCT03927833 596 598 O
care NCT03927833 599 603 O
, NCT03927833 604 605 O
or NCT03927833 606 608 O
the NCT03927833 609 612 O
pH NCT03927833 613 615 B-Observation-Name___Observation-Type-Value:lab
is NCT03927833 616 618 O
< NCT03927833 619 620 B-Eq-Operator___Eq-Operator-Value:LT
6.80 NCT03927833 622 626 B-Eq-Value
or NCT03927833 627 629 O
persistent NCT03927833 630 640 B-Condition-Name
bradycardia NCT03927833 641 652 I-Condition-Name
with NCT03927833 653 657 O
hypoxemia NCT03927833 658 667 B-Condition-Name
for NCT03927833 668 671 O
> NCT03927833 672 673 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03927833 675 676 B-Eq-Value
h NCT03927833 677 678 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
. NCT03927833 679 680 O

Inclusion NCT03929822 0 9 O
Criteria NCT03929822 10 18 O
: NCT03929822 19 20 O

- NCT03929822 24 25 O
Women NCT03929822 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
called NCT03929822 33 39 O
back NCT03929822 40 44 O
from NCT03929822 45 49 O
a NCT03929822 50 51 O
screening NCT03929822 52 61 B-Procedure-Name
mammography NCT03929822 62 73 I-Procedure-Name
by NCT03929822 74 76 O
either NCT03929822 77 83 O
FFDM NCT03929822 84 88 B-Procedure-Name
or NCT03929822 89 91 O
tomosynthesis NCT03929822 92 105 B-Procedure-Name
with NCT03929822 106 110 O
soft NCT03929822 111 115 B-Condition-Name
tissue NCT03929822 116 122 I-Condition-Name
abnormalities NCT03929822 123 136 I-Condition-Name
including NCT03929822 137 146 O
masses NCT03929822 147 153 B-Condition-Name
, NCT03929822 154 155 O
asymmetries NCT03929822 156 167 B-Condition-Name
, NCT03929822 168 169 O
focal NCT03929822 170 175 B-Condition-Name
asymmetries NCT03929822 176 187 I-Condition-Name
or NCT03929822 188 190 O
architectural NCT03929822 191 204 B-Condition-Name
distortion NCT03929822 205 215 I-Condition-Name
with NCT03929822 216 220 O
or NCT03929822 221 223 O
without NCT03929822 224 231 O
calcifications NCT03929822 232 246 B-Condition-Name
. NCT03929822 247 248 O
Patients NCT03929822 250 258 O
will NCT03929822 259 263 O
be NCT03929822 264 266 O
questioned NCT03929822 267 277 O
regarding NCT03929822 278 287 O
the NCT03929822 288 291 O
possibility NCT03929822 292 303 O
of NCT03929822 304 306 O
pregnancy NCT03929822 307 316 B-Condition-Name
and NCT03929822 317 320 O
will NCT03929822 321 325 O
need NCT03929822 326 330 O
a NCT03929822 331 332 O
negative NCT03929822 333 341 B-Polarity___Polarity-Value:negative
pregnancy NCT03929822 342 351 B-Observation-Name
test NCT03929822 352 356 I-Observation-Name
prior NCT03929822 357 362 O
the NCT03929822 363 366 O
study NCT03929822 367 372 O
intervention NCT03929822 373 385 O
. NCT03929822 386 387 O

Exclusion NCT03929822 389 398 O
Criteria NCT03929822 399 407 O
: NCT03929822 408 409 O

- NCT03929822 413 414 O
Age NCT03929822 416 419 O
< NCT03929822 420 421 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03929822 423 425 B-Eq-Value
years NCT03929822 426 431 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03929822 432 435 O

- NCT03929822 438 439 O
Screening NCT03929822 441 450 B-Procedure-Name
mammography NCT03929822 451 462 I-Procedure-Name
with NCT03929822 463 467 O
only NCT03929822 468 472 O
calcifications NCT03929822 473 487 B-Condition-Name
abnormalities NCT03929822 488 501 I-Condition-Name

- NCT03929822 504 505 O
Male NCT03929822 507 511 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
patients NCT03929822 512 520 O

- NCT03929822 523 524 O
Pregnant NCT03929822 526 534 B-Condition-Name
or NCT03929822 535 537 O
lactating NCT03929822 538 547 B-Condition-Name
patients NCT03929822 548 556 O

- NCT03929822 559 560 O
Patients NCT03929822 562 570 O
with NCT03929822 571 575 O
any NCT03929822 576 579 O
allergy NCT03929822 580 587 O
to NCT03929822 588 590 O
iodinated NCT03929822 591 600 B-Allergy-Name
contrast NCT03929822 601 609 I-Allergy-Name

- NCT03929822 612 613 O
Patients NCT03929822 615 623 O
with NCT03929822 624 628 O
eGFR NCT03929822 629 633 B-Observation-Name___Observation-Type-Value:lab
< NCT03929822 634 635 B-Eq-Operator___Eq-Operator-Value:LT
45 NCT03929822 637 639 B-Eq-Value

- NCT03929822 643 644 O
Patients NCT03929822 646 654 O
that NCT03929822 655 659 O
may NCT03929822 660 663 O
be NCT03929822 664 666 O
treated NCT03929822 667 674 O
with NCT03929822 675 679 O
radioactive NCT03929822 680 691 B-Procedure-Name
iodine NCT03929822 692 698 I-Procedure-Name

Inclusion NCT03924453 0 9 O
Criteria NCT03924453 10 18 O
: NCT03924453 19 20 O

1 NCT03924453 25 26 O
. NCT03924453 26 27 O
Female NCT03924453 29 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
( NCT03924453 36 37 O
mandatory NCT03924453 38 47 O
) NCT03924453 48 49 O

2 NCT03924453 54 55 O
. NCT03924453 55 56 O
Not NCT03924453 58 61 O
currently NCT03924453 62 71 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnant NCT03924453 72 80 B-Condition-Name
or NCT03924453 81 83 O
nursing NCT03924453 84 91 B-Condition-Name
( NCT03924453 92 93 O
mandatory NCT03924453 94 103 O
) NCT03924453 104 105 O

3 NCT03924453 110 111 O
. NCT03924453 111 112 O
Aged NCT03924453 114 118 O
21 NCT03924453 120 122 B-Eq-Value
- NCT03924453 123 124 B-Eq-Operator___Eq-Operator-Value:BETWEEN
45 NCT03924453 126 128 B-Eq-Value
( NCT03924453 129 130 O
advanced NCT03924453 131 139 O
age NCT03924453 140 143 O
can NCT03924453 144 147 O
hinder NCT03924453 148 154 O
hormone NCT03924453 155 162 O
levels NCT03924453 163 169 O
) NCT03924453 170 171 O

4 NCT03924453 176 177 O
. NCT03924453 177 178 O
Not NCT03924453 180 183 O
be NCT03924453 184 186 O
diagnosed NCT03924453 187 196 O
as NCT03924453 197 199 O
sub NCT03924453 200 203 B-Condition-Name
fertile NCT03924453 204 211 I-Condition-Name
( NCT03924453 212 213 O
infertility NCT03924453 214 225 O
causes NCT03924453 226 232 O
inconsistent NCT03924453 233 245 O
hormone NCT03924453 246 253 O
levels NCT03924453 254 260 O
) NCT03924453 261 262 O

5 NCT03924453 267 268 O
. NCT03924453 268 269 O
Not NCT03924453 271 274 O
have NCT03924453 275 279 O
used NCT03924453 280 284 O
any NCT03924453 285 288 O
form NCT03924453 289 293 O
of NCT03924453 294 296 O
hormonal NCT03924453 297 305 B-Procedure-Name
birth NCT03924453 306 311 I-Procedure-Name
control NCT03924453 312 319 I-Procedure-Name
in NCT03924453 320 322 O
the NCT03924453 323 326 B-Eq-Operator___Eq-Operator-Value:LTEQ
past NCT03924453 327 331 I-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03924453 333 334 B-Eq-Value
months NCT03924453 335 341 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
( NCT03924453 342 343 O
mandatory NCT03924453 344 353 O
) NCT03924453 354 355 O

6 NCT03924453 360 361 O
. NCT03924453 361 362 O
Currently NCT03924453 364 373 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
trying NCT03924453 374 380 O
to NCT03924453 381 383 O
conceive NCT03924453 384 392 B-Condition-Name
( NCT03924453 393 394 O
ideal NCT03924453 395 400 O
but NCT03924453 401 404 O
not NCT03924453 405 408 O
required NCT03924453 409 417 O
) NCT03924453 418 419 O

7 NCT03924453 424 425 O
. NCT03924453 425 426 O
Currently NCT03924453 428 437 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
reside NCT03924453 438 444 O
in NCT03924453 445 447 O
the NCT03924453 448 451 O
US NCT03924453 452 454 B-Location___Location-Value:residence
( NCT03924453 455 456 O
mandatory NCT03924453 457 466 O
, NCT03924453 467 468 O
this NCT03924453 469 473 O
study NCT03924453 474 479 O
is NCT03924453 480 482 O
for NCT03924453 483 486 O
US NCT03924453 487 489 O
residents NCT03924453 490 499 O
only NCT03924453 500 504 O
) NCT03924453 505 506 O

Exclusion NCT03924453 508 517 O
Criteria NCT03924453 518 526 O
: NCT03924453 527 528 O

1 NCT03924453 533 534 O
. NCT03924453 534 535 O
Male NCT03924453 537 541 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

2 NCT03924453 545 546 O
. NCT03924453 546 547 O
Pregnant NCT03924453 549 557 B-Condition-Name

3 NCT03924453 561 562 O
. NCT03924453 562 563 O
Nursing NCT03924453 565 572 B-Condition-Name

Inclusion NCT03921112 0 9 O
Criteria NCT03921112 10 18 O
: NCT03921112 19 20 O

- NCT03921112 24 25 O
Mechanically NCT03921112 27 39 B-Procedure-Name
ventilated NCT03921112 40 50 I-Procedure-Name
patients NCT03921112 51 59 O

- NCT03921112 62 63 O
ASAI NCT03921112 65 69 B-Condition-Name
, NCT03921112 70 71 O
ASAII NCT03921112 72 77 B-Condition-Name
, NCT03921112 78 79 O
ASAIII NCT03921112 80 86 B-Condition-Name

Exclusion NCT03921112 87 96 O
Criteria NCT03921112 97 105 O
: NCT03921112 106 107 O

- NCT03921112 111 112 O
Patients NCT03921112 114 122 O
or NCT03921112 123 125 O
gurdians NCT03921112 126 134 O
refuse NCT03921112 135 141 O

- NCT03921112 144 145 O
Patients NCT03921112 147 155 O
with NCT03921112 156 160 O
pneumthorax NCT03921112 161 172 B-Condition-Name

- NCT03921112 175 176 O
Patients NCT03921112 178 186 O
with NCT03921112 187 191 O
pleural NCT03921112 192 199 B-Condition-Name
effusion NCT03921112 200 208 I-Condition-Name

- NCT03921112 211 212 O
Patients NCT03921112 214 222 O
with NCT03921112 223 227 O
surgical NCT03921112 228 236 B-Condition-Name
emphysema NCT03921112 237 246 I-Condition-Name

- NCT03921112 249 250 O
Glasco NCT03921112 252 258 B-Observation-Name___Observation-Type-Value:clinical-score
coma NCT03921112 259 263 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03921112 264 269 B-Eq-Unit
more NCT03921112 270 274 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03921112 275 279 I-Eq-Operator___Eq-Operator-Value:GT
8 NCT03921112 281 282 B-Eq-Value

- NCT03921112 286 287 O
Patients NCT03921112 289 297 O
on NCT03921112 298 300 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
high NCT03921112 301 305 B-Polarity___Polarity-Value:high
inotropic NCT03921112 306 315 B-Drug-Name
support NCT03921112 316 323 I-Drug-Name

- NCT03921112 326 327 O
patients NCT03921112 329 337 O
with NCT03921112 338 342 O
diaphragmatic NCT03921112 343 356 B-Condition-Name
paralysis NCT03921112 357 366 I-Condition-Name

Inclusion NCT03928678 0 9 O
Criteria NCT03928678 10 18 O
: NCT03928678 19 20 O

- NCT03928678 24 25 O
Age NCT03928678 27 30 O
≤ NCT03928678 31 32 B-Eq-Operator___Eq-Operator-Value:LTEQ
60 NCT03928678 34 36 B-Eq-Value
years NCT03928678 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03928678 43 44 O

- NCT03928678 48 49 O
Good NCT03928678 51 55 O
nutrition NCT03928678 56 65 O
, NCT03928678 66 67 O

- NCT03928678 71 72 O
No NCT03928678 74 76 O
systemic NCT03928678 77 85 B-Condition-Name
infection NCT03928678 86 95 I-Condition-Name
and NCT03928678 96 99 O

- NCT03928678 102 103 O
Elective NCT03928678 105 113 O
laparoscopic NCT03928678 114 126 B-Procedure-Name
surgery NCT03928678 127 134 I-Procedure-Name

Exclusion NCT03928678 135 144 O
Criteria NCT03928678 145 153 O
: NCT03928678 154 155 O

- NCT03928678 159 160 O
Age NCT03928678 162 165 O
> NCT03928678 166 167 B-Eq-Operator___Eq-Operator-Value:GT
75 NCT03928678 169 171 B-Eq-Value
years NCT03928678 172 177 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03928678 178 179 O

- NCT03928678 183 184 O
Malnutrition NCT03928678 186 198 B-Condition-Name
or NCT03928678 199 201 O
an NCT03928678 202 204 O
organ NCT03928678 205 210 B-Condition-Name
system NCT03928678 211 217 I-Condition-Name
infection NCT03928678 218 227 I-Condition-Name

- NCT03928678 230 231 O
Associated NCT03928678 233 243 O
with NCT03928678 244 248 O
obstruction NCT03928678 249 260 B-Condition-Name
, NCT03928678 261 262 O
bleeding NCT03928678 263 271 B-Condition-Name
, NCT03928678 272 273 O
emergency NCT03928678 274 283 B-Procedure-Name
surgery NCT03928678 284 291 I-Procedure-Name
or NCT03928678 292 294 O
other NCT03928678 295 300 O
surgical NCT03928678 301 309 B-Procedure-Name
intervention NCT03928678 310 322 I-Procedure-Name

- NCT03928678 325 326 O
Tumor NCT03928678 328 333 B-Condition-Name
with NCT03928678 334 338 I-Condition-Name
extensive NCT03928678 339 348 I-Condition-Name
metastasis NCT03928678 349 359 I-Condition-Name

- NCT03928678 362 363 O
Prior NCT03928678 365 370 O
to NCT03928678 371 373 O
surgery NCT03928678 374 381 B-Procedure-Name
, NCT03928678 382 383 O
patient NCT03928678 384 391 O
was NCT03928678 392 395 O
fasting NCT03928678 396 403 B-Observation-Name
, NCT03928678 404 405 O
underwent NCT03928678 406 415 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
gastrointestinal NCT03928678 416 432 B-Procedure-Name
decompression NCT03928678 433 446 I-Procedure-Name
and NCT03928678 447 450 O
received NCT03928678 451 459 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
nutritional NCT03928678 460 471 B-Procedure-Name
support NCT03928678 472 479 I-Procedure-Name

- NCT03928678 482 483 O
Previous NCT03928678 485 493 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03928678 494 501 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928678 502 504 O
abdominal NCT03928678 505 514 B-Procedure-Name
surgery NCT03928678 515 522 I-Procedure-Name

- NCT03928678 525 526 O
Patient NCT03928678 528 535 O
have NCT03928678 536 540 O
previously NCT03928678 541 551 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
undergone NCT03928678 552 561 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
gastrostomy NCT03928678 562 573 B-Procedure-Name

Inclusion NCT03921853 0 9 O
Criteria NCT03921853 10 18 O
: NCT03921853 19 20 O

Inclusion NCT03921853 22 31 O
Criteria NCT03921853 32 40 O
: NCT03921853 41 42 O

- NCT03921853 46 47 O
Older NCT03921853 49 54 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03921853 55 59 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03921853 61 63 B-Eq-Value
and NCT03921853 64 67 O
younger NCT03921853 68 75 O
and NCT03921853 76 79 O
≤ NCT03921853 80 81 B-Eq-Operator___Eq-Operator-Value:LTEQ
65 NCT03921853 83 85 B-Eq-Value
years NCT03921853 86 91 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921853 92 94 O
age NCT03921853 95 98 O
. NCT03921853 99 100 O

- NCT03921853 104 105 O
With NCT03921853 107 111 O
risk NCT03921853 112 116 O
factors NCT03921853 117 124 O
to NCT03921853 125 127 O
Metabolic NCT03921853 128 137 B-Condition-Name
syndrome NCT03921853 138 146 I-Condition-Name

- NCT03921853 149 150 O
With NCT03921853 152 156 O
obesity NCT03921853 157 164 B-Condition-Name
and NCT03921853 165 168 O
morbid NCT03921853 169 175 B-Condition-Name
obesity NCT03921853 176 183 I-Condition-Name
condition NCT03921853 184 193 O

- NCT03921853 196 197 O
Medical NCT03921853 199 206 O
authorization NCT03921853 207 220 O
by NCT03921853 221 223 O
a NCT03921853 224 225 O
physician NCT03921853 226 235 O
. NCT03921853 236 237 O

Exclusion NCT03921853 239 248 O
Criteria NCT03921853 249 257 O
: NCT03921853 258 259 O

- NCT03921853 263 264 O
Physical NCT03921853 266 274 B-Condition-Name
limitations NCT03921853 275 286 I-Condition-Name
( NCT03921853 287 288 O
e NCT03921853 289 290 O
. NCT03921853 291 292 O
g NCT03921853 293 294 O
. NCT03921853 295 296 O
, NCT03921853 297 298 O
restricting NCT03921853 299 310 O
injuries NCT03921853 311 319 B-Condition-Name
of NCT03921853 320 322 O
the NCT03921853 323 326 O
musculoskeletal NCT03921853 327 342 O
system NCT03921853 343 349 O
, NCT03921853 350 351 O
or NCT03921853 352 354 O
dependent NCT03921853 355 364 B-Observation-Name
of NCT03921853 365 367 I-Observation-Name
a NCT03921853 368 369 I-Observation-Name
third NCT03921853 370 375 I-Observation-Name
person NCT03921853 376 382 I-Observation-Name
) NCT03921853 383 384 O
. NCT03921853 386 387 O

- NCT03921853 391 392 O
Exercise NCT03921853 394 402 B-Condition-Name
- NCT03921853 403 404 I-Condition-Name
related NCT03921853 405 412 I-Condition-Name
dyspnoea NCT03921853 413 421 I-Condition-Name
or NCT03921853 422 424 O
respiratory NCT03921853 425 436 B-Condition-Name
alterations NCT03921853 437 448 I-Condition-Name
. NCT03921853 449 450 O

- NCT03921853 454 455 O
Chronic NCT03921853 457 464 O
heart NCT03921853 465 470 B-Condition-Name
disease NCT03921853 471 478 I-Condition-Name
with NCT03921853 479 483 O
any NCT03921853 484 487 O
worsening NCT03921853 488 497 B-Stability___Stability-Value:change
in NCT03921853 498 500 O
the NCT03921853 501 504 O
last NCT03921853 505 509 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
month NCT03921853 510 515 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03921853 516 517 O

- NCT03921853 521 522 O
Adherence NCT03921853 524 533 B-Observation-Name
rate NCT03921853 534 538 I-Observation-Name
of NCT03921853 539 541 O
less NCT03921853 542 546 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03921853 547 551 I-Eq-Operator___Eq-Operator-Value:LT
80 NCT03921853 553 555 B-Eq-Value
% NCT03921853 556 557 B-Eq-Unit
of NCT03921853 558 560 O
the NCT03921853 561 564 O
total NCT03921853 565 570 O
interventions NCT03921853 571 584 O
. NCT03921853 585 586 O

Inclusion NCT03923088 0 9 O
Criteria NCT03923088 10 18 O
: NCT03923088 19 20 O

- NCT03923088 24 25 O
Children NCT03923088 27 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
: NCT03923088 36 37 O
6 NCT03923088 39 40 B-Eq-Value
to NCT03923088 41 43 B-Eq-Operator___Eq-Operator-Value:BETWEEN
9 NCT03923088 45 46 B-Eq-Value
years NCT03923088 47 52 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03923088 53 56 O
children NCT03923088 57 65 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
. NCT03923088 66 67 O
Teeth NCT03923088 69 74 O
: NCT03923088 75 76 O
tooth NCT03923088 77 82 O
requiring NCT03923088 83 92 O
dental NCT03923088 93 99 B-Procedure-Name
treatment NCT03923088 100 109 I-Procedure-Name

Exclusion NCT03923088 110 119 O
Criteria NCT03923088 120 128 O
: NCT03923088 129 130 O

- NCT03923088 134 135 O
Children NCT03923088 137 145 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
having NCT03923088 146 152 O
allergy NCT03923088 153 160 O
to NCT03923088 161 163 O
local NCT03923088 164 169 B-Procedure-Name
anaesthesia NCT03923088 170 181 I-Procedure-Name
or NCT03923088 182 184 O
systemic NCT03923088 185 193 O
problem NCT03923088 194 201 B-Condition-Name
. NCT03923088 202 203 O
Refusal NCT03923088 205 212 O
of NCT03923088 213 215 O
participation NCT03923088 216 229 O
Mentally NCT03923088 230 238 B-Condition-Name
ill NCT03923088 239 242 I-Condition-Name
or NCT03923088 243 245 O
mentally NCT03923088 246 254 B-Condition-Name
retarded NCT03923088 255 263 I-Condition-Name
children NCT03923088 264 272 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child

Inclusion NCT03921489 0 9 O
Criteria NCT03921489 10 18 O
: NCT03921489 19 20 O

- NCT03921489 24 25 O
BME NCT03921489 27 30 B-Condition-Name
diagnosed NCT03921489 31 40 O
on NCT03921489 41 43 O
MRI NCT03921489 44 47 B-Procedure-Name

- NCT03921489 50 51 O
Pain NCT03921489 53 57 B-Condition-Name
to NCT03921489 58 60 O
that NCT03921489 61 65 O
area NCT03921489 66 70 O

- NCT03921489 73 74 O
Failed NCT03921489 76 82 O
3 NCT03921489 84 85 B-Eq-Value
months NCT03921489 86 92 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921489 93 95 O
conservative NCT03921489 96 108 B-Procedure-Name
treatment NCT03921489 109 118 I-Procedure-Name

Exclusion NCT03921489 119 128 O
Criteria NCT03921489 129 137 O
: NCT03921489 138 139 O

- NCT03921489 143 144 O
Patient NCT03921489 146 153 O
< NCT03921489 154 155 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03921489 157 159 B-Eq-Value
years NCT03921489 160 165 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921489 166 168 O
age NCT03921489 169 172 O

- NCT03921489 175 176 O
Presence NCT03921489 178 186 O
of NCT03921489 187 189 O
osteomyelitis NCT03921489 190 203 B-Condition-Name
of NCT03921489 204 206 O
poor NCT03921489 207 211 O
surgical NCT03921489 212 220 O
candidates NCT03921489 221 231 O
due NCT03921489 232 235 O
to NCT03921489 236 238 O
comorbidities NCT03921489 239 252 O
such NCT03921489 253 257 O
as NCT03921489 258 260 O
diabetics NCT03921489 261 270 B-Condition-Name
with NCT03921489 271 275 O
an NCT03921489 276 278 O
HbA NCT03921489 279 282 B-Observation-Name___Observation-Type-Value:lab
1c NCT03921489 283 285 I-Observation-Name___Observation-Type-Value:lab
of NCT03921489 286 288 O
> NCT03921489 289 290 B-Eq-Operator___Eq-Operator-Value:GT
8 NCT03921489 292 293 B-Eq-Value
% NCT03921489 294 295 B-Eq-Unit

- NCT03921489 299 300 O
Patient NCT03921489 302 309 O
with NCT03921489 310 314 O
previous NCT03921489 315 323 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
foot NCT03921489 324 328 O
and NCT03921489 329 332 O
ankle NCT03921489 333 338 O
surgeries NCT03921489 339 348 B-Procedure-Name
that NCT03921489 349 353 O
may NCT03921489 354 357 O
interfere NCT03921489 358 367 O
with NCT03921489 368 372 O
future NCT03921489 373 379 O
outcomes NCT03921489 380 388 O

Inclusion NCT03926494 0 9 O
Criteria NCT03926494 10 18 O
: NCT03926494 19 20 O

- NCT03926494 24 25 O
All NCT03926494 27 30 O
comatose NCT03926494 31 39 B-Condition-Name
patients NCT03926494 40 48 O
( NCT03926494 49 50 O
Glasgow NCT03926494 51 58 B-Observation-Name___Observation-Type-Value:clinical-score
coma NCT03926494 59 63 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03926494 64 69 I-Observation-Name___Observation-Type-Value:clinical-score
< NCT03926494 70 71 B-Eq-Operator___Eq-Operator-Value:LT
8 NCT03926494 73 74 B-Eq-Value
) NCT03926494 75 76 O
due NCT03926494 77 80 O
to NCT03926494 81 83 O
carbon NCT03926494 84 90 B-Condition-Name
monoxide NCT03926494 91 99 I-Condition-Name
poisoning NCT03926494 100 109 I-Condition-Name
, NCT03926494 110 111 O
treated NCT03926494 112 119 O
by NCT03926494 120 122 O
hyperbaric NCT03926494 123 133 B-Procedure-Name
oxygen NCT03926494 134 140 I-Procedure-Name
therapy NCT03926494 141 148 I-Procedure-Name
in NCT03926494 149 151 O
a NCT03926494 152 153 O
tertiary NCT03926494 154 162 B-Location___Location-Value:hospital
hospital NCT03926494 163 171 I-Location___Location-Value:hospital
in NCT03926494 172 174 I-Location___Location-Value:hospital
Île NCT03926494 175 178 I-Location___Location-Value:hospital
de NCT03926494 179 181 I-Location___Location-Value:hospital
France NCT03926494 182 188 I-Location___Location-Value:hospital
area NCT03926494 189 193 O
; NCT03926494 193 194 O

- NCT03926494 197 198 O
Aged NCT03926494 200 204 O
≥ NCT03926494 205 206 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03926494 208 210 B-Eq-Value
years NCT03926494 211 216 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03926494 216 217 O

- NCT03926494 220 221 O
Hospitalized NCT03926494 223 235 B-Encounter-Type___Encounter-Type-Value:inpatient
in NCT03926494 236 238 O
hyperbaric NCT03926494 239 249 B-Location___Location-Value:unit
medicine NCT03926494 250 258 I-Location___Location-Value:unit
unity NCT03926494 259 264 I-Location___Location-Value:unit
of NCT03926494 265 267 O
Raymond NCT03926494 268 275 B-Location___Location-Value:hospital
Poincaré NCT03926494 276 284 I-Location___Location-Value:hospital
hospital NCT03926494 285 293 I-Location___Location-Value:hospital
in NCT03926494 294 296 O
Garches NCT03926494 297 304 B-Location
. NCT03926494 305 306 O

Exclusion NCT03926494 308 317 O
Criteria NCT03926494 318 326 O
: NCT03926494 327 328 O

- NCT03926494 332 333 O
Pregnant NCT03926494 335 343 B-Condition-Name
woman NCT03926494 344 349 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
; NCT03926494 349 350 O

- NCT03926494 353 354 O
Patient NCT03926494 356 363 O
present NCT03926494 364 371 O
clinical NCT03926494 372 380 O
signes NCT03926494 381 387 O
of NCT03926494 388 390 O
stroke NCT03926494 391 397 B-Condition-Name
and NCT03926494 398 401 O
without NCT03926494 402 409 O
CO NCT03926494 410 412 B-Condition-Name
detection NCT03926494 413 422 I-Condition-Name
. NCT03926494 423 424 O

In NCT03926494 426 428 O
case NCT03926494 429 433 O
of NCT03926494 434 436 O
unusable NCT03926494 437 445 O
data NCT03926494 446 450 O
, NCT03926494 451 452 O
patient NCT03926494 453 460 O
will NCT03926494 461 465 O
be NCT03926494 466 468 O
excluded NCT03926494 469 477 O
from NCT03926494 478 482 O
study NCT03926494 483 488 O
. NCT03926494 489 490 O

Inclusion NCT03927638 0 9 O
Criteria NCT03927638 10 18 O
: NCT03927638 19 20 O

- NCT03927638 24 25 O
healthy NCT03927638 27 34 B-Condition-Name
adult NCT03927638 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult

Exclusion NCT03927638 41 50 O
Criteria NCT03927638 51 59 O
: NCT03927638 60 61 O

- NCT03927638 65 66 O
Have NCT03927638 68 72 O
a NCT03927638 73 74 O
history NCT03927638 75 82 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927638 83 85 O
cancer NCT03927638 86 92 B-Condition-Name
, NCT03927638 93 94 O
cardiac NCT03927638 95 102 B-Condition-Name
issues NCT03927638 103 109 I-Condition-Name
, NCT03927638 110 111 O
hypertension NCT03927638 112 124 B-Condition-Name
, NCT03927638 125 126 O
pulmonary NCT03927638 127 136 B-Condition-Name
disease NCT03927638 137 144 I-Condition-Name
, NCT03927638 145 146 O
stroke NCT03927638 147 153 B-Condition-Name
, NCT03927638 154 155 O
neurological NCT03927638 156 168 O
or NCT03927638 169 171 O
muscular NCT03927638 172 180 O
dystrophy NCT03927638 181 190 B-Condition-Name
, NCT03927638 191 192 O
uncontrolled NCT03927638 193 205 O
diabetes NCT03927638 206 214 B-Condition-Name
, NCT03927638 215 216 O
or NCT03927638 217 219 O
any NCT03927638 220 223 O
life NCT03927638 224 228 B-Condition-Name
threatening NCT03927638 229 240 I-Condition-Name
chronic NCT03927638 241 248 I-Condition-Name
conditions NCT03927638 249 259 I-Condition-Name
. NCT03927638 260 261 O

- NCT03927638 265 266 O
Are NCT03927638 268 271 O
currently NCT03927638 272 281 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
being NCT03927638 282 287 O
treated NCT03927638 288 295 O
for NCT03927638 296 299 O
infectious NCT03927638 300 310 B-Condition-Name
mononucleosis NCT03927638 311 324 I-Condition-Name
, NCT03927638 325 326 O
hepatitis NCT03927638 327 336 B-Condition-Name
, NCT03927638 337 338 O
pneumonia NCT03927638 339 348 B-Condition-Name
, NCT03927638 349 350 O
or NCT03927638 351 353 O
other NCT03927638 354 359 O
infectious NCT03927638 360 370 B-Condition-Name
diseases NCT03927638 371 379 I-Condition-Name
. NCT03927638 380 381 O

- NCT03927638 385 386 O
Are NCT03927638 388 391 O
unable NCT03927638 392 398 O
or NCT03927638 399 401 O
unwilling NCT03927638 402 411 O
to NCT03927638 412 414 O
stand NCT03927638 415 420 B-Observation-Name
in NCT03927638 421 423 I-Observation-Name
one NCT03927638 424 427 I-Observation-Name
position NCT03927638 428 436 I-Observation-Name
continuously NCT03927638 437 449 O
for NCT03927638 450 453 O
15 NCT03927638 455 457 B-Eq-Value
- NCT03927638 458 459 B-Eq-Operator___Eq-Operator-Value:BETWEEN
20 NCT03927638 461 463 B-Eq-Value
minutes NCT03927638 464 471 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
at NCT03927638 472 474 O
a NCT03927638 475 476 O
time NCT03927638 477 481 O
. NCT03927638 482 483 O

- NCT03927638 487 488 O
Use NCT03927638 490 493 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
nicotine NCT03927638 494 502 B-Drug-Name
products NCT03927638 503 511 I-Drug-Name
, NCT03927638 512 513 O
or NCT03927638 514 516 O
non NCT03927638 517 520 B-Procedure-Name
- NCT03927638 521 522 I-Procedure-Name
contraceptive NCT03927638 523 536 I-Procedure-Name
hormonal NCT03927638 537 545 I-Procedure-Name
therapy NCT03927638 546 553 I-Procedure-Name
( NCT03927638 554 555 O
birth NCT03927638 556 561 B-Procedure-Name
control NCT03927638 562 569 I-Procedure-Name
is NCT03927638 570 572 O
okay NCT03927638 573 577 O
) NCT03927638 578 579 O
. NCT03927638 581 582 O

- NCT03927638 586 587 O
Are NCT03927638 589 592 O
pregnant NCT03927638 593 601 B-Condition-Name
or NCT03927638 602 604 O
trying NCT03927638 605 611 O
to NCT03927638 612 614 O
become NCT03927638 615 621 O
pregnant NCT03927638 622 630 B-Condition-Name
. NCT03927638 631 632 O

- NCT03927638 636 637 O
Are NCT03927638 639 642 O
not NCT03927638 643 646 O
between NCT03927638 647 654 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03927638 656 658 B-Eq-Value
and NCT03927638 659 662 O
50 NCT03927638 664 666 B-Eq-Value
years NCT03927638 667 672 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03927638 673 675 O
age NCT03927638 676 679 O
. NCT03927638 680 681 O

Inclusion NCT03929198 0 9 O
Criteria NCT03929198 10 18 O
: NCT03929198 19 20 O

- NCT03929198 24 25 O
Dysfunctional NCT03929198 27 40 B-Condition-Name
lipids NCT03929198 41 47 I-Condition-Name
, NCT03929198 48 49 O
blood NCT03929198 50 55 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03929198 56 64 I-Observation-Name___Observation-Type-Value:vital
and NCT03929198 65 68 O
glycemic NCT03929198 69 77 B-Condition-Name
control NCT03929198 78 85 I-Condition-Name
determined NCT03929198 86 96 O
at NCT03929198 97 99 O
a NCT03929198 100 101 O
screening NCT03929198 102 111 O
visit NCT03929198 112 117 O
: NCT03929198 118 119 O

- NCT03929198 128 129 O
Triglycerides NCT03929198 131 144 B-Observation-Name___Observation-Type-Value:lab
> NCT03929198 145 146 B-Eq-Operator___Eq-Operator-Value:GT
150 NCT03929198 148 151 B-Eq-Value
mg NCT03929198 152 154 B-Eq-Unit
/ NCT03929198 155 156 O
dL NCT03929198 157 159 B-Eq-Unit
OR NCT03929198 160 162 O
HDL NCT03929198 163 166 B-Observation-Name___Observation-Type-Value:lab
< NCT03929198 167 168 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03929198 170 172 B-Eq-Value
in NCT03929198 173 175 O
females NCT03929198 176 183 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03929198 184 185 O
< NCT03929198 186 187 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03929198 189 191 B-Eq-Value
mg NCT03929198 192 194 B-Eq-Unit
/ NCT03929198 195 196 O
dL NCT03929198 197 199 B-Eq-Unit
in NCT03929198 200 202 O
males NCT03929198 203 208 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03929198 216 217 O
Systolic NCT03929198 219 227 B-Observation-Name___Observation-Type-Value:vital
blood NCT03929198 228 233 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03929198 234 242 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03929198 243 244 B-Eq-Operator___Eq-Operator-Value:GTEQ
130 NCT03929198 246 249 B-Eq-Value
mmHg NCT03929198 250 254 B-Eq-Unit
OR NCT03929198 255 257 O
diastolic NCT03929198 258 267 B-Observation-Name___Observation-Type-Value:vital
blood NCT03929198 268 273 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03929198 274 282 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03929198 283 284 B-Eq-Operator___Eq-Operator-Value:GTEQ
80 NCT03929198 286 288 B-Eq-Value
mmHg NCT03929198 289 293 B-Eq-Unit
( NCT03929198 294 295 O
or NCT03929198 296 298 O
on NCT03929198 299 301 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hypertension NCT03929198 302 314 B-Condition-Name
medication NCT03929198 315 325 O
) NCT03929198 326 327 O

- NCT03929198 336 337 O
HbA NCT03929198 339 342 B-Observation-Name___Observation-Type-Value:lab
1c NCT03929198 343 345 I-Observation-Name___Observation-Type-Value:lab
≥ NCT03929198 346 347 B-Eq-Operator___Eq-Operator-Value:GTEQ
5.7 NCT03929198 349 352 B-Eq-Value
% NCT03929198 353 354 B-Eq-Unit
or NCT03929198 355 357 O
higher NCT03929198 358 364 O

- NCT03929198 367 368 O
No NCT03929198 370 372 O
diagnosis NCT03929198 373 382 O
or NCT03929198 383 385 O
treatment NCT03929198 386 395 O
for NCT03929198 396 399 O
cancer NCT03929198 400 406 B-Condition-Name
in NCT03929198 407 409 O
the NCT03929198 410 413 O
past NCT03929198 414 418 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03929198 419 423 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03929198 426 427 O
No NCT03929198 429 431 O
diagnosis NCT03929198 432 441 O
of NCT03929198 442 444 O
mild NCT03929198 445 449 B-Condition-Name
cognitive NCT03929198 450 459 I-Condition-Name
impairment NCT03929198 460 470 I-Condition-Name
or NCT03929198 471 473 O
dementia NCT03929198 474 482 B-Condition-Name
in NCT03929198 483 485 O
the NCT03929198 486 489 O
past NCT03929198 490 494 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03929198 495 499 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03929198 502 503 O
Ability NCT03929198 505 512 O
to NCT03929198 513 515 O
perform NCT03929198 516 523 O
daily NCT03929198 524 529 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
exercise NCT03929198 530 538 B-Observation-Name
, NCT03929198 539 540 O
including NCT03929198 541 550 O
aerobic NCT03929198 551 558 B-Observation-Name
activity NCT03929198 559 567 I-Observation-Name
and NCT03929198 568 571 O
resistance NCT03929198 572 582 B-Observation-Name
exercise NCT03929198 583 591 I-Observation-Name

- NCT03929198 594 595 O
Non NCT03929198 597 600 O
- NCT03929198 601 602 O
smoker NCT03929198 603 609 B-Condition-Name
in NCT03929198 610 612 O
the NCT03929198 613 616 O
past NCT03929198 617 621 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03929198 622 626 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03929198 627 636 O
Criteria NCT03929198 637 645 O
: NCT03929198 646 647 O

- NCT03929198 651 652 O
Positive NCT03929198 654 662 B-Polarity___Polarity-Value:positive
exercise NCT03929198 663 671 B-Observation-Name___Observation-Type-Value:measurement
stress NCT03929198 672 678 I-Observation-Name___Observation-Type-Value:measurement
test NCT03929198 679 683 I-Observation-Name___Observation-Type-Value:measurement

Inclusion NCT03922230 0 9 O
Criteria NCT03922230 10 18 O
: NCT03922230 19 20 O

1 NCT03922230 25 26 O
. NCT03922230 26 27 O
Diagnosis NCT03922230 29 38 O
of NCT03922230 39 41 O
esophageal NCT03922230 42 52 O
squamous NCT03922230 53 61 B-Condition-Name
cell NCT03922230 62 66 I-Condition-Name
carcinoma NCT03922230 67 76 I-Condition-Name
by NCT03922230 77 79 O
pathological NCT03922230 80 92 B-Procedure-Name
cytology NCT03922230 93 101 I-Procedure-Name
and NCT03922230 102 105 O
histology NCT03922230 106 115 B-Procedure-Name
. NCT03922230 116 117 O

2 NCT03922230 122 123 O
. NCT03922230 123 124 O
Clinically NCT03922230 126 136 O
judged NCT03922230 137 143 O
patients NCT03922230 144 152 O
with NCT03922230 153 157 O
p NCT03922230 158 159 O
0 NCT03922230 160 161 O
~ NCT03922230 162 163 O
pIV NCT03922230 164 167 O
initial NCT03922230 168 175 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
treatment NCT03922230 176 185 O
. NCT03922230 186 187 O
（ NCT03922230 188 189 O
1 NCT03922230 191 192 O
Variable NCT03922230 193 201 O
risk NCT03922230 202 206 O
factors NCT03922230 207 214 O
are NCT03922230 215 218 O
overeating NCT03922230 219 229 B-Condition-Name
food NCT03922230 230 234 O
( NCT03922230 235 236 O
habits NCT03922230 237 243 O
) NCT03922230 244 245 O
and NCT03922230 246 249 O
family NCT03922230 250 256 O
history NCT03922230 257 264 O
. NCT03922230 265 266 O
2 NCT03922230 269 270 O
Among NCT03922230 271 276 O
all NCT03922230 277 280 O
the NCT03922230 281 284 O
patients NCT03922230 285 293 O
, NCT03922230 294 295 O
the NCT03922230 296 299 O
ratio NCT03922230 300 305 O
of NCT03922230 306 308 O
male NCT03922230 309 313 O
to NCT03922230 314 316 O
female NCT03922230 317 323 O
is NCT03922230 324 326 O
3 NCT03922230 328 329 O
: NCT03922230 330 331 O
1 NCT03922230 333 334 O
, NCT03922230 335 336 O
and NCT03922230 337 340 O
the NCT03922230 341 344 O
age NCT03922230 345 348 O
is NCT03922230 349 351 O
between NCT03922230 352 359 O
50 NCT03922230 361 363 B-Eq-Value
and NCT03922230 364 367 O
70 NCT03922230 369 371 B-Eq-Value
years NCT03922230 372 377 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03922230 378 381 O
. NCT03922230 382 383 O
In NCT03922230 385 387 O
addition NCT03922230 388 396 O
to NCT03922230 397 399 O
eating NCT03922230 400 406 O
too NCT03922230 407 410 O
hot NCT03922230 411 414 O
food NCT03922230 415 419 O
, NCT03922230 420 421 O
other NCT03922230 422 427 O
eating NCT03922230 428 434 O
habits NCT03922230 435 441 O
( NCT03922230 442 443 O
such NCT03922230 444 448 O
as NCT03922230 449 451 O
eating NCT03922230 452 458 O
fresh NCT03922230 459 464 O
fruits NCT03922230 465 471 O
and NCT03922230 472 475 O
vegetables NCT03922230 476 486 O
, NCT03922230 487 488 O
eating NCT03922230 489 495 O
preserved NCT03922230 496 505 O
food NCT03922230 506 510 O
, NCT03922230 511 512 O
etc NCT03922230 513 516 O
. NCT03922230 517 518 O
) NCT03922230 519 520 O
are NCT03922230 521 524 O
consistent NCT03922230 525 535 O
, NCT03922230 536 537 O
other NCT03922230 538 543 O
factors NCT03922230 544 551 O
( NCT03922230 552 553 O
such NCT03922230 554 558 O
as NCT03922230 559 561 O
BMI NCT03922230 562 565 B-Observation-Name___Observation-Type-Value:vital
, NCT03922230 566 567 O
smoking NCT03922230 568 575 B-Condition-Name
, NCT03922230 576 577 O
drinking NCT03922230 578 586 B-Condition-Name
, NCT03922230 587 588 O
etc NCT03922230 589 592 O
. NCT03922230 593 594 O
) NCT03922230 595 596 O
as NCT03922230 597 599 O
much NCT03922230 600 604 O
as NCT03922230 605 607 O
possible NCT03922230 608 616 O
. NCT03922230 617 618 O
3 NCT03922230 621 622 O
In NCT03922230 623 625 O
order NCT03922230 626 631 O
to NCT03922230 632 634 O
rule NCT03922230 635 639 O
out NCT03922230 640 643 O
the NCT03922230 644 647 O
interference NCT03922230 648 660 O
of NCT03922230 661 663 O
other NCT03922230 664 669 O
diseases NCT03922230 670 678 O
, NCT03922230 679 680 O
each NCT03922230 681 685 O
sample NCT03922230 686 692 O
needs NCT03922230 693 698 O
to NCT03922230 699 701 O
be NCT03922230 702 704 O
determined NCT03922230 705 715 O
to NCT03922230 716 718 O
have NCT03922230 719 723 O
no NCT03922230 724 726 O
history NCT03922230 727 734 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03922230 735 737 O
other NCT03922230 738 743 O
diseases NCT03922230 744 752 B-Condition-Name
( NCT03922230 753 754 O
such NCT03922230 755 759 O
as NCT03922230 760 762 O
neurodegenerative NCT03922230 763 780 B-Condition-Name
diseases NCT03922230 781 789 I-Condition-Name
, NCT03922230 790 791 O
leukemia NCT03922230 792 800 B-Condition-Name
) NCT03922230 801 802 O
. NCT03922230 804 805 O
） NCT03922230 806 807 O

3 NCT03922230 811 812 O
. NCT03922230 812 813 O
The NCT03922230 815 818 O
normal NCT03922230 819 825 O
population NCT03922230 826 836 O
comes NCT03922230 837 842 O
from NCT03922230 843 847 O
the NCT03922230 848 851 O
healthy NCT03922230 852 859 O
population NCT03922230 860 870 O
of NCT03922230 871 873 O
Nanfang NCT03922230 874 881 B-Location___Location-Value:hospital
Hospital NCT03922230 882 890 I-Location___Location-Value:hospital
Health NCT03922230 891 897 I-Location___Location-Value:hospital
Center NCT03922230 898 904 I-Location___Location-Value:hospital
of NCT03922230 905 907 O
Southern NCT03922230 908 916 O
Medical NCT03922230 917 924 O
University NCT03922230 925 935 O
. NCT03922230 936 937 O

Exclusion NCT03922230 939 948 O
Criteria NCT03922230 949 957 O
: NCT03922230 958 959 O

1 NCT03922230 964 965 O
. NCT03922230 965 966 O
Pre NCT03922230 968 971 O
operative NCT03922230 972 981 O
patients NCT03922230 982 990 O
have NCT03922230 991 995 O
received NCT03922230 996 1004 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
relevant NCT03922230 1005 1013 O
treatment NCT03922230 1014 1023 O
, NCT03922230 1024 1025 O
such NCT03922230 1026 1030 O
as NCT03922230 1031 1033 O
radiotherapy NCT03922230 1034 1046 B-Procedure-Name
and NCT03922230 1047 1050 O
chemotherapy NCT03922230 1051 1063 B-Procedure-Name
; NCT03922230 1063 1064 O

2 NCT03922230 1068 1069 O
. NCT03922230 1069 1070 O
The NCT03922230 1072 1075 O
subject NCT03922230 1076 1083 O
has NCT03922230 1084 1087 O
other NCT03922230 1088 1093 O
diseases NCT03922230 1094 1102 B-Condition-Name
, NCT03922230 1103 1104 O
such NCT03922230 1105 1109 O
as NCT03922230 1110 1112 O
tumors NCT03922230 1113 1119 B-Condition-Name
in NCT03922230 1120 1122 O
other NCT03922230 1123 1128 O
parts NCT03922230 1129 1134 O
; NCT03922230 1134 1135 O

3 NCT03922230 1139 1140 O
. NCT03922230 1140 1141 O
Patients NCT03922230 1143 1151 O
do NCT03922230 1152 1154 O
not NCT03922230 1155 1158 O
meet NCT03922230 1159 1163 O
the NCT03922230 1164 1167 O
age NCT03922230 1168 1171 O
; NCT03922230 1171 1172 O

4 NCT03922230 1176 1177 O
. NCT03922230 1177 1178 O
There NCT03922230 1180 1185 O
is NCT03922230 1186 1188 O
no NCT03922230 1189 1191 O
guarantee NCT03922230 1192 1201 O
that NCT03922230 1202 1206 O
other NCT03922230 1207 1212 O
eating NCT03922230 1213 1219 O
habits NCT03922230 1220 1226 O
( NCT03922230 1227 1228 O
such NCT03922230 1229 1233 O
as NCT03922230 1234 1236 O
eating NCT03922230 1237 1243 O
fresh NCT03922230 1244 1249 O
fruits NCT03922230 1250 1256 O
and NCT03922230 1257 1260 O
vegetables NCT03922230 1261 1271 O
, NCT03922230 1272 1273 O
not NCT03922230 1274 1277 O
eating NCT03922230 1278 1284 O
preserved NCT03922230 1285 1294 O
foods NCT03922230 1295 1300 O
) NCT03922230 1301 1302 O
and NCT03922230 1303 1306 O
other NCT03922230 1307 1312 O
factors NCT03922230 1313 1320 O
( NCT03922230 1321 1322 O
such NCT03922230 1323 1327 O
as NCT03922230 1328 1330 O
BMI NCT03922230 1331 1334 B-Observation-Name___Observation-Type-Value:vital
, NCT03922230 1335 1336 O
smoking NCT03922230 1337 1344 B-Condition-Name
, NCT03922230 1345 1346 O
drinking NCT03922230 1347 1355 B-Condition-Name
, NCT03922230 1356 1357 O
etc NCT03922230 1358 1361 O
. NCT03922230 1362 1363 O
) NCT03922230 1364 1365 O
are NCT03922230 1366 1369 O
basically NCT03922230 1370 1379 O
the NCT03922230 1380 1383 O
same NCT03922230 1384 1388 O
. NCT03922230 1389 1390 O

Inclusion NCT03922542 0 9 O
Criteria NCT03922542 10 18 O
: NCT03922542 19 20 O

- NCT03922542 24 25 O
Documented NCT03922542 27 37 O
keratoconus NCT03922542 38 49 B-Condition-Name
or NCT03922542 50 52 O
ectasia NCT03922542 53 60 B-Condition-Name
after NCT03922542 61 66 O
refractive NCT03922542 67 77 B-Procedure-Name
surgery NCT03922542 78 85 I-Procedure-Name

Exclusion NCT03922542 86 95 O
Criteria NCT03922542 96 104 O
: NCT03922542 105 106 O

- NCT03922542 110 111 O
Insufficient NCT03922542 113 125 B-Condition-Name
corneal NCT03922542 126 133 I-Condition-Name
thickness NCT03922542 134 143 I-Condition-Name

- NCT03922542 146 147 O
Ocular NCT03922542 149 155 B-Condition-Name
condition NCT03922542 156 165 I-Condition-Name
that NCT03922542 166 170 O
may NCT03922542 171 174 O
predispose NCT03922542 175 185 O
the NCT03922542 186 189 O
eye NCT03922542 190 193 B-Condition-Name
to NCT03922542 194 196 I-Condition-Name
complications NCT03922542 197 210 I-Condition-Name

- NCT03922542 213 214 O
History NCT03922542 216 223 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03922542 224 226 O
chemical NCT03922542 227 235 B-Condition-Name
injury NCT03922542 236 242 I-Condition-Name
or NCT03922542 243 245 O
delayed NCT03922542 246 253 B-Condition-Name
epithelial NCT03922542 254 264 I-Condition-Name
healing NCT03922542 265 272 I-Condition-Name

- NCT03922542 275 276 O
Condition NCT03922542 278 287 O
that NCT03922542 288 292 O
would NCT03922542 293 298 O
interfere NCT03922542 299 308 B-Stability___Stability-Value:change
with NCT03922542 309 313 O
or NCT03922542 314 316 O
prolong NCT03922542 317 324 B-Stability___Stability-Value:change
epithelial NCT03922542 325 335 B-Condition-Name
healing NCT03922542 336 343 I-Condition-Name

- NCT03922542 346 347 O
Known NCT03922542 349 354 O
sensitivity NCT03922542 355 366 B-Condition-Name
to NCT03922542 367 369 O
treatment NCT03922542 370 379 O
medications NCT03922542 380 391 O

- NCT03922542 394 395 O
Pregnancy NCT03922542 397 406 B-Condition-Name

Inclusion NCT03923660 0 9 O
Criteria NCT03923660 10 18 O
: NCT03923660 19 20 O

- NCT03923660 24 25 O
Severe NCT03923660 27 33 B-Severity___Severity-Value:severe
COPD NCT03923660 34 38 B-Condition-Name
( NCT03923660 39 40 O
FEV NCT03923660 41 44 B-Observation-Name
1 NCT03923660 45 46 I-Observation-Name
[ NCT03923660 47 48 O
forced NCT03923660 49 55 B-Observation-Name___Observation-Type-Value:measurement
expiratory NCT03923660 56 66 I-Observation-Name___Observation-Type-Value:measurement
volume NCT03923660 67 73 I-Observation-Name___Observation-Type-Value:measurement
in NCT03923660 74 76 I-Observation-Name___Observation-Type-Value:measurement
1 NCT03923660 78 79 I-Observation-Name___Observation-Type-Value:measurement
second NCT03923660 80 86 I-Observation-Name___Observation-Type-Value:measurement
] NCT03923660 87 88 O
/ NCT03923660 89 90 O
FVC NCT03923660 91 94 B-Observation-Name
[ NCT03923660 95 96 O
forced NCT03923660 97 103 B-Observation-Name___Observation-Type-Value:measurement
vital NCT03923660 104 109 I-Observation-Name___Observation-Type-Value:measurement
capacity NCT03923660 110 118 I-Observation-Name___Observation-Type-Value:measurement
] NCT03923660 119 120 O
< NCT03923660 121 122 B-Eq-Operator___Eq-Operator-Value:LT
70 NCT03923660 124 126 B-Eq-Value
% NCT03923660 127 128 B-Eq-Unit
et NCT03923660 129 131 O
FEV NCT03923660 132 135 B-Observation-Name
1 NCT03923660 136 137 I-Observation-Name
< NCT03923660 138 139 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03923660 141 143 B-Eq-Value
% NCT03923660 144 145 B-Eq-Unit
) NCT03923660 147 148 O

- NCT03923660 152 153 O
Informed NCT03923660 155 163 O
consent NCT03923660 164 171 O

- NCT03923660 174 175 O
Affiliation NCT03923660 177 188 O
to NCT03923660 189 191 O
a NCT03923660 192 193 O
social NCT03923660 194 200 O
security NCT03923660 201 209 O
scheme NCT03923660 210 216 O

Exclusion NCT03923660 217 226 O
Criteria NCT03923660 227 235 O
: NCT03923660 236 237 O

- NCT03923660 241 242 O
Effort NCT03923660 244 250 B-Procedure-Name
oxygen NCT03923660 251 257 I-Procedure-Name
therapy NCT03923660 258 265 I-Procedure-Name

- NCT03923660 268 269 O
Cardiovascular NCT03923660 271 285 O
, NCT03923660 286 287 O
neuromuscular NCT03923660 288 301 O
or NCT03923660 302 304 O
musculoskeletal NCT03923660 305 320 O
disorders NCT03923660 321 330 B-Condition-Name
that NCT03923660 331 335 O
can NCT03923660 336 339 O
provide NCT03923660 340 347 O
significant NCT03923660 348 359 B-Severity___Severity-Value:severe
dyspnea NCT03923660 360 367 B-Condition-Name
or NCT03923660 368 370 O
limit NCT03923660 371 376 B-Stability___Stability-Value:change
exercise NCT03923660 377 385 B-Observation-Name

- NCT03923660 388 389 O
Legal NCT03923660 391 396 B-Condition-Name
incapacity NCT03923660 397 407 I-Condition-Name

- NCT03923660 410 411 O
Low NCT03923660 413 416 B-Polarity___Polarity-Value:low
or NCT03923660 417 419 O
no NCT03923660 420 422 O
cooperation NCT03923660 423 434 B-Observation-Name
anticipated NCT03923660 435 446 O

Inclusion NCT03928912 0 9 O
Criteria NCT03928912 10 18 O
: NCT03928912 19 20 O

- NCT03928912 24 25 O
The NCT03928912 27 30 O
tibial NCT03928912 31 37 O
shaft NCT03928912 38 43 O
fracture NCT03928912 44 52 B-Condition-Name
was NCT03928912 53 56 O
caused NCT03928912 57 63 O
by NCT03928912 64 66 O
trauma NCT03928912 67 73 B-Condition-Name
. NCT03928912 74 75 O

Exclusion NCT03928912 77 86 O
Criteria NCT03928912 87 95 O
: NCT03928912 96 97 O

- NCT03928912 101 102 O
The NCT03928912 104 107 O
tibial NCT03928912 108 114 O
shaft NCT03928912 115 120 O
fracture NCT03928912 121 129 B-Condition-Name
was NCT03928912 130 133 O
caused NCT03928912 134 140 O
by NCT03928912 141 143 O
tumor NCT03928912 144 149 B-Condition-Name
, NCT03928912 150 151 O
infection NCT03928912 152 161 B-Condition-Name
and NCT03928912 162 165 O
other NCT03928912 166 171 O
reasons NCT03928912 172 179 O
. NCT03928912 180 181 O

Inclusion NCT03922581 0 9 O
Criteria NCT03922581 10 18 O
: NCT03922581 19 20 O

- NCT03922581 24 25 O
ability NCT03922581 27 34 O
to NCT03922581 35 37 O
provide NCT03922581 38 45 O
informed NCT03922581 46 54 O
consent NCT03922581 55 62 O

- NCT03922581 65 66 O
willingness NCT03922581 68 79 O
to NCT03922581 80 82 O
participate NCT03922581 83 94 O
in NCT03922581 95 97 O
study NCT03922581 98 103 O

- NCT03922581 106 107 O
self NCT03922581 109 113 O
- NCT03922581 114 115 O
identity NCT03922581 116 124 O
as NCT03922581 125 127 O
African NCT03922581 128 135 B-Ethnicity
American NCT03922581 136 144 I-Ethnicity

- NCT03922581 147 148 O
history NCT03922581 150 157 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03922581 158 160 O
childhood NCT03922581 161 170 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
and NCT03922581 171 174 O
/ NCT03922581 175 176 O
or NCT03922581 177 179 O
adult NCT03922581 180 185 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
trauma NCT03922581 186 192 B-Condition-Name
exposure NCT03922581 193 201 I-Condition-Name
( NCT03922581 202 203 O
3 NCT03922581 205 206 B-Eq-Value
total NCT03922581 207 212 O
criterion NCT03922581 213 222 B-Eq-Unit
A NCT03922581 223 224 I-Eq-Unit
traumas NCT03922581 225 232 I-Eq-Unit
) NCT03922581 233 234 O

- NCT03922581 238 239 O
positive NCT03922581 241 249 B-Polarity___Polarity-Value:positive
PTSD NCT03922581 250 254 B-Condition-Name
screen NCT03922581 255 261 O
( NCT03922581 262 263 O
PC NCT03922581 264 266 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03922581 267 268 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
PTSD NCT03922581 269 273 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
≥ NCT03922581 274 275 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03922581 277 278 B-Eq-Value
) NCT03922581 279 280 O

- NCT03922581 284 285 O
positive NCT03922581 287 295 B-Polarity___Polarity-Value:positive
MDD NCT03922581 296 299 B-Condition-Name
screen NCT03922581 300 306 O
( NCT03922581 307 308 O
PHQ NCT03922581 309 312 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03922581 313 314 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
9 NCT03922581 316 317 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
≥ NCT03922581 318 319 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03922581 321 322 B-Eq-Value
) NCT03922581 323 324 O

Exclusion NCT03922581 326 335 O
Criteria NCT03922581 336 344 O
: NCT03922581 345 346 O

- NCT03922581 350 351 O
presence NCT03922581 353 361 O
of NCT03922581 362 364 O
intellectual NCT03922581 365 377 B-Condition-Name
disability NCT03922581 378 388 I-Condition-Name
, NCT03922581 389 390 O
bipolar NCT03922581 391 398 B-Condition-Name
, NCT03922581 399 400 O
or NCT03922581 401 403 O
psychotic NCT03922581 404 413 B-Condition-Name
disorder NCT03922581 414 422 I-Condition-Name

- NCT03922581 425 426 O
presence NCT03922581 428 436 O
of NCT03922581 437 439 O
current NCT03922581 440 447 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03922581 448 457 B-Condition-Name
use NCT03922581 458 461 I-Condition-Name
disorder NCT03922581 462 470 I-Condition-Name
( NCT03922581 471 472 O
past NCT03922581 473 477 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
1 NCT03922581 479 480 B-Eq-Value
month NCT03922581 481 486 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03922581 486 487 O
see NCT03922581 488 491 O
cut NCT03922581 492 495 O
off NCT03922581 496 499 O
scores NCT03922581 500 506 O
in NCT03922581 507 509 O
psychological NCT03922581 510 523 O
measures NCT03922581 524 532 O
below NCT03922581 533 538 O
) NCT03922581 539 540 O

- NCT03922581 544 545 O
active NCT03922581 547 553 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
suicidality NCT03922581 554 565 B-Condition-Name

Inclusion NCT03920553 0 9 O
Criteria NCT03920553 10 18 O
: NCT03920553 19 20 O

- NCT03920553 24 25 O
No NCT03920553 27 29 O
systemic NCT03920553 30 38 O
disease NCT03920553 39 46 B-Condition-Name
, NCT03920553 47 48 O

- NCT03920553 52 53 O
the NCT03920553 55 58 O
presence NCT03920553 59 67 O
of NCT03920553 68 70 O
high NCT03920553 71 75 B-Condition-Name
labial NCT03920553 76 82 I-Condition-Name
frenulum NCT03920553 83 91 I-Condition-Name
attachment NCT03920553 92 102 I-Condition-Name
diagnosed NCT03920553 103 112 O
according NCT03920553 113 122 O
to NCT03920553 123 125 O
Mirko NCT03920553 126 131 O
et NCT03920553 132 134 O
al NCT03920553 135 137 O
. NCT03920553 138 139 O
, NCT03920553 140 141 O
- NCT03920553 142 143 O
periodontally NCT03920553 144 157 B-Observation-Name
healthy NCT03920553 158 165 I-Observation-Name
or NCT03920553 166 168 O
a NCT03920553 169 170 O
requirement NCT03920553 171 182 O
for NCT03920553 183 186 O
periodontal NCT03920553 187 198 B-Procedure-Name
treatment NCT03920553 199 208 I-Procedure-Name
that NCT03920553 209 213 O
would NCT03920553 214 219 O
only NCT03920553 220 224 O
require NCT03920553 225 232 O
removing NCT03920553 233 241 B-Procedure-Name
of NCT03920553 242 244 I-Procedure-Name
dental NCT03920553 245 251 I-Procedure-Name
plaque NCT03920553 252 258 I-Procedure-Name
, NCT03920553 259 260 O

- NCT03920553 264 265 O
full NCT03920553 267 271 B-Observation-Name___Observation-Type-Value:clinical-score
mouth NCT03920553 272 277 I-Observation-Name___Observation-Type-Value:clinical-score
plaque NCT03920553 278 284 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03920553 285 290 I-Observation-Name___Observation-Type-Value:clinical-score
< NCT03920553 291 292 B-Eq-Operator___Eq-Operator-Value:LT
15 NCT03920553 294 296 B-Eq-Value
% NCT03920553 297 298 B-Eq-Unit
, NCT03920553 300 301 O
probing NCT03920553 302 309 B-Observation-Name___Observation-Type-Value:measurement
pocket NCT03920553 310 316 I-Observation-Name___Observation-Type-Value:measurement
depth NCT03920553 317 322 I-Observation-Name___Observation-Type-Value:measurement
< NCT03920553 323 324 O
3 NCT03920553 326 327 B-Eq-Value
mm NCT03920553 328 330 B-Eq-Unit
in NCT03920553 331 333 O
all NCT03920553 334 337 O
teeth NCT03920553 338 343 O

- NCT03920553 346 347 O
no NCT03920553 349 351 O
history NCT03920553 352 359 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920553 360 362 O
periodontal NCT03920553 363 374 B-Procedure-Name
surgery NCT03920553 375 382 I-Procedure-Name
. NCT03920553 383 384 O

Exclusion NCT03920553 386 395 O
Criteria NCT03920553 396 404 O
: NCT03920553 405 406 O

- NCT03920553 410 411 O
not NCT03920553 413 416 O
meet NCT03920553 417 421 O
the NCT03920553 422 425 O
optimal NCT03920553 426 433 O
level NCT03920553 434 439 O
of NCT03920553 440 442 O
oral NCT03920553 443 447 B-Observation-Name
hygiene NCT03920553 448 455 I-Observation-Name
, NCT03920553 456 457 O

- NCT03920553 461 462 O
had NCT03920553 464 467 O
any NCT03920553 468 471 O
condition NCT03920553 472 481 O
that NCT03920553 482 486 O
could NCT03920553 487 492 O
affect NCT03920553 493 499 B-Stability___Stability-Value:change
wound NCT03920553 500 505 B-Condition-Name
healing NCT03920553 506 513 I-Condition-Name
, NCT03920553 514 515 O

- NCT03920553 519 520 O
were NCT03920553 522 526 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pregnant NCT03920553 527 535 B-Condition-Name
or NCT03920553 536 538 O
lactating NCT03920553 539 548 B-Condition-Name
, NCT03920553 549 550 O

- NCT03920553 554 555 O
were NCT03920553 557 561 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
cigarette NCT03920553 562 571 B-Condition-Name
smokers NCT03920553 572 579 I-Condition-Name
or NCT03920553 580 582 O
were NCT03920553 583 587 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
takiing NCT03920553 588 595 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
any NCT03920553 596 599 O
medication NCT03920553 600 610 O
that NCT03920553 611 615 O
might NCT03920553 616 621 O
affect NCT03920553 622 628 B-Stability
the NCT03920553 629 632 O
outcome NCT03920553 633 640 O
of NCT03920553 641 643 O
the NCT03920553 644 647 O
study NCT03920553 648 653 O
, NCT03920553 654 655 O

Inclusion NCT03926650 0 9 O
Criteria NCT03926650 10 18 O
: NCT03926650 19 20 O

- NCT03926650 24 25 O
surgery NCT03926650 27 34 B-Procedure-Name
continues NCT03926650 35 44 O
more NCT03926650 45 49 B-Eq-Operator___Eq-Operator-Value:GT
then NCT03926650 50 54 I-Eq-Operator___Eq-Operator-Value:GT
1 NCT03926650 56 57 B-Eq-Value
hour NCT03926650 58 62 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

- NCT03926650 65 66 O
between NCT03926650 68 75 B-Eq-Operator___Eq-Operator-Value:BETWEEN
ages NCT03926650 76 80 O
18 NCT03926650 82 84 B-Eq-Value
- NCT03926650 85 86 O
65 NCT03926650 88 90 B-Eq-Value

- NCT03926650 94 95 O
ASA NCT03926650 97 100 B-Condition-Name
I NCT03926650 101 102 B-Eq-Value
, NCT03926650 103 104 O
II NCT03926650 105 107 B-Eq-Value
and NCT03926650 108 111 O
III NCT03926650 112 115 B-Eq-Value
patients NCT03926650 116 124 O

Exclusion NCT03926650 125 134 O
Criteria NCT03926650 135 143 O
: NCT03926650 144 145 O

- NCT03926650 149 150 O
The NCT03926650 152 155 O
patients NCT03926650 156 164 O
who NCT03926650 165 168 O
has NCT03926650 169 172 O
allergical NCT03926650 173 183 O
reactions NCT03926650 184 193 O
of NCT03926650 194 196 O
the NCT03926650 197 200 O
drugs NCT03926650 201 206 O
used NCT03926650 207 211 O

- NCT03926650 214 215 O
neurological NCT03926650 217 229 O
or NCT03926650 230 232 O
neuromuscular NCT03926650 233 246 O
diseases NCT03926650 247 255 B-Condition-Name

- NCT03926650 258 259 O
the NCT03926650 261 264 O
patients NCT03926650 265 273 O
who NCT03926650 274 277 O
use NCT03926650 278 281 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
drugs NCT03926650 282 287 O
effecting NCT03926650 288 297 B-Stability___Stability-Value:change
the NCT03926650 298 301 O
neuromuscular NCT03926650 302 315 B-Condition-Name
junction NCT03926650 316 324 I-Condition-Name

- NCT03926650 327 328 O
pregnant NCT03926650 330 338 B-Condition-Name
patients NCT03926650 339 347 O

- NCT03926650 350 351 O
electrolyte NCT03926650 353 364 B-Condition-Name
disregulations NCT03926650 365 379 I-Condition-Name

- NCT03926650 382 383 O
major NCT03926650 385 390 B-Severity___Severity-Value:severe
organ NCT03926650 391 396 B-Condition-Name
failures NCT03926650 397 405 I-Condition-Name
, NCT03926650 406 407 O
liver NCT03926650 408 413 B-Condition-Name
failure NCT03926650 414 421 I-Condition-Name
, NCT03926650 422 423 O
kidney NCT03926650 424 430 B-Condition-Name
failure NCT03926650 431 438 I-Condition-Name

- NCT03926650 441 442 O
obese NCT03926650 444 449 B-Condition-Name
and NCT03926650 450 453 O
cachectic NCT03926650 454 463 B-Condition-Name
patients NCT03926650 464 472 O

Inclusion NCT03928899 0 9 O
Criteria NCT03928899 10 18 O
: NCT03928899 19 20 O

- NCT03928899 24 25 O
singleton NCT03928899 27 36 B-Condition-Name
pregnant NCT03928899 37 45 I-Condition-Name
women NCT03928899 46 51 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03928899 54 55 O
in NCT03928899 57 59 O
vertex NCT03928899 60 66 B-Condition-Name
presentation NCT03928899 67 79 I-Condition-Name

- NCT03928899 82 83 O
GDM NCT03928899 85 88 B-Condition-Name
that NCT03928899 89 93 O
is NCT03928899 94 96 O
controlled NCT03928899 97 107 O
with NCT03928899 108 112 O
only NCT03928899 113 117 O
diet NCT03928899 118 122 O
and NCT03928899 123 126 O
exercise NCT03928899 127 135 O

- NCT03928899 138 139 O
at NCT03928899 141 143 O
37 NCT03928899 145 147 B-Eq-Value
weeks NCT03928899 148 153 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
0 NCT03928899 155 156 B-Eq-Value
days NCT03928899 157 161 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
to NCT03928899 162 164 O
37 NCT03928899 166 168 B-Eq-Value
weeks NCT03928899 169 174 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
6 NCT03928899 176 177 B-Eq-Value
days NCT03928899 178 182 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03928899 183 185 O
gestation NCT03928899 186 195 B-Observation-Name

- NCT03928899 198 199 O
more NCT03928899 201 205 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03928899 206 210 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03928899 212 214 B-Eq-Value
years NCT03928899 215 220 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03928899 221 224 O

- NCT03928899 227 228 O
have NCT03928899 230 234 O
no NCT03928899 235 237 O
other NCT03928899 238 243 O
contraindications NCT03928899 244 261 O
to NCT03928899 262 264 O
vaginal NCT03928899 265 272 B-Procedure-Name
delivery NCT03928899 273 281 I-Procedure-Name
. NCT03928899 282 283 O

Exclusion NCT03928899 285 294 O
Criteria NCT03928899 295 303 O
: NCT03928899 304 305 O

- NCT03928899 309 310 O
prior NCT03928899 312 317 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
caesarean NCT03928899 318 327 B-Procedure-Name
section NCT03928899 328 335 I-Procedure-Name
or NCT03928899 336 338 O
myomectomy NCT03928899 339 349 B-Procedure-Name

- NCT03928899 352 353 O
any NCT03928899 355 358 O
known NCT03928899 359 364 O
contraindications NCT03928899 365 382 O
to NCT03928899 383 385 O
vaginal NCT03928899 386 393 B-Procedure-Name
delivery NCT03928899 394 402 I-Procedure-Name

- NCT03928899 405 406 O
uncertain NCT03928899 408 417 O
gestational NCT03928899 418 429 B-Observation-Name
age NCT03928899 430 433 I-Observation-Name

- NCT03928899 436 437 O
non NCT03928899 439 442 B-Condition-Name
reassuring NCT03928899 443 453 I-Condition-Name
foetal NCT03928899 454 460 I-Condition-Name
wellbeing NCT03928899 461 470 I-Condition-Name
necessitating NCT03928899 471 484 O
delivery NCT03928899 485 493 B-Procedure-Name

- NCT03928899 496 497 O
maternal NCT03928899 499 507 O
pregnancy NCT03928899 508 517 B-Condition-Name
- NCT03928899 518 519 I-Condition-Name
related NCT03928899 520 527 I-Condition-Name
disease NCT03928899 528 535 I-Condition-Name
necessitating NCT03928899 536 549 O
delivery NCT03928899 550 558 B-Procedure-Name
( NCT03928899 559 560 O
any NCT03928899 561 564 O
hypertensive NCT03928899 565 577 B-Condition-Name
disorder NCT03928899 578 586 I-Condition-Name
, NCT03928899 587 588 O
cardiac NCT03928899 589 596 B-Condition-Name
disease NCT03928899 597 604 I-Condition-Name
, NCT03928899 605 606 O
renal NCT03928899 607 612 B-Condition-Name
insufficiency NCT03928899 613 626 I-Condition-Name
、 NCT03928899 627 628 O
immune NCT03928899 629 635 B-Condition-Name
diseases NCT03928899 636 644 I-Condition-Name
, NCT03928899 645 646 O
et NCT03928899 647 649 O
al NCT03928899 650 652 O
. NCT03928899 653 654 O
) NCT03928899 655 656 O

- NCT03928899 660 661 O
placenta NCT03928899 663 671 B-Condition-Name
previa NCT03928899 672 678 O
, NCT03928899 679 680 O
accreta NCT03928899 681 688 O
, NCT03928899 689 690 O
vasa NCT03928899 691 695 O
previa NCT03928899 696 702 O

- NCT03928899 705 706 O
known NCT03928899 708 713 O
foetal NCT03928899 714 720 B-Condition-Name
anomaly NCT03928899 721 728 I-Condition-Name

- NCT03928899 731 732 O
negative NCT03928899 734 742 O
reproductive NCT03928899 743 755 B-Condition-Name
history NCT03928899 756 763 I-Condition-Name

- NCT03928899 766 767 O
ruptured NCT03928899 769 777 B-Condition-Name
membranes NCT03928899 778 787 I-Condition-Name
or NCT03928899 788 790 O
known NCT03928899 791 796 O
oligohydramnios NCT03928899 797 812 B-Condition-Name
( NCT03928899 813 814 O
defined NCT03928899 815 822 O
as NCT03928899 823 825 O
AFI NCT03928899 826 829 B-Observation-Name
< NCT03928899 830 831 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03928899 833 834 B-Eq-Value
or NCT03928899 835 837 O
MVP NCT03928899 838 841 B-Observation-Name
< NCT03928899 842 843 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03928899 845 846 B-Eq-Value
) NCT03928899 847 848 O
before NCT03928899 849 855 O

37 NCT03928899 862 864 B-Eq-Value
weeks NCT03928899 865 870 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
6 NCT03928899 872 873 B-Eq-Value
days NCT03928899 874 878 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03928899 879 881 O
gestation NCT03928899 882 891 B-Observation-Name

- NCT03928899 894 895 O
fetal NCT03928899 897 902 B-Condition-Name
growth NCT03928899 903 909 I-Condition-Name
restriction NCT03928899 910 921 I-Condition-Name
, NCT03928899 922 923 O
defined NCT03928899 924 931 O
as NCT03928899 932 934 O
EFW NCT03928899 935 938 B-Observation-Name
< NCT03928899 939 940 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03928899 942 944 B-Eq-Value
th NCT03928899 945 947 O
percentile NCT03928899 948 958 B-Eq-Unit

- NCT03928899 961 962 O
known NCT03928899 964 969 O
HIV NCT03928899 970 973 B-Condition-Name
positivity NCT03928899 974 984 B-Polarity___Polarity-Value:positive
because NCT03928899 985 992 O
of NCT03928899 993 995 O
modified NCT03928899 996 1004 O
delivery NCT03928899 1005 1013 O
plan NCT03928899 1014 1018 O

- NCT03928899 1021 1022 O
signs NCT03928899 1024 1029 O
of NCT03928899 1030 1032 O
labor NCT03928899 1033 1038 B-Condition-Name
( NCT03928899 1039 1040 O
regular NCT03928899 1041 1048 B-Condition-Name
painful NCT03928899 1049 1056 I-Condition-Name
contractions NCT03928899 1057 1069 I-Condition-Name
with NCT03928899 1070 1074 O
cervical NCT03928899 1075 1083 B-Condition-Name
change NCT03928899 1084 1090 I-Condition-Name
) NCT03928899 1091 1092 O
before NCT03928899 1093 1099 O
37 NCT03928899 1101 1103 B-Eq-Value
weeks NCT03928899 1104 1109 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
6 NCT03928899 1111 1112 B-Eq-Value
days NCT03928899 1113 1117 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03928899 1118 1120 O
gestation NCT03928899 1121 1130 B-Observation-Name
. NCT03928899 1131 1132 O

Inclusion NCT03923933 0 9 O
Criteria NCT03923933 10 18 O
: NCT03923933 19 20 O

- NCT03923933 24 25 O
glomerular NCT03923933 27 37 B-Observation-Name___Observation-Type-Value:lab
filtration NCT03923933 38 48 I-Observation-Name___Observation-Type-Value:lab
rate NCT03923933 49 53 I-Observation-Name___Observation-Type-Value:lab
less NCT03923933 54 58 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03923933 59 63 I-Eq-Operator___Eq-Operator-Value:LT
30 NCT03923933 65 67 B-Eq-Value
ml NCT03923933 68 70 B-Eq-Unit
/ NCT03923933 71 72 O
min NCT03923933 73 76 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
/ NCT03923933 77 78 O
1.73 NCT03923933 80 84 B-Eq-Unit
m NCT03923933 85 86 I-Eq-Unit

- NCT03923933 89 90 O
Without NCT03923933 92 99 O
replacement NCT03923933 100 111 B-Procedure-Name
therapy NCT03923933 112 119 I-Procedure-Name
( NCT03923933 120 121 O
dialysis NCT03923933 122 130 B-Procedure-Name
or NCT03923933 131 133 O
hemodialysis NCT03923933 134 146 B-Procedure-Name
) NCT03923933 147 148 O

- NCT03923933 152 153 O
Volume NCT03923933 155 161 B-Condition-Name
overload NCT03923933 162 170 I-Condition-Name

- NCT03923933 173 174 O
At NCT03923933 176 178 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03923933 179 184 I-Eq-Operator___Eq-Operator-Value:GTEQ
100 NCT03923933 186 189 B-Eq-Value
ml NCT03923933 190 192 B-Eq-Unit
per NCT03923933 193 196 O
day NCT03923933 197 200 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03923933 201 203 O
residual NCT03923933 204 212 B-Observation-Name___Observation-Type-Value:measurement
diuresis NCT03923933 213 221 I-Observation-Name___Observation-Type-Value:measurement

- NCT03923933 224 225 O
Use NCT03923933 227 230 O
of NCT03923933 231 233 O
a NCT03923933 234 235 O
loop NCT03923933 236 240 B-Drug-Name
diuretic NCT03923933 241 249 I-Drug-Name
for NCT03923933 250 253 O
at NCT03923933 254 256 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03923933 257 262 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03923933 263 266 B-Eq-Value
month NCT03923933 267 272 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Exclusion NCT03923933 273 282 O
Criteria NCT03923933 283 291 O
: NCT03923933 292 293 O

- NCT03923933 297 298 O
Allergies NCT03923933 300 309 O
known NCT03923933 310 315 O
to NCT03923933 316 318 O
diuretics NCT03923933 319 328 B-Drug-Name

- NCT03923933 331 332 O
Patients NCT03923933 334 342 O
with NCT03923933 343 347 O
severe NCT03923933 348 354 B-Severity___Severity-Value:severe
infections NCT03923933 355 365 B-Condition-Name

- NCT03923933 368 369 O
Patients NCT03923933 371 379 O
with NCT03923933 380 384 O
hemodynamic NCT03923933 385 396 B-Condition-Name
instability NCT03923933 397 408 I-Condition-Name

- NCT03923933 411 412 O
Amputees NCT03923933 414 422 B-Condition-Name

- NCT03923933 425 426 O
Patients NCT03923933 428 436 O
with NCT03923933 437 441 O
cognitive NCT03923933 442 451 B-Condition-Name
impairment NCT03923933 452 462 I-Condition-Name

- NCT03923933 465 466 O
Patients NCT03923933 468 476 O
with NCT03923933 477 481 O
acute NCT03923933 482 487 B-Severity___Severity-Value:severe
renal NCT03923933 488 493 B-Condition-Name
failure NCT03923933 494 501 I-Condition-Name

- NCT03923933 504 505 O
Patients NCT03923933 507 515 O
with NCT03923933 516 520 O
graft NCT03923933 521 526 B-Condition-Name
loss NCT03923933 527 531 I-Condition-Name

Inclusion NCT03922620 0 9 O
Criteria NCT03922620 10 18 O
: NCT03922620 19 20 O

1 NCT03922620 25 26 O
. NCT03922620 26 27 O
Patients NCT03922620 29 37 O
18 NCT03922620 39 41 B-Eq-Value
years NCT03922620 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03922620 48 50 O
age NCT03922620 51 54 O
or NCT03922620 55 57 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03922620 58 63 I-Eq-Operator___Eq-Operator-Value:GTEQ

2 NCT03922620 67 68 O
. NCT03922620 68 69 O
Patients NCT03922620 71 79 O
undergoing NCT03922620 80 90 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03922620 91 99 O
primary NCT03922620 100 107 O
ankle NCT03922620 108 113 O
or NCT03922620 114 116 O
hindfoot NCT03922620 117 125 O
surgery NCT03922620 126 133 B-Procedure-Name
( NCT03922620 134 135 O
ankle NCT03922620 136 141 B-Procedure-Name
arthrodesis NCT03922620 142 153 I-Procedure-Name
, NCT03922620 154 155 O
subtalar NCT03922620 156 164 B-Procedure-Name
arthrodesis NCT03922620 165 176 I-Procedure-Name
, NCT03922620 177 178 O
triple NCT03922620 179 185 B-Procedure-Name
arthrodesis NCT03922620 186 197 I-Procedure-Name
, NCT03922620 198 199 O
total NCT03922620 200 205 B-Procedure-Name
ankle NCT03922620 206 211 I-Procedure-Name
arthroplasty NCT03922620 212 224 I-Procedure-Name
, NCT03922620 225 226 O
peroneal NCT03922620 227 235 B-Procedure-Name
tendon NCT03922620 236 242 I-Procedure-Name
debridement NCT03922620 243 254 O
/ NCT03922620 255 256 O
transfer NCT03922620 257 265 O
, NCT03922620 266 267 O
Cavus NCT03922620 268 273 B-Procedure-Name
Reconstruction NCT03922620 274 288 I-Procedure-Name
, NCT03922620 289 290 O
Medial NCT03922620 291 297 B-Procedure-Name
Displacement NCT03922620 298 310 I-Procedure-Name
Calcaneal NCT03922620 311 320 I-Procedure-Name
Osteotomy NCT03922620 321 330 I-Procedure-Name
, NCT03922620 331 332 O
Dwyer NCT03922620 333 338 B-Procedure-Name
Osteotomy NCT03922620 339 348 I-Procedure-Name
) NCT03922620 349 350 O

Exclusion NCT03922620 352 361 O
Criteria NCT03922620 362 370 O
: NCT03922620 371 372 O

1 NCT03922620 377 378 O
. NCT03922620 378 379 O
Patients NCT03922620 381 389 O
who NCT03922620 390 393 O
are NCT03922620 394 397 O
undergoing NCT03922620 398 408 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
revision NCT03922620 409 417 B-Procedure-Name
surgical NCT03922620 418 426 I-Procedure-Name
procedure NCT03922620 427 436 I-Procedure-Name

2 NCT03922620 440 441 O
. NCT03922620 441 442 O
Patients NCT03922620 444 452 O
who NCT03922620 453 456 O
have NCT03922620 457 461 O
taken NCT03922620 462 467 O
opioid NCT03922620 468 474 B-Drug-Name
pain NCT03922620 475 479 I-Drug-Name
medications NCT03922620 480 491 I-Drug-Name
in NCT03922620 492 494 O
the NCT03922620 495 498 O
past NCT03922620 499 503 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03922620 505 506 B-Eq-Value
months NCT03922620 507 513 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03922620 514 519 O
to NCT03922620 520 522 O
surgical NCT03922620 523 531 B-Procedure-Name
procedure NCT03922620 532 541 I-Procedure-Name

3 NCT03922620 545 546 O
. NCT03922620 546 547 O
Patients NCT03922620 549 557 O
who NCT03922620 558 561 O
have NCT03922620 562 566 O
allergies NCT03922620 567 576 O
to NCT03922620 577 579 O
any NCT03922620 580 583 O
of NCT03922620 584 586 O
the NCT03922620 587 590 O
medications NCT03922620 591 602 O
or NCT03922620 603 605 O
components NCT03922620 606 616 O
of NCT03922620 617 619 O
medications NCT03922620 620 631 O
investigated NCT03922620 632 644 O
in NCT03922620 645 647 O
the NCT03922620 648 651 O
study NCT03922620 652 657 O

4 NCT03922620 661 662 O
. NCT03922620 662 663 O
Patients NCT03922620 665 673 O
currently NCT03922620 674 683 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
incarcerated NCT03922620 684 696 B-Observation-Name

5 NCT03922620 700 701 O
. NCT03922620 701 702 O
Patients NCT03922620 704 712 O
who NCT03922620 713 716 O
can NCT03922620 717 720 O
not NCT03922620 720 723 O
read NCT03922620 724 728 O
and NCT03922620 729 732 O
speak NCT03922620 733 738 O
English NCT03922620 739 746 B-Language

Inclusion NCT03922152 0 9 O
Criteria NCT03922152 10 18 O
: NCT03922152 19 20 O

- NCT03922152 24 25 O
histologically NCT03922152 27 41 O
proven NCT03922152 42 48 O
advanced NCT03922152 49 57 B-Severity___Severity-Value:severe
esophageal NCT03922152 58 68 O
cancer NCT03922152 69 75 B-Condition-Name

- NCT03922152 78 79 O
excluded NCT03922152 81 89 O
from NCT03922152 90 94 O
curative NCT03922152 95 103 B-Procedure-Name
therapy NCT03922152 104 111 I-Procedure-Name
because NCT03922152 112 119 O
of NCT03922152 120 122 O
disease NCT03922152 123 130 O
stage NCT03922152 131 136 O
and NCT03922152 137 140 O
/ NCT03922152 141 142 O
or NCT03922152 143 145 O
presence NCT03922152 146 154 O
of NCT03922152 155 157 O
multiple NCT03922152 158 166 B-Eq-Operator___Eq-Operator-Value:GT
comorbidities NCT03922152 167 180 B-Condition-Name
and NCT03922152 181 184 O
/ NCT03922152 185 186 O
or NCT03922152 187 189 O
poor NCT03922152 190 194 B-Condition-Name
performance NCT03922152 195 206 I-Condition-Name
status NCT03922152 207 213 I-Condition-Name

- NCT03922152 216 217 O
age NCT03922152 219 222 O
> NCT03922152 223 224 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03922152 226 228 B-Eq-Value
years NCT03922152 229 234 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03922152 237 238 O
Eastern NCT03922152 240 247 B-Condition-Name
Cooperative NCT03922152 248 259 I-Condition-Name
Oncology NCT03922152 260 268 I-Condition-Name
Group NCT03922152 269 274 I-Condition-Name
( NCT03922152 275 276 O
ECOG NCT03922152 277 281 B-Condition-Name
) NCT03922152 282 283 O
< NCT03922152 284 285 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03922152 287 288 B-Eq-Value

Exclusion NCT03922152 290 299 O
Criteria NCT03922152 300 308 O
: NCT03922152 309 310 O

- NCT03922152 314 315 O
prior NCT03922152 317 322 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiotherapy NCT03922152 323 335 B-Procedure-Name
to NCT03922152 336 338 O
the NCT03922152 339 342 O
same NCT03922152 343 347 O
region NCT03922152 348 354 O

Inclusion NCT03929991 0 9 O
Criteria NCT03929991 10 18 O
: NCT03929991 19 20 O

- NCT03929991 24 25 O
All NCT03929991 27 30 O
pregnant NCT03929991 31 39 B-Condition-Name
women NCT03929991 40 45 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
undergoing NCT03929991 46 56 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03929991 57 58 O
C NCT03929991 59 60 B-Procedure-Name
/ NCT03929991 61 62 I-Procedure-Name
S NCT03929991 63 64 I-Procedure-Name
in NCT03929991 65 67 O
on NCT03929991 68 70 O
the NCT03929991 71 74 O
hospitals NCT03929991 75 84 B-Location___Location-Value:hospital
during NCT03929991 85 91 O
the NCT03929991 92 95 O
study NCT03929991 96 101 O
period NCT03929991 102 108 O
will NCT03929991 109 113 O
be NCT03929991 114 116 O
eligible NCT03929991 117 125 O
to NCT03929991 126 128 O
participate NCT03929991 129 140 O
in NCT03929991 141 143 O
this NCT03929991 144 148 O
study NCT03929991 149 154 O
. NCT03929991 155 156 O

Exclusion NCT03929991 158 167 O
Criteria NCT03929991 168 176 O
: NCT03929991 177 178 O

The NCT03929991 180 183 O
following NCT03929991 184 193 O
conditions NCT03929991 194 204 O
will NCT03929991 205 209 O
not NCT03929991 210 213 O
be NCT03929991 214 216 O
considered NCT03929991 217 227 O
as NCT03929991 228 230 O
outcome NCT03929991 231 238 O
, NCT03929991 239 240 O
unless NCT03929991 241 247 O
they NCT03929991 248 252 O
present NCT03929991 253 260 O
with NCT03929991 261 265 O

systemic NCT03929991 266 274 O
repercussion NCT03929991 275 287 B-Condition-Name
due NCT03929991 288 291 O
to NCT03929991 292 294 O
infection NCT03929991 295 304 B-Condition-Name
. NCT03929991 305 306 O
For NCT03929991 308 311 O
example NCT03929991 312 319 O
: NCT03929991 320 321 O

- NCT03929991 325 326 O
Vaginosis NCT03929991 328 337 B-Condition-Name
, NCT03929991 338 339 O
candidiasis NCT03929991 340 351 B-Condition-Name

- NCT03929991 354 355 O
Lower NCT03929991 357 362 O
tract NCT03929991 363 368 O
urinary NCT03929991 369 376 O
infection NCT03929991 377 386 B-Condition-Name

- NCT03929991 389 390 O
Fungal NCT03929991 392 398 O
infections NCT03929991 399 409 B-Condition-Name
of NCT03929991 410 412 O
the NCT03929991 413 416 O
skin NCT03929991 417 421 O
( NCT03929991 422 423 O
athlete NCT03929991 424 431 B-Condition-Name
's NCT03929991 431 433 I-Condition-Name
foot NCT03929991 434 438 I-Condition-Name
, NCT03929991 439 440 O
jockitch NCT03929991 441 449 B-Condition-Name
, NCT03929991 450 451 O
ringworm NCT03929991 452 460 B-Condition-Name
, NCT03929991 461 462 O
and NCT03929991 463 466 O
yeast NCT03929991 467 472 B-Condition-Name
infections NCT03929991 473 483 I-Condition-Name
) NCT03929991 484 485 O

- NCT03929991 489 490 O
Otitis NCT03929991 492 498 B-Condition-Name

- NCT03929991 501 502 O
Pharyngitis NCT03929991 504 515 B-Condition-Name

- NCT03929991 518 519 O
Herpes NCT03929991 521 527 B-Condition-Name
simplex NCT03929991 528 535 I-Condition-Name
, NCT03929991 536 537 O
Herpes NCT03929991 538 544 B-Condition-Name
Zoster NCT03929991 545 551 I-Condition-Name
( NCT03929991 552 553 O
Shingles NCT03929991 554 562 B-Condition-Name
) NCT03929991 563 564 O

- NCT03929991 568 569 O
Uncomplicated NCT03929991 571 584 O
chronic NCT03929991 585 592 B-Condition-Name
infection NCT03929991 593 602 I-Condition-Name

- NCT03929991 605 606 O
Sexually NCT03929991 608 616 B-Condition-Name
transmitted NCT03929991 617 628 I-Condition-Name
infections NCT03929991 629 639 I-Condition-Name
( NCT03929991 640 641 O
Gonorrhoea NCT03929991 642 652 B-Condition-Name
, NCT03929991 653 654 O
Syphilis NCT03929991 655 663 B-Condition-Name
, NCT03929991 664 665 O
Trichomonas NCT03929991 666 677 B-Condition-Name
, NCT03929991 678 679 O
Chlamydia NCT03929991 680 689 B-Condition-Name
, NCT03929991 690 691 O
Hepatitis NCT03929991 692 701 B-Condition-Name
, NCT03929991 702 703 O
HIV NCT03929991 704 707 B-Condition-Name
) NCT03929991 708 709 O

- NCT03929991 713 714 O
Tuberculosis NCT03929991 716 728 B-Condition-Name

- NCT03929991 731 732 O
Bacterial NCT03929991 734 743 B-Condition-Name
colonization NCT03929991 744 756 I-Condition-Name
( NCT03929991 757 758 O
presence NCT03929991 759 767 O
of NCT03929991 768 770 O
microorganisms NCT03929991 771 785 O
without NCT03929991 786 793 O
clinical NCT03929991 794 802 O
signs NCT03929991 803 808 O
/ NCT03929991 809 810 O
symptoms NCT03929991 811 819 O
) NCT03929991 820 821 O

- NCT03929991 825 826 O
Known NCT03929991 828 833 O
vaginal NCT03929991 834 841 O
, NCT03929991 842 843 O
urethral NCT03929991 844 852 O
and NCT03929991 853 856 O
/ NCT03929991 857 858 O
or NCT03929991 859 861 O
rectal NCT03929991 862 868 O
GBS NCT03929991 869 872 B-Condition-Name
colonization NCT03929991 873 885 I-Condition-Name

- NCT03929991 888 889 O
Asymptomatic NCT03929991 891 903 B-Condition-Name
bacteriuria NCT03929991 904 915 I-Condition-Name

- NCT03929991 918 919 O
Known NCT03929991 921 926 O
oropharyngeal NCT03929991 927 940 B-Condition-Name
colonization NCT03929991 941 953 I-Condition-Name

- NCT03929991 956 957 O
Non NCT03929991 959 962 O
- NCT03929991 963 964 O
infectious NCT03929991 965 975 O
hypothermia NCT03929991 976 987 B-Condition-Name
/ NCT03929991 988 989 O
hyperthermia NCT03929991 990 1002 B-Condition-Name
( NCT03929991 1003 1004 O
e NCT03929991 1005 1006 O
. NCT03929991 1007 1008 O
g NCT03929991 1009 1010 O
. NCT03929991 1011 1012 O
related NCT03929991 1014 1021 O
to NCT03929991 1022 1024 O
epidural NCT03929991 1025 1033 B-Procedure-Name
, NCT03929991 1034 1035 O
thyroid NCT03929991 1036 1043 B-Condition-Name
storm NCT03929991 1044 1049 I-Condition-Name
, NCT03929991 1050 1051 O
prostaglandin NCT03929991 1052 1065 B-Drug-Name
administration NCT03929991 1066 1080 O
) NCT03929991 1081 1082 O
during NCT03929991 1083 1089 O
hospital NCT03929991 1090 1098 B-Encounter-Type___Encounter-Type-Value:inpatient
stay NCT03929991 1099 1103 I-Encounter-Type___Encounter-Type-Value:inpatient

Inclusion NCT03928457 0 9 O
Criteria NCT03928457 10 18 O
: NCT03928457 19 20 O

- NCT03928457 24 25 O
preterm NCT03928457 27 34 B-Condition-Name
neonates NCT03928457 35 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
born NCT03928457 44 48 O
at NCT03928457 49 51 O
26 NCT03928457 53 55 B-Eq-Value
to NCT03928457 56 58 B-Eq-Operator___Eq-Operator-Value:BETWEEN
34 NCT03928457 60 62 B-Eq-Value
weeks NCT03928457 63 68 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03928457 69 71 O
gestational NCT03928457 72 83 B-Observation-Name
age NCT03928457 84 87 I-Observation-Name

- NCT03928457 90 91 O
signed NCT03928457 93 99 O
written NCT03928457 100 107 O
informed NCT03928457 108 116 O
consent NCT03928457 117 124 O
form NCT03928457 125 129 O

Exclusion NCT03928457 130 139 O
Criteria NCT03928457 140 148 O
: NCT03928457 149 150 O

- NCT03928457 154 155 O
infants NCT03928457 157 164 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
infected NCT03928457 165 173 B-Condition-Name

- NCT03928457 176 177 O
infants NCT03928457 179 186 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
suffering NCT03928457 187 196 O
from NCT03928457 197 201 O
neurological NCT03928457 202 214 B-Condition-Name
disorders NCT03928457 215 224 I-Condition-Name

- NCT03928457 227 228 O
serious NCT03928457 230 237 B-Severity___Severity-Value:severe
heart NCT03928457 238 243 O
, NCT03928457 244 245 O
respiratory NCT03928457 246 257 O
, NCT03928457 258 259 O
digestive NCT03928457 260 269 O
or NCT03928457 270 272 O
metabolic NCT03928457 273 282 O
diseases NCT03928457 283 291 B-Condition-Name

- NCT03928457 294 295 O
infants NCT03928457 297 304 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
born NCT03928457 305 309 O
from NCT03928457 310 314 O
mothers NCT03928457 315 322 O
aged NCT03928457 323 327 O
less NCT03928457 328 332 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03928457 333 337 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03928457 339 341 B-Eq-Value
years NCT03928457 342 347 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03928457 348 351 O
or NCT03928457 352 354 O
deprived NCT03928457 355 363 B-Observation-Name
of NCT03928457 364 366 I-Observation-Name
their NCT03928457 367 372 I-Observation-Name
parental NCT03928457 373 381 I-Observation-Name
rights NCT03928457 382 388 I-Observation-Name

- NCT03928457 391 392 O
non NCT03928457 394 397 O
covered NCT03928457 398 405 O
by NCT03928457 406 408 O
national NCT03928457 409 417 O
health NCT03928457 418 424 O
insurance NCT03928457 425 434 B-Insurance

Inclusion NCT03922191 0 9 O
Criteria NCT03922191 10 18 O
: NCT03922191 19 20 O

- NCT03922191 24 25 O
post NCT03922191 27 31 O
- NCT03922191 32 33 O
cardiac NCT03922191 34 41 B-Procedure-Name
surgery NCT03922191 42 49 I-Procedure-Name
mediastinitis NCT03922191 50 63 B-Condition-Name

- NCT03922191 66 67 O
patients NCT03922191 69 77 O
of NCT03922191 78 80 O
the NCT03922191 81 84 O
CHU NCT03922191 85 88 B-Location___Location-Value:hospital
Brugmann NCT03922191 89 97 I-Location___Location-Value:hospital
( NCT03922191 98 99 O
adults NCT03922191 100 106 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
) NCT03922191 107 108 O
and NCT03922191 109 112 O
HUDERF NCT03922191 113 119 B-Location___Location-Value:hospital
( NCT03922191 120 121 O
pediatric NCT03922191 122 131 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
) NCT03922191 132 133 O
Hospitals NCT03922191 134 143 O

Exclusion NCT03922191 144 153 O
Criteria NCT03922191 154 162 O
: NCT03922191 163 164 O

- NCT03922191 167 168 O
none NCT03922191 169 173 O

Inclusion NCT03929952 0 9 O
Criteria NCT03929952 10 18 O
: NCT03929952 19 20 O

- NCT03929952 24 25 O
Patient NCT03929952 27 34 O
with NCT03929952 35 39 O
a NCT03929952 40 41 O
wifi NCT03929952 42 46 O
connexion NCT03929952 47 56 O
at NCT03929952 57 59 O
home NCT03929952 60 64 O

- NCT03929952 67 68 O
Patient NCT03929952 70 77 O
with NCT03929952 78 82 O
the NCT03929952 83 86 O
ability NCT03929952 87 94 O
to NCT03929952 95 97 O
modulate NCT03929952 98 106 B-Observation-Name
the NCT03929952 107 110 I-Observation-Name
height NCT03929952 111 117 I-Observation-Name
of NCT03929952 118 120 I-Observation-Name
the NCT03929952 121 124 I-Observation-Name
candle NCT03929952 125 131 I-Observation-Name
by NCT03929952 132 134 O
thinking NCT03929952 135 143 O
in NCT03929952 144 146 O
the NCT03929952 147 150 O
alpha NCT03929952 151 156 B-Observation-Name
synchrony NCT03929952 157 166 I-Observation-Name
test NCT03929952 167 171 I-Observation-Name
. NCT03929952 172 173 O

- NCT03929952 177 178 O
Patient NCT03929952 180 187 O
with NCT03929952 188 192 O
chronic NCT03929952 193 200 B-Condition-Name
low NCT03929952 201 204 I-Condition-Name
back NCT03929952 205 209 I-Condition-Name
pain NCT03929952 210 214 I-Condition-Name
for NCT03929952 215 218 O
more NCT03929952 219 223 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929952 224 228 I-Eq-Operator___Eq-Operator-Value:GT
six NCT03929952 229 232 B-Eq-Value
months NCT03929952 233 239 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
with NCT03929952 240 244 O
a NCT03929952 245 246 O
visual NCT03929952 247 253 B-Observation-Name___Observation-Type-Value:measurement
analogue NCT03929952 254 262 I-Observation-Name___Observation-Type-Value:measurement
pain NCT03929952 263 267 I-Observation-Name___Observation-Type-Value:measurement
scale NCT03929952 268 273 I-Observation-Name___Observation-Type-Value:measurement
greater NCT03929952 274 281 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929952 282 286 I-Eq-Operator___Eq-Operator-Value:GT
5 NCT03929952 288 289 B-Eq-Value
impacting NCT03929952 290 299 O
activities NCT03929952 300 310 O
of NCT03929952 311 313 O
daily NCT03929952 314 319 O
living NCT03929952 320 326 O
, NCT03929952 327 328 O
hobbies NCT03929952 329 336 O
and NCT03929952 337 340 O
work NCT03929952 341 345 O

- NCT03929952 348 349 O
Patient NCT03929952 351 358 O
having NCT03929952 359 365 O
given NCT03929952 366 371 O
free NCT03929952 372 376 O
and NCT03929952 377 380 O
informed NCT03929952 381 389 O
consent NCT03929952 390 397 O
and NCT03929952 398 401 O
signed NCT03929952 402 408 O
consent NCT03929952 409 416 O
. NCT03929952 417 418 O

- NCT03929952 422 423 O
Affected NCT03929952 425 433 O
patient NCT03929952 434 441 O
or NCT03929952 442 444 O
beneficiary NCT03929952 445 456 O
of NCT03929952 457 459 O
a NCT03929952 460 461 O
health NCT03929952 462 468 O
insurance NCT03929952 469 478 O
plan NCT03929952 479 483 O
. NCT03929952 484 485 O

- NCT03929952 489 490 O
Patient NCT03929952 492 499 O
who NCT03929952 500 503 O
is NCT03929952 504 506 O
at NCT03929952 507 509 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929952 510 515 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03929952 517 519 B-Eq-Value
years NCT03929952 520 525 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03929952 526 529 O
( NCT03929952 530 531 O
≥ NCT03929952 533 534 O
) NCT03929952 536 537 O
and NCT03929952 538 541 O
younger NCT03929952 542 549 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03929952 550 554 I-Eq-Operator___Eq-Operator-Value:LT
75 NCT03929952 556 558 B-Eq-Value
years NCT03929952 559 564 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03929952 565 568 O
( NCT03929952 569 570 O
< NCT03929952 572 573 O
) NCT03929952 575 576 O
. NCT03929952 578 579 O

Exclusion NCT03929952 581 590 O
Criteria NCT03929952 591 599 O
: NCT03929952 600 601 O

- NCT03929952 605 606 O
Pregnant NCT03929952 608 616 B-Condition-Name
or NCT03929952 617 619 O
breastfeeding NCT03929952 620 633 B-Condition-Name
patient NCT03929952 634 641 O

- NCT03929952 644 645 O
Patient NCT03929952 647 654 O
with NCT03929952 655 659 O
a NCT03929952 660 661 O
contraindication NCT03929952 662 678 O
to NCT03929952 679 681 O
performing NCT03929952 682 692 O
a NCT03929952 693 694 O
fMRI NCT03929952 695 699 B-Procedure-Name
scan NCT03929952 700 704 I-Procedure-Name
: NCT03929952 705 706 O
ferromagnetic NCT03929952 707 720 B-Procedure-Name
implant NCT03929952 721 728 I-Procedure-Name
in NCT03929952 729 731 O
the NCT03929952 732 735 O
body NCT03929952 736 740 O
, NCT03929952 741 742 O
piercing NCT03929952 743 751 B-Condition-Name
, NCT03929952 752 753 O
claustrophobia NCT03929952 754 768 B-Condition-Name
, NCT03929952 769 770 O
unable NCT03929952 771 777 B-Condition-Name
to NCT03929952 778 780 I-Condition-Name
remain NCT03929952 781 787 I-Condition-Name
in NCT03929952 788 790 I-Condition-Name
the NCT03929952 791 794 I-Condition-Name
scanner NCT03929952 795 802 I-Condition-Name
stationary NCT03929952 803 813 I-Condition-Name
for NCT03929952 814 817 O
40 NCT03929952 819 821 B-Eq-Value
minutes NCT03929952 822 829 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

- NCT03929952 832 833 O
Patient NCT03929952 835 842 O
already NCT03929952 843 850 O
included NCT03929952 851 859 O
in NCT03929952 860 862 O
another NCT03929952 863 870 O
study NCT03929952 871 876 O

- NCT03929952 879 880 O
Patient NCT03929952 882 889 O
in NCT03929952 890 892 O
a NCT03929952 893 894 O
exclusion NCT03929952 895 904 O
period NCT03929952 905 911 O
determined NCT03929952 912 922 O
by NCT03929952 923 925 O
a NCT03929952 926 927 O
previous NCT03929952 928 936 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
study NCT03929952 937 942 O

- NCT03929952 945 946 O
The NCT03929952 948 951 O
subject NCT03929952 952 959 O
is NCT03929952 960 962 O
under NCT03929952 963 968 O
the NCT03929952 969 972 O
protection NCT03929952 973 983 B-Observation-Name
of NCT03929952 984 986 I-Observation-Name
justice NCT03929952 987 994 I-Observation-Name
, NCT03929952 995 996 O
guardianship NCT03929952 997 1009 O
or NCT03929952 1010 1012 O
curatorship NCT03929952 1013 1024 O
. NCT03929952 1025 1026 O

- NCT03929952 1030 1031 O
The NCT03929952 1033 1036 O
subject NCT03929952 1037 1044 O
refuses NCT03929952 1045 1052 O
to NCT03929952 1053 1055 O
sign NCT03929952 1056 1060 O
the NCT03929952 1061 1064 O
consent NCT03929952 1065 1072 O
. NCT03929952 1073 1074 O

- NCT03929952 1078 1079 O
It NCT03929952 1081 1083 O
is NCT03929952 1084 1086 O
not NCT03929952 1087 1090 O
possible NCT03929952 1091 1099 O
to NCT03929952 1100 1102 O
give NCT03929952 1103 1107 O
the NCT03929952 1108 1111 O
subject NCT03929952 1112 1119 O
informed NCT03929952 1120 1128 O
information NCT03929952 1129 1140 O
. NCT03929952 1141 1142 O

Inclusion NCT03920787 0 9 O
Criteria NCT03920787 10 18 O
: NCT03920787 19 20 O

- NCT03920787 24 25 O
8 NCT03920787 28 29 B-Eq-Value
- NCT03920787 30 31 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03920787 33 35 B-Eq-Value
years NCT03920787 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03920787 42 45 O

- NCT03920787 48 49 O
overweight NCT03920787 51 61 B-Condition-Name
or NCT03920787 62 64 O
obesity NCT03920787 65 72 B-Condition-Name

- NCT03920787 75 76 O
basal NCT03920787 78 83 B-Drug-Name
insulin NCT03920787 84 91 I-Drug-Name
≥ NCT03920787 92 93 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03920787 95 97 B-Eq-Value
uU NCT03920787 98 100 B-Eq-Unit
/ NCT03920787 101 102 O
ml NCT03920787 103 105 B-Eq-Unit

Exclusion NCT03920787 106 115 O
Criteria NCT03920787 116 124 O
: NCT03920787 125 126 O

- NCT03920787 130 131 O
pubertal NCT03920787 133 141 B-Condition-Name
delay NCT03920787 142 147 I-Condition-Name

- NCT03920787 150 151 O
hypogonadism NCT03920787 153 165 B-Condition-Name

- NCT03920787 168 169 O
hypothyroidism NCT03920787 171 185 B-Condition-Name
or NCT03920787 186 188 O
hyperthyroidism NCT03920787 189 204 B-Condition-Name

- NCT03920787 207 208 O
obesity NCT03920787 210 217 B-Condition-Name
- NCT03920787 218 219 O
related NCT03920787 220 227 O
genetic NCT03920787 228 235 B-Condition-Name
diseases NCT03920787 236 244 I-Condition-Name

Inclusion NCT03923517 0 9 O
Criteria NCT03923517 10 18 O
: NCT03923517 19 20 O

- NCT03923517 24 25 O
informal NCT03923517 27 35 O
carer NCT03923517 36 41 O
of NCT03923517 42 44 O
a NCT03923517 45 46 O
person NCT03923517 47 53 O
with NCT03923517 54 58 O
YOD NCT03923517 59 62 B-Condition-Name
who NCT03923517 63 66 O
has NCT03923517 67 70 O
been NCT03923517 71 75 O
diagnosed NCT03923517 76 85 O
with NCT03923517 86 90 O
either NCT03923517 91 97 O
Frontal NCT03923517 98 105 B-Condition-Name
Temporal NCT03923517 106 114 I-Condition-Name
Dementia NCT03923517 115 123 I-Condition-Name
( NCT03923517 124 125 O
FTD NCT03923517 126 129 B-Condition-Name
) NCT03923517 130 131 O
or NCT03923517 132 134 O
Alzheimer NCT03923517 135 144 B-Condition-Name
's NCT03923517 144 146 I-Condition-Name
Disease NCT03923517 147 154 I-Condition-Name
( NCT03923517 155 156 O
AD NCT03923517 157 159 B-Condition-Name
) NCT03923517 160 161 O
12 NCT03923517 163 165 B-Eq-Value
months NCT03923517 166 172 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
ago NCT03923517 173 176 O
or NCT03923517 177 179 B-Eq-Operator___Eq-Operator-Value:LTEQ
less NCT03923517 180 184 I-Eq-Operator___Eq-Operator-Value:LTEQ
; NCT03923517 184 185 O

- NCT03923517 188 189 O
the NCT03923517 191 194 O
carer NCT03923517 195 200 O
has NCT03923517 201 204 O
face NCT03923517 205 209 B-Observation-Name
- NCT03923517 210 211 I-Observation-Name
to NCT03923517 212 214 I-Observation-Name
- NCT03923517 215 216 I-Observation-Name
face NCT03923517 217 221 I-Observation-Name
contact NCT03923517 222 229 I-Observation-Name
with NCT03923517 230 234 O
the NCT03923517 235 238 O
person NCT03923517 239 245 O
with NCT03923517 246 250 O
YOD NCT03923517 251 254 B-Condition-Name
at NCT03923517 255 257 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03923517 258 263 I-Eq-Operator___Eq-Operator-Value:GTEQ
twice NCT03923517 264 269 B-Eq-Value
a NCT03923517 270 271 O
weak NCT03923517 272 276 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03923517 276 277 O

- NCT03923517 280 281 O
the NCT03923517 283 286 O
carer NCT03923517 287 292 O
has NCT03923517 293 296 O
a NCT03923517 297 298 O
working NCT03923517 299 306 O
computer NCT03923517 307 315 O
and NCT03923517 316 319 O
internet NCT03923517 320 328 O
access NCT03923517 329 335 O
in NCT03923517 336 338 O
his NCT03923517 339 342 O
home NCT03923517 343 347 O
; NCT03923517 347 348 O

- NCT03923517 351 352 O
the NCT03923517 354 357 O
carer NCT03923517 358 363 O
is NCT03923517 364 366 O
available NCT03923517 367 376 O
for NCT03923517 377 380 O
the NCT03923517 381 384 O
intervention NCT03923517 385 397 O
duration NCT03923517 398 406 O
of NCT03923517 407 409 O
approximately NCT03923517 410 423 O
eight NCT03923517 424 429 B-Eq-Value
weeks NCT03923517 430 435 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03923517 435 436 O

- NCT03923517 439 440 O
the NCT03923517 442 445 O
carer NCT03923517 446 451 O
is NCT03923517 452 454 O
fluent NCT03923517 455 461 O
in NCT03923517 462 464 O
German NCT03923517 465 471 B-Language
; NCT03923517 471 472 O

- NCT03923517 475 476 O
signed NCT03923517 478 484 O
consent NCT03923517 485 492 O
form NCT03923517 493 497 O
. NCT03923517 498 499 O

Exclusion NCT03923517 501 510 O
Criteria NCT03923517 511 519 O
: NCT03923517 520 521 O

- NCT03923517 525 526 O
the NCT03923517 528 531 O
carer NCT03923517 532 537 O
has NCT03923517 538 541 O
face NCT03923517 542 546 B-Observation-Name
- NCT03923517 547 548 I-Observation-Name
to NCT03923517 549 551 I-Observation-Name
- NCT03923517 552 553 I-Observation-Name
face NCT03923517 554 558 I-Observation-Name
contact NCT03923517 559 566 I-Observation-Name
with NCT03923517 567 571 O
the NCT03923517 572 575 O
person NCT03923517 576 582 O
with NCT03923517 583 587 O
YOD NCT03923517 588 591 B-Condition-Name
less NCT03923517 592 596 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03923517 597 601 I-Eq-Operator___Eq-Operator-Value:LT
twice NCT03923517 602 607 B-Eq-Value
a NCT03923517 608 609 O
week NCT03923517 610 614 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03923517 614 615 O

- NCT03923517 618 619 O
the NCT03923517 621 624 O
person NCT03923517 625 631 O
with NCT03923517 632 636 O
YOD NCT03923517 637 640 B-Condition-Name
the NCT03923517 641 644 O
carer NCT03923517 645 650 O
is NCT03923517 651 653 O
caring NCT03923517 654 660 O
for NCT03923517 661 664 O
has NCT03923517 665 668 O
a NCT03923517 669 670 O
different NCT03923517 671 680 O
dementia NCT03923517 681 689 B-Condition-Name
cause NCT03923517 690 695 O
other NCT03923517 696 701 O
than NCT03923517 702 706 O
FTD NCT03923517 707 710 B-Condition-Name
or NCT03923517 711 713 O
AD NCT03923517 714 716 B-Condition-Name
or NCT03923517 717 719 O
the NCT03923517 720 723 O
diagnosis NCT03923517 724 733 O
is NCT03923517 734 736 O
older NCT03923517 737 742 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03923517 743 747 I-Eq-Operator___Eq-Operator-Value:GT
12 NCT03923517 749 751 B-Eq-Value
months NCT03923517 752 758 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03923517 758 759 O

- NCT03923517 762 763 O
the NCT03923517 765 768 O
carer NCT03923517 769 774 O
does NCT03923517 775 779 O
not NCT03923517 780 783 O
have NCT03923517 784 788 O
a NCT03923517 789 790 O
working NCT03923517 791 798 O
computer NCT03923517 799 807 O
and NCT03923517 808 811 O
internet NCT03923517 812 820 O
access NCT03923517 821 827 O
at NCT03923517 828 830 O
home NCT03923517 831 835 O
or NCT03923517 836 838 O
is NCT03923517 839 841 O
not NCT03923517 842 845 O
confident NCT03923517 846 855 O
to NCT03923517 856 858 O
use NCT03923517 859 862 O
them NCT03923517 863 867 O
; NCT03923517 867 868 O

- NCT03923517 871 872 O
the NCT03923517 874 877 O
carer NCT03923517 878 883 O
is NCT03923517 884 886 O
not NCT03923517 887 890 O
available NCT03923517 891 900 O
for NCT03923517 901 904 O
the NCT03923517 905 908 O
approximately NCT03923517 909 922 O
eight NCT03923517 923 928 B-Eq-Value
week NCT03923517 929 933 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
intervention NCT03923517 934 946 O
duration NCT03923517 947 955 O
; NCT03923517 955 956 O

- NCT03923517 959 960 O
the NCT03923517 962 965 O
carer NCT03923517 966 971 O
is NCT03923517 972 974 O
not NCT03923517 975 978 O
fluent NCT03923517 979 985 O
in NCT03923517 986 988 O
German NCT03923517 989 995 B-Language
; NCT03923517 995 996 O

- NCT03923517 999 1000 O
the NCT03923517 1002 1005 O
carer NCT03923517 1006 1011 O
has NCT03923517 1012 1015 O
a NCT03923517 1016 1017 O
significant NCT03923517 1018 1029 B-Severity___Severity-Value:severe
health NCT03923517 1030 1036 O
problem NCT03923517 1037 1044 O
or NCT03923517 1045 1047 O
disability NCT03923517 1048 1058 B-Condition-Name
, NCT03923517 1059 1060 O
which NCT03923517 1061 1066 O
precludes NCT03923517 1067 1076 O
him NCT03923517 1077 1080 O
/ NCT03923517 1081 1082 O
her NCT03923517 1083 1086 O
from NCT03923517 1087 1091 O
participating NCT03923517 1092 1105 O
in NCT03923517 1106 1108 O
the NCT03923517 1109 1112 O
study NCT03923517 1113 1118 O
; NCT03923517 1118 1119 O

- NCT03923517 1122 1123 O
no NCT03923517 1125 1127 O
signed NCT03923517 1128 1134 O
informed NCT03923517 1135 1143 O
consent NCT03923517 1144 1151 O
. NCT03923517 1152 1153 O

Inclusion NCT03928873 0 9 O
Criteria NCT03928873 10 18 O
: NCT03928873 19 20 O

1 NCT03928873 25 26 O
. NCT03928873 26 27 O
Older NCT03928873 29 34 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03928873 35 39 I-Eq-Operator___Eq-Operator-Value:GT
20 NCT03928873 41 43 B-Eq-Value
years NCT03928873 44 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03928873 50 52 O
age NCT03928873 53 56 O

2 NCT03928873 60 61 O
. NCT03928873 61 62 O
Grade NCT03928873 64 69 B-Eq-Unit
2 NCT03928873 71 72 B-Eq-Value
~ NCT03928873 73 74 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03928873 76 77 B-Eq-Value
trigger NCT03928873 78 85 B-Condition-Name
finger NCT03928873 86 92 I-Condition-Name
based NCT03928873 93 98 O
on NCT03928873 99 101 O
the NCT03928873 102 105 O
Quinnell NCT03928873 106 114 O
classification NCT03928873 115 129 O

Exclusion NCT03928873 130 139 O
Criteria NCT03928873 140 148 O
: NCT03928873 149 150 O

1 NCT03928873 155 156 O
. NCT03928873 156 157 O
Previous NCT03928873 159 167 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03928873 168 177 O
by NCT03928873 178 180 O
physical NCT03928873 181 189 B-Procedure-Name
therapy NCT03928873 190 197 I-Procedure-Name
, NCT03928873 198 199 O
local NCT03928873 200 205 B-Procedure-Name
corticosteroid NCT03928873 206 220 I-Procedure-Name
injection NCT03928873 221 230 I-Procedure-Name
, NCT03928873 231 232 O
or NCT03928873 233 235 O
surgical NCT03928873 236 244 O
release NCT03928873 245 252 O
for NCT03928873 253 256 O
trigger NCT03928873 257 264 B-Condition-Name
finger NCT03928873 265 271 I-Condition-Name
before NCT03928873 272 278 O
the NCT03928873 279 282 O
study NCT03928873 283 288 O

2 NCT03928873 292 293 O
. NCT03928873 293 294 O
The NCT03928873 296 299 O
presence NCT03928873 300 308 O
of NCT03928873 309 311 O
a NCT03928873 312 313 O
musculoskeletal NCT03928873 314 329 B-Condition-Name
disease NCT03928873 330 337 I-Condition-Name
or NCT03928873 338 340 O
previous NCT03928873 341 349 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
nerve NCT03928873 350 355 B-Condition-Name
injuries NCT03928873 356 364 I-Condition-Name
at NCT03928873 365 367 O
the NCT03928873 368 371 O
upper NCT03928873 372 377 O
extremities NCT03928873 378 389 O

3 NCT03928873 393 394 O
. NCT03928873 394 395 O
Multiple NCT03928873 397 405 B-Condition-Name
trigger NCT03928873 406 413 I-Condition-Name
finger NCT03928873 414 420 I-Condition-Name
; NCT03928873 420 421 O
local NCT03928873 422 427 B-Condition-Name
infection NCT03928873 428 437 I-Condition-Name
; NCT03928873 437 438 O
malignancy NCT03928873 439 449 B-Condition-Name
; NCT03928873 449 450 O
inflammatory NCT03928873 451 463 B-Condition-Name
arthritis NCT03928873 464 473 I-Condition-Name
; NCT03928873 473 474 O
cardiac NCT03928873 475 482 B-Condition-Name
arrhythmia NCT03928873 483 493 I-Condition-Name
or NCT03928873 494 496 O
cardiac NCT03928873 497 504 B-Procedure-Name
pacemaker NCT03928873 505 514 I-Procedure-Name
; NCT03928873 514 515 O
and NCT03928873 516 519 O
pregnancy NCT03928873 520 529 B-Condition-Name
. NCT03928873 530 531 O

Inclusion NCT03922386 0 9 O
Criteria NCT03922386 10 18 O
: NCT03922386 19 20 O

1 NCT03922386 25 26 O
. NCT03922386 26 27 O
Any NCT03922386 29 32 O
subject NCT03922386 33 40 O
newly NCT03922386 41 46 O
implanted NCT03922386 47 56 O
according NCT03922386 57 66 O
to NCT03922386 67 69 O
the NCT03922386 70 73 O
most NCT03922386 74 78 O
recent NCT03922386 79 85 O
guidelines NCT03922386 86 96 O
from NCT03922386 97 101 O
the NCT03922386 102 105 O
European NCT03922386 106 114 O
Society NCT03922386 115 122 O
of NCT03922386 123 125 O
Cardiology NCT03922386 126 136 O
( NCT03922386 137 138 O
ESC NCT03922386 139 142 O
) NCT03922386 143 144 O
for NCT03922386 145 148 O
less NCT03922386 149 153 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03922386 154 158 I-Eq-Operator___Eq-Operator-Value:LT
10 NCT03922386 159 161 B-Eq-Value
days NCT03922386 162 166 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
with NCT03922386 167 171 O
: NCT03922386 172 173 O

- NCT03922386 182 183 O
a NCT03922386 185 186 O
Single NCT03922386 187 193 O
Chamber NCT03922386 194 201 O
( NCT03922386 202 203 O
SR NCT03922386 204 206 O
) NCT03922386 207 208 O
or NCT03922386 209 211 O
a NCT03922386 212 213 O
Dual NCT03922386 214 218 O
Chamber NCT03922386 219 226 O
( NCT03922386 227 228 O
DR NCT03922386 229 231 O
) NCT03922386 232 233 O
pacemaker NCT03922386 234 243 B-Procedure-Name
from NCT03922386 244 248 O
Microport NCT03922386 249 258 O
CRM NCT03922386 259 262 O
S NCT03922386 263 264 O
. NCT03922386 265 266 O
r NCT03922386 267 268 O
. NCT03922386 269 270 O
l NCT03922386 271 272 O
. NCT03922386 273 274 O

- NCT03922386 283 284 O
any NCT03922386 286 289 O
right NCT03922386 290 295 O
atrial NCT03922386 296 302 O
and NCT03922386 303 306 O
/ NCT03922386 307 308 O
or NCT03922386 309 311 O
right NCT03922386 312 317 O
ventricular NCT03922386 318 329 O
XFINE NCT03922386 330 335 B-Procedure-Name
lead NCT03922386 336 340 I-Procedure-Name

2 NCT03922386 344 345 O
. NCT03922386 345 346 O
Have NCT03922386 348 352 O
reviewed NCT03922386 353 361 O
, NCT03922386 362 363 O
signed NCT03922386 364 370 O
and NCT03922386 371 374 O
dated NCT03922386 375 380 O
the NCT03922386 381 384 O
informed NCT03922386 385 393 O
consent NCT03922386 394 401 O

Exclusion NCT03922386 402 411 O
Criteria NCT03922386 412 420 O
: NCT03922386 421 422 O

1 NCT03922386 427 428 O
. NCT03922386 428 429 O
Included NCT03922386 431 439 O
in NCT03922386 440 442 O
another NCT03922386 443 450 O
clinical NCT03922386 451 459 O
study NCT03922386 460 465 O
that NCT03922386 466 470 O
could NCT03922386 471 476 O
confound NCT03922386 477 485 B-Stability___Stability-Value:change
the NCT03922386 486 489 O
results NCT03922386 490 497 O
of NCT03922386 498 500 O
this NCT03922386 501 505 O
study NCT03922386 506 511 O
such NCT03922386 512 516 O
as NCT03922386 517 519 O
studies NCT03922386 520 527 O
involving NCT03922386 528 537 O
intra NCT03922386 538 543 B-Procedure-Name
- NCT03922386 544 545 I-Procedure-Name
cardiac NCT03922386 546 553 I-Procedure-Name
device NCT03922386 554 560 I-Procedure-Name

2 NCT03922386 564 565 O
. NCT03922386 565 566 O
Contraindication NCT03922386 568 584 O
to NCT03922386 585 587 O
a NCT03922386 588 589 O
maximum NCT03922386 590 597 B-Eq-Operator___Eq-Operator-Value:LTEQ
single NCT03922386 598 604 O
dose NCT03922386 605 609 O
of NCT03922386 610 612 O
310 NCT03922386 614 617 B-Eq-Value
µg NCT03922386 618 620 B-Eq-Unit
Dexamethasone NCT03922386 621 634 B-Drug-Name
Sodium NCT03922386 635 641 I-Drug-Name
Phosphate NCT03922386 642 651 I-Drug-Name
( NCT03922386 652 653 O
DSP NCT03922386 654 657 B-Drug-Name
) NCT03922386 658 659 O

3 NCT03922386 664 665 O
. NCT03922386 665 666 O
Tricuspid NCT03922386 668 677 B-Condition-Name
valvular NCT03922386 678 686 I-Condition-Name
disease NCT03922386 687 694 I-Condition-Name
or NCT03922386 695 697 O
tricuspid NCT03922386 698 707 B-Procedure-Name
replacement NCT03922386 708 719 I-Procedure-Name
heart NCT03922386 720 725 I-Procedure-Name
valve NCT03922386 726 731 I-Procedure-Name
( NCT03922386 732 733 O
mechanical NCT03922386 734 744 O
or NCT03922386 745 747 O
tissue NCT03922386 748 754 O
) NCT03922386 755 756 O
only NCT03922386 757 761 O
for NCT03922386 762 765 O
subject NCT03922386 766 773 O
with NCT03922386 774 778 O
DR NCT03922386 779 781 B-Procedure-Name
pacemaker NCT03922386 782 791 I-Procedure-Name

4 NCT03922386 795 796 O
. NCT03922386 796 797 O
Active NCT03922386 799 805 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
myocarditis NCT03922386 806 817 B-Condition-Name
, NCT03922386 818 819 O
pocket NCT03922386 820 826 O
and NCT03922386 827 830 O
/ NCT03922386 831 832 O
or NCT03922386 833 835 O
lead NCT03922386 836 840 O
infection NCT03922386 841 850 B-Condition-Name

5 NCT03922386 854 855 O
. NCT03922386 855 856 O
Age NCT03922386 858 861 O
less NCT03922386 862 866 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03922386 867 871 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03922386 873 875 B-Eq-Value
years NCT03922386 876 881 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03922386 882 885 O
or NCT03922386 886 888 O
under NCT03922386 889 894 O
guardianship NCT03922386 895 907 O
or NCT03922386 908 910 O
kept NCT03922386 911 915 O
in NCT03922386 916 918 O
detention NCT03922386 919 928 O

6 NCT03922386 932 933 O
. NCT03922386 933 934 O
Life NCT03922386 936 940 B-Observation-Name
expectancy NCT03922386 941 951 I-Observation-Name
less NCT03922386 952 956 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03922386 957 961 I-Eq-Operator___Eq-Operator-Value:LT
1 NCT03922386 963 964 B-Eq-Value
year NCT03922386 965 969 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

7 NCT03922386 973 974 O
. NCT03922386 974 975 O
Known NCT03922386 977 982 O
pregnancy NCT03922386 983 992 B-Condition-Name
, NCT03922386 993 994 O
women NCT03922386 995 1000 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
breastfeeding NCT03922386 1001 1014 B-Condition-Name
or NCT03922386 1015 1017 O
in NCT03922386 1018 1020 O
childbearing NCT03922386 1021 1033 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
age NCT03922386 1034 1037 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
without NCT03922386 1038 1045 O
an NCT03922386 1046 1048 O
adequate NCT03922386 1049 1057 O
contraceptive NCT03922386 1058 1071 B-Procedure-Name
method NCT03922386 1072 1078 I-Procedure-Name

8 NCT03922386 1082 1083 O
. NCT03922386 1083 1084 O
Be NCT03922386 1086 1088 O
unavailable NCT03922386 1089 1100 O
for NCT03922386 1101 1104 O
the NCT03922386 1105 1108 O
scheduled NCT03922386 1109 1118 O
follow NCT03922386 1119 1125 O
- NCT03922386 1126 1127 O
up NCT03922386 1128 1130 O
associated NCT03922386 1131 1141 O
with NCT03922386 1142 1146 O
this NCT03922386 1147 1151 O
clinical NCT03922386 1152 1160 O
study NCT03922386 1161 1166 O
or NCT03922386 1167 1169 O
refusal NCT03922386 1170 1177 O
to NCT03922386 1178 1180 O
cooperate NCT03922386 1181 1190 O

Inclusion NCT03925402 0 9 O
Criteria NCT03925402 10 18 O
: NCT03925402 19 20 O

- NCT03925402 24 25 O
Adults NCT03925402 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
, NCT03925402 34 35 O
either NCT03925402 36 42 O
sex NCT03925402 43 46 O
, NCT03925402 47 48 O
ages NCT03925402 49 53 O
18 NCT03925402 55 57 B-Eq-Value
years NCT03925402 58 63 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03925402 64 66 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03925402 67 72 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03925402 75 76 O
Patients NCT03925402 78 86 O
with NCT03925402 87 91 O
3 NCT03925402 93 94 B-Condition-Name
GCRE NCT03925402 95 99 I-Condition-Name
bacteremia NCT03925402 100 110 I-Condition-Name

- NCT03925402 113 114 O
Patients NCT03925402 116 124 O
admitted NCT03925402 125 133 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03925402 134 136 O
any NCT03925402 137 140 O
of NCT03925402 141 143 O
the NCT03925402 144 147 O
study NCT03925402 148 153 O
sites NCT03925402 154 159 O

Exclusion NCT03925402 160 169 O
Criteria NCT03925402 170 178 O
: NCT03925402 179 180 O

- NCT03925402 184 185 O
Discontinuation NCT03925402 187 202 B-Stability___Stability-Value:change
of NCT03925402 203 205 O
antibiotic NCT03925402 206 216 B-Drug-Name
due NCT03925402 217 220 O
to NCT03925402 221 223 O
transition NCT03925402 224 234 B-Encounter-Type___Encounter-Type-Value:transfer
to NCT03925402 235 237 O
hospice NCT03925402 238 245 B-Location___Location-Value:clinic
care NCT03925402 246 250 I-Location___Location-Value:clinic

- NCT03925402 253 254 O
Polymicrobial NCT03925402 256 269 B-Condition-Name
bacteremia NCT03925402 270 280 I-Condition-Name

- NCT03925402 283 284 O
Empirical NCT03925402 286 295 B-Drug-Name
antibiotic NCT03925402 296 306 I-Drug-Name
after NCT03925402 307 312 O
24 NCT03925402 314 316 B-Eq-Value
hours NCT03925402 317 322 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03925402 323 325 O
first NCT03925402 326 331 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
evidence NCT03925402 332 340 O
of NCT03925402 341 343 O
bacteremia NCT03925402 344 354 B-Condition-Name

Inclusion NCT03928132 0 9 O
Criteria NCT03928132 10 18 O
: NCT03928132 19 20 O

- NCT03928132 24 25 O
French NCT03928132 27 33 B-Language
- NCT03928132 34 35 O
speaking NCT03928132 36 44 O
health NCT03928132 45 51 O
professionals NCT03928132 52 65 O
( NCT03928132 66 67 O
in NCT03928132 68 70 O
practice NCT03928132 71 79 O
and NCT03928132 80 83 O
in NCT03928132 84 86 O
training NCT03928132 87 95 O
) NCT03928132 96 97 O
. NCT03928132 99 100 O

Inclusion NCT03921658 0 9 O
Criteria NCT03921658 10 18 O
: NCT03921658 19 20 O

- NCT03921658 24 25 O
Age NCT03921658 27 30 O
≥ NCT03921658 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03921658 34 36 B-Eq-Value

- NCT03921658 40 41 O
Ability NCT03921658 43 50 O
to NCT03921658 51 53 O
read NCT03921658 54 58 O
and NCT03921658 59 62 O
write NCT03921658 63 68 O
in NCT03921658 69 71 O
English NCT03921658 72 79 B-Language

- NCT03921658 82 83 O
women NCT03921658 85 90 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03921658 91 95 O
newly NCT03921658 96 101 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnosed NCT03921658 102 111 O
with NCT03921658 112 116 O
ovarian NCT03921658 117 124 O
, NCT03921658 125 126 O
primary NCT03921658 127 134 O
peritoneal NCT03921658 135 145 O
, NCT03921658 146 147 O
or NCT03921658 148 150 O
fallopian NCT03921658 151 160 O
tube NCT03921658 161 165 O
cancer NCT03921658 166 172 B-Condition-Name

- NCT03921658 175 176 O
Treatment NCT03921658 178 187 O
plan NCT03921658 188 192 O
includes NCT03921658 193 201 O
chemotherapy NCT03921658 202 214 B-Procedure-Name

- NCT03921658 217 218 O
Able NCT03921658 220 224 O
to NCT03921658 225 227 O
provide NCT03921658 228 235 O
written NCT03921658 236 243 O
voluntary NCT03921658 244 253 O
consent NCT03921658 254 261 O
before NCT03921658 262 268 O
performance NCT03921658 269 280 O
of NCT03921658 281 283 O
any NCT03921658 284 287 O
study NCT03921658 288 293 O
related NCT03921658 294 301 O
procedure NCT03921658 302 311 O
. NCT03921658 312 313 O

- NCT03921658 317 318 O
Cohort NCT03921658 320 326 O
1 NCT03921658 328 329 O
only NCT03921658 330 334 O
: NCT03921658 335 336 O
within NCT03921658 337 343 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03921658 345 346 B-Eq-Value
years NCT03921658 347 352 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921658 353 355 O
completing NCT03921658 356 366 O
initial NCT03921658 367 374 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
chemotherapy NCT03921658 375 387 B-Procedure-Name
treatment NCT03921658 388 397 I-Procedure-Name

- NCT03921658 400 401 O
Cohort NCT03921658 403 409 O
2 NCT03921658 411 412 O
only NCT03921658 413 417 O
: NCT03921658 418 419 O
prior NCT03921658 420 425 O
to NCT03921658 426 428 O
starting NCT03921658 429 437 O
chemotherapy NCT03921658 438 450 B-Procedure-Name

Exclusion NCT03921658 451 460 O
Criteria NCT03921658 461 469 O
: NCT03921658 470 471 O

- NCT03921658 475 476 O
Inability NCT03921658 478 487 O
to NCT03921658 488 490 O
provide NCT03921658 491 498 O
informed NCT03921658 499 507 O
written NCT03921658 508 515 O
consent NCT03921658 516 523 O

- NCT03921658 526 527 O
Previous NCT03921658 529 537 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
exposure NCT03921658 538 546 O
to NCT03921658 547 549 O
chemotherapy NCT03921658 550 562 B-Procedure-Name

- NCT03921658 565 566 O
Life NCT03921658 568 572 B-Observation-Name
expectancy NCT03921658 573 583 I-Observation-Name
< NCT03921658 584 585 B-Eq-Operator___Eq-Operator-Value:LT
3 NCT03921658 587 588 B-Eq-Value
months NCT03921658 589 595 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03921658 596 598 O
in NCT03921658 599 601 O
hospice NCT03921658 602 609 B-Observation-Name
care NCT03921658 610 614 I-Observation-Name
or NCT03921658 615 617 O
nursing NCT03921658 618 625 B-Observation-Name
home NCT03921658 626 630 I-Observation-Name

Inclusion NCT03929562 0 9 O
Criteria NCT03929562 10 18 O
: NCT03929562 19 20 O

- NCT03929562 24 25 O
Referred NCT03929562 27 35 B-Encounter-Type___Encounter-Type-Value:referral
for NCT03929562 36 39 O
elective NCT03929562 40 48 O
or NCT03929562 49 51 O
semi NCT03929562 52 56 O
- NCT03929562 57 58 O
elective NCT03929562 59 67 O
surgery NCT03929562 68 75 B-Procedure-Name
or NCT03929562 76 78 O
pre NCT03929562 79 82 B-Observation-Name
- NCT03929562 83 84 I-Observation-Name
operative NCT03929562 85 94 I-Observation-Name
assessment NCT03929562 95 105 I-Observation-Name
in NCT03929562 106 108 O
the NCT03929562 109 112 O
next NCT03929562 113 117 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
120 NCT03929562 119 122 B-Eq-Value
days NCT03929562 123 127 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03929562 130 131 O
Meet NCT03929562 133 137 O
criteria NCT03929562 138 146 O
for NCT03929562 147 150 O
" NCT03929562 151 152 O
risky NCT03929562 152 157 B-Condition-Name
drinking NCT03929562 158 166 I-Condition-Name
" NCT03929562 166 167 O
as NCT03929562 168 170 O
defined NCT03929562 171 178 O
by NCT03929562 179 181 O
study NCT03929562 182 187 O
staff NCT03929562 188 193 O

Exclusion NCT03929562 194 203 O
Criteria NCT03929562 204 212 O
: NCT03929562 213 214 O

- NCT03929562 218 219 O
Displays NCT03929562 221 229 O
or NCT03929562 230 232 O
shows NCT03929562 233 238 O
evidence NCT03929562 239 247 O
of NCT03929562 248 250 O
psychotic NCT03929562 251 260 B-Condition-Name
symptoms NCT03929562 261 269 O

- NCT03929562 272 273 O
Undergoing NCT03929562 275 285 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surgeries NCT03929562 286 295 B-Procedure-Name
that NCT03929562 296 300 O
commonly NCT03929562 301 309 O
require NCT03929562 310 317 O
local NCT03929562 318 323 B-Procedure-Name
anesthesia NCT03929562 324 334 I-Procedure-Name
only NCT03929562 335 339 O


Inclusion NCT03920397 0 9 O
Criteria NCT03920397 10 18 O
: NCT03920397 19 20 O

- NCT03920397 24 25 O
Diagnosis NCT03920397 27 36 O
of NCT03920397 37 39 O
Type NCT03920397 40 44 B-Condition-Name
1 NCT03920397 46 47 I-Condition-Name
Diabetes NCT03920397 48 56 I-Condition-Name
according NCT03920397 57 66 O
to NCT03920397 67 69 O
the NCT03920397 70 73 O
American NCT03920397 74 82 O
Diabetes NCT03920397 83 91 O
Association NCT03920397 92 103 O
criteria NCT03920397 104 112 O
for NCT03920397 113 116 O
a NCT03920397 117 118 O
period NCT03920397 119 125 O
less NCT03920397 126 130 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03920397 131 135 I-Eq-Operator___Eq-Operator-Value:LT
four NCT03920397 136 140 B-Eq-Value
months NCT03920397 141 147 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03920397 148 149 O

- NCT03920397 153 154 O
Pancreatic NCT03920397 156 166 B-Condition-Name
Autoimmunity NCT03920397 167 179 I-Condition-Name
( NCT03920397 180 181 O
positive NCT03920397 182 190 B-Polarity___Polarity-Value:positive
anti NCT03920397 191 195 B-Condition-Name
- NCT03920397 196 197 I-Condition-Name
glutamic NCT03920397 198 206 I-Condition-Name
acid NCT03920397 207 211 I-Condition-Name
decarboxylase NCT03920397 212 225 I-Condition-Name
[ NCT03920397 226 227 O
GAD NCT03920397 228 231 B-Condition-Name
] NCT03920397 232 233 O
; NCT03920397 234 235 O
and NCT03920397 236 239 O
/ NCT03920397 240 241 O
or NCT03920397 242 244 O
Islet NCT03920397 245 250 B-Condition-Name
antigen NCT03920397 251 258 I-Condition-Name
2 NCT03920397 260 261 I-Condition-Name
[ NCT03920397 262 263 O
anti NCT03920397 264 268 B-Condition-Name
- NCT03920397 269 270 I-Condition-Name
IA NCT03920397 271 273 I-Condition-Name
2 NCT03920397 274 275 I-Condition-Name
] NCT03920397 276 277 O
) NCT03920397 279 280 O
. NCT03920397 282 283 O

Exclusion NCT03920397 285 294 O
Criteria NCT03920397 295 303 O
: NCT03920397 304 305 O

- NCT03920397 309 310 O
Clinical NCT03920397 312 320 O
evidence NCT03920397 321 329 O
of NCT03920397 330 332 O
malignancy NCT03920397 333 343 B-Condition-Name
or NCT03920397 344 346 O
prior NCT03920397 347 352 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03920397 353 360 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
. NCT03920397 361 362 O

- NCT03920397 366 367 O
Pregnancy NCT03920397 369 378 B-Condition-Name
or NCT03920397 379 381 O
desire NCT03920397 382 388 O
to NCT03920397 389 391 O
become NCT03920397 392 398 O
pregnant NCT03920397 399 407 B-Condition-Name
within NCT03920397 408 414 B-Eq-Operator___Eq-Operator-Value:LTEQ
12 NCT03920397 416 418 B-Eq-Value
months NCT03920397 419 425 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03920397 426 428 O
the NCT03920397 429 432 O
study NCT03920397 433 438 O
. NCT03920397 439 440 O

- NCT03920397 444 445 O
Breastfeeding NCT03920397 447 460 B-Condition-Name
. NCT03920397 462 463 O

- NCT03920397 467 468 O
HIV NCT03920397 470 473 B-Condition-Name
( NCT03920397 474 475 B-Polarity___Polarity-Value:positive
+ NCT03920397 477 478 I-Polarity___Polarity-Value:positive
) NCT03920397 480 481 I-Polarity___Polarity-Value:positive
, NCT03920397 483 484 O
Hepatitis NCT03920397 485 494 B-Condition-Name
B NCT03920397 495 496 I-Condition-Name
( NCT03920397 497 498 B-Polarity___Polarity-Value:positive
+ NCT03920397 500 501 I-Polarity___Polarity-Value:positive
) NCT03920397 503 504 I-Polarity___Polarity-Value:positive
, NCT03920397 506 507 O
Hepatitis NCT03920397 508 517 B-Condition-Name
C NCT03920397 518 519 I-Condition-Name
( NCT03920397 520 521 B-Polarity___Polarity-Value:positive
+ NCT03920397 523 524 I-Polarity___Polarity-Value:positive
) NCT03920397 526 527 I-Polarity___Polarity-Value:positive
. NCT03920397 529 530 O

- NCT03920397 534 535 O
Diabetic NCT03920397 537 545 B-Condition-Name
ketoacidosis NCT03920397 546 558 I-Condition-Name
at NCT03920397 559 561 O
diagnosis NCT03920397 562 571 O
. NCT03920397 572 573 O

- NCT03920397 577 578 O
Glomerular NCT03920397 580 590 B-Observation-Name___Observation-Type-Value:lab
filtration NCT03920397 591 601 I-Observation-Name___Observation-Type-Value:lab
rate NCT03920397 602 606 I-Observation-Name___Observation-Type-Value:lab
less NCT03920397 607 611 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03920397 612 616 I-Eq-Operator___Eq-Operator-Value:LT
60 NCT03920397 618 620 B-Eq-Value
ml NCT03920397 621 623 B-Eq-Unit
/ NCT03920397 624 625 O
min NCT03920397 626 629 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
. NCT03920397 630 631 O

- NCT03920397 635 636 O
Use NCT03920397 638 641 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03920397 642 644 O
immunosuppressors NCT03920397 645 662 B-Drug-Name
or NCT03920397 663 665 O
glucocorticoids NCT03920397 666 681 B-Drug-Name
. NCT03920397 682 683 O

Inclusion NCT03922594 0 9 O
Criteria NCT03922594 10 18 O
: NCT03922594 19 20 O

- NCT03922594 24 25 O
All NCT03922594 27 30 O
infants NCT03922594 31 38 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
or NCT03922594 39 41 O
fetuses NCT03922594 42 49 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
with NCT03922594 50 54 O
microcephaly NCT03922594 55 67 B-Condition-Name
, NCT03922594 68 69 O
( NCT03922594 70 71 O
defined NCT03922594 72 79 O
as NCT03922594 80 82 O
head NCT03922594 83 87 B-Observation-Name___Observation-Type-Value:measurement
circumference NCT03922594 88 101 I-Observation-Name___Observation-Type-Value:measurement
≤ NCT03922594 102 103 B-Eq-Operator___Eq-Operator-Value:LTEQ
- NCT03922594 105 106 O
3 NCT03922594 108 109 B-Eq-Value
SD NCT03922594 110 112 B-Eq-Unit
according NCT03922594 113 122 O
to NCT03922594 123 125 O
INTERGROWTH NCT03922594 126 137 O
standards NCT03922594 138 147 O
for NCT03922594 148 151 O
gestational NCT03922594 152 163 O
age NCT03922594 164 167 O
and NCT03922594 168 171 O
sex NCT03922594 172 175 O
, NCT03922594 176 177 O
detected NCT03922594 178 186 O
during NCT03922594 187 193 O
the NCT03922594 194 197 O
mother NCT03922594 198 204 O
's NCT03922594 204 206 O
pregnancy NCT03922594 207 216 B-Condition-Name
, NCT03922594 217 218 O
or NCT03922594 219 221 O
at NCT03922594 222 224 O
the NCT03922594 225 228 O
end NCT03922594 229 232 O
of NCT03922594 233 235 O
the NCT03922594 236 239 O
mother NCT03922594 240 246 O
's NCT03922594 246 248 O
pregnancy NCT03922594 249 258 B-Condition-Name
at NCT03922594 259 261 O
one NCT03922594 262 265 O
of NCT03922594 266 268 O
the NCT03922594 269 272 O
participating NCT03922594 273 286 O
maternities NCT03922594 287 298 O
) NCT03922594 299 300 O

- NCT03922594 304 305 O
and NCT03922594 307 310 O
with NCT03922594 311 315 O
abnormal NCT03922594 316 324 B-Polarity___Polarity-Value:abnormal
ultrasound NCT03922594 325 335 B-Procedure-Name
and NCT03922594 336 339 O
/ NCT03922594 340 341 O
or NCT03922594 342 344 O
clinical NCT03922594 345 353 B-Observation-Name
examination NCT03922594 354 365 I-Observation-Name
findings NCT03922594 366 374 I-Observation-Name
for NCT03922594 375 378 O
newborns NCT03922594 379 387 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
. NCT03922594 388 389 O

Exclusion NCT03922594 391 400 O
Criteria NCT03922594 401 409 O
: NCT03922594 410 411 O

- NCT03922594 415 416 O
Infants NCT03922594 418 425 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
/ NCT03922594 426 427 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
fetuses NCT03922594 428 435 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:infant
with NCT03922594 436 440 O
microcephaly NCT03922594 441 453 B-Condition-Name
whose NCT03922594 454 459 O
mothers NCT03922594 460 467 O
are NCT03922594 468 471 O
under NCT03922594 472 477 B-Eq-Operator___Eq-Operator-Value:LT
the NCT03922594 478 481 O
age NCT03922594 482 485 O
of NCT03922594 486 488 O
18 NCT03922594 490 492 B-Eq-Value
years NCT03922594 493 498 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03922594 499 500 O

- NCT03922594 504 505 O
or NCT03922594 507 509 O
inability NCT03922594 510 519 O
or NCT03922594 520 522 O
refusal NCT03922594 523 530 O
of NCT03922594 531 533 O
mothers NCT03922594 534 541 O
/ NCT03922594 542 543 O
guardians NCT03922594 544 553 O
to NCT03922594 554 556 O
give NCT03922594 557 561 O
informed NCT03922594 562 570 O
consent NCT03922594 571 578 O
. NCT03922594 579 580 O

Inclusion NCT03921710 0 9 O
criteria NCT03921710 10 18 O
: NCT03921710 19 20 O

- NCT03921710 24 25 O
< NCT03921710 27 28 B-Eq-Operator___Eq-Operator-Value:LT
38 NCT03921710 30 32 B-Eq-Value
years NCT03921710 33 38 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03921710 41 42 O
PCOS NCT03921710 44 48 B-Condition-Name
patients NCT03921710 49 57 O
with NCT03921710 58 62 O
polycystic NCT03921710 63 73 B-Condition-Name
ovarian NCT03921710 74 81 I-Condition-Name
morphology NCT03921710 82 92 I-Condition-Name
: NCT03921710 93 94 O
at NCT03921710 95 97 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03921710 98 103 I-Eq-Operator___Eq-Operator-Value:GTEQ
25 NCT03921710 105 107 B-Eq-Value
follicles NCT03921710 108 117 B-Observation-Name
( NCT03921710 118 119 O
2 NCT03921710 121 122 B-Eq-Value
- NCT03921710 123 124 B-Eq-Operator___Eq-Operator-Value:BETWEEN
9 NCT03921710 126 127 B-Eq-Value
mm NCT03921710 128 130 B-Eq-Unit
) NCT03921710 131 132 O
throughout NCT03921710 133 143 O
the NCT03921710 144 147 O
whole NCT03921710 148 153 O
ovary NCT03921710 154 159 O
and NCT03921710 160 163 O
/ NCT03921710 164 165 O
or NCT03921710 166 168 O
increased NCT03921710 169 178 B-Polarity___Polarity-Value:high
ovarian NCT03921710 179 186 B-Observation-Name___Observation-Type-Value:measurement
volume NCT03921710 187 193 I-Observation-Name___Observation-Type-Value:measurement
( NCT03921710 194 195 O
> NCT03921710 197 198 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03921710 200 202 B-Eq-Value
ml NCT03921710 203 205 B-Eq-Unit
) NCT03921710 206 207 O
( NCT03921710 208 209 O
it NCT03921710 210 212 O
is NCT03921710 213 215 O
sufficient NCT03921710 216 226 O
that NCT03921710 227 231 O
1 NCT03921710 233 234 O
ovary NCT03921710 235 240 O
fits NCT03921710 241 245 O
these NCT03921710 246 251 O
criteria NCT03921710 252 260 O
) NCT03921710 261 262 O

- NCT03921710 266 267 O
No NCT03921710 269 271 O
major NCT03921710 272 277 O
uterine NCT03921710 278 285 O
or NCT03921710 286 288 O
ovarian NCT03921710 289 296 O
abnormalities NCT03921710 297 310 B-Condition-Name

Exclusion NCT03921710 311 320 O
criteria NCT03921710 321 329 O
: NCT03921710 330 331 O

- NCT03921710 335 336 O
High NCT03921710 338 342 B-Polarity
( NCT03921710 343 344 O
> NCT03921710 346 347 B-Eq-Operator___Eq-Operator-Value:GT
grade NCT03921710 348 353 B-Eq-Unit
2 NCT03921710 355 356 B-Eq-Value
) NCT03921710 357 358 O
grade NCT03921710 359 364 O
endometriosis NCT03921710 365 378 B-Condition-Name

- NCT03921710 381 382 O
Cases NCT03921710 384 389 O
with NCT03921710 390 394 O
extremely NCT03921710 395 404 B-Severity___Severity-Value:severe
poor NCT03921710 405 409 B-Condition-Name
sperm NCT03921710 410 415 I-Condition-Name
( NCT03921710 416 417 O
OAT NCT03921710 418 421 B-Condition-Name
) NCT03921710 422 423 O
such NCT03921710 424 428 O
as NCT03921710 429 431 O
azoospermia NCT03921710 432 443 B-Condition-Name
or NCT03921710 444 446 O
cryptozoospermia NCT03921710 447 463 B-Condition-Name

Inclusion NCT03920618 0 9 O
Criteria NCT03920618 10 18 O
: NCT03920618 19 20 O

1 NCT03920618 25 26 O
. NCT03920618 26 27 O
Positive NCT03920618 29 37 B-Polarity___Polarity-Value:positive
hepatitis NCT03920618 38 47 B-Observation-Name___Observation-Type-Value:lab
b NCT03920618 48 49 I-Observation-Name___Observation-Type-Value:lab
surface NCT03920618 50 57 I-Observation-Name___Observation-Type-Value:lab
antigen NCT03920618 58 65 I-Observation-Name___Observation-Type-Value:lab
or NCT03920618 66 68 O
hepatitis NCT03920618 69 78 B-Observation-Name___Observation-Type-Value:lab
b NCT03920618 79 80 I-Observation-Name___Observation-Type-Value:lab
virus NCT03920618 81 86 I-Observation-Name___Observation-Type-Value:lab
DNA NCT03920618 87 90 I-Observation-Name___Observation-Type-Value:lab
> NCT03920618 91 92 B-Eq-Operator___Eq-Operator-Value:GT
0.5 NCT03920618 94 97 B-Eq-Value
year NCT03920618 98 102 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03920618 102 103 O

2 NCT03920618 107 108 O
. NCT03920618 108 109 O
Age NCT03920618 111 114 O
from NCT03920618 115 119 O
18 NCT03920618 121 123 B-Eq-Value
to NCT03920618 124 126 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03920618 128 130 B-Eq-Value
years NCT03920618 131 136 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03920618 137 140 O
; NCT03920618 140 141 O

3 NCT03920618 145 146 O
. NCT03920618 146 147 O
Serum NCT03920618 149 154 B-Observation-Name___Observation-Type-Value:lab
total NCT03920618 155 160 I-Observation-Name___Observation-Type-Value:lab
bilirubin NCT03920618 161 170 I-Observation-Name___Observation-Type-Value:lab
level NCT03920618 171 176 I-Observation-Name___Observation-Type-Value:lab
> NCT03920618 177 178 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03920618 180 182 B-Eq-Value
times NCT03920618 183 188 O
upper NCT03920618 189 194 B-Eq-Unit___Eq-Unit-Value:ref-range-normal
limit NCT03920618 195 200 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
of NCT03920618 201 203 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
normal NCT03920618 204 210 I-Eq-Unit___Eq-Unit-Value:ref-range-normal
; NCT03920618 210 211 O

4 NCT03920618 215 216 O
. NCT03920618 216 217 O
Prothrombin NCT03920618 219 230 B-Observation-Name___Observation-Type-Value:lab
time NCT03920618 231 235 I-Observation-Name___Observation-Type-Value:lab
activity NCT03920618 236 244 I-Observation-Name___Observation-Type-Value:lab
< NCT03920618 245 246 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03920618 248 250 B-Eq-Value
% NCT03920618 251 252 O
or NCT03920618 253 255 O
prothrombin NCT03920618 256 267 B-Observation-Name___Observation-Type-Value:lab
time NCT03920618 268 272 I-Observation-Name___Observation-Type-Value:lab
international NCT03920618 273 286 I-Observation-Name___Observation-Type-Value:lab
ratio NCT03920618 287 292 I-Observation-Name___Observation-Type-Value:lab
> NCT03920618 293 294 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03920618 296 299 B-Eq-Value
； NCT03920618 300 301 O

5 NCT03920618 305 306 O
. NCT03920618 306 307 O
Do NCT03920618 309 311 O
not NCT03920618 312 315 O
receive NCT03920618 316 323 O
nucleotide NCT03920618 324 334 O
/ NCT03920618 335 336 O
nucleoside NCT03920618 337 347 O
analogues NCT03920618 348 357 B-Procedure-Name
treatment NCT03920618 358 367 I-Procedure-Name
in NCT03920618 368 370 O
the NCT03920618 371 374 O
past NCT03920618 375 379 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
half NCT03920618 380 384 B-Eq-Value
year NCT03920618 385 389 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03920618 390 391 O

Exclusion NCT03920618 393 402 O
Criteria NCT03920618 403 411 O
: NCT03920618 412 413 O

1 NCT03920618 418 419 O
. NCT03920618 419 420 O
Other NCT03920618 422 427 O
active NCT03920618 428 434 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
liver NCT03920618 435 440 B-Condition-Name
diseases NCT03920618 441 449 I-Condition-Name
; NCT03920618 449 450 O

2 NCT03920618 454 455 O
. NCT03920618 455 456 O
Hepatocellular NCT03920618 458 472 B-Condition-Name
carcinoma NCT03920618 473 482 I-Condition-Name
or NCT03920618 483 485 O
other NCT03920618 486 491 O
malignancy NCT03920618 492 502 B-Condition-Name
; NCT03920618 502 503 O

3 NCT03920618 507 508 O
. NCT03920618 508 509 O
Pregnancy NCT03920618 511 520 B-Condition-Name
or NCT03920618 521 523 O
lactation NCT03920618 524 533 B-Condition-Name
; NCT03920618 533 534 O

4 NCT03920618 538 539 O
. NCT03920618 539 540 O
Human NCT03920618 542 547 B-Condition-Name
immunodeficiency NCT03920618 548 564 I-Condition-Name
virus NCT03920618 565 570 I-Condition-Name
infection NCT03920618 571 580 I-Condition-Name
or NCT03920618 581 583 O
congenital NCT03920618 584 594 B-Condition-Name
immune NCT03920618 595 601 I-Condition-Name
deficiency NCT03920618 602 612 I-Condition-Name
diseases NCT03920618 613 621 I-Condition-Name
; NCT03920618 621 622 O

5 NCT03920618 626 627 O
. NCT03920618 627 628 O
Severe NCT03920618 630 636 B-Severity___Severity-Value:severe
diabetes NCT03920618 637 645 B-Condition-Name
, NCT03920618 646 647 O
autoimmune NCT03920618 648 658 B-Condition-Name
diseases NCT03920618 659 667 I-Condition-Name
; NCT03920618 667 668 O

6 NCT03920618 672 673 O
. NCT03920618 673 674 O
Other NCT03920618 676 681 O
important NCT03920618 682 691 O
organ NCT03920618 692 697 B-Condition-Name
dysfunctions NCT03920618 698 710 I-Condition-Name
; NCT03920618 710 711 O

7 NCT03920618 715 716 O
. NCT03920618 716 717 O
Using NCT03920618 719 724 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
glucocorticoid NCT03920618 725 739 B-Drug-Name
; NCT03920618 739 740 O

8 NCT03920618 744 745 O
. NCT03920618 745 746 O
Patients NCT03920618 748 756 O
can NCT03920618 757 760 O
not NCT03920618 761 764 O
follow NCT03920618 765 771 O
- NCT03920618 772 773 O
up NCT03920618 774 776 O
; NCT03920618 776 777 O

9 NCT03920618 781 782 O
. NCT03920618 782 783 O
Investigator NCT03920618 785 797 O
considering NCT03920618 798 809 O
inappropriate NCT03920618 810 823 O
. NCT03920618 824 825 O

Inclusion NCT03928522 0 9 O
Criteria NCT03928522 10 18 O
: NCT03928522 19 20 O

- NCT03928522 24 25 O
Age NCT03928522 27 30 O
over NCT03928522 31 35 O
18 NCT03928522 37 39 B-Eq-Value

- NCT03928522 43 44 O
Total NCT03928522 46 51 B-Procedure-Name
knee NCT03928522 52 56 I-Procedure-Name
arthroplasty NCT03928522 57 69 I-Procedure-Name
for NCT03928522 70 73 O
primary NCT03928522 74 81 O
osteoarthritis NCT03928522 82 96 B-Condition-Name
performed NCT03928522 97 106 O
by NCT03928522 107 109 O
Dr NCT03928522 110 112 O
. NCT03928522 113 114 O
Rick NCT03928522 116 120 O
Wright NCT03928522 121 127 O
. NCT03928522 128 129 O

- NCT03928522 133 134 O
Primary NCT03928522 136 143 O
diagnosis NCT03928522 144 153 O
of NCT03928522 154 156 O
knee NCT03928522 157 161 O
osteoarthritis NCT03928522 162 176 B-Condition-Name

- NCT03928522 184 185 O
Exclusion NCT03928522 187 196 O
Criteria NCT03928522 197 205 O
: NCT03928522 206 207 O

- NCT03928522 211 212 O
Diminished NCT03928522 214 224 B-Condition-Name
mental NCT03928522 225 231 I-Condition-Name
capacity NCT03928522 232 240 I-Condition-Name

- NCT03928522 243 244 O
Vancomycin NCT03928522 246 256 B-Drug-Name
allergy NCT03928522 257 264 O

- NCT03928522 267 268 O
Tobramycin NCT03928522 270 280 B-Drug-Name
allergy NCT03928522 281 288 O

- NCT03928522 291 292 O
Patient NCT03928522 294 301 O
history NCT03928522 302 309 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
requiring NCT03928522 310 319 O
IV NCT03928522 320 322 O
administration NCT03928522 323 337 O
of NCT03928522 338 340 O
vancomycin NCT03928522 341 351 B-Drug-Name
or NCT03928522 352 354 O
tobramycin NCT03928522 355 365 B-Drug-Name
peri NCT03928522 366 370 O
operatively NCT03928522 371 382 O

- NCT03928522 385 386 O
Chronic NCT03928522 388 395 O
kidney NCT03928522 396 402 B-Condition-Name
disease NCT03928522 403 410 I-Condition-Name
stage NCT03928522 411 416 B-Eq-Unit
III NCT03928522 417 420 B-Eq-Value
and NCT03928522 421 424 O
stage NCT03928522 425 430 O
IV NCT03928522 431 433 B-Eq-Value

Inclusion NCT03929614 0 9 O
Criteria NCT03929614 10 18 O
: NCT03929614 19 20 O

- NCT03929614 24 25 O
AIS NCT03929614 27 30 B-Condition-Name
. NCT03929614 31 32 O

- NCT03929614 36 37 O
10 NCT03929614 40 42 B-Eq-Value
- NCT03929614 43 44 B-Eq-Operator___Eq-Operator-Value:BETWEEN
16 NCT03929614 46 48 B-Eq-Value
years NCT03929614 49 54 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03929614 55 58 O
, NCT03929614 59 60 O
with NCT03929614 61 65 O
brace NCT03929614 66 71 B-Procedure-Name
treatment NCT03929614 72 81 I-Procedure-Name
. NCT03929614 82 83 O

- NCT03929614 87 88 O
Ability NCT03929614 90 97 O
to NCT03929614 98 100 O
read NCT03929614 101 105 O
and NCT03929614 106 109 O
understand NCT03929614 110 120 O
English NCT03929614 121 128 B-Language
or NCT03929614 129 131 O
French NCT03929614 132 138 B-Language
. NCT03929614 139 140 O

- NCT03929614 144 145 O
Physical NCT03929614 147 155 O
and NCT03929614 156 159 O
mental NCT03929614 160 166 O
ability NCT03929614 167 174 O
to NCT03929614 175 177 O
adhere NCT03929614 178 184 O
to NCT03929614 185 187 O
bracing NCT03929614 188 195 O
protocol NCT03929614 196 204 O
. NCT03929614 205 206 O

Exclusion NCT03929614 208 217 O
Criteria NCT03929614 218 226 O
: NCT03929614 227 228 O

- NCT03929614 232 233 O
Diagnosis NCT03929614 235 244 O
of NCT03929614 245 247 O
other NCT03929614 248 253 O
musculoskeletal NCT03929614 254 269 O
or NCT03929614 270 272 O
developmental NCT03929614 273 286 O
illness NCT03929614 287 294 B-Condition-Name
that NCT03929614 295 299 O
might NCT03929614 300 305 O
be NCT03929614 306 308 O
responsible NCT03929614 309 320 O
for NCT03929614 321 324 O
the NCT03929614 325 328 O
spinal NCT03929614 329 335 B-Condition-Name
curvature NCT03929614 336 345 I-Condition-Name
. NCT03929614 346 347 O

- NCT03929614 351 352 O
Patients NCT03929614 354 362 O
with NCT03929614 363 367 O
symptom NCT03929614 368 375 O
of NCT03929614 376 378 O
a NCT03929614 379 380 O
neurological NCT03929614 381 393 B-Condition-Name
disorder NCT03929614 394 402 I-Condition-Name
. NCT03929614 403 404 O

- NCT03929614 408 409 O
Patients NCT03929614 411 419 O
with NCT03929614 420 424 O
any NCT03929614 425 428 O
other NCT03929614 429 434 O
disorder NCT03929614 435 443 B-Condition-Name
of NCT03929614 444 446 I-Condition-Name
the NCT03929614 447 450 I-Condition-Name
musculoskeletal NCT03929614 451 466 I-Condition-Name
system NCT03929614 467 473 I-Condition-Name
affecting NCT03929614 474 483 O
the NCT03929614 484 487 O
lower NCT03929614 488 493 O
limbs NCT03929614 494 499 O
, NCT03929614 500 501 O

Inclusion NCT03926533 0 9 O
Criteria NCT03926533 10 18 O
: NCT03926533 19 20 O

- NCT03926533 24 25 O
index NCT03926533 27 32 O
ICU NCT03926533 33 36 B-Encounter-Type___Encounter-Type-Value:icu
stay NCT03926533 37 41 I-Encounter-Type___Encounter-Type-Value:icu
with NCT03926533 42 46 O
a NCT03926533 47 48 O
diagnosis NCT03926533 49 58 O
of NCT03926533 59 61 O
sepsis NCT03926533 62 68 B-Condition-Name
or NCT03926533 69 71 O
acute NCT03926533 72 77 B-Severity___Severity-Value:severe
respiratory NCT03926533 78 89 B-Condition-Name
distress NCT03926533 90 98 I-Condition-Name
syndrome NCT03926533 99 107 I-Condition-Name
projected NCT03926533 108 117 O
to NCT03926533 118 120 O
be NCT03926533 121 123 O
discharged NCT03926533 124 134 B-Encounter-Type___Encounter-Type-Value:discharge
alive NCT03926533 135 140 B-Condition-Name
as NCT03926533 141 143 O
these NCT03926533 144 149 O
patients NCT03926533 150 158 O
are NCT03926533 159 162 O
at NCT03926533 163 165 O
the NCT03926533 166 169 O
highest NCT03926533 170 177 B-Polarity___Polarity-Value:high
risk NCT03926533 178 182 O
for NCT03926533 183 186 O
developing NCT03926533 187 197 O
PICS NCT03926533 198 202 B-Condition-Name

Exclusion NCT03926533 203 212 O
Criteria NCT03926533 213 221 O
: NCT03926533 222 223 O

1 NCT03926533 228 229 O
. NCT03926533 229 230 O
no NCT03926533 232 234 O
access NCT03926533 235 241 O
to NCT03926533 242 244 O
computer NCT03926533 245 253 O
, NCT03926533 254 255 O
electronic NCT03926533 256 266 O
device NCT03926533 267 273 O
( NCT03926533 274 275 O
e NCT03926533 276 277 O
. NCT03926533 278 279 O
g NCT03926533 280 281 O
. NCT03926533 282 283 O
, NCT03926533 284 285 O
tablet NCT03926533 286 292 O
, NCT03926533 293 294 O
smartphone NCT03926533 295 305 O
) NCT03926533 306 307 O
, NCT03926533 309 310 O
and NCT03926533 311 314 O
/ NCT03926533 315 316 O
or NCT03926533 317 319 O
internet NCT03926533 320 328 O
connection NCT03926533 329 339 O
for NCT03926533 340 343 O
virtual NCT03926533 344 351 O
clinic NCT03926533 352 358 O
visit NCT03926533 359 364 O
, NCT03926533 365 366 O

2 NCT03926533 371 372 O
. NCT03926533 372 373 O
primary NCT03926533 375 382 O
care NCT03926533 383 387 O
received NCT03926533 388 396 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
outside NCT03926533 397 404 O
of NCT03926533 405 407 O
VUMC NCT03926533 408 412 B-Location___Location-Value:hospital
network NCT03926533 413 420 O
, NCT03926533 421 422 O

3 NCT03926533 427 428 O
. NCT03926533 428 429 O
hospice NCT03926533 431 438 B-Location___Location-Value:clinic
care NCT03926533 439 443 I-Location___Location-Value:clinic
at NCT03926533 444 446 O
discharge NCT03926533 447 456 B-Encounter-Type___Encounter-Type-Value:discharge
, NCT03926533 457 458 O

4 NCT03926533 463 464 O
. NCT03926533 464 465 O
substance NCT03926533 467 476 B-Condition-Name
abuse NCT03926533 477 482 I-Condition-Name
or NCT03926533 483 485 O
psychiatric NCT03926533 486 497 B-Condition-Name
disorder NCT03926533 498 506 I-Condition-Name
that NCT03926533 507 511 O
prevents NCT03926533 512 520 O
independent NCT03926533 521 532 B-Condition-Name
living NCT03926533 533 539 I-Condition-Name
, NCT03926533 540 541 O

5 NCT03926533 546 547 O
. NCT03926533 547 548 O
blind NCT03926533 550 555 B-Condition-Name
, NCT03926533 556 557 O
deaf NCT03926533 558 562 B-Condition-Name
, NCT03926533 563 564 O
unable NCT03926533 565 571 O
to NCT03926533 572 574 O
speak NCT03926533 575 580 O
English NCT03926533 581 588 B-Language
, NCT03926533 589 590 O
or NCT03926533 591 593 O

6 NCT03926533 597 598 O
. NCT03926533 598 599 O
severe NCT03926533 601 607 B-Condition-Name
dementia NCT03926533 608 616 I-Condition-Name
prior NCT03926533 617 622 O
to NCT03926533 623 625 O
index NCT03926533 626 631 O
hospitalization NCT03926533 632 647 B-Encounter-Type___Encounter-Type-Value:inpatient

Inclusion NCT03928496 0 9 O
Criteria NCT03928496 10 18 O
: NCT03928496 19 20 O

- NCT03928496 24 25 O
male NCT03928496 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03928496 32 34 O
female NCT03928496 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03928496 44 45 O
age NCT03928496 47 50 O
18 NCT03928496 52 54 B-Eq-Value
- NCT03928496 55 56 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03928496 58 60 B-Eq-Value

- NCT03928496 64 65 O
meets NCT03928496 67 72 O
International NCT03928496 73 86 B-Condition-Name
Classification NCT03928496 87 101 I-Condition-Name
Headache NCT03928496 102 110 I-Condition-Name
Disorders NCT03928496 111 120 I-Condition-Name
II NCT03928496 121 123 B-Eq-Value
( NCT03928496 124 125 O
ICHD NCT03928496 126 130 B-Condition-Name
- NCT03928496 131 132 O
II NCT03928496 133 135 B-Eq-Value
) NCT03928496 136 137 O
criteria NCT03928496 138 146 O
for NCT03928496 147 150 O
post NCT03928496 151 155 B-Condition-Name
- NCT03928496 156 157 I-Condition-Name
traumatic NCT03928496 158 167 I-Condition-Name
headache NCT03928496 168 176 I-Condition-Name

- NCT03928496 179 180 O
average NCT03928496 182 189 O
pain NCT03928496 190 194 B-Observation-Name
score NCT03928496 195 200 I-Observation-Name
of NCT03928496 201 203 O
greater NCT03928496 204 211 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03928496 212 216 I-Eq-Operator___Eq-Operator-Value:GT
4 NCT03928496 218 219 B-Eq-Value
/ NCT03928496 220 221 O
10 NCT03928496 223 225 B-Eq-Unit
in NCT03928496 226 228 O
severity NCT03928496 229 237 O
on NCT03928496 238 240 O
the NCT03928496 241 244 O
numerical NCT03928496 245 254 O
rating NCT03928496 255 261 O
system NCT03928496 262 268 O

- NCT03928496 271 272 O
Rancho NCT03928496 274 280 B-Observation-Name___Observation-Type-Value:clinical-score
Los NCT03928496 281 284 I-Observation-Name___Observation-Type-Value:clinical-score
Amigos NCT03928496 285 291 I-Observation-Name___Observation-Type-Value:clinical-score
cognitive NCT03928496 292 301 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03928496 302 307 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03928496 308 313 I-Observation-Name___Observation-Type-Value:clinical-score
greater NCT03928496 314 321 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03928496 322 326 I-Eq-Operator___Eq-Operator-Value:GT
seven NCT03928496 327 332 B-Eq-Value
. NCT03928496 333 334 O

Exclusion NCT03928496 336 345 O
Criteria NCT03928496 346 354 O
: NCT03928496 355 356 O

- NCT03928496 360 361 O
Uncontrolled NCT03928496 363 375 O
medical NCT03928496 376 383 O
condition NCT03928496 384 393 O
other NCT03928496 394 399 O
than NCT03928496 400 404 O
PTH NCT03928496 405 408 B-Condition-Name

- NCT03928496 411 412 O
Severe NCT03928496 414 420 B-Severity___Severity-Value:severe
additional NCT03928496 421 431 O
chronic NCT03928496 432 439 O
pain NCT03928496 440 444 B-Condition-Name
complaint NCT03928496 445 454 O
which NCT03928496 455 460 O
could NCT03928496 461 466 O
not NCT03928496 467 470 O
be NCT03928496 471 473 O
distinguished NCT03928496 474 487 O
from NCT03928496 488 492 O
headache NCT03928496 493 501 O
pain NCT03928496 502 506 B-Condition-Name

- NCT03928496 509 510 O
pregnancy NCT03928496 512 521 B-Condition-Name
, NCT03928496 522 523 O
breast NCT03928496 524 530 B-Condition-Name
feeding NCT03928496 531 538 I-Condition-Name
, NCT03928496 539 540 O

- NCT03928496 544 545 O
prior NCT03928496 547 552 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03928496 553 562 O
with NCT03928496 563 567 O
botulinum NCT03928496 568 577 B-Drug-Name
toxin NCT03928496 578 583 I-Drug-Name
within NCT03928496 584 590 B-Eq-Operator___Eq-Operator-Value:LTEQ
one NCT03928496 591 594 B-Eq-Value
year NCT03928496 595 599 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03928496 600 602 O
enrollment NCT03928496 603 613 O

- NCT03928496 616 617 O
current NCT03928496 619 626 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03928496 627 636 B-Condition-Name
abuse NCT03928496 637 642 I-Condition-Name
/ NCT03928496 643 644 O
dependence NCT03928496 645 655 B-Condition-Name

- NCT03928496 658 659 O
medical NCT03928496 661 668 O
condition NCT03928496 669 678 O
that NCT03928496 679 683 O
would NCT03928496 684 689 O
increase NCT03928496 690 698 B-Stability___Stability-Value:change
risk NCT03928496 699 703 O
of NCT03928496 704 706 O
neuromuscular NCT03928496 707 720 B-Condition-Name
junction NCT03928496 721 729 I-Condition-Name
blockade NCT03928496 730 738 I-Condition-Name
with NCT03928496 739 743 O
botulinum NCT03928496 744 753 B-Drug-Name
toxin NCT03928496 754 759 I-Drug-Name
( NCT03928496 760 761 O
myasthenia NCT03928496 762 772 B-Condition-Name
gravis NCT03928496 773 779 I-Condition-Name
, NCT03928496 780 781 O
Eaton NCT03928496 782 787 B-Condition-Name
Lambert NCT03928496 788 795 I-Condition-Name
, NCT03928496 796 797 O
amyotrophic NCT03928496 798 809 B-Condition-Name
lateral NCT03928496 810 817 I-Condition-Name
sclerosis NCT03928496 818 827 I-Condition-Name
) NCT03928496 828 829 O

- NCT03928496 833 834 O
poorly NCT03928496 836 842 O
controlled NCT03928496 843 853 O
psychiatric NCT03928496 854 865 O

- NCT03928496 868 869 O
initiation NCT03928496 871 881 O
of NCT03928496 882 884 O
a NCT03928496 885 886 O
new NCT03928496 887 890 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
anti NCT03928496 891 895 B-Drug-Name
- NCT03928496 896 897 I-Drug-Name
depressant NCT03928496 898 908 I-Drug-Name
or NCT03928496 909 911 O
anti NCT03928496 912 916 B-Drug-Name
- NCT03928496 917 918 I-Drug-Name
seizure NCT03928496 919 926 I-Drug-Name
medication NCT03928496 927 937 I-Drug-Name
within NCT03928496 938 944 B-Eq-Operator___Eq-Operator-Value:LTEQ
three NCT03928496 945 950 B-Eq-Value
months NCT03928496 951 957 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03928496 958 960 O
enrolling NCT03928496 961 970 O
in NCT03928496 971 973 O
study NCT03928496 974 979 O

- NCT03928496 982 983 O
ongoing NCT03928496 985 992 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
disability NCT03928496 993 1003 B-Condition-Name
or NCT03928496 1004 1006 O
litigation NCT03928496 1007 1017 O
claim NCT03928496 1018 1023 O
. NCT03928496 1024 1025 O

Inclusion NCT03925818 0 9 O
Criteria NCT03925818 10 18 O
: NCT03925818 19 20 O

- NCT03925818 23 24 O
Positive NCT03925818 25 33 B-Polarity___Polarity-Value:positive
for NCT03925818 34 37 O
H NCT03925818 38 39 B-Organism-Name
. NCT03925818 40 41 I-Organism-Name
pylori NCT03925818 43 49 I-Organism-Name
infection NCT03925818 50 59 B-Condition-Name

Exclusion NCT03925818 60 69 O
Criteria NCT03925818 70 78 O
: NCT03925818 79 80 O

- NCT03925818 84 85 O
Presence NCT03925818 87 95 O
of NCT03925818 96 98 O
malignancy NCT03925818 99 109 B-Condition-Name

- NCT03925818 112 113 O
Pregnancy NCT03925818 115 124 B-Condition-Name
or NCT03925818 125 127 O
lactation NCT03925818 128 137 B-Condition-Name

- NCT03925818 140 141 O
Clinically NCT03925818 143 153 O
significant NCT03925818 154 165 B-Severity___Severity-Value:severe
diseases NCT03925818 166 174 B-Condition-Name

- NCT03925818 177 178 O
History NCT03925818 180 187 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925818 188 190 O
drug NCT03925818 191 195 O
or NCT03925818 196 198 O
alcohol NCT03925818 199 206 O
abuse NCT03925818 207 212 B-Condition-Name

- NCT03925818 215 216 O
Allergy NCT03925818 218 225 O
to NCT03925818 226 228 O
pantoprazole NCT03925818 229 241 B-Drug-Name
or NCT03925818 242 244 O
to NCT03925818 245 247 O
any NCT03925818 248 251 O
component NCT03925818 252 261 O
of NCT03925818 262 264 O
regimens NCT03925818 265 273 O
used NCT03925818 274 278 O
in NCT03925818 279 281 O
the NCT03925818 282 285 O
study NCT03925818 286 291 O

- NCT03925818 294 295 O
Use NCT03925818 297 300 O
of NCT03925818 301 303 O
anti NCT03925818 304 308 B-Drug-Name
- NCT03925818 309 310 I-Drug-Name
secretory NCT03925818 311 320 I-Drug-Name
drugs NCT03925818 321 326 I-Drug-Name
, NCT03925818 327 328 O
antibiotics NCT03925818 329 340 B-Drug-Name
or NCT03925818 341 343 O
probiotics NCT03925818 344 354 B-Drug-Name
4 NCT03925818 356 357 B-Eq-Value
weeks NCT03925818 358 363 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
preceding NCT03925818 364 373 O
the NCT03925818 374 377 O
enrollment NCT03925818 378 388 O
. NCT03925818 389 390 O

Inclusion NCT03929978 0 9 O
Criteria NCT03929978 10 18 O
: NCT03929978 19 20 O

- NCT03929978 24 25 O
Inclusion NCT03929978 27 36 O
criteria NCT03929978 37 45 O
and NCT03929978 46 49 O
justification NCT03929978 50 63 O
hereof NCT03929978 64 70 O
: NCT03929978 71 72 O

1 NCT03929978 82 83 O
. NCT03929978 83 84 O
Have NCT03929978 86 90 O
a NCT03929978 91 92 O
colostomy NCT03929978 93 102 B-Procedure-Name
, NCT03929978 103 104 O
ileostomy NCT03929978 105 114 B-Procedure-Name
( NCT03929978 115 116 O
jejunostomy NCT03929978 117 128 B-Procedure-Name
) NCT03929978 129 130 O
, NCT03929978 132 133 O
loop NCT03929978 134 138 B-Procedure-Name
stoma NCT03929978 139 144 I-Procedure-Name
, NCT03929978 145 146 O
or NCT03929978 147 149 O
two NCT03929978 150 153 B-Eq-Value
stomas NCT03929978 154 160 B-Procedure-Name
placed NCT03929978 161 167 O
closely NCT03929978 168 175 O
together NCT03929978 176 184 O

2 NCT03929978 193 194 O
. NCT03929978 194 195 O
Have NCT03929978 197 201 O
given NCT03929978 202 207 O
written NCT03929978 208 215 O
informed NCT03929978 216 224 O
consent NCT03929978 225 232 O
( NCT03929978 233 234 O
the NCT03929978 235 238 O
legal NCT03929978 239 244 O
authorized NCT03929978 245 255 O
representative NCT03929978 256 270 O
of NCT03929978 271 273 O
the NCT03929978 274 277 O
subject NCT03929978 278 285 O
) NCT03929978 286 287 O

Exclusion NCT03929978 289 298 O
Criteria NCT03929978 299 307 O
: NCT03929978 308 309 O

- NCT03929978 313 314 O
The NCT03929978 316 319 O
subjects NCT03929978 320 328 O
are NCT03929978 329 332 O
not NCT03929978 333 336 O
allowed NCT03929978 337 344 O
to NCT03929978 345 347 O
participate NCT03929978 348 359 O
in NCT03929978 360 362 O
case NCT03929978 363 367 O
they NCT03929978 368 372 O
: NCT03929978 373 374 O

Are NCT03929978 376 379 O
currently NCT03929978 380 389 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
suffering NCT03929978 390 399 O
from NCT03929978 400 404 O
peristomal NCT03929978 405 415 B-Condition-Name
skin NCT03929978 416 420 I-Condition-Name
problems NCT03929978 421 429 I-Condition-Name
i NCT03929978 430 431 O
. NCT03929978 432 433 O
e NCT03929978 434 435 O
. NCT03929978 436 437 O
bleeding NCT03929978 439 447 B-Condition-Name
and NCT03929978 448 451 O
/ NCT03929978 452 453 O
or NCT03929978 454 456 O
broken NCT03929978 457 463 B-Condition-Name
skin NCT03929978 464 468 I-Condition-Name

( NCT03929978 470 471 O
assessed NCT03929978 472 480 O
by NCT03929978 481 483 O
the NCT03929978 484 487 O
investigator NCT03929978 488 500 O
) NCT03929978 501 502 O

Inclusion NCT03924284 0 9 O
Criteria NCT03924284 10 18 O
: NCT03924284 19 20 O

- NCT03924284 24 25 O
Nasopharyngeal NCT03924284 27 41 B-Observation-Specimen
or NCT03924284 42 44 O
saliva NCT03924284 45 51 B-Observation-Specimen
specimens NCT03924284 52 61 O
of NCT03924284 62 64 O
patients NCT03924284 65 73 O
in NCT03924284 74 76 O
Queen NCT03924284 77 82 B-Location___Location-Value:hospital
Mary NCT03924284 83 87 I-Location___Location-Value:hospital
Hospital NCT03924284 88 96 I-Location___Location-Value:hospital
of NCT03924284 97 99 I-Location___Location-Value:hospital
Hong NCT03924284 100 104 I-Location___Location-Value:hospital
Kong NCT03924284 105 109 I-Location___Location-Value:hospital

- NCT03924284 112 113 O
Tested NCT03924284 115 121 O
for NCT03924284 122 125 O
influenza NCT03924284 126 135 B-Observation-Name___Observation-Type-Value:lab
A NCT03924284 136 137 I-Observation-Name___Observation-Type-Value:lab
virus NCT03924284 138 143 I-Observation-Name___Observation-Type-Value:lab
using NCT03924284 144 149 O
a NCT03924284 150 151 O
commercially NCT03924284 152 164 O
available NCT03924284 165 174 O
assay NCT03924284 175 180 O
or NCT03924284 181 183 O
by NCT03924284 184 186 O
the NCT03924284 187 190 O
Public NCT03924284 191 197 B-Location___Location-Value:clinic
Health NCT03924284 198 204 I-Location___Location-Value:clinic
Laboratory NCT03924284 205 215 I-Location___Location-Value:clinic
Services NCT03924284 216 224 I-Location___Location-Value:clinic
Branch NCT03924284 225 231 I-Location___Location-Value:clinic
in NCT03924284 232 234 O
Hong NCT03924284 235 239 B-Location
Kong NCT03924284 240 244 I-Location

Exclusion NCT03924284 245 254 O
Criteria NCT03924284 255 263 O
: NCT03924284 264 265 O

- NCT03924284 269 270 O
Insufficient NCT03924284 272 284 O
specimen NCT03924284 285 293 O
volume NCT03924284 294 300 O

Inclusion NCT03922178 0 9 O
Criteria NCT03922178 10 18 O
: NCT03922178 19 20 O

- NCT03922178 24 25 O
Patient NCT03922178 27 34 O
of NCT03922178 35 37 O
the NCT03922178 38 41 O
CHU NCT03922178 42 45 B-Location___Location-Value:hospital
Brugmann NCT03922178 46 54 I-Location___Location-Value:hospital
Hospital NCT03922178 55 63 I-Location___Location-Value:hospital
receiving NCT03922178 64 73 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03922178 74 82 O
coronary NCT03922178 83 91 B-Procedure-Name
surgery NCT03922178 92 99 I-Procedure-Name
. NCT03922178 100 101 O

- NCT03922178 105 106 O
Patient NCT03922178 108 115 O
in NCT03922178 116 118 O
sinusal NCT03922178 119 126 B-Condition-Name
rhythm NCT03922178 127 133 I-Condition-Name
before NCT03922178 134 140 O
the NCT03922178 141 144 O
operation NCT03922178 145 154 O
and NCT03922178 155 158 O
during NCT03922178 159 165 O
the NCT03922178 166 169 O
collection NCT03922178 170 180 O
of NCT03922178 181 183 O
hemodynamic NCT03922178 184 195 O
data NCT03922178 196 200 O
. NCT03922178 201 202 O

- NCT03922178 206 207 O
Patients NCT03922178 209 217 O
with NCT03922178 218 222 O
conserved NCT03922178 223 232 B-Condition-Name
left NCT03922178 233 237 I-Condition-Name
ventricular NCT03922178 238 249 I-Condition-Name
function NCT03922178 250 258 I-Condition-Name
( NCT03922178 259 260 O
based NCT03922178 261 266 O
on NCT03922178 267 269 O
left NCT03922178 270 274 B-Observation-Name___Observation-Type-Value:measurement
ventricular NCT03922178 275 286 I-Observation-Name___Observation-Type-Value:measurement
ejection NCT03922178 287 295 I-Observation-Name___Observation-Type-Value:measurement
fraction NCT03922178 296 304 I-Observation-Name___Observation-Type-Value:measurement
assessed NCT03922178 305 313 O
by NCT03922178 314 316 O
pre NCT03922178 317 320 O
operative NCT03922178 321 330 O
echocardiography NCT03922178 331 347 B-Procedure-Name
and NCT03922178 348 351 O
superior NCT03922178 352 360 B-Eq-Operator___Eq-Operator-Value:GT
to NCT03922178 361 363 O
50 NCT03922178 365 367 B-Eq-Value
% NCT03922178 368 369 B-Eq-Unit
) NCT03922178 371 372 O

Exclusion NCT03922178 374 383 O
Criteria NCT03922178 384 392 O
: NCT03922178 393 394 O

- NCT03922178 398 399 O
Hypertrophic NCT03922178 401 413 B-Condition-Name
cardiomyopathy NCT03922178 414 428 I-Condition-Name
( NCT03922178 429 430 O
diastolic NCT03922178 431 440 B-Observation-Name___Observation-Type-Value:measurement
septal NCT03922178 441 447 I-Observation-Name___Observation-Type-Value:measurement
thickness NCT03922178 448 457 I-Observation-Name___Observation-Type-Value:measurement
> NCT03922178 458 459 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03922178 461 463 B-Eq-Value
mm NCT03922178 464 466 B-Eq-Unit
) NCT03922178 467 468 O

- NCT03922178 472 473 O
Heart NCT03922178 475 480 B-Condition-Name
failure NCT03922178 481 488 I-Condition-Name
with NCT03922178 489 493 O
left NCT03922178 494 498 B-Observation-Name___Observation-Type-Value:measurement
ventricular NCT03922178 499 510 I-Observation-Name___Observation-Type-Value:measurement
ejection NCT03922178 511 519 I-Observation-Name___Observation-Type-Value:measurement
fraction NCT03922178 520 528 I-Observation-Name___Observation-Type-Value:measurement
< NCT03922178 529 530 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03922178 532 534 B-Eq-Value
% NCT03922178 535 536 B-Eq-Unit

- NCT03922178 540 541 O
Presence NCT03922178 543 551 O
of NCT03922178 552 554 O
cardiac NCT03922178 555 562 B-Condition-Name
valvulopathy NCT03922178 563 575 I-Condition-Name
, NCT03922178 576 577 O
concerning NCT03922178 578 588 O
both NCT03922178 589 593 O
right NCT03922178 594 599 O
and NCT03922178 600 603 O
left NCT03922178 604 608 O
atrio NCT03922178 609 614 O
- NCT03922178 615 616 O
ventricular NCT03922178 617 628 O
and NCT03922178 629 632 O
ventriculo NCT03922178 633 643 O
- NCT03922178 644 645 O
arterial NCT03922178 646 654 O
valves NCT03922178 655 661 O

- NCT03922178 664 665 O
Presence NCT03922178 667 675 O
of NCT03922178 676 678 O
valvular NCT03922178 679 687 B-Procedure-Name
prosthesis NCT03922178 688 698 I-Procedure-Name

- NCT03922178 701 702 O
Congenital NCT03922178 704 714 B-Condition-Name
heart NCT03922178 715 720 I-Condition-Name
disease NCT03922178 721 728 I-Condition-Name

- NCT03922178 731 732 O
Pregnancy NCT03922178 734 743 B-Condition-Name

- NCT03922178 746 747 O
Participation NCT03922178 749 762 O
to NCT03922178 763 765 O
another NCT03922178 766 773 O
clinical NCT03922178 774 782 O
study NCT03922178 783 788 O

Inclusion NCT03927014 0 9 O
Criteria NCT03927014 10 18 O
: NCT03927014 19 20 O

- NCT03927014 24 25 O
preeclampsia NCT03927014 27 39 B-Condition-Name

- NCT03927014 42 43 O
healthy NCT03927014 45 52 B-Condition-Name
pregnancy NCT03927014 53 62 B-Condition-Name

Exclusion NCT03927014 63 72 O
Criteria NCT03927014 73 81 O
: NCT03927014 82 83 O

- NCT03927014 87 88 O
pregnant NCT03927014 90 98 B-Condition-Name
women NCT03927014 99 104 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03927014 105 109 O
any NCT03927014 110 113 O
systemic NCT03927014 114 122 O
condition NCT03927014 123 132 B-Condition-Name
( NCT03927014 133 134 O
such NCT03927014 135 139 O
as NCT03927014 140 142 O
chronic NCT03927014 143 150 B-Condition-Name
hypertension NCT03927014 151 163 I-Condition-Name
, NCT03927014 164 165 O
diabetes NCT03927014 166 174 B-Condition-Name
mellitus NCT03927014 175 183 I-Condition-Name
, NCT03927014 184 185 O
thyroid NCT03927014 186 193 B-Condition-Name
diseases NCT03927014 194 202 I-Condition-Name
, NCT03927014 203 204 O
liver NCT03927014 205 210 O
and NCT03927014 211 214 O
kidney NCT03927014 215 221 O
diseases NCT03927014 222 230 B-Condition-Name
) NCT03927014 231 232 O

- NCT03927014 236 237 O
women NCT03927014 239 244 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
with NCT03927014 245 249 O
a NCT03927014 250 251 O
history NCT03927014 252 259 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927014 260 262 O
drug NCT03927014 263 267 B-Condition-Name
use NCT03927014 268 271 I-Condition-Name
throughout NCT03927014 272 282 O
pregnancy NCT03927014 283 292 B-Condition-Name

- NCT03927014 295 296 O
history NCT03927014 298 305 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927014 306 308 O
medication NCT03927014 309 319 O
for NCT03927014 320 323 O
PE NCT03927014 324 326 B-Condition-Name
treatment NCT03927014 327 336 O
at NCT03927014 337 339 O
the NCT03927014 340 343 O
time NCT03927014 344 348 O
of NCT03927014 349 351 O
first NCT03927014 352 357 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
admission NCT03927014 358 367 B-Encounter-Type___Encounter-Type-Value:inpatient

- NCT03927014 370 371 O
patients NCT03927014 373 381 O
who NCT03927014 382 385 O
had NCT03927014 386 389 O
fetal NCT03927014 390 395 B-Condition-Name
congenital NCT03927014 396 406 I-Condition-Name
abnormalities NCT03927014 407 420 I-Condition-Name
or NCT03927014 421 423 O
genetic NCT03927014 424 431 B-Condition-Name
syndromes NCT03927014 432 441 I-Condition-Name

- NCT03927014 444 445 O
multiple NCT03927014 447 455 B-Condition-Name
gestation NCT03927014 456 465 I-Condition-Name

- NCT03927014 468 469 O
active NCT03927014 471 477 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
labor NCT03927014 478 483 B-Condition-Name

Inclusion NCT03920592 0 9 O
Criteria NCT03920592 10 18 O
: NCT03920592 19 20 O

- NCT03920592 24 25 O
All NCT03920592 27 30 O
pupils NCT03920592 31 37 O
assisting NCT03920592 38 47 O
5 NCT03920592 49 50 O
th NCT03920592 51 53 O
and NCT03920592 54 57 O
6 NCT03920592 59 60 O
th NCT03920592 61 63 O
grade NCT03920592 64 69 O
of NCT03920592 70 72 O
primary NCT03920592 73 80 O
school NCT03920592 81 87 O
( NCT03920592 88 89 O
Spain NCT03920592 90 95 O
education NCT03920592 96 105 O
system NCT03920592 106 112 O
) NCT03920592 113 114 O
of NCT03920592 115 117 O
the NCT03920592 118 121 O
" NCT03920592 122 123 B-Location
Escola NCT03920592 123 129 I-Location
Parc NCT03920592 130 134 I-Location
del NCT03920592 135 138 I-Location
Guinardó NCT03920592 139 147 I-Location
" NCT03920592 147 148 I-Location
school NCT03920592 149 155 I-Location

- NCT03920592 158 159 O
Pupils NCT03920592 161 167 O
who NCT03920592 168 171 O
s NCT03920592 171 172 O
parents NCT03920592 173 180 O
have NCT03920592 181 185 O
read NCT03920592 186 190 O
, NCT03920592 191 192 O
understand NCT03920592 193 203 O
and NCT03920592 204 207 O
approved NCT03920592 208 216 O
the NCT03920592 217 220 O
informed NCT03920592 221 229 O
consent NCT03920592 230 237 O
of NCT03920592 238 240 O
the NCT03920592 241 244 O
study NCT03920592 245 250 O
. NCT03920592 251 252 O

Exclusion NCT03920592 254 263 O
Criteria NCT03920592 264 272 O
: NCT03920592 273 274 O

- NCT03920592 278 279 O
Pupils NCT03920592 281 287 O
whose NCT03920592 288 293 O
parents NCT03920592 294 301 O
have NCT03920592 302 306 O
not NCT03920592 307 310 O
approved NCT03920592 311 319 O
their NCT03920592 320 325 O
inclusion NCT03920592 326 335 O
in NCT03920592 336 338 O
the NCT03920592 339 342 O
study NCT03920592 343 348 O
. NCT03920592 349 350 O

Inclusion NCT03921840 0 9 O
Criteria NCT03921840 10 18 O
: NCT03921840 19 20 O

- NCT03921840 24 25 O
Intact NCT03921840 27 33 B-Condition-Name
cognition NCT03921840 34 43 I-Condition-Name

- NCT03921840 46 47 O
Poor NCT03921840 49 53 B-Condition-Name
sleep NCT03921840 54 59 I-Condition-Name
quality NCT03921840 60 67 I-Condition-Name

- NCT03921840 70 71 O
Self NCT03921840 73 77 O
- NCT03921840 78 79 O
reported NCT03921840 80 88 O
presence NCT03921840 89 97 O
of NCT03921840 98 100 O
pain NCT03921840 101 105 B-Condition-Name

- NCT03921840 108 109 O
Capacity NCT03921840 111 119 O
for NCT03921840 120 123 O
mild NCT03921840 124 128 B-Severity___Severity-Value:mild
to NCT03921840 129 131 O
moderate NCT03921840 132 140 B-Severity___Severity-Value:moderate
physical NCT03921840 141 149 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03921840 150 158 I-Observation-Name___Observation-Type-Value:social-habit
. NCT03921840 159 160 O

Exclusion NCT03921840 162 171 O
Criteria NCT03921840 172 180 O
: NCT03921840 181 182 O

- NCT03921840 186 187 O
Non NCT03921840 189 192 O
- NCT03921840 193 194 O
ambulatory NCT03921840 195 205 B-Condition-Name
or NCT03921840 206 208 O
have NCT03921840 209 213 O
severely NCT03921840 214 222 B-Severity___Severity-Value:severe
impaired NCT03921840 223 231 B-Condition-Name
mobility NCT03921840 232 240 I-Condition-Name
, NCT03921840 241 242 O

- NCT03921840 246 247 O
Visual NCT03921840 249 255 O
or NCT03921840 256 258 O
hearing NCT03921840 259 266 O
impairment NCT03921840 267 277 B-Condition-Name
that NCT03921840 278 282 O
interfered NCT03921840 283 293 O
with NCT03921840 294 298 O
assessments NCT03921840 299 310 O
, NCT03921840 311 312 O
and NCT03921840 313 316 O

- NCT03921840 319 320 O
An NCT03921840 322 324 O
acute NCT03921840 325 330 B-Severity___Severity-Value:severe
or NCT03921840 331 333 O
a NCT03921840 334 335 O
terminal NCT03921840 336 344 O
illness NCT03921840 345 352 B-Condition-Name

- NCT03921840 355 356 O
Neuropathic NCT03921840 358 369 O
pain NCT03921840 370 374 B-Condition-Name

Inclusion NCT03929549 0 9 O
Criteria NCT03929549 10 18 O
: NCT03929549 19 20 O

- NCT03929549 24 25 O
Moderate NCT03929549 27 35 B-Severity___Severity-Value:moderate
to NCT03929549 36 38 O
severe NCT03929549 39 45 B-Severity___Severity-Value:severe
OSA NCT03929549 46 49 B-Condition-Name
( NCT03929549 50 51 O
AHI NCT03929549 52 55 B-Observation-Name
> NCT03929549 56 57 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03929549 59 61 B-Eq-Value
) NCT03929549 62 63 O

- NCT03929549 67 68 O
Age NCT03929549 70 73 O
18 NCT03929549 75 77 B-Eq-Value
years NCT03929549 78 83 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03929549 84 86 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03929549 87 92 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03929549 95 96 O
BMI NCT03929549 98 101 B-Observation-Name___Observation-Type-Value:vital
< NCT03929549 102 103 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03929549 105 107 B-Eq-Value
, NCT03929549 108 109 O

- NCT03929549 114 115 O
Baseline NCT03929549 117 125 O
polysomnogram NCT03929549 126 139 B-Procedure-Name
completed NCT03929549 140 149 O
within NCT03929549 150 156 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03929549 157 160 O
last NCT03929549 161 165 O
12 NCT03929549 167 169 B-Eq-Value
months NCT03929549 170 176 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
with NCT03929549 177 181 O
no NCT03929549 182 184 O
significant NCT03929549 185 196 B-Severity___Severity-Value:severe
weight NCT03929549 197 203 B-Observation-Name___Observation-Type-Value:vital
changes NCT03929549 204 211 B-Stability___Stability-Value:change
( NCT03929549 212 213 O
< NCT03929549 215 216 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03929549 218 220 B-Eq-Value
lbs NCT03929549 221 224 B-Eq-Unit
. NCT03929549 225 226 O
weight NCT03929549 228 234 O
fluctuation NCT03929549 235 246 O
) NCT03929549 247 248 O
. NCT03929549 250 251 O

- NCT03929549 255 256 O
The NCT03929549 258 261 O
baseline NCT03929549 262 270 O
sleep NCT03929549 271 276 O
study NCT03929549 277 282 O
must NCT03929549 283 287 O
be NCT03929549 288 290 O
diagnostic NCT03929549 291 301 O
with NCT03929549 302 306 O
adequate NCT03929549 307 315 O
sample NCT03929549 316 322 O

Exclusion NCT03929549 323 332 O
Criteria NCT03929549 333 341 O
: NCT03929549 342 343 O

- NCT03929549 347 348 O
BMI NCT03929549 350 353 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03929549 354 355 B-Eq-Operator___Eq-Operator-Value:GTEQ
40 NCT03929549 357 359 B-Eq-Value

- NCT03929549 363 364 O
pregnancy NCT03929549 366 375 B-Condition-Name

- NCT03929549 378 379 O
Central NCT03929549 381 388 B-Condition-Name
sleep NCT03929549 389 394 I-Condition-Name
apnea NCT03929549 395 400 I-Condition-Name
( NCT03929549 401 402 O
CSA NCT03929549 403 406 B-Condition-Name
) NCT03929549 407 408 O
- NCT03929549 409 410 O
5 NCT03929549 412 413 B-Eq-Value
or NCT03929549 414 416 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03929549 417 421 I-Eq-Operator___Eq-Operator-Value:GTEQ
central NCT03929549 422 429 B-Observation-Name
apneas NCT03929549 430 436 I-Observation-Name
per NCT03929549 437 440 O
hour NCT03929549 441 445 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

- NCT03929549 448 449 O
Psychoactive NCT03929549 451 463 B-Drug-Name
medications NCT03929549 464 475 I-Drug-Name
that NCT03929549 476 480 O
influence NCT03929549 481 490 B-Stability___Stability-Value:change
sleep NCT03929549 491 496 B-Condition-Name

- NCT03929549 499 500 O
Chronic NCT03929549 502 509 O
opioid NCT03929549 510 516 B-Drug-Name
use NCT03929549 517 520 O

- NCT03929549 523 524 O
Other NCT03929549 526 531 O
sleep NCT03929549 532 537 B-Condition-Name
disorders NCT03929549 538 547 I-Condition-Name

- NCT03929549 550 551 O
Active NCT03929549 553 559 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
temporomandibular NCT03929549 560 577 O
joint NCT03929549 578 583 O
( NCT03929549 584 585 O
TMJ NCT03929549 586 589 O
) NCT03929549 590 591 O
Disorders NCT03929549 592 601 B-Condition-Name

- NCT03929549 604 605 O
Fibromyalgia NCT03929549 607 619 B-Condition-Name
with NCT03929549 620 624 O
significant NCT03929549 625 636 B-Severity___Severity-Value:severe
facial NCT03929549 637 643 O
pain NCT03929549 644 648 B-Condition-Name

- NCT03929549 651 652 O
Inability NCT03929549 654 663 O
to NCT03929549 664 666 O
protrude NCT03929549 667 675 B-Observation-Name
the NCT03929549 676 679 I-Observation-Name
mandible NCT03929549 680 688 I-Observation-Name
beyond NCT03929549 689 695 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03929549 697 698 B-Eq-Value
mm NCT03929549 699 701 B-Eq-Unit

- NCT03929549 704 705 O
Inability NCT03929549 707 716 O
to NCT03929549 717 719 O
follow NCT03929549 720 726 O
- NCT03929549 727 728 O
up NCT03929549 729 731 O
after NCT03929549 732 737 O
surgery NCT03929549 738 745 B-Procedure-Name

- NCT03929549 748 749 O
Uncontrolled NCT03929549 751 763 O
psychiatric NCT03929549 764 775 B-Condition-Name
disorders NCT03929549 776 785 I-Condition-Name

- NCT03929549 788 789 O
Dental NCT03929549 791 797 B-Condition-Name
disorders NCT03929549 798 807 I-Condition-Name
including NCT03929549 808 817 O
loose NCT03929549 818 823 B-Condition-Name
teeth NCT03929549 824 829 I-Condition-Name
and NCT03929549 830 833 O
periodontal NCT03929549 834 845 B-Condition-Name
disease NCT03929549 846 853 I-Condition-Name

Inclusion NCT03920579 0 9 O
Criteria NCT03920579 10 18 O
: NCT03920579 19 20 O

1 NCT03920579 25 26 O
. NCT03920579 26 27 O
Healthy NCT03920579 29 36 B-Condition-Name
volunteers NCT03920579 37 47 O
aged NCT03920579 48 52 O
between NCT03920579 53 60 O
≥ NCT03920579 61 62 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03920579 64 66 B-Eq-Value
and NCT03920579 67 70 B-Eq-Operator___Eq-Operator-Value:BETWEEN
≤ NCT03920579 71 72 B-Eq-Operator___Eq-Operator-Value:LTEQ
45 NCT03920579 74 76 B-Eq-Value
years NCT03920579 77 82 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03920579 83 86 O

2 NCT03920579 90 91 O
. NCT03920579 91 92 O
Weight NCT03920579 94 100 B-Observation-Name___Observation-Type-Value:vital
≥ NCT03920579 101 102 B-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03920579 104 106 B-Eq-Value
kg NCT03920579 107 109 B-Eq-Unit
, NCT03920579 110 111 O
with NCT03920579 112 116 O
calculated NCT03920579 117 127 O
body NCT03920579 128 132 B-Observation-Name___Observation-Type-Value:vital
mass NCT03920579 133 137 I-Observation-Name___Observation-Type-Value:vital
index NCT03920579 138 143 I-Observation-Name___Observation-Type-Value:vital
( NCT03920579 144 145 O
BMI NCT03920579 146 149 B-Observation-Name___Observation-Type-Value:vital
) NCT03920579 150 151 O
of NCT03920579 152 154 O
≥ NCT03920579 155 156 B-Eq-Operator___Eq-Operator-Value:GTEQ
18.5 NCT03920579 158 162 B-Eq-Value
and NCT03920579 163 166 O
≤ NCT03920579 167 168 B-Eq-Operator___Eq-Operator-Value:LTEQ
27.0 NCT03920579 170 174 B-Eq-Value
kg NCT03920579 175 177 B-Eq-Unit
/ NCT03920579 178 179 O
m NCT03920579 180 181 B-Eq-Unit
2 NCT03920579 182 183 I-Eq-Unit

3 NCT03920579 187 188 O
. NCT03920579 188 189 O
Those NCT03920579 191 196 O
who NCT03920579 197 200 O
have NCT03920579 201 205 O
no NCT03920579 206 208 O
congenital NCT03920579 209 219 B-Condition-Name
chronic NCT03920579 220 227 I-Condition-Name
disease NCT03920579 228 235 I-Condition-Name
or NCT03920579 236 238 O
chronic NCT03920579 239 246 B-Condition-Name
disease NCT03920579 247 254 I-Condition-Name
requiring NCT03920579 255 264 O
treatment NCT03920579 265 274 O
and NCT03920579 275 278 O
who NCT03920579 279 282 O
have NCT03920579 283 287 O
no NCT03920579 288 290 O
pathological NCT03920579 291 303 B-Condition-Name
symptoms NCT03920579 304 312 O
or NCT03920579 313 315 O
findings NCT03920579 316 324 O

4 NCT03920579 328 329 O
. NCT03920579 329 330 O
Those NCT03920579 332 337 O
who NCT03920579 338 341 O
are NCT03920579 342 345 O
judged NCT03920579 346 352 O
to NCT03920579 353 355 O
be NCT03920579 356 358 O
eligible NCT03920579 359 367 O
for NCT03920579 368 371 O
clinical NCT03920579 372 380 O
trials NCT03920579 381 387 O
based NCT03920579 388 393 O
on NCT03920579 394 396 O
laboratory NCT03920579 397 407 B-Observation-Name___Observation-Type-Value:lab
and NCT03920579 408 411 O
ECG NCT03920579 412 415 B-Observation-Name___Observation-Type-Value:measurement
results NCT03920579 416 423 O
during NCT03920579 424 430 O
screening NCT03920579 431 440 O
tests NCT03920579 441 446 O

5 NCT03920579 450 451 O
. NCT03920579 451 452 O
Those NCT03920579 454 459 O
who NCT03920579 460 463 O
voluntarily NCT03920579 464 475 O
decide NCT03920579 476 482 O
to NCT03920579 483 485 O
participate NCT03920579 486 497 O
and NCT03920579 498 501 O
agree NCT03920579 502 507 O
to NCT03920579 508 510 O
comply NCT03920579 511 517 O
with NCT03920579 518 522 O
the NCT03920579 523 526 O
cautions NCT03920579 527 535 O
after NCT03920579 536 541 O
hearing NCT03920579 542 549 O
and NCT03920579 550 553 O
fully NCT03920579 554 559 O
understanding NCT03920579 560 573 O
the NCT03920579 574 577 O
detailed NCT03920579 578 586 O
description NCT03920579 587 598 O
of NCT03920579 599 601 O
this NCT03920579 602 606 O
clinical NCT03920579 607 615 O
trial NCT03920579 616 621 O

Exclusion NCT03920579 622 631 O
Criteria NCT03920579 632 640 O
: NCT03920579 641 642 O

1 NCT03920579 647 648 O
. NCT03920579 648 649 O
History NCT03920579 651 658 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920579 659 661 O
presence NCT03920579 662 670 O
of NCT03920579 671 673 O
hepatobiliary NCT03920579 674 687 O
, NCT03920579 688 689 O
renal NCT03920579 690 695 O
, NCT03920579 696 697 O
cardiovascular NCT03920579 698 712 O
, NCT03920579 713 714 O
endocrine NCT03920579 715 724 O
, NCT03920579 725 726 O
respiratory NCT03920579 727 738 O
, NCT03920579 739 740 O
gastrointestinal NCT03920579 741 757 O
, NCT03920579 758 759 O
hematological NCT03920579 760 773 O
, NCT03920579 774 775 O
neurologic NCT03920579 776 786 O
, NCT03920579 787 788 O
psychiatric NCT03920579 789 800 O
or NCT03920579 801 803 O
musculoskeletal NCT03920579 804 819 O
disorders NCT03920579 820 829 B-Condition-Name
affecting NCT03920579 830 839 B-Stability___Stability-Value:change
absorption NCT03920579 840 850 O
, NCT03920579 851 852 O
distribution NCT03920579 853 865 O
, NCT03920579 866 867 O
metabolism NCT03920579 868 878 O
and NCT03920579 879 882 O
excretion NCT03920579 883 892 O
of NCT03920579 893 895 O
the NCT03920579 896 899 O
drug NCT03920579 900 904 O

2 NCT03920579 908 909 O
. NCT03920579 909 910 O
Genetic NCT03920579 912 919 B-Condition-Name
problems NCT03920579 920 928 I-Condition-Name
such NCT03920579 929 933 O
as NCT03920579 934 936 O
galactose NCT03920579 937 946 B-Condition-Name
intolerance NCT03920579 947 958 I-Condition-Name
, NCT03920579 959 960 O
Lapp NCT03920579 961 965 B-Condition-Name
lactose NCT03920579 966 973 I-Condition-Name
deficiency NCT03920579 974 984 I-Condition-Name
or NCT03920579 985 987 O
glucose NCT03920579 988 995 B-Condition-Name
- NCT03920579 996 997 I-Condition-Name
galactose NCT03920579 998 1007 I-Condition-Name
malabsorption NCT03920579 1008 1021 I-Condition-Name

3 NCT03920579 1025 1026 O
. NCT03920579 1026 1027 O
Those NCT03920579 1029 1034 O
who NCT03920579 1035 1038 O
are NCT03920579 1039 1042 O
deemed NCT03920579 1043 1049 O
unfit NCT03920579 1050 1055 O
by NCT03920579 1056 1058 O
the NCT03920579 1059 1062 O
investigators NCT03920579 1063 1076 O
to NCT03920579 1077 1079 O
participate NCT03920579 1080 1091 O
in NCT03920579 1092 1094 O
the NCT03920579 1095 1098 O
clinical NCT03920579 1099 1107 O
trial NCT03920579 1108 1113 O
for NCT03920579 1114 1117 O
other NCT03920579 1118 1123 O
reasons NCT03920579 1124 1131 O
including NCT03920579 1132 1141 O
the NCT03920579 1142 1145 O
results NCT03920579 1146 1153 O
of NCT03920579 1154 1156 O
laboratory NCT03920579 1157 1167 O
tests NCT03920579 1168 1173 O

Inclusion NCT03929575 0 9 O
Criteria NCT03929575 10 18 O
: NCT03929575 19 20 O

- NCT03929575 24 25 O
Body NCT03929575 27 31 B-Observation-Name___Observation-Type-Value:vital
Mass NCT03929575 32 36 I-Observation-Name___Observation-Type-Value:vital
Index NCT03929575 37 42 I-Observation-Name___Observation-Type-Value:vital
between NCT03929575 43 50 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18.5 NCT03929575 52 56 B-Eq-Value
and NCT03929575 57 60 O
35 NCT03929575 62 64 B-Eq-Value
kg NCT03929575 65 67 B-Eq-Unit
/ NCT03929575 68 69 O
m^ NCT03929575 70 72 B-Eq-Unit
2 NCT03929575 73 74 I-Eq-Unit

- NCT03929575 78 79 O
Non NCT03929575 81 84 O
- NCT03929575 85 86 O
smoking NCT03929575 87 94 B-Condition-Name
( NCT03929575 95 96 O
assessed NCT03929575 97 105 O
by NCT03929575 106 108 O
Health NCT03929575 109 115 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
History NCT03929575 116 123 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03929575 124 137 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03929575 138 139 O

- NCT03929575 143 144 O
English NCT03929575 146 153 B-Language
- NCT03929575 154 155 O
speaking NCT03929575 156 164 O

- NCT03929575 167 168 O
Regular NCT03929575 170 177 O
participation NCT03929575 178 191 O
in NCT03929575 192 194 O
physical NCT03929575 195 203 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03929575 204 212 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03929575 213 214 O
> NCT03929575 216 217 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03929575 219 220 B-Eq-Value
hours NCT03929575 221 226 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
per NCT03929575 227 230 O
week NCT03929575 231 235 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03929575 236 237 O

Exclusion NCT03929575 239 248 O
Criteria NCT03929575 249 257 O
: NCT03929575 258 259 O

- NCT03929575 263 264 O
Medical NCT03929575 266 273 O
conditions NCT03929575 274 284 O
that NCT03929575 285 289 O
prohibit NCT03929575 290 298 O
physical NCT03929575 299 307 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03929575 308 316 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03929575 317 318 O
assessed NCT03929575 319 327 O
by NCT03929575 328 330 O
Health NCT03929575 331 337 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
History NCT03929575 338 345 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03929575 346 359 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03929575 360 361 O

- NCT03929575 365 366 O
Pregnant NCT03929575 368 376 B-Condition-Name
women NCT03929575 377 382 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
or NCT03929575 383 385 O
women NCT03929575 386 391 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
expecting NCT03929575 392 401 O
/ NCT03929575 402 403 O
trying NCT03929575 404 410 O
to NCT03929575 411 413 O
become NCT03929575 414 420 O
pregnant NCT03929575 421 429 B-Condition-Name

- NCT03929575 432 433 O
BMI NCT03929575 435 438 B-Observation-Name___Observation-Type-Value:vital
greater NCT03929575 439 446 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03929575 447 451 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03929575 452 454 I-Eq-Operator___Eq-Operator-Value:GTEQ
equal NCT03929575 455 460 I-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03929575 461 463 O
35 NCT03929575 465 467 B-Eq-Value
kg NCT03929575 468 470 B-Eq-Unit
/ NCT03929575 471 472 O
m^ NCT03929575 473 475 B-Eq-Unit
2 NCT03929575 476 477 I-Eq-Unit

- NCT03929575 481 482 O
Current NCT03929575 484 491 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
smoker NCT03929575 492 498 B-Condition-Name
( NCT03929575 499 500 O
assessed NCT03929575 501 509 O
by NCT03929575 510 512 O
Health NCT03929575 513 519 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
History NCT03929575 520 527 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03929575 528 541 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
) NCT03929575 542 543 O

Inclusion NCT03928119 0 9 O
Criteria NCT03928119 10 18 O
: NCT03928119 19 20 O

- NCT03928119 24 25 O
ST NCT03928119 27 29 B-Condition-Name
- NCT03928119 30 31 I-Condition-Name
Segment NCT03928119 32 39 I-Condition-Name
Elevation NCT03928119 40 49 I-Condition-Name
Myocardial NCT03928119 50 60 I-Condition-Name
Infarction NCT03928119 61 71 I-Condition-Name
patients NCT03928119 72 80 O
within NCT03928119 81 87 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03928119 89 91 B-Eq-Value
days NCT03928119 92 96 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
since NCT03928119 97 102 O
symptoms NCT03928119 103 111 O
onset NCT03928119 112 117 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time

Exclusion NCT03928119 118 127 O
Criteria NCT03928119 128 136 O
: NCT03928119 137 138 O

- NCT03928119 142 143 O
None NCT03928119 145 149 O

Inclusion NCT03923361 0 9 O
Criteria NCT03923361 10 18 O
: NCT03923361 19 20 O

- NCT03923361 24 25 O
Age NCT03923361 27 30 O
18 NCT03923361 32 34 B-Eq-Value
- NCT03923361 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03923361 38 40 B-Eq-Value

- NCT03923361 44 45 O
Diagnosis NCT03923361 47 56 O
of NCT03923361 57 59 O
major NCT03923361 60 65 O
depressive NCT03923361 66 76 B-Condition-Name
disorder NCT03923361 77 85 I-Condition-Name
or NCT03923361 86 88 O
bipolar NCT03923361 89 96 B-Condition-Name
disorder NCT03923361 97 105 I-Condition-Name

- NCT03923361 108 109 O
Current NCT03923361 111 118 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
moderate NCT03923361 119 127 B-Severity___Severity-Value:moderate
- NCT03923361 128 129 O
to NCT03923361 130 132 O
- NCT03923361 133 134 O
severe NCT03923361 135 141 B-Severity___Severity-Value:severe
depressive NCT03923361 142 152 B-Condition-Name
episode NCT03923361 153 160 I-Condition-Name

- NCT03923361 163 164 O
Episode NCT03923361 166 173 O
duration NCT03923361 174 182 O
more NCT03923361 183 187 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03923361 188 192 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03923361 194 195 B-Eq-Value
months NCT03923361 196 202 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03923361 203 206 O
less NCT03923361 207 211 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03923361 212 216 I-Eq-Operator___Eq-Operator-Value:LT
5 NCT03923361 218 219 B-Eq-Value
years NCT03923361 220 225 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923361 228 229 O
Failure NCT03923361 231 238 O
of NCT03923361 239 241 O
at NCT03923361 242 244 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03923361 245 250 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03923361 252 253 B-Eq-Value
adequate NCT03923361 254 262 O
antidepressant NCT03923361 263 277 B-Drug-Name
medication NCT03923361 278 288 I-Drug-Name
trials NCT03923361 289 295 O
within NCT03923361 296 302 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03923361 303 306 O
past NCT03923361 307 311 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03923361 313 314 B-Eq-Value
years NCT03923361 315 320 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923361 323 324 O
Body NCT03923361 326 330 B-Observation-Name___Observation-Type-Value:vital
mass NCT03923361 331 335 I-Observation-Name___Observation-Type-Value:vital
index NCT03923361 336 341 I-Observation-Name___Observation-Type-Value:vital
< NCT03923361 342 343 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03923361 345 347 B-Eq-Value

- NCT03923361 351 352 O
16 NCT03923361 355 357 B-Observation-Name
- NCT03923361 358 359 I-Observation-Name
item NCT03923361 360 364 I-Observation-Name
Quick NCT03923361 365 370 I-Observation-Name
Inventory NCT03923361 371 380 I-Observation-Name
of NCT03923361 381 383 I-Observation-Name
Depressive NCT03923361 384 394 I-Observation-Name
Symptomatology NCT03923361 395 409 I-Observation-Name
, NCT03923361 410 411 O
self NCT03923361 412 416 O
- NCT03923361 417 418 O
rated NCT03923361 419 424 O
> NCT03923361 425 426 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03923361 428 430 B-Eq-Value

Exclusion NCT03923361 432 441 O
Criteria NCT03923361 442 450 O
: NCT03923361 451 452 O

- NCT03923361 456 457 O
Contraindication NCT03923361 459 475 O
to NCT03923361 476 478 O
propofol NCT03923361 479 487 B-Drug-Name
or NCT03923361 488 490 O
midazolam NCT03923361 491 500 B-Drug-Name

- NCT03923361 503 504 O
Daily NCT03923361 506 511 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
use NCT03923361 512 515 O
of NCT03923361 516 518 O
benzodiazepine NCT03923361 519 533 B-Drug-Name
, NCT03923361 534 535 O
opioid NCT03923361 536 542 B-Drug-Name
, NCT03923361 543 544 O
ACE NCT03923361 545 548 B-Drug-Name
inhibitor NCT03923361 549 558 I-Drug-Name
, NCT03923361 559 560 O
or NCT03923361 561 563 O
ARB NCT03923361 564 567 B-Drug-Name
medication NCT03923361 568 578 I-Drug-Name

- NCT03923361 581 582 O
Symptomatic NCT03923361 584 595 O
coronary NCT03923361 596 604 B-Condition-Name
artery NCT03923361 605 611 I-Condition-Name
disease NCT03923361 612 619 I-Condition-Name
or NCT03923361 620 622 O
heart NCT03923361 623 628 B-Condition-Name
failure NCT03923361 629 636 I-Condition-Name

- NCT03923361 639 640 O
Poorly NCT03923361 642 648 O
controlled NCT03923361 649 659 O
hypertension NCT03923361 660 672 B-Condition-Name
or NCT03923361 673 675 O
diabetes NCT03923361 676 684 B-Condition-Name

- NCT03923361 687 688 O
Abnormal NCT03923361 690 698 B-Polarity___Polarity-Value:abnormal
kidney NCT03923361 699 705 O
or NCT03923361 706 708 O
liver NCT03923361 709 714 O
function NCT03923361 715 723 B-Condition-Name

- NCT03923361 726 727 O
Pregnant NCT03923361 729 737 B-Condition-Name
or NCT03923361 738 740 O
breast NCT03923361 741 747 B-Condition-Name
feeding NCT03923361 748 755 I-Condition-Name

- NCT03923361 758 759 O
Traumatic NCT03923361 761 770 B-Condition-Name
brain NCT03923361 771 776 I-Condition-Name
injury NCT03923361 777 783 I-Condition-Name
or NCT03923361 784 786 O
significant NCT03923361 787 798 B-Severity___Severity-Value:severe
neurologic NCT03923361 799 809 B-Condition-Name
signs NCT03923361 810 815 O
( NCT03923361 816 817 O
past NCT03923361 818 822 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03923361 823 827 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03923361 828 829 O

- NCT03923361 833 834 O
Substance NCT03923361 836 845 B-Condition-Name
use NCT03923361 846 849 I-Condition-Name
disorder NCT03923361 850 858 I-Condition-Name
( NCT03923361 859 860 O
past NCT03923361 861 865 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03923361 866 870 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03923361 871 872 O

- NCT03923361 876 877 O
Obsessive NCT03923361 879 888 B-Condition-Name
compulsive NCT03923361 889 899 I-Condition-Name
disorder NCT03923361 900 908 I-Condition-Name
( NCT03923361 909 910 O
current NCT03923361 911 918 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
) NCT03923361 919 920 O

- NCT03923361 924 925 O
Post NCT03923361 927 931 B-Condition-Name
- NCT03923361 932 933 I-Condition-Name
traumatic NCT03923361 934 943 I-Condition-Name
stress NCT03923361 944 950 I-Condition-Name
disorder NCT03923361 951 959 I-Condition-Name
( NCT03923361 960 961 O
current NCT03923361 962 969 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
) NCT03923361 970 971 O

- NCT03923361 975 976 O
Schizophrenia NCT03923361 978 991 B-Condition-Name
- NCT03923361 992 993 I-Condition-Name
spectrum NCT03923361 994 1002 I-Condition-Name
disorder NCT03923361 1003 1011 I-Condition-Name
( NCT03923361 1012 1013 O
lifetime NCT03923361 1014 1022 O
) NCT03923361 1023 1024 O

- NCT03923361 1028 1029 O
Neurocognitive NCT03923361 1031 1045 B-Condition-Name
disorder NCT03923361 1046 1054 I-Condition-Name
( NCT03923361 1055 1056 O
current NCT03923361 1057 1064 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
) NCT03923361 1065 1066 O

- NCT03923361 1070 1071 O
Personality NCT03923361 1073 1084 B-Condition-Name
disorder NCT03923361 1085 1093 I-Condition-Name
as NCT03923361 1094 1096 O
a NCT03923361 1097 1098 O
current NCT03923361 1099 1106 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
focus NCT03923361 1107 1112 O
of NCT03923361 1113 1115 O
treatment NCT03923361 1116 1125 O

- NCT03923361 1128 1129 O
ECT NCT03923361 1131 1134 B-Procedure-Name
within NCT03923361 1135 1141 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03923361 1142 1145 O
past NCT03923361 1146 1150 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03923361 1152 1153 B-Eq-Value
months NCT03923361 1154 1160 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03923361 1163 1164 O
Inappropriate NCT03923361 1166 1179 O
for NCT03923361 1180 1183 O
ECT NCT03923361 1184 1187 B-Procedure-Name
, NCT03923361 1188 1189 O
or NCT03923361 1190 1192 O
poor NCT03923361 1193 1197 O
response NCT03923361 1198 1206 O
to NCT03923361 1207 1209 O
ECT NCT03923361 1210 1213 B-Procedure-Name
within NCT03923361 1214 1220 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03923361 1221 1224 O
past NCT03923361 1225 1229 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
5 NCT03923361 1231 1232 B-Eq-Value
years NCT03923361 1233 1238 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03923361 1241 1242 O
Incompetent NCT03923361 1244 1255 O
to NCT03923361 1256 1258 O
provide NCT03923361 1259 1266 O
consent NCT03923361 1267 1274 O

Inclusion NCT03923413 0 9 O
Criteria NCT03923413 10 18 O
: NCT03923413 19 20 O

- NCT03923413 24 25 O
Inclusion NCT03923413 27 36 O
Criteria NCT03923413 37 45 O
: NCT03923413 46 47 O
chronic NCT03923413 48 55 B-Condition-Name
heart NCT03923413 56 61 I-Condition-Name
failure NCT03923413 62 69 I-Condition-Name
INTERMASC NCT03923413 70 79 B-Observation-Name
5 NCT03923413 81 82 B-Eq-Value
- NCT03923413 83 84 B-Eq-Operator___Eq-Operator-Value:BETWEEN
7 NCT03923413 86 87 B-Eq-Value
or NCT03923413 88 90 O

- NCT03923413 93 94 O
Patients NCT03923413 96 104 O
on NCT03923413 105 107 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
LVAD NCT03923413 108 112 B-Procedure-Name
support NCT03923413 113 120 I-Procedure-Name

Exclusion NCT03923413 121 130 O
Criteria NCT03923413 131 139 O
: NCT03923413 140 141 O

- NCT03923413 145 146 O
current NCT03923413 148 155 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
thrombembolic NCT03923413 156 169 O
or NCT03923413 170 172 O
bleeding NCT03923413 173 181 O
event NCT03923413 182 187 B-Condition-Name

Inclusion NCT03927885 0 9 O
Criteria NCT03927885 10 18 O
: NCT03927885 19 20 O

- NCT03927885 24 25 O
Patient NCT03927885 27 34 O
with NCT03927885 35 39 O
a NCT03927885 40 41 O
diagnosis NCT03927885 42 51 O
of NCT03927885 52 54 O
advanced NCT03927885 55 63 B-Severity___Severity-Value:severe
cancer NCT03927885 64 70 B-Condition-Name
( NCT03927885 71 72 O
metastatic NCT03927885 73 83 O
or NCT03927885 84 86 O
recurrent NCT03927885 87 96 O
incurable NCT03927885 97 106 O
solid NCT03927885 107 112 B-Condition-Name
tumors NCT03927885 113 119 I-Condition-Name
) NCT03927885 120 121 O

- NCT03927885 125 126 O
Presence NCT03927885 128 136 O
of NCT03927885 137 139 O
fatigue NCT03927885 140 147 B-Condition-Name
of NCT03927885 148 150 O
> NCT03927885 151 152 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03927885 154 155 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03927885 157 158 B-Eq-Value
/ NCT03927885 159 160 O
10 NCT03927885 162 164 B-Eq-Unit
on NCT03927885 165 167 O
Edmonton NCT03927885 168 176 B-Observation-Name
Symptom NCT03927885 177 184 I-Observation-Name
Assessment NCT03927885 185 195 I-Observation-Name
System NCT03927885 196 202 I-Observation-Name
( NCT03927885 203 204 O
ESAS NCT03927885 205 209 B-Observation-Name
) NCT03927885 210 211 O
Fatigue NCT03927885 212 219 O
item NCT03927885 220 224 O
( NCT03927885 225 226 O
0 NCT03927885 228 229 O
- NCT03927885 230 231 O
10 NCT03927885 233 235 O
severity NCT03927885 236 244 O
scale NCT03927885 245 250 O
) NCT03927885 251 252 O

- NCT03927885 256 257 O
Patient NCT03927885 259 266 O
should NCT03927885 267 273 O
describe NCT03927885 274 282 O
fatigue NCT03927885 283 290 B-Condition-Name
as NCT03927885 291 293 O
being NCT03927885 294 299 O
present NCT03927885 300 307 O
for NCT03927885 308 311 O
a NCT03927885 312 313 O
minimum NCT03927885 314 321 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03927885 322 324 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03927885 326 327 B-Eq-Value
weeks NCT03927885 328 333 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03927885 334 339 O
to NCT03927885 340 342 O
screening NCT03927885 343 352 O

- NCT03927885 355 356 O
Uncontrolled NCT03927885 358 370 O
pain NCT03927885 371 375 B-Condition-Name
; NCT03927885 375 376 O
patient NCT03927885 377 384 O
is NCT03927885 385 387 O
on NCT03927885 388 390 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
opioids NCT03927885 391 398 B-Drug-Name
for NCT03927885 399 402 O
the NCT03927885 403 406 O
treatment NCT03927885 407 416 O
of NCT03927885 417 419 O
cancer NCT03927885 420 426 B-Condition-Name
pain NCT03927885 427 431 B-Condition-Name
, NCT03927885 432 433 O
he NCT03927885 434 436 O
/ NCT03927885 437 438 O
she NCT03927885 439 442 O
must NCT03927885 443 447 O
have NCT03927885 448 452 O
had NCT03927885 453 456 O
no NCT03927885 457 459 O
major NCT03927885 460 465 O
dose NCT03927885 466 470 O
change NCT03927885 471 477 B-Stability___Stability-Value:change
( NCT03927885 478 479 O
> NCT03927885 481 482 B-Eq-Operator___Eq-Operator-Value:GT
25 NCT03927885 484 486 B-Eq-Value
% NCT03927885 487 488 B-Eq-Unit
) NCT03927885 490 491 O
for NCT03927885 492 495 O
at NCT03927885 496 498 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03927885 499 504 I-Eq-Operator___Eq-Operator-Value:GTEQ
48 NCT03927885 506 508 B-Eq-Value
hours NCT03927885 509 514 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
prior NCT03927885 515 520 O
to NCT03927885 521 523 O
study NCT03927885 524 529 O
entry NCT03927885 530 535 O
. NCT03927885 536 537 O
Change NCT03927885 539 545 B-Stability___Stability-Value:change
in NCT03927885 546 548 O
opioid NCT03927885 549 555 B-Drug-Name
dose NCT03927885 556 560 O
after NCT03927885 561 566 O
study NCT03927885 567 572 O
entry NCT03927885 573 578 O
is NCT03927885 579 581 O
allowed NCT03927885 582 589 O

- NCT03927885 592 593 O
Patient NCT03927885 595 602 O
must NCT03927885 603 607 O
be NCT03927885 608 610 O
willing NCT03927885 611 618 O
to NCT03927885 619 621 O
engage NCT03927885 622 628 O
in NCT03927885 629 631 O
telephone NCT03927885 632 641 O
follow NCT03927885 642 648 O
up NCT03927885 649 651 O
with NCT03927885 652 656 O
research NCT03927885 657 665 O
staff NCT03927885 666 671 O

- NCT03927885 674 675 O
Patient NCT03927885 677 684 O
must NCT03927885 685 689 O
have NCT03927885 690 694 O
telephone NCT03927885 695 704 O
access NCT03927885 705 711 O
to NCT03927885 712 714 O
be NCT03927885 715 717 O
contacted NCT03927885 718 727 O
by NCT03927885 728 730 O
the NCT03927885 731 734 O
research NCT03927885 735 743 O
staff NCT03927885 744 749 O

- NCT03927885 752 753 O
Hemoglobin NCT03927885 755 765 B-Observation-Name___Observation-Type-Value:lab
level NCT03927885 766 771 O
of NCT03927885 772 774 O
> NCT03927885 775 776 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03927885 778 779 I-Eq-Operator___Eq-Operator-Value:GTEQ
9 NCT03927885 781 782 B-Eq-Value
g NCT03927885 783 784 B-Eq-Unit
/ NCT03927885 785 786 O
dL NCT03927885 787 789 B-Eq-Unit
. NCT03927885 790 791 O
Patient NCT03927885 793 800 O
may NCT03927885 801 804 O
receive NCT03927885 805 812 O
packed NCT03927885 813 819 B-Procedure-Name
red NCT03927885 820 823 I-Procedure-Name
blood NCT03927885 824 829 I-Procedure-Name
cell NCT03927885 830 834 I-Procedure-Name
( NCT03927885 835 836 O
PRBC NCT03927885 837 841 B-Procedure-Name
) NCT03927885 842 843 O
transfusion NCT03927885 844 855 O
so NCT03927885 856 858 O
as NCT03927885 859 861 O
to NCT03927885 862 864 O
have NCT03927885 865 869 O
hemoglobin NCT03927885 870 880 B-Observation-Name
level NCT03927885 881 886 O
of NCT03927885 887 889 O
> NCT03927885 890 891 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03927885 893 894 I-Eq-Operator___Eq-Operator-Value:GTEQ
9 NCT03927885 896 897 B-Eq-Value
g NCT03927885 898 899 B-Eq-Unit
/ NCT03927885 900 901 O
dL NCT03927885 902 904 B-Eq-Unit
so NCT03927885 905 907 O
at NCT03927885 908 910 O
participate NCT03927885 911 922 O
in NCT03927885 923 925 O
the NCT03927885 926 929 O
study NCT03927885 930 935 O

Exclusion NCT03927885 936 945 O
Criteria NCT03927885 946 954 O
: NCT03927885 955 956 O

- NCT03927885 960 961 O
Surgery NCT03927885 963 970 B-Procedure-Name
, NCT03927885 971 972 O
or NCT03927885 973 975 O
pain NCT03927885 976 980 B-Procedure-Name
relieving NCT03927885 981 990 I-Procedure-Name
procedures NCT03927885 991 1001 I-Procedure-Name
within NCT03927885 1002 1008 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03927885 1010 1011 B-Eq-Value
weeks NCT03927885 1012 1017 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03927885 1018 1020 O
entry NCT03927885 1021 1026 O
into NCT03927885 1027 1031 O
the NCT03927885 1032 1035 O
study NCT03927885 1036 1041 O
or NCT03927885 1042 1044 O
during NCT03927885 1045 1051 O
the NCT03927885 1052 1055 O
study NCT03927885 1056 1061 O
period NCT03927885 1062 1068 O

- NCT03927885 1071 1072 O
Patients NCT03927885 1074 1082 O
with NCT03927885 1083 1087 O
history NCT03927885 1088 1095 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927885 1096 1098 O
substance NCT03927885 1099 1108 B-Condition-Name
abuse NCT03927885 1109 1114 I-Condition-Name
( NCT03927885 1115 1116 O
Cut NCT03927885 1117 1120 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
down NCT03927885 1121 1125 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
, NCT03927885 1126 1127 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Annoyed NCT03927885 1128 1135 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
, NCT03927885 1136 1137 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Guilty NCT03927885 1138 1144 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
, NCT03927885 1145 1146 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Eye NCT03927885 1147 1150 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
opener NCT03927885 1151 1157 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
[ NCT03927885 1158 1159 O
CAGE NCT03927885 1160 1164 B-Observation-Name
] NCT03927885 1165 1166 O
> NCT03927885 1167 1168 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03927885 1170 1171 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03927885 1173 1174 B-Eq-Value
+ NCT03927885 1175 1176 O
) NCT03927885 1178 1179 O
, NCT03927885 1181 1182 O
cognitively NCT03927885 1183 1194 B-Condition-Name
impaired NCT03927885 1195 1203 I-Condition-Name
( NCT03927885 1204 1205 O
MD NCT03927885 1206 1208 B-Condition-Name
Anderson NCT03927885 1209 1217 I-Condition-Name
Symptom NCT03927885 1218 1225 I-Condition-Name
[ NCT03927885 1226 1227 O
MDAS NCT03927885 1228 1232 B-Condition-Name
] NCT03927885 1233 1234 O
> NCT03927885 1235 1236 B-Eq-Operator___Eq-Operator-Value:GT
7 NCT03927885 1238 1239 B-Eq-Value
) NCT03927885 1240 1241 O

Inclusion NCT03927846 0 9 O
Criteria NCT03927846 10 18 O
: NCT03927846 19 20 O
- NCT03927846 21 22 O

1 NCT03927846 27 28 O
. NCT03927846 28 29 O
patients NCT03927846 31 39 O
at NCT03927846 40 42 O
the NCT03927846 43 46 O
primary NCT03927846 47 54 B-Location___Location-Value:clinic
care NCT03927846 55 59 I-Location___Location-Value:clinic
or NCT03927846 60 62 O
rheumatology NCT03927846 63 75 B-Location___Location-Value:clinic
clinic NCT03927846 76 82 I-Location___Location-Value:clinic
with NCT03927846 83 87 O
daily NCT03927846 88 93 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
pain NCT03927846 94 98 B-Condition-Name
for NCT03927846 99 102 O
6 NCT03927846 104 105 B-Eq-Value
months NCT03927846 106 112 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03927846 113 115 B-Eq-Operator___Eq-Operator-Value:GTEQ
longer NCT03927846 116 122 I-Eq-Operator___Eq-Operator-Value:GTEQ
affecting NCT03927846 123 132 O
the NCT03927846 133 136 O
low NCT03927846 137 140 O
back NCT03927846 141 145 O
, NCT03927846 146 147 O
neck NCT03927846 148 152 O
, NCT03927846 153 154 O
hip NCT03927846 155 158 O
, NCT03927846 159 160 O
knee NCT03927846 161 165 O
or NCT03927846 166 168 O
widespread NCT03927846 169 179 B-Condition-Name
pain NCT03927846 180 184 I-Condition-Name
; NCT03927846 184 185 O

2 NCT03927846 189 190 O
. NCT03927846 190 191 O
at NCT03927846 193 195 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03927846 196 201 I-Eq-Operator___Eq-Operator-Value:GTEQ
moderate NCT03927846 202 210 B-Severity___Severity-Value:moderate
in NCT03927846 211 213 O
average NCT03927846 214 221 O
pain NCT03927846 222 226 B-Condition-Name
severity NCT03927846 227 235 O
, NCT03927846 236 237 O
defined NCT03927846 238 245 O
as NCT03927846 246 248 O
a NCT03927846 249 250 O
weekly NCT03927846 251 257 O
average NCT03927846 258 265 O
pain NCT03927846 266 270 B-Observation-Name
severity NCT03927846 271 279 I-Observation-Name
score NCT03927846 280 285 I-Observation-Name
of NCT03927846 286 288 O
5 NCT03927846 290 291 B-Eq-Value
or NCT03927846 292 294 B-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03927846 295 302 I-Eq-Operator___Eq-Operator-Value:GTEQ
24 NCT03927846 304 306 O
; NCT03927846 307 308 O

3 NCT03927846 312 313 O
. NCT03927846 313 314 O
at NCT03927846 316 318 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03927846 319 324 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03927846 326 328 B-Eq-Value
years NCT03927846 329 334 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03927846 335 337 O
age NCT03927846 338 341 O
; NCT03927846 341 342 O

4 NCT03927846 346 347 O
. NCT03927846 347 348 O
reliable NCT03927846 350 358 O
phone NCT03927846 359 364 O
( NCT03927846 365 366 O
landline NCT03927846 367 375 O
or NCT03927846 376 378 O
cell NCT03927846 379 383 O
) NCT03927846 384 385 O
, NCT03927846 387 388 O
and NCT03927846 389 392 O

5 NCT03927846 396 397 O
. NCT03927846 397 398 O
have NCT03927846 400 404 O
home NCT03927846 405 409 O
computer NCT03927846 410 418 O
with NCT03927846 419 423 O
reliable NCT03927846 424 432 O
internet NCT03927846 433 441 O
access NCT03927846 442 448 O
. NCT03927846 449 450 O

Exclusion NCT03927846 452 461 O
Criteria NCT03927846 462 470 O
: NCT03927846 471 472 O

1 NCT03927846 477 478 O
. NCT03927846 478 479 O
planned NCT03927846 481 488 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
elective NCT03927846 489 497 O
surgery NCT03927846 498 505 B-Procedure-Name
during NCT03927846 506 512 O
the NCT03927846 513 516 O
study NCT03927846 517 522 O
period NCT03927846 523 529 O
; NCT03927846 529 530 O

2 NCT03927846 534 535 O
. NCT03927846 535 536 O
very NCT03927846 538 542 O
severe NCT03927846 543 549 B-Severity___Severity-Value:severe
symptoms NCT03927846 550 558 O
of NCT03927846 559 561 O
depression NCT03927846 562 572 B-Condition-Name
( NCT03927846 573 574 O
i NCT03927846 575 576 O
. NCT03927846 577 578 O
e NCT03927846 579 580 O
. NCT03927846 581 582 O
, NCT03927846 583 584 O
PHQ NCT03927846 585 588 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
8 NCT03927846 589 590 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
score NCT03927846 591 596 O
of NCT03927846 597 599 O
≥ NCT03927846 600 601 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03927846 603 605 B-Eq-Value
) NCT03927846 606 607 O
; NCT03927846 608 609 O

3 NCT03927846 613 614 O
. NCT03927846 614 615 O
ongoing NCT03927846 617 624 O
unresolved NCT03927846 625 635 O
disability NCT03927846 636 646 O
claims NCT03927846 647 653 O
; NCT03927846 653 654 O

4 NCT03927846 658 659 O
. NCT03927846 659 660 O
inflammatory NCT03927846 662 674 B-Condition-Name
arthritis NCT03927846 675 684 I-Condition-Name
( NCT03927846 685 686 O
e NCT03927846 687 688 O
. NCT03927846 689 690 O
g NCT03927846 691 692 O
. NCT03927846 693 694 O
, NCT03927846 695 696 O
lupus NCT03927846 697 702 B-Condition-Name
, NCT03927846 703 704 O
rheumatoid NCT03927846 705 715 B-Condition-Name
arthritis NCT03927846 716 725 I-Condition-Name
, NCT03927846 726 727 O
ankylosing NCT03927846 728 738 B-Condition-Name
spondylitis NCT03927846 739 750 I-Condition-Name
, NCT03927846 751 752 O
etc NCT03927846 753 756 O
. NCT03927846 757 758 O
) NCT03927846 759 760 O
; NCT03927846 761 762 O

5 NCT03927846 766 767 O
. NCT03927846 767 768 O
cancer NCT03927846 770 776 B-Condition-Name
- NCT03927846 777 778 O
related NCT03927846 779 786 O
musculoskeletal NCT03927846 787 802 O
pain NCT03927846 803 807 B-Condition-Name
; NCT03927846 807 808 O

6 NCT03927846 812 813 O
. NCT03927846 813 814 O
history NCT03927846 816 823 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927846 824 826 O
bipolar NCT03927846 827 834 B-Condition-Name
disorder NCT03927846 835 843 I-Condition-Name
or NCT03927846 844 846 O
schizophrenia NCT03927846 847 860 B-Condition-Name
; NCT03927846 860 861 O
and NCT03927846 862 865 O

7 NCT03927846 869 870 O
. NCT03927846 870 871 O
takes NCT03927846 873 878 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
daily NCT03927846 879 884 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
opioid NCT03927846 885 891 B-Drug-Name
for NCT03927846 892 895 O
more NCT03927846 896 900 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03927846 901 905 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03927846 906 909 B-Eq-Value
year NCT03927846 910 914 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03927846 915 916 O

Inclusion NCT03920683 0 9 O
Criteria NCT03920683 10 18 O
: NCT03920683 19 20 O

- NCT03920683 24 25 O
Age NCT03920683 27 30 O
≥ NCT03920683 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03920683 34 36 B-Eq-Value
ans NCT03920683 37 40 O

- NCT03920683 43 44 O
Diabetes NCT03920683 46 54 B-Condition-Name
mellitus NCT03920683 55 63 I-Condition-Name
( NCT03920683 64 65 O
type NCT03920683 66 70 B-Eq-Unit
1 NCT03920683 72 73 B-Eq-Value
or NCT03920683 74 76 O
2 NCT03920683 78 79 B-Eq-Value
) NCT03920683 80 81 O

- NCT03920683 85 86 O
Patients NCT03920683 88 96 O
addressed NCT03920683 97 106 O
to NCT03920683 107 109 O
a NCT03920683 110 111 O
one NCT03920683 112 115 B-Eq-Value
- NCT03920683 116 117 O
day NCT03920683 118 121 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
hospitalization NCT03920683 122 137 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03920683 138 140 O
assess NCT03920683 141 147 O
cardiovascular NCT03920683 148 162 B-Condition-Name
comorbidities NCT03920683 163 176 I-Condition-Name
, NCT03920683 177 178 O
between NCT03920683 179 186 B-Eq-Operator___Eq-Operator-Value:BETWEEN
January NCT03920683 187 194 B-Eq-Value
2014 NCT03920683 196 200 I-Eq-Value
and NCT03920683 201 204 O
May NCT03920683 205 208 B-Eq-Value
2017 NCT03920683 210 214 I-Eq-Value
, NCT03920683 215 216 O
in NCT03920683 217 219 O
the NCT03920683 220 223 O
diabetes NCT03920683 224 232 B-Location___Location-Value:unit
department NCT03920683 233 243 I-Location___Location-Value:unit
, NCT03920683 244 245 O
in NCT03920683 246 248 O
the NCT03920683 249 252 O
Pitié NCT03920683 253 258 B-Location___Location-Value:hospital
- NCT03920683 259 260 I-Location___Location-Value:hospital
Salpêtrière NCT03920683 261 272 I-Location___Location-Value:hospital
hospital NCT03920683 273 281 I-Location___Location-Value:hospital

- NCT03920683 284 285 O
Coronary NCT03920683 287 295 B-Observation-Name___Observation-Type-Value:measurement
artery NCT03920683 296 302 I-Observation-Name___Observation-Type-Value:measurement
calcium NCT03920683 303 310 I-Observation-Name___Observation-Type-Value:measurement
score NCT03920683 311 316 I-Observation-Name___Observation-Type-Value:measurement
available NCT03920683 317 326 O

- NCT03920683 329 330 O
Toe NCT03920683 332 335 B-Observation-Name___Observation-Type-Value:measurement
- NCT03920683 336 337 I-Observation-Name___Observation-Type-Value:measurement
brachial NCT03920683 338 346 I-Observation-Name___Observation-Type-Value:measurement
index NCT03920683 347 352 I-Observation-Name___Observation-Type-Value:measurement
available NCT03920683 353 362 O

Exclusion NCT03920683 363 372 O
Criteria NCT03920683 373 381 O
: NCT03920683 382 383 O

- NCT03920683 387 388 O
History NCT03920683 390 397 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920683 398 400 O
coronary NCT03920683 401 409 B-Condition-Name
artery NCT03920683 410 416 I-Condition-Name
disease NCT03920683 417 424 I-Condition-Name

- NCT03920683 427 428 O
History NCT03920683 430 437 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920683 438 440 O
Raynaud NCT03920683 441 448 B-Condition-Name
's NCT03920683 448 450 I-Condition-Name
syndrome NCT03920683 451 459 I-Condition-Name

- NCT03920683 462 463 O
Opposition NCT03920683 465 475 O
of NCT03920683 476 478 O
the NCT03920683 479 482 O
patient NCT03920683 483 490 O

Inclusion NCT03929328 0 9 O
Criteria NCT03929328 10 18 O
: NCT03929328 19 20 O

- NCT03929328 24 25 O
Adult NCT03929328 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03929328 33 41 O
aged NCT03929328 42 46 O
18 NCT03929328 48 50 B-Eq-Value
years NCT03929328 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03929328 57 59 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03929328 60 64 I-Eq-Operator___Eq-Operator-Value:GTEQ
, NCT03929328 65 66 O
both NCT03929328 67 71 O
gender NCT03929328 72 78 B-Life-Stage-And-Gender

- NCT03929328 81 82 O
Receiving NCT03929328 84 93 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
endotracheal NCT03929328 94 106 O
intubation NCT03929328 107 117 B-Procedure-Name
and NCT03929328 118 121 O
mechanical NCT03929328 122 132 O
ventilation NCT03929328 133 144 B-Procedure-Name
for NCT03929328 145 148 O
more NCT03929328 149 153 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929328 154 158 I-Eq-Operator___Eq-Operator-Value:GT
12 NCT03929328 160 162 B-Eq-Value
hours NCT03929328 163 168 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour

- NCT03929328 171 172 O
Recovery NCT03929328 174 182 O
from NCT03929328 183 187 O
the NCT03929328 188 191 O
precipitating NCT03929328 192 205 O
illness NCT03929328 206 213 O

- NCT03929328 216 217 O
Weaning NCT03929328 219 226 O
readiness NCT03929328 227 236 O
according NCT03929328 237 246 O
to NCT03929328 247 249 O
the NCT03929328 250 253 O
following NCT03929328 254 263 O
criteria NCT03929328 264 272 O
: NCT03929328 273 274 O

1 NCT03929328 284 285 O
. NCT03929328 285 286 O
Respiratory NCT03929328 288 299 O
criteria NCT03929328 300 308 O
: NCT03929328 309 310 O

1 NCT03929328 325 326 O
. NCT03929328 326 327 O
PaO NCT03929328 329 332 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03929328 333 334 I-Observation-Name___Observation-Type-Value:measurement
: NCT03929328 335 336 O
FIO NCT03929328 337 340 O
2 NCT03929328 341 342 O
> NCT03929328 343 344 B-Eq-Operator___Eq-Operator-Value:GT
150 NCT03929328 346 349 B-Eq-Value
with NCT03929328 350 354 O
FIO NCT03929328 355 358 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03929328 359 360 I-Observation-Name___Observation-Type-Value:measurement
≤ NCT03929328 361 362 B-Eq-Operator___Eq-Operator-Value:LTEQ
0.4 NCT03929328 364 367 B-Eq-Value
, NCT03929328 368 369 O
PEEP NCT03929328 370 374 B-Observation-Name___Observation-Type-Value:measurement
< NCT03929328 375 376 B-Eq-Operator___Eq-Operator-Value:LT
8 NCT03929328 378 379 B-Eq-Value
cm NCT03929328 380 382 B-Eq-Unit
H NCT03929328 383 384 B-Eq-Unit
2O NCT03929328 385 387 I-Eq-Unit

2 NCT03929328 401 402 O
. NCT03929328 402 403 O
Arterial NCT03929328 405 413 B-Observation-Name___Observation-Type-Value:measurement
pH NCT03929328 414 416 I-Observation-Name___Observation-Type-Value:measurement
> NCT03929328 417 418 B-Eq-Operator___Eq-Operator-Value:GT
7.35 NCT03929328 420 424 B-Eq-Value

3 NCT03929328 439 440 O
. NCT03929328 440 441 O
Rapid NCT03929328 443 448 B-Observation-Name___Observation-Type-Value:measurement
shallow NCT03929328 449 456 I-Observation-Name___Observation-Type-Value:measurement
breathing NCT03929328 457 466 I-Observation-Name___Observation-Type-Value:measurement
index NCT03929328 467 472 I-Observation-Name___Observation-Type-Value:measurement
( NCT03929328 473 474 O
RSBI NCT03929328 475 479 B-Observation-Name
) NCT03929328 480 481 O
< NCT03929328 482 483 B-Eq-Operator___Eq-Operator-Value:LT
105 NCT03929328 485 488 B-Eq-Value

4 NCT03929328 503 504 O
. NCT03929328 504 505 O
Maximum NCT03929328 507 514 B-Observation-Name___Observation-Type-Value:measurement
inspiratory NCT03929328 515 526 I-Observation-Name___Observation-Type-Value:measurement
pressure NCT03929328 527 535 I-Observation-Name___Observation-Type-Value:measurement
( NCT03929328 536 537 O
MIP NCT03929328 538 541 B-Observation-Name
) NCT03929328 542 543 O
< NCT03929328 544 545 B-Eq-Operator___Eq-Operator-Value:LT
- NCT03929328 546 547 B-Eq-Value
20 NCT03929328 549 551 I-Eq-Value
cm NCT03929328 552 554 B-Eq-Unit
H NCT03929328 555 556 B-Eq-Unit
20 NCT03929328 557 559 I-Eq-Unit

2 NCT03929328 569 570 O
. NCT03929328 570 571 O
Clinical NCT03929328 573 581 O
criteria NCT03929328 582 590 O
: NCT03929328 591 592 O

1 NCT03929328 607 608 O
. NCT03929328 608 609 O
Absence NCT03929328 611 618 O
of NCT03929328 619 621 O
electrocardiographic NCT03929328 622 642 B-Procedure-Name
signs NCT03929328 643 648 O
of NCT03929328 649 651 O
myocardial NCT03929328 652 662 B-Condition-Name
ischemia NCT03929328 663 671 I-Condition-Name

2 NCT03929328 685 686 O
. NCT03929328 686 687 O
No NCT03929328 689 691 O
vasoactive NCT03929328 692 702 B-Drug-Name
drugs NCT03929328 703 708 I-Drug-Name
, NCT03929328 709 710 O
or NCT03929328 711 713 O
vital NCT03929328 714 719 B-Observation-Name___Observation-Type-Value:vital
signs NCT03929328 720 725 I-Observation-Name___Observation-Type-Value:vital
are NCT03929328 726 729 O
stable NCT03929328 730 736 B-Stability___Stability-Value:stable
with NCT03929328 737 741 O
using NCT03929328 742 747 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
vasoactive NCT03929328 748 758 B-Drug-Name
drugs NCT03929328 759 764 I-Drug-Name

3 NCT03929328 778 779 O
. NCT03929328 779 780 O
Heart NCT03929328 782 787 B-Observation-Name___Observation-Type-Value:vital
rate NCT03929328 788 792 I-Observation-Name___Observation-Type-Value:vital
< NCT03929328 793 794 B-Eq-Operator___Eq-Operator-Value:LT
140 NCT03929328 796 799 B-Eq-Value
/ NCT03929328 800 801 O
min NCT03929328 802 805 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
, NCT03929328 806 807 O

4 NCT03929328 822 823 O
. NCT03929328 823 824 O
Hemoglobin NCT03929328 826 836 B-Observation-Name___Observation-Type-Value:lab
> NCT03929328 837 838 B-Eq-Operator___Eq-Operator-Value:GT
8 NCT03929328 840 841 B-Eq-Value
g NCT03929328 842 843 B-Eq-Unit
/ NCT03929328 844 845 O
dL NCT03929328 846 848 B-Eq-Unit

5 NCT03929328 862 863 O
. NCT03929328 863 864 O
Temperature NCT03929328 866 877 B-Observation-Name___Observation-Type-Value:lab
< NCT03929328 878 879 B-Eq-Operator___Eq-Operator-Value:LT
38 NCT03929328 881 883 B-Eq-Value
° NCT03929328 884 885 B-Eq-Unit
C NCT03929328 885 886 I-Eq-Unit

6 NCT03929328 900 901 O
. NCT03929328 901 902 O
No NCT03929328 904 906 O
need NCT03929328 907 911 O
for NCT03929328 912 915 O
sedatives NCT03929328 916 925 B-Drug-Name
, NCT03929328 926 927 O
or NCT03929328 928 930 O
mental NCT03929328 931 937 B-Condition-Name
status NCT03929328 938 944 I-Condition-Name
are NCT03929328 945 948 O
stable NCT03929328 949 955 B-Stability___Stability-Value:stable
with NCT03929328 956 960 O
sedatives NCT03929328 961 970 B-Drug-Name

7 NCT03929328 984 985 O
. NCT03929328 985 986 O
Presence NCT03929328 988 996 O
of NCT03929328 997 999 O
respiratory NCT03929328 1000 1011 B-Condition-Name
stimulus NCT03929328 1012 1020 I-Condition-Name
, NCT03929328 1021 1022 O
and NCT03929328 1023 1026 O
appropriate NCT03929328 1027 1038 O
spontaneous NCT03929328 1039 1050 B-Condition-Name
cough NCT03929328 1051 1056 I-Condition-Name

8 NCT03929328 1070 1071 O
. NCT03929328 1071 1072 O
Absence NCT03929328 1074 1081 O
of NCT03929328 1082 1084 O
excessive NCT03929328 1085 1094 B-Severity___Severity-Value:severe
tracheobronchial NCT03929328 1095 1111 B-Condition-Name
secretions NCT03929328 1112 1122 I-Condition-Name

Exclusion NCT03929328 1123 1132 O
Criteria NCT03929328 1133 1141 O
: NCT03929328 1142 1143 O

- NCT03929328 1147 1148 O
Tracheostomy NCT03929328 1150 1162 B-Procedure-Name
status NCT03929328 1163 1169 O

- NCT03929328 1172 1173 O
Decision NCT03929328 1175 1183 O
to NCT03929328 1184 1186 O
stop NCT03929328 1187 1191 O
life NCT03929328 1192 1196 B-Procedure-Name
- NCT03929328 1197 1198 I-Procedure-Name
supportive NCT03929328 1199 1209 I-Procedure-Name
therapies NCT03929328 1210 1219 I-Procedure-Name
before NCT03929328 1220 1226 O
enrollment NCT03929328 1227 1237 O

Inclusion NCT03922269 0 9 O
Criteria NCT03922269 10 18 O
: NCT03922269 19 20 O

- NCT03922269 24 25 O
Participant NCT03922269 27 38 O
self NCT03922269 39 43 O
- NCT03922269 44 45 O
identifies NCT03922269 46 56 O
as NCT03922269 57 59 O
transgender NCT03922269 60 71 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:transgender
and NCT03922269 72 75 O
/ NCT03922269 76 77 O
or NCT03922269 78 80 O
has NCT03922269 81 84 O
a NCT03922269 85 86 O
current NCT03922269 87 94 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
gender NCT03922269 95 101 B-Condition-Name
identity NCT03922269 102 110 I-Condition-Name
which NCT03922269 111 116 O
differs NCT03922269 117 124 O
from NCT03922269 125 129 O
gender NCT03922269 130 136 B-Life-Stage-And-Gender
assigned NCT03922269 137 145 O
at NCT03922269 146 148 O
birth NCT03922269 149 154 O
( NCT03922269 155 156 O
includes NCT03922269 157 165 O
all NCT03922269 166 169 O
gender NCT03922269 170 176 O
diverse NCT03922269 177 184 O
people NCT03922269 185 191 O
) NCT03922269 192 193 O

- NCT03922269 197 198 O
Age NCT03922269 200 203 O
> NCT03922269 204 205 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03922269 207 209 B-Eq-Value
years NCT03922269 210 215 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03922269 218 219 O
HIV NCT03922269 221 224 B-Condition-Name
infection NCT03922269 225 234 I-Condition-Name
diagnosis NCT03922269 235 244 O
at NCT03922269 245 247 O
any NCT03922269 248 251 O
time NCT03922269 252 256 O
before NCT03922269 257 263 O
study NCT03922269 264 269 O
consent NCT03922269 270 277 O

- NCT03922269 280 281 O
Having NCT03922269 283 289 O
been NCT03922269 290 294 O
prescribed NCT03922269 295 305 O
antiretroviral NCT03922269 306 320 B-Procedure-Name
therapy NCT03922269 321 328 I-Procedure-Name
at NCT03922269 329 331 O
any NCT03922269 332 335 O
time NCT03922269 336 340 O
( NCT03922269 341 342 O
including NCT03922269 343 352 O
people NCT03922269 353 359 O
for NCT03922269 360 363 O
who NCT03922269 364 367 O
antiretroviral NCT03922269 368 382 B-Procedure-Name
therapy NCT03922269 383 390 I-Procedure-Name
initiation NCT03922269 391 401 O
is NCT03922269 402 404 O
planned NCT03922269 405 412 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
after NCT03922269 413 418 O
study NCT03922269 419 424 O
enrolment NCT03922269 425 434 O
) NCT03922269 435 436 O

- NCT03922269 440 441 O
Willing NCT03922269 443 450 O
to NCT03922269 451 453 O
sign NCT03922269 454 458 O
an NCT03922269 459 461 O
informed NCT03922269 462 470 O
consent NCT03922269 471 478 O
and NCT03922269 479 482 O
take NCT03922269 483 487 O
part NCT03922269 488 492 O
in NCT03922269 493 495 O
the NCT03922269 496 499 O
study NCT03922269 500 505 O

Exclusion NCT03922269 506 515 O
Criteria NCT03922269 516 524 O
: NCT03922269 525 526 O

- NCT03922269 530 531 O
Age NCT03922269 533 536 O
< NCT03922269 537 538 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03922269 540 542 B-Eq-Value
years NCT03922269 543 548 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03922269 551 552 O
Unable NCT03922269 554 560 O
to NCT03922269 561 563 O
take NCT03922269 564 568 O
part NCT03922269 569 573 O
in NCT03922269 574 576 O
the NCT03922269 577 580 O
study NCT03922269 581 586 O
according NCT03922269 587 596 O
to NCT03922269 597 599 O
the NCT03922269 600 603 O
Investigator NCT03922269 604 616 O
opinion NCT03922269 617 624 O
( NCT03922269 625 626 O
example NCT03922269 627 634 O
: NCT03922269 635 636 O
unable NCT03922269 637 643 O
to NCT03922269 644 646 O
understand NCT03922269 647 657 O
the NCT03922269 658 661 O
study NCT03922269 662 667 O
information NCT03922269 668 679 O
leaflet NCT03922269 680 687 O
, NCT03922269 688 689 O
unable NCT03922269 690 696 O
to NCT03922269 697 699 O
provide NCT03922269 700 707 O
written NCT03922269 708 715 O
consent NCT03922269 716 723 O
, NCT03922269 724 725 O
etc NCT03922269 726 729 O
. NCT03922269 730 731 O
) NCT03922269 732 733 O

Inclusion NCT03925506 0 9 O
Criteria NCT03925506 10 18 O
: NCT03925506 19 20 O

- NCT03925506 24 25 O
Inpatient NCT03925506 27 36 B-Encounter-Type___Encounter-Type-Value:inpatient
≥ NCT03925506 37 38 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03925506 40 42 B-Eq-Value
y NCT03925506 43 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03925506 45 46 O
o NCT03925506 47 48 O
. NCT03925506 49 50 O
who NCT03925506 52 55 O
are NCT03925506 56 59 O
scheduled NCT03925506 60 69 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
elective NCT03925506 70 78 O
colonoscopy NCT03925506 79 90 B-Procedure-Name
during NCT03925506 91 97 O
hospitalization NCT03925506 98 113 O
irrespective NCT03925506 114 126 O
of NCT03925506 127 129 O
the NCT03925506 130 133 O
indication NCT03925506 134 144 O
. NCT03925506 145 146 O

Exclusion NCT03925506 148 157 O
Criteria NCT03925506 158 166 O
: NCT03925506 167 168 O

- NCT03925506 172 173 O
Urgent NCT03925506 175 181 O
colonoscopy NCT03925506 182 193 B-Procedure-Name

- NCT03925506 196 197 O
Patients NCT03925506 199 207 O
who NCT03925506 208 211 O
are NCT03925506 212 215 O
not NCT03925506 216 219 O
hospitalized NCT03925506 220 232 B-Encounter-Type___Encounter-Type-Value:inpatient
when NCT03925506 233 237 O
taking NCT03925506 238 244 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
bowel NCT03925506 245 250 B-Procedure-Name
preparation NCT03925506 251 262 I-Procedure-Name
or NCT03925506 263 265 O
when NCT03925506 266 270 O
undergoing NCT03925506 271 281 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
colonoscopy NCT03925506 282 293 B-Procedure-Name

Inclusion NCT03927339 0 9 O
Criteria NCT03927339 10 18 O
: NCT03927339 19 20 O

- NCT03927339 24 25 O
: NCT03927339 27 28 O
knee NCT03927339 29 33 O
OA NCT03927339 34 36 B-Condition-Name
with NCT03927339 37 41 O
obesity NCT03927339 42 49 B-Condition-Name
; NCT03927339 49 50 O
sedentary NCT03927339 51 60 B-Condition-Name
with NCT03927339 61 65 O
no NCT03927339 66 68 O
previous NCT03927339 69 77 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
education NCT03927339 78 87 B-Observation-Name
; NCT03927339 88 89 O
ability NCT03927339 90 97 O
to NCT03927339 98 100 O
understand NCT03927339 101 111 O
and NCT03927339 112 115 O
follow NCT03927339 116 122 O
commands NCT03927339 123 131 O
; NCT03927339 131 132 O
and NCT03927339 133 136 O
ability NCT03927339 137 144 B-Condition-Name
to NCT03927339 145 147 I-Condition-Name
walk NCT03927339 148 152 I-Condition-Name
independently NCT03927339 153 166 O
. NCT03927339 167 168 O

Exclusion NCT03927339 170 179 O
Criteria NCT03927339 180 188 O
: NCT03927339 189 190 O

- NCT03927339 194 195 O
Medical NCT03927339 197 204 O
conditions NCT03927339 205 215 O
contraindicating NCT03927339 216 232 O
moderate NCT03927339 233 241 B-Severity___Severity-Value:moderate
aerobic NCT03927339 242 249 B-Observation-Name
exercising NCT03927339 250 260 I-Observation-Name
( NCT03927339 261 262 O
as NCT03927339 263 265 O
determined NCT03927339 266 276 O
through NCT03927339 277 284 O
prescreening NCT03927339 285 297 O
questions NCT03927339 298 307 O
, NCT03927339 308 309 O
i NCT03927339 310 311 O
. NCT03927339 312 313 O
e NCT03927339 314 315 O
. NCT03927339 316 317 O
, NCT03927339 318 319 O
cardiac NCT03927339 320 327 O
or NCT03927339 328 330 O
coronary NCT03927339 331 339 O
artery NCT03927339 340 346 B-Condition-Name
disease NCT03927339 347 354 I-Condition-Name
as NCT03927339 355 357 O
ischemic NCT03927339 358 366 B-Condition-Name
cardiomyopathy NCT03927339 367 381 I-Condition-Name
, NCT03927339 382 383 O
chronic NCT03927339 384 391 B-Condition-Name
lung NCT03927339 392 396 I-Condition-Name
disease NCT03927339 397 404 I-Condition-Name
, NCT03927339 405 406 O
asthma NCT03927339 407 413 B-Condition-Name
, NCT03927339 414 415 O
uncontrolled NCT03927339 416 428 O
hypertension NCT03927339 429 441 B-Condition-Name
) NCT03927339 442 443 O
, NCT03927339 445 446 O
inability NCT03927339 447 456 O
to NCT03927339 457 459 O
exercise NCT03927339 460 468 B-Observation-Name
via NCT03927339 469 472 I-Observation-Name
treadmill NCT03927339 473 482 I-Observation-Name
( NCT03927339 483 484 O
i NCT03927339 485 486 O
. NCT03927339 487 488 O
e NCT03927339 489 490 O
. NCT03927339 491 492 O
no NCT03927339 494 496 O
neuromuscular NCT03927339 497 510 O
or NCT03927339 511 513 O
lower NCT03927339 514 519 O
extremity NCT03927339 520 529 O
conditions NCT03927339 530 540 B-Condition-Name
or NCT03927339 541 543 O
any NCT03927339 544 547 O
other NCT03927339 548 553 O
medical NCT03927339 554 561 O
contraindication NCT03927339 562 578 O
that NCT03927339 579 583 O
could NCT03927339 584 589 O
prevent NCT03927339 590 597 O
them NCT03927339 598 602 O
from NCT03927339 603 607 O
floor NCT03927339 608 613 B-Observation-Name
walking NCT03927339 614 621 I-Observation-Name
as NCT03927339 622 624 O
upset NCT03927339 625 630 O
affecting NCT03927339 631 640 B-Stability___Stability-Value:change
movement NCT03927339 641 649 B-Condition-Name
of NCT03927339 650 652 O
the NCT03927339 653 656 O
pelvic NCT03927339 657 663 O
arch NCT03927339 664 668 O
or NCT03927339 669 671 O
pace NCT03927339 672 676 O
, NCT03927339 677 678 O
story NCT03927339 679 684 O
of NCT03927339 685 687 O
previous NCT03927339 688 696 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
hip NCT03927339 697 700 O
or NCT03927339 701 703 O
knee NCT03927339 704 708 O
operating NCT03927339 709 718 B-Procedure-Name
room NCT03927339 719 723 O
, NCT03927339 724 725 O
periarticular NCT03927339 726 739 O
fractures NCT03927339 740 749 B-Condition-Name
, NCT03927339 750 751 O
or NCT03927339 752 754 O
lower NCT03927339 755 760 O
limb NCT03927339 761 765 O
injuries NCT03927339 766 774 B-Condition-Name
) NCT03927339 775 776 O
. NCT03927339 778 779 O
History NCT03927339 780 787 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927339 788 790 O
recent NCT03927339 791 797 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
reefer NCT03927339 798 804 B-Condition-Name
transmission NCT03927339 805 817 I-Condition-Name
or NCT03927339 818 820 O
acute NCT03927339 821 826 B-Severity___Severity-Value:severe
joint NCT03927339 827 832 B-Condition-Name
lighting NCT03927339 833 841 I-Condition-Name
. NCT03927339 843 844 O
History NCT03927339 845 852 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927339 853 855 O
recent NCT03927339 856 862 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
joint NCT03927339 863 868 B-Procedure-Name
injection NCT03927339 869 878 I-Procedure-Name
( NCT03927339 879 880 O
steroid NCT03927339 881 888 B-Drug-Name
, NCT03927339 889 890 O
hyaluronic NCT03927339 891 901 B-Drug-Name
acid NCT03927339 902 906 I-Drug-Name
, NCT03927339 907 908 O
etc NCT03927339 909 912 O
. NCT03927339 913 914 O
) NCT03927339 915 916 O
within NCT03927339 917 923 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03927339 925 926 B-Eq-Value
calendar NCT03927339 927 935 O
week NCT03927339 936 940 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03927339 941 943 O
study NCT03927339 944 949 O
. NCT03927339 950 951 O
Ingestion NCT03927339 953 962 O
of NCT03927339 963 965 O
antioxidant NCT03927339 966 977 B-Drug-Name
supplementation NCT03927339 978 993 I-Drug-Name
and NCT03927339 994 997 O
the NCT03927339 998 1001 O
use NCT03927339 1002 1005 O
of NCT03927339 1006 1008 O
psychotropic NCT03927339 1009 1021 B-Drug-Name
agents NCT03927339 1022 1028 I-Drug-Name
. NCT03927339 1029 1030 O

Inclusion NCT03924817 0 9 O
Criteria NCT03924817 10 18 O
: NCT03924817 19 20 O

- NCT03924817 24 25 O
Prescription NCT03924817 27 39 O
of NCT03924817 40 42 O
a NCT03924817 43 44 O
Narval NCT03924817 45 51 B-Procedure-Name
CC NCT03924817 52 54 I-Procedure-Name
mandibular NCT03924817 55 65 I-Procedure-Name
advancement NCT03924817 66 77 I-Procedure-Name
device NCT03924817 78 84 I-Procedure-Name

- NCT03924817 87 88 O
Age NCT03924817 90 93 O
≥ NCT03924817 94 95 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03924817 97 99 B-Eq-Value
years NCT03924817 100 105 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03924817 108 109 O
Ability NCT03924817 111 118 O
to NCT03924817 119 121 O
understand NCT03924817 122 132 O
the NCT03924817 133 136 O
study NCT03924817 137 142 O
information NCT03924817 143 154 O
and NCT03924817 155 158 O
information NCT03924817 159 170 O
on NCT03924817 171 173 O
usage NCT03924817 174 179 O
of NCT03924817 180 182 O
personal NCT03924817 183 191 O
data NCT03924817 192 196 O

- NCT03924817 199 200 O
Signed NCT03924817 202 208 O
and NCT03924817 209 212 O
dated NCT03924817 213 218 O
informed NCT03924817 219 227 O
consent NCT03924817 228 235 O

Exclusion NCT03924817 236 245 O
Criteria NCT03924817 246 254 O
: NCT03924817 255 256 O

- NCT03924817 260 261 O
Patients NCT03924817 263 271 O
with NCT03924817 272 276 O
central NCT03924817 277 284 B-Condition-Name
sleep NCT03924817 285 290 I-Condition-Name
apnea NCT03924817 291 296 I-Condition-Name
( NCT03924817 297 298 O
central NCT03924817 299 306 B-Observation-Name
AI NCT03924817 307 309 I-Observation-Name
> NCT03924817 310 311 B-Eq-Operator___Eq-Operator-Value:GT
5 NCT03924817 313 314 B-Eq-Value
/ NCT03924817 315 316 O
hour NCT03924817 317 321 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
) NCT03924817 322 323 O

- NCT03924817 327 328 O
Patients NCT03924817 330 338 O
with NCT03924817 339 343 O
loose NCT03924817 344 349 B-Condition-Name
teeth NCT03924817 350 355 I-Condition-Name
and NCT03924817 356 359 O
severe NCT03924817 360 366 B-Severity___Severity-Value:severe
parodontitis NCT03924817 367 379 B-Condition-Name

- NCT03924817 382 383 O
Patients NCT03924817 385 393 O
with NCT03924817 394 398 O
completely NCT03924817 399 409 O
missing NCT03924817 410 417 B-Condition-Name
teeth NCT03924817 418 423 I-Condition-Name
or NCT03924817 424 426 O
removable NCT03924817 427 436 B-Procedure-Name
tooth NCT03924817 437 442 I-Procedure-Name
replacement NCT03924817 443 454 I-Procedure-Name
, NCT03924817 455 456 O
or NCT03924817 457 459 O
with NCT03924817 460 464 O
a NCT03924817 465 466 O
teeth NCT03924817 467 472 B-Condition-Name
health NCT03924817 473 479 I-Condition-Name
insufficient NCT03924817 480 492 O
to NCT03924817 493 495 O
retain NCT03924817 496 502 O
an NCT03924817 503 505 O
MAD NCT03924817 506 509 B-Procedure-Name
Patients NCT03924817 510 518 O
with NCT03924817 519 523 O
missing NCT03924817 524 531 B-Condition-Name
molars NCT03924817 532 538 I-Condition-Name
Patients NCT03924817 539 547 O
with NCT03924817 548 552 O
maximum NCT03924817 553 560 B-Observation-Name___Observation-Type-Value:measurement
protrusion NCT03924817 561 571 I-Observation-Name___Observation-Type-Value:measurement
of NCT03924817 572 574 O
less NCT03924817 575 579 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03924817 580 584 I-Eq-Operator___Eq-Operator-Value:LT
5 NCT03924817 586 587 B-Eq-Value
mm NCT03924817 588 590 B-Eq-Unit

Inclusion NCT03928977 0 9 O
Criteria NCT03928977 10 18 O
: NCT03928977 19 20 O

- NCT03928977 24 25 O
Patient NCT03928977 27 34 O
admitted NCT03928977 35 43 O
in NCT03928977 44 46 O
for NCT03928977 47 50 O
a NCT03928977 51 52 O
transient NCT03928977 53 62 B-Condition-Name
neurologic NCT03928977 63 73 I-Condition-Name
deficit NCT03928977 74 81 I-Condition-Name
and NCT03928977 82 85 O
suspicion NCT03928977 86 95 O
of NCT03928977 96 98 O
TIA NCT03928977 99 102 B-Condition-Name
of NCT03928977 103 105 O
carotid NCT03928977 106 113 O
circulation NCT03928977 114 125 O

- NCT03928977 128 129 O
Prescription NCT03928977 131 143 O
for NCT03928977 144 147 O
conventionnal NCT03928977 148 161 O
MRI NCT03928977 162 165 B-Procedure-Name

Exclusion NCT03928977 166 175 O
Criteria NCT03928977 176 184 O
: NCT03928977 185 186 O

- NCT03928977 190 191 O
Contraindication NCT03928977 193 209 O
to NCT03928977 210 212 O
MRI NCT03928977 213 216 B-Procedure-Name

- NCT03928977 219 220 O
Previous NCT03928977 222 230 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
neurological NCT03928977 231 243 B-Condition-Name
disease NCT03928977 244 251 I-Condition-Name
( NCT03928977 252 253 O
with NCT03928977 254 258 O
lesions NCT03928977 259 266 B-Condition-Name
) NCT03928977 267 268 O

- NCT03928977 272 273 O
Severe NCT03928977 275 281 B-Severity___Severity-Value:severe
psychiatric NCT03928977 282 293 B-Condition-Name
disease NCT03928977 294 301 I-Condition-Name

Inclusion NCT03922282 0 9 O
Criteria NCT03922282 10 18 O
: NCT03922282 19 20 O

- NCT03922282 24 25 O
Subject NCT03922282 27 34 O
who NCT03922282 35 38 O
will NCT03922282 39 43 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
have NCT03922282 44 48 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
thyroid NCT03922282 49 56 B-Procedure-Name
surgery NCT03922282 57 64 I-Procedure-Name

Exclusion NCT03922282 65 74 O
Criteria NCT03922282 75 83 O
: NCT03922282 84 85 O

- NCT03922282 89 90 O
Subject NCT03922282 92 99 O
who NCT03922282 100 103 O
underwent NCT03922282 104 113 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
thyroid NCT03922282 114 121 B-Procedure-Name
surgery NCT03922282 122 129 I-Procedure-Name

- NCT03922282 132 133 O
Subject NCT03922282 135 142 O
who NCT03922282 143 146 O
underwent NCT03922282 147 156 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
any NCT03922282 157 160 O
radiotherapy NCT03922282 161 173 B-Procedure-Name
on NCT03922282 174 176 O
neck NCT03922282 177 181 O

- NCT03922282 184 185 O
Subject NCT03922282 187 194 O
who NCT03922282 195 198 O
need NCT03922282 199 203 O
to NCT03922282 204 206 O
neck NCT03922282 207 211 O
dissection NCT03922282 212 222 B-Procedure-Name

- NCT03922282 225 226 O
Subject NCT03922282 228 235 O
under NCT03922282 236 241 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03922282 243 245 B-Eq-Value
years NCT03922282 246 251 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03922282 252 254 O
over NCT03922282 255 259 B-Eq-Operator___Eq-Operator-Value:GT
70 NCT03922282 261 263 B-Eq-Value
years NCT03922282 264 269 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03922282 272 273 O
Bad NCT03922282 275 278 B-Condition-Name
general NCT03922282 279 286 I-Condition-Name
condition NCT03922282 287 296 I-Condition-Name

- NCT03922282 299 300 O
High NCT03922282 302 306 B-Polarity___Polarity-Value:high
American NCT03922282 307 315 B-Condition-Name
Society NCT03922282 316 323 I-Condition-Name
of NCT03922282 324 326 I-Condition-Name
Anesthesiologists NCT03922282 327 344 I-Condition-Name
( NCT03922282 345 346 O
ASA NCT03922282 347 350 B-Condition-Name
) NCT03922282 351 352 O
score NCT03922282 353 358 O
( NCT03922282 359 360 O
over NCT03922282 361 365 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03922282 367 368 B-Eq-Value
) NCT03922282 369 370 O

- NCT03922282 374 375 O
Breast NCT03922282 377 383 B-Condition-Name
feeder NCT03922282 384 390 I-Condition-Name
or NCT03922282 391 393 O
pregnancy NCT03922282 394 403 B-Condition-Name

- NCT03922282 406 407 O
Subject NCT03922282 409 416 O
who NCT03922282 417 420 O
disagree NCT03922282 421 429 O
to NCT03922282 430 432 O
do NCT03922282 433 435 O
this NCT03922282 436 440 O
trial NCT03922282 441 446 O

Inclusion NCT03929705 0 9 O
Criteria NCT03929705 10 18 O
: NCT03929705 19 20 O
Cohort NCT03929705 21 27 O
1 NCT03929705 29 30 O
a NCT03929705 31 32 O
and NCT03929705 33 36 O
1 NCT03929705 38 39 O
b NCT03929705 40 41 O

- NCT03929705 44 45 O
• NCT03929705 47 48 O
Must NCT03929705 49 53 O
be NCT03929705 54 56 O
at NCT03929705 57 59 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929705 60 65 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03929705 67 69 B-Eq-Value
years NCT03929705 70 75 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03929705 76 78 O
age NCT03929705 79 82 O

- NCT03929705 90 91 O
Must NCT03929705 93 97 O
be NCT03929705 98 100 O
able NCT03929705 101 105 O
to NCT03929705 106 108 O
provide NCT03929705 109 116 O
informed NCT03929705 117 125 O
consent NCT03929705 126 133 O

- NCT03929705 141 142 O
Must NCT03929705 144 148 O
be NCT03929705 149 151 O
able NCT03929705 152 156 O
to NCT03929705 157 159 O
provide NCT03929705 160 167 O
a NCT03929705 168 169 O
minimum NCT03929705 170 177 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03929705 178 180 O
10 NCT03929705 182 184 B-Eq-Value
mL NCT03929705 185 187 B-Eq-Unit
of NCT03929705 188 190 O
whole NCT03929705 191 196 B-Observation-Name___Observation-Type-Value:lab
blood NCT03929705 197 202 I-Observation-Name___Observation-Type-Value:lab
at NCT03929705 203 205 O
each NCT03929705 206 210 O
visit NCT03929705 211 216 O
( NCT03929705 217 218 O
16 NCT03929705 220 222 B-Eq-Value
mL NCT03929705 223 225 B-Eq-Unit
for NCT03929705 226 229 O
immunocompromised NCT03929705 230 247 B-Condition-Name
i NCT03929705 248 249 O
. NCT03929705 250 251 O
e NCT03929705 252 253 O
. NCT03929705 254 255 O
HIV NCT03929705 257 260 B-Condition-Name
+ NCT03929705 261 262 B-Polarity___Polarity-Value:positive
) NCT03929705 264 265 O

- NCT03929705 274 275 O
Must NCT03929705 277 281 O
be NCT03929705 282 284 O
T NCT03929705 285 286 B-Observation-Name___Observation-Type-Value:lab
- NCT03929705 287 288 I-Observation-Name___Observation-Type-Value:lab
SPOT NCT03929705 289 293 I-Observation-Name___Observation-Type-Value:lab
. NCT03929705 294 295 I-Observation-Name___Observation-Type-Value:lab
TB NCT03929705 296 298 I-Observation-Name___Observation-Type-Value:lab
positive NCT03929705 299 307 B-Polarity___Polarity-Value:positive

- NCT03929705 315 316 O
First NCT03929705 318 323 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
visit NCT03929705 324 329 O
suspect NCT03929705 330 337 O
TB NCT03929705 338 340 B-Condition-Name
subjects NCT03929705 341 349 O
with NCT03929705 350 354 O
no NCT03929705 355 357 O
prior NCT03929705 358 363 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03929705 364 371 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929705 372 374 O
TB NCT03929705 375 377 B-Condition-Name
diagnosis NCT03929705 378 387 O
Inclusion NCT03929705 388 397 O
Criteria NCT03929705 398 406 O
: NCT03929705 407 408 O
Cohort NCT03929705 409 415 O
2 NCT03929705 417 418 O
a NCT03929705 419 420 O
and NCT03929705 421 424 O
2 NCT03929705 426 427 O
b NCT03929705 428 429 O

- NCT03929705 437 438 O
Must NCT03929705 440 444 O
be NCT03929705 445 447 O
at NCT03929705 448 450 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929705 451 456 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03929705 458 460 B-Eq-Value
years NCT03929705 461 466 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03929705 467 469 O
age NCT03929705 470 473 O

- NCT03929705 481 482 O
Must NCT03929705 484 488 O
be NCT03929705 489 491 O
able NCT03929705 492 496 O
to NCT03929705 497 499 O
provide NCT03929705 500 507 O
informed NCT03929705 508 516 O
consent NCT03929705 517 524 O

- NCT03929705 532 533 O
Must NCT03929705 535 539 O
be NCT03929705 540 542 O
able NCT03929705 543 547 O
to NCT03929705 548 550 O
provide NCT03929705 551 558 O
a NCT03929705 559 560 O
minimum NCT03929705 561 568 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03929705 569 571 I-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03929705 573 575 B-Eq-Value
mL NCT03929705 576 578 B-Eq-Unit
of NCT03929705 579 581 O
whole NCT03929705 582 587 B-Observation-Name
blood NCT03929705 588 593 I-Observation-Name
at NCT03929705 594 596 O
each NCT03929705 597 601 O
visit NCT03929705 602 607 O
( NCT03929705 608 609 O
16 NCT03929705 611 613 B-Eq-Value
mL NCT03929705 614 616 B-Eq-Unit
for NCT03929705 617 620 O
immunocompromised NCT03929705 621 638 B-Condition-Name
i NCT03929705 639 640 O
. NCT03929705 641 642 O
e NCT03929705 643 644 O
. NCT03929705 645 646 O
HIV NCT03929705 648 651 B-Condition-Name
+ NCT03929705 652 653 B-Polarity___Polarity-Value:positive
) NCT03929705 655 656 O

- NCT03929705 665 666 O
Must NCT03929705 668 672 O
be NCT03929705 673 675 O
T NCT03929705 676 677 B-Condition-Name
- NCT03929705 678 679 I-Condition-Name
SPOT NCT03929705 680 684 I-Condition-Name
. NCT03929705 685 686 I-Condition-Name
TB NCT03929705 687 689 I-Condition-Name
positive NCT03929705 690 698 B-Polarity___Polarity-Value:positive

- NCT03929705 706 707 O
No NCT03929705 709 711 O
prior NCT03929705 712 717 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03929705 718 725 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929705 726 728 O
TB NCT03929705 729 731 B-Condition-Name
diagnosis NCT03929705 732 741 O

Exclusion NCT03929705 742 751 O
Criteria NCT03929705 752 760 O
: NCT03929705 761 762 O
Cohort NCT03929705 763 769 O
1 NCT03929705 771 772 O
a NCT03929705 773 774 O
and NCT03929705 775 778 O
1 NCT03929705 780 781 O
b NCT03929705 782 783 O

- NCT03929705 786 787 O
• NCT03929705 789 790 O
Negative NCT03929705 791 799 B-Polarity___Polarity-Value:negative
in NCT03929705 800 802 O
the NCT03929705 803 806 O
T NCT03929705 807 808 B-Observation-Name___Observation-Type-Value:lab
- NCT03929705 809 810 I-Observation-Name___Observation-Type-Value:lab
SPOT NCT03929705 811 815 I-Observation-Name___Observation-Type-Value:lab
. NCT03929705 816 817 I-Observation-Name___Observation-Type-Value:lab
TB NCT03929705 818 820 I-Observation-Name___Observation-Type-Value:lab
test NCT03929705 821 825 I-Observation-Name___Observation-Type-Value:lab

- NCT03929705 833 834 O
Previous NCT03929705 836 844 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03929705 845 847 O
pre NCT03929705 848 851 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03929705 852 853 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03929705 854 862 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
confirmed NCT03929705 863 872 O
TB NCT03929705 873 875 B-Condition-Name
diagnosis NCT03929705 876 885 O

- NCT03929705 893 894 O
On NCT03929705 896 898 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
anti NCT03929705 899 903 O
- NCT03929705 904 905 O
TB NCT03929705 906 908 B-Condition-Name
treatment NCT03929705 909 918 O
for NCT03929705 919 922 O
more NCT03929705 923 927 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929705 928 932 I-Eq-Operator___Eq-Operator-Value:GT
1 NCT03929705 934 935 B-Eq-Value
week NCT03929705 936 940 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
* NCT03929705 940 941 O

- NCT03929705 949 950 O
Not NCT03929705 952 955 O
meeting NCT03929705 956 963 O
inclusion NCT03929705 964 973 O
criteria NCT03929705 974 982 O
Exclusion NCT03929705 983 992 O
Criteria NCT03929705 993 1001 O
: NCT03929705 1002 1003 O
Cohort NCT03929705 1004 1010 O
2 NCT03929705 1012 1013 O
a NCT03929705 1014 1015 O
and NCT03929705 1016 1019 O
2 NCT03929705 1021 1022 O
b NCT03929705 1023 1024 O

- NCT03929705 1032 1033 O
Negative NCT03929705 1035 1043 B-Polarity___Polarity-Value:negative
T NCT03929705 1044 1045 B-Observation-Name___Observation-Type-Value:lab
- NCT03929705 1046 1047 I-Observation-Name___Observation-Type-Value:lab
SPOT NCT03929705 1048 1052 I-Observation-Name___Observation-Type-Value:lab
. NCT03929705 1053 1054 I-Observation-Name___Observation-Type-Value:lab
TB NCT03929705 1055 1057 I-Observation-Name___Observation-Type-Value:lab
test NCT03929705 1058 1062 I-Observation-Name___Observation-Type-Value:lab

- NCT03929705 1070 1071 O
Previous NCT03929705 1073 1081 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03929705 1082 1084 O
pre NCT03929705 1085 1088 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03929705 1089 1090 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
existing NCT03929705 1091 1099 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
confirmed NCT03929705 1100 1109 O
TB NCT03929705 1110 1112 B-Condition-Name
diagnosis NCT03929705 1113 1122 O

- NCT03929705 1130 1131 O
On NCT03929705 1133 1135 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
anti NCT03929705 1136 1140 O
- NCT03929705 1141 1142 O
TB NCT03929705 1143 1145 B-Condition-Name
treatment NCT03929705 1146 1155 O

- NCT03929705 1163 1164 O
Symptoms NCT03929705 1166 1174 O
of NCT03929705 1175 1177 O
active NCT03929705 1178 1184 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
TB NCT03929705 1185 1187 B-Condition-Name

- NCT03929705 1195 1196 O
Not NCT03929705 1198 1201 O
meeting NCT03929705 1202 1209 O
inclusion NCT03929705 1210 1219 O
criteria NCT03929705 1220 1228 O

Inclusion NCT03927066 0 9 O
Criteria NCT03927066 10 18 O
: NCT03927066 19 20 O

- NCT03927066 24 25 O
Non NCT03927066 27 30 O
- NCT03927066 31 32 O
obese NCT03927066 33 38 B-Condition-Name
( NCT03927066 39 40 O
BMI NCT03927066 41 44 B-Observation-Name___Observation-Type-Value:vital
< NCT03927066 45 46 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03927066 48 50 B-Eq-Value
) NCT03927066 51 52 O

- NCT03927066 56 57 O
Non NCT03927066 59 62 O
- NCT03927066 63 64 O
smokers NCT03927066 65 72 O

- NCT03927066 75 76 O
Free NCT03927066 78 82 O
of NCT03927066 83 85 O
any NCT03927066 86 89 O
systemic NCT03927066 90 98 O
diseases NCT03927066 99 107 B-Condition-Name
including NCT03927066 108 117 O
hypertension NCT03927066 118 130 B-Condition-Name
, NCT03927066 131 132 O
diabetes NCT03927066 133 141 B-Condition-Name
, NCT03927066 142 143 O
coronary NCT03927066 144 152 B-Condition-Name
artery NCT03927066 153 159 I-Condition-Name
disease NCT03927066 160 167 I-Condition-Name
, NCT03927066 168 169 O
neurologic NCT03927066 170 180 B-Condition-Name
disease NCT03927066 181 188 I-Condition-Name
, NCT03927066 189 190 O
or NCT03927066 191 193 O
any NCT03927066 194 197 O
other NCT03927066 198 203 O
major NCT03927066 204 209 B-Severity___Severity-Value:severe
medical NCT03927066 210 217 B-Condition-Name
co NCT03927066 218 220 I-Condition-Name
- NCT03927066 221 222 I-Condition-Name
morbidity NCT03927066 223 232 I-Condition-Name

- NCT03927066 235 236 O
Women NCT03927066 238 243 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
will NCT03927066 244 248 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
be NCT03927066 249 251 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
either NCT03927066 252 258 O
surgically NCT03927066 259 269 B-Procedure-Name
sterilized NCT03927066 270 280 I-Procedure-Name
or NCT03927066 281 283 O
non NCT03927066 284 287 O
- NCT03927066 288 289 O
pregnant NCT03927066 290 298 B-Condition-Name
as NCT03927066 299 301 O
determined NCT03927066 302 312 O
by NCT03927066 313 315 O
a NCT03927066 316 317 O
urine NCT03927066 318 323 B-Observation-Name___Observation-Type-Value:lab
pregnancy NCT03927066 324 333 I-Observation-Name___Observation-Type-Value:lab
test NCT03927066 334 338 I-Observation-Name___Observation-Type-Value:lab

Inclusion NCT03925103 0 9 O
Criteria NCT03925103 10 18 O
: NCT03925103 19 20 O

- NCT03925103 24 25 O
Clinical NCT03925103 27 35 O
NSCLC NCT03925103 36 41 O
early NCT03925103 42 47 O
stage NCT03925103 48 53 O
( NCT03925103 54 55 O
stage NCT03925103 56 61 O
I NCT03925103 62 63 O
- NCT03925103 64 65 O
II NCT03925103 66 68 O
) NCT03925103 69 70 O
. NCT03925103 72 73 O

- NCT03925103 77 78 O
Both NCT03925103 80 84 O
forced NCT03925103 85 91 B-Observation-Name___Observation-Type-Value:measurement
expiratory NCT03925103 92 102 I-Observation-Name___Observation-Type-Value:measurement
volume NCT03925103 103 109 I-Observation-Name___Observation-Type-Value:measurement
in NCT03925103 110 112 I-Observation-Name___Observation-Type-Value:measurement
one NCT03925103 113 116 I-Observation-Name___Observation-Type-Value:measurement
second NCT03925103 117 123 I-Observation-Name___Observation-Type-Value:measurement
( NCT03925103 124 125 O
FEV NCT03925103 126 129 B-Observation-Name
1 NCT03925103 130 131 I-Observation-Name
) NCT03925103 132 133 O
and NCT03925103 134 137 O
diffusion NCT03925103 138 147 B-Observation-Name___Observation-Type-Value:measurement
capacity NCT03925103 148 156 I-Observation-Name___Observation-Type-Value:measurement
of NCT03925103 157 159 I-Observation-Name___Observation-Type-Value:measurement
carbon NCT03925103 160 166 I-Observation-Name___Observation-Type-Value:measurement
monoxide NCT03925103 167 175 I-Observation-Name___Observation-Type-Value:measurement
( NCT03925103 176 177 O
DLCO NCT03925103 178 182 B-Observation-Name
) NCT03925103 183 184 O
> NCT03925103 186 187 B-Eq-Operator___Eq-Operator-Value:GT
60 NCT03925103 189 191 B-Eq-Value
% NCT03925103 192 193 B-Eq-Unit

- NCT03925103 197 198 O
Both NCT03925103 200 204 O
predicted NCT03925103 205 214 O
post NCT03925103 215 219 O
operative NCT03925103 220 229 O
( NCT03925103 230 231 O
PPO NCT03925103 232 235 O
) NCT03925103 236 237 O
FEV NCT03925103 238 241 B-Observation-Name
1 NCT03925103 242 243 I-Observation-Name
and NCT03925103 244 247 O
PPO NCT03925103 248 251 O
DLCO NCT03925103 252 256 B-Observation-Name
> NCT03925103 257 258 B-Eq-Operator___Eq-Operator-Value:GT
35 NCT03925103 260 262 B-Eq-Value
% NCT03925103 263 264 O

- NCT03925103 268 269 O
American NCT03925103 271 279 B-Condition-Name
Society NCT03925103 280 287 I-Condition-Name
of NCT03925103 288 290 I-Condition-Name
Anesthesia NCT03925103 291 301 I-Condition-Name
( NCT03925103 302 303 O
ASA NCT03925103 304 307 B-Condition-Name
) NCT03925103 308 309 O
score NCT03925103 310 315 B-Eq-Unit
< NCT03925103 316 317 B-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03925103 319 320 I-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03925103 322 323 B-Eq-Value

- NCT03925103 327 328 O
Body NCT03925103 330 334 B-Observation-Name___Observation-Type-Value:vital
mass NCT03925103 335 339 I-Observation-Name___Observation-Type-Value:vital
index NCT03925103 340 345 I-Observation-Name___Observation-Type-Value:vital
( NCT03925103 346 347 O
BMI NCT03925103 348 351 B-Observation-Name___Observation-Type-Value:vital
) NCT03925103 352 353 O
> NCT03925103 354 355 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03925103 357 359 B-Eq-Value
< NCT03925103 360 361 B-Eq-Operator___Eq-Operator-Value:LT
28 NCT03925103 363 365 B-Eq-Value

Exclusion NCT03925103 367 376 O
Criteria NCT03925103 377 385 O
: NCT03925103 386 387 O

- NCT03925103 391 392 O
Clinical NCT03925103 394 402 O
NSCLC NCT03925103 403 408 B-Condition-Name
stage NCT03925103 409 414 B-Eq-Unit
> NCT03925103 415 416 B-Eq-Operator___Eq-Operator-Value:GT
II NCT03925103 417 419 B-Eq-Value

- NCT03925103 422 423 O
History NCT03925103 425 432 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925103 433 435 O
Neoadjuvant NCT03925103 436 447 B-Procedure-Name
chemotherapy NCT03925103 448 460 I-Procedure-Name
or NCT03925103 461 463 O
radiotherapy NCT03925103 464 476 B-Procedure-Name

- NCT03925103 479 480 O
Radiologic NCT03925103 482 492 B-Procedure-Name
evidence NCT03925103 493 501 O
of NCT03925103 502 504 O
extensive NCT03925103 505 514 B-Severity___Severity-Value:severe
pleural NCT03925103 515 522 B-Condition-Name
adhesions NCT03925103 523 532 I-Condition-Name
. NCT03925103 533 534 O

- NCT03925103 538 539 O
Age NCT03925103 541 544 O
< NCT03925103 545 546 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03925103 548 550 B-Eq-Value
or NCT03925103 551 553 O
> NCT03925103 554 555 B-Eq-Operator___Eq-Operator-Value:GT
80 NCT03925103 557 559 B-Eq-Value
years NCT03925103 560 565 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03925103 566 567 O

- NCT03925103 571 572 O
Patients NCT03925103 574 582 O
with NCT03925103 583 587 O
previous NCT03925103 588 596 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pleurodesis NCT03925103 597 608 B-Procedure-Name
or NCT03925103 609 611 O
thoracotomy NCT03925103 612 623 B-Procedure-Name
in NCT03925103 624 626 O
the NCT03925103 627 630 O
affected NCT03925103 631 639 O
hemithorax NCT03925103 640 650 O
. NCT03925103 651 652 O

- NCT03925103 656 657 O
Patients NCT03925103 659 667 O
who NCT03925103 668 671 O
will NCT03925103 672 676 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
undergo NCT03925103 677 684 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
surgical NCT03925103 685 693 B-Procedure-Name
lung NCT03925103 694 698 I-Procedure-Name
resection NCT03925103 699 708 I-Procedure-Name
other NCT03925103 709 714 O
than NCT03925103 715 719 O
lobectomy NCT03925103 720 729 B-Procedure-Name
. NCT03925103 730 731 O

- NCT03925103 735 736 O
Patients NCT03925103 738 746 O
with NCT03925103 747 751 O
severe NCT03925103 752 758 B-Severity___Severity-Value:severe
comorbidity NCT03925103 759 770 B-Condition-Name
contraindicating NCT03925103 771 787 O
lobectomy NCT03925103 788 797 B-Procedure-Name
. NCT03925103 798 799 O

- NCT03925103 803 804 O
Patients NCT03925103 806 814 O
refusal NCT03925103 815 822 O
or NCT03925103 823 825 O
noncompliance NCT03925103 826 839 O
to NCT03925103 840 842 O
general NCT03925103 843 850 B-Procedure-Name
surgery NCT03925103 851 858 I-Procedure-Name
and NCT03925103 859 862 O
one NCT03925103 863 866 O
- NCT03925103 867 868 O
lung NCT03925103 869 873 O
ventilation NCT03925103 874 885 B-Procedure-Name
. NCT03925103 886 887 O

Inclusion NCT03924037 0 9 O
Criteria NCT03924037 10 18 O
: NCT03924037 19 20 O

- NCT03924037 24 25 O
American NCT03924037 27 35 B-Ethnicity
Indian NCT03924037 36 42 I-Ethnicity
youth NCT03924037 43 48 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
aged NCT03924037 49 53 O
13 NCT03924037 55 57 B-Eq-Value
- NCT03924037 58 59 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03924037 61 63 B-Eq-Value
years NCT03924037 64 69 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03924037 70 73 O
who NCT03924037 74 77 O
are NCT03924037 78 81 O
San NCT03924037 82 85 B-Ethnicity
Felipe NCT03924037 86 92 I-Ethnicity
tribal NCT03924037 93 99 I-Ethnicity
members NCT03924037 100 107 I-Ethnicity
living NCT03924037 108 114 O
in NCT03924037 115 117 O
the NCT03924037 118 121 O
Pueblo NCT03924037 122 128 B-Location___Location-Value:residence

- NCT03924037 131 132 O
Endorse NCT03924037 134 141 O
suicidal NCT03924037 142 150 B-Condition-Name
ideation NCT03924037 151 159 O
or NCT03924037 160 162 O
behaviors NCT03924037 163 172 O
on NCT03924037 173 175 O
a NCT03924037 176 177 O
universal NCT03924037 178 187 B-Procedure-Name
screen NCT03924037 188 194 I-Procedure-Name
by NCT03924037 195 197 O
their NCT03924037 198 203 O
primary NCT03924037 204 211 B-Provider-Role
care NCT03924037 212 216 I-Provider-Role
provider NCT03924037 217 225 I-Provider-Role
. NCT03924037 226 227 O

Exclusion NCT03924037 229 238 O
Criteria NCT03924037 239 247 O
: NCT03924037 248 249 O

- NCT03924037 253 254 O
Younger NCT03924037 256 263 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03924037 264 268 I-Eq-Operator___Eq-Operator-Value:LT
age NCT03924037 269 272 O
of NCT03924037 273 275 O
13 NCT03924037 277 279 B-Eq-Value
years NCT03924037 280 285 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03924037 286 289 O
or NCT03924037 290 292 O

- NCT03924037 295 296 O
Older NCT03924037 298 303 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03924037 304 308 I-Eq-Operator___Eq-Operator-Value:GT
the NCT03924037 309 312 O
age NCT03924037 313 316 O
of NCT03924037 317 319 O
24 NCT03924037 321 323 B-Eq-Value
, NCT03924037 324 325 O

- NCT03924037 330 331 O
Not NCT03924037 333 336 O
American NCT03924037 337 345 B-Ethnicity
Indian NCT03924037 346 352 I-Ethnicity
, NCT03924037 353 354 O

- NCT03924037 358 359 O
Youth NCT03924037 361 366 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
who NCT03924037 367 370 O
do NCT03924037 371 373 O
not NCT03924037 374 377 O
receive NCT03924037 378 385 O
health NCT03924037 386 392 O
services NCT03924037 393 401 O
at NCT03924037 402 404 O
either NCT03924037 405 411 O
of NCT03924037 412 414 O
the NCT03924037 415 418 O
IHS NCT03924037 419 422 B-Location___Location-Value:clinic
clinics NCT03924037 423 430 I-Location___Location-Value:clinic
at NCT03924037 431 433 O
the NCT03924037 434 437 O
Pueblo NCT03924037 438 444 B-Location___Location-Value:residence
of NCT03924037 445 447 I-Location___Location-Value:residence
San NCT03924037 448 451 I-Location___Location-Value:residence
Felipe NCT03924037 452 458 I-Location___Location-Value:residence
, NCT03924037 459 460 O

- NCT03924037 464 465 O
Youth NCT03924037 467 472 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
who NCT03924037 473 476 O
screen NCT03924037 477 483 O
negative NCT03924037 484 492 B-Polarity___Polarity-Value:negative
for NCT03924037 493 496 O
suicidal NCT03924037 497 505 B-Condition-Name
ideation NCT03924037 506 514 O
and NCT03924037 515 518 O
/ NCT03924037 519 520 O
or NCT03924037 521 523 O
behavior NCT03924037 524 532 O
, NCT03924037 533 534 O

- NCT03924037 538 539 O
Refuse NCT03924037 541 547 O
to NCT03924037 548 550 O
participate NCT03924037 551 562 O
in NCT03924037 563 565 O
the NCT03924037 566 569 O
study NCT03924037 570 575 O
, NCT03924037 576 577 O
and NCT03924037 578 581 O
/ NCT03924037 582 583 O
or NCT03924037 584 586 O

- NCT03924037 589 590 O
Cognitively NCT03924037 592 603 B-Condition-Name
unable NCT03924037 604 610 I-Condition-Name
to NCT03924037 611 613 O
provide NCT03924037 614 621 O
informed NCT03924037 622 630 O
consent NCT03924037 631 638 O
as NCT03924037 639 641 O
demonstrated NCT03924037 642 654 O
by NCT03924037 655 657 O
a NCT03924037 658 659 O
brief NCT03924037 660 665 O
cognitive NCT03924037 666 675 B-Procedure-Name
screen NCT03924037 676 682 I-Procedure-Name
prior NCT03924037 683 688 O
to NCT03924037 689 691 O
completion NCT03924037 692 702 O
of NCT03924037 703 705 O
the NCT03924037 706 709 O
baseline NCT03924037 710 718 O
interview NCT03924037 719 728 O
. NCT03924037 729 730 O

Inclusion NCT03922334 0 9 O
Criteria NCT03922334 10 18 O
: NCT03922334 19 20 O

- NCT03922334 24 25 O
Pregnant NCT03922334 27 35 B-Condition-Name
( NCT03922334 36 37 O
any NCT03922334 38 41 O
plurality NCT03922334 42 51 O
) NCT03922334 52 53 O
delivering NCT03922334 54 64 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
at NCT03922334 65 67 B-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03922334 68 70 I-Eq-Operator___Eq-Operator-Value:GTEQ
after NCT03922334 71 76 I-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03922334 78 80 B-Eq-Value
weeks NCT03922334 81 86 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03922334 87 89 O
gestation NCT03922334 90 99 B-Observation-Name
OR NCT03922334 100 102 O
postpartum NCT03922334 103 113 B-Condition-Name
( NCT03922334 114 115 O
during NCT03922334 116 122 O
hospitalization NCT03922334 123 138 B-Encounter-Type___Encounter-Type-Value:inpatient
) NCT03922334 139 140 O
, NCT03922334 142 143 O
regardless NCT03922334 144 154 O
of NCT03922334 155 157 O
perinatal NCT03922334 158 167 O
outcome NCT03922334 168 175 O

- NCT03922334 178 179 O
16 NCT03922334 182 184 B-Eq-Value
years NCT03922334 185 190 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03922334 191 193 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03922334 194 199 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03922334 202 203 O
Low NCT03922334 205 208 O
- NCT03922334 209 210 O
income NCT03922334 211 217 O
socioeconomic NCT03922334 218 231 O
status NCT03922334 232 238 O
( NCT03922334 239 240 O
publicly NCT03922334 241 249 O
funded NCT03922334 250 256 O
prenatal NCT03922334 257 265 O
care NCT03922334 266 270 O
) NCT03922334 271 272 O

- NCT03922334 276 277 O
Ability NCT03922334 279 286 O
to NCT03922334 287 289 O
speak NCT03922334 290 295 O
and NCT03922334 296 299 O
read NCT03922334 300 304 O
English NCT03922334 305 312 B-Language
or NCT03922334 313 315 O
Spanish NCT03922334 316 323 B-Language

- NCT03922334 326 327 O
Established NCT03922334 329 340 O
patient NCT03922334 341 348 O
at NCT03922334 349 351 O
the NCT03922334 352 355 O
Northwestern NCT03922334 356 368 B-Location___Location-Value:clinic
Medicine NCT03922334 369 377 I-Location___Location-Value:clinic
Prentice NCT03922334 378 386 I-Location___Location-Value:clinic
Ambulatory NCT03922334 387 397 I-Location___Location-Value:clinic
Care NCT03922334 398 402 I-Location___Location-Value:clinic
clinical NCT03922334 403 411 O
site NCT03922334 412 416 O
( NCT03922334 417 418 O
at NCT03922334 419 421 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03922334 422 427 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03922334 428 431 B-Eq-Value
antenatal NCT03922334 432 441 B-Location___Location-Value:clinic
clinical NCT03922334 442 450 I-Location___Location-Value:clinic
visit NCT03922334 451 456 B-Encounter-Type___Encounter-Type-Value:outpatient
) NCT03922334 457 458 O
. NCT03922334 460 461 O

Exclusion NCT03922334 463 472 O
Criteria NCT03922334 473 481 O
: NCT03922334 482 483 O

- NCT03922334 487 488 O
Intent NCT03922334 490 496 O
to NCT03922334 497 499 O
transfer NCT03922334 500 508 B-Encounter-Type___Encounter-Type-Value:transfer
care NCT03922334 509 513 I-Encounter-Type___Encounter-Type-Value:transfer
to NCT03922334 514 516 O
an NCT03922334 517 519 O
outside NCT03922334 520 527 O
institution NCT03922334 528 539 B-Location___Location-Value:hospital

- NCT03922334 542 543 O
HIV NCT03922334 545 548 B-Condition-Name
( NCT03922334 549 550 O
as NCT03922334 551 553 O
these NCT03922334 554 559 O
patients NCT03922334 560 568 O
already NCT03922334 569 576 O
receive NCT03922334 577 584 O
intensive NCT03922334 585 594 O
social NCT03922334 595 601 O
support NCT03922334 602 609 O
and NCT03922334 610 613 O
navigation NCT03922334 614 624 O
- NCT03922334 625 626 O
like NCT03922334 627 631 O
services NCT03922334 632 640 O
at NCT03922334 641 643 O
this NCT03922334 644 648 O
institution NCT03922334 649 660 O
) NCT03922334 661 662 O

Inclusion NCT03923764 0 9 O
Criteria NCT03923764 10 18 O
: NCT03923764 19 20 O

- NCT03923764 24 25 O
Diagnosed NCT03923764 27 36 O
with NCT03923764 37 41 O
COPD NCT03923764 42 46 B-Condition-Name

- NCT03923764 49 50 O
Participating NCT03923764 52 65 O
in NCT03923764 66 68 O
ongoing NCT03923764 69 76 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
lung NCT03923764 77 81 B-Procedure-Name
rehabilitating NCT03923764 82 96 I-Procedure-Name
programme NCT03923764 97 106 O
at NCT03923764 107 109 O
Hvidovre NCT03923764 110 118 B-Location___Location-Value:hospital
and NCT03923764 119 122 O
Bispebjerg NCT03923764 123 133 B-Location___Location-Value:hospital
Hospital NCT03923764 134 142 I-Location___Location-Value:hospital

- NCT03923764 145 146 O
over NCT03923764 148 152 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03923764 154 156 B-Eq-Value
years NCT03923764 157 162 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03923764 163 172 O
Criteria NCT03923764 173 181 O
: NCT03923764 182 183 O

- NCT03923764 187 188 O
Plasma NCT03923764 190 196 B-Observation-Name___Observation-Type-Value:lab
creatinin NCT03923764 197 206 I-Observation-Name___Observation-Type-Value:lab
over NCT03923764 207 211 B-Eq-Operator___Eq-Operator-Value:GT
200 NCT03923764 213 216 B-Eq-Value
mikrog NCT03923764 217 223 B-Eq-Unit
/ NCT03923764 224 225 O
l NCT03923764 226 227 B-Eq-Unit

- NCT03923764 230 231 O
dementia NCT03923764 233 241 B-Condition-Name

- NCT03923764 244 245 O
unable NCT03923764 247 253 O
to NCT03923764 254 256 O
read NCT03923764 257 261 O
or NCT03923764 262 264 O
speak NCT03923764 265 270 O
danish NCT03923764 271 277 B-Language

Inclusion NCT03925467 0 9 O
Criteria NCT03925467 10 18 O
: NCT03925467 19 20 O

Patients NCT03925467 22 30 O
meet NCT03925467 31 35 O
at NCT03925467 36 38 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03925467 39 44 I-Eq-Operator___Eq-Operator-Value:GTEQ
three NCT03925467 45 50 B-Eq-Value
out NCT03925467 51 54 O
of NCT03925467 55 57 O
the NCT03925467 58 61 O
following NCT03925467 62 71 O
six NCT03925467 72 75 B-Eq-Value
conditions NCT03925467 76 86 O
: NCT03925467 87 88 O

- NCT03925467 92 93 O
Any NCT03925467 95 98 O
gender NCT03925467 99 105 O
aged NCT03925467 106 110 O
50 NCT03925467 112 114 B-Eq-Value
years NCT03925467 115 120 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03925467 121 123 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03925467 124 129 I-Eq-Operator___Eq-Operator-Value:GTEQ
; NCT03925467 129 130 O

- NCT03925467 133 134 O
Have NCT03925467 136 140 O
less NCT03925467 141 145 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03925467 146 150 I-Eq-Operator___Eq-Operator-Value:LT
30 NCT03925467 152 154 B-Eq-Value
mins NCT03925467 155 159 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
of NCT03925467 160 162 O
morning NCT03925467 163 170 B-Observation-Name
stiffness NCT03925467 171 180 I-Observation-Name
; NCT03925467 180 181 O

- NCT03925467 184 185 O
Crepitus NCT03925467 187 195 B-Condition-Name
on NCT03925467 196 198 I-Condition-Name
active NCT03925467 199 205 I-Condition-Name
motion NCT03925467 206 212 I-Condition-Name
; NCT03925467 212 213 O

- NCT03925467 216 217 O
Bony NCT03925467 219 223 B-Condition-Name
tenderness NCT03925467 224 234 I-Condition-Name
; NCT03925467 234 235 O

- NCT03925467 238 239 O
Bony NCT03925467 241 245 B-Condition-Name
enlargement NCT03925467 246 257 I-Condition-Name
; NCT03925467 257 258 O

- NCT03925467 261 262 O
No NCT03925467 264 266 O
palpable NCT03925467 267 275 B-Condition-Name
warmth NCT03925467 276 282 I-Condition-Name
. NCT03925467 283 284 O

Exclusion NCT03925467 286 295 O
Criteria NCT03925467 296 304 O
: NCT03925467 305 306 O

- NCT03925467 310 311 O
Subjects NCT03925467 313 321 O
who NCT03925467 322 325 O
are NCT03925467 326 329 O
unable NCT03925467 330 336 B-Condition-Name
to NCT03925467 337 339 I-Condition-Name
walk NCT03925467 340 344 I-Condition-Name
. NCT03925467 345 346 O

- NCT03925467 350 351 O
Malignancy NCT03925467 353 363 B-Condition-Name
, NCT03925467 364 365 O

- NCT03925467 369 370 O
Any NCT03925467 372 375 O
acute NCT03925467 376 381 B-Severity___Severity-Value:severe
medical NCT03925467 382 389 O
condition NCT03925467 390 399 O
, NCT03925467 400 401 O

- NCT03925467 405 406 O
Poorly NCT03925467 408 414 O
controlled NCT03925467 415 425 O
diabetes NCT03925467 426 434 B-Condition-Name
or NCT03925467 435 437 O
hypertension NCT03925467 438 450 B-Condition-Name
, NCT03925467 451 452 O

- NCT03925467 456 457 O
A NCT03925467 459 460 O
motor NCT03925467 461 466 O
or NCT03925467 467 469 O
sensory NCT03925467 470 477 O
nerve NCT03925467 478 483 B-Condition-Name
defect NCT03925467 484 490 I-Condition-Name
, NCT03925467 491 492 O

- NCT03925467 496 497 O
Blood NCT03925467 499 504 O
clotting NCT03925467 505 513 O
disease NCT03925467 514 521 O
, NCT03925467 522 523 O

- NCT03925467 527 528 O
Mental NCT03925467 530 536 B-Condition-Name
illness NCT03925467 537 544 I-Condition-Name
, NCT03925467 545 546 O

- NCT03925467 550 551 O
Dementia NCT03925467 553 561 B-Condition-Name
, NCT03925467 562 563 O

- NCT03925467 567 568 O
Mental NCT03925467 570 576 B-Condition-Name
retardation NCT03925467 577 588 I-Condition-Name
or NCT03925467 589 591 O
other NCT03925467 592 597 O
abnormal NCT03925467 598 606 O
person NCT03925467 607 613 O
on NCT03925467 614 616 O
the NCT03925467 617 620 O
organic NCT03925467 621 628 O
mind NCT03925467 629 633 O
. NCT03925467 634 635 O

- NCT03925467 639 640 O
Subjects NCT03925467 642 650 O
with NCT03925467 651 655 O
intra NCT03925467 656 661 O
- NCT03925467 662 663 O
articular NCT03925467 664 673 O
solid NCT03925467 674 679 O
or NCT03925467 680 682 O
hyaluronic NCT03925467 683 693 O
acid NCT03925467 694 698 O
injection NCT03925467 699 708 B-Procedure-Name
in NCT03925467 709 711 O
the NCT03925467 712 715 O
past NCT03925467 716 720 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03925467 722 723 B-Eq-Value
months NCT03925467 724 730 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03925467 731 732 O

- NCT03925467 736 737 O
Knee NCT03925467 739 743 O
surgery NCT03925467 744 751 B-Procedure-Name
, NCT03925467 752 753 O

- NCT03925467 757 758 O
Knee NCT03925467 760 764 O
trauma NCT03925467 765 771 B-Condition-Name
, NCT03925467 772 773 O

- NCT03925467 777 778 O
Congenital NCT03925467 780 790 O
knee NCT03925467 791 795 O
deformation NCT03925467 796 807 B-Condition-Name
, NCT03925467 808 809 O

- NCT03925467 813 814 O
Severe NCT03925467 816 822 B-Severity___Severity-Value:severe
knee NCT03925467 823 827 O
varus NCT03925467 828 833 B-Condition-Name
or NCT03925467 834 836 O
valgus NCT03925467 837 843 B-Condition-Name
deformation NCT03925467 844 855 I-Condition-Name
, NCT03925467 856 857 O

- NCT03925467 861 862 O
Endocrine NCT03925467 864 873 O
, NCT03925467 874 875 O
metabolic NCT03925467 876 885 O
, NCT03925467 886 887 O
infectious NCT03925467 888 898 O
, NCT03925467 899 900 O
inflammatory NCT03925467 901 913 O
, NCT03925467 914 915 O
secondary NCT03925467 916 925 O
degenerative NCT03925467 926 938 O
knee NCT03925467 939 943 O
arthritis NCT03925467 944 953 B-Condition-Name
caused NCT03925467 954 960 O
by NCT03925467 961 963 O
problems NCT03925467 964 972 O
with NCT03925467 973 977 O
rheumatic NCT03925467 978 987 B-Condition-Name
immune NCT03925467 988 994 I-Condition-Name
diseases NCT03925467 995 1003 I-Condition-Name
. NCT03925467 1004 1005 O

- NCT03925467 1009 1010 O
Subjects NCT03925467 1012 1020 O
who NCT03925467 1021 1024 O
are NCT03925467 1025 1028 O
hypersensitive NCT03925467 1029 1043 B-Condition-Name
to NCT03925467 1044 1046 O
needles NCT03925467 1047 1054 O
. NCT03925467 1055 1056 O

- NCT03925467 1060 1061 O
Subjects NCT03925467 1063 1071 O
who NCT03925467 1072 1075 O
are NCT03925467 1076 1079 O
unwilling NCT03925467 1080 1089 O
to NCT03925467 1090 1092 O
cooperate NCT03925467 1093 1102 O
or NCT03925467 1103 1105 O
sign NCT03925467 1106 1110 O
the NCT03925467 1111 1114 O
subject NCT03925467 1115 1122 O
consent NCT03925467 1123 1130 O
. NCT03925467 1131 1132 O

Inclusion NCT03924180 0 9 O
Criteria NCT03924180 10 18 O
: NCT03924180 19 20 O

- NCT03924180 24 25 O
Phenylketonuric NCT03924180 27 42 B-Condition-Name
patient NCT03924180 43 50 O
diagnosed NCT03924180 51 60 O
in NCT03924180 61 63 O
neonatal NCT03924180 64 72 B-Procedure-Name
screening NCT03924180 73 82 I-Procedure-Name

- NCT03924180 85 86 O
Patient NCT03924180 88 95 O
with NCT03924180 96 100 O
Phenylalaninemia NCT03924180 101 117 B-Observation-Name
≥ NCT03924180 118 119 B-Eq-Operator___Eq-Operator-Value:GTEQ
900 NCT03924180 121 124 B-Eq-Value
μmol NCT03924180 125 129 B-Eq-Unit
/ NCT03924180 130 131 O
L NCT03924180 132 133 B-Eq-Unit
on NCT03924180 134 136 O
blotter NCT03924180 137 144 O
made NCT03924180 145 149 O
during NCT03924180 150 156 O
the NCT03924180 157 160 O
screening NCT03924180 161 170 O
period NCT03924180 171 177 O
( NCT03924180 178 179 O
or NCT03924180 180 182 O
average NCT03924180 183 190 O
blotting NCT03924180 191 199 O
results NCT03924180 200 207 O
≥ NCT03924180 208 209 B-Eq-Operator___Eq-Operator-Value:GTEQ
900 NCT03924180 211 214 B-Eq-Value
μmol NCT03924180 215 219 B-Eq-Unit
/ NCT03924180 220 221 O
L NCT03924180 222 223 B-Eq-Unit
if NCT03924180 224 226 O
several NCT03924180 227 234 B-Eq-Operator___Eq-Operator-Value:GT
blots NCT03924180 235 240 O
made NCT03924180 241 245 O
during NCT03924180 246 252 O
the NCT03924180 253 256 O
screening NCT03924180 257 266 O
period NCT03924180 267 273 O
) NCT03924180 274 275 O

- NCT03924180 279 280 O
Untreated NCT03924180 282 291 O
patient NCT03924180 292 299 O
: NCT03924180 300 301 O
not NCT03924180 302 305 O
taking NCT03924180 306 312 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
any NCT03924180 313 316 O
amino NCT03924180 317 322 B-Drug-Name
acid NCT03924180 323 327 I-Drug-Name
supplement NCT03924180 328 338 I-Drug-Name
for NCT03924180 339 342 O
his NCT03924180 343 346 O
PKU NCT03924180 347 350 B-Condition-Name
, NCT03924180 351 352 O
regardless NCT03924180 353 363 O
of NCT03924180 364 366 O
diet NCT03924180 367 371 O

Exclusion NCT03924180 372 381 O
Criteria NCT03924180 382 390 O
: NCT03924180 391 392 O

- NCT03924180 396 397 O
Protected NCT03924180 399 408 O
patient NCT03924180 409 416 O
: NCT03924180 417 418 O
court NCT03924180 419 424 B-Condition-Name
bail NCT03924180 425 429 I-Condition-Name
, NCT03924180 430 431 O
curatorship NCT03924180 432 443 B-Condition-Name
, NCT03924180 444 445 O
guardianship NCT03924180 446 458 B-Condition-Name

- NCT03924180 461 462 O
Patient NCT03924180 464 471 O
with NCT03924180 472 476 O
concomitant NCT03924180 477 488 B-Condition-Name
diseases NCT03924180 489 497 I-Condition-Name
/ NCT03924180 498 499 O
conditions NCT03924180 500 510 O
that NCT03924180 511 515 O
may NCT03924180 516 519 O
compromise NCT03924180 520 530 B-Stability___Stability-Value:change
the NCT03924180 531 534 O
study NCT03924180 535 540 O
, NCT03924180 541 542 O
at NCT03924180 543 545 O
the NCT03924180 546 549 O
discretion NCT03924180 550 560 O
of NCT03924180 561 563 O
the NCT03924180 564 567 O
investigator NCT03924180 568 580 O

- NCT03924180 583 584 O
Participated NCT03924180 586 598 O
in NCT03924180 599 601 O
a NCT03924180 602 603 O
clinical NCT03924180 604 612 O
trial NCT03924180 613 618 O
or NCT03924180 619 621 O
trial NCT03924180 622 627 O
to NCT03924180 628 630 O
evaluate NCT03924180 631 639 O
PKU NCT03924180 640 643 B-Condition-Name
foods NCT03924180 644 649 O
or NCT03924180 650 652 O
treatments NCT03924180 653 663 O
in NCT03924180 664 666 O
the NCT03924180 667 670 O
last NCT03924180 671 675 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
7 NCT03924180 677 678 B-Eq-Value
days NCT03924180 679 683 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03924180 684 689 O
to NCT03924180 690 692 O
inclusion NCT03924180 693 702 O
or NCT03924180 703 705 O
planned NCT03924180 706 713 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
during NCT03924180 714 720 O
the NCT03924180 721 724 O
next NCT03924180 725 729 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
6 NCT03924180 731 732 B-Eq-Value
months NCT03924180 733 739 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03924180 742 743 O
Participation NCT03924180 745 758 O
in NCT03924180 759 761 O
an NCT03924180 762 764 O
interventional NCT03924180 765 779 O
study NCT03924180 780 785 O
with NCT03924180 786 790 O
health NCT03924180 791 797 O
products NCT03924180 798 806 O
during NCT03924180 807 813 O
the NCT03924180 814 817 O
next NCT03924180 818 822 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
6 NCT03924180 824 825 B-Eq-Value
months NCT03924180 826 832 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03924180 835 836 O
Pregnancy NCT03924180 838 847 B-Condition-Name
project NCT03924180 848 855 O
within NCT03924180 856 862 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03924180 864 865 B-Eq-Value
months NCT03924180 866 872 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03924180 873 874 O
pre NCT03924180 875 878 B-Condition-Name
- NCT03924180 879 880 I-Condition-Name
conception NCT03924180 881 891 I-Condition-Name
diet NCT03924180 892 896 I-Condition-Name
, NCT03924180 897 898 O
pregnancy NCT03924180 899 908 B-Condition-Name
or NCT03924180 909 911 O
breastfeeding NCT03924180 912 925 B-Condition-Name

- NCT03924180 928 929 O
Refusal NCT03924180 931 938 O
to NCT03924180 939 941 O
consume NCT03924180 942 949 O
only NCT03924180 950 954 O
validated NCT03924180 955 964 O
complements NCT03924180 965 976 O
for NCT03924180 977 980 O
the NCT03924180 981 984 O
protocol NCT03924180 985 993 O

- NCT03924180 996 997 O
Phenylketonuria NCT03924180 999 1014 B-Condition-Name
undergoing NCT03924180 1015 1025 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03924180 1026 1035 O
with NCT03924180 1036 1040 O
BH NCT03924180 1041 1043 B-Drug-Name
4 NCT03924180 1044 1045 I-Drug-Name

- NCT03924180 1048 1049 O
Allergy NCT03924180 1051 1058 O
to NCT03924180 1059 1061 O
the NCT03924180 1062 1065 O
product NCT03924180 1066 1073 O
under NCT03924180 1074 1079 O
study NCT03924180 1080 1085 O

Inclusion NCT03921749 0 9 O
Criteria NCT03921749 10 18 O
: NCT03921749 19 20 O

- NCT03921749 24 25 O
people NCT03921749 27 33 O
aged NCT03921749 34 38 O
45 NCT03921749 40 42 B-Eq-Value
years NCT03921749 43 48 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03921749 49 51 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03921749 52 56 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03921749 59 60 O
subjects NCT03921749 62 70 O
diagnosed NCT03921749 71 80 O
with NCT03921749 81 85 O
knee NCT03921749 86 90 O
OA NCT03921749 91 93 B-Condition-Name
according NCT03921749 94 103 O
to NCT03921749 104 106 O
the NCT03921749 107 110 O
clinical NCT03921749 111 119 O
criteria NCT03921749 120 128 O
of NCT03921749 129 131 O
the NCT03921749 132 135 O
American NCT03921749 136 144 O
College NCT03921749 145 152 O
of NCT03921749 153 155 O
Rheumatology NCT03921749 156 168 O

- NCT03921749 171 172 O
subjects NCT03921749 174 182 O
diagnosed NCT03921749 183 192 O
with NCT03921749 193 197 O
grade NCT03921749 198 203 B-Eq-Unit
II NCT03921749 204 206 B-Eq-Value
or NCT03921749 207 209 O
III NCT03921749 210 213 B-Eq-Value
OA NCT03921749 214 216 B-Condition-Name
during NCT03921749 217 223 O
radiologicalexamination NCT03921749 224 247 B-Procedure-Name
as NCT03921749 248 250 O
defined NCT03921749 251 258 O
by NCT03921749 259 261 O
the NCT03921749 262 265 O
radiological NCT03921749 266 278 O
classification NCT03921749 279 293 O
of NCT03921749 294 296 O
Kellgren NCT03921749 297 305 O
and NCT03921749 306 309 O
Lawrence NCT03921749 310 318 O
( NCT03921749 319 320 O
K NCT03921749 321 322 O
- NCT03921749 323 324 O
L NCT03921749 325 326 O
) NCT03921749 327 328 O
scale NCT03921749 329 334 O
for NCT03921749 335 338 O
knee NCT03921749 339 343 O
OA NCT03921749 344 346 O

- NCT03921749 349 350 O
subjects NCT03921749 352 360 O
with NCT03921749 361 365 O
tenderness NCT03921749 366 376 B-Condition-Name
in NCT03921749 377 379 O
the NCT03921749 380 383 O
medial NCT03921749 384 390 O
tibial NCT03921749 391 397 O
plateau NCT03921749 398 405 O
area NCT03921749 406 410 O

- NCT03921749 413 414 O
subjects NCT03921749 416 424 O
who NCT03921749 425 428 O
had NCT03921749 429 432 O
pain NCT03921749 433 437 B-Condition-Name
on NCT03921749 438 440 O
one NCT03921749 441 444 O
side NCT03921749 445 449 O
of NCT03921749 450 452 O
the NCT03921749 453 456 O
knee NCT03921749 457 461 O
. NCT03921749 462 463 O

Exclusion NCT03921749 465 474 O
Criteria NCT03921749 475 483 O
: NCT03921749 484 485 O

- NCT03921749 489 490 O
patients NCT03921749 492 500 O
with NCT03921749 501 505 O
a NCT03921749 506 507 O
history NCT03921749 508 515 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921749 516 518 O
spinal NCT03921749 519 525 B-Condition-Name
stenosis NCT03921749 526 534 I-Condition-Name
, NCT03921749 535 536 O
evidence NCT03921749 537 545 O
of NCT03921749 546 548 O
neurologic NCT03921749 549 559 B-Condition-Name
disease NCT03921749 560 567 I-Condition-Name
by NCT03921749 568 570 O
history NCT03921749 571 578 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
or NCT03921749 579 581 O
physical NCT03921749 582 590 B-Procedure-Name
examination NCT03921749 591 602 I-Procedure-Name
, NCT03921749 603 604 O
or NCT03921749 605 607 O
secondary NCT03921749 608 617 O
causes NCT03921749 618 624 O
of NCT03921749 625 627 O
arthritis NCT03921749 628 637 B-Condition-Name
( NCT03921749 638 639 O
inflammatory NCT03921749 640 652 O
or NCT03921749 653 655 O
metabolic NCT03921749 656 665 O
) NCT03921749 666 667 O

- NCT03921749 671 672 O
those NCT03921749 674 679 O
who NCT03921749 680 683 O
had NCT03921749 684 687 O
a NCT03921749 688 689 O
surgical NCT03921749 690 698 B-Procedure-Name
intervention NCT03921749 699 711 I-Procedure-Name
or NCT03921749 712 714 O
intra NCT03921749 715 720 B-Procedure-Name
- NCT03921749 721 722 I-Procedure-Name
articular NCT03921749 723 732 I-Procedure-Name
injection NCT03921749 733 742 I-Procedure-Name
in NCT03921749 743 745 O
the NCT03921749 746 749 O
affected NCT03921749 750 758 O
knee NCT03921749 759 763 O
in NCT03921749 764 766 O
the NCT03921749 767 770 O
previous NCT03921749 771 779 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03921749 781 782 B-Eq-Value
months NCT03921749 783 789 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03921749 792 793 O
any NCT03921749 795 798 O
contraindication NCT03921749 799 815 O
to NCT03921749 816 818 O
extracorporeal NCT03921749 819 833 B-Procedure-Name
shock NCT03921749 834 839 I-Procedure-Name
wave NCT03921749 840 844 I-Procedure-Name
( NCT03921749 845 846 O
pregnancy NCT03921749 847 856 B-Condition-Name
, NCT03921749 857 858 O
cancer NCT03921749 859 865 B-Condition-Name
, NCT03921749 866 867 O
coagulation NCT03921749 868 879 B-Condition-Name
disorders NCT03921749 880 889 I-Condition-Name
, NCT03921749 890 891 O
inflammatory NCT03921749 892 904 B-Condition-Name
disease NCT03921749 905 912 I-Condition-Name
, NCT03921749 913 914 O
pacemakers NCT03921749 915 925 B-Procedure-Name
, NCT03921749 926 927 O
or NCT03921749 928 930 O
other NCT03921749 931 936 O
electronic NCT03921749 937 947 B-Procedure-Name
implants NCT03921749 948 956 I-Procedure-Name
) NCT03921749 957 958 O
. NCT03921749 960 961 O

Inclusion NCT03926026 0 9 O
Criteria NCT03926026 10 18 O
: NCT03926026 19 20 O

- NCT03926026 24 25 O
history NCT03926026 27 34 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926026 35 37 O
blepharitis NCT03926026 38 49 B-Condition-Name
and NCT03926026 50 53 O
meet NCT03926026 54 58 O
qualifying NCT03926026 59 69 O
criteria NCT03926026 70 78 O
for NCT03926026 79 82 O
an NCT03926026 83 85 O
acute NCT03926026 86 91 B-Severity___Severity-Value:severe
exacerbation NCT03926026 92 104 B-Stability___Stability-Value:change
of NCT03926026 105 107 O
blepharitis NCT03926026 108 119 B-Condition-Name
in NCT03926026 120 122 O
both NCT03926026 123 127 O
eyes NCT03926026 128 132 O
at NCT03926026 133 135 O
Screening NCT03926026 136 145 O
and NCT03926026 146 149 O
Baseline NCT03926026 150 158 O
/ NCT03926026 159 160 O
Day NCT03926026 161 164 O
1 NCT03926026 166 167 O
Visits NCT03926026 168 174 O

- NCT03926026 177 178 O
have NCT03926026 180 184 O
a NCT03926026 185 186 O
qualifying NCT03926026 187 197 O
best NCT03926026 198 202 B-Condition-Name
- NCT03926026 203 204 I-Condition-Name
corrected NCT03926026 205 214 I-Condition-Name
visual NCT03926026 215 221 I-Condition-Name
acuity NCT03926026 222 228 I-Condition-Name

Exclusion NCT03926026 229 238 O
Criteria NCT03926026 239 247 O
: NCT03926026 248 249 O

- NCT03926026 253 254 O
abnormality NCT03926026 256 267 B-Condition-Name
of NCT03926026 268 270 O
the NCT03926026 271 274 O
eyelids NCT03926026 275 282 O
or NCT03926026 283 285 O
lashes NCT03926026 286 292 O
( NCT03926026 293 294 O
other NCT03926026 295 300 O
than NCT03926026 301 305 O
blepharitis NCT03926026 306 317 B-Condition-Name
) NCT03926026 318 319 O
, NCT03926026 321 322 O
or NCT03926026 323 325 O
previous NCT03926026 326 334 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
eyelid NCT03926026 335 341 O
surgery NCT03926026 342 349 B-Procedure-Name

- NCT03926026 352 353 O
IOP NCT03926026 355 358 B-Observation-Name___Observation-Type-Value:measurement
> NCT03926026 359 360 B-Eq-Operator___Eq-Operator-Value:GT
21 NCT03926026 362 364 B-Eq-Value
mmHg NCT03926026 365 369 B-Eq-Unit
at NCT03926026 370 372 O
Screening NCT03926026 373 382 O
or NCT03926026 383 385 O
Baseline NCT03926026 386 394 O
/ NCT03926026 395 396 O
Day NCT03926026 397 400 O
1 NCT03926026 402 403 O
Visits NCT03926026 404 410 O

- NCT03926026 413 414 O
use NCT03926026 416 419 O
of NCT03926026 420 422 O
steroids NCT03926026 423 431 B-Drug-Name
in NCT03926026 432 434 O
the NCT03926026 435 438 O
past NCT03926026 439 443 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
30 NCT03926026 445 447 B-Eq-Value
days NCT03926026 448 452 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
or NCT03926026 453 455 O
retinoids NCT03926026 456 465 B-Drug-Name
in NCT03926026 466 468 O
the NCT03926026 469 472 O
past NCT03926026 473 477 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
12 NCT03926026 479 481 B-Eq-Value
months NCT03926026 482 488 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03926026 491 492 O
uncontrolled NCT03926026 494 506 O
systemic NCT03926026 507 515 B-Condition-Name
disease NCT03926026 516 523 I-Condition-Name

Inclusion NCT03929315 0 9 O
Criteria NCT03929315 10 18 O
: NCT03929315 19 20 O

- NCT03929315 24 25 O
Pediatric NCT03929315 27 36 O
residents NCT03929315 37 46 O
and NCT03929315 47 50 O
fellows NCT03929315 51 58 O
from NCT03929315 59 63 O
the NCT03929315 64 67 O
Hospital NCT03929315 68 76 B-Location___Location-Value:hospital
for NCT03929315 77 80 I-Location___Location-Value:hospital
Sick NCT03929315 81 85 I-Location___Location-Value:hospital
Children NCT03929315 86 94 I-Location___Location-Value:hospital
, NCT03929315 95 96 O
Toronto NCT03929315 97 104 B-Location___Location-Value:residence

Exclusion NCT03929315 105 114 O
Criteria NCT03929315 115 123 O
: NCT03929315 124 125 O

- NCT03929315 129 130 O
Refusal NCT03929315 132 139 O
to NCT03929315 140 142 O
participate NCT03929315 143 154 O
in NCT03929315 155 157 O
study NCT03929315 158 163 O

- NCT03929315 166 167 O
Previous NCT03929315 169 177 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
experience NCT03929315 178 188 O
with NCT03929315 189 193 O
at NCT03929315 194 196 O
most NCT03929315 197 201 O
two NCT03929315 202 205 O
OLV NCT03929315 206 209 O
in NCT03929315 210 212 O
children NCT03929315 213 221 O

- NCT03929315 224 225 O
Previous NCT03929315 227 235 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
experience NCT03929315 236 246 O
with NCT03929315 247 251 O
at NCT03929315 252 254 O
most NCT03929315 255 259 O
two NCT03929315 260 263 O
OLV NCT03929315 264 267 O
in NCT03929315 268 270 O
manikins NCT03929315 271 279 O

Inclusion NCT03920319 0 9 O
Criteria NCT03920319 10 18 O
: NCT03920319 19 20 O

- NCT03920319 24 25 O
Treatment NCT03920319 27 36 O
- NCT03920319 37 38 O
seeking NCT03920319 39 46 O
cigarette NCT03920319 47 56 B-Condition-Name
smoker NCT03920319 57 63 I-Condition-Name

- NCT03920319 66 67 O
Meet NCT03920319 69 73 O
DSM NCT03920319 74 77 O
- NCT03920319 78 79 O
IV NCT03920319 80 82 O
criteria NCT03920319 83 91 O
for NCT03920319 92 95 O
nicotine NCT03920319 96 104 B-Condition-Name
dependence NCT03920319 105 115 I-Condition-Name

- NCT03920319 118 119 O
Negative NCT03920319 121 129 B-Polarity___Polarity-Value:negative
result NCT03920319 130 136 O
on NCT03920319 137 139 O
urine NCT03920319 140 145 B-Observation-Name___Observation-Type-Value:lab
test NCT03920319 146 150 I-Observation-Name___Observation-Type-Value:lab
for NCT03920319 151 154 I-Observation-Name___Observation-Type-Value:lab
drug NCT03920319 155 159 I-Observation-Name___Observation-Type-Value:lab
use NCT03920319 160 163 I-Observation-Name___Observation-Type-Value:lab
during NCT03920319 164 170 O
screening NCT03920319 171 180 O

Exclusion NCT03920319 181 190 O
Criteria NCT03920319 191 199 O
: NCT03920319 200 201 O

- NCT03920319 205 206 O
History NCT03920319 208 215 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920319 216 218 O
any NCT03920319 219 222 O
Axis NCT03920319 223 227 B-Eq-Unit
I NCT03920319 228 229 B-Eq-Value
psychiatric NCT03920319 230 241 B-Condition-Name
diagnosis NCT03920319 242 251 I-Condition-Name
other NCT03920319 252 257 O
than NCT03920319 258 262 O
nicotine NCT03920319 263 271 B-Condition-Name
dependence NCT03920319 272 282 I-Condition-Name

- NCT03920319 285 286 O
Medical NCT03920319 288 295 O
conditions NCT03920319 296 306 O
that NCT03920319 307 311 O
might NCT03920319 312 317 O
affect NCT03920319 318 324 B-Stability___Stability-Value:change
brain NCT03920319 325 330 B-Condition-Name
function NCT03920319 331 339 I-Condition-Name

- NCT03920319 342 343 O
Current NCT03920319 345 352 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03920319 353 356 O
of NCT03920319 357 359 O
medications NCT03920319 360 371 O
that NCT03920319 372 376 O
could NCT03920319 377 382 O
alter NCT03920319 383 388 B-Stability___Stability-Value:change
brain NCT03920319 389 394 B-Condition-Name
function NCT03920319 395 403 I-Condition-Name

- NCT03920319 406 407 O
Pregnancy NCT03920319 409 418 B-Condition-Name

- NCT03920319 421 422 O
Current NCT03920319 424 431 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
illicit NCT03920319 432 439 B-Condition-Name
drug NCT03920319 440 444 I-Condition-Name
use NCT03920319 445 448 I-Condition-Name
other NCT03920319 449 454 O
than NCT03920319 455 459 O
occasional NCT03920319 460 470 O
use NCT03920319 471 474 O
of NCT03920319 475 477 O
marijuana NCT03920319 478 487 B-Condition-Name

Inclution NCT03921775 0 9 O
Criteria NCT03921775 10 18 O
: NCT03921775 19 20 O

1 NCT03921775 25 26 O
. NCT03921775 26 27 O
18 NCT03921775 30 32 B-Eq-Value
~ NCT03921775 33 34 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03921775 36 38 B-Eq-Value
years NCT03921775 39 44 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03921775 45 46 O
female NCT03921775 47 53 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
or NCT03921775 54 56 O
male NCT03921775 57 61 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

2 NCT03921775 65 66 O
. NCT03921775 66 67 O
Patients NCT03921775 69 77 O
scheduled NCT03921775 78 87 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03921775 88 91 O
an NCT03921775 92 94 O
elective NCT03921775 95 103 B-Procedure-Name
surgical NCT03921775 104 112 I-Procedure-Name
procedure NCT03921775 113 122 I-Procedure-Name
( NCT03921775 123 124 O
mechanical NCT03921775 125 135 B-Procedure-Name
ventilation NCT03921775 136 147 I-Procedure-Name
via NCT03921775 148 151 O
endotracheal NCT03921775 152 164 B-Procedure-Name
tube NCT03921775 165 169 I-Procedure-Name
) NCT03921775 170 171 O

3 NCT03921775 176 177 O
. NCT03921775 177 178 O
BMI NCT03921775 180 183 B-Observation-Name___Observation-Type-Value:vital
: NCT03921775 184 185 O
18 NCT03921775 187 189 B-Eq-Value
~ NCT03921775 190 191 B-Eq-Operator___Eq-Operator-Value:BETWEEN
30 NCT03921775 193 195 B-Eq-Value
kg NCT03921775 196 198 B-Eq-Unit
/ NCT03921775 199 200 O
m NCT03921775 201 202 B-Eq-Unit
2 NCT03921775 203 204 I-Eq-Unit

4 NCT03921775 208 209 O
. NCT03921775 209 210 O
Patients NCT03921775 212 220 O
understand NCT03921775 221 231 O
clearly NCT03921775 232 239 O
and NCT03921775 240 243 O
participate NCT03921775 244 255 O
in NCT03921775 256 258 O
the NCT03921775 259 262 O
study NCT03921775 263 268 O
voluntarily NCT03921775 269 280 O
, NCT03921775 281 282 O
and NCT03921775 283 286 O
sign NCT03921775 287 291 O
the NCT03921775 292 295 O
informed NCT03921775 296 304 O
consent NCT03921775 305 312 O

Exclusion NCT03921775 313 322 O
criteria NCT03921775 323 331 O
: NCT03921775 332 333 O

1 NCT03921775 338 339 O
. NCT03921775 339 340 O
Patients NCT03921775 342 350 O
scheduled NCT03921775 351 360 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03921775 361 364 O
emergency NCT03921775 365 374 B-Procedure-Name
surgery NCT03921775 375 382 I-Procedure-Name

2 NCT03921775 386 387 O
. NCT03921775 387 388 O
Patients NCT03921775 390 398 O
with NCT03921775 399 403 O
a NCT03921775 404 405 O
history NCT03921775 406 413 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921775 414 416 O
drug NCT03921775 417 421 B-Condition-Name
abuse NCT03921775 422 427 I-Condition-Name
and NCT03921775 428 431 O
/ NCT03921775 432 433 O
or NCT03921775 434 436 O
alcohol NCT03921775 437 444 B-Condition-Name
abuse NCT03921775 445 450 I-Condition-Name
2 NCT03921775 452 453 B-Eq-Value
years NCT03921775 454 459 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
prior NCT03921775 460 465 O
to NCT03921775 466 468 O
the NCT03921775 469 472 O
screening NCT03921775 473 482 O
period NCT03921775 483 489 O

3 NCT03921775 493 494 O
. NCT03921775 494 495 O
One NCT03921775 497 500 O
or NCT03921775 501 503 O
more NCT03921775 504 508 O
of NCT03921775 509 511 O
the NCT03921775 512 515 O
laboratory NCT03921775 516 526 B-Observation-Name___Observation-Type-Value:lab
findings NCT03921775 527 535 I-Observation-Name___Observation-Type-Value:lab
fall NCT03921775 536 540 O
out NCT03921775 541 544 O
of NCT03921775 545 547 O
the NCT03921775 548 551 O
limitations NCT03921775 552 563 O
for NCT03921775 564 567 O
this NCT03921775 568 572 O
study NCT03921775 573 578 O
( NCT03921775 579 580 O
platelet NCT03921775 581 589 B-Observation-Name___Observation-Type-Value:lab
, NCT03921775 590 591 O
hemoglobin NCT03921775 592 602 B-Observation-Name___Observation-Type-Value:lab
, NCT03921775 603 604 O
aspartate NCT03921775 605 614 B-Observation-Name___Observation-Type-Value:lab
aminotransferase NCT03921775 615 631 I-Observation-Name___Observation-Type-Value:lab
, NCT03921775 632 633 O
etc NCT03921775 634 637 O
. NCT03921775 638 639 O
) NCT03921775 640 641 O

4 NCT03921775 646 647 O
. NCT03921775 647 648 O
Pregnant NCT03921775 650 658 B-Condition-Name
women NCT03921775 659 664 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
or NCT03921775 665 667 O
those NCT03921775 668 673 O
in NCT03921775 674 676 O
lactation NCT03921775 677 686 B-Condition-Name
period NCT03921775 687 693 O

5 NCT03921775 697 698 O
. NCT03921775 698 699 O
Allergic NCT03921775 701 709 O
to NCT03921775 710 712 O
drugs NCT03921775 713 718 O
used NCT03921775 719 723 O
in NCT03921775 724 726 O
the NCT03921775 727 730 O
study NCT03921775 731 736 O

6 NCT03921775 740 741 O
. NCT03921775 741 742 O
Patients NCT03921775 744 752 O
with NCT03921775 753 757 O
respiratory NCT03921775 758 769 B-Condition-Name
management NCT03921775 770 780 I-Condition-Name
difficulties NCT03921775 781 793 I-Condition-Name
( NCT03921775 794 795 O
Modified NCT03921775 796 804 B-Condition-Name
Mallampati NCT03921775 805 815 I-Condition-Name
grade NCT03921775 816 821 B-Eq-Unit
IV NCT03921775 822 824 B-Eq-Value
) NCT03921775 825 826 O

7 NCT03921775 831 832 O
. NCT03921775 832 833 O
Patients NCT03921775 835 843 O
have NCT03921775 844 848 O
participated NCT03921775 849 861 O
in NCT03921775 862 864 O
other NCT03921775 865 870 O
clinical NCT03921775 871 879 O
trial NCT03921775 880 885 O
within NCT03921775 886 892 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03921775 893 896 O
3 NCT03921775 898 899 B-Eq-Value
months NCT03921775 900 906 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03921775 907 912 O
to NCT03921775 913 915 O
randomization NCT03921775 916 929 O

8 NCT03921775 933 934 O
. NCT03921775 934 935 O
Any NCT03921775 937 940 O
patient NCT03921775 941 948 O
judged NCT03921775 949 955 O
by NCT03921775 956 958 O
the NCT03921775 959 962 O
Principal NCT03921775 963 972 O
Investigator NCT03921775 973 985 O
( NCT03921775 986 987 O
PI NCT03921775 988 990 O
) NCT03921775 991 992 O
or NCT03921775 993 995 O
Sub NCT03921775 996 999 O
- NCT03921775 1000 1001 O
Investigator NCT03921775 1002 1014 O
to NCT03921775 1015 1017 O
be NCT03921775 1018 1020 O
inappropriate NCT03921775 1021 1034 O
for NCT03921775 1035 1038 O
the NCT03921775 1039 1042 O
subject NCT03921775 1043 1050 O
for NCT03921775 1051 1054 O
any NCT03921775 1055 1058 O
other NCT03921775 1059 1064 O
reason NCT03921775 1065 1071 O

Inclusion NCT03925922 0 9 O
Criteria NCT03925922 10 18 O
: NCT03925922 19 20 O

- NCT03925922 24 25 O
Nulliparous NCT03925922 27 38 O
singleton NCT03925922 39 48 O
pregnancy NCT03925922 49 58 B-Condition-Name

- NCT03925922 61 62 O
gestational NCT03925922 64 75 B-Observation-Name
age NCT03925922 76 79 I-Observation-Name
between NCT03925922 80 87 B-Eq-Operator___Eq-Operator-Value:BETWEEN
37 NCT03925922 89 91 B-Eq-Value
week NCT03925922 92 96 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
and NCT03925922 97 100 O
42 NCT03925922 102 104 B-Eq-Value
weeks NCT03925922 105 110 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03925922 113 114 O
Cephalic NCT03925922 116 124 B-Condition-Name
presentation NCT03925922 125 137 I-Condition-Name

- NCT03925922 140 141 O
Bishop NCT03925922 143 149 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03925922 150 155 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03925922 156 158 O
5 NCT03925922 160 161 B-Eq-Value
or NCT03925922 162 164 B-Eq-Operator___Eq-Operator-Value:LTEQ
less NCT03925922 165 169 I-Eq-Operator___Eq-Operator-Value:LTEQ

- NCT03925922 172 173 O
No NCT03925922 175 177 O
clinical NCT03925922 178 186 O
evidence NCT03925922 187 195 O
of NCT03925922 196 198 O
regular NCT03925922 199 206 B-Condition-Name
contraction NCT03925922 207 218 I-Condition-Name

Exclusion NCT03925922 219 228 O
Criteria NCT03925922 229 237 O
: NCT03925922 238 239 O

- NCT03925922 243 244 O
Rupture NCT03925922 246 253 B-Condition-Name
of NCT03925922 254 256 I-Condition-Name
membrane NCT03925922 257 265 I-Condition-Name

- NCT03925922 268 269 O
Vaginal NCT03925922 271 278 B-Condition-Name
bleeding NCT03925922 279 287 I-Condition-Name

- NCT03925922 290 291 O
Any NCT03925922 293 296 O
contraindication NCT03925922 297 313 O
to NCT03925922 314 316 O
vaginal NCT03925922 317 324 O
delivery NCT03925922 325 333 B-Procedure-Name

Inclusion NCT03920696 0 9 O
Criteria NCT03920696 10 18 O
: NCT03920696 19 20 O

- NCT03920696 24 25 O
Age NCT03920696 27 30 O
≥ NCT03920696 31 32 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03920696 34 36 B-Eq-Value
years NCT03920696 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03920696 45 46 O
Patients NCT03920696 48 56 O
with NCT03920696 57 61 O
Pityriasis NCT03920696 62 72 B-Condition-Name
Lichenoides NCT03920696 73 84 I-Condition-Name
selected NCT03920696 85 93 O
from NCT03920696 94 98 O
histological NCT03920696 99 111 O
coding NCT03920696 112 118 O
OT NCT03920696 119 121 O
0431 NCT03920696 122 126 O
, NCT03920696 127 128 O
seen NCT03920696 129 133 O
at NCT03920696 134 136 O
Henri NCT03920696 137 142 B-Location___Location-Value:hospital
Mondor NCT03920696 143 149 I-Location___Location-Value:hospital
and NCT03920696 150 153 O
with NCT03920696 154 158 O
a NCT03920696 159 160 O
diagnosis NCT03920696 161 170 O
verified NCT03920696 171 179 O
from NCT03920696 180 184 O
medical NCT03920696 185 192 O
records NCT03920696 193 200 O
. NCT03920696 201 202 O

Exclusion NCT03920696 204 213 O
Criteria NCT03920696 214 222 O
: NCT03920696 223 224 O

- NCT03920696 228 229 O
Histological NCT03920696 231 243 O
coding NCT03920696 244 250 O
error NCT03920696 251 256 O

- NCT03920696 259 260 O
Histological NCT03920696 262 274 O
records NCT03920696 275 282 O
of NCT03920696 283 285 O
patients NCT03920696 286 294 O
in NCT03920696 295 297 O
care NCT03920696 298 302 O
outside NCT03920696 303 310 O
Henri NCT03920696 311 316 B-Location___Location-Value:hospital
Mondor NCT03920696 317 323 I-Location___Location-Value:hospital
( NCT03920696 324 325 O
cases NCT03920696 326 331 O
referred NCT03920696 332 340 O
for NCT03920696 341 344 O
histological NCT03920696 345 357 O
expertise NCT03920696 358 367 O
only NCT03920696 368 372 O
but NCT03920696 373 376 O
not NCT03920696 377 380 O
seen NCT03920696 381 385 O
clinically NCT03920696 386 396 O
) NCT03920696 397 398 O

- NCT03920696 402 403 O
Clinical NCT03920696 405 413 B-Condition-Name
lesions NCT03920696 414 421 I-Condition-Name
incompatible NCT03920696 422 434 O
with NCT03920696 435 439 O
Pityriasis NCT03920696 440 450 B-Condition-Name
Lichenoides NCT03920696 451 462 I-Condition-Name
according NCT03920696 463 472 O
to NCT03920696 473 475 O
classically NCT03920696 476 487 O
published NCT03920696 488 497 O
semiological NCT03920696 498 510 O
data NCT03920696 511 515 O

- NCT03920696 518 519 O
Missing NCT03920696 521 528 O
or NCT03920696 529 531 O
insufficient NCT03920696 532 544 O
medical NCT03920696 545 552 O
records NCT03920696 553 560 O
for NCT03920696 561 564 O
data NCT03920696 565 569 O
exploitation NCT03920696 570 582 O

For NCT03924427 0 3 O
more NCT03924427 4 8 O
information NCT03924427 9 20 O
regarding NCT03924427 21 30 O
Bristol NCT03924427 31 38 O
- NCT03924427 39 40 O
Myers NCT03924427 41 46 O
Squibb NCT03924427 47 53 O
Clinical NCT03924427 54 62 O
Trial NCT03924427 63 68 O
participation NCT03924427 69 82 O
, NCT03924427 83 84 O
please NCT03924427 85 91 O

visit NCT03924427 92 97 O
www NCT03924427 98 101 O
. NCT03924427 102 103 O
BMSStudyConnect NCT03924427 104 119 O
. NCT03924427 120 121 O
com NCT03924427 122 125 O

Inclusion NCT03924427 126 135 O
Criteria NCT03924427 136 144 O
: NCT03924427 145 146 O

a NCT03924427 148 149 O
. NCT03924427 150 151 O
For NCT03924427 153 156 O
participants NCT03924427 157 169 O
with NCT03924427 170 174 O
plaque NCT03924427 175 181 B-Condition-Name
psoriasis NCT03924427 182 191 I-Condition-Name
: NCT03924427 192 193 O
i NCT03924427 194 195 O
. NCT03924427 196 197 O
Stable NCT03924427 199 205 B-Stability___Stability-Value:stable
plaque NCT03924427 206 212 B-Condition-Name
psoriasis NCT03924427 213 222 I-Condition-Name
for NCT03924427 223 226 O
at NCT03924427 227 229 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03924427 230 235 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03924427 237 238 B-Eq-Value
months NCT03924427 239 245 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

ii NCT03924427 246 248 O
. NCT03924427 249 250 O
Moderate NCT03924427 252 260 B-Severity___Severity-Value:severe
to NCT03924427 261 263 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03924427 264 270 B-Severity___Severity-Value:severe
disease NCT03924427 271 278 O
iii NCT03924427 279 282 O
. NCT03924427 283 284 O
Candidate NCT03924427 286 295 O
for NCT03924427 296 299 O
phototherapy NCT03924427 300 312 B-Procedure-Name
or NCT03924427 313 315 O
systemic NCT03924427 316 324 B-Procedure-Name
therapy NCT03924427 325 332 I-Procedure-Name
b NCT03924427 333 334 O
. NCT03924427 335 336 O

Additional NCT03924427 338 348 O
protocol NCT03924427 349 357 O
- NCT03924427 358 359 O
specified NCT03924427 360 369 O
inclusion NCT03924427 370 379 O
criteria NCT03924427 380 388 O
apply NCT03924427 389 394 O
for NCT03924427 395 398 O
subjects NCT03924427 399 407 O
with NCT03924427 408 412 O
psoriatic NCT03924427 413 422 B-Condition-Name
arthritis NCT03924427 423 432 I-Condition-Name
, NCT03924427 433 434 O
erythrodermic NCT03924427 435 448 B-Condition-Name
psoriasis NCT03924427 449 458 I-Condition-Name
, NCT03924427 459 460 O
or NCT03924427 461 463 O
generalized NCT03924427 464 475 B-Condition-Name
pustular NCT03924427 476 484 I-Condition-Name
psoriasis NCT03924427 485 494 I-Condition-Name

Exclusion NCT03924427 495 504 O
Criteria NCT03924427 505 513 O
: NCT03924427 514 515 O

1 NCT03924427 520 521 O
. NCT03924427 521 522 O
Guttate NCT03924427 524 531 O
, NCT03924427 532 533 O
inverse NCT03924427 534 541 O
, NCT03924427 542 543 O
or NCT03924427 544 546 O
drug NCT03924427 547 551 O
- NCT03924427 552 553 O
induced NCT03924427 554 561 O
psoriasis NCT03924427 562 571 B-Condition-Name
at NCT03924427 572 574 O
Screening NCT03924427 575 584 O
or NCT03924427 585 587 O
Baseline NCT03924427 588 596 O

2 NCT03924427 600 601 O
. NCT03924427 601 602 O
History NCT03924427 604 611 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924427 612 614 O
recent NCT03924427 615 621 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
infection NCT03924427 622 631 B-Condition-Name

3 NCT03924427 635 636 O
. NCT03924427 636 637 O
Prior NCT03924427 639 644 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
exposure NCT03924427 645 653 O
to NCT03924427 654 656 O
BMS NCT03924427 657 660 B-Drug-Name
- NCT03924427 661 662 I-Drug-Name
986165 NCT03924427 664 670 I-Drug-Name
Other NCT03924427 671 676 O
protocol NCT03924427 677 685 O
defined NCT03924427 686 693 O
inclusion NCT03924427 694 703 O
/ NCT03924427 704 705 O
exclusion NCT03924427 706 715 O
criteria NCT03924427 716 724 O
could NCT03924427 725 730 O
apply NCT03924427 731 736 O


Inclusion NCT03925077 0 9 O
Criteria NCT03925077 10 18 O
: NCT03925077 19 20 O

1 NCT03925077 25 26 O
. NCT03925077 26 27 O
demonstrate NCT03925077 29 40 O
readiness NCT03925077 41 50 O
to NCT03925077 51 53 O
physical NCT03925077 54 62 B-Observation-Name
activity NCT03925077 63 71 I-Observation-Name
by NCT03925077 72 74 O
completing NCT03925077 75 85 O
the NCT03925077 86 89 O
online NCT03925077 90 96 O
Physical NCT03925077 97 105 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Activity NCT03925077 106 114 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Readiness NCT03925077 115 124 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
Questionnaire NCT03925077 125 138 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03925077 139 140 O
PAR NCT03925077 141 144 B-Observation-Name
- NCT03925077 145 146 I-Observation-Name
Q NCT03925077 147 148 I-Observation-Name
) NCT03925077 149 150 O
; NCT03925077 151 152 O

2 NCT03925077 156 157 O
. NCT03925077 157 158 O
have NCT03925077 160 164 O
a NCT03925077 165 166 O
SCI NCT03925077 167 170 B-Condition-Name
resulting NCT03925077 171 180 O
in NCT03925077 181 183 O
incomplete NCT03925077 184 194 O
or NCT03925077 195 197 O
complete NCT03925077 198 206 O
( NCT03925077 207 208 O
C NCT03925077 209 210 B-Eq-Value
5 NCT03925077 211 212 I-Eq-Value
and NCT03925077 213 216 B-Eq-Operator___Eq-Operator-Value:LTEQ
below NCT03925077 217 222 I-Eq-Operator___Eq-Operator-Value:LTEQ
) NCT03925077 223 224 O
paraplegia NCT03925077 225 235 B-Condition-Name
or NCT03925077 236 238 O
tetraplegia NCT03925077 239 250 B-Condition-Name
; NCT03925077 250 251 O

3 NCT03925077 255 256 O
. NCT03925077 256 257 O
have NCT03925077 259 263 O
broadband NCT03925077 264 273 O
internet NCT03925077 274 282 O
access NCT03925077 283 289 O
; NCT03925077 289 290 O

4 NCT03925077 294 295 O
. NCT03925077 295 296 O
between NCT03925077 298 305 O
the NCT03925077 306 309 O
ages NCT03925077 310 314 O
of NCT03925077 315 317 O
18 NCT03925077 319 321 B-Eq-Value
to NCT03925077 322 324 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03925077 326 328 B-Eq-Value
years NCT03925077 329 334 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03925077 334 335 O

5 NCT03925077 339 340 O
. NCT03925077 340 341 O
have NCT03925077 343 347 O
the NCT03925077 348 351 O
ability NCT03925077 352 359 O
to NCT03925077 360 362 O
converse NCT03925077 363 371 O
and NCT03925077 372 375 O
read NCT03925077 376 380 O
English NCT03925077 381 388 B-Language
. NCT03925077 389 390 O

Exclusion NCT03925077 392 401 O
Criteria NCT03925077 402 410 O
: NCT03925077 411 412 O

1 NCT03925077 417 418 O
. NCT03925077 418 419 O
significant NCT03925077 421 432 B-Severity___Severity-Value:severe
visual NCT03925077 433 439 B-Condition-Name
impairment NCT03925077 440 450 I-Condition-Name
that NCT03925077 451 455 O
prevents NCT03925077 456 464 O
seeing NCT03925077 465 471 O
a NCT03925077 472 473 O
computer NCT03925077 474 482 O
screen NCT03925077 483 489 O
to NCT03925077 490 492 O
follow NCT03925077 493 499 O
a NCT03925077 500 501 O
home NCT03925077 502 506 B-Procedure-Name
exercise NCT03925077 507 515 I-Procedure-Name
program NCT03925077 516 523 I-Procedure-Name
; NCT03925077 523 524 O

2 NCT03925077 528 529 O
. NCT03925077 529 530 O
active NCT03925077 532 538 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pressure NCT03925077 539 547 B-Condition-Name
ulcer NCT03925077 548 553 I-Condition-Name
; NCT03925077 553 554 O

3 NCT03925077 558 559 O
. NCT03925077 559 560 O
any NCT03925077 562 565 O
contraindications NCT03925077 566 583 O
to NCT03925077 584 586 O
exercise NCT03925077 587 595 B-Observation-Name
based NCT03925077 596 601 O
on NCT03925077 602 604 O
the NCT03925077 605 608 O
American NCT03925077 609 617 O
College NCT03925077 618 625 O
of NCT03925077 626 628 O
Sports NCT03925077 629 635 O
Medicine NCT03925077 636 644 O
guidelines NCT03925077 645 655 O
; NCT03925077 655 656 O

4 NCT03925077 660 661 O
. NCT03925077 661 662 O
significant NCT03925077 664 675 B-Severity___Severity-Value:severe
hearing NCT03925077 676 683 B-Condition-Name
impairment NCT03925077 684 694 I-Condition-Name
impeding NCT03925077 695 703 O
ability NCT03925077 704 711 B-Condition-Name
to NCT03925077 712 714 I-Condition-Name
hear NCT03925077 715 719 I-Condition-Name
music NCT03925077 720 725 O
to NCT03925077 726 728 O
engage NCT03925077 729 735 B-Observation-Name
in NCT03925077 736 738 I-Observation-Name
exercise NCT03925077 739 747 I-Observation-Name
. NCT03925077 748 749 O

Inclusion NCT03925038 0 9 O
Criteria NCT03925038 10 18 O
: NCT03925038 19 20 O

- NCT03925038 24 25 O
Patients NCT03925038 27 35 O
ages NCT03925038 36 40 O
12 NCT03925038 42 44 B-Eq-Value
- NCT03925038 45 46 B-Eq-Operator___Eq-Operator-Value:BETWEEN
100 NCT03925038 48 51 B-Eq-Value
years NCT03925038 52 57 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03925038 60 61 O
With NCT03925038 63 67 O
any NCT03925038 68 71 O
diagnosis NCT03925038 72 81 O
of NCT03925038 82 84 O
a NCT03925038 85 86 O
mood NCT03925038 87 91 O
or NCT03925038 92 94 O
anxiety NCT03925038 95 102 O
disorder NCT03925038 103 111 B-Condition-Name

- NCT03925038 114 115 O
Already NCT03925038 117 124 O
established NCT03925038 125 136 O
and NCT03925038 137 140 O
receiving NCT03925038 141 150 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
care NCT03925038 151 155 O
in NCT03925038 156 158 O
community NCT03925038 159 168 O
psychiatry NCT03925038 169 179 O
at NCT03925038 180 182 O
the NCT03925038 183 186 O
Johns NCT03925038 187 192 B-Location___Location-Value:hospital
Hopkins NCT03925038 193 200 I-Location___Location-Value:hospital
Bayview NCT03925038 201 208 I-Location___Location-Value:hospital
Medical NCT03925038 209 216 I-Location___Location-Value:hospital
Center NCT03925038 217 223 I-Location___Location-Value:hospital
or NCT03925038 224 226 O
at NCT03925038 227 229 O
Johns NCT03925038 230 235 B-Location___Location-Value:hospital
Hopkins NCT03925038 236 243 I-Location___Location-Value:hospital
Hospital NCT03925038 244 252 I-Location___Location-Value:hospital
. NCT03925038 253 254 O

Exclusion NCT03925038 256 265 O
Criteria NCT03925038 266 274 O
: NCT03925038 275 276 O

- NCT03925038 280 281 O
Non NCT03925038 283 286 O
- NCT03925038 287 288 O
English NCT03925038 289 296 B-Language
speaking NCT03925038 297 305 O

Inclusion NCT03924440 0 9 O
Criteria NCT03924440 10 18 O
: NCT03924440 19 20 O

1 NCT03924440 25 26 O
. NCT03924440 26 27 O
Female NCT03924440 29 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
( NCT03924440 36 37 O
mandatory NCT03924440 38 47 O
) NCT03924440 48 49 O

2 NCT03924440 54 55 O
. NCT03924440 55 56 O
Not NCT03924440 58 61 O
currently NCT03924440 62 71 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnant NCT03924440 72 80 B-Condition-Name
or NCT03924440 81 83 O
nursing NCT03924440 84 91 B-Condition-Name
( NCT03924440 92 93 O
pregnancy NCT03924440 94 103 B-Condition-Name
affects NCT03924440 104 111 B-Stability___Stability-Value:change
PdG NCT03924440 112 115 B-Observation-Name___Observation-Type-Value:lab
levels NCT03924440 116 122 I-Observation-Name___Observation-Type-Value:lab
) NCT03924440 123 124 O

3 NCT03924440 129 130 O
. NCT03924440 130 131 O
Aged NCT03924440 133 137 O
18 NCT03924440 139 141 B-Eq-Value
- NCT03924440 142 143 B-Eq-Operator___Eq-Operator-Value:BETWEEN
34 NCT03924440 145 147 B-Eq-Value
( NCT03924440 148 149 O
advanced NCT03924440 150 158 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:elderly
age NCT03924440 159 162 I-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:elderly
can NCT03924440 163 166 O
hinder NCT03924440 167 173 B-Stability___Stability-Value:change
PdG NCT03924440 174 177 B-Observation-Name___Observation-Type-Value:lab
levels NCT03924440 178 184 I-Observation-Name___Observation-Type-Value:lab
) NCT03924440 185 186 O

4 NCT03924440 191 192 O
. NCT03924440 192 193 O
Cycle NCT03924440 195 200 B-Observation-Name___Observation-Type-Value:measurement
length NCT03924440 201 207 I-Observation-Name___Observation-Type-Value:measurement
of NCT03924440 208 210 O
26 NCT03924440 212 214 B-Eq-Value
- NCT03924440 215 216 B-Eq-Operator___Eq-Operator-Value:BETWEEN
39 NCT03924440 218 220 B-Eq-Value
days NCT03924440 221 225 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
( NCT03924440 226 227 O
long NCT03924440 228 232 O
or NCT03924440 233 235 O
short NCT03924440 236 241 O
cycles NCT03924440 242 248 B-Observation-Name
have NCT03924440 249 253 O
inconsistent NCT03924440 254 266 B-Stability___Stability-Value:change
PdG NCT03924440 267 270 B-Observation-Name___Observation-Type-Value:lab
levels NCT03924440 271 277 I-Observation-Name___Observation-Type-Value:lab
) NCT03924440 278 279 O

5 NCT03924440 284 285 O
. NCT03924440 285 286 O
Currently NCT03924440 288 297 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03924440 298 301 O
other NCT03924440 302 307 O
fertility NCT03924440 308 317 B-Procedure-Name
monitoring NCT03924440 318 328 I-Procedure-Name
tools NCT03924440 329 334 I-Procedure-Name
( NCT03924440 335 336 O
this NCT03924440 337 341 O
allows NCT03924440 342 348 O
us NCT03924440 349 351 O
to NCT03924440 352 354 O
compare NCT03924440 355 362 O
Proov NCT03924440 363 368 O
- NCT03924440 369 370 O
Ovulation NCT03924440 371 380 O
Double NCT03924440 381 387 O
Check NCT03924440 388 393 O
test NCT03924440 394 398 O
results NCT03924440 399 406 O
with NCT03924440 407 411 O
other NCT03924440 412 417 O
fertility NCT03924440 418 427 O
tracking NCT03924440 428 436 O
methods NCT03924440 437 444 O
) NCT03924440 445 446 O

Exclusion NCT03924440 448 457 O
Criteria NCT03924440 458 466 O
: NCT03924440 467 468 O

1 NCT03924440 473 474 O
. NCT03924440 474 475 O
Male NCT03924440 477 481 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

2 NCT03924440 485 486 O
. NCT03924440 486 487 O
Pregnant NCT03924440 489 497 B-Condition-Name

3 NCT03924440 501 502 O
. NCT03924440 502 503 O
Nursing NCT03924440 505 512 B-Condition-Name


Inclusion NCT03922958 0 9 O
Criteria NCT03922958 10 18 O
: NCT03922958 19 20 O

- NCT03922958 24 25 O
All NCT03922958 27 30 O
adults NCT03922958 31 37 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
undergoing NCT03922958 38 48 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
cardiac NCT03922958 49 56 B-Procedure-Name
surgery NCT03922958 57 64 I-Procedure-Name
with NCT03922958 65 69 O
CPB NCT03922958 70 73 B-Procedure-Name
will NCT03922958 74 78 O
be NCT03922958 79 81 O
considered NCT03922958 82 92 O
for NCT03922958 93 96 O
enrollment NCT03922958 97 107 O
. NCT03922958 108 109 O

Exclusion NCT03922958 111 120 O
Criteria NCT03922958 121 129 O
: NCT03922958 130 131 O

- NCT03922958 135 136 O
Factors NCT03922958 138 145 O
that NCT03922958 146 150 O
affect NCT03922958 151 157 B-Stability___Stability-Value:change
immune NCT03922958 158 164 B-Condition-Name
function NCT03922958 165 173 I-Condition-Name
or NCT03922958 174 176 O
AKI NCT03922958 177 180 B-Condition-Name
assessment NCT03922958 181 191 O
are NCT03922958 192 195 O
the NCT03922958 196 199 O
basis NCT03922958 200 205 O
for NCT03922958 206 209 O
exclusion NCT03922958 210 219 O
criteria NCT03922958 220 228 O
: NCT03922958 229 230 O

- NCT03922958 239 240 O
Concurrent NCT03922958 242 252 O
disease NCT03922958 253 260 B-Condition-Name
associated NCT03922958 261 271 O
with NCT03922958 272 276 O
immunosuppression NCT03922958 277 294 B-Condition-Name
including NCT03922958 295 304 O
malignancy NCT03922958 305 315 B-Condition-Name
, NCT03922958 316 317 O
chronic NCT03922958 318 325 B-Condition-Name
infection NCT03922958 326 335 I-Condition-Name
( NCT03922958 336 337 O
e NCT03922958 338 339 O
. NCT03922958 340 341 O
g NCT03922958 342 343 O
. NCT03922958 344 345 O
, NCT03922958 346 347 O
HIV NCT03922958 348 351 B-Condition-Name
, NCT03922958 352 353 O
Hepatitis NCT03922958 354 363 B-Condition-Name
C NCT03922958 364 365 I-Condition-Name
) NCT03922958 366 367 O
, NCT03922958 369 370 O
organ NCT03922958 371 376 B-Procedure-Name
transplant NCT03922958 377 387 I-Procedure-Name
and NCT03922958 388 391 O
immunosuppressant NCT03922958 392 409 B-Drug-Name
medications NCT03922958 410 421 I-Drug-Name

- NCT03922958 429 430 O
Documented NCT03922958 432 442 O
acute NCT03922958 443 448 B-Condition-Name
infection NCT03922958 449 458 I-Condition-Name
with NCT03922958 459 463 O
the NCT03922958 464 467 B-Eq-Operator___Eq-Operator-Value:LTEQ
past NCT03922958 468 472 I-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03922958 474 475 B-Eq-Value
month NCT03922958 476 481 O
( NCT03922958 482 483 O
e NCT03922958 484 485 O
. NCT03922958 486 487 O
g NCT03922958 488 489 O
. NCT03922958 490 491 O
, NCT03922958 492 493 O
pneumonia NCT03922958 494 503 B-Condition-Name
, NCT03922958 504 505 O
urinary NCT03922958 506 513 B-Condition-Name
tract NCT03922958 514 519 I-Condition-Name
infection NCT03922958 520 529 I-Condition-Name
) NCT03922958 530 531 O

- NCT03922958 540 541 O
Prednisone NCT03922958 543 553 B-Drug-Name
or NCT03922958 554 556 O
other NCT03922958 557 562 O
steroid NCT03922958 563 570 B-Drug-Name
use NCT03922958 571 574 O
currently NCT03922958 575 584 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03922958 585 587 O
within NCT03922958 588 594 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03922958 595 598 O
past NCT03922958 599 603 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
one NCT03922958 604 607 B-Eq-Value
month NCT03922958 608 613 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03922958 621 622 O
AKI NCT03922958 624 627 B-Condition-Name
at NCT03922958 628 630 O
the NCT03922958 631 634 O
time NCT03922958 635 639 O
of NCT03922958 640 642 O
surgery NCT03922958 643 650 B-Procedure-Name

- NCT03922958 658 659 O
ESRD NCT03922958 661 665 B-Condition-Name
requiring NCT03922958 666 675 O
renal NCT03922958 676 681 B-Procedure-Name
replacement NCT03922958 682 693 I-Procedure-Name
therapy NCT03922958 694 701 I-Procedure-Name

- NCT03922958 709 710 O
Estimated NCT03922958 712 721 O
GFR NCT03922958 722 725 B-Observation-Name___Observation-Type-Value:lab
< NCT03922958 726 727 B-Eq-Operator___Eq-Operator-Value:LT
45 NCT03922958 729 731 B-Eq-Value
mL NCT03922958 732 734 B-Eq-Unit
/ NCT03922958 735 736 O
min NCT03922958 737 740 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
( NCT03922958 741 742 O
as NCT03922958 743 745 O
judged NCT03922958 746 752 O
by NCT03922958 753 755 O
the NCT03922958 756 759 O
Chronic NCT03922958 760 767 O
Kidney NCT03922958 768 774 O
Disease NCT03922958 775 782 O
Epidemiology NCT03922958 783 795 O
Collaboration NCT03922958 796 809 O
( NCT03922958 810 811 O
CKD NCT03922958 812 815 O
- NCT03922958 816 817 O
EPI NCT03922958 818 821 O
) NCT03922958 822 823 O
equation NCT03922958 824 832 O

Inclusion NCT03927820 0 9 O
Criteria NCT03927820 10 18 O
: NCT03927820 19 20 O

- NCT03927820 24 25 O
Adult NCT03927820 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patient NCT03927820 33 40 O
admitted NCT03927820 41 49 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03927820 50 52 O
Vanderbilt NCT03927820 53 63 B-Location___Location-Value:hospital
University NCT03927820 64 74 I-Location___Location-Value:hospital
Medical NCT03927820 75 82 I-Location___Location-Value:hospital
Center NCT03927820 83 89 I-Location___Location-Value:hospital
( NCT03927820 90 91 O
VUMC NCT03927820 92 96 B-Location___Location-Value:hospital
) NCT03927820 97 98 O
( NCT03927820 99 100 O
excluding NCT03927820 101 110 O
surgery NCT03927820 111 118 B-Provider-Type
services NCT03927820 119 127 O
) NCT03927820 128 129 O

- NCT03927820 133 134 O
on NCT03927820 136 138 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03927820 139 140 O
long NCT03927820 141 145 B-Drug-Name
acting NCT03927820 146 152 I-Drug-Name
inhaler NCT03927820 153 160 I-Drug-Name
or NCT03927820 161 163 O
prescribed NCT03927820 164 174 O
a NCT03927820 175 176 O
long NCT03927820 177 181 B-Drug-Name
acting NCT03927820 182 188 I-Drug-Name
inhaler NCT03927820 189 196 I-Drug-Name
during NCT03927820 197 203 O
admission NCT03927820 204 213 B-Encounter-Type___Encounter-Type-Value:inpatient
. NCT03927820 214 215 O

Exclusion NCT03927820 217 226 O
Criteria NCT03927820 227 235 O
: NCT03927820 236 237 O

- NCT03927820 241 242 O
Diagnosis NCT03927820 244 253 O
of NCT03927820 254 256 O
cystic NCT03927820 257 263 B-Condition-Name
fibrosis NCT03927820 264 272 I-Condition-Name

- NCT03927820 275 276 O
Diagnosis NCT03927820 278 287 O
of NCT03927820 288 290 O
graft NCT03927820 291 296 B-Condition-Name
versus NCT03927820 297 303 I-Condition-Name
host NCT03927820 304 308 I-Condition-Name
disease NCT03927820 309 316 I-Condition-Name
( NCT03927820 317 318 O
GVHD NCT03927820 319 323 B-Condition-Name
) NCT03927820 324 325 O

- NCT03927820 329 330 O
no NCT03927820 332 334 O
medication NCT03927820 335 345 O
insurance NCT03927820 346 355 B-Insurance

- NCT03927820 358 359 O
discharge NCT03927820 361 370 B-Encounter-Type___Encounter-Type-Value:discharge
to NCT03927820 371 373 O
any NCT03927820 374 377 O
post NCT03927820 378 382 B-Location___Location-Value:clinic
- NCT03927820 383 384 I-Location___Location-Value:clinic
acute NCT03927820 385 390 I-Location___Location-Value:clinic
care NCT03927820 391 395 I-Location___Location-Value:clinic
facility NCT03927820 396 404 I-Location___Location-Value:clinic
or NCT03927820 405 407 O
inpatient NCT03927820 408 417 B-Location___Location-Value:hospital
hospice NCT03927820 418 425 I-Location___Location-Value:hospital

- NCT03927820 428 429 O
death NCT03927820 431 436 O
during NCT03927820 437 443 O
hospitalization NCT03927820 444 459 B-Encounter-Type___Encounter-Type-Value:inpatient

Cystic NCT03921060 0 6 B-Condition-Name
Fibrosis NCT03921060 7 15 I-Condition-Name
Main NCT03921060 16 20 O
Study NCT03921060 21 26 O
Inclusion NCT03921060 27 36 O
Criteria NCT03921060 37 45 O
: NCT03921060 46 47 O

- NCT03921060 51 52 O
Must NCT03921060 54 58 O
have NCT03921060 59 63 O
CF NCT03921060 64 66 B-Condition-Name
diagnosis NCT03921060 67 76 O
confirmed NCT03921060 77 86 O
by NCT03921060 87 89 O
sweat NCT03921060 90 95 B-Observation-Name
test NCT03921060 96 100 I-Observation-Name
or NCT03921060 101 103 O
genotype NCT03921060 104 112 B-Procedure-Name
analysis NCT03921060 113 121 I-Procedure-Name

- NCT03921060 124 125 O
Subjects NCT03921060 127 135 O
( NCT03921060 136 137 O
and NCT03921060 138 141 O
parents NCT03921060 142 149 O
/ NCT03921060 150 151 O
legal NCT03921060 152 157 O
guardians NCT03921060 158 167 O
as NCT03921060 168 170 O
applicable NCT03921060 171 181 O
) NCT03921060 182 183 O
must NCT03921060 184 188 O
have NCT03921060 189 193 O
the NCT03921060 194 197 O
ability NCT03921060 198 205 O
to NCT03921060 206 208 O
read NCT03921060 209 213 O
and NCT03921060 214 217 O
write NCT03921060 218 223 O
in NCT03921060 224 226 O
English NCT03921060 227 234 B-Language

Sub NCT03921060 235 238 O
- NCT03921060 239 240 O
study NCT03921060 241 246 O
Exclusion NCT03921060 247 256 O
Criteria NCT03921060 257 265 O
: NCT03921060 266 267 O

- NCT03921060 271 272 O
No NCT03921060 274 276 O
CF NCT03921060 277 279 B-Condition-Name
diagnosis NCT03921060 280 289 O

- NCT03921060 292 293 O
Men NCT03921060 295 298 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03921060 299 301 O
women NCT03921060 302 307 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
without NCT03921060 308 315 O
osteoporosis NCT03921060 316 328 B-Condition-Name

- NCT03921060 331 332 O
Less NCT03921060 334 338 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03921060 339 343 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03921060 345 347 B-Eq-Value
years NCT03921060 348 353 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921060 354 356 O
age NCT03921060 357 360 O

- NCT03921060 363 364 O
Unwilling NCT03921060 366 375 O
to NCT03921060 376 378 O
return NCT03921060 379 385 O
annually NCT03921060 386 394 O
for NCT03921060 395 398 O
study NCT03921060 399 404 O
visits NCT03921060 405 411 O
for NCT03921060 412 415 O
up NCT03921060 416 418 B-Eq-Operator___Eq-Operator-Value:LTEQ
to NCT03921060 419 421 I-Eq-Operator___Eq-Operator-Value:LTEQ
5 NCT03921060 423 424 B-Eq-Value
years NCT03921060 425 430 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03921060 433 434 O
Unwilling NCT03921060 436 445 O
and NCT03921060 446 449 O
/ NCT03921060 450 451 O
or NCT03921060 452 454 O
medically NCT03921060 455 464 O
unable NCT03921060 465 471 O
to NCT03921060 472 474 O
take NCT03921060 475 479 O
denosumab NCT03921060 480 489 B-Drug-Name

Inclusion NCT03928093 0 9 O
Criteria NCT03928093 10 18 O
: NCT03928093 19 20 O

- NCT03928093 24 25 O
Age NCT03928093 27 30 O
: NCT03928093 31 32 O
> NCT03928093 33 34 B-Eq-Operator___Eq-Operator-Value:GT
8 NCT03928093 36 37 B-Eq-Value
- NCT03928093 38 39 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03928093 41 43 B-Eq-Value
years NCT03928093 44 49 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03928093 50 51 O
we NCT03928093 52 54 O
selected NCT03928093 55 63 O
this NCT03928093 64 68 O
range NCT03928093 69 74 O
due NCT03928093 75 78 O
to NCT03928093 79 81 O
lack NCT03928093 82 86 O
of NCT03928093 87 89 O
data NCT03928093 90 94 O
in NCT03928093 95 97 O
younger NCT03928093 98 105 O
population NCT03928093 106 116 O
and NCT03928093 117 120 O
the NCT03928093 121 124 O
difficulty NCT03928093 125 135 O
in NCT03928093 136 138 O
getting NCT03928093 139 146 O
patient NCT03928093 147 154 O
reported NCT03928093 155 163 O
outcomes NCT03928093 164 172 O
in NCT03928093 173 175 O
younger NCT03928093 176 183 O
patients NCT03928093 184 192 O
) NCT03928093 193 194 O

- NCT03928093 198 199 O
Diagnosis NCT03928093 201 210 O
of NCT03928093 211 213 O
RDEB NCT03928093 214 218 B-Condition-Name
( NCT03928093 219 220 O
by NCT03928093 221 223 O
a NCT03928093 224 225 O
dermatologist NCT03928093 226 239 B-Provider-Type
and NCT03928093 240 243 O
/ NCT03928093 244 245 O
or NCT03928093 246 248 O
EB NCT03928093 249 251 B-Provider-Type
specialist NCT03928093 252 262 I-Provider-Type
and NCT03928093 263 266 O
/ NCT03928093 267 268 O
or NCT03928093 269 271 O
genetic NCT03928093 272 279 B-Procedure-Name
confirmation NCT03928093 280 292 I-Procedure-Name
) NCT03928093 293 294 O

- NCT03928093 298 299 O
Evidence NCT03928093 301 309 O
of NCT03928093 310 312 O
neuropathy NCT03928093 313 323 B-Condition-Name
defined NCT03928093 324 331 O
by NCT03928093 332 334 O
: NCT03928093 335 336 O
thermal NCT03928093 337 344 B-Condition-Name
sensory NCT03928093 345 352 I-Condition-Name
loss NCT03928093 353 357 I-Condition-Name
( NCT03928093 358 359 O
determined NCT03928093 360 370 O
by NCT03928093 371 373 O
a NCT03928093 374 375 O
thermal NCT03928093 376 383 B-Procedure-Name
roller NCT03928093 384 390 I-Procedure-Name
, NCT03928093 391 392 O
ROLLTEMP NCT03928093 393 401 O
2 NCT03928093 402 403 O
, NCT03928093 404 405 O
Sometic NCT03928093 406 413 O
, NCT03928093 414 415 O
Sweden NCT03928093 416 422 O
) NCT03928093 423 424 O
14 NCT03928093 426 428 O
and NCT03928093 429 432 O
> NCT03928093 433 434 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03928093 436 437 B-Eq-Value
/ NCT03928093 438 439 O
10 NCT03928093 441 443 B-Eq-Unit
score NCT03928093 444 449 O
using NCT03928093 450 455 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03928093 456 457 O
screening NCT03928093 458 467 O
tool NCT03928093 468 472 O
for NCT03928093 473 476 O
neuropathic NCT03928093 477 488 B-Observation-Name
pain NCT03928093 489 493 I-Observation-Name
, NCT03928093 494 495 O
the NCT03928093 496 499 O
DN NCT03928093 500 502 O
4 NCT03928093 503 504 O
questionnaire NCT03928093 505 518 O
15 NCT03928093 520 522 O

- NCT03928093 526 527 O
Pain NCT03928093 529 533 B-Observation-Name
intensity NCT03928093 534 543 I-Observation-Name
of NCT03928093 544 546 O
> NCT03928093 547 548 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03928093 550 551 B-Eq-Value
/ NCT03928093 552 553 O
10 NCT03928093 555 557 B-Eq-Unit
on NCT03928093 558 560 O
a NCT03928093 561 562 O
0 NCT03928093 564 565 O
- NCT03928093 566 567 O
10 NCT03928093 569 571 O
VAS NCT03928093 572 575 O
scale NCT03928093 576 581 O
measured NCT03928093 582 590 O
daily NCT03928093 591 596 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
( NCT03928093 597 598 O
reduced NCT03928093 599 606 O
frequency NCT03928093 607 616 O
is NCT03928093 617 619 O
also NCT03928093 620 624 O
acceptable NCT03928093 625 635 O
) NCT03928093 636 637 O
at NCT03928093 638 640 O
night NCT03928093 641 646 O
over NCT03928093 647 651 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03928093 653 654 B-Eq-Value
weeks NCT03928093 655 660 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03928093 663 664 O
Itch NCT03928093 666 670 B-Observation-Name
intensity NCT03928093 671 680 I-Observation-Name
of NCT03928093 681 683 O
> NCT03928093 684 685 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03928093 687 688 B-Eq-Value
/ NCT03928093 689 690 O
10 NCT03928093 692 694 B-Eq-Unit
on NCT03928093 695 697 O
a NCT03928093 698 699 O
0 NCT03928093 701 702 O
- NCT03928093 703 704 O
10 NCT03928093 706 708 O
VAS NCT03928093 709 712 O
scale NCT03928093 713 718 O
measures NCT03928093 719 727 O
daily NCT03928093 728 733 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
( NCT03928093 734 735 O
reduced NCT03928093 736 743 O
frequency NCT03928093 744 753 O
is NCT03928093 754 756 O
also NCT03928093 757 761 O
acceptable NCT03928093 762 772 O
) NCT03928093 773 774 O
at NCT03928093 775 777 O
night NCT03928093 778 783 O
over NCT03928093 784 788 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03928093 790 791 B-Eq-Value
weeks NCT03928093 792 797 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03928093 800 801 O
Consent NCT03928093 803 810 O
to NCT03928093 811 813 O
follow NCT03928093 814 820 O
with NCT03928093 821 825 O
study NCT03928093 826 831 O
procedures NCT03928093 832 842 O

Exclusion NCT03928093 843 852 O
Criteria NCT03928093 853 861 O
: NCT03928093 862 863 O

- NCT03928093 867 868 O
Intolerance NCT03928093 870 881 B-Condition-Name
and NCT03928093 882 885 O
/ NCT03928093 886 887 O
or NCT03928093 888 890 O
allergy NCT03928093 891 898 O
to NCT03928093 899 901 O
Pregabalin NCT03928093 902 912 B-Drug-Name
or NCT03928093 913 915 O
gabapentin NCT03928093 916 926 B-Drug-Name

- NCT03928093 929 930 O
Lactose NCT03928093 932 939 B-Condition-Name
intolerance NCT03928093 940 951 I-Condition-Name
( NCT03928093 952 953 O
placebo NCT03928093 954 961 O
capsules NCT03928093 962 970 O
contain NCT03928093 971 978 O
lactose NCT03928093 979 986 O
) NCT03928093 987 988 O

- NCT03928093 992 993 O
Pregabalin NCT03928093 995 1005 B-Drug-Name
use NCT03928093 1006 1009 O
within NCT03928093 1010 1016 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03928093 1018 1019 B-Eq-Value
weeks NCT03928093 1020 1025 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03928093 1026 1032 O
study NCT03928093 1033 1038 O
enrolment NCT03928093 1039 1048 O

- NCT03928093 1051 1052 O
Ongoing NCT03928093 1054 1061 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03928093 1062 1071 O
with NCT03928093 1072 1076 O
gabapentin NCT03928093 1077 1087 B-Drug-Name
, NCT03928093 1088 1089 O
amitriptyline NCT03928093 1090 1103 B-Drug-Name
, NCT03928093 1104 1105 O
duloxetine NCT03928093 1106 1116 B-Drug-Name
, NCT03928093 1117 1118 O
nortriptyline NCT03928093 1119 1132 B-Drug-Name
, NCT03928093 1133 1134 O
other NCT03928093 1135 1140 O
tricyclics NCT03928093 1141 1151 B-Drug-Name
or NCT03928093 1152 1154 O
SNRIs NCT03928093 1155 1160 B-Drug-Name

- NCT03928093 1163 1164 O
Medical NCT03928093 1166 1173 O
conditions NCT03928093 1174 1184 O
that NCT03928093 1185 1189 O
would NCT03928093 1190 1195 O
be NCT03928093 1196 1198 O
considered NCT03928093 1199 1209 O
as NCT03928093 1210 1212 O
contraindications NCT03928093 1213 1230 O
for NCT03928093 1231 1234 O
pregabalin NCT03928093 1235 1245 B-Drug-Name
treatment NCT03928093 1246 1255 O
( NCT03928093 1256 1257 O
ischemic NCT03928093 1258 1266 B-Condition-Name
heart NCT03928093 1267 1272 I-Condition-Name
disease NCT03928093 1273 1280 I-Condition-Name
, NCT03928093 1281 1282 O
cardiac NCT03928093 1283 1290 B-Condition-Name
dysrhythmia NCT03928093 1291 1302 I-Condition-Name
, NCT03928093 1303 1304 O
glaucoma NCT03928093 1305 1313 B-Condition-Name
, NCT03928093 1314 1315 O
history NCT03928093 1316 1323 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928093 1324 1326 O
urinary NCT03928093 1327 1334 B-Condition-Name
retention NCT03928093 1335 1344 I-Condition-Name
) NCT03928093 1345 1346 O

- NCT03928093 1350 1351 O
Pregnancy NCT03928093 1353 1362 B-Condition-Name

- NCT03928093 1365 1366 O
History NCT03928093 1368 1375 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928093 1376 1378 O
use NCT03928093 1379 1382 O
of NCT03928093 1383 1385 O
restrictive NCT03928093 1386 1397 B-Condition-Name
substances NCT03928093 1398 1408 I-Condition-Name
or NCT03928093 1409 1411 O
alcohol NCT03928093 1412 1419 B-Condition-Name
abuse NCT03928093 1420 1425 I-Condition-Name

- NCT03928093 1428 1429 O
Allergy NCT03928093 1431 1438 O
to NCT03928093 1439 1441 O
gelatin NCT03928093 1442 1449 B-Allergy-Name

Inclusion NCT03922347 0 9 O
Criteria NCT03922347 10 18 O
: NCT03922347 19 20 O

- NCT03922347 24 25 O
Inclusion NCT03922347 27 36 O
criteria NCT03922347 37 45 O
were NCT03922347 46 50 O
living NCT03922347 51 57 O
in NCT03922347 58 60 O
one NCT03922347 61 64 O
of NCT03922347 65 67 O
the NCT03922347 68 71 O
non NCT03922347 72 75 O
- NCT03922347 76 77 O
institutionalized NCT03922347 78 95 O
urban NCT03922347 96 101 B-Location___Location-Value:residence
or NCT03922347 102 104 O
rural NCT03922347 105 110 B-Location___Location-Value:residence
residential NCT03922347 111 122 I-Location___Location-Value:residence
areas NCT03922347 123 128 I-Location___Location-Value:residence
in NCT03922347 129 131 O
one NCT03922347 132 135 O
of NCT03922347 136 138 O
the NCT03922347 139 142 O
survey NCT03922347 143 149 O
area NCT03922347 150 154 O
, NCT03922347 155 156 O
being NCT03922347 157 162 O
resident NCT03922347 163 171 O
in NCT03922347 172 174 O
the NCT03922347 175 178 O
same NCT03922347 179 183 B-Stability___Stability-Value:stable
address NCT03922347 184 191 B-Observation-Name
for NCT03922347 192 195 O
at NCT03922347 196 198 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03922347 199 204 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03922347 206 207 B-Eq-Value
months NCT03922347 208 214 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
during NCT03922347 215 221 O
the NCT03922347 222 225 O
year NCT03922347 226 230 O
before NCT03922347 231 237 O
the NCT03922347 238 241 O
enrolment NCT03922347 242 251 O
, NCT03922347 252 253 O
age NCT03922347 254 257 O
50 NCT03922347 259 261 B-Eq-Value
and NCT03922347 262 265 B-Eq-Operator___Eq-Operator-Value:GTEQ
over NCT03922347 266 270 I-Eq-Operator___Eq-Operator-Value:GTEQ
and NCT03922347 271 274 O
Iranian NCT03922347 275 282 B-Ethnicity
nationality NCT03922347 283 294 O
. NCT03922347 295 296 O

Inclusion NCT03920020 0 9 O
Criteria NCT03920020 10 18 O
: NCT03920020 19 20 O

- NCT03920020 24 25 O
Diagnosis NCT03920020 27 36 O
of NCT03920020 37 39 O
primary NCT03920020 40 47 O
knee NCT03920020 48 52 O
osteoarthritis NCT03920020 53 67 B-Condition-Name
according NCT03920020 68 77 O
to NCT03920020 78 80 O
American NCT03920020 81 89 O
College NCT03920020 90 97 O
of NCT03920020 98 100 O
Radiology NCT03920020 101 110 O

- NCT03920020 113 114 O
Being NCT03920020 116 121 O
radiographically NCT03920020 122 138 B-Condition-Name
K NCT03920020 139 140 B-Eq-Unit
- NCT03920020 141 142 I-Eq-Unit
L NCT03920020 143 144 I-Eq-Unit
grade NCT03920020 145 150 I-Eq-Unit
2 NCT03920020 152 153 B-Eq-Value
- NCT03920020 154 155 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03920020 157 158 B-Eq-Value

- NCT03920020 162 163 O
Presence NCT03920020 165 173 O
of NCT03920020 174 176 O
symptoms NCT03920020 177 185 O
for NCT03920020 186 189 O
at NCT03920020 190 192 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03920020 193 198 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03920020 200 201 B-Eq-Value
months NCT03920020 202 208 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03920020 211 212 O
Patients NCT03920020 214 222 O
who NCT03920020 223 226 O
have NCT03920020 227 231 O
been NCT03920020 232 236 O
planned NCT03920020 237 244 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
a NCT03920020 245 246 O
conventional NCT03920020 247 259 O
physiotherapy NCT03920020 260 273 B-Procedure-Name
programme NCT03920020 274 283 O
because NCT03920020 284 291 O
of NCT03920020 292 294 O
knee NCT03920020 295 299 O
osteoarthritis NCT03920020 300 314 B-Condition-Name

- NCT03920020 317 318 O
Presence NCT03920020 320 328 O
of NCT03920020 329 331 O
functional NCT03920020 332 342 O
capacity NCT03920020 343 351 O
for NCT03920020 352 355 O
outpatient NCT03920020 356 366 B-Procedure-Name
physical NCT03920020 367 375 I-Procedure-Name
therapy NCT03920020 376 383 I-Procedure-Name

Exclusion NCT03920020 384 393 O
Criteria NCT03920020 394 402 O
: NCT03920020 403 404 O

- NCT03920020 408 409 O
Patients NCT03920020 411 419 O
with NCT03920020 420 424 O
seconder NCT03920020 425 433 O
knee NCT03920020 434 438 O
osteoarthritis NCT03920020 439 453 B-Condition-Name

- NCT03920020 456 457 O
History NCT03920020 459 466 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920020 467 469 O
lower NCT03920020 470 475 O
extremity NCT03920020 476 485 O
or NCT03920020 486 488 O
spine NCT03920020 489 494 O
surgery NCT03920020 495 502 B-Procedure-Name

- NCT03920020 505 506 O
History NCT03920020 508 515 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920020 516 518 O
intraarticular NCT03920020 519 533 B-Procedure-Name
injection NCT03920020 534 543 I-Procedure-Name
in NCT03920020 544 546 O
last NCT03920020 547 551 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
1 NCT03920020 553 554 B-Eq-Value
month NCT03920020 555 560 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03920020 563 564 O
Patients NCT03920020 566 574 O
with NCT03920020 575 579 O
neurological NCT03920020 580 592 B-Condition-Name
disease NCT03920020 593 600 I-Condition-Name
that NCT03920020 601 605 O
will NCT03920020 606 610 O
affect NCT03920020 611 617 B-Stability___Stability-Value:change
muscle NCT03920020 618 624 B-Condition-Name
strength NCT03920020 625 633 I-Condition-Name
, NCT03920020 634 635 O
balance NCT03920020 636 643 B-Condition-Name
and NCT03920020 644 647 O
coordination NCT03920020 648 660 B-Condition-Name

Inclusion NCT03925831 0 9 O
Criteria NCT03925831 10 18 O
: NCT03925831 19 20 O

Individuals NCT03925831 22 33 O
died NCT03925831 34 38 O
from NCT03925831 39 43 O
cancer NCT03925831 44 50 B-Condition-Name
between NCT03925831 51 58 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2008 NCT03925831 60 64 B-Eq-Value
and NCT03925831 65 68 O
2017 NCT03925831 70 74 B-Eq-Value
. NCT03925831 74 75 O

Exclusion NCT03925831 77 86 O
Criteria NCT03925831 87 95 O
: NCT03925831 96 97 O

- NCT03925831 100 101 O

Inclusion NCT03928938 0 9 O
Criteria NCT03928938 10 18 O
: NCT03928938 19 20 O

1 NCT03928938 25 26 O
. NCT03928938 26 27 O
Signed NCT03928938 29 35 O
informed NCT03928938 36 44 O
consent NCT03928938 45 52 O

2 NCT03928938 56 57 O
. NCT03928938 57 58 O
Advanced NCT03928938 60 68 B-Severity___Severity-Value:severe
cancers NCT03928938 69 76 B-Condition-Name

3 NCT03928938 80 81 O
. NCT03928938 81 82 O
Immune NCT03928938 84 90 B-Procedure-Name
checkpoint NCT03928938 91 101 I-Procedure-Name
inhibitor NCT03928938 102 111 I-Procedure-Name
therapy NCT03928938 112 119 I-Procedure-Name
initiated NCT03928938 120 129 O
within NCT03928938 130 136 B-Eq-Operator___Eq-Operator-Value:LTEQ
+ NCT03928938 137 138 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
/ NCT03928938 140 141 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
- NCT03928938 143 144 I-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
2 NCT03928938 146 147 B-Eq-Value
wks NCT03928938 148 151 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

4 NCT03928938 155 156 O
. NCT03928938 156 157 O
Age NCT03928938 159 162 O
> NCT03928938 163 164 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03928938 166 168 B-Eq-Value
y NCT03928938 169 170 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

5 NCT03928938 174 175 O
. NCT03928938 175 176 O
ECOG NCT03928938 178 182 B-Observation-Name___Observation-Type-Value:measurement
0 NCT03928938 184 185 B-Eq-Value
- NCT03928938 186 187 B-Eq-Operator___Eq-Operator-Value:BETWEEN
3 NCT03928938 189 190 B-Eq-Value

6 NCT03928938 195 196 O
. NCT03928938 196 197 O
Patient NCT03928938 199 206 O
compliant NCT03928938 207 216 O
with NCT03928938 217 221 O
the NCT03928938 222 225 O
study NCT03928938 226 231 O
procedures NCT03928938 232 242 O

Exclusion NCT03928938 243 252 O
Criteria NCT03928938 253 261 O
: NCT03928938 262 263 O

1 NCT03928938 268 269 O
. NCT03928938 269 270 O
Immune NCT03928938 272 278 B-Procedure-Name
checkpoint NCT03928938 279 289 I-Procedure-Name
inhibitor NCT03928938 290 299 I-Procedure-Name
therapy NCT03928938 300 307 I-Procedure-Name
initiated NCT03928938 308 317 O
> NCT03928938 318 319 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03928938 321 322 B-Eq-Value
wks NCT03928938 323 326 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
ago NCT03928938 327 330 O

2 NCT03928938 334 335 O
. NCT03928938 335 336 O
General NCT03928938 338 345 B-Condition-Name
vulnerability NCT03928938 346 359 I-Condition-Name
affecting NCT03928938 360 369 B-Stability___Stability-Value:change
the NCT03928938 370 373 O
participation NCT03928938 374 387 O
in NCT03928938 388 390 O
the NCT03928938 391 394 O
trial NCT03928938 395 400 O

3 NCT03928938 404 405 O
. NCT03928938 405 406 O
No NCT03928938 408 410 O
internet NCT03928938 411 419 O
access NCT03928938 420 426 O

Inclusion NCT03925207 0 9 O
Criteria NCT03925207 10 18 O
: NCT03925207 19 20 O

- NCT03925207 24 25 O
Patients NCT03925207 27 35 O
were NCT03925207 36 40 O
included NCT03925207 41 49 O
if NCT03925207 50 52 O
they NCT03925207 53 57 O
underwent NCT03925207 58 67 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
orbital NCT03925207 68 75 B-Procedure-Name
ball NCT03925207 76 80 I-Procedure-Name
implants NCT03925207 81 89 I-Procedure-Name
after NCT03925207 90 95 O
enucleation NCT03925207 96 107 B-Procedure-Name
surgery NCT03925207 108 115 I-Procedure-Name
by NCT03925207 116 118 O
one NCT03925207 119 122 O
ophthalmologist NCT03925207 123 138 B-Provider-Type
surgeon NCT03925207 139 146 I-Provider-Type
specializing NCT03925207 147 159 O
in NCT03925207 160 162 O
oculoplastic NCT03925207 163 175 O
and NCT03925207 176 179 O
orbital NCT03925207 180 187 O
surgery NCT03925207 188 195 O
at NCT03925207 196 198 O
our NCT03925207 199 202 O
centre NCT03925207 203 209 B-Location___Location-Value:clinic
. NCT03925207 210 211 O

Exclusion NCT03925207 213 222 O
Criteria NCT03925207 223 231 O
: NCT03925207 232 233 O

- NCT03925207 237 238 O
Patients NCT03925207 240 248 O
were NCT03925207 249 253 O
excluded NCT03925207 254 262 O
if NCT03925207 263 265 O
they NCT03925207 266 270 O
underwent NCT03925207 271 280 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
other NCT03925207 281 286 O
concurrent NCT03925207 287 297 O
surgical NCT03925207 298 306 B-Procedure-Name
procedures NCT03925207 307 317 I-Procedure-Name
, NCT03925207 318 319 O
or NCT03925207 320 322 O
were NCT03925207 323 327 O
under NCT03925207 328 333 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03925207 335 337 B-Eq-Value
yr NCT03925207 338 340 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03925207 341 343 O
age NCT03925207 344 347 O
. NCT03925207 348 349 O

Inclusion NCT03922568 0 9 O
Criteria NCT03922568 10 18 O
: NCT03922568 19 20 O

- NCT03922568 24 25 O
Full NCT03922568 27 31 O
Term NCT03922568 32 36 O
Delivery NCT03922568 37 45 B-Condition-Name

- NCT03922568 48 49 O
ICSI NCT03922568 51 55 B-Procedure-Name
cases NCT03922568 56 61 O
using NCT03922568 62 67 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
DGC NCT03922568 68 71 B-Procedure-Name
for NCT03922568 72 75 I-Procedure-Name
sperm NCT03922568 76 81 I-Procedure-Name
selection NCT03922568 82 91 I-Procedure-Name

- NCT03922568 94 95 O
ICSI NCT03922568 97 101 B-Procedure-Name
cases NCT03922568 102 107 O
using NCT03922568 108 113 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
MACS NCT03922568 114 118 B-Procedure-Name
for NCT03922568 119 122 I-Procedure-Name
sperm NCT03922568 123 128 I-Procedure-Name
selection NCT03922568 129 138 I-Procedure-Name

- NCT03922568 141 142 O
ICSI NCT03922568 144 148 B-Procedure-Name
cases NCT03922568 149 154 O
using NCT03922568 155 160 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
PICSI NCT03922568 161 166 B-Procedure-Name
dishes NCT03922568 167 173 I-Procedure-Name
for NCT03922568 174 177 I-Procedure-Name
sperm NCT03922568 178 183 I-Procedure-Name
selection NCT03922568 184 193 I-Procedure-Name

- NCT03922568 196 197 O
Fresh NCT03922568 199 204 B-Procedure-Name
blastocyst NCT03922568 205 215 I-Procedure-Name
stage NCT03922568 216 221 I-Procedure-Name
embryo NCT03922568 222 228 I-Procedure-Name
transfer NCT03922568 229 237 I-Procedure-Name
at NCT03922568 238 240 O

- NCT03922568 243 244 O
Fresh NCT03922568 246 251 B-Condition-Name
ejaculate NCT03922568 252 261 I-Condition-Name

Exclusion NCT03922568 262 271 O
Criteria NCT03922568 272 280 O
: NCT03922568 281 282 O

- NCT03922568 286 287 O
Frozen NCT03922568 289 295 B-Procedure-Name
sperm NCT03922568 296 301 I-Procedure-Name

- NCT03922568 304 305 O
Frozen NCT03922568 307 313 B-Procedure-Name
Embryo NCT03922568 314 320 I-Procedure-Name
transfer NCT03922568 321 329 I-Procedure-Name

- NCT03922568 332 333 O
Fresh NCT03922568 335 340 B-Procedure-Name
cleavage NCT03922568 341 349 I-Procedure-Name
stage NCT03922568 350 355 I-Procedure-Name
embryo NCT03922568 356 362 I-Procedure-Name
transfer NCT03922568 363 371 I-Procedure-Name

- NCT03922568 374 375 O
Vanishing NCT03922568 377 386 B-Condition-Name
Twin NCT03922568 387 391 I-Condition-Name
Syndrome NCT03922568 392 400 I-Condition-Name

- NCT03922568 403 404 O
Fetal NCT03922568 406 411 B-Procedure-Name
Reduction NCT03922568 412 421 I-Procedure-Name

- NCT03922568 424 425 O
Preimlantation NCT03922568 427 441 O
genetically NCT03922568 442 453 B-Procedure-Name
screened NCT03922568 454 462 I-Procedure-Name
embryo NCT03922568 463 469 I-Procedure-Name
transfer NCT03922568 470 478 I-Procedure-Name

Inclusion NCT03927404 0 9 O
Criteria NCT03927404 10 18 O
: NCT03927404 19 20 O

- NCT03927404 24 25 O
1 NCT03927404 28 29 O
. NCT03927404 29 30 O
Ages NCT03927404 32 36 O
of NCT03927404 37 39 O
18 NCT03927404 41 43 B-Eq-Value
and NCT03927404 44 47 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03927404 48 53 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03927404 56 57 O
2 NCT03927404 60 61 O
. NCT03927404 61 62 O
Unilateral NCT03927404 64 74 O
transtibial NCT03927404 75 86 O
or NCT03927404 87 89 O
transfemoral NCT03927404 90 102 O
amputee NCT03927404 103 110 B-Condition-Name

- NCT03927404 113 114 O
3 NCT03927404 117 118 O
. NCT03927404 118 119 O
Ambulate NCT03927404 121 129 B-Condition-Name
at NCT03927404 130 132 O
a NCT03927404 133 134 O
K NCT03927404 135 136 B-Eq-Value
2 NCT03927404 137 138 I-Eq-Value
level NCT03927404 139 144 B-Eq-Unit
or NCT03927404 145 147 B-Eq-Operator___Eq-Operator-Value:GTEQ
higher NCT03927404 148 154 I-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03927404 157 158 O
4 NCT03927404 161 162 O
. NCT03927404 162 163 O
At NCT03927404 164 166 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03927404 167 172 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03927404 174 175 B-Eq-Value
months NCT03927404 176 182 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
post NCT03927404 183 187 O
- NCT03927404 188 189 O
amputation NCT03927404 190 200 B-Procedure-Name
per NCT03927404 201 204 O
physician NCT03927404 205 214 O
discretion NCT03927404 215 225 O

- NCT03927404 228 229 O
5 NCT03927404 232 233 O
. NCT03927404 233 234 O
Residual NCT03927404 235 243 B-Observation-Name___Observation-Type-Value:measurement
limb NCT03927404 244 248 I-Observation-Name___Observation-Type-Value:measurement
length NCT03927404 249 255 I-Observation-Name___Observation-Type-Value:measurement
greater NCT03927404 256 263 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03927404 264 268 I-Eq-Operator___Eq-Operator-Value:GT
6.5 NCT03927404 270 273 B-Eq-Value
inches NCT03927404 274 280 B-Eq-Unit
in NCT03927404 281 283 O
length NCT03927404 284 290 O

- NCT03927404 293 294 O
6 NCT03927404 297 298 O
. NCT03927404 298 299 O
Able NCT03927404 300 304 O
to NCT03927404 305 307 O
follow NCT03927404 308 314 O
directions NCT03927404 315 325 O
and NCT03927404 326 329 O
give NCT03927404 330 334 O
informed NCT03927404 335 343 O
consent NCT03927404 344 351 O
on NCT03927404 352 354 O
their NCT03927404 355 360 O
own NCT03927404 361 364 O

- NCT03927404 367 368 O
7 NCT03927404 371 372 O
. NCT03927404 372 373 O
Must NCT03927404 374 378 O
be NCT03927404 379 381 O
able NCT03927404 382 386 B-Condition-Name
to NCT03927404 387 389 I-Condition-Name
ambulate NCT03927404 390 398 I-Condition-Name
without NCT03927404 399 406 O
assistance NCT03927404 407 417 O

Exclusion NCT03927404 418 427 O
Criteria NCT03927404 428 436 O
: NCT03927404 437 438 O

- NCT03927404 442 443 O
1 NCT03927404 446 447 O
. NCT03927404 447 448 O
Conditions NCT03927404 450 460 O
that NCT03927404 461 465 O
prevent NCT03927404 466 473 O
wearing NCT03927404 474 481 B-Condition-Name
a NCT03927404 482 483 I-Condition-Name
prosthetic NCT03927404 484 494 I-Condition-Name
socket NCT03927404 495 501 I-Condition-Name

- NCT03927404 504 505 O
2 NCT03927404 508 509 O
. NCT03927404 509 510 O
Cognitive NCT03927404 512 521 B-Condition-Name
deficits NCT03927404 522 530 I-Condition-Name
or NCT03927404 531 533 O
mental NCT03927404 534 540 B-Condition-Name
health NCT03927404 541 547 I-Condition-Name
problems NCT03927404 548 556 I-Condition-Name
that NCT03927404 557 561 O
would NCT03927404 562 567 O
limit NCT03927404 568 573 O
ability NCT03927404 574 581 O
to NCT03927404 582 584 O
consent NCT03927404 585 592 O
and NCT03927404 593 596 O
participate NCT03927404 597 608 O
fully NCT03927404 609 614 O
in NCT03927404 615 617 O
the NCT03927404 618 621 O
study NCT03927404 622 627 O
protocol NCT03927404 628 636 O

- NCT03927404 639 640 O
3 NCT03927404 643 644 O
. NCT03927404 644 645 O
Women NCT03927404 646 651 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03927404 652 655 O
are NCT03927404 656 659 O
pregnant NCT03927404 660 668 B-Condition-Name
or NCT03927404 669 671 O
who NCT03927404 672 675 O
plan NCT03927404 676 680 O
to NCT03927404 681 683 O
become NCT03927404 684 690 O
pregnant NCT03927404 691 699 B-Condition-Name
in NCT03927404 700 702 O
the NCT03927404 703 706 O
near NCT03927404 707 711 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
future NCT03927404 712 718 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future

Inclusion NCT03929367 0 9 O
Criteria NCT03929367 10 18 O
: NCT03929367 19 20 O

- NCT03929367 24 25 O
Male NCT03929367 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03929367 32 34 O
female NCT03929367 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
> NCT03929367 42 43 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03929367 45 47 B-Eq-Value
and NCT03929367 48 51 O
< NCT03929367 52 53 B-Eq-Operator___Eq-Operator-Value:LT
60 NCT03929367 55 57 B-Eq-Value
years NCT03929367 58 63 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03929367 64 66 O
age NCT03929367 67 70 O
, NCT03929367 71 72 O
Body NCT03929367 73 77 B-Observation-Name___Observation-Type-Value:vital
Mass NCT03929367 78 82 I-Observation-Name___Observation-Type-Value:vital
Index NCT03929367 83 88 I-Observation-Name___Observation-Type-Value:vital
( NCT03929367 89 90 O
BMI NCT03929367 91 94 B-Observation-Name___Observation-Type-Value:vital
) NCT03929367 95 96 O
< NCT03929367 97 98 B-Eq-Operator___Eq-Operator-Value:LT
40 NCT03929367 100 102 B-Eq-Value
. NCT03929367 102 103 O

- NCT03929367 107 108 O
Generally NCT03929367 110 119 O
in NCT03929367 120 122 O
good NCT03929367 123 127 B-Condition-Name
health NCT03929367 128 134 I-Condition-Name
as NCT03929367 135 137 O
determined NCT03929367 138 148 O
by NCT03929367 149 151 O
the NCT03929367 152 155 O
Principal NCT03929367 156 165 O
Investigator NCT03929367 166 178 O
based NCT03929367 179 184 O
on NCT03929367 185 187 O
prior NCT03929367 188 193 O
medical NCT03929367 194 201 O
history NCT03929367 202 209 O
, NCT03929367 210 211 O
American NCT03929367 212 220 B-Condition-Name
Society NCT03929367 221 228 I-Condition-Name
of NCT03929367 229 231 I-Condition-Name
Anesthesiologists NCT03929367 232 249 I-Condition-Name
physical NCT03929367 250 258 O
status NCT03929367 259 265 B-Eq-Unit
I NCT03929367 266 267 B-Eq-Value
or NCT03929367 268 270 O
II NCT03929367 271 273 B-Eq-Value

- NCT03929367 276 277 O
Normal NCT03929367 279 285 B-Polarity___Polarity-Value:normal
blood NCT03929367 286 291 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03929367 292 300 I-Observation-Name___Observation-Type-Value:vital
( NCT03929367 301 302 O
systolic NCT03929367 303 311 B-Observation-Name___Observation-Type-Value:vital
90 NCT03929367 313 315 B-Eq-Value
- NCT03929367 316 317 B-Eq-Operator___Eq-Operator-Value:BETWEEN
140 NCT03929367 319 322 B-Eq-Value
mmHg NCT03929367 323 327 B-Eq-Unit
; NCT03929367 327 328 O
diastolic NCT03929367 329 338 B-Observation-Name___Observation-Type-Value:vital
50 NCT03929367 340 342 B-Eq-Value
- NCT03929367 343 344 B-Eq-Operator___Eq-Operator-Value:BETWEEN
90 NCT03929367 346 348 B-Eq-Value
mmHg NCT03929367 349 353 B-Eq-Unit
) NCT03929367 354 355 O
resting NCT03929367 356 363 B-Observation-Name___Observation-Type-Value:vital
heart NCT03929367 364 369 I-Observation-Name___Observation-Type-Value:vital
rate NCT03929367 370 374 I-Observation-Name___Observation-Type-Value:vital

45 NCT03929367 381 383 B-Eq-Value
- NCT03929367 384 385 B-Eq-Operator___Eq-Operator-Value:BETWEEN
100 NCT03929367 387 390 B-Eq-Value
beats NCT03929367 391 396 B-Eq-Unit
per NCT03929367 397 400 O
minute NCT03929367 401 407 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
) NCT03929367 408 409 O
without NCT03929367 410 417 O
medication NCT03929367 418 428 O

- NCT03929367 431 432 O
Female NCT03929367 434 440 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subjects NCT03929367 441 449 O
of NCT03929367 450 452 O
child NCT03929367 453 458 B-Condition-Name
- NCT03929367 459 460 I-Condition-Name
bearing NCT03929367 461 468 I-Condition-Name
potential NCT03929367 469 478 I-Condition-Name
and NCT03929367 479 482 O
those NCT03929367 483 488 O
< NCT03929367 489 490 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03929367 492 493 B-Eq-Value
year NCT03929367 494 498 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
post NCT03929367 499 503 O
- NCT03929367 504 505 O
menopausal NCT03929367 506 516 B-Condition-Name
, NCT03929367 517 518 O
must NCT03929367 519 523 O
be NCT03929367 524 526 O
practicing NCT03929367 527 537 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
highly NCT03929367 538 544 O
effective NCT03929367 545 554 O
methods NCT03929367 555 562 O
of NCT03929367 563 565 O
birth NCT03929367 566 571 B-Procedure-Name
control NCT03929367 572 579 I-Procedure-Name
such NCT03929367 580 584 O
as NCT03929367 585 587 O
hormonal NCT03929367 588 596 B-Procedure-Name
methods NCT03929367 597 604 I-Procedure-Name

Exclusion NCT03929367 605 614 O
Criteria NCT03929367 615 623 O
: NCT03929367 624 625 O

- NCT03929367 629 630 O
Hypersensitivity NCT03929367 632 648 B-Condition-Name
, NCT03929367 649 650 O
allergy NCT03929367 651 658 O
, NCT03929367 659 660 O
or NCT03929367 661 663 O
significant NCT03929367 664 675 B-Severity___Severity-Value:severe
reaction NCT03929367 676 684 B-Condition-Name
to NCT03929367 685 687 O
any NCT03929367 688 691 O
ingredient NCT03929367 692 702 O
of NCT03929367 703 705 O
Pitocin NCT03929367 706 713 B-Drug-Name
® NCT03929367 713 714 O

- NCT03929367 717 718 O
Any NCT03929367 720 723 O
disease NCT03929367 724 731 B-Condition-Name
, NCT03929367 732 733 O
diagnosis NCT03929367 734 743 O
, NCT03929367 744 745 O
or NCT03929367 746 748 O
condition NCT03929367 749 758 O
( NCT03929367 759 760 O
medical NCT03929367 761 768 O
or NCT03929367 769 771 O
surgical NCT03929367 772 780 O
) NCT03929367 781 782 O
that NCT03929367 783 787 O
, NCT03929367 788 789 O
in NCT03929367 790 792 O
the NCT03929367 793 796 O
opinion NCT03929367 797 804 O
of NCT03929367 805 807 O
the NCT03929367 808 811 O
Principal NCT03929367 812 821 O
Investigator NCT03929367 822 834 O
, NCT03929367 835 836 O
would NCT03929367 837 842 O
place NCT03929367 843 848 O
the NCT03929367 849 852 O
subject NCT03929367 853 860 O
at NCT03929367 861 863 O
increased NCT03929367 864 873 B-Polarity___Polarity-Value:high
risk NCT03929367 874 878 O
( NCT03929367 879 880 O
active NCT03929367 881 887 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
gynecologic NCT03929367 888 899 B-Condition-Name
disease NCT03929367 900 907 I-Condition-Name
in NCT03929367 908 910 O
which NCT03929367 911 916 O
increased NCT03929367 917 926 O
tone NCT03929367 927 931 O
would NCT03929367 932 937 O
be NCT03929367 938 940 O
detrimental NCT03929367 941 952 O
e NCT03929367 953 954 O
. NCT03929367 955 956 O
g NCT03929367 957 958 O
. NCT03929367 959 960 O
, NCT03929367 961 962 O
uterine NCT03929367 963 970 B-Condition-Name
fibroids NCT03929367 971 979 I-Condition-Name
with NCT03929367 980 984 O
ongoing NCT03929367 985 992 O
bleeding NCT03929367 993 1001 B-Condition-Name
) NCT03929367 1002 1003 O
, NCT03929367 1005 1006 O
compromise NCT03929367 1007 1017 B-Stability___Stability-Value:change
the NCT03929367 1018 1021 O
subject NCT03929367 1022 1029 O
's NCT03929367 1029 1031 O
compliance NCT03929367 1032 1042 O
with NCT03929367 1043 1047 O
study NCT03929367 1048 1053 O
procedures NCT03929367 1054 1064 O
, NCT03929367 1065 1066 O
or NCT03929367 1067 1069 O
compromise NCT03929367 1070 1080 O
the NCT03929367 1081 1084 O
quality NCT03929367 1085 1092 O
of NCT03929367 1093 1095 O
the NCT03929367 1096 1099 O
data NCT03929367 1100 1104 O

- NCT03929367 1107 1108 O
Women NCT03929367 1110 1115 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03929367 1116 1119 O
are NCT03929367 1120 1123 O
pregnant NCT03929367 1124 1132 B-Condition-Name
( NCT03929367 1133 1134 O
positive NCT03929367 1135 1143 B-Polarity___Polarity-Value:positive
result NCT03929367 1144 1150 O
for NCT03929367 1151 1154 O
serum NCT03929367 1155 1160 B-Observation-Name___Observation-Type-Value:lab
pregnancy NCT03929367 1161 1170 I-Observation-Name___Observation-Type-Value:lab
test NCT03929367 1171 1175 I-Observation-Name___Observation-Type-Value:lab
at NCT03929367 1176 1178 O
screening NCT03929367 1179 1188 O
visit NCT03929367 1189 1194 O
) NCT03929367 1195 1196 O
, NCT03929367 1198 1199 O
women NCT03929367 1200 1205 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03929367 1206 1209 O
are NCT03929367 1210 1213 O
currently NCT03929367 1214 1223 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
nursing NCT03929367 1224 1231 B-Condition-Name
or NCT03929367 1232 1234 O
lactating NCT03929367 1235 1244 B-Condition-Name
, NCT03929367 1245 1246 O
women NCT03929367 1247 1252 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
that NCT03929367 1253 1257 O
have NCT03929367 1258 1262 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
been NCT03929367 1263 1267 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pregnant NCT03929367 1268 1276 B-Condition-Name
within NCT03929367 1277 1283 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03929367 1285 1286 B-Eq-Value
years NCT03929367 1287 1292 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03929367 1295 1296 O
Subjects NCT03929367 1298 1306 O
with NCT03929367 1307 1311 O
neuropathy NCT03929367 1312 1322 B-Condition-Name
, NCT03929367 1323 1324 O
chronic NCT03929367 1325 1332 O
pain NCT03929367 1333 1337 B-Condition-Name
, NCT03929367 1338 1339 O
diabetes NCT03929367 1340 1348 B-Condition-Name
mellitus NCT03929367 1349 1357 I-Condition-Name
, NCT03929367 1358 1359 O
or NCT03929367 1360 1362 O
taking NCT03929367 1363 1369 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
benzodiazepines NCT03929367 1370 1385 B-Drug-Name
or NCT03929367 1386 1388 O
pain NCT03929367 1389 1393 B-Drug-Name
medications NCT03929367 1394 1405 I-Drug-Name
on NCT03929367 1406 1408 O
a NCT03929367 1409 1410 O
daily NCT03929367 1411 1416 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
basis NCT03929367 1417 1422 O
. NCT03929367 1423 1424 O

Inclusion NCT03922971 0 9 O
Criteria NCT03922971 10 18 O
: NCT03922971 19 20 O

- NCT03922971 24 25 O
Facilities NCT03922971 27 37 O
that NCT03922971 38 42 O
bill NCT03922971 43 47 O
to NCT03922971 48 50 O
fee NCT03922971 51 54 O
for NCT03922971 55 58 O
service NCT03922971 59 66 O
Medicare NCT03922971 67 75 O
for NCT03922971 76 79 O
gastrointestinal NCT03922971 80 96 B-Procedure-Name
endoscopy NCT03922971 97 106 I-Procedure-Name

Exclusion NCT03922971 107 116 O
Criteria NCT03922971 117 125 O
: NCT03922971 126 127 O

- NCT03922971 130 131 O

Inclusion NCT03920800 0 9 O
Criteria NCT03920800 10 18 O
: NCT03920800 19 20 O

- NCT03920800 24 25 O
Patients NCT03920800 27 35 O
followed NCT03920800 36 44 O
within NCT03920800 45 51 O
the NCT03920800 52 55 O
CHU NCT03920800 56 59 B-Location___Location-Value:hospital
Brugmann NCT03920800 60 68 I-Location___Location-Value:hospital
Hospital NCT03920800 69 77 I-Location___Location-Value:hospital
( NCT03920800 78 79 O
no NCT03920800 80 82 O
private NCT03920800 83 90 B-Location
practices NCT03920800 91 100 I-Location
) NCT03920800 101 102 O
. NCT03920800 104 105 O

- NCT03920800 109 110 O
HSIL NCT03920800 112 116 B-Condition-Name
lesions NCT03920800 117 124 I-Condition-Name
confirmed NCT03920800 125 134 O
by NCT03920800 135 137 O
anatomopathologic NCT03920800 138 155 O
analysis NCT03920800 156 164 O
on NCT03920800 165 167 O
cervical NCT03920800 168 176 B-Procedure-Name
biopsies NCT03920800 177 185 I-Procedure-Name
or NCT03920800 186 188 O
cone NCT03920800 189 193 B-Observation-Specimen
specimen NCT03920800 194 202 I-Observation-Specimen
without NCT03920800 203 210 O
evidence NCT03920800 211 219 O
of NCT03920800 220 222 O
invasive NCT03920800 223 231 B-Condition-Name
lesions NCT03920800 232 239 I-Condition-Name

Exclusion NCT03920800 240 249 O
Criteria NCT03920800 250 258 O
: NCT03920800 259 260 O

- NCT03920800 264 265 O
Invasive NCT03920800 267 275 B-Condition-Name
lesions NCT03920800 276 283 I-Condition-Name

Inclusion NCT03927612 0 9 O
Criteria NCT03927612 10 18 O
: NCT03927612 19 20 O

- NCT03927612 24 25 O
Aged NCT03927612 27 31 O
9 NCT03927612 33 34 B-Eq-Value
- NCT03927612 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03927612 38 40 B-Eq-Value

- NCT03927612 44 45 O
English NCT03927612 47 54 B-Language
- NCT03927612 55 56 O
speaking NCT03927612 57 65 O

- NCT03927612 68 69 O
Meet NCT03927612 71 75 O
DSM NCT03927612 76 79 O
- NCT03927612 80 81 O
5 NCT03927612 83 84 O
criteria NCT03927612 85 93 O
for NCT03927612 94 97 O
oppositional NCT03927612 98 110 B-Condition-Name
defiant NCT03927612 111 118 I-Condition-Name
disorder NCT03927612 119 127 I-Condition-Name
( NCT03927612 128 129 O
ODD NCT03927612 130 133 B-Condition-Name
) NCT03927612 134 135 O
, NCT03927612 137 138 O
conduct NCT03927612 139 146 B-Condition-Name
disorder NCT03927612 147 155 I-Condition-Name
( NCT03927612 156 157 O
CD NCT03927612 158 160 B-Condition-Name
) NCT03927612 161 162 O
, NCT03927612 164 165 O
or NCT03927612 166 168 O
Other NCT03927612 169 174 O
Specified NCT03927612 175 184 O
or NCT03927612 185 187 O
Unspecified NCT03927612 188 199 O
Disruptive NCT03927612 200 210 O
, NCT03927612 211 212 O
Impulse NCT03927612 213 220 O
- NCT03927612 221 222 O
Control NCT03927612 223 230 O
, NCT03927612 231 232 O
and NCT03927612 233 236 O
Conduct NCT03927612 237 244 O
Disorder NCT03927612 245 253 B-Condition-Name

- NCT03927612 256 257 O
Right NCT03927612 259 264 O
- NCT03927612 265 266 O
handed NCT03927612 267 273 O

- NCT03927612 276 277 O
Estimated NCT03927612 279 288 O
full NCT03927612 289 293 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03927612 294 295 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03927612 296 301 I-Observation-Name___Observation-Type-Value:clinical-score
IQ NCT03927612 302 304 I-Observation-Name___Observation-Type-Value:clinical-score
greater NCT03927612 305 312 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03927612 313 317 I-Eq-Operator___Eq-Operator-Value:GT
75 NCT03927612 319 321 B-Eq-Value

Exclusion NCT03927612 323 332 O
Criteria NCT03927612 333 341 O
: NCT03927612 342 343 O

- NCT03927612 347 348 O
Bipolar NCT03927612 350 357 B-Condition-Name
disorder NCT03927612 358 366 I-Condition-Name
, NCT03927612 367 368 O
any NCT03927612 369 372 O
disorder NCT03927612 373 381 B-Condition-Name
involving NCT03927612 382 391 O
psychosis NCT03927612 392 401 B-Condition-Name
, NCT03927612 402 403 O
pervasive NCT03927612 404 413 B-Condition-Name
developmental NCT03927612 414 427 I-Condition-Name
disorders NCT03927612 428 437 I-Condition-Name
, NCT03927612 438 439 O
current NCT03927612 440 447 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03927612 448 450 O
past NCT03927612 451 455 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
substance NCT03927612 456 465 B-Condition-Name
use NCT03927612 466 469 I-Condition-Name
disorder NCT03927612 470 478 I-Condition-Name
, NCT03927612 479 480 O
or NCT03927612 481 483 O
current NCT03927612 484 491 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
major NCT03927612 492 497 B-Severity___Severity-Value:severe
depressive NCT03927612 498 508 B-Condition-Name
disorder NCT03927612 509 517 I-Condition-Name

- NCT03927612 520 521 O
History NCT03927612 523 530 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927612 531 533 O
neurological NCT03927612 534 546 B-Condition-Name
problems NCT03927612 547 555 I-Condition-Name
( NCT03927612 556 557 O
e NCT03927612 558 559 O
. NCT03927612 560 561 O
g NCT03927612 562 563 O
. NCT03927612 564 565 O
, NCT03927612 566 567 O
epilepsy NCT03927612 568 576 B-Condition-Name
, NCT03927612 577 578 O
traumatic NCT03927612 579 588 B-Condition-Name
brain NCT03927612 589 594 I-Condition-Name
injury NCT03927612 595 601 I-Condition-Name
) NCT03927612 602 603 O

- NCT03927612 607 608 O
Contraindications NCT03927612 610 627 O
for NCT03927612 628 631 O
MRI NCT03927612 632 635 B-Procedure-Name

Inclusion NCT03929159 0 9 O
Criteria NCT03929159 10 18 O
: NCT03929159 19 20 O

- NCT03929159 24 25 O
Electively NCT03929159 27 37 O
scheduled NCT03929159 38 47 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03929159 48 51 O
surgical NCT03929159 52 60 B-Procedure-Name
operation NCT03929159 61 70 I-Procedure-Name
that NCT03929159 71 75 O
require NCT03929159 76 83 O
general NCT03929159 84 91 B-Procedure-Name
anesthesia NCT03929159 92 102 I-Procedure-Name
and NCT03929159 103 106 O
expected NCT03929159 107 115 O
duration NCT03929159 116 124 O
of NCT03929159 125 127 O
hospitalization NCT03929159 128 143 B-Encounter-Type___Encounter-Type-Value:inpatient
of NCT03929159 144 146 O
longer NCT03929159 147 153 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929159 154 158 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03929159 159 162 B-Eq-Value
day NCT03929159 163 166 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
( NCT03929159 167 168 O
for NCT03929159 169 172 O
patients NCT03929159 173 181 O
in NCT03929159 182 184 O
Peri NCT03929159 185 189 B-Procedure-Name
operative NCT03929159 190 199 I-Procedure-Name
Evaluation NCT03929159 200 210 I-Procedure-Name
& NCT03929159 211 212 I-Procedure-Name
Management NCT03929159 213 223 I-Procedure-Name
[ NCT03929159 224 225 O
POEM NCT03929159 226 230 B-Procedure-Name
] NCT03929159 231 232 O
) NCT03929159 234 235 O
or NCT03929159 236 238 O
high NCT03929159 239 243 B-Polarity___Polarity-Value:high
clinical NCT03929159 244 252 O
suspicion NCT03929159 253 262 O
of NCT03929159 263 265 O
sepsis NCT03929159 266 272 B-Condition-Name
by NCT03929159 273 275 O
the NCT03929159 276 279 O
emergency NCT03929159 280 289 B-Provider-Type
physician NCT03929159 290 299 B-Provider-Role
( NCT03929159 300 301 O
for NCT03929159 302 305 O
patients NCT03929159 306 314 O
in NCT03929159 315 317 O
emergency NCT03929159 318 327 B-Encounter-Type___Encounter-Type-Value:emergency
center NCT03929159 328 334 I-Encounter-Type___Encounter-Type-Value:emergency
) NCT03929159 335 336 O

- NCT03929159 340 341 O
Ability NCT03929159 343 350 O
to NCT03929159 351 353 O
give NCT03929159 354 358 O
informed NCT03929159 359 367 O
consent NCT03929159 368 375 O
. NCT03929159 376 377 O
If NCT03929159 379 381 O
the NCT03929159 382 385 O
patient NCT03929159 386 393 O
is NCT03929159 394 396 O
incapacitated NCT03929159 397 410 O
and NCT03929159 411 414 O
unable NCT03929159 415 421 O
to NCT03929159 422 424 O
give NCT03929159 425 429 O
informed NCT03929159 430 438 O
consent NCT03929159 439 446 O
, NCT03929159 447 448 O
the NCT03929159 449 452 O
next NCT03929159 453 457 O
- NCT03929159 458 459 O
of NCT03929159 460 462 O
- NCT03929159 463 464 O
kin NCT03929159 465 468 O
or NCT03929159 469 471 O
a NCT03929159 472 473 O
person NCT03929159 474 480 O
who NCT03929159 481 484 O
has NCT03929159 485 488 O
the NCT03929159 489 492 O
power NCT03929159 493 498 O
of NCT03929159 499 501 O
attorney NCT03929159 502 510 O
must NCT03929159 511 515 O
be NCT03929159 516 518 O
present NCT03929159 519 526 O
for NCT03929159 527 530 O
informed NCT03929159 531 539 O
consent NCT03929159 540 547 O
. NCT03929159 548 549 O

- NCT03929159 553 554 O
For NCT03929159 556 559 O
patients NCT03929159 560 568 O
in NCT03929159 569 571 O
the NCT03929159 572 575 O
emergency NCT03929159 576 585 B-Encounter-Type___Encounter-Type-Value:emergency
center NCT03929159 586 592 I-Encounter-Type___Encounter-Type-Value:emergency
only NCT03929159 593 597 O
, NCT03929159 598 599 O
two NCT03929159 600 603 B-Eq-Value
or NCT03929159 604 606 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03929159 607 611 I-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03929159 612 614 O
the NCT03929159 615 618 O
following NCT03929159 619 628 O
SIRS NCT03929159 629 633 B-Condition-Name
criteria NCT03929159 634 642 O
: NCT03929159 643 644 O

- NCT03929159 653 654 O
Leukocytes NCT03929159 656 666 B-Observation-Name___Observation-Type-Value:lab
> NCT03929159 667 668 B-Eq-Operator___Eq-Operator-Value:GT
12 NCT03929159 670 672 B-Eq-Value
, NCT03929159 673 674 I-Eq-Value
000 NCT03929159 675 678 I-Eq-Value
/ NCT03929159 679 680 O
mm^ NCT03929159 681 684 B-Eq-Unit
3 NCT03929159 685 686 I-Eq-Unit
or NCT03929159 687 689 O
< NCT03929159 690 691 B-Eq-Operator___Eq-Operator-Value:LT
4 NCT03929159 693 694 B-Eq-Value
, NCT03929159 695 696 I-Eq-Value
000 NCT03929159 697 700 I-Eq-Value
/ NCT03929159 701 702 O
mm^ NCT03929159 703 706 B-Eq-Unit
3 NCT03929159 707 708 I-Eq-Unit
or NCT03929159 709 711 O
> NCT03929159 712 713 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03929159 715 717 B-Eq-Value
% NCT03929159 718 719 B-Eq-Unit
immature NCT03929159 720 728 B-Observation-Name___Observation-Type-Value:lab
( NCT03929159 729 730 I-Observation-Name___Observation-Type-Value:lab
band NCT03929159 731 735 I-Observation-Name___Observation-Type-Value:lab
) NCT03929159 736 737 I-Observation-Name___Observation-Type-Value:lab
forms NCT03929159 738 743 I-Observation-Name___Observation-Type-Value:lab
, NCT03929159 744 745 O
provided NCT03929159 746 754 O
that NCT03929159 755 759 O
no NCT03929159 760 762 O
filgrastim NCT03929159 763 773 B-Drug-Name
or NCT03929159 774 776 O
pegfilgrastim NCT03929159 777 790 B-Drug-Name
was NCT03929159 791 794 O
administered NCT03929159 795 807 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
within NCT03929159 808 814 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03929159 816 818 B-Eq-Value
days NCT03929159 819 823 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
and NCT03929159 824 827 O
no NCT03929159 828 830 O
leukemia NCT03929159 831 839 B-Condition-Name

- NCT03929159 847 848 O
Heart NCT03929159 850 855 B-Observation-Name___Observation-Type-Value:vital
rate NCT03929159 856 860 I-Observation-Name___Observation-Type-Value:vital
> NCT03929159 861 862 B-Eq-Operator___Eq-Operator-Value:GT
90 NCT03929159 864 866 B-Eq-Value
beats NCT03929159 867 872 B-Eq-Unit
/ NCT03929159 873 874 O
minute NCT03929159 875 881 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
( NCT03929159 882 883 O
min NCT03929159 884 887 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
) NCT03929159 888 889 O

- NCT03929159 898 899 O
Respiratory NCT03929159 901 912 B-Observation-Name___Observation-Type-Value:vital
rate NCT03929159 913 917 I-Observation-Name___Observation-Type-Value:vital
> NCT03929159 918 919 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03929159 921 923 B-Eq-Value
breaths NCT03929159 924 931 B-Eq-Unit
/ NCT03929159 932 933 O
min NCT03929159 934 937 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
or NCT03929159 938 940 O
partial NCT03929159 941 948 B-Observation-Name___Observation-Type-Value:measurement
pressure NCT03929159 949 957 I-Observation-Name___Observation-Type-Value:measurement
of NCT03929159 958 960 I-Observation-Name___Observation-Type-Value:measurement
carbon NCT03929159 961 967 I-Observation-Name___Observation-Type-Value:measurement
dioxide NCT03929159 968 975 I-Observation-Name___Observation-Type-Value:measurement
( NCT03929159 976 977 O
CO NCT03929159 978 980 B-Observation-Name
2 NCT03929159 981 982 I-Observation-Name
) NCT03929159 983 984 O
< NCT03929159 985 986 B-Eq-Operator___Eq-Operator-Value:LT
32 NCT03929159 988 990 B-Eq-Value
mmHg NCT03929159 991 995 B-Eq-Unit

- NCT03929159 1003 1004 O
Oral NCT03929159 1006 1010 O
temperature NCT03929159 1011 1022 B-Observation-Name___Observation-Type-Value:vital
> NCT03929159 1023 1024 B-Eq-Operator___Eq-Operator-Value:GT
38 NCT03929159 1026 1028 B-Eq-Value
degrees NCT03929159 1029 1036 B-Eq-Unit
Celsius NCT03929159 1037 1044 I-Eq-Unit
( NCT03929159 1045 1046 O
C NCT03929159 1047 1048 B-Eq-Unit
) NCT03929159 1049 1050 O
or NCT03929159 1051 1053 O
< NCT03929159 1054 1055 B-Eq-Operator___Eq-Operator-Value:LT
36 NCT03929159 1057 1059 B-Eq-Value
degrees NCT03929159 1060 1067 B-Eq-Unit
C NCT03929159 1068 1069 I-Eq-Unit
or NCT03929159 1070 1072 O
axillary NCT03929159 1073 1081 O
temperature NCT03929159 1082 1093 B-Observation-Name___Observation-Type-Value:vital
> NCT03929159 1094 1095 B-Eq-Operator___Eq-Operator-Value:GT
37 NCT03929159 1097 1099 B-Eq-Value
degrees NCT03929159 1100 1107 B-Eq-Unit
C NCT03929159 1108 1109 I-Eq-Unit
or NCT03929159 1110 1112 O
< NCT03929159 1113 1114 B-Eq-Operator___Eq-Operator-Value:LT
35 NCT03929159 1116 1118 B-Eq-Value
degrees NCT03929159 1119 1126 B-Eq-Unit
C NCT03929159 1127 1128 I-Eq-Unit

Exclusion NCT03929159 1129 1138 O
Criteria NCT03929159 1139 1147 O
: NCT03929159 1148 1149 O

- NCT03929159 1153 1154 O
Inability NCT03929159 1156 1165 O
to NCT03929159 1166 1168 O
give NCT03929159 1169 1173 O
informed NCT03929159 1174 1182 O
consent NCT03929159 1183 1190 O
or NCT03929159 1191 1193 O
a NCT03929159 1194 1195 O
person NCT03929159 1196 1202 O
who NCT03929159 1203 1206 O
has NCT03929159 1207 1210 O
power NCT03929159 1211 1216 O
of NCT03929159 1217 1219 O
attorney NCT03929159 1220 1228 O
for NCT03929159 1229 1232 O
medical NCT03929159 1233 1240 O
decision NCT03929159 1241 1249 O
is NCT03929159 1250 1252 O
not NCT03929159 1253 1256 O
available NCT03929159 1257 1266 O

- NCT03929159 1269 1270 O
Being NCT03929159 1272 1277 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
moribund NCT03929159 1278 1286 B-Condition-Name
( NCT03929159 1287 1288 O
for NCT03929159 1289 1292 O
patients NCT03929159 1293 1301 O
in NCT03929159 1302 1304 O
emergency NCT03929159 1305 1314 B-Encounter-Type___Encounter-Type-Value:emergency
center NCT03929159 1315 1321 I-Encounter-Type___Encounter-Type-Value:emergency
) NCT03929159 1322 1323 O
or NCT03929159 1324 1326 O
cancellation NCT03929159 1327 1339 O
of NCT03929159 1340 1342 O
surgery NCT03929159 1343 1350 B-Procedure-Name
( NCT03929159 1351 1352 O
for NCT03929159 1353 1356 O
patients NCT03929159 1357 1365 O
in NCT03929159 1366 1368 O
POEM NCT03929159 1369 1373 B-Procedure-Name
) NCT03929159 1374 1375 O

- NCT03929159 1379 1380 O
Active NCT03929159 1382 1388 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
" NCT03929159 1389 1390 O
Do NCT03929159 1390 1392 B-Observation-Name
Not NCT03929159 1393 1396 I-Observation-Name
Resuscitate NCT03929159 1397 1408 I-Observation-Name
" NCT03929159 1408 1409 O
or NCT03929159 1410 1412 O
" NCT03929159 1413 1414 O
Do NCT03929159 1414 1416 B-Observation-Name
Not NCT03929159 1417 1420 I-Observation-Name
Intubate NCT03929159 1421 1429 I-Observation-Name
" NCT03929159 1429 1430 O
order NCT03929159 1431 1436 O


Inclusion NCT03928535 0 9 O
Criteria NCT03928535 10 18 O
: NCT03928535 19 20 O

- NCT03928535 24 25 O
Clinical NCT03928535 27 35 O
diagnosis NCT03928535 36 45 O
of NCT03928535 46 48 O
AECOPD NCT03928535 49 55 B-Condition-Name

- NCT03928535 58 59 O
Extubation NCT03928535 61 71 B-Procedure-Name
must NCT03928535 72 76 O
be NCT03928535 77 79 O
performed NCT03928535 80 89 O
after NCT03928535 90 95 O
48 NCT03928535 97 99 B-Eq-Value
hours NCT03928535 100 105 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03928535 106 108 O
invasive NCT03928535 109 117 O
ventilation NCT03928535 118 129 B-Procedure-Name

- NCT03928535 132 133 O
Must NCT03928535 135 139 O
be NCT03928535 140 142 O
treated NCT03928535 143 150 O
sequentially NCT03928535 151 163 O
with NCT03928535 164 168 O
HFNC NCT03928535 169 173 B-Procedure-Name
or NCT03928535 174 176 O
NIV NCT03928535 177 180 B-Procedure-Name
after NCT03928535 181 186 O
extubation NCT03928535 187 197 B-Procedure-Name

- NCT03928535 200 201 O
PaCO NCT03928535 203 207 B-Observation-Name___Observation-Type-Value:measurement
2 NCT03928535 208 209 I-Observation-Name___Observation-Type-Value:measurement
≥ NCT03928535 210 211 B-Eq-Operator___Eq-Operator-Value:GTEQ
50 NCT03928535 213 215 B-Eq-Value
mmHg NCT03928535 216 220 B-Eq-Unit
when NCT03928535 221 225 O
extubation NCT03928535 226 236 B-Procedure-Name

- NCT03928535 239 240 O
Positive NCT03928535 242 250 B-Observation-Name___Observation-Type-Value:measurement
End NCT03928535 251 254 I-Observation-Name___Observation-Type-Value:measurement
Expiratory NCT03928535 255 265 I-Observation-Name___Observation-Type-Value:measurement
Pressure NCT03928535 266 274 I-Observation-Name___Observation-Type-Value:measurement
( NCT03928535 275 276 O
PEEP NCT03928535 277 281 B-Observation-Name
) NCT03928535 282 283 O
≤ NCT03928535 284 285 B-Eq-Operator___Eq-Operator-Value:LTEQ
8 NCT03928535 287 288 B-Eq-Value
cmH NCT03928535 289 292 B-Eq-Unit
2O NCT03928535 293 295 I-Eq-Unit
( NCT03928535 296 297 O
1 NCT03928535 299 300 O
cmH NCT03928535 301 304 O
2O NCT03928535 305 307 O
= NCT03928535 308 309 O
0.098 NCT03928535 311 316 O
kPa NCT03928535 317 320 O
) NCT03928535 321 322 O
when NCT03928535 323 327 O
extubation NCT03928535 328 338 B-Procedure-Name

Exclusion NCT03928535 339 348 O
Criteria NCT03928535 349 357 O
: NCT03928535 358 359 O

- NCT03928535 363 364 O
Do NCT03928535 366 368 B-Observation-Name
- NCT03928535 369 370 I-Observation-Name
not NCT03928535 371 374 I-Observation-Name
- NCT03928535 375 376 I-Observation-Name
intubate NCT03928535 377 385 I-Observation-Name

- NCT03928535 388 389 O
Tracheostomies NCT03928535 391 405 B-Procedure-Name

- NCT03928535 408 409 O
Accidental NCT03928535 411 421 O
extubation NCT03928535 422 432 B-Procedure-Name

- NCT03928535 435 436 O
Self NCT03928535 438 442 O
- NCT03928535 443 444 O
extubation NCT03928535 445 455 B-Procedure-Name

Inclusion NCT03925987 0 9 O
Criteria NCT03925987 10 18 O
: NCT03925987 19 20 O

1 NCT03925987 25 26 O
. NCT03925987 26 27 O
DSM NCT03925987 29 32 O
- NCT03925987 33 34 O
V NCT03925987 35 36 O
diagnosis NCT03925987 37 46 O
of NCT03925987 47 49 O
an NCT03925987 50 52 O
Anxiety NCT03925987 53 60 B-Condition-Name
disorder NCT03925987 61 69 I-Condition-Name
( NCT03925987 70 71 O
Generalized NCT03925987 72 83 B-Condition-Name
Anxiety NCT03925987 84 91 I-Condition-Name
Disorder NCT03925987 92 100 I-Condition-Name
, NCT03925987 101 102 O
Social NCT03925987 103 109 B-Condition-Name
Anxiety NCT03925987 110 117 I-Condition-Name
Disorder NCT03925987 118 126 I-Condition-Name
, NCT03925987 127 128 O
Panic NCT03925987 129 134 B-Condition-Name
Disorder NCT03925987 135 143 I-Condition-Name
, NCT03925987 144 145 O
Agoraphobia NCT03925987 146 157 B-Condition-Name
) NCT03925987 158 159 O

2 NCT03925987 164 165 O
. NCT03925987 165 166 O
Anxiety NCT03925987 168 175 B-Observation-Name___Observation-Type-Value:clinical-score
Sensitivity NCT03925987 176 187 I-Observation-Name___Observation-Type-Value:clinical-score
Index NCT03925987 188 193 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03925987 194 195 O
ASI NCT03925987 196 199 B-Observation-Name
- NCT03925987 200 201 I-Observation-Name
3 NCT03925987 203 204 I-Observation-Name
) NCT03925987 205 206 O
total NCT03925987 207 212 B-Eq-Unit
score NCT03925987 213 218 I-Eq-Unit
> NCT03925987 219 220 B-Eq-Operator___Eq-Operator-Value:GT
29 NCT03925987 222 224 B-Eq-Value

3 NCT03925987 229 230 O
. NCT03925987 230 231 O
Overall NCT03925987 233 240 B-Observation-Name___Observation-Type-Value:clinical-score
Anxiety NCT03925987 241 248 I-Observation-Name___Observation-Type-Value:clinical-score
Severity NCT03925987 249 257 I-Observation-Name___Observation-Type-Value:clinical-score
and NCT03925987 258 261 I-Observation-Name___Observation-Type-Value:clinical-score
Impairment NCT03925987 262 272 I-Observation-Name___Observation-Type-Value:clinical-score
Scale NCT03925987 273 278 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03925987 279 280 O
OASIS NCT03925987 281 286 B-Observation-Name___Observation-Type-Value:clinical-score
) NCT03925987 287 288 O
score NCT03925987 289 294 B-Eq-Unit
> NCT03925987 295 296 B-Eq-Operator___Eq-Operator-Value:GT
8 NCT03925987 298 299 B-Eq-Value

4 NCT03925987 304 305 O
. NCT03925987 305 306 O
Between NCT03925987 308 315 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03925987 317 319 B-Eq-Value
- NCT03925987 320 321 O
55 NCT03925987 323 325 B-Eq-Value
years NCT03925987 326 331 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03925987 332 334 O
age NCT03925987 335 338 O

5 NCT03925987 342 343 O
. NCT03925987 343 344 O
Subject NCT03925987 346 353 O
must NCT03925987 354 358 O
be NCT03925987 359 361 O
" NCT03925987 362 363 O
treatment NCT03925987 363 372 O
- NCT03925987 373 374 O
seeking NCT03925987 375 382 O
" NCT03925987 382 383 O
and NCT03925987 384 387 O
willing NCT03925987 388 395 O
to NCT03925987 396 398 O
enroll NCT03925987 399 405 O
in NCT03925987 406 408 O
the NCT03925987 409 412 O
10 NCT03925987 414 416 B-Eq-Value
- NCT03925987 417 418 O
week NCT03925987 419 423 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
group NCT03925987 424 429 O
- NCT03925987 430 431 O
based NCT03925987 432 437 O
Exposure NCT03925987 438 446 B-Procedure-Name
Therapy NCT03925987 447 454 I-Procedure-Name

Exclusion NCT03925987 455 464 O
Criteria NCT03925987 465 473 O
: NCT03925987 474 475 O

1 NCT03925987 480 481 O
. NCT03925987 481 482 O
Comorbid NCT03925987 484 492 O
Bipolar NCT03925987 493 500 B-Condition-Name
Disorder NCT03925987 501 509 I-Condition-Name
, NCT03925987 510 511 O
Schizophrenia NCT03925987 512 525 B-Condition-Name
, NCT03925987 526 527 O
Anorexia NCT03925987 528 536 B-Condition-Name
or NCT03925987 537 539 O
Bulimia NCT03925987 540 547 B-Condition-Name
Nervosa NCT03925987 548 555 I-Condition-Name
, NCT03925987 556 557 O
or NCT03925987 558 560 O
Obsessive NCT03925987 561 570 B-Condition-Name
- NCT03925987 571 572 I-Condition-Name
Compulsive NCT03925987 573 583 I-Condition-Name
Disorder NCT03925987 584 592 I-Condition-Name

2 NCT03925987 596 597 O
. NCT03925987 597 598 O
Current NCT03925987 600 607 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
Substance NCT03925987 608 617 B-Condition-Name
Use NCT03925987 618 621 I-Condition-Name
Disorder NCT03925987 622 630 I-Condition-Name
> NCT03925987 631 632 B-Eq-Operator___Eq-Operator-Value:GT
moderate NCT03925987 633 641 B-Severity___Severity-Value:moderate
( NCT03925987 642 643 O
within NCT03925987 644 650 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
the NCT03925987 651 654 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
past NCT03925987 655 659 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03925987 661 662 B-Eq-Value
months NCT03925987 663 669 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
) NCT03925987 670 671 O

3 NCT03925987 676 677 O
. NCT03925987 677 678 O
Currently NCT03925987 680 689 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
taking NCT03925987 690 696 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
a NCT03925987 697 698 O
psychotropic NCT03925987 699 711 B-Drug-Name
medication NCT03925987 712 722 I-Drug-Name

4 NCT03925987 726 727 O
. NCT03925987 727 728 O
Currently NCT03925987 730 739 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
receiving NCT03925987 740 749 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
psychotherapy NCT03925987 750 763 B-Procedure-Name
/ NCT03925987 764 765 O
counseling NCT03925987 766 776 B-Procedure-Name
for NCT03925987 777 780 O
anxiety NCT03925987 781 788 B-Condition-Name

5 NCT03925987 792 793 O
. NCT03925987 793 794 O
Currently NCT03925987 796 805 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
being NCT03925987 806 811 O
treated NCT03925987 812 819 O
as NCT03925987 820 822 O
an NCT03925987 823 825 O
inpatient NCT03925987 826 835 B-Encounter-Type___Encounter-Type-Value:inpatient

6 NCT03925987 839 840 O
. NCT03925987 840 841 O
Active NCT03925987 843 849 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
suicidal NCT03925987 850 858 B-Condition-Name
ideation NCT03925987 859 867 I-Condition-Name
with NCT03925987 868 872 O
intent NCT03925987 873 879 O
or NCT03925987 880 882 O
plan NCT03925987 883 887 O

7 NCT03925987 891 892 O
. NCT03925987 892 893 O
History NCT03925987 895 902 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925987 903 905 O
neurological NCT03925987 906 918 O
, NCT03925987 919 920 O
cardiovascular NCT03925987 921 935 O
or NCT03925987 936 938 O
respiratory NCT03925987 939 950 O
problems NCT03925987 951 959 B-Condition-Name
( NCT03925987 960 961 O
e NCT03925987 962 963 O
. NCT03925987 964 965 O
g NCT03925987 966 967 O
. NCT03925987 968 969 O
, NCT03925987 970 971 O
asthma NCT03925987 972 978 B-Condition-Name
, NCT03925987 979 980 O
severe NCT03925987 981 987 B-Severity___Severity-Value:severe
brain NCT03925987 988 993 O
injury NCT03925987 994 1000 B-Condition-Name
) NCT03925987 1001 1002 O

Inclusion NCT03928509 0 9 O
criteria NCT03928509 10 18 O
: NCT03928509 19 20 O

- NCT03928509 24 25 O
Participants NCT03928509 27 39 O
will NCT03928509 40 44 O
have NCT03928509 45 49 O
been NCT03928509 50 54 O
previously NCT03928509 55 65 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
joined NCT03928509 66 72 O
for NCT03928509 73 76 O
a NCT03928509 77 78 O
public NCT03928509 79 85 O
health NCT03928509 86 92 O
survey NCT03928509 93 99 O
and NCT03928509 100 103 O
have NCT03928509 104 108 O
agreed NCT03928509 109 115 O
to NCT03928509 116 118 O
be NCT03928509 119 121 O
contacted NCT03928509 122 131 O
again NCT03928509 132 137 O
for NCT03928509 138 141 O
this NCT03928509 142 146 O
study NCT03928509 147 152 O
; NCT03928509 153 154 O

- NCT03928509 157 158 O
Age NCT03928509 160 163 O
: NCT03928509 164 165 O
18 NCT03928509 167 169 B-Eq-Value
years NCT03928509 170 175 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03928509 176 178 B-Eq-Operator___Eq-Operator-Value:GTEQ
over NCT03928509 179 183 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03928509 184 185 O

- NCT03928509 189 190 O
Place NCT03928509 192 197 O
of NCT03928509 198 200 O
residence NCT03928509 201 210 O
: NCT03928509 211 212 O
Sherbrooke NCT03928509 213 223 B-Location___Location-Value:residence
, NCT03928509 224 225 O
Moncton NCT03928509 226 233 B-Location___Location-Value:residence
or NCT03928509 234 236 O
Saguenay NCT03928509 237 245 B-Location___Location-Value:residence
- NCT03928509 246 247 I-Location___Location-Value:residence
Lac NCT03928509 248 251 I-Location___Location-Value:residence
- NCT03928509 252 253 I-Location___Location-Value:residence
St NCT03928509 254 256 I-Location___Location-Value:residence
- NCT03928509 257 258 I-Location___Location-Value:residence
Jean NCT03928509 259 263 I-Location___Location-Value:residence
. NCT03928509 264 265 O

Inclusion NCT03924778 0 9 O
Criteria NCT03924778 10 18 O
: NCT03924778 19 20 O

- NCT03924778 24 25 O
female NCT03924778 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03924778 36 37 O
non NCT03924778 39 42 O
- NCT03924778 43 44 O
Hispanic NCT03924778 45 53 B-Ethnicity
, NCT03924778 54 55 O
black NCT03924778 56 61 B-Ethnicity
or NCT03924778 62 64 O
white NCT03924778 65 70 B-Ethnicity

- NCT03924778 73 74 O
age NCT03924778 76 79 O
19 NCT03924778 81 83 B-Eq-Value
- NCT03924778 84 85 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03924778 87 89 B-Eq-Value
years NCT03924778 90 95 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03924778 98 99 O
BMI NCT03924778 101 104 B-Observation-Name___Observation-Type-Value:vital
> NCT03924778 105 106 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03924778 108 109 I-Eq-Operator___Eq-Operator-Value:GTEQ
30 NCT03924778 111 113 B-Eq-Value
kg NCT03924778 114 116 B-Eq-Unit
/ NCT03924778 117 118 O
m^ NCT03924778 119 121 B-Eq-Unit
2 NCT03924778 122 123 I-Eq-Unit

- NCT03924778 127 128 O
able NCT03924778 130 134 O
to NCT03924778 135 137 O
visit NCT03924778 138 143 O
Bionutrition NCT03924778 144 156 B-Location___Location-Value:unit
Unit NCT03924778 157 161 I-Location___Location-Value:unit
daily NCT03924778 162 167 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

Exclusion NCT03924778 168 177 O
Criteria NCT03924778 178 186 O
: NCT03924778 187 188 O

- NCT03924778 192 193 O
gastrointestinal NCT03924778 195 211 O
( NCT03924778 212 213 O
GI NCT03924778 214 216 B-Condition-Name
) NCT03924778 217 218 O
conditions NCT03924778 219 229 O
i NCT03924778 230 231 O
. NCT03924778 232 233 O
e NCT03924778 234 235 O
. NCT03924778 236 237 O
, NCT03924778 238 239 O
irritable NCT03924778 240 249 B-Condition-Name
bowel NCT03924778 250 255 I-Condition-Name
, NCT03924778 256 257 O
diverticulitis NCT03924778 258 272 B-Condition-Name
, NCT03924778 273 274 O
peptic NCT03924778 275 281 B-Condition-Name
ulcers NCT03924778 282 288 I-Condition-Name
, NCT03924778 289 290 O
Crohn NCT03924778 291 296 B-Condition-Name
's NCT03924778 296 298 I-Condition-Name
, NCT03924778 299 300 O
GI NCT03924778 301 303 O
cancers NCT03924778 304 311 B-Condition-Name
, NCT03924778 312 313 O
and NCT03924778 314 317 O
adenatomous NCT03924778 318 329 B-Condition-Name
polyps NCT03924778 330 336 I-Condition-Name

- NCT03924778 339 340 O
antibiotic NCT03924778 342 352 B-Drug-Name
or NCT03924778 353 355 O
probiotic NCT03924778 356 365 B-Drug-Name
use NCT03924778 366 369 O
in NCT03924778 370 372 O
the NCT03924778 373 376 O
previous NCT03924778 377 385 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
90 NCT03924778 387 389 B-Eq-Value
days NCT03924778 390 394 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03924778 397 398 O
tobacco NCT03924778 400 407 B-Condition-Name
use NCT03924778 408 411 I-Condition-Name

- NCT03924778 414 415 O
heavy NCT03924778 417 422 B-Severity___Severity-Value:severe
alcohol NCT03924778 423 430 B-Condition-Name
consumption NCT03924778 431 442 I-Condition-Name

- NCT03924778 445 446 O
major NCT03924778 448 453 O
medical NCT03924778 454 461 O
conditions NCT03924778 462 472 O
( NCT03924778 473 474 O
e NCT03924778 475 476 O
. NCT03924778 477 478 O
g NCT03924778 479 480 O
. NCT03924778 481 482 O
, NCT03924778 483 484 O
renal NCT03924778 485 490 B-Condition-Name
disease NCT03924778 491 498 I-Condition-Name
, NCT03924778 499 500 O
diabetes NCT03924778 501 509 B-Condition-Name
, NCT03924778 510 511 O
cancer NCT03924778 512 518 B-Condition-Name
) NCT03924778 519 520 O

Inclusion NCT03922321 0 9 O
Criteria NCT03922321 10 18 O
: NCT03922321 19 20 O

1 NCT03922321 25 26 O
. NCT03922321 26 27 O
Male NCT03922321 29 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03922321 34 36 O
female NCT03922321 37 43 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
≥ NCT03922321 44 45 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03922321 47 49 B-Eq-Value
years NCT03922321 50 55 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03922321 56 58 O
age NCT03922321 59 62 O
. NCT03922321 63 64 O

2 NCT03922321 69 70 O
. NCT03922321 70 71 O
Clinical NCT03922321 73 81 O
diagnosis NCT03922321 82 91 O
of NCT03922321 92 94 O
Graves NCT03922321 95 101 B-Condition-Name
' NCT03922321 101 102 I-Condition-Name
disease NCT03922321 103 110 I-Condition-Name
with NCT03922321 111 115 O
hyperthyroidism NCT03922321 116 131 B-Condition-Name
associated NCT03922321 132 142 O
with NCT03922321 143 147 O
active NCT03922321 148 154 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
, NCT03922321 155 156 O
moderate NCT03922321 157 165 B-Severity___Severity-Value:moderate
to NCT03922321 166 168 O
severe NCT03922321 169 175 B-Severity___Severity-Value:severe
GO NCT03922321 176 178 B-Condition-Name
with NCT03922321 179 183 O
a NCT03922321 184 185 O
Clinical NCT03922321 186 194 B-Observation-Name___Observation-Type-Value:clinical-score
Activity NCT03922321 195 203 I-Observation-Name___Observation-Type-Value:clinical-score
Score NCT03922321 204 209 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03922321 210 211 O
CAS NCT03922321 212 215 B-Observation-Name
) NCT03922321 216 217 O
≥ NCT03922321 218 219 B-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03922321 221 222 B-Eq-Value
for NCT03922321 223 226 O
the NCT03922321 227 230 O
most NCT03922321 231 235 O
severely NCT03922321 236 244 B-Severity___Severity-Value:severe
affected NCT03922321 245 253 O
eye NCT03922321 254 257 O
at NCT03922321 258 260 O
Screening NCT03922321 261 270 O
( NCT03922321 271 272 O
on NCT03922321 273 275 O
the NCT03922321 276 279 O
7 NCT03922321 281 282 O
- NCT03922321 283 284 O
item NCT03922321 285 289 O
scale NCT03922321 290 295 O
) NCT03922321 296 297 O
and NCT03922321 298 301 O
Baseline NCT03922321 302 310 O
( NCT03922321 311 312 O
on NCT03922321 313 315 O
the NCT03922321 316 319 O
10 NCT03922321 321 323 O
- NCT03922321 324 325 O
item NCT03922321 326 330 O
scale NCT03922321 331 336 O
) NCT03922321 337 338 O
. NCT03922321 340 341 O

3 NCT03922321 346 347 O
. NCT03922321 347 348 O
Onset NCT03922321 350 355 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03922321 356 358 O
active NCT03922321 359 365 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
GO NCT03922321 366 368 B-Condition-Name
within NCT03922321 369 375 B-Eq-Operator___Eq-Operator-Value:LTEQ
9 NCT03922321 377 378 B-Eq-Value
months NCT03922321 379 385 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03922321 386 388 O
screening NCT03922321 389 398 O
. NCT03922321 399 400 O

4 NCT03922321 405 406 O
. NCT03922321 406 407 O
Moderate NCT03922321 409 417 B-Severity___Severity-Value:severe
- NCT03922321 418 419 O
to NCT03922321 420 422 O
- NCT03922321 423 424 O
severe NCT03922321 425 431 B-Severity___Severity-Value:severe
active NCT03922321 432 438 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
GO NCT03922321 439 441 B-Condition-Name
( NCT03922321 442 443 O
not NCT03922321 444 447 O
sight NCT03922321 448 453 B-Condition-Name
- NCT03922321 454 455 I-Condition-Name
threatening NCT03922321 456 467 I-Condition-Name
but NCT03922321 468 471 O
has NCT03922321 472 475 O
an NCT03922321 476 478 O
appreciable NCT03922321 479 490 O
impact NCT03922321 491 497 B-Stability___Stability-Value:change
on NCT03922321 498 500 O
daily NCT03922321 501 506 B-Observation-Name
life NCT03922321 507 511 I-Observation-Name
) NCT03922321 512 513 O
, NCT03922321 515 516 O
usually NCT03922321 517 524 O
associated NCT03922321 525 535 O
with NCT03922321 536 540 O
one NCT03922321 541 544 O
or NCT03922321 545 547 O
more NCT03922321 548 552 O
of NCT03922321 553 555 O
the NCT03922321 556 559 O
following NCT03922321 560 569 O
: NCT03922321 570 571 O
lid NCT03922321 572 575 B-Observation-Name___Observation-Type-Value:measurement
retraction NCT03922321 576 586 I-Observation-Name___Observation-Type-Value:measurement
≥ NCT03922321 587 588 B-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03922321 590 591 B-Eq-Value
mm NCT03922321 592 594 B-Eq-Unit
, NCT03922321 595 596 O
moderate NCT03922321 597 605 B-Severity___Severity-Value:moderate
or NCT03922321 606 608 O
severe NCT03922321 609 615 B-Severity___Severity-Value:severe
soft NCT03922321 616 620 B-Condition-Name
tissue NCT03922321 621 627 I-Condition-Name
involvement NCT03922321 628 639 I-Condition-Name
, NCT03922321 640 641 O
proptosis NCT03922321 642 651 B-Observation-Name
≥ NCT03922321 652 653 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03922321 655 656 B-Eq-Value
mm NCT03922321 657 659 B-Eq-Unit
above NCT03922321 660 665 B-Eq-Unit___Eq-Unit-Value:ref-range-high
normal NCT03922321 666 672 I-Eq-Unit___Eq-Unit-Value:ref-range-high
for NCT03922321 673 676 O
race NCT03922321 677 681 O
and NCT03922321 682 685 O
gender NCT03922321 686 692 O
, NCT03922321 693 694 O
and NCT03922321 695 698 O
/ NCT03922321 699 700 O
or NCT03922321 701 703 O
inconstant NCT03922321 704 714 O
or NCT03922321 715 717 O
constant NCT03922321 718 726 O
diplopia NCT03922321 727 735 B-Condition-Name
. NCT03922321 736 737 O

5 NCT03922321 742 743 O
. NCT03922321 743 744 O
Other NCT03922321 746 751 O
, NCT03922321 752 753 O
more NCT03922321 754 758 O
specific NCT03922321 759 767 O
inclusion NCT03922321 768 777 O
criteria NCT03922321 778 786 O
are NCT03922321 787 790 O
defined NCT03922321 791 798 O
in NCT03922321 799 801 O
the NCT03922321 802 805 O
protocol NCT03922321 806 814 O

Exclusion NCT03922321 815 824 O
Criteria NCT03922321 825 833 O
: NCT03922321 834 835 O

1 NCT03922321 840 841 O
. NCT03922321 841 842 O
Use NCT03922321 844 847 O
of NCT03922321 848 850 O
any NCT03922321 851 854 O
steroid NCT03922321 855 862 B-Drug-Name
( NCT03922321 863 864 O
intravenous NCT03922321 865 876 O
[ NCT03922321 877 878 O
IV NCT03922321 879 881 O
] NCT03922321 882 883 O
or NCT03922321 884 886 O
oral NCT03922321 887 891 O
) NCT03922321 892 893 O
with NCT03922321 894 898 O
a NCT03922321 899 900 O
cumulative NCT03922321 901 911 O
dose NCT03922321 912 916 O
equivalent NCT03922321 917 927 O
to NCT03922321 928 930 O
≥ NCT03922321 931 932 B-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03922321 934 935 B-Eq-Value
g NCT03922321 936 937 B-Eq-Unit
of NCT03922321 938 940 O
methylprednisolone NCT03922321 941 959 B-Drug-Name
for NCT03922321 960 963 O
the NCT03922321 964 967 O
treatment NCT03922321 968 977 O
of NCT03922321 978 980 O
GO NCT03922321 981 983 B-Condition-Name
within NCT03922321 984 990 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03922321 992 993 B-Eq-Value
weeks NCT03922321 994 999 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03922321 1000 1005 O
to NCT03922321 1006 1008 O
Screening NCT03922321 1009 1018 O
. NCT03922321 1019 1020 O

2 NCT03922321 1025 1026 O
. NCT03922321 1026 1027 O
Use NCT03922321 1029 1032 O
of NCT03922321 1033 1035 O
rituximab NCT03922321 1036 1045 B-Drug-Name
, NCT03922321 1046 1047 O
tocilizumab NCT03922321 1048 1059 B-Drug-Name
, NCT03922321 1060 1061 O
or NCT03922321 1062 1064 O
any NCT03922321 1065 1068 O
monoclonal NCT03922321 1069 1079 B-Drug-Name
antibody NCT03922321 1080 1088 I-Drug-Name
for NCT03922321 1089 1092 O
immunomodulation NCT03922321 1093 1109 B-Condition-Name
within NCT03922321 1110 1116 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03922321 1117 1120 I-Eq-Operator___Eq-Operator-Value:LTEQ
past NCT03922321 1121 1125 I-Eq-Operator___Eq-Operator-Value:LTEQ
9 NCT03922321 1127 1128 B-Eq-Value
months NCT03922321 1129 1135 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03922321 1136 1141 O
to NCT03922321 1142 1144 O
Baseline NCT03922321 1145 1153 O
. NCT03922321 1154 1155 O

3 NCT03922321 1160 1161 O
. NCT03922321 1161 1162 O
Total NCT03922321 1164 1169 B-Observation-Name___Observation-Type-Value:lab
IgG NCT03922321 1170 1173 I-Observation-Name___Observation-Type-Value:lab
level NCT03922321 1174 1179 I-Observation-Name___Observation-Type-Value:lab
< NCT03922321 1180 1181 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03922321 1183 1184 B-Eq-Value
g NCT03922321 1185 1186 B-Eq-Unit
/ NCT03922321 1187 1188 O
L NCT03922321 1189 1190 B-Eq-Unit
at NCT03922321 1191 1193 O
Screening NCT03922321 1194 1203 O
. NCT03922321 1204 1205 O

4 NCT03922321 1210 1211 O
. NCT03922321 1211 1212 O
Absolute NCT03922321 1214 1222 B-Observation-Name___Observation-Type-Value:lab
neutrophil NCT03922321 1223 1233 I-Observation-Name___Observation-Type-Value:lab
count NCT03922321 1234 1239 I-Observation-Name___Observation-Type-Value:lab
< NCT03922321 1240 1241 B-Eq-Operator___Eq-Operator-Value:LT
1500 NCT03922321 1243 1247 B-Eq-Value
cells NCT03922321 1248 1253 B-Eq-Unit
/ NCT03922321 1254 1255 O
mm NCT03922321 1256 1258 B-Eq-Unit
3 NCT03922321 1259 1260 I-Eq-Unit
at NCT03922321 1261 1263 O
Screening NCT03922321 1264 1273 O
. NCT03922321 1274 1275 O

5 NCT03922321 1280 1281 O
. NCT03922321 1281 1282 O
Participants NCT03922321 1284 1296 O
with NCT03922321 1297 1301 O
decreased NCT03922321 1302 1311 B-Polarity___Polarity-Value:low
best NCT03922321 1312 1316 B-Condition-Name
corrected NCT03922321 1317 1326 I-Condition-Name
visual NCT03922321 1327 1333 I-Condition-Name
acuity NCT03922321 1334 1340 I-Condition-Name
due NCT03922321 1341 1344 O
to NCT03922321 1345 1347 O
optic NCT03922321 1348 1353 B-Condition-Name
neuropathy NCT03922321 1354 1364 I-Condition-Name
as NCT03922321 1365 1367 O
defined NCT03922321 1368 1375 O
by NCT03922321 1376 1378 O
a NCT03922321 1379 1380 O
decrease NCT03922321 1381 1389 B-Observation-Name___Observation-Type-Value:measurement
in NCT03922321 1390 1392 I-Observation-Name___Observation-Type-Value:measurement
vision NCT03922321 1393 1399 I-Observation-Name___Observation-Type-Value:measurement
of NCT03922321 1400 1402 O
2 NCT03922321 1404 1405 B-Eq-Value
lines NCT03922321 1406 1411 B-Eq-Unit
on NCT03922321 1412 1414 O
the NCT03922321 1415 1418 O
Snellen NCT03922321 1419 1426 O
chart NCT03922321 1427 1432 O
, NCT03922321 1433 1434 O
new NCT03922321 1435 1438 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
visual NCT03922321 1439 1445 B-Condition-Name
field NCT03922321 1446 1451 I-Condition-Name
defect NCT03922321 1452 1458 I-Condition-Name
, NCT03922321 1459 1460 O
or NCT03922321 1461 1463 O
color NCT03922321 1464 1469 B-Condition-Name
defect NCT03922321 1470 1476 I-Condition-Name
secondary NCT03922321 1477 1486 O
to NCT03922321 1487 1489 O
optic NCT03922321 1490 1495 B-Condition-Name
nerve NCT03922321 1496 1501 I-Condition-Name
involvement NCT03922321 1502 1513 O
within NCT03922321 1514 1520 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03922321 1521 1524 O
last NCT03922321 1525 1529 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03922321 1531 1532 B-Eq-Value
months NCT03922321 1533 1539 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
at NCT03922321 1540 1542 O
Screening NCT03922321 1543 1552 O
. NCT03922321 1553 1554 O

6 NCT03922321 1559 1560 O
. NCT03922321 1560 1561 O
Previous NCT03922321 1563 1571 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
orbital NCT03922321 1572 1579 B-Procedure-Name
irradiation NCT03922321 1580 1591 I-Procedure-Name
or NCT03922321 1592 1594 O
surgery NCT03922321 1595 1602 B-Procedure-Name
for NCT03922321 1603 1606 O
GO NCT03922321 1607 1609 B-Condition-Name
. NCT03922321 1610 1611 O

7 NCT03922321 1616 1617 O
. NCT03922321 1617 1618 O
Other NCT03922321 1620 1625 O
, NCT03922321 1626 1627 O
more NCT03922321 1628 1632 O
specific NCT03922321 1633 1641 O
exclusion NCT03922321 1642 1651 O
criteria NCT03922321 1652 1660 O
are NCT03922321 1661 1664 O
defined NCT03922321 1665 1672 O
in NCT03922321 1673 1675 O
the NCT03922321 1676 1679 O
protocol NCT03922321 1680 1688 O

Inclusion NCT03926806 0 9 O
Criteria NCT03926806 10 18 O
: NCT03926806 19 20 O

- NCT03926806 24 25 O
BMI NCT03926806 27 30 B-Observation-Name___Observation-Type-Value:vital
27 NCT03926806 32 34 B-Eq-Value
- NCT03926806 35 36 B-Eq-Operator___Eq-Operator-Value:BETWEEN
36 NCT03926806 38 40 B-Eq-Value

- NCT03926806 44 45 O
HbA NCT03926806 47 50 B-Observation-Name___Observation-Type-Value:lab
1C NCT03926806 51 53 I-Observation-Name___Observation-Type-Value:lab
< NCT03926806 54 55 B-Eq-Operator___Eq-Operator-Value:LT
8.5 NCT03926806 57 60 B-Eq-Value
% NCT03926806 61 62 B-Eq-Unit

- NCT03926806 66 67 O
Constant NCT03926806 69 77 B-Stability___Stability-Value:stable
body NCT03926806 78 82 B-Observation-Name___Observation-Type-Value:vital
weight NCT03926806 83 89 I-Observation-Name___Observation-Type-Value:vital
and NCT03926806 90 93 O
dietary NCT03926806 94 101 B-Observation-Name___Observation-Type-Value:social-habit
habits NCT03926806 102 108 I-Observation-Name___Observation-Type-Value:social-habit
for NCT03926806 109 112 O
the NCT03926806 113 116 O
last NCT03926806 117 121 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03926806 123 124 B-Eq-Value
months NCT03926806 125 131 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03926806 134 135 O
Stable NCT03926806 137 143 B-Stability___Stability-Value:stable
dose NCT03926806 144 148 O
of NCT03926806 149 151 O
oral NCT03926806 152 156 B-Drug-Name
medication NCT03926806 157 167 I-Drug-Name
for NCT03926806 168 171 O
at NCT03926806 172 174 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926806 175 180 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03926806 182 183 B-Eq-Value
months NCT03926806 184 190 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03926806 193 194 O
Diagnosed NCT03926806 196 205 O
with NCT03926806 206 210 O
T NCT03926806 211 212 B-Condition-Name
2DM NCT03926806 213 216 I-Condition-Name
for NCT03926806 217 220 O
more NCT03926806 221 225 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03926806 226 230 I-Eq-Operator___Eq-Operator-Value:GT
1 NCT03926806 232 233 B-Eq-Value
year NCT03926806 234 238 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03926806 239 248 O
Criteria NCT03926806 249 257 O
: NCT03926806 258 259 O

- NCT03926806 263 264 O
History NCT03926806 266 273 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926806 274 276 O
cardiovascular NCT03926806 277 291 O
, NCT03926806 292 293 O
gastrointestinal NCT03926806 294 310 O
, NCT03926806 311 312 O
renal NCT03926806 313 318 O
and NCT03926806 319 322 O
endocrinological NCT03926806 323 339 O
diseases NCT03926806 340 348 B-Condition-Name

- NCT03926806 351 352 O
Treatment NCT03926806 354 363 O
for NCT03926806 364 367 O
weight NCT03926806 368 374 B-Condition-Name
reduction NCT03926806 375 384 I-Condition-Name

- NCT03926806 387 388 O
Lactose NCT03926806 390 397 B-Condition-Name
intolerance NCT03926806 398 409 I-Condition-Name

- NCT03926806 412 413 O
Allergies NCT03926806 415 424 O
to NCT03926806 425 427 O
milk NCT03926806 428 432 B-Allergy-Name
and NCT03926806 433 436 O
dairy NCT03926806 437 442 B-Allergy-Name
products NCT03926806 443 451 O

- NCT03926806 454 455 O
Alcohol NCT03926806 457 464 B-Observation-Name___Observation-Type-Value:social-habit
consumption NCT03926806 465 476 I-Observation-Name___Observation-Type-Value:social-habit
( NCT03926806 477 478 O
> NCT03926806 480 481 B-Eq-Operator___Eq-Operator-Value:GT
2 NCT03926806 483 484 B-Eq-Value
drinks NCT03926806 485 491 B-Eq-Unit
per NCT03926806 492 495 O
day NCT03926806 496 499 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03926806 500 501 O

- NCT03926806 505 506 O
Intake NCT03926806 508 514 O
of NCT03926806 515 517 O
supplements NCT03926806 518 529 B-Drug-Name

- NCT03926806 532 533 O
Receiving NCT03926806 535 544 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
insulin NCT03926806 545 552 B-Drug-Name

Inclusion NCT03921827 0 9 O
Criteria NCT03921827 10 18 O
: NCT03921827 19 20 O

1 NCT03921827 25 26 O
. NCT03921827 26 27 O
Patients NCT03921827 29 37 O
with NCT03921827 38 42 O
recent NCT03921827 43 49 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
stroke NCT03921827 50 56 B-Condition-Name
/ NCT03921827 57 58 O
TIA NCT03921827 59 62 B-Condition-Name
and NCT03921827 63 66 O
severe NCT03921827 67 73 B-Severity___Severity-Value:severe
stenosis NCT03921827 74 82 B-Condition-Name
of NCT03921827 83 85 I-Condition-Name
intracranial NCT03921827 86 98 I-Condition-Name
ICA NCT03921827 99 102 O
or NCT03921827 103 105 O
MCA NCT03921827 106 109 O
and NCT03921827 110 113 O
impaired NCT03921827 114 122 B-Condition-Name
CVR NCT03921827 123 126 I-Condition-Name
within NCT03921827 127 133 B-Eq-Operator___Eq-Operator-Value:LTEQ
previous NCT03921827 134 142 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03921827 143 148 B-Eq-Value
months NCT03921827 149 155 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
but NCT03921827 156 159 O
not NCT03921827 160 163 O
before NCT03921827 164 170 O
3 NCT03921827 172 173 B-Eq-Value
weeks NCT03921827 174 179 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03921827 180 185 O
acute NCT03921827 186 191 B-Severity___Severity-Value:severe
stroke NCT03921827 192 198 B-Condition-Name
. NCT03921827 199 200 O
This NCT03921827 202 206 O
is NCT03921827 207 209 O
to NCT03921827 210 212 O
differentiate NCT03921827 213 226 O
between NCT03921827 227 234 O
patients NCT03921827 235 243 O
with NCT03921827 244 248 O
a NCT03921827 249 250 O
long NCT03921827 251 255 B-Condition-Name
- NCT03921827 256 257 I-Condition-Name
standing NCT03921827 258 266 I-Condition-Name
fixed NCT03921827 267 272 I-Condition-Name
- NCT03921827 273 274 I-Condition-Name
stenosis NCT03921827 275 283 I-Condition-Name
from NCT03921827 284 288 O
patients NCT03921827 289 297 O
with NCT03921827 298 302 O
partially NCT03921827 303 312 B-Condition-Name
recanalized NCT03921827 313 324 I-Condition-Name
intracranial NCT03921827 325 337 I-Condition-Name
artery NCT03921827 338 344 I-Condition-Name
( NCT03921827 345 346 O
masquerading NCT03921827 347 359 O
as NCT03921827 360 362 O
severe NCT03921827 363 369 B-Severity___Severity-Value:severe
stenosis NCT03921827 370 378 B-Condition-Name
) NCT03921827 379 380 O
. NCT03921827 382 383 O

2 NCT03921827 388 389 O
. NCT03921827 389 390 O
Age NCT03921827 392 395 O
> NCT03921827 396 397 B-Eq-Operator___Eq-Operator-Value:GT
21 NCT03921827 399 401 B-Eq-Value
years NCT03921827 402 407 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

Exclusion NCT03921827 408 417 O
Criteria NCT03921827 418 426 O
: NCT03921827 427 428 O

1 NCT03921827 433 434 O
. NCT03921827 434 435 O
Patients NCT03921827 437 445 O
with NCT03921827 446 450 O
atrial NCT03921827 451 457 B-Condition-Name
fibrillation NCT03921827 458 470 I-Condition-Name
/ NCT03921827 471 472 O
arrhythmias NCT03921827 473 484 B-Condition-Name
. NCT03921827 485 486 O

2 NCT03921827 491 492 O
. NCT03921827 492 493 O
Within NCT03921827 495 501 B-Eq-Operator___Eq-Operator-Value:LTEQ
2 NCT03921827 503 504 B-Eq-Value
weeks NCT03921827 505 510 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03921827 511 513 O
cardiac NCT03921827 514 521 B-Procedure-Name
catheterization NCT03921827 522 537 I-Procedure-Name
or NCT03921827 538 540 O
arterial NCT03921827 541 549 B-Procedure-Name
puncture NCT03921827 550 558 I-Procedure-Name
at NCT03921827 559 561 O
femoral NCT03921827 562 569 O
puncture NCT03921827 570 578 O
site NCT03921827 579 583 O
. NCT03921827 584 585 O

3 NCT03921827 590 591 O
. NCT03921827 591 592 O
Decompensated NCT03921827 594 607 O
heart NCT03921827 608 613 B-Condition-Name
failure NCT03921827 614 621 I-Condition-Name
, NCT03921827 622 623 O
usually NCT03921827 624 631 O
class NCT03921827 632 637 O
3 NCT03921827 639 640 B-Eq-Value
or NCT03921827 641 643 O
4 NCT03921827 645 646 B-Eq-Value

4 NCT03921827 651 652 O
. NCT03921827 652 653 O
LV NCT03921827 655 657 B-Observation-Name___Observation-Type-Value:measurement
EF NCT03921827 658 660 I-Observation-Name___Observation-Type-Value:measurement
< NCT03921827 661 662 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03921827 664 666 B-Eq-Value
% NCT03921827 667 668 B-Eq-Unit

5 NCT03921827 673 674 O
. NCT03921827 674 675 O
Moderate NCT03921827 677 685 B-Severity___Severity-Value:moderate
or NCT03921827 686 688 O
severe NCT03921827 689 695 B-Severity___Severity-Value:severe
AR NCT03921827 696 698 B-Condition-Name

6 NCT03921827 702 703 O
. NCT03921827 703 704 O
Persistent NCT03921827 706 716 B-Stability___Stability-Value:stable
and NCT03921827 717 720 O
uncontrolled NCT03921827 721 733 O
hypertension NCT03921827 734 746 B-Condition-Name
( NCT03921827 747 748 O
BP NCT03921827 749 751 B-Observation-Name___Observation-Type-Value:vital
persistently NCT03921827 752 764 B-Stability___Stability-Value:stable
> NCT03921827 765 766 B-Eq-Operator___Eq-Operator-Value:GT
160 NCT03921827 768 771 B-Eq-Value
/ NCT03921827 772 773 O
100 NCT03921827 775 778 B-Eq-Value
mmHg NCT03921827 779 783 B-Eq-Unit
) NCT03921827 784 785 O

7 NCT03921827 790 791 O
. NCT03921827 791 792 O
Bleeding NCT03921827 794 802 B-Condition-Name
diathesis NCT03921827 803 812 I-Condition-Name

8 NCT03921827 816 817 O
. NCT03921827 817 818 O
Active NCT03921827 820 826 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
thrombophlebitis NCT03921827 827 843 B-Condition-Name
/ NCT03921827 844 845 O
venous NCT03921827 846 852 B-Condition-Name
disease NCT03921827 853 860 I-Condition-Name
of NCT03921827 861 863 O
lower NCT03921827 864 869 O
limbs NCT03921827 870 875 O

9 NCT03921827 879 880 O
. NCT03921827 880 881 O
Severe NCT03921827 883 889 B-Severity___Severity-Value:severe
lower NCT03921827 890 895 O
extremity NCT03921827 896 905 O
vaso NCT03921827 906 910 B-Condition-Name
- NCT03921827 911 912 I-Condition-Name
occlusive NCT03921827 913 922 I-Condition-Name
disease NCT03921827 923 930 I-Condition-Name

10 NCT03921827 933 935 O
. NCT03921827 935 936 O
Presence NCT03921827 938 946 O
of NCT03921827 947 949 O
a NCT03921827 950 951 O
documented NCT03921827 952 962 O
aortic NCT03921827 963 969 B-Condition-Name
aneurysm NCT03921827 970 978 I-Condition-Name
/ NCT03921827 979 980 O
dissection NCT03921827 981 991 B-Procedure-Name
requiring NCT03921827 992 1001 O
surgical NCT03921827 1002 1010 B-Procedure-Name
repair NCT03921827 1011 1017 I-Procedure-Name

11 NCT03921827 1020 1022 O
. NCT03921827 1022 1023 O
Pregnancy NCT03921827 1025 1034 B-Condition-Name

Inclusion NCT03920293 0 9 O
Criteria NCT03920293 10 18 O
: NCT03920293 19 20 O

1 NCT03920293 25 26 O
. NCT03920293 26 27 O
Diagnosed NCT03920293 29 38 O
with NCT03920293 39 43 O
Myasthenia NCT03920293 44 54 B-Condition-Name
Gravis NCT03920293 55 61 I-Condition-Name
at NCT03920293 62 64 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03920293 65 70 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03920293 72 73 B-Eq-Value
months NCT03920293 74 80 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
( NCT03920293 81 82 O
180 NCT03920293 84 87 B-Eq-Value
days NCT03920293 88 92 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03920293 93 94 O
prior NCT03920293 95 100 O
to NCT03920293 101 103 O
the NCT03920293 104 107 O
date NCT03920293 108 112 O
of NCT03920293 113 115 O
the NCT03920293 116 119 O
Screening NCT03920293 120 129 O
Visit NCT03920293 130 135 O
as NCT03920293 136 138 O
confirmed NCT03920293 139 148 O
by NCT03920293 149 151 O
specific NCT03920293 152 160 O
criteria NCT03920293 161 169 O
. NCT03920293 170 171 O

2 NCT03920293 176 177 O
. NCT03920293 177 178 O
Myasthenia NCT03920293 180 190 B-Condition-Name
Gravis NCT03920293 191 197 I-Condition-Name
Foundation NCT03920293 198 208 I-Condition-Name
of NCT03920293 209 211 I-Condition-Name
America NCT03920293 212 219 I-Condition-Name
Clinical NCT03920293 220 228 I-Condition-Name
Classification NCT03920293 229 243 I-Condition-Name
Class NCT03920293 244 249 B-Eq-Unit
II NCT03920293 250 252 B-Eq-Value
to NCT03920293 253 255 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IV NCT03920293 256 258 B-Eq-Value
at NCT03920293 259 261 O
screening NCT03920293 262 271 O
. NCT03920293 272 273 O

3 NCT03920293 278 279 O
. NCT03920293 279 280 O
MG NCT03920293 282 284 B-Observation-Name___Observation-Type-Value:clinical-score
- NCT03920293 285 286 I-Observation-Name___Observation-Type-Value:clinical-score
ADL NCT03920293 287 290 I-Observation-Name___Observation-Type-Value:clinical-score
profile NCT03920293 291 298 O
must NCT03920293 299 303 O
be NCT03920293 304 306 O
≥ NCT03920293 307 308 B-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03920293 310 311 B-Eq-Value
at NCT03920293 312 314 O
screening NCT03920293 315 324 O
and NCT03920293 325 328 O
randomization NCT03920293 329 342 O
( NCT03920293 343 344 O
Day NCT03920293 345 348 O
1 NCT03920293 350 351 O
) NCT03920293 352 353 O
. NCT03920293 355 356 O

4 NCT03920293 361 362 O
. NCT03920293 362 363 O
Vaccinated NCT03920293 365 375 O
against NCT03920293 376 383 O
meningococcal NCT03920293 384 397 B-Condition-Name
infections NCT03920293 398 408 I-Condition-Name
within NCT03920293 409 415 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03920293 417 418 B-Eq-Value
years NCT03920293 419 424 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
prior NCT03920293 425 430 O
to NCT03920293 431 433 O
, NCT03920293 434 435 O
or NCT03920293 436 438 O
at NCT03920293 439 441 O
the NCT03920293 442 445 O
time NCT03920293 446 450 O
of NCT03920293 451 453 O
, NCT03920293 454 455 O
initiating NCT03920293 456 466 O
study NCT03920293 467 472 O
drug NCT03920293 473 477 O
to NCT03920293 478 480 O
reduce NCT03920293 481 487 O
the NCT03920293 488 491 O
risk NCT03920293 492 496 O
of NCT03920293 497 499 O
meningococcal NCT03920293 500 513 O
infection NCT03920293 514 523 B-Condition-Name
( NCT03920293 524 525 O
N NCT03920293 526 527 B-Organism-Name
meningitidis NCT03920293 528 540 I-Organism-Name
) NCT03920293 541 542 O
. NCT03920293 544 545 O

Exclusion NCT03920293 547 556 O
Criteria NCT03920293 557 565 O
: NCT03920293 566 567 O

Medical NCT03920293 569 576 O
Conditions NCT03920293 577 587 O

1 NCT03920293 591 592 O
. NCT03920293 592 593 O
Any NCT03920293 595 598 O
active NCT03920293 599 605 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03920293 606 608 O
untreated NCT03920293 609 618 O
thymoma NCT03920293 619 626 B-Condition-Name
. NCT03920293 627 628 O
History NCT03920293 630 637 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920293 638 640 O
thymic NCT03920293 641 647 B-Condition-Name
carcinoma NCT03920293 648 657 I-Condition-Name
or NCT03920293 658 660 O
thymic NCT03920293 661 667 B-Condition-Name
malignancy NCT03920293 668 678 I-Condition-Name
unless NCT03920293 679 685 O
deemed NCT03920293 686 692 O
cured NCT03920293 693 698 O
by NCT03920293 699 701 O
adequate NCT03920293 702 710 O
treatment NCT03920293 711 720 O
with NCT03920293 721 725 O
no NCT03920293 726 728 O
evidence NCT03920293 729 737 O
of NCT03920293 738 740 O
recurrence NCT03920293 741 751 O
for NCT03920293 752 755 O
≥ NCT03920293 756 757 B-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03920293 759 760 B-Eq-Value
years NCT03920293 761 766 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
before NCT03920293 767 773 O
screening NCT03920293 774 783 O
. NCT03920293 784 785 O

2 NCT03920293 790 791 O
. NCT03920293 791 792 O
History NCT03920293 794 801 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920293 802 804 O
thymectomy NCT03920293 805 815 B-Procedure-Name
within NCT03920293 816 822 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03920293 823 826 O
12 NCT03920293 828 830 B-Eq-Value
months NCT03920293 831 837 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03920293 838 843 O
to NCT03920293 844 846 O
screening NCT03920293 847 856 O
. NCT03920293 857 858 O

3 NCT03920293 863 864 O
. NCT03920293 864 865 O
History NCT03920293 867 874 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920293 875 877 O
N NCT03920293 878 879 B-Organism-Name
meningitidis NCT03920293 880 892 I-Organism-Name
infection NCT03920293 893 902 B-Condition-Name
. NCT03920293 903 904 O

4 NCT03920293 909 910 O
. NCT03920293 910 911 O
Use NCT03920293 913 916 O
of NCT03920293 917 919 O
the NCT03920293 920 923 O
following NCT03920293 924 933 O
within NCT03920293 934 940 O
the NCT03920293 941 944 O
time NCT03920293 945 949 O
period NCT03920293 950 956 O
specified NCT03920293 957 966 O
below NCT03920293 967 972 O
: NCT03920293 973 974 O

- NCT03920293 983 984 O
IV NCT03920293 986 988 B-Drug-Name
immunoglobulin NCT03920293 989 1003 I-Drug-Name
within NCT03920293 1004 1010 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03920293 1012 1013 B-Eq-Value
weeks NCT03920293 1014 1019 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03920293 1020 1022 O
randomization NCT03920293 1023 1036 O

- NCT03920293 1044 1045 O
Use NCT03920293 1047 1050 O
of NCT03920293 1051 1053 O
plasma NCT03920293 1054 1060 B-Procedure-Name
exchange NCT03920293 1061 1069 I-Procedure-Name
within NCT03920293 1070 1076 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03920293 1078 1079 B-Eq-Value
weeks NCT03920293 1080 1085 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03920293 1086 1088 O
randomization NCT03920293 1089 1102 O

- NCT03920293 1110 1111 O
Use NCT03920293 1113 1116 O
of NCT03920293 1117 1119 O
rituximab NCT03920293 1120 1129 B-Drug-Name
within NCT03920293 1130 1136 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03920293 1138 1139 B-Eq-Value
months NCT03920293 1140 1146 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03920293 1147 1149 O
screening NCT03920293 1150 1159 O

5 NCT03920293 1163 1164 O
. NCT03920293 1164 1165 O
Participants NCT03920293 1167 1179 O
who NCT03920293 1180 1183 O
have NCT03920293 1184 1188 O
received NCT03920293 1189 1197 O
previous NCT03920293 1198 1206 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03920293 1207 1216 O
with NCT03920293 1217 1221 O
complement NCT03920293 1222 1232 B-Drug-Name
inhibitors NCT03920293 1233 1243 I-Drug-Name
( NCT03920293 1244 1245 O
for NCT03920293 1246 1249 O
example NCT03920293 1250 1257 O
, NCT03920293 1258 1259 O
eculizumab NCT03920293 1260 1270 B-Drug-Name
) NCT03920293 1271 1272 O
. NCT03920293 1274 1275 O

Inclusion NCT03928340 0 9 O
Criteria NCT03928340 10 18 O
: NCT03928340 19 20 O

- NCT03928340 24 25 O
Diabetic NCT03928340 27 35 B-Condition-Name
pregnant NCT03928340 36 44 B-Condition-Name
patients NCT03928340 45 53 O
with NCT03928340 54 58 O
type NCT03928340 59 63 B-Condition-Name
one NCT03928340 64 67 I-Condition-Name
diabetes NCT03928340 68 76 I-Condition-Name
and NCT03928340 77 80 O
no NCT03928340 81 83 O
other NCT03928340 84 89 O
chronic NCT03928340 90 97 O
disorders NCT03928340 98 107 B-Condition-Name

- NCT03928340 110 111 O
Patients NCT03928340 113 121 O
on NCT03928340 122 124 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
insulin NCT03928340 125 132 B-Drug-Name
in NCT03928340 133 135 O
the NCT03928340 136 139 O
3 NCT03928340 141 142 B-Eq-Value
rd NCT03928340 143 145 I-Eq-Value
trimester NCT03928340 146 155 B-Eq-Unit
of NCT03928340 156 158 O
pregnancy NCT03928340 159 168 B-Condition-Name
( NCT03928340 169 170 O
on NCT03928340 171 173 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
insulin NCT03928340 174 181 B-Drug-Name
therapy NCT03928340 182 189 I-Drug-Name
since NCT03928340 190 195 O
start NCT03928340 196 201 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03928340 202 204 O
gestation NCT03928340 205 214 B-Condition-Name
) NCT03928340 215 216 O

- NCT03928340 220 221 O
Patients NCT03928340 223 231 O
pregnant NCT03928340 232 240 B-Condition-Name
in NCT03928340 241 243 O
single NCT03928340 244 250 O
living NCT03928340 251 257 O
fetus NCT03928340 258 263 O
with NCT03928340 264 268 O
no NCT03928340 269 271 O
apparent NCT03928340 272 280 O
congenital NCT03928340 281 291 B-Condition-Name
anomalies NCT03928340 292 301 I-Condition-Name

- NCT03928340 304 305 O
Haemoglobin NCT03928340 307 318 B-Observation-Name___Observation-Type-Value:lab
A NCT03928340 319 320 I-Observation-Name___Observation-Type-Value:lab
1 NCT03928340 322 323 I-Observation-Name___Observation-Type-Value:lab
C NCT03928340 324 325 I-Observation-Name___Observation-Type-Value:lab
( NCT03928340 326 327 O
HbA NCT03928340 328 331 B-Observation-Name___Observation-Type-Value:lab
1c NCT03928340 332 334 I-Observation-Name___Observation-Type-Value:lab
) NCT03928340 335 336 O
level NCT03928340 337 342 O
between NCT03928340 343 350 B-Eq-Operator___Eq-Operator-Value:BETWEEN
7 NCT03928340 352 353 B-Eq-Value
% NCT03928340 354 355 B-Eq-Unit
to NCT03928340 356 358 O
11 NCT03928340 360 362 B-Eq-Value
% NCT03928340 363 364 B-Eq-Unit

- NCT03928340 368 369 O
All NCT03928340 371 374 O
patients NCT03928340 375 383 O
have NCT03928340 384 388 O
done NCT03928340 389 393 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03928340 394 395 O
dating NCT03928340 396 402 O
ultrasound NCT03928340 403 413 B-Procedure-Name
to NCT03928340 414 416 O
confirm NCT03928340 417 424 O
gestational NCT03928340 425 436 B-Observation-Name
age NCT03928340 437 440 I-Observation-Name
, NCT03928340 441 442 O
viability NCT03928340 443 452 O
and NCT03928340 453 456 O
rule NCT03928340 457 461 O
out NCT03928340 462 465 O
any NCT03928340 466 469 O
abnormality NCT03928340 470 481 B-Condition-Name

Exclusion NCT03928340 482 491 O
Criteria NCT03928340 492 500 O
: NCT03928340 501 502 O

- NCT03928340 506 507 O
Patients NCT03928340 509 517 O
with NCT03928340 518 522 O
type NCT03928340 523 527 O
2 NCT03928340 529 530 O
or NCT03928340 531 533 O
gestational NCT03928340 534 545 O
diabetes NCT03928340 546 554 B-Condition-Name

- NCT03928340 557 558 O
Patients NCT03928340 560 568 O
with NCT03928340 569 573 O
intolerance NCT03928340 574 585 B-Condition-Name
or NCT03928340 586 588 O
hypersensitivity NCT03928340 589 605 B-Condition-Name
to NCT03928340 606 608 O
metformin NCT03928340 609 618 B-Drug-Name

- NCT03928340 621 622 O
Patients NCT03928340 624 632 O
with NCT03928340 633 637 O
congestive NCT03928340 638 648 B-Condition-Name
heart NCT03928340 649 654 I-Condition-Name
failure NCT03928340 655 662 I-Condition-Name
or NCT03928340 663 665 O
a NCT03928340 666 667 O
history NCT03928340 668 675 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928340 676 678 O
congestive NCT03928340 679 689 B-Condition-Name
heart NCT03928340 690 695 I-Condition-Name
failure NCT03928340 696 703 I-Condition-Name

- NCT03928340 706 707 O
Patients NCT03928340 709 717 O
with NCT03928340 718 722 O
renal NCT03928340 723 728 B-Condition-Name
insufficiency NCT03928340 729 742 I-Condition-Name

- NCT03928340 745 746 O
Patients NCT03928340 748 756 O
having NCT03928340 757 763 O
current NCT03928340 764 771 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
significant NCT03928340 772 783 B-Severity___Severity-Value:severe
gastrointestinal NCT03928340 784 800 B-Condition-Name
problems NCT03928340 801 809 I-Condition-Name
such NCT03928340 810 814 O
as NCT03928340 815 817 O
severe NCT03928340 818 824 B-Severity___Severity-Value:severe
vomiting NCT03928340 825 833 B-Condition-Name
requiring NCT03928340 834 843 O
intravenous NCT03928340 844 855 B-Drug-Name
fluids NCT03928340 856 862 I-Drug-Name
or NCT03928340 863 865 O
hospitalization NCT03928340 866 881 B-Encounter-Type___Encounter-Type-Value:inpatient

- NCT03928340 884 885 O
Presence NCT03928340 887 895 O
of NCT03928340 896 898 O
acute NCT03928340 899 904 B-Severity___Severity-Value:severe
or NCT03928340 905 907 O
chronic NCT03928340 908 915 O
metabolic NCT03928340 916 925 B-Condition-Name
acidosis NCT03928340 926 934 I-Condition-Name
, NCT03928340 935 936 O
including NCT03928340 937 946 O
diabetic NCT03928340 947 955 B-Condition-Name
ketoacidosis NCT03928340 956 968 I-Condition-Name
, NCT03928340 969 970 O
a NCT03928340 971 972 O
history NCT03928340 973 980 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928340 981 983 O
diabetic NCT03928340 984 992 B-Condition-Name
ketoacidosis NCT03928340 993 1005 I-Condition-Name
or NCT03928340 1006 1008 O
history NCT03928340 1009 1016 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03928340 1017 1019 O
lactic NCT03928340 1020 1026 B-Condition-Name
acidosis NCT03928340 1027 1035 I-Condition-Name

- NCT03928340 1038 1039 O
Patients NCT03928340 1041 1049 O
with NCT03928340 1050 1054 O
liver NCT03928340 1055 1060 O
impairment NCT03928340 1061 1071 B-Condition-Name

- NCT03928340 1074 1075 O
Patients NCT03928340 1077 1085 O
with NCT03928340 1086 1090 O
known NCT03928340 1091 1096 O
higher NCT03928340 1097 1103 O
order NCT03928340 1104 1109 O
pregnancies NCT03928340 1110 1121 B-Condition-Name
( NCT03928340 1122 1123 O
twins NCT03928340 1124 1129 O
, NCT03928340 1130 1131 O
triplets NCT03928340 1132 1140 O
, NCT03928340 1141 1142 O
etc NCT03928340 1143 1146 O
. NCT03928340 1147 1148 O
) NCT03928340 1149 1150 O

- NCT03928340 1154 1155 O
Patients NCT03928340 1157 1165 O
having NCT03928340 1166 1172 O
a NCT03928340 1173 1174 O
known NCT03928340 1175 1180 O
potentially NCT03928340 1181 1192 O
fetal NCT03928340 1193 1198 B-Condition-Name
lethal NCT03928340 1199 1205 I-Condition-Name
anomaly NCT03928340 1206 1213 I-Condition-Name

Inclusion NCT03925116 0 9 O
Criteria NCT03925116 10 18 O

- NCT03925116 21 22 O
Women NCT03925116 24 29 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
at NCT03925116 30 32 O
risk NCT03925116 33 37 O
for NCT03925116 38 41 O
pregnancy NCT03925116 42 51 B-Condition-Name

- NCT03925116 54 55 O
Women NCT03925116 57 62 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
able NCT03925116 63 67 O
to NCT03925116 68 70 O
read NCT03925116 71 75 O
and NCT03925116 76 79 O
write NCT03925116 80 85 O
in NCT03925116 86 88 O
English NCT03925116 89 96 B-Language

Exclusion NCT03925116 97 106 O
Criteria NCT03925116 107 115 O

- NCT03925116 118 119 O
Women NCT03925116 121 126 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03925116 127 130 O
have NCT03925116 131 135 O
undergone NCT03925116 136 145 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
permanent NCT03925116 146 155 B-Procedure-Name
sterilization NCT03925116 156 169 I-Procedure-Name

- NCT03925116 172 173 O
Women NCT03925116 175 180 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
not NCT03925116 181 184 O
sexually NCT03925116 185 193 B-Condition-Name
active NCT03925116 194 200 I-Condition-Name
with NCT03925116 201 205 O
a NCT03925116 206 207 O
male NCT03925116 208 212 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
partner NCT03925116 213 220 O

- NCT03925116 223 224 O
Women NCT03925116 226 231 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03925116 232 235 O
intend NCT03925116 236 242 O
to NCT03925116 243 245 O
become NCT03925116 246 252 O
pregnant NCT03925116 253 261 B-Condition-Name
in NCT03925116 262 264 O
the NCT03925116 265 268 O
next NCT03925116 269 273 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
12 NCT03925116 275 277 B-Eq-Value
months NCT03925116 278 284 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03926351 0 9 O
Criteria NCT03926351 10 18 O
: NCT03926351 19 20 O

- NCT03926351 24 25 O
Age NCT03926351 27 30 O
> NCT03926351 31 32 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03926351 34 36 B-Eq-Value
years NCT03926351 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03926351 45 46 O
SCD NCT03926351 48 51 B-Condition-Name
or NCT03926351 52 54 O
MCI NCT03926351 55 58 B-Condition-Name

- NCT03926351 61 62 O
No NCT03926351 64 66 O
evidence NCT03926351 67 75 O
of NCT03926351 76 78 O
neurodegeneration NCT03926351 79 96 B-Condition-Name
( NCT03926351 97 98 O
i NCT03926351 99 100 O
. NCT03926351 101 102 O
e NCT03926351 103 104 O
. NCT03926351 105 106 O
CSF NCT03926351 108 111 B-Observation-Name___Observation-Type-Value:lab
phospho NCT03926351 112 119 I-Observation-Name___Observation-Type-Value:lab
and NCT03926351 120 123 O
total NCT03926351 124 129 B-Observation-Name___Observation-Type-Value:lab
tau NCT03926351 130 133 I-Observation-Name___Observation-Type-Value:lab
- NCT03926351 134 135 I-Observation-Name___Observation-Type-Value:lab
levels NCT03926351 136 142 I-Observation-Name___Observation-Type-Value:lab
below NCT03926351 143 148 B-Eq-Operator___Eq-Operator-Value:LT
cut NCT03926351 149 152 B-Eq-Unit___Eq-Unit-Value:ref-range-low
- NCT03926351 153 154 I-Eq-Unit___Eq-Unit-Value:ref-range-low
off NCT03926351 155 158 I-Eq-Unit___Eq-Unit-Value:ref-range-low
) NCT03926351 159 160 O

- NCT03926351 164 165 O
Scandinavian NCT03926351 167 179 B-Language
mother NCT03926351 180 186 O
tongue NCT03926351 187 193 O

- NCT03926351 196 197 O
Completed NCT03926351 199 208 O
2 NCT03926351 210 211 B-Eq-Value
- NCT03926351 212 213 O
year NCT03926351 214 218 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
follow NCT03926351 219 225 O
- NCT03926351 226 227 O
up NCT03926351 228 230 O
in NCT03926351 231 233 O
the NCT03926351 234 237 O
DDI NCT03926351 238 241 O
- NCT03926351 242 243 O
study NCT03926351 244 249 O

- NCT03926351 252 253 O
Stable NCT03926351 255 261 B-Stability___Stability-Value:stable
medication NCT03926351 262 272 O
for NCT03926351 273 276 O
at NCT03926351 277 279 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926351 280 285 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03926351 287 288 B-Eq-Value
months NCT03926351 289 295 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03926351 296 301 O
to NCT03926351 302 304 O
baseline NCT03926351 305 313 O
exam NCT03926351 314 318 O

Exclusion NCT03926351 319 328 O
Criteria NCT03926351 329 337 O
: NCT03926351 338 339 O

- NCT03926351 343 344 O
Dementia NCT03926351 346 354 B-Condition-Name
( NCT03926351 355 356 O
defined NCT03926351 357 364 O
as NCT03926351 365 367 O
MMSE NCT03926351 368 372 B-Observation-Name
< NCT03926351 373 374 B-Eq-Operator___Eq-Operator-Value:LT
26 NCT03926351 376 378 B-Eq-Value
and NCT03926351 379 382 O
/ NCT03926351 383 384 O
or NCT03926351 385 387 O
CDR NCT03926351 388 391 B-Observation-Name
> NCT03926351 392 393 B-Eq-Operator___Eq-Operator-Value:GTEQ
/ NCT03926351 395 396 I-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03926351 398 399 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03926351 401 402 B-Eq-Value
) NCT03926351 403 404 O
) NCT03926351 406 407 O

- NCT03926351 411 412 O
Other NCT03926351 414 419 O
dementia NCT03926351 420 428 B-Condition-Name
giving NCT03926351 429 435 O
disease NCT03926351 436 443 O
than NCT03926351 444 448 O
AD NCT03926351 449 451 B-Condition-Name

- NCT03926351 454 455 O
Other NCT03926351 457 462 O
brain NCT03926351 463 468 B-Condition-Name
disease NCT03926351 469 476 I-Condition-Name

- NCT03926351 479 480 O
Significant NCT03926351 482 493 B-Severity___Severity-Value:severe
depression NCT03926351 494 504 B-Condition-Name

- NCT03926351 507 508 O
Unstable NCT03926351 510 518 B-Stability___Stability-Value:change
coronary NCT03926351 519 527 B-Condition-Name
heart NCT03926351 528 533 I-Condition-Name
disease NCT03926351 534 541 I-Condition-Name
or NCT03926351 542 544 O
heart NCT03926351 545 550 B-Condition-Name
failure NCT03926351 551 558 I-Condition-Name
in NCT03926351 559 561 O
need NCT03926351 562 566 O
of NCT03926351 567 569 O
treatment NCT03926351 570 579 O

- NCT03926351 582 583 O
Systemic NCT03926351 585 593 O
inflammatory NCT03926351 594 606 B-Condition-Name
diseases NCT03926351 607 615 I-Condition-Name

- NCT03926351 618 619 O
Somatic NCT03926351 621 628 B-Condition-Name
disease NCT03926351 629 636 I-Condition-Name
that NCT03926351 637 641 O
might NCT03926351 642 647 O
affect NCT03926351 648 654 B-Stability___Stability-Value:change
cognitive NCT03926351 655 664 B-Condition-Name
function NCT03926351 665 673 I-Condition-Name
adversely NCT03926351 674 683 O

- NCT03926351 686 687 O
Usage NCT03926351 689 694 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03926351 695 697 O
anticoagulants NCT03926351 698 712 B-Drug-Name

- NCT03926351 715 716 O
Prior NCT03926351 718 723 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiation NCT03926351 724 733 B-Procedure-Name
- NCT03926351 734 735 O
or NCT03926351 736 738 O
chemo NCT03926351 739 744 B-Procedure-Name
- NCT03926351 745 746 I-Procedure-Name
therapy NCT03926351 747 754 I-Procedure-Name
possibly NCT03926351 755 763 O
affecting NCT03926351 764 773 B-Stability___Stability-Value:change
CNS NCT03926351 774 777 B-Condition-Name

- NCT03926351 780 781 O
Relevant NCT03926351 783 791 O
cancer NCT03926351 792 798 B-Condition-Name
or NCT03926351 799 801 O
other NCT03926351 802 807 O
serious NCT03926351 808 815 B-Severity___Severity-Value:severe
disease NCT03926351 816 823 B-Condition-Name
with NCT03926351 824 828 O
expected NCT03926351 829 837 B-Observation-Name
survival NCT03926351 838 846 I-Observation-Name
< NCT03926351 847 848 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03926351 850 851 B-Eq-Value
years NCT03926351 852 857 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03926351 860 861 O
Fish NCT03926351 863 867 B-Drug-Name
meal NCT03926351 868 872 I-Drug-Name
intake NCT03926351 873 879 O
more NCT03926351 880 884 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03926351 885 889 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03926351 891 892 B-Eq-Value
times NCT03926351 893 898 O
a NCT03926351 899 900 O
week NCT03926351 901 905 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03926351 908 909 O
Regularly NCT03926351 911 920 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
intake NCT03926351 921 927 O
of NCT03926351 928 930 O
Omega NCT03926351 931 936 B-Drug-Name
- NCT03926351 937 938 I-Drug-Name
3 NCT03926351 940 941 I-Drug-Name
supplements NCT03926351 942 953 I-Drug-Name
over NCT03926351 954 958 O
the NCT03926351 959 962 O
last NCT03926351 963 967 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03926351 969 970 B-Eq-Value
months NCT03926351 971 977 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03927729 0 9 O
Criteria NCT03927729 10 18 O
: NCT03927729 19 20 O

- NCT03927729 24 25 O
Conscious NCT03927729 27 36 B-Condition-Name
patient NCT03927729 37 44 O

- NCT03927729 47 48 O
Age NCT03927729 50 53 O
≥ NCT03927729 54 55 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03927729 57 59 B-Eq-Value
years NCT03927729 60 65 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03927729 68 69 O
Acute NCT03927729 71 76 B-Severity___Severity-Value:severe
pain NCT03927729 77 81 B-Condition-Name
of NCT03927729 82 84 O
monotraumatic NCT03927729 85 98 O
origin NCT03927729 99 105 O

- NCT03927729 108 109 O
Pain NCT03927729 111 115 B-Observation-Name
> NCT03927729 116 117 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03927729 119 120 B-Eq-Value
on NCT03927729 121 123 O
a NCT03927729 124 125 O
visual NCT03927729 126 132 O
numerical NCT03927729 133 142 O
scale NCT03927729 143 148 O

Exclusion NCT03927729 149 158 O
Criteria NCT03927729 159 167 O
: NCT03927729 168 169 O

- NCT03927729 173 174 O
State NCT03927729 176 181 B-Condition-Name
of NCT03927729 182 184 I-Condition-Name
shock NCT03927729 185 190 I-Condition-Name
with NCT03927729 191 195 O
unstable NCT03927729 196 204 B-Stability___Stability-Value:change
hemodynamics NCT03927729 205 217 B-Condition-Name
( NCT03927729 218 219 O
PA NCT03927729 220 222 B-Observation-Name
< NCT03927729 223 224 B-Eq-Operator___Eq-Operator-Value:LT
90 NCT03927729 226 228 B-Eq-Value
/ NCT03927729 229 230 O
60 NCT03927729 232 234 B-Eq-Unit
) NCT03927729 235 236 O

- NCT03927729 240 241 O
Suspected NCT03927729 243 252 O
or NCT03927729 253 255 O
proven NCT03927729 256 262 O
trauma NCT03927729 263 269 B-Condition-Name
to NCT03927729 270 272 O
the NCT03927729 273 276 O
chest NCT03927729 277 282 O
, NCT03927729 283 284 O
abdomen NCT03927729 285 292 O
or NCT03927729 293 295 O
pelvis NCT03927729 296 302 O

- NCT03927729 305 306 O
Serious NCT03927729 308 315 O
head NCT03927729 316 320 O
trauma NCT03927729 321 327 O

- NCT03927729 330 331 O
Consciousness NCT03927729 333 346 B-Condition-Name
disorder NCT03927729 347 355 I-Condition-Name
with NCT03927729 356 360 O
Glasgow NCT03927729 361 368 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03927729 369 374 I-Observation-Name___Observation-Type-Value:clinical-score
< NCT03927729 375 376 B-Eq-Operator___Eq-Operator-Value:LT
15 NCT03927729 378 380 B-Eq-Value

- NCT03927729 384 385 O
Patient NCT03927729 387 394 O
who NCT03927729 395 398 O
has NCT03927729 399 402 O
already NCT03927729 403 410 O
received NCT03927729 411 419 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
analgesics NCT03927729 420 430 B-Drug-Name
( NCT03927729 431 432 O
with NCT03927729 433 437 O
the NCT03927729 438 441 O
exception NCT03927729 442 451 O
of NCT03927729 452 454 O
paracetamol NCT03927729 455 466 B-Drug-Name
) NCT03927729 467 468 O

- NCT03927729 472 473 O
Patient NCT03927729 475 482 O
receiving NCT03927729 483 492 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
an NCT03927729 493 495 O
intravenous NCT03927729 496 507 O
approach NCT03927729 508 516 O
for NCT03927729 517 520 O
analgesia NCT03927729 521 530 B-Drug-Name

- NCT03927729 533 534 O
Renal NCT03927729 536 541 O
or NCT03927729 542 544 O
hepatic NCT03927729 545 552 O
disorders NCT03927729 553 562 B-Condition-Name
known NCT03927729 563 568 O

- NCT03927729 571 572 O
Hypersensitivity NCT03927729 574 590 B-Condition-Name
to NCT03927729 591 593 O
fluoridated NCT03927729 594 605 O
anesthetics NCT03927729 606 617 O
or NCT03927729 618 620 O
history NCT03927729 621 628 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03927729 629 631 O
malignant NCT03927729 632 641 B-Condition-Name
hyperthermia NCT03927729 642 654 I-Condition-Name
in NCT03927729 655 657 O
the NCT03927729 658 661 O
patient NCT03927729 662 669 O
or NCT03927729 670 672 O
family NCT03927729 673 679 O

- NCT03927729 682 683 O
Pregnant NCT03927729 685 693 B-Condition-Name
or NCT03927729 694 696 O
nursing NCT03927729 697 704 B-Condition-Name
woman NCT03927729 705 710 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03927729 713 714 O
Patient NCT03927729 716 723 O
under NCT03927729 724 729 O
judicial NCT03927729 730 738 B-Observation-Name
protection NCT03927729 739 749 I-Observation-Name

- NCT03927729 752 753 O
Non NCT03927729 755 758 B-Condition-Name
communicating NCT03927729 759 772 I-Condition-Name
patient NCT03927729 773 780 O
or NCT03927729 781 783 O
with NCT03927729 784 788 O
difficulties NCT03927729 789 801 B-Condition-Name
of NCT03927729 802 804 I-Condition-Name
understanding NCT03927729 805 818 I-Condition-Name

Exclusion NCT03927729 819 828 O
Criteria NCT03927729 829 837 O
: NCT03927729 838 839 O

- NCT03927729 843 844 O
Intravenous NCT03927729 846 857 O
injection NCT03927729 858 867 O
for NCT03927729 868 871 O
analgesia NCT03927729 872 881 B-Drug-Name

Inclusion NCT03920046 0 9 O
Criteria NCT03920046 10 18 O
: NCT03920046 19 20 O

- NCT03920046 24 25 O
ASA NCT03920046 27 30 B-Condition-Name
( NCT03920046 31 32 O
American NCT03920046 33 41 B-Condition-Name
Society NCT03920046 42 49 I-Condition-Name
of NCT03920046 50 52 I-Condition-Name
Anesthesiologists NCT03920046 53 70 I-Condition-Name
) NCT03920046 71 72 O
I NCT03920046 73 74 B-Eq-Value
- NCT03920046 75 76 O
ASA NCT03920046 77 80 O
II NCT03920046 81 83 B-Eq-Value
patients NCT03920046 84 92 O

- NCT03920046 95 96 O
Aged NCT03920046 98 102 O
1 NCT03920046 104 105 B-Eq-Value
- NCT03920046 106 107 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03920046 109 111 B-Eq-Value
Year NCT03920046 112 116 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03920046 117 120 O
patients NCT03920046 121 129 O

Exclusion NCT03920046 130 139 O
Criteria NCT03920046 140 148 O
: NCT03920046 149 150 O

- NCT03920046 154 155 O
Smoker NCT03920046 157 163 B-Condition-Name
patients NCT03920046 164 172 O

Inclusion NCT03920085 0 9 O
Criteria NCT03920085 10 18 O
: NCT03920085 19 20 O

- NCT03920085 24 25 O
Participants NCT03920085 27 39 O
must NCT03920085 40 44 O
be NCT03920085 45 47 O
enrolled NCT03920085 48 56 O
in NCT03920085 57 59 O
LifeScan NCT03920085 60 68 O
Patient NCT03920085 69 76 O
Registry NCT03920085 77 85 O
. NCT03920085 86 87 O

- NCT03920085 91 92 O
Participants NCT03920085 94 106 O
must NCT03920085 107 111 O
have NCT03920085 112 116 O
read NCT03920085 117 121 O
the NCT03920085 122 125 O
Information NCT03920085 126 137 O
sheet NCT03920085 138 143 O
and NCT03920085 144 147 O
signed NCT03920085 148 154 O
an NCT03920085 155 157 O
informedconsent NCT03920085 158 173 O
form NCT03920085 174 178 O
> NCT03920085 179 180 O
prior NCT03920085 181 186 O
to NCT03920085 187 189 O
study NCT03920085 190 195 O
participation NCT03920085 196 209 O
. NCT03920085 210 211 O

- NCT03920085 215 216 O
Participants NCT03920085 218 230 O
must NCT03920085 231 235 O
be NCT03920085 236 238 O
16 NCT03920085 240 242 B-Eq-Value
years NCT03920085 243 248 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03920085 249 251 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03920085 252 257 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03920085 258 259 O

- NCT03920085 263 264 O
Participants NCT03920085 266 278 O
must NCT03920085 279 283 O
be NCT03920085 284 286 O
diagnosed NCT03920085 287 296 O
with NCT03920085 297 301 O
Diabetes NCT03920085 302 310 B-Condition-Name

Exclusion NCT03920085 311 320 O
Criteria NCT03920085 321 329 O
: NCT03920085 330 331 O

> NCT03920085 334 335 O
Participants NCT03920085 336 348 O
not NCT03920085 349 352 O
enrolled NCT03920085 353 361 O
in NCT03920085 362 364 O
the NCT03920085 365 368 O
LifeScan NCT03920085 369 377 O
Patient NCT03920085 378 385 O
Registry NCT03920085 386 394 O

Inclusion NCT03928223 0 9 O
Criteria NCT03928223 10 18 O
: NCT03928223 19 20 O

- NCT03928223 24 25 O
Dermatology NCT03928223 27 38 B-Provider-Type
in NCT03928223 39 41 B-Encounter-Type___Encounter-Type-Value:inpatient
- NCT03928223 42 43 O
and NCT03928223 44 47 O
outpatients NCT03928223 48 59 B-Encounter-Type___Encounter-Type-Value:outpatient
with NCT03928223 60 64 O
itch NCT03928223 65 69 B-Condition-Name

Exclusion NCT03928223 70 79 O
Criteria NCT03928223 80 88 O
: NCT03928223 89 90 O

- NCT03928223 94 95 O
color NCT03928223 97 102 B-Condition-Name
blindness NCT03928223 103 112 I-Condition-Name

- NCT03928223 115 116 O
lack NCT03928223 118 122 O
of NCT03928223 123 125 O
time NCT03928223 126 130 O

- NCT03928223 133 134 O
lack NCT03928223 136 140 O
of NCT03928223 141 143 O
German NCT03928223 144 150 B-Language
language NCT03928223 151 159 I-Language
. NCT03928223 160 161 O

Inclusion NCT03924141 0 9 O
Criteria NCT03924141 10 18 O
: NCT03924141 19 20 O

- NCT03924141 24 25 O
Third NCT03924141 27 32 O
year NCT03924141 33 37 O
nursing NCT03924141 38 45 O
student NCT03924141 46 53 O

Exclusion NCT03924141 54 63 O
Criteria NCT03924141 64 72 O
: NCT03924141 73 74 O

- NCT03924141 78 79 O
Has NCT03924141 81 84 O
to NCT03924141 85 87 O
talk NCT03924141 88 92 O
and NCT03924141 93 96 O
understand NCT03924141 97 107 O
Norwegian NCT03924141 108 117 B-Language

Inclusion NCT03922256 0 9 O

- NCT03922256 12 13 O
Age NCT03922256 15 18 O
> NCT03922256 19 20 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03922256 22 24 B-Eq-Value
years NCT03922256 25 30 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03922256 30 31 O

- NCT03922256 34 35 O
Unilateral NCT03922256 37 47 O
fracture NCT03922256 48 56 B-Condition-Name
of NCT03922256 57 59 O
distal NCT03922256 60 66 O
radius NCT03922256 67 73 O
without NCT03922256 74 81 O
misalignment NCT03922256 82 94 O
( NCT03922256 95 96 O
dorsal NCT03922256 97 103 B-Observation-Name___Observation-Type-Value:measurement
angulation NCT03922256 104 114 I-Observation-Name___Observation-Type-Value:measurement
< NCT03922256 115 116 B-Eq-Operator___Eq-Operator-Value:LT
10 NCT03922256 118 120 B-Eq-Value
° NCT03922256 121 122 B-Eq-Unit
, NCT03922256 123 124 O
axial NCT03922256 125 130 B-Observation-Name___Observation-Type-Value:measurement
radial NCT03922256 131 137 I-Observation-Name___Observation-Type-Value:measurement
shortening NCT03922256 138 148 I-Observation-Name___Observation-Type-Value:measurement
< NCT03922256 149 150 B-Eq-Operator___Eq-Operator-Value:LT
5 NCT03922256 152 153 B-Eq-Value
mm NCT03922256 154 156 B-Eq-Unit
) NCT03922256 157 158 O
, NCT03922256 160 161 O
< NCT03922256 162 163 B-Eq-Operator___Eq-Operator-Value:LT
2 NCT03922256 165 166 B-Eq-Value
mm NCT03922256 167 169 B-Eq-Unit
intraarticular NCT03922256 170 184 B-Observation-Name
stepoff NCT03922256 185 192 I-Observation-Name
; NCT03922256 192 193 O

- NCT03922256 196 197 O
Independent NCT03922256 199 210 B-Condition-Name
in NCT03922256 211 213 O
activities NCT03922256 214 224 O
of NCT03922256 225 227 O
daily NCT03922256 228 233 O
living NCT03922256 234 240 O
; NCT03922256 240 241 O

- NCT03922256 244 245 O
Capable NCT03922256 247 254 O
and NCT03922256 255 258 O
willing NCT03922256 259 266 O
of NCT03922256 267 269 O
signing NCT03922256 270 277 O
informed NCT03922256 278 286 O
consent NCT03922256 287 294 O
. NCT03922256 295 296 O

Exclusion NCT03922256 298 307 O

- NCT03922256 310 311 O
Children NCT03922256 313 321 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
under NCT03922256 322 327 B-Eq-Operator___Eq-Operator-Value:LT
the NCT03922256 328 331 O
age NCT03922256 332 335 O
of NCT03922256 336 338 O
18 NCT03922256 340 342 B-Eq-Value
; NCT03922256 343 344 O

- NCT03922256 347 348 O
Fracture NCT03922256 350 358 B-Condition-Name
of NCT03922256 359 361 O
the NCT03922256 362 365 O
contralateral NCT03922256 366 379 O
arm NCT03922256 380 383 O
; NCT03922256 383 384 O

- NCT03922256 387 388 O
Other NCT03922256 390 395 O
fractures NCT03922256 396 405 B-Condition-Name
of NCT03922256 406 408 O
the NCT03922256 409 412 O
ipsilateral NCT03922256 413 424 O
arm NCT03922256 425 428 O
; NCT03922256 428 429 O

- NCT03922256 432 433 O
Open NCT03922256 435 439 O
fractures NCT03922256 440 449 B-Condition-Name
; NCT03922256 449 450 O

- NCT03922256 453 454 O
Fractures NCT03922256 456 465 B-Condition-Name
that NCT03922256 466 470 O
require NCT03922256 471 478 O
reduction NCT03922256 479 488 B-Procedure-Name
. NCT03922256 489 490 O

Inclusion NCT03929471 0 9 O
Criteria NCT03929471 10 18 O
: NCT03929471 19 20 O

- NCT03929471 24 25 O
Adult NCT03929471 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03929471 33 34 O
> NCT03929471 36 37 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03929471 39 41 B-Eq-Value
years NCT03929471 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03929471 48 51 O
) NCT03929471 52 53 O
outpatients NCT03929471 54 65 B-Encounter-Type___Encounter-Type-Value:outpatient
on NCT03929471 66 68 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
3 NCT03929471 70 71 B-Eq-Value
- NCT03929471 72 73 B-Eq-Operator___Eq-Operator-Value:BETWEEN
4 NCT03929471 75 76 B-Eq-Value
times NCT03929471 77 82 O
per NCT03929471 83 86 O
week NCT03929471 87 91 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
HD NCT03929471 92 94 B-Procedure-Name
sessions NCT03929471 95 103 O
for NCT03929471 104 107 O
at NCT03929471 108 110 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929471 111 116 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03929471 118 119 B-Eq-Value
weeks NCT03929471 120 125 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
with NCT03929471 126 130 O
a NCT03929471 131 132 O
life NCT03929471 133 137 B-Observation-Name
expectancy NCT03929471 138 148 I-Observation-Name
> NCT03929471 149 150 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03929471 152 153 B-Eq-Value
months NCT03929471 154 160 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03929471 161 162 O

- NCT03929471 166 167 O
Fluid NCT03929471 169 174 B-Observation-Name___Observation-Type-Value:measurement
overload NCT03929471 175 183 I-Observation-Name___Observation-Type-Value:measurement
≥ NCT03929471 184 185 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.1 NCT03929471 187 190 B-Eq-Value
L NCT03929471 191 192 B-Eq-Unit
. NCT03929471 193 194 O

- NCT03929471 198 199 O
Medically NCT03929471 201 210 O
stable NCT03929471 211 217 B-Stability___Stability-Value:stable
patient NCT03929471 218 225 O
. NCT03929471 226 227 O

- NCT03929471 231 232 O
Minimum NCT03929471 234 241 B-Eq-Operator___Eq-Operator-Value:GTEQ
of NCT03929471 242 244 O
3 NCT03929471 246 247 B-Eq-Value
hours NCT03929471 248 253 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
of NCT03929471 254 256 O
dialysis NCT03929471 257 265 B-Procedure-Name
per NCT03929471 266 269 O
session NCT03929471 270 277 O
. NCT03929471 278 279 O

Exclusion NCT03929471 281 290 O
Criteria NCT03929471 291 299 O
: NCT03929471 300 301 O

- NCT03929471 305 306 O
Pregnancy NCT03929471 308 317 B-Condition-Name
or NCT03929471 318 320 O
lactation NCT03929471 321 330 B-Condition-Name
. NCT03929471 331 332 O

- NCT03929471 336 337 O
Declined NCT03929471 339 347 O
informed NCT03929471 348 356 O
consent NCT03929471 357 364 O
. NCT03929471 365 366 O

- NCT03929471 375 376 O
Patients NCT03929471 378 386 O
with NCT03929471 387 391 O
cognitive NCT03929471 392 401 B-Condition-Name
dysfunction NCT03929471 402 413 I-Condition-Name
. NCT03929471 414 415 O

- NCT03929471 424 425 O
Severe NCT03929471 427 433 B-Severity___Severity-Value:severe
life NCT03929471 434 438 O
- NCT03929471 439 440 O
limiting NCT03929471 441 449 O
Comorbidities NCT03929471 450 463 O
( NCT03929471 464 465 O
malignant NCT03929471 466 475 B-Condition-Name
tumour NCT03929471 476 482 I-Condition-Name
, NCT03929471 483 484 O
tuberculosis NCT03929471 485 497 B-Condition-Name
, NCT03929471 498 499 O
. NCT03929471 501 502 O
. NCT03929471 503 504 O
. NCT03929471 505 506 O
. NCT03929471 507 508 O
) NCT03929471 509 510 O

- NCT03929471 519 520 O
Surgery NCT03929471 522 529 B-Procedure-Name
within NCT03929471 530 536 B-Eq-Operator___Eq-Operator-Value:LTEQ
six NCT03929471 537 540 B-Eq-Value
weeks NCT03929471 541 546 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03929471 547 549 O
the NCT03929471 550 553 O
study NCT03929471 554 559 O
. NCT03929471 560 561 O

- NCT03929471 570 571 O
Nocturnal NCT03929471 573 582 O
dialysis NCT03929471 583 591 B-Procedure-Name
patients NCT03929471 592 600 O
. NCT03929471 601 602 O

- NCT03929471 611 612 O
Patients NCT03929471 614 622 O
expected NCT03929471 623 631 O
to NCT03929471 632 634 O
receive NCT03929471 635 642 O
a NCT03929471 643 644 O
transplant NCT03929471 645 655 B-Procedure-Name
or NCT03929471 656 658 O
move NCT03929471 659 663 B-Observation-Name
to NCT03929471 664 666 O
another NCT03929471 667 674 O
center NCT03929471 675 681 B-Location
within NCT03929471 682 688 O
the NCT03929471 689 692 O
duration NCT03929471 693 701 O
of NCT03929471 702 704 O
the NCT03929471 705 708 O
study NCT03929471 709 714 O
. NCT03929471 715 716 O

- NCT03929471 725 726 O
Patients NCT03929471 728 736 O
with NCT03929471 737 741 O
arteriovenous NCT03929471 742 755 B-Condition-Name
fistula NCT03929471 756 763 I-Condition-Name
issues NCT03929471 764 770 O
. NCT03929471 771 772 O

Inclusion NCT03922295 0 9 O
Criteria NCT03922295 10 18 O
: NCT03922295 19 20 O

- NCT03922295 24 25 O
Patients NCT03922295 27 35 O
with NCT03922295 36 40 O
chronic NCT03922295 41 48 B-Condition-Name
suppurative NCT03922295 49 60 I-Condition-Name
otitis NCT03922295 61 67 I-Condition-Name
media NCT03922295 68 73 I-Condition-Name
with NCT03922295 74 78 O
total NCT03922295 79 84 O
or NCT03922295 85 87 O
subtotal NCT03922295 88 96 O
tympanic NCT03922295 97 105 B-Condition-Name
membrane NCT03922295 106 114 I-Condition-Name
perforation NCT03922295 115 126 I-Condition-Name
with NCT03922295 127 131 O
limited NCT03922295 132 139 B-Condition-Name
anterior NCT03922295 140 148 I-Condition-Name
remnant NCT03922295 149 156 I-Condition-Name
. NCT03922295 157 158 O

- NCT03922295 162 163 O
dry NCT03922295 165 168 B-Condition-Name
perforation NCT03922295 169 180 I-Condition-Name
for NCT03922295 181 184 O
at NCT03922295 185 187 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03922295 188 193 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03922295 195 196 B-Eq-Value
months NCT03922295 197 203 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03922295 204 205 O

Exclusion NCT03922295 207 216 O
Criteria NCT03922295 217 225 O
: NCT03922295 226 227 O

- NCT03922295 231 232 O
Recurrent NCT03922295 234 243 B-Condition-Name
perforation NCT03922295 244 255 I-Condition-Name
after NCT03922295 256 261 O
previous NCT03922295 262 270 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
myringoplasty NCT03922295 271 284 B-Procedure-Name
. NCT03922295 285 286 O

- NCT03922295 290 291 O
Ossicular NCT03922295 293 302 B-Procedure-Name
disruption NCT03922295 303 313 O
or NCT03922295 314 316 O
fixation NCT03922295 317 325 O
. NCT03922295 326 327 O

- NCT03922295 331 332 O
immune NCT03922295 334 340 B-Condition-Name
- NCT03922295 341 342 I-Condition-Name
compromised NCT03922295 343 354 I-Condition-Name
patients NCT03922295 355 363 O
including NCT03922295 364 373 O
uncontrolled NCT03922295 374 386 O
diabetics NCT03922295 387 396 B-Condition-Name
, NCT03922295 397 398 O
chronic NCT03922295 399 406 O
liver NCT03922295 407 412 O
and NCT03922295 413 416 O
kidney NCT03922295 417 423 O
diseases NCT03922295 424 432 B-Condition-Name
. NCT03922295 433 434 O

Inclusion NCT03921944 0 9 O
Criteria NCT03921944 10 18 O
: NCT03921944 19 20 O

- NCT03921944 24 25 O
age NCT03921944 27 30 O
> NCT03921944 31 32 B-Eq-Operator___Eq-Operator-Value:GT
45 NCT03921944 34 36 B-Eq-Value
yrs NCT03921944 37 40 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03921944 43 44 O
primary NCT03921944 46 53 O
diagnosis NCT03921944 54 63 O
of NCT03921944 64 66 O
osteoarthritis NCT03921944 67 81 B-Condition-Name
of NCT03921944 82 84 O
the NCT03921944 85 88 O
shoulder NCT03921944 89 97 O

- NCT03921944 100 101 O
total NCT03921944 103 108 B-Procedure-Name
shoulder NCT03921944 109 117 I-Procedure-Name
replacement NCT03921944 118 129 I-Procedure-Name
performed NCT03921944 130 139 O
by NCT03921944 140 142 O
Dr NCT03921944 143 145 O
. NCT03921944 146 147 O
Armstrong NCT03921944 149 158 O

- NCT03921944 161 162 O
administered NCT03921944 164 176 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03921944 177 178 O
local NCT03921944 179 184 B-Procedure-Name
anesthetic NCT03921944 185 195 I-Procedure-Name
mixture NCT03921944 196 203 O
and NCT03921944 204 207 O
not NCT03921944 208 211 O
regional NCT03921944 212 220 B-Procedure-Name
anesthesia NCT03921944 221 231 I-Procedure-Name

- NCT03921944 234 235 O
all NCT03921944 237 240 O
genders NCT03921944 241 248 O

- NCT03921944 251 252 O
Fluent NCT03921944 254 260 O
in NCT03921944 261 263 O
written NCT03921944 264 271 O
and NCT03921944 272 275 O
spoken NCT03921944 276 282 O
English NCT03921944 283 290 B-Language

- NCT03921944 293 294 O
Patients NCT03921944 296 304 O
capable NCT03921944 305 312 O
of NCT03921944 313 315 O
giving NCT03921944 316 322 O
informed NCT03921944 323 331 O
consent NCT03921944 332 339 O

Exclusion NCT03921944 340 349 O
Criteria NCT03921944 350 358 O
: NCT03921944 359 360 O

- NCT03921944 364 365 O
Known NCT03921944 367 372 O
contraindications NCT03921944 373 390 O
to NCT03921944 391 393 O
CT NCT03921944 394 396 B-Procedure-Name
/ NCT03921944 397 398 O
EMG NCT03921944 399 402 B-Procedure-Name

- NCT03921944 405 406 O
Inability NCT03921944 408 417 O
to NCT03921944 418 420 O
provide NCT03921944 421 428 O
informed NCT03921944 429 437 O
consent NCT03921944 438 445 O

- NCT03921944 448 449 O
History NCT03921944 451 458 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921944 459 461 O
recent NCT03921944 462 468 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
trauma NCT03921944 469 475 B-Condition-Name
to NCT03921944 476 478 O
the NCT03921944 479 482 O
shoulder NCT03921944 483 491 O

- NCT03921944 494 495 O
Atypical NCT03921944 497 505 O
shoulder NCT03921944 506 514 O
pain NCT03921944 515 519 B-Condition-Name

- NCT03921944 522 523 O
Other NCT03921944 525 530 O
suspected NCT03921944 531 540 O
shoulder NCT03921944 541 549 O
pathology NCT03921944 550 559 O
( NCT03921944 560 561 O
i NCT03921944 562 563 O
. NCT03921944 564 565 O
e NCT03921944 566 567 O
. NCT03921944 568 569 O
tumor NCT03921944 571 576 B-Condition-Name
, NCT03921944 577 578 O
infection NCT03921944 579 588 B-Condition-Name
) NCT03921944 589 590 O

- NCT03921944 594 595 O
Pregnancy NCT03921944 597 606 B-Condition-Name

- NCT03921944 609 610 O
Bilateral NCT03921944 612 621 O
total NCT03921944 622 627 B-Procedure-Name
shoulder NCT03921944 628 636 I-Procedure-Name
arthroplasty NCT03921944 637 649 I-Procedure-Name

Inclusion NCT03921788 0 9 O
Criteria NCT03921788 10 18 O
: NCT03921788 19 20 O

- NCT03921788 24 25 O
The NCT03921788 27 30 O
reproductive NCT03921788 31 43 B-Observation-Name
age NCT03921788 44 47 I-Observation-Name
of NCT03921788 48 50 O
the NCT03921788 51 54 O
woman NCT03921788 55 60 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03921788 63 64 O
Blood NCT03921788 66 71 B-Condition-Name
reflux NCT03921788 72 78 I-Condition-Name
in NCT03921788 79 81 O
the NCT03921788 82 85 O
parametric NCT03921788 86 96 O
, NCT03921788 97 98 O
uterine NCT03921788 99 106 O
, NCT03921788 107 108 O
gonadal NCT03921788 109 116 O
veins NCT03921788 117 122 O

- NCT03921788 125 126 O
The NCT03921788 128 131 O
absence NCT03921788 132 139 O
of NCT03921788 140 142 O
any NCT03921788 143 146 O
concomitant NCT03921788 147 158 O
pathology NCT03921788 159 168 B-Condition-Name
, NCT03921788 169 170 O
accompanied NCT03921788 171 182 O
by NCT03921788 183 185 O
chronic NCT03921788 186 193 O
pelvic NCT03921788 194 200 B-Condition-Name
pain NCT03921788 201 205 I-Condition-Name

Exclusion NCT03921788 206 215 O
Criteria NCT03921788 216 224 O
: NCT03921788 225 226 O

- NCT03921788 230 231 O
The NCT03921788 233 236 O
absence NCT03921788 237 244 O
of NCT03921788 245 247 O
blood NCT03921788 248 253 B-Condition-Name
reflux NCT03921788 254 260 I-Condition-Name
in NCT03921788 261 263 O
in NCT03921788 264 266 O
the NCT03921788 267 270 O
parametric NCT03921788 271 281 O
, NCT03921788 282 283 O
uterine NCT03921788 284 291 O
, NCT03921788 292 293 O
gonadal NCT03921788 294 301 O
veins NCT03921788 302 307 O

- NCT03921788 310 311 O
The NCT03921788 313 316 O
presence NCT03921788 317 325 O
of NCT03921788 326 328 O
diseases NCT03921788 329 337 B-Condition-Name
, NCT03921788 338 339 O
the NCT03921788 340 343 O
clinical NCT03921788 344 352 O
course NCT03921788 353 359 O
of NCT03921788 360 362 O
which NCT03921788 363 368 O
suggests NCT03921788 369 377 O
the NCT03921788 378 381 O
presence NCT03921788 382 390 O
of NCT03921788 391 393 O
chronic NCT03921788 394 401 O
pelvic NCT03921788 402 408 B-Condition-Name
pain NCT03921788 409 413 I-Condition-Name
and NCT03921788 414 417 O
other NCT03921788 418 423 O
varieties NCT03921788 424 433 O
of NCT03921788 434 436 O
chronic NCT03921788 437 444 O
pain NCT03921788 445 449 B-Condition-Name
, NCT03921788 450 451 O
including NCT03921788 452 461 O
migraine NCT03921788 462 470 B-Condition-Name

- NCT03921788 473 474 O
Pregnancy NCT03921788 476 485 B-Condition-Name

Inclusion NCT03929263 0 9 O
Criteria NCT03929263 10 18 O
: NCT03929263 19 20 O

- NCT03929263 24 25 O
Eligible NCT03929263 27 35 O
for NCT03929263 36 39 O
fMRI NCT03929263 40 44 B-Procedure-Name

- NCT03929263 47 48 O
Sufficient NCT03929263 50 60 O
English NCT03929263 61 68 B-Language
fluency NCT03929263 69 76 O
to NCT03929263 77 79 O
complete NCT03929263 80 88 O
tasks NCT03929263 89 94 O

- NCT03929263 97 98 O
BMI NCT03929263 100 103 B-Observation-Name___Observation-Type-Value:vital
≦ NCT03929263 104 105 B-Eq-Operator___Eq-Operator-Value:LTEQ
40.0 NCT03929263 107 111 B-Eq-Value

- NCT03929263 115 116 O
Right NCT03929263 118 123 B-Condition-Name
- NCT03929263 124 125 I-Condition-Name
handed NCT03929263 126 132 I-Condition-Name

- NCT03929263 135 136 O
Biological NCT03929263 138 148 O
female NCT03929263 149 155 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male

- NCT03929263 158 159 O
Co NCT03929263 161 163 B-Observation-Name___Observation-Type-Value:social-habit
- NCT03929263 164 165 I-Observation-Name___Observation-Type-Value:social-habit
residing NCT03929263 166 174 I-Observation-Name___Observation-Type-Value:social-habit
at NCT03929263 175 177 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929263 178 183 I-Eq-Operator___Eq-Operator-Value:GTEQ
4 NCT03929263 185 186 B-Eq-Value
days NCT03929263 187 191 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
/ NCT03929263 192 193 O
week NCT03929263 194 198 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03929263 201 202 O
Adult NCT03929263 204 209 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
participants NCT03929263 210 222 O
: NCT03929263 223 224 O
Biological NCT03929263 225 235 O
mother NCT03929263 236 242 O
of NCT03929263 243 245 O
adolescent NCT03929263 246 256 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
participant NCT03929263 257 268 O

- NCT03929263 271 272 O
Adult NCT03929263 274 279 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
participants NCT03929263 280 292 O
: NCT03929263 293 294 O
Primary NCT03929263 295 302 O
caregiver NCT03929263 303 312 O
> NCT03929263 313 314 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03929263 316 318 B-Eq-Value
% NCT03929263 319 320 B-Eq-Unit
of NCT03929263 321 323 O
child NCT03929263 324 329 O
's NCT03929263 329 331 O
lifespan NCT03929263 332 340 B-Observation-Name

- NCT03929263 343 344 O
Adult NCT03929263 346 351 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
participants NCT03929263 352 364 O
: NCT03929263 365 366 O
BMI NCT03929263 367 370 B-Observation-Name___Observation-Type-Value:vital
≧ NCT03929263 371 372 B-Eq-Operator___Eq-Operator-Value:GT
18.0 NCT03929263 374 378 B-Eq-Value

- NCT03929263 382 383 O
Adolescent NCT03929263 385 395 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
participants NCT03929263 396 408 O
: NCT03929263 409 410 O
Age NCT03929263 411 414 O
13 NCT03929263 416 418 B-Eq-Value
- NCT03929263 419 420 B-Eq-Operator___Eq-Operator-Value:BETWEEN
17 NCT03929263 422 424 B-Eq-Value
years NCT03929263 425 430 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03929263 433 434 O
Adolescent NCT03929263 436 446 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
participants NCT03929263 447 459 O
: NCT03929263 460 461 O
BMI NCT03929263 462 465 B-Observation-Name___Observation-Type-Value:vital
≧ NCT03929263 466 467 B-Eq-Operator___Eq-Operator-Value:GTEQ
16.0 NCT03929263 469 473 B-Eq-Value

Exclusion NCT03929263 475 484 O
Criteria NCT03929263 485 493 O
: NCT03929263 494 495 O

- NCT03929263 499 500 O
Current NCT03929263 502 509 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
psychiatric NCT03929263 510 521 B-Condition-Name
diagnosis NCT03929263 522 531 I-Condition-Name

- NCT03929263 534 535 O
Medications NCT03929263 537 548 O
influencing NCT03929263 549 560 B-Stability___Stability-Value:change
fMRI NCT03929263 561 565 B-Procedure-Name

- NCT03929263 568 569 O
Medical NCT03929263 571 578 O
conditions NCT03929263 579 589 O
influencing NCT03929263 590 601 B-Stability___Stability-Value:change
fMRI NCT03929263 602 606 B-Procedure-Name

- NCT03929263 609 610 O
Alcohol NCT03929263 612 619 B-Drug-Name
or NCT03929263 620 622 O
psychoactive NCT03929263 623 635 B-Drug-Name
drug NCT03929263 636 640 I-Drug-Name
on NCT03929263 641 643 O
scan NCT03929263 644 648 O
day NCT03929263 649 652 O

- NCT03929263 655 656 O
Adolescent NCT03929263 658 668 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
participants NCT03929263 669 681 O
: NCT03929263 682 683 O
Neurodevelopmental NCT03929263 684 702 B-Condition-Name
delay NCT03929263 703 708 I-Condition-Name

- NCT03929263 711 712 O
Adolescent NCT03929263 714 724 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
participants NCT03929263 725 737 O
: NCT03929263 738 739 O
History NCT03929263 740 747 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929263 748 750 O
mood NCT03929263 751 755 O
or NCT03929263 756 758 O
psychotic NCT03929263 759 768 O
disorder NCT03929263 769 777 B-Condition-Name

- NCT03929263 780 781 O
Adolescent NCT03929263 783 793 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
participants NCT03929263 794 806 O
: NCT03929263 807 808 O
History NCT03929263 809 816 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929263 817 819 O
obsessive NCT03929263 820 829 B-Condition-Name
- NCT03929263 830 831 I-Condition-Name
compulsive NCT03929263 832 842 I-Condition-Name
disorder NCT03929263 843 851 I-Condition-Name
( NCT03929263 852 853 O
OCD NCT03929263 854 857 B-Condition-Name
) NCT03929263 858 859 O
or NCT03929263 860 862 O
attention NCT03929263 863 872 B-Condition-Name
- NCT03929263 873 874 I-Condition-Name
deficit NCT03929263 875 882 I-Condition-Name
/ NCT03929263 883 884 I-Condition-Name
hyperactivity NCT03929263 885 898 I-Condition-Name
disorder NCT03929263 899 907 I-Condition-Name
( NCT03929263 908 909 O
ADHD NCT03929263 910 914 B-Condition-Name
) NCT03929263 915 916 O

Inclusion NCT03924960 0 9 O
Criteria NCT03924960 10 18 O
: NCT03924960 19 20 O

- NCT03924960 24 25 O
Subjects NCT03924960 27 35 O
diagnosed NCT03924960 36 45 O
according NCT03924960 46 55 O
to NCT03924960 56 58 O
the NCT03924960 59 62 O
American NCT03924960 63 71 O
College NCT03924960 72 79 O
of NCT03924960 80 82 O
Rheumatology NCT03924960 83 95 O
2016 NCT03924960 97 101 O
diagnostic NCT03924960 102 112 O
criteria NCT03924960 113 121 O
for NCT03924960 122 125 O
fibromyalgia NCT03924960 126 138 B-Condition-Name
. NCT03924960 139 140 O

Exclusion NCT03924960 142 151 O
Criteria NCT03924960 152 160 O
: NCT03924960 161 162 O

- NCT03924960 166 167 O
History NCT03924960 169 176 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924960 177 179 O
comorbid NCT03924960 180 188 B-Condition-Name
inflammatory NCT03924960 189 201 I-Condition-Name
rheumatic NCT03924960 202 211 I-Condition-Name
/ NCT03924960 212 213 O
connective NCT03924960 214 224 B-Condition-Name
tissue NCT03924960 225 231 I-Condition-Name
diseases NCT03924960 232 240 I-Condition-Name

- NCT03924960 243 244 O
History NCT03924960 246 253 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924960 254 256 O
cardiovascular NCT03924960 257 271 O
or NCT03924960 272 274 O
musculoskeletal NCT03924960 275 290 O
problems NCT03924960 291 299 B-Condition-Name
that NCT03924960 300 304 O
could NCT03924960 305 310 O
prevent NCT03924960 311 318 O
them NCT03924960 319 323 O
to NCT03924960 324 326 O
participate NCT03924960 327 338 O
in NCT03924960 339 341 O
an NCT03924960 342 344 O
exercise NCT03924960 345 353 B-Procedure-Name
program NCT03924960 354 361 I-Procedure-Name
. NCT03924960 362 363 O

Inclusion NCT03928431 0 9 O
Criteria NCT03928431 10 18 O
: NCT03928431 19 20 O

- NCT03928431 24 25 O
Infants NCT03928431 27 34 O
of NCT03928431 35 37 O
healthy NCT03928431 38 45 B-Condition-Name
mothers NCT03928431 46 53 O
with NCT03928431 54 58 O
uncomplicated NCT03928431 59 72 O
pregnancies NCT03928431 73 84 B-Condition-Name
at NCT03928431 85 87 O
term NCT03928431 88 92 O
, NCT03928431 93 94 O
mothers NCT03928431 95 102 O
of NCT03928431 103 105 O
any NCT03928431 106 109 O
ethnic NCT03928431 110 116 O
or NCT03928431 117 119 O
social NCT03928431 120 126 O
background NCT03928431 127 137 O
that NCT03928431 138 142 O
can NCT03928431 143 146 O
speak NCT03928431 147 152 O
, NCT03928431 153 154 O
read NCT03928431 155 159 O
, NCT03928431 160 161 O
and NCT03928431 162 165 O
understand NCT03928431 166 176 O
Swedish NCT03928431 177 184 B-Language
to NCT03928431 185 187 O
the NCT03928431 188 191 O
extent NCT03928431 192 198 O
that NCT03928431 199 203 O
they NCT03928431 204 208 O
can NCT03928431 209 212 O
consent NCT03928431 213 220 O
in NCT03928431 221 223 O
Swedish NCT03928431 224 231 B-Language
. NCT03928431 232 233 O
An NCT03928431 235 237 O
additional NCT03928431 238 248 O
inclusion NCT03928431 249 258 O
criterion NCT03928431 259 268 O
for NCT03928431 269 272 O
mothers NCT03928431 273 280 O
in NCT03928431 281 283 O
the NCT03928431 284 287 O
CS NCT03928431 288 290 O
groups NCT03928431 291 297 O
is NCT03928431 298 300 O
vaginal NCT03928431 301 308 B-Observation-Name___Observation-Type-Value:lab
pH NCT03928431 309 311 I-Observation-Name___Observation-Type-Value:lab
≤ NCT03928431 312 313 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03928431 315 316 B-Eq-Value
at NCT03928431 317 319 O
the NCT03928431 320 323 O
time NCT03928431 324 328 O
of NCT03928431 329 331 O
birth NCT03928431 332 337 O
. NCT03928431 338 339 O

Exclusion NCT03928431 341 350 O
Criteria NCT03928431 351 359 O
: NCT03928431 360 361 O

- NCT03928431 365 366 O
Infants NCT03928431 368 375 O
of NCT03928431 376 378 O
mothers NCT03928431 379 386 O
with NCT03928431 387 391 O
pre NCT03928431 392 395 B-Condition-Name
- NCT03928431 396 397 I-Condition-Name
eclampsia NCT03928431 398 407 I-Condition-Name
or NCT03928431 408 410 O
complicated NCT03928431 411 422 O
pregnancies NCT03928431 423 434 B-Condition-Name
, NCT03928431 435 436 O
mothers NCT03928431 437 444 O
< NCT03928431 445 446 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03928431 448 450 B-Eq-Value
years NCT03928431 451 456 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03928431 457 459 O
> NCT03928431 460 461 B-Eq-Operator___Eq-Operator-Value:GT
40 NCT03928431 463 465 B-Eq-Value
years NCT03928431 466 471 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03928431 472 474 O
age NCT03928431 475 478 O
, NCT03928431 479 480 O
genital NCT03928431 481 488 B-Condition-Name
herpes NCT03928431 489 495 I-Condition-Name
simplex NCT03928431 496 503 I-Condition-Name
, NCT03928431 504 505 O
genital NCT03928431 506 513 B-Condition-Name
warts NCT03928431 514 519 I-Condition-Name
, NCT03928431 520 521 O
HIV NCT03928431 522 525 B-Condition-Name
, NCT03928431 526 527 O
Hepatitis NCT03928431 528 537 B-Condition-Name
B NCT03928431 538 539 I-Condition-Name
or NCT03928431 540 542 O
complications NCT03928431 543 556 B-Condition-Name
during NCT03928431 557 563 O
delivery NCT03928431 564 572 B-Condition-Name
, NCT03928431 573 574 O
infants NCT03928431 575 582 O
delivered NCT03928431 583 592 O
prior NCT03928431 593 598 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
to NCT03928431 599 601 O
37 NCT03928431 603 605 B-Eq-Value
weeks NCT03928431 606 611 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
of NCT03928431 612 614 O
gestation NCT03928431 615 624 B-Observation-Name___Observation-Type-Value:measurement
. NCT03928431 625 626 O
Additional NCT03928431 628 638 O
exclusion NCT03928431 639 648 O
criteria NCT03928431 649 657 O
for NCT03928431 658 661 O
mothers NCT03928431 662 669 O
in NCT03928431 670 672 O
the NCT03928431 673 676 O
CS NCT03928431 677 679 O
group NCT03928431 680 685 O
: NCT03928431 686 687 O
Mothers NCT03928431 688 695 O
positive NCT03928431 696 704 B-Polarity___Polarity-Value:positive
to NCT03928431 705 707 O
Group NCT03928431 708 713 B-Condition-Name
B NCT03928431 714 715 I-Condition-Name
Streptococcus NCT03928431 716 729 I-Condition-Name
, NCT03928431 730 731 O
Group NCT03928431 732 737 B-Condition-Name
A NCT03928431 738 739 I-Condition-Name
Streptococcus NCT03928431 740 753 I-Condition-Name
, NCT03928431 754 755 O
bacterial NCT03928431 756 765 B-Condition-Name
vaginosis NCT03928431 766 775 I-Condition-Name
, NCT03928431 776 777 O
vaginal NCT03928431 778 785 B-Observation-Name___Observation-Type-Value:lab
pH NCT03928431 786 788 I-Observation-Name___Observation-Type-Value:lab
> NCT03928431 789 790 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03928431 792 793 B-Eq-Value
at NCT03928431 794 796 O
the NCT03928431 797 800 O
time NCT03928431 801 805 O
of NCT03928431 806 808 O
birth NCT03928431 809 814 O
. NCT03928431 815 816 O
Mothers NCT03928431 818 825 O
with NCT03928431 826 830 O
fecal NCT03928431 831 836 B-Observation-Specimen
samples NCT03928431 837 844 B-Observation-Name___Observation-Type-Value:lab
positive NCT03928431 845 853 B-Polarity___Polarity-Value:positive
for NCT03928431 854 857 O
Salmonella NCT03928431 858 868 B-Organism-Name
, NCT03928431 869 870 O
Shigella NCT03928431 871 879 B-Organism-Name
, NCT03928431 880 881 O
Campylobacter NCT03928431 882 895 B-Organism-Name
or NCT03928431 896 898 O
Yersinia NCT03928431 899 907 B-Organism-Name
. NCT03928431 908 909 O

Inclusion NCT03925129 0 9 O
Criteria NCT03925129 10 18 O
: NCT03925129 19 20 O

- NCT03925129 24 25 O
Patients NCT03925129 27 35 O
seeking NCT03925129 36 43 O
medication NCT03925129 44 54 O
abortion NCT03925129 55 63 B-Procedure-Name
with NCT03925129 64 68 O
a NCT03925129 69 70 O
definite NCT03925129 71 79 O
, NCT03925129 80 81 O
singleton NCT03925129 82 91 O
, NCT03925129 92 93 O
intrauterine NCT03925129 94 106 O
pregnancy NCT03925129 107 116 B-Condition-Name
( NCT03925129 117 118 O
IUP NCT03925129 119 122 B-Condition-Name
) NCT03925129 123 124 O
< NCT03925129 125 126 B-Eq-Operator___Eq-Operator-Value:LT
70 NCT03925129 128 130 B-Eq-Value
days NCT03925129 131 135 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
' NCT03925129 135 136 O
gestation NCT03925129 137 146 B-Observation-Name
on NCT03925129 147 149 O
ultrasound NCT03925129 150 160 B-Procedure-Name

- NCT03925129 163 164 O
Rapid NCT03925129 166 171 B-Observation-Name___Observation-Type-Value:clinical-score
Estimate NCT03925129 172 180 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03925129 181 183 I-Observation-Name___Observation-Type-Value:clinical-score
Adult NCT03925129 184 189 I-Observation-Name___Observation-Type-Value:clinical-score
Literacy NCT03925129 190 198 I-Observation-Name___Observation-Type-Value:clinical-score
in NCT03925129 199 201 I-Observation-Name___Observation-Type-Value:clinical-score
Medicine NCT03925129 202 210 I-Observation-Name___Observation-Type-Value:clinical-score
- NCT03925129 211 212 I-Observation-Name___Observation-Type-Value:clinical-score
Short NCT03925129 213 218 I-Observation-Name___Observation-Type-Value:clinical-score
Form NCT03925129 219 223 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03925129 224 225 O
REALM NCT03925129 226 231 B-Observation-Name
- NCT03925129 232 233 I-Observation-Name
SF NCT03925129 234 236 I-Observation-Name
) NCT03925129 237 238 O
22 NCT03925129 240 242 O
score NCT03925129 243 248 B-Eq-Unit
> NCT03925129 249 250 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03925129 252 253 B-Eq-Value

- NCT03925129 257 258 O
Age NCT03925129 260 263 O
equal NCT03925129 264 269 B-Eq-Operator___Eq-Operator-Value:GTEQ
to NCT03925129 270 272 I-Eq-Operator___Eq-Operator-Value:GTEQ
or NCT03925129 273 275 I-Eq-Operator___Eq-Operator-Value:GTEQ
greater NCT03925129 276 283 I-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03925129 284 288 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03925129 290 292 B-Eq-Value
years NCT03925129 293 298 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03925129 301 302 O
Provide NCT03925129 304 311 O
informed NCT03925129 312 320 O
consent NCT03925129 321 328 O
to NCT03925129 329 331 O
participate NCT03925129 332 343 O

- NCT03925129 346 347 O
Willing NCT03925129 349 356 O
to NCT03925129 357 359 O
adhere NCT03925129 360 366 O
to NCT03925129 367 369 O
study NCT03925129 370 375 O
procedures NCT03925129 376 386 O
, NCT03925129 387 388 O
including NCT03925129 389 398 O
access NCT03925129 399 405 O
to NCT03925129 406 408 O
a NCT03925129 409 410 O
smart NCT03925129 411 416 O
phone NCT03925129 417 422 O
, NCT03925129 423 424 O
ability NCT03925129 425 432 O
to NCT03925129 433 435 O
receive NCT03925129 436 443 O
text NCT03925129 444 448 O
messages NCT03925129 449 457 O
and NCT03925129 458 461 O
answer NCT03925129 462 468 O
online NCT03925129 469 475 O
surveys NCT03925129 476 483 O
on NCT03925129 484 486 O
smart NCT03925129 487 492 O
phone NCT03925129 493 498 O

Exclusion NCT03925129 499 508 O
Criteria NCT03925129 509 517 O
: NCT03925129 518 519 O

- NCT03925129 523 524 O
Contraindication NCT03925129 526 542 O
to NCT03925129 543 545 O
medication NCT03925129 546 556 O
abortion NCT03925129 557 565 B-Procedure-Name

- NCT03925129 568 569 O
Allergy NCT03925129 571 578 O
to NCT03925129 579 581 O
mifepristone NCT03925129 582 594 B-Drug-Name
or NCT03925129 595 597 O
misoprostol NCT03925129 598 609 B-Drug-Name

- NCT03925129 612 613 O
Contraindication NCT03925129 615 631 O
or NCT03925129 632 634 O
allergy NCT03925129 635 642 O
to NCT03925129 643 645 O
ibuprofen NCT03925129 646 655 B-Drug-Name

- NCT03925129 658 659 O
History NCT03925129 661 668 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925129 669 671 O
cardiac NCT03925129 672 679 B-Condition-Name
arrhythmia NCT03925129 680 690 I-Condition-Name

- NCT03925129 693 694 O
Presence NCT03925129 696 704 O
of NCT03925129 705 707 O
an NCT03925129 708 710 O
implantable NCT03925129 711 722 B-Procedure-Name
device NCT03925129 723 729 I-Procedure-Name
with NCT03925129 730 734 O
electrical NCT03925129 735 745 O
discharge NCT03925129 746 755 O
, NCT03925129 756 757 O
i NCT03925129 758 759 O
. NCT03925129 760 761 O
e NCT03925129 762 763 O
. NCT03925129 764 765 O
cardiac NCT03925129 767 774 B-Procedure-Name
pacemaker NCT03925129 775 784 I-Procedure-Name

- NCT03925129 787 788 O
History NCT03925129 790 797 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925129 798 800 O
chronic NCT03925129 801 808 O
pain NCT03925129 809 813 B-Condition-Name
disorder NCT03925129 814 822 I-Condition-Name

- NCT03925129 825 826 O
Any NCT03925129 828 831 O
opioid NCT03925129 832 838 B-Drug-Name
use NCT03925129 839 842 O
during NCT03925129 843 849 O
previous NCT03925129 850 858 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
30 NCT03925129 860 862 B-Eq-Value
days NCT03925129 863 867 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

- NCT03925129 870 871 O
Current NCT03925129 873 880 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03925129 881 883 O
prior NCT03925129 884 889 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
use NCT03925129 890 893 O
of NCT03925129 894 896 O
TENS NCT03925129 897 901 B-Procedure-Name

- NCT03925129 904 905 O
BMI NCT03925129 907 910 B-Observation-Name___Observation-Type-Value:vital
> NCT03925129 911 912 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03925129 914 916 B-Eq-Value

Inclusion NCT03925883 0 9 O
Criteria NCT03925883 10 18 O
: NCT03925883 19 20 O

- NCT03925883 24 25 O
Positive NCT03925883 27 35 B-Polarity___Polarity-Value:positive
FIT NCT03925883 36 39 B-Observation-Name
test NCT03925883 40 44 I-Observation-Name

Exclusion NCT03925883 45 54 O
Criteria NCT03925883 55 63 O
: NCT03925883 64 65 O

- NCT03925883 69 70 O
Prior NCT03925883 72 77 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
colorectal NCT03925883 78 88 O
cancer NCT03925883 89 95 B-Condition-Name

- NCT03925883 98 99 O
Dialysis NCT03925883 101 109 B-Procedure-Name
patient NCT03925883 110 117 O

Inclusion NCT03920904 0 9 O
Criteria NCT03920904 10 18 O
: NCT03920904 19 20 O

- NCT03920904 24 25 O
ASA NCT03920904 27 30 B-Condition-Name
l NCT03920904 31 32 B-Eq-Value
- NCT03920904 33 34 B-Eq-Operator___Eq-Operator-Value:BETWEEN
lll NCT03920904 35 38 B-Eq-Value

- NCT03920904 41 42 O
Undergoing NCT03920904 44 54 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
sternotomy NCT03920904 55 65 B-Procedure-Name
for NCT03920904 66 69 O
cardiac NCT03920904 70 77 B-Procedure-Name
surgery NCT03920904 78 85 I-Procedure-Name
under NCT03920904 86 91 O
a NCT03920904 92 93 O
PIFB NCT03920904 94 98 B-Procedure-Name
and NCT03920904 99 102 O
general NCT03920904 103 110 B-Procedure-Name
anesthesia NCT03920904 111 121 I-Procedure-Name

Exclusion NCT03920904 122 131 O
Criteria NCT03920904 132 140 O
: NCT03920904 141 142 O

- NCT03920904 146 147 O
Patient NCT03920904 149 156 O
's NCT03920904 156 158 O
refusal NCT03920904 159 166 O
or NCT03920904 167 169 O
inability NCT03920904 170 179 O
to NCT03920904 180 182 O
consent NCT03920904 183 190 O

- NCT03920904 193 194 O
Allergy NCT03920904 196 203 O
, NCT03920904 204 205 O
hypersensibility NCT03920904 206 222 B-Condition-Name
or NCT03920904 223 225 O
resistance NCT03920904 226 236 B-Condition-Name
to NCT03920904 237 239 O
local NCT03920904 240 245 B-Procedure-Name
anesthetic NCT03920904 246 256 I-Procedure-Name

- NCT03920904 259 260 O
Contraindication NCT03920904 262 278 O
to NCT03920904 279 281 O
regional NCT03920904 282 290 B-Procedure-Name
anesthesia NCT03920904 291 301 I-Procedure-Name
: NCT03920904 302 303 O
infection NCT03920904 304 313 B-Condition-Name
in NCT03920904 314 316 O
the NCT03920904 317 320 O
designated NCT03920904 321 331 O
area NCT03920904 332 336 O
, NCT03920904 337 338 O
severe NCT03920904 339 345 B-Severity___Severity-Value:severe
congenital NCT03920904 346 356 O
coagulopathy NCT03920904 357 369 B-Condition-Name
or NCT03920904 370 372 O
inadequate NCT03920904 373 383 O
hemostasis NCT03920904 384 394 B-Procedure-Name
before NCT03920904 395 401 O
PIFB NCT03920904 402 406 B-Procedure-Name

- NCT03920904 409 410 O
Severe NCT03920904 412 418 B-Severity___Severity-Value:severe
hepatic NCT03920904 419 426 O
( NCT03920904 427 428 O
Child NCT03920904 429 434 O
B NCT03920904 435 436 O
and NCT03920904 437 440 O
C NCT03920904 441 442 O
) NCT03920904 443 444 O
or NCT03920904 445 447 O
renal NCT03920904 448 453 O
insufficiency NCT03920904 454 467 B-Condition-Name
( NCT03920904 468 469 O
GFR NCT03920904 470 473 B-Observation-Name___Observation-Type-Value:lab
< NCT03920904 474 475 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03920904 477 479 B-Eq-Value
mL NCT03920904 480 482 B-Eq-Unit
/ NCT03920904 483 484 O
min NCT03920904 485 488 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
) NCT03920904 489 490 O

Inclusion NCT03922685 0 9 O
Criteria NCT03922685 10 18 O
: NCT03922685 19 20 O

- NCT03922685 24 25 O
postmenopausal NCT03922685 27 41 B-Condition-Name

- NCT03922685 44 45 O
normal NCT03922685 47 53 B-Polarity___Polarity-Value:normal
blood NCT03922685 54 59 B-Observation-Name___Observation-Type-Value:lab
glucose NCT03922685 60 67 I-Observation-Name___Observation-Type-Value:lab

- NCT03922685 70 71 O
no NCT03922685 73 75 O
cholesterol NCT03922685 76 87 B-Condition-Name
medication NCT03922685 88 98 O

- NCT03922685 101 102 O
age NCT03922685 104 107 O
between NCT03922685 108 115 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03922685 117 119 B-Eq-Value
an NCT03922685 120 122 O
65 NCT03922685 124 126 B-Eq-Value
years NCT03922685 127 132 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03922685 135 136 O
overweight NCT03922685 138 148 B-Condition-Name
but NCT03922685 149 152 O
not NCT03922685 153 156 O
obese NCT03922685 157 162 B-Condition-Name

- NCT03922685 165 166 O
BMI NCT03922685 168 171 B-Observation-Name___Observation-Type-Value:vital
between NCT03922685 172 179 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03922685 181 183 B-Eq-Value
and NCT03922685 184 187 O
30 NCT03922685 189 191 B-Eq-Value
kg NCT03922685 192 194 B-Eq-Unit
/ NCT03922685 195 196 O
m NCT03922685 197 198 B-Eq-Unit
2 NCT03922685 199 200 I-Eq-Unit

- NCT03922685 203 204 O
weight NCT03922685 206 212 B-Observation-Name___Observation-Type-Value:vital
- NCT03922685 213 214 O
stable NCT03922685 215 221 B-Stability___Stability-Value:stable
during NCT03922685 222 228 O
past NCT03922685 229 233 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03922685 235 236 B-Eq-Value
months NCT03922685 237 243 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03922685 246 247 O
exercise NCT03922685 249 257 B-Observation-Name___Observation-Type-Value:social-habit
less NCT03922685 258 262 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03922685 263 267 I-Eq-Operator___Eq-Operator-Value:LT
20 NCT03922685 269 271 B-Eq-Value
minutes NCT03922685 272 279 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
three NCT03922685 280 285 B-Eq-Value
times NCT03922685 286 291 O
a NCT03922685 292 293 O
week NCT03922685 294 298 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

Exclusion NCT03922685 299 308 O
Criteria NCT03922685 309 317 O
: NCT03922685 318 319 O

- NCT03922685 323 324 O
metabolic NCT03922685 326 335 B-Condition-Name
disease NCT03922685 336 343 I-Condition-Name
other NCT03922685 344 349 O
than NCT03922685 350 354 O
hormonally NCT03922685 355 365 O
- NCT03922685 366 367 O
corrected NCT03922685 368 377 O
hypothyroidism NCT03922685 378 392 B-Condition-Name

- NCT03922685 395 396 O
musculo NCT03922685 398 405 B-Condition-Name
- NCT03922685 406 407 I-Condition-Name
skeletal NCT03922685 408 416 I-Condition-Name
disability NCT03922685 417 427 I-Condition-Name
that NCT03922685 428 432 O
would NCT03922685 433 438 O
preclude NCT03922685 439 447 O
exercise NCT03922685 448 456 B-Observation-Name

- NCT03922685 459 460 O
smoker NCT03922685 462 468 B-Condition-Name

- NCT03922685 471 472 O
do NCT03922685 474 476 O
not NCT03922685 477 480 O
meet NCT03922685 481 485 O
inclusion NCT03922685 486 495 O
criteria NCT03922685 496 504 O

Inclusion NCT03921398 0 9 O
Criteria NCT03921398 10 18 O
( NCT03921398 19 20 O
ESRD NCT03921398 21 25 B-Condition-Name
group NCT03921398 26 31 O
) NCT03921398 32 33 O
: NCT03921398 35 36 O

- NCT03921398 40 41 O
Age NCT03921398 43 46 O
≥ NCT03921398 47 48 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03921398 50 52 B-Eq-Value
years NCT03921398 53 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03921398 59 60 O

- NCT03921398 64 65 O
History NCT03921398 67 74 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921398 75 77 O
biopsy NCT03921398 78 84 O
- NCT03921398 85 86 O
proven NCT03921398 87 93 O
lupus NCT03921398 94 99 B-Condition-Name
nephritis NCT03921398 100 109 I-Condition-Name

- NCT03921398 112 113 O
All NCT03921398 115 118 O
classes NCT03921398 119 126 O
of NCT03921398 127 129 O
lupus NCT03921398 130 135 B-Condition-Name
nephritis NCT03921398 136 145 I-Condition-Name

- NCT03921398 148 149 O
Written NCT03921398 151 158 O
informed NCT03921398 159 167 O
consent NCT03921398 168 175 O

- NCT03921398 178 179 O
Affiliation NCT03921398 181 192 O
to NCT03921398 193 195 O
a NCT03921398 196 197 O
social NCT03921398 198 204 O
security NCT03921398 205 213 O
regime NCT03921398 214 220 O

Exclusion NCT03921398 221 230 O
Criteria NCT03921398 231 239 O
( NCT03921398 240 241 O
ESRD NCT03921398 242 246 B-Condition-Name
group NCT03921398 247 252 O
) NCT03921398 253 254 O
: NCT03921398 256 257 O

- NCT03921398 261 262 O
Past NCT03921398 264 268 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
- NCT03921398 269 270 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
history NCT03921398 271 278 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03921398 279 281 O
kidney NCT03921398 282 288 O
transplantation NCT03921398 289 304 B-Procedure-Name

- NCT03921398 307 308 O
Active NCT03921398 310 316 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03921398 317 326 B-Condition-Name

- NCT03921398 329 330 O
Active NCT03921398 332 338 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
allergy NCT03921398 339 346 O
( NCT03921398 347 348 O
such NCT03921398 349 353 O
as NCT03921398 354 356 O
hay NCT03921398 357 360 B-Condition-Name
fever NCT03921398 361 366 I-Condition-Name
) NCT03921398 367 368 O

- NCT03921398 372 373 O
Pregnant NCT03921398 375 383 B-Condition-Name
or NCT03921398 384 386 O
breastfeeding NCT03921398 387 400 B-Condition-Name
women NCT03921398 401 406 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03921398 409 410 O
Protected NCT03921398 412 421 O
adults NCT03921398 422 428 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03921398 429 430 O
individuals NCT03921398 431 442 O
under NCT03921398 443 448 B-Observation-Name
guardianship NCT03921398 449 461 I-Observation-Name
by NCT03921398 462 464 O
court NCT03921398 465 470 O
order NCT03921398 471 476 O
) NCT03921398 477 478 O

Inclusion NCT03921398 480 489 O
criteria NCT03921398 490 498 O
( NCT03921398 499 500 O
non NCT03921398 501 504 O
ESRD NCT03921398 505 509 B-Condition-Name
group NCT03921398 510 515 O
) NCT03921398 516 517 O
: NCT03921398 519 520 O

- NCT03921398 524 525 O
Age NCT03921398 527 530 O
≥ NCT03921398 531 532 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03921398 534 536 B-Eq-Value
years NCT03921398 537 542 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03921398 543 544 O

- NCT03921398 548 549 O
Biopsy NCT03921398 551 557 B-Procedure-Name
proven NCT03921398 558 564 O
ACTIVE NCT03921398 565 571 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
lupus NCT03921398 572 577 B-Condition-Name
nephritis NCT03921398 578 587 I-Condition-Name

- NCT03921398 590 591 O
First NCT03921398 593 598 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
event NCT03921398 599 604 O
of NCT03921398 605 607 O
lupus NCT03921398 608 613 B-Condition-Name
nephritis NCT03921398 614 623 I-Condition-Name

- NCT03921398 626 627 O
No NCT03921398 629 631 O
immunosuppressive NCT03921398 632 649 B-Procedure-Name
therapy NCT03921398 650 657 I-Procedure-Name
( NCT03921398 658 659 O
including NCT03921398 660 669 O
corticosteroids NCT03921398 670 685 B-Drug-Name
) NCT03921398 686 687 O

- NCT03921398 691 692 O
Written NCT03921398 694 701 O
informed NCT03921398 702 710 O
consent NCT03921398 711 718 O

- NCT03921398 721 722 O
Affiliation NCT03921398 724 735 O
to NCT03921398 736 738 O
a NCT03921398 739 740 O
social NCT03921398 741 747 O
security NCT03921398 748 756 O
regime NCT03921398 757 763 O

Exclusion NCT03921398 764 773 O
criteria NCT03921398 774 782 O
( NCT03921398 783 784 O
non NCT03921398 785 788 O
ESRD NCT03921398 789 793 B-Condition-Name
group NCT03921398 794 799 O
) NCT03921398 800 801 O
: NCT03921398 802 803 O

- NCT03921398 807 808 O
Immunosuppressive NCT03921398 810 827 B-Procedure-Name
treatment NCT03921398 828 837 I-Procedure-Name

- NCT03921398 840 841 O
Relapse NCT03921398 843 850 B-Condition-Name
of NCT03921398 851 853 O
lupus NCT03921398 854 859 B-Condition-Name
nephritis NCT03921398 860 869 I-Condition-Name
under NCT03921398 870 875 O
treatment NCT03921398 876 885 O

- NCT03921398 888 889 O
Pregnant NCT03921398 891 899 B-Condition-Name
or NCT03921398 900 902 O
breastfeeding NCT03921398 903 916 B-Condition-Name
women NCT03921398 917 922 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03921398 925 926 O
Protected NCT03921398 928 937 B-Observation-Name
adults NCT03921398 938 944 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03921398 945 946 O
individuals NCT03921398 947 958 O
under NCT03921398 959 964 B-Observation-Name
guardianship NCT03921398 965 977 I-Observation-Name
by NCT03921398 978 980 O
court NCT03921398 981 986 O
order NCT03921398 987 992 O
) NCT03921398 993 994 O

Inclusion NCT03927924 0 9 O
Criteria NCT03927924 10 18 O
: NCT03927924 19 20 O

- NCT03927924 24 25 O
Visible NCT03927924 27 34 B-Condition-Name
index NCT03927924 35 40 I-Condition-Name
lesion NCT03927924 41 47 I-Condition-Name
( NCT03927924 48 49 O
s NCT03927924 50 51 O
) NCT03927924 52 53 O
on NCT03927924 54 56 O
MRI NCT03927924 57 60 B-Procedure-Name

- NCT03927924 63 64 O
Index NCT03927924 66 71 B-Observation-Name___Observation-Type-Value:measurement
lesion NCT03927924 72 78 I-Observation-Name___Observation-Type-Value:measurement
( NCT03927924 79 80 O
s NCT03927924 81 82 O
) NCT03927924 83 84 O
greater NCT03927924 85 92 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03927924 93 97 I-Eq-Operator___Eq-Operator-Value:GT
0.5 NCT03927924 99 102 B-Eq-Value
cm NCT03927924 103 105 B-Eq-Unit
3 NCT03927924 106 107 I-Eq-Unit

- NCT03927924 110 111 O
Found NCT03927924 113 118 O
to NCT03927924 119 121 O
have NCT03927924 122 126 O
localized NCT03927924 127 136 O
low NCT03927924 137 140 B-Polarity___Polarity-Value:low
- NCT03927924 141 142 O
risk NCT03927924 143 147 O
or NCT03927924 148 150 O
intermediate NCT03927924 151 163 B-Polarity___Polarity-Value:medium
- NCT03927924 164 165 O
risk NCT03927924 166 170 O
prostate NCT03927924 171 179 B-Condition-Name
cancer NCT03927924 180 186 I-Condition-Name
after NCT03927924 187 192 O
MRI NCT03927924 193 196 B-Procedure-Name
- NCT03927924 197 198 I-Procedure-Name
USG NCT03927924 199 202 I-Procedure-Name
fusion NCT03927924 203 209 I-Procedure-Name
targeted NCT03927924 210 218 I-Procedure-Name
biopsy NCT03927924 219 225 I-Procedure-Name
and NCT03927924 226 229 O
saturation NCT03927924 230 240 B-Procedure-Name
biopsy NCT03927924 241 247 I-Procedure-Name
: NCT03927924 248 249 O

1 NCT03927924 259 260 O
. NCT03927924 260 261 O
Clinical NCT03927924 263 271 O
tumour NCT03927924 272 278 B-Condition-Name
stage NCT03927924 279 284 B-Eq-Unit
T NCT03927924 285 286 B-Eq-Value
2 NCT03927924 287 288 I-Eq-Value
, NCT03927924 289 290 O
or NCT03927924 291 293 O

2 NCT03927924 302 303 O
. NCT03927924 303 304 O
Gleason NCT03927924 306 313 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03927924 314 319 I-Observation-Name___Observation-Type-Value:clinical-score
7 NCT03927924 321 322 B-Eq-Value
, NCT03927924 323 324 O
or NCT03927924 325 327 O

3 NCT03927924 336 337 O
. NCT03927924 337 338 O
PSA NCT03927924 340 343 B-Observation-Name___Observation-Type-Value:lab
20 NCT03927924 345 347 B-Eq-Value
ng NCT03927924 348 350 B-Eq-Unit
/ NCT03927924 351 352 O
ml NCT03927924 353 355 B-Eq-Unit

Exclusion NCT03927924 356 365 O
Criteria NCT03927924 366 374 O
: NCT03927924 375 376 O

- NCT03927924 380 381 O
Prostate NCT03927924 383 391 B-Observation-Name___Observation-Type-Value:measurement
size NCT03927924 392 396 I-Observation-Name___Observation-Type-Value:measurement
larger NCT03927924 397 403 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03927924 404 408 I-Eq-Operator___Eq-Operator-Value:GT
50 NCT03927924 410 412 B-Eq-Value
ml NCT03927924 413 415 B-Eq-Unit

- NCT03927924 418 419 O
Patients NCT03927924 421 429 O
unfit NCT03927924 430 435 O
for NCT03927924 436 439 O
contrast NCT03927924 440 448 B-Procedure-Name
MRI NCT03927924 449 452 I-Procedure-Name
exam NCT03927924 453 457 O

- NCT03927924 460 461 O
Patients NCT03927924 463 471 O
with NCT03927924 472 476 O
previous NCT03927924 477 485 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treatment NCT03927924 486 495 O
of NCT03927924 496 498 O
prostate NCT03927924 499 507 O
cancer NCT03927924 508 514 B-Condition-Name

- NCT03927924 517 518 O
Patients NCT03927924 520 528 O
with NCT03927924 529 533 O
previous NCT03927924 534 542 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
surgery NCT03927924 543 550 B-Procedure-Name
on NCT03927924 551 553 O
the NCT03927924 554 557 O
prostate NCT03927924 558 566 O

- NCT03927924 569 570 O
Patients NCT03927924 572 580 O
with NCT03927924 581 585 O
active NCT03927924 586 592 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
urinary NCT03927924 593 600 O
tract NCT03927924 601 606 O
infection NCT03927924 607 616 B-Condition-Name

- NCT03927924 619 620 O
Patients NCT03927924 622 630 O
with NCT03927924 631 635 O
bladder NCT03927924 636 643 B-Condition-Name
pathology NCT03927924 644 653 I-Condition-Name
including NCT03927924 654 663 O
bladder NCT03927924 664 671 B-Condition-Name
stone NCT03927924 672 677 I-Condition-Name
and NCT03927924 678 681 O
bladder NCT03927924 682 689 O
cancer NCT03927924 690 696 B-Condition-Name

- NCT03927924 699 700 O
Patients NCT03927924 702 710 O
with NCT03927924 711 715 O
urethral NCT03927924 716 724 B-Condition-Name
stricture NCT03927924 725 734 I-Condition-Name

- NCT03927924 737 738 O
Patients NCT03927924 740 748 O
with NCT03927924 749 753 O
neurogenic NCT03927924 754 764 B-Condition-Name
bladder NCT03927924 765 772 I-Condition-Name
and NCT03927924 773 776 O
/ NCT03927924 777 778 O
or NCT03927924 779 781 O
sphincter NCT03927924 782 791 B-Condition-Name
abnormalities NCT03927924 792 805 I-Condition-Name

- NCT03927924 808 809 O
Fail NCT03927924 811 815 O
to NCT03927924 816 818 O
give NCT03927924 819 823 O
informed NCT03927924 824 832 O
consent NCT03927924 833 840 O

Inclusion NCT03928418 0 9 O
Criteria NCT03928418 10 18 O
: NCT03928418 19 20 O

- NCT03928418 24 25 O
Age NCT03928418 27 30 O
18 NCT03928418 32 34 B-Eq-Value
years NCT03928418 35 40 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03928418 41 44 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03928418 45 50 I-Eq-Operator___Eq-Operator-Value:GTEQ
; NCT03928418 50 51 O

- NCT03928418 54 55 O
HIV NCT03928418 57 60 B-Condition-Name
positive NCT03928418 61 69 B-Polarity___Polarity-Value:positive
; NCT03928418 69 70 O

- NCT03928418 73 74 O
On NCT03928418 76 78 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
ART NCT03928418 79 82 B-Procedure-Name
for NCT03928418 83 86 O
at NCT03928418 87 89 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03928418 90 95 I-Eq-Operator___Eq-Operator-Value:GTEQ
six NCT03928418 96 99 B-Eq-Value
months NCT03928418 100 106 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03928418 106 107 O

- NCT03928418 110 111 O
Reported NCT03928418 113 121 O
alcohol NCT03928418 122 129 B-Drug-Name
use NCT03928418 130 133 O
in NCT03928418 134 136 O
the NCT03928418 137 140 O
prior NCT03928418 141 146 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
year NCT03928418 147 151 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
at NCT03928418 152 154 O
clinic NCT03928418 155 161 O
entry NCT03928418 162 167 O
; NCT03928418 167 168 O

- NCT03928418 171 172 O
Fluency NCT03928418 174 181 O
in NCT03928418 182 184 O
Runyakole NCT03928418 185 194 B-Language
; NCT03928418 194 195 O

- NCT03928418 198 199 O
Living NCT03928418 201 207 O
within NCT03928418 208 214 B-Eq-Operator___Eq-Operator-Value:LTEQ
two NCT03928418 215 218 B-Eq-Value
hours NCT03928418 219 224 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
travel NCT03928418 225 231 B-Observation-Name___Observation-Type-Value:measurement
time NCT03928418 232 236 I-Observation-Name___Observation-Type-Value:measurement
from NCT03928418 237 241 O
the NCT03928418 242 245 O
clinic NCT03928418 246 252 B-Location___Location-Value:clinic
; NCT03928418 252 253 O

- NCT03928418 256 257 O
Owning NCT03928418 259 265 O
or NCT03928418 266 268 O
having NCT03928418 269 275 O
daily NCT03928418 276 281 O
access NCT03928418 282 288 O
to NCT03928418 289 291 O
a NCT03928418 292 293 O
cell NCT03928418 294 298 O
phone NCT03928418 299 304 O
; NCT03928418 304 305 O

- NCT03928418 308 309 O
Screening NCT03928418 311 320 O
positive NCT03928418 321 329 B-Polarity___Polarity-Value:positive
on NCT03928418 330 332 O
the NCT03928418 333 336 O
AUDIT NCT03928418 337 342 B-Observation-Name
- NCT03928418 343 344 I-Observation-Name
C NCT03928418 345 346 I-Observation-Name

Exclusion NCT03928418 347 356 O
Criteria NCT03928418 357 365 O
: NCT03928418 366 367 O

- NCT03928418 371 372 O
Plans NCT03928418 374 379 O
to NCT03928418 380 382 O
move NCT03928418 383 387 B-Observation-Name
out NCT03928418 388 391 I-Observation-Name
of NCT03928418 392 394 O
the NCT03928418 395 398 O
catchment NCT03928418 399 408 O
area NCT03928418 409 413 O
within NCT03928418 414 420 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03928418 422 423 B-Eq-Value
months NCT03928418 424 430 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
; NCT03928418 430 431 O

- NCT03928418 434 435 O
Unable NCT03928418 437 443 O
to NCT03928418 444 446 O
provide NCT03928418 447 454 O
informed NCT03928418 455 463 O
consent NCT03928418 464 471 O
. NCT03928418 472 473 O

- NCT03928418 477 478 O
Participation NCT03928418 480 493 O
in NCT03928418 494 496 O
another NCT03928418 497 504 O
research NCT03928418 505 513 O
study NCT03928418 514 519 O
. NCT03928418 520 521 O

Inclusion NCT03924544 0 9 O
Criteria NCT03924544 10 18 O
: NCT03924544 19 20 O

- NCT03924544 24 25 O
Primary NCT03924544 27 34 O
Open NCT03924544 35 39 O
Angle NCT03924544 40 45 O
Glaucoma NCT03924544 46 54 B-Condition-Name

Exclusion NCT03924544 55 64 O
Criteria NCT03924544 65 73 O
: NCT03924544 74 75 O

- NCT03924544 79 80 O
Secondary NCT03924544 82 91 O
Glaucoma NCT03924544 92 100 B-Condition-Name
, NCT03924544 101 102 O
Closed NCT03924544 103 109 O
angle NCT03924544 110 115 O
glaucoma NCT03924544 116 124 B-Condition-Name

Inclusion NCT03924791 0 9 O
Criteria NCT03924791 10 18 O
: NCT03924791 19 20 O

- NCT03924791 24 25 O
Diagnosed NCT03924791 27 36 O
with NCT03924791 37 41 O
sciatica NCT03924791 42 50 B-Condition-Name
by NCT03924791 51 53 O
GP NCT03924791 54 56 O

- NCT03924791 59 60 O
NRS NCT03924791 62 65 B-Observation-Name___Observation-Type-Value:measurement
leg NCT03924791 66 69 I-Observation-Name___Observation-Type-Value:measurement
pain NCT03924791 70 74 I-Observation-Name___Observation-Type-Value:measurement
of NCT03924791 75 77 O
6 NCT03924791 79 80 B-Eq-Value
or NCT03924791 81 83 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03924791 84 88 I-Eq-Operator___Eq-Operator-Value:GTEQ
on NCT03924791 89 91 O
a NCT03924791 92 93 O
10 NCT03924791 95 97 O
- NCT03924791 98 99 O
point NCT03924791 100 105 O
NRS NCT03924791 106 109 O
scale NCT03924791 110 115 O

- NCT03924791 118 119 O
Minimum NCT03924791 121 128 B-Eq-Operator___Eq-Operator-Value:GTEQ
duration NCT03924791 129 137 O
of NCT03924791 138 140 O
symptoms NCT03924791 141 149 O
of NCT03924791 150 152 O
3 NCT03924791 154 155 B-Eq-Value
weeks NCT03924791 156 161 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
and NCT03924791 162 165 O
maximum NCT03924791 166 173 B-Eq-Operator___Eq-Operator-Value:LTEQ
duration NCT03924791 174 182 O
of NCT03924791 183 185 O
8 NCT03924791 187 188 B-Eq-Value
weeks NCT03924791 189 194 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

Exclusion NCT03924791 195 204 O
Criteria NCT03924791 205 213 O
: NCT03924791 214 215 O

- NCT03924791 219 220 O
Age NCT03924791 222 225 O
under NCT03924791 226 231 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03924791 233 235 B-Eq-Value
years NCT03924791 236 241 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03924791 244 245 O
Condition NCT03924791 247 256 O
preventing NCT03924791 257 267 O
to NCT03924791 268 270 O
receive NCT03924791 271 278 O
transforaminal NCT03924791 279 293 O
epidural NCT03924791 294 302 B-Procedure-Name
injection NCT03924791 303 312 I-Procedure-Name

- NCT03924791 315 316 O
Severe NCT03924791 318 324 B-Severity___Severity-Value:severe
scoliosis NCT03924791 325 334 B-Condition-Name

- NCT03924791 337 338 O
Transforaminal NCT03924791 340 354 O
epidural NCT03924791 355 363 B-Procedure-Name
injection NCT03924791 364 373 I-Procedure-Name
received NCT03924791 374 382 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
in NCT03924791 383 385 O
6 NCT03924791 387 388 B-Eq-Value
months NCT03924791 389 395 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
before NCT03924791 396 402 O
randomization NCT03924791 403 416 O
date NCT03924791 417 421 O

- NCT03924791 424 425 O
Surgery NCT03924791 427 434 B-Procedure-Name
for NCT03924791 435 438 O
sciatica NCT03924791 439 447 B-Condition-Name
at NCT03924791 448 450 O
the NCT03924791 451 454 O
same NCT03924791 455 459 O
level NCT03924791 460 465 O

- NCT03924791 468 469 O
Surgery NCT03924791 471 478 B-Procedure-Name
for NCT03924791 479 482 O
sciatica NCT03924791 483 491 B-Condition-Name
at NCT03924791 492 494 O
another NCT03924791 495 502 O
level NCT03924791 503 508 O
within NCT03924791 509 515 B-Eq-Operator___Eq-Operator-Value:LTEQ
one NCT03924791 516 519 B-Eq-Value
year NCT03924791 520 524 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
before NCT03924791 525 531 O
inclusion NCT03924791 532 541 O

- NCT03924791 544 545 O
Pregnancy NCT03924791 547 556 B-Condition-Name

Inclusion NCT03929289 0 9 O
Criteria NCT03929289 10 18 O
: NCT03929289 19 20 O

- NCT03929289 24 25 O
Male NCT03929289 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03929289 32 34 O
female NCT03929289 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03929289 44 45 O
Aged NCT03929289 47 51 O
18 NCT03929289 53 55 B-Eq-Value
to NCT03929289 56 58 B-Eq-Operator___Eq-Operator-Value:BETWEEN
35 NCT03929289 60 62 B-Eq-Value
years NCT03929289 63 68 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03929289 69 72 O

- NCT03929289 75 76 O
Signed NCT03929289 78 84 O
written NCT03929289 85 92 O
informed NCT03929289 93 101 O
consent NCT03929289 102 109 O

- NCT03929289 112 113 O
Insurance NCT03929289 115 124 B-Insurance
coverage NCT03929289 125 133 O

Exclusion NCT03929289 134 143 O
Criteria NCT03929289 144 152 O
: NCT03929289 153 154 O

- NCT03929289 158 159 O
Neurological NCT03929289 161 173 O
or NCT03929289 174 176 O
psychiatric NCT03929289 177 188 O
or NCT03929289 189 191 O
ophthalmological NCT03929289 192 208 O
disorder NCT03929289 209 217 B-Condition-Name

- NCT03929289 220 221 O
Non NCT03929289 223 226 O
- NCT03929289 227 228 O
stabilized NCT03929289 229 239 B-Stability___Stability-Value:stable
medical NCT03929289 240 247 O
condition NCT03929289 248 257 O

- NCT03929289 260 261 O
Ongoing NCT03929289 263 270 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03929289 271 280 O
with NCT03929289 281 285 O
drugs NCT03929289 286 291 O
that NCT03929289 292 296 O
affect NCT03929289 297 303 B-Stability___Stability-Value:change
the NCT03929289 304 307 O
central NCT03929289 308 315 B-Condition-Name
nervous NCT03929289 316 323 I-Condition-Name
system NCT03929289 324 330 I-Condition-Name

- NCT03929289 338 339 O
Uncorrected NCT03929289 341 352 O
visual NCT03929289 353 359 B-Condition-Name
inadequacy NCT03929289 360 370 I-Condition-Name

- NCT03929289 378 379 O
No NCT03929289 381 383 O
fluency NCT03929289 384 391 O
in NCT03929289 392 394 O
French NCT03929289 395 401 B-Language
reading NCT03929289 402 409 O

- NCT03929289 417 418 O
Pregnant NCT03929289 420 428 B-Condition-Name
and NCT03929289 429 432 O
/ NCT03929289 433 434 O
or NCT03929289 435 437 O
breastfeeding NCT03929289 438 451 B-Condition-Name
woman NCT03929289 452 457 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03929289 458 459 O
this NCT03929289 460 464 O
exclusion NCT03929289 465 474 O
criterion NCT03929289 475 484 O
will NCT03929289 485 489 O
be NCT03929289 490 492 O
sought NCT03929289 493 499 O
by NCT03929289 500 502 O
questioning NCT03929289 503 514 O
the NCT03929289 515 518 O
subject NCT03929289 519 526 O

- NCT03929289 534 535 O
Subject NCT03929289 537 544 O
commonly NCT03929289 545 553 O
in NCT03929289 554 556 O
care NCT03929289 557 561 O
in NCT03929289 562 564 O
a NCT03929289 565 566 O
health NCT03929289 567 573 O
or NCT03929289 574 576 O
social NCT03929289 577 583 O
facility NCT03929289 584 592 O
for NCT03929289 593 596 O
purposes NCT03929289 597 605 O
other NCT03929289 606 611 O
than NCT03929289 612 616 O
that NCT03929289 617 621 O
of NCT03929289 622 624 O
research NCT03929289 625 633 O

- NCT03929289 641 642 O
Subject NCT03929289 644 651 O
under NCT03929289 652 657 B-Observation-Name
guardianship NCT03929289 658 670 I-Observation-Name

- NCT03929289 678 679 O
Subject NCT03929289 681 688 O
deprived NCT03929289 689 697 B-Observation-Name
of NCT03929289 698 700 I-Observation-Name
liberty NCT03929289 701 708 I-Observation-Name
by NCT03929289 709 711 O
a NCT03929289 712 713 O
judicial NCT03929289 714 722 O
or NCT03929289 723 725 O
administrative NCT03929289 726 740 O
decision NCT03929289 741 749 O

- NCT03929289 757 758 O
Incompatibility NCT03929289 760 775 O
with NCT03929289 776 780 O
the NCT03929289 781 784 O
Magnetic NCT03929289 785 793 B-Procedure-Name
Resonance NCT03929289 794 803 I-Procedure-Name
Imaging NCT03929289 804 811 I-Procedure-Name
( NCT03929289 812 813 O
MRI NCT03929289 814 817 B-Procedure-Name
) NCT03929289 818 819 O
examination NCT03929289 820 831 O
determined NCT03929289 832 842 O
by NCT03929289 843 845 O
answering NCT03929289 846 855 O
the NCT03929289 856 859 O
following NCT03929289 860 869 O
questions NCT03929289 870 879 O
: NCT03929289 880 881 O

- NCT03929289 885 886 O
Carrier NCT03929289 888 895 O
of NCT03929289 896 898 O
a NCT03929289 899 900 O
neurological NCT03929289 901 913 B-Procedure-Name
stimulator NCT03929289 914 924 I-Procedure-Name
, NCT03929289 925 926 O
cardiac NCT03929289 927 934 B-Condition-Name
( NCT03929289 935 936 O
battery NCT03929289 937 944 O
) NCT03929289 945 946 O
or NCT03929289 947 949 O
defibrillator NCT03929289 950 963 B-Procedure-Name

- NCT03929289 966 967 O
Carrier NCT03929289 969 976 O
of NCT03929289 977 979 O
a NCT03929289 980 981 O
cardiac NCT03929289 982 989 O
prosthesis NCT03929289 990 1000 B-Procedure-Name
( NCT03929289 1001 1002 O
valve NCT03929289 1003 1008 B-Procedure-Name
, NCT03929289 1009 1010 O
stent NCT03929289 1011 1016 B-Procedure-Name
. NCT03929289 1018 1019 O
. NCT03929289 1020 1021 O
. NCT03929289 1022 1023 O
) NCT03929289 1024 1025 O
or NCT03929289 1026 1028 O
vascular NCT03929289 1029 1037 O

- NCT03929289 1040 1041 O
Holder NCT03929289 1043 1049 O
of NCT03929289 1050 1052 O
intracranial NCT03929289 1053 1065 B-Procedure-Name
clips NCT03929289 1066 1071 O
or NCT03929289 1072 1074 O
clamps NCT03929289 1075 1081 O
( NCT03929289 1082 1083 O
staples NCT03929289 1084 1091 B-Procedure-Name
) NCT03929289 1092 1093 O

- NCT03929289 1097 1098 O
Carrier NCT03929289 1100 1107 O
of NCT03929289 1108 1110 O
a NCT03929289 1111 1112 O
cerebrospinal NCT03929289 1113 1126 B-Procedure-Name
fluid NCT03929289 1127 1132 I-Procedure-Name
bypass NCT03929289 1133 1139 I-Procedure-Name

- NCT03929289 1142 1143 O
Presence NCT03929289 1145 1153 O
of NCT03929289 1154 1156 O
metal NCT03929289 1157 1162 B-Procedure-Name
chips NCT03929289 1163 1168 I-Procedure-Name
in NCT03929289 1169 1171 O
the NCT03929289 1172 1175 O
eyes NCT03929289 1176 1180 O

- NCT03929289 1183 1184 O
Metal NCT03929289 1186 1191 B-Procedure-Name
prosthesis NCT03929289 1192 1202 I-Procedure-Name
carrier NCT03929289 1203 1210 O
( NCT03929289 1211 1212 O
teeth NCT03929289 1213 1218 O
, NCT03929289 1219 1220 O
knees NCT03929289 1221 1226 O
) NCT03929289 1227 1228 O

- NCT03929289 1232 1233 O
Pump NCT03929289 1235 1239 B-Procedure-Name
carrier NCT03929289 1240 1247 I-Procedure-Name
or NCT03929289 1248 1250 O
infusion NCT03929289 1251 1259 B-Procedure-Name
system NCT03929289 1260 1266 I-Procedure-Name

- NCT03929289 1269 1270 O
Presence NCT03929289 1272 1280 O
of NCT03929289 1281 1283 O
metal NCT03929289 1284 1289 B-Procedure-Name
tattoo NCT03929289 1290 1296 I-Procedure-Name
near NCT03929289 1297 1301 O
the NCT03929289 1302 1305 O
head NCT03929289 1306 1310 O

- NCT03929289 1313 1314 O
Presence NCT03929289 1316 1324 O
of NCT03929289 1325 1327 O
permanent NCT03929289 1328 1337 B-Procedure-Name
makeup NCT03929289 1338 1344 I-Procedure-Name

- NCT03929289 1347 1348 O
Claustrophobia NCT03929289 1350 1364 B-Condition-Name
or NCT03929289 1365 1367 O
respiratory NCT03929289 1368 1379 B-Condition-Name
disorders NCT03929289 1380 1389 I-Condition-Name

Inclusion NCT03928197 0 9 O
Criteria NCT03928197 10 18 O
: NCT03928197 19 20 O

- NCT03928197 24 25 O
Age NCT03928197 27 30 O
between NCT03928197 31 38 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03928197 40 42 B-Eq-Value
years NCT03928197 43 48 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03928197 49 52 O
60 NCT03928197 54 56 B-Eq-Value
years NCT03928197 57 62 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03928197 65 66 O
For NCT03928197 68 71 O
the NCT03928197 72 75 O
volunteers NCT03928197 76 86 O
with NCT03928197 87 91 O
venous NCT03928197 92 98 B-Condition-Name
insuffiency NCT03928197 99 110 I-Condition-Name
: NCT03928197 111 112 O
clearly NCT03928197 113 120 O
visual NCT03928197 121 127 O
venous NCT03928197 128 134 B-Condition-Name
insufficiency NCT03928197 135 148 I-Condition-Name
( NCT03928197 149 150 O
CEAP NCT03928197 151 155 B-Condition-Name
1 NCT03928197 157 158 B-Eq-Value
and NCT03928197 159 162 O
2 NCT03928197 164 165 B-Eq-Value
) NCT03928197 166 167 O

- NCT03928197 171 172 O
BMI NCT03928197 174 177 B-Observation-Name___Observation-Type-Value:vital
between NCT03928197 178 185 B-Eq-Operator___Eq-Operator-Value:BETWEEN
24 NCT03928197 187 189 B-Eq-Value
and NCT03928197 190 193 O
30 NCT03928197 195 197 B-Eq-Value

Exclusion NCT03928197 199 208 O
Criteria NCT03928197 209 217 O
: NCT03928197 218 219 O

- NCT03928197 223 224 O
Volunteers NCT03928197 226 236 O
using NCT03928197 237 242 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
medication NCT03928197 243 253 O
( NCT03928197 254 255 O
exception NCT03928197 256 265 O
for NCT03928197 266 269 O
contraception NCT03928197 270 283 B-Drug-Name
) NCT03928197 284 285 O

- NCT03928197 289 290 O
Volunteers NCT03928197 292 302 O
having NCT03928197 303 309 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
comorbidities NCT03928197 310 323 O

- NCT03928197 326 327 O
Pregnant NCT03928197 329 337 B-Condition-Name
women NCT03928197 338 343 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03928197 346 347 O
Women NCT03928197 349 354 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03928197 355 358 O
menstruate NCT03928197 359 369 B-Condition-Name
on NCT03928197 370 372 O
the NCT03928197 373 376 O
test NCT03928197 377 381 O
date NCT03928197 382 386 O

- NCT03928197 389 390 O
Volunteers NCT03928197 392 402 O
with NCT03928197 403 407 O
an NCT03928197 408 410 O
implanted NCT03928197 411 420 B-Procedure-Name
elektronical NCT03928197 421 433 I-Procedure-Name
device NCT03928197 434 440 I-Procedure-Name
( NCT03928197 441 442 O
IPG NCT03928197 443 446 B-Procedure-Name
, NCT03928197 447 448 O
Pacemaker NCT03928197 449 458 B-Procedure-Name
) NCT03928197 459 460 O


Inclusion NCT03922451 0 9 O
Criteria NCT03922451 10 18 O
: NCT03922451 19 20 O

- NCT03922451 24 25 O
supported NCT03922451 27 36 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
on NCT03922451 37 39 O
ECMO NCT03922451 40 44 B-Procedure-Name

- NCT03922451 47 48 O
receive NCT03922451 50 57 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
piperacillin NCT03922451 58 70 B-Drug-Name
- NCT03922451 71 72 I-Drug-Name
tazobactam NCT03922451 73 83 I-Drug-Name
or NCT03922451 84 86 O
cefazolin NCT03922451 87 96 B-Drug-Name
as NCT03922451 97 99 O
part NCT03922451 100 104 O
of NCT03922451 105 107 O
routine NCT03922451 108 115 B-Procedure-Name
care NCT03922451 116 120 I-Procedure-Name
or NCT03922451 121 123 O
infection NCT03922451 124 133 B-Procedure-Name
management NCT03922451 134 144 I-Procedure-Name

Exclusion NCT03922451 145 154 O
Criteria NCT03922451 155 163 O
: NCT03922451 164 165 O

- NCT03922451 169 170 O
> NCT03922451 172 173 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03922451 175 176 I-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03922451 178 180 B-Eq-Value
years NCT03922451 181 186 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03922451 189 190 O
No NCT03922451 192 194 O
Consent NCT03922451 195 202 O
provided NCT03922451 203 211 O

Key NCT03926637 0 3 O
Inclusion NCT03926637 4 13 O
Criteria NCT03926637 14 22 O
: NCT03926637 23 24 O

- NCT03926637 28 29 O
Ability NCT03926637 31 38 O
to NCT03926637 39 41 O
understand NCT03926637 42 52 O
the NCT03926637 53 56 O
purpose NCT03926637 57 64 O
and NCT03926637 65 68 O
risks NCT03926637 69 74 O
of NCT03926637 75 77 O
the NCT03926637 78 81 O
study NCT03926637 82 87 O
and NCT03926637 88 91 O
provide NCT03926637 92 99 O
signed NCT03926637 100 106 O
and NCT03926637 107 110 O
dated NCT03926637 111 116 O
informed NCT03926637 117 125 O
consent NCT03926637 126 133 O
and NCT03926637 134 137 O
authorization NCT03926637 138 151 O
to NCT03926637 152 154 O
use NCT03926637 155 158 O
confidential NCT03926637 159 171 O
health NCT03926637 172 178 O
information NCT03926637 179 190 O
in NCT03926637 191 193 O
accordance NCT03926637 194 204 O
with NCT03926637 205 209 O
applicable NCT03926637 210 220 O
participant NCT03926637 221 232 O
privacy NCT03926637 233 240 O
regulations NCT03926637 241 252 O

- NCT03926637 255 256 O
Diagnosis NCT03926637 258 267 O
of NCT03926637 268 270 O
MS NCT03926637 271 273 B-Condition-Name
, NCT03926637 274 275 O
including NCT03926637 276 285 O
Clinically NCT03926637 286 296 B-Condition-Name
Isolated NCT03926637 297 305 I-Condition-Name
Syndrome NCT03926637 306 314 I-Condition-Name

- NCT03926637 317 318 O
Ability NCT03926637 320 327 O
to NCT03926637 328 330 O
understand NCT03926637 331 341 O
the NCT03926637 342 345 O
audio NCT03926637 346 351 O
and NCT03926637 352 355 O
visual NCT03926637 356 362 O
instructions NCT03926637 363 375 O
for NCT03926637 376 379 O
the NCT03926637 380 383 O
test NCT03926637 384 388 O
modules NCT03926637 389 396 O

- NCT03926637 399 400 O
Visual NCT03926637 402 408 B-Condition-Name
function NCT03926637 409 417 I-Condition-Name
, NCT03926637 418 419 O
based NCT03926637 420 425 O
on NCT03926637 426 428 O
the NCT03926637 429 432 O
investigator NCT03926637 433 445 O
's NCT03926637 445 447 O
clinical NCT03926637 448 456 O
judgement NCT03926637 457 466 O
that NCT03926637 467 471 O
does NCT03926637 472 476 O
not NCT03926637 477 480 O
preclude NCT03926637 481 489 B-Stability___Stability-Value:change
an NCT03926637 490 492 O
ability NCT03926637 493 500 O
to NCT03926637 501 503 O
interact NCT03926637 504 512 O
with NCT03926637 513 517 O
the NCT03926637 518 521 O
Multiple NCT03926637 522 530 B-Observation-Name___Observation-Type-Value:clinical-score
Sclerosis NCT03926637 531 540 I-Observation-Name___Observation-Type-Value:clinical-score
Performance NCT03926637 541 552 I-Observation-Name___Observation-Type-Value:clinical-score
Test NCT03926637 553 557 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03926637 558 559 O
MSPT NCT03926637 560 564 B-Observation-Name
) NCT03926637 565 566 O
. NCT03926637 568 569 O

Key NCT03926637 571 574 O
Exclusion NCT03926637 575 584 O
Criteria NCT03926637 585 593 O
: NCT03926637 594 595 O

- NCT03926637 599 600 O
Unable NCT03926637 602 608 O
or NCT03926637 609 611 O
unwilling NCT03926637 612 621 O
to NCT03926637 622 624 O
provide NCT03926637 625 632 O
informed NCT03926637 633 641 O
consent NCT03926637 642 649 O

- NCT03926637 652 653 O
Participants NCT03926637 655 667 O
younger NCT03926637 668 675 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03926637 676 680 I-Eq-Operator___Eq-Operator-Value:LT
18 NCT03926637 682 684 B-Eq-Value
years NCT03926637 685 690 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03926637 691 693 O
age NCT03926637 694 697 O
, NCT03926637 698 699 O
unless NCT03926637 700 706 O
their NCT03926637 707 712 O
parent NCT03926637 713 719 O
or NCT03926637 720 722 O
legal NCT03926637 723 728 O
guardian NCT03926637 729 737 O
provides NCT03926637 738 746 O
the NCT03926637 747 750 O
required NCT03926637 751 759 O
signed NCT03926637 760 766 O
and NCT03926637 767 770 O
dated NCT03926637 771 776 O
informed NCT03926637 777 785 O
consent NCT03926637 786 793 O
and NCT03926637 794 797 O
authorization NCT03926637 798 811 O
to NCT03926637 812 814 O
use NCT03926637 815 818 O
confidential NCT03926637 819 831 O
health NCT03926637 832 838 O
information NCT03926637 839 850 O
and NCT03926637 851 854 O
the NCT03926637 855 858 O
participant NCT03926637 859 870 O
provides NCT03926637 871 879 O
assent NCT03926637 880 886 O
in NCT03926637 887 889 O
accordance NCT03926637 890 900 O
with NCT03926637 901 905 O
national NCT03926637 906 914 O
and NCT03926637 915 918 O
local NCT03926637 919 924 O
subject NCT03926637 925 932 O
privacy NCT03926637 933 940 O
regulations NCT03926637 941 952 O

NOTE NCT03926637 953 957 O
: NCT03926637 958 959 O
Other NCT03926637 960 965 O
protocol NCT03926637 966 974 O
defined NCT03926637 975 982 O
Inclusion NCT03926637 983 992 O
/ NCT03926637 993 994 O
Exclusion NCT03926637 995 1004 O
criteria NCT03926637 1005 1013 O
may NCT03926637 1014 1017 O
apply NCT03926637 1018 1023 O
. NCT03926637 1024 1025 O

Inclusion NCT03929510 0 9 O
Criteria NCT03929510 10 18 O
: NCT03929510 19 20 O

- NCT03929510 24 25 O
Male NCT03929510 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
participants NCT03929510 32 44 O
who NCT03929510 45 48 O
are NCT03929510 49 52 O
healthy NCT03929510 53 60 B-Condition-Name
as NCT03929510 61 63 O
determined NCT03929510 64 74 O
by NCT03929510 75 77 O
medical NCT03929510 78 85 B-Procedure-Name
evaluation NCT03929510 86 96 I-Procedure-Name
including NCT03929510 97 106 O
a NCT03929510 107 108 O
detailed NCT03929510 109 117 O
medical NCT03929510 118 125 O
history NCT03929510 126 133 O
, NCT03929510 134 135 O
full NCT03929510 136 140 O
physical NCT03929510 141 149 B-Procedure-Name
examination NCT03929510 150 161 I-Procedure-Name
, NCT03929510 162 163 O
including NCT03929510 164 173 O
blood NCT03929510 174 179 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03929510 180 188 I-Observation-Name___Observation-Type-Value:vital
( NCT03929510 189 190 O
BP NCT03929510 191 193 B-Observation-Name___Observation-Type-Value:vital
) NCT03929510 194 195 O
and NCT03929510 196 199 O
pulse NCT03929510 200 205 B-Observation-Name___Observation-Type-Value:vital
rate NCT03929510 206 210 I-Observation-Name___Observation-Type-Value:vital
( NCT03929510 211 212 O
PR NCT03929510 213 215 B-Observation-Name___Observation-Type-Value:vital
) NCT03929510 216 217 O
measurement NCT03929510 218 229 O
, NCT03929510 230 231 O
12 NCT03929510 233 235 B-Procedure-Name
lead NCT03929510 236 240 I-Procedure-Name
ECG NCT03929510 241 244 I-Procedure-Name
, NCT03929510 245 246 O
and NCT03929510 247 250 O
clinical NCT03929510 251 259 O
laboratory NCT03929510 260 270 B-Observation-Name___Observation-Type-Value:lab
tests NCT03929510 271 276 I-Observation-Name___Observation-Type-Value:lab
. NCT03929510 277 278 O

- NCT03929510 282 283 O
Body NCT03929510 285 289 B-Observation-Name___Observation-Type-Value:vital
mass NCT03929510 290 294 I-Observation-Name___Observation-Type-Value:vital
index NCT03929510 295 300 I-Observation-Name___Observation-Type-Value:vital
( NCT03929510 301 302 O
BMI NCT03929510 303 306 B-Observation-Name___Observation-Type-Value:vital
) NCT03929510 307 308 O
of NCT03929510 309 311 O
17.5 NCT03929510 313 317 B-Eq-Value
to NCT03929510 318 320 B-Eq-Operator___Eq-Operator-Value:BETWEEN
30.5 NCT03929510 322 326 B-Eq-Value
kg NCT03929510 327 329 B-Eq-Unit
/ NCT03929510 330 331 O
m NCT03929510 332 333 B-Eq-Unit
2 NCT03929510 334 335 I-Eq-Unit
; NCT03929510 335 336 O
and NCT03929510 337 340 O
a NCT03929510 341 342 O
total NCT03929510 343 348 O
body NCT03929510 349 353 B-Observation-Name___Observation-Type-Value:vital
weight NCT03929510 354 360 I-Observation-Name___Observation-Type-Value:vital
> NCT03929510 361 362 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03929510 364 366 B-Eq-Value
kg NCT03929510 367 369 B-Eq-Unit
( NCT03929510 370 371 O
110 NCT03929510 373 376 B-Eq-Value
lb NCT03929510 377 379 B-Eq-Unit
) NCT03929510 380 381 O
. NCT03929510 383 384 O

Exclusion NCT03929510 386 395 O
Criteria NCT03929510 396 404 O
: NCT03929510 405 406 O

- NCT03929510 410 411 O
Known NCT03929510 413 418 O
immunodeficiency NCT03929510 419 435 B-Condition-Name
disorder NCT03929510 436 444 I-Condition-Name
, NCT03929510 445 446 O
including NCT03929510 447 456 O
positive NCT03929510 457 465 B-Polarity___Polarity-Value:positive
serology NCT03929510 466 474 O
for NCT03929510 475 478 O
human NCT03929510 479 484 B-Condition-Name
immunodeficiency NCT03929510 485 501 I-Condition-Name
virus NCT03929510 502 507 I-Condition-Name
( NCT03929510 508 509 O
HIV NCT03929510 510 513 B-Condition-Name
) NCT03929510 514 515 O
at NCT03929510 516 518 O
screening NCT03929510 519 528 O
, NCT03929510 529 530 O
or NCT03929510 531 533 O
a NCT03929510 534 535 O
first NCT03929510 536 541 O
degree NCT03929510 542 548 O
relative NCT03929510 549 557 O
with NCT03929510 558 562 O
a NCT03929510 563 564 O
hereditary NCT03929510 565 575 O
immunodeficiency NCT03929510 576 592 B-Condition-Name
. NCT03929510 593 594 O

- NCT03929510 598 599 O
Infection NCT03929510 601 610 B-Condition-Name
with NCT03929510 611 615 I-Condition-Name
hepatitis NCT03929510 616 625 I-Condition-Name
B NCT03929510 626 627 I-Condition-Name
or NCT03929510 628 630 O
hepatitis NCT03929510 631 640 B-Condition-Name
C NCT03929510 641 642 I-Condition-Name
viruses NCT03929510 643 650 I-Condition-Name
. NCT03929510 651 652 O

- NCT03929510 656 657 O
Participants NCT03929510 659 671 O
with NCT03929510 672 676 O
selected NCT03929510 677 685 O
acute NCT03929510 686 691 B-Severity___Severity-Value:severe
or NCT03929510 692 694 O
chronic NCT03929510 695 702 B-Condition-Name
infections NCT03929510 703 713 I-Condition-Name
or NCT03929510 714 716 O
infection NCT03929510 717 726 B-Condition-Name
history NCT03929510 727 734 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
. NCT03929510 735 736 O

- NCT03929510 740 741 O
Participants NCT03929510 743 755 O
have NCT03929510 756 760 O
a NCT03929510 761 762 O
known NCT03929510 763 768 O
present NCT03929510 769 776 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
or NCT03929510 777 779 O
a NCT03929510 780 781 O
history NCT03929510 782 789 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929510 790 792 O
malignancy NCT03929510 793 803 B-Condition-Name
other NCT03929510 804 809 O
than NCT03929510 810 814 O
a NCT03929510 815 816 O
successfully NCT03929510 817 829 O
treated NCT03929510 830 837 O
or NCT03929510 838 840 O
excised NCT03929510 841 848 O
non NCT03929510 849 852 O
metastatic NCT03929510 853 863 O
basal NCT03929510 864 869 O
cell NCT03929510 870 874 O
or NCT03929510 875 877 O
squamous NCT03929510 878 886 O
cell NCT03929510 887 891 O
cancer NCT03929510 892 898 B-Condition-Name
of NCT03929510 899 901 O
the NCT03929510 902 905 O
skin NCT03929510 906 910 O
. NCT03929510 911 912 O

- NCT03929510 916 917 O
History NCT03929510 919 926 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929510 927 929 O
alcohol NCT03929510 930 937 B-Condition-Name
abuse NCT03929510 938 943 I-Condition-Name
or NCT03929510 944 946 O
binge NCT03929510 947 952 B-Condition-Name
drinking NCT03929510 953 961 I-Condition-Name
and NCT03929510 962 965 O
/ NCT03929510 966 967 O
or NCT03929510 968 970 O
any NCT03929510 971 974 O
other NCT03929510 975 980 O
illicit NCT03929510 981 988 B-Condition-Name
drug NCT03929510 989 993 I-Condition-Name
use NCT03929510 994 997 I-Condition-Name
or NCT03929510 998 1000 O
dependence NCT03929510 1001 1011 B-Condition-Name
within NCT03929510 1012 1018 B-Eq-Operator___Eq-Operator-Value:LTEQ
6 NCT03929510 1020 1021 B-Eq-Value
months NCT03929510 1022 1028 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
of NCT03929510 1029 1031 O
Screening NCT03929510 1032 1041 O
. NCT03929510 1042 1043 O

- NCT03929510 1047 1048 O
Use NCT03929510 1050 1053 O
of NCT03929510 1054 1056 O
tobacco NCT03929510 1057 1064 B-Drug-Name
/ NCT03929510 1065 1066 O
nicotine NCT03929510 1067 1075 B-Drug-Name
containing NCT03929510 1076 1086 O
products NCT03929510 1087 1095 O
within NCT03929510 1096 1102 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03929510 1104 1105 B-Eq-Value
months NCT03929510 1106 1112 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
prior NCT03929510 1113 1118 O
to NCT03929510 1119 1121 O
dosing NCT03929510 1122 1128 O
or NCT03929510 1129 1131 O
positive NCT03929510 1132 1140 B-Polarity___Polarity-Value:positive
urine NCT03929510 1141 1146 B-Observation-Name___Observation-Type-Value:lab
cotinine NCT03929510 1147 1155 I-Observation-Name___Observation-Type-Value:lab
test NCT03929510 1156 1160 I-Observation-Name___Observation-Type-Value:lab
. NCT03929510 1161 1162 O

Inclusion NCT03924752 0 9 O
Criteria NCT03924752 10 18 O
: NCT03924752 19 20 O

- NCT03924752 24 25 O
Between NCT03924752 27 34 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03924752 36 38 B-Eq-Value
- NCT03924752 39 40 B-Eq-Operator___Eq-Operator-Value:BETWEEN
85 NCT03924752 42 44 B-Eq-Value
years NCT03924752 45 50 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03924752 51 53 O
age NCT03924752 54 57 O

- NCT03924752 60 61 O
Subjects NCT03924752 63 71 O
should NCT03924752 72 78 O
be NCT03924752 79 81 O
capable NCT03924752 82 89 B-Condition-Name
of NCT03924752 90 92 I-Condition-Name
walking NCT03924752 93 100 O
, NCT03924752 101 102 O
ascending NCT03924752 103 112 O
/ NCT03924752 113 114 O
descending NCT03924752 115 125 O
stairs NCT03924752 126 132 O
and NCT03924752 133 136 O
ramps NCT03924752 137 142 O
with NCT03924752 143 147 O
full NCT03924752 148 152 B-Condition-Name
capability NCT03924752 153 163 I-Condition-Name
in NCT03924752 164 166 I-Condition-Name
lower NCT03924752 167 172 I-Condition-Name
extremity NCT03924752 173 182 I-Condition-Name
passive NCT03924752 183 190 I-Condition-Name
range NCT03924752 191 196 I-Condition-Name
of NCT03924752 197 199 I-Condition-Name
motion NCT03924752 200 206 I-Condition-Name
( NCT03924752 207 208 O
knee NCT03924752 209 213 B-Observation-Name___Observation-Type-Value:measurement
flexion NCT03924752 214 221 I-Observation-Name___Observation-Type-Value:measurement
contracture NCT03924752 222 233 I-Observation-Name___Observation-Type-Value:measurement
of NCT03924752 234 236 O
> NCT03924752 237 238 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03924752 240 242 B-Eq-Value
degrees NCT03924752 243 250 B-Eq-Unit
, NCT03924752 251 252 O
knee NCT03924752 253 257 B-Observation-Name___Observation-Type-Value:measurement
flexion NCT03924752 258 265 I-Observation-Name___Observation-Type-Value:measurement
ROM NCT03924752 266 269 I-Observation-Name___Observation-Type-Value:measurement
< NCT03924752 270 271 B-Eq-Operator___Eq-Operator-Value:LT
90 NCT03924752 273 275 B-Eq-Value
degrees NCT03924752 276 283 B-Eq-Unit
, NCT03924752 284 285 O
hip NCT03924752 286 289 B-Observation-Name___Observation-Type-Value:measurement
flexion NCT03924752 290 297 I-Observation-Name___Observation-Type-Value:measurement
contracture NCT03924752 298 309 I-Observation-Name___Observation-Type-Value:measurement
< NCT03924752 310 311 B-Eq-Operator___Eq-Operator-Value:LT
25 NCT03924752 313 315 B-Eq-Value
degrees NCT03924752 316 323 B-Eq-Unit
, NCT03924752 324 325 O
and NCT03924752 326 329 O
ankle NCT03924752 330 335 B-Observation-Name___Observation-Type-Value:measurement
plantar NCT03924752 336 343 I-Observation-Name___Observation-Type-Value:measurement
flexion NCT03924752 344 351 I-Observation-Name___Observation-Type-Value:measurement
contracture NCT03924752 352 363 I-Observation-Name___Observation-Type-Value:measurement
of NCT03924752 364 366 O
> NCT03924752 367 368 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03924752 370 372 B-Eq-Value
degrees NCT03924752 373 380 B-Eq-Unit
) NCT03924752 381 382 O
. NCT03924752 384 385 O

- NCT03924752 389 390 O
Subjects NCT03924752 392 400 O
must NCT03924752 401 405 O
be NCT03924752 406 408 O
able NCT03924752 409 413 B-Condition-Name
to NCT03924752 414 416 I-Condition-Name
walk NCT03924752 417 421 I-Condition-Name
for NCT03924752 422 425 O
at NCT03924752 426 428 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03924752 429 434 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03924752 436 437 B-Eq-Value
minutes NCT03924752 438 445 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
and NCT03924752 446 449 O
willing NCT03924752 450 457 O
and NCT03924752 458 461 O
able NCT03924752 462 466 B-Condition-Name
to NCT03924752 467 469 I-Condition-Name
participate NCT03924752 470 481 I-Condition-Name
over NCT03924752 482 486 O
a NCT03924752 487 488 O
1 NCT03924752 490 491 B-Eq-Value
- NCT03924752 492 493 B-Eq-Operator___Eq-Operator-Value:BETWEEN
6 NCT03924752 495 496 B-Eq-Value
hours NCT03924752 497 502 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
experiment NCT03924752 503 513 O
with NCT03924752 514 518 O
breaks NCT03924752 519 525 O
and NCT03924752 526 529 O
rest NCT03924752 530 534 O
enforced NCT03924752 535 543 O
regularly NCT03924752 544 553 O
and NCT03924752 554 557 O
as NCT03924752 558 560 O
needed NCT03924752 561 567 O
. NCT03924752 568 569 O

- NCT03924752 573 574 O
Subjects NCT03924752 576 584 O
must NCT03924752 585 589 O
be NCT03924752 590 592 O
able NCT03924752 593 597 B-Condition-Name
to NCT03924752 598 600 I-Condition-Name
transfer NCT03924752 601 609 I-Condition-Name
( NCT03924752 610 611 O
sit NCT03924752 612 615 B-Condition-Name
- NCT03924752 616 617 I-Condition-Name
to NCT03924752 618 620 I-Condition-Name
- NCT03924752 621 622 I-Condition-Name
stand NCT03924752 623 628 I-Condition-Name
and NCT03924752 629 632 O
stand NCT03924752 633 638 B-Condition-Name
- NCT03924752 639 640 I-Condition-Name
to NCT03924752 641 643 I-Condition-Name
- NCT03924752 644 645 I-Condition-Name
sit NCT03924752 646 649 I-Condition-Name
) NCT03924752 650 651 O
with NCT03924752 652 656 O
no NCT03924752 657 659 O
external NCT03924752 660 668 O
support NCT03924752 669 676 O
( NCT03924752 677 678 O
arm NCT03924752 679 682 O
rests NCT03924752 683 688 O
OK NCT03924752 689 691 O
) NCT03924752 692 693 O
and NCT03924752 694 697 O
to NCT03924752 698 700 O
ambulate NCT03924752 701 709 B-Condition-Name
over NCT03924752 710 714 O
small NCT03924752 715 720 O
slopes NCT03924752 721 727 O
( NCT03924752 728 729 O
3 NCT03924752 731 732 B-Eq-Value
degrees NCT03924752 733 740 B-Eq-Unit
) NCT03924752 741 742 O
and NCT03924752 743 746 O
a NCT03924752 747 748 O
few NCT03924752 749 752 O
steps NCT03924752 753 758 O
( NCT03924752 759 760 O
6 NCT03924752 762 763 B-Eq-Value
steps NCT03924752 764 769 B-Eq-Unit
) NCT03924752 770 771 O
. NCT03924752 773 774 O

Exclusion NCT03924752 776 785 O
Criteria NCT03924752 786 794 O
: NCT03924752 795 796 O

- NCT03924752 800 801 O
History NCT03924752 803 810 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924752 811 813 O
neurological NCT03924752 814 826 B-Condition-Name
injury NCT03924752 827 833 I-Condition-Name
, NCT03924752 834 835 O
gait NCT03924752 836 840 B-Condition-Name
pathology NCT03924752 841 850 I-Condition-Name
, NCT03924752 851 852 O
or NCT03924752 853 855 O
cardiovascular NCT03924752 856 870 B-Condition-Name
condition NCT03924752 871 880 I-Condition-Name
that NCT03924752 881 885 O
would NCT03924752 886 891 O
limit NCT03924752 892 897 B-Stability___Stability-Value:change
your NCT03924752 898 902 O
ability NCT03924752 903 910 B-Condition-Name
to NCT03924752 911 913 I-Condition-Name
ambulate NCT03924752 914 922 I-Condition-Name
for NCT03924752 923 926 O
multiple NCT03924752 927 935 B-Eq-Operator___Eq-Operator-Value:GT
hours NCT03924752 936 941 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
. NCT03924752 942 943 O

Inclusion NCT03929276 0 9 O
Criteria NCT03929276 10 18 O
: NCT03929276 19 20 O

- NCT03929276 24 25 O
Subjects NCT03929276 27 35 O
with NCT03929276 36 40 O
adhesive NCT03929276 41 49 B-Condition-Name
capsulitis NCT03929276 50 60 I-Condition-Name
diagnosis NCT03929276 61 70 O
by NCT03929276 71 73 O
physical NCT03929276 74 82 B-Procedure-Name
examination NCT03929276 83 94 I-Procedure-Name
( NCT03929276 95 96 O
Compared NCT03929276 97 105 O
with NCT03929276 106 110 O
intact NCT03929276 111 117 O
side NCT03929276 118 122 O
, NCT03929276 123 124 O
there NCT03929276 125 130 O
is NCT03929276 131 133 O
more NCT03929276 134 138 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929276 139 143 I-Eq-Operator___Eq-Operator-Value:GT
25 NCT03929276 145 147 B-Eq-Value
% NCT03929276 148 149 B-Eq-Unit
limitation NCT03929276 150 160 O
in NCT03929276 161 163 O
at NCT03929276 164 166 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929276 167 172 I-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03929276 173 176 B-Eq-Value
directions NCT03929276 177 187 B-Eq-Unit
of NCT03929276 188 190 O
shoulder NCT03929276 191 199 B-Observation-Name___Observation-Type-Value:measurement
range NCT03929276 200 205 I-Observation-Name___Observation-Type-Value:measurement
of NCT03929276 206 208 I-Observation-Name___Observation-Type-Value:measurement
motion NCT03929276 209 215 I-Observation-Name___Observation-Type-Value:measurement
) NCT03929276 216 217 O

- NCT03929276 221 222 O
Subjects NCT03929276 224 232 O
have NCT03929276 233 237 O
complaints NCT03929276 238 248 B-Condition-Name
for NCT03929276 249 252 O
at NCT03929276 253 255 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929276 256 261 I-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03929276 263 264 B-Eq-Value
month NCT03929276 265 270 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03929276 273 274 O
No NCT03929276 276 278 O
pregnancy NCT03929276 279 288 B-Condition-Name
/ NCT03929276 289 290 O
breastfeeding NCT03929276 291 304 B-Condition-Name

Exclusion NCT03929276 305 314 O
Criteria NCT03929276 315 323 O
: NCT03929276 324 325 O

- NCT03929276 329 330 O
History NCT03929276 332 339 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929276 340 342 O
bilateral NCT03929276 343 352 O
adhesive NCT03929276 353 361 B-Condition-Name
capsulitis NCT03929276 362 372 I-Condition-Name

- NCT03929276 375 376 O
History NCT03929276 378 385 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929276 386 388 O
shoulder NCT03929276 389 397 O
trauma NCT03929276 398 404 B-Condition-Name
, NCT03929276 405 406 O
fracture NCT03929276 407 415 B-Condition-Name
, NCT03929276 416 417 O
shoulder NCT03929276 418 426 B-Procedure-Name
shoulder NCT03929276 427 435 I-Procedure-Name
surgery NCT03929276 436 443 I-Procedure-Name
, NCT03929276 444 445 O
calcific NCT03929276 446 454 B-Condition-Name
tendinopathy NCT03929276 455 467 I-Condition-Name
, NCT03929276 468 469 O
glenohumeral NCT03929276 470 482 B-Condition-Name
osteoarthritis NCT03929276 483 497 I-Condition-Name
, NCT03929276 498 499 O
inflammatory NCT03929276 500 512 B-Condition-Name
rheumatic NCT03929276 513 522 I-Condition-Name
diseases NCT03929276 523 531 I-Condition-Name
, NCT03929276 532 533 O
tumor NCT03929276 534 539 B-Condition-Name
, NCT03929276 540 541 O
infection NCT03929276 542 551 B-Condition-Name

- NCT03929276 554 555 O
History NCT03929276 557 564 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929276 565 567 O
corticosteroid NCT03929276 568 582 B-Drug-Name
injection NCT03929276 583 592 O
in NCT03929276 593 595 O
the NCT03929276 596 599 O
shoulder NCT03929276 600 608 O
during NCT03929276 609 615 O
the NCT03929276 616 619 O
last NCT03929276 620 624 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
3 NCT03929276 626 627 B-Eq-Value
months NCT03929276 628 634 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03929276 637 638 O
History NCT03929276 640 647 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929276 648 650 O
recent NCT03929276 651 657 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
lung NCT03929276 658 662 O
, NCT03929276 663 664 O
breast NCT03929276 665 671 O
or NCT03929276 672 674 O
bypass NCT03929276 675 681 O
surgery NCT03929276 682 689 B-Procedure-Name

- NCT03929276 692 693 O
History NCT03929276 695 702 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929276 703 705 O
cervical NCT03929276 706 714 B-Condition-Name
radiculopathy NCT03929276 715 728 I-Condition-Name
/ NCT03929276 729 730 O
brachial NCT03929276 731 739 B-Condition-Name
plexus NCT03929276 740 746 I-Condition-Name
lesion NCT03929276 747 753 I-Condition-Name

- NCT03929276 756 757 O
History NCT03929276 759 766 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929276 767 769 O
neuromuscular NCT03929276 770 783 B-Condition-Name
disease NCT03929276 784 791 I-Condition-Name

- NCT03929276 794 795 O
History NCT03929276 797 804 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03929276 805 807 O
physical NCT03929276 808 816 B-Procedure-Name
therapy NCT03929276 817 824 I-Procedure-Name
program NCT03929276 825 832 O
for NCT03929276 833 836 O
the NCT03929276 837 840 O
same NCT03929276 841 845 O
shoulder NCT03929276 846 854 O
in NCT03929276 855 857 O
the NCT03929276 858 861 O
last NCT03929276 862 866 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
6 NCT03929276 868 869 B-Eq-Value
months NCT03929276 870 876 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

Inclusion NCT03921164 0 9 O
Criteria NCT03921164 10 18 O
: NCT03921164 19 20 O

- NCT03921164 24 25 O
Patients NCT03921164 27 35 O
> NCT03921164 36 37 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03921164 39 41 B-Eq-Value
years NCT03921164 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03921164 48 49 O
scheduled NCT03921164 50 59 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03921164 60 63 O
an NCT03921164 64 66 O
elective NCT03921164 67 75 B-Procedure-Name
interventional NCT03921164 76 90 B-Procedure-Name
neuroradiology NCT03921164 91 105 I-Procedure-Name
procedure NCT03921164 106 115 I-Procedure-Name
under NCT03921164 116 121 O
general NCT03921164 122 129 B-Procedure-Name
anesthesia NCT03921164 130 140 I-Procedure-Name
requiring NCT03921164 141 150 O
a NCT03921164 151 152 O
continuous NCT03921164 153 163 O
monitoring NCT03921164 164 174 O
of NCT03921164 175 177 O
mean NCT03921164 178 182 B-Observation-Name___Observation-Type-Value:measurement
arterial NCT03921164 183 191 I-Observation-Name___Observation-Type-Value:measurement
pressure NCT03921164 192 200 I-Observation-Name___Observation-Type-Value:measurement
and NCT03921164 201 204 O
cardiac NCT03921164 205 212 B-Observation-Name___Observation-Type-Value:measurement
output NCT03921164 213 219 I-Observation-Name___Observation-Type-Value:measurement
. NCT03921164 220 221 O

Exclusion NCT03921164 223 232 O
Criteria NCT03921164 233 241 O
: NCT03921164 242 243 O

- NCT03921164 247 248 O
age NCT03921164 250 253 O
< NCT03921164 254 255 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03921164 257 259 B-Eq-Value
years NCT03921164 260 265 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03921164 268 269 O
Patient NCT03921164 271 278 O
who NCT03921164 279 282 O
has NCT03921164 283 286 O
not NCT03921164 287 290 O
signed NCT03921164 291 297 O
the NCT03921164 298 301 O
consent NCT03921164 302 309 O

- NCT03921164 312 313 O
Pregnant NCT03921164 315 323 B-Condition-Name
woman NCT03921164 324 329 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03921164 332 333 O
Patient NCT03921164 335 342 O
under NCT03921164 343 348 O
judicial NCT03921164 349 357 B-Observation-Name
protection NCT03921164 358 368 I-Observation-Name

- NCT03921164 371 372 O
Patient NCT03921164 374 381 O
without NCT03921164 382 389 O
affiliation NCT03921164 390 401 O
to NCT03921164 402 404 O
a NCT03921164 405 406 O
social NCT03921164 407 413 O
security NCT03921164 414 422 O
scheme NCT03921164 423 429 O

Inclusion NCT03928626 0 9 O
Criteria NCT03928626 10 18 O
: NCT03928626 19 20 O

1 NCT03928626 25 26 O
. NCT03928626 26 27 O
Adults NCT03928626 29 35 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
ages NCT03928626 36 40 O
18 NCT03928626 42 44 B-Eq-Value
- NCT03928626 45 46 B-Eq-Operator___Eq-Operator-Value:BETWEEN
25 NCT03928626 48 50 B-Eq-Value

2 NCT03928626 55 56 O
. NCT03928626 56 57 O
Capability NCT03928626 59 69 O
of NCT03928626 70 72 O
performing NCT03928626 73 83 O
the NCT03928626 84 87 O
experimental NCT03928626 88 100 O
tasks NCT03928626 101 106 O
( NCT03928626 107 108 O
e NCT03928626 109 110 O
. NCT03928626 111 112 O
g NCT03928626 113 114 O
. NCT03928626 115 116 O
, NCT03928626 117 118 O
can NCT03928626 119 122 O
read NCT03928626 123 127 O
, NCT03928626 128 129 O
able NCT03928626 130 134 O
to NCT03928626 135 137 O
use NCT03928626 138 141 O
computers NCT03928626 142 151 O
) NCT03928626 152 153 O

3 NCT03928626 158 159 O
. NCT03928626 159 160 O
Native NCT03928626 162 168 O
or NCT03928626 169 171 O
fluent NCT03928626 172 178 O
speaker NCT03928626 179 186 O
of NCT03928626 187 189 O
English NCT03928626 190 197 B-Language

4 NCT03928626 201 202 O
. NCT03928626 202 203 O
Provides NCT03928626 205 213 O
informed NCT03928626 214 222 O
consent NCT03928626 223 230 O

5 NCT03928626 234 235 O
. NCT03928626 235 236 O
Normal NCT03928626 238 244 B-Polarity___Polarity-Value:normal
or NCT03928626 245 247 O
corrected NCT03928626 248 257 O
- NCT03928626 258 259 O
to NCT03928626 260 262 O
- NCT03928626 263 264 O
normal NCT03928626 265 271 B-Polarity___Polarity-Value:normal
vision NCT03928626 272 278 B-Condition-Name

6 NCT03928626 282 283 O
. NCT03928626 283 284 O
Willing NCT03928626 286 293 O
to NCT03928626 294 296 O
commit NCT03928626 297 303 O
to NCT03928626 304 306 O
the NCT03928626 307 310 O
full NCT03928626 311 315 O
length NCT03928626 316 322 O
of NCT03928626 323 325 O
the NCT03928626 326 329 O
protocol NCT03928626 330 338 O

7 NCT03928626 342 343 O
. NCT03928626 343 344 O
Heavy NCT03928626 346 351 B-Condition-Name
drinking NCT03928626 352 360 I-Condition-Name
or NCT03928626 361 363 O
binge NCT03928626 364 369 B-Condition-Name
- NCT03928626 370 371 I-Condition-Name
drinking NCT03928626 372 380 I-Condition-Name

Exclusion NCT03928626 381 390 O
Criteria NCT03928626 391 399 O
. NCT03928626 400 401 O

1 NCT03928626 406 407 O
. NCT03928626 407 408 O
Present NCT03928626 410 417 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
DSM NCT03928626 418 421 B-Condition-Name
disorders NCT03928626 422 431 I-Condition-Name
, NCT03928626 432 433 O
apart NCT03928626 434 439 O
from NCT03928626 440 444 O
alcohol NCT03928626 445 452 B-Condition-Name
use NCT03928626 453 456 I-Condition-Name
disorders NCT03928626 457 466 I-Condition-Name

2 NCT03928626 470 471 O
. NCT03928626 471 472 O
Reports NCT03928626 474 481 O
of NCT03928626 482 484 O
neurological NCT03928626 485 497 O
or NCT03928626 498 500 O
systemic NCT03928626 501 509 O
disorders NCT03928626 510 519 B-Condition-Name
that NCT03928626 520 524 O
can NCT03928626 525 528 O
cause NCT03928626 529 534 O
cognitive NCT03928626 535 544 B-Condition-Name
impairment NCT03928626 545 555 I-Condition-Name

3 NCT03928626 559 560 O
. NCT03928626 560 561 O
Minor NCT03928626 563 568 B-Severity___Severity-Value:mild
cognitive NCT03928626 569 578 B-Condition-Name
impairment NCT03928626 579 589 I-Condition-Name
evidenced NCT03928626 590 599 O
by NCT03928626 600 602 O
an NCT03928626 603 605 O
inability NCT03928626 606 615 B-Condition-Name
to NCT03928626 616 618 I-Condition-Name
correctly NCT03928626 619 628 I-Condition-Name
understand NCT03928626 629 639 I-Condition-Name
study NCT03928626 640 645 O
information NCT03928626 646 657 O

4 NCT03928626 661 662 O
. NCT03928626 662 663 O
Reports NCT03928626 665 672 O
entirely NCT03928626 673 681 O
no NCT03928626 682 684 O
interest NCT03928626 685 693 O
in NCT03928626 694 696 O
reducing NCT03928626 697 705 B-Stability___Stability-Value:change
the NCT03928626 706 709 O
amount NCT03928626 710 716 O
of NCT03928626 717 719 O
drinking NCT03928626 720 728 B-Condition-Name
( NCT03928626 729 730 O
Alcohol NCT03928626 731 738 B-Observation-Name___Observation-Type-Value:clinical-score
Contemplation NCT03928626 739 752 I-Observation-Name___Observation-Type-Value:clinical-score
Ladder NCT03928626 753 759 I-Observation-Name___Observation-Type-Value:clinical-score
score NCT03928626 760 765 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03928626 766 768 O
9 NCT03928626 770 771 B-Eq-Value
or NCT03928626 772 774 O
10 NCT03928626 776 778 B-Eq-Value
) NCT03928626 779 780 O
. NCT03928626 782 783 O

Inclusion NCT03926780 0 9 O
Criteria NCT03926780 10 18 O
: NCT03926780 19 20 O

- NCT03926780 24 25 O
Evidence NCT03926780 27 35 O
of NCT03926780 36 38 O
LV NCT03926780 39 41 B-Condition-Name
thrombus NCT03926780 42 50 I-Condition-Name
as NCT03926780 51 53 O
assessed NCT03926780 54 62 O
by NCT03926780 63 65 O
trans NCT03926780 66 71 B-Procedure-Name
- NCT03926780 72 73 I-Procedure-Name
thoracic NCT03926780 74 82 I-Procedure-Name
echocardiography NCT03926780 83 99 I-Procedure-Name
( NCT03926780 100 101 O
TTE NCT03926780 102 105 B-Procedure-Name
) NCT03926780 106 107 O
. NCT03926780 109 110 O

Exclusion NCT03926780 112 121 O
Criteria NCT03926780 122 130 O
: NCT03926780 131 132 O

- NCT03926780 136 137 O
Creatinine NCT03926780 139 149 B-Observation-Name___Observation-Type-Value:lab
clearance NCT03926780 150 159 I-Observation-Name___Observation-Type-Value:lab
less NCT03926780 160 164 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03926780 165 169 I-Eq-Operator___Eq-Operator-Value:LT
50 NCT03926780 171 173 B-Eq-Value
ml NCT03926780 174 176 B-Eq-Unit
/ NCT03926780 177 178 O
min NCT03926780 179 182 B-Eq-Unit
. NCT03926780 183 184 O

Inclusion NCT03922243 0 9 O
Criteria NCT03922243 10 18 O
: NCT03922243 19 20 O

- NCT03922243 24 25 O
Dental NCT03922243 27 33 B-Procedure-Name
treatment NCT03922243 34 43 I-Procedure-Name
performed NCT03922243 44 53 O
in NCT03922243 54 56 O
the NCT03922243 57 60 O
time NCT03922243 61 65 O
frame NCT03922243 66 71 O

Exclusion NCT03922243 72 81 O
Criteria NCT03922243 82 90 O
: NCT03922243 91 92 O

- NCT03922243 96 97 O
Dental NCT03922243 99 105 B-Procedure-Name
treatment NCT03922243 106 115 I-Procedure-Name
not NCT03922243 116 119 O
performed NCT03922243 120 129 O

Inclusion NCT03920332 0 9 O
Criteria NCT03920332 10 18 O
: NCT03920332 19 20 O

- NCT03920332 24 25 O
Inherited NCT03920332 27 36 B-Condition-Name
fibrinogen NCT03920332 37 47 I-Condition-Name
disorders NCT03920332 48 57 I-Condition-Name
( NCT03920332 58 59 O
hypofibrinogenemia NCT03920332 60 78 B-Condition-Name
, NCT03920332 79 80 O
dysfibrinogenemia NCT03920332 81 98 B-Condition-Name
, NCT03920332 99 100 O
hypodysfibrinogenemia NCT03920332 101 122 B-Condition-Name
) NCT03920332 123 124 O

- NCT03920332 128 129 O
At NCT03920332 131 133 B-Eq-Operator___Eq-Operator-Value:GTEQ
lest NCT03920332 134 138 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03920332 139 142 B-Eq-Value
past NCT03920332 143 147 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pregnancy NCT03920332 148 157 B-Condition-Name

- NCT03920332 160 161 O
Adult NCT03920332 163 168 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult

Exclusion NCT03920332 169 178 O
Criteria NCT03920332 179 187 O
: NCT03920332 188 189 O

- NCT03920332 193 194 O
No NCT03920332 196 198 O
past NCT03920332 199 203 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pregnancy NCT03920332 204 213 B-Condition-Name

- NCT03920332 216 217 O
Not NCT03920332 219 222 O
confirmed NCT03920332 223 232 O
fibrinogen NCT03920332 233 243 B-Condition-Name
disorder NCT03920332 244 252 I-Condition-Name

Inclusion NCT03929458 0 9 O
Criteria NCT03929458 10 18 O
: NCT03929458 19 20 O

- NCT03929458 24 25 O
Both NCT03929458 27 31 O
sexes NCT03929458 32 37 O
aged NCT03929458 38 42 O
between NCT03929458 43 50 O
20 NCT03929458 52 54 B-Eq-Value
- NCT03929458 55 56 B-Eq-Operator___Eq-Operator-Value:BETWEEN
90 NCT03929458 58 60 B-Eq-Value
years NCT03929458 61 66 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03929458 67 68 O

- NCT03929458 72 73 O
Received NCT03929458 75 83 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
stable NCT03929458 84 90 B-Stability___Stability-Value:stable
hemodialysis NCT03929458 91 103 B-Procedure-Name
at NCT03929458 104 106 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03929458 107 112 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03929458 114 115 B-Eq-Value
months NCT03929458 116 122 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03929458 123 124 O

- NCT03929458 128 129 O
Written NCT03929458 131 138 O
informed NCT03929458 139 147 O
consent NCT03929458 148 155 O
. NCT03929458 156 157 O

Exclusion NCT03929458 159 168 O
Criteria NCT03929458 169 177 O
: NCT03929458 178 179 O

- NCT03929458 183 184 O
patients NCT03929458 186 194 O
with NCT03929458 195 199 O
severe NCT03929458 200 206 B-Severity___Severity-Value:severe
infections NCT03929458 207 217 B-Condition-Name
, NCT03929458 218 219 O
severe NCT03929458 220 226 B-Severity___Severity-Value:severe
heart NCT03929458 227 232 B-Condition-Name
disease NCT03929458 233 240 I-Condition-Name
and NCT03929458 241 244 O
liver NCT03929458 245 250 B-Condition-Name
disease NCT03929458 251 258 I-Condition-Name
, NCT03929458 259 260 O
malignancy NCT03929458 261 271 B-Condition-Name
, NCT03929458 272 273 O
autoimmune NCT03929458 274 284 B-Condition-Name
disorders NCT03929458 285 294 I-Condition-Name
, NCT03929458 295 296 O
severe NCT03929458 297 303 B-Condition-Name
malnutrition NCT03929458 304 316 I-Condition-Name
, NCT03929458 317 318 O
or NCT03929458 319 321 O
clinical NCT03929458 322 330 O
conditions NCT03929458 331 341 O
requiring NCT03929458 342 351 O
oral NCT03929458 352 356 B-Drug-Name
nutrition NCT03929458 357 366 I-Drug-Name
supplements NCT03929458 367 378 I-Drug-Name
; NCT03929458 378 379 O

- NCT03929458 382 383 O
Inability NCT03929458 385 394 O
to NCT03929458 395 397 O
follow NCT03929458 398 404 O
protocol NCT03929458 405 413 O
. NCT03929458 414 415 O

- NCT03929458 419 420 O
Pregnancy NCT03929458 422 431 B-Condition-Name
or NCT03929458 432 434 O
wishing NCT03929458 435 442 O
/ NCT03929458 443 444 O
trying NCT03929458 445 451 O
to NCT03929458 452 454 O
get NCT03929458 455 458 O
pregnant NCT03929458 459 467 B-Condition-Name

Inclusion NCT03921762 0 9 O
Criteria NCT03921762 10 18 O
: NCT03921762 19 20 O

- NCT03921762 24 25 O
> NCT03921762 27 28 B-Eq-Operator___Eq-Operator-Value:GT
50 NCT03921762 30 32 B-Eq-Value
years NCT03921762 33 38 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03921762 39 42 O

- NCT03921762 45 46 O
Bilateral NCT03921762 48 57 O
age NCT03921762 58 61 O
- NCT03921762 62 63 O
related NCT03921762 64 71 O
cataract NCT03921762 72 80 B-Condition-Name

- NCT03921762 83 84 O
Qualify NCT03921762 86 93 O
for NCT03921762 94 97 O
bilateral NCT03921762 98 107 B-Procedure-Name
implantation NCT03921762 108 120 I-Procedure-Name
within NCT03921762 121 127 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03921762 129 130 B-Eq-Value
month NCT03921762 131 136 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03921762 139 140 O
No NCT03921762 142 144 O
previous NCT03921762 145 153 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
refractive NCT03921762 154 164 O
or NCT03921762 165 167 O
ocular NCT03921762 168 174 O
surgery NCT03921762 175 182 B-Procedure-Name

- NCT03921762 185 186 O
Available NCT03921762 188 197 O
IOL NCT03921762 198 201 B-Observation-Name___Observation-Type-Value:measurement
dioptre NCT03921762 202 209 I-Observation-Name___Observation-Type-Value:measurement
range NCT03921762 210 215 I-Observation-Name___Observation-Type-Value:measurement
: NCT03921762 216 217 O
18 NCT03921762 219 221 B-Eq-Value
to NCT03921762 222 224 B-Eq-Operator___Eq-Operator-Value:BETWEEN
27 NCT03921762 226 228 B-Eq-Value
D NCT03921762 229 230 B-Eq-Unit

- NCT03921762 233 234 O
Expected NCT03921762 236 244 O
post NCT03921762 245 249 O
operative NCT03921762 250 259 B-Procedure-Name
astigmatism NCT03921762 260 271 B-Observation-Name___Observation-Type-Value:measurement
≤ NCT03921762 272 273 B-Eq-Operator___Eq-Operator-Value:LTEQ
0.75 NCT03921762 275 279 B-Eq-Value
D NCT03921762 280 281 B-Eq-Unit

Exclusion NCT03921762 282 291 O
Criteria NCT03921762 292 300 O
: NCT03921762 301 302 O

- NCT03921762 306 307 O
Pupil NCT03921762 309 314 B-Observation-Name___Observation-Type-Value:measurement
> NCT03921762 315 316 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03921762 318 319 B-Eq-Value
mm NCT03921762 320 322 B-Eq-Unit

- NCT03921762 325 326 O
Occupation NCT03921762 328 338 O
requiring NCT03921762 339 348 O
night NCT03921762 349 354 O
- NCT03921762 355 356 O
time NCT03921762 357 361 O
driving NCT03921762 362 369 O
or NCT03921762 370 372 O
any NCT03921762 373 376 O
occupation NCT03921762 377 387 O
incompatible NCT03921762 388 400 O
with NCT03921762 401 405 O
multifocality NCT03921762 406 419 O

- NCT03921762 422 423 O
Acute NCT03921762 425 430 B-Severity___Severity-Value:severe
or NCT03921762 431 433 O
chronic NCT03921762 434 441 O
disease NCT03921762 442 449 B-Condition-Name
or NCT03921762 450 452 O
illness NCT03921762 453 460 O
that NCT03921762 461 465 O
would NCT03921762 466 471 O
increase NCT03921762 472 480 B-Stability___Stability-Value:change
risk NCT03921762 481 485 O
or NCT03921762 486 488 O
confound NCT03921762 489 497 B-Stability___Stability-Value:change
study NCT03921762 498 503 O
results NCT03921762 504 511 O
[ NCT03921762 512 513 O
e NCT03921762 514 515 O
. NCT03921762 516 517 O
g NCT03921762 518 519 O
. NCT03921762 520 521 O
diabetes NCT03921762 523 531 B-Condition-Name
mellitus NCT03921762 532 540 I-Condition-Name
( NCT03921762 541 542 O
with NCT03921762 543 547 O
retinopathy NCT03921762 548 559 B-Condition-Name
) NCT03921762 560 561 O
, NCT03921762 563 564 O
immunocompromised NCT03921762 565 582 B-Condition-Name
, NCT03921762 583 584 O
glaucoma NCT03921762 585 593 B-Condition-Name
, NCT03921762 594 595 O
epiretinal NCT03921762 596 606 B-Condition-Name
membrane NCT03921762 607 615 I-Condition-Name
, NCT03921762 616 617 O
cornea NCT03921762 618 624 B-Condition-Name
guttata NCT03921762 625 632 I-Condition-Name
, NCT03921762 633 634 O
etc NCT03921762 635 638 O
… NCT03921762 638 639 O
. NCT03921762 640 641 O
] NCT03921762 642 643 O
found NCT03921762 644 649 O
to NCT03921762 650 652 O
be NCT03921762 653 655 O
relevant NCT03921762 656 664 O
by NCT03921762 665 667 O
the NCT03921762 668 671 O
investigators NCT03921762 672 685 O

- NCT03921762 688 689 O
Amblyopia NCT03921762 691 700 B-Condition-Name
, NCT03921762 701 702 O
strabismus NCT03921762 703 713 B-Condition-Name

- NCT03921762 716 717 O
Extremely NCT03921762 719 728 B-Severity___Severity-Value:severe
shallow NCT03921762 729 736 B-Condition-Name
anterior NCT03921762 737 745 I-Condition-Name
chamber NCT03921762 746 753 I-Condition-Name

- NCT03921762 756 757 O
Capsule NCT03921762 759 766 O
or NCT03921762 767 769 O
zonular NCT03921762 770 777 O
abnormalities NCT03921762 778 791 B-Condition-Name
that NCT03921762 792 796 O
may NCT03921762 797 800 O
affect NCT03921762 801 807 B-Stability___Stability-Value:change
post NCT03921762 808 812 O
operative NCT03921762 813 822 B-Procedure-Name
centration NCT03921762 823 833 O
or NCT03921762 834 836 O
tilt NCT03921762 837 841 O
of NCT03921762 842 844 O
the NCT03921762 845 848 O
lens NCT03921762 849 853 B-Condition-Name
( NCT03921762 854 855 O
e NCT03921762 856 857 O
. NCT03921762 858 859 O
g NCT03921762 860 861 O
. NCT03921762 862 863 O
pseudoexfoliation NCT03921762 865 882 B-Condition-Name
syndrome NCT03921762 883 891 I-Condition-Name
, NCT03921762 892 893 O
uveitis NCT03921762 894 901 B-Condition-Name
, NCT03921762 902 903 O
Marfan NCT03921762 904 910 B-Condition-Name
's NCT03921762 910 912 I-Condition-Name
syndrome NCT03921762 913 921 I-Condition-Name
) NCT03921762 922 923 O

- NCT03921762 927 928 O
Pupil NCT03921762 930 935 B-Condition-Name
abnormalities NCT03921762 936 949 I-Condition-Name
( NCT03921762 950 951 O
non NCT03921762 952 955 B-Condition-Name
- NCT03921762 956 957 I-Condition-Name
reactive NCT03921762 958 966 I-Condition-Name
, NCT03921762 967 968 O
tonic NCT03921762 969 974 B-Condition-Name
pupils NCT03921762 975 981 I-Condition-Name
, NCT03921762 982 983 O
abnormally NCT03921762 984 994 B-Condition-Name
shaped NCT03921762 995 1001 I-Condition-Name
pupils NCT03921762 1002 1008 I-Condition-Name
or NCT03921762 1009 1011 O
pupils NCT03921762 1012 1018 B-Condition-Name
that NCT03921762 1019 1023 I-Condition-Name
do NCT03921762 1024 1026 I-Condition-Name
not NCT03921762 1027 1030 I-Condition-Name
dilate NCT03921762 1031 1037 I-Condition-Name
under NCT03921762 1038 1043 O
mesopic NCT03921762 1044 1051 O
/ NCT03921762 1052 1053 O
scotopic NCT03921762 1054 1062 O
conditions NCT03921762 1063 1073 O
) NCT03921762 1074 1075 O

- NCT03921762 1079 1080 O
Instability NCT03921762 1082 1093 B-Stability___Stability-Value:change
to NCT03921762 1094 1096 O
place NCT03921762 1097 1102 B-Procedure-Name
the NCT03921762 1103 1106 I-Procedure-Name
intraocular NCT03921762 1107 1118 I-Procedure-Name
lens NCT03921762 1119 1123 I-Procedure-Name
safely NCT03921762 1124 1130 O
at NCT03921762 1131 1133 O
the NCT03921762 1134 1137 O
location NCT03921762 1138 1146 O
planned NCT03921762 1147 1154 O

- NCT03921762 1157 1158 O
Pregnancy NCT03921762 1160 1169 B-Condition-Name
( NCT03921762 1170 1171 O
pregnancy NCT03921762 1172 1181 B-Observation-Name
test NCT03921762 1182 1186 I-Observation-Name
will NCT03921762 1187 1191 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
be NCT03921762 1192 1194 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
taken NCT03921762 1195 1200 O
pre NCT03921762 1201 1204 O
- NCT03921762 1205 1206 O
operatively NCT03921762 1207 1218 B-Procedure-Name
in NCT03921762 1219 1221 O
women NCT03921762 1222 1227 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03921762 1228 1230 O
reproductive NCT03921762 1231 1243 B-Condition-Name
age NCT03921762 1244 1247 I-Condition-Name
) NCT03921762 1248 1249 O

Inclusion NCT03925909 0 9 O
Criteria NCT03925909 10 18 O
: NCT03925909 19 20 O

- NCT03925909 24 25 O
30 NCT03925909 28 30 B-Eq-Value
- NCT03925909 31 32 B-Eq-Operator___Eq-Operator-Value:BETWEEN
60 NCT03925909 34 36 B-Eq-Value
years NCT03925909 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03925909 45 46 O
Increased NCT03925909 48 57 B-Polarity___Polarity-Value:high
fasting NCT03925909 58 65 B-Observation-Name___Observation-Type-Value:lab
blood NCT03925909 66 71 I-Observation-Name___Observation-Type-Value:lab
glucose NCT03925909 72 79 I-Observation-Name___Observation-Type-Value:lab
from NCT03925909 80 84 O
6.1 NCT03925909 86 89 B-Eq-Value
to NCT03925909 90 92 B-Eq-Operator___Eq-Operator-Value:BETWEEN
7.0 NCT03925909 94 97 B-Eq-Value
mmol NCT03925909 98 102 B-Eq-Unit
/ NCT03925909 103 104 O
L NCT03925909 105 106 B-Eq-Unit
or NCT03925909 107 109 O
, NCT03925909 110 111 O

- NCT03925909 115 116 O
Decreased NCT03925909 118 127 B-Polarity___Polarity-Value:low
glucose NCT03925909 128 135 B-Observation-Name___Observation-Type-Value:lab
tolerance NCT03925909 136 145 I-Observation-Name___Observation-Type-Value:lab
of NCT03925909 146 148 O
7 NCT03925909 150 151 B-Eq-Value
, NCT03925909 152 153 O
8 NCT03925909 155 156 B-Eq-Value
to NCT03925909 157 159 B-Eq-Operator___Eq-Operator-Value:BETWEEN
11.1 NCT03925909 161 165 B-Eq-Value
mmol NCT03925909 166 170 B-Eq-Unit
/ NCT03925909 171 172 O
L NCT03925909 173 174 B-Eq-Unit
or NCT03925909 175 177 O
, NCT03925909 178 179 O

- NCT03925909 183 184 O
Glycated NCT03925909 186 194 O
hemoglobin NCT03925909 195 205 B-Observation-Name___Observation-Type-Value:lab
with NCT03925909 206 210 O
values NCT03925909 211 217 O
between NCT03925909 218 225 B-Eq-Operator___Eq-Operator-Value:BETWEEN
5.7 NCT03925909 227 230 B-Eq-Value
and NCT03925909 231 234 O
6.4 NCT03925909 236 239 B-Eq-Value
% NCT03925909 240 241 B-Eq-Unit

Exclusion NCT03925909 243 252 O
Criteria NCT03925909 253 261 O
: NCT03925909 262 263 O

- NCT03925909 267 268 O
Use NCT03925909 270 273 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hypoglycemic NCT03925909 274 286 B-Drug-Name
, NCT03925909 287 288 O
hypolipidemic NCT03925909 289 302 B-Drug-Name
drugs NCT03925909 303 308 O
, NCT03925909 309 310 O

- NCT03925909 314 315 O
Use NCT03925909 317 320 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
dietary NCT03925909 321 328 B-Drug-Name
supplements NCT03925909 329 340 I-Drug-Name
( NCT03925909 341 342 O
vitamins NCT03925909 343 351 B-Drug-Name
, NCT03925909 352 353 O
minerals NCT03925909 354 362 B-Drug-Name
, NCT03925909 363 364 O
bioflavonoids NCT03925909 365 378 B-Drug-Name
, NCT03925909 379 380 O
prebiotics NCT03925909 381 391 B-Drug-Name
, NCT03925909 392 393 O
probiotics NCT03925909 394 404 B-Drug-Name
or NCT03925909 405 407 O
other NCT03925909 408 413 O
bioactive NCT03925909 414 423 B-Drug-Name
compounds NCT03925909 424 433 I-Drug-Name
) NCT03925909 434 435 O
, NCT03925909 437 438 O

- NCT03925909 442 443 O
Exercise NCT03925909 445 453 B-Condition-Name
intensely NCT03925909 454 463 B-Severity___Severity-Value:severe
( NCT03925909 464 465 O
more NCT03925909 466 470 B-Eq-Operator___Eq-Operator-Value:GTEQ
than NCT03925909 471 475 I-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03925909 477 479 B-Eq-Value
hours NCT03925909 480 485 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
per NCT03925909 486 489 O
week NCT03925909 490 494 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03925909 495 496 O

- NCT03925909 500 501 O
History NCT03925909 503 510 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925909 511 513 O
cardiovascular NCT03925909 514 528 B-Condition-Name
diseases NCT03925909 529 537 I-Condition-Name
, NCT03925909 538 539 O
diabetes NCT03925909 540 548 B-Condition-Name
mellitus NCT03925909 549 557 I-Condition-Name
, NCT03925909 558 559 O
liver NCT03925909 560 565 O
and NCT03925909 566 569 O
kidney NCT03925909 570 576 O
disease NCT03925909 577 584 B-Condition-Name
. NCT03925909 585 586 O

Inclusion NCT03928587 0 9 O
Criteria NCT03928587 10 18 O
: NCT03928587 19 20 O

1 NCT03928587 25 26 O
. NCT03928587 26 27 O
Healthy NCT03928587 29 36 B-Condition-Name
children NCT03928587 37 45 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03928587 46 50 O
absence NCT03928587 51 58 O
of NCT03928587 59 61 O
severe NCT03928587 62 68 B-Severity___Severity-Value:severe
chronic NCT03928587 69 76 O
disease NCT03928587 77 84 B-Condition-Name

2 NCT03928587 88 89 O
. NCT03928587 89 90 O
Age NCT03928587 92 95 O
5 NCT03928587 97 98 B-Eq-Value
- NCT03928587 99 100 B-Eq-Operator___Eq-Operator-Value:BETWEEN
8 NCT03928587 102 103 B-Eq-Value
years NCT03928587 104 109 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
, NCT03928587 110 111 O
both NCT03928587 112 116 O
inclusive NCT03928587 117 126 O
, NCT03928587 127 128 O
at NCT03928587 129 131 O
inclusion NCT03928587 132 141 O

3 NCT03928587 145 146 O
. NCT03928587 146 147 O
Ability NCT03928587 149 156 O
to NCT03928587 157 159 O
cooperate NCT03928587 160 169 O
at NCT03928587 170 172 O
dental NCT03928587 173 179 B-Procedure-Name
examination NCT03928587 180 191 I-Procedure-Name

4 NCT03928587 195 196 O
. NCT03928587 196 197 O
Ability NCT03928587 199 206 O
to NCT03928587 207 209 O
cooperate NCT03928587 210 219 O
to NCT03928587 220 222 O
a NCT03928587 223 224 O
daily NCT03928587 225 230 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
intake NCT03928587 231 237 O
of NCT03928587 238 240 O
a NCT03928587 241 242 O
lozenge NCT03928587 243 250 B-Drug-Name

5 NCT03928587 254 255 O
. NCT03928587 255 256 O
Parents NCT03928587 258 265 O
/ NCT03928587 266 267 O
legal NCT03928587 268 273 O
guarding NCT03928587 274 282 O
provided NCT03928587 283 291 O
voluntary NCT03928587 292 301 O
written NCT03928587 302 309 O
informed NCT03928587 310 318 O
consent NCT03928587 319 326 O

Exclusion NCT03928587 327 336 O
Criteria NCT03928587 337 345 O
: NCT03928587 346 347 O

1 NCT03928587 352 353 O
. NCT03928587 353 354 O
Children NCT03928587 356 364 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
with NCT03928587 365 369 O
severe NCT03928587 370 376 B-Severity___Severity-Value:severe
medical NCT03928587 377 384 O
conditions NCT03928587 385 395 O

2 NCT03928587 399 400 O
. NCT03928587 400 401 O
Mentally NCT03928587 403 411 O
or NCT03928587 412 414 O
physically NCT03928587 415 425 O
disabled NCT03928587 426 434 B-Condition-Name
children NCT03928587 435 443 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child

3 NCT03928587 447 448 O
. NCT03928587 448 449 O
Children NCT03928587 451 459 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
of NCT03928587 460 462 O
parents NCT03928587 463 470 O
with NCT03928587 471 475 O
language NCT03928587 476 484 O
barriers NCT03928587 485 493 O
and NCT03928587 494 497 O
not NCT03928587 498 501 O
able NCT03928587 502 506 O
to NCT03928587 507 509 O
give NCT03928587 510 514 O
written NCT03928587 515 522 O
informed NCT03928587 523 531 O
consent NCT03928587 532 539 O

Inclusion NCT03923439 0 9 O
Criteria NCT03923439 10 18 O
: NCT03923439 19 20 O

- NCT03923439 24 25 O
Patients NCT03923439 27 35 O
older NCT03923439 36 41 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03923439 42 46 I-Eq-Operator___Eq-Operator-Value:GT
18 NCT03923439 48 50 B-Eq-Value
years NCT03923439 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03923439 57 60 O

- NCT03923439 63 64 O
Cerebral NCT03923439 66 74 B-Condition-Name
infarct NCT03923439 75 82 I-Condition-Name
within NCT03923439 83 89 O
the NCT03923439 90 93 O
anterior NCT03923439 94 102 O
circulation NCT03923439 103 114 O
due NCT03923439 115 118 O
to NCT03923439 119 121 O
occlusion NCT03923439 122 131 B-Condition-Name
of NCT03923439 132 134 I-Condition-Name
intracranial NCT03923439 135 147 I-Condition-Name
carotid NCT03923439 148 155 I-Condition-Name
artery NCT03923439 156 162 I-Condition-Name
or NCT03923439 163 165 O
proximal NCT03923439 166 174 O
( NCT03923439 175 176 O
M NCT03923439 177 178 B-Eq-Value
1 NCT03923439 179 180 I-Eq-Value
) NCT03923439 181 182 O
MCA NCT03923439 183 186 B-Condition-Name
. NCT03923439 187 188 O

- NCT03923439 192 193 O
With NCT03923439 195 199 O
acute NCT03923439 200 205 B-Severity___Severity-Value:severe
MRI NCT03923439 206 209 B-Procedure-Name
performed NCT03923439 210 219 O
within NCT03923439 220 226 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03923439 227 230 O
first NCT03923439 231 236 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
24 NCT03923439 238 240 B-Eq-Value
h NCT03923439 241 242 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
and NCT03923439 243 246 O
showing NCT03923439 247 254 O
significant NCT03923439 255 266 B-Severity___Severity-Value:severe
penumbra NCT03923439 267 275 B-Condition-Name
defined NCT03923439 276 283 O
as NCT03923439 284 286 O
ratio NCT03923439 287 292 B-Observation-Name___Observation-Type-Value:measurement
between NCT03923439 293 300 I-Observation-Name___Observation-Type-Value:measurement
the NCT03923439 301 304 I-Observation-Name___Observation-Type-Value:measurement
volumes NCT03923439 305 312 I-Observation-Name___Observation-Type-Value:measurement
of NCT03923439 313 315 O
critically NCT03923439 316 326 O
hypoperfused NCT03923439 327 339 O
tissue NCT03923439 340 346 O
( NCT03923439 347 348 O
defined NCT03923439 349 356 O
by NCT03923439 357 359 O
Tmax NCT03923439 360 364 B-Observation-Name
> NCT03923439 365 366 B-Eq-Operator___Eq-Operator-Value:GT
6 NCT03923439 368 369 B-Eq-Value
s NCT03923439 370 371 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:second
) NCT03923439 372 373 O
and NCT03923439 374 377 O
the NCT03923439 378 381 O
ischemic NCT03923439 382 390 O
core NCT03923439 391 395 O
( NCT03923439 396 397 O
defined NCT03923439 398 405 O
by NCT03923439 406 408 O
ADC NCT03923439 409 412 B-Observation-Name
< NCT03923439 413 414 B-Eq-Operator___Eq-Operator-Value:LT
600 NCT03923439 416 419 B-Eq-Value
× NCT03923439 420 421 O
10 NCT03923439 423 425 B-Eq-Value
- NCT03923439 426 427 B-Eq-Operator___Eq-Operator-Value:BETWEEN
6 NCT03923439 429 430 B-Eq-Value
mm NCT03923439 431 433 B-Eq-Unit
2 NCT03923439 434 435 I-Eq-Unit
/ NCT03923439 436 437 O
s NCT03923439 438 439 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:second
) NCT03923439 440 441 O
of NCT03923439 442 444 O
1.8 NCT03923439 446 449 B-Eq-Value
or NCT03923439 450 452 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03923439 453 457 I-Eq-Operator___Eq-Operator-Value:GTEQ
, NCT03923439 458 459 O
with NCT03923439 460 464 O
an NCT03923439 465 467 O
absolute NCT03923439 468 476 B-Observation-Name___Observation-Type-Value:measurement
difference NCT03923439 477 487 I-Observation-Name___Observation-Type-Value:measurement
of NCT03923439 488 490 O
15 NCT03923439 492 494 B-Eq-Value
mL NCT03923439 495 497 B-Eq-Unit
or NCT03923439 498 500 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03923439 501 505 I-Eq-Operator___Eq-Operator-Value:GTEQ
and NCT03923439 506 509 O
ischemic NCT03923439 510 518 B-Observation-Name___Observation-Type-Value:measurement
core NCT03923439 519 523 I-Observation-Name___Observation-Type-Value:measurement
volume NCT03923439 524 530 I-Observation-Name___Observation-Type-Value:measurement
of NCT03923439 531 533 O
less NCT03923439 534 538 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03923439 539 543 I-Eq-Operator___Eq-Operator-Value:LT
70 NCT03923439 545 547 B-Eq-Value
mL NCT03923439 548 550 B-Eq-Unit
. NCT03923439 551 552 O

- NCT03923439 556 557 O
Successful NCT03923439 559 569 O
recanalization NCT03923439 570 584 B-Procedure-Name
( NCT03923439 585 586 O
TICI NCT03923439 587 591 B-Condition-Name
2 NCT03923439 593 594 B-Eq-Value
b NCT03923439 595 596 I-Eq-Value
- NCT03923439 597 598 I-Eq-Value
3 NCT03923439 600 601 I-Eq-Value
) NCT03923439 602 603 O
by NCT03923439 604 606 O
thrombectomy NCT03923439 607 619 B-Procedure-Name
alone NCT03923439 620 625 O
or NCT03923439 626 628 O
in NCT03923439 629 631 O
combination NCT03923439 632 643 O
with NCT03923439 644 648 O
IV NCT03923439 649 651 O
thrombolysis NCT03923439 652 664 B-Procedure-Name
( NCT03923439 665 666 O
if NCT03923439 667 669 O
within NCT03923439 670 676 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03923439 677 680 O
first NCT03923439 681 686 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
4.5 NCT03923439 688 691 B-Eq-Value
h NCT03923439 692 693 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
) NCT03923439 694 695 O
. NCT03923439 697 698 O

- NCT03923439 702 703 O
Patient NCT03923439 705 712 O
/ NCT03923439 713 714 O
Legally NCT03923439 715 722 O
Authorized NCT03923439 723 733 O
Representative NCT03923439 734 748 O
has NCT03923439 749 752 O
signed NCT03923439 753 759 O
the NCT03923439 760 763 O
Informed NCT03923439 764 772 O
Consent NCT03923439 773 780 O
form NCT03923439 781 785 O
. NCT03923439 786 787 O

Exclusion NCT03923439 789 798 O
Criteria NCT03923439 799 807 O
: NCT03923439 808 809 O

- NCT03923439 813 814 O
History NCT03923439 816 823 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03923439 824 826 O
symptomatic NCT03923439 827 838 O
cerebral NCT03923439 839 847 B-Condition-Name
infarct NCT03923439 848 855 I-Condition-Name
with NCT03923439 856 860 O
functional NCT03923439 861 871 B-Condition-Name
deficit NCT03923439 872 879 I-Condition-Name
( NCT03923439 880 881 O
pre NCT03923439 882 885 O
- NCT03923439 886 887 O
stroke NCT03923439 888 894 B-Condition-Name
modified NCT03923439 895 903 B-Observation-Name
Rankin NCT03923439 904 910 I-Observation-Name
Scale NCT03923439 911 916 I-Observation-Name
score NCT03923439 917 922 B-Eq-Unit
≥ NCT03923439 923 924 B-Eq-Operator___Eq-Operator-Value:GTEQ
1 NCT03923439 926 927 B-Eq-Value
) NCT03923439 928 929 O
to NCT03923439 930 932 O
measure NCT03923439 933 940 O
the NCT03923439 941 944 O
impact NCT03923439 945 951 B-Stability___Stability-Value:change
of NCT03923439 952 954 O
the NCT03923439 955 958 O
infarct NCT03923439 959 966 B-Condition-Name
and NCT03923439 967 970 O
selective NCT03923439 971 980 B-Condition-Name
neuronal NCT03923439 981 989 I-Condition-Name
loss NCT03923439 990 994 I-Condition-Name
on NCT03923439 995 997 O
long NCT03923439 998 1002 O
- NCT03923439 1003 1004 O
term NCT03923439 1005 1009 O
outcome NCT03923439 1010 1017 O
without NCT03923439 1018 1025 O
being NCT03923439 1026 1031 O
biased NCT03923439 1032 1038 O
by NCT03923439 1039 1041 O
pre NCT03923439 1042 1045 O
- NCT03923439 1046 1047 O
existing NCT03923439 1048 1056 O
deficits NCT03923439 1057 1065 O
. NCT03923439 1066 1067 O

- NCT03923439 1071 1072 O
History NCT03923439 1074 1081 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03923439 1082 1084 O
severe NCT03923439 1085 1091 B-Severity___Severity-Value:severe
cognitive NCT03923439 1092 1101 B-Condition-Name
impairment NCT03923439 1102 1112 I-Condition-Name
( NCT03923439 1113 1114 O
dementia NCT03923439 1115 1123 B-Condition-Name
) NCT03923439 1124 1125 O
or NCT03923439 1126 1128 O
DSMIV NCT03923439 1129 1134 B-Eq-Unit
axis NCT03923439 1135 1139 I-Eq-Unit
1 NCT03923439 1141 1142 B-Eq-Value
psychiatric NCT03923439 1143 1154 B-Condition-Name
disorders NCT03923439 1155 1164 I-Condition-Name
that NCT03923439 1165 1169 O
would NCT03923439 1170 1175 O
confound NCT03923439 1176 1184 B-Stability___Stability-Value:change
the NCT03923439 1185 1188 O
neurological NCT03923439 1189 1201 B-Procedure-Name
evaluations NCT03923439 1202 1213 I-Procedure-Name
. NCT03923439 1214 1215 O

- NCT03923439 1219 1220 O
Pregnant NCT03923439 1222 1230 B-Condition-Name
or NCT03923439 1231 1233 O
breast NCT03923439 1234 1240 B-Condition-Name
- NCT03923439 1241 1242 I-Condition-Name
feeding NCT03923439 1243 1250 I-Condition-Name
women NCT03923439 1251 1256 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
. NCT03923439 1257 1258 O

- NCT03923439 1262 1263 O
Contraindications NCT03923439 1265 1282 O
to NCT03923439 1283 1285 O
MRI NCT03923439 1286 1289 B-Procedure-Name
. NCT03923439 1290 1291 O

Inclusion NCT03925844 0 9 O
Criteria NCT03925844 10 18 O
: NCT03925844 19 20 O

- NCT03925844 24 25 O
population NCT03925844 27 37 O
aged NCT03925844 38 42 O
55 NCT03925844 44 46 B-Eq-Value
to NCT03925844 47 49 B-Eq-Operator___Eq-Operator-Value:BETWEEN
74 NCT03925844 51 53 B-Eq-Value
years NCT03925844 54 59 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
from NCT03925844 60 64 O
NEDICES NCT03925844 65 72 O
2 NCT03925844 74 75 O
study NCT03925844 76 81 O

- NCT03925844 84 85 O
to NCT03925844 87 89 O
have NCT03925844 90 94 O
signed NCT03925844 95 101 O
informed NCT03925844 102 110 O
consent NCT03925844 111 118 O

- NCT03925844 121 122 O
to NCT03925844 124 126 O
have NCT03925844 127 131 O
done NCT03925844 132 136 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
the NCT03925844 137 140 O
neuropsicological NCT03925844 141 158 B-Procedure-Name
assessment NCT03925844 159 169 I-Procedure-Name

Exclusion NCT03925844 170 179 O
Criteria NCT03925844 180 188 O
: NCT03925844 189 190 O

- NCT03925844 194 195 O
to NCT03925844 197 199 O
have NCT03925844 200 204 O
a NCT03925844 205 206 O
dementia NCT03925844 207 215 B-Condition-Name
diagnosis NCT03925844 216 225 O
at NCT03925844 226 228 O
baseline NCT03925844 229 237 O
. NCT03925844 238 239 O

Inclusion NCT03928145 0 9 O
Criteria NCT03928145 10 18 O
: NCT03928145 19 20 O

- NCT03928145 24 25 O
Adults NCT03928145 27 33 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03928145 34 35 O
age NCT03928145 36 39 O
30 NCT03928145 41 43 B-Eq-Value
to NCT03928145 44 46 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03928145 48 50 B-Eq-Value
years NCT03928145 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03928145 57 58 O
. NCT03928145 60 61 O

- NCT03928145 65 66 O
Diagnosis NCT03928145 68 77 O
of NCT03928145 78 80 O
primary NCT03928145 81 88 B-Condition-Name
hypertension NCT03928145 89 101 I-Condition-Name
based NCT03928145 102 107 O
on NCT03928145 108 110 O
ABPM NCT03928145 111 115 B-Procedure-Name
( NCT03928145 116 117 O
mean NCT03928145 118 122 B-Eq-Unit
24 NCT03928145 124 126 B-Eq-Value
- NCT03928145 127 128 O
h NCT03928145 129 130 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
systolic NCT03928145 131 139 B-Observation-Name___Observation-Type-Value:vital
BP NCT03928145 140 142 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03928145 143 144 B-Eq-Operator___Eq-Operator-Value:GTEQ
130 NCT03928145 146 149 B-Eq-Value
mmHg NCT03928145 150 154 B-Eq-Unit
or NCT03928145 155 157 O
mean NCT03928145 158 162 B-Eq-Unit
24 NCT03928145 164 166 B-Eq-Value
- NCT03928145 167 168 O
h NCT03928145 169 170 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
diastolic NCT03928145 171 180 B-Observation-Name___Observation-Type-Value:vital
BP NCT03928145 181 183 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03928145 184 185 B-Eq-Operator___Eq-Operator-Value:GTEQ
80 NCT03928145 187 189 B-Eq-Value
mmHg NCT03928145 190 194 B-Eq-Unit
) NCT03928145 195 196 O
. NCT03928145 198 199 O

- NCT03928145 203 204 O
No NCT03928145 206 208 O
current NCT03928145 209 216 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03928145 217 220 O
of NCT03928145 221 223 O
antihypertensive NCT03928145 224 240 B-Drug-Name
medication NCT03928145 241 251 I-Drug-Name
. NCT03928145 252 253 O

Exclusion NCT03928145 255 264 O
Criteria NCT03928145 265 273 O
: NCT03928145 274 275 O

- NCT03928145 279 280 O
Low NCT03928145 282 285 B-Polarity___Polarity-Value:low
life NCT03928145 286 290 B-Observation-Name
expectancy NCT03928145 291 301 I-Observation-Name
. NCT03928145 302 303 O

- NCT03928145 307 308 O
Other NCT03928145 310 315 O
indications NCT03928145 316 327 O
for NCT03928145 328 331 O
the NCT03928145 332 335 O
use NCT03928145 336 339 O
of NCT03928145 340 342 O
diuretics NCT03928145 343 352 B-Drug-Name
. NCT03928145 353 354 O

- NCT03928145 358 359 O
Intolerance NCT03928145 361 372 B-Condition-Name
or NCT03928145 373 375 O
contraindications NCT03928145 376 393 O
to NCT03928145 394 396 O
the NCT03928145 397 400 O
study NCT03928145 401 406 O
drugs NCT03928145 407 412 O
. NCT03928145 413 414 O

- NCT03928145 418 419 O
Cardiovascular NCT03928145 421 435 B-Condition-Name
disease NCT03928145 436 443 I-Condition-Name
( NCT03928145 444 445 O
heart NCT03928145 446 451 B-Condition-Name
failure NCT03928145 452 459 I-Condition-Name
, NCT03928145 460 461 O
myocardial NCT03928145 462 472 B-Condition-Name
infarction NCT03928145 473 483 I-Condition-Name
or NCT03928145 484 486 O
stroke NCT03928145 487 493 B-Condition-Name
) NCT03928145 494 495 O
. NCT03928145 497 498 O

- NCT03928145 502 503 O
Secondary NCT03928145 505 514 O
hypertension NCT03928145 515 527 B-Condition-Name
. NCT03928145 528 529 O

- NCT03928145 533 534 O
Chronic NCT03928145 536 543 O
kidney NCT03928145 544 550 O
disease NCT03928145 551 558 B-Condition-Name
and NCT03928145 559 562 O
/ NCT03928145 563 564 O
or NCT03928145 565 567 O
abnormal NCT03928145 568 576 B-Polarity___Polarity-Value:abnormal
renal NCT03928145 577 582 O
function NCT03928145 583 591 B-Condition-Name
( NCT03928145 592 593 O
creatinine NCT03928145 594 604 B-Observation-Name___Observation-Type-Value:lab
> NCT03928145 605 606 B-Eq-Operator___Eq-Operator-Value:GT
1.5 NCT03928145 608 611 B-Eq-Value
mg NCT03928145 612 614 B-Eq-Unit
/ NCT03928145 615 616 O
dL NCT03928145 617 619 B-Eq-Unit
) NCT03928145 620 621 O
. NCT03928145 623 624 O

- NCT03928145 628 629 O
Hyperkalemia NCT03928145 631 643 B-Condition-Name
( NCT03928145 644 645 O
serum NCT03928145 646 651 B-Observation-Name___Observation-Type-Value:lab
potassium NCT03928145 652 661 I-Observation-Name___Observation-Type-Value:lab
> NCT03928145 662 663 B-Eq-Operator___Eq-Operator-Value:GT
5.5 NCT03928145 665 668 B-Eq-Value
mEq NCT03928145 669 672 B-Eq-Unit
/ NCT03928145 673 674 O
L NCT03928145 675 676 B-Eq-Unit
) NCT03928145 677 678 O
. NCT03928145 680 681 O

- NCT03928145 685 686 O
Gout NCT03928145 688 692 B-Condition-Name
. NCT03928145 693 694 O

- NCT03928145 698 699 O
Previous NCT03928145 701 709 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
antihypertensive NCT03928145 710 726 B-Drug-Name
treatment NCT03928145 727 736 O
with NCT03928145 737 741 O
more NCT03928145 742 746 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03928145 747 751 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03928145 752 755 B-Eq-Value
drug NCT03928145 756 760 O
. NCT03928145 761 762 O

- NCT03928145 766 767 O
Systolic NCT03928145 769 777 B-Observation-Name___Observation-Type-Value:vital
blood NCT03928145 778 783 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03928145 784 792 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03928145 793 794 B-Eq-Operator___Eq-Operator-Value:GTEQ
160 NCT03928145 796 799 B-Eq-Value
mmHg NCT03928145 800 804 B-Eq-Unit
or NCT03928145 805 807 O
diastolic NCT03928145 808 817 B-Observation-Name___Observation-Type-Value:vital
blood NCT03928145 818 823 I-Observation-Name___Observation-Type-Value:vital
pressure NCT03928145 824 832 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03928145 833 834 B-Eq-Operator___Eq-Operator-Value:GTEQ
100 NCT03928145 836 839 B-Eq-Value
mmHg NCT03928145 840 844 B-Eq-Unit
measured NCT03928145 845 853 O
through NCT03928145 854 861 O
office NCT03928145 862 868 O
blood NCT03928145 869 874 O
pressure NCT03928145 875 883 O
. NCT03928145 884 885 O

- NCT03928145 889 890 O
Pregnancy NCT03928145 892 901 B-Condition-Name
or NCT03928145 902 904 O
prospective NCT03928145 905 916 O
pregnancy NCT03928145 917 926 B-Condition-Name
during NCT03928145 927 933 O
the NCT03928145 934 937 O
study NCT03928145 938 943 O
. NCT03928145 944 945 O

- NCT03928145 949 950 O
Lactating NCT03928145 952 961 B-Condition-Name
women NCT03928145 962 967 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
. NCT03928145 968 969 O

Inclusion NCT03922737 0 9 O
Criteria NCT03922737 10 18 O
: NCT03922737 19 20 O

1 NCT03922737 23 24 O
. NCT03922737 24 25 O
Subjects NCT03922737 27 35 O
over NCT03922737 36 40 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03922737 42 44 B-Eq-Value
and NCT03922737 45 48 O
under NCT03922737 49 54 B-Eq-Operator___Eq-Operator-Value:LT
75 NCT03922737 56 58 B-Eq-Value
years NCT03922737 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03922737 65 67 O
age NCT03922737 68 71 O
undergoing NCT03922737 72 82 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
elective NCT03922737 83 91 O
primary NCT03922737 92 99 O
orthopaedic NCT03922737 100 111 B-Procedure-Name
surgery NCT03922737 112 119 I-Procedure-Name
at NCT03922737 120 122 O
Thomas NCT03922737 123 129 B-Location___Location-Value:hospital
Jefferson NCT03922737 130 139 I-Location___Location-Value:hospital
University NCT03922737 140 150 I-Location___Location-Value:hospital
Hospital NCT03922737 151 159 I-Location___Location-Value:hospital
, NCT03922737 160 161 O
Rothman NCT03922737 162 169 B-Location___Location-Value:hospital
Orthopaedic NCT03922737 170 181 I-Location___Location-Value:hospital
Specialty NCT03922737 182 191 I-Location___Location-Value:hospital
Hospital NCT03922737 192 200 I-Location___Location-Value:hospital
or NCT03922737 201 203 O
Methodist NCT03922737 204 213 B-Location___Location-Value:hospital
Hospital NCT03922737 214 222 I-Location___Location-Value:hospital
who NCT03922737 223 226 O
have NCT03922737 227 231 O
the NCT03922737 232 235 O
capability NCT03922737 236 246 O
to NCT03922737 247 249 O
utilize NCT03922737 250 257 O
a NCT03922737 258 259 O
telecommunications NCT03922737 260 278 O
platform NCT03922737 279 287 O
( NCT03922737 288 289 O
computer NCT03922737 290 298 O
, NCT03922737 299 300 O
tablet NCT03922737 301 307 O
or NCT03922737 308 310 O
similar NCT03922737 311 318 O
device NCT03922737 319 325 O
at NCT03922737 326 328 O
home NCT03922737 329 333 O
with NCT03922737 334 338 O
a NCT03922737 339 340 O
webcam NCT03922737 341 347 O
, NCT03922737 348 349 O
microphone NCT03922737 350 360 O
and NCT03922737 361 364 O
access NCT03922737 365 371 O
to NCT03922737 372 374 O
high NCT03922737 375 379 O
- NCT03922737 380 381 O
speed NCT03922737 382 387 O
internet NCT03922737 388 396 O
) NCT03922737 397 398 O
. NCT03922737 400 401 O

Exclusion NCT03922737 403 412 O
Criteria NCT03922737 413 421 O
: NCT03922737 422 423 O

1 NCT03922737 428 429 O
. NCT03922737 429 430 O
Subjects NCT03922737 432 440 O
who NCT03922737 441 444 O
are NCT03922737 445 448 O
unable NCT03922737 449 455 O
to NCT03922737 456 458 O
access NCT03922737 459 465 O
the NCT03922737 466 469 O
telemedicine NCT03922737 470 482 O
platform NCT03922737 483 491 O
or NCT03922737 492 494 O
who NCT03922737 495 498 O
are NCT03922737 499 502 O
uncomfortable NCT03922737 503 516 O
with NCT03922737 517 521 O
following NCT03922737 522 531 O
up NCT03922737 532 534 O
in NCT03922737 535 537 O
this NCT03922737 538 542 O
fashion NCT03922737 543 550 O

2 NCT03922737 554 555 O
. NCT03922737 555 556 O
Subjects NCT03922737 558 566 O
who NCT03922737 567 570 O
are NCT03922737 571 574 O
unable NCT03922737 575 581 O
or NCT03922737 582 584 O
unwilling NCT03922737 585 594 O
to NCT03922737 595 597 O
provide NCT03922737 598 605 O
post NCT03922737 606 610 O
- NCT03922737 611 612 O
operative NCT03922737 613 622 B-Procedure-Name
radiographs NCT03922737 623 634 O
electronically NCT03922737 635 649 O
or NCT03922737 650 652 O
who NCT03922737 653 656 O
are NCT03922737 657 660 O
unable NCT03922737 661 667 O
or NCT03922737 668 670 O
unwilling NCT03922737 671 680 O
to NCT03922737 681 683 O
obtain NCT03922737 684 690 O
them NCT03922737 691 695 O

3 NCT03922737 699 700 O
. NCT03922737 700 701 O
Subjects NCT03922737 703 711 O
with NCT03922737 712 716 O
workman NCT03922737 717 724 B-Insurance
's NCT03922737 724 726 I-Insurance
compensation NCT03922737 727 739 I-Insurance
or NCT03922737 740 742 O
automotive NCT03922737 743 753 O
claims NCT03922737 754 760 O
or NCT03922737 761 763 O
other NCT03922737 764 769 O
ongoing NCT03922737 770 777 O
litigation NCT03922737 778 788 O

4 NCT03922737 792 793 O
. NCT03922737 793 794 O
Subjects NCT03922737 796 804 O
that NCT03922737 805 809 O
are NCT03922737 810 813 O
unable NCT03922737 814 820 O
or NCT03922737 821 823 O
unwilling NCT03922737 824 833 O
to NCT03922737 834 836 O
consent NCT03922737 837 844 O
for NCT03922737 845 848 O
enrollment NCT03922737 849 859 O

5 NCT03922737 863 864 O
. NCT03922737 864 865 O
Patients NCT03922737 867 875 O
under NCT03922737 876 881 B-Eq-Operator___Eq-Operator-Value:LT
the NCT03922737 882 885 O
age NCT03922737 886 889 O
of NCT03922737 890 892 O
18 NCT03922737 894 896 B-Eq-Value
years NCT03922737 897 902 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

6 NCT03922737 906 907 O
. NCT03922737 907 908 O
Pregnant NCT03922737 910 918 B-Condition-Name
or NCT03922737 919 921 O
breastfeeding NCT03922737 922 935 B-Condition-Name
women NCT03922737 936 941 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

7 NCT03922737 945 946 O
. NCT03922737 946 947 O
Patients NCT03922737 949 957 O
undergoing NCT03922737 958 968 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
surgery NCT03922737 969 976 B-Procedure-Name
for NCT03922737 977 980 O
tumor NCT03922737 981 986 B-Condition-Name
, NCT03922737 987 988 O
trauma NCT03922737 989 995 B-Condition-Name
or NCT03922737 996 998 O
infection NCT03922737 999 1008 B-Condition-Name
or NCT03922737 1009 1011 O
who NCT03922737 1012 1015 O
require NCT03922737 1016 1023 O
revision NCT03922737 1024 1032 O
or NCT03922737 1033 1035 O
staged NCT03922737 1036 1042 O
procedures NCT03922737 1043 1053 O

8 NCT03922737 1057 1058 O
. NCT03922737 1058 1059 O
Patients NCT03922737 1061 1069 O
without NCT03922737 1070 1077 O
English NCT03922737 1078 1085 B-Language
- NCT03922737 1086 1087 O
language NCT03922737 1088 1096 O
proficiency NCT03922737 1097 1108 O

9 NCT03922737 1112 1113 O
. NCT03922737 1113 1114 O
Patients NCT03922737 1116 1124 O
with NCT03922737 1125 1129 O
unforeseen NCT03922737 1130 1140 O
intra NCT03922737 1141 1146 O
- NCT03922737 1147 1148 O
operative NCT03922737 1149 1158 B-Procedure-Name
or NCT03922737 1159 1161 O
peri NCT03922737 1162 1166 O
operative NCT03922737 1167 1176 B-Procedure-Name
complications NCT03922737 1177 1190 B-Condition-Name


Inclusion NCT03925064 0 9 O
Criteria NCT03925064 10 18 O
: NCT03925064 19 20 O

- NCT03925064 24 25 O
18 NCT03925064 28 30 B-Eq-Value
- NCT03925064 31 32 B-Eq-Operator___Eq-Operator-Value:BETWEEN
40 NCT03925064 34 36 B-Eq-Value
years NCT03925064 37 42 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03925064 43 46 O
pregnant NCT03925064 47 55 B-Condition-Name
women NCT03925064 56 61 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

Exclusion NCT03925064 62 71 O
Criteria NCT03925064 72 80 O
: NCT03925064 81 82 O

- NCT03925064 86 87 O
fetal NCT03925064 89 94 B-Condition-Name
cardiac NCT03925064 95 102 I-Condition-Name
anomalies NCT03925064 103 112 I-Condition-Name

- NCT03925064 115 116 O
multiple NCT03925064 118 126 B-Condition-Name
gestations NCT03925064 127 137 I-Condition-Name

Inclusion NCT03921216 0 9 O
Criteria NCT03921216 10 18 O
: NCT03921216 19 20 O

Diabetic NCT03921216 22 30 B-Condition-Name
nephropathy NCT03921216 31 42 I-Condition-Name
, NCT03921216 43 44 O
because NCT03921216 45 52 O
of NCT03921216 53 55 O
type NCT03921216 56 60 B-Condition-Name
2 NCT03921216 62 63 I-Condition-Name
diabetes NCT03921216 64 72 I-Condition-Name
, NCT03921216 73 74 O
undergoing NCT03921216 75 85 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hemodialysis NCT03921216 86 98 B-Procedure-Name
and NCT03921216 99 102 O
subjects NCT03921216 103 111 O
with NCT03921216 112 116 O
chronic NCT03921216 117 124 O
kidney NCT03921216 125 131 B-Condition-Name
disease NCT03921216 132 139 I-Condition-Name
of NCT03921216 140 142 O
other NCT03921216 143 148 O
causes NCT03921216 149 155 O
undergoing NCT03921216 156 166 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
hemodialysis NCT03921216 167 179 B-Procedure-Name
. NCT03921216 180 181 O

Exclusion NCT03921216 183 192 O
Criteria NCT03921216 193 201 O
: NCT03921216 202 203 O

- NCT03921216 207 208 O
Active NCT03921216 210 216 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
infection NCT03921216 217 226 B-Condition-Name
that NCT03921216 227 231 O
increases NCT03921216 232 241 B-Polarity___Polarity-Value:high
the NCT03921216 242 245 O
risk NCT03921216 246 250 O
of NCT03921216 251 253 O
secondary NCT03921216 254 263 B-Condition-Name
infection NCT03921216 264 273 I-Condition-Name
in NCT03921216 274 276 O
the NCT03921216 277 280 O
skin NCT03921216 281 285 O
where NCT03921216 286 291 O
the NCT03921216 292 295 O
vesicles NCT03921216 296 304 B-Condition-Name
containing NCT03921216 305 315 I-Condition-Name
interstitial NCT03921216 316 328 I-Condition-Name
fluid NCT03921216 329 334 I-Condition-Name
have NCT03921216 335 339 O
been NCT03921216 340 344 O
emptied NCT03921216 345 352 O
of NCT03921216 353 355 O
interstitial NCT03921216 356 368 O
fluid NCT03921216 369 374 O
with NCT03921216 375 379 O
a NCT03921216 380 381 O
fine NCT03921216 382 386 B-Procedure-Name
needle NCT03921216 387 393 I-Procedure-Name
and NCT03921216 394 397 O
the NCT03921216 398 401 O
bladder NCT03921216 402 409 B-Condition-Name
roof NCT03921216 410 414 I-Condition-Name
is NCT03921216 415 417 O
intact NCT03921216 418 424 O
. NCT03921216 425 426 O

- NCT03921216 430 431 O
Treatment NCT03921216 433 442 O
with NCT03921216 443 447 O
Warfarin NCT03921216 448 456 B-Drug-Name
due NCT03921216 457 460 O
to NCT03921216 461 463 O
increased NCT03921216 464 473 B-Polarity___Polarity-Value:high
risk NCT03921216 474 478 O
of NCT03921216 479 481 O
Calciphylaxis NCT03921216 482 495 B-Condition-Name
( NCT03921216 496 497 O
calcific NCT03921216 498 506 B-Condition-Name
uremic NCT03921216 507 513 I-Condition-Name
arteriolopathy NCT03921216 514 528 I-Condition-Name
, NCT03921216 529 530 O
CUA NCT03921216 531 534 B-Condition-Name
) NCT03921216 535 536 O


Inclusion NCT03924622 0 9 O
Criteria NCT03924622 10 18 O
: NCT03924622 19 20 O

- NCT03924622 24 25 O
Men NCT03924622 27 30 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03924622 31 34 O
women NCT03924622 35 40 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03924622 43 44 O
Age NCT03924622 46 49 O
18 NCT03924622 51 53 B-Eq-Value
to NCT03924622 54 56 B-Eq-Operator___Eq-Operator-Value:BETWEEN
55 NCT03924622 58 60 B-Eq-Value

- NCT03924622 64 65 O
Meet NCT03924622 67 71 O
the NCT03924622 72 75 O
physical NCT03924622 76 84 O
standards NCT03924622 85 94 O
for NCT03924622 95 98 O
military NCT03924622 99 107 O
personnel NCT03924622 108 117 O

- NCT03924622 120 121 O
Weigh NCT03924622 123 128 B-Observation-Name___Observation-Type-Value:vital
less NCT03924622 129 133 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03924622 134 138 I-Eq-Operator___Eq-Operator-Value:LT
250 NCT03924622 140 143 B-Eq-Value
pounds NCT03924622 144 150 B-Eq-Unit

- NCT03924622 153 154 O
Be NCT03924622 156 158 O
able NCT03924622 159 163 O
to NCT03924622 164 166 O
remain NCT03924622 167 173 O
in NCT03924622 174 176 O
the NCT03924622 177 180 O
study NCT03924622 181 186 O
position NCT03924622 187 195 B-Observation-Name
for NCT03924622 196 199 O
the NCT03924622 200 203 O
duration NCT03924622 204 212 O
of NCT03924622 213 215 O
the NCT03924622 216 219 O
study NCT03924622 220 225 O
. NCT03924622 226 227 O

Exclusion NCT03924622 229 238 O
Criteria NCT03924622 239 247 O

- NCT03924622 250 251 O
Previous NCT03924622 253 261 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
injuries NCT03924622 262 270 B-Condition-Name
to NCT03924622 271 273 O
sacrum NCT03924622 274 280 O
/ NCT03924622 281 282 O
buttocks NCT03924622 283 291 O
with NCT03924622 292 296 O
scarring NCT03924622 297 305 O

- NCT03924622 308 309 O
History NCT03924622 311 318 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924622 319 321 O
pressure NCT03924622 322 330 O
injuries NCT03924622 331 339 B-Condition-Name

- NCT03924622 342 343 O
Cardiovascular NCT03924622 345 359 B-Condition-Name
disease NCT03924622 360 367 I-Condition-Name

- NCT03924622 370 371 O
Neurological NCT03924622 373 385 B-Condition-Name
disease NCT03924622 386 393 I-Condition-Name
that NCT03924622 394 398 O
would NCT03924622 399 404 O
affect NCT03924622 405 411 B-Stability___Stability-Value:change
vascular NCT03924622 412 420 O
response NCT03924622 421 429 B-Condition-Name

- NCT03924622 432 433 O
Diabetes NCT03924622 435 443 B-Condition-Name

- NCT03924622 446 447 O
History NCT03924622 449 456 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924622 457 459 O
malignancy NCT03924622 460 470 B-Condition-Name

- NCT03924622 473 474 O
Current NCT03924622 476 483 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
skin NCT03924622 484 488 B-Condition-Name
condition NCT03924622 489 498 I-Condition-Name
( NCT03924622 499 500 O
e NCT03924622 501 502 O
. NCT03924622 503 504 O
g NCT03924622 505 506 O
. NCT03924622 507 508 O
, NCT03924622 509 510 O
eczema NCT03924622 511 517 B-Condition-Name
or NCT03924622 518 520 O
psoriasis NCT03924622 521 530 B-Condition-Name
) NCT03924622 531 532 O

- NCT03924622 536 537 O
Current NCT03924622 539 546 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
neck NCT03924622 547 551 O
/ NCT03924622 552 553 O
back NCT03924622 554 558 O
pain NCT03924622 559 563 B-Condition-Name
or NCT03924622 564 566 O
history NCT03924622 567 574 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924622 575 577 O
chronic NCT03924622 578 585 O
neck NCT03924622 586 590 O
/ NCT03924622 591 592 O
back NCT03924622 593 597 O
pain NCT03924622 598 602 B-Condition-Name

- NCT03924622 605 606 O
Known NCT03924622 608 613 O
vertebral NCT03924622 614 623 O
/ NCT03924622 624 625 O
spinal NCT03924622 626 632 O
cord NCT03924622 633 637 O
disease NCT03924622 638 645 B-Condition-Name
/ NCT03924622 646 647 O
injury NCT03924622 648 654 B-Condition-Name
( NCT03924622 655 656 O
scoliosis NCT03924622 657 666 B-Condition-Name
, NCT03924622 667 668 O
kyphosis NCT03924622 669 677 B-Condition-Name
, NCT03924622 678 679 O
or NCT03924622 680 682 O
lordosis NCT03924622 683 691 B-Condition-Name
) NCT03924622 692 693 O

- NCT03924622 697 698 O
Self NCT03924622 700 704 O
- NCT03924622 705 706 O
reported NCT03924622 707 715 O
pregnancy NCT03924622 716 725 B-Condition-Name

- NCT03924622 728 729 O
Concern NCT03924622 731 738 O
about NCT03924622 739 744 O
ability NCT03924622 745 752 O
to NCT03924622 753 755 O
remain NCT03924622 756 762 B-Observation-Name
in NCT03924622 763 765 O
the NCT03924622 766 769 O
vacuum NCT03924622 770 776 O
spine NCT03924622 777 782 O
board NCT03924622 783 788 O
for NCT03924622 789 792 O
120 NCT03924622 794 797 B-Eq-Value
minutes NCT03924622 798 805 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute

Inclusion NCT03925272 0 9 O
Criteria NCT03925272 10 18 O
: NCT03925272 19 20 O

- NCT03925272 24 25 O
unprotected NCT03925272 27 38 O
adults NCT03925272 39 45 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
with NCT03925272 46 50 O
social NCT03925272 51 57 O
security NCT03925272 58 66 O
who NCT03925272 67 70 O
have NCT03925272 71 75 O
attested NCT03925272 76 84 O
their NCT03925272 85 90 O
consent NCT03925272 91 98 O
after NCT03925272 99 104 O
receiving NCT03925272 105 114 O
any NCT03925272 115 118 O
relevant NCT03925272 119 127 O
information NCT03925272 128 139 O
about NCT03925272 140 145 O
the NCT03925272 146 149 O
study NCT03925272 150 155 O

- NCT03925272 158 159 O
subjects NCT03925272 161 169 O
whose NCT03925272 170 175 O
ethno NCT03925272 176 181 B-Ethnicity
- NCT03925272 182 183 I-Ethnicity
geographical NCT03925272 184 196 I-Ethnicity
origin NCT03925272 197 203 I-Ethnicity
of NCT03925272 204 206 O
both NCT03925272 207 211 O
parents NCT03925272 212 219 O
is NCT03925272 220 222 O
known NCT03925272 223 228 O

- NCT03925272 231 232 O
subjects NCT03925272 234 242 O
for NCT03925272 243 246 O
whom NCT03925272 247 251 O
data NCT03925272 252 256 O
on NCT03925272 257 259 O
principal NCT03925272 260 269 O
vaccinations NCT03925272 270 282 O
( NCT03925272 283 284 O
diphtheria NCT03925272 285 295 B-Condition-Name
, NCT03925272 296 297 O
tetanus NCT03925272 298 305 B-Condition-Name
, NCT03925272 306 307 O
poliomyelitis NCT03925272 308 321 B-Condition-Name
, NCT03925272 322 323 O
hepatitis NCT03925272 324 333 B-Condition-Name
B NCT03925272 334 335 I-Condition-Name
, NCT03925272 336 337 O
possibly NCT03925272 338 346 O
tuberculosis NCT03925272 347 359 B-Condition-Name
) NCT03925272 360 361 O
are NCT03925272 362 365 O
documented NCT03925272 366 376 O

- NCT03925272 379 380 O
subjects NCT03925272 382 390 O
who NCT03925272 391 394 O
consented NCT03925272 395 404 O
to NCT03925272 405 407 O
carry NCT03925272 408 413 O
out NCT03925272 414 417 O
serological NCT03925272 418 429 B-Observation-Name___Observation-Type-Value:lab
tests NCT03925272 430 435 I-Observation-Name___Observation-Type-Value:lab
HIV NCT03925272 436 439 B-Condition-Name
, NCT03925272 440 441 O
HCV NCT03925272 442 445 B-Condition-Name
, NCT03925272 446 447 O
HBV NCT03925272 448 451 B-Condition-Name

Exclusion NCT03925272 452 461 O
Criteria NCT03925272 462 470 O
: NCT03925272 471 472 O

- NCT03925272 476 477 O
Any NCT03925272 479 482 O
conditions NCT03925272 483 493 O
that NCT03925272 494 498 O
would NCT03925272 499 504 O
not NCT03925272 505 508 O
allow NCT03925272 509 514 O
participation NCT03925272 515 528 O
in NCT03925272 529 531 O
the NCT03925272 532 535 O
present NCT03925272 536 543 O
study NCT03925272 544 549 O
, NCT03925272 550 551 O
on NCT03925272 552 554 O
the NCT03925272 555 558 O
opinion NCT03925272 559 566 O
of NCT03925272 567 569 O
the NCT03925272 570 573 O
investigator NCT03925272 574 586 O
( NCT03925272 587 588 O
documenting NCT03925272 589 600 O
) NCT03925272 601 602 O
, NCT03925272 604 605 O
ie NCT03925272 606 608 O
any NCT03925272 609 612 O
acute NCT03925272 613 618 B-Severity___Severity-Value:severe
or NCT03925272 619 621 O
chronic NCT03925272 622 629 O
pathology NCT03925272 630 639 B-Condition-Name
that NCT03925272 640 644 O
may NCT03925272 645 648 O
interfere NCT03925272 649 658 B-Stability___Stability-Value:change
with NCT03925272 659 663 O
the NCT03925272 664 667 O
immune NCT03925272 668 674 B-Condition-Name
system NCT03925272 675 681 I-Condition-Name
, NCT03925272 682 683 O
such NCT03925272 684 688 O
as NCT03925272 689 691 O
progressive NCT03925272 692 703 O
or NCT03925272 704 706 O
chronic NCT03925272 707 714 O
pathology NCT03925272 715 724 B-Condition-Name
severe NCT03925272 725 731 B-Severity___Severity-Value:severe
or NCT03925272 732 734 O
uncontrolled NCT03925272 735 747 O
by NCT03925272 748 750 O
current NCT03925272 751 758 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatments NCT03925272 759 769 O
or NCT03925272 770 772 O
a NCT03925272 773 774 O
pathology NCT03925272 775 784 O
requiring NCT03925272 785 794 O
the NCT03925272 795 798 O
administration NCT03925272 799 813 O
of NCT03925272 814 816 O
immune NCT03925272 817 823 B-Drug-Name
impact NCT03925272 824 830 I-Drug-Name
drugs NCT03925272 831 836 I-Drug-Name
: NCT03925272 837 838 O
long NCT03925272 839 843 O
- NCT03925272 844 845 O
term NCT03925272 846 850 O
anti NCT03925272 851 855 B-Drug-Name
- NCT03925272 856 857 I-Drug-Name
inflammatory NCT03925272 858 870 I-Drug-Name
, NCT03925272 871 872 O
immunosuppressive NCT03925272 873 890 B-Drug-Name
, NCT03925272 891 892 O
etc NCT03925272 893 896 O

- NCT03925272 899 900 O
Pregnant NCT03925272 902 910 B-Condition-Name
or NCT03925272 911 913 O
lactating NCT03925272 914 923 B-Condition-Name
women NCT03925272 924 929 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

- NCT03925272 932 933 O
For NCT03925272 935 938 O
the NCT03925272 939 942 O
realization NCT03925272 943 954 O
of NCT03925272 955 957 O
skin NCT03925272 958 962 O
biopsies NCT03925272 963 971 B-Procedure-Name
: NCT03925272 972 973 O
allergy NCT03925272 974 981 O
to NCT03925272 982 984 O
local NCT03925272 985 990 B-Drug-Name
anesthetics NCT03925272 991 1002 I-Drug-Name
, NCT03925272 1003 1004 O
cardiac NCT03925272 1005 1012 B-Condition-Name
valvulopathy NCT03925272 1013 1025 I-Condition-Name

- NCT03925272 1028 1029 O
For NCT03925272 1031 1034 O
the NCT03925272 1035 1038 O
realization NCT03925272 1039 1050 O
of NCT03925272 1051 1053 O
Tubertest NCT03925272 1054 1063 B-Observation-Name___Observation-Type-Value:lab
: NCT03925272 1064 1065 O
Subject NCT03925272 1066 1073 O
presenting NCT03925272 1074 1084 O
a NCT03925272 1085 1086 O
contraindication NCT03925272 1087 1103 O
to NCT03925272 1104 1106 O
tuberculin NCT03925272 1107 1117 B-Drug-Name

Inclusion NCT03928756 0 9 O
Criteria NCT03928756 10 18 O
: NCT03928756 19 20 O

1 NCT03928756 25 26 O
. NCT03928756 26 27 O
Have NCT03928756 29 33 O
an NCT03928756 34 36 O
iPhone NCT03928756 37 43 O
smartphone NCT03928756 44 54 O
on NCT03928756 55 57 O
which NCT03928756 58 63 O
the NCT03928756 64 67 O
app NCT03928756 68 71 O
can NCT03928756 72 75 O
be NCT03928756 76 78 O
downloaded NCT03928756 79 89 O

2 NCT03928756 93 94 O
. NCT03928756 94 95 O
Self NCT03928756 97 101 O
- NCT03928756 102 103 O
reported NCT03928756 104 112 O
past NCT03928756 113 117 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03928756 118 119 O
month NCT03928756 120 125 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
binge NCT03928756 126 131 B-Condition-Name
drinking NCT03928756 132 140 I-Condition-Name
( NCT03928756 141 142 O
4 NCT03928756 144 145 B-Eq-Value
/ NCT03928756 146 147 B-Eq-Operator___Eq-Operator-Value:BETWEEN
5 NCT03928756 149 150 B-Eq-Value
or NCT03928756 151 153 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03928756 154 158 I-Eq-Operator___Eq-Operator-Value:GTEQ
drinks NCT03928756 159 165 B-Observation-Name___Observation-Type-Value:social-habit
on NCT03928756 166 168 O
one NCT03928756 169 172 B-Eq-Value
occasion NCT03928756 173 181 B-Eq-Unit
, NCT03928756 182 183 O
tailored NCT03928756 184 192 O
by NCT03928756 193 195 O
sex NCT03928756 196 199 B-Condition-Name
) NCT03928756 200 201 O
OR NCT03928756 202 204 O
any NCT03928756 205 208 O
past NCT03928756 209 213 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03928756 214 215 O
month NCT03928756 216 221 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
marijuana NCT03928756 222 231 B-Condition-Name
use NCT03928756 232 235 I-Condition-Name
without NCT03928756 236 243 O
a NCT03928756 244 245 O
medical NCT03928756 246 253 B-Observation-Name
marijuana NCT03928756 254 263 I-Observation-Name
card NCT03928756 264 268 I-Observation-Name

3 NCT03928756 272 273 O
. NCT03928756 273 274 O
Meet NCT03928756 276 280 O
study NCT03928756 281 286 O
verification NCT03928756 287 299 O
criteria NCT03928756 300 308 O
( NCT03928756 309 310 O
i NCT03928756 311 312 O
. NCT03928756 313 314 O
e NCT03928756 315 316 O
. NCT03928756 317 318 O
, NCT03928756 319 320 O
use NCT03928756 321 324 O
of NCT03928756 325 327 O
CAPTCHA NCT03928756 328 335 O
, NCT03928756 336 337 O
IP NCT03928756 338 340 O
address NCT03928756 341 348 O
checks NCT03928756 349 355 O
, NCT03928756 356 357 O
social NCT03928756 358 364 O
media NCT03928756 365 370 O
checks NCT03928756 371 377 O
) NCT03928756 378 379 O
. NCT03928756 381 382 O

Exclusion NCT03928756 384 393 O
Criteria NCT03928756 394 402 O
: NCT03928756 403 404 O

1 NCT03928756 407 408 O
. NCT03928756 408 409 O
Unable NCT03928756 411 417 O
to NCT03928756 418 420 O
understand NCT03928756 421 431 O
English NCT03928756 432 439 B-Language

Inclusion NCT03928795 0 9 O
Criteria NCT03928795 10 18 O
: NCT03928795 19 20 O

- NCT03928795 24 25 O
Monofetal NCT03928795 27 36 O
pregnancy NCT03928795 37 46 B-Condition-Name

- NCT03928795 49 50 O
Age NCT03928795 52 55 O
over NCT03928795 56 60 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03928795 62 64 B-Eq-Value
years NCT03928795 65 70 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03928795 71 74 O

- NCT03928795 77 78 O
Term NCT03928795 80 84 B-Condition-Name
Pregnancy NCT03928795 85 94 I-Condition-Name
≥ NCT03928795 95 96 B-Eq-Operator___Eq-Operator-Value:GTEQ
37 NCT03928795 98 100 B-Eq-Value
SA NCT03928795 101 103 B-Eq-Unit

- NCT03928795 106 107 O
Indication NCT03928795 109 119 O
for NCT03928795 120 123 O
Elective NCT03928795 124 132 O
caesarean NCT03928795 133 142 B-Procedure-Name
section NCT03928795 143 150 I-Procedure-Name

Exclusion NCT03928795 151 160 O
Criteria NCT03928795 161 169 O
: NCT03928795 170 171 O

- NCT03928795 175 176 O
- NCT03928795 178 179 O
Fetal NCT03928795 180 185 O
pathology NCT03928795 186 195 B-Condition-Name
known NCT03928795 196 201 O
prenatally NCT03928795 202 212 O
like NCT03928795 213 217 O
intrauterine NCT03928795 218 230 O
severe NCT03928795 231 237 B-Severity___Severity-Value:severe
growth NCT03928795 238 244 B-Condition-Name
retardation NCT03928795 245 256 I-Condition-Name
with NCT03928795 257 261 O
Doppler NCT03928795 262 269 B-Condition-Name
abnormalities NCT03928795 270 283 B-Polarity___Polarity-Value:abnormal
, NCT03928795 284 285 O
fetal NCT03928795 286 291 O
malformation NCT03928795 292 304 B-Condition-Name
or NCT03928795 305 307 O
a NCT03928795 308 309 O
known NCT03928795 310 315 O
fetal NCT03928795 316 321 O
genetic NCT03928795 322 329 B-Condition-Name
defect NCT03928795 330 336 I-Condition-Name
. NCT03928795 337 338 O

- NCT03928795 342 343 O
Anomaly NCT03928795 345 352 B-Condition-Name
of NCT03928795 353 355 O
placental NCT03928795 356 365 O
adhesion NCT03928795 366 374 O
. NCT03928795 375 376 O

- NCT03928795 380 381 O
Caesarean NCT03928795 383 392 B-Procedure-Name
in NCT03928795 393 395 O
a NCT03928795 396 397 O
context NCT03928795 398 405 O
of NCT03928795 406 408 O
medical NCT03928795 409 416 O
or NCT03928795 417 419 O
obstetric NCT03928795 420 429 O
emergency NCT03928795 430 439 B-Observation-Name
. NCT03928795 440 441 O

- NCT03928795 445 446 O
Caesarean NCT03928795 448 457 B-Procedure-Name
section NCT03928795 458 465 I-Procedure-Name
performed NCT03928795 466 475 O
under NCT03928795 476 481 O
general NCT03928795 482 489 B-Procedure-Name
anesthesia NCT03928795 490 500 I-Procedure-Name
following NCT03928795 501 510 O
failure NCT03928795 511 518 O
of NCT03928795 519 521 O
locoregional NCT03928795 522 534 O
anesthesia NCT03928795 535 545 B-Procedure-Name
. NCT03928795 546 547 O

- NCT03928795 551 552 O
Refusal NCT03928795 554 561 O
of NCT03928795 562 564 O
the NCT03928795 565 568 O
woman NCT03928795 569 574 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
to NCT03928795 575 577 O
participate NCT03928795 578 589 O
in NCT03928795 590 592 O
the NCT03928795 593 596 O
study NCT03928795 597 602 O
. NCT03928795 603 604 O

- NCT03928795 608 609 O
Impossibility NCT03928795 611 624 O
or NCT03928795 625 627 O
failure NCT03928795 628 635 O
to NCT03928795 636 638 O
study NCT03928795 639 644 O
the NCT03928795 645 648 O
neonatal NCT03928795 649 657 O
acid NCT03928795 658 662 B-Observation-Name
- NCT03928795 663 664 I-Observation-Name
base NCT03928795 665 669 I-Observation-Name
balance NCT03928795 670 677 I-Observation-Name
on NCT03928795 678 680 O
the NCT03928795 681 684 O
umbilical NCT03928795 685 694 O
cord NCT03928795 695 699 O
. NCT03928795 700 701 O

Inclusion NCT03924024 0 9 O
Criteria NCT03924024 10 18 O
: NCT03924024 19 20 O

- NCT03924024 24 25 O
Male NCT03924024 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03924024 32 34 O
female NCT03924024 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
, NCT03924024 42 43 O
18 NCT03924024 45 47 B-Eq-Value
to NCT03924024 48 50 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03924024 52 54 B-Eq-Value
years NCT03924024 55 60 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03924024 61 63 O
age NCT03924024 64 67 O
. NCT03924024 68 69 O

- NCT03924024 73 74 O
Able NCT03924024 76 80 O
to NCT03924024 81 83 O
provide NCT03924024 84 91 O
informed NCT03924024 92 100 O
consent NCT03924024 101 108 O
. NCT03924024 109 110 O

- NCT03924024 114 115 O
Present NCT03924024 117 124 O
to NCT03924024 125 127 O
Stanford NCT03924024 128 136 B-Location___Location-Value:hospital
Emergency NCT03924024 137 146 I-Location___Location-Value:hospital
Department NCT03924024 147 157 I-Location___Location-Value:hospital
as NCT03924024 158 160 O
a NCT03924024 161 162 O
trauma NCT03924024 163 169 B-Condition-Name
with NCT03924024 170 174 O
a NCT03924024 175 176 O
major NCT03924024 177 182 O
operative NCT03924024 183 192 O
lower NCT03924024 193 198 O
extremity NCT03924024 199 208 O
injury NCT03924024 209 215 B-Condition-Name

- NCT03924024 218 219 O
Glasgow NCT03924024 221 228 B-Observation-Name___Observation-Type-Value:clinical-score
coma NCT03924024 229 233 I-Observation-Name___Observation-Type-Value:clinical-score
scale NCT03924024 234 239 I-Observation-Name___Observation-Type-Value:clinical-score
of NCT03924024 240 242 O
15 NCT03924024 244 246 B-Eq-Value
within NCT03924024 247 253 B-Eq-Operator___Eq-Operator-Value:LTEQ
24 NCT03924024 255 257 B-Eq-Value
hours NCT03924024 258 263 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
after NCT03924024 264 269 O
admission NCT03924024 270 279 B-Encounter-Type___Encounter-Type-Value:inpatient
or NCT03924024 280 282 O
extubation NCT03924024 283 293 B-Procedure-Name

- NCT03924024 296 297 O
Negative NCT03924024 299 307 B-Polarity___Polarity-Value:negative
urinary NCT03924024 308 315 B-Observation-Name___Observation-Type-Value:lab
toxicology NCT03924024 316 326 I-Observation-Name___Observation-Type-Value:lab
screen NCT03924024 327 333 O
for NCT03924024 334 337 O
illicit NCT03924024 338 345 O
substances NCT03924024 346 356 O
; NCT03924024 356 357 O

- NCT03924024 360 361 O
Negative NCT03924024 363 371 B-Polarity___Polarity-Value:negative
pregnancy NCT03924024 372 381 B-Condition-Name
test NCT03924024 382 386 O
if NCT03924024 387 389 O
female NCT03924024 390 396 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
and NCT03924024 397 400 O
less NCT03924024 401 405 B-Eq-Operator___Eq-Operator-Value:LTEQ
then NCT03924024 406 410 I-Eq-Operator___Eq-Operator-Value:LTEQ
60 NCT03924024 412 414 B-Eq-Value
y NCT03924024 415 416 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
/ NCT03924024 417 418 O
o NCT03924024 419 420 O
; NCT03924024 420 421 O

- NCT03924024 424 425 O
No NCT03924024 427 429 O
suspicion NCT03924024 430 439 O
for NCT03924024 440 443 O
a NCT03924024 444 445 O
head NCT03924024 446 450 O
injury NCT03924024 451 457 B-Condition-Name
and NCT03924024 458 461 O
/ NCT03924024 462 463 O
or NCT03924024 464 466 O
negative NCT03924024 467 475 B-Polarity___Polarity-Value:negative
head NCT03924024 476 480 O
CT NCT03924024 481 483 B-Procedure-Name
scan NCT03924024 484 488 I-Procedure-Name
for NCT03924024 489 492 O
intracranial NCT03924024 493 505 B-Condition-Name
hemorrhage NCT03924024 506 516 I-Condition-Name
or NCT03924024 517 519 O
injury NCT03924024 520 526 B-Condition-Name
based NCT03924024 527 532 O
on NCT03924024 533 535 O
standard NCT03924024 536 544 O
of NCT03924024 545 547 O
care NCT03924024 548 552 O

- NCT03924024 555 556 O
No NCT03924024 558 560 O
history NCT03924024 561 568 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924024 569 571 O
seizure NCT03924024 572 579 B-Condition-Name
disorder NCT03924024 580 588 I-Condition-Name
or NCT03924024 589 591 O
other NCT03924024 592 597 O
neurological NCT03924024 598 610 B-Condition-Name
disorders NCT03924024 611 620 I-Condition-Name
. NCT03924024 621 622 O

- NCT03924024 626 627 O
All NCT03924024 629 632 O
patients NCT03924024 633 641 O
included NCT03924024 642 650 O
must NCT03924024 651 655 O
screen NCT03924024 656 662 O
positive NCT03924024 663 671 B-Polarity___Polarity-Value:positive
for NCT03924024 672 675 O
PHQ NCT03924024 676 679 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03924024 680 681 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
9 NCT03924024 683 684 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
score NCT03924024 685 690 B-Eq-Unit
> NCT03924024 691 692 B-Eq-Operator___Eq-Operator-Value:GT
4 NCT03924024 694 695 B-Eq-Value
( NCT03924024 696 697 O
positive NCT03924024 698 706 B-Polarity___Polarity-Value:positive
symptoms NCT03924024 707 715 O
of NCT03924024 716 718 O
depression NCT03924024 719 729 B-Condition-Name
) NCT03924024 730 731 O
and NCT03924024 732 735 O
CES NCT03924024 736 739 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
- NCT03924024 740 741 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
T NCT03924024 742 743 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
score NCT03924024 744 749 B-Eq-Unit
< NCT03924024 750 751 B-Eq-Operator___Eq-Operator-Value:LT
36 NCT03924024 753 755 B-Eq-Value
( NCT03924024 756 757 O
poor NCT03924024 758 762 B-Condition-Name
coping NCT03924024 763 769 I-Condition-Name
self NCT03924024 770 774 I-Condition-Name
- NCT03924024 775 776 I-Condition-Name
efficacy NCT03924024 777 785 I-Condition-Name
) NCT03924024 786 787 O
. NCT03924024 789 790 O

Exclusion NCT03924024 792 801 O
Criteria NCT03924024 802 810 O
: NCT03924024 811 812 O

- NCT03924024 816 817 O
Incarceration NCT03924024 819 832 B-Observation-Name
, NCT03924024 833 834 O

- NCT03924024 838 839 O
Pregnant NCT03924024 841 849 B-Condition-Name
females NCT03924024 850 857 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
, NCT03924024 858 859 O

- NCT03924024 863 864 O
Prior NCT03924024 866 871 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
psychotic NCT03924024 872 881 B-Condition-Name
disorder NCT03924024 882 890 I-Condition-Name
, NCT03924024 891 892 O

- NCT03924024 896 897 O
Current NCT03924024 899 906 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03924024 907 910 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03924024 911 913 O
anti NCT03924024 914 918 B-Drug-Name
- NCT03924024 919 920 I-Drug-Name
depressant NCT03924024 921 931 I-Drug-Name
or NCT03924024 932 934 O
anti NCT03924024 935 939 B-Drug-Name
- NCT03924024 940 941 I-Drug-Name
psychotic NCT03924024 942 951 I-Drug-Name
medications NCT03924024 952 963 I-Drug-Name
, NCT03924024 964 965 O

- NCT03924024 969 970 O
Prior NCT03924024 972 977 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
- NCT03924024 978 979 O
admission NCT03924024 980 989 B-Encounter-Type___Encounter-Type-Value:inpatient
opioid NCT03924024 990 996 B-Condition-Name
use NCT03924024 997 1000 I-Condition-Name
within NCT03924024 1001 1007 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03924024 1009 1011 B-Eq-Value
days NCT03924024 1012 1016 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
( NCT03924024 1017 1018 O
patients NCT03924024 1019 1027 O
will NCT03924024 1028 1032 O
be NCT03924024 1033 1035 O
screened NCT03924024 1036 1044 O
for NCT03924024 1045 1048 O
recent NCT03924024 1049 1055 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
prescription NCT03924024 1056 1068 O
opioid NCT03924024 1069 1075 B-Drug-Name
use NCT03924024 1076 1079 O
using NCT03924024 1080 1085 O
the NCT03924024 1086 1089 O
CURES NCT03924024 1090 1095 B-Observation-Name
report NCT03924024 1096 1102 O
) NCT03924024 1103 1104 O
, NCT03924024 1106 1107 O

- NCT03924024 1111 1112 O
Heavy NCT03924024 1114 1119 B-Severity___Severity-Value:severe
alcohol NCT03924024 1120 1127 B-Condition-Name
use NCT03924024 1128 1131 I-Condition-Name
, NCT03924024 1132 1133 O

- NCT03924024 1137 1138 O
Lesional NCT03924024 1140 1148 O
neurological NCT03924024 1149 1161 B-Condition-Name
disorder NCT03924024 1162 1170 I-Condition-Name
or NCT03924024 1171 1173 O
brain NCT03924024 1174 1179 O
implant NCT03924024 1180 1187 B-Procedure-Name
or NCT03924024 1188 1190 O
intracranial NCT03924024 1191 1203 B-Condition-Name
ferromagnetic NCT03924024 1204 1217 I-Condition-Name
material NCT03924024 1218 1226 I-Condition-Name
, NCT03924024 1227 1228 O

- NCT03924024 1232 1233 O
Seizure NCT03924024 1235 1242 B-Condition-Name
disorder NCT03924024 1243 1251 I-Condition-Name

Inclusion NCT03926169 0 9 O
Criteria NCT03926169 10 18 O
: NCT03926169 19 20 O

- NCT03926169 24 25 O
Participant NCT03926169 27 38 O
with NCT03926169 39 43 O
moderate NCT03926169 44 52 B-Severity___Severity-Value:moderate
to NCT03926169 53 55 B-Eq-Operator___Eq-Operator-Value:BETWEEN
severe NCT03926169 56 62 B-Severity___Severity-Value:severe
Hidradenitis NCT03926169 63 75 B-Condition-Name
Suppurativa NCT03926169 76 87 I-Condition-Name
( NCT03926169 88 89 O
HS NCT03926169 90 92 B-Condition-Name
) NCT03926169 93 94 O
for NCT03926169 95 98 O
at NCT03926169 99 101 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926169 102 107 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03926169 108 111 B-Eq-Value
year NCT03926169 112 116 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
prior NCT03926169 117 122 O
to NCT03926169 123 125 O
Baseline NCT03926169 126 134 O
visit NCT03926169 135 140 O
. NCT03926169 141 142 O

- NCT03926169 146 147 O
HS NCT03926169 149 151 B-Condition-Name
lesions NCT03926169 152 159 I-Condition-Name
present NCT03926169 160 167 O
in NCT03926169 168 170 O
at NCT03926169 171 173 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926169 174 179 I-Eq-Operator___Eq-Operator-Value:GTEQ
two NCT03926169 180 183 B-Eq-Value
distinct NCT03926169 184 192 B-Eq-Unit
anatomical NCT03926169 193 203 I-Eq-Unit
areas NCT03926169 204 209 I-Eq-Unit
. NCT03926169 210 211 O

- NCT03926169 215 216 O
Draining NCT03926169 218 226 B-Observation-Name___Observation-Type-Value:measurement
fistula NCT03926169 227 234 I-Observation-Name___Observation-Type-Value:measurement
count NCT03926169 235 240 I-Observation-Name___Observation-Type-Value:measurement
of NCT03926169 241 243 O
< NCT03926169 244 245 B-Eq-Operator___Eq-Operator-Value:LTEQ
= NCT03926169 247 248 I-Eq-Operator___Eq-Operator-Value:LTEQ
20 NCT03926169 250 252 B-Eq-Value
at NCT03926169 253 255 O
Baseline NCT03926169 256 264 O
visit NCT03926169 265 270 O
. NCT03926169 271 272 O

- NCT03926169 276 277 O
Total NCT03926169 279 284 O
abscesses NCT03926169 285 294 B-Observation-Name___Observation-Type-Value:measurement
and NCT03926169 295 298 I-Observation-Name___Observation-Type-Value:measurement
nodule NCT03926169 299 305 I-Observation-Name___Observation-Type-Value:measurement
count NCT03926169 306 311 I-Observation-Name___Observation-Type-Value:measurement
( NCT03926169 312 313 O
AN NCT03926169 314 316 B-Observation-Name___Observation-Type-Value:measurement
count NCT03926169 317 322 I-Observation-Name___Observation-Type-Value:measurement
) NCT03926169 323 324 O
of NCT03926169 325 327 O
> NCT03926169 328 329 B-Eq-Operator___Eq-Operator-Value:GTEQ
= NCT03926169 331 332 I-Eq-Operator___Eq-Operator-Value:GTEQ
5 NCT03926169 334 335 B-Eq-Value
at NCT03926169 336 338 O
Baseline NCT03926169 339 347 O
visit NCT03926169 348 353 O
. NCT03926169 354 355 O

- NCT03926169 359 360 O
Participants NCT03926169 362 374 O
are NCT03926169 375 378 O
required NCT03926169 379 387 O
to NCT03926169 388 390 O
use NCT03926169 391 394 O
a NCT03926169 395 396 O
daily NCT03926169 397 402 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
antiseptic NCT03926169 403 413 B-Procedure-Name
wash NCT03926169 414 418 I-Procedure-Name
on NCT03926169 419 421 O
their NCT03926169 422 427 O
HS NCT03926169 428 430 B-Condition-Name
lesions NCT03926169 431 438 I-Condition-Name
. NCT03926169 440 441 O

- NCT03926169 445 446 O
Participant NCT03926169 448 459 O
must NCT03926169 460 464 O
have NCT03926169 465 469 O
a NCT03926169 470 471 O
history NCT03926169 472 479 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926169 480 482 O
inadequate NCT03926169 483 493 B-Condition-Name
response NCT03926169 494 502 I-Condition-Name
or NCT03926169 503 505 O
intolerance NCT03926169 506 517 B-Condition-Name
to NCT03926169 518 520 O
an NCT03926169 521 523 O
adequate NCT03926169 524 532 O
trial NCT03926169 533 538 O
of NCT03926169 539 541 O
oral NCT03926169 542 546 B-Drug-Name
antibiotics NCT03926169 547 558 I-Drug-Name
for NCT03926169 559 562 O
treatment NCT03926169 563 572 O
of NCT03926169 573 575 O
HS NCT03926169 576 578 B-Condition-Name
. NCT03926169 579 580 O

Exclusion NCT03926169 582 591 O
Criteria NCT03926169 592 600 O
: NCT03926169 601 602 O

- NCT03926169 606 607 O
Participant NCT03926169 609 620 O
has NCT03926169 621 624 O
a NCT03926169 625 626 O
history NCT03926169 627 634 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926169 635 637 O
active NCT03926169 638 644 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
skin NCT03926169 645 649 B-Condition-Name
disease NCT03926169 650 657 I-Condition-Name
other NCT03926169 658 663 O
than NCT03926169 664 668 O
HS NCT03926169 669 671 B-Condition-Name
that NCT03926169 672 676 O
could NCT03926169 677 682 O
interfere NCT03926169 683 692 B-Stability___Stability-Value:change
with NCT03926169 693 697 O
the NCT03926169 698 701 O
assessment NCT03926169 702 712 B-Procedure-Name
of NCT03926169 713 715 O
HS NCT03926169 716 718 B-Condition-Name
. NCT03926169 719 720 O

- NCT03926169 724 725 O
Participant NCT03926169 727 738 O
has NCT03926169 739 742 O
active NCT03926169 743 749 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
tuberculosis NCT03926169 750 762 B-Condition-Name
( NCT03926169 763 764 O
TB NCT03926169 765 767 B-Condition-Name
) NCT03926169 768 769 O
or NCT03926169 770 772 O
concurrent NCT03926169 773 783 O
treatment NCT03926169 784 793 O
for NCT03926169 794 797 O
latent NCT03926169 798 804 O
TB NCT03926169 805 807 B-Condition-Name
or NCT03926169 808 810 O
evidence NCT03926169 811 819 O
of NCT03926169 820 822 O
hepatitis NCT03926169 823 832 B-Condition-Name
B NCT03926169 833 834 I-Condition-Name
virus NCT03926169 835 840 I-Condition-Name
( NCT03926169 841 842 O
HBV NCT03926169 843 846 B-Condition-Name
) NCT03926169 847 848 O
or NCT03926169 849 851 O
hepatitis NCT03926169 852 861 B-Condition-Name
C NCT03926169 862 863 I-Condition-Name
virus NCT03926169 864 869 I-Condition-Name
( NCT03926169 870 871 O
HCV NCT03926169 872 875 B-Condition-Name
) NCT03926169 876 877 O
or NCT03926169 878 880 O
human NCT03926169 881 886 B-Condition-Name
immuno NCT03926169 887 893 I-Condition-Name
deficiency NCT03926169 894 904 I-Condition-Name
virus NCT03926169 905 910 I-Condition-Name
( NCT03926169 911 912 O
HIV NCT03926169 913 916 B-Condition-Name
) NCT03926169 917 918 O
infection NCT03926169 919 928 B-Condition-Name
. NCT03926169 929 930 O

- NCT03926169 934 935 O
Participant NCT03926169 937 948 O
has NCT03926169 949 952 O
prior NCT03926169 953 958 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
exposure NCT03926169 959 967 O
to NCT03926169 968 970 O
anti NCT03926169 971 975 O
- NCT03926169 976 977 O
interleukin NCT03926169 978 989 B-Condition-Name
- NCT03926169 990 991 I-Condition-Name
1 NCT03926169 993 994 I-Condition-Name
( NCT03926169 995 996 O
anti NCT03926169 997 1001 O
- NCT03926169 1002 1003 O
IL NCT03926169 1004 1006 B-Condition-Name
- NCT03926169 1007 1008 I-Condition-Name
1 NCT03926169 1010 1011 I-Condition-Name
) NCT03926169 1012 1013 O
treatment NCT03926169 1014 1023 O
within NCT03926169 1024 1030 B-Eq-Operator___Eq-Operator-Value:LTEQ
3 NCT03926169 1032 1033 B-Eq-Value
months NCT03926169 1034 1040 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
or NCT03926169 1041 1043 O
5 NCT03926169 1045 1046 B-Eq-Value
half NCT03926169 1047 1051 B-Eq-Unit
- NCT03926169 1052 1053 I-Eq-Unit
lives NCT03926169 1054 1059 I-Eq-Unit
, NCT03926169 1060 1061 O
whichever NCT03926169 1062 1071 O
is NCT03926169 1072 1074 O
longer NCT03926169 1075 1081 O
, NCT03926169 1082 1083 O
prior NCT03926169 1084 1089 O
to NCT03926169 1090 1092 O
baseline NCT03926169 1093 1101 O
. NCT03926169 1102 1103 O

- NCT03926169 1107 1108 O
Participant NCT03926169 1110 1121 O
has NCT03926169 1122 1125 O
received NCT03926169 1126 1134 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
prescription NCT03926169 1135 1147 O
topical NCT03926169 1148 1155 B-Drug-Name
therapies NCT03926169 1156 1165 I-Drug-Name
( NCT03926169 1166 1167 O
including NCT03926169 1168 1177 O
topical NCT03926169 1178 1185 B-Drug-Name
antibiotics NCT03926169 1186 1197 I-Drug-Name
) NCT03926169 1198 1199 O
within NCT03926169 1200 1206 B-Eq-Operator___Eq-Operator-Value:LTEQ
14 NCT03926169 1208 1210 B-Eq-Value
days NCT03926169 1211 1215 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
prior NCT03926169 1216 1221 O
to NCT03926169 1222 1224 O
the NCT03926169 1225 1228 O
Baseline NCT03926169 1229 1237 O
visit NCT03926169 1238 1243 O
. NCT03926169 1244 1245 O

- NCT03926169 1249 1250 O
Participant NCT03926169 1252 1263 O
has NCT03926169 1264 1267 O
received NCT03926169 1268 1276 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
systemic NCT03926169 1277 1285 O
non NCT03926169 1286 1289 B-Procedure-Name
- NCT03926169 1290 1291 I-Procedure-Name
biologic NCT03926169 1292 1300 I-Procedure-Name
therapies NCT03926169 1301 1310 I-Procedure-Name
that NCT03926169 1311 1315 O
can NCT03926169 1316 1319 O
also NCT03926169 1320 1324 O
be NCT03926169 1325 1327 O
used NCT03926169 1328 1332 O
to NCT03926169 1333 1335 O
treat NCT03926169 1336 1341 O
HS NCT03926169 1342 1344 B-Condition-Name
within NCT03926169 1345 1351 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03926169 1353 1354 B-Eq-Value
weeks NCT03926169 1355 1360 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03926169 1361 1366 O
to NCT03926169 1367 1369 O
the NCT03926169 1370 1373 O
Baseline NCT03926169 1374 1382 O
visit NCT03926169 1383 1388 O
. NCT03926169 1389 1390 O

- NCT03926169 1394 1395 O
Participant NCT03926169 1397 1408 O
has NCT03926169 1409 1412 O
received NCT03926169 1413 1421 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
any NCT03926169 1422 1425 O
systemic NCT03926169 1426 1434 O
( NCT03926169 1435 1436 O
including NCT03926169 1437 1446 O
oral NCT03926169 1447 1451 O
) NCT03926169 1452 1453 O
antibiotic NCT03926169 1454 1464 B-Drug-Name
treatment NCT03926169 1465 1474 O
within NCT03926169 1475 1481 B-Eq-Operator___Eq-Operator-Value:LTEQ
4 NCT03926169 1483 1484 B-Eq-Value
weeks NCT03926169 1485 1490 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
prior NCT03926169 1491 1496 O
to NCT03926169 1497 1499 O
the NCT03926169 1500 1503 O
Baseline NCT03926169 1504 1512 O
visit NCT03926169 1513 1518 O
. NCT03926169 1519 1520 O

Inclusion NCT03921606 0 9 O
Criteria NCT03921606 10 18 O
: NCT03921606 19 20 O

- NCT03921606 24 25 O
aged NCT03921606 27 31 O
18 NCT03921606 33 35 B-Eq-Value
years NCT03921606 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03921606 42 44 B-Eq-Operator___Eq-Operator-Value:GTEQ
above NCT03921606 45 50 I-Eq-Operator___Eq-Operator-Value:GTEQ
, NCT03921606 51 52 O

- NCT03921606 56 57 O
able NCT03921606 59 63 O
to NCT03921606 64 66 O
speak NCT03921606 67 72 O
Cantonese NCT03921606 73 82 B-Language
and NCT03921606 83 86 O
read NCT03921606 87 91 O
Chinese NCT03921606 92 99 B-Language

- NCT03921606 102 103 O
do NCT03921606 105 107 O
not NCT03921606 108 111 O
intend NCT03921606 112 118 O
to NCT03921606 119 121 O
quit NCT03921606 122 126 B-Condition-Name
smoking NCT03921606 127 134 I-Condition-Name
( NCT03921606 135 136 O
pre NCT03921606 137 140 B-Condition-Name
- NCT03921606 141 142 I-Condition-Name
contemplation NCT03921606 143 156 I-Condition-Name
stage NCT03921606 157 162 I-Condition-Name
) NCT03921606 163 164 O
, NCT03921606 166 167 O
but NCT03921606 168 171 O
are NCT03921606 172 175 O
willing NCT03921606 176 183 O
to NCT03921606 184 186 O
promote NCT03921606 187 194 O
their NCT03921606 195 200 O
health NCT03921606 201 207 B-Condition-Name

- NCT03921606 210 211 O
use NCT03921606 213 216 O
a NCT03921606 217 218 O
smartphone NCT03921606 219 229 O
and NCT03921606 230 233 O
can NCT03921606 234 237 O
use NCT03921606 238 241 O
an NCT03921606 242 244 O
instant NCT03921606 245 252 O
messaging NCT03921606 253 262 O
tool NCT03921606 263 267 O
( NCT03921606 268 269 O
e NCT03921606 270 271 O
. NCT03921606 272 273 O
g NCT03921606 274 275 O
. NCT03921606 276 277 O
, NCT03921606 278 279 O
WhatsApp NCT03921606 280 288 O
/ NCT03921606 289 290 O
WeChat NCT03921606 291 297 O
) NCT03921606 298 299 O

- NCT03921606 303 304 O
willing NCT03921606 306 313 O
to NCT03921606 314 316 O
receive NCT03921606 317 324 O
health NCT03921606 325 331 O
promotion NCT03921606 332 341 O
advice NCT03921606 342 348 O
and NCT03921606 349 352 O
interact NCT03921606 353 361 O
with NCT03921606 362 366 O
our NCT03921606 367 370 O
interventionist NCT03921606 371 386 O
via NCT03921606 387 390 O
WhatsApp NCT03921606 391 399 O
/ NCT03921606 400 401 O
WeChat NCT03921606 402 408 O
on NCT03921606 409 411 O
a NCT03921606 412 413 O
smartphone NCT03921606 414 424 O
throughout NCT03921606 425 435 O
the NCT03921606 436 439 O
study NCT03921606 440 445 O
period NCT03921606 446 452 O

Exclusion NCT03921606 453 462 O
Criteria NCT03921606 463 471 O
: NCT03921606 472 473 O

- NCT03921606 477 478 O
inability NCT03921606 480 489 O
to NCT03921606 490 492 O
give NCT03921606 493 497 O
informed NCT03921606 498 506 O
consent NCT03921606 507 514 O
or NCT03921606 515 517 O
participate NCT03921606 518 529 O
in NCT03921606 530 532 O
our NCT03921606 533 536 O
intervention NCT03921606 537 549 B-Procedure-Name
due NCT03921606 550 553 O
to NCT03921606 554 556 O
impaired NCT03921606 557 565 B-Condition-Name
mental NCT03921606 566 572 I-Condition-Name
status NCT03921606 573 579 I-Condition-Name
, NCT03921606 580 581 O
cognitive NCT03921606 582 591 B-Condition-Name
impairment NCT03921606 592 602 I-Condition-Name
or NCT03921606 603 605 O
communication NCT03921606 606 619 B-Condition-Name
barriers NCT03921606 620 628 I-Condition-Name

- NCT03921606 631 632 O
participate NCT03921606 634 645 O
in NCT03921606 646 648 O
another NCT03921606 649 656 O
smoking NCT03921606 657 664 B-Procedure-Name
cessation NCT03921606 665 674 I-Procedure-Name
programme NCT03921606 675 684 O
or NCT03921606 685 687 O
service NCT03921606 688 695 O

Inclusion NCT03924232 0 9 O
Criteria NCT03924232 10 18 O
: NCT03924232 19 20 O

- NCT03924232 24 25 O
All NCT03924232 27 30 O
patients NCT03924232 31 39 O
aged NCT03924232 40 44 O
18 NCT03924232 46 48 B-Eq-Value
or NCT03924232 49 51 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03924232 52 57 I-Eq-Operator___Eq-Operator-Value:GTEQ
and NCT03924232 58 61 O
with NCT03924232 62 66 O
a NCT03924232 67 68 O
recent NCT03924232 69 75 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
( NCT03924232 76 77 O
< NCT03924232 79 80 B-Eq-Operator___Eq-Operator-Value:LT
48 NCT03924232 82 84 B-Eq-Value
h NCT03924232 85 86 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
) NCT03924232 87 88 O
ICU NCT03924232 89 92 B-Encounter-Type___Encounter-Type-Value:icu
entry NCT03924232 93 98 I-Encounter-Type___Encounter-Type-Value:icu
requiring NCT03924232 99 108 O
mechanical NCT03924232 109 119 B-Procedure-Name
ventilation NCT03924232 120 131 I-Procedure-Name
for NCT03924232 132 135 O
at NCT03924232 136 138 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03924232 139 144 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03924232 146 147 B-Eq-Value
days NCT03924232 148 152 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
will NCT03924232 153 157 O
be NCT03924232 158 160 O
considered NCT03924232 161 171 O
for NCT03924232 172 175 O
enrolment NCT03924232 176 185 O

Exclusion NCT03924232 186 195 O
Criteria NCT03924232 196 204 O
: NCT03924232 205 206 O

- NCT03924232 210 211 O
not NCT03924232 213 216 O
intubated NCT03924232 217 226 B-Procedure-Name
patients NCT03924232 227 235 O

- NCT03924232 238 239 O
patients NCT03924232 241 249 O
with NCT03924232 250 254 O
an NCT03924232 255 257 O
ICU NCT03924232 258 261 B-Encounter-Type___Encounter-Type-Value:icu
prevision NCT03924232 262 271 I-Encounter-Type___Encounter-Type-Value:icu
of NCT03924232 272 274 I-Encounter-Type___Encounter-Type-Value:icu
stay NCT03924232 275 279 I-Encounter-Type___Encounter-Type-Value:icu
less NCT03924232 280 284 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03924232 285 289 I-Eq-Operator___Eq-Operator-Value:LT
3 NCT03924232 291 292 B-Eq-Value
days NCT03924232 293 297 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day

Inclusion NCT03925662 0 9 O
Criteria NCT03925662 10 18 O
: NCT03925662 19 20 O

- NCT03925662 24 25 O
Colorectal NCT03925662 27 37 O
cancer NCT03925662 38 44 B-Condition-Name
stage NCT03925662 45 50 B-Eq-Unit
4 NCT03925662 52 53 B-Eq-Value
. NCT03925662 53 54 O

Exclusion NCT03925662 56 65 O
Criteria NCT03925662 66 74 O
: NCT03925662 75 76 O

- NCT03925662 80 81 O
Agranulocytosis NCT03925662 83 98 B-Condition-Name

- NCT03925662 101 102 O
Pregnancy NCT03925662 104 113 B-Condition-Name

- NCT03925662 116 117 O
Allergy NCT03925662 119 126 O
to NCT03925662 127 129 O
mebendazole NCT03925662 130 141 B-Drug-Name
. NCT03925662 142 143 O

Inclusion NCT03924583 0 9 O
Criteria NCT03924583 10 18 O
: NCT03924583 19 20 O

- NCT03924583 24 25 O
central NCT03924583 27 34 B-Procedure-Name
venous NCT03924583 35 41 I-Procedure-Name
catheter NCT03924583 42 50 I-Procedure-Name
more NCT03924583 51 55 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03924583 56 60 I-Eq-Operator___Eq-Operator-Value:GT
48 NCT03924583 62 64 B-Eq-Value
hours NCT03924583 65 70 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
in NCT03924583 71 73 O
situ NCT03924583 74 78 O

- NCT03924583 81 82 O
consent NCT03924583 84 91 O
of NCT03924583 92 94 O
a NCT03924583 95 96 O
patient NCT03924583 97 104 O

Exclusion NCT03924583 105 114 O
Criteria NCT03924583 115 123 O
: NCT03924583 124 125 O

- NCT03924583 129 130 O
technical NCT03924583 132 141 O
difficulties NCT03924583 142 154 O
of NCT03924583 155 157 O
ultrasound NCT03924583 158 168 B-Procedure-Name
machine NCT03924583 169 176 I-Procedure-Name

- NCT03924583 179 180 O
unfavorable NCT03924583 182 193 O
local NCT03924583 194 199 O
findings NCT03924583 200 208 O
- NCT03924583 209 210 O
inflammation NCT03924583 211 223 B-Condition-Name
of NCT03924583 224 226 I-Condition-Name
skin NCT03924583 227 231 I-Condition-Name
, NCT03924583 232 233 O
excoriation NCT03924583 234 245 B-Condition-Name
etc NCT03924583 246 249 O
. NCT03924583 250 251 O

Inclusion NCT03925688 0 9 O
Criteria NCT03925688 10 18 O
: NCT03925688 19 20 O

- NCT03925688 24 25 O
Have NCT03925688 27 31 O
a NCT03925688 32 33 O
previous NCT03925688 34 42 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03925688 43 50 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925688 51 53 O
elbow NCT03925688 54 59 O
joint NCT03925688 60 65 O
fracture NCT03925688 66 74 B-Condition-Name
or NCT03925688 75 77 O
dislocation NCT03925688 78 89 B-Condition-Name
that NCT03925688 90 94 O
conform NCT03925688 95 102 O
to NCT03925688 103 105 O
its NCT03925688 106 109 O
manifestations NCT03925688 110 124 O
and NCT03925688 125 128 O
signs NCT03925688 129 134 O
. NCT03925688 135 136 O
And NCT03925688 138 141 O
it NCT03925688 142 144 O
is NCT03925688 145 147 O
diagnosed NCT03925688 148 157 O
by NCT03925688 158 160 O
X NCT03925688 161 162 B-Procedure-Name
- NCT03925688 163 164 I-Procedure-Name
ray NCT03925688 165 168 I-Procedure-Name
test NCT03925688 169 173 I-Procedure-Name
. NCT03925688 174 175 O
HO NCT03925688 177 179 O
must NCT03925688 180 184 O
accord NCT03925688 185 191 O
with NCT03925688 192 196 O
the NCT03925688 197 200 O
relative NCT03925688 201 209 O
diagnostic NCT03925688 210 220 O
criteria NCT03925688 221 229 O
5 NCT03925688 230 231 O
and NCT03925688 232 235 O
have NCT03925688 236 240 O
imaging NCT03925688 241 248 B-Procedure-Name
evidences NCT03925688 249 258 O
of NCT03925688 259 261 O
heterotopic NCT03925688 262 273 B-Condition-Name
ossification NCT03925688 274 286 I-Condition-Name
. NCT03925688 287 288 O

- NCT03925688 292 293 O
Have NCT03925688 295 299 O
complete NCT03925688 300 308 O
clinical NCT03925688 309 317 O
and NCT03925688 318 321 O
imaging NCT03925688 322 329 B-Procedure-Name
dates NCT03925688 330 335 O
. NCT03925688 336 337 O

- NCT03925688 341 342 O
The NCT03925688 344 347 O
age NCT03925688 348 351 O
＞ NCT03925688 352 353 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03925688 355 357 B-Eq-Value
and NCT03925688 358 361 O
no NCT03925688 362 364 O
gender NCT03925688 365 371 O
limitation NCT03925688 372 382 O
. NCT03925688 383 384 O

- NCT03925688 388 389 O
The NCT03925688 391 394 O
patient NCT03925688 395 402 O
is NCT03925688 403 405 O
being NCT03925688 406 411 O
a NCT03925688 412 413 O
relatively NCT03925688 414 424 O
stable NCT03925688 425 431 B-Stability___Stability-Value:stable
physical NCT03925688 432 440 O
and NCT03925688 441 444 O
mental NCT03925688 445 451 O
state NCT03925688 452 457 B-Condition-Name
without NCT03925688 458 465 O
acute NCT03925688 466 471 B-Severity___Severity-Value:severe
injection NCT03925688 472 481 B-Procedure-Name
or NCT03925688 482 484 O
diseases NCT03925688 485 493 B-Condition-Name
. NCT03925688 494 495 O

Exclusion NCT03925688 497 506 O
Criteria NCT03925688 507 515 O
: NCT03925688 516 517 O

- NCT03925688 521 522 O
Have NCT03925688 524 528 O
a NCT03925688 529 530 O
history NCT03925688 531 538 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925688 539 541 O
diabetes NCT03925688 542 550 B-Condition-Name
mellitus NCT03925688 551 559 I-Condition-Name
or NCT03925688 560 562 O
impaired NCT03925688 563 571 B-Condition-Name
blood NCT03925688 572 577 I-Condition-Name
glucose NCT03925688 578 585 I-Condition-Name
, NCT03925688 586 587 O
metabolic NCT03925688 588 597 B-Condition-Name
syndrome NCT03925688 598 606 I-Condition-Name
and NCT03925688 607 610 O
gout NCT03925688 611 615 B-Condition-Name
or NCT03925688 616 618 O
renal NCT03925688 619 624 O
dysfunction NCT03925688 625 636 B-Condition-Name
( NCT03925688 637 638 O
creatinine NCT03925688 639 649 B-Observation-Name___Observation-Type-Value:lab
≥ NCT03925688 650 651 B-Eq-Operator___Eq-Operator-Value:GTEQ
1.5 NCT03925688 653 656 B-Eq-Value
mg NCT03925688 657 659 B-Eq-Unit
/ NCT03925688 660 661 O
dL NCT03925688 662 664 B-Eq-Unit
) NCT03925688 665 666 O
that NCT03925688 667 671 O
apparently NCT03925688 672 682 O
influence NCT03925688 683 692 B-Stability___Stability-Value:change
glucose NCT03925688 693 700 O
, NCT03925688 701 702 O
lipid NCT03925688 703 708 O
and NCT03925688 709 712 O
protein NCT03925688 713 720 O
metabolic NCT03925688 721 730 B-Condition-Name
of NCT03925688 731 733 O
the NCT03925688 734 737 O
body NCT03925688 738 742 O
. NCT03925688 743 744 O

- NCT03925688 748 749 O
Have NCT03925688 751 755 O
a NCT03925688 756 757 O
history NCT03925688 758 765 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925688 766 768 O
taking NCT03925688 769 775 O
drugs NCT03925688 776 781 O
that NCT03925688 782 786 O
can NCT03925688 787 790 O
influence NCT03925688 791 800 B-Stability___Stability-Value:change
uric NCT03925688 801 805 B-Condition-Name
acid NCT03925688 806 810 I-Condition-Name
metabolic NCT03925688 811 820 I-Condition-Name
including NCT03925688 821 830 O
gout NCT03925688 831 835 B-Condition-Name
suppressant NCT03925688 836 847 B-Drug-Name
, NCT03925688 848 849 O
diuretic NCT03925688 850 858 B-Drug-Name
, NCT03925688 859 860 O
small NCT03925688 861 866 B-Polarity___Polarity-Value:low
- NCT03925688 867 868 O
dose NCT03925688 869 873 O
aspirin NCT03925688 874 881 B-Drug-Name
( NCT03925688 882 883 O
75 NCT03925688 885 887 B-Eq-Value
~ NCT03925688 888 889 B-Eq-Operator___Eq-Operator-Value:BETWEEN
300 NCT03925688 891 894 B-Eq-Value
mg NCT03925688 895 897 B-Eq-Unit
/ NCT03925688 898 899 O
d NCT03925688 900 901 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03925688 902 903 O
or NCT03925688 904 906 O
large NCT03925688 907 912 B-Polarity___Polarity-Value:high
- NCT03925688 913 914 O
dose NCT03925688 915 919 O
aspirin NCT03925688 920 927 B-Drug-Name
( NCT03925688 928 929 O
＞ NCT03925688 931 932 B-Eq-Operator___Eq-Operator-Value:GT
3 NCT03925688 934 935 B-Eq-Value
g NCT03925688 936 937 B-Eq-Unit
/ NCT03925688 938 939 O
d NCT03925688 940 941 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
) NCT03925688 942 943 O
, NCT03925688 945 946 O
anti NCT03925688 947 951 O
- NCT03925688 952 953 O
tuberculosis NCT03925688 954 966 B-Condition-Name
drugs NCT03925688 967 972 O
, NCT03925688 973 974 O
immunosuppressor NCT03925688 975 991 B-Drug-Name
, NCT03925688 992 993 O
nicotinic NCT03925688 994 1003 B-Drug-Name
acid NCT03925688 1004 1008 I-Drug-Name
and NCT03925688 1009 1012 O
anti NCT03925688 1013 1017 O
- NCT03925688 1018 1019 O
tumor NCT03925688 1020 1025 B-Condition-Name
drugs NCT03925688 1026 1031 O
such NCT03925688 1032 1036 O
as NCT03925688 1037 1039 O
cyclophosphamide NCT03925688 1040 1056 B-Drug-Name
and NCT03925688 1057 1060 O
so NCT03925688 1061 1063 O
on NCT03925688 1064 1066 O
. NCT03925688 1067 1068 O

Inclusion NCT03924596 0 9 O
Criteria NCT03924596 10 18 O
: NCT03924596 19 20 O

- NCT03924596 24 25 O
Participants NCT03924596 27 39 O
with NCT03924596 40 44 O
renal NCT03924596 45 50 B-Observation-Name___Observation-Type-Value:measurement
stones NCT03924596 51 57 I-Observation-Name___Observation-Type-Value:measurement
equal NCT03924596 58 63 B-Eq-Operator___Eq-Operator-Value:LTEQ
or NCT03924596 64 66 I-Eq-Operator___Eq-Operator-Value:LTEQ
less NCT03924596 67 71 I-Eq-Operator___Eq-Operator-Value:LTEQ
than NCT03924596 72 76 I-Eq-Operator___Eq-Operator-Value:LTEQ
10 NCT03924596 78 80 B-Eq-Value
mm NCT03924596 81 83 B-Eq-Unit
in NCT03924596 84 86 O
size NCT03924596 87 91 O

Exclusion NCT03924596 92 101 O
Criteria NCT03924596 102 110 O
: NCT03924596 111 112 O

- NCT03924596 116 117 O
Participants NCT03924596 119 131 O
with NCT03924596 132 136 O
renal NCT03924596 137 142 B-Condition-Name
pathology NCT03924596 143 152 I-Condition-Name
( NCT03924596 153 154 O
Renal NCT03924596 155 160 O
anomalies NCT03924596 161 170 B-Condition-Name
, NCT03924596 171 172 O
multiple NCT03924596 173 181 O
renal NCT03924596 182 187 O
cysts NCT03924596 188 193 B-Condition-Name
, NCT03924596 194 195 O
renal NCT03924596 196 201 O
tumors NCT03924596 202 208 B-Condition-Name
) NCT03924596 209 210 O

- NCT03924596 214 215 O
Participants NCT03924596 217 229 O
with NCT03924596 230 234 O
comorbidities NCT03924596 235 248 B-Condition-Name
( NCT03924596 249 250 O
DM NCT03924596 251 253 B-Condition-Name
, NCT03924596 254 255 O
CKD NCT03924596 256 259 B-Condition-Name
) NCT03924596 260 261 O

Key NCT03921411 0 3 O
Inclusion NCT03921411 4 13 O
Criteria NCT03921411 14 22 O

- NCT03921411 25 26 O
Male NCT03921411 28 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03921411 33 35 O
female NCT03921411 36 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
subjects NCT03921411 43 51 O
≥ NCT03921411 52 53 B-Eq-Operator___Eq-Operator-Value:GTEQ
12 NCT03921411 55 57 B-Eq-Value
to NCT03921411 58 60 B-Eq-Operator___Eq-Operator-Value:BETWEEN
< NCT03921411 61 62 O
18 NCT03921411 64 66 B-Eq-Value
years NCT03921411 67 72 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03921411 73 75 O
age NCT03921411 76 79 O

- NCT03921411 82 83 O
Chronic NCT03921411 85 92 O
AD NCT03921411 93 95 B-Condition-Name
that NCT03921411 96 100 O
has NCT03921411 101 104 O
been NCT03921411 105 109 O
documented NCT03921411 110 120 O
for NCT03921411 121 124 O
at NCT03921411 125 127 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03921411 128 133 I-Eq-Operator___Eq-Operator-Value:GTEQ
2 NCT03921411 135 136 B-Eq-Value
years NCT03921411 137 142 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03921411 145 146 O
Eczema NCT03921411 148 154 B-Observation-Name___Observation-Type-Value:clinical-score
Area NCT03921411 155 159 I-Observation-Name___Observation-Type-Value:clinical-score
and NCT03921411 160 163 I-Observation-Name___Observation-Type-Value:clinical-score
Severity NCT03921411 164 172 I-Observation-Name___Observation-Type-Value:clinical-score
Index NCT03921411 173 178 I-Observation-Name___Observation-Type-Value:clinical-score
( NCT03921411 179 180 O
EASI NCT03921411 181 185 B-Observation-Name
) NCT03921411 186 187 O
score NCT03921411 188 193 O
≥ NCT03921411 194 195 B-Eq-Operator___Eq-Operator-Value:GTEQ
16 NCT03921411 197 199 B-Eq-Value

- NCT03921411 203 204 O
IGA NCT03921411 206 209 B-Observation-Name___Observation-Type-Value:clinical-score
score NCT03921411 210 215 O
≥ NCT03921411 216 217 B-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03921411 219 220 B-Eq-Value

- NCT03921411 224 225 O
AD NCT03921411 227 229 B-Observation-Name___Observation-Type-Value:measurement
involvement NCT03921411 230 241 I-Observation-Name___Observation-Type-Value:measurement
≥ NCT03921411 242 243 B-Eq-Operator___Eq-Operator-Value:GTEQ
10 NCT03921411 245 247 B-Eq-Value
% NCT03921411 248 249 B-Eq-Unit
of NCT03921411 250 252 O
Body NCT03921411 253 257 B-Eq-Unit
Surface NCT03921411 258 265 I-Eq-Unit
Area NCT03921411 266 270 I-Eq-Unit
( NCT03921411 271 272 O
BSA NCT03921411 273 276 B-Eq-Unit
) NCT03921411 277 278 O

- NCT03921411 282 283 O
Documented NCT03921411 285 295 O
recent NCT03921411 296 302 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
history NCT03921411 303 310 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921411 311 313 O
inadequate NCT03921411 314 324 O
response NCT03921411 325 333 O
to NCT03921411 334 336 O
topical NCT03921411 337 344 B-Drug-Name
medications NCT03921411 345 356 I-Drug-Name

- NCT03921411 359 360 O
Women NCT03921411 362 367 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
of NCT03921411 368 370 O
childbearing NCT03921411 371 383 B-Condition-Name
potential NCT03921411 384 393 O
must NCT03921411 394 398 O
agree NCT03921411 399 404 O
to NCT03921411 405 407 O
be NCT03921411 408 410 O
strictly NCT03921411 411 419 O
abstinent NCT03921411 420 429 B-Condition-Name
or NCT03921411 430 432 O
to NCT03921411 433 435 O
use NCT03921411 436 439 O
an NCT03921411 440 442 O
effective NCT03921411 443 452 O
and NCT03921411 453 456 O
approved NCT03921411 457 465 O
method NCT03921411 466 472 O
of NCT03921411 473 475 O
contraception NCT03921411 476 489 B-Procedure-Name
throughout NCT03921411 490 500 O
the NCT03921411 501 504 O
study NCT03921411 505 510 O
and NCT03921411 511 514 O
for NCT03921411 515 518 O
12 NCT03921411 520 522 B-Eq-Value
weeks NCT03921411 523 528 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
after NCT03921411 529 534 O
the NCT03921411 535 538 O
last NCT03921411 539 543 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
study NCT03921411 544 549 O
drug NCT03921411 550 554 B-Procedure-Name
injection NCT03921411 555 564 I-Procedure-Name
. NCT03921411 565 566 O

Key NCT03921411 568 571 O
Exclusion NCT03921411 572 581 O
Criteria NCT03921411 582 590 O

- NCT03921411 593 594 O
Body NCT03921411 596 600 B-Observation-Name___Observation-Type-Value:vital
weight NCT03921411 601 607 I-Observation-Name___Observation-Type-Value:vital
< NCT03921411 608 609 B-Eq-Operator___Eq-Operator-Value:LT
30 NCT03921411 611 613 B-Eq-Value
kg NCT03921411 614 616 B-Eq-Unit

- NCT03921411 619 620 O
Cutaneous NCT03921411 622 631 O
infection NCT03921411 632 641 B-Condition-Name
within NCT03921411 642 648 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03921411 650 651 B-Eq-Value
week NCT03921411 652 656 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
or NCT03921411 657 659 O
any NCT03921411 660 663 O
infection NCT03921411 664 673 B-Condition-Name
requiring NCT03921411 674 683 O
treatment NCT03921411 684 693 O
with NCT03921411 694 698 O
oral NCT03921411 699 703 O
or NCT03921411 704 706 O
parenteral NCT03921411 707 717 O
antibiotics NCT03921411 718 729 B-Procedure-Name
, NCT03921411 730 731 O
antivirals NCT03921411 732 742 B-Drug-Name
, NCT03921411 743 744 O
antiparasitics NCT03921411 745 759 B-Drug-Name
, NCT03921411 760 761 O
or NCT03921411 762 764 O
antifungals NCT03921411 765 776 B-Drug-Name
within NCT03921411 777 783 B-Eq-Operator___Eq-Operator-Value:LTEQ
1 NCT03921411 785 786 B-Eq-Value
week NCT03921411 787 791 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week

- NCT03921411 794 795 O
History NCT03921411 797 804 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921411 805 807 O
hypersensitivity NCT03921411 808 824 B-Condition-Name
( NCT03921411 825 826 O
including NCT03921411 827 836 O
anaphylaxis NCT03921411 837 848 B-Condition-Name
) NCT03921411 849 850 O
to NCT03921411 851 853 O
an NCT03921411 854 856 O
immunoglobulin NCT03921411 857 871 B-Drug-Name
product NCT03921411 872 879 I-Drug-Name
( NCT03921411 880 881 O
plasma NCT03921411 882 888 O
- NCT03921411 889 890 O
derived NCT03921411 891 898 O
or NCT03921411 899 901 O
recombinant NCT03921411 902 913 O
, NCT03921411 914 915 O
eg NCT03921411 916 918 O
, NCT03921411 919 920 O
monoclonal NCT03921411 921 931 B-Drug-Name
antibody NCT03921411 932 940 I-Drug-Name
) NCT03921411 941 942 O

- NCT03921411 946 947 O
Any NCT03921411 949 952 O
clinically NCT03921411 953 963 O
significant NCT03921411 964 975 B-Severity___Severity-Value:severe
issue NCT03921411 976 981 O
, NCT03921411 982 983 O
based NCT03921411 984 989 O
investigator NCT03921411 990 1002 O
judgement NCT03921411 1003 1012 O

Inclusion NCT03924804 0 9 O
Criteria NCT03924804 10 18 O
: NCT03924804 19 20 O

- NCT03924804 24 25 O
1 NCT03924804 28 29 O
. NCT03924804 29 30 O
ethnic NCT03924804 32 38 O
Chinese NCT03924804 39 46 B-Ethnicity
; NCT03924804 46 47 O

- NCT03924804 50 51 O
2 NCT03924804 54 55 O
. NCT03924804 55 56 O
age NCT03924804 58 61 O
, NCT03924804 62 63 O
18 NCT03924804 65 67 B-Eq-Value
to NCT03924804 68 70 B-Eq-Operator___Eq-Operator-Value:BETWEEN
65 NCT03924804 72 74 B-Eq-Value
years NCT03924804 75 80 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03924804 81 84 O
; NCT03924804 84 85 O

- NCT03924804 88 89 O
3 NCT03924804 92 93 O
. NCT03924804 93 94 O
American NCT03924804 96 104 B-Condition-Name
Society NCT03924804 105 112 I-Condition-Name
of NCT03924804 113 115 I-Condition-Name
Anaesthesiologists NCT03924804 116 134 I-Condition-Name
( NCT03924804 135 136 O
ASA NCT03924804 137 140 B-Condition-Name
) NCT03924804 141 142 O
physical NCT03924804 143 151 O
status NCT03924804 152 158 O
I NCT03924804 159 160 B-Eq-Value
or NCT03924804 161 163 O
II NCT03924804 164 166 B-Eq-Value
; NCT03924804 166 167 O

- NCT03924804 170 171 O
4 NCT03924804 174 175 O
. NCT03924804 175 176 O
Daytime NCT03924804 178 185 O
patients NCT03924804 186 194 O
scheduled NCT03924804 195 204 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03924804 205 208 O
general NCT03924804 209 216 B-Procedure-Name
anesthesia NCT03924804 217 227 I-Procedure-Name

Exclusion NCT03924804 228 237 O
Criteria NCT03924804 238 246 O
: NCT03924804 247 248 O

- NCT03924804 252 253 O
Patients NCT03924804 255 263 O
unwilling NCT03924804 264 273 O
to NCT03924804 274 276 O
cooperate NCT03924804 277 286 O
with NCT03924804 287 291 O
the NCT03924804 292 295 O
experiment NCT03924804 296 306 O

- NCT03924804 309 310 O
Body NCT03924804 312 316 B-Observation-Name___Observation-Type-Value:vital
mass NCT03924804 317 321 I-Observation-Name___Observation-Type-Value:vital
index NCT03924804 322 327 I-Observation-Name___Observation-Type-Value:vital
exceeding NCT03924804 328 337 B-Eq-Operator___Eq-Operator-Value:GT
30 NCT03924804 339 341 B-Eq-Value
kg NCT03924804 342 344 B-Eq-Unit
/ NCT03924804 345 346 O
m NCT03924804 347 348 B-Eq-Unit
2 NCT03924804 349 350 I-Eq-Unit
; NCT03924804 350 351 O

- NCT03924804 354 355 O
Patients NCT03924804 357 365 O
with NCT03924804 366 370 O
a NCT03924804 371 372 O
history NCT03924804 373 380 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03924804 381 383 O
heart NCT03924804 384 389 O
, NCT03924804 390 391 O
liver NCT03924804 392 397 O
and NCT03924804 398 401 O
Renal NCT03924804 402 407 O
failure NCT03924804 408 415 B-Condition-Name
, NCT03924804 416 417 O
hypertension NCT03924804 418 430 B-Condition-Name
, NCT03924804 431 432 O
diabetes NCT03924804 433 441 B-Condition-Name
mellitus NCT03924804 442 450 I-Condition-Name
or NCT03924804 451 453 O
arteriosclerosis NCT03924804 454 470 B-Condition-Name
; NCT03924804 470 471 O
and NCT03924804 472 475 O
any NCT03924804 476 479 O
allergy NCT03924804 480 487 O
to NCT03924804 488 490 O
drugs NCT03924804 491 496 O
used NCT03924804 497 501 O
in NCT03924804 502 504 O
the NCT03924804 505 508 O
study NCT03924804 509 514 O
. NCT03924804 515 516 O

- NCT03924804 520 521 O
Patients NCT03924804 523 531 O
with NCT03924804 532 536 O
the NCT03924804 537 540 O
urinary NCT03924804 541 548 B-Condition-Name
diseases NCT03924804 549 557 I-Condition-Name
, NCT03924804 558 559 O
such NCT03924804 560 564 O
as NCT03924804 565 567 O
kidney NCT03924804 568 574 B-Condition-Name
, NCT03924804 575 576 O
ureteral NCT03924804 577 585 B-Condition-Name
calculi NCT03924804 586 593 I-Condition-Name
and NCT03924804 594 597 O
tumors NCT03924804 598 604 B-Condition-Name
, NCT03924804 605 606 O
prostatic NCT03924804 607 616 B-Condition-Name
hypertrophy NCT03924804 617 628 I-Condition-Name
. NCT03924804 629 630 O

Inclusion NCT03926975 0 9 O
Criteria NCT03926975 10 18 O
: NCT03926975 19 20 O

- NCT03926975 24 25 O
young NCT03926975 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
, NCT03926975 33 34 O
normal NCT03926975 35 41 O
individuals NCT03926975 42 53 O

Exclusion NCT03926975 54 63 O
Criteria NCT03926975 64 72 O
: NCT03926975 73 74 O

- NCT03926975 78 79 O
IOP NCT03926975 81 84 B-Observation-Name___Observation-Type-Value:measurement
> NCT03926975 85 86 B-Eq-Operator___Eq-Operator-Value:GT
20 NCT03926975 88 90 B-Eq-Value
mm NCT03926975 91 93 B-Eq-Unit
in NCT03926975 94 96 O
either NCT03926975 97 103 O
eye NCT03926975 104 107 O
, NCT03926975 108 109 O
and NCT03926975 110 113 O
h NCT03926975 114 115 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
/ NCT03926975 116 117 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
o NCT03926975 118 119 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
ocular NCT03926975 120 126 B-Condition-Name
hypertension NCT03926975 127 139 I-Condition-Name
, NCT03926975 140 141 O
glaucoma NCT03926975 142 150 B-Condition-Name
, NCT03926975 151 152 O
or NCT03926975 153 155 O
ocular NCT03926975 156 162 O
surgery NCT03926975 163 170 B-Procedure-Name
that NCT03926975 171 175 O
can NCT03926975 176 179 O
affect NCT03926975 180 186 B-Stability___Stability-Value:change
IOP NCT03926975 187 190 B-Observation-Name___Observation-Type-Value:measurement
. NCT03926975 191 192 O

- NCT03926975 196 197 O
h NCT03926975 199 200 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
/ NCT03926975 201 202 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
o NCT03926975 203 204 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
scleral NCT03926975 205 212 B-Condition-Name
lens NCT03926975 213 217 I-Condition-Name
wear NCT03926975 218 222 O
or NCT03926975 223 225 O
current NCT03926975 226 233 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
scleral NCT03926975 234 241 B-Condition-Name
lens NCT03926975 242 246 I-Condition-Name
wear NCT03926975 247 251 O

Inclusion NCT03925298 0 9 O
Criteria NCT03925298 10 18 O
: NCT03925298 19 20 O

- NCT03925298 24 25 O
Participants NCT03925298 27 39 O
were NCT03925298 40 44 O
eligible NCT03925298 45 53 O
for NCT03925298 54 57 O
inclusion NCT03925298 58 67 O
in NCT03925298 68 70 O
the NCT03925298 71 74 O
study NCT03925298 75 80 O
if NCT03925298 81 83 O
they NCT03925298 84 88 O
had NCT03925298 89 92 O
evidence NCT03925298 93 101 O
suggesting NCT03925298 102 112 O
acute NCT03925298 113 118 B-Severity___Severity-Value:severe
ischemic NCT03925298 119 127 B-Condition-Name
stroke NCT03925298 128 134 I-Condition-Name
that NCT03925298 135 139 O
lasted NCT03925298 140 146 O
for NCT03925298 147 150 O
≤ NCT03925298 151 152 B-Eq-Operator___Eq-Operator-Value:LTEQ
4.5 NCT03925298 154 157 B-Eq-Value
hours NCT03925298 158 163 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
. NCT03925298 165 166 O

- NCT03925298 170 171 O
Those NCT03925298 173 178 O
Participants NCT03925298 179 191 O
were NCT03925298 192 196 O
treated NCT03925298 197 204 O
with NCT03925298 205 209 O
intravenous NCT03925298 210 221 O
thrombolytic NCT03925298 222 234 B-Procedure-Name
therapy NCT03925298 235 242 I-Procedure-Name
( NCT03925298 243 244 O
( NCT03925298 246 247 O
recombinant NCT03925298 248 259 B-Drug-Name
tissue NCT03925298 260 266 I-Drug-Name
plasminogen NCT03925298 267 278 I-Drug-Name
activator NCT03925298 279 288 I-Drug-Name
( NCT03925298 289 290 O
rt NCT03925298 291 293 B-Drug-Name
- NCT03925298 294 295 I-Drug-Name
PA NCT03925298 296 298 I-Drug-Name
) NCT03925298 299 300 O
) NCT03925298 302 303 O
. NCT03925298 305 306 O

Exclusion NCT03925298 308 317 O
Criteria NCT03925298 318 326 O
: NCT03925298 327 328 O

- NCT03925298 332 333 O
Those NCT03925298 335 340 O
who NCT03925298 341 344 O
had NCT03925298 345 348 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
hemorrhagic NCT03925298 349 360 B-Condition-Name
stroke NCT03925298 361 367 I-Condition-Name

- NCT03925298 370 371 O
participants NCT03925298 373 385 O
presented NCT03925298 386 395 O
with NCT03925298 396 400 O
acute NCT03925298 401 406 B-Condition-Name
myocardial NCT03925298 407 417 I-Condition-Name
infarction NCT03925298 418 428 I-Condition-Name
, NCT03925298 429 430 O
cerebrovascular NCT03925298 431 446 B-Condition-Name
stroke NCT03925298 447 453 I-Condition-Name
in NCT03925298 454 456 O
the NCT03925298 457 460 O
previous NCT03925298 461 469 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03925298 470 475 B-Eq-Value
months NCT03925298 476 482 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03925298 483 484 O

- NCT03925298 488 489 O
serious NCT03925298 491 498 B-Severity___Severity-Value:severe
head NCT03925298 499 503 O
trauma NCT03925298 504 510 B-Condition-Name
in NCT03925298 511 513 O
the NCT03925298 514 517 O
previous NCT03925298 518 526 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03925298 527 532 B-Eq-Value
months NCT03925298 533 539 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
. NCT03925298 540 541 O

- NCT03925298 545 546 O
urinary NCT03925298 548 555 O
tract NCT03925298 556 561 O
, NCT03925298 562 563 O
lung NCT03925298 564 568 O
, NCT03925298 569 570 O
or NCT03925298 571 573 O
gastrointestinal NCT03925298 574 590 O
hemorrhage NCT03925298 591 601 B-Condition-Name
within NCT03925298 602 608 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03925298 609 612 O
three NCT03925298 613 618 B-Eq-Value
weeks NCT03925298 619 624 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03925298 625 626 O

- NCT03925298 630 631 O
serious NCT03925298 633 640 B-Severity___Severity-Value:severe
trauma NCT03925298 641 647 B-Condition-Name
or NCT03925298 648 650 O
major NCT03925298 651 656 O
surgery NCT03925298 657 664 B-Procedure-Name
within NCT03925298 665 671 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03925298 672 675 O
previous NCT03925298 676 684 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
two NCT03925298 685 688 B-Eq-Value
weeks NCT03925298 689 694 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03925298 695 696 O

- NCT03925298 700 701 O
lumbar NCT03925298 703 709 O
or NCT03925298 710 712 O
arterial NCT03925298 713 721 O
puncture NCT03925298 722 730 B-Condition-Name
at NCT03925298 731 733 O
a NCT03925298 734 735 O
non NCT03925298 736 739 O
- NCT03925298 740 741 O
compressible NCT03925298 742 754 O
site NCT03925298 755 759 O
within NCT03925298 760 766 B-Eq-Operator___Eq-Operator-Value:LTEQ
one NCT03925298 767 770 B-Eq-Value
week NCT03925298 771 775 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
. NCT03925298 776 777 O

- NCT03925298 781 782 O
those NCT03925298 784 789 O
received NCT03925298 790 798 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
heparin NCT03925298 799 806 B-Drug-Name
within NCT03925298 807 813 B-Eq-Operator___Eq-Operator-Value:LTEQ
48 NCT03925298 815 817 B-Eq-Value
hours NCT03925298 818 823 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
, NCT03925298 824 825 O
resulting NCT03925298 826 835 O
in NCT03925298 836 838 O
an NCT03925298 839 841 O
activated NCT03925298 842 851 B-Observation-Name___Observation-Type-Value:measurement
partial NCT03925298 852 859 I-Observation-Name___Observation-Type-Value:measurement
thromboplastin NCT03925298 860 874 I-Observation-Name___Observation-Type-Value:measurement
time NCT03925298 875 879 I-Observation-Name___Observation-Type-Value:measurement
greater NCT03925298 880 887 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03925298 888 892 I-Eq-Operator___Eq-Operator-Value:GT
the NCT03925298 893 896 O
upper NCT03925298 897 902 B-Eq-Unit___Eq-Unit-Value:ref-range-high
limit NCT03925298 903 908 I-Eq-Unit___Eq-Unit-Value:ref-range-high
of NCT03925298 909 911 I-Eq-Unit___Eq-Unit-Value:ref-range-high
normal NCT03925298 912 918 I-Eq-Unit___Eq-Unit-Value:ref-range-high
. NCT03925298 919 920 O

- NCT03925298 924 925 O
systolic NCT03925298 927 935 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03925298 936 944 I-Observation-Name___Observation-Type-Value:vital
> NCT03925298 945 946 B-Eq-Operator___Eq-Operator-Value:GT
185 NCT03925298 948 951 B-Eq-Value
mmHg NCT03925298 952 956 B-Eq-Unit
or NCT03925298 957 959 O
diastolic NCT03925298 960 969 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03925298 970 978 I-Observation-Name___Observation-Type-Value:vital
> NCT03925298 979 980 B-Eq-Operator___Eq-Operator-Value:GT
110 NCT03925298 982 985 B-Eq-Value
mmHg NCT03925298 986 990 B-Eq-Unit
. NCT03925298 991 992 O

- NCT03925298 996 997 O
blood NCT03925298 999 1004 B-Observation-Name___Observation-Type-Value:lab
glucose NCT03925298 1005 1012 I-Observation-Name___Observation-Type-Value:lab
< NCT03925298 1013 1014 B-Eq-Operator___Eq-Operator-Value:LT
50 NCT03925298 1016 1018 B-Eq-Value
or NCT03925298 1019 1021 O
> NCT03925298 1022 1023 B-Eq-Operator___Eq-Operator-Value:GT
400 NCT03925298 1025 1028 B-Eq-Value
mg NCT03925298 1029 1031 B-Eq-Unit
/ NCT03925298 1032 1033 O
dL NCT03925298 1034 1036 B-Eq-Unit
. NCT03925298 1037 1038 O

- NCT03925298 1042 1043 O
current NCT03925298 1045 1052 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
use NCT03925298 1053 1056 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
of NCT03925298 1057 1059 O
anticoagulants NCT03925298 1060 1074 B-Drug-Name
with NCT03925298 1075 1079 O
an NCT03925298 1080 1082 O
International NCT03925298 1083 1096 B-Observation-Name___Observation-Type-Value:measurement
Normalized NCT03925298 1097 1107 I-Observation-Name___Observation-Type-Value:measurement
Ratio NCT03925298 1108 1113 I-Observation-Name___Observation-Type-Value:measurement
> NCT03925298 1114 1115 B-Eq-Operator___Eq-Operator-Value:GT
1.7 NCT03925298 1117 1120 B-Eq-Value
or NCT03925298 1121 1123 O
prothrombin NCT03925298 1124 1135 B-Observation-Name___Observation-Type-Value:lab
time NCT03925298 1136 1140 I-Observation-Name___Observation-Type-Value:lab
> NCT03925298 1141 1142 B-Eq-Operator___Eq-Operator-Value:GT
15 NCT03925298 1144 1146 B-Eq-Value
sec NCT03925298 1147 1150 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:second
; NCT03925298 1150 1151 O
platelet NCT03925298 1152 1160 B-Observation-Name___Observation-Type-Value:lab
count NCT03925298 1161 1166 I-Observation-Name___Observation-Type-Value:lab
< NCT03925298 1167 1168 B-Eq-Operator___Eq-Operator-Value:LT
100 NCT03925298 1170 1173 B-Eq-Value
, NCT03925298 1174 1175 I-Eq-Value
000 NCT03925298 1176 1179 I-Eq-Value
/ NCT03925298 1180 1181 O
mm NCT03925298 1182 1184 B-Eq-Unit
3 NCT03925298 1185 1186 I-Eq-Unit
. NCT03925298 1186 1187 O

- NCT03925298 1191 1192 O
pregnancy NCT03925298 1194 1203 B-Condition-Name
; NCT03925298 1203 1204 O
serious NCT03925298 1205 1212 B-Severity___Severity-Value:severe
heart NCT03925298 1213 1218 O
, NCT03925298 1219 1220 O
lung NCT03925298 1221 1225 O
, NCT03925298 1226 1227 O
kidney NCT03925298 1228 1234 O
or NCT03925298 1235 1237 O
other NCT03925298 1238 1243 O
organ NCT03925298 1244 1249 O
dysfunction NCT03925298 1250 1261 B-Condition-Name
. NCT03925298 1262 1263 O

- NCT03925298 1267 1268 O
allergy NCT03925298 1270 1277 O
to NCT03925298 1278 1280 O
active NCT03925298 1281 1287 O
ingredients NCT03925298 1288 1299 O
of NCT03925298 1300 1302 O
rt NCT03925298 1303 1305 B-Drug-Name
- NCT03925298 1306 1307 I-Drug-Name
PA NCT03925298 1308 1310 I-Drug-Name
; NCT03925298 1310 1311 O
patients NCT03925298 1312 1320 O
with NCT03925298 1321 1325 O
> NCT03925298 1326 1327 B-Eq-Operator___Eq-Operator-Value:GT
4.5 NCT03925298 1329 1332 B-Eq-Value
hours NCT03925298 1333 1338 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
from NCT03925298 1339 1343 O
the NCT03925298 1344 1347 O
last NCT03925298 1348 1352 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
time NCT03925298 1353 1357 I-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:most-recent-time
known NCT03925298 1358 1363 O
to NCT03925298 1364 1366 O
be NCT03925298 1367 1369 O
asymptomatic NCT03925298 1370 1382 B-Condition-Name
. NCT03925298 1383 1384 O

- NCT03925298 1388 1389 O
those NCT03925298 1391 1396 O
in NCT03925298 1397 1399 O
whom NCT03925298 1400 1404 O
troponin NCT03925298 1405 1413 B-Observation-Name___Observation-Type-Value:lab
was NCT03925298 1414 1417 O
not NCT03925298 1418 1421 O
measured NCT03925298 1422 1430 O
at NCT03925298 1431 1433 O
admission NCT03925298 1434 1443 B-Encounter-Type___Encounter-Type-Value:inpatient
were NCT03925298 1444 1448 O
excluded NCT03925298 1449 1457 O
from NCT03925298 1458 1462 O
the NCT03925298 1463 1466 O
study NCT03925298 1467 1472 O

Inclusion NCT03928964 0 9 O
criteria NCT03928964 10 18 O
: NCT03928964 19 20 O

1 NCT03928964 25 26 O
. NCT03928964 26 27 O
Patients NCT03928964 29 37 O
with NCT03928964 38 42 O
locally NCT03928964 43 50 O
advanced NCT03928964 51 59 O
or NCT03928964 60 62 O
metastatic NCT03928964 63 73 O
renal NCT03928964 74 79 O
cell NCT03928964 80 84 O
carcinoma NCT03928964 85 94 B-Condition-Name

2 NCT03928964 98 99 O
. NCT03928964 99 100 O
Whose NCT03928964 102 107 O
first NCT03928964 108 113 B-Procedure-Name
- NCT03928964 114 115 I-Procedure-Name
line NCT03928964 116 120 I-Procedure-Name
treatment NCT03928964 121 130 I-Procedure-Name
included NCT03928964 131 139 O
at NCT03928964 140 142 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03928964 143 148 I-Eq-Operator___Eq-Operator-Value:GTEQ
one NCT03928964 149 152 B-Eq-Value
anti NCT03928964 153 157 B-Drug-Name
- NCT03928964 158 159 I-Drug-Name
angiogenic NCT03928964 160 170 I-Drug-Name
agent NCT03928964 171 176 I-Drug-Name
( NCT03928964 177 178 O
tyrosine NCT03928964 179 187 B-Drug-Name
kinase NCT03928964 188 194 I-Drug-Name
inhibitor NCT03928964 195 204 I-Drug-Name
or NCT03928964 205 207 O
monoclonal NCT03928964 208 218 B-Drug-Name
antibodies NCT03928964 219 229 I-Drug-Name
) NCT03928964 230 231 O
and NCT03928964 232 235 O
/ NCT03928964 236 237 O
or NCT03928964 238 240 O
an NCT03928964 241 243 O
mTOR NCT03928964 244 248 B-Drug-Name
inhibitor NCT03928964 249 258 I-Drug-Name
; NCT03928964 258 259 O

3 NCT03928964 263 264 O
. NCT03928964 264 265 O
Whatever NCT03928964 267 275 O
was NCT03928964 276 279 O
the NCT03928964 280 283 O
overall NCT03928964 284 291 O
ECOG NCT03928964 292 296 B-Observation-Name
- NCT03928964 297 298 I-Observation-Name
PS NCT03928964 299 301 I-Observation-Name
score NCT03928964 302 307 O
( NCT03928964 308 309 O
Eastern NCT03928964 310 317 B-Observation-Name___Observation-Type-Value:clinical-score
Cooperative NCT03928964 318 329 I-Observation-Name___Observation-Type-Value:clinical-score
Oncology NCT03928964 330 338 I-Observation-Name___Observation-Type-Value:clinical-score
Group NCT03928964 339 344 I-Observation-Name___Observation-Type-Value:clinical-score
Performance NCT03928964 345 356 I-Observation-Name___Observation-Type-Value:clinical-score
Status NCT03928964 357 363 I-Observation-Name___Observation-Type-Value:clinical-score
) NCT03928964 364 365 O
at NCT03928964 366 368 O
treatment NCT03928964 369 378 O
initiation NCT03928964 379 389 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
time NCT03928964 390 394 O

4 NCT03928964 398 399 O
. NCT03928964 399 400 O
With NCT03928964 402 406 O
first NCT03928964 407 412 B-Procedure-Name
- NCT03928964 413 414 I-Procedure-Name
line NCT03928964 415 419 I-Procedure-Name
treatment NCT03928964 420 429 I-Procedure-Name
carried NCT03928964 430 437 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
out NCT03928964 438 441 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
between NCT03928964 442 449 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2007 NCT03928964 451 455 B-Eq-Value
and NCT03928964 456 459 O
June NCT03928964 460 464 B-Eq-Value
2016 NCT03928964 466 470 I-Eq-Value
. NCT03928964 470 471 O

Exclusion NCT03928964 473 482 O
criteria NCT03928964 483 491 O
: NCT03928964 492 493 O

1 NCT03928964 498 499 O
. NCT03928964 499 500 O
Patient NCT03928964 502 509 O
previously NCT03928964 510 520 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
treated NCT03928964 521 528 O
with NCT03928964 529 533 O
only NCT03928964 534 538 O
one NCT03928964 539 542 B-Eq-Value
cytokine NCT03928964 543 551 B-Drug-Name
( NCT03928964 552 553 O
Interferon NCT03928964 554 564 B-Drug-Name
α NCT03928964 565 566 I-Drug-Name
2 NCT03928964 567 568 I-Drug-Name
a NCT03928964 569 570 I-Drug-Name
, NCT03928964 571 572 O
high NCT03928964 573 577 B-Polarity___Polarity-Value:high
- NCT03928964 578 579 O
dose NCT03928964 580 584 O
interleukin NCT03928964 585 596 B-Drug-Name
- NCT03928964 597 598 I-Drug-Name
2 NCT03928964 600 601 I-Drug-Name
) NCT03928964 602 603 O

2 NCT03928964 608 609 O
. NCT03928964 609 610 O
Refusal NCT03928964 612 619 O
of NCT03928964 620 622 O
processing NCT03928964 623 633 O
of NCT03928964 634 636 O
personal NCT03928964 637 645 O
data NCT03928964 646 650 O

Inclusion NCT03926949 0 9 O
Criteria NCT03926949 10 18 O
: NCT03926949 19 20 O

1 NCT03926949 25 26 O
. NCT03926949 26 27 O
Patients NCT03926949 29 37 O
18 NCT03926949 39 41 B-Eq-Value
years NCT03926949 42 47 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03926949 48 50 O
age NCT03926949 51 54 O
or NCT03926949 55 57 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03926949 58 63 I-Eq-Operator___Eq-Operator-Value:GTEQ

2 NCT03926949 67 68 O
. NCT03926949 68 69 O
Patients NCT03926949 71 79 O
screened NCT03926949 80 88 O
at NCT03926949 89 91 O
risk NCT03926949 92 96 O
of NCT03926949 97 99 O
malnutrition NCT03926949 100 112 B-Condition-Name
by NCT03926949 113 115 O
Canadian NCT03926949 116 124 B-Observation-Name
Nutrition NCT03926949 125 134 I-Observation-Name
Screening NCT03926949 135 144 I-Observation-Name
Tool NCT03926949 145 149 I-Observation-Name
( NCT03926949 150 151 O
CNST NCT03926949 152 156 B-Observation-Name
) NCT03926949 157 158 O
and NCT03926949 159 162 O
identified NCT03926949 163 173 O
as NCT03926949 174 176 O
malnourished NCT03926949 177 189 B-Condition-Name
by NCT03926949 190 192 O
subjective NCT03926949 193 203 B-Procedure-Name
global NCT03926949 204 210 I-Procedure-Name
assessment NCT03926949 211 221 I-Procedure-Name
( NCT03926949 222 223 O
SGA NCT03926949 224 227 B-Procedure-Name
) NCT03926949 228 229 O
B NCT03926949 230 231 O
or NCT03926949 232 234 O
C NCT03926949 235 236 O

Exclusion NCT03926949 237 246 O
Criteria NCT03926949 247 255 O
: NCT03926949 256 257 O

1 NCT03926949 262 263 O
. NCT03926949 263 264 O
Patients NCT03926949 266 274 O
undergoing NCT03926949 275 285 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
minor NCT03926949 286 291 O
or NCT03926949 292 294 O
laparoscopic NCT03926949 295 307 O
surgery NCT03926949 308 315 B-Procedure-Name

2 NCT03926949 319 320 O
. NCT03926949 320 321 O
Pregnancy NCT03926949 323 332 B-Condition-Name

3 NCT03926949 336 337 O
. NCT03926949 337 338 O
Patients NCT03926949 340 348 O
with NCT03926949 349 353 O
severe NCT03926949 354 360 B-Severity___Severity-Value:severe
systemic NCT03926949 361 369 O
diseases NCT03926949 370 378 B-Condition-Name
defined NCT03926949 379 386 O
by NCT03926949 387 389 O
American NCT03926949 390 398 B-Condition-Name
Society NCT03926949 399 406 I-Condition-Name
of NCT03926949 407 409 I-Condition-Name
Anesthesiologists NCT03926949 410 427 I-Condition-Name
( NCT03926949 428 429 O
ASA NCT03926949 430 433 B-Condition-Name
) NCT03926949 434 435 O
classification NCT03926949 436 450 B-Eq-Unit
III NCT03926949 451 454 B-Eq-Value
to NCT03926949 455 457 B-Eq-Operator___Eq-Operator-Value:BETWEEN
V NCT03926949 458 459 B-Eq-Value

4 NCT03926949 463 464 O
. NCT03926949 464 465 O
Patients NCT03926949 467 475 O
with NCT03926949 476 480 O
diabetes NCT03926949 481 489 B-Condition-Name
mellitus NCT03926949 490 498 I-Condition-Name

5 NCT03926949 502 503 O
. NCT03926949 503 504 O
Patients NCT03926949 506 514 O
with NCT03926949 515 519 O
planned NCT03926949 520 527 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
palliative NCT03926949 528 538 B-Procedure-Name
treatment NCT03926949 539 548 I-Procedure-Name

Inclusion NCT03921983 0 9 O
Criteria NCT03921983 10 18 O
: NCT03921983 19 20 O

- NCT03921983 24 25 O
COPD NCT03921983 27 31 B-Condition-Name
diagnostic NCT03921983 32 42 O

- NCT03921983 45 46 O
Both NCT03921983 48 52 O
sex NCT03921983 53 56 O

- NCT03921983 59 60 O
18 NCT03921983 63 65 B-Eq-Value
< NCT03921983 66 67 B-Eq-Operator___Eq-Operator-Value:LT
Age NCT03921983 68 71 O
< NCT03921983 72 73 B-Eq-Operator___Eq-Operator-Value:LT
80 NCT03921983 75 77 B-Eq-Value
years NCT03921983 78 83 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03921983 84 87 O

- NCT03921983 90 91 O
LTOT NCT03921983 93 97 B-Condition-Name
- NCT03921983 98 99 B-Polarity___Polarity-Value:negative
group NCT03921983 100 105 O
: NCT03921983 106 107 O
PaO NCT03921983 108 111 B-Observation-Name___Observation-Type-Value:vital
2 NCT03921983 112 113 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03921983 114 115 B-Eq-Operator___Eq-Operator-Value:GTEQ
65 NCT03921983 117 119 B-Eq-Value
mmHg NCT03921983 120 124 B-Eq-Unit
and NCT03921983 125 128 O
SaO NCT03921983 129 132 B-Observation-Name___Observation-Type-Value:vital
2 NCT03921983 133 134 I-Observation-Name___Observation-Type-Value:vital
≥ NCT03921983 135 136 B-Eq-Operator___Eq-Operator-Value:GTEQ
92 NCT03921983 138 140 B-Eq-Value
% NCT03921983 141 142 B-Eq-Unit

- NCT03921983 146 147 O
LTOT NCT03921983 149 153 B-Condition-Name
+ NCT03921983 154 155 B-Polarity___Polarity-Value:positive
group NCT03921983 156 161 O
: NCT03921983 162 163 O
long NCT03921983 164 168 O
term NCT03921983 169 173 O
oxygenotherapy NCT03921983 174 188 B-Procedure-Name
prescribed NCT03921983 189 199 O
for NCT03921983 200 203 O
more NCT03921983 204 208 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03921983 209 213 I-Eq-Operator___Eq-Operator-Value:GT
3 NCT03921983 215 216 B-Eq-Value
months NCT03921983 217 223 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
, NCT03921983 224 225 O
with NCT03921983 226 230 O
daily NCT03921983 231 236 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
use NCT03921983 237 240 O
between NCT03921983 241 248 B-Eq-Operator___Eq-Operator-Value:BETWEEN
12 NCT03921983 250 252 B-Eq-Value
and NCT03921983 253 256 O
15 NCT03921983 258 260 B-Eq-Value
hours NCT03921983 261 266 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
. NCT03921983 267 268 O

Patients NCT03921983 270 278 O
in NCT03921983 279 281 O
both NCT03921983 282 286 O
groups NCT03921983 287 293 O
will NCT03921983 294 298 O
be NCT03921983 299 301 O
matched NCT03921983 302 309 O
for NCT03921983 310 313 O
age NCT03921983 314 317 O
( NCT03921983 318 319 O
± NCT03921983 321 322 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
5 NCT03921983 324 325 B-Eq-Value
years NCT03921983 326 331 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03921983 332 333 O
, NCT03921983 335 336 O
sex NCT03921983 337 340 B-Life-Stage-And-Gender
and NCT03921983 341 344 O
physical NCT03921983 345 353 B-Observation-Name___Observation-Type-Value:social-habit
activity NCT03921983 354 362 I-Observation-Name___Observation-Type-Value:social-habit

estimated NCT03921983 363 372 O
by NCT03921983 373 375 O
GPAQ NCT03921983 376 380 B-Observation-Name___Observation-Type-Value:survey-or-questionnaire
questionnaire NCT03921983 381 394 I-Observation-Name___Observation-Type-Value:survey-or-questionnaire
( NCT03921983 395 396 O
± NCT03921983 398 399 B-Eq-Operator___Eq-Operator-Value:PLUS-MINUS
15 NCT03921983 401 403 B-Eq-Value
% NCT03921983 404 405 B-Eq-Unit
Mets NCT03921983 406 410 O
. NCT03921983 411 412 O
min NCT03921983 413 416 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
/ NCT03921983 417 418 O
week NCT03921983 419 423 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03921983 424 425 O
. NCT03921983 427 428 O

Exclusion NCT03921983 430 439 O
Criteria NCT03921983 440 448 O
: NCT03921983 449 450 O

- NCT03921983 454 455 O
Recent NCT03921983 457 463 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:recent
cardiorespiratory NCT03921983 464 481 B-Condition-Name
exacerbation NCT03921983 482 494 I-Condition-Name
( NCT03921983 495 496 O
< NCT03921983 498 499 B-Eq-Operator___Eq-Operator-Value:LT
6 NCT03921983 501 502 B-Eq-Value
weeks NCT03921983 503 508 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
) NCT03921983 509 510 O
. NCT03921983 512 513 O

- NCT03921983 517 518 O
Pulmonary NCT03921983 520 529 B-Procedure-Name
rehabilitation NCT03921983 530 544 I-Procedure-Name
program NCT03921983 545 552 O
during NCT03921983 553 559 O
the NCT03921983 560 563 O
last NCT03921983 564 568 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
2 NCT03921983 570 571 B-Eq-Value
months NCT03921983 572 578 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03921983 581 582 O
Continuous NCT03921983 584 594 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
LTOT NCT03921983 595 599 B-Procedure-Name
( NCT03921983 600 601 O
24 NCT03921983 603 605 B-Eq-Value
hours NCT03921983 606 611 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:hour
) NCT03921983 612 613 O
or NCT03921983 614 616 O
deambulation NCT03921983 617 629 O
O NCT03921983 630 631 B-Procedure-Name
2 NCT03921983 632 633 I-Procedure-Name
therapy NCT03921983 634 641 I-Procedure-Name
alone NCT03921983 642 647 O

- NCT03921983 650 651 O
Anticoagulant NCT03921983 653 666 O
drugs NCT03921983 667 672 O

- NCT03921983 675 676 O
Hematocrit NCT03921983 678 688 B-Observation-Name___Observation-Type-Value:lab
outside NCT03921983 689 696 B-Polarity___Polarity-Value:abnormal
the NCT03921983 697 700 I-Polarity___Polarity-Value:abnormal
normal NCT03921983 701 707 I-Polarity___Polarity-Value:abnormal
range NCT03921983 708 713 I-Polarity___Polarity-Value:abnormal
( NCT03921983 714 715 O
35 NCT03921983 717 719 B-Eq-Value
- NCT03921983 720 721 B-Eq-Operator___Eq-Operator-Value:BETWEEN
50 NCT03921983 723 725 B-Eq-Value
% NCT03921983 726 727 B-Eq-Unit
) NCT03921983 729 730 O

Inclusion NCT03922087 0 9 O
Criteria NCT03922087 10 18 O
: NCT03922087 19 20 O

- NCT03922087 24 25 O
Pregnant NCT03922087 27 35 B-Condition-Name
women NCT03922087 36 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03922087 42 45 O
have NCT03922087 46 50 O
plan NCT03922087 51 55 O
to NCT03922087 56 58 O
delivery NCT03922087 59 67 B-Condition-Name
and NCT03922087 68 71 O
participate NCT03922087 72 83 O
in NCT03922087 84 86 O
child NCT03922087 87 92 O
care NCT03922087 93 97 O
in NCT03922087 98 100 O
Huizhou NCT03922087 101 108 B-Location___Location-Value:hospital
hospital NCT03922087 109 117 I-Location___Location-Value:hospital
; NCT03922087 117 118 O

- NCT03922087 121 122 O
Pregnant NCT03922087 124 132 B-Condition-Name
women NCT03922087 133 138 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03922087 139 142 O
have NCT03922087 143 147 O
resided NCT03922087 148 155 B-Observation-Name
in NCT03922087 156 158 O
Huizhou NCT03922087 159 166 B-Location___Location-Value:residence
for NCT03922087 167 170 O
at NCT03922087 171 173 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03922087 174 179 I-Eq-Operator___Eq-Operator-Value:GTEQ
3 NCT03922087 181 182 B-Eq-Value
years NCT03922087 183 188 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
; NCT03922087 188 189 O

- NCT03922087 192 193 O
Pregnant NCT03922087 195 203 B-Condition-Name
women NCT03922087 204 209 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03922087 210 213 O
are NCT03922087 214 217 O
consent NCT03922087 218 225 O
for NCT03922087 226 229 O
specimens NCT03922087 230 239 O
and NCT03922087 240 243 O
data NCT03922087 244 248 O
collection NCT03922087 249 259 O
and NCT03922087 260 263 O
follow NCT03922087 264 270 O
- NCT03922087 271 272 O
ups NCT03922087 273 276 O
for NCT03922087 277 280 O
both NCT03922087 281 285 O
mother NCT03922087 286 292 O
and NCT03922087 293 296 O
infant NCT03922087 297 303 O
. NCT03922087 304 305 O

Exclusion NCT03922087 307 316 O
Criteria NCT03922087 317 325 O
: NCT03922087 326 327 O

- NCT03922087 331 332 O
Pregnant NCT03922087 334 342 B-Condition-Name
women NCT03922087 343 348 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03922087 349 352 O
are NCT03922087 353 356 O
with NCT03922087 357 361 O
gestational NCT03922087 362 373 B-Observation-Name___Observation-Type-Value:measurement
age NCT03922087 374 377 I-Observation-Name___Observation-Type-Value:measurement
more NCT03922087 378 382 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03922087 383 387 I-Eq-Operator___Eq-Operator-Value:GT
24 NCT03922087 389 391 B-Eq-Value
weeks NCT03922087 392 397 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
; NCT03922087 398 399 O

- NCT03922087 402 403 O
Pregnant NCT03922087 405 413 B-Condition-Name
women NCT03922087 414 419 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03922087 420 423 O
refuse NCT03922087 424 430 O
to NCT03922087 431 433 O
participate NCT03922087 434 445 O
or NCT03922087 446 448 O
be NCT03922087 449 451 O
unwilling NCT03922087 452 461 O
to NCT03922087 462 464 O
sign NCT03922087 465 469 O
informed NCT03922087 470 478 O
consent NCT03922087 479 486 O
; NCT03922087 486 487 O

- NCT03922087 490 491 O
Pregnant NCT03922087 493 501 B-Condition-Name
women NCT03922087 502 507 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03922087 508 511 O
are NCT03922087 512 515 O
mentally NCT03922087 516 524 B-Condition-Name
incapacitated NCT03922087 525 538 I-Condition-Name
and NCT03922087 539 542 O
need NCT03922087 543 547 O
guardians NCT03922087 548 557 O
. NCT03922087 558 559 O

Inclusion NCT03923400 0 9 O
Criteria NCT03923400 10 18 O
: NCT03923400 19 20 O

- NCT03923400 24 25 O
Any NCT03923400 27 30 O
kind NCT03923400 31 35 O
of NCT03923400 36 38 O
primary NCT03923400 39 46 O
mesenchymal NCT03923400 47 58 B-Condition-Name
tumor NCT03923400 59 64 I-Condition-Name
of NCT03923400 65 67 O
the NCT03923400 68 71 O
gastrointestinal NCT03923400 72 88 O
tract NCT03923400 89 94 O
with NCT03923400 95 99 O
a NCT03923400 100 101 O
histomorphological NCT03923400 102 120 O
and NCT03923400 121 124 O
immunohistochemical NCT03923400 125 144 O
( NCT03923400 145 146 O
CD NCT03923400 147 149 B-Condition-Name
117 NCT03923400 150 153 I-Condition-Name
( NCT03923400 154 155 B-Polarity___Polarity-Value:positive
+ NCT03923400 157 158 I-Polarity___Polarity-Value:positive
) NCT03923400 160 161 I-Polarity___Polarity-Value:positive
and NCT03923400 162 165 O
/ NCT03923400 166 167 O
or NCT03923400 168 170 O
DOG NCT03923400 171 174 B-Condition-Name
1 NCT03923400 175 176 I-Condition-Name
( NCT03923400 177 178 B-Polarity___Polarity-Value:positive
+ NCT03923400 180 181 I-Polarity___Polarity-Value:positive
) NCT03923400 183 184 I-Polarity___Polarity-Value:positive
) NCT03923400 186 187 O
profile NCT03923400 188 195 B-Condition-Name
consistent NCT03923400 196 206 O
with NCT03923400 207 211 O
GIST NCT03923400 212 216 B-Condition-Name
. NCT03923400 217 218 O

Exclusion NCT03923400 220 229 O
Criteria NCT03923400 230 238 O
: NCT03923400 239 240 O

- NCT03923400 243 244 O

Inclusion NCT03921203 0 9 O
Criteria NCT03921203 10 18 O
: NCT03921203 19 20 O

- NCT03921203 24 25 O
Over NCT03921203 27 31 B-Eq-Operator___Eq-Operator-Value:GT
18 NCT03921203 33 35 B-Eq-Value
years NCT03921203 36 41 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03921203 42 43 O

- NCT03921203 47 48 O
For NCT03921203 50 53 O
the NCT03921203 54 57 O
T NCT03921203 58 59 B-Condition-Name
2D NCT03921203 60 62 I-Condition-Name
study NCT03921203 63 68 O
group NCT03921203 69 74 O
: NCT03921203 75 76 O
Diagnosed NCT03921203 77 86 O
with NCT03921203 87 91 O
type NCT03921203 92 96 B-Condition-Name
2 NCT03921203 98 99 I-Condition-Name
diabetes NCT03921203 100 108 I-Condition-Name
. NCT03921203 109 110 O

Exclusion NCT03921203 112 121 O
Criteria NCT03921203 122 130 O
: NCT03921203 131 132 O

For NCT03921203 134 137 O
subjects NCT03921203 138 146 O
with NCT03921203 147 151 O
type NCT03921203 152 156 B-Condition-Name
2 NCT03921203 158 159 I-Condition-Name
diabetes NCT03921203 160 168 I-Condition-Name
: NCT03921203 169 170 O

- NCT03921203 174 175 O
Systemic NCT03921203 177 185 O
inflammatory NCT03921203 186 198 B-Condition-Name
disease NCT03921203 199 206 I-Condition-Name
that NCT03921203 207 211 O
requires NCT03921203 212 220 O
active NCT03921203 221 227 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03921203 228 237 O

- NCT03921203 240 241 O
Thyroid NCT03921203 243 250 B-Condition-Name
disease NCT03921203 251 258 I-Condition-Name
that NCT03921203 259 263 O
requires NCT03921203 264 272 O
active NCT03921203 273 279 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03921203 280 289 O

- NCT03921203 292 293 O
Skin NCT03921203 295 299 B-Condition-Name
disease NCT03921203 300 307 I-Condition-Name
that NCT03921203 308 312 O
requires NCT03921203 313 321 O
active NCT03921203 322 328 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03921203 329 338 O
and NCT03921203 339 342 O
causes NCT03921203 343 349 O
significant NCT03921203 350 361 B-Severity___Severity-Value:severe
changes NCT03921203 362 369 B-Condition-Name
in NCT03921203 370 372 I-Condition-Name
the NCT03921203 373 376 I-Condition-Name
area NCT03921203 377 381 I-Condition-Name
of NCT03921203 382 384 I-Condition-Name
the NCT03921203 385 388 I-Condition-Name
skin NCT03921203 389 393 I-Condition-Name
that NCT03921203 394 398 O
is NCT03921203 399 401 O
to NCT03921203 402 404 O
be NCT03921203 405 407 O
investigated NCT03921203 408 420 O

- NCT03921203 423 424 O
Treatment NCT03921203 426 435 O
with NCT03921203 436 440 O
oral NCT03921203 441 445 B-Drug-Name
glucocorticoids NCT03921203 446 461 I-Drug-Name

- NCT03921203 464 465 O
Levels NCT03921203 467 473 O
of NCT03921203 474 476 O
SR NCT03921203 477 479 B-Observation-Name___Observation-Type-Value:lab
, NCT03921203 480 481 O
TSH NCT03921203 482 485 B-Observation-Name___Observation-Type-Value:lab
, NCT03921203 486 487 O
T NCT03921203 488 489 B-Observation-Name___Observation-Type-Value:lab
4 NCT03921203 490 491 I-Observation-Name___Observation-Type-Value:lab
or NCT03921203 492 494 O
Hemoglobin NCT03921203 495 505 B-Observation-Name___Observation-Type-Value:lab
in NCT03921203 506 508 O
the NCT03921203 509 512 O
blood NCT03921203 513 518 O
pronouncedly NCT03921203 519 531 B-Severity___Severity-Value:severe
outside NCT03921203 532 539 B-Polarity___Polarity-Value:abnormal
the NCT03921203 540 543 I-Polarity___Polarity-Value:abnormal
reference NCT03921203 544 553 I-Polarity___Polarity-Value:abnormal
range NCT03921203 554 559 I-Polarity___Polarity-Value:abnormal

- NCT03921203 562 563 O
Pregnancy NCT03921203 565 574 B-Condition-Name

For NCT03921203 575 578 O
healthy NCT03921203 579 586 O
controls NCT03921203 587 595 O
: NCT03921203 596 597 O

- NCT03921203 601 602 O
Registered NCT03921203 604 614 O
disease NCT03921203 615 622 B-Condition-Name
in NCT03921203 623 625 O
the NCT03921203 626 629 O
health NCT03921203 630 636 O
declaration NCT03921203 637 648 O
that NCT03921203 649 653 O
requires NCT03921203 654 662 O
continuous NCT03921203 663 673 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
systemic NCT03921203 674 682 O
treatment NCT03921203 683 692 O
. NCT03921203 693 694 O
Exception NCT03921203 696 705 O
to NCT03921203 706 708 O
the NCT03921203 709 712 O
above NCT03921203 713 718 O
: NCT03921203 719 720 O
well NCT03921203 721 725 O
controlled NCT03921203 726 736 O
hypertension NCT03921203 737 749 B-Condition-Name
in NCT03921203 750 752 O
which NCT03921203 753 758 O
case NCT03921203 759 763 O
the NCT03921203 764 767 O
subject NCT03921203 768 775 O
should NCT03921203 776 782 O
not NCT03921203 783 786 O
have NCT03921203 787 791 O
treatment NCT03921203 792 801 O
with NCT03921203 802 806 O
more NCT03921203 807 811 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03921203 812 816 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03921203 817 820 B-Eq-Value
antihypertensive NCT03921203 821 837 B-Drug-Name
drug NCT03921203 838 842 I-Drug-Name
, NCT03921203 843 844 O
the NCT03921203 845 848 O
drug NCT03921203 849 853 O
must NCT03921203 854 858 O
not NCT03921203 859 862 O
be NCT03921203 863 865 O
an NCT03921203 866 868 O
alpha NCT03921203 869 874 B-Drug-Name
- NCT03921203 875 876 I-Drug-Name
blocker NCT03921203 877 884 I-Drug-Name
or NCT03921203 885 887 O
beta NCT03921203 888 892 B-Drug-Name
- NCT03921203 893 894 I-Drug-Name
blocker NCT03921203 895 902 I-Drug-Name
or NCT03921203 903 905 O
thiazide NCT03921203 906 914 B-Drug-Name
diuretic NCT03921203 915 923 I-Drug-Name

- NCT03921203 926 927 O
Skin NCT03921203 929 933 B-Condition-Name
disease NCT03921203 934 941 I-Condition-Name
that NCT03921203 942 946 O
requires NCT03921203 947 955 O
active NCT03921203 956 962 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
treatment NCT03921203 963 972 O
and NCT03921203 973 976 O
causes NCT03921203 977 983 O
significant NCT03921203 984 995 B-Severity___Severity-Value:severe
changes NCT03921203 996 1003 B-Condition-Name
in NCT03921203 1004 1006 I-Condition-Name
the NCT03921203 1007 1010 I-Condition-Name
area NCT03921203 1011 1015 I-Condition-Name
of NCT03921203 1016 1018 I-Condition-Name
the NCT03921203 1019 1022 I-Condition-Name
skin NCT03921203 1023 1027 I-Condition-Name
that NCT03921203 1028 1032 O
is NCT03921203 1033 1035 O
to NCT03921203 1036 1038 O
be NCT03921203 1039 1041 O
investigated NCT03921203 1042 1054 O

- NCT03921203 1057 1058 O
Blood NCT03921203 1060 1065 B-Observation-Name___Observation-Type-Value:vital
pressure NCT03921203 1066 1074 I-Observation-Name___Observation-Type-Value:vital
pronouncedly NCT03921203 1075 1087 B-Severity___Severity-Value:severe
above NCT03921203 1088 1093 B-Eq-Operator___Eq-Operator-Value:GT
140 NCT03921203 1095 1098 B-Eq-Value
/ NCT03921203 1099 1100 O
90 NCT03921203 1102 1104 B-Eq-Unit

- NCT03921203 1108 1109 O
Blood NCT03921203 1111 1116 B-Observation-Name___Observation-Type-Value:lab
test NCT03921203 1117 1121 I-Observation-Name___Observation-Type-Value:lab
results NCT03921203 1122 1129 O
pronouncedly NCT03921203 1130 1142 B-Severity___Severity-Value:severe
outside NCT03921203 1143 1150 B-Polarity___Polarity-Value:abnormal
the NCT03921203 1151 1154 I-Polarity___Polarity-Value:abnormal
reference NCT03921203 1155 1164 I-Polarity___Polarity-Value:abnormal
range NCT03921203 1165 1170 I-Polarity___Polarity-Value:abnormal

- NCT03921203 1173 1174 O
Pregnancy NCT03921203 1176 1185 B-Condition-Name

Inclusion NCT03929887 0 9 O
Criteria NCT03929887 10 18 O
: NCT03929887 19 20 O

- NCT03929887 24 25 O
Diagnosis NCT03929887 27 36 O
of NCT03929887 37 39 O
glomerulonephritis NCT03929887 40 58 B-Condition-Name
( NCT03929887 59 60 O
MCD NCT03929887 61 64 B-Condition-Name
, NCT03929887 65 66 O
FSGS NCT03929887 67 71 B-Condition-Name
, NCT03929887 72 73 O
MN NCT03929887 74 76 B-Condition-Name
, NCT03929887 77 78 O
IgAN NCT03929887 79 83 B-Condition-Name
, NCT03929887 84 85 O
RPGN NCT03929887 86 90 B-Condition-Name
, NCT03929887 91 92 O
lupus NCT03929887 93 98 B-Condition-Name
nephritis NCT03929887 99 108 I-Condition-Name
and NCT03929887 109 112 O
etc NCT03929887 113 116 O
. NCT03929887 117 118 O
) NCT03929887 119 120 O
on NCT03929887 121 123 O
first NCT03929887 124 129 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnostic NCT03929887 130 140 O
kidney NCT03929887 141 147 O
biopsy NCT03929887 148 154 B-Procedure-Name
, NCT03929887 155 156 O
as NCT03929887 157 159 O
per NCT03929887 160 163 O
specified NCT03929887 164 173 O
pathology NCT03929887 174 183 O
definitions NCT03929887 184 195 O

- NCT03929887 198 199 O
First NCT03929887 201 206 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
diagnostic NCT03929887 207 217 O
kidney NCT03929887 218 224 O
biopsy NCT03929887 225 231 B-Procedure-Name
since NCT03929887 232 237 B-Eq-Operator___Eq-Operator-Value:GTEQ
2010 NCT03929887 239 243 B-Eq-Value

- NCT03929887 247 248 O
Willingness NCT03929887 250 261 O
to NCT03929887 262 264 O
comply NCT03929887 265 271 O
with NCT03929887 272 276 O
study NCT03929887 277 282 O
requirements NCT03929887 283 295 O
, NCT03929887 296 297 O
including NCT03929887 298 307 O
intention NCT03929887 308 317 O
to NCT03929887 318 320 O
fully NCT03929887 321 326 O
participate NCT03929887 327 338 O
in NCT03929887 339 341 O
protocol NCT03929887 342 350 O
- NCT03929887 351 352 O
specified NCT03929887 353 362 O
follow NCT03929887 363 369 O
- NCT03929887 370 371 O
up NCT03929887 372 374 O
at NCT03929887 375 377 O
a NCT03929887 378 379 O
clinical NCT03929887 380 388 O
study NCT03929887 389 394 O
site NCT03929887 395 399 O

- NCT03929887 402 403 O
Informed NCT03929887 405 413 O
consent NCT03929887 414 421 O
and NCT03929887 422 425 O
, NCT03929887 426 427 O
where NCT03929887 428 433 O
age NCT03929887 434 437 O
appropriate NCT03929887 438 449 O
, NCT03929887 450 451 O
informed NCT03929887 452 460 O
assent NCT03929887 461 467 O
( NCT03929887 468 469 O
clinical NCT03929887 470 478 O
data NCT03929887 479 483 O
, NCT03929887 484 485 O
human NCT03929887 486 491 O
derived NCT03929887 492 499 O
materials NCT03929887 500 509 O
including NCT03929887 510 519 O
genomic NCT03929887 520 527 O
data NCT03929887 528 532 O
) NCT03929887 533 534 O

Exclusion NCT03929887 536 545 O
Criteria NCT03929887 546 554 O
: NCT03929887 555 556 O

- NCT03929887 560 561 O
Unwillingness NCT03929887 563 576 O
to NCT03929887 577 579 O
give NCT03929887 580 584 O
informed NCT03929887 585 593 O
consent NCT03929887 594 601 O

- NCT03929887 604 605 O
Not NCT03929887 607 610 O
enough NCT03929887 611 617 O
kidney NCT03929887 618 624 B-Observation-Name
tissue NCT03929887 625 631 I-Observation-Name
to NCT03929887 632 634 O
confirm NCT03929887 635 642 O
a NCT03929887 643 644 O
diagnosis NCT03929887 645 654 O
( NCT03929887 655 656 O
adequate NCT03929887 657 665 O
tissue NCT03929887 666 672 O
: NCT03929887 673 674 O
more NCT03929887 675 679 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03929887 680 684 I-Eq-Operator___Eq-Operator-Value:GT
2 NCT03929887 686 687 B-Eq-Value
cores NCT03929887 688 693 B-Eq-Unit
of NCT03929887 694 696 O
kidney NCT03929887 697 703 B-Observation-Name
tissues NCT03929887 704 711 I-Observation-Name
( NCT03929887 712 713 O
10 NCT03929887 715 717 B-Eq-Value
x NCT03929887 718 719 O
1.2 NCT03929887 721 724 B-Eq-Value
mm NCT03929887 725 727 B-Eq-Unit
) NCT03929887 728 729 O
including NCT03929887 730 739 O
over NCT03929887 740 744 B-Eq-Operator___Eq-Operator-Value:GT
10 NCT03929887 746 748 B-Eq-Value
- NCT03929887 749 750 B-Eq-Operator___Eq-Operator-Value:BETWEEN
15 NCT03929887 752 754 B-Eq-Value
glomerulus NCT03929887 755 765 B-Eq-Unit
each NCT03929887 766 770 O
) NCT03929887 771 772 O

Inclusion NCT03926546 0 9 O
Criteria NCT03926546 10 18 O
: NCT03926546 19 20 O

- NCT03926546 24 25 O
Participants NCT03926546 27 39 O
must NCT03926546 40 44 O
be NCT03926546 45 47 O
adults NCT03926546 48 54 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
18 NCT03926546 56 58 B-Eq-Value
years NCT03926546 59 64 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03926546 65 67 B-Eq-Operator___Eq-Operator-Value:GTEQ
older NCT03926546 68 73 I-Eq-Operator___Eq-Operator-Value:GTEQ
. NCT03926546 74 75 O

- NCT03926546 79 80 O
Participants NCT03926546 82 94 O
must NCT03926546 95 99 O
have NCT03926546 100 104 O
the NCT03926546 105 108 O
capacity NCT03926546 109 117 O
and NCT03926546 118 121 O
ability NCT03926546 122 129 O
to NCT03926546 130 132 O
give NCT03926546 133 137 O
informed NCT03926546 138 146 O
consent NCT03926546 147 154 O
. NCT03926546 155 156 O

- NCT03926546 160 161 O
Participants NCT03926546 163 175 O
have NCT03926546 176 180 O
been NCT03926546 181 185 O
given NCT03926546 186 191 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
an NCT03926546 192 194 O
assessment NCT03926546 195 205 B-Procedure-Name
and NCT03926546 206 209 O
received NCT03926546 210 218 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03926546 219 220 O
diagnosis NCT03926546 221 230 O
of NCT03926546 231 233 O
OCD NCT03926546 234 237 B-Condition-Name
. NCT03926546 238 239 O

- NCT03926546 243 244 O
Participants NCT03926546 246 258 O
must NCT03926546 259 263 O
speak NCT03926546 264 269 O
English NCT03926546 270 277 B-Language
. NCT03926546 278 279 O

- NCT03926546 283 284 O
Participants NCT03926546 286 298 O
must NCT03926546 299 303 O
be NCT03926546 304 306 O
able NCT03926546 307 311 O
to NCT03926546 312 314 O
physically NCT03926546 315 325 O
attend NCT03926546 326 332 O
treatment NCT03926546 333 342 O
. NCT03926546 343 344 O

Exclusion NCT03926546 346 355 O
Criteria NCT03926546 356 364 O
: NCT03926546 365 366 O

- NCT03926546 370 371 O
Prisoners NCT03926546 373 382 B-Observation-Name
or NCT03926546 383 385 O
any NCT03926546 386 389 O
other NCT03926546 390 395 O
high NCT03926546 396 400 B-Polarity___Polarity-Value:high
- NCT03926546 401 402 O
risk NCT03926546 403 407 O
population NCT03926546 408 418 O
group NCT03926546 419 424 O
. NCT03926546 425 426 O

- NCT03926546 430 431 O
experiencing NCT03926546 433 445 O
active NCT03926546 446 452 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
psychosis NCT03926546 453 462 B-Condition-Name

- NCT03926546 465 466 O
experiencing NCT03926546 468 480 O
active NCT03926546 481 487 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03926546 488 497 B-Condition-Name
abuse NCT03926546 498 503 I-Condition-Name
disorder NCT03926546 504 512 I-Condition-Name

- NCT03926546 515 516 O
experiencing NCT03926546 518 530 O
active NCT03926546 531 537 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
suicidality NCT03926546 538 549 B-Condition-Name

Inclusion NCT03926234 0 9 O
Criteria NCT03926234 10 18 O
: NCT03926234 19 20 O

- NCT03926234 24 25 O
Patients NCT03926234 27 35 O
, NCT03926234 36 37 O
older NCT03926234 38 43 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03926234 44 48 I-Eq-Operator___Eq-Operator-Value:GT
14 NCT03926234 50 52 B-Eq-Value
years NCT03926234 53 58 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
and NCT03926234 59 62 O
admitted NCT03926234 63 71 O
to NCT03926234 72 74 O
the NCT03926234 75 78 O
ED NCT03926234 79 81 B-Encounter-Type___Encounter-Type-Value:emergency
, NCT03926234 82 83 O
were NCT03926234 84 88 O
eligible NCT03926234 89 97 O
for NCT03926234 98 101 O
this NCT03926234 102 106 O
study NCT03926234 107 112 O
. NCT03926234 113 114 O

Exclusion NCT03926234 116 125 O
Criteria NCT03926234 126 134 O
: NCT03926234 135 136 O

- NCT03926234 140 141 O
Gynecologic NCT03926234 143 154 O
and NCT03926234 155 158 O
obstetric NCT03926234 159 168 O
emergencies NCT03926234 169 180 B-Condition-Name

- NCT03926234 183 184 O
Patients NCT03926234 186 194 O
, NCT03926234 195 196 O
who NCT03926234 197 200 O
left NCT03926234 201 205 B-Observation-Name
against NCT03926234 206 213 I-Observation-Name
medical NCT03926234 214 221 I-Observation-Name
advice NCT03926234 222 228 I-Observation-Name
or NCT03926234 229 231 O
had NCT03926234 232 235 O
n't NCT03926234 235 238 O
been NCT03926234 239 243 O
aided NCT03926234 244 249 O
by NCT03926234 250 252 O
a NCT03926234 253 254 O
doctor NCT03926234 255 261 O

Inclusion NCT03927664 0 9 O
Criteria NCT03927664 10 18 O

- NCT03927664 21 22 O
Patients NCT03927664 24 32 O
diagnosed NCT03927664 33 42 O
with NCT03927664 43 47 O
peritoneal NCT03927664 48 58 B-Condition-Name
tuberculosis NCT03927664 59 71 I-Condition-Name

- NCT03927664 74 75 O
Patients NCT03927664 77 85 O
who NCT03927664 86 89 O
have NCT03927664 90 94 O
undergone NCT03927664 95 104 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
a NCT03927664 105 106 O
computed NCT03927664 107 115 B-Procedure-Name
tomographic NCT03927664 116 127 I-Procedure-Name
examination NCT03927664 128 139 I-Procedure-Name

Exclusion NCT03927664 140 149 O
Criteria NCT03927664 150 158 O
: NCT03927664 159 160 O

- NCT03927664 164 165 O
Age NCT03927664 167 170 O
< NCT03927664 171 172 B-Eq-Operator___Eq-Operator-Value:LT
12 NCT03927664 174 176 B-Eq-Value

- NCT03927664 180 181 O
Unclear NCT03927664 183 190 O
diagnosis NCT03927664 191 200 O

- NCT03927664 203 204 O
More NCT03927664 206 210 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03927664 211 215 I-Eq-Operator___Eq-Operator-Value:GT
one NCT03927664 216 219 B-Eq-Value
etiology NCT03927664 220 228 B-Condition-Name
for NCT03927664 229 232 O
ascites NCT03927664 233 240 B-Condition-Name

- NCT03927664 243 244 O
Not NCT03927664 246 249 O
willing NCT03927664 250 257 O
for NCT03927664 258 261 O
consent NCT03927664 262 269 O

Inclusion NCT03926208 0 9 O
Criteria NCT03926208 10 18 O
: NCT03926208 19 20 O

1 NCT03926208 25 26 O
. NCT03926208 26 27 O
≥ NCT03926208 29 30 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03926208 32 34 B-Eq-Value
years NCT03926208 35 40 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03926208 41 43 O
age NCT03926208 44 47 O

2 NCT03926208 51 52 O
. NCT03926208 52 53 O
Patient NCT03926208 55 62 O
requires NCT03926208 63 71 O
a NCT03926208 72 73 O
foot NCT03926208 74 78 O
or NCT03926208 79 81 O
ankle NCT03926208 82 87 O
operative NCT03926208 88 97 B-Procedure-Name
procedure NCT03926208 98 107 I-Procedure-Name

3 NCT03926208 111 112 O
. NCT03926208 112 113 O
Patient NCT03926208 115 122 O
provides NCT03926208 123 131 O
informed NCT03926208 132 140 O
consent NCT03926208 141 148 O

Exclusion NCT03926208 149 158 O
Criteria NCT03926208 159 167 O
: NCT03926208 168 169 O

1 NCT03926208 174 175 O
. NCT03926208 175 176 O
Patient NCT03926208 178 185 O
refuses NCT03926208 186 193 O

2 NCT03926208 197 198 O
. NCT03926208 198 199 O
Patient NCT03926208 201 208 O
is NCT03926208 209 211 O
incarcerated NCT03926208 212 224 B-Observation-Name
, NCT03926208 225 226 O
incapacitated NCT03926208 227 240 B-Condition-Name
, NCT03926208 241 242 O
or NCT03926208 243 245 O
otherwise NCT03926208 246 255 O
unable NCT03926208 256 262 O
to NCT03926208 263 265 O
provide NCT03926208 266 273 O
appropriate NCT03926208 274 285 O
informed NCT03926208 286 294 O
consent NCT03926208 295 302 O

Inclusion NCT03921567 0 9 O
Criteria NCT03921567 10 18 O
: NCT03921567 19 20 O

- NCT03921567 24 25 O
Age NCT03921567 27 30 O
of NCT03921567 31 33 O
both NCT03921567 34 38 O
genders NCT03921567 39 46 B-Life-Stage-And-Gender
from NCT03921567 47 51 O
18 NCT03921567 53 55 B-Eq-Value
to NCT03921567 56 58 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03921567 60 62 B-Eq-Value
years NCT03921567 63 68 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03921567 71 72 O
ASA NCT03921567 74 77 B-Condition-Name
physiological NCT03921567 78 91 O
status NCT03921567 92 98 O
I NCT03921567 99 100 B-Eq-Value
- NCT03921567 101 102 B-Eq-Operator___Eq-Operator-Value:BETWEEN
III NCT03921567 103 106 B-Eq-Value

- NCT03921567 109 110 O
Participation NCT03921567 112 125 O
in NCT03921567 126 128 O
abdominal NCT03921567 129 138 O
, NCT03921567 139 140 O
orthopedic NCT03921567 141 151 O
, NCT03921567 152 153 O
laparoscopical NCT03921567 154 168 O
, NCT03921567 169 170 O
gynecological NCT03921567 171 184 O
and NCT03921567 185 188 O
urological NCT03921567 189 199 O
interventions NCT03921567 200 213 O
. NCT03921567 214 215 O

Exclusion NCT03921567 217 226 O
Criteria NCT03921567 227 235 O
: NCT03921567 236 237 O

- NCT03921567 241 242 O
Patient NCT03921567 244 251 O
rejection NCT03921567 252 261 O

- NCT03921567 264 265 O
History NCT03921567 267 274 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921567 275 277 O
chronic NCT03921567 278 285 O
opioid NCT03921567 286 292 B-Drug-Name
intake NCT03921567 293 299 O

- NCT03921567 302 303 O
History NCT03921567 305 312 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03921567 313 315 O
renal NCT03921567 316 321 O
, NCT03921567 322 323 O
hepatic NCT03921567 324 331 O
or NCT03921567 332 334 O
psychiatric NCT03921567 335 346 O
disorders NCT03921567 347 356 B-Condition-Name

- NCT03921567 359 360 O
Heart NCT03921567 362 367 B-Condition-Name
failure NCT03921567 368 375 I-Condition-Name
, NCT03921567 376 377 O

- NCT03921567 381 382 O
Organ NCT03921567 384 389 B-Procedure-Name
transplant NCT03921567 390 400 I-Procedure-Name
history NCT03921567 401 408 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
, NCT03921567 409 410 O

- NCT03921567 414 415 O
Lidocaine NCT03921567 417 426 B-Drug-Name
allergy NCT03921567 427 434 O

- NCT03921567 437 438 O
Family NCT03921567 440 446 O
history NCT03921567 447 454 O
of NCT03921567 455 457 O
malignant NCT03921567 458 467 B-Condition-Name
hyperthermia NCT03921567 468 480 I-Condition-Name

Inclusion NCT03925701 0 9 O
Criteria NCT03925701 10 18 O
: NCT03925701 19 20 O

- NCT03925701 24 25 O
NAFLD NCT03925701 27 32 B-Condition-Name
and NCT03925701 33 36 O
type NCT03925701 37 41 B-Condition-Name
2 NCT03925701 43 44 I-Condition-Name
DM NCT03925701 45 47 I-Condition-Name

Exclusion NCT03925701 48 57 O
Criteria NCT03925701 58 66 O
: NCT03925701 67 68 O

- NCT03925701 72 73 O
Viral NCT03925701 75 80 B-Condition-Name
hepatitis NCT03925701 81 90 I-Condition-Name
. NCT03925701 91 92 O

- NCT03925701 96 97 O
Child NCT03925701 99 104 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:child
score NCT03925701 105 110 O
more NCT03925701 111 115 B-Eq-Operator___Eq-Operator-Value:GT
than NCT03925701 116 120 I-Eq-Operator___Eq-Operator-Value:GT
6 NCT03925701 122 123 B-Eq-Value
. NCT03925701 123 124 O

- NCT03925701 128 129 O
renal NCT03925701 131 136 O
impairment NCT03925701 137 147 B-Condition-Name
. NCT03925701 148 149 O

Inclusion NCT03926585 0 9 O
Criteria NCT03926585 10 18 O
: NCT03926585 19 20 O

- NCT03926585 24 25 O
Patients NCT03926585 27 35 O
admitted NCT03926585 36 44 B-Encounter-Type___Encounter-Type-Value:inpatient
to NCT03926585 45 47 O
the NCT03926585 48 51 O
department NCT03926585 52 62 O
of NCT03926585 63 65 O
endocrinology NCT03926585 66 79 B-Provider-Type
with NCT03926585 80 84 O
the NCT03926585 85 88 O
diagnose NCT03926585 89 97 O
hypothyroidism NCT03926585 98 112 B-Condition-Name
because NCT03926585 113 120 O
of NCT03926585 121 123 O
persistent NCT03926585 124 134 O
hypothyroid NCT03926585 135 146 B-Condition-Name
symptoms NCT03926585 147 155 O
despite NCT03926585 156 163 O
treatment NCT03926585 164 173 O
with NCT03926585 174 178 O
L NCT03926585 179 180 O
- NCT03926585 181 182 B-Drug-Name
thyroxine NCT03926585 183 192 O
mono NCT03926585 193 197 B-Procedure-Name
- NCT03926585 198 199 I-Procedure-Name
therapy NCT03926585 200 207 I-Procedure-Name
and NCT03926585 208 211 O
normal NCT03926585 212 218 B-Polarity___Polarity-Value:normal
and NCT03926585 219 222 O
stable NCT03926585 223 229 B-Stability___Stability-Value:stable
TSH NCT03926585 230 233 B-Observation-Name___Observation-Type-Value:lab
( NCT03926585 234 235 O
for NCT03926585 236 239 O
at NCT03926585 240 242 B-Eq-Operator___Eq-Operator-Value:GTEQ
least NCT03926585 243 248 I-Eq-Operator___Eq-Operator-Value:GTEQ
6 NCT03926585 250 251 B-Eq-Value
months NCT03926585 252 258 O
) NCT03926585 259 260 O
. NCT03926585 262 263 O

- NCT03926585 267 268 O
Started NCT03926585 270 277 O
in NCT03926585 278 280 O
combination NCT03926585 281 292 B-Procedure-Name
therapy NCT03926585 293 300 I-Procedure-Name
with NCT03926585 301 305 O
L NCT03926585 306 307 B-Drug-Name
- NCT03926585 308 309 I-Drug-Name
thyroxine NCT03926585 310 319 I-Drug-Name
and NCT03926585 320 323 O
Liothyronine NCT03926585 324 336 B-Drug-Name
in NCT03926585 337 339 O
an NCT03926585 340 342 O
approximately NCT03926585 343 356 O
17 NCT03926585 358 360 B-Eq-Value
/ NCT03926585 361 362 O
1 NCT03926585 364 365 B-Eq-Unit
ratio NCT03926585 366 371 B-Eq-Unit

- NCT03926585 374 375 O
Exclusion NCT03926585 377 386 O
of NCT03926585 387 389 O
an NCT03926585 390 392 O
alternative NCT03926585 393 404 O
explanation NCT03926585 405 416 O
for NCT03926585 417 420 O
persistent NCT03926585 421 431 O
hypothyroid NCT03926585 432 443 B-Condition-Name
symptoms NCT03926585 444 452 O

Exclusion NCT03926585 453 462 O
Criteria NCT03926585 463 471 O
: NCT03926585 472 473 O

- NCT03926585 477 478 O
Initiation NCT03926585 480 490 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
of NCT03926585 491 493 O
L NCT03926585 494 495 B-Drug-Name
- NCT03926585 496 497 I-Drug-Name
thyroxine NCT03926585 498 507 I-Drug-Name
treatment NCT03926585 508 517 O
in NCT03926585 518 520 O
patients NCT03926585 521 529 O
with NCT03926585 530 534 O
s NCT03926585 535 536 B-Observation-Name___Observation-Type-Value:lab
- NCT03926585 537 538 I-Observation-Name___Observation-Type-Value:lab
TSH NCT03926585 539 542 I-Observation-Name___Observation-Type-Value:lab
below NCT03926585 543 548 B-Eq-Operator___Eq-Operator-Value:LT
upper NCT03926585 549 554 B-Eq-Unit___Eq-Unit-Value:ref-range-low
normal NCT03926585 555 561 I-Eq-Unit___Eq-Unit-Value:ref-range-low
limit NCT03926585 562 567 I-Eq-Unit___Eq-Unit-Value:ref-range-low
( NCT03926585 568 569 O
with NCT03926585 570 574 O
assay NCT03926585 575 580 O
in NCT03926585 581 583 O
current NCT03926585 584 591 O
use NCT03926585 592 595 O
, NCT03926585 596 597 O
that NCT03926585 598 602 O
is NCT03926585 603 605 O
TSH NCT03926585 606 609 B-Observation-Name___Observation-Type-Value:lab
< NCT03926585 610 611 B-Eq-Operator___Eq-Operator-Value:LT
4 NCT03926585 613 614 B-Eq-Value
mU NCT03926585 615 617 B-Eq-Unit
/ NCT03926585 618 619 O
L NCT03926585 620 621 B-Eq-Unit
) NCT03926585 622 623 O

- NCT03926585 627 628 O
Ongoing NCT03926585 630 637 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
pregnancy NCT03926585 638 647 B-Condition-Name

- NCT03926585 650 651 O
Age NCT03926585 653 656 O
below NCT03926585 657 662 B-Eq-Operator___Eq-Operator-Value:LT
18 NCT03926585 664 666 B-Eq-Value
years NCT03926585 667 672 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
or NCT03926585 673 675 O
above NCT03926585 676 681 B-Eq-Operator___Eq-Operator-Value:GT
80 NCT03926585 683 685 B-Eq-Value
years NCT03926585 686 691 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
. NCT03926585 692 693 O

- NCT03926585 697 698 O
Patients NCT03926585 700 708 O
who NCT03926585 709 712 O
do NCT03926585 713 715 O
not NCT03926585 716 719 O
read NCT03926585 720 724 O
and NCT03926585 725 728 O
understand NCT03926585 729 739 O
information NCT03926585 740 751 O
material NCT03926585 752 760 O
given NCT03926585 761 766 O

- NCT03926585 769 770 O
Patients NCT03926585 772 780 O
who NCT03926585 781 784 O
are NCT03926585 785 788 O
not NCT03926585 789 792 O
competent NCT03926585 793 802 O
to NCT03926585 803 805 O
give NCT03926585 806 810 O
informed NCT03926585 811 819 O
consent NCT03926585 820 827 O


Inclusion NCT03928769 0 9 O
Criteria NCT03928769 10 18 O
: NCT03928769 19 20 O

- NCT03928769 24 25 O
Male NCT03928769 27 31 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
or NCT03928769 32 34 O
female NCT03928769 35 41 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
≥ NCT03928769 42 43 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03928769 45 47 B-Eq-Value
years NCT03928769 48 53 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03928769 56 57 O
Patient NCT03928769 59 66 O
for NCT03928769 67 70 O
whom NCT03928769 71 75 O
a NCT03928769 76 77 O
vascular NCT03928769 78 86 O
surgery NCT03928769 87 94 B-Procedure-Name
is NCT03928769 95 97 O
programmed NCT03928769 98 108 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
, NCT03928769 109 110 O
and NCT03928769 111 114 O
whose NCT03928769 115 120 O
nature NCT03928769 121 127 O
allows NCT03928769 128 134 O
obtaining NCT03928769 135 144 O
of NCT03928769 145 147 O
arterial NCT03928769 148 156 B-Condition-Name
segment NCT03928769 157 164 I-Condition-Name
without NCT03928769 165 172 O
any NCT03928769 173 176 O
harm NCT03928769 177 181 B-Stability___Stability-Value:change
for NCT03928769 182 185 O
the NCT03928769 186 189 O
health NCT03928769 190 196 B-Condition-Name
of NCT03928769 197 199 O
the NCT03928769 200 203 O
patient NCT03928769 204 211 O

- NCT03928769 214 215 O
Patient NCT03928769 217 224 O
for NCT03928769 225 228 O
whom NCT03928769 229 233 O
a NCT03928769 234 235 O
blood NCT03928769 236 241 B-Observation-Specimen
sample NCT03928769 242 248 B-Observation-Name
is NCT03928769 249 251 O
planned NCT03928769 252 259 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
on NCT03928769 260 262 O
the NCT03928769 263 266 O
day NCT03928769 267 270 O
of NCT03928769 271 273 O
the NCT03928769 274 277 O
procedure NCT03928769 278 287 B-Procedure-Name

- NCT03928769 290 291 O
Person NCT03928769 293 299 O
who NCT03928769 300 303 O
has NCT03928769 304 307 O
received NCT03928769 308 316 O
complete NCT03928769 317 325 O
information NCT03928769 326 337 O
on NCT03928769 338 340 O
the NCT03928769 341 344 O
organization NCT03928769 345 357 O
of NCT03928769 358 360 O
the NCT03928769 361 364 O
research NCT03928769 365 373 O
and NCT03928769 374 377 O
who NCT03928769 378 381 O
has NCT03928769 382 385 O
not NCT03928769 386 389 O
objected NCT03928769 390 398 O
to NCT03928769 399 401 O
his NCT03928769 402 405 O
participation NCT03928769 406 419 O
and NCT03928769 420 423 O
the NCT03928769 424 427 O
exploitation NCT03928769 428 440 O
of NCT03928769 441 443 O
his NCT03928769 444 447 O
data NCT03928769 448 452 O

- NCT03928769 455 456 O
Compulsory NCT03928769 458 468 O
affiliation NCT03928769 469 480 O
to NCT03928769 481 483 O
social NCT03928769 484 490 O
security NCT03928769 491 499 O

Exclusion NCT03928769 500 509 O
Criteria NCT03928769 510 518 O
: NCT03928769 519 520 O

- NCT03928769 524 525 O
Patient NCT03928769 527 534 O
who NCT03928769 535 538 O
has NCT03928769 539 542 O
previously NCT03928769 543 553 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
undergone NCT03928769 554 563 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
radiotherapy NCT03928769 564 576 B-Procedure-Name
at NCT03928769 577 579 O
the NCT03928769 580 583 O
sampling NCT03928769 584 592 O
site NCT03928769 593 597 O

- NCT03928769 600 601 O
Patient NCT03928769 603 610 O
with NCT03928769 611 615 O
cancer NCT03928769 616 622 B-Condition-Name
at NCT03928769 623 625 O
the NCT03928769 626 629 O
sampling NCT03928769 630 638 O
site NCT03928769 639 643 O

Inclusion NCT03925259 0 9 O
Criteria NCT03925259 10 18 O
: NCT03925259 19 20 O

- NCT03925259 24 25 O
Long NCT03925259 27 31 O
term NCT03925259 32 36 O
physical NCT03925259 37 45 B-Condition-Name
health NCT03925259 46 52 I-Condition-Name
condition NCT03925259 53 62 I-Condition-Name
and NCT03925259 63 66 O
comorbid NCT03925259 67 75 B-Condition-Name
mental NCT03925259 76 82 I-Condition-Name
health NCT03925259 83 89 I-Condition-Name
problem NCT03925259 90 97 I-Condition-Name

- NCT03925259 100 101 O
Age NCT03925259 103 106 O
16 NCT03925259 108 110 B-Eq-Value
+ NCT03925259 111 112 B-Eq-Operator___Eq-Operator-Value:GTEQ

- NCT03925259 116 117 O
Referred NCT03925259 119 127 B-Encounter-Type___Encounter-Type-Value:referral
to NCT03925259 128 130 O
a NCT03925259 131 132 O
psychological NCT03925259 133 146 B-Provider-Type
therapies NCT03925259 147 156 I-Provider-Type
service NCT03925259 157 164 I-Provider-Type

Exclusion NCT03925259 165 174 O
Criteria NCT03925259 175 183 O
: NCT03925259 184 185 O

- NCT03925259 189 190 O
Diagnosis NCT03925259 192 201 O
of NCT03925259 202 204 O
' NCT03925259 205 206 O
medically NCT03925259 206 215 B-Condition-Name
unexplained NCT03925259 216 227 I-Condition-Name
symptoms NCT03925259 228 236 I-Condition-Name
' NCT03925259 236 237 O
including NCT03925259 238 247 O
somatoform NCT03925259 248 258 B-Condition-Name
disorders NCT03925259 259 268 I-Condition-Name
( NCT03925259 269 270 O
e NCT03925259 271 272 O
. NCT03925259 273 274 O
g NCT03925259 275 276 O
. NCT03925259 277 278 O
pain NCT03925259 280 284 B-Condition-Name
disorder NCT03925259 285 293 I-Condition-Name
, NCT03925259 294 295 O
conversion NCT03925259 296 306 B-Condition-Name
disorder NCT03925259 307 315 I-Condition-Name
, NCT03925259 316 317 O
body NCT03925259 318 322 B-Condition-Name
dysmorphic NCT03925259 323 333 I-Condition-Name
disorder NCT03925259 334 342 I-Condition-Name
, NCT03925259 343 344 O
hypochondriasis NCT03925259 345 360 B-Condition-Name
) NCT03925259 361 362 O
and NCT03925259 363 366 O
functional NCT03925259 367 377 B-Condition-Name
somatic NCT03925259 378 385 I-Condition-Name
syndromes NCT03925259 386 395 I-Condition-Name
( NCT03925259 396 397 O
e NCT03925259 398 399 O
. NCT03925259 400 401 O
g NCT03925259 402 403 O
. NCT03925259 404 405 O
irritable NCT03925259 407 416 B-Condition-Name
bowel NCT03925259 417 422 I-Condition-Name
syndrome NCT03925259 423 431 I-Condition-Name
, NCT03925259 432 433 O
chronic NCT03925259 434 441 B-Condition-Name
fatigue NCT03925259 442 449 I-Condition-Name
syndrome NCT03925259 450 458 I-Condition-Name
, NCT03925259 459 460 O
fibromyalgia NCT03925259 461 473 B-Condition-Name
, NCT03925259 474 475 O
non NCT03925259 476 479 O
- NCT03925259 480 481 O
cardiac NCT03925259 482 489 O
chest NCT03925259 490 495 O
pain NCT03925259 496 500 B-Condition-Name
, NCT03925259 501 502 O
non NCT03925259 503 506 B-Condition-Name
- NCT03925259 507 508 I-Condition-Name
epileptic NCT03925259 509 518 I-Condition-Name
seizures NCT03925259 519 527 I-Condition-Name
) NCT03925259 528 529 O

- NCT03925259 533 534 O
Mental NCT03925259 536 542 B-Condition-Name
health NCT03925259 543 549 I-Condition-Name
diagnoses NCT03925259 550 559 O
in NCT03925259 560 562 O
addition NCT03925259 563 571 O
to NCT03925259 572 574 O
anxiety NCT03925259 575 582 B-Condition-Name
or NCT03925259 583 585 O
depression NCT03925259 586 596 B-Condition-Name
( NCT03925259 597 598 O
e NCT03925259 599 600 O
. NCT03925259 601 602 O
g NCT03925259 603 604 O
. NCT03925259 605 606 O
personality NCT03925259 608 619 B-Condition-Name
disorder NCT03925259 620 628 I-Condition-Name
, NCT03925259 629 630 O
bipolar NCT03925259 631 638 B-Condition-Name
disorder NCT03925259 639 647 I-Condition-Name
or NCT03925259 648 650 O
psychosis NCT03925259 651 660 B-Condition-Name
) NCT03925259 661 662 O

- NCT03925259 666 667 O
Currently NCT03925259 669 678 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
accesses NCT03925259 679 687 O
secondary NCT03925259 688 697 O
care NCT03925259 698 702 O
mental NCT03925259 703 709 B-Provider-Type
health NCT03925259 710 716 I-Provider-Type
services NCT03925259 717 725 I-Provider-Type

- NCT03925259 728 729 O
Significant NCT03925259 731 742 B-Severity___Severity-Value:severe
current NCT03925259 743 750 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
suicidal NCT03925259 751 759 B-Condition-Name
risk NCT03925259 760 764 O

- NCT03925259 767 768 O
Current NCT03925259 770 777 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
substance NCT03925259 778 787 B-Condition-Name
misuse NCT03925259 788 794 I-Condition-Name

- NCT03925259 797 798 O
Previous NCT03925259 800 808 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
contact NCT03925259 809 816 O
with NCT03925259 817 821 O
mental NCT03925259 822 828 B-Provider-Type
health NCT03925259 829 835 I-Provider-Type
services NCT03925259 836 844 I-Provider-Type
( NCT03925259 845 846 O
defined NCT03925259 847 854 O
as NCT03925259 855 857 O
two NCT03925259 858 861 B-Eq-Value
or NCT03925259 862 864 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03925259 865 869 I-Eq-Operator___Eq-Operator-Value:GTEQ
prior NCT03925259 870 875 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
episodes NCT03925259 876 884 O
of NCT03925259 885 887 O
service NCT03925259 888 895 O
contact NCT03925259 896 903 O
without NCT03925259 904 911 O
significant NCT03925259 912 923 B-Severity___Severity-Value:severe
change NCT03925259 924 930 B-Stability___Stability-Value:change
) NCT03925259 931 932 O

- NCT03925259 936 937 O
Inpatient NCT03925259 939 948 B-Encounter-Type___Encounter-Type-Value:inpatient
admission NCT03925259 949 958 I-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03925259 959 962 O
mental NCT03925259 963 969 B-Condition-Name
health NCT03925259 970 976 I-Condition-Name
difficulties NCT03925259 977 989 I-Condition-Name
within NCT03925259 990 996 B-Eq-Operator___Eq-Operator-Value:LTEQ
the NCT03925259 997 1000 O
last NCT03925259 1001 1005 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
five NCT03925259 1006 1010 B-Eq-Value
years NCT03925259 1011 1016 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03925259 1019 1020 O
History NCT03925259 1022 1029 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925259 1030 1032 O
self NCT03925259 1033 1037 B-Condition-Name
- NCT03925259 1038 1039 I-Condition-Name
injury NCT03925259 1040 1046 I-Condition-Name

- NCT03925259 1049 1050 O
A NCT03925259 1052 1053 O
stated NCT03925259 1054 1060 O
reluctance NCT03925259 1061 1071 O
to NCT03925259 1072 1074 O
engage NCT03925259 1075 1081 O
in NCT03925259 1082 1084 O
psychotherapy NCT03925259 1085 1098 B-Procedure-Name
. NCT03925259 1099 1100 O

Inclusion NCT03927300 0 9 O
Criteria NCT03927300 10 18 O
: NCT03927300 19 20 O

- NCT03927300 24 25 O
Adult NCT03927300 27 32 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
patients NCT03927300 33 41 O
( NCT03927300 42 43 O
≥ NCT03927300 45 46 B-Eq-Operator___Eq-Operator-Value:GTEQ
18 NCT03927300 48 50 B-Eq-Value
years NCT03927300 51 56 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
) NCT03927300 57 58 O
with NCT03927300 59 63 O
no NCT03927300 64 66 O
age NCT03927300 67 70 O
limit NCT03927300 71 76 O
; NCT03927300 76 77 O

- NCT03927300 80 81 O
Patients NCT03927300 83 91 O
receiving NCT03927300 92 101 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
peritoneal NCT03927300 102 112 B-Procedure-Name
dialysis NCT03927300 113 121 I-Procedure-Name
on NCT03927300 122 124 O
the NCT03927300 125 128 O
investigation NCT03927300 129 142 B-Location___Location-Value:clinic
center NCT03927300 143 149 I-Location___Location-Value:clinic
between NCT03927300 150 157 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2012 NCT03927300 159 163 B-Eq-Value
and NCT03927300 164 167 O
2014 NCT03927300 169 173 B-Eq-Value
( NCT03927300 174 175 O
Group NCT03927300 176 181 O
1 NCT03927300 182 183 O
) NCT03927300 184 185 O
and NCT03927300 186 189 O
between NCT03927300 190 197 B-Eq-Operator___Eq-Operator-Value:BETWEEN
2016 NCT03927300 199 203 B-Eq-Value
and NCT03927300 204 207 O
2018 NCT03927300 209 213 B-Eq-Value
( NCT03927300 214 215 O
Group NCT03927300 216 221 O
2 NCT03927300 223 224 O
) NCT03927300 225 226 O
; NCT03927300 227 228 O

- NCT03927300 231 232 O
Patient NCT03927300 234 241 O
information NCT03927300 242 253 O
in NCT03927300 254 256 O
this NCT03927300 257 261 O
retrospective NCT03927300 262 275 O
study NCT03927300 276 281 O
; NCT03927300 281 282 O

Exclusion NCT03927300 283 292 O
Criteria NCT03927300 293 301 O
: NCT03927300 302 303 O

- NCT03927300 307 308 O
Patients NCT03927300 310 318 O
who NCT03927300 319 322 O
have NCT03927300 323 327 O
started NCT03927300 328 335 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
a NCT03927300 336 337 O
peritoneal NCT03927300 338 348 B-Procedure-Name
dialysis NCT03927300 349 357 I-Procedure-Name
program NCT03927300 358 365 O
before NCT03927300 366 372 O
the NCT03927300 373 376 O
periods NCT03927300 377 384 O
of NCT03927300 385 387 O
investigation NCT03927300 388 401 O
; NCT03927300 401 402 O

- NCT03927300 405 406 O
Patients NCT03927300 408 416 O
who NCT03927300 417 420 O
have NCT03927300 421 425 O
been NCT03927300 426 430 O
equipped NCT03927300 431 439 O
with NCT03927300 440 444 O
apTeleCare NCT03927300 445 455 B-Procedure-Name
during NCT03927300 456 462 O
the NCT03927300 463 466 O
dialysis NCT03927300 467 475 B-Procedure-Name
program NCT03927300 476 483 O
; NCT03927300 483 484 O

- NCT03927300 487 488 O
Subject NCT03927300 490 497 O
under NCT03927300 498 503 B-Observation-Name
guardianship NCT03927300 504 516 I-Observation-Name
, NCT03927300 517 518 O
curators NCT03927300 519 527 O
or NCT03927300 528 530 O
safeguard NCT03927300 531 540 O
of NCT03927300 541 543 O
justice NCT03927300 544 551 O
; NCT03927300 551 552 O

- NCT03927300 555 556 O
Patient NCT03927300 558 565 O
not NCT03927300 566 569 O
affiliated NCT03927300 570 580 O
to NCT03927300 581 583 O
a NCT03927300 584 585 O
French NCT03927300 586 592 O
social NCT03927300 593 599 O
protection NCT03927300 600 610 O
; NCT03927300 610 611 O


Inclusion NCT03924609 0 9 O
Criteria NCT03924609 10 18 O
: NCT03924609 19 20 O

A NCT03924609 22 23 O
. NCT03924609 24 25 O
Histologically NCT03924609 27 41 B-Procedure-Name
proven NCT03924609 42 48 O
breast NCT03924609 49 55 O
cancer NCT03924609 56 62 B-Condition-Name
confirmed NCT03924609 63 72 O
by NCT03924609 73 75 O
biopsy NCT03924609 76 82 B-Procedure-Name
or NCT03924609 83 85 O
pathological NCT03924609 86 98 B-Procedure-Name
examination NCT03924609 99 110 I-Procedure-Name
of NCT03924609 111 113 O
the NCT03924609 114 117 O
resected NCT03924609 118 126 O
tumor NCT03924609 127 132 B-Condition-Name
. NCT03924609 133 134 O

B NCT03924609 136 137 O
. NCT03924609 138 139 O
Histologically NCT03924609 141 155 B-Procedure-Name
confirmed NCT03924609 156 165 O
breast NCT03924609 166 172 O
cancer NCT03924609 173 179 B-Condition-Name
patients NCT03924609 180 188 O
, NCT03924609 189 190 O
fulfilling NCT03924609 191 201 O
any NCT03924609 202 205 O
of NCT03924609 206 208 O
the NCT03924609 209 212 O
following NCT03924609 213 222 O
: NCT03924609 223 224 O

1 NCT03924609 229 230 O
. NCT03924609 230 231 O
Multiple NCT03924609 233 241 B-Eq-Operator___Eq-Operator-Value:GT
bone NCT03924609 242 246 O
metastases NCT03924609 247 257 B-Condition-Name
indicated NCT03924609 258 267 O
by NCT03924609 268 270 O
bone NCT03924609 271 275 B-Procedure-Name
scan NCT03924609 276 280 I-Procedure-Name

2 NCT03924609 284 285 O
. NCT03924609 285 286 O
Bone NCT03924609 288 292 B-Procedure-Name
scan NCT03924609 293 297 I-Procedure-Name
positive NCT03924609 298 306 B-Polarity___Polarity-Value:positive
, NCT03924609 307 308 O
and NCT03924609 309 312 O
proven NCT03924609 313 319 O
by NCT03924609 320 322 O
other NCT03924609 323 328 O
imaging NCT03924609 329 336 B-Procedure-Name
examinations NCT03924609 337 349 I-Procedure-Name
, NCT03924609 350 351 O
including NCT03924609 352 361 O
computed NCT03924609 362 370 B-Procedure-Name
tomography NCT03924609 371 381 I-Procedure-Name
( NCT03924609 382 383 O
CT NCT03924609 384 386 B-Procedure-Name
) NCT03924609 387 388 O
, NCT03924609 390 391 O
magnetic NCT03924609 392 400 B-Procedure-Name
resonance NCT03924609 401 410 I-Procedure-Name
imaging NCT03924609 411 418 I-Procedure-Name
( NCT03924609 419 420 O
MRI NCT03924609 421 424 B-Procedure-Name
) NCT03924609 425 426 O
and NCT03924609 427 430 O
X NCT03924609 431 432 B-Procedure-Name
- NCT03924609 433 434 I-Procedure-Name
ray NCT03924609 435 438 I-Procedure-Name
. NCT03924609 439 440 O

3 NCT03924609 445 446 O
. NCT03924609 446 447 O
Bone NCT03924609 449 453 B-Procedure-Name
scan NCT03924609 454 458 I-Procedure-Name
positive NCT03924609 459 467 B-Polarity___Polarity-Value:positive
, NCT03924609 468 469 O
with NCT03924609 470 474 O
clinical NCT03924609 475 483 O
symptoms NCT03924609 484 492 B-Condition-Name
, NCT03924609 493 494 O
including NCT03924609 495 504 O
bone NCT03924609 505 509 O
pain NCT03924609 510 514 B-Condition-Name
, NCT03924609 515 516 O
pathologic NCT03924609 517 527 B-Condition-Name
fracture NCT03924609 528 536 I-Condition-Name
, NCT03924609 537 538 O
spinal NCT03924609 539 545 B-Condition-Name
cord NCT03924609 546 550 I-Condition-Name
compression NCT03924609 551 562 I-Condition-Name
and NCT03924609 563 566 O
so NCT03924609 567 569 O
on NCT03924609 570 572 O
. NCT03924609 573 574 O

4 NCT03924609 579 580 O
. NCT03924609 580 581 O
Bone NCT03924609 583 587 O
metastases NCT03924609 588 598 B-Condition-Name
indicated NCT03924609 599 608 O
by NCT03924609 609 611 O
PET NCT03924609 612 615 B-Procedure-Name
- NCT03924609 616 617 I-Procedure-Name
CT NCT03924609 618 620 I-Procedure-Name

5 NCT03924609 624 625 O
. NCT03924609 625 626 O
Histologically NCT03924609 628 642 B-Procedure-Name
proven NCT03924609 643 649 O
bone NCT03924609 650 654 O
metastases NCT03924609 655 665 B-Condition-Name

Exclusion NCT03924609 666 675 O
Criteria NCT03924609 676 684 O
: NCT03924609 685 686 O

A NCT03924609 688 689 O
. NCT03924609 690 691 O
No NCT03924609 693 695 O
bone NCT03924609 696 700 O
metastases NCT03924609 701 711 B-Condition-Name
confirmed NCT03924609 712 721 O
by NCT03924609 722 724 O
pathological NCT03924609 725 737 B-Procedure-Name
examination NCT03924609 738 749 I-Procedure-Name

B NCT03924609 751 752 O
. NCT03924609 753 754 O
Bone NCT03924609 756 760 O
metastases NCT03924609 761 771 B-Condition-Name
secondary NCT03924609 772 781 O
to NCT03924609 782 784 O
other NCT03924609 785 790 O
malignant NCT03924609 791 800 B-Condition-Name
tumor NCT03924609 801 806 I-Condition-Name
other NCT03924609 807 812 O
than NCT03924609 813 817 O
breast NCT03924609 818 824 O
cancer NCT03924609 825 831 B-Condition-Name

C NCT03924609 833 834 O
. NCT03924609 835 836 O
Secondary NCT03924609 838 847 O
primary NCT03924609 848 855 O
tumor NCT03924609 856 861 B-Condition-Name


Inclusion NCT03926793 0 9 O
Criteria NCT03926793 10 18 O
: NCT03926793 19 20 O

1 NCT03926793 25 26 O
. NCT03926793 26 27 O
Adult NCT03926793 29 34 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:adult
( NCT03926793 35 36 O
males NCT03926793 37 42 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03926793 43 46 O
females NCT03926793 47 54 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
) NCT03926793 55 56 O
aged NCT03926793 57 61 O
18 NCT03926793 63 65 B-Eq-Value
to NCT03926793 66 68 B-Eq-Operator___Eq-Operator-Value:BETWEEN
75 NCT03926793 70 72 B-Eq-Value
years NCT03926793 73 78 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
( NCT03926793 79 80 O
inclusive NCT03926793 81 90 O
) NCT03926793 91 92 O
with NCT03926793 93 97 O
pulmonary NCT03926793 98 107 B-Condition-Name
arterial NCT03926793 108 116 I-Condition-Name
hypertension NCT03926793 117 129 I-Condition-Name
( NCT03926793 130 131 O
PAH NCT03926793 132 135 B-Condition-Name
) NCT03926793 136 137 O

2 NCT03926793 142 143 O
. NCT03926793 143 144 O
A NCT03926793 146 147 O
current NCT03926793 148 155 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
diagnosis NCT03926793 156 165 O
of NCT03926793 166 168 O
symptomatic NCT03926793 169 180 O
PAH NCT03926793 181 184 B-Condition-Name
classified NCT03926793 185 195 O
by NCT03926793 196 198 O
one NCT03926793 199 202 B-Eq-Value
of NCT03926793 203 205 O
the NCT03926793 206 209 O
following NCT03926793 210 219 O
: NCT03926793 220 221 O

1 NCT03926793 231 232 O
. NCT03926793 232 233 O
Idiopathic NCT03926793 235 245 B-Condition-Name
( NCT03926793 246 247 O
IPAH NCT03926793 248 252 B-Condition-Name
) NCT03926793 253 254 O
or NCT03926793 255 257 O
heritable NCT03926793 258 267 O
pulmonary NCT03926793 268 277 B-Condition-Name
arterial NCT03926793 278 286 I-Condition-Name
hypertension NCT03926793 287 299 I-Condition-Name
( NCT03926793 300 301 O
HPAH NCT03926793 302 306 B-Condition-Name
) NCT03926793 307 308 O

2 NCT03926793 318 319 O
. NCT03926793 319 320 O
PAH NCT03926793 322 325 B-Condition-Name
associated NCT03926793 326 336 O
with NCT03926793 337 341 O
one NCT03926793 342 345 B-Eq-Value
of NCT03926793 346 348 O
the NCT03926793 349 352 O
following NCT03926793 353 362 O
connective NCT03926793 363 373 B-Condition-Name
tissue NCT03926793 374 380 I-Condition-Name
diseases NCT03926793 381 389 I-Condition-Name
( NCT03926793 390 391 O
CTDs NCT03926793 392 396 B-Condition-Name
) NCT03926793 397 398 O
: NCT03926793 400 401 O

limited NCT03926793 413 420 B-Condition-Name
scleroderma NCT03926793 421 432 I-Condition-Name
, NCT03926793 433 434 O
mixed NCT03926793 435 440 B-Condition-Name
connective NCT03926793 441 451 I-Condition-Name
tissue NCT03926793 452 458 I-Condition-Name
disease NCT03926793 459 466 I-Condition-Name
or NCT03926793 467 469 O
overlap NCT03926793 470 477 B-Condition-Name
syndrome NCT03926793 478 486 I-Condition-Name
, NCT03926793 487 488 O
or NCT03926793 489 491 O
systemic NCT03926793 492 500 O
lupus NCT03926793 501 506 B-Condition-Name
erythematosus NCT03926793 507 520 I-Condition-Name

3 NCT03926793 529 530 O
. NCT03926793 530 531 O
PAH NCT03926793 533 536 B-Condition-Name
associated NCT03926793 537 547 O
with NCT03926793 548 552 O
anorexigen NCT03926793 553 563 B-Drug-Name
or NCT03926793 564 566 O
methamphetamine NCT03926793 567 582 B-Drug-Name
use NCT03926793 583 586 O

3 NCT03926793 590 591 O
. NCT03926793 591 592 O
World NCT03926793 594 599 B-Condition-Name
Health NCT03926793 600 606 I-Condition-Name
Organization NCT03926793 607 619 I-Condition-Name
( NCT03926793 620 621 O
WHO NCT03926793 622 625 B-Condition-Name
) NCT03926793 626 627 O
/ NCT03926793 629 630 O
New NCT03926793 631 634 B-Condition-Name
York NCT03926793 635 639 I-Condition-Name
Heart NCT03926793 640 645 I-Condition-Name
Association NCT03926793 646 657 I-Condition-Name
( NCT03926793 658 659 O
NYHA NCT03926793 660 664 B-Condition-Name
) NCT03926793 665 666 O
functional NCT03926793 667 677 O
class NCT03926793 678 683 B-Eq-Unit
II NCT03926793 684 686 B-Eq-Value
- NCT03926793 687 688 B-Eq-Operator___Eq-Operator-Value:BETWEEN
IV NCT03926793 689 691 B-Eq-Value
symptomatology NCT03926793 692 706 O

Exclusion NCT03926793 707 716 O
Criteria NCT03926793 717 725 O
: NCT03926793 726 727 O

1 NCT03926793 732 733 O
. NCT03926793 733 734 O
Clinically NCT03926793 736 746 O
significant NCT03926793 747 758 B-Severity___Severity-Value:severe
systemic NCT03926793 759 767 B-Condition-Name
hypertension NCT03926793 768 780 I-Condition-Name
or NCT03926793 781 783 O
hypotension NCT03926793 784 795 B-Condition-Name

2 NCT03926793 799 800 O
. NCT03926793 800 801 O
History NCT03926793 803 810 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926793 811 813 O
left NCT03926793 814 818 O
- NCT03926793 819 820 O
sided NCT03926793 821 826 O
heart NCT03926793 827 832 B-Condition-Name
disease NCT03926793 833 840 I-Condition-Name
and NCT03926793 841 844 O
/ NCT03926793 845 846 O
or NCT03926793 847 849 O
clinically NCT03926793 850 860 O
significant NCT03926793 861 872 B-Severity___Severity-Value:severe
cardiac NCT03926793 873 880 B-Condition-Name
disease NCT03926793 881 888 I-Condition-Name

3 NCT03926793 892 893 O
. NCT03926793 893 894 O
History NCT03926793 896 903 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03926793 904 906 O
decompensated NCT03926793 907 920 O
right NCT03926793 921 926 B-Condition-Name
heart NCT03926793 927 932 I-Condition-Name
failure NCT03926793 933 940 I-Condition-Name
within NCT03926793 941 947 B-Eq-Operator___Eq-Operator-Value:LTEQ
30 NCT03926793 949 951 B-Eq-Value
days NCT03926793 952 956 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:day
of NCT03926793 957 959 O
screening NCT03926793 960 969 O
( NCT03926793 970 971 O
e NCT03926793 972 973 O
. NCT03926793 974 975 O
g NCT03926793 976 977 O
. NCT03926793 978 979 O
, NCT03926793 980 981 O
hospitalization NCT03926793 982 997 B-Encounter-Type___Encounter-Type-Value:inpatient
for NCT03926793 998 1001 O
PAH NCT03926793 1002 1005 B-Condition-Name
or NCT03926793 1006 1008 O
the NCT03926793 1009 1012 O
need NCT03926793 1013 1017 O
to NCT03926793 1018 1020 O
add NCT03926793 1021 1024 O
an NCT03926793 1025 1027 O
additional NCT03926793 1028 1038 O
PAH NCT03926793 1039 1042 B-Condition-Name
medication NCT03926793 1043 1053 O
) NCT03926793 1054 1055 O

Inclusion NCT03928782 0 9 O
Criteria NCT03928782 10 18 O
: NCT03928782 19 20 O

- NCT03928782 24 25 O
subjects NCT03928782 27 35 O
who NCT03928782 36 39 O
suffer NCT03928782 40 46 O
from NCT03928782 47 51 O
acute NCT03928782 52 57 B-Severity___Severity-Value:severe
leukemic NCT03928782 58 66 B-Condition-Name
subjects NCT03928782 67 75 O
who NCT03928782 76 79 O
accept NCT03928782 80 86 O
chemotherapy NCT03928782 87 99 B-Procedure-Name
within NCT03928782 100 106 B-Eq-Operator___Eq-Operator-Value:LTEQ
one NCT03928782 107 110 B-Eq-Value
month NCT03928782 111 116 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month
and NCT03928782 117 120 O
will NCT03928782 121 125 O
be NCT03928782 126 128 O
pre NCT03928782 129 132 O
treated NCT03928782 133 140 O
by NCT03928782 141 143 O
whole NCT03928782 144 149 B-Procedure-Name
- NCT03928782 150 151 I-Procedure-Name
body NCT03928782 152 156 I-Procedure-Name
irradiation NCT03928782 157 168 I-Procedure-Name
peripheral NCT03928782 169 179 O
blood NCT03928782 180 185 O
cells NCT03928782 186 191 O
of NCT03928782 192 194 O
subjects NCT03928782 195 203 O
are NCT03928782 204 207 O
approximate NCT03928782 208 219 O
to NCT03928782 220 222 O
those NCT03928782 223 228 O
of NCT03928782 229 231 O
healthy NCT03928782 232 239 O
person NCT03928782 240 246 O
aged NCT03928782 247 251 O
between NCT03928782 252 259 B-Eq-Operator___Eq-Operator-Value:BETWEEN
18 NCT03928782 261 263 B-Eq-Value
and NCT03928782 264 267 O
50 NCT03928782 269 271 B-Eq-Value
years NCT03928782 272 277 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
old NCT03928782 278 281 O
subjects NCT03928782 282 290 O
who NCT03928782 291 294 O
are NCT03928782 295 298 O
competent NCT03928782 299 308 O
to NCT03928782 309 311 O
give NCT03928782 312 316 O
written NCT03928782 317 324 O
informed NCT03928782 325 333 O
consent NCT03928782 334 341 O
subjects NCT03928782 342 350 O
without NCT03928782 351 358 O
other NCT03928782 359 364 O
systemic NCT03928782 365 373 O
diseases NCT03928782 374 382 O

Exclusion NCT03928782 383 392 O
Criteria NCT03928782 393 401 O
: NCT03928782 402 403 O

- NCT03928782 407 408 O
subjects NCT03928782 410 418 O
who NCT03928782 419 422 O
suffer NCT03928782 423 429 O
from NCT03928782 430 434 O
serious NCT03928782 435 442 B-Severity___Severity-Value:severe
other NCT03928782 443 448 O
systemic NCT03928782 449 457 O
diseases NCT03928782 458 466 B-Condition-Name
subjects NCT03928782 467 475 O
who NCT03928782 476 479 O
are NCT03928782 480 483 O
unwilling NCT03928782 484 493 O
or NCT03928782 494 496 O
unable NCT03928782 497 503 O
to NCT03928782 504 506 O
cooperate NCT03928782 507 516 O
with NCT03928782 517 521 O
this NCT03928782 522 526 O
clinical NCT03928782 527 535 O
study NCT03928782 536 541 O
other NCT03928782 542 547 O
serious NCT03928782 548 555 B-Severity___Severity-Value:severe
cases NCT03928782 556 561 O
that NCT03928782 562 566 O
probably NCT03928782 567 575 O
hinder NCT03928782 576 582 B-Stability___Stability-Value:change
this NCT03928782 583 587 O
clinical NCT03928782 588 596 O
study NCT03928782 597 602 O

Inclusion NCT03925675 0 9 O
Criteria NCT03925675 10 18 O
: NCT03925675 19 20 O

1 NCT03925675 25 26 O
. NCT03925675 26 27 O
Patients NCT03925675 29 37 O
evaluated NCT03925675 38 47 O
for NCT03925675 48 51 O
residual NCT03925675 52 60 O
or NCT03925675 61 63 O
recurrent NCT03925675 64 73 O
gliomas NCT03925675 74 81 B-Condition-Name
after NCT03925675 82 87 O
initial NCT03925675 88 95 B-Eq-Temporal-Recency___Eq-Temporal-Recency-Value:first-time
tumor NCT03925675 96 101 B-Condition-Name
surgery NCT03925675 102 109 B-Procedure-Name
, NCT03925675 110 111 O
external NCT03925675 112 120 B-Procedure-Name
beam NCT03925675 121 125 I-Procedure-Name
radiation NCT03925675 126 135 I-Procedure-Name
and NCT03925675 136 139 O
/ NCT03925675 140 141 O
or NCT03925675 142 144 O
chemotherapy NCT03925675 145 157 B-Procedure-Name
with NCT03925675 158 162 O
temozolamide NCT03925675 163 175 B-Drug-Name
. NCT03925675 176 177 O

2 NCT03925675 182 183 O
. NCT03925675 183 184 O
Male NCT03925675 186 190 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03925675 191 194 O
female NCT03925675 195 201 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female

3 NCT03925675 205 206 O
. NCT03925675 206 207 O
Ages NCT03925675 209 213 O
18 NCT03925675 215 217 B-Eq-Value
to NCT03925675 218 220 B-Eq-Operator___Eq-Operator-Value:BETWEEN
70 NCT03925675 222 224 B-Eq-Value

Exclusion NCT03925675 226 235 O
Criteria NCT03925675 236 244 O
: NCT03925675 245 246 O

1 NCT03925675 251 252 O
. NCT03925675 252 253 O
Patient NCT03925675 255 262 O
diagnosis NCT03925675 263 272 O
with NCT03925675 273 277 O
glioma NCT03925675 278 284 B-Condition-Name
but NCT03925675 285 288 O
before NCT03925675 289 295 O
surgery NCT03925675 296 303 B-Procedure-Name
, NCT03925675 304 305 O
external NCT03925675 306 314 B-Procedure-Name
beam NCT03925675 315 319 I-Procedure-Name
radiation NCT03925675 320 329 I-Procedure-Name
and NCT03925675 330 333 O
/ NCT03925675 334 335 O
or NCT03925675 336 338 O
chemotherapy NCT03925675 339 351 B-Procedure-Name
with NCT03925675 352 356 O
temozolamide NCT03925675 357 369 B-Drug-Name
. NCT03925675 370 371 O

2 NCT03925675 376 377 O
. NCT03925675 377 378 O
Women NCT03925675 380 385 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
who NCT03925675 386 389 O
were NCT03925675 390 394 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
pregnant NCT03925675 395 403 B-Condition-Name
, NCT03925675 404 405 O
breast NCT03925675 406 412 B-Condition-Name
feeding NCT03925675 413 420 I-Condition-Name
, NCT03925675 421 422 O
or NCT03925675 423 425 O
possibly NCT03925675 426 434 O
pregnant NCT03925675 435 443 B-Condition-Name
. NCT03925675 444 445 O

3 NCT03925675 450 451 O
. NCT03925675 451 452 O
Patients NCT03925675 454 462 O
with NCT03925675 463 467 O
hepatic NCT03925675 468 475 O
or NCT03925675 476 478 O
renal NCT03925675 479 484 O
dysfunction NCT03925675 485 496 B-Condition-Name
. NCT03925675 497 498 O

4 NCT03925675 503 504 O
. NCT03925675 504 505 O
Patients NCT03925675 507 515 O
with NCT03925675 516 520 O
MRI NCT03925675 521 524 B-Procedure-Name
contraindications NCT03925675 525 542 O
( NCT03925675 543 544 O
i NCT03925675 545 546 O
. NCT03925675 547 548 O
e NCT03925675 549 550 O
. NCT03925675 551 552 O
pacemakers NCT03925675 554 564 B-Procedure-Name
, NCT03925675 565 566 O
non NCT03925675 567 570 B-Procedure-Name
- NCT03925675 571 572 I-Procedure-Name
MR NCT03925675 573 575 I-Procedure-Name
compatible NCT03925675 576 586 I-Procedure-Name
devices NCT03925675 587 594 I-Procedure-Name
) NCT03925675 595 596 O
. NCT03925675 598 599 O

5 NCT03925675 604 605 O
. NCT03925675 605 606 O
Patients NCT03925675 608 616 O
with NCT03925675 617 621 O
a NCT03925675 622 623 O
history NCT03925675 624 631 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03925675 632 634 O
drug NCT03925675 635 639 O
hypersensitivity NCT03925675 640 656 B-Condition-Name
to NCT03925675 657 659 O
18 NCT03925675 661 663 B-Drug-Name
F NCT03925675 664 665 I-Drug-Name
- NCT03925675 666 667 I-Drug-Name
Fluciclovine NCT03925675 668 680 I-Drug-Name
. NCT03925675 681 682 O

Inclusion NCT03920917 0 9 O
Criteria NCT03920917 10 18 O
: NCT03920917 19 20 O

- NCT03920917 24 25 O
1 NCT03920917 28 29 O
. NCT03920917 29 30 O
Patient NCT03920917 32 39 O
with NCT03920917 40 44 O
paroxysmal NCT03920917 45 55 B-Condition-Name
atrial NCT03920917 56 62 I-Condition-Name
fibrillation NCT03920917 63 75 I-Condition-Name
who NCT03920917 76 79 O
is NCT03920917 80 82 O
scheduled NCT03920917 83 92 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:future
for NCT03920917 93 96 O
ablation NCT03920917 97 105 B-Procedure-Name
procedure NCT03920917 106 115 I-Procedure-Name
and NCT03920917 116 119 O
≥ NCT03920917 120 121 B-Eq-Operator___Eq-Operator-Value:GTEQ
20 NCT03920917 123 125 B-Eq-Value
and NCT03920917 126 129 O
≤ NCT03920917 130 131 B-Eq-Operator___Eq-Operator-Value:LTEQ
80 NCT03920917 133 135 B-Eq-Value
years NCT03920917 136 141 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year
of NCT03920917 142 144 O
age NCT03920917 145 148 O

- NCT03920917 151 152 O
2 NCT03920917 155 156 O
. NCT03920917 156 157 O
Left NCT03920917 159 163 B-Observation-Name___Observation-Type-Value:measurement
atrium NCT03920917 164 170 I-Observation-Name___Observation-Type-Value:measurement
size NCT03920917 171 175 I-Observation-Name___Observation-Type-Value:measurement
< NCT03920917 176 177 B-Eq-Operator___Eq-Operator-Value:LT
45 NCT03920917 179 181 B-Eq-Value
mm NCT03920917 182 184 B-Eq-Unit

- NCT03920917 187 188 O
3 NCT03920917 191 192 O
. NCT03920917 192 193 O
paroxysmal NCT03920917 195 205 B-Condition-Name
atrial NCT03920917 206 212 I-Condition-Name
fibrillation NCT03920917 213 225 I-Condition-Name
that NCT03920917 226 230 O
is NCT03920917 231 233 O
recurrence NCT03920917 234 244 O
during NCT03920917 245 251 O
antiarrhythmic NCT03920917 252 266 B-Drug-Name
drug NCT03920917 267 271 I-Drug-Name
treatment NCT03920917 272 281 O
or NCT03920917 282 284 O
is NCT03920917 285 287 O
not NCT03920917 288 291 O
able NCT03920917 292 296 O
to NCT03920917 297 299 O
use NCT03920917 300 303 O
an NCT03920917 304 306 O
antiarrhythmic NCT03920917 307 321 B-Drug-Name
drug NCT03920917 322 326 I-Drug-Name
. NCT03920917 327 328 O

- NCT03920917 332 333 O
4 NCT03920917 336 337 O
. NCT03920917 337 338 O
Patient NCT03920917 340 347 O
who NCT03920917 348 351 O
is NCT03920917 352 354 O
indicated NCT03920917 355 364 O
for NCT03920917 365 368 O
anticoagulation NCT03920917 369 384 B-Procedure-Name
therapy NCT03920917 385 392 I-Procedure-Name
( NCT03920917 393 394 O
for NCT03920917 395 398 O
prevention NCT03920917 399 409 O
of NCT03920917 410 412 O
cerebral NCT03920917 413 421 B-Condition-Name
infarction NCT03920917 422 432 I-Condition-Name
) NCT03920917 433 434 O

Exclusion NCT03920917 436 445 O
Criteria NCT03920917 446 454 O
: NCT03920917 455 456 O

- NCT03920917 460 461 O
1 NCT03920917 464 465 O
. NCT03920917 465 466 O
Patients NCT03920917 468 476 O
with NCT03920917 477 481 O
persistent NCT03920917 482 492 O
or NCT03920917 493 495 O
permanent NCT03920917 496 505 O
atrial NCT03920917 506 512 B-Condition-Name
fibrillation NCT03920917 513 525 I-Condition-Name

- NCT03920917 528 529 O
2 NCT03920917 532 533 O
. NCT03920917 533 534 O
Atrial NCT03920917 536 542 B-Condition-Name
fibrillation NCT03920917 543 555 I-Condition-Name
associated NCT03920917 556 566 O
with NCT03920917 567 571 O
severe NCT03920917 572 578 B-Severity___Severity-Value:severe
cardiac NCT03920917 579 586 B-Condition-Name
malformation NCT03920917 587 599 I-Condition-Name
or NCT03920917 600 602 O
a NCT03920917 603 604 O
structural NCT03920917 605 615 O
heart NCT03920917 616 621 B-Condition-Name
disease NCT03920917 622 629 I-Condition-Name
that NCT03920917 630 634 O
is NCT03920917 635 637 O
hemodynamically NCT03920917 638 653 O
affected NCT03920917 654 662 B-Stability___Stability-Value:change

- NCT03920917 665 666 O
3 NCT03920917 669 670 O
. NCT03920917 670 671 O
Patients NCT03920917 673 681 O
with NCT03920917 682 686 O
severe NCT03920917 687 693 B-Severity___Severity-Value:severe
renal NCT03920917 694 699 B-Condition-Name
impairment NCT03920917 700 710 I-Condition-Name
or NCT03920917 711 713 O
CT NCT03920917 714 716 B-Procedure-Name
imaging NCT03920917 717 724 I-Procedure-Name
difficulty NCT03920917 725 735 O
using NCT03920917 736 741 O
contrast NCT03920917 742 750 B-Procedure-Name
media NCT03920917 751 756 I-Procedure-Name

- NCT03920917 759 760 O
4 NCT03920917 763 764 O
. NCT03920917 764 765 O
Patients NCT03920917 767 775 O
with NCT03920917 776 780 O
a NCT03920917 781 782 O
past NCT03920917 783 787 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
history NCT03920917 788 795 I-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
of NCT03920917 796 798 O
radiofrequency NCT03920917 799 813 B-Procedure-Name
ablation NCT03920917 814 822 I-Procedure-Name
for NCT03920917 823 826 O
atrial NCT03920917 827 833 B-Condition-Name
fibrillation NCT03920917 834 846 I-Condition-Name
or NCT03920917 847 849 O
other NCT03920917 850 855 O
cardiac NCT03920917 856 863 B-Procedure-Name
surgery NCT03920917 864 871 I-Procedure-Name

- NCT03920917 874 875 O
5 NCT03920917 878 879 O
. NCT03920917 879 880 O
Patients NCT03920917 882 890 O
with NCT03920917 891 895 O
active NCT03920917 896 902 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
internal NCT03920917 903 911 B-Condition-Name
bleeding NCT03920917 912 920 I-Condition-Name

- NCT03920917 923 924 O
6 NCT03920917 927 928 O
. NCT03920917 928 929 O
Patients NCT03920917 931 939 O
with NCT03920917 940 944 O
contraindications NCT03920917 945 962 O
for NCT03920917 963 966 O
anticoagulation NCT03920917 967 982 B-Procedure-Name
therapy NCT03920917 983 990 I-Procedure-Name
( NCT03920917 991 992 O
for NCT03920917 993 996 O
prevention NCT03920917 997 1007 O
of NCT03920917 1008 1010 O
cerebral NCT03920917 1011 1019 B-Condition-Name
infarction NCT03920917 1020 1030 I-Condition-Name
) NCT03920917 1031 1032 O
and NCT03920917 1033 1036 O
antiarrhythmic NCT03920917 1037 1051 B-Drug-Name
drugs NCT03920917 1052 1057 I-Drug-Name

- NCT03920917 1060 1061 O
7 NCT03920917 1064 1065 O
. NCT03920917 1065 1066 O
Patients NCT03920917 1068 1076 O
with NCT03920917 1077 1081 O
valvular NCT03920917 1082 1090 O
atrial NCT03920917 1091 1097 B-Condition-Name
fibrillation NCT03920917 1098 1110 I-Condition-Name
( NCT03920917 1111 1112 O
mitral NCT03920917 1113 1119 B-Condition-Name
stenosis NCT03920917 1120 1128 I-Condition-Name
> NCT03920917 1129 1130 B-Eq-Operator___Eq-Operator-Value:GT
grade NCT03920917 1131 1136 B-Eq-Unit
2 NCT03920917 1138 1139 B-Eq-Value
, NCT03920917 1140 1141 O
mechanical NCT03920917 1142 1152 B-Procedure-Name
valve NCT03920917 1153 1158 I-Procedure-Name
, NCT03920917 1159 1160 O
mitral NCT03920917 1161 1167 B-Procedure-Name
valvuloplasty NCT03920917 1168 1181 I-Procedure-Name
) NCT03920917 1182 1183 O

- NCT03920917 1187 1188 O
8 NCT03920917 1191 1192 O
. NCT03920917 1192 1193 O
Patients NCT03920917 1195 1203 O
with NCT03920917 1204 1208 O
a NCT03920917 1209 1210 O
severe NCT03920917 1211 1217 B-Severity___Severity-Value:severe
comorbid NCT03920917 1218 1226 B-Condition-Name
disease NCT03920917 1227 1234 I-Condition-Name

- NCT03920917 1237 1238 O
9 NCT03920917 1241 1242 O
. NCT03920917 1242 1243 O
Expected NCT03920917 1245 1253 B-Observation-Name
survival NCT03920917 1254 1262 I-Observation-Name
< NCT03920917 1263 1264 B-Eq-Operator___Eq-Operator-Value:LT
1 NCT03920917 1266 1267 B-Eq-Value
year NCT03920917 1268 1272 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:year

- NCT03920917 1275 1276 O
10 NCT03920917 1279 1281 O
. NCT03920917 1281 1282 O
Drug NCT03920917 1284 1288 B-Condition-Name
addicts NCT03920917 1289 1296 I-Condition-Name
or NCT03920917 1297 1299 O
alcoholics NCT03920917 1300 1310 B-Condition-Name

- NCT03920917 1313 1314 O
11 NCT03920917 1317 1319 O
. NCT03920917 1319 1320 O
Patients NCT03920917 1322 1330 O
who NCT03920917 1331 1334 O
can NCT03920917 1335 1338 O
not NCT03920917 1338 1341 O
read NCT03920917 1342 1346 O
the NCT03920917 1347 1350 O
consent NCT03920917 1351 1358 O
form NCT03920917 1359 1363 O
( NCT03920917 1364 1365 O
illiterates NCT03920917 1366 1377 B-Condition-Name
, NCT03920917 1378 1379 O
foreigners NCT03920917 1380 1390 B-Ethnicity
, NCT03920917 1391 1392 O
etc NCT03920917 1393 1396 O
. NCT03920917 1397 1398 O
) NCT03920917 1399 1400 O

- NCT03920917 1404 1405 O
12 NCT03920917 1408 1410 O
. NCT03920917 1410 1411 O
Other NCT03920917 1413 1418 O
patients NCT03920917 1419 1427 O
who NCT03920917 1428 1431 O
are NCT03920917 1432 1435 O
judged NCT03920917 1436 1442 O
by NCT03920917 1443 1445 O
the NCT03920917 1446 1449 O
principal NCT03920917 1450 1459 O
or NCT03920917 1460 1462 O
sub NCT03920917 1463 1466 O
- NCT03920917 1467 1468 O
investigator NCT03920917 1469 1481 O
to NCT03920917 1482 1484 O
be NCT03920917 1485 1487 O
ineligible NCT03920917 1488 1498 O
for NCT03920917 1499 1502 O
participation NCT03920917 1503 1516 O
in NCT03920917 1517 1519 O
this NCT03920917 1520 1524 O
clinical NCT03920917 1525 1533 O
study NCT03920917 1534 1539 O

Inclusion NCT03923205 0 9 O
Criteria NCT03923205 10 18 O
: NCT03923205 19 20 O

Healthy NCT03923205 22 29 B-Condition-Name
and NCT03923205 30 33 O
T NCT03923205 34 35 B-Condition-Name
2D NCT03923205 36 38 I-Condition-Name
( NCT03923205 39 40 O
controlled NCT03923205 41 51 O
by NCT03923205 52 54 O
diet NCT03923205 55 59 B-Procedure-Name
and NCT03923205 60 63 O
lifestyle NCT03923205 64 73 B-Observation-Name___Observation-Type-Value:social-habit
or NCT03923205 74 76 O
metformin NCT03923205 77 86 B-Drug-Name
) NCT03923205 87 88 O
volunteers NCT03923205 89 99 O
; NCT03923205 99 100 O
Age NCT03923205 101 104 O
18 NCT03923205 106 108 B-Eq-Value
+ NCT03923205 109 110 B-Eq-Operator___Eq-Operator-Value:GTEQ
; NCT03923205 111 112 O
males NCT03923205 113 118 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:male
and NCT03923205 119 122 O
females NCT03923205 123 130 B-Life-Stage-And-Gender___Life-Stage-And-Gender-Type:female
. NCT03923205 131 132 O

Exclusion NCT03923205 135 144 O
Criteria NCT03923205 145 153 O
: NCT03923205 154 155 O

For NCT03923205 157 160 O
the NCT03923205 161 164 O
healthy NCT03923205 165 172 B-Condition-Name
group NCT03923205 173 178 O
: NCT03923205 179 180 O

- NCT03923205 184 185 O
taking NCT03923205 187 193 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
prescribed NCT03923205 194 204 O
medication NCT03923205 205 215 O

- NCT03923205 218 219 O
HbA NCT03923205 221 224 B-Observation-Name___Observation-Type-Value:lab
1c NCT03923205 225 227 I-Observation-Name___Observation-Type-Value:lab
above NCT03923205 228 233 B-Eq-Operator___Eq-Operator-Value:GT
48 NCT03923205 235 237 B-Eq-Value
mmol NCT03923205 238 242 B-Eq-Unit
/ NCT03923205 243 244 O
mol NCT03923205 245 248 B-Eq-Unit
( NCT03923205 249 250 O
or NCT03923205 251 253 O
6.5 NCT03923205 255 258 B-Eq-Value
% NCT03923205 259 260 B-Eq-Unit
) NCT03923205 262 263 O

- NCT03923205 267 268 O
pregnant NCT03923205 270 278 B-Condition-Name
or NCT03923205 279 281 O
breastfeeding NCT03923205 282 295 B-Condition-Name

- NCT03923205 298 299 O
blood NCT03923205 301 306 B-Observation-Name___Observation-Type-Value:social-habit
donation NCT03923205 307 315 I-Observation-Name___Observation-Type-Value:social-habit
in NCT03923205 316 318 O
the NCT03923205 319 322 O
last NCT03923205 323 327 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03923205 328 333 B-Eq-Value
months NCT03923205 334 340 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03923205 343 344 O
unable NCT03923205 346 352 O
to NCT03923205 353 355 O
give NCT03923205 356 360 O
written NCT03923205 361 368 O
informed NCT03923205 369 377 O
consent NCT03923205 378 385 O

- NCT03923205 388 389 O
eating NCT03923205 391 397 B-Condition-Name
disorders NCT03923205 398 407 I-Condition-Name
such NCT03923205 408 412 O
as NCT03923205 413 415 O
anorexia NCT03923205 416 424 B-Condition-Name
, NCT03923205 425 426 O
bulimia NCT03923205 427 434 B-Condition-Name
, NCT03923205 435 436 O
binge NCT03923205 437 442 B-Condition-Name
eating NCT03923205 443 449 I-Condition-Name
or NCT03923205 450 452 O
night NCT03923205 453 458 B-Condition-Name
eating NCT03923205 459 465 I-Condition-Name
syndrome NCT03923205 466 474 I-Condition-Name
. NCT03923205 475 476 O

- NCT03923205 480 481 O
significant NCT03923205 483 494 B-Severity___Severity-Value:severe
health NCT03923205 495 501 O
issue NCT03923205 502 507 O

- NCT03923205 510 511 O
taking NCT03923205 513 519 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
vitamin NCT03923205 520 527 B-Drug-Name
or NCT03923205 528 530 O
mineral NCT03923205 531 538 B-Drug-Name
supplements NCT03923205 539 550 I-Drug-Name
( NCT03923205 551 552 O
unless NCT03923205 553 559 O
they NCT03923205 560 564 O
agree NCT03923205 565 570 O
to NCT03923205 571 573 O
discontinue NCT03923205 574 585 O
supplementation NCT03923205 586 601 B-Drug-Name
2 NCT03923205 603 604 B-Eq-Value
weeks NCT03923205 605 610 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
or NCT03923205 611 613 B-Eq-Operator___Eq-Operator-Value:GTEQ
more NCT03923205 614 618 I-Eq-Operator___Eq-Operator-Value:GTEQ
before NCT03923205 619 625 O
the NCT03923205 626 629 O
start NCT03923205 630 635 O
of NCT03923205 636 638 O
the NCT03923205 639 642 O
study NCT03923205 643 648 O
) NCT03923205 649 650 O

- NCT03923205 654 655 O
Food NCT03923205 657 661 B-Allergy-Name
allergies NCT03923205 662 671 O
/ NCT03923205 672 673 O
intolerances NCT03923205 674 686 B-Condition-Name

For NCT03923205 687 690 O
the NCT03923205 691 694 O
T NCT03923205 695 696 B-Condition-Name
2D NCT03923205 697 699 I-Condition-Name
groups NCT03923205 700 706 O
: NCT03923205 707 708 O

- NCT03923205 712 713 O
T NCT03923205 715 716 B-Condition-Name
2D NCT03923205 717 719 I-Condition-Name
controlled NCT03923205 720 730 O
by NCT03923205 731 733 O
medication NCT03923205 734 744 O
other NCT03923205 745 750 O
than NCT03923205 751 755 O
metformin NCT03923205 756 765 B-Drug-Name

- NCT03923205 768 769 O
pregnant NCT03923205 771 779 B-Condition-Name
or NCT03923205 780 782 O
breastfeeding NCT03923205 783 796 B-Condition-Name

- NCT03923205 799 800 O
blood NCT03923205 802 807 B-Observation-Name___Observation-Type-Value:social-habit
donation NCT03923205 808 816 I-Observation-Name___Observation-Type-Value:social-habit
in NCT03923205 817 819 O
the NCT03923205 820 823 O
last NCT03923205 824 828 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:past
three NCT03923205 829 834 B-Eq-Value
months NCT03923205 835 841 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:month

- NCT03923205 844 845 O
unable NCT03923205 847 853 O
to NCT03923205 854 856 O
give NCT03923205 857 861 O
written NCT03923205 862 869 O
informed NCT03923205 870 878 O
consent NCT03923205 879 886 O

- NCT03923205 889 890 O
eating NCT03923205 892 898 B-Condition-Name
disorders NCT03923205 899 908 I-Condition-Name
such NCT03923205 909 913 O
as NCT03923205 914 916 O
anorexia NCT03923205 917 925 B-Condition-Name
, NCT03923205 926 927 O
bulimia NCT03923205 928 935 B-Condition-Name
, NCT03923205 936 937 O
binge NCT03923205 938 943 B-Condition-Name
eating NCT03923205 944 950 I-Condition-Name
or NCT03923205 951 953 O
night NCT03923205 954 959 B-Condition-Name
eating NCT03923205 960 966 I-Condition-Name
syndrome NCT03923205 967 975 I-Condition-Name
. NCT03923205 976 977 O

- NCT03923205 981 982 O
any NCT03923205 984 987 O
other NCT03923205 988 993 O
significant NCT03923205 994 1005 B-Severity___Severity-Value:severe
health NCT03923205 1006 1012 O
issue NCT03923205 1013 1018 O
other NCT03923205 1019 1024 O
than NCT03923205 1025 1029 O
T NCT03923205 1030 1031 B-Condition-Name
2D NCT03923205 1032 1034 I-Condition-Name

- NCT03923205 1037 1038 O
taking NCT03923205 1040 1046 B-Eq-Temporal-Period___Eq-Temporal-Period-Value:present
vitamin NCT03923205 1047 1054 B-Drug-Name
or NCT03923205 1055 1057 O
mineral NCT03923205 1058 1065 B-Drug-Name
supplements NCT03923205 1066 1077 I-Drug-Name
( NCT03923205 1078 1079 O
unless NCT03923205 1080 1086 O
they NCT03923205 1087 1091 O
agree NCT03923205 1092 1097 O
to NCT03923205 1098 1100 O
discontinue NCT03923205 1101 1112 O
supplementation NCT03923205 1113 1128 B-Drug-Name
2 NCT03923205 1130 1131 B-Eq-Value
weeks NCT03923205 1132 1137 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:week
before NCT03923205 1138 1144 O
the NCT03923205 1145 1148 O
start NCT03923205 1149 1154 O
of NCT03923205 1155 1157 O
the NCT03923205 1158 1161 O
study NCT03923205 1162 1167 O
) NCT03923205 1168 1169 O

- NCT03923205 1173 1174 O
food NCT03923205 1176 1180 B-Allergy-Name
allergies NCT03923205 1181 1190 O
/ NCT03923205 1191 1192 O
intolerances NCT03923205 1193 1205 B-Condition-Name


Inclusion NCT03924973 0 9 O
Criteria NCT03924973 10 18 O
: NCT03924973 19 20 O

- NCT03924973 24 25 O
Inclusion NCT03924973 27 36 O
in NCT03924973 37 39 O
the NCT03924973 40 43 O
initial NCT03924973 44 51 O
IDEA NCT03924973 52 56 O
trail NCT03924973 57 62 O

- NCT03924973 65 66 O
Requiring NCT03924973 68 77 O
less NCT03924973 78 82 B-Eq-Operator___Eq-Operator-Value:LT
than NCT03924973 83 87 I-Eq-Operator___Eq-Operator-Value:LT
40 NCT03924973 89 91 B-Eq-Value
minutes NCT03924973 92 99 B-Eq-Temporal-Unit___Eq-Temporal-Unit-Value:minute
travel NCT03924973 100 106 B-Observation-Name
to NCT03924973 107 109 O
the NCT03924973 110 113 O
assessment NCT03924973 114 124 B-Location
center NCT03924973 125 131 I-Location

Exclusion NCT03924973 132 141 O
Criteria NCT03924973 142 150 O
: NCT03924973 151 152 O

- NCT03924973 156 157 O
Impossibility NCT03924973 159 172 O
of NCT03924973 173 175 O
coming NCT03924973 176 182 B-Observation-Name
in NCT03924973 183 185 I-Observation-Name
for NCT03924973 186 189 O
assessment NCT03924973 190 200 B-Procedure-Name

- NCT03924973 203 204 O
Exclusion NCT03924973 206 215 O
from NCT03924973 216 220 O
IDEA NCT03924973 221 225 O

